<SEC-DOCUMENT>0000950170-25-036823.txt : 20250311
<SEC-HEADER>0000950170-25-036823.hdr.sgml : 20250311
<ACCEPTANCE-DATETIME>20250311071816
ACCESSION NUMBER:		0000950170-25-036823
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		111
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250311
DATE AS OF CHANGE:		20250311

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Q32 Bio Inc.
		CENTRAL INDEX KEY:			0001661998
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				473468154
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38433
		FILM NUMBER:		25725849

	BUSINESS ADDRESS:	
		STREET 1:		830 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		781-999-0232

	MAIL ADDRESS:	
		STREET 1:		830 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Homology Medicines, Inc.
		DATE OF NAME CHANGE:	20151228
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>qttb-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-10T15:13:32.1592+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:qttb="http://www.q32bio.com/20241231" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_9cfbe1f8-5f8f-41d0-b3db-4798c26e5880" name="dei:DocumentFiscalPeriodFocus" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4">FY</ix:nonNumeric><ix:nonNumeric id="F_578c6acd-83ad-45ff-8794-1ccd67233baf" name="dei:CurrentFiscalYearEndDate" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" format="ixt:date-month-day">12-31</ix:nonNumeric><ix:nonNumeric id="F_776eeb8c-fd57-4258-935e-ce8e81fd9305" name="dei:AmendmentFlag" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric id="F_9fa94d41-e9a3-4418-8238-b9101b45bc6c" name="dei:EntityCentralIndexKey" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4">0001661998</ix:nonNumeric><ix:nonNumeric id="F_6994ebc2-a8e4-4d70-b9c8-221efdc299c3" name="dei:EntityWellKnownSeasonedIssuer" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4">No</ix:nonNumeric><ix:nonNumeric id="F_1e63f389-cf78-44fa-a0c8-964947c90695" name="dei:EntityVoluntaryFilers" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4">Yes</ix:nonNumeric><ix:nonNumeric id="F_4ca2bbca-c47f-48be-bdab-b2587e4a03f9" name="dei:EntityCurrentReportingStatus" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4">Yes</ix:nonNumeric><ix:nonNumeric id="F_693f647c-0866-4ea0-a41f-1b369dedf0a1" name="dei:EntityInteractiveDataCurrent" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4">Yes</ix:nonNumeric><ix:nonFraction id="F_af1eeaf7-a09a-4e74-921e-8ff968478338" name="us-gaap:CommitmentsAndContingencies" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_ac451028-dcee-467f-94e3-aef335ebd430" name="us-gaap:CommitmentsAndContingencies" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_4b3c95c9-00db-4ff5-871a-392543c3c948" name="us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" contextRef="C_5062bd0a-61c4-478f-887d-27fbcabc427e">http://www.q32bio.com/20241231#LeaseholdImprovements</ix:nonNumeric><ix:nonNumeric id="F_a45e6167-40b6-49f4-9625-e8ce6cbfd3a5" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79">http://www.q32bio.com/20241231#AccruedExpensesAndOtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric id="F_cb90d7dd-2025-4f37-8452-ccbb5dfb30b4" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3">http://www.q32bio.com/20241231#AccruedExpensesAndOtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric id="F_a1c527db-8fab-40c5-be93-17f92684f3c3" name="us-gaap:LeaseExpirationDate1" contextRef="C_a0bd1a63-9f30-4e12-871d-7a9578431c43" format="ixt:date-year-month-day">2031/12/31</ix:nonNumeric><ix:nonFraction id="F_e5dd5eea-55d7-4cae-a2e1-4551e45e0690" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" unitRef="U_shares" xsi:nil="true"></ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="qttb-20241231.xsd"/></ix:references><ix:resources><xbrli:context id="C_81e3e422-e365-4f92-a2df-f3bed9e3c0f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_82ffbe69-bdc0-46ed-85f6-2f2135943e2a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_854a149a-1eef-4a0c-9335-f2a517e54274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">qttb:WalthamMassauchetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_85eed7d4-bc70-4689-9015-4f85ad5cfc18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8a29bb8f-c595-4983-9066-bd39e268ab4c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8aa53aac-d504-4db3-8d89-b2114c402b69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:BempikibartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8b219b81-3c35-41c8-a792-9c9b2b87e1e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-12</xbrli:startDate><xbrli:endDate>2023-07-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8cb16126-e20f-478a-92f3-f4ef3f29dcee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:EighthAmendmentToTheLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8e0c7ce3-b7e7-477e-b694-44fd0989eef1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_99f336ed-ce75-4357-a041-46da4ea43896"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-05</xbrli:startDate><xbrli:endDate>2022-08-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9f64b245-b6aa-4495-a613-76961dbfa794"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a0bd1a63-9f30-4e12-871d-7a9578431c43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a3049491-9ddc-4b12-9eb9-4faf6e1e2fec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">qttb:WalthamMassauchetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">qttb:RestrictedCashAndCashEquivalentsNonCurrentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a37febd5-2c47-4a82-98a5-85fdad081713"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a865d4dd-0f4a-4429-92aa-0aae67bd396c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aab7e459-1871-48ff-b109-9c732f133214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ad732baa-4828-4c30-98cf-2d02dbdb87b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_afa19969-608f-48e9-9aca-73182815530d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b2dac488-8c36-4522-ba90-ecd7c08b1ede"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b2f6b4cb-fe35-486b-9f70-f7fd1fa0f798"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b39ec590-34ba-4ee9-954b-860129dbb68c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b5225717-0e5a-4c67-907b-047d72ad665b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b555dfd2-6633-4e32-b92f-2a1f6100178b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithTheUniversityOfColoradoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b56ad3a0-64a3-4549-bf92-0952e7e3df5b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b58f761f-bef4-4b59-803e-8a93d0543c79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b5c40c56-08b5-4a22-b751-a8f232a74aca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b8978390-12c0-4352-9c18-d59c00c5a494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bb6c3e3c-07de-46ab-8b95-1ab3fb082d09"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bdaefca0-fea1-4732-b40e-bf35def7a224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bdd74796-2135-43f6-a03b-39e6bd90c9b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be2666e6-1b34-4583-add6-12ea7a5cce3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bf697f63-fffd-47b1-a9e7-28e55b7595fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SeventhAmendmentToTheLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-02</xbrli:startDate><xbrli:endDate>2023-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c11e5447-4a20-4d83-b060-fbc22d8f5724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c18fd5f0-cb42-4f14-9f5c-4fb10a0505bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c38a2141-3bcb-42d1-8a58-cef5d94d0819"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3c34d76-204f-422a-8542-9570869264f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c58e837a-179e-40c1-aa34-7a9794f2d652"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c73c0232-3eb2-4afd-9b9d-d70bdfd8a5f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">qttb:MeasurementInputProbabilityOfEachScenarioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c8e96e70-b220-40a4-8caa-3388400e3cae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c8ee0693-2174-48d4-893c-58e9b89264b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c995ff6f-a52c-4c87-a8d6-71a52474fd48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca4b638b-76d0-401e-9369-6f2d51d1cb2f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">qttb:HomologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb1dbfd4-a164-4593-8d87-17d41a661f8b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">qttb:ConsultingAndAdvisoryAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cbe1c2b6-e46f-4db2-a96d-16d62994fde1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesARedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cc753916-5b65-451d-90ed-193a32758aa9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cd0b4904-8ce8-4c84-a53a-8d845df8dc43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cd782b8d-e977-40bc-a2ef-507ab008dfca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-20</xbrli:startDate><xbrli:endDate>2022-05-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cda9fef4-e02f-4ed8-8897-35539a06a8b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ce9f954b-cafc-43d9-af6e-e2bba9ac13af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cec18033-5a14-4ccd-b752-d0126402b130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cf98c657-870f-4570-8592-2aff0b91640f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">qttb:SalesBasedMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:HorizonCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cfdb4851-27cb-4dd2-a181-f26f91524080"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="qttb:TrancheAxis">qttb:TrancheThreeMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d1e4c313-5593-44fa-8319-69d7287a8c1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeFirstOfJulyTwoThousandAndTwentyFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d3e98f3d-7cf9-4d47-9a53-26eaa914cc76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d5a319e9-4550-4a20-9794-c5a7a6ad12aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-25</xbrli:startDate><xbrli:endDate>2025-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d63b5539-4625-4fac-978b-86e1f8037d8e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d6eb1df1-653a-48d1-820d-e7936097d20b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d70d9c60-682f-4b4c-8180-b6b1535a6f0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="qttb:TrancheAxis">qttb:TrancheThreeMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_da508a90-18ff-4feb-864f-c062a92713e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-19</xbrli:startDate><xbrli:endDate>2024-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_db8118be-101e-441a-a13b-f4b57e3c5a64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df3c79d3-1293-482f-9102-cd57669625a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e0d1d750-c63b-49fa-8efe-0c104dbe276f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e112c2ce-ff85-4995-a056-7c0f11496a6f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SeventhAmendmentToTheLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e26a9287-f885-4441-9d0e-9148098a8888"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e48e03f7-6e15-41e5-8e77-78e73c096383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e59a1e86-c7f5-494a-9d42-f6faee31d00f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-15</xbrli:startDate><xbrli:endDate>2024-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e5fdb991-d520-4075-b2d8-b05c3d677e35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eac1650d-1927-493f-a242-2bc1e837c904"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ec27399a-2953-4340-94d1-aa507faddcf4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_edd2dd2b-4bf5-49ec-8e4a-ca61edc70f98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-23</xbrli:startDate><xbrli:endDate>2025-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f0a36e6a-206a-49c7-88ab-7db254725cf3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f316cace-cb53-4a10-84c5-1335a8b032e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f497268d-14c0-4133-8bfb-04326a1ba996"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f5ea5ca1-ed8b-413d-bbea-b4a5e23ee94a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-25</xbrli:startDate><xbrli:endDate>2025-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f6927f9d-eca2-421d-8a4f-efa4995457ae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-15</xbrli:startDate><xbrli:endDate>2024-03-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">qttb:WalthamMassauchetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f94caa77-06ab-4033-aaf4-c31aca13beda"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fdc54320-1c67-4e15-8365-d084e65e9e52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_00125eea-3c46-4a9a-8949-a3a86ae55b5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_012ce485-8c2e-404f-b146-20b8651d7c1b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandSeventeenStockOptionAndGrantPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_01c6b47c-31c0-4923-b0b0-6e5450394be0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-11-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_01f11a58-84ba-4030-8559-1f45b7816019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_02ecb717-f14e-405e-8487-adc80c2116b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_05094c91-23e2-4d70-8075-18f488df283f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0679ebcb-aaa9-4d96-a6a8-350341c1609b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0708f559-d98c-480b-8223-bba4a0a87863"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">qttb:OxbSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_09d4667e-d0d3-40c4-96f5-1346195ceecb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithTheUniversityOfColoradoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09e3fcc5-c0b6-4005-8960-a3541b369346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0beb16c7-e3a6-42dc-8c19-40c1f98d5c9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0e4b5ed3-9477-4f24-a78d-80cd55c51631"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1080c6e9-b757-4406-9324-738d36ed0c95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_130917d7-9d2c-4093-8e70-15724bdc27cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:HorizonCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_13bab75d-170f-40f3-93c6-4fd2884489bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_13ef4388-e7d7-4520-984c-b50faaa55355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_15a4f89a-2a77-4b59-9f76-99dff39d02e8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_186a100e-16ef-48da-90b9-7456802bc057"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1a893f00-2a32-48ba-a06a-042beb70f237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1ae14b8d-dea6-450a-bd61-6382bf1f8395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1ec25630-4304-4291-a5ab-390b64487da5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1f079b94-52d3-4513-9e59-1f9abf527de4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2018c79e-e353-411e-9686-5d75f0b411cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:ADXZeroNineSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_20e3aba0-5377-41a2-bf8e-222ee59cf7b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21aa18f8-fcb9-4858-ab9d-ae3b4a5f7444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_223d39dc-f768-49d4-88fb-37a27c35a8a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_24eebe14-f497-4909-b6f9-5294ab34c796"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:ADXZeroNineSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2636fb0b-847b-44cc-8769-e36df6784f40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2747d7eb-c32e-4ac2-b584-639f88844157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_29d5eced-fc9f-4f1c-ae83-4350d8af4754"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2ac02e70-62cb-4d11-bf94-77b56c0a5fb8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:DiscoveryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2aef5253-5673-488f-b176-618a6a1a9ffa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">qttb:MeasurementInputProbabilityOfEachScenarioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2b84e1db-55c0-4034-aafc-134bb2bada3d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2f4b5de3-a9e7-4c16-bcfe-43adba24582e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-10</xbrli:startDate><xbrli:endDate>2025-02-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2f60cbad-ab1b-4beb-9829-e1cf73ad1860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2f8c0c8d-9454-4f58-ba8a-5a0c25ee32f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_302992f5-5a2f-4079-b1ae-a9f51ed191d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31964b05-1da6-44db-b544-4f27ff581508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3543f0be-6692-47f6-a4e8-a5c6d56417eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:ChangeDuringPeriodFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_354585ed-60d7-4f70-a77e-d50cc01415c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-25</xbrli:startDate><xbrli:endDate>2025-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_36984301-045f-4eac-9a05-c4a64d0c8422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_36ec1662-19ea-4f36-95c0-480643ad7851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:EighthAmendmentToTheLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_36fe52b2-0dba-48bb-aaf0-4023627944b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_370a860c-228f-4147-bdf4-dcb48b39a303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_37196b4a-4692-492f-b903-2a6e19a6a232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_37c8672c-5d7c-4a2e-802c-2bb52b924851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">qttb:MeasurementInputProbabilityOfEachScenarioMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_385a8942-b234-40ba-9087-cb65594b34d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_393ed9e3-2fa2-4a7b-b49b-0b0d93cbf89e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">qttb:RestrictedCashNonCurrentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3e39319d-0b8a-4d79-9a97-72ff6fa10227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">qttb:ConsultingAndAdvisoryAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4260d2af-256d-45f6-b503-aace9db4b45f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_42dc6c69-0cf8-467e-b208-73239c144b07"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_440034cc-e9c7-4544-91a9-9d19b1167f0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-11</xbrli:startDate><xbrli:endDate>2020-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_44dc2e47-aa49-4844-acd8-9cb650ca6caf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_482f7b29-7345-4d72-8fd8-5f3199ef1c23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_49e1f5d1-7824-4873-b567-c71038b76681"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4a20caa7-c241-467a-98e1-fba745a92230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a798c23-fd95-415f-8bab-1a4a602a0895"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">qttb:HomologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-25</xbrli:startDate><xbrli:endDate>2024-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a91fccb-1956-4e07-b38a-1f2ba2811311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b875fb6-8c1f-48c4-8ed9-bb8c9bf74e9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:BempikibartMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">qttb:LegacyQ32Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c2e3250-49a3-4f3c-9ba7-60f0718101be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c584b28-2bfc-476b-9e14-f321da0f4ddb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c7a1808-d8e4-4443-87ff-8a728e83b4d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">qttb:ConsultingAndAdvisoryAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4cbc437d-5afa-447b-9f58-e212caafd669"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4d576cb9-10b9-46a1-bca3-697ecd9396be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">qttb:ConsultingAndAdvisoryAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4de6188d-bc41-4c0b-986d-59e12a08b2a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4ea385ae-a09a-44a7-ba4f-9e1d5dfc76b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5062bd0a-61c4-478f-887d-27fbcabc427e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50665618-c890-4c3e-9bd9-6c41d79b5f14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_53138904-18f8-426d-9bb6-72a8e8db3721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">qttb:WalthamMassauchetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_538446b8-7409-4894-a71d-dabb73e1ef55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_53fa66be-5ca3-40fc-8c45-f08ab061bfff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_548856aa-e248-42ff-bd02-f8b3fa277e06"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="qttb:TrancheAxis">qttb:TrancheTwoMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56ea366c-6225-4b69-bccd-5ec940307d3b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_57c23963-7764-4e09-9834-07d94af003db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourStockOptionAndIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58806157-945d-4f05-9b65-2c51d8ce8b75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5a0e9c05-aa5e-42de-ac3a-a0fb7d656d48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5d6ee64c-bb12-4d4b-a81c-6f731ee26fbf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5d9c9fa2-97d6-4b1c-b918-3a60f9e20e25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">qttb:CurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5dad7a66-e70c-49a5-aa41-6710e38a1a05"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5e588eaa-63cf-4ef1-8b8e-0d333a72ff23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f1339d1-c9c7-4c62-85fe-43ee887e097f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">qttb:OxbSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f18540e-b79b-4adf-83b8-c467b6d3c37d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_60e298bc-492e-4648-ae4c-77f0946662a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_61d6fc78-c8ec-418e-a4dc-fcee1281ac6c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_62c12364-19f9-412d-b7a5-93a8a2255606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_63d3da21-2d2f-4d33-8fc7-fd05ece7069d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_64e18bd2-6e71-4f81-8713-6d9b2f8a6ed2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_65695aa9-2863-4310-b8da-f3be3d8e4280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-25</xbrli:startDate><xbrli:endDate>2025-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6881a1d6-1e0a-490c-8f2b-d88e0d5e92d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6a7ed391-5281-4830-b9f9-03de3a4d8b00"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:DiscoveryAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6acff699-1bcb-4e5c-83d0-0ecc48abc809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6b897fb9-c5ec-48c3-9610-95cfe8b4cd07"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6d5ea821-818d-4edc-977d-9c88e7922cd7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6e7474c2-50c6-4141-93a0-c56ced950809"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6f68a357-a32f-44ae-979a-875bc449d3b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_71403a30-e992-4c00-b708-e2cd6dde2a39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-25</xbrli:startDate><xbrli:endDate>2025-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7173717f-2d2d-4169-9a96-9df1da9fef47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithTheUniversityOfColoradoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_742e9ad2-7322-4178-acf9-30981e53d1af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="qttb:TrancheAxis">qttb:TrancheTwoMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_75a6ef14-59cd-493d-a00e-544f5be1fdf1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7794054f-4239-439e-b660-23e5bc99154a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_79b9f15f-c77c-4650-8ec5-e400e55b0820"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_79f15b34-ea52-436c-a16f-c67bd97ffb1d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-21</xbrli:startDate><xbrli:endDate>2022-12-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7a96c710-1576-4302-aade-91b06ff915be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7bb2bb04-b139-49f5-801e-31f1d770bc43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7cdabbbf-9d0e-48aa-9f1d-1c17d1a6755a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7d9baed7-c6de-4298-867d-06f8f3ee91b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7ec0ac51-4871-4881-a34d-77b8a09d8ea0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7f47faa6-d3bb-45d0-9ae1-b46cda818a27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">qttb:HomologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7f536b74-399c-4e82-9152-d5daf6993f87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7fe7497c-530e-4a3f-be8e-af26a160d3fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001661998</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-23</xbrli:startDate><xbrli:endDate>2022-12-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_b499c890-2785-42b0-a234-7b2081cf5a95" fromRefs="F_11ae9ab9-bffd-4d14-b07e-d75b947ac16f F_bc6b58cf-984e-43a1-9d3e-ec625096065d"/></ix:resources></ix:header></div>
  <div style="padding-top:0.35in;z-index:-3;min-height:0.35in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="border-top:1.5pt double;padding-top:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:2.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a414a837-051a-4a6d-9f98-f5398f57eca4" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:2.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Mark One)</span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:96%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_d656e3b7-9856-4889-ba3c-f875636664a7" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4149ddd3-12fb-4d33-9438-716aa76162a5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b8756ead-01aa-48a5-8016-eb0c41d7e74a" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:DocumentFiscalYearFocus"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OR</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4%;box-sizing:content-box;"/>
    <td style="width:96%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_595c7faa-7c4e-4555-9d50-13e2f2ca082e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:9pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the transition period from _________________ to _________________</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File Number: </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1216cf62-8488-4a17-bf29-017f585b1229" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">001-38433</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:20pt;font-family:Times New Roman;"><ix:nonNumeric id="F_eaf358bc-b6d1-43ad-97ab-067cf7aa1bdd" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:20pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 Bio Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as specified in its Charter)</span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"/>
    <td style="width:50%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_c6b5a7bf-4a42-4129-aacd-6469e81ea8fe" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_cc0a4f41-ff85-457a-b16c-e3b811123984" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">47-3468154</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(I.R.S. Employer</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
   <tr style="height:9pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_7584d0bc-e6a7-4bd3-b7de-ad6cadf09a8f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">830 Winter Street</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_8c741b30-9bd1-4c88-bc49-317210c3cdbc" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Waltham</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;"><ix:nonNumeric id="F_1f04a78d-d99e-4291-8a79-1e104f2054ce" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">MA</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_e158c08b-c628-426d-a2cd-6476e26989e0" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">02451</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registrant&#8217;s telephone number, including area code: (</span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_30bc9ca2-7cf2-4615-bdda-d7de22d94eb2" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">781</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b2115229-71df-4a76-9f30-c0474028a832" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">999-0232</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:38%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:15%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:45%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of each class</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading</span></p><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Symbol(s)</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:7pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_028c41ac-920f-4cc1-97eb-b2fa22e438f3" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock, par value $0.0001 per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_7f7697d9-6f31-48e6-9721-60a1d2363ec0" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">QTTB</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:8pt;"><ix:nonNumeric id="F_85be0b74-4b92-4f23-8886-376d28dcc279" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     </span><span style="font-size:8pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6994ebc2-a8e4-4d70-b9c8-221efdc299c3;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NO</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  </span><span style="font-size:8pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1e63f389-cf78-44fa-a0c8-964947c90695;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">YES </span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     NO </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="font-size:8pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_4ca2bbca-c47f-48be-bdab-b2587e4a03f9;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">YES</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     NO </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).  </span><span style="font-size:8pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_693f647c-0866-4ea0-a41f-1b369dedf0a1;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">YES</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     NO </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:18.9%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:55.84%;box-sizing:content-box;"/>
    <td style="width:1.06%;box-sizing:content-box;"/>
    <td style="width:20.1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:2.1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;"><ix:nonNumeric id="F_15c7fce3-8ccd-4a1c-922c-f0e5742cb406" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_d6fdf467-499c-424a-bf84-af41e2ebb862" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_b8a2e11b-8729-469c-994b-252280328775" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </span><span style="font-size:7pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_212545f6-87f8-479b-8a90-c2d448835ae1" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-size:7pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.  </span><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_5ed79d7e-f93a-41e6-871e-58980843a3b3" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).  </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  YES </span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     NO </span><span style="font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;"><ix:nonNumeric id="F_b0311362-009f-43fd-9bdc-24077e074c42" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant, based on the closing price of the shares of common stock on The Nasdaq Global Market on June 30, 2024, the last business day of the Registrant&#8217;s most recently completed second fiscal quarter, was approximately $</span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a7651cd-9527-4f51-9ab9-fb8cf698271a" contextRef="C_0e4b5ed3-9477-4f24-a78d-80cd55c51631" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">136.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The number of shares of Registrant&#8217;s common stock, par value $0.0001 per share, outstanding as of March 3, 2025 was </span><span style="font-size:8pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03b79603-40f4-4bf4-abf4-e40292a5647a" contextRef="C_05094c91-23e2-4d70-8075-18f488df283f" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">12,197,615</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <div style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bb22069c-7845-48f1-b250-c8c7930f76ba" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain portions of the information required to be furnished pursuant to Part III of this Annual Report on Form 10-K will be set forth in, and incorporated by reference from, the Registrant&#8217;s definitive proxy statement for the annual meeting of stockholders or an amendment to this Annual Report on Form 10-K which will be filed with the Securities and Exchange Commission no later than 120 days after the end of the fiscal year ended December 31, 2024.</span></p></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Auditor Firm Id: </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8dca468f-d969-4622-9bb0-0e8040e24b67" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:AuditorFirmId"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">					</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Auditor Name: </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d180beb4-f6b5-4262-826d-8626addcab59" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:AuditorName"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ernst &amp; Young LLP</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">				</span><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Auditor Location: </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_85e29998-e432-4ee9-b82b-cae15ddac35b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="dei:AuditorLocation"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Boston, Massachusetts, USA</span></ix:nonNumeric></span></p>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1.5pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:4pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.35in;min-height:0.28in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Table of Contents</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:81.92%;box-sizing:content-box;"/>
    <td style="width:7.08%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART I</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1_business"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Business</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1a_risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 1C.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_1c_cybersecurity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Cybersecurity</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 2.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_2_properties"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Properties</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 3.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_3_legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 4.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART II</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 5.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_5_market_for_registrants_common_e"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 6.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_6__reserved"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">[Reserved]</span></a><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7_mda"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">82</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_7a_quantitative_and_qualitative_dis"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">98</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 8.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_8_financial_statements_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9_changes_in_and_disagreements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9a_controls_and_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9b_other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 9C.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign_jur"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART III</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 10.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_10_directors_executive_officers_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 11.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_11_executive_compensatio"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 12.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_12_security_ownership_of_certain_b"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 13.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_13_certain_relationships_and"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 14.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_14_principal_accounting_fees"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Principal Accounting Fees and Services</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101</span></p></td>
   </tr>
   <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PART IV</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 15.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_15_exhibits_financial_statement"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits, Financial Statement Schedules</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">102</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:6.85pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:6.85pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Item 16.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#item_16_form_10_k_summary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">i</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report on Form 10-K contains statements that are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements include, but are not limited to, statements regarding our or our management team&#8217;s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Annual Report on Form 10-K may include, for example, statements about:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to achieve and sustain profitability in the future;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our strategies, prospects, plans, expectations or objectives of management for our future operations;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">estimates of our future expenses, revenues, capital requirements, and our needs for additional financing;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our estimates of and anticipated use of our existing cash, cash equivalents and marketable securities;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the progress, scope or timing of the development of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our expectations surrounding the potential safety, efficacy, and regulatory and clinical progress of our product candidates, including bempikibart, and our anticipated milestones and timing therefor;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain and maintain regulatory approval of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to achieve and maintain market acceptance and adoption of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the benefits that may be derived from any of our future products or the commercial or market opportunity with respect to any of our future products;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to maintain patent protection for our product candidates and protect our intellectual property rights;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to successfully compete against other companies developing similar products to ours;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our anticipated operations, financial position, ability to raise capital to fund our operations, revenues, costs or expenses;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to evaluate and execute on strategic options for our tissue-targeted complement inhibitor platform, inclusive of ADX-097 and early-stage assets;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to implement and achieve cost savings in connection with the strategic restructuring plan, including the reduction in force;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to retain our key executives and to attract and retain highly qualified personnel;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to successfully protect against cyber-attacks, security breaches and other disruptions to our information technology systems;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish and maintain an effective system of internal controls over financial reporting;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the effect of uncertainties related to economic downturns, public health crises, and other macroeconomic conditions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our reliance on third parties in the supply and manufacture of our product candidates;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of applicable laws and regulations, whether in the U.S. or foreign jurisdictions, and any changes thereto;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the statements regarding our future economic conditions or performance, statements of belief and any statement of assumptions underlying any of the foregoing; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">other risks and uncertainties, including those listed under the caption &#8220;Risk Factors.&#8221;</span></div></div>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These forward-looking statements are based on information available to us at the time of this Annual Report on Form 10-K and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and except as otherwise required by applicable law, we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The outcome of the events described in these forward-looking statements is subject to known and unknown risks, uncertainties, and other factors. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements, including those set forth in this Annual Report on Form 10-K in the section titled &#8220;Risk Factors&#8221; and in our periodic filings with the SEC. Our SEC filings are available publicly on the SEC&#8217;s website at www.sec.gov. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. Should one or more of the risks or uncertainties described in this Annual Report on Form 10-K, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ii</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Annual Report on Form 10-K includes statistical and other industry and market data that we obtained from industry publications and research, surveys and studies conducted by third parties. Industry publications and third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. We are responsible for all of the disclosure contained in this Annual Report on Form 10-K, and we believe these industry publications and third-party research, surveys and studies are reliable.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iii</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SUMMARY OF MATERIAL RISKS ASSOCIATED WITH OUR BUSINESS</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to implement our business strategy is subject to numerous risks that you should be aware of before making an investment decision. These risks include the following, among others:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant losses since inception, expect to incur significant losses for the foreseeable future and may not be able to achieve or sustain profitability in the future. We have no products for sale, have not generated any product revenue and may never generate product revenue or become profitable.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will require substantial additional capital to finance our operations in the future. If we are unable to raise such capital when needed, or on acceptable terms, we may be forced to delay, reduce or eliminate clinical trials, product development programs or future commercialization efforts.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have a limited operating history and have no products approved for commercial sale, which may make it difficult for you to evaluate our current business and likelihood of success and viability.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face competition from entities that have developed or may develop programs for the diseases we plan to address with bempikibart or other product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart and the rest of our pipeline are in early stages of development and may fail in development or suffer delays that materially and adversely affect their commercial viability. If we or our current or future collaborators are unable to complete development of, or commercialize, our product candidates, or experience significant delays in doing so, our business will be materially harmed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our strategic refocus and the associated workforce reduction announced in February 2025 may not result in anticipated cost savings, could result in total costs and expenses that are greater than expected and could disrupt our business.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are substantially dependent on the success of our most advanced product candidate, bempikibart, and our clinical trials of our lead candidate may not be successful.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our rights to develop and commercialize our product candidates are, and in the future may be, subject to the terms and conditions of licenses granted to us by others. If we fail to comply with our obligations in the agreements under which we license intellectual property rights from third parties, or these agreements are terminated, or we otherwise experience disruption to our business relationships with our licensors, we could lose license rights that are important to our business.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to protect our patents and other proprietary rights is uncertain, exposing us to the possible loss of competitive advantage.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our quarterly and annual operating results may fluctuate in the future. As a result, we may fail to meet or exceed the expectations of research analysts or investors, which could cause our stock price to decline and negatively impact our financing or funding ability, as well as negatively impact our ability to exist as a standalone company.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to attract and retain qualified key management and scientists, staff, consultants and advisors, our ability to implement our business plan may be adversely affected.</span></div></div>
  <p style="text-indent:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:'Segoe UI',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The summary risk factors described above should be read together with the text of the full risk factors below in the section titled &#8220;Risk Factors&#8221; and the other information set forth in this Annual Report on Form 10-K, or Form 10-K, including our consolidated financial statements and the related notes, as well as in other documents that we file with the U.S. Securities and Exchange Commission, or SEC. The risks summarized above or described in full below are not the only risks that we face. Additional risks and uncertainties not precisely known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition, results of operations, and future growth prospects.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">iv</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RT I</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1_business"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1. B</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">usiness.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Merger with Homology</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 25, 2024, Q32 Bio Inc., a Delaware corporation (previously named Homology Medicines, Inc., a Delaware corporation and our predecessor company, or Homology), consummated the previously announced merger pursuant to the terms of the Agreement and Plan of Merger, dated as of November 16, 2023, or the Merger Agreement, by and among Homology, Kenobi Merger Sub, Inc., or Merger Sub, and Q32 Bio Operations Inc. (previously named Q32 Bio Inc.), or Legacy Q32.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Merger Agreement, on the Closing Date, (i) Homology effected a reverse stock split of Homology&#8217;s issued common stock at a ratio of 1:18, or the Reverse Stock Split, (ii) Homology changed its name to &#8220;Q32 Bio Inc.,&#8221; and (iii) Merger Sub merged with and into Legacy Q32, or the Merger, with Legacy Q32 as the surviving company in the Merger and, after giving effect to such Merger, Legacy Q32 becoming a wholly-owned subsidiary of Q32 Bio Inc., or together with its consolidated subsidiaries, Q32, the Company, we or us. As of the open of trading on March 26, 2024, our common stock began trading on the Nasdaq Global Market, or Nasdaq, under the symbol &#8220;QTTB.&#8221;</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. To achieve this goal of restoring homeostasis to a dysregulated immune system, we are advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive and innate immunity. The adaptive immune system is largely composed of T- and B-cell mediated cellular and antibody responses; while the innate immune system is a first line of defense employing leukocytes such as monocytes, macrophages, neutrophils, dendritic cells and natural killer cells that are responsible for clearing pathogens and cellular debris, and modulating T- and B-cell function. We believe that targeting these key pathways of immune dysregulation in autoimmune and inflammatory diseases will deliver therapeutics for indications with clear unmet medical need in the near term, while enabling us to build a broad and diverse pipeline in the long term. We have multiple product candidates across a variety of autoimmune and inflammatory diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart (ADX-914), our most advanced product candidate, is a fully human anti&#8211;interleukin-7 receptor alpha, or IL-7R&#945;, antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7, or IL-7, and thymic stromal lymphopoietin, or TSLP. We have completed two Phase 2a clinical trials evaluating bempikibart; SIGNAL-AA for the treatment of alopecia areata, or AA, and SIGNAL-AD for the treatment of atopic dermatitis, or AD.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 10, 2024, we announced topline results from both of these trials, as well as our intention to advance bempikibart for the treatment of AA and enroll patients into Part B of the SIGNAL-AA trial in the first half of 2025. Patients in the SIGNAL Phase 2a clinical trials were dosed with 200mg subcutaneous, or SC, bempikibart every two weeks. In the SIGNAL-AA trial, 44 patients with severe and very severe AA were enrolled. Patients were dosed for 24 weeks and followed for an additional 12 weeks off-treatment. At the 24-week endpoint, we observed more hair regrowth compared to placebo and evidence of durable responses in patients. The average hair regrowth across patients in the trial continued to improve from week 24 to week 36 despite patients being off therapy during the 12-week follow-up period. In AD, bempikibart was evaluated in two parts, Part A (15 patients) and Part B (106 patients). While encouraging results were seen in Part A, the primary endpoint was not met in Part B.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Across the trials, at the 200mg Phase 2a dose, we achieved our desired receptor occupancy, or RO, and observed favorable pharmacokinetics, or PK, / pharmacodynamic, or PD, properties, consistent with those from the Phase 1 clinical trial. Minimal anti-drug antibodies, or ADAs, were observed in the trials.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, across the two trials, we observed changes in biomarkers consistent with the IL-7R&#945; mechanism and activity mediated by both the TSLP and IL-7 receptors. In the SIGNAL-AD trial, we observed meaningful decreases in key Th2 biomarkers of TARC, IgE, and eosinophils, each of which were statistically significant at multiple timepoints suggestive of potent TSLP inhibition. In the SIGNAL-AA trial, we observed a CD3+ T cell decrease, which was also statistically significant at multiple timepoints, suggestive of potent IL-7 inhibition. These findings were consistent with expected target engagement and IL-7R&#945; blockade.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Across all clinical trials, bempikibart has been dosed in 130 patients to-date and has demonstrated a favorable safety and tolerability profile, with no Grade 3 or higher related adverse events. We plan to enroll approximately 20 additional AA patients through 36 weeks of treatment in a Part B expansion of the SIGNAL-AA Phase 2a clinical trial and report initial data from SIGNAL-AA Part B in the first half of 2026.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2025, we announced a corporate restructuring to focus on the advancement of bempikibart for the treatment of patients with AA.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADX-097, a Phase 2 asset and the lead product candidate from our complement inhibitor platform, is a humanized anti-C3d monoclonal antibody, or mAb, fusion protein. ADX-097 is designed to restore complement regulation&#8212;an integral part of the innate immune system&#8212;through a tissue-targeted mechanism. ADX-097 is designed to inhibit alternative pathway complement activation locally in diseased tissues where complement-mediated pathology is actively manifest. We believe ADX-097 has the potential to drive improved clinical activity and address the limitations of the currently available systemic approaches to complement inhibition, including infection risk and the need for high drug doses and frequent administration, to achieve therapeutic levels of inhibition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In preclinical studies, ADX-097 distributed to affected tissues/organs and demonstrated durable tissue PK and PD properties. We have completed a Phase 1 clinical trial of ADX-097 in healthy volunteers and observed circulating PK/PD consistent with preclinical studies, which established </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> integrity of ADX-097. ADX-097 was also shown to be well-tolerated and demonstrated minimal ADAs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional discovery and earlier development efforts from our complement inhibitor platform include ADX-096, a C3d mAb &#8211; CR1 fusion protein which demonstrated preclinical data supportive of its use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2025, we announced that we are discontinuing the Phase 2 renal basket clinical trial of ADX-097 and are evaluating strategic options for our tissue-targeted complement inhibitor platform, inclusive of ADX-097 and early-stage assets, to prioritize the clinical development of bempikibart.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our development pipeline is shown in the figure below.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 1: Our Development Pipeline.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img226925499_0.jpg" alt="img226925499_0.jpg" style="width:619px;height:253px;"/></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart (ADX-914)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our most advanced product candidate, bempikibart, is a fully human antibody anticipated to block IL-7- and TSLP-mediated signaling via their cognate receptors. Increased levels of IL-7 and TSLP are associated with inflammatory and autoimmune diseases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2023, Amgen Inc., or Amgen, completed the acquisition of Horizon Therapeutics public limited company, or Horizon plc. Following the acquisition, Legacy Q32 agreed with Amgen to mutually terminate the Collaboration and Option</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Agreement, or the Horizon Collaboration Agreement, and the Asset Purchase Agreement, or the Purchase Agreement, and together with the Horizon Collaboration Agreement, the Horizon Agreements, each between Legacy Q32 and Horizon Therapeutics Ireland DAC, or Horizon. In November 2023, Legacy Q32 entered into a termination agreement with Horizon, or the Horizon Termination Agreement, pursuant to which Horizon&#8217;s option to acquire the bempikibart program was terminated. As a result, Legacy Q32 retained the initial consideration and development funding received under the Horizon Collaboration Agreement and regained full development and commercial rights to bempikibart. In consideration for the Horizon Termination Agreement, Legacy Q32 agreed to pay Horizon regulatory and sales milestone payments of up to an aggregate amount of $75.1 million upon the first achievement of certain regulatory and sales milestones with respect to bempikibart. For more information see the section titled &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business&#8212;Collaboration and License Agreements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T cell pathology has been strongly implicated in AD and AA. Accumulating evidence suggests that multiple pathways are important in the pathogenesis of AD. This emerging view supports the belief that novel therapeutics, such as bempikibart, that more specifically address the underlying immune-phenotypic progression of the disease are needed. TH1 has long been implicated in the pathogenesis of AA supporting the potential for bempikibart to directly address the underlying driver of follicle damage and hair loss. In addition, given that AA is a disease often diagnosed in young adults, there is a critical need for effective novel treatments with a safety profile suitable for long-term, chronic treatment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We own and have in-licensed various patents, patent applications, know-how and trade secrets relating to the development and commercialization of our IL-7R&#945; -targeted antagonistic antibody therapy candidates and platform technologies. Patents that have issued or may issue in the future protect composition of the bempikibart product candidate to the beginning of 2040, and protect methods of use to 2044, excluding any patent term adjustments and/or any patent term extensions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have completed two Phase 2a clinical trials and intend to advance bempikibart for the treatment of AA in the Phase 2a Part B clinical trial.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADX-097</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADX-097 is an anti-C3d antibody linked to two moieties of a fragment of human factor H, or fH. C3d is a ubiquitous marker of complement activation, located adjacent to C3 convertase complexes. Factor H is an important negative regulator of the complement alternative pathway, or AP. While complement can be activated through three pathways, the AP is central to all because it amplifies signaling. This aspect of AP activation is commonly known as the &#8220;amplification loop&#8221; and is responsible for much of the damage observed in complement-mediated diseases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have evaluated ADX-097 in a Phase 1 clinical trial in healthy volunteers where we observed circulating PK/PD consistent with preclinical studies, which established </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> ADX-097 integrity and informed our dosing strategy for next stage clinical testing. In addition, no severe or serious AEs were reported and minimal ADAs were observed in this Phase 1 clinical trial.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These Phase 1 data and our preclinical studies have enabled targeted indication selection for our Phase 2 program as well as informed our key Phase 2 dose.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2025, we announced that we are discontinuing the Phase 2 renal basket clinical trial of ADX-097 and are evaluating strategic options for our tissue-targeted complement inhibitor platform, inclusive of ADX-097 and early-stage assets, to prioritize the clinical development of bempikibart.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that the tissue-directed approach to addressing complement dysregulation has the potential to drive improved efficacy and better safety across indications. This tissue directed AP approach also has the potential to avoid the additive infection risk associated with systemic complement treatments, which is of significant importance to patients where the underlying condition is marked by high mortality due to infection.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Complement activation is an essential part of innate and humoral immunity, and uncontrolled and sustained tissue complement activity plays a significant role in the pathogenesis of multiple human inflammatory and autoimmune diseases. The first approved complement inhibitor, eculizumab, targets C5 systemically, one of the effector arms of the complement pathway. The next generation of marketed and development stage complement therapeutics continue to rely on systemic complement blockade. While commercial and clinical success provide validation of complement as a therapeutic target, clinical experience reveals the inherent drawbacks of systemic inhibition as a therapeutic approach, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limited activity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> due to reliance on systemic blockade for control of complement dysregulation at the tissue level; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">high treatment burden</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including high doses and/or frequent administration due to high abundance and rapid turnover of most target complement proteins; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">infection risk</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> due to systemic blockade. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our aim is to solve for these inherent drawbacks with our proprietary approach designed to generate tissue targeted inhibitors of complement activation, which have the following advantages:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">enhanced activity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through tissue targeted inactivation of convertases directly at the site of destruction; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">convenient dosing</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with a subcutaneous route and weekly dosing, with potential for every 2 week dosing; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">improved risk/benefit profile</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> by maximizing therapeutic index while maintaining intact systemic immune surveillance. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We own various patents, patent applications, know-how and trade secrets relating to the development and commercialization of our targeted complement inhibitor candidates and platform technologies. Patents that have issued or may issue in the future protect composition of the ADX-097 complement product candidate to the end of 2039, and protect methods of use to the end of 2044, excluding any patent term adjustments and/or any patent term extensions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Team</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have assembled a team of industry-leading research, drug development, and operational experts, who have deep experience in advancing drug candidates in autoimmune and inflammatory diseases. The team is led by Jodie Morrison, our Chief Executive Officer, who brings extensive biopharma leadership experience from early stage through mid-size public biotech and pharmaceutical companies; Shelia Violette, Ph.D., Founder and Chief Scientific Officer, has more than 30 years of biotech experience in inflammatory and autoimmune diseases and served as an Entrepreneur in Residence at Atlas Venture; Jason Campagna, M.D., Ph.D., Chief Medical Officer, has more than 15 years of experience advancing all stages of clinical development pipelines; Lee Kalowski, President and Chief Financial Officer, has 20 years of life science industry experience and has previously served as CFO at multiple biotech companies and in equity research; and Saul Fink, Ph.D., Chief Technical Officer, has more than 25 years of experience leading manufacturing and nonclinical development of small molecules and biologics.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our company was built upon the discoveries and findings from renowned researchers in immunology: Michael Holers, M.D. and Joshua Thurman, M.D., from the University of Colorado and Stephen Tomlinson, Ph.D. from the Medical University of South Carolina. They are pioneers in the field of tissue targeted regulation of complement system.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are supported by leading biotechnology investors and pharmaceutical companies including OrbiMed, Atlas Venture, Abingworth, BMS, Acorn Bioventures, Osage University Partners, CU Healthcare Innovation Fund and Sanofi Ventures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Strategy</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our mission is to develop therapeutics that restore healthy immune regulation for patients with severe autoimmune and inflammatory diseases. Our strategic initiatives are to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advance bempikibart for the treatment of AA in the SIGNAL-AA Phase 2a Part A open-label extension (OLE)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We plan to initiate an open-label extension (OLE) following the same bempikibart dosing regimen leveraged in Part A to enable longer-term follow-up of patients and to further elucidate the durability of response and potential remittive effect. We plan to initiate the OLE in the first half of 2025;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advance bempikibart for the treatment of AA in the SIGNAL-AA Phase 2a Part B clinical trial. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We plan to enroll approximately 20 additional patients in a Part B expansion of the SIGNAL-AA Phase 2a clinical trial to further evaluate bempikibart in AA, with data expected in the first half of 2026;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Maximize value of ADX-097 and our tissue-targeted complement inhibitor platform.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> We believe that the tissue-directed approach to addressing complement dysregulation has the potential to drive improved efficacy and better safety across indications and we intend to maximize the value of ADX-097 and our tissue-targeted complement inhibitor platform as we evaluate our strategic options.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Programs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart in AA and AD</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart blocks both IL-7 and TSLP cytokine signaling pathways. IL-7 lowers the threshold needed for T cells to respond in low antigen microenvironments promoting pathogenic T-effector cell function, induces TH2 cell-mediated antibody production, and inhibits the immunosuppressive properties of T regulatory cells. When uncontrolled, IL-7 can promote inflammation and autoimmune disease. By blocking IL-7 signaling, we believe bempikibart has the potential to re-regulate immunity by rebalancing the T-effector / T-regulatory ratio to inhibit inflammation and invoke tolerance, and mitigating T-cell dependent autoantibody responses. TSLP is a cytokine that promotes TH2 cell differentiation and production of TH2 cytokines, such as IL-4, IL-5, and IL-13, and promotes inflammation, particularly at the epidermis, in response to environmental stimuli. IL-7 and TSLP signaling have been biologically linked to numerous inflammatory and autoimmune diseases including our initial target diseases of AA and AD. The figures below illustrate the mechanistic rationale for bempikibart in AA and AD.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 2: Bempikibart Has the Potential to Block TH1-and TH2-Driven Disease Pathology in AA</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img226925499_1.jpg" alt="img226925499_1.jpg" style="width:487px;height:257px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img226925499_2.jpg" alt="img226925499_2.jpg" style="width:372px;height:369px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 3: Bempikibart Has the Potential to Modulate Immune Cells Important in Both Acute and Chronic AD Pathogenesis.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img226925499_3.jpg" alt="img226925499_3.jpg" style="width:482px;height:280px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img226925499_4.jpg" alt="img226925499_4.jpg" style="width:290px;height:285px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2023, Amgen Inc., or Amgen, completed the acquisition of Horizon plc. Following the acquisition of Horizon plc, Legacy Q32 agreed with Amgen to mutually terminate the Horizon Agreements. In November 2023, Legacy Q32 entered into the Horizon Termination Agreement with Horizon pursuant to which Horizon&#8217;s option to acquire the bempikibart program was terminated. As a result, Legacy Q32 retained the initial consideration and development funding received under the Horizon Collaboration Agreement and regained full development and commercial rights to bempikibart. In consideration for the Horizon Termination Agreement, Legacy Q32 agreed to pay Horizon regulatory and sales milestones payments of up to an aggregate amount of $75.1 million upon the first achievement of certain regulatory and sales milestones with respect to bempikibart. For more information, see the section titled &#8220;Business&#8212;Collaboration and License Agreements.&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart Preclinical and Clinical Data</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart was evaluated in a series of in vitro assays and demonstrated potent inhibition of IL-7-and TSLP-mediated intracellular signaling.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart, or a mouse surrogate, SB14, was evaluated in vivo in animal models of inflammation and autoimmunity. Activity was observed as determined by various endpoints, including disease activity measures, body weight, inflammatory cytokine production and tissue damage.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preclinical studies evaluating bempikibart PK, PD and toxicology were carried out in non-Good Laboratory Practice, or GLP, single dose and GLP repeat dose studies of 6 weeks, 3-months, and 6-months duration in cynomolgus monkeys. Bempikibart exposure was maintained above the desired PK threshold throughout the dosing phase in most animals despite detectable ADAs. PD evaluations included T cell receptor occupancy, or RO, inhibition of IL-7&#8211;induced phosphorylation of STAT5, or pSTAT5, an immediate proximal marker of IL-7R intracellular signaling, and keyhole limpet hemocyanin, or KLH-induced T cell dependent antibody response. There was a favorable PK/PD relationship, with bempikibart demonstrating &gt;95% RO, &#8805;90% inhibition of pSTAT5 and up to 80% suppression of a KLH-induced IgG response.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart was generally well tolerated in all preclinical studies described above. The no-observed-adverse-effect level, or NOAEL, in the 6-month GLP study was 150 mg/kg, the highest dose tested, with exposure &gt;50x the anticipated area under the curve at the dose presently being utilized for the ongoing Phase 2 studies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Phase 1 Clinical Trial Results</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We completed a Phase 1 trial to assess the safety, PK, and PD of bempikibart after subcutaneous, or SC, administration in healthy volunteers. Pharmacodynamic analyses showed bempikibart treatment at SC doses achieving desired RO and inhibition of IL-7 mediated intracellular signaling, as demonstrated by phosphorylation of STAT5, or pSTAT5, in T-cells. At doses greater than 1 mg/kg, bempikibart demonstrated sustained full RO for at least 2 weeks. In addition, a separate analysis of overall numbers of lymphocytes and lymphocyte subsets demonstrated modest, dose-dependent effects consistent with the expected and desired bempikibart pharmacology.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Safety data showed that bempikibart demonstrated a favorable safety profile at single doses up to the highest evaluated dose of 4 mg/kg and repeat doses of 1 mg/kg every 2 weeks in healthy subjects. There were no safety-related treatment discontinuations, no serious or severe AEs reported, and no deaths.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Role of IL-7 and TSLP in AA</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">AA</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AA is an immune-mediated disorder that results in hair loss and shares some similarity in pathophysiology with AD. Studies have indicated that multiple immunomodulators are involved in the development of AA, with hair follicle immune privilege collapse being a key marker in the course of the disease. Immune system activation in lesional skin contributes to the progression of disease.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IL-7 has been shown to be involved in the pathogenesis of AA. IL-7 expression is upregulated at the site of AA lesions and animal studies demonstrated IL-7&#8211;dependent acceleration of disease progression and beneficial effects with IL-7R&#945; inhibition. Cumulatively, substantial evidence suggests that inhibition of IL-7R&#945; may be an effective modulator of the T-cell response that could act to reverse alopecia.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Current Treatment Landscape and Unmet Need in AA</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AA is an autoimmune condition that affects hair follicles and leads to hair loss. This condition may develop at any age and in both sexes, and the incidence of this disease has been estimated to be 2% of the population worldwide. The disease most commonly affects scalp and facial hair and although some patients recover spontaneously, many patients progress to alopecia totalis (total scalp hair loss) or alopecia universalis (total body hair loss). The disease is associated with significant quality of life impairment and is associated with a high burden of psychosocial comorbidities, such as depression. Although pathophysiology has not been fully delineated, development of the condition is mediated by inflammatory mechanisms, and it is thought to have genetic and environmental components. IL-7 upregulation has been shown to be involved in the pathogenesis of AA, and evidence suggests that inhibition of IL-7R&#945; may be an effective modulator of the T-cell response driving injury in the disease.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Baricitinib and ritlecitinib, both JAK inhibitors, are the only current FDA-approved treatments for AA. Although JAK inhibitors have demonstrated hair regrowth in patients with severe disease (&#8805;50% hair loss), increased risk of serious side effects may preclude this option for some patient populations. Other standard-of-care approaches for alopecia include topical corticosteroids, immunotherapy, and light therapy. Because hair loss can affect such disparate body locations, these treatments often have limited usefulness across the patient population.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further Clinical Development of Bempikibart: Clinical Trial Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For patients with a wide range of autoimmune diseases, we believe the blockade of IL-7 and/or TSLP signaling may offer a new therapeutic approach to modulate the autoimmune response. A high unmet medical need exists for more broadly effective therapies in these conditions, and we are developing bempikibart with the goal of addressing this need. Based on the totality of data to date, bempikibart has shown a favorable safety profile and has not been associated with clinically meaningful ADA. At exposures that can be achieved via SC administration, bempikibart has shown full receptor occupancy and signaling inhibition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overall, the available clinical and nonclinical data for bempikibart support the continued clinical development of bempikibart. To this end, we are continuing to advance bempikibart into Part B of the SIGNAL-AA Phase 2a Clinical Trial.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNAL-AA Phase 2a Clinical Trial</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNAL-AA is a Phase 2a, randomized, double-blind, placebo-controlled, proof-of-concept clinical trial evaluating the efficacy, safety and tolerability of bempikibart in participants with severe and very severe AA, as defined by a baseline Severity of Alopecia Tool, or SALT, score of 50-100. In Part A of the trial, bempikibart or placebo was dosed SC for 24 weeks, with a follow-up period of 12 weeks.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The study recruited adults with a current episode of severe hair loss with no spontaneous improvement over the past six months, along with the investigator&#8217;s assessment that hair loss had been stable for at least three months and regrowth was possible.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Forty-four participants were enrolled and randomly assigned (3:1) to receive 200 mg bempikibart or placebo administered SC every two weeks for 24 weeks. The primary efficacy endpoint was the mean relative percent change in SALT score at 24 weeks compared with baseline. A key secondary endpoint was the percentage of patients achieving a SALT score of less than or equal to 20 (SALT-20) compared to placebo. Patients were followed for an additional 12 weeks after end of treatment.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compared to placebo, the average hair regrowth and achievement of SALT-20 was greater in patients on bempikibart compared to patients on placebo. Average hair re-growth continued to improve in the 12-week period through week 36, despite patients being off therapy. Bempikibart was observed to be generally well tolerated in the SIGNAL-AA trial. There were no serious adverse events, or SAEs, or Grade 3 or higher adverse events related to treatment.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We plan to enroll approximately 20 additional patients through 36 weeks of treatment in a Part B expansion of the SIGNAL-AA Phase 2a clinical trial to further evaluate bempikibart in AA. SIGNAL-AA Part B is an open-label clinical trial, dosing patients with bempikibart for 36 weeks, with follow-up out to 52 weeks, in approximately 20 evaluable patients with severe or very severe AA. Dosing will include an initial loading regimen of 200mg of bempikibart dosed weekly over four weeks, followed by a maintenance dose of 200mg every-other-week over a 32-week period for a total of 36 weeks. The primary efficacy endpoints include the proportion of patients achieving a 30% or greater reduction in SALT score and proportion of patients achieving a SALT-20 at week 36, with follow-up through week 52. The trial is intended to enable advancement into pivotal trials upon completion, pending review of the results. We expect to report initial data from SIGNAL-AA Part B in the first half of 2026.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADX-097 in LN, IgAN, C3G and AAV</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Complement is an integral part of the innate immune system used as a first line of defense for removing bacteria and other pathogens, as well as damaged cells, and for modulating an adaptive immune response. In spite of these beneficial functions, when the complement system becomes dysregulated it can be a critical driver of chronic inflammatory and autoimmune diseases.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are three main branches of the complement system: the classical, or CP, the lectin, or LP, and the AP. These pathways can lead to the generation of cellular/tissue bound protein complexes, called convertases, the gatekeepers that catalyze the cleavage of the complement component 3 and 5 proteins, or C3 and C5, respectively. This cleavage, predominantly happening on the cellular/tissue surface, ultimately leads to the formation of C3a and C5a, chemotactic factors that recruit inflammatory immune cells, and the assembly of C5b-9 forming the membrane attack complex, or MAC, on cell membranes. Uncontrolled and persistent production of these complement activation products ultimately leads to pathological tissue inflammation and cellular damage.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The AP is central to the complement system. It provides for amplification of complement signaling downstream of all 3 complement pathways, commonly referred to as the &#8220;amplification loop&#8221; (see figure below). Consequently, sustained overactivation of the complement system in many diseases is driven by AP activation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 4: Schematic of the Complement System Showing Critical Elements of the Three Pathways.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img226925499_5.jpg" alt="img226925499_5.jpg" style="width:327px;height:308px;"/></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MAC: Membrane attack complex.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under normal conditions, inactivation of convertases, to maintain proper balance of the complement system, is endogenously controlled by several complement negative regulatory proteins. Among these is fH, a protein that binds and inactivates AP convertases. Factor H both catalyzes dissociation of AP C3 and C5 convertases and, in combination with Factor I, leads to irreversible catalytic degradation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given the central role of the AP in driving complement activity, gaining control of this pathway provides a mechanism to restore proper regulation of the complement system when it becomes dysregulated in disease.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADX-097</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADX-097 is a C3d mAb recombinantly linked to 2 moieties of human fH1-5. ADX-097 was designed to provide a unique tissue targeted therapeutic approach to restore proper complement regulation on the surfaces of cells in diseased tissue where AP convertase assembly occurs and the amplification loop magnifies complement activation. The fH1-5 component of ADX-097 consists of the first five N-terminal domains of fH, which catalyzes the dissociation and irreversible proteolytic degradation of the AP C3/C5 convertases. When C3 is cleaved as a consequence of complement activation it leads to the generation of high-density surface bound C3d deposits positioned adjacent to the AP C3/C5 convertases. Our preclinical studies demonstrate that the binding of the antibody portion of ADX-097 to C3d brings the human fH1-5 protein into proximity with surface-bound C3/C5 AP convertases, allowing fH1-5 to interrupt complement activation. Thus, we believe, based on preclinical studies, that ADX-097 has the potential to durably restore control of the complement system at specific sites of ongoing injury and at doses where complement surveillance is maintained in circulation. See Figure 5 for a depiction of ADX-097&#8217;s targeted mechanism of action.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 5: Schematic of ADX-097 Targeted Mechanism of Action</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img226925499_6.jpg" alt="img226925499_6.jpg" style="width:429px;height:337px;"/></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fH1-5: first 5 N-terminal short consensus repeats of human factor H; mAb: monoclonal antibody</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Given the ubiquitous nature of C3d deposition in tissue where complement is activated, and the importance of the AP in maintaining complement activation, we believe ADX-097 has therapeutic potential for multiple diseases. We also believe that by inhibiting complement in a tissue-directed manner, a greater potential for clinical activity is possible.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have completed a robust preclinical and translational package and have also completed a Phase 1 clinical trial in healthy volunteers.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2025, we announced that we are discontinuing the Phase 2 renal basket clinical trial of ADX-097 and are evaluating strategic options for our tissue-targeted complement inhibitor platform, inclusive of ADX-097 and early-stage assets, to prioritize the clinical development of bempikibart.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADX-097 Preclinical and Clinical Data</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preclinical pharmacology, PD, PK, and toxicology of ADX-097 were assessed in a wide range of in vitro experiments and in vivo nonclinical studies in mice, rats and NHPs. Three non-GLP and two GLP PK, PD and toxicology studies were completed to support clinical development of ADX-097.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These studies have provided compelling evidence for the therapeutic potential of ADX-097. These studies have demonstrated that ADX-097 or a pharmacologically equivalent mouse homolog, ADX-118, which contains the parent mouse anti-C3d antibody used in ADX-097 recombinantly linked to mouse fH1-5, were able to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bind C3d and inhibit complement in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> assays; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Distribute and bind C3d present in rodent kidney, liver, and skin and to NHP skin; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provide durable anti-complement activity in rodent and NHP tissue, with limited and transient systemic inhibition: durable (&gt;7 days) tissue PD after 1-3 mg/kg SC dosing; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reduce glomerular C3 fragment deposition, proteinuria/albuminuria, and additional biomarkers of renal injury in rodent models of kidney disease; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Demonstrate increased functional potency compared to similar non-targeted fH1-5 in a passive Heymann nephritis, or PHN, model of kidney disease. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ADX-097 preclinical toxicology studies were conducted in pharmacologically relevant species, mice and cynomolgus monkeys. It included a cross-reactivity study using human tissues to identify any potential off-target tissue binding, repeat-dose non-GLP studies of 28-day duration in mice and cynomolgus monkeys by SC or intravenous, or IV, administration, and a 29-day GLP repeat-dose toxicology study in cynomolgus monkeys by SC or IV administration. It also included a non-GLP 28-day study and a GLP 3-month study with ADX-118, a mouse homolog protein of ADX-097 with equivalent pharmacological activity, to minimize immunogenicity with long-term dosing. No ADX-097-mediated pharmacological adverse effects were observed in up to 29-day repeat-dose studies in either mice or monkeys. All adverse effects were attributable to an immune-mediated response to a humanized/human fusion protein in NHPs and mice. Consistent with all ADX-097 adverse events being mediated by an immune response to the humanize/human protein, no ADX-118-mediated adverse effects were observed in the 3-month repeat dose studies in mice. The NOAEL was determined at 250 mg/kg by IV weekly dosing (QW), the highest dose tested in the 3-month mouse study, providing support for chronic administration of ADX-097. Overall, the ADX-097 preclinical toxicology analysis provided a &gt; 40x safety margin.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 1 Clinical Trial Data</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADX-097 has been evaluated in a completed Phase 1 study conducted in healthy volunteers, study ADX-097-101.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This was a randomized, double-blind, placebo-controlled, single ascending dose, or SAD, and multiple dose study to assess the safety, tolerability, PK, and PD of ADX-097. Data from this study provided initial characterization of the safety, PK, PD, and immunogenicity profile of ADX-097 across a wide range of dose levels, using both IV and SC routes of administration.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In total, 56 healthy volunteers were dosed (randomized 2:1; n=4 ADX-097 and n=2 placebo per cohort): 49 volunteers in the SAD portion of the study and 7 participants in the multiple dose portion. The SAD portion of the study included Cohort 1 (0.1 mg/kg IV), Cohort 2 (0.3 mg/kg IV), Cohort 3 (1 mg/kg IV), Cohort 4a (3 mg/kg IV), Cohort 4b (3 m/kg [actual: 3.75 mg/kg] SC), Cohort 6a (10 mg/kg IV), Cohort 6b (10 mg/kg SC), and Cohort 8 (30 mg/kg IV). The multiple dose portion of the study included multiple ascending dose, or MAD, Cohort 1 (450 mg SC fixed weekly dose).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Blinded safety data indicated that ADX-097 was generally well tolerated across all dose levels with single or repeat dosing with no observed clinically significant drug-related safety findings or trends. All observed treatment-emergent adverse events, or TEAEs, were mild or moderate in severity. There were no observed serious adverse events, no severe TEAEs, no discontinuations due to study drug, and no dose-related trends in TEAEs. Except for one observed TEAE of blood creatine phosphokinase increase in SAD Cohort 1 that was deemed mild by the investigator, there were no observed clinically significant drug-related laboratory findings or trends. In addition, there were no observed clinically significant findings related to vital signs or electrocardiograms, no TEAEs related to immunogenicity, and SC administration was generally well tolerated with only mild injection site reactions observed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the PK analysis, ADX-097 demonstrated dose-dependent PK and the minimum drug concentration at a dose of 450 mg SC weekly dosing at steady state is estimated to achieve a target threshold associated with tissue pharmacological activity in over 90% of patients. The PD analysis demonstrated increasing inhibition of circulating AP activity and more sustained inhibition with increasing doses. No apparent change in circulating AP activity was observed following 450mg SC weekly dosing. No clinically significant ADA was identified in the ADX-097-101 study, consistent with low immunogenicity potential of ADX-097 in humans. See Figure 6 and Figure 7 for a summary of ADX-097-101 PK and PD data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 6: ADX-097-101: Plasma ADX-097 Concentrations and % of Baseline Wieslab AP Activity After Single Dose IV of ADX-097</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img226925499_7.jpg" alt="img226925499_7.jpg" style="width:600px;height:221px;"/></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Figure 7: ADX-097-101: Plasma ADX-097 Concentrations and % of Baseline Wieslab AP Activity After Single/Multiple Dose SC of ADX-097</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img226925499_8.jpg" alt="img226925499_8.jpg" style="width:600px;height:200px;"/></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Collaboration and License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Bempikibart&#8212;License Agreement &#8211; Bristol-Myers Squibb Company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2019, we entered into a license agreement, as amended in August 2021 and July 2022, or the BMS License Agreement, with Bristol-Myers Squibb Company, or BMS, pursuant to which we obtained sublicensable licenses from BMS to research, develop and commercialize licensed products, including bempikibart, for any and all uses worldwide. The licenses granted to us are exclusive with respect to BMS&#8217;s patent rights and know-how relating to certain antibody fragments (including certain fragments of bempikibart) and non-exclusive with respect to BMS&#8217;s patent rights and know-how relating to the composition of matter and use of a specific region of bempikibart. BMS retained the right for it and its affiliates to use the exclusively licensed patents and know-how for internal, preclinical research purposes. Under the BMS License Agreement, we are prohibited from engaging in certain clinical development or commercialization of any antibody other than a licensed compound with the same mechanism of action until the earlier of the expiration of our obligation to pay BMS royalties or September 2029.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In consideration for the license, we made an upfront payment to BMS of $8 million, issued 6,628,788 Series A preferred shares to BMS and agreed to use commercially reasonable efforts to develop and commercialize at least one licensed product in key geographic markets. In addition, we agreed to pay BMS (i) development and regulatory milestone payments in aggregate amounts ranging from $32 million to $49 million per indication for the first three indications and commercial milestone payments in an aggregate amount of up to $215 million on net sales of licensed products, (ii) tiered royalties ranging from rates in the mid-single digit percentages to up to 10% of net sales, with increasing rates depending on the cumulative net sales, (iii) up to 60% of sublicense income, which percentage decreases based on the development stage of bempikibart at the time of the sublicensing event, and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our obligation to pay BMS royalties under subsection (ii) above commences, on a licensed product-by-licensed product and country-by-country basis, on the first commercial sale of a licensed product in a country and expires on the later of (x) 12 years from the first commercial sale of such licensed product in such country, (y) the last to expire licensed patent right covering bempikibart or such licensed product in such country, and (z) the expiration or regulatory or marketing exclusivity for such licensed product in such country, or the Royalty Term. If we undergo a change of control prior to certain specified phase of development, the development and milestone payments are subject to increase by a low double-digit percentage and the royalty rates are subject to increase by a low sub-single-digit percentage.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless terminated earlier by either party pursuant to its terms, the BMS License Agreement will expire on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last to expire Royalty Term with respect to such licensed product in such country. Either party may terminate the BMS License Agreement for the other party&#8217;s material breach, subject to a specified notice and cure period. BMS may terminate the BMS License Agreement if we fail to meet its diligence obligations under the BMS License Agreement, for our insolvency, or if we or our affiliates challenges the validity, scope, enforceability, or patentability of any of the licensed patents. We may terminate the BMS License Agreement for any reason upon prior written notice to BMS, with a longer notice period if a licensed product has received regulatory approval. If the BMS Agreement is terminated for our material breach, BMS will regain rights to bempikibart and we must grant BMS an exclusive license under our patent rights covering bempikibart, subject to a low single-digit percentage royalty on net sales of bempikibart payable to us by BMS.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Bempikibart &#8211; Collaboration and Option Agreement, Asset Purchase Agreement and Termination Agreement &#8211; Horizon Therapeutics Ireland DAC</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From August 2022 until November 2023, Legacy Q32 was a party to the Collaboration and Option Agreement, or the Horizon Collaboration Agreement, and the Asset Purchase Agreement, or the Purchase Agreement, and together with the Horizon Collaboration Agreement, the Horizon Agreements each with Horizon Therapeutics Ireland DAC, or Horizon, pursuant to which Legacy Q32 received $55.0 million in initial consideration and staged development funding to complete two ongoing Phase 2 trials for bempikibart, and granted Horizon an option to acquire the bempikibart program at a prespecified price, subject to certain adjustments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2023, Amgen Inc., or Amgen, completed the acquisition of Horizon Therapeutics public limited company, or Horizon plc. Following the acquisition of Horizon plc, Legacy Q32 agreed with Amgen to mutually terminate the Horizon Agreements and in November 2023, Legacy Q32 entered into a termination agreement with Horizon, or the Horizon Termination Agreement, pursuant to which Horizon&#8217;s option to acquire the bempikibart program was terminated. As a result, Legacy Q32 retained all initial consideration and development funding received under the Horizon Collaboration Agreement and regained full development and commercial rights to bempikibart. In consideration for the Horizon Termination Agreement, Legacy Q32 agreed to pay Horizon regulatory and sales milestones payments of up to an aggregate amount of $75.1 million upon the first achievement of certain regulatory and sales milestones with respect to bempikibart.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ADX-097&#8212;License Agreement &#8211; The Regents of the University of Colorado</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2017, we entered into an exclusive license agreement, as amended in February 2018, September 2018, and April 2019, or the Colorado License Agreement, with The Regents of the University of Colorado, or Colorado, pursuant to which we obtained worldwide, royalty-bearing, sublicensable licenses under certain patents and know-how owned by Colorado and Medical University of South Carolina, or MUSC, relating to the research, development and commercialization of ADX-097. The licenses granted to us are exclusive with respect to certain patent families and know-how and non-exclusive with certain other patent families and know-how. The licenses granted to us are also subject to certain customary retained rights of Colorado and MUSC and rights of the United States government owing to federal funding giving rise to inventions covered by the licensed patents. We agreed to use commercially reasonable efforts to develop, manufacture and commercialize ADX-097, including by using commercially reasonable efforts to achieve specified development and regulatory milestones by specified dates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we agreed to pay Colorado (i) development and sales milestone payments in an aggregate amount of up to $2.2 million per licensed product for the first three products, (ii) tiered royalty rates on cumulative net sales of licensed products in the low single digit percentages, (iii) 15% of sublicense income and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents. Our obligation to pay royalties to Colorado commences, on a licensed product-by-licensed product and country-by-country basis, from the first commercial sale of a licensed product in any country and expires on the later of (i) the last to expire valid claim within the licensed patents covering such licensed product in such country, and (ii) 20 years following the effective date of the Colorado License Agreement, or April 2037, or the Royalty Term.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless earlier terminated by either party pursuant to its terms, the Colorado License Agreement will expire upon the expiration of the Royalty Term in all countries. We may terminate the Colorado License Agreement for convenience upon providing prior written notice to Colorado. Colorado may terminate the Colorado License Agreement or convert our exclusive license to a non-exclusive license if we breach certain obligations under the Colorado License Agreement and fail to cure such breach. The Colorado License Agreement will terminate automatically upon our dissolution, insolvency, or bankruptcy.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competition</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect to face intense competition from other biopharmaceutical companies that are developing agents for the treatment of autoimmune and inflammatory diseases. Drug development is highly competitive and subject to rapid and significant technological advancements. Our ability to compete will significantly depend upon our ability to complete necessary clinical trials and regulatory approval processes, and effectively market any drug that we may successfully develop. Our current and potential future competitors include pharmaceutical and biotechnology companies, as well as academic institutions and government agencies. The primary competitive factors that will affect the commercial success of any product candidate for which we may receive marketing approval include efficacy, safety and tolerability profile, dosing convenience, price, coverage, reimbursement and public opinion. Many of our existing or potential competitors have substantially greater financial, technical and human resources than we do and significantly greater experience in the discovery and development of product candidates, as well as in obtaining regulatory approvals of those product candidates in the U.S. and in foreign countries. Our current and potential future competitors also have significantly more experience commercializing drugs that have been approved for marketing. Mergers and acquisitions in the biopharmaceutical industry could result in even more resources being concentrated among a small number of our competitors. Accordingly, competitors may be more successful than us in obtaining regulatory approval for therapies and in achieving widespread market acceptance of their drugs. It is also possible that the development of a cure or more effective treatment method for any of our targeted indications by a competitor could render our product candidate non-competitive or obsolete, or reduce the demand for our product candidate before we can recover its development and commercialization expenses.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Manufacturing</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not currently own or operate facilities for product manufacturing, testing, storage, and distribution. We contract with third parties for the manufacture, storage and distribution of our product candidates. Because we rely on contract manufacturers, we employ and contract with personnel with extensive technical, manufacturing, analytical and quality experience. Our staff has strong knowledge and understanding of the extensive regulations that govern manufacturing, documentation, quality assurance, and quality control of drug supply that are required to support our regulatory filings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intellectual Property</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We strive to protect and enhance the proprietary technology, inventions, and improvements that are commercially important to our business, including by seeking, maintaining, and defending patent rights, whether developed internally or licensed from third parties. We also rely on trade secrets and know-how relating to our proprietary technology and product candidates, continuing technological innovation, and in-licensing opportunities to develop, strengthen, and maintain our proprietary position in the field of autoimmune and inflammatory diseases. Our future success depends, in part, on our ability to obtain and maintain patent and other proprietary protection for our commercially important technology, inventions, and know-how, defend and enforce our intellectual property rights (in particular our patent rights), preserve the confidentiality of our trade secrets, and operate without infringing, misappropriating, or violating the valid and enforceable patents and proprietary rights of third parties. Our ability to stop third parties from making, using, selling, offering to sell, or importing products identical or similar to ours may depend on the extent to which we have rights under valid and enforceable patents that cover these activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent position of biotechnology and pharmaceutical companies are generally uncertain and can involve complex legal, scientific, and factual issues. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary protection from competitors. We also cannot ensure that patents will issue with respect to any patent applications that we or our licensors may file in the future, nor can we ensure that any of our owned or licensed patents or future patents will be commercially useful in protecting our product candidates and methods of manufacturing. In addition, the coverage claimed in a patent application may be significantly reduced before a patent is issued, and its scope can be reinterpreted and even challenged after issuance. As a result, we cannot guarantee that any of our products will be protected or remain protectable by valid and enforceable patents. Moreover, any of our patents may be challenged, circumvented, or invalidated by third parties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prosecution is a lengthy process, during which the scope of the claims initially submitted for examination by the U.S. Patent and Trademark Office, or USPTO, may be significantly narrowed before issuance, if issued at all. We expect this may be the case with respect to some of our pending patent applications referred to below.</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to bempikibart, as of December 31, 2024, we exclusively licensed from Bristol Myers Squibb, or BMS, one patent family relating to antibodies against the IL-7R alpha subunit and uses thereof comprising two issued U.S. patents, two issued patents in Japan, one issued patent in each of China, South Korea, Russia, Saudi Arabia and Singapore, one pending U.S. patent application, and 30 pending patent applications in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Europe, Hong Kong, India, Indonesia, Israel, Japan, South Korea, Malaysia, Mexico, New Zealand, Peru, Philippines, South Africa, Singapore, Taiwan, Thailand, United Arab Emirates, Qatar, Bahrain, Egypt, Kuwait, and Oman. The issued patents are expected to expire in January 2040 and any patents that issue from these pending patent applications are expected to expire in 2040, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad.</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also own one pending international PCT patent application relating to the use of bempikibart for the treatment of hair-loss disorders such as AA, and another pending international PCT patent application relating to the use of bempikibart for the treatment of AD. Any patents that issue from patent applications derived from or claiming priority to these pending PCT applications are expected to expire in 2044, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to our ADX-097 program, as of December 31, 2024, we own one patent family relating to ADX-097 and the underlying anti-C3d antibodies, and other fusion constructs of the underlying anti-C3d antibodies and different complement modulators. This family includes three issued U.S. patents, one pending U.S. patent application, one issued patent in each of Australia, Russia and Japan, and 22 pending applications in Australia, Canada, China, Europe, Hong Kong, India, Indonesia, Israel, Japan, South Korea, Malaysia, Mexico, New Zealand, Philippines, Saudi Arabia, Singapore, South Africa, United Arab Emirates, Qatar, Bahrain, Kuwait, and Oman. The issued patent that covers ADX-097, and any patents that issue from these pending patent applications are expected to expire in December 2039, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad.</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also own one pending international Patent Cooperation Treaty, or PCT, patent application and one pending patent application in Taiwan, relating to the use of ADX-097 for the treatment of ANCA-associated vasculitis, and another pending international PCT patent application and another pending patent application in Taiwan relating to the use of ADX-097 for the treatment of certain complement-associated renal diseases (such as LN, IgAN, and C3G). Any patents that issue from these Taiwan applications, or patent applications derived from or claiming priority to these pending Taiwan or PCT applications, are expected to expire in 2044, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We also own one pending PCT patent application relating to targeted treatment of complement-media disease through local complement inhibition based on detection of a urinary biomarker. Any patents that issue from patent applications derived from or claiming priority to this PCT application are expected to expire in 2044, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have licensed from various institutions additional patent families that are generally related to C3d targeted complement inhibitors, but that do not specifically cover ADX-097:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One patent family from the Regents of the University of Colorado, or CU, the MUSC Foundation For Research Development, or MUSC, and the U.S. Department of Veterans Affairs, or USDVA, relating to targeted complement inhibitor constructs based on natural antibodies and uses thereof includes two granted Australian patents and one granted patent in each of Israel and Japan. These patents are expected to expire in 2034, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Two patent families from CU, the first relating to MAP44 polypeptides and tissue-targeted fusion constructs and uses thereof, and the second relating to modulating the alternative complement pathway; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The first CU patent family includes one granted patent in each of Australia and Israel and pending patent applications in the U.S., Canada and Australia. The issued patents and any patents that issue from the pending patent applications are expected to expire in 2035, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad. The second CU patent family includes three issued U.S. patents, which are expected to expire in 2029, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Two patent families from MUSC and USDVA, the first relating to compositions and methods for treating central nervous system injury using a targeted complement inhibitor and another agent or therapy and the second relating to compositions and methods for treating and preventing transplant-associated injury. The first patent family includes two issued U.S. patents, one pending U.S. patent application, and one pending patent application in Europe. The issued patents and any patents that issue from the pending patent applications are expected to expire in 2037, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad. The second patent family includes one pending U.S. patent application and one pending patent application in Europe. Any patents that issue from these pending patent applications are expected to expire in 2037, without accounting for potentially available patent term adjustments or extensions in the U.S. or abroad; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">One patent family from CU and MUSC relating to antibodies against the C3d fragment of complement component 3 includes one reissue patent in the U.S. This reissue U.S. patent is expected to expire in 2031, without accounting for potentially available patent term extensions in the U.S. or abroad.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While we believe that the specific and generic claims contained in our patents provide protection for the claimed compounds, pharmaceutical compositions and methods of use, third parties may nevertheless challenge such claims. If any such claims are invalidated or rendered unenforceable for any reason, we could lose valuable intellectual property rights and our ability to prevent others from competing with our products and technology would be impaired.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in which we pursue patent protection, the patent term is 20 years from the earliest date of filing a non-provisional patent application. In the United States, the term of a patent covering an FDA-approved drug may, in certain cases, be eligible for a patent term extension under the Hatch-Waxman Act as compensation for the loss of patent term during the FDA regulatory review process. The period of extension may be up to five years, but the remaining term of a patent cannot be extended beyond a total of 14 years from the date of product approval. Only one patent among those eligible for an extension and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar provisions are available in Europe and in certain other jurisdictions to extend the term of a patent that covers an approved drug. We intend to seek patent term extension for patents covering our products if available.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to patent protection, we may also rely, in some circumstances, on trade secrets to protect our technology. To that end, we also enter into confidentiality agreements with those who have access to our confidential information, including our employees, contractors, consultants, collaborators and advisors. We also enter into agreements requiring assignment of inventions with selected consultants, scientific advisors, and collaborators. However, trade secrets are difficult to protect. These agreements may not provide meaningful protection and may be breached without an adequate remedy for any such breach. In addition, our trade secrets and/or confidential information and know-how may become known or be independently developed by a third party, or misused by any collaborator to whom we disclose such information. Despite any measures taken to protect our intellectual property, unauthorized parties may attempt to copy aspects of our products or obtain or use information that we regard as proprietary. Although we take steps to protect our proprietary information, third parties may independently develop the same or similar proprietary information or may otherwise gain access to our proprietary information. As a result, we may be unable to meaningfully protect our trade secrets and proprietary information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our success will also depend in part on not infringing upon the proprietary rights of third parties. It is uncertain whether the issuance of any third-party patent would require us to alter our strategies, obtain licenses, or cease certain activities. Our breach of any license agreements or failure to obtain a license to proprietary rights that we need may have an adverse impact on our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For more information and comprehensive risks related to our proprietary technology, inventions, improvements and product candidates, see the section titled &#8220;Risk Factors&#8212;Risks Relating to Our Intellectual Property.&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Government Regulation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. Food and Drug Administration, or the FDA, and other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting of biologics such as those we are developing. We, along with third-party contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we are currently conducting and in the future may conduct studies or seek approval or licensure of our product candidates. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or post-market may subject an applicant to administrative</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or judicial sanctions. These sanctions could include, among other actions, the FDA&#8217;s refusal to approve pending applications, withdrawal of an approval, a clinical hold, untitled or warning letters, product recalls or market withdrawals, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement and civil or criminal penalties. Any agency or judicial enforcement action could have a material adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">U.S. Biologics Regulation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States, biological products are subject to regulation under the Federal Food, Drug, and Cosmetic Act, or the FDCA, and the Public Health Service Act, or the PHSA, and their implementing regulations, as well as other federal, state, local, and foreign statutes and regulations. The process required by the FDA before biologic product candidates may be marketed in the United States generally involves the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">completion of preclinical laboratory tests and animal studies performed in accordance with applicable regulations, including the FDA&#8217;s Good Laboratory Practices, or GLP; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">submission to the FDA of an investigational new drug application, or IND, which must become effective before clinical trials may begin and must be updated annually or when significant changes are made; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">approval by an independent institutional review board, or IRB, or independent ethics committee at each clinical site before the trial may commence; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">manufacture of the proposed biologic candidate in accordance with current Good Manufacturing Practices, or cGMPs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">performance of adequate and well-controlled human clinical trials in accordance with applicable IND regulations, Good Clinical Practice, or GCP, requirements and other clinical-trial related regulations to establish the safety, purity and potency of the proposed biologic product candidate for its intended purpose; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">preparation of and submission to the FDA of a biologics license application, or BLA, after completion of all pivotal clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of an FDA Advisory Committee review, if applicable; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a determination by the FDA within 60 days of its receipt of a BLA to file the application for review; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">satisfactory completion of an FDA pre-approval inspection of the manufacturing facility or facilities at which the proposed product is produced to assess compliance with cGMPs, and to assure that the facilities, methods and controls are adequate to preserve the biological product&#8217;s continued safety, purity and potency, and potential audit of selected clinical investigation sites to assess compliance with GCPs and cGMPs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payment of user fees for FDA review of the BLA, unless a waiver is applicable; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FDA review and approval of a BLA to permit commercial marketing of the product for a particular indication(s) for use in the United States. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical and Clinical Development</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to beginning the first clinical trial with a product candidate, a sponsor must submit an IND to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug product to humans. The central focus of an IND submission is on the general investigational plan and the protocol or protocols for preclinical studies and clinical trials. The IND also includes results of animal and in vitro studies assessing the toxicology, pharmacokinetics, pharmacology and pharmacodynamic characteristics of the product, chemistry, manufacturing and controls information, and any available human data or literature to support the use of the investigational product. An IND must become effective before clinical trials may begin. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the 30-day period, raises safety concerns or questions about the proposed clinical trial. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before the clinical trial can begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical trial.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCPs, which include the requirement that all research participants provide their informed consent for their participation in any clinical study. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A separate submission to the existing IND must be made for each successive clinical trial conducted during product development and for any subsequent protocol amendments. Furthermore, an independent IRB for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins at that site, and must monitor the study until completed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulatory authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight by an independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board, which provides authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may recommend halting the clinical trial if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy. There are also requirements governing the reporting of ongoing preclinical studies and clinical trials and clinical study results to public registries. Sponsors of clinical trials of FDA-regulated products, including biological products, are required to register and disclose certain clinical trial information, which is publicly available at www.clinicaltrials.gov.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A sponsor who wishes to conduct a clinical trial outside of the United States may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. If a foreign clinical trial is not conducted under an IND, the sponsor may submit data from the clinical trial to the FDA in support of a BLA. The FDA will accept a well-designed and well-conducted foreign clinical trial not conducted under an IND if the trial was conducted in accordance with GCP requirements and the FDA is able to validate the data through an onsite inspection if deemed necessary.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For purposes of BLA approval, human clinical trials are typically conducted in three sequential phases that may overlap.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 1. The investigational product is initially introduced into healthy human subjects or patients with the target disease or condition. These studies are designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 2. The investigational product is administered to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase 2 clinical trials may be conducted to obtain information prior to beginning larger and more expensive Phase 3 clinical trials.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Phase 3. The investigational product is administered to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some cases, the FDA may require, or companies may voluntarily pursue, additional clinical trials after a product is approved to gain more information about the product. These so-called Phase 4 studies may be made a condition to approval of the BLA. Concurrent with clinical trials, companies may complete additional animal studies and develop additional information about the biological characteristics of the product candidate, and must finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, must develop methods for testing the safety, purity and potency of the final product. Additionally, appropriate packaging must be selected and tested and long-term stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During all phases of clinical development, regulatory agencies require extensive monitoring and auditing of all clinical activities, clinical data and clinical study investigators. Written IND safety reports must be promptly submitted to the FDA and the investigators for serious and unexpected suspected adverse events, any findings from other studies, tests in laboratory animals or in vitro testing that suggest a significant risk for human subjects, or any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must submit an IND safety report within 15 calendar days after the sponsor determines that the information qualifies for reporting. The sponsor also must notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction within seven calendar days after the sponsor&#8217;s initial receipt of the information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">BLA Submission and Review</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, preclinical studies and clinical trials are submitted to the FDA as part of a BLA requesting approval to market the product for one or more indications. FDA approval of a BLA must be obtained before a biologic may be marketed in the United States. The BLA must include all relevant data available from pertinent preclinical studies and clinical trials, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing, controls, and proposed labeling, among other things. Data can come from company-sponsored clinical studies intended to test the safety and effectiveness of the product, or from a number of alternative sources, including studies initiated and sponsored by investigators. The submission of a BLA requires payment of a substantial application user fee to the FDA, unless a waiver or exemption applies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, under the Pediatric Research Equity Act, or PREA, a BLA or supplement to a BLA must contain data to assess the safety and effectiveness of the biological product candidate for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The Food and Drug Administration Safety and Innovation Act requires that a sponsor who is planning to submit a marketing application for a biological product that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial pediatric study plan, or PSP, within sixty days after an end-of-Phase 2 meeting or, if there is no such meeting, as early as practicable before the initiation of the Phase 3 or Phase 2/3 study as may be agreed between the sponsor and FDA. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with supporting information. The FDA and the sponsor must reach an agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from preclinical studies, early phase clinical trials and/or other clinical development programs. Unless otherwise required by regulation, PREA does not apply to any biological product for an indication for which orphan designation has been granted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Within 60 days following submission of the application, the FDA reviews the BLA to determine if it is substantially complete before the agency accepts it for filing. The FDA may refuse to file any BLA that it deems incomplete or not properly reviewable at the time of submission and may request additional information. In this event, the BLA must be resubmitted with the additional information. Once a BLA has been accepted for filing, the FDA&#8217;s goal is to review standard applications within ten months after the filing date, or, if the application qualifies for priority review, six months after the FDA accepts the application for filing. In both standard and priority reviews, the review process may also be extended by FDA requests for additional information or clarification. The FDA reviews a BLA to determine, among other things, whether a product is safe, pure and potent and the facilities in which it is manufactured, processed, packed or stored meet standards designed to assure the product&#8217;s continued safety, purity and potency. The FDA may convene an advisory committee to provide clinical insight on application review questions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before approving a BLA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure compliance with GCPs. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it typically will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After the FDA evaluates a BLA and conducts inspections of manufacturing facilities where the investigational product and/or its drug substance will be produced, the FDA may issue an approval letter or a complete response letter, or a Complete Response Letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A Complete Response Letter will describe all of the deficiencies that the FDA has identified in the BLA, except that where the FDA determines that the data supporting the application are inadequate to support approval, the FDA may issue the Complete Response Letter without first conducting required inspections, testing submitted product lots and/or reviewing proposed labeling. In issuing the Complete Response Letter, the FDA may recommend actions that the applicant might take to place the BLA in condition for approval, including requests for additional information or clarification. If a Complete Response Letter is issued, the applicant may either resubmit the BLA, addressing all of the deficiencies identified in the letter, or withdraw the application or request an opportunity for a hearing. The FDA may delay or refuse approval of a BLA</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If regulatory approval of a product is granted, such approval will be granted for particular indications and may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the BLA with a Risk Evaluation and Mitigation Strategy, or REMS, to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with pre-and post-marketing requirements is not maintained or if problems occur after the product reaches the marketplace. The FDA may require one or more Phase 4 post-market studies and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization, and may limit further marketing of the product based on the results of these post-marketing studies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expedited Development and Review Programs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA offers a number of expedited development and review programs for qualifying product candidates. The fast track program is intended to expedite or facilitate the process for reviewing new products that meet certain criteria. Specifically, new product candidates are eligible for fast track designation if they are intended to treat a serious or life-threatening disease or condition and demonstrate the potential to address unmet medical needs for the disease or condition. Fast track designation applies to the combination of the product candidate and the specific indication for which it is being studied. The sponsor of a fast track product candidate has opportunities for more frequent interactions with the review team during product development and, once a BLA is submitted, the product candidate may be eligible for priority review. A fast track product candidate may also be eligible for rolling review, where the FDA may consider for review sections of the BLA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the BLA, the FDA agrees to accept sections of the BLA and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the BLA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A product candidate intended to treat a serious or life-threatening disease or condition may also be eligible for breakthrough therapy designation to expedite its development and review. A product candidate can receive breakthrough therapy designation if preliminary clinical evidence indicates that the product candidate, alone or in combination with one or more other drugs or biologics, may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. The designation includes all of the fast track program features, as well as more intensive FDA interaction and guidance beginning as early as Phase 1 and an organizational commitment to expedite the development and review of the product, including involvement of senior managers.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any marketing application for a biologic submitted to the FDA for approval, including a product candidate with a fast track designation and/or breakthrough therapy designation, may be eligible for other types of FDA programs intended to expedite the FDA review and approval process, such as priority review and accelerated approval. A product candidate is eligible for priority review if it has the potential to provide a significant improvement in the treatment, diagnosis or prevention of a serious disease or condition. For original BLAs, priority review designation means the FDA&#8217;s goal is to take action on the marketing application within six months of the 60-day filing date (as compared to ten months under standard review).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, product candidates studied for their safety and effectiveness in treating serious or life-threatening diseases or conditions may receive accelerated approval upon a determination that the product candidate has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of accelerated approval, the FDA will generally require the sponsor to perform adequate and well-controlled post-marketing clinical studies with due diligence to verify and describe the anticipated effect on irreversible morbidity or mortality or other clinical benefit. Under the Food and Drug Omnibus Reform Act of 2022, or FDORA, the FDA may require, as appropriate, that such studies be underway prior to approval or within a specific time period after the date of approval for a product granted accelerated approval. Under FDORA, the FDA has increased authority for expedited procedures to withdraw approval of a product or indication approved under accelerated approval if the sponsor fails to conduct the required post-marketing studies or if such studies fail to verify the predicted clinical benefit. In addition, the FDA currently requires as a condition for accelerated approval pre-approval of promotional materials, which could adversely impact the timing of the commercial launch of the product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fast track designation, breakthrough therapy designation and priority review do not change the standards for approval but may expedite the development or approval process. Even if a product candidate qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Orphan Drug Designation and Exclusivity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the Orphan Drug Act of 1983, the FDA may grant orphan drug designation to a product candidate intended to treat a rare disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the United States, or 200,000 or more individuals in the United States for which there is no reasonable expectation that the cost of developing and making available in the United States a drug or biologic for this type of disease or condition will be recovered from sales in the United States for that product candidate. Orphan drug designation must be requested before submitting a BLA. After the FDA grants orphan drug designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. The orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review or approval process.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a product that has orphan drug designation subsequently receives the first FDA approval for the disease or condition for which it has such designation, the product is entitled to orphan drug exclusive approval (or exclusivity), which means that the FDA may not approve any other applications, including a full BLA, to market the same product for the same indication for seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity by means of greater effectiveness, greater safety or providing a major contribution to patient care or if the holder of the orphan drug exclusivity cannot assure the availability of sufficient quantities of the orphan drug to meet the needs of patients with the disease or condition for which the product was designated. Orphan drug exclusivity does not prevent the FDA from approving a different drug or biologic for the same disease or condition, or the same drug or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the BLA application fee.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it received orphan drug designation. In addition, exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Post-Approval Requirements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any products manufactured or distributed by us pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record-keeping, reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. As part of the manufacturing process, the manufacturer is required to perform certain tests on each lot of the product before it is released for distribution. After a BLA is approved for a biological product, the product also may be subject to official lot release. If the product is subject to official release by the FDA, the manufacturer submits batch data from each lot of product to the FDA together with a release protocol showing a summary of the history of manufacture of the lot and the results of all of the manufacturer&#8217;s tests performed on the lot. The FDA also may perform certain confirmatory tests on lots of some products before releasing the lots for distribution by the manufacturer. In addition, the FDA conducts laboratory research related to the regulatory standards on the safety, purity, potency and effectiveness of biologics. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing user fee requirements, under which the FDA assesses an annual program fee for each product identified in an approved BLA. Biologic manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMPs, which impose certain procedural and documentation requirements upon us and our third-party manufacturers. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMPs and impose reporting requirements upon us and any third-party manufacturers that we may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMPs and other aspects of regulatory compliance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">or clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">restrictions on the marketing or manufacturing of a product, complete withdrawal of the product from the market or product recalls; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">fines, warning letters or holds on post-approval clinical studies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of existing product approvals; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">product seizure or detention, or refusal of the FDA to permit the import or export of products; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mandated modification of promotional materials and labeling and the issuance of corrective information; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the issuance of safety alerts, Dear Healthcare Provider letters, press releases and other communications containing warnings or other safety information about the product; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">injunctions or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA closely regulates the marketing, labeling, advertising and promotion of biologics. Such products can only be promoted in a manner that is consistent with the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties. Physicians may prescribe legally available products for uses that are not described in the product&#8217;s labeling and that differ from those tested by the sponsor and approved by the FDA. Such off-label uses are common across medical specialties. Physicians may believe that such off-label uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#8217;s communications on the subject of off-label use of their products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Biosimilars and Reference Product Exclusivity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the ACA, includes a subtitle called the Biologics Price Competition and Innovation Act of 2009, or BPCIA, which created an abbreviated approval pathway for biological products that are highly similar, or &#8220;biosimilar,&#8221; to or interchangeable with an FDA-approved reference biological product. The FDA has issued several guidance documents outlining an approach to review and approval of biosimilars.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Biosimilarity, which requires that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity, and potency, is generally shown through analytical studies, animal studies, and a clinical study or studies. Interchangeability requires that a product is biosimilar to the reference product and the product must demonstrate that it can be expected to produce the same clinical results as the reference product in any given patient and, for products that are administered multiple times to an individual, the biologic and the reference biologic may be alternated or switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. A product shown to be biosimilar or interchangeable with an FDA-approved reference biological product may rely in part on the FDA&#8217;s previous determination of safety and effectiveness for the reference product for approval, which can potentially reduce the cost and time required to obtain approval to market the product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing that applicant&#8217;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of its product. The BPCIA also created certain exclusivity periods for biosimilars approved as interchangeable products. FDA-approved interchangeable biosimilars may be substituted for the reference product without the intervention of the prescribing health care provider, subject to state pharmacy laws, which differ by state. The BPCIA is complex and continues to be interpreted and implemented by the FDA.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A biological product can also obtain pediatric market exclusivity in the United States. Pediatric exclusivity, if granted, adds six months to existing exclusivity periods for all formulations, dosage forms, and indications of the biologic. This</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six-month exclusivity, which runs from the end of other exclusivity protection, may be granted based on the voluntary completion of a pediatric study in accordance with an FDA-issued &#8220;Written Request&#8221; for such a study, provided that at the time pediatric exclusivity is granted there is not less than nine months of term remaining.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed below, the Inflation Reduction Act of 2022, or IRA, is a significant new law that intends to foster generic and biosimilar competition and to lower drug and biologic costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Healthcare Laws and Compliance Requirements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pharmaceutical companies are subject to additional healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which they conduct their business. Such laws include, without limitation: the federal Anti-Kickback Statute, or AKS; the federal False Claims Act, or FCA; the Health Insurance Portability and Accountability Act of 1996, or HIPAA, and similar foreign, federal and state fraud, abuse and transparency laws.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The AKS prohibits, among other things, persons and entities from knowingly and willfully soliciting, receiving, offering or paying remuneration, to induce, or in return for, either the referral of an individual, or the purchase, lease, order, arrangement, or recommendation of an item or service for which payment may be made under any federal healthcare program. The term remuneration has been interpreted broadly to include anything of value. The AKS has been interpreted to apply to arrangements between pharmaceutical manufacturers on one hand, and prescribers and purchasers on the other. The government often takes the position that to violate the AKS, only one purpose of the remuneration need be to induce referrals, even if there are other legitimate purposes for the remuneration. A person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it to have committed a violation. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from AKS prosecution, but they are drawn narrowly and practices that involve remuneration, such as consulting agreements, that may be alleged to be intended to induce prescribing, purchasing or recommending may be subject to scrutiny if they do not qualify for an exception or safe harbor. Our practices may not in all cases meet all of the criteria for protection under a statutory exception or regulatory safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the AKS. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. Violations are subject to civil and criminal fines and penalties for each violation, plus up to three times the remuneration involved, imprisonment, and exclusion from government healthcare programs. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal False Claims Act or federal civil monetary penalties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Civil and criminal false claims laws, including the FCA, and civil monetary penalty laws, which impose criminal and civil penalties and can be enforced through civil whistleblower or qui tam actions, prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment of federal government funds, including in federal healthcare programs, that are false or fraudulent; knowingly making, using or causing to be made or used, a false statement of record material to a false or fraudulent claim or obligation to pay or transmit money or property to the federal government or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay money to the federal government. Pharmaceutical and other healthcare companies have been prosecuted under these laws for engaging in a variety of different types of conduct that &#8220;caused&#8221; the submission of false claims to federal healthcare programs. Under the AKS, for example, a claim resulting from a violation of the AKS is deemed to be a false or fraudulent claim for purposes of the FCA. Manufacturers can be held liable under the federal False Claims Act even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims. The federal False Claims Act also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the federal False Claims Act and to share in any monetary recovery.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA created additional federal criminal statutes that prohibit, among other things, executing a scheme to defraud any healthcare benefit program, including private third-party payors, and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements or representations relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH and their respective implementing regulations, including the Final Omnibus Rule published in January 2013, which impose requirements on certain covered healthcare providers, health plans, and healthcare clearinghouses as well as their respective business associates, independent contractors or agents of covered entities, that perform services for them that involve the creation, maintenance, receipt, use, or disclosure of, individually identifiable health information relating to the privacy, security and transmission of individually identifiable health information. HITECH also created new tiers of civil monetary penalties,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. In addition, there may be additional federal, state and non-U.S. laws which govern the privacy and security of health and other personal information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The U.S. federal Physician Payments Sunshine Act requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, to annually report to the Centers for Medicaid &amp; Medicare Services, or CMS, information related to payments or other transfers of value made to various healthcare professionals including physicians, certain other licensed health care practitioners, and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of our product candidates are approved, we will also be subject to federal price reporting laws and federal consumer protection and unfair competition laws. Federal price reporting laws require manufacturers to calculate and report complex pricing metrics to government programs, where such reported prices may be used in the calculation of reimbursement and/ or discounts on approved products. Federal consumer protection and unfair competition laws broadly regulate marketplace activities and activities that potentially harm consumers.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, we are subject to additional similar U.S. state and foreign law equivalents of each of the above federal laws, which, in some cases, differ from each other in significant ways, and may not have the same effect, thus complicating compliance efforts. If our operations are found to be in violation of any of such laws or any other governmental regulations that apply, it may be subject to penalties, including, without limitation, civil, criminal and administrative penalties, damages, fines, exclusion from government-funded healthcare programs, such as Medicare and Medicaid or similar programs in other countries or jurisdictions, integrity oversight and reporting obligations to resolve allegations of non-compliance, disgorgement, individual imprisonment, contractual damages, reputational harm, diminished profits and the curtailment or restructuring of its operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Data Privacy and Security</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Numerous state, federal and foreign laws govern the collection, dissemination, use, access to, confidentiality and security of personal information, including health-related information. As our operations and business grow, we may become subject to or affected by U.S. federal and state laws and regulations, including the Health Information Portability and Accountability Act of 1996, and its implementing regulations, as amended, or HIPAA, that govern the collection, use, disclosure, and protection of health-related and other personal information. At the federal level, in addition to HIPAA, failing to take appropriate steps to keep consumers&#8217; personal information secure may constitute unfair acts or practices in or affecting commerce in violation of Section 5(a) of the Federal Trade Commission Act (the FTCA), 15 U.S.C &#167; 45(a). The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business and the cost of available tools to improve security and reduce vulnerabilities. Regulators and legislators in the U.S. are also increasingly scrutinizing and restricting certain personal data transfers and transactions involving foreign countries. For example, the Biden Administration&#8217;s executive order Preventing Access to Americans&#8217; Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern as implemented by Department of Justice regulations issued in December 2024, prohibits data brokerage transactions involving certain sensitive personal data categories, including health data, genetic data, and biospecimens, to countries of concern, including China. The regulations also restrict certain investment agreements, employment agreements and vendor agreements involving such data and countries of concern, absent specified cybersecurity controls. Actual or alleged violations of these regulations may be punishable by criminal and/or civil sanctions, and may result in exclusion from participation in federal and state programs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, certain state laws govern the privacy and security of personal information. For example, in California the California Consumer Protection Act, or CCPA, which went into effect on January 1, 2020 and was amended effective January 1, 2023 by the California Privacy Rights Act, or CPRA, established a comprehensive privacy framework for covered businesses by creating an expanded definition of personal information, establishing new data privacy rights for consumers in the State of California, imposing special rules on the collection of consumer data from minors, and creating a new and potentially severe statutory damages framework for violations of the CCPA and for businesses that fail to implement reasonable security procedures and practices to prevent data breaches. While clinical trial data and information governed by HIPAA are currently exempt from the current version of the CCPA, other personal information may be applicable and possible changes to the CCPA may broaden its scope. In addition, effective January 1, 2023, the CPRA, imposed additional obligations on companies covered by the CCPA. The CPRA significantly modified the CCPA, including by expanding consumers&#8217; rights with respect to certain sensitive personal information and by establishing the California Privacy Protection Agency to enforce the CCPA.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other states have passed similar privacy legislation and more states may do so in the future. If enacted, proposed legislation may add additional complexity, variation in requirements, restrictions and potential legal risk, require additional investment of resources in compliance programs, impact strategies and the availability of previously useful data and could result in increased compliance costs and/or changes in business practices and policies. The existence of comprehensive privacy laws in different states in the country would make our compliance obligations more complex and costly and may increase the likelihood that we may be subject to enforcement actions or otherwise incur liability for noncompliance. There are also states that are specifically regulating health information. For example, Washington&#8217;s My Health My Data Act, which became effective on March 31, 2024, regulates the collection and sharing of health information and has a private right of action, which further increases the relevant compliance risk. Connecticut and Nevada have also passed similar laws regulating consumer health data. In addition, other states have proposed and/or passed legislation that regulates the privacy and/or security of certain specific types of information. For example, a small number of states have passed laws that regulate biometric data specifically. These various privacy and security laws may impact our business activities, including our identification of research subjects, relationships with business partners and ultimately the marketing and distribution of our products. State laws are changing rapidly and there are discussions in the U.S. Congress of new comprehensive federal data privacy laws to which we could become subject to, if enacted.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Non-U.S. laws, including for example the European data protection laws, also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. The collection, use, storage, disclosure, transfer, or other processing of personal information regarding individuals in the EEA and UK, including personal health data, is subject to the EU General Data Protection Regulation, or EU GDPR, with respect to the EEA and the UK General Data Protection Regulation and UK Data Protection Act 2018 with respect to the UK, or UK GDPR, and collectively with the EU GDPR referred to as the &#8220;GDPR&#8221; in this document unless specified otherwise. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal information, including requirements relating to processing of special categories of personal information (such as health data), relying on a legal basis or condition for processing personal information, where required obtaining consent of the individuals to whom the personal information relates, providing information to individuals regarding data processing activities, conducting privacy impact assessments for &#8220;high risk&#8221; processing, implementing safeguards to protect the security and confidentiality of personal information, implementing limitations on the retention of personal information, providing mandatory notification of data breaches, and taking certain measures when engaging third-party processors. The GDPR also imposes strict rules on the transfer of personal information to countries outside the EEA and UK to non-adequate territories, including the United States in certain circumstances unless derogation exists or a valid GDPR transfer mechanism (for example, the European Commission approved Standard Contractual Clauses, or SCCs, and the UK International Data Transfer Agreement/Addendum, or UK IDTA) have been put in place. Where relying on the SCCs /UK IDTA for data transfers, we may also be required to carry out transfer impact assessments to assess whether the recipient is subject to local laws which allow public authority access to personal information. Failure to comply with the GDPR, and any supplemental EEA Member State or UK national data protection laws which may apply by virtue of the location of the individuals whose personal information we collect, may result in substantial penalties, including potential fines of up to &#8364;20 million (&#163;17.5 million for the UK GDPR) or 4% of annual global revenues for the preceding financial year, whichever is greater. The GDPR also confers a private right of action on data subjects and consumer associations to lodge complaints with supervisory authorities, seek judicial remedies, and obtain compensation for damages resulting from violations of the GDPR. The GDPR increases our responsibility and liability in relation to personal information that we process where such processing is subject to the GDPR, and requires us to put in place additional mechanisms to ensure compliance with the GDPR, including as implemented by individual countries. Compliance with the GDPR will be a rigorous and time-intensive process that may increase our cost of doing business or require us to change our business practices, and despite those efforts, there is a risk that we may be subject to fines and penalties, litigation, and reputational harm in connection with our European activities.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All of these evolving compliance and operational requirements impose significant costs, such as costs related to organizational changes, implementing additional protection technologies, training employees and engaging consultants and legal advisors, which are likely to increase over time. In addition, such requirements may require us to modify our data processing practices and policies, utilize management&#8217;s time and/or divert resources from other initiatives and projects. Failure, or perceived failure, to comply with these laws, where applicable, can result in damage to our reputation, as well as proceedings or litigation by governmental agencies or other third parties as well as the imposition of significant civil and/or criminal penalties and private class action litigation. Privacy and security laws, regulations, and other obligations are constantly evolving, may conflict with each other to complicate compliance efforts, and can result in investigations, proceedings, or actions that lead to significant civil and/or criminal penalties and restrictions on data processing. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Coverage and Reimbursement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the United States and markets in other countries, patients generally rely on third-party payors to reimburse all or part of the costs associated with their treatment. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product acceptance. Our ability to successfully commercialize our product candidates will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow it to establish or maintain pricing sufficient to realize a sufficient return on its investment. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Significant uncertainty exists as to the coverage and reimbursement status of any pharmaceutical or biological product for which we obtain regulatory approval. Sales of any product, if approved, depend, in part, on the extent to which such product will be covered by third-party payors, such as federal, state, and foreign government healthcare programs, commercial insurance and managed healthcare organizations, and the level of reimbursement, if any, for such product by third-party payors. Decisions regarding whether to cover any of our product candidates, if approved, the extent of coverage and amount of reimbursement to be provided are made on a plan-by-plan basis. Further, no uniform policy for coverage and reimbursement exists in the United States, and coverage and reimbursement can differ significantly from payor to payor. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement rates, but also have their own methods and approval process apart from Medicare determinations. As a result, the coverage determination process is often a time-consuming and costly process that will require it to provide scientific and clinical support for the use of our product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. Factors payors consider in determining reimbursement are based on whether the product is:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a covered benefit under its health plan; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">safe, effective and medically necessary; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">appropriate for the specific patient; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cost-effective; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">neither experimental nor investigational. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third-party payors are increasingly challenging the prices charged for medical products and services, examining the medical necessity and reviewing the cost effectiveness of pharmaceutical or biological products, medical devices and medical services, in addition to questioning safety and efficacy. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit sales of any product that receives approval. Decreases in third-party reimbursement for any product or a decision by a third-party not to cover a product could reduce physician usage and patient demand for the product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For products administered under the supervision of a physician, obtaining coverage and adequate reimbursement may be particularly difficult because of the higher prices often associated with such drugs. Additionally, separate reimbursement for the product itself or the treatment or procedure in which the product is used may not be available, which may impact physician utilization. In addition, companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to companion diagnostics.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are challenging the prices charged for medical products. We cannot be sure that reimbursement will be available for any product candidate that it commercializes and, if reimbursement is available, the level of reimbursement. In addition, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price, or ASP, and best price. Penalties may apply in some cases when such metrics are not submitted accurately and timely. Further, these prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Finally, in some foreign countries, the proposed pricing for a drug must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. For example, the European Union, or EU,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provides options for its member states to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. To obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost effectiveness of a particular product candidate to currently available therapies. A member state may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our product candidates. Historically, products launched in the EU do not follow price structures of the U.S. and generally prices tend to be significantly lower.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Healthcare Reform</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The United States and some foreign jurisdictions are considering or have enacted a number of reform proposals to change the healthcare system. There is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by federal and state legislative initiatives, including those designed to limit the pricing, coverage, and reimbursement of pharmaceutical and biopharmaceutical products, especially under government-funded health care programs, and increased governmental control of drug pricing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The ACA, which was enacted in 2010, substantially changed the way healthcare is financed by both governmental and private insurers in the United States, and significantly affected the pharmaceutical industry. The ACA contains a number of provisions of particular import to the pharmaceutical and biotechnology industries, including, but not limited to, those governing enrollment in federal healthcare programs. Since its enactment, there have been judicial and Congressional challenges to certain aspects of the ACA, and we expect there will be additional challenges and amendments to the ACA in the future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other legislative changes have been proposed and adopted since the ACA was enacted. For example, the American Rescue Plan Act of 2021 eliminated the statutory Medicaid drug rebate cap, previously set at 100% of a drug&#8217;s average manufacturer price, for single source and innovator multiple source drugs, effective January 1, 2024. The Budget Control Act of 2011 and subsequent legislation, among other things, created measures for spending reductions that include aggregate reductions of Medicare payments to providers of 2% per fiscal year, which remain in effect through 2031. Also, the U.S. American Taxpayer Relief Act of 2012 further reduced Medicare payments to several types of providers and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. Due to the Statutory Pay-As-You-Go Act of 2010, estimated budget deficit increases resulting from the American Rescue Plan Act of 2021, and subsequent legislation, Medicare payments to providers were further reduced starting on January 1, 2025; however, legislation has been introduced (but not passed) in the U.S. Congress that would reverse these payment reductions.  These laws and regulations may result in additional reductions in Medicare and other healthcare funding available for healthcare providers and may otherwise affect the price we can obtain for any of our product candidates for which we may obtain regulatory approval or the frequency with which any such product candidate is prescribed or used.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Inflation Reduction Act of 2022, or IRA, includes several provisions that may impact our business to varying degrees, including provisions that reduce the out-of-pocket spending cap for Medicare Part D beneficiaries from $7,050 to $2,000 starting in 2025, thereby effectively eliminating the coverage gap; impose new manufacturer financial liability on certain drugs under Medicare Part D, allow the U.S. government to negotiate Medicare Part B and Part D price caps for certain high-cost drugs and biologics without generic or biosimilar competition; require companies to pay rebates to Medicare for certain drug prices that increase faster than inflation; and delay until January 1, 2032 the implementation of the HHS rebate rule that would have limited the fees that pharmacy benefit managers can charge. Further, under the IRA, orphan drugs are exempted from the Medicare drug price negotiation program, but only if they have one orphan designation and for which the only approved indication is for that disease or condition. If a product receives multiple orphan designations or has multiple approved indications, it may not qualify for the orphan drug exemption. The implementation of the IRA is currently subject to ongoing litigation that challenges the constitutionality of the IRA&#8217;s Medicare drug price negotiation program. The effects of the IRA on our business and the healthcare industry in general is not yet known.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, there has recently been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed and enacted federal and state measures designed to, among other things, reduce the cost of prescription drugs, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, the U.S. government, state legislatures and foreign governments have continued implementing cost-containment programs, including price controls, restrictions on coverage and reimbursement and requirements for substitution of generic products. The IRA includes several provisions that may impact our business to varying degrees, including provisions that reduce the out-of-pocket spending cap for Medicare Part D beneficiaries from $7,050 to $2,000 starting in 2025, thereby effectively eliminating the coverage gap; impose new manufacturer financial liability on certain drugs under Medicare Part D, allow the U.S. government to negotiate Medicare Part B and Part D price caps for certain high-cost drugs and biologics without generic or biosimilar competition; require companies to pay rebates to Medicare for certain drug prices that increase faster than inflation; and delay until January 1, 2032 the implementation of the HHS rebate rule that would have limited the fees that pharmacy benefit managers can charge. Further, under the IRA, orphan drugs are exempted from the Medicare drug price negotiation program, but only if they have one rare disease designation and for which the only approved indication is for that disease or condition. If a product receives multiple rare disease designations or has multiple approved indications, it may not qualify for the orphan drug exemption. The implementation of the IRA is currently subject to ongoing litigation challenging the constitutionality of the IRA&#8217;s Medicare drug price negotiation program. The effects of the IRA on our business and the healthcare industry in general is not yet known.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">President Trump has also issued multiple executive orders that have sought to reduce prescription drug costs. Although a number of these and other proposed measures may require authorization through additional legislation to become effective, and the Trump administration may reverse or otherwise change these measures, both the Trump administration and Congress have indicated that they will continue to seek new legislative measures to control drug costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the IRA and President Trump&#8217;s executive orders, continued legislative and enforcement interest exists in the United States with respect to specialty drug pricing practices. Specifically, we expect regulators to continue pushing for transparency to drug pricing, reducing the cost of prescription drugs under Medicare, reviewing the relationship between pricing and manufacturer patient programs, and reforming government program reimbursement methodologies for drugs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individual states in the United States have also become increasingly active in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain drug access and marketing cost disclosure and transparency measures, and designed to encourage importation from other countries and bulk purchasing. Legally mandated price controls on payment amounts by third-party payors or other restrictions could harm our business, financial condition, results of operations and prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. This could reduce the ultimate demand for its drugs or put pressure on its drug pricing, which could negatively affect our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Government Regulation Outside of the United States</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Regulation Outside of the United States</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EU Drug Development</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to regulations in the United States, we are subject to a variety of regulations in other jurisdictions governing clinical studies, commercial sales, and distribution of our products. Most countries outside of the United States require that clinical trial applications be submitted to and approved by the local regulatory authority for each clinical study. In the EU, for example, an application must be submitted to the national competent authority and an independent ethics committee in each country in which we intend to conduct clinical trials, much like the FDA and IRB, respectively. Under the new Clinical Trials Regulation (EU) No 536/2014, which replaced the Clinical Trials Directive 2001/20/EC on January 31, 2022, a single application is now made through the Clinical Trials Information System for clinical trial authorization in up to 30 EU/EEA countries at the same time and with a single set of documentation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The assessment of applications for clinical trials is divided into two parts (Part I contains scientific and medicinal product documentation and Part II contains the national and patient-level documentation). Part I is assessed by a coordinated review by the competent authorities of all EU Member States in which an application for authorization of a clinical trial has been submitted (Member States Concerned) of a draft report prepared by a Reference Member State (as defined below). Part II is assessed separately by each Member State Concerned. The role of the relevant ethics committees in the assessment procedure will continue to be governed by the national law of the Member State Concerned, however overall related timelines are defined by the Clinical Trials Regulation. The new Clinical Trials Regulation also provides for simplified reporting procedures for clinical trial sponsors.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EU Drug Review and Approval</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, whether or not we obtain FDA approval for a product, we must obtain approval of a product by the comparable regulatory authorities of countries outside the United States before we can commence marketing of the product in those countries. The approval process and requirements vary from country to country, so the number and type of nonclinical, clinical, and manufacturing studies needed may differ, and the time may be longer or shorter than that required for FDA approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To obtain regulatory approval for our medicinal products under the EU regulatory system, a marketing authorization application, or MAA, needs to be submitted. There are a number of potential routes open to obtain a marketing authorization, or MA. The centralized procedure allows applicants to obtain a MA that is valid throughout the EU, and the additional Member States of the European Economic Area (Iceland, Liechtenstein and Norway), or EEA. It is compulsory for medicinal products manufactured using biotechnological processes, orphan medicinal products, advanced therapy medicinal products (gene-therapy, somatic cell-therapy or tissue-engineered medicines) and human products containing a new active substance which is not authorized in the EU and which is intended for the treatment of HIV, AIDS, cancer, neurodegenerative disorders, auto-immune and other immune dysfunctions, viral diseases or diabetes. The centralized procedure is optional for any other products containing new active substances not authorized in the EU or for products which constitute a significant therapeutic, scientific, or technical innovation or for which a centralized authorization is in the interests of patients at EU level. When a company wishes to place on the market a medicinal product that is eligible for the centralized procedure, it sends an application directly to the European Medicines Agency, or EMA, to be assessed by the Committee for Medicinal Products for Human Use, or CHMP. The CHMP is responsible for conducting the assessment of whether a medicine meets the required quality, safety, and efficacy requirements, and whether the product has a positive risk/benefit profile. The procedure results in a European Commission decision, which is valid in all EU Member States. The centralized procedure is as follows: full copies of the MAA are sent to a rapporteur and a co-rapporteur designated by the competent EMA scientific committee. They coordinate the EMA&#8217;s scientific assessment of the medicinal product and prepare draft reports. Once the draft reports are prepared (other experts might be called upon for this purpose), they are sent to the CHMP, whose comments or objections are communicated to the applicant. The rapporteur acts as an EMA contact person for the applicant and continues to play this role, even after the MA has been granted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rapporteur and co-rapporteur then assess the applicant&#8217;s replies, submit them for discussion to the CHMP, and taking into account the conclusions of this debate, prepare a final assessment report. Once the evaluation is completed, the CHMP gives a favorable or unfavorable opinion as to whether to grant the authorization. When the opinion is favorable, it shall include the draft summary of product characteristics, or SmPC, the package leaflet, and the texts proposed for the various packaging materials. The time limit for the evaluation procedure is 210 days (excluding clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP). The EMA then has fifteen days to forward its opinion to the European Commission, which will make a binding decision on the grant of an MA within 67 days of the receipt of the CHMP opinion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are two other procedures in the EU for the grant of an MA in multiple EU Member States. The decentralized procedure provides for approval by one or more other, or concerned member states, of an assessment of an application performed by one Member State, known as the Reference Member State. Under this procedure, an applicant submits an application, or dossier, and related materials including a draft SmPC, and draft labeling and package leaflet, to the Reference Member State and concerned member states. The Reference Member State prepares a draft assessment and drafts of the related materials within 120 days after receipt of a valid application. Within 90 days of receiving the Reference Member State&#8217;s assessment report, each concerned member state must decide whether to approve the assessment report and related materials. If a Member State cannot approve the assessment report and related materials on the grounds of potential serious risk to the public health, the disputed points may eventually be referred to the European Commission, whose decision is binding on all member states. Where a product has already been authorized for marketing in a EU Member State, this national MA can be recognized in other member states through the mutual recognition procedure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EU New Chemical Entity Exclusivity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the EU, innovative medicinal products approved on the basis of a complete and independent data package qualify for eight years of data exclusivity upon marketing authorization and an additional two years of market exclusivity. The data exclusivity, if granted, prevents generic or biosimilar applicants from referencing the innovator&#8217;s preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar MA in the EU, during a period of eight years from the date on which the reference product was first authorized in the EU. During the additional two-year period of market exclusivity, a generic or biosimilar MAA can be submitted, and the innovator&#8217;s data may be referenced, but no generic or biosimilar product can be placed on the EU market until the expiration of the market exclusivity. The overall ten-year period will be extended to a maximum of 11 years if, during the first eight years of those ten years, the marketing authorization holder</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are determined to bring a significant clinical benefit in comparison with currently approved therapies. There is no guarantee that a product will be considered by the EMA to be an innovative medicinal product, and products may not qualify for data exclusivity. Even if a product is considered to be an innovative medicinal product so that the innovator gains the prescribed period of data exclusivity, however, another company could nevertheless also market another version of the product if such company obtained an MA based on an MAA with a complete and independent data package of pharmaceutical tests, preclinical tests and clinical trials.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EU Orphan Designation and Exclusivity</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The criteria for designating an &#8220;orphan medicinal product&#8221; in the EU are similar in principle to those in the United States. Under Article 3 of Regulation (EC) 141/2000, a medicinal product may be designated as an orphan medicinal product if it is intended for the diagnosis, prevention, or treatment of a life-threatening or chronically debilitating condition that affects no more than five in 10,000 persons in the EU when the application is made. In addition, orphan designation can be granted if the product is intended for a life threatening, seriously debilitating, or serious and chronic condition in the EU and, without incentives, it is unlikely that sales of the product in the EU would be sufficient to justify the necessary investment in its development. Orphan designation is only available if there is no other satisfactory method approved in the EU of diagnosing, preventing, or treating the applicable orphan condition, or if such a method exists, the proposed orphan medicinal product will be of significant benefit to patients affected by such condition, as defined in Regulation (EC) 847/2000.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Orphan designation provides opportunities for fee reductions, protocol assistance, and access to the centralized procedure. Fee reductions are limited to the first year after an MA, except for small and medium enterprises. In addition, if a product which has an orphan designation subsequently receives a centralized MA for the indication for which it has such designation, the product is entitled to orphan market exclusivity, which means the EMA may not approve any other application to market a similar medicinal product for the same indication for a period of ten years. A &#8220;similar medicinal product&#8221; is defined as a medicinal product containing a similar active substance or substances as contained in an authorized orphan medicinal product, and which is intended for the same therapeutic indication. The exclusivity period may be reduced to six years if, at the end of the fifth year, it is shown that the designation criteria are no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market exclusivity. Additionally, an MA may be granted to a similar medicinal product for the same indication at any time if:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the second applicant can establish that its product, although similar to the authorized product, is safer, more effective or otherwise clinically superior; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the MA holder of the authorized product consents to a second orphan medicinal product application; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the MA holder of the authorized product cannot supply enough orphan medicinal product. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">EU Pediatric Investigation Plan</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A pediatric investigation plan, or PIP, in the EU is aimed at ensuring that the necessary data are obtained to support the authorization of a medicine for children, through studies in children. All applications for MAs for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral or waiver. This requirement also applies when an MA holder wants to add a new indication, pharmaceutical form, or route of administration for a medicine that is already authorized and covered by intellectual property rights. Several rewards and incentives for the development of pediatric medicines for children are available in the EU. Medicines authorized across the EU with the results of studies from a PIP included in the product information are eligible for an extension of their supplementary protection certificate, or SPC, by six months (provided an application for such extension is made at the same time as filing the SPC application for the product, or at any point up to two years before the SPC expires). This is the case even when the studies&#8217; results are negative. For orphan medicinal products, the incentive is an additional two years of market exclusivity. Scientific advice and protocol assistance at the EMA are free of charge for questions relating to the development of pediatric medicines. Medicines developed specifically for children that are already authorized but are not protected by a patent or supplementary protection certificate are eligible for a pediatric-use MA, or PUMA. If a PUMA is granted, the product will benefit from ten years of market protection as an incentive.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">PRIME Scheme</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In March 2016, the EMA launched an initiative, the PRIority Medicines, or PRIME, scheme, to facilitate development of product candidates in indications, often rare, for which few or no therapies currently exist. The PRIME scheme is intended to encourage development of products in areas of unmet medical need and provides accelerated assessment of products</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">representing substantial innovation reviewed under the centralized procedure. Products from small- and medium-sized enterprises may qualify for earlier entry into the PRIME scheme than larger companies on the basis of compelling non-clinical data and tolerability data from initial clinical trials. Many benefits accrue to sponsors of product candidates with PRIME designation, including but not limited to, early and proactive regulatory dialogue with the EMA, frequent discussions on clinical trial designs and other development program elements, and potentially accelerated MAA assessment once a dossier has been submitted. Importantly, once a candidate medicine has been selected for the PRIME scheme, a dedicated contact and rapporteur from the CHMP or from the Committee for Advanced Therapies, or CAT, are appointed early in the PRIME scheme facilitating increased understanding of the product at the EMA&#8217;s committee level. An initial meeting with the CHMP/CAT rapporteur initiates these relationships and includes a team of multidisciplinary experts at the EMA to provide guidance on the overall development and regulatory strategies. PRIME eligibility does not change the standards for product approval, and there is no assurance that any such designation or eligibility will result in expedited review or approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The aforementioned EU rules are generally applicable in the EEA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Reform of the Regulatory Framework in the EU</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The European Commission introduced legislative proposals in April 2023, that if implemented, will replace the current regulatory framework in the EU for all medicines (including those for rare diseases and for children). The European Commission has provided the legislative proposals to the European Parliament and the European Council for their review and approval. The European Parliament and the European Council may propose amendments to the proposals. Once the proposals are approved (with or without amendment), they will be adopted into EU law.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Brexit and the Regulatory Framework in the United Kingdom</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The United Kingdom left the EU on January 31, 2020, and the United Kingdom and the EU have concluded a trade and cooperation agreement, or TCA, which was provisionally applicable since January 1, 2021 and has been formally applicable since May 1, 2021.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The TCA includes specific provisions concerning pharmaceuticals, which include the mutual recognition of GMP, inspections of manufacturing facilities for medicinal products and GMP documents issued, but does not provide for wholesale mutual recognition of United Kingdom and EU pharmaceutical regulations. At present, Great Britain has implemented EU legislation on the marketing, promotion and sale of medicinal products through the Human Medicines Regulations 2012 (as amended). Except in respect of the new EU Clinical Trials Regulation, the regulatory regime in Great Britain therefore largely aligns with current EU medicines regulations, however it is possible that these regimes will diverge more significantly in future now that Great Britain&#8217;s regulatory system is independent from the EU and the TCA does not provide for mutual recognition of United Kingdom and EU pharmaceutical legislation. However, notwithstanding that there is no wholesale recognition of EU pharmaceutical legislation under the TCA, under a new framework mentioned below which will be put in place by the Medicines and Healthcare products Regulatory Agency, or MHRA, the United Kingdom&#8217;s medicines regulator, from January 1, 2024, the MHRA has stated that it will take into account decisions on the approval of MAs from the EMA (and certain other regulators) when considering an application for a Great Britain MA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 27, 2023, the United Kingdom government and the European Commission announced a political agreement in principle to replace the Northern Ireland Protocol with a new set of arrangements, known as the &#8220;Windsor Framework&#8221;. This new framework fundamentally changes the existing system under the Northern Ireland Protocol, including with respect to the regulation of medicinal products in the United Kingdom. In particular, the MHRA will be responsible for approving all medicinal products destined for the United Kingdom market (i.e., Great Britain and Northern Ireland), and the EMA will no longer have any role in approving medicinal products destined for Northern Ireland. A single United Kingdom-wide MA will be granted by the MHRA for all medicinal products to be sold in the United Kingdom, enabling products to be sold in a single pack and under a single authorization throughout the United Kingdom. The Windsor Framework was approved by the EU-United Kingdom Joint Committee on March 24, 2023, so the United Kingdom government and the EU will enact legislative measures to bring it into law. On June 9, 2023, the MHRA announced that the medicines aspects of the Windsor Framework will apply from January 1, 2025.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The MHRA has introduced changes to national licensing procedures, including procedures to prioritize access to new medicines that will benefit patients, an accelerated assessment procedure and new routes of evaluation for novel products and biotechnological products. All existing EU MAs for centrally authorized products were automatically converted (grandfathered) into United Kingdom MAs free of charge on January 1, 2021. For a period of three years from January 1, 2021, the MHRA may rely on a decision taken by the European Commission on the approval of a new MA in the centralized procedure, in order to more quickly grant a new Great Britain MA. A separate application will, however, still be required. On January 24, 2023, the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">MHRA announced that a new international recognition framework will be put in place from January 1, 2024, which will have regard to decisions on the approval of MAs made by the EMA and certain other regulators when determining an application for a new Great Britain MA. There is now no pre-MA orphan designation in Great Britain. Instead, the MHRA reviews applications for orphan designation in parallel to the corresponding MAA. The criteria are essentially the same, but have been tailored for the Great Britain market, i.e., the prevalence of the condition in Great Britain (rather than the EU) must not be more than five in 10,000. Should an orphan designation be granted, the period of market exclusivity will be set from the date of first approval of the product in Great Britain.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Human Capital</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had 42 full-time employees, of which 6 have M.D. or Ph.D. degrees. Within our workforce, 31 employees are engaged in research and development and 12 are engaged in general management and administration. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. The principal purposes of our equity incentive plans are to attract, retain and reward personnel through the granting of equity-based compensation awards in order to increase shareholder value and the success of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Facilities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our principal office is located at 830 Winter Street, Waltham, Massachusetts 02451, where we lease approximately 15,771 square feet of office space. The lease term began in January 2022 and will end in December 2031. We believe that this facility will be adequate to meet our near-term needs. If required, we believe that suitable additional or substitute space will be available in the future on commercially reasonable terms to accommodate any such expansion our operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate Information</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We were incorporated under the laws of the State of Delaware on April 10, 2017. Our principal executive office is located at 830 Winter Street, Waltham, Massachusetts 02451, and our telephone number is (781) 999-0232. Our website address is www.q32bio.com. References to our website address to not constitute incorporation by reference of the information contained on the website, and the information on the website is not part of this document.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 25, 2024, Kenobi Merger Sub, Inc., or Merger Sub, a wholly-owned subsidiary of Homology Medicines, Inc., or Homology, completed its merger with and into Q32 Bio Operations Inc. (previously named Q32 Bio Inc. and referred to herein as Legacy Q32), with Legacy Q32 continuing as the surviving entity as a wholly-owned subsidiary of Homology. This transaction is referred to as the Merger. Homology changed its name to Q32 Bio, Inc., and Legacy Q32, which remains as a wholly-owned subsidiary of ours, changed its name to Q32 Bio Operations, Inc. The Merger was effected pursuant to an Agreement and Plan of Merger, or the Merger Agreement, dated as of November 16, 2023, by and among Homology, Legacy Q32, and Merger Sub. Effective March 26, 2024, our common stock is listed on the Nasdaq Global Market, under the trading symbol &#8220;QTTB.&#8221;</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Available Information</span></p>
  <p style="text-indent:5.133%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We file electronically with the Securities and Exchange Commission, or SEC, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements and other information. Our SEC filings are available to the public over the Internet at the SEC's website at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">http://www.sec.gov</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. We make available on our website at www.q32bio.com, under &#8220;Investors &amp; Media,&#8221; free of charge, copies of these reports as soon as reasonably practicable after filing or furnishing these reports with the SEC. A copy of our Corporate Governance Guidelines, Code of Business Conduct and Ethics and the charters of the Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee and Research and Development Committee of our Board of Directors are posted on our website, www.q32bio.com, under &#8220;Investors &amp; Media&#8221;. The information contained in the websites referenced in this Annual Report on Form 10-K is not incorporated by reference into this Annual Report on Form 10-K.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1a_risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1A. Risk F</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">actors.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">You should consider carefully the risks and uncertainties described below, together with all of the other information in this Annual Report on Form 10-K and in our other filings with the Securities and Exchange Commission, or SEC. We operate in a dynamic and rapidly changing industry that involves numerous risks and uncertainties. The risks and uncertainties described below are not the only ones we face. Other risks and uncertainties, including those that we do not currently consider material, may impair our business. If any of the risks discussed below actually occur, our business, financial condition, operating results or cash flows could be materially adversely affected. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks we face as described below and elsewhere in this Annual Report on Form 10-K.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Limited Operating History, Financial Position and Need for Capital</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have incurred significant losses since inception, expect to incur significant losses for the foreseeable future and may not be able to achieve or sustain profitability in the future. We have no products for sale, have not generated any product revenue and may never generate product revenue or become profitable.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investment in biotechnology product development is a highly speculative undertaking and entails substantial upfront expenditures and significant risks that any program will fail to demonstrate adequate efficacy or an acceptable safety profile, gain regulatory approval and become commercially viable. We have no products approved for commercial sale nor have we generated any revenue from product sales to date and we continue to incur significant research and development and other expenses related to our ongoing operations. We do not expect to generate product revenue unless or until it successfully completes clinical development and obtains regulatory approval of, and then successfully commercializes, at least one product candidate. We may never succeed in these activities and, even if it does, may never generate product revenue or revenues that are significant or large enough to achieve profitability. If we are unable to generate sufficient revenue through the sale of any approved products, it may be unable to continue operations without additional funding.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred recurring operating losses since inception. Our net loss for the years ended December 31, 2024 and 2023 was $47.7 million and $53.7 million, respectively. We expect to continue to incur significant losses for the foreseeable future. Our operating expenses and net losses may fluctuate significantly from quarter to quarter and year to year. We anticipate that our expenses will increase substantially if and as we:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">advance our existing and future programs through preclinical and clinical development, including expansion into additional indications; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seek to identify additional programs and additional product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">maintain, expand, enforce, defend and protect our intellectual property portfolio; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seek regulatory and marketing approvals for product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">seek to identify, establish and maintain additional collaborations and license agreements; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ultimately establish a sales, marketing and distribution infrastructure to commercialize any drug products for which we may obtain marketing approval, either by ourselves or in collaboration with others; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">commence commercial sales of products for which we receive marketing approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hire additional personnel including research and development, clinical and commercial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">add operational, financial and management information systems and personnel, including personnel to support product development; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">acquire or in-licenses products, intellectual property and technologies; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish commercial-scale current good manufacturing practices, or cGMP, capabilities through a third-party or our own manufacturing facility. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, our expenses will increase if, among other things, we are required by the U.S. Food and Drug Administration, or the FDA, or other regulatory authorities to perform trials or studies in addition to, or different than, those that we currently anticipate, there are any delays in completing our clinical trials or the development of any product candidates, or there are any third-party challenges to our intellectual property or we need to defend against any intellectual property-related claim.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we obtain marketing approval for, and are successful in commercializing, one or more product candidates, we expect to incur substantial additional research and development and other expenditures to develop and market additional programs and/or to expand the approved indications of any marketed product. We may encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may adversely affect our business. The size of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our failure to become profitable would decrease our value and could impair our ability to raise capital, maintain our research and development efforts, expand our business and/or continue our operations. A decline in our value could also cause you to lose all or part of your investment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will require substantial additional capital to finance our operations in the future. If we are unable to raise such capital when needed, or on acceptable terms, we may be forced to delay, reduce or eliminate clinical trials, product development programs or future commercialization efforts.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Developing biotechnology products is a very long, time-consuming, expensive and uncertain process that takes years to complete. Since inception, we have funded our operations primarily through private equity and debt financings and have incurred significant recurring losses. We expect our expenses to increase in connection with our ongoing activities, particularly as we conduct our clinical trials for bempikibart, initiate additional clinical trials, and continue to research, develop and conduct preclinical studies of our other potential product candidates, and continue to operate as a public company. In addition, if we obtain regulatory approval for any product candidate for commercial sale, we anticipate incurring significant commercialization expenses related to product manufacturing, marketing, sales and distribution activities to launch any such product. Our expenses could increase beyond expectations if we are required by the FDA or other regulatory agencies to perform preclinical studies or clinical trials in addition to those that we currently anticipate. Because the design and outcome of our current, planned and anticipated clinical trials are highly uncertain, and many of our near-term plans are subject to regulatory feedback, we cannot reasonably estimate the actual amount of funding that will be necessary to successfully complete the development and commercialization of any product candidate we develop. Our future capital requirements depend on many factors, including factors that are not within our control.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will also incur additional costs associated with operating as a public company. We will require substantial additional funding to continue our operations. Based on our current operating plan, we believe that our existing cash, cash equivalents and short-term investments should be sufficient to fund our operations to the second half of 2026. We have based this estimate on assumptions that may prove to be wrong, and we could use our available capital resources sooner than we currently expect. Our future capital requirements will depend on many factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing and progress of preclinical and clinical development activities, including our ongoing Phase 2 clinical trial for bempikibart in alopecia areata, or AA; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and scope of preclinical and clinical programs we pursue; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish an acceptable safety profile with IND-enabling toxicology studies to enable clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">successful patient enrollment in, and the initiation and completion of, larger and later-stage clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">per subject trial costs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and extent of trials required for regulatory approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the countries in which the trials are conducted; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the length of time required to enroll eligible subjects in clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of subjects that participate in the trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the drop-out and discontinuation rate of subjects; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential additional safety monitoring requested by regulatory agencies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the duration of subject participation in the trials and follow-up; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we encounter any serious adverse events in our clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing of receipt of regulatory approvals from applicable regulatory authorities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing, receipt and terms of any marketing approvals and post-marketing approval commitments from applicable regulatory authorities; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we establish or maintain collaborations, strategic partnerships, or other strategic arrangements with third parties, if any, and the performance of any such third parties in connection therewith; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">hiring and retaining research and development personnel; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our arrangements with our contract development and manufacturing organizations, or CDMOs, and contract research organizations, or CROs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">development and timely delivery of clinical and commercial-grade drug formulations that can be used in our planned clinical trials and for commercial launch, respectfully; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the impact of any business interruptions to our operations or to those of the third parties with whom we work; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining, maintaining, defending and enforcing patent claims and other intellectual property rights. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adequate additional financing may not be available to us on acceptable terms, or at all, and we may be required to seek additional funds sooner than planned through public equity offerings, debt financings, collaborations and licensing arrangements or other sources. Such financing may dilute our stockholders or the failure to obtain such financing may restrict our operating activities. Any additional fundraising efforts may divert our management from our day-to-day activities, which may adversely affect our business. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences and anti-dilution protections that adversely affect your rights as a stockholder. Debt financing or refinancing may result in imposition of debt covenants, increased fixed payment obligations or other restrictions that may affect our business. If we raise additional funds through upfront payments or milestone payments pursuant to future collaborations with third parties, we may have to relinquish valuable rights to product development programs, or grant licenses on terms that are not favorable to us. Our ability to raise additional capital may be adversely impacted by global macroeconomic conditions and volatility in the credit and financial markets in the U.S. and worldwide, over which we may have no or little control. Our failure to raise capital as and when needed or on acceptable terms would have a negative impact on our financial condition and ability to pursue our business strategy, and we may have to delay, reduce the scope of, suspend or eliminate clinical trials, product development programs or future commercialization efforts.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have a limited operating history and have no products approved for commercial sale which may make it difficult for you to evaluate our current business and likelihood of success and viability.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical-stage biotechnology company with limited operating history. Since our inception in 2017, we have incurred significant operating losses and have utilized substantially all of our resources to conduct research and development activities (including with respect to our bempikibart and ADX-097 programs) and undertake preclinical studies of product candidates, as well as for conducting clinical trials of our most advanced product candidates and the manufacturing of such product candidates, business planning, developing and maintaining our intellectual property portfolio, hiring personnel, raising capital, and providing general and administrative support for these activities. We have limited significant experience as a company in initiating, conducting or completing clinical trials. In part because of this lack of experience, we cannot be certain that our current and planned clinical trials will begin or be completed on time, if at all. We have not yet demonstrated our ability to successfully complete Phase 3 or other pivotal clinical trials, obtain regulatory or marketing approvals, manufacture a commercial-scale product or arrange for a third party to do so on our behalf, or conduct sales, marketing and distribution activities necessary for successful product commercialization. Additionally, we expect our financial condition and operating results to continue to fluctuate significantly from period to period due to a variety of factors, many of which are beyond our control. Consequently, any predictions made about our future success or viability may not be as accurate as they could be if we had a longer operating history.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, as our business grows, we may encounter unforeseen expenses, restrictions, difficulties, complications, delays and other known and unknown factors. We will need to transition at some point from a company with an early research and development focus to a company capable of supporting larger scale clinical trials and eventually commercial activities. We may not be successful in such a transition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Discovery, Development and Commercialization</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We face competition from entities that have developed or may develop programs for the diseases we plan to address with bempikibart or other product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The development and commercialization of drugs and biologics is highly competitive. Our product candidates may compete with other product candidates in development for similar indications, and if approved, bempikibart or other product candidates will face significant competition and our failure to effectively compete may prevent us from achieving significant</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">market penetration. We compete with a variety of multinational biopharmaceutical companies, specialized biotechnology companies and emerging biotechnology companies, as well as academic institutions, governmental agencies, and public and private research institutions, among others. Many of the companies with which we are currently competing or will compete against in the future have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals, and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical and biotechnology industry may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites, patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, bempikibart or other product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our competitors have developed, are developing or may develop programs and processes competitive with bempikibart or other product candidates and processes. Competitive therapeutic treatments include those that have already been approved and accepted by the medical community and any new treatments. Our success will depend partially on our ability to develop and commercialize products that have a competitive safety, efficacy, dosing and/or presentation profile. Our commercial opportunity and success will be reduced or eliminated if competing products are safer, more effective, have a more attractive dosing profile or presentation or are less expensive than any products we may develop, if any, or if competitors develop competing products or if generic products or biosimilars enter the market more quickly than we are able to, if at all, and are able to gain market acceptance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Bempikibart and the rest of our pipeline are in early stages of development and may fail in development or suffer delays that materially and adversely affect their commercial viability. If we or our current or future collaborators are unable to complete development of, or commercialize, our product candidates, or experience significant delays in doing so, our business will be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have no products on the market and bempikibart and the rest of our pipeline are in the early stages of development. As a result, we expect it will be many years before we commercialize any product candidate, if any. Our ability to achieve and sustain profitability depends on obtaining regulatory approvals for, and successfully commercializing, bempikibart or other product candidates either alone or with third parties, and we cannot guarantee that we will ever obtain regulatory approval for any product candidates. We have limited experience as a company in conducting and managing the clinical trials necessary to obtain regulatory approvals, including approval by the FDA or comparable foreign regulatory authorities. We have also not yet demonstrated our ability to obtain regulatory approvals, manufacture a commercial scale product or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful product commercialization. Before obtaining regulatory approval for the commercial distribution of product candidates, we or an existing or future collaborator must conduct extensive preclinical tests and clinical trials to demonstrate the safety and efficacy in humans of such product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We or our collaborators may experience delays in initiating or completing clinical trials. We or our collaborators also may experience numerous unforeseen events during, or as a result of, any current or future clinical trials that could delay or prevent our ability to receive marketing approval or commercialize bempikibart or any other product candidates, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">regulators or Institutional Review Boards, or IRBs, the FDA or ethics committees may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may experience delays in reaching, or fail to reach, agreement on acceptable terms with prospective trial sites and prospective CROs, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trial sites deviating from trial protocol or dropping out of a trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical trials of any product candidates may fail to show safety or efficacy, produce negative or inconclusive results and we may decide, or regulators may require us, to conduct additional preclinical studies or clinical trials or we may decide to abandon product development programs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number of subjects required for clinical trials of any our product candidates may be larger than we anticipate, especially if regulatory bodies require completion of non-inferiority or superiority trials compared to approved products, enrollment in these clinical trials may be slower than we anticipate or subjects may drop out of these clinical trials or fail to return for post-treatment follow-up at a higher rate than we anticipate; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all, or may deviate from the clinical trial protocol or drop out of the trial, which may require that we add new clinical trial sites or investigators, or expand the scope of our planned clinical trials to accrue sufficient data from such trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may elect to, or regulators, IRBs or ethics committees may require that we or our investigators, suspend or terminate clinical research or trials for various reasons, including noncompliance with regulatory requirements or a finding that the participants in our trials are being exposed to unacceptable health risks; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost of clinical trials of any of our product candidates may be greater than we anticipate; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the quality of our product candidates or other materials necessary to conduct clinical trials of our product candidates may be inadequate to initiate or complete a given clinical trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our inability to manufacture sufficient quantities of our product candidates for use in clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">reports from clinical testing of other therapies may raise safety or efficacy concerns about our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our failure to establish an appropriate safety profile for a product candidate based on clinical or preclinical data for such product candidate as well as data emerging from other therapies in the same class as our product candidates; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA or other regulatory authorities may require us to submit additional data such as long-term toxicology studies or impose other requirements before permitting us to initiate a clinical trial. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commencing clinical trials in the U.S. is subject to the FDA allowing an Investigational New Drug Application, or IND, to proceed after an evaluation of the proposed clinical trial design. In the event that the FDA requires us to complete additional preclinical studies or we are required to satisfy other FDA requests prior to commencing clinical trials, the start of our clinical trials may be delayed. Even after we receive and incorporate guidance from the FDA, the FDA could disagree that we have satisfied their requirements to commence any clinical trial or change their position on the acceptability of our trial design or the clinical endpoints selected, which may require us to complete additional preclinical studies or clinical trials, delay the enrollment of our clinical trials or impose stricter approval conditions than we currently expect. There are comparable processes and risks applicable to clinical trial applications needed to initiate clinical trials in other countries, including countries in the European Union, or EU.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not have the financial resources to continue development of, or to modify existing or enter into new collaborations for, a product candidate if we experience any issues that delay or prevent regulatory approval of, or our ability to commercialize, bempikibart or any other product candidates. We or our current or future collaborators&#8217; inability to complete development of, or commercialize, bempikibart or any other product candidates or significant delays in doing so, could have a material and adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are substantially dependent on the success of our most advanced product candidate, bempikibart, and our clinical trials of our lead candidate may not be successful.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future success is substantially dependent on our, or our current or future strategic partners&#8217;, ability to timely obtain marketing approval for, and then successfully commercialize, our most advanced product candidate, bempikibart. We are investing a majority of our efforts and financial resources into the research and development of bempikibart. We are developing bempikibart to treat autoimmune and inflammatory diseases, with the aim of achieving the optimal balance of efficacy, tolerability and convenience for patients via infrequently administered subcutaneous doses. We have completed a Phase 1 double-blind, placebo-controlled, single ascending dose and multiple dose study to assess the safety, pharmacokinetic, or PK, and pharmacodynamic, or PD, of bempikibart after subcutaneous administration in healthy subjects. This study supported further evaluation of bempikibart, including through demonstration of a PK/PD profile supporting evaluation of every two-week subcutaneous dosing in clinical trials. Subsequent to this study, we advanced bempikibart into two Phase 2a clinical trials. The Phase 2a SIGNAL-AD trial evaluated the use of bempikibart for the treatment of atopic dermatitis, or AD, and the Phase 2a SIGNAL-AA trial is evaluating bempikibart for the treatment of alopecia areata, or AA. We completed enrollment and dosing through the 12-week and 24-week periods for the SIGNAL-AD and SIGNAL-AA trials, respectively, and in December 2024, we announced topline data from both clinical trials. The success of bempikibart may depend on having a comparable safety and efficacy profile and a more favorable dosing schedule (i.e., less frequent dosing) with patient-friendly administration (i.e., S.C. self-administration) to products currently approved or in development for the indications we plan to pursue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We previously completed a Phase 1 clinical trial of ADX-097 in healthy volunteers and initiated a Phase 2 clinical trial of this candidate. However, in February 2025, we announced that we were discontinuing the Phase 2 clinical trial of ADX-097 to focus our resources on the bempikibart clinical development program.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart will require additional clinical development, evaluation of clinical and manufacturing activities, marketing approval in multiple jurisdictions, substantial investment and significant marketing efforts before we generate any revenues from product sales, if any. We are not permitted to market or promote any product candidates, before we receive marketing approval from the FDA and/or comparable foreign regulatory authorities, and we may never receive such marketing approvals.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The success of bempikibart will depend on a variety of factors. We do not have complete control over many of these factors, including certain aspects of clinical development and the regulatory submission process, potential threats to our intellectual property rights and the manufacturing, marketing, distribution and sales efforts of any current or future collaborator or other third party. Accordingly, we cannot guarantee that we will ever be able to generate revenue through the sale of any of our product candidates, even if approved. If we are not successful in commercializing bempikibart, or are significantly delayed in doing so, our business will be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we do not achieve our projected development goals in the time frames we announce and expect, the commercialization of bempikibart or any other product candidates may be delayed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we estimate the timing of the anticipated accomplishment of various scientific, clinical, regulatory and other product development goals, which we sometimes refer to as milestones. These milestones may include the commencement or completion of scientific studies, preclinical studies and clinical trials and the submission of regulatory filings. From time to time, we may publicly announce the expected timing of some of these milestones. All of these milestones are and will be based on numerous assumptions. The actual timing of these milestones can vary dramatically compared to our estimates, in some cases for reasons beyond our control. If we do not meet these milestones as publicly announced, or at all, the commercialization of bempikibart or any other product candidates may be delayed or never achieved.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our approach to the discovery and development of product candidates is unproven, and we may not be successful in our efforts to build a pipeline of product candidates with commercial value.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our approach to the discovery and/or development of bempikibart leverages the understanding of cytokine and complement biology in diverse tissues and indications. Bempikibart is directed at target pathways, IL-7 and thymic stromal lymphopoietin, or TSLP, signaling, that have been implicated in several inflammatory and autoimmune diseases. However, the scientific research that forms the basis of efforts to develop bempikibart is ongoing and has not been successfully proven in clinical trials. The long-term safety and exposure profile of bempikibart is also unknown.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may ultimately discover that our technologies for our specific targets and indications and bempikibart and any product candidates resulting therefrom do not possess certain properties required for therapeutic effectiveness. We currently have only data from our Phase 1 clinical trial and our Phase 2 Part A AA and AD clinical trials related to bempikibart, and only data from our Phase 1 clinical trial regarding properties of ADX-097, and the same data or results may not be seen in larger, later-stage clinical trials. In addition, product candidates using investigational technologies and approaches may demonstrate different chemical and pharmacological properties in patients than they do in laboratory studies and bempikibart and ADX-097 may interact with human biological systems in unforeseen, ineffective or possibly harmful ways.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may in the future seek to discover and develop product candidates that are based on novel targets and technologies that are unproven. If our discovery activities fail to identify novel targets or technologies for drug discovery, or such targets prove to be unsuitable for treating human disease, we may not be able to develop viable additional product candidates. We and our existing or future collaborators may never receive approval to market and commercialize bempikibart or future product candidates. Even if we or an existing or future collaborator obtains regulatory approval, the approval may be for targets, disease indications or patient populations that are not as broad as we intended or desired or may require labeling that includes significant use or distribution restrictions or safety warnings.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preclinical and clinical development involves a lengthy and expensive process that is subject to delays and with uncertain outcomes, and results of earlier studies and trials may not be predictive of future clinical trial results. If our preclinical studies and clinical trials are not sufficient to support regulatory approval of any of our product candidates, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development of such product candidate.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before obtaining marketing approval from regulatory authorities for the sale of any product candidate, we must complete preclinical studies and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidate in humans. Our clinical trials may not be conducted as planned or completed on schedule, if at all, and failure can occur at any time during the preclinical study or clinical trial process. For example, we depend on the availability of non-human primates, or NHPs, to conduct certain preclinical studies that we are required to complete prior to submitting an IND and initiating clinical development. There is currently a global shortage of certain types of NHPs available for Good Laboratory Practice, or GLP, testing for drug development. This could cause the cost of obtaining NHPs for our future preclinical studies to increase significantly, and if the shortage continues, and could result in delays to our development timelines. Furthermore, a failure of one or more clinical trials can occur at any stage of testing. The outcome of preclinical studies and early-stage clinical trials may not be predictive of the success of later clinical trials. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates. In addition, we expect to rely on patients to provide feedback on measures, which are subjective and inherently difficult to evaluate. These measures can be influenced by factors outside of our control, and can vary widely from day to day for a particular patient, and from patient to patient and from site to site within a clinical trial.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we plan to seek regulatory guidance in designing and conducting our development plans, we cannot be sure that the FDA or comparable foreign regulatory authorities will agree with these plans. If the FDA or comparable regulatory authorities requires us to revise or amend a clinical study, generate additional pre-clinical data in support of clinical conduct (e.g., toxicology studies), conduct additional trials or enroll additional patients, our development timelines may be delayed. We cannot be sure that submission of an IND, clinical trial application, or CTA, or similar application will result in the FDA or comparable foreign regulatory authorities, as applicable, allowing clinical trials to begin in a timely manner, if at all. Moreover, even if these trials begin, issues may arise that could cause regulatory authorities to suspend or terminate such clinical trials. Events that may prevent successful or timely initiation or completion of clinical trials include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">inability to generate sufficient preclinical, toxicology or other </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vivo</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">in vitro</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> data to support the initiation or continuation of clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in reaching a consensus with regulatory authorities on study design or implementation of the clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays or failure in obtaining regulatory authorization to commence a trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in reaching agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in identifying, recruiting and training suitable clinical investigators; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in obtaining required IRB or ethics committee approval at each clinical trial site; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">difficulties in patient enrollment in our clinical trials for a variety of reasons; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">delays in manufacturing, testing, releasing, validating or importing/exporting sufficient stable quantities of our product candidates for use in clinical trials or the inability to do any of the foregoing; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure by our CROs, other third parties or us to adhere to clinical trial protocols; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">failure to perform in accordance with the FDA&#8217;s or any other regulatory authority&#8217;s Good Clinical Practices, or GCPs, or regulations or applicable regulations or regulatory guidelines in other countries; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes to the clinical trial protocols; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">clinical sites deviating from trial protocol or dropping out of a trial; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">selection of clinical endpoints that require prolonged periods of observation or analyses of resulting data; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">transfer of manufacturing processes to larger-scale facilities operated by a CDMO, and delays or failure by our CDMOs or us to make any necessary changes to such manufacturing processes; and </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third parties being unwilling or unable to satisfy their contractual obligations to us. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We could also encounter delays if a clinical trial is placed on clinical hold, suspended or terminated by us, the FDA, the competent authorities of the EU Member States or other regulatory authorities or the IRBs or ethics committees of the institutions in which such trials are being conducted, if a clinical trial is recommended for suspension or termination by the data safety monitoring board, or DSMB, or equivalent body for such trial, or on account of changes to federal, state, or local laws. If we are required to conduct additional clinical trials or other testing of bempikibart or any other product candidates beyond those that we contemplate, if we are unable to successfully complete clinical trials of bempikibart or any other product candidates, if the results of these trials are not positive or are only moderately positive or if there are safety concerns, our business and results of operations may be adversely affected and we may incur significant additional costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be successful in our efforts to identify or discover additional product candidates in the future.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A key part of our long-term business strategy is to identify and develop additional product candidates. Our preclinical research and clinical trials may initially show promise in identifying potential product candidates yet fail to yield product candidates for clinical development for a number of reasons. For example, we may be unable to identify or design additional product candidates with the pharmacological and pharmacokinetic drug properties that we desire, including, but not limited to, adequate tissue targeting, acceptable safety profile or the potential for the product candidate to be delivered in a convenient formulation. Research programs to identify new product candidates require substantial technical, financial, and human resources. If we are unable to identify suitable complement targeting strategies for preclinical and clinical development, we may not be able to successfully implement our business strategy, and may have to delay, reduce the scope of, suspend or eliminate one or more of our product candidates, clinical trials or future commercialization efforts, which would negatively impact our financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we encounter difficulties enrolling patients in our future clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may experience difficulties in patient enrollment in our future clinical trials for a variety of reasons. The timely completion of clinical trials in accordance with their protocols depends, among other things, on the ability to enroll a sufficient number of patients who remain in the trial until its conclusion. The enrollment of patients in future trials for bempikibart or any other product candidates will depend on many factors, including if patients choose to enroll in clinical trials, rather than using approved products, or if our competitors have ongoing clinical trials for product candidates that are under development for the same indications as our product candidates, and patients instead enroll in such clinical trials. Additionally, the number of patients required for clinical trials of bempikibart or any other product candidates may be larger than we anticipate, especially if regulatory bodies require the completion of non-inferiority or superiority trials compared to approved products. Even if we are able to enroll a sufficient number of patients for our future clinical trials, we may have difficulty maintaining patients in our clinical trials. Our inability to enroll or maintain a sufficient number of patients would result in significant delays in completing clinical trials or receipt of marketing approvals and increased development costs or may require us to abandon one or more clinical trials altogether.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Preliminary, &#8220;topline&#8221; or interim data from our clinical trials that we announce or publish from time to time may change as more patient data becomes available and are subject to audit and verification procedures.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may publicly disclose preliminary or topline data from our preclinical studies and clinical trials, which are based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data. We also make assumptions, estimations, calculations and conclusions as part of our analyses of these data without the opportunity to fully and carefully evaluate complete data. As a result, the preliminary or topline results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated or subsequently made subject to audit and verification procedures. Any preliminary or topline data should be viewed with caution until the final data is available. From time to time, we may also disclose interim data from our preclinical studies and clinical trials. Interim data are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available or as patients from our clinical trials continue other treatments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular product candidate, the approvability or commercialization of a particular product candidate and us in general. In addition, the information we choose to publicly disclose regarding a particular preclinical study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is material or otherwise appropriate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">information to include in our disclosure. If the preliminary, topline or interim data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, bempikibart or any other product candidate may be harmed, which could harm our business, operating results, prospects or financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our current or future clinical trials or those of our future collaborators may reveal significant adverse events or undesirable side effects not seen in our preclinical and/or early clinical studies and may result in a safety profile that could halt clinical development, inhibit regulatory approval or limit commercial potential or market acceptance of any of bempikibart or any other product candidates or result in potential product liability claims.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of our clinical trials could reveal a high and unacceptable severity and prevalence of side effects, adverse events or unexpected characteristics. While our completed preclinical studies and our completed and ongoing clinical trials in humans have not shown any such characteristics to date, significant further evaluation must be done of each of our product candidates. If significant adverse events or other side effects are observed in any of our current or future clinical trials, we may have difficulty recruiting patients to such trials, patients may drop out of our trials, patients may be harmed, or we may be required to abandon the trials or our development efforts of one or more product candidates altogether. We, the FDA, the European Medicines Agency, or the EMA, or other applicable regulatory authorities, or an IRB or ethics committee, may suspend any clinical trials of bempikibart or any other product candidates at any time for various reasons, including a belief that subjects or patients in such trials are being exposed to unacceptable health risks or adverse side effects. Some potential products developed in the biotechnology industry that initially showed therapeutic promise in early-stage trials have later been found to cause side effects that prevented their further development. Even if the side effects do not preclude a product candidate from obtaining or maintaining marketing approval, undesirable side effects may inhibit market acceptance of an approved product due to its tolerability versus other therapies. Treatment-emergent adverse events could also affect patient recruitment or the ability of enrolled subjects to complete our clinical trials or could result in potential product liability claims. Potential side effects associated with bempikibart or any other product candidates may not be appropriately recognized or managed by the treating medical staff, as toxicities resulting from bempikibart or any other product candidates may not be normally encountered in the general patient population and by medical personnel. Any of these occurrences could harm our business, financial condition, results of operations and prospects significantly.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, even if we successfully advance bempikibart or any other product candidates through clinical trials, such trials will only include a limited number of patients and limited duration of exposure to such product candidates. As a result, we cannot be assured that adverse effects of bempikibart or any other product candidates will not be uncovered when a significantly larger number of patients are exposed to such product candidate after approval. Further, any clinical trials may not be sufficient to determine the effect and safety consequences of using our product candidate over a multi-year period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of the foregoing events occur or if bempikibart or any other product candidates prove to be unsafe, our entire pipeline could be affected, which would have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may expend our limited resources to pursue a particular product candidate, such as bempikibart, and fail to capitalize on candidates that may be more profitable or for which there is a greater likelihood of success.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because we have limited financial and managerial resources, we intend to focus our research and development efforts on certain selected product candidates. For example, we initially focused on our most advanced product candidates, bempikibart and ADX-097, and announced in February 2025 that we were discontinuing our ongoing clinical trial of ADX-097 to focus on the bempikibart clinical development program. As a result, we may forgo or delay pursuit of opportunities with other potential candidates that may later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs for specific indications may not yield any commercially viable product candidates. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such candidate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if regulatory approval is obtained, any approved products may not achieve adequate market acceptance among clinicians, patients, healthcare third-party payors and others in the medical community necessary for commercial success and we may not generate any future revenue from the sale or licensing of such products.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if regulatory approval is obtained for bempikibart or any other product candidates, they may not gain market acceptance among physicians, patients, healthcare payors or the medical community. We may not generate or sustain revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from sales of the product due to factors such as whether the product can be sold at a competitive cost and whether it will otherwise be accepted in the market. There are several approved products and product candidates in later stages of development for the treatment of AA. Market participants with significant influence over acceptance of new treatments, such as clinicians and third-party payors, may not adopt a drug or biologic with a target product profile such as that of bempikibart for its targeted indications, and we may not be able to convince the medical community and third-party payors to accept and use, or to provide favorable reimbursement for, any product candidates developed by us or our existing or future collaborators. Market acceptance of bempikibart or any other product candidates will depend on many factors, including factors that are not within our control.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Sales of products also depend on the willingness of clinicians to prescribe the treatment. We cannot predict whether clinicians, clinicians&#8217; organizations, hospitals, other healthcare providers, government agencies or private insurers will determine that any of our approved products are safe, therapeutically effective, cost effective or less burdensome as compared with competing treatments. If bempikibart or any other product candidate is approved but does not achieve an adequate level of acceptance by such parties, we may not generate or derive sufficient revenue from that product and may not become or remain profitable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have never commercialized a product candidate and may lack the necessary expertise, personnel and resources to successfully commercialize a product candidate on our own or together with suitable collaborators.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never commercialized a product candidate, and we currently have no sales force, marketing or distribution capabilities. To achieve commercial success for a product candidate, which we may license to others, we may rely on the assistance and guidance of those collaborators. For a product candidate for which we retain commercialization rights and marketing approval, we will have to develop our own sales, marketing and supply organization or outsource these activities to a third party. Factors that may affect our ability to commercialize a product candidate, if approved, on our own include recruiting and retaining adequate numbers of effective sales and marketing personnel, developing adequate educational and marketing programs to increase public acceptance of our approved product candidate, ensuring regulatory compliance of us, employees and third parties under applicable healthcare laws and other unforeseen costs associated with creating an independent sales and marketing organization. Developing a sales and marketing organization will be expensive and time-consuming and could delay the launch of a product candidate upon approval. We may not be able to build an effective sales and marketing organization. If we are unable to build our own distribution and marketing capabilities or to find suitable partners for the commercialization of an approved product candidate, we may not generate revenues from them or be able to reach or sustain profitability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have never completed any late-stage clinical trials and we may not be able to submit applications for regulatory authorizations to commence additional clinical trials on the timelines we expect, and, even if we are able to, the FDA, EMA or comparable foreign regulatory authorities may not permit us to proceed and could also suspend/terminate the trial after it has been initiated.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are early in our development efforts and will need to successfully complete later-stage and pivotal clinical trials in order to obtain FDA, EMA or comparable foreign regulatory approval to market our product candidates. Carrying out clinical trials and the submission of a successful IND or CTA is a complicated process. As an organization, we have limited experience as a company in preparing, submitting and prosecuting regulatory filings. We may not be able to initiate or complete our planned clinical trials in accordance with our desired timelines. For example, we may experience manufacturing delays or other delays with IND-or CTA-enabling studies, including with suppliers, study sites, or third-party contractors and vendors on whom we depend. Moreover, we cannot be sure that submission of an IND or a CTA or submission of a trial to an IND or a CTA will result in the FDA or EMA or comparable foreign regulatory authorities allowing further clinical trials to begin, or that, once begun, issues will not arise that lead us to suspend or terminate clinical trials. Upon submission of an IND or CTA, the FDA or EMA may recommend changes to the proposed study designs, which may impact the number and size of registrational clinical trials required to be conducted in such development programs and may change predicted timelines for clinical development. Consequently, we may be unable to successfully and efficiently execute and complete necessary clinical trials in a way that leads to regulatory submission and approval of our product candidates. Additionally, even if regulatory authorities agree with the design and implementation of the clinical trials set forth in an IND or a CTA, such regulatory authorities may change their requirements in the future. The FDA, EMA or comparable foreign regulatory authorities may require the analysis of data from trials assessing different doses of the product candidate alone or in combination with other therapies to justify the selected dose prior to the initiation of large trials in a specific indication. Any delays or failure to file INDs or CTAs, initiate clinical trials, or obtain regulatory authorizations for our trials may prevent us from completing our clinical trials or commercializing our products on a timely basis, if at all. We are subject to similar risks related to the review and authorization of our protocols and amendments by comparable foreign regulatory authorities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to our Intellectual Property</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our ability to protect our patents and other proprietary rights is uncertain, exposing it to the possible loss of competitive advantage.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely upon a combination of patents, trade secret protection and confidentiality agreements to protect the intellectual property related to our product candidates and to prevent third parties from infringing on our patents and trademarks or misappropriating or violating our other intellectual property rights, thus eroding our competitive position in our market. Our success depends in large part on our ability to obtain and maintain patent protection for our product candidates and their uses, components, formulations, methods of manufacturing and methods of treatment, as well as our ability to operate without infringing on or violating the proprietary rights of others. We have licensed know-how and patent families that pertain to, among other things, composition of matter and certain methods of use relating to our leading product candidate, bempikibart. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our product candidates and novel discoveries that are important to our business. Our intellectual property strategy is, where appropriate, to file new patent applications on inventions, including improvements to existing products candidates and processes to improve our competitive edge or to improve business opportunities. We continue to assess and refine our intellectual property strategy to ensure appropriate protection and rights are secured. However, our pending and future patent applications may not result in patents being issued. We cannot assure you that issued patents will afford sufficient protection of our product candidates or their intended uses against competitors, nor can there be any assurance that the patents issued will not be infringed, designed around, invalidated by third parties, or effectively prevent others from commercializing competitive products or product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Obtaining and enforcing patents is expensive and time-consuming, and we may not be able to file, prosecute, maintain, enforce or license all necessary or desirable patent applications or maintain and/or enforce patents that may issue based on our patent applications, at a reasonable cost or in a timely manner. We may not be able to obtain or maintain patent applications and patents due to the subject matter claimed in such patent applications and patents being in disclosures in the public domain. It is also possible that we will fail to identify patentable aspects of our research and development results before it is too late to obtain patent protection. Although we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research and development output, such as our employees, corporate collaborators, outside scientific collaborators, CROs, CDMOs, consultants, advisors and other third parties, any of these parties may breach these agreements and disclose such results before a patent application is filed, thereby jeopardizing our ability to seek patent protection. Consequently, we may not be able to prevent any third parties from using any of our technology that is in the public domain to compete with our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Composition of matter patents for biotechnology and pharmaceutical product candidates often provide a strong form of intellectual property protection for those types of products, as such patents provide protection without regard to any method of use. However, we cannot be certain that the claims in our pending patent applications directed to the composition of matter of our product candidates will be considered patentable by the United States Patent and Trademark Office, or USPTO, or by patent offices in foreign jurisdictions, or that the claims in any of our issued patents will be considered valid and enforceable by courts in the United States or foreign jurisdictions. Method of use patents protect the use of a product for the specified method. This type of patent does not prevent a competitor from making and marketing a product that is identical to our product candidates for an indication that is outside the scope of the patented method. Moreover, even if competitors do not actively promote their product for our targeted indications, clinicians may prescribe these products &#8220;off-label.&#8221; Although off-label prescriptions may infringe or contribute to the infringement of method of use patents, the practice is common and such infringement is difficult to prevent or prosecute.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our current or future patent applications may not result in patents being issued which protect our technology or drug candidates or which do not effectively prevent others from commercializing competitive technologies and drug candidates. The patent examination process may require us or our licensors to narrow the scope of our claims or our licensors&#8217; pending and future patent applications, which may limit the scope of patent protection that may be obtained. We cannot assure you that all of the potentially relevant prior art relating to our patents and patent applications has been found. If such prior art exists, it can invalidate a patent or prevent a patent application from being issued as a patent.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The issuance of a patent does not ensure that it is valid or enforceable, nor does it give us the right to practice the patented invention. Issued patents may be challenged, narrowed, invalidated or circumvented and third parties may have blocking patents that could prevent us from commercializing our product candidates or technologies. While we endeavor to identify and circumvent third-party patents and patent applications which may block our product candidates or technologies to minimize this risk, relevant documents may be overlooked or missed, which may in turn impact our ability to commercialize the relevant asset.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, court decisions may introduce uncertainty in the enforceability or scope of patents owned by pharmaceutical and biotechnology companies. Thus, any of our issued patents, including patents that we may rely on to protect our market for approved drugs, may be held invalid or unenforceable by a court of final jurisdiction.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A third party may also claim that our patent rights are invalid or unenforceable in a litigation. The outcome following legal assertions of invalidity and unenforceability is unpredictable. An adverse result in any legal proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly and could allow third parties to commercialize our products and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize our technology, products or product candidates without infringing third-party patent rights.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because patent applications in the U.S., Europe and many other jurisdictions are typically not published until 18 months after filing, and because publications of discoveries in scientific literature lag behind actual discoveries, we cannot be certain that we were the first to make the inventions claimed in our issued patents or future patent applications, or that we were the first to file for protection of the inventions set forth in our patents or patent applications. As a result, we may not be able to obtain or maintain protection for certain inventions. Therefore, the enforceability and scope of our future patents in the U.S., Europe and in many other jurisdictions cannot be predicted with certainty and, as a result, any future patents that we own, or license may not provide sufficient protection against competitors. We may not be able to obtain or maintain patent protection from our patent applications that we may file in the future, or from those we may license from third parties. Moreover, even if we are able to obtain patent protection, such patent protection may be of insufficient scope to achieve our business objectives.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such product candidates might expire before or shortly after such candidates are commercialized. The degree of future protection for our proprietary rights is uncertain. Only limited protection may be available and may not adequately protect our rights or permit us to gain or keep any competitive advantage. Any failure to obtain or maintain patent protection with respect to our product candidates or their uses could adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our rights to develop and commercialize our product candidates are, and in the future, may be subject to the terms and conditions of licenses granted to us by others. If we fail to comply with our obligations in the agreements under which we license intellectual property rights from third parties, or these agreements are terminated, or we otherwise experience disruptions to our business relationships with our licensors, we could lose license rights that are important to our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are dependent on patents rights, know-how and proprietary technology licensed from third parties. In particular, we depend substantially on our license agreement with Bristol Myers Squibb Company, or BMS, under which we in-license patent rights and know-how that cover bempikibart, or BMS Agreement, and The Regents of the University of Colorado, or Colorado Agreement, under which we in-license patent rights and know-how relating to ADX-097. For more information regarding the BMS Agreement and Colorado Agreement, please see the section titled &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business&#8211;Collaboration and License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#8221; We may also enter into additional agreements with third parties in the future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current and future license agreements may impose diligence, development and commercialization timelines, milestone payments, royalties, indemnification, insurance, or other obligations on us. For example, under both the BMS License Agreement and Colorado Agreement, the counterparties may terminate the agreements if we fail to meet our diligence obligations, including using commercially reasonable efforts to meet diligence milestones by specified dates. If we fail to comply with our obligations to our licensors or collaborators, our counterparties may have the right to terminate these agreements. Termination of these agreements or reduction or elimination of our rights under these agreements may result in us having to negotiate new or reinstated agreements with less favorable terms, or cause us to lose our rights under these agreements, including our rights to important intellectual property or technology that are necessary for our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain patent filings relating to our product candidates may be subject to step-in rights of certain of our licensors. We may have limited control over our licensor&#8217;s activities or use or licensing of any other intellectual property that may be related to our in-licensed intellectual property. If any of our licensors or licensees having rights to file, prosecute, maintain, and defend our patent rights fail to conduct these activities for patents or patent applications covering any of our product candidates, our ability to develop and commercialize those product candidates may be adversely affected and we may not be able to prevent competitors or other third parties from making, using or selling competing products. We cannot be certain that such activities by our licensors have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents or other intellectual property rights. Pursuant to the terms of the license agreements with our licensors, such licensors may have the right to control enforcement of our licensed patents or defense of any claims asserting the invalidity of such patents and, even if we are permitted to pursue such enforcement or defense, we cannot ensure the cooperation of our licensors or, in some cases, other necessary parties, such as any co-owners of patents or other intellectual property from which</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we have not yet obtained a license. We cannot be certain that our licensors, and in some cases, their co-owners, will allocate sufficient resources or prioritize their or our enforcement of such patents or defense of such claims to protect our interests in the licensed patents. Even if we are not a party to these legal actions, an adverse outcome could harm our business because it might prevent us from continuing to license intellectual property that we may need to operate our business. In addition, even when we have the right to control patent prosecution of licensed patents and patent applications, enforcement of licensed patents, or defense of claims asserting the invalidity of those patents, we may still be adversely affected or prejudiced by actions or inactions of our licensors and their counsel that took place prior to or after assuming control.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current or future license agreements may not provide exclusive or sufficient rights to use such intellectual property and technology in all relevant fields of use and in all territories in which we may wish to develop or commercialize our product candidates in the future. Some licenses granted to us may be subject to certain preexisting rights held by the licensors or certain third parties. As a result, we may not be able to prevent third parties from developing and commercializing competitive products in certain territories or fields.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the event that our third party licensors determine that, in spite of our efforts, we have materially breached a license agreement or have failed to meet certain obligations thereunder, it may elect to terminate the license agreement or, in some cases, one or more license(s) under the applicable license agreement. Such termination could result in us losing the ability to develop and commercialize product candidates and technology covered by the licensed intellectual property. In the event of such termination of a third-party in-license, or if the underlying patent rights under a third-party in-license fail to provide the intended exclusivity, third parties may be able to seek regulatory approval of, and to market, products identical to ours. Moreover, our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to claims, regardless of their merit, that we are infringing or otherwise violating the licensor&#8217;s rights. Any of these events could have a material adverse effect on our competitive position, business, financial conditions, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If our current or future license agreements are terminated, or if the underlying patent rights fail to provide the intended exclusivity, competitors or other third parties may be able to seek regulatory approval of, and to market, products identical to ours and we may be required to cease the development and commercialization of our product candidates. Any of the foregoing could have a material adverse effect on our competitive position, business, financial condition, results of operations and prospects. Disputes may arise regarding intellectual property subject to a licensing agreement, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope of rights granted under the license agreement and other interpretation-related issues; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which our technology and processes infringe, misappropriate or violate intellectual property of the licensor that is not subject to the licensing agreement; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the sublicensing of patent rights to third parties under our license agreements or collaborative development relationships; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our diligence obligations under the license agreement with respect to the use of the licensed technology in relation to the development and commercialization of our product candidates and what activities satisfy those diligence obligations; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensor and us and our partners; or </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the priority of invention of patented technology. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our current or future license agreements may be subject to certain rights retained by third parties.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current or future licensors may retain certain rights under the relevant agreements with us, including the right to use the underlying product candidates for academic and research use, to publish general scientific findings from research related to the product candidates, to make customary scientific and scholarly disclosures of information relating to the product candidates, or to develop or commercialize the licensed product candidates in certain regions. In addition, the United States federal government retains certain rights in inventions produced with its financial assistance under the Patent and Trademark Law Amendments Act, or Bayh-Dole Act, including a &#8220;nonexclusive, nontransferable, irrevocable, paid-up license&#8221; for its own benefit. We may at times choose to collaborate with academic institutions to accelerate our preclinical research or development that are subject to the Bayh-Dole Act. The Bayh-Dole Act also provides federal agencies with &#8220;march-in rights.&#8221; March-in rights allow the government, in specified circumstances, to require the contractor or successors in title to the patent to grant a &#8220;nonexclusive, partially exclusive, or exclusive license&#8221; to a &#8220;responsible applicant or applicants.&#8221; If the patent owner refuses to do so, the government may grant the license itself.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the United States government requires that any products embodying the subject invention or produced through the use of the subject invention be manufactured substantially in the United States. The manufacturing preference requirement can be waived if the owner of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible. This preference for United States manufacturers may limit our ability to contract with non-United States product manufacturers for products covered by such intellectual property. Any exercise by the government of any of the foregoing rights could harm our competitive position, business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We cannot ensure that patent rights relating to inventions described and claimed in our current or future licensors pending patent applications will issue or that patents based on us or any of our current future licensors patent applications will not be challenged and rendered invalid and/or unenforceable.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The patent application process is subject to numerous risks and uncertainties, and there can be no assurance that we or any potential future licensors or collaborators will be successful in protecting our product candidates by obtaining and defending patents. We have several pending United States and foreign patent applications in our portfolio. We cannot predict:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">if and when patents may issue based on our patent applications; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope of protection of any patent issuing based on our patent applications; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the claims of any patent issuing based on our patent applications will provide protection against competitors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether or not third parties will find ways to invalidate or circumvent our patent rights; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether or not others will obtain patents claiming aspects similar to those covered by our patents and patent applications; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether we will need to initiate litigation or administrative proceedings to enforce and/or defend our patent rights which will be costly whether we win or lose; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">whether the patent applications that we own will result in issued patents with claims that cover our product candidates or uses thereof in the United States or in other foreign countries. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot be certain that the claims in our or any future licensors&#8217; pending patent applications directed to our product candidates will be considered patentable by the USPTO or by patent offices in foreign countries. There can be no assurance that any such patent applications will issue as granted patents. One aspect of the determination of patentability of our or any future licensors&#8217; inventions depends on the scope and content of the &#8220;prior art,&#8221; information that was or is deemed available to a person of skill in the relevant art prior to the priority date of the claimed invention. There may be prior art of which we are not aware that may affect the patentability of our or any future licensors&#8217; patent claims or, if issued, affect the validity or enforceability of a patent claim. Even if the patents do issue based on our or any future licensors&#8217; patent applications, third parties may challenge the validity, enforceability or scope thereof, which may result in such patents being narrowed, invalidated or held unenforceable. Furthermore, even if they are unchallenged, patents in our or any future licensors&#8217; portfolio may not adequately exclude third parties from practicing relevant technology or prevent others from designing around our claims. If the breadth or strength of our intellectual property position with respect to our product candidates is threatened, it could dissuade companies from collaborating with us to develop and threaten our ability to commercialize our product candidates. In the event of litigation or administrative proceedings, we cannot be certain that the claims in any of our issued patents will be considered valid by courts in the United States or foreign countries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We enjoy only limited geographical protection with respect to our patents and licensed patents and may not be able to protect our intellectual property rights throughout the world.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world and the legal systems in certain countries may not favor enforcement or protection of patents, trade secrets and other intellectual property. Patents are of national or regional effect, and although we currently have issued patents and pending applications in the United States, filing, prosecuting and defending patents on all of our research programs and product candidates in all countries throughout the world would be prohibitively expensive. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States, even in jurisdictions where we do pursue patent protection. Consequently, we may not be able to prevent third parties from practicing our or any of our licensors&#8217; inventions in all countries outside the United States, even in jurisdictions where we or any of our current or future licensors do pursue patent protection, or from selling or importing products made using our or any of our licensors&#8217; inventions in and into the United States or other</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">jurisdictions. Competitors may use our or any of our licensors&#8217; technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we or any future licensors have patent protection, but enforcement is not as strong as that in the United States. These competitor products may compete with our product candidates, and our or any of our licensors&#8217; patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Various companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of many countries do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biotechnology and pharmaceutical products, which could make it difficult for us to stop the infringement of our or our licensors&#8217; patents or marketing of competing products in violation of our proprietary rights.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, some countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. Many countries also limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of our licensors is forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business and financial condition may be adversely affected. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain countries outside the United States have laws that may impact a patent owner&#8217;s right to claim priority or require a patent applicant to obtain a foreign filing license or first file patent applications in a foreign jurisdiction to the extent that foreign nationals are involved in the development of the claimed subject matter of the resulting patent. our pending and future patent applications may not result in patents being issued that comply with the law of each foreign jurisdiction. Pending applications and issued patents may be challenged in various jurisdictions for failure to comply with local foreign laws, which could result in the rejection of pending applications or invalidation of issued patents. Further, the standards applied by the USPTO and foreign patent offices in granting patents are not always applied uniformly or predictably. As such, we do not know the degree of future protection that we will have on our product candidates. While we will endeavor to try to protect our product candidates with intellectual property rights, such as patents, as appropriate, the process of obtaining patents is time consuming, expensive and unpredictable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, geo-political actions in the United States and in foreign countries could increase the uncertainties and costs surrounding the prosecution or maintenance of our patent applications or those of any current or future licensors and the maintenance, enforcement or defense of our issued patents or those of any current or future licensors. For example, the United States and foreign government actions related to Russia&#8217;s conflict in Ukraine may limit or prevent filing, prosecution, and maintenance of patent applications in Russia. Government actions may also prevent maintenance of issued patents in Russia. These actions could result in abandonment or lapse of our patents or patent applications, resulting in partial or complete loss of patent rights in Russia. If such an event were to occur, it could have a material adverse effect on our business. In addition, a decree was adopted by the Russian government in March 2022, allowing Russian companies and individuals to exploit inventions owned by patentees from the United States without consent or compensation. Consequently, we would not be able to prevent third parties from practicing our inventions in Russia or from selling or importing products made using our inventions in and into Russia. Accordingly, our competitive position may be impaired, and our business, financial condition, results of operations and prospects may be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated if we fail to comply with these requirements.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Periodic maintenance and annuity fees on any issued patent are due to be paid to the U.S. Patent and Trademark Office, or USPTO, and foreign patent agencies over the lifetime of a patent. In addition, the USPTO and other foreign patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent application process. While an inadvertent failure to make payment of such fees or to comply with such provisions can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which such non-compliance will result in the abandonment or lapse of the patent or patent application, and the partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include failure to respond to official actions within prescribed time limits, and non-payment of fees and failure to properly legalize and submit formal documents within prescribed time limits. If we or our licensors fail to maintain the patents and patent applications covering our drug candidates or if we or our licensors otherwise allow our patents or patent applications to be abandoned or lapse, our competitors might be able to enter the market, which would hurt our competitive</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">position and could impair our ability to successfully commercialize our drug candidates in any indication for which they are approved.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Issued patents covering one or more of our product candidates could be found invalid or unenforceable.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any issued patents that we may license or own covering our product candidates could be narrowed or found invalid or unenforceable if challenged in court or before administrative bodies in the U.S. or abroad, including the USPTO. Patent terms, including any extensions or adjustments that may or may not be available to us, may be inadequate to protect our competitive position with respect to our product candidates for an adequate amount of time, and we may be subject to claims challenging the inventorship, validity, enforceability of our patents and/or other intellectual property. Further, if we encounter delays in our clinical trials or delays in obtaining regulatory approval, the period of time during which we could market our product candidates under patent protection would be reduced. Thus, the patents that we own and license may not afford us any meaningful competitive advantage.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, we or our licensors may be subject to a third-party pre-issuance submission of prior art to the USPTO or the European Patent Office or become involved in opposition, derivation, revocation, reexamination, inter partes review, post-grant review or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our product candidates and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize drugs without infringing third-party patent rights. If the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent terms may be inadequate to protect our competitive position with respect to our product candidates for an adequate amount of time.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patents have a limited lifespan. In the U.S., if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Once patents covering our product candidates have expired, we may be open to competition from competitive products, including generics or biosimilars. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we do not obtain patent term extension in the U.S. under the Hatch-Waxman Act and in foreign countries under similar legislation, thereby potentially extending the term of our marketing exclusivity for our product candidates, if approved, our business may be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the U.S., the patent term of a patent that covers an FDA-approved drug may be eligible for limited patent term extension, which permits patent term restoration as compensation for the patent term lost during the FDA regulatory review process. The Drug Price Competition and Patent Term Restoration Act of 1984, also known as the Hatch-Waxman Act, permits a patent term extension of up to five years beyond the expiration of the patent. The length of the patent term extension is related to the length of time the drug is under regulatory review. However, a patent extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval, only one patent applicable to an approved drug may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar provisions are available in Europe and certain other non-U.S. jurisdictions to extend the term of a patent that covers an approved drug. While, in the future, if and when our product candidates receive FDA approval, we expect to apply for patent term extension on patents covering such product candidates, there is no guarantee that the applicable authorities will agree with our assessment of whether such extension should be granted, and even if granted, the length of such extension. we may not be granted patent term extension either in the U.S. or in any foreign country because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover, the term of extension, as well as the scope of patent protection during any such extension, afforded by the governmental authority could be less than we request. If we are unable to obtain any patent term extension or the term of any such extension is less than we request, our competitors may obtain approval of competing products following the expiration of our patent rights, and our business, financial condition, results of operations and prospects could be materially harmed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Also, there are detailed rules and requirements regarding the patents that may be submitted to the FDA for listing in the Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations, or the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purple Book, a searchable, online database that contains information about biological products, including biosimilar and interchangeable biological products, licensed (approved) by the FDA under the Public Health Service Act. We may be unable to obtain patents covering our product candidates that contain one or more claims that satisfy the requirements for listing in the Purple Book. Even if we submit a patent for listing in the Purple Book, the FDA may decline to list the patent, or a manufacturer of generic drugs may challenge the listing. If any of our product candidates are approved and patents covering such product candidates not listed in the Purple Book, a manufacturer of generic drugs would not have to provide advance notice to us of any abbreviated new drug application filed with the FDA to obtain permission to sell a generic version of such product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Changes to patent laws in the U.S. and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our intellectual property.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in either the patent laws or interpretation of patent laws in the U.S., including patent reform legislation such as the Leahy-Smith America Invents Act, or the Leahy-Smith Act, could increase the uncertainties and costs surrounding the prosecution of our future owned and in-licensed patent applications and the maintenance, enforcement or defense of our owned and in-licensed issued patents. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These changes include provisions that affect the way patent applications are prosecuted, redefine prior art, provide more efficient and cost-effective avenues for competitors to challenge the validity of patents, and enable third-party submission of prior art to the USPTO during patent prosecution and additional procedures to challenge the validity of a patent at USPTO-administered post-grant proceedings, including post-grant review, inter partes review, and derivation proceedings. Assuming that other requirements for patentability are met, prior to March 2013, in the U.S., the first to invent the claimed invention was entitled to the patent, while outside the U.S., the first to file a patent application was entitled to the patent. After March 2013, under the Leahy-Smith Act, the U.S. transitioned to a first-to-file system in which, assuming that the other statutory requirements for patentability are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. As such, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and altered the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the validity and enforceability of patents once obtained. Depending on future legislation by the U.S. Congress, decisions by the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our patent rights and our ability to protect, defend and enforce our patent rights in the future. For example, in the case Amgen v. Sanofi, the Supreme Court held broad functional antibody claims invalid for lack of enablement. Similarly, in the case Juno v. Kite, the Federal Circuit held genus claims directed to CAR-T cells invalid for lack of written description for failing to provide disclosure commensurate with the scope of the claims. While we do not believe that any of the patents licensed or owned by us will be found invalid based on these decisions, we cannot predict how future decisions by the courts, the U.S. Congress or the USPTO may impact the value of our patents. Similarly, changes in the patent laws of other jurisdictions could adversely affect our ability to obtain and effectively enforce our patent rights, which would have a material adverse effect on our business and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, in 2012, the European Union Patent Package, or EU Patent Package, regulations were passed with the goal of providing a single pan-European Unitary Patent, or UP, covering all participating European Union member states, and a new European Unified Patent Court, UPC, for litigation involving European patents including all UPs. The EU Patent Package was implemented on June 1, 2023. As a result, all European patents, including those issued prior to ratification of the EU Patent Package, now by default automatically fall under the jurisdiction of the UPC. It is uncertain how the UPC will impact granted European patents in the biotechnology and pharmaceutical industries. Our European patent applications, if issued, could be challenged in the UPC if not opted out. During the first seven years of the UPC&#8217;s existence, the UPC legislation allows a patent owner to opt its European patents out of the jurisdiction of the UPC. We may decide to opt out our future European patents from the UPC, but doing so may preclude us from realizing the benefits of the UPC. Moreover, if we do not meet all of the formalities and requirements for opt-out under the UPC before the prescribed deadlines, our future European patents could remain under the jurisdiction of the UPC. The UPC will provide our competitors with a new forum to centrally revoke its European patents that have not been opted out, and allow for the possibility of a competitor to obtain pan-European injunction. Such a loss of patent protection could have a material adverse impact on our business and our ability to commercialize our technology and product candidates and, resultantly, on our business, financial condition, prospects and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not identify relevant third-party patents or may incorrectly interpret the relevance, scope or expiration of a third-party patent, which might adversely affect our ability to develop and market our product candidates, if approved.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot guarantee that any of our patent searches or analyses, including the identification of relevant third party patents, the scope of said patent claims or the expiration of relevant patents, are complete, accurate or thorough, nor can we be certain that we have identified each and every third-party patent and pending application in the U.S. and abroad that is relevant to or necessary for the commercialization of our product candidates, if approved, in any jurisdiction. The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#8217;s prosecution history. Our interpretation of the relevance or the scope of a patent or a pending application may be incorrect. Our determination of the expiration date of any patent in the U.S. or abroad that we consider relevant may be incorrect. Our failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, because some patent applications in the U.S. may be maintained in secrecy until the patents are issued, patent applications in the U.S. and many foreign jurisdictions are typically not published until 18 months after filing, and publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed patent applications for technology covered by our issued patents or our pending applications, or that we were the first to invent the technology. Our competitors may have filed, and may in the future file, patent applications covering our product candidates or technology similar to ours. Any such patent application may have priority over our patent applications or patents, which could require us to obtain rights to issued patents covering such product candidates or technologies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be subject to claims that former employees, collaborators or other third parties have an interest in our or any future licensors&#8217; patents or other intellectual property as an inventor or co-inventor. The failure to name the proper inventors on a patent application can result in the patents issuing thereon being unenforceable. Inventorship disputes may arise from conflicting views regarding the contributions of different individuals named as inventors, the effects of foreign laws where foreign nationals are involved in the development of the subject matter of the patent, conflicting obligations of third parties involved in developing our product candidates or as a result of questions regarding co-ownership of potential joint inventions. Litigation may be necessary to resolve these and other claims challenging inventorship or ownership. Alternatively, or additionally, we may enter into agreements to clarify the scope of our rights in such intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, valuable intellectual property. Such an outcome could adversely affect our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our current or future licensors may have relied on third-party consultants or collaborators or on funds from third parties, such as the United States government, such that these licensors are not the sole and exclusive owners of the patents we in-licensed. If other third parties have ownership rights or other rights to our in-licensed patents, they may be able to license such patents to our competitors, and our competitors could market competing products and technology. This could adversely affect our competitive position, business, financial condition, results of operations, and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, while it is our policy to require our employees, consultants, and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, it may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached or challenged, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Such claims could adversely affect our business, financial condition, results of operations, and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to claims asserting that our employees, consultants or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers or claims asserting ownership of what we regard as our own intellectual property.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain of our employees, consultants or advisors have in the past and may in the future be employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants and advisors do not use the proprietary information or know-how of others in their work for us, it may be subject to claims that these individuals or we have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s current or former employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">intellectual property rights. An inability to incorporate such technologies or features would harm our business and may prevent us from successfully commercializing our technologies or product candidates. In addition, we may lose personnel as a result of such claims and any such litigation, or the threat thereof, may adversely affect our ability to hire employees or contract with independent contractors. A loss of key personnel or their work product could hamper or prevent our ability to commercialize our technologies, or product candidates, which could adversely affect our business, financial condition, results of operations and prospects. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we may in the future be subject to claims by former employees, consultants or other third parties asserting an ownership right in our patents or patent applications. An adverse determination in any such submission or proceeding may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar technology and therapeutics, without payment to us, or could limit the duration of the patent protection covering our technologies and product candidates. Such challenges may also result in our inability to develop, manufacture or commercialize our technologies and product candidates without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future technologies and product candidates. Any of the foregoing could adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time-consuming and unsuccessful.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Competitors or other third parties may infringe our patents or trademarks or misappropriate or violate our other intellectual property rights. To counter infringement, misappropriation or unauthorized use, we or any future licensors may be required to file infringement or misappropriation claims, which can be expensive and time consuming and divert the time and attention of our management and scientific personnel. We or any future licensors&#8217; pending patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringed their patents, in addition to counterclaims asserting that our patents or any future licensors&#8217; patents are invalid or unenforceable, or both. In patent litigation in the United States, defendant counterclaims alleging invalidity and/or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, non-enablement, insufficient written description, obviousness-type double patenting, or failure to claim patent-eligible subject matter. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO or made a misleading statement during prosecution. The outcome following legal assertions of invalidity and unenforceability is unpredictable. In any patent infringement proceeding, there is a risk that a court will decide that a patent of our or any future licensors is invalid or unenforceable, in whole or in part, and that we do not have the right to stop the other party from using the invention at issue. There is also a risk that, even if the validity of such patents is upheld, the court will construe the patent&#8217;s claims narrowly or decide that we do not have the right to stop the other party from using the invention at issue on the grounds that our or any future licensors&#8217; patent claims do not cover the invention, or decide that the other party&#8217;s use of our or any future licensors&#8217; patented technology falls under the safe harbor to patent infringement under 35 U.S.C. &#167;271(e)(1). An adverse outcome in a litigation or proceeding involving our or any future licensors&#8217; patents could limit our ability to assert our or any future licensors&#8217; patents against those parties or other competitors and may curtail or preclude our ability to exclude third parties from making and selling similar or competitive products. Any of these occurrences could adversely affect our competitive position, and our business, financial condition, results of operations and prospects. Similarly, if we assert trademark infringement claims, a court may determine that the marks we have asserted are invalid or unenforceable, or that the party against whom we have asserted trademark infringement has superior rights to the marks in question. In this case, we could ultimately be forced to cease use of such trademarks.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we establish infringement, the court may decide not to grant an injunction against further infringing activity and instead award only monetary damages, which may or may not be an adequate remedy. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could adversely affect the price of shares of our common stock. Moreover, we cannot assure you that it will have sufficient financial or other resources to file and pursue such infringement claims, which typically last for years before they are concluded. Even if we ultimately prevail in such claims, the monetary cost of such litigation and the diversion of the attention of our management and scientific personnel could outweigh any benefit we receive as a result of the proceedings.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may become involved in third-party claims of intellectual property infringement, misappropriation or violation, which may prevent or delay our product discovery and development efforts.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our commercial success depends in part on us avoiding infringement of the patents or trademarks and misappropriation or violation of other proprietary rights of third parties. There is a substantial amount of litigation involving the infringement of patents or trademarks and misappropriation or violation of other intellectual property rights in the biotechnology and pharmaceutical industries. We may be exposed to, or threatened with, future litigation by third parties having patent, trademark or other intellectual property rights and who allege that our product candidates, uses and/or other proprietary technologies infringe their patents or trademarks or misappropriate or violate their other intellectual property rights. Numerous United States and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk that our product candidates may give rise to claims of infringement of the patent rights of others increases. Moreover, it is not always clear to industry participants, including us, which patents exist which may be found to cover various types of drugs, products or their methods of use or manufacture. Thus, because of the large number of patents issued and patent applications currently pending in our fields, there may be a risk that third parties may allege they have patent rights which are infringed by our product candidates, technologies or methods.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If a third party alleges that we infringed its patents or trademarks or misappropriate or violate its other intellectual property rights, we may face a number of issues, including, but not limited to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patent and trademark infringement and other intellectual property misappropriation or violation which, regardless of merit, may be expensive and time-consuming to litigate and may divert our management&#8217;s attention from our core business; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">substantial damages for infringement, misappropriation or violation, which we may have to pay if a court decides that the product candidate or technology at issue infringes on, misappropriates or violates the third-party&#8217;s rights; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">an injunction prohibiting us from manufacturing, marketing or selling our product candidates, or from using our proprietary technologies, unless the third party agrees to license its patent rights to us; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">even if a license is available from a third party, we may have to pay substantial royalties, upfront fees and other amounts, and/or grant cross-licenses to intellectual property rights protecting our product candidates or processes; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be forced to try to redesign our product candidates or processes so they do not infringe third-party patents or trademarks or misappropriate or violate other third party intellectual property rights, an undertaking which may not be possible or which may require substantial monetary expenditures and time. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations or could otherwise have a material adverse effect on our business, results of operations, financial condition and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Third parties may assert that we are employing their proprietary technology without authorization. Generally, conducting preclinical and clinical trials and other development activities in the United States is not considered an act of infringement. While we may believe that patent claims or other intellectual property rights of a third party would not have a materially adverse effect on the commercialization of our product candidates, we may be incorrect in this belief, or we may not be able to prove it in litigation. In this regard, patents issued in the United States by law enjoy a presumption of validity that can be rebutted only with evidence that is &#8220;clear and convincing,&#8221; a heightened standard of proof. There may be issued third-party patents of which we are currently unaware with claims to compositions, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our product candidates. Patent applications can take many years to issue. There may be currently pending patent applications which may later result in issued patents that may be infringed by our product candidates. Moreover, we may fail to identify relevant patents or incorrectly conclude that a patent is invalid, not enforceable, exhausted, or not infringed by its activities. If any third-party patents, held now or obtained in the future by a third party, were found by a court of competent jurisdiction to cover the manufacturing process of our product candidates, the holders of any such patents may be able to block our ability to commercialize the product candidate unless we obtain a license under the applicable patents, or until such patents expire or they are finally determined to be held invalid or unenforceable. Similarly, if any third-party patent were held by a court of competent jurisdiction to cover any aspect of our formulations, any combination therapies or patient selection methods, the holders of any such patent may be able to block our ability to develop and commercialize the product candidate unless we obtain a license or until such patent expires or is finally determined to be held invalid or unenforceable. In either case, such a license may not be available on commercially reasonable terms or at all. If we are unable to obtain a necessary license to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">a third-party patent on commercially reasonable terms, or at all, our ability to commercialize our product candidates may be impaired or delayed, which could in turn significantly harm our business. Even if we obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Parties making claims against us may seek and obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize our product candidates. Defense of these claims, regardless of their merit, could involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#8217; fees for willful infringement, obtain one or more licenses from third parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure. We cannot predict whether any such license would be available at all or whether it would be available on commercially reasonable terms. Furthermore, even in the absence of litigation, we may need or may choose to obtain licenses from third parties to advance our research or allow commercialization of our product candidates. We may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all. In that event, we would be unable to further develop and commercialize our product candidates, which could harm our business significantly.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the protection afforded by patents, we rely on trade secret protection and confidentiality agreements to protect proprietary know-how that is not patentable or which we elect not to patent, processes for which patents are difficult to enforce and any other elements of our discovery and development processes that involve proprietary know-how, information or technology that is not covered by patents. We may also rely on trade secret protection as temporary protection for concepts that may be included in a future patent filing. However, trade secret protection will not protect us from innovations that a competitor develops independently of its proprietary know-how. If a competitor independently develops a technology that we protect as a trade secret and files a patent application on that technology, then we may not be able to patent that technology in the future, may require a license from the competitor to use its own know-how, and if the license is not available on commercially viable terms, then we may not be able to launch our product candidate. Additionally, trade secrets can be difficult to protect and some courts inside and outside the United States are less willing or unwilling to protect trade secrets. The laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws within the United States. We may need to share our trade secrets and proprietary know-how with current or future partners, collaborators, contractors and others located in countries at heightened risk of theft of trade secrets, including through direct intrusion by private parties or foreign actors, and those affiliated with or controlled by state actors. As a result, we may encounter significant problems in protecting and defending our intellectual property both in the United States and abroad. If we are unable to prevent unauthorized material disclosure of our intellectual property to third parties, we will not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, operating results and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Monitoring unauthorized disclosure and detection of unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. If we were to enforce a claim that a third party had illegally obtained and was using our trade secrets, it would be expensive and time-consuming, and the outcome would be unpredictable. These lawsuits may consume our time and other resources even if we are successful. For example, significant elements of our products, including confidential aspects of sample preparation, methods of manufacturing, cell culturing conditions, computational-biological algorithms, and related processes and software, are based on unpatented trade secrets. Although we require all of our employees to assign their inventions to us, and require all of our employees, consultants, advisors and any third parties who have access to our proprietary know-how, information or technology to enter into confidentiality agreements, we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors will not otherwise gain access to our trade secrets. If our trade secrets are not adequately protected, our business, financial condition, results of operations and prospects could be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be subject to damages resulting from claims that we or our employees or consultants have wrongfully used or disclosed confidential information of our competitors or are in breach of non-competition or non-solicitation agreements with our competitors. These claims may be costly to defend and if we do not successfully do so, it may be required to pay monetary damages and may lose valuable intellectual property rights or personnel.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As is common in the biotechnology and pharmaceutical industries, we employ individuals and engage the services of consultants who previously worked for or are concurrently employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although no claims against us are currently pending, we may be subject to claims that these employees or we have inadvertently or otherwise used or disclosed trade secrets or other proprietary</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">information of their former employers, or that our consultants have used or disclosed trade secrets or other proprietary information of their former or current clients. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. A loss of key research personnel or their work product could hamper our ability to develop and commercialize, or prevent us from developing and commercializing, our product candidates, which could severely harm our business. Even if we are successful in defending against such claims, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and, if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. This type of litigation or proceeding could substantially increase our operating losses and reduce our resources available for development activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can. Uncertainties resulting from the initiation and continuation of patent litigation or other intellectual property related proceedings could adversely affect our ability to compete in the marketplace.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to effectively secure first-tier technologies when competing against other companies or investors.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future success may require that we acquire patent rights and know-how to new or complementary technologies. However, we compete with a substantial number of other companies that may also compete for technologies we desire. In addition, many venture capital firms and other institutional investors, as well as other biotechnology companies, invest in companies seeking to commercialize various types of emerging technologies. Many of these companies have greater financial, scientific and commercial resources than us. Therefore, we may not be able to secure the technologies we desire. Furthermore, should any commercial undertaking by us prove to be successful, there can be no assurance competitors with greater financial resources will not offer competitive products and/or technologies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future registered or unregistered trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. During trademark registration proceedings, we may receive rejections of our applications by the USPTO or in other foreign jurisdictions. Although we are given an opportunity to respond to such rejections, we may be unable to overcome them. In addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, which may not survive such proceedings. Moreover, any name we have proposed to use with our product candidate in the United States must be approved by the FDA, regardless of whether we have registered it, or applied to register it, as a trademark. Similar requirements exist in Europe. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with other product names. If the FDA or an equivalent administrative body in a foreign jurisdiction objects to any of our proposed proprietary product names, we may be required to expend significant additional resources in an effort to identify a suitable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. Furthermore, in many countries, owning and maintaining a trademark registration may not provide an adequate defense against a subsequent infringement claim asserted by the owner of a senior trademark.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors or other third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively, and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade names, domain name or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Numerous factors may limit any potential competitive advantage provided by our intellectual property rights.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The degree of future protection afforded by our intellectual property rights, whether owned or in-licensed, is uncertain because intellectual property rights have limitations, and may not adequately protect our business, provide a barrier to entry against our competitors or potential competitors, or permit us to maintain our competitive advantage. Moreover, if a third party has intellectual property rights that cover the practice of our technology, we may not be able to fully exercise or extract value</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">from our intellectual property rights. The factors that may limit any potential competitive advantage provided by our intellectual property rights include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pending patent applications that we may file or license may not lead to issued patents; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">patents, should they issue, that we own or license, may not provide us with any competitive advantages, or may be challenged and held invalid or unenforceable </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">others may be able to develop and/or practice technology that is similar to our technology or aspects of our technology but that is not covered by the claims of any of our owned or in-licensed patents, should any such patents issue; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third parties may compete with us in jurisdictions where we do not pursue and obtain patent protection; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we (or our licensors) might not have been the first to make the inventions covered by a pending patent application that we own or license; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we (or our licensors) might not have been the first to file patent applications covering a particular invention; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">others may independently develop similar or alternative technologies without infringing our intellectual property rights; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not be able to obtain and/or maintain necessary licenses on reasonable terms or at all; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third parties may assert an ownership interest in our intellectual property and, if successful, such disputes may preclude us from exercising exclusive rights, or any rights at all, over that intellectual property; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not be able to maintain the confidentiality of our trade secrets or other proprietary information; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may not develop or in-license additional proprietary technologies that are patentable; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the patents of others may have an adverse effect on our business. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Should any of these events occur, they could significantly harm our business and results of operation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Government Regulation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The regulatory approval processes of the FDA and other comparable foreign regulatory authorities are lengthy, time-consuming and inherently unpredictable. If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals for our product candidates, we will not be able to commercialize, or will be delayed in commercializing, such product candidates, and our ability to generate revenue will be materially impaired.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The process of obtaining regulatory approvals, both in the U.S. and abroad, is unpredictable, expensive and typically takes many years following commencement of clinical trials, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. We cannot commercialize product candidates in the U.S. without first obtaining regulatory approval from the FDA. Similarly, we cannot commercialize product candidates outside of the U.S. without obtaining regulatory approval from comparable foreign regulatory authorities. Before obtaining regulatory approvals for the commercial sale of our product candidates, including our most advanced product candidate, bempikibart, we must demonstrate through lengthy, complex and expensive preclinical and clinical trials that such product candidates are both safe and effective for each targeted indication. Securing regulatory approval also requires the submission of information about the drug manufacturing process to, and inspection of manufacturing facilities by, the relevant regulatory authority. Further, a product candidate may not be effective, may be only moderately effective or may prove to have undesirable or unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval. The FDA and comparable foreign regulatory authorities have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and require additional preclinical, clinical or other data. A product candidate could be delayed in receiving, or fail to receive, regulatory approval for many reasons, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a product candidate is safe and effective for our proposed indication; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the results of clinical trials may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">serious and unexpected drug-related side effects may be experienced by participants in our clinical trials or by individuals using drugs similar to a product candidate, which may result in inquiries from or actions by regulatory authorities to address such events; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">we may be unable to demonstrate that a candidate&#8217;s clinical and other benefits outweigh our safety risks; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the data collected from clinical trials of a product candidate may not be acceptable or sufficient to support the submission of a Biologics License Application, or BLA, a new drug application, or NDA, or similar marketing application to obtain regulatory approval in the U.S. or elsewhere, and we may be required to conduct additional clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA or the applicable foreign regulatory authority may disagree regarding the formulation, labeling and/or the specifications of a product candidate; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the FDA or comparable foreign regulatory authorities may fail to approve the manufacturing processes or facilities of third-party manufacturers with which we may contract for clinical and commercial supplies; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Of the large number of drugs in development, only a small percentage successfully complete the FDA or foreign regulatory approval processes and are commercialized. The lengthy approval process as well as the unpredictability of future clinical trial results may result in us failing to obtain regulatory approval to market bempikibart or other product candidates, which would significantly harm our business, results of operations and prospects. The FDA&#8217;s and other regulatory authorities&#8217; policies may change, and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates. For example, the U.S. Supreme Court&#8217;s July 2024 decision to overturn prior established case law giving deference to regulatory agencies&#8217; decisions and interpretations of ambiguous statutory language has introduced uncertainty regarding the extent to which the FDA&#8217;s regulations, policies and decisions may become subject to increasing legal challenges, delays, and/or changes. The U.S. Supreme Court stripped federal agencies of this presumptive deference and held that courts must exercise their independent judgment when deciding whether an agency such as the FDA acted within its statutory authority under the Administrative Procedure Act, or the APA. Decisions such as this could introduce additional uncertainty into the regulatory process and may result in additional legal challenges to actions taken by federal regulatory agencies, including the FDA and CMS, that we rely on. In addition to potential changes to regulations as a result of legal challenges, these decisions may result in increased regulatory uncertainty and delays and other impacts, any of which could adversely impact our business and operations. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any regulatory approval that we may have obtained, which would adversely affect our business, prospects and ability to achieve or sustain profitability.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we were to obtain approval, regulatory authorities may approve any such product candidate for fewer or more limited indications than we request, including failing to approve the most commercially promising indications, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals for a product candidate, we will not be able to commercialize, or will be delayed in commercializing, such product candidate and our ability to generate revenue may be materially impaired. With the change in presidential administrations in 2025, there is substantial uncertainty as to how, if at all, the new administration will seek to modify or revise the requirements and policies of the FDA and other regulatory agencies with jurisdiction over our product candidates. The impending uncertainty could present new challenges or potential opportunities as we navigate the clinical development and approval process for our product candidates.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Inadequate funding for the FDA, the SEC and other government agencies, including from government shutdowns, or other disruptions to these agencies&#8217; operations, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Currently, federal agencies in the U.S. are operating under a continuing resolution that is set to expire on March 14, 2025. Without appropriation of additional funding to federal agencies, our business operations related to our product development</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">activities for the U.S. market could be impacted. The ability of the FDA to review and approve regulatory submissions can be affected by a variety of factors, including government budget and funding levels, the ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disruptions at the FDA and other agencies may also slow the time necessary for new product candidates to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process regulatory submissions, which could have a material adverse effect on our business. Further, future government shutdowns could impact our ability to access the public markets and obtain necessary capital to properly capitalize and continue our operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may not be able to meet requirements for the chemistry, manufacturing and control of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In order to receive approval of our products by the FDA and comparable foreign regulatory authorities, we must show that we and our contract manufacturing partners are able to characterize, control and manufacture our drug and biologic products safely and in accordance with regulatory requirements. This includes synthesizing the active ingredient, developing an acceptable formulation, performing tests to adequately characterize the formulated product, documenting a repeatable manufacturing process and demonstrating that our products meet stability requirements. Meeting these chemistry, manufacturing and control, or CMC, requirements is a complex task that requires specialized expertise. If we are not able to meet the CMC requirements, we may not be successful in advancing our clinical studies or obtaining regulatory approvals for our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have and may in the future conduct clinical trials for our product candidates at sites outside the U.S., and the FDA may not accept data from trials conducted in such locations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have conducted and may in the future choose to conduct clinical trials for our product candidates outside the U.S. Although the FDA may accept data from clinical trials conducted outside the U.S., acceptance of this data is subject to conditions imposed by the FDA. For example, the clinical trial must be well designed and conducted and performed by qualified investigators in accordance with ethical principles. The trial population must also adequately represent the U.S. population, and the data must be applicable to the U.S. population and U.S. medical practice in ways that the FDA deems clinically meaningful. In addition, while these clinical trials are subject to the applicable local laws, FDA acceptance of the data will depend on its determination that the trials also complied with all applicable U.S. laws and regulations. If the FDA does not accept the data from any trial that we conduct outside the U.S., it would likely result in the need for additional trials, which would be costly and time-consuming and would delay or permanently halt our development of the applicable product candidates. Even if the FDA accepted such data, it could require us to modify our planned clinical trials to receive clearance to initiate such trials in the U.S. or to continue such trials once initiated.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other risks inherent in conducting international clinical trials include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the need to comply with foreign regulatory requirements, differences in healthcare services, and differences in cultural customs that could restrict or limit our ability to conduct our clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">administrative burdens of conducting clinical trials under multiple sets of foreign regulations; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">foreign exchange fluctuations; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">diminished protection of intellectual property in some countries; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">political and economic risks relevant to foreign countries. </span></div></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our product candidates for which it intends to seek approval as biologics may face competition sooner than anticipated.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Biologics Price Competition and Innovation Act of 2009, or BPCIA, was enacted as part of the ACA to establish an abbreviated pathway for the approval of biosimilar and interchangeable biological products. The regulatory pathway establishes legal authority for the FDA to review and approve biosimilar biologics, including the possible designation of a biosimilar as &#8220;interchangeable&#8221; based on its similarity to an approved biologic. Under the BPCIA, an application for a highly similar or &#8220;biosimilar&#8221; product may not be submitted to the FDA until four years following the date that the reference product was first approved by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first approved. During this 12-year period of exclusivity, another company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing the sponsor&#8217;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of their product.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our investigational biological products, if approved, could be considered reference products entitled to the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider a product candidate to be reference products for competing products, potentially creating the opportunity for competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of litigation. The approval of a biosimilar of any of our product candidates could have a material adverse impact on our business due to increased competition and pricing pressure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we receive regulatory approval of bempikibart or other product candidates, we will be subject to extensive ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any regulatory approvals that we may receive for bempikibart or other product candidates will require the submission of reports to regulatory authorities and surveillance to monitor the safety and efficacy of such product candidates, may contain significant limitations related to use restrictions for specified age groups, warnings, precautions or contraindications, and may include burdensome post-approval study or risk management requirements. For example, the FDA may require a risk evaluation and mitigation strategy in order to approve a product candidate, which could entail requirements for a medication guide, physician training and communication plans or additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In addition, if the FDA or comparable foreign regulatory authorities approve a product candidate, the products and the activities associated with their development and commercialization, including their design, testing, manufacture, safety, efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale, distribution, import and export will be subject to comprehensive regulation by the FDA and other regulatory agencies in the U.S. and by comparable foreign regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as ongoing compliance with cGMPs and GCPs for any clinical trials that we conduct following approval. In addition, manufacturers of drug substances and products and their facilities are subject to continual review and periodic, unannounced inspections by the FDA and other regulatory authorities for compliance with cGMPs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we or a regulatory authority discovers previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facilities where the product is manufactured, a regulatory authority may impose restrictions on that product, the manufacturing facility or us, including requiring recall or withdrawal of the product from the market or suspension of manufacturing, restrictions on our ability to conduct clinical trials, including full or partial clinical holds on ongoing or planned trials, restrictions on the manufacturing process, warning or untitled letters, civil and criminal penalties, injunctions, product seizures, detentions or import bans, voluntary or mandatory publicity requirements and imposition of restrictions on operations, including costly new manufacturing requirements. The occurrence of any event or penalty described above may inhibit our ability to commercialize bempikibart or other product candidates and generate revenue and could require us to expend significant time and resources in response and could generate negative publicity.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may face difficulties from healthcare legislative reform measures.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Existing regulatory policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of bempikibart or other product candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the U.S. or abroad. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability. See the section titled &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business-Government Regulation-Healthcare Reform</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; elsewhere in this Annual Report on Form 10-K for a more detailed description of healthcare reforms measures that may prevent us from being able to generate revenue, attain profitability, or commercialize product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The continuing efforts of the government, insurance companies, managed care organizations and other payers of healthcare services to contain or reduce costs of healthcare may adversely affect:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the demand for any of our product candidates, if approved; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to set a price that we believe is fair for any of our product candidates, if approved; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to generate revenues and achieve or maintain profitability; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the level of taxes that we are required to pay; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of capital. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for pharmaceutical and biologic products. We cannot be sure whether additional legislative changes will be enacted, or whether FDA regulations, guidance or interpretations will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be. In addition, increased scrutiny by the U.S. Congress of the FDA&#8217;s approval process may significantly delay or prevent marketing approval, as well as subject us to more stringent product labeling and post-marketing testing and other requirements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that the healthcare reform measures that have been adopted and may be adopted in the future, may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved product and could seriously harm our future revenues. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business operations and current and future arrangements with investigators, healthcare professionals, consultants, third-party payors, patient organizations and customers will be subject to applicable healthcare regulatory laws, which could expose us to penalties.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business operations and current and future arrangements with investigators, healthcare professionals, consultants, third-party payors, patient organizations and customers may expose us to fraud and abuse and other healthcare laws and regulations. These laws may constrain the business or financial arrangements and relationships through which we conduct our operations, including how we research, market, sell and distribute our product candidates, if approved. See the section titled &#8220;Business-Government Regulation-Other Healthcare Laws and Compliance Requirements&#8221; elsewhere in this Annual Report on Form 10-K for a more detailed description of the laws that may affect our ability to operate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ensuring that our internal operations and future business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. If our operations are found to be in violation of any of these laws or any other governmental laws and regulations that may apply to it, we may be subject to significant penalties, including civil, criminal and administrative penalties, damages, fines, exclusion from government-funded healthcare programs, integrity oversight and reporting obligations to resolve allegations of non-compliance, disgorgement, individual imprisonment, contractual damages, reputational harm, diminished profits and the curtailment or restructuring of our operations. Further, defending against any such actions can be costly and time-consuming and may require significant personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Even if we are able to commercialize bempikibart or other product candidates, due to unfavorable pricing regulations and/or third-party coverage and reimbursement policies, we may not be able to offer such products at competitive prices which would seriously harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We intend to seek approval to market bempikibart and other product candidates in both the U.S. and in selected foreign jurisdictions. If we obtain approval in one or more foreign jurisdictions for such product candidates, we will be subject to rules and regulations in those jurisdictions. Our ability to successfully commercialize any product candidates that we may develop will depend in part on the extent to which reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. Government authorities and other third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for and establish reimbursement levels. Government authorities and other third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for medications. These entities may create preferential access policies for a competitor&#8217;s product, including a branded or generic/biosimilar product, over our products in an attempt to reduce their costs, which may reduce our commercial opportunity. Additionally, if any of our product candidates are approved and we are found to have improperly promoted off-label uses of those programs, we may become subject to significant liability, which would materially adversely affect our business and financial condition. See the sections titled &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business-Government Regulation-Coverage and Reimbursement</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; and &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">-Regulation in the EU</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; elsewhere in this Annual Report on Form 10-K for a more detailed description of the government regulations and third-party payor practices that may affect our ability to commercialize our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations. We can face criminal liability and other serious consequences for violations, which can harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, various economic and trade sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Controls, the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, the USA PATRIOT Act, and other state and national anti-bribery and anti-money laundering laws in the countries in which we conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, contractors, and other collaborators from authorizing, promising, offering, or providing, directly or indirectly, improper payments or anything else of value to or from recipients in the public or private sector. We may engage third parties to sell products outside the U.S., to conduct clinical trials, and/or to obtain necessary permits, licenses, patent registrations, and other regulatory approvals. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We can be held liable for the corrupt or other illegal activities of our employees, agents, contractors, and other collaborators, even if we do not explicitly authorize or have actual knowledge of such activities. Any violations of the laws and regulations described above may result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Governments outside the U.S. tend to impose strict price controls, which may adversely affect our revenue, if any.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In some countries, particularly Member States of the EU, the pricing of prescription drugs is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after receipt of marketing approval for a therapeutic. In addition, there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various Member States and parallel distribution, or arbitrage between low-priced and high-priced Member States, can further reduce prices. To obtain coverage and reimbursement or pricing approvals in some countries, we or current or future collaborators may be required to conduct a clinical trial or other studies that compare the cost-effectiveness of a product to other available therapies in order to obtain or maintain reimbursement or pricing approval. Publication of discounts by third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If reimbursement of any product approved for marketing is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business, financial condition, results of operations or prospects could be materially and adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may seek one or more designations or expedited programs for our product candidates, but may not receive such designations or be allowed to proceed on expedited program pathways, and even if we do receive such designations and proceed on such expedited program pathways in the future, such designations or expedited programs may not lead to a faster development or regulatory review or approval process, and each designation does not increase the likelihood that any of our product candidates will receive regulatory approval in the U.S.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may seek fast track designation for some of our product candidates, where applicable. If a drug is intended for the treatment of a serious or life-threatening condition and nonclinical or clinical data for the drug demonstrates the potential to address an unmet medical need for such a condition, the drug sponsor may apply for fast track designation. The FDA has broad discretion whether to grant this designation, so even if we believe a particular product candidate is eligible for this designation, we cannot provide assurance that the FDA would decide to grant this designation. Even if our candidates receive fast track designation, these candidates may not experience a faster development process, review or approval compared to conventional FDA procedures. The FDA may withdraw fast track designation if it believes that the designation is no longer supported by data from the clinical development program. Fast track designation alone does not guarantee qualification for the FDA&#8217;s priority review procedures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may seek a breakthrough therapy designation for some of our product candidates. A breakthrough therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For drugs that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Drugs designated as breakthrough therapies by the FDA may also be eligible for priority review and accelerated approval. Designation as a breakthrough therapy is within the discretion of the FDA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accordingly, even if we believe one of our product candidates meets the criteria for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a breakthrough therapy designation for a product candidate may not result in a faster development process, review or approval compared to therapies considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify as breakthrough therapies, the FDA may later decide that such product candidates no longer meet the conditions for qualification or decide that the time for FDA review or approval will not be shortened.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the future, we may also seek approval of product candidates under the FDA&#8217;s accelerated approval pathway. A product may be eligible for accelerated approval if it is designed to treat a serious or life-threatening disease or condition and generally provides a meaningful advantage over available therapies upon a determination that the product candidate has an effect on a surrogate endpoint or intermediate clinical endpoint that is reasonably likely to predict clinical benefit. The FDA considers a clinical benefit to be a positive therapeutic effect that is clinically meaningful in the context of a given disease, such as irreversible morbidity or mortality. For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit but is not itself a measure of clinical benefit. An intermediate clinical endpoint is a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit. The accelerated approval pathway may be used in cases in which the advantage of a new drug over available therapy may not be a direct therapeutic advantage but is a clinically important improvement from a patient and public health perspective. If granted, accelerated approval is usually contingent on the sponsor&#8217;s agreement to conduct, in a diligent manner, additional post-approval confirmatory studies to verify and describe the drug&#8217;s clinical benefit. Under the Food and Drug Omnibus Reform Act of 2022, or FDORA, the FDA is permitted to require, as appropriate, that a post-approval confirmatory study or studies be underway prior to approval or within a specified time after the date of accelerated approval was granted. FDORA also requires sponsors to send updates to the FDA every 180 days on the status of such studies, including progress toward enrollment targets, and the FDA must promptly post this information publicly. FDORA also gives the FDA increased authority to withdraw approval of a drug or biologic granted accelerated approval on an expedited basis if the sponsor fails to conduct such studies in a timely manner, send the necessary updates to the FDA, or if such post-approval studies fail to verify the drug&#8217;s predicted clinical benefit. Under FDORA, the FDA is empowered to act, such as issuing fines, against companies that fail to conduct with due diligence any post-approval confirmatory study or submit timely reports to the agency on their progress. In addition, for products being considered for accelerated approval, the FDA generally requires, unless otherwise informed by the Agency, that all advertising and promotional materials intended for dissemination or publication within 120 days of regulatory approval be submitted to the Agency for review during the pre-approval review period. Thus, even if we seek to utilize the accelerated approval pathway, we may not be able to obtain accelerated approval and, even if we do, we may not experience a faster development, regulatory review or approval process for that product. Moreover, even if we received accelerated approval, any post-approval studies required to confirm and verify clinical benefit may not show such benefit, which could lead to withdrawal of any approvals we have obtained. In addition, receiving accelerated approval does not assure that the product&#8217;s accelerated approval will eventually be converted to a traditional approval.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the FDA determines that a product candidate offers a treatment for a serious condition and, if approved, the product would provide a significant improvement in safety or effectiveness, the FDA may designate the product candidate for priority review. A priority review designation means that the goal for the FDA to review an application is six months, rather than the standard review period of ten months. We may request priority review for our product candidates. The FDA has broad discretion with respect to whether to grant priority review status to a product candidate, so even if we believe a particular product candidate is eligible for such designation or status, the FDA may decide not to grant it. Moreover, a priority review designation does not necessarily result in an expedited regulatory review or approval process or necessarily confer any advantage with respect to approval compared to conventional FDA procedures. Receiving priority review from the FDA does not guarantee approval within the six-month review cycle or at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may pursue orphan drug designation for certain of our product candidates, but may not be able to obtain such designation, or obtain or maintain the benefits of such designation including orphan drug exclusivity, and even if we do obtain orphan designation for our product candidates, any orphan drug exclusivity it receives may not prevent regulatory authorities from approving other competing products.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may seek orphan drug designation for some of our product candidates; however, we may never receive such designation. Under the Orphan Drug Act, the FDA may designate a product as an orphan drug if it is a drug or biologic intended to treat a rare disease or condition, defined as a patient population of fewer than 200,000 in the U.S., or a patient population of 200,000 or more in the U.S. where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the U.S. Orphan drug designation must be requested before submitting an NDA or a BLA. A similar regulatory scheme governs orphan products in the EU.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and application fee waivers. After the FDA grants orphan drug designation, the generic identity of the drug and its potential orphan use are disclosed publicly by the FDA. In addition, if a product candidate with an orphan drug designation subsequently receives the first regulatory approval for the indication for which it has such designation, the product is entitled to a period of marketing exclusivity, which precludes the FDA from approving another marketing application for the same product for the same therapeutic indication for seven years.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different products can be approved for the same condition. In addition, even after an orphan drug is approved, the FDA can subsequently approve the same product for the same condition if the FDA concludes that the later product is clinically superior in that it is shown to be safer, more effective or makes a major contribution to patient care. Orphan drug exclusivity may also be lost if the FDA determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the product to meet the needs of the patients with the rare disease or condition. Further, even if we obtain orphan drug designation, we may not be the first to obtain regulatory approval for any indication due to the uncertainties associated with developing pharmaceutical products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The FDA may further reevaluate the Orphan Drug Act and its regulations and policies. Additionally, legislation has been proposed by the European Commission that, if implemented, has the potential in some cases to shorten the ten-year period of orphan marketing exclusivity. It is unclear if, when, or how the FDA or other regulatory authorities may change the orphan drug regulations and policies in the future, and it is uncertain how any changes might affect our business. Depending on what changes the FDA or other regulatory authorities may make to their orphan drug regulations and policies, our business could be adversely impacted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Third Party Relationships</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We currently rely and expect to rely on third parties in the future to conduct our clinical trials and some aspects of our research, as well as some aspects of our delivery methods, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research or testing.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently, and expect to continue to, rely on third parties, such as but not limited to CROs, clinical data management organizations, medical institutions, preclinical laboratories and clinical investigators, to conduct some aspects of our research. For example, we may rely on a third party to supply components of our product candidates, or to conduct some of our preclinical animal experiments. Any of these third parties may terminate their engagements with us at any time under certain criteria. If we need to enter into alternative arrangements, it may delay our product research and development activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our reliance on these third parties for research and development activities will reduce our control over these activities but will not relieve us of our responsibilities. For example, we will remain responsible for ensuring that each of our preclinical studies and clinical trials is conducted in accordance with the general investigational plan and protocols. Moreover, the FDA, the EMA and other regulatory authorities require us and the study sites and investigators we work with to comply with standards, commonly referred to as GLPs and GCPs for conducting, recording and reporting the results of preclinical studies and clinical trials to assure, amongst other things, that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have collaborations and license agreements with third parties, including our existing license agreements with BMS and Colorado and expect to collaborate with third parties in the future. We may not be successful in finding strategic collaborators for continuing development of certain of our future product candidates or successfully commercializing or competing in the market for certain indications.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We currently collaborate with third-parties with respect to bempikibart and ADX-097. If any of our collaborators, licensors or licensees experience delays in performance of, or fail to perform their obligations under, their applicable agreements with us, disagree with our interpretation of the terms of such agreement or terminate their agreement with us, our pipeline of product candidates would be adversely affected. If we fail to comply with any of the obligations under our collaborations or license agreements, including payment terms and diligence terms, our collaborators, licensors or licensees may have the right to terminate our agreements, in which event we may lose intellectual property rights, market or sell the products covered by such agreements or may face other penalties under such agreements. Our collaborators, licensors or licensees may also fail to properly maintain or defend the intellectual property we have licensed from them, or infringe upon other third party intellectual property rights, leading to the potential invalidation of such third party&#8217;s intellectual property or subjecting us to litigation or arbitration, any of which would be time-consuming and expensive and could harm our ability to develop or commercialize our product candidates. Further, any of these relationships may require us to increase our near and long-term expenditures, issue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">securities that dilute our existing stockholders or disrupt our management and business. In addition, collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates and products if the collaborators believe that the competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than under the agreements with us.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the future, we may decide to collaborate with entities such as, but not limited to, non-profit organizations, universities, pharmaceutical and biotechnology companies for the development and potential commercialization of existing and new product candidates. We face significant competition in seeking appropriate collaborators. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#8217;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#8217;s evaluation of several factors. Those factors may include the design or results of clinical trials, the likelihood of approval by the FDA or similar regulatory authorities outside the U.S., the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of competing drugs, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us for our product candidate. The terms of any additional collaborations or other arrangements that we may establish may not be favorable to us. Collaborations are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, it may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay our development program or one or more of our other development programs, delay our potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates or bring them to the market and generate product revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The success of any potential collaboration arrangements will depend heavily on the efforts and activities of our collaborators. Collaborators generally have significant discretion in determining the efforts and resources that they will apply to these collaborations. Disagreements between parties to a collaboration arrangement regarding clinical development and commercialization matters can lead to delays in the development process or commercializing the applicable product candidate and, in some cases, termination of such collaboration arrangements. These disagreements can be difficult to resolve if neither of the parties has final decision-making authority. Collaborations with pharmaceutical or biotechnology companies and other third parties often are terminated or allowed to expire by the other party. Any such termination or expiration would adversely affect us financially and could harm our business reputation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Future acquisitions or strategic alliances could disrupt our business and harm our financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may acquire additional businesses or drugs, form strategic alliances or create joint ventures with third parties that we believe will complement or augment our existing business. If we acquire businesses with promising markets or technologies, we may not be able to realize the benefit of acquiring such businesses if we are unable to successfully integrate them with our existing operations and company culture. We may encounter numerous difficulties in developing, manufacturing and marketing any new drugs resulting from a strategic alliance or acquisition that delay or prevent us from realizing their expected benefits or enhancing our business. We cannot assure you that, following any such acquisition, we will achieve the expected synergies to justify the transaction. The risks we face in connection with acquisitions, include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">diversion of management time and focus from operating our business to addressing acquisition integration challenges; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">coordination of research and development efforts; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">retention of key employees from the acquired company; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in relationships with strategic partners because of product acquisitions or strategic positioning resulting from the acquisition; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cultural challenges associated with integrating employees from the acquired company into our company; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the need to implement or improve controls, procedures, and policies at a business that prior to the acquisition may have lacked sufficiently effective controls, procedures and policies; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">liability for activities of the acquired company before the acquisition, including intellectual property infringement claims, violation of laws, commercial disputes, tax liabilities, and other known liabilities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unanticipated write-offs or charges; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">litigation or other claims in connection with the acquired company, including claims from terminated employees, customers, former stockholders or other third parties. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our failure to address these risks or other problems encountered in connection with our past or future acquisitions or strategic alliances could cause us to fail to realize the anticipated benefits of these transactions, cause us to incur unanticipated liabilities and harm the business generally. There is also a risk that future acquisitions will result in the incurrence of debt, contingent liabilities, amortization expenses or incremental operating expenses, any of which could harm our financial condition or results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We rely, and anticipate that we will rely, on third parties to assist in designing, conducting, supervising and monitoring our preclinical studies and clinical trials, and if those third parties perform in an unsatisfactory manner, it may harm our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely, and anticipate that we will rely, on third party clinical investigators, CROs, clinical data management organizations and consultants to help design, conduct, supervise and monitor preclinical studies and clinical trials of our product candidates. Because we rely on third parties and do not have the ability to conduct preclinical studies or clinical trials independently, we have less control over the timing, quality and other aspects of preclinical studies and clinical trials than we would if we conducted them on our own, including our inability to control whether sufficient resources are applied to our programs. If any of our CROs are acquired or consolidated, these concerns are likely to be exacerbated and our preclinical studies or clinical trials may be further impacted due to potential integration, streamlining, staffing and logistical changes. These investigators, CROs and consultants are not our employees and we have limited control over the amount of time and resources that they dedicate to our programs. These third parties may have contractual relationships with other entities, some of which may be our competitors, which may draw time and resources from our programs. Further, these third parties may not be diligent, careful or timely in conducting our preclinical studies or clinical trials, resulting in the preclinical studies or clinical trials being delayed or unsuccessful.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we cannot contract with acceptable third parties on commercially reasonable terms, or at all, or if these third parties do not carry out their contractual duties, satisfy legal and regulatory requirements for the conduct of preclinical studies or clinical trials or meet expected deadlines, our preclinical and clinical development programs could be delayed and otherwise adversely affected. In all events, we are responsible for ensuring that each of our preclinical studies and clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. The FDA and other health authorities require certain preclinical studies to be conducted in accordance with GLP, and clinical trials to be conducted in accordance with GCP, including conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of clinical trial participants are protected. If we or our CROs fail to comply with these requirements, the data generated in our clinical trials may be deemed unreliable or uninterpretable and the FDA and other health authorities may require us to perform additional clinical trials. Our reliance on third parties that we do not control does not relieve us of these responsibilities and requirements. In the U.S., we are also required to register certain clinical trials and post the results of completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions. Any such event could adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We rely on third parties in the supply and manufacture of our product candidates for our research, preclinical and clinical activities, and may do the same for commercial supplies of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have not yet manufactured our product candidates on a commercial scale and may not be able to do so for any of our product candidates. We currently rely on third parties in the supply and manufacture of materials for our research, preclinical and clinical activities and may continue to do so for the foreseeable future, including if we received regulatory approval for any product candidate. We may do the same for the commercial supply of our drug product, if any. We use third parties to perform additional steps in the manufacturing process, such as the filling, finishing and labeling of vials and storage and shipping of our product candidates and we expect to do so for the foreseeable future. There can be no assurance that our supply of research, preclinical and clinical development drug candidates and other materials will not be limited, interrupted or restricted or will be of satisfactory quality or continue to be available at acceptable prices. Replacement of any of the third parties we may engage</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">could require significant effort and expertise because there may be a limited number of qualified replacements. In addition, raw materials, reagents, and components used in the manufacturing process, particularly those for which we have no other source or supplier, may not be available, may not be suitable or acceptable for use due to material or component defects, or may introduce variability into the supply of our product candidates. Furthermore, with the increase of companies developing fusion protein based antibodies and/or monoclonal antibodies, there may be increased competition for the supply of the raw materials that are necessary to make our fusion protein based antibodies and/or monoclonal antibodies, which could severely impact the manufacturing of our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may be unable to identify manufacturers on acceptable terms or at all because the number of potential manufacturers is limited, and they must be acceptable to the FDA or approved by foreign regulatory authorities. Suppliers and manufacturers, including us, must meet applicable manufacturing requirements, including compliance with cGMP regulations, and undergo rigorous facility and process validation tests required by regulatory authorities to comply with regulatory standards. In the event that any of our suppliers or manufacturers fail to comply with such requirements or to perform their obligations to us in relation to quality, timing or otherwise, some of which may be out of their or our control, or if our supply of components or other materials becomes limited or interrupted for other reasons, we may be forced to increase the manufacturing of the materials ourselves, for which we currently have limited capabilities and resources, or enter into an agreement with another third party, which we may not be able to do on reasonable terms, if at all. Any interruption of the development or operation of the manufacturing of our product candidates, such as order delays for equipment or materials, equipment malfunction, quality control and quality assurance issues, regulatory delays and possible negative effects of such delays on supply chains and expected timelines for product availability, production yield issues, shortages of qualified personnel, discontinuation of a facility or business or failure or damage to a facility resulting from natural disasters, could result in the cancellation of shipments, loss of product in the manufacturing process or a shortfall in available product candidates or materials. In some cases, the technical skills or technology required to manufacture our product candidates may be unique or proprietary to the original manufacturer and we may have difficulty, or there may be contractual restrictions prohibiting us from, transferring such skills or technology to another third party and a feasible alternative may not exist. These factors would increase our reliance on such manufacturer or require us to obtain a license from such manufacturer in order to have another third-party manufacture our product candidates. If we are required to change manufacturers for any reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines. The delays associated with the verification of a new manufacturer could negatively affect our ability to develop product candidates in a timely manner or within budget. Regional or single-source dependencies may in some cases accentuate these risks. For example, the pharmaceutical industry generally, and in some cases of third parties on which we rely, depend on China-based suppliers or service producers for certain materials, products and services, or other activities. Our ability or the ability of the third parties we rely on to continue to engage these China-based suppliers or service providers for certain materials could be restricted due to geopolitical developments between the United States and China, including as a result of the escalation of tariffs or other trade restrictions.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we currently rely on foreign CROs and CDMOs, including WuXi Biologics, and will likely continue to rely on foreign CROs and CDMOs in the future. Foreign CDMOs may be subject to U.S. legislation, including, for example, legislation previously considered in the U.S. Congress (but not enacted) called the BIOSECURE Act.  If the BIOSECURE Act or similar legislation is passed in the future, it could prohibit the U.S. government from entering contracts or providing grants or loans to procure biotechnology equipment and services provided or produced by so-called &#8220;biotechnology companies of concern.&#8221; It also could prohibit the U.S. government from entering contracts or providing grants or loans to entities who use biotechnology equipment or services provided or produced by &#8220;biotechnology companies of concern&#8221; in connection with such contracts, grants, or loans. WuXi Biologics, along with several other entities, was identified in the legislation as a &#8220;biotechnology company of concern.&#8221; Even though the final version of the BIOSECURE Act considered by Congress did include a delayed implementation date to permit companies to wind down from impacted relationships, any additional executive action, legislative action or potential sanctions with China could materially impact WuXi Biologics, and our agreement with them. In addition, foreign CDMOs may be subject to sanctions, trade restrictions and other foreign regulatory requirements which could increase the cost or reduce the supply of material available to us, delay the procurement or supply of such material or have an adverse effect on our ability to manufacture our product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may also be required to enter into long-term manufacturing agreements that contain exclusivity provisions and/or substantial termination penalties which could have a material adverse effect on our business prior to or after commercialization of any of our product candidates. If we are unable to obtain or maintain third-party manufacturing for product candidates, or to do so on commercially reasonable terms, we may not be able to develop and commercialize our product candidates successfully. Failure to execute our manufacturing requirements, either by us or by one of our third-party vendors, could adversely affect our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our relationships with healthcare providers, physicians, and third-party payors will be subject to applicable anti-kickback, fraud and abuse, anti-bribery and other healthcare laws and regulations, which could expose it to criminal sanctions, civil penalties, contractual damages, reputational harm, and diminished profits and future earnings.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Healthcare providers, physicians, and third-party payors play a primary role in the recommendation and prescription of any product candidates that we may develop for which it obtains marketing approval. Our future arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we market, sell, and distribute our medicines for which we obtain marketing approval. Restrictions under applicable federal and state healthcare laws and regulations listed in the section above titled &#8220;Risk Factors&#8212;Risks Related to Government Regulation,&#8221; including certain laws and regulations applicable only if we have marketed products.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some state laws also require pharmaceutical companies to comply with specific compliance standards, restrict financial interactions between pharmaceutical companies and healthcare providers or require pharmaceutical companies to report information related to payments to health care providers or marketing expenditures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Given the breadth of the laws and regulations, limited guidance for certain laws and regulations and evolving government interpretations of the laws and regulations, governmental authorities may possibly conclude that our business practices may not comply with healthcare laws and regulations. If our operations are found to be in violation of any of the laws described above or any other government regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines, exclusion from participation in government health care programs, such as Medicare and Medicaid, imprisonment, and the curtailment or restructuring of our operations, any of which could adversely affect our business, financial condition, results of operations, and prospects.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The provision of benefits or advantages to physicians to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order, or use of medicinal products is prohibited in the EU. The provision of benefits or advantages to physicians is also governed by the national anti-bribery laws of EU Member States, such as the U.K. Bribery Act 2010. Infringement of these laws could result in substantial fines and imprisonment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payments made to physicians in certain EU Member States must be publicly disclosed. Moreover, agreements with physicians often must be the subject of prior notification and approval by the physician&#8217;s employer, his or her competent professional organization, and/or the regulatory authorities of the individual EU Member States. These requirements are provided in the national laws, industry codes, or professional codes of conduct applicable in the EU Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Business, Personnel and Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our strategic refocus and the associated workforce reduction announced in February 2025 may not result in anticipated cost savings, could result in total costs and expenses that are greater than expected and could disrupt our business.</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2025, we announced a reduction in workforce in connection with the strategic refocus of our business to prioritize and focus on the advancement of bempikibart in patients with alopecia areata. We may not realize, in full or in part, the anticipated benefits, savings and improvements in our operating structure from our restructuring efforts due to unforeseen difficulties, delays or unexpected costs. If we are unable to realize the expected operational efficiencies and cost savings from the restructuring, our results of operation and financial condition would be adversely affected. We expect to incur additional costs as we recognize one-time employee termination-related charges. We also cannot guarantee that we will not have to undertake additional workforce reductions or restructuring activities in the future. Furthermore, our strategic restructuring plan may be disruptive to our operations. For example, our workforce reductions could yield unanticipated consequences, such as attrition beyond planned staff reductions, increased difficulties in our day-to-day operations and reduced employee morale. If employees who were not affected by the reduction in force seek alternate employment, this could result in us seeking contract support which may result in unplanned additional expense or harm our productivity. Our workforce reductions could also harm our ability to attract and retain qualified management, scientific, and clinical personnel who are critical to our business. Any failure to attract or retain qualified personnel could prevent us from successfully developing our product candidates in the future.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our future growth may depend, in part, on our ability to operate in foreign markets, where we would be subject to additional regulatory burdens and other risks and uncertainties.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our future growth may depend, in part, on our ability to develop and commercialize bempikibart or other product candidates in foreign markets for which we may rely on collaboration with third parties. We are not permitted to market or promote any product candidates before we receive regulatory approval from the applicable foreign regulatory authority and may never receive such regulatory approval for any product candidates. To obtain separate regulatory approval in many other countries, we must comply with numerous and varying regulatory requirements of such countries regarding safety and efficacy and governing, among other things, clinical trials and commercial sales, pricing and distribution of bempikibart or other product candidates, and we cannot predict success in these jurisdictions. If we fail to comply with the regulatory requirements in international markets or to receive applicable marketing approvals, our target market will be reduced and our ability to realize the full market potential of bempikibart or other product candidates will be harmed, and our business will be adversely affected. Moreover, even if we obtain approval of bempikibart or other product candidates and ultimately commercialize such product candidates in foreign markets, we would be subject to the risks and uncertainties, including the burden of complying with complex and changing foreign regulatory, tax, accounting and legal requirements and reduced protection of intellectual property rights in some foreign countries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs, CDMOs, suppliers and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are exposed to the risk that our employees, independent contractors, consultants, commercial collaborators, principal investigators, CROs, CDMOs, suppliers and vendors acting for or on our behalf may engage in misconduct or other improper activities. It is not always possible to identify and deter misconduct by these parties and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our internal computer systems, or those of any of our CROs, manufacturers, other contractors, third party service providers or consultants or potential future collaborators, may fail or suffer security incidents, data privacy breaches or other unauthorized or improper access to, use of, or destruction of our proprietary or confidential data, employee data or personal data, which could result in additional costs, loss of revenue, significant liabilities, harm to our brand and material disruption of our operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Despite the implementation of security measures in an effort to protect systems that store our information, given their size and complexity and the increasing amounts of information maintained on our internal information technology systems and those of our third-party CROs, other contractors (including sites performing our clinical trials), third party service providers and supply chain companies, and consultants, as well as other partners, these systems are potentially vulnerable to breakdown or other damage or interruption from service interruptions, system malfunction, natural disasters, terrorism, war and telecommunication and electrical failures, as well as security breaches from inadvertent or intentional actions by our employees, contractors, consultants, business partners and/or other third parties, or from cyber-attacks by malicious third parties, which may compromise our system infrastructure or lead to the loss, destruction, alteration or dissemination of, or damage to, our data. To the extent that any disruption or security breach were to result in a loss, destruction, unavailability, alteration or dissemination of, or damage to, our data or applications, or for us to be believed or reported that any of these occurred, we could incur liability and reputational damage and the development and commercialization of bempikibart or other product candidates could be delayed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As our employees work remotely and utilize network connections, computers, and devices outside our premises or network, including working at home, while in transit and in public locations, there are risks to our information technology systems and data. Additionally, business transactions (such as acquisitions or integrations) could expose us to additional cybersecurity threats, risks and vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired or integrated entities&#8217; systems and technologies or threats presented by malicious third parties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We, like other organizations in our industry, expect to experience cybersecurity incidents and threats to our infrastructure. While we have implemented security measures designed to protect against security incidents, there can be no assurance that these measures will be effective. We may be unable in the future to detect vulnerabilities in our information technology systems because such threats and techniques change frequently, are often sophisticated in nature, and may not be detected until after a security incident has occurred. Further, we may experience delays in developing and deploying remedial measures designed to address any such identified vulnerabilities. Applicable data privacy and security obligations may require us to notify relevant</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">stakeholders of security incidents. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to adverse consequences.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We rely on third-party service providers and technologies to operate critical business systems to process sensitive information in a variety of contexts. Our ability to monitor these third parties&#8217; information security practices is limited, and these third parties may not have adequate information security measures in place. If our third-party service providers experience a security incident or other interruption, we could experience adverse consequences. While we may be entitled to damages if our third-party service providers fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. In addition, supply-chain attacks have increased in frequency and severity, and we cannot guarantee that third parties&#8217; infrastructure in our supply chain or our third-party partners&#8217; supply chains have not been compromised.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we (or a third party upon whom we rely) experience a security incident or are perceived to have experienced a security incident, we may experience adverse consequences, such as government enforcement actions (for example, investigations, fines, penalties, audits, and inspections); additional reporting requirements and/or oversight; restrictions on processing sensitive information (including personal data); litigation (including class claims); indemnification obligations; negative publicity; reputational harm; monetary fund diversions; interruptions in our operations (including availability of data); increased investigation and compliance costs; financial loss; and other similar harms. Security incidents and attendant consequences may cause stakeholders (including investors and potential customers) to stop supporting our research and development activities, deter new customers from products, and negatively impact our ability to grow and operate our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our contracts may not contain limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and security obligations. We cannot be sure that our insurance coverage will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our privacy and security practices or from disruptions in, or failure or security breach of, our systems or third-party systems where information important to our business operations or commercial development is stored, or that such coverage will continue to be available on commercially reasonable terms or at all, or that such coverage will pay future claims.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We are subject to stringent and changing laws, regulations and standards, and contractual obligations relating to privacy, data protection, and data security. The actual or perceived failure to comply with such obligations could lead to government enforcement actions (which could include civil or criminal penalties), fines and sanctions, private litigation and/or adverse publicity and could negatively affect our operating results and business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We, and third parties with whom we work, are or may become subject to numerous domestic and foreign laws, regulations, and standards relating to privacy, data protection, and data security, the scope of which are changing, subject to differing applications and interpretations, and may be inconsistent among countries, or conflict with other rules. We are or may become subject to the terms of contractual obligations related to privacy, data protection, and data security. Our obligations may also change or expand as our business grows. The actual or perceived failure by us or third parties related to us to comply with such laws, regulations and obligations could increase our compliance and operational costs, expose us to regulatory scrutiny, actions, fines and penalties, result in reputational harm, lead to a loss of customers, result in litigation and liability, and otherwise cause a material adverse effect on our business, financial condition, and results of operations. See the sections titled &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business-Government Regulation-Data Privacy and Security</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; and &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Regulatory Matters</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8221; elsewhere in this Annual Report on Form 10-K for a more detailed description of the laws that may affect our ability to operate.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations may involve the use of hazardous and flammable materials, including chemicals and biological and radioactive materials. In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development or commercialization efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we are unable to attract and retain qualified key management and scientists, staff, consultants and advisors, our ability to implement our business plan may be adversely affected.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are highly dependent upon our senior management and our scientific, clinical and medical staff and advisors. The loss of the service of any of the members of our senior management or other key employees could delay our research and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">68</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">development programs and materially harm our business, financial condition, results of operations and prospects. In addition, we expect that we will continue to have an increased need to recruit and hire qualified personnel as we advance our programs and expand operations. Failure to successfully recruit and retain personnel could impact our anticipated development plans and timelines. We are dependent on the continued service of our technical personnel because of the highly technical and novel nature of our product candidates, platform and technologies and the specialized nature of the regulatory approval process. Replacing such personnel may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully execute our business strategy, and we cannot assure you that we will be able to identify or employ qualified personnel for any such position on acceptable terms, if at all. Many of the biotechnology and pharmaceutical companies with whom we compete for qualified personnel have greater financial and other resources, different risk profiles and longer histories in the industry than we do. Because our management team and key employees are not obligated to provide us with continued service, they could terminate their employment with us at any time without penalty. We do not maintain key person life insurance policies on any of our management team members or key employees. Our future success will depend in large part on our continued ability to attract and retain highly qualified scientific, technical and management personnel, as well as personnel with expertise in preclinical and clinical testing, manufacturing, governmental regulation and commercialization. In order to do so, we may need to pay higher compensation or fees to our employees or consultants than we currently expect, and such higher compensation payments may have a negative effect on our operating results. We face increased competition for personnel from other companies, universities, public and private research institutions, government entities and other organizations. If we are unable to attract and retain qualified personnel, the rate and success at which we may be able to discover and develop our product candidates and implement our business plan will be limited.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We expect to expand our research, development, delivery, manufacturing, commercialization, regulatory and future sales and marketing capabilities over time, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had 42 full-time employees, including 3 who hold Ph.D. degrees and 3 who hold M.D. degrees, and one part-time employee; 31 employees are engaged in research and development and 12 employees in management or general and administrative activities. In connection with the growth and advancement of our pipeline and operating as a public company, we expect to increase the number of our employees and the scope of our operations, particularly in the areas of drug development, regulatory affairs and sales and marketing. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities, and continue to recruit and train additional qualified personnel. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expected expansion of our operations or recruit and train additional qualified personnel. Moreover, our current physical laboratory space may be insufficient for our near-term research and development hiring plans, and the expected physical expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a growing biotechnology company, we are actively pursuing new platforms and product candidates in many therapeutic areas and across a wide range of diseases. Successfully developing product candidates for and fully understanding the regulatory and manufacturing pathways to all of these therapeutic areas and disease states requires a significant depth of talent, resources and corporate processes in order to allow simultaneous execution across multiple areas. Due to our limited resources, we may not be able to effectively manage this simultaneous execution and the expansion of our operations or recruit and train additional qualified personnel. This may result in weaknesses in our infrastructure, give rise to operational mistakes, legal or regulatory compliance failures, loss of business opportunities, loss of employees and reduced productivity among remaining employees. The physical expansion of our operations may lead to significant costs and may divert financial resources from other projects, such as the development of our potential product candidates. If our management is unable to effectively manage the expected development and expansion, our expenses may increase more than expected, our ability to generate or increase our revenue could be reduced and we may not be able to implement our business strategy. Our future financial performance and our ability to compete effectively and commercialize any product candidates it may develop will depend in part on our ability to effectively manage the future development and our expansion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General Risk Factors</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our business may not grow at similar rates, or at all.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our market opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates which may not prove to be accurate. Our estimates and forecasts relating to size and expected growth of our target</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">69</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">market may prove to be inaccurate. Even if the markets in which we compete meet our size estimates and growth forecasts, our business may not grow at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many risks and uncertainties.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our revenue will be dependent, in part, upon the size of the markets in the territories for which we gain regulatory approval, the accepted price for the product, the ability to obtain coverage and reimbursement and whether we own the commercial rights for that territory. If the number of our addressable patients is not as significant as we estimate, the indication approved by regulatory authorities is narrower than we expect or the treatment population is narrowed by competition, physician choice or treatment guidelines, we may not generate significant revenue from sales of such products, even if approved.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may become exposed to costly and damaging liability claims, either when testing a product candidate in the clinical or at the commercial stage, and our product liability insurance may not cover all damages from such claims.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are exposed to potential product liability and professional indemnity risks that are inherent in the research, development, manufacturing, marketing, and use of pharmaceutical products. While we currently have no products that have been approved for commercial sale, the current and future use of a product candidate in clinical trials, and the sale of any approved products in the future, may expose us to liability claims. These claims may be made by patients that use the product, healthcare providers, pharmaceutical companies, or others selling such product. Any claims against us, regardless of their merit, could be difficult and costly to defend and could materially and adversely affect the market for our products or any prospects for commercialization of our products. Although we believe we currently maintain adequate product liability insurance for our product candidates, it is possible that our liabilities could exceed our insurance coverage or that in the future we may not be able to maintain insurance coverage at a reasonable cost or obtain insurance coverage that will be adequate to satisfy any liability that may arise. If a successful product liability claim or series of claims is brought against us for uninsured liabilities or in excess of insured liabilities, our assets may not be sufficient to cover such claims and our business operations could be impaired.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litigation costs and the outcome of litigation could have a material adverse effect on our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may be subject to litigation claims through the ordinary course of our business operations regarding, but not limited to, employment matters, security of patient and employee personal information, contractual relations with collaborators and intellectual property rights. Litigation to defend itself against claims by third parties, or to enforce any rights that we may have against third parties, may continue to be necessary, which could result in substantial costs and diversion of our resources, causing a material adverse effect on our business, financial condition, results of operations or cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our business could be adversely affected by economic downturns, inflation, increases in interest rates, natural disasters, public health crises, political crises, geopolitical events, such as the conflict between Russia and Ukraine and the conflict in Israel and Gaza, or other macroeconomic conditions, which could have a material and adverse effect on our results of operations and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The global economy, including credit and financial markets, has experienced extreme volatility and disruptions, including, among other things, diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, supply chain shortages, increases in inflation rates, higher interest rates, and uncertainty about economic stability. The Federal Reserve has raised interest rates multiple times in response to concerns about inflation and it may raise them again. Higher interest rates, coupled with reduced government spending and volatility in financial markets, may increase economic uncertainty and affect consumer spending. Similarly, the global geopolitical disruptions, including the military conflict between Russia and Ukraine, the conflict in Israel and Gaza and U.S.&#8217;s rising tensions with China have created extreme volatility in the global capital markets and may have further global economic consequences, including disruptions of the global supply chain. Any such volatility and disruptions may adversely affect our business or the third parties on whom we rely. If the equity and credit markets deteriorate, including as a result of political unrest or war, it may make any necessary debt or equity financing more costly, more dilutive, or more difficult to obtain in a timely manner or on favorable terms, if at all. Increased inflation rates can adversely affect us by increasing our costs, including labor and employee benefit costs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may in the future experience disruptions as a result of such macroeconomic conditions, including delays or difficulties in initiating or expanding clinical trials and manufacturing sufficient quantities of materials. Any one or a combination of these events could have a material and adverse effect on our results of operations and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since inception, we have incurred losses and may never achieve profitability. As of December 31, 2024 and December 31, 2023, we had federal and state NOLs of $233.4 million and $119.3 million, respectively. Under current law, our federal NOLs</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">70</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">generated in taxable years beginning after December 31, 2017, may be carried forward indefinitely, but the deductibility of such federal NOLs is limited to 80% of its taxable income annually for tax years beginning after December 31, 2020. Federal NOLs generated in taxable years beginning before January 1, 2018, however, have a 20-year carryforward period, but are not subject to the 80% limitation. Our state NOLs expire at various dates from 2040 through 2044. As of December 31, 2024, we had federal research and development tax credit carryforwards of $6.2 million that expire at various dates from 2041 through 2044. In addition, as of December 31, 2024, we had state research and development tax credit carryforwards of $2.3 million that expire at various dates from 2038 through 2044.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under Sections 382 and 383 of the Internal Revenue Code of 1986, or the Code, if a corporation undergoes an &#8220;ownership change,&#8221; generally defined as one or more shareholders or groups of shareholders who own at least 5 percent of the corporation&#8217;s equity increasing their equity ownership in the aggregate by more than 50 percentage points (by value) over a rolling three-year period, the corporation&#8217;s ability to use our pre-change NOLs and other pre-change tax attributes (such as research and development tax credits) to offset our post-change income or taxes may be limited. Similar rules may apply under state tax laws. Our prior equity offerings and other changes in our stock ownership may have resulted in such ownership changes in the past. We have not conducted a formal study to assess whether an ownership change has occurred or whether there have been multiple ownership changes since our inception. In addition, we may experience ownership changes in the future as a result of future securities offering or subsequent shifts in our stock ownership, some of which are outside of our control. As a result, even if we earn net taxable income in the future, our ability to use our pre-change NOLs or other pre-change tax attributes to offset U.S. federal taxable income or income taxes may be subject to limitations, which could potentially result in increased future tax liability to us. There is a risk that due to changes under the tax law, regulatory changes or other unforeseen reasons, our existing NOLs or business tax credits could expire or otherwise be unavailable to offset future income tax liabilities. At the state level, there may also be periods during which the use of NOLs or business tax credits is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed by us. For these reasons, we may not be able to realize a tax benefit from the use of our NOLs or tax credits, even if we attain profitability.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The U.S. Congress, the Trump administration, or any new administration may make substantial changes to fiscal, tax, and other federal policies that may adversely affect our business.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The rules dealing with U.S. federal, state and local income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. Changes to tax laws (which changes may have retroactive application) could adversely affect our business and financial condition. In recent years, many such changes have been made and changes are likely to continue to occur in the future. In 2017, the U.S. Congress and the Trump administration made substantial changes to U.S. policies, which included comprehensive corporate and individual tax reform. In addition, the Trump administration called for significant changes to U.S. trade, healthcare, immigration and government regulatory policy. With the transition to the Biden administration in early 2021, changes to U.S. policy occurred and since the start of the Trump Administration in 2025, U.S. policy changes have been implemented at a rapid pace and additional changes are likely. Changes to U.S. policy implemented by the U.S. Congress, the Trump administration or any new administration have impacted and may in the future impact, among other things, the U.S. and global economy, international trade relations, unemployment, immigration, healthcare, taxation, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business. Until we know what policy changes are made, whether those policy changes are challenged and subsequently upheld by the court system and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adverse developments affecting the financial services industry could adversely affect our current and projected business operations and our financial condition and results of operations.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adverse developments that affect financial institutions, such as events involving liquidity that are rumored or actual, have in the past and may in the future lead to bank failures and market-wide liquidity problems. For example, on March 10, 2023, Silicon Valley Bank, or SVB, was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation, or FDIC, as receiver. Similarly, on March 12, 2023, Signature Bank was also swept into receivership. The U.S. Department of Treasury, the Federal Reserve Board, or the Federal Reserve, and the FDIC released a statement that indicated that all depositors of SVB would have access to all of their funds, including funds held in uninsured deposit accounts, after only one business day of closure. The U.S. Department of Treasury, FDIC and Federal Reserve have announced a program to provide up to $25 billion of loans to financial institutions secured by certain government securities held by financial institutions to mitigate the risk of potential losses on the sale of such instruments and help address liquidity pressures that may arise. There is no guarantee, however, that the U.S. Department of Treasury, FDIC and Federal Reserve will provide access to uninsured funds in the future in the event of the closure of other banks or financial institutions, or that they would do so in a timely fashion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">71</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At this time, we hold the majority of our cash on deposit at SVB (which has been assumed by First Citizens) and we have not experienced any adverse impact to our current and projected business operations, financial condition or results of operations as a result of the closure of SVB or any other banks. We have diversified our cash deposit holdings between multiple financial institutions. However, uncertainty remains over liquidity concerns in the broader financial services industry, and our business, business partners, or industry as a whole may be adversely impacted in ways that we cannot predict at this time. If, for example, other banks and financial institutions enter receivership or become insolvent in the future in response to financial conditions affecting the banking system and financial markets, our ability to access our existing cash, cash equivalents and investments may be threatened.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although we have assessed our banking relationships as we believe necessary or appropriate, our access to cash in amounts adequate to finance or capitalize our current and projected future business operations could be significantly impaired by factors that affect the financial institutions with which we have banking relationships, and in turn, us. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could also include factors involving financial markets or the financial services industry generally. The results of events or concerns that involve one or more of these factors could include a variety of material and adverse impacts on our current and projected business operations and our financial condition and results of operations. These could include, but may not be limited to, delayed access to deposits or other financial assets or the uninsured loss of deposits or other financial assets; or termination of cash management arrangements and/or delays in accessing or actual loss of funds subject to cash management arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, widespread investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to meet our operating expenses, financial obligations or fulfill our other obligations, result in breaches of our financial and/or contractual obligations or result in violations of federal or state wage and hour laws. Any of these impacts, or any other impacts resulting from the factors described above or other related or similar factors not described above, could have material adverse impacts on our liquidity and our current and/or projected business operations and financial condition and results of operations. In addition, one or more of our critical vendors, third party manufacturers, or other business partners could be adversely affected by any of the liquidity or other risks that are described above, which in turn, could have a material adverse effect on our current and/or projected business operations and results of operations and financial condition. Any business partner bankruptcy or insolvency, or any breach or default by a business partner, or the loss of any significant supplier relationships, could result in material adverse impacts on our current and/or projected business operations and financial condition.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We do not anticipate that we will pay any cash dividends in the foreseeable future.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The current expectation is that we will retain our future earnings, if any, to fund the growth of our business as opposed to paying dividends. As a result, capital appreciation, if any, of our common stock will be your sole source of gain, if any, for the foreseeable future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">An active trading market for our common stock may not develop and our stockholders may not be able to resell their shares of common stock for a profit, if at all.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the Merger, there had been no public market for shares of Legacy Q32 capital stock. An active trading market for our shares of common stock may never develop or be sustained. If an active market for our common stock does not develop or is not sustained, it may be difficult for our stockholders to sell their shares at an attractive price or at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Future sales of shares by existing stockholders could cause our stock price to decline.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If existing securityholders of Homology and Legacy Q32 sell, or indicate an intention to sell, substantial amounts of our common stock in the public market after legal restrictions on resale lapse, the trading price of our common stock could decline. As of December 31, 2024, we had 12,197,615 shares of common stock outstanding. Certain of these shares are subject to lock-up agreements between Homology and Legacy Q32 on the one hand and certain securityholders of Homology and Legacy Q32 on the other hand. Following the expiration of these lock-up agreements, the relevant stockholders will not be restricted from selling shares our common stock held by them, other than by applicable securities laws. Stockholders not subject to these lock-up agreements will not be restricted from selling shares of our common stock held by them, other than by applicable securities laws. In addition, shares of common stock that are subject to outstanding options or warrants of Legacy Q32 will become</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">72</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eligible for sale in the public market to the extent permitted by the provisions of various vesting agreements and Rules 144 and 701 under the Securities Act. If these shares are sold, the trading price of our common stock could decline.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our executive officers, directors and principal stockholders have the ability to control or significantly influence all matters submitted to our stockholders for approval.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, our executive officers, directors and principal stockholders, in the aggregate, beneficially own approximately 62.2% of our outstanding shares of common stock. As a result, if these stockholders were to choose to act together, they would be able to control or significantly influence all matters submitted to our stockholders for approval, as well as our management and affairs. For example, these stockholders, if they choose to act together, would control or significantly influence the election of directors and approval of any merger, consolidation or sale of all or substantially all of our assets. This concentration of voting power could delay or prevent an acquisition of our company on terms that other stockholders may desire.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If equity research analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business or our market, our stock price and trading volume could decline.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading market for our common stock will be influenced by the research and reports that equity research analysts publish about us and our business. Equity research analysts may elect to not provide research coverage of our common stock and such lack of research coverage may adversely affect the market price of our common stock. In the event we do have equity research analyst coverage, we will not have any control over the analysts or the content and opinions included in their reports. The price of our common stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of us or fails to publish reports on us regularly, demand for our common stock could decrease, which in turn could cause our stock price or trading volume to decline.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our quarterly and annual operating results may fluctuate in the future. As a result, we may fail to meet or exceed the expectations of research analysts or investors, which could cause our stock price to decline and negatively impact our financing or funding ability, as well as negatively impact our ability to exist as a standalone company.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our financial condition and operating results have varied in the past and will continue to fluctuate from quarter-to-quarter and year-to-year in the future due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these fluctuations include the following, as well as other factors described elsewhere in this Annual Report:</span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will require substantial additional capital to finance our operations in the future. If we are unable to raise such capital when needed, or on acceptable terms, we may be forced to delay, reduce or eliminate clinical trials, product development programs or future commercialization efforts.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We face competition from entities that have developed or may develop programs for the diseases we plan to address with bempikibart or other product candidates.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart and the rest of our pipeline are in early stages of development and may fail in development or suffer delays that materially and adversely affect their commercial viability. If we or our current or future collaborators are unable to complete development of, or commercialize, our product candidates, or experience significant delays in doing so, our business will be materially harmed.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are substantially dependent on the success of our most advanced product candidate, bempikibart, and our clinical trials of our lead candidate may not be successful.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our rights to develop and commercialize our product candidates are, and in the future, may be subject to the terms and conditions of licenses granted to us by others. If we fail to comply with our obligations in the agreements under which we license intellectual property rights from third parties, or these agreements are terminated, or we otherwise experience disruptions to our business relationships with our licensors, we could lose license rights that are important to our business.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our ability to protect our patents and other proprietary rights is uncertain, exposing us to the possible loss of competitive advantage.</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are unable to attract and retain qualified key management and scientists, staff, consultants and advisors, our ability to implement our business plan may be adversely affected.</span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">73</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to the various factors mentioned herein, and others, the results of any of our prior quarterly or annual periods should not be relied upon as indications of our future operating performance.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our financial results may fluctuate significantly from quarter-to-quarter and year-to-year, such that a period-to-period comparison of our results of operations may not be a good indication of our future performance. In any particular quarter or quarters, our operating results could be below the expectations of securities analysts or investors, which could cause our stock price to decline. Our stock price may also decline as a result of unexpected clinical trial results in one or more of our ongoing or future clinical trials.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We have broad discretion in the use of our cash and cash equivalents and may invest or spend the proceeds in ways with which you do not agree and in ways that may not increase the value of your investment.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have broad discretion over the use of our cash and cash equivalents. You may not agree with our decisions, and our use of these resources may not yield any return on your investment. Our failure to apply these resources effectively could compromise our ability to pursue our growth strategy and we might not be able to yield a significant return, if any, on our investment of these net proceeds. You will not have the opportunity to influence our decisions on how to use our cash resources.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unfavorable global economic conditions could adversely affect our business, financial condition, results of operations or cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets. A severe or prolonged economic downturn could result in a variety of risks to our business, including, weakened demand for our product candidates and our ability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy could also strain our suppliers, possibly resulting in supply disruption. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Our certificate of incorporation and bylaws and the provisions under Delaware law could make an acquisition of our company more difficult and may prevent attempts by our stockholders to replace or remove out management.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provisions in our certificate of incorporation and bylaws may discourage, delay or prevent a merger, acquisition or other change in control that stockholders may consider favorable, including transactions in which our common stockholders might otherwise receive a premium price for their shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition, because our board of directors will be responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors. Among other things, these provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish a classified board of directors such that all members of the board are not elected at one time; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">do not provide for cumulative voting in the election of directors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">allow the authorized number of our directors to be changed only by resolution of our board of directors; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provide that only the board of directors may fill vacancies on the board of directors created by the expansion of the board of directors or the resignation, death or removal of a director; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limit the manner in which stockholders can remove directors from the board; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establish advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted on at stockholder meetings; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require that stockholder actions must be effected at a duly called stockholder meeting and prohibit actions by our stockholders by written consent; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">limit who may call a special meeting of stockholders; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">74</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">authorize our board of directors to issue preferred stock and to determine the terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the stock ownership of a potential hostile acquirer, effectively preventing acquisitions that have not been approved by our board of directors; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">require the approval of the holders of at least 66.67% of the votes that all our stockholders would be entitled to cast to amend or repeal certain provisions of our charter or bylaws. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Moreover, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the DGCL, which prohibits stockholders owning in excess of 15% of the outstanding voting stock from merging or combining with us. Although Homology and Legacy Q32 believe these provisions collectively will provide for an opportunity to receive higher bids by requiring potential acquirors to negotiate with our board of directors, they would apply even if the offer may be considered beneficial by some stockholders. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove then current management by making it more difficult for stockholders to replace members of the board of directors, which is responsible for appointing the members of management.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, certain designated courts will be the sole and exclusive forum for certain legal actions between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or agents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our certificate of incorporation provides that, unless we consent in writing to an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for state law claims for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of or based on a breach of a fiduciary duty owed by any of our current or former directors, officers, or other employees of the company or our stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL, our certificate of incorporation or our bylaws, or (iv) any action asserting a claim that is governed by the internal affairs doctrine, in each case subject to the Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein, which for purposes of this risk factor refers to herein as the &#8220;Delaware Forum Provision.&#8221; The Delaware Forum Provision will not apply to any causes of action arising under the Securities Act and the Exchange Act. Our bylaws further provide that, unless we consent in writing to an alternative forum, federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, which for purposes of this risk factor is referred to herein as the &#8220;Federal Forum Provision.&#8221; In addition, our certificate of incorporation and bylaws that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock is deemed to have notice of and consented to the foregoing Delaware Forum Provision and Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived its compliance with the U.S. federal securities laws and the rules and regulations thereunder.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Delaware Forum Provision and the Federal Forum Provision may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware. Additionally, the forum selection clauses in our bylaws may limit our stockholders&#8217; ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage such lawsuits against us and our directors, officers and employees even though an action, if successful, might benefit our stockholders.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risks Related to Our Operations Following the Merger</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If any of the events described in &#8220;Risks Related to Our Business&#8221; occur, those events could cause potential benefits of the Merger not to be realized. To the extent any of the events in the risks described in that section occurs, the potential benefits of the Merger may not be realized and our results of operations and financial condition could be adversely affected in a material way. This could cause the market price of our common stock to decline.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">75</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We may be unable to successfully integrate Homology&#8217;s and Legacy Q32&#8217;s businesses and realize the anticipated benefits of the Merger.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Merger involved the combination of two companies that operated as independent companies. Following the Merger, we are required to devote significant management attention and resources to integrating our business practices and operations. We may fail to realize some or all of the anticipated benefits of the Merger if the integration process takes longer than expected or is more costly than expected. Potential difficulties we may encounter in the integration process include the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the inability to successfully combine our businesses in a manner that permits us to achieve the anticipated benefits from the Merger, which would result in the anticipated benefits of the Merger not being realized partly or wholly in the time frame currently anticipated or at all; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">creation of uniform standards, controls, procedures, policies and information systems; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential unknown liabilities and unforeseen increased expenses, delays or regulatory conditions associated with the Merger. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, prior to the Merger, we operated independently. It is possible that the integration process also could result in the diversion of our management&#8217;s attention, the disruption or interruption of, or the loss of momentum in our ongoing businesses or inconsistencies in standards, controls, procedures and policies, any of which could adversely affect our ability to maintain our business relationships or the ability to achieve the anticipated benefits of the Merger, or could otherwise adversely affect our business and financial results.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders could file lawsuits relating to the Merger.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Potential plaintiffs may file lawsuits relating to the Merger. The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to us, including any costs associated with the indemnification of directors and officers.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">We will continue to incur additional costs and increased demands upon management as a result of complying with the laws and regulations affecting public companies.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will continue to incur significant legal, accounting and other expenses as a public company, including costs associated with public company reporting obligations under the Exchange Act. Our management team consists of the executive officers of Legacy Q32 prior to the Merger, some of whom have not previously managed and operated a public company. These executive officers and other personnel will need to devote substantial time to gaining expertise related to public company reporting requirements and compliance with applicable laws and regulations to ensure that we comply with all of such requirements. Any changes we make to comply with these obligations may not be sufficient to allow us to satisfy our obligations as a public company on a timely basis, or at all. These reporting requirements, rules and regulations, coupled with the increase in potential litigation exposure associated with being a public company, could also make it more difficult for us to attract and retain qualified persons to serve on the board of directors or on board committees or to serve as executive officers, or to obtain certain types of insurance, including directors&#8217; and officers&#8217; insurance, on acceptable terms.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Once we are no longer a smaller reporting company or otherwise no longer qualify for applicable exemptions, we will be subject to additional laws and regulations affecting public companies that will increase our costs and the demands on management and could harm our operating results and cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are subject to the reporting requirements of the Exchange Act, which requires, among other things, that we file with the SEC, annual, quarterly and current reports with respect to our business and financial condition as well as other disclosure and corporate governance requirements. As an emerging growth company, Homology took advantage of exemptions from various requirements such as an exemption from the requirement to have our independent auditors attest to our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002 as well as an exemption from the &#8220;say on pay&#8221; voting requirements pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010. Homology ceased to qualify as an emerging growth company effective December 31, 2023. We qualify as a &#8220;smaller reporting company,&#8221; as such term is defined in Rule 12b-2 under the Exchange Act, which allows us to take advantage of many of the same exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation in this Annual Report on Form 10-K and in our other periodic reports and proxy statements. Once we are no longer a smaller reporting company or otherwise no longer qualify for these exemptions, we will be required to comply with these additional legal and regulatory requirements applicable to public companies and will incur significant legal, accounting and other expenses to do so. If we are not able to</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">76</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">comply with the requirements in a timely manner or at all, our financial condition or the market price of our common stock may be harmed. For example, if we identify, or if our independent auditor identifies deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, we could face additional costs to remedy those deficiencies, the market price of our stock could decline or we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provided we continue to be listed on Nasdaq, we will be subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act and the rules and regulations of Nasdaq. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We must perform system and process evaluations and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal controls over financial reporting in our Annual Report on Form 10-K filing for that year, as required by Section 404 of the Sarbanes-Oxley Act. As a private company, Legacy Q32 was never required to test its internal controls within a specified period. This will require that we incur substantial professional fees and internal costs to expand our accounting and finance functions and that we expend significant management efforts. We may experience difficulty in meeting these reporting requirements in a timely manner.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We may discover weaknesses in our system of internal financial and accounting controls and procedures that could result in a material misstatement of our financial statements. Our internal control over financial reporting will not prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud will be detected.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If we are not able to comply with the requirements of Section 404 of the Sarbanes-Oxley Act, or if we are unable to maintain proper and effective internal controls, we may not be able to produce timely and accurate financial statements. If that were to happen, the market price of our common stock could decline and we could be subject to sanctions or investigations by Nasdaq, the SEC or other regulatory authorities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Legacy Q32 and its independent registered public accounting firm identified a material weakness in our internal control over financial reporting, which has been remediated as of December 31, 2024. If we identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect our business and the market price of our common stock.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In preparation of its consolidated financial statements to meet the requirements applicable to the Merger, Legacy Q32 and its independent registered public accounting firm identified a material weakness in its internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The material weakness identified related to deficiencies in Legacy Q32&#8217;s controls over complex accounting topics. Specifically, Legacy Q32&#8217;s accounting and internal control infrastructure did not allow for adequate review processes over complex accounting topics due to lack of sufficient personnel. Due to this material weakness, material errors were identified and corrected in Legacy Q32&#8217;s unaudited condensed consolidated financial statements for the nine months ended September 30, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have implemented measures designed to improve internal controls over financial reporting to remediate the control deficiencies that led to the material weakness, including strengthening reviews by our finance team and expanding our accounting and finance team to add additional qualified accounting and finance resources, which includes augmenting our finance team with third party consultants that possess the required expertise to assist management with its review of complex accounting topics.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We implemented and formally documented improved processes and controls, including process narratives and risk and control matrices, to appropriately mitigate risks of material misstatement to the financial statements. We implemented enhanced procedures to make sure all steps are being performed as part of the control procedures to detect any material issues, and that the correct individuals are assigned as control owners to ensure that an appropriate, sufficient, and independent review is taking</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">77</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">place. Our remediated controls have been operating for a sufficient period of time and we have concluded, through testing, that these controls are operating effectively and that the material weakness is remediated as of December 31, 2024.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We cannot assure you that the measures we have taken to date, and actions we may take in the future, will prevent or avoid potential future material weaknesses. In addition, our independent registered public accounting firm has not performed an evaluation of our internal control over financial reporting in accordance with the provisions of the Sarbanes-Oxley Act because no such evaluation has been required. Had Legacy Q32 or its independent registered public accounting firm performed an evaluation of its internal control over financial reporting in accordance with the provisions of the Sarbanes-Oxley Act, additional material weaknesses may have been identified. If we are unable to successfully remediate any future material weaknesses in our internal control over financial reporting, or identify any additional material weaknesses in the future, or otherwise fail to maintain an effective system of internal controls, the accuracy and timing of our financial reporting may be adversely affected, we may be unable to maintain compliance with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting, and the market price of our common stock may decline as a result.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">78</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1B. Unresolved S</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">taff Comments.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a1267dba-76a3-497c-b449-35fb9ec7a5e1" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_1c_cybersecurity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cyb</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ersecurity.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity Risk Management and Strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We designed and assess our program based on the National Institute of Standards and Technology Cybersecurity Framework (NIST CSF).</span></p><div><ix:nonNumeric id="F_f821c872-a0bf-4acb-853f-5bc36ec0b110" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management program is </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f5446b3c-e2ed-4151-9cb3-5bb8e96ba70b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into our overall risk management program, and shares common methodologies, reporting channels and governance processes that apply across the risk management program to other legal, compliance, strategic, operational, and financial risk areas.</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We leverage the support of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0d337897-b41f-4846-a2b1-92a15ddb0d08" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party information technology and security providers</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including for periodic security testing, as part of our risk management process, designed to identify, assess, and manage cybersecurity risks. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9c129179-cc84-4262-9527-fe8f2ad062a1" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain an incident response and notification plan designed to assist us in identifying, responding to, and recovering from cybersecurity incidents, and we have a process to assess the security practices of certain third-party vendors. We have also engaged a third-party with specialized expertise in cybersecurity to conduct an audit, which resulted in no notable findings, and reported the results to the Audit Committee.</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We, like other companies in our industry, face a number of cybersecurity risks in connection with our business. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fc799ae2-bfcc-4a07-8955-87f88166d321" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although such risks have not materially affected us, including our business strategy, results of operations or financial condition, to date, we and/or our vendors have, from time to time, experienced threats to, or security incidents, related to our data and systems or that had the potential to otherwise impact our business.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity Governance</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0509b216-80d0-4149-abc8-db7d2acc8745" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board considers cybersecurity risk as part of its risk oversight function and has delegated to</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c6d61b3d-a05c-499d-951b-54e2df426356" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the Audit Committee (the &#8220;Committee&#8221;) oversight of cybersecurity risks, including oversight of management&#8217;s implementation of our cybersecurity risk management program.</span></ix:nonNumeric></span></p><div><ix:nonNumeric id="F_f9936a7e-ac2d-424e-b38b-238bc941bc67" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee receives periodic reports from management on our cybersecurity risks. In addition, management updates the Committee, as necessary, regarding any significant cybersecurity incidents.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6beecce7-c5aa-4644-98fd-2b123d79422b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" escape="true"><div><ix:nonNumeric id="F_69ddef0e-6a34-4ecb-9b1f-7a0ca954389f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_09f4d41d-6377-4527-b0cf-5a654e6d0d15" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee reports to the full Board regarding its activities, including those related to cybersecurity.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The full Board also periodically receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our management team as part of the Board&#8217;s continuing education on topics that impact public companies.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_d8b1387a-069c-4845-8d62-8eb0789daa3c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team, with the assistance of the Company&#8217;s third-party information technology providers, is responsible for assessing and managing our material risks from cybersecurity threats. Internal personnel, including our Senior Vice President, Finance, have primary responsibility for our overall cybersecurity risk management program and supervise both our internal cybersecurity personnel and our retained external cybersecurity consultants. Members of our senior management do not have direct cybersecurity expertise obtained through certifications, but their experience managing the Company, which includes consulting and coordinating as necessary with third-party information technology and cybersecurity experts, enables them to assess and manage material risks from cybersecurity threats.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_499f138d-72cf-4bbb-bbb9-45a4e134ce6e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team stays informed about and monitors efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include:</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c2c011e6-04e0-4e82-be86-7cedb123a43c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in our IT environment.</span></ix:nonNumeric></span></p></ix:nonNumeric></div></ix:nonNumeric></div></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">79</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_2_properties"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 2. Prop</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">erties.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our principal office is located at 830 Winter Street, Waltham, Massachusetts 02451, where we lease approximately 15,771 square feet of office space. The lease term began in January 2022 and will end in December 2031. We believe that this facility will be adequate to meet our near-term needs. If required, we believe that suitable additional or substitute space will be available in the future on commercially reasonable terms to accommodate any such expansion of our operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_3_legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3. Legal Pro</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ceedings.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, we may become involved in litigation relating to claims arising from the ordinary course of business. We record a liability for such matters when it is probable that future losses will be incurred and that such losses can be reasonably estimated. Our management believes that there are currently no claims or actions pending against us, the ultimate disposition of which could have a material adverse effect on our results of operations or financial condition.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_4_mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 4. Mine Safety Dis</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">closures.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">80</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_ii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">II</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_5_market_for_registrants_common_e"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5. Market for Registrant&#8217;s Co</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mmon Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock is currently listed on the Nasdaq Global Market under the symbol &#8220;QTTB.&#8221; Prior to the consummation of the Merger, the common stock was listed on the Nasdaq Global Select Market under the symbol &#8220;FIXX.&#8221;</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holders</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 1, 2025, we had approximately 12,197,615 shares of common stock issued and outstanding held of record by approximately 29 registered holders. The number of holders of record does not include a substantially greater number of &#8220;street name&#8221; holders or beneficial holders whose shares of Company common stock are held of record by banks, brokers and other financial institutions.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dividends</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have never declared or paid cash dividends on our capital stock. We intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any cash dividends on our capital stock in the foreseeable future. Notwithstanding the foregoing, any determination to pay cash dividends will be at the discretion of our board of directors and will depend upon a number of factors, including our results of operations, financial condition, future prospects, contractual restrictions, restrictions imposed by applicable law and other factors our board of directors deems relevant.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Authorized for Issuance under Equity Compensation Plans</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information about our equity compensation plans is incorporated herein by reference to Item 12, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, of this Annual Report on Form 10-K.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Sales of Unregistered Securities; Purchases of Equity Securities by the Issuer or Affiliated Purchaser</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We did not repurchase any of our equity securities or issue any securities that were not registered under the Securities Act during the year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Use of Proceeds</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_6__reserved"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 6. [Reser</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ved]</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">81</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7_mda"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7. Management&#8217;s Disc</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ussion and Analysis of Financial Condition and Results of Operations.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and the related notes appearing elsewhere in this Annual Report on Form 10-K. This discussion and other parts of this Annual Report on Form 10-K contain forward-looking statements that involve risks and uncertainties, such as statements regarding our plans, objectives, expectations, intentions and projections. Our actual results could differ materially from those described in or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the &#8220;Risk Factors&#8221; section of this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unless otherwise indicated or the context otherwise requires, references to &#8220;Legacy Q32&#8221; refers to the business and operations of Q32 Bio Operations (previously Q32 Bio Inc.) and its consolidated subsidiaries prior to the Merger, and references to &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to the business and operations of Q32 Bio Inc. (previously Homology Medicines, Inc., or Homology) and its consolidated subsidiary following the Merger.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a clinical stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. To achieve this goal of restoring homeostasis to a dysregulated immune system, we are advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive and innate immunity. The adaptive immune system is largely composed of T- and B-cell mediated cellular and antibody responses; while the innate immune system is a first line of defense employing leukocytes such as monocytes, macrophages, neutrophils, dendritic cells and natural killer cells that are responsible for clearing pathogens and cellular debris, and modulating T- and B-cell function. We believe that targeting these key pathways of immune dysregulation in autoimmune and inflammatory diseases will deliver therapeutics for indications with clear unmet medical need in the near term, while enabling us to build a broad and diverse pipeline in the long term. We have multiple product candidates across a variety of autoimmune and inflammatory diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Bempikibart (ADX-914), our most advanced product candidate, is a fully human anti&#8211;interleukin-7 receptor alpha, or IL-7R&#945;, antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7, or IL-7, and thymic stromal lymphopoietin, or TSLP. We have completed two Phase 2a clinical trials evaluating bempikibart; SIGNAL-AA for the treatment of alopecia areata, or AA, and SIGNAL-AD for the treatment of atopic dermatitis, or AD. On December 10, 2024, we announced topline results from both of these trials, as well as our intention to advance bempikibart for the treatment of AA and enroll patients into Part B of the SIGNAL-AA trial in the first half of 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Patients in the SIGNAL Phase 2a clinical trials were dosed with 200mg subcutaneous, or SC, bempikibart every two weeks. In the SIGNAL-AA trial, 44 patients with severe and very severe AA were enrolled. Patients were dosed for 24 weeks and followed for an additional 12 weeks off-treatment. At the 24-week endpoint, we observed more hair regrowth compared to placebo and evidence of durable responses in patients. The average hair regrowth across patients in the trial continued to improve from week 24 to week 36 despite patients being off therapy during the 12-week follow-up period. In AD, bempikibart was evaluated in two parts, Part A (15 patients) and Part B (106 patients). While encouraging results were seen in Part A, the primary endpoint was not met in Part B.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Across the trials, at the 200mg Phase 2a dose, we achieved our desired receptor occupancy, or RO, and observed favorable pharmacokinetics, or PK, / pharmacodynamic, or PD, properties, consistent with those from the Phase 1 clinical trial. Minimal anti-drug antibodies, or ADAs, were observed in the trials.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, across the two trials, we observed changes in biomarkers consistent with the IL-7R&#945; mechanism and activity mediated by both the TSLP and IL-7 receptors. In the SIGNAL-AD trial, we observed meaningful decreases in key Th2 biomarkers of TARC, IgE, and eosinophils, each of which were statistically significant at multiple timepoints suggestive of potent TSLP inhibition. In the SIGNAL-AA trial, we observed a CD3+ T cell decrease, which was also statistically significant at multiple timepoints, suggestive of potent IL-7 inhibition. These findings were consistent with expected target engagement and IL-7R&#945; blockade.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Across all clinical trials, bempikibart has been dosed in 130 patients to-date and has demonstrated a favorable safety and tolerability profile, with no Grade 3 or higher related adverse events. We plan to enroll approximately 20 additional AA patients through 36 weeks of treatment in a Part B expansion of the SIGNAL-AA Phase 2a clinical trial and report initial data from SIGNAL-AA Part B in the first half of 2026.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">82</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2025, we announced a corporate restructuring to focus on the advancement of bempikibart for the treatment of patients with AA.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ADX-097, a Phase 2 asset and the lead product candidate from our complement inhibitor platform, is a humanized anti-C3d monoclonal antibody, or mAb, fusion protein. ADX-097 is designed to restore complement regulation &#8211; an integral part of the innate immune system &#8211; through a tissue targeted mechanism. ADX-097 is designed to inhibit alternative pathway complement activation locally in diseased tissues where complement-mediated pathology is actively manifest. We believe ADX-097 has the potential to drive improved clinical activity and address the limitations of the currently available systemic approaches to complement inhibition, including infection risk and the need for high drug doses and frequent administration, to achieve therapeutic levels of inhibition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In preclinical studies, ADX-097 distributed to affected tissues/organs and demonstrated durable tissue PK and PD properties. We have completed a Phase 1 clinical trial of ADX-097 in healthy volunteers and observed circulating PK/PD consistent with preclinical studies, which established in vivo integrity of ADX-097. ADX-097 was also shown to be well-tolerated and demonstrated minimal ADAs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional discovery and earlier development efforts from our complement inhibitor platform include ADX-096, a C3d mAb &#8211; CR1 fusion protein which demonstrated preclinical data supportive of its use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In February 2025, we announced that we are discontinuing the Phase 2 renal basket clinical trial of ADX-097 and are evaluating strategic options for our tissue-targeted complement inhibitor platform, inclusive of ADX-097 and early-stage assets, to prioritize the clinical development of bempikibart (the "Restructuring Plan"). The Restructuring Plan includes a reduction in force, which we expect to substantially complete by the end of the second quarter of 2025. As part of this Restructuring Plan, we expect to incur severance and severance-related charges of approximately $1.1 million. We may also incur other charges or cash expenditures not currently contemplated or that cannot be currently estimated due to events that may occur as a result of, or be associated with, the Restructuring Plan.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rights to Bempikibart</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2023, Amgen Inc., or Amgen, completed the acquisition of Horizon Therapeutics public limited company, or Horizon plc. Following the acquisition, Legacy Q32 agreed with Amgen to mutually terminate the Collaboration and Option Agreement, or the Horizon Collaboration Agreement, and the Asset Purchase Agreement, or the Purchase Agreement, and together with the Horizon Collaboration Agreement, the Horizon Agreements, each between Legacy Q32 and Horizon Therapeutics Ireland DAC, or Horizon. In November 2023, Legacy Q32 entered into a termination agreement with Horizon, or the Horizon Termination Agreement, pursuant to which Horizon&#8217;s option to acquire the bempikibart program was terminated. As a result, Legacy Q32 retained the initial consideration and development funding received under the Horizon Collaboration Agreement and regained full development and commercial rights to bempikibart. In consideration for the Horizon Termination Agreement, Legacy Q32 agreed to pay Horizon regulatory and sales milestone payments of up to an aggregate amount of $75.1 million upon the first achievement of certain regulatory and sales milestones with respect to bempikibart.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These potential payments to Horizon are not in exchange for a distinct good or service and therefore, the Company accounts for consideration payable to Horizon as a reduction of the transaction price under the Financial Accounting Standards Board, or FASB, Accounting Standards Update, or ASC, Topic 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, or ASC 606. The Company concluded that the $55.0 million of arrangement consideration previously recognized should be fully constrained as a result of the contingent consideration payable to Horizon, and accordingly, the amounts previously recognized were reversed in the fourth quarter of 2023 and a refund liability was established for the $55.0 million cash received during the term of the Horizon Collaboration Agreement. No amounts have been recognized related to the remaining potential payment to Horizon (up to $20.1 million) as it is not probable that the respective milestones will be achieved at this time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Merger with Homology and Pre-Closing Financing</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 16, 2023, Legacy Q32 entered into an Agreement and Plan of Merger and Reorganization, or the Merger Agreement, with Homology and Kenobi Merger Sub, Inc., a wholly-owned subsidiary of Homology, or Merger Sub. The Merger was completed on March 25, 2024. Pursuant to the Merger Agreement, Merger Sub merged with and into Legacy Q32, with Legacy Q32 continuing as the surviving company and as a wholly-owned subsidiary of Homology, or the Merger. Homology changed its name to Q32 Bio Inc., or Q32, and Legacy Q32, which remains as a wholly-owned subsidiary of Q32, changed its name to Q32 Bio Operations Inc. On March 26, 2024, the combined company&#8217;s common stock began trading on the Nasdaq Global Market, or Nasdaq, under the ticker symbol &#8220;QTTB.&#8221; The business of Legacy Q32 continues as the business of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">83</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the combined company. The Merger is intended to qualify for federal income tax purposes as a tax-free reorganization under the provisions of Section 368(a) of the Internal Revenue Code of 1986, as amended. In connection with the Merger Agreement, certain parties entered into a subscription agreement with us to purchase shares of our common stock for an aggregate purchase price of $42.0 million, or the Pre-Closing Financing.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 25, 2024, or the Closing Date, following approval by our stockholders and by Homology&#8217;s stockholders, the Pre-Closing Financing closed immediately prior to the consummation of the Merger. Shares of Legacy Q32&#8217;s common stock issued pursuant to the Pre-Closing Financing were converted into the right to receive 1,682,045 shares of Homology common stock after taking into account the Reverse Stock Split. On March 25, 2024, in connection with, and prior to the completion of the Merger, Homology effected a one-for-eighteen reverse stock split, or the Reverse Stock Split, of its then outstanding common stock. Subject to the terms and conditions of the Merger Agreement, at the effective time of the Merger, which was March 25, 2024, all issued and outstanding shares of the Legacy Q32&#8217;s common stock (including common stock issued upon the conversion of all Legacy Q32&#8217;s Series A, Series A-1 and Series B preferred stock, conversion of Legacy Q32 convertible notes, but excluding the common stock issued in Pre-Closing Financing) converted into the right to receive 7,017,842 shares of Homology&#8217;s common stock based on the final exchange ratio of 0.0480, or the Exchange Ratio. Lastly, each option to purchase Legacy Q32&#8217;s shares that was outstanding and unexercised immediately prior to the effective time of the Merger was converted into an option to purchase shares of Homology common stock based on the final Exchange Ratio. Immediately following the Merger, Legacy Q32 stockholders owned approximately 74.4% of the outstanding common stock of the combined company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Merger was accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of America, or GAAP. For accounting purposes, Legacy Q32 is considered the accounting acquirer and Homology is the acquired company based on the terms of the Merger Agreement and other factors, such as relative voting rights and the composition of the combined company&#8217;s board of directors and senior management. Accordingly, the Merger was treated as the equivalent of Legacy Q32&#8217;s issuing stock to acquire the net assets of Homology. As a result of the Merger, the net assets of Homology were recorded at their acquisition-date fair value in the financial statements of the combined company and the reported operating results prior to the Merger are those of Legacy Q32. Legacy Q32&#8217;s historical financial statements became the historical consolidated financial statements of the combined company. All issued and outstanding Legacy Q32 common stock, convertible preferred stock and options prior to the effective date of the Merger have been retroactively adjusted to reflect the Exchange Ratio, which reflects the impact of the reverse stock split, for all periods presented.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the effective time of the Merger, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#8217;s common stock received a contractual contingent value right, or CVR, issued by Homology subject to and in accordance with the terms and conditions of a Contingent Value Rights Agreement between Homology and the rights agent, or the CVR Agreement, representing the contractual right to receive cash payments from the combined company upon the receipt of certain proceeds from a disposition of Homology&#8217;s pre-merger assets, calculated in accordance with the CVR Agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial Overview</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had cash and cash equivalents of $78.0 million. We expect that our cash and cash equivalents will be sufficient to enable us to fund our operating expenses and capital expenditure requirements to the second half of 2026. This estimate is based on assumptions that may prove to be wrong, and we could use our capital resources sooner than currently anticipated.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not expect our existing cash and cash equivalents will be sufficient for us to advance any of our programs through regulatory approval, and we will need to raise additional capital to complete the development and potential commercialization of any of our programs. We may also use a portion of our cash and cash equivalents to acquire, in-license or invest in products, technologies or businesses that are complementary to our business. The amounts and timing of actual expenditures will depend on numerous factors, including the progress of development efforts, operating costs and other factors described under &#8220;Risk Factors&#8221; in this Annual Report on Form 10-K.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected use of proceeds represents current intentions based upon present plans and business conditions. As of the date of this Annual Report on Form 10-K, we cannot predict with complete certainty all of the particular uses for our current cash and cash equivalents or the actual amounts that we will spend on the uses set forth above.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">84</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Components of Results of Operations</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since its inception, Legacy Q32 has not generated any revenue from product sales, and our management does not expect the combined company to generate any revenue from the sale of products in the foreseeable future.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legacy Q32 entered into the Horizon Agreements on August 12, 2022. Per the terms of the Horizon Collaboration Agreement, Legacy Q32 received a total of $55.0 million upon initiation of certain development activities associated with the planned clinical trials and related activities. Prior to its termination, the Purchase Agreement also provided Horizon the option to purchase bempikibart, which would have triggered a prespecified payment to Legacy Q32, if exercised. Legacy Q32 was also entitled to receive from Horizon additional payments based on the achievement of future development and regulatory milestones as well as royalty payments on annual net sales.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the termination agreement, Legacy Q32 concluded that the arrangement was within the scope of ASC 606. Specifically, Legacy Q32 concluded that the research services required to be performed as part of the Horizon Collaboration Agreement represented an output of Legacy Q32&#8217;s ordinary activities, and this represented a contract with a customer. At the commencement of the collaboration arrangement with Horizon, Legacy Q32 identified two performance obligations related to the development activities of bempikibart, one of each of the specified clinical trials in AD and AA, with each composing the services related to the clinical trial and other related development activity. Legacy Q32 also identified a material right related to the option for Horizon to purchase bempikibart. The material right was considered a separate performance obligation pursuant to the provisions of ASC 606. Legacy Q32 determined the transaction price to be $55.0 million which it allocated to the three performance obligations based on the estimated stand-alone selling price of each performance obligation. Legacy Q32 concluded that the consideration allocated to the research service performance obligations should be recognized over time as Horizon received the benefit of the research activities as the activities were performed. Legacy Q32 determined that this method was most appropriate as progress towards completion of research is largely driven by time and effort spent and costs incurred to perform this research. As of December 31, 2023, Legacy Q32 had received the full $55.0 million, which the combined company retains. The Termination Agreement is accounted for as a modification because it does not result in the addition of distinct goods or services. Since the two performance obligations and the material right are terminated with no further performance obligations aside from the contingent payments to Horizon of up to $75.1 million, Legacy Q32 recognized the remaining deferred revenue in the fourth quarter of 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon the execution of the Horizon Termination Agreement, Legacy Q32 became obligated to pay Horizon up to $75.1 million contingent on regulatory and sales-based milestones or up to $20.1 million in excess of the cash received. These potential payments to the customer are not in exchange for a distinct good or service; therefore, we are accounting for consideration payable to a customer as a reduction of the transaction price under ASC 606. Legacy Q32 concluded that the $55.0 million of arrangement consideration previously recognized should be fully constrained as a result of the contingent consideration payable to the customer, and accordingly, all amounts previously recognized as revenue were reversed in the fourth quarter of 2023 and a refund liability was established for the $55.0 million cash received during the term of the collaboration agreement. No amounts have been recognized related to the remaining potential payment to Horizon (up to $20.1 million) as it cannot be deemed probable that the respective milestones will be achieved at this time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating expenses since inception have consisted solely of research and development costs and general and administrative costs.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses account for a significant portion of our operating expenses and consist primarily of external and internal expenses incurred in connection with the discovery and development of our product candidates. External expenses include:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">expenses incurred in connection with our research and development activities, including costs related to agreements with third parties such as consultants, contractors and clinical research organizations, or CROs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">costs related to contract development and manufacturing organizations, or CDMOs, that are primarily engaged to provide drug substance and product for our preclinical studies, clinical trials and research and development programs, as well as investigative sites and consultants that conduct our clinical trials, preclinical studies and other scientific development services; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">85</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">costs related to compliance with quality and regulatory requirements; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">employee-related expenses, including salaries, benefits, and stock-based compensation expense, for personnel engaged in research and development functions;</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">facilities-related expenses, depreciation, supplies, travel expenses and other allocated expenses; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payments made under third-party licensing agreements.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expense research and development costs as incurred. Costs are recognized based on an evaluation of the progress to completion of specific tasks using information provided to us by our service providers or our estimate of the level of service that has been performed at each reporting date. Payments for these activities are based on the terms of the individual agreements, which may differ from the pattern of costs incurred, and may be reflected in our consolidated financial statements as prepaid or accrued expenses. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses and expensed as the related goods are delivered or the services are performed or when it is no longer expected that the goods will be delivered or the services rendered.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We do not allocate direct external research and development costs to specific programs or product candidates until there is an internally designated development candidate. We typically use our employee and infrastructure resources across our product candidates and development programs. We do not allocate personnel costs or other internal costs to research and development programs and product candidates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect that future changes to our research and development expenses will depend significantly on the success of our clinical data. We expect that research and development expenses will increase substantially as we continue to advance our programs into and through clinical development. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. At this time, we cannot accurately estimate or know the nature, timing and costs of the efforts that will be necessary to complete the preclinical and clinical development of any product candidates. A change in the outcome of any number of variables with respect to product candidates we may develop could significantly change the costs and timing associated with the development of that product candidate. We may never succeed in obtaining regulatory approval for any product candidates we may develop. The successful development of any product candidate is highly uncertain. This is due to the numerous risks and uncertainties associated with product development, including the following:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the timing and progress of preclinical and clinical development activities; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the number and scope of preclinical and clinical programs we decide to pursue; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the ability to raise additional funds necessary to complete clinical development of and commercialize our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the successful initiation, enrollment and completion of clinical trials with safety, tolerability and efficacy profiles that are satisfactory to the FDA or any comparable foreign regulatory authority; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the receipt and related terms of regulatory approvals from applicable regulatory authorities for any product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the availability of raw materials for use in production of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">establishing agreements with third-party manufacturers for supply of product candidate components for our clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to maintain our current research and development programs and to establish new programs; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant and changing government regulations; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to obtain and maintain patents, trade secret protection and regulatory exclusivity, both in the United States and internationally; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to protect our other rights in our intellectual property portfolio; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">commercializing product candidates, if and when approved, whether alone or in collaboration with others; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">obtaining and maintaining third-party insurance coverage and adequate reimbursement for any approved products. </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">86</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses primarily consist of salaries, bonuses, related benefits, and stock-based compensation expense for personnel in executive, finance, and administrative functions; professional fees for corporate legal and patent matters, consulting, accounting, and audit services; and travel expenses, insurance, technology costs and other allocated expenses. General and administrative expenses also include corporate facility costs, including rent, utilities, depreciation, and maintenance, not otherwise included in research and development expense. We recognize general and administrative expenses in the periods in which they are incurred. General and administrative expenses are expected to increase as we continue to operate as a public company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in Fair Value of Convertible Notes</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legacy Q32 recognized a liability as a result of the issuance of convertible promissory notes, or the Convertible Notes. We account for all convertible notes issued under the fair value option election of FASB ASC Topic 825, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, or ASC 825. The financial instrument is initially measured at its issue-date estimated fair value and then subsequently remeasured at estimated fair value on a recurring basis at each reporting period date. The estimated fair value adjustment is recognized within other income (expense), net in the accompanying consolidated statements of operations and the portion of the fair value adjustment attributed to a change in the instrument-specific credit risk is recognized as a component of other comprehensive loss, if any.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon closing of the Merger, Legacy Q32 converted the outstanding Convertible Notes plus accrued interest into shares of common stock at 90% of the purchase price of the mandatory conversion event. As the Convertible Notes are recorded at fair value, a noncash gain of $15.9 million on the change in fair value prior to the conversion of convertible notes is reflected in the consolidated statement of operation for the year ended December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income (Expense), net</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other income (expense), net consists of interest income primarily earned on money market fund accounts and interest expense related to our debt obligations. We use the cost method to account for an investment in an entity in which we do not have the ability to exercise significant influence over operating and financial policies. Investments recorded using the cost method are assessed for any decrease in value that has occurred that is other than temporary and the other than temporary decrease in value is recognized in other income (expense), net. We recognize the change in fair value of the CVR liability in other income (expense), net.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since inception, we have not recorded any U.S. federal or state income tax benefits for the net losses we have incurred in each year or for earned research and development tax credits, due to the uncertainty of realizing a benefit from those items. As of December 31, 2024, we had federal and state net operating loss carryforwards of $121.3 million and $112.1 million, respectively, that expire at various dates through 2040, to the extent subject to expiration. As of December 31, 2024, we also had federal and state research and development tax credit carryforwards of $6.2 million and $2.3 million, respectively, that expire at various dates through 2040.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loss from equity method investment</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We use the equity method of accounting to account for an investment in an entity that we do not control, but in which we have the ability to exercise significant influence over operating and financial policies. Our proportionate share of the net income or loss of the entity is recorded as loss from equity method investment. Prior to May 22, 2024, we accounted for our investment in Oxford Biomedica (US) LLC, or OXB (US) LLC, using the equity method of accounting and recorded our share of gains or losses from OXB (US) LLC on a quarterly basis.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">87</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of Operations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comparison of the Years Ended December 31, 2024 and 2023</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our results of operations for the years ended December 31, 2024 and 2023:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.477%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration arrangement revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(6,651</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,651</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,143</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,729</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,414</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,959</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,875</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,084</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66,102</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,604</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,498</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(66,102</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(48,255</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(17,847</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of convertible notes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,890</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(6,193</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,083</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income (expense), net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,125</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,023</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,102</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income (expense), net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,015</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(5,170</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,185</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss before provision for income taxes and loss from equity method investment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(46,087</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(53,425</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,338</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(21</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(318</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">297</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from equity method investment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,625</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,625</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(47,733</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(53,743</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,010</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Collaboration Arrangement Revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognized no collaboration arrangement revenue for the year ended December 31, 2024, compared to negative $6.7 million for the year ended December 31, 2023. Upon execution of the Horizon Termination Agreement in November 2023, and pursuant to ASC 606, all previously recognized amounts in 2022 were reversed in 2023. See further discussion under &#8220;Revenue&#8221; above.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our research and development expenses for the years ended December 31, 2024 and 2023:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:57.477%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.399%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:10.776%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended<br/>December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Change</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Direct research and development expense by program:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Bempikibart</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,726</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,722</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,004</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADX-097</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,253</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,185</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,932</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Discovery and other</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">856</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(38</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unallocated expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related and consulting (including stock-based <br/>&#160;&#160;&#160;compensation)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,435</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,629</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">806</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indirect research and development expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,873</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,299</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">574</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total research and development expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,143</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,729</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,414</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development expenses were $48.1 million for the year ended December 31, 2024, compared to $31.7 million for the year ended December 31, 2023. The increase of $16.4 million was due to increased spend related to our bempikibart program including increased clinical spend of $11.7 million as we completed enrollment and treated patients in our two Phase 2a clinical trials, SIGNAL-AA and SIGNAL-AD, and incurred a development milestone payment of $4.0 million to Bristol-Myers Squibb Company, or BMS, pursuant to the BMS License Agreement. In addition, manufacturing costs related to our bempikibart program increased by approximately $6.2 million related to a cGMP manufacturing run to supply future studies.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">88</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Expenses related to our ADX-097 program decreased by $1.9 million primarily due to lower clinical trial costs as the trial was winding down after the completion of the Phase 1 clinical trials in 2023.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The increase in personnel-related and consultant costs was primarily related to higher headcount as compared to the same period in the prior year. Personnel-related and consultant costs for the year ended December 31, 2024 and 2023 included stock-based compensation expense of $1.1 million and $0.5 million, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses were $18.0 million for the year ended December 31, 2024, compared to $9.9 million for the year ended December 31, 2023. The increase is primarily due to costs associated with the Merger, including severance and retention payments to former employees of Homology, as well as other public company-related costs. General and administrative expenses include stock-based compensation expense of $3.3 million and $0.9 million for the years ended December 31, 2024 and 2023, respectively.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Change in Fair Value of Convertible Notes</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon closing of the Merger in March 2024, Legacy Q32 converted its outstanding Convertible Notes plus accrued interest into shares of common stock at 90% of the purchase price of the mandatory conversion event. As the Convertible Notes are recorded at fair value, a gain of $15.9 million on the change in fair value prior to the conversion of the Convertible Notes is reflected in the consolidated statement of operation for the year ended December 31, 2024. The change in the fair value of the convertible notes was $6.2 million for the year ended December 31, 2023.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Income (Expense), Net</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other income (expense), net was $4.1 million for the year ended December 31, 2024, compared to $1.0 million for the year ended December 31, 2023. Other income (expense), net for the year ended December 31, 2024 includes interest income of $3.9 million, as well as a gain recorded for the change in fair value of the CVR liability of $2.2 million. These increases are partially offset by interest expense of $1.1 million on our venture debt and an other-than-temporary impairment charge of approximately $0.7 million we recorded because it was determined that the fair value of our equity investment in OXB (US) LLC was less than its carrying value. The increase in other income (expense), net is primarily due to the change in fair value of the CVR liability that was not present in the prior year, as well as a higher average cash balance resulting in higher interest income for the year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Provision for Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provision for income taxes was less than $0.1 million for the year ended December 31, 2024, compared to $0.3 million for the year ended December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since inception, Legacy Q32 has not recorded any U.S. federal or state income tax benefits for the net losses it has incurred in each year or for its earned research and development tax credits, due to its uncertainty of realizing a benefit from those items. As of December 31, 2023, Legacy Q32 had no gross unrecognized tax benefits.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loss from equity method investment</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to May 22, 2024, we accounted for our investment in OXB (US) LLC using the equity method of accounting and recorded our share of gains or losses from OXB (US) LLC on a quarterly basis. For the year ended December 31, 2024, we recorded a loss from equity method investment of $1.6 million, representing our share of OXB (US) LLC&#8217;s net loss. See Notes 2 and 6 to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for more information regarding the equity method of accounting.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Sources of Liquidity</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Since inception, we have incurred significant operating losses and negative cash flows from operations. We have not yet commercialized any of our product candidates, which are in various phases of preclinical and clinical development, and we do not expect to generate revenue from sales of any products for several years, if at all. To date, we have funded our operations primarily from proceeds from the sales of our convertible preferred stock, convertible notes, venture debt, and proceeds from the</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">89</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Horizon Collaboration Agreement and from the Merger with Homology and accompanying Pre-Closing Financing. From inception through December 31, 2024, we raised $111.4 million in aggregate cash proceeds, net of issuance costs, from the sales of our Series A convertible preferred stock, Series A-1 convertible preferred stock and Series B convertible preferred stock and received payments of $55.0 million in connection with the Horizon Collaboration Agreement. We also received $30.0 million from the sales of convertible notes, $12.5 million from our venture debt, $61.3 million, net of issuance costs, in connection with the Merger with Homology and $42.0 million pursuant to the Pre-Closing Financing. As of December 31, 2024, we had cash and cash equivalents of $78.0 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Going Concern</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have incurred significant operating losses since inception and, as of December 31, 2024, had an accumulated deficit of $234.8 million. We expect negative cash flows from operations and net losses for the foreseeable future as we continue to invest significantly in research and development of our product candidates and platform. We have not yet commercialized any product and do not expect to generate revenue from sales of any products for several years, if at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, we had cash and cash equivalents of $78.0 million. We expect that our cash and cash equivalents as of December 31, 2024, will be sufficient to fund our operations to the second half of 2026. Management based its projections of operating capital requirements on our current operating plan, which includes several assumptions that may prove to be incorrect, and we may use all of our available capital resources sooner than management expects. We expect to seek to raise additional capital through private or public equity or debt financings, loans or other capital sources, which could include collaborations, partnerships or other marketing, distribution, licensing or other strategic arrangements with third parties, or from grants, and may be required to seek additional capital sooner than planned. However, there can be no assurances that we will be able to raise additional capital from these sources on favorable terms, or at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flows</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our cash flows for the periods indicated:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(67,715</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(18,677</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by (used in) investing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,925</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(5</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">95,138</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">406</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Increase/(decrease) in cash, cash equivalents and restricted cash</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,348</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(18,276</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:8pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Activities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cash flows from operating activities are greatly influenced by our use of cash for operating expenses and working capital requirements to support our business. We have historically experienced negative cash flows from operating activities as we invested in developing clinical programs, drug discovery efforts and related infrastructure.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024, net cash used in operating activities was $67.7 million, which was primarily utilized for the funding of our operating expenses of $66.1 million as we incurred expenses associated with research and development activities including clinical trial activities associated with our bempikibart and ADX-097 programs, adjusted for non-cash expenses of $10.3 million. Non-cash expenses include a gain of $15.9 million recognized on the change in fair value prior to the conversion of the Convertible Notes pursuant to the Merger with Homology on March 25, 2024, a gain of $2.2 million recognized on the change in fair value of the CVR liability and amortization of premium on short-term investments of $0.2 million, partially offset by stock-based compensation expense of $4.4 million, losses related to our investment in OXB (US) LLC of $2.3 million, non-cash lease expenses of $0.6 million, depreciation expense of $0.5 million and amortization of debt discount and issuance costs of $0.2 million. The change in net operating assets and liabilities was primarily attributable to a decrease in accrued expenses and other current liabilities of $7.7 million, a decrease in accounts payable of $1.0 million, and a decrease in our operating lease liability of $1.5 million, partially offset by a decrease in other noncurrent assets of $0.4 million and a decrease in prepaid expenses and other current assets of $0.3 million.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2023, </span><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">net cash used in operating activities of $18.7 million was primarily due to a net loss of $53.7 million partially offset by a change in net operating assets and liabilities of $26.3 million and net non-cash operating expenses of $8.7 million. The change in net operating assets and liabilities was primary attributable to an increase in a</span><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">90</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contingent liability, accounts payables, accrued expenses and other current liabilities, prepaid expenses and other current assets and other non-current assets of $52.6 million, partially offset by a decrease in deferred revenue and operating lease liability of $26.3 million. The non-cash operating expenses consisted of a $6.2 million change in fair value of convertible notes, stock-based compensation expense of $1.4 million, non-cash lease expenses of $0.5 million, and depreciation and amortization of $0.6 million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing Activities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024, net cash provided by investing activities consisted of maturities of short-term investments during the period since the Merger, partially offset by purchases of property and equipment.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2023, net cash used in investing activities consisted of purchases of property and equipment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financing Activities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2024, net cash provided by financing activities consisted of $53.2 million of cash acquired as part of the Merger, $42.0 million of proceeds from the issuance of common stock in the pre-closing financing, $7.0 million of proceeds from the borrowings under a new loan and security agreement and $1.7 million of proceeds from the exercise of stock options, slightly offset by payments of $8.7 million of transaction costs related to the Merger.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the year ended December 31, 2023, net cash provided by financing activities consisted of $5.5 million of proceeds from the borrowings under a new loan and security agreement, partially offset by payments of $5.2 million associated with the repayment of Legacy Q32's initial loan and security agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pre-Closing Financing</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with the Merger Agreement, certain third parties entered into the Pre-Closing Financing as described above under &#8220;&#8212;Recent Developments&#8212;Merger with Homology and the Pre-Closing Financing.&#8221; On the Closing Date, following approval by the stockholders of Legacy Q32 and Homology, the Pre-Closing Financing closed immediately prior to the consummation of the Merger. Shares of Legacy Q32&#8217;s common stock issued pursuant to the Pre-Closing Financing were converted into the right to receive 1,682,045 shares of Homology common stock, after taking into account the Reverse Stock Split.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Funding Requirements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We expect our expenses to increase substantially in connection with our ongoing research and development activities, particularly as we advance the preclinical activities and clinical trials of our product candidates. In addition, we expect to continue to incur additional costs associated with operating as a public company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of the numerous risks and uncertainties associated with research, development and commercialization of product candidates, we are unable to estimate the exact amount and timing of our capital requirements. Our future funding requirements will depend on many factors, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, timing, progress, results, and costs of researching and developing bempikibart and conducting larger and later-stage clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the scope, timing, progress, results, and costs of researching and developing other product candidates that we may pursue; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs, timing, and outcome of regulatory review of our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of future activities, including product sales, medical affairs, marketing, manufacturing, and distribution, for any of our product candidates for which we receive marketing approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of manufacturing commercial-grade products and sufficient inventory to support commercial launch; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the revenue, if any, received from commercial sale of our products, should any of our product candidates receive marketing approval; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the cost and timing of attracting, hiring, and retaining skilled personnel to support our operations and continued growth; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">91</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our ability to establish, maintain, and derive value from collaborations, partnerships or other marketing, distribution, licensing, or other strategic arrangements with third parties on favorable terms, if at all; and</span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the extent to which we acquire or in-license other product candidates and technologies, if any.</span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A change in the outcome of any of these or other factors with respect to the development of any of our product candidates could significantly change the costs and timing associated with the development of that product candidate. Furthermore, our operating plans may change in the future, and we may need additional capital to meet the capital requirements associated with such operating plans.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We believe that, based on our current operating plan, our cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements to the second half of 2026. Management based its projections of operating capital requirements on our current operating plan, which includes several assumptions that may prove to be incorrect, and we may use all of our available capital resources sooner than we expect.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To complete the development of our product candidates and to build the sales, marketing and distribution infrastructure that management believes will be necessary to commercialize our product candidates, if approved, we will require substantial additional capital. Accordingly, until such time that we can generate sufficient revenue from product sales or other sources, if ever, management expects to seek to raise any necessary additional capital through private or public equity or debt financings, loans or other capital sources, which could include income from collaborations, partnerships or other marketing, distribution, licensing or other strategic arrangements with third parties, or from grants. To the extent that we raise additional capital through equity financings or convertible debt securities, the ownership interest of our stockholders will be or could be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, including restricting our operations and limiting our ability to incur liens, issue additional debt, pay dividends, repurchase our own common stock, make certain investments or engage in merger, consolidation, licensing, or asset sale transactions. If we raise capital through collaborations, partnerships, and other similar arrangements with third parties, we may be required to grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. We may be unable to raise additional capital from these sources on favorable terms, or at all. Our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from recent bank failures. The failure to obtain sufficient capital on acceptable terms when needed could have a material adverse effect on our business, results of operations or financial condition, including requiring us to delay, reduce or curtail our research, product development or future commercialization efforts. We may also be required to license rights to product candidates at an earlier stage of development or on less favorable terms than we would otherwise choose. Management cannot provide assurance that we will ever generate positive cash flow from operating activities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contractual Obligations and Commitments</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lease Obligations</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We lease space under an operating lease for administrative offices and lab space in Waltham, Massachusetts, which expires in December 2031. In addition, prior to the Merger, Homology was subleasing office and research and development laboratory space in Bedford, Massachusetts, under a sublease agreement with OXB (US) LLC that expired in December 2024.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes our contractual obligations and commitments as of December 31, 2024 (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.38%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.184000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.184000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.184000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.22%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:9.184000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="14" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Payments Due by Period</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">1 to 3 years</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">3 to 5 years</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">More than 5<br/>years</span></p></td>
    <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease obligation</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,121</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,276</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,580</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,265</span></p></td>
    <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have agreements with certain vendors for various services, including services related to preclinical and clinical operations and support, for which we are not contractually able to terminate for convenience and avoid any and all future obligations to the vendors. Our most significant contracts relate to agreements with CROs for clinical trials and preclinical studies and CDMOs, which we enter into in the normal course of business. Certain agreements provide for termination rights subject to termination fees or wind down costs. Under such agreements, we are contractually obligated to make certain payments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">92</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to vendors to reimburse them for their unrecoverable outlays incurred prior to cancellation. The exact amounts of such obligations are dependent on the timing of termination and the exact terms of the relevant agreement and cannot be reasonably estimated. We do not include these payments in the table above as they are not fixed and estimable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we enter into standard indemnification agreements and/or indemnification sections in other agreements in the ordinary course of business. Pursuant to these agreements, we agree to indemnify, hold harmless and reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally our business partners. The term of these indemnification agreements is generally perpetual upon execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification agreements cannot be reasonably estimated and therefore is not included in the table above.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Collaboration and License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Bempikibart&#8212;License Agreement &#8211; Bristol-Myers Squibb Company</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2019, Legacy Q32 entered into a license agreement, as amended in August 2021 and July 2022, or the BMS License Agreement, with Bristol-Myers Squibb Company, or BMS, pursuant to which we obtained sublicensable licenses from BMS to research, develop and commercialize licensed products, including bempikibart, for any and all uses worldwide. The licenses granted to us are exclusive with respect to BMS&#8217;s patent rights and know-how relating to certain antibody fragments (including certain fragments of bempikibart) and non-exclusive with respect to BMS&#8217;s patent rights and know-how relating to the composition of matter and use of a specific region of bempikibart. BMS retained the right for it and its affiliates to use the exclusively licensed patents and know-how for internal, preclinical research purposes. Under the BMS License Agreement, we are prohibited from engaging in certain clinical development or commercialization of any antibody other than a licensed compound with the same mechanism of action until the earlier of the expiration of our obligation to pay BMS royalties or September 2029.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In consideration for the license, we made an upfront payment to BMS of $8 million, issued 318,278 Series A preferred shares to BMS and agreed to use commercially reasonable efforts to develop and commercialize at least one licensed product in key geographic markets. In addition, we agreed to pay BMS (i) development and regulatory milestone payments in aggregate amounts ranging from $32 million to $49 million per indication for the first three indications and commercial milestone payments in an aggregate amount of up to $215 million on net sales of licensed products, (ii) tiered royalties ranging from rates in the mid-single digit percentages to up to 10% of net sales, with increasing rates depending on the cumulative net sales, (iii) up to 60% of sublicense income, which percentage decreases based on the development stage of bempikibart at the time of the sublicensing event, and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our obligation to pay BMS royalties under subsection (ii) above commences, on a licensed product-by-licensed product and country-by-country basis, on the first commercial sale of a licensed product in a country and expires on the later of (x) 12 years from the first commercial sale of such licensed product in such country, (y) the last to expire licensed patent right covering bempikibart or such licensed product in such country, and (z) the expiration or regulatory or marketing exclusivity for such licensed product in such country, or the Royalty Term. If we undergo a change of control prior to certain specified phase of development, the development and milestone payments are subject to increase by a low double digit percentage and the royalty rates are subject to increase by a low sub-single digit percentage.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless terminated earlier by either party pursuant to its terms, the BMS License Agreement will expire on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last to expire Royalty Term with respect to such licensed product in such country. Either party may terminate the BMS License Agreement for the other party&#8217;s material breach, subject to a specified notice and cure period. BMS may terminate the BMS License Agreement if we fail to meet our diligence obligations under the BMS License Agreement, for our insolvency, or if we or our affiliates challenges the validity, scope, enforceability, or patentability of any of the licensed patents. We may terminate the BMS License Agreement for any reason upon prior written notice to BMS, with a longer notice period if a licensed product has received regulatory approval. If the BMS Agreement is terminated for our material breach, BMS will regain rights to bempikibart and we must grant BMS an exclusive license under our patent rights covering bempikibart, subject to a low single digit percentage royalty on net sales of bempikibart payable to us by BMS. We have the right to terminate the agreement for any reason upon written notice, and therefore, this agreement has not been included in the discussion above. In July 2024, we made a $4.0 million development milestone payment to BMS.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">93</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Bempikibart &#8211; Collaboration and Option Agreement, Asset Purchase Agreement and Termination Agreement &#8211; Horizon Therapeutics Ireland DAC</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From August 2022 until November 2023, Legacy Q32 was a party to the Horizon Agreements, pursuant to which Legacy Q32 received $55.0 million in initial consideration and staged development funding to complete two ongoing Phase 2 trials for bempikibart, and granted Horizon an option to acquire the bempikibart program at a prespecified price, subject to certain adjustments.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In October 2023, Amgen completed the acquisition of Horizon plc. Following its acquisition of Horizon plc, Legacy Q32 agreed with Amgen to mutually terminate the Horizon Agreements and in November 2023, Legacy Q32 and Horizon entered into the Horizon Termination Agreement, pursuant to which Horizon&#8217;s option to acquire the bempikibart program was terminated. As a result, Legacy Q32 retained all initial consideration and development funding received under the Horizon Collaboration Agreement and regained full development and commercial rights to bempikibart. In consideration for the Horizon Termination Agreement, Legacy Q32 agreed to pay Horizon regulatory and sales milestones payments of up to an aggregate amount of $75.1 million upon the first achievement of certain regulatory and sales milestones with respect to bempikibart.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">ADX-097&#8212;License Agreement &#8211; The Regents of the University of Colorado</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2017, Legacy Q32 entered into an exclusive license agreement, as amended in February 2018, September 2018, and April 2019, or the Colorado License Agreement, with The Regents of the University of Colorado, or Colorado, pursuant to which we obtained worldwide, royalty-bearing, sublicensable licenses under certain patents and know-how owned by Colorado and Medical University of South Carolina, or MUSC, relating to the research, development and commercialization of ADX-097. The licenses granted to us are exclusive with respect to certain patent families and know-how and non-exclusive with certain other patent families and know-how. The licenses granted to us are also subject to certain customary retained rights of Colorado and MUSC and rights of the United States government owing to federal funding giving rise to inventions covered by the licensed patents. We agreed to use commercially reasonable efforts to develop, manufacture and commercialize ADX-097, including by using commercially reasonable efforts to achieve specified development and regulatory milestones by specified dates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, we agreed to pay Colorado (i) development and sales milestone payments in an aggregate amount of up to $2.2 million per licensed product for the first three products, (ii) tiered royalty rates on cumulative net sales of licensed products in the low single digit percentages, (iii) 15% of sublicense income and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents. Our obligation to pay royalties to Colorado commences, on a licensed product-by-licensed product and country-by-country basis, from the first commercial sale of a licensed product in any country and expires on the later of (i) the last to expire valid claim within the licensed patents covering such licensed product in such country, and (ii) 20 years following the effective date of the Colorado License Agreement, or April 2037, or the Royalty Term.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless earlier terminated by either party pursuant to its terms, the Colorado License Agreement will expire upon the expiration of the Royalty Term in all countries. We may terminate the Colorado License Agreement for convenience upon providing prior written notice to Colorado. Colorado may terminate the Colorado License Agreement or convert our exclusive license to a non-exclusive license if we breach certain obligations under the Colorado License Agreement and fail to cure such breach. The Colorado License Agreement will terminate automatically upon our dissolution, insolvency, or bankruptcy. We have the right to terminate the agreement for any reason upon written notice, and therefore, this agreement has not been included in the discussion above.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Accounting Policies and Significant Judgments and Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management&#8217;s discussion and analysis of its financial condition and results of operations is based on its consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. Actual results could materially differ from those estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">94</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">While our significant accounting policies are described in more detail in the notes to our consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K, management believes that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under ASC 606, an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. We only apply the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once a contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Arrangements that include rights to additional goods or services that are exercisable at a customer&#8217;s discretion are generally considered options. We assess if these options provide a material right to the customer and if so, they are considered performance obligations. The identification of material rights requires judgments related to the determination of the value of the underlying good or service relative to the option exercise price. The exercise of a material right is accounted for as a contract modification for accounting purposes.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We assess whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, we consider factors such as the license terms, the research, manufacturing and commercialization capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. We also consider the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The transaction price is determined and allocated to the identified performance obligations in proportion to their stand-alone selling prices, or SSP, on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, we consider applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. We validate the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the consideration promised in a contract includes a variable amount, we estimate the amount of consideration to which we will be entitled in exchange for transferring the promised goods or services to a customer. We determine the amount of variable consideration by using the expected value method or the most likely amount method. The amount of variable consideration included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty related to the variable consideration is resolved. At the end of each subsequent reporting period, we re-evaluate the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjust our estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an arrangement includes development and regulatory milestone payments, we evaluate whether the milestones are considered probable of being reached and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">95</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in the transaction price. Milestone payments that are not within our control or the licensee&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, we recognize royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the transaction price, we adjust consideration for the effects of the time value of money if the timing of payments provides us with a significant benefit of financing. We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time recognition is based on the use of an output or input method.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses and Related Accrued and Prepaid Expenses</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and development expenses are comprised of costs incurred in performing research and development activities, including salaries, stock-based compensation and benefits, costs for clinical research organizations, manufacturing expenses and costs of other outside vendors and other outsourced activities; laboratory supplies; technology licenses, software and other information technology support; facilities and depreciation.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upfront payments and milestone payments made for the licensing of technology are expensed as research and development expenses in the period in which they are incurred. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related goods are delivered or the services are performed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the process of preparing our consolidated financial statements, management is required to estimate our accrued research and development expenses. This process involves reviewing open contracts and purchase orders, communicating with our personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated costs incurred for the services when we have not yet been invoiced or otherwise notified of the actual costs. The majority of our service providers invoice us in arrears for services performed, on a pre-determined schedule or when contractual milestones are met; however, some require advanced payments. Management makes estimates of its prepaid and accrued expenses as of each balance sheet date in its financial statements based on facts and circumstances known to us at that time. Management periodically confirms the accuracy of the estimates with the service providers and make adjustments if necessary. Examples of estimated prepaid and accrued research and development expenses include fees paid to:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CROs and investigative sites in connection with performing research services, preclinical studies and clinical trials; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">vendors, including research laboratories, in connection with preclinical and clinical development activities; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">vendors, including CDMOs, related to product manufacturing, development and distribution of preclinical studies and clinical trial materials. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management bases the expense recorded related to contract research and manufacturing on its estimates of the services received and efforts expended pursuant to quotes and contracts with multiple CDMOs and CROs that supply materials and conduct services. The financial terms of these agreements are subject to negotiation, vary from contract to contract and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the expense. In accruing service fees, management estimates the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, management adjusts the accrual or prepaid expense accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in reporting amounts that are too high or too low in any particular period.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">96</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Convertible Notes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We account for all convertible notes issued under the fair value option election of ASC 825. The financial instrument is initially measured at its issue-date estimated fair value and then subsequently remeasured at estimated fair value on a recurring basis at each reporting period date. The estimated fair value adjustment is recognized within other income (expense), net in the accompanying consolidated statements of operations and the portion of the fair value adjustment attributed to a change in the instrument-specific credit risk is recognized as a component of other comprehensive loss, if any. The fair value is based on significant inputs not observable in the market, namely potential financing scenarios, the likelihood of such scenarios, the expected time for each scenario to occur, and the required market rates of return utilized in modeling these scenarios.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon closing of the Merger, Legacy Q32 converted the outstanding Convertible Notes plus accrued interest into shares of common stock at 90% of the purchase price of the mandatory conversion event. As the Convertible Notes are recorded at fair value, a gain of $15.9 million on the change in fair value prior to the conversion of the Convertible Notes is reflected in the consolidated statement of operations for the year ended December 31, 2024. We recorded a loss of $6.2 million related to the change in fair value of the Convertible Notes for the year ended December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation Expense</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We account for stock-based awards in accordance with FASB ASC Topic 718, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compensation &#8211; Stock Compensation,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or ASC 718. ASC 718 requires all stock-based awards issued to employees and members of our board of directors, or the Board, for their services to be recognized as expense in the statements of operations based on their grant date fair values. We use the value of our common stock to determine the fair value of its stock-based awards. For stock options and time-based restricted stock awards, we expense the fair value of the awards on a straight-line basis over each award&#8217;s service period, which is generally the period in which the related services are received. For performance-based stock awards, we use the accelerated attribution method to expense the awards over the implicit service period based on the probability of achieving the performance conditions. We account for stock-based awards to non-employees consistently with the accounting for awards to employees and measure stock-based awards granted to non-employees based on their grant date fair value and recognize the resulting value as stock-based compensation expense during the period the related services are rendered. We account for forfeitures as they occur.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Determination of the Fair Value of Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the Merger, given the absence of an active market for our common stock, the fair values of the shares of common stock underlying Legacy Q32's stock-based awards were determined on each grant date by the Board with input from management, considering its most recently available third-party valuations of our common stock and the Board&#8217;s assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent valuation through the grant date. Historically, these independent third-party valuations of our equity instruments were performed contemporaneously with identified value inflection points. The third-party valuations were prepared in accordance with the framework of the American Institute of Certified Public Accountants&#8217; Technical Practice Aid, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Valuation of Privately-Held Company Equity Securities Issued as Compensation</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, or the Practice Aid. The Practice Aid identifies various available methods for allocating enterprise value across classes and series of capital stock to determine the estimated fair value of common stock at each valuation date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to considering the results of these third-party valuations, the Board considered various objective and subjective factors to determine the fair value of our equity instruments as of each grant date, which may be later than the most recently available third-party valuation date, including:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the lack of liquidity of our equity as a private company; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the prices of our convertible preferred stock sold to outside investors in arm&#8217;s length transactions and the rights, preferences and privileges of our convertible preferred stock as compared to those of our common stock, including the liquidation preferences of our convertible preferred stock; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the progress of our research and development efforts, including the status of preclinical studies and clinical trials for our product candidates; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">our stage of development and business strategy and the material risks related to our business and industry; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the achievement of enterprise milestones, including entering into strategic collaborative and license agreements; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the valuation of publicly traded companies in the life sciences and biotechnology sectors, as well as recently completed mergers and acquisitions of peer companies; </span></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">97</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">any external market conditions affecting the biotechnology industry and trends within the biotechnology industry; </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the likelihood of achieving a liquidity event, such as an initial public offering or a sale of our company, given prevailing market conditions; and </span></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the analysis of initial public offerings and the market performance of similar companies in the biotechnology industry. </span></div></div>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our common stock valuations were prepared using either an option pricing method, or OPM, or a hybrid method, both of which used market approaches to estimate our enterprise value. The OPM treats common stock and convertible preferred stock as call options on the total equity value of a company, with exercise prices based on the value thresholds at which the allocation among the various holders of a company&#8217;s securities changes. Under this method, the common stock has value only if the funds available for distribution to stockholders exceeded the value of the convertible preferred stock liquidation preferences at the time of the liquidity event, such as a strategic sale or a merger. A discount for lack of marketability of the common stock is then applied to arrive at an indication of value for the common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The hybrid method is a probability-weighted expected return method, or PWERM, by which the equity value in one or more scenarios is calculated using an OPM. The PWERM is a scenario-based methodology that estimates the fair value of common stock based upon an analysis of future values for the company, assuming various outcomes. The common stock value is based on the probability-weighted present value of expected future investment returns considering each of the possible outcomes available as well as the rights of each class of stock. The future value of the common stock under each outcome is discounted back to the valuation date at an appropriate risk-adjusted discount rate and probability weighted to arrive at an indication of value for the common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The assumptions underlying these valuations were highly complex and subjective and represented management&#8217;s best estimates, which involved inherent uncertainties and the application of management&#8217;s judgment. As a result, if we had used significantly different assumptions or estimates, the fair value of our common stock and stock-based compensation expense could be materially different.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Now that a public trading market for our common stock has been established in connection with the completion of the Merger, it will no longer be necessary for the Board to estimate the fair value of our common stock in connection with our accounting for granted stock options and restricted stock awards, as the fair value of our common stock will be determined based on the trading price of our common stock on Nasdaq.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued and Adopted Accounting Pronouncements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A description of recently issued and certain recently adopted accounting pronouncements that have or may potentially impact our financial position and results of operations is included in Note 2 to our consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K. We have determined that the effects of any such pronouncements will not have a material impact on our consolidated financial position and results of operations.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_7a_quantitative_and_qualitative_dis"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7A. Quantitati</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ve and Qualitative Disclosures About Market Risk.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">98</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_8_financial_statements_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 8. Financial S</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tatements and Supplementary Data.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The financial statements required to be filed pursuant to this Item 8 are appended to this Annual Report on Form 10-K beginning on page F-1. An index of those financial statements is found in Item 15, Exhibits and Financial Statement Schedules, of this Annual Report on Form 10-K.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9_changes_in_and_disagreements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9. Cha</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nges in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9a_controls_and_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9A. Controls and Proc</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">edures.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management&#8217;s Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time period specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2024 and, based on this evaluation, concluded that our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) was effective as of December 31, 2024. We previously identified a material weakness in our internal control over financial reporting related to Legacy Q32&#8217;s controls over complex accounting topics. Specifically, Legacy Q32&#8217;s accounting and internal control infrastructure did not allow for adequate review processes over complex accounting topics due to lack of sufficient personnel. We have concluded that this material weakness in our internal control over financial reporting was due to the fact that we had limited resources and did not have the necessary business processes and related internal controls formally designed and implemented coupled with the appropriate resources to oversee our business processes and controls and has been remediated as of December 31, 2024. A material weakness (as defined in Rule 12b-2 under the Exchange Act) is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Remediation Efforts to Address Material Weakness</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During 2024, we have taken a number of actions to improve the Company&#8217;s internal control over financial reporting in an effort to remediate the material weakness, We have implemented measures designed to improve our internal control over financial reporting, including strengthening reviews by our finance team as well as expanding our accounting and finance team to add additional qualified accounting and finance resources which includes augmenting our finance team with third party consultants that possess the required expertise to assist management with its review of complex accounting topics.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We implemented and formally documented improved processes and controls, including process narratives and risk and control matrices, to appropriately mitigate risks of material misstatement to the financial statements. We implemented enhanced procedures to make sure all steps are being performed as part of the control procedures to detect any material issues, and that the correct individuals are assigned as control owners to ensure that an appropriate, sufficient, and independent review is taking place. Our remediated controls have been operating for a sufficient period of time and we have concluded, through testing, that these controls are operating effectively and that the material weakness is remediated as of December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except with respect to the changes in connection with our implementation of the remediation plan discussed above, there have been no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the three months ended December 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">99</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9b_other_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9B. Othe</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">r Information.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(a)</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(b)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Trading Arrangements</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Rule 10b5-1 plans or non-Rule 10b5-1 trading arrangements, as defined in Item 408(c) of Regulation S-K, were </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e6055b6b-b2ec-4ae0-865c-8c358b5d8fc5" contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_1296f426-226b-48c5-9953-1402f89416a4" contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9abd9abd-5800-4edb-8335-ebbefe6539fd" contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902" name="qttb:Rule10B51ArrModifiedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_36a3bac6-36cc-4314-9d49-ab48b373b8d7" contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902" name="qttb:NonRule10B51ArrModifiedFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">modified</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, or </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9a359e90-f50e-433f-a2ed-655d0d5601d0" contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_ec2d2878-85f5-4112-bbdd-41284e33fc60" contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">terminated</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> by officers or directors of the Company, nor were there any material changes to the procedures by which security holders may recommend nominees to the Company&#8217;s board of directors, during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_9c_disclosure_regarding_foreign_jur"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9C. Disclosure Re</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">garding Foreign Jurisdictions that Prevent Inspections.</span></p>
  <p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">100</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> III</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_10_directors_executive_officers_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 10. Directors, Executiv</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e Officers and Corporate Governance.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the Securities and Exchange Commission not later than 120 days after the close of our fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_11_executive_compensatio"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 11. Exec</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">utive Compensation.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the Securities and Exchange Commission not later than 120 days after the close of our fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_12_security_ownership_of_certain_b"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 12. Security Own</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the Securities and Exchange Commission not later than 120 days after the close of our fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_13_certain_relationships_and"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 13. Certain Relati</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">onships and Related Transactions, and Director Independence.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the Securities and Exchange Commission not later than 120 days after the close of our fiscal year ended December 31, 2024.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_14_principal_accounting_fees"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 14. Principal Acco</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">unting Fees and Services.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information required under this item is incorporated herein by reference to our definitive proxy statement pursuant to Regulation 14A, which proxy statement will be filed with the Securities and Exchange Commission not later than 120 days after the close of our fiscal year ended December 31, 2024.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">101</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_iv"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">RT IV</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_15_exhibits_financial_statement"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 15. Exhibits, Fin</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ancial Statement Schedules.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(1) Financial Statements.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For a list of the financial statements included herein, see Index to the Consolidated Financial Statements on page F-1 of this Annual Report on Form 10-K, incorporated into this Item by reference.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(2) Financial Statement Schedules.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All financial schedules have been omitted because the required information is either presented in the consolidated financial statements or the notes thereto or is not applicable or required.</span></p>
  <p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(3) Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:2.02%;box-sizing:content-box;"/>
    <td style="width:86.98%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex21.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Agreement and Plan of Merger, dated as of November 16, 2023, by and among Homology Medicines, Inc., Kenobi Merger Sub, Inc. and Q32 Bio Inc (incorporated by reference to Exhibit 2.1 of the Registrant&#8217;s Registration Statement on form S-4 filed December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312518106196/d535307dex31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Restated Certificate of Incorporation, as currently in effect (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Form 8-K filed April 3, 2018 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company-reverse stock split and authorized share increase, dated March 25, 2024 (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex32.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company-name change, dated March 25, 2024 (incorporated by reference to Exhibit 3.2 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312520321448/d69248dex31.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Bylaws, as currently in effect (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Form 8-K filed December 18, 2020 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524094768/d800222dex41.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Description of Registrant&#8217;s Securities (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Form 10-K/A filed April 12, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex101.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Subscription Agreement, dated November 16, 2023, by and among Q32 Bio Operations Inc. (formerly Q32 Bio Inc.) and certain parties thereto (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex102.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Registration Rights Agreement, dated March 25, 2024, by and among Q32 Bio Operations Inc. (formerly Q32 Bio Inc.) and certain parties thereto (incorporated by reference to Exhibit 10.2 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex103.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Lock-Up Agreement (incorporated by reference to Exhibit 10.3 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex104.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Contingent Value Rights Agreement dated March 23, 2024, by and between Homology Medicines Inc. and Equiniti Trust Company, LLC (incorporated by reference to Exhibit 10.4 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex106.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Indemnification Agreement for Officers of Q32 Bio Inc. (incorporated by reference to Exhibit 10.6 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex107.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Indemnification Agreement for Directors of Q32 Bio Inc. (incorporated by reference to Exhibit 10.7 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.7#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex108.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. 2017 Stock Incentive Plan, and form of award agreements thereunder (incorporated by reference to Exhibit 10.8 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.8#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex109.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. 2024 Stock Option and Incentive Plan, and form of award agreements thereunder (incorporated by reference to Exhibit 10.9 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.9#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex1010.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. 2024 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.10 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.10#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex1011.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. Non-Employee Director Compensation Policy (incorporated by reference to Exhibit 10.11 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.11#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex1012.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. Senior Executive Cash Incentive Bonus Plan (incorporated by reference to Exhibit 10.12 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">102</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:2.02%;box-sizing:content-box;"/>
    <td style="width:86.98%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.12</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex1013.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. Warrant to Purchase Common Stock dated December 11, 2020 (incorporated by reference to Exhibit 10.13 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.13</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex1014.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. Warrant to Purchase Common Stock dated July 12, 2023 (incorporated by reference to Exhibit 10.14 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.14#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex1015.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement between Q32 Bio Inc. and Jodie Morrison, dated March 25, 2024 (incorporated by reference to Exhibit 10.15 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.15#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex1016.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement between Q32 Bio Inc. and Lee Kalowski, dated March 25, 2024 (incorporated by reference to Exhibit 10.16 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.16#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex1017.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement between Q32 Bio Inc. and Jason Campagna, dated March 25, 2024 (incorporated by reference to Exhibit 10.17 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.17#</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex1018.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement between Q32 Bio Inc. and Shelia Violette, dated March 25, 2024 (incorporated by reference to Exhibit 10.18 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.18+&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1036.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Asset Purchase Agreement, dated August 12, 2022, by and between Q32 Bio Inc. and Horizon Therapeutics Ireland DAC (incorporated by reference to Exhibit 10.36 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.19+&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1037.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Collaboration and Option Agreement, dated August 12, 2022, by and between Q32 Bio Inc. and Horizon Therapeutics Ireland DAC (incorporated by reference to Exhibit 10.37 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.20&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1038.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Termination Agreement, dated November 10, 2023, between Q32 Bio Inc. and Horizon Therapeutics DAC (incorporated by reference to Exhibit 10.38 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.21+&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1039.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exclusive License Agreement, dated August 9, 2017, between Q32 Bio Inc. and The Regents of the University of Colorado (incorporated by reference to Exhibit 10.39 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.22&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1040.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">First Amendment to the Exclusive License Agreement, dated February 8, 2017, between Q32 Bio Inc. and The Regents of the University of Colorado (incorporated by reference to Exhibit 10.40 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.23&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1041.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amendment to the Exclusive License Agreement, dated September 27, 2018, between Q32 Bio Inc. and The Regents of the University of Colorado (incorporated by reference to Exhibit 10.41 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.24&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1042.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Third Amendment to the Exclusive License Agreement, dated April 9, 2019, between Q32 Bio Inc. and The Regents of the University of Colorado (incorporated by reference to Exhibit 10.42 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.25+&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1043.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">License Agreement, dated as of September 14, 2019, between Q32 Bio Inc. and Bristol-Myers Squibb Company (incorporated by reference to Exhibit 10.43 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.26&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1044.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">First Amendment to License Agreement, dated as of August 13, 2021, between Q32 Bio Inc. and Bristol-Myers Squibb Company (incorporated by reference to Exhibit 10.44 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.27</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1045.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amendment to License Agreement, dated as of July 26, 2022, between Q32 Bio Inc. and Bristol-Myers Squibb Company (incorporated by reference to Exhibit 10.45 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.28&#134;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1046.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Third Amendment to License Agreement, dated as of July 26, 2022, between Q32 Bio Inc. and Bristol-Myers Squibb Company (incorporated by reference to Exhibit 10.46 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.29+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1047.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Lease Agreement, dated March 20, 2021, by and between Q32 Bio Inc. and PPF OFF 828-830 WINTER STREET LLC (incorporated by reference to Exhibit 10.47 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.30+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1050.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Loan and Security Agreement, dated as of December 11, 2020, by and between Q32 Bio Inc. and Silicon Valley Bank, as amended (incorporated by reference to Exhibit 10.50 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.31</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1051.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">First Amendment to Loan and Security Agreement, dated December 30, 2021, by and between Q32 Bio Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 10.51 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.32</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1052.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amendment to Loan and Security Agreement, dated June 30, 2022, by and between Q32 Bio Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 10.52 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">103</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:11%;box-sizing:content-box;"/>
    <td style="width:2.02%;box-sizing:content-box;"/>
    <td style="width:86.98%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.33+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1053.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Third Amendment to Loan and Security Agreement, dated August 10, 2022, by and between Q32 Bio Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 10.53 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.34+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1054.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Fourth Amendment to Loan and Security Agreement, dated December 21, 2022, by and between Q32 Bio Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 10.54 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.35+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1055.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Fifth Amendment to Loan and Security Agreement, dated April 26, 2023, by and between Q32 Bio Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 10.55 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.36+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1056.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Sixth Amendment to Loan and Security Agreement, dated July 12, 2023, by and between Q32 Bio Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 10.56 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.37</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312523296880/d938280dex1057.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Seventh Amendment to Loan and Security Agreement, dated November 2, 2023, by and between Q32 Bio Inc. and Silicon Valley Bank (incorporated by reference to Exhibit 10.57 of the Registrant&#8217;s Form S-4 filed on December 18, 2023 (File No. 333-276093)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.38+</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524077930/d811189dex105.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent and Eighth Amendment to Loan and Security Agreement, by and between Q32 Bio, Inc. and Silicon Valley Bank, a division of First-Citizens Bank &amp; Trust Company, dated March 22, 2024 (incorporated by reference to Exhibit 10.5 of the Registrant&#8217;s Form 8-K filed March 27, 2024 (File No. 001-38433)).</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.1*</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="qttb-ex19_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Insider Trading Policy.</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524094768/d800222dex211.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Subsidiaries of the Registrant (incorporated by reference to Exhibit 21.1 of the Registrant&#8217;s Form 10-K/A filed April 12, 2024 (File No. 001-38433)).</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23.1*</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="qttb-ex23_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consent of Ernst &amp; Young LLP, independent registered public accounting firm of the Registrant.</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1*</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="qttb-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2*</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="qttb-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.1**</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="qttb-ex32_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.2**</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="qttb-ex32_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">97.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1661998/000119312524094768/d800222dex971.htm" style="-sec-extract:exhibit;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Compensation Recovery Policy (incorporated by reference to Exhibit 97.1 of the Registrant&#8217;s Form 10-K/A filed April 12, 2024 (File No. 001-38433))</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">.</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.5pt solid;margin-right:80%;text-align:left;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Filed herewith.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">** Furnished herewith. This certification will not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by reference into such filing.</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#134; Certain confidential portions of this Exhibit were omitted by means of marking such portions with brackets (&#8220;[***]&#8221;) because the identified confidential portions (i) are not material and (ii) is the type of information that the registrant treats as private or confidential.</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">+ Annexes, schedules and exhibits have been omitted pursuant to Item 601(b)(2) or 601(a)(5), as applicable, of Regulation S-K. The registrant agrees to furnish supplementally a copy of any omitted attachment to the SEC on a confidential basis upon request.</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"># Indicates a management contract or any compensatory plan, contract or arrangement.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;" id="item_16_form_10_k_summary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 16. Form 10-K Sum</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mary</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">104</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.4in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50%;box-sizing:content-box;"/>
    <td style="width:50%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Q32 BIO INC.</span></p></td>
   </tr>
   <tr style="height:12.25pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 11, 2025</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:0.75pt solid #000000;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jodie Morrison</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name: Jodie Morrison</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title: Chief Executive Officer and Director</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:31.302%;box-sizing:content-box;"/>
    <td style="width:1.043%;box-sizing:content-box;"/>
    <td style="width:46.64%;box-sizing:content-box;"/>
    <td style="width:1.043%;box-sizing:content-box;"/>
    <td style="width:19.971%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Signature</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jodie Morrison</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Jodie Morrison</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Principal Executive Officer</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Lee Kalowski</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer and President</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lee Kalowski</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Principal Financial Officer and Principal</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Accounting Officer</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ David Grayzel</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">David Grayzel</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Diyong Xu</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diyong Xu</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Isaac Manke</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Isaac Manke</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Arthur Tzianabos</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Arthur Tzianabos</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Kathleen LaPorte</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Kathleen LaPorte</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Mary Thistle</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mary Thistle</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Mark Iwicki</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Mark Iwicki</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Bill Lundberg</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Director</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Bill Lundberg</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">105</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:92.92%;box-sizing:content-box;"/>
    <td style="width:7.08%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#report_of_independent_registered_public"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Report of Independent Registered Public Accounting Firm</span></a><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;(PCAOB ID: 0042)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Balance Sheets as of December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statements_of_operations"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Operations for the Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#comprehensive_loss"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Comprehensive Loss for the Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#stockholders_equity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) for the Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Consolidated Statements of Cash Flows for the Years ended December 31, 2024 and 2023</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_coconsolidated_financial_stmt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="report_of_independent_registered_public"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Report of Ind</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ependent Registered Public Accounting Firm</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.5pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To the Stockholders and the Board of Directors of Q32 Bio</span><span style="color:#333333;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Inc.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Opinion on the Financial Statements</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of </span><span style="color:#333333;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 Bio Inc.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (the Company) as of December 31, 2024 and 2023, the related consolidated statements of operations, comprehensive loss, </span><span style="color:#333333;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">convertible preferred stock and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> stockholders&#8217; equity (deficit) and cash flows for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Audit Matters</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:24%;box-sizing:content-box;"/>
    <td style="width:3%;box-sizing:content-box;"/>
    <td style="width:73%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0.01in;text-indent:46.95pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="text-indent:-54.7pt;padding-left:54.7pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.04861111111111111in;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Accrued and Prepaid Research and Development Expenses</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Matter</span></p></td>
    <td style="padding-top:0.01in;text-indent:-99.55pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.04861111111111111in;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Company&#8217;s accrued external research and development expenses totaled $2.6 million at December 31, 2024. In addition, the Company&#8217;s current and noncurrent prepaid external research and development expenses were $2.1 million and $0.1 million, respectively, at December 31, 2024. As discussed in Note 2 to the consolidated financial statements, the Company analyzes the progress of the research activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued and prepaid balances at the end of any reporting period for the Company&#8217;s clinical trials costs, and costs to manufacture its product candidates. The Company is required to estimate such accruals and prepaids using judgment based on certain information, including actual costs incurred or level of effort expended, as reported to the Company by its vendors. Payments for such activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Auditing the Company&#8217;s accrued and prepaid research and development expenses was complex, as accounting for the costs associated with the clinical trials, and costs to manufacture its product candidates, requires subjective estimates of the level of services performed and the associated costs incurred by multiple service providers that perform service on the Company&#8217;s behalf. In addition, while the Company&#8217;s estimates of accrued and prepaid research and development expenses are primarily based on information received related to each contract from its vendors, the Company may need to make an estimate based on its evaluation of the status of the related services since the actual amounts incurred are not typically known at the time the consolidated financial statements are issued.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">How We Addressed the Matter in Our Audit</span></p></td>
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.04861111111111111in;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">To evaluate the accrued and prepaid research and development expenses, our audit procedures included, among others, testing the accuracy and completeness of the underlying data used in the estimates and evaluating the significant judgments and estimates made by management to determine the recorded accruals and prepayments. To test the significant judgments and estimates, we corroborated the progress of research and development activities through discussion with the Company&#8217;s research and development personnel that oversee the research and development projects and inspected the Company&#8217;s contracts with vendors and pending change orders to assess the impact on amounts recorded. In addition, we inspected information obtained by the Company from certain vendors, which indicated the vendors&#8217; estimate of costs incurred to date. We obtained direct confirmations from certain vendors confirming costs incurred as of the reporting date to verify that prepaids and accruals are complete and accurate. We also analyzed fluctuations in prepaids and accruals by vendor and by clinical trial throughout the period subject to audit and tested subsequent invoices received from vendors.</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.04861111111111111in;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Accounting for Reverse Merger Acquisition of Homology Medicines, Inc.</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Description of the Matter</span><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">  </span></p></td>
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.04861111111111111in;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">As further described in Notes 1 and 3 to the consolidated financial statements, on March 25, 2024, the Company completed a reverse merger with Homology Medicines, Inc. (&#8220;Homology&#8221;), with Legacy Q32 continuing as the surviving entity as a wholly-owned subsidiary of Homology. The reverse merger was accounted for as a reverse recapitalization in accordance with U.S. generally accepted accounting principles with Legacy Q32 as the accounting acquirer of Homology. Accordingly, the reverse merger was treated as the equivalent of Legacy Q32 issuing stock to acquire the net assets of Homology.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">We identified the evaluation of the reverse merger with Homology as a critical audit matter. Evaluating the Company's accounting treatment of the reverse merger required a high degree of auditor judgment to evaluate the Company's (i) determination of the accounting acquirer, and (ii) assessment of the transaction as a reverse recapitalization.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">How We Addressed the Matter in Our Audit</span></p></td>
    <td style="padding-top:0.01in;text-indent:18pt;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="margin-left:18pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.04861111111111111in;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">To evaluate the accounting for the reverse merger acquisition of Homology, our audit procedures included, among others, evaluating (i) management's technical accounting analysis</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:24%;box-sizing:content-box;"/>
    <td style="width:3%;box-sizing:content-box;"/>
    <td style="width:73%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;padding-right:0.01in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">performed to determine the accounting acquirer in the transaction, and (ii) the assessment of the transaction as a reverse recapitalization, supported by our subject matter resources. We inspected minutes of board of directors&#8217; meetings, executed transaction agreements, and other information to assess the nature and structure of the reverse merger in evaluating management&#8217;s conclusions with the assistance of professionals in our firm with expertise in accounting for business combinations.</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Ernst &amp; Young LLP</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have served as the Company&#8217;s auditor since 2020.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Boston, Massachusetts</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 11, 2025</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART I&#8212;FINANCIAL INFORMATION</span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1. Financial Statements.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 BIO INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED BAL</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ANCE SHEETS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(amounts in thousands, except share and per share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current assets:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ca6e009-fb86-4ecb-ae86-d1b4cc69a9cc" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77,965</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4607e1a5-b047-43c8-b7a7-996651964cd0" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,617</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d9f36e1-54e8-4035-9449-39c2f07b6d7a" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,912</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d965a6d9-eaff-423d-b252-ab222ec4f2e0" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,099</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc99f168-8c06-4183-ba24-afcc74bd06c4" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,877</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a6a6f57-0346-4e65-8bb9-b1947ae20ee0" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,716</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity investment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d03dffc-e96b-437a-8560-31abc683acf8" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:EquityMethodInvestmentAggregateCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,600</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b236670-178d-4e90-b038-46e28fda8259" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:EquityMethodInvestmentAggregateCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76927634-b565-4cc1-9428-58e00c83d3b9" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,370</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d670dc2d-0afe-45fd-93eb-e2db3f4da003" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,782</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use asset, operating leases</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9932bdb0-32d6-4445-ad0d-5dbdfec55a66" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,722</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca8d5e12-0dba-4443-a55f-64b84cd5888a" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,301</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash and restricted cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db435d5e-a84e-4525-90aa-15b1bfbdd3f8" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">647</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df6b64c3-b50d-4ed9-bcf6-7a39776b71a8" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,647</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other noncurrent assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a616f496-4c1f-4e3e-acfb-29d8b6d470c5" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">116</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e369317d-899e-4e16-acc5-e7b2d8263796" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,611</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_631763ee-f6f7-4b87-b323-8e434289bffa" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92,332</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3b06374-cf0b-46d7-9724-573c8ab82f6f" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,057</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75bc6b5a-8e87-4f7f-8f33-f1abfb9e9aa7" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,989</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f30b304-0394-464d-acde-e06a0d14c82f" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,468</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fca669a-05fd-4bc2-8a29-1c9e3b3e49a9" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:AccruedExpensesAndOtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,479</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_901131b1-6609-49b8-82ec-b6dfbbbb131c" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="qttb:AccruedExpensesAndOtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,763</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CVR liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_054b086e-c78c-4c36-93e8-f7ad0bf5d404" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:CvrLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,900</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f67b182f-f89f-4dd1-947e-744d01e8515f" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="qttb:CvrLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Venture debt, current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3fb315c-cebd-4f1b-a8bb-a4a1095411bc" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LinesOfCreditCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,097</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf1fc506-095a-47b2-bc68-56cd9dd4913f" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:LinesOfCreditCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">878</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e799cd2-6536-4b39-8801-764c4950f693" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,465</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8797161-32e7-45de-8bf1-f5c31e4f4e74" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,109</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability, net of current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb83105c-7f36-47f0-841d-abbdae1c3d2b" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,636</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5bddd185-db1c-47dc-9de6-0393e422e066" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,248</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Venture debt, net of current portion</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8c5eedc-7744-4533-becc-cae170a9d39c" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LongTermLineOfCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,556</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72f14b07-fa23-4091-b3f0-05a7d0d2304e" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:LongTermLineOfCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,581</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible notes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5897cf1-8908-441f-9862-aa2e5eb35ac7" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ConvertibleDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c4cbe22-83aa-4fd1-a75d-fe3b88b6c7b8" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:ConvertibleDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,595</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other noncurrent liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_372a094a-efea-4b7c-9b6f-44b8aa8e7287" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_322bfbd2-5c0e-4720-9346-084ffc0573d7" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b311f8e8-2aa1-4967-a8b5-854f9edc50e1" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">86,657</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f399152b-de48-4fe1-81b6-73ebb216220d" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">118,533</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_af1eeaf7-a09a-4e74-921e-8ff968478338;"><span style="-sec-ix-hidden:F_ac451028-dcee-467f-94e3-aef335ebd430;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commitments and contingencies (Note 10)</span></span></span></span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fd6e230-2f31-4daa-88fd-e54008a08701" contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_78ad2d98-e511-480a-a52c-cd804fcafcf5" contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_776c1df0-89ea-48e5-b63c-bb1631e16283" contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f7bcc499-fb60-4646-976e-b40bfa661af0" contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_adb31f5e-e847-4245-8556-ac53af959e04" contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca415837-eaec-45b7-b1a6-b06bdc9522bf" contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_fbcaefb5-32bb-4009-a083-8be4ac451cfd" contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b2703f92-36e0-4dfd-a316-c5678c998220" contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,286,873</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/>&#160;&#160;&#160;shares authorized, issued and outstanding as of  December 31, 2024 and 2023,<br/>&#160;&#160;&#160;respectively (liquidation preference of $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_868974b6-ee7e-4a44-ad2f-b7e9479ec456" contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">47,629</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;at December 31, 2023)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_508eeb4c-207d-462a-aa6c-d445a606ce25" contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_376d281f-0c24-46b3-8202-cec19ec3266b" contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,458</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A-1 convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6c8c486-759e-4818-9583-20e376d6e8ec" contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_3498ebf6-7638-482e-8508-f6e8653ef8e9" contextRef="C_7a96c710-1576-4302-aade-91b06ff915be" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5237202a-3757-4c57-92bf-81786af430f1" contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_8484a4b0-cda2-4152-b2f2-ce7d97c44f27" contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ad29569d-0cfb-4c2c-9c09-6864a7d25b2b" contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6045f44e-e912-4e12-86ee-957b32ba4ef3" contextRef="C_7a96c710-1576-4302-aade-91b06ff915be" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_28f6f013-0c2b-4494-9db2-8f2284060fd7" contextRef="C_7a96c710-1576-4302-aade-91b06ff915be" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6aeb7360-9eb2-48a1-bb2a-8fa92452aa57" contextRef="C_7a96c710-1576-4302-aade-91b06ff915be" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">312,094</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/>&#160;&#160;&#160;shares authorized, issued and outstanding at December 31, 2024 and 2023,<br/>&#160;&#160;&#160;respectively (liquidation preference of $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5b0c5b2-ba77-437d-8cd2-691c9b745da0" contextRef="C_7a96c710-1576-4302-aade-91b06ff915be" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">5,753</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;as of December 31, 2023)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0331407b-6a4a-4d68-8de2-0955043b8f0a" contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_67756376-bb54-4e1a-a73f-48a8f7174571" contextRef="C_7a96c710-1576-4302-aade-91b06ff915be" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,132</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B convertible preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a22d64a-f2c6-4d5d-a8ae-1dc87af66fa6" contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_843dcf4c-2e3e-46a1-bc62-268df0482635" contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dcb2ea0a-50c5-4de8-b9b0-3cad6f432436" contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_c8f1bc72-eddd-4588-ba6f-d748e51942f5" contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_91c8aaa2-578e-4425-beac-f8ce4b175656" contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eecd9ecd-126e-4f95-900e-47bdbe789e42" contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c45b5bb0-f066-4192-9b13-327afe3a6ab2" contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_db8bc435-13c8-44bc-bfa0-559f78edf250" contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,625,896</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><br/>&#160;&#160;&#160;shares authorized, issued and outstanding at December 31, 2024 and 2023,<br/>&#160;&#160;&#160;respectively (liquidation preference of $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca65d5a3-9344-488c-88c9-7306f534c1a5" contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">60,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;as of December 31, 2023)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a5977b1-da32-4a91-9a40-d8dc8fb96037" contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_878cab6e-e22d-450c-87a4-416aa42352fc" contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,855</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total convertible preferred stock</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_815cc3a3-a876-4d94-b8e7-b2bf38d632b8" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82e2d106-d6ad-4034-a356-6b302923a983" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,445</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity (deficit):</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f67e9a8-7a14-4817-9d76-2f2fa56371cc" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_974ef59e-b0c9-40cf-a670-b49b6aa2667b" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34789ae4-785a-414e-a2b6-2f7e64856508" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_66e1f8db-3508-47c1-99bd-9db35fa5202d" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">400,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized, <br/>&#160;&#160;&#160;</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d46e4e6-0ae6-406e-b769-447740eb4dfd" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_15de671c-4335-49f3-bb8e-07852d49a449" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">12,197,615</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7416a7e-8704-405d-b42c-b772af69468d" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction id="F_2eef5a64-5839-453f-ac8a-21563b479d1e" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">359,569</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding at December 31, 2024<br/>&#160;&#160;&#160;2023, respectively</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fb70284-c3e3-4f0d-83cb-f99f2fc4cb3e" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97282515-4dac-4721-a4c8-8e5543c3b332" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5be90240-f63b-41fe-b09c-a4d55b3fcdbb" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">240,487</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2f70f75-628c-4f6a-8667-c0f257a3ddd2" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,159</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated other comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adf3f90e-6932-4b2d-ada7-4248b7494901" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b744fb22-8609-4f0d-aba1-d5acadf10c28" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74e8f460-751d-4b22-9eae-ada01d91d088" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">234,814</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0dd9fee1-9a4c-452e-9d14-c9403b767ed6" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">187,081</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity (deficit)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9e247d9-468c-40b9-8938-577ea344d9a2" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,675</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d373dcff-911d-458a-885d-897cb3eb8f40" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">182,921</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities, convertible preferred stock and stockholders&#8217; equity (deficit)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98208a3b-6fef-4433-8a3c-0fb9f25d5d99" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92,332</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f4d98cf-13e1-4504-87f4-334301c1b9ab" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,057</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 BIO INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statements_of_operations"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS O</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F OPERATIONS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(amounts in thousands, except share and per share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaboration arrangement revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c616afc0-415b-457a-8938-9c37b970014a" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1315e26-f99d-448a-9aa9-7cd731794653" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:Revenues" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,651</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a673744a-322b-4c72-910a-a66bc429f4a4" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,143</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bacbe10a-a566-4ac6-b0a7-69c7a5eed264" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,729</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71629f4f-8d7b-4441-b4e0-299c51e3de01" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,959</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d230b1bb-5e07-4fbc-9088-8801d2082a46" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,875</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f11763c-ded6-43af-b9b0-f7830ac7236b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">66,102</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1682740-9c36-4453-9d1c-26d83f8d1351" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,604</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18084279-9b5d-409f-8901-47c3e5591b39" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">66,102</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_301d3f10-d3f0-49ec-bd61-10ba4f280789" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">48,255</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of convertible notes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18bf44a2-eac8-4347-958e-8576562072df" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:ChangeInFairValueOfConvertibleNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,890</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90b8a3d5-9375-47ce-84c5-3dca0eb0fadc" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:ChangeInFairValueOfConvertibleNotes" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,193</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other income (expense), net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d69d0db-f0e0-4f99-94c1-a52e733d734f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,125</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0ea5235-59a7-4326-89b5-37a58ca62f4d" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,023</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other income (expense), net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40c23fa9-bd59-4fe3-9bf3-72cf2f29eaeb" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,015</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f33ba99-1f7e-4ec9-811c-d73edcab2992" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">5,170</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss before provision for income taxes and loss from equity method investment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3053650-eec5-4dec-8474-9c87daf7b3d9" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">46,087</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b5c0a95-773b-4cdd-9760-363f40a4d5e4" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,425</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7df6c119-bdc6-485a-850c-97825609d545" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_faa439a8-d5f3-4f89-966e-9748902012b6" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">318</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from equity method investment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87864e62-63f1-4663-a80c-99325aaea4a5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,625</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c24fe8e9-6102-44e7-a181-c91b83ef2863" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0eedc531-6f21-4ba5-b8b3-98848f51774c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,733</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a943663-6c18-413c-bfe7-3666fb4abc86" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,743</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share&#8212;basic</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_05a8110c-49b2-4768-9e97-6ff1722b2a1f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">5.12</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9c0ea3b-4d19-42f8-aaae-36480a2cf509" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">153.96</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss per share&#8212;diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9e1707cd-85c9-4d95-a69f-2f7d2ebd24d8" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">6.58</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec821f72-1ede-43f3-a3e8-15cc4a7e9a70" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">153.96</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares&#8212;basic</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ae787f1-2f71-4bfe-80e2-c73ac14c9eba" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,320,884</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc6ab5f2-b975-4ae4-812a-d08071b01039" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">349,060</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares&#8212;diluted</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff4b3076-37df-4040-b787-7638cea9a2d5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,657,696</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df031f7d-1f05-40a8-9b34-88999836d7af" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">349,060</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 BIO INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="comprehensive_loss"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEME</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NTS OF COMPREHENSIVE LOSS</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(amounts in thousands, except share and per share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_719add18-386c-406e-a905-944e64f349fa" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,733</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3dc6d78-66af-4270-a6f6-5af1db57546c" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,743</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other comprehensive income (loss):</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in unrealized gain (loss) on available for<br/>&#160;&#160;sale securities, net</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ed2d696-e656-45f7-a0ea-abca2c3a5082" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15a24a6c-0668-487f-b51b-d03f0ea51237" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other comprehensive gain (loss)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f287177-433c-4bb3-bc05-5d0593315fe8" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff16bbe8-e0ef-4a74-ac63-aaac365265f2" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9aaec9a9-6ae6-4d82-b128-0f2fed602723" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,733</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecaa97d8-bdf6-49e8-a313-208a69a9670f" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,743</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 BIO INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="stockholders_equity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED S</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TOCK AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(amounts in thousands, except share data)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:15.794%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4.578%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.459%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4.578%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:2.519%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4.578%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:3.199%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4.578%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:2.359%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4.318%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4.318%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:4.318%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:5.418%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series A Convertible<br/>Preferred Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series A-1 Convertible<br/>Preferred Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Series B Convertible<br/>Preferred Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional<br/>Paid in</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Other<br/>Comprehensive</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total<br/>Stockholders&#8217;<br/>Equity</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gain (Loss)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Deficit</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Deficit)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31,<br/>&#160;&#160;&#160;2022</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cff3cf45-6281-42a2-956c-688ac5534cf6" contextRef="C_4cbc437d-5afa-447b-9f58-e212caafd669" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,286,873</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06cb4e2a-af45-434e-a2fb-6c16841e8c49" contextRef="C_4cbc437d-5afa-447b-9f58-e212caafd669" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,458</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_976476ec-5b96-4ffa-bacf-51a9ce3edb8b" contextRef="C_afa19969-608f-48e9-9aca-73182815530d" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">312,094</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f22d024f-a404-4c8a-a1af-c1f5bc6b4e47" contextRef="C_afa19969-608f-48e9-9aca-73182815530d" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,132</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0182e92f-d323-480b-a655-5adf9caec375" contextRef="C_e5fdb991-d520-4075-b2d8-b05c3d677e35" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,625,896</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_385a13be-8ba9-47a1-84e5-3ed7d9b723b0" contextRef="C_e5fdb991-d520-4075-b2d8-b05c3d677e35" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,855</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57aaeb6b-9779-43f5-a823-9a0fc6bf1ab8" contextRef="C_7ec0ac51-4871-4881-a34d-77b8a09d8ea0" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">343,550</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_066a9338-9e57-4790-a69f-a3d6cacf25c6" contextRef="C_7ec0ac51-4871-4881-a34d-77b8a09d8ea0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7bd1be78-9df3-405c-90dc-a06e97abc83a" contextRef="C_37196b4a-4692-492f-b903-2a6e19a6a232" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,625</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c890abbc-c4bb-4689-8ce7-0d3ef4bdb976" contextRef="C_b5225717-0e5a-4c67-907b-047d72ad665b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">133,338</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6da27eae-40eb-4c08-98b8-74dd70f24b6a" contextRef="C_e26a9287-f885-4441-9d0e-9148098a8888" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">130,712</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock from<br/>&#160;&#160;&#160;option exercises</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25071d61-22be-47e6-ba20-d84397109a25" contextRef="C_00125eea-3c46-4a9a-8949-a3a86ae55b5a" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">16,019</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2a5ddf0-a420-4594-b2b3-d47524043daf" contextRef="C_7cdabbbf-9d0e-48aa-9f1d-1c17d1a6755a" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72582ce2-7800-4f2b-9b07-721c8f2587e9" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation<br/>&#160;&#160;&#160;expense</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_236549d9-8fcd-40b9-95e8-5a03769b2512" contextRef="C_7cdabbbf-9d0e-48aa-9f1d-1c17d1a6755a" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,428</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_045959f8-a2ec-42f9-8e79-ca960af1f002" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,428</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec67d721-3d23-4118-a4be-016c2483fe1a" contextRef="C_62c12364-19f9-412d-b7a5-93a8a2255606" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,743</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8670d0d-acf0-471f-b1cc-2949389fe916" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,743</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31,<br/>&#160;&#160;&#160;2023</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07fc39a0-36a2-4298-88aa-32fb322d3c2e" contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,286,873</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db0fa9f1-de37-437b-9924-4c2dd652211c" contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,458</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e82ad4f-b1f9-4cf0-b17a-c9b6d3a37e20" contextRef="C_7a96c710-1576-4302-aade-91b06ff915be" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">312,094</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2d73bf1-b2bd-4986-a8c6-48416f6b22fd" contextRef="C_7a96c710-1576-4302-aade-91b06ff915be" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,132</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d8a1d8e-dfcb-4856-bba4-fa109dd4deae" contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,625,896</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18d41eea-7575-4a51-9f4c-f9c08a7bac41" contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">59,855</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef958ad6-f6f4-4ba4-abf3-59c7d3a10600" contextRef="C_4a91fccb-1956-4e07-b38a-1f2ba2811311" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">359,569</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a388fac3-cb3c-460e-ac55-8fbeb7dd44e1" contextRef="C_4a91fccb-1956-4e07-b38a-1f2ba2811311" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f990199-8939-40c4-9256-e18fba2605a2" contextRef="C_75a6ef14-59cd-493d-a00e-544f5be1fdf1" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,159</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0abb56d3-38bf-4cd1-aa8e-9eb74eb27de4" contextRef="C_482f7b29-7345-4d72-8fd8-5f3199ef1c23" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">187,081</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1649ab8d-4664-4fe7-a3e4-914e08dc7852" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">182,921</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Conversion of convertible<br/>&#160;&#160;&#160;preferred stock to<br/>&#160;&#160;&#160;common stock in<br/>&#160;&#160;&#160;connection with the<br/>&#160;&#160;&#160;Merger</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e236b967-0b54-43cb-b5ea-b4b28c3878e4" contextRef="C_be2666e6-1b34-4583-add6-12ea7a5cce3f" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">2,286,873</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eda1cfcc-94cf-46b1-ba4f-1b5ea94cfedf" contextRef="C_be2666e6-1b34-4583-add6-12ea7a5cce3f" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,458</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9acbf39-4023-4d3d-9027-0afe41ec588a" contextRef="C_01f11a58-84ba-4030-8559-1f45b7816019" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">312,094</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_693c8fcb-0ba2-4992-8931-fa0604a3924e" contextRef="C_01f11a58-84ba-4030-8559-1f45b7816019" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,132</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52d930c0-945a-4720-ad61-460a237c3e4b" contextRef="C_1ec25630-4304-4291-a5ab-390b64487da5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" sign="-" format="ixt:num-dot-decimal">2,625,896</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e521aa6-2868-4479-9e4b-e3c45664109f" contextRef="C_1ec25630-4304-4291-a5ab-390b64487da5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">59,855</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d895a6a7-bce8-4717-ac9f-b2e9d68bfff5" contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,224,863</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b771d575-b682-4d36-8bee-8010c9e398ea" contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ff083eb-418b-4646-95cd-46abf45d5eab" contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,444</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_324f4e7d-5de6-4516-b2b6-96d64873154e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,445</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common<br/>&#160;&#160;&#160;stock in the pre-<br/>&#160;&#160;&#160;closing financing</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d4a90ba-3291-4b83-bb70-0116c2c9f6ff" contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230" name="qttb:IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,682,045</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_205f5f80-ede4-49b0-b7b1-557d4bb527ae" contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d" name="qttb:IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79fa872d-8c06-4340-b6bd-c6f5ca760185" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common<br/>&#160;&#160;&#160;stock for conversion<br/>&#160;&#160;&#160;of convertible notes</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_482d968e-012a-4ed1-a4fd-95b9ff493ed1" contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,433,410</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb2f74a5-6bef-48fd-a2ca-c82563ab2738" contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,705</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e0e88a1-4950-44b2-887e-67ac3a0dbe63" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,705</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common<br/>&#160;&#160;&#160;stock to Homology<br/>&#160;&#160;&#160;shareholders in<br/>&#160;&#160;&#160;reverse recapitalization</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3ac74443-1f22-4989-a2d2-c8461b19b28a" contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230" name="qttb:StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,229,633</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1345c95c-4444-4a3e-80f4-cc2c15b6a81e" contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d" name="qttb:StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,292</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cbc8bd0-6936-4da7-95ec-f58565b91df5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">64,292</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock from<br/>&#160;&#160;&#160;option exercises</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_391c16aa-4639-4b6a-bd2c-071491975b65" contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">255,486</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2b29761-b0a1-4991-80c8-2eca253b3ceb" contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,694</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91fd79f6-e5fa-4074-ba09-6edcd7b454a2" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,694</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of common stock from<br/>&#160;&#160;&#160;RSU vesting</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3014d412-464d-48f7-a2f0-5abefeb7f4bf" contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230" name="qttb:IssuanceOfCommonStocksFromRsuVesting" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,609</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Reverse recapitalization<br/>&#160;&#160;&#160;transaction costs</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8494345-1cdf-46d6-a195-3046fe94af53" contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">10,013</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e809cab0-9fa0-4bbb-a540-32e6e11f90b5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:StockholdersEquityNoteSpinoffTransaction" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">10,013</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of CVR at fair<br/>&#160;&#160;&#160;value</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_862f090e-da03-4251-9ba5-bec9c56ef243" contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a26b7bfb-0e22-49d7-b0ea-5b1494b4cb72" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based<br/>&#160;&#160;&#160;compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26d8a979-860c-40c2-8953-2c39e2bd7e6f" contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,386</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36530d7e-f15a-481c-a6f0-1cad5d605100" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,386</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other comprehensive loss</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:8pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:8pt;text-indent:0;font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d270e629-0edf-4e29-a694-e06ea2b5c128" contextRef="C_7d9baed7-c6de-4298-867d-06f8f3ee91b1" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,733</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecf00a65-6c7d-46c0-8eb2-c376639f203e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,733</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:6pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance as of December 31,<br/>&#160;&#160;&#160;2024</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;border-right:0.5pt solid #000000;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b233e31a-7af1-418d-8767-6609413bfe20" contextRef="C_b5c40c56-08b5-4a22-b751-a8f232a74aca" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">12,197,615</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_feb4e501-4220-4a2b-961a-ce8c92fa72c7" contextRef="C_b5c40c56-08b5-4a22-b751-a8f232a74aca" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26665af4-1ebe-4cee-8c21-fbda2ddee23b" contextRef="C_ce9f954b-cafc-43d9-af6e-e2bba9ac13af" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">240,487</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:6pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5b72964-e0fe-41af-b62b-8046c90f6671" contextRef="C_c18fd5f0-cb42-4f14-9f5c-4fb10a0505bc" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">234,814</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:6pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_357dbc0f-2c29-4fc8-9805-548706d18a83" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,675</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 BIO INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="cash_flows"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED STATEMENTS OF CA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SH FLOWS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(amounts in thousands)</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.993%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:1.62%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
    <td style="width:12.883000000000001%;box-sizing:content-box;"/>
    <td style="width:1%;box-sizing:content-box;"/>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net loss</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0774c4b1-0344-487e-9042-e69e6c5b158e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,733</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c1108bd-6d9e-4dac-9d68-eb8bd31ee4a3" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,743</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt discount and issuance costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3725427-80b0-46da-afff-00a354a72320" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b19b8a8f-5aa0-40d8-8384-7eb705a80e7d" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">87</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of premium on short-term investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0cc15d07-ebe5-4acf-a00c-beede27594c0" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">221</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0bedd1f7-4dc0-43a3-8860-78e07068568d" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0fd46f73-de8f-483f-afee-9a14808aee95" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">487</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_894f9370-1ef5-4ed7-832b-62aa5646740b" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">499</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8cc21201-ac38-4ffb-aa74-9473b19bfc25" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,386</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f68e88ea-34ee-4e8f-b5dd-dc8540ca620b" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,428</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash lease expense</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23fe2022-6c7c-47d1-bdf9-0416964b4fa6" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">579</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6aa1696f-4700-4f3d-b9f9-84c1fc6fefdf" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">544</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss from equity method investment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9cdde02b-93ed-4b1e-aa9c-c432558948fd" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,625</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff427190-73d5-43d6-b8dc-e71fa4f62df6" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on impairment of equity investment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54bd0405-4b37-4e8d-abeb-3ab431829cf0" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:LossOnImpairmentOfEquityInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">675</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f61e976-4ffc-4a6c-98a7-6e8af547cfa9" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:LossOnImpairmentOfEquityInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of CVR liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db49f4c1-ec43-4e75-811b-aacb6db1c36b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:ChangeInFairValueOfEquityInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec5def19-be41-41f9-957f-e2ff66daa537" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:ChangeInFairValueOfEquityInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of convertible notes</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d179ed81-4ce5-46b4-b58e-37f9fda0552d" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:ChangeInFairValueOfConvertibleNotes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,890</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07a381d4-ec1d-4647-ad53-fabde20f1e08" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:ChangeInFairValueOfConvertibleNotes" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,193</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5c01dff-1a38-4bbc-8064-04c5353a293b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">276</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3909fd33-1c7e-488c-a07a-ed69106a8b6a" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other noncurrent assets</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b8517ad-ba64-439f-9948-e88cb5470d31" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">386</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70ba7e9d-0f55-4680-97e4-a8e32ab1e43d" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,503</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3802fe35-f67c-40aa-9a9c-64f96bc3dd8f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,043</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0701afde-8d2b-461a-84ae-c4e8938b609f" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,033</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2f408de-7e49-4fb1-93a9-31e7bcc42327" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,542</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7788b9ac-942b-4b41-a8d8-f78dad6761f4" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">471</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9a306c2-e9f4-43d2-bf88-5c6fe097a66c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,714</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af963bb0-c146-486f-bb8f-2312236cd01c" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">199</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent liability</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c40a3f64-ff8c-4d67-b241-a25e3ee1694a" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:IncreaseDecreaseInContingentLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97391e2d-0b87-48dc-a755-18ea4289e9b2" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:IncreaseDecreaseInContingentLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">55,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred revenue</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09c0f5e8-62b9-46bc-8d6f-4c1c59ea4740" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncreaseDecreaseInDeferredRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e44f67f3-02d5-44a8-a9a6-284ea1034ee4" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncreaseDecreaseInDeferredRevenue" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">25,849</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f78a58d-cf68-4e8e-bb80-8a30ad30d55e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">67,715</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_652d8ebc-fab2-40aa-8287-928551f846f4" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">18,677</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0451d125-c725-4e0a-aa8d-5f749fb733a3" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">75</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_acd7e7ed-5cd5-4cf4-b336-30e38a17544f" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Maturities of short-term investments</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3ba180e-5f33-4207-bd3b-d6cce2c57cef" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f019ca2-0aec-4c23-b48c-4349c08473f3" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by (used in) investing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe747830-ab2c-4e39-8c47-5995839d8a6c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,925</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ad6d514-5ddf-45d4-bdb5-abeb3eacb5a3" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from borrowings under loan and security agreement</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f73fbae-cfbb-4751-ae6d-426aaed2e937" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ProceedsFromLongTermLinesOfCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a089aa87-0068-4dfe-ad96-a9af70326606" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ProceedsFromLongTermLinesOfCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,500</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payments on borrowings under loan and security agreement</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cffd3c5-a6df-48c8-875a-300a967913b4" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2f2c7bd-8222-4c69-8694-9c22a747225e" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,200</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from issuance of common stock in pre-closing financing</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44e8c4e8-2a78-4391-9a14-17ba1433bc09" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">42,000</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be17c921-3bd6-41bf-a89d-7aa8269bbe85" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash acquired in connection with reverse recapitalization</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7136ebe-f803-4cbe-aba4-6054b9a4e236" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:ProceedsFromReverseRecapitalization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,158</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_743b77b2-3663-42cc-8fbe-aae905e30b05" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:ProceedsFromReverseRecapitalization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payment of reverse recapitalization transaction costs</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_347ef51e-c675-460f-a2e0-555d50c945d6" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:PaymentOfReverseRecapitalizationTransactionCosts" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">8,714</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_543ab4b6-f573-454e-8f7e-1e3599bd96fd" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:PaymentOfReverseRecapitalizationTransactionCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from exercise of common stock options</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_714e9906-8a63-4aac-933f-acbcc15d80a5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,694</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef6a1da8-2b88-4671-b632-416cdd1ebd6d" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4dc0d729-a647-4237-b4ae-0b9d7779620b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95,138</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99463a9c-09a0-48da-9048-7596df6a0d71" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">406</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents, restricted cash and<br/>&#160;&#160;&#160;restricted cash equivalents</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6aa067e4-c131-4fdd-b398-216c6abae811" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,348</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01321fcc-a233-4396-9c87-29a55322ea8e" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">18,276</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, restricted cash and restricted cash equivalents<br/>&#160;&#160;&#160;at beginning of period</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e341aaf-8945-47b0-b74b-9121e5612310" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,264</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38413a9c-5fc4-49e6-8dff-6fc977001acc" contextRef="C_e26a9287-f885-4441-9d0e-9148098a8888" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49,540</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, restricted cash and restricted cash equivalents<br/>&#160;&#160;&#160;at end of period</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bd277ed-0ec0-4192-bc1b-552d6eddf8e1" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,612</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecf358de-e7a0-4961-a890-e67d50c2a3ad" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,264</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosure of non-cash operating, investing and<br/>&#160;&#160;&#160;financing activities:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest payments on venture debt</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97a03012-d999-411d-b606-ade748ed7021" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">856</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6a64c41-011d-4e0c-b3f0-bdeb6e8782ee" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">422</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments acquired in connection with reverse recapitalization</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96621368-41a0-46b4-8c87-471a6757bb76" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:ShortTermInvestmentsAcquiredInReverseRecapitalization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,905</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1261b80a-49a7-4ae5-9fdd-6e970e2007ac" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:ShortTermInvestmentsAcquiredInReverseRecapitalization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of CVR at fair value</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8d18359-48f6-4068-9d6e-912378c48db4" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:IssuanceOfCvrAtFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">180</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
    <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc76373b-d044-4cf5-8287-250a719a18a9" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:IssuanceOfCvrAtFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
    <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 BIO INC.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_coconsolidated_financial_stmt"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OLIDATED FINANCIAL STATEMENTS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
  <div><ix:nonNumeric id="F_78a3ea18-7754-483e-9225-11f338007891" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" escape="true" continuedAt="F_78a3ea18-7754-483e-9225-11f338007891_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. Nature of the Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. (&#8220;Q32&#8221; or the &#8220;Company&#8221;) is a clinical stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. Q32 has multiple product candidates across a variety of autoimmune and inflammatory diseases. The Company was formed in 2017 as Admirx, Inc. under the laws of the state of Delaware and is headquartered in Waltham, Massachusetts. On March 20, 2020, the Company changed its name to Q32 Bio Inc.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Merger with Homology</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 25, 2024, Kenobi Merger Sub, Inc. (&#8220;Merger Sub&#8221;), a wholly-owned subsidiary of Homology Medicines, Inc. (&#8220;Homology&#8221;), completed its merger with and into Q32 Bio Operations Inc. (previously named Q32 Bio Inc. and referred to herein as &#8220;Legacy Q32&#8221;), with Legacy Q32 continuing as the surviving entity as a wholly-owned subsidiary of Homology. This transaction is referred to as the &#8220;Merger.&#8221; Homology changed its name to Q32 Bio Inc., and Legacy Q32, which remains as a wholly-owned subsidiary of the Company, changed its name to Q32 Bio Operations, Inc. The Merger was effected pursuant to an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), dated as of November 16, 2023, by and among Homology, Legacy Q32, and Merger Sub. In connection with the Merger Agreement, certain parties entered into a subscription agreement with the Company to purchase shares of Legacy Q32&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s common stock for an aggregate purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f02f7fa6-fb1d-432d-a1a9-471e5c1f397a" contextRef="C_01c6b47c-31c0-4923-b0b0-6e5450394be0" name="us-gaap:CommonStockSharesSubscriptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">42.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Pre-Closing Financing&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 25, 2024 (the &#8220;Closing Date&#8221;), the Pre-Closing Financing closed immediately prior to the consummation of the Merger. Shares of Legacy Q32&#8217;s common stock issued pursuant to the Pre-Closing Financing were converted into the right to receive </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ae8fafc-51d6-426f-84df-75f849256eea" contextRef="C_4a798c23-fd95-415f-8bab-1a4a602a0895" name="qttb:BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,682,045</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Homology common stock after taking into account the Reverse Stock Split. On March 25, 2024, Homology effected a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d7f9976c-5ef9-473e-bf30-75d699017866" contextRef="C_4a798c23-fd95-415f-8bab-1a4a602a0895" name="us-gaap:StockholdersEquityReverseStockSplit"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one-for-eighteen</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reverse stock split of its then outstanding common stock </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the &#8220;Reverse Stock Split&#8221;) where </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all issued and outstanding shares of Legacy Q32&#8217;s common stock (including common stock issued upon the conversion of all Legacy Q32&#8217;s Series A, Series A-1 and Series B preferred stock, conversion of Legacy Q32 convertible notes, but excluding the common stock issued in Pre-Closing Financing) converted into the right to receive an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc67827f-5873-40f7-9543-9b0f55406140" contextRef="C_4a798c23-fd95-415f-8bab-1a4a602a0895" name="us-gaap:ConversionOfStockSharesConverted1" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,017,842</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Homology&#8217;s common stock based on the final exchange ratio of 0.0480 (the &#8220;Exchange Ratio&#8221;). Lastly, each option to purchase the Legacy Q32&#8217;s shares that was outstanding and unexercised immediately prior to the Merger was converted into an option to purchase shares of Homology based on the Exchange Ratio. Immediately following the Merger, Legacy Q32 stockholders owned approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f73e0291-7156-47d5-8a90-35c1ddef81d4" contextRef="C_ca4b638b-76d0-401e-9369-6f2d51d1cb2f" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">74.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding common stock of the combined company.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Merger was accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). For accounting purposes, Legacy Q32 is considered the accounting acquirer and Homology is the acquired company based on the terms of the Merger Agreement and other factors, such as relative voting rights and the composition of the combined company&#8217;s board of directors and senior management. Accordingly, the Merger was treated as the equivalent of Legacy Q32&#8217;s issuing stock to acquire the net assets of Homology. As a result of the Merger, the net assets of Homology were recorded at their acquisition-date fair value in the financial statements of the combined company and the reported operating results prior to the Merger are those of Legacy Q32. Legacy Q32&#8217;s historical financial statements became the historical consolidated financial statements of the combined company. All issued and outstanding Legacy Q32 common stock, convertible preferred stock and options prior to the effective date of the Merger have been retroactively adjusted to reflect the Exchange Ratio, which reflects the impact of the reverse stock split, for all periods presented.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the effective time of the Merger, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#8217;s common stock received a contractual contingent value right (&#8220;CVR&#8221;) issued by Homology representing the contractual right to receive cash payments from the combined company upon the receipt of certain proceeds from a disposition of Homology&#8217;s pre-merger assets (see Note 3 for more details surrounding the accounting for the Merger and the CVRs).</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including but not limited to, risks associated with completing preclinical studies and clinical trials, obtaining regulatory approvals for product candidates, development by competitors of new biopharmaceutical products, dependence on key personnel, protection of proprietary technology, compliance with government regulations and the ability to secure additional capital to fund operations. Programs currently under development will require significant additional research and development efforts, including preclinical</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_78a3ea18-7754-483e-9225-11f338007891_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and clinical testing, and will need to obtain regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel and infrastructure and extensive compliance-reporting capabilities. Even if the Company&#8217;s product development efforts are successful, it is uncertain when, if ever, the Company will realize revenue from product sales. Since its inception, the Company&#8217;s operations have been focused on organizing and staffing, business planning, raising capital, establishing the Company&#8217;s intellectual property portfolio and performing research and development of its product candidates, programs and platform. The Company has primarily funded its operations with proceeds from the sale of convertible preferred stock, convertible notes, venture debt, the Merger with Homology and accompanying Pre-Closing Financing and its collaboration arrangement with Horizon.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity and Going Concern</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disclosure of Uncertainties about an Entity&#8217;s ability to Continue as a Going Concern (Subtopic 205-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has evaluated whether they are conditions and events, considered in the aggregate, that raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company had an accumulated deficit of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_549e37c8-0856-4e0c-9ca5-02983ab7b319" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">234.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and cash and cash equivalents of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b40d973f-a72f-425b-a68b-c983cb58ffb6" contextRef="C_f316cace-cb53-4a10-84c5-1335a8b032e1" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">78.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company expects that its cash and cash equivalents will be sufficient to fund its operating expenditures and capital expenditure requirements necessary to advance its research efforts and clinical trials for at least one year from the date of issuance of these consolidated financial statements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has incurred recurring operating losses since its inception. During the year ended December 31, 2024, the Company incurred a net loss of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a661cfce-80b1-4f5f-ad54-284978b21f6b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="6" decimals="-5" sign="-" format="ixt:num-dot-decimal">47.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company expects its operating losses and negative operating cash flows to continue into the foreseeable future. The future viability of the Company is dependent on its ability to raise additional capital to finance its operations. The Company&#8217;s inability to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies. There can be no assurance that the current operating plan will be achieved or that additional funding will be available on terms acceptable to the Company, or at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_0726c143-1135-42c3-ac00-f6acfb02987f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true" continuedAt="F_0726c143-1135-42c3-ac00-f6acfb02987f_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d1efdf49-7c40-4006-8cbe-7d922e497956" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in conformity with GAAP and have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b7d664c0-e1b1-4826-906a-8c34ed97b8a3" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ConsolidationPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements include those of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in the consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9bf7576c-31f0-489f-9188-b8a44c08920f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:UseOfEstimates" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could materially differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the fair value of the common stock and convertible notes prior to the effective date of the Merger, the fair value of CVR liability, and the prepaid and accrued research and development expenses. The Company utilizes certain estimates to record expenses relating to research and development contracts. These contract estimates, which are primarily related to the length of service of each contract and the amount of service provided as of each measurement date, are determined by the Company based on input from internal project management, as well as from service providers. Estimates are periodically reviewed considering changes in circumstances, facts and historical experience. Actual results may differ from the Company&#8217;s estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_0726c143-1135-42c3-ac00-f6acfb02987f_1" continuedAt="F_0726c143-1135-42c3-ac00-f6acfb02987f_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9032364d-e342-4d84-8163-bd9c7395ab71" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker (&#8220;CODM&#8221;), or decision-making group, in determining how to allocate resources and in assessing performance. The Company has one reporting segment (see Note 20). The segment consists of the development of clinical and preclinical product candidates for the development of the Company&#8217;s novel biologics. The Company&#8217;s chief operating decision maker is the chief executive officer (&#8220;CEO&#8221;).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss, which is reported on the income statement. The measure of segment assets is reported on the balance sheet as total consolidated assets.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM uses cash forecast models in deciding how to invest into the segment. Such cash forecast models are reviewed to assess the entity-wide operating results and performance. Net loss is used to monitor budget versus actual results. Monitoring budget versus actual results is used in assessing the performance of the segment and in establishing management&#8217;s compensation, along with cash forecast model.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f0041f05-d1e6-4ecd-a4e9-41581e49c426" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Currency Translations</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s functional currency is the United States dollar. Foreign currency transaction gains and losses are recorded in the consolidated statement of operations.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cba4b75a-b557-4fa2-b40e-5b578782ba36" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risk and Significant Suppliers</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments that potentially expose the Company to credit risk primarily consist of cash, cash equivalents, restricted cash and restricted cash equivalents. The Company maintains its cash, cash equivalents, restricted cash and restricted cash equivalents balances with accredited financial institutions and, consequently, the Company does not believe it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s cash management limits investment to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. The Company maintains its cash in bank deposit accounts that are Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insured up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18423f7e-db86-47fb-bd1b-7eb99cb5a96b" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CashFDICInsuredAmount" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. At times, the Company&#8217;s bank accounts may exceed the federal insurance limit.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is dependent on contract development and manufacturing organizations (&#8220;CDMOs&#8221;) to supply products for research and development activities in its programs. In particular, the Company relies and expects to continue to rely on a small number of manufacturers to supply it with its requirements for the active pharmaceutical ingredients, other raw materials and formulated drugs related to these programs. These programs could be adversely affected by a significant interruption in the supply of active pharmaceutical ingredients, other raw materials and formulated drugs. The Company is also dependent on contract research organizations (&#8220;CROs&#8221;) which provide services related to the research and development activities in its programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e4c32571-0457-44b9-98d2-101fd9b17fa8" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:OffBalanceSheetCreditExposurePolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Off Balance Sheet Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had no off balance sheet risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_33126e08-b3d2-4b83-b5ec-d7f96ca90ff0" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Income (Loss)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive income (loss) includes net loss as well as other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_d0240cbb-8cd0-49fb-9268-4ea5602efc83" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true" continuedAt="F_d0240cbb-8cd0-49fb-9268-4ea5602efc83_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments that are readily convertible into cash with maturities of three months or less at the date of purchase to be cash equivalents. Cash equivalents are comprised of money market accounts invested in U.S. Treasury securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted cash and restricted cash equivalents are comprised of deposits held by financial institutions as collateral for the company&#8217;s venture debt and used to collateralize letters of credit related to the Company&#8217;s lease arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_0726c143-1135-42c3-ac00-f6acfb02987f_2" continuedAt="F_0726c143-1135-42c3-ac00-f6acfb02987f_3"><div><ix:continuation id="F_d0240cbb-8cd0-49fb-9268-4ea5602efc83_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company includes the restricted cash and restricted cash equivalents balance together with its cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e3238ddf-39d6-464d-8aa1-09bd5bb8a22c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" escape="true" continuedAt="F_e3238ddf-39d6-464d-8aa1-09bd5bb8a22c_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, restricted cash and restricted cash equivalents consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:66.993%;box-sizing:content-box;"/>
          <td style="width:1.62%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:12.883000000000001%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:1.62%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
          <td style="width:12.883000000000001%;box-sizing:content-box;"/>
          <td style="width:1%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86beda87-a956-4b59-b5ca-3d1731714a01" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77,965</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33caf2c4-f263-46c1-bc5f-22538cd53e33" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,617</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash and cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea228d15-bd35-469f-baf5-e25b92d14857" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:RestrictedCashAndCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">647</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0e8972d-affc-4573-9e3a-8d8c174bdc36" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:RestrictedCashAndCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,647</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents, restricted cash and restricted<br/>&#160;&#160;&#160;cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22b50a80-ebd8-4d22-8751-88803b6e5a92" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">78,612</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a99b4f8-dd13-435b-9b99-9eaea07f4254" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,264</ix:nonFraction></span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></ix:nonNumeric></div></ix:continuation></div><div><ix:continuation id="F_e3238ddf-39d6-464d-8aa1-09bd5bb8a22c_1"></ix:continuation></div><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0e8adb5e-8fb9-4c60-8831-5b9b7e1fafc8" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:MarketableSecuritiesPolicy" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-Term Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Short-term investments represent holdings of available-for-sale marketable securities in accordance with the Company&#8217;s investment policy and cash management strategy. Short-term investments have maturities of greater than 90 days at the time of purchase and mature within one year from the balance sheet date. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#8217; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the underlying security. Such amortization and accretion, together with interest on securities, are included in interest income in the Company&#8217;s consolidated statements of operations. The cost of marketable securities sold is determined based on the specific identification method and any realized gains or losses on the sale of investments are reflected as a component of other income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#8217;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#8217;s industry, and any significant deterioration in economic conditions.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a174e3cd-90ed-4619-8d4d-7eb09fdfde30" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:DeferredChargesPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Transaction Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings as deferred transaction costs until such financings are consummated. After consummation of an equity financing, these costs are recorded as a reduction of the proceeds from the transaction, either as a reduction of the carrying value of the preferred stock or in stockholders&#8217; deficit as a reduction of additional paid-in capital generated as a result of the transaction. Should the in-process equity financing be abandoned, the deferred transaction costs would be expensed immediately as a charge to operating expenses in the consolidated statements of operations.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8b4f3657-89e0-4417-be26-ea1ef56ab577" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 1 &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Quoted prices in active markets for identical assets or liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 2 &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 3 &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_0726c143-1135-42c3-ac00-f6acfb02987f_3" continuedAt="F_0726c143-1135-42c3-ac00-f6acfb02987f_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ce488d96-882c-4035-af80-8e7ad57f209c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EquityMethodInvestmentsPolicy" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in Equity Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the equity method of accounting to account for an investment in an entity that it does not control, but in which it has the ability to exercise significant influence over operating and financial policies. The Company's proportionate share of the net income or loss of the entity is included in consolidated net income (loss). Judgments regarding the level of influence over the equity method investment include consideration of key factors such as the Company's ownership interest, representation on the board of directors or other management body and participation in policy-making decisions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the equity method of accounting, the Company&#8217;s investment is initially recorded at fair value on the consolidated balance sheets. Upon initial investment, the Company evaluates whether there are basis differences between the carrying value and fair value of the Company&#8217;s proportionate share of the investee&#8217;s underlying net assets. Typically, the Company amortizes basis differences identified on a straight-line basis over the underlying assets&#8217; estimated useful lives when calculating the attributable earnings or losses, excluding the basis differences attributable to in-process research and development that has no alternative future use. If the Company is unable to attribute all of the basis differences to specific assets or liabilities of the investee, the residual excess of the cost of the investment over the proportional fair value of the investee&#8217;s assets and liabilities is considered to be equity method goodwill and is recognized within the equity investment balance, which is tracked separately within the Company&#8217;s memo accounts. The Company subsequently records in the statements of operations its share of income or loss of the other entity within other income/expense, which results in an increase or decrease to the carrying value of the investment. If the share of losses exceeds the carrying value of the Company&#8217;s investment, the Company will suspend recognizing additional losses and will continue to do so unless it commits to providing additional funding; however, if there are intra-entity profits this can cause the investment balance to go negative.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that a decline in value has occurred that is other than temporary. Evidence considered in this evaluation includes, but would not necessarily be limited to, the financial condition and near-term prospects of the investee, recent operating trends and forecasted performance of the investee, market conditions in the geographic area or industry in which the investee operates and the Company&#8217;s strategic plans for holding the investment in relation to the period of time expected for an anticipated recovery of its carrying value. If the investment is determined to have a decline in value deemed to be other than temporary it is written down to estimated fair value.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the cost method to account for an investment in an entity in which it does not have the ability to exercise significant influence over operating and financial policies. Investments recorded using the cost method will be assessed for any decrease in value that has occurred that is other than temporary and the other than temporary decrease in value shall be recognized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As and when circumstances and facts change, the Company will evaluate the Company&#8217;s ability to significantly influence operational and financial policy to establish a basis for converting the investment accounted for using the cost method to the equity method of accounting and vice versa.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company accounted for its investment in Oxford Biomedica (US) LLC (&#8220;OXB (US) LLC&#8221;) using the cost method (see Note 6).</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_e6e8bb3a-2f85-416c-8ee4-3831946073b2" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. Upon retirement or sale,</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7e337e4b-f1e8-4bfc-be50-8780ef779ec0" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock" escape="true" continuedAt="F_7e337e4b-f1e8-4bfc-be50-8780ef779ec0_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.</span></ix:nonNumeric></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_7e337e4b-f1e8-4bfc-be50-8780ef779ec0_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:70.32%;box-sizing:content-box;"/>
          <td style="width:1.7%;box-sizing:content-box;"/>
          <td style="width:27.98%;box-sizing:content-box;"/>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Useful Life (Years)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_71bb4923-c015-49a9-978b-94d2327038f7" contextRef="C_36fe52b2-0dba-48bb-aaf0-4023627944b9" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_70a794c0-153c-4128-9fcf-6e44f92337f6" contextRef="C_42dc6c69-0cf8-467e-b208-73239c144b07" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9051aa1a-dc3a-4cd2-a8d3-26ebae2192a8" contextRef="C_c8ee0693-2174-48d4-893c-58e9b89264b1" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_4b3c95c9-00db-4ff5-871a-392543c3c948;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of useful life or<br/>term of<br/>associated lease</span></span></span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_0726c143-1135-42c3-ac00-f6acfb02987f_4" continuedAt="F_0726c143-1135-42c3-ac00-f6acfb02987f_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0ade1c58-1a24-42d6-90b2-e7fb28440d9e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates whether an arrangement is or contains a lease at contract inception. If a contract is or contains a lease, lease classification is determined at lease commencement, which represents the date at which the underlying asset is made available for use by the Company. The Company&#8217;s lease terms are generally measured at the respective lease&#8217;s noncancelable term and exclude any optional extension terms as the Company is not reasonably certain to exercise such options. The Company elected the short-term lease exemption and therefore does not recognize lease liabilities and right of use assets for lease arrangements with original lease terms of twelve months or less.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lease liabilities represent the Company&#8217;s obligation to make lease payments under a lease arrangement. Lease liabilities are measured as the present value of fixed lease payments, discounted using an incremental borrowing rate, as interest rates implicit in the Company&#8217;s lease arrangements are generally not readily determinable. The Company elected the practical expedient to not separate lease and non-lease components for its real estate leases and therefore both are considered when determining the lease payments in a lease arrangement. Variable lease costs are expensed as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The incremental borrowing rate represents the interest rate at which the Company could borrow a fully collateralized amount equal to the lease payments, over a similar term, in a similar economic environment. The Company determines the incremental borrowing rate at lease commencement, generally using a synthetic credit rating based on the Company&#8217;s financial position and negative cash flows, factoring in adjustments for additional risks based on the Company&#8217;s economic condition, a survey of comparable companies with similar credit and financial profiles, as well as additional market risks, as may be applicable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Right-of-use assets represent the Company&#8217;s right to use an underlying asset over its lease term. Right-of-use assets are initially measured as the associated lease liability, adjusted for prepaid rent and tenant incentives. The Company remeasures right-of-use assets and lease liabilities when a lease is modified, and the modification is not accounted for as a separate contract. A modification is accounted for as a separate contract if the modification grants the Company an additional right of use not included in the original lease agreement and the increase in lease payments is commensurate with the additional right of use. The Company assesses its right-of-use assets for impairment consistent with its policy for impairment of long-lived assets held and used in operations.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d2d8658e-601b-4702-bffc-5eb2080a524b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may be impaired, and assesses their recoverability based upon estimated future undiscounted future cash flows expected to be generated by the long-lived assets. If the estimated aggregate undiscounted cash flows are less than the carrying amount of the long-lived assets, an impairment charge, calculated as the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets, is recorded. The estimated fair value of the long-lived assets is determined based on the estimated discounted cash flows expected to be generated from the long-lived assets.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5f47bbe5-baa7-4083-8ccb-048b53a8f32d" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:DebtPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt and Warrant Issuance Costs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying value of the Company&#8217;s venture debt was recorded net of issuance costs and discount relating to the issuance of warrants. The amounts are amortized over the term of the debt using the effective interest method and recognized as interest expense.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_dbbfff14-79e0-438a-848e-b27b64e55ec5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true" continuedAt="F_dbbfff14-79e0-438a-848e-b27b64e55ec5_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and Development expenses are comprised of costs incurred in performing research and development activities, including salaries, stock-based compensation and benefits, costs for clinical research organizations and other outsourced activities; laboratory supplies; technology licenses, software and other information technology support; facilities and depreciation.  Upfront payments and milestone payments made for the licensing of technology are expensed as research and development expenses in the period in which they are incurred. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related goods are delivered or the services are performed.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company has entered into various research and development related contracts with external parties. The payments under these agreements are recorded as research and development expenses as the underlying services are performed or the goods are received. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued and prepaid balances at</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_0726c143-1135-42c3-ac00-f6acfb02987f_5" continuedAt="F_0726c143-1135-42c3-ac00-f6acfb02987f_6"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_dbbfff14-79e0-438a-848e-b27b64e55ec5_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">end of any reporting period. Actual results could differ from the Company&#8217;s estimates. The Company&#8217;s historical accrual estimates have not been materially different from the actual costs.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a37d2670-3970-4a95-b8d5-6efdccc5201b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:PatentsCostsPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Costs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expenses all costs as incurred in connection with patent applications, including direct application fees, and the legal and consulting expenses related to making such applications, and such costs are included in general and administrative expenses within the Company&#8217;s statement of operations.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_7c19df42-5955-4f69-b333-14ea93fba7ef" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true" continuedAt="F_7c19df42-5955-4f69-b333-14ea93fba7ef_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under FASB Accounting Standards Codification (&#8220;ASC&#8221; Topic 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 606), an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Arrangements that include rights to additional goods or services that are exercisable at a customer&#8217;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. The identification of material rights requires judgments related to the determination of the value of the underlying good or service relative to the option exercise price. The exercise of a material right is accounted for as a contract modification for accounting purposes.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the license terms, the research, manufacturing and commercialization capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The transaction price is determined and allocated to the identified performance obligations in proportion to their stand-alone selling prices (SSP) on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The amount of variable consideration included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty related to the variable consideration is resolved. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.</span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_0726c143-1135-42c3-ac00-f6acfb02987f_6" continuedAt="F_0726c143-1135-42c3-ac00-f6acfb02987f_7"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_7c19df42-5955-4f69-b333-14ea93fba7ef_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#8217;s control or the licensee&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time recognition is based on the use of an output or input method.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_eb3bd713-2846-4118-8056-8b4f286ef38f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for stock-based awards in accordance with FASB ASC Topic 718, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compensation &#8211; Stock Compensation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ASC 718). ASC 718 requires all stock-based awards issued to employees and members of the Company&#8217;s board of directors for their services to be recognized as expense in the statements of operations based on their grant date fair values. For stock options and time-based restricted stock awards, the Company expenses the fair value of the awards on a straight-line basis over each award&#8217;s service period, which is generally the period in which the related services are received. For performance-based stock awards, the Company uses the accelerated attribution method to expense the awards over the implicit service period based on the probability of achieving the performance conditions. The Company accounts for stock-based awards to non-employees consistently with the accounting for awards to employees and measures stock-based awards granted to non-employees based on their grant date fair value and recognizes the resulting value as stock-based compensation expense during the period the related services are rendered. The Company has not issued any stock-based awards with market-based vesting conditions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of options on the date of grant is calculated using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company&#8217;s estimates of these assumptions are primarily based on the trading price of the Company&#8217;s stock, historical data, peer company data and judgment regarding future trends and factors. The Company accounts for forfeitures as they occur.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s equity incentive plan allows for the issuance of restricted stock awards to employees and non-employee consultants that may be subject to vesting. The unvested shares of any restricted stock awards are held in escrow as the stock award vests or until award holder termination, whichever occurs first. In the event of a sale of the Company, the Company has the obligation to repurchase at cost, the portion of unvested stock awards from the award holder. For all unvested stock awards, a liability is established related to the Company&#8217;s obligation for unvested awards at cost.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_f75db224-cf29-4174-8b73-77338400e838" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true" continuedAt="F_f75db224-cf29-4174-8b73-77338400e838_1"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income taxes are recorded in accordance with FASB ASC Topic 740, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 740), which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. Should the actual amounts differ from these estimates, the amount of the Company&#8217;s valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to the tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income taxes are accounted for using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial carrying</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_0726c143-1135-42c3-ac00-f6acfb02987f_7"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_f75db224-cf29-4174-8b73-77338400e838_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applicable to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance against deferred tax assets is recorded if, based upon the weight of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_60049988-ff82-46d6-b001-993ef846baf5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeTaxExaminationDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3b676183-fe40-4fb2-b42b-4c71aabe582e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SubsequentEventsPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Event Considerations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that require additional disclosure. The Company has evaluated events occurring after the date of its consolidated balance sheet through the date these consolidated financial statements were issued (see Note 21).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_07a74bbe-c031-47f5-b769-e16de8930ede" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280)&#8212;Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASU 2023-07&#8221;). The amendments in this update improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses. All disclosure requirements of the update are required for entities with a single reportable segment. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and should be applied on a retrospective basis to all periods presented. The Company adopted this standard as of January 1, 2024. The Company determined that adopting the amendments in ASU 2023-07 had no impact on the Company&#8217;s reportable segment identified and additional required disclosures have been included.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Standards Not Yet Adopted</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 14, 2023, the FASB issued ASU No. 2023-09,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Income Taxes (Topic 740)&#8212;Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASU 2023-09&#8221;). ASU 2023-09 provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and incomes taxes paid information. For public companies, the amendments are effective for annual periods beginning after December 15, 2024 and should be applied prospectively. The Company has determined that the effects of adopting the amendments in ASU 2023-09 will only impact its disclosures and not have a material impact on its consolidated financial position and the results of its operations when such amendment is adopted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></ix:continuation></div>
  <div><ix:nonNumeric id="F_cb2a1b5c-b2cb-4e62-ab8c-67896668433e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" escape="true" continuedAt="F_cb2a1b5c-b2cb-4e62-ab8c-67896668433e_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Accounting for the Merger</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in Note 1, Merger Sub merged with and into Legacy Q32, with Legacy Q32 surviving as a wholly-owned subsidiary of the Company on March 25, 2024. The Merger was accounted for as a reverse recapitalization in accordance with GAAP with Legacy Q32 as the accounting acquirer of Homology. Legacy Q32 was determined to be the accounting acquirer based on the terms of the Merger Agreement and other factors, including: (i) Legacy Q32&#8217;s shareholders own a majority of the voting rights in the combined company; (ii) Legacy Q32 designated a majority (seven of nine) of the initial members of the board of directors of the combined company; (iii) Legacy Q32's executive management team became the management team of the combined company; (iv) the pre-combination assets of Homology were primarily cash and cash equivalents, short-term investments, and other non-operating assets; and (v) the combined company was named Q32 Bio Inc. and is headquartered in Legacy Q32&#8217;s office in Waltham, Massachusetts.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_cb2a1b5c-b2cb-4e62-ab8c-67896668433e_1" continuedAt="F_cb2a1b5c-b2cb-4e62-ab8c-67896668433e_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the effective time of the Merger, substantially all of the assets of Homology consisted of cash and cash equivalents, short-term investments, as well as other non-operating assets. Under such reverse recapitalization accounting, the assets and liabilities of Homology were recorded at their fair value in the Company&#8217;s financial statements at the effective time of the Merger, which approximated book value due to the short-term nature, except for the equity method investment as described below. Homology&#8217;s development programs had ceased prior to the Merger and were deemed to be de minimis in value at the transaction date. No goodwill or intangible assets were recognized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consequently, the consolidated financial statements of the Company reflect the operations of Legacy Q32 for accounting purposes together with a deemed issuance of shares, equivalent to the shares held by the former stockholders Homology, the legal acquirer, and a recapitalization of the equity of Legacy Q32, the accounting acquirer.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b0486b63-8a4c-4629-9f1b-5ca5b497c84e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the recapitalization, the Company obtained the assets and liabilities listed below:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"/>
        <td style="width:1.94%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.823%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65d55440-afa7-4cf6-a479-1bb0ac671314" contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">53,158</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfa26754-6e01-482c-9c7e-7a6bd1dc3bc5" contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3" name="us-gaap:ShortTermInvestments" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">19,905</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7a92f85-a4fe-4be6-8a5f-86cafa72e4ad" contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3" name="us-gaap:PrepaidExpenseCurrentAndNoncurrent" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">964</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity method investment</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1309cea5-b8bc-4016-82d6-01e90a85ed13" contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3" name="us-gaap:EquityMethodInvestmentAggregateCost" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">4,900</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_917ab1d4-658a-46f4-964a-9dde21466852" contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">7,903</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CVR liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39b91968-c7bd-486a-b6bd-64bbbf2dd209" contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3" name="us-gaap:AssetAcquisitionContingentConsiderationLiability" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">5,080</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net assets acquired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae4188e2-e4d2-430d-9277-88a4881d6627" contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3" name="us-gaap:Assets" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">65,944</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7623376b-70ef-43e3-a7ee-5db826d97e8f" contextRef="C_c8e96e70-b220-40a4-8caa-3388400e3cae" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in personnel cost related to severance payments and retention bonuses to Homology employees and this amount was recorded in general and administrative expense in the accompanying consolidated statement of operations for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company also incurred transaction costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eff845b8-f466-4f72-a169-0901fd1b4295" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and this amount is recorded in additional paid-in capital in the accompanying consolidated statements of convertible preferred stock and stockholders&#8217; equity (deficit) for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to the CVRs issued in connection with the Merger, each CVR represents the contractual right to receive payments from the Company upon the actual receipt by the Company or its subsidiaries of certain contingent proceeds derived from any cash consideration that is paid to the Company or its subsidiaries as a result of the sale, transfer, license, assignment or other divestiture, disposition or commercialization of any of the Company&#8217;s assets, rights and interests relating to the following pre-merger assets of Homology: HMI-103, HMI-204, capsids and human hematopoietic stem cell-derived adeno-associated virus vector (&#8220;AAVHSC&#8221;) platform, including any equity interests held directly or indirectly by the Company in OXB (US) LLC.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company believes that the achievement of the milestones outlined in the CVR agreement related to Homology&#8217;s HMI-103, HMI-204, capsids and AAVHSC platform are highly susceptible to factors outside the Company's influence that are not expected to be resolved for a long period of time, if at all. In particular, these amounts are primarily influenced by the actions and judgments of third parties and the licensors of such assets and are based on the licensors of such assets progressing the in-process research and development assets, and in the case of one of the draft agreements, to certain milestones. As of March 25, 2024, the date of the Merger, the Company recorded a CVR liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9600afa-9cd8-4ae2-b992-ee05c47b07ed" contextRef="C_302992f5-5a2f-4079-b1ae-a9f51ed191d0" name="us-gaap:AssetAcquisitionContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the balance sheet relating to such contingent payments.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the portion of the CVR agreement that is related to Homology's equity interest in OXB (US) LLC, the Company recorded a CVR liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99d227fc-2a92-4fab-b41b-73b51be19221" contextRef="C_6f68a357-a32f-44ae-979a-875bc449d3b4" name="us-gaap:AssetAcquisitionContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million representing its estimated fair value as of the date of the Merger. Pursuant to the Amended and Restated Limited Liability Company Agreement of OXB (US) LLC, at any time following the three-year anniversary of the closing of the transaction between OXB (US) LLC, Oxford Biomedica (US), Inc. and the Company (formerly known as Homology Medicines, Inc.) on March 10, 2022, (i) Oxford Biomedica (US), Inc. will have an option to cause the Company to sell and transfer to Oxford Biomedica (US), Inc., and (ii) the Company will have an option to cause Oxford Biomedica (US), Inc. to purchase from the Company, in each case, all of the Company&#8217;s equity ownership interest in OXB (US) LLC based on the Company's pro rata share of OXB (US) LLC (10%) times a predetermined multiple of revenue for the immediately preceding 12-month period increased by OXB (US) LLC's cash balance and decreased by OXB (US) LLC's debt balance as of the exercise date (together, the &#8220;Options&#8221;), subject to a maximum amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21662f61-d6be-46d8-87e5-8b10f8b94ba2" contextRef="C_cc753916-5b65-451d-90ed-193a32758aa9" name="us-gaap:EquityMethodInvestmentAggregateCost" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">74.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company utilized a monte carlo simulation model, also known as a probability simulation, to estimate the fair value of the CVR liability. For each simulated path of future revenue, a market approach using the predetermined revenue multiple was employed to determine the future value of the equity interest, which was then discounted to present value using OXB (US) LLC's estimated cost of debt.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_cb2a1b5c-b2cb-4e62-ab8c-67896668433e_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to a change in control provision in the Amended and Restated Limited Liability Company Agreement of OXB (US) LLC, on March 1, 2025, Oxford Biomedica (US), Inc. caused the Company to sell and transfer to Oxford Biomedica (US), Inc., all of the Company's equity interest in OXB (US) LLC. See Note 21.</span></p></ix:continuation></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5e3804eb-8eb6-4a6a-bb6d-2fa2d5034037" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. Short-Term Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may invest its excess cash in fixed income instruments denominated and payable in U.S. dollars, including U.S. treasury securities, commercial paper, corporate debt securities and asset-backed securities in accordance with the Company&#8217;s investment policy that primarily seeks to maintain adequate liquidity and preserve capital.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d7c0db8-f1b1-4d72-8920-33434374d2c0" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ShortTermInvestments" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_488bcfac-1933-4db5-a3bc-44d921fab76c" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:ShortTermInvestments" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t have any short-term investments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_d275b148-4b84-4edf-9d0d-7e81d0060c08" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:FairValueDisclosuresTextBlock" escape="true" continuedAt="F_d275b148-4b84-4edf-9d0d-7e81d0060c08_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying values of the Company&#8217;s prepaid expenses and other current assets, accounts payable, and accrued expenses and other current liabilities approximate their fair value due to their short-term nature. The carrying value of the Company&#8217;s term loan as of December 31, 2024 (see Note 11) approximated fair value based on interest rates currently available to the Company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The tables below present information about the Company&#8217;s assets and liabilities that are regularly measured and carried at fair value on a recurring basis at December 31, 2024 and December 31, 2023 and indicate the level within the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value, which is described further within Note 2, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_03b26b55-90c5-457e-bdde-4108a56a7c14" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are summarized as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.38%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as<br/>of December 31,<br/>2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7632692c-7a7e-44bd-b4ba-e5a404abb34a" contextRef="C_9f64b245-b6aa-4495-a613-76961dbfa794" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,089</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_96ec3701-775c-4597-8907-154919d036b6" contextRef="C_49e1f5d1-7824-4873-b567-c71038b76681" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,089</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d81b5746-8e9d-4cd8-8400-3b74275b6a4a" contextRef="C_7bb2bb04-b139-49f5-801e-31f1d770bc43" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,089</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f72e230-d2ee-4f79-82b0-26cd37d3459e" contextRef="C_c11e5447-4a20-4d83-b060-fbc22d8f5724" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,089</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15ce5466-3605-4e36-83e7-26e0e48917d2" contextRef="C_7bb2bb04-b139-49f5-801e-31f1d770bc43" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,089</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eb08b5e2-c48d-4abc-b201-5a03d9fbb32b" contextRef="C_c11e5447-4a20-4d83-b060-fbc22d8f5724" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">76,089</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CVR liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0097f7c4-3d3a-4a0c-973b-8f77e9d5631d" contextRef="C_7bb2bb04-b139-49f5-801e-31f1d770bc43" name="qttb:CvrLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,900</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8191bb9b-f0db-4174-bd7e-e0d59d7a5fba" contextRef="C_20e3aba0-5377-41a2-bf8e-222ee59cf7b2" name="qttb:CvrLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,900</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4372fd97-5b67-4df7-8096-cbc4d6e91c0a" contextRef="C_7bb2bb04-b139-49f5-801e-31f1d770bc43" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,900</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5f68714-7732-4278-8228-f4e96f812590" contextRef="C_20e3aba0-5377-41a2-bf8e-222ee59cf7b2" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,900</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 are summarized as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.239%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:11.325000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.184000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as<br/>of December 31,<br/>2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_293c6c6d-baa9-40d2-8c90-c5fa0faa861e" contextRef="C_02ecb717-f14e-405e-8487-adc80c2116b1" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,100</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5643a5ec-60a9-48bd-bce4-816426a1e8b8" contextRef="C_21aa18f8-fcb9-4858-ab9d-ae3b4a5f7444" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,100</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52661613-0652-419f-aa9f-7092abe88bf8" contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,100</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_edac79c2-6fbd-427c-8060-87c9341149c5" contextRef="C_c58e837a-179e-40c1-aa34-7a9794f2d652" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,100</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted cash equivalents:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a39f4f21-1c01-45e0-9fd4-c6e932a3a117" contextRef="C_02ecb717-f14e-405e-8487-adc80c2116b1" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6c82b59-9bfe-4959-ad8c-dbd1c14c7d90" contextRef="C_21aa18f8-fcb9-4858-ab9d-ae3b4a5f7444" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total restricted cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9df7fff5-d512-41c2-954a-9d41833d1581" contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_212f9f1b-dd9a-44ac-8d99-1af9d5f8fa8b" contextRef="C_c58e837a-179e-40c1-aa34-7a9794f2d652" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,000</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f908a4e2-fefb-42c3-9087-01ed1aa783d0" contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,100</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e87ed88-7929-4393-8360-695c6a7ec457" contextRef="C_c58e837a-179e-40c1-aa34-7a9794f2d652" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,100</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible notes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdf2fbcd-4c6a-413c-87a7-99f42eda8194" contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a" name="us-gaap:ConvertibleDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,595</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3523a82-acb1-4818-bfab-ecdcef155559" contextRef="C_c3c34d76-204f-422a-8542-9570869264f0" name="us-gaap:ConvertibleDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,595</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1fd80313-d16d-4e33-9bae-cb818faf67e6" contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,595</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_381bac0d-d87d-463d-bed8-bd9a7a47adab" contextRef="C_c3c34d76-204f-422a-8542-9570869264f0" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,595</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_d275b148-4b84-4edf-9d0d-7e81d0060c08_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds were valued by the Company using quoted prices in active markets for identical securities, which represent a Level 1 measurement within the fair value hierarchy.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Notes 1 and 3, at the effective time of the Merger, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#8217;s common stock received a CVR, issued by Homology subject to and in accordance with the terms and conditions of a CVR Agreement, representing the contractual right to receive cash payments from the combined company upon the receipt of certain proceeds from a disposition of Homology&#8217;s pre-merger assets, calculated in accordance with the CVR Agreement. The Company concluded that the CVR liability is a derivative liability and is accounted for at fair value. The fair value of the CVR liability is based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. For the portion of the CVR liability that is related to Homology's equity interest in OXB (US) LLC, the Company utilized a monte carlo simulation model, also known as a probability simulation, to estimate the fair value of the CVR liability. This model requires the use of estimates and assumptions including estimated future revenues and discount rates. For the portion of the CVR liability related to Homology's HMI-103, HMI-204, capsids and AAVHSC platform, the Company's fair value assessment includes judgments around the probability of progressing the in-process research and development assets, and in the case of one of the draft agreements, to certain milestones.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CVR liability had an estimated fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_496c69ba-dac3-4e42-8a21-6dd0fc0da69d" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:CvrLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company recorded in other income (expense), net, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58e47530-88a4-4d0f-bea7-7227b0b099ff" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:OtherOperatingIncomeExpenseNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the change in estimated fair value during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, there were no transfers between Level 1, Level 2 and Level 3 measurements. There have been no impairments of the Company&#8217;s assets measured and carried at fair value during the years ended December 31, 2024 and 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legacy Q32 issued convertible notes (the &#8220;Convertible Notes&#8221;) totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfaa0187-bd9f-43a0-bccd-ae307dba921b" contextRef="C_d63b5539-4625-4fac-978b-86e1f8037d8e" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the year ended December 31, 2022. Legacy Q32 concluded that the Convertible Notes and its related features are within the scope of FASB ASC Topic 825, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ASC 825), as a combined financial instrument, and Legacy Q32 elected the fair value option where changes in fair value of the Convertible Notes are measured through the accompanying consolidated statement of operations until settlement. The Convertible Notes liability represents a Level 3 measurement within the fair value hierarchy as it has been valued using certain unobservable inputs. These inputs include the underlying fair value of the equity instrument into which the Convertible Notes are convertible.</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e032fdcd-84a1-4816-90ab-e8ec635ab41a" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" escape="true" continuedAt="F_e032fdcd-84a1-4816-90ab-e8ec635ab41a_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The fair value is based on significant inputs not observable in the market, namely potential financing scenarios, the likelihood of such scenarios, the expected time for each scenario to occur, and the required market rates of return utilized in modeling these scenarios. </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e032fdcd-84a1-4816-90ab-e8ec635ab41a_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:12.775%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:12.775%;box-sizing:content-box;"/>
        <td style="width:1.399%;box-sizing:content-box;"/>
        <td style="width:12.775%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scenario 1</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scenario 2</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scenario 3</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Probability of each scenario</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1923deae-57bd-4eb1-b057-328cbf485568" contextRef="C_2aef5253-5673-488f-b176-618a6a1a9ffa" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" decimals="0" format="ixt:num-dot-decimal">80</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73c8aa3e-c80c-4a64-9920-35d084910432" contextRef="C_c73c0232-3eb2-4afd-9b9d-d70bdfd8a5f8" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" decimals="0" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7180c8e8-c950-463c-ad9c-c0a6afc950b9" contextRef="C_37c8672c-5d7c-4a2e-802c-2bb52b924851" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" decimals="0" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected Term (years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b08b6e18-6159-4999-bf6b-8b1438d80afa" contextRef="C_1080c6e9-b757-4406-9324-738d36ed0c95" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">0.25</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73c4478b-41ee-45e6-af76-937c06c80d2d" contextRef="C_79b9f15f-c77c-4650-8ec5-e400e55b0820" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">0.25</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df2497ef-6718-462a-8b2c-cbc4fa26b328" contextRef="C_db8118be-101e-441a-a13b-f4b57e3c5a64" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">0.42</ix:nonFraction></span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Required market rates of return</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73d407d0-b3f5-4f73-8cc8-5d0ecbeb9dd4" contextRef="C_81e3e422-e365-4f92-a2df-f3bed9e3c0f4" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" scale="0" decimals="1" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a88d3359-0e49-49e2-8869-99aa4df6d9d1" contextRef="C_6e7474c2-50c6-4141-93a0-c56ced950809" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" scale="0" decimals="1" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38ab1c0e-d682-4be4-b61f-6447be3cfb13" contextRef="C_1ae14b8d-dea6-450a-bd61-6382bf1f8395" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" scale="0" decimals="1" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Convertible Notes had an estimated fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7b18ff3-ade4-4753-ab05-85c749363a06" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">38.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of December 31, 2023. The Company recorded in other income (expense), net, an interest expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5aa83c68-7a2a-4730-aca7-c96bb79e883e" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and a charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f70227f2-9c21-47ce-aaaa-2aedce285a58" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:FairValueOfInterestExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the change in estimated fair value during the year ended December 31, 2023. There was no change in fair value attributable to the instrument-specific credit risk for the year ended December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon closing of the Merger, Legacy Q32 converted the outstanding Convertible Notes plus accrued interest into shares of common stock at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d84b9910-6c2a-4bf6-9b02-07266a146991" contextRef="C_b56ad3a0-64a3-4549-bf92-0952e7e3df5b" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">90</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the purchase price of the mandatory conversion event. As the Convertible Notes are recorded at fair value, a gain of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29567c23-350d-410a-afd0-f2a85499a4bb" contextRef="C_b56ad3a0-64a3-4549-bf92-0952e7e3df5b" name="qttb:GainOnConvertibleNotes" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the change in the fair value prior to the conversion of convertible notes is reflected in the consolidated statement of operations for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (see Note 11).</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_927ac097-5761-41e8-be1f-498db2d644f1" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" escape="true" continuedAt="F_927ac097-5761-41e8-be1f-498db2d644f1_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Investment in Equity Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the Merger, the Company obtained Homology's </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e3597cf-fd13-40b5-86d9-2977f5ba15e5" contextRef="C_7f47faa6-d3bb-45d0-9ae1-b46cda818a27" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">20</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in OXB (US) LLC, an AAV vector process development and manufacturing services company. At that time, the Company had significant influence over, but did not control, OXB (US) LLC through its noncontrolling representation on OXB (US) LLC&#8217;s board of directors and the Company&#8217;s equity interest in OXB (US) LLC. Accordingly, the Company did not consolidate the financial statements of OXB (US) LLC and accounted for its investment using the equity method of accounting.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_927ac097-5761-41e8-be1f-498db2d644f1_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recorded its equity method investment in OXB (US) LLC at fair value upon the effective date of the Merger. The fair value of the equity method investment was determined based on the market approach. This approach estimated the fair value of OXB (US) LLC based on the implied value for the entity, including the Options (as defined in Note 3 above), for a controlling interest in OXB (US) LLC at the entity&#8217;s formation. As part of its fair value analysis, the Company determined that the Options are embedded in the Company&#8217;s ownership units of OXB (US) LLC because the Options are not legally detachable or separately exercisable. Accordingly, the equity method investment and the Options represent one unit of account and the fair value recorded reflects the value of the equity interest and the Options (refer to Note 3 for more information for how the fair value was determined).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of transactions by OXB (US) LLC, the Company&#8217;s investment was diluted to a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52789693-4dce-4549-99ae-8681791af984" contextRef="C_0708f559-d98c-480b-8223-bba4a0a87863" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in OXB (US) LLC on May 22, 2024, and the Company no longer has the ability to exert significant influence over the operating and financial policies of OXB (US) LLC. The Company discontinued the equity method of accounting for the investment in OXB (US) LLC on May 22, 2024 and determined the remaining investment to be an equity security accounted for in accordance with FASB ASC Topic 321, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments&#8212;Equity Securities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 321) at the date the investment no longer qualifies for the equity method of accounting. The Company recorded the equity instrument at fair value and applied the measurement alternative under ASC 321 such that the Company would not change the amount recorded for the equity instrument unless the Company identified observable price changes in orderly transactions for the identical or similar investment of the same issuer or the equity instrument was otherwise deemed to be impaired.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At each reporting period, the Company is required to make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. If deemed impaired, the Company is required to estimate the fair value of the investment and recognize an impairment loss equal to the difference between the fair value of the investment and its carry amount. As of September 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company performed an assessment to evaluate whether the investment was impaired and determined that the fair value of its investment in OXB (US) LLC was negatively impacted due to a change in OXB (US) LLC's forecasted performance. The Company utilized a monte carlo simulation model, also known as a probability simulation, to estimate the fair value of its investment. This model requires the use of estimates and assumptions including estimated future revenues and discount rates which are significant unobservable inputs representing Level 3 measurements within the fair value hierarchy. The Company determined that the decline in value was deemed to be other than temporary and recorded an impairment charge of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ac07c5a-7459-4080-8526-a04d208810cb" contextRef="C_e0d1d750-c63b-49fa-8efe-0c104dbe276f" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to reduce its investment to fair value. The impairment charge is included in other income (expense), net in the Company's consolidated statements of operations. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the carrying value of the equity investment was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd0c266d-8d84-4e71-8cf1-99fed3bfce29" contextRef="C_5f1339d1-c9c7-4c62-85fe-43ee887e097f" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company determined that the investment was not impaired.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to May 22, 2024, the Company was recording its share of income or losses from OXB (US) LLC on a quarterly basis under the equity method of accounting.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_65a78882-856e-4db2-953a-292f7cc8f49d" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. Property and Equipment, Net</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_52a91fbb-fa1c-4ec0-906f-e1cd128c9a06" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true" continuedAt="F_52a91fbb-fa1c-4ec0-906f-e1cd128c9a06_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">roperty and equipment, net consisted of the following as of (in thousands): </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_52a91fbb-fa1c-4ec0-906f-e1cd128c9a06_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2fbd784-d31d-41a4-8ce6-83a0188f0fae" contextRef="C_36fe52b2-0dba-48bb-aaf0-4023627944b9" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,382</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aba230cb-05cb-423d-8d66-507b017e11f9" contextRef="C_6b897fb9-c5ec-48c3-9610-95cfe8b4cd07" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,382</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_79345f46-5a5f-43c1-8fc9-1c987b3aa7d2" contextRef="C_42dc6c69-0cf8-467e-b208-73239c144b07" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">351</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69376da2-8e43-4f84-9a27-e85a060d6fd6" contextRef="C_538446b8-7409-4894-a71d-dabb73e1ef55" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">341</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f15a6d95-5763-4372-93be-446dadef57e4" contextRef="C_c8ee0693-2174-48d4-893c-58e9b89264b1" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd289575-34a4-4b12-aa82-44a5993d62a9" contextRef="C_bb6c3e3c-07de-46ab-8b95-1ab3fb082d09" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">85</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce64b9cc-16c4-414d-bc50-30c362476ff7" contextRef="C_5062bd0a-61c4-478f-887d-27fbcabc427e" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,001</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4176b06-02e8-4fdd-a7a9-c568cbd146d4" contextRef="C_4de6188d-bc41-4c0b-986d-59e12a08b2a6" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">940</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ec0ae50-8da5-43a7-bc79-48697fd1b222" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,823</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_28e50ad3-358e-45a7-b712-ce34e7eacf80" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,748</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less accumulated depreciation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0827d83a-df92-4f10-8320-f28240305688" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,453</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4a1a690-61e1-47f3-81a2-5cd031e55fe0" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">966</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e3500ab-7a91-473d-b500-bb3959ba5dec" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,370</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01ebbef4-b911-4fe1-bc75-bd7609de804b" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,782</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation expense for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1d6974d-cd8e-4b08-b313-eff84dc984af" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6a760059-6eb0-4edd-84a9-bbe6ef9198ac" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in each period</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e730355-2c18-41f9-bb7e-c0f5b7e90330" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_88e9e379-f809-4d65-8842-028f4380ba7e" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairment losses occurred in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e8a5418-a8c3-4ab6-8230-988bf28693e6" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_3c126560-f73d-4e04-802c-4d653b1fea46" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> losses on disposal of fixed assets in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:nonNumeric id="F_6f31be50-27af-4445-8108-7d3e8e37e574" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. Prepaid Expenses, Other Current Assets and Other Noncurrent Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bdc86635-5cb0-439e-833b-e800f85aa99f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following as of (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid external research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0426f3ac-59a9-470c-9b23-91e7f3607d10" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:PrepaidExternalResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,076</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ac1b66c-b13b-4cb2-8eb1-d2bc298bb56d" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="qttb:PrepaidExternalResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,834</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payroll tax credit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20138887-11e5-4322-8995-1dfe8b0c6b4d" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:PayrollTaxCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">555</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64a9f385-3219-4d40-8d33-fd25ed1c999f" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="qttb:PayrollTaxCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">755</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92fe767b-f7f9-42ec-8d30-55595094b067" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:PrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">885</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e738e11-fdb3-419c-b469-e7ded90ccad8" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:PrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">427</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50574ac5-eac3-486f-bf5b-349f6cce3b40" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">396</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77c24549-54fe-49a0-ba63-8f1a6493da71" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b9993ef-f4e9-4b65-9760-761802e5320f" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,912</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94cf4f15-8ed4-453f-999f-dc28988a295a" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,099</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_71b1c3c4-ea91-42e6-9295-4cb910212c23" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock" escape="true" continuedAt="F_71b1c3c4-ea91-42e6-9295-4cb910212c23_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other noncurrent assets consisted of the following as of (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred transaction costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86850839-162e-4552-a056-8fcfb025e1c0" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c901472c-eb94-45b2-b983-77982664c6d8" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,912</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid external research and development - long term</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9d15fe7-6ceb-407a-be49-eb35434cf199" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:PrepaidExternalResearchAndDevelopmentNonurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">116</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d7b3a26-3b95-493e-8808-b62c5707d2ce" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="qttb:PrepaidExternalResearchAndDevelopmentNonurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">676</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d63fbcfe-d57f-48ca-a27d-d13aa56afdb2" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:PrepaidExpenseOtherNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5b181c7-e3bd-44f6-bc75-2369c72887b4" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:PrepaidExpenseOtherNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other noncurrent assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e97acd62-397a-46ac-91c0-ff33beddcb01" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">116</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5787c12b-bea9-4ac5-8a01-e33b911dbbfd" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,611</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <div><ix:continuation id="F_71b1c3c4-ea91-42e6-9295-4cb910212c23_1"></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_7e5f0523-4a01-4d0b-a632-8822ab484e6c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. Accrued Expenses and Other Current Liabilities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c1f6ac02-0499-46d2-808b-0b48ea27625b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true" continuedAt="F_c1f6ac02-0499-46d2-808b-0b48ea27625b_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following as of (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and related expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc0fe0aa-dab0-40ca-b790-3a2764a436df" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,782</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d859ac57-9ee2-4913-8661-a3f25febfc67" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,003</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued external research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6e7498e-7c15-46fc-a53a-3d9d7f7a0bd7" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:AccruedResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,611</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_256a05ea-26e5-4f89-b557-e3d4282b4c5b" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="qttb:AccruedResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,578</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services and other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba5b5d0b-2d28-472e-af52-6df443127976" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,474</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e72f8f1f-024d-4313-8195-e91c8377e0c2" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="qttb:AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,328</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a45e6167-40b6-49f4-9625-e8ce6cbfd3a5;"><span style="-sec-ix-hidden:F_cb90d7dd-2025-4f37-8452-ccbb5dfb30b4;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability, current</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_120fb633-3037-47a4-8d42-4e677d1691e2" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">612</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03130ffa-3e91-4521-a4ff-e3f4b6f228b8" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">538</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued taxes payable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_baa2c915-d9e2-403f-81d1-ac6ca3da874b" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:TaxesPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03476f4d-6579-45a2-bcf4-112148c4b2a4" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:TaxesPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">316</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c8e383e-0960-4abd-940a-ec9a805649d9" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,479</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f6b0c6e-bc4e-44d9-ad85-9981b600c1d1" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,763</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <div><ix:continuation id="F_c1f6ac02-0499-46d2-808b-0b48ea27625b_1"></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4302ba6e-763e-444d-923f-3b1efb748526" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_4302ba6e-763e-444d-923f-3b1efb748526_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company had several ongoing clinical studies in various clinical trial stages. Its most significant contracts relate to agreements with CROs for clinical trials and preclinical studies and CDMOs for manufacturing which the Company enters into in the normal course of business. The contracts with CROs and CDMOs are generally cancellable, with notice, at the Company&#8217;s option.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2021 the Company entered into a long-term operating lease agreement for its current corporate headquarters in Waltham, Massachusetts (&#8220;headquarters lease&#8221;). The headquarters lease provides approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_843a1d22-71aa-4305-ab7b-04a14306f539" contextRef="C_854a149a-1eef-4a0c-9335-f2a517e54274" name="us-gaap:AreaOfRealEstateProperty" unitRef="U_sqft" decimals="0" format="ixt:num-dot-decimal">15,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet for general office use and research lab facilities. The lease commencement date was January 1, 2022 and the Company did not take control or have the right to use the leased property until this time. The lease term ends in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_a1c527db-8fab-40c5-be93-17f92684f3c3;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 2031</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has an option to extend the lease term for an additional </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1cd3672d-f2c8-4a06-9960-bb2ca9d8f9c0" contextRef="C_854a149a-1eef-4a0c-9335-f2a517e54274" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The initial rent for the office space is approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3cca82e-8cba-461f-9bf1-a81b29bdf5ad" contextRef="C_854a149a-1eef-4a0c-9335-f2a517e54274" name="qttb:SubleaseAggregateBaseRentObligation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per year, increasing every year by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_589eb0f9-a37b-4698-8c59-6cd3febc20d4" contextRef="C_53138904-18f8-426d-9bb6-72a8e8db3721" name="qttb:LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% for total aggregate payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea8f4f03-1e75-4d6e-a783-839f8d2ccbac" contextRef="C_53138904-18f8-426d-9bb6-72a8e8db3721" name="qttb:AnnualRentOperatingLeaseAggregateAfterIncrease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">11.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Upon the commencement date, the Company established a right-of-use asset and lease liability on the consolidated balance sheet. As part of the agreement, the Company arranged for a letter of credit for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d608a6b-bdfd-4a3e-82db-151718c00337" contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac" name="us-gaap:SecurityDeposit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as a security for lease, which is considered restricted cash and included as restricted cash and restricted cash equivalents in the consolidated balance sheet. The Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d585ce01-f197-4e79-950d-9fda3f21a6ba" contextRef="C_a3049491-9ddc-4b12-9eb9-4faf6e1e2fec" name="us-gaap:IncentiveFromLessor" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in a tenant improvement allowance that was applied against the right-of-use asset.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company&#8217;s headquarters lease had a weighted-average remaining lease term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ccdc4d7a-d716-4edf-9a8b-7fadecce0ec9" contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.0</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and weighted average incremental borrowing rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a77063c-0d51-4fdd-ac6f-34eea81484fe" contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_4302ba6e-763e-444d-923f-3b1efb748526_1" continuedAt="F_4302ba6e-763e-444d-923f-3b1efb748526_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e4c21752-c0c1-4f86-8a54-f8a5af686d27" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts reported in the consolidated balance sheet for leases where the Company is the lessee as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and December 31, 2023 were as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa2a1b95-ef16-4997-9b43-9668cc1317f4" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,722</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d16c65e-f10a-48b2-81af-e63de09bb04b" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,301</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f1857a3-9de8-43b7-885d-04bc7fb26b40" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,722</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06ed344b-04b4-46de-b286-6052bb21c189" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,301</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6732e2f5-7509-4abe-ac57-cbf792380db9" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">612</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ee7b8fc-d0c5-43bf-ad9e-5e7db51edf45" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">538</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncurrent:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_437b2b9e-f00f-4d62-9aa8-322cec082fb1" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,636</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1978e66-0278-4850-b1e2-83126fb17570" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,248</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0206602f-b826-4a6e-a6d2-1e397c57bce2" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,248</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aaf752f8-3728-4515-8a5d-cbd413171ea2" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,786</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_98fca37a-9579-4a5b-9b51-87e1414f5cbc" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes operating lease costs for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9416d861-a7c6-405c-b5f3-925b21dbbdd0" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,029</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd419251-dd25-481f-b369-e434bdb82720" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">999</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4e779d2-585c-4838-9066-600c0152003e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bb1dec7-2a38-4fe7-b390-c6fd02f8baec" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_583019c2-aad6-45e6-b68a-7b7d2904480d" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,072</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_97f3712b-86f6-44c2-8438-ea5920517b33" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,072</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Variable lease costs were primarily related to operating expenses, taxes and insurances associated with the operating lease, which were assessed based on the Company&#8217;s proportionate share of such costs for the leased premises. As these costs are generally variable in nature, they were not included in the measurement of the operating lease right-of-use asset and related lease liability. Total lease costs are included as operating expenses in the Company&#8217;s consolidated statements of operations.</span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e5088a99-1cb9-499e-87c2-646d9913f80e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true" continuedAt="F_e5088a99-1cb9-499e-87c2-646d9913f80e_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Future minimum lease payments under non-cancelable lease agreement as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and a reconciliation to the carrying amount of the lease liabilities presented in the consolidated balance sheet are as follows (in thousands): </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_e5088a99-1cb9-499e-87c2-646d9913f80e_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"/>
        <td style="width:1.94%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:15.823%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Minimum<br/>Rental<br/>Payments</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca3c8aab-290b-417e-b86d-6941f53e50d1" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,060</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c48c0369-429e-446f-984c-ff12396e9c71" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,092</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_965c388c-5992-42be-b789-85b392504ca0" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,124</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cacccba3-e669-4859-8ee2-dce504c4e3bc" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,158</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de91ec7c-6fa3-4c65-b1de-cdfaa923c700" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,193</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6cf42679-b86b-4729-869d-31f80b66a446" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,494</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef861437-e538-497b-ae5e-1816af4d7263" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,121</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40181f5b-bc98-4427-b713-29bfadc4ef4c" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,873</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_adb0bb75-fedf-4ce4-aeb9-151d2ac9bbb6" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,248</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability, current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c257f3be-c53e-46a3-934d-2408ec322097" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">612</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2503dea8-52ef-4eb7-9a47-072d68d2e838" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,636</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4f822d1-2826-4d9f-acab-7d3e76b3dae6" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,248</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the Merger, Homology was subleasing office and research and development laboratory space in Bedford, Massachusetts, under a sublease agreement with OXB (US) LLC that expired in December 2024. During the first quarter of 2024, prior to the Merger, Homology had fully abandoned the space and accordingly, had shortened the remaining useful of its right-of-use asset to equal the time remaining until the planned abandonment date. At the effective time of the Merger, the Company recorded a liability of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9a764c6-e0e5-4a09-8044-64f3568dd96c" contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac" name="qttb:FutureMinimumLeasePaymentDueUnderThisSublease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million representing the present value of the future minimum lease payments due under</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4302ba6e-763e-444d-923f-3b1efb748526_2" continuedAt="F_4302ba6e-763e-444d-923f-3b1efb748526_3"><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">this sublease. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there are no future lease payments due under the Homology sublease and therefore </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_440d6015-540b-49bd-9f58-174a29036f3a" contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="6" decimals="-6" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> liability on the Company's consolidated balance sheet.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">License Agreement with the University of Colorado</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2017, the Company entered into an exclusive license agreement, as amended in February 2018, September 2018, and April 2019 (the &#8220;Colorado License Agreement&#8221;), with The Regents of the University of Colorado (&#8220;Colorado&#8221;), pursuant to which the Company obtained worldwide, royalty-bearing, sublicensable licenses under certain patents and know-how owned by Colorado and Medical University of South Carolina (&#8220;MUSC&#8221;) relating to the research, development and commercialization of ADX-097. The licenses granted to the Company are exclusive with respect to certain patent families and know-how and non-exclusive with certain other patent families and know-how. The licenses granted to the Company are also subject to certain customary retained rights of Colorado and MUSC and rights of the United States government owing to federal funding giving rise to inventions covered by the licensed patents. The Company agreed to use commercially reasonable efforts to develop, manufacture and commercialize ADX-097, including by using commercially reasonable efforts to achieve specified development and regulatory milestones by specified dates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company agreed to pay Colorado (i) development and sales milestone payments in an aggregate amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0f6d375-6edf-40cf-8923-2f0a56d5286b" contextRef="C_b555dfd2-6633-4e32-b92f-2a1f6100178b" name="qttb:DevelopmentAndSalesMilestonePaymentPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per licensed product for the first three products, (ii) tiered royalty rates on cumulative net sales of licensed products in the low single digit percentages, (iii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed9fcf6a-f3c0-4279-b454-e17ac051a82c" contextRef="C_7173717f-2d2d-4169-9a96-9df1da9fef47" name="qttb:PercentageOfSublicenseFees" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">15</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of sublicense income and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents. The Company&#8217;s obligation to pay royalties to Colorado commences, on a licensed product-by-licensed product and country-by-country basis, from the first commercial sale of a licensed product in any country and expires on the later of (a) the last to expire valid claim within the licensed patents covering such licensed product in such country, and (b) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6ef97dc5-574a-43b5-ad55-1331d6ce2c4a" contextRef="C_7173717f-2d2d-4169-9a96-9df1da9fef47" name="qttb:PeriodOfObligationToPayRoyalties" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years following the effective date of the Colorado License Agreement, or April 2037 (the &#8220;Royalty Term&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless earlier terminated by either party pursuant to its terms, the Colorado License Agreement will expire upon the expiration of the Royalty Term in all countries. The Company may terminate the Colorado License Agreement for convenience upon providing prior written notice to Colorado. Colorado may terminate the Colorado License Agreement or convert the Company&#8217;s exclusive license to a non-exclusive license if the Company breaches certain obligations under the Colorado License Agreement and fails to cure such breach. The Colorado License Agreement will terminate automatically upon the Company&#8217;s dissolution, insolvency, or bankruptcy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9dc339b0-b22b-436f-8008-7ef427fe7469" contextRef="C_7173717f-2d2d-4169-9a96-9df1da9fef47" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_7058c803-e7ac-467b-aca1-f8b30a402cfc" contextRef="C_09d4667e-d0d3-40c4-96f5-1346195ceecb" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> research and development expense for any milestone related to the Colorado License Agreement. The financial statements as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 do not include liabilities with respect to royalty fees on the license agreement as the Company has not yet generated revenue and the achievement of certain milestones is not yet probable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">License Agreement with Bristol-Myers Squibb Company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2019, the Company entered into a license agreement, as amended in August 2021 and July 2022 (the BMS License Agreement), with Bristol-Myers Squibb Company (&#8220;BMS&#8221;), pursuant to which the Company obtained sublicensable licenses from BMS to research, develop and commercialize licensed products, including bempikibart, for any and all uses worldwide. The licenses granted to the Company are exclusive with respect to BMS&#8217;s patent rights and know-how relating to certain antibody fragments (including certain fragments of bempikibart) and non-exclusive with respect to BMS&#8217;s patent rights and know-how relating to the composition of matter and use of a specific region of bempikibart. BMS retained the right for it and its affiliates to use the exclusively licensed patents and know-how for internal, preclinical research purposes. Under the BMS License Agreement, the Company is prohibited from engaging in certain clinical development or commercialization of any antibody other than a licensed compound with the same mechanism of action until the earlier of the expiration of Q32&#8217;s obligation to pay BMS royalties or September 2029.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In consideration for the license, the Company made an upfront payment to BMS of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fcc65e1-8b0e-4a71-8b1c-90cf0460c624" contextRef="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c" name="qttb:UpfrontPaymentMade" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c70bbf6-c3e0-4cf6-ae9f-385848f9153b" contextRef="C_cbe1c2b6-e46f-4db2-a96d-16d62994fde1" name="us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,628,788</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Series A preferred shares to BMS and agreed to use commercially reasonable efforts to develop and commercialize at least one licensed product in key geographic markets. In addition, the Company agreed to pay BMS (i) development and regulatory milestone payments in aggregate amounts ranging from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_023d9827-de23-472d-bad5-508db5f7328a" contextRef="C_cfdb4851-27cb-4dd2-a181-f26f91524080" name="qttb:DevelopmentAndSalesMilestonePaymentPayable" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">32</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_624ef7c9-b075-4eaa-9e87-88539d8fe6e7" contextRef="C_d70d9c60-682f-4b4c-8180-b6b1535a6f0c" name="qttb:DevelopmentAndSalesMilestonePaymentPayable" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">49</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per indication for the first three indications and commercial milestone payments in an aggregate amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6171de62-a349-4a51-bc12-6c0038ca6ed8" contextRef="C_c995ff6f-a52c-4c87-a8d6-71a52474fd48" name="qttb:CommercialMilestonePaymentPayable" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">215</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on net sales of licensed products, (ii) tiered royalties ranging from rates in the mid-single digit percentages to up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53282364-d018-4051-8a98-6729265edc10" contextRef="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c" name="qttb:RoyaltyAsAPercentageOfNetSales" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">10</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of net sales, with increasing rates depending on the cumulative net sales, (iii) up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e955e20-e721-4044-96cc-63af58fb841b" contextRef="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c" name="qttb:PercentageOfSublicenseFees" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">60</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of sublicense income, which percentage decreases based on the development stage of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_4302ba6e-763e-444d-923f-3b1efb748526_3"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">bempikibart at the time of the sublicensing event, and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s obligation to pay BMS royalties under subsection (ii) above commences, on a licensed product-by-licensed product and country-by-country basis on the first commercial sale of a licensed product in a country and expires on the later of (x) </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d22e19fb-055a-4888-9987-c3d3c42441d1" contextRef="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c" name="qttb:PeriodOfObligationToPayRoyalties" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years from the first commercial sale of such Licensed Product in such country, (y) the last to expire licensed patent right covering bempikibart or such licensed product in such country, and (z) the expiration or regulatory or marketing exclusivity for such licensed product in such country (Royalty Term). If the Company undergoes a change of control prior to certain specified phase of development, the development and milestone payments are subject to increase by a low double digit percentage and the royalty rates are subject to increase by a low sub single digit percentage.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless terminated earlier by either party pursuant to its terms, the BMS License Agreement will expire on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last to expire Royalty Term with respect to such licensed product in such country. Either party may terminate the BMS License Agreement for the other party&#8217;s material breach, subject to a specified notice and cure period. BMS may terminate the BMS License Agreement if the Company fails to meet its diligence obligations under the BMS License Agreement, for the Company&#8217;s insolvency, or if the Company or its affiliates challenges the validity, scope, enforceability, or patentability of any of the licensed patents. The Company may terminate the BMS License Agreement for any reason upon prior written notice to BMS, with a longer notice period if a licensed product has received regulatory approval. If the BMS Agreement is terminated for the Company&#8217;s material breach, BMS will regain rights to bempikibart and the Company must grant BMS an exclusive license under the Company&#8217;s patent rights covering bempikibart, subject to a low single digit percentage royalty on net sales of bempikibart payable to the Company by BMS.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2024, the Company made a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27205ce3-e682-4b72-9e1e-f4e0df326795" contextRef="C_186a100e-16ef-48da-90b9-7456802bc057" name="qttb:DevelopmentMilestonePaymentPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million development milestone payment to BMS and recorded it as research and development expenses. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, no further events have occurred that would require payment of milestones, royalties or sublicense fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal Proceedings</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is not currently party to any material legal proceedings. The Company accounts for estimated losses with respect to legal proceedings and claims when such losses are probable and reasonably estimable. Legal costs associated with these matters are expensed when incurred.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indemnification Arrangements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As permitted under Delaware law, the Company has agreements whereby it indemnifies certain of its investors, stockholders, employees, officers, and directors (collectively, the &#8220;Indemnified Parties&#8221;) for certain events or occurrences while the Indemnified Parties are, or were serving, at its request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has an Executive Liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f311f5a-5967-4ba4-a4d6-37617be48e3c" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:SelfInsuranceReserve" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company believes the estimated fair value of these indemnification agreements is minimal. The Company enters into standard indemnification agreements in the ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless, and agrees to reimburse the Indemnified Parties for losses suffered or incurred by the Indemnified Parties, generally the Company&#8217;s business partners or customers, in connection with any U.S. patent or any copyright or other intellectual property infringement claim by any third party with respect to the Company&#8217;s products. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_d8beea53-38ef-4f4d-92cb-362423989ee3" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:DebtDisclosureTextBlock" escape="true" continuedAt="F_d8beea53-38ef-4f4d-92cb-362423989ee3_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. Debt</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Venture Debt</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 11, 2020, the Company entered into a Loan and Security Agreement with Silicon Valley Bank, a California corporation (&#8220;Loan Agreement&#8221;) for a lending facility of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6991515-0728-4cb4-9ae3-9fc14cd9205b" contextRef="C_61d6fc78-c8ec-418e-a4dc-fcee1281ac6c" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe9f9e1c-cb19-4b77-9c08-6b5401493551" contextRef="C_440034cc-e9c7-4544-91a9-9d19b1167f0e" name="us-gaap:ProceedsFromLongTermLinesOfCredit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon execution of the Agreement (&#8220;2020 Term A Loan Advance&#8221;) and had the ability to draw up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b20bacee-b33b-4d01-ae40-b4384df5bb65" contextRef="C_85eed7d4-bc70-4689-9015-4f85ad5cfc18" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in three separate term loan advances if certain performance milestones are met. The term loan bears interest at an annual rate equal to the greater of the prime rate or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c994b95-cf7e-45e5-9b7a-e789b6e46552" contextRef="C_df3c79d3-1293-482f-9102-cd57669625a7" name="us-gaap:LongTermDebtPercentageBearingVariableInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. The Loan Agreement provides for interest-only payments until April 30, 2022, and repayment of the aggregate outstanding principal balance of the term loan in monthly installments starting on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9165c3b7-be03-48e9-a2d1-0180950978ef" contextRef="C_53fa66be-5ca3-40fc-8c45-f08ab061bfff" name="us-gaap:LineOfCreditFacilityDateOfFirstRequiredPayment1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 1, 2022</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6a997c1b-7f12-4f6d-b97a-20c9f8f851fa" contextRef="C_53fa66be-5ca3-40fc-8c45-f08ab061bfff" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 1, 2023</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The commencement of principal payments and the maturity date will be deferred by one year upon the occurrence of a contingent event. In addition, the Company paid a fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8ba5219-88f2-4f9b-bb3d-0c99ae0c8ff1" contextRef="C_440034cc-e9c7-4544-91a9-9d19b1167f0e" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon closing and is required to pay a fee of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58f125df-7cce-4d72-a2b6-1bce9c5af517" contextRef="C_440034cc-e9c7-4544-91a9-9d19b1167f0e" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the aggregate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_d8beea53-38ef-4f4d-92cb-362423989ee3_1" continuedAt="F_d8beea53-38ef-4f4d-92cb-362423989ee3_2"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amount </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of advances under the Loan Agreement at maturity. At its option, the Company may elect to prepay all or a portion of the outstanding advances by paying the principal balance, and all accrued and unpaid interest, and a prepayment premium. In connection with the Loan Agreement, the Company granted the lender a security interest in all of its personal property now owned or hereafter acquired, excluding intellectual property (but including the rights to payment and proceeds from the sale, licensing or disposition of intellectual property), and a negative pledge on intellectual property. The Loan Agreement also contains certain events of default, representations, warranties and non-financial covenants of the Company. If the Company fails to make payments when due or breaches any operational covenant or has any event of default, this could have a material adverse effect on its business and financial condition. The Company was in compliance with all covenants at December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 30, 2022, a second amendment to the Loan Agreement was entered into with the lender that extended the interest-only payment until December 31, 2022 followed by </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5459a2bd-76a9-45e7-b47a-c9629fc22470" contextRef="C_4ea385ae-a09a-44a7-ba4f-9e1d5dfc76b2" name="us-gaap:LineOfCreditFacilityFrequencyOfPayments"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24 equal monthly payments of principal plus interest, with a loan maturity date of</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0f38565a-48ce-40de-920f-1439e9e2bfb4" contextRef="C_4ea385ae-a09a-44a7-ba4f-9e1d5dfc76b2" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The amendment increased the final payment from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b272a697-e05c-4366-a183-2db46945bf8c" contextRef="C_85eed7d4-bc70-4689-9015-4f85ad5cfc18" name="qttb:LongTermDebtBalloonPaymentPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">2.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e831359a-7715-482b-8198-9dc15ebf2786" contextRef="C_4c584b28-2bfc-476b-9e14-f321da0f4ddb" name="qttb:LongTermDebtBalloonPaymentPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">4.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the advanced payment and modified the prepayment premium.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 10, 2022, a third amendment to the Loan Agreement was entered into with the lender. Per the terms of the amendment and in conjunction with the Collaboration Agreement (as defined below), the Company transferred $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b88b68c5-f4d4-4746-9549-9f07d14eeef3" contextRef="C_393ed9e3-2fa2-4a7b-b49b-0b0d93cbf89e" name="us-gaap:DebtInstrumentCollateralAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million into a restricted cash collateral money market account which is included as Restricted cash and restricted cash equivalents on the balance sheet. This restricted cash equivalent covers the amount of the debt outstanding as of the third amendment effective date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 21, 2022, a fourth amendment to the Loan Agreement was entered into with the lender that extended the interest-only payment until July 1, 2023 followed by </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e686f873-ee9b-44c6-b1af-cc04f0728667" contextRef="C_79f15b34-ea52-436c-a16f-c67bd97ffb1d" name="us-gaap:DebtInstrumentPaymentTerms"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 equal monthly payments of principal plus interest, with a loan maturity date of</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fd482a46-adb0-46a7-9a28-cbf2497d29d7" contextRef="C_79f15b34-ea52-436c-a16f-c67bd97ffb1d" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 1, 2024</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 26, 2023, a fifth amendment to the Loan Agreement was entered into with the lender. The amendment provides that the Company must maintain at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f80de71-43bc-40ae-90a7-af2fbd9fe663" contextRef="C_6acff699-1bcb-4e5c-83d0-0ecc48abc809" name="qttb:PercentageOfConsolidatedCashToBeMaintainedWithTheLender" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of its consolidated cash with the lender. In addition, the Company shall at all times have on deposit in operating and depository accounts maintained with the lender, unrestricted and unencumbered cash in an amount equal to the lesser of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b2617d5-1072-440c-aedb-c2e42149e20c" contextRef="C_6acff699-1bcb-4e5c-83d0-0ecc48abc809" name="qttb:UnrestrictedAndUnencumberedCashPercentageToBeMaintained" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the dollar value of the Company&#8217;s consolidated cash and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0fe247d-f2c9-40a6-9c83-a2d34b2364fb" contextRef="C_6acff699-1bcb-4e5c-83d0-0ecc48abc809" name="qttb:PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">110</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the then-outstanding obligations of the Company to the bank. So long as the Company is in compliance with those terms, the Company shall be permitted to maintain accounts with other banks or financial institutions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 12, 2023, a sixth amendment to the Loan Agreement was entered into with the lender. The amendment provides for one term loan advance (the &#8220;2023 Term A Loan Advance&#8221;) in an original principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b692f8e-e163-4322-bd18-b470f7c5be12" contextRef="C_f94caa77-06ab-4033-aaf4-c31aca13beda" name="qttb:LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and required the Company to repay the outstanding 2020 Term A Loan Advance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d80554a-30f6-4df6-8170-809fd4a98894" contextRef="C_f94caa77-06ab-4033-aaf4-c31aca13beda" name="us-gaap:LinesOfCreditCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, including the final payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f384d613-7463-4fc1-a4da-a86abbe294a1" contextRef="C_f94caa77-06ab-4033-aaf4-c31aca13beda" name="us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Upon the occurrence of a contingent event, the lender shall make up to three additional term loan advances at the Company&#8217;s request in original principal amounts of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ac9762a-8b2d-431c-bce6-af663d609f2e" contextRef="C_44dc2e47-aa49-4844-acd8-9cb650ca6caf" name="qttb:LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_73bb0e00-d96f-4b44-bf8d-6b893a7bdaed" contextRef="C_82ffbe69-bdc0-46ed-85f6-2f2135943e2a" name="qttb:LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_729ab7f4-761b-4998-bb64-dcf07bf43943" contextRef="C_d1e4c313-5593-44fa-8319-69d7287a8c1a" name="qttb:LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The amounts must be drawn by the Company before March 31, 2024, March 31, 2025 and July 1, 2025, respectively. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_547837bb-cc86-473f-b3ce-316ad9fc1169" contextRef="C_8b219b81-3c35-41c8-a792-9c9b2b87e1e7" name="us-gaap:DebtInstrumentPaymentTerms"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The interest-only period was extended through June 30, 2024 followed by 36 equal monthly payments of principal plus interest.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The term loan bears interest at an annual rate equal to the greater of the prime rate minus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98c10281-33e2-4ca6-848b-e62d10928c94" contextRef="C_8b219b81-3c35-41c8-a792-9c9b2b87e1e7" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">0.25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a576c7c9-580d-4e99-881b-c0b2d64bf554" contextRef="C_cda9fef4-e02f-4ed8-8897-35539a06a8b8" name="us-gaap:LongTermDebtPercentageBearingVariableInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">8.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 2, 2023, a seventh amendment to the Loan Agreement was entered into with the lender. The additional loan advance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6083c2cf-27c8-4fb7-aaed-d82324294630" contextRef="C_e112c2ce-ff85-4995-a056-7c0f11496a6f" name="qttb:FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, the first advance stated in the sixth amendment to the Loan Agreement, could be drawn down once the company received net cash proceeds of at least $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f36244b7-d714-4fa3-8ce7-8d0d2f36aab7" contextRef="C_bf697f63-fffd-47b1-a9e7-28e55b7595fb" name="qttb:EstimatedAggregateProceedsFromDebtAndEquity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">75.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from (a) the issuance and sale of its equity securities to investors satisfactory to the lender and/or (b) a business development transaction satisfactory to the lender; provided that, at least, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe6b9947-0447-4f72-b2bc-9678715e4f6c" contextRef="C_bf697f63-fffd-47b1-a9e7-28e55b7595fb" name="qttb:EstimatedAggregateProceedsFromEquity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">37.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of such net cash proceeds must be received from the issuance and sale of equity securities to investors satisfactory to the lender. The seventh amendment extended the time the Company has to receive the net proceeds to March 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 21, 2024, an eighth amendment to the Loan Agreement was entered into with the lender. The eighth amendment extended the time the Company had to receive the net proceeds to May 31, 2024 and also extended the time the Company could draw down on the first advanced payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6620072-f4e6-40ac-a8c1-2af57cc9ca88" contextRef="C_36ec1662-19ea-4f36-95c0-480643ad7851" name="qttb:LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from March 31, 2024 to May 31, 2024. The date changes were adjusted to align the milestone in the Loan Agreement with the closing of the Merger. On March 26, 2024, the Company received the first advance payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c4a5fb72-9a87-45c0-87b2-fe7efc03dce1" contextRef="C_8cb16126-e20f-478a-92f3-f4ef3f29dcee" name="qttb:ReceivedAdvancePayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per the terms of the Loan Agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 19, 2024, a ninth amendment to the Loan Agreement was entered into with the lender that extends the interest-only period through July 1, 2025 followed by </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1b997391-6a15-4761-afcb-55aef8b9c18d" contextRef="C_da508a90-18ff-4feb-864f-c062a92713e3" name="us-gaap:DebtInstrumentPaymentTerms"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24 equal monthly payments of principal plus interest.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The loan matures on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_14a104a2-61e8-4394-9354-12ad265eca02" contextRef="C_da508a90-18ff-4feb-864f-c062a92713e3" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 1, 2027</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In conjunction with the Loan Agreement, the Company issued warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a2a1eb5-52e8-4b07-b25f-4960d0fc5f81" contextRef="C_bdd74796-2135-43f6-a03b-39e6bd90c9b9" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">7,988</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the lender at a per share price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_150a5f8e-978a-4547-abfe-6f372a730961" contextRef="C_bdd74796-2135-43f6-a03b-39e6bd90c9b9" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.87</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with a maximum contractual term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3d9660c3-6eeb-4f3b-8bc9-f969b561b83e" contextRef="C_bdd74796-2135-43f6-a03b-39e6bd90c9b9" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10 years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrants had a total relative fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_875bd5b1-1f32-4f48-aa71-0673fd1672c7" contextRef="C_548856aa-e248-42ff-bd02-f8b3fa277e06" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand upon issuance and were recorded as a debt discount.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_d8beea53-38ef-4f4d-92cb-362423989ee3_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In conjunction with the sixth amendment, the Company issued warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fc9378f-a901-45e9-9cea-021d54245e08" contextRef="C_2b84e1db-55c0-4034-aafc-134bb2bada3d" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">10,156</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the lender at a per share price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0aebe344-b8a8-4bd7-a7e5-1e3db16c8b6c" contextRef="C_2b84e1db-55c0-4034-aafc-134bb2bada3d" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">7.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with a maximum contractual term of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_42965916-a239-400b-acf1-1fc1a91faa9c" contextRef="C_2b84e1db-55c0-4034-aafc-134bb2bada3d" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10 years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrants were issued in two separate tranches of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38c69a40-a5f0-4348-ac93-00cc8845a344" contextRef="C_742e9ad2-7322-4178-acf9-30981e53d1af" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">5,078</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> based upon certain milestone events. The warrants had a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> total relative fair value at the time of issuance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to FASB ASC Topic 480, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Distinguishing Liabilities from Equity </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and FASB ASC Topic 815, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the warrants were classified as equity and were initially measured at fair value. Subsequent changes to fair value will not be recognized so long as the instrument continues to be equity classified.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e40f1edb-693a-49b7-86e1-834ae25f1f17" contextRef="C_64e18bd2-6e71-4f81-8713-6d9b2f8a6ed2" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5672d195-899b-4ac9-8cd5-665277fdd58a" contextRef="C_13ef4388-e7d7-4520-984c-b50faaa55355" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The effective rate on the Loan Agreement, including the amortization of the debt discount and issuance costs was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c0444e1f-095d-43d1-a3e2-c830c8e73cb2" contextRef="C_29d5eced-fc9f-4f1c-ae83-4350d8af4754" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">9.55</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ac1ffc2-a955-4a28-9798-ab0ebdb12a14" contextRef="C_0679ebcb-aaa9-4d96-a6a8-350341c1609b" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">10.42</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, at each of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_641c4300-1569-417a-a491-8a7bf306bab5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:DisclosureInTabularFormOfVentureDebtTableTextBlock" escape="true" continuedAt="F_641c4300-1569-417a-a491-8a7bf306bab5_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of the long-term debt balance are as follows (in thousands): </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_641c4300-1569-417a-a491-8a7bf306bab5_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal amount of term loans</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5801372e-bd2d-4504-b143-8078f7528955" contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bedd996d-7841-4e4e-972d-19c6a58205a3" contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unamortized debt discount and issuance costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_507c9e22-790c-4628-b1ae-89d7a972009f" contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">153</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e55fa96b-7eb1-4fca-8d13-50111e03317f" contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Carrying amount</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe57b255-8de8-4774-9f7b-3443351f98b1" contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4" name="us-gaap:LongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,653</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4bd2f11-7503-41c7-bfd6-eb7a335cccbf" contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c" name="us-gaap:LongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,459</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70cf7fb1-f8bf-48c7-bdb5-5d24b43f12d4" contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,097</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d0298a94-d6cf-4001-87d6-2a4d9b80e35d" contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">878</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30923f5b-a64a-434f-92d1-add4d43a74f2" contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,556</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7fdf55d-0b1b-4b94-8b6c-c5c75887b485" contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,581</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 20, 2022, the Company entered into an agreement with the existing investors of the Company to issue, and for the existing investors to purchase, the Convertible Notes for up to an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6437443-fe86-49a8-b5fe-f6f42b290d1a" contextRef="C_fdc54320-1c67-4e15-8365-d084e65e9e52" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Convertible Notes bear interest at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5767b9e-a26e-4c7b-8fe1-9dca2fd85fdf" contextRef="C_fdc54320-1c67-4e15-8365-d084e65e9e52" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum. The Convertible Notes become due on demand of the Convertible Noteholders one year from the date of issuance. On April 27, 2023, the Company amended the maturity dates for the Convertible Notes. On May 20, August 5 and December 23, 2022, the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60d564ca-8caf-4b07-88da-2a15c4a47235" contextRef="C_cd782b8d-e977-40bc-a2ef-507ab008dfca" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8916e0da-2be8-4413-b1b5-3d817388ae12" contextRef="C_99f336ed-ce75-4357-a041-46da4ea43896" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf246f95-41a6-42e6-8585-ff1150cedcd6" contextRef="C_7fe7497c-530e-4a3f-be8e-af26a160d3fa" name="us-gaap:ProceedsFromConvertibleDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">16.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, in exchange for issuance of the Convertible Notes. Interest expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_674b61ab-618c-4cac-a04c-55f105c75374" contextRef="C_385a8942-b234-40ba-9087-cb65594b34d3" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62e04b5c-868d-41f7-b3e0-994a9a868c96" contextRef="C_ad732baa-4828-4c30-98cf-2d02dbdb87b8" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively. The Convertible Notes converted into share of common stock in March 2024 per the Merger (see discussion below and in Note 1).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Convertible Notes contain mandatory conversion features whereby the total outstanding amount of principal and accrued and unpaid interest of the Convertible Notes shall automatically convert into shares of common stock upon certain qualified financings. The total outstanding amount of principal and accrued and unpaid interest of the Convertible Notes convert into shares of common stock at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36a44d06-ac0a-426e-af03-2bff67ae1409" contextRef="C_fdc54320-1c67-4e15-8365-d084e65e9e52" name="qttb:DebtInstrumentConversionPricePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">90</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the purchase price of the mandatory conversion events. If the mandatory conversion events do not occur the holders of the Convertible Notes may request the Convertible Notes plus accrued interest be converted into Series B preferred stock at the Series B convertible price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_524d2e8c-8eb4-4c0c-be53-c9a828e14575" contextRef="C_7f536b74-399c-4e82-9152-d5daf6993f87" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">1.0971</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company elected to account for the Convertible Notes at fair value where changes in fair value of the notes are measured through the consolidated statements of operations until settlement. Subsequent to December 31, 2023 and per the Merger further discussed in Note 1, the Convertibles Notes converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da8adecd-8d56-41d2-aaef-2079542a8a2d" contextRef="C_385a8942-b234-40ba-9087-cb65594b34d3" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,433,410</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. The Company recorded a gain on the change in fair value prior to the conversion of the Convertible Notes of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ede330ac-4bbd-4e9e-99ae-d59148d2f209" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncreaseDecreaseInNotesPayableCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in other income (expense), net during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the Convertible Notes were settled with equity securities subsequent to December 31, 2023 but prior to the issuance of the financial statements, per FASB ASC Topic 470, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded the Convertible Notes at the fair value totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b733d402-c07f-4ff1-8b80-775be2c3182b" contextRef="C_5d9c9fa2-97d6-4b1c-b918-3a60f9e20e25" name="us-gaap:ConvertibleDebtFairValueDisclosures" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">38.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as a long-term liability on its consolidated balance sheet as of December 31, 2023. The Company recorded in other income (expense), net interest expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_743250ea-67df-4ffd-96e7-c5827c82761f" contextRef="C_3543f0be-6692-47f6-a4e8-a5c6d56417eb" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and a charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_56058f92-b122-4042-b4e6-f8763ccc4cef" contextRef="C_3543f0be-6692-47f6-a4e8-a5c6d56417eb" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the change in estimated fair value during the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_b3b49bbb-9f06-45b1-b8a7-345c5721866c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:DisclosureInEntiretyOfTemporaryEquity" escape="true" continuedAt="F_b3b49bbb-9f06-45b1-b8a7-345c5721866c_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Convertible Preferred Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 25, 2024, immediately prior to completing the Merger, all classes of convertible preferred stock of Legacy Q32 were converted to Legacy Q32 common stock, and then exchanged in the Merger for shares of the Company&#8217;s common stock using the Exchange Ratio. The Series A convertible preferred stock converted into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb6e2fd6-3419-450b-9891-d2366420806a" contextRef="C_d5a319e9-4550-4a20-9794-c5a7a6ad12aa" name="qttb:ConversionOfTemporaryEquityIntoPermanentEquityShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,286,873</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Legacy Q32 common stock, the Series A-1 convertible preferred stock converted into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f0e9fea-8579-4db5-94b5-07536fb686f9" contextRef="C_f5ea5ca1-ed8b-413d-bbea-b4a5e23ee94a" name="qttb:ConversionOfTemporaryEquityIntoPermanentEquityShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">312,094</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of Legacy Q32</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_b3b49bbb-9f06-45b1-b8a7-345c5721866c_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">common </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">stock and the Series B convertible preferred stock converted into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f75ac85f-54d3-449d-85e5-b4f321ea582c" contextRef="C_71403a30-e992-4c00-b708-e2cd6dde2a39" name="qttb:ConversionOfTemporaryEquityIntoPermanentEquityShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,625,896</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Legacy Q32 common stock. The conversion of the Legacy Q32 preferred stock into shares of Legacy Q32 common stock resulted in an increase of less than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c44533c4-cb42-4abc-a4c0-623b8cbce2a5" contextRef="C_65695aa9-2863-4310-b8da-f3be3d8e4280" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" unitRef="U_USD" scale="3" decimals="-2" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to common stock and an increase of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a474d485-633e-4faa-a9f2-31f13878fe65" contextRef="C_354585ed-60d7-4f70-a77e-d50cc01415c0" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">111.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to additional paid-in-capital immediately prior to completing the Merger.</span></p></ix:continuation></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f5c269b4-5d80-42bf-892e-adc6fb93340e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company&#8217;s Certificate of Incorporation, as amended, authorized the Company to issue </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4f053ed-1740-4cf8-9660-4dc53d3a1450" contextRef="C_b5c40c56-08b5-4a22-b751-a8f232a74aca" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">400,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38c9b686-35d8-4a6a-9735-0aa6d44934cf" contextRef="C_b5c40c56-08b5-4a22-b751-a8f232a74aca" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_09809ef5-c321-49d9-a16f-c4407e00eb58" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has reserved the following shares of common stock for future issuance:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of authorized<br/>&#160;&#160;&#160;Series A preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_169e9909-00c9-4ff3-b66c-dcabf28774bf" contextRef="C_0beb16c7-e3a6-42dc-8c19-40c1f98d5c9a" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_216aa48e-fe4c-414a-9fb5-521de0b733c8" contextRef="C_2f60cbad-ab1b-4beb-9829-e1cf73ad1860" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,286,873</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of authorized<br/>&#160;&#160;&#160;Series A-1 preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6163bf04-83d8-4c1d-ba5a-b966fd07c038" contextRef="C_223d39dc-f768-49d4-88fb-37a27c35a8a0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58239527-0a9d-4517-bba8-fba5a7c1ebb4" contextRef="C_cd0b4904-8ce8-4c84-a53a-8d845df8dc43" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">312,094</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of authorized<br/>&#160;&#160;&#160;Series B preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db10a901-45d4-4cfb-a5f7-0d1c79fa2e0f" contextRef="C_58806157-945d-4f05-9b65-2c51d8ce8b75" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9846569b-e7d2-49c7-9d08-88ccf6e2a671" contextRef="C_ec27399a-2953-4340-94d1-aa507faddcf4" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">2,625,896</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future issuance under the 2017 Stock<br/>&#160;&#160;&#160;Incentive Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7300c2d-2737-4799-bf39-b5ed7aa0bb36" contextRef="C_36984301-045f-4eac-9a05-c4a64d0c8422" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b9e2878-917c-42aa-9d0d-d6c86e8cf417" contextRef="C_4260d2af-256d-45f6-b503-aace9db4b45f" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">56,065</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future issuance under the 2024 Stock<br/>&#160;&#160;&#160;Incentive Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49434849-7bfe-4ffc-b335-e11eb0d77d3f" contextRef="C_31964b05-1da6-44db-b544-4f27ff581508" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,760,657</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_caf09832-2488-4d8b-940e-b6efcaa9bf3d" contextRef="C_6d5ea821-818d-4edc-977d-9c88e7922cd7" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future issuance under the 2024<br/>&#160;&#160;&#160;Employee Stock Purchase Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dc85bc5-77a4-4e83-8d47-61c24b6bf862" contextRef="C_56ea366c-6225-4b69-bccd-5ec940307d3b" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">120,836</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_789d341a-392d-4f0f-aa69-134ae7bd8ea3" contextRef="C_d3e98f3d-7cf9-4d47-9a53-26eaa914cc76" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of the convertible<br/>&#160;&#160;&#160;notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_738f2a9c-aad0-468d-89b2-3dd8052efef1" contextRef="C_6881a1d6-1e0a-490c-8f2b-d88e0d5e92d3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b30f481-b494-4c36-b123-b85612c55a80" contextRef="C_5e588eaa-63cf-4ef1-8b8e-0d333a72ff23" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,433,411</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for stock option exercises</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_edd25e45-c96f-4846-84e3-6d1fb3b93d0d" contextRef="C_4c2e3250-49a3-4f3c-9ba7-60f0718101be" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,942,920</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cba6f1e-1d6b-4643-887e-fa374c3ca131" contextRef="C_b2f6b4cb-fe35-486b-9f70-f7fd1fa0f798" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">1,112,275</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49182ac8-22df-4d3e-af07-1dd545cc0a96" contextRef="C_bdaefca0-fea1-4732-b40e-bf35def7a224" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">18,144</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81614d9b-1be2-4f09-b371-cee696da2bcc" contextRef="C_63d3da21-2d2f-4d33-8fc7-fd05ece7069d" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">18,144</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6182d51b-d718-447a-81d4-15fc4fdf0908" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,842,557</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08668cd1-681b-4126-887e-4c3c33b1b4a4" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,844,758</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_0798f9ed-0dea-4159-a9d9-2e2e7d56916d" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_0798f9ed-0dea-4159-a9d9-2e2e7d56916d_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14. Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2017 Stock Option and Grant Plan</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legacy Q32 adopted the 2017 Stock Option and Grant Plan and subsequent amendments (the &#8220;2017 Plan&#8221;) with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4230b668-7f40-4431-8c06-f0436cf4b5d2" contextRef="C_012ce485-8c2e-404f-b146-20b8651d7c1b" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,246,290</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock reserved for issuance to employees, directors, and consultants. The 2017 Plan allowed for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock unit awards and other stock awards. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f942244d-e4d3-4436-867b-94286452f1c1" contextRef="C_012ce485-8c2e-404f-b146-20b8651d7c1b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares available for future grant under the 2017 Plan.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 Stock Option and Incentive Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 15, 2024, Homology&#8217;s board of directors adopted and subsequently, Homology&#8217;s stockholders approved the Q32 Inc. 2024 Stock Option and Incentive Plan (the &#8220;2024 Plan&#8221;), which became effective upon the closing of the Merger. The 2024 Plan replaced the 2017 Plan, as well as the Homology 2015 Stock Incentive Plan (the &#8220;Homology 2015 Plan&#8221;), and the Homology 2018 Plan (together with the Homology 2015 Plan, the &#8220;Homology Incentive Plans.&#8221;) Upon effectiveness of the 2024 Plan, the Company ceased granting new awards under the 2017 Plan and the Homology Incentive Plans.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Plan provides for the grant of incentive stock options, nonqualified stock options, restricted stock awards, restricted stock units, stock appreciation rights and other stock or cash-based awards to officers, employees, directors and consultants of the Company. The number of shares of common stock initially available for issuance under the 2024 Plan was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7dec0693-8f7b-44fe-9903-1eaed4eb1746" contextRef="C_57c23963-7764-4e09-9834-07d94af003db" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,839,888</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. The 2024 Plan provides that the number of shares reserved and available for issuance under the 2024 Plan will automatically increase each January 1, beginning on January 1, 2025, by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5eb1653-aa4f-4fb5-ab4b-3e059f552b04" contextRef="C_e59a1e86-c7f5-494a-9d42-f6faee31d00f" name="qttb:IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding number of shares on the immediately preceding December 31, or such lesser amount as determined by the plan administrator. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22584ae9-4c81-49de-8bfe-cdbd0f658df9" contextRef="C_2636fb0b-847b-44cc-8769-e36df6784f40" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,760,657</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares available for future grant under the 2024 Plan.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_0798f9ed-0dea-4159-a9d9-2e2e7d56916d_1" continuedAt="F_0798f9ed-0dea-4159-a9d9-2e2e7d56916d_2"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 Employee Stock Purchase Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 15, 2024, Homology&#8217;s board of directors adopted and subsequently, Homology&#8217;s stockholders approved the Q32 Inc. 2024 Employee Stock Purchase Plan (the &#8220;2024 ESPP&#8221;). The 2024 ESPP allows employees to buy Company stock through after-tax payroll deductions at a discount from market value. The 2024 ESPP is intended to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Internal Revenue Code. The number of shares of common stock initially available for issuance under the 2024 ESPP was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecf481cf-91fa-4db1-bd04-63e6147be915" contextRef="C_5f18540e-b79b-4adf-83b8-c467b6d3c37d" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">120,836</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. The 2024 ESPP provides that the number of shares reserved and available for issuance under the plan will automatically increase each January 1, beginning on January 1, 2025, by the lesser of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3bbbf425-ed53-4c3a-995a-ce5204efdc4f" contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae" name="qttb:IncreaseInCommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">241,677</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, a number of shares equal </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a591292-485c-43b4-9a02-9f2830f236e3" contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae" name="qttb:IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding number of shares on the immediately preceding December 31, or such lesser amount as determined by the plan administrator.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the 2024 ESPP, employees may purchase common stock through after-tax payroll deductions at a price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da01492e-86c9-435f-91ff-2261b74dac6c" contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae" name="qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the lower of the fair market value on the first trading day of an offering period or the last trading day of an offering period. The 2024 ESPP generally provides for offering periods of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_866a0093-9ab9-424c-a671-73a05ac4fe27" contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae" name="qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in duration that end on the final trading day of each February and August. In accordance with the Internal Revenue Code, no employee will be permitted to accrue the right to purchase stock under the 2024 ESPP at a rate in excess of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6846ca5-b5fc-45f1-b3db-ea161e7110ed" contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae" name="qttb:ExcessOfAccruedRightToPurchaseStock" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">25,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> worth of shares during any calendar year during which such a purchase right is outstanding (based on the fair market value per share of the Company&#8217;s common stock as of the first day of the offering period).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfc6c651-cb7d-45c9-9004-745ec3040baa" contextRef="C_a37febd5-2c47-4a82-98a5-85fdad081713" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued under the 2024 ESPP during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock Options</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock options granted by the Company typically vest over a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f7328783-cab0-44e0-80af-d29638aa69d9" contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period and have a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a0158b43-f799-444a-bb23-d015a3855373" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> contractual term. </span><span><ix:nonNumeric id="F_007b3dfd-434c-45a9-a9e3-cec4824af081" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true" continuedAt="F_007b3dfd-434c-45a9-a9e3-cec4824af081_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company&#8217;s stock option activity during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_007b3dfd-434c-45a9-a9e3-cec4824af081_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.11%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.662%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:8.942%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.662%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.22%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:9.182%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Shares</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(In Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in<br/>thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebaf5576-404b-4920-97f0-15df6e6cca67" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,112,275</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5c44b40-fa2c-4cc9-89f1-525fbfd3e3c1" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">7.50</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_821bcc7d-5985-4a58-a89f-29c78ec841bf" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.87</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3285cbcc-1c59-4144-a9c7-c44a97eac4b6" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">10,712</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed in reverse recapitalization</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8cf5585-617c-4684-b4af-c5c0d95c3be8" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">32,685</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41591f3b-c32d-4258-8435-dd4e9f2f5932" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">7.56</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2db77cb6-0205-4003-8cf2-6d5853b20e57" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,071,073</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7978e71-596c-4dc1-95bf-15fba54e1fd3" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">17.27</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1041042f-3684-477d-bafd-bb73aa7e5638" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">255,486</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_319c74e8-334f-45e5-8027-37d38d61ea65" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">6.81</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a38f6935-7cf4-47d5-bf98-78c4261f20a0" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">17,627</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c020fad6-5a1b-46e5-b461-2be7006a087a" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">17.63</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3c175d1-c1c5-4655-a41e-55de288caf70" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,942,920</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ae83872-c6d4-4439-97bb-892ba22c0b3b" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.93</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_9e7125bb-3463-49de-8690-68057fca0d71" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.33</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e7d7c31-d13c-414d-b12f-77b243444250" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">12,380</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest at<br/>&#160;&#160;&#160;December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e215a29b-64bd-4402-8db2-de11196506f0" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,942,920</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01411c41-9f5a-4142-91ff-f9d26421ed36" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.93</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_ba879237-c23d-4991-9062-576e3c610857" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.33</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d85efab-9ec3-42fc-886e-7535e2a1c623" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">12,380</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fe3bcc5-37e1-4d90-adde-812ae2102f0f" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">673,356</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e398d0ec-f25f-4038-8a39-f71389ebb376" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">8.43</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_66dcb45b-ae5f-473e-bf97-cc74fd44adcf" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.04</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_530e673c-6dcb-47c6-a924-c8fc7318e456" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">12,380</ix:nonFraction></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The per share weighted-average grant date fair value per share of options granted in the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_492ea15b-4a5b-4760-b40d-b1889db0a42b" contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">12.42</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The total fair value of options vested during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1887e9f-6b23-4453-9ac2-ed03528a0e56" contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, total unrecognized compensation costs to the unvested stock options were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_377b9db6-9572-433d-989d-3be6c4f185a8" contextRef="C_4c2e3250-49a3-4f3c-9ba7-60f0718101be" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">12.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1dcbfa0b-85b6-4c01-b05b-5c3afc1d53cc" contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.7</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years. The total intrinsic value of options exercised during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95720daa-12fb-482d-8235-777bdc41da37" contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation Expense</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the purpose of calculating stock-based compensation, the Company estimates the fair value of stock options using the Black-Scholes option-pricing model. This model incorporates various assumptions, including the expected volatility, expected term, and interest rates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_0798f9ed-0dea-4159-a9d9-2e2e7d56916d_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_34eff0ec-d7fd-40ea-a85e-e347fb13c74d" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The underlying assumptions used to value stock options granted using the Black-Scholes option-pricing model during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023 were as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate range</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8d0bede8-b43a-4e1a-886a-126f8c87b49c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.48</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_278fbe86-c34e-4414-861d-10cc1591aab6" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.34</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b985629-d322-497b-88d6-91477f14b3d8" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">3.59</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08683f4b-452d-45e1-b2c5-7638df036595" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.67</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93311895-8267-461f-aad2-85b34b2cdce6" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b77abcc-3a43-483f-a83e-51712a7ddc8a" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (years) range</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ab6ce522-567d-41b6-8938-b3472d002941" contextRef="C_8e0c7ce3-b7e7-477e-b694-44fd0989eef1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.17 </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">- </span><span><ix:nonNumeric id="F_5c18bcc5-266e-4070-a6dd-3189b2b7b17d" contextRef="C_eac1650d-1927-493f-a242-2bc1e837c904" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.11</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e8dab34e-a0cd-4ca3-bd6d-1c28c6a79f77" contextRef="C_7794054f-4239-439e-b660-23e5bc99154a" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.08 </span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">- </span><span><ix:nonNumeric id="F_820d9556-3303-4c9b-bc58-d9a99de268a6" contextRef="C_5a0e9c05-aa5e-42de-ac3a-a0fb7d656d48" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.12</span></ix:nonNumeric></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility range</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee3166f8-fffc-4a69-a7a0-2e366e8e31ef" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">92.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc469a45-6c81-451d-860d-75346f7400ad" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">94.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16005647-77af-4ff6-8f36-0c9f08fa5bac" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">88.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3269e56b-efe5-48d5-8287-4314db703780" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">94.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk-Free Interest Rate &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#8217;s stock options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Dividend &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Term &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected term of stock options represents the weighted average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term, which calculates the expected term as the average time-to-vesting and the contractual life of the options for stock options issued to employees. The expected term for options granted to non-employees is based on the contractual life of the options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Volatility &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to the Company&#8217;s limited operating history and lack of sufficient company-specific historical or implied volatility, the expected volatility assumption was determined by examining the historical volatilities of a group of industry peers whose share prices are publicly available. The Company expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#8211; Prior to the Merger, as there had been no public market for the Company&#8217;s common stock, the estimated fair value of its common stock was determined by the Company using estimates and assumptions on the respective grant dates of the awards. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of preferred securities and the superior likelihood of achieving a liquidity event, such as an IPO or sale. Significant changes to the key assumptions used in the valuations could result in different fair values of common stock at each valuation date.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e3f993c9-c25a-4f1f-90f5-e7872574f0ac" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true" continuedAt="F_e3f993c9-c25a-4f1f-90f5-e7872574f0ac_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recorded stock-based compensation expense in the following expense categories of its statements of operations (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e365262-c330-43bc-a3f1-3167f4706820" contextRef="C_2f8c0c8d-9454-4f58-ba8a-5a0c25ee32f6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,105</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_857665d7-b774-4710-9340-c23ed337475b" contextRef="C_370a860c-228f-4147-bdf4-dcb48b39a303" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2eadd44-60e2-44a6-93a7-d248eec18478" contextRef="C_c8e96e70-b220-40a4-8caa-3388400e3cae" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,281</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8316105-b7aa-4759-bb85-8a6863b717ea" contextRef="C_e48e03f7-6e15-41e5-8e77-78e73c096383" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">928</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bea699c8-aa8d-4c86-be3d-0841325f617c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,386</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_da430c44-c9e4-46fb-a4c3-e7dd1d013972" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,428</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <div><ix:continuation id="F_e3f993c9-c25a-4f1f-90f5-e7872574f0ac_1"></ix:continuation></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</span><span><ix:nonNumeric id="F_a81f375c-4d80-4613-abc9-1421e7e12688" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" escape="true" continuedAt="F_a81f375c-4d80-4613-abc9-1421e7e12688_1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Agreements with Horizon </span></ix:nonNumeric></span><span style=""></span></p>
  <div><ix:continuation id="F_a81f375c-4d80-4613-abc9-1421e7e12688_1" continuedAt="F_a81f375c-4d80-4613-abc9-1421e7e12688_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From August 2022 until November 2023, Legacy Q32 was a party to the Collaboration and Option Agreement (the &#8220;Horizon Collaboration Agreement&#8221;) and the Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;), and together with the Horizon Collaboration Agreement, the &#8220;Horizon Agreements&#8221;), each between Legacy Q32 and Horizon Therapeutics Ireland DAC (&#8220;Horizon&#8221;), pursuant to which Legacy Q32 received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f527d023-2fd3-4c50-8d36-1da5c05f7918" contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3" name="us-gaap:BusinessCombinationContingentConsiderationAssetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">55.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in initial consideration and staged development funding for the completion of the two ongoing Phase 2 trials for bempikibart, and Horizon had an option to acquire the bempikibart program at a prespecified price, subject to certain adjustments.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he Company has received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2a65650-1119-4055-9b91-cbdd56409202" contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd" name="us-gaap:ProceedsFromCollaborators" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">55.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1154a851-bac3-4d7b-9929-a8ad4b42ade8" contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd" name="qttb:CollaborationAgreementTransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">55.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">transaction price from Horizon. In October 2023, Amgen Inc. (&#8220;Amgen&#8221;) completed its acquisition of Horizon Therapeutics public limited company (&#8220;Horizon plc&#8221;). Following the closing of Amgen&#8217;s acquisition of Horizon plc, the Company agreed with Amgen to mutually terminate the Horizon Agreements and in November 2023, the Company and Horizon entered into a termination agreement (the &#8220;Horizon Termination Agreement&#8221;), pursuant to which Horizon&#8217;s option to acquire the bempikibart program was terminated. As a result, the Company retained all</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_a81f375c-4d80-4613-abc9-1421e7e12688_2"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">initial </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consideration and development funding received under the Horizon Collaboration Agreement (as defined below) and regained full development and commercial rights to bempikibart. In consideration for the Horizon Termination Agreement, the Company agreed to pay Horizon regulatory and sales milestones payments of up to an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e0068e4-f696-48fc-903e-83535c2540c6" contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd" name="qttb:CollaborativeArrangementMilestonePayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">75.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon the first achievement of certain regulatory and sales milestones with respect to bempikibart.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that the consideration allocated to the research service performance obligations should be recognized over time as Horizon received the benefit of the research activities as the activities were performed. The Company has determined that this method was most appropriate as progress towards completion of research is largely driven by time and effort spent and costs incurred to perform this research. The Horizon Termination Agreement is accounted for as a modification because it does not result in the addition of distinct goods or services. Since the two performance obligations and the material right are terminated with no further performance obligations aside from the contingent payments to Horizon of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e30a1b5-6c26-4e79-bc1d-232b6813e5f9" contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd" name="qttb:CollaborationAgreementContingentPayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">75.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, the Company recognized the remaining deferred revenue in the fourth quarter of 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon the execution of the Horizon Termination Agreement, the Company became obligated to pay Horizon up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ef5f3b9-c392-44cd-bd5b-5215a4030e81" contextRef="C_cf98c657-870f-4570-8592-2aff0b91640f" name="qttb:CollaborationAgreementContingentPayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">75.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million contingent on regulatory and sales-based milestones or up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2435e7d6-83f8-42d9-b0ee-84a9645496ce" contextRef="C_cf98c657-870f-4570-8592-2aff0b91640f" name="qttb:CollaborationAgreementContingentPaymentPayableExcessOfCashReceived" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in excess of the cash received. These potential payments to Horizon are not in exchange for a distinct good or service; therefore, the Company accounts for consideration payable to Horizon as a reduction of the transaction price under ASC 606</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company concluded that the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07319157-ca77-452d-b22a-33329e16790b" contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd" name="qttb:CollaborationAgreementTransactionPrice" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">55.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of arrangement consideration previously recognized should be fully constrained as a result of the contingent consideration payable to Horizon, and accordingly, all amounts previously recognized as revenue were reversed in the fourth quarter of 2023 and a refund liability was established for the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_494ba3f4-a1aa-4e63-84d7-594724a188b9" contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd" name="qttb:AmountOfRefundLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">55.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million cash received during the term of the Horizon Collaboration Agreement. No amounts have been recognized related to the remaining potential payment to Horizon (up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df36472d-9659-4de6-b8f9-fd1fa6ce3bdd" contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd" name="qttb:PaymentToHorizon" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million) as it is not probable that the respective milestones will be achieved at this time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0a84fddd-122d-4d6a-94b0-9e4db9e2c677" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16. Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has consulting and advisory agreements with certain investors and board members which are considered to be related party transactions. The Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ed12bfe-27cb-4cdd-9b2b-72303cf1e323" contextRef="C_3e39319d-0b8a-4d79-9a97-72ff6fa10227" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_ead2a7d1-79c6-4187-88bc-96ca6f1edf0a" contextRef="C_cb1dbfd4-a164-4593-8d87-17d41a661f8b" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t incur expense for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 related to services provided by these investors and board members.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ca94ecc-a610-412e-b055-462d630ef104" contextRef="C_4c7a1808-d8e4-4443-87ff-8a728e83b4d2" name="us-gaap:OtherLiabilities" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f13927c9-75ff-4c6d-be77-ec1e4722efe4" contextRef="C_4d576cb9-10b9-46a1-bca3-697ecd9396be" name="us-gaap:OtherLiabilities" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amounts were due to related parties at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 or December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_88de532c-4cc0-4f97-a31f-f613ecf8e19b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:DefinedContributionPlanTextBlock" escape="true"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17. Defined Contribution Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has a defined contribution savings plan under Section 401(k) of the Internal Revenue Code (the 401(k) Plan). The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants the option to elect to defer a portion of their annual compensation on a pretax basis, as well as Roth post tax deferrals. As currently designed, the Company is not required to make and has not made any contributions to the 401(k) Plan.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_17ca162b-7bf7-4508-bff8-641e2e45e4d3" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_17ca162b-7bf7-4508-bff8-641e2e45e4d3_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18. Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded current and deferred income tax expense of less than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42229524-2bf4-4b0d-91f0-34f3572633ee" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13c49f19-1c6e-488c-898e-dc1d4a10ea95" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. The Company&#8217;s effective tax rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5ca806e-30c3-4957-a5f8-d03db4dc1a03" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:CompanysEffectiveTaxRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% differs from the U.S. statutory tax rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82126609-f31f-49b8-ac8f-b007be50176d" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:USStatutoryTaxRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">21</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% primarily as a result of the valuation allowance maintained against the Company&#8217;s net deferred tax assets.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9606dde7-f2e5-4cb3-8c96-1900b30fe1f1" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For financial reporting purposes, loss from operations before income taxes includes the following components (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pretax loss:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae5507bc-9232-49fe-90c8-3b7f31275ab6" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,716</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b3fe2a8-7aab-4897-8335-9ffe74b15ca8" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,430</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_997fd2c3-9bba-4c72-9602-1c3b62c041b9" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5a4eabf-68d5-468a-9f5b-cb6e43c435c6" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss before provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85eab5b6-fc61-41aa-a12e-ac24ac5af76d" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:IncomeLossBeforeProvisionForIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">47,712</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c7b102e-2b6b-4a79-9402-58bd243a39fd" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:IncomeLossBeforeProvisionForIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,425</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div><ix:nonNumeric id="F_829defac-09c1-4150-9ca5-cee2a07cb0c8" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" escape="true" continuedAt="F_829defac-09c1-4150-9ca5-cee2a07cb0c8_1"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of the Company's provision for income taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:continuation id="F_17ca162b-7bf7-4508-bff8-641e2e45e4d3_1" continuedAt="F_17ca162b-7bf7-4508-bff8-641e2e45e4d3_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_829defac-09c1-4150-9ca5-cee2a07cb0c8_1" continuedAt="F_829defac-09c1-4150-9ca5-cee2a07cb0c8_2">
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46651644-eae2-42e9-832b-49b7b5e063e7" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c700081a-face-4a53-8476-c8bdb2255683" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">316</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d771ca4c-b93c-4b72-a113-ce263bc5ebd1" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b1931a96-e70d-4c03-9283-dd80b9dbe343" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2554198f-5020-4c97-9002-a383ecd4f5d8" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:CurrentForeignTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_899131dd-003b-4255-aba1-ba0f177af2a4" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:CurrentForeignTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ecde6e7-5b11-46d7-b829-559707f2abd9" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:TotalCurrentExpenseBenifit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d6ff448-c628-4a56-b527-5d7908b1bd6c" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:TotalCurrentExpenseBenifit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">318</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax provision</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7989e1b4-3835-4d57-a5d2-9d128f88c114" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c4dba37-7260-4197-b31d-261567a2a1cd" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">318</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e9f48f18-3500-4925-af3a-68a320857018" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><ix:continuation id="F_829defac-09c1-4150-9ca5-cee2a07cb0c8_2"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of income tax expense (benefit) computed at the statutory federal income tax rate to income ta</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">xes as reflected in the financial statements is as follows:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.2%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.74%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.08%;box-sizing:content-box;"/>
        <td style="width:1.08%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.74%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:2.08%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="9" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal income tax expense at statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7a8a2986-d31a-484f-a4a4-02ac73046a3c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">21.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9689429a-336a-4e12-b7f6-2d4b633d82e6" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">21.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c05ef2a6-be23-4b56-8ecd-ba75d3000071" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">9.1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80831916-03ad-45e1-95c8-63d194669c1b" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.9</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent differences</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a81e9569-708c-4cc1-bfd1-8df4b25c662e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_449cd77d-9467-4902-b8e8-eb15d1a9fb7b" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a5b337a-f61f-4da2-a8f4-426206f00fe5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">1.3</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bbe424a-00c0-4608-9143-5c6358fcc686" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain/loss on convertible note conversion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_303c663b-52eb-4c26-a2a2-55a693749742" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">7.1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2c042d2-0097-4fb5-826d-158cfc989006" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible note revaluation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3259cff-9eaa-449a-9498-9dbad64f977a" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23824749-e967-4572-85db-9944bc054216" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">1.8</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca7611c9-4e69-4c4e-8f5a-c77058a99b0f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">3.8</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06e62142-ae0e-43c5-baf9-8ad59e8efe6d" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">3.1</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7471823-9376-4c1e-8ded-42d5f10b22eb" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">42.2</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb188285-b52f-455c-b470-f9d59c76580d" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">27.6</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effective income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64225f24-78f4-46f4-9cce-9468656efa37" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ffb7aec-79d5-45c6-b115-aa37b2b8634c" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. </span><span><ix:nonNumeric id="F_a4285912-a701-46c9-b2fd-60311b207fa2" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_a4285912-a701-46c9-b2fd-60311b207fa2_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The significant components of the Company&#8217;s deferred tax assets and liabilities consisted of the following (in thousands): </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_a4285912-a701-46c9-b2fd-60311b207fa2_1"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1158a2f8-7719-4941-8dae-e22b2a489d28" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,468</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d496173c-5d4f-4042-97dd-bd2872b3efe3" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,412</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9a34a16-c52d-4fe5-a4ea-e17918934af3" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,086</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78a4b161-4200-420c-9d34-80f2c9fecf91" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,500</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25bb827c-2c06-4565-8ee5-61af8729c69c" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsFrequentFlierLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,801</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c13b145-20e4-4570-a5ca-dd0126e19835" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsFrequentFlierLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,876</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ea1cc38-b1a4-4f15-b6f6-edd2c47076f3" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">743</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bf10b53-1c5d-4fa6-a5a6-ef4e03624e12" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">818</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized intangible assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5665f49b-d86b-46a9-a5ae-75fa6b15938f" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:CapitalizedIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,591</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e758c2b1-7821-4ae2-9c13-cc17f27d5f36" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="qttb:CapitalizedIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,828</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credit carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7e5b4e9-6aba-4730-a3ae-f5cfafbc1408" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,978</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4790d26-f70b-4335-b926-cdbf236f98bf" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,762</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized R&amp;D expenditures</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_facb05e3-eae6-402e-8e0d-2d889ac8d984" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,552</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1d4d203-e350-4dc6-bb8d-71da89416378" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,546</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc249c88-0b59-409e-9b20-9f52f240c360" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="qttb:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,682</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d928fdd-6b82-433e-bce7-c491095efaf0" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="qttb:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,835</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock compensation and other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9be88fbf-7235-46d1-bb1a-3d557bee377a" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">733</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e653aa19-294b-4763-9567-1a09320b9669" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">544</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total gross deferred tax assets before valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55ee4a9e-dbe0-48bb-b977-ba768e68f4a6" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">108,634</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5a7d2a1-d261-4daa-bb15-1a5b23487ca7" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">57,121</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3139867-faec-4e54-b3a0-b9b66495282a" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,876</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0893307c-95f1-4a5f-9c70-993a4f522183" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,078</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab56b68e-e122-41dd-9aaa-86561513c7f8" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,758</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e25095db-d4f6-4ea3-a5b0-acebda37c50a" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,043</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fbf5d15b-4164-4728-8829-d29fd94b3dea" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:DeferredTaxLiabilitiesFixedAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">218</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc002337-f1a3-440d-9838-2686d56e5ec5" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:DeferredTaxLiabilitiesFixedAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">339</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right of use asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_597ede79-ab34-4148-b1a4-93088fdb7772" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,540</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4cf35645-b945-4e03-a390-de664aa99ef7" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,704</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d3fb3fe-1551-4da1-a5be-4a8790ccd729" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c219217-7933-4d6b-9d45-476eaf9c3810" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had gross deferred tax assets before valuation allowances of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8462f5e-b85a-425f-9157-ab703176d5d9" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">108.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_982a83dc-a67e-47a2-9efe-e35d5a4a36ca" contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">57.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, principally attributable to net operating losses, the contingent liability and capitalized R&amp;D expenditures. The Company has provided a valuation allowance for the full amount of the deferred tax assets as, based on all available evidence, it is considered more likely than not that all the recorded deferred tax assets will not be realized in a future period. The Company recorded an increase to the valuation allowance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2e0cfc4-8254-4e33-a6ad-899dcad4bcb9" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">51.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 as a result of the 2024 book losses and the Merger with Homology.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe9ef927-431d-4c98-990d-11fb804d4821" contextRef="C_15a4f89a-2a77-4b59-9f76-99dff39d02e8" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">121.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of federal net operating loss carryforwards which can be carried forward indefinitely, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5b97396-23e0-43d4-9a0b-301aa2b3e7dd" contextRef="C_aab7e459-1871-48ff-b109-9c732f133214" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">112.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of state net operating loss carryforwards that expire at various dates beginning in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dfb25997-c620-47ff-bb0c-11117644a596" contextRef="C_a865d4dd-0f4a-4429-92aa-0aae67bd396c" name="qttb:NetOperatingLossCarryForwardsExpirationYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2040</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_17ca162b-7bf7-4508-bff8-641e2e45e4d3_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to the limitations described below, as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal and state research and development tax credit carryforwards of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0930e738-5253-4f97-ae32-7eb6d99ed664" contextRef="C_5d6ee64c-bb12-4d4b-a81c-6f731ee26fbf" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83fda379-cedb-410e-bdea-6990928d5d3f" contextRef="C_b39ec590-34ba-4ee9-954b-860129dbb68c" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively available to reduce future tax liabilities which start to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1d8b9c01-adb5-41b4-87ca-3100b37d5be6" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:TaxCreditCarryforwardsExpirationYear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2038</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has generated federal and state research and development credits but has not conducted a study to document the qualified activity. This study may result in an adjustment to the Company&#8217;s research and development credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts are being presented as uncertain tax position. A full valuation allowance has been provided against the Company&#8217;s research and development credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the deferred tax asset established for the research and development credit carryforwards and the valuation allowance.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Realization of the future tax benefits is dependent on many factors, including the Company&#8217;s ability to generate taxable income within the net operating loss carryforward period. Under the provisions of the Internal Revenue Code, the net operating loss and tax credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service (IRS) and state tax authorities. Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a three-year period in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_46d5f40e-68d6-499b-9ac4-bc4dd83714f6" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:CumulativeChangesOwnershipInterest" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, as defined under Sections 382 and 383 of the Internal Revenue Code, respectively, as well as similar state provisions. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382 of the Internal Revenue Code, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section 382 of the Internal Revenue Code, which is determined by first multiplying the value of the Company&#8217;s stock at the time of the ownership change by the applicable long-term-tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitations may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. Further, until a study is completed by the Company and any limitation is known, no amounts are being presented as an uncertain tax position</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company files income tax returns in the United States, Australia and Massachusetts. The statute of limitations for assessment by the IRS and state tax authorities is closed prior to 2021, although carryforward attributes that were generated prior to tax year 2021 may still be adjusted upon examination by the IRS or state tax authorities if they either have been or will be used in a future period. The Company is currently not under examination by the IRS or any other jurisdictions for any tax years. The statute of limitations for assessment by the Australian Taxation Office is four years from the date of return filing. The Company is not currently under examination by the Australian Taxation Office for any tax years.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s current intention is to permanently reinvest the total amount of its unremitted earnings in the local international jurisdiction. As such, the Company has not provided for taxes on the unremitted earnings of its international subsidiary. As of December 31, 2024, the Company&#8217;s foreign subsidiary does not have any unremitted foreign earnings.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company establishes reserves for uncertain tax positions based on management&#8217;s assessment of exposures associated with tax positions taken on tax return filings. The tax reserves are analyzed periodically, and adjustments are made as events occur to warrant adjustments to the reserve.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f30352f-0110-4aad-ae09-7c64fec4a4be" contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> gross unrecognized tax benefits. The Company does not expect the unrecognized tax benefits to change significantly over the next 12 months. The Company recognizes both interest and penalties associated with uncertain tax positions as a component of income tax expense. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57d2ac25-2c7d-47ec-b761-2dcc6cabdcbc" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued penalties and provisions for interest</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div>
  <div><ix:nonNumeric id="F_addae78d-a3fb-45b6-a784-131d83ad2ed4" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EarningsPerShareTextBlock" escape="true" continuedAt="F_addae78d-a3fb-45b6-a784-131d83ad2ed4_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19. Net Income (Loss) per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the applicable period. In computing diluted net income (loss) per share, only potential shares of common stock that are dilutive are included. The Company considered each issue or series of issues of potential shares of common stock separately when determining whether potential shares of common stock are dilutive or antidilutive. The Company made such determination in sequence from the most dilutive to the least dilutive and concluded that its Convertible Notes are dilutive to net income per share for the year ended December 31, 2024. Pursuant to FASB ASC Topic 260, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Earnings Per Share</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company applied the if-converted method to determine the effect of its Convertible Notes on the diluted earnings per share calculations. </span><span><ix:nonNumeric id="F_c5a775c8-bc9e-4717-b20b-8b148cc4bc5b" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true" continuedAt="F_c5a775c8-bc9e-4717-b20b-8b148cc4bc5b_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to such method, the Company adjusted the numerator for the gains or losses recognized during the period </span></ix:nonNumeric></span><span style=""></span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_addae78d-a3fb-45b6-a784-131d83ad2ed4_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_c5a775c8-bc9e-4717-b20b-8b148cc4bc5b_1"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">net income from the Convertible Notes and the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the Convertible Notes were converted as of the beginning the period.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands, except per share amounts)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss)-basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ce2901f-c76f-47f1-892d-a28fb16fbdbb" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">47,733</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_443c6b47-6743-47e1-a07e-b481e0bdbea0" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">53,743</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss)-diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c58bbe5-3b03-4ef3-b0c3-86bd34e43ba8" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">63,533</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f104c82-664c-485e-876c-56bacaaf6a9b" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" unitRef="U_USD" decimals="0" sign="-" format="ixt:num-dot-decimal">53,743</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Denominator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding-basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b4be1ae-3b61-4f22-80a5-97d0e709e1e8" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,320,884</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a23c3e4c-8f68-4d67-9609-05629fd03fc8" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">349,060</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bec73222-ae24-4a9a-af9d-deea455c4423" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">336,812</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_e5dd5eea-55d7-4cae-a2e1-4551e45e0690;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding-diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2aa8bcce-5c45-4a5f-a6fe-7a7055a532c2" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,657,696</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10dfde50-a3b3-44e8-8fd0-a02d0fc4d7b9" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">349,060</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss) per share-basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2957811-2b30-4ee0-bc00-66f3066b0e09" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">5.12</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_236fd843-5425-452c-92bd-a0379c796805" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">153.96</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss) per share-diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d46dc75-b302-4397-b19b-5b2d9f54ef6c" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">6.58</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2acdbaf-e50c-4ad5-9b59-d6467fee1b94" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:num-dot-decimal">153.96</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company&#8217;s potentially dilutive securities, which include stock options and warrants, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. As of December 31, 2023, the Company&#8217;s potentially dilutive securities, which include convertible preferred stock, convertible notes, stock options and warrants, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a62ba70d-1ca9-4016-b7f6-bf9daba4dac5" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.16%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:13.357%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A convertible preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01b66bcf-eb6b-423e-9df2-19e00661016a" contextRef="C_5dad7a66-e70c-49a5-aa41-6710e38a1a05" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa0b2de7-e742-4ff4-83a8-0b1f81884c5b" contextRef="C_2747d7eb-c32e-4ac2-b584-639f88844157" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,286,874</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A-1 convertible preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d0daa4b-705f-4330-87b6-b70e1092f004" contextRef="C_1a893f00-2a32-48ba-a06a-042beb70f237" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d82614df-04f7-4c0f-af02-1903e369e87e" contextRef="C_cec18033-5a14-4ccd-b752-d0126402b130" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">312,094</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B convertible preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5869d25-ab73-424c-a2fe-f014fdf64d6a" contextRef="C_b8978390-12c0-4352-9c18-d59c00c5a494" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a986332-835b-4182-9cf7-dd5f6b98ce52" contextRef="C_f497268d-14c0-4133-8bfb-04326a1ba996" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">2,625,897</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_92322ead-45d6-4cf4-8802-225126182b35" contextRef="C_b2dac488-8c36-4522-ba90-ecd7c08b1ede" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,942,920</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab922ef7-4df0-4a32-9fc7-aeffeaf816af" contextRef="C_f0a36e6a-206a-49c7-88ab-7db254725cf3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,120,014</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a93a4e90-35bf-40eb-ad03-603bfc83e69c" contextRef="C_09e3fcc5-c0b6-4005-8960-a3541b369346" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,145</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_684b32a8-fe2e-4bbd-a3a9-b89b3115b513" contextRef="C_c38a2141-3bcb-42d1-8a58-cef5d94d0819" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">18,145</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, during the year ended December 31, 2022, Legacy Q32 issued the Convertible Notes with a principal balance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38a2a222-5a9d-417e-91a7-9ae5f25f3d83" contextRef="C_e26a9287-f885-4441-9d0e-9148098a8888" name="us-gaap:ConvertibleNotesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">30.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. As described in Note 11, the Convertible Notes contained conversion features whereby the Convertible Notes and any accrued interest may have converted into either a variable number of shares of common stock or into shares of Series B preferred stock based on a fixed exchange ratio. Any shares of Series B preferred stock issued to settle the Convertible Notes would then be convertible into shares of common stock. The Convertible Notes were excluded from the computation of diluted net loss per share attributable to common stockholders for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023, because including them would have had an anti-dilutive effect</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Per the Merger further discussed in Note 1, the Convertible Notes converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4a54939-305e-4c16-9d44-d9536ef943ec" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,433,410</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at the effective date of the Merger.</span></p></ix:continuation></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span><span><ix:nonNumeric id="F_debc60b8-06d1-4be1-bc0b-e5c2505da9e1" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true" continuedAt="F_debc60b8-06d1-4be1-bc0b-e5c2505da9e1_1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Segment Reporting </span></ix:nonNumeric></span><span style=""></span></p>
  <div><ix:continuation id="F_debc60b8-06d1-4be1-bc0b-e5c2505da9e1_1" continuedAt="F_debc60b8-06d1-4be1-bc0b-e5c2505da9e1_2"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company operates as one operating segment, focused on research, development, and discovering, developing and delivering therapies for its novel biologics. The Company&#8217;s CEO, as the chief operating decision maker ("CODM"), manages and allocates resources to the operations of the Company on a consolidated basis. Managing and allocating resources on a total-company basis enables the CODM to assess the overall level of resources available and how to best deploy those resources across research and development projects that are in line with our long-term company-wide strategic goals. Consistent with this decision-making process, the Company&#8217;s CODM uses consolidated, single-segment financial information for purposes of evaluating performance, forecasting future period financial results, allocating resources and setting incentive targets. When evaluating the Company&#8217;s overall performance, the CODM is focused on the timing and progress of its preclinical and clinical development activities. The CODM regularly reviews total expenses, as well as direct research and development expenses by program and makes decisions using this information on a company-wide basis.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accounting policies of the reportable segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance and decides how to allocate resources based on consolidated net loss. This measure is</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_debc60b8-06d1-4be1-bc0b-e5c2505da9e1_2"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">used to monitor budget versus actual results to assess performance of the segment. The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6cd290f6-2609-4470-9d6a-3b37f442b7ee" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents reportable segment net loss, including significant expenses regularly provided to the CODM, attributable to the Company&#8217;s reportable segment for the years ended December 31, 2024 and 2023:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:1.62%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
        <td style="width:12.883000000000001%;box-sizing:content-box;"/>
        <td style="width:1%;box-sizing:content-box;"/>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Direct research and development expense by program:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Bempikibart</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5230178e-b216-4973-b7fc-f234fdbcf30c" contextRef="C_4b875fb6-8c1f-48c4-8ed9-bb8c9bf74e9a" name="us-gaap:OtherResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,726</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_915803ef-db58-4c61-a8f9-893be63041a8" contextRef="C_8aa53aac-d504-4db3-8d89-b2114c402b69" name="us-gaap:OtherResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,722</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADX-097</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_165facfd-ae78-4c9b-9b74-8b96b5263473" contextRef="C_2018c79e-e353-411e-9686-5d75f0b411cc" name="us-gaap:OtherResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,253</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_deeacbdb-6b66-4a54-8007-d608e9f8f0a9" contextRef="C_24eebe14-f497-4909-b6f9-5294ab34c796" name="us-gaap:OtherResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,185</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Discovery and other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_876795ae-161f-4b83-8293-b5f20b474de7" contextRef="C_2ac02e70-62cb-4d11-bf94-77b56c0a5fb8" name="us-gaap:OtherResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">856</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2328acf2-ac43-43b1-82c7-ce6030b5fe0f" contextRef="C_6a7ed391-5281-4830-b9f9-03de3a4d8b00" name="us-gaap:OtherResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">894</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related costs (excluding stock-based compensation)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe783eb4-218b-48f9-9fd4-c4ae9683816f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:PersonnelRelatedCostsExcludingStockBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,122</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4203ea00-4fb9-4d8b-bb22-589da1669b6c" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:PersonnelRelatedCostsExcludingStockBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,166</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other G&amp;A expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_054cdadb-0696-410d-8b11-bdb5d90cb6b4" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:OtherGAExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,586</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d4488a3-05a9-4e8a-8295-f1247eedaa08" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:OtherGAExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,824</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest (income) expense, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cc59c3c-7fbc-462e-9883-8826b1f381e1" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:InterestIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,832</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a01b3d3-d80a-4735-bed5-9b2d3a7d8126" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:InterestIncomeExpenseNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">693</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment items (1)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11ae9ab9-bffd-4d14-b07e-d75b947ac16f" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SegmentReportingOtherItemAmount" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">9,978</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc6b58cf-984e-43a1-9d3e-ec625096065d" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="us-gaap:SegmentReportingOtherItemAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,645</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total segment net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_510977ce-b83a-48e5-8fa3-972c2434bdce" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="qttb:TotalSegmentNetLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,733</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e2a3c0db-afcf-491d-bd28-6a8a4b6e0cae" contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e" name="qttb:TotalSegmentNetLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">53,743</ix:nonFraction></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><ix:footnote id="FNT_b499c890-2785-42b0-a234-7b2081cf5a95" xml:lang="en-US"><p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) Other segment items are included in order to reconcile to total segment net loss. Other segment items include non-cash items such as depreciation and amortization expense and stock-based compensation expense, gains and losses on the change in fair value of convertible notes, change in fair value of contingent value rights and loss from equity method investment. In 2023, other segment items also includes the reversal of collaboration arrangement revenue related to the termination of the Horizon Agreement (see Note 15).</span></p></ix:footnote></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div><ix:nonNumeric id="F_99d49db2-f610-4d12-a291-d0559f20906e" contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4" name="us-gaap:SubsequentEventsTextBlock" escape="true" continuedAt="F_99d49db2-f610-4d12-a291-d0559f20906e_1"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21. Subsequent Events</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Restructuring</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 10, 2025, the Company notified its employees of a strategic restructuring plan adopted by the Company&#8217;s board of directors to focus its resources on the advancement of bempikibart in patients with AA (the &#8220;Restructuring Plan&#8221;). In connection with the Restructuring Plan, the Company is discontinuing its Phase 2 renal basket clinical trial of ADX-097 and is evaluating strategic options for its tissue-targeted complement inhibitor platform, inclusive of ADX-097 and early-stage assets, in combination with other cost-saving measures. The Restructuring Plan includes a reduction in force, which the Company expects to substantially complete by the end of the second quarter of 2025. As part of this Restructuring Plan, the Company expects to incur severance and severance-related charges of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91f6e502-9c66-4856-92aa-39fffa3c1e18" contextRef="C_2f4b5de3-a9e7-4c16-bcfe-43adba24582e" name="us-gaap:SeveranceCosts1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company may also incur other charges or cash expenditures not currently contemplated or that cannot be currently estimated due to events that may occur as a result of, or be associated with, the Restructuring Plan.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Option Repricing</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 23, 2025, the Company's board of directors approved a stock option repricing (the &#8220;Option Repricing&#8221;), which was effective on February 24, 2025 (the &#8220;Repricing Date&#8221;). The Option Repricing applied to outstanding options to purchase shares of common stock of the Company granted under the Company&#8217;s 2017 Plan and 2024 Plan (collectively, &#8220;the Plans&#8221;), which, as of the Repricing Date, were held by current employees and non-employee directors of the Company and had an exercise price in excess of the current trading price of the common stock (so-called &#8220;underwater options&#8221;) with grant dates prior to February 23, 2025 (the &#8220;Eligible Options&#8221;). As of the Repricing Date, the Eligible Options were repriced such that the exercise price per share for such Eligible Options was reduced to the closing price of the common stock on the Nasdaq Global Market on the Repricing Date (the &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Repriced Exercise Price&#8221;). The total number of shares of common stock underlying all Eligible Options was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ea07825-142a-4452-9511-9565630842e2" contextRef="C_edd2dd2b-4bf5-49ec-8e4a-ca61edc70f98" name="qttb:NumberOfCommonStockUnderlyingShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,904,998</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Eligible Options will revert to the original exercise price (the &#8220;Original Price&#8221;) if (i) such Eligible Options are exercised prior to the one-year anniversary of the Repricing Date (the &#8220;Retention Date&#8221;), (ii) an Eligible Option holder's employment is terminated by the Company for Cause (as defined in the 2024 Plan) prior to the Retention Date, or (iii) an Eligible Option holder resigns for any reason prior to the Retention Date. If an Eligible Option holder is terminated by the Company other than for Cause prior to the Retention Date (a &#8220;Terminated Employee&#8221;), any Eligible Options vested as of the date of such termination shall be exercisable at the Repriced Exercise Price (the &#8220;Terminated Employee Vested Options&#8221;), even prior to the Retention Date; provided that any unvested Eligible Options as of the date of such termination shall revert to the Original Price as of the date of termination. The deadline to exercise any Terminated Employee Vested Options, and any other Eligible Options held by a Terminated Employee that may become vested, shall be extended (but not truncated) to the later of (a) the one-year anniversary of the Terminated Employee&#8217;s termination date and (b) to align with the Eligible Option holder&#8217;s severance period (whether now or later implemented); provided that no extension shall exceed the Terminated Employee Vested Option&#8217;s expiration date, if earlier. In the event of a change-in-control prior to the Retention Date, each Eligible Option shall retain the Repriced Exercise Price to the extent it has not otherwise reverted to the Original Price. For the avoidance of doubt, the Eligible Options as modified by the Option Repricing are subject to the severance or change-in-control provisions in the current or future employment agreements, programs, policies or plans the Company has entered into or implemented or will enter into or implement with its directors, executive officers and other employees. There were no changes to the number of shares, the vesting schedule, or the expiration date of the Repriced Options except as outlined above.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Plans, the Company's board of directors, as the administrator of the Plans, has discretionary authority, exercisable on such terms and conditions that it deems appropriate under the circumstances, to reduce the exercise price in effect for or effect repricing through cancellation and re-grants of outstanding options under the Plans. In approving the Option Repricing, the board of directors considered the impact of the Original Price of outstanding stock options on the incentives provided to employees and directors, the lack of retention value provided by the outstanding stock options to employees and directors, and the impact of such options on the capital structure of the Company.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expects that the Option Repricing will result in additional share-based compensation expense that will be recognized in the Company&#8217;s statements of operations in future periods; however, the amount of additional share-based compensation expense and the periods over which it will be recognized have not yet been determined.</span></p></ix:nonNumeric></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_99d49db2-f610-4d12-a291-d0559f20906e_1"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Call Option by OXB (US) LLC</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Notes 1 and 3, at the effective time of the merger with Homology, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#8217;s common stock received a CVR issued by Homology representing the contractual right to receive cash payments, if any, from the combined company upon the receipt of certain proceeds, net of permitted deductions for expenses incurred in connection with pre-merger Homology assets, from a disposition of Homology&#8217;s pre-merger assets, including any equity interests held directly or indirectly by the Company in OXB (US) LLC. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9565c5d8-bbd8-418c-a8fa-cdc4a6ce8dec" contextRef="C_edd2dd2b-4bf5-49ec-8e4a-ca61edc70f98" name="qttb:ExerciseOfCallOptionDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 1, 2025, Oxford Biomedica (US), Inc. exercised its option to cause the Company to sell and transfer to Oxford Biomedica (US), Inc. all of the Company&#8217;s equity ownership interest in OXB (US) LLC. The sale price is based on a formula using the Company's pro rata share of OXB (US) LLC (10%), times a predetermined multiple of revenue for the immediately preceding 12-month period increased by OXB (US) LLC's cash balance and decreased by OXB (US) LLC's debt balance as of the exercise date.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Company and Oxford Biomedica (US), Inc. expect to finalize the transaction and pay the CVR holders by the end of the second quarter of 2025.</span></p></ix:continuation></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">F-</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>2
<FILENAME>qttb-ex19_1.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html>
 <head>
  <title>EX-19.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 19.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 BIO INC.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading POLICY</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) has adopted the following policy and procedures for securities trading by Company directors and employees (our &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insider Trading Policy</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). Our Insider Trading Policy is intended to prevent the misuse of material nonpublic information, insider trading in securities, and the severe consequences associated with violations of insider trading laws.  It is your obligation to review, understand, and comply with this Insider Trading Policy and applicable laws.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Our Board of Directors has approved this Insider Trading Policy, and we have appointed Lee Kalowski, our Chief Financial Officer, as the Compliance Officer (with his designees, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compliance Officer</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) to administer the policy and to be available to answer your questions.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:18pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART I.  OVERVIEW</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Who Must Comply?</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Insider Trading Policy applies to all of our employees and members of our Board of Directors, including anyone employed by or acting as a director of any of the Company&#x2019;s subsidiaries, as well as any other individuals whom the Compliance Officer may designate as Insiders (defined below) because they have access to material nonpublic information about the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, all of our directors, executive officers (as defined by Section 16 of the Securities Exchange Act of 1934, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;)) and other designated employees must comply with the Trading Procedures included in Part II of this Insider Trading Policy (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Procedures</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;); we will refer to these individuals in this policy as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insiders</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d; The Trading Procedures provide rules for when Insiders can trade in our securities and explain the process for mandatory pre-clearance of proposed trades. You will be notified if you are considered to be an Insider who is required to comply with the Trading Procedures.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Insider Trading Policy and, for Insiders, the Trading Procedures also apply to the following persons (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Affiliated Persons</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;):</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">your &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Family Members</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Family Members</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; are (a) your spouse or domestic partner, children, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws who reside in the same household as you, (b) your children or your spouse&#x2019;s children who do not reside in the same household as you but are financially dependent on you, (c) any of your other family members who do not reside in your household but whose transactions are directed by you, and (d) any other individual over whose account you have control and to whose financial support you </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">materially contribute</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (materially contributing to financial support would include, for example, paying an individual&#x2019;s rent but not just a phone bill);</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all trusts, family partnerships and other types of entities formed for your benefit or for the benefit of a member of your family and over which you have the ability to influence or direct investment decisions concerning securities; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all persons who execute trades on your behalf; and</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all investment funds, trusts, retirement plans, partnerships, corporations and other types of entities over which you have the ability to influence or direct investment decisions concerning securities; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that the Trading Procedures do not apply to any such entity that engages in the investment of securities in the ordinary course of its business (e.g., an investment fund, venture fund or partnership) if the entity has established its own insider trading controls and procedures in compliance with applicable securities laws and it (or an affiliated entity) has represented to the Company that it (and/or such affiliated entity):  (a) engages in the investment of securities in the ordinary course of its respective business; (b) has established insider trading controls and procedures in compliance with securities laws; and (c) is aware the securities laws prohibit any person or entity who has material nonpublic information concerning the Company from purchasing or selling securities of the Company or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell securities.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You are responsible for ensuring compliance with this Insider Trading Policy, including the Trading Procedures contained herein, by all of your Affiliated Persons.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">What is Prohibited by this Insider Trading Policy?</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You and your Affiliated Persons are prohibited from engaging in insider trading and from trading in securities in violation of this Insider Trading Policy. &#x201c;Insider trading&#x201d; is (1) trading (buying or selling) the securities of a company whether for your account or for the account of another, while in the possession of material nonpublic information (see definition below) about that company or (2) disclosing material nonpublic information about a company to others who may trade on the basis of that information. Insider trading can result in criminal prosecution, jail time, significant fines and public embarrassment for you and the Company.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prohibition on Trading in Company Securities</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">When you are in possession of material nonpublic information about the Company, whether positive or negative, you are prohibited from trading (whether for your account of for the account of another) in the Company&#x2019;s securities, which include common stock, options to purchase common stock, any other type of securities that the Company may issue (such as preferred stock, convertible debentures, warrants and exchange-traded options), and any derivative securities that provide the economic equivalent of ownership of any of the Company&#x2019;s securities or an opportunity, direct or indirect, to profit from any change in the value of the Company&#x2019;s securities, except for trades made pursuant to plans approved by the Compliance Officer in accordance with this policy that are intended to comply with Rule 10b5-1 under the Exchange Act.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading prohibitions in this Insider Trading Policy do </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> apply to: (1) an exercise of an employee stock option when payment of the exercise price is made in cash or (2) the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock units to satisfy applicable tax withholding requirements if (a) such withholding is required by the applicable plan or award agreement or (b) the election to exercise such tax withholding right was made by the Insider in compliance with the Trading Procedures.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading prohibitions in this Insider Trading Policy </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">do</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> apply, however, to the use of outstanding Company securities to pay part or all of the exercise price of a stock option, any sale of stock as part of a broker-assisted cashless exercise of an option, and any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prohibition on Tipping</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Providing material nonpublic information about the Company to another person who may trade or advise others to trade on the basis of that information is known as &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tipping</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and is illegal.  You are prohibited from providing material nonpublic information about the Company to a friend, relative, or anyone else who might buy or sell a security or other financial instrument on the basis of that information, whether or not you intend to or actually do realize a profit (or any other benefit) from such tipping.  Additionally, you are prohibited from recommending to any person that such person engage in or refrain from engaging in any transaction involving the Company&#x2019;s securities, or otherwise give trading advice concerning the Company&#x2019;s securities, if you are in possession of material nonpublic information about the Company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prohibition on Trading in Securities of Other Companies</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This policy&#x2019;s prohibitions against insider trading and tipping also apply to trading in securities of other companies, including the Company&#x2019;s customers, suppliers, partners and other enterprises with which we are working (such as when negotiating an acquisition, investment or other transaction that could be material to the other company).  Whenever, during the course of your service to or employment by the Company, you become aware of material nonpublic information about another company, including any confidential information that is reasonably likely to affect the market price of that company&#x2019;s securities (for example, discussions of licensing a product or acquiring that other company), neither you nor your Affiliated Persons may trade in any securities of that company, give trading advice about that company, tip or disclose that information, pass it on to others, or engage in any other action to take advantage of that information.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If your work regularly involves handling or discussing confidential information of one of our partners, suppliers or customers, you should consult with the Compliance Officer before trading in any of that company&#x2019;s securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Prohibited Transactions</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Short Sales</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may not at any time sell any securities of the Company that are not owned by you at the time of the sale (a &#x201c;short sale&#x201d;).  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Purchases or Sales of Derivative Securities or Hedging Transactions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">.  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not buy or sell puts, calls, other derivative securities of the Company or any derivative securities that provide the economic equivalent of ownership of any of the Company&#x2019;s securities or an opportunity, direct or indirect, to profit from any change in the value of our securities or engage in any other hedging transaction with respect to our securities.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Company Securities Subject to Margin Calls</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not use the Company&#x2019;s securities as collateral in a margin account.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Pledges</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may not pledge Company securities as collateral for a loan (or modify an existing pledge).</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Duration of Trading Prohibitions</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">These trading prohibitions continue whenever and for as long as you know or are in possession of material nonpublic information.  Remember, anyone scrutinizing your transactions will be doing so after the fact, with the benefit of hindsight.  As a practical matter, before engaging in any transaction, you should carefully consider even the appearance of improper insider trading and how enforcement authorities and others might view the transaction in hindsight.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Insider Trading Policy applies to you and your Affiliated Persons so long as you are associated with the Company. If you leave the Company for any reason, this Insider Trading Policy, including, if applicable, the Trading Procedures described in Part III, will continue to apply to you and your Affiliated Persons until the first trading day after any material nonpublic information known to you has become public or is no longer material.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">What is Material Nonpublic Information?</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Insider Trading Policy prohibits you from trading in a company&#x2019;s securities if you are in possession of information about the company that is both &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">material</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; and &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">nonpublic</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d;  If you have a question whether certain information you are aware of is material or has been made public, you should consult with the Compliance Officer.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Material&#x201d; Information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Information about our Company or any other company is &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">material</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; if it could reasonably be expected to affect the investment decisions of a stockholder or potential investor or if disclosure of the information could reasonably be expected to significantly alter the total mix of information in the marketplace about us or any other company.  We speak mostly in this Insider Trading Policy about determining whether information about us is material and nonpublic, but the same analysis applies to information about other companies that would preclude you from trading in their securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In simple terms, material information is any type of information that could reasonably be expected to affect the market price of our securities.  Both positive and negative information may be material.  While it is not possible to identify all information that would be deemed &#x201c;material,&#x201d; the following items are examples of the types of information that could be material:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">developments regarding any programs in preclinical or clinical development, including regulatory interactions and/or data recently generated from ongoing or recently completed pre-clinical studies or clinical trials;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">developments regarding the intellectual property and/or freedom to operate for any of the Company&#x2019;s current programs or product candidates;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">information regarding licensing or collaboration arrangements, or other research and development collaborations or partnerships;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">projections of future earnings or losses, or other earnings guidance;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">quarterly or annual financial results that are known but have not been publicly disclosed;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential restatements of the Company&#x2019;s financial statements, changes in auditors or auditor notification that the Company may no longer rely on an auditor&#x2019;s audit report;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">pending or proposed corporate mergers, acquisitions, tender offers, joint ventures or dispositions of significant assets;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in senior management or members of our Board of Directors;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant actual or threatened litigation or governmental investigations or major developments in such matters;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">cybersecurity risks and incidents, including the discovery of significant vulnerabilities or breaches;</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">significant developments regarding products, customers, suppliers, orders, contracts or financing sources (e.g., the acquisition or loss of a contract);</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">changes in dividend policy, declarations of stock splits, or proposed securities offerings or other financings; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">potential defaults under our credit agreements or indentures or potential material liquidity issues; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:7.14323979728499%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">bankruptcies or receiverships.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The above items will not always be material. For example, some new products or contracts may clearly be material while others may not be. No &#x201c;bright-line&#x201d; standard or list of items can adequately address the range of situations that may arise; information and events should be carefully considered in terms of their materiality to the Company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Nonpublic&#x201d; Information</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Material information is &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">nonpublic</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; if it has not been disseminated in a manner making it available to investors generally.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To demonstrate that information is public, one must be able to point to some fact that establishes that the information has become publicly available, such as the filing of a report with the SEC, the distribution of a press release, publishing the information on our website or posting on social media if those are regular ways we communicate with investors, or by other means that are reasonably designed to provide broad public access.  Before a person with material nonpublic information can trade, the market must have adequate time to absorb the information that has been disclosed.  For the purposes of this Insider Trading Policy, information will be considered public after the completion of one full day of trading following our public release of the information.  For that purpose, a full day of trading means a session of regular trading hours on the Nasdaq Stock Market (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nasdaq</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) between 9:30 a.m. and 4:00 p.m. Eastern Time (or such earlier closing time as has been set by exchange rules) has occurred.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For example, if the Company publicly discloses material nonpublic information of which you are aware before trading begins on a Tuesday, the first time you can buy or sell Company securities is the opening of the market on Wednesday.  However, if the Company publicly discloses material information after trading begins on a Tuesday, the first time that you can buy or sell Company securities is the opening of the market on Thursday.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">What are the Penalties for Insider Trading and Noncompliance with this Insider Trading Policy?</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Both the U.S. Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SEC</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and the national securities exchanges, through the Financial Industry Regulatory Authority (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FINRA</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), investigate and are very effective at detecting insider trading.  The U.S. government pursues insider trading violations vigorously, successfully prosecuting, for example, trading by employees in foreign accounts, trading by family members and friends of insiders, and trading involving only a small number of shares.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The penalties for violating rules against insider trading can be severe and include:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">forfeiting any profit gained or loss avoided by the trading;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payment of the loss suffered by the persons who, contemporaneously with the purchase or sale of securities that are subject of a violation, have purchased or sold securities of the same class;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payment of criminal penalties of up to $5.0 million; </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">payment of civil penalties of up to three times the profit made or loss avoided; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.571084182443509%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">imprisonment for up to 20 years.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and/or the supervisors of the person engaged in insider trading may also be required to pay civil penalties or fines of $2.0 million or more, up to three times the profit made or loss avoided, as well as criminal penalties of up to $25.0 million, and could under some circumstances be subject to private lawsuits.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Violation of this Insider Trading Policy or any federal or state insider trading laws may subject you to disciplinary action by the Company, including termination of your employment or other relationship with the Company.  The Company reserves the right to determine, in its own discretion and on the basis of the information available to it, whether this Insider Trading Policy has been violated.  The Company may determine that specific conduct violates this Insider Trading Policy whether or not it also violates the law.  It is not necessary for the Company to await the filing or conclusion of a civil or criminal action against an alleged violator before taking disciplinary action.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">E.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">How Do You Report a Violation of this Insider Trading Policy?</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If you have a question about this Insider Trading Policy, including whether certain information you are aware of is material or has been made public, you should consult with the Compliance Officer.  In addition, if you violate this Insider Trading Policy or any federal or state laws governing insider trading or know of any such violation by any director or employee of the Company, you should report the violation immediately to the Compliance Officer.  However, if the conduct in question involves the Compliance Officer, or if you have reported such conduct to the Compliance Officer and you do not believe the Compliance Officer has dealt with it properly, or if you do not feel that you can discuss the matter with the Compliance Officer, you may raise the matter with the Chief Executive Officer.</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II.  TRADING PROCEDURES</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">A.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Special Trading Restrictions Applicable to Insiders</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to needing to comply with the restrictions on trading in our securities set forth above, Insiders and their Affiliated Persons are subject to the following special trading restrictions:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Trading During Special Blackout Windows. </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There are times when the Company or certain members of its board of directors or senior management or support staff may be aware of a material, nonpublic development. Although an employee may not know the specifics of such development, if an employee engages in a trade before such development is disclosed to the public or resolved, such employee and the Company might be exposed to a charge of insider trading that could be costly and difficult to refute. In addition, a trade by an employee during such a period could result in adverse publicity for the </font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;visibility:hidden;word-break:keep-all;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company. Therefore, employees may not trade in Company securities if they are notified by the Compliance Officer that the trading window is closed. The Compliance Officer may subsequently notify the employees once the material, nonpublic development is disclosed to the public or resolved and that, as a result, the trading window is again open. It is each employee&#x2019;s individual duty to ensure that they do not make any trade in Company securities when material, nonpublic information exists, regardless of whether such employee is aware of such development. Per the below section titled &#x201c;Special Pre-Clearance Procedures for Insiders,&#x201d; all Insiders will need to pre-clear trades regardless of whether a special blackout is in place.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Short Sales</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may not at any time sell any securities of the Company that are not owned by you at the time of the sale (a &#x201c;short sale&#x201d;).  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Purchases or Sales of Derivative Securities or Hedging Transactions</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">.  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not buy or sell puts, calls, other derivative securities of the Company or any derivative securities that provide the economic equivalent of ownership of any of the Company&#x2019;s securities or an opportunity, direct or indirect, to profit from any change in the value of our securities or engage in any other hedging transaction with respect to our securities.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Company Securities Subject to Margin Calls</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">You may not use the Company&#x2019;s securities as collateral in a margin account.</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">No Pledges</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  You may not pledge Company securities as collateral for a loan (or modify an existing pledge).</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Gifts and Other Distributions in Kind</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">    </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Insider may donate or make any other transfer of Company securities without consideration when the Insider is not permitted to trade unless the donee agrees not to sell the shares until the Insider is permitted to sell. In addition to charitable donations or gifts to family members, friends, trusts or others, this prohibition applies to distributions to limited partners by limited partnerships that are subject to this Insider Trading Policy.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Pre-Clearance Procedures </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Insider may trade in our securities, even during an open trading window, unless the trade has been approved by the Compliance Officer in accordance with the procedures described below.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Gifts of Company securities are considered a trade in securities for purposes of this Part II.B. In reviewing trading requests, the Compliance Officer may consult with our other officers and/or outside legal counsel and will seek approval of his/her/their own trades from the Chief Executive Officer.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Procedures.  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Insider may trade in our securities unless:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Insider has notified the Compliance Officer of the amount and nature of the proposed trade(s) using the Stock Transaction Request form attached to this Insider Trading Policy.  To provide adequate time for the preparation of any required reports under Section 16 of the Exchange Act, a Stock Transaction Request form should, if practicable, be received by the Compliance Officer at least two (2) business days before the intended trade date;</font></div></div>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Insider has certified to the Compliance Officer in writing before the proposed trade(s) that the Insider does not possess material nonpublic information concerning the Company;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the Insider is an executive officer or director, the Insider has informed the Compliance Officer, using the Stock Transaction Request form, whether, to the Insider&#x2019;s best knowledge, (a) the Insider has (or is deemed to have) engaged in any opposite way transactions within the previous six months that were not exempt from Section 16(b) of the Exchange Act and (b) if the transaction involves a sale by an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; of the Company or of &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">restricted securities</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; (as such terms are defined under Rule 144 under the Securities Act of 1933, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 144</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;)), whether the transaction meets all of the applicable conditions of Rule 144; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compliance Officer has approved the trade(s) and has certified their approval in writing (which may be by email). </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Compliance Officer does not assume responsibility for, and approval by the Compliance Officer does not protect the Insider from, the consequences of prohibited insider trading.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additional Information.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insiders shall provide to the Compliance Officer any documentation the Compliance Officer reasonably requires in furtherance of the foregoing procedures.  Any failure to provide such information will be grounds for the Compliance Officer to deny approval of the trade request.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notification of Brokers of Insider Status</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Insiders who are required to file reports under Section 16 of the Exchange Act shall inform their broker-dealers that (a) the Insider is subject to Section 16; (b) the broker shall confirm that any trade by the Insider or any of their affiliates has been precleared by the Company; and (c) the broker is to provide transaction information to the Insider and/or Compliance Officer on the day of a trade.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Obligation to Approve Trades.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The foregoing approval procedures do not in any way obligate the Compliance Officer to approve any trade.  The Compliance Officer has sole discretion to reject any trading request.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, an event may occur that is material to the Company and is known by only by a limited number of directors and employees.  The Compliance Officer may decline an Insider&#x2019;s request to preclear a proposed trade based on the existence of a material nonpublic development &#x2013; even if the Insider is not aware of that material nonpublic development.  If any Insider engages in a trade before a material nonpublic development is disclosed to the public or resolved, the Insider and the Company might be exposed to a charge of insider trading that could be costly and difficult to refute even if the Insider was unaware of the development.  So long as the event remains material and nonpublic, the Compliance Officer may decide not to approve any transactions in the Company&#x2019;s securities.  The Compliance Officer will subsequently notify the Insider once the material nonpublic development is disclosed to the public or resolved.  If an Insider requests preclearance of a trade during the pendency of such an event, the Compliance Officer may reject the trading request without disclosing the reason.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Completion of Trades.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">After receiving written clearance to engage in a trade signed by the Compliance Officer, an Insider must complete the proposed trade within three (3) full business days or make a new trading request.  Even if an Insider has received clearance, the Insider may not engage in a trade if (i) such clearance has been rescinded by the Compliance Officer, (ii) the Insider has otherwise received notice that the trading window has closed or (iii) the Insider has or acquires material nonpublic information.</font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">6.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Post-Trade Reporting.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The details of any transactions in our securities (including transactions effected pursuant to a Rule 10b5-1 Plan) by an Insider (or an Affiliated Person) who is required to file reports under Section 16 of the Exchange Act must be reported to the Compliance Officer by the Insider or their brokerage firm on the same day on which a trade order is placed or such a transaction otherwise is entered into.  The report shall include the date of the transaction, quantity of shares, the price and the name of the broker-dealer that effected the transaction.  This reporting requirement may be satisfied by providing (or having the Insider&#x2019;s broker provide) a trade order confirmation to the Compliance Officer if the Compliance Officer receives such information by the required date.  Compliance by directors and executive officers with this provision is imperative given the requirement of Section 16 of the Exchange Act that these persons generally report changes in ownership of Company securities within two (2) business days.  The sanctions for noncompliance with this reporting deadline include mandatory disclosure in the Company&#x2019;s proxy statement for the next annual meeting of stockholders, as well as possible civil or criminal sanctions for chronic or egregious violators.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">C.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exemptions</font></div></div>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-Approved Rule 10b5-1 Plan.  </font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transactions made pursuant to an approved Rule 10b5-1 Plan (as defined below) will not be subject to our trading windows or pre-clearance procedures, and Insiders are not required to complete a Stock Transaction Request form for such transactions.  Rule 10b5-1 of the Exchange Act provides an affirmative defense from insider trading liability under the federal securities laws for trading plans, arrangements or instructions that meet specified requirements.  A trading plan, arrangement or instruction that meets the requirements of the SEC&#x2019;s Rule 10b5-1 (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) enables Insiders to trade in Company securities outside of our trading windows, even when in possession of material nonpublic information.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has adopted a separate Rule 10b5-1 Trading Plan Policy that sets forth the requirements for putting in place a Rule 10b5-1 Plan with respect to Company securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="item-list-element-wrapper" style="text-indent:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;word-break:keep-all;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4%;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Employee Equity and Retirement Plans.</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Stock Options</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The trading prohibitions and restrictions set forth in the Trading Procedures do not apply to the exercise for cash of an option to purchase securities of the Company.  However, the exercise is subject to the current reporting requirements of Section 16 of the Exchange Act and, therefore, Insiders must comply with the post-trade reporting requirement described in Section C above for any such transaction.  In addition, the securities acquired upon the exercise of an option to purchase Company securities are subject to all of the requirements of this Insider Trading Policy, including the Trading Procedures.  Moreover, the Trading Procedures apply to the use of outstanding Company securities to pay part or all of the exercise price of an option, any net option exercise, any exercise of a stock appreciation right, share withholding and any sale of stock as part of a broker-assisted cashless exercise of an option or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Tax Withholding on Restricted Stock/Units</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The trading prohibitions and restrictions set forth in the Trading Procedures do not apply to the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock units to satisfy tax withholding requirements if (a) withholding is required by the applicable plan or award agreement or (b) the election to exercise the tax withholding right was made by the Insider in compliance with the Trading Procedures.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Stock Purchase Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">trading prohibitions and restrictions set forth in the Trading Procedures do not apply to periodic wage withholding contributions by the Company or its employees that are used to purchase Company stock pursuant to the employees&#x2019; advance instructions under the Company&#x2019;s 2024 Employee Stock Purchase Plan.  However, an Insider may not: (a) elect to participate in the plan or alter their instructions regarding the level of withholding or purchase by the Insider of Company securities under the plan; or (b) make cash contributions to the plan (other than through periodic wage withholding) without complying with the Trading Procedures.  Any sale of securities acquired under the plan is subject to the prohibitions and restrictions of the Trading Procedures.</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:6.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:6.667%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">D.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Waivers</font></div></div>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A waiver of any provision of this Insider Trading Policy or the Trading Procedures may be authorized in writing by the Compliance Officer. All waivers shall be reported to the Board of Directors.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART III.  	AMENDMENT</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Insider Trading Policy may be amended from time to time with the approval of the Board of Directors or a designated committee thereof.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART IV.	ACKNOWLEDGEMENT</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We will deliver a copy of this Insider Trading Policy to all current employees and directors and consultants and to future employees and directors and consultants at the start of their employment or relationship with the Company.  Each of these individuals must acknowledge that they have received a copy and agree to comply with the terms of this Insider Trading Policy, and, if applicable, the Trading Procedures contained herein.  The attached acknowledgment must be completed and submitted to the Company within ten days of receipt.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At our request, directors and employees and consultants will be required to re-acknowledge and agree to comply with the Insider Trading Policy (including any amendments or modifications).  For that purpose, an individual will be deemed to have acknowledged and agreed to comply with the Insider Trading Policy, as amended from time to time, when copies of those items have been delivered by regular or electronic mail (or other delivery option used by the Company) to the Compliance Officer.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*	*	*</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Questions regarding this Insider Trading Policy are encouraged and may be directed to the Compliance Officer.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adopted: March 25, 2024</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT A</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">STOCK TRANSACTION REQUEST</font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Q32 Bio Inc.&#x2019;s Insider Trading Policy, I hereby notify Q32 Bio Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) of my intent to trade the securities of the Company as indicated below:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:20%;box-sizing:content-box;"></td>
    <td style="width:4%;box-sizing:content-box;"></td>
    <td style="width:25%;box-sizing:content-box;"></td>
    <td style="width:49%;box-sizing:content-box;"></td>
    <td style="width:2%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="5" style="border-top:0.5pt solid;padding-top:0in;border-right:0.5pt solid;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">REQUESTER INFORMATION</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Insider&#x2019;s Name:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="5" style="padding-top:0in;border-right:0.5pt solid;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">INTENT TO PURCHASE</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Number of shares:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intended trade date:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Means of acquiring shares:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisition through employee benefit plan (please specify):</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:middle;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase through a broker on the open market</font></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other (please specify):</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:6pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">INTENT TO SELL</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Number of shares:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intended trade date:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Means of selling shares:</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale through employee benefit plan (please specify):</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td colspan="2" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale through a broker on the open market</font></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other (please specify):</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:1pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:4%;box-sizing:content-box;"></td>
    <td style="width:34%;box-sizing:content-box;"></td>
    <td style="width:3%;box-sizing:content-box;"></td>
    <td style="width:4%;box-sizing:content-box;"></td>
    <td style="width:52.5%;box-sizing:content-box;"></td>
    <td style="width:2.5%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:3.5pt;font-family:Times New Roman;margin-bottom:2.9pt;border-bottom:0.75pt solid;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">SECTION 16</font></p></td>
    <td style="padding-top:0in;text-indent:115.2pt;vertical-align:top;padding-bottom:0in;"><p style="text-indent:-27.119%;padding-left:21.333%;font-size:10pt;margin-top:3.5pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;text-align:left;"><p style="font-size:10pt;margin-top:3.5pt;font-family:Times New Roman;margin-bottom:2.9pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">RULE 144 (Not applicable if transaction requested involves a purchase)</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I am subject to Section 16.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td rowspan="4" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I am not an &#x201c;affiliate&#x201d; of the Company and the transaction requested above does not involve the sale of &#x201c;restricted securities&#x201d; (as those terms are defined in Rule 144 under the Securities Act of 1933, as amended).</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td rowspan="6" style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td rowspan="6" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">To the best of my knowledge, I have not (and am not deemed to have) engaged in an opposite way transaction within the previous six (6) months that was not exempt from Section 16(b) of the Exchange Act.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td rowspan="3" style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">To the best of my knowledge, the transaction requested above will meet all of the applicable conditions of Rule 144.</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;text-indent:6.5pt;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="margin-left:1.2%;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">None of the above.</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The transaction requested will be made pursuant to an effective registration statement covering such transaction.</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">None of the above.</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;border-right:0.5pt solid;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:3pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:2.46%;box-sizing:content-box;"></td>
    <td style="width:42.82%;box-sizing:content-box;"></td>
    <td style="width:9.4%;box-sizing:content-box;"></td>
    <td style="width:42.84%;box-sizing:content-box;"></td>
    <td style="width:2.48%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="5" style="border-top:0.5pt solid;padding-top:0in;border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">CERTIFICATION</font></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I hereby certify that I am not (1) in possession of any material nonpublic information concerning the Company, as defined in the Company&#x2019;s Insider Trading Policy and (2) purchasing any securities of the Company on margin in contravention of the Company&#x2019;s Trading Procedures.  I understand that, if I trade while possessing such information or in violation of such trading restrictions, I may be subject to severe civil and/or criminal penalties and may be subject to discipline by the Company including termination of my employment.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:16.55pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Insider&#x2019;s Signature</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="5" style="padding-top:0in;border-right:0.5pt solid;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">APPROVAL</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0in;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Signature of Compliance Officer (or designee)</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="border-top:0.5pt solid;padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date</font></p></td>
    <td style="border-top:0.5pt solid #ffffff03;padding-top:0in;border-right:0.5pt solid;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="margin-left:0.093%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="margin-left:0.053%;font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">*NOTE: Multiple lots must be listed on separate forms or broken out.</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT B</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ACKNOWLEDGEMENT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I hereby acknowledge that I have read, that I understand, and that I agree to comply with the Insider Trading Policy of Q32 Bio Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  I further acknowledge and agree that I am responsible for ensuring compliance with the Insider Trading Policy and the Trading Procedures by all of my &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Affiliated Persons</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.&#x201d; </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I also understand and agree that I will be subject to sanctions, including termination of employment, that may be imposed by the Company, in its sole discretion, for violation of the Insider Trading Policy, and that the Company may give stop-transfer and other instructions to the Company&#x2019;s transfer agent or any brokerage firm managing the Company&#x2019;s equity incentive plan(s) against the transfer of any Company securities that the Company considers to be in contravention of the Insider Trading Policy.</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This acknowledgement constitutes consent for the Company to impose sanctions for violation of the Insider Trading Policy, including the Trading Procedures, and to issue any stop-transfer orders to the Company&#x2019;s transfer agent that the Company, in its sole discretion, deems appropriate to ensure compliance.</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.102%;box-sizing:content-box;"></td>
    <td style="width:23.725%;box-sizing:content-box;"></td>
    <td style="width:17.784%;box-sizing:content-box;"></td>
    <td style="width:13.203%;box-sizing:content-box;"></td>
    <td style="width:37.187%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;text-align:right;">
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Signature:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:11pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</font></p></td>
    <td style="padding-top:0in;padding-left:0.075in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="font-size:11pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Send signed Acknowledgement to:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 Bio Inc.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">830 Winter Street</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Waltham, MA 02451</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attn: Jodie Morrison, President and Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Email: JMorrison@q32bio.com</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>qttb-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 23.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We consent to the incorporation by reference in the following Registration Statements:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-1 No. 333-278829) of Q32 Bio Inc.,</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-8 No. 333-279877) pertaining to Q32 Bio, Inc. 2017 Stock Option and Grant Plan, Q32 Bio Inc. 2023 Stock Option and Incentive Plan, Q32 Bio Inc. 2024 Employee Stock Purchase Plan,</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-8 No. 333-270398) pertaining to the Homology Medicines, Inc. 2018 Incentive Award Plan and Homology Medicines, Inc. 2018 Employee Stock Purchase Plan, and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statement (Form S-8 No. 333-224030) pertaining to the Homology Medicines, Inc. 2015 Stock Incentive Plan, as amended, Homology Medicines, Inc. 2018 Incentive Award Plan and Homology Medicines, Inc. 2018 Employee Stock Purchase Plan; </font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of our report dated March 11, 2025, with respect to the consolidated financial statements of Q32 Bio, Inc. included in this Annual (Form 10-K) of Q32 Bio, Inc. for the year ended December 31, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">/s/ Ernst &amp; Young LLP</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Boston, Massachusetts</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 11, 2025</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>qttb-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PURSUANT TO RULES 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Jodie Morrison, certify that:</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2024 of Q32 Bio Inc.;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.451%;box-sizing:content-box;"></td>
    <td style="width:5.059%;box-sizing:content-box;"></td>
    <td style="width:3.039%;box-sizing:content-box;"></td>
    <td style="width:46.451%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 11, 2025</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jodie Morrison</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Jodie Morrison</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(principal executive officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>qttb-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 31.2</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PURSUANT TO RULES 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Lee Kalowski, certify that:</font></p>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2024 of Q32 Bio Inc.;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></div></div>
  <div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.537%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.451%;box-sizing:content-box;"></td>
    <td style="width:5.059%;box-sizing:content-box;"></td>
    <td style="width:3.039%;box-sizing:content-box;"></td>
    <td style="width:46.451%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 11, 2025</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Lee Kalowski</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lee Kalowski</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer and President</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(principal financial officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>qttb-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Jodie Morrison, Chief Executive Officer of Q32 Bio, Inc. (the &#x201c;Company&#x201d;) hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the &#x201c;Report&#x201d;) fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.451%;box-sizing:content-box;"></td>
    <td style="width:5.059%;box-sizing:content-box;"></td>
    <td style="width:3.039%;box-sizing:content-box;"></td>
    <td style="width:46.451%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 11, 2025</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Jodie Morrison</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Jodie Morrison</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Executive Officer and Director</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(principal executive officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>qttb-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;">
  <div style="padding-top:0.5in;z-index:-3;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 32.2</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Lee Kalowski, Chief Financial Officer of Q32 Bio, Inc. (the &#x201c;Company&#x201d;) hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:</font></p>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the &#x201c;Report&#x201d;) fully complies with the requirements of Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</font></div></div>
  <div class="item-list-element-wrapper" style="margin-left:4.528%;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:4.7521786492374725%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.451%;box-sizing:content-box;"></td>
    <td style="width:5.059%;box-sizing:content-box;"></td>
    <td style="width:3.039%;box-sizing:content-box;"></td>
    <td style="width:46.451%;box-sizing:content-box;"></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date: March 11, 2025</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Lee Kalowski</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Lee Kalowski</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </font></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chief Financial Officer and President</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(principal financial officer)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
  <div class="page-border-spacing"><div style="z-index:-3;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img226925499_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img226925499_0.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ;-$*(# 2(  A$! Q$!_\0
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M\5_C[\?OB=H_QV^(]A8?$?Q;8V%KXDU*"WM;;7+J.*&-;J151%$@"J   !P
M*[\)A)8N3C%VL<M>NJ"3:O<_:5I0.],-P/6OP@_X:,^+!_YJ?XS_ /"@N_\
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M\Z#^T(_RG[O_ &E?6C[2OK7X0?\ #17Q6_Z*=XR_\']W_P#'*/\ AHKXK?\
M13O&7_@_N_\ XY1_8U3^=!_:$?Y3]W_M*^M'VE?6OP@_X:*^*W_13O&7_@_N
M_P#XY1_PT5\5O^BG>,O_  ?W?_QRC^QJG\Z#^T(_RG[O_:5]:/M*^M?A!_PT
M5\5O^BG>,O\ P?W?_P <H_X:*^*W_13O&7_@_N__ (Y1_8U3^=!_:$?Y3]W_
M +2OK1]I7UK\(/\ AHKXK?\ 13O&7_@_N_\ XY1_PT5\5O\ HIWC+_P?W?\
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MXK?]%.\9?^#^[_\ CE'_  T5\5O^BG>,O_!_=_\ QRC^QJG\Z#^T(_RG[O\
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M?N_]I7UH^TKZU^$'_#17Q6_Z*=XR_P#!_=__ !RC_AHKXK?]%.\9?^#^[_\
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MBM_T4[QE_P"#^[_^.4?\-%?%;_HIWC+_ ,']W_\ '*/[&J?SH/[0C_*?N_\
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M_N__ (Y1_8U3^=!_:$?Y3]W_ +2OK1]I7UK\(/\ AHKXK?\ 13O&7_@_N_\
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M/W?^TKZT?:5]:_"#_AHKXK?]%.\9?^#^[_\ CE'_  T5\5O^BG>,O_!_=_\
MQRC^QJG\Z#^T(_RG[O\ VE?6C[2OK7X0?\-%?%;_ **=XR_\']W_ /'*/^&B
MOBM_T4[QE_X/[O\ ^.4?V-4_G0?VA'^4_=_[2OK1]I7UK\(/^&BOBM_T4[QE
M_P"#^[_^.4?\-%?%;_HIWC+_ ,']W_\ '*/[&J?SH/[0C_*?N_\ :5]:/M*^
MM?A!_P -%?%;_HIWC+_P?W?_ ,<H_P"&BOBM_P!%.\9?^#^[_P#CE']C5/YT
M']H1_E/W?^TKZT?:5]:_"#_AHKXK?]%.\9?^#^[_ /CE'_#17Q6_Z*=XR_\
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M &E?6C[2OK7X0?\ #17Q6_Z*=XR_\']W_P#'*/\ AHKXK?\ 13O&7_@_N_\
MXY1_8U3^=!_:$?Y3]W_M*^M'VE?6OP@_X:*^*W_13O&7_@_N_P#XY1_PT5\5
MO^BG>,O_  ?W?_QRC^QJG\Z#^T(_RG[O_:5]:/M*^M?A!_PT5\5O^BG>,O\
MP?W?_P <H_X:*^*W_13O&7_@_N__ (Y1_8U3^=!_:$?Y3]W_ +2OK1]I7UK\
M(/\ AHKXK?\ 13O&7_@_N_\ XY1_PT5\5O\ HIWC+_P?W?\ \<H_L:I_.@_M
M"/\ *?N_]I7UH^TKZU^$'_#17Q6_Z*=XR_\ !_=__'*/^&BOBM_T4[QE_P"#
M^[_^.4?V-4_G0?VA'^4_=_[2OK1]I7UK\(/^&BOBM_T4[QE_X/[O_P".4?\
M#17Q6_Z*=XR_\']W_P#'*/[&J?SH/[0C_*?N_P#:5]:/M*^M?A!_PT5\5O\
MHIWC+_P?W?\ \<H_X:*^*W_13O&7_@_N_P#XY1_8U3^=!_:$?Y3]W_M*^M'V
ME?6OP@_X:*^*W_13O&7_ (/[O_XY1_PT5\5O^BG>,O\ P?W?_P <H_L:I_.@
M_M"/\I^[_P!I7UH^TKZU^$'_  T5\5O^BG>,O_!_=_\ QRC_ (:*^*W_ $4[
MQE_X/[O_ ..4?V-4_G0?VA'^4_=_[2OK1]I7UK\(/^&BOBM_T4[QE_X/[O\
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M_=_[2OK1]I7UK\(/^&BOBM_T4[QE_P"#^[_^.4?\-%?%;_HIWC+_ ,']W_\
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M_P <H_X:*^*W_13O&7_@_N__ (Y1_8U3^=!_:$?Y3]W_ +2OK1]I7UK\(/\
MAHKXK?\ 13O&7_@_N_\ XY1_PT5\5O\ HIWC+_P?W?\ \<H_L:I_.@_M"/\
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M9?\ @_N__CE']C5/YT']H1_E/W?^TKZT?:5]:_"#_AHKXK?]%.\9?^#^[_\
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M^=!_:$?Y3]W_ +2OK1]I7UK\(/\ AHKXK?\ 13O&7_@_N_\ XY1_PT5\5O\
MHIWC+_P?W?\ \<H_L:I_.@_M"/\ *?N_]I7UH^TKZU^$'_#17Q6_Z*=XR_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!Z?\ M1?\G'_$[_L8[_\ ]'O7F%>G
M_M1?\G'_ !._[&.__P#1[UYA6-'^''T1I4^-^H4445L9A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#U#]IC_DM&N?\ 7"Q_](X*\OKU#]IC_DM&N?\ 7"Q_](X*
M\OK&C_#CZ(TJ?&PHHHK8S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***^
MKOA]_P $UOBM\0_!FD>)+>^\-Z3:ZI;I=06NIW<ZSB-QE"RI X&5(.-V>><'
MBLJE2%&/-4=D7"$JDN6*NSY1HKL/BU\+=9^"_P 0-5\'>(&M7U73602O92F2
M)@Z*ZE6(!Y5AU /M7'U4)QJ14XNZ82C*$G&2LT%%%%60%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %>G_  ?_ .1'^,G_ &*<?_IXTVO,
M*]/^#_\ R(_QD_[%./\ ]/&FUC5^'YK\T:0W^_\ (\PHHHK8S"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T_P ?_P#)$?A3_P!Q;_TI
M6O,*]/\ '_\ R1'X4_\ <6_]*5KS"L:7P_-_FS2>_P E^04445L9A1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >G_M1?\G'_$[_ +&._P#_ $>]>85Z
M?^U%_P G'_$[_L8[_P#]'O7F%8T?X<?1&E3XWZA1116QF%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 C=*%[T-TH7O0MP/J3_@G?_R6C7?^Q=G_ /2FVK]#[/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRHTI=7;1=/D>U1HT/JL*U1=$WOUM_F<=JW_!(S4H;21M,^)MK>7('R1W>BM
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M312H?1E8 @_6H4XR=DRG&25VBI1115DA14EO;RWEQ%!!$\\\K!(XXU+,[$X
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M]_DOR"BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 C=*%[T-TH7O0MP/J3_@G?_P EHUW_ +%V?_TIMJ_0^S_UHK\\
M/^"=_P#R6C7?^Q=G_P#2FVK]#[/_ %HKXS-?]Y?HCZ/ _P $[G0>@KLK/[HK
MC=!Z"NRL_NBO'/0+M%%% %:Y^Z:_"#]HK_DX+XG?]C1JG_I7+7[OW/W37X0?
MM%?\G!?$[_L:-4_]*Y:^BR;^)/T/)S#X8GE]_P#ZP?3_ !J&.IK_ /U@^G^-
M0QU[\OC/)6Q;CJPM5XZL+6\=C*6XM%%%62%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!Z?\!?\ C_\ ''_8GZM_
MZ(->85Z?\!?^/_QQ_P!B?JW_ *(->85E'XY?(T?PH****U,PHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#U#]IC_DM&N?]<+'_ -(X*\OKU#]IC_DM&N?]<+'_ -(X*\OK
M&C_#CZ(TJ?&PHHHK8S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#]_\ X2_\DJ\&?]@6R_\ 1"5^4_\ P4K_ .3J-7_[!UG_ .BZ
M_5CX2_\ )*O!G_8%LO\ T0E?E/\ \%*_^3J-7_[!UG_Z+KY##?\ (R?K+]3W
M8?\ (MC_ (8_^VGRQ7Z#?\$GOB==QZ]XN\ 7$[R6,MLNL6D3'B*166.7'^\'
MC_[X^M?GS7V%_P $M+=Y?VDKYU&5B\/W3/[ RP#^9%?2XJ*EAZB:Z/\ #7]#
MQZ3:JP:[K\[?D?H'^V-X/@\;?LR_$&QFC\QH-+DU"'U$EO\ OE(_%,?B:_*+
M]C.SM]0_:B^'4%U!'<PG4PQCF0.I(1R#@^A (]P*_87]H"=+;X$_$661MJ+X
M=U#)_P"W:2OR _8G_P"3J/AS_P!A'_VD]>#E#?+57I^O^2/6S6*]E"77WOT_
MS9^T?C*QMM0\(:S:W5O%<VTEE,KPS(&1AL/!!X(K\"?!/A.]\>>,=$\-Z<%^
MW:M>PV,);.T-(X4$X[#.3["OW]\3_P#(MZM_UZ3?^@&OPD^ GC2T^'7QJ\$^
M);_BPTW5K>>Y;!.V(. [8'7"DG'M2R/^+57^'_VX,U;5&#6_O?DC]H/@O\"O
M!?[.?@E-.T&QM[4PP!M0UB95^T7149:263KCJ0OW5'0"O%+[_@J!\&;/Q"^F
MHGB*[M5?9_:T&GI]F(_O -*)<?\ ;//M7U/>6NG^+O#L]NSK>:7J=JT9>%_E
MEAD3&58=BK<$>M?F-\9O^"6_C7PU<75]\/=2MO%FE [H]/NY%MK]1G[N3B*3
M _BW(3V6N##NE7K2>,D_^#UOVZ6Z'74C*G1BL,O^&_7S.T_X*#?&KX5?&SX"
MZ!J?A/Q#I.MZY#K,8BC7]W?PP&*42!HG E5"P3.0%)"]>*^*/@;\']7^.WQ.
MT?P=HY\F6]<M/=,I9+6!1F25A[#H,C)*C(S7+^*/">M>"=;N='\0:5>:-JMN
M<2V=]"T4B^AVL.A['H1R*^]O^"2?A"";4_B#XHEB5KB"*UTZ"3^)5<O)(/QV
M1?E7TM.$,#AISINZ6J^=DOE>QXU:I/%580FK/;\V_G:_W'VW\&?@1X+^ /A6
M/2?"VEPV>V-1=ZE*H-U=L!R\TF,GG)QPJYX %<I=?MM? ZS\2'0I?B+IGVX/
ML,B1S/; _P#7P$,./??BN1_X*+_$2]\ _LT:I%I\KV]UKUW%I'FQ\%8W#/*,
M_P"TD;+_ ,"K\<J\/!X5X]RK5I/>W]>1ZF(JK!QC"FM]?EM]^C/U7_X*3^#O
M!_BK]GE/'EK;:==ZO!=6@L=;M-K//!(Q!3S5^^A#%@"2.,CW^%?V2_V:[W]I
M;XE+HYFEL/#]@@N=6U"( M'%G"QID8\QSD#/  8X.W!\G;Q7K;^'$\/MK&H-
MH*3_ &E=+-TYM1-@CS!%G;NP2-V,\U^J7_!+KP9!H/[/-UKH1?M>NZK-(\G?
MRXL1(OT#+(?^!&O5C3>68:HU*^MUY7LOPU9Y\ZGUVM335NC^5W^6GD?1O@CX
M=^!O@+X-DM-!TW3O"VA6<1EN;EBL>54<RSS,<L0!RSGH*X;3?VVO@?JWB/\
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M9[V]:61$ :0B=U!8]S@ <]@*^1?^"JFDPV7[0.B7D8Q)>^'X6EXZLL\R@_D
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M)GU*J*^^/VLOA9_PN+]G_P 7>'HHO-U#[*;RQ48S]HA_>1J/3<5V?1C3QO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 >G^/_\ DB/PI_[BW_I2M>85Z?X__P"2(_"G_N+?
M^E*UYA6-+X?F_P V:3W^2_(****V,PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /3_VHO\ DX_XG?\ 8QW_ /Z/>O,*]/\ VHO^3C_B=_V,=_\ ^CWK
MS"L:/\./HC2I\;]0HHHK8S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ^_O^"4/PK^W^)?%?Q!NH<Q:?$NDV+MT\V3#S$>ZH(Q])#7KG_!4
MCXG#PO\ !73/"-O*%O/$U\/-3//V: B1S_W\,(^F:]H_8Y^%?_"H?V>/"6C3
M0F'4KBW_ +1OPP ;SYOG*M[J"J?\ K\X/^"C?Q./Q _:0U+38)O,T[PU FE1
M!6ROFCYYC['>Y0_]<Q7RU3_;,R45M#_VW_.7X,]RA_L^"=3K+_V[1?\ DOXH
M_0S]AKXG'XH?LU>%+N:42ZCI<1T>[^;<V^#"H6]VC\MO^!5\>?\ !5;X5_V+
M\0O#GCRTA*V^MVQL;QU7@7$/*$GU:-@/I%5W_@E#\3SIWB_Q7X"N92(=2MUU
M2S1CP)8B$E ]V1E/TBKZX_;@^%?_  MC]G#Q190P&;4]+C_M>Q"KEO,A!9E4
M>K1^8O\ P*LL5_L>8*KT;O\ )[_<[_<7@_\ :,*Z/5:?=K']+GXG5^LG_!+*
MU@C_ &=]1G2&-9Y->N \JJ S 10X!/4XK\FZ_6G_ ():_P#)M][_ -AZY_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** /4/VF/\ DM&N?]<+'_TC@KR^O4/VF/\
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MF;U *@]*QHMX['^U2]U:_)*T?GM]S+?^R83DD]7I\WO]R?Y':?\ !.CXH_\
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M\9^&?#=L;/1-/ND2VMVE:7RU:)'*[F)8X+'J2:_3;_@F_P#\FG>&O^ON^_\
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MA1116QF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !178_!_X;W'Q>^)GAWP=:WD>G3ZQ
M="W%U,A=8A@DMM'7 !XR,GN.M?:?B'_@DO=Z3H%_>V?Q/AN[NWMWF2WFT,PH
M[*I.TN+ABH..NT_2N2OBJ.&2=65C>C1J5WRTU=_YGY]T445UF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 >G^/_ /DB/PI_[BW_ *4K7F%>G^/_ /DB/PI_[BW_ *4K7F%8TOA^;_-F
MD]_DOR"BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHI5&Y@/6A)MV0"45^A.D_\ !)&YOM)M
M;FY^*,5O<RQ+(\,6@F1%8@' <W*DCWVCZ5\0?%3P!<_"OXC>(O"-W=17MQH]
MY):-<P@JDNT\, >1D8X[>]<=/%T:TW3A*[7J=$J%2$%4DM/\SE:***[#G"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **T-#\/:KXHU!+#1M,O-
M6OG&5M;&W>:5L=<*H)-=FW[.GQ76/S#\,/&03KN/A^[Q^?EU$IQC\3L4HN6R
M//**LZEIMWH]]-97]K-8WD#;);>YC,<D;#LRD @_6JU5>^J%MHPHHHIB"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M))QDU-_P21_Y$SXB?]A"T_\ 1<E>A6Q*Q6!K3BK)67_DT3S/8NABZ$9;MO\
M])D=#_P5@_Y(7X5_[&./_P!);BOFS_@ES_R<O<?]@&Z_]&0U])_\%8/^2%^%
M?^QCC_\ 26XKYL_X)<_\G+W'_8!NO_1D-<N!_P!PJ_\ ;WY'7C/]YI_]N_\
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M<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXJ\<JLH^ORG_ (#7Q9^R/^QW/^U/'XCG'BJ/PQ;Z,T*%OL!NWE:0.?N^9&
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MO7S?7TM_P48_Y.V\7?\ 7"Q_])(J?^R5^Q3<?M2:'KVK'Q='X8MM+N4M0O\
M9YNWE9DW$X\R,* ,=SG)Z8Y[,)4C2P4*DW9)+_(K'1<L6X1W=O\ TE,^9J*^
MKOB5_P $\O&GA?XO:)X$\*ZE'XN;4K+[=)J<EJ;.&RC$A1FF^:0*O (P26Y
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MP=_X)3WNJZ7;ZC\2/$TFCS3+N.C:*B2319 (#SME PY!548>C&O3-2_X)/\
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MM?T/HZ+_ ()0_"M;95D\3>,&N-N&=;JU5"WJ%^SD@>V?QK\R?B'X9C\$^/\
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MU:;N?4?@/_@I%\:?!.GI9W.I:9XJBC 6-M>LS)(H Q@R1-&S'W<L?>MS7?\
M@J1\9-7T^6WM;3PQHLSC N['3Y6E3W FFD7/U4U\@45A+!X>3YG!&D<15BK*
M3.A\=?$+Q)\3?$,VN>*M:N]=U648-Q>2;BJY)"J.B*"3A5  SP*YZBBNJ,5%
M<L59&,I.3O)W9[E\&?VT/BK\#;&'3-#UU=0T.'/EZ1K$7VFWC]D.0Z#_ &48
M#))Q7K-Q_P %5OB[- T::+X/@<C ECL;DL/?YKDC]*^-**YZF%HU9<TX)LTA
M6J4URQE9'H?Q:_:"^('QRNHIO&GB6ZU>*%MT%F L-M$>>5B0!-V"1NQNQU)K
MSRBBMX0C37+!61$IRF[R=V?0?PI_;P^,/PEL(-.L_$$>O:3 NR*QUZ'[4L8[
M 2964 #@+OP!T%>DR_\ !5CXNR1%%T+P=$Q&/,6QNLCWYN2/TKXSHKGGA:%1
M\TH*YI"M4IJT9:'IWQ@_:4^(_P =9%7QAXEN+^QC??%IL*K!:1G)P?*0 ,1G
M 9LMCO7F-%%;PIPIKE@K(SE.51WD[L*]@^&O[7/Q<^$/AJ+P_P"%/&4^FZ-"
MS/%9RVEO<K$6.6">=&Y4$DG (&23W->/T4Y1C-<LE="C)Q=XNS/;?''[:?QH
M^(WAF^\/:_XXGNM(OHS%<V\%C:VQE0]4+11*VT]",X(R#P:\2HHJ84X4_@BE
MZ%2J3G\3N%>N?![]J[XG_ R!+/PMXFFCTA7WG2;U%N;7J20J."8\DDGRRI/<
MUY'15RC&:Y9*Z(3<7=;GV='_ ,%6OBXD84Z#X-D(_B:QNLG\KD"N4\8?\%)/
MC;XJA\JUU?3?#,; JXT?3U#,#_M3&1E^JD&OERBN18+#)WY$='UFM_,RWJVK
M7VO:G=:CJ=Y<:AJ%U(TL]U=2-)+*Y.2S,Q)))[FO4OAC^UI\6/@YX:7P_P"$
M?%TNE:,LC3):/96UPJ,QRVTRQN5!/. <9)/<UY%173*$)1Y)*Z[&/-+FYKZG
M<?%;XV>-OC?K%KJGC;7I=<O+6+R(&:&*%(T)R0J1JJC)ZG&3@>@KAZ**<81I
MKE@K(4I2F[R=V%?:W_!*WPGK6I_&G7->M+R:TT32],,5]&A&VY>5L11L".@*
M.^1R"@[$U\4U^I__  3[\<_"CX5_L^V:ZAX_\,:7XAU:[FO=2M]0U6"VGC8,
M8T0I(RM@(BGIC+$CK7+C9NGAIM*[>GW_ / O\S2C%5*T(O:]_NU_.Q]*?M&_
M$Q?@_P#!'Q?XK\Q8[FRL76TW=#<R?NX1_P!_'7\,U^#TDC22,[L7=CDLQR2?
M6OT#_P""E?[3'ACQUX9\/>!O!GB.SU^$W1U#4[C2YQ-" B[88S(N5;)9V(!.
M-BYZBOSZKS<HH.G"522LY/\ !?\ !N>EF%52<:<7MK\W_P #\SZ"_82^%G_"
MU/VDO#,$T7F:;HS'6;S/3;"08Q^,IB&/0FOUS^-7Q&M_A)\*?%/BZX*XTJQD
MFB1S@238VQ)_P)RJ_C7Y9_L-?M3^"OV99_%<WBC0]7U"[U9;=(+O24BD:.--
MY9"LCI@$L#D$YQTXKK?VS_V\M#_:!^'EIX/\'Z5K&FV,EVEUJ$^K)%&TBH"4
MC58Y'R-Q#$DC[@X.>(S+#UL57A3C'W5;7UW?R6GR)P%6G0C*I-Z]O39?-_F?
M&.H:A<:M?W-[=S-<7=S*TTTSG+.[$EF/N22:KT45]"DHJR/*;<G=[A1113$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7I_P?\
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M44 %%%% !1110 4444 %%%% !1110!Z?X_\ ^2(_"G_N+?\ I2M>85Z?X_\
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MOM$%O]E@MT63:5W$11IDX) )SC)]:]O_ ."7/_)R]Q_V ;K_ -&0U\A5]/\
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MY+,[C_99RO .,BI=%_;L^.?A_0;+1K#QW)#IUG;I:P1MIMF[I&JA5&]H2Q(
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M -8/I_C4,=37_P#K!]/\:ACKWY?&>2MBW'5A:KQU86MX[&4MQ:***LD****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZS_P""8O\ R=!#_P!@>\_]
MDK]1?C5876J_!WQU965M->7ESH5]#!;VZ%Y)7:W<*BJ.68D@ #DDU^77_!,7
M_DZ"'_L#WG_LE?K3KVN67AG0]1UC4YOLVG:?;R7=S-L9_+BC4L[;5!)P 3@
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MM_PKS^W_ +.WF?\ "*_8?M7D;EW9\CYMF[9GMG;[5XD\1A94Y0IT>F_;Y_\
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M\@/V^/\ D[CX@_\ 7:U_](X*BC0CB,?.G/;WG]S_ ."94ZKHX"G..]HK\/\
M@'V]^QK^WM?_ +0/C*?P=XNT73]*UQ[=[FRNM++K!.$P6B,<C,P8+E@=Q!"M
MP,<^W_M<>#;7QS^S;\0=.NHEE,.DS7T.[^&6!3,ASVY0?@37Y:_L!NT?[6W@
M$J<$R70_ VDP-?K=\>/^2'_$/_L7=0_])I*>:T(8:I"5)6NK_--_Y(Z,KG*O
M+DJ.^J^YGX'4445]B?-!1110 4444 %%%% !1110!ZA^TQ_R6C7/^N%C_P"D
M<%>7UZA^TQ_R6C7/^N%C_P"D<%>7UC1_AQ]$:5/C84445L9A1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %>G_!__D1_C)_V*<?_ *>--KS"O3_@_P#\
MB/\ &3_L4X__ $\:;6-7X?FOS1I#?[_R/,****V,PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *='_K%^HIM
M.C_UB_45I3^./J#V/Z'M(_Y!-E_UP3_T$5^2O[;'P/\ B-XM_:B\<:IH?@'Q
M1K&F7,UL8+ZPT>XF@EQ:PJ2LBH5.""#@\$&OUJTC_D$V7_7!/_017C_C[]LW
MX._"_P 7:AX8\3>,/[,US3V1;FU_LR\E\LLBNOSQPLIRK*>">M? X6K.CB'.
MG'F=GI\T?35(1J8>,9NRT_)GS7_P3Y_8V\6?#7QC/\0O'>G?V+<1VK6VEZ9*
MZM/F0 /-(%)V87*A2=WS-D# S]9?M)?%2S^#?P4\5>);J9(IX;-X+)&/,MU(
MI6) ._S$$^@!/:O$O'7_  4\^#_AJS8Z"VK>+[QE;RX[.S:VB#8X#O.$*@GN
MJM]*_//]I+]J?Q?^TMK\-SK;1Z=HEFS&PT6T8F&#/&YB>9),<%SCO@*"17;/
M#XG,JJE6CRQV[:>76[U_K0QIU*&!@_9N[W^99_8G_P"3J/AS_P!A'_VD]?MV
M[K&K,S!549+,< #UK\1/V)_^3J/AS_V$?_:3U^U7B?\ Y%O5O^O2;_T U6>2
MY>679,PRM<U2:_P_J?"G[0G_  5"3PGXJN-"^&.DZ;K\5E)Y<^MZH9'MIF!P
MRP)&REE':0M@\X!&&/T?^R5^TO;?M-_#N?6FT]=(UG3[C[)J%C')O0-M#+(A
M/.Q@> >00PR<9/XAU^B__!(J9S'\4(BW[M3IK!?<_:03^@_*NW$9?1I8.<HK
MWHI._P TOU,Z>+JU,1'L^G]>9O\ _!67P7:W7@#P7XK6("^L]2?36D'5HI8V
MD /KAH>/]X^M?#'[,_Q8L?@?\</#'C34[2XOM/TV27[1!:!3*4DA>(E Q )&
M_."1G'45^AO_  56_P"3?=#_ .QB@_\ 2>>OSC^!?P6UWX^_$;3_  CH.R*>
MX!EN+N8$QVL"XWRMCJ!D #N2H[T\I?\ LLD]KO[FM?S8\R5JD&MVE^;2_0^L
M_BQ_P59\3:I=36OP\\-VFAZ?RJW^M#[1=-TPPC5A'&1SP?,'3FO-?!O_  4H
M^-6@^(K:\UK6K/Q-I@D!GTZZTZW@#)GY@KPHC*V,X)) .,@]*^YOA=_P3O\
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M5U'PK_Y*?X0_[#%G_P"CTKEZZCX5_P#)3_"'_88L_P#T>E5'XD95OX<O1G]
M=?A+^U)_R<A\3?\ L8K[_P!'-7[M5^$O[4G_ "<A\3?^QBOO_1S5\;E'^\/_
M  O\T?68[_='_BC^4CRZBBBOL#Y@**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T_P ?_P#)$?A3_P!Q
M;_TI6O,*]/\ '_\ R1'X4_\ <6_]*5KS"L:7P_-_FS2>_P E^04445L9A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\/WEI$B7.J7=Y=7<B@9>19WB&?HD2"OD;_@JQ_R7[P__ -B[#_Z43U/^P/\
MMI:3\&+.;P'XXEDM_#-Q<-<6.JJK.+&1OOI(HR?+8C.5!VL3D8)*^E"G.OEB
MA#?]$WI_7:R.:O*-''<TMM/QCN=__P %+/C#\6/ /CG1--\/:OK'ACP;-8I(
ME_I+O;?:+K>^]&G0ALJH3Y,C@YP:^</AO^WY\:?AS(B_\)0?%%FH(^R>)$-X
M"3W,N1-Q_P!=,>U?L#!<>%OBIX5+1/I/BWPW?I@X,5Y:3KZ'[RL/:OE;X^?\
M$T_ ?CO3[S4? 2?\(7XCPTD=O&S-I]P_7:T9R8@>@,> N?N&N'"XJA2A[#$4
M_G;\^ITXBA4K2]K2G^/Y'Y7:GJ%YXI\07=[*GFW^I73S.L2_>DD<DA1[D\"O
MW0_9U^#>G? GX1Z#X5L88UN885FU"X5<-<73 &61CWYX&>BJH[5^-/PQ\)7_
M (;_ &C/"/AS7K)[/4+/Q/9V=Y:2XRCK=(K*>Q'N."*_>&NW-:BC0ITZ?POM
MV25OEK^1QX*$I5YSJ;K\VW?\OS/R6_; _;<\?>)OBIKWA[PCXDU#PMX8T6\>
MQB&D3M;37,D3%'E>5"'P6!PH(7:!QG)KU[_@G1^UEXQ\>^-KSX>^--8F\0))
M9/=Z;?WS;[E'C(WQ,_60%26RQ)&P\X/'T5JO_#*_]J7G]I?\*?\ [1\Y_M/V
MK^RO.\W<=^_=SNW9SGG.<U;\->*_V9?!>K)JGA_6/A/H6IQJR)>:;=:9;S*K
M## .A! (Z\UQPKTOJWL?8MZ;^=M_O.FK3J2K>T51+7;ROM]WXZG!_P#!2KX7
MV7C3]GF\\1?9U;5_#$\=W;SJOS^2[K',F?[I#*WUC%?D-7["?M>?M%?#'4/V
M<?'.G:;X]\.ZSJ6H6!M+:RTK5(+J:21V 'R1L3@=23P *_'NNW)^>,)PDM+_
M )[_ .?S,,QY9<DEOK_P/U"BBBOH3QPK] /^"8?[.5Y>>()?BSK=JT.G6B26
MNB+(N#/,P*2S#_95=R ]RS?W:\<_8K_8_O/VBO$W]L:W'-:> =,F NYU)5KV
M08/V>,]1P1N8= <#DC'ZX75WX>^%_@QIIWL_#WAG1;0#)Q%!;0(N  .P
MKQ,RQJH0=&'Q-?<G^K7X?(]#!X9UY*;^%/[VO\GO]W<S?BY\4-%^#7P]UGQ=
MKTPCL=/A+B,$!YY#PD29ZLS8 ^N>@K\(/''C#4/B!XQUKQ+JK^9J.K7<MY.0
M3@,[%L#V&<#V KW']LK]K:__ &DO%RVFG&:Q\#Z7(W]GV;_*UP_0W$H_O$9"
MC^%3CJ6S\Y5.68-T(NK47O/\%_FS;'8A5/W4'HM_-_\  _KH%%%%>Z>2%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'I_[47_ "<?\3O^QCO_ /T>]>85Z?\ M1?\G'_$[_L8[_\ ]'O7F%8T
M?X<?1&E3XWZA1116QF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 C=*%[T-TH7O
M0MP/J3_@G?\ \EHUW_L79_\ TIMJ_0^S_P!:*_/#_@G?_P EHUW_ +%V?_TI
MMJ_0^S_UHKXS-?\ >7Z(^CP/\$[G0>@KLK/[HKC=!Z"NRL_NBO'/0+M%%% %
M:Y^Z:_"#]HK_ )."^)W_ &-&J?\ I7+7[OW/W37X0?M%?\G!?$[_ +&C5/\
MTKEKZ+)OXD_0\G,/AB>7W_\ K!]/\:ACJ:__ -8/I_C4,=>_+XSR5L6XZL+5
M>.K"UO'8REN+1115DA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!L?.!R!T-<E*C568N;B[7EK;3KU+52'U",+Z\L=.O0H?L*_\G8_#O_K[F_\
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M+.,['Y2?M _L>^(_V<_AWX2\1>(]4M9=1UJ:2"YTJW3/V%PH=5\W<1(2,[L
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M110 4444 %.C_P!8OU%-I5;:P/H<U=-VFF^X']#^D?\ ()LO^N"?^@BOQ?\
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M  OT2^D4B2ZTFYT^&=P>2"8R&/TKNECJE.4H5J-_R:.2.%C5IJ5.I9V^:?\
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M/^'A7[/_ /T/W_E&U#_Y'KYO"K$X6HZD:3>EMGY?Y'OUIT:U+V3FMT]UTO\
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M\'>&_$=L++6;:*>6>V#!C%YMQ)*JL1_$%< CL<BL#Q#\>/V:_AE=WGC"/6O
M\FN2Y,EYX>CMKO49V/8M &<D^K$#U(KSOX5_\%,_AQXHNO$<OC*\?P9;1W83
M2+>2SN+J2:VV#YY&A1P'+;LKT V@%N2<<1B*V,H>SITFDK-_+2R^\VI4J>'J
M\\ZE[[?YL^<?^"K'_)?O#_\ V+L/_I1/7S5-\!_B!#\-[+Q]_P (K?R^$+SS
M#'JENHE151BK-(J$M&N5(W.%!QP37KG[?WQJ\(_'+XQ:9K/@S4GU;2K71XK-
M[IK:2 &02RN0%D56P Z\D"OI#]B#]M[X<>$?A'H7@#QEJ$GAK4]+,D,5Y<0L
M]I<H\KNIWH#L(W8.\!> 0><#MHNMA\#%PA>2>WE=_P# ,<0Z=;%OFE[K2U\[
M+_@GY_?#_P"*'BWX5ZRFJ>$?$%_H-Z&4LUG,527!R%D3[LB_[+ CVK]U?A'K
M^M>*OA;X3UGQ'9_V?KU_IEO<WUKY9C\N9HP6&T\KR?NGD=*\VA\;_LSC6U\1
M1ZW\*TUH-YHU+[1IRW8;^]OSO!_'-<#\<O\ @H[\-?AWI-Y;^$;Y?&_B7:4@
MBLE;['&^.&DG("LH](]Q/3Y>H\S%UIXV,80I/F_K0Z</1CAY.3J*W]:GQ?\
MMQ:_:^$OVW-7UO2D#7.FW.FWLJ\ &>.&%\<>P7.>^:_7/PUX@LO%GAW3-;TV
M9;G3]1MH[NWF7H\;J&4_D17\_GBWQ5J?CCQ/JGB#6KIKS5=2N'NKF=OXG8Y.
M/0=@.P %?7/[&O[?3_!/2(/!7CBWN=3\(QO_ *%?6H#W&GACDH5)'F19)/!W
M+SC<,*._$8&<\'3IK64/QTU_+0YHXJ*Q4ZGV9:?=L_SOZG!_ME_LP^+OA/\
M%;Q-K4>C7E]X/U2]EU"UU:U@9X8EE<N8I"N1&RLQ4;L;@ 1[>!>'?"6N>+[S
M[)H.BZAK=U_SPTZUDN'_ .^4!-?MQX;_ &NO@QXJT]+RS^)7AVWB?HFI7R6,
M@^L<^QA^57-3_:E^#VDVSSS_ !.\*.BC)%KJ\%P_X+&S,?P%<M''UZ%-4ITF
MVM.WZ&]7#4JTW4C.US\;/'W[.?Q(^%OA#3_$_BSPI>:#HU].+:":\>-9/,*L
MP5HMWF(<*WWU'2O.*^[O^"@7[7W@#XW>!](\(>";NZUAK?4DU"?46M7@@"K'
M(@11(%<ME\_=Q@=37PC7MX2K5K0<JL>5W_ \W$4Z=.2C3E?37U"O7_V5?@'-
M^T9\7K#PN;EK+3(HFOM2N4QO2V1E#!,_Q,S*H)Z;LX.,5Y!7T[^P!\=/"?P(
M^+>K:EXRO9-,TC4-*>T%XD$DXCD\V-U#)&K-@A6&0#SCZCIJ.482<-TG;UMH
M<R2<DGM=?=?4_77P=X/T?X?^%]-\/:!81Z;H^GPB"WMHAPJCU/4DG))/)))/
M)KX8_;2^'O[1_P"T1X@;0M"\"2V/@#3YLV\)UBP1[^0<">4?:.!_=0] <GD\
M>Z_\/"OV?_\ H?O_ "C:A_\ (]'_  \*_9__ .A^_P#*-J'_ ,CU\33AB:=7
MVSIN3\T]^_K_ %N?3RE1=/V<9I+R:V['YU?\.]?V@/\ H0?_ "LZ?_\ )%>8
M?%KX%^.?@7J5C8>.-!?0[F^B::V!N(9UE53AL/$[+D'&1G(R..17ZR?\/"OV
M?_\ H?O_ "C:A_\ (]?$7_!1;]H;P+\>=9\#_P#"#ZPVM6^E07?VF<VDUNJM
M*T6U0)44DXC)R!CD5[F'Q>,J5HPJ4[1>[L^S_4\VKA\/&G*4)W:VU7='QY11
M17O'DA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!Z?^U%_P G'_$[_L8[_P#]'O7F%>G_ +47_)Q_Q._[&.__
M /1[UYA6-'^''T1I4^-^H4445L9A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%:GA;PY>^,/$VDZ#IRJ^H:I=Q65NKG"F21PBY/8985]^6
MO_!(B=[:)KGXJ1Q7!4&2.+P^716QR QN5)'O@?05SUL12PZ3JNUS6G2G6;4%
M>Q^=]%?;GQB_X)=^)OA[X)U#7_#?BV'QA+I\37$^G'36M)FB498Q8ED#L!SM
M.,X.,G /Q'2HXFEB+^RE>Q52A4HVYU:X445Z!\"_@GK_ ,?_ (B67A+P\(H[
MB9&GGNKC/E6T*XW2/@$XY  '4L!WS70VDFWT,#S^BOT43_@D.Q4;OBN V.0O
MAW(_/[57@W[6/[#^I?LP>'](UY?$\7BC2;ZZ^Q22"Q-I)!*4+J-OF2 J0C\Y
M&".G-<$,?AJDE",M7Y/_ ".QX2M%.3CHO0^9**]3_9?^%>G_ !J^.WA3P=JL
MTUOIFH32-<M;D"0QQPO*RJ<<%A'MSVS7Z?ZI_P $Y?@/?:3<6EMX3N--N9(R
MB7UOJUVTL3$<. \K(2.N"I'M3Q6,IX-Q51/773[B:&'GB&^72W<_&VBM+Q-H
MK>&_$FJZ0\@F>PNY;4R*,!RCE<CZXK]__!FGVNG^#]%M;6VBMK6.RA1(84"(
MJ[!P%' %9XG&QP].-6*YE+Y%4<.ZE5TI.S1_/=17L_[9=E;Z?^U!\18+6".V
M@74RPCA0(H)16)P/4DGZDUXQ77AZOUBC"M:W,D_O5S&M3]E4E3O>S:^X****
MZ#$**** "BBB@ HHK6\,>$==\;:E_9WAW1=1U[4-AD^R:7:27,NT8!;8@)P,
MCG'<4@,FBNM\4?"'QWX'T\7_ (C\%>(O#]@7$8NM4TJ>VBW'HNYT R?2N2I1
MDI:Q=RG%QW044451(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "-TH7O0W2
MA>]"W ^I/^"=_P#R6C7?^Q=G_P#2FVK]#[/_ %HK\\/^"=__ "6C7?\ L79_
M_2FVK]#[/_6BOC,U_P!Y?HCZ/ _P3N=!Z"NRL_NBN-T'H*[*S^Z*\<] NT44
M4 5KG[IK\(/VBO\ DX+XG?\ 8T:I_P"E<M?N_<_=-?A!^T5_R<%\3O\ L:-4
M_P#2N6OHLF_B3]#R<P^&)Y??_P"L'T_QJ&.IK_\ U@^G^-0QU[\OC/)6Q;CJ
MPM5XZL+6\=C*6XM%%%62%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5^UO["_CS1_&_[,_@V/2YXS<:
M/:+IE];*PWPS1Y!W =-PPX]0U?BE75_#GXJ^+OA'K@U?P?K]YH-_@!WM7^25
M1T61#E9%]F!%<6,P_P!:I>SO9[HWH571J*HO3^ON/TN_:]_X)^WOQZ\>7'C;
MPMXCM-,UJZ@BBNK'54?R)6C4(KK(@9D^4*"NP],Y%>8_"/\ X)3ZQ8^*+*_^
M(7BC2I=*M9UE?3M#$LQNU4YV-)(D>P$]<*QQD#'4>9Z)_P %2/C)I5C%!=6O
MAC6947#7-]I\JR/[D13(N?HHJ35O^"IWQAU&SDAM]/\ "NER,N!<6FGS,Z'U
M DG=<_52*\JE1S##Q5.G)66WEZ'HU*N%Q$N>HG<_3WXF?$KP]\(/!6H>)O$E
M]'I^EV49/S,-TK8^6*,?Q.Q& !7X/?$#Q?/\0/'?B'Q-<Q^5/K&H3W[QYSL,
MDC/MSWQG'X5I_$SXR>-?C'JJ:CXS\27VO7$>?*6X<+%#D#/EQ* B9P,[5&<<
MUQM=6!P#PK<YN\G^!CBL6JT53@K1_K\@HHHKV#S0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /3_@+_ ,?_ (X_[$_5O_1!KS"O3_@+_P ?_CC_ +$_5O\ T0:\
MPK*/QR^1H_A04445J9A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'J'[3'_):-<_ZX6/\
MZ1P5Y?7J'[3'_):-<_ZX6/\ Z1P5Y?6-'^''T1I4^-A1116QF%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7[=?L1_\ )JGPY_[!
M[?\ HZ2OQ%K]NOV(_P#DU3X<_P#8/;_T=)7CYM_NG_;R_*1U8'_?%_AE^<#R
MG]N#]LCQI^S3XR\.:3X8TS0;^VU*P>ZE;5K>>1U82%<*8YD &!W!KF_V8O\
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M46_Y-'\8?]=K#_TLAK\::X,E_@S_ ,7_ +;$]#,OXD/3]6%%%%?0'D!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Z?\'_\ D1_C
M)_V*<?\ Z>--KS"O3_@__P B/\9/^Q3C_P#3QIM8U?A^:_-&D-_O_(\PHHHK
M8S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T_Q__P D
M1^%/_<6_]*5KS"O3_'__ "1'X4_]Q;_TI6O,*QI?#\W^;-)[_)?D%%%%;&84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5Z5TCL^IPII.M.S9^1\D;1NR.I1U."K#!!]#7W1_P28 _P"%K>-CCG^Q4_\
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M0QBX?7VC:8*-Y46\)"D]< L>/<^M>Q4Q,88=XB&JLG][2_4\Z-&3K*C+1_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'I_P !?^/_ ,<?]B?J
MW_H@UYA7I_P%_P"/_P <?]B?JW_H@UYA64?CE\C1_"@HHHK4S"BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'I_C__ )(C\*?^XM_Z4K7F%>G^/_\ DB/PI_[BW_I2M>85C2^'
MYO\ -FD]_DOR"BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T_
M]J+_ )./^)W_ &,=_P#^CWKS"O3_ -J+_DX_XG?]C'?_ /H]Z\PK&C_#CZ(T
MJ?&_4****V,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?4[6X>9]^Y6R4G1<!D8=*QE[1YC/V7Q<TK7^?Z'334%@X\WPV7Z?J>8_#?\
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MN.K"U7CJPM;QV,I;BT4459(4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'I_P%_X_P#QQ_V)^K?^B#7F%>G_  %_
MX_\ QQ_V)^K?^B#7F%91^.7R-'\*"BBBM3,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3@@JW8D@ #P/0_\ @D;I-O?*VL?$N\OK/^**QT=+:0_1VFD _P"^:\*\)_\
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M(OVV&IR]I3CK^7<^Q?\ @KI_J_AC]=0_]MZY+_@DQ_R57QM_V!4_]'I7RO\
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M/&FUC5^'YK\T:0W^_P#(\PHHHK8S"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#T_Q_\ \D1^%/\ W%O_ $I6O,*]/\?_ /)$?A3_ -Q;
M_P!*5KS"L:7P_-_FS2>_R7Y!1116QF%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!Z?^U%_R<?\ $[_L8[__ -'O7F%>G_M1?\G'_$[_ +&._P#_ $>]
M>85C1_AQ]$:5/C?J%%%%;&84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'HG[.7_ "<%\,_^QET[_P!*8Z_>9ONGZ5_/#HNL7OAW6+'5=-N7
ML]1L9TN;:XC.&BD1@R,/<$ _A7O$_P"W_P#'RXM7MW^($@C92I*:78J^/9A
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'I_P !?^/_ ,<?]B?JW_H@UYA7I_P%_P"/
M_P <?]B?JW_H@UYA64?CE\C1_"@HHHK4S"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /4/
MVF/^2T:Y_P!<+'_TC@KR^O4/VF/^2T:Y_P!<+'_TC@KR^L:/\./HC2I\;"BB
MBMC,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT_X/_P#(C_&3_L4X
M_P#T\:;7F%>G_!__ )$?XR?]BG'_ .GC3:QJ_#\U^:-(;_?^1YA1116QF%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'I_C__ )(C\*?^
MXM_Z4K7F%>G^/_\ DB/PI_[BW_I2M>85C2^'YO\ -FD]_DOR"BBBMC,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#T_]J+_ )./^)W_ &,=_P#^CWKS
M"O3_ -J+_DX_XG?]C'?_ /H]Z\PK&C_#CZ(TJ?&_4****V,PHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU_\ ZP?3_&H8Z]^7QGDK8MQU86J\=6%K>.QE+<6BBBK)"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]/^ O_'_X
MX_[$_5O_ $0:\PKT_P" O_'_ ../^Q/U;_T0:\PK*/QR^1H_A04445J9A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'J'[3'_):-<_ZX6/_I'!7E]>H?M,?\EHUS_KA8_^
MD<%>7UC1_AQ]$:5/C84445L9A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %>G_!_P#Y$?XR?]BG'_Z>--KS"O3_ (/_ /(C_&3_ +%./_T\:;6-7X?F
MOS1I#?[_ ,CS"BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /3_'_P#R1'X4_P#<6_\ 2E:\PKT_Q_\ \D1^%/\ W%O_ $I6O,*Q
MI?#\W^;-)[_)?D%%%%;&84444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MI_[47_)Q_P 3O^QCO_\ T>]>85Z?^U%_R<?\3O\ L8[_ /\ 1[UYA6-'^''T
M1I4^-^H4445L9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (W2A>]#=*%[T+<#Z
MD_X)W_\ ):-=_P"Q=G_]*;:OT/L_]:*_/#_@G?\ \EHUW_L79_\ TIMJ_0^S
M_P!:*^,S7_>7Z(^CP/\ !.YT'H*[*S^Z*XW0>@KLK/[HKQST"[1110!6N?NF
MOP@_:*_Y."^)W_8T:I_Z5RU^[]S]TU^$'[17_)P7Q._[&C5/_2N6OHLF_B3]
M#R<P^&)Y??\ ^L'T_P :ACJ:_P#]8/I_C4,=>_+XSR5L6XZL+5>.K"UO'8RE
MN+1115DA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 >G_ 7_ (__ !Q_V)^K?^B#7F%>G_ 7_C_\<?\ 8GZM_P"B
M#7F%91^.7R-'\*"BBBM3,**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]0_:8_Y+1KG_7"Q
M_P#2."O+Z]0_:8_Y+1KG_7"Q_P#2."O+ZQH_PX^B-*GQL****V,PHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O3_@__P B/\9/^Q3C_P#3QIM>85Z?
M\'_^1'^,G_8IQ_\ IXTVL:OP_-?FC2&_W_D>84445L9A1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!Z?X_P#^2(_"G_N+?^E*UYA7I_C_
M /Y(C\*?^XM_Z4K7F%8TOA^;_-FD]_DOR"BBBMC,**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#T_P#:B_Y./^)W_8QW_P#Z/>O,*]/_ &HO^3C_ (G?
M]C'?_P#H]Z\PK&C_  X^B-*GQOU"BBBMC,**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@!&Z4+WH;I0O>A;@?4G_!._\ Y+1KO_8NS_\ I3;5^A]G_K17YX?\$[_^
M2T:[_P!B[/\ ^E-M7Z'V?^M%?&9K_O+]$?1X'^"=SH/05V5G]T5QN@]!796?
MW17CGH%VBBB@"M<_=-?A!^T5_P G!?$[_L:-4_\ 2N6OW?N?NFOP@_:*_P"3
M@OB=_P!C1JG_ *5RU]%DW\2?H>3F'PQ/+[__ %@^G^-0QUZ;X'_9W^(/Q:T>
M76/"GA_^U=-AG:TDF^VV\.)557*[9)%/W74YQCGZUT]O^P_\:YN$\%Y/_85L
MO_CU>S4KTHS:E)+YGFQISE&ZB_N/%HZL+7O-K^P/\=[@#R_ N[_N+V'_ ,?K
M0C_X)[_']NG@'_RLZ?\ _)%:1Q5"W\1?>B'1JW^%_<?.]%?1?_#O7]H#_H0?
M_*SI_P#\D4?\.]?V@/\ H0?_ "LZ?_\ )%5]:H?\_%]Z%[&K_*_N/G2BOHO_
M (=Z_M ?]"#_ .5G3_\ Y(H_X=Z_M ?]"#_Y6=/_ /DBCZU0_P"?B^]![&K_
M "O[CYTHKZ+_ .'>O[0'_0@_^5G3_P#Y(H_X=Z_M ?\ 0@_^5G3_ /Y(H^M4
M/^?B^]![&K_*_N/G2BOHO_AWK^T!_P!"#_Y6=/\ _DBC_AWK^T!_T(/_ )6=
M/_\ DBCZU0_Y^+[T'L:O\K^X^=**^B_^'>O[0'_0@_\ E9T__P"2*/\ AWK^
MT!_T(/\ Y6=/_P#DBCZU0_Y^+[T'L:O\K^X^=**^B_\ AWK^T!_T(/\ Y6=/
M_P#DBC_AWK^T!_T(/_E9T_\ ^2*/K5#_ )^+[T'L:O\ *_N/G2BOHO\ X=Z_
MM ?]"#_Y6=/_ /DBC_AWK^T!_P!"#_Y6=/\ _DBCZU0_Y^+[T'L:O\K^X^=*
M*^B_^'>O[0'_ $(/_E9T_P#^2*/^'>O[0'_0@_\ E9T__P"2*/K5#_GXOO0>
MQJ_RO[CYTHKZ+_X=Z_M ?]"#_P"5G3__ )(H_P"'>O[0'_0@_P#E9T__ .2*
M/K5#_GXOO0>QJ_RO[CYTHKZ+_P"'>O[0'_0@_P#E9T__ .2*/^'>O[0'_0@_
M^5G3_P#Y(H^M4/\ GXOO0>QJ_P K^X^=**^B_P#AWK^T!_T(/_E9T_\ ^2*/
M^'>O[0'_ $(/_E9T_P#^2*/K5#_GXOO0>QJ_RO[CYTHKZ+_X=Z_M ?\ 0@_^
M5G3_ /Y(H_X=Z_M ?]"#_P"5G3__ )(H^M4/^?B^]![&K_*_N/G2BOHO_AWK
M^T!_T(/_ )6=/_\ DBC_ (=Z_M ?]"#_ .5G3_\ Y(H^M4/^?B^]![&K_*_N
M/G2BOHO_ (=Z_M ?]"#_ .5G3_\ Y(H_X=Z_M ?]"#_Y6=/_ /DBCZU0_P"?
MB^]![&K_ "O[CYTHKZ+_ .'>O[0'_0@_^5G3_P#Y(H_X=Z_M ?\ 0@_^5G3_
M /Y(H^M4/^?B^]![&K_*_N/G2BOHO_AWK^T!_P!"#_Y6=/\ _DBC_AWK^T!_
MT(/_ )6=/_\ DBCZU0_Y^+[T'L:O\K^X^=**^B_^'>O[0'_0@_\ E9T__P"2
M*/\ AWK^T!_T(/\ Y6=/_P#DBCZU0_Y^+[T'L:O\K^X^=**^B_\ AWK^T!_T
M(/\ Y6=/_P#DBC_AWK^T!_T(/_E9T_\ ^2*/K5#_ )^+[T'L:O\ *_N/G2BO
MHO\ X=Z_M ?]"#_Y6=/_ /DBC_AWK^T!_P!"#_Y6=/\ _DBCZU0_Y^+[T'L:
MO\K^X^=**^B_^'>O[0'_ $(/_E9T_P#^2*/^'>O[0'_0@_\ E9T__P"2*/K5
M#_GXOO0>QJ_RO[CYTHKZ+_X=Z_M ?]"#_P"5G3__ )(H_P"'>O[0'_0@_P#E
M9T__ .2*/K5#_GXOO0>QJ_RO[CYTHKZ+_P"'>O[0'_0@_P#E9T__ .2*/^'>
MO[0'_0@_^5G3_P#Y(H^M4/\ GXOO0>QJ_P K^X^=**^B_P#AWK^T!_T(/_E9
MT_\ ^2*/^'>O[0'_ $(/_E9T_P#^2*/K5#_GXOO0>QJ_RO[CYTHKZ+_X=Z_M
M ?\ 0@_^5G3_ /Y(H_X=Z_M ?]"#_P"5G3__ )(H^M4/^?B^]![&K_*_N/G2
MBOHO_AWK^T!_T(/_ )6=/_\ DBC_ (=Z_M ?]"#_ .5G3_\ Y(H^M4/^?B^]
M![&K_*_N/G2BOHO_ (=Z_M ?]"#_ .5G3_\ Y(H_X=Z_M ?]"#_Y6=/_ /DB
MCZU0_P"?B^]![&K_ "O[CYTHKZ+_ .'>O[0'_0@_^5G3_P#Y(H_X=Z_M ?\
M0@_^5G3_ /Y(H^M4/^?B^]![&K_*_N/G2BOHO_AWK^T!_P!"#_Y6=/\ _DBC
M_AWK^T!_T(/_ )6=/_\ DBCZU0_Y^+[T'L:O\K^X^=**^B_^'>O[0'_0@_\
ME9T__P"2*/\ AWK^T!_T(/\ Y6=/_P#DBCZU0_Y^+[T'L:O\K^X^=**^B_\
MAWK^T!_T(/\ Y6=/_P#DBC_AWK^T!_T(/_E9T_\ ^2*/K5#_ )^+[T'L:O\
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MCZU0_P"?B^]![&K_ "O[CYTHKZ+_ .'>O[0'_0@_^5G3_P#Y(H_X=Z_M ?\
M0@_^5G3_ /Y(H^M4/^?B^]![&K_*_N/G2BOHO_AWK^T!_P!"#_Y6=/\ _DBC
M_AWK^T!_T(/_ )6=/_\ DBCZU0_Y^+[T'L:O\K^X^=**^B_^'>O[0'_0@_\
ME9T__P"2*/\ AWK^T!_T(/\ Y6=/_P#DBCZU0_Y^+[T'L:O\K^X^=**^B_\
MAWK^T!_T(/\ Y6=/_P#DBC_AWK^T!_T(/_E9T_\ ^2*/K5#_ )^+[T'L:O\
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MU_: _P"A!_\ *SI__P D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_: _P"A!_\
M*SI__P D4?\ #O7]H#_H0?\ RLZ?_P#)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\
M#O7]H#_H0?\ RLZ?_P#)%'_#O7]H#_H0?_*SI_\ \D4?6J'_ #\7WH/8U?Y7
M]Q\Z45]%_P##O7]H#_H0?_*SI_\ \D4?\.]?V@/^A!_\K.G_ /R11]:H?\_%
M]Z#V-7^5_<?.E%?1?_#O7]H#_H0?_*SI_P#\D4?\.]?V@/\ H0?_ "LZ?_\
M)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\.]?V@/\ H0?_ "LZ?_\ )%'_  [U_: _
MZ$'_ ,K.G_\ R11]:H?\_%]Z#V-7^5_<?.E%?1?_  [U_: _Z$'_ ,K.G_\
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M /R11_P[U_: _P"A!_\ *SI__P D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_:
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M ,K.G_\ R11_P[U_: _Z$'_RLZ?_ /)%'UJA_P _%]Z#V-7^5_<?.E%?1?\
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M *$'_P K.G__ "16GUJA_P _%]Z(]C5_E?W'SI17T7_P[U_: _Z$'_RLZ?\
M_)%'_#O7]H#_ *$'_P K.G__ "11]:H?\_%]Z#V-7^5_<?.E%?1?_#O7]H#_
M *$'_P K.G__ "11_P .]?V@/^A!_P#*SI__ ,D4?6J'_/Q?>@]C5_E?W'SI
M17T7_P .]?V@/^A!_P#*SI__ ,D4?\.]?V@/^A!_\K.G_P#R11]:H?\ /Q?>
M@]C5_E?W'SI17T7_ ,.]?V@/^A!_\K.G_P#R11_P[U_: _Z$'_RLZ?\ _)%'
MUJA_S\7WH/8U?Y7]Q\Z45]%_\.]?V@/^A!_\K.G_ /R11_P[U_: _P"A!_\
M*SI__P D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_: _P"A!_\ *SI__P D4?\
M#O7]H#_H0?\ RLZ?_P#)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\ #O7]H#_H0?\
MRLZ?_P#)%'_#O7]H#_H0?_*SI_\ \D4?6J'_ #\7WH/8U?Y7]Q\Z45]%_P##
MO7]H#_H0?_*SI_\ \D4?\.]?V@/^A!_\K.G_ /R11]:H?\_%]Z#V-7^5_<?.
ME%?1?_#O7]H#_H0?_*SI_P#\D4?\.]?V@/\ H0?_ "LZ?_\ )%'UJA_S\7WH
M/8U?Y7]Q\Z45]%_\.]?V@/\ H0?_ "LZ?_\ )%'_  [U_: _Z$'_ ,K.G_\
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MW'SI17T7_P .]?V@/^A!_P#*SI__ ,D4?\.]?V@/^A!_\K.G_P#R11]:H?\
M/Q?>@]C5_E?W'SI17T7_ ,.]?V@/^A!_\K.G_P#R11_P[U_: _Z$'_RLZ?\
M_)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\.]?V@/^A!_\K.G_ /R11_P[U_: _P"A
M!_\ *SI__P D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_: _P"A!_\ *SI__P D
M4?\ #O7]H#_H0?\ RLZ?_P#)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\ #O7]H#_H
M0?\ RLZ?_P#)%'_#O7]H#_H0?_*SI_\ \D4?6J'_ #\7WH/8U?Y7]Q\Z45]%
M_P##O7]H#_H0?_*SI_\ \D4?\.]?V@/^A!_\K.G_ /R11]:H?\_%]Z#V-7^5
M_<?.E%?1?_#O7]H#_H0?_*SI_P#\D4?\.]?V@/\ H0?_ "LZ?_\ )%'UJA_S
M\7WH/8U?Y7]Q\Z45]%_\.]?V@/\ H0?_ "LZ?_\ )%'_  [U_: _Z$'_ ,K.
MG_\ R11]:H?\_%]Z#V-7^5_<?.E%?1?_  [U_: _Z$'_ ,K.G_\ R11_P[U_
M: _Z$'_RLZ?_ /)%'UJA_P _%]Z#V-7^5_<?.E%?1?\ P[U_: _Z$'_RLZ?_
M /)%'_#O7]H#_H0?_*SI_P#\D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_: _Z$
M'_RLZ?\ _)%'_#O7]H#_ *$'_P K.G__ "11]:H?\_%]Z#V-7^5_<?.E%?1?
M_#O7]H#_ *$'_P K.G__ "11_P .]?V@/^A!_P#*SI__ ,D4?6J'_/Q?>@]C
M5_E?W'SI17T7_P .]?V@/^A!_P#*SI__ ,D4?\.]?V@/^A!_\K.G_P#R11]:
MH?\ /Q?>@]C5_E?W'SI17T7_ ,.]?V@/^A!_\K.G_P#R11_P[U_: _Z$'_RL
MZ?\ _)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\.]?V@/^A!_\K.G_ /R11_P[U_:
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MU_: _P"A!_\ *SI__P D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_: _P"A!_\
M*SI__P D4?\ #O7]H#_H0?\ RLZ?_P#)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\
M#O7]H#_H0?\ RLZ?_P#)%'_#O7]H#_H0?_*SI_\ \D4?6J'_ #\7WH/8U?Y7
M]QP?C_\ Y(C\*?\ N+?^E*UYA7V-XP_8;^-VJ?"WX?:1:^"O-U'2O[0^V0_V
MK8CRO-G5H_F,^#E03P3COBN$_P"'>O[0'_0@_P#E9T__ .2*SIXF@HZS6[ZK
MNRYT:M_A?3IY'SI17T7_ ,.]?V@/^A!_\K.G_P#R11_P[U_: _Z$'_RLZ?\
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MD4?\.]?V@/\ H0?_ "LZ?_\ )%'UJA_S\7WH/8U?Y7]Q\Z45]%_\.]?V@/\
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M#_H0?_*SI_\ \D4?6J'_ #\7WH/8U?Y7]Q\Z45]%_P##O7]H#_H0?_*SI_\
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M7]H#_H0?_*SI_P#\D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_: _Z$'_RLZ?\
M_)%'_#O7]H#_ *$'_P K.G__ "11]:H?\_%]Z#V-7^5_<?.E%?1?_#O7]H#_
M *$'_P K.G__ "11_P .]?V@/^A!_P#*SI__ ,D4?6J'_/Q?>@]C5_E?W'SI
M17T7_P .]?V@/^A!_P#*SI__ ,D4?\.]?V@/^A!_\K.G_P#R11]:H?\ /Q?>
M@]C5_E?W'SI17T7_ ,.]?V@/^A!_\K.G_P#R11_P[U_: _Z$'_RLZ?\ _)%'
MUJA_S\7WH/8U?Y7]Q\Z45]%_\.]?V@/^A!_\K.G_ /R11_P[U_: _P"A!_\
M*SI__P D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_: _P"A!_\ *SI__P D4?\
M#O7]H#_H0?\ RLZ?_P#)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\ #O7]H#_H0?\
MRLZ?_P#)%'_#O7]H#_H0?_*SI_\ \D4?6J'_ #\7WH/8U?Y7]Q\Z45]%_P##
MO7]H#_H0?_*SI_\ \D4?\.]?V@/^A!_\K.G_ /R11]:H?\_%]Z#V-7^5_<?.
ME%?1?_#O7]H#_H0?_*SI_P#\D4?\.]?V@/\ H0?_ "LZ?_\ )%'UJA_S\7WH
M/8U?Y7]Q\Z45]%_\.]?V@/\ H0?_ "LZ?_\ )%'_  [U_: _Z$'_ ,K.G_\
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MW'SI17T7_P .]?V@/^A!_P#*SI__ ,D4?\.]?V@/^A!_\K.G_P#R11]:H?\
M/Q?>@]C5_E?W'SI17T7_ ,.]?V@/^A!_\K.G_P#R11_P[U_: _Z$'_RLZ?\
M_)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\.]?V@/^A!_\K.G_ /R11_P[U_: _P"A
M!_\ *SI__P D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_: _P"A!_\ *SI__P D
M4?\ #O7]H#_H0?\ RLZ?_P#)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\ #O7]H#_H
M0?\ RLZ?_P#)%'_#O7]H#_H0?_*SI_\ \D4?6J'_ #\7WH/8U?Y7]Q\Z45]%
M_P##O7]H#_H0?_*SI_\ \D4?\.]?V@/^A!_\K.G_ /R11]:H?\_%]Z#V-7^5
M_<?.E%?1?_#O7]H#_H0?_*SI_P#\D4?\.]?V@/\ H0?_ "LZ?_\ )%'UJA_S
M\7WH/8U?Y7]Q\Z45]%_\.]?V@/\ H0?_ "LZ?_\ )%'_  [U_: _Z$'_ ,K.
MG_\ R11]:H?\_%]Z#V-7^5_<?.E%?1?_  [U_: _Z$'_ ,K.G_\ R11_P[U_
M: _Z$'_RLZ?_ /)%'UJA_P _%]Z#V-7^5_<?.E%?1?\ P[U_: _Z$'_RLZ?_
M /)%'_#O7]H#_H0?_*SI_P#\D4?6J'_/Q?>@]C5_E?W'SI17T7_P[U_: _Z$
M'_RLZ?\ _)%'_#O7]H#_ *$'_P K.G__ "11]:H?\_%]Z#V-7^5_<?.E%?1?
M_#O7]H#_ *$'_P K.G__ "11_P .]?V@/^A!_P#*SI__ ,D4?6J'_/Q?>@]C
M5_E?W'SI17T7_P .]?V@/^A!_P#*SI__ ,D4?\.]?V@/^A!_\K.G_P#R11]:
MH?\ /Q?>@]C5_E?W'SI17T7_ ,.]?V@/^A!_\K.G_P#R11_P[U_: _Z$'_RL
MZ?\ _)%'UJA_S\7WH/8U?Y7]Q\Z45]%_\.]?V@/^A!_\K.G_ /R11_P[U_:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HK@OC7\;/#/P#\#S^*?%,TZV*2+!%;VB!Y[B5NB1J2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M])48V^Y_>'U:>ZJ._P#70H_"WXD:1\7OA_HOB_0O/&EZK#YL2W*;)4PQ5E8
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MIET5'FJ[R .BMUVF,.2.GR@]A7;[?#>W]E[%.+E:_J[)G-"E6E2]I[1IVO\
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>5_M5?\
M)M?Q-_[%Z]_]$M7JE>5_M5?\FU_$W_L7KW_T2U;4?XL?5&=3X'Z'S3_P28_Y
M)5XV_P"PTG_HA*^ZJ^%?^"3'_)*O&W_8:3_T0E?=5=68?[U,PPO\&(4445YY
MUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&&W8 2>,'CU\NG%3FHMV3ZG=)\L7)*]CZLHK\X?^&(?VJO\ HM,/_A5:K_\
M&:^TOV<_A[XG^%_PETG0/&7B.7Q5XDB:62[U&2YEN 2\C,$624!RJJ0.0._
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MDDGL *_)S7+K4O\ @H-^V)%96K3)X-L6*(PR!!ID3_/)[/*QX]Y%'\-?2O\
MP4L_:&_X5_\ #N+X?:/<;-=\31G[6T;?-!8@X;Z&0@I_NAZZ_P#X)]_L\_\
M"E_A!'K.JVWE^*?$ZI>7(=</;V^,PP^QP2S#U?!^Z*WP:6'IRQLMUI'UZOY?
MYKJ3BFZCCA8]=9>2_P"#_DSZ:TK2[30]+M-.L+=+6QM(4@@@C&%CC4!54#T
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M>()6"II>FW%X2?\ IG&S#]17YI?\$L?#$GB'XZ^)?$UQF3^S-*<;SS^^GE4
MY_W5D_.N?+/<E5K_ ,L?Q>WXQ-L?[U*%+^:2_#1_^E'ZGT445XYZ!^=/_!6S
MQ>=WP^\+(W'^DZG,N?\ =CC/_HROJ+]DW^P? '[-O@#2I=7TZVF72H[J=&NH
MP5DFS,X//4&0_E7P+^WM=3_%C]LZ'PI92_O(1I^@PMC<%DE(<G'LT_3VKUD?
M\$AQD9^+&1_V+G_W77T,84UE].%6?+S-RV;OO;\&CRZDI/&2<(WY4EVM?_@I
MGK/[7G[<W@[X=^!=5T'P;KMGXB\9:A"]K$=,F6:&P# JTLDBY7<HSA 2<XR
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M]P@1<^DC5^C?B;Q)IW@[P[J>NZO<K9Z7IMO)=75PP)$<:*68X')X'05\?_\
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M_P $U_BEI^G_ ++_ (A&M7D=G8>%-0N)9II3A8K=T6;<?^!&6OGOP/I.K?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)''TVRL*_8FOG3XT_L)_#SXZ?$4^--=OM?L=5>.*.6/2[J&.&7RQA20T3-G
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %>5_M5?\FU_$W_ +%Z]_\
M1+5ZI7E?[57_ ";7\3?^Q>O?_1+5M1_BQ]49U/@?H?-/_!)C_DE7C;_L-)_Z
M(2ONJOA7_@DQ_P DJ\;?]AI/_1"5]U5U9A_O4S#"_P &(4445YYUA1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS;_^/KY/]9Y/3YO3C->T45I3G[.2E9.W?8F4>:+5['YT_P#&P#_/_"/T?\;
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M/SI_XV ?Y_X1^C_C8!_G_A'Z_1:BCZ]_TZA_X#_P0^K?]/)?>?G3_P ; /\
M/_"/T?\ &P#_ #_PC]?HM11]>_Z=0_\  ?\ @A]6_P"GDOO/SI_XV ?Y_P"$
M?H_XV ?Y_P"$?K]%J*/KW_3J'_@/_!#ZM_T\E]YYS^SS_P + _X4_H'_  M+
M_D>_](_M'_CW_P"?B3RO^/?]U_JO+^[^/.:]&HHKSI2YI.5K7.N*Y4D%%%%2
M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5Y7^U5_R;7\3?^Q>O?\ T2U>J5Y7^U5_R;7\3?\ L7KW
M_P!$M6U'^+'U1G4^!^A\T_\ !)C_ ))5XV_[#2?^B$K[JKX5_P""3'_)*O&W
M_8:3_P!$)7W575F'^]3,,+_!B%%%%>>=84444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 12]Z_*+_@JA_R<)H'_
M &*]O_Z5W=?J[+WK\HO^"J'_ "<)H'_8KV__ *5W=>QE/^\KT9Y^._@LYG_@
MG?\ \EHUW_L79_\ TIMJ_0^S_P!:*_/#_@G?_P EHUW_ +%V?_TIMJ_0^S_U
MHHS7_>7Z(,#_  3N=!Z"NRL_NBN-T'H*[*S^Z*\<] NT444 5KG[IK\(/VBO
M^3@OB=_V-&J?^E<M?N_<_=-?A!^T5_R<%\3O^QHU3_TKEKZ+)OXD_0\G,/AB
M?9?_  3T_P"2(ZU_V,,__I-;5]7Z3_K!7RA_P3T_Y(CK7_8PS_\ I-;5]7Z3
M_K!7F8[_ 'F?J=N&_@Q._P!#^ZM=1;]*Y?0_NK746_2N Z2Q1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5Y7^U5_R;7\3?\ L7KW_P!$M7JE>5_M
M5?\ )M?Q-_[%Z]_]$M6U'^+'U1G4^!^A\T_\$F/^25>-O^PTG_HA*^ZJ^%?^
M"3'_ "2KQM_V&D_]$)7W575F'^]3,,+_  8A1117GG6%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/_Z36U?5^D_ZP5YF._WF?J=N&_@Q._T/[JUU%OTKE]#^ZM=1;]*X#I+%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7E?[57_ ";7\3?^Q>O?_1+5
MZI7E?[57_)M?Q-_[%Z]_]$M6U'^+'U1G4^!^A\T_\$F/^25>-O\ L-)_Z(2O
MNJOA7_@DQ_R2KQM_V&D_]$)7W575F'^]3,,+_!B%%%%>>=84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y7^U5_R;7\3?
M^Q>O?_1+5ZI7E?[57_)M?Q-_[%Z]_P#1+5M1_BQ]49U/@?H?-/\ P28_Y)5X
MV_[#2?\ HA*^ZJ^%?^"3'_)*O&W_ &&D_P#1"5]U5U9A_O4S#"_P8A1117GG
M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5Y7^U5_R;7\3?^Q>O?\ T2U>J5Y7^U5_R;7\3?\ L7KW_P!$M6U'^+'U1G4^
M!^A\T_\ !)C_ ))5XV_[#2?^B$K[JKX5_P""3'_)*O&W_8:3_P!$)7W575F'
M^]3,,+_!B%%%%>>=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 12]Z_*+_@JA_R<)H'_ &*]O_Z5W=?J[+WK
M\HO^"J'_ "<)H'_8KV__ *5W=>QE/^\KT9Y^._@LYG_@G?\ \EHUW_L79_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% $4O>ORB_X*H?\G":!_V*]O\
M^E=W7ZNR]Z_*+_@JA_R<)H'_ &*]O_Z5W=>QE/\ O*]&>?COX+.9_P""=_\
MR6C7?^Q=G_\ 2FVK]#[/_6BOSP_X)W_\EHUW_L79_P#TIMJ_0^S_ -:*,U_W
ME^B# _P3N=!Z"NRL_NBN-T'H*[*S^Z*\<] NT444 5KG[IK\(/VBO^3@OB=_
MV-&J?^E<M?N_<_=-?A!^T5_R<%\3O^QHU3_TKEKZ+)OXD_0\G,/AB?9?_!/3
M_DB.M?\ 8PS_ /I-;5]7Z3_K!7RA_P $]/\ DB.M?]C#/_Z36U?5^D_ZP5YF
M._WF?J=N&_@Q._T/[JUU%OTKE]#^ZM=1;]*X#I+%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7E?[57_ ";7\3?^Q>O?_1+5ZI7E?[57_)M?Q-_[
M%Z]_]$M6U'^+'U1G4^!^A\T_\$F/^25>-O\ L-)_Z(2ONJOA7_@DQ_R2KQM_
MV&D_]$)7W575F'^]3,,+_!B%%%%>>=84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7U?I/^L%>9CO]YGZG;AOX,3O]#^ZM=1;]*Y?0_NK746_2N Z2Q1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5Y7^U5_R;7\3?^Q>O?_1+5ZI7E?[5
M7_)M?Q-_[%Z]_P#1+5M1_BQ]49U/@?H?-/\ P28_Y)5XV_[#2?\ HA*^ZJ^%
M?^"3'_)*O&W_ &&D_P#1"5]U5U9A_O4S#"_P8A1117GG6%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M":E#=SV<LZPFXB17&U6<A<AF1L,0/EZ^O)%<TE%NR;7RUW.CHWY/\MOF=/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M /C)/\5OV@]8LHK@OHGAIVTFSC!^7>A_?O\ 5I 1GT1:^B?V-/C]^SS^SO\
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M^2NCGK1JX>M3O.[E;\7:Q^GGQ/\ &"?#WX<>)_$S[<:3IMQ>@-T+)&S*/Q(
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M4E^K)P=\1BZE5=?_ &Y_\ _%C]N/Q@?&G[4?CJY67S8+.Z73HL= ($6-@/\
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M*@>&)9=0NLG +,00A/&%09']XUZ-_P %6/C).DWASX9V%PR0-'_:VIJIQO\
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MLBPQ1M'&K DL2220%5B1Q7T?_P %0O&']@?LYPZ0CXEUS5H+<KGDQQAIF_\
M'D3\Z_/K]DW]GR?]HWXMV?A^1Y+;0[5/MNJW47#);J0-JG& [DA1Z9)YQ7!E
MN'IU*%6I56FU^R2O=>>OX'9CJTJ<J<8;[^NMDG]WXF]\5_V[OB_\4-6FFA\4
MWGA+3-Y:WT[P],UH(E[!I4(D<XZ[FQGH!TKTC]C?]MWQ]HOQ6T#POXP\0WGB
MCPUK=W'8,VK2F>XM99&"QR+,WSXW%058D8)Q@\U]Y?&'X=^"OAW^RUXYT*QT
M"QT[PY9Z#=,MI%$ "ZPL4<G&2^X*=YRV><YK\B/V;-!G\2_M ?#O3[<$O)KM
MFYQV5)5=C^"J3^%>A@I8;%J=)4[15OQO^.G=G'BXUJ,8U93O)W^5K?AKV/U>
M_;G^-GB'X$_ N77/"TRVFN7>H06$%X\*2BWW!W9]K@J3MC*C((^;I7Y#_%#X
ML>*_C-XG_P"$A\9:L=9UCR$MOM!@BAQ&N2JA8U51C<>W>OWYGF2VADFD8+'&
MI=F/8 9)K\ _'FN7'Q(^*6OZK'NFN-;U>>>->I)EF)4?^/ 5PY+:4Y0Y;O>_
M:^B7Y]3LS&\::GS66UN^[O\ +0[;X7_M:_%KX0^&8?#/@WQ1_96D+,\J6J:9
M:3DR.<L=TD+,23CJ:_9_X43>(;GX8^%)O%CF3Q/+I=O)J3&)8S]H,:F3*J J
MG<3D  >PK1\%>'8O!_@W0M!@&(=,L(+),>D<:H/Y5M5R8[&4\1>,():[]7^!
M>%P\Z:4I2Z;=KA7F_P"T;\2[CX/_  1\7^+K(PB_TVR+6GGKN3SV8)'D9&1N
M8<5Z17QQ_P %2?%_]A_L^V&BHV)=;U>&,J#UCB5I6_\ 'EC_ #KRZ</:5(P[
MM+[V>CS**<GT3?W*YX-^R;^V/\;OBU^T)X4\,ZQXJCU+1KZ:1KRU.EVD8\E(
MGD;#1Q*P^[P=WIUK]'OB)XLC\"> ?$?B.8J(])TZXO3NZ'RXV8#\2*_,O_@E
M5X1_M?XX:_K[H&BT?1V16Q]V6:157_QQ9*^Q?^"A7C ^$OV6/%*QN$GU5X-,
M3GJ)) 7'_?"O7LYK3A[:%&E%*Z2TTU;M_D>;ETY24JE1W2?X)79\;_ S_@H5
M\2IOB;#>?$#QA%-X,M8+FZO;&/3+6-I L3>7%$R1J^YI#&H^;OSQFN%^-'_!
M0'XK?%+5[C^R=<N?!.@[_P#1]/T.4PRJN>"]PN)&;'7!5?117E_[//P7U#X^
M_%C1O!]B[6\5PQEO;M1G[/;)S))]<<#U9E'>OV5T_P"#_@/X3_!W6/#FEZ#9
M6?AR/39A>(\:LURHC.]YG(R[$ Y)_#' KT,=+"X%JHZ:;MHMMKZ^O3Y'+A/;
MXINFIV3>K]>B_/IN?F/^S;^W1\1OA[\0=(@\3>*-1\5>%;RYC@O[?6;AKJ2-
M&8*98Y7)=67.<9VG!!'0C]A00P!'(K^?+P/HLOB;QQH&DVJGS]0U&WM8EZG<
M\JJ/YU_08B^6BJ.=HQ6&<4J<%3E%6;O?Y6_S'E\YRG.+=TK?J.K/\0:Y9^&-
M"U'6-0E$%AI]O)=7$IZ+&BEF/Y UH5\Y_P#!03Q7+X4_96\7&!]DVHF#3@?]
MF250X_% X_&OFU%S:A'=M+[]#W59.\MEJ_1:L_)KXT?%+5?C?\4=;\6:DTCW
M&I7!^SV^2WD0@XBB4>BK@<=3D]Z_7+]C;]FG3?V>_A?8^?9QGQCJL*7&KWK*
M#(&8;A;J>R)G&!U8$]^/RQ_9'\'P^.OVE/A]I%P@EMVU-+F6,C(9809B#[$1
MXK]S:^HS2:P]&&&IZ+]%M_7D>#@TZ]>5:INOS?\ D%?EG_P5:\(Z=H_Q<\+Z
MY:0K#>:QIC"[*#'F-$^U7/J=K!<^BBOU,K\H/^"IGC*+7OCUI>AP.'70](CC
ME .=LLKM(1_WP8_SKQ\NO]<IV\_NL_UL>IBK?5JE^R_]*1Z#_P $C;Z?^T?B
M79;S]F,5A-L[;LSC/Y?RKU;_ (*E>+_[#_9]L-%1\2ZWJ\,;+ZQQ*TC?^/"/
M\ZX__@DOX1EL_ _COQ+(A6/4+^"QB8]_)C9VQ^,X_*O/O^"LWC#[;\0/!/AE
M)<KI^G2WTD8/1II-HS^$/ZUZ6*BJV:0@O[OX+F_2QPX27)@YS_Q?C[OYNYQW
M_!+OPA_;W[15QK#IF+0](GG#8Z22%8E'_?+O^5?K57P'_P $EO!_V7P=X\\4
M/'S>7T&G1.1VB0NV/QF7\J^_*Y\WGS8GE_E27Z_J/+HVI.7=O\-/T$9@JEB<
M #)-?@7\;/%S>/?C!XS\0&3S5U'5[F:-O^F9D;8/^^=HK]N/CUXO'@+X*^-]
M?W;7L=(N9(SG'[SRR$'_ 'T5K\*O!_A'5_'_ (HTWP[H-FVH:SJ4PM[6V5U0
MR.>@W,0H^I( K7)87JSJ/HDOO>OY(O,9<M&,>[_)?\$_=CX$^$!X!^#/@GP_
ML\N33](MHI5_Z:>6ID/_ 'T6KNJ_%_\ X=Z_M ?]"#_Y6=/_ /DBOJO_ ()[
M_LE_$+X*?$3Q#XG\<Z0NA(^F?V?:6_VV"X:8O*CLW[IW "B(#D@_-QWJ,3A:
M+YZWMTWJ[:?YF=&M4A&%+V3TLO\ @['WK1117A'K'RW_ ,%!/CAXV^!7POT'
M5?!-_'I=Y?:J+2>[>UCG9$\IW 59%91DKU(KSC_@GC^U'\0_CEXU\5Z+XYUY
M-;CM-/2\M3]A@MVC/F!&YBC0$'<.N?:NT_X*?:.-1_9E:ZVY.GZS:SYQT#!X
M_P#VH*^5O^"5NH?9OVA]8MCTN?#UP!]5G@;^6:]_ TJ=7!5I.*NKZ^D4SR\9
M.=.O247H[?\ I31^C/[0WQ=MO@;\(/$7B^?8UQ9P;+.&3I-<O\L2>XW$$^P-
M?FO\)O\ @H!\:M9^+/A2RUGQ9#>Z+?:O;6UU9-I=I&AADE56 98@XX)P=WYU
MV'_!4KXV'Q%XYTGX;Z;/NLM#47FH*AX:[D7Y$/\ N1G/UE/I7QQ#I^H_#WX@
M6=OJ<+66I:7?0R30N>8F5E?!]Q77E&#IS@JE6*;GM?LO\^_:QAF5></<INW*
MM;=WT_KK<_H%)"@D\"OR5^,W_!1#XM2?%'Q)%X-\51Z5X9M[Z6WT^"+3+2;=
M$C%5<M)$[$MC=U[U]\_MD_&)/@]^SSXCU>&?R=5U"'^S=-P1N\Z8%=P_W4WO
M_P !K\O?V*?@VWQH_:!\/Z?<0&;1M,?^U=2)&5\F(@A#_ON43Z,?2N+*J$)R
MG6K*\8K_ (+^Y6^\Z<=6<*<8T_BE_P ,OO?Y'ZW^&_%6N^&/@#9^)?&DL<OB
M&Q\/_P!HZHPC$:^<L'F."JX P1@XP..*_-;X:_MW?'OQ[\6O#.CIXJM_L^K:
MO;VIL(](M/*"22JI4'R_,P 3SOSQUK[L_;T\7_\ "'_LL>-9%;;-J$4>FQX.
M,^=(JL/^^-_Y5^<W_!/7PC_PEG[5'A5V0/!I27&IR9'39$P0_P#?QTK;+84Z
MCK8BI!-+I;16O)V^31ECI3ITJ=&$GS/KU>R7XW/T$_;Y^/'B;X"_!^PU'PC<
M+8:WJ6J1V27S0)-Y";'D8A75E).P+R#U/?%?DG\2OB=XF^+WBN?Q+XNU1M7U
MJ=$B>Y,,<.51=J@)&JJ,#T%?OQJVHQ:/I=Y?SG;!:PO/(WHJJ6/Z"OP$F>\^
M)OQ(D903?^(-6)&>3YD\W^+T\EY93E#EU6M_72WX,K,KQIJ?-9;6[VU;_(]%
M^&/[77QB^&7AK3_"/@SQ0VGZ5#(PM;&+2K.=B\CEB SPL[$LQZD]0!V%?L%J
M'BG5/!/P'F\0^)IE.MZ9X=-YJ,FQ4!N4M]TGRC@?.#P./2NRT72X="T>PTVV
M7;;V=O';Q+Z*BA0/R%?/?_!0KQ@?"7[+'BE8W"3ZJ\&F)SU$D@+C_OA7KS\;
MB88UJG""3D[7ZN^BZ>>NYT8.A+#M5)RNDKVZ+J_R/R%\'WFG2>.-*O?$4LC:
M6MZES?LB[I)(PV]U4=V8 @9XR1FO=_C-_P % /BM\4=5G&D:W<>"-!#8M]/T
M.4PRJHZ%[A<2,V.N"J^BBO,_V=/@G?\ [0'Q8TCPA92-;03$SWUXHS]FMDP9
M'QZ\A1ZLRU^REG\)? GPE^#NL^']+\/V-GX;ATV8WD3Q*QN5$9WO,Q&9&(')
M;->]F6(H851E4CS-)M+MY_AIZ'EX*E5Q$Y1A*U[)OKZ?CJ?F%^SA^W1\2/AW
MX_TF'Q)XGU+Q7X6N[E(;^UUFX:ZD1&8*9(Y7)=67.<9VG&".A'[$ A@".17\
M]WA#19?$_C#1=(M4)FU"_AM8DSGYI)%4#]:_H/BC$4:(.B@#\JXLXI4X*G.*
MLW>_RM_F;9?.;G.+=TK?J/HHHKYH]L**** "BBB@ HHHH BE[U^47_!5#_DX
M30/^Q7M__2N[K]79>]?E%_P50_Y.$T#_ +%>W_\ 2N[KV,I_WE>C//QW\%G,
M_P#!._\ Y+1KO_8NS_\ I3;5^A]G_K17YX?\$[_^2T:[_P!B[/\ ^E-M7Z'V
M?^M%&:_[R_1!@?X)W.@]!796?W17&Z#T%=E9_=%>.>@7:*** *US]TU^$'[1
M7_)P7Q._[&C5/_2N6OW?N?NFOP@_:*_Y."^)W_8T:I_Z5RU]%DW\2?H>3F'P
MQ/LO_@GI_P D1UK_ +&&?_TFMJ^K])_U@KY0_P"">G_)$=:_[&&?_P!)K:OJ
M_2?]8*\S'?[S/U.W#?P8G?Z']U:ZBWZ5R^A_=6NHM^E<!TEBBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ KRO]JK_ )-K^)O_ &+U[_Z):O5*\K_:
MJ_Y-K^)O_8O7O_HEJVH_Q8^J,ZGP/T/FG_@DQ_R2KQM_V&D_]$)7W57PK_P2
M8_Y)5XV_[#2?^B$K[JKJS#_>IF&%_@Q"BBBO/.L**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ#M*GGC/0@UZ!X+_ ."FGQ@\'^&[32)8_#_B'[+&(DOM7LY6N2H& &:.9 Q
MQR1D]R3S7VU3VN)P].>#E;^EI\CYY\M+$U/;JZ>WWO7Y_H??7P]_81^"WPYO
M8+ZT\(1ZOJ$/*7.M3/>8/8^6Q\O(/0[,BO?E4(H50%4#  ' K\D_"_[5G[0O
M[37Q&T3PWI.M7>GVMS?0?:(/#-K]G2WB\P;Y))5S(J!<D[GQ@5^LNHWBZ=I]
MU=NK,D$32LJC)(4$X [GBOG<=2K4(QEB)W;OI>]K6_KY'IX6=.I)PHQMM\[W
M/Q8_;K\8'QE^U+XXG#[X+&X338L'@"&-48?]]A_SK]/_ -B?P:/ _P"R_P"
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M.J@8 $DT;M@#H,\5]?C,*LPC"K0DM%;Y;GSN'J/!SE"K'<_8/XQ?&#P[\#_
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M028]=TDH!_"*OJK]M?Q</!?[+_C^\#[);FP_L^/!P2T[K#Q^#D_A7$?\$W/
ML_@W]F>PN;NUDM+O6[^XU%EF0JY3(B0X/8K$"/9LUQO_  57\23Z=\$?#VCP
MI)Y>I:RKS.JG:$BC<@$].693_P !IX[_ &C'\G2\5^5_U)P'[K#^TZ^\_NO;
M\D?$_P"PKX0_X3+]J;P- R;X;&Y?4I.,X\B-I%/_ 'VJ#\:_;"OS!_X)0^!9
M[WXE>*_%LMK*+2PTP6,-PR$(999%8@-T)"Q'([;O>OT^K;.:G-6C!=%^+?\
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MOTG_ %@KS,=_O,_4[<-_!B=_H?W5KJ+?I7+Z']U:ZBWZ5P'26**** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %>5_M5?\ )M?Q-_[%Z]_]$M7JE>5_M5?\FU_$W_L7KW_T2U;4?XL?5&=3
MX'Z'S3_P28_Y)5XV_P"PTG_HA*^ZJ^%?^"3'_)*O&W_8:3_T0E?=5=68?[U,
MPPO\&(4445YYUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^%V$TI:,IZ5H]AH5FEIIMC;:?:)]V"UA6)%^BJ !5RBBEON/8****0!1110
M4444 %%%% '#ZQ\#/AOXAOGO=5^'WA74[QSN>XO-%MI9&/J69"372Z!X9T?P
MI8BQT32;'1[('(M]/MD@C!_W4 %:=%5S2MRWT%RJ][:A1114C"BBB@ HHHH
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M_&NUHIJ3B[IB:35F5['3[72[.*TLK:&TM85VQP01A$0>@4< 58HHI#"BBB@
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MS]F/PC;O';1ZMXKU,,NFZ:[$( /O32D<[%)' P6/ (Y(_-F\_:5_:,^.VO7
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M,C:T=4/Q-\3_ &G?YGEC4I!!G_KCGR\>VW'M7V%\*_\ @J(NG_!W56\;V/\
M:GC[3RD5@MK'Y4>IA@<22;1MC*$?/@ '*[1R<=5;*J]*',O>\D<]/'4YSY7I
MYL_1*BOQ \??MG?&3X@:Y+J,_CS6-%1F)CLM!NY+"")>RA8F!8#U<L?>O?\
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M/@#_ +"=Q_Z*%==7VO\ :$?;6YKQVVZ6_ YJ"IK"R]G>UI;_ #./_P""1O\
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MYT']H1_E/WEHK\&O^&D/BW_T5'QI_P"%!=__ !RC_AI#XM_]%1\:?^%!=_\
MQRC^QJG\Z#^T(_RG[RT5^#7_  TA\6_^BH^-/_"@N_\ XY1_PTA\6_\ HJ/C
M3_PH+O\ ^.4?V-4_G0?VA'^4_>6BOP:_X:0^+?\ T5'QI_X4%W_\<H_X:0^+
M?_14?&G_ (4%W_\ '*/[&J?SH/[0C_*?O+17X-?\-(?%O_HJ/C3_ ,*"[_\
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MC_AI#XM_]%1\:?\ A0W?_P <H_L:I_.@_M"/\I^\U%?@S_PTA\6_^BH^-/\
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M_P#HJ/C3_P *&[_^.4?V-4_G0?VA'^4_>:BOP9_X:0^+?_14?&G_ (4-W_\
M'*/^&D/BW_T5'QI_X4-W_P#'*/[&J?SH/[0C_*?O-17X,_\ #2'Q;_Z*CXT_
M\*&[_P#CE'_#2'Q;_P"BH^-/_"AN_P#XY1_8U3^=!_:$?Y3]YJ*_!G_AI#XM
M_P#14?&G_A0W?_QRC_AI#XM_]%1\:?\ A0W?_P <H_L:I_.@_M"/\I^\U%?@
MS_PTA\6_^BH^-/\ PH;O_P".4?\ #2'Q;_Z*CXT_\*&[_P#CE']C5/YT']H1
M_E/WFHK\&?\ AI#XM_\ 14?&G_A0W?\ \<H_X:0^+?\ T5'QI_X4-W_\<H_L
M:I_.@_M"/\I^\U%?@S_PTA\6_P#HJ/C3_P *&[_^.4?\-(?%O_HJ/C3_ ,*&
M[_\ CE']C5/YT']H1_E/WFHK\&?^&D/BW_T5'QI_X4-W_P#'*/\ AI#XM_\
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M/C3_ ,*&[_\ CE']C5/YT']H1_E/WFHK\&?^&D/BW_T5'QI_X4-W_P#'*/\
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M_P#CE']C5/YT']H1_E/WFHK\&?\ AI#XM_\ 14?&G_A0W?\ \<H_X:0^+?\
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M:?\ A0W?_P <H_L:I_.@_M"/\I^\U%?@S_PTA\6_^BH^-/\ PH;O_P".4?\
M#2'Q;_Z*CXT_\*&[_P#CE']C5/YT']H1_E/WFHK\&?\ AI#XM_\ 14?&G_A0
MW?\ \<H_X:0^+?\ T5'QI_X4-W_\<H_L:I_.@_M"/\I^\U%?@S_PTA\6_P#H
MJ/C3_P *&[_^.4?\-(?%O_HJ/C3_ ,*&[_\ CE']C5/YT']H1_E/WFHK\&?^
M&D/BW_T5'QI_X4-W_P#'*/\ AI#XM_\ 14?&G_A0W?\ \<H_L:I_.@_M"/\
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M_P".4?\ #2'Q;_Z*CXT_\*&[_P#CE']C5/YT']H1_E/WFHK\&?\ AI#XM_\
M14?&G_A0W?\ \<H_X:0^+?\ T5'QI_X4-W_\<H_L:I_.@_M"/\I^\U%?@S_P
MTA\6_P#HJ/C3_P *&[_^.4?\-(?%O_HJ/C3_ ,*&[_\ CE']C5/YT']H1_E/
MWFHK\&?^&D/BW_T5'QI_X4-W_P#'*/\ AI#XM_\ 14?&G_A0W?\ \<H_L:I_
M.@_M"/\ *?O-17X,_P##2'Q;_P"BH^-/_"AN_P#XY1_PTA\6_P#HJ/C3_P *
M&[_^.4?V-4_G0?VA'^4_>:BOP9_X:0^+?_14?&G_ (4-W_\ '*/^&D/BW_T5
M'QI_X4-W_P#'*/[&J?SH/[0C_*?O-17X,_\ #2'Q;_Z*CXT_\*&[_P#CE'_#
M2'Q;_P"BH^-/_"AN_P#XY1_8U3^=!_:$?Y3]YJ*_!G_AI#XM_P#14?&G_A0W
M?_QRC_AI#XM_]%1\:?\ A0W?_P <H_L:I_.@_M"/\I^\U%?@S_PTA\6_^BH^
M-/\ PH;O_P".4?\ #2'Q;_Z*CXT_\*&[_P#CE']C5/YT']H1_E/WFHK\&?\
MAI#XM_\ 14?&G_A0W?\ \<H_X:0^+?\ T5'QI_X4-W_\<H_L:I_.@_M"/\I^
M\U%?@S_PTA\6_P#HJ/C3_P *&[_^.4?\-(?%O_HJ/C3_ ,*&[_\ CE']C5/Y
MT']H1_E/WFHK\&?^&D/BW_T5'QI_X4-W_P#'*/\ AI#XM_\ 14?&G_A0W?\
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M@_M"/\I^\U%?@S_PTA\6_P#HJ/C3_P *&[_^.4?\-(?%O_HJ/C3_ ,*&[_\
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MW_8T:I_Z5RU^[]S]TU^$'[17_)P7Q._[&C5/_2N6OHLF_B3]#R<P^&)]E_\
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M'KVZ5^_.K?\ (*O?^N+_ /H)K^?[X?\ _(^^&_\ L)VW_HU:_H!U;_D%7O\
MUQ?_ -!-;\0?P8?]O?DCFRG^/+_MW\V?SUI9OJ&L+:Q8$D\_E+NZ99L#/YU^
MY/[/O[._AGX!?#FT\.:=96]S>RPK_:NHO$#)?3$?,6)&=@)(53P![Y)_$+0_
M^1PT_P#Z_P"/_P!&"OZ$ZZ,XG*-&G!/25[_*W^9&#BI8FHW]FUOFW_D06-C;
M:9:16MG;Q6EK"NR.&! B(OH%' 'TK\&_VA/^2\?$3_L8+[_T>]?O77X*?M"?
M\EX^(G_8P7W_ */>O/R?_>7_ (7^:._'?[M_V\ORD?MQ\%_^2.^!/^P#8?\
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MR7Y(\A16,QDE]E*WZ)_G(^"?^"5OQ4_X1_XFZ]X%NIL6NOVOVJU5CP+F $D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#@\5\=C<!+"^]'6/Y>I]!A\4JWNO1GKM%%%>2=P4444 %%%% !1110 4444
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MR:^X/VH/^"DVG_$[X=ZCX1\!:'JFF1ZM$;>^U+6/+CE6$_?CCCC=QEAD%BW
M)P,G(\V_X)[_ +.^H_%;XP:=XKO+-T\)^&;A;R6ZD3Y)[I,-%"I[D-M=L= H
MSC<,WE=*>"53$5U9:?A?\[V1GF%2.)A"C2=WK^-O\C[Z_;Y4K^R-X\!.XB*T
M&?7_ $N&OSK_ ."=_P#R=IX._P"N=[_Z2RU^BW[?G_)I/C[_ *Y6O_I7#7XV
M^%=:UCPSK]GK.@7%S9ZMIS_:X+JUSOA*<[^.P YSQC.>*RR9<U"O'NVOOBD:
MYDO=I6Z/\K']"M?B9^W3?VVH_M7?$&2T*M&EW%"S+T+I!&C_ ),I'X5[I;_\
M%8O%\?@<Z?-X,TR7Q1Y)C76ENV6#=C D-ML.3WQY@&>P'%?'7A_0O$7QB^(=
MMIMDDVL>)=?OC\QY:6:1BSNQ[#DLQZ  GH*O+L!6P^(=2IHDFO6[7^746*Q=
M.I0Y([MI^EK_ .?0_3?X$Z=>0_\ !,N\A16$\OAW6I4"D@E6DN6'Z5^7G@CP
MG=>//&6B>&[&:WMKW5[V&Q@ENW*Q+)(X12Y ) R1T!/M7[O^!?AIIW@SX3Z/
MX% %QIUEI2:9(<8\T>7L=C_O$L?QK\3_ (T?"KQ#^SG\7+[0[M9K2YT^Z^TZ
M9?J"!/"'W0S(WX#/HP([56 Q$*F-KZ_&[K[W_FB,31G'!4UUC>_JTOU7Y'T-
M_P .H_BW_P!#%X+_ / Z[_\ D6C_ (=1_%O_ *&+P7_X'7?_ ,BUZ_\ #?\
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MU_\ :>\51^);G1O[)\.Z7_H%A#&I<0[\OB27 #2/L)QP,+P."3]G_P#!)?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOACJ_P 9?B%H_@W0GMHM4U21DADO&984VHSLSE58@!5/0&OU&_X*=>+AX?\
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MR./+[2MZ+[M?U/(S1MPA36[N_OT7Y,_H ACM](TY(P4M[2UB"@L0JHBCN>P
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M?RKF?^"2?A,R:O\ $'Q.Z<0P6VFQ-Z[V>1Q_XY'^=:4\1/$8"I5K>?\ DO\
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MP6VFPR?[[-)(/_'(_P ZC_X*S>/Y9M=\$>"HI<006\FK7$8[N[&*(GZ!)?\
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M5K5IXBHZD]W_ ,,>U2I1HPY(;?TPHHHK U(I>]?E%_P50_Y.$T#_ +%>W_\
M2N[K]79>]?E%_P %4/\ DX30/^Q7M_\ TKNZ]C*?]Y7HSS\=_!9S/_!._P#Y
M+1KO_8NS_P#I3;5^A]G_ *T5^>'_  3O_P"2T:[_ -B[/_Z4VU?H?9_ZT49K
M_O+]$&!_@G<Z#T%=E9_=%<;H/05V5G]T5XYZ!=HHHH K7/W37X0?M%?\G!?$
M[_L:-4_]*Y:_=^Y^Z:_"#]HK_DX+XG?]C1JG_I7+7T63?Q)^AY.8?#$^R_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=?%O]GOX??'0:?\ \)QX<CUQM/WBU<W,T#QA\;@&B=20=HX)[5=^%'P2\$_
M_2+O3/!&A1Z'9W<HGG59Y9FD<# )>5F8X'09P.:[BBDJDU#V:D^7MT^X'",I
M<[6O<BNK6"^M9K:YACN+>9#')#*H9'4C!5@>"".QKYC\??\ !.#X+>.+^2\M
M]+U'PK/*Q>0:#=B*,D^D<BR(@]D4#VKZAHHIU)TGS4W9CE&,URR5T?)?A/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<ZG*HI77716M8\>I&M2Q4ZL(WO>W;5W/U!HHHKY4]L^,?^"E7[0P^'?PWC\
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M/%W)5I6V ?\  =HK]T_AGX5C\#?#GPQX=B7:FE:9;6>/=(U4G\P:_//X7?\
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MJ_Q*E3G/&NHU[JV?HN5?>M3\XO\ @JOXN_M;XU^'= 1MT>CZ0)&'I)-(Q/\
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MC1JG_I7+7[OW/W37X0?M%?\ )P7Q._[&C5/_ $KEKZ+)OXD_0\G,/AB?9?\
MP3T_Y(CK7_8PS_\ I-;5]7Z3_K!7RA_P3T_Y(CK7_8PS_P#I-;5]7Z3_ *P5
MYF._WF?J=N&_@Q._T/[JUU%OTKE]#^ZM=1;]*X#I+%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7E?[57_)M?Q-_[%Z]_P#1+5ZI7E?[57_)M?Q-
M_P"Q>O?_ $2U;4?XL?5&=3X'Z'XIZE_R2KP[_P!AK4__ $185RE=7J7_ "2K
MP[_V&M3_ /1%A7*5^B0V^_\ ,^2EN%%%%62%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5]&_\ !/?Q,?#7[5OA ,2(=1%S82<XSO@<J/\ OM4KYRKU/]E>
M\^P_M)_#&3.-WB&RB_[[F5/_ &:L,1'FHSCY,VI/EJ1?F?NQ1117YR?6A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!4-W=1V-K-<3,$AA1I'8] H&2?RJ:FNBR(R.H96&"K#((]*3O9V&K7U/P"\2
MZA=_%+XJZG>1;I;WQ#K,DD8/)+SS$J/S85^]WAW18?#?A_3-)M@%M["UBM8U
M'0*B!1^@KF]+^"/PZT36(M6T[P#X7L-5B?S8[ZUT:VCG1^NX.J!@??-=K7K8
MO&1KTJ=*$;*/_ 2^XX*6'E"M.M-W<O\ .[_0****\H[@HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV\,_]B['_P"E,]>7A:2KUX4I;._Y-_H>C5DZ=*=1;I?JE^I]D?\ #PK]G_\
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M  [FO =4_;X^ NCWTUG<?$&!YHF*L;;3KR>/(..'CA96'N"17 ?\%&OVBO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH *\K_:J_Y-K^)O\ V+U[_P"B6KU2O*_VJO\ DVOXF_\
M8O7O_HEJVH_Q8^J,ZGP/T/Q3U+_DE7AW_L-:G_Z(L*Y2NKU+_DE7AW_L-:G_
M .B+"N4K]$AM]_YGR4MPHHHJR0HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O5_V3[(ZA^TM\,H@NXKK]I+C_<D#Y_\=KRBOIG_ ()S^%SXD_:J\-SLA>'2
M;>ZU"3'08A:-2?\ @<B5SXB7+1G+R9M17-4BO,_9*BBBOSH^M"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK-\0>)=(\)Z7
M)J6N:K9:-IT9 >\U"X2"%<],NY 'YUE^$OB=X.\?33Q>&/%FA^(Y8%#3)I.I
M0W31@\ L(V.!]:I1;5TA-I:,Z:BBBI&%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45Y)\3OVL/A/\
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MZ?I.WY$5O=S"*7E_Z0?<U%%%?-'KA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\
M6_\ !4;XJ_\ "*?!O3?!UK-LOO$UV#,JGG[+"0[?FYB'T!K[2K\:?^"@WQ5_
MX6;^T?K5O;S>;I?AU1H]N <KN0DS,/?S&8?117?@:/M\3"+V6K^7_!L8UZGL
MJ,I]=EZO_@79ZW_P3&^!]GXXA^(?B36;83:;-8-X=AWC(;SUW3D>X3RQ_P #
M-?'NM:?K'P7^*EW:*[6VM^&=6*QRXP1+!+E7'L2H/T-?L=^QA\+S\)_V<O".
ME30^3J-Y;_VG>AAAO.G^?#>ZJ43_ (#7P-_P4\^&'_"'_'>V\36\6RR\3V:S
MLRCC[1%B.3\U\H_\"->]2QG_  IRC?1^ZO6.O_R3/(^K\V N]_B^3T_+E^X_
M43X;^-[/XE> /#WBFP/^B:O8Q7B+_<WJ"5/NIR#[BO/_ -L+Q-JW@_\ 9K\=
M:OH>H7&E:I;6:F"\M)#'+$3*BDJPY!P3R.>:\*_X)9_%/_A)OA'K'@NZFW7G
MAN\\V!6//V6?+ #Z2"7_ +Z%>Q?MS?\ )J/Q#_Z\X_\ T?'7S^,H_5\2Z:VN
MK>C:_0]7!5/;4X2>^S]5_5S\V_@S^W#\1/AA'XJN-2\4ZYXJO;W3#;:9#K5_
M+>0VUR9$_?D2,<;4$G ZD@'BO.?[+^+7CC48_B =/\7:S-/<AD\2);7,BF7=
M@!9P-H(/  /'2K?[+7PQT[XQ?'SP?X2U=W32[ZY=[E8SAI(XHGF://;<(]N1
MTW9K]S-,TVTT73K73["VBL[&UB6&"W@0(D2*,*J@<   #%?3XO$4\OJ1J0@G
M)_DO\_\ A^AXF'ISQ*<'+W5^;_X;^KL\D_::_:(L/V;?A2WB&\A%]K-QBUTW
M3W.//N"N<OW"* 68_AU(K\I[SQA\;?VQ/&DVGPW6L^++R7,W]E6<ABL;5,]=
MF1%&HX&YL9XR2:]S_P""KOBR?4/C!X6\/;V^RZ;H_P!J$?./,FE8,?\ OF)*
MS?V)?VP/AM^S/X!UG3]?T3Q!>^(=4O\ SYKK2[6WDC,"HJQ)N>9&X/F'&,?/
MUKAP%%0PSQ*AS3=[+YV_X/X'5BJC52.'YK125W\K_P# ]=3Q/Q5\+OC5^RG>
M6>J:E9ZYX'>X?;#J&G7P,3L.=AE@D9<X'W6/(!XQ7Z(?L%?M?7W[0&CW_AGQ
M8T;>,M'A6?[7&BH+^WR%,A4<!U8@-@ '<I ZUXO^TO\ \% OA7\</@IXD\'6
M?A[Q0FHWT:&SFOK.V6**9)%=6++<,PZ'H#UKP?\ X)VZM/IG[67A&*%B$O8K
MRVE /5/LTCX/_ D4_A77R5,9AZGUFGRRBFT_17_X#.>4H8:I"5"5T]U^?X;'
MW?\ \% /VCO%7[/W@'0O^$0\FUU/7+F6W.I31"4VR(@)V*WR[R6&"P( !X[C
MX%M_@-^TE^T5!_;5UHWB;Q%!)\\=QKU\+=&!Y!B%S(@*^FP8]*_8#QS'X3M]
M)36/&$6CKIVD2"\2]UE(C'9R 8$BM(,(W. 1@\XKYW\7?\%+O@IX9N&AM+[6
M/$I4D%](T\[<CT,S1@_49%>+@JTJ<7&C2YIWWWM_7J>IB::FTYSY8]N[/S0U
M[1?BS^RUXLAM+U]<\":P5$T1M;LHDR@]5>-BDBYX(!([&OU(_89_:4O_ -HK
MX6W4FO>6?%.AS+:7TT2A%N59<QS;1PI;# @<90D8!P/B+]N3]KCP/^TUH?A6
MW\,:1K=C?:3<S22S:O;PQ@QR*HVJ8YG)Y4$Y Z5Z=_P2,N'75OB9!QL:#3W/
MKD-./ZUZ^(A+$X&<\1#EFO\ -?I^)YL7&CB(*C*\7O\ U^)\N_M#?\+H_M&^
M_P"%C_\ ";?V'_:LWV/_ (2'[5]B\W+X\CS/W>=F[&S^'..*Y/X2_P#"SO[3
MO_\ A6'_  EO]H>2/M?_  B7VKS?*W<>9]GYVY]>,U^AW_!63_DC/A#_ +#X
M_P#2::O)/^"2W_)2_'7_ &"(O_1PJ\+B>;!RJ<J]W3ULD&+I\N(BK_%^%VSW
MK_@G7_PMO^P_&O\ PM+_ (2S'VFV_L__ (2W[3YWW9/-\OS_ )MO^KZ<9]\U
M\S?M(_M.?&SXM?&CQ+\/_!4FLV%AI>H3V,.D^&(I!=3+$Y0R2R1CS"#C)&0@
M!''<_JW7D7Q(^-7PA_9SO+RZ\0ZEI'AW5]5;[3<065J'O;QL8$DB1*7;IC>_
M''6O"CBHU,2ZSIIW5DO/3_)GI^P<*'LXSMK>_EK_ )H_+/5_V(?V@(K&;7K[
MP-J-P%4SO(-0MI[D]R?+64R%O8+FF?L\?MB>/O@1XNL!<ZUJ&L^%EE6*^T/4
M)VE019PQB#D^4X'(VXR1@@BON2^_X*I?""SN&CBTGQ=>H#@306%N%/N-]PI_
M,5^8_P 6/$VF^-/B?XL\0:-;36>E:IJES>VL%PJK)'')*SJ&"D@'!YP2/>OH
M<+4KXB3AB:24;=OP_KL>37ITJ<>:E4]Z_?\ $_?BPOH-3L;:\MI!+;7$:S12
M#HRL 0?R-6*X7X$W#WGP1^'\TF-\GA^P8X_Z]TKNJ^/K0]G4E!=&T>Y1FZE*
M,WU284445D;!1110 4444 %%%% !1110 4444 %>5_M5?\FU_$W_ +%Z]_\
M1+5ZI7E?[57_ ";7\3?^Q>O?_1+5M1_BQ]49U/@?H?BGJ7_)*O#O_8:U/_T1
M85RE=7J7_)*O#O\ V&M3_P#1%A7*5^B0V^_\SY*6X44459(4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7Z0_\ !)OX<36VF^-/'5Q$5CNFCTFS<C[P7]Y,
M0?3)B'X&OSGTW3KG6-1M;"SA:XO+J58(84^\[L0JJ/<D@5^[G[//PGA^"7P=
M\,^$(]K7%C;!KN1 !YEPY+RMQU^9B![ 5XF;5O9T/9K>7Y'I8&GS5.;L>C44
M45\:?0A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO7['_LU^'==\)_ ;P/I7B:6YEUZWTR,7?VQRTL;'+"-B><H"$_X#7S+\*/\
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M5M&\R-;9F.%,D<COE,D98,,#G!K]#JSQ&%JX5I5%N.CB*=:_(]@HKQ;]I/\
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M,-04(1I7>B;ZWZV_RT-:F'K5YR;G9:V7Y7_SU/B']G/_ (*+>/? ?B;3]/\
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M (9O^$G_ $2WP7_X3UI_\;KO[&QMM+L;>SLK>*TL[>-8H;>! D<:*,*JJ.
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MM2U..R1B.2D$>[\LSG\J^[J\ _8/\'_\(;^RQX(B:/9/J$$FIR>K>=(SH?\
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M_8&^*O\ PM+]F[P_Y\PEU/0<Z-=<Y/[H#RB?K$8^?4&OC?\ X*O?\EV\,_\
M8NQ_^E,]>Y?\$\/@+\6O@/X@\6VWC70%T;P[J=K%)'NO[>X)N8VP,+%(^,H[
MY)QT6LK_ (*$?LI_$KXW?$GP]XA\$:)%KEG!I0L9XQ?06\D3K+(^2)G0$$2#
M&">AR!4R=*GF<:D9+E;;O?36+O\ B%+G>!G3DG=*R^4E;\/R,O\ X)D_%;P3
MX!^$OBBS\3^,= \.7<VMF6*WU;4X+61T\B(;E61@2,@C(]#7TI\1/VW?@S\.
MM)FNY?&VFZ_<*I,5CX?F6^EF;'"@QDHOU=E'O7YJ_P##O7]H#_H0?_*SI_\
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M88)M804C/XLTI'J"IK[*JMINFVFC:=:V%A;16=E:Q+#!;PH%2*-0 JJ!P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBO7?V:?V<]>_:.\?V^C:<CVVCP.LFJ
M:GMRMM#GG'8N1G:OK[5$YQIQ<YNR148N;Y8[GT1_P3._9O?QAXP;XGZW:YT;
M0Y3%I:R XGO,<N/41ANO]XCNM?J-6'X)\%Z1\._">F>'-"M%LM)TZ%8((5[
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M/M)7P]^W!XR_X3;]J+QU=++YL%G=KIT6.@$"+&0/^!*Q_&OU0_8Y\'_\(/\
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MB: C[HM%TA"RYZ2S.SM_XZL=?1G_  2U\ P^'_@3J/B9X M]X@U.3$V.6@A
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MO O^"EWP=^''PK@\/W_AK0%TWQ3XDU*ZO;Z[^V7$IE0 ,_R/(R+F24'Y5'3
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MX44459(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML</7P\FZ+33[GYU^#/!/CS]K;XR7"6JR:IKVL7)NM0U"12(;5"?FED/1$48
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M1P#N;;D5]17G["O[.WQZO)/$OA/6;BVM;EC+)%X3U2!K;<>3^[>.3R^OW!M
MZ8%<Y^T!X=^"_P"QO\"/%>B>$8[./QUX@L&TJ)Y;D7.IR)+A9'8G)CC";B0
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M<=J[:&98;"R:I0:C^+?GKMM8Y:V$KUX>_+WOP2^74]GAA2WA2*-0D:*%51T
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M@_:*_P"3@OB=_P!C1JG_ *5RU]%DW\2?H>3F'PQ/LO\ X)Z?\D1UK_L89_\
MTFMJ^K])_P!8*^4/^">G_)$=:_[&&?\ ])K:OJ_2?]8*\S'?[S/U.W#?P8G?
MZ']U:ZBWZ5R^A_=6NHM^E<!TEBBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M /)%?M!11_;&(_E7X_YA_9]+N_Z^1^+_ /P[U_: _P"A!_\ *SI__P D4?\
M#O7]H#_H0?\ RLZ?_P#)%?M!11_;&(_E7X_YA_9]+N_Z^1^+_P#P[U_: _Z$
M'_RLZ?\ _)%'_#O7]H#_ *$'_P K.G__ "17[044?VQB/Y5^/^8?V?2[O^OD
M?B__ ,.]?V@/^A!_\K.G_P#R11_P[U_: _Z$'_RLZ?\ _)%?M!11_;&(_E7X
M_P"8?V?2[O\ KY'XO_\ #O7]H#_H0?\ RLZ?_P#)%'_#O7]H#_H0?_*SI_\
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M_P##O7]H#_H0?_*SI_\ \D4?\.]?V@/^A!_\K.G_ /R17[044?VQB/Y5^/\
MF']GTN[_ *^1^+__  [U_: _Z$'_ ,K.G_\ R11_P[U_: _Z$'_RLZ?_ /)%
M?M!11_;&(_E7X_YA_9]+N_Z^1^+_ /P[U_: _P"A!_\ *SI__P D4?\ #O7]
MH#_H0?\ RLZ?_P#)%?M!11_;&(_E7X_YA_9]+N_Z^1^+_P#P[U_: _Z$'_RL
MZ?\ _)%'_#O7]H#_ *$'_P K.G__ "17[044?VQB/Y5^/^8?V?2[O^OD?B__
M ,.]?V@/^A!_\K.G_P#R11_P[U_: _Z$'_RLZ?\ _)%?M!11_;&(_E7X_P"8
M?V?2[O\ KY'XO_\ #O7]H#_H0?\ RLZ?_P#)%'_#O7]H#_H0?_*SI_\ \D5^
MT%%']L8C^5?C_F']GTN[_KY'XO\ _#O7]H#_ *$'_P K.G__ "11_P .]?V@
M/^A!_P#*SI__ ,D5^T%%']L8C^5?C_F']GTN[_KY'XO_ /#O7]H#_H0?_*SI
M_P#\D4?\.]?V@/\ H0?_ "LZ?_\ )%?M!11_;&(_E7X_YA_9]+N_Z^1^+_\
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M0?\ RLZ?_P#)%?M!11_;&(_E7X_YA_9]+N_Z^1^+_P#P[U_: _Z$'_RLZ?\
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M(_E7X_YA_9]+N_Z^1^+_ /P[U_: _P"A!_\ *SI__P D4?\ #O7]H#_H0?\
MRLZ?_P#)%?M!11_;&(_E7X_YA_9]+N_Z^1^+_P#P[U_: _Z$'_RLZ?\ _)%'
M_#O7]H#_ *$'_P K.G__ "17[044?VQB/Y5^/^8?V?2[O^OD?B__ ,.]?V@/
M^A!_\K.G_P#R11_P[U_: _Z$'_RLZ?\ _)%?M!11_;&(_E7X_P"8?V?2[O\
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M8?V?2[O^OD?B_P#\.]?V@/\ H0?_ "LZ?_\ )%'_  [U_: _Z$'_ ,K.G_\
MR17[044?VQB/Y5^/^8?V?2[O^OD?B_\ \.]?V@/^A!_\K.G_ /R11_P[U_:
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M_P#R11_P[U_: _Z$'_RLZ?\ _)%?M!11_;&(_E7X_P"8?V?2[O\ KY'XO_\
M#O7]H#_H0?\ RLZ?_P#)%'_#O7]H#_H0?_*SI_\ \D5^T%%']L8C^5?C_F']
MGTN[_KY'XO\ _#O7]H#_ *$'_P K.G__ "11_P .]?V@/^A!_P#*SI__ ,D5
M^T%%']L8C^5?C_F']GTN[_KY'XO_ /#O7]H#_H0?_*SI_P#\D4?\.]?V@/\
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M!_\ *SI__P D5^T%%']L8C^5?C_F']GTN[_KY'XO_P##O7]H#_H0?_*SI_\
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MVQB/Y5^/^8?V?2[O^OD?B_\ \.]?V@/^A!_\K.G_ /R11_P[U_: _P"A!_\
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M _Z$'_RLZ?\ _)%?M!11_;&(_E7X_P"8?V?2[O\ KY'XO_\ #O7]H#_H0?\
MRLZ?_P#)%'_#O7]H#_H0?_*SI_\ \D5^T%%']L8C^5?C_F']GTN[_KY'XO\
M_#O7]H#_ *$'_P K.G__ "15RR_X)R_'FZQYOA*UL_\ KMJ]H<?]\2-7[*44
M?VQB.R_'_,/[/I=W_7R/RF\-?\$J?BAJ;(^L:]X;T6$_>59YKB5?^ K&%/\
MWW7OWP]_X)5_#_P_<07/BOQ!JOBN2/!:UB"V5LY]PI9\?1Q7VW17-4S+$U-.
M:WH;1P=&/2YRGP_^%/@_X5Z>UCX1\-Z=H%N^/,^Q0!7DQT+O]YS_ +Q-=711
M7F2DY.[=V=B22L@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%V?_ -*;:OT/L_\ 6BOSP_X)W_\ ):-=_P"Q=G_]*;:OT/L_]:*,U_WE^B#
M_P $[G0>@KLK/[HKC=!Z"NRL_NBO'/0+M%%% %:Y^Z:_"#]HK_DX+XG?]C1J
MG_I7+7[OW/W37X0?M%?\G!?$[_L:-4_]*Y:^BR;^)/T/)S#X8GV7_P $]/\
MDB.M?]C#/_Z36U?5^D_ZP5\H?\$]/^2(ZU_V,,__ *36U?5^D_ZP5YF._P!Y
MGZG;AOX,3O\ 0_NK746_2N7T/[JUU%OTK@.DL4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %>5_M5?\FU_$W_ +%Z]_\ 1+5ZI7E?[57_ ";7\3?^
MQ>O?_1+5M1_BQ]49U/@?H?-/_!)C_DE7C;_L-)_Z(2ONJOA7_@DQ_P DJ\;?
M]AI/_1"5]U5U9A_O4S#"_P &(4445YYUA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%>?_ !X^,%A\!_A;K/C74+234(=/$82SBD"-/([JBJ&(..6R3@\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@"*7O7Y1?\%4/^3A- _[%>W_ /2N[K]79>]?E%_P
M50_Y.$T#_L5[?_TKNZ]C*?\ >5Z,\_'?P6<S_P $[_\ DM&N_P#8NS_^E-M7
MZ'V?^M%?GA_P3O\ ^2T:[_V+L_\ Z4VU?H?9_P"M%&:_[R_1!@?X)W.@]!79
M6?W17&Z#T%=E9_=%>.>@7:*** *US]TU^$'[17_)P7Q._P"QHU3_ -*Y:_=^
MY^Z:_"#]HK_DX+XG?]C1JG_I7+7T63?Q)^AY.8?#$^R_^">G_)$=:_[&&?\
M])K:OJ_2?]8*^4/^">G_ "1'6O\ L89__2:VKZOTG_6"O,QW^\S]3MPW\&)W
M^A_=6NHM^E<OH?W5KJ+?I7 =)8HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *\K_:J_Y-K^)O_8O7O_HEJ]4KRO\ :J_Y-K^)O_8O7O\ Z):MJ/\
M%CZHSJ? _0^:?^"3'_)*O&W_ &&D_P#1"5]U5\*_\$F/^25>-O\ L-)_Z(2O
MNJNK,/\ >IF&%_@Q"BBBO/.L**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.FG_ +/OPCU7Q)=%9-1D4VNF6A;!GNG!V#_=7EF]E/?%?)G_  23\(>7IOQ
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M[_>9^IVX;^#$[_0_NK746_2N7T/[JUU%OTK@.DL4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %>5_M5?\FU_$W_L7KW_T2U>J5Y7^U5_R;7\3?^Q>
MO?\ T2U;4?XL?5&=3X'Z'S3_ ,$F/^25>-O^PTG_ *(2ONJOA7_@DQ_R2KQM
M_P!AI/\ T0E?=5=68?[U,PPO\&(4445YYUA1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MACX?V4K1C5I&U&_"G&Z&(A8D/L7);ZQBN"_X)1_"^?4/&WBCQ]<0D66FVO\
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M5,/5DG>37ZV_)OYF_P#\$L?@Y9^)O&^O^/\ 4[99TT!4M=.$BY5;F4$M(/\
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MGP;X(^+.A>(/'FGW^J^']-E-TUCIT,<KS2J,Q!ED=%VA\,>>=N,<U][^,/\
M@K+X-M]+E_X17P9KE_J)4B,:PT-K"I[$^6\A('IQGU%>'?\ !.GX!_#GX[7G
MCF#QUHXUN?3H[-[*#[9/;E%<RB1AY4B%N50<YQQZU]UZ#^PU\"O#ERL]I\.]
M/F=>@OY[B\3\5FD=3^5>YF57#>U5.NFVETVUU/+P<*O*YTFE?OY'Y3?#7X4^
M-_VL/BU>'3+%I;C5+]KS5=32(K:V0ED+.['H.K;5SDXP,U^H7[9'C@? 7]E'
M4[?1I6MKF2U@\/Z>X.&0.NPD'U$2N1[@5[[H/A[2O"VEPZ;HNF6>D:=",1V=
MA;I!"G^ZB@ ?@*^*/^"LMQ*GPC\&0JQ$4FMLSCL2('Q_,UY=;$K&U*5!1M!-
M:?-?IH>C1HO#\]>3O.S=_/?\SXC_ &/_ (-0?'3X]>'_  [?H9-%B+7^I*#C
M=;Q#)3Z.VQ/;?FOV\LK&VTVQ@L[2WBM;2"-8HK>% D<: 8"JHX  XP*_+?\
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MTO\ 9'PS4;O)\^_+<<;ML&/QQG]:\>E4EB<93E4W<E^&OZ'I*G&C0E&'1/\
M)GQ?^S_^SGXM_:0\4W&C>%UM85LXUFO;Z^EV0VZ$X!. 68D@@!0?P'-?4OBO
M_@D[KNB^$;W4=+^(%IJVL6\#3+ILFEM;QRE1DHLWG-R<<93&>N.M;G_!(S[-
MYWQ-^9?MFW3\*>OEYN.1[9QG\*^T_P!H7XJ:=\&_@_XE\3ZA-'&T%H\=I$S8
M,]RZE8HU]26(^@!/:O8S/'8BA6=*@[:+INVOZ1YV7X:E67-577\#\3?A!\2-
M7^$/Q*T+Q1I%S):W6GW2-(J$@2Q;@)(F'=67((]Z_?6*02QHXZ, P_&OP7^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *\K_:J_Y-K^)O\ V+U[_P"B6KU2O*_VJO\ DVOX
MF_\ 8O7O_HEJVH_Q8^J,ZGP/T/FG_@DQ_P DJ\;?]AI/_1"5]U5\*_\ !)C_
M ))5XV_[#2?^B$K[JKJS#_>IF&%_@Q"BBBO/.L**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH \\^.GP-\/_ +0G@8^%/$EQJ%KIWVE+H2:9,L4H= 0.65E(
M^8\%3V]*XK]GO]C'P%^S;KVH:UX:N-8U#5+RV^R-<:O<QR&.(LK%4$<: 9*K
MDD$\5[Q16T*U2G!PA*R>YG.G"HU*2NUM^84445B:!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>5_M5?\ )M?Q
M-_[%Z]_]$M7JE>5_M5?\FU_$W_L7KW_T2U;4?XL?5&=3X'Z'S3_P28_Y)5XV
M_P"PTG_HA*^ZJ^%?^"3'_)*O&W_8:3_T0E?=5=68?[U,PPO\&(4445YYUA11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?$[_ +&C5/\ TKEKZ+)OXD_0\G,/AB?9?_!/3_DB.M?]C#/_ .DUM7U?I/\
MK!7RA_P3T_Y(CK7_ &,,_P#Z36U?5^D_ZP5YF._WF?J=N&_@Q._T/[JUU%OT
MKE]#^ZM=1;]*X#I+%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E
M?[57_)M?Q-_[%Z]_]$M7JE>5_M5?\FU_$W_L7KW_ -$M6U'^+'U1G4^!^A\T
M_P#!)C_DE7C;_L-)_P"B$K[JKX5_X),?\DJ\;?\ 8:3_ -$)7W575F'^]3,,
M+_!B%%%%>>=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7E?[57_)M?Q-_[%Z]_P#1+5ZI7E?[57_)M?Q-_P"Q>O?_ $2U
M;4?XL?5&=3X'Z'S3_P $F/\ DE7C;_L-)_Z(2ONJOA7_ (),?\DJ\;?]AI/_
M $0E?=5=68?[U,PPO\&(4445YYUA1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!%+WK\HO^"J'_)PF@?\ 8KV_
M_I7=U^KLO>ORB_X*H?\ )PF@?]BO;_\ I7=U[&4_[RO1GGX[^"SF?^"=_P#R
M6C7?^Q=G_P#2FVK]#[/_ %HK\\/^"=__ "6C7?\ L79__2FVK]#[/_6BC-?]
MY?H@P/\ !.YT'H*[*S^Z*XW0>@KLK/[HKQST"[1110!6N?NFOP@_:*_Y."^)
MW_8T:I_Z5RU^[]S]TU^$'[17_)P7Q._[&C5/_2N6OHLF_B3]#R<P^&)]E_\
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MU_$W_L7KW_T2U;4?XL?5&=3X'Z'S3_P28_Y)5XV_[#2?^B$K[JKX5_X),?\
M)*O&W_8:3_T0E?=5=68?[U,PPO\ !B%%%%>>=84444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5]7Z3_K!7F8[_>9^IVX;^#$[_0_NK746_2N7T/[JUU%OTK@.DL4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %>5_M5?\ )M?Q-_[%Z]_]$M7JE>5_
MM5?\FU_$W_L7KW_T2U;4?XL?5&=3X'Z'S3_P28_Y)5XV_P"PTG_HA*^ZJ^%?
M^"3'_)*O&W_8:3_T0E?=5=68?[U,PPO\&(4445YYUA1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%+WK\HO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E?[57_)M?Q-_[%Z]_
M]$M7JE>5_M5?\FU_$W_L7KW_ -$M6U'^+'U1G4^!^A\T_P#!)C_DE7C;_L-)
M_P"B$K[JKX5_X),?\DJ\;?\ 8:3_ -$)7W575F'^]3,,+_!B%%%%>>=84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E?[5
M7_)M?Q-_[%Z]_P#1+5ZI7E?[57_)M?Q-_P"Q>O?_ $2U;4?XL?5&=3X'Z'S3
M_P $F/\ DE7C;_L-)_Z(2ONJOA7_ (),?\DJ\;?]AI/_ $0E?=5=68?[U,PP
MO\&(4445YYUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!%+WK\HO^"J'_)PF@?\ 8KV__I7=U^KLO>ORB_X*
MH?\ )PF@?]BO;_\ I7=U[&4_[RO1GGX[^"SF?^"=_P#R6C7?^Q=G_P#2FVK]
M#[/_ %HK\\/^"=__ "6C7?\ L79__2FVK]#[/_6BC-?]Y?H@P/\ !.YT'H*[
M*S^Z*XW0>@KLK/[HKQST"[1110!6N?NFOP@_:*_Y."^)W_8T:I_Z5RU^[]S]
MTU^$'[17_)P7Q._[&C5/_2N6OHLF_B3]#R<P^&)]E_\ !/3_ )(CK7_8PS_^
MDUM7U?I/^L%?*'_!/3_DB.M?]C#/_P"DUM7U?I/^L%>9CO\ >9^IVX;^#$[_
M $/[JUU%OTKE]#^ZM=1;]*X#I+%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7E?[57_)M?Q-_P"Q>O?_ $2U>J5Y7^U5_P FU_$W_L7KW_T2U;4?
MXL?5&=3X'Z'S3_P28_Y)5XV_[#2?^B$K[JKX5_X),?\ )*O&W_8:3_T0E?=5
M=68?[U,PPO\ !B%%%%>>=84444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIVX;^#$[_0_NK746_2N7T/[JUU%OTK@.DL4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %>5_M5?\ )M?Q-_[%Z]_]$M7JE>5_M5?\FU_$W_L7KW_T
M2U;4?XL?5&=3X'Z'S3_P28_Y)5XV_P"PTG_HA*^ZJ^%?^"3'_)*O&W_8:3_T
M0E?=5=68?[U,PPO\&(4445YYUA1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!%+WK\HO\ @JA_R<)H'_8KV_\
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MZP5YF._WF?J=N&_@Q._T/[JUU%OTKE]#^ZM=1;]*X#I+%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7E?[57_)M?Q-_[%Z]_]$M7JE>5_M5?\FU_
M$W_L7KW_ -$M6U'^+'U1G4^!^A\T_P#!)C_DE7C;_L-)_P"B$K[JKX5_X),?
M\DJ\;?\ 8:3_ -$)7W575F'^]3,,+_!B%%%%>>=84444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 12]Z_*+_@JA
M_P G":!_V*]O_P"E=W7ZNR]Z_*+_ (*H?\G":!_V*]O_ .E=W7L93_O*]&>?
MCOX+.9_X)W_\EHUW_L79_P#TIMJ_0^S_ -:*_/#_ ()W_P#):-=_[%V?_P!*
M;:OT/L_]:*,U_P!Y?H@P/\$[G0>@KLK/[HKC=!Z"NRL_NBO'/0+M%%% %:Y^
MZ:_"#]HK_DX+XG?]C1JG_I7+7[OW/W37X0?M%?\ )P7Q._[&C5/_ $KEKZ+)
MOXD_0\G,/AB?9?\ P3T_Y(CK7_8PS_\ I-;5]7Z3_K!7RA_P3T_Y(CK7_8PS
M_P#I-;5]7Z3_ *P5YF._WF?J=N&_@Q._T/[JUU%OTKE]#^ZM=1;]*X#I+%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7E?[57_)M?Q-_[%Z]_P#1
M+5ZI7E?[57_)M?Q-_P"Q>O?_ $2U;4?XL?5&=3X'Z'S3_P $F/\ DE7C;_L-
M)_Z(2ONJOA7_ (),?\DJ\;?]AI/_ $0E?=5=68?[U,PPO\&(4445YYUA1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!%+WK\HO^"J'_)PF@?\ 8KV__I7=U^KLO>ORB_X*H?\ )PF@?]BO;_\
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M #_0?6*G_/MGZ?45^8/_  P3^TQ_T4&T_P#"CO?_ (W1_P ,$_M,?]%!M/\
MPH[W_P"-T?4Z'_/]!]8J?\^V?I]17Y@_\,$_M,?]%!M/_"CO?_C='_#!/[3'
M_10;3_PH[W_XW1]3H?\ /]!]8J?\^V?I]17Y@_\ #!/[3'_10;3_ ,*.]_\
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M\,$_M,?]%!M/_"CO?_C='U.A_P _T'UBI_S[9^GU%?F#_P ,$_M,?]%!M/\
MPH[W_P"-T?\ #!/[3'_10;3_ ,*.]_\ C='U.A_S_0?6*G_/MGZ?45^8/_#!
M/[3'_10;3_PH[W_XW1_PP3^TQ_T4&T_\*.]_^-T?4Z'_ #_0?6*G_/MGZ?45
M^8/_  P3^TQ_T4&T_P#"CO?_ (W1_P ,$_M,?]%!M/\ PH[W_P"-T?4Z'_/]
M!]8J?\^V?I]17Y@_\,$_M,?]%!M/_"CO?_C='_#!/[3'_10;3_PH[W_XW1]3
MH?\ /]!]8J?\^V?I]17Y@_\ #!/[3'_10;3_ ,*.]_\ C='_  P3^TQ_T4&T
M_P#"CO?_ (W1]3H?\_T'UBI_S[9^GU%?F#_PP3^TQ_T4&T_\*.]_^-T?\,$_
MM,?]%!M/_"CO?_C='U.A_P _T'UBI_S[9^GU%?F#_P ,$_M,?]%!M/\ PH[W
M_P"-T?\ #!/[3'_10;3_ ,*.]_\ C='U.A_S_0?6*G_/MGZ?45^8/_#!/[3'
M_10;3_PH[W_XW1_PP3^TQ_T4&T_\*.]_^-T?4Z'_ #_0?6*G_/MGZ?45^8/_
M  P3^TQ_T4&T_P#"CO?_ (W1_P ,$_M,?]%!M/\ PH[W_P"-T?4Z'_/]!]8J
M?\^V?I]17Y@_\,$_M,?]%!M/_"CO?_C='_#!/[3'_10;3_PH[W_XW1]3H?\
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M_"CO?_C='U.A_P _T'UBI_S[9^GU%?F#_P ,$_M,?]%!M/\ PH[W_P"-T?\
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M%!M/_"CO?_C='_#!/[3'_10;3_PH[W_XW1]3H?\ /]!]8J?\^V?I]17Y@_\
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MI_S[9^GU%?F#_P ,$_M,?]%!M/\ PH[W_P"-T?\ #!/[3'_10;3_ ,*.]_\
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M #_0?6*G_/MGZ?45^8/_  P3^TQ_T4&T_P#"CO?_ (W1_P ,$_M,?]%!M/\
MPH[W_P"-T?4Z'_/]!]8J?\^V?I]17Y@_\,$_M,?]%!M/_"CO?_C='_#!/[3'
M_10;3_PH[W_XW1]3H?\ /]!]8J?\^V?I]17Y@_\ #!/[3'_10;3_ ,*.]_\
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M\,$_M,?]%!M/_"CO?_C='U.A_P _T'UBI_S[9^GU%?F#_P ,$_M,?]%!M/\
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M?\^V?I]17Y@_\,$_M,?]%!M/_"CO?_C='_#!/[3'_10;3_PH[W_XW1]3H?\
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M_"CO?_C='U.A_P _T'UBI_S[9^GU%?F#_P ,$_M,?]%!M/\ PH[W_P"-T?\
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M%!M/_"CO?_C='_#!/[3'_10;3_PH[W_XW1]3H?\ /]!]8J?\^V?I]17Y@_\
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MI_S[9^GU%?F#_P ,$_M,?]%!M/\ PH[W_P"-T?\ #!/[3'_10;3_ ,*.]_\
MC='U.A_S_0?6*G_/MGZ?45^8/_#!/[3'_10;3_PH[W_XW1_PP3^TQ_T4&T_\
M*.]_^-T?4Z'_ #_0?6*G_/MGZ?45^8/_  P3^TQ_T4&T_P#"CO?_ (W1_P ,
M$_M,?]%!M/\ PH[W_P"-T?4Z'_/]!]8J?\^V?I]17Y@_\,$_M,?]%!M/_"CO
M?_C='_#!/[3'_10;3_PH[W_XW1]3H?\ /]!]8J?\^V?I]17Y@_\ #!/[3'_1
M0;3_ ,*.]_\ C='_  P3^TQ_T4&T_P#"CO?_ (W1]3H?\_T'UBI_S[9^GU%?
MF#_PP3^TQ_T4&T_\*.]_^-T?\,$_M,?]%!M/_"CO?_C='U.A_P _T'UBI_S[
M9^GU%?F#_P ,$_M,?]%!M/\ PH[W_P"-T?\ #!/[3'_10;3_ ,*.]_\ C='U
M.A_S_0?6*G_/MGZ?45^8/_#!/[3'_10;3_PH[W_XW1_PP3^TQ_T4&T_\*.]_
M^-T?4Z'_ #_0?6*G_/MGZ?45^8/_  P3^TQ_T4&T_P#"CO?_ (W1_P ,$_M,
M?]%!M/\ PH[W_P"-T?4Z'_/]!]8J?\^V?I]17Y@_\,$_M,?]%!M/_"CO?_C=
M'_#!/[3'_10;3_PH[W_XW1]3H?\ /]!]8J?\^V?I]17Y@_\ #!/[3'_10;3_
M ,*.]_\ C='_  P3^TQ_T4&T_P#"CO?_ (W1]3H?\_T'UBI_S[9^GU%?F#_P
MP3^TQ_T4&T_\*.]_^-T?\,$_M,?]%!M/_"CO?_C='U.A_P _T'UBI_S[9^GU
M%?F#_P ,$_M,?]%!M/\ PH[W_P"-T?\ #!/[3'_10;3_ ,*.]_\ C='U.A_S
M_0?6*G_/MGZ?45^8/_#!/[3'_10;3_PH[W_XW1_PP3^TQ_T4&T_\*.]_^-T?
M4Z'_ #_0?6*G_/MGZ?45^8/_  P3^TQ_T4&T_P#"CO?_ (W1_P ,$_M,?]%!
MM/\ PH[W_P"-T?4Z'_/]!]8J?\^V?I]17Y@_\,$_M,?]%!M/_"CO?_C='_#!
M/[3'_10;3_PH[W_XW1]3H?\ /]!]8J?\^V?I]17Y@_\ #!/[3'_10;3_ ,*.
M]_\ C='_  P3^TQ_T4&T_P#"CO?_ (W1]3H?\_T'UBI_S[9^GU%?F#_PP3^T
MQ_T4&T_\*.]_^-T?\,$_M,?]%!M/_"CO?_C='U.A_P _T'UBI_S[9^GU%?F#
M_P ,$_M,?]%!M/\ PH[W_P"-T?\ #!/[3'_10;3_ ,*.]_\ C='U.A_S_0?6
M*G_/MGZ?45^8/_#!/[3'_10;3_PH[W_XW1_PP3^TQ_T4&T_\*.]_^-T?4Z'_
M #_0?6*G_/MGZ?45^8/_  P3^TQ_T4&T_P#"CO?_ (W1_P ,$_M,?]%!M/\
MPH[W_P"-T?4Z'_/]!]8J?\^V?I]17Y@_\,$_M,?]%!M/_"CO?_C='_#!/[3'
M_10;3_PH[W_XW1]3H?\ /]!]8J?\^V?I]17Y@_\ #!/[3'_10;3_ ,*.]_\
MC='_  P3^TQ_T4&T_P#"CO?_ (W1]3H?\_T'UBI_S[9^GU%?F#_PP3^TQ_T4
M&T_\*.]_^-T?\,$_M,?]%!M/_"CO?_C='U.A_P _T'UBI_S[9^GU%?F#_P ,
M$_M,?]%!M/\ PH[W_P"-T?\ #!/[3'_10;3_ ,*.]_\ C='U.A_S_0?6*G_/
MMGZ?45^8/_#!/[3'_10;3_PH[W_XW1_PP3^TQ_T4&T_\*.]_^-T?4Z'_ #_0
M?6*G_/MGZ<R]Z_*+_@JA_P G":!_V*]O_P"E=W70O^P7^TN.OQ M/_"CO?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7E?[57_ ";7\3?^Q>O?_1+5ZI7E?[57_)M?Q-_[%Z]_]$M6U'^+'U1G4^!^
MA\T_\$F/^25>-O\ L-)_Z(2ONJOA7_@DQ_R2KQM_V&D_]$)7W575F'^]3,,+
M_!B%%%%>>=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)TB4GT!8CFL?_A:7@S_H;M!_\&</_P 54RK4H/EE))^HI5(0=I22.HHKE_\
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M;)NURI245>3L;%%%%44%%%5[[4+72[26ZO;F&TM8AF2:=PB(/4L>!2;45=[
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MC1Q->VO+:-^[Z_>U<****^Q/KPHHHH *\K_:J_Y-K^)O_8O7O_HEJ]4KRO\
M:J_Y-K^)O_8O7O\ Z):MJ/\ %CZHSJ? _0^:?^"3'_)*O&W_ &&D_P#1"5]U
M5\*_\$F/^25>-O\ L-)_Z(2ONJNK,/\ >IF&%_@Q"BBBO/.L**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBWZ5P'26**** "OA?5E'CK]HV6&;]Y#<ZX("&/\ RS60+C_OE:^Z*^$)[A?
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M%'AWP!X?T[;M:"RB#C_:*@M^I-> _MG:UNNO#>D*?NI+=/\ B0J_R:O2SO\
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M&SN+F4[8X8VD8^@ R?Y5\;?LWVK^+/C@^JRC?Y(N+YR?[S94?J]?2_QPUO\
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M[CXT_:EU"3Q#\7[?2HOF-M!#:JH_ON=W_LXKZ_T?3TTC2;*QC_U=K D*_15
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MH;6_[#^$.OR!MLEQ&MJGU=@I_3->[CZWU?"U:JW47]]M/Q/H9S5.+J2V2O\
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MQ>O?_1+5ZI7E?[57_)M?Q-_[%Z]_]$M6U'^+'U1G4^!^A\T_\$F/^25>-O\
ML-)_Z(2ONJOA7_@DQ_R2KQM_V&D_]$)7W575F'^]3,,+_!B%%%%>>=84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;C3[5R1GUE<E5^O'UKV;_AI?X;?]#'_Y(W/_ ,;H_P"&E_AM_P!#'_Y(W/\
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MQ_\ DC<__&ZZ,;#!XO%+%PQ:A)*RM*/GY^=CJQ<<)BI4Y_65%PV]Y?>>0?\
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M&;3[^\NWF:&X0I($ "KE3R.A//K7L%>8?\-+_#;_ *&/_P D;G_XW1_PTO\
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M,X_*M']FOPC>>#_AG!#J-I+97UU<27$L,Z%'7)"J"#R.%!_&I?\ AI?X;?\
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M7DG[5%CK.L^ [+3=&TN]U1Y[U7F6R@>4JJJ2,A0>,D?E6S_PTO\ #;_H8_\
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M  %?Y'F'_#-'PV_Z%S_R>N?_ (Y1_P ,T?#;_H7/_)ZY_P#CE>GT4?V=@O\
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M_P"3US_\<H_X9H^&W_0N?^3US_\ '*]/HH_L[!?\^(_^ K_(/J.$_P"?4?\
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M%_SXC_X"O\@^HX3_ )]1_P# 5_D>8?\ #-'PV_Z%S_R>N?\ XY1_PS1\-O\
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MC_X"O\CS#_AFCX;?]"Y_Y/7/_P <H_X9H^&W_0N?^3US_P#'*]/HH_L[!?\
M/B/_ ("O\@^HX3_GU'_P%?Y'F'_#-'PV_P"A<_\ )ZY_^.4?\,T?#;_H7/\
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M_P GKG_XY1_PS1\-O^A<_P#)ZY_^.5Z?11_9V"_Y\1_\!7^0?4<)_P ^H_\
M@*_R/,/^&:/AM_T+G_D]<_\ QRC_ (9H^&W_ $+G_D]<_P#QRO3Z*/[.P7_/
MB/\ X"O\@^HX3_GU'_P%?Y'F'_#-'PV_Z%S_ ,GKG_XY1_PS1\-O^A<_\GKG
M_P".5Z?11_9V"_Y\1_\  5_D'U'"?\^H_P#@*_R/,/\ AFCX;?\ 0N?^3US_
M /'*/^&:/AM_T+G_ )/7/_QRO3Z*/[.P7_/B/_@*_P @^HX3_GU'_P !7^1Y
MA_PS1\-O^A<_\GKG_P".4?\ #-'PV_Z%S_R>N?\ XY7I]%']G8+_ )\1_P#
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M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5Y7^U5_R;7\3?^Q>O?\ T2U>J5Y7^U5_R;7\3?\ L7KW_P!$M6U'^+'U1G4^
M!^A\T_\ !)C_ ))5XV_[#2?^B$K[JKX5_P""3'_)*O&W_8:3_P!$)7W575F'
M^]3,,+_!B%%%%>>=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 12]Z_*+_@JA_R<)H'_ &*]O_Z5W=?J[+WK
M\HO^"J'_ "<)H'_8KV__ *5W=>QE/^\KT9Y^._@LYG_@G?\ \EHUW_L79_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% $4O>ORB_X*H?\G":!_V*]O\
M^E=W7ZNR]Z_*+_@JA_R<)H'_ &*]O_Z5W=>QE/\ O*]&>?COX+.9_P""=_\
MR6C7?^Q=G_\ 2FVK]#[/_6BOSP_X)W_\EHUW_L79_P#TIMJ_0^S_ -:*,U_W
ME^B# _P3N=!Z"NRL_NBN-T'H*[*S^Z*\<] NT444 5KG[IK\(/VBO^3@OB=_
MV-&J?^E<M?N_<_=-?A!^T5_R<%\3O^QHU3_TKEKZ+)OXD_0\G,/AB?9?_!/3
M_DB.M?\ 8PS_ /I-;5]7Z3_K!7RA_P $]/\ DB.M?]C#/_Z36U?5^D_ZP5YF
M._WF?J=N&_@Q._T/[JUU%OTKE]#^ZM=1;]*X#I+%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7E?[57_ ";7\3?^Q>O?_1+5ZI7E?[57_)M?Q-_[
M%Z]_]$M6U'^+'U1G4^!^A\K_ /!+?Q)I'A7X5^+/[;U6RT?[5JZRV_V^X2#S
MD$2J63>1N 8$9'<$5]J?\+2\&?\ 0W:#_P"#.'_XJORP^!?_ "2S1/\ MO\
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MT-V@_P#@SA_^*K\[**/];*__ #Z7WL/]9*O_ #[7WL_1/_A:7@S_ *&[0?\
MP9P__%4?\+2\&?\ 0W:#_P"#.'_XJOSLHH_ULK_\^E][#_62K_S[7WL_1/\
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M\^U][/T3_P"%I>#/^ANT'_P9P_\ Q5'_  M+P9_T-V@_^#.'_P"*K\[**/\
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M*_\ SZ7WL/\ 62K_ ,^U][/T3_X6EX,_Z&[0?_!G#_\ %4?\+2\&?]#=H/\
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M_1/_ (6EX,_Z&[0?_!G#_P#%4?\ "TO!G_0W:#_X,X?_ (JOSLHH_P!;*_\
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M_P!#=H/_ (,X?_BJ_.RBC_6RO_SZ7WL/]9*O_/M?>S]$_P#A:7@S_H;M!_\
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M</\ \51_PM+P9_T-V@_^#.'_ .*K\[**/];*_P#SZ7WL/]9*O_/M?>S]$_\
MA:7@S_H;M!_\&</_ ,51_P +2\&?]#=H/_@SA_\ BJ_.RBC_ %LK_P#/I?>P
M_P!9*O\ S[7WL_1/_A:7@S_H;M!_\&</_P 51_PM+P9_T-V@_P#@SA_^*K\[
M**/];*__ #Z7WL/]9*O_ #[7WL_1/_A:7@S_ *&[0?\ P9P__%4?\+2\&?\
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MX,_Z&[0?_!G#_P#%4?\ "TO!G_0W:#_X,X?_ (JOSLHH_P!;*_\ SZ7WL/\
M62K_ ,^U][/T3_X6EX,_Z&[0?_!G#_\ %4?\+2\&?]#=H/\ X,X?_BJ_.RBC
M_6RO_P ^E][#_62K_P ^U][/T3_X6EX,_P"ANT'_ ,&</_Q5'_"TO!G_ $-V
M@_\ @SA_^*K\[**/];*__/I?>P_UDJ_\^U][/T3_ .%I>#/^ANT'_P &</\
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M_P ^E][#_62K_P ^U][/T3_X6EX,_P"ANT'_ ,&</_Q5'_"TO!G_ $-V@_\
M@SA_^*K\[**/];*__/I?>P_UDJ_\^U][/T3_ .%I>#/^ANT'_P &</\ \51_
MPM+P9_T-V@_^#.'_ .*K\[**/];*_P#SZ7WL/]9*O_/M?>S]$_\ A:7@S_H;
MM!_\&</_ ,51_P +2\&?]#=H/_@SA_\ BJ_.RBC_ %LK_P#/I?>P_P!9*O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRARO2:W7ZKR_(_2<MS.&/C9Z36Z_5&W1117T![84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKT=GY;F[17&?&3^U!\,?$/\ 8WG?VA]F.S[/GS,9&[;CG.W=TKXK^$O]L_\
M"RM"_LK[3]L^V1^9Y6[.S<-^_'\.,YSQC->=BLV^JXZG@_9M\]M?5VVMK;KJ
M<&89E]0G"/)S<W]=M6?H/1117T![84444 %8.H>/O#&DWCVE[XCTFSNT.&@N
M+Z)'4^A4MD5O5^>GQB_Y*GXJ_P"PC-_Z$:^<SG-9Y6J;A#FYK_A;_,\C,\;+
M 455C&]W;\'_ )'Z$0S)<1)+$ZR1.H970Y# ]"#W%/KE/A1_R3/PM_V#8/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *]&^"/Q9N/A;XH225Y)-#NR$O;=>>.TBC
M^\OZC(KSFBMZ%>IAJL:U)VDC:C6G0J*K3=FC]-;.\@U"S@NK:59[:=%EBD0Y
M5U89!'L0:FKYQ_9)^)C:CI]QX/OY=TUFIGL68\F+/SQ_\!)!'L3V%?1U?MV
MQD,=AXUX==_)]4?K6#Q4<90C6CU_!A1117H':%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^%>9?M7?\DAN?^ON#_T(U]EG?_(OK>GZGW.)G&I@ZDX[.$G_ .2L^??V7?\
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M4EGJ>CKH-I'!).U[)>^:JA1G!'EKUZ#&3G Q7IOQ9_Y)EXH_[!TW_H!K\_\
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MNO5;_>OR/L.'<0XU)X=[/5>J_K\#UFBBBOTH^]"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_*OF,AS#$9E"I5KVLFK:>M_T/FLMQ];&XFJG;DCM\WI^"+=%%%?4GT@4444
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M[E6&VMXVEED;HJ@9)_*OS[^)GCB[^)OCB\U5E<I,XAM(.I2,'"*/<]3[DU]
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ML%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:01VUM"H2.&)0J(HZ  =!4]%%>H>BDHJR"BBB@84444 %%%% !1110 4444
M%%%% !1110 5Y7^U5_R;7\3?^Q>O?_1+5ZI7E?[57_)M?Q-_[%Z]_P#1+5M1
M_BQ]49U/@?H?FY\"_P#DEFB?]M__ $?)7>5P?P+_ .26:)_VW_\ 1\E=Y7X=
MGG_(UQ7_ %\G_P"E,_'<1_&GZO\ ,****\4P"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *]_\ V-;<MX[UJ;'"::4S_O2H?_9:
M\ KZD_8OTDK8^)]39>))(;9&_P!T,S#_ ,>2O?R&#J9C2\KO[DSV<G@YXZGY
M7?X,^EZ***_9C]4"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y_Q_P"*T\#^#=5U
MQXC-]CA+K&!]YB<*#[9(S[5C6JPH4Y5:CTBKOY";45=GSU^UQ\2_/N+?P=8R
M_)$5N+\J>K=4C/T'S'ZCTKP[POX;\82F+5O#FE:XY1F6.^TNWF.TXP0'0<'G
M!Y[TFBZ3K'Q1\;);Q[[K4M3N2\LQ!(7<<L[>@ R?PK] ?"OANS\(>';#1K!-
MEK9Q"-?5CW8^Y.2?K7YQ@<!5SRM4QU:3@KZ6_)>BMZOYGP-.C//,7.LVXPCH
MOT7ZL^*?^+S_ /4]_P#D[7G^O6^J6NK7*ZU%>1:HS;YUOU=9BQYRV[YLG.>?
M6OTLKXL_:RTEK#XJ-=;"([VSBD#8X)&4/_H(K'.\H>!H1K*HYZVUZ73_ ,BL
MRREX;#.JJCE:V_W'T7^SOJ?]J?!_P\Q;<\,;P-_P%V _3%>*?ME:Y]H\3:%I
M*ME;:U:=E_VG; _1/UKT']D*[EF^&MW!(C!(;^3RV8$ AE4\'OSG\Z\#_:0U
M*;4OC!KGFQM&(#'!&&!&55!R/8G)KUL^Q+EE=#O/E;_\!N_QL=6(Q#_L2'G:
M/W/_ .U/7/V,]#\O2?$6KLO,TT=LC>R@LW_H2_E7T-JVL66A6$M[J-W#96D0
MR\T[A5'XFOSJT?QKXA\/VIM=+U[4]-MBQ<PV=Y)$A8XR<*P&>!S[596W\6^/
M[E!LUCQ%/GY2WFW)'XG.*Y<+Q"J&&AAL/1<I15OGU>FN^IPX#.(X3#1H0IN4
ME?\ %G:_M!?&%?B?K\-OIQ=="L"1!N&#,YZR$=N. #V^M>@?LB?#J8W=WXPO
M(BD*HUM8[A]YC]]Q[ ?+^)]*R_AC^R?JVIW<-[XN(TS3U(;[#&X:>7V8C(0?
MCGV'6OHGQIXDT[X3^ ;B_ALPMI81+%;6D"87<?E1>.@SU/UKJRW U:-2>;9E
MHU=VZ^K7IHEO]ROV8/!U\5B7C\:N5+6WIMIT2W.)_:*^,@^'NA_V3IDV/$%^
MA"LIYMHCP9/J>@_/M7S9\%?A=<_%7Q<L,WF#2K8B:_N,\[<_<!_O,<_J>U8+
MG7_BQXU9]LFH:QJ4_.T'"Y.!_NJH_  5]T_#'X>V7PS\)VVD6FV24?O+FXQ@
MS2GJWT[ =@!6.!HU,]QCQN(7[J&R_3]9?=MME'GSW%W>E&']?>_P1\B_M(^!
M8/ _Q$D%C;K;Z;?0I<01H/E7 VLH_$9_&O:OV0_&']J^#;W09I,SZ9-OB4]?
M*DR?T8-^8JY^UEX-;Q!X!AU:WB,EUI,V]MHR?*?"M^1VG\#7A/[,_B*XT'XL
M:;%$CR0Z@K6DRH,_*1D$^P8 U&$OEF>2H_9J:+_M[5?=+3[R<1'^S<VC4BK1
MG^NC^YZV]#ZU^*WP]/Q.\(RZ&-2;2Q),DIG$/FYVG.TKN7^?:O$O^&*?^IR_
M\I?_ -NKZ>HKZ_$Y3@L94]K7A>7J_P!&?68G+\-C)*=>-VE;=[?)^9XS\(_V
M;K;X7^)FUJ76FU>X6%HH5^R^2(RW#-]]LG'';J:^;_VAF9OC)XEW9XF0#/IY
M25][5\H?M7?"_4(_$'_"76-N]Q87$2I>&-<F%U& S?[)&.>Q'N*^:X@P"HX"
MG'#1M"#U7:]]?O\ S/'S3 0I9>Z>&C9*2D]WT:?Y_@>R?LX>5_PIGP]Y1!^6
M7?C^]YKYKD/VMO',>C^#H/#L,O\ INJ.'D4'E84.>?JP _ U\V>$/BQXM\!V
M<MIH>M2V5K(VXPF-)4#'J0'4X/TQ3=+T7Q7\8/$S&%+K6]2F(\VYE)*QCIEV
M/"J/_K"N#%9T\?A(X+"TWSR23_6UN_G;0\>.<+ZC'"4H/GMR_I==;O\ ,[_]
ME'P:^O\ Q$_M:1,VFD1&4L1P96!5!]?O'_@-?:%<9\)_AO:_"_PC!I4++-=,
M?-N[A1CS9".<>PZ#Z>]>*?M ?&KQ=X&^)2V6C79LK""VC/ER0*\<[-\S-\PY
M[#@]J^EIU*/#^ I0KW=WK;^9W;^2M;Y(]K!PCD^!]I76K=W;STM\O\SZ'UCP
M?H/B"82ZIHFG:E*!@/>6D<K#\6!KR;]H'Q!H7PO^']WI6BV-CIFIZRAMTALH
M$B(B/WW(4#C'R_4^U>0W7[7GCBXM#"D&D6TA&/M$5LY<>^&<K^E<KX=\#^-?
MCEXB:]87%X9FQ/JMYD0QCT!QCCLJ_E7C8W-H8Z$L-EU-N<]&[6T>_P#P[LEN
M<N(SBC5BXX2#=26B=MOU-K]F7P%)XN^(EO?RQDZ=I!%U*Q'!D_Y9K]<\_137
MV]7+?#?X>:;\,_#,.D:<-Y'SSW+##SR'JQ_H.PJUX\\6P^!O">I:W-$\ZVL>
MY8HP278\*/89(R>PKZ7 X:GE&!Y9OX;RD_/K_DN]CU<JP7U##_O/B>K\O+Y?
MYGD'[4GQ:_X1O1O^$6TR;;J>H)FZ=&YA@/\ #[%OY9]17@OP/^&,OQ.\90VT
MJ,-)M<3WL@_N \(#ZL>/ID]JY?4+[5_B#XJGNG274-6U";=LC4L68G@ #L.
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M[BOJ*']CWP5&X9K_ %N4?W7N(L?I$*^6_$'AS7OA?XI$%W%-IVHV<HD@N%!
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M+[[GYC+'+%5_;8U.26R6B_X;\7W/T'T;1;'P]I=OIVFVL=G96Z[(X8A@*/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *\K_ &JO^3:_B;_V+U[_ .B6KU2O*_VJO^3:_B;_ -B]>_\
MHEJVH_Q8^J,ZGP/T/S<^!?\ R2S1/^V__H^2N\K@_@7_ ,DLT3_MO_Z/DKO*
M_#L\_P"1KBO^OD__ $IGX[B/XT_5_F%%%%>*8!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M110 4444 %%%% !1110!%+WK\HO^"J'_ "<)H'_8KV__ *5W=?J[+WK\HO\
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M$[_0_NK746_2N7T/[JUU%OTK@.DL4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>5_M5?\FU_$W_L7KW_ -$M7JE>5_M5?\FU_$W_ +%Z]_\ 1+5M
M1_BQ]49U/@?H?FY\"_\ DEFB?]M__1\E=Y7!_ O_ ))9HG_;?_T?)7>5^'9Y
M_P C7%?]?)_^E,_'<1_&GZO\PHHHKQ3 **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBO8/V>O@S+\1->35-3MS_ ,(W9/F3>,"YD'(B
M'J.[>W'>NK"X:IC*T:-)7;_JYT8?#U,555*FM6>Q_LJ_"]O"_AN3Q+?Q%-1U
M9 (%8<QVV<C_ +[.&^@6O>*;&BQHJ(H1%& JC  ]!3J_;L'A88*A&A3V7XOJ
MS]:PN'AA*,:,-D%%%%=IUA1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %>5_M5?\FU_$W_L7KW_T2U>J5Y7^U5_R;7\3?^Q>O?\
MT2U;4?XL?5&=3X'Z'YN? O\ Y)9HG_;?_P!'R5WE<'\"_P#DEFB?]M__ $?)
M7>5^'9Y_R-<5_P!?)_\ I3/QW$?QI^K_ #"BBBO%, HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M #H*GK]:RO*J66T[1UF]W_70_2LORZG@(6CK)[O^N@4445[9ZP4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDL4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>5_M5?\ )M?Q-_[%
MZ]_]$M7JE>5_M5?\FU_$W_L7KW_T2U;4?XL?5&=3X'Z'YN? O_DEFB?]M_\
MT?)7>5ZC_P $F/\ DE7C;_L-)_Z(2ONJOC,VX5]KCZ]7V]N:3E\/=WM\72Y\
M7'(/K'[WVMN;7;_@GYB45^G=%>3_ *I?]/\ _P E_P#MA_ZM?]/O_)?^"?F)
M17Z=T4?ZI?\ 3_\ \E_^V#_5K_I]_P"2_P#!/S$HK].Z*/\ 5+_I_P#^2_\
MVP?ZM?\ 3[_R7_@GYB45^G=%'^J7_3__ ,E_^V#_ %:_Z??^2_\ !/S$HK].
MZ*/]4O\ I_\ ^2__ &P?ZM?]/O\ R7_@GYB45^G=%'^J7_3_ /\ )?\ [8/]
M6O\ I]_Y+_P3\Q**_3NBC_5+_I__ .2__;!_JU_T^_\ )?\ @GYB45^G=%'^
MJ7_3_P#\E_\ M@_U:_Z??^2_\$_,2BOT[HH_U2_Z?_\ DO\ ]L'^K7_3[_R7
M_@GYB45^G=%'^J7_ $__ /)?_M@_U:_Z??\ DO\ P3\Q**_3NBC_ %2_Z?\
M_DO_ -L'^K7_ $^_\E_X)^8E%?IW11_JE_T__P#)?_M@_P!6O^GW_DO_  3\
MQ**_3NBC_5+_ *?_ /DO_P!L'^K7_3[_ ,E_X)^8E%?IW11_JE_T_P#_ "7_
M .V#_5K_ *??^2_\$_,2BOT[HH_U2_Z?_P#DO_VP?ZM?]/O_ "7_ ()^8E%?
MIW11_JE_T_\ _)?_ +8/]6O^GW_DO_!/S$HK].Z*/]4O^G__ )+_ /;!_JU_
MT^_\E_X)^8E%?IW11_JE_P!/_P#R7_[8/]6O^GW_ )+_ ,$_,2BOT[HH_P!4
MO^G_ /Y+_P#;!_JU_P!/O_)?^"?F)17Z=T4?ZI?]/_\ R7_[8/\ 5K_I]_Y+
M_P $_,2BOT[HH_U2_P"G_P#Y+_\ ;!_JU_T^_P#)?^"?F)17Z=T4?ZI?]/\
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M7_3_ /\ )?\ [8/]6O\ I]_Y+_P3\Q**_3NBC_5+_I__ .2__;!_JU_T^_\
M)?\ @GYB45^G=%'^J7_3_P#\E_\ M@_U:_Z??^2_\$_,2BOT[HH_U2_Z?_\
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M ,$_,2BOT[HH_P!4O^G_ /Y+_P#;!_JU_P!/O_)?^"?F)17Z=T4?ZI?]/_\
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M_3__ ,E_^V#_ %:_Z??^2_\ !/S$HK].Z*/]4O\ I_\ ^2__ &P?ZM?]/O\
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M)17Z=T4?ZI?]/_\ R7_[8/\ 5K_I]_Y+_P $_,2BOT[HH_U2_P"G_P#Y+_\
M;!_JU_T^_P#)?^"?F)17Z=T4?ZI?]/\ _P E_P#M@_U:_P"GW_DO_!/S$HK]
M.Z*/]4O^G_\ Y+_]L'^K7_3[_P E_P""?F)17Z=T4?ZI?]/_ /R7_P"V#_5K
M_I]_Y+_P3\Q**_3NBC_5+_I__P"2_P#VP?ZM?]/O_)?^"?F)17Z=T4?ZI?\
M3_\ \E_^V#_5K_I]_P"2_P#!/S$HK].Z*/\ 5+_I_P#^2_\ VP?ZM?\ 3[_R
M7_@GYB45^G=%'^J7_3__ ,E_^V#_ %:_Z??^2_\ !/S$HK].Z*/]4O\ I_\
M^2__ &P?ZM?]/O\ R7_@GYB45^G=%'^J7_3_ /\ )?\ [8/]6O\ I]_Y+_P3
M\Q**_3NBC_5+_I__ .2__;!_JU_T^_\ )?\ @GYB45^G=%'^J7_3_P#\E_\
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M48*R\@HHHK0L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"*7O7Y1?\ !5#_ ).$T#_L5[?_ -*[NOU=
ME[U^47_!5#_DX30/^Q7M_P#TKNZ]C*?]Y7HSS\=_!9S/_!.__DM&N_\ 8NS_
M /I3;5^A]G_K17YX?\$[_P#DM&N_]B[/_P"E-M7Z'V?^M%&:_P"\OT08'^"=
MSH/05V5G]T5QN@]!796?W17CGH%VBBB@"M<_=-?A!^T5_P G!?$[_L:-4_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KRO\ :J_Y-K^)O_8O7O\ Z):O5*\K_:J_Y-K^)O\
MV+U[_P"B6K:C_%CZHSJ? _0^:?\ @DQ_R2KQM_V&D_\ 1"5]U5\*_P#!)C_D
ME7C;_L-)_P"B$K[JKJS#_>IF&%_@Q"BBBO/.L**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O*_VJO^3:_B;_ -B]>_\ HEJ]
M4KRO]JK_ )-K^)O_ &+U[_Z):MJ/\6/JC.I\#]#YI_X),?\ )*O&W_8:3_T0
ME?=5?"O_  28_P"25>-O^PTG_HA*^ZJZLP_WJ9AA?X,0HHHKSSK"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M"*7O7Y1?\%4/^3A- _[%>W_]*[NOU=E[U^47_!5#_DX30/\ L5[?_P!*[NO8
MRG_>5Z,\_'?P6<S_ ,$[_P#DM&N_]B[/_P"E-M7Z'V?^M%?GA_P3O_Y+1KO_
M &+L_P#Z4VU?H?9_ZT49K_O+]$&!_@G<Z#T%=E9_=%<;H/05V5G]T5XYZ!=H
MHHH K7/W37X0?M%?\G!?$[_L:-4_]*Y:_=^Y^Z:_"#]HK_DX+XG?]C1JG_I7
M+7T63?Q)^AY.8?#$^R_^">G_ "1'6O\ L89__2:VKZOTG_6"OE#_ ()Z?\D1
MUK_L89__ $FMJ^K])_U@KS,=_O,_4[<-_!B=_H?W5KJ+?I7+Z']U:ZBWZ5P'
M26**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O*_VJO\ DVOXF_\
M8O7O_HEJ]4KRO]JK_DVOXF_]B]>_^B6K:C_%CZHSJ? _0^:?^"3'_)*O&W_8
M:3_T0E?=5?"O_!)C_DE7C;_L-)_Z(2ONJNK,/]ZF887^#$****\\ZPHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MWZ5P'26**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@_:*_P"3@OB=_P!C1JG_ *5RU]%DW\2?H>3F'PQ/LO\ X)Z?\D1UK_L89_\
MTFMJ^K])_P!8*^4/^">G_)$=:_[&&?\ ])K:OJ_2?]8*\S'?[S/U.W#?P8G?
MZ']U:ZBWZ5R^A_=6NHM^E<!TEBBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*WYUA?MC:Y]J\8Z/I2OE;.T,K+Z-(W^"BN]_8]T3['X#U/4BN'O;W8#ZK&H
M_5FKXO!U:F*SZJU)\L$]+Z:)1_-W/E:U2=?.84HM\L;?E?\ /0]\HKD?&7Q8
M\*?#^[AM=?U=;"XF3S$B\F25BN2,X13@9!Z^E:?A'QIHWCK2SJ.A7HO[,2&(
MR"-TPP )&& /<=J^SAB*-2;IPFG);I-77JCZKVU+VGLN9<W:^OW&W16/XJ\7
M:1X)TDZEK=ZMA9!PGF,K-ECT "@DG@]!6/X/^+OA+Q]J$ECH.KB^NXXS*T7V
M>6,A00"?G49Y(_.CZQ1]I['G7/VNK_=N$JU*$U3E)*3V5]6=A117EOC+]I'P
M3X,OGLI+R?5+N,[9(]-C$@0^A8LJY]@3BHQ&*H86/-7FHKS"K6IT(\]622\S
MU*BO,_ ?[0W@_P"(&HII]I<7&GW\AQ%;ZA&(VE/HI5F4GVSGVJY=?'KP%9ZT
M^DR^((Q?)-Y#1K;S,H?.,;PFWKQUJ8XW#2C&2J1M+;5:OLO/R,(XW#2A[15%
MR[7NCT"N2\9?%?PI\/[J&UU[5TL;B9/,2+R9)6*YQG"*<#(/7TK1\7>-=%\"
M:6-1UV^6PM&D$0=D9R6/0!5!)Z'M7Q)\>_&UCX^^)%YJ6EW!NM-6**&"4HR;
M@J\\, 1\Q;J*\7.<W_LZFE1:<[[/HK7NTFGV^\Y,RQZP-%RBUSZ63_.V]MS[
M<\(^--&\=:6=1T*^6_LQ(8C($9,, "00P!'4=JVJ^;O@+\8/ ?@'X;V6FZEK
MGV;46EDGN(OLD[[69L 96,@_*%Z&OH;^UK/^R?[3-PBV'D_://;A1'MW;CGH
M,<UZ^%Q=/$4544XMI)RLTTFUKZ==^QM@,8L71C)R7,U=I=/ENCX]\<?M0>-)
MO%%^NC:A%IFFPS-'#"EK%(6520&8NK')QVP*^I/A;KVH^*/A]H>JZLJKJ%U;
MB278NT'DX;';(P?QKR6SC^ /BCQ5&EO';7&K7=QA(]EY'&\C'I@XCY/X5] 0
MPQVL"11(L4,:A41  JJ!@ #L *\C):.(A&I5Q&(56_9W2[^FZT1P8"G6EB:E
M:==3CK9)WM=Z:;+0DHK@M-^.O@;5]>AT:SUY)]1FE\B.(6\P#/G& Q3;U]ZA
M\>?'CPA\/;E[2_OGN]03[UE8IYLB_P"\<A5/L2#[5[$L=A8T_;.K'EVO=6OV
M]?(]=XJ@HN;FK+?5:'H=%>6>"/VD?!WCG5HM-@EN]-O)CMACU&)4$K?W0RLP
MS[$C/:O4ZWHUZ6(A[2C)27D51Q%+$+FHR37D%%9WB#Q%IGA72Y=1U:]AL+*/
M[TTS8&?0=R3Z#DUY%=?M=^![>[,,<&KW,8./M$5L@0^_S.&_2L*^.PN%DHUJ
MBB_-DUL50P]O;32N>W45Q5G\9/!U]X4E\1IK<*Z7"RI,[*V^-ST5DQNR?8<X
MXJWX+^*/ACXA37,7A_5!J$ELH:5?(EC*@G /SJ,_A6T<11E-4XS3DU=*ZO;O
MZ#CB:$G%*:][;5:^AU5%%%=!TA165XD\4:3X0TQ]0UF_AT^S7CS)FZGT4=6/
ML 37DMY^UYX(M;AHX[;6+M <":&V0*?<;I%/Z5P5\?A<++EK5$GVOJ<M;%4,
M/_&FD>WTUF6-2S$*JC))Z 5PWP_^-7A7XDW!M=)O)%OU0R&SNHC')M'4CJI_
M FL;XM?&SPMX7TG7]$?5E_X2!;.2..U2&1CYCH=H+A2H/(/)J:^/H4<.\1SI
MJSMJM6NB[L(XK#NG[7G7+WNOZN75_:(^'C7PM!XDC,Q?RQBVGV;LX^_LVX]\
MXKT>OS>\$S:?;^+]&FU6;[/IL=W')<2E&?;&&!/"@D\#L*^[/"?QF\'>.=6&
MF:)K'VV^*-((OLTT?RCJ<N@'?UKRLFS9X^FW7E%3O9).S:LGLVW_ ,,>'E>;
M/&2DJ[C':RV;O?N]>AVM%<YXR^(7A[X?6]O/X@U)=/CN&*Q9C>0N1UP$4GC(
M_.L^/XP^#YO"<OB5-:C.CQR&$SM&Z$R  [%1E#$X(X KW)8JA%RC*HDXZO5:
M+N^VZ/H)5J49<DI)/>U];=SLZ*\O\!_M$>&/B)XF30],M]2BNY%=D>Y@18V"
M@D\JY(X'<"O1=6U:RT/3YK[4+J*RLX5W233.%51]33IXFC6I>VIR3CWZ$T<1
M2Q$7.E)-+0MT5XIJ7[7'@:QNVAACU74$4X\^VME"'W&]U;]*[;0/C)X1\1>&
M;O7K;5DCL;-0UT)E*R09Z;DZ\]L9![9K"EF&$K<RIU4[:O7IW]/,RACL-4G[
M.%1-^IVM%<=X/^+WA'Q]J,EAH.KB^NXXS*T7V>6,[00"?G0 \D53^('QF\*^
M 9+FPU'55AU<6YECM5ADD))!V@E5(7)'<CUJZF-P].C[=S7+T=U9^2[O0UCB
M*$H>T]HN7O=6^\KW_P"T)\/M,U":RN/$<:W$+F-PEM,ZA@<$;E0K^M>@P3)<
MPQS1,'BD4.K#H01D&OS4L9(KK6('O9?*ADG5IY2"=JEOF; R3QGI7WCX5^-O
M@;Q1JEIHNC:T+F]E!6&#[)/'D*I.,L@ X![UX62YP\?&7UEQC*]DD[-]]&[O
MR^9X&79Q]:J359QBE:W1N]^[U^1WU%-DD6*-G=@B*,LS'  ]37E'BC]I[P+X
M:NFMUO+C6)4.&_LR(2*#_OL54_@37T&(Q5#"J]>:CZL^@K5Z5"/-5DDO,]9H
MKQO0_P!J_P "ZQ=K!,^H:3N.!+?6XV9]RC-CZGBO7K6[@OK:*XMIH[BWE4/'
M+$P974]"".HIT,31Q4>:A-27D11Q5#$?P9IDU%1SSQVL,DTTBQ0QJ6>21@JJ
MHY))/05Y#X@_:K\"Z'>O;127VKE#AI=/@5H\^S.RY^HR*C$8S#X6WMYJ-^Y5
M;$4L/'FJR45YGL5%<#X&^.'A+Q_#.UA?FVGMXVFEM;U?*D5 ,ENI! '7!..]
M/\/_ !Q\$>*M:ATC2]<6ZU"8E8XOLTRAB 2<,R!>@/>JCB\/)Q4:B][;5:^G
M<B.+P\HJ2J*ST6JU?8[F1Q&C.QPJC)-?%GBC]J3QQ>:_=R:7J,6F:>LK+#;1
MVL4GR \99U))(Z\BOLS4M0M=)T^XO;V9+>SMXS)++(<*J@9)->#:':? +Q+X
MJ@AT^"VN=6N9OW<+)>)&[D] K8C_  Z5X6;T\1B*M*EA\0J;[<UF[VM9+?KH
M>=FL:LX0A1K*FV^KM?T/8OA_J]]K_@G0]2U-%CO[JTCFE"# RPSD#MD<_C70
M4V.-8HU1%"(HPJJ,  =A7*>./BIX9^'<:G6]32"=QN2UC!DF<>H4<@>YP/>O
MHJM:G0CSU9)+N]#U8VH4E[66R5V_S.MHKPU?VP?!33;#8ZVJYQYAMXMOU_UN
M?TKU#P3\0-"^(>FO>Z%?"\BC8)*I1D>-B,X92 1_(US8?'8;%-QH5%)KSU,:
M6.PU>7)3J)OL=%1117<=H45PGB#XY>!_"VM3:3J>NI;ZA"P62%;>:382,X+*
MA'?UJWXV^+'A?X?VD4VL:DL<DR>9#;0J9)I%[$*.@]S@>]<;QF&493=2-HZ/
M5:/L_,YWB**<DYKW=]5IZ]CL**\8T7]K'P-J^H1VLHU+3%<[1<7L""('W*.Q
M ]R*]DBE2:-)(W62-P&5U.0P/0@^E7A\31Q4>>A-27D31Q5'$W]C-.P^BFR2
M+%&SNP1%&69C@ >IKRCQ1^T]X%\-736ZWEQK$J'#?V9$)%!_WV*J?P)I8C%4
M,*KUYJ/JRZU>E0CS59)+S/6:*\;T/]J_P+K%VL$SZAI.XX$M];C9GW*,V/J>
M*]>M;N"^MHKBVFCN+>50\<L3!E=3T((ZBG0Q-'%1YJ$U)>1%'%4,1_!FF345
MYQ>_M$_#S3[Z:TG\1*D\+F-U%I<, P.",B/'7WKT&SO(=0LX+JVD6:WF19(Y
M%Z,I&01]0:='$4<1=T9J5M[-/\C2%>E4DX0FFUNDR:BN+\6_&/P=X%U+^S];
MUN.SO=H<PK#+*R@],[%./QJ2/XN>$I/",GB<:PHT-)?)-TT$JY?CY0A7<3SV
M'\JCZYAKR7M(WCOJM.FO8GZQ14G!S5UNKJY/XS^)WACX?-;IK^JI8/< M%'Y
M;R,P'4X12<>]6?!OCW0?B!8S7>@:@NH00OY<C"-XRK8S@AP#T]J^-_VB_B!I
MOQ#\=Q7>CW7VS3+>T2&.7RWCRV2S<, >IQT[5Z/^SK\6/!'P]\!R6>L:T+34
MKB[>>2+[).^%P%7YE0CH,]>]?-8//57QM6C5E&-.-[.]KV:6[=G??0^?6<*6
M.=!./LUUOY=[VW/J&BJNEZI:ZUIMKJ%E+Y]I=1K-#)@C<C#(.",CCUJU7V!]
M-&2DE*+NF%%-DD6*-G=@B*,LS'  ]37DWB;]J#P+X;NWMDNKK6)4.USIL0=
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MC1JG_I7+7[OW/W37X0?M%?\ )P7Q._[&C5/_ $KEKZ+)OXD_0\G,/AB?9?\
MP3T_Y(CK7_8PS_\ I-;5]7Z3_K!7RA_P3T_Y(CK7_8PS_P#I-;5]7Z3_ *P5
MYF._WF?J=N&_@Q._T/[JUU%OTKE]#^ZM=1;]*X#I+%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M70PR7+Z$J$,34C>5VUOT=O3I<^0_VQ=;^U^-M)TQ7RMG9^8R^C2,?Z**\_\
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M<[6%K:LWS2G&Z,G_ &0#S_NX[T?ME76COI^A6S2_\3V.1I$C50<0$88L>WS
M8^AKY9KYNMBIY/C,32PSTEHO*]G]\=4<6-K2RS,IU*/VE^?_  =?0[WP+X/U
MGXW?$!TEF>1[B0W-_?,,B-">3]3T ^G85]9?$+X(V?C#P'I?A73;[^P;'3Y5
MDC*P><& 5A@C<O)+$YSUIO[._A;1_#_PSTRZTL^=+J48N+FY90&>3H5^BG(
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M_2N[K]79>]?E%_P50_Y.$T#_ +%>W_\ 2N[KV,I_WE>C//QW\%G,_P#!._\
MY+1KO_8NS_\ I3;5^A]G_K17YX?\$[_^2T:[_P!B[/\ ^E-M7Z'V?^M%&:_[
MR_1!@?X)W.@]!796?W17&Z#T%=E9_=%>.>@7:*** *US]TU^$'[17_)P7Q._
M[&C5/_2N6OW?N?NFOP@_:*_Y."^)W_8T:I_Z5RU]%DW\2?H>3F'PQ/LO_@GI
M_P D1UK_ +&&?_TFMJ^K])_U@KY0_P"">G_)$=:_[&&?_P!)K:OJ_2?]8*\S
M'?[S/U.W#?P8G?Z']U:ZBWZ5R^A_=6NHM^E<!TEBBBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KRO]JK_ )-K^)O_ &+U[_Z):O5*\K_:J_Y-K^)O
M_8O7O_HEJVH_Q8^J,ZGP/T/FG_@DQ_R2KQM_V&D_]$)7W57PK_P28_Y)5XV_
M[#2?^B$K[JKJS#_>IF&%_@Q"BBBO/.L**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *XKXT:V?#_P +?$EXIVR?9&A3_>?Y
M!_Z%7:UR7Q2\ +\3/!]SH37[Z=YKI()UC\S!4YP5R,C\17GYA"K4PE6G15Y-
M-+YZ&=3F]G+D^*SMZVT_$^#? \VGVWC'19M6F%OIL5W')<2E&?:BL">%!)Z=
MA7VA_P -+_#;_H8__)&Y_P#C=>8?\,4_]3E_Y2__ +=1_P ,4_\ 4Y?^4O\
M^W5\5E]'.LMI.E1H1:;OJU?HNDEV/AL#ALTR]2]E13YN[73_ +>1[)X8^-_@
MGQEK4.DZ/K7VO4)@QCA^RSQ[L D\L@'0'O7;3PK<021,,JZE3]",5XS\)OV:
M[?X8^*AKDNN'5IHX7CAC^R>2$+#!;.]L\9&..M>U5]KA'B*N'7UR*4W>Z7;[
MW^9]=@:F+E!RQ<5&5]+=OO?6Y^:MTLF@^(9E4;9;.Z8 >A1__K5O32ZY\:/B
M*6"^?JFJW&%49VQ+Z>RJH_(5]"^+/V0X/$7B34M4M_$[6,=Y.\_V=K#S-A8D
MD;O,7(R?2NX^#_P(TSX3M=72W;:MJEP-ANY(1&$3^ZBY.,GJ<\X%?GV!X?QD
MJD:6+5J2=WJM?N?7OT5SXQ9+BY5Y4[6IN6]ULKVT]'_F=GX+\)V?@?PQI^BV
M*X@M8PI;'+MU9S[DY-?,O[9=I*GB[0;DJ?)DL6C5L<;ED)(_)A^=?6U<5\5O
MA;I_Q6\.C3KN5K6YA?S+:[10QB;&#D=U/<9':OLLZP,\=@W2HKWDTTMMNGW;
M'U^,P?ML%+#4M-%;Y-/]+'SM^S/\8O#_ ,/;#6--\07#V4=Q(MQ#.L+2*2!M
M*D("0>F.,=:S_CO\>G^)R#1M#AF@T&!O-EDD&'N".A(_A0=AWX)]*TH_V-?%
M!O0KZUI"VF[_ %JF4R;?79L S[;OQKTZ+]EK1K+P)>:'9:E)#J=ZT9N-6E@$
MC,JL&V*FX;5) .,YXY)KY=87.,5@_JLX\L(JWG*VRW_RT[GR^'P^:/#O!\O+
M!7UZOK;?KM^;L>$_LQ:'_;'Q=TV1EW1V,<ETWL0NU?\ QYA7U+\>-<_L#X2^
M([@/LDEM_LR'WD(3^1-8WP9^ =O\(]2O[\ZNVKW5S$(0WV80B-<Y/&YLDD#O
MVKH_BU\-S\4O"HT7^TVTL>>DYF6'S<[0?E*[E]?7M7MX? XC#Y-+#1C^\DI7
M5UNW;?;X;'KY7@Z^#P=2,H_O'=I77;3RW/COX :+_;OQ<\.PD92&<W3?2-2_
M\P*^WO'$CQ^"]?>+/F+83E<=<^6U><?"#]G6W^%?B&;6'UIM7N&@:"-?LHA"
M9()/WVR>,=NM>P21K-&T;J'1@596&00>HK?*\OJ8?+98:I[LY<U_)O3IY)%Y
M)@ZF#I2]LK2;\MOE\S\T]%ODTW6;"\D3S([>>.5D_O!6!(_2OK#X@?M8^'[+
M073PL\NHZM.F$>2!HX[8D=6W ;B/09'O7+^,OV.[^;6)I_#6K62V,K%UM]0+
MHT63]T,JMN'X#^M;OPY_9'L]%OHK_P 4WT>K/$=RV-LI$!([NQP6'M@>^>E?
M-9?@\XP\9X.G%0C)ZR?3IH[_ *?<>#A,)F>!G.E1BO>ZO;3JOO[/T/E74)+J
MXOI9KPR/=3-YLC2?>8M\V3]<Y_&OT,^&.BCP[\/?#VG[=C0V46]?]HKN;]2:
M\FUS]DV#7O&5WK<_B5DM[BZ-PUFEB 0I;.P/YF,8XSM_"O?U4*H & . *]WA
M_+:V C5=>-G)JVST5^W>_P"!ZF4Y=6PF(JU*WHGWUW_!;GYW_%2SDL/B3XF@
ME7:ZZA,?P+D@_D17T?X!_:9\(:'\-M+M]0FN%U:QMEMVL8K=F:0H-H*MC9@@
M#J16O\:_V<X?B5J7]M:5>QZ;K!0),LZDPSXX!)'*D#C.#D <5YWX<_8UU:2^
M4Z]KEE!9J<E=.#RR./3+JH7ZX/TKPL)@\VRRO4I86":EU>VE[/??7;\&<4L+
MC\%CJE;#0YE*_I9N_=;'DGQ2^(FI?$_Q(^LWL9@MO]3:VZDE8D'.T'N><D^_
MTKZ"_8UT/[/X7UW5F7FZNEMU/M&N3^K_ *5J^.?V5],\31:1;:1JW]@V.GP&
M%8/LGGF1BV6D9MZG<>,_0?2O2?AGX!M_AKX1M="M[AKSRF:1[ADV&1F.2=N3
MCL.O:O4R?*L3A<=4KXG71V=UJVU=]^^]C;"9;BHY@L1B-;:WTW:M:WE?33H<
M3^U5J$ME\(KN.,D"YNH87(_NY+?^RBOF;X#^+-'\$_$BQU;7)&ALHXY5\Y8R
M_ELRD D $D<GH.]?;'C[P39?$+PK>Z'?LT<5P 5E0 M&X.589]#^F:^8[K]C
M?Q2MTRVVLZ/+;9^625I4<CU*A"!^=<^:83'PS*.-PT.>UK?E9ZKU^9IG&$Q-
M3$TL10CS<MOO3;V/H_P+\4O#_P 2)M130;B6ZCL2@DF>%HU;=G&W=@_PGJ!7
MS3^V!K0OOB#8:<K$K8V2[AV#.Q8_H%KZ ^"OPE3X2^'[FT>\6_OKN42SS(FQ
M>!A5 ST'//O7&_$C]E\_$/QE?:\WBAK/[45_T=K'S=@50N WF+QQZ5Z&;X7'
M8W TJ487FVG*S22T>FK[^;V.S%4\;BLNY)17M)/5+32]^K\EU%_9!T7[#\.K
MS4&7#WUZV#ZJBA1^NZN3_;.UL-/X;TA3RJRW3CZD*O\ )J^@/ /@ZW\ ^$=.
MT&VF:XCM$(,SJ%+L6+%L=N2:\Z^+O[.I^*GBA-8/B-M-"P+ +<V?G  $G(/F
M+U)-:9I@<1/+(8/#1NURIZI;+?6W5(4L'6IY5]5IQ]^W==7=^7<X[]C'1-MG
MXCU=DY=XK6-OH"S#]5KTO]H[6QHGPAUL[MLET$M4QWWL,C_OD-6W\*OAO;_"
MWPHNC07;7S&9IY;AHPF]FP/NY.   .IJK\8/A@?BOX;@TG^U6TI8K@7!D$'F
MAL*1@C<OKZUT5,'6IY1]4HJ\^6UO-_%K\V;X/"U<+E_L4O?M+[W>WZ'R=^S9
MHO\ ;7Q>T;<NZ.T\RZ;VVJ=O_CQ6OIC]IJSEO/@YK/E+N\IX96_W1(N35?X-
M_L^V_P )M8O-3;66U:YG@\A?]&$*HI8$G&YLG@=Z]2U33+;6M-NK"]B6>TN8
MVBEC;HRD8(KGP>5U(91+!STG+F?S>VWDD<^59?4P^$J4JRLYW7?1JW3YGP#\
M'?&5MX!^(FDZU>JS6<+,DVP995=2I8#OC.?PKW_XI_M6:/%HLUCX/EEOM0N$
M*?;FB:*. '@D!@&+>G&!UR>E<SXD_8WU==2D.@:U8R6#,2BZ@7CD0>A*(P;Z
M\?2K,W[/>F?"7P5K'B?Q#J$>J:G:VS?9((P4@CF8;4//+D,01P!QT-?-T:>;
M83!U,.XJ%-7;D][6U2UZ]/-[H\7"4,SP2G0IQ48O5R?3S7R\CYQMX9+^]CB&
MYYII OJ2Q./YFOTFT/34T71;#3XQA+6WC@7Z*H']*^#/@CH+>)/BKX=M=GF(
MET+B3O\ +'\YS_WS^M?H#7M<*T>3"3J_S2M\HK_@LWX;IW=6L_)?J_T"L#QQ
MXVT[X?>&[C6]4\TVD)52L"AG8L0 %!('?U[5OUQ_Q4^','Q0\)R:+/>26'[U
M9HYXU#X9<XRN1D<GC(KZG%NO&A)X97GT/LZG/[.7L_BL[>O3\2OHOQN\"Z]:
M+<0^)].MP1S'>SK;N/;;)C]*^5?VDO$'A;Q%XYCN/#/DRXAQ>75LN(YI=QY'
M]XXZL.OOBNDO/V-_%4<["TUG1YX<\/,TL;'\ C?SKI_!?[',5M=QW'BC6%NX
MD.39Z>K*K^QD;!Q[  ^XKXG&4\US>,</4H*"3O?^K_A<^/Q,LSQU)X:=!*]M
M?3YG0?L@Z'<Z;\/[^^G5DCO[PM"&'554+N'MG(_"O&OVJKZ2[^+UY$Y^2VMH
M8D'L5W']6-?:EC8V^EV4%I:0I;VL""..*,85% P !7CWQP_9Y'Q/U"+6-,OH
MM/U=8Q%(MPI,4RC[I)'*D=,X.1BO1SG+:U3+Z6'PWO<C7S235_UL=^(R^I'+
M%A:6LE^.MV<1\ ?C9X,\ ?#<Z=JMY+:ZBEQ),T*V[N9=V,%2HV] !R1TKZ-C
MUZVG\-IK2;ELWM!>+O&"$*;^?0XKY>T/]C?7FU"+^U]:TV&S# O]C\R5R.X
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M 4444 %%%% !1110!%+WK\HO^"J'_)PF@?\ 8KV__I7=U^KLO>ORB_X*H?\
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M[U,PPO\ !B%%%%>>=84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNK746_2N7T/[JUU%OTK@.DL4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?\-K?]2;_P"53_[37S%11_K!F7_/W\(_Y!_;6/\ ^?GX1_R/IW_AM;_J3?\
MRJ?_ &FC_AM;_J3?_*I_]IKYBHH_U@S+_G[^$?\ (/[:Q_\ S\_"/^1]._\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **Y/QY\4O#?PWMXWUR_$,THS%:Q*7FD]PHZ#W.![UY[9?
MM=^"+N\2![;6+96;;YTUM&4'N=LA/Z5Y]3,,)2J>QG52EVN<5;&X;#RY:LTF
M>W44U'$B*RG*L,@TZO0.R]]4%%%% PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O*_VJO^3:_B;_ -B]>_\ HEJ]4KRO]JK_
M )-K^)O_ &+U[_Z):MJ/\6/JC.I\#]#\W/@7_P DLT3_ +;_ /H^2N\K@_@7
M_P DLT3_ +;_ /H^2N\K\.SS_D:XK_KY/_TIGX[B/XT_5_F%%%%>*8!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5TOP[\>:A\.?%-KK6GMEHSLF
MA)^6:(_>0_7MZ$ ]JYJBM*=25*:J0=FMBX3E3DIP=FC]*?#OB"R\5:'8ZOIT
MOG65Y$)8VZ'![$=B#D$=B#6E7RS^R#\0C#>7O@^\E_=S W=B&/1@/WB#ZCYL
M?[+>M?4U?MV6XU8_#1KK?KZ]3]:P&+6,P\:JWZ^H4445Z9Z 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'<W"6EO+/(=L<:%V/H ,FODW]C;5##XPURP+86XLA*%]61P/Y.:^@OC/K?\
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MWLR)KTJ>&E(^5/\ @(.?J?:O#/"GB[5O!&KKJFBW*VE^J,BS-#'*5!X. ZD
MX[]:_*\XS&CBL?&G4NZ5-ZVZ]^WI^*/@<]QL:M:.%3]V+]ZW?_@+\;GWK'X'
MM-$^&,_A>R7]PFG26P..69D(+'W+$G\:^ _#]\^C>(M.O!\LEK=1R_0JX/\
M2N]/[2WQ(/!\1\?]>-M_\;KS265IIGD<Y=F+$@8Y/-<^:9K1Q>*HXG#Q:Y.]
MEL[JUF_,X,TQV'Q=*E3P\7'DNM;;:>;VL?ILCB1%=3E6&0:^=?VR];\GP]H&
MDJ^#<7+W#K[(N!^K_I7M?P\U/^V? ?AZ]W;FFL(68_[6P9_7-?*G[7.M_P!H
M?$N"Q4Y73[)$/^\Y+G]"M?9<3UE2P+@G\4DOU_0^OS'$?\)LJJ^TE^-OTN:G
M['&B?:O&&LZHR96TM!$K>C.P_HA_.OKBO!OV/]$^P^ -1U%EP]]>D#W6-0!^
MI:O<[R\M].M9;JZFCMK:)2\DTK!511U))Z"O2RFFL/EU&+T]V_W^]^HLCI>S
MP47UDV_QM^21XW^UIJT5C\+/L;,!+>WD2(O<A<N3^@_.OGG]G'36U/XQ:"%&
M1 TD['T"HQ_GC\ZL_M"?%9/B9XL1+!V.BZ>#%;$\>:Q/S28]\ #V'O7J/['_
M ("EM;?4?%=W$4%POV2SW#[R@YD8>V0!GV-?&X>?]J9[[>G\$'>_^'9_.6WJ
M>!BYK,LUIPI:J-E?R3N_S:/I:OAS]IS4M&U3XJ7DFDR>;)'$D-XZ@;#,N0=I
M[X&T'W!KWS]HSXRKX T0Z/I<P_M^^0@,I&;:(\%S_M'D#\3VKYR^"/PKN/BG
MXM5)PZZ/:D2WT_J,\(#_ 'F_09-=6>5GF6(AEF&5VG=OL[?HM7]VYZ&=XGVM
ML!27-.37R[?/\EZGG]C'#->01W$C0P-(JR2*N2JD\D#O@5^C?A#P[IOA/PW8
M:9I$:I80QCRRO._/)<GN3US[U\$_%7PA_P (+X_UG1U4K!#,7@S_ ,\F^9/T
M('X5]@_LZ>,/^$N^%NFF1]]WI_\ H,W//R8V'_O@K^1I<*RC"=:A)6FK>MEH
MU\G;^D<&216&QM3#U%[VJOZ/6WKO\CT+5M:T_0;,W>IWUMIUJ"%,]W,L2 GH
M-S$#-8?_  M+P9_T-V@_^#.'_P"*KE/C]\+];^*F@Z9I^CWEG:BWN#-,MX[J
MK_+A<;5;D9/;O7AO_#'/C/\ Z">@_P#@1-_\9KW,9CLPHUY4Z&'YHJVO?3^D
M?1XS%8RC4Y</1YE;<^KM%\8:#XCFDATG6].U2:-=[QV5W',RKG&2%)P,U\1_
MM#ZXVN?%W7G)REM(MHGL$4 _KFOHG]G_ .!.H_"J_P!4U#5[RSN;NYB6");)
MG953.YB2RKR2!V[5\F_$"9[CQWXBD<Y9M1N,G_MHU?-\15ZU3"X95X\LI<S:
M[6T7X/\ $\3-L17J9?%UH<K<MO))GV5^S3H:Z+\(=(;;MDO3)=O[[F('_CJK
M6I\>-9&A_"7Q)/NV/);?9T^LA"?R)K:^&L"6WP\\,QQ_<&FVY&/>-2:\1_;$
M\91PZ7I7AB&0&::3[9<*.JHN0@/U))_X#7U.<5(X'+)TU_+R+[N7\%K\CVH3
MC@\L4^T%][7^;/#/@II+:U\5?#-NHR%O$F;_ '4^<_HM?2/[6_A2\UWP+9:C
M:1M,-+N#),B#)$;+@M] 0/SKSW]CWPB]]XHU+Q#*G[BQA^SQ,?\ GJ_7'T4'
M_OH5]:LH=2K ,I&"#T->5EF6+$9,\/-V]H^;TU5O_24_F>1DF#57!5.?13T^
M2TO]]S\_/A-\5+[X3Z_-J%K:QWT-Q%Y,]M(Q7>N<@AAG!![X/4UZ3XL_; US
M6+"2VT?1K;1C(I1IY9C<N,]U^50#]0:]XU7]G[X?:S>/<W/AJW65SEOL\LL"
MY_W8V4?I7E'[1&E^$/A;X*31/#^D6=EJNJL TBKOF6!3ECO8E@"0!UYYKS*^
M$S++,%*,\0E36R6[N]MDU=OOW9FL#C\NHS<:ZC35WY_+31OUW/G;PCI$GB+Q
M9I&FIEGN[N.+\V )KZY_:OUXZ+\+18Q-L;4+J.# _N+ER/\ QT5Y#^R;X'?7
M/'4FNRQYLM)0E6(X,S@A1^ W'\J[+]M*9AI_A:+^%I;AC]0$']:RI4Y83A^I
M4>]1K[KI?Y_)G+EL)4<OQ&)_F5E^5_O?X'SGX1DUR'7K=O#BW3:O\RP_8T+R
MC(()7 )!P3R.E=;XD^#?Q(CL9];UG1[ZXC53)+/+<I/*!U)90Y?ZY%>H_L7V
M,;7OB>\(_>I'!$#[$N3_ .@BOH[Q9JMOH?AC5;^[8+;V]K)(Y;T"GC\>GXUI
MA<CIULM6(K56M')+HM_\KO8K*\IIXS#>TJS:3;T6VFESXD^$/QFUSX?^(+*-
M[Z>ZT.258[BQF<N@0G!9 ?NL.O'7'-?>"L&4$<@\BOS7\/Z9+KWB+3["W3=-
M=W*1(H]68#^M?I/'&(HT0=%  _"O9X8K5:N$DJCND[*_IJOZ[G7P[5J252FW
M>*M;\1U>:_M">.I/ GPVO9[63R[^](L[=@<%2P.YA[A0WXXKTJOF#]M'4'W^
M%[+_ )9D3S'Z_(/\?SKT<]Q$L/E]24-W9?>]?PN?2X^L\/A:E6.Z7XO1?BSQ
M?X1_#V3XF^.+32&=X[3F:[F7JL2]<>Y. /<U]DWGP(\"7>A'2_\ A'+*&+9M
M6XBC"W"G^]YOWB?J37C?[%^GQ-<>*+XX\Y$@A'KM)<G]5'Y5[C\6?'EM\//
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MBO;_ /I7=U^KLO>ORB_X*H?\G":!_P!BO;_^E=W7L93_ +RO1GGX[^"SF?\
M@G?_ ,EHUW_L79__ $IMJ_0^S_UHK\\/^"=__):-=_[%V?\ ]*;:OT/L_P#6
MBC-?]Y?H@P/\$[G0>@KLK/[HKC=!Z"NRL_NBO'/0+M%%% %:Y^Z:_"#]HK_D
MX+XG?]C1JG_I7+7[OW/W37X0?M%?\G!?$[_L:-4_]*Y:^BR;^)/T/)S#X8GV
M7_P3T_Y(CK7_ &,,_P#Z36U?5^D_ZP5\H?\ !/3_ )(CK7_8PS_^DUM7U?I/
M^L%>9CO]YGZG;AOX,3O]#^ZM=1;]*Y?0_NK746_2N Z2Q1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M HHHH **** "BBB@ HHHH **** "BBB@#6\)^(9_"?B;3-8MO]=97"3!1_$
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M-N00>&!'0GM78ZA^T/\ $34K=H9O$TZ(PP3;P0PM_P!](@/ZU]F_\*M\&?\
M0HZ#_P""R'_XFI;?X<>$K.020>%]%@D'(:/3X5(_$+7D4^'L=3C[..)M'LKV
M^ZYY=/(\717+3K\J?:Z/A'PSX#\5?$O4F;3K"\U.65\RWLN?+![EY6XS]3DU
M]@_!7X(6/PJT][B9TOM>N%VSW0'RQKUV1Y[>IZG';I7IT<:QHJ(H1%& JC
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN3#XNABN94)J5M['-3Q5&K4E2A).2W1>HHHKK.D**** "BBB@ HHHH ****
M"BBB@ HHHH **** "O*_VJO^3:_B;_V+U[_Z):O5*\K_ &JO^3:_B;_V+U[_
M .B6K:C_ !8^J,ZGP/T/S<^!?_)+-$_[;_\ H^2N\K@_@7_R2S1/^V__ */D
MKO*_#L\_Y&N*_P"OD_\ TIGX[B/XT_5_F%%%%>*8!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ^3/$'[(_BW5-?O[R/6=(EBN;AYO,FDE
M60[F)Y41D9Y]:]5^#O[.^F_#&Z_M2[NO[6UO:52;9LC@!'.P9.3VW'MV%>O4
M5X>#R7!8&?M:4/>6S;O;^N^YY$,JPE.M[?EO*]]7U"BBBO</7"BBB@ HHHH
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MO\OF7F6<4<5A'2IIIR[VZ-/N>^?L[_ SPQXV\#S:SK]G)?3S7#PPJ)WC6-5
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M5R_,J&94W.B]5NGNC? YE1QUU#22Z,O4445ZAZP4444 %%%% !1110 4444
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110!%+WK\HO^"J'_)PF@?\
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M9X@Q'LL*J2WF_P %J_QL?8?[+/A+_A'?AC%?2)MN=6E:Y8XY\L?*@_($_P#
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MX( _X""3]=M/-^;.,QC@\/\ 8O=_G\E:WKH=&=5/KF(IX&EO?5]K_P"2U?\
MP#E/@-J6D:7\5-#GUI UMYNV-V.%CF(Q&[>P;'TX/:OONOSL^)'@JY^'?C34
M=&FW;8)-T$O]^(\HWY?J#7V'^SW\2O\ A8?@6$7,F_5M.Q;763R^!\DG_ @/
MS!KT.&,4E">!FK2BV_T=_-/^M"<CJO"UZF"JJTK_ (K=?=JOF7=8_: \ ^']
M4NM-O]?$-Y:R&*:,6D[[6!P1E4(/X&J?_#2_PV_Z&/\ \D;G_P"-UPOBK]D.
M/Q'XEU/58O%)LTO;A[@6YT_S-FXDD;O-&>OI67_PQ3_U.7_E+_\ MU='UK/[
M_P"[Q^__ .W/3JU\WC4DJ=&+C=VUZ=/M'G'[3E]#J7Q4GNK>436TUE;212+T
M9&C!!'USG\:]V_9#_P"25S_]A*;_ - CKQ;]I[PF/"GBS0H(V:2 :1! LC#!
M8Q90GZX _.O4/V-]<BF\+:WI.X">WNQ<;<\E74#/YI^M>;DUJ>=XJ+Z\]O\
MP-/\CQZ#E#.OWNDG^;C<]?\ BEY9^&_B?S3A/[-GS_W[./UKX(\#?\CIH/\
MU_P?^C%K[<^/^O1:!\)?$$DCJDES#]DB!/+,YVX'X9/X5\??!/1I-=^*OAJV
M12P6\2=\=EC^<_HM&;?O,[PT([KD_P#2F_RU->(O?JT:<=]?Q:2_(]!_:A^%
M>H:/XMNO%%G:R3Z1?XDGDC7(@EP =V.@. 0>F217)?#W]H+Q7\-])_LNP-G>
MV"L6CAOXF<1$G)VE64X)[$D5]WLH92K %3P0>]<[-\-_"5Q,9I?"VBRRDY,C
MZ?"6)]<E:]"ID-:EB)5\#6Y.;=>NOW=NQZ.)R><L0\3AJG))[_K]Y\1?$#XH
M>+_B=:+<ZQ(S:5;R@+';0;+>.0@X!/=L XW$GKBNZ_8]B9OB1J#C[J::^?QD
MCKI?VOM>L;&QT#PM8+#"8F:[DMX%"K&N-J# Z9RQ_"IOV,_#<B1Z_K\B$1OL
MLHF]<?.__LE>-EV'E'/7%S<^2]Y/_#;SV;L>"\/..:TJ4ZCG)6;?IK;[CYO\
M0N9-?U-F.6:ZE)/_  ,UZ=X=_9S\??$"UCU6X,-HDZ*T<VK7+;Y%Q\IP S 8
MZ9 XKS[QUIKZ/XUUVRD&UH+Z9,>P<X_2OOKX;:E%JWP_\.74+!DDL(>5Z9"
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M?C7Z$^%?A]H/@WPZNC:?I\(LRFR;S$#-<'')D)'S$^_T'%? ?@;_ )'30?\
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M ,@[Q7_UUMOY25KE\53SZM&"LM?T9K4BH9_%1TO_ /*V?2M%%%?H)]L%%%%
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MO!=;_H?H;X+_ .1/T+_KP@_]%K7YVZU_R,%__P!?4G_H9K]$O!?_ ")^A?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"]H>CW'B#6K'3+1=US>3I!&/]IF 'X<U^C^AZ1!X?T6PT
MRV&+>S@CMX_]U%"C^5?*G[(_P^_M?Q)=>*;J+-IIH\FVW#AIV')'^ZI_-U/:
MOKFOU#A?!NCAY8B2UGMZ+_-GZ%P_A73HRKRWEMZ+_@A1117VI]6%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_K_@GVQ2UYG\#=-O/ _P?L?^$A>6S>%);F5+O(:WCR2%(/(PHSCMFOFCXO\
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MI.JV.IJGWS9W*3!?KM)Q7PT?!OQ%^+_VGQ(=/OM90[C]ID=44@?PQ*Q&0/1
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MM7KU%%>O1I^QI0I;\J2^Y)?H;X6A]6HQHWO9!7PS^T[$Z?&3669&572 J2,
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MZ:O]#LP>"KT*CJUZSF[6MTZ?Y!1117M'M!1110 4444 %%%% !1110 4444
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M2N>6<^Y.36[117[/"$:<5""LEHC]5C&-.*C%62"BBBK*"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK&L.'Z<<7CJ^-:O9Z>7,W^B:#"PCC,XJU)*ZC?\ "R7^9Y3^V1JBP>#=$T_
M,EQ>F4>P1"#_ .ABN,_8UTAI_%NN:D1\EO9K#_P)W!_DAJM^V'K8O/'6EZ:K
M96RLMS+Z,[$_R5:]&_8]T7[%X!U+42,/?7I4>ZQJ /U9JTP7^U<05:J^Q?\
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M%M/\-;JTCD4W-O?R-+'GY@&5=I(]#@_D:Z7X^?$JU\ >![V)9U&L:A$UO:0
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M\_'?P6<S_P $[_\ DM&N_P#8NS_^E-M7Z'V?^M%?GA_P3O\ ^2T:[_V+L_\
MZ4VU?H?9_P"M%&:_[R_1!@?X)W.@]!796?W17&Z#T%=E9_=%>.>@7:*** *U
MS]TU^$'[17_)P7Q._P"QHU3_ -*Y:_=^Y^Z:_"#]HK_DX+XG?]C1JG_I7+7T
M63?Q)^AY.8?#$^R_^">G_)$=:_[&&?\ ])K:OJ_2?]8*^4/^">G_ "1'6O\
ML89__2:VKZOTG_6"O,QW^\S]3MPW\&)W^A_=6NHM^E<OH?W5KJ+?I7 =)8HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *H:QH&E^(;=8-5TVTU.!3N6.\@650?4!@>:OT5,HQFN62NA-)JS,[
M1O#NE>'87BTG3+/3(G.72SMTA5CZD*!FM&BBFDHJR%&*BK15D%%%%,H****
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M7O\ Z):MJ/\ %CZHSJ? _0_-SX%_\DLT3_MO_P"CY*[RN#^!?_)+-$_[;_\
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M_F>]]4I+#O#05HM6T\SYY_9I^#/B+P#KVJ:MXAL4L6>V%O!'Y\<C'+ L?D)
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MORB_X*H?\G":!_V*]O\ ^E=W7ZNR]Z_*+_@JA_R<)H'_ &*]O_Z5W=>QE/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,U]BT4?ZM9?V?WA_8."[/[SXZ_X8Y\9_]!/0?_ B;_XS1_PQSXS_ .@GH/\
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M1-_\9K[%HH_U:R_L_O#^P<%V?WGQU_PQSXS_ .@GH/\ X$3?_&:/^&.?&?\
MT$]!_P# B;_XS7V+11_JUE_9_>']@X+L_O/CK_ACGQG_ -!/0?\ P(F_^,T?
M\,<^,_\ H)Z#_P"!$W_QFOL6BC_5K+^S^\/[!P79_>?'7_#'/C/_ *">@_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7E?[57_)M?Q-_[%Z]_P#1
M+5ZI7E?[57_)M?Q-_P"Q>O?_ $2U;4?XL?5&=3X'Z'S3_P $F/\ DE7C;_L-
M)_Z(2ONJOA7_ (),?\DJ\;?]AI/_ $0E?=5=68?[U,PPO\&(4445YYUA1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!%+WK\HO^"J'_)PF@?\ 8KV__I7=U^KLO>ORB_X*H?\ )PF@?]BO;_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_2N7T/[JUU%OTK@.DL4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M>5_M5?\ )M?Q-_[%Z]_]$M7JE>5_M5?\FU_$W_L7KW_T2U;4?XL?5&=3X'Z'
MS3_P28_Y)5XV_P"PTG_HA*^ZJ^%?^"3'_)*O&W_8:3_T0E?=5=68?[U,PPO\
M&(4445YYUA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ._T/[JUU%OTKE]#^ZM=1;]*X#I+%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7E?[57_)M?Q-_[%Z]_]$M7JE>5_M5?\FU_$W_L7KW_ -$M6U'^
M+'U1G4^!^A\T_P#!)C_DE7C;_L-)_P"B$K[JKX5_X),?\DJ\;?\ 8:3_ -$)
M7W575F'^]3,,+_!B%%%%>>=84444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC1JG_I7+7[OW/W37X0?M%?\ )P7Q._[&C5/_ $KEKZ+)OXD_0\G,/AB?9?\
MP3T_Y(CK7_8PS_\ I-;5]7Z3_K!7RA_P3T_Y(CK7_8PS_P#I-;5]7Z3_ *P5
MYF._WF?J=N&_@Q._T/[JUU%OTKE]#^ZM=1;]*X#I+%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7E?[57_)M?Q-_[%Z]_P#1+5ZI7E?[57_)M?Q-
M_P"Q>O?_ $2U;4?XL?5&=3X'Z'S3_P $F/\ DE7C;_L-)_Z(2ONJOA7_ (),
M?\DJ\;?]AI/_ $0E?=5=68?[U,PPO\&(4445YYUA1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%+WK\HO^"J'
M_)PF@?\ 8KV__I7=U^KLO>ORB_X*H?\ )PF@?]BO;_\ I7=U[&4_[RO1GGX[
M^"SF?^"=_P#R6C7?^Q=G_P#2FVK]#[/_ %HK\\/^"=__ "6C7?\ L79__2FV
MK]#[/_6BC-?]Y?H@P/\ !.YT'H*[*S^Z*XW0>@KLK/[HKQST"[1110!6N?NF
MOP@_:*_Y."^)W_8T:I_Z5RU^[]S]TU^$'[17_)P7Q._[&C5/_2N6OHLF_B3]
M#R<P^&)]E_\ !/3_ )(CK7_8PS_^DUM7U?I/^L%?*'_!/3_DB.M?]C#/_P"D
MUM7U?I/^L%>9CO\ >9^IVX;^#$[_ $/[JUU%OTKE]#^ZM=1;]*X#I+%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7E?[57_)M?Q-_P"Q>O?_ $2U
M>J5Y7^U5_P FU_$W_L7KW_T2U;4?XL?5&=3X'Z'S3_P28_Y)5XV_[#2?^B$K
M[JKX5_X),?\ )*O&W_8:3_T0E?=5=68?[U,PPO\ !B%%%%>>=84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDL4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>5_M5?\ )M?Q-_[%
MZ]_]$M7JE>5_M5?\FU_$W_L7KW_T2U;4?XL?5&=3X'Z'S3_P28_Y)5XV_P"P
MTG_HA*^ZJ^%?^"3'_)*O&W_8:3_T0E?=5=68?[U,PPO\&(4445YYUA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^ZM=1;]*X#I+%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7E?[57
M_)M?Q-_[%Z]_]$M7JE>5_M5?\FU_$W_L7KW_ -$M6U'^+'U1G4^!^A\T_P#!
M)C_DE7C;_L-)_P"B$K[JKX5_X),?\DJ\;?\ 8:3_ -$)7W575F'^]3,,+_!B
M%%%%>>=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX0?M%?\ )P7Q._[&C5/_ $KEKZ+)OXD_0\G,/AB?9?\ P3T_Y(CK7_8PS_\
MI-;5]7Z3_K!7RA_P3T_Y(CK7_8PS_P#I-;5]7Z2W[P5YF._WF?J=N&_@Q._T
M/[JUU%OTKE]$(VK73V[#%<!TEFBDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!
M:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR*
M%HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H
M 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B
M@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR
M* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC
M(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*
M,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(
MHR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,
MBC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:\K_ &JO^3:_B;_V+U[_
M .B6KU/(KRO]JHC_ (9K^)O_ &+U[_Z):MJ/\6/JC.I\#]#YJ_X),?\ )*O&
MW_8:3_T0E?=5?"G_  29_P"25>-O^PTG_HA*^ZLBNK,/]ZF887^#$6BDR*,B
MO/.L6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR
M*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3
M(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI
M,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6B
MDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:
M*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %
MHI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H
M6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@
M!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR*
M %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(
MH 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,
MB@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(H
MR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,B
MC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR
M*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3
M(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI
M,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6B
MDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:
M*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %
MHI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H
M6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@
M!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR*
M %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(
MH 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,
MB@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(H
MR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,B
MC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR
M*,B@!:*3(HR* %HI,BC(H 6BDR*,B@!:*3(HR* %HI,BC(H 6BDR*,B@".7O
M7Y1?\%4/^3A- _[%>W_]*[NOU<E88K\HO^"J!_XR$T#_ +%BW_\ 2N[KV,I_
MWE>C//QW\%G-?\$[_P#DM&N_]B[/_P"E-M7Z'V?^M%?GA_P3O_Y+1KO_ &+L
M_P#Z4VU?H=9_ZT49K_O+]$&!_@G=:#T%=E9_=%<;H/05V5G]T5XYZ!=HHHH
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M_P!#W_Y1[_\ ^,5^-5%']CX?^9_A_D']H5>R_KYG[*_\/"O@-_T/?_E'O_\
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M/A_YG^'^0?VA5[+^OF?LK_P\*^ W_0]_^4>__P#C%'_#PKX#?]#W_P"4>_\
M_C%?C511_8^'_F?X?Y!_:%7LOZ^9^RO_  \*^ W_ $/?_E'O_P#XQ1_P\*^
MW_0]_P#E'O\ _P",5^-5%']CX?\ F?X?Y!_:%7LOZ^9^RO\ P\*^ W_0]_\
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M^'^0?VA5[+^OF?LK_P /"O@-_P!#W_Y1[_\ ^,4?\/"O@-_T/?\ Y1[_ /\
MC%?C511_8^'_ )G^'^0?VA5[+^OF?LK_ ,/"O@-_T/?_ )1[_P#^,4?\/"O@
M-_T/?_E'O_\ XQ7XU44?V/A_YG^'^0?VA5[+^OF?LK_P\*^ W_0]_P#E'O\
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M_H>__*/?_P#QBOQJHH_L?#_S/\/\@_M"KV7]?,_97_AX5\!O^A[_ /*/?_\
MQBC_ (>%? ;_ *'O_P H]_\ _&*_&JBC^Q\/_,_P_P @_M"KV7]?,_97_AX5
M\!O^A[_\H]__ /&*/^'A7P&_Z'O_ ,H]_P#_ !BOQJHH_L?#_P S_#_(/[0J
M]E_7S/V5_P"'A7P&_P"A[_\ */?_ /QBC_AX5\!O^A[_ /*/?_\ QBOQJHH_
ML?#_ ,S_  _R#^T*O9?U\S]E?^'A7P&_Z'O_ ,H]_P#_ !BC_AX5\!O^A[_\
MH]__ /&*_&JBC^Q\/_,_P_R#^T*O9?U\S]E?^'A7P&_Z'O\ \H]__P#&*/\
MAX5\!O\ H>__ "CW_P#\8K\:J*/['P_\S_#_ "#^T*O9?U\S]E?^'A7P&_Z'
MO_RCW_\ \8H_X>%? ;_H>_\ RCW_ /\ &*_&JBC^Q\/_ #/\/\@_M"KV7]?,
M_97_ (>%? ;_ *'O_P H]_\ _&*/^'A7P&_Z'O\ \H]__P#&*_&JBC^Q\/\
MS/\ #_(/[0J]E_7S/V5_X>%? ;_H>_\ RCW_ /\ &*/^'A7P&_Z'O_RCW_\
M\8K\:J*/['P_\S_#_(/[0J]E_7S/V5_X>%? ;_H>_P#RCW__ ,8H_P"'A7P&
M_P"A[_\ */?_ /QBOQJHH_L?#_S/\/\ (/[0J]E_7S/V5_X>%? ;_H>__*/?
M_P#QBC_AX5\!O^A[_P#*/?\ _P 8K\:J*/['P_\ ,_P_R#^T*O9?U\S]E?\
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MS_#_ "#^T*O9?U\S]E?^'A7P&_Z'O_RCW_\ \8H_X>%? ;_H>_\ RCW_ /\
M&*_&JBC^Q\/_ #/\/\@_M"KV7]?,_97_ (>%? ;_ *'O_P H]_\ _&*/^'A7
MP&_Z'O\ \H]__P#&*_&JBC^Q\/\ S/\ #_(/[0J]E_7S/V5_X>%? ;_H>_\
MRCW_ /\ &*/^'A7P&_Z'O_RCW_\ \8K\:J*/['P_\S_#_(/[0J]E_7S/V5_X
M>%? ;_H>_P#RCW__ ,8H_P"'A7P&_P"A[_\ */?_ /QBOQJHH_L?#_S/\/\
M(/[0J]E_7S/V5_X>%? ;_H>__*/?_P#QBC_AX5\!O^A[_P#*/?\ _P 8K\:J
M*/['P_\ ,_P_R#^T*O9?U\S]E?\ AX5\!O\ H>__ "CW_P#\8H_X>%? ;_H>
M_P#RCW__ ,8K\:J*/['P_P#,_P /\@_M"KV7]?,_97_AX5\!O^A[_P#*/?\
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M_AX5\!O^A[_\H]__ /&*_&JBC^Q\/_,_P_R#^T*O9?U\S]E?^'A7P&_Z'O\
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M (>%? ;_ *'O_P H]_\ _&*/^'A7P&_Z'O\ \H]__P#&*_&JBC^Q\/\ S/\
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M /\ &*/^'A7P&_Z'O_RCW_\ \8K\:J*/['P_\S_#_(/[0J]E_7S/V5_X>%?
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M_#_(/[0J]E_7S/V5_P"'A7P&_P"A[_\ */?_ /QBC_AX5\!O^A[_ /*/?_\
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M_&JBC^Q\/_,_P_R#^T*O9?U\S]E?^'A7P&_Z'O\ \H]__P#&*/\ AX5\!O\
MH>__ "CW_P#\8K\:J*/['P_\S_#_ "#^T*O9?U\S]E?^'A7P&_Z'O_RCW_\
M\8H_X>%? ;_H>_\ RCW_ /\ &*_&JBC^Q\/_ #/\/\@_M"KV7]?,_97_ (>%
M? ;_ *'O_P H]_\ _&*/^'A7P&_Z'O\ \H]__P#&*_&JBC^Q\/\ S/\ #_(/
M[0J]E_7S/V5_X>%? ;_H>_\ RCW_ /\ &*/^'A7P&_Z'O_RCW_\ \8K\:J*/
M['P_\S_#_(/[0J]E_7S/V5_X>%? ;_H>_P#RCW__ ,8H_P"'A7P&_P"A[_\
M*/?_ /QBOQJHH_L?#_S/\/\ (/[0J]E_7S/V5_X>%? ;_H>__*/?_P#QBC_A
MX5\!O^A[_P#*/?\ _P 8K\:J*/['P_\ ,_P_R#^T*O9?U\S]E?\ AX5\!O\
MH>__ "CW_P#\8H_X>%? ;_H>_P#RCW__ ,8K\:J*/['P_P#,_P /\@_M"KV7
M]?,_97_AX5\!O^A[_P#*/?\ _P 8H_X>%? ;_H>__*/?_P#QBOQJHH_L?#_S
M/\/\@_M"KV7]?,_97_AX5\!O^A[_ /*/?_\ QBC_ (>%? ;_ *'O_P H]_\
M_&*_&JBC^Q\/_,_P_P @_M"KV7]?,_97_AX5\!O^A[_\H]__ /&*/^'A7P&_
MZ'O_ ,H]_P#_ !BOQJHH_L?#_P S_#_(/[0J]E_7S/V5_P"'A7P&_P"A[_\
M*/?_ /QBC_AX5\!O^A[_ /*/?_\ QBOQJHH_L?#_ ,S_  _R#^T*O9?U\S]E
M?^'A7P&_Z'O_ ,H]_P#_ !BC_AX5\!O^A[_\H]__ /&*_&JBC^Q\/_,_P_R#
M^T*O9?U\S]E?^'A7P&_Z'O\ \H]__P#&*/\ AX5\!O\ H>__ "CW_P#\8K\:
MJ*/['P_\S_#_ "#^T*O9?U\S]E?^'A7P&_Z'O_RCW_\ \8H_X>%? ;_H>_\
MRCW_ /\ &*_&JBC^Q\/_ #/\/\@_M"KV7]?,_97_ (>%? ;_ *'O_P H]_\
M_&*/^'A7P&_Z'O\ \H]__P#&*_&JBC^Q\/\ S/\ #_(/[0J]E_7S/V5_X>%?
M ;_H>_\ RCW_ /\ &*/^'A7P&_Z'O_RCW_\ \8K\:J*/['P_\S_#_(/[0J]E
M_7S/V5_X>%? ;_H>_P#RCW__ ,8H_P"'A7P&_P"A[_\ */?_ /QBOQJHH_L?
M#_S/\/\ (/[0J]E_7S/V5_X>%? ;_H>__*/?_P#QBC_AX5\!O^A[_P#*/?\
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MQ\/_ #/\/\@_M"KV7]?,_97_ (>%? ;_ *'O_P H]_\ _&*/^'A7P&_Z'O\
M\H]__P#&*_&JBC^Q\/\ S/\ #_(/[0J]E_7S/V5_X>%? ;_H>_\ RCW_ /\
M&*/^'A7P&_Z'O_RCW_\ \8K\:J*/['P_\S_#_(/[0J]E_7S/V5_X>%? ;_H>
M_P#RCW__ ,8H_P"'A7P&_P"A[_\ */?_ /QBOQJHH_L?#_S/\/\ (/[0J]E_
M7S/V5_X>%? ;_H>__*/?_P#QBC_AX5\!O^A[_P#*/?\ _P 8K\:J*/['P_\
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MK\:J*/['P_\ ,_P_R#^T*O9?U\S]E?\ AX5\!O\ H>__ "CW_P#\8H_X>%?
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M_H>__*/?_P#QBOQJHH_L?#_S/\/\@_M"KV7]?,_97_AX5\!O^A[_ /*/?_\
MQBC_ (>%? ;_ *'O_P H]_\ _&*_&JBC^Q\/_,_P_P @_M"KV7]?,_97_AX5
M\!O^A[_\H]__ /&*/^'A7P&_Z'O_ ,H]_P#_ !BOQJHH_L?#_P S_#_(/[0J
M]E_7S/V5_P"'A7P&_P"A[_\ */?_ /QBC_AX5\!O^A[_ /*/?_\ QBOQJHH_
ML?#_ ,S_  _R#^T*O9?U\S]E?^'A7P&_Z'O_ ,H]_P#_ !BC_AX5\!O^A[_\
MH]__ /&*_&JBC^Q\/_,_P_R#^T*O9?U\S]E?^'A7P&_Z'O\ \H]__P#&*/\
MAX5\!O\ H>__ "CW_P#\8K\:J*/['P_\S_#_ "#^T*O9?U\S]E?^'A7P&_Z'
MO_RCW_\ \8H_X>%? ;_H>_\ RCW_ /\ &*_&JBC^Q\/_ #/\/\@_M"KV7]?,
M_97_ (>%? ;_ *'O_P H]_\ _&*/^'A7P&_Z'O\ \H]__P#&*_&JBC^Q\/\
MS/\ #_(/[0J]E_7S/V5_X>%? ;_H>_\ RCW_ /\ &*/^'A7P&_Z'O_RCW_\
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=IJ^E3QV87M6AL%&T4 11Q!:F48HI: "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img226925499_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img226925499_1.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ;G#1(# 2(  A$! Q$!_\0
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M\MO2CRV]*^<A\=M8/\=._P"%Z:S_ 'Z/[.K]A_VAA_YCZ+\MO2CRV]*^=?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5[]HCX7P?&;P/*;F-9#:Q&0$CI@5^7=OX\\1?#M-=\-Z5J,EOI]Q(T4\0_B
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M66I>!+Y]$MUEU+'[N-%ZUX$LOQ2PW*Y:+6Q]+#,\&\7SJ.KTN=A^S?XE&N?
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MD>,?L'_M(+H;6WP^GM<1W&<3D\5Z#\4/V0/&_C+QUJ.LZ9XXN+.RN&W)"DA
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MX@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-R?M9[L[,7745]7I:17XB$[B2:2BBN\\D**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM^)1_P PP_E7!?:/''_/'_QVC[1XX_YX_P#CM+ZS#^1#_L"'\QWZ_%[Q,O\
MS"S^5/7XQ>)E_P"86?RKSW[1XX_YX_\ CM'VCQQ_SQ_\=I?6(?R(?]@P_F/1
M1\:/$Z_\PL_E2CXU^)Q_S"_TKSG[1XX_YX_^.T?:/''_ #Q_\=I>WI_R(?\
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M6K_S!_TIR_M/>+EZ:/\ I7C7VCQQ_P \?_':/M'CC_GC_P".TN:A_P ^T/\
MLB7_ #\/:!^U%XN_Z _Z4\?M3>+Q_P P;]*\4^T>./\ GC_X[1]H\<?\\?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I
M54MTH5=QQ7@O[6WQ^/P;^']Q<Z5<(-6^[MSR*B<U3BY,UITY59J$=V<%^VQ^
MV%;?"'P__8WAB:'4]:O-T$L,9RT>>/SKY\_8E_9/OOB=XF?XA^-'G2YAG\^&
MWGR0V3GO7C?P!^'VN?M6?%FXU=UDG>*?SIC)]W&<U^POA'PQ:>$= L["UB6,
MQ1*C[1U(%>;33Q,_:2V6Q[E>4<#2]C3^)[LUXXXK>-(X(UAC48"H,"EHHKU3
MY\****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 .C^^/K7RA^T_$EQ\2-.CD&Y"HR*^KX_OCZU\I?M-?\E,TW_=6NW!_Q
M?D7'<]1^'OPY\,WGA>&6?3HWD(Y8K70_\*O\*?\ 0,C_ .^:;\-/^11@^E=-
M1*4N9ZG.V[G-_P#"K_"G_0,C_P"^:/\ A5_A3_H&1_\ ?-=)14<TNXKLYO\
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MFC_A5_A3_H&1_P#?-=)11S2[A=G-_P#"K_"G_0,C_P"^:/\ A5_A3_H&1_\
M?-=)0H+$ <DT<TNX79S?_"K_  I_T#(_^^:/^%7^%/\ H&1_]\UMW6K6.GW2
M6MU<+#<O]V-CR:L9#<CD4<TNX79SG_"K_"G_ $#(_P#OFC_A5_A3_H&1_P#?
M-=)11S2[A=G-_P#"K_"G_0,C_P"^:/\ A5_A3_H&1_\ ?-=)11S2[A=G-_\
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MU OGMMP3]:]M/))H"J@"QJ$0=%48 HKU814(I(^=J5'4DY2ZA1115F84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1KYF4>63BG>Q]K3DYP4FK7"BBBH+"BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI[4E>8 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %<G\5/B):_"KP3>^(;E!*MNN
M?+)QFNHNKN'3;26\N9!%;0J6=VZ #O7YB?M\?M7/KVO/X4\-W"W6ARKMFF4]
M&[US5ZJI0OU.W"8=XBHH]#YQ_:$^,NK?&[XD7-\;B1M-NI=J698E5R?2OOG_
M ()^_LSP?#K19=<U2W6Z>^020F9<^7WXS7R1^PU^S['\5_B(8]>C==*A'FI)
MCJ1SBOV T71[;P[H]KI=HFVWM4")]!7!A*3G+VLCV<QQ"I06'IEP^@^Z.@I*
M**]@^9"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_;-(9F'R_=S7I5R?WS5PV@Z?-XVUH^,->&_7-Q&_VKM68LQ)ZU]93BXPC%]
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MX1^#[?2-/.Z-E5V^N/\ Z]?(/_!.G]GUM'TR\UCQ':[I6Q);%A7WKT4*.BC
MJ\'1Y8\[W9EF>)]I/V<=D%%%%>D>&%%%% !112[?<?G0 E%.VC^\OYT;1_>7
M\Z &T4[:/[R_G1M']Y?SH ;13MH_O+^=(1CN#0 E%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !113MO\ M+^= #:*=M']Y?SHVC^\OYT -HIVT?WE_.C:/[R_G0 VBG;1
M_>7\Z;0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% #H_OCZU\J?M+C/Q.TW_=%?5<?WQ]:^4OVFO^2FZ;_NK79A
M/XOR+CN8'QR\0?8?A-#%=H6M0PQGI7%^"->M-2T&T2)U10G S7K7QT\"7/Q
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M%=^<@D5F37&I>68K;4IK5?[L;$5S3R:$E[KLPYC]/+SPWX+\1I]GF:TO@/\
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M'_S_ ,?YT?\ "8Z'_P _\?YT<T>X<DNQKT5D_P#"8:)_S_Q_G1_PF&B?\_\
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MT56AU*UNAF*97'M5D'/2J)"BBB@04444 %%%% !1110 4444 %%%% !1110
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M'\(=$B4*I? ]ZMP_#72H1A2V/K74T57LH=B?:U'O(Y&X^%ND73;F+9^M1_\
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M=W/,H;?3-5?R]-D=I.V:ANO!/BA6!MHV*9KUC_A'M&\-Q_:8+0*1_=%8%_\
M&2RTV0Q-93-MXX6ATHQ7OL%7G-_NHW1S6D^#/$#,OVI"!WYKNM,\#Q>4#<$[
MOK7):E\:DO!Y=I:31D]RIK-&I^(=87S(+QH0>@8XIJ5*.VHG"M/66AZE#X3M
M(&#*QX]ZU%41*%R,#WKQN'1?%DC;CK* >F^M:STS78\>=JL;?\#%7&NEM$SE
MAI/>1Z'>:Q:V'^N?%9T_CK2;90SR8%8*Z7)<+BYNHY3_ +U.;PO9SH%D"L*;
MK-[(2P\?M,U&^)6AJI8RG JG_P +>\-\CSS^555\%Z9M*M "#47_  KO0O\
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MMRVT^&U "H#CU%6**T45'9&;E*6[%^7^XOY4GX8HHJB HHHH **** "BBB@
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MYMHO 0OUKL[?P19QPJ&8[OK7G6H?%*\UV8QV,<MOGH2,5$(?%-ZH9-3\O/\
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M5V.YX-Y [8&,U^U:Z*OAWP+_ &:K%EAAQD\GI5TW=DR5CY*TW_D-:G_UT/\
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M0?\  JU+/X36-JP?[3(2/]JK5:?\I#P]/^8]%_MJP7I=H!]:/^$@TX=;U/\
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M?_0*?\JL?\+$\/?\]$_*E_X6%X?_ .>B?E1[67\Q7L8?R%;_ (6KJG_0*?\
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M3_@(JS'XHLH^4MD7Z"N(N/$NFS0,L$N6[5FQ7$]Q_J^31[=H/JR9ZE'XR1F
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MK-\0)&ZZ/G_@--7Q[X=4 ><IIQ\?>'/^>J_E1[:7<?L(K[)')X]=5R-"#?\
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M'G/(O_ J?UF?\HOJE/\ F/:O^$HT;_H(0_\ ?5/C\1:5,<1WT;GV:O*X?A!
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M]QV,W_A8G_3$4?\ "Q/^F(K2_P"$&L/[U'_"#6']ZCFQO\P?N.QF_P#"Q/\
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MS\.OV8Y8X#KNG>(-?5LF9&4N37V/J%^FJ>&9KN-=J21$@?A6E-69$CX^T_\
MY#FJ?]=#_.E\3?\ (%EI-/\ ^0YJG_70_P Z/$__ "!)OI7VL-T0SS#X<_\
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MZ6_Z4?8_#'I;_I1RR[CYH?RGFTGQ/NOX5D_*JTGQ-U'^'S/RKU+['X9]+?\
M2C['X9]+?]*GEEW*YX_RGDK?$S5V^Z9/RJK-\2M?/W'<?A7L#6/AH_\ /O\
MI43:7X<;D&W_ #%+DE_,/VD?Y3Q\?$CQ&6 \UORK6L?$WBK4%REQM^M=]-IV
M@*3@P_I521M-A4B*6-/H12Y7U97/%[1,.&W\8W2Y%ZH_&GMX?\73??O4/XU)
M=2;F)CU$(/9JQ;R:]R1%J3-]&HT!7?8T9/ OB&X_UEW&?QJJWPHU&=LRSH?^
M!5A37&NQ'*W<S#ZFH!K7B"-OOSM^=3>/5%VET9U]K\)67_6NA'^]6E!\*[-<
M;PI_&N%37_$''RSG\ZN6_B#7.-R3?K33CV):GW/0;7X9Z,F/,C4_C5S_ (5S
MX?[0#\ZX:UU[56QN27]:V+?7K]0,Q2&M$X]C)J?<Z+_A7.@?\^]+_P *ZT'_
M )]ZR$\57:XS;N?PJ8>,[E?^71S^%/W>Q-I]S1_X5[H7_/O2K\/=#9@!;]:S
MSXVN=O\ QXN?PJ&^^(EQI.FW-^]A(4MUWGCTI^X%JG<\@_:T\9>%/AI\/=2T
ME8O+UJ>,F!L]#7Y-W&HW6K7$ES>N9)F8_,?2O>_VROCH?C5XZBN+0?9H;4^6
MT8/7%?/S.$V]MS8KSJLE*6A]!A:3IT_>W9ZC^SQ\&=5^-'C2VBTS&VSE5Y<^
M@-?L'HOPQT*Q\/:;:26P$T,*HY'&2!S7QI^P+\/+_P"'+3>();626&^CRIV\
M<U]C3>++MV8BTD&3Z5TT8I1NSS<9.4ZG+%Z(N?\ "M_#_>W_ %H_X5MX=_YX
MC\ZRY/$5](I MI!^!K*NKS59<E5E'YUO>/8XDI]SH;KX9Z$W^JC4?C6?-\+;
M!L[ @_&N7N;G6E^Z9OUK/GU#7Q]TS?K6;<>QHHS_ )CJKGX4QE?W+(I^M4?^
M%:ZG!_J;B,?C7*2:EXC'0S_K4]E<>(68%Y9\?C4WCV+Y9=SI5\(^)+<?NKI?
MSJCJ5UXJT.,E[C<H]*U=*U#4X\>:9&^M;1N!=+_I$6X?[55:^Q%W?74\T_X6
M)XB4X\QORI?^%D>(_P#GJ_Y5Z9';:3_';QC\*M1VV@\;HX1^5'++N/GC_*>4
M?\+(\2'_ ):/^568OB1KN/G9S^%>MPV_AL]1;_I4LD/A>%2TAMT4=SBGR2_F
M)]I#^4\HB^)6J9^=G4>I%4->^/D7A2U:XO+@.B]0IKG?VD/CYX<\#V;:7I=M
M#=37"E?.BP=AKX[C@\4>-KIC%#<7EI(WWE!(&:]G"Y;4JI3J2LCYC,,]I8>3
MI48WE^1]&^,?VRC?6C+H\S12]J\@N/VHOB8]Q(8;V9HR?EVYKTKP+^P[=>(M
M)MM4GO?LS/AC"PP17T)X'_9UT+PK;I'>VD-XRC!+*#7M1IX6@K15_4^5G6S#
M%RYIRY?0^([O]HGXCW_$TURWX&J/_"[/'?\ >N?R-?I$OPT\'A0/[!M_^^!2
M_P#"M?!__0!MO^^!5^VI?R$/"XE[UF?FY_PNWQW_ 'KG\C1_PNSQW_>N?R-?
MI'_PK7P?_P! &V_[X%'_  K7P?\ ] &V_P"^!1[:E_(+ZIB/^?I^;G_"[/'?
M]ZY_(T?\+L\=_P!ZY_(U^D?_  K7P?\ ] &V_P"^!1_PK7P?_P! &V_[X%'M
MJ7\@?5,1_P _3\W/^%V^._[US^1I?^%W>._[US^1K](O^%:^#_\ H VW_? H
M_P"%:^#_ /H VW_? H]M2_D#ZIB/^?I^;W_"\/'G]ZX_[Y-'_"\?'G]ZX_[Y
M-?I#_P *U\'_ /0!MO\ O@4?\*U\'_\ 0!MO^^!1[:E_('U3$?\ /T_-_P#X
M7EX\_O7'_?)H_P"%Y>//[UQ_WR:_2#_A6O@__H VW_? H_X5KX/_ .@#;?\
M? H]M2_D#ZIB/^?I^;I^-WCMNK7'_?)J*3XR>-Y/O&X_[Y-?I/\ \*U\'_\
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M5S^%2#QM<]/L3_E5>[V%:?<O_P#"O=#_ .?>E_X5_H?_ #[UGGQQ=#_EQ?\
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M8UCX:[?9Q^5+EEW'SQ_E/'YOB5KQ^X[C\*A_X61XC_YZM^5>PMI?AQN0;?\
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M2/\ YYR?E7:_8_#'I;_I1]C\,>EO^E/EEW%S0_E.,7XIHQ_U<GY4C?%2//\
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M1/\ =%6_AO\ \BO']*J?\%"/^2HZ)_NBK7PW_P"17C^E=N'_ -Q@+J=!=_\
M'C<?[A_E7H?[%/\ J=:_ZZ'^=>>7?_'C<?[A_E7H/[%N3;ZWCKYA_G7FX_\
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MQX1U"+I++^9KWN2-9/O 5!)IL$GWES^%'LT)5F?/LN@W\?667\S562QO8_\
MEM)^9KZ#D\.V4OWDJ!O!VF/UCJ?9=C15D?/;)=IUFD_,U#)-,O69_P S7T(W
M@/2'ZQU"_P -]#DZQ"I]DRO;Q['@MG*)I,2W#*OUK=TV&UCD#)<%S[FO6O\
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M"4)<YZ8SS6V(H1QM/FCI)''@\54RJMRSUIL_1AM<UL,1_9R_]\TG]N:W_P!
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M:U_T#5_[YJ^/B=I!IX^)6DFC3^86O\IG?VYK?_0-7_OF@ZYK?_0.7_OFM/\
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MSVWX;_\ !82U\.Z1%:ZYH]SJ,JJ 9#ZUW:_\%D/"#0^8=!D!_N\YKY=^!?\
MP3;\0_$BXW^)H;G1!(<E=NW&:^DY/^"+?A=XEV^+;E'(R3UI:]1Z'VW\$_BM
M:?'+X<V7C&PB\BVNAE4KMJX/X#_"&T^ 7PRL/!5C<&[MK,869NIKO*WC>VIB
M_(****8@HHHH **** "BBB@ HHHH DMY/+E#8S7Q/^U5^Q[I?QJ\5W-_=^([
M+3'EZI/(%(_,U]MV/_'RM?CG_P %,M<URS^*][%I^KW=JF[B*&5E!]N#6<BX
M[G?6'_!(ZTU=-VF^)[*_(&3Y,N['Y&KK_P#!'F^<#=JD)Q[U\Z_ 7X^?&_\
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M+GB_Z![_ )4J_&1&_P"8?)^1KI5\%V2_P+^53+X3LD_Y9)^5.T^XKT^QR?\
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M_P 'K2Z.7N#FE[W0:Y/M%5?C?9@?\>]*/C=:-TM2:4_!"Q_Y^*GM_@W8V_\
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M%:"ZA!(H/VF,?B*?LXOJ+VLH]#R_3?A7N0?:@V[ZUJP?"?368>9NQ]:[O[7
M?^7F,_\  A2_:(6_Y;H?QJE3B0ZLSC_^%2Z)ZO\ G1_PJ?1?]O\ .NP\R+M(
MI_&EWI_?%5R1[$^TGW.0_P"%3Z(/[_YTO_"JM%_VOSKK\CUHX]:.6/87M)=S
MD/\ A5>B^K_G1_PJK1?]O\ZZ[(]11N']X4<L>P>TEW.1_P"%5:+_ +?YT?\
M"JM%_P!K\ZZ[<G]X4;T_OK^='+'L'M)=SD?^%4Z+_M?G3?\ A4NA^K_G77^9
M'_ST7\Z/-B_YZK^='+'L/VD^YQ4_PETC;^[W9^M5O^%8V\()C#;ATYKO?M$
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M>ITUVTDZ/7%7'AJ67/D#95&3P3K,G^KN=OXTN9H%&+/25U.W;HX_.I/MD/\
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MCR?3O$"%K9=N,5^KWA'_ ()O?!_0]0TW5K:S<W40#KR.37YJ?\$V?^2H77_
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M_=%3_#;_ )%F.N[#_P"XP%U.CN_^/&X_W#_*O0/V+_\ CUUS_KH?YUY_=_\
M'C<?[A_E7H'[%_\ QZZY_P!=#_.O-QW\(H^C:***^>)"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ ZU3NO$^EZ6QCN[];=QU4MBM&V*B9=W K\^?VSO#
MGQLU+QI=R>!=/>XL#]QES4R=BDKGW5_PG'AMN3JL1/\ O"I[+QMX<^TIMU6'
M=VRPK\<4\$_M6[1_Q)I?UI\?@W]JZ-@PT:7(^M9\S>A?*=;\?KNRU3_@I%;7
M%G(EQ$0OSKS7ZBZ;_P D\7_KC_2OR6^"7[,GQKU+X^6/BWQ;HLD6T_O)6Z=L
M 5^MT%M)8^!?(F&V58<$?A5T]PD?)&G_ /(<U3_KH?YU%XR_Y%V:I=/_ .0Y
MJG_70_SJ'QI_R+<WTK[:GO'Y&;/,/A;_ ,CDO^_7Z!^)O^2(:I_UXM_Z#7Y^
M?"O_ )'!?]^OT#\3?\D0U3_KQ;_T&O+SC^/'Y!$_+'X-_P#(<U3_ *^F_F:^
MJ-)_X\4^E?*_P=^76M5/_3TW\S7U/HYW:>A]J]VK_#B#W/(/VDO^1B\'?]?:
M?^A"OT*UC4KC1_@[:WMJI>XBL4**O4_+7YZ_M)?\C%X._P"OM/\ T(5^D_AR
MUAOO!NAV]P,PO:(&!_W17SF9[0^91^,6@^$7_:._;J72?$:>4K-DI,,]#[U]
M%?\ !47Q1I/P_P#A#X8\!>%-:6.\AE6"2VMI,-MX&"!7G7[87PA^*'P(_:.N
MOBOX)TKS-)5=J3J,COD$5XO\./@3\4?VIOBM;^)-?LYWC>Y6=PV<8W _TKY[
MR-/,^A/V9_V&[:/]G?Q/K_B:S0SW=F9DFG09 VYXS7A?[!UQ=>$?VL-/\/Z=
MK$DNEF<AH4<[3SW%?6__  46_:#\8? GP3X6^&GA6WCC75+!;:=E3+?=Q@5S
MG_!-_P#8YET4P_$'Q'%)#K:R>8BOZ$YIVU207TNS],-0XN#CT%5ZDN)?.D+5
M'6RV,6%%%%,1F^+O^1)US_KW;^5?'7[+NCVFIOK[7-\+0BZ; )QW-?8OB[CP
M3KA_Z=W_ )5\A_LH>#[;Q-)K[SNR8NF'RGW-:3_W2KZH]'!NTF>YR^"].9LK
MXBV_1Z9_PA=C_P!#(?\ ONMYO@_I7_/>3\Z3_A3^E?\ />3\Z^9Y7V/7]HOY
MCGKK0[73US'KOF_\#K"O/$4FFL?+NVEQ[UWZ_"'21_RVD/XTY?A%H_=V/UI<
MDNA2J0ZL\ZA^(UU'_>/XU<A^*MQ'_!FN[_X5)HWJ:/\ A4>C>II<DP]I2[')
MP?%R5L*8\5IQ?$A7C!) /UK:_P"%2Z..A-'_  J?2/[[?G5I3)<J3V,I/B&D
MAP7 _&K,?BRVN,!KI4S[U<_X5/I/]]OSI/\ A4^DYSYC_G3][L1[G1G*ZSXX
M-E<M%#+YB_W@:Q)/B-<[B 6_.O1O^%3Z1W9C2?\ "I-'/\1J'&9I&=-+4\S;
MX@73?Q-^=-C\7W%])L:X:,'OFO3/^%1Z/ZFF_P#"H-'[,U+DF5[2F<?9Z?%J
M'^LUHQ9_VJT5\&6.,GQ&>?\ ;KH/^%0Z2>DKC\:3_A3^E'_EM)^=/D?8GVD>
MY@?\(-IK-D^(0?\ @=6H?!NC)C=K*/\ 5JU/^%.Z5_SVD_[ZIC_".Q4_)-(?
M^!4^5]A<Z_F$M?#.@PG_ (_HG_*MFUT_0(<'?"_Y5CK\*[:-25E?/;YJA7X>
MS1]"V/\ >IZKH+1_:.PC_L,\*D)_ 5(+?1VZ00G\!7(?\(?=0+E-Q/UJ":SU
M'3?F<$ 57,^Q'*NC.[73; _<M8_R%2#3;8=+9?RKS.X\>7NGJ1CD5A7/QBU:
M.4JB_+]*7M(HI49O8]K%C$O2 #\*=]F4?\LOTKP[_A<FL_W?TI?^%Q:S_=_2
ME[6(_83/<?)'9,4NPCM7BL/Q<U>3JOZ5>A^*&IO]Y?TI^TB3[&1ZY\WO2_-[
MUY<OQ&U!L8'Z5*OC[5&Z+^E/VB%[*1Z;E\=Z3YO>O./^$UU?;G943>/-43JO
MZ4>T0O9R/2_F]Z-A]*\O?XC:BHY7]*IS?%'4H^B_I1[2(_92/6_)'=,TGV=?
M^>=>+3?%[55X"_I5?_A<FL_W?TJ?:Q*]A,]P-G&W6$'\*:VG6[=;93^%>(_\
M+DUC^Z,_2K5K\4?$%T?DCR/I1[2(>QFCV!M)L3RUG&?^ BHFT_2D^]:PC_@(
MKSN#Q9XGO, 0]?:K7E>)+KEXN#5<RZ(GD?5G;/#HB=885_ 5FW=CH,V?WD,?
MY5S/_".ZS=-B5"!]:6/P#=3$^;N'XTKM]"E%+[1=N?#NBR'(U&./\:SYO".E
M2=-;5/\ @56X?A?'*I\V1P?]ZIE^$>G2+\\TF?K2Y6^A7,E]HQ&\%V';Q'C_
M ('0O@ZQCY_X2//_  .MS_A3^E?\]I/SI?\ A4.E?\]Y/SI<K[#]HOYCE+ZS
MATW/EZP9<?[58LGC*XL9"J3-(/K7HO\ PJ'2>\KG\:D7X1Z,BEBS;5Y-+DET
M&JD.IXS\0_C(NC>!=72>Y\BX>%O+RV#G':ORQU[7+SQ?KUS/>3//)YK;6<Y.
M,U]@_P#!1+5M*T6ZTRS\/W!<_=F56KXXTN!E<7)'R]2:X*TFG9]#V\+!*',N
MHZ^D\FU%M_$*^KO^"?>C)9ZMJ5UJ5LNT?-&T@KY'OI#=ZQ:[,D/,JG'UK]?_
M (!_ G0].^&NB:@H*3W,"L^..U%"#;T%C*D80L^IV,?CZ)@L?F!57@<U/_PD
MEK,I)O%4_6KG_"I])_OM^=)_PJ;2?^>C_G7I^]V/ ]SHSBM2\?2V\[QQN75>
MAS68_P 1KD\9;\Z])_X5/HYZLQIC?"/1C_$:SY9FJJ4SS-_']TPQO8?C4MIK
MDNI-A[UHL_[5>C?\*AT;/WC1_P *AT?L["ER3'[2F<M:^';:^4-)KYB/^_5G
M_A"[!ASXCS_P.M\_"'2CTED'T-)_PI_2C_RVD_.GR/L3[1=S"C\#:6K9;Q &
M_P"!U=A\'Z(OWM5C?ZFM%?@]I?\ SWD_[ZJ(_"6S5OEEDQ_O4^5]A<Z_F)[3
MP_H%OC_2X7_*MFUM] @Q_J7_  %<[)\,8X_]7(Y_X%2)X"GCZ%OSJM5T)]U_
M:.QB716D7;'">?05\4?M]6<+>)=,:SB54V?-L%?54GAF^M0#$"2/>O)OC]\/
MX=;\(WNIZ@/](MXR4KOP594:\921X^:85XG"3A!^?W'E/[(.LX\0VUEO[_=K
M[?N.)6K\X_V1]8-O\7(8Y&Q"&(YK]&YI%FD+H<J>AKZ+$QM,^*R^7-1&4445
MR'I!1110 4444 %%%% !7P-_P6._Y)AX9_Z[K_,5]\U\=_\ !3GX,^+/C9X!
MT*S\(:>VI7%K*'EB7KBLZGPLUHNU1-GEW_!'?_D2O%_^^:^2/^"B?_)?+G_K
MF?YBOO+_ ()E? WQC\%?"WB2#Q=IK:;+>-F&-NO2OG']M7]D'XI?$CXQ3ZOH
M&@M?Z?(FU74XQS]*Q:?(D=<)1]LW<^SOV*_C#X#T']FCPQ8ZEXEL[2[CB DA
MDD 8'BO;+3XY?#FXNXH;?Q59R7#G"(L@R37XJP_L+_'NWC$<6@W<:#HJSL!_
M*NB^'?[%GQUTKX@:#>7>C7D5O!=(\DK3,0J@\\4*<EI8F5&#;?,?I_\ &S]D
MW0/CYXAAUV^,+NJ_*SJ#D5Y\?^"<'A(RQ/BVS&P<?NQVKZG\-V\MEX?T^";B
M:.!5?Z@5HYK?E3.13DM$S/\ ">@Q^&?#NG:%!CR;51&NWI7QI_P4H_:2;X8^
M$[OP-Y.YM4A(#=^17VGJDT]OH]Y-9C=?1H6A7U;M7Y,_M9? 'X^_M%?$@:I?
MZ 9+:#,4)7@!<]>GI4U&TK(THI.=Y&?_ ,$PO@KJ5]\4+#QE=6;2Z4@*JQ7Y
M?SK]@[K8LSB,!8^P'2O!_P!B7X87_P '_@39>']8M%M]1C.6!'->YTZ<>5"K
M3YYW"BBBM#$**** "BBB@ HHHH *K:TVSP[J;CJL+']*LU@^.M;BT3POJ/FM
MM\R%@,_2FM63)V39^97C/4Y-6\9WP<EMD[#GZU]6?!/Q?<:1X(2V0D+[5\L^
M$;*'Q)\:$L+C_CWN;L@_0FOT>TGX&Z#H=A%;P$["@-1F\GR1IKU+X;BO:SK2
MVV/.I/'5U)\OFL/QK0L[HZICS-2:'/\ M5WI^$.C$YW&D_X5#I':1A^-?+\D
M^I]_[2GT.<M_"-G,N]O$14^F^I'\$Z?)U\1?^/UO?\*?TK_GM)^=)_PI[2_^
M>TGYFJY7V(]HOYC'A\$:4OWM=5_^!5=@\):%'C=J4;_4U<_X5#IJCY9I,_[U
M1K\*+1>DK_\ ?5'*^P<Z_F+]IH^@6^!Y\+_E6O N@QJ ! ?P%<K)\-C$^(W<
MK]:>O@6>+D%OSJM5T)=G]HZ]8]&;I%"?P%2)I^FR<I:QGZ 5Q<F@ZE:\J#M'
MO563Q'?:1\I'2GS=T3R7V9Z&NF6G:U3\J<-/@7I;J/PKQ_4OBUJ5KQ$,_A5#
M_A<FLG^']*GVD2O8S/<1:HO2(?E3O) _Y9XKP[_A<6L_W?TI\?Q@UAF^[^E'
MM8A["9[=Y9'1:7:WO7CL/Q6U1^J_I5Z+XE:C(.G/TJO:1%[&1ZK\WO1\WO7F
M*_$'4FZ+^E2IXXU9^B4>T1/LI'I/S>]'S>]>:MXYU9.J?I4;?$+4DZK^E'M$
M'LI'INUCVI/+_P!FO*IOB9J*=!^E4)_BUJD7\/Z4O:1*5&3/9/(!_P"6=)]E
M1NL7Z5X>_P 8M8!X7CZ4G_"Y-7_NC\J7M8E>PF>WFP@;K;J?PIC:7:-UM$/X
M5XM#\7=;N&PB GZ5K6GCGQ-=XV0Y'TI^TBQ>QFNIZ<VEZ:OWK2(?\!%1M:Z,
MG6WA'X"N'6\\3WWWH>M#Z/KMQC='C/7FCF[(GE[LZVZAT*3@B%/P%8]WHFB3
M9VWD4?TQ6.?!.H3./,# =^:GC^&QEDQ*S!?K2U?0I67VALWA72),XU=5_P"!
M51D\%Z:QROB$+]'K83X463GYY9!^-./P?TO_ )[R?]]4N5]BN=?S&%_PAEC_
M -#(?^^Z;<>'[2RCW)K_ )A]-]= /A#I7_/>3\Z/^%0Z3G_72'\:.5]A^TCW
M."O-<?36_=WK2X_VJAC^(MU'QEC^->C)\(]'7.78TO\ PJ31O4U/)/H5[2GU
M.#A^*ES#U3-7H?BY*S &+K77_P#"I=']31_PJ;1_4T^6H3S4GT,:/XD*R@E@
M/QJ1?B&CG!<#\:U?^%3Z1_?;\Z/^%3Z3_?;\ZNTR;TRE'XQM[C :X"_C63X@
M\8+IK*+>?S@WH>E=$?A-I)_Y:/\ G2_\*GTGN['\:&I-;"3@G>YYU-\1+E6P
M"WYU7;X@W3?Q,/QKTP_"71FZDTW_ (5%H_J:SY)FOM*78\R7QE<W3A3.R ]\
MUL65FFJ8\S6##G_:KM/^%0Z/_>-'_"H=)[2./QHY)=0=2'0Y]/!MD5Y\28_X
M'2?\(-IS-D^(L_\  ZZ#_A3^E?\ /:3\Z/\ A3^E_P#/>3_OJJY'V)]HOYC)
MA\%Z.OWM:23ZM5^V\+Z#"03?Q.?PJ1_A'81_ZN:0C_>I%^%=LO25\_[U'*^P
MN9?S&K:Z;H$./WD+_E6I'_86 %2$_@*Y'_A7<L+G8S%?K4H\&W,*Y4MN^M5=
M]B&EW.N%OH[=((3^ J5=-T]N4M8_^^:X633=2L5WL#M'O5.;QO>Z>I3'W:.9
M=4+D;V9Z4--M1TM5_*G"QA7I !^%>+WWQ>U6WDQ&N1]*A_X7%K']T?E2]I$K
MV,SW#[*HZ1?I2^2.R8KPW_A<6L_W?TJQ#\7=7?JOZ4>UB'L)GM>P^E'S>]>0
MP_%+5'ZK^E74^)&H,.G/TJO:1)]C(]2^;WH^?WKS)?'VIOT7]*L)XTU9HRVR
MG[1"]E(]%^;WI/F]Z\T;QYJB]4_2HV^(NH+U7]*7M$'LI'I^T^E)Y/JE>3S?
M$_4H^B_I6=-\7M5CX"_I2]I$I49L]H^SK_SSI#:1MUA!_"O$/^%R:QG[O'TI
M#\9-8[+^E+VL2O83/;CI]N>MLI_"HVTFQ;EK.,_517CMM\5=>NF 2,'\*UX/
M&'B>Z4;81@T_:18G2FMV>CMIVE)]ZUB'_ 14;0:*G6"$?@*X@?\ "2WBAFBQ
MFFMX?UNX;YT(_&CF[(7+W9U-W::#-GYX8_RK&N?#^BR$D:A''^-9Z^ ;R=OW
MNX#ZU/#\,4F8^:[@?[U+5]"M%]HKS^$]*DZ:VJ?\"JHW@O3\\>(\?\#K;C^$
MFG2 ^9-(#]:7_A3^E?\ />3\Z7*^P^=?S&&O@VR7G_A(R?\ @=5+S3[?3LF/
M6O-_X%74?\*ATK_GO)^= ^$.D]Y7/XTN1]A^TCU9YW<>+I[&3:EPT@'O4D?Q
M(N8_4_C7H2_"'1E_B8T[_A4NC=<FER3*]I3.'@^+%Q#P8\U?M_BU)+(J-'M!
M[UU7_"I=&]31_P *FT?U:FHS%S4NQD?\+&3^\/SIZ?$".3K(!^-:G_"I](_O
MM^='_"I])_OM^=7[YG>GW*7_  E%M/&6-TJGZUSFJ^/'M9BD4F]?4&NP_P"%
M3Z3_ ,]'_.@?";2/[S&DU)] BX+=GF\GQ$NL]6_.H'\?W3#[[#\:].;X2:.W
M<TS_ (5#H_\ >-1R3-?:4^QYO:>(IM18![MHL^];MGH-OJ',FO&+_@==7_PJ
M'1QT=J3_ (5#I/:60?C1R2ZB=2'1F#_PAEB1@^(__'Z2/P-IF[+>(0WU>M\_
M!_2S_P MI/SH'P?TL?\ +>3_ +ZJN1]A>T7\QFP^#=%3EM6C?ZFM*U\.Z!#C
M_3(7_*HV^$MDK?)+)C_>I)/A?%&H\J1R?]ZCE?8GF3^T;UK:Z!;XYA?\!5Y1
MHC?=CA/X"N07X?S1]"V/K3V\*WMNG[H$GZU=WV):C_,=@MKI+_=MX2?H*E72
M['^&UC_(5Y_)+?Z7RX(Q5&\^)%[9*0!R/:ESI;A[.3V9ZB--MQTME'X4\6<2
M](0/PKQ"3XR:P'P%X^E'_"X]8_N_I2]K$KV$SW#[.H_Y9TOE>BXKP[_A<6LG
M'RC\JMP_%K5FQE?TH]K$7L)GL^UO2CYO>O)H?B?J4G5?TJTOQ$U%NB_I5>T1
M/LI'J'S>]'S^]>:+X[U5NB?I3CXVU<?P4>T0O9R/2?F]Z3#>]>9MX^U-.J_I
M44GQ(U!1T_2CVB#V4CU'RR>HI/)!_@S7D-Q\5-3CSA?TJA-\8-67[J_I2]K$
MKV,SVS[.O_//]*0V43=8 ?PKP_\ X7)K']T?E0OQCUEFP$Y^E+VL2O83/;3I
MMLW6U4_A4;:38#EK./\ [Y%>26OQ*\171^2('\*UXO$7B>^4#R>M/GB^A/LI
M+=G?M8Z0GWK:$?@*BFAT3;@QPK^ KC&L_$5P,O%UJ-O"^KW2_.A'XT<S[!R]
MV=%=Z;H4V<3PQ_E61/X;T=\XU2-/QJLOP[GE \PL#WYJTGPKMY!^\DD!_P!Z
MEJ^A5TOM&?-X/TN3IKRI_P "JO\ \(78]O$F!_OUNK\(=-89::3/UH_X5!I7
M_/>3\Z7*^P^=?S&&OA&RA4M_PD>2/]NLN^D33<^7JAEQ_M5V'_"H=*_Y[R?G
M3O\ A4.D9YD<_C2Y'T0_:1ZL\X'CJYMI-HD9P.^:LQ?$ZYCZ@G\:]!'PDT9?
MXB:/^%1Z-_>-+DF/VE+L<9#\7)T&#%6A9_%1KAL.NT5TG_"I=']31_PJ?2/[
MS"J49B<J1D?\+&3/WA^=31^.HIOO2A?QK1_X5/I/]]OSH_X5/I/]]OSJO>[$
M7I]S)U/Q7##:F:.Y#/\ W0:Y>Y^(MPH^4G\Z[W_A4ND=Y'/XTO\ PJ;1_5J4
MHS>Q494UOJ>:M\0KIN[#\:@D\>73\>8P_&O4/^%2Z/ZFF-\(=&8YR:CDF7[2
MGV//K&_?5<&346AS_M5N6_A6TNE#/XAV'TWUTO\ PJ'2.SL*3_A4&E=II/SI
MJ$NJ%[2/1F W@G3WZ^(L_P# ZDA\$Z5'][7E?ZM6U_PI[2_^>TG_ 'U0WP?T
MQ1E9I,_[U/E?8GVB_F*4/A'0DQNU.-_QK5L]$T"#'^D0O^54Q\)[13Q*^/\
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M&4%..Z/S*M1EEF+=*:M%[>A^B5%5]+U*#7-.@OK=PXF7>0O;-6*Y#TPHHHH
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M6IO^$'TV7_6PAJY!OC>4;#69!IR_&Y6ZVN*?- 7)4.O_ .%?Z%_SZC\J/^$
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M77M,(_X_8O\ OH57ND^\,7P_8+TBQ0WA^P;K$*?_ &[I?_/]%_WU1_;NE_\
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M@V49_P" U5I]R+T^QR__  N'3?\ GUE_*C_A<&F_\^LOY5U7_"/Z5_SXQ?\
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MKL/C"PDZW$8_&G[HO?)AX3TM>D J0>&]/7I"*='XATR09^V1C_@5/_MW2_\
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MBC2='4%XV([\59C^,OA^#A87X_V:3Q^&VE42''"UOLP;,&ZOO%%YDMIBC/\
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M_P!)Y'?FGW'A;2+%?]+B9O6ES2#EAW.QB\7Z)<_<D1_PJ/4=;18MUG!'(?\
M=KC(=8\):8=GV>3(]JT8?B+X<MP D$F![4<W=CY.R94OO$WB1V*0Z6C+_NUC
MWLGB>_C*/IJJ#_LUV5I\4M'D8+'$P_X#6[9^+K2^QLPN?6E92^T/F<?LGB$_
M@G7;ARS69!/M4?\ P@.M_P#/JWY5]$+<JZ@B2/'U%9^K>)+?1(R\^&'7Y142
MA""YI.R*C6G)VBCP^W\ ZQT:W8?A6E:?#F^D8>9&RUVDGQNT2-BIB8D?[-1R
M?&W164!(W!_W:XOKF"7_ "]1U>QQ3_Y=LJVOP],D860,N*F_X57!+]Z9Q^-6
M(OB)#J&/(##/M5E_$5R4^4G-:+%T)+W7<Q=*M'?0H)\'+)C\UU(/QI__  IJ
MP_Y_)?\ OJKG]I:DT/F;_EJ./7[Q,[V-'UBCU0<E7I(K_P#"F[#_ )_9?^^J
M/^%.V&W_ (_)?^^JF'CI+;)FW$"H7^,NC6[;)(Y"WTI?7,)'XI)#]CB7\*N)
M_P *<L/^?R;_ +ZH/P<L/^?N7\Z5/C5H4CA1')DG'2NKT?7K;6XO,@.%_P!J
MM:6(PM9\M.2;,ZD,125YIHX[_A4=I'RMQ(?QJIJGP[:RA#6A:1_2O3AM_P">
MB?G2C;_?7\ZZ^2)A[274\7_LG7[5OW=GN'N*;-9^([A2IL/_ !VO:_,']]*/
M,']]*7)YC]IUL?/=QX/UZXDW-9D?A5FU\.Z]:D#[#D>XKWKS5_OI2&1&XWQU
M/LEW+]N^QY3IEG>Q$>?:JOX5UVFW%I;@&5$!^E;.H2V=NA:4J1[&N6OO%OA^
MW8B6-C]*=N7J3=SZ'0-XBTB/[XC'X5$_C+P_'PSQ@_2N1E\7^$ILAXFJI-K7
M@J7EH6)HYO-#Y/)G=Q^,-$D^Y*E68_$6G2<),*\INO$7A:WR88),5D77C33U
M!^S1R#\*XIX^A3?+.:3.B.#J35XQ9[Q#?03_ .K?/XU8",:^=;?QQJ<DF+4N
M!VXK9MO$_BJZ8".8BDLRP[^&5_0'@:L=]#W'RV]*/+:O&6U3QCP!/4LEUXSM
MU5GGX:K^O0[,CZJ_YD>P^6U'EM7C_P#;/BJ&,O)-D"J%UX^URR7=)(Q'TJ7F
M%&/Q.PU@ZDOAU/;_ "SZ4>6U>!GXN:DO4OGZ5/9_%#5=0D$<;,&/'(I+,L))
MV51%/ 5TKN)[KY;4>6U>:6:^++^(2QW"A3ZFK/\ 9_B_M=)_WU7>I\RND<CI
MV=FST+RVH\MJ\\_L_P 8_P#/:FMI_C/M-3YO(/9^9WTMW%;DAVP:JR>(+"/[
MTV/QKSVZ\-^+;K):7)^M58? ?B*1LS/D5/.^Q7LX]6>B2>+M)B^]<#\ZA/CK
M05.&N%)KDX?A_*J[[H;@.M5[C1_#NGMFY@<D=<4<TA\L.AW4?B;2+@9C,;_A
M63K'B"ZA_P"/&SCE]/EK M_%'A.QPJ02*5]JT8_B9X=@^ZA'UHYK]0Y&MD9%
MQX@\47 (&E)C_=K%U"Q\1ZHI#Z>%^BUZ%:_$[2)ES&./I5>\^,6CV+8>-C]%
MKGJ5:-)7JSL;4XU9.T('E3> ]<9B3:'\J='X!UO=_P >K?E7I?\ PO#0\9\I
MO^^:?%\6=/U'_CW1A]5KE^MX-[5$SH]GB5O \]A^'^KMC=;L/PK5L/AG=-(K
M2(PQ7:+XNFN&RAX^E-;7KZ1@$:K^L4>FIFXU>NA07X="X4;RR\4?\*EM9?O3
MNOXU?FUK4(& 9NM(?%4MLNZ4DBJ^M4?M&:I5.C*:_!RQ[W<@_&G?\*=L/^?R
M7\Z&^+6G6+8N$<_04-\;-"7K')^53]>P76:1?U?%](MBCX.V _Y?)O\ OJD_
MX4[8?\_DW_?5:NC_ !&TS76 MU92?45TT<B2*&#J![FNNG*C65Z;NCGG[:F[
M3T.$_P"%.6'_ #^3?G37^#=AMXNY"?K7?_+_ 'U/XT?+_>7\ZV]G'L9^TGW/
M/?\ A4]M#]V9V/UK*U+P3>6#?Z(C2UZQ\O\ ?7\Z7<H_C3\Z.1= ]I+J>+_8
M_$5O\JV.X?2JUYI/B*\7#6.!]*]R\P?WTH\T?WTI<GF/VGD?//\ PANO(^[[
M(2?I6E8Z+KD+#S++ _W:]S\U?[Z4UFC;J\?YU/LET9?MF^AYSI<$T./M$"K^
M%=1:7VGVJ@NB9^E2:IJ6F6>?/*GZ&N8OO''AJWR)(V;Z42<::O)B2=1Z(ZEO
M$VC1_?\ +'X5%_PFOAX-M\R,-]*X6;QQX-F^];R'\*IS^)/!+KN2VD\SZ5PO
M,<,O^7B.A8.J_L,]-C\5Z1)]R9?PJQ'KMC-]R4&O*(;[2+S_ (](W7TS3KNQ
MOU4-:,13CCJ<M8NXGA9+1Z'L$<RS<HV?QJ7RVKQFWC\71PF2*;""D_M/QDN?
MW]5]>AU3)^JOI)'L_EM1Y;5X>WBGQ5 6WRG"U1F^*>LVK[9'<GZ4O[1P\?BE
M8M8&M+X5<]^\MJ/+/I7@2_%W4B0-SY^E=-HVM>(]>4-;S;1C/S5I3QV'K/EI
MRNR)X.K35YJQZOY;4>6U>?\ ]G^+3_R](/QIK:?XO[7"GZ&NOF\CFY/,]"\M
MJ/+:O//[/\8_\]J/[/\ &/\ SVHYO(.3S/0_+:D9"O)KSW^S_&./]=S4;Z;X
MR<8,W%'-Y#]GYG>R:E;P</)C\:K/XDTZ/[TX'XUYS=^$_%ERW,OUYI;;P!K;
M'_2&R/K4\TNQ7LX]6=[)XST:/[URM1KXXT&0X$ZL:Y;_ (06VMH]UY@^O-4V
M3PGH[9FC);V-'-+J'+%['=MKVG31EK=8W;MQ7-ZIXDUB)C]CTZ.0=OEK/C\?
M>%-/'R0OQ[5:A^,GAZ+[D+_]\URU,9AZ;Y9U$F;QPU62O&#:,>XU;Q5=9SI2
MC/\ LU@ZAX<\0ZDQ+V.WZ"N^7XS:1<?)%&P;_=J7_A//M3#R1@'U%8_6\-+X
M:ES7V-:.\+'E@\ :[_SZ'\JEA\ :YNYM6'X5ZI)XDNMOR]?I2/K&I1PB0L-I
M]J/;4NEP_>>1YU#\.]4?&^!A6]I?PYFCQYBL*Z6/Q-=HI:0Y ]JKR?$>"S4M
M,&('7BG]:H1UD["=.M+2*N5_^%:Q3?>=A2?\*CM)3\UQ(/QJ5?C5HBK\T<F?
MI4UK\8M$O9 B(X)XZ4UC<%)_Q$+ZOBEKR,A'P<L/^?N4?C1_PIRP_P"?R;\Z
M[/3]2AU*+S(V 7WJW\O_ #T7\Z[XQA)71R.I43LV<-!\(;&+.+R4Y_VJC;X.
MV!8G[9-_WU7>KC^\/SHP/[P_.JY(]B?:3[G _P#"G+#_ )_)?SJ-_@[9+TNI
M#^->A<?WA^=)\O\ ?7\Z7LX]A^TGW/.Y/A;!#&2LC.1V)ZUX3\:O@-=ZE'+J
MEK:DRQCA5'6OKL;?[Z_G3;B&*[A,,K(8VZ@UU8:M+"U%4INUAJK+J?G#\-?B
M7K7P;\5!QN,V[:\+YP!GTK[_ /AW\3M%^)&D036-TLVH%09XU/W37CGQT_9I
MM?%&GS7WAY(X]3^\[9[5\J>&?%GB'X.:Y<6NGRO%.C;9CV-?:.-'-J?M*3M-
M"G35976Y^G;QM']X4ROF/X:?M>:5;Z?Y?B21I;KL:]X\'?$?1O'ENDVGRHBM
MTW'%>%6PM6@_?CIW."5.4=T=)14ICC!Q]IB_[Z%)LC_Y[Q_]]"N0S(Z*DV)_
MSWC_ .^J-B?\]X_^^J (Z*DV)_SWC_[ZHV)_SWC_ .^J (Z*DV)_SWC_ .^J
M-B?\]X_^^J (Z*DV)_SWC_[ZHV)_SWC_ .^J (Z*D\N+_GXB'_ A6-XF\5:=
MX1LY+J]FC:-!D[6%-)R=D/<UU0N<#K6)XO\ &FC^ ],EN]8N5MOE)CR>K=J\
M0\>?M=^'?[+EAT9V2^Z!J^5O'_Q4\1_$^[CL=1>6>W9\1;<]:]G#995JN]3W
M4=-.A*7Q:(Z/XT?&_5_BQKC6L9*11L5A$9X<=J];_9F_9_2/R?$NJQ;+R,Y$
M3#@USWPK_9=UF.*WU._0-D!XL]A7T%8Z#XJTNV6"VD"Q@8P*C,<QA2A]5PNW
M5H[K)1Y8L]+\K;PB*B]E7I4<C"'ECBO/FT_QEVFJ&;1_&$ZX><?G7R7,^QE[
M-=SO9-9LX?ORX_&J[^*-,C^]<#\Z\XD\$^)II,O<)C_>I\W@Z\T^#S;UPZ=]
MIJ'4<5=HM4XO2YW;^.-#C^_<K2Q^,M#N/N2H_P"%>4MK7A>WD,=S!(S+P>*T
M;/Q5X+M5^2VD#?2N'^T<->SJ(Z?J=7I!GHMYK4'DEK2&.1NW%<I?>)O$6\K;
MZ7&Z]OEJ&U\9Z3-A;2-E';(K:AUZ54#1]#TXIK&T9_#*_H3]7G#XE]YR=U/X
MHO58-IBC=Z+7.W7@O7KR3>UF0?I7J*:WJ,JLRD8'M3(_$=]N^8\?2I>(IO>Y
M:C-;6/*_^$ US_GU;\JGA\!:S_%;,/PKTS_A.6@E*R#I[5%)\8M)L_EGC8M[
M+4_6L+'XIV+Y,0_AC<X>W^'-_+@21,M=-I_P]981')N J\WQPT(=8G'_  &N
M@T/QM8^(U#6P*@_WA6U+$X6I+EIU$V95*>(BKSA9',_\*N@F^]*X_&E7X/V3
M'FYD'XUZ""I_Y:(/QI?E_OK^==W)$Y/:2[G _P#"G+#_ )_)?SH/P;L,'_3)
MOSKOL#^\/SI,#^\/SH]G'L'M9]RIX#\)P>$[:6."9I@YYW&M/Q1_R")*L:9C
M8V#FJ_BC_D$25U25L.[=CS)MNM=G)> /^0O+7H7EEV.*\]^'_P#R&)*\U_;.
M^*7B3X7^"[F^\..Z72PLPV#/.*\G J]+YF]?XSZ/$#8(..A%?!/AG]D7Q/IO
M[9FM>/'L6&F7!)6;(VFOS^/_  46^/OG2_\ %03?>/R^2WR^W6E;_@I1\>57
MRF\2$'T,1S_.O6]FUL<MS]\K.U>WM8D.,K[UX5^T%^QSX5_:*U**\\022))&
MH4;!GBOR!_X>,?'QN1X@F(_ZY-_C2_\ #Q?X^?\ 0P3?]^6_QH5.P7/W ^#?
MPCTWX+>![;PQH[%K*#[I;@UY5^V=\"Y/CEX7L].C1G,)/W:_*#P__P %%OCM
M>:W;6S>(6FWR*K1[2#C/UK]LO@CX@OO$WPH\/ZMJ3>9?W-LKRL>[&IDG'49Y
M!^Q'\ 9/@'X7U*PE1H_M#[OFKZ1IS.6ZTVL6VRCGO'7_ "#EJC\-_P#5W'UJ
M]XZ_Y!RU1^&_^KN/K7!#_?HF[_@L[*BBBOHS@"BBB@ HHHH **** "BBB@ H
MHHH 9,QC@=AU XKXI^/FI3W7Q:T\.K 9'6OMAONG/2OCW]HAHW^*VGA ,\=*
MJCS?68V=M&=E"W+*Z/HGX:_\BC!]!72US_PTM)?^$1M_EZCBNF^QS?W/UKHF
MUS,\UD-%3?8YO[GZT?8YO[GZU%T(AHJ;['-_<_6C['-_<_6BZ AHJ;['-_<_
M6C['-_<_6BZ CCE>/[K;:BDABFF$SKNF7HW>K/V.;^Y^M'V.;^Y^M%T UKB1
MEP7)%1U-]CF_N?K1]CF_N?K1= 1K(T?W3BDN#]K39/\ O$]#4OV.;^Y^M'V.
M;^Y^M%T!''(T$8CC)5!T IOO4WV.;^Y^M'V.;^Y^M%T!#14WV.;^Y^M'V.;^
MY^M%T!#14WV.;^Y^M'V.;^Y^M%T!#14WV.;^Y^M'V.;^Y^M%T!#14WV.;^Y^
MM'V.;^Y^M%T!#14WV.;^Y^M'V.;^Y^M%T!#14WV.;^Y^M'V.;^Y^M%T!#14W
MV.;^Y^M'V.;^Y^M%T!#14WV.;^Y^M'V.;^Y^M%T!#14WV.;^Y^M'V.;^Y^M%
MT!#14WV.;^Y^M'V.;^Y^M%T!#14WV.;^Y^M'V.;^Y^M%T SSGV[=QV^E1QJL
M3;D&UO6I_L<W]S]:/L<W]S]:+H!DD\D@PS%A3*F^QS?W/UH^QS?W/UHN@&1S
MR1C"L0*B\F/S_/V_OO[U6/L<W]S]:/L<W]S]:+H!C3/(,,Q(IE3?8YO[GZT?
M8YO[GZT70$-%3?8YO[GZT?8YO[GZT70$-%3?8YO[GZT?8YO[GZT70$-%3?8Y
MO[GZT?8YO[GZT70$-%3?8YO[GZT?8YO[GZT70&/XN_Y$G7/^O=_Y&OD7]D_1
M[+4SX@-U LK_ &I\%A[FOK_Q?:RCP5K:[>3;/C\C7Q]^RKK5II/_  D*3RA)
MC=/M4_4U&*</J-7GVNCT\#S<_N[GT1=^"XC'BT00''4"N<;PGJ5I.[C7A$!S
MLWU<F\::VUYLM;(RVYXW@5$WP[?Q!)]KN+N6"1SDH">*_-ZG)6THP;:\['U5
M/GI:U9)+[Q;+XF77A/,,D<FHGIN7FK\/QPEFX_LN4?\  34<-OIO@FXBM;AU
MF:7H9.:ZJ&.QN(P\5O&5QU"BMZ+Q=N15K6Z6O;YF51X?XG3O?KM<R8_BQ)(N
M?L$@_"GGXJ28S]AD_*M%I+&,D%(P?H*:MQ8GJD8_"NSGQ/6K^!S?N?\ GW^)
MB7'QDDM_^8;*WX54;XZ2*N3I4H'^[75QPV<RY6"-A]!5?4AIEG;%KJ**&,C&
MX@5G)XQ+F5>R]#2,L/>SI?B<E-\?HIV$/V9HV;C)[5)B_P#%$?F6NK>26Y"A
MJH-\.=#\27$LUG=AFZX7M6-=>%=4\)ZA'+IPDN54YV\XKQYUL;\6)]Z'E_P#
MT8PPVU#W9>?_  3J;'P9XAM;C?+JLCKZ$UIZI:1:?9^;?1_:]HR<\UA:5\2K
MQKP0ZO%]D7IEN*Z[[18^);=HK>82AA@XKNH_5ZD&J+U[/_)G)5=:$DZJT\C!
M\(S:'XN6<IIR1^4<'BM6XT[1[%N+--WTI?#GA.+PJLXA;=YQR:J:HCK<9/2K
MC"5.BO:17-UT,Y24ZC]G)\OJ/6]MHFS%"$'TJ[;ZI!,P7R\&L+(J6WC:20;!
MGZ4HU&GH.4%;4Z:Z>"WA,TF GJ:KV\VGZBH"%)/9>:@U?2VU;1)+-F*%A]X=
M:R_"/@L>&Y!+]H:4^C&NF4JGM%%0O'JS",8>S;<O>-Z31-/FXDME;ZBJ_P#P
MBFC?\^,?Y5J'YFIL\B6L9DF.Q!U-;.G3>KBON,E.>R;,IO"6E=8K-$?U JCJ
M7AJ]DA*VUV;9?RJ?4_%UG%;G[#*L]Q_<%85CX@US79)+>YM&@A/ <5PU)X>_
M)%:OM_FCLIQK6YF]%W,B]\-ZMI]O+<#Q )2O/EA^:Y=O%7B%050SN.FX9KO%
M^%L-M(;R;4)"OWBK,<5K:-K&D"\738EBE?Z<UQTX5Z<DE+V=_.]SLE5IRC=K
MGMY6L>:6FO>(YFY><?G6M'?:^J@F:;]:]9DM[6'K!&OX5"UQ9+QL2O24<3'X
MJWX'$ZU*7PTSS#^UM<C7)DE/YU5E\9ZW:_\ +.9OP->LK/92<;$S]*F^S6K#
M/V>,C_=IM8J7PUOP$JM&/Q4SR)/B7J=NN989E'N#4]E\1Y]8N%@$YAW<;B:[
MWQ-:Z.\8AO?+MC)PO %<E)\(=/FA>>TNV)/(VFO/K2S&,N6%1277HSMIRP<H
M\TH.+^\O2>%]8U:(/;:P>>?E:M#2/"FL6/%SJ#3#H<FN,M[SQ!X-NO*M[:2X
M@7^)JZ_P_P#$2"^DV:E(+:7LI]:BA4P\I_O+QEYMV%6C7C'W+./DE<K>)[W3
M/#DR+>6*W3MSN(K5T'3M#U[31>#3XXU],59U?PW:^*BLV\%1T-31Z2-)TK[+
M!R*[8T9JK*4HIPZ:')*I%TU%-J74HR0Z3:R%8K) 1W I8KVVA/R0A15&12K$
M-UIN16?/9Z)(KENM6=%97D%PPV(%:I+VZLK3#3.@8G^(UCZ3&_VI7 ^2H/%7
M@O\ MQD<7#(=V<*:Z/:5/9.4(W9BH0]I:4K(Z(6EI=QJYC5P>14,GA[2YO\
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M/"TZ,<2O<57E?;?\2ZE6DES>SYEWV. T?5K181]HTDNWNM;::QI*Q[SH@/\
MP&NID:RAX:.-?PI?M%EY?W$Q]*]"/MUHZJ^XXI3IO50_$X^;QAI%N/\ D7\X
M_P!BJJ_%+3[=OD\/,N.^RNZC6SN/N0QM^ I+BWL8('DEMXDC7[S;14/ZWO&L
ME\BHSH;.F_O.+_X7U:6GR_V>86]",5,NN7'C!!+;:C]D+]%W52O_  CX<\6Z
MAN@O$$I_@6L;7/AW=^'=LNG222LISM4UY-2MCM74?/#R_P" >A&&%T4/=EYG
M1)X*\1^<LG]L2%,Y^]6XVDS6UH7OI/M6T<@\YKDM/^(FL:>8+?4;4P1+P7:N
MXM-<T[6XA'!<+(S#H#75AWAIIJFW?LW_ )G-7]O&W.E;R.7T75]$UK7'TS^S
M$61>K8KH[O0]&L>391DCVJ#3O \&D:U)J:M^\?\ AJ77E=B&[5K3IRA3;K15
M[]NAE.I&4U[*3MZ]2M]ILHV_=6X0#T%6K?5H&PICK&R*55+L O)J54:V*<$]
MSK1(C0;S]T#-5+>_L;QF19$8@XP#1';--I[1,2NY<9KFM!\ C3+Y[@W+MEMV
MTFNJ<ZG-%0C=/<PA&G:7-*SZ'5OIEG)P\((^E5V\,Z0S9-FA/TK1)SCVH8>6
MI9N%'>MW3@]XHQ4Y+9LS#X8TH<I9HK=B!5>\T.\,+):W#6X]JDO/%6FPQNL=
MPK7 Z)GO7,+XOUZ\O1 +$BV;_EH!7%4J8>'NI;]O^ =5.%>6M]NY&WAO5;>Y
M>23Q" !SY9>DM?B@^DN]O<63W^WC>!G-3S?#$:M,;V6^EB9N2FXXJU:WNB^&
MYH[0O'-*QV_,,FN*,:U&7-%^S7=N]_DSL<J=16:YWV2M8JI\2-.OF_>>'VS[
MI5R/Q/H[KG^P0/\ @%=4MO9^6L@MHPI&?NBHVFL4_@CS]*]1?6H_%57W'"Y4
M7\-/\3FCXFT<#(T+G_<K.N_B#;VO$.C,OT6NU6XL6_@C_*IEM[23D6\;?@*&
M\3+X:J^X2E1C\5/\3S2;XJW2K\MA+&OT-9%Q\2KO49!$DK0,3CKTKU364TF.
MS*W210)_>P*XU_A7I.L,UU:W>0W(VUY]:68)\M.JI>6B.ZC+!M<TX-?B5K/P
MOK6KQ"2'7#\PSM#5M:3X-UVPD#3ZF\J^A-<J^EZSX)N/] CDNDSGG-=#HOQ*
MEDG6+5E%KV.:YZ52CS6KIQEZNQI4C5Y;T6G'T5S0\2QV>@V8NK^W6\W>M1>%
M6T+Q2KE=,CB">HK<U&SLO&%FL<4HDBZAA3=)\-Q>'K>583DL,5Z'L9.MS))P
M.'VD52Y6VIE>YL=&T]]L=DF?4"HH[FUA?*0!:K31O'(WF=<]Z9D5FYV>B2*4
M=-7<W+74+>=@/+ -7+R>VACWSLHP/XJYRVC>29?+&<'FKGB/PV=>L]IE:,[<
M<&NB-2;@W%79BX04TF[(U+?['J4.]0LB>U-DT'3;@8DM58>XJCX5T#^P=/$!
MD:0@]6K<Y:MZ:YX)U(JYE-\LFH2T,O\ X1/1?^?&/\J0^%].C.;:U6)O4"M&
MZNH;%"]PWEH.I-<_J7C& PM_9;BZF[**SG["G\27ZEP]M/X6_P!"/6/#NHS0
M[8K\VJ]N<5R.I:'J^EQO*NO^<5&=BOS6U#J&M>*&-K>VS6D?]X<4#X7P6.;V
M6^D=4^8JS<5YDXNL^>C%^K;7X'H0E[+W:LEZ6O\ B>>KXI\1EB ;@@'&>:N6
M^L>([CK).OYUZ7HGB+1;J06L0A>0?+C S71R0VMN,M#&H^@KJI?69QYE7NO0
MSJ5*4'9T;,\?5O$$@&Z>7'IS5RVNIK7FYM6G]<BO3_M%EV5/RH6:QD; 1"?I
M73^_Z5?P.?VE/_GV>=_\)GIUJN'T N?790WQ(T:#!E\/[!ZLM>D_9+5O^7:,
M_P# 17-^)(_#VI*+:XEBMY,XX '-857C*<;JLOFD:TY8>;LZ3^\YE?%NA^*6
M$5O9QV;'C<>*L?\ "N;VZ7S+'4-JGG*FH+[X0VT=L\UI<L2PRNVJ.FZUXA\&
MP?9DM7F@!_UC5YDJE6_^W)^J_P" =RC!K_9)?)_\$[/1_"VIZ>@6XO6E'?)K
M-\2ZMI/AN\@AN[%;B28XW$5H:%\0+.^55O)EAG/5<U9U[P9;>++BWO&DP(N5
M]Z[W&-2C_LKN_/4XE*4*O^T:+RT)+'2]&OK,7'V%%&,XQ43-IMN=L5HJX]!6
MA/9_8]/,4?88XKG\%>&ZUK42IV7*K^AE%N=W=V]32CU*&/I'Q6I8W4-U\RJ%
M;M7-9%7M*AF^U)(H.P44ZDKI"G!6N:EWJEC;R;9Y463T8\U.MK:W40?RU=&K
MC_$WPY&O:J;S[5)'DYVJ>*Z_2[7^S].AML[O+&-QK6G*I*<E4A9+;S(G&G&$
M7"5WU(9/#NE3'+VB,?I3/^$7T<];*/\ *M-5+=!FJ=YK%CIN1=3"+ZFMI4Z2
M5Y11DI5'I%LJGP_%#G[(GD^FVN>U?PSJ\DP/]M&U7T9L4[5O&U\K#^R8/M:D
M]1Z5#<:'>^-U1KUI+)E'13BO-JRI5;PI1;?EHOO.^FJE.TZC27WO[B"'Q!?>
M#;A6DO&U,+_"ISFM)?CK+(W_ ""IA_P&JT?A2P\&Q_:KBZ\\KVDYKI]*O=-U
MBV6:&"%L^BBG1^M1?LXU.3RW_$=1T&N=PYO/8SX/BX]RO.GR+^%.D\>072EI
M=+9_JM:\GV*'[T4:_@*?'<6/E']W'CZ5Z,98G:57\#BDZ.ZI_B<A=>,M*0EF
MT'>?]VLUOB-I"L1_PC1/_ *[Z/[%,<+%&Q^@I\EK9K&S-;1A1R3M%8M8N6L:
MWX(U52@M'3?WGF\WQ4T.W&#H@@;MD8I8;A/&$>^RNEL"W09Q5W6O#?AOQ9?
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M8DF6-O1CBMYTZ=1IS5[&4:DX7Y':Y4U*Z80R+_L$5^5?[6A+?%+32>OVY?\
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MV'A'2=<U/4M7^SK<0/Y2NV!G!Z5^._BN^GU;QWJYEG:XB-RWELQSQDU]\_\
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M$&FPB'^S'EQ_$171:7\0)9L?;X_LO^]Q6S?>--(TN[-K<%1-T(Q46H>%]/\
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MU>\=?\@Y:H_#?_5W'UKAA_OT3=_P6=E1117T9P!1110 4444 %%%% !1110
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MAA1U%9//]TUT7]O:2_!O8S[;A0VH:4RY\^,#UR*<J<).ZDA1E.*LXLYY59F
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M%K-$1RZXKF_"WA%?#\D[N #(VX5AW'Q0U."9D729& [[:EL_'&I:](L3V$D
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MW>OKJ</9^/AH<:V5_#)-<KP7 KKK'4K?4K=9 ZH&&=K'FEETNQF):2V1W/\
M$17):I\/;JXN#<07S0HIW"-3^E9?[116GOKML:?N*KU]UE[5O!<.I:U;WJJ"
ML9R:Z=56-0J# QBN!_X3;4M#F2S^PR3KT,F*Z[3]:BN;(7%RPM_9J>'J4'*7
M)HWN*M"JHQY]5T&:IIWG*63@]ZPV5E8C:>*Z+_A(-*Z&^C_[Z%)_:6E."1/&
M??-7.$)NZDB(RG%6<6<[AC_":T;. 6*_:)_N'UK174=( _X^(OS%4=>;3]:L
MQ!'?I%[@U'(H)R339?,Y.S32+UCJ=OK*211X*#AA4=OX7TRTN!/% %F!SFL7
MPKI]CX3:5IM327S.F6K6O/$<,:EK1EN1_L\U<)QE!2KI<R^9,HRC)QI-V-=O
MF5@><C%<OH'@\:/JMU=L,>:<BL:\^)VI6LQ1=*D<>NVBW^(6IZM(L3:;)""<
M;L5S3Q6%J35[MK;1F\</B(1=MGYGH&Z->#*J_4U3U+6(-+@,I82CT7FN:OO!
MMYK*"1;YX"1G&:DT?P'/I[ W%XURO]UCFNAU:\G:-.WG<Q5.BE>4_D)'\3+:
M\:2WBMY%DQA6QWK,M_"^N:IJ"W%[<>9:DYV'TKMXM'L(<%;5 _\ >Q4\LRV\
M1.=H'05+P\ZEOK$[V[:%>WC3_@QM?OJ&GZ?;Z>JI;IL7'-+<6T4SG>N:SH=>
MS-MV5%>>(C&LN$R0.*ZO:4U"W0YO9U'(MW&@Z?=*5DC5QW%4;KPG9V]BZ:=$
M(9ST:LOP+KEUJMU>"XB9%5OEW5V%8T_98B'.H[FL_:49<C>QY];:3XDT>Y,]
MU=>9:CG8#6GI_P 2+2YN!:- ZR*=I8BNM=1(N'&Y?0UF:AX=L[R-A%"D,A'W
M@.:R^KU*/\"6GGJ:>VA4_BQ^[0MWT,.I:>T)D1A(/NYKG-!\#Q:)JGVM$Q6=
M-X/O_#ZOJ"WLEQY9R(L]:71OB-J&H70MYM->).F\BL95:;J1^L0Y9=.IK&G-
M0:H2O'KT.\D^<,/6N=O]->%BPY!YK6_M>SBB5Y[A8B>S&F?V[I,G!O(V_P"!
M"N^IR36LD<<.>.R.=Y_NFI(8VDD4;3UK=-_I77SXP/K1<:II4.EWTZ3QEH8F
M<8/H*Y_8Q_G1M[27\K/S[_X*2:*FK^/O!VG,RR"X8*0#[U]8_LQ?#6T\$_"U
M-(>)?L\RABH^E?G_ /%+Q[=?&S]H72+50S06%[L,G4 !J_4+PV=-\+Z#9VIO
MXW;R5_B]J]2M:E"%%_#;4\^DO:3E56YIZ?H=EI/_ !Z1;*9KFDKK%J\3#)(P
M*SM5\6264)DMH#<KV*\US;?%35$8@:1)@?[->34Q.&IKV<MO)'I4Z%>;YX[^
MIT_@WPY_PB]G+"Y WG-;WF1=YD!^M<1IOB+4/%1VRVSVF>,D8I+SX;WUQ=&5
M=3=5_NYI4ZW+32PT.:*^0YT^:;=>=G]YNZOXPMM%!+(9<?W>:RE\92>*+26+
M3$:WGZ*S#%:>B^%(]-4B[(N\C^+FM>'3[2U.8+=8C_LBM.7$5/BE9/IU^\SY
MJ,/A5WWZ?<<UX=\(SV[BZU8B>]_OUUD,2)G:,57O+Y;6/<3EO2J,/B'<?N5M
M35+#^XC.;J5O>9H36<$S'S /QJE<>%]*O.)85<?2N5\9>,KJQ91;6[2Y_NUO
M>!]2N-6T<S7,;129^ZU8QK4:U5T;7?H:.E5ITU5O8K:YX7N%L1%HC"W<=ZR-
M)OM6\'B1M:D:Z4_=V\UWX)'2HYK>"Z_U\8E'^T,TY85<WM*;L_P^X(XA\O)-
M77X_>8>B>-K373A$,/./GXJQXJT*+Q%IXMPRR<YX-5=<\&IJBD6;"S)[IQ6(
M\>H^ [42J9-08=NM8SG4C%PQ$;QZM?Y&D8PE)2HNTNW_  3I_#_A^'0;=4B3
M:V,&M"ZA^T0LH^\:YWP[XSN-;)-S:-;#K\PQ6X^N:;%P]Y&A]V%=5*=%TUR.
MT?N,*D*JG[ZU,"XM'M9"K#)J'YO[IKHO[8TF8_\ 'U&Y^HI!J.DAN;B/\Q6+
MI0Z21I[276+,>SLGNY!Q@5IP:K;V-ZNG])6JRNKZ5&<K<QC\17-W>CV5UXA3
M5QJ2JJ_PYH?[I)TVF[ZZ] 7[QM35E^IT-_X?L-28?:HA(0<BKL,:V\:1H,1I
MP!6?-XBL(TQ%=)*_H#6!J_CR[T_'DV+3CV%:RK4*5Y_D9QI5:EHK\2?Q/X+7
MQ!?K<,N<5NZ/8II.GI;;E4+7#+\4]5?Y?[(D'_ :U;:.]\4VX9B]HS?A7'2K
M4)5'.@KR?R.JI2K*"C5=HHZ]IH4C9O.0[><9KF=0^(UIIDWEM [\]5%9EK\-
M;ZWNFD;4W=2?NYKJ;'P_9V\6V>%)F_O,,UOS8FHM(\GKJ8\N'I[OF_ Y>^NM
M8\50^;I,IMD8]#Z5T6@^'(-*MEDD0&_8?O9/4UJPPPVJXA01+Z+5&]U@6V0!
MN-7&C&F_:5'=_A\B95937)!67];G7^%T"PR8J?Q1_P @B2L[P/?_ -H6\K8V
MX-:/BC_D$25])3:EA+KL?/U4UB+,Y+P!_P A>6O0&^\:\_\  '_(7EKT!OO&
MO-P7\(UK?&0WT,MQ921P-ME*G!K\?O!O@G1?%'_!1;Q#8^,(TDMHW+*9ON[L
M\=:_8F-MF6]C7X3_ +<FI>*;?]J#6KS0-.N[*:*7>MS;(<R<^H[5ZM/J<S/W
M0T>"VT_2;6WL2GV.) D6WIM'2KL<A9L$C%?D1X*_X*F>/?"/A'3-%N/ ]W=S
MV<8C:X9#E\#K6I=_\%9O'5Q:O$G@*[1V'#!#1RS3#0\W_P""FWARVU7X_P!Q
M/IR";56F7<8NI&?:OU6_9=MY;7]G_P '17 *S+9(&#=<U^)$GQO\7ZC\<Y?B
M/JWA6ZU&&0Y^PRH2M?4MA_P5=\8Z/IL=G:_#NXA@A7"(L9P!5N+LDA'ZP'ZY
MI*^2/V._VPM>_:*M[F35?#TND&)]HWJ1FOKEEQCW&:YVK:,LYSQU_P @Y:H_
M#?\ U=Q]:O>.O^0<M4?AO_J[CZUP0_WZ)N_X+.RHHHKZ,X HHHH **** "BB
MB@ HHHH **** ([C_CWD^E>4^(,?;#GD9KU><;H7'M7GNI:29+S<PRN:\7,X
MN458]3 R49.YF:*O[X$1J%_O 5N3,(XWD/W5&33(;=+=<*,5(ZI+$\;NH5A@
M@FO+IQ<(V.^<N:5SG+3Q]I-W>_9%G!FSM"UTFT\?G7*W'A'P]H=P;_8OG*=V
M0:S]8^*EDT1@M8W\_H&Q7$L0Z"?UJ23Z6.MT56:^KIVZW.YF86\9>0X0<FN0
MUKQQI<BO!8&-[SH!CO6#:6GBG7&$OG?Z(_\ #[5U.E_#_2;.2.Y:'_2AR6]Z
MS]M7Q*M2CRKN_P!"U3HT'>I*[\OU.*AT'7/$%QMU&)H(6/5>.*W[?X0:>J@M
M=2;OK7::IJBZ79&XF&8T'0"L30?'EAXDOFM;:-ED7NPJ%A,)3FH57S2??<KZ
MSB:D7*FK178Q]0\&Z+I;10W5XZ,_"\]:L_\ "L=/,8?[3)M//6G^-O"USKE]
M:3QGY8&R:MW%_(L:1(<!1@T_8THSDITU9;>8>UJ.,7&>KW,Z+P'I5O)Q=N3_
M +U%U\+=/OD,@N9-PY'S5(6+-DGFK5MJ$T;JN[C-)4\.])4U8'4KK6,]3EH]
M-UKP[>+#:0>=;9Y9N:ZFU\9Z39J(-0$<=UW4BNECF\R(<<$5@ZIX%TC5)C<2
MQCS_ .\>*V6'J4%?#N_D]C/V].L_WRMYHW;=H;J!9H(T\MN00*=R.*X&;2/$
MFGS8M;A?L,9R%![5=A^(]E:R):W$;M/T)QWK2.+BM*JY?7KZ$/#2>M-\WH=5
M>WT.FVYGN6VQ#J:HZ7XJTO6YFALIA)*.U.NEMO$NFF%BHC;^%CBLWPYX+L_#
MMZUQ;@!CZ&M)2J^TC[-)PZ]S.,:?(^>_-T)=::02 2?*.U9U=7=6L=Y_K!D]
MJRY=%8M\O2LZE*3E=:EPJ*UF8_RY&X!OK72Z8I$2_($&.,"H+;1U7_6#-::J
M$4*.%%:4:;B[LBI-25D5=2U*'2[5YYFVJO)J#1]?M-:@$EO)OJSJ&FVNJ6[P
M7#J4;@C-8+W&C>![;]VN57LO-.I*=.?,VE 4(QG'E2;D=0JEC@=:HZIK5AHF
M/M[JH/K7"ZO\1CK86'1U>.;IDBI-/\'ZMK++)KK^=&>G/:N66,]H^7#+F??H
M="PO(N:N[+MU)->\4'4MPT*-96[;165HW@&\UZX:35VD@+<\&O0-*\+Z=H9#
M6D>TBE\2>*+?PS;+<7:%T;^Z*SEA5+][BY;=.AI'$./[O#+?KU.<B^$^G6>7
M^U2$+[U7?POH%S>K:B^?[0> NZNDT7Q+;>++27[(K)Q_$*Y:3P7>6?B!-3)_
M=H:BI1HJ,94*:E%E0J57*2K3::-*3X8Z?#R]S(/QHB\#:7@QK=.<\?>JU=:E
M+<L?F^6JZL8VW*>:MT\.G[L$0IUFM9E*[^%=K9QM=6UQ(\Z\JN:I:9J&MZ3>
M;;VU460_C85UNG:I(TRHYS6Q>6\>H0^3.N8S5K"TY>_0]VWX^I+Q$U[M;WC*
MTWQ5HVI-Y4/EM,.JXK:\H!0515'M7+W'@>RLO,ETX"&Y8=2>]8UM)XAT.8RZ
ME-YELIS@>E:^WJTK*M'YK8S]C3J:TI?)[GH&:I:IK5GHD:R7LGEHW K'L?B'
MIVI7 @CC96Z9(IWC3PZ/%5C B2+\ISC-:RK<]-RP[4FB(T>6:C65D:\.HP:G
M:L]J^\8R*YZXW+(0_6MCP_HZZ-:+$.>,'%6;K38[@$A?FI2A.I!.6X*482:6
MQS/\526ZJUPF5#<]Q6E_8LF[VJ_;Z7%%@E>16,:,F]3256-BY&,JH QQ61JW
MBK3]';;<R[&SBMA?EQS@>]8^L>%=)U;]Y=[7/7K775]IR?NK7\SGI\G-^\O;
MR-*SNH[ZV2>([HW&0:L+&S=*Y*^\<:3X6MEM@A94&%"\US5QXFUGQ1-G17:)
M?]JN6>-I4[1^*79'1'"U)^]M'NSMM7\7Z-H\Q@O'03^C#-</K%YK>K2EM.M]
MUHYX91VK8TOX>+J&)]>7SKKNU=K9VL6F6XAMUVQ(.!67LZ^*_B/ECTMO\S15
M*6'^#WI>>WR/.M'^%,5_&TE]/+'(W)&:U&^'.EZ+;F66[D$0ZDM6QJ7C:STW
M4(;.6-C+*< @5<\2::^KZ.UO']YQD4HX7"J,O9Q4I1_,<L1B')<\FDSF;7P+
MH^JG?;WCL#_M5+)\-],MF!>ZD'_ J;HVBW?AN(&1OEJU<74ERV7.141IT>7W
MZ=I%2J5>;W9W1$WP^TV_C*"ZDQ_O5DW?@.7PNWGZ6SW$O]UCFMF.YDM_N'%;
M^EZ@9HPK<O5K#X>K]FTNY+K5J?VKKL<KI?B*?2/FUZ!(%;H2*ZO2=7TW78S)
M8K'(HZG I-9T.S\01JE\F]5Z5SMWX3N=)B:/09%A#=LULE7P[M\4?_)C)NE6
M5_AE^!V++M[!?I3<\$]JX2V\2WOA<8UHM*1UVC-='I/BZRUQ3Y(*!O[W%;4\
M53J/EO:79[F<\/."O:Z[DL_BC3+6Y2WEF"S.<!:L:H=UB2I]ZYC7/ ZZAK5M
M>QNN(SD\UU_DJT*QMRN,44Y59N<:BLN@35.*BX._<Y$>_6E^O2MZXT=&_P!6
M,5!%HK!OG&17.Z,T[&JJQ*VDJ?M"E8EV_P![%=&W<]@,FH;>U2V7"C%3_+M(
M+JN>#DUW4X<D;,Y)RYG<YP^/='COC:/< 39V[?>NA7YU5AT89%<S?>"O#UO<
M-?RHK3 [\@]ZH:I\4-/MX#;01N95&U2!7&J\J-_K4DNUCJ]BJMOJZ;[W.VD_
M<Q[W.%'O7+:QXVT9=\$+1M==,8YS7,6\?BGQ"HFAFQ:M_":Z;3/A[ID:QSW4
M6Z\ZLWO6?MZ^(5J,;+N_T+]C2HZU97?9?J<>=/\ $&N7.VX@:.U<\,OI6[:_
M"&Q\L,]U(&ZXS7<W%TMA8F0C]U$.F.U<[I?Q#T_6-2%C%$ZRGC)'%9_5,+3D
ME7?-)[7+^LXBHFZ2LEV,W4/ ^CZ/"GVN\=$8X4YJ>/X9:?-"LJW,AC89!S5W
MQUX=N/$%M#'%UC;<:/MTMM9PVRG!C7::IT:,:DHSI^ZMA*M5E!.,]>IGKX T
MJWDS]K?=_O4LWPQT[4 6^U2#N,-4C2,[;B>:FAOIH2 IP,U*IX?:5-6'[2ON
MIZG-/H>K^&;D)IT37$1."6YXKIK/Q;8Z:JQ:LD<-P>BD5TMK<&2!3WQS63K'
MA#3-<F$]U'F4=&K98>=%7P[^3V,G7C5=JR^:W-2RFMM0MQ/;1H8ST8"I3E>.
ME<#=>'_$-A<%-,N%6R7D*#5F/XA0:-LMK]'>?[I('>M%BXQTK+E\^GR)>&<M
M:3YO+J=C<7"6ENTTQVQ+R369I_B[2=6N/(M9P\OI3Y+JW\1:3)$C!5E7HQKG
M/#?P_CT+51=(5/.>#3J5*W/'V23B]V3"G3Y)>T;4EL;FN-*!AQA:R17774*7
M@(<9':LJ;126^0<4ZM*3E=!3J)*S,5L=QD5T.DC]RN(U5?4"H[?1@I'F#(K3
MCC6) B\+3HTW%\S%4J*2LB*\O(K&!Y96VJHS6=HWBBQUH,(9=S XK2O+&WOX
M6BF=2K#!&:Y[['HG@R)YD4<')VFJJ2J1FI72CU)IQA*+5GS=#J I)JMJ.I6N
MD('O6"I[UP>J?$V+58_)TQ'2?H#BH['PWKVN;7U:3S+9NBY[5S2QJF^7#KF?
M?H="PCBN:L^5?B7O$'BZ'4/DT15ED_V1WK TWP3J/B*\$FK>9 #Z'%>@:7X/
MTO1MKVT6V0<GZU<U[78M!L#=W*[HQV45E+"NI^\Q4M%T6QI'$>S_ '>'6_5[
MG+1?"/3K=MPNI3CGK45SX4T/SDMY+UUE/ &ZM_0?&%GXH5UM49#C^(5@ZIX/
MNY-5CO ?DC;)J9T:'(I8>FI)CC4K<[C6FTT67^&.GQKN:YD Z]:2'P+I<3$+
M=.3T^]5RXU*6;"AN ,55#%6R.M4Z>'3]V")52LU[TRM<_"FRPUS%<R&5>57/
M6LVTFUS2;Q5EM0;%3R["NKL=4D614<Y!Z5O7$:W=OY4HS&PYJEA:4O>H^Z_(
MEXBI'W:OO(Q-/\7:+=.+<>7]H[KBMY45D#HBJIZ8KFKCP+IL+-<6B".Y/\1-
M8,</B72+II+J??9J<@#TK7VU6CI6C?S7ZD>RIU?X4K>IZ)&ID<**^0?V^?BA
M8M\/[GPJ)P+S.=F>:^F=)^)6F27L43(RL.&9AQ7YA?MT:X=0^.5TL,F^W(_A
M.175&M"JOW<KET*$E47.K'AWA&V\R2.-N3G%=QXAL3I=O&P)4%<USV@V1MO+
MF SWXK=\4:H-0LP,\HN*XZCYIGT$=(G'VFES^*M9CM+=?,E9A@"OUC^ .E/H
M_P )=&L9X@)8U (85^=7['VCQ:_\=M/M+E-\+'G(XK]<H?#MKI(%O$FV- ,"
MNB=-RM%;'DXJJH^ZRS;C]P@ QQ69K7BBQT([;F78U:ZX7 !P!63K7A?2]<R]
MYM=OK6M3VG)^ZM?S/*I\G-^\V\BWI>HQ:M9K<P-NC;H:NK&S=*Y.;Q3I'@VT
M^RHN8UZ!>:YF[\8:EXFEVZ*S1'/\0KDEC*=)*,G>79'1'"SJ-R2M'NSO-9\4
M:5H+B/4'42'H&YKAM:UC5-9F+Z/;A[5NC**OZ;X#N-8Q+XB_?R]C7::7I=MH
MMN(+1-D8[5ER5\7\?N1_'YFBE1P_P^]+\#SK1OAB=5=IM2EDBD;DC-;2?##3
M=-B:5KJ3RUY))K:USQG::#)&EPC,9#M&T5>OH_[6T5TBX,RY6B&$PL;QBDY+
M[PEB<0[.3M%G)6_@O1=6?]Q>.Q_WJGD^&VFP'+W4@_X%5?1_#]YX>R[GOFM"
M:\DN#\YR*RC3I<MZE-*1I*I4YK0J71%_P@FF7:>6MT_I]ZLJ\^&PT%OM6G2R
M33KR%)S6O',\/*'!K:TG4FDPDG+5HJ&'JZ.-GW(=:O3U4KHY72_$%]I+"76[
M=8;?^\PKK-'\0:5X@R+$1R%>O%3ZOI-KKUOY%ZF^/TKFKGP8VC*?[ =8';KS
M6JC7P[LO>C^)GS4:RN_=E^!V+1[>BA?I2<UP5OK6I^%\G66:4=?EYKH-'\;6
M.N?ZE2F>/FXK:GBJ<WRO1]GN93P\XJZU7=%J]\3:;ILBQW,P1V. *LW<GF6)
M=.589!KE_%7@H:[<031.GR,&/-=9;PB.SB@;D*N#3IRJRG.,U9=!2C3C&,HO
M7J<F.^3DYJ5_]6*W+C2(V'[M<&JRZ.^?FZ5@Z,UH:^TBREIJ%IE*1*PSR<5T
MLUS!8P&>Z;RX%7)8FH;>VAL(2Y*QJ.I;BOC_ /;4_;#T?P3X:O/"FDR,^ORC
M$;0G/6N_#T9?"CCK55\3/'OV[OVD)O'MZO@;3+AEACG";H3R><=J^AOV%/V?
MH/A'X675YH/-FU*(.7F&3DBO%?V//V47\:-!\1/'R+=6ET/,17/S9ZU]MW7Q
M%T;P_8KI=G$PAMQLA"CH!71BL52PT?9RE9&6'P]2O+G4;L[.3Y%+L<*/>N:U
MKQMHMGN@9T-STP1S7)6]QXE\3L9;*4I:YY!KH=-^'=A,BS:E'YEWU+5XOUBM
MB%:A&R[O;Y'J>PI47>M*_DCEKB#7]>N>("MDY^5E]*V[7X0V,D8>6YE#D9(W
M5W2;-/L2J "&%>!CM7+VOQ.TR\U);%8G$K-MSBLGA<-2:>(E=OO^AI]8KU$_
M8*R78J7G@/2-%L_-NKN1(>F[=3[7X;Z9?6ZW$%U(T+<@YK5\;Z#/XAT?[)$>
M3S5+37GT;1X+#.'C&#52HTHU7&5/W;;^9,:M25-253WK_@5O^%>Z7#(,W<F[
MZUX5^V]I^B:/\"]2$=^XO^BINYKZ A9KBY3>>2:_.O\ X*">.+R3QJ?"\$A=
M)"OR*<UUX.A1G624$K:G-B:U6-)WEOH:W[!/P=\3>%9HO&-O9M+!=K_K&&<U
M]_V?BRUT_P#Y#*1PR/T!%<=^R%;2:;^SSX?MY%VNL8SD<UZ)J_A73==8->1[
MF7H:VQ4:LJTJM.6O9[&>'E3C35.:T[K<OZ?>6>K0^=:)&R>H J<C;QTKA;[P
MWK6GSA-%G5+7NN:EC\=)X=C6#5%:2X'!(%<ZQ2CI67+Y]#=X?FUI/F\NIV<C
MB.-I'.$49)K&MO&^BWEV+6*X#3DXV^]6;35[?7;!Q&=BRK_%Q7)Z9\-8+#6%
MO5*E@V[@TZM6M>+H)-/<5.G3M)5FTUL=9JIE6&7(PFP\U^5W[6?_ "5+3?\
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MA#H?P]C9=+A2(,<G:H%=K245D4<]XZ_Y!RU1^&_^KN/K5[QU_P @Y:H_#?\
MU=Q]:X8?[]$W?\%G94445]&< 4444 %%%% !1110 4444 %%%% $5TQCM97
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M]72H74,MG%@\YP*Q^H8K_G_^!K]:P]OX7XGGMGKUSKT31_9GMR1C<17+:AX
MUK=+,NJOM)R%S7LUU9^3&2D"J<=@*Y*9F\U@3WZ553+X58I5I-O[A4\5*#;I
M*R^\\9CAOM%UI&O8I+^)3R",@UZ!HOB>P:0&/2A:G^]MQ71&.)OO0JQ]2*KW
M>GPW<>P(L?NHKCI97/#MNG4OZK]3KJ8R-:RG'\?T-9-6LVB4O=(O'0D4Y=0L
MY/N74;?0UP]U\/8;IB3>2+GT-6-#^'L-K<*GVN1P3W-;_P"U\UO9JWJ<[CA[
M7YW?T.LN+'3]0'[^-)A[U/!;Q6ZA8$"(.@6LN_T2ZTW(M@TN.E<UJ&O>*--W
M&#3V=%ZG%14JJB[S@[^2N$:+JJT9?>SN+RV:YB*\US<]C+;R%0C-^%<I#\2_
M$5Q)Y4=CN?.,8JZ?%GC#OI&?^ UQU,52J?9E]S.J.%JPTNOO-K[/-D#RF_*M
M?3-+9/G8'-<;_P )7XO_ .@/_P".TY?%GC!C@Z40/I4PQ%*+NXR?_;K'*A5D
MK77WGHRLB_>..*\H\9:A?V^L9AN62+?V/%=1IMQK%]C[;;M #UK4NO!>G:I!
M^^GVN>M=%:G5QM.U)6_ RHRAA9WJ:_B3V=YIFH:5;+=W$4S[1N#$5A^)O[/M
M=/DATZ%%F8</'38?A'IL<A<:E)CTW5O:;X+TZR8'[29<?WC6JP^)JQY:D$O.
M]R.>A3?-";?E8\=T>/Q!>ZIY!N9HXP<Y).*]/DU]] L8ED!G<#!-=>OA^T(W
M(J@_W@*JW'@VVNL[FR#6F'RMX>+M4;;ZBK8V->2O&R1Y[=?&+[/)M%BS'Z5/
M_P +<D^R>9_9[Y],5UJ_#/3_ #Q(2#CVK.U+0'L[WRX;57@_O8JOJ6*3?[[\
M ]OAG_R[_$P++XM27DH0Z<Z_A6MJ$%UXJM\V\S6AQ726>C^'H[4-++&ESC[F
M.]<YJ1U*WO%2QM]\!/W@*U6 J*-J]3F3^1E]9IRE>C#E:.+U;P5K>GQL?[4>
M4=<9K/\ #VJ?V7?,M_IK7F.-S+FO6[72[BYAS.AW>AJPFA)'D_9U)^E<,LFB
MIJ=*=O77\SL68/E<:D;^FAAZ'XFLSQ';"R!_"M\ZI8G&;R//^\*YK6?"=QJ0
M?;&8L=-O%<FWPTU%I"WF3=?4ULZ>*I>["*E^!@EAZFLI<OXGJBW5O(/DF5@?
M0U3_ + TAYO.^R1F;.=V.:X*WT/7-);;%%)(!TS4C:AXIMR=E@S?A2G*<4G6
MI_J$::;_ '<_T/2E4KC:.!P*H:EI[7"E@.?I7"KXJ\8Q<#2R1]*7_A+O&7_0
M*/Y5SRQM)KE<9?<S2.$J)W4E]YMM:S(Q7RV./:GPV$MPP4HRY]JP/^$L\7_]
M C_QVHI_''BFS4M+I>P#OMKE]O2OM+_P%F_L:O=?>>C6-F;*WV'FI)I$%O*-
MX#%3BN TOQ1XMUI0\6F%H.[ 5K0O<7P>*;*7 '*5Z-.NJBM3@_FK'%.BX.\Y
M+Y.YB>'8KRUU:>2YU$B+?D*S=J[:Z;0K[#7,D$S8_B(KB/\ A#=1UJX=)D>&
M/. RULV?P3MO+W/?S!NN-U84</BJ2Y%337FSHJ5*%1\SG9^2.=\:SE8S%I!\
ML#IY=4_A_#K%_-(]U=R*L?.&/6O3=-^&]GIN/WIE_P![FM$>$;9?N'9].*TC
ME,I556G*WDMA/'1C3=**OYG)ZMXY.C@*MNTVT8X%8A^,DB_\PV3\J]&;P=:M
M]_#?6F2>!["1=I1?RKKJ8+$R=X5;+T.>%?#I6E3O\SSH_&<K][3V ^E7])^*
MB:E<(GV;:":ZRY^&^GW,>TA5'L*K6?PKT^Q8E).:B."Q2=Y5KKT*E7PS6E.S
M]3F?$?AR]URY-Y;ZG]EB(^[NQ7$:WH^I:=M)U%KI0>5!SFO:[GP'!<6_D^>R
MK[&N?UOX=C3;8/:LUP_]T\UGB,HIU;M-IOK?]#2ACY4[)VMZ''>'_$VFPJJ3
M:2ID'!<K7H.D^(K*:$!72W3^[G%97A7PK;7C/'K(%HQ.%XQFL37/!D#>,8M*
MMKE_LL@Y=33A@L1AH)P:E^!,Z]&O-Q::_$] _M73V/%Y&3_O"G-+:W"%#(LB
M-U&:YZ/X(VEK-N&H2G_@5:4W@TZ3"/L\K2D#N:J*Q5FZE-)>MS*2H;0G?Y%F
MWT?3;5M]O;(C=<J*O#?SUKB-1O/$&G@_9K-I,=.*QSXX\5P_*VFD'Z5S/%PI
M/E<&O1&WU6I45^9/U9UVH:5)'*T@!;=[50^SS?\ /)ORKG_^$\\4GKIN?PH_
MX3OQ/_T"Q_WS7)+$46[I2_\  6="H54M6OO.IM-,EN& *LOX5T4,?V>%4/&*
M\T_X3SQ0.FF8_"K.G^)O$NJS;)+ H/I6U+%4HZ1C*[\F9SPU26K:MZG5^++K
MR=!NC#)B7:=N.M87PSUI9M!==2NQYFX_ZP\UOZ?X9DU6!A>;H\]152Z^#-E<
M2;ENWB']U3BMI4<5*K&O3C=6M:]B(SH1INC4?7>Q:O%\/QH\N())2.#D9S7E
M?B)M:DO"-/\ -6(GC9G%>DK\&;2, _;I&*\@9J22ZO?#4T4$=BLUJIP\C+G
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ML3&?NTXOYJQR5,/*/O3DODSC]+U>]7QA>+-=,EL&^7<>*]&D?1=0B0W$L,[
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M8ZV['A_F:3R)9,>HS7EWBJ\O7O&737:.//'EUN^'OA/<73*;R>9![FO0M-\
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M4TUWN<W^S-7YVOD;-Q!8WZXF"3#WIUK8VME'LM8A&G]U15+4?#;Z7&#;,T@
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M^E:?4L7>ZK?@1[?"VM[/\3BH?C+YTH0V+#WQ6Q<:P_BJP$<#_9'/\6<5KMX
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M9$E$C#Y:6YU*VLN5M]_NHK)N/B,MJ_EBQD/X4:+<?O2V1V:MMX 7\J:UPL;
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M:-_:(@TC5MUQI<=Z87VCC;NQ7Z\?"?X6Z'\&/!]OH?AZ$163('92.^*^'/\
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M+D?OU'R8K@M*A>T\711W7^OSQ]*]/C^^*\QU>0K\5+9<X&*RGT-J>MT>FO\
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MWRO]H;>,GUJ"LG)FJBBY_;%S_>I\>L7 ;YFXJA12NRK(Z2SUB.3 .-U:(DR
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M\-_]7<?6N&'^_1-W_!9V5%%%?1G %%%% !1110 4444 %%%% !1110!7U/\
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M#I7_ &$%_P#0A7ZSP\+(/]@U^2_[:7_)8=*_[""_^A"MZ:LSFK.Z/U.\"_\
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M&I5)IMENMS))(_9+[#+_ +/YT?89?]G\Z_(6U^,'[1UYC9J]P,^N:U[;QO\
MM+72Y76YA]<T^3S)]H?J_+;M"I+E0/\ >K.GUBU@SND4?\"%?EW'JW[2^IC:
M==DP?<U8B\'_ +2.I?\ ,=;G_:-3R^9:GY'Z7'Q98QL=\R@?[PH_X3;1AP;E
M<_[U?FJWPG_:.N/O:Z?^^J;_ ,*0_:)9L_VX<_[U+E\Q\S_E/TJD\>:'%]ZZ
M4?\  A5:3XH>&X?O7B#_ ($*_..']GG]HK4'V#7.?]ZI6_9-_:(F/S:UG_@1
MJN5=R>:78_0V3XR>$H?O7R#_ ($*KM\=?!41.[44'_ A7Y[-^QC^T#<<MK _
M[ZJ/_AA?X]W'WM77_OL_XT^5=R>>78^J_B-\<O!MSJ">7J*X$F3AJ]$TS]IC
MX=6NCVB2:L@94 /(K\VM2_8\^+4.JM9W.H!IPV"=U=7;_P#!/+XQW5O'(=27
M8PR!OK.,(7;3-9U*G*DXGWW)^U9\,HOO:R@_'_Z]59/VP/A3#]_7$'XC_&OA
M#_AW!\6)/]9?J?\ @=,;_@F?\2I?]9=J?^!UKRQ[F/-/L?=$G[:?PAA^]KR?
MG_\ 7J _MP?!L?\ ,P)^8_QKX6NO^"9?CN!<SW"MG_;JH/\ @FAXN)Y=?^^C
M2M#N%ZG8^\_^&XO@U_T,"?G_ /7I/^&X_@T/^9@3\_\ Z]?"2_\ !-'Q2/O.
M/^^JT[/_ ()LZW'CSL'_ (%1[G<?[SL?;)_;F^#(_P"9@7_/XTG_  W1\&/^
MA@7_ #^-?)VD_P#!.)F95FA4G_>KK['_ ()LZ?'CS[56_&CW.X?O.Q] ?\-U
M_!?_ *&!?\_C2?\ #=WP77G_ (2!3_GZUY#9?\$Y_"\>/.T\-Z\UT6G?\$\_
MA_&R^?I0([\TO='[YB>-OVV/AO<^+HKRPU820+U:M;_AX-X MK0*FJ@N/:N9
M\<?L5_#SP_JR)%I.V#N*]/\ !O[#_P &]1\.P7$^@J\K#EJSCR<S2-Y^TY$W
M8\[O?^"C'A://DZ@#^%<_??\%)=-C)\B[5OPKWW_ (85^"__ $+R_P"?PIP_
M87^#'_0O+_G\*U]PY_?/EZ__ ."F4T>?L\JM_P !KG=0_P""GVOQY\@*W_ :
M^N-4_8@^#5O;930%5OI6,O[%_P (?^@&O_?-2YP70I0J2UN?(DG_  5'\9Y.
M(EQ_NU"?^"I/C?\ AA4_\!K[#_X8Q^$/_0#3_OFC_AC+X1?] -/^^:/:0[![
M*IW/CY?^"H7C^3[ENA_X#4G_  \Q^)DA^2T4_P# *^PX_P!CWX3Q?=T51_P&
MN@T+]DCX5R*W_$E0D>U-3@]+"=.HM;GP_P#\/(OBS)_J[!3_ , IZ_\ !1#X
MS2_ZO35/_ *^]X_V4?AC']W1D'X?_6JU'^S+\.8?N:0@_ 57-'L3RR[GYS^)
MOVV/C+XJ$9N=,"B/IA#5WP[^VI\<;&U,-EI8D3W4U^A>I_L[^ H=*N632T#*
MA(^6O// 7P]\'PZHUA-8+O9\#*UDYPC+8VC3J2CI+8^3E_;,_:"N/NZ,/^^3
M4B_M9?M$7'W=%S_P _X5^AR_!SPE#C;8(/\ @(JQ'\+_  U%]VS0?\!%:<R[
M&?)+N?G//^T=^T7>(2VB?+_NG_"J2_'#]H>?[NB_^.FOTM7P#H2KM%JN/]T5
MFWG@+3X9"\,"A/\ =J7)=BXP?\Q^="_%7]HV?[NAG_ODTV3QE^TA?C']AMS_
M +)K]#UT:VMS@0K_ -\U/'"L?W8Q_P!\UG[1=B_9/^8_-N:+]I"]R3HDG/L:
MI_\ "&_M'WS'9HTV?8&OU!M$N9L! H'^Z*Z*S=[:,9"[^_RU<9OL1*FNY^1]
MU\(_VCKS._2;@9^M9%U^SQ^T->9W:9=#/N:_8_[=+_L_E4UI>223 ';C![5?
M.9.GH?A+\2O@U\4?!.F&[\5P7$%IG^-C7F=KI%Y?+F%6:OK_ /;T^+6O:K\6
M-2\+3W&[2XS\L6*^>O#D)MU.!@8KSJV.E3ORH]RCE5.I%.<GJ<C'X.UF6,R(
MC[%ZFH)/#^H01[Y0V/<U[7I4X72)U.,FN.URZ'V5H^^:YHYE5D[<J.EY-02O
MS,H_"WX0ZW\5=5:RTB!KB1#\VWJ*^FO#?_!/;Q'=I&=0DO8P>HWGBN@_X):V
M*S?$#6&F4, A(R*_326X8.RC& ?2O5IUI3C=GBXC#0HU.2)^?6@_\$U=(N(U
M-_?WJMW_ 'AKI(?^"8O@QC^\U&[_ .^S7VX9&:DW&KYI=S#V<>Q\:V__  2]
M^'K$>;J%T1_OFMJS_P""9OPSL\8N9G_WJ^K\T<=SBCF?</9Q['BO@G]D'P3X
M#E22RC64ITWJ#7LMKI^GV=M' FG6NQ!@?NQ_A4NY.\BC\:0R1C_EJGYU-RN5
M"B&S7E;"W4^T8_PKA/BM8QQZ+]H2)8SN'W1BNRN=1AM8R[,"!Z&N.\1:]:^+
M(&TJ%#YOJ16<K-6-J?NOF.A\&7(F\-V:ALD+SS6S7F&@WM[X)D87^Z2W'"JM
M;(^*VGL<""3/TH4K*S&X.3O'4[:EVFN-3X@07'W8W'X5!<:U?WV?LK,GIFGS
M(7LWU.Z\LTFPUYC>6_BN=AY%R5%,@T7QG(XW7?'UJ>?R*]GYGITDBQC+'BJL
MFK6L7WGQ7,6-GK%C\U_+YBCDUT&@:AHWB-W@$6R6/ABW&:UBN;J82:AK:Z%;
MQ%8*<&2G+X@L6Z2UG^*FT6PG738X=UY,/E9>@KEX/ ^KK>&0R?N3VS4RO%VW
M-(<LU?8[5O$VG1YW2]*P=>URS\01-96[[UD&#3%\%R-]_GUK2T_PC;:?,LB)
MAA4^\]RO=CJC"T#4X_!A%A.=EKG)-=)_PFVCL,K/D59O_#>GZH<W$6\U67P3
MHZK@0<4]5ML*\7K+<C;QYHJYS<=*C'Q&T#_GYJ5O .BMG-OP:8GPZ\-*?WJQ
MQ?[[ 4O?#]WUN<ZOQ/MO[6=?,_T7LU=!#X^TB:W:83KM09;)Q7A?Q2^)G@CX
M$:I/?Z^T=WIIX2.)@3FOCG]HC]L:#QU<6EE\,K>ZM%F.V0JIQS1"-205)THG
MVW\9_P!L[P-\.?#%Z;35$;7D4^5#G.37YX^//C%\5?VP;T:#I5M(\3R<^5D?
M+FNI^#O[#_CCXS:]:>)O$<AFTU2&DCD)R:^\O _[.&D_".**[\.VB6M\H +@
M?G71=4UW9RJ,JK[(X#]EG]D#PU\'-#L]2O1YFORH#<),,X:OINZ\5:?I<:)*
MRQ*HP M4+KQ9H]O8B"Z3=J4@VEA_>K*T;P5/?,\NJ_O8G.4'M6<WKH[FU..F
MJLC77XC:%WN*CG\?:9=Q-%:S;RXP:G_X5UH'_/M4MOX%T6T;=%;[36?O=37W
M.AQ5K-/X<O\ S[89MI&W2MZ5UR?$C064 W/S8YK7DT.RDA,+1YC(P163_P *
MYT#)/V;FBS7P@I1E\1*/'NB,,BXXIEUX[TE;.9X9\R*,J*>O@+1%&!;\4RZ\
M":2UC,D,&)6&%-'OA[A3\+>/+;4[61[R3:X; K=7Q%8.,B7BL#PGX"M]+M)$
MO4W.S9%:4GA>$2'REPO:DN:VH2Y+Z&DNL6C<AZ>NI6[+D-Q7-R>&;OYMAP.U
M98\*Z['>*XF_T?/*YI\S[!RQ[G?V]Y%*) IR=AK\G/VTO^2P:5_V$%_]"%?J
M)I6K07%Y)I$2E;WRS\YZ5^6'[:%O/;_%RQCD<-(+]<8]=PKHIKJ<=5K8_5OP
M*A_X5[X;_P"O./\ ]!%6]4U"/2[5II6VBO)?!6D^,;GP/H!BN\1_94VC/;:*
MZW3]#U611'K$GG1=Q6'-=['7R**O>Y2TNW%CK3ZM.-MM.?D?UKT.,B2%)%Y5
MAD5B:I;VMQI:V:Q_)&/D&.AKFM'OM5TF:1;UV>W!_=KZ"AVB]!*]17>AZ#17
M)R_$2SM>)(G)^E)'\3-/DZ02?E1S1[AR2['6A<T8]0*\\\2>/_.:$6.Z+GYL
M]ZZ?PSK']H6>^5OF]Z.9-V&X-*YN# ["O&OVCOV8?#7[0GAN2#4HQ!=VZ%H6
MB&&+8XKV-9(V_P"6BC\:<KJK B12?K5WL9-75F?D7I5O\5_V,M>N4AM9GT42
M$K)+D_(#_A7W9^S3^V-X4^,^EP:=>:@B^)V^7[/G%>R^.OAWX?\ B78M;:];
M)<QD;<8'2OSN^.7[#?C#X5>/I/'?PSD&GV$/S!$;G\JTNI;F'+*&VQ^G$EN\
M:Y.,>QJ/=MYK\QO@;^WIXB^&_BR:P^)INKN%?D#%3C-?=WP]^/WAGXO>';N^
MT>XCM_+7=MD8 U,HN)K&2EH5_%4,6J>.H(B<N>U>E:=:_8;-(<8VUXYX7O&U
MCQM#<EQ+M; (YKVZ3[U<]/6[.JK[MHC:***V,"IJ5N;FW*@9-<U-"T+%6&*[
M"J\MC#-DLN34.-RHRL<I16S<:(S-^[&!3K?1=K R#(J.5FG,C'AA:9@$&:Z3
M3;,6<?'4]:DBL88>47!JQ5QC8SE*X44459)B>+-433]+FC<X$BD5RWPOTJ"6
MWFN8_F.\G-,^,#R/)9V\+?ZS@XKH/A[HDF@Z.8Y.K\UCO,Z/AI^IT]%%%;'.
M17$WDPL_<5S=Y?/=,<GBMC5V;RR!TKG:RDS2(<^M'/K114&A)#</;R!U))KH
M]/OUNT )^?N*YBM/P_\ \?3547J1):'04445L9!_"Q]!7C?BW6&U#Q%;P]1'
M*/YU[(?]7)_NFO$;6P>^\7SL>0LF?UK&I?0WI6U;/:[?_CSM_P#<'\J?38?E
MMXAZ*!3JU, HI.@)K*U#51'\L9P:+V&E<TI)DB^\<5'_ &A!_>KFI+R:7[S9
MJ/S&]:CF+Y3KHY5D^Z<T^N3COIHC\K<5MZ=J2S*%8Y>FI7)<;&C1115DBI]X
M5XE\4)O^)\R?[5>W1_>%>%_$_P#Y&1O]ZL:OPG10^(]>\*_\BW9?[@K4K,\*
M_P#(MV?^X*TZTCLC"6["C-%07=TMI'N;OTIB)V;:.3437D:\%JYV;5)G8[6^
M6JYN)&Y+5',:<IUBSP2?\LT?ZBG^3:G[UE WU05R2WDT?W6K0T_6&5]LQSGI
M0I$N)MR6EA-&4;3K7!_Z9C_"O(?B-^RGX-^)TCOJ,20%^OEJ!7KZL&4$4M:$
M66Q\EWW_  3)^&UYR+RXC/;:<?UKQCXN?\$_O#WA&X6'1]0NV=A\OSFOT;7J
M*\V^+&CS7<B7D72(>E*<Y):#ITX2E:1^8%K^RG\8_!_B(:CX6MKN\MD.5+,2
M*]7C^+7[3?PZT^-+C0"(8QPS*:_0_P"&&I3R>%TW%20<=*V-9TFT\10^3?Q+
M)'Z;:M5.9)M&<J7+)I,_,&Z_X*)?%SPZVS6-/6';U^2O6/@__P %)-+UHH/%
MMVMKS\W&*^H=<_9?^&WB5F.H:.DI;KQ7%^(/V%_@\VGR-#H*I+C@BJYHVV(4
M9WT93D_;:^$FI2877%^;IS73:+\<O!?B0+_9^HK+NZ?-7Q]\2_\ @G9-J5])
M)X6B%M'G*<]*Y*S_ &)?C3X7P=-U,1*O3YC6?+!]37GJ+1H_273V758?-M75
MD]=PJW';3VK;P5_[ZK\T==T7]HWX;Z>[G6W:&,<JI)KSSPW^V)\5?#'B;R?$
M,]Y<6R'D!2:7LF]F/VR6C1^QFG71N5VGJ.M7*^#? _\ P4F\*Z/:1KJNFWC3
M8^=C&:]"T_\ X*8?#6^P/LL\9_VABJ49=B74C?0^L*S?$&DQ:MI\HE_@4D5Q
M'PS_ &A/"OQ65#IEQ%!OZ>8X%>CS26302I_:-K\RX_U@_P :370I2UN>)^$_
M#^EZIJ%U!>SM$X?:@!Q7K&B>&K?P_"(H'9UZ_-7EEYHHTOQ=;R1W<+(TF3M8
M>M>THPDC0H=PVCD5A37D=563TLPIDR^9$R^HI^#Z45N<QRMW9O;N<CBJV:Z^
M6WCG^^,U1N-'C8?NUP:R<312.>H52[87DULQ:(RME^E:$>FP1X(7YA1RL?,B
MII.F^2!*W#UJT@&.!2UHM#-NX4JG%)13$>4?$GP^MG>0WP&"\@KTS1V#:/:8
M_N#^5<G\6I%CTFW9N@;-7/A[K7]K:>$S_JUQ6*M&31O*\H)G5T445L8!36C5
MQ@@4ZB@"J=/B+9J>.-8Q@ 4^BD%PHHX]:,C^\/SI@%%&Y?[Z_G2-)'&I9I%P
M/>D!R/Q&A":++<$=*O\ @*3SO#%NXZ5FZQ=+XDU,:2K#RY.N>E1>'K[^P];?
M1V<>5%T]*CKS=#7IR]3MZ*3S(VY$BX^M&Y/^>B_G6AD+14;7$2_\M%/XU!/J
M4-NN20?H:0[,MT5BMXKMES^[;CVJJ_CRRC;:8GS]*7,A\LNQTE*5Q7)W'Q&L
M4@E A??M...]<MX1^(4[7=S]M+2)N^0>@J7-7L4J<FKGJE%8,?C"VG VQL/P
MJ?\ M0W,;>7D$CBJYD3RLE\0R(NGRV['YY5PHKB/"]IJOA61VGBV:>S;F:I-
M0\,^)=0NC*;C* Y3GI2W7AWQ3?6IMIKD-">"*B]]6C6UE9-'<66L6FIJ&MI-
MXJ[L->86/@GQ#IJ[;>?:/K5EM"\8;AMN^._-',^J%R+HST;::3::X2XDUO0[
M<S7<I=5&3BKEGKT[:2-6D?%MTVGK5*5R'&W4Z_::78:Y:VU.ZUB/?;,5##BJ
M5YI/B63/E7&/3FCF'R=V=KMQ4<EQ'%]YJX*/0_%FW#763]:BD\,^*)?O7.?Q
MI<S[#Y%W._\ MT']ZHYM6M;=2TCX%<#_ ,(GXE_Y^!^=0W'@OQ'<*5:<%3[T
MN9]A\D>YT?B"ZE\16XM],_>./0U6\/V9TF0)J@$;GA?K6-IW@_Q-I$GF6MP$
M?ZT:AX1\4ZI(LD]P&=3D<T7TO;4?+K:ZL>GJNY01]W'%)7 6&B^*[>1/.N<Q
M+VS731W<]M&!,26JE+R,W'LS9HK"F\506:EI$9L>U4(?B9ILVX")@5[&GS(7
M)+L=917+?\+&T_IY3!O3'-2Q>/+*;I$_Y4N9=Q\DNQTE%8<?C"UDZ1M5B+Q%
M!-R$84^9"Y6:E%9_]MP_W34-SXDM[5=S(Q'M3NA<K-B/[XKR:>S34/BA+%(,
MKUKJ[CQ_;73&TMXW2X;A6Q7-VNEW7AWQ$==U%Q)$W''6LY>]:QM#W;WW9Z=%
M"+>-8E^ZO2G56L]4M]3A6>-U56Y )JSN7LZG\:T,-0HH_6BF!4NM-BNN6X-4
MGT-!TK8HJ;(=V8\>AHWWJOVEA'9YV<YJS119!=L****H05QWQ$UP6EC)I^?F
MF7 %=CG;R>@KRKQS/'J7C*PB4Y&0*SF]#6FKR.M^&MFUCX:6-A@YS7457L;,
M6-LL0XXJQ515E8B3NVPJGJW_ !XM5RFR1K*NUN13)1QHI:TK[27CD+K]SM6<
MRLIP0:QM8WN)11SZ'\JLV^GRW.-O%("YX?&9&K>JO9VB6L8 'S]ZL5LM$8MW
M84RX;99SN.JJ33ZS/$.HKINGRES@,I%-@M6>/V]Y>>(/&$3E<QPRX_6O=/X4
M_P!T5YK\,;2"^N+R=5Y#DYKTFLJ:TN:U7=V[!114=PVVW<CKBMC$IW^IBVX0
M_-61-JTTW!JK)(TLA+')S3:Q<F;**)!<.&SFKD.LS1D ]*SZ*5V.QU5G>)<(
M.?FJS7,Z3,8[D>E=*K;AFM8NYE)6%HHI5ZGZ51)YO\4+H7@M8"?NR#^==[I(
MVZ/9CT0?RKQ_QQJ!D\0"'.=LG]:]ATK_ )!-I_N"L8N\F;S5HHLT445L8!44
MUU'!]\XJKJ5\+5, \FL":ZDN"=YS4.5BE&YT7]JVW]^G)J5O(<!N:Y7:*<K%
M3D<&IYB^5'8JP89'2EKGM/U.19%5VXK?5PZY%6G<S:L.H7K115"//?BE;^=9
M28^]71?#]=GA2U4]0*SOB%#NL)#CFM'P.W_$A@7OBLE\9LW[B1T%%+\B\O(L
M8]6.*\A^+G[57@WX)S&+6)%NF SB%@:UW,&[:GL2V[LA?C:!GDUY=X[_ &EO
MA[\-7>+7=52VF4XVY'6OSV^*7[;WCKXH^-)[?X>2W=EITIVI\I JHO[%'Q9^
M+DECK/B>^^U6\K"1E9CG'6KY4OB9ESN7PJY[=\:/^"D&GZ&LG_"&W2WC ?+Q
MFO*O"_[=?QY^)(,&B:0LY?(&$_\ K5]$> _V&_AWI.FQ)K&DK+<JH#,>>:]=
M\(_!OPA\/W5]"L$MV7I\M3[2"V1?LYR=VS\]/%_P_P#VA?B5?-/J&E3P^8V3
MLR*CL_V.?BS?*IN[>\3/7YC7ZDIJ<\?W2O\ WR*W-&UB>X0^85..G%$:KVL$
MJ*WN?EC;_L%^-KS'VDWR^OSFI+K_ ()\^*TC_=27Q;_?-?JW]J?V_*C[2_M^
M55SLCV<3\EV_8#\7PV\LLWVPA1GYF-1Z#^PKXBU:)B)KP,#C <U^L.MW$C:+
M=XQNV''%>2^ =?N;?7/LLC?>?TK.55Q:1M&A&46SX/\ ^'?'B?\ YZWW_?9H
M_P"'?/B?_GK??]]FOU6:X<-V_*D^TO[?E6OM&8^SB?E/-_P3[\3QQ%_-ON/]
MLUG?\,'^)/\ GK>_]]FOUEN)9)H608R?:N7NVEMIBA _*HE4DBXT8L_-C2_V
M!=4E8?:;B\4?[YKL-+_X)YV$V/M5_>+_ -M#7W@;ESZ?E33*Q]/RJ/:R-/8P
M/DC2_P#@FQX"N+4->ZE=/)Z,Y->G?#G]CKP1\.[E'L@LY7^^,U[,36GH]GYD
MNYQ\M3SREU*]G"/0TM'T/3='M$CAL+; '7RQFK_RKPB+&/11@4T#:,#I2UH9
M@>58>HKR?QQHL6GZU:7#_+NDS^M>L5Y]\7=-GOH+>6#_ )9<FLZBT-J3]ZQW
M&G7*W5E"5.0% JS7&?"R^EOM(D\YMS(<5V=5%W5R)+E;056O+".\Y;J*LT4R
M3GKC1W5L1KD5#_95Q_<KIZ,FIY47S,YVWT>1VQ(N!6W:V:6D>U>:GS132L2Y
M-A1115""N2^*"LWAOY>N:ZVN7^)$R0^'^?F).-HZU$MF7#XD87PHOC<;XB<E
M!7HIKS/PC"?!"QWUXK&*\^YQTS7I,4T<\:R+(N&&>M*&BLQU+-W6P^BDW+_?
M7\Z7<G_/1?SK0S"BD+H/^6B_G3&FC7^,?G2 DHJ W4?/-5GUN&/.5/%%QV9H
M45BMXKME4GRVXJM)XZLX^L3_ )4N9#Y9=CHZRO%@W>';M>Y6LU?B%8LP7R7R
M3CI6+JFN3ZAXGLK9=PLI3\X/2ES)Z(I1:U9R?PSF>'Q,(7R%S7M\GWB:YCQU
MH>FZ#H[7FF1JEZ",%3S5?P[JUU%ID5Q>EGW"CE]F^5AS>V7.CK:*Y_\ X32T
M+;1&V?I3_P#A*H/[C?E3YD3RLW:*QEUQ9%W $"E_M@'C!HN'*S8HK(_M)O0T
M?VD_O1<.4UZ*R/[2?WH&HN?6G<.4UZIZQ>PV.GS+,VUI$*I]<54FFN9XR(CA
MJY+4/"_B'4+HR3S[H$.5&:AR[(J,5?5F[\'='N]*CU![I-BRN63W&:Z_Q1_R
M")*QO!NL&.(VUR?WB_*,UL^*/^00]=+LL.TNQY]1MUKR.2\ ?\A>6O0&^\:\
M_P# '_(7EKT!OO&O(P7\(UK?&&>"/;%?(OQ7_P""8_PT^+_CJ]\5:M>7L=_=
MG,BQ-A3^M?7-<EJWQ7\/Z)?/9W5Y!'.O56< UZ,6T<[/D?\ X<__  B_Y_;_
M /[Z_P#KTV;_ ((^_"5H6$5[?>9VW-Q_.OK#_A=7AC_G_M_^_@JOJ/Q\\)Z/
M9R7<]_!Y:#)VR#-7SL5C\E= TD_L+?M>2B&%7\/QG8LMP,]Z_8_P-XIB\<>#
M].UZ' CO8Q*NWI@U^)7[?'QFTSXR?&-[?P]&\S&=?]6,]Z_8']EVVEL_V??!
MT,RLLJ62!E;K525TFP/3J***P*.>\=?\@Y:H_#?_ %=Q]:O>.O\ D'+5'X;_
M .KN/K7##_?HF[_@L[*BBBOHS@"BBB@ HHHH **** "BBB@ HHHH @U!BFGW
M##@A2:X?PQ''J'FW$R!YD;ACU%=OJ?\ R"[G_</\JXGP7_Q[W'^^:Y:VZ.W#
M[,Z$DGK1117.=(444>] !14#7T$9PSX-)_:-L> ]*X698I=Q]:8C"097D4ZF
M NX^M&X^M)10 DL:7$3K*N]<=#7DZR7NEZ]<1VTK-'*V-JGH*]9_Y9O_ +IK
MS/P/*;_Q9J2.NX(YQFLI;JQM#9W.RT?PW;6D(>>)9I'^;)'2M+^S[91\L*K^
M%6.G%%:6,N9LS+G1_.SY;>7]*S9O"MU(<K=%?QKI:*7*AJ31Q=UX%U";[FH,
MGXUS'B[PKK7A^UAFBO9+DNV"JD\5ZWFD95?AU#CT;FH=-,N-1IG#Z'X-U!;.
M&=[U@T@R5)Z5?NK"\T]<B5I<5U73@<"DV@]0#5<J0N=MG S>+K[3?^7227\*
MC_X6)?7*F,:=(A/&<5Z#Y41ZQ(?PH\F#_GA'_P!\BERON/FCV.,\.VL]QJ,=
MY=;L*<[6K7U[0K5K\ZM!*HFQ]Q>M:FJ26FFZ?+?7C+;V<0R[],"OCG]I;]L3
MPS\.]+GF\+ZLE_J>=H@W9K5;<J1A)^]SN5CZ:7XL:#IJ31ZIJ,-D\(S^]8#-
M?,/QM_X*4:/\.[\Z/I=BFJS2DJLD+9KXUU%_BC^TI?6]Q]CN;:TN'!+0Y'!-
M?5GP>_X)IZ!=)9ZSXBO9S?1 .(Y><G\:KEC'=W,W*4]E8^:_B3^TY\3/B9(Y
MT>RU"P23H8PPJ[\'O@K\6_C5>?9-3\3ZAIT6,YF9@*_370?@+X9\.VJ016<$
M@48R4%=);^"]/TM=UG;QPL/^>:XI>T>R1?LD]7(^#;C_ ()7^(]40-=^-7G+
M==S$TVQ_X)*75O('E\1+*/>ONRZU#5[7*PQ,P'2LH^*?%"S!19L4]:GVS0_J
MZ>Q\CV__  2SBA^_JL;?A6A!_P $Q;&+&Z]A;\*^OK37=9909X"@[U8'C2SM
MVVW4_EM]:?M'W#V/D?)=O_P37TF'[TT#?\!K3M_^"=>A0XW"W;_@(KZC'C[1
M=P!O #]:T+/7K+4/^/>??^-'M/,/96Z'RX/V _#=K:RR-;VS;%S]P5@>%_V.
M/#>L7S@65OLC?!&P5]:>(M>2RC6W5^9OD//K7.V=O'X,U2&'=\UX=W/O42E)
MZWT+C".S6K/-;?\ 8J\(0XW:9:M_P 5I6_['_@J'&[1K1O\ MF*]W*M@'MBF
M\U=V1RKL>.6_[*G@2'&[0+-O^V8K4MOV:?A];XW>&K-O^V8KT_-%*["R/,I/
MV<?A\K%QX9L\>GEBJK? WP!&VT>$[0X_Z9"O5Z3:O]T5+1:LNAY3'\#_  "S
M ?\ ")VH_P"V0K4M?@#\/EPY\,6?T\L5Z%M7^Z*6A+S"Z[''+\$?ATJ@?\(I
M8_\ ?H4[_A2GP[_Z%2Q_[]"NOHJKLCE1R'_"E?AY_P!"I8_]^A4=U\'?AQ;V
MLN_PQ8QEE(!\L5V=<'\5M3-K;V2POAFD .*F4N57+C!2=C%^'OP9\'6,U\TO
MA^V=68E-R#@5VJ?#/P=']W0+5?H@K4T6%8M+MG'5T!/Y5=HCH@E9NYBIX"\,
M1_<T>W7Z(*+CPCH4<#[--B7CLHK:ILB^9&R^M4(X1=%TR-CLM%'/I4RV=K']
MR$+]*T+[3GMY"5&4]:I9%8:FX>7&.BTNU?2DR*<B-(<*,FD,O:*V+X8)KIS(
M<]36/I6F^3B5QA_2M6M8[&,MQ_G/_>-/CN) 3\YZ5#3DZGZ59!X?X@DED\;2
MX9B=]>UZ;=3#3;8;V^Z*\F^SK<>.KD'D[J]8MEVVL:^@K&GNSIJNZ2+/VJ7^
M^:/M4N#\YZ5%1ZUL<QSNHZI/-,R>8V%/K5/[5-_ST;\ZM:M9_9Y"X_B-4*P>
MYT+8E^U3?\]&_.C[5+_ST;\ZBHI#)X;J6.56WMQ73V-Y)<0!BQKEK6$S3* ,
MC-=1:P^1$%%7$SD6/,;^\:!(V>M-HK4S.#^)NF^=8R71&=O>MOX?MN\*VU.\
M>()/"]P"*S/ASJ ;2XK8'.*RVF;;TSLJ***U,3.UJ,_9<CFN<%=C+&)EVMTK
M$OM(9&W1#.:SDC2+Z&514[6,Z]4H%C.W1*S+(*W/#Z,J/D8JK9:0TC_O1M K
M>CC$2A5%7%=2)/H/HHI1&3VK4S(YHQ-"\9Z,,5Y1J6CPZ+XVMILJ@SG%>O+"
M^X<5Y5\6-%O_ .U(]0@C)BC')!K*IM<VI?%8].AN5NXED7IBGUB^ %GOO#,,
MK#D^]=#]AE_N_K6BU5S&5HMH@I"-W!Y%6/L,O]W]:/L,O]W]:8KHJ?9XCU04
M?98?^>8_*K?V&;^[^M(UI(O4?K2#F\RNL:1_=7%.IS+MZ_SJ"2\@A^^X'XT#
M):IZWKT?A72I=4F&8X@2<USWBGX@6?A^ZMHQ*NR0X8Y%>??M-_%#1;/X(:Q)
M97JM>>6=JAN<XJ7+1V-(PNTGU/S&_:P\21>,OCEJ.JP@".1CT^M<SIL \F(#
MJU<T=4;Q%J3W=T?WC,>OUKI;/4+6W>#+\*:^?K\TGHCZ^DX0BDWL:UU;R::%
M0DX<9KB=?FVW6W/4XKM?$OB:PO)(2LJ_*O.*\[\07\$]]&T;Y42 GZ5%&G/F
M^$JI6IK[2/T-_P""<O@V3PS?7.JW2&"&XC^5VX!K[IDU2R\QO]*CZ^M?*'P)
M^.OPDTOX2Z'8ZEX@ALM0BB E4, V:["3X\?!5LY\8)_W\KZ"G&48I6/DZ]2%
M2HY-GOO]I6;?=N4;\:CDU*-%+*0V*\(M_P!H+X*6K;AXP0_]M*U(_P!JKX,0
M+C_A*X2/]ZM+2['.Y074[B_^)1L;Q;?[*26.!700Q3:M8FZD9K5,9RW%>"^)
M_P!J#X,R+]K@\2PO<0_,J@]37.WW[>'@C6/#-Q9/J\4)^ZI4X.*J$7KS"G):
M<C/9O[/U/7-<DL[>XD6 =)AG!JZOPQUA)"3JDA'UKYYTG]N[P7H.D);0ZI"[
MK_&>IK.O_P#@HUH<.?)OHFJ52OJT4Z]M$SZHA\ WZ8$EVT@[@UJ6'@]+&02A
M/WG]['-?$=Y_P4MMXB?*FB;\*QKG_@IY<+D1"%OPJE29FZ]^I^A<FD0W"!9[
M;S?J*A_X1G3^VGK_ -\U^<]Q_P %0M<&?)MXF_X#69<?\%1/&7/DZ=$W_ :O
MV;(]JEU/TN7P_:+]VR _X#4R:7'']VWV_A7Y<S?\%1_B/N_=:-&P_P!RD3_@
MJ!\49/NZ%&?^ ?\ UJ/9L7MD?J6+-EZ1-^5.$,HZ(WY5^7\'_!23XOW7^J\.
MHV?]C_ZU:,'_  4!^.-U_JO"RM_VS_\ K4<C#VJ/TN:U>3AXV8?2N#^(VE26
M<"W&GDV3*,N5&,U\/0?MN_M!W7^J\'!L_P#3/_ZU4M<_:0_:,\3VDB2>#F6-
MA@D(:F5-M%QJI,^Y_AOJ5CJUC)<ZA<(]Q$<!Y#R*[.3Q-HT/^LU2%/JPK\M-
M)\:?M"-#+'9^&)BKG)VJ:H:I:_M&:IG?X=NTSZ TXPTU83J7>B/U1D\<>&8_
M]9KEJGUD%0-\1O!R_>\260_[:BOR)U+X7?M":IG?H]\F?3-<\_[.7Q[NYOWE
MAJ2J3SRU7R+N9>T?8_9&3XH>"(ER?$]B/^VRUROBK]HOP7X:LY9X]=L[AD4G
M:LJ\U^8GA[]C7XIZKM_M$ZE#GK\[?XU[9X+_ ."=4>K1I_;VMW\!/WE:0_XT
MG&*W8U*;V1U?BS_@JUI6@ZI)I]IHJWK[BJE#G->)?%[]KCXE?&.WD3P[X?U+
M35DX62%6XKZ-T7_@F'\.-)U2TU,ZO)/-"P;:YR#7U5X,^'_AWPEIB6=IIUK.
MB#&]HP3_ "HYHK8.2;WT/R[^%/[&?Q"_:&6%/%6MW<$0^<K=9Q^M?<WP,_8O
M\*_"&V\O4K"UU691A9&0&OH-(+>W_P"/>VCM_P#KFH%.+$]3FDY-E1IJ)#I]
MC:Z-;BWT^%;6#^X@P*G;YHWW<_*:2E_Y9O\ [IJ#4\"OHW;QDX9MRB7@?C7O
M-M_QYVX_V!7A5[_R.3_]=?ZU[I;?\><'^X*PI]3IK;(DHHHK<Y@HHJ*2YCA^
M^V* ):*K?VE;?WZDBN8Y_N-FD.S)<DT444Q!DTNX]SQ244 <]KS0Z&)M1CC
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M2Y!_P$U:M_'EW=-M-@Z_A79^1!_SPC_[Y%+Y,/:%!^%'++N+FCV.=M[RYOF
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M)U';CZT;CZTF**8"[CZT;CZTE% #)[6.]C,4J[U;UKS7Q)<?\3,Z)$/+ASG
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MC(AZ$4FM 3=SQ[P3>7MYXQ%K?3M<09_U;'BO9I+.W&8Q$-@Z+7DGAVU-K\1
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M8>806SSUKVG]C_\ 8ET_X3:+'JGB2"+4M7N,3B9AEE)YKZE\5:H-!T/,7R1
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M5C6GC>3P?-_9=Z6NY/6G^(-+;QQ:HUJ/LIZFF^3EO%ZB]_FM):=RVOQ TQY
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MF7_@E;?+C[1K$/\ P(]:=H=Q7F^A[E)_P4K^$+'!:4_\!IJ_\%+/A"G0S?\
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M37=O^AI#N_O-1ROL+VD>Y]=T5X5H?[87A36U4_:+>+/]Z05UUG^T!X3N\?\
M$VLU_P"VH_QI69?,CT>BN1M?BYX2NL?\3ZQ7_MJO^-:D?C[PG(NX>(K#_O\
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M5#]MMN\Z#\:<+JW;[LR$_6F+4DS[44T2(>C@T[Z<TP"BDWKNVAAN_NTNT^E
M!39#B-OI3MI]*Q_%FK+I.CR2J=TO]P=:3T0TKNQQ^A?Z9XPNH^NTUZ.J[5"^
ME>6?#F21O$$]]=*84EZ;^*]4)#<CD'I40V-*FCL%%%%:&0AY4@]#5.;28),G
M'-7:*0&.VBCL*EAT:+^(5IT4N5#YF1V]NEJNV,8%24450@'+ 5Y)^TA^T-H7
MP%\)7;7DX_M>6(M:A#DAL<5TWQ=^*.G?"GPK=7U[(JL\3>7N..<5^5-O#XJ_
M:V^+G[^:>ZTJ&ZV@-DJ%S5QC?5F4Y6T1?T[P?\1_VNM6D\7ZO(TV@K+M(8D?
M+FOT*_9C^%^C_#?0;9+&!4N0N&)%;'AWX5V/PB^$K:-91HC,@)"#OBI/A-J+
M/>?9Y!M*CO6,YOG2Z'13IKV;D]SU=V+,2>II*5OO&DJR H[8HHH K/IT$ARP
MYIJZ7;J<@<U;HVGTI60[L15"+@#BEHP?2BF(**3<HZL!33-$OWI%'XT /'6N
M.\>:,FIPMD9;%=5-?00QLXE5RO.T&N9M;F?6_$L+>4ZVX."I'!J6N;0J+Y?>
M#P+J$-O9II@^61/6NM(P<5SOC/PW':DW-A.L,_4HIYK'TWXA2Q)]GELY'>/@
MOCK1+]V^5A%^U7-$[JBN7M_&YNFV_8W7/M5UY9[^/"9C)I<RZ#Y6MS<P/[RC
M\:9)(L:DE@1]:XB^\&:U=N6BU%HQZ9JWI'A/5+)A]HO3*/K2YGV'RQ[F[<:_
M;6H)<$UER_$'3(6VLK9^E;2Z; R8DC#FHF\.Z8YRUJA/TI^\)<O4S5\76]T,
M0A@3TXK-U6]UD1M);-A:ZF/1[*+&R!1BI_L\6W;M^7THLWNQ\R6R/.]!\3:K
MJ6I?8I'(<=<UW%UX=TR&%+O4 #*GS+SWJIK7AF.ZAWV(%M<+\Q<=37G7B?Q?
M=WVI6.FAF3R7"NW]ZG&2II\RNR90E5DN1V1W4^O:SK$P;2VVVT?RX-:4"7]U
M%MO<'UJ]86\5G9PB%0FY 6QWJ;-5S2>K9/+%:)'/R^ ])N)?-DC)<\UK:?IL
M&EILMUPM6J*5D/F;'>8?0?E2;J2DR!U.*8A:*;YB?WA2[@>AS0 M%%% !7)?
M%'!\-C<,@-FNMK%\7:8=7TEH1R>M3+8N&DD8OPWUHZA9I;;LK&O KM*\Q^%-
ML;'6KV%V^[QBO3CU-3#X1U+*6@444AX!/I6AF#,$4D]!5";688R1GFL_5M0:
M23;&< =:S#\W)YK-R[&BCW-L:TN[KQ5B/6H&(!ZUSE'3D=:GF8^5'8HXD7(-
M.KGM+OG698V.<UT-:)W,VK!45RRK"P8@5+7/>(/#M]K&H12VUR88EZKGK381
MWU.1%W#:^,MV:]*MYA/"KKT->*:Q9S6/C3[.TF6]:]CT5"NFPY.3CK64'=LV
MJ1LDR[112K6Q@9^HZ@+=,*?FK"N+V6Y/SGBGZFQ-XX)XJK6,F;10FVI8;A[=
MLH>:CHJ2C<TW5B[;93SVK6[ UR$)Q,GUKKHVW1K]*UB[F4D.H7[PHH7[PJR#
MA?&7_(XZ5_O"O0_%'_(&/TKSSQE_R..E?[PKT/Q1_P @8_2C_EU,RK?% Y'P
M!_R%Y:] ;[QKS_P!_P A>6O0&^\:\W!?PB:WQAGJ/;%?)7Q2_P""=?P[^+'C
MJ]\3:O;$7ER<N[/@&OK>-/,;%?F1_P %#/V^-0TO4+OX9^"X;JTUZVF'FWD!
M)/T&/I7IQ3>QSL]6D_X)4_"E?N6?F_[CYHC_ ."5/PI;[UGY?^\^*YK_ ()E
M_$#Q_JWAWQ-J_CVXOIK6S@,J-=@C('/&:\5_:[_X**ZSXH\23:'X"CNH98F,
M/^C$DD@X[5?O7LF(^EK'_@EK\+=,O([B&R+LC!@ROD<5[%\:/V3?"GQH^'NA
M^$]8MW>PTI0L 5L%<5\E?L/_ /!0ZZU&^M/A_P".;::VU@'FZO"5)_/FOTFL
MKZ/4;6.[MY!)#(,JRG(-1+F3U'H>2?LW_LV^&OV;=#N]-\.0-%#<MN?<<DFO
M7Z4L6ZG-)47;&<]XZ_Y!RU1^&_\ J[CZU>\=?\@Y:H_#?_5W'UK@A_OT3=_P
M6=E1117T9P!1110 4444 %%%% !1110 4444 5]3_P"07<_[A_E7$^"_^/>X
M_P!\UVVI_P#(+N?]P_RKB?!?_'O<?[YKEK;H[</LSH:***YSI(;J/S;=U[UR
M]Q;M;L0PP*ZZH+BRBNOOBHDKE1E8Y.BMF?11N_=CBFQZ*<C<.*CE9IS(R%4N
M<*,FN@TG3_LZB4\,>U36^EPPL& ^:KG2JC&Q$I=A:***T(,/QE<BUTM7)QDX
MJQX?LXX;&*=.L@S6#\6)&B\.QE>N\5T'A<EO#=B3UV"L_M&GV$S2HHHK0S$?
M_5O]*Y"9BTSY.>:Z\\J1ZUA:II91B\0XZFHD7%F511161J%20W%M8M]HO9!!
M;*,M(3C%,C4R2*HZDXKYO_;.^/6F_#?P'J&AB<QZS*O[M5//-5%.3LB)245=
MGSY^W!^V!KOCGQ!/\,_#R,EC')M%[;D[F[=17O/_  3]_9GM_ACI3^(-7M%O
MKO48P_F7* D$\YYKPO\ 8@_9:UKXF>(HO'GB^W\S0[@[XY&ZD]J_3NQL;?1[
M"'3[1 EK -L>!VKKD^5<J.*$>9\S'R31QMMSL'9:X[XJ2K/X:\N)LR;AP*Z3
M5;.2X@9H/]=_#7EZMJ6I>*CI=V,C.<5RS>ECNIQUOV/2/!T?E^%[($8;;S6O
M4%A;_8[..#IM&*GK1;&3U84R29(5R[8%/^M<UJEX\LS1D_**3=@2N7KK7/);
M$8#"J_\ PD$@_@K+HK/F9KRHW[361,V)/E%:4<BR<J<UQU:6E7QA?:QZ\"FI
M=R7'L=#12#E0?6EK4S(;B[AM,&9PF>F:)+V*WMFN2_[M1DM5/7-+&J1*/XEZ
M5P'B^YU72]/EMFXA88_"HE+E-(Q4B5-+/B;QHM]&/,M>F[M7I45NMJ@C08 ]
M*\K^'2ZS'I>ZV7-MGDGK7?Z/JKWD[02?ZQ>M1!K<NHGMV-?)IK1H_P!] WUI
MU17$P@C+&M3 >66%?[B^U1-?6_=P?K6!>:E)<,0#\G:J1RW4U',:*)U/G64G
MWE1OJ*<UE:W$>%@C ]0!7**2O0UH6.JO"P5S\E'-W#E[$6H> H;YB1.T6?[O
M%9O_  JM5D$@OY#CMFNWBD$L88=#3Z?+$.>2T.'EN-1\+G9;VIO57^\,U8N+
MFY\;6JQZC;_V>D/S# Q78Y]@?PJ*ZMX[R,I(,+CG%5JM+Z$/E;O;7N<98^([
MZ.X2UL(3=0(=K..U=.VM6]N!]ID$38Y!KC]8:[\-ZA'#H W),?WF>:U?^$:E
MU:(-?@^81VJ;KIN6T]WM^)L#Q1I+-M%VI/UJW#J5K<?ZJ4-7)-\.+.,[H]V[
MZTT^']1L/^/0'%*\NJ'RQ>S.W4%NG-1+=1-,80^91_#7$2_\)6G^I6L+1KS7
M&\4/'-_Q\]_2ES^0U3\SUG::*QXY-152THZ=:KR>+[2SR)V.1[5?,NIGROH=
M!17+-\2='C^\S?E4?_"T]#!QO;\J7-'N/DEV.MK \>220^&Y6B!WY[4EKXUT
M_4V$=JQ,C<"N7\2:IJDVL#33S&W.*).Z'%/F+BK<^'?"MEJ=I#YUQ*1Y@QT%
M=/IOB2QOK6(F=1<$?.GH:SM#M]1^SBVN5'V;&!4UOX(T^SE>:+=YC'/6F^G*
M)=>8W5F1N0W%+O7UK&:SNXSB,?+5>:#5/^68HN'*NYT6X>M)O7UKF/*UK^[4
ML4&J[3O'-+F#E\SHO,7UIW"PO,W$48W.WH*Y+Q#K'_"'Z.^IZK(L=LHR<GFO
M@S]IK]OR^MI'\/>!+AI;JZ8P2!1GKQ5Q3D]#.;4%=L^I?C/^V-X+^&>BWT^F
M:O;WFI6RG]QN!^8=J_/KXC_M.?$[]J6*:'1=+N+>&1MJR6N1Q^%;GP-_8;\4
M_$[5!KGC"*9K.\?SI,L>AYK[+\%_ _2/A+J\.D>%;93M )WKGFJE*-/;5F<(
M2K/71'RS\&?^"?\ -\1-/MY?&^O7EO*!N:.X8GG\:^P/A+^RWX#^#R; UMJ
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M7KL5NEM&BIP,5C&SDY(Z)WC%18^BBFNWEH6/05L<Y%<726ZG+8;TK(FUURQ
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M<?6KWCK_ )!RU1^&_P#J[CZUPP_WZ)N_X+.RHHHKZ,X HHHH **** "BBB@
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MWK_>XK..K;-9:144)1116AD%%5YKR*$?>&?2J,FN[6P!FE<=FS6HK,AUH2,
MPP*OQSQR_=;)HN%F24444Q!N-5M3L(-2M7%RGF"-=R^QJR.:XSQ#XTO]+>>!
M+,O'@@/BIDTEJ5%-O0YC3[[5M>UA[6"X864+[6C[8]*]3L;"WTR%4MD$8(RV
M/6O+?ACJ$\.I7C^07\Y\GVKUGL#ZU$-5=FE3W79#O,;UI1,R]#3**U,25;J5
M>C4[[=-_?_2H**!61!>:?;:AD7,8DSUR*Y/6O@GX&\29_M+1HKC/7<M=G10!
MY3)^R5\(I V[PK;G/^Q7@_Q8_P""=N@^*II'\.64.G@G*XXQ7V=2B1EZ,15<
MS1/(C\SU_P""9OQ+T^Z#Z5XACM0#\N'Z?K7F7Q9D^.7[.>K+H%YK]UJ-GC)2
M$D@BOV 2:3</G;\Z\7^+6AZ9?>)$N-1T^*\(&,RJ#2E5<5=A"@INUSY ^#__
M  45E\"Z#;VGB#0K^X>,89VC./Y5].?!#]N;PC\<;J6V@1=*>,X/VA@O\ZZF
MZ^ ?@_Q[X/2-=%L[9I%QYBQ#/\J^8_%W_!,$:7_:.KZ!XFFL9F!D6&W)7\.*
MI.,EV(DIQ?<^](=4TN["_9]3MKAF'"QR G^=3[6'8_E7Y!:+<?&/]G;Q6EY]
MCU/7+&U?DR;BI KZD^#O_!1R#QIXB31_%-I%H+ 88R_*10X/H$:BV9]L45S?
MAOXF^$_&<9_L+68-1E499(6!(J_<:R\#8*8K-NVYNES;&K163%KGF-@C%:$-
MU'*O#C-%PLR:BBBF(YSQYX>D\3:=%#&<>6VXU>\.W2-8QVBL"\"[3BM1^890
M.NTXK@_ Q.EZMJ3WLAC1F)7=6;T=S1>]&W8[VBH;>]M[U2UO*)5]14U69A45
MQ<+;H6;MVJ7IS7/:Y,7F !P*3=D-*XEUK#3,3&2HJM_:%Q_STJO165V;6+<.
MIS(P+/D5LV>J)<D+C!KFZ?#,;>0.*:E83C<["BH+*0S6RN>M3UJ8C);=+N,Q
M2KN0]17G6@RM9_$*>U_U=LO3/2O2 <5P?Q(M3I=JE_;C$S/@E>M1/N:T]^7N
M=ZV-QP<CUI*H>'[C[3H=I(QR[(":OU9D]".>'SHRM<K=1F.X=<=#775G7^EK
M<@L.#4R5RHNQSM%3R64R,0$)%,^S3?W#61J1U8L;=IKA6'0&G6^GRS-AE*BM
MZPT];-?4FJBA-V+0^Z/I2T45L8BKZ>M>6^.KF/2_&-HQX;UKU%3@@UYW\4O#
M)OE.IAB#"*SJ7MH:TK<VIW.DWGV^Q67.[/>K=<S\-YC<>%8F8Y/K73547=7(
MDK-HD2XDC^ZV*S?$/A_3O%]BUEK$"W=JW5&'%7J*H@\7\4_L?_##7;*X2'P[
M;I<2*0K[>]?(GB#_ ()P^//"^I7FI^#]933(-Y=8XVP<5^D=.,C,NTL2O<9J
ME)HEP3/R4M_B5\7/@!XX@3Q)<WVM6,)^98P6! KZH^%__!2/PKXNO(M&NM+E
MT^[&%9KCY?YU]7WGA'PYJC%[[1+6[<C&Z2,&OE'XN?\ !.;1?B)XDO-<TO45
MT-Y,LL=N-N/RJKQ>YGRRCL?5FB^+-$U^Q@NK?5;5O-&1&L@S_.M7:<9 R/7%
M?DEX\^#WQ5_9Q\1VMWHESJ?B"SMY-Q4%BN :]U^&'_!234+KQ%IWA[Q9HRZ*
MI C>:;C'O2Y.J&JG1GWO_"P]J\:\9::MOX@@E*XW2C^==[X:^+'@WQ>H32M=
MM[RX9<^7&X)K UBPF\4:DQ2(JMJV[<!UQ6$XMZ'72E:[Z'H=I_QX6W^X/Y5)
M6-X?UV._@$,A"/%\H'KBMK:?2K1FU9B44NT^E)3$&31DU4U#4$T^W,C'D4^Q
MO$O+59@>&I7'9[EC)HIOF+_>H\Q!U;B@0ZBH_M,/]\4ANH1UD% $T?WA7EGB
M#CQT<\#UKO-6\36FFVDCQ3+)<J/ECSR:X[5])FUW2?[:V&*[S_JN^*B2YM$:
M1?)K+J=_I_\ QY1XY&*L5SWA_7K6+28H[F98YD7E6/-7M)U^VU7S-DBD(<<5
M29+B]S3HIGVB+^^*;]JA_P">@IDDN31DTP31MT84[<OK3 7)HH W<CFEVGTH
M 2BEVGTHVGTH BNN+.<_[)KQ&&3[5XRA/7;)_6O8]3U.VM[66)Y55W&T FO(
MK?0[O2_%,4\D3"%WW;STQFL*EW:QT4FE>Y[:WW4^E)21R)<1JT3;UQU%+@UL
M<X4C ,N#TI:*8%2;3H9.0G-5FT49Z5J44K#NRC#I<2?>4&KB1K&NU1@4ZB@5
MPHHHI@-DF6W1G;IBO*-!TN'5O'-Z\@#KG(KO?&UX;#0))EXKAOA3')-KEQ=/
MG#CO6,G>21O3TBY'J<:".-4'11@4ZAOO&BMC #]UOI7(W<92X<D8R:ZZJ&I:
M:MVNX?*1425RHNQS=%326<T9/R'%1^6_]VLC4;4MJI>X04):RNP 0ULZ;I8A
MP[=::0FS1AC\N,"I***V,15Y8"O,_B3JTEY>'1HR3OKT:\N/LEG).>B#->2V
M>IIKWQ!ADP&0'%9U'T-J2U<NQZ/X.M7T_P -VUN_516Q04$?RJ,"BM%HK&3=
MW<*K7UVMI#N/6K(ZUSFL2,;AES\M*3L@BKL@FU":5B0V%-5F^;D\T45B;#TF
M>/[AQ6AI^K-')B4[@:S*%^\#[TTPM<[)6#*".AI:I:9(TD/S=JNBMC 2J'B"
M0#1KJ/.'9"!69JVL7EC,WDV[2"N2U;Q5J5YJ]E%+:M%&6 /'6H<D:Q@V[G0?
M#"SDM-(G68$,7)&:["FQ1I'#'Y:! 5!(%.JHJRL1)\SN%%%(Q"\G@51(NX]*
M*B:ZA7K(,T+=0M_&*0$M%(K!N0<BEI@%%%% #HR0W%>+^()+Y_&DZV$ICD+8
M8CTKV5I1"I<\"O,_#B+<?$B[D(WJ>F:RGT1M3TNSN?#^CV^FV<<J1[;F09D;
MU-:I8GK0V Q &!25IL9-WU"BBE1=SJ/4TQ&%X^\41>!O!>HZ_*<):(7(K\L/
M"XMOVL_VMH[V[L6GTMFP=X)7@U],_P#!13X]W?P]T:3P?:PF1M4AP,>]7O\
M@G3\([;3?A9#XCN[=8]3:0MN*_-S6D?=5S"7O2L?6OASP_;^#_#]MH=F@CM+
M90J(HX J_2R.9&)/6DK,V"@>GK110,\^^(GF:-- VGYB$I_>;>]=#X)D$FF%
MAU[TOC#3Q>6#R%=WEKFJ'PSG\_2Y_P#9;%9?:-MX'74445J8A1110 45$US$
MG5P#2"\A/_+04@)J*:LBO]TYIU, JCKFG_VMI<MI_>J]3H_O4@V.0\*WJ:;=
M?V*.&CKK3P<5YG:-]C^)5Q-(V(SZUZ6)!*-Z\@]*B#T-*BU3%HHHK0S&R2"-
M22<5CW.N*V508(I-;NBX"*<8K'K.4C2,2TVI3YX<U+#JLB'+-FJ%%1=EV.EL
M]42ZXZ$5>KCX9##(K XQ73V%U]LAW8QBM(NYG*-BS3)HOM%O)#_?&*?0.#5D
M'D-YIK>&/'%I"IVQ2-D^E>O>8L@#(P9<=17"?$S0S<6KZDK;7A'!K3^&U\;[
MPS&[OODSWK&/NR:-Y^]%2.HHQNXHHK8P.:UB,K=$@<51KK+NS6[C*D8/K6'=
M:2\'W,M63B:QD9]%3&SG_P">9I\.GRR. 4(%18HABC,T@"\G-=9;C;;H.^*I
MV&E+:MO)R:T*UBK&<G<****L@\\^,2R+:VDD0.5.3BM+X8ZL=5TM]QY3BM[Q
M%IL>H:7<&10=B$C/TKD?@ZW^CZ@N,!9"*QVF=&CI^AZ#1116QSA44EK%,<NN
M34M% %;^S[?_ )YBGI9PQ\JF#4U%*P7"BBBF 44;2>@J.:ZAM1F>01KW)I <
M3\4[#;HK7(&3NKHO!K!O"]D<\[>E8]Y=S>,-5.D)#NT_K]H'2D\.&ZT359[&
MYC:.SBX21NAJ$G?FZ&O,K<G4[&BJZZE:29V3JWXTK7ULHR9E JS*S)Z*J-J]
MBO+7*@?6F-KVFKUNT'XT70[,O9-%4?[?TS_G\C_.D;Q#I:];V,?C1=!ROL7Z
M*SO^$FTC_G^C_.D_X2;1_P#G_C_.BZ#E?8TJ%ZBLT^*-'_Y_H_SJK?>)%:/&
MFXNV;KMYQ1=!RLP_%T9D\8:64&X!AG%>@^*/^0,?I6!X7T22^D-U>QE9%.5#
M"M[Q1_R!WJW%JC-OJ<M6:E4BET.2\ ?\A>6O0&^\:\_\ ?\ (7EKT!OO&O+P
M7\(JM\8E<WX^^&OAKXIZ/_9?BG38M4L0<B&49%=)17H;&!XGHO[%?P;T#4X+
M^T\(6D=S X>)]OW".F.*]9\0^%]+\6:#-H>K6J76E2IY;P,.&4# %:=%/F8K
M' > ?V?_ (?_  MO/MGA?0+?2[GGYXEP>:] 9BS9/6DHI-W&%%%%(#GO'7_(
M.6J/PW_U=Q]:O>.O^0<M4?AO_J[CZUPP_P!^B;O^"SLJ***^C. **** "BBB
M@ HHHH **** "BBB@ KE_%GBX:3FTM,/?L/D4]ZZ.\8QV<SC@A<BN&TW3XM6
MO&OKA=\\;?*U85IN*LCIHP4G>6R,X>#SXIMQ<:QNANFZJO%1_P#"HM)_Y[2?
MG7;LQ8Y-)7#RI[GH*<EHM#B1\(])'_+:3\ZDC^%>F1-D2R?G7944<D>P_:2[
MG)?\*UT[_GJ_YTA^&]E'_JY')^M==0IP0:.5"]I+N>(^(=!?3_$26\)8M6I'
MI?B-(QY,1*=J[;5/#+WVN)?#HM=%;[H853TK-0U-G5T1YG8VOB8MB:$@5I_\
M(_>WC!KD,M=[YAIK?-UK11L9.;9QVJ6-II.EJR']^*=X5\0W=YO6XXA0<&NE
MN-+MKQ<3)N%<AXK9/#,]J(QMBD8 @>E-[W8H[66YT$GC#2XGV-+AJ5?%VF,<
M"6L/7HM&OX8;>UM_]*E7AQZU5TOX?W%KC[00QZTI73LM1QY9*[T.RM]8M;K_
M %;YJXO[SD&N>F\/R1P@6WR..]8]WH/B1I!Y%SM7ZT7:Z!RI]3NMI%(S>7%)
M*>D:[C^%<QIUAK-JH-U/OJ+6/'EOI.EZE'-"[.L#<@>QHYEU%R/IJ?GA_P %
M#?&%C\8OB1X7\-6LY?\ ?B"15/OBOMW]EGX,V_P,^',.DVZE5N$$ISUY%?EA
M=:I)XS_:BLYHMQ2'4L\]OGK]J;2X5])TT%@"+=!^@K>6B2.2&K;)**3S(_\
MGJOYTCS11J6\U3CMFLCH,'Q9/NM'M3]QQS4W@^U6RT58D^[FN3\>:T\FZ2!&
MVJ.<"ND^']V;WPZDC'#9^Z>M9I^\;-6@=%1116IB%%%% #)(UDZBH/[.BSFK
M5%(+C8XUC7 %.HHI@%%%*/NMVXH XWX@7ETDMBED-Q,@#X^M=3K'AX3Z''<V
M\8^WI$"@]3BO/;3QA;VOB"[M[Z-I\MB+ S@UO_9?$<LB31W6(&Y5<]!1"44F
MWK<=2$FTEI870?%+6T/V;6CY5_G[OM740R+<1AXSE37%ZAX-N]2G^TRMNN?[
MU4)?"_BF/"VUWM0=LUE=KH:\JEU/1MII*XRWCUG2(=][,9 HYQ4;?%"TL_EE
MMY&8>U/G74GD;VU.LN--BNFRW%4IM$1?N5FZ?\1K+4F"K"ZD^HKH8=1BF4,&
M"Y]:?NRV%:4=RC#HB-]_BKUO816K96IQ)$W_ "U3\Z7?'_ST7\Z=D*[%HI,C
ML0:6J) <YKS/QE(WB74H[.'YVA?)'XUZ)J&I0Z5:M/(0P ^Z.M><> 9AJ7C2
M_G(_=MD@&LIZV1M3TO+L>DV$8AT^VC9!E4 .14V%[(H_"@\$XZ45H8E/4[LV
MD.Y.M<Y-.UPVYC6CK6_<<GY<UE5E)FL5H%'XT45)98L[V2UD&TY!ZUT\$RSQ
MAE.?6N0KHM$SY#9JXLSDNIHT445J9F3XM<+X:O03R4-8/PC4KX9D!Z[S4_Q"
MOOLVES19P76H_A.I7PVV[KNK+[9M:U-G8T445J8C9)%A0NW"BL.ZU>5WD\OF
M)1DGVJ;6KAES&#\IKR/X\?%BP^"_@6;6+UMRRH4"J><D5F[MV1:LE=GSK^W%
M^U==^'[:'PSX,F$]_>DV\Z YP3Q6-^Q#^R/]D<^-_&D++K@D^T0))R#GFO$_
MV?OAKJO[3OQAU#Q JL+&WN//3S1VSGBOU,L;5-/TRSM$ 4P1B,X'H*UF^1<J
MW,:<?:2YY;&];Z\995#HL,8& J# K85A(H9>0:XVNBTFY\V,)Z"LHLWE'L:-
M%%%:&9P/QC_Y!=E_UT'\Z['0VW:)98_YYC^5<W\3[3[9IMN,9VMFM+P;??:M
M/2/.?+7%9+XV;/6FC?HHHK4Q*6J7AM8\?WJYN20R,236SXB!*QX%8E8RW-8[
M!1114ECHY&A8.IY%=-IMTUU;AG^]7+'I70Z*I^S@]JJ.Y$MC3HHHK8R.6^($
M?V#19=1B'[].E7/ ^H/JGANWGE_UK=:U=0T^/5;5K:9=T;=17&>%M2%OXIFT
MB/Y88N@K/:5S5>]"W8[N@4K<,:2M#(Y_6+5UF,N/EK,KL)(EF7:XR*R;K1#(
MV8N!63B:1D8M%:7]@3^M.CT&4-\QXJ>5E710M;=[B0!!G!KJX5V1J.^.:BM;
M)+51M7#=ZL5I%6,Y.X56U34K?2-/N+FX;8$C++]<59RO=@*\R^.&N+#X5NHH
M9!Y@C.<'VJ*U3V<'(Z<)0^LUHTNC/S7_ &T/C%>?%3Q4UE<,&AL92L>/3->-
M^'EVV9%0>-+J2^\=:F)#N_?'^=:EK +>$ <9KPJ\N9:]3ZJE35/W8[(Z/P9,
M+74G=NFVLK6GWW]VXZ9)JQ:J]O'YPX!K/NVWK,W<BN(Z#E%C;4-26$#+,<"O
MUO\ V.=:L- ^"MI8W#;)Q_#BORL^%]NFH?$G3K>4;HVD (_&OU\^%.@Z)I?A
M>WB^SX.T5[5"7+4Y5V/)QU+FH>T>R9WDFM030R&#EBORUQMAXDUNSN)HFB^9
MV_=\5W-G:Z>W$486K;:3:/(LI0%UZ&O1LV?.J2CT.%EU3QD'^6W^7Z4Z&^\6
MS-B6WPM>B^8U'F&GR^8>T\CD+;0[G45Q>@IGK3?^%7Z8TXF,KEO3-=?DFBGR
MKJ3SRZ'-K\/]/5LAV'T-8?CKPK<,MK+IZDB [F(KT"EX92AY5N"*;BK6!3:=
MSEO"OBZ*^B6VNGVW"_*!74LI7K7E_C+P_*OBBVBTIO(D<Y_&NI:ZOO".GK)J
MI:=AUV\U,;ZWZ#FHW5GN=-16)H_BRVUK_5H8_P#>K966)O\ EJGYU=[D--;C
MJ*3?'VE0_C6)XA\76OAN-6G4MO.!BAM+<$F]$;A^523TK,N_$EA8L1-)@U@W
M$.KZT\-Q9S>7;-R5]JVD\-6EQ$/MD?F2=S4W;V+Y4MS+U/XB:7;1KY4WS$XJ
MTWB3S].,UL=TI7*_6JVM?#_3+R!!! %<'-;-AH=K9VL483#*,&E[U]1ODMH<
MEH=O>ZI?C4]23;=0M^[7L15KQ/I^I:\Q;R]O^[77BUB7HM2J=HP*M?#RF;:<
MN8\K;2_$=G&$MXBRCBFQZ7XEDXDB(!ZUZQYAH\PUG[/S-?:/L>4:KX1U2YTT
MJ%825?\ #?@%9;=4O'=7 YYKT<L33!&JMD#!H]FKW#VKM8XG4_AQ;QP.UL[M
M)CCFL?2_#K6+?\3AFBM<\MFO4*RO%&F_VMI$D.,L:?*EJB>=O1F+JGA7PW9Z
M4M]'<N8I!A#GO7/^'_A^^K33/?LZVIYB;/44OA)?MVJ'1KW]Y!#RJUZ:L:PQ
MK$@PB< 4W:>MK N:GHW<XL?"/2<Y\Z3\ZT[+P'I]B@5&+#WKHJ*:BEL)SD]V
M<\W@:R:3?YC?3-)>^ ]/ODVNS*.G%=%13LB>9G$_\*CTG_GM)^=)_P *BTG_
M )[2?G7;T5/)'L7[2?<XEOA+I:J=LTF?K6)#\,3'K2+\WV3NU>HTNXXQ2]G$
M:J2[G(M\,]-SQ+)^=9&L^ 9+9?\ 0"[MVYKT2E5BO2CD0E4DC@/"6DV:R"QU
MB1H[YS\JYKKM2\/:/X?M1-=RLD70'-9?C2S@M;&35@O^EQ#Y7KE/!]]?>,;O
M;JLAFLNR&KC*,5RM:DRA*;YU*R.CU33H-3M?^)<[.C#BJ/AK2]4\/R-MCW*3
MG+5V=K80:>H2W38@X JP6+#!HZW%TY7JBAJ'D^)-+EM=0'EC83E>#7Y*?M=Q
MBQ^+&EV\9)@BOUVD_P"\*_7=;6*02[E_@-?DS^VA"D?Q>TM0.#J"@_\ ?0K:
M,G*5V<\XJ,;(_2WP3XVLK7P!X=6XDVXM(Q_XZ*V4^(6B/TG-5?!_A/2KSX>^
M'#+ &)LXS_XZ*OKX$T1>EM7-[YUKDL/A\9:5<'"2YK1M]0@NAF-LU@W7@FU7
M)MH]AK-D\+:S#D6TVP=N:+R0[1>S.Z5=W3'YT;37G'_"-^+EDR+WY/K6K!:Z
MWI\.^YGW@4<WD+D7<[&BN'7XA16,WDSQ.S9QG%;UMXBBOE'E@Y-4I7V)E%QW
M-M5+=*X#X@M%XB>"UMCODA;YQ71ZCHNLZC;[K&;RR?7TJUI_A!=-TV>XG :[
MV$LWJ<5?LY2T:T(]K"&J>I6\*6<=E8A(^N.:VJX_X?ZL;YKY93L*.0-W%=A]
M.16<=BY7OJ%%%%62%(RANH%+10!&(5!SBI./0444 %%%%  .3BN%^(FH)?6K
M:6K?O2>E=O+.MK&97^ZO)KSW7/#=SXHU0WFGS+&?4FHE=JR-(-1=Y'7^$[4V
M?AVUB8?,HYK6KC-)\;0Z?MTJXC9[F'AG X-=3#J$4RJV=H/K1%JUA23O<M4>
MM,6XA;_EJ@_&G>9%_P ]D_.K(,34M*;=OB&<]:RGC:,X88-=AN1APZD?6H'T
M^"0Y*Y-9N/8M2[G*5+#:R7!^0<5TG]F6_P#<J6.VCA^X,4N4?,5=-L?L\?S#
M!J_116FQGN%4/$!;^P[OR_\ 6;>*OCK7#^.M6N+/7K"UB8F&4@,!2D[(N*YF
M7?AU#-_8[O=+^]W'&:ZNHK6U2UA58Q@$9J6B*LK"D^9W"J.I7RVT97/S]JO5
MSVO_ /'V..U$M$$=69\DC3,68\TVBBL38*FMKM[5@5-0TA[4".OM9O.A5SU-
M2U1TM6$"D],5>K=&+"N8^(5X++20P5<GO73UPWQ>E\O18?=L5,_A9=/62*'P
M;D:9KYG4<GCBO2*X/X3VOD6LC8QN%=Y2I_".I\;"BBF22"-2Q/2M#(?437"1
M]36%>ZL\DG[HX%4VNY7ZM6?,6HG5),DG0U)7)+>31]&J_I^K,K;93G--2!Q-
MZBF1R"1=R]*?5D%34)IX8RT RPKR?QTNH7VZ>X3"CO7L1YXKF/B):Q_\(M<.
MJX<=ZRG&Z-J<K,K_  YGNVT>&-U_< <&NQ[\C(]#7+?#J[23PU;Q?QCK7454
M=D1/XF5=8TFQUW39;&YM(#%(,$E!FOD_XR?\$]? GB07.N6DDT.J."0L9P,U
M]=5GZUE;7(J^9K8SY5+1GY&:3X"^,'[)WBC4=2T>VFFTEV)5I26^6OIW]G7]
MNC0?%UK+8^-KP6VL!MB1].:^J->T2P\768M-7B6>WQ@J5[5\E?'S]A'3_$>J
M)J7@&U33KE?F+#CYO6CFC/XA<DJ>L#ZYT?4;;Q!IJZA82+):MR&#5;@G:W<,
MIK\P? _QP^('[*OQ4CT7QW<7%]X?C.&502M??WPQ^.WAKXR0BXTF6.V5UW!)
M& -9R@XZHTA44M.I[+I]V+N/@Y(JU61X?4JLF.F>O8UKU2V$]RKJ#SI;M]G&
M7Q7D^L6^N3:O'%=Q>7;R-C*^E>Q51UVS6\TZ9L9F53L/H:F4>8TA/EZ$6@Z%
M!H5FL<#%@PR<G-:=<CX$OKJ&WEM]2DWSEODSZ5UU5';0B2:>H5@ZY;E90RCB
MMZHYH$F4AAFFU<2=F<A16O<:&[R$Q\"JS:-,IP36/*S6Z*-/AA:XD"*.:OQZ
M%,>2>*U;*QAM5!9E$GUIJ(G(FLXS#;JAZBIJ:TL:\^8I_&LW4/$$.G(6="X'
MI6MTC.S9J53U71X=;M6AG^ZHW"N8;XI6.X@6TGY5F:MX^DUA!;::DD,I."Q'
M:HYHO0T5.5S1\ ZPUYJM[8 YCMSM6NUKSN\@'@O[#<(1]HNR/,*UZ%"WF6\3
M@YW*#Q3BG'W63)J7O+8=1115D"8!["D\M1VIU% !QZ"BBB@ HHHH *Q/&Z>9
MX6NUQVK;K&\8,K>';E%==Y' S4RV*C\2.*^&&MS6\*V4G$(->G_>&1R*Y;PG
MX7ANO!\;1%8[XG[QJUIOAW6[)W>XN!)".0 :<:<HQ6EQ2J0E)ZV-ZBL"Z\51
M:>2LJ-D=3BLQOB?8K-Y0@=CZ@4G)+<:BY;'98I=IKGH=0GUB/?;$Q@^M9VH:
M1XAFSY%SM_&ES#Y>[.P8A.IK/NO$-E8G$TF,5REKX?\ $RC]]=;OQJ_#X2FG
M/^F'S/6ES/HBN6*W9;NO'/AVXMI8)TBD5Q@[D!KYF^,G[*WPQ^*"S:GYSPZC
MR4$/RU].+X%T9E^>W!-/C\#Z+#RML!3O,5J?4_)75OAM\2?V<?%\NM>%X[B?
M2D/RM(21BOI3]EO]O71VO[JP\?7:V=U(-@##'S5]JZMX#T'7[ V5_:++;$8V
MD5\H_M)?\$_="\:6L=YX'L8]/U%#O=^F371"6OO')4AT@]#Z6T.^T/QAILNJ
M^&K@7'\8PU8MUXD\5V<Q+0?NAWQ7YLZ?\1OB7^QSXXL+'Q#<W%UH8<>:L8)7
M:*_2+X,_'SPK\>?#D.H6$D5NKJ 8Y& .:SJ0>Z-J51;,MZ+XG\0ZY<&&WCW2
M+UK1U/7=6T.:*&\0)))T%3^+;&;P[$EUHS>4^<NZ]"*K^']1'CYUEN/GEMN"
M3ZUEHE;J;:MWM[IBZ\/$NJ\10Y@/>KFFQ^([6Q2(0]*]%C411A%&%IVXT<G6
MX>TTM8X> Z^P.^+%:%I%J<@Q,F*ZC>:-QI\OF2Y>1SYTV<^M2V^DM)D2Y K:
MR:*?*+F9S<G@2RDODNV=C(AR!GBMQ;=5X"\8QCM5BBFO=V)E[VYR^I^!+&XC
MNKDNROM)P#7'_#.TF:34$C+,$<@9KU=E#HR'[K#!JII^CVFDLYM8_+,ARU0X
MW=S6,[1:9Q]Y;:XEUB*/,/K71^'?[.U<FU:0_;XQF1<UM!C7"^*BG@V9M2@&
MV6X.W(]ZJ-H.[V(E>HK+1FUKNI6MKN@LWW7 X ]ZY>.;Q6TGS0?(>E:W@OP_
M*Q:_OSYAF^=/:NS\P].U)^]KL-?N]-SSMKWQ9&<)!E?I3?[0\8#I;_I7HWF&
MCS&I<GF5[3R/-FU+QEM.+;GZ5';ZQXR\X":WPG>O3?,:FL=W6CD\P]HNQRZZ
M+::G'#-J#LDRG<0#WK;U#4-'NH$AN6"J@V@@<U,]G#)]Y:@DT.RF^_'FM5)Q
MT2,'%2=VV<+J?BV;1=2^SZ:=]C_>-:5C\082!]H?:?I71?\ ",::>##Q43>#
M=(<Y-O65I7N;\T+6*]OXRL;@@+)DFK_]N6T:[G? J$^$]-B0^3#M?M6!>^%[
MU+L3,V;4=5IZK<FR>QOMXNTQ.LM,7QII3' E.:DT/3]!U3_1V@'GJ.<U3\0-
MX9\.3)$]D9'D.!M&<5JX.W-=6,E47-R\KN:4/B&QN/N29J\DR2+E3Q7-R:+%
M?0^98)Y0(R*Q[CPSXDW'R;G:O;FLW=>9JDI>1Z %W="*;*RP(7<X4=>:\V;P
MQXPR<7N!]:FL?#?BG[0OVN[WP9^89J>9]BN1;W+?C+4CX@M&TZR^=R>E7_ U
ME;:?;K;CB\0?.M6HKS2O#<GF2VQ:<#[P%<1=>+/^)Y+<6<3IN.3Q3DHQUOJ*
M+E+W;61ZN:*XC_A:5G;(BRP.7QR<5(/BMIH7)B:CGB+V<NQV=%<E'\3-.D4,
M$;FK4?CJSDP%C8YI\R#DEV.A9 ZX(%0?88LY[U3C\10R8Q&W/M5I=21AG8:-
M&*S+$<:Q]!3ZJ?VBG]TT?VE".&(4^YIZ"LRW163>>)K>Q!)4N!Z5AR?%&R$A
MB%O)NZ XJ7)(:A)[(UO%.I1Q6YTXMB:X&U17!^%] 7P[XJC@N?EN6.X UO1V
MTVNZE!J3@[(3N -8_BKQ)'!XPAU)X798QC@5,K6YF:QNGRH]4D^]3:SM&UR#
M6K-+A2(PPZ-Q6AN0])%/T-:&%K"UF:MI_F1F1.7K3I#SQ0U<:=CC64J<'K17
M2W6EQ2\JOS51;0Y">*RY6:\R,BIK6V>XD4(,X/-:L&BE6^<9%:4%I';\HN#3
M41.0Z"$0QJ!UQS4E%%:&0CX6&1]H)5<]*XKP_?+XNU2X$RJ#;-A<"NC\0:Q'
MH]J#)TD^6J/A/18]-\ZYC7'VCYJEZNQI'2+9T/0 >G%%%%69C)9!$A8FL&[U
MB1F*K]VK?B"1HT4*<9K"K.3Z&D4*[&1LDT(Y0Y!-)1699H6NK21R*&^YWKH(
M9EN$WH<BN//2MW1)#Y07M5Q9$D:U%%%:F9F>)KC[+HLLO3%><_#B[^U^+IGS
MDFN[\>-M\+W!K@?A/;?\39IO6L)?&CIA\#9ZZWWC24K?>-)6YS!4-]?1Z78S
M7<K;8X5WD^PI;BX6UCWMTK@_B'KGV?P/X@:1\#[*^W)_V34MV&D?GG^U5\0-
M(^.'[3GA33K6;SX(YA%(%Y'6OT>^'N@Z?\/_  S;:5:_)%Y:G'X5^:O[&?PG
M7XB_$76?$MR@EDL+YBC-SC#&OTIF?S!'G^%0M54E:R1G2CS7DSJH;R*XX0Y-
M35R$-P]NP*'%=%IEX+R/W'6H4KFKC8NT4459)3USC0[T_P#3,UR'P?D,FDWA
M/_/0UUVN_P#(!OO^N9_E7'_!W_D$WG_70UD_C1M'^&SO:***U,1&8*,GI6)J
M&KNLQ2/E*U;XD6<A%<GN+9)K.3+BA\DS3-EC3!D=S1169J6X-3EM^!R*W[*\
M6ZC'/S]ZY6M+0F/VDCM5Q>I$EH=#0IQ116ID>;_$FQ.E;=1CX9G S7<^'Y#/
MH-G*W5D!KF_BT-WAN//.&S2?#7Q(FL6"6J_\L5Q6*LIV-W>5-,[2BBBMC P=
M:MC'\X'6LJNNN($N$PXSZ5BW&ARY+*>*RE$TC(RZ*EDMWC;!%2P:=+<'"\5%
MBRLJ[V"CJ:Z;2[=K:WVL.35?3](^SMNE&3VK4K6*L9RET"BBBK(*6M:>-6TN
M:T89$@Q7GW@^YFT7Q4=$'$"\UZ>K;6S7F7C*SET'7&UI> 3C-93TM(VIZWB>
MFN-K$4E4]%NCJ&DV]R3DR+FKE:&.P4?AFBBF <>@_*CCT%%% !1110 4444
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M^$?RZEJP_P!L_P ZR?Q(VC\#/1Z***U,2*X@6XC*L,USMYIKV\AV@L#73TF
M>HS4N-QIV./,;KU4B@1NWW5)KJI;..;J,4D-C';G(YJ.4OF,"ST]YI!N4@5T
M5O +>,**6>:.T@::3"1KR33;"\AU2#SK5O,C]:M)(EMM$U%*5*]:K3W\%J"9
M7VBF26H\[N*\LU*^CT'Q=-<C&]VQ79:AXPM8X66RD$MSV6N(NM$_M:[:\O\
M,3]<5C4DNAUT:<I7/4;*7[59Q3#^,9J;:?2O+X_'U[9LMG;)O5/E6M=/$7B&
M2/<EKG\*I33,I4I1>IV[,%ZG%5I-6LH3A[I%/H36+IUUJE\O^EQ>63UJ"\^'
M=KJ,GFR7$BL>2 :J[Z$<J7Q,W9=7BVY@82_[IK%OO&-U9DA;-G^@K2TGPW!H
MZ[4=I/\ >K5\N/O&I_"C5A>*.'_X6)?,V/[-?\JBG^(U^&"KIDGY5WGEQ?\
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MCF0N1G045SR^/M%9MOVD9JROC#2&&1<#%/F7<7)+L;%'0$G@#J:Q6\9:./\
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M[:#!IVMWD5OXK7]TMH."<5<HJUXF49.]I;GTO1QW&13Y(7A?8P^:FLNQ2QX
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M77O#\&M:6]FJ+&&[UJT4[(7,]S.T#23H>FQV@;<$K2W'UI*,4;";N[A1113
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MPW_U=Q]:X8?[]$W?\%G94445]&< 4444 %%%% !1110 4444 %%%% %?4O\
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M^"CWB]_$$_@57M'@$=XA^8=?F%:4YIR2.>K3DHML^G_V8O!,.@_#^RW1[3+
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MXQ****[S **** "BBB@ HHHH Y[QU_R#EJC\-_\ 5W'UJ]XZ_P"0<M4?AO\
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M_P 7I&AO+*=1@Q\UT_@/5GUG1_-D.2O%80]V31T5/>@I'14445N<YFZEIBW
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M*7-.YJVXTTNY9^RVPP!;Q_\ ?(H^RV__ #[Q_P#?(J2BMCF(_LMM_P ^\?\
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MK-H\C1+G[1G"_6H]27Q;(V(,>6>E4G;43C?0ZJX\1Z=;2-$]PHE7JN:YR_\
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M5F*^MI_]7*&KIN>?9HGHI!STYIVT^E,1"]K#)RR9-0:E8P#0-6P@_P"/9_\
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M)W5T%%2XW&I-',?V7)G%6(=#D8Y+<5O;1Z4M+E17,R&VM4MD 48;N:FHHJB
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M*\U99]:\5.\RE'WY*'M7/4E=61U4H6=V>[:+QHED/]@?RJW4&GKY>FVZ?W5
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MI* 9# CUKI]-N/.B ]!7,JI9@!R<UT^GV_DP@]R*N)$MBW1116ID<]XW\/\
M_"0::V>L2DC-<K\+M8%C]HLYVR^_:N37I,J>="\?9QBO(-<TM?"?C"T;S=L,
MC;F/:L9Z-2.BG[T7!GL-%1VUW#?P++;N)(\?>%25J<X4C -UYI:*8$?V>/\
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M?F3\Z/\ A";G_GYD_.CZC0_E_$.6'\_X#/\ A&5_Y^$_.C_A&5_Y^$_.G_\
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M3$OWES5R.)(1A!@4U$3D$*^7$J>E/HHK4S"O/_C+,\.DP!.K'%>@5Y]\9/\
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MV<9Q6BFCG=&:Z'645GV6M0WRAA\F?6KPDC;[LJL?0&K,K-#OP%%%%,04444
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MH"XVBG;11M% 7&TH^\*7:* !N%,+G6>'_P#CW-1>,O\ D!25-H/^H-0^,O\
MD!25[$?X9\V_]Z7J<'\-_P#D-3?C7I+?>/%>;?#?_D-2_C7I+?>-80V/3QG\
M42BEHK0XA**6B@!**6B@!**6B@#F/B!_R#$XJK\)?]7=?6K/Q _Y!B56^$O^
MKNOK41_B'9/_ '*1WU%%%=IX 4444 %%%% !1110 4444 %%%% "-]TUR.O+
M_I0KKF^Z:Y+7O^/H5R8GX#TL#_$,TT4I%*>E>:>\- HQS3ATI * $HI<4K4
M-%%.[4BT -I:6EQDT6$VEN- HV^]._E2#BK43"500\\TN<TW--9JTY3G<QQ.
M*-U,+<4W=UJN4R=0D5BC9!KY/_;B^%:W?A./5-,LO.O7;+M&OS5]5;JI:YID
M&M:/>P7"+)^Z8(&&><5I'W7='/4DJD7$_'GPWX>EUGQ)8:.ZE7F<1OGMDXK]
M4_@#\,_^%1>"4TU)2XG4/Q[U\V_!#]G"ZNOB5K.JZ[;&WBAN2]MQP1GBOM%9
M-L,48Z1J%%;57S:(X\*N2\F3;CCK2Y]Z@W<TNZN;E/0]H-OK-+V%E V2'H_<
M51T[3;G1V\UKEI\=B:TMV:=N^6ERE\REN5CXWN5F\O[(Q&?O8K<M=<@D0&:1
M8B>QK.7;C[B_E6??:#%J#;G=D^AHNQ<D7L=?#>03_P"JD5_I4V#7&Q6<FCV^
M;4F1QTS1I?B'56NF%Y%LA'0T<R%[.2.RHK)3Q3IVX(9OGZ5J0R+<*&0Y%.XK
M-;CJ*",4#GBF(!COP*\W^)'BJ:93I5FI,N?O+UKJO&'B2#0=,E!?%UCY5KAO
M FF7NN:S_:MW%^Y8]3TK&;O[J-Z<;>^SJ/A_X4_L>S2\E.Z:5<L#UKKZ-H0;
M5X4=**T2Y58RE)R=V%5[RZ^RQ[CWJQ67X@_X]UIO82W,>XNY)G)W$"H#SUYH
MHK V"I(KB2)P0QP*CHH ZJQNOM<.[&,59K+\/_\ 'JU:E;K8Q>X444*-QQ3$
M-DN([6-I)7\M,?>->0KJ\EQXHO([2/S YQN6NA^)'B$-;-ID#_Z03T7K5_X?
M>%8M)L8[UANN)!\VZL)>\[(Z8?NX\W4-#^'\=BWVBX<3F3YBK=JUM4\+V]]:
MF*!5@)_B45M&BM.56L8N<F[L\WO/AG?PKOCU*3CG:#56TU[5_"[&,VTET!QN
M()KU+Z\TC1QLI!C4_A4\G8OVC^TKG%Z7\1FNYUCNH/LV>[<5?D\<6YO?L\)6
M3Z&I-:\'Z??9GG;RE']WBN&TWPFUMXBDDLRTL ^Z32;DM"DH2U/6;=C/"LF/
MO#-.KSV76/%5K<>5%:9@4XSCM70V?B1HH=U]^[;'-6I7,I1L=#7G?Q?E2:/3
MT1MS"09'XUOS>.+%LI!*&E]*X[5M/O-3OEN9%)A#;LTIZJPZ=T[GINF872;/
M Q^[&?RJ?=6=HNI6VHV:);/N,0PWM5QCBME$Y93=R3<<US'Q;7SOA+XG3^]:
MN/TKHM]<Y\4I!_PJWQ(#WMF_E5<NIFYNQ^0_[('A?[)^U':3%MP^UDX_&OVB
MU2UCDF'R ?**_(3]E.(K^TE:G_IZ/\Z_7R^D_?#_ '16E2*N94:CL9Z::B-G
M&:MI#&HR$ -,##UI=U8\J.GVC)LBEJ$&G;C2L4IHDHINZG*I;I2+NCA?BZH&
MEVK#@A\UL>"=2%_ID:YSL4"L7XF3Q:S9+9VA\RYC/*BL_P"&=\V@>9;ZJ?)>
M3B,'O6%_?.OEO2N>F44JJ64,.AZ4OEFMSE&T4K+MZU%)<1PC+' H DS16;-X
MBL+?_62XJNWC31UZW%3=#Y7V-JBN>E\?Z)&#FYH;QE8M:?:DE!A_O4<R[E<D
MNQT6TGM36(CY;@5Q>H>)=8N(EETN+SD;H:9I]]XAOI%6\M]B'J<5/,/V;.ND
MU:QAXDN45O0FO/?%_B&Y\23G3K-&"1G(D7O727W@"TU*0223.K=P#6EI'AFU
MT7!C^<^K4FI2T*BX1UW9R.DW-WJ-NME/:LNT;=["KMC\-(H;]+J1PZ@Y*&NV
M(103L4?052N=5BC4[&^:A02W*E6E+8FCTNRA(,=JB'V%6/X=O\/3%8!UZ;L!
M4]MK1=OWIP*KF1CRLU([>&#/E1A,]<5)44-U%<#*-FI:HD9=$_8;K_KF?Y5\
M>_$R]-GH^O7./]7N-?7&L7@L].N"3C<A%?'?Q9S)X/\ $KCNK&O&S!ZP1]AP
M_'W:LO(_.SQ9K!\3:Y+.1@AR/UK7T]?+LT6N6TM?,U28'_GH?YUUZ+M4"N*M
MTB=$=6VR]HL9?5;8CLPK=^([;M2M_P#<JEX3M_-NU;^Z:L?$"02:E%M.<+BN
M8VZ'%ZX<6=7_ (0Z6VI^)+=E&=D@)_.L[Q!_QXUZS^Q[H,&N:O?O,.8N175!
MVI-BIQ<ZJBC[X^&$/^@V8[J@'Z5Z]:Z>]U(H(*KCK7 ?!W2UNH"3_ <"O8)Y
MX-,AS*0JCO7J8./[I,\'.)WQ32Z$D,?DPK'UQ3R-O)X%8S>*["966WEW2@<"
MN;D\1:]+>"/R/]')^][5W.21XL:<I':R:E:0<27"H?<US'B/Q5)&HCM(S*K'
M&Y:K7WAV/5#OED9&/7!JY8Z9'I\81?G _O5FYM['5##I:R*^GZ3"L8GDC#22
M<\CI5/5/#=QJ$VZ&[:!?[JFM[IT% %9G79'/Z;X9NK&;=)>M*/0FMDV<+@>9
M&KGW%3]>M'-,+(B2UAB_U<:I]!4J[CP,FE"GH*\T^+7Q8C^'VG.\3K]H7^$U
MO0H3Q$U3IJ[9C6K0P\'4J.R1Z7Y;^AH\IO0U\G+^U]>,H)V_E2_\->7?^S^5
M>W_J_C_Y3QO[<P7\Q]8>6WI1Y;>E?)__  UY=_[/Y4?\->7?^S^5'^K^/_E#
M^W,%_,?6'EMZ&CRVST-?)_\ PUY=_P"S^5'_  UY=_[/Y4?ZOX_^4/[<P7\Q
M]8&)O0T>6WH:^3_^&O+O_9_*C_AKR[_V?RH_U?Q_\H?VY@OYCZP$;>E'EMGH
M:^3_ /AKR[_V?RH_X:\N_P#9_*C_ %?Q_P#*']N8+^8^L#$WH:/+;TKY/_X:
M\N_]G\J/^&O+O_9_*C_5_'_RA_;F"_F/K 1MZ4>6WH:^3_\ AKR[_P!G\J/^
M&O+O_9_*C_5_'_RA_;F"_F/K#RV]#1Y;>AKY/_X:\N_]G\J/^&O+O_9_*C_5
M_'_RA_;F"_F/K#RV]#1Y;>E?)_\ PUY=_P"S^5'_  UY=_[/Y4?ZOX_^4/[<
MP7\Q]8>4V>AH\MO0U\G_ /#7EW_L_E1_PUY=_P"S^5'^K^/_ )0_MS!?S'UA
MY;>E C;TKY/_ .&O+O\ V?RH_P"&O+O_ &?RH_U?Q_\ *']N8+^8^L/*;/0T
M&-O0U\G_ /#7EW_L_E1_PUY=_P"S^5'^K^/_ )0_MS!?S'UAY3'M0L3=,5\G
M_P##7EW_ +/Y4?\ #7EW_L_E1_J_C_Y0_MS!?S'UAY3 ]*&A;CBOD_\ X:\N
M_P#9_*C_ (:\N_\ 9_*C_5_'_P H?VY@OYCZP\IB.E"Q-TQ7R?\ \->7?^S^
M5'_#7EW_ +/Y4?ZOX_\ E#^W,%_,?6'EMZ&H;_2WU2S>T5S$9!C>.U?*O_#7
MEW_L_E1_PV!>1_,-N1[4?ZOX_P#E!YY@OYCPK]IKXX>+/@S\3+K18S<RV2@_
MO\G%?*'C+XD7?C;5XM0N&9GCD$@+'OFON_\ :BT.Q^+/P/E\46J++KKG[JCF
MOS@:WFT]6AN%V3Q@[EKC]DZ,G":M):&56ISVE%WB]4?1WA/]K#Q%JU]I?AR"
M6?>P6) &/TK],?@):ZG;> X_[6,ANF&[][G-?G#^PM\#8_BAXH@\2>69!IDP
M;IQP:_65MOEQ*JJ@5 N%%<5:R?*CTL&I27/)D97BC&:4YZ4=*YCTA%':C&#2
MXHQF@!"M+SCK1S10 FT2##<BH#I]KNSY*Y^E6*,4 4=0TQKJ(I#)Y.1CY:S-
M-\/WFDW N&O'F _A)KH>32^U G%/<S9O'%U:R>6+-G&<;L5N6'B**XC#7!$!
M/]ZJFU?[BG\*SM2T*+5,;W*?[M4I-'/*A%['5+JEDXRMRA'UJK?>(+2VA;RI
MEEDQ]T&N8M_"\-K'L65R/K26_A."WN&G$K,S=B:KVC,UA]=6<S<07/BS7$9D
M9XXGZ=J];L[6.SMHXXD$8VC(%</:WP\+WOS*-LQZFNZM;B.\A62(Y!&:=.VY
MG6NG;H24445L<P=:YW6+=EN"X'RUT51SP+<1[&Z5+5QIV.0HK9O-%"KF+DU2
M_LJX_NUERLUYD4ZGL[5KJ0 #BKMKHQD/[T8K7MK*.U^[341.5B6%=D2KZ"GT
M45L9",P49)P*YSQEXK30;$I%B2248&.U:^LWMOIMBTUT_EQXX->+W3:EXKU:
M0V2&:*%LK64Y6T1M3AS:LWO OA.YUR\;4[\L-C[E5_2O5@JHH5%VJ!T%<QX/
MN=3-L([Z 0E>!@8KJ*<$DA5)-O4****T,@ILT:31LLB[QCH:=10!PTG@>+6+
MB4N@C&>.*@;X7O9YDANRN/X5KT#CL,45GR(U]I);'D#6^LZ'JC.IEG0=N:Z"
M+XD3VJQQSVI0G@EJ[[:G.8U/X5BZKX1L]8;,GR'KQ4\K6S+]I&7Q(?IWBBRO
MHP7G2-CVS6K'-',,QN''M7GWB#X=I:0M/9R.SJ.!FH-+U;5-/TT1PIONQ_":
M.=QT8>S4]8,]+*D=117$:;XVN;1O^)R! M:R_$#0CR;G%7S(S=.2TL3^,IOL
M^@RR9P!WKSOX3R>=XHN9,Y!%=-XBUR+Q1:M9V;>9 W<5SOPYL'\.^(IOM0V1
M'A2:RD[S1T1BU3=SUMOO&DI?O_..5;D4E=!QA1110!&UO&PY09JJ^EH_H*O4
M4K#NRM#8QQ]5!J=55.%&!3J*!!11M.,T4P"JNJ1^;8NOK5JJ6N72:=ILD\IP
MBTGL-;GGGA2U&G^,)Y6. :]0W;OF[&O+KR&ZN]M_IZ[PQZBNMLO%5O8V<:W[
M^6X'-8PDEHSJJTY.S1TE%<ZWQ!T,=+G-4KKQNMTI&FL)9.PK3F1SJG)]#KR-
MO)X%59M6LH#M>X17_NDUYS>^,/$4-Q''-;[8Y#C-=)_P@\&K>3=W$KI)@' -
M3S\WPENGR_$&J>-+FSGV6]FUQ'_>455NM!O?%D*2_:'LR>2.E=;:64&DV>TJ
MK(/XFIEGK%G?SM#;N#(O515J#DK]">=1V*&A>&1I4)CN7^U9_O<UJPV=M;_Z
MF%8_]T5-1322(;;"?+6-V!]\Q,%^N*_*']HSXE>-_@QXXO9KF\NX[:XF)B#,
M0,9[5^KZ]1Z5\;?\%'_@S=?$[P_9:A8V@9=/0O(Z#T]:TAOJ8U$[:'YSZI\:
M]4UCQ]8^+)Y9)+NUQM9B<U[3HG[=?BR^OK>UL[2XOIV=4*J23BOE&5EMY9HW
MX\E]AKZ^_P"">OP&UKQ!\3$U[5=/W>'&7*3,N036\K6NSEBY-V1^E/PBTV\U
M3X>V6I:A*XGU* %X7_@R*\T\7:+_ ,*[\3Q6<)\R.[;<6';-?0\-K%IL*VMN
M L$7" =*XCXI^$[;4M'GU5O^/JW7*5V9;B?85N27PRTMY]"L51]I3NMT>7>+
M+)K[2P+8[9<@[EZUZ=\*_%2:EI,&EEMT]NN&/>O,_"=Y+>:29)Q\^2,&KGP[
MOK;P;XJN;J^E\M+@X3/2O?Q='VM"=%ZN.J]3R\/4Y*BET>Y[YTI"H;AAD4D<
M@N(4F3E)!N!IU?%'T)SVJ:>RRM)&N0>U9Q5EZC%=D%W<8S69JL=EIZ&2[<(O
M6HY')VCN7S6W.?IZPR.1M4FFV_BWPQ<70MX[L&8G 7-=39Q0^6'B^9>QJI4*
ME/\ B1:$JL9?"[D&EZ?]E7>>2U:%%%&Q+U"BC&:S]<\06'AF%9=1E$,;=#FJ
MC%R?+%78FTE=FAY:S#8XW(W537E/B*#^S?&RBUC\M>N%%=+-\4M$OK:1-+NA
M->8^1?4U3T>SN=0?^T-2CV7?9?:LZ\)TVHS33.K#6G>2=T:>D^+)Y93;S0%
MO\9K4O->2WC+1@2''051FB69<%0OTJO#IR0MG)/UK+G9T/#Q;*__  GEV\_E
M?8F _O8J+5+6ZU^+"S-;D^E:^U?[@_*C\,5/,V:1I0CT,;2O#\^FY\VZ:<'U
M-:7V&V<9>%6/TJ?FCFD:V(HK6*(_NT"?05)SZTO-&#0 C ^M&WY:7FE52W H
M :JT@7FJ6J:]8Z&NZ\E$8K N_B-IDG_'C.)/6NFGAJU;6$6UWZ&$Z]*G\4CK
M66C;\M<YHOCK3=2N%M&F'VQNB5TK*5X-9U*52C+EJ*S+IU(55S0=QJK2!>>M
M.YHYK(T&LO-*5X%+S1S0 @7BA5YI>:.: &E>:5EI>:.: $V_+2./+MIY1RT:
M%@/7 IW-"]QV/!H ^+OB5_P4-U'X8^(KK3M0\,,D,4A1'<$!P#7RAXY_:MC\
M5?'32?B/!I2VPL,'[.H^]BOJ;_@HA\"M0\8Z;9ZKH5B)([53)<-&O2OS6'$D
MD7\4;;&'N*]"G&+5T>%B*E2,N5O0^][G_@J]<75S D?AS!D98^E?<_PWU^3Q
MEX-TW7Y$,1OHA)Y?ID5^/G[*/PUM?B]\5$T6X7*QD/P/2OV7\+Z&OA;PU8Z/
M&,):H(Q^%85HQCHCLPDZE1.4GH7]OS4K+S2X-'-<QZ(A7B@+P:7FCF@!JKS0
M5YZT[FCF@!&6@+\M+S1S0 BK2;>:=S1S0 C+1M^6EYHYH 15I-O-.YHP: $9
M:"O%+S1S0 BK2*O-.YHYH :R\TK+2\T<T (%XH5?>EYHYH 3G/6DD0.,-R*=
M@T<T 0?V?:_>\A=WKBHKK3VN(]D3^5_NU<YHYH Q;30;BWEW/=-(N>A-7-1T
M:WU"V,)10Q_BQ5[FCFD!E^&_$#:=='2YX_*MX^DK=#7817UM<?ZJ97^AKF=2
MTV/5(1&_R8_B7K5.'3'T6%FM&:1\<9K2,FM&<E2AS.\3N-I]**X?2/$VLM-B
M]AV1 XS[5T*^+-,,GEF;]YZ5JI)G)*G*/0UZ:R*_WES1"ZW"!T.5/2G=*HS*
M\EE')T4"FQ:?'&<D U:HHL.[&K$B_=4"G444Q!4-Y>)86LD[G&P9QZU-_"3V
M R:\R\=>*Q?7D5A9-O+'8^*B4N5%PCS.QC:M>7GQ \1)#%NBM<[6QTKT_0_#
M-MH-BENB*9%_Y: <U2\&>&TT6QRZ?O&^;)KI*F,>KW+J3^S'9"#@8I:*@NKI
M;>,DGYNU:&),2%Z\4WSHQU<5STVL2R9&.*JO<._4U',7RG6+(C?=;-.KE8=0
ME@Z'-:VGZK]HPKG#4U(3B:E&2*2EJR2*:U@N.9HED_WA61KGAD:I:B&UD^R8
M[KQ6Y12:3&FT<!>F_P# *QE2]_OZ]\5;L?B!<7;+OLRB=VQTK=\2ZI::7:DW
M94;AQNKB-'NKO7+ORK2(/8LV'<#I6,KQ=D=4%&4;R.[M_$FGS*/,ND1O[I-/
M.N6;,%CG5S[&N?N/A9I\\AE^T2!L9QFL#POX/O+76;P3[_LZ<Q$]ZKFELT9<
ML'=IGIZ_,H(Y!I=I]*\\OM7\56KLEM:[HU. <5-IOB;7@P^WP>6._%/G0O9O
M>YWE*IVL#7-CQQIMN,7,VUN],O/'6EW%E*MG/OGQ\H]Z?,B>278Y'Q9:B^\?
M6Y'(KTS3X?L]HD8[5YMIXF$QU74QY90\'VKT?2;R/4[%)X6W(W0U%/=LVJQ<
M4D6J/I1BBMCF/"?VSOA$GQ<^$<VF6L %Z/G\U%^;BOQ>\1:&_A#7+O19CF6S
M)5L]>*_H97:T4RNH<,A7#5^/O[<7P$F^'OQ%_M9X&C77+G;'@<')K:G+H<U6
M/4Y[]C7X)W/Q(^(FEZZL;2V5G,/,7&5Z]Z_9:WT6ST^&&*V@6&)4 V*,"OF[
M]@GX*7/PA^'TC:A:^6]^@E1G'.",U].5$WS,TIKE0Q88UZ( :?114&H4444
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M0 E%+@T;30 E)3MIHVF@!M+2[31M- "44NTT8- "=\T&EVFC!H 2BEVFC::
M&TM+M-&TT )12[31M- "44N#1M- "4#[RTN#0!\PH&=7H/\ J34/C+_D!25-
MH/\ J3]*A\9?\@*2O6C_  SYK_F)7J<'\-_^0U+^->DM]XUYM\-_^0U+^->D
MM]XUA#8]3&?Q0HHHK0X@HHHH **** "BBB@#E_B!_P @Q*K?"7_5W7UJS\0/
M^08E5OA+_J[KZU$?XAV2_P!RD=]1117:> %%%% !1110 4444 %%%% !1110
M C?=-<GKI_TH5UC?=-<IKG_'U7+B?@/1P/\ $,VEHHKS#WKB44M% 7$I:**
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M+10%Q**6B@+B44M% 7$HI:* N)0/O+2T+]X4!<ZK0O\ 4FH/&7_("DJ?0_\
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MD8J]ILC;_P#9K:*..<C79\5&S9J-VQR:B:2MU$XY3)MW7Z5YIXNUA]2U*.U
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M*7M,0Y'Z#2I^PR^,.^IYEX?B!M=_>M3K6?H VV-:"_ZQ![URU/B9A'8[KP/
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MVC;3J* &[:-M.I* $VT;:=10 W;1MIU)0 FVC;3J* &[:-M.HH ;MHVTM+0
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M/>9A_M<UIELTE9G2HJ.P@C1?NJ%^E&VEHH*$VT;:6B@!-M&VEHH 3;1MI:*
M$VT;:6B@!-M&VEHH 3;1MI:* $VT;:6B@!-M&VEHH 3;1MI:* $VT;:6B@!-
MM&VEHH 3;1MI:* $VT;:6B@!-M&VEHH 3;1MI:* $VTH'S"B@?>6@#J=#XA-
M5_&7_("DJQHG^I-5_&7_ " I*]:/\,^=_P"8E>IP?PW_ .0U+^->DM]XUYM\
M-_\ D-2_C7I+?>-80V/4QG\4****T.(**** "BBB@ HHHH Y?X@?\@Q*K?"7
M_5W7UJS\0/\ D&)5;X2_ZNZ^M1'^(=DO]RD=]1117:> %%%% !1110 4444
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M_6AN\::D.QG;^=>#2^*;/M\7I2I+R-O2T\NVQ5Q?]='_ +U1PIY<8'M4D?\
MKXO]X5S/5W./H>DZM)]GT.$?WDKS;_EHWUKOO&$WV?1K(?WD%<"/O&I*9RFM
M-_Q,0O\ M5]B?LNV:PV>X#!9*^.=:_Y"B_[P_G7VS^S1;E-/MCC[RBNNI_#1
MM@_XK9]F?"^V^S:7*/4UV+5@^"[?[/IP&,9%;]>O15J:1\WBI<U>4A*%I:*V
M.43^*AJ6BBP"=J%I:* $_BH:EHH =&/F%?(7[77^M/\ UT6OKZ+[XKY!_:\_
MUI_ZZ"OH^'_]_B>!G?\ N<CTZ\_Y-HC_ .O _P#H)K\+M1U"_P!*^(5[=Z6T
MB7\5[(T+1 E@VX]*_=&\_P"39X_^O _^@FOQK^"T<%Q^T]HT=Q$L\+:PP:-Q
MD,-QXK;'?QY>K/(PW\->B+&K_M#_ !HM[,&_UO6;:W"[=TB.HQ]377?LJ_LV
MZS^U1\0!<R:N'NHI5N)FD.6;!SS^5?IK^WM\&],\3?L]SIX?\/VJ:F85*_9X
M@&Z>PK\NOV3?C]K/[*?Q8>5[)C+<.MM-"_\ #DXS^M<CCRR7-L="?,O=/U&_
M:HT3_A%O@*^B'F2QL3"S#OA<5^:7[ -E!J/[15A;W48E@:4Y4]^37Z6_M5:X
MOBGX"R:YT>^L3,R^F5S7YK?\$]W4?M):;D_\M?ZFM:G\2)G#X6>\?\%0/!>@
M:"#<Z=81VUPTB@NHP371_P#!*?X=^&?$WGW>K:7%=W4 5XG=<[3ZTW_@JQI-
MY!I*7<D++;-*NV3'!Z52_P""4OQ<\)>%9[K3]>U>'3[R;$<$<C8WMTQ2>E1C
MUY#SW_@KH GQPTR->$2U(4>@XKV[]GSQG<> ?V(;/4K5V25DVY7KTKQ'_@KH
MPD^.&ER*<QR6I9&]1QS7OO[+O@I_B)^Q=9Z9$ID81EL 9[41O[1@_@1^:%UX
MKM4^+EUKNIVIOH6NS-)$>=W(S7UQ\0OVTO@QXL^$MQX:T[X:+;:Y);^4EX(A
MD-C&:^3/$6GP^%_C+>Z;>;5MH[X03%Q]U21DU]^7GP/_ &?['X=P:S#XPL'U
M46XD-OE<[L=*RA?6Q<K:7/G'_@FF+FW_ &G-+7RW6/R7W@@C'I7)_M>:A<:U
M^U5KMK>RM/;+J:1K&QX"E@"*^S?V)]/^'\GQ42[TO5+>350C*L*$9-?'?[9'
MA?5_"O[2VLZMJ=E+;6,VHK+',R_*P# G^55*-J:!.\C]7_!O[+GPVU/X)Z3#
M#X:MH[^]L5_?>6,[BO6OFOP__P $O_$'A?XN6WBS2M5CM+*&3S5A7@BO;OAW
M^V7\/K/X%VL\NOVJ:IIUDHBM]XR[!>E?/OP]_P""H?BKX@?%"U\-6FC+);7,
MIBC93DMCOBMY<FES%<^ID_\ !2;3KG1OAO8V=Y+Y]PDJAI/7I6C_ ,$D]%L-
M;TGQ!!?VZW$++@JP[5G_ /!2F^N=3^'-C<WT1@NGE4M&>V<5M_\ !'_Y[+7E
M7EL8Q4?\O2OL'S=_P4?\)Z+X4^.$%MHUDEG;NFYD08!.17Z,?L"_#_PUI_[/
M\&N6NF11:P]LV^Y"_,?E]:_/O_@J-')9_'BW$B[7$)8 _45][_\ !/OXK^$M
M8_9_M_#]OK$+Z^ELQ>RW?../2E'^([#E\"/RB^*3%OVJ=5).2=<7_P!"%?J)
M^TQ_R; W_8.7_P!!%?EU\4OE_:HU7/;7%S_WT*_43]IH@?LOM_V#E_\ 011#
M:0Y]#\\_^"=_A#1?&G[0EA8:[9)?6)3)BD&0>:^KO^"LWPF\&_#_ , Z%/X<
MT6#3)Y)U#M"N,C(KYF_X)FG_ (R2T_\ W/ZU]A?\%E/^2>>'Q_T\+_,5$?X?
M]>02?OHX'_@E#\OP\\<D<%LY_*OD#]L[_DL%U_NG^=?7_P#P2C/_ !;OQQ^/
M\J^/_P!LX@_&"ZQ_=/\ .B7\-#C\;/JO]HG_ )1S^!/JG]*\D_X)V_#GP]X\
M\47HUW3H[](G&T.N<=*]:_:)8?\ #N?P)SW3^E?/O[#/QLTWX3^-A'JEQ';6
MUW*H>20XP.*IVYU<%?E=C]#/VV?V<_A[HW[.>LZWI?AVWM;Z"'Y)E0 CBOB;
M_@E7J4\?[02VGF'R&AW;,\9R:^F_V\/VR/">H?"FZ\(>'=3@U.*]@^:2-LD$
MCI7SE_P2M\*ZE_PO!-::U==/\G8)B."<FF[>T5B8WY'<_86^_P"/N7ZUP/QV
M_P"21:W_ -<S7>WQ#74I'3-<%\=O^21:W_US->KA_P"-#U1Q5?X<O0\G_9%_
MY%>/_?-?2K?>-?-?[(?_ "+$?^^:^E7^\:\3.O\ ?ZGJ?393_N<!BT?Q4M%>
M&>P(U':EHH$(M'\5+10,1J.U+10 BT#[U+1180AZB@]*6B@8BT@IU% "-UH/
M2EHH 04BTZB@!I^]2M2T46 3M0M+10 WO2M2T4 )GCBE#'IFBB@1#<1"XMY(
MCU88K"M(9_",,DV3)'G)1>]='2,JR<.H<>AHV!I25F-T3Q=%K2!FB, /][BM
MM9HI/N2JQ]C7-7VDQWD>R/\ <?[O%4(=-G\/AY8I&N&QG:35J;ZG+*C_ "G;
MT5R&D>+KZY8BZMO)13C<1700:_I]Q((DN%,O]W-:*29SRA*.Y?J)K6%^60$U
M*OS#(Y%%400_8H/^>8IZ0QQ_<7%/HI %%%%, KSCXK:DTS6EK:S ,YVG!KT&
M\O(;&W>2=PBXZFO'M-TH^)O%$TJ2M+'')N'/O651Z61O22OS/H>A> _#DGAS
M32LK[VE&ZNEIL:[(8T_NKBG5HE96,9-R=V%9NKWIMEV#JU:58OB"%I&5E&0!
M2EL..YCLQ=LL<FDHHK$V"A6:,[E.#12&@#J-+N#+;+N.6JY6;H\1$*M6E6RV
M,'N17"-)"RH=K'O7 ?$":XL='82LS+7HE<=\657_ (15CCG/6IGLS2G\21R7
MP3?S-4NF]17KS?>->/? W_C_ +CZ5["WWC4TOA*K?&PJ"\N1:Q%CWJ>L_6H6
MFMQMYQ6KV,5N8$\S3R,6.1GBHZ.AQWHK V"CIR.M%% S;T>^.WRW.XUL5SFD
M1,\P8#*BNCK6.QC+<*S/%&C'Q#H%UIZ';),NT-Z5ITJMM8&M8R<)*4=T0TI*
MS/FZSLV\#ZH?#]PV^3.?,[5?US2UU2  _,8^5-=5\8O ^ZWDUVV)>['\(KBO
M#>M+>6R02MBX4?,O>OMJ-?ZS!8B#]Y;^O<^=JTO8RY'MT.@^&OQ%FT:Z_LW4
MBT@=ML;-T45[6K+(BNC!U(SD5\]:SHZW8^T1?)+'RNWO75_#/X@2K,FD7G$C
M' W=:\W'X-5D\116O5'9A<0XOV<WZ'K=-\M?2G'';D45\P>N XZ44NT]<51N
MM:L;$D3W"QMZ$T!N7:3S(U8!Y%3ZFN8UCQ9<6P5K&'[0K=Q7-^*M0GN?#]SJ
M$KM;3Q+E4SC-$;U)*$=V:<C2<I:)&3\4_&=OK%\_AE4WGKO'2L?3[7^S]/2'
MM&*Y[PO:G5F_M:=B9LXYK1\3:V^DQQ)&NXSG8?;-?=TZ'LXQPT%JM_7J?+U*
MGM).H_EZ%.3S_$FO6L5OEK56Q*HZ&O<-)TNVT6S2WM8A%'C)4>M<S\-_"$?A
MVQ:X?]Z]R-^6'3-=C7S&:8M5YJE3^&/XGTN PWL8<\_B8WIDUY1\7I)M1U*Q
M2&38BMAE]:]9]J\T^*'A^[:>">RC:8J<D+6>4RC#%Q<GW+S",I8=J)2M8UM8
MT6)=HQSBL33KI?!_BEM7E3>DAVU5;5O$JD*-*<@<?=JWOB\06PM;DB*]7DQ=
MQ7U_L])*;3C+1V=]#Y52E"2DE9K8]IT^_BU2SBNHF!$@SM':K#=:\9\%^,+G
MPUJ#6=Z"L).U"]>QV]Q'>0I)$V]6&>*^(QN#E@YV?PO9GU^%Q4<1"ZWZD@Y4
M_2O(?&\W]MZE]GZ^4]>P)T;Z5X/8WS7/C?4XFY"L<5Z&34[U)U%]E7.+-)VI
MQAW9)?MG4K*S/1\+BO7_  _IHTG3UA P",UXIK+NOCC2@HRN\9KZ ;[J?[HK
MHSEN,*4>C5S#*4KSEV&-TH'2EHKY<^@&K1_%3J*+#$:L_P 1:LNA:+/?$9\L
M9VUH\#D\#O7E7Q,\52'6H=(@7S+:88=AVKNP.&>*KJ"VW?H<F*KK#TG)F!8'
M_A(M6;70-F[C:>M;DV)(W5N PQ5-5@\/:>%=@D?8UGVTFL:U(Y2S86Z\I(!]
MZOMY)2U3M%:(^.7-)]VQ;&2Y\&7!N;<L8,[GC7O7:^&OB_:^)+Y;1K5K7/&]
M^!7 37GB"WF$;:4TD70DK4LTEE>1?9Y76QNSV7@UGB,'1Q2YJBO+NGMZHZ*.
M*K89V6W9GNL<T,W$4JRG_9.:4<&O#=+US4O TZ2P![Z)SABQS@>M>Q:#X@M/
M$5FDMM*LDF,R*I^Z:^2QF7U,):2?-'O_ )]CZ3"XR&)TVEV-%NM!Z4M%>6>@
M(*1:=10 T_>I6I:*+ )VH6EHIV(<DAO\5*U+06JN4R=0.E(O)HW4W=BJY3-S
M'9[4$TWS!WI=XI\HN<5NE*#Q[TSS*56I<H^<6BEW"DW9-3REJHP:CM2\45/*
M:J:$6D[TZBE8TN(U'\-+10 BTG>G446 1NM!^[2T4 (M(M.HH :>M*W2EHH
M0=*1:=10 W^*E:EHH 3M0M+10 WO2M2T46 3^&A:6B@!HI6ZTM% "'I0*6B@
M0U:#]ZG446&(>:.U+10(0<<4=.:6BBPQ#1U%+10(0>E )6EHHL,@N+*"[_U\
M8D^M9FHZ'/)"$T^3[-SVK:HHL(Q5UFY\+PK]IW71([5MZ'XHBUJ,NR?9\?WN
M*:T<<G^L0/\ 450U'1TOHRD;>0#_ '>*I2:,94HRV.H6:*3[DBO]#3ZX:.SN
M/#5OYD#M<N.Q.:OZ/XLN[IB+N#R$'<BK4UU.:5*43JJ*H6^O:?=-MCN59^F
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MK_\ !.$X^)5_\BO^['##-147-428X_#H>>^/_A-\5_AS$;O[7JT]DJ[GF1V
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MJ7\./H@HHHK(U  L<#DUA:]\1/"?A&7RM>UNWTV7^[*X%=%:?\?,?UK\HO\
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MLFD07+6Z87</2E2J.=[CG'E$HJ2:W>'[V/P.:CKH,PHHHH *XCX[?\DBUO\
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M4 )S0,TM% &-XJT6/6M)G\Q!))&A*9'>O&?#2R6_VFTU'*,SD(C]Q7T I&X
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M/^08E5OA+_J[KZU$?XAV2_W*1WU%%%=IX 4444 %%%% !1110 4444 %%%%
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MPKYK&9E[2/LL/I'OU?\ D>YAL"J;YZFK_(:3T'8<"DIVVC;7@'K"44NVC;0
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M#Q-:RV_B*%HOW=O_ !>E>S@Y\RE2?77[CSD^29>HI=P;E3N'J*2N@ZPHHHH
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M5EO_ ,>5M_N#^5.I+?\ X\;?_<'\J6OI#X1[L*.:**+ '.?:BBBBP!11118
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M6QFF&$BC0=T1\T4NT^E&#Z4QB4<T446 .:***+ %'-%%%@#O11118 HHHHL
M<T<T44 %%%%%@#FCFBBBP!11118 YHYHI>%Y8X'J: $;Y5)/ '-<;KWBB:[F
M-KIARRG$E-\4:]+J$YTZR8I(#S(.E1:=IR648)'[\_?;UKTJ&'27/,^2S#,I
M3DZ&'>G5_HB&RTA(V$LF?-ZFM+FBBO0/GXQ4=@.>U%%%(H*3FEHH 3FEHHH
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MZ.N:\/.(/ZQ[6VDDK?(][+I+V/)U0O.?:@Y[445X5CU0HHI?E'+L$7^\>E
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MVVC;0 VBG;:-M #:*=MHVT -HIVVC;0 U>::PQ4FVDVY!JD93(2.]0N.:L'
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M+X1N[AIW0!R<]*[+PI\/='\&A196\3[>FY17&\NQ%9*%:I[J-%6A'6*U//O
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M2;52*1\:_LD>,KCPOXN:VBROVB15;'X"OTUC@ADAMIVB4S,@._O7Y3_L]_\
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M$/"NI2([7-P8&YSN/2NOEPM*"]YI>A9[#X$^+_@&*S\R3Q+:P'/^K\P"NO\
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MCVI5H_BH 3%&*5J.U "8HQ2K1_%0 G2C;2M2F@!N**4=*!U- "48I3U%!Z4
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M#[7_ +]BC_ABWPE_T#[7_OV*CW#;EJ=S@?\ AZ-X _Z M[_WP?\ "C_AZ/X
M_P"@+>_]\'_"N^_X8M\)?] ^U_[]B@?L6^$O^@?:_P#?L4O<#EJ=S@?^'H_@
M#_H"WO\ WP?\*/\ AZ/X _Z M[_WP?\ "N^_X8M\)9_Y!]K_ -^Q0?V+?"7_
M $#[7_OV*?N!RU.YP/\ P]'\ ?\ 0%O?^^#_ (4?\/1_ '_0%O?^^#_A7??\
M,6^$O^@?:_\ ?L4?\,6^$O\ H'VO_?L4>X'+4[G _P##T?P!_P! 6]_[X/\
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M>_\ ?!_PKO\ _ABWPE_T#[7_ +]BD_X8M\)?] ^U_P"_8H]P.6IW.!_X>C^
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MAEW*102<;??+J$'_ %T'\Z_2CX2_\B?X<_W%K\V=47;JD(_Z:#^=?I)\*/\
MD3/#I_V%KIK?#%G7@=ZGH?0TBLVMZ81TVBO27[?2N"T^,375E*>BJ*[O<)%!
M'3%>Y0^$_/\ 9M!12[: M=("44;>?>E*T )12[: M "448YI2M "44NV@+0
ME%&VC;0 44I6C;0 E*!N.!UH"TY=BG+31H?]HXH"YQ'B[XS^$?A\Q_X2#45L
MU!QEJ/"'QM\%>/V(T+5([LCKAJ^9?^"GGA'2[?X/Q:K;R1F]:7DQOR:_-?X?
M_%WQ3\.85?0KQX69><M6T:?,CDE6Y9>1^_4,+7"AX\%?K2M;NG4?K7XH6?[=
M/Q?T]0JZNQ0=@:^O_P!DG]HCQU\7M2@LK^>5W;DLPXI.FUJ7&NI.Q[]^U1\3
M+[X<>';86*Y^V?NVKX^M]*N=4BFU#R]V\EV/UYK["_:@^&>H>//"MJ(,-+9C
M?)^%?'UGKESI\,]@K; AV,I]N*_5N$_9_5)>R^.^I_/OB1[7ZY2]O?V=G:W<
MI8 R" >U<MJ%B]CKUA<P2- QG4YC..XKJ<YR2?>N7U'4!=Z_IMO$K2L+A 0@
MS_$*^YK6Y'<_)<LY_K,?9GU]\6O"\'CK1_"=_=2LDMG A&#UP*Y/6/%%GI-O
MM:0"9%P!FK?[4VN7_A#P]X.32]T:RVZ>9Q[5X9J&@Z]XZT\M83#[4>AS7YAE
ME'FI.I)VC=V^\_L.=U&">]E^0NI:IK/Q.\1_V/X:B:]N]^)8U&<+W-?;_P"S
M[\"=/^#>B+=0NYU*]0-<QM_"W<5YO^R+!X*T*\&FQ6OE^.(TQ=7#C@_C7U),
M TC'S%=L\[37S^;X^I5E]72Y8K\3T<-2C%<U[LCSS11MI2M?-'H&!XY\-IXH
M\-7]N799C$PCVGJ<5^?.@_LC^+]>^(C6^K6<W]CS3G?,PSA<U^DZ1EB*76->
M@\-Z//J-UM^SPKN8 <UZ&%Q]3"*4:?4QJ6M=GE\/@[1?@[X!7P[X?2.>[49#
M,!OS7FT/C34]%>Y_X3&$:?ILRE8YB.N:ZG0UU/X@_$ ^)K)BOAWIY;]>*XS]
MH3XY> =/DCTCQ5;/)!&^U<#%?*<1<.TN(\*J6(DU).Z?F>7A<WJ4,0Y05X[&
M MUX2A\)^(-/\+WWVR^U%6VQ^K&O7?V/?">K>#/AA-9ZU ;:Z>4L%;T-<O\
M!C2?AGXH:WU#PYI\D#KA@T@XKKKKX@7]O\8K/0%8FS91PHXKBX?X7AD-*I)U
M'.I/5M^78Z,1G'UJM&/+RQV/9J*?*NU\4ROI#L"BBB@ HHHH **** "BBB@
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MMYH9:X#Z02BEVX%"K0 F:*-O-*RB@!**7;\M"K0 F:*4+0RC- "44I7B@+0
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MG+)CBO3?XC7(_#NR":(DC##5UPZUB>AA8\M-%;6/^03<#_9KL?@RFSPPP/\
M>KBM4F#,MMGF3BO3?A]I9TS1O*(QDYH9[. C?$<RZ(ZZ 5H0\52A7I6A#'TK
M6)]A3+4(XJW#CO5:-=N*M(/RKHB>A G7'%3KBHD7I4RJ*U1VQ'4B_>IVV@#D
M51T&OI_^KJAXR_Y 4E7[#_5U0\9?\@*2N]? >7'_ 'A>IP?PW_Y#4OXUZ2WW
MC7FWPW_Y#4OXUZ2WWC7-#8];&?Q0HHHK0X@HHHH **** "BBB@#E_B!_R#$J
MM\)?]7=?6K/Q _Y!B56^$O\ J[KZU$?XAV2_W*1WU%%%=IX 4444 %%%% !1
M110 4444 %%%% "-]TUD:@,RBM=ONFLF_P#]8*PK?"=>'^(J[?>C;[TM%<1Z
M5Q-OO1MI:* N)M]Z-OO2T4!<3;[T;:6B@6C(V6F;:GINVM$SGE$K^7SFHGCJ
MV4R:8P[5HF<\HE)HS3&C_&KK)DTQH_:M%(YI0*!AIC0U>,>:88ZOF,'3*7DF
MD6,[ASWJX8STQ0L?S#CO5<QE[(_.G_@K='\F@[N?EKU3_@F#'_Q9&\QP-]>8
M_P#!79=L>@?[M>K_ /!+M=WP/O/]^B^MS7D_=\I]6>232^3[5;V'IBG>7[4N
M8R5(K)%ZT\1XJPL=/\OTI<QLJ9 (C4RQU)LXZ4]8ZS;-XP&HE/5.:<H)XQ3U
M7%9MG3&(T(:>JTN">U.K-LZ8Q$VT;?>EHJ#<3;[T;:6B@+B;?>C;[TM% 7$V
M^]&WWI:* N)MHV^]+10%Q-OO1M]Z6B@+B;:-OO2T4!<3;[T;?>EHH"XFVD*T
MZC;FFF1)7(BM1LM3LM1LO/%:IG+)%9XZ@:/%7&4U$T9K5,Y)Q*,D=5VCK0:/
MVJ&1./>MDSAG Q]0TV&_C*3('XXSVKB=3\'W6G[KR&8^6G/EKWKT=XSZ57DB
MSP1D>AKMHXB5+;8X91<7='FFGZ^UP^R:$PCIN88K66:*3_5R*_T-;6N>&(-9
MMC%@0Y_B7BN7F\*S^'(]UH6N&]#S7IQJ4JOPZ/L:1K6TD:'-%9%G>:HQ8W-L
M8U'?%6#KEE#Q+,%;TJG3DG9:^AT*<9;,OT5336K&3[LP-3+>02?=?-3RR6Z+
MNB:BH6O(8_O/BH7UJRC^],!0HR>R"Z+E'-45URQFXCF#-Z5!=7>IKS;6YD7U
MQ5*G*]GIZD.<8[LTVECC_P!8X3ZUF:AK1MF1(8C-YAV[EYQ5BV\,W'B.#_2]
MUNW4XJUX:UKPPE_)I5K?1W5]!\KQDY(-3*=.GOJ^W_!.:6(Z1/&/B9\6+SX9
M_$'0M%N=-EN].U%AYMWM.R$'U-?1VCMI=W8Q2:-<Q7=LR@EH"" ?3BJ7C/X?
M:=\0?#-WH=]!'']L0H+O WQY[@U\R:3_ ,)9^RAK'_"-V,,VJ^%=^]M2GRV,
M]LUQU*KQ"M?5=#E?,I7GJCZZCAQUJPL=<M\-_B/H?Q(LT&FWB7&H;<R0J>E=
MCY3(Q5AAAP:\V5T[,]&G%-70B1U82.DCCJ95K!L[X1'0Y1@0<,#P:^3_ -L;
MX#:EXXN/^$KAD:X:S3B%1DFOK((:D\N.1=DL2RH>JL,BM<-BIX2JJM/="Q6#
MIXZBZ%79GX[VMYJ6B76^!GTN_5L,O1L5Z4]SIOQ8T>*S'EZ;J5JN9;E^#*:^
MF/VCOV2;/7I;GQ5HBL=2;G[+&./RKX>U[P[K?AW5S%J,4FG^2W&,C=7WU/%4
M<R@I4G:HOZ^9^8UL#7RFI*%9<U%[^GZ,L:QX=O-%OUF@W":$_)< =,=\U]"?
M ']J*]\*S0:=K$SWH!P9'.17F'A_Q1::^D5CJ>R" @*TIZX]:S/&W@.70)#?
MZ2&GT4<_:QTS6E2G3Q<?JV,5I=_Z_(RHU:N!G];P$KPZK_@?J?J5X7\4:?XP
MTJ&^L;B.5I%R8T8$K6KM/?K7YD_ OXX>*/ .M1MHL4FJPR$+*K9(1>YK] O"
MOQD\+>)K2S0:E'_:DRCS+<-RK=Q7P.8X"67U.23T>Q^J9/F2S:BZE.+O'?33
M[SM-OO1M]ZDDA>+&X8SR*97E'MW0FWWHV^]+10%PQ\KY/\->56,,L.J:PS_=
M(.*]'UN\_L^S\PG&>*Y&]DBBL;B?@&137+7>@XZR27<^9/B].R>!]>D)^Z&K
M\YFD.H:@[?[9K]#/C5<"/P#KR_W@U?GEX?7??N#_ 'S7B4=(R9^@8[XH)=CJ
MK5?+MU6I*-NWB@]*YCD.A\#K_P 3N(UUWQ._Y!"?6L#P):EKI):W_B=_R!T^
MM!70\O7[HIRTU?NBG+2).1UH?\3B'_KH/YU^C'PCOH[CP;H**P)1%S7YT:T/
M^)HI_P!L5]M_LZ:F]UHD*%LB-!BNJK\$6=."E^\E'N?9]K?+#HGVA3DHM=7X
M0OCJFC+.?7%>:^"Y6U3P[=1GGM7H_@FW%EH:P]\UZ^&E='Q&)I^QK2@^C-S;
M[T;?>EP:*[CGN)M]Z-OO2T4!<3;[TJQLWW033E4LP%>(?'+]HY/A#J/V" )+
M>LN5B;J:VHT9UYJG35VSFQ&(IX6FZM5V2/7KOQ#HNG2&*\U2WMIAU220 BI;
M'5M.UC/]G7T5Z5Z^4P;'Y5^7WQ(\4:O\4M>FUBXOKBQDE.3%&Y %=+\$_C%K
M7P-NI3#))JD-QQ(9F+;17TLN'<5&GS+?L?&PXNP<JW*[J/<_24J1P>*-OO7F
M_P (_C=I'Q,L0?M48O3_ ,LE/>O3WLY8URRX%?+SA*G)QDK,^UIUJ=6*G!W3
M(5C9ON@GZ4-&8U+291!U8CI7@/[8W[1&K_LY^&]/U#1K-;R>Y;:589KY77]N
MCXV?$+2Y;72?!YE29<;XXSGFA0;02JI.Q^B-UXQ\,V+%+K7;.!Q_#)*H-<#\
M0OVC_"/@.Q>X35[.]*C.U)5-?F;-\$_C9\5O%BW.LV>I:9#(<ML+ "OHGP7_
M ,$RK7Q#ID4VN^);])6&6C>0G^M7RI;LS]I.6R-+6/\ @J?IT%U-9:?X;DOI
M =JM$,YKQ7XG?M?_ !&^(LK#1?#VJ::K_=98V%?6'PW_ .">/@[X;ZC'>)=?
M;V1MV)@#FOI.S\*:!8VZ1)HEEA1C/DK_ (4<T5LA*,Y+5GY(:;\$_BO\;M/D
M_P"$AU:^-BB&007&[ _.OFOQ%I+>&_$5YHG^LN+9S&%[L17]!EQI5A_9=]%!
M8PPLT#!0B <X-?F;\'OV(=6^(W[07B+7O%UG+IMA:7IFM=RX64;LU<9[W,IT
M]DCR#]F?]DG7OBYJUM?:A:S:?:AAE)D(##UK]7OA+\%="^$_AV.TL[*%;Z%,
MFX1>3Q79:;H^GZ-86UK9V4-NL*! 8T S@8S4UU>)96TLDS;5*D9-92DY'1"F
MH(^9/$'[523^-+SPN+%I-LGDO(.G7&:I>//V8[+Q+''K6E:U;P22+YC6ZD9)
M/.*YB[\$V>E>/M:U2,B5KIR<D=,U:T>SN=%U:._6^FE$;;A"S';]*^VH4:N$
M4:N#ERRMKYGS^887"YI!T,;#FC^*.#M?@#K6L:]_9+2O:(>/M## KK/#/P>T
M+]F#5)_$FOW]OXI:092UR&,9^E>H:I\5KC5;<Q"RCA?;M\Q1@U\W_$SPO+87
MDFKR:A-<><<F&1B57\*]!U\PS!JE7ERQ>]NIXV7\/95E,O:8>%Y>9[5:_%+P
M]^U):W.F7%I'H[0_NX))L#;Z8KR#7_!NL? GQ(MO:&77;)CN^T0 LHSVR*QO
M WAF+Q):7$MG=-;2Q_\ /$XKO_!/Q<UGPG>KX3UC2TN=%E.'U&X7++^)K"6'
MJX%OZL^:'6/^1].JD:RM4T?<T?"NO6$S-J=BT=CJ\RX?!PXK7\%_&;6?A#XH
MCM=8\[7(=6E"H_)$63UK+\=?!_2I(_\ A(O &H-K&KR?,]E&V0H^E<YH/C1[
M.86GBZW2QNXSMC$@YW>U3RX?'P>FO;JB??H/R/NNWU;3[J.W*7D1FG0.(@PS
MSVQ5WR6SAN#7Q-K&LZIX?4>*=%GEO;RU&8K;<2&_"OI#X2_&JV\6>!;75/$[
MQZ7JTGRO;GC%?)8S+ZN%7,M4>A3Q"FO,]/4",98[5'5C7C?Q.\5/=>--/TFR
M_P!/T^8A9Q%\RCZXKU#7M4M(]%/FS>7!>ILCDSZBN,\!^ [7P*+F19#?M<.9
M \O)7/I7!AX<SNSS<QK2C%4X=3.^(7C73OA#X/,NEQ+<3@?\@^'EORKXM_:2
MOX_VB(?#D>EZ*UI?Q7*O<J$^;&1G-?37QJ\*CP3<2>/X)6O;G[OV&3E/RK+_
M &=?#-S>:U?>+=2TU(X[I#((V7Y5^E>@SR(6@N9'I_A_0M&\"_#'34L[:*TU
M&.T4&-1AG8+63I'BW1-"T*3Q+K"11:S"V%AEP)"/QJOX@OHO$4EQXC6;;#HS
M%FB4_+@>M?&_QF^(C?%7QO\ VS9W+06\/[LP0G"''M54Z,L5/V4=NI]'D&55
M,QK\VR/T=\&^/-'\=:5#=65]#)=.,M;(P++^%="T;+]X$?6ORE^%OCK6?@GX
MLN?$>GW,U^\PQ]E=B5'X5]=?L[_MF6_Q%U"XL?&[PZ)=NVVTC;CS#6&*R^IA
MW=:H^GS#*:^!=[7CW/I[;1MJ;R'\L2 91AD'VJ.O+/#N-VT;:=10 W;1MIU%
M #=M&VG44 -VT;:=10 W;1MIU% #=M&VG44 -VT;:=10 W;1MIU% #=M&VG4
M4 -VT;:=10 W;1MIU% #=M1R0YY%344QIV*>T^M&WWJ:2/N*BJ[FMQ-OO1M]
MZ<JEN@HP:!W&[?>N6^(/S:;$O^U755R_Q"^72XS_ +5;T/XL3S,R_P!SJ>AE
MVG%G$/:I*CL_^/.+Z5)7M'Q,=D%%%%,H5?O"OD?_ (*5_P#) ;SZU]<+]X5\
MC_\ !2O_ )(#>?6HG\+-\/\ Q8GR'_P3*_Y*+JW_ %R_I7W7\<O^21>*/^N+
M_P J^%/^"97_ "475O\ KE_2ONOXY?\ )(O%'_7%_P"571_A'CYG_P C!?(_
M&SP;X7_X3#QLFF;MHEF;D_[U?JO\'_@'X4\.?"YI9-*@DOX[8MY^T9SCK7YC
M?!?_ )*M:?\ 79O_ $*OV \#YD^&\L8^]);E1]<5EAHIW9Z.=U9QY(Q=D?CQ
M\4?$US??$Z_.HR-=VEE>,J0,> H/2O>?"G[6'PZT/PS_ &?=> 8;FYV[?.*"
MO$OCAX'U/P9\3-1;5[5[>WNKII(V8?>4FO=_@Q\'?@SXO\.?:O$OB:'3[S'^
MK+ 5C'FYFD>IB/8>QA*:;7E_P#Y]N_B C?%#_A(M MCI$$LPVQ1\8R:^D?VW
M/$$NO?"WP)-,2TK(I9CWXK$\-_"SX6:M\6GT%?$$?]D0MF.X!^\>U=E_P4&\
M-VWAWP9X2M=.?S]/A 6.4?Q#'6J46H2;.>56G/$T8Q33\_0[+_@G;\)_"_B#
MP/?W7B#2(=2F9RRM(H.!Z5X1^W)X'T?PQX[G;1[*.Q@# !(QBO9?^"?7QR\(
M^"_!U]9>)M5CT^4.0H=L9'K7A7[;'Q*TCQM\0IQH=VMY9%LB13FKER^Q1ST(
MUO[2FW>WX'UQ^Q(=WA"S/_3(?RKZ?A;R[I7]#7S!^Q*-OA&S'_3(?RKZ<;[Q
M^M==/X$?-8[3$R/3=!G-Q8!B<U?K(\(_\@FM>LGN>Y2?-3BS*U6/=J]D?]H5
MZ8H_=I]*\SU63;K%B/5A7IJY\M/I7G8S[)])DF]7U0FWWHV^]+17G'U%Q-OO
M1M]Z6B@+B;?>C;[TM%(+B;?>C;[TM%,+B;?>C;[TM% 7$V^]<?\ %+XCP_"W
MPW=ZQ/%YR6\9D*^N!FNQYKD?B=\.;;XG^';K2+N0Q17$9C+#W%-;B>VA\,2_
M\%EM$ANIHCX6D*QN5# ?>QWKB_&7_!6;3/%68V\.R"WSD(1Q7?:G_P $??!L
M*W-V_B.X5"S/MW$!>^*_-K]H3X7V/PE^*FH>&=/N6NK6W("RL<DY)%>A0FZ4
MO:4^AY=52:Y9'VQ:_P#!5'2;6U2%?#CX08 Q7J'PC_;HT[XMQRM'I?V5XVVE
M3UKQWX9_\$V?#?C?X<Z/XAFUF>*:]B#L@8X&17KG@;]BO1/@KH=Y=6>H27,G
MWB6.2>*]B+Q#?-+8\]JFE9&'\2O^"C6G?#;Q-)HSZ&URT8R7 KEA_P %5]*+
M ?\ ".N!]*^,_P!J#]Y\5KP>VW]:^J/A7_P3K\,^./A7IOB>[UJ:"XNH@_EA
MR!DBL8U*]2;C KEA%79[!X+_ ."@OA[QG-'"]O':"0X+,0,5Z)=>+%\7L+C3
MKP3VA7),;9%?EY^T9\$Q\#]>AM+.[EDBE)PVXBO?/V(?BE+#IG_".SS&9Y2Q
M!D.2!Z5[N6UW2Q/L,1'WNYQXB'-3YX/0Z7XB?MI6/P]\6WFAR:2UP]L<-(!7
M1_!W]J+3OB_=3V_V06$D9QAN]?%'[3L?E_&;71_MC^M87PA\4W?AOQKIGD/M
MCFN%5P#CO6/]KXB&*<)OW4[%_582IW2U/U=V@J#V(R*Y#XK?$J'X0^&?[<FB
M\U<_=KKM/F2^TVQ>)MVZ%2?RKY8_;9^(5C=>$3X?2=3=QN,QYYKZK&5_88>5
M1/6VAYE*'/-19O>%?^"EUO8W\<$VD2212,%W'MFOM3X6_$J#XJ:&-2MXO)7:
M&VU^%>DC=J=J/^FB_P Z_63]D'Q!+I_AN&S W+(HY_"OCL+4K8Z4G)ZH]6I&
M%%)(^GZ*5AC'TI*T("LCQ7^[TAG]Q6O6)XV?R_#\A]Q6U'6K%>9,OA9[/\-V
M\SP79-ZK71[?>N8^%K>9X%L#_LUU%?%XK2O47FSZFB_W<?1";?>C;[TM%<QM
M<3;[T;?>EHH"XFWWHV^]+10%Q-OO1M]Z6B@+B;?>C;[TM% 7$V^]&WWI:*07
M$V^]&WWI:*87$V^]&WWI:*07$V^]&WWI:*87$V^],*5)05IHB6J*[+4$D=6I
M,U"RDCFMTS@FBC)'526.M&1>M5I(ZZ(L\VI$Y+QAHCZII^R ^7*#G<*YW2Y\
M1BU+;I(N&->BRK\I!&<C%>=>)-$N/#]W]LLE,PE;+_[(KV<+4YX^Q;]#AC+V
M<M=B]14-G>17T(:)M[ ?-[&IJW::=F=H4444@$=5D4HXW+Z5S^M>$8]20^2!
M$>N:Z&BM(5)4W>+%**EHSRK4O#UQIK;0K2?050^QW/\ SP?\J]C,<;?>C5OJ
M*:]O"RD>4H_"O2CF$DO>C<YW071GCOV6X_YXM^5+]CN3C]P_Y5ZW_9T'_/-?
MRJ98854#R5_*K>8=HB]AYGFNF^$Y]2'.8_K77:/X2ATU0)E$I%;P55^ZH7Z4
MM<=7%U*FFR-8THQ$50BA4&U!T%+14<TPMX6D_NUQ&I3UJZ,-F1$<R_W1UK?\
M*:>JV,=RR;9V'.1S6+H6E'5-26_;)0?P]J[R*,+PJX'I66)J*$?9K?K_ )'G
MU)>TE9;#X8S5R*.HXE]JLQJ:\>3.NG$DC7%65CS3(U/I4R USR9ZE-#E2I0O
M%(N>!BG8K"1Z%-=1-OO1M]Z6BLS:XFWWHV^]+10%Q-OO1M]Z6B@+B;?>C;[T
MM%,+F#X^'_%(7O\ NU\X_"TE?'38XY-?1_C[_D3[W_=KYO\ A?\ \CRWU-?8
MY1_N-<\/&?[U2/?))&WMS3%D;^\:)%_>-1%&TIVJ,FO&6Q[3;$\UL_>-*)&Z
M[C4LMA/ NYTPOK3+>VDN&Q&NXU5B1/,?^\:>LC#^(T36TEN0)%VTT"G838\2
M-G[U/61O[QJ$=:D6F22^8W]ZI%D?'WC4(XJQ#:RSCY$S0 +(_P#>-/$K_P!X
MTD=N\DA0+EAU&:?-;26[ 2+MIDCEE?IN-3"1L?>-011F1L+R:LR6KVZ@R+M!
MZ<TR6)YS_P!XT])G_O&G"PG9-X3Y?7-1*.<4"+*S/G[QKQ?X^,6US1LG/SC^
M=>RH,-7C/QZ_Y#FC?[X_G7J9;_O"]'^1P8S^$_D>L>#5_P")/%_NBMS;[UB^
M#,_V/'_NBMNOE*W\67J>O3^!";?>C;[TM%8&EQ-OO1M]Z6B@+B;?>C;[TM%
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M@I_CA\0)K>]L9$BM&\Q;B53M;'H:ZW)8>E*O/H3&//)11]!77P#.D^%]$O\
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M:^,_#_CY]04Z;JEI)9S1#:)IUVAC^->@>#?$E]X3D^T"[^T6H.XQH<\5R8O
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M%)&M2A16+9W0B XI:4BC'%8G8M!,T9I0**+#$S12XHQ18!**7%%%@$I:**+
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MMJ>;T;O8UZ"OPJN%;)E&*U-/^':6S S!7I$QPE5[H\LAC:XD"(K;C[5T^B^
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M:'$%%%% !1110 4444 <O\0/^08E5OA+_J[KZU9^('_(,2JWPE_U=U]:B/\
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MX8AGOM*MBVFVX+.W^R*\>MAI0]Z&Q^HY3GU'&)4<4DI=^YX[XRUA-28:J$6
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MW?:6"FN:NH?M$)6L7PS,;7QEIRCC]^H_6NJE[T'$E2<)J2/U+\"Z@?MEB?\
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M_0+2)'GT.PED_P!;)$K/]<5X.=X=4,1>.B:/-RW$2KTKS=W<L;:-M+17SQ[
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MZA%I^D6S7<,AVR2(,[:]\^'O[(L,EDE_?WTB3,,F)JZW]F?X22>"]'EO-2@
M>Y_>1;AG@U[FQST&/I7S..S*<IN%)V2.:=1WLCY<\:_L;P+%-?V>I2-*HW")
M3U/I7@$DNI^&]0FL-?M&T]8VVPM(,;QZU^D2GU ->>?%SX*Z)\5K/SKZ/9>V
MZ_N=G&34X/-)TY<M;5!&JU\1\9QNLR;XSN7U%+5OQI\+_%GP[OGN9[8KH49^
M9\=JPM-\26.L2;+9B3[C%?74ZL*T>:#NCJ33V-*BG%"/2FUJ,**** "BBB@
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M** "LR\_UE:=9MY_K!6%78Z:'Q%:BGT5R'>,HI]% #**?10 RBGT4 ,HI]%
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MKYJU/PS%=0E+#%BY&-T?!K+TF]UOX9RFZ^U3:H%.X(237E5<JIU-</*WD_\
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MO#UB]U=7$:;1GRV8 U\F?M)?M2-JVBOHWA*X:POE)$TF<!E[@5X1XY^/NO\
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M\Q<\UTOQP^($GA?188M&7[?J,D@22WBY90?6J_AK5/#O@/3[*\U_4H-$O-3
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M2ZLWCGN>)(F7D#WKWJWT_2K?PKJ$VAVL,=\T1+^0H#;L=\5^6>(&?QRRHJ>
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M ^)TOPM\>1ZU%.VQFV%&/R_E7ZM>"?%D'C3PU9:G&ZM)<(&8*:_)WXZ>!/\
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M7M0* &BEQ1@TN* $Q1BE-':@! *,4H!HP<T (1BC'%*1FCM0 @%)3AFDP<T
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M2T'^CV_^Z*\5\>3?\5X4]JZ\&OWC]#JAN:/AN%IK["=CVKU6%3]GC'<"O-?
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MQ\0W,\SQW5D]LJG&YQC-:POK1L!;A"?3->Q^)?!5CXFA,;HL&1C<@P:X2X^
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MOW2EB/?BJH\M1-V%6YH<J/Z1?@U\0[;XA^ ]"U!9UFO)H$:XVG/S$<U\.?\
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MP^5H<TFV''UKM/V"_CEI_@75[C1M6F8O>.$@#'/6OIK]N;2TU[X9P0SX9$Y
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M7;1MH"XG>@TNVC;0 <8H&*-M&V@+B"CO2[:-M "&EP#1MHVT (,4=Z7;1MH
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M@?\ (,2JWPE_U=U]:L_$#_D&)5;X2_ZNZ^M9Q_B'H2_W*1WU%%%=IX 4444
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MQ_\ KFG\J]:I_&B>-2_W>9^<WPQ\-^/];G?_ (0NVU">3'S?8R:]"_X5W^T
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MR;="U:J\L!7D'Q\\<'1X!H ;'VY-N/K73AJ+KUHP2_X8SJ2Y8W/(M/N3X_\
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M:D*KYH1Y>Z/(_'W_ "%[O_<-?FQ\<KZ6Z\77L3@A5E.,_6OTE\?_ /(8NO\
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M^_Y FJ?]>S_^@FOS>_85_P"2]?$'_K]?_P!"K](;[_D"ZI_U[/\ ^@FOS?\
MV%?^2]?$'_K]?_T*KZ&+^(_23GRX_I1SBE_Y9I]*/X:@V$&:3GTIRTE "'/I
M2\TIH[4 )S2#-.[&D% "<^E*<T&E:@!.<4@S3NU H ;SZ4'/I2TIH 3G%(,T
M[^&@4 -Y]*#FEI30 G.*!FE[4 T -&:#FE%!H 0YI><4I-':@!HS1SZ4X4E
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M ***/I0 444OUH ;2T44 %%+10 WO2T44 %%+]*3M[T %%'UHH **/I1V]Z
M"DIWUI* "BBEH :*.]+10 &BBE^E ""BBCZT %%%!]J "DIW;WH^M #:6BB@
M"*\A$UI-N&<*2*\.6YEGU*[61-H1R!7N_#*5[-P:\_\ &7@N=KA)-+3.XY>N
MS#3C%N,NII!VW.7T)1:Z[%=]UKV*UNOMENLV.M>5:+X/UI=?A:XCQ9?Q&O6(
MH$M8Q'']P4\4XMJSN$QU HI:XC,?'_Q[W7_7)OY5^8'[-/\ R=QX[_Z^F_\
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MY4_\%3?CYX?^+,GAKPMX=U*.[E2Z$;K$V3R<?UKR6/\ :@_:._:DL_\ A'[
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MQ9^@U<7@\=AI<Z;CZ/\  ^X-&_:@TGQ%I<.HVNEW'D3#*_*:M_\ #1%C_P!
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MEK>I]_1FJV7I]M#Y\\-MNMC6M6/X7(^RFMBLJGQLYX[&_P"#?^/X_6O6(_\
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M8IVVC;0%QM&*=MHVT!<;BC%.VT;: N-HIVVC;0%QN*,4[;1MH"XW%%.VT;:
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MT;: N.3_ (][G_KDW\J_+_\ 9I_Y.X\=_P#7TW\Z_4%1_H]S_P!<F_E7Y?\
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M7XA_ ?XI>-?V2_VB%T[Q+?WE]I\9\LI=.Q4\^]?M%X-\31^-O"MAK\*A8KQ
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ML?\ "(W6>E>Q_LY[U^'MF1]RN3,?]S7^([<+\315;7_B$&(%EQ]*/[?^(?\
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M/_016DMC&.Z)>:!GO1169L)S2\T44 '-'-%% "<TO-%%  <]J*** "CFBB@
MHHHH **** "BBB@ YHHHH **** "BBB@ HHHH *.:** "BBB@ HHHH ****
M"BBB@ YHHHH **** "BBB@ HHHH *.:** "BBB@ YHHHH **** "BBB@ YHH
MHH **** "BBB@ HYHHH **** "L[Q%XBL?".BSZOJDGDV$ S(_H*T:P/B)X2
M7Q]X+O\ 06 (ND*G/2FA,\]@_;$^%5Q;SE-=0#8PP>_MUK\^?@#\5/#/AS]I
MOQCKFH78CTRZN&:&3/49KP?]I;P?>_"+XM7WAV(21PQDG@G;7E@O)86:56(;
MJ3FM;'.Y:G[LZ+^U9\--:NK73K/6%DNY0%2/W_.O5;6Y2\A66(Y1AD&OQJ_8
ME^!OBCXK_$'3/$]I,?[*T^8&=2QY -?LS'!%:V\44*[55 ,5G)&L6V'-%%%2
M:!1110 4444 %%%% !1S110 4444 %%%% !1110 4444 '-%%% !1110 444
M4 %%%% !1S110 4444 %%%% !1110 <T444 %%%% !1110 4444 %*O>DI5H
M _.O]NS_ ).=^&G_ %\I_.OT4C_X\++_ *XK_(5^=G[=G_)SWPT_Z^4_G7Z)
MQ_\ 'C9?]<5_D*T>QDOB$HHHK,U"BBB@ HHHH .:*** "BBB@ HHHH ****
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MC)I<3[#; S'/L/\ ZU?E!\!/@#?>-OC<MA;YDM]%O LRJ,@@-5IF#6I][?\
M!-OX&V_AWX</JNMVF=7\S,;L.0/6OM=LMR:H^']#LO#NBV5I8VZVR+$JE5&.
M<"K]2S:(W;1MIU%(H;MHVTZB@!NVC;3J* &[:-M.HH ;MHVTZB@!NVC;3J*
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MVT;:=10 W;1MIU% #=M&VG44 -VT;:=10 W;1MIU% #=M&VG44 -VT;:=10
MW;1MIU% #=M&VG44 -VT;:=10 W;1MIU% #=M&VG44 -VT;:=10 W;1MIU%
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MPA7S;ACDN<=:3*C9ZG5T445)N<O\0/\ D&)5;X2_ZNZ^M6?B!_R#$JM\)?\
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MCK^]^E)_PNSQU_>_2C^P\3_-'[P^NP[/[CZT\MO2CRV]*^3/^%U^.O7]*/\
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M)_>?G9I'[:_B3X931PZYH^HZF4.&*QL<_I7?1_\ !4G1A&H;P3J@;'/[MO\
M"OL.?P'X7NCF?P_8RG_;@4U5F^&'@V92I\,Z?S_T[J/Z5M[:A+5P_$CV&(CH
MJFGH?+>G_P#!0#1/B4ITE?"U] 9.\J''\J[+0=2>] N#$T$#_=5ABO7%^"GA
M:"[^T6^CVD#_ .Q&!_2J'Q(\'B'2(!IT 'E\G8*^<SC#4\13]K25FCZ?):]6
MC-T*\KJ7X,X^BJ6FWWVE3&W#Q\&KM?!GUS3B[,****!!1110 4444 '/:H9K
M6*=2'7)J:B@-MCF;S0Y("S@Y'7%9VUAU4BNW(#=1D56N-/CN%("A:#KAB&M)
M'(45OMX;1CG?BJ=QHC0_=RU.YTJM!]3,HJ9K&<'B,FC['<?\\C3->9=R&BM*
MWT5YOO#;5Q?#2]2]*YDZT([LPMI/0$U:M=-DNS@?+706NEQVV,@-5Q45?NJ!
M082Q'2)GZ?HZ6RGS0&;M6@%"KA>!2T4CCE)R=V%%%% @[U!>W0M8<G^+BI\A
M>6.!5;2]/?Q5JPLEX1#G(JX0E4DH1W8U97E+9;G9?"/02LUQ<W*9#<INKT_V
M[57TNR33M-@MT0*R+@D=ZL\U^A86@L/25-'Q.*Q#Q-9U&)12\T<^E=9R"44O
MX4<T )11S2_A0 E%+SZ4J=:-Q#U%8OCC_D5[O_=-;?-8GCC_ )%>[_W377!>
M\CEQ'\*7HSXJ^#S%?VC;O'7!K[ N9G\]^>]?'_P?_P"3C+OZ&OKRY_U[_6O6
MQ7QQ]$?F?#O^[5?\<CG?B5X]B^%_@+4O%MXAFM;!"[QCOBOG'X"_\%(O#O[0
MGQ!@\(6&BS:?<S@F.60<,!WKUG]K@!OV9_%P(R/L[?RK\GO^"9ZC_AI[2#CD
M1MC\Q7 WK8^TI4U*G*3Z'ZC_ +3'[7FD_LMVL$VJV$FH-,VQ4C')-2_LN_M:
MZ7^UA8:C<Z382::;$XDCD'-?)_\ P5[4?V/IAQS]H7^E7?\ @C8H'AWQ80.3
M)R?PHOK8?LU['GZGZ'>>_K1Y[^M,I*LY"3SW]:599&. 23458OCGQ7+X#\*W
M6N00_:9H%.(O6D&IQGQP_:4\/_ 706U+4[B*XE7K;!AO'X5\QG_@L5X,%QY7
M_"/7!3.-^TXKX8_:&F\=_'3XV:C=/:7WV2ZF"I""?+1<\\5].6__  2=L)/A
M"WBN37Y8[]+,W+6WIA<XJ+OH>@J5."7.]6?<GP'_ &FO#G[0.BOJ&GW4-C(O
M2WD8!F^@KU3SI!U.*_!#]E?5M5\._M&>'M.M=2N(K>+4##)&LA".JL1@CIVK
M]\))OM$<#XQ^Z7^5..ISUJ?LY:,3SW]://?UJ.BK.<D\]_6CSW]:CHH YOXI
M3.? .LC/'DM_*O(_V+1_Q+;O_KNW\Z]9^*7_ "(.L_\ 7%OY5Y-^Q;_R#;O_
M *[M_.NN/^[3]4?.5/\ D>8;_"SZZ;[U(1BE?.ZDYKR+'Z:&VC%'/I1S18 Q
M1BCF@YHL 8HQ1SCI1S18  S1BCF@Y]*+ &,4;:.:!GTHL 8S3E_U<O\ N&F\
MTX?ZN7_<- F?(3>%[WQQ\0]7MH9MFR0]377_ /#.&J)'ODOTCCQDLS8 JK\/
MW,?Q2UO!Q^\/\Z]1^-.H3V_PCUN2"9HI5@;:ZGD<5^895E.#QT)U,0FY<TNO
MF?HF:9IB\%.%.@TERKIY'EY^!MLK;&\56"R?W3,N?YU,_P"SW<PQB:;6K>*W
M/W9FD 4_CFOQA\<?$;QE%\6'A3Q/J"K]H& )V  STQFOTF_:1\2ZS:_L8^$;
MJVU2X@O6@!>X1R&;CN:^AEPSEJM[KU\SP8\19A*_O+3R/</^%)V(Z^+M/!_Z
M[K_C2?\ "E;#_H;]._\  A?\:_$SPGJ7Q&\?:\]CIOB#59YFDVEEN'/?TS7M
M/_#+_P <-J-_:VM?,,_ZR3_&J?#&6+=/[R5Q%F+V:^X_4^W^ PU!BEAXCL[Z
M0<E(90Q'Y&F-\#[6-C'+XKL(Y5X:-IU!'ZU\L?\ !.SX/?$?X<_$3Q'J7BN^
MU&6Q^P.%6YD=EW8//S&O@/XY?$SQ9:_&;Q=Y/B34D"ZA*$"7+A0N> !G%3'A
MG+).RB_O'+B+,8Q3<E]Q^U</[.][>+OL]6ANXO[\3Y'Z4DW[/-Y8IYE[J\-G
M#_STF<*/UKY\_P""7/[2%IK'@*;P[X@UXW&NR2[88IY,NW;C->B_\%4M<U/0
M_P!G'SM-OI["X\X9DA<JQ''&14_ZM9;S<O*_O*_UAS"U^9?<=W;_  #.H9&G
M^(;2^8=1#*&Q^1J?_AFW5_\ G\7\Z^$?^"2WC+6K[QIXA;5-:O+FQ@C#$7,[
M.%XR3DFOTTM_C[\/;R^%A!XJLY+[=M\E9!G/I2EPWEL7;E?WCCQ!F#2?,ON/
M.?\ AFW5_P#G\7\Z/^&;=7_Y_%_.O=[?4%O(Q);R>9'C.X'M7'W_ ,>? &DZ
MHVEWOBFTM]15MAMVD 8-Z5"X=RU_9?WFCS[,%]I?<><?\,VZO_S^+^='_#-N
MK_\ /XOYU[K;ZHEY D\$OF0R#<C@\$>M2?:F_OFE_J[EG\K^\K^W<Q_F7W'S
MIX@^ NJZ'8M</=JP SUKH?V7Y)EN-4@E?=Y;8KT;XA73-H<@+'[I[UYU^S+_
M ,A36C_MFO+IX'#X'.</'#II._7R/2GC*^,RFO+$--JW3S/>R*,4O-(,U^DV
M/@ Q1BCFCGTHL 8HVT<XZ4<T6  ,T8[4<T'/I18 HHY]*.:+ %%'-'X46 2E
M/W:.:7^&@#Y<U^WBNOC3.DR[T]*](7PWI>WFV4_A7G>L?\ELGKU1?NU]1C92
MBJ5G]E'+@XIJ5UU,\^&M+_Y]E_*E_P"$:TK'_'LOY5H-R13NJUYGM)_S,[^6
M/8S?^$9TL#_CV7\J%\,Z7_S[+^5:PMY-N=AQ3(T9B0!DT>TG_,PY(]C+;PSI
M>?\ CV7\J/\ A&=+_P"?9?RK6DMY%Y*$"HJ?M)_S,?+'L9W_  C6E_\ /LOY
M4?\ ",Z7_P ^R_E6C2FG[2?\S%R1[&=_PC>E_P#/LOY4#PUI7_/JOY5H_P -
M*#1[2?\ ,PY(]C._X1O2S_RZK^5+_P (WI7_ #[+^5:*C)P.32LI0\C%'M)_
MS,.2/8S?^$:TK_GU7\J/^$:TK_GU7\JTTC:0_*N:D-K-_P \S3]I/^9AR1[&
M3_PC6E'_ )=5_*G+X8TK_GV7\JU5M9=O^K-*T$D:Y9"!1[2?\S%RQ[&4/#.E
M?\^J_E1_PC.E9_X]5_*M*EXW4>TG_,Q<L>QG?\(OI/\ SZK^5*/#&D_\^J_E
M6E4D<+R?=4FCVD^[#DCV,M?#&D_\^J_E2-X8TG_GU7\JU3&T?#+@T[[/(RY"
M$T>TG_,PY(]C)'A?2?\ GU7\J7_A&-)_Y]5_*M+&TX(P:!1[2?\ ,PY(]C/'
MA?2?^?5?RI?^$7TD_P#+JOY5HU,+65E!"$BCVD_YF')'L9*^%])_Y]5_*E7P
MOI/_ #ZK^5:CQM%]Y=OUI%H]I/\ F8<D>QG#POI'_/JOY4[_ (172/\ GT7\
MJU(XFD/RJ34IM95Y,;8H]I/^9D\L>QC_ /"*Z1_SZK^5._X171\?\>B_E6D?
MO4[^&G[2?\S%RQ[&:OA71_\ GT7\J<OA/1_^?1?RK26E6E[2?\S#ECV.'^)?
MAW3+3PG-)!;*CCH0*XW]FD?\55=X_NFO0OBI_P B?-7GW[-/_(U7?^Z:]BG)
MRRZK=GEUTEB86/I23[Q^M)3GSN;ZTWFOC['J!24OX4<T6 */>CGTH&:+ %%'
M-!SZ46 **.<=*.:+ %%'-'X46 **.:.?2BP!11S1^%%@$I>E'-'/I18 ]Z*.
M:.:+ %%!SZ4<T6 **!FCFBP!11^%'-%@"BCGTHYHL 44<T<^E%@#I11S1S18
M HHYH.?2BP!11S0,T6 ,9I4^]2<TY,[A0!\^?M%?\>[?[XK?\#_\BAI_^X*P
M?VBO^/8_[PK>\#_\BAI_^X*^GJ?\B^EZG%A_]XGZ%[5M8A\-Z3/JUSS;VX+/
MGTK\:OVZOVA]=^*GQ-O=(TS4YF\.<!+"(Y5FSW%?J]^TE.]G^S[XLFC)1UMV
M(8=N*_%[]E73XO%OQXTZ/44%VLKEF$O.>17B3Z([JCV1[S\%_P#@F#XG^(W@
MFQ\3W-]'%;7L>8X&^5ESZUY%^T=^RYXM_8_\3:7<37OFO,=\%Q .4],FOVV\
M'VJZ-X7M+.V_<P1J-L:\ 5Q_Q=^!^E_&MK=M61)O)&%\P9_G3]FK: Z:MH>,
M?\$^?C-JOBKX)W&J^+YI+F>W+(LD_H.G6OST_;<^,WB3XA_&+5]".JRSZ$DP
M6WM V4!)Q7Z8_%;X:VOP4_9_U:/2=L(52?W8QVK\FOAGIJ_$#XX.U\?-;SMW
MS\]ZF=[*),[V43Z/^&/_  2I\3^+_"%CKEUJ,(3480\*#C9D=Z^?OCY^SWXO
M_9'^(%G;F\D-ZH\V&]M5^Z>W-?N-\/5;3OA[H=O&[*L,*A<'VKE/B9\#=&^+
MEP)]5MXYY@,!Y%!(_.K=-6T*=-6T/#OV4_BMJWQ _9KA'B626ZU@Q,&FF^\1
MBORQ\;6R+^T7<Q[?E.LQDC_@8K]J?^%167PS\'7$%EM6)8FPJC Z5^+/C9MW
M[1UP?^HPG_H8J)[),B=[*Y^^WA/CP#X;';[%'_Z"*TK=0V[/H:S?"?\ R(/A
MO_KRC_\ 015]*Z3<_.7]O?XR?$/PS?QV?A26_M09MK26RD\?A7P-\8->^(>N
M&QF\=7UW=NZ[H?M1.1Q7] \_A?P_JLRMJ.C6MZV>LJ U^8G_  5_TC3=)\6>
M%TTZQBLDV'*Q* #\IK"I%VO<QG'J?1?_  2=C6+]G2\VC&Z=B?KDUZC^V!^S
MK<?M,> [;0+258987#AF]17F'_!*'_DW.[_Z[-_6OL6-BIRK%3[5I%7A8N.L
M;'Y@6_\ P2#UM]B'4(RW0G>?\:^<_P!J3]E!/V:Y#8ZA.DMTR[D(8Y_G7[CZ
MMK+Z!H5]J[NQCLT,C9/' S7XF?MK?%>Y_:>^.]M;Z.3<.G^CK%&<C=D#-93B
MHK0RE%)'IO\ P2Q^$>JI\5K3QG-&1IXC*(V#BOT6_:F8-9VQ'3-9/[$?P['P
MY_9_TG2[RQ%OJ2*"S,N&[5H?M-_\@JSKV,I5L53.;%*V'D=#^RK_ ,BQ=_6O
M;/>O%/V5?^17N_\ >KVOFN#-?]]J>H83^#$**.:#GTKRK'8%%'- S18 HHYH
M_"BP!11S1SZ46 ,44<T<T6 *.E'/I1S18 HHYHYHL 44'/I1S18 HH&:.:+
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M2JWPE_U=U]:L_$#_ )!B56^$O^KNOK41_B'9+_<I'?4445VG@!1110 4444
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M4J<<3'=:'VO14C(%/)INT=N:^</S2XVBG;11M% 7&T4[:*-HH"XVBG;11M%
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M-G)*6QFO_P %$/@9&I+:V, 9/->F^!?B5X1_:,\)3W?AFY^V:1]UVK\SY/\
M@D?X_P!K;+V+...E?=G[$'[/FJ_LT_#>]\/:S(LMU<2&3*].<FI5^IT5(4HQ
MO!W9W6F_L]>%;"^-['!&TH^8EE%>+?MN?M/6GP0\!R:'I<ZEKR%H&13D\C&*
M] _:C_:1T;X!^!YM0N)EEN7!C6*-LON/3BOR;\/Z+XQ_;4^*TTL]ZW]FI<;]
MDS<(A/0>^*&^B*HTW+WY[(T/V*?@WXM^)WQJTWQ7I>GM)H]G?M-=7!Z#))(_
M6OW%F6-%B6/HL:@_7%>7?LZ_!C0O@+X*BTK2FMX#-&#*%(Y;'->F<=B&'J*<
M58SK5/:2NM@HHHJCG"BBB@#F/BE_R(.L_P#7%OY5Y/\ L6_\@V[_ .N[?SKU
MCXI?\B#K/_7%OY5Y1^Q7_P @VZ_Z[G^==<?]VG\CYRI_R/,-_A9]=M]ZFT]A
MS2;17DGZ9<;13MHHVB@+C:*=M%&T4!<;13MHHVB@+C:*=M%&T4!<;13MHHVB
M@+C:=_RSE_W31M%+C]W)_NF@#Y?\$MM^*&M_]=#_ #KT/XV2?\6AUSG_ )8-
M_*O.?!V?^%H:W_UU/\Z[[XU,?^%1ZV/^F#?RK\^R*5J<_P#$_P S[G.HWG!_
MW5^1^"?CG_DKY_Z[_P!:_3#]I1S_ ,,5^$1_TP'\J_,[QU_R5X_]=_ZU^E?[
M2#8_8O\ ")/_ #P'\J^WJO6!\=25U,^&?V//BEX<^%OQ!-YXCD6*W6XW$N.V
M:_5AO^"CGP%C@AW:U!PH&-B\>U?B]\+/@OK/QJ\3RZ?H[QQRM+M!?U)KZ?;_
M ()&_%7RT9;ZQ^8!N?\ ]=.HJ=_>E8SI\_+HKGZJ^"?CEX.^+GAK4YO"UQ'.
MC6KD,@ )^4U^!'Q9T>YUWX[>(M-M5WW5SJCQ1KZL3Q7[!?LA_LPZ[^SSX/U"
MWUF=976S=3M.>QK\I;R8+^UP\G;_ (2#/_CU9T&N:7+JC6M&T8WZAH6E>)?V
M2_C+X>U/78)+*YAVW"[<_,IQUK]#_P!N#XF+\9?V&-/\5JZ-]H9<[3WK,_X*
M+?LPW?Q \"6?Q"M &&GV"91!\Q^45^;D_P <?$UQ\,XO =U>2'1(#\MLQ/'X
M5I']\E-;HB7[EN+V>Q]:_P#!*FU;4]3\:Z='_K;JV\M<=<E<5XQ^TIX#\3_L
MR_&J.]EGN(IIIFN8U9S@C.:]S_X)#MM^(6N-Z!?Y"NP_X*W?#K5O$GB33O$E
MM&9+:S@P^!VJ>>U=Q?4KDO14ET/J7]G7X^3W7[*\?C74Y0)?+*[F/M7Y->)I
M-?\ C'^TI?7FAM<74DFHK)N1SA%##->[:7\;+?2?^"?8\.VERL6I!\<-S5K_
M ().^#X/$WQ2UB[U" S(D6Y7<9RW6E']VIS'+]XXP/UD\ VS:;\/_#UO*3Y\
M=I&LF>N=HS6WYU5=HA41)PB< 4;CZUYCF[GJQIV1C^/I/^)))_NFN)_9B_Y"
M6L_[Y_G76^.V_P")*_\ NFN2_9@_Y".L_P"^:^=J.^=8?Y_D>Y%6RBO\OS/?
M:*>12;17Z"?"W&T4[:*-HH"XVBG;11M% 7&T4[:*-HH"XVBG;11M% 7&T4[:
M*-HH"XVC^&G;101\IH"Y\O:Q_P ENGKU5/NBO*M9_P"2VSUZK']T5]+CMJ7^
M%&&#VEZACFLOQ7JIT'0Y;Q>"JDUJ=ZY?XJ_\B7=?[A_E7EGH,^)]1_X*":G9
M_%)_#7G+Y2SB+'XXKZ>^,7QDG^'GP]L]=B<+)-;";)^F:_';Q%&O_#2DP_ZB
M /ZU^E?[7ZAO@#HX/3^SQ_Z#6,9-IF,9-IG)_L[_ +=VI_%SXG6WARXE5HY9
M-N!]:^\;J+R92H] :_#W]@-1_P -):+_ +,G'YU^Y&I#_2C_ +H_E5TY76I5
M.5UJ4Z6G;:7RS_=-:7-+C.U4]8UJR\/6<EW?R+'#&NYB3CBM#80I)':OBS]N
MK1?B)XO@T_2_!E[):B=_+EV'&0>*3=D)RLCT?QY^WS\(_"^EWL4>KK_:D60B
M9_BKM?V??C)%\:?"::U;R"6%FP&%?BO^T#^S_P")_@/K5G;>)YEGO+Y/.W*2
M3SSS7Z<?\$QUV_ >UQW;-91DW*S,HS;=F>F?MG?M 3_LX^$;#5+9BKW#;>!F
MOC9?^"INJLH)=L_[AK]&?B5\)?"OQCT^*P\7V"ZA:1'*(PSBO.HOV$?@F[JB
M^&8O0?+5RC)O1E24KZ'Q?'_P5*U61MHE(/\ M*17M'[+/[;NI?&[QQ+HMU(K
M(HR *\K_ &\_AW\%/A#X,O=$T708[3Q(1^ZE48(K#_X):_!;5+7QY_PE^H0X
MTV:';&/7KS6:<E*US-.7-8_4J/YHU;UIVWYJ?-@3.$^YG@4SG=70;#]OR.?[
MHS7QY^U1^V)?_ ZXCCM9 I9MN*^Q%_U,O^X:_([_ (*:(/[<LCW\TU$VTM")
MNRT/NO\ 9/\ VA[KXZ?#G5-?NG#26N>17SS\;/\ @H=JWPY\=/HUO*/+5PIX
MZ#-7O^"6ZA?V?_%?N[?UKX(_:Z0+\:-4QW_QK.4GRID.344?N7\(O%3^/OAE
MH_B.0YDO(PY/U%=8J[FP.M>6?LF+M_9K\(CM]G7^5>L6>/M49;IGFM^ALMCS
M[XH_'+PI\(=+FNM?O%M_+!)R:_/_ ,?_ /!4Z^M/$]Q%X>F\[2PW[MPI/%<#
M_P %/=0\4:E\;)=,MTNY=&*#;'"I*EO?%?3G[)G[#GP[U[X#VVM^)=!6?49K
M4MND7Y@V.IK%RE)V1DY.3LBY^S/_ ,%%O"OCB]73/&.H+!J-TP2V3IEC7VA=
M:E:Z=IRZC<.%LV3>'SVK\"_BU\.F^#7QM5;5XS:+J'F6Z1'E &X%?I?XB^*F
MO>)/V+M6O+;SCJ\4&V)@#NZ41D];BC)]1O[2G_!0WPS\./.T[PY?B75XCAHU
MYKPKP3_P52U:\UJW36IO*LMX\QF7'RYYKP7]BOX&R_'CXW-!XLL;BZA(WR/<
MH0"V>>M?0G_!2;]E7P/\*?">C3^$=-CTVZ49F;&-U1S2>I-V]3]!_@W\:O"O
MQ[\-KJ_A*[%W#"H$YST;O7=8XS7Y _\ !,_XKZIX5\1?\([:^;]DO+C]YMSM
MYK]@[B,)LQT*@UO&7,KFD7=#%&:5:1:5:HHY?XI_\B?-7G_[-/\ R-5W_NFO
M0/BG_P B?-7 ?LT?\C5=_P"Z:]NC_P BZJ>3B/\ >8'TK)]\_6FT]Q\QI-HK
MY$]$;13MHHVB@+C:*=M%&T4!<;13MHHVB@+C:*=M%&T4!<;13MHHVB@+C:*=
MM%&T4!<;13MHHVB@+C:*=M%&T4!<;13MHHVB@+C:*=M%&T4!<;13MHHVB@+C
M:*=M%&T4!<;13MHHVB@+C:*=M%&T4!<;13MHHVB@+C:*=M%&T4!<;13MHHVB
M@+C:5?O4NT4J@;J N?/?[1G_ ![M_O"M[P/_ ,B?I_\ N"L/]HS_ (]F_P!X
M5N>!S_Q1^G_[@KZ:I_R+Z7J<F'_WB?H8'Q^TYM9^"'B:Q0;FF@8 ?A7XH?!O
M5H/@K\=[:XUHFWM[>4KN/H3Q7[RRVMO?PM;7B>9:R<.GJ*_+'_@H=^QSK.AZ
MW?\ Q$T*%3X=(PUO&N7!]0!7BU(]3OJ)[GZ;?#'4XO&G@'3=:L)$DM+E5*-N
M%>:?M)?M'Z%^SG-91Z[=+ UT,H%.2:_)3X;_ +7?Q3^'NBQ:3:7MZ^EPIMAA
M5& 3TK UKQ!\2/VH?&VFV>MSW=_<R2>7 TL;;8\GWI>TTT)]IIH?K'=_%+2_
MVEO@3J<FB2_:H&!'%?E)8WR_"/X]S)< QHMP%/MDU^N'[%O[.LW[/OPN?0O$
M86XGNP9?EY'S<_UKX'_X*!?LC^)_!/B_4?B%;()M$OI08XXERZ<^U$T[)A.]
MDS]7?A?&^L?#/P[>1LA6X@5E^8=Q7DO[07[57A7]GO68M*UZ]6WO)5W*H.:_
M*;P/^V9\6_!6BKI:W]_-:PQ[+9=C#R\=*Y&3_A8G[57Q,TZRU.6XOM8NCY4<
MT\;!4!]<T>TTT%[330_8;P[\;-.^,'@.74-,F\ZVDB;##Z5^.7C5?^,D+A?^
MHS'_ .ABOUV^"/[/]Q^S_P# %?#^JA9]9CA+-)'SU%?CS\7HM3M?C'KUW#97
M"317QD0^4W4$$'I14O97%.]E<_H.\)V$A\ ^&_F3_CRC_B_V15UK-X5W$J1[
M-FOPPM?VV?C+9V-O:1WU\(8$"(NU^ /PKWG]B+]J3XF?$3X^:9HGB&\NKC39
MP2ZNK +TZYJU43T+51/0_5*+_6#ZU^7O_!8S_D</"_\ N'_T$U^I5U&L5\RK
M]T$5^7'_  6'MYYO&'A@QP221JA)D520.*=3X!U/A/H+_@E#_P FYW?_ %V;
M^M?8L><XKX[_ ."44<L/[.MXL\+P-YS8$@P2,GFOL3/EV=U-_P \8R_Y"G#X
M4$?A1\W_ +='Q^M/@C\/;O2[J;RI-6@:- .IR*_-3]A/X2^(/'/QRTKQ1;6)
MFT:VNV>:9QD<MFMS]OGXV7_QZ^)5OX?L]+NVETV<PJS(<,<D<<5]W?\ !-7X
M.W?PL^$MVFMQ 7MR_FIQTSSBL_CF9_%(^OITCA9$A54C"*,*,#I7C'[37_(*
MLZ]B5LM7CO[37_(*LZ]O+?\ >Z9AC/X$CH_V5/\ D5[O_>KVRO%/V4_^17N_
M]ZO;=HKS<T_WVIZF>%_@Q&T4[:*-HKRCKN-HIVT4;10%QM%.VBC:* N-HIVT
M4;10%QM%.VBC:* N-HIVT4;10%QM%.VBC:* N-HIVT4;10%QM%.VBC:* N-H
MIVT487N<4!<;13OE_O#\Z/E_O#\Z N-HIWR_WA^='R_WA^= 7&T4[Y?[P_.C
MY?[P_.@+C:*=\O\ >'YT?+_>'YT!<;13OE_O#\Z/E_O#\Z N-HIWR_WA^='R
M_P!X?G0%P50ZN#_=K\F_VLOC!\4/A3\3-6F$;1Z(TI$#\\C-?K)E1T8?G7Q_
M_P %&/@3<_%7X<P/HJ+%>6S&21E'51S3)9^6OBSXU^(/'FO6&M:BQ-W9$/%S
M7JO@#]IKXF_$CQ19^'=,W37;[51 3TKYRU"W;1;JYLI?FFM3L?'J.*^Y/^"<
M?[,>L>(?%FG_ !,\Y(]+MWP8WZFJ(1^D_P $[/6-/^&FEP:^GEZJJ?O5/KQ7
M:U)(R,?O"F_+_>'YU!HF-HIWR_WA^='R_P!X?G0.XVBG?+_>'YT?+_>'YT!<
M;13OE_O#\Z/E_O#\Z N-HIWR_P!X?G1\O]X?G0%QM%.^7^\/SH^7^\/SH"XV
MBG?+_>'YT?+_ 'A^= 7&T4[Y?[P_.CY?44!<;13MHHP* N--8OC+_D!25MMU
MK$\9?\@*2M7\)-+^-'U.#^&__(:E_&O26^\:\V^&_P#R&I?QKTEOO&N2&Q[.
M,_BBCT]L5\._&O\ X)I^'?B]\1[_ ,4W5W<I-='+*DI K[A_A)]B:_-#]H[_
M (*#ZS\+?B]JGANWL[Z2&V. T:G'X5JKGGRMU-G_ (=&^%/^?R[_ ._Q_P :
MLZ;_ ,$B_!K7T8NKR[^S_P 7[TUXO_P]&U__ )\-2_[]G_"C_AZ+KW_/AJ7_
M '[/^%/4SO ^VO@K_P $Z?AI\#?%D?B31S+<ZA&, 7!W*/IDU].)'_"@55'8
M<"OR6\/_ /!3;6K_ %:"!]/U'#N%^X?7Z5]7?M0?M5W/P:^"?A3Q7':W,TNJ
M(K%8QR,COZ4F5%I(^NV4KUI*^:OV&_VC9?VD/">HZE-;3VS6S;<3C&?I7TK2
M-$[G+_$#_D&)5;X2_P"KNOK5GX@?\@Q*K?"7_5W7UJ(_Q#ME_N4COJ***[3P
M HHHH **** "BBB@ HHHH **** "G+3:>E1+8N.X44IS2\UD:C:*=S2<T )1
M2\TIS0 VBG<T#- #:*7FE.: &T4[G% S0 VBEYI3F@!M%.YHYH ;12\T<T )
M13N:.: &T4X9I.: $HIQS1SB@!M%.&:3F@!**<<T<T -HIPS2<T )12\TO-
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M&W7_ %W;^==D/]WGZH^:K:9YAO\ "SZ\;K24YB<TF3Z5Y)^EB44N3Z49/I0
ME%+D^E&3Z4 )12Y/I1D^E "44N3Z49/I0 E%+D^E&3Z4 )2_\LY/]TT9/I0<
M^7)_NF@#Y:\'_P#)4-;_ .NI_G7>_&HX^$>MGI^X;^5<'X-Y^*&M_P#74_SK
MV+Q%X?@\5>'+C2+H[;>X3:Q'O7YYD?\ "F_[S_,^\SCXX+^ZOR/YZO'%Q'_P
MMQCN&!< $_C7Z5?M)2*O[%OA)BP"^0.?PKO-6_X):?#;6O$1UF6^N%G9]Y0'
MC/YU[3XT_9G\/>.OAII_@:]E==,L4V1L.I%?95*L9.-NA\E3IRBI7ZGY.?L!
MW:Q_$U0LF&-R",'WK]O!=2_9[?YV/[L=_:OF'X3_ /!/'P'\&]<&JZ3=S2SA
M]X#GTKZ>"D1HO91M%<]>2J2O$WP\.6-I%?49&?0]5+$G_1GZ_P"Z:_G\OI$_
MX:MD;<-O]O\ 7_@5?T$RQ^=:SV[?<F0QM]"*^19O^"7_ ,.YOB$?&)U*Z%X;
MK[7Y&[Y-^<],U>'FJ=[D8B#FU8^GF\/VWB[P'8:1>J)+2>S0,C<@_**_#W]N
M3X+7OPQ^,6KR6^EO;:&[XBF5,1YR:_=RUMQ96=O;1_<@C$:GV Q7FOQ\_9U\
M-_M&>$1X?UY!;QAMPN(QA\_6HHU/9RN]BZU/VD/,_.#_ ()&N!X^U]<_-L4X
M_"OT$_; \,PZ]^SUXH862W=\MNWEC;ELUB_LZ_L0>$?V9=3NK_0;V>\N+D8=
MIFR:]M\76<=]X9NX)E#1LI!5AQTIU)J57G04HM4N5G\VEU)JFGQOI=PUQ @?
MYK63(&[Z5^W'[!7P+LOA[\*]&\3P[1<ZA "P4<\BOR\_:FT2T@_:2GL(D6*
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ML9],4ZVT)='TRUL[6VBMX+:,1CR\#( Q3,_+6\596-$K*PY32K2+2K3&<O\
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MG;ZWO-3L]'GAEVF"XF5,XSD\UU*5HIG*X^\T?F7XFT7QE^QO\:C:6UX;37+
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M #/SG_X:.^(?_/S-_P!\&C_AH[XA_P#/S-_WP:_1C_A4_@__ *%^S_[]T?\
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M )\O[PY,1_.?,7_"XKC_ )YS?]\FC_A<4_\ SSF_[Y-?3O\ P@/AW_H$V_\
MWS1_P@/AW_H$V_\ WS1_:&"_Y\O[PY,1_.?,7_"XKC_GG-_WR:7_ (7)<?W)
MO^^37TY_P@/AW_H$V_\ WS1_P@/AW_H$V_\ WS1_:&#_ .?+^\.3$?SGS'_P
MN2?_ )YS?]\FE_X7)..D<W_?)KZ;_P"$!\._] FW_P"^:/\ A ?#O_0)M_\
MOFC^T,'_ ,^7]XO9XC^<^9!\9)_[DW_?)H_X7+<?W)O^^37TW_P@/AW_ *!-
MO_WS1_P@/AW_ *!-O_WS1_:&#_Y\O[P]GB/YSYE_X7-<?W)O^^30/C-.O\$W
M_?)KZ:_X0'P[_P! FW_[YH_X0'P[_P! FW_[YH_M#!_\^7]X_9XC^<^9O^%T
M7'_/.;_ODT[_ (75<?W)O^^37TO_ ,(#X=_Z!-O_ -\T?\(#X=_Z!-O_ -\T
M?VA@_P#GR_O%[/$?SGS3_P +KG'\$O\ WS2CXV7']R;_ +YKZ5_X0'P[_P!
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M'L<#R!65_P %*?\ DV?4_P#KLG]:UOV#_P#DAOA__K@*9)])GO1112&%%%%
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M\F_9^_Y&#5_^NQ_G7S6,=\RPOS/H<,K9?B?D?2./E'THI?X125]^?#!1110
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MU_@>'?\ #+MA_P!!.;\S1_PR[8?]!.;\S7N-%'^KN6?\^5^(_P"WLQ_Y^O\
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M ,6@\/\ _7LO\J]XCPTH!Z5Q2^)G*]Q8+66?[BYJQ_9ER/\ EG^HKXM_;/\
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M[M058B^[4R&AU%+14%"44M% "44M% "44M% "44M% "44M% "44M% "44M%
M"44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M%
M"44M% "44M% "44M% "44M% "?A5#4->TS275+V_M;1VZ+/*J$_F:T*^*/\
M@H?\!]8\;:$WC'3->N]+&DP9:*W<J&P.^* -_P#X*/:[I5]^S3JB6^I6LTS3
M(4CBE5BW7/0UK?L->(-%L?@7H"3ZM:0SB  Q22JI'YFOQBE\8^(M:ADM]0UN
MZO;97*^5+(2O'UJ2U\5>([5H;.PUR[M5D.R.*.0@9/:@#^B^PUBPU7<;.\M[
MO;U\F17Q^1JW7Q!_P3-^'_C+PKX2U*]\637DOVG#P&Z).0?3-?<% "44M% "
M44M% "44M% "44M% '.?$3_D2M7_ .N!KYU^!OS2,IY!D(_6OHKXB?\ (E:O
M_P!<#7SI\#?]<W_70_SK\^SS_D:X;T?YGW>2_P#(MQ'JOR.X\1?LZ_#/Q7J,
ME]J_AFUO+R3EY'0$FJ%E^RW\)=-N4N+7PC9Q3QG*L(QD&O4&C9FX%(8V7J*]
M_GEW/%]G$KZ;8V^BVJVUC&((%& BCBN"\0_LW_##Q?K3ZQK7A>UO=38[FN)$
MRQ->ATX1LPR!4J36Q<H1>YFZ'X;TOPO:):Z3:K:6\8VK&@P *37_  SI/BS3
MY;#6+1;RSE&'B<9!%:/2@#-*[W*Y5:QP/A/]GGX;> =6_M7P[X:M=.U'KYT:
M8-=Q?V5OJUN\%Y&)H7&&5AU%6&C9>HQ3:;DWN*,5%61YE>?LM?"74+AY[GPC
M9RS2'<S&,<FKOA_]G7X9^$[Y;W1_#-K9W:_=D1 "*]"$;-T6D9&7J,4^>7<C
MV<;C=JK;FW _<,-I7VKSG5/V:/A9KMU)=:AX5M+BXD.YW9!DFO1Z=Y;=<4E)
MK8J4%+<\J_X9/^#W_0G6?_?L4?\ #)OP>WH__"'6>Y#N4^6.#7J>,457/+N3
M[*)3CT6QAT,:*D"KI(3ROL^.-O3%>?V_[+OPFM;A[B+PE9I.[;V<1C)/K7IE
M%)2:V*=-,K:/I=GX<TU-.TR$6UBGW8E& *\B_:M^-O\ PI?X<Z@1I4^JOJ%N
M\2K I;;D$5[-M([54U+1=.URW:#4K&&^C(P%F0,!^=$96=V*4=+(_(O_ ()_
M?LPZO\7OB-??$"Y1M.M]/OFG6&92I.6R>M?L'))N6,?W5"_E6!X3\%:9X+CG
MCTBTBLXYFW,L*A1^E;OEL.U:5:CJ2N9TJ2IJQ5U4_P#$KNO^N9_E7EG[/G_(
M?U;_ *['^=>I:MQIEU_US;^5>6_L]_\ (?U;_KJ?YU\YBO\ D987YGOT/^1?
MB?D?20^Z**%^Z*6OT(^!$HI:* $HI:* $HI:* $HI:H:YJBZ+I-U?,-RP(7(
MH"]M3SGXP>#?AW=0RZUXKT.TU:[B7Y8W ,C>P%><6/B2'Q=I2:-X TZ3PJ8N
MC*NT8JY:^'5^*_BY?%[W["V@.S[%N^0X]JVIO$4NCW]XD.E);6T*%A,BXSBM
MDM-3QJV)JUKPB[1,KPQX*^S226_Q$URWU&24[84NI "?IFO,/BO^V+X-_9:\
M<6O@RRT?[0UW\P^SCKFO./'5QH_[3WB"ZNK?Q@^E:KX=D+164$I!F8'H17S]
MIOAB^^(G[6'AR+QE"UG<0D1Q1W YD4=#S2;["IT8K670^Z/A'I_BKQYXT;XA
MS:F\?ARZ7Y-,<\KGVKWAI!Y^]!@9R*\8\(ZOK^A_%J;PHNEO!X<A0>7<*N$-
M>SW.RS9I93L@0Y+'IBJ1C/<\A^.GAC3=2F37;_RS<6JY5GZBO#/%.GP_$+PN
M8TVNBG/J.*]1^+&DW?QB\:V.AZ!*]QI$QV7%S"3B/US7(ZIX9T[X0^)#X+@O
MOMDH7=ECSS7O9944;Q6^YOA%=2:[G;?LG_%2+QYI^M> )X&4Z?;-'&6'&<8X
MKPRVT.^^#?CK4[/5)&;[?<L8=W8$FGIXVO\ X ^.K/4])L?M#ZG<+'+M'0$B
MO:_VNOA[=^,+'PUXTL[=D%O L\X0< XSS7;IA<5_<J?F>E\43A;/7-.^%'BN
M#QW=V?VIH<#:H^;FOM;X>^-(/B#X1L->MH7MX;M-ZQOU%?"GAV^B^(OALF=0
M8T."#R.*]Z_9E^,%[KVM3>"VTU8;/38R$N ,9 KCS/#NW/;5;^@X/H?2=%+1
M7S)L)12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )12T4 )1
M2T4 )12T4 -9 PJJZE6Q5RFLH88K*=/FU1496*=%/="I]J96"T-@HHHI@%%%
M% !1110 4444 *HW,!7AW[4W[05A\&_!&H(DX35&B)BPV"#7HOQ0^)6@_"KP
MG>ZKKNHP:?LB=X1*V"[ < ?C7Y(76M>-OV\OCI:K;V5POA:&X\F6ZB!*;<]3
M6D8]R&SHOV>?@WJW[4_Q=7Q;XEB>\T^1\YG!(ZU^LGA7PS9^#/#UKH]C&L5O
M;*%55Z5S?P;^#^D?!/P;;:!IB+)Y8YGV@,37<\GKS2D[@D)1114%A1110 44
M44 %%%% !7&?%_X>^'_B'X&U:#Q!I46J+%:RM$LBY*MM.,?C79TJ@-\K#*-P
M5/0TT)GY#?L6_'6?X$_&;4_!%UIEQIUOJ6H-'")%*C;N.*_7KY6CC93D,H.:
M_-;_ (*8>#==\+_$;PSXX\)^&EDM]+42W-Q;1 #(.<G%?6G[&?QFG^.'P=MM
M<O4\J[4^6R9Y&!6DE?4A'N=%%%9&@4444 %%%% !2CFA5+=*L1Q!>:J,7(EN
MPL<6T<]:?2T5T)6,A**6BF(2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2
MBEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2
MBEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2
MBEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH HW.BV5Y
M(9)K=7?U(J'_ (1K3?\ GTC_ "K4HJ^>7<5D9?\ PC6F_P#/I'^5'_"-:;_S
MZ1_E6I11SR[A9&7_ ,(UIO\ SZ1_E1_PC6F_\^D?Y5J44<\NX61E_P#"-:;_
M ,^D?Y4?\(UIO_/I'^5:E%'/+N%D9?\ PC6F_P#/I'^5'_"-:;_SZ1_E6I11
MSR[A9&7_ ,(UIO\ SZ1_E1_PC6F_\^D?Y5J44<\NX61E_P#"-:;_ ,^D?Y4?
M\(UIO_/I'^5:E%'/+N%D9?\ PC6F_P#/I'^5'_"-:;_SZ1_E6I11SR[A9&7_
M ,(UIO\ SZ1_E1_PC6F_\^D?Y5J44<\NX61E_P#"-:;_ ,^D?Y4?\(UIO_/I
M'^5:E%'/+N%D9?\ PC6F_P#/I'^5'_"-:;_SZ1_E6I11SR[A9&7_ ,(UIO\
MSZ1_E1_PC6F_\^D?Y5J44<\NX61E_P#"-:;_ ,^D?Y4?\(UIO_/I'^5:E%'/
M+N%D9?\ PC6F_P#/I'^5'_"-:;_SZ1_E6I11SR[A9&7_ ,(UIO\ SZ1_E1_P
MC6F_\^D?Y5J44<\NX61E_P#"-:;_ ,^D?Y4?\(UIO_/I'^5:E%'/+N%D9?\
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M 4444 %6(ONU7JQ%]VID-#Z***@H**** "BBB@ HHHH **** "BBB@ HHHH
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M]$,2L> V< 5"HQG4M'9%.M*-.\MSZ\\=_P#!3_PE9WVW1;_S(<]0,UM?#_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!\)?M'?MC^*OAU\0W\/Z.RC9,$(([9K[ ^%WBW_A,O
M!.DZE)(K74T"M, >C5\1?MU?!5]%U"X\;84K+)D8ZYKJO^">/Q(O?$EOJ-A?
MW6Y(4Q$CM7O5J%.>$C5I+;<U:7+='V^WW37R!KG_ "<1<5]?G[IKY US_DXB
MXKX7-=J7^)'@9G\-/_$CVU?]6*7!I%SY8XI>:U$)1SFBBD A[4M'-!S0 #-'
M- S1SZ4 +WYI3FDZFE.: "D[T[FF\YJ2D+2LOF1/&WW7&#12]J0'RQ\</V-M
M(^(/Q,T'Q#%&TPM90\F[D=<U]-Z+HMKX=T^"SLD6.)$"X48J_'(R*0.E-&=W
M2J<FU9EN3:L#9IXZ4UL^AI_/I4B%7)I5SNI%S3E^]04+S2\TGX4XY/:@$"BG
M &FKGTIXSZ4%#^:49Q2?A2@\4%(<N:<N::N?2GC/I04/IW--YIW-!0],DBO+
MOC[_ ,BG>_[E>I)G(X->6_'W_D4[W_<KEQ7\&7H<N*_@2.F_9@_Y)79?[YKU
MNO(_V7_^25V7^^:]<KU\#_NU/T1UX/\ W>'HB";[U8/C+_D!25O3?>K!\9?\
M@*2O0?PG?1_BQ]3@_AO_ ,AJ7\:]);[QKS;X;_\ (:E_&O26^\:Y(;'M8S^*
M%%%%:'$%%%% !1110 4444 <O\0/^08E5OA+_J[KZU9^('_(,2JWPE_U=U]:
MB/\ $.R7^Y2.^HHHKM/ "BBB@ HHHH **** "BBB@ HHHH *L1?=JO5B+[M3
M(:'T445!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %>#?M">-+_ ,.ZM86MB7,DJ\*A
MZU[S7SY\<,#XI>&R0&&5X-?,\12G' /V<K-N*OZL^BR&,)8U<ZNDF[>B//O^
M$J\:_P#/C=?D:/\ A*_&G_/C=?D:^K5F@$4?^CQ?='\(I!-!_P ^T7_?(KPO
M]7JG_07+[CV_[=I_] L?O/E/_A*_&G_/C=?D:/\ A*_&O_/C=?D:^K/.A_Y]
MHO\ OD5E^*O%VC^"]%FU?5UAM]/A&7D*CBC_ %>J?]!<ON#^W:?_ $"Q^\^9
M_P#A*_&O_/C=?D:/^$K\:?\ /C=?D:](\-_MC?"3Q9K!TK3-9M[B]!QY85>M
M=+\3/V@/ ?P=L;.[\5WD&G078S"S*/FJO]7*M[?6Y?<3_;].U_JL?O/$O^$K
M\:?\^-U^1H_X2OQK_P ^-U^1KK!^WU\#>O\ PD5M_P!\K1_PWU\#O^ABMO\
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M&/B*]\6>!=(U;4(UBO+J$22(HP :ZBOA9)Q;3.@****0!1110 4444 %%%%
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M_GTC_P"^*/[!QG9?>']J8?S^X^^Z*^!/^&X?&7_/I'_WQ1_PW#XR_P"?2/\
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M^D?_ 'Q1_P -P^,O^?2/_OBC^P<9V7WA_:F'\_N/ONBO@3_AN'QE_P ^D?\
MWQ1_PW#XR_Y](_\ OBC^P<9V7WA_:F'\_N/ONBO@3_AN'QE_SZ1_]\4?\-P^
M,O\ GTC_ .^*/[!QG9?>']J8?S^X^^Z*^!/^&X?&7_/I'_WQ1_PW#XR_Y](_
M^^*/[!QG9?>']J8?S^X^^Z*^!/\ AN'QE_SZ1_\ ?%'_  W#XR_Y](_^^*/[
M!QG9?>']J8?S^X^^Z*^!/^&X?&7_ #Z1_P#?%(?VXO&6/^/2/_OBC^P<9V7W
MA_:F'\_N/ORBOCGX0_M?ZWXT\866CZC''&;APO Q7V-7EXK!U<')0JK5G=0Q
M$,1'FIA1117"=(4457OK^#3;5[BX<1Q(,EC0!8I.E>-^+OVJO 7AVWNHQK$;
M7L8($?'7\Z^1OB)_P4(\3VFH26VDQ1R6A) D5><5WT<#7K?"OO+46SZ@_:NM
M?#/CKP#/HE[K=O:W,;%PF\9Z5^?'P@\;S_"SXI6NEZ?*SV\MRL?F(>&&<53F
M/C7]H+Q%+<V GENY>3&I.*S_ !1\-/%?P<U"QU+Q#9M;/&P>-F'4BOIL-AXT
M*;H2E=OH;QC96/V6TN;[5I=I*#GS(5;\U%?&?Q(\0)X5^.EQ>28X[&O6OV._
MBK?_ !5^'37E]C=;LL2_3'_UJZGQI^SOX<\<:\^JWS2+</UV]*_.<WP=:=J=
M/XHL\+,,/5K02I;IW/(?^&A[91CRT_.C_AHBW_YYI^=>A_\ #)?A+_GI/_G\
M:/\ ADOPE_STG_S^->+]7S/NCROJV8=T>>?\-$6__/-/SH_X:(M_^>:?G7H?
M_#)?A+_GI/\ Y_&C_ADOPE_STG_S^-'U?,^Z#ZMF'='GG_#1%O\ \\T_.C_A
MHBW_ .>:?G7H?_#)?A+_ )Z3_P"?QH_X9+\)?\])_P#/XT?5\S[H/JV8=T>>
M?\-$6_\ SS3\Z/\ AHBW_P">:?G7H?\ PR7X2_YZ3_Y_&C_ADOPE_P ])_\
M/XT?5\S[H/JV8=T>>?\ #1%OU\M/SI?^&B;?_GFGYUZ%_P ,E^$O^>D_^?QH
M_P"&2_"7_/2?_/XTOJV9]T'U;,.Z//?^&B+?_GFGYT?\-#V_7RTKT+_ADOPE
M_P ])_\ /XT?\,E^$O\ GI/_ )_&CZMF7=#^KYAW1Y[_ ,-$6^/]6GYTX?M$
MV^/]4GYUZ!_PR7X2_P">D_\ G\:/^&2_"7_/2?\ S^-'U;,^Z#ZOF'='GW_#
M15NO_+-/SI?^&BK?.?+3\Z] _P"&2_"7_/2?_/XT?\,E^$O^>D_^?QH^K9GW
M0?5\P[HX)?VAH9.%B5CZ TLG[1$,7WH5'UKB/VN_ /A_X!?#VWU[3Y9$E>;R
MCYA^G^-4OV3?!^@_'?1[F\OYG8Q(&PA]<4?5<S[K[Q_5\P[H]#7]HRW_ .>:
M?G2_\-&6_P#SS3\Z[S_ADOPE_P ])_\ /XT?\,E^$O\ GI/_ )_&CZMF7=!]
M7S#NC@_^&CK?_GDE._X:/M_^>2?G7=?\,E^$O^>D_P#G\:/^&2_"7_/2?_/X
MT?5LR[H/89AW1PH_:0MA_P LD_.E_P"&D;?_ )Y)^==S_P ,F>$O^>D_^?QH
M_P"&3/"7_/2?_/XT?5LR[K[Q^PS'NCB/^&DK;_GDGYT[_AI.V7_EDGYUVO\
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M[5>K$7W:F0T/HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-[76[;PW;_V[/Y]VZ*V<],BI;CX:>%[G4%OI-$M&NU;<)MGS9]:Z55"J !@
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MKTG]EG]IRX_:"\62WPMGM+61"RPGH* /K*BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9^&;Q9+M$U=X\V\!/+&OSAU35-=^)OBA]8N)IA<NQ'V<,=N/I7K/_!187?\
MPMCPYY);RO+7.#QVJ'X<:#;QZ?'?[/\ 2,=:^WRNE3H8?V]KR9A4=W8R]'^$
M]K=6Z27:^7,1EN*W[/X:Z?9\(0Q^E=6S%FR:0-M.:[76G+J9G.:/\-?#_C[Q
M-%X7FNO*NY#G:O6O8?C)\0M/_91^%UKI?ABW@OM5(\F0, 6 (QFLCX&^!+6Y
M^+UMKS#,Z(<<U\S?M4>*M1U;XZ:UITTI:UCE^5<\5R8>E_:&-5&H_=CJUW/"
MSW'SRW!.K3^)Z'G4UUK?BW69]5DU"ZA>Z?S'C20@+GMUK8D\,W5Q& VKW:G_
M *ZM_C6KIMK':VL?EC!8<U:52[;1R:_2H4:<5:Q_,F(S7$U:G-&;1ZI\#?VC
M=4^&DT&BZ@QN--/[M99CGK7J_P"T5IH\/:?H>OZ/$)/[68-)M' SS7R;>V*7
M1C6=3B-@WY5]0?"G7[CX_P#A5]!A):72(ML1DZ @<5\3G>!AA9QQE%674_8>
M",^K8URP6*DVTM#D]2UIK2&&VM!YNLRJ#%!W8FL[XL?L7W'CWX2OXHU!IXO$
MC#<UCSMQ]*^A_@E^SW)I%RVK^+X!/K%O+_HS \!:]_NK>.ZM9(I%#(RD$$>U
M?&XS'<Z]G2VZGZ]&-M3^<GQ)HTWA7Q%=:4VZWGMV*G;P14_A_P 8Z[X;U&&\
M@U:[8Q'(3S#C^==O^U%H\NE_'[Q23&R0&X;;D8'6O+Y9#&I.UB/4"O$-#Z^\
M!_\ !3[QOX%TV'2O[/CNHE(422C<:_3']G/XH^(/BQX-LM>U6Q6UAN8]RLJX
M!XK\O?V'OV>=)^+GC:SD\0QI-I1.3&3R2*_8OPOX8T[P;H=IH^E0?9["U39%
M'Z"@#6HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ILD@CC
M9VX51DTZJ>LQRS:1?1P_ZYH'5/\ >*G'ZT ?E%_P5<\86OBCQ5HD5K*&6U&U
ML'-?#%O,MY,L,)WRG@+BONCQ%^PK\7_BI\6I]1UO;+H NBV&/\&?\*^PO!/_
M  3V^%VB65O+>Z1YM^H!9L@8- 'Y:>!_V7?BYXDGTW5]'TR\BL1*LBS0Y&X9
MS7[0?L_WGB/_ (073;#Q%9-;7-I L>]NK8'>N\\,^&K#PCHMMI6FPB"SMUVH
M@K5H **** "BBB@!**6B@!*-H]*6B@!-H]*-H]*6B@!,#THI:* $I:** "BB
MB@ HHHH \C_:0^(?BOX;^#?[4\*:8-3NT),D97.%'>OR*_:-_;%\1?M":A_9
MVO:;':/IY,>Q5Q@U^Y-]8PZE9RVUP@DAE4JRGN#7YW_ME?\ !/5=8D.O_#NR
M6V=MTMXN>2>] 'YC7&Y8R Y"%N4'2OU+_P"":]G''9P2J &,7;Z5^9/C;PIJ
M7@75&TS4X)%G5L%MO'6OTX_X)L29LX%_Z9?TH _02BBB@ HI-P]:-P]: %HI
M-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI
M-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HI
M-P]:-P]: %HI-P]:-P]: %HI-P]:-P]: %HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAA@C(]*6B@"NNGVL;;EMH5;^\(P#5BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /B3_ (*N?\D'LO\ K[_PK$_X):_\BGJ/_7)?Z5M_\%7/
M^2#V7_7W_A6)_P $M?\ D4]1_P"N2_TH ^]J*** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@"";[U8/C+_D!25O3?>K!\9?\@*2J?PET?XL?4X/X;_\
MAJ7\:]);[QKS;X;_ /(:E_&O26^\:Y(;'M8S^*%%%%:'$%%%% !1110 4444
M <O\0/\ D&)5;X2_ZNZ^M6?B!_R#$JM\)?\ 5W7UJ(_Q#LE_N4COJ***[3P
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MYPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_/A!_P!\"C^Q<?\ ]!C^X/[7P7_0)^)\U_\ "Z]?_P"?"Z_[Y-'_  NO7_\
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MUXAZA^$GQSX^.L9'7[4?_0J_8+]D;9??!>*WNQYUNRX*'ITK\?/CI_R71/\
MKZ/_ *%7["?L=PO)\'X JY.T5QT?B9O4V1\-_P#!3S]G/3/A[IUKXOL88X7O
M9P/D&#R16[_P35\::K=?!OXA":\DDDLH&%NS'E/EXKL?^"N7C#1=2^&>C:5:
MWRRZC!<+YD ;)7D5YC_P3/MS)\'_ (G-V$+?^@BEM5T#[&IY%\*_CM\0M0_:
M4M--N?$MU+9-=%3 S_+MS7Z\37LZ_#V>X#GSQ;%@_OBOQ1^#RE_VJ[(#D_:6
M_F*_:NXA=OAM< +S]E/_ *#546VG<53='XX6GQY^(;?M,16!\47IM3K(A-OY
MG[O9NZ8^E>^?\%-OBQXQ\#^./"]OH6NW6F6\U@CR+;OC<V!7R39C;^U="#_T
M'A_Z%7T7_P %8?\ D??"7_8/3_T$5C=\DC1I<R/$/!OQ2^.'Q%MQ8:;K&JRQ
M8W?:@&Q^=5-&_: ^*OP_\<65MK7B'4D2"Y594G8A67//-?J;_P $X?#FD3?L
MLZ7=3Z/;37##!G:,%CQZU\D_\%2O .E>&3IE]8VT4$MQ-\WEJ!3<6H\UP4DY
M<MC[.\2?&U/'W[)>M:]X>NA%JEG8\W$3<A@O6OSK_8I^/GQ%\4_'O2]/U7Q5
M?7]C-N,L$\F5ZCI7J?[$=Q-/^Q?\51+*TJJCA58D[1CH*^<?V"/^3C-(_'^8
MIRDVXL2BDFC[1_X*W$M\+] )Y/GI_,5PO_!,N\GTWX'_ !/N[5S%=11,8Y!U
M!VUW7_!6[_DEN@?]=T_F*X#_ ()K_P#)!/BI_P!<6_\ 0:M_QB?^79\Y^"_V
M@OB1=?&1+.7Q1>/!]J93$9#MVYK]@O">JWD_P3^W2S,]Y]F+>;GG.*_$'P#\
MWQV3'/\ I3?SK]N/!T3-\!\ <_9#_P"@T4&W>X5.A^1>G_'CXAR?M*V]DWBF
M^-L=:6$V_F?N]F_ICZ5[U_P4V^+/C'P3\1/#=MH6O76EVLFGK(ZV[XW-@=:^
M2]-&/VJ+8'_H/+_Z%7T3_P %8/\ DI7A?_L')_Z"*QN^21I9<R/(/!?QL^,O
MQ(L1HFEZSJ33*-WVI2W(^M<[_P +X^+/P[\6VQU3Q#JBM9W"F2.1CMD /(Z>
ME??7_!-'2=*N/!MK)/IL$\IC.9'0$]*\#_X*8:'8:7XB@DM+6*W+S'/EJ!3<
M6H*5Q<RYN6QE?%[]IKXD_M(C3;WP*VI:9;:?"(KE+<D;V Z\ UYGX _:C^)7
MP=^($$WB+5=1NX8S^]L[A^WJ!7WM_P $B]%TN^^&NIF[TZWN7+9W2(#7Q3_P
M4ELK6P_:8U:*SMX[:$(,1QC ZFE*]N>X1M?EL?I_K_[2P\,_L\Z=XSCTN:_E
MU:V_=I&"60D5^6&H_%+XX?%3QQ<0Z==ZU80W5P1&NQPJ*3QSBOTY^%OB3PCX
M2_8_\,WOB^XM[>&.T#0+<8P[ <#FOC"W_P""A>M?\)7=6'A#X?6.IB.8I \,
M()< X!X%;5-;79$>MD>!^-OB3\8?@3XMBL-5\47TK@"3:SG!'<5^MO[*_P 5
MD^)G[/IN+B<3ZBUBQD).6^Z:_(']JKXE>,/B7XL&H^+O#?\ PCUV0,1%-O%?
M;W_!-&ZG;PSJ<33,T0L'PA/ ^4U%-^^UT'->[<_.GXG37=I\:/$$M@66\CU.
M0Q%.N[=QBO2[[Q-\>?\ A&_[;N-9U>WL[=1MR6'R^V17/M&DW[6#)(@DC;Q
M04;H1OZ5^W'Q>^'^A:]\%$T[^RK:V6:S7YTC (^45$(\U]2Y2Y;'YY?\$_?V
MLM?UCX@1:!XJU.6[3;Q)._7_ .O7ZAZI<)>:#>7$1!B>,E2/I7X/'3W^&O[1
M4MCI<A54FP"G'>OV^\ SO=?!73IY23(]J"2?I75AY/9F%5+='R=X>_Y.,T?_
M *^/ZU^DM?FUX>_Y.,T?_KX_K7Z2UZ^>_%1_PGGY7M4]0HHHKY8]P**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^)/
M^"KG_)![+_K[_P *Q/\ @EK_ ,BGJ/\ UR7^E;?_  5<_P"2#V7_ %]_X5B?
M\$M?^13U'_KDO]* /O:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M @F^]6#XR_Y 4E;TWWJP?&7_ " I*I_"71_BQ]3@_AO_ ,AJ7\:]);[QKS;X
M;_\ (:E_&O26^\:Y(;'M8S^*%%%%:'$%%%% !1110 4444 <O\0/^08E5OA+
M_J[KZU9^('_(,2JWPE_U=U]:B/\ $.R7^Y2.^HHHKM/ "BBB@ HHHH ****
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MVB?\^,U7"GPW3DIJHM/Z[$2J<03BXNF]3V>QL8M/MUAB&$458KQ#_AJ;1/\
MGQFH_P"&IM$_Y\9J^I7$&515E61\V\CS.3NZ+/;Z*\0_X:FT3_GQFH_X:FT3
M_GQFI_ZPY7_S_7XB_L',O^?+/;Z*\0_X:FT3_GQFH_X:FT3_ )\9J/\ 6'*_
M^?Z_$/[!S+_GRSV^BO$HOVI-#DD"FSF7/<UZSX:U^'Q-I$.H6XQ%+TKNPF9X
M/'2<</44FCBQ678O!Q4L13<4S4HHHKU#S0HHHH **** "BBB@ HHHH ****
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MB;_SSKZ3^W/ZT?;G]?TH_P!7J'_/^?WA_;M?_GS#[CYL_P"$2^)O_//]:/\
MA$_B;_SS_6OI/[<_][]*/MS^OZ4?ZO4/^?\ /[P_MVO_ ,^8?<?-G_")_$W_
M )YT?\(G\3?^>=?2?VY_6C[<_K1_J]0_Y_S^\/[=K_\ /F'W'S9_PB?Q-_YY
MT?\ ")_$W_GG^M?2?VY_7]*/MS^OZ4?ZO4/^?\_O#^W:_P#SYA]Q\V?\(G\3
M?^>='_")_$W_ )Y_K7TG]N?UH^W/ZT?ZO4/^?\_O#^W:_P#SYA]Q\V?\(G\3
M?^>='_")_$W_ )Y_K7TG]N?U_2C[<_\ >_2C_5ZA_P _Y_>']NU_^?,/N/FU
M?"'Q.D.!'5/P=XV\2:'XR?3-0.)U.&6OJ&&\9FP3VKY:UB0R?&J\8G)WUXV9
M8!96Z-6A6DVY6U9Z^7XW^T55IUJ44E&^B/JG3IFN+&"5_O,H)KDOC+_R3K5O
M^N==5H__ ""[;_<%<K\9/^2=ZO\ ]<Z^^QVN!J-_RO\ (^'P>F-IV_F7YG._
M .3'PWM_]XUZ!YGO7F_P'?'PYMQ_M&N^\RO,RN7^P4/\*/4S&'^VUO\ $RSY
MGO1YGO7(?$+XD:/\,O#=WK&JW4,2VZ%_)=P&;Z"OC75O^"PWP_TN^DMET*YG
MV,5+1J2./PKUH\TMCRI-1/OKS/>CS/>OBSX8_P#!4KP'\4-<32XM.DT^5R &
MG^7K]:^L-4\86&F^#9_$L<R75I%#YS"-L\8S2E>.X1M)'1>9[T>9[U\'^)O^
M"NW@/PQJTVGR:'<SO$Q5FC!/3\*R_P#A\KX _P"A=O/^^#_A5\LNQ'.C]!?,
M]Z/,]Z_/I_\ @LMX 521X=O"?38?\*][^&'[:7AWXJ?!?6?B59V$EOIVEDK+
M;O\ >R*34H[E1DI:'T3YGO1YGO7Y_P!Q_P %D/ $%T(1X>NG&_:6"G YZ]*^
MS_AM\1].^*/A'3_$&G$"&\C$BQYY7-*7-'<<6I;'9>9[T>9[U5\P?Q-M'J:^
M0_CE_P %-/!GP)\?7/A.]TF;4+FW&7FA&0*46Y:(<K15V?8WF>])YGO7S3^S
M3^W-X:_:AU+4;+1M.FLI;&,ROY@QD"N+^+G_  4Z\&?!WQ!)H]]I$]W<(Y4^
M6,]#C-/WKV)NK7/LKS/>E\SWK\^_^'RGP_+?\B]>#_@!_P *](^%?_!2GP)\
M5]22RM[?[#(QQF5L4W&2Z"4D]#Z\\SWI/,]ZSM/U2WU2QAN[:9)HY5W H<U8
M\RLN<VY2SYGO2^9[U5\RCS*.<?(6O,]Z3S/>JWF4>91SAR%GS/>E\SWJKYE'
MF4<X<A:\SWKR/]IB3=X9L?\ KH*]2\RO)OVDFW>&['_KH*\3.Y7RVLO(]?)X
MVS"EZG4_ G_D ?\  !7J5>6_ G_D ?\  !7J5>MD_P#N-+T/)S7_ 'RIZA11
M17LGDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1_Y*YJG^ZW]:^EJ^9O@@W_%V-3/JIKZ3:8AB*\[A?7 R_P <OS.OB-_[8O\
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MWA]<K_\ /IGVTOCKPXO35H1_P*AO'7AQNNK0G_@5?$O_  SS\7?^?*;]:/\
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M/#HZ:O$/^!U\2?\ #//Q=_Y\IOUH_P"&>?B[_P ^4WZT?V=A?^?Z^\/KE?\
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M_A7Q^3N^?XCT_5'U&;:9)0]?T.ZHHHK],/SP**** "BBB@ HHHH */4T4O\
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M^L8I5^&OA)AD>'[8_P#;,4<N7_\ /J7WA_M?\Z^XX3_AO#P?_P! R]_[Y/\
MA2_\-Z>"E_UUG=0+_>D&!_*N[_X5KX1C9?,\/VRC/>,5\E?MZ>"?)\!ZC'X1
M\/;[HQG8UK'SG\*F7]GQ5_92^\:^MMVYU]Q[U_PWMX%?_40S7!](^?Z4G_#>
M/A#_ *!E\/\ @)_PKX7_ ."<OPQUW_A*DF\8:)<&TR<+>QG^M?I/-\-?"4EQ
M)Y?AZV89[1BE%Y?)7]E+[PDL7%VYU]QP/_#>7A#_ *!M]_WR?\*3_AO#P?\
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MI:C;GS'MW>-I%Y^[UKP']@'Y?VK?#^/^>DG_ *$*U<KJ2[&:C:4'W/JK_@K
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M'^X*]-KZ?)O]QI>A\SFO^^U/4****]H\D**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUF^?3G.'PQVX^E?5'[-/[!OA[X!ZS#XAM[LW-^JX_><FJC[1M=$2^2Q\,?\
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M8;EM(FE*^N!FN3^""_\ %OX/]ZNF\9*?^$#\0\?\NDG_ *":\'+(_P"Q4?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^Y2.^HHHKM/ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH J:S_R!+__ *XM_*OE+X9_\C9>_P#7P?YU]6ZS_P @2_\
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M 4O\+_2DI?X7^E 'Q%^UU_R/GAG_ *^5_G7TWI__ "!=._ZX+_(5\R?M=?\
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MX)ZI;6_A&))& ;<>]>N>-]#D\3^%[S3(FV23+@-7@EC^SSXJTN/RK?5-B9R
M#7PN;T\93S&&)P]%S7*UIZGV>55,+/ 3P]>JH/FOKZ'L7]M6?_/1?SH_MNS_
M .>B_G7DW_"B_&7_ $%S_P!]4?\ "B_&/_07/_?5<_U[,_\ H$E^!T?5,O\
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M 'U1]>S/_H$E^ ?5,O\ ^@I?B>L_VW9_\]%_.C^V[/\ YZ+^=>3?\*+\8_\
M07/_ 'U1_P *+\8_]!<_]]4?7LS_ .@27X!]4R__ *"E^)ZS_;=G_P ]%_.C
M^V[/_GHOYUY-_P *+\8_]!<_]]4?\*+\8_\ 07/_ 'U1]>S/_H$E^ ?5,O\
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M #[G]Z. _P"%\:'_ 'G_ "H_X7QH?]Y_RKO_ /A3_AG_ *!\?Y4?\*?\,_\
M0/C_ "H^HYW_ ,_(?<P^O9/_ ,^Y_>C@/^%\:'_>?\J/^%\:'_>?\J[_ /X4
M_P"&?^@?'^5'_"G_  S_ - ^/\J/J.=_\_(?<P^O9/\ \^Y_>C@XOCUH2MDL
M_P"5>8Z7K$?B/XF37MLK&)VR#BOHK_A3_AG_ *!\?Y5>TGX;Z#H\_FV]BB-Z
M@5S5LES3&2IK$5(\L7?1,Z*6;Y=A8S]A3ES25M6C>TC_ )!-MG^Z*YGXQ?\
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M%\TMS\+-%\3+\<?CE!>>/;MYK.:5A)@X 4'I7TG^T-\&/@)IOPSAD\$EAXB
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MM,X4-GMS7TI_P4<^,.A>%_!MWI8NX+R:\A8#RG#8S]*<I252R(C&+AJ>#_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0W_!.?\ :QU#1]>?PEXINB&5U@A$AY],&B5%6O%W'&O+FM)'Z/\ BKXP>!O
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M9X)_B<[R'+&[K&+\#YH_X)V_#'6],M=>U#Q7K5W92R#>D-Q(WS>W->!_MN>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M' X P/2HK:V6UCV)TZU+77%<JL<TI<SN &XX'6IOLDW_ #S:N?\ 'FJS>'_
MVK:K:_\ 'S;1%T^N*^ 9_P!N3XB1W$JB6$!6( (/'-85L1"BTI'9A\'5Q2;I
M]#]'?LDW_/-J:\3Q_>4BOSB7]NCXAAANEA(KV+X(_MEKXBODL_%5PL4\S!(@
M.YK..,I3=C>IEN(IQYFK^A]<4=:CM[A+JWCFC.Y)%W ^U25VGE#(=1ET>\A,
M"\.WS$5ZY8WD5]:QO$X<[><5Y',,Q/@9;'%=;\+[B2*SG2Y/SD_*#7/4CU-X
M2NK';4DB^9$\?]X8I:*R-"Q\-/%)^&^M+I?_ !\"_DZMVYKZ1_A1O[PS7RM=
M6,7]L6FIRG'V8[LU]&>"_$4?BC1ENHVW*HVUYN)C:7,CZG+ZWM*?*^AN4445
MQGJ!1110 4444 %%%% !6+XR_P"0%)6U6+XR_P"0%)4RV-J/\6/J<'\-_P#D
M-2_C7I+?>->;?#?_ )#4OXUZ2WWC7'#8]K&?Q0HHHK0X@HHHH **** "BBB@
M#E_B!_R#$JM\)?\ 5W7UJS\0/^08E5OA+_J[KZU$?XAV2_W*1WU%%%=IX 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3]++=/(7_P!!KZC$?[I0^9XE'^/5^1^#_P"W#:S67[16LQ3G,@9<_F:_9?\
M9C_Y-T\'\Y_T9/Y5^5/_  4B^'6KZ7\<M5\2FRD72YF $Q'RYSQS7U7^P7^V
M]HOB7PW:>#?$<T.B1:7"JI-,X ?%?/TVHU&F>M+6*L?>4=PEN=\DZ0 ?Q2'
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M5A_;"^.=O#"B>(-36.)=J?N6P!7%Z7%#=?M"6L<Z++ ^L*KJW0C=TK]Y]/\
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MKY\_8A_Y+)J_^XW]:]O#_P#(NKGEUO\ ?*1][2??--ITGWS3:^.6Q]"%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 % .#FBB@!WF-1YC4VB@!WF-1YC4VB@!WF-1YC4VB@
M!WF-1YC4VB@!WF-1YC4VB@!WF-1YC4VB@!WF-1YC4VB@!WF-1YC4VB@!WF-1
MYC4VB@!WF-1YC4VB@!WF-1YC4VB@!WF-1YC4VB@!WF-1YC4VB@!WF-1YC4VB
M@!2<]:2BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^&M]9_YX7?\ WR:/^&M]9_YX7?\ WR:^G/\ A"?#'_0$MO\ O@4?\(3X8_Z
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M31_PUOK/_/"[_P"^37TY_P (3X7_ .@);?\ ? H_X0GPQ_T!+;_O@4_;T?\
MGV']FYM_T&?@?,?_  UOK/\ SPN_^^31_P -;ZS_ ,\+O_ODU].?\(3X8_Z
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MWC7FWPW_ .0U+^->DM]XUQPV/:QG\4****T.(**** "BBB@ HHHH Y?X@?\
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M]M:AIJ_:LYY6O4=%U_QSH/A== M]-'V-8_*'R]L8KZ<_LBU_YYC\J/[(M?\
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M&-N.,?05#_PTIX5_R:B.!K0V@RGB:<MY(]2J#4K&'6M(O-,N45X+R,Q.6&<
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ML?XT[@.HIOVFU_Y^X?\ OL?XT?:;7_G[A_[['^-%P'44W[3:_P#/W#_WV/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#H)ZQ_X_7[=?V-I?\ T#;7_ORO^%']C:7_ - VU_[\K_A56$?B+]G^/_\
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MW*1WU%%%=IX 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M /%3Q]X_GU32+*.XM7)QN.,<U^A/P(^%/@CX$^%;2PTBYL;6^$82YFC=1YC
M<FO4%\6:;&,+K5N!_P!=!5\KM9G \5%5'*+7WGXJ_P##L7XS_P#0,A_[Z-:7
MA?\ X)I_&33?%&DW,VG1QV\-S'+)(KG*A6!_I7[-?\)=I_\ T&[?_OM:0^+M
M.((.MV^/]]:7(/ZZ^Z^\R_"=A+I/A?2[*?\ UUO;K&_U %:E5CKFC'DZM:_]
M_!1_;FC?]!:U_P"_@J]>QR<\/YE]Y9HJM_;FC?\ 06M?^_@H_MS1O^@M:_\
M?P4:]@YX?S+[SSO]I[_DD%Y7G?[#?_(2?_KF:[O]IK5]+N/A'>)!J-O-)V17
M!-<)^PW_ ,A)_P#<->C3_P!TD?&UFGQ'0L_LH^SI/OGZT@.#FED^^?K3:\L_
M52AX@\/V/BJR%IJ$2R0AMPR,\U:L[2/3[.*UA&(8QM4>U2T4 %%%% @HHHH
M**** "BBB@ HHHH =&VU@:\!^,7AB+PQJ\OBFX0^4YQE:]\JAKV@V?B;3GL[
M^%9X,9VL.]:4Y^SES&5:FJT'!GSC97B:C9Q74?W)!D5+5*^L9/#?B&[MY%,-
MF&VQ*W _"KO4 CH:]A-25T?&5*;I2<&%*K;:2BJ,C,U;PU8ZY_Q])GZ5F0_#
MO2;/_4IBNFHH P#X-L2,%.*A;X=Z1,V9(^:Z6BG=BLEL9^F:!9Z.N+9<#WK1
M9MQS244AA1110 4C,(XWD/1!DTM9>K7327%O;VO[]G<*Z1\D#WI%QBYR44;/
MPYT&V^)&O1ZC;H3]@?YBW'0U]*'[J#T&*YGP#X3L_"NCQM:0K"UPH:0 =372
MUX]6?M)7/LL/25&FH(****R.@**** "BBB@ HHHH *Q?&7_("DK:K%\9?\@*
M2IEL;4?XL?4X/X;_ /(:E_&O26^\:\V^&_\ R&I?QKTEOO&N.&Q[6,_BA111
M6AQ!1110 4444 %%%% '+_$#_D&)5;X2_P"KNOK5GX@?\@Q*K?"7_5W7UJ(_
MQ#LE_N4COJ***[3P HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ I)%$D$L1Z2*5_,8I:* /F/6?V&[#4]>
MO=4AUZ>U>Z<N5CR,9-0?\,,K_P!#9>?]]M7U'175]:K?S'S+X:RJ3<G1W\W_
M )GRY_PPRO\ T-EY_P!]M1_PPRO_ $-EY_WVU?4=%'UJM_,+_5G*O^?/XO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM_SS'Y4>R?</KM/^0\V_X277O^>/Z4?\)+KW_/']*])_LNV_YYC\J/[+MO\
MGF/RH]D^X?7:?\AY7J=]K.M1"&6'CM75_#71[O2(9S=ILW]*ZD:9;*01'S5K
M^$#L*J-+E=VS*MC/:4_9QC9!1116YYH4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !]*K76J6-DWESWD,4^,B)W 8
M_A47B+6H?#.B76I7! 6!"^TGKBOC?5--N/C1\1X/B(FO3:9I^G-Y;62.0C8]
M?RKP,[SG#Y'@Y8S$;+1+N^B.S"X:6*J*G$^NK?QE93WQM7=8<?QL<"MM7210
MT;K(I[KS7S-XB:T\=V1MM/U?R[F/YMT3<G%:WP%^*>JS:I=:%K=NUO%:GRXI
MY/\ EI[U\GPWQQA\_KO#3I.E4Z)N]SOQF5SPL/:)\R/H2B@'<H8<AN117Z6>
M(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^/K";4+2^$,"N0=S8KY#,\ZK87%1PN&I.<FKGU.7931Q6&>)Q%3DBG8^FO\
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M]HC7@RJ&_NDT?V5EW_/B(?VEC_\ G\S@/^&=/"__ #T?\Z/^&=/"_P#ST?\
M.N_\XTC7ENO#W<*-_=9P#3_LK+O^?$0_M+'K_E\S@?\ AG3PO_ST?\Z/^&=/
M"_\ ST?\Z[[[=:_\_L'_ 'V*%NHFY2='3NRGBC^RLN_Y\1%_:>/_ .?S.!_X
M9T\+_P#/1_SH_P"&=/"__/1_SKOOMUK_ ,_D(/\ OBC[9;MPMW"Q] XH_LG+
MO^?$0_M/'_\ /YG _P##.GA?_GH_YT?\,Z>%_P#GH_YUWYF/U%'G&E_967?\
M^(C_ +2S#_G\S@/^&=/"_P#ST?\ .C_AG3PO_P ]'_.N_P#.-'G&G_967?\
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M?"Y/_ 3_ (4G_#3&B?\ 0/NO^^:/]8,L_P"?Z#^Q,Q_Y\L]>HKR'_AIG1/\
MH'W/_?-'_#3&B?\ /A<_]\__ %J/]8,L_P"?Z#^Q,Q_Y\L]>HKR'_AIC0_\
MGPN?^^?_ *U'_#3.B?\ /A<_]\T?V_EG_/\ 0?V)F/\ SY9Z]17D/_#3&A_\
M^%S_ -\G_"C_ (:9T3_H'W/_ 'S1_;^6?\_T']B9C_SY9Z]17D/_  TSHG_0
M/N?^^:7_ (:8T/O87(^JT?V_EG_/]!_8F8_\^6>NT5Y%_P -,:'VL+D_\!_^
MM2?\-,Z)_P ^%S_WS1_;^6?\_P!!_8F8_P#/EGKU%>0_\-,:'_SX7/\ WR?\
M*7_AIC1.UA<G_@)_PH_M_+/^?Z#^Q,Q_Y\L]=HKR'_AIC1/^@?=?]\T?\-,Z
M)_T#[G_OFC_6#+/^?Z#^Q,Q_Y\L]>HKR'_AIG1/^@?<_]\T?\-,Z)_T#[G_O
MFC^W\L_Y_H/[$S'_ )\L]>HKR'_AIG1/^@?<_P#?-6-+_:.T+5-3@L1;312S
M':N\8IQS[+)-15979,LES&*<G1=D>K44V-A)&KCHPR*26>&W7=/,D"_WI& '
MZU[YXP^BLQO%&EJQ7[; <=PXI/\ A)K!ON3QR#U5A3"S[&I167_PDU@OWYXT
M'^TPH_X2G2_^?V'_ +[% 6?8U**R_P#A*-+_ .?R'_OL4?\ "4:7_P _D/\
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M/Z+FO66.'YCS$"?RK\S_ /@J?\1/$_A?1],;1M;NM-#3X?[/(5)%?4#?M^?
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MLTO_ ()>^"[S2[6X?Q+JOF21J[%9#CD9]:^(Y*-K\S^X_1O:XB]N1?>?5?\
MPN;P#_T-NF?^! H_X7-X!_Z&W3/_  (%?+O_  ZU\%?]#+JW_?P_XT?\.M?!
M7_0RZM_W\/\ C2Y:/\[^XKVF)_D7WGU%_P +F\ _]#;IG_@0*/\ A<W@'_H;
M=,_\"!7R[_PZU\%?]#+JW_?P_P"-'_#K7P5_T,NK?]_#_C1RT?YW]P>TQ/\
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M)''-ODBS^@#0;IKKPOHURQ^>:V1S^*BKBL6W'/W036/X7D_XHOP__P!><?\
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MU:AXALW:.YCME<,IYY7-?BII;[_VMXF]?$!/_CQK]A/V]FS^QWJH_P"G1/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$5W/_!2#]CN\^)5C=_$+1'Q)I\1S9QKEI/PINI:HXRV9"IWIJ45JCZG^"OQ
MT_\ :(^#,?B!94FBF@(VY^;@>E?B?X^N%\,?M6:B^TQ10:R!\PQQD<U]!?\
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M154_X4B9_P 6)^Q-VW^D2?6HMW%/N_\ CXD^M15YYZ*M9'B+'/QI%?3.G_\
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M_E.N38@^C9)?G;ZUXI^V=)GX :O_ +I_D:]B>3YF^M>*_MF2$_ '5_\ =/\
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M _PH_LO3_P#GQ@_[X'^%3T4 0?V7I_\ SXP?]\#_  I5TZP0Y6RA4^R"IJ*
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M4);PK!$.B(, 4YH8YD,<T:S1-]Z-QD'\*L;:-E'*',<[<?#_ ,,7%QYQ\/V
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M&GAGQ%X8\%W\/B.SDLKIYMRI)UQ7OU?+WP#_ &M+?6;==+\:7"QZW*_[K:
M1Z5]-V=Y%J%NL\)#1L,@@U\GC:%:A6DJT;,^FP>.P^.IJKAYJ2)J***X#N"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MROXT^%NL66N-=6LC!V<LK+VJK_9'CCC_ (F$WIWKZN:V@DYDA5S[BD^QVO\
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M /?L4?V#I7_0.M_^_8K+^S,U_P"@I?\ @"_S-?[2RW_H&?\ X$>'?\-"1_\
M0%N/^^#1_P -"1_] 6X_[X->X_V#I7_0.M_^_8H_L'2O^@=;_P#?L4?V9FO_
M $%+_P  7^8?VEEO_0,__ CP[_AH2/\ Z MQ_P!\&C_AH2/_ * MQ_WP:]Q_
ML'2O^@=;_P#?L4?V#I7_ $#K?_OV*/[,S7_H*7_@"_S#^TLM_P"@9_\ @1X=
M_P -"1_] 6X_[X-'_#0D?_0%N/\ O@U[C_8.E?\ 0.M_^_8H_L'2O^@=;_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD_WY?^^J/^&;])_OR_\ ?5>UYHS1_J]EG_/E!_;N8_\ /UGBG_#-^D_WY?\
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M=![%GW*N?X:]4N?A?9O8[(XE$^,;O>I>;6?4X/K,;_"?-'_"I]+V;OM$V/\
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M=/'VI4U:*/TCASAFCDL?:2UJ/J!.XYI***^5/N0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-<E9L>SYJ+_A2OBC^[/^9H_UDS/_ * _S#_5_+_^@O\ (^K/^$PT+_H)P?\
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M5Z8%E*[N,?6FQ^9,Q"]1[U[7]D9?_P ^D>1_:F-_Y^GFO_"@-.]8_P J/^%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9 W14_Q;>37X/_!/X*ZC\:-5O['3G9)+2 S$J,] ?\*^FOV)?VJI_@#>>)O
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M^^/YU[*J_,*\<^,G_)0/#W^^*\'/%_L?_;T?S/:RAWQ7_;LOR/H.S_X\X/\
M<'\J^,O^"K S\%--_P"OO_"OLVS_ ./.#_<'\J^,O^"K! ^"FFY_Y^_\*^_H
M_%$^5P?^]0]3X[\,G_BD=-_ZXK_*OIC]GUC_ ,(U+]:^9_#(/_"(Z;Q_RQ7^
M5?3'[/JG_A&I>.]>1X@_\B"7^*)^Z5OX*^1!\=&/]AGZUX#&3Y:U[]\=%/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *KZI_P @F]_ZY-_*K%5]
M4_Y!-[_UR;^514^!EP^)'Q/H_P#R4X?]?']:V?\ @I,Q/[*.J_[@_E6-H_\
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M].*^7M0LX]2^('V*?F":?:_TS7T W[)_@"\CBEDLY-S*"3OZ\5\[P;:^*O\
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MWR==3Y<<GYUYK]7OVJ&*_LG[@C-_Q*U^51S]P5%;5P-*-K3/RY_9$_9QT_\
M:$\8II6H7TEG&[E=T9P:^W]8_P""1'A+3M)U.Z7Q)>,UK TJ@N><#-?/W_!+
MV1O^%J0*8G $A^8KQVK]@_%G_(K^(./^7.3_ -!-37J3C.R8Z-.$H7:/YX_
MFD)X=^/VF:;&Q=+/5O)5CU(5B*_3#]M_PU]K_9NN=2W'Y;=>.W2OS;TF1O\
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M8_?8]*\"W6^BL8 DN>_7K7HX?#4ZL;RE9GS^/S"OA:G+3IW1]?\ _"PO#O\
MS_I^='_"PO#I_P"7]/SKY _MB#^[+^M5=8U^*VTJY>-91.$)0X/6NE8&D].8
M\S^VL5_SZ1]FCQSH+=+U/SI?^$XT+_G]3\Z_*:^\9?$V^O)6T^X80*Q R>U0
M?\)-\6O^?D_]]5Z']AO^8[%F.+_EB?K!_P )QH7_ #^I^='_  G&A?\ /ZGY
MU^3_ /PDWQ:_Y^3_ -]4?\)-\6O^?D_]]4?V&_YA_P!H8O\ EC]Y^L'_  G&
MA?\ /ZGYT?\ "<:#_P _J?G7Y/\ _"3?%K_GY/\ WU4L'B;XK^8/,N3MSS\U
M']AO^87]HXO^6/WGZEZ_\1M*T_0[NZL[F.:ZC0F.//WCZ5\M:UX[N?&VI/J.
MKQBUND8JJ=.*^>;+XA>+]*OK9M2G)AS\XS7J=KJ47BJ%;^ _(!@U<<O6#=WK
M<\3,L9B,1%1J))>1W6AZ]&MV!%)N8G!7->GZ3XV'@^^L8;>WCC-XP#LHP3FO
M#/#MGY6H+(H.2:[[Q19W-UKGAQH/NJZ[OSK+$14HV9S9?4E"HG$^K8VWP1/W
M=0U+3;?_ (\;;/7RU_D*=7RY^EA1110!QGQ@_P"1+FKP[]GO_D;+_P"AKW'X
MP?\ (ES5X=^SW_R-E_\ 0U^;YQ_R/,,??Y3_ ,B;$'O[D[C]:1<L< <TKM\Q
M^M9'BY-2DT&<:.=M^%)6OK#YSH;OV.;:&V\?6OG[]LU3_P *IUSC_EU?^5?
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MU>_X*JKM_9=G'^TO\J_$C1;_ %2Q\\Z;--#N7$GDDC(]Z_4W]H'XH:A\:/\
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MF_:LAQBKLHQ2;L3=N3:5R#]@GXH:;\!OV@-2BFO%:SF_<1R.<;N<#^=?H_\
MMFWBZQ\&;W4$.8[JT9U/L1FOQF\<?"OQ1\$_'EC'XEA:&YANT+R#/9AGGZ5^
MJ'Q4^+&B_$W]EN*+1Y/,ELM,"R\]P@J*D?>4D73>CBS\?+&ZU&XDGTJQWN9Y
M20B]^:^K/^":_C#PY\,OC_.?&GDVD30^6GVI1P_/K^%)_P $\_A9X>\??%**
M378O. F90#R!S3_V^OV9=:^#'Q0NO%ME:^7X;FG4P,G!7!K:4DWR&,8M+G/V
MMM[R'5+6*\LBKV,XW0E?NE3TQ7!?M'V^OVWP5UR7PS9FYUM8R8(DZDU\Z?L7
M_M0+\6/@;J]C:7&S5=!L<(LIPP8+Q7RMX-_X*.?$3P/\:%MO'-T[>'8[EDDC
M*G[@-<:IRN_([)5%9>9X#\<;/XW7'AS[3X[T>^L-(,O+RJ0O7ZU]W_\ !*W3
M?"EG8W$NAWRW.IM%_I$8/*GO7*_MT?MV_"SXY?!67P]X=F:>_D;=AE&5XZ"N
M&_X(ZI<_\+&\1M"&">2-S?P]*Z)7<'T.>.DT?K+(3YC<=Z;D^E/D;YCGKGFF
M[JX3T 4G</K7CGQD_P"2@>'O]\5[&K?,*\<^,G_)0/#W^^*\#//]R_[>C^9[
M63_[W_V[+\CZ#L_^/.#_ '!_*OFO]OWX4:K\7/A;::;I%LUU<QS>9L09]*^E
M+/\ X\X/]P?RJ=6V]L_6ONX-QLT?'0J.E4YX[IGY"V/P/^+.GZ;#9)X:F*0H
M%!V&O9_A%X3^)_AK1)(+CP_(C$]"M?HMYW^R*3S#Z+^51FE..;X5X3$+W;I_
M<?6/BC%./*XH_.;XI>$/B?XATHQ0^'Y';/0+7DJ?!OXM!0/^$:E_[X-?KGYA
M]%_*E\[_ &13RN,<IPZPV'7NWN./%&*BK**/R,_X4W\6O^A:E_[X-'_"F_BU
M_P!"U+_WP:_7/SO]D4>=_LBO6_M"KV*_UJQ?\J/R,_X4W\6O^A:E_P"^#1_P
MIOXM?]"U+_WP:_7/SO\ 9%'G?[(H_M"KV#_6K%_RH_+OX'_!?XD7WQ1L[;7]
M!ELM')!><KC%?>_Q!LK7PGX/TZP\S$4;*H8UZ89,C&!7E/[1'@_7/&/AFV30
MB/-MG\V3_=')KCJUI5I*4CY;.,PK9DG4FM4K:'E'QX\5^+;"'0]#\-Z"FL:5
MJBB.[N&3=Y2GJ:\Q\2?LA^'_ (-VO_"R["3[5J]L!-]B<94L>2,5]!?#?XO:
M-K7AVYMHUQ/HL>V\,B]P.<5R%YXNB^,5Q(--;=H"MLF4^M?-YWG&&R'"/&8J
M[BG;3>[/$R[#U,=-4J/S+?P__:)\,>)O!5M<:O<PZ;JDGR&U3@#\*]9^%>F3
M0R3Z@5_T2X&Z-_45X-)^SWX-+23K WG!2R;6Z-VJY^ROX@^(>A^+-<TSQS./
M^$>1BFECT7/%?+\/\<9?G]=X6"<9]$^OIYGN5\EJ8+]]>Z/JZBC(8!A]UN11
M7Z*<04444 %&2.E%%  RI)_K$$@_VN::MO;QG*6\:'U50*=10 NX^M)110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY3?W:.5O<:DEH>8Q_LR_"R+6#JR>%+0:D7\PW'EC.[UKT&RM$TU%2U7RD48
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MO@#J##!U>Z(]W-)8_-4K+"?^3 \%EC=_K/\ Y*>L:EJ>G7VEZA:B_A#7,+1
M[AQD8K\V+/\ X)?Z[;?&B/QB?%=B=.74?MWE[AO^]G&<U]F_\,^7O_04N/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/_H(J??_ , /]8*G_/B'W'S9_8OQ1_YX"C^Q?BC_ ,\!7TGYC4>8U'^K=/\
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M+^UC_:_[YKZ,_P"%3^%/^@9'^5'_  J?PI_T#(_RH_L+._\ H*7XA_;>3_\
M0,_P/G/_ (7]K'^U_P!\T?\ "_M8_P!K_OFOHS_A4_A3_H&1_E1_PJ?PI_T#
M(_RH_L+._P#H*7XA_;>3_P#0,_P/G/\ X7]K'^U_WS1_PO[5_P#:_P"^:^C/
M^%3^%/\ H&1_E1_PJ?PI_P! R/\ *C^PL[_Z"E^(?VWD_P#T#/\  ^<_^%_:
MQ_M?]\T?\+^UC_:_[YKZ,_X5/X4_Z!D?Y4?\*G\*?] R/\J/["SO_H*7XA_;
M>3_] S_ ^<_^%_:O_M?]\T?\+^U?_:_[YKZ,_P"%3^%/^@9'^5'_  J?PI_T
M#(_RH_L+._\ H*7XA_;>3_\ 0,_P/G/_ (7]K'^U_P!\T?\ "_M8_P!K_OFO
MHS_A4_A3_H&1_E1_PJ?PI_T#(_RH_L+._P#H*7XA_;>3_P#0,_P/FG5/CAJF
MJ69MY-VT_P"S75_LPR277BK4+AP1O4GD5[7_ ,*G\*?] R/\JU-%\(:1X<D+
MZ;:K;NW!*UO@^'\PIXVEBL564E#U,,7GN!J8.IAL-1<7+T-AOO'ZTE%%?HI\
M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_ 444 'X"C\!110 ?@*/P%%% !^ H_ 444 'X"C\!110 ?@*/P%%% !^ H_
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M#9Z=,?:GQT\<>,/ _A&"3P'X0D\8^)[^Z6SM;7)6WMR59C-.V0%C7;CEER6
MW#-%:A[-P<'=32:Z;Z:]ATZCDY1DK.._W7/1J*_+OXC>!?B3X@_:U^$_AOXF
M>+T\1ZUJ-U;ZI/I>G@K9:9")F8QQC@$[(6RVT'@<MUK]1**M!4J<)\U^:^WE
MIOU%"KSU)0M:UOQ"BBBN0W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOPT^!6N0ZWX5TBXAUM;)K&2_NKR69YE8J69E9M@8E1]U5'7BO9J*1F"J6)P
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M^&*7SW?XLBC)3G4FNLG;T6B_(=1117GG4%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:^&O"GCWP5I.BVK.T5JOB6WEP78LQ+O,S$DD]2:P/^'?/P!_Z$+_ ,K&H?\
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B>4WI1Y3>E%%',PL'E-Z4>4WI111S,+!Y3>E%%%',PL?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img226925499_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img226925499_2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" :;!JH# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ2O;\_\ (SHXKVM3V;C9VO\ E_F?F[_P4P\7CQ%^TI-IJ2;XM#TRWL]N> [
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M2O\ P4BFC\-Z1I'PQ:.WU?4-/@N]1U9E$GV!I8PYMX@1@R+NPS$$+T W9V_
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M_P#'KXQ>+/B-X=TV#XF>+7NM2U.WME0ZQ<-'NDE5?]67VD<],8K]M,A%RS<
M<L?YU6.AB,/2A3J3O'MZ6_S%AYTJU64XQU77UN.HK\Y?VKO^"C>IQ:U>^%/A
M1<1VMK:LT-UXD:,2/,X.&6W5@551R-Y!)ZK@ $_&T>F_$_XY75Q>Q6GBSQ]/
M"?WL\<5SJ+1D\X) ;;6>'RVI6A[2;Y5YFM;%0I2Y%JS]XZ*_!'0?''CWX-:]
M)%I>KZYX1U6UD EM4EEMG5ASMDB.,_[K#!]*_4?]A?\ :TN_VA_#FH:-XF$*
M>,=%1'EFA4(M] 3M$VP<*P;A@.,LI &<"L1ELZ-/VL)<R1G3QD9SY)JS/J>B
MN>^(?BA/!/@'Q'X@D8(FEZ=<7F6Z?NXV8?J*_'?X9?M.?$:X^*_AZ_\ $7Q2
M\36^C+J45SJ/F:K,8/LZN'E40[MA!4, @7DD "N3"866+<DG;EM^-_\ (Z<1
M66'BI-7O?\+?YG[4T5^._P"T5^W=X^^,VL75IHFI7?A#PBK%8-/T^8Q3S)_>
MGE4[F)'5 =HZ8.,GYYT7Q+J_AS58]3TG5+W3-2C;<EY9W#Q3*?4.I!S^->A1
MRFI4CS5)<OEO]YRU<="#M!7/Z#J*^;_V$?C]JGQZ^#LDWB&87/B/1;HV%W<X
M"FY7:&CE(' 8@E3ZE">]?2%>17HRP]1TI[H[*-55H*<>H445Y_\ '[QU-\-/
M@KXT\36LODWFG:7-);2$ [9BNV,X/!^=EXKG9T17,TCY2\??\$L=-\7>.-8U
MS3_B'<:59ZC=R79LIM(%P\9=RS*)!,F1DG&5Z8ZU]6_ OX*Z%\ ?AY9^$M :
M:>WA=IYKJYQYMQ,_WG;  [  #H% ]Z_(#PG\?_C'XH\<:-8V_P 3/%K7NHW\
M-O&G]L7!CWR2!0/+W[<9/3&/:OV]0%(U#-N('+'O[U[F.AB,/1A3J3O%]/2W
M^9Y>'G2KUI3C'5:W];CJ*_%OXQ_M3?$SQ!\7O%%SI/Q"\1:7I;:K/'96MAJT
MUO;QPK(5C 1&"XV@9)'/>O2_VC?V_P#Q;XB2+PCX"UNXTO1;"%+6Y\00-LO=
M4D50KRK(.8D9@2-N&/4D9VC-9;6E&$H_:_#U^\UEBZ<9SA+[/XGZLT5_/9+K
MFI3:H=3DU"ZDU+?YGVQIF,V[KNWYSGWS7Z9_\$V_VE/$/Q.L]<\#^+-2FUC4
M-)@2\L-0NG+SO;EMCH['E]K%"&))PQ'85K7RN=&DZBE>VYC3QT9S46K7/N"B
MBBO#/3"BBO*_VF/C9:? /X0ZSXHE*/J 3[-IMN__ "VNG!$8QW Y8^RFC5Z)
M78UJ?#G_  4V_:"_X2;Q5:?#'1KG=INC,+G56C;B6[(^2,^HC4Y/^T_JM?$M
M[H.H:;IFG:C<VDD-EJ*R-:3.,+,$;8Y7V# CZ@UT_P /O!FO_'GXL:=H=O+)
M>:WX@ORT]U(-Q&YB\TS^RC<Q^E?7G_!2SX5:9\.?!?PAM-$@\C3-*MKG2$&.
M2%$3AF/=F.]B>Y)/>OLZ7)E\:6'^U)Z_<]?OLEY>AX%1O&3J36T5I_7I=OS]
M3I?^"2_B+=8?$70F?_5RV=[&O^\)$<_^.I7Z$U^4O_!+?Q$=+_: U33&;$>I
MZ),H7/5XY(W'_CH>OU:KQLWCRXGF[I?Y?H=67RO2<>S?^?ZGE7[5'B__ (0;
M]G?Q_JZR>5*FE300MG!$DH\I,>^YQ7XF^"_#LOB_QCH6A0\S:G?P628]9)%0
M?^A5^HW_  5!\7?V'^S[9Z.CXEUO5H8F7UCC5I6_\>6/\Z^'_P!@_P (_P#"
M8?M2>"XVC\R#3Y9=2EX^[Y,;,A_[^;/SKNR9*G3J5WT?X15_U9GF<FU"FM]?
MO;M^A^S5C9Q:?96]K H2&"-8D4= JC 'Y"IZR?%7BK2O!'AO4=>UN\CT_2=/
MA:XN;F3.$11R>.2?0#DD@"ORM_:)_P""B'CGXEZI=Z=X)O;CP7X55BD3VC;+
M^Y7/WWE',>?[L9&,X):O"H8>KBYM0^;/2J5(8>"<MNA^M%%?@Q'\.?B7\0+%
M_$<?ACQ7XDLY,NVK+I]S=1MCJ3+M(/3U[5?^&/[1'Q&^#FI07'AKQ5J-G%"V
M6TZ>9I;23GE7A8E>>F< C/!!KUO[(;TC45U_7]:'!]?Z\FA^[%%>4?LR_'BR
M_:)^%-AXI@@6ROU=K34;)&W""X0 L >NT@JPSV8#J#7+?MT?%'5/A/\ LZZU
MJ>AZA)I>M7D\%A:7<#;9(R[Y<H>Q\M7Y'(ZCUKQ)T9TZOL9+WKI?>['I4ZD:
MD/:1>EK_ ';GT!17XY?L]_MA>,OA[XXNO$/BWQKXE\3:99Z?.T>B7VJS3QWM
MPP"1)B1F"@,^\L!D!#C/0\)\9/VHOB-\<-2N)O$/B&ZBTV1CY>C6,C0V42YX
M7RP?FQ_>?<WO7K?V35]IR)JUM_T]3A6.I\CDUK?;]?0_<BBOP,^''Q8\7?"7
M78=6\)Z]>:-=1L&98)3Y4P'\,D?W77V8$5^UG[//Q>A^.GP?\/>,8XEMKB]A
M*7=NAR(KA&*2J/;<I(SV(K'%Y?/"QYT[HJAC(UI<C5F>CT5YQ\>OCMX=_9\\
M W/B;7Y#(<^59Z?$P$UY,1Q&F>W<MV )] ?RM^(?[5'QG_:9\6+I.F7NJ6\-
MXYCM/#7ADR(I7T;9\TO R2Y(&"<*.*YL+@ZF*;Y-$MV=%:O"@DY[L_9FBOQ'
M\:?LE_&CX9^'YO%>N^#[[3].MP)9;Z&\@G>$?WW6*1G4#N2!CO7I?[)O[<7C
M+X;^-M)T/Q;K=YXC\&WTZ6TRZE*9IK+<0HECD;+;5XRA)7&< 'FO0_LOGBW0
MJ*37]=V<3QW)K5@TC];:*3/?M7YV_M??\%#M3T[7M0\%_"VZ2T6S=K>^\1A5
M=WD!PR6X.0 #D&0@DG[N,!CY%&C/$35.FM3T9SC3BYR>A^B=%?@O;Z+\2?C;
M>W-_;V'BGQY=Q']_<PP7.HNA/3<P#$?C72_"OXP?%;X&^.K'3=%U36-*O4NH
MX9/#^H>9Y$K,P'ER6[\9.<9P&&>"#7N+)W)\JJ+F[?U_D>9+,%%.7+[O?^O\
MS]PZ^%_B5_P2WTWQQX^UOQ#I_P 0KC1[;5+R6]>RFTD7+1O(Y=P)!,G&2<97
MCWKZP^-7C:7X<_!WQ?XF1A%=Z9I4]Q$>"!,(SLZ]?G*U^.6A_M#?&3Q)XLT^
MWM_B9XM:^OKN.&.-=8N!&7=PH'EA]N,GIC%<F6T:U6I)T9<K5E?U_P"&.C%U
M:=.DG45T_P!/^'/U_P#@)\#=!_9[^'MOX4T%YKF(2M<W-Y<X\VYF; 9VP,#A
M5  Z!1UZGT:HK>-X;>)))#*ZH TC=6(')K\Y/VS/^"@&L+XAU#P/\,-0_LVS
MLW:WO_$%N?WTT@X:.!OX%4Y&\?,2/E( RW'&%7&5K+63ZFZY*%*[T2_K[S](
M**_GNU;Q!JFO:DVH:GJ5YJ-^S;FNKN=Y92?4NQ)S^-?0GP7_ &Z_B%\*_"^N
M^'KW5;O7M/NM/FATV:[E\VXTRY*$121N^24!QE#D#&5QR&]2ID]2,'*$KOL<
M4<?&4TI*R[G[&T5^0_[(OQ@^*OQ"_:2\%:3=_$+Q1J%E->F:[M;K5IY8)(8T
M:1U:-F*X(0CIWXK]>*\_%X26$<5)WN=-#$*O>RV"BBBN ZPHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /RT_P""J/C#^UOC-X=\/(V8]'TD2N,]))I"3_XZD?YU
M\G>$?AIXO\?QW,GACPIK?B..U*K.VD:=-="(MG:&,:G:3@XSUP:]#_;(\8?\
M)Q^TQX]U!9?-AAU V,1[;8%$/'XH3^-?>W_!+WPC_8?[/U]K+KB76M7FE5L=
M8XE6)?\ QY9/SKZ^A/ZGET:EM;7_ / G?]3PL0O;8UP^7W*WZ'YS?\,X_%G_
M *)?XS_\)^[_ /C=8OBKX3>./ NGI?\ B3P;X@\/6,D@A2ZU72Y[:)G()"AG
M0 M@$XZ\&OWVK\]_^"LOBX)IW@'PNC<R2W&I2KG^Z%C0_P#CTGY5ST<TJ5JL
M:7(M7_P7^!M/ PA"4W+9?\-^)\3_ +/OA$^//CAX&T$IYD=YJ]L)5QG]TKAI
M/_'%:OW ^(/C&T^'O@;7_$U\?]$TFRFO'&<;MB%@H]R0!^-?E9_P31\(#Q)^
MTM;:BZ;HM#TVYOLD<!V A7\?WI/X5]N_\%$M?ET/]E?Q(D+E'U"XM;,D=U:9
M68?B$-9YPW4J4J"Z_P#MSM^@9:DN>J]E^BO^I^2'C#Q7J?Q!\7ZKX@U65KK5
M=5NGN9FY.7=L[1[#@ =@ *_83]D']E_0_@)\.],N)]-@E\:W]NL^I:E+&&FC
M9P"8$8C*HO P/O$$GMC\I?V<M$@\2?'SX>Z;=*'MKC7;-9%(R&43*2#['&/Q
MK]VZWS6I[&C"C3T3_)6LC'!KVU:52>K6OS=]?P_$^&_^"GGPQ\%P_"VU\:-I
ML-EXN_M&&SAO+55C:Z5PQ99L#YP%0D$\@CK@D'XC_9!\(#QQ^TK\/]-=-\2:
MFE[(,9&V &8@^Q\O'XU]$?\ !4;XT6GB;QAH?P]TR=9X]!W7>HLAR!<R* D?
MU5,D_P#73'8UC_\ !+'P?_;'QOUS7Y$W1:-I#*C8Z2S.JC_QQ9/SJLN<J."E
M5EYM?=I\FU?YCS!*I7C36^B?S?Z)_@?IYXHUR'PSX9U;6+A@L&GVDUW(S= J
M(6/Z"OY_M6U*?7-6O+^X8R7-Y.\\C=R[L6)_,U^S_P"W%XN_X0W]EWQS<!ML
MMY:KIT>#R3.ZQG_QUF/X5^1WP+\(GQY\9?!.@>7YL=_J]M%*O_3+S%,A_! Q
M_"N?)(+FJ5'MHOU?YHWS.?+2C%;ZO_+]3]L_@OX3_P"$#^$?@WP\4V2:=I-K
M;R#_ *:")=Y_[ZS7Y#_MO>+SXR_:@\<W(E\V"SNUTZ+!X A18R/^^E;\Z_:#
M6-2AT/1[W4)SMM[.!YW/HJ*6/Z"OY_?$VMR^)O$FJZO/_K]0NY;M_P#>D<L?
MU-999>OBYUGV?WR?_ 9>*7L<)&FO)?)+7]#[1_X)X_LDZ;\2GG^(OC.P2_T&
MSG,&EZ;<+NBNYE^_+(IX9$. %/!;.?NX/Z7-H&F-=V5TVFVANK%2EK,8%WVZ
MD;2(VQE01QQCBN*_9W\%Q_#WX&^!] 2(0R6NDP&=0,?OG0/*?J79C^->B5Q9
MAB)5J\E?1:+^O,O!TE"DI=9:O_+Y!1117FG>?#?_  5:\8'3OA?X1\-QR;7U
M/5'NI%!ZQPQD<^VZ5?RK\PZ^SO\ @J9XN_MCXX:)H2/NBT?2$9E])9G9F_\
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M*_&?]OKPSIWA7]J3Q9!IELEI;W(M[QXHU"J))(59R /5LM]2:_9EF"*68A5
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M[>%;6WL;*WO_ !-)&/[0UV2(&::0CYE0GE(QT"C'3)R<FO@?_@F#X)C\1?M
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M&L@,OQ49T[A/#P4_G]J->E>!_P#@E]\*_#EU%<Z[?ZUXK=/O6]Q.MM;-]5B
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M.#/,>(XE]2S$#\SVKBS:M*==T^D;67G_ )]#;+J:]GSK=M_@[?\ !/Q2^/\
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MG^^(VV#_ +ZQ7YZ?\$I?"/\ :/Q2\7>(WCW)I>E+:HW823R _GMA;\Z^G?\
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M IX/]YEK\9F8NQ9B68G))ZFO=RG#>TJ.O+:.WK_P%^?D>?CJWLZ?LUO+\O\
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M%>7WR>_W6/TR^$WP9\*?!;P=;>'?#.E06MM'&%GN#&OG7CXP9)GQEV/OP.@
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MV;+W4[[PQ)JM]J&H1+!+=ZM<)(XC#;MBA$10"<$\9X'-883&4L/A)T_M2O\
MCHOPL;8JA.O5@U\*M^=W^I+^V/XO_P"$)_9G\?7XE\J6;3FL8F'7?.PA&/\
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MLBK&A_\ (DGY5];_  /_ &=_!'[/>BW&G^$-->"2[*F\O[J4RW-T5!"EVX
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MBOHGPQX3T3P3I,6E^'](L=$TV/E+33[=(8P>YVJ ,GU[US+'X;#)K#4]?/\
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MW?ESZBMCX@?\$K? VO7TMSX5\3ZIX561BWV2XA6_@C]DRR.!_O.Q]ZY[0?\
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M.>:\N\&_\$H?".FW:2^)O&VJZ]$K!O(L+2.Q5O9B6E.#[$'W%?97@+P#X?\
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M;>"%?0=6)[L3DDGDDD]ZW:*]#&8Z>+2C:R70X</A8T&Y7NPHHHKS#N"BBB@
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M>A3IQI14([!1116)J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?./_!03Q!=:%^RWXHCM(999=0DM[)FB0ML1
MI59RV.@VJ1D^HK\SOV1O -U\0OVA_ UE%9375G;ZG%>W;)&62.*$^:2Y' !V
M8Y[D#O7[?T5Z>#QSP<))1NV[WOY?TSCQ6'^L\J;LD%%%%>8=@4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%5[^^CT^U>>4X1!DT 6**\UC^/WA:3Q%'HOVG%[(=H4L*]%DN$BA\TGY,9S0
M!+17 S?&CP]!XDCT1IO]-<X"Y%=XC;U##H1F@!U%%% !1110 4444 %%%% !
M1137;:C-Z#- #J*\3N/VAM)A^(Q\,&;_ $H-C;7LME<BZMUD7HPI@3T45P7B
MGXT>'/"%XUMJ%QLE4X(R*0'>T5F>'?$%IXGTJ+4+)]]O)]TUIT %%%% !111
M0 44E+0 4444 %%%% !1110 44AZ5QGC#XKZ)X)V?VE+Y>YMHYH [2BL_0M:
MM_$&FPWUJVZ"494UB>.OB1I'P^MXIM5E\M)#@<T =716-X;\567BBRCNK)M\
M4@R#6S0 44UVVJ6/0#-<#JGQHT+2=0^R32$2[MOXT >@457L+Q-0LXKF,YCD
M7<M6* "BF2.(HW=C\J@DUY'XN_:>\'>#;I[>^N")%." 10!Z_17@@_;,\"%D
M F?Y^E>F^!OB7I7C^(R::Q90,\T".NHHIDK^7&S'HHS0,?17C'CC]H#2O".K
MP6=Q-M>1]@Y]Z=\0_C]I7@B/2&N9=OV[;LYZYH ]EHK@M2^+NCZ!IMC<WLA"
MW2ADQ[UT7AOQ99^*(/-LVRN,T ;=%%5[ZY%G9S3MPL:EC^% %BBO$8?VB-)F
MU[^SA-^\\S9C/O7M-K,+BVBE'1U##\:8$M%%%( HHHH **** "BBB@ HHHH
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M_A3PS!J$!"0;,BN.UC]NGPM_;9TNWG)N%?:0M>9)-(/A+IXR?FCQUK!_9A^
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MXGN(V95);)%?2=G^QGX/MM3#_P!G*(-V3Q7LNE_#?1M$\-MHEG;+'9D8VXH
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M&4X;!Q]:YKQMKW]@_'K5I?&JO-HGF':I'%??_A?X*Z#X6\33:U:6JQW<GWG
MK)^)G[.OA?X@;Y[FQ5[ESECCK0!^?'[2WC[X>:[X1LH/"UHR7/F#E5KT[QI,
MTW[,_AQ=C%L+D8^E?1=G^QAX(\F-9M-0E#GD5Z#>?!'0;OP_!H[VJFSAQM7%
M 'R.J/\ \*ITT;&SL':NT_9"\S_A,9PRL!M/45]&_P#"G=$_LJ.Q^S+Y*# 7
M%7/"/PQTGP?>-<6,"QR-U(% '9U\@_\ !1)6;P/I@56;][V'O7U]7'_$3X;Z
M7\1K&*VU2$31QG(!%(#Q[]DS1;.3P1IKO%\_E \BO<?$WAFWU+1[N)(P':)@
M/RIOA'P78^$+&.VLHA''&, "NA//':@9^87@C6[O]G+XX:UK.LJZ6,TK;<#W
MKM/VGOVG-*^+GAW2]/\ #1D^T-(-_'J:^N_B1\ ?#'Q"A)O;%7E)R3CK7'^#
M_P!D7P?H=\)I=.4A#E>*8CYZU_X=W7A?X<Z1JEQ&WF3HI)Q6E\*-[V=\VUN8
MCV]J^R?$?P^TOQ!H]OILT -K",(F.E9>D?"+1='B=(+=5##!XH ^.OV55=?B
M!XS)1A\LG4>QK%_9NTU]4^,'CB'8V6:0#(^M?;GA7X.:'X5U"]N[.V6.6Z!#
MD#KFF>$O@SH?A'7KO5+*V6.XN6)=@.N: /A#1-6N?V<?B=J>K:H'CM;F<D8'
M;->T^.OVW-.U:QTJ#PS+(EU*RB3 KWWXD_ ?PS\1H,:A9+(XYZ5Q?A/]D7PA
MH]\)IM/4B,Y3B@#Y\_:ZU+5-=T#PM>W^Z7S61NGO4_CGX9WGCKX;Z7):1L4@
M@#/QVQ7V!XR^$&A>,+&RM;JU5X;7'EJ1TQ6QI/@;3=,TG[ D \C9LVX[4 ?G
M+\"?$'PT\+ZAJ=EXMLR\T65Y7N*]M^$>J_#GQ-XBD/A^T\O;)D?+[UZAXJ_9
M%\(ZIJ#W<&GJ))6RY ZUUWPY_9]\,?#_ />V5DL<QZF@#T2-531@J#"B+ _*
MOSZ_:>5_^$^TK",1]I7H/]JOT1\I?)\L#"XQBO/?$_P5T'Q1?Q75W;+)+&VX
M$CO2 ^*OVMED\OP!M1CS%G ^E?8$+O\ \** (.?L'_LE:GBSX)Z#XN&GB]M5
MD^QX\O(Z8KKE\.6RZ'_983_1MGE[?;&*8'PC^P\K_P#"?^)-R,/](;J/>ON[
MQ-J']E^&+^ZSCRH&;]*Y;P1\&]#\#:A<W>G6RQ2SMN8@=:[35M/35-.FLY%W
M12J58>U 'Y>>)-!O?VDOB%)&4>:.TN"/F'H:^B+[]CFV/@MD%JOG>1C'?I7T
M!X%^"/A_P1?W%W96BQRS-N8X[YKT9D#(5(X(Q2 _+GX?V]Y^SOKEWI[*\*7<
MA&%'J:W_ !O(=8\8:)M1B;B12>/4U]N^,/@3X>\6W\=W=6BO*AR#BF_\*)\/
MM>6ERUJOF6Y!0XZ8I@?%_P"TUX+U+P;XF\)ZQ$C+:0[))-H[=:]2\1?ML>%]
M4^'LVB6ID_M&2U\CIWQBOJ#QE\-=%\<Z<EKJ=LLRQIM7(Z<5XW9_L:^$(=6%
MP=/7&[/2@#YV_9W^&^IZUX%\6ZK>(Q1P\B%AVZUQ/P+^-6G?"OQ=<QZD2$6X
M.<?6OT,\1>$=.\$?"_7+/2+<0)]E;[HY/%? 'P)^#]A\0/$NJMJ=J9&^T-C<
M/>F(Z;]H[]H*P^+GC+0K#P^9#&Y57X]:?X]_9WU*S\-#5&@/D>5O;CVKZA\'
M_LF^#]%N+:^>P7[1'AE.*]CU+PW8ZMI!TVXA5[8ILVX[4AGYQ? GQ=\*=!T+
M4K?Q-9%[Q"0-RUZWX7M? GQ"\)ZE;>&K39)("J_+7IVN_L>>$;J_:6WT]0DA
MR_%>B?#OX(^'/A_:[+&S5&/- CX.\,>))_V;/&T%OJP=+667<0!VS7N?BC]M
M*SU[Q1I6F^&I9$\W ;CN:]O^)?[/?ACXC.+B_LEDN$'RG%<WX+_9/\)>']0C
MOI-/7[1$V4.*+C/G3X]76I:MXNTZ?4]TC, P.*3Q$NNP?#V^ELBZV"Q'>HK[
M(\3?"'0_$ES#-/;*S1# XJT/A;HCZ#-I;VRFWE7:PQ3 _/'X4_$CX9V?POUN
MWU^T9]9)8(Q'.:R?V;]8LM0^)=FVG1.D!G&..V:^R+C]C+P:UZQ33E\EVRW%
M==X3_9H\)>"M0ANM,L5B>,Y! I >JSWB6&G^?)]Q$!/Y5^;?[4FHWGQ0^.5A
MHUL'>UF<(R]J_2:\M%N[-X&&588KSR/X$>'6\20ZT]HIO8FW*^* /G_P_P#L
M3P6>BK:FU4+,N6KY_P!:^'5[\!_CUI:6\;16BR G;TK]2_2N%\9_"'0_&FJ)
MJ%_;++<H,*Q%%P/@_P"*GB4^+OCMH]Y&KL%"@G'TKZ]\<>'9O%WP#O["!<SR
M0X'Y5JP_L\^&UU2.^-FOGH>&Q7I5EH\%G8?9%0>3C&V@#\JOAC8^$OA7XF&G
M>,[1G8RDG(]Z^A-&\4?"36O'=G;Z#9;)FP =O>O=_B%^S!X3\:7IOY;!6NO7
M%1^ _P!E_P +>%;Z._\ L*K=QG*MB@#XY_:&DU+0?BI!)<!_^$:&"Z <8JC\
M4_B5\++[X/7MKI-FRZF5P"%[U^@'COX*^'/'%F\=[9*[E< D5YA:?L6^"O*:
M*;35*$Y/% 'B/['&_4O@?+;1HP=B< BN4\*^.;3P%^TA9VNI*P(?T]Z^Z_ O
MP=T+P#8BRTRV6*V'\(%<MXH_9I\-:]XL77FLE-XIR'Q0(^5/VJ_%&HZWXZ_M
M0&1O#84;E'I7(^,/B5\++CX&7-I9V;#6,8!V\YK[WUGX&^'O$'AU]/O+-7W+
MCD5YO;?L6^"\&.735,1.2,4#/$_V";U9K&U"(RC=QN%??M>=^ _@KH'P\V+I
M-JL*+TP*]$I#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#,U[P[8>)K,VNH0B>$_PFO(]4_9/\$Z
MEJ!G;34()STKV^B@#EO!WPWT/P/;I'I=HL.T8R!74T44 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 5M2L(M4L9K68;HI5VL/:N2\*_"7
M0O"-Q)-86RQ.[;B0*[:B@!.E+110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !124M !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 44F:6@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *9-*L,3R,0%49)-.)QR>E> ?M%_&)/#^FQV.FS'[0S[6V
M'FDW;4:5S:M_C%%KGBJ?2+4MYD38)%>NZ>[26<3-]XCFO#?@'\-6C5/$=Z@9
M[I=_S=:]Z50H  P*4;]0?D+1115""BBB@ HHHH **** "BBB@ HHHH ****
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MVU!VOH%%%%4(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2UG:]KEMH.GRW5S(J*B
MDC)H X[XR_%*R^&'AQKNZ8;I0549YKY/^"7AO4OBY\3+S4M4+3Z4[F2)7Y K
MA/BA\0M3_:&^(T_AC3I)&BMI_7C&:^Z_@O\ #^U\#^"].@$"I>+$!(^.:Q^-
M^1M;D7F=OI6FQ:1I\-I -L42[5 JW116QB%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 445R'Q.\<VO@?PK?WTTJI)'$649YZ4 >>?M(?&JT\ Z/-I"O_IUU&53:>02
M*\G_ &5_AO=^++BYUO7U,SK)OB:09QS7B.AS:O\ M.?$J'4(WD>RL[C#ANF
M:_1WPCX9L_"^C6UK:0K%B-0VT=3BL8^^[]#:7N*W4V8T$<:H.B@ 4ZBBMC$*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[*K3N^6.R%HHHKH.<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#16+XM\46OA/2);
MVZ<*JJ2,G% 'CO[5WQMM_A=X+EDCG F8$?*>:_,7X5>&-3_:(^,$]Q/NFMWE
MWC=R.M:?[6'QBOOBMX\N=%LY7E@\_ 53D=:^VOV&?V?T\&^'['7+B!?-DC!R
M1SFN!OVU2W1'I)*A3N]V?3/PJ\%VW@?P;I^G0PK&\48#$"NQHHKOV/-"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *1F"J23@"BN!^,7Q&LO /A._GGD"3>2Q7)QVI-
MVU&M=#YS_;E_:)C\!Z/+I-I<?O)XROR-WQ7Q[^Q_\&K_ .+WC)M<OD:6..??
M\XSWKS[X@>+-3^/OQ4AMU>2>$7&WU&,U^J_[*_P7A^%OA&(F%5EFC4YQ[5Q1
MO6G?HCT)?N*=ENSV;0=(@T32K:UMXUC6.-5X'M6C117<><%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 (S!023@#DU\#_MZ?M'1Z=HDVB:?/LN$8J=IKZB_:&^
M*T'PO\&S7CRA792,9YK\;O&VNZC\;?BA-Y3O-#)-G;U[URUZG*N5;L[<-2YI
M<TMD>J_L8_!RZ^)WQ"&HZA$94<[]SC/>OU]\+Z#%X:T.VT^%0J0KC KQ+]DS
MX.6O@3P+IMX85CNFC&>.:^@JNC3Y(F5>I[2=Q:***W.<**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5S7C_P 80>"_#\]_.0 %(&3[5TM?$'[>
MOQPCTWPG<:1:2[9U)!VGFHG+E5RX1<Y**/A3]J7XJ7'C3XB7T:S,]L\A 7/'
M6O:?V!?@FVJ>+X=0N8=T#?,-PXKY+\,Z3<?$+Q%$ #)*TF2>IZU^S_[*?POM
M_!OP[TR=HPERT8[<]*\ZA'VDW-GKXF2HTU3B>VZ?8QZ;:1V\(VQH, 59HHKU
M#Q0HHHH **** "BBB@ HHHH **** "BBB@ HHI* "FB9"<!U)^M>.?'3]H"S
M^$MK'N599)?E [UX%)^UEJ^GW45V=+N7MYCD':<8H$?<=%>:?!_XPV_Q/L]R
M0^5*BY85Z!-JUE;OLDNX4;IM9P#0,M%@O4XI%D1_NL&^AKB_B3XK7P_HLES$
MX?:A;Y3FO+OV=/C9!X^UG5K6XN5C> D!9& S^= 'T/14,-W!<9\J:.7'78P-
M-GU"UM?]=<1Q?[[@4 6**KV^H6MU_J;B.7_<<&GS7,5LN994C'JQ H EHJG#
MJ]C<-MBNX9#Z*X-69)HX5W.ZHOJQQ0 ^BJ<>L6,S;4O(7;T$@S5II%C7<S!5
M]2>* '452_MJP+[!>P;O[OF#-63<1A=QD4+ZYH DHJ)+B*0$I(K@=2ISBD6Z
MA?A94;Z,* )J*JSZI9VQQ+<Q1G_:<"I(+R"Z&89HY1_L,#0!-1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7EOQ\^)5OX"\'WW
MF.$EDA;:2?:O3+JX6UM9)GX6-2Q_"OS*_P""A7QR_M*ZCL;&;"IE&"FLJD^2
M+9M1INI-11\;_$KQA=>/_&MY'+(TH>9@N3GO7Z ?\$]/@DMC8RW]]#T 92PK
MX/\ @KX%G\=>-M/E1"ZF92V![U^W?PE\$6_@SPG8PPH$=H5W #VKAPT7*3FS
MT<9-0BJ2.UCC$<:HO 48%/HHKTSR HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#F?B#XNA\%^'9[^9@H"D#/TK\5_VH/B=-XS^)%^HE+V[2' SQUK[X_;U^,R:
M9X.N-*M90DZD@[3S7Y8>7/XJU**0;I)GDY/?K7FXJI?W$>O@J=OWDCZ>_81^
M$[>(/B!%+/#N@/(R.*_7G1=+CT?38;2(82,8&*^8OV)_A*GAOP7IVK/$%F9!
MSCFOJNNNC#D@CAQ%3VDVPHHI#6YS"T5R_C#XA:1X/L7FNKV!77^!G&:^>O$G
M[<VG:+>200:>+H*<;E.<TP/JVBOCA?\ @H! W_,";\C2_P##?T/_ $ V_(T6
M%<^QJ*^.?^&_H?\ H!-^1H_X;^A_Z 3?D: N?8U%?'/_  W]#_T F_(T?\-_
M0_\ 0";\C0%S[&HKXY_X;^A_Z 3?D:/^&_H?^@$WY&@+GV-17QS_ ,-_0_\
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MB;&-R _I4M(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXV@_8BU:/7/M3:TS6V_=Y6_C&>E?0_A_X0Z9H?A6XTI((_,FCV-( /2O0J*
M/CS5OV([^2\NGL=6^S0W#$LBM@<UW/PK_97C^'^GW,$DZSM-U;K7T513N*Q\
MK>.OV0K_ ,07):QU4VT3'YD5L UU_P '/V9[;X;_ +RY=+F;.=QP37O5%(8V
M-0JA1T48IU%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !112'B@!:*SKK7K*S.)9T0^YJJ_B[35&3=1X_WA
M5<K?0#;HKGY/&FF1C)NH\?[PJ*3QYID?6YC_ .^A3]G+L.S.EHKE9?B%ID8!
M^T1_]]"H9/B3ID>,SQ\_[0I^SGV#E9V%%<:_Q,TU%!,\?/\ M"D_X6;IG&9X
M_P#OH4_93[#Y6=G17*Q_$+3' _TB/_OH5<M?&6FW#8^TQC_@0I>SDN@K,WJ*
M@M[Z"[&895D_W34VZLQ"UY[\:/'EMX+\'W[RN$D>%@N3[5W\L@AC9V^ZHR:_
M/#_@HA\9O)C@L+*; ^XP4UG4ER1;-:</:243X3^+7C.?QIXMU,R.7596VY.>
M]?0W[!OPH;Q=K NYH=P@<$9'O7RC90/J/B*V4#<URXS^-?KO^PS\,!X+\-M<
MO%AID# D>M>90C[2?,SV<5)4J2@CZETNV%GI]M HP(XPN/H*M4E#,%Y)P*]<
M\$6BH3>0+UE0?C4?]J6@ZW$?_?5.S M450.N6 S_ *5'_P!]5'_PDFF\_P"E
M1_\ ?0I\K[ :=%9#>*M-_P"?J/\ [Z%-'BS36Z74?_?0HY9=AZFS16.OBK36
MY^U1_P#?0IR^*--;I=1_]]"CEEV#4UJ*S5\1:<W2[C_[Z%.77M/;D74?_?5'
M*^P&A15%=<L&Z74?_?5.&L63<BZC/_ J7*^PBY15>+4+:8XCG1S[&K%( HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /FC]HO7-2TZYG%H9,=MN:^?;?QEXBFLF'[_=GWK[L
M\4> ;;Q-(S3!3GU%<_:_!/3+<_ZN,CZ5[5#&4Z=-1:U-XU.56L?' \0>))+,
MKBXS^-,_M'Q,]KMVW&?QK[?@^%>EPX_T>,_\!%78?AWI,?\ RZ1G_@(K5YC!
M;1'[9]CX5%QXG:UV[+C/XTC'Q.]KL\NXS]#7WJO@?2%_Y<XL?[HJ=?!^D+_R
MXQ'_ ("*G^TE_*+VS['P+M\3_8]GEW&?H:9Y/BC[/M$=QGZ&OT!_X172?^?"
M'_OD4O\ PB^D]/L$'_? I?VDOY ]LS\^Y)O%-K;9,=S^1JI'X[UBS(2::6-A
MZDU^A5UX/TBZA:-K&$9&,A17R-\>?A?'I^I7$\"B-,_PBC^TH]8GH8."Q4^1
MNS(_AA\8;C3-0B:XN&D7./F-?7/A7Q1;^(M,CN5D4%ATS7YI6+/!?B /MP>M
M?4OP>\07$%K##YK. /6L,T<*=!8F*,ZV'<9N#W1]-:IJ<.EV<EQ,X554FOQ^
M_;4^*3^)O'VHZ:DI:$.<#/%?>7[3'Q</A7P!*ZR;9-N.M?D7XZUV3Q-XLGU-
MWW>8QZU\C+%QKT_=+PM!J=Y"_#?PS)XJU^"P1"Y#C@#WK]L_V:?!D7A3X8Z7
M&8PLVP9X]J_+K]B[PD+[XDQSRQ;X\YY%?K'9^*X/#NCI!M5%C7BBC6I4?B>H
M8SFJ2LCLK_4H-/A:2615 &>37C?C']H*UTFXEMHPOR\;@:\T^+GQNDD\VWA<
MJ.F0:^?%OM0\8:MY<>]RS=J^QPN%C*G[6MHCFIX=R=K'M^I?M#7=Q<7*PABI
M4]#7Q-!XPN;SXU:A=.&9F<G'XU^@/P]_9I6\T$7EU+LD>,X5AWQ7QUX;^&L4
MG[2.J:66&U)2/UIUJN'NE!;&5244[);'KFB_%#6ULDAC$PC X SBE_X3[Q T
MS-^_Q]37U!X<_9_T]='@+>7N(STK:B^!>G1CE8S^%=/UZ@MHC]JNQ\@Q^-/$
M,DS?Z_'XT0^+/$2SL3Y^/QK[%B^">F1MGRX_R%3_ /"F],[11_\ ?(I?7Z7\
MH>V\CXWMO%'B/SV;_2,?C3X/%?B..=RPN,?C7V9#\(],B_Y8QG\*=+\)=,D'
M$$8_X"*7U^G_ "B]MY'Q?%XX\1QW#Y$^/QJ2W^(GB&.5RRSX_&OL)O@SIA_Y
M91_E4,GP3TR3I'&/^ T?7J/\H_:KL?(EK\3_ ! MP^5GQ^-2V_Q8UZ*1]RS8
M_&OJ_P#X43IG9(\_2H)O@%ILF<+&/PI_7:#^R'M5V/GCX<?%K6+[7!',LH4M
MCG-?:6@W!NM'M96ZL@->9:7\ ['3+H31E 0<\"O5;"U%C:1P#D(,5YV+JTZK
M3IHRE+FV18HHI"=H)/2O/,P9@HR3@5$MY!(VU949O0&O /VD_P!H@?"VUABM
M(_M$LIVX7K7SM??M7>(?"5U97MQIT_DWC @L#CDTP/K[XU?%Y/A7!92,F_[0
M<8_&MSX<^/!XXL4N FT,NZOC_P#: ^(<GQ*T3P_.1Y;,5)%>E^"/B%-\-?",
M+1P&X+Q#H,XXH$?4?VR -M\U-W3&:EW#&<\5\!:M^U-J.G^(@TD4BHTG0Y]:
M]SA_:234O"_VB) 9(XMQ Z]* N?0K7D$9PTJJ?<U(LBN,J=P]J_/:']K'Q!X
MOU:^2UTZ<QV;'+*#VKW#]GO]I3_A.K'5%OH_(>R4Y#GKB@+GTK=74=G \DCJ
MBJ,\FO$?%7[1L&@>(+?3E02>;)LS^->(_$7]JK4_$%Y?66DV4DZP,RDQ GI]
M*\,TGQEJ7BKQUIQOH)+<B=?O@^M 'ZEZ;=?;M/M[C&/-0/\ F*M5F>&?^1?T
M[_K@G\JTZ0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F3?ZI_]TT^FMRI
M'KQ0!\<?'KQ+K&GZA(+4RXW_ ,.:\QF\6>(KBUBV_:,_C7VYXB^%MEX@F9YE
M0DG/(JC:_!?3+? ,49 ]J]VGC:<().)T1JV5K'QG=:[XEGAC"BXS^-)=:AXF
MFBC"K<9_&ON&'X7Z5'UMHS_P$5=B^'NDQ];2(_\  15?VC!;1#VS['PC--XG
MDC0!+CCZTEU_PD\RH!'<<>QK[XC\$Z0G_+E$?^ BIE\(:0O_ "XPG_@(J?[2
M7\@O;/L? EPGB>2- (KCCV-1W$/BAE0".Y&/8U^@8\*Z2/\ EPA_[YI?^$7T
MG_GP@_[YI?VDOY!^V9^?-U?>*+&-2T=R .O6H+?XA:I#(%DN)$(ZY)K[\USP
M/I.HZ?-']BA5BIP0H]*^(OB[\//[#U*XE3Y%W$@"FLRA>THGIX.C]<O&^IZ;
M\'_C-)8W"17,QDWD#YC7U/I>J0ZE9Q3(ZG>,X!K\SO"MQ)_:2 2%=C5]?_"_
MQ//]BB#2%@H'>N#-Y0PT(UXK1G'4H/F:ZGK7Q!\26_ASPMJ-Q+(J,L+;<GVK
M\2/VA/'\OCSQAJ*O(62&5L<^]??7[:WQL;0]'%I%+M,J%3@U^7M[,U[JMU,Q
MRTQ)KYBIB%6@G$ZL'1<9.4CTG]GOP')XV\7Z<RH66&5<\>]?MSX!T&'P_P"%
M=.MXT"LL*Y_*OS6_X)\^$5^U7%S<0YVMN!85^AVK?$*'1M+(("LBX'X5=&O2
MI>ZWJS'%*52>FQU6M^(+71;5Y99%!49P37A_B[]HZWMQ-%$%7;D#!KR/XL?&
MNXU&62**1E'(X->6>&]+U'QUK$:('*L^"17V5#"0A!5*YE3P[D>M7'[0%_=>
M=Y8?VP:YYOC/K,BR\2^W)KVSPM^R_#'8PRS2KN=02#71+^S?IZ_Q)^5;?6<+
M'9&;J16ECYAM_BAKLZR?Z[GIR:BB\>^(-K_Z_GZU]7V_[/NGP?\ /,_A5U?@
M;IJC[D?Y4?7J'2(O:KL?(,/C+Q"Z/_K_ -:2W\6>(U1\_:,_C7V/#\%=-B_Y
M9Q_E4W_"G-,!_P!5'_WR*3Q]+^4/;>1\;VOBGQ&(7R+C/XT0>+O$<,;[A<?K
M7V?'\)=+C&/(C_[Y%-F^$6ER=(8Q_P !%3]?I_RA[;R/C.W\=>(HXGR)\_C3
MK?XD>(8X7W+/G\:^P?\ A3&F?\\H_P A4,GP/TR3I'&/^ T_KU'^4/;>1\CV
MGQ0\0+"^5GS^-/C^+FNPVLA99L_C7U@?@3IG9(Q^%5;C]G[3IE( C /M3^NT
M.L0]JNQY#\$?B9J>M:G#'<"0!GQ\V:^N8FW1H?4"O,O#7P5L_#MVDT14%3G@
M5Z<B[54>@Q7E8JI"I.\$8RES.Z'4445QD!1110 4444 %%%% !1110 4444
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MM^R^?%&AV\'G%6MEX_"F(^9/&FFZ9X@MTO5EBA=ANVY%3_#60FWO(#+YB*I
MYXZ5U=U^RCJNI71MQ<RI'&<#KBO1_ ?[+,WA^UD5YF8NN#F@"3]E?PWI+Z7X
MK>:QAE?RW.YE![5X;X166R\0>+UL?W:[I/E3\:^R/@_\)F\!V.LQ%RQO$9?S
M%<7X%_9O_L;6-<GE?>+YF//O2&>4?L2IHK7WB@Z^;<ON;;]HQZ^]8/Q3;1E^
M)-@-),.W[2/]5C^][5UOC;]E74_#U]/+I5[+"+EB3Y1(Z_2JO@']D74;?7;;
M4+V]DF*.'^<D]Z8C[6\+_P#(NZ;_ -<$_E6I532;7[#IMK;_ //*-4_(5;J2
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH 9-_J7^AKY!_:7O(86(4C<2<U]1>+_$D/A[3)9)& 8H<9-? OQB\7/XDUJ1
M V5#GO[U=.'M)J"/?RN,H.5=[(Y?PK8FZU($-M^:OJOP';C2?#ES/(<;(\\_
M2OGSP'X?-U=VS(<\C.*]K^*7B"/P3X%E4L$9X2.OM4\255&G##Q,;N<G)GP5
M^U]\0F\6:X]M')D0R$<'WKP+2K5KS6+")1G>P!K1\9:R^N>*-2D=MP\QB/SK
MH_@OX;;Q'XJL=J;PDJYX]Z^9BE&-NQWKW*9^C7[*_@E?"_AM+@IL+Q@]/:M#
MXP>*/)5DCEZ9X!KT#0[./PYX'M%4!3Y(_E7S9\2-4-W>3?O,\GC->CD&%6*Q
M3K3VB>?)]#B+F:37M36,#.YL5]>_LU_#>&QLS<W$()QD$BOFSX3^&VUS7(3L
MR X_G7Z">#]#CT72+=$4*2@S7T>-KNM5LMD=N)DL+AE!?%(W%4(H4#  P*=1
M2;AZUP'S0M%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !3)9-D3O_=&:?6-XHU5-+TF
M=F."4.*"HQ<FDCYT_:(\?M-&UO#)MVY!P:^6X%.K7SESSFNY^*&O-?:U=AFR
M-YQ7*>&=.-U?ISC<U>OEE.\G5?0^OQ45AL-"A'J>S_!OPUL)F;Y@O->4_MS?
M$(6&GV]I!)CC:0#7TCX/L4\.^%[JX;C$1.?PK\V_VH/'#>*O$EQ )-PBD(QG
MWKXK'5WC,;*?1'E4XW:1XK)^\FED/WI.:^J/V'O!/]K:I+/(F=C9!(KY7A4O
M>6L7]X@5^D/[$O@\:3I,MR\>W<N>E<=>7+39U5W96/<_B#JBZ7H<=ONVX3%?
M)_BF9IM4(#;MS5[K\:=8$F4$F-N:\'T^W.J:Y @^?+@5]OD]/ZI@'5>[,*%/
MVM51/I#]F3P7]H'GNG3GI7U/=ZE::/:YN)TB5%_B.*\F^%K6O@3PG)<SE4?R
MMP#<9XKP;XG?&R^\9:A-:6Q:)58J-IJ<-AI8AMK8YL?4=?$-+9'O/C#]H2ST
M$R+;^7,5]#FO+KO]K:Y^T$+;<9KR70_!6IZI-OF>1PYS\V37;0_!8/")&^]U
MQBNZ<L!A7RU9:G-&@NIZ?X0_:A34IDBNHEC#'&6KW;0/$EGX@M5EMYE<D9PI
MKX,\6> KK2Y T1:,+W%==\&?BG<^$]3AL)I6E$C!?F/2JJ86E6I^UP[N93I<
MNJ/MRBJFF7R:A8PSHP.]0>*MUXASA1110 4444 %%%% !1136<(,GB@!U%5U
MNE=L*<U.O2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-?1'QD_:"M=4DETFPTZ%(8R5#QJ.:\;TJZANKPSR0*2QSR*\;$9@HOEIGW&
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4:!B@R0.:[.O7Q6(E6E9[(\R4G)ZA45T=MK,?]AOY5(V "3T%>3?&GXV:?X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'\5/'$L,CQQGC)!Q7+@\%/,,1R1V/+;L=C?_ !.M(9#&0C8..:GTOQAIFH2
M,L8)^E?+&H:Y=W5QF M(2><5K:'JES;W4+3.T>#T)K[A\/8;E<(2]X3NDFS[
M!B:)HU:(#!':EKE_A_K?]JV*@G.U:ZENIK\WKT98>K*G+=%"4HY.*2E7[PK
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1(C1EEC8'I7Z8>#]%30?#UG:*@4QH >*]7+J'_+QGR_$F.Y4L-!^IM@!1@#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@UQ1R'!0J>T<M#R_:HRM2UZ^U?4GDM2TA)X"U!'J?B.UDYMI=OK@U]0?#/\
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MA7'^&?@GI7ANZ,T9$ASD9'2O1HXQ'&J#@*,"@8ZBBBD 4444 %%%% !1110
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MO8=LG#+N%?4*J%4 = ,5]5@</[*%WNS\HSW,?K=;V<'[L1:***](^6"BBB@
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M0HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M++V<3[?AW+?^8FHO0CM8=D8SR:?-)M7CK2R/M'%5_O-FO /T 6/Y6W=Z,EY
M%Y).*%!=@J\L3BO;O@?\!KSQEJ<4EY;LMMG(;%:TZ<JTN6)S8G$T\)3=2HQO
MP'^!MYXTUB.2]MV%MD,&Q7Z&>"?!]KX1T:"TAC4%%QG%5_ ?@2R\%Z3!;P1J
M'5<9Q755]9A\/&A&RW/R+,LRJ9A4N_A6P4445UGBA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHHKH/-"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N2^)>M#1_
M#4\H;#8KK.]?/O[0GBW[-:W%D'P<=*3.[!477KQB?+OQ0U]M6OI9 VYR:P_"
MMBL^QI.'S67?7$EUJK+U&:Z;18U@9">#FO,S"IRJ-%==3FXDQ2J5U0CM$^B/
MAW&+?2D4=-M?'G[8FJ!KR[AW=Z^Q? >/[#5^VVO@W]KC4?-\6W<6[O7MUO<P
M:7D>;ED>:NCYOL_]3^-2R'"TRW7;&!1.<+^-?*=#[[J>^?LCV7G?$"!L=Z_1
M/7L0:/M/'RU\'?L;:?O\8028K[L\=2?9]+8MP-M?7Y?[M"Y\+F<KXD^<?'T\
MS74GEKNYK&\*7#1WT>_AMU;?B:Z-Q.XA^=_2N6T>25=84.-K;NE>%@Y*56JO
M4[.'*G)C7%]3]#_@S>";PI;*#D[14OQ<^(,'@/PY+=-*JRX(QFN#^$OC2RT'
MPY$]W,(U"=S7RW^TI\9[CQ9KEUI<$NZU#'!4UOB*ZH4[]3Z.CEL\7CG"WNWU
M/+_B9XPG\9^*[FY9RT3L3UXKF!B-=HIL*^5&-QY]Z;YBS-MC.7KX^4G.3DS]
M6ITXT8*$=D))A>31:VTNH3".V&]R<8 KLO!OPG\0>++E!%9N\3'J%KZW^$'[
M)NGV*Q7>I1%)L D$5V4<)4K=+(\G'9MA\%'5W9XU\#?V<[SQ/?13ZG;,D!PP
M8BON_P %^";+P=I<-K;QJ"BXSBM/0] M/#]FEM:QJJ(, XYK2KZ6AAX4(VB?
ME^/S*MCYWF].P4445U'DA1110 4444 %%%% !1110 4444 %%%% !1110 44
M4WS%W;<\T .HHIK,$&2<"@!U-+ =Z56##(.17SG^U!\;-0^%NKZ/;V7W;IU#
M?C0!]%[AZTH(/2OF;Q?\=-2T?0;&[C/S31AC^5=A^SO\4;SXC6]X]WUBZ4"/
M:J*9)(L>-QQGI3NO2@8M%%-\Q=V,\T .HI.:1F"]3B@!U%(#N&1S0* %HIOF
M*6QD9IU !12&C.T9- "T4V.19%RIR*YSXB^*$\'^$=0U1G"M!&6&: -^:ZB@
M8*[A2>E2+(KC(.17Y\:#^TMX]^)7CR)-(MFN=-2;8[IR!S7W7X/DNY=(A>]0
MI,5!(-,1O45XA\5OBAXA\*^-+33M.AWVLA&XUZGX2U.XU;35GN5VR$"D!N44
MQI%5@I.">E.Z4#%HIJ2"1<J<BEH 6BFM(J$ G!I: %HIJR*_W3FE^M "T4A-
M+0 444WS%W;<_-Z4 .HHIK.$7+' H =12*P901R*,\4 +12"D\Q=^W/S>E #
MJ*2B@!:*\W^-GC;4_!GA=[W2$\RX!X%3?!GQAJ?C+PO#>ZI'LN6ZB@1Z%24&
MLSQ#?2Z?ILDT(S(.E S4IN\=,UX-X1^+'B75_B!-I=U 5L5!PU>>Z5^TAJMY
M^T!=>$B?]$C? _.@1]>T5!9R&6W1SU(S4BR*S%0<D4#'T4E(SA>IQ0 ZBD]Z
M* %HIBR*SE0?F':GT %%%% !1110 4444 %%%% !1110 5Y=\<?$PT/1<*^&
M8$'FO3I'VQ.WH":^2OVB/%WVSS;</RA(QFDSU<MH>WKJ^R/G/QUJ#ZAJ3R(=
MVYLFM;P?8HTL!/#9%<K:M)>7SAQD9KM_#JK;W4.#SD5Y..J7JPHKH>+GV+^L
MXOE6T3Z*TD>7X9D/3;%_2OSD_:KU/[=K4L><[9#_ #K]&89!%X1G8_\ /$_R
MK\O?CU??;/%EZN<XE/\ .O>S!\N'BA91&]:YYO#Q"@]J'^\!2I]T?2F/_KHQ
M[U\H?;GV)^Q#8;KJ=L5]>>-YO)T[;[5\T?L-Z?Q.V.U?0_Q+N!;VY#G K[+#
M+EPNI^?XUWQ,CYV\523R7CE4R :VOAE>;=9M@3R''\ZS=>N))FE\A=XYS5;X
M?3M%KD1;@[QG\Z^?P$N:%1=CW.&*G[RI3[GZ0^#;K[1H=L0<X05YG^T/\6H?
M!&B2VT<RB65"#S5C1?B-I_AOP?(]Q<*DJQ94$^U?"'QL^*%Y\0M=F1Y"8HW(
M7!]ZO%XA48:;GMY;E<L7BWS+W4SA];U6?Q!K%U<3L6#.6&3[U6;@8%)N6-1N
M..*;'OO)!';?.YZ 5\DVY.Y^K1BH126B1#(RQ]35O2])N]:N4BLXS(6..!7H
M/P_^!>O^+;F,RV4A@8C+;>U?8_PG_9;T?PW!%<W,>)A@[2.]>A0P=2MJ]$>#
MC\YP^#347>1Y)^S_ /LTO?217NK6[1E2&&X5]HZ'H=MH-C';V\84*,9 JS8V
M,.GVZ0PH%51C@58KZ6C1A1CRQ/R_&8ZKC:G/48M%%%;GGA1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!JG6M6N9++Q0?L\^[:JMZUYIX=\<>*=8EUY/"EF+VW#,)& S@5Y-H[ZO\
M\)Y;'58VMY3.,J..<U1)]._M.?M4^(?AKJVFV>BC>;P@*/7->?:C^T1\7])D
ML[^?3Y$L6 =W(.,=:S/VB]-AU#QYX(\XY.^/%?9WQ#\):7<?!.X$T,:&+3@P
M?'^S2&<]\&?VB[;Q]X)U#4KB=3<6<9+\]"!7SWXP_:T\9>*-6N8/"L?VM('*
M_)[&N1_8WM[:ZT_QEIS3,899'0\]LFHYOA[XC^&VIW=WX+LVOH7D+R,1G'-
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M[H.G:_>ZG<WK>;<1W#%0_/<T#+OA']J3Q]X2\66&F>*K=K2&X<;MXQP:[?\
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MT89!%?F'HGPO\=:]\>(/$&L:?);G<"<# ZU^DG@V"2WT.!)1AP!G-(:/F?\
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M^6#S7A$'[3OQ0\,QQ:SK%FT%A(W^L8<8KQOXI:QK,WQ^OXK$-+)OX3M7H7Q
MTGXF^//A_;Z5+I#+9*1AU7F@#['T_P#:*TL_"ZW\07-TBW$J9Z]Z^8[W]ICX
MG>*_%ES%H%FUSIX)*,H)XKSWXK>%];\$_ W3H+U)(-I -?67[%OA?2I/AU::
M@%2:Z>+YMPR: /%_AC^UUXWOO'DGA_6XC#Y1PRGM7NWQD_:17P?X(BN-)F5]
M388*9YS7S=XLT2ULOV@M9EB 6;<WRBO(OBQK6J76N/;0;GVOPM,#V6X_::^*
M>CP0:W<V3I83-Q(1QBOL#X'?&.V^)&@VK2S*VH,H+IFOB#4K3XF>+OACI^FC
M2";%0-KA>U>W?L=?#[6O"VK"74X7B^7HU(#['HHHI%!1110 4444 %%%% !1
M110!C>*-472]+F<G&4-? ?Q<UY[K7+K+9!8XK[+^-FI?V?H0P<9!KX'^(%TU
MSJ3%#DEJ<?BU/I\OM0PM7$$7AJV>25WD7"]J[?P99PZAJ04G[K5SNBCRK-3*
M-N5KM/A?903:H[(=QS7S-.7M\6F^Y^8RDZE1R?5GKOB!A8^#[@ X A/\J_*G
MXK77VKQCJ/.?WK?SK]1?B==?8?"EP,X_='^5?E/XVG^T>,-1.<_O&_G7TV:N
MT(Q/J\EC[TF9"\**C/\ Q]P#U:I:C7G4K0?[8_G7S9]9W/T)_8ILS;V;MCJH
MKUKXP2(T8#G%<#^R-9_9]&#8ZH/Y5UWQ>8,WSG S7U\O=P;/SC$N]:3/&[S=
M"LGV8;\CFLOPP[P7S2,,.&S6Y)B.&7[/\QQS7.Z/+)]LDWC'-?+Y6_>G$]+A
MV3CC4NYU/B[Q-?ZC9+"S,(P,<5Y+-X=O+RZ/V%&E=CSQ7M>E^&KWQ1=00VT1
MDC8@-@5]-?#;]F_2--M8[J[C_>L <8HJX66(J.[T/U&IF=/+;I+5GQ5X2^ _
MB?Q%/'YMC)Y3'D[:^H_A;^R)I=JD=SJ$925<'!%?3.C^'++1(A';Q* .^VM/
MI791P5.EKN?,8S/L3BO=B^5>1B>&O"-AX7M1#:Q* !C.VMNEHKT#YMR<G=A1
M110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:JC'%?-/[..EF.\ADQQBOIJO?1]7F\N;$M=A,4M%%,\0**** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M** "BBB@ HHHH *3K2T4 4YM)MKB0.\:LPZ$BK:J%4 =!2T4 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@!&^Z?I7QI^TA)_Q/9Z^RI#MC;Z
M5\5_M(2?\3ZX^M+JCW\F_CM^1X5HPD;5EQTS7TO\/%Q8)GKBOFWP_N?4E(Z9
MKZ9\ #;8(3Z5]?/^#%'C9L_B]3Y\_;&N<>&[I,]J^![/_5?B:^X/VQ[S_B6W
M<>:^'['_ %'XU\%F+_?'H93I0+%=%\*X_/\ &$2@9^85SHKL/@A#Y_CV)?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=./D;=%%%0?+!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQE_6C_A@_P =?\^,OZU^W7]FVW_/%/\ OFC^S;;_ )XI_P!\T<H?6I'XB_\
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MVSZ+.G^\C$GHHHIGS@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU]P::OEV<8]J^2?Q,^DSE^_!>1:HHHH/FPHHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ I*HZIK-KH\!EN)%51[UPNH?'OPQITK1RW'S+[B@#T
MFDKQZY_:@\(V[8\_/XBM#1?VB?"NMR+'!/\ .?\ :%,1ZCFEJKI^HP:G;)/
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MS$U%3I3F9C3:_ 7NS]/C\*&1_-JUE_UT'\Z^NI)Y+/P7;"(XW1<X^E?(T/\
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M_P!HCQ-9-\/YT21"VWL:]W&-7D?$XC7$1/S.\:/YWB:5O]HUFU9\1SK/KDC
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M /02E_[Z-'_"E/C_ /\ 02E_[Z-?IIY*?W1^5'DI_='Y47"Q^9?_  I3X_\
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M+*I)]#6RCB10PZ'F@!U%%% !116;J6N6VDLBSOM+=.: -*BL.?Q?86\D:-(
M7Z<UKPS+<1AT/RGF@"6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F21K,A5AE3UI]%
M%6UTVWL6)AC"$]<5)<6D5T,2(&J:B@"M#I\%O"T21A4;J*R)? FB32F1[)"^
M<YKH** ,ZWT&QM8RD4"JOI4D>CVD2LJQ *W6KM% %:TT^"QSY,83/7%6:**
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M]8^I]6_LUS?Z9 M?4%?*/[-,V[4H17U=7R<3NS9?[2PHHHJCQ0K \6>--/\
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M60KN&:^W/ 5Q)=>';.20Y9HU)_*O@?XE8_X2KP[_ +RU]Z?#O_D6;'_KDO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2K2((UPHP*0QU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD96//-U+NKH+GPK*&.WI4,7A>9FQ2->9&)RV !72>&])8R>8PXJ[8>&1$V9
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M[D(<2+N"@U\!:'X:_P"$@G6>/ N6.=W?-:'BC2=<TO5--MM1N3-!(P4*3VH
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MG&D=V^T8YKVAMGDR?.O3UKQCQKC[8^#GYJ^/XL_Y%LCT\M_WF)BK_JQ10O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MIWAFT2&RMDAVC&5%=]'!N_-,^3S+B&"@Z>%W?4K^#/"-KX1T6WM((E1XUP6
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MJ_SK%M_2K/[./PROOA^=1^V-N\XY'YU[=Y*$8V\41Q+']U<4 /HHHH&%%%%
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MU!]A7[U?HU&<Y1>K/F,NC3=^<O\ PI^#^E:O?1)/:HX+ <BOKBQ_91\*R:?
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M=?/<!MV*SG0A1HJ4_B8.*C&[W9ZDO*@TM%%>68!1110 4444 %%%% !1110
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MNP/F'-.\9? 6;Q+J%K,"-L; FF!\Z:M8Z7;ZAHS2VJJ[,O+"M']I0Q1KX?\
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MSR%>M?#_ ,:+XVTG[:D9C'H:^,KTY7]IRV3/,E%[V.JHHHKD("BBB@ HHHH
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M-9\+BYQNW+7S1X@VVNK. FTANN*^_M[7#RB<&3UG&4?)GV'^SSXA^U"&V+<
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M%?6U2-!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4"*, 5O3C;5C0DF.]=U\-?$VL^'[[S+-9MI&!LS7$6NGR:Q=Q01 EMPSBOT
M^ WPETS3_"MG=WMI'-*R#[ZUY^88B%"G:2O<QK345J?,4OAOQK\4-8"B\N88
MR^?F)K[.^$?@^]\*>&[6WO)C+*J@$FNMM?#FF63;H+&&)O55Q6BJA1@# KY+
M$8MUDHI62/.G4YM!:***X#(*9-_J7_W3_*GTR;_4R?[I_E0!^7/[;4]_+K-P
MD=PRKYAXS[UX+I6CWS:7"QG.<>M>^_MH?\ARXQ_SU/\ .O'=')_LF#Z5^T\,
M4:=3"7G&Y\OC)-5-#-_L>]_Y[_K2?V+>_P#/<X^M;F31DU]?]5H_R(X>:7<P
M?^$;=N78$]Z=_P (SM1]I&<5N9-+EMK=>E-86C_*'-+N<OX7GN]"O+HB8J,'
MO7">,M4;4[Z3>VXYKH_$FH'39)#G&ZN!N)C<3,Y[FOP;C&T<5R1T1]MD4;WD
MR(<"EHHK\\/L HHHH **** $K>\)Z[-H?FB)S'O]*PJ9)(8V&.*WH2Y:L6<^
M(CSTI(]-T.&YUV1VDEWCKR:V1X7 ],UA_#.5I5?))KNB6R:_J'+*%*>#IR<3
M\GJR<9M)F%_PC\T?^JDVTO\ 8U]_S\?K6YDT9->G]6H_R(QYI=S$_L>]_P">
M_P"M4=4TF^BC+BX(('K74Y-9^L$_9W^AJ98:CR/W$-2E?<^O_P#@G/=WDEK?
M+<3&3!XR:^\*^#O^"=/^IO\ ZU]XU_/>8_[S.Q]9A_X:"BBBO-.DR_$FN+X?
MTFXO67>(E+8KY!^)7[8/VV.[T^TMI(Y!E 5S7V%KVEKK6E3VC8Q(NWFOG2\_
M9#@NM<%ZSQ%-^XKQ7I8.6'BVZZ-J;@OB/G+X<?#_ %KXP>)8K^]\QH1)G$@/
M3-??'@OX;Z5X7TF*W6TB+[1N^6IO!?@#3?!]BL5O;1HX&-RBNDN[J.RMWFE8
M*B#))HQ>,EB)6CI%!4J.;TV/ ?VAO@7:>)-.FU.T2.W\E-Q %?"=]:G2;R:!
MFW%6(K['_:#_ &DK72[6?2;7]X9%*_(:^;/A[\+M1^*FJF94>-9'SDCUKW\N
ME4HT7*L[1Z'71;C&\MCB%G/T%2,_<&OI7Q5^Q[=>'_#\VH?:E;R4W%0>:\4\
M'_#V?Q3X@734."TFS=^->G3QE&K%RB]$;QJQDKHY+SN.M/CL;N]0F&WDD'JH
MKUGXH?L]WGPYDB>23S$9=V:]T_99\%:)KWAJ62Z@BFD4XP0":PK9A"G2]K#4
MB591CS(^5OAOXB;P9XNLYKNW9 C@_,,5^COP\\>67C;1XKBW9054 C-?-_[3
M'P1@M[.?4].A6%8US\HQ7$?LI^.KVPU)--FF9@9-O6O)Q48XZC]8ANC"I:M'
MG1]ZT4V,[HU/M3J^8.$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /B?]O>%KS6-&MXW\N1P &]*\W\/_ +-_B_4O!EYJ*>*)
M([5(M[0^9P1CI7M_[9WP_O?%5YIU[:*[&W /RBO'?#_C;Q%:Z)<:"+6Z43)Y
M6[!QZ51)%^S]XA@\'^"_%.G31BXN"'7S.O/K78_LDR;TUJ2>X5 TK$!CTYK6
M^ _[-MZGAO69+R0^9=[F&_KS7G&N>$==^#NH7-M:I-*L[DYC!]:0&E\?9/\
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M:'_SSC_[ZKQ;_A@'6_\ H.C_ +[H_P"& =;_ .@Z/^^Z /:?^&MM#_YYQ_\
M?5'_  UMH?\ SSC_ .^J\6_X8!UO_H.C_ONC_A@'6_\ H.C_ +[H ]I_X:VT
M/_GG'_WU1_PUMH?_ #SC_P"^J\6_X8!UO_H.C_ONC_A@'6_^@Z/^^Z /:?\
MAK;0_P#GG'_WU1_PUMH?_/./_OJO%O\ A@'6_P#H.C_ONC_A@'6_^@Z/^^Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^H;.S2SA6-%"J!C J41JO10*YX8B=.+A#9D*;2LA8UVHH]!BG445RD!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!6O--M=07
M%S DP_VQFLY?!FAJ^\:7;!O796U10!#;VD-I'LAC6-?115*]\-Z7J3;KJQAG
M;U=<UIT4 9MOX;TNT_U-C#'_ +JXJPVEVC$$V\9(]JM44 9UUX=TR^_U]E#+
M_O+FF6?AG2M/;=;6$$)]47%:E% "4M%% !1110 4444 %%%% !1110 4444
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M%%%>28!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<^#@^]=W\>M 3Q%X)L+NW >1E#-MK\-XGR]TYR:6Q];E%3EDI(\,^&5XBZM
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M:P<#(!6O$=4_:IU/4I&V-+&"?4UQ3Q=.)])A^'\767,U8_2K^U+,]+J$_P#
MQ4L=U%+]R16_W3FOR_A_:0U>W;<9Y2/]XUW7@W]LJYTNXC$\;R 'N:F.-IR=
MC>IPWBH*\=3]"Z*\8^&'[1VE>/(XQ(T=O(W&"<5['#/'<1AXG61#T*G-=L9*
M:O$^9K8>IAY<E569)1115G.%%%% !1110 4444 %%%% !1110 4444 %%%%
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ME6=)D3S/*=-S#^*J;3FWCS)U]34VG7UL9=S2JI^M,#3OK=9/E1,4MNL2Q[
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MG<#HM+\?7.DRJQ+/S7L7@WQM!XBA2-@H<BOGHJ&ZBND^'5]+:ZU\K$C^[33
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_;W$=U"LL3AXVY##H: ):*** "BDIDEQ'"0'<*3TS0!)12*=W(Z4M !1110
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M<?3-7C7<=@->^:?>K?VRRKT-?%X[#?5YZ;,]2C4YT6J***\TW"BBB@ HHHH
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M\8/V1Y?$C:;/;ET9)%9@H]Z^[_)CSGRUS_NBE:&-NL:GZ@4Q'R3\5/@1+>>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ!8'_EY3\ZECU>SE.%G0GZU7));H+HN44U6#KE3D4M0,6BBB@ HHHH ****
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MU*LCT#]D?X*R2QC4+^ QLAW+N%?;,,8BB1!T4 5P&E^,/"7@_38[>VOH %4
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MXQA17WN19;*DOK%5:O8^KRO!N'[V:)J***^S/I0HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML%VQ\\5X^*P\DHX6GT.:I%Z4XGUU',DRY1@PI]><_!?6=3USPG976HQ-%,Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:SL8K)-L2A1Z 59HHH R_$?A^V\3::]E=#,3=:I^%_!EEX3M1!9C"#VK?HH
M9-$D\91P&4]C7DGC#]FCPUXRU1KZZ+)*QSA1Q7KWO2T <;X3^%^D^$=+6QME
MWQ 8^85R'BG]F7PSXJU5K^XW)(3G"CBO8:* .!T[X-Z-IVAKI:@M /[PJ>;X
M3Z/-I8L"G[GZ5VV.]+0(R?#OAZV\,Z>EG:C$2]*UJ3WI:!A1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%2(3%<CXJ^'=AXBC8NN&Z]*Z^DK*I2A6CRS5T9SIQJ+EDKH^<-<^$UW93/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXS<4T3:1)))I\32C$A'-6)+>.88=%8>XIRKMX'2G5Q&8U$6-0JJ%'H*=110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIDLJ0QO)(P2- 69CT '4
MT 5]4U2VT:QEN[N4101C)8_H!ZFO#/&GC^\\53-"A:WT]3\L*G[WH6]:3Q]X
MRE\5:FRQL5T^%L0IZ_[1]S7+5])A,(J:4Y_%^1Y->NYOECL%%%%>H<04444
M%%%% !1110 5Z3X#^*$EF\5AK$IDM_NI=,<LGH&]1[UYM16-6C"M'EFC2%25
M-WB?4ZL)%#*0RL,@@Y!%+7E'PH\;,LB:)?291N+5V/0_W/\ "O5Z^4K494)\
MDCVJ=15(\R"BBBL#4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MLX%1!C JQ7Y]6J.K-S?4]F$>6-@HHHK$L**** "BBB@ J.2".88=%;ZBI**
M*J:;;QMD1)GZ5950O   ]J6B@ I*6B@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8$MXPJ# J2O Q&+GB'[VQV4Z:@%%%%<1L%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1117J'$%%%% !4%Y96^HVLEM=P175O(-KPS('1AZ$'@U/10 4444 %%%>D>
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MQ9/_ (\36/<>/O$-SG?JMP/^N9"?^@@5@45UQH4H[11TQH4H[11?EU[4Y_\
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MZ2A5+88J"I4'+J #FO-_%W_!433K*:ZO/"GPRUOQ+X7M9?*EUVYN#9P[LXX
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M5Y)V;:(****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_KS$32>7!VACX4?7U_&L:O<HY>EK5U\CVJ.7I:U=?(U=7\3ZCK3$7-PWE_\
M/*/Y4_+O^-95%%>O&,8*T59'K1C&"M%6"BBBJ*"BBB@ HHHH **** "BBB@
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M1*K'\2"?QKAOC9^RKX1^/GB[POX@\37NL)-X>.;:SL9XDMY?WBN1(&C9CDJ
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M:?\ 2O3?^"DGC#_A%_V7M6LTE\N?6KVVT]0.I7?YKC_OF(C\:]F^!_P4\/\
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MI?:E?\7_ )'L<<:Q1JB#:BC  [ 5^=/A53\7_P#@J7JUZ<367A@RD <A?LT
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M7?B#Q@EWJ5U+>3+%>VNP/(Y=@N;8G&2>I)]ZS?\ AU'\)/\ H8O&G_@=:?\
MR+7LTJF'IT>2,W&3^)VU]%V1Y]6-6=6[C>*V5_Q?=_D?76B>+-#\3-*NCZSI
M^JM" 9!8W4<Q3.<9VDXS@]?2OS]_X*H:7>Z+XY^&'C 6YFTZW$ENS8RHE259
M0I_WE)Q_NFOJO]G7]D?P7^S+<ZW<^%[S6+^XU9(HYI=7N(I"BH6(5/+C0#);
MG(/05Z1\0OASX<^*WA6[\.>*M*AUC1[K!>WFR"&'1E92&5AV92"*Y*=2&%Q,
M*M)\RB[]NEG^9O*#KT9TJJMS*W]?,Q?#?Q\^'OBCP7!XJM?&.BQZ-)"LSSW%
M_%'Y&0"4D#,-C#."IP0:^#OBEK\G_!0+]J;P]X5\+^=<?#GPS\UWJ(1E1HRP
M,\W/3?M6-,\G&>F<>V'_ ()8_!XZF;K^T?%8@W[OL7]H0^5C/W<^1OQ_P+/O
M7TI\,?A'X0^#?AT:)X.T.VT2PSOD$(+23-_>DD8EG;W8G X'%;PJ8;#3]M2;
M<ELFMO-][&4HUZL/93LD]WW].US-^,'QC\(_L\> 'UWQ%<+9Z?;J+>SL;< R
MW+A?DAB3C)P/8 #)( KX)\/1:Q^WMX\C\4_$[Q5IW@OX8:;.WV#0/[2BBEFP
M<%45F!R>C3,/4(.NW[5_:*_9:\*_M-6NAV_BC4=:L(](>62#^R)XH]QD"AM_
MF1.#C8,8QU->)?\ #J/X2?\ 0Q>-/_ ZT_\ D6C!U*%.+J5':IT=KV\_7SZ?
MF\1"I)*%->[UZ7\O0^D_"?BCX:^#-!T_0/#VO>&]-TNS006ME:ZA %4>@&[D
MD\DGDDDG)-=[7QQIO_!*_P"$FFZE:W?]M^+[G[/*LODS7MKLDVD':VVV!P<8
M."#[BOKS5--35=)N[!Y)(([F!X#) VUT#*5RI[$9X-<>(5/XJ<W)N][JW^9M
M1Y[\LXJ,5;8R=6\?>'](TV]O)=:T_;:PO*Z_:DSA5)(QGVK\_P#_ ()D7%IJ
M_P 1/BEX^UF]M;2ZNRD*-<3*A9IY7FEQD]BB?G7J/_#J/X2_]#%XT_\  ZT_
M^1:/^'4?PD_Z&+QI_P"!UI_\BUWT98:C&HO:.\E;X=N_7J<U55JO(N163OOO
MVZ=#[+M;J&^MTGMYH[B%QE9(F#*WT(ZU+7*_"[X;Z1\(? .B^$-"\\Z5I4/D
MPO=.&E?+%F9R  6+,2< #GH*ZJO*FHJ347='=%R<4Y*S"BBBH*"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCG@D6:&0;E=#D$5\O5T_@WQS=^$[@+S/8L?G@)Z>Z^AKR,3@5+WZ6C['DXC
MJ7O4M'V/?Z*HZ/K5IKUBEU92B6)OS4^A'8U>KY]IQ=F>"TXNS"BBBD(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5DZ]K']GP^7%S<R<*/3WJWJ>H)
MIMJTK\GHJ^IKF+6.2YF:[N.9'.1[4 /LK4PJ7<[I7Y8FI;BXCM8))I7$<48W
M,S= *DKS+Q_XH-_=-I]L_P#HT1Q(RG[[>GT%=.'HNO/E1TT*+KSY48_BKQ))
MXBU ODK;1\11^WJ?<UB445]9"$:<5&.R/J805.*C'9!1115EA1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!T7@GQ=-X4U029+V<GRS1>H]1[BO?K.[AO[6*X@<2PR*&1U
M/!!KY?KT#X7>-#I5XNE7;_Z'.V(V8_ZMS_0UY..PWM%[2&Z/+QN&]HO:1W1[
M-1117SI\\%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %,FF2WB:20[449)I]<KK6H-
MJMU]EA/[B,_.P[F@"":9]:O#/("+=#A$-6Z2.-8T"J,*.E,N+A+6"2:5ML<:
MEF8]@* .?\<>(O[#TTQQ-B[G!5/51W:O)"23D\FM#7M8DUS5)KJ0_*QPB_W5
M'05G5]9A:'L*=GN]SZK"T?8PMU>X4445V'6%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4H)4@@X-)10![M\-O%G_"1:.()WS?6H"OGJZ]FKL*^;O#.O3>&]8M[
MV(G"G$B_WE/45]%V=U%?6L5Q"P>*50ZL.X(KYC&X?V,^:.S/FL90]C/F6S)J
M***\X\\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#,\027$>GD6ZDECM9AU45C6=L+6$*.6
M/)-=6>>#R*QM0LC;MO4?NS^E %.N(^)FM_9[6+3HFP\WSRX_NCH/Q/\ *NUD
MD6&-G<[44%B?0"O$-<U1M8U6XNV)P[?*/11T'Y5Z> H^TJ<SV1Z6!I>TJ<SV
M10HHHKZ4^C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KUWX.^(_
MM%G-I$SYDA_>0[C_  'J/P/\Z\BK3\-ZP^@:W:7R$XB<;P.ZGAA^5<V)I>VI
MN/4YL12]M3<>I])T4R&9+B%)8SNC=0RMZ@C(I]?('R84444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !3642*589!ZTZB@#SKXGW1T716A1OFNF\M3_L]6_3C\:\>KN?B]JWV[
MQ,+56S':1A./[QY/]/RKAJ^IP5/V=%>>I]/@Z?LZ*\]0HHHKO.X**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#W+X4:U_:GAA;=VS+9MY1_W
M>J_X?A7:5XC\(]6^P>)_LS-B.\C*<_WAR/ZC\:]NKY7&4_9UG;KJ?+XRG[.L
M[==0HHHKA.(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT5]KE^7_ %#G_>.7-;?I:_\ F>OA\)["?/SMA1117KGH!1110 4444 %%%%
M!1110 5[1\&[SSO#,\!ZPW#8^A /\\UXO7J7P1N#G5H#T_=N/_'@?Z5Y^.C>
M@WV.#'1O0?D>J4445\N?,A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>@?!<_\ %378[?9&_P#0TKDQ?\"1RXK^!(]FHHHKY(^4"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[L<:_F2?Z5QXQVH2.3%NU"1ZU1117R9\J%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G/QJMM^B
MV$^/]7<%/^^E)_\ 9:]&KE?B=8_;?!M[C[T.V4?@1G]":Z<-+EK1?F=.&ERU
MHOS/ Z***^O/K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KU_P""EMMT?4;C'^LG"9_W5S_[-7D%>]?"^Q^Q>#;,GAIBTI_$X'Z
M5YN82Y:-N[/.Q\K4;=V=91117S)\V%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHHKU3U HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***DM[=[JXCA
MB7=)(P15]23@4 >K_!?1?)L[S4W',S>3'_NCDG\\?E7I=9^@Z2FAZ/:6,?2&
M,*3ZMW/YYK0KX_$5/:U',^1KU/:U',****YS **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"O-QU;V=/E6[//QM;V=/E6[-BBBBOF3YH**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M @CAB4(B@= *FKY&O6=:;FSY2O6=:;DPHHHKG.<**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5P?Q$^'RZ]&]_8(%U!1ED' F'_Q7\Z[RBM:=25*7-$UIU)4I<T3Y;DC:
M-V1U*NIP588(/I3:]P\<_#F#Q&KW=F%M]2QD]EE]C[^]>+7EE/IUU);W,30S
M1G#(PP17U.'Q$,1&ZW['T]#$0KJZW[$%%%%=1TA1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<<\96GUMZ%33M)LM)B\NRM8K9.XC0#/U]:MT45Q-MN[.-MMW84444A!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
K %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img226925499_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img226925499_3.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ;9"\(# 2(  A$! Q$!_\0
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M_P -X>$O^A6\3?\ ?B+_ ..5\E))4RO7M_V%@OY7]Y\W_K1B^R/J_P#X;O\
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MC^R\'_(_O92SW%>1['_PV]X>_P"A+\6?^ D?_P 72_\ #;GA_P#Z$KQ;_P"
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M\-7)_P!$Q\>_^"H?_%4O_#5J_P#1,/'O_@I_^RKVN.9NF34Z2M_>-1[;#?\
M/G_R9EJ-;_GY^"/ M6_;$T_0=/DOM3^'GC;3[./&^XNM.6*-<G RS.!R:]TT
M+5HM?T/3M4@1XX;VWCN423&Y5=0P!QWP:\<_;2<M^SOX@R<_OK;_ -'+7IWP
MU_Y)SX5_[!5K_P"B5JZT*4L-&M3CRMMK>^R7^84I5%6=.<KJR>WJ='1117F'
M:%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=_[02>#?AO8>&O#FI :MXFC6<W5K)\T=CG.]2.GF'"@^@?%:G[!?PPUCP_X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*UV5/]QA_BE^42:/^\R_PK\V='1117DGHA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9)96L]N]]IR%.0>,X/X"H/@Q\&]%^"6@7>EZ--<72W=Q]HFN+K&]CM"@< #
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ME3H]<L*,*2M!6.NIB*E9WJ2N7XY-K UX-\)?V-O"GPB^*,GCK3-8U:[U*07
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M_P"$JU0\A+4C_KPA_P#B*^[R'%>PPTHV^U^B/G<SR/\ M:<92>B]3HEU)!_
MU2+J\:_P-7,_\)5JG_/.V_\  "'_ .(H_P"$JU3_ )YVW_@!#_\ $5])_:/D
M>+_J;3_F7WLZI=<B7_EF_P"E2+X@B'6-_P!*Y'_A*M4_YYVW_@!#_P#$4?\
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M "[3_P#CO^-2+\1+)?\ EUN/_'?\:\P_X2K5/^>=M_X 0_\ Q%'_  E6J?\
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M_P#B*/\ A*M4_P">=M_X 0__ !%+VU'^7\1_ZMS_ )E^)[JOQLTM?^7"\_\
M'/\ &GK\<-)'_,/O?_'/\:\'_P"$JU3_ )YVW_@!#_\ $4?\)5JG_/.V_P#
M"'_XBI]K1_E?WE?ZN3_F7XGOJ_'725_YAU[_ ..?XT\?'K2!_P PV^_\<_\
MBJ^?_P#A*M4_YYVW_@!#_P#$4?\ "5:I_P \[;_P A_^(I<]#^5_>/\ U=J?
MSK\3Z$7X_:.O_,-OO_'/_BJE7]H/1A_S#+__ ,<_^*KYV_X2K5/^>=M_X 0_
M_$4?\)5JG_/.V_\  "'_ .(I<U#^5_>5_J_5_G7XGT:O[0^BK_S"]0_\A_\
MQ52+^T9HB_\ ,+U#_P A_P#Q5?-W_"5:I_SSMO\ P A_^(H_X2K5/^>=M_X
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MSSMO_ "'_P"(H_X2K5/^>=M_X 0__$4O983^1_>5_9&)_G7XGU\O[7WAL?\
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M_"5:I_SSMO\ P A_^(I?5<%_(_O*_L[&?\_%_7R/M]?VX?"B_P#,O:U^</\
M\74B_MS>$Q_S+NM?G#_\77PY_P )5JG_ #SMO_ "'_XBC_A*M4_YYVW_ ( 0
M_P#Q%+ZI@OY']X_[/QG_ #\C]W_ /JOXX?M5>'OB=\-=2\.V&C:I:75R\3K-
M<^5L&QPQSM8GM7VW\-?^2<^%?^P5:_\ HE:_'>3Q9J:QL2EJ!CO80_\ Q%?L
M-\,I&F^&WA.1L;FTFT8[0 ,F%>PZ5X^;1I4Z,*=%65V_P1T4,+6H3<ZLD[JV
MATM%%%?+G<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 >$?MP?\FS^*O\ ?M/_ $ICKK?@
MDH_X4SX#X'_(!L>W_3NE<E^W!_R;/XJ_W[3_ -*8ZZWX)?\ )&? ?_8!L?\
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M4 %%%% !1110 445S7Q#^(&D?#'PI>:_K4I2U@&$ACP9;B0_=BC'=F/X#DG
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_!?]DC0?%]Y']H-AX:L?LUKG!N+AH(UBB'^\Y&?09/:K?[<'_)L_BK_?M/\
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M_P!\4_\ X1K2?^@=;?\ ?L4_92[H7MH/HSGAXXT8_P#+WC_@#?X4X>--&/\
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M/%6U\=:+_P _1'_;,UT*^&=)7IIUM_W[%!\,Z2W73K?_ +]BJ]E+N3[:'9F
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M ;P3HS?\N8'T8_XU'_P@>C?\^[_]_#1[2?8/8P[LZ3_A)-)/_,1M?^_HI?\
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MG1E_Y<P?J['^M2+X1T=?^7"+]?\ &E[2?D/V5/S+7_"PM!_Y_#_W[;_"E'Q
MT(_\OO\ Y#;_  JK_P (GI'_ #X1?K2'PCHY_P"7"+]?\:7M)^0_94_,N_\
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M%?*3G*I)SENQGS_^W9_R;=K?_7[9_P#HX5W/PY\=Z3;_  [\+Q.\N^/2K56
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M;N';OC)_F:/^%>(WW]3N6_#_ .O2?\+"6$XN=,N(3_GU J>/XB:6WWTN(_\
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M]9HQ]7%0R7%A,"));9QZ,RFI]D^DB_;+K$YJW\::/<=+P1_]=%*U<CU[39B
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M "=U\1O^O33O_2=*]@L_^/.#_KFO\A7='_=:7H+J>>_&+_D,?"W_ +'?2O\
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MN-/\(Q\K>S _],R3_2IO+O\ B5RQZ1_ UETCQ/,,G7^/]DD_TI?^$9UY_O\
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MKK]])_K-2O /]AS_ (BCF0<DCLO^$1UE?NZ_-^;?XT'POKJ\_P#"0.![EO\
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M:(?OV]B/^ H*F\_YBU&G_*<BOC[7;@\7EG#_ +RJ/YYJS'X@\0W7W=;T]?\
M@:#_ -EK4N=+\+KS(+-/=9<?R-9\VF>$.]RB_P"[*U3>7?\ $NT/Y?P)(_\
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M._\ 5Q<O]6+4TFKVX^;Q="/K)5.3Q!JUFP*^)H9O^^F_DIK3@TOP@O2>%_\
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MPIOD^,/^>MK_ .._X4?9_&/_ #VM?S7_  HT[!>7\P'X:V/:ZN!_WS_A2?\
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MN7ECT*/)@U+4 ?\ KG_^JJCZD8/^/?4[X_FO_LU+F_JX^3M^1V7_  ANH/\
M?U^Z/T+?XT?\(+.WW];NV_/_ .*KC4\3ZK%]S4)\?[1S_.IT\;:Q'_R^EO\
M>5?\*.:(^21U?_"OT/WM4NF_S]:/^%=6K?>OKIOQ%<VGC;7&^[+O_P"V(/\
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M'C_72_\ 8.?_ -FK[4_9)_Y-E^&?_8#M_P#T&JS3^!3 ^+/VD/\ D[KXC?\
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MPY'\JJM87*?>MI5^L9_PKQ;_ (>"ZS_T)^G?^!TG_P 31_P\$UG_ *$[3?\
MP.D_^)I?ZN9A_)^*_P RO[<P?\WX/_(]IAA3>1.9(AC@K'N.?H2*MPV^EG_6
MWMPO_;N/_BJ\*/\ P4#UAN#X-TTCWO9/_B:B?]OC4)/O^!M(;_>NF/\ [)1_
MJYF'\GXK_,/[<P?\WX/_ "/H>&S\.-C?J=T/^V&*T;?2_"C?>U.4_P"\=O\
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M1_Z&VS_\ W_^*H_LK ?]!/\ Y*P_M#%?\^?Q/LO_ (3'0/\ H.Z9_P"!D?\
M\51_PF.@?]!W3/\ P,C_ /BJ^-/^&%M1_P"AML__  #?_P"*H_X86U'_ *&V
MS_\  -__ (JC^RL!_P!!/_DK#^T,5_SY_$^R_P#A,= _Z#NF?^!D?_Q5'_"8
MZ!_T'=,_\#(__BJ^-/\ AA;4?^AML_\ P#?_ .*H_P"&%M1_Z&VS_P# -_\
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MU#0K+PW;Z;?O>Q23337@>0*%8*% 5EP>2<DUY2/VP/B^P!'@^Q(/3_B47?\
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M/\-M]_5;C\8<?TKYK?\ :R^*\GW_  -IC?[VAW1_]GJO)^U%\3I?O^ -*/\
MW!+H?^U*/]7<;_=^\/[<PW][[CZK@TGPF?O:G(W^\VW^E:5OHGA1L8GBD_W[
M@C^HKXYD_:2^)$G7P!IJ_P"[H]X/_:E5I/VA/B._3P-:*?\ 9TR]_P#CM'^K
MV-_N_>3_ &UA>\ON/N.WT'0./*M[23_@0?\ K6C#I=C#_JK6!/\ =C%? C?'
MSXEMT\(Q)_NZ7=?U>A/V@/BC']SPQL_W=,NA_P"S57^K^-[1_P# A?VQA>\O
MN/T$6-8_NHJ_[HQ3J^ $_:.^+,?W= D'_</N_P#XNIU_::^,$?W=#D'_ '#;
MK_XJG_8&-_N_^!$_VMA>[^X^^**^"U_:B^,:]-$D_P#!9<__ !5.'[4WQE'_
M # V/UTJY_\ BJ?]@8W^[]XO[6POG]Q]Y45\(#]JOXRK_P P$'_N$W'_ ,53
MQ^UA\9A_S+\9^NCS_P#Q5']@8W^[]X?VOAO/[C[LHKX5_P"&L_C-T_X1Z+_P
M2S_XTQOVKOC,W_, 0?31[C_XJC^P,;_=^\/[7PWG]Q]VT5\'M^U1\96_Y@6/
MII-Q_P#%5&?VI/C(W71'_#3+G_XJC^P,;_=^\/[7POG]Q]Z4<U\#M^TY\8).
M#H<A_P"X;=?_ !5=E\ _C5XL^+GCBZ\.:H(;:9;5[A'B,L>TH0&5@S'U]L8K
M"ODN,H4I59)-1WLS:EF6&K35--W?D?8C;6X;!'O52XBT\C$RVO\ P,+7!3>
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M1Z'JK<I9W/X*17IL?BC2ICA;^'/NV*G76K!^E[;G_MH*?*NY/M)=CS5=$\0
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M[5<+-X)UMO\ F*>9]9'%49O >M'J\4O_ &U/]12YGV'RQ[G>W$>G-_KEM?\
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MH-_WSC]:SY!9-N$271;'R[F7K] *[-?&-A ?WFAO!_VS7_"K,?C[1N\$R?\
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MBX?\OMN?R_PH^R^+Q_R]6Q_+_"M2/QCHTG_+\B_[X(_I5J/Q!ID@RM_;GZR
M?SIW7<6O8P?L_C ?\MK4_P#?/^%)Y/C#_GK:_P#CO^%=*NJ63_=O+=OI*O\
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M +]K_A7.?%7X@67PI^&OB;QAJ&#:Z+82WA0G'F,J_(G_  )MJ_C7Y[?LH_\
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MPL9/O="6_A7W(R.HE+EZC4;JY]U_8;7_ )]H?^_:_P"%'V&U_P"?:'_OVO\
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M096_MS]9 *F75+)_NWENWTE7_&CYBN^QS7D^,/\ GK:_^._X4>7XP_YZ6O\
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M_P"WOS/CF[XZN_3\BSYC_P!YOSH\Q_[S?G61XLO9M-\*ZU>6S^5<6]C/-$^
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M&\#W<P_?ZW<2>HY_QIZ?#NQ_Y:W-S*?]X"EKV"Z[_@<M=>&9E8F35+%S_M7
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MH>2_\(_?_P#0-O?S_P#L::VAWB<MIU\!]?\ [&O7**.4?M#R*.UCB.)]/O\
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M^!I\R)L_(D_LGQ4O35(F^N/_ (FC^S_%G_00@/Y?X4D?Q'ME;$]C<0GV(/\
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M_)&? ?\ V ;'_P!)TKQO]KB;PU)^S[XD&GHJW>ZVV95MW^OCSUXZ5[)\$O\
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M2N]7L;.>>=+J]55E8RON((7C@U\MZY_R>%\:_P#KGI/_ *2+7W@K!E5E(96
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M_6JU[BM%=&9#?$V'^&Q?\9!_A4+_ !&N9/\ 4:<#]6)_D*[*&WLL PQV^/\
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M[X5_!/XE7/@?Q5/K-IK4'DEY(M/WV^V5%=6$A<94!N3C@@CM7WN(:AA,+?\
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MSQ_PB_[;<GPU/Q3_ .$OUL6/V7^T?L/]J*+S[+MW^;]FQMV[>=GWL?PUE?\
M!6"UNK3]J;1+N\5O[-FT.T,!;E2JR2"3 ^N:_66UUO1X_!D.LK<01^'UTY;P
M7#$"%;41!MV>FT)^E:).I)IO8F_*DTMSY:_X)\?MFZA^TQH>J^'_ !;';IXT
MT-$F>ZMD$<=_;,=OF;!PKJV P7@[@0!R*^+M:_;,^/.@_M(>-/#_ (;\1:QX
MFG?5M1TG2-#DS<1QNTKQQ,D./F9 ,J#P" 3P,5=_X)0VDUY^UAJ=[:0N;&'1
M+TR2*"517DC" GW/3Z4W]EW_ )2>7Y_ZF'6OYSUES2E&.O4JR39]$? ?XF?&
MC]G3X$_%KQ]\<8==OKRR%K)H]IKL^\32R$H%!4G8"[)N'&*\9^#]U^UK^VA8
MZYXS\.?$R/0M-L[XVBVWVYK&%9@BOY<4<2-A55U^9NN>I.37Z1?'BQ\":U\*
M]<T;XD:M8:+X3U6+[%<7FH7:6J(S<H5D<X#A@"ON*_.G0/V'_B_\/?M'BG]G
M'XOZ?XH\.7$CF.?1]5%N9S'QLD4%H)6!ROWNO9<XK246FENB8M.[ZGI/['O[
M27QK/C[6/A=\7M)U?5(6AO(+;7KRP</;W$2N2CS!0LD;;6 8G(.,$@XKN/V/
M=4ETF\\5RK<Q6D+6]LDDDSHB_>? RW&>OY5YU^R'^W=\1/$WQ(U#X.?%R(7.
MLM%=V4%^\0ANH;N!'WPSJORMG8PW  @CN#Q7\&>!]<^('PX\8:7X?TJ?6+\7
M.FS&WMU#-L4W +<]AD?G7MX.$:V78BG*5DW'7MJ<4O=Q]!V[_D?:DFK65PVY
M]7TLMZF_@'_L]"W5BW_,8TG\=3M__BZ^$?\ AEWXI?\ 0@ZK_P!^5_QH_P"&
M7?BE_P!"#JO_ 'Y7_&O*_L?"_P#00OP_S/J_;2['WB);%O\ F,Z-^.JVW_Q=
M.#6/_0;T0?\ <6MO_BZ^#/\ AEWXI?\ 0@ZK_P!^5_QH_P"&7?BE_P!"#JO_
M 'Y7_&C^Q\+_ ,_U^'^8O;2/O7-B?^8[H8_[BUO_ /%T?Z#_ -![0_\ P;6_
M_P 77P5_PR[\4O\ H0=5_P"_*_XT?\,N_%+_ *$'5?\ ORO^-/\ L?"_\_U^
M'^8>VD?>A-B/^8YH9^FK6_\ \73&FL5_YC.CGZ:I;G_V>O@[_AEWXI?]"#JO
M_?E?\:/^&7?BE_T(.J_]^5_QI?V/A?\ G^OP_P P]M(^ZVU#3UZZKI9^FH0'
M_P!GIC:MIR]=5TW_ ,#H?_BJ^%_^&7?BE_T(.J_]^5_QH_X9=^*7_0@ZK_WY
M7_&C^Q\+_P!!"_#_ #'[9]C[LM_%5CIY+1ZSIB'WNX&_FU?#O[46J#6?C9KE
MVMS%=AX[8>;"RLIQ @X*\=JJ_P##+OQ2_P"A!U7_ +\K_C7#^)O"FK>"=:GT
M?6]/FTO4H IDM9U = RAER/<$'\:]3+L!1PM5SIU>9VM;3R\R)3YEL=W;:I+
MJ6CZ4TP ^S645LNT?PH"!^-?IU\*]';P_P##3PMISQK%+;Z;;K(B] ^P%OS8
MD_C7Y<:/_P @.V_ZY5^LFB,'T33F4Y4VT1!'^X*TSCW:=.*VU'B/@BBY1117
MRYPA7YU?\%J/^20_#K_L.S_^D]?HK7YU?\%J/^20_#K_ +#L_P#Z3TGL)['3
M?\$;O^37_$'_ &-5S_Z2VM?;OB:SN]1\,ZO:6$GDWUQ9316\G]V1HV"G\R*^
M(O\ @C=_R:_X@_[&JY_]);6ONV21(4+R.L:#JSD #\30M@6Q_/1^RWXM\-_
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M]^A_]FK\[T_9C^)\GW/ NIM_NQJ?ZT__ (9=^*G_ $(.K?\ ?E?\:7]DX?\
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MBV2/4+=90JPW,T46%8'D1J!FIA.4FXW^8Y122=CPC_A\EX0_Z)KK?_@SA_\
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M&^(OB%H_PG_X*4>(/%^OO-'H^C^,;VZN3;QF20J&DX5>Y)( [<\D"OI_1_\
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MJ7QSU^*VB::0)>-M7KCSA7O8:7-@,3+^ZOU/.J1_VN@O[Q]]OKVFQC)OH/\
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M8@ Q0H=[ [AM!..S"ONYR2RS"N7][\SY#E_VZNEY?D>^>.O^1'\1?]@VY_\
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MBJ#\S[SC^+*V^,>(],P/X3=08_G4Z_&R)?O:[HS?6YB_^*K\_/\ AE_XI_\
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M]M&J:#P#JJR*6OD4>H=CVHYGV%RQ[G?TF:\__P"%?ZI_S_1_]]-33\/-4/\
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MGO',N'0_0U\"_$+_ ()):MX'\;Z3XI^#WBQY[:TOH9Y-'U>;R+J.,2 L(KA
M%?Y>S!> >3TK].:^$/V_/VM/B1\ ?C=\-?#7@W5+2QTG7;>.2]CN+&*=F8W1
MC)#."5^7CBE)+=CBWLCTK]N AO$_P5(Z'Q+-C_P':N<KH_VX%"^*/@J!T'B6
M8?\ DNU<Y7T^#_@1^?YDGB'QP/\ Q,-0'_3@?_06K[<_9)_Y-E^&?_8#M_\
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M_P#KGI/_ *2+7M_["'QB\3_'C]FW1/&/C"ZAO==NKR[AEF@MT@0K'*54!%
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M*,M04VCYZ_8W_9 T?]E'PC=Q"\76O%>K;&U/550HFU>5AB!Y$:DDY/+$Y.,
M#P#X)_L/_$KP#^VI=_%'55T@>%Y-6U&]4PWN^?RY_-\OY-O7YQD9XK]!**?L
MXZ+L',]3A_C5\(=#^._PSUKP3XB$BZ=J48 FA.)()%8-'*GNK '!X/(/6O@#
MPS^Q]^UQ^SFVH:%\*/'.GW7AF\F,F8KF&-<GC>8;E#Y3D 9,9/0<G%?IO13E
M34G?J)2:T/A+]E7]@#6OA'XNU?XH?$SQ!;Z_XTDM[J6"VM':9(II4;S)Y9G
M+R'<PX& 23ENW1_L5>(+G0=6\5-;+&QEMK<,'&>CO_C7U[KG_(%U#_KVD_\
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M2=/TWQYH*:]9:?.UQ;1/-)%Y<A7:6RC GCUH8,^4/^"-W_)K_B#_ +&JY_\
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MH(R/QK\\/!O_  3B^*GP-^/R>./ACXK\-Q:-8WS26=IJUU<I-+9L?FMY@D#
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M7_)&? ?_ & ;'_TG2N#_ &U?^3;_ !1_OVO_ *41UWGP2_Y(SX#_ .P#8_\
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MX/T5@-^M(Y_V71?YFM:U\&Z!QB3SS_UW'/Y4[R8K010N/B8G/D6#'T,DF/T
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M *$7P_\ ^"Z+_"C^T\L_Y\2^_P#X(?4,;_S]7W'SC_PW-IG_ $*=Y_X%I_\
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MH[_A1?PY_P"A%\/_ /@NB_PH_P"%%_#G_H1?#_\ X+HO\*/[3RS_ )\2^_\
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M?^ -K_\ $4?48_\ /^G_ .!#^LR_Y]3_ / 3[4HKXK_X3S]H?^]J7_@#:_\
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M^I?<?7]%?(']H_M/_P#/CK'_ ( VG_Q-']H_M/\ _/CK'_@#:?\ Q-'U!?\
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M&_YF+2U_[:I_\35<Q'+YG;T5Q.[6V4G_ (2;3.!G'FI_\37-MXPUAN#?R?@
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M$C_^)H_M; ?] W_DS#^SL7_S_P#_ "4^,?\ AN^?_H4+?_P9'_XW1_PW?/\
M]"A;_P#@R/\ \;K[._X1G1O^@/I__@)'_P#$T?\ ",Z-_P! ?3__  $C_P#B
M:/[6P'_0-_Y,P_L[%_\ /_\ \E/C'_AN^?\ Z%"W_P#!D?\ XW1_PW?/_P!"
MA;_^#(__ !NOL[_A&=&_Z ^G_P#@)'_\31_PC.C?] ?3_P#P$C_^)H_M; ?]
M W_DS#^SL7_S_P#_ "4^,?\ AN^?_H4+?_P9'_XW1_PW?/\ ]"A;_P#@R/\
M\;K[._X1G1O^@/I__@)'_P#$T?\ ",Z-_P! ?3__  $C_P#B:/[6P'_0-_Y,
MP_L[%_\ /_\ \E/C'_AN^?\ Z%"W_P#!D?\ XW1_PW?/_P!"A;_^#(__ !NO
ML[_A&=&_Z ^G_P#@)'_\31_PC.C?] ?3_P#P$C_^)H_M; ?] W_DS#^SL7_S
M_P#_ "4^,?\ AN^?_H4+?_P9'_XW1_PW?/\ ]"A;_P#@R/\ \;K[._X1G1O^
M@/I__@)'_P#$T?\ ",Z-_P! ?3__  $C_P#B:/[6P'_0-_Y,P_L[%_\ /_\
M\E/C+_ANZ?\ Z$^W_P#!D?\ XW1_PW=/_P!"?;_^#(__ !NOLF3PAH4OW]#T
MUO\ >LX__B:I7'P_\*S?ZS0=,7_=MT7^0I?VO@?^@7_R9_Y#_L[%?\__ /R5
M'R'_ ,-W3_\ 0GV__@R/_P ;H_X;NG_Z$^W_ /!D?_C=?55U\,_![?\ +C9V
M_P#NA/ZBL>Z^''A-&.RYL8O9X8F_I4_VQ@?^@7_R=_Y%K+,2_P#E_P#^2_\
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M_P"A0M__  9'_P"-U[HUT&X-M9?A90C_ -EJ"18Y.MO;_P#@.@_I4_VU@/\
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M.L).M%8FG\4?R_X!](Z!KUAXHT6RU?2[E+O3[R)9H9D.0RD?H1T([$$5H5\
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M)^]?RG_@ _QIW_"M+3_G]F_[Y6NRHHY4'/+N<QI/P_M;'4[6X%U,YBD5PI
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MHA)_K&^M?G?\7O\ D.?"O_L=]+_]#:OT0D_UC?6O!S#>'S&)1117D""BBB@
MHHHH **** "BBB@ HHHH **** "OS?\ V@O^"4/B+XU?&CQ=XYM?B'I&EV^N
M7S7:6<]A,[Q @#:6!P3QVK](**4HJ6Y2;6Q^3O\ PY0\5?\ 14M#_P#!;/\
M_%4?\.4/%7_14M#_ /!;/_\ %5^L5%1[.)7.SQK]D;X"WG[-/P.TKP%?ZO;Z
M[<V5S<W!O;6)HD82R%P-K'/'2OG/7/\ D\+XU_\ 7/2?_21:^\:^#M<_Y/"^
M-?\ USTG_P!)%KU\OTJ->7ZHG<ZE?O"OFJQ_Y*Y\+_\ L;[#_P!'K7TJ.M?.
M"JB_&CX:B,YC'C*Q"D>GGC%?2P_A5/0GJ?J3KW_(#U+_ *]I?_0#7Y1_L_\
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M\#Z,O_+J3]7-%I=Q7I]C&'Q,3O8-_P!_/_K4]/B9;D_-92@>S@UM#P=HZ_\
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M+<G_ (&O^%;Z:M8R?=O(&^DB_P"-2?;K;_GXB_[[%/EB+FD8"_#W21U\\_\
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MT)\6>.O#_@6Q:[U_6+32H0-P^T2 .W^ZOWF_ 5\K?&#]M>6_AN-*\!026D3
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M\GXQC_&ND;Q%I:]=1MOPE!J%_%FCQ];^+_@.3_(4N6(^:9SC?#$?PW_YQ_\
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MO_+BGXD_XT]?"NDITL(OQ!-.TNXKP[&-_P +*LO^?6<?B*?'\1[!F ^SW _
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M]G7Q/"ES"\I>UPBN"?\ CXC[5Z+\$O\ DC/@/_L V/\ Z3I7A'[5GA#4=-^
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M"6/\JNP_#$?\M;_/^Y%_B:[FBJY$3[21QZ_#2R'WKN=OP45*OPXTQ>LMPW_
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M+&$GU5<']*7*ULPYXO='/0?$:P7&;"2+_<VFK\?Q TF3&YYD_P!Z,TEQ\/\
M29N4$T!_V),C]<UG3?#.-O\ 57[@=@\8/]:/?#]VS=B\8:/+TOD7_>!']*N0
MZWI]QS'>P-_VT K@;WP0+/);5K,>TAVFL*ZL4M6Q]KMI_P#KD6(_E2YFMQ^S
MB]F>QI=0R?=FC;_=<&I>M>&[BK9'R_2I5O)T^[-*OT<T>T'[+S/;:*\9BUK4
M(?N7LZ_]M#6W%JUY]GCD_P"$F5'89,3JY*^V=II\Y+IM=3TNBO+O^$LU2$_+
MJJ2_5"?YK1_PG>L+_P O,;?]LA_A3YT'LF>HT+]X5YA_PL#5_P"_#_WZ%/@\
M?ZNTT8+0L"P&/+ZT<Z%[.1Z917F9^(FJ^EN/^V?_ ->D_P"%AZKZP?\ ?O\
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MZK"<+JB2_P# #_5:7_A.]87_ )>8V_[9#_"GSH/9,]1H7K7F'_"P-7_OP_\
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MMBOWKJ=OP45*OPYTP=9+@_\  A_A7544^5"YY=SEO^%<Z7_?N/\ OL?X4?\
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M^V0_PIW_  L#5_[\/_?L4<Z#V4CU*W_UR?6M*O*_#_C?5+S6[&"5HFCDE5&
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M7<^R]I]#1M/H:^0X?V1_BP^-_P :]1C_ .!7!/\ Z-JVO[(/Q+P,_';5@?\
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MM$KFF8?_  A-_!_Q[:Y<+[-N'\FH_L7Q1;_ZK5HYAZ/_ /7%:3^--&3_ )?
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MY%.6)!T1?R%.HH B:T@+',,9Y_N"F_8;;_GWB_[X%3M]XT4 5SI]J>MK"?\
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M?#_2 ,;)O^_G_P!:H)OASIS@^7+/&?\ >!_I1[P_<[EB;Q]H\?2263_=C/\
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M;J#,/^F<>/YFB\NPK0[G4QZ]ILGW;^W/_;45.FH6LGW;F%OI(*YR+X<::O\
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M_#<W"?0C_"G>78FT>YU>Y3T8'\:=@^E<@?AS /N:C<K^5-_X5Z>VJW&/I_\
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M%<^?A')-_P ?'B&\F/?Y?\6-36_P>M(Y QU6]8X([=P12^K+K(GEBMI?@_\
M,TI? NNW'32+:#_=E _]FI(_A?K<GWDMXO\ >E_P!K);X-VO\.KWBGW -"_"
MW4+3YK+Q1>0N.GWE_4/2^JQ_F'Z2_#_@G2V_PFO\@RWT,7_7,,Q_I5T_#2ZM
MUR-=>,>^0/YUPVH^%_'JPB.+Q'+=QKT"W+QM^?\ ]>N*US0?%4.3J,.H3J.2
M[2-*OY@FFL*NX1ISE]M'K]_H<>D\R^,H(/\ KK-_]E6!>^++73/E7QHDY':&
M.1_U Q7ENAW6F6=X?[6L);R//W5E*%?PQS^=>I>&9_ M\5%K;6L$YX\J\7YO
MPW9!_"M/JL%O<T=+D^)M_)&'<_%:]20K:WMW>>A50H/Y\U%'X\\=7W-EI]S(
MO9FW?_$UZS;6-K:J/L]O#"I_YY1JH_2K%-4::Z$\T%M$\I74/BQ>9:-+>W4]
M-^T$?F:/L/Q9N6&[6+>W'^RR?T4UZM6;?7[I(8X_EQU;O5J$>B&JG:*^X\[;
MP=\2IN9/%\:#_9=O_B:1OAUXZF7]YXT?'?:[UVS2,QRS$GW-(KLIRK$'V-5R
MQ[%<[[+[C@7^#WBBX;,WBZ1S[F0_UJ%O@KXC'W?%.?\ >#_XUZI8W[M(L<AW
M!N W>M*BR["]M-?\,>-+\'?%<?W/$\1_WE:D;X4>-(_N>(K9SZ-N'_LM>S44
MN6/9"]M+R^X\4C\$_$/39&,<FG7P_P"FFP_^A 5:2\^(VCX+>'-,N0/^>4",
M3^1KV&BI]G#^4/:WWBCR=?BUXQTG N_"BQ+W*1D?RJS#\?Y]VVYTEX3WRA/\
MC7ILDJ0QEY'5$'5G. *X_P 0>./"EMN6Y-OJ4@XV10B7]2,?K2]C![(%R2^P
M16/QHBO<!(("Q_A=V0_J*WX_&U_(H;^Q)G4]&CW$'\<5Y3??9_$K,-%\'.F[
M_EMEP![X&%'YUH^'?!?C?35(M=0?28VZK]I./^^1D5G+#=I!*E"W;U/2?^$Z
MG7[^B7@_ _X4?\)\!][2;L?A_P#6KD7^'6O:ASJ/BR[D/HK.P_5A3/\ A3<+
M',NLW<C>NT?XFI^KO^;\#/V=/J_S.P_X6% OWM.NE_*C_A8UE_%:7"_@*Y-O
M@U8F-1_:EYGGGY?\*A_X4S"AS#K-U&?78#_(BCZO_>_ /9T^YV?_  LC3N\%
MP/P'^-+_ ,+'TW_GC<_]\C_&N,'PY\0:?SI_B>7 _AEW@?EDBL+6/!WC?+L]
MU+>J>3Y-UU_X#D4?5Y?S#5*#ZGIK_$[2(_OB9/\ >"C_ -FJC<?&SPM;9\R[
M8$=@%)_0UX5J6CWUC(?M]G/$W<S1D9_$UU7AF\\#%4CU+2'AE[RR.9$/Y8Q^
M5:+#=Y&WU>"5]7Z'<7'[1'A*%3L-],?1(!_4BLZ;]HRQF^73M!U"Z<]-P 'Z
M9KJ-&T;PQ<0K)IMEILR=FBC1B/TS6W';0Q* D4: = J@4_901E:DOLO[SS9O
MC!XMU# LO"QM\_Q3*2/U(IK>,OB)=+Q;6EL#Z"/C\V->G>6O]T?E3)F2&-G*
MC"CTJ^2/8?-#I!'F$>H?$*XSOU6*#\$_HM+M\=O][Q'@_P"R?_L:[::\DF)R
MVT?W5X%0U7*NR+YE_*CB9=)\:7!R_B.7_@+,/Y"F?\(SXM;G_A(KDM_O25WL
M5Q)"<JY'MVK8L[K[3%NQAAP:=K"]HUT1Y5_PC/CC^#7Y6'HS2$4K>%_'DG_,
M4A?_ 'H\_P#LM>MT5-EV%[5]D>,S>"_'RY9+BQF/HR@?S%5V\._$6-<?V9I\
MN.ZN@)_\>%>W44N2#W2#VS[(\(\OQI:DBY\.A\=3'G'Z9J2W\12V\F-1T^YL
M\'DQJ3C\\5[G5'5-8T[2XRU_=P0+Z2L,G\.IJ/8TW]D?M%+[)Y[IGB30;LJI
M\27=@Q[30.!^:DBNOTS0TUC_ )!?C&*Z/]U9"3^6:Y#7O&GA.\8PV^B#5I3T
M,<(CS^.-WZ5S3>$=8UNX2;3?#S:3&#D,9&7\<L?Y"D\+#IH#I\VM[>MCVG_A
M"O$<?W->S]0U,;PKXM4X75XV'KN(_I7#6?A'QQ+;K#<>)Y;:(#&U;AV;\Q_C
M4C?">ZN.;KQ)>3,>O!/ZEJS^K+^8PY&MY+[CM%\+^+LC.JQ_]]G_  J5O#/B
MQF)&K0 9X_SMKAU^#=I_%JUZ?I@4Z;X.VC.Q&K7HR<\X-/ZM'^8?*OYOP.W_
M .$6\5MUUF$?0'_"H_\ A!_$,A^?7<?[NZN)'PGN;?FU\27D)'3Y2/Y-3;KP
MKXYM[=HK;Q1+<1_W6N'5OS/^-+ZLOYA<CZ37W'=_\*]U';F7Q!,!WZ_XUEZC
MX-L;/+W?BF*/U,SC/_H5>4:UX=\9QJWVT:A>1]V6=IA^A-<[9-!97P_M*SEN
M(Q]Z'>8V_/%6L+'JS:-"3UY_N1ZIJ"^%K#[_ (LAE/I#"TG_ *#FN<OO$.B0
MMBUN[B\/M;;?YM6UX;OO -VR 6<-I/\ W;X$C\R<5Z#9Z;I\"J]I:VJ*>C0Q
MJ!^8%'U:FMT&D-[GBRZIJ]\Q&G:++<#L6##^0J>UTWX@39,&C64:G_GX49'_
M 'T:]NZ=.**M4J:VB'M5TB>/1Z/\31CRX-)MO]V.'_ U>32OBD%'_$XM(1Z1
MA1_):]&O[UK?")]XC)/I68\KR'+,6^IJU"/1#Y[_ &5]QQATCXE-]_Q /^ Y
M_P *K-X7\=2',NOR_P# 6DKN@Q7H2*MVNH21L Y+I[]15<JZ#YVMDON/.O\
MA%_&,?3Q!<?]]25)%I/C>W^YXAF_X$6/\Q7K&:*1/M?)'EGE>/$Z>(6/^]G_
M .)IO]K?$:R<%;R&[4=FV8/YJ*]5I*5EV%[1=8H\P/Q$^(-CS-HUM<J.H102
M?R?^E<S\5/VC?$_A'X8^*=4B\-RZ=J-GID\]O>%=RQ2*A*N58$$ X.#Q7NNT
M>E?/G[>OBH>$?V6?&+1S_9KC4Q!I<1"YW^;*OF)^,2RU+A'L1.<.5MQ/,_V*
M_P!L?Q3XZT'Q+>?$K4Y=:>&[B@LFL["" 1#86?/EA<YRO7/2OJ.T^//A2\QM
MN)HS_=E0*?U-?)O_  3J'A_PC^SW?7^L&.2XU?6)IUMW@\QMD:)&I&1T.T_D
M:]VU*_T?Q%(PTCP6;B1NDH5E'UVIQ^M3[%25]@HTXRIIR3/5(?B9H]P@>(3R
M(?XD52/_ $*I/^%C:7_SSNO^_8_^*KR/1/AUXI@G\ZUC72<G/,P&!]!G/XUT
M?_"LM<U#G4/$;8_NQ!B/RR!63P[_ )BG2II[G<?\+&TS_GE=?]\#_&C_ (6-
MIO\ SQN?^^!_C7$#X*V[\S:O<2'U\L#^9-3)\%].6%U_M&Z.['.U>WX4?5W_
M #?@+V=+N=A_PL;3O^>-S_WR/\:3_A8UA_#;7+?\!'^-<9_PI>U7F+5KF,^N
MP?XBG+\-=:T_G3O%-Q&?1MZC]&-'U=_S?@+V=/HSL/\ A8EN?NZ?=-^51R_$
M:.+EM-G4>KL!_2N"U;PQX^;+?VO->C&/W-V4)_#BN'UC2-<LY"VHVUZ#_?F#
M,/SZ4UAF_M&D:$9=3V*Y^,VGVI(>)$([&;G]!63=?'_3T!5;%I_8*Y!_2N!\
M,:EX:MU5-7TN:=\\S)*2/^^>/YUZKX=A\(:A&!ID&GR-UV,@,@_!N:OZNENV
M.5*$-TSD9OCC]LR+?PB;ECTS&/Z"OB;_ (*&?$+Q.MYX+D@MKWP<CQ7)QI]Q
M+;^?RG+8(SC^M?I=%;Q6Z[8XDC7T10*_._\ X*S_ /'_ /#G_KA>?^A)3]G"
M.J1RUY1]F^6-CZ$^'>E_$+6/ASX3GCTZS"2:19N+B253)*# AWL6<DD]2?4U
MT$/P]^(5PWSWEG;#W=3_ "4UZ!\'3M^#_@4GH- T_P#])HZU[C4))F.T[$[
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M^4H=",MM#J5.G+[+7S/2+7XB2:C'YEGI4MS'_>C8L/T%3MXHUBX&%\.RN/\
M:#'^E>5:+X'\70W7VBP1]%W'(Q<E,#TX)/YUU+>!_%6I ?VAXMN-O=8Y)"/R
MR!6+P[_F(E2@GHT=+)/K-U_S*D?/]Z*JC>']9NN1X9M4)]1M_P#9A6#_ ,*?
M$O,^O7DI]=O^)-2Q_!VS56SJM\21CJOJ*/JRZR_ 7+%;2_!_YFE)X UVX;/]
MF6\'^[,!_P"S&G1?"W6I/O?9HO\ >D)_D*QC\&X%YCUF\0]C@'^M.7X:ZS8_
M-I_BJ[B;T)=!^C4OJL?Y@L^D_P #I[7X3WJX,FHQQ'_IFK$_GQ5IOAS<VN"W
MB!XE_P!HE?\ V:N U;PU\0&7C7)KU5&!Y5VT9_+BN&UK1O$-JQ;4K>^./^6D
MFYQ_WUR*I85=QQI3E]M'L=]I\&DDB7QM;0D=GFR?T-8-YXWMM/++'XO-RR]H
MH9"#^)&*X+PO?>&[=@NLZ;/.V?\ 7)*2/Q7C^=>J^';3P=J" Z9!82M_<=07
M'X-S5_5H+>Y3I\GQ7?W'&S?%;4V8K:S7ET>Q  S^AI8?&OQ"O&5K339RO9I
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MX5VVDZ]I]XNIW<KP3+($;&TX/0UZ]6M.FJ;:3N<&)5FM;_*P4445J<04444
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M89OY"L*\^+UK)(8=)TZZU*<]/EVK^0R:+,2IR?0] JGJ6L6.CQ>9?7<5JO\
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M%EU'RQCN_N,B7XDZIKLC0^'-&EFYQ]HG7('X#@?B:^#_ /@HYXT\076M^%O
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M[5>D4QR?R;G\C2Q_%BZTV00ZYHDUK)T+1Y&?P;_&BSZ H/[.IU/V:7_GD_\
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MW(DYOIQQY=L-PS_O=*P_^$@\9>*^-,T]=(M&_P"6TWWL?5A_(5UVB^#='T
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M4%N#(H( ]Z[RO.]&_P"0M:?]=5_G7HE+J<&*W04444'"%%%% !1110 4444
M<G=1(+V<A%SO8YQ[TE<9K/Q<T?3]8OK9X+MY(9WC;:BXR&(./F]JS9?C9I@'
M[K3[MS_M%%_J:T<6>["G/E6AZ+17E4WQLE=MMMI"[CP/,F+9_("IX?$GCOQ!
MD6>G1V$9_P"6CQ;<?B_^%3RLT]E);Z'IW09/ ]:RM0\4Z/I>?M6I6T3#JOF
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M(/56N)&'Y5ZM52]OOLV%49<\_2GS#]H^B1Y6OP4U%L;]1M1ZX5C4W_"DI_\
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ML^S1Z)2,H;A@"/<5YW_PL[5--&[5O#EQ!&.#)'N 'YC'ZU(GQIT<_>L[U/\
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MEQ=9[I]N\_W47J['^ZH)K\U_CY^U'XR_;"\61?#CX8Z-=P^'[J38(40"ZU
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M*'LWT/12 PP1D4W[/%@_NU_*N C^-6D_QV5ZA]@A_P#9JF7XS:'L8^3>#I_
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M3Q$LP7HLKL?T8$4];KXB6N UM:70'?"Y/Y$4K>8O9KI)'HM%>=?\)UXIL?\
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M$_&'A7XS_">TM[X&?Q9X?1;/4+::;EXQQ%.JC&59< ^C*1Z9^J;+P]I>G?\
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MC5%:]AM7+"U>259"-J*<Y]:@3Q-X<CY75+'/_793_6IO^$QT+_H,67_?]?\
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M)/#4@R-4LA_VV _K3E\2>&UZ:I8Y]YU/]:96O8=;6KW#C PO=JW*QQXPT$#
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MO+XTT%QD:Q9_C,!1J3RR70K45+-XK\.,1OU2Q)/<2C^E,_X2'PW_ -!2R_\
M @?XTRM>PWKP.:U--M6AW2.,$C %4H_%7AZ+E-4L5_[;+_C3_P#A,M"_Z#%E
M_P!_U_QI:B=^QLT5@2>/O#T?)U:W/^Z2?Y"J,GQ4\-Q_\OCO_NPM2LQ<DNQU
MM%<'<?&+1T.+>WN[H_[*!?YFJQ^*=_??+IGARZG;_;R?Y"GRLKV<^QZ+17G7
M]K>/]4YM]-M].7_IH #_ ./$_P J3_A"_%NL<ZEXA^SHWWHH"?RXP*+!R=V=
MW?:M9::NZ[NX;8?]-' KF-2^*V@V.5AEDOI>@2!#@_B>*K67P?T>%MUW/=7S
M?[;[1^G^-9GQ(^)?PU_9WT,:IXDO++1PP_<6Z();RY/I'&/F;Z\ =R*-!?NX
MZO4LS:IXH\=0O;6E@NCZ;*-KW%QRS*?3/]!^-=)H_@?2-$TV*%K2&X,8R]Q/
M&"6/<DGH*_/[XB?\%*/'/Q U@Z%\)?";6)F^2*XGMS?7\O.,K$OR)^(8].1T
MKE8?V6OVE/CY-#>^./$%UIUI,?,QX@U-B8\KPPM8\A#T!&%([BIYNB,'7YM*
M:/T/U7XB?"_14VW_ (E\*6VTD%7O+?((ZC .:YJ;XY? EF*R>-/"&>X^U1U\
MA:7_ ,$K=UJKZG\14ANB?F6ST?S$_P"^FE4_I73VG_!*[PI(BK)\0M6\W')&
MGQ*"?8;C_.CWB>:MV/H.^^*WP O8V7_A.?#%NQZ-!J(0C]<5@?\ "S/AAI+%
M]$^,^@VI/)62^4?J#_2O)O\ AT_X7_Z'_5__  !A_P :/^'3_A?_ *'_ %?_
M , 8?\:.:12K5UT/6H_VLO#?A^0+=>._"^M6^<;X;]-WYCG\Q74:/^V-\)-2
MVK<^--)TZ4]IKE2O_?0_K7S[_P .G_"__0_ZO_X P_XTO_#J'PO_ -#_ *Q_
MX Q?XT7?83J5)?81]._\-0?"$_\ -2O#?_@>M+_PT_\ "'_HI/AO_P #UKY8
MO?\ @D_H7EYM/'^HF3^[/8QX/XAJX[4O^":4.ARYO=<U:6WSS+:VL;C'KUX_
M&C5BC[66R7WGVQ_PT_\ "'_HI/AO_P #UILG[3GPAD1E/Q*\-\C'_'^E?%-E
M_P $_P#X>S?+=>.O$%B_I)IL+#]&K:A_X)N_#:< K\5+]?\ ?LHE_F:+2[#Y
M:Z^R?44G[27PH1B/^%C>'&]Q?I3?^&E/A1_T43P[_P"!RU\S?\.T?AS_ -%6
MNO\ OQ!_\52+_P $T_APV<?%:[X];: ?^S4_>[#YJW\I]-?\-*?"C_HHGAW_
M ,#EIR_M)?"AF _X6+X<'UOTKYD_X=H_#K_HJUU_WX@_^*H_X=H_#G_HJUU_
MWX@_^*H][L'-6_E/K2']IOX0PQ*G_"RO#9VC'_'^M/\ ^&G_ (0_]%)\-_\
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M)4>]E-_C55O^"6WB!3A?B#I;>_V*4?UHNWT*=6K+:)^A<FI>"YV"_;?#[D@
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M^NSMM@\40S-VVV,O/ZT6EV*Y:W\A^I?_  F7A[_H8-)_\#HO_BJ/^$R\/?\
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M^%M>'<G_ *828_G3N^P^:K_(?H)_PEV@?]!W2_\ P-B_^*H_X2[0?^@[I?\
MX&Q?_%5^?O\ P[2N/^BM>'/^_,G_ ,51_P .T;C_ **UX<_[\R?_ !5%WV#G
MJ_R'Z+Z=XJT"WC9GU_2@S=OMT7_Q57/^$R\/?]#!I/\ X'1?_%5^;;?\$TYU
M&3\6O#O_ 'XD_P#BJ@F_X)P20C)^+&A-_N6<[?R-+7L3>J_L'Z5_\)EX>_Z&
M#2?_  .B_P#BJ/\ A,O#W_0P:3_X'1?_ !5?F-)_P3U,?_-3M-?_ '=,N/\
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MG^$=5'[A-'NQ_P!,7C?_ -!-1:A\+_#]]&0+#[*W9X&*D?ATK\]O^'6_C)I
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M]W_/2V6+G\"_]:TO^'IWPS_Z%OQ-_P!^H/\ XY7L/_#$_P #/^B:Z3_WW/\
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M^%;:4V.[23D_^C*G4S<:G='SWKW_  5&\,ZE&]O8^']8L(7&TR,D3R8/7^/
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M^><;$?RJC<?&#0H_]2+JY;T6/'\S3LS7V<GT.XHKSMOBX;CY;'0;R=STW?\
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MEO\ @F7\0UQ_Q7^B\C/_ "]?_$U#%^P;^T!X/NB_A3QE:N0I_>:?KMQ92'V
M('\Z+LGVE1?9/T5U+X6^'[Z,A+1K.3L\#D8_ \5C?\*YUS10?[$\0R(@Y$4N
M5'TXR/TKX!;XH?M=_LX*AU^TUG5='MPN7U2U75+;9NZ&>,EE)]W#8/:O9?@_
M_P %0_"GB22WL?'^BR^%;EL*VIV!:YLRW<LN/,0=?[^/4T^<N.)Z/\3Z7_X3
M#Q7X8_Y#>DB\M^]Q;X'ZKD?GBM[1_B7H.L;5^U?8YC_RSN1M_P#'NGZUK^&_
M$VD>,M%M]7T+4[36-*N1F*\LIEEB?\0>OMUJIK'@;1-<):YL8UE/)EA^1C]2
M.M.Z-^:$MU]QN1R+-&'1E=&Y#*<@_C3J\YD^&NJ:'(TWA[6I(>_D3' /MD<'
M\12)X\\0^'6\O7M$>9!Q]HMQ@'\LJ?THMV#V=_A=ST>H;J'[1 R X/45R-C\
M6M NL"9YK-^ZRQY _$5KQ>.O#\P!75[49_O/M_G2LR>22Z$<D;1-M==IIM69
M/%V@.OS:M8L/>934'_"2>&I!D:I9#_ML!_6J*U[#:GM;5[AQ@87NU,7Q)X;7
MIJEB?K.I_K4P\8:"O U>R _Z[+_C2%KV-FBL1_&^@1G!U>T_X#(#_*J4_P 3
M/#D#8.HA^_[N-C_2E9D\LNQU%%<5/\7?#\2YC>XG;^ZL6/YU1;XP0RG;:Z+>
M3L>F<#/Y9I\K*]G/L>AT5YTOC'QCJ7%EX<^SANCS*W]<"@Z3X_U;Y;C4;?3D
M_P"F9 /_ (Z*.4?L^[1Z')(D*EI&5%'5F.!6!J7Q T#2\B74HY&_N0YD/Z5S
ML?PD-XPDU;6KJ\D[A3Q^;9K>TWX<^'],P4T]9F_O7!,G\^*- M!;NYAO\3KS
M6',/A[19[M^GG3<*/?C^IJUH/@2:XU*75_$C17U_(," *#'&,=^Q-=K'&D*!
M(T5$' 51@"HYKN*WX9N?[HY-%^P<W2*L&DZ'IMMJ%L\6GVL;JX*LL*Y!SU!Q
M79UQFFZHLFI6R!#\T@&2?>NSJ.IYF*O=7"BBBF<04444 %%%% !1110!YQJG
M_(2NO^NK?S--LPYN8]G7//TK5O--C>^N&8L<R,<?C3XH4A&$4+6DF>W&7NHD
MHHJO>:A:Z>F^ZN8K=>N97"_SK,"Q17(ZE\4_#^GY"7+WCC^&W0D?F<"N0U+X
MQ:C?,8M+LH[8'I)*=[?X"J46S54Y/H>MR2)#&7D98T7DLQP!^-<EKGQ/T+2E
M:-93J,W3R[<!ES[L>/YUYC-=?VQ()/$/B!V3/^H@!E;\A\H_.MK1_%'A30<&
MQT.ZO)QTGN-K,??V_ 5LJ,NQ7+".[N%U#K/CQ]UCX=M+"W;I<20@,?\ @9'/
MX"M+2_@FN%;4=1)/>.V3 _[Z/^%6#\5-4F_X]_#LA'8LS?X5$OQ"\53 ^7H4
M8_W@W^-:>QJ=@]K*UHZ&Y;?"7P] /GAFG/\ TTF/],5*WPL\-MTLG7Z3-_C7
M/_\ "=>+_P#H"V_Y'_XJFGXA>*X5+2:%$RCLH;/\Z7L*A'M)=SH?^%5^'/\
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M![B2U;_IM&0/S&:ETZD=HE>TY?@1G6/P8TJ%!]JN[FY?OM(0?UK57X6>&U4
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M9]M:W\0M#T,,LMVMS,/^6-O\Y^A/0?B:X;4-8U'QW(RZ5X9MQ$>/M4\(9O\
MOH@ ?K7R_HO[2VI:,PD_X1+3+R8='N3*P'T&<5U2_MP>+D4*OAG2E4#  $H
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ML=5LM24-:7<-RI[Q2!OY5C*$H[HBS6XNI!S;'9Z\X]*QJZ.JTNGPRG.W:?\
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ML\7_ #RC_P"^!1]GB_YY1_\ ? I+R[@L+6>ZNIH[:V@C:66:5@J1HH)9F/8
M DGVK\5?VI/V]/'WQ(^,&KWO@3QGK_A;PA:G[%IMKI5_+:B>-"?W[JC#+N26
MYY VCM14J*FM1QAS'[5_9XO^>4?_ 'P*/L\7_/*/_O@5QO@_Q5%I/P6T7Q+K
MMXY@M?#\.HW]Y,Q=RJVPDD=CU)P"?>OS$TOXX_M(_MW?%K6+3X:>(KSP=H6G
M*9TM;+4&L(+.W+;4,TL?SRR-Z<\@X  HE4Y;>8HQN?K;]GB_YY1_]\"C[/%_
MSRC_ .^!7Y3_  S_ &I/C;^R+^T):?#_ .-6LWOB+0KJ:)+LZC<F\>**4@)=
M6\YRQ4=2I.,!A@-S7VW^VY^TE<_LR?!1_$6D6\-YK^I7::;IGG#=#'(R.YE8
M?Q!41B!T)([41JIIM]!N#3L>^_9XO^>4?_? H^SQ?\\H_P#O@5^1?PT\)?MC
M?M#?#^]^)&A?$771ITSRFVM_[?DLWO#&2'\B&/"* 05 ^4$@@5[O_P $W?VT
M/%OQ=\1:C\-?B!=-K&L6UH]YIVK2H%G=(R!)#-@ ,0""&//!!SUJ8UKM)JUQ
MNG97/OW[/%_SRC_[X%'V>+_GE'_WP*_-K]M;]L3XH:U\<'^#/P@DN]*EAN8]
M.GOM/4"[O;MU&8XY3_JD0L 6&#E6)( Y\W^*_AW]L/\ 95\/V/CS7?B/JNHZ
M7#-''/MUR348K=W.%6:&7*D$_+N (R0,Y(H=:S=EL"IGZV_9XO\ GE'_ -\"
MC[/%_P \H_\ O@5XG^QS^T0W[3'P2L/%5W;Q6>MV\[Z?JD%N"(Q<(%.] >BL
MK*V,\9(KW"ME+F5T9M6=B/[/%_SRC_[X%'V>+_GE'_WP*DHI@<Y\0H(AX!\3
M$11@_P!EW7\(_P">+5\5?LZVES=2:Y]GA,Q5(B0/JWM7VQ\0O^1 \3_]@NZ_
M]$M7S/\ L-Y^T>+O^N5O_-Z]FA_R+Z]^\?S.:G)T\?1DO/\ (Z_2M6U#P[<&
M:3PVE[CI]H <#Z#(KM;'X_BVA5;W0I+95'.P,H_ ;3_.O164-]Y0WU&:H7GA
M_3K\'S[.%B?X@NT_F*\!Q@]T?8?6.;XD<H_[27AI5Q]DOR_IL 'YYJ%?C1J&
MO+_Q*+"&WC;I-<$G\<G _G4^L_"NRO%+6WED_P#/.X0,/SQ7*'P_+X4N,2V/
ME1D_=R?+;Z8.*N-.EV#VD'LCH9(==\0?\A#Q$L<;=8K>3C\A@5/;>!]'LU,D
M[M<[1N9I9./R%-T6QT'7L(&FL[K_ )XE\@_[I(YK0OOAO:W=K+ MY/&)$*$X
M!ZBM>9+38GGCW$T&?1+XR+IT,.Z+KB/!^N3VK3NIHH$PXY/15ZUQGA;X,S^&
M[B>4:VTC.-BA8R,#.>?FZU/>>$-0>YD/]KOUQ_%_C3O&^C#W+_$:[WCAOE3(
M]VYJ>WD-SP%(;T-<U_PB&I#IJS?FW^-20^$]2216_MAP0>V[_&GS+N.\>YUB
M6;-]XX%6E41J .!7!>// FN7=C;"UU:Y>,.3*D*L3T&.AZ=:U_#W@&[31;1-
M1U.=YU7Y@PYZ\ \]<5-U:]Q7C:]SI&DC'WG4#W(K.O/['G4BY^R/Z[MI-2+X
M!L?XY[A_^!#_  JQ#X)TJ(<PO+_ON?Z5/,B>:/<\\\<WW@OPCX:U77K^9[:T
MT^W>XE,!/(49VC(QDG 'N:_/KX,^#]7_ &HOC5J?B_7+=KO2+"5;B:WF):-L
M']Q: _W0!S[*?[U>_P#_  4L\<67A;P9X?\  ^F(L%UJ\QO[W9][[/%PBD^C
M2'./^F8KU3]E+X>ZG\.?@MH>B:;8+9W]VGV_4[R1,,T\@!()(_A7:F.2-M<\
MI>TFET1E*2G)+HC5NM0OF=+6\\()ISD?)<P;D3'KMSMQ].GI6Y9P'3+4O'XB
ME@N3]V&T60K^+9'\C7;VG@.*1_.U.ZEOICR?F('Y]36]:Z+86.!!9PQGUV G
M\S5RC!O0Z7B96LCRZ/QMXQLVQ;W$MV@Z>9@_S%6&^*'CB# ;3T?@?-Y:^E>J
MJ O"C'T%.?D\\\#^53RP_E)^L/JD>5Q_%KQ4^U9+:*%N^Z)"/YU8NOB1XG"#
M;=6?_;.(9_45Z'<6%M=+MFMXI5]'0&L/4/ >F7F3"K6C^L9ROY&CDAV']8_N
MHX)_%/C;6I#%;W<F[^[&W3WPH_K56X^&?C/7?FN-62#=U\YF)_F36]?>$]6T
M&3[1;,TRH<B6WR&'U%:FA_$ [EAU-?;SU'_H0_PK514=8H;K3^R<.OP!NTP]
MU>_;V[JC[1^M:$-C8^";J&U?0;?SF ^?RS(W/0ELG%>NPS1W$:R1.LD;#(93
MD&N<U[P8-:U9+L7'E(0!(N,GCTJU4?4S]M)_$9R^)ELQMN-.DM@.?E& /T%1
M_P#"P--;A6=?=U/]*ZS5CMMTCQE6X.>>E<_-HUA<9\RSA8GOL&:2DNP*<7NA
M;7Q9I]PP!N(E)_VZUEFCD *R*P]F%<U-X-TJ8$"W,9]4<U:M_ MK-I\@AGN$
ME"LJ'<.N..WK3YD.\#>^G-%>:>"?AOJMIJET\U_>00E<-YP/S-GJ.>>]=M_P
MAMZOW=8DQ]#_ (TVXKJ#Y5U+EU80W8^>-'_WE!%8EYX*TVZSOLHU/]Z([3^E
M7?\ A#]1[:P__CW^--D\*ZA$K.^L[(U&2S$@#]:%)=QJ2[G/M\.6MY/,TZ_N
M+)^WS<?F,&KMKJWBKPD1+=+'J]K'R6/4#USU_G69J%Q>M-]FTO49K^X/ 95;
M:/UR:KK\(]?UYA)K7B6>.,\_9X@>/UP/UIOEE\9?,NK/1K?XM^'I+%9YIY+>
M7^*W:,EA]".#^=9MU\<-&A)$5M<2^Y95_K6-IWP4T2QY=Y;E_P"_+\Q_7BMN
M'X>Z3#C"R8'8$#^0KG]G17<GVD"C)\?M*C0L;&X.#C"L#_(56/[26@1?ZVPO
MU/\ LJ/ZXKIXO".E1KG[)N([L['^M6ET73TZ6-MGU\I3_2ER4NPO:P['G6K?
M&;PIKXX\.M>2'O,FQ_S4$_K7&RWSW]T9+#2Y=/CSQOD*@?B3G]*]MO/">DW@
M.ZRCB8_QPC8?TKF=4^',D>7L)_-'_/.7@_@::A31HL196BK'-6>F_$215_LS
M4)+5.QF=L?\ CW;\*GD\$>/M3.=6U\7*]XT<$?T'Z5>L/$FJ^&)A;74;O$O_
M "QFZ@?[)_R*[O1_$%GKD6ZWDQ(/O1-PR_A6GP;)&<JT^IYTW@VYT.V>YN;6
M.9$'S/*P/Z UJZ*NIWUOY^GV=HL6=N0B*0?0UV.O:2-;TR2U+^66(96QG!!J
MOX<T,^'=-DB,@FD9B[,!@=.@I\[:(]H['/7"^(HSMWPHWHI Q^E0#2=6N?\
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M;^66;\"!BN*3X6^*O$!#ZOXEDMH3S]GAW?RSC^=;-C\&[6R S?23O_>F!?\
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M9]W58T QCZTQ?B=XXN?E6P2/@G=Y:]AFO3X;.WME"Q01Q+Z*@%68L[CCT/\
M(U'+!= ]N_Y4>//XR\7WC8NKN:T0]?+P/Y"IETFRUF,O=>*Y$N>I6\@D*_\
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MJG(4>E6=6\06.BJ?M,P\S'$2\N?P_P :74.NAHU@ZUXPM-+8PP_Z9=]!%'R
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M=#J=OAE.0?EDKNP%UBJ?JCS\?=86IZ'4?LL_\D/\/_6;_P!&-7K%>3_LL_\
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MS3)?BU^WMI/A:[NA>PVNHV>G32;=X"Q 2S*0>H#&0'VK]/PJH J*$0<*JC
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M/JMJ&I6VEP&:ZF6).V>I]@.]<[J'C4W$WV71K=KRX/'F;3M'N!W_ !XI-/\
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MJEOBYX* &2="( _[>9*PK? 9S^$_0_PAQX1T''3^S[;_ -%+6M6!\/[&?3?
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M_P!@JT_]$)6)I>O:I<>+WM968P^8RM#CA%&<'^5;'P]4K\/_  N#U_LFT_\
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MXQCO7U5K.G_VMHVH6&_ROM=M+;^9C.W>A7..^,U<HIQBHJR$VV[L^0?V0/V
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M1M-1C+6DZ3(IP=AZ4_4K-=0L[BV9BJRJ4+#J,UC^%_"Y\.M<.UQY[R@#Y5P
M!_6CH,M7WB;3]/U!;.>4K,V,X4D+GIDTJ^&[!=4.H"+_ $G.[.[Y<^N/6JFJ
M>#K35-46]DDD1N"Z+C#8_E6EJ&L66EKFYN$B/9<Y;\J?H'H8&H>"Y+SQ$+\7
M"K SK(R\[LC' _*NLKD9O'3W<ABTK3Y;MNF]@<?D*C;3?$VM#_2;I;"$_P#+
M-.#^0Y_6G9]1V?4Z6^UBRTT?Z3=1Q'^Z6RWY=:Y77/%NAZC&8Y+.2\(^Z^ A
M'T/6KMK\/+",[KB::Y?J>=H/]?UK6M_#.EVPPEC%_P "&X_K1H@T1Y9;WSVM
MQFVN);5-W&USE1^'6OB+_@H1J,^H?%3P<\UTUT8]*VJ[+@@?:7->G?\ !2+X
M6WFCKHWQ$\/W%U:0$+INJP6LS(BGDPS;5(QGE"?9/Q^![S4+O4)%>[NI[IU&
M%:>5G('H"37)6J7]VQE4G?2Q^R$?B34;G1;.,ZHKQ^1&"D?R'[HX/ S6CX<U
MK2-+VO<6,DMQ_P ]LAQ]0#TK\D/A5X;\3?%CXA:#X1TO4[X7.IW*PF3[1)B&
M,<R2'GHJ!C^%?L/IWPET31-&LM,TUKBVM[.!((MTA<E5 &26Y).,DYZFMZ=1
M36QI&:ET-ZQ\5Z7J! CNU1S_  R_(?UK6ZC(Y%>?WGPYNX\FVN8YQV5QM-48
MX_$7AMOD6=(QV \Q/RYK3E70KE3V9W7B#P_#X@@CCED>)HVRK)_*K6EZ='I-
MC%:Q$E(QC+=3WS7)Z;\1QPE_;;3WDA_JIKJ=/UJQU10;:Y20_P!S.&_(\TG=
M$M-%QW6-&=B%51DD]A5'3->L=8>1+2<2,G)7!!QZU<N(%N;>2%\[)%*''H1B
ML3P[X2B\/W$LRSM.SKL&Y0,#-+0-#3NM/6X8LIV/WXX-0_V3)L3+J!D]*T:>
MW^K7ZF@1F+?:?IUTMFUS&ER^,(QY/I4^I:E!I-JUQ<OLB4XX&23Z 5@ZMX*_
MM/6Q??:O+0LK/'MR>/0_A6UK.DPZW8M;3,R*2&#+U!%/0>A4:/3/&6GJQW2P
MJ_!Y5E;TJ+7/#":AHL5C:LL A(:,-G'T-6M)TJV\-:>T8EQ'NWO+*0,FL_4/
M'>GVK&.WWWLO0+$./S_PHUZ#UOH:'AS1VT/2TMFD$CY+,PZ9/I6A--';QEY9
M%B0=6<@"N2_M+Q-K/_'K:+81'^.0<_F?\*(_ <MY)YFJ:C)</_=3_$_X46[A
M;N7]0\::/"K1M(;L'@I&FX'\^*X+6+VPN+H2:=:R67K\_P#(=OSKT.U\&:1:
MX_T7S6'\4K%O_K5?72=/MUR+2W0#OL%--+8::6QYK9^(K^UA4)JDJMG_ %<B
ME@!]>:M?\)?JC*P_M6,'''[K&?QVUZ!YMCG&V+_O@?X4ATK3[A<FTMY!Z[!1
M=!S+L>70:A')?^?JBRZ@OH)<?Y'MQ7<:9XTT58UA0-8H.BM'A?TJU=>"](NL
MG[-Y+'^*)BOZ=*QKSX;H<FUO6'HLRY_44[IA=,["VNH;R/?!*DR?WHV!J21!
M)&R,,JP(/XUYG)X1UO29/,MU9B/X[9^?RZU:M/'&J:6PBOX/. _YZ*4?\^]+
ME[!R]CIM#\(VVA7DEQ%+)*S*54/C"@UNUA:;XTTS4<*9?LTI_@FX_(]*W%82
M*&4AE/0J<BI=^I+OU*%]X@L--NDM[FX6.5^0N#QGIGTJY- EQ'M<<=B*P]<\
M&P:UJ*7;3O$V KJH!W ?RKH%4*H Z 8%&@:=#.727W':ZD8/7CM7YX?\%1K%
M;7Q7X';Y6D?3+D%@.<"08'ZG\Z]M_;0_:%^*'[.^M:'?>&XM'N/"VJQ-$'O;
M%I'AN4^\A8.!AE(8<=F]!7P5\=/VA?%/[0U_I=WXJ33TETV%X(/[/@:(;7()
MW99LG(KEJS5G$QG+2Q^Q'P\N([KX?^&'A=9$_LJT&Y3GD0H"*N0^)-.N]2?3
MTEW3Y*X*G:2.H!K\N_!/[>WQ9T6STWP_HMGH-RQ,5K;1/8.\DC86-%_U@R3@
M#ZFOTG\%^"[S3[/3+[7KB*?Q (%>]%HFRW%P1E]@))V@D@9/;-;0G&6QI%IF
M_IGAVPTBXEFMHBLD@P26S@>@]*Q]#\&2:5KCWCSJ\2EC&JYW'/K6OJ7B73M*
MR)[E3(/^6<?S-^0K#;QEJ&I,5TK2WD':20$C_#]:VU+U.OK-O_$FFZ:2)[N,
M./X$.YOR%8#>'=>UK!U'41;Q'K%'_@.*N6?P_P!+M\&42W+?[;8'Y"EH%EU,
M#Q%XBT35E8K82//C GR(S^/7/XU@Z;J5Q9R?N[V:U3'5,L/IBO4H?#^FVX 2
MQ@&/5 ?YU)ML;7*B.%/94'^%5S+8?,CSU?%^J+@?VHN/]J'_ .QJGJFN7^H?
M)-J'VB'^['\@/X8'ZUZ=Y-A><&&"0^C(*@N/#.E70P]C$/=!M/Z470<R['*>
M'_$VB:2J@6$L$N,-,<2'\^OY"NOL-?T_4\"WNHW;^X3M;\C6'=?#NPER8)YK
M<^A(85BWGP\U"'+02Q7 ^NT_K1HPT9Z+6'KGA&VUZZCN)99(G5=I"8PPKCXM
M2\0^&^)%F\I?X9E+I^?;\ZW=-^(MK-A;R%K=O[\?S+_B*5FMA6:V.NC01QJB
MC"J !^%17EY#I]L]Q<.(XD&2QI+/4+;4(]]M/',O^PV3^51:QI<>LZ?+:2,T
M:O@[EZ@@Y%22/T_4K;5K?SK602QYP>,8/H14-QI8=BT;;?\ 9/2HO#^@Q^'[
M1X4E:8NVYF88[8Z5J4>@_0SSI+%UWN,8'W?I3[/4;%KA[."XC:>/[T:GGWK0
MD^\/H/Y5RVF^"QI^O'4/M6^,,SK'MP<G/4_C0MM0WW-;5]>L]#2-KIV7S#A5
M5<DXZU!=:/IGB1;>\D3SAMRCJ<97T-+X@\-P>(%A\V1XGBSM9,=#U&/PJS']
MCT#3XHGF6&")=H:1N33] ]#.\1^$X]?>!Q.;=HEV<+D$?2MBSM5LK2&W0DI$
M@0$]>!BN<O/'UL)/*L+>6^E[;00/\:@W>*=:Z!-,A/X-C]3_ "HL^H[/J=5=
M7UO8ION)XX%_Z:,!7.:KXTT26%H9(VOD/50G'YG%1V_P]AD?S+^]FNI#UVG'
MZG)K7MO">DVOW;)&/K)EOYT:!H>875W"+QI;!);1.R^9DC\:U(?$^HVZJ(]6
M<\<^;&3@^G0UZ+]@L+4 _9K>/T^04GF6,GRE(B#ZH,?RJN8KF\CSV3Q9JDT)
M U5 QXVJFT_GMJMH^I6%O=-/J5K)?2$Y#%\C\0>OYUZ4^BZ=,,M96[ ]]@K,
MNO FDW'*1R6[>L3G^1S1S(.9#[#QII%T%C$WV8] DJ[0/QZ5N1R),@>-E=#T
M93D5P]Y\-Y.MM>A_]F9<?J*R_P"P=?T!C) LJ@<EK=MP/U'_ -:E9=&*R>S/
M1=2T^/5;&6UF+".08)7J.^:I^'_#T/A^"2.*1Y6D;+,_Z"N6L/B%=VK"+4+;
MS<<%E&Q_Q'2NHTWQ5IFJ8$5RL<G_ #SE^5J5FA6:-:L]?$%A)J1L%N%-T#C9
M@XSZ9]:T*YZ/P9;QZ\=2$[G]X9?)QQN/OZ9I:=1*W4VKJS2Z'/RL.C"JJZ3)
MY;_.N,CU]ZT:>O\ JW^HI",F2:QT-5DN[A(F<X5G_H*T&GC6 S%U\H+OWYXV
MXSFL3Q1X7/B+[.R3B!XLCYER"#C_  K2M-,CM])CL&)DC6+RB3U(Q@T]!E.T
MU?3/%$-Q:QL95Q\Z,I4D>HIT7AJTM=)NK&V#1+<*0SDY.2.M1Z%X6M?#\TTT
M4KR,Z[<R8&U>M)J7C'3--RIG\^0?P0_-^O2GZ#]"#PGX7D\/M<233+)))A0$
MS@ =^>]=$S!5))P!U)KC_P#A)M<U?(TW3?)C/2649_'G I/^$/U/5F#:KJ;$
M=3''R/Z"GZ@_,V;[Q=I5CD-=+*_]V$;_ .7%<-XBU?2=38O:6,D$^>9=P4'Z
MJ*[&U\"Z3; ;H7G/K*Y_D,5IQZ)IT/W;*!?^V8HND%TCS#3]:O+16V:C-!C[
MJ\LI_P *T$\8:GN"G58U']XP_P#V->@;K&'Y0D0 [*@Q_*C[#87>3]GMY/7Y
M!FCF'S+L>6WFK7&H7*M?W#WL2G)1'VC'MQQ^5=9HOB_0[&,11VLEB#U;:&S]
M2.36W=>$])NOO6:(?6,E?Y5CW7PYMGR;:ZEB/99 &%.Z8[IG2V.J6>I+FVN8
MYO96Y_+K5JO-;KP'JMDV^ I/MY#1-M;\C7&?%KXJ^-_A'X!U'7M-TF/6Y=.
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MN621'  95QA@.GTJM+CTN>7_ !F^/GPX^!'BS3QXO35+>^OH3<VTUK9/-#(
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MX9K?^U=<'DR1ADP(;K VD8XK]B3I>C:.DE]]AT^Q6W1I7N5MT3RU )9MP&0
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M>2NX[1^/4UTMI8V]A'LMX4A7T1<5@:5XUAGF^S:A$;"Z!Q\_"D_CT_&NE!#
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M9\P6DWF&/[RD$'Z\]JMW-NEU;RP2?<D4HV/0C%9'A_PK!X?FFECF>9Y!MRP
MP,YI:"T-RJEYI-G?\7%K%*?5E&?SJ'Q!#=7&CW,=F2+EE^7:<'J,@'Z9K-\%
M6FHV=C,E^'4;_P!VDARP&.?PHZ7#I<CN_A_IL^6A,MJW;8V0/P-5AX9UW3?^
M/'5O-3H$E)'\\BNOHI\S#F9R#:IXGTOFYL8[R,=6CZ_I_A3H?B/9, );6>-N
M^,&M;6O$]GHJE6?SKG^&",Y8GW]*R_#?AS[0USJ&J6L;37+;EAD0'8.N<>II
MZ;LK3JB=OB)I7DJ0+@G)XV?3WJI-\2;10?*M)G/^T0!72MHFG-"H-A;$9/\
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MO@UT3:)IQB4&PML9/_+)?;VH=@=CY,_;M\)6/Q>^$_\ :6G64IU[PVS7D$A
MR]N1^_CXZ\ ,/=/?G\R*_>"?PGH]RK+)IT!5A@JJ[01Z<5^3_P =OV8=4\(_
MM+IX \/VS/:^(;E)M$9@0HAE)R"?2([P?90>XKDKQ5U)&%1+='M'_!.G]GO^
MW(M1^(^KJT5J&;3]+7'S/C_72#/0=$!_WZ^_M.T&PTL#[/;(K#^-AEOS-<'\
M/(8/A+X3T7PB^G&TTW2[=;6":,?>QU=O4L<L2.YKT:UNX;Z%9;>59HVZ,IS7
M1&+A%(U2<58FIBR([,JNK,O4 Y(I6!96 ."1P:XOPCX?U+3M<GFN59(MK!F+
M9$A/0U0SM:Q;RZ:XD(!^0=!_6MEUW(R],C%<^ZF-BIX(.*$"$J2&=[>0,I^H
M]:CHJAG01R"6-7'1AFJ%_P"(+#3+J.WN9Q'*_(&"0,],GM5NSC,-LBGKUK&U
MSP?;:Y?)=2321L %=5 PP'\JE6ZB5NIOTV2))T*R(LB]PPR*<JA5 '0# KC+
M[2];?Q<L\1D^S>8I$@?Y G&01GZT($;-YX.TF\R3:B)C_%"=OZ=*RF\!26C%
M].U.:W;LK9_F/\*["DIW8<S.1\GQ98_=EAO%7L<9/\J:OCJXT]_*U739(9.S
M1\9_ _XUU=U=0V<)EGE6&,=6<X%<?J%T_CB^AM;.(BP@?=)<..OL*:UW*6NY
MO>&O'NFWFO:?"$G226=$7*#&20!WKV*O-/#^BZ?;ZO9-%96Z,LJD,L8R"#US
M7I=<5:W-H<U6VE@HHHK$YPHHHH **** "BBB@#SS4O\ D(7?_75OYFLZSU*T
MU R"VN(YS&<,$.<53UYI&U+4HQ(RAY9%X/J2*Q_!?AR72KBXN995;*^6JIGU
M!R?RKTK:';%:'6UG:QH%EK<>+F+Y\?+*O##\:T:*0SB_L^M^$>8&_M+3U_@.
M25'TZC\.*WM%\466N*%B?RI^\,G#?AZUK5@ZWX/M-48S0_Z)=YR)(QP3[C^M
M.Z>Y6CW-ZA@&!!&0:XY-0\2:%^[N+0:E"O21>3CZC^HIO_"R$7(DT]U8=1Y@
M_P *.5ARLZ&?2CN)B(Q_=:HETN<GD*/QK'3XA>8N4TNX<>JG(_E3_P#A8< /
MS:?=#\J=F%F;=Q&VEZ;<SPKYUPD991CJ?I65X+U^]UI+D78#>61MD5=O7M4/
M_"PH&.$T^Z;TZ5!<?$)[=<KI4B#/61MH_E19]AV9V=%<5;>*M<U92UAI\)3.
M"V=V/U%3?V7XHU ?O]0CM%](SS^E*PN7N=7<74-HF^>5(5]78"L"_P#'>FVO
MRP%KR7H%B''YFJ]O\/[=G\R^NYKR3J><#^IK>L=%L=,_X]K6.(_WL9;\Z- T
M.<^U>)/$'$,2Z7:M_&W#8^IY_*M#2?!=G82">X9KZZZ[Y>0#Z@?XUT%%%Q7[
M!2_P_C69?7[;S'&=H'!852\U\9WMG/K2L%C5N=5L[.XC@GN8XII/NHQP35JN
M)U+PV=>U2.9[HQY 5LKD\>E=LHVJ!Z#%#!C)H8[F)HY462-N"K#(-<K>>#9]
M/G-UHERUO+U,+-\I]L_T-=;11<+V.5T_QHT,XM-9MVLK@<>9C"GW/I_*NICD
M65 Z,'1N0RG(-5M1TNUU: Q742RKV/=?<'M7,?V'K/AIF;2IOMEJ3G[/)U'X
M?X4]&/1G8U7NK-+H9^ZXZ-7*OX\NK'"7VE/"_P#O$9^F10GQ'CD;":?*Y]%8
M'^E'*PY6;;:7,#QM(^M6+?2PK!I2&/\ ='2L'_A8")_K-,N5-+_PL2V[6%T3
MZ<4[,+,CUCQ1J-CXG2SBC4V^Y5$>SEP>I!_STKL:Y!O'P;YH]*N']"?_ -55
M%^(%Y>3"&UT^/S3P%:0D_P!*+,=GV.YH)V@D\#U-<CN\6:A_##8K^&?ZTG_"
M$WM\P.I:O)*O]R/)_G_A2L3;S-J^\4:7I^1+=HS#^&/YC^E8K^,-0U5C'H^G
M.P_Y[2C(_P /UK4L?!NE6."+;SG'\4QW?ITK:50BA5 51T &!1H/0Y.'P?>:
MI()M:OGE[^1&>!^/3\JZ>SLH-/@6&WB6&-?X5%35!>70M8\]6/ %*]Q7;+"_
M>%17%Q%:PO+,ZQ1*,LS' %8S7$LCY9V/XU3U2W?4M/EM3*RJ^#GKR#FBP6.C
ML[V"_A$UM*LT9XW*<BIJQ?">BC1=/=?.\YI6WD@8 XQBMJ@3,36O"=EK&9,?
M9[GJ)H^.?<=ZQQJ>M>$V"7T?V^Q' F7J/Q_QKLZ&4,I! (/!!IW'<I:7K5IK
M,/F6LH?'WD/#+]15VN8U3P6OV@7>E2_8+I>0J\(?\/Y56_X2/7M)7;?Z7]H5
M?^6L>1GWR,BBW8=NQU\D:R*589!KP3]KRP^S_"E75LI_:4 P>OW7KTC_ (65
M%WL9 ?\ KH/\*\D_:H\5'6OA:D'V&:W7^T(6\Q^G"OQT]Z]# )K%4_5'!CT_
MJM3T9Z+^RS_R0_P_]9O_ $8U>LQ_ZQ?K7DW[+/\ R0_P_P#6;_T8U>LJ<,I/
MK2Q?^\5/5_F>3A_X,/1'XT_L6_\ *2&'_L+:Y_Z)NJ_3W]K*XNK3]F'XJ2V>
M1.OAN^P5."J^2P8@^RY/X5\1?LO_ +(OQ<^'_P"VY%X[\0>#Y=/\)C4=6G.H
MM>VSC9-%<+$=BRE_F+K_  \9YQ7Z4ZQI%GX@TB^TO4;=+O3[Z![:XMY!E9(W
M4JRGZ@FO+I1?*TSMFUS)GXK?L'^)OC=X7U#QC<?!7PEI'B>]DAMH]3;4D5G@
MCW2&,)F:/ 8[L]<[1Z5WO[17P$_:M_:>\2:9KOBWX86-OJ&GVGV.-])D@A#Q
M[RX#[IVS@LV.1U-;OB7]B_X_?LC_ !2O?%GP.DN=?T1E?RGLGC>X^SD@_9[B
MV<_O<<?=#9QG -=O\.?#7[:7QX^(GA'7?%FI7'@#0='NA=^9=P16:-C*N&LT
MP\C,I9<2 ##'D5SJ+MR23-&]>96.3_X*WQWD.F_ V/4%*7Z:5>)<*<9$@6T#
MCCWS7TOJ?QZ\._LZ_L&_#+Q/KVC0^(II-"TVTTW2IT5DN+IK;<NXL"%4*K,3
MC. 0.37$?\%./V;OB/\ '[4OAW+X!\-2>(4TN&^6\:.Z@@\HR- 4_P!;(N<[
M&Z9QBNK^-7[(_B/XU?L2_#[P(ACTGQOX8L+&XCL[F5?+:XBMC%+ [KD#AVPP
M.,J.<5M:2E)I$:6C<\A^%/Q6_;&_:.\+P>(_AS9^$? OA-II8[1HK.WABG97
MPVU95E8X;(+!5!(/<&O$?^"5XE7]L!Q.0T_]CZCYA'0M\N?UKMO@KX=_;9^'
M?A]?A-X:\/S^'=&A9]NHW]M;>79K,Q+M'=DD-@L6PA9ADX%=+^PS^R-\8/@#
M^U''KOBKPC)_PCOV>^T^36H;ZV>,[@=DVP2>9M8J/X<_,,@<UFKN47J6[),^
MK_VUOVK++]E_X7O<VLD4_C/5U>WT6R8@[6QAKAU_N1Y'U8@>N/E7_@FS^RK>
M^-->D^//Q$274)IKB2?1([[+/<W!8[[Y\]0#D)GJV6[*:X']J_\ 9-_:4^.'
MQ\\4^)F\&7&LZ2+V2WT>3^T+-(UL4<B$*C3 @%<$Y )+$GDUW>FS?\% -'TZ
MUL+'P]%9V5K$L$%O"-(5(HU "JH$G   %4Y.4[R3LB;)1LF5/^"S$US_ &]\
M*XF)^R?9=0=?0R;X WZ;?SK[S_9;M;&S_9T^%\.F!?L/_"/6)CV@ -NB4DGW
M)))]237C/QE_9=\2_M6_LL^$M+\<30Z/\6=-MQ=_:IEC*)=$$20R&+*A'4+R
MF0"%/.*^2?"NC_MO_!'PS%\,- T'53I$GF0V5Q;6]O=I;H6.?+N\D0J221O9
M<9Z"JNX3<FMQ?%&USFOV;HXM+_X*>^1X>7%BOB/5H@D8PHA\NX$@ ] -WY4W
MXN6L-]_P58CM[F&.XMY?'.E))%*@9'4M;Y!!X(KZK_8!_85UGX%ZU=_$+XA-
M"WC*Z@:"ST^.43FQ63_6O)(,@RL/E^4G +<G->;^/OV2?BSK/_!0R#XD6?A"
M6?P4OBW3M2.JB]M@OV>-H3))L,F_C8W&W/' K/DERK3J7S+F^1^A_P 0&+>
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MZQ9V2Z;>:.\R1/)$LCNDD3.0I(,C J2,C&/2L[37/9%>Z^6YY/\ M 3?M?\
MBW]GGQ+X@\=R>'_#_P /KBQAFO=!@@MDG$!DC,85=KR(=Q3Y3(",<XKO_P#@
MD!_R1_XF_P#83B_])S7GNH>&?VU_VD/A?J?@[Q%IDFD^'+>T*3)J5K!87.I/
M  T<.3AW+LJ?,=J$C):O=/\ @FS\#?B1\"_"/Q T+QYX3E\/_P!H30W5E,]W
M;S"=O+='3]U(V,84\X^]1!/G3U^8Y6Y6CY5_X)%_\G/ZO_V*]W_Z46U>T?\
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M*.OU]:L+]X?6H+NY%M%NZL> *R6N999 6<]>F>*0&U<SQVL<DLKK'&G+,QP
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M;L==-"MQ&5<<?RK-DTJ53\A5A^58/_"RHCP+"0G_ 'Q_A4P^(&.7TNY"^O\
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M869O_9_[/M9I8U\V94) ]2!TK \&>([_ %FZN8KL*Z(NX.J;=IS]W_/I2?\
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MZ)MO7YMQ'ZBBS&XL[:F331VZ;Y9%B7^\[ "N4.G^*M1SYMY%9*>R'G]*=#X
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M7\=:.GF/J]K/#WDAGE('U^7BCZGA?^@A?=_P1\^*_P"?#^\^W_.C_P">B?\
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MX8]\<_\ 0QZ=_P"!$W_Q-(W['_CA%+-XDTU5'))N)@!_X[1]3PG_ $$+[O\
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MW45O:I;+A>2>I/>I:0CGE\9P-KW]F^0_^L\H39'WOIZ9KH:S_P"P-/74#?\
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MX^OXUDZ7-KMQ#Y6B>&7MX6YW.A /ODX!K7A\ >,-8_X_M2ATV(]5C.6_)?\
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MF_QJI%XKUK3PZ:KH,\3Q'$CQJ=OUS@C]:OW9:Q9+CV-G7/#-GKSQ/<&1'C&
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M"V]P3G_@53Q_#KPU"VY='MR?]K+#\B:U]O3[,KW3S.Y^)4.2EG9RWDW\*J,
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MDU")G/KGC]*EDUC1[KEKVW)]=^#5*-MP2L4/M$__ #R7_OJM/2S<*&E,2C/
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MTRGK$S=L"@"RC!UR*6FHNQ<4ZI *I33?8-068=)(V!'J0,C^E7:R]<Z0_P#
MOY4]]!B6NBV5Q:H]Q9V\[R?,S21*Q.?J*JW'@+P[=,6DT>U+'NJ;?Y5M6G_'
MK%_NC^52U7-);,+G*2_"WPQ,P)TQ5_W)&']:I2_"CPPK$"RDS_UW?_&NXJ&6
M$LQ*_E5*I/\ F879QL7PO\-Q$'^S]_\ ORL?ZU=@\">'[=@R:1;!AT)7/\ZW
MRI7J,4E/VDWU"[(+6QMK'_CWMH8/^N<87^0J]',6(5JA"D]!FI8H2&#-^59L
M1/1114@1SQB:%T/1ABL^&<WGV"%N1$&+>Y!P*U*Q=)_X_3]&_G30S:HHHI"$
M9@JY-5VG9NG JPZ[U(-5FA9>V?I30#=Q]31N/J:2BF ]9F7OFI)(8;R/$L22
MK_=D4,/UJ)8V;M5F-/+7%(#*NO".B7HQ-I5H_P#VR _E6?)\-/#,H(.DPKG^
MZ6']:Z>BJ4Y+9CNSA+OX5^&+>]@D^P.$8%6"S.,\<=Z-+^$OAK[,LKV+LSY8
M[IW_ ,:ZG7/]5#_O_P!*M:?_ ,>4/^Z*OVD[?$QW9A0_#?PU"H TB!L=WRQ_
M4UIVOAG2+%0(-,M8P.F(5S^>*TJ*ASD]V*[(7D$/R( ,>G05$TC-U-2S0ECN
M7KZ5"5*]1BD(3<?6E$C+T)I*4*3T&: )HYR2 WYU-4$<)W MQ4]( ILD8EC9
M&&0PP:=12 R8IFNHK*U;D1NV[WQTK6K%T_\ Y"C_ %?^=;5-Z#"D9@JDGI2T
MC+N4@TA%>29GR/X?2LZXT73KHDS6%M*3U+1*3_*M!H67MD4RK3ML,YZ;X?\
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M0YR>[%=E52L*[(8UB3L$4"D+,>I)I[0LO3D5'2$&X^M/69E[Y^M,IRQLW04
M6(Y/,7T-/ID4?EKZFGU(!5.__<R6UPO#1R ?@:N53U;_ (\S_O#^=,86+?:)
MKFY/)=R!]!5RJ.C_ /'B/]XU>H>F@!4<LOE\#DU)4<T7F<CK2$0-*S=35.XT
MNSNSF>T@F/K)&I/ZBK;(R]125?H,PKCP-H%TQ,FDVV3W5-O\JKM\-?#4K#?I
MB*/]AV']:Z7!/05+' 6^]P*OVDEU"[.5_P"%1^&/^?*3_O\ O_C4L/PJ\,0D
M$:=OQ_?E8_UKK:*7M9_S,=V<_#X \.6[!DT>UR.A9<_SHAL;6Q@ELK>UAAW3
M@ QQA3MZXX%=!6-)_P AA?\ KH/Y5/,Y;L1L*H50HX X%+114""J[W!/W>!5
M@\C%5GA9>G(I@,W$]S2;CZT8/I15 .65E[Y^M6(Y/,'H:K+&S=!5B*/RQSUJ
M6!)1112 IZEF-(KA?OQ."/\ "EM6^T7MW<'G+[%^@HU3_CQD_#^=,T?_ (]G
M_P"NA_I3Z7&6IK>*X7;+&DJ^CJ"/UK-NO">BWBXFTJT<?]<@/Y5K44)M; <M
M<?#KPSM(.D0@M_=+#'ZUFR?"OPU)_P N+K_NS./ZUV\T?F<CK5=HV7J*U52?
M\S"[./7X3^&E.?L4C?[T[_XU;A^'/AR$ #2H6]W)8_J:Z2C!/04_:3[L=V4;
M'P_I-@H6'3+1 .XA7-;2JJ* H"KV"C JND#-UX%6:R;N(****D1DR2M!#=V:
MG >50OL#S_2M5%$:*JC 48%8UW_R%A_OI6U38PHHHI"*[W!Z+P*C+,>I-/>%
MEZ<BH\$=15 &X^M.65E[TVE6-FZ"@"S')YGL:>?F&#R*CAC\OD]:DJ0*5QH>
MG763-86LI/4M"I/\JP-8^'WAV2W,W]D6ZNC!LJI7O[&NLJMJ7_'C-]*N,I)Z
M,>IR2_#'PSJ%]=3'30B#"*J2, ..>]/_ .%0^&/^?*3_ +_O_C71Z-_J9?\
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M[_XU:M_AOX<M^FF1O_UT9F_F:Z:E56;H,T_:3_F8[LSM/\)Z%:9$.DVD;?\
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M^^!1]GO?^?I?^^* +U%4?L]]_P _2_\ ? I/L]]_S]+_ -\46 OT50^SW_\
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ML?\ ?4?_ ,31]2RO_GY+[E_D'US'_P D?Z^9[2W[3'PN52?^$UTTD?[_ /\
M$UEV'[1GPSM[B-V\9Z;APV?O_+SW^6O*O^&(_"'_ $&M8_[ZC_\ B:/^&(_"
M'_0:UC_OJ/\ ^)H^IY9_S\E]R_R']<Q_\D?Z^9[5_P -+_"[_H=M-_\ '_\
MXFC_ (:7^%W_ $.VF_\ C_\ \37BO_#$?A#_ *#6L?\ ?4?_ ,31_P ,1^$/
M^@UK'_?4?_Q-'U+*_P#GY+[E_D+ZYC_Y(_U\SVK_ (:7^%W_ $.VF_\ C_\
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M2_9;S_G[7_OBE8"ZS!%+,<*.2:QH5,4T5ZPQ%)(PS_6I[C3[J9<-<B0?W2"
M:O6]Y#=0O9W<2P%5SMS\I [BDWRK03T):*R+=;EF86DK?9P<*TH%3F'4>T\?
MY?\ UJ=AFA1688]3'_+1#^7^%-(U3U!_[YIV U:,#TK(+:H.V?H%IC3:FO\
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MCNOA#\.O"^GWZW5KXGF'B#=$/E>U2,>2<\'!,V<'^[[5Z?\ \$H_@W=?#_\
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MR@@Y!I:Q_P!ZD[)I\DDD /5@,#Z9J=8M1;K-&/P'^%78HT:*H"WO^]R@_P"
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MIOEZE_ST0_E_A2L!IX'I16:(M2_YZQC\O\*7R-1[W$?Y?_6HL!HT50^SW_\
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M]\4?9[[_ )^D_P"^*+ 7J*H_9[[_ )^E_P"^*/L][_S]K_WQ0!>HJC]FO?\
MG[7_ +XH^RWO_/VO_?% %ZBJ/V6]_P"?M?\ OBFR6M]L.VZ#'TVXHL!*_P#I
M&JVD2\F-O,;VK;K+\/\ DJDB[66Z'^LWG)/N/:M2B+U:.6KN%%%%:& 4444
M%%%% !1110!AVW[Z_O)FY(?RQ[ 5<JGI_P#KKS_KNU7*4_B.Z.P4445F4%%%
M-\U/[PH =131(K="*=0 4444 %95U.UC-<QQ':)XP?H<X_QK5K%U;_C^0?["
M_P#H54E?<9K6\*V\*1J, "I***D04444 %%%&: "BBB@ HHHH AO(1<6TB$9
M../K53[9)JD-M;!BJ!,S$'DXXQ6C61H:_O)V^@IVZC-2*%(5"QJ%7VI]%%(0
M4444 %%%% !1110 4UT612K ,I[&G44 9T=\VEI=6RDG@&$'MFK5G:BUA ZN
M>6;N35&Y02ZU$.H"@G\,UJTQA1112$%%%% !1110 4444 1S0)<1E)%W#^50
MVNH/I\<]O,V[RT+Q,>X]*M5FZY"&AC?NK8_.BREHPM?1EC38?*M5)Y=_F8^I
M-6J1.$4#TI: "BBDW"@!:*89*8TP'5A^=*Y/,B:O(/BZIE\56*]5^SIQ]7:O
M6?,#="#7E7Q2.?%%G_UP3_T-J[<'*U4X\5*],]60@(H]A3MP]:KHWRK]*^8?
MV^/VG+[]GOX9VMGX<E6+QAXB=[>RG.";.%0/-N /[PW*JYXR<\[<5ES&%SV[
MQ]\=/AW\+9U@\7>-M"\.W++N6VO[Z..4CU"9W=QV[U7\ _'SX;_%"\DM?!_C
MG0?$5V$WM:V%_&\P'KY>=WZ5^5'[,_["_BW]JZSU+QIK/B1M#T:6X>,:K?0O
M=W6H3@_.5!9<J"2"Y;J" #@X9^T]^PGXJ_94L=-\::/XC;7M'BG6-M4LX6L[
MK3YB?D) =L*2,!U;KP0.,QSOL7H?LL62WA:21@B*I9F8\  9)->9:3^U/\&M
M>U2TTW3OBIX0OM0NY5@M[6#68&DED8X5%4-DDDX KR;_ ()]_M0ZA^T%\,;N
MP\27 N/&/AMXX+RYP UY"X/E3L!QN.UE;U*Y[U^?_P#P4C_93F^"7QJ'C/PN
M&LO#/BB9KZV,(*"RO@=TL2L/NY.)%_WB/X<U;GI= K'[5].#7G?B[]HOX5^
M->N-$\3?$;PQH&LVX4S:?J.JPPSQAE#+N1F!&001[$5X=\&OVXM(U3]B^\^*
MOBB5#KGABU-CJ]GN >XOU4+"%'_3<E&'IN;LIK\O_P!F_P"$_B']NK]JJ6;7
MY9KBVO;Q];\27ZYQ';[P613V+$K&H[9]%H<NPTC]Y?#_ (@TSQ5HMEK&C7]O
MJNDWL0FM;VTD$D4T9Z,C#@@^HJ_5?3=-M-'TZUT^PMH[.QM8D@M[>%0J11J
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M",@]/2LGQY\4O!WPMLK6\\9>*=(\+6MU(8K>;5[R.V65P,E5+D9('/%?G/\
M\$?_ -ICS8=4^"^NW?S)YFI^'VE;'R];BW!/_?P#_KI[5\V?M^?'K4/VKOVF
M%T#POYNIZ'H]Q_86@VMOD_:YF<+),J^LDF #_=5*7-I<+:G[1^ _BUX*^*"W
MLW@SQ7H_BJ*S*K<OI%XERL+-G:&*$X) .,^E=:L?<\M7C'[)_P"SQ8?LR?!7
M0_!UN(Y=5V_;-8O(Q_Q\7C@;SGNJ@!%]D'J:[#XW?&#0O@-\+M?\<>(9=NGZ
M7 76$, ]S,>(H4]6=L#VY/0&JZ78AGC;X^_#3X:ZT-(\6^/_  YX:U4Q+/\
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M'-=E^QA^R7^SYX3^,=_XO^%?Q'UOQ?KOA&:;3[JVN+JVDMP9H2A<;($+IAV
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M/'GW_P#KTMA;>5&)'^::3YF8]>:HZM\D\G^W$!_X\*UUX4#VIVMKW 6BBBD
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MI$-=Q&N35=IF;O@>U.N/O#TQ454 9-.61EZ&FT4P+,<V_@\&I*I [2"*NU+
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M6:OB#_@E?X'NG\<^,O%S1LMA:Z>NEI(1P\LDBR, ?55B&?\ ?%>Q_P#!1?\
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M ]^>U?*_PJ\=?M:_ #P5#X7^'_@75-,T:*9YS WA 2R22,<L[2-&69N .>@
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M@3\1M-_X*5S^+[KP-X@M_"I\8:G=C6I=.E6T\ES/LD\TKMVMN7!S@Y%>Y_\
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M58BE\S@]:J;J?"_[P8I"YD7**;NH:0(I+$ #J:D.9"GH:Q]'_P"/M_\ </\
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MY?Q7^8?VAA_YOP9]@ D=.**^/_\ ANC6?^A2T[_P,D_^)H_X;HUG_H4M._\
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M2QP*F%N.YJ55"]!BBX"(NQ0*=114@%96O?=A^IK5K,UP96#ZG^55'<9>M?\
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M[_Q?XT?V7\0_[]U_W_B_QKU^BCZY+^2/W"^JQ_F9Y#_9?Q#_ +]U_P!_HO\
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M-=MG96Z%4<%A^6:^FIJ$J"J.*VN=\<!3<%+F?W_\ ^NO)^(5K&J.UX@4!?\
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MJ^<OV _V)_B_\#OVD=+\4>*/#T%GI,-C=P/-%?12E7DC*KPK$]:"K/0^H?\
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M&H_=FG\R9X>M3UG!KY&E;/-M8HH!8Y+M_2I3 TG^LE9O8<"IJ*W.8B6UB7^
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M-1QZEXH (DSS#:*1UD]3S]W\Z9\9_BY/I$Y\*^&)0_B&=?\ 2+I>5L(SW/\
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MM1:5J$SR^#KZ3;%(Y).GRD_^@'O^?KGZ<5@ZAE(96&0P.01ZUZE.HJBNC[K
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M  QTZYK:G3]H[(J,>9V/5U<-T-.KQOPOXLN_#.IP175U+=:5<.(V-PY=X&/
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M+T5C)+(6Y*H%'THY4_>?0+7U-*WMH[5 L:@>I[FI:** "BBB@ HHHH ****
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M6.I*K3?KY,=I_P#I#2W;\O*QQ[+Z5=JII?\ QX1?C_,U;KC9W!1112$%%%%
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MU^%_S1Q8M7I7[6.>HHJOJ5X-/T^YN20!%&S\].!Q7J).3LCRS6^#WA]?%7Q
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M@K"\6;,:.)>8O[2@WY_NY.:]O#_Q8^IY$_A9[W96*:;)IUDA_=00Q1KG_90
M?RKHJQ[SY=5,H^ZC(/SK8KY*3YM6?1[*P4445 %.0EG)/K25--"<[E_*H:H
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M$XR0=!2UYMKW[27PO\+ZQ>:3JWC?2K#4K.0PW%M-(P>-QU4\=:H?\-8?!_\
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M1_J]R@8&3S@\XKYOUBZ\4_8W9->U#<OS86]E!_G7IWQ6\-WWA759]3O=&O\
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M:7[7$WQ.U"3X8_#R62[T=YEM[Z^L\LVIR[L"&+'6+=CD??/MU^B_V*_V55^
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MXE/X8I: 3 @\@Y%%4O[+C4YBDDA/^RU'D7L?W+A9!_TT6@"[16;)?W5LRK+
MAW' 96XJSYUYWL)/P8&@19K.UK+0QQKR[-D >PIMQJ<\+;&B6%_1VR?R%2:?
M>644QGN)VDG(QED(51[4;:AMJ6K63S;6)O514M9EM?06LSPB0/!G,;CL#V-:
M*2+(,JP8>QS0 ZBBBD!#)#NY7KZ5"RE>HQ5RBG<"ES3UA9NV![U:HHN V.,1
MK@4ZBBD 5EK&?[-%THSY5PS?\!/!JS<W!D;[-;_/._''11W)K6M[.."S6VQN
M0+M.>_K4RERV)D[%-6#*&!R#R*6J;*^COY<H9[7/R2 9Q[&K$=Q%(,I(K#V-
M5YHHDKY6_;,U$2>*/"&G8;,-G=7)../G>-!^/[LU]3F15ZL!^-?#W[2&O)X@
M^-FN&-MT6FP6^G*V[*EE3S'(].9<'W6O.Q\N6@UW/K^%J+J9E&7\J;_3]3;^
M%/[2&E_#OX30:-8:9+K?B%;R\=XVS#;0;IF*[Y",L<8.U ?<BN?G^(GQ2^-.
MI366F7.I7@'^LL?#B?9+:'V>8MD<_P!Z3/M6M\"_@;;_ !"B37O$<DEKX7W'
M[-9PDI)J&#RQ8<K%G/0Y;!Y Z_6NDMI/AW38=/TFPCL;"!=L5O:Q+'&H]@*Y
MZ%&O7@N>5H^1[.8X_+LMQ-1X>DJE9MMN6J3;V7IY6]3Y5T#]C3Q3J;K<:O>Z
M+HQ<[GX>^N.?4_*"?^!5V-G^Q/9+C[7XRO)/:VTZ&(?^/%Z^B;>ZNK\$V\"8
M]6<?RJ2:TNXX6EN+N."-1D^6N374L%AXZ-:GSU7B7,ZCTJ\J[)+_ "N?-FH?
ML0V$RCR?%TV ?^7S2X91_P".LE8,W[,OCKP.SR>%/&-KA7#+%:W4]@S>Y0%X
M\_7-?4$>GSWWSM(RQGH9#DD?2K,>APK]YF?]*T^I4.BMZ$QXBS&UJE1279Q3
M_0^/[[QY\<_ ,3_VG=ZP+<$_Z3-9V]_&.<9\Q$; _P![%<;<?%[QEXLO(K:[
M\>S:997!:.:\7]Q!#W^?[.F\9/?@#N17WW%86\."L2Y]3S7'>-/@CX*\>LTV
MJ:' E\1@:A9?Z/<C_@:8W?1LCVKGJ82I_P NZCMV;_R/3PN?8._^T86*?\T8
MJZ^37ZGDGPM_9?\ #4<=OKMY?)XRDD(F24,OV(OUW;06,C<]78_05[XFAR.<
MR2JOL!FOF_4_V;?'/PMOI-6^&OB2:Y!.7M"RV\[*.0&4_N9^_P!X*?0UK>"?
MVM9=/U'^Q/B-HLVC:A&0LEY!;NFWMNEMV^=1_M)N4]>!5TJT*'N2CR?D_F<V
M-PF(S)O$8>M[=+IM)+_!_D?0<>BP+]XM)]3@5:CM88?N1*OX57T76]/\1:9!
MJ.E7MOJ-A.-T=Q;2!T8?4?RJ[7H7N?)-.+L]PJ&ZM([I,,,-V8=14U%!)F27
MCW"6UM.<O'-AC_>&.#6G6+J@\F^60=P&_$&MD'< 1T-.UEH,6BBBD(***,XY
M/% !141N%'0$T"X7N"*8$M%(&##(.12T@"BBB@#%7]SK'_;3^8K:K%U+]WJ"
MOV^5OR-;54QA7QU^UQXV?Q#XZM?#-K+NM-)4&15Z&X< G/\ NKM'MD^]?7>J
M:E#HVEWFH7+*EO:PO/(S' "JI)S^5?G.-0F\2^)=1UBZ+/-<S/<.7.3N=B?T
MKZWAO"^UQ$JTOL_F_P#@7/BN*,9]7PJI+[7Y+_@V+]O"MO"D:CA1BGT=Z*_4
M3\/O=W84Y<BFTOI4%$@YI:8M/J0%':EI!VXI:EEC(OO?A4U0Q_?J8#/ %2RA
M?6E[T%2,Y&#]*#4E#:<*;3]I7J,?A4ECJ6DI>QJ"D/6EIJT[M4%(6LWQ#8?;
MM-< 9DC^=?PZC\JTAWH/3IFI-8MQ=T>[?L=^.CK'A&^\-W,FZXTJ3S8 QY,#
MD\?16S]-PKZ$KX0^!/B ^!_C9I89_+M;R4V,F20"LOW?K\VW\17W?TK\USS#
MJABW*.T]?\_\_F?M>08KZS@DGO'3Y=/\OD%0W#< 5-5>X^\/I7SY](144450
M!2JVU@:2B@"[12+]T?2EJ "L;4^=04>R_P ZV:Q=0_Y"@_X!_.JCN,VJ***D
M056F?<V.PJS5(]330!24M-8_+2G+EBY#0BU/&V1BH%[5+']ZO!B;,LBGKUI@
MIZ]:Z8F<AU>=_$3Q%)I]HFFVC[;R_#!F'5(L_,?QZ?G7H4C!(V8G  ))/:O!
M+C4F\0:[?:HQRCMY4 ](U.!^?6N',L1["ARQWEI_F>IEM!5:O/):1_/I_G\A
MT,*V\21H,*HP*?117PY]4>+>,?VRO@[X \4:CX=U_P 8KI^LZ=+Y-U;'3[M_
M+? .-RQ%3P1T)K&_X;Z^ W_0^I_X*[W_ .,USWQ-_P"">OP^^*7CS6_%NJZQ
MKT&H:M<&XFCMI8A&K8 PH*$XX[FOS]_;&^!NA_L^_%J+PQX?NKR[L7TV"\,E
M\RM)O<N",J ,?**^CPF$P.*:A&4N:VNWSZ'@XG%8S#IS<8\M_/\ S/TA_P"&
M^O@1_P!#Y'_X*[W_ .,UI>.OVL/#.C? /4_BIX3 \7Z/9W"6H0>9:;W,BHP_
M>(&&-V?N\U\Z?!O_ ()T_#KXA?"?PCXGU#6-?AOM6TV&\GC@EB$:NXR0N4SB
MNK_:8^#.B_ /]AGQ-X3T*ZN[NP6_@N5DOF4R%GN(R1\H QQZ5FZ&"]K&G3<F
M^9)WVM?4T5;&>SE4J))<K:L>G_LF_M8C]J!/$K#PW_PCW]C&#_E[\_S?,W_[
M"XQL_6O>+C5+:VR'E!;^ZO)K\Q/^"?'Q.\/_  K\,?$C5_$NM0Z+II>Q3?*W
MS2MB<A$4?,S=> *^FO!O[:_PC\;Z[!I%GXBEL;NX(2%M3M6MXG8D +O/ ))[
MXK'&X*4*\U1@^56[OH=N!KTZE"$J]1*3]%U/I5O$D /RQ2,/7@4R3Q3;0Q/+
M,ABB0;GD=@%4>I)Z"N6UBXFL]'U">!<W$-M+)&N,Y=4)48[\@<5^8GC+PA^T
M=\:O#>K>)/%JZO;>'M/M9;^2'4I/L-N(XU9B$M_ERVW.,KDCO7/A<(L2VY34
M4N_GV.O&5HX5)1IN3?;R[GZ>^&?C]\/O&7C*?PIHGBBRU/7X('N9;6U)D"(C
M*K$R*"@(9E&W=GGI7=6^&.0<C%?DW_P39_Y+YJ?_ &+]S_Z.@K].--U":QY1
MLKGE&Z4\=A8X2K[*+OHC+ SEC*'M=G=Z'9T54L-2COTRORN/O(>HJW7FF[3B
M[,9+&LT;(XRK#!KT+X5Z^][I<NDW#9NM/PJL?XXC]T_AT_*N JQH.J'P_P"*
M-/O]VV&1OLT_.!L8XR?H<&O1P&(^KUTWL]&<F*H_6*,H==UZ_P#!/<****^]
M/B0HHHH *@FMXKA=LB!A^M3TUNM;4WK8"#3;A[*Z%G(Q:-QF)CU'M4NL-8QJ
M!-")9F^ZJ#YC5+4I!"UM+W23/^-.L5,VZ[DYEE.?H.P%:\FO,+EUN5(X+U&S
M"&B3LCN&J=;RZB_UUJ6']Z.M"BKN45(]4MY#@OY;>CC%6E8,,J0P]C39(4F&
M'17'^T,U6;2H,YCW0GU1J- +E%4OLMW%_J[K>/21<_K1YE\G6*.3W5L46 NT
M52^V7*];)OP84?:KI_N6FWW=J+ /U)@ME)ZL-H_&FZ23]DV-PT;%2/2JP::.
MZ2:]A:2)#D",\ ^N.]6)I4AN&O(3YEI-RY4?<;W%'D+R+M%,CGCF7*.K#V-/
MI %1R1>9R.#4E% %1HV7J*;5VN0\<?%#1? J^5<2&\U-Q^ZT^V^:5CVS_='N
M?R-;4Z<ZTN2FKLF4XP7-)V1?\3>(;3PGH=UJM^VRW@7..A=NRCW)KP;PZMU>
MR7VM:@,7^J2F=U/\"_PK^7]*GU2ZUGX@:G%J/B(K!:PG=:Z5$?DC]V]6_P \
M=*TJ^AI45A:;A>\GO_E_F>-5J^VDGT6P5@>.K<W'AJY91EX2LH]1@\G\LUOT
MR:%+B%XI!NC=2K#V-:TY^SFI]C&2YDT>S:#=1^)M':^MR&2XM89DP<X;:#C/
MMR*U[287%NCCJ1S]>]>7_L\^)%LH[_P?>MMO;-S-:LW_ "U@/8?[IY^A]J].
MN[9],G>:-"]JYRZKU0^OTKYO$T_85Y4GMT\UT/9HU55BF6**ABO(9ERDBGVS
M@U+O7KN'YUSG0+7)>//B1H_@2W47;&ZU"4?N+"#F60^_]T>Y_#-9?Q.^*"^$
MXX]+T@)>^(KH?NHOO+ I_P"6C_T'?'I7E6E:&;:YEU"^G;4-7G;?-=S')R>H
M'H*]C"X-2BJM?;HNK_R7](X*^(Y7R4]_R+&MZSXF\?L3JMR=&TINFFV389AZ
M.W?\?R%.TW2;/1X?+M(%A'<@?,WU/>GZAJ5MI5LT]U,L,8[MU/L!W-1Z+X=\
M5^/U$FFVQT72&Z7UTOSR#U1?\_6O8N^3I""^2_X+^]GFZREWE_7W!J6LV6D1
M[[NY2'T4G+'Z#K46ECQ'XN('A_0I6MR<?;K[]U"/?GK^&?I7I7A7X*Z5X=D6
MYEC34=0SDW5\/-8'U53\H_G[UW0TO< )9Y' X"@[0/PKSZF.HT]*4>9]WM]W
M^;^1VPPDY?&[>G^9Y+IWP.-V5E\6>(9+KN;&Q/EQCIP3U/X ?6O1?#GA_1?#
M,/DZ#HZ0DC!DCC^9O]YSR:UFT>V*X"$'U!YJ6TO)=-F2"=_,MW.$D/53Z&O+
MKXRM6C:4M.VR^Y';"A3IZQ6I#<:>(;<W5W-Y$[/N&P9/3@"JD=O?W'/FNB'H
M7.#^0J_*?MVJ2LW,=N=J+[]S5JN.+=M3=7ZF6NBE^9IV8^W_ ->K$>DVT>/D
MWG_:.:N44[L8R.%(_N(J_04^BBD(**** "BBB@ K%A_T?5MO0;R/S%;58NK
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MASM_M2#!_P#'Z_-+_AD3XM#KX%NQ_P!M8/\ XNF?\,E?%=?^9(NQ_P!M(?\
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MO[;_ (KAT^XMKO1-'GU:;FTN84EC@B4??\R,R,SGE<8=>I].:/\ PVA\1/\
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MP\;K(AZ,A!'YBG4 20SRVS[X9'B?^\C$']*ZC1_B-J6GLJ76+^'OOX<?1O\
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M$O'_ /V ;[_T0]?+S26*:7\WZGUU-N6#3?\ +^A\"_\ !-PX^/6J?]B_<_\
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MY,APZ?0TYPIXB*A66VSZK_->14)RI2YH_<?0_P#9=MM"F$<=^]<K\0/$VC^
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MKRQ+/>VJ2N%$<1"Y(Z9)_.HP\,1.NJ496>^PYN"AS-'<_ O]JR;XZ1>+H8M
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MBO(Q6,Q,)J+ARQ;MWO\ UZ'13I4VKWNS]O?#FN1Z]!V2X0[9(_ZCVKX,U?\
MX*O/I>K7ME_PKE)/LT\D._\ M0C=M8C/^K]J^K=)U231]2CNH_X3AE_O+W%=
M(GP:^&]\HN?^$!\*R^=^\\QM$M26SSDGR^366.PTZ4DZ;LF52FI+WCX?N/\
M@K-]JMY(9/ALA212I_XFAZ$?]<Z]/_9<_P""BTWQB^*'A7X=2>"UT\ZAYT7]
MH_;S(4$<,DH^38,\)CKWKI/VQHOAO\#/@3KFKVW@3PG#KE^/[,TO&B6N[SY
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MA,*P_%T+:A!INE1_ZS4+V* 9Z8W9.?:MWT%0>$[(^(?BC!_%;:+;F9O3S7X
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MXB:*D:NMOJ5L2UM.W3GJC>QP/IBO#+&P^)OPZ:2PT^VU.&%F+;;:#[1$3ZC
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MXY#'[CTIE%=9X9<!W $=*6HK=OE(]*EJ "LW6TW1Q-T^8C\Q6E5+5UW61/\
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MHS2T4 5FA0'[M12+CZ5;D'>H)%K-G/)%&5:I3+6E(M4YEK"2.2:,F=.M<?\
M$#P[#XH\+7^ES8'VA,1M_<D'*M^! KN)TZU@ZHOF7$,7;.37-*)YM:FIIQDM
M&?/?A6_FNM-:UNQLU"Q<VURC=0RG&?QQ6M5WXN>'G\,ZY%XNLXBUG-B#5(T'
M3LLO]#^'K5))$GC22-@\;C<K+T(/>N1GQS@Z4G2ENOQ71_UU&L*;4G7ZTQA4
MD-"4A 8$$9%+14B/,/&GP_DM9)+[2XS) QW/;J,LGNOJ/Y5P=?1=<]KG@;2]
M<9I&B-M<G_EM#P3]1T-!Y=;!\SYJ9XQ17:7_ ,*]2@8FUGAND_VCL;_"LF3P
M+KL773W;_=96_D:#SY4*D=XLP::W6M^/P+KLO33I!_O,J_S-:5G\+=5N&!N)
M(+5>^6WG\A3$J-26T6<A6WX=\(WWB.53$ABM<_-<./E'T]37?Z/\-=+T]EDN
M2U_*.?WG"?\ ?(_K761QK&JHBA%48"J, 4CNI8)WO4*.AZ%:Z!8K;6J8'5W;
M[SGU-:(I56EVY/M5H]B,5%617O[Z/2[&>[F.(X4+GW]JZWX,>'9=.\,G4[M?
M^)AJ[_:Y<]0I^XOY<_C7"V^EGQ[XOM]#3+:78D7&HNO0X^[%GU)_KZ5[[;0A
M% 4  #  [5I%'HX"E[2HZKV6B]>O^7WEFW2M.S3]XM588^E:MG#M^8]ZZXH^
MIIQ+D*U<C6H(EJW&*Z(H[X(EC%9^D_N[YE]F'ZUIJ*S+7]WJV/5V'Z9KHCU.
MR"-JBBBF:",NY2#51E*L0:N4UXQ(.:8'SO\ M!?M&:I\-_$EIX4\+Z7;7^NS
M6HO)KF^8^1;QEB%^4$%B<'N,9'6O/M!_;%\::',O_"5>%+'5;'=^\N-%=HY4
M7V1B<X^HS7??M/? /6O&E]8^,O"*K<^(-/MS;7&GR-M^V6X)8*N>-X)/&><^
MH%?+7_"56]G>26.K0W&A:E$=LMIJ$;1,I'!ZCUKZ;!T,+7HI-7EU[G?2A3G'
M;4^U_"/[2GPW\96R26OBFSLIF'S6NI-]FE3U!#<?B"14_BC]I[X8^#K:4W'B
MNSOIXA_QZZ:3<2N?0!>/Q) ]Z^([NQT'55\RXCL9]W.\E<G\1S6>-2\-:+(D
M=E#!-=,V(X;*+S92WH,=ZK^RJ5[\SL/ZO&^YT_B#Q9>_$_XB:YXVOK-M/6^"
M6]E:28WQ6Z#"[O<XY^II:U--^%'Q;U_3AJ6G^ Y(K,C>D=]<QPSRK[(S @_4
M<]LUSFCZLNK6\A,,EM<PR-#/;2C#Q2 X*D5ZM*5.W)3:T.B+C:T>A?HHHK<L
M*\X^)GA\QS+JL*?(^$GQV;LWX]*]'J.X@CNH9(94$D4@VLK="#0!X!2YKI/%
MG@V?P_,TT*M-8,?E<<E/9O\ &N:J0"BBB@ I:2B@ KJ/ ?AMM9U-;B5/]#MR
M&;/1V[+_ %-5_#/@Z[\12"0YM[('YIF'7V4=S7K6GZ?;Z59QVMM&(X4' ]?<
M^II@6:***8!114-[>1Z?9S7,QVQ1(78_2@#O/V8=!E\2?'Z?4XHUEA\.Z:QW
M,3A9I?E&/?:S<>E?:GDWTGWITB'^P,UX1^Q+X3_LGX6W?B*XYU'Q%>M<R^JQ
MIE8U_5F_X'7T+7Q>/J^TQ$O+0\NM+FFS,GTF21<_:&D;TDZ&M+1;B%E:$0K;
MSI]Y0.OOFEJCJ#&UDANEX93M;W!KS9+F5C!JZ'0'[=>S73<A6V1^P%7*J:6N
MVQB]3DG\ZMT_( HHHH **** "BBB@ HHHH *Q=4.S4%/J%/ZUM5C:W\L\;?[
M/]:J.XT;-%(OW1]*6I$%%%% !13'E5/<TS[2/[M $U%,297XZ&GT %%%% "-
M]T_2L;0?^/B;_=_K6RWW3]*QM!_X^)O]W^M4MF,VJ***D0444C,%&2<4 +14
M)N!V&:5;A3U&* ):1J4'/(YI&Z4"EL0/5>0=:M/5=Q6J.&:,;6.(5_WZKVR_
MZ*GOS5G6N%C'N?Y4R-,6L0_V:Z(['FU8Z'C_ ,2K0Z7X_P!*U  "+4+9K21O
M]M#N7Z<$?D:@KL?BQX?DUSPC<&V7=>V3+>6^!SN3D@?49KA-+U"/5-/M[N(Y
M25 WT/<?G7TF'G[2BGVT_K^NA\3BJ?LZ\ET>O^?]>9:HHHK<Y@J&\M4O;2:W
MD^Y*A0_B,5-10!X5>6DEC=S6THQ)$Q1OPJ&O1?B!X8:[7^T[5"TJ#$R+U91_
M%^'\J\ZKV:<U4C<\"K3=.5F%%%%:&(D9VDK^5(6W?=''K37.&X],5(!M&*8#
M=I_O&D9688R#3Z* &;ROWA7I_P .=)^QZ6]Y(,271&T'L@Z?GU_*N6\(>%9-
M=NEFF4I8QG+,?XS_ '1_6O5EC15"JH55&  .E<.(J*W(CTL+2=_:,=6=Y(U/
MQIX=L3S''*U[-W^5!D9'H3Q5_P L=N*3X<V+ZEK&LZ\QS;AA86S'NJ\N1^./
MUKS9RY(2EY?GH>K"/M*D8=W^6IZ[:XD56'(/-:,*UBVLUQ;HH:'* <&M&WU*
M,X#*R_K7S4C[.C$UHEJT@JE;W4,F,2+GWXJ_'\V*Y9'JTT3)VJ5>E1K3I95A
MC+N<**R9Z--&3J[>;>)&.P _$FMA5VJ .@&*R?)<S6UU(-HFEX![ =*UZ&;!
M1114B"HI(=W(ZU+10!3967J,4*I;H,U<HIW BBAV\GDU+112 **** ,75OWE
MZ%'4*H_,UM=.*Q9L2ZQM_P"FB_H*VJI]!A1114B*LPQ(:95B:/<,CJ*KU0!1
M113 =&,R+4>O>(--\+:/=:KJ][#IVG6J;YKF=MJH/ZGT Y-1ZIJ]AX9T>\U?
M5;J.QT^TB,T]Q,<+&@ZDU\-_&#XP:C\6]<$\JSVWA^WE"Z9I(4EG8G"RR(,[
MI6[+_#D <Y-<.)Q$:"[M['T&4915S6K9:06[_1>9TGQ@_:0UCX@?:-/T66;P
MYX5'#R;O+N[Q?5VS^Z0_W0=Q[D=*R/A5^S[XD^)$-O<V\2^&_#1Z:A=1'?,O
M_3"'C<#_ 'VP/3=7KGP1_9CCL1:^(O'-JEQJ8(EM-%9@\-K_ '6F'227OCE5
M]R,U]'5PT\+.N_:8A_(^CQ>>8?+8/!Y1%*V\M[OR[^KT[*QY!\/?@)X-\%ZL
MDD>FC5M0C+8OM5Q/)GU4$;4_X"HKU_)/6L6R7&JD^K/6U7L*$::M!61\+7Q%
M;$S]I6DY/S=PILG,;?2G44SF*5%/EC\MO;M3*L HHH4%C@=: )[;^(U-38UV
M*!3J@ J"^7S+.8?[-3TC+N5E]1B@9FZ&_P LRYSR&_,5IUC:*VVX9?5/Y&MF
MF]P"BBBD(ADM^Z_E47E/_=-6Z*=P*RV[-UX%6%4(N!2T4@"BBB@ JMJ,?F6<
MH[@9'X59IDS!89">FTY_*@90T63=%(GHV1^-:59-O$]A!;7>"89%VR>W/!K5
M5UD4,I#*>A%-@+1144ES%%]^15_&D(EHJDVK0#[FZ3_=6J\FN$'"0\_[1IV8
MS5HK'6[U"Y_U<>T?[N/U-/\ [/O)O];<;1Z YIV TGF2/[[JOU-02:I;1_\
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MV749(J2L.SM&DN9O(E:-4X#=<U>_T^'O'./R-.P%UN14+"J_]IM'_K[>2/W
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MI4JKL\^"V7SB,YP9#ECSZFNJJ#4-0MM*L;B]O;B.TL[>,RS3S,%2- ,EB3T
MK656I/1R;^8^:3T;)^3[FO@/XY7.A77[1.MS>%IX[BVEM5.K-;D&'[8,@[2.
M-W S[[N^:Z'XN_M,:[\6)[S1/!<\N@^$ 6AGU7&VYOAT(3NB$>G)!Y(Z5YMI
M.DVVBV:VUK'L0<ECRS'U)[FOHLOP<Z+]K/2_3_,[J-)Q]YERBBBO=.L****
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M!$CZ?=VZ%OMD8C R6D7&*IQNLDN]DFU J>.-J5.DK:Q(I?(@C RO]YJOJH4
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M JM<+B3/K5FFR1B1<=^U BI12LI4X(Q250!3X5W2#VYIBJ6. ,U:BC\M?>D
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MZ+3+Y_)LY2>XQ^=3JM4=5S(\%N.KMD_Y_.HZG=3B6=,A\FS3U;YC^-6J0 *
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M'7K3#"A[4^B@!JQJO08IU%% !1110 C-M4D] ,U3T=<6*G^\Q-6+IMMM*?\
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MLB  #81@?2J.@@?9Y#WW?TJ^5/WC:RW+D-C! /EC!/JW)J?IP.!110 4444
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M@KP]I(TRP\*Z1#98P8VLT<MD8.68$DGU)J[X!OCJ/@S1YB &^SK&P'8K\O\
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M H:RH:U4?Q%P%J['&(HU0=%&*SWF-YJ,46QE6)BQW=\=ZTJ8PHHHI""BBB@
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M'Y<U4=QHT;:TCM%81C&XY/.:FID+>9$C>J@T^I$<;X^^$?A;XE0_\3K35:Z
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M&;5%%%2(*KS1[3N'2K%% %-6P:F6G-"K>WTIR1A>,YKGJ4_M(8U5+&I@,#%
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MUJ55L])^VV+R.3%-(YD1NZ^E(TUW9_+<6SOC_EI$,@T<R;L@NBW15!M65?\
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MF3-M3W/%/J&YZ+2$044458!2HVU@:2B@"[12)]Q?I2U !6.O^B:T1T63^O\
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MG&/0=S6S#&(84C'10!5+1K>U6,S0R>?(WWI&Z_3':M"E&5VT<M5[(****T,
MHHHH **** "BBB@#&U"0ZA?&V!Q!%@OC^(^E6$18U"J JCH!52RYNKXGKYQ%
M7*4][';#2(4445F6%%%% #'C1E.44_45F:3:PW%O(9(U<A\#/TK6J*WM4M59
M4S@G/-.^@R!M)MFZ*R_[K&@::8_]7<SQ_1ZN447 JB.^BYCO6;VD7(JM#&\E
MT44BSNVYV]8Y/IZ5IU5U*+?;,Z\21_.K>F*0@9K^#_66GF#^]$<_I4;:M'&V
MV6.2)O1EJS<:N\D,$5MS<2H&9NR"H8M-B7YI<SR'JS\T1N_B0*_45-4MI/\
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M,(#2K#,AW(S$#!K.M]24MY<Y$<HXSGY3^-.CTJ!>9 9G/5G)HDTBVD'";/\
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MO@+PZ=%\,VH;'VJX'VB=O5VY_08'X5W5*GLX7ZFLGRHVHXUC1410B*,*JC
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M_">O_L2ZM=R?LI_#=<L[?8),R,"['_2)>I->W[)[CF6*XF']TG8M>1?L*_\
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M_O2<FK-;:&A1^SWEQ_K9Q$O]V,<_G4D.FP0G.S>W]Y^35JBBX!1112$%%%%
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M\G.1&[9(H74T74UJ*I1ZI'NVRJT#^CCBKBL& (.1ZB@8M%%% @HHHH ****
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M*^&?^&,_'/\ T-NF_P#?ZY_^)H_X8S\=?]#=IO\ W^N?_B:K^RL+_P!!*_\
M 7_F1_:5;_GP_O\ ^ ?<W]J1=HYC_P  I&U:)?\ EG+G_<KX;_X8U\=?]#?I
MW_?^Y_\ B:3_ (8S\='KXNTT_P#;:Y_^)H_LK"_]!*_\!?\ F+^TJW_/A_?_
M , ^Z%N+JXP(+*0YZ-(-HI1#_9LJW%V3<73<1Q1CA:^&/^&-O'G_ $.&G_\
M?^Y_^)I/^&-/'6<_\)?IV?\ KO<__$U+RG#/_F*7_@+_ ,Q?VE7_ .?#^_\
MX!]PWEO<ZDV\V,<1_O$G=^.*A70[D_>EP/0 FOB3_AC7QW_T-^G?]_[G_P")
MH_X8U\=_]#?IW_?^Y_\ B:I97AEHL2O_  %_YC_M*O\ \^']_P#P#[?7P\/X
MW<_1<5.FBP+UB9O]XFOAG_AC7QW_ -#?IW_?^Y_^)H_X8U\=_P#0WZ=_W_N?
M_B:/[+PW_04O_ 7_ )A_:=?_ )\/[_\ @'W;'8QQ_=@5?^ U-Y;?W3^5?!G_
M  QKX[_Z&_3O^_\ <_\ Q-'_  QKX[_Z&_3O^_\ <_\ Q-+^RL+_ -!2_P#
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M^ *?_'*B;]N?X<M_RRUT#_KQ3_XY6G_PS5\,O^A1M?\ O_-_\71_PS5\,O\
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M:OAE_P!"C:_]_P";_P"+H]EE7\L_O0>VS#^:/W,R?^&XOAQ_SQUW_P  4_\
MCE'_  W%\./^>.N_^ *?_'*UO^&:OAE_T*-K_P!_YO\ XNC_ (9J^&7_ $*-
MK_W_ )O_ (NCV>5_RS^]#]OC^\?N9D_\-Q?#C_GCKO\ X I_\<H_X;B^''_/
M'7?_  !3_P".5K?\,U?#+_H4;7_O_-_\71_PS5\,O^A1M?\ O_-_\71[/*_Y
M9_>@]OC^\?N907]NKX;!0/)U[_P!3_XY2_\ #=7PU_YXZ]_X I_\<J]_PS5\
M,O\ H4;7_O\ S?\ Q='_  S5\,O^A1M?^_\ -_\ %T>RRK^6?WH7MLP_FC]S
M*/\ PW5\-?\ GCKW_@"G_P <J/3_ -LCX>Z_XDL+6#^UX'NIXH4DN+-5168A
M06(<D#)'.*TO^&:OAE_T*-K_ -_YO_BZ^9/CUX*T3P'\<O#FFZ!I\>F6+1V4
MYAC9F!<SL"V6)/11^5=.'P>6XF3ITU).SW:,JF,QU!*4W%J_8_10]:***^+/
MJ@JFZ[6(JY3)(Q(/0TP*M%*T;+U%)5 %6+==JY]:9'"6Y;@58J6 4444@*.L
M'_0PO]YP*=I(Q8H>Y)/ZU#KC?N8@/[V?R%6M/7;8PC_9S5=!]"Q1114B*UQ_
MK/PJ.I[A>C?A4%4 4444P%7[P^M7*J1+ND'YU;J6 5!=6,5W@R+DCH0<5/12
M YV\M5BNO)B+'H/F]3VK<M/,%N@E 5P,8%95E_I6IF3MDO\ T%;=7+L,5/O+
M]:_*_P#8Y_Y2->*/^OC7O_0VK]4$^\OUK\K_ -CG_E(UXH_Z^->_]#:H,I]#
M]3Z*BDG"\#DU%Y[^M,T+5%5UN#W&:G5@PR*0"T444 %(RAE((R#VI:* *"Q?
M99FM0<6UT"H']UNU/L;@*HMY?DGC^4JW?WHU'K; ?>\Y<4W491K$I6WA3:IQ
M]H;K^%'4.I>HK-CT^ZA7Y+LY]".*1KZYLVQ<Q!T_OI3MV&:=%06]Y#=#]V^3
M_=/!J>D(*@N&Z+4]59O]8:: 91115 %.C;:P--HH NU1DNAINI&;L\)X]2.E
M71T%9&K#SKZWCZG&#^)J4KZ,992Q:] FO':1VYVYP%]J=_8]K_<8?\"-7:*+
M@9S:)#_"SJ?P-1-HKC.V1&_WDK6HHNP,4Z7<1_=1?JCD']:3R[V/H)Q]&#5M
MT4^8#%%U?QGHY_WDJ1=6N5^_;9^@(K6HS1?R S/[<1?O0NM.CU1[IMEO;L[G
M^\P K0*ANH!^HJO-IUO-R8PC?WDX-&@ N@RR1-+)*!>$AE(^ZN.U1R7EQ:+_
M *3:L,=73[M36=Y-8W$=O._FPR'"2-U!]#44C'5[IW<G[+&VU$[,?4UFN:]G
ML2KWU&+K$++D)(3[+2_VO#_=E_[XJZJA  HVCT%+5Z%&5-K8#)Y:G&?FW#M4
MG]N0?W7_ $I^I6[S26Y1,A7Y_2KNU?[H_*GH!G?V[%_SS<_E7YH_\%:KU;WQ
MU\/&52NW2KH<_P#785^GWE)_<7\J_,G_ (*Z*%\>?#K  _XE-UT_Z[+2T,ZG
MPGZ ?##6X5^&OA!2C\:-9#M_SP2NJ&L6Y[2?]\UB_"Y1_P *Q\'\#_D"V7;_
M *8)73[1Z4:%K8IC5K?OO3W9:L-=PJF\RKM]<U(RAA@@$>XK-FM(;&ZCN/*5
MX,X=&&0/<4:#)[:X22[^VOE+6%2JLP^\3Z55FC>ZF,MG ULK?Q%\ _A5RX8:
MAJ3+UM[< *O8L>]6J2[B\S.6VU#HURJ_K3O[/G?_ %EY(?\ =XJ_13N,HKH\
M'5R\A_VFJ9=/MU4@1*/?&:L4478$5K;+:0B-"2,YR>M2T44A!1110!6U"'SK
M5\?>7YE/H15;19?,28'KNW?G6D1G@]*Q])'DWT\7MC\C5=!FQ1114B*;G<Q/
MO24LB[7(I*H HHHI@.A.)%JW56%=T@_.K52P"BJ<VI1HVR(&>7^ZE,^R7%YS
M<R>6G_/*/^IHL,=<:I'&2D0,TGHO05!9W$+70DU#<"/N*4^05H0P1VZ[8T"#
MVI[HLBE7 93V-&FP#]:N0NENT; ^9A RGUJ*&(01)&HP%&*RKZ-[.-H%),$A
MW(/[K#M6I!*)H4<=&&:F,>5$I61)1113&%%%% !15>2<GA>!46X^M.P%VBJJ
MRLO?/UJQ'()!QUH =115>\DGCC7R$#L3@Y[4@(=8CW6F_NC _P!*=I,F^S4=
MU)6JTEI?7$;>9,H4CE:30Y#^]0]\-_2KZ#-:BBBH$0W/1:^&?^"L'_)'?!W_
M &'&_P#1#5]T7"[DSZ5\+_\ !6#_ )([X._[#C?^B&I]")_"SVO]AO\ Y-+^
M&O\ V#Y/_2B6O=*\+_8;_P"32_AK_P!@^3_THEKW2F5'9!5N/[B_2J@&2!5Q
M1M4"DQBT444@,74_W>HJW^Z?UK:K&UI?](C;_9_K6PO*@^U4]D,6BBBI$4V7
M:Q%)5B:+?R.M5R".#Q5 %%%/CC,GL/6F!);KU-34BJ%  Z4M0 53U8_Z!)^'
M\Q5RJ6K_ /'D1ZL/YTUN,;HW_'F3ZN:OU2T<8L5_WC_.KM#W *KW'WA]*L5'
M,FY>.HH$5J***H HHJ2%-S9["D!9HHHJ0"L6X_TC5@O4;U'Y5M5BZ;^^U)I.
MOWFS^E4AFU1114B"HI)MO ZT^1MJ$U4IH!6D9NI-*LC+T)IM%,"Q%-NX/!J6
MJ57%;<H-)@+1112 *_+#P7(8O^"JFO,.O]O:F/SM9*_4^ORS\"P_:/\ @JUK
M,?\ >\0:EG_P&DIHSENC]/=*LQ#"LK#,C#C/8>E7Z  HP.!10:C9(DF7:ZAQ
MZ$52;37@8M:RF,_W&Y4U?HHN!GKJ3V[!;J(QG^^O(-78YDF7<C!A[4YE$BE6
M 9?0U0DTORVWVLAA?^[G@T: :%%9R:E);L$NXRA_OJ.#5^.19E#(P9?446 =
M1112$1SMM7'<U6J:Y^\M0U2 ****8 "5.1UJXK;E!]:IU:A_U:U+ H0Z;')J
M,L&XQ%E\R-UZ@]Q]*+B[GTV413-'<?[IPWXBB^NFL]021?O^40OU/%6;.S6W
M3+#=*W+.>3FC6]V'4A75E89\B4?A3AJ\'\0D3_>6KM& >HS1H,JKJEJW_+8?
MB"*E6[@?[LJ'_@5*UO$WWHT/U45&VG6S]85_#BC0"=6#="#]#2U2;1[?^'>G
M^ZU)_9KK_J[N9?8G-&@%ZBJ/V:]7[MTK?[RT>7J _P"6T1_X#18"]4%JOG:V
M#U$,?/U-0%M0C_@BD^AQ4V@SQJ\L<A9;R1MS!QC/TJ9:19,MBU?:2D\AGBD-
MM-W<=#]:QGU.:WD*;H[G'\48-:&I2M?7AM%8K#& 92.Y]*DCA2%0J*% ]*4+
MI:A';4S/[:D[VQ_,_P"%+_;F/O0$?C6K2;1Z"M+KL49?]OI_SQ/_ 'T*4:\G
M>%OS%:>U?[H_*D\M/[B_E1IV S?[>C_YY/\ F*/[?B_YY-^8K2\M/[B_E2[5
M_NC\J-.P&'!J"QWTLPC;;(/NCK5W^VHL9,<@_"G26S_VI'*%_=[<$_G5W ]*
M'8"E'?37N5M+=G;NS' %:FGV8TVU;S'!<G?(YZ9K,N+=K5OM5K\DB\LHZ,/I
M3[^[&J&U@C.(Y%\V3Z>E9R3DTEL1*[T)9=:DN=R6MMYR="\G"G\*SYM/GN#E
MHK>$_P"P#6HJA%"J, < "EIQ2CL4DEL9"Z"W\4P_X"*E70X1]Z1V_(5I45?,
MQE-=(M5_@+?[Q-,DTM/M,,D:JJ+]Y<=:OT4KL  "\ 8HHHI""D(# @C(/44M
M% &/8#R]4:,DXCW!1Z5L5CM^XUP>CG^8K8JI#"H+ANB_C4]5KC_6?A20B.BB
MBJ *56VL#244 7:*1?NCZ4M0 456N-0BMSMSYDG9$Y-0^3=7O^M;[/%_<7[Q
MIV&/N=0"-Y4(\V<\!1T'UIEOI**=\Y\V0\G/2K5O:QVJ[8UQZGN:EHOV 0 *
M  ,#TI:**0@HHHH **** "LK6H?FCD'?Y#_,5JU7U"'SK211U R/PIK<8ZSF
M\^UC?N1S]:FK,T6;<LD?H=P_&M.AZ, ILC;4)IU1S_ZLTA%:BBBK *_,R;_E
M+:O_ &&5_P#36*_3.OS,F_Y2VK_V&5_]-8I$2Z'Z?1MNC!IU1P?ZL5)4EA6/
MKB_O(F_V2*V*S=<7]S$V,X;'YBJCN,T(VWQHWJ :=5?3VWV4)_V:L5(@JI(N
MV0BK=,EC\P>],"K12LI7@C%)5 %36Z_,34:1F0\=/6K2J%7 I,!:***D""^_
MX\YO]P_RJ[I?_(-MO^N8JE??\><W^X?Y5=TO_D&VW_7,5I'8QJ[(M4444SE"
MBBB@ HHHH **** ,2Q_U][_UW:K=<AK7B.>QU"XTS38Q+J<\K-EONQ+_ 'C5
M,>#5O?WFJWUS?SGD_O"JCZ"G*.NIZ=.G>*;=CNZ*X3_A ].7[DEU'Z;9CQ2_
M\(3 OW-0U!/]V?\ ^M4\J[FGLX]SN]I]*88U[K7#CPC(N-FM:DOUF)IW_".Z
MG'_JO$5ZO^\,_P!:.7S%[-=SMU4+T&*6N)%CXEM^8M>67VGA!IXU#Q;;=4T^
M\'XJ?Z4N5A[-]&=G7Q1^V[_R5WPC_P!@^/\ ]*7KZG'B[7+?_CX\/,_O;S!O
MTKY&_; UEM:^*?A65K.:R9+&-#'-U/\ I#G(]N:[\#%JLOF?!<;0E')Y-_S1
M_,^P'^\WUKS+]IO_ )-S^)O_ &+M[_Z):O37^\WUKS+]IO\ Y-S^)O\ V+M[
M_P"B6KDZ'3'XD?EG_P $F_\ D[!/^P#??R2O0/\ @LE_R4_X=?\ 8$F_]*&K
MS_\ X)-_\G8)_P!@&^_DE>@?\%DO^2H?#K_L"3?^E#5G]D]1_P"\+T/N/]AC
M_DT7X7_]@K_VJ]>Z5X7^PQ_R:+\+_P#L%?\ M5Z]TK1;'FU/C9S^N?$3PGX7
MOOL6L^*=#T>]V"3[-J&I0P2[3T;:[ X.#SCM4&F_%3P3K-]!8Z?XR\.W][.V
MR*VM=6MY99&]%57))]@*^0_VQ/\ @GCX@_:<^,)\9Z;XQTG0[;^SH++[+>6T
MLDFZ/=ELKQ@[JXWX!_\ !+7Q/\'?C+X0\:W?CS1=2MM#OX[R2T@M)EDE5<_*
MI/ //>E=]C50I\MW+4^L?BW^Q_\ "7XZ>*AXC\;^%FUK6!;I:BX_M*[@ C7.
MU0L4JJ.IYQGFNYU+4O"OP-^&;75W+%H/A#PU8*HW,2L$$:A509)+' "@<DDC
MN:W=>U[3?"VB7VL:Q?0:9I5C"UQ=7ETX2.&-1DLQ/05^/?[4G[3?C#]NOXJ:
M=\.OAU8W;^$Q=B/3=-0%9-0E&0;JX[*H&2 >$7D\]!Z"IPE5T;T1QWPITC4_
MVQOVY%UBQLI+.TU+7FUV\* ?Z'9QR!R6/(W;55?=F [U]Y?\%;&\S]F*V;IN
M\06Q_P#'):]9_9"_91T/]E?X??V= T>H^*=1"R:QJX7_ %KCI%'GD1)S@=SD
MGKQY+_P5H_Y-?M/^P_;?^@2U-K(V=13JQ4=D>'?\$M_C_P##GX/_  W\<6'C
M;QCIOAJ\O-6@GMX;YF#2H(2I884\9XKIO^"CO[8GPO\ B!\"V\#>#=?M?%NK
M:I>V\[S62,8;.*)]Y8NP'SD@* ,\,V<<9^=OV*?V%=/_ &LO"/B36KWQC=>&
MFTB_CLQ#;Z>MR)0T9?<29$QCIBO(_B9\+#^R_P#M&2>&?%VFKXDTK1=1AG>"
M0-$FIV)8.I&&R-Z<<'@Y&>*5W8Z.2G*JW?5'WQ_P1Y^'NK:'\/\ QWXNO86@
MTW7+NUM;'>I!E%N)?,<>J[I@N?56K]"JY_X>ZAX=U?P+X?OO"4=K%X8N;&*;
M38[*,1PK R@H%4  8!QCL<UT%:+1'G5)<\W)GQ[\8/\ D[;1O^OK3OY+7W<W
MWC]:^$/C"=O[6FCGTN=._DM?<LDS,[<XY[5UXKX*7H>-PG_'Q_\ U\_S+-%4
M_,8?Q&IHY\\-^=>=8_1":BBBD 4444 4[JQ+-YT!\N<>G1O8U':ZLDB@3CRF
MZ;OX36A5.QFMX8;\W(5H?-X4C.3[4[Z 6U8.,J0P]0<TM8SVKW#;[6V:V4]"
M9.OX4C2ZA9<OET]_F%.PS8D02+@U59"AP14=OK$<F!*/*/KU6K_#+D884M@*
M= !;@#-6O)3TIRJ%Z#%%Q#(8MG)ZU(3M!)Z455U*;R;.0]R-H_&C<9%I7[WS
MYS_RT?CZ5?JO80^39Q+WQD_C5BA[@%%%'3K2$%%0M<#^$9IOVAO04P+%%1I,
M&X/!J2D 4444 %8VK?-?(G^R!^9K9K%N_P!YJZCT91_6JCN-&VO45^4/P4_Y
M2B7O_8RZS_Z+N*_5Y?O"ORA^"G_*42]_[&76?_1=Q4F4]T?J[1110:'P]^W%
M_P EL\'?]@Z#_P!*I*^M7^\WUKY*_;B_Y+9X._[!T'_I5)7UJ_WF^M?75_\
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MB!H5RVW[;Y+>DR%?UQBIY7V'R2WL="1N&#TJO)"5Z<BDM=4LKT9@NX)A_L2
MU:H)*5.6-GZ"K6!Z4M%Q#(XQ&/4T^BBD 5!?2^3:2MWQ@?C4]9VM2[88T_O-
MD_A36XQFAQ8223WVC\*U*K:='Y-G&.Y&X_C5FA[@*GWE^M?E9^Q^Q7_@HQXI
MQ_S\:]_Z&U?JFGWE^M?E7^R!_P I%_%/_7QKW_H;4C*6Z/U&HHHJS0*?"^UO
M8TRBD!=HH%%2 445!>7'V6W=_P"+HOUH S+^1KN^$2'A3L'U[FM>&)88U11A
M5&*S-&M]S-,W./E7Z]S6M5/L,*" PP1D445(C.N='20[X3Y3^G;_ .M42:A<
M6+".Z0LO9N__ ->M:FR1K(I5U#*>QJK]QC8+B.X7=&P8?J*9<+R&_"J-QI#1
MMYEJY4_W<_R-,AU:2)C'=(3ZG&#1;L!;HI5VS+OB;>OMU%)@^E,04Z-=[@=J
M%B9NV/K5F.,1K@4@'5C6[?:M99^H4DC\.!6K<2>3;R/_ '5)K-T.//FRG_='
M\S0MFQFM1114B"BBHWF"\#DT 2457^T-Z"G+<?WABF!-10#GD44@"BBB@"AK
M#;;>,]]XYJ72UVV,7N,_K5?7C_H\8_V_Z5<LUVVD(]%%5T&34445(@HHHH *
M_,C_ (*[?\CY\.O^P3=?^CEK]-Z_,C_@KM_R/GPZ_P"P3=?^CEH,ZGPGZ(?"
M[_DF/@__ + ME_Z(2NGKF/A=_P DQ\'_ /8%LO\ T0E=/06M@J"^7?9S#_9-
M3TR==T,@_P!D_P J"C/T,_NY<\G(/Z5IUD:"QS*#W"G^=:]5+< HHILD@C7)
MJ1#J3(]:JM(S]33:=@+M%54E9>^1Z595@ZY%(!:*** "LJ1?(UI&[2#^F*U:
MS=94IY$XZHU4AFE12*P90PZ$9I:D1%-'NY'6J]7:8T:OU'-.X%6BII(XXE+N
M^U1W-5%:6^X@!AAZ&0_>/TIC)9+R*S^7F28_P+UIGV>YON9V\F+_ )YIU_&K
M-M9Q6J_(OS=V/)-3TK@1PV\=NNV- H_4U)112$%%%% %;4+?[1:NH'S+\R_4
M54T6XR'B/^\O]:U*PYP=/U$,.%SN'T/452U5AFY10"& (Y!HJ1!45PV% ]:E
MJO<?>'TI@144450!3HVVN#VIM% %VBBBH *Q;3_1M6*= 69?ZBMJL75,P:@D
MH[@-^55'L,VJ* <@$=**D05\+_\ !62/9\'O!Q'3^W&_]$-7W17PW_P5H_Y(
MWX._[#C?^B&H(G\)['^PW_R:7\-?^P?)_P"E$M>Z $\#FO%/V%D5OV1_AGD
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MCWW19%'+(7LY=CIEMS_$:F50HP.!7/6WQ T&Y./MPB;TE1E_IBMBUU:ROO\
MCWO()_\ <D!J7?J0XM;HM4444B2*ZD\NWE?T4UGZ''_K7QZ+5C5WVV3#NQ"T
M:1'MLP<8W$FJZ#Z%VBBBI$17'^K_ !JO5N1=RD54JD 4444P"K,'^K%5E!8X
M'6KBKM4"I8"T444@,J>.[L%:59P\><D-7YD?"]C)_P %6-48\DZ]J9/_ ("R
M5^FNLSEW6!>W)^O85^9GPSC\G_@JWJJ==NO:D/\ R5DJGL1/H?J51114EA11
M10 4444 ->-9%*NH93V-9\FF/"WF6DA0_P!PG@UI44[C,^'5-K^7<IY+^O:K
MZL& (.1ZBF36\=PNV10PJ@UK<:>2UNWFQ]3&W6GHP+\Z[ESZ56J2SOX[L8'R
MR#JAITD!ZK^5 B&B@J1U%.6-FZ"@!JC<P JXHVJ!3(HO+Y/)I[,%4D]!S2 R
M9O\ 2-:5>H3'Z<UKUCZ3F:^FE/H3^9K8IR[#"BBBI$%%,>54Z\FHC<-V % %
MBBH%N/4?E4RL&&0<T +1110 53U*/_1_-7B6([E;O5RJ^H'%E-_NTT,ATN3S
MOM$QZR29J]5#15Q8@^K&K]#W ****0@HHHH **** "BBB@ Z\&L;2/EO&7T4
M@?G6S6+8CR]6?W+"J6S&;5%%%2(**1F"C)Z56>9F]A3 LY'K2U2IRR,O0T6
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MMT$@P:A:W;L<U5P(J_,V1=W_  5N0?\ 4:7_ --=?INMNW<XK\RY%V_\%=%
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MZU];B/\ <\-Z/\SY>'^]5_5?D?DW_P %B/\ DL?@C_L!-_Z/>OJ#P'_P3_\
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M>CZ/XV@\+Z#X;3[)?:Y]JDM)M4G8%E65H07=@A . %Q@MDFOLK_@HC_R9?\
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M7V8?K6U52W&PJK*VYSZ=*M52/4TD(****H J2W;#8[&HZ=#_ *Q:0%NBBBI
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MU_ 8I_7I?RK[@_U)P/\ S_J_^!K_ .1/B7_A4?Q__P"?S4O_  =)_P#%T?\
M"H_C_P#\_FI?^#I/_BZ^U#I^S_52LGL>17,?$SQ[:_"?P%KOBS6C&=.TFU:X
M<;PAD8<)&,_Q,Q51[M5?79?RK[@_U)P'_/\ J_\ @:_^1/E+_A4?Q_\ ^?S4
MO_!TG_Q='_"H_C__ ,_FI?\ @Z3_ .+KT/\ 8A_:;F_: ^'NI#7YHQXKTF\<
M7:*  T$K,\+ #L!F/_MF/7GZ45U;E2#]*/KD_P"5?<*/!.!DKJO5_P# E_\
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M&Z&)4/Y@5XCI/F<D[7/0YU9)H_.7]@K]B3QC#\2%^,OQ:M[FSU-9I+S3]-U
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MJ0"BBJDE\9)/)M4\^;VZ+]30!+=726L>YCD]E'4TVUF32XY)[H_Z3.<B)>6
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M7W8QGU/-?FI-_P I;%_[#*_^FL5+:,:CV]3](Q]I?I$$_P!XTHM;A_O3!?\
M=%7:*.9FMSS;XA:,L>IV]PSR/YD6.O5E.?Y&O0=/9)+.&2, +(BMQ[BN=^(-
MOOTVVGZ>7+M)_P!EA@_TK1\'W'VCP[9D_>13&?\ @)(H;;1I)W@C9HHHJ#(*
M**S+V],C%$.$'!([T M2[)>0QG#.,^@YI$O(9#@.,^_%8U%58OE.@HK(M+QH
M&"L<Q^GI6N#GD=*1+5@HHHI",2^_Y';PY_O2_P#H-=W7"7W_ ".WAS_>E_\
M0:[NJ6YRXC>/H%%%%6<84444 %%%% !1110!Y[X)_P"/&]_Z^Y/YUT5<[X)_
MX\;W_K[D_G714JGQ'K!5'5),1HG]XY/X5>JAJJ\1M]14(:W,ZBBBJ- I58JP
M(X(YI** -Z-MZ*WJ,TZFQ+MB0'J !3J@R$WKNV;AOQG;GG'K7"_$2X+WMK;K
M@E(F;'NQVBMK7O"\M_>?;[*\DMKU0 ,D[3CM[5QLTUW>>)8(M1^:=98XGV#/
M0^U4C:"5[GIEA;BTL;> =(XU7\A4]!HJ3$***IWE]Y)*)R_<^E %ROSF_P""
MI7QT^T7FC_"K2[G]W!LU36=AZN0?(A/T!,A'^TGX?;'Q,^(5A\,_ FN>*]9E
M/V'2K9[AUW8,C ?+&ONS84?6OP[\;^,M2^(7C#6/$NL3>=J>J73W4[9X!8Y"
MCV P![ 4S&L^56/3OV0_C<?@/\;M&UJYD(T&^8:=JT>?E-O(P'F$=_+;:_\
MP$COFOVL6SMKB-)86!C=0RR1-E64C((/<$5_/2<'@]*_7G_@G?\ ';_A;/P3
MBT'4;GSO$7A3;8S;VR\MJ0?L\I[_ '04)]8\]Z+M;&=&7V3Z@CL(8VS@N?\
M:.:+Z$R0Y7[RG<*L44^9WN=5RI#*)D##\:Q?%UB9M-^VPG9>61\Z*0=>.2*W
M)K%68O&QB?VZ5B>*KZ72] O'F3>&3RU9.Y/ XK1--Z&D=U8ZK2;X:IIEK=@8
M\Z-7(]"1S4<^N:=:R>7+?V\<F<;6E&:\_P!'NKKQ+86VF6MRUKI=G&L<TD9P
M\KXR5!]!6[!X/T>"/9]ACD]6DRS'\:GE[D^S2>K.NAN(KF,20R)+&>C1L&'Y
MBGUPTGA,V$IN-%NY--G_ +@.Z-O8BK-GXVN--E6WU^T-J2<+=P@M$WU]*7+V
M)=/^74["BHX+B*ZA66&198F&5=#D&I*@Q"BBB@"*ZN!;0/(>W3ZUF:3;^=,\
MT@W <<]R>M&K3F:X2!.=I_\ 'C6G;0"V@2,?PCGZU6R&2(BQJ%50J^@I:**D
M05&TZKP.33;B3'RC\:@IV F^TG^[4B3*W'0U5HIV NT5%#)N7!ZBI:D HHHH
M :Z+(I5E#*>QK.M=/=KZ>*"<PE0'4=00>QK3K)6\D;4)_L_^LD'EJWH!U-/6
MV@$]Q=76G'%PD;CU1\'\J6'6+>3ABT9_VAQ4D.FPQ\N/.D/5WY)HFTRWF7_5
MA#_>7BGIU&6%99%RI#+[<T>6O]T?E6/)IEQ:,7A<N/\ 9X/Y4^WUB1#MF3?C
MN!AA^%%NP&O144%U%<KF-P?4=Q26MTET'*9PIQS4@34444"&3?ZI_P#=-9F@
M+\DI]P*T;IMMK*?13_*J6AKBV<^K?TJN@S37[PK\H?@I_P I1+W_ +&76?\
MT7<5^KZJ=PX-?E!\%/\ E*->C_J9=9_]%W%293Z'ZNU!-#_$OXBK&T^AI*#0
M^&/VV/\ DM7A#_L'P?\ I5)7UV_WF^M?-W[9WPK\8^+/'7AW7?#>A7>L6T-B
M+=FL8_,>.597<;E'(&&&#TX(KA#XB_:5//\ 9/B+_P %2_\ Q-?<1HQQ>#H*
M-2*<4[W?F?(U*DJ&*JMP;NULC[+HKXT_X2']I7_H$^(O_!4O_P 31_PD/[2O
M_0)\1?\ @J7_ .)K+^S7_P _8?\ @0_KG_3N7W'V717QI_PD/[2O_0)\1?\
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M^!!]<_Z=R^X^RZ*^-/\ A(?VE?\ H$^(O_!4O_Q-'_"0_M*_] GQ%_X*E_\
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M_/V'_@0?7/\ IW+[C[+HKXT_X2']I7_H$^(O_!4O_P 31_PD/[2O_0)\1?\
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MWP]_Z'#2O^_W_P!:O(?^&'="_P"AGU'_ ,!X_P#&C_AAW0O^AGU'_P !X_\
M&B^5_P#/V7W?\ ?L<Q_Y]K[_ /@GKW_"]OA[_P!#AI7_ '^_^M1_PO;X>_\
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MJQ4-G&8[9 >N,U-4&05P/Q(8F^M #]V%B?Q(%=]7 >/6WZ[;Q_\ 3%1^;_\
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MULWREK5\?6L:J1<0HHHIE!6OI\ADMAGJIQ616KIJ[;?/J329,BW1114D&-?
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MAD&IYK>.<8=<^_>JS6TUOS$WFK_=;K5IICN8)\/WFAS-<:#=&')RUG,<Q/\
M3TK5TGQQ;W$PL]2B;2[_ *;)ON-_NM5B.Z5FVM\C_P!UJCU#2[7583%=0K*G
M;/4?0]J;5]RG:7Q'15%=3BV@>0]AQ[FN)ACUGPGS92-JNG+R;68_O$'^R?\
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M[5IU6L;<P0\_>;DU9J3-[A7/Q^.-*<RJTK1O'D .IPV/0^]=!7'^/X[.&SA
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MR@VO'G!*_2K,,R3QAT;<IJ;MJ[$/HHHH **** "OS(_X*[?\CY\.O^P3=?\
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M% !1110 4444 %>?W \[XAH>I6X7I[+7?LRQJ68[549)/85P%NK_ -K6VO2
MK:7-^T:L1VQ@'Z?X&J1I#J>@4445)F%%%% !1110 4444 %%%,FE6"%Y&X5%
M+'\!0!P&O?\ $[\9QVH^9%=(?P'+5Z%]*X#P+"VHZ]=7SC.P,^3_ 'G/^&:[
M^J?8TJ:604445)F8=RQ:XD)_O&HZGO(S'<..Q.14%4:+8****8RSI[%;I1Z@
MBM>LK38RUQN[**U:EF<MPHHHI"/!/VV/A/;?&'X%ZGI"PK)KULXO=';C<+A
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M$7_E6G_PH_M6K_T#O[Q_VK4_Y\,^N8XC&N,'/>G;3Z&OD7_A3OQ._P"AC_\
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M/A+Y9@VL:6O\8_UT0_J/\\5U6CZY9:[;^=93K*/XEZ,OU':J#0S6OW/WT?\
M=/45A:AH=M-<?:[.273-07D21# )]QWJK*6PVE([NL.9CJ5\%4_)T'LO<US\
M/B[4K61+/7+8V]NQVG4HE)1A[CL:ZC0F@NH9+FW=98G;:C*<C:*FW*8RBX[F
MFJB-0JC  P*6BBH("FR_ZMOI3J.O% %*BE92K$&DJP"BBB@">W^Z:FID2[$
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M:-I]#7R =-\8#_F/77_@PEIOV#Q?_P!!VZ_\#Y?\:/[/J=Q_V1#_ )_K[O\
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M^*K3DCW/$69XS?V"^\^I?^%G>#?^ANT'_P &D'_Q='_"SO!O_0W:#_X-(/\
MXNOE;_AW=<_]#I;_ /@ ?_BJ/^'=US_T.EO_ . !_P#BJ.6/<O\ M3&_\^%]
MY]4_\+.\&_\ 0W:#_P"#2#_XNC_A9W@W_H;M!_\ !I!_\77RM_P[NN?^ATM_
M_  __%4J_P#!.VY9L?\ ":V__@ ?_BJ.6/</[4QO_/A?>?8-O\5/!2V\8/C+
MP\#M'_,5M_\ XNI/^%J>"?\ H<O#W_@VM_\ XNOC[_AW3<?]#M;_ /@O/_Q5
M'_#NFX_Z':W_ /!>?_BJ7)'N1_:>-_Y\+[SZYOOC%X&T^W,K^+]#D&<;8=2@
M=OR#UQ/BSXS>"M>MX4AU_3%DB<D.]_  5(Y'W_I7SY_P[IN/^AVM_P#P7G_X
MJC_AW3<?]#M;_P#@O/\ \5348]RXYIC(Z^P7WGU/X0^+G@^;0X4N/%VA12PY
MC(DU2!20.AY?T_E6U_PM3P3_ -#EX>_\&UO_ /%U\:1_\$];A[@Q-XSMU.<9
M^P'_ .*JU_P[IN/^AVM__!>?_BJ.2/<EYGC6[^P7WGV#_P +4\$_]#EX>_\
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M+#N/^U,7_P ^/_)CZ?;]H+P&.GB/3F_[?8?_ (NHV_:&\#=M=L#_ -OUN/\
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MXD[D#HBCNS,0H'<D5^"O[0GQ \6_'#QE>?%+Q':RP6.OWL]KIV[/E1QP"/\
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M/?MZ> OV9]2&A7%M=>*/%A19'TC3Y%C6W4@%3-*V0A(.0H5CT) !S7S3H_\
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M7L?P-?#O[=&KMJWB[P<9.9X=,:)S_>Q,<'\16]/XKGBY[[V!E+S7YGWAH/\
MR =+_P"O2'_T!:O51T'_ ) .E_\ 7I#_ .@+7Y5_\%!/VK?BW\*OVH?$7ASP
MGXZU/0]#M[2Q>*RMMFQ&>VC9R,J3RQ)_&I.2G%RT1^K[1[N1P:9L;TKQ#XE^
M.M>T?]BG5_%UEJ<UOXEA\%KJ,>I)CS%N#:J_F=,9W$GI7R#_ ,$R?VEOB?\
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M'/UJ;-8^G3M:QJ9.(9#PW]UNX-:ZL& (.1[&@3'BG U#),D*Y=PM,2XEN/\
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MI5(SM)M#BXW21^F7[%/CSPWXH_9U^'VD:/KNGZGJND>';&/4;*UN%DEM&,>
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M^4O^"PW_ "0SP7_V,8_])IJ]E_X)U_\ )G?@#_<NO_2F2O&O^"PW_)#/!?\
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MX+!+M^*7P^_[ <O_ *4/7U_^Q6I/[$OA _\ 4(N__0Y:ZY?PHG3+^&C\TO\
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M444 %%%% !1110 4444 ?.O[<W_))-/_ .PK%_Z ]9G[/?\ R2#P_P#[DO\
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M_P#7:#_T%ZX35/\ D'W/_7-OY&N[_97_ .0;XC_Z[0?^@O7#F7\/^NYWUO\
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MVT7P]I5IHFD6VX06-C$(H8\DL=JC@9))_&M:BBW4 HHHI@?(G[=G_(9\'_\
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MLII-NZ9F7YE4@\$5[K8_\%"?@-?7D%O#XSD>>9UCC3^S;CEB0 /N>IKRA?\
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M)_Z&]?-__!5#]GOQQXUL]!^(W@?^T[]M'M'L-6TW39'\P0;S)'.J*<M@NX;
M)P5/0&OOG2]*L=#T^WL--LK?3K"W79#:VD*Q11+_ '510 H]@*M9QTXH!3Y9
M<R/Q[_9]_P""K7B;X/\ PSLO!_B+PC#XN;2;?[-INH?;6MI@@SL2?Y6WA1@
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MX/U-L:G'EJ1]#[(_X)!_"@Z9X0\7_$2[AVRZG<+I%@S _P"IBP\S#V+LB_\
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M\$D9Z5[-7$86EA88KV"M+I9?Y>1T2E",%/EW/E[_ (:C^*'_ $.MW_WZA_\
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M,P]:A>K+('56SD _A5"XM?)8S6_R2#DJ.AK0:H)& SDU:&C/O+X-;1O&,N_
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M@X/J*BM[>&TB$4$,<$62VR) JY)R3@>IKXO_ .'D$?\ T(W_ )4Q_P#&Z/\
MAY!'_P!"-_Y4Q_\ &Z.278/KV'_F_!GVI17Q7_P\@C_Z$;_RIC_XW1_P\@C_
M .A&_P#*F/\ XW1R2[!]>P_\WX,^U**^*_\ AY!'_P!"-_Y4Q_\ &Z/^'D$?
M_0C?^5,?_&Z.278/KV'_ )OP9]J45\5_\/((_P#H1O\ RIC_ .-T?\/((_\
MH1O_ "IC_P"-T<DNP?7L/_-^#/M2BOBO_AY!'_T(W_E3'_QNC_AY!'_T(W_E
M3'_QNCDEV#Z]A_YOP9]J45\5_P##R"/_ *$;_P J8_\ C='_  \@C_Z$;_RI
MC_XW1R2[!]>P_P#-^#/M2BOBO_AY!'_T(W_E3'_QNC_AY!'_ -"-_P"5,?\
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MV3+_ )_R&LF;_P"7\CY@_P"$S^+/_0.NO_!:O_Q-'_":?%G_ *!UU_X+5_\
MB:^E<T9I_P!DR_Y_R*_L5_\ /^1\W+XN^+S $:5>$>HTQ?\ XFE_X2SXO_\
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MI?\ AI74_P#H$6?_ ']:OJ+[';_\^\7_ '['^%'V.W_Y]XO^_8_PH_L?,O\
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M0 JTZFK3JXJOQ&T=@HHHK(H**** "BBB@ HHHH **** "BBB@ HHHH ****
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MVCX%_P"?/6O_  'C_P#CE==_PS)\-/\ H68O^_\ )_\ %4?\,R?#3_H68O\
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M?#3_ *%F+_O_ "?_ !5'L\J_DG]Z']9S'^:/W'(_\-H^!?\ GSUK_P !X_\
MXY7N7PS\>:5\2/"-MK>C2O+9R,T>)%VO&RGE&'8C^HKYQ_:(^!_@GP5\*M2U
M;1=#CLM0BEA5)EE=B S@'@G'2N[_ &(Q_P 61SZZK<_R2LL9@\(L']9PZ:]Z
MVIM@\9B9XGV%=IZ7T/G[_@H9_P E4\/_ /8''_HYZ^AOV(?^3=M%_P"ON[_]
M&FOGG_@H9_R53P__ -@<?^CGKZ&_8A_Y-VT7_K[N_P#T::RQ'_(NI^O^9]!U
M/2/B)9^9!9W('*L86/LPR/U'ZUN^&KW^T-#LYB<MLV-]1P?Y4WQ19_;M!O(P
M,LJ>8OU7FL7X>7F^WN[8G[K"91[,.?U%?/\ 0VWAZ'7T445)F%1R6\4ARR G
MUJ2B@");6*,Y$:YJ6BB@ HHHH **KWVH6VFPF6ZF6%/]H]?H.]9$.I:MXD;9
MHUGY-OT-]=#"_51WH';J6?$FKC3+$I'\]Y/^[@B7[Q8\9KI/"^D'0]!L[-O]
M8BY?_>)R?U-4?#_@N#2;C[;=3/J&HG_EO+T7_=':NCKGG)/1'/4FFN5!1116
M1@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!\'_ /!3/_D,?#W_ *][[_T*"O5?^">?_)O[_P#8
M8NOY)7E7_!3/_D,?#W_KWOO_ $*"O5?^">?_ ";^_P#V&+K^25]-5_Y%,/7]
M66_A/INBBBOF2 HHHH **** "BBB@ KG==\$V.L2?:8BUA?CE;FWX.?<=ZZ*
MBFFUL5&3B[H\\FU#5?##B/6;?[1:YPM_;C(_X$.U;-G?6^H0B6VF2:,_Q(<_
M_JKJ&59%*LH96&"K#(-<KJGP_MY)C=:3.VDW?4^7S&WU6MXU$]SHC4C+XM"S
M2,P52S$!0,DGH*QMGBNQ_=R:7;W^.!-#,%S[X/\ A3D\+ZYXA8+JLL>G6.?F
MM[=MSN/0FM.9;W-/=W;.1OF;Q9XDC5,_9Y&\N,_],U/S-^)KT1$6-%11M51@
M =@*P_L<.G^/);:*-8H8[%%@1>@&>?ZUO55[HJ4KI6"BBBD2%9VI6YW>:HX_
MBK1H(R,'D4 CGZ*TYM,5R2C;#Z=J@_LN7^\M4:713K4TZW,:F1AAFZ#VI;?3
MDB(9SO;]*MTB6PILDBPQL[G:B@L3Z 4ZFRQI-&T<BAT8893T(]*1)RWBKQ%8
M7GA^>.UNXY7E*IM4\XSS3O 30QZ7*3+'YLLS';N&<#@<5C^-M(T_2VM5MH%A
M=P[OM)Z <<?6M#3_  #8W6F6TDKSQSO&&8JPQDCT(J]+&_N\IV-%16ENMG:P
MP(25C0(">IP.M2U!@4M3FVQK&.K<GZ5F5<U3_CX7_=JG5&BV"BBBF,GLYC#.
MI_A/!K9K '45O#H*ED2%HHHI$G :'_R/5Q_UVGKY5_X*,?\ (W>"O^P?/_Z-
M%?5&BDCQW-[W$XKY7_X*,?\ (W>"O^P?/_Z-%>MEO^]1^?Y%5>AZ7_P3W_Y(
MSK/_ &'IO_1$%?3K,%4D]!S7S%_P3W_Y(SK/_8>F_P#1$%?3-UG[/)C^Z:Y\
M=_O,_4A&/-(9I&<]33***Y#8**** -BQF,T SRR\&K%4-)^[)Z9%7ZDS>X5Y
MUXVT6XM;A;N6Z:X2:1E16S^['4#->BUSWCJW\[P^[X_U,BOQZ9P?YT+<J#M(
MN>%8UC\/V6QVD#)N+-UR>H_.M6N>\"W!ET%8S]Z&1DQZ<Y'\ZZ&ABENPK.U*
MW.[S5'!X:M&@\\'D4B5H<_16E-IBL28VV>QZ5"-+D[LHJC2Z*=:FG6YB0NPP
MS=/I2P:?'$P9CO;WZ5;I$MA1112)"JVI6*:E8SVLGW9%*_0]C^=6:* //_".
MH/H^J26]U\D<S>2Y/195Z?F*] KG]&T6UU[6_$MI.FZW;RCN7JDF#R#Z]:G;
M1?$NA?N[;R=9M5X3S&V2@>ASU_6DY*]BI2BW;9FS5/4M8L])CWW4ZQ>B]6/T
M%4EL_%>J-Y8MK?28SUE=Q(P^@%:^B^ ]/TR87-P6U&^SDSW'.#[#M2<HQ(<H
MQW9AV\>M^+/^/5#I&FM_R\2C]ZX_V1_GZUU&@^$]/\/+FWBWW!^_<2_-(WX]
MOPK9HK"4W(YY5'+39!11169D%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*\_["S_^CS7U.22E)U+OM^II$_8!OA9X,W'_ (I+1/\ P7Q?_$TG_"J_!?\
MT*6B?^"^+_XFNI;[QHKYCVD_YF9D5K:PV-K#;6T,=O;PH(XX8E"HB@8"@#H
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MDI_]IT_[%S#_ )]_BO\ ,I9O@O\ GY^#_P CZEHKY8_X;LM/^A/E_P#!DO\
M\;H_X;LM/^A/E_\ !DO_ ,;I_P!BX_\ Y]_BO\RO[7P/_/S\'_D?5UG"9IU'
M\(Y-;-?(D'[?5A;IM7P5-[G^TUY_\A5)_P / ;/_ *$J;_P9K_\ &J7]BYA_
MS[_%?YD/-\$_^7GX/_(^MZ*^2/\ AX#9_P#0E3?^#-?_ (U1_P / ;/_ *$J
M;_P9K_\ &J7]B9A_S[_%?YB_M;!?\_/P?^1[KHO_ "/DW_7Q/7RQ_P %&/\
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MOF_^*H_U<QO]W[P_M;#>?W'W[17P%_PW!\5?^@'IG_@OF_\ BJ/^&X/BK_T
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M*O\ T ],_P#!?-_\51_JYC?[OWA_:V&\_N/OVBO@+_AN#XJ_] /3/_!?-_\
M%4?\-P?%7_H!Z9_X+YO_ (JC_5S&_P!W[P_M;#>?W'W[3*^!?^&X/BJ.3H>F
M ?\ 8/F_^*KW;]E']HC7?CA)XBM=>LK*"?3%AECFLE9 ZR%QM*DGD;.N>]34
MR;%82E*M4M9=F73S"A7FJ<+W?D?0E%%%>6=P4444 %%%% !1110 JTZFK3JX
MJOQ&T=@HHHK(H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY4_X*%_\DY\+?\
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M_+0+M?\ ,<US\OP]FL26T?5[BT'_ #QG_>)7Q*J19]>IP?D:-%8LD?BK2_\
M76%OJ<8ZM;/M;\O_ *U0KXSM87\N_MKK3I.XGB./SK3?8TM?;4Z"H;ZZ6RLY
M[ASA8T+9^@K.D\6:1''YAOXR/1<D_E52&VO/'4T<:PR6>B*P:2608:?'\('I
M1MJPM;66QB^![5_[8,D@P4MO,YZY=L_RKY>_;D ;XJ>&P1D?V>O_ *--?8>I
M1+H/C=6*B*TOX%CC(&%#K@;?RQ^=?'G[<G_)5/#7_8/7_P!&FOHLA?-C8OR?
MY'AYW+FPC?FOS/J)? ?AG:O_ !3>C]/^@?#_ /$TO_"!^&/^A;T?_P %\/\
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MQR7<:LI]""V0:LV.HVFJ(SV5W;WJ+]YK:59 /KM)Q1[2?<.2/8RO^$#\,?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK#@@CH15JF 457AU"TN+B:WAN[>:XA_UL,<JL\?^\H.1^-6* "BBB@ HHHH
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M<Q3YQ6!^PGXR\+^ ?^">NH>(?&D$-YX9TZ_U":[M9[=;A9@'CVQB-AM8LY4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_M/?"2>_UN**'Q5HMR+'4C H2.?*[HYE4?=W#((Z94XXKYA^&?\ P5HTGQ)
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?*G_  4+_P"2<^%O^PN?_1$E?5=?*G_!
M0O\ Y)SX6_["Y_\ 1$E>WDO_ ",*7K^C/.S'_=9_UU.E_9W_ .2)^$?^O/\
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MJAUSAF#*VUCG/;!!KZ@_::^+L_QT_P""7=IXTO$6/4;^:P2]50 IN(KORI6
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MEG9L''*CMD_65%%;1BHJR,V[N["OC_Q1_P GR:%_V%-/_P#0%K[ KX_\4?\
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M%*HH(50%&6.,=6-9NE>:D4I^ZT?E[^U-,TW_  4PG#'(3Q-HZ+]-MM_C7O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6Z7D<,MN(+Y'4>7,[R,$4@2#)P P7)YK]!M)_P"018?]>\?_ * *^>/VAOV
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MVEV-M965O':6=M&L,%O"H5(HU "JH'0   #VK6$9<[G(B37+RH;J7_(-O/\
MKA)_Z":^:O\ @G3_ ,ACQS_UZV?_ *'+7TKJ7_(-O/\ KA)_Z":^:O\ @G3_
M ,ACQS_UZV?_ *'+7MTO^1?B?^W?S/-J?[W1^?Y'VW1117RQ[84444 %%%%
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M ,%A-%FUF'X7>+]/>*_\/-#=V0OK602Q&1F1UPRY!!4-@YYVGTKA/@+^P/\
M"?XX?"_2?%,'QN&F7LELK:EIEQ:VZ26$X \Q&#S@[0W1R,$$'VK]&-!_9L\-
M#]G31/@_XK2/Q9H>GV$=E)/)#]G:5D8LLJ ,QC<$\$,<>M?(>O?\$;]"N-6N
M)=$^)^H:;IKG]W:WFD)<RH.X,BS1AO\ OD?C1*FW+FM>XXR5K7L=5^Q'^R7\
M,?AW\:-1\5>!?B[_ ,)YJ'AT2Z9?6$5FD:(TT>-V\2'<HY^9<KE2,Y!KY-_9
M1\4:1X0_X**2ZAKFI6NDV']M:U ;J\D$<2O(MPB L>!EB!D\9(K]*_V7_P!C
MOP-^RO9W<GA\W6JZ]?(L=YK.H%?-= 0WEHJ@*B;@#@9)P,DX%>"V_P#P2=\*
MZIXX\6:YXG\:7FLV>N&ZEAM+33Q:RV,\LPD2593*X<H-RX9,,&/2ATY6C9;
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M_LKGY[1Y!<+O0J2H.W(PIZC-:^L?\$]X=6_:J_X71_PG;Q/_ &S'J_\ 8O\
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M^I]%4445\2?0A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D^+O\ D5-:_P"O&?\
M]%M7Q#^P?][QC_USLO\ VM7W#XFADNO#>K0Q(TDLEG,B(HR68H0 /?-?F/\
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MU]\1_P#H4K'_ , KG_XJC^R<3Y?>'U^CY_<?8U%?'/\ PU]\1_\ H4K'_P
MKG_XJC_AK[XC_P#0I6/_ (!7/_Q5']DXGR^\/K]'S^X^QJ*^.?\ AK[XC_\
M0I6/_@%<_P#Q5'_#7WQ'_P"A2L?_  "N?_BJ/[)Q/E]X?7Z/G]Q]C45\<_\
M#7WQ'_Z%*Q_\ KG_ .*H_P"&OOB/_P!"E8_^ 5S_ /%4?V3B?+[P^OT?/[C[
M&KX_\4?\GR:%_P!A33__ $!:A_X:^^(__0I6/_@%<_\ Q58/PWU+Q-\4OVGO
M"WB*]T.:WN7U&WFG6WMI%BCCB RV6S@!5R<FNS#X.KA8U:E6UN274YJV)A7<
M(PO?F70_22BBBOS,^O"BBB@ HHHH *^#?V^/^2M^&/\ L&K_ .CFK[RKXO\
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MR'_@0?78?R2^X^P**^/_ /A;'[17_0KZA_X3C?\ Q-'_  MC]HK_ *%?4/\
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M.*_Y]O[A_6J'\Z/<**\/_P"&Q_AQ_P ]=6_\ /\ [*C_ (;'^''_ #UU;_P
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M #UU;_P _P#LJ/\ AL?X<?\ /75O_ #_ .RH^HXK_GV_N#ZU0_G1[A17A_\
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M/O#ZQ5_Y\R^X^O=I]*-I]*^0O^%&_M)_\_=__P"#R'_XY1_PHW]I/_G[O_\
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M  HW]I/_ )^[_P#\'D/_ ,<H^J8?_H)A]X?6*O\ SYE]Q]>[3Z4;3Z5\A?\
M"C?VD_\ G[O_ /P>0_\ QRC_ (4;^TG_ ,_=_P#^#R'_ ..4?5,/_P!!,/O#
MZQ5_Y\R^X^O=I]*-I]*^0O\ A1O[2?\ S]W_ /X/(?\ XY1_PHW]I/\ Y^[_
M /\ !Y#_ /'*/JF'_P"@F'WA]8J_\^9?<?7NT^E&T^E?(7_"C?VD_P#G[O\
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M0 9HS110 9HS110 9HS110 9HS110 9HS110 9HS110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/OA'_P!"BO\ X'7/_P <H_X8^^$?_0HK_P"!US_\<KV6BC^T,9_S^E_X$_\
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M17_P.N?_ (Y1_P ,??"/_H45_P# ZY_^.5[+11_:&,_Y_2_\"?\ F'U7#_\
M/M?<CQK_ (8^^$?_ $**_P#@=<__ !RC_AC[X1_]"BO_ ('7/_QRO9:*/[0Q
MG_/Z7_@3_P P^JX?_GVON1XU_P ,??"/_H45_P# ZY_^.5V?P]^$?A'X517B
M>%M&CTK[85,[+))(TFW.T%G8G R>!QS794RM8XO$5HN-2I)KS;8O84:;4H02
M?H@HHHJ2PHHHH **** "BBB@!5IU-6G5Q5?B-H[!1116104444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3*?
M3*Z:/4SF%%%%=)F%%%% !1110 4444 *M.IJTZN*K\1M'8****R*"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *93Z9731ZF<PHHHKI,PHHHH **** "BBB@!5IU-6G5Q5?B-H[!1116104
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !3*?3*Z:/4SF%%%%=)F%%%% !1110 4444 *M.IJTZN*K\1M'8*
M***R*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *93Z9731ZF<PHHHKI,PHHHH **** "BBB@!5IU-6G5Q5
M?B-H[!1116104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !3*?3*Z:/4SF%%%%=)F%%%% !1110 4444 *M.
MIJTZN*K\1M'8****R*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKX^
MUS]O2\L]8O8+#PE;2V44K1Q27%XRNX!(R0%P,XZ50_X;\U?_ *$_3_\ P.?_
M .(KZ6/#N922?L_Q7^9\\\_R].W/^#_R/M"BOB__ (;\U?\ Z$_3_P#P.?\
M^(H_X;\U?_H3]/\ _ Y__B*?^K>9?\^_Q7^8O]8,O_G_  ?^1]H45\7_ /#?
MFK_]"?I__@<__P 11_PWYJ__ $)^G_\ @<__ ,11_JWF7_/O\5_F'^L&7_S_
M (/_ "/M"BOB_P#X;\U?_H3]/_\  Y__ (BC_AOS5_\ H3]/_P# Y_\ XBC_
M %;S+_GW^*_S#_6#+_Y_P?\ D?:%%?%__#?FK_\ 0GZ?_P"!S_\ Q%'_  WY
MJ_\ T)^G_P#@<_\ \11_JWF7_/O\5_F'^L&7_P _X/\ R/M"BOB__AOS5_\
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MS_\ Q%'^K>9?\^_Q7^8?ZP9?_/\ @_\ (^T**^+_ /AOS5_^A/T__P #G_\
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M<_\ \11_JWF7_/O\5_F'^L&7_P _X/\ R/L^BOC#_AOS6/\ H3K#_P #G_\
MB*/^&_-8_P"A.L/_  .?_P"(H_U;S+_GW^*_S#_6#+_Y_P '_D?9]%?&'_#?
MFL?]"=8?^!S_ /Q%'_#?FL?]"=8?^!S_ /Q%'^K>9?\ /O\ %?YA_K!E_P#/
M^#_R/L^BOC#_ (;\UC_H3K#_ ,#G_P#B*/\ AOS6/^A.L/\ P.?_ .(H_P!6
M\R_Y]_BO\P_U@R_^?\'_ )'V?17QA_PWYK'_ $)UA_X'/_\ $4?\-^:Q_P!"
M=8?^!S__ !%'^K>9?\^_Q7^8?ZP9?_/^#_R/L^BOC#_AOS6/^A.L/_ Y_P#X
MBC_AOS6/^A.L/_ Y_P#XBC_5O,O^??XK_,/]8,O_ )_P?^1]GT5\8?\ #?FL
M?]"=8?\ @<__ ,11_P -^:Q_T)UA_P"!S_\ Q%'^K>9?\^_Q7^8?ZP9?_/\
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M "/L^BOC#_AOS6/^A.L/_ Y__B*/^&_-8_Z$ZP_\#G_^(H_U;S+_ )]_BO\
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M^A.L/_ Y_P#XBC_5O,O^??XK_,/]8,O_ )_P?^1]GT5\8?\ #?FL?]"=8?\
M@<__ ,11_P -^:Q_T)UA_P"!S_\ Q%'^K>9?\^_Q7^8?ZP9?_/\ @_\ (^SZ
M*^,/^&_-8_Z$ZP_\#G_^(H_X;\UC_H3K#_P.?_XBC_5O,O\ GW^*_P P_P!8
M,O\ Y_P?^1]GT5\8?\-^:Q_T)UA_X'/_ /$4?\-^:Q_T)UA_X'/_ /$4?ZMY
ME_S[_%?YA_K!E_\ /^#_ ,C[/HKXP_X;\UC_ *$ZP_\  Y__ (BC_AOS6/\
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MP_\  Y__ (BC_5O,O^??XK_,/]8,O_G_  ?^1]GT5\8?\-^:Q_T)UA_X'/\
M_$4?\-^:Q_T)UA_X'/\ _$4?ZMYE_P ^_P 5_F'^L&7_ ,_X/_(^SZ*^,/\
MAOS6/^A.L/\ P.?_ .(H_P"&_-8_Z$ZP_P# Y_\ XBC_ %;S+_GW^*_S#_6#
M+_Y_P?\ D?9]%?&'_#?FL?\ 0G6'_@<__P 11_PWYK'_ $)UA_X'/_\ $4?Z
MMYE_S[_%?YA_K!E_\_X/_(^SZ*^,/^&_-8_Z$ZP_\#G_ /B*/^&_-8_Z$ZP_
M\#G_ /B*/]6\R_Y]_BO\P_U@R_\ G_!_Y'V?17QA_P -^:Q_T)UA_P"!S_\
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MO\5_F'^L&7_S_@_\C[/HKXP_X;\UC_H3K#_P.?\ ^(H_X;\UC_H3K#_P.?\
M^(H_U;S+_GW^*_S#_6#+_P"?\'_D?9]%?&'_  WYK'_0G6'_ ('/_P#$4?\
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ML/\ P.?_ .(H_P"&^]8_Z$ZP_P# Y_\ XBC_ %;S+_GW^*_S#_6#+_Y_P?\
MD?9]%?&'_#?>L?\ 0G6'_@<__P 11_PWWK'_ $)UA_X'/_\ $4?ZMYE_S[_%
M?YA_K!E_\_X/_(^SZ*^,/^&^]8_Z$ZP_\#G_ /B*/^&^]8_Z$ZP_\#G_ /B*
M/]6\R_Y]_BO\P_U@R_\ G_!_Y'V?17QA_P -]ZQ_T)UA_P"!S_\ Q%'_  WW
MK'_0G6'_ ('/_P#$4?ZMYE_S[_%?YA_K!E_\_P"#_P C[/HKXP_X;[UC_H3K
M#_P.?_XBC_AOO6/^A.L/_ Y__B*/]6\R_P"??XK_ ##_ %@R_P#G_!_Y'V?1
M7QA_PWWK'_0G6'_@<_\ \11_PWWK'_0G6'_@<_\ \11_JWF7_/O\5_F'^L&7
M_P _X/\ R/L^BOC#_AOO6/\ H3K#_P #G_\ B*/^&^]8_P"A.L/_  .?_P"(
MH_U;S+_GW^*_S#_6#+_Y_P '_D?9]%?&'_#?>L?]"=8?^!S_ /Q%'_#?>L?]
M"=8?^!S_ /Q%'^K>9?\ /O\ %?YA_K!E_P#/^#_R/L^BOC#_ (;[UC_H3K#_
M ,#G_P#B*/\ AOO6/^A.L/\ P.?_ .(H_P!6\R_Y]_BO\P_U@R_^?\'_ )'V
M?17QA_PWWK'_ $)UA_X'/_\ $4?\-]ZQ_P!"=8?^!S__ !%'^K>9?\^_Q7^8
M?ZP9?_/^#_R/L^BOC#_AOO6/^A.L/_ Y_P#XBC_AOO6/^A.L/_ Y_P#XBC_5
MO,O^??XK_,/]8,O_ )_P?^1]GT5\8?\ #?>L?]"=8?\ @<__ ,11_P -]ZQ_
MT)UA_P"!S_\ Q%'^K>9?\^_Q7^8?ZP9?_/\ @_\ (^SZ*^,/^&^]8_Z$ZP_\
M#G_^(H_X;[UC_H3K#_P.?_XBC_5O,O\ GW^*_P P_P!8,O\ Y_P?^1]GT5\8
M?\-]ZQ_T)UA_X'/_ /$4?\-]ZQ_T)UA_X'/_ /$4?ZMYE_S[_%?YA_K!E_\
M/^#_ ,C[/HKXP_X;[UC_ *$ZP_\  Y__ (BC_AOO6/\ H3K#_P #G_\ B*/]
M6\R_Y]_BO\P_U@R_^?\ !_Y'V?17QA_PWWK'_0G6'_@<_P#\11_PWWK'_0G6
M'_@<_P#\11_JWF7_ #[_ !7^8?ZP9?\ S_@_\C[/HKXP_P"&^]8_Z$ZP_P#
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M'_0G6'_@<_\ \11_PWWK'_0G6'_@<_\ \11_JWF7_/O\5_F'^L&7_P _X/\
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M^M8_Z$ZP_P# Y_\ XBC_ %;S+_GW^*_S#_6#+_Y_P?\ D?9]%?&'_#?6L?\
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M?:<02:QSL^B_(^6R&*>"5UU9G?\ "/Z7_P! VS_\!T_PI#X?TO\ Z!MG_P"
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MPY8]BA_8.F?] ZS_ / =/\*:="TS_H'6?_@.G^%:%--/FEW%RQ[&?_86F?\
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MT_\ Y\+7_OPO^%']BZ?_ ,^%K_WX7_"KE%'-+N+E78I?V+I__/A:_P#?A?\
M"F_V-I__ #X6O_?A?\*O4VGS2[BY5V*7]CZ?_P ^%K_WX7_"D_L?3_\ GPM?
M^_"_X5<-)3YI=Q<J[%+^QM/_ .?"U_[\+_A2?V-I_P#SX6O_ 'X7_"KM)34I
M=PY5V*7]BZ?_ ,^%K_WY7_"D_L73_P#GPM?^_"_X5=I*KF?<GE78I?V/I_\
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MY)_WR*0V\7_/)/\ O@5)2&J)(_(B_P">:?\ ?(I/(B_YYI_WR*DHH B,$?\
MSS3_ +Y%-\F/_GFG_?(J4TTT78B/R8_^>:?]\BD\F/\ YYI_WR*?13N(C,,?
M_/-?^^12>3'_ ,\U_P"^14AIIIB(_)C_ .>:_P#?(I/)C_YYI_WR*DI*8F1F
M&/\ YYK_ -\BD\F/_GFO_?(J0TE,1'Y,?_/-/^^12>3'_P \T_[Y%24E F1^
M3'_SS3_OD4WR8_\ GFG_ 'R*D--IDC/)C_YYI_WR*3R8_P#GFO\ WR*?13 C
M\F/_ )YK_P!\BFF&/_GFO_?(J6F&F(9Y*?W%_P"^12>2G]Q?^^13Z2F2,\E/
M[B_]\BD\E/[B_P#?(I])0 SR4_YYK_WR*3R8_P"XO_?(I])30AGDQ_\ /-?^
M^13?)C_YYK_WR*DI*8AGDQ_\\U_[Y%-,,?\ <7_OD5)24 1F%/[B_P#?(IIB
M3^XO_?(J0TTTR2/RD_N+_P!\BD\I/[B_]\BGT50B/R4_N+_WR*3RD_N+_P!\
MBGTE #/*3^XO_?(I/*3^XO\ WR*D_P ]:;3)&>4G]Q?^^11Y2?W%_P"^:?24
M"(_*3^XO_?(I/*3^XO\ WR*?2&J C\M/[B_]\BFF-/[B_P#?(J2FF@D9Y:?W
M%_[YI/+3^XO_ 'R*?24P&>6G]Q?R%)Y:?W%_[YI])3(&>6G]Q?\ OD4GEI_<
M7_OFGTE #/*3^XO_ 'S2>6G]Q?R%/I*8AGEI_<7_ +YIOEI_<7_OD5)3:H0S
MRT_N+_WS2>4G]Q?^^13Z2@!GEI_<7\J:8T_N+^524TT"&&-/[B_]\TWRT_N+
M^0J0TVF2-\M/[B_]\TTQI_<7_OD4_P#SUI*H!GEI_<7\A1Y:?W%_[YIU)0(9
MY:_W5_(4AC7^ZOY4^D-,DC\M?[J_E1Y:_P!U?RIU%,!AC3^ZOY4WRU_NK^52
M&FT 1F-?[J_E2>6O]U?RI])3)&>6O]U?RI/+7^ZOY4ZBJ 9Y:_W1^5)Y:_W5
M_*G4E AOEI_=7\J;Y:_W5_*GTE!(SRU_NK^5'EK_ '5_*G4E4 PQK_=7\J0Q
MK_='Y4^FFF2,*+_='Y4FQ?[H_*G&DH$,V+_='Y4GEK_=7\J?_GK24$C-B_W1
M^5&Q?[H_*G4E4 S8O]T?E2;%_NC\J?24 ,V+_='Y4FQ?[J_E3Z2F2,,:_P!T
M?E3=B_W1^5/--IB&;%_NC\J38O\ ='Y4ZD_SUI@)L7^Z/RINU?[H_*GTVF2-
MV+_='Y4FT?W1^5.I*8ANT>@_*DVCT'Y4ZD-,!NU?[H_*DV+_ '1^5.I*"1FU
M?[H_*FE1Z#\JDIM4 S:/0?E2;1Z#\J<:2@0W:O\ ='Y4A4>@_*G4AH$-VCT'
MY4FT>@_*EI*8ANT>@_*C:/0?E2T8-4(;M'H/RINT>@_*GFF[AZT"&E1Z#\J;
MM'H/RIS,/4?G4;31KUD4?5J!!M'H/RHVCT%1_;(/^>\?_?8IIOK=>L\?_?0J
MDF*S)=H]!^5-VCT'Y5 VJ6B]9U_.F_VI:?\ /=?UJN5]@Y7V+&T>GZ4FT>E5
M6U>T'_+7/T!IG]M6G]]O^^33Y9=@Y9=BYM'I^E(5'I^E4FUJU[%S_P !J-M<
M@[)(?P'^--1EV#DEV-#:/3]*3:/3]*SSKT']Q_T_QJ-O$$7:,_BPJN278/9R
M[&GM'I^E)M'H/RK*_P"$@3_GF/\ OO\ ^M1_;A;[L.?QI\D@]G/L:FT>GZ4W
M:/0?E6;_ &I<M]VV)_!JGA;5+G_4Z;/+G^Y"[?R%'+;<:HU'LBSM'I^E(5'I
M^E/BT'Q1<_ZGP_J4G^Y8RM_2KL/@'QW<?ZOPCK3^_P#9<V/_ $&LW.$=Y+[S
M58.O+:+,[:/2DP/3]*WXOA'\2+G[G@[6/QLF7^=7(O@+\4[C[G@_5/\ @2(O
M\S63Q&'CO5C]Z-5EV*EM3?W/_(Y+:/3]*,#T_2N[A_9L^*]Q_P RM<Q_[\L0
M_P#9JNP_LH_%>XQ_Q(UC_P!^]B7^M9O'8..]:/\ X$C193C9;4I?<_\ (\VP
M/3]*;M'I7K$/['OQ5D^]9647^]J*'^578?V*OB3-_K)=*B_WKPG^2UF\SP$=
MZ\?O-EDF/?\ RZ?W,\:P/3]*:<5[I#^POX\D^_J^AQ?[T\Q_E'5Z']@WQ6W^
MM\2Z.G^XLS?S45D\XRY;UE^)JN'\PE_R[?\ 7S/GPLOJ*:67U%?2</[ VL-C
MSO%]BG^Y9NW\V%7H?V 9/^6WC9#_ -<]-(_G+63SW+5_R^_!_P"1JN&\P?V/
MQ7^9\MF1!_$M,\V/^^OYU];0_L":>/\ 6^,;H_\ 7.R4?S8U=A_8'\.K_K?%
M6K/_ +D,2_T-9/B'+5_R\?W/_(U7"^/>\?Q7^9\=F:/^\M-\^/\ O#\J^U8?
MV$?!J?ZS6]9E_P"!1K_[+5^']ASX?)_K+K6I?^WI5_\ 9*S?$F7+JW\C6/"F
M->]OO/AKSX_[P_*FFXC]?TK[TA_8J^&D/WH-4E_ZZ7Q_H!5^']CWX7PXSHUQ
M+_UTO9?Z$5D^*, ME+[E_F;+A'%/>2^__@'Y]_:8_0_E2?:$]/TK]%(?V4?A
M7#_S*L<A]9+NX/\ [4J_#^S3\,8/N^#K _[YD;^;&LGQ5@^D)?A_F:K@^OUG
M'[W_ )'YM&X7^Z:0W*_W:_32'X!_#B#[O@K13_OVBM_.K\/P?\"V_P#JO!VA
MQ_[NGQ#_ -EK)\68?I2E^!LN#Y]:B_$_+DW2>WYT@N%8X&"?8U^J\/P_\+VW
M^J\-Z3'_ +ME&/\ V6KL7AG2(>(])L4_W;9!_2LGQ=3Z47]__ -EP>NM1?<_
M\S\H5CGD^Y;R/_NH3_2IETO49/N:==/_ +MNY_I7ZPQZ7:1_<LX$_P!V)1_2
MK"1B/[B!?]T8K)\7=J'_ )-_P#6/!]+K5_#_ ()^4,/A'Q!<_P"JT+4I/]VS
MD/\ 2K\/PR\977^J\*:U)_NV$I_]EK]4<D=3BF-,J]9%'U85F^+JO2BOO_X!
MM'A'#K>I^'_!/R_A^"?Q#N/N>"M=(]6T^11^HJ]#^SQ\2KC[O@S5!_OQA?YF
MOTLDU"UA&9+F&,>K2*/ZU2F\6:';_P"MUG3XO]^[C'\S6?\ K7BG\-)?B;QX
M2PG63^Y?Y'YW0_LO?%*XQM\(W2_[\\"_S>K\/[)'Q2FZ^'4C_P"NE[#_ $8U
M]YS?$KPC;_ZWQ5HD?^_J,(_]FJC-\9O =OG?XQT3_@-]&W\C4_ZS9C+X:2^Z
M7^9O'A/!]Y?A_D?%$/[&GQ.FZZ=I\7_72^3^F:NP_L2?$>3_ %G]CQ?6\)_D
ME?74_P"T%\-[?[_C+2_^ R[OY"J,O[3GPOASGQC9,?1$D/\ [+2_M_-I;4U_
MX"_\S=<+8/M+^OD?,4/["_CJ3_6:GHL7_;5V_DM7X?V#/%C8\SQ)HT?T25O_
M &6OH";]K'X70_\ ,R"3_KG;2G_V6J$W[8WPPAZ:M>2?]<["4_TJ?[8SJ6T/
M_)3>/#.#7V'][/'(?V!]:/\ KO%NGK_N6KG^9%7X?V YC_KO&J+_ -<]/)_G
M(*]'F_;6^&T?W)-5F_W;$C^9JA-^W)X!C^Y8:Y-_NV\8_G(*G^TL]EM=?]NK
M_(V7#>"7_+I_>_\ ,Y:']@.Q7_6^-;E_]S3E7^<AJ]#^P3X?7_6^*M4?_<@B
M7^>:NS?MX>#U_P!5X?UQ_P#?$*_^U#5";]O?05_U7A/4G_W[F-?Y TOK>?2^
MT_NB;+A[!K:C^+_S-"']@_P:O^MU[79/]UX5'_HNK\/[#?P_CQOO-:E_WKE!
M_)*Y*;]OVT'^J\%3-[OJ2C^4=49OV^KEO]3X-A'^_?D_R05//GLMYO[T;1R'
M"+_ERCTF']BGX:1_?@U27_>OF'\@*O0_L=_"^''_ !)[J3_KI?2G^M>,S?MZ
M:\W^I\)Z<O\ OW$A_D*IR?MV>,9N(O#>D(?^VS?UI>SSN6]5_P#@1LLDPRVH
MQ^Y'T##^RA\+H<?\4PDG_72XE/\ [-5Z']F7X7P<KX-L2?\ ::1OYM7S-)^V
MM\19O]3H^EQ_2UD;_P!FJK)^V!\5YO\ 5VEA'_NZ8Y_FU3]4S>6]9_\ @3-H
MY/06U*/W+_(^LH?@#\.;?[G@W2?^!0;OYU?A^#O@2WQL\&Z%_P "T^)OYK7Q
MO)^U'\9+G[C)'_USTM1_,55D_:&^-EQ]W4[B+_<T^ ?S2I_LW,9?%6_\F9O'
M*X+:G'[O^ ?<,/PZ\*6_^J\,:-%_N:?"/Y+6A:^'=)L)%>VTNRMW7E6BMT4C
MZ$"O@&[^-WQI,,DTWB#4(HD4LS"*!  ._"U]&?L=_$SQ'\1/#.OCQ%J+ZI+8
M74:PSRJH?:RDE20!GD=^>:X<7EV)P])U:E2Z7FRI8-45S61]!T445X!D%%%%
M !1110 4444 %%%% !1110 4444 %,I],KIH]3.84445TF84444 %%%% !11
M10 JTZFK3JXJOQ&T=@HHHK(H**** "BBB@ HHHH **** "BBB@ HHHH *%^\
M**%^\* /B+]A_P#Y+)XF_P"O"7_T>M?<E?#?[#__ "63Q-_UX2_^CUK[D_ST
MK[+B'_?GZ+\CY?(/]R7JQM%+337SA]$)24M)02%-I:2F TTVG&FTR1*2EI*8
M"&DI324"$I#2TE!(E)2TG^>E4 AIIIQIIIB&TVG4V@04VEI*8A***3_/2F E
M)2TE,D*;2_YZ4E,!#3:<:;0(::2EI*9(4VG?YZ4TTP$-)2FDIDB4E+24Q"4E
M+2?YZ4"&TAI:0T"&TE+2?YZ50"4AI:::9(E)2TG^>E A*2EI*8"4E+_GI24R
M1#3:<:;3$-HHHH 2FTZFU0A#3:4TE @III:2F@$HHI/\]*HEB4TTZFF@0E%%
M%!+&FFGI3C335"$I*6D_STH ;11102)3:=_GI3:8!24O^>E-IH04TTM(:9(E
M,IU-I@(:2E-)3 2D-+24R!*2EI/\]* $I*6DJ@8AI*4TAH)&FFFG4TT -HHI
M/\]*8A*2EI*HD2DI:2@!*2E_STI*"!*1J6D-,!M%%'^>E4(0TTTXTTT"&TAI
M:;3 *2BC_/2F2-HHHH$(:;2FDIH IM+_ )Z4E42)333C3:!#324II* $I*6D
MJD(2DI:2F(2D-+2&@0E)2TE F(:::4TAJA#:;3J;02)110:8AM)2TE,3$-)2
MFDIB"FTM)0 E-IQIIJA#324II*9(4TTZFT )3:=3:!!2&BD-42)1110 TTTT
MXTTT -HHHIHD0TTTXTTU0"4E+24$L0TE*:2F(2DI:2F)B4VE--IDA24O^>E)
M3 2FFG4TTQ#:2EI*!"444G^>E A*2EI*I"84VE_STI*8A*0TM(: &FFFG&FF
M@D0TE%%4(0TVG?YZ4VF 4TTZFT$A24M)_GI3 ;2&EI#3 ;333J::9 E)2TE,
M!*2EI/\ /2F0)24M)0 E)2_YZ4E,0E(:6FU0A*2E_P ]*2@!*0TM-- A#3:<
M:;3)"FFEI,'T_2F E%+M/I3&95ZD#ZT"84AIC7,*]9HQ_P #%,:]MEZW$(_X
M&/\ &KLR22BJ<FM6$7W[VW7ZRK_C41\1Z5_T$;7_ +^K_C5*,NP7- TVLQ_%
M&D+UU"#\&S_*H&\9Z*IQ]N7_ +X8_P!*KV<^S%=&P:2L1O&VC#_E\S](V_PJ
M"3QYI"=))7_W8C5*E4_E)NCH**YL_$#2O^G@_P#;/_Z]1O\ $/35^[%<-_P$
M#^M5[&I_*+F1T]-KDV^(UGVM)_S7_&F-\2+7M9R_BZU7L*G87,CKZ::XJ3XE
MI_#9+_P*7']*:/B0\G"6"L?:4G^E5]7J]B>9';45Q?\ PF^I2_ZK2B?^ NW\
MA3H_$GB*8XCT21_]VUE-'L)K?\RM7LCL*::YR.;QI=?ZGPU>M_N6,I_I5F/P
M_P#$JZ_U/A35F_W-+D/_ ++4.*6\DOF4J526T7]QL&DJI%\/_BS<?=\'ZP/]
M[363^8%64^#_ ,8;K[OA?4D^L<:?S-9N5&.]6*_[>1JL+B);4Y?<Q:0U;A_9
M_P#C/<8QX?NU'K)<VR_S>KD?[,OQDN/O:<(O]^^A'\C6;KX2.]>'_@2+6 Q<
MMJ,O_ 68])70Q_LC_%N?EA:1?[^IX_D#5R']C3XH2X\W4--C^NH.W_LM0\9@
M5O7C]YHLKQK_ .7,ON.1I*[E/V'?'EQ_KM<TE/\ >EE;_P!EJW#^P;XJ;_6^
M*-)0?[,<Q_I4/,<N6]=?B:K)\>_^73_#_,\X:5%^\ZCZD"H3>VXZW$0_X&*]
M;A_8'U9O]=XPLU_W+1V_FPJ]#^P"6_UWC4+_ +FFY_G(*S>;99'>O^#_ ,C1
M9%F#_P"77XK_ #/%&U"U7K<Q?]_!4#ZS81];R$?\"%?0$/[ >F+_ *WQE=O_
M +E@B_S<U?A_8)\-+_K?$^K/_N11+_0UG_;66+_EZW_VZ_\ (T7#^8/['XK_
M #/FPZ]IW_/[#_WU4;>(M.7_ )>T/^[DU]30_L(^"8_]9K6O2_\ ;6%1^D=7
MH?V'_AY']^?69O\ >NU'\EK-Y]EJ^U)_(U7#F.?1?>?(_P#PE&F_\_!_[]M_
MA3&\5:<.DS'Z1G_"OLF']BWX91XW6FI2_P"]?N/Y8J]#^R!\+X?^8)/)_P!=
M+V4_UK-\19<ME/[E_F:+AG&/=Q^]_P"1\1-XOL%Z"9OH@_QII\86/]R;_OD?
MXU]W0_LJ_"V'_F589/\ KI/*?_9JO0_LU_#&W^YX-T__ (%O;^;5F^)< MH2
M_#_,U7"^*ZSC^/\ D?G^WC*V'W893]2!47_":0_\^K_]]BOT4A^ _P .[?[G
M@W1_^!6P;^=7X?A'X'M\>7X.T('U.G0G^:UF^)\)TI2^]&JX6K=:B_$_-IO&
MD?:V/XN*B;QH_:W3\7_^M7Z<P^ ?#%O_ *KPWI$7^Y8Q#^2U>A\/Z5;_ .JT
MRSB_W+=!_(5F^*:"VH/_ ,"_X!HN%9=:J^[_ ()^74?BJZG_ -78^9_N[F_I
M4ZW^N7'^IT>X?_=MI&_D*_4E;6%?NPQCZ(*D6,+T0#Z"LGQ5'IA__)O^ :KA
M2/6M_P"2_P#!/RZAL_%]Q_JO#>H2?[NGS'^E78_"?Q NL>5X4U0_33Y/ZBOT
MZ^;WJ)[J*/[\R)_O.!4/BJ?2@OO?^1JN%:76J_N/S4B^&'Q1N?\ 5>$=8/TL
MB/YBKL/P5^+5QC'A+4E_WX47^9K]%I-:T^/[]_:I_O3J/ZU5F\7:%;Y\W6].
MC_WKN,?UJ/\ 6C$OX:,?Q-5PKA^LW^'^1^?T?[.OQ>N<8\.72?[T\*?S:KL/
M[+7Q@FZZ/Y8_V]1@'_L]?<LWQ,\(6W^M\4Z-'_O7\0_]FK/F^-?P_M_]9XUT
M%3Z?VA$3^AI?ZQYA+X:,?_ 7_F;+A;"=7+\/\CXVC_9$^+$_WX+.+_?U!/Z9
MJU#^Q7\3)OOW>DP_[]_)_1#7UC-^T-\-K?.[QII1_P!R;=_(&J$W[3_PNM_O
M>+[4_P"Y#,W\DI?V]FTOAI+_ ,!9O'A?!]I?U\CYKA_8=\?28\W7-&3Z7$S?
M^R"KD7[!OBJ3_7>)])3Z1RM_A7O4W[6GPMAZ>)#+_P!<[.?^J"J$W[9'PRAZ
M:E>R_P"Y8O\ UQ1_;&=2VA;_ +=-H\,X-?8?WL\@A_8%U<_Z[QA8C_KG9.?Y
MM5^']@-_^6WC,?\ ;.Q_Q:O0I?VVOAO'G;_;$I_V;+'\VJC-^W-X$C_U>G:S
M+_VP1?YM2_M+/9=__ 5_D;+AO!+_ )=/[W_F<S#^P'IW_+7QE=G_ '+%/ZM5
MZ']@GPZO^M\4ZI)_NPQK_C5F;]O'PFG^J\.ZS+^,2_\ LU4IOV^-$7_5>$M1
M;_KI<QK_ "S4_6L^E]I_^2FRX>P:_P"7/XO_ #-.']A'P6O^MUO6Y/\ =>)?
M_9#5^']AWX>1_?NM=F_WKN,?RC%<=-^WY;C/D^#)&_ZZ:@!_)#5";]OR[;B'
MP5;KZ;]29OY1BIYL]E]M_>C:.0X1?\N4>G0_L6_#2+[UMJ<W^_?-_0"K\/['
MWPMA^]H5Q+_OZA/_ $<5XM+^WEXBD_U/A'3E_P!Z>5OY 53E_;F\<2?ZGPUH
MZ_[T4[?^SBI]GG<MZK_\"_X)K')<,O\ ES'[D?0</[*GPMAQCPM&_P#UTN9F
M_F]7X?V:_AC#T\&Z<W_70,W\S7S*_P"V=\2[D9AT73$'^Q92G^;U5D_:R^+M
MQ_JK.VC_ -S3"?YFI^J9M+XJS_\  F;QRB@MJ4?N7^1]90? 3X=6W^K\%Z.O
M_;L#5^'X1^"+?_5^$M'7_MRC/]*^.&_:5^-EUPA*?[FDJ/YBJ\GQR^.-U_R_
M74?^Y9Q+_2I_LW,)?%6_\F9M'+(+:$?N_P" ?;T7P_\ "\&/+\-Z0G^[8Q?_
M !-78?#.CV_^JTBQC_W+5!_2O@N3XI?'.Y_YC>II_NB!?Z5"_B[XV77^L\1Z
MLN?^GM%_E4_V/B7\55?>S98"VR7W'Z#16-O!_JK>*/\ W$ J?GWK\Z)+SXOW
M7^L\4:L/^XJZ_P C5=M'^)MW_K_%&H'_ *Z:O,W]:G^PYO>JC58.1^C_ #[T
MUFV#+':/4G%?FU)X#\:W7^OU^5_]^]E:J[?"37YFS+JT1/JTDAJUD/>K^'_!
M*^IR[GZ1RZQ8P?ZV^MH_]^91_6J<WC#08/\ 6ZYIL?\ OWD8_P#9J_.L?!>_
M;[^KQ?\ ?+FG?\*1D;[^JH?^V!/]:T614^M7\/\ @E?4WW/T%F^)/A*W_P!9
MXHT=?^WZ+_XJJ$WQH\!V_P#K/%^CK_V]H?ZU\'1_ ^'^/56/^[;@?^S587X)
MV*]=2G/TB45:R.CUJ/[BOJ7F?;,W[0GPU@SN\:Z1G_9GW?RJE-^TY\,(>OB^
MS?\ ZYI(W\EKXY7X+Z8OWK^[/T"C^E3K\'=%7K->-_P,?X5:R3#=9O\ #_(?
MU-=SZPF_:S^%D/7Q,7_ZYV4[?R2J,W[8WPPB^[JMY-_N:?+_ % KYA7X1:"O
M473?67_ZU3Q_"KPZG6VF?_>F:K62X3O+\/\ (KZG'N?1,W[;'PWBSM.L3?[E
MD/ZL*H3?MS> 5SY>G:](?>VB7_VI7A:_#/PXO_+AGZR-_C4J_#OP[&0?[+C/
M^\S'^M6LHP:[_>/ZG$]@F_;P\)+GRO#^L2?[QB7_ -F-4)OV^-$4_NO".HR?
M[UU&O]#7FB^!]!7II5M_WQFI5\(Z*G32K3\8@:T658+^5_>ROJ<#N9OV^[7G
MR?!LW_;2^7^BU0F_;ZN^?)\'0?\ ;2^/]$KFT\/Z9&,)IUHOT@7_  J9=+LT
M^[:6Z_2)?\*T668)?\N_Q?\ F5]4@:,G[>VO/D0^$M-7_>NI&_\ 91523]N;
MQI+_ *GPWI*?59F_]F%-6VB3[L4:_1 *=M _A'Y5?]GX-?\ +M?B5]4I]BK)
M^VK\29L^5HND(/:QG8_^C*KR?M<?%NX_U=E91_\ 7/3&_JQK3HR?6K6"PB_Y
M=(KZK3[&%)^T]\:+C_5R"+_<TJ/^JFJ[?'[XWW?_ #$;E?\ <T^!/_9*Z,YI
M*T6%PRVI1^Y#^KT^QRLOQ;^-UUUUO4D_W5B3^E57\=?&FXSN\2ZPN?2[1:[2
MD_STJU1HK:FON17L(=CA)-6^+EW_ *WQ/JG_  +4<?R-59+'XE77^M\2Z@?K
MJD@_D:]$I*M1@MHK[BO8P['FK>$?&US_ *[Q!<'_ ']0F:H7^&OB"X_UVL!_
M]Z:1OYUZA1_GI5IVV17LXGE7_"GKYVS)J-O[G8QJ9?@T_P#%J<?X0G_&O3O\
M]*/\]*KG8_9Q/-5^#:?Q:G^4(_QJ:/X.V@^_J,Q_W8E']:]#HI\S'R1['!+\
M(-._BO;D_0**E7X2:2OWKB[;_@:C^E=Q24<S'R1[''+\*]$7K]I;ZRC_  J1
M?ACH*]89F^LQKK?\]*2B['RQ[',I\.= 3_ER+?[TKG^M2+X!T%?^8=&?JS'^
MM=#11=CY5V,-?!6AQ\C2[?\ $9J9?"^CKTTRU'_;,5J_YZ4E(.5=C/7P_IB]
M-/MA_P!LE_PJ9=,LX_NVD"_2)?\ "K5)0.R(5M8%Z0QCZ(!3U55Z*!]!3O\
M/2BF F31DT44QA24M)0!F^)/^1>U+_KW?^1KU/\ 8&_Y%WQ?_P!?<'_H#5Y9
MXD_Y%[4O^O=^WL:]3_8&_P"1=\7_ /7W!_Z U>1F_P#N4_E^9YV-^ ^JZ***
M_/#P@HHHH **** "BBB@ HHHH **** "BBB@ IE/IE=-'J9S"BBBNDS"BBB@
M HHHH **** %6G4U:=7%5^(VCL%%%%9%!1110 4444 %%%% !1110 4444 %
M%%% !0OWA10OWA0!\1?L/_\ )9/$W_7A+_Z/6ON3_/6OAO\ 8?\ ^2R>)O\
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MM-IU-H)$H-%%,0VDI:2F)B&DI324Q"4E.IM "&FTZFU0AII*4TE,D*;3J::
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M^Y9+_5Q5&;]NCP*O^JTK79/]Z")?_:AI?VCGTMK_ /@,?\C5<-X+_GT_O?\
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M2EHH 3_/6DI:* $I*=24#$HHHJAA24M%,8VDIU)0 E)2T4 -HI:2@!*2G4E
M"4E.I*H!**** ,WQ)_R+VI?]>[_R->I?L#?\B[XO_P"ON#_T!J\M\2?\B]J7
M_7N_\C7J7[ W_(N^+_\ K[@_] :O(S;_ '*?R_,\[&_ ?5=%%%?GAX04444
M%%%% !1110 4444 %%%% !1110 4RGTRNFCU,YA111729A1110 4444 %%%%
M "K3J:M.KBJ_$;1V"BBBLB@HHHH **** "BBB@ HHHH **** "BBB@ H7[PH
MH7[PH ^(OV'_ /DLGB;_ *\)?_1ZU]R?YZ5\-_L/_P#)9/$W_7A+_P"CUK[D
M_P ]:^RXA_WY^B_(^7R#_<EZL2FFEI#7SA]$)24M)3)$I*6DH ::;3J;3)$I
M*6DI@(:2E-)0(2DI:2@D2D_STI:2J 0TTTZFFF(;3:<:;0(2DI:2F(2D_P ]
M*6DI@)24M)3)$_STI*6DH 0TVG&FTQ#:2EI*9(?YZ4TTZFTP$-)2FFTR0I*6
MFTQ!2?YZ4M)0(;2&EIIH$)2?YZ4M)5 )333J::9(E)_GI2TE A*2EI* $_ST
MI*6DJB1#3:<:;3$-HHHH 2FTZFU0AII*4TE A*2EI*: 2D_STI:2J)8E--.I
MIH$)11102QIIIIQIIJA"4G^>E+24 -HHHH)$_P ]*;2TE, _STIM.IM-"$I#
M2TAIDC:;3J;3 0TE*:2F E)2TE,@2D_STI:2@!*2EI*H&(:0TIIM!(E--.--
M- #:3_/2EI*8A*2EI*HD2DI:2@!/\]*2EI*"!*0TM(:: ;1_GI11_GK5"$--
M-.--P:!#:;3]I]#364CJ,4P&T?YZ4%@.I _&HWN(D^]+&OU<51#'455DU:QC
M^_>VZ_[TRC^M59O%.BVXS+K%A&/5[I!_6J49/9$\R6[-(TE84GC[PS'][Q!I
MGX7:'^1JM)\3/"<?WO$.G_A,#_*M%1J/[+^XCVD/YD=+_GI25Q\GQ@\%Q-@^
M(;4G_9#G_P!EJL_QL\%I_P QI&_W8G/]*T6&KO[#^YD>WI?SK[T=P:;7G\WQ
MZ\%P_P#,1FD_ZYVSG^E5)/VAO!Z_=GO'^EJP_G5K!XA_\NW]Q'UFBOMK[STD
MTE>7R?M&>%5^['J#_2$#^;53D_:6\/+G;IFIM]5C'_L]6L#B7]AD?6Z'\Z/6
MZ2O')/VFM'7[NCWQ_P!Z1!_6J<W[3]DO^JT&5_\ ?NU7_P!E-:K+\4_L?D0\
M;A_YOS/;J2O"6_:>W?ZOP^OXW>?Y+43_ +2U^W^J\/PY[;IF/\A5_P!FXK^7
M\41]>H?S?@SWJD-?/_\ PT5XBF.(M M<^PE;^M2I\:O'-U_J/#0;_<M)FI_V
M;B%O9?-!]=I/:_W'O5)7A0^(?Q5O#_HWA:ZQZ)H\S_TJ:/7/C3=_ZOPKJ2Y_
MZ@TB_P Q4_49KXIQ7S']94MH2?R/;32&O&19_'>\&(_#VJ)GTL$7_P!"%2)X
M,_: NO\ F$ZHH]62V2I^JP6]:"_[>*]K4>U*?_@+/8*;7E"?"CX_W76VO8_]
MZYA7^1J1?V?_ (\W?+33Q_[VKJH_(-4^RPZ^+$0_\"'_ +1+:A/[CU/FC:?0
M_E7F4?[+_P :KG_7:DD?^_JY/\JF_P"&/?BK><7&NV*C_IIJ$K?R6IM@H[XF
M):IXQ[8>1Z(WR]>/KQ4;3Q+]Z6-?JPKAH_V'_'\G^N\3Z2G_ &\7#'_T"K<?
M["/BB3_7^+]/7UVQRM_/%3[3+H[XE?<ROJ^/EMAW]Z.G?4K-,[KRW7ZRJ/ZU
M!)X@TN/.[4K1?K.O^-9$/[ -\YS-XSM5/?;IS-_.05?A_8!A7_6^-&/_ %ST
MX#^<AJ?K.5K?$?\ DK*6#S)_\N/_ "9#)O&>@6_^MUO3X_\ >N$']:K/\0_#
M"==?T\_[LZG^5;</[ NC+_K?%U^W_7.UC'\R:O0_L%^%D_UGB76)/HL2_P#L
MM3]=RI?\OF_^W7_D7_9^9/\ Y=K[T<=)\3_"D8YURU/^Z2W\A5-_C!X07_F,
MH?\ =AD_^)KTR']A;P,G^LU36I?^VR+_ "6KT/[$/PYCQO;693[WH'\EJ/[2
MRE?:F_DBO[+S)_9BOF>/2?&;PDO346;_ ';=_P#"JLWQR\*Q])KN3_<MS_4U
M[S#^QG\,H?O6%_+_ +]\_P#3%7X?V1OA;#U\.O+_ -=+V;^C"I_M;*ETF_N_
MS+649B^L%]_^1\X/\>O#2_=2^;_M@!_6JTGQ_P!!4?)9WTA_W5']:^IH?V6_
MA;!]WPA;'_?N)V_F]7X?V=?AI!]WP9I9_P!^,M_,FH_MK+%M3G^'^9:R7']9
MQ_'_ "/D!OVA=*_ATB]/U=/\:@D_:(LA]W1Y_P#@4RC^E?:D/P/^'MOC9X)T
M+/JUA&Q_45H0_"WP;;?ZKPIHL?\ NV$0_P#9:AYYEZVH2^\I9%C'O67W'PA)
M^T6H/R:(I'^W=X_]EJ+_ (:$NYO]5H<)^D[-_):_0.'P9X?M_P#5:%IL?^[9
MQC^E7(]#TZ/[FG6J?[L"C^E3_K!@UMAO_)O^ 7_8&(ZU_P#R7_@GYWM\<-?F
M_P!1X?CS_N2O_+%"_%KQI<<1>'%)_P!BRG/]:_1B.SAC^Y!&G^Z@%3<]!Q4_
MZQ4%MAE_X%_P"UP_4ZXC_P E_P""?G3'XV^)-W_J/"]P?]S39C4L=Y\8KMOW
M/A;5#GLFC.?_ &6OT09]O5L?4U&UQ$O65!]6%1_K&OLX:):X=[UY'Y]QZ/\
M'"Z^[X8U9/\ >TT)_,5,/ /QWO/NZ)J4?_ 88_YFOO6;6].M_P#6ZA:1?[\Z
M#^M49O''ANW_ -;XATJ+_?OHA_-J/]8JWV</'[F6N'*?6K+\#X?C^#OQ[NNN
MGWJ#U>\ME_D]65_9\^.=U]\/%G^_J48_D:^R)OBMX)M\^9XOT)3Z?VE"3_Z%
M5";XY?#ZW^_XRT?_ (#=*W\J/[>QS^&A'_P%_P"9JN&\/UG-_/\ X!\E)^RO
M\9[@Y>_ACSUWZP_] :L1_L>_%6?_ %VN62?[VHRM_P"RU].S?M'_  SM_O\
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MJ\C-_P#<I_+\SSL;\!]5T445^>'A!1110 4444 %%%% !1110 4444 %%%%
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M>C^B"N F_;^ SY7@M3_UTU/'\HZI/^WSJLQQ;^#K,'WOG?\ D@J;Y[+>;_\
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MB-X4M5S-XFT>,?[5_%_\57@4/[ =S_RV\8P_]L[$_P!7J]!^P%9_\MO&4_\
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M<_\ 734 /Y)7U!!\&? EM_J_"&C+_P!N:'^E7X?AOX3M_P#5^&-'7_MQB_\
MB:7]IY4ML.W_ -O#_L_,GO72_P"W3Y$?]MNZ?_5>$X?^!7C'^2U7D_;2UU\^
M3X5L@>VZ:1OY5]H0^$-"@_U6B:;'_N6D8_\ 9:N1:390?ZJRMX_]R)1_2E_:
M^7K;"?\ DS'_ &7CGOB?_)4?#'_#7WC6X.(?#>GY_P!F*9OZT]?VF?BC>?\
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M4M% #:*=24P&T4M)3&-HIU)0,;12TE "44M% #:*6DI@%)2T4P$_SUI*=24
M)24ZDH 2FTZB@!M)3J2@!*2EHH ;12TE "44M%,8E)3J2F,2DIU)3 2BEI*!
MB4E.I* $I*6B@!M)3J* &TE+15 -I*=10 VD_P ]:=24#&T4ZDIC&T?YZTM)
M0,/\]:2EHH$)1110 E%+24 )24ZDH ;13J2J&-_SUI*=10 VDIU)0 VBEHH
M;12TE !1110 G^>M'^>M+24QB44M% #:2G4E Q*2G4E,!M'^>M+24P$I*=24
M )2?YZTM% #:*6B@!M%+24P"C_/6BBF E%+24P$I*=24 )24ZDH&-HI:2@8E
M)3J2@8VBEI* "D_SUI:* $I*=24P$HI:2F E%+24 )24ZDH&)24M% #:2G4E
M,8E)_GK2T4#$I*=24P$HHHI@)12TE "44M% #:*6DH 2DIU)0 VBG4E #?\
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MN(?[.A?XK7TT58]C^M)L;T-5[2@MJ,0O'^5'S"GQ._:+U#[EKJ$6?738XO\
MT("GMJ_[2=VN1<7\8/\ =>T0_J:^F]I]#^5)M/H:?MZ:VHQ^X?,OY4?+;0?M
M'W3;7U'5D![_ &VV4?\ CK5(O@;X_7_,OB:\A_W]7*_^@U]0;3Z&C:?0U7UK
MM3BOD'/Y(^6)O@_\;KC_ %OBNX?V.O3XJ-/V>?BE>_\ 'WXJ">N_4YY*^JMI
M]*3:?2J^N36R7W#]HSY8D_9/\7W2YG\6V;GT=IVID?['^OLW[[Q/8A?]F.4G
M]:^JMI]#^5)M/H:?UZMT?X(/:R/F:']C9F'^D>*\'_IG9;OYN*D_X8QM?^AK
MD_\ !<O_ ,<KZ4VGTI-I]*7UVO\ S?D'M)]SYYM?V.-%CQ]H\0WTG_7*WC3^
M>:OK^R#X4 YU?62?9X1_[3KW?:?0TFT^AJ?KE=_:%[27<\.A_9'\(1-E]0UB
M8>C31C^2"M*']EGP%&N'MK^8^K7C#^5>O;3Z4;3Z&I>*K/[;%SR[GDP_9?\
MA\#G^S[P_6^D_P :O6_[.WP_M\?\2!9O^NT\C?UKTK:?0T;3Z5/UBJ_MO[PY
MY=S@/^%$_#\#_D5;(_C)_P#%5/;_  5\"VIS%X6T\?[R%OYDUVVT^E&T^E3[
M:I_,_O#F?<YN+X<>$X1A?#.D8][&,_S6I%\ ^&$8%?#>D*?46$0_]EK?VGT-
M&T^E+GEW"[*%OH6FV?\ J-.M(/\ KG J_P A5K[-%_SRC_[X%2[3Z48/I4W
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M@%%)N7^\/SHW+_>'YT##_/2DI=R_WA^=)N7^\/SH *2C<O\ >7\Z-R_WA^=
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MI-P]1^= P_STI*-R^H_.C</4?G3 **3</4?G1N'J/SI@%%&X>H_.C</4?G0
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M%VKZG%XMM+NWN[F2:-KN>97"LQ(4J%(&!@<<<5S3_L+^-Y#E]:T1SZM+*?\
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M_P"&%?&W_08T/_OY+_\ $5]S44?VUC.Z^X/K%0^&?^&%?&W_ $&-#_[^2_\
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M[\4?^ARM?_!A<_\ Q-?:=%']L8KR^X/;S/BS_ACWXH_]#E:_^#"Y_P#B:/\
MACWXH_\ 0Y6O_@PN?_B:^TZ*/[8Q7E]P>WF?%G_#'OQ1_P"ARM?_  87/_Q-
M'_#'OQ1_Z'*U_P#!A<__ !-?:=%']L8KR^X/;S/BS_ACWXH?]#C:?^#"Y_\
MB:/^&//BA_T.-I_X,+G_ .)K[3HH_MC%>7W![>9\5_\ #'?Q0_Z'&T_\&%S_
M /$T?\,=_%#_ *'&T_\ !A<__$U]J44?VQBO+[@]O,^*_P#ACOXH?]#C:?\
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M)K[6HH_MC%>7W!]8F?%/_#&_Q-_Z&ZR_\#KG_P")H_X8W^)G_0W67_@=<_\
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M_P"AJT__ ,#+C_XFC_AC'XD_]#5I_P#X&7'_ ,37VQ11_;.*[K[@^L3/B?\
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M%?;E%']M8ONON#ZQ,^(_^&*OB)_T,VF?^!4__P 11_PQ5\1/^AFTS_P*G_\
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M?]#)I?\ X%3_ /Q%'_#$_P 0O^ADTO\ \"I__B*^WJ*/[:Q?=?<'UBH?$/\
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MO44?VUB^Z^X/K%0^(?\ AB7X@_\ 0Q:5_P"!,_\ \11_PQ+\0?\ H8M*_P#
MF?\ ^(K[>HH_MK%]U]P?6*A\0_\ #$OQ!_Z&+2O_  )G_P#B*/\ AB7X@_\
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M'_#$GQ _Z&+2O_ F?_XBOM^BC^VL7W7W!]8J'Q!_PQ)\0/\ H8M*_P# F?\
M^(H_X8D^('_0Q:5_X$S_ /Q%?;]%']M8ONON#ZQ4/B#_ (8D^('_ $,6E?\
M@3/_ /$4?\,2?$#_ *&+2O\ P)G_ /B*^WZ*/[:Q?=?<'UBH?$'_  Q)\0/^
MABTK_P "9_\ XBC_ (8D^('_ $,6E?\ @3/_ /$5]OT4?VUB^Z^X/K%0^(/^
M&)/B!_T,6E?^!,__ ,11_P ,2?$#_H8M*_\  F?_ .(K[?HH_MK%]U]P?6*A
M\0?\,2?$#_H8M*_\"9__ (BC_AB3X@?]#%I7_@3/_P#$5]OT4?VUB^Z^X/K%
M0^(/^&)/B!_T,6E?^!,__P 11_PQ)\0/^ABTK_P)G_\ B*^WZ*/[:Q?=?<'U
MBH?$'_#$GQ _Z&+2O_ F?_XBC_AB3X@?]#%I7_@3/_\ $5]OT4?VUB^Z^X/K
M%0^(/^&)/B!_T,6E?^!,_P#\11_PQ)\0/^ABTK_P)G_^(K[?HH_MK%]U]P?6
M*A\0?\,2?$#_ *&+2O\ P)G_ /B*/^&)/B!_T,6E?^!,_P#\17V_11_;6+[K
M[@^L5#X@_P"&)/B!_P!#%I7_ ($S_P#Q%'_#$?Q _P"ABTG_ ,")_P#XBOM^
MBC^VL7W7W!]8J'Q!_P ,1_$#_H8M)_\  B?_ .(H_P"&(_B!_P!#%I/_ ($3
M_P#Q%?;]%']M8ONON#ZQ4/B#_AB/X@?]#%I/_@1/_P#$4?\ #$?Q _Z&+2?_
M  (G_P#B*^WZ*/[:Q?=?<'UBH?$'_#$?Q _Z&+2?_ B?_P"(H_X8C^('_0Q:
M3_X$3_\ Q%?;]%']M8ONON#ZQ4/B#_AB/X@?]#%I/_@1/_\ $4?\,1_$#_H8
MM)_\")__ (BOM^BC^VL7W7W!]8J'Q!_PQ'\0/^ABTG_P(G_^(H_X8C^('_0Q
M:3_X$3__ !%?;]%']M8ONON#ZQ4/B#_AB/X@?]#%I/\ X$3_ /Q%'_#$?Q _
MZ&+2?_ B?_XBOM^BC^VL7W7W!]8J'Q!_PQ'\0/\ H8M)_P# B?\ ^(H_X8C^
M('_0Q:3_ .!$_P#\17V_11_;6+[K[@^L5#X@_P"&(_B!_P!##I/_ ($3_P#Q
M%'_#$?C_ /Z&'2?_  (G_P#B*^WZ*/[:Q?=?<'UBH?$'_#$?C_\ Z&'2?_ B
M?_XBC_AB/Q__ -##I/\ X$3_ /Q%?;]%']M8ONON#ZQ4/B#_ (8C\?\ _0PZ
M3_X$3_\ Q%'_  Q'X_\ ^AATG_P(G_\ B*^WZ*/[:Q?=?<'UBH?$'_#$?C__
M *&'2?\ P(G_ /B*/^&(_'__ $,.D_\ @1/_ /$5]OT4?VUB^Z^X/K%0^(/^
M&(_'_P#T,.D_^!$__P 11_PQ'X__ .AATG_P(G_^(K[?HH_MK%]U]P?6*A\0
M?\,1^/\ _H8=)_\  B?_ .(H_P"&(_'_ /T,.D_^!$__ ,17V_11_;6+[K[@
M^L5#X?\ ^&(O'_\ T,.D_P#@1/\ _$4?\,1>/_\ H8=)_P# B?\ ^(K[@HH_
MMK%]U]P?6*A\/_\ #$7C_P#Z&'2?_ B?_P"(H_X8B\?_ /0PZ3_X$3__ !%?
M<%%']M8ONON#ZQ4/A_\ X8B\?_\ 0PZ3_P"!$_\ \11_PQ%X_P#^AATG_P "
M)_\ XBON"BC^VL7W7W!]8J'P_P#\,1>/_P#H8=)_\")__B*/^&(O'_\ T,.D
M_P#@1/\ _$5]P44?VUB^Z^X/K%0^'_\ AB+Q_P#]##I/_@1/_P#$4?\ #$7C
M_P#Z&'2?_ B?_P"(K[@HH_MK%]U]P?6*A\/_ /#$7C__ *&'2?\ P(G_ /B*
M/^&(O'__ $,.D_\ @1/_ /$5]P44?VUB^Z^X/K%0^'_^&(O'_P#T,.D_^!$_
M_P 11_PQ%X__ .AATG_P(G_^(K[@HH_MK%]U]P?6*A\/_P##$7C_ /Z&'2?_
M  (G_P#B*/\ AB+Q_P#]##I/_@1/_P#$5]P44?VUB^Z^X/K%0^'_ /AB+Q__
M -##I/\ X$3_ /Q%'_#$7C__ *&'2?\ P(G_ /B*^X**/[:Q?=?<'UBH?#__
M  Q%X_\ ^AATG_P(G_\ B*/^&(O'_P#T,.D_^!$__P 17W!11_;6+[K[@^L5
M#X?_ .&(O'__ $,.D_\ @1/_ /$4?\,1>/\ _H8=)_\  B?_ .(K[@HH_MK%
M]U]P?6*A\/\ _#$7C_\ Z&'2?_ B?_XBC_AB+Q__ -##I/\ X$3_ /Q%?<%%
M']M8ONON#ZQ4/A__ (8B\?\ _0PZ3_X$3_\ Q%'_  Q%X_\ ^AATG_P(F_\
MB*^X**/[:Q?=?<'UBH?#_P#PQ%X__P"AATG_ ,")O_B*/^&(?'__ $,.D_\
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M_P#$5]PT4?VUB^Z^X?UBH?#W_##_ (]_Z#^D?^!$W_Q%'_##_CW_ *#^D?\
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M\-?]"=K'_@1#_C1_P\6\-?\ 0G:Q_P"!$/\ C7M/_"COAU_T(GAW_P %D/\
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M_P#Q-'L\+_(_O"V8?\_5]QXM_P /%O#7_0G:Q_X$0_XT?\/%O#7_ $)VL?\
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M=_\ !9#_ /$T>SPO\C^\+9A_S]7W'BW_  \6\-?]"=K'_@1#_C1_P\6\-?\
M0G:Q_P"!$/\ C7M/_"COAU_T(GAW_P %D/\ \31_PH[X=?\ 0B>'?_!9#_\
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MP^_Z$?P]_P""V'_XFCV>%_D?WA[3'_\ /Q?<>4?\/%O#7_0G:Q_X$0_XT?\
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M?\/%O#7_ $)VL?\ @1#_ (T?\/%O#7_0G:Q_X$0_XUZO_P *5^'W_0C^'O\
MP6P__$T?\*5^'W_0C^'O_!;#_P#$T>SPO\C^\/:8_P#Y^+[CRC_AXMX:_P"A
M.UC_ ,"(?\:/^'BWAK_H3M8_\"(?\:]7_P"%*_#[_H1_#W_@MA_^)H_X4K\/
MO^A'\/?^"V'_ .)H]GA?Y']X>TQ__/Q?<>4?\/%O#7_0G:Q_X$0_XT?\/%O#
M7_0G:Q_X$0_XUZO_ ,*5^'W_ $(_A[_P6P__ !-'_"E?A]_T(_A[_P %L/\
M\31[/"_R/[P]IC_^?B^X\H_X>+>&O^A.UC_P(A_QH_X>+>&O^A.UC_P(A_QK
MU?\ X4K\/O\ H1_#W_@MA_\ B:/^%*_#[_H1_#W_ (+8?_B:/9X7^1_>'M,?
M_P _%]QY1_P\6\-?]"=K'_@1#_C1_P /%O#7_0G:Q_X$0_XUZO\ \*5^'W_0
MC^'O_!;#_P#$T?\ "E?A]_T(_A[_ ,%L/_Q-'L\+_(_O#VF/_P"?B^X\H_X>
M+>&O^A.UC_P(A_QH_P"'BWAK_H3M8_\  B'_ !KU?_A2OP^_Z$?P]_X+8?\
MXFC_ (4K\/O^A'\/?^"V'_XFCV>%_D?WA[3'_P#/Q?<>4?\ #Q;PU_T)VL?^
M!$/^-'_#Q;PU_P!"=K'_ ($0_P"->K_\*5^'W_0C^'O_  6P_P#Q-'_"E?A]
M_P!"/X>_\%L/_P 31[/"_P C^\/:8_\ Y^+[CRC_ (>+>&O^A.UC_P "(?\
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M  \6\-?]"=K'_@1#_C7J_P#PI7X??]"/X>_\%L/_ ,31_P *5^'W_0C^'O\
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M ,%L/_Q-'_"E?A]_T(_A[_P6P_\ Q-'L\+_(_O#VF/\ ^?B^X\H_X>+>&O\
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M(A_QH_X>+>&O^A.UC_P(A_QKSS_A!_#O_0"T[_P%3_"C_A!_#O\ T M._P#
M5/\ "C^RJ';\P^L8[_GXON/0_P#AXMX:_P"A.UC_ ,"(?\:/^'BWAK_H3M8_
M\"(?\:\\_P"$'\._] +3O_ 5/\*/^$'\._\ 0"T[_P !4_PH_LJAV_,/K&._
MY^+[CT/_ (>+>&O^A.UC_P "(?\ &C_AXMX:_P"A.UC_ ,"(?\:\\_X0?P[_
M - +3O\ P%3_  H_X0?P[_T M._\!4_PH_LJAV_,/K&._P"?B^X]#_X>+>&O
M^A.UC_P(A_QH_P"'BWAK_H3M8_\  B'_ !KSS_A!_#O_ $ M._\  5/\*/\
MA!_#O_0"T[_P%3_"C^RJ';\P^L8[_GXON/0_^'BWAK_H3M8_\"(?\:/^'BWA
MK_H3M8_\"(?\:\\_X0?P[_T M._\!4_PH_X0?P[_ - +3O\ P%3_  H_LJAV
M_,/K&._Y^+[CT/\ X>+>&O\ H3M8_P# B'_&C_AXMX:_Z$[6/_ B'_&O//\
MA!_#O_0"T[_P%3_"C_A!_#O_ $ M._\  5/\*/[*H=OS#ZQCO^?B^X]#_P"'
MBWAK_H3M8_\  B'_ !H_X>+>&O\ H3M8_P# B'_&O//^$'\._P#0"T[_ ,!4
M_P */^$'\._] +3O_ 5/\*/[*H=OS#ZQCO\ GXON/0_^'BWAK_H3M8_\"(?\
M:/\ AXMX:_Z$[6/_  (A_P :\\_X0?P[_P! +3O_  %3_"C_ (0?P[_T M._
M\!4_PH_LJAV_,/K&._Y^+[CT/_AXMX:_Z$[6/_ B'_&C_AXMX:_Z$[6/_ B'
M_&O//^$'\._] +3O_ 5/\*/^$'\._P#0"T[_ ,!4_P */[*H=OS#ZQCO^?B^
MX]#_ .'BWAK_ *$[6/\ P(A_QH_X>+>&O^A.UC_P(A_QKSS_ (0?P[_T M._
M\!4_PH_X0?P[_P! +3O_  %3_"C^RJ';\P^L8[_GXON/0_\ AXMX:_Z$[6/_
M  (A_P :/^'BWAK_ *$[6/\ P(A_QKSS_A!_#O\ T M._P# 5/\ "C_A!_#O
M_0"T[_P%3_"C^RJ';\P^L8[_ )^+[CT/_AXMX:_Z$[6/_ B'_&C_ (>+>&O^
MA.UC_P "(?\ &O//^$'\._\ 0"T[_P !4_PH_P"$'\._] +3O_ 5/\*/[*H=
MOS#ZQCO^?B^X]#_X>+>&O^A.UC_P(A_QH_X>+>&O^A.UC_P(A_QKSS_A!_#O
M_0"T[_P%3_"C_A!_#O\ T M._P# 5/\ "C^RJ';\P^L8[_GXON/0_P#AXMX:
M_P"A.UC_ ,"(?\:/^'BWAK_H3M8_\"(?\:\\_P"$'\._] +3O_ 5/\*/^$'\
M._\ 0"T[_P !4_PH_LJAV_,/K&._Y^+[CT/_ (>+>&O^A.UC_P "(?\ &C_A
MXMX:_P"A.UC_ ,"(?\:\\_X0?P[_ - +3O\ P%3_  H_X0?P[_T M._\!4_P
MH_LJAV_,/K&._P"?B^X]#_X>+>&O^A.UC_P(A_QH_P"'BWAK_H3M8_\  B'_
M !KSS_A!_#O_ $ M._\  5/\*/\ A!_#O_0"T[_P%3_"C^RJ';\P^L8[_GXO
MN/0_^'BWAK_H3M8_\"(?\:/^'BWAK_H3M8_\"(?\:\\_X0?P[_T M._\!4_P
MH_X0?P[_ - +3O\ P%3_  H_LJAV_,/K&._Y^+[CT/\ X>+>&O\ H3M8_P#
MB'_&C_AXMX:_Z$[6/_ B'_&O//\ A!_#O_0"T[_P%3_"C_A!_#O_ $ M._\
M 5/\*/[*H=OS#ZQCO^?B^X]#_P"'BWAK_H3M8_\  B'_ !H_X>+>&O\ H3M8
M_P# B'_&O//^$'\._P#0"T[_ ,!4_P */^$'\._] +3O_ 5/\*/[*H=OS#ZQ
MCO\ GXON/0_^'BWAK_H3M8_\"(?\:/\ AXMX:_Z$[6/_  (A_P :\\_X0?P[
M_P! +3O_  %3_"C_ (0?P[_T M._\!4_PH_LJAV_,/K&._Y^+[CT/_AXMX:_
MZ$[6/_ B'_&C_AXMX:_Z$[6/_ B'_&O//^$'\._] +3O_ 5/\*/^$'\._P#0
M"T[_ ,!4_P */[*H=OS#ZQCO^?B^X]#_ .'BWAK_ *$[6/\ P(A_QH_X>+>&
MO^A.UC_P(A_QKSS_ (0?P[_T M._\!4_PH_X0?P[_P! +3O_  %3_"C^RJ';
M\P^L8[_GXON/0_\ AXMX:_Z$[6/_  (A_P :/^'BWAK_ *$[6/\ P(A_QKSS
M_A!_#O\ T M._P# 5/\ "C_A!_#O_0"T[_P%3_"C^RJ';\P^L8[_ )^+[CT/
M_AXMX:_Z$[6/_ B'_&C_ (>+>&O^A.UC_P "(?\ &O//^$'\._\ 0"T[_P !
M4_PH_P"$'\._] +3O_ 5/\*/[*H=OS#ZQCO^?B^X]#_X>+>&O^A.UC_P(A_Q
MH_X>+>&O^A.UC_P(A_QKSS_A!_#O_0"T[_P%3_"C_A!_#O\ T M._P# 5/\
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M3,**** "BBB@ HHHH 5:=35IU<57XC:.P4445D4%%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MG-Y#;@80+NVW%M_NX;@=@R^@K]#M-U"#5]-M+ZU;?;7423Q-ZJP!!_(U\?\
M[>EC')\/_#=WY:F:'5&C$G<*T3$C\2J_E7O?[,E\=0^ /@:5N2NFI#_WP2G_
M ++1C5ST857OL1EK]GB*M!;;GIU%%%>*?1A116+XUNC9>#=?N%<QM%I]PX9>
MH(C8Y%-*[2%)\J;/SY\57L_[4?[2UXLDSMX>LY'BC*9 2RA8CC(X,C<\_P!_
MVKZOL[.#3K."TM84M[:!!'%%&,*B@8  ]*^8/V*;-);KQ5?.NZY6*VB$G?#&
M1F'XE5_*OJ6ONHQ4(J$=D? 46ZEZLMY,****HZ HHHH **** "BBB@ HHHH
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M6SA$52S,<>@!-1:;K6G:UYG]G:A:ZAY9VO\ 99TEVGT.TG%9'Q*_Y)OXN_[
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M,JQID]!EB!FF9EBBD1EDC5T8.C#*LIR"/4'O2T %%%% !1110 4444 %%%%
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MF$%Q-;I(HCD*[@IWJIZ<\5\X?\%2O^398?\ L.6O_H,E<C_P2/\ ^22^._\
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MBB@ HHHH **** "BBB@ HHHH X/X[?\ )'_%7_7F?_0A5/\ X)V?\D^\6?\
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M\"_#/5(--\4>)+71KZ:$7$<,Z2,6C+,H;Y5(QE6'X5W%?G9_P4<_Y+'X?_[
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M_P#L$/\ ^E,=>9F'^[R]#%?[W0]6??-%%%?"GV 4444 %%%% !1110 4444
M%%%% !1110 4RGTRNFCU,YA111729A1110 4444 %%%% "K3J:M.KBJ_$;1V
M"BBBLB@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OBS_@I!_J_
M 7_;]_[0K[3KXL_X*0?ZOP%_V_?^T*]#+_\ >8_/\CR<V_W.?R_-'TA\)_\
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M-.X+$R.1G+,<GW.:[;]OW_@H=XY\%_%JZ^%7PGG72KO3GCM]0UB.%)[F:Z<
M^1"K@JH7<%)P6+$XQ@$O[-F+[6AXE\3?^"5OQ#^%OP5U/XA7/B[2[S4=(T\Z
MGJ&CP+*LD42J'D"RGAF0;B1@9V\$U] ?\$E_VJ?%?Q(NO$/PQ\7ZG=:\VEV
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M %%%% !1110 4444 %%%% !1110!\/?M_?\ )1/!O_8.;_T>:^\K'_CQM_\
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M!T/V>Z3([$JZGNKL._'O_P#P1S_Y.'\5_P#8L2_^E5O0I7DAN/+"5MF>D?\
M!3K]M3Q-X7\9/\)O FKW&AK:01RZYJ5BYCN)))%#I;I(.54(RLQ4Y);&>"*\
M>TS_ ()4_&;6/AJGBUM0TN'79K?[7'X;GGD^V,I&X(7V[!(1_"3UX)S7 ?M1
M>1I?_!03Q5+X@ 33D\7PSW/V@?+]E,L;9.?X?+(_"OW94B1@8N5;[FWT[4TN
M9NY$I.E&/+U/RE_X)L_MF^+=/^)UG\(?'NJ76KZ5J3/:Z7/J3L]Q872 D0EV
MY,;;2NUC\I"XP,@\A_P5^N)H?VF-$5)71?\ A&;;A6('^ON*\HTV6'6/^"BT
M$V@;9;2;XF"6V-L/E,/]I;LC'\.S)^E>J?\ !83_ ).:T3_L6;;_ -'W%3?W
M6:J*51-=4:6C_L)?M _M5?#/0/&GB+QC801_V5!'H&AZI<2@_9%B58=JHI2+
M>JJ<GELAFZUQ7_!.OXT>*?@W^T]I/@6\U"XCT#7+Y](U+2II"T27'S*DBKT#
MB10N1C()!XK]:?V:?^3>_A=_V+6F_P#I-'7XR_"G_E(5H_\ V/[_ /I8U-KE
MLT1&7.I1>Q^Y&N>+]!\,RQ1:QKFFZ3)*I:-+Z[CA+@'!(#$9&?2L^+XH>#+B
M5(HO%^@R2.P5434X"6).  -W)KYV_;5_85E_:\\2>&=4C\:IX5&BVDMJ8FTL
MW?G;Y-^[(E3;CIC!KP/PK_P1QG\-^)]'U<_%F&Y&GWD-V8?^$>*^9L<-MS]I
M.,XQG!K1N5]$<T8P:NY:G:_\%D/^3??!O_8T+_Z27%:7_!(-UC_9@UQY&"(O
MB6Y+,QP !;V^2:SO^"RC^9\ ?![8QN\4J?\ R5N*Q?\ @F['/-^P3\4H[56:
MZ>XUA8E0$L7.GQ[0,=\XI?;-/^7/S/F7]H#]HKXD_MU?'I/A]X'O;J+PO=WS
M66CZ+#,8(9T3)-S<G^+A#(=V0@' R.:_QR_8/^+?[(/A:S^(]EXHMKR"RF07
M-]X>N9H;C3Y'.%8Y"DJ2=I9?49&#7B/[-/A?XA>,OBUI^D?"_66T/QI<0S?9
M+A-1%C(RA"TB++D<E0W&>0#7UOXH_8W_ &V/&V@W>B:_XMNM:TB\ 6XL;[Q<
M)890&# ,C/@\@'\*R^+4Z7:#44TD?6O[#W[7=Y\;OV<]>\1>*E^U>)?!L<HU
M62%0IO8TA:6.4#H'9493CC<N>,X'YU>$)/B-_P %)?VC/[%USQBNE1SI/?1P
M3N[6MA;)C,=O #AGP0.Q;!+-P37W'_P3J_9,\?\ [-4GQ#3XC6>FV^E:W:VT
M44<5_'<QOL,@D#@' !5P.>N<5XM\8_\ @E7XETGQI-XB^!OBRQFMUF^T6^ES
MW_V:\L"3TCG4D,HR<%BK8P/F/-6[M(QBX1E*S/._BM^Q'\<?V1?'^BZM\)]4
M\0^+H[A&>+4_#-C,LT!0J3'<1(77:V00"2K8/'!K[C^+'CCQ/\0?^"<GC'7_
M !CH%WX6\5W'AN9-1TV[MVMY$F241LXC;E5?;O ]'%?"UQ^U#^UC^QKXFT[3
MO']UJ=]93,TD=EXI"WL-X@9=_EW.2_3 X?Y=P..17W;\8_C%IGQ\_P""=?C7
MQYI$,EK:ZMX<F9K:4Y:"5)1'+&3WVNC#/< 'O1&VMA3YO=;U\SY&_P""-=Q+
M-\7O'_F2._\ Q(8_O,3_ ,O"5=_X*3?MG>+-0^)MY\(? .J7.DZ5IK);:I<:
M9*4N+^Z< F'>O(1-P4J#\S;L] *SO^",_P#R5_Q__P!@&/\ ]*$KPGQ$R:;_
M ,%&+F35V6&WB^)XEN'N.$$?]IABS9_AV\_2IO[J1KRIU6WT/1]6_P""4_QF
MT3X;2>+$U'2[C78+?[7)X<MYY#>*H&XHKXV-(!_"#UX!)KV#_@F/^VKXF\3>
M,X_A)X]U:XUL7<$CZ'J-\YDN$DC4N]N[GEU**S*6.04(SR!7Z<L0C$OP%.6S
MV]:_"+]EV2'6/V_O"<_AM"NGR^+II[581M M/,D<\=@(L_A5-<K5C.,G5C)2
MZ';?\%7+J:W_ &O+WRY73&BZ>?E8C^ UVNN?L _M#?M%>"K;XB>*_%^GW>LW
M.GQW&GZ!?74GF+;^6IBC3"^5$2H'RCC)R3DDUPO_  5B_P"3N[[_ + MA_Z+
M-?L'\+_^26^#/^P%8?\ I-'0HJ4G<<IN$(M'Y*?\$L_CQXD\'_M!:?\ #NXU
M"YN/#'B1+B%M/FE+16US'$\J2HI^ZQ\LH<8SN&>@KZE_X*->./CU?7VG^!?A
M'X5\6/HDEH+G5==\/6$[M.[$[;=)HQ\H4+EMI!)8 \#GX/\ V _^3X/A]_V$
M;K_TFGK[6_X**?M[>*_@AXP@^'/P[>'3=96UCN]1UN6)9I(O,Y2*%&!4' W%
MF!Z@ #DE1?N:CG']ZK(^>KC_ ()5_$J'X-W/CJ_\2V-KK\.G/JDOAVXCE%PB
M+&9&B:3H)<#[N,9XSFO1_P#@E+^U)XLUKQQ<_"?Q+JEQK>CR6$EWI,U[*TDM
MF\6W="K'),94G"GA=O& <5%;_LM?M=^,/AG<^,-=^-UYI-M>:9+J,^BW&O7O
MF>08C(4:.)?+!9/X <#.#BO$?^"5_P#R>#H7_8.OO_1)I;-6&_>A*[N=!_P5
MT_Y.HMO^Q?L__0I*_4_]FG_DW?X:?]B]9?\ HE:_+#_@KI_R=1;?]B_9_P#H
M4E?J?^S3_P F[_#3_L7K+_T2M:1^)F-3^'$]*4;F ]>*_%7]H3XQ>/OVTOVJ
MC\-;/Q"="\-2:Z^C:5I\\[0VD820IY\RC[\C;"W()!(5??\ :G.WG.*_.?\
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MC#+YXUB!F7OM,! /TR#7=6_>UXTF]+'#1_<X>56*]Z]CY0\3:/\ %K_@GO\
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M#SWJR%'19(X]@V G.9 ?P-?J%XN_Y1WW'_9.H?\ TA2OC?\ X)-?\E^\3_\
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M?_!(_P#Y)+X[_P"PY%_Z3BNE_P""G'_)J>F_]A6R_P#13US7_!(__DDOCO\
M[#D7_I.*]!_[VO0\Y?[F_4^[:_/K_@IW^TAXL\"ZGHOP[\,:A/HEMJ%A_:&H
MWUH[1SS*TC(D*N,%5_=DMCKD#H"#^@M?-'[8W[(WA_\ ::L["Z37;?PYXRTN
M)H;6[G(:*:(DL(9ESN"[B2&'(W-PV<5TXB,Y4VH;G-AY0C43GL?'N@_\$S?$
M_B;X(V?CFP\96MWX@OM.74[;1HH&=)8VCWB(3AN9#TQMVYXS7K'["^K?'*RD
MUKX<?$'P[XG@\,7VDW":;JFO6,X%A/LPL?FNO^K8$X4G@J .M>,7WP%_:O\
MV6=-FO?#FJ:K)H%AOG;_ (1_4?M=JJ*.9&M6[8YYC.,$]J^BOV$_VZ-;^.7B
M27P)XY@MFU];5[FQU6U41"Z"8WQR1CC?M^8%< A6R*\^DH1J15G%_F>C6<Y4
MY.ZDOR/@O]J#]G/6/V:/&VF^'M:UNSUVXOM/6_2>S60*BF21-IW@'.8R?QK[
MH_X)Y?LI:[\,KG2_BA?>(K&_TKQ'X;7R-.@67SH/.:*5=V1MX"$<'J:\2_X*
MS_\ )=O"O_8MQ_\ I3<5^@?[+<BP_LR_#!Y#M1?#5DS-Z 0J2:="E!8B2["Q
M%:;P\7WW/@CX]^'_ -HW]JKXS-H<GAGQ-X:\$R:@;2PCNK.XM]-@@5R%N)VV
MX8D#<6.>N%QQ7GO[1'[''C?]D'2=$\:67C"._B>[%O\ ;=),MK/:3E"0<YSM
M.& 8'/'(YKO/&7[97QC_ &HOC)'X$^$^I-X8TK4+B2WT]+-EAGEB0%S/-.1N
M3Y$+D(1@9'/?#_:T_9Y^-WPP^%L.L_$/XJR>,]$:_B@&FG5+RY"S,K%7VS*%
MX (SUYK&:A-2G%-^9M3<X.,)-1\C[>_87_:"U#XY? <ZOXFN%EUO0[A['4+S
M 7SE5 Z2MV#%#S[KGO7YU_%[XP?$']M_XY0>']"DN9=.N[QK?0]#24QP0Q#/
M[Z0=-VP%W<]!D=!BOHC_ ()\6US>?L>?'2WLE=[R9;R.%8_O&0Z<P4#WR17C
M7_!+^XL8?VI;9+PH)Y='O$L]_4S85CM]_+$GX9K2<I58TH-Z/<SA&-*56<5J
MMB]\5_V.?C#^RO\ #'6_$=EXMM;WP[=VJV6NVNE7$B 12,$ >-P Z[F W#D%
MN.IKT_\ X)#32SZU\4 [M(?LVG8W$G^.XKZA_;\_Y-#^(?\ UPM?_2R"OEK_
M ()![CK'Q2"?>^S:?CZ[[BK]G&EB81CM_P .9^UE6PLY2WO_ )'(?ML?M3>,
MOC'\7KOX5> KRZAT"VO1I(M]-E*2:M=;MC[V!&4W$J%SC@D]>.<^(W_!._XI
M_!GX>W'CU-=TZ[NM(A^W7MKI=Q*MS:*F&9T? #%.I*GH"17A>C:3XLU;]H$:
M;X?OFTWQG/K\D-I=_:?LS1W9F8 ^:3\AW=\U]8:M^RW^V9KFF7FFZCXPOKVP
MNXF@N+6X\5AXY8V!#(RE\$$$@@URJ]9RE*+;\NAU.U%1C&22\^I[C_P3C_:B
MUGXU>&-8\)>+;UM1\1Z D<T%_,1YMU:,=OS_ -YD; +'J'7.37V97P;^P7^Q
M]\2OV>_BUK&O^,+*PM=,NM&EL4:UOXYV,IGA< JIR!B-N?:OO*O7PW/[-<^Y
MX^)Y/:OV>P4445U'*%%%% !1110 4444 %%%% !1110!P?QV_P"2/^*O^O,_
M^A"J?_!.S_DGWBS_ +"R?^B5JY\=O^2/^*O^O,_^A"J?_!.S_DGWBS_L+)_Z
M)6O/S#_=W\C7!_[]#T9]9T445\D?9A1110!^8FA?\G'>,?\ K_U+_P!'FO6Z
M\DT+_DX[QC_U_P"I?^CS7K=?HM#^&CXG"_#+U84445T'8%%%% !1110 4444
M %%%% %#7KM]/T'5+J-MLD%I-*C>C*C$'\Q7Y?\ ['.DKXJ_:4\-27A$C0RS
M7[;@#N=(V8?^/8/X5^H>M6;ZEHNHV<?^LN+:6%?]YD*C]37Y<?LFZRO@3]I7
MPW'J)6WW74NFRM(=H1W5HP/KNP/QKQL=_&HWVO\ Y'=A_P"'.VY^J=>+_$O]
MDGP!\5_%UUXDUR&_&I7*(DAM;GRT.Q0H.,=< 9->T=.*^>_BM^VMX.^$OCJ_
M\+7NE:KJE[9;!--8>48PS*&V?,X.1D \5Z-=TE']]MYG-3YV_P!WN>8?\%&K
M--/\$_#VTC9FCMYYX59SEBJQ1 9/K@5Y'\$_V?\ XD?'OX8Q6UGXAM]%\%V-
MU+]FM[F1PD]P2"[;$!SC(&YNG0=Z];_X*-78U#P3\/+H1M$)YYY1&_WEW11'
M!]QFO2/V!_\ DWFS_P"PE=?S6O(E2C6QLHRVM_D=JFX4$UO<^*]#UCQC^R?\
M:S92W;6]SI]S&E];PR,UO>6YP2".-RE3D'&0?<5]:_\ !0Z[$WP2\/7$#LJ2
MZS$ZD'!VFWE(_G7S5^W7_P G':Y_UZVG_HE:^A_V^/\ DWCP=_V$;7_TDDK&
M'N4Z])/1;?>7+WI4Y]6?*?PU\#_%+XU>$SX8\+VUU?>&]/O&NIP9UAMUGD51
MEV9AO8*@P.2 2<<U].>-/B3XA_9._9@\(^%S&EGXYOOM$,;;EE%K&)"SR@C(
M)PZ >A;/:N@_X)T_\D9UK_L-R?\ HF*O*/\ @I)!>+\0/"$SEOL#Z7(D/IY@
MF8R?HT?Z548>PPOMXM\S5O343E[2M[-K1'$?"W]EGXA?M&Z/<^,;O6X[:"XD
M80WNLS222WCKPQ& 3M!&W<>."!TJ+P%\4O'G[(?Q5D\.:[/-/I5M,J:AI+2F
M2"2)\-YT.>C8.X$8ST/>ON;]E6:UF_9W\"&SV^4-/VMM_P">@=A)_P"/[J^,
M_P#@H=<03?':S2)E:6+1;=9MI&0QDE(!]#M(/T(I5:"P]&->F_>T_$<*CJ5'
M3DM#V3_@HIJ$=Y\*O!=W9S;X+C4S+')&>&1H"0?Q!%>%? [X+_$S]H#X>MI.
MG^((]%\$Z?=R,%NI'"3W+;2WR("7( 7EN!V[UZ5^V#')%^RO\&TF!$JQ6H8$
M<C_05XKTW_@GK_R0N[_["\W_ * E:2@J^,<9;-?H0I.G0NNY\8W\/C3]D_XQ
M&V6]\C5M->.1C:RMY%Y"P#;3TW(PX((X(/<5]U?MC:LFK?LLZOJ5JQ6&[6QN
M(R#CY7EC8?H:^4?^"@/_ "<#)_V"K7_V:OI3]I;_ ),IA_[!VD_SAJ:*]FJ]
M);*_ZE3]YTYO=GGW_!-2228>/PSLYS8XW'/_ #VKS[]I;XY^*_C=\6)? 'A.
MZN(]#2]_LRWLK5S']NF#;6>4CJN[. >  #UKO/\ @FJ&:'XAA/OE;(+]<3XK
MQ']F?%I^UAX=34O]>NK3QMOY/G8D _'=6?-+ZO1IIV4F[_>59>UG/M_D;/Q.
M_8]\??!'PB/&8UFTNA8M')='2YI$FM"6 #AB!N 8@94Y&<]*^I_V)_CMJGQ@
M\$:EIWB"8W>N:"\4;WC?>N(9 WEL_JP*,">^ 37O^O7&EVNCW<VM2V<.E(F;
MF2_9%@5/]LO\H'3K6)X)U;P1JCW@\'WGA^[9 GVK^PY8'*@YV;_*/'1L9]Z]
M2GA50JJ5.5EV..=9U(6DM>YU5?G9_P %'/\ DL?A_P#[ $?_ *47%?HG7YV?
M\%'/^2Q^'_\ L 1_^E%Q4YE_N[]4/"_Q#ZP\%^.[/X9?LG^&/%%^IDM]-\,6
M<HB!P97\E B#_>8@>V<U\.>'=(^)?[:OQ!OO.U8&*V7SY6N)&6SL(V;"HD8S
MR>@ &3M.3Q7T/\;DE?\ X)^^%?+#$+IVCE]H_AVKR?;.*^9_V=_!/Q6\90ZV
MGPSUV32_LYC:^A@U7[&SYW;&(R-PX(S7#B9.4Z=)IN-D[+J=-&*C&4]G<T_&
MW@7XD?L7^--)U"TUI?+NLO!=V,CFVN0A&Z*6-L9Z]&'0Y!ST^R?'W[1TEE^R
MS'\3-#MUCU#4+>**"-QN6VN7<QN2#]X(ROC/7 ZBOFKQ9^RG^T3X\M[>W\1:
ME_;D%NQDBCO]=698V(P2 S'!Q7T=\)?@"]C^S2_PX^(B0PF>><GR;E'\K<^^
M-T?IN!YQ]?6M,/&K&4X0BXQ:TOT9-64)*+DTW?H?)?P)^ >O_M97WB#7=;\9
MRP&RD2.:XN5:ZN)'<$KA2P 0 'OQT K;\+^!_C=^S'\4GM]!TO6_$6BV\Z-<
M#3K2::QOX2!GC& VWC/WE(J_JO[%WQ7^&NJW&I_#KQ$NJ0 ,([G2;\V=T5_N
MLNX GV#$?2F^ ?VQ/B;\(_&T?AWXEQW&I64,JPWD&H0+'>6Z<#>K@#?@?-\V
M=WKSFN6,(TN7VJ<97^(V<G._(TUV/7?^"BERS?!OPO,GF0F36HVVMPRYMI3@
M^XK3_P""?=TL?P"U&>XEVQQZW=.\DAX51# 22?0#-97_  48F2X^#?A>:)M\
M4FM1NC>JFVE(/Y51_8]CEF_8_P#'*0@F5IM4"@=2?L<? KOO;'-^1S;X=+S/
M"?B9\7/''[67Q6C\+>';B>'1;FY,&FZ4DIBB,:Y/G3XZG"[B3G;C ''*_%#]
MD_XA?L^Z##XQM-:BNX;1U,]UH\TL<UFS<!CD [<G&X>H]:L_\$_9H(_V@469
ME6232KI80QY+_(<#WVAOR-?<?[2D]K;_  !\>O>!3!_94JX;^^<!/_'RM<M&
M@L31E7J/WM?E8VG4=*:IQ6AP7[&/[05]\:?"-[I^OR";Q)HK()KD+C[3"^=D
MA XW @@XZ\'O7P[?:AXFM_VE-5_X129U\1/XENHK#D8$KW#HOWN/XN]>O?\
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MZJ0<$$<'J#7[@LQ8Y))/O2B5U& [ ?6FXW5A*5G<9&=JH>X K^>K]M+X._\
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M]#M!=0"<=JZK_@HI^P)XE^(WC.;XH_#.Q.K:G=H@UC1(6"SO(@"K/ #C<2H
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M35</B1%3X&?#'[$W_'OXL_[=/Y2U]/5\P_L3?\>_BS_MT_E+7T]7W;/@</\
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MKW8Y"AN,9-?KJK,OW25^AI?,;=NW'=ZYYK+ZFK.*DTGT-?KCNI.*;74^&?\
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M^[I\)\Q_L Z#J?A[X0ZQ;ZKIUWIEPVL2.L5Y T3%?)B&0& .,@\^U=M^U%\
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MBBBN8[0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB*5;L!@0PME!$(/URS?\#KQLTJ*-!KJS.A'VV-@E]F[9]&4445\6?7!1110
M4444 %%%% !1110 4444 %%%% !3*?3*Z:/4SF%%%%=)F%%%% !1110 4444
M *M.IJTZN*K\1M'8****R*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /B7]IK]F37/"7BF3XD?#A)DV2_;;JSL!B:TF'+31 =4/)*CID\
M$'C6^$G[<^C:G9PV'CV%](U)/D;4K6)GMY<#[SHN60^H (^G;[$KR'XF?LK?
M#SXH337=[I']EZK)DMJ&ED02,WJX VN?<C/O7KTL9&45"NMNO4\*K@:M*;JX
M1VONGL:.F_&SX?ZLH-IXTT.8E=VT7T88#W!.1^-7O^%H>#O^AJT;_P #H_\
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M?^!T?^-?-G_#N"'_ *'MO_!4/_CM'_#N"'_H>V_\%0_^.T<V%_Y^?@PY\?\
M\^5]Z/I/_A:'@[_H:M&_\#H_\:/^%H>#O^AJT;_P.C_QKYL_X=P0_P#0]M_X
M*A_\=H_X=P0_]#VW_@J'_P =HYL+_P _/P8<^/\ ^?*^]'TG_P +0\'?]#5H
MW_@='_C1_P +0\'?]#5HW_@='_C7S9_P[@A_Z'MO_!4/_CM'_#N"'_H>V_\
M!4/_ ([1S87_ )^?@PY\?_SY7WH^D_\ A:'@[_H:M&_\#H_\:/\ A:'@[_H:
MM&_\#H_\:^;/^'<$/_0]M_X*A_\ ':/^'<$/_0]M_P""H?\ QVCFPO\ S\_!
MASX__GROO1])_P#"T/!W_0U:-_X'1_XT?\+0\'?]#5HW_@='_C7S9_P[@A_Z
M'MO_  5#_P".T?\ #N"'_H>V_P#!4/\ X[1S87_GY^##GQ__ #Y7WH^D_P#A
M:'@[_H:M&_\  Z/_ !H_X6AX._Z&K1O_  .C_P :^;/^'<$/_0]M_P""H?\
MQVC_ (=P0_\ 0]M_X*A_\=HYL+_S\_!ASX__ )\K[T?2?_"T/!W_ $-6C?\
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MT/!W_0U:-_X'1_XT?\+0\'?]#5HW_@='_C7S9_P[@A_Z'MO_  5#_P".T?\
M#N"'_H>V_P#!4/\ X[1S87_GY^##GQ__ #Y7WH^D_P#A:'@[_H:M&_\  Z/_
M !H_X6AX._Z&K1O_  .C_P :^;/^'<$/_0]M_P""H?\ QVC_ (=P0_\ 0]M_
MX*A_\=HYL+_S\_!ASX__ )\K[T?2?_"T/!W_ $-6C?\ @='_ (T?\+0\'?\
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M1_XT?\+*\(_]#1H__@='_C7S_P#\.X(?^A[;_P %0_\ CM'_  [@A_Z'MO\
MP5#_ ..T<^%_Y^?@PY<?_P ^?Q1] ?\ "RO"/_0T:/\ ^!T?^-'_  LKPC_T
M-&C_ /@='_C7S_\ \.X(?^A[;_P5#_X[1_P[@A_Z'MO_  5#_P".T<^%_P"?
MGX,.7'_\^?Q1] ?\+*\(_P#0T:/_ .!T?^-'_"RO"/\ T-&C_P#@='_C7S__
M ,.X(?\ H>V_\%0_^.T?\.X(?^A[;_P5#_X[1SX7_GY^##EQ_P#SY_%'T!_P
MLKPC_P!#1H__ ('1_P"-'_"RO"/_ $-&C_\ @='_ (U\_P#_  [@A_Z'MO\
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M\(_]#1H__@='_C1_PLKPC_T-&C_^!T?^-?/_ /P[@A_Z'MO_  5#_P".T?\
M#N"'_H>V_P#!4/\ X[1SX7_GY^##EQ__ #Y_%'T!_P +*\(_]#1H_P#X'1_X
MT?\ "RO"/_0T:/\ ^!T?^-?/_P#P[@A_Z'MO_!4/_CM'_#N"'_H>V_\ !4/_
M ([1SX7_ )^?@PY<?_SY_%'T!_PLKPC_ -#1H_\ X'1_XT?\+*\(_P#0T:/_
M .!T?^-?/_\ P[@A_P"A[;_P5#_X[1_P[@A_Z'MO_!4/_CM'/A?^?GX,.7'_
M //G\4?0'_"RO"/_ $-&C_\ @='_ (T?\+*\(_\ 0T:/_P"!T?\ C7S_ /\
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M<?\ \^?Q1] ?\+*\(_\ 0T:/_P"!T?\ C1_PLKPC_P!#1H__ ('1_P"-?/\
M_P .X(?^A[;_ ,%0_P#CM'_#N"'_ *'MO_!4/_CM'/A?^?GX,.7'_P#/G\4?
M0'_"RO"/_0T:/_X'1_XT?\+*\(_]#1H__@='_C7S_P#\.X(?^A[;_P %0_\
MCM'_  [@A_Z'MO\ P5#_ ..T<^%_Y^?@PY<?_P ^?Q1] ?\ "RO"/_0T:/\
M^!T?^-'_  LKPC_T-&C_ /@='_C7S_\ \.X(?^A[;_P5#_X[1_P[@A_Z'MO_
M  5#_P".T<^%_P"?GX,.7'_\^?Q1] ?\+*\(_P#0T:/_ .!T?^-'_"RO"/\
MT-&C_P#@='_C7S__ ,.X(?\ H>V_\%0_^.T?\.X(?^A[;_P5#_X[1SX7_GY^
M##EQ_P#SY_%'T!_PLKPC_P!#1H__ ('1_P"-'_"RO"/_ $-&C_\ @='_ (U\
M_P#_  [@A_Z'MO\ P5#_ ..T?\.X(?\ H>V_\%0_^.T<^%_Y^?@PY<?_ ,^?
MQ1] ?\+*\(_]#1H__@='_C1_PLKPC_T-&C_^!T?^-?/_ /P[@A_Z'MO_  5#
M_P".T?\ #N"'_H>V_P#!4/\ X[1SX7_GY^##EQ__ #Y_%'T!_P +*\(_]#1H
M_P#X'1_XT?\ "RO"/_0T:/\ ^!T?^-?/_P#P[@A_Z'MO_!4/_CM'_#N"'_H>
MV_\ !4/_ ([1SX7_ )^?@PY<?_SY_%'T!_PLKPC_ -#1H_\ X'1_XT?\+*\(
M_P#0T:/_ .!T?^-?/_\ P[@A_P"A[;_P5#_X[1_P[@A_Z'MO_!4/_CM'/A?^
M?GX,.7'_ //G\4>QZY^T%\./#]O)+=>,=+D*<&*TF^T29] B9-?-?Q8_:GUW
MXLW \(?#K3;Z""^/D-,B9O+L'@HJK_JU/<YSCN!7IF@_\$[?#=K,CZOXKU/4
M$5@3%:P1VZL.X).X_D:^A/AS\'?!_P *;,P>&=$M["1EVRW1&^XE_P!Z1LL?
MIG'M4/$X:EK"\G^!2P>,Q'NU+0CY:L\Q_95_9IC^"^D2:OK:0S^+KZ/9(R'<
MMG%U\I#ZG^)AUP .!S] T45X]6K*M-SGN?04*,,/35.FM$%%%%9&X4444 >1
M_M'? &Q^.WA-(%DCLO$-AN?3[YAP"?O1OCDHV!]" ?K\:^"_BQXL_9YUJ3P=
MXUTJY>PMFVB"3_6P+G[T+'AXSU Z<\$=*_2:N:\<?#?PS\2M,^P>)M%M=6MQ
M]PS)\\9]4<893]"*]3"8YX=<DE>)XV-RY8B7M:3Y9_@_4^>M"^/7@+Q!;++%
MXDL[1CC,-\WD2*3VPV,_@2*Z ?$#PP1D>(M+(_Z_(_\ &N;\2?\ !//PE?32
M2:+XCU72%8_+#,J7*+Z]=K?K7.?\.X8?^A[;_P %0_\ CM>TL?AG]JWR9XKP
M>.CI[-/YH]'_ .$_\,?]#%I?_@9'_C1_PG_AC_H8M+_\#(_\:\X_X=PP_P#0
M^-_X*A_\=H_X=PP_]#XW_@J'_P =I_7L-_/^#%]5QW_/K\5_F>C_ /"?^&/^
MABTO_P #(_\ &C_A/_#'_0Q:7_X&1_XUYQ_P[AA_Z'QO_!4/_CM'_#N&'_H?
M&_\ !4/_ ([1]>PW\_X,/JN._P"?7XK_ #/1_P#A/_#'_0Q:7_X&1_XT?\)_
MX8_Z&+2__ R/_&O./^'<,/\ T/C?^"H?_':/^'<,/_0^-_X*A_\ ':/KV&_G
M_!A]5QW_ #Z_%?YGH_\ PG_AC_H8M+_\#(_\:/\ A/\ PQ_T,6E_^!D?^-><
M?\.X8?\ H?&_\%0_^.T?\.X8?^A\;_P5#_X[1]>PW\_X,/JN._Y]?BO\ST?_
M (3_ ,,?]#%I?_@9'_C1_P )_P"&/^ABTO\ \#(_\:\X_P"'<,/_ $/C?^"H
M?_':/^'<,/\ T/C?^"H?_':/KV&_G_!A]5QW_/K\5_F>C_\ "?\ AC_H8M+_
M / R/_&C_A/_  Q_T,6E_P#@9'_C7G'_  [AA_Z'QO\ P5#_ ..T?\.X8?\
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MT,6E_P#@9'_C1_PG_AC_ *&+2_\ P,C_ ,:\X_X=PP_]#XW_ (*A_P#':/\
MAW##_P!#XW_@J'_QVCZ]AOY_P8?5<=_SZ_%?YGH__"?^&/\ H8M+_P# R/\
MQH_X3_PQ_P!#%I?_ (&1_P"-><?\.X8?^A\;_P %0_\ CM'_  [AA_Z'QO\
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MQ7^9SO\ PE&C_P#05LO^_P"O^-'_  E&C_\ 05LO^_Z_XUT7_#N&+_H?&_\
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MX8O^A\;_ ,%0_P#CM']J8?\ F_/_ "#V.._Y]?BO\SG?^$HT?_H*V7_?]?\
M&C_A*-'_ .@K9?\ ?]?\:Z+_ (=PQ?\ 0^-_X*A_\=H_X=PQ?]#XW_@J'_QV
MC^U,/_-^?^0>QQW_ #Z_%?YG._\ "4:/_P!!6R_[_K_C1_PE&C_]!6R_[_K_
M (UT7_#N&+_H?&_\%0_^.T?\.X8O^A\;_P %0_\ CM']J8?^;\_\@]CCO^?7
MXK_,YW_A*-'_ .@K9?\ ?]?\:/\ A*-'_P"@K9?]_P!?\:Z+_AW#%_T/C?\
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MA_\ ':/[4P_\WY_Y![''?\^OQ7^9SO\ PE&C_P#05LO^_P"O^-'_  E&C_\
M05LO^_Z_XUT7_#N&+_H?&_\ !4/_ ([1_P .X8O^A\;_ ,%0_P#CM']J8?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M];P?_0)'^OD'U'%?]!4OZ^9\@?\ #4GQK_Z!<?\ X))/\:/^&I/C7_T"X_\
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M<?4T_K6#_P"@2/\ 7R#ZCB_^@J7]?,^2/^&I?C5_T"X__!+)_C1_PU+\:O\
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MT?\ #4WQJ_Z!D7_@ED_QKZSR?4TFX^IH^M8/_H$C_7R#ZEBO^@J7]?,^3?\
MAJ;XU?\ 0,B_\$LG^-'_  U-\:O^@9%_X)9/\:^LMQ]:-Q]:/K6#_P"@2/\
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MA_\ !*_^-?4>X^M)N/K1]:P?_0+'^OD'U/%_]!4OZ^9\N_\ #4_QI_Z!L/\
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M  3/_C7TSN/K1D^M+ZS@_P#H%C_7R#ZIB_\ H*E_7S/F;_AJKXS_ /0.A_\
M!,_^-'_#57QG_P"@=#_X)G_QKZ8R?6C)]:?UC!_] L?Z^0?5<7_T%2_KYGS/
M_P -5?&?_H'0_P#@F?\ QH_X:J^,_P#T#H?_  3/_C7TON/J:3<?6CZQ@_\
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MU5\9O^@?!_X)G_QH_P"&JOC-_P! ^#_P3/\ XU]&\^M)N/J:/K&#_P"@6/\
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M1_PU=\9/^?&W_P#!._\ C7O>3ZTF3ZT>WP?_ $"Q_KY!]7Q?_03+^OF>"_\
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M+'^OD'U?%_\ 03+^OF>'?\-7_&3_ )\;?_P3O_C1_P -7_&3_GQM_P#P3O\
MXU[AN/K1N/J:/;8/_H%C_7R#ZOB_^@F7]?,\._X:P^,?_/E;?^"=_P#&C_AK
M#XQ_\^5M_P""=_\ &O<-Q]32;CZFCVV#_P"@6/\ 7R%]7Q?_ $$R_KYGB'_#
M6'QC_P"?*V_\$[_XT?\ #6'QC_Y\K;_P3O\ XU[?N/J:-Q]:/;8/_H%C_7R#
MV&+_ .@F7]?,\0_X:P^,?_/E;?\ @G?_ !H_X:P^,?\ SY6W_@G?_&O;]Q]:
M-Q]:/;8/_H%C_7R#V&+_ .@F7]?,\0_X:P^,?_/E;?\ @H?_ !H_X:P^,?\
MSY6W_@H?_&O;LGUI,GU-'ML'_P! L?Z^0>PQ?_03+^OF>)?\-8?&/_GRMO\
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M'_GTM?\ P4-_C1_PUG\8?^?2U_\ !0W^->LDGU-)GWH]K@O^@6/]?(/8XO\
MZ"9?U\SR?_AK3XP_\^EK_P""AO\ &D_X:T^,/_/I:_\ @H;_ !KUC-'-/VF"
M_P"@6/\ 7R#V.+_Z"9?U\SRC_AK3XP_\^EK_ ."AO\:3_AK3XP_\^EK_ ."A
MO\:]8R:.?6CVF"_Z!8_U\@]CB_\ H)E_7S/)_P#AK3XP_P#/I:_^"AO\:/\
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MEH[TP&T8I:* &TE._"DQ0(2DQ2T4P&TE._"DQ0(2DQ2T4 -HI:,4"&T4M)0
M8I*7\*/PH 2DIU)0 E%+24 )BDQ3J/PI@-I*=24 -Q1BEH_"F VBEQ24P$HQ
M2TE "8HI?PHH$-HI:2@!*,4M% AM%+^%)0 E%+24"$Q12T?A0 VBEHH ;12T
M4 )BDI:/PH ;12XI* "DQ2T4 -HI?PHQ0 VDQ3J2@!M%+^%&*H0VC%+24P$I
M*=^%)0(2BEI* "DI:* $Q1BE_"D_"@!*2G4E "4F*6C\* &T4M)0 E)BG4GX
M4 -HI:* &T8I:*!#:*7\*2F(2BEI*!"8HI:/PH ;12TE,!**6B@!,4E+1^%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*6BF VBEI* $HQ110 E)2TE "48I:2@!*2G4V@ HHHH 2C%%'^>E "4E+15
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M2DH 2DQ2T4 -Q13J3_/2F E)2T4"$I,4M% #<44ZD_STIB$HHHH 3%)BG4E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ:S_ .!5M_\ %4?\(Y^TS_?UC_P*M?\ XJC^SZ?_ $$T_P#P(/[2G_T#U/\
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M_P!!-/\ \"#^T9_] \__  $^L:*^3O\ A&?VE_[VL?\ @5;?_%4?\(S^TO\
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M ,!/JBBOE?\ X13]I7_J,?\ @5;?_%4?\(I^TKZZQ_X%6W_Q5'U&E_T$T_\
MP(/[0G_T#U/_  $^IZ2OEC_A$_VE/^HQ_P"!5M_\51_PB?[2G_48_P# JV_^
M*I_4:7_033_\"#^T)_\ 0//_ ,!/J>DKY9_X1/\ :4_ZC'_@5;?_ !5'_")_
MM*?]1C_P*MO_ (JCZC2_Z":?_@0?VA/_ *!Y_P#@)]2_A^E%?+7_  B?[2G_
M %&/_ JV_P#BJ/\ A$OVE/\ J+_^!5M_\51]1I?]!-/_ ,"%_:$_^@>I_P"
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M_:$_^@>?_@)]0TE?+_\ PB'[2?IJ_P#X%6W_ ,51_P (A^TEZ:O_ .!5M_\
M%4?4:7_033_\"#^T)_\ 0//_ ,!/I^C\*^7_ /A#_P!I+TU?_P "K;_XJC_A
M#_VDO35__ JV_P#BJ/J-+_H)I_\ @0?VA/\ Z!Y_^ GT_25\P_\ "'_M)>FK
M_P#@5;?_ !5'_"'_ +27IJ__ (%6W_Q5'U&E_P!!-/\ \"#^T*G_ $#S_P#
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M(+^T;_SRU;_P*MO_ (JC_A!?VC?^>6K?^!5M_P#%4?4Z7_013_\  @^O5/\
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MYXZK_P"!5M_\51_P@/[17_/'5?\ P*MO_BJ?U2E_T$4__ A?7:G_ $#S_P#
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MC_T$4_\ P(/K=3_H'G_X">XTE>'_ /"N?VAO^?75/_ FV_\ BJ/^%<_M#?\
M/KJG_@3;?_%4?5:/_013_P# D'UNI_T#S_\  3W"C_/2O#_^%<_M#?\ /KJG
M_@3;?_%4?\*Y_:&_Y]=4_P# FV_^*H^JT?\ H(I_^!"^MU/^@>?_ (">WTE>
M(_\ "N/VA?\ GUU3_P "K;_XJD_X5O\ M"_\^NJ?^!5M_P#%4?5:/_013_\
M D'UNI_T#S_\!/;Z2O$?^%;_ +0O_/KJG_@3;?\ Q5'_  K?]H7_ )]=4_\
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M #XG_P" GL?^>E)7CO\ PK/]H+_GSU/_ ,";;_XJC_A67[07_/GJ?_@5;?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ IE/IE=-'J9S"BBBNDS"BBB@ HHHH **** %6G4U:=7%5^(VCL%%%%9%!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %07UY#IME<7=S((K:WC:660@D*J@DGCT J>L#X@?\B%XE_[!ES_Z
M*:KA'FDHOJ*3LFSPUOV^/AJK$+;:](N>&%F@!]_OTG_#?'PW_P"?37O_  #3
M_P".5\_?L>_#'PO\1QXG'B32(M5%FMKY'F22)LW>;NQM8==HZ^E?2'_#,?PN
M_P"A0M?_  (G_P#CE?=XC+\KPU5TI1DVO-'S-+%8VM!3BXZ^10_X;X^&_P#S
MZ:]_X!I_\<H_X;X^&_\ SZ:]_P" :?\ QRKQ_9C^%_\ T*%K_P"!$_\ \<I/
M^&8_A?\ ]"C:_P#@1/\ _'*Y_JN4_P D_O1I[;'?S1_$I?\ #?'PW_Y]->_\
M T_^.4?\-\?#?_GTU[_P#3_XY5O_ (9D^&'_ $*-K_X$3_\ QRD_X9E^&'_0
MHVO_ ($3_P#QRG]5RG^2?WH/;X[^:)5_X;X^&_\ SZ:]_P" :?\ QRC_ (;X
M^&__ #Z:]_X!I_\ '*L_\,R_##_H4;;_ ,")_P#XY3?^&9_AC_T*-K_X$3__
M !RCZIE/\L_O0OK&._FB0?\ #?'PW_Y]->_\ T_^.4?\-\?#?_GTU[_P#3_X
MY4__  S/\,?^A2MO_ B?_P".4G_#,_PQ_P"A2M?_  (G_P#CE'U3*?Y9_>@^
ML8[O$A_X;X^&_P#SZ:]_X!I_\<H_X;X^&_\ SZ:]_P" :?\ QRI?^&:/AC_T
M*5M_X$3_ /QRD_X9H^&7_0I6W_?^?_XY3^IY3_+/[T'UC'=XD?\ PWQ\-_\
MGTU[_P  T_\ CE'_  WQ\-_^?37O_ -/_CE/_P"&:?AE_P!"E;?]_P"?_P"+
MI#^S3\,O^A2MO_ B?_XY1]3RG^6?WH7UC'=XC?\ AOCX;_\ /IKW_@&G_P <
MH_X;X^&__/IKW_@&G_QRE_X9I^&7_0IVW_@1/_\ %TG_  S5\,O^A2MO_ B?
M_P".4?4\J_EG]Z#ZQCN\0_X;X^&__/IKW_@&G_QRC_AOCX;_ //IKW_@&G_Q
MRD_X9K^&?_0IVW_?^?\ ^+I/^&:_AG_T*=M_W_G_ /BZ?U/*OY9_>A?6<;WC
M]P[_ (;X^&__ #Z:]_X!I_\ '*/^&^/AO_SZ:]_X!I_\<J/_ (9M^&G_ $*=
MM_W_ )__ (ND/[-OPT_Z%.V_[_S_ /Q=/ZEE7\L_O0?6<;WB2_\ #?'PW_Y]
M->_\ T_^.4?\-\?#?_GTU[_P#3_XY4/_  S=\-/^A3MO^_\ /_\ %TG_  S?
M\-?^A4MO^_\ /_\ %T?4LJ_EG]Z#ZUC>\2?_ (;X^&__ #Z:]_X!I_\ '*/^
M&^/AO_SZ:]_X!I_\<JO_ ,,W_#7_ *%2V_[_ ,W_ ,72']F_X:_]"I;?]_YO
M_BZ?U+*OY9_>A?6L;WC]Q9_X;X^&_P#SZ:]_X!I_\<H_X;X^&_\ SZ:]_P"
M:?\ QRJO_#-_PV_Z%2V_[_S?_%TG_#.'PV_Z%2V_[_S?_%T?4<J_EG]Z%]:Q
MO>/W%O\ X;X^&_\ SZ:]_P" :?\ QRC_ (;X^&__ #Z:]_X!I_\ '*I_\,X_
M#;_H5;;_ +_S?_%TG_#./PV_Z%6V_P"_\W_Q='U'*OY9_>@^MXWO'[B[_P -
M\?#?_GTU[_P#3_XY1_PWQ\-_^?37O_ -/_CE4?\ AG+X;_\ 0JVW_?\ F_\
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M_P"_\W_Q=)_PSS\.O^A7M_\ O_-_\71_9^5_RR^]!]=QG=?<;/\ PWQ\-_\
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M OA__P!"U;_]_IO_ (NC^S,L_EE]Z#^T,9W7W'5?\-\?#?\ Y]->_P# -/\
MXY1_PWQ\-_\ GTU[_P  T_\ CE<F?@'X _Z%JW_[_3?_ !=)_P *$\ ?]"U;
M_P#?Z;_XNG_9F6?RR^]!_:&,[K[CK?\ AOCX;_\ /IKW_@&G_P <H_X;X^&_
M_/IKW_@&G_QRN1_X4'X _P"A;@_[_3?_ !=)_P *%\ ?]"W;_P#?Z;_XNC^R
M\L_EE]Z%_:&+[K[CK_\ AOCX;_\ /IKW_@&G_P <H_X;X^&__/IKW_@&G_QR
MN/\ ^%"^ ?\ H6[?_O\ 3?\ Q=)_PH;P#_T+=O\ ]_IO_BZ?]EY9_++[T']H
MXONON.Q_X;X^&_\ SZ:]_P" :?\ QRC_ (;X^&__ #Z:]_X!I_\ '*XW_A0W
M@'_H6X/^_P!-_P#%TG_"A_ /_0MV_P#W^E_^+H_LO+/Y9?>@_M'%]U]QV?\
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MH?\ O]+_ /%TG_"D? __ $+T'_?Z7_XNG_8^6]I?>']J8KNON/1?^&^/AO\
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M_BJ3_A6?AG_H$Q?]_'_^*H_U=P':7WA_;]?R^[_@GT'_ ,-\?#?_ )]->_\
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M-\?#?_GTU[_P#3_XY1_PWQ\-_P#GTU[_ , T_P#CE?.?_"NO#G_0*C_[^/\
M_%4W_A7?AS_H%Q_]]O\ _%4?ZN8#L_O#_6"O_2_X)]'?\-\?#?\ Y]->_P#
M-/\ XY1_PWQ\-_\ GTU[_P  T_\ CE?./_"N_#G_ $"X_P#OM_\ XJD_X5WX
M=_Z!<?\ WV__ ,53_P!6\!Y_>+_6&O\ TO\ @GT?_P -\?#?_GTU[_P#3_XY
M1_PWQ\-_^?37O_ -/_CE?-__  KWP[_T"X_^^W_^*I#\/?#O_0+C_P"^W_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9?A?_D6='_Z\X?\ T6M:E?@%3XV?M,?A04445!04444 %%%% !1110 4444
M%%%% !3*?3*Z:/4SF%%%%=)F%%%% !1110 4444 *M.IJTZN*K\1M'8****R
M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3$,IM24E,1'ZTE.-%,D8:8:EIIJA$9I*>:::"1M-I])3 924^DJB1E)3J2F
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS\5_)^*%]9I?S'U'3<5\N_\ #;R?]"I_Y/#_ .)H_P"&W4_Z%3_R>'_Q-/\
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M,_\ PVDO_0K?^3O_ -C2?\-H+_T*P_\  W_[&CZCB/Y?R%]8I]SZ7I*^:/\
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M4Z_\OY"]K#N?1=)7SI_PU\G_ $+?_DY_]C2?\-?)_P!"V/\ P,_^QI_4Z_\
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MW_R;_P#L:3_AK)?^A='_ (%__8T_JM;^47/'N?05)7S[_P -9+_T+H_\"_\
M[&C_ (:Q7_H71_X%_P#V-/ZK6_E#GB?0-)7S_P#\-8+_ -"Z/_ O_P"QI/\
MAK!?^A>'_@7_ /8T?5:W8GFB>_TE> ?\-7I_T+P_\"__ +&C_AJY/^A>'_@7
M_P#8T_JM;^4.9'OQ%-->!?\ #5J?]"\/_ O_ .QI/^&K$_Z%X?\ @7_]C3^J
MU>PN9'OE-->"?\-5)_T+P_\  O\ ^QH_X:J3_H7_ /R;_P#L:?U:KV%S(]ZI
M*\%_X:H3_H7_ /R;_P#L:3_AJA/^A?'_ (%?_8T_JU7L',CWJFUX-_PU.G_0
MOC_P*_\ L:/^&ID_Z%\?^!7_ -C1]6J]A71[Q25X/_PU*O\ T !_X%?_ &-'
M_#4B_P#0 '_@5_\ 8T_J]7L*Z/=Z:17A/_#4B_\ 0 '_ (%?_8TG_#4:_P#0
M '_@5_\ 8T_J]7L3H>ZFFUX9_P -1)_T !_X%?\ V-(?VH$_Z '_ )-?_8T_
MJ]7L![I337AG_#4"?]  ?^!7_P!C1_PT^G_0!_\ )H?_ !-/ZO4["/<J;7AW
M_#3R?] $?^!7_P!C2?\ #3J?] '_ ,FO_L:/J]7L(]QI*\._X:<7_H C_P "
MO_L:/^&G%_Z (_\  K_[&G["IV ]PI#7A_\ PTTO_0"'_@5_]C2?\--+_P!
M(?\ @5_]C3]A4[$GN%)7B'_#3*_] (?^!7_V-)_PTPO_ $ A_P"!7_V-/V-3
ML![=337B?_#3"?\ 0"_\FO\ [&D_X:67_H!C_P "?_L:?L:G85CVLTVO%?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_0HZ#_X+(/\ XFNGHH]O5_F?WA[.'\J.8_X5?X,_Z%'0?_!9!_\ $T?\*O\
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M-'_"K_!G_0HZ#_X+(/\ XFNGHH]O5_F?WA[.'\J.8_X5?X,_Z%'0?_!9!_\
M$T?\*O\ !G_0HZ#_ ."R#_XFNGHH]O5_F?WA[.'\J.8_X5?X,_Z%'0?_  60
M?_$T?\*O\&?]"CH/_@L@_P#B:Z>BCV]7^9_>'LX?RHYC_A5_@S_H4=!_\%D'
M_P 31_PJ_P &?]"CH/\ X+(/_B:Z>BCV]7^9_>'LX?RHYC_A5_@S_H4=!_\
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M)KIZ*/;U?YG]X>SA_*CF/^%7^#/^A1T'_P %D'_Q-'_"K_!G_0HZ#_X+(/\
MXFNGHH]O5_F?WA[.'\J.8_X5?X,_Z%'0?_!9!_\ $T?\*O\ !G_0HZ#_ ."R
M#_XFNGHH]O5_F?WA[.'\J.8_X5?X,_Z%'0?_  60?_$T?\*O\&?]"CH/_@L@
M_P#B:Z>BCV]7^9_>'LX?RHYC_A5_@S_H4=!_\%D'_P 31_PJ_P &?]"CH/\
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9 4444 %,I],KIH]3.84445TF84444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img226925499_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img226925499_4.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 9C!G\# 2(  A$! Q$!_\0
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M 'V__P 31_PK/5/^>UG_ -]O_P#$UZ;11[60>SB>9?\ "L]4_P">UG_WV_\
M\31_PK/5/^>UG_WV_P#\37IM%'M9![.)YE_PK/5/^>UG_P!]O_\ $T?\*SU3
M_GM9_P#?;_\ Q->FT4>UD'LXGF7_  K/5/\ GM9_]]O_ /$T?\*SU3_GM9_]
M]O\ _$UZ;11[60>SB>9?\*SU3_GM9_\ ?;__ !-'_"L]4_Y[6?\ WV__ ,37
MIM%'M9![.)YE_P *SU3_ )[6?_?;_P#Q-'_"L]4_Y[6?_?;_ /Q->FT4>UD'
MLXGF7_"L]4_Y[6?_ 'V__P 31_PK/5/^>UG_ -]O_P#$UZ;11[60>SB>9?\
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MG_WV_P#\37IM%'M9![.)YE_PK/5/^>UG_P!]O_\ $T?\*SU3_GM9_P#?;_\
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MUG_WV_\ \31_PK/5/^>UG_WV_P#\37IM%'M9![.)YE_PK/5/^>UG_P!]O_\
M$T?\*SU3_GM9_P#?;_\ Q->FT4>UD'LXGF7_  K/5/\ GM9_]]O_ /$T?\*S
MU3_GM9_]]O\ _$UZ;11[60>SB>9?\*SU3_GM9_\ ?;__ !-'_"L]4_Y[6?\
MWV__ ,37IM%'M9![.)YE_P *SU3_ )[6?_?;_P#Q-'_"L]4_Y[6?_?;_ /Q-
M>FT4>UD'LXGF7_"L]4_Y[6?_ 'V__P 31_PK/5/^>UG_ -]O_P#$UZ;11[60
M>SB>9?\ "L]4_P">UG_WV_\ \31_PK/5/^>UG_WV_P#\37IM%'M9![.)YE_P
MK/5/^>UG_P!]O_\ $T?\*SU3_GM9_P#?;_\ Q->FT4>UD'LXGF7_  K/5/\
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M_P#?;_\ Q->FT4>UD'LXGF7_  K/5/\ GM9_]]O_ /$T?\*SU3_GM9_]]O\
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M5/\ GM9_]]O_ /$T?\*SU3_GM9_]]O\ _$UZ;11[60>SB>9?\*SU3_GM9_\
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M 'V__P 31_PK/5/^>UG_ -]O_P#$UZ;11[60>SB>9?\ "L]4_P">UG_WV_\
M\31_PK/5/^>UG_WV_P#\37IM%'M9![.)YE_PK/5/^>UG_P!]O_\ $T?\*SU3
M_GM9_P#?;_\ Q->FT4>UD'LXGF7_  K/5/\ GM9_]]O_ /$T?\*SU3_GM9_]
M]O\ _$UZ;11[60>SB>9?\*SU3_GM9_\ ?;__ !-'_"L]4_Y[6?\ WV__ ,37
MIM%'M9![.)YE_P *SU3_ )[6?_?;_P#Q-)_PKS68.8YX"1_<E8?T%>G44_:R
M%[.)Y>UOXKT/Y@;IE']UO.7\N<5>TSXES1L(]0MPX!P9(>&'U4__ %J]!K+U
M;P]I^LH1<VZE^TB\./Q_QI<ZE\2#D:V9/INK6FK0^;:3+(O?!Y'U':KGX5YA
MJOAG4O"=Q]ML9G>!?^6J<,H]&'I^E=3X7\91:VHMY]L-Z!T_A?W'O[4I0TO'
M5#C+6TMSJ****S-!.,5Q_CCQ1_9D1L;5L74B_.X/^K4_U-=!K6J)H^FS73\^
M6/E7^\QX _.N"\':._B+6)M0O/WD4;[VST>0\@?0?X5I"*^)[&<F]D:?@OP<
M(XX]0OX\RGYHH6'W?1B/7VKNZ**F4G)W948J*L@HHHJ2@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@!IPP((R#U%>=^,/"1TM_[2T\,D2M
MN=$_Y9G^\/;^5>B[::RK(I5@&5A@J1D$549.+NB914E8YWP?XF&O6OER_+=P
M@;Q_>']X?UKHQ7ENJV<O@GQ+'<6^?L['?'SU7^)#_GTKTRTNX[VUCN(CNCD4
M.I]C53BEJMF3"3>CW.%^)6IF2XM=/C.0H\UU'<GA1^6?SKKO#^EKH^D6]L!\
MZKN<^K'D_P"?:N#7_B>?$([ONK<'Z;8Q_7;^M>GTY^[%1%#5MBT445D:A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <YXWT
MD:GH4S*,S6_[U/PZC\OY"L[X;ZF;C3IK-V^:!MR9[*>WYY_.NQ90RE2,@C!%
M>9>$F.B^,I;4G"$R0D_3)'_H(_.M8^]%HREI),=\/_\ 2/%$TIY(B=\_5@/Z
MUZ=7F/PS_P"0]-_U[-_Z&E>G4ZOQ!3^$****Q-0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** $KR?Q-)_9_C&\=>-K9_-!_C
M7K%>1^.O^1JOO^ ?^@+6M+=F538O_#/_ )#TW_7LW_H:5Z=7F/PS_P"0]-_U
M[-_Z&E>G4ZOQ!3^$****Q-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** $KR/QU_R-5]_P  _P#0%KURO(_'7_(U7W_ /_0%
MK6E\3,JFQ?\ AG_R'IO^O9O_ $-*].KS'X9_\AZ;_KV;_P!#2O3J=7X@I_"%
M%%%8FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2O(_'7_ "-5]_P#_P!
M6O7*\C\=?\C5??\  /\ T!:UI?$S*IL7_AG_ ,AZ;_KV;_T-*].KS'X9_P#(
M>F_Z]F_]#2O3J=7X@I_"%%%%8FH4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "5Y'XZ_Y
M&J^_X!_Z M>N5Y'XZ_Y&J^_X!_Z M:TOB9E4V+_PS_Y#TW_7LW_H:5Z=7F/P
MS_Y#TW_7LW_H:5Z=3J_$%/X0HHHK$U"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBDH 0T@/S5\"?$3_ (*H-X!\?>)/#7_"L1?_ -CZA/8?:O[?\OS?*D9-
M^W[*=N=N<9.,]36=H?\ P5WTNZU*)-9^&=Y8:>3^\GL=92ZF4>HC:&,'_OL5
MZ,,NQ4XJ<8:/S7^9Y\\?AZ<G"4K-.ST9^AE+7'?"_P"*GAOXP>"['Q1X6OUU
M'2;H'# %9(W'WHW0\JZ]P?8C((-?$G@+_@IQKOB[X_Z?X7G\(V,/A#5-532[
M8Q&4ZA$7D$:2NVXHW)!*!!UP&..>>EA:M:<H0CK'<VGB:5."J-^Z^I^AU%(#
M\H-%<QU"T444 %%%)0 F!WHKX._;*_;L\??L\_&,^$_#NE>'+W31I\%WYNJ6
MUQ)-O<MD92=!CY1VKZ<^*OQG;X5? '4?B)<Z=_:4UGIT-U]CA8HKRR%%49Y*
MKN<9/) !ZUT2P]2-.-1K23LO4YXUX2J2I+=;GJM&./>OC#]B?]N3Q!^T?XVU
M?POXHT'3]/O;>R;4+:ZTE95B\M71&CD5V<[OW@(8, <$8Z5]G^W>E6P]3#RY
M*BUW"C7AB(\T'IL.HHHK Z HHHH **** &4G%?,'[6W[:\?[+?B'0-)7PC_P
MD\VJ6TETS?VG]D\A58*!CR9-V3N],8JQ^R-^VC:?M37WB*P;PT/"NH:3'#,D
M!U#[7]HC<LK,#Y4>W:0H/!^^*ZUA*TJ/MU'W.^GIZG)+%4H5?8N7O=CZ9Q2;
M>M>8?M&_'&S_ &>/A3J?C2[T_P#M5K62*"WT\3^0;B1W"A=^UMN!N;.T\*:^
M=/@#_P %)D^-WQ:T'P5-\/SH"ZL\J+J']L_:?+98GD \O[.F<E-OWAC.:FEA
M:U>$JE.-U'?;U*JXFE1DHU'9O8^W:*3-+7,=(4444 -H]JR/%7B:P\&^&]5U
MW5)A!IVF6LEY<2'^&-%+,?R%?GE\%?\ @IUXO\;?&3P_H/BC1O#NG^%]4O\
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MIX>*E4=DS]&AQU-!K\]_#_\ P5VTBYOT37/AI?:=9$_/-I^K)=R#Z(\40/\
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M"""0:[VB490DXR5FA0G&I%2B[ICJ***1844E+0 4444 %%%% !1110 4444
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M&DBC !4$+AR,Y(&>:^.OBYX=N?&'[4/B[0;-XHKS5/%MS90O.2(U>2[9%+$
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M$A&23=^NVI^KGQ;^.?@GX%:38ZEXXUK^Q+*^G-M;R_9)[C?(%+%<1(Y' /)
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MT/FH@4-M\M00A&.1D]<$>*_\$J-=O++X^:YI<<K"ROM"DDFAS\K/'-$4;'J
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M"O2OA#J=]^V1^W)HGB'4[=DLXY8=1GMV.Y8H;2)2J?[K2*H_[:&N?_;BM)?
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M0_B;^TAX5\,>)++^T=$U"ZG2YMO.DB\Q5AE<#=&RL/F4'@CI7[D:OSI-V?\
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M?LKX;\5:9XL\+Z?XBTR\6XT;4+2.^MKID:,/"Z!U<AP"H*D'# $=Z^9?'?\
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MKP3C9ZI]M-48T,;+VT:4VI7ZKH^S/N"BBBO#/<"BBB@ HHHH **** "BBB@
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MV,P\FY_W0=CY_N,WK6%'!K$3J0I3NXZK3=?H;5<5*C3A4J1LF[/78_8OMTI
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M,/A72+V?4F>X:\N[^=0C3SL%5F"C(5<(H"Y. .I/->L;@.._I7RI_P $T?\
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MN]K'?2E.4$YJS];CJ***S-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVKGJYBE.G]7C:,._7H[G12P,I*H\1*\I::=#\I/A+^UU\#/"_P )]/TOQ?\
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MUGNO/4RJX.K[652BU[V]UU\C _8<\06/Q"\ S^+H?A%X?^&DMT1;1WFB6L<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(DVWT\TS%<^^S\*VP^.IRH0I5)N#CIIU1%?!S5:56$%)2Z/HS?\ V"/A_P#
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MTTZYLM6OH[9V\L;5>/>1Y@90#\N<$D'I7TC\2_AGX=^+W@^^\,>*=.34](O
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M^&?_ "'IO^O9O_0TKTZG5^(*?PA1116)J%%%% !1110 4444 %%%% !1110
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M",84H**T2.TI:KV]Q'=PQS12++#(H=)(V#*RD9!!'4$58J-C0**** "DI:*
M"BBB@!*-HKB=-^-/P_UKQ"- T_QUX:OM=:5H1I=KJ]O)<^8N=R")7+;AM;(Q
MD8/I7; YIN+6Z)4D]A:***104444 )2T44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E>1^.O^1JO
MO^ ?^@+7KE>1^.O^1JOO^ ?^@+6M+XF95-B_\,_^0]-_U[-_Z&E>G5YC\,_^
M0]-_U[-_Z&E>G4ZOQ!3^$****Q-0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ$'QT\3? ']D6P\>_%349/$7C&\A6:*S>"&U+SS_ #06VV)% "IRYP2-K]<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E+110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 E>1^.O^1JOO^ ?^@+7KE>1^.O^1JOO
M^ ?^@+6M+XF95-B_\,_^0]-_U[-_Z&E>G5YC\,_^0]-_U[-_Z&E>G4ZOQ!3^
M$****Q-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBDH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI*6@ HHHH ***
M* "BDR*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M31G_ ($I(K4KS;-:,]!-/86BBB@84444 %%%% !1110 4444 %%%% !1110
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M'*\+1^S=^>O_  #R*N8XBK]JR\M#[U_X)J?$GQ7\1OVF/$-[XH\1:GX@N?\
MA%KDHVH73S;?]+L_NACA1[#%?J%7Y-_\$G_^3C/$'_8K7/\ Z5VE?K)[U\GF
MT5'%.*5M$?2Y7)RP]WW8M%%%>.>N%%%% !1110 4444 %%%% !1110 4444
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M_DSOP#_W$/\ TX7-?1PZUCB_]XJ>K_,TPO\  AZ+\AU%%%<QU!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )7Q;_P %8/\
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M_@/!_P#'J/\ 5W-_^@:7W!_K!E?_ #_B?3-%?,W_  WQX#_Z WB+_P !X/\
MX]1_PWQX#_Z WB+_ ,!X/_CU'^KN;_\ 0-+[@_U@RO\ Y_Q/IFBOF;_AOCP'
M_P! ;Q%_X#P?_'J/^&^/ ?\ T!O$7_@/!_\ 'J/]7<W_ .@:7W!_K!E?_/\
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M?B"G\(4445B:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/\1:7#>V%U;:GIMW'OBN+>19H9HR.JL"0RD=QQ7YV_\ !2S]FOP)X'\'Z?\
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MUCB_]XJ>K_,TPW\"'HOR'4445S'4%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 E?%O_  5@_P"3==!_[&>V_P#26[K[2KXM
M_P""L'_)NN@_]C/;?^DMW7=@?]ZI^IQ8W_=Y^A^35%%%?II^>!1110 4444
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MFAD2:)QN62-@RL/4$=:GKA.X***3- !0:\V^(G[1GPT^%:N/%'C/2=-G7/\
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M*** "BBB@ HHHH **** "BBB@#[3_P""3O\ R<9X@_[%6Y_]++2OUEK\FO\
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MQNO_ ([1_P ,??"3_H53_P"#&Z_^.U[)17F?VSF7_03/_P #E_F>C_9&7_\
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M ([1_P ,??"3_H53_P"#&Z_^.U[)11_;.9?]!,__  .7^8?V1E__ $#P_P#
M5_D>-_\ #'WPD_Z%4_\ @QNO_CM'_#'WPD_Z%4_^#&Z_^.U[)11_;.9?]!,_
M_ Y?YA_9&7_] \/_  %?Y'C?_#'WPD_Z%4_^#&Z_^.T?\,??"3_H53_X,;K_
M ..U[)11_;.9?]!,_P#P.7^8?V1E_P#T#P_\!7^1XW_PQ]\)/^A5/_@QNO\
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M9?\ 03/_ ,#E_F']D9?_ - \/_ 5_D>-_P##'WPD_P"A5/\ X,;K_P".T?\
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MTC,S$LS')8G))]:2BBN[8X@HHHIB"BBB@ HHHH **** "BBB@ HHHH ****
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M_*ZEKC/V^O\ DD^B_P#8;B_]$3UV7['O_)O/A;ZW?_I5-7W=;_DEZ7_7Y_\
MI+/B*/\ R4E3_KW^J/:****^$/MPHHHH **** "BBB@ HHHH **** "BBB@
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M +O/T/R:HHHK]-/SP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ^T_^"3O_)QGB#_L5;G_ -++2OUEK\FO^"3O_)QGB#_L5;G_ -++
M2OUEK\^SC_>WZ(^XRK_=E\PHHHKQ3V HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH CE_U;_2O@7]@S_DLFI_]@2;_ -'P5]]2_P"K?Z5\"_L&?\EDU/\
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MIAOX$/1?D.HHHKF.H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@!*^+?^"L'_)NN@_\ 8SVW_I+=U]I5\6_\%8/^3==!_P"Q
MGMO_ $ENZ[L#_O5/U.+&_P"[S]#\FJ***_33\\"BBB@ HHHH **** "BBB@
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M  2Q^*^D:9>7T_B#P:8;6)YG5+V[+%54L0,VO7 K];C6'XZ&?!.O_P#7A/\
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MT4445\(?;A1110 4444 %%%% !1110 4444 %%%% !1110 E>1^.O^1JOO\
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MHI:* $VCTHQ[4M% ";1Z"DVKZ#\J=10*R$QCH,4M%% PHHHH **** "BBB@
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M%/\ P5D_Y-Y\.?\ 8U6__I'>5W8#_>J?J<>._P!WGZ'H_P#P3O\ ^3._ /\
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M_P""LOQ.:]\3^$/ %M*?*L86U>\0=#)(3'"#[JJR'Z2"OI+_ ()V_"T_#?\
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M["=ZE]^RGX ="I"VTT9VG/*W$JG]173G$(1PBY%;WM?6S./*Y2EBTY._NO\
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M'$X7#U93YFV][GQO1117V2T1\H]PHHHJA!1110 4444 %%%% !1110 4444
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M "2?1?\ L-Q?^B)Z[+]CW_DWGPM];O\ ]*IJ^[J_\DM3_P"OS_\ 26?$4?\
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MW<0>>UQ+ 4,?^MF)(>0F0YQD#;]YL\?I7_P3</\ QB;X7'?[3>_^E,E?./\
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MCM%?G'_P^"/_ $24?^%)_P#<E'_#X(_]$E'_ (4G_P!R5S_V7C/Y/Q7^9O\
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M\'!_^,4?\/#'_P"A"'_@X/\ \8KZ3_X4C\/O^A'\._\ @J@_^)H_X4C\/O\
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M0"PY')KW;'H:\RK&$9M4W>/1G?1E.5-.HK2ZH=11161N%%%% !1110 4444
M%%%% !1110!E>*/^1=U/_KWD_P#037XQ_P#!/O\ Y.Z\!?[UY_Z13U^SGBC_
M )%W4_\ KWD_]!-?C'_P3[_Y.Z\!?[UY_P"D4]?19/\ !B?\/Z,\'-=Z'J_T
M/N+_ (*L?\FXZ3_V,5M_Z(N*YW_@DE_R2KQM_P!AE/\ T0M=%_P58_Y-QTG_
M +&*V_\ 1%Q7._\ !)+_ ))7XV_[#*?^B%J</_R*ZW^)?^VEXC_D84?\+_4^
M\,"DZ4HXKSBZ_:+^%-A=36US\3/!\%Q"YCEAEU^T5T8'!5@9,@@\8-> HMZ1
M5SV9245>3L>C-R,5\9S?\$Z]#\??&SQAX[^(NK3:S8ZIJ4ES9:-82O"ODG&T
M3R\/D#C:A7&T?,>@^H_!_P 4/!_Q#EN4\+^*M$\2/:A6G72-1ANS$&SM+B-C
MMS@XSZ&OF']N;]L3QK^S+XD\+:?X7TC1;VWU2UFN)IM8@GD^9'50J>7+&!@'
M)SGJ.G?JPRK1JJ%+235OU.6O[*=)SJ:Q3N>"?\%!/V/_ (?_  1\!:+XN\#6
M<VB&345TZXT^2[EN(I T<CB13*S.&!CP?FQ@]*[7_@D;K^H7&B?$;1I97;3+
M2XLKJ"-L[4EE699"/J(H\_05\=_'+]J/QO\ M,:MI:^--1M[/2;.3,5AI5L5
MMX"W#2!"Y9VQ_><\<#&37Z:_L#>'?AIX;^#?E_#OQ"/$\LT_F:QJ$L)@N#<[
M<!'A;F-5 PHR0>2"V2:^CQ"JX?+Y0Q#<I2>G6VJW9X5.5*MC8RH)126O2_HC
MR/\ :[\._'[X_?&;4/AEX0MKK2?A[!!;M/J#;K6SN-\89S-/C,H#$KY29^[D
MJ>M? \_@M_AQ^T /"LMTM])HOB);!KE$*+*8[@(6"Y. <=,U^]O!7!Y]:_#O
MXO8_X;,\4XZ?\)I+_P"EE99-B)2J*@DDE&_FWIJS;-Z$?9.LVV[I+LE8_<=/
MNK]*=34^ZOTIU?+'T2V04444#"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#YE_;Z_P"23Z+_ -AN+_T1/79?L>_\F\^%OK=_^E4U<;^WU_R2?1?^PW%_
MZ(GKLOV/?^3>?"WUN_\ TJFK[NK_ ,DM3_Z_/_TEGQ%'_DI*G_7O]4>T4445
M\(?;A1110 4444 %%%% !1110 4444 %%%% !1110 E>1^.O^1JOO^ ?^@+7
MKE>1^.O^1JOO^ ?^@+6M+XF95-B_\,_^0]-_U[-_Z&E>G5YC\,_^0]-_U[-_
MZ&E>G4ZOQ!3^$****Q-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** $KYY_X* ?\FC^/_P#KE:_^E<-?0WO7C?[7/P^UWXJ?
ML[^,/"WANT6^US4(H1;6[RI$)"EQ'(1N<A1\J'J154VHU(-]&OS$]CXI_P""
M1O\ R/'Q"_Z\+3_T.2G?\%<N/&WP\S_SX7?_ *''7I__  3J_9I^(OP)\1^,
MK[QSX?70H=0M;>"U'VVWN&D97=F_U,CX !'7%+_P46_9G^(GQVU_P9?^!M#3
M7(]/M[B"ZC^V06[QEG1E/[YT!!P>A)XZ5]+4KTO[4A44ERKK?39]3YVG1FLO
MJ4W%\SZ==T>O_P#!/\C_ (9+\"?]<[K_ -*YJ]<^*7@5/B=\-_$OA%[PZ>FM
M:?-8&Z6/S##YB%=^W(W8SG&1GU%?EMX?_9A_;&\*Z3;Z9H@\4Z-IEN"(;+3_
M !E;P0QY)8[42["C))/ ZDU]/_L/_#7]H;P7\0-<NOBY?:Y/H,VF^7;1ZQX@
M34A]H\U""BK-)L(4/D\=:Y,9AX2G4Q$:L=6W:^IMA,14IPA1=-Z65[:'G/\
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M'_#-/PA_Z)9X+_\ "?M/_C=>E45R^TGW?WG3[*G_ "H\U_X9I^$/_1+/!?\
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MA_Z)9X+_ /"?M/\ XW7I5%'M9]W]X>RI_P J/-?^&:?A#_T2SP7_ .$_:?\
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MI^IT8W_=Y^A^35%%%?II^>A1110 4444 %%%% !1110 4444 %%%% !1110
M4>]*.]?8G_!+&WBG_:0OS)&DC)X?N70LH)5O.@&1Z'!(_&L*U3V-.52VR;^Y
M&U*G[2I&'=I?>?'8QWI",5^D7_!7BWC73?AE*L:K)YVH+YFT;B-MOQGTK\WL
M8-<V"Q7UNBJEK;^>S.K&83ZI-0O>ZN)1117H'GA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?:?_!)W_DXSQ!_V*MS_ .EE
MI7ZRU^37_!)W_DXSQ!_V*MS_ .EEI7ZRU^?9Q_O;]$?<95_NR^84445XI[ 4
M444 %%%% !1110 4444 %%%% !1110 4444 1R_ZM_I7P+^P7_R634_^P)-_
MZ/@K[ZE_U;_2O@7]@S_DLFI_]@2;_P!'P5]SD?\ R*,R_P ,/S9\/G7_ "-,
M!ZR_0^_*_%'_ (*!?\G;^.?]ZU_])8J_:[^=?E_^V1^QA\7_ (F?M#>)?%/A
M3PLFLZ)J2V[PW,>I6L)!6%$96665&!!0]L<CFOG<HJPHXM3J.RL]_D?2YE"5
M3#.,%=W1^EGAG'_".:9_U[1_^@BOSZ_X*F?'C1=0TG2/ACI%['>ZG%>#4-6$
M#!EM]J,L43$?QDN6*]0%7/45Y>?V;?VT-0M_L-Q>^+/L;+Y9CG\:Q-%MQC!4
M79XQQC%=W\%?^"5NLW&L6^I?%#7;6'3E<2/I&CR-)/<=RDDQ4!!GKLW$@G!4
M\UUTL/AJ%;V]6JFD[V6OH<4J^(J4O8TZ33:M=Z'IW_!+'X:W/A_X-^(/$M["
MT:^);T);JX^_;P*R!_H7>4?\!K\^+ZWN_P!GW]HYOM4#FX\)^(UF,;#!D2&<
M.N/9E (]FK]UM#T.P\+Z-8Z3I=K%8Z;8PI;V]K NU(HU "JH] !7R'^VW^PJ
M_P >+S_A,O!DMM9>,XXA'=6MRVR+4D483Y^B2@#:">", D8S2P^8Q^NRJU-(
MST_RN56P#^I*C!^]'7U[GUQX<\0:?XLT#3]9TFZCO=,OX$N;:XC.5DC<!E8?
M@:DU36]/T.."34K^VT]+B=+:%KF58Q),[;4C4L1EF) "CDD\5^0_@VR_:X_9
MS2;0/#.A^,]/L]Q/V2TTD:M9HQ.28_W<L:Y)R2A&>]>H?"G]G/\ :*^/GQ9\
M*>,?BO?:AIVBZ+?P:B/[;E6-SY;J_EP6:8$;-M )*H,<_,1@Y5,NIQES^UCR
M=[Z_<7#'3Y>5TWS]K:'W5\??V?\ PM^T5X+/A[Q1',JQ2>?9WUHP6>UEP1N0
MD$$$'!4@@CWP1^8_QZ_87^(W[,-G+XWT/7DU?0M.D5O[6TMWM+VSR0JNZ9RH
MR0-R.W7G KZY_;V^$_Q>\2^(/!OC+X4/J#7FB07,-RFDWOD72AV1@0NX>8IV
M8*C).!P1T^3?%>I?M@_''1V\%Z_HWC&]TJX95EM[G04TZ&7:00))_)C!&0#\
MSXX!K7+O:P@I4ZD4F]8OU)QSA*3C4IMM+1K[['UW_P $Y_VE?$/QR\&Z]H?B
MRZ.I:WX=>'9J4@ DN;>4.%\S'WG4QL"W<%<\Y)^Q :^8?V%?V6[_ /9M\!ZG
M)K\\,GBC798YKR*W??';1QAA'#NZ,P+N2PXRV!D#)^GL5YN82HRQ,G0^'3;:
M]M?Q.W JJJ$?:[_C;H/HHHK@/0"BBB@ HHHH **** "BBB@ HHHH RO$Q_XI
MW4_^O:3_ -!-?C+_ ,$^Q_QEUX"_W[S_ -(IZ_9W6K9[S1[VWC_ULL+HHZ<E
M2!7YH?L>_L7_ !@^%?[1WA?Q+XG\+)IFA:8;HSW@U*UF!WVTL:[4CE9SEG7^
M'IUKW,KJTZ<,0IR2O'2_71[?>>+F5.=1TG%7L];?(]R_X*K#_C'+2#V_X2*V
M_P#1%Q7-_P#!)/\ Y)7XV_[#*_\ HA*]9_;[^#/BSXX_!&TT+P;I\>J:O;ZO
M!>FU>XCA+QK'*C;6D95R#(#@D< _2OA;PE^R+^UMX!M9[;PQIVO^&[:9_-EA
MTGQ9:VJ2/C&YECN@"<<9-:X/V=3 U*$IJ+D^K]/\B,9SPQ=.M&+DDNB]3]@#
MSD5^>.N?\$D5UC7-0OX_BF8([JXDG6)O#^\H&8L%+?:AG&>N!GT%5_V:_@[^
MU?X<^-_A74?'>H>)G\)V\\K:@NI>*H[V!HS"X :$7+EOF*X^4X.#QC-?HLO3
MUK@DYY?/]S43;72S.N/+CH-58-)/K='R[^R/^Q,G[+?B+7M6/C!O$\NIVT=L
M(QIOV-8@KEB?];)N)X],8/7/'U%\OIFALXZXK\O/&WPK_:N_9Y\;^([[P%>:
MWJWAJ]U"XO+?^QW348L2RL_-G(&*O\WS$1XSGDU$>?'56ZLTI6W>B+:C@Z?[
MN#:OLM?F?0O_  4B^%/A+6/V?]<\7WFFV=MXFTF2W:SU*.-4G??,D;1,PY=2
MKL=IS@C(KY*_X);ZUJ5C^T=-86LDGV"]TB?[9&"=F$*,C$>H; !_VSZUB>,?
M"G[5_P"T[=6>E^*?#_BW4HK=]\4&I:8NDVB-C&\ADBC+8)Y//)Q7W-^Q'^QO
M_P ,V:5?:SX@N;?4/&FJQK#,UKDPVD (;R48@%B6 +-@#*J!P,M[<7# X*I2
MJS4G+9)WM?\ JYY$^;&8F%2E!I1M=M6V9]45^'7Q>RO[9GBD#_H=)?\ TLK[
M/_;"^%/[3GB[XTW>H?#+4/$4?A%K.W2"/2?$R:?$) I\P&(W$9W;LG=CD$<\
M5\MWG["'[2=_K4NL7?@^[NM6FG-S)?S:_8O.\Q;<9#(;G<6SSNSG/-995"EA
MY>WG4BKJUKZHVS.52M!T(0;U3O;0_9I/NJ/:EKX*_8[^%/[3/A#XS6]_\3[_
M ,02>%%L;B.5-6\3)J$32$#R\1">0[L\[L# !YYP?O/[W0UX>(HQHSY8S4K]
M4>MAZTJT;RBXVTU'TM)2US'4%%%% !1110 4444 %%%% !1110 4444 %%%%
M 'S+^WU_R2?1?^PW%_Z(GKLOV/?^3>?"WUN__2J:N-_;Z_Y)/HO_ &&XO_1$
M]=E^Q[_R;SX6^MW_ .E4U?=U?^26I_\ 7Y_^DL^(H_\ )25/^O?ZH]HHHHKX
M0^W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*\C\=?\C5??\ _] 6O7
M*\C\=?\ (U7W_ /_ $!:UI?$S*IL7_AG_P AZ;_KV;_T-*].KS'X9_\ (>F_
MZ]F_]#2O3J=7X@I_"%%%%8FH4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !24M% !1110 4E+10 4444
M )_%7Q3_ ,%9/^3>?#G_ &-5O_Z1WE?:W\5?%/\ P5D_Y-Y\.?\ 8U6__I'>
M5WX#_>J?J<.._P!WGZ'H_P#P3O\ ^3._ /\ W$/_ $X7-?1PKYQ_X)W_ /)G
M?@'_ +B'_IPN:^CAUK'%_P"\5/5_F:8;^!#T7Y#J***YCJ"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2OBW_@K!_R;KH/_
M &,]M_Z2W=?:5?%O_!6#_DW70?\ L9[;_P!);NN[ _[U3]3BQO\ N\_0_)JB
MBBOTT_/ HHHH **** "BBB@ HHHH **** "ND^&OAB#QM\0_"_AVYFDM[;5M
M4M;"6:+&]%EE5"RYXR W&:YNN\^ /_)=?AW_ -C%IW_I3'4O17&C[N^)G_!*
M70EM=#B\ ^(-:%Y<:@L>HW.O3P30VUIL<O(J1Q1LS[@@"YYW<X&6'H_A']A'
M]FK2;W_A#[TP>*?%UO%YMQ;WGB"1+_:>=Y@@E3:O(Q\G3&2>M>T_M5?$35?A
M1^SYXS\5:&R1ZM86BBVE< B-Y)4B#X/!*[]P!XR!FOQ+\(^/M9\)?$'3?&-M
M>SR:W9WRZA]JDE)DEDW[F+L>3NY#9ZACGK7QV"6+S"#7M6DNO6[/K,9'#X+E
MFJ:;?W:'UM^V]^P=8?!'06\=^ Y;J7PQ'*L6H:9=2>:]CO;:DB.>6C+%5(;+
M D')!.W,_P""5?\ R<AJ?_8NW/\ Z/MZ_2OXR:+;^/?@;XPTV7:8=2T.Y168
M9"EH6*M^!P?PK\T_^"5?_)R&I_\ 8NW/_H^WK7"8JI6PE>G4=W%/U,L50A3Q
M%&K35E)K]#[J_:F_9:L/VF-6\%?VYK,FD>'=!:\GO?LV!<3>8L0549@50?(Q
M+$'H !SD<7H?["_[,?Q T"X/AC3[;58US;MJVC>(Y[IHI .>1,\8<=<%<>U<
M3_P5<^(&O>&OAWX0\.Z;?R6>F:]<W(U%(3M:=8EB*1D_W,R$D=\#TKP?_@E7
MKEY9?'[5M-CF=;"^T.9YH<_*SQRQ%&(]1N<#_>/K7'AJ->6#E5C4<5&]DNMM
M7<[<76I0Q,*<X*3E97?FSQO]K+]FV]_9E^)AT/[4^IZ%?1?:]*U"1-KR1;B"
MCXX\Q",''!!5L#=@>@?L8_L1_P##3%G?>(]:UM](\*6%V;)X[%5:[N)@BNRJ
M6!6-0'0[B&SDC'>O?/\ @KMI:MH?PUU!57='<WT!;^+#+"P'T^0_I7R1\![K
MXX>./#NL?#CX6S:O+HM]-]LU*UTXQP1JS*%S)<MM,894 VEP'VXP:]G#XBMB
M<#SJ24EI=^3W/'Q6'I4,6DXMQ>MEOZ'W]:_L@?LE:7K$/A>\;1;GQ*"(?L5U
MXLF2]E?WA2X7YCZ!!]*\H_:U_P""<?AKPGX!UCQK\-);RRDTF%KNZT.ZF,\3
MP(,NT3M\X95!;#,V<8&#U\RL?^"5/QAN;>.:75_"-E(P!,,]_<%U/H2ENPS]
M":_3*ST&]TWX/QZ1K\\>HZA#H@M;Z97+)/(L&V1@2 2&()R0#S7B8C$2PC52
ME7<WU70]:A2C7;A4H<J[]3\0/@;\'-8^/'Q)TKP=HC)!<7C%YKN128[:!1F2
M5@.N!T'&20,C-?I=;_L$_LX?"3PK;2^/9X[@LPC;5_$>O/IZ22$9VJ(Y8D'?
M"\G'<]:^.O\ @F[X^T?P)^TE:KK,\=I'K6G3:5;S3$*@G=XW0$GIN,>P>I8#
MO7WC^VC^Q[-^U)INBWFE^(%T;7M%29+6*\1GM+A9-I*OM^:,Y1?G ;C(*G@C
MTLTQ%2-:%-S<(-7;1YV7T(3ISJ<JE);)GSM^UU^Q/\*/#/P/U/XE_#6]DLXM
M.$,@@M=0^W6-U&\J1DJ[LS!AO!!#D<8QSD?&/P-^"NO_ !^^(%EX2\/*B7$R
MF:XNYL^5:P*1OE?'.!D  =2P'>N@^,'P3^+'[-MO>:#XF@U'2_#VK2*CRV%V
M[Z9J+(2R;BIVLPP6"R ,,9P*^V/^"2O@VT@\ ^-?%10&^N]3331(>JQQ1+)@
M>F3-S_NCTKKC5>$PDZJJ<]MGZV6OH8SIK$XB%+DY'U_,Z_3/^"?_ .SQ\(?"
MD5S\0KQ-0+%4DU?Q#K3:;"9"/NH(Y(U4$@D*2Q]S6?\ $C_@FK\*/B)X1_M'
MX8WK>'KZ2$RV-Q;Z@]_I]UGD;R[.VT] R/QG.&QBJ7[97[%OQ7_:2^*RZYI?
MB#PY!X:L[2.VTZQU&\N4DBX!E8HD#J&9\\@G(5,],5Z5^PW^SGX^_9M\/^)=
M#\7ZOH^I:9>3Q76GPZ3/-*(9-K+,6\R),!@(L8S]T]._@?6)^R]O]8?/OR_/
M[CV?80C55'V*<?YOD?D!XJ\,:IX*\2:GH&M6CV.K:;</:W5O)U213@C/0CT(
MX(P162:^L/\ @IMH-KHO[4MY<6R!'U+2K2\GP,9DPT6?^^8EKY0^\U?8X.N\
M10A4:U:U]>I\MBZ2HUI0CLA****[3C"BBB@ HHHH **** "BBB@ HHHH ^T_
M^"3O_)QGB#_L5;G_ -++2OUEK\FO^"3O_)QGB#_L5;G_ -++2OUEK\^SC_>W
MZ(^XRK_=E\PHHHKQ3V HHHH **** "BBB@ HHHH **** "BBB@ HHHH CE_U
M;_2O@7]@S_DLFI_]@2;_ -'P5]]2_P"K?Z5\"_L&?\EDU/\ [ DW_H^"ON<C
M_P"11F7^&'YL^'SK_D:8#UE^A]_4E%+7PQ]P%%%% !1110 F/:EHHH *3 ]*
M6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* $Q[4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!\R_M]?\ ))]%_P"PW%_Z(GKLOV/?^3>?"WUN_P#TJFKC?V^O^23Z+_V&
MXO\ T1/79?L>_P#)O/A;ZW?_ *535]W5_P"26I_]?G_Z2SXBC_R4E3_KW^J/
M:****^$/MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH 2O(_'7_(U7W_
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M _\ <0_].%S7T<.M?./_  3O_P"3._ /_<0_].%S7T<.M8XO_>*GJ_S-,-_
MAZ+\AU%%%<QU!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]9:_)K_@D[_R<9X@_P"Q5N?_ $LM*_66OS[./][?HC[C*O\ =E\PHHHKQ3V
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH CE_U;_2O@7]@S_DLFI_]@2;
M_P!'P5]]2_ZM_I7P+^P9_P EDU/_ + DW_H^"ON<C_Y%&9?X8?FSX?.O^1I@
M/67Z'WZ:_%#_ (*!?\G;^.?]ZU_])8J_:\U^*'_!0+_D[?QS_O6O_I+%7A9'
M_OOR?Z'T6:_[J_5'UM_P5$_Y-Q^'G_87B_\ 2.6MW_@DU_R03Q+_ -C+-_Z2
MVU87_!43_DW'X>?]A>+_ -(Y:W?^"3?_ "0/Q)_V,LW_ *2VU='_ #+JO^+_
M ".)_P"^T?\ #^C/MRBLKQ%XETGPCI$^JZYJEGHNEP8\V]U"X2"&/) &YW(4
M9) Y/4UQ3?M+?"+_ **CX+_\*&S_ /CE?.J,I;*Y]!*<8_$['$_MF>,OB5X.
M^%-O_P *LTNZO_$FI:C'8F2RM#<S6T3(Y,BK@@'*J-[#"Y['!'Y<?M'?L[^.
M/@O9^&]=^(6J+>^)/%+7$\UNUPUS-#Y?E\S3$D.Y,AR%) VCYCGC]LM!\1:7
MXJT>VU71=1M-7TNX!:&]L9DGAE )!*NA*MR".#U%?GE_P5XXNOAE_NZA_P"V
M]>SE>(E2Q$**BE=N[ZVML>9CZ4:U&52^B6BZ7[GNW_!,\?\ &*^B_P#7_>_^
MCFK1_:N_9%N?VH?&/@=[OQ =&\,:,EU]OCA!>YF:0Q;1$"-@.$8%VSCCY6[9
MW_!,_P#Y-7T7_K_O/_1S5ZG^U%\5-9^"?P-\2>,M L;;4-4TU83%#>([PX>9
M$9G",K$ ,3PP^M8XJ4X8Z4H?%?3U96$C&>#49[-:GB'Q)_X)P_!NW^&.L+HF
ME7FCZY9V,DT&L_VC/*YD1"P,B.QC*DCD*J\$XQ7P3^PUX@U'0/VI/ 9TZ22-
MKN[:TN%3.)(7C8.K =1CYO8J#VKI_BM_P44^+7Q8\(WWARX.B^'M/OHVANVT
M.UDCFFC(PR%Y)9"H(X.W!(XS@FO4?^"9?AGX7-X\CUC4/$OVGXC)#(FFZ'=V
MQ@CA!4B22*0DB:0H2,#!52YVGJ/>H1Q&'H598EN5UHM^GY'B5Y4*]6G##I1:
M>KV['ZC+]T4M%%?&'UX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'S+^WU_R2?1?^PW%_Z(GKLOV/?^3>?"WUN__2J:N-_;Z_Y)/HO_ &&X
MO_1$]=E^Q[_R;SX6^MW_ .E4U?=U?^26I_\ 7Y_^DL^(H_\ )25/^O?ZH]HH
MHHKX0^W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*\C\=?\C5??\ _]
M 6O7*\C\=?\ (U7W_ /_ $!:UI?$S*IL7_AG_P AZ;_KV;_T-*].KS'X9_\
M(>F_Z]F_]#2O3J=7X@I_"%%%%8FH4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 AZ8K\Q_^"N.?^$V^'?\ UXW?_HR.
MOTWKX6_X*+?LU_$7X[>)/!M[X&T!=<BTZVN(+H?;;>W:-F="O^MD3((!Z9KO
MRZ<*>+ISF[)/]#AQT7/#5(Q5VU^I[%_P3_\ ^32? G_7.Z_]*YJ_,OXB?\GR
M:SV_XKQO_2ZOU7_9%^'VN?"O]GOPEX6\2VJV.MV,4WVBV65)1&7GD<#<A*GY
M6'0FOS_^.?[#WQSU[X]>,?$WAKPJ;NQO-:GU*QU"UUBT@;:\ID1@'F1U89'8
M8(X]:]?!UZ4,QJU)27*^;6^FYY>(I5)9=3IJ+OII;79GZQ+]T9]*\-_:R_9G
M7]J+P/I7AYO$;>&GL-0%^MTME]J#XC="A3S$_OYSGMTKX0_X4#^V[_T$O&O_
M (747_R97WW^R3X;^(/A3X'Z/IOQ,N+RX\6QSW#3-J%\+V<1F5C&'F#N&^7&
M/F. 0.V*\VKAUADJM.K&33Z;G?2Q$J[]G.FTFNI\E_\ #G\_]%9'_A-__==:
MG[?GP1\8P_!'X/\ @SPAI&L^,++P]$;2Z.F6$L\A:*WBCBE>.,-M! DZ],XS
M7Z#_ $XH;!4CK4/,:\IQE.5U%WM9?H7' T*:DH*S::W9^/O@+Q_^UY\,?"MA
MX;\+^&O&6DZ)8J4M[2/P0CA06+$EFM"S$DDDL2237@GQ)U_QSKWQ0U+5?&D5
M]#XZDGB>[CO; 6MP) B"/= $4*=H3 VC/'K7[^\#@5^8_P"TE^QC\7?B#^U-
MKGBS0?"\=_X=OKZUFBO_ .TK6,!5BB5BR/('X*-T4^V:]O YE3J8ANI",;IZ
M[/[_ #/&QF G3P_N2<K-:;K[CZ@_8;\:?&'QMX)\03?%ZSU*"_AOUCL'U;25
MTV9HO+4L!&L<>5#=&V]21GCCZ9^M(@(49'.*=]*^9K5%5J.:BHWZ+8^BH4W2
MIJ#;=NX?Q5\4_P#!63_DWGPY_P!C5;_^D=Y7VM_%7Q3_ ,%9/^3>?#G_ &-5
MO_Z1WE=. _WJGZF&._W>?H>C_P#!._\ Y,[\ _\ <0_].%S7T<.M?./_  3O
M_P"3._ /_<0_].%S7T<.M8XO_>*GJ_S-,-_ AZ+\AU%%%<QU!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )7Q;_ ,%8/^3=
M=!_[&>V_]);NOM*OBW_@K!_R;KH/_8SVW_I+=UW8'_>J?J<6-_W>?H?DU111
M7Z:?G@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]I
M_P#!)W_DXSQ!_P!BK<_^EEI7ZRU^37_!)W_DXSQ!_P!BK<_^EEI7ZRU^?9Q_
MO;]$?<95_NR^84445XI[ 4444 %%%% !1110 4444 %%%% !1110 4444 1R
M_P"K?Z5\"_L&?\EDU/\ [ DW_H^"OOJ7_5O]*^!?V#/^2R:G_P!@2;_T?!7W
M.1_\BC,O\,/S9\/G7_(TP'K+]#[[K\4O^"@7_)V_CG_>M?\ TEBK]K:_,']L
M#]B_XO?%+]HKQ+XH\+^%H]3T+43;M#>?VE:PXVP1HVY))588*GM7SV3U84<7
MS5'96>K^1]+F4)5,,XP5W='HW_!43_DW/X>_]A>'_P!(Y:WO^"3O_) _$G_8
MRS?^DMM72_MW_ /QK\:?@GX5T/P;I<6JZMI>HQ7$]I]JB@)06[QDJTC*IP6'
M4CCI7QMX4_9+_:Y\":?)8>&;'Q#X<L993-):Z3XMMK6)Y" "Y6.Z +851GK@
M#TKMHNE6PE2BZBBW+JSSZRJ4\12JJ#DHQZ(_2[]H[X*I^T'\)]6\$OJ[:']N
M>&1;Y;?[1Y9CE609CW+N!VX^\.M?&G_#G\G_ )JT/_";_P#NNM/]E/X0_M2^
M%_CIH&I?$74/$DG@^$7'VY-4\41W\+Y@<1CRA<.2?,*$';QC/%?H3V'K7GNK
M5R]^SH5$T]7:S\OT.Z,*>.]^M3::T5[H\T_9Z^#J? 7X2:'X'CU5M:&F>=F^
M:#R/-,DSRGY-S;0"^/O'I7Q3_P %=_\ CZ^&1_V=0_G;U]3?MG>%?B=XO^#Z
MV'PGNKZU\2#489)#INI+83O;A7WJLI= /F*$C<,@'KTK\\_%W['7[5WQ ^RG
MQ1I&M>)3:[OLYU?Q3:7?D[L;MGF71VYP,XZX%;8!*I76*K5$FF[WT;OU_$C&
M-TJ+P]*#::Z:V/MO_@FC_P FJZ-_U_WG_HYJ^JOKTK\B?"_[*_[8/@O2XM,\
M/0>)=!TY&+I9Z;XPM[>%68Y8A$NPN2>3QS7TG^U]\!_CEJGBSPIX^^&.JWC:
MM8:+%INHVNG:B+>X,B.SLX#%5E1BW*Y))'W3GBL9AZ=3$\T:L;3??;U(P=:=
M.ARNF[Q7;?T/KWQY\._#?Q-\/7>B>*-&L]8TVX0HT=U$K%<C[R$\HPZAA@@\
MBOP@DFF\!?%:9O#5W(9]'UAO[-NHVR[&*<B)@1U)VKTZYKZ2\3?$#]M#Q?IE
MQX:U/3O'36EPI@E^S>&A;;U/!!N(H%.".IWX->C_ +(/_!.GQ-9>,M+\8_$Z
MUBT>RTR9;JUT+S4EGN)E(9&E*$JB X.W)8XP0!U]# QCEW-.M5379.]SBQDY
M8[EITJ;OW:M8_2FW):WC+##$ D>AQ4]-QC I3TKY-[GTT59)"T444B@HHHH
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MBKXI_P""LG_)O/AS_L:K?_TCO*[\!_O5/U.''?[O/T/1_P#@G?\ \F=^ ?\
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M_P"Q5N?_ $LM*_66OS[./][?HC[C*O\ =E\PHHHKQ3V HHHH **** "BBB@
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MZ?"]"$]'*JY+T2:/A\*_:<1UY1VC!)^K:9Z;1117PA]P%%%% !1110 4444
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M_P#3A<U]'#K6.+_WBIZO\S3#?P(>B_(=1117,=04444 %%%% !1110 4444
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M^'?_  *G_P#C-'_#!?Q"_P"@GX=_\"I__C-']AY1_P!#)?\ @#_S#^VLT_Z
M'_X%_P  ^^O,3^^/SH\Q/[X_.O@7_A@OXA?]!/P[_P"!4_\ \9H_X8+^(7_0
M3\._^!4__P 9H_L/*/\ H9+_ , ?^8?VUFG_ $ /_P "_P" ??7F)_?'YT>8
MG]\?G7P+_P ,%_$+_H)^'?\ P*G_ /C-'_#!?Q"_Z"?AW_P*G_\ C-']AY1_
MT,E_X _\P_MK-/\ H ?_ (%_P#[Z\Q/[X_.CS$_OC\Z^!?\ A@OXA?\ 03\.
M_P#@5/\ _&:/^&"_B%_T$_#O_@5/_P#&:/[#RC_H9+_P!_YA_;6:?] #_P#
MO^ ??7F)_?'YT>8G]\?G7P+_ ,,%_$+_ *"?AW_P*G_^,T?\,%_$+_H)^'?_
M  *G_P#C-']AY1_T,E_X _\ ,/[:S3_H ?\ X%_P#[Z\Q/[X_.CS$_OC\Z^!
M?^&"_B%_T$_#O_@5/_\ &:/^&"_B%_T$_#O_ (%3_P#QFC^P\H_Z&2_\ ?\
MF']M9I_T /\ \"_X!]]>8G]\?G1YB?WQ^=? O_#!?Q"_Z"?AW_P*G_\ C-'_
M  P7\0O^@GX=_P# J?\ ^,T?V'E'_0R7_@#_ ,P_MK-/^@!_^!?\ ^^O,3^^
M/SH\Q/[X_.O@7_A@OXA?]!/P[_X%3_\ QFC_ (8+^(7_ $$_#O\ X%3_ /QF
MC^P\H_Z&2_\  '_F']M9I_T /_P+_@'WUYB?WQ^='F)_?'YU\"_\,%_$+_H)
M^'?_  *G_P#C-'_#!?Q"_P"@GX=_\"I__C-']AY1_P!#)?\ @#_S#^VLT_Z
M'_X%_P  ^^O,3^^/SH\Q/[X_.O@7_A@OXA?]!/P[_P"!4_\ \9H_X8+^(7_0
M3\._^!4__P 9H_L/*/\ H9+_ , ?^8?VUFG_ $ /_P "_P" ??7F)_?'YT>8
MG]\?G7P+_P ,%_$+_H)^'?\ P*G_ /C-'_#!?Q"_Z"?AW_P*G_\ C-']AY1_
MT,E_X _\P_MK-/\ H ?_ (%_P#[Z\Q/[X_.CS$_OC\Z^!?\ A@OXA?\ 03\.
M_P#@5/\ _&:/^&"_B%_T$_#O_@5/_P#&:/[#RC_H9+_P!_YA_;6:?] #_P#
MO^ ??7F)_?'YT>8G]\?G7P+_ ,,%_$+_ *"?AW_P*G_^,T?\,%_$+_H)^'?_
M  *G_P#C-']AY1_T,E_X _\ ,/[:S3_H ?\ X%_P#[Z\Q/[X_.CS$_OC\Z^!
M?^&"_B%_T$_#O_@5/_\ &:/^&"_B%_T$_#O_ (%3_P#QFC^P\H_Z&2_\ ?\
MF']M9I_T /\ \"_X!]]>8G]\?G1YB?WQ^=? O_#!?Q"_Z"?AW_P*G_\ C-'_
M  P7\0O^@GX=_P# J?\ ^,T?V'E'_0R7_@#_ ,P_MK-/^@!_^!?\ ^^O,3^^
M/SH\Q/[X_.O@7_A@OXA?]!/P[_X%3_\ QFC_ (8+^(7_ $$_#O\ X%3_ /QF
MC^P\H_Z&2_\  '_F']M9I_T /_P+_@'WUYB?WQ^='F)_?'YU\"_\,%_$+_H)
M^'?_  *G_P#C-'_#!?Q"_P"@GX=_\"I__C-']AY1_P!#)?\ @#_S#^VLT_Z
M'_X%_P  ^^O,3^^/SH\Q/[X_.O@7_A@OXA?]!/P[_P"!4_\ \9H_X8+^(7_0
M3\._^!4__P 9H_L/*/\ H9+_ , ?^8?VUFG_ $ /_P "_P" ??7F)_?'YT>8
MG]\?G7P+_P ,%_$+_H)^'?\ P*G_ /C-'_#!?Q"_Z"?AW_P*G_\ C-']AY1_
MT,E_X _\P_MK-/\ H ?_ (%_P#[Z\Q/[X_.CS$_OC\Z^!?\ A@OXA?\ 03\.
M_P#@5/\ _&:/^&"_B%_T$_#O_@5/_P#&:/[#RC_H9+_P!_YA_;6:?] #_P#
MO^ ??7F)_?'YT>8G]\?G7P+_ ,,%_$+_ *"?AW_P*G_^,T?\,%_$+_H)^'?_
M  *G_P#C-']AY1_T,E_X _\ ,/[:S3_H ?\ X%_P#[Z\Q/[X_.CS$_OC\Z^!
M?^&"_B%_T$_#O_@5/_\ &:/^&"_B%_T$_#O_ (%3_P#QFC^P\H_Z&2_\ ?\
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M'DCR4H*T8]E_FSV\HRM9;3DYRYJDW>4N[_R'T445\\>^%%%% !1110 4444
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M[:>%BO\ D8T/1_\ MQ]M_%+QU:_"_P"'/B/Q7>8^SZ38RW94_P ;*I*I]6;
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MA_N@U]1_#G_@DK=S".;QWXVCM\@%K+0H"Y![CSI !_XX:\^MF&&H_%-7^_\
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MQ<:,(O=)?D.HHHK Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH YWQ9X"\.>/-/:R\1Z#INN6K*5\K4+5)@
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M$?XY'SQ\$_A;>_%#P&L&K:Q>6'ANWGD6"ST]@C32$@M)(6!! R !CL>G?>^
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MW_9X_M&WIYFT;_US6EZU]2?20ES13M:XZBDI:"PHHHH **** "BBB@ HHHH
M2O(_'7_(U7W_  #_ - 6O7*\C\=?\C5??\ _] 6M:7Q,RJ;%_P"&?_(>F_Z]
MF_\ 0TKTZO,?AG_R'IO^O9O_ $-*].IU?B"G\(4445B:A1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ I*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:2WW"7YB06<?-M'3*EE('('->P_'SQ9)X1^$DTVB.(1=>5:036QPL<;#JA'
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MF_\ 0TKTZG5^(*?PA1116)J%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI:** $P/2C ]*6B@ HHHH **** "BBB@!,9ZBEHHH 0J&Z@'\* H7H *6BD
M4444P"BBB@ HHHH **** "BBB@ HHHH 2O(_'7_(U7W_  #_ - 6O7*\C\=?
M\C5??\ _] 6M:7Q,RJ;%_P"&?_(>F_Z]F_\ 0TKTZO,?AG_R'IO^O9O_ $-*
M].IU?B"G\(4445B:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJW@G5M'@OID@@NF!*EG("D[D48Y'0FE]>P_M/8\VM[==_4*F,H49<DY:_?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFOC'Q5^V9XJU7?'HMA9Z)"2<2,/M$N.W+87_ ,=KQ[Q-\0O$WC&0MK6N7VH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!I[5X#^VC_ ,DLT[_L+P_^BIJ]^/:O ?VT
M?^26:=_V%X?_ $5-71A?XT?4YL1_"D?%-%%%?6GS 4444 %%%% !1110 4Y'
M:-E9&*LIR&4X(--HH [_ ,*_'CQUX/\ +6R\07,MNG2WO#Y\>/3#Y(_ BO8O
M"W[;-R@2/Q%X?CF'&;C39-A^NQ\C_P >%?+U%<T\-2J?%$Z(8BK3VD?H+X5_
M:/\  /BK8D6MI83L0!#J*^0<G_:/R_D:])M;R"\A6:"5)HF&5DC8,I^A%?EC
M6WX=\::_X1F$NC:Q>::P.<6\S*I^JYP?Q%>?/+E]B1W0Q[^VC].J,U\1>%?V
MQ/&6BA(]5@L]=A4 ;I$\F4_\"3C_ ,=KV/PK^V%X-UHI'JL5YH,S'&Z9/.B_
M[Z3G\UKSYX.M#I?T.Z&*I3ZV]3WJ@UB>'?&>A>*[<3:/JUGJ28S_ */,K,/J
M,Y'XUN5QM-.S.M-/8****!A1110 4444 %%%% !115+4M7LM'MS/?WEO90CK
M+<2K&OYDT 6^*#7C_BG]JCP%X;WI!J+ZU<+TCTZ/>N?3><+^1->.^*OVU-;O
M-\>@:-:Z;'_#-=L9Y/K@84?K75#"5JFT3EGB:4-V?86>YKB/%7QG\%^#=XU/
MQ#9K,HS]GA?SI?IM3)'XU\(^*?BYXP\9LPU77[VXB8D^0DGE1<]MBX'Z5R%>
MA3R[^>7W'#/,/Y%]Y]=>*OVUM+M?,B\/:'<7K]!<7KB)/KM7)/YBO'O%7[3_
M (_\4;U355T>W8G]UIL8C./3><M^M>345Z$,)1I[1.&6)JSWD6+[4+K5+AI[
MRYFNYVZRSR%V/XGFJ]%%=9S!1110(**** "BBB@ HHHH ]^_8K_Y*IJG_8&E
M_P#1\%?:]?%'[%?_ "535/\ L#2_^CX*^U_6OF<=_'9]%@OX2%HHHK@.X***
M* "BBB@ HHHH **** "BBB@ HHHH **** $XQ[4#I1BJ>I:E:Z/8SWE[<16E
MI"A>6>9PB(HZDD\ 4).3LMR9245=EK)[C%'7BOD'XH?MV16-[+8^!],COEC)
M0ZGJ 81N>F8XP0Q'NQ'TK@/^%Y?M$:XHN+"TU@0,,J;/P\KH0?0F%OYU]G0X
M2S"I356LXTD]N>5G]UG^)\C6XHP-.;ITE*HU_*KK[]#[_P#PH_"O@'_A;G[2
M_P#SZ^)/_":3_P",4?\ "W/VE_\ GU\2?^$TG_QBM_\ 5*O_ -!-'_P/_@&/
M^M5#_H'J?^ _\$^_OPH_"O@'_A;G[2__ #Z^)/\ PFD_^,4?\+<_:7_Y]?$G
M_A-)_P#&*/\ 5*O_ -!-'_P/_@#_ -:J'_0/4_\  ?\ @GW]^%'X5\ _\+<_
M:7_Y]?$G_A-)_P#&*/\ A;G[2_\ SZ^)/_":3_XQ1_JE7_Z":/\ X'_P _UJ
MH?\ 0/4_\!_X)]_?A1^%? /_  MS]I?_ )]?$G_A-)_\8H_X6Y^TO_SZ^)/_
M  FD_P#C%'^J5?\ Z":/_@?_   _UJH?] ]3_P !_P""??WX4?A7P#_PMS]I
M?_GU\2?^$TG_ ,8H_P"%N?M+_P#/KXD_\)I/_C%'^J5?_H)H_P#@?_ #_6JA
M_P! ]3_P'_@GW]^%'X5\ _\ "W/VE_\ GU\2?^$TG_QBC_A;G[2__/KXD_\
M":3_ .,4?ZI5_P#H)H_^!_\  #_6JA_T#U/_  '_ ()]_?A1^%? /_"W/VE_
M^?7Q)_X32?\ QBC_ (6Y^TO_ ,^OB3_PFD_^,4?ZI5_^@FC_ .!_\ /]:J'_
M $#U/_ ?^"??WX4?A7P#_P +<_:7_P"?7Q)_X32?_&*/^%N?M+_\^OB3_P )
MI/\ XQ1_JE7_ .@FC_X'_P  /]:J'_0/4_\  ?\ @GW]^%'X5\ _\+<_:7_Y
M]?$G_A-)_P#&*/\ A;G[2_\ SZ^)/_":3_XQ1_JE7_Z":/\ X'_P _UJH?\
M0/4_\!_X)]_?A1^%? /_  MS]I?_ )]?$G_A-)_\8H_X6Y^TO_SZ^)/_  FD
M_P#C%'^J5?\ Z":/_@?_   _UJH?] ]3_P !_P""??WX4?A7P#_PMS]I?_GU
M\2?^$TG_ ,8H_P"%N?M+_P#/KXD_\)I/_C%'^J5?_H)H_P#@?_ #_6JA_P!
M]3_P'_@GW]^%'X5\ _\ "W/VE_\ GU\2?^$TG_QBC_A;G[2__/KXD_\ ":3_
M .,4?ZI5_P#H)H_^!_\  #_6JA_T#U/_  '_ ()]_?A1^%? /_"W/VE_^?7Q
M)_X32?\ QBC_ (6Y^TO_ ,^OB3_PFD_^,4?ZI5_^@FC_ .!_\ /]:J'_ $#U
M/_ ?^"??WX4?A7P#_P +<_:7_P"?7Q)_X32?_&*/^%N?M+_\^OB3_P )I/\
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M_P#H)H_^!_\  #_6JA_T#U/_  '_ ()]_?A1^%? /_"W/VE_^?7Q)_X32?\
MQBC_ (6Y^TO_ ,^OB3_PFD_^,4?ZI5_^@FC_ .!_\ /]:J'_ $#U/_ ?^"??
MM(3CK7P&OQA_:2M3YDMKXB9!U$GAM0OXD0#^=;?@_P#;D\5>'=2%CXUT2*^B
MC;;,T$9M[J/ZH3M)]L+]:B?"&/Y'*A.%1KI&5W^*0X<58+F4:T)POUE'3\+G
MW#1NKEO 7Q&T#XE:!%JV@WJWEJ_#KTDB?&2CKU5AZ?B,CFNI7FOBZE.=&3A4
MBU);I[H^OIU(5H*=-WB]FA]%%%0:A1110 4444 %%%% !1110 4444 %%%%
M!1110 E>1^.O^1JOO^ ?^@+7KE>1^.O^1JOO^ ?^@+6M+XF95-B_\,_^0]-_
MU[-_Z&E>G5YC\,_^0]-_U[-_Z&E>G4ZOQ!3^$****Q-0HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 -/:O ?VT?^26:=_V%X?_ $5-7OQ[5X#^VC_R2S3O^PO#_P"BIJZ,+_&C
MZG-B/X4CXIHHHKZT^8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /?OV*_^2J:I_V!I?\ T?!7VO7Q1^Q7_P E4U3_ + TO_H^"OM?
MUKYG'?QV?18+^$A:***X#N"BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
M.7_5O]*^!?V#/^2R:G_V!)O_ $?!7WU+_JW^E? O[!G_ "634_\ L"3?^CX*
M^YR/_D49E_AA^;/A\Z_Y&F ]9?H??U%%%?#'W 444F: %HI,T9% !15>XN8K
M.WEGGE2"")2[RR,%5% R22>  .]<QX5^+7@CQ[J$MAX:\8Z!X@O8D,DEOI6I
MP74B*" 6*QN2!D@9]Z:BY7LMB7)*UWN=A1112*"BBDH 6BBDH 0]>E'KQ7S'
M;_\ !0'X;:A\9HOAM8V'B&_UB35!I*WUO9Q-9F;?L)W>;OV!LY;9T!/2OIL-
M_*M)4YTTG-6OL91JPG)QB[M;CZ*3(]:,BLS4*!5'5M6L=!TVXU#4KVWT_3[=
M#)-=7<JQ11*.K,[$ #W)K%\'_$WPC\0FN1X7\4Z)XD^S8\_^R-0AN_*STW>6
MQVYP>OI346T[+8ER2M=[G4T444B@HI*,CUH 6BDS1D>M "T4F1ZTM !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!\R_M]?\ ))]%_P"PW%_Z(GKLOV/?^3>/"WUN_P#TJFKC?V^O^23Z+_V&
MXO\ T1/79?L>_P#)O/A;ZW?_ *535]W5_P"26I_]?G_Z2SXBC_R4E3_KW^J/
M:****^$/MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH 2O(_'7_(U7W_
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MC'#+#IMV3>KU['[P@BLOQ-XBL/"?A[4];U2?[-ING6TEU<S;2=D:*69L#D\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #3VKP']M'_ ))9
MIW_87A_]%35[\>U> _MH_P#)+-._["\/_HJ:NC"_QH^IS8C^%(^*:***^M/F
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#W[]BO\
MY*IJG_8&E_\ 1\%?:]?%'[%?_)5-4_[ TO\ Z/@K[7]:^9QW\=GT6"_A(6BB
MBN [@HHHH **** "BBB@ HHHH **** "BBB@ HHHH CE_P!6_P!*^!?V#/\
MDLFI_P#8$F_]'P5]]2_ZM_I7P+^P9_R634_^P)-_Z/@K[G(_^11F7^&'YL^'
MSK_D:8#UE^A]_4445\,?<!1110!^8W_!73_D=OAY_P!>%W_Z,CKZD_X)U_\
M)HO@G_>OO_2V>OEO_@KI_P CM\//^O"[_P#1D=?4G_!.O_DT7P1_O7W_ *6S
MU]'+_D3P7][_ #/!_P"9H_3]$>I_M!_\D(^(G_8NZA_Z325^8O\ P2[L;:\_
M::>2>WBG>WT.YEA:1 QB??$NY<]#M9AD=F([U^G?[0?_ "0CXB?]B[J'_I-)
M7YF?\$L?^3EKO_L 7/\ Z-@K/+-*&)_P_HS3,?XF'_Q?_(GV=_P4GB23]D_Q
M(60,8[JR921]T_:8QD?@2/QKQ#_@D1G[!\3!G/[S3_Y7%>Y_\%)/^33/$_\
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M[_\ 2J:ONZO_ "2U/_K\_P#TEGQ%'_DI*G_7O]4>T4445\(?;A1110 4444
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M$GAD&<X9&!!&0.HK*\-?#/PEX+T^]L- \*Z+H5C?#_2K;3=/AMXKC@C]XJ*
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M-/AM/-QTW>6HW8R>M=12U/-+77<OECIIL%%%%(H**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /F7]OK_DD^B_
M]AN+_P!$3UV7['O_ ";SX6^MW_Z535QO[?7_ "2?1?\ L-Q?^B)Z[+]CW_DW
MGPM];O\ ]*IJ^[J_\DM3_P"OS_\ 26?$4?\ DI*G_7O]4>T4445\(?;A1110
M 4444 %%%% !1110 4444 %%%% !1110 E>1^.O^1JOO^ ?^@+7KE>1^.O\
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M^<?^"=__ "9WX!_[B'_IPN:^CAUK'%_[Q4]7^9IAOX$/1?D.HHHKF.H****
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M_P DM3_Z_/\ ])9\11_Y*2I_U[_5'M%%%%?"'VX4444 %%%% !1110 4444
M%%%% !1110 4444 )7D?CK_D:K[_ (!_Z M>N5Y'XZ_Y&J^_X!_Z M:TOB9E
M4V+_ ,,_^0]-_P!>S?\ H:5Z=7F/PS_Y#TW_ %[-_P"AI7IU.K\04_A"BBBL
M34**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#\0-(Q_PW-:Y_P"BBK_Z<Z_3;]O[_DT7Q_\ ]<;7_P!*X:VH_P!C3X.6_P 0
M%\;1^#8T\2K?_P!J"\%]=;1<[_,\SRO-\O._YL;<9[5Z;XW\#Z)\1_"VH^&O
M$>GQZIHFH1^5=6DC,H=00P^92&!! (((((!%>KB<7"JJ%D_<M?Y6V/-PV&G1
MJ59MZ2>GXGY#?L-?M/>%_P!F3Q#XIO\ Q/I^KW\.K6T$$*Z1#%(RLCLQ+>9*
MF!AATS7VKX7_ ."H7PK\6>)=)T2WT/Q=;7&I7D5G'-<V=J(D:1P@9RMR3M!(
MS@$X[&NV_P"'=W[/G_0@'_P<ZA_\D5<T']@GX%>&]<T_5].\"B#4+"XCNK>1
MM6OI DB,&5BK3E6P0.""#W%=F(Q6!Q-3VE2,K_+_ #.*CAL90CR0E&WS/H+
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MHHH **** $KR/QU_R-5]_P  _P#0%KURO(_'7_(U7W_ /_0%K6E\3,JFQ?\
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M]M[^IY]&.-]E'DE&UE;?:QYO_P /9/A+_P!"YXT_\ K/_P"2J/\ A[)\)?\
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MEO\ +/\  .7'_P T?Q/-_P#A[)\)?^A<\:?^ 5G_ /)5'_#V3X2_]"YXT_\
M *S_ /DJO2/^'=_[/G_0@'_P=:A_\D4?\.[_ -GS_H0#_P"#K4/_ )(HYLM_
MEG^ <N/_ )H_B>;_ /#V3X2_]"YXT_\  *S_ /DJC_A[)\)?^A<\:?\ @%9_
M_)5>D?\ #N_]GS_H0#_X.M0_^2*/^'=_[/G_ $(!_P#!UJ'_ ,D4<V6_RS_
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MB3_PF4_^,4?\+<_:6_Y]?$G_ (3*?_&*^_-H_NC\J-H_NC\J/]9L/_T+Z/\
MX"'^KM?_ *#:GWGP'_PMS]I;_GU\2?\ A,I_\8H_X6Y^TM_SZ^)/_"93_P",
M5]^;1_='Y4;1_='Y4?ZS8?\ Z%]'_P !#_5VO_T&U/O/@/\ X6Y^TM_SZ^)/
M_"93_P",4?\ "W/VEO\ GU\2?^$RG_QBOOS:/[H_*C:/[H_*C_6;#_\ 0OH_
M^ A_J[7_ .@VI]Y\!_\ "W/VEO\ GU\2?^$RG_QBC_A;G[2W_/KXD_\ "93_
M .,5]^;1_='Y4;1_='Y4?ZS8?_H7T?\ P$/]7:__ $&U/O/@/_A;G[2W_/KX
MD_\ "93_ .,4?\+<_:6_Y]?$G_A,I_\ &*^_-H_NC\J-@_NC\J/]9L/_ -"^
MC_X"'^KN(_Z#:GWGP&?BU^TLP.;3Q)CO_P 4RG_QBE_8-S_PN34_^P)-_P"C
MX*^^9% C?@9Q7P-^P9G_ (7)J?\ V!)O_1\%>]A\TIYCD^/Y,/"ERJ/P*U[M
M[^EM/4\+$9=4P&:X+GKRJ<SE\3O:UMO6^I]_4445^3GZF)WKYK_X*)_\FD>,
MO]ZS_P#2J*OI3O7S7_P43_Y-(\9?[UG_ .E45:T?XT/\2_-$5/@EZ,^9?^"0
M_P#R,/Q*_P"O:P_]#GKD_P#@K)_R7CPQ_P!B['_Z4SUUG_!(?_D8?B5_U[6'
M_H<]<G_P5D_Y+SX8_P"Q=C_]*9Z^KJ?\C>'I_P"VGS5+_D65/ZZHN?!__@F&
M?BO\,?#?C ?$G^RAK-FEW]B_L+SO)W#[N_[2N['KM'TKZ\_9#_8]'[*O_"3M
M_P )6?$\FN?9@3_9_P!D$0A\W''FR;B?-/<8Q77?L>_\FP_#;_L#0?RKV+'I
M7CX['5Y3J47+W+M6LMD].AZ&#P='V=.KR^]9.]WO8_';]NP[?VWM<_W]-'_D
MM!7W;^WU\!?^%T? R[N]/MO.\2^&]VI6.Q<O+&!^^A'<[D&0.[(M?"/[=W_)
M[VN9_P">FF_^DT%?L.$#+@\@CI6V)J.GA<)..Z5U^!-&*EB\1&:NGRK\&?BM
M\"/CD-#^ _Q;^&.K3#[!K.EO?:8)#PMW&4,B#_?C7=]8O4U]%_\ !(7_ (^O
MBC_NZ9_[=5\Y?MR? =O@7\<-2BLK9HO#6N%M2TQ@N$56/[R$?[CDC']TIZU]
M'_\ !(6,_:/BDW.,:8,XXZW5>U7=.K@:N(I_;2OZIH\BG&=+%0P\OLMV]&>6
M_P#!0+39?A7^V%;>+[*\M;Z>Y%CK,=KY@+P20[5"2*.0&,(8'N&]J[[]HC_@
MI1X;^*GP0U;PEX?\,:M9:WK5N+6\DU Q?9[9#@R>6RN6D/!4$JG7/;%>6_MB
M1:M\&?VVKOQ;J$=CKJM?VNMV=K-.L@DA39MBE0'<F-A49'0 C(KNM%_X*(?#
M?1]:&K6_[.'AW3=6#[QJ%E<6RS[CU;>+-6S^-<U.DZF$H7I\_*NC2MY/N=%2
MLZ>+K6GR7MNKW/=_^"8/P:U[X<_#/7_$>O6<VFR>))X7M+.X4I)]GB5]LI4\
MC>9&QGJ%!Z$5]JU\^?LW_MI^!?VD;R?2M)CO-$\16\1F?2M25=TD8QN>)U)#
M@9&1PW?&.:^@J^>QTJM2O*5:/*WT\NA[6"C3A14:4KI=?,?1117"=X4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!\R_M]?\DGT7_L-Q?\ HB>NR_8]_P"3
M>?"WUN__ $JFKC?V^O\ DD^B_P#8;B_]$3UV7['O_)O/A;ZW?_I5-7W=7_DE
MJ?\ U^?_ *2SXBC_ ,E)4_Z]_JCVBBBBOA#[<**** "BBB@ HHHH **** "B
MBB@ HHHH **** $KR/QU_P C5??\ _\ 0%KURO(_'7_(U7W_  #_ - 6M:7Q
M,RJ;%_X9_P#(>F_Z]F_]#2O3J\Q^&?\ R'IO^O9O_0TKTZG5^(*?PA1116)J
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %)1Z5Y/^U-X^UGX8? 'QGXH\/3K::SIUHLEM/)$L@C8R(N[:P(. QZ@B
MB/O-)=0/5A2^]? 7_!/7]J3XF?'#XC>(M'\;>(EURRM=+^UP+]AM[=HY!,B=
M88TR,,>#FOOS-=.)P\\+4]G/?R.3#8F.)BY03LG;4&]10M?D]^T5_P %!OBG
M:?&7Q58>!?%4>D>%].NWL;2*/3K2?S/+^1I"\L3L=S!B.<8(XKZV_P""?W[2
MFM_M ?#S68O%FH1ZCXIT6\"33K#'"9H)%S$Y1%50=RR+P!]T>M=,\NKT\.L2
M[<NCMUU,(XZE*O[!7O=KRNCZKH_&DSU/>ORY\9_ML?&+2?VL-1\)6GBJ.+PU
M;^*_[*33O[-M67[.+GR]I<Q>9G;WW9KGPN&GBZGLZ;5[7U.C$8B.&I^TGM>Q
M^I&:,UQ?Q7^*&C?!SX?ZMXOU^?RM.TZ$R;,@/-(>$B3/5F; 'U]*_.WX#?M:
M_M$?M$_'K3]'T37X+/0Y;O[9>V*Z9:O;V=@KC>#(8_,/RD*/G#%B.1GBL/A*
MF(4I1:2CNWL37Q4,/R\VKELEN?J*W7WI>*^4O^"@OQN\?_ WX;Z'J/@23[!-
M>7[0WFJ?8TN/LZ!,JN)%9!N.>64_=P*O_L!_&3Q[\;/A)J&L^/6-W=0ZBUO9
MZE]E2V^UPA$).U%53M8L-R@#MU!J8X:<J#Q":LG;S*EB(QK1HM.[5_(^G_XJ
M^*?^"LG_ ";SX<_[&JW_ /2.\K[6_BKXI_X*R?\ )O/AS_L:K?\ ]([RM<!_
MO5/U,\=_N\_0]'_X)W_\F=^ ?^XA_P"G"YKZ.'6OG'_@G?\ \F=^ ?\ N(?^
MG"YKZ.'6L<7_ +Q4]7^9IA?X$/1?D.HHHKF.H**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** &_K7YX_"']E?XH^%_V^K[XC:GX7^S>
M#)/$&MWR:E_:%J^8;B.[$+>4LID^8RQ\;<C=R!@X_0[Z"DXYKHHUYT8S4?M*
MS.>K0C6<7+[+N*>U> _MH_\ )+-._P"PO#_Z*FKWXUX#^VC_ ,DLT[_L+P_^
MBIJ,+_&CZBQ'\*1\4T445]:?,!1110 4444 %%%% !1110 4444 %%%% !11
M6WH_@;Q)K]K]JTSP]JFI6V2/.L[*65,CJ-RJ14RE&.K*46]$8E=3\.?AWJGQ
M0\1?V+I,EO%=>2TYDNF*1JJX!R0I/4CH*Y[4-/N])O)+6]M9K.ZC.'@N(RCJ
M?0J1D5[;^QQ_R5V7_L&3?^A1UG4ERTY3CV+A&\XQ?=?F<;\4O@;K_P ([>PG
MUBXT^YBO79(S92NY#* 2#N1?7MGI7GE?7G[;^?\ A'?"X')^UR_^@"OF:3X;
M>+8;,W4GA;6DME7>9FTZ8(%ZYW;<8KFPM=SI\U1]3JQ5%0J)4UT.<HHHKO.
M**Z2U^&OB^^MTN+;PKK5Q XW++#ITS*P]00N#6-J>DWVBW36NHV5Q872C)AN
MHFC<?56 -3SQD[7+Y':]BI116[I7@/Q+KUJMUIOA[5M0MFZ36MC+*A_%5(HE
M)1U9*BY:(PJ*O:MH>I>'[K[-JFGW6FW&-WDW<+1/CUPP!JC5*2EJ@::T845N
M:/X&\1^(;;[3I?A_5=3M\X\ZSLI94SZ952*IZSX=U7P[.L&K:9>:7,PRL=Y;
MO"Q'J P%3SQO:^I7+*U[:&?1115$!1110 4444 %%%% !1110 4444 %%%%
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MSX6^MW_Z535]W5_Y):G_ -?G_P"DL^(H_P#)25/^O?ZH]HHHHKX0^W"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!*\C\=?\ (U7W_ /_ $!:]<KR/QU_
MR-5]_P  _P#0%K6E\3,JFQ?^&?\ R'IO^O9O_0TKTZO,?AG_ ,AZ;_KV;_T-
M*].IU?B"G\(4445B:A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7@W[=/_)I_Q$_Z\H__ $?'7O->#?MT_P#)I_Q$
M_P"O*/\ ]'QU5/\ B1]5^:%T/B/_ (),_P#)9O%G_8#_ /;B.OO_ /:>^*"?
M!SX%^+O$ZR!+RWLFALLGK<R_NXOR9@?H#7Y__P#!)K_DLWBS_L!_^W$==_\
M\%9/BH4M?"'P\M9L&5FUB_16_A&8X 1Z$^:?^ BOHL?1>(S"-+O:_INSY[+Z
MGL<)4J=FV>1?L%_LZQ_&S1?BKJ&HQ[XFT:31[*:09Q>3C>) 3_$GEI_W\K&_
MX)X_$:?X3_M-6VA:B6M;;7EDT6ZAD.-EP#NBR/[WF)L_[:&OH+]BS]J#X&_
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M $5-7OQ[5X#^VC_R2S3O^PO#_P"BIJZ,+_&CZG-B/X4CXIHHHKZT^8"BBB@
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MK-+,3(P +%I&9B<*HZ]JSCBHK"2P]G=N_D7/#3EBH5[JR5F=KVKXI_X*Q?\
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MJE2M14ZF['4445PG<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?,O[?7_
M "2?1?\ L-Q?^B)Z[+]CW_DWGPM];O\ ]*IJXW]OK_DD^B_]AN+_ -$3UV7[
M'O\ R;SX6^MW_P"E4U?=U?\ DEJ?_7Y_^DL^(H_\E)4_Z]_JCVBBBBOA#[<*
M*** "BBB@ HHHH **** "BBB@ HHHH **** $KR/QU_R-5]_P#_T!:]<KR/Q
MU_R-5]_P#_T!:UI?$S*IL7_AG_R'IO\ KV;_ -#2O3J\Q^&?_(>F_P"O9O\
MT-*].IU?B"G\(4445B:A1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 -/:O ?VT?^26:=_P!A>'_T5-7OQ[5X#^VC_P DLT[_ +"\/_HJ
M:NC"_P :/J<V(_A2/BFBBBOK3Y@**** "BBB@ HHHH **** "BBB@ JWI.H/
MI.J6=\BJ[VLR3*K="58$ _E52B@36EF?0_CS]KN7QMX,U30E\+)8M?PF%KDW
MYE" XR0OEK_.OGBBBL:=&G1OR*US>I6G4MSN]@HHHK8Q"BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?,O[?7_ "2?1?\ L-Q?^B)Z[+]CW_DWGPM];O\
M]*IJXW]OK_DD^B_]AN+_ -$3UV7['O\ R;SX6^MW_P"E4U?=U?\ DEJ?_7Y_
M^DL^(H_\E)4_Z]_JCVBBBBOA#[<**** "BBB@ HHHH **** "BBB@ HHHH *
M*** $KR/QU_R-5]_P#_T!:]<KR/QU_R-5]_P#_T!:UI?$S*IL7_AG_R'IO\
MKV;_ -#2O3J\Q^&?_(>F_P"O9O\ T-*].IU?B"G\(4445B:A1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 -/:O ?VT?^26:=_P!A>'_T
M5-7OQ[5X#^VC_P DLT[_ +"\/_HJ:NC"_P :/J<V(_A2/BFBBBOK3Y@****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #3VKP']M'_ ))9
MIW_87A_]%35[\>U> _MH_P#)+-._["\/_HJ:NC"_QH^IS8C^%(^*:***^M/F
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#W[]BO\
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MW1\+E\EBL^Q&(IZQA%1OYW3.LHHHKX(^Z"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!*\C\=?\C5??\  /\ T!:]<KR/QU_R-5]_P#_T!:UI?$S*IL7_
M (9_\AZ;_KV;_P!#2O3J\Q^&?_(>F_Z]F_\ 0TKTZG5^(*?PA1116)J%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 T]J\!_;1_Y)9IW
M_87A_P#14U>_&O ?VT?^26:=_P!A>'_T5-71A?XT?4YL1_"9\4T445]:?,!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'OW[%?_)5-
M4_[ TO\ Z/@K[7KXH_8K_P"2J:I_V!I?_1\%?:_K7S.._CL^BP7\)"T445P'
M<%%%% !1110 4444 %%%% !1110 4444 %%%% #".AKQW]HOX"VOQK\.QF!H
M[/Q!9 FSNW7Y6!ZQ/CG:?7^$\^H/LGTIN/QKJPN+K8&M'$4)6E'8Y,5A:6,H
MRH5E>,C\\_ _QF^(7[+VJ-X:UW2I+G2XW8KIMZ2@'.2\$P!&TDYXW+R>,DFO
M;+']OOP<\"F[T#7()L<I L,BC\3(O\J^B_$'A?1_%=F;/6--M-4MC_RRNX%E
M4'U 8'!]Z\VO/V3/A3?2;Y/"<:-_TQN[B(?DL@%?;5,WR3,?WN8864:CW=-Z
M/SLVOU]3X^&59Q@/W>!Q$94ULI+5>5TF<+_PWSX$_P"@+XA_\!X/_CU'_#?/
M@3_H"^(?_ >#_P"/5V?_  Q[\)?^A5;_ ,&-U_\ ':/^&/OA+_T*K?\ @QNO
M_CM9>UX6_P"?=;[X_P"9K['B3_GY3_'_ ".,_P"&^? G_0%\0_\ @/!_\>H_
MX;Y\"?\ 0%\0_P#@/!_\>KL_^&/OA+_T*K?^#&Z_^.T?\,??"7_H56_\&-U_
M\=H]MPM_S[K??'_,/8\2?\_*?X_Y'&?\-\^!/^@+XA_\!X/_ (]1_P -\^!/
M^@+XA_\  >#_ ./5V?\ PQ]\)?\ H56_\&-U_P#':/\ AC[X2_\ 0JM_X,;K
M_P".T>VX6_Y]UOOC_F'L>)/^?E/\?\CC/^&^? G_ $!?$/\ X#P?_'J/^&^?
M G_0%\0_^ \'_P >KL_^&/OA+_T*K?\ @QNO_CM'_#'WPE_Z%5O_  8W7_QV
MCVW"W_/NM]\?\P]CQ)_S\I_C_D<9_P -\^!/^@+XA_\  >#_ ./4?\-\^!/^
M@+XA_P# >#_X]79_\,??"7_H56_\&-U_\=H_X8^^$O\ T*K?^#&Z_P#CM'MN
M%O\ GW6^^/\ F'L>)/\ GY3_ !_R.,_X;Y\"?] 7Q#_X#P?_ !ZC_AOGP)_T
M!?$/_@/!_P#'J[/_ (8^^$O_ $*K?^#&Z_\ CM'_  Q]\)?^A5;_ ,&-U_\
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M )A['B3_ )^4_P ?\CC/^&^? G_0%\0_^ \'_P >H_X;Y\"?] 7Q#_X#P?\
MQZNS_P"&/OA+_P!"JW_@QNO_ ([1_P ,??"7_H56_P#!C=?_ !VCVW"W_/NM
M]\?\P]CQ)_S\I_C_ )'&?\-\^!/^@+XA_P# >#_X]1_PWSX$_P"@+XA_\!X/
M_CU=G_PQ]\)?^A5;_P &-U_\=H_X8^^$O_0JM_X,;K_X[1[;A;_GW6^^/^8>
MQXD_Y^4_Q_R.,_X;Y\"?] 7Q#_X#P?\ QZC_ (;Y\"?] 7Q#_P" \'_QZNS_
M .&/OA+_ -"JW_@QNO\ X[1_PQ]\)?\ H56_\&-U_P#':/;<+?\ /NM]\?\
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M^&?_ "'IO^O9O_0TKTZO,?AG_P AZ;_KV;_T-*].IU?B"G\(4445B:A1110
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MZ04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M"5Y'XZ_Y&J^_X!_Z M>N5Y'XZ_Y&J^_X!_Z M:TOB9E4V+_PS_Y#TW_7LW_H
M:5Z=7F/PS_Y#TW_7LW_H:5Z=3J_$%/X0HHHK$U"BBB@ HHHH **** "BBB@
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MSXU^!8?$GB;Q1>1SR0L;&UM\"*,("H=U[LQ7)Q@^_8>E_M&?\D;U_P#W(?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX@I_"%%%%8FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*YKQ,OCG]HC4=+TNY\+7/A30[6;S;B:\#@DXQN!=4+<$@*!U/)]..I&;PU3
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]%%%=AU"8'I1M'I2T4 %)2TE !@#H*6BB@ HHI* #:/2BEI* %I, =!BBEH
M*3 ]*6B@!*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $KR/QU_R-5]_P
M_P#0%KURO(_'7_(U7W_ /_0%K6E\3,JFQ?\ AG_R'IO^O9O_ $-*].KS'X9_
M\AZ;_KV;_P!#2O3J=7X@I_"%%%%8FH4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MN)6E&_;L10<E^IZ8P"2:PI/VA_#2:;97ZVVJ2VTQQ<R1VA86'SE,3G.$.0>
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M*_E1]4^#?BSI_CCQ#<:9I]M.L<5NTYN)L+NPRK@*,_WNN>W2N\'%?-_[./\
MR/%[_P!@^3_T;%7TC7'6@J<^5'51FYQNPHHHK$V"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "DI:* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ I*6B@ HHHH **** $I:** "BBB@ HHHH
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M!\.ZUH32W[2:F[.'TNZM^\H)X$IXP!C'YU[SSFE(#=J!FNC#T/J\.5.^M_\
MAC>G1]G*4D]W<=2T45U'0%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 E>1^.O\ D:K[_@'_ * M>N5Y'XZ_Y&J^_P" ?^@+
M6M+XF95-B_\ #/\ Y#TW_7LW_H:5Z=7F/PS_ .0]-_U[-_Z&E>G4ZOQ!3^$*
M***Q-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $KRO
M]H[_ )$>T_Z_X_\ T7)7JE>5_M'?\B/:?]?\?_HN2M:/\2)C6^!GS=1117T!
MXH4444 /AFDMY%DB=HW7D,A((_&NPT3XO>*="VK'J;W42C'EW@\T?F>?UKC*
M*B48R^)%1DX[,]UT3]I*-MJ:OI31\X,MFV1]=K?XUZ'H?Q3\,^(-JVVK0Q2M
M_P L;@^4W_CW7\*^1Z*Y986G+;0Z8XF:WU/N-6610RL&4\@@Y%.KXST7QAK?
MATC^SM4N;51_ LA*?]\GC]*]!T/]HK6K/:NIV=OJ*9Y=/W3X_#(_2N26$G'X
M7<Z8XJ#^+0^C**\UT/X]>&=6VK<R3:9*>UPF5_[Z7/ZXKO--UBQUB$365Y!=
MQD9W0R!Q^E<LH2C\2.F,XRV9>HHHJ"PHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BDI: $HP*AGN(K6,R32I$B]7D8*!^)KC=<^,GA71-RMJ(O
M)1D>79KYGZ_=_6G&,I;(F4E'=G<8HKP37/VDKF3<FDZ4D0QQ+=ON/UVK@?J:
M\]USXF>)?$.X7>K3K$W_ "Q@/E)],+C/XUUQPM26^AS2Q,%MJ?4&M^--"\.Y
M_M#5;>V<?\LR^Y_^^1D_I7GNM_M&:3:;DTRPN+]\<22XB3/ZG]!7STS%B23D
MGDDTE=<<'!?%J<TL5)[:'HFN_';Q1K&Y8)XM,B/1;5/F_P"^CD_EBN%U#5+S
M59C->W4UW*3G?-(7/ZU5HKJC3C#X4<TIRENPHHHK0@**** /5?V</^1XO?\
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MX\!_] ;Q%_X#P?\ QZC_ (;X\!_] ;Q%_P" \'_QZC_5W-_^@:7W!_K!E?\
MS_B?3-%?,W_#?'@/_H#>(O\ P'@_^/4?\-\> _\ H#>(O_ >#_X]1_J[F_\
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MO_G_ !/IFBOF;_AOCP'_ - ;Q%_X#P?_ !ZC_AOCP'_T!O$7_@/!_P#'J/\
M5W-_^@:7W!_K!E?_ #_B?3-%?,W_  WQX#_Z WB+_P !X/\ X]1_PWQX#_Z
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M!X/_ (]1_J[F_P#T#2^X/]8,K_Y_Q/IFBOF;_AOCP'_T!O$7_@/!_P#'J/\
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M  S_ .0]-_U[-_Z&E>G5YC\,_P#D/3?]>S?^AI7IU.K\04_A"BBBL34****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*\K_:._P"1'M/^
MO^/_ -%R5ZH:\K_:._Y$>T_Z_P"/_P!%R5K1_B1,:WP,^;J***^@/%"BBB@
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M/^&/OA)_T*I_\&-U_P#':]DHH_MG,O\ H)G_ .!R_P P_LC+_P#H'A_X"O\
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MC[X2?]"J?_!C=?\ QVC_ (8^^$G_ $*I_P#!C=?_ !VO9*6C^V<R_P"@F?\
MX'+_ ##^R,O_ .@>'_@*_P CQ:3]C[X3O&0/##QD]UU&ZR/SE(KR3XJ?L+VT
M=C/?^!;V;[0H+?V7J#AE?_923 *GTW9S_>%?8F*/PKLPO$>:86:G&O*7E)N2
M?R9RXC(,MQ,'!T5'S22?X'Q7^R_^T7JV@^(XO 'C>6;8TGV2SGO01-;3 [1#
M)GG!/RC/*G Z'C[3S7Q-^W5\/8-#US0O&>G)]GEOF-M=M'\I,R -%)Q_$5#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^C8J^D*\3%?Q&>MA_P"&A:***Y3J"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@".3_5/]*^!?V#R9/C+J;,=S'19CD^OGP<_K7WU)_JW^E? O[!G_ "63
M4_\ L"3?^CX*^YR/_D49E_AA^;/A\Z_Y&F ]9?H??U%%%?#'W 4444 %%%%
M!1124 +1110 4444 %%%% !1110 4444 %%%% !1110 444E "T444 %%%%
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M\B/:?]?\?_HN2M:/\2)C6^!GS=1117T!XH4444 %%%% !1110 4444 %%%%
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MEUGA^4DI\NXY(Z5ZK^S!K'@3Q!\%?#NH?#?1YM \(3+,+2PN$VRQE9G23?\
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M]=E^Q[_R;SX6^MW_ .E4U<;^WU_R2?1?^PW%_P"B)Z[+]CW_ )-Y\+?6[_\
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MT445RG4%%%% !1110 4444 %%%% !1110 4444 %%%% $<O^K?Z5\"_L&?\
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M^??^"N^?M7PR_P!S4/\ VWKW[]@K3_[8_8I\,V&=IN8=2ASZ;KNX7^M<4O\
MD31_Q?\ R1W?\S-7_E/S>^"OA>7]JC]JG3[7Q#+))'X@U2?4-1;>0QA4/,Z
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M_P $C_\ D0_'W_81M_\ T4U<F%G*GEM:4'9\WY\IU8F"EC:$)ZW6ORN>4_\
M!3SX(>#_ (7ZQX)UOPGH=EX=_MA;J"[L]-@6"W8Q>45<1KA5.)"#@#.!7U!^
MQ/X?T[XO?L2:!X<\66O]KZ-=+=V4UO)(Z;X4NI"B[E8,,8&""","O'?^"O7_
M "#_ (8?]=M1_P#0;>O<_P#@FY_R:;X8_P"OF^_]*9*F4Y5,I4I.[4O\S;DC
M#,5RJUXGYG_M0_#_ $#X=_M+>*?"GA[3_P"SM L;NWCM[/SI)=BM#$S#>[,Q
MR68\D]:_6OX5?LE_"CX.^)(_$G@_PH-)UGR&@%TU_=7!"/C< LLK*,XZ@9_.
MORT_;>86G[8GCF27,:+>6KDD'[OV:'FOV<TK7-/U*ST^2TOK>X2\@$]NT4JM
MYT> =Z8/S+@CD>HK;'U:OU+#R4GJM==]%O\ \$YL)3A]=K1:6CTT\^AK4445
M\P?2!1110 4444 %%%% !1110!\R_M]?\DGT7_L-Q?\ HB>NR_8]_P"3>?"W
MUN__ $JFKC?V^O\ DD^B_P#8;B_]$3UV7['O_)O/A;ZW?_I5-7W=7_DEJ?\
MU^?_ *2SXBC_ ,E)4_Z]_JCVBBBBOA#[<**** "BBB@ HHHH **** "BBB@
MHHHH **** $KR/QU_P C5??\ _\ 0%KURO(_'7_(U7W_  #_ - 6M:7Q,RJ;
M%_X9_P#(>F_Z]F_]#2O3J\Q^&?\ R'IO^O9O_0TKTZG5^(*?PA1116)J%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4 %%%% !1110 4444 )7E?[1W_(CVG_7_'_Z+DKU2O*_VCO^1'M/^O\ C_\
M1<E:T?XD3&M\#/FZBBBOH#Q0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ4]E["_NWO;S.OV,/:>UM[UK7/B#]JS_ ()QP_&+Q?=^,? VLV>@:]?MOO\
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 )7E?[1W_ "(]I_U_Q_\
MHN2O5*\K_:._Y$>T_P"O^/\ ]%R5K1_B1,:WP,^;J***^@/%"BBB@ HHHH *
M*** "BBB@ HHHH **DMX6N)XXDQND8*,],DXKVN/]F=F12WB(*V.0+'(S]?,
MK*=2-.SDRX0E4;43Q"BO;W_9F?:=GB)6;L&LL#\_,-><^-/AOK7@5D:_B26U
MD.U+JW):,GT.0"#]1],THUZ<W9,N5&I%7:.6HHHK8Q"BBB@ HHHH **T['PM
MK.J6XN+/2+^\MSD"6WMG=#CKR!BL^:)[>5XI4:.1"59'&"I'4$=C2YE>P[/<
M9116]X)\+GQEXCMM*%R+3S@Q,Q3?MVJ3TR,]/6G)\JN+R,&BO<O^&93_ -#)
M_P"2/_VRC_AF4_\ 0R?^2/\ ]LKF^LTN_P"9T?5Y]CPVBO<O^&9?^IC_ /)#
M_P"V5XMJ5F=.U"ZM&8.T$K1%EZ':2,_I6D*T*CM%D2I3@KR16HHHK4R"BBB@
M HHHH **** "BBB@ HHHH **** /5?V</^1XO?\ L'R?^C8J^D*^;_V</^1X
MO?\ L'R?^C8J^D*\3%?Q&>MA_P"&A:***Y3J"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@".7_5O]*^!?V#/^2R:G_P!@2;_T?!7WU+_JW^E? O[!G_)9
M-3_[ DW_ */@K[G(_P#D49E_AA^;/A\Z_P"1I@/67Z'W]1117PQ]P%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 444E "T444 %%%% !1110 44
M44 %%%% !129I: "BBB@!*6BB@ HHHH **** "BBB@ HHHH **** "BDR/6E
MH **** "BBB@ HHHH ^9?V^O^23Z+_V&XO\ T1/79?L>_P#)O/A;ZW?_ *53
M5QO[?7_))]%_[#<7_HB>NR_8]_Y-Y\+?6[_]*IJ^[J_\DM3_ .OS_P#26?$4
M?^2DJ?\ 7O\ 5'M%%%%?"'VX4444 %%%% !1110 4444 %%%% !1110 4444
M )7D?CK_ )&J^_X!_P"@+7KE>1^.O^1JOO\ @'_H"UK2^)F538O_  S_ .0]
M-_U[-_Z&E>G5YC\,_P#D/3?]>S?^AI7IU.K\04_A"BBBL34**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &U\3
M?\%8/^2"^'/^Q@C_ /2>:OMFOB;_ (*P_P#)!?#G_8P1_P#I/-75A/\ >*?^
M)?F8U_X,_1_DRE_P25_Y(KXN_P"P^?\ TFAKXHU;_D^2;_LH(_\ 3@*^U_\
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M%?Q&>MA_X:%HHHKE.H**** "BBB@ HHHH **** "BBB@ HHHH **** (Y?\
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M'X9_\AZ;_KV;_P!#2O3J=7X@I_"%%%%8FH4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 -["OG?]MC]G?7_P!I
M3X7Z=X>\.W^G6&H6>I)?;M3>1(F41R(5W(CD'YP?N]J^B/:D_"JA-TY*<=UJ
M3**E%Q>S5OO/G#]B']F_Q#^S3\.]:T+Q+?Z;J%_?ZF;U6TMY'B1/*1 "TB(<
MY0GIWKY9^+G_  3(^)?C;XI>+/$.D>(O"HTW5M3N+Z!;RXN8IE620OM95@<
MC=CACT_"OTWI.*[(XZO&LZZ?O-6_+_(XW@Z4J*H->ZG<_)O_ (=/_%W_ *&#
MP9_X'7?_ ,BU^@G[*7PBUKX&_ _0/!NOW]KJ&IZ>;AI);)W> "29Y%5"ZJQ
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M[4_X:6^$7_14_!?_ (4%I_\ '*/^&EOA%_T5/P7_ .%!:?\ QROBO_AS^?\
MHK0_\)S_ .ZZ/^'/Y_Z*T/\ PG/_ +KH^KX#_G^_N8>WQW_/I?>C[4_X:6^$
M7_14_!?_ (4%I_\ '*/^&EOA%_T5/P7_ .%!:?\ QROBO_AS^?\ HK0_\)S_
M .ZZ/^'/Y_Z*T/\ PG/_ +KH^KX#_G^_N8>WQW_/I?>C[4_X:6^$7_14_!?_
M (4%I_\ '*/^&EOA%_T5/P7_ .%!:?\ QROBO_AS^?\ HK0_\)S_ .ZZ/^'/
MY_Z*T/\ PG/_ +KH^KX#_G^_N8>WQW_/I?>C[4_X:6^$7_14_!?_ (4%I_\
M'*/^&EOA%_T5/P7_ .%!:?\ QROBO_AS^?\ HK0_\)S_ .ZZ/^'/Y_Z*T/\
MPG/_ +KH^KX#_G^_N8>WQW_/I?>C[4_X:6^$7_14_!?_ (4%I_\ '*/^&EOA
M%_T5/P7_ .%!:?\ QROBO_AS^?\ HK0_\)S_ .ZZ/^'/Y_Z*T/\ PG/_ +KH
M^KX#_G^_N8>WQW_/I?>C[4_X:6^$7_14_!?_ (4%I_\ '*/^&EOA%_T5/P7_
M .%!:?\ QROBO_AS^?\ HK0_\)S_ .ZZ/^'/Y_Z*T/\ PG/_ +KH^KX#_G^_
MN8>WQW_/I?>C[4_X:6^$7_14_!?_ (4%I_\ '*/^&EOA%_T5/P7_ .%!:?\
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M !BOI/\ X4C\/O\ H1_#O_@J@_\ B:/^%(_#[_H1_#O_ (*H/_B:/[1X=_Z
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M_#O_ (*H/_B:/[1X=_Z '_X'+_,/[/X@_P"@Q?\ @*_R/FS_ (>&/_T(0_\
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MY>2'YSCAG[ _@/X+_%+Q!KWAKXGZ;!<ZS+Y,VC-<ZE<6:R@;A+$OERH&?E"
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M2?\ T;7/A],KK7_F7_MITXF_]HT?1_J?=]%%%> >X%%%% !1110!\R_M]?\
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M _\ <0_].%S7T<.M?./_  3O_P"3._ /_<0_].%S7T<.M98O_>*GJ_S-,+_
MAZ+\AU%%%<IU!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MA7B8K^(SUL/_  T+1117*=04444 %%%% !1110 4444 %%%% !1110 4444
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M?_%?PW?W AO=/\,7MK-<V:=6;]S'&RD#."=ZDC!Y(->@_'7]I_XN^&OVN(/
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MBB@ HHHH 2O*_P!H[_D1[3_K_C_]%R5ZI7E?[1W_ "(]I_U_Q_\ HN2M:/\
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M*D8#'VP/QZ5A]9I7L:_5ZEKV/':***ZSF"BBB@ HHHH **** "BBB@ HHHH
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M7MJ.(O>"T^??^NQ^F?[;6C6FN?LL_$**]B65(=.-U'N'W9(W5T8>^0*^(_\
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MJ%TR_:+BZ:1]HP,D'@#TK2G3G&4I2ZHSJ5(."C'6Q[-\>O\ DG5Q_P!=XO\
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M\2]11!A%U1\#_MI7U/XDU<Z!X=U#4A'YK6MN\HC)QN(&0*^7/%__ "4[4_\
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M4U-/$<=QI<&HM\V^YF$3JWJ8V(&[/\6,^]<M\7_C!8WVE3:)H4_VHS_)<W2
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EHHH
M**** "BBB@ HHHH **** "BBB@!*6BB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $KRO]H[_D1[3_
M *_X_P#T7)7JE>5_M'?\B/:?]?\ '_Z+DK6C_$B8UO@9\W4445] >*%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >J_LX?\CQ>_P#8
M/D_]&Q5](5\W_LX?\CQ>_P#8/D_]&Q5](5XF*_B,];#_ ,-"T445RG4%%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@!*\K_ &CO^1'M/^O^/_T7)7JE
M>5_M'?\ (CVG_7_'_P"BY*UH_P 2)C6^!GS=1117T!XH4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^9/V^5_
MXM/HQ_ZC<7_HB>NT_8^_Y-X\*_6[_P#2J:O*OV_O%=NNC^&/#:L&N9+A]0D4
M'E%13&A(_P!HNV/]PU[?^SCX?E\,_!'PE8SIY<WV,3LIZ@RLTN#[_/S7W>*3
MI\+T(3T<JKDO1)H^'PK]IQ'7E':,$GZMIGIM%%%?"'W 4444 %%%% !1110
M4444 %%%% !1110 4444 )7D?CK_ )&J^_X!_P"@+7KE>1^.O^1JOO\ @'_H
M"UK2^)F538O_  S_ .0]-_U[-_Z&E>G5YC\,_P#D/3?]>S?^AI7IU.K\04_A
M"BBBL34**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P Q_P!M9I_T /\ \"_X!]]>8G]\?G1YB?WQ^=? O_#!?Q"_Z"?AW_P*G_\
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MAY1_T,E_X _\P_MK-/\ H ?_ (%_P#[Z\Q/[X_.CS$_OC\Z^!?\ A@OXA?\
M03\._P#@5/\ _&:/^&"_B%_T$_#O_@5/_P#&:/[#RC_H9+_P!_YA_;6:?] #
M_P# O^ ??7F)_?'YT>8G]\?G7P+_ ,,%_$+_ *"?AW_P*G_^,T?\,%_$+_H)
M^'?_  *G_P#C-']AY1_T,E_X _\ ,/[:S3_H ?\ X%_P#[Z\Q/[X_.CS$_OC
M\Z^!?^&"_B%_T$_#O_@5/_\ &:/^&"_B%_T$_#O_ (%3_P#QFC^P\H_Z&2_\
M ?\ F']M9I_T /\ \"_X!]]>8G]\?G1YB?WQ^=? O_#!?Q"_Z"?AW_P*G_\
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MAY1_T,E_X _\P_MK-/\ H ?_ (%_P#[Z\Q/[X_.CS$_OC\Z^!?\ A@OXA?\
M03\._P#@5/\ _&:/^&"_B%_T$_#O_@5/_P#&:/[#RC_H9+_P!_YA_;6:?] #
M_P# O^ ??7F)_?'YT>8G]\?G7P+_ ,,%_$+_ *"?AW_P*G_^,T?\,%_$+_H)
M^'?_  *G_P#C-']AY1_T,E_X _\ ,/[:S3_H ?\ X%_P#[Z\Q/[X_.CS$_OC
M\Z^!?^&"_B%_T$_#O_@5/_\ &:/^&"_B%_T$_#O_ (%3_P#QFC^P\H_Z&2_\
M ?\ F']M9I_T /\ \"_X!]]>8G]\?G1YB?WQ^=? O_#!?Q"_Z"?AW_P*G_\
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MAY1_T,E_X _\P_MK-/\ H ?_ (%_P#[Z\Q/[X_.CS$_OC\Z^!?\ A@OXA?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAT5Z]H?[.>KW6U]4O[>P3/,<(,K_ -!^IKT+0_@7X7T?:T\$FIS#^*Z?Y?\
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M HHHH **** "BBB@ HHHH **** "BBB@!*\C\=?\C5??\ _] 6O7*\C\=?\
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MDW$<8./-1=Z?]]+D5UQK0GLSGE3G'='/4445L8A1110 4444 %%%% !1110
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M<?A74!0H 48 IU%<SDY:MG0HJ.R%HHHI%!1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 E>1^.O^1JOO^ ?^@+7KE>1^.O^1JOO^ ?^@+6M+XF95-B_\,_^0]-_U[-_
MZ&E>G5YC\,_^0]-_U[-_Z&E>G4ZOQ!3^$****Q-0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH CDC612KJ&4\$,,@UR6N?"GPQX@W-/I4
M,,K?\MK;]TV?7Y>#^(KL/K1FG&4H[,EQ4MT<!HOP1\*:/\S6+W\F>&O9-_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 )7D?CK_ )&J^_X!_P"@+7KE>1^.O^1JOO\
M@'_H"UK2^)F538O_  S_ .0]-_U[-_Z&E>G5YC\,_P#D/3?]>S?^AI7IU.K\
M04_A"BBBL34**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!*\C\=?\C5??\ _] 6O7*\C\=?\C5??\ _] 6M:7Q,RJ;%_X9_\
MAZ;_ *]F_P#0TKTZO,?AG_R'IO\ KV;_ -#2O3J=7X@I_"%%%%8FH4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "5Y'XZ_Y&
MJ^_X!_Z M>N5Y'XZ_P"1JOO^ ?\ H"UK2^)F538O_#/_ )#TW_7LW_H:5Z=7
MF/PS_P"0]-_U[-_Z&E>G4ZOQ!3^$****Q-0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2O3J=7X@I_"%%%%8FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 444E "T444 %%%% !1110
M4444 %%)2T %%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?0'[ /Q>\2?%3]GF/5O&5S)=WFFWLUBNJ77#W,$:HPD=OXB-Q4L>3LR<G)/
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MVQMY*+GT&QC_ ,#-:7_!2+XK6?@/]GC4= %PJZQXHD2QMX ?G,2LKS/C^Z%
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M-USXBZ:NM_%?XGZQ?^++I-[1P'[2MJQR=ADE8E\9Z*% Y R.:YKX5PI\6?\
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MFJW-YNQR43; H_.%OSKMOVZ/!'A;Q'^S;XUU+7].M);O2[!KFPO9(U\Z"X!
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MQ26/JH$0:\E'XJ<'Z5^D]?FS^QR/^%L?M[_$SQQ(F^UT\WTD$G4 O,((N?\
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M/_!+_5/#.F#7/!_Q5U:U^($*F87LD9@BGEZX#H_F1Y/\1+_2N?\ ^"7NG_\
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M_P 1?"WQ*U_2_$>EM&ZRWEPD;7<C,%V1/$$='.21RW0Y]1C?LD_L>_$#Q_\
M!W3O%WA?XTZU\/K+5YIF.F:4+A5+12-#O8QW$88GRSU7(%>X:/\ \$S=,UK6
M(=2^)OQ-\3?$66$@I'.[0*5[HS/)*^T_[+*?>NN<J6%J*G"I91W5KMM;W]?4
MYH*IB8NI.G=O;6R2Z6-CX7^+/$W[1'_!/W7[GQ&TD^NW>BZE:"\*A3=^4'$<
MF!W.T*3W*D]ZQ/\ @E'XB.I? O7])=]SZ;K<A1<_=CDBC8?^/!Z^O=&\(Z1X
M=\+V_AW2K&#3]&M[?[+#9VZ;8XX\8V@?C^/6OS^_X)F:DG@'XF?&3P??7"P0
MV!69VD.U4%M--%(Q/88=<_2N.$H5J>(Y5:]FE\_\CIE&=%X?G=[-I_-'HG_!
M47XI2>'_ (4Z/X#TZ1FU3Q1> RPQ$[S;1$$C _O2&,8[X:OHO]FOX8_\*;^!
MWA+PFXVW5C9AKKG/^D2$R2_@'=@/8"OC'X16\W[:W[:VI_$:XBDE\ ^#'1--
M\P'9(T;'[,H![L^Z<CM@ ]17Z.#TK&O^XP\,.]W[TOT7W&U+]_B)5E\*5EY]
MV!/''6OS;\#K_P +A_X*E:WJ3$7-EX<DN#QR%%M +<?E,P/UK]%M;U:'0=&O
M]2N#B"S@>>3V55+']!7YZ?\ !+72Y?%GQ ^*GQ!O%/VBY>.!)#W:>5YY1^:1
M_G1@?=5:MVC;YO0,;[RITOYI+YI:L_1G%?'O_!4J\M;?]FNWAG"F>XURU6#)
MY#!)6)'_  $,/QK[!STK\S/V\/'T_P"TI\?/"'P9\%3#4%T^[,=W-"=T8O'X
MD)(_AAC#%CVRX[5C@:;JXF%NCN_)+4VQ=2-.A-OM;YL^G_V==<?X;_L)Z!KE
MV[*=-\.7&H[FZ[?WDJ#\BH'X5\&_LBZ+\4/C-I>N_#[P1J\_A?3=1OO[2\3^
M*E+>9Y14+' "I!)8^:VT,"^3DA5.?M[]MZ[M?A#^Q;JN@:8/*@:ULM!M!G!\
MO<BD?]^XVK3_ ."?'PWM_ '[,WANX2$)?Z\'U:ZDQR_F,1$?H(EC_7UKT85H
MQIXC$VOSRLK_ #?]>9YTJ4F\/AD[-*[MVLD5?V>OV5K+]CNR\=>(CXMNO$-G
M=6*SF.YMQ (!"LCR,<.P8MD<X& ._6O&/^"4^CW6N7?Q0\=7Y:2XU&\AMO,8
MYW.3)-+^LD=?1_[<GC >"_V6_'UT'*RW=F-.CP<',[K$?_'68_A7'_\ !-?P
MB/#'[+NC7;+LEUJ\NM0D'_;3R5_\=A7\ZQA4G/#5JU35OEBG^+_ WG3C3K4J
M-/1:MK\$SKOVZ/&1\#_LM>.KN.0Q7%Y:KIT14X.9Y%C.#_NLQ_"N4_X)T^&T
M\$_LH:+?WC?9QJ4UUJDSR' 5-Y0,<]!LB4_C7D'_  5>^*MK'X9\+_#JSF$F
MI75T-5NX4.3'$BLD08?[3,Q'_7.O6_C]YWP-_8#O])M6,%S:>'[31MRG:=TO
MEPR'ZG>Y_&LXP<<$E]J<E;T6GYFDI*6+2Z1BV_)O_@'S]J'BSXA_\%$OB_K7
MAOPMXANO"/PET5ML]S;AAYZ$D(TBAE,KR;250G:JC)Y'S:?C_P#9%\:_L9^'
M[OXE?"3XAWEQ:Z.GVC5-&U152.XA'#DA2$D'/W"H8=5;< *]B_X)F^$[;0/V
M8M.U.)5%SKE]=7DS8Y.R4P*/H!#^IJI_P4T^*UKX,^ 4WA9+A1J_B>XCMHX0
MWS"WC=9)7(]/E1?^!UUU*DZ>)6$H+W4TFK7OW;.:G3C6I/$U]]7OLELD87_!
M*S0;C_A5OC'Q7>LTEYKNML&D<Y+B) 2WXO+)^5?;XKPG]B'P=_PA/[+O@&T9
M-DUU8_VA)D8)-P[3#/\ P%U'X5[IW%>?CY*>*J6VO;[M#LP,7'#Q;W>OWZGR
M;_P4T\7#PW^S'?6"R;)M<U"VL5'<JK&9OTB_6N^_8A\'CP3^R[X!LV3RYKJQ
M_M&3CDFX=IAGWVNH_"OF#_@JIK5QXC\3?"[P%9?/<74LMT8QU+R.D,7'U\RO
MT!\-Z+;^&O#VF:3:+MMK&UCM8E]$10JC\@*UE[F BOYY-_=H1_$QO^&-OFW_
M )&G7YF?LLJFL_\ !2;XAWFG#;9PSZO*_E'*E?.$>3[%V!^N*^WOVD/CAI?P
M!^%.L>)[^>/[<L;0:9:LV&N;I@?+0#N ?F/HJDU\M_\ !+7X4ZA;:/XJ^*&M
MI(;KQ!+]ELI9A\TL2N7FESW#28'UC-/!KV=&M7>UN7U;_P A8Q\\Z5%;MI_)
M'/\ [<TC_$S]LSX0_#Y"\MK;M:R7$:DX'G7.Z0_411 YKWO]OC]H+6O@#\';
M67PW)]F\0ZY=_8+:\*AOLJ!"TDB@\;L  9Z%L]J\"^%NWXM?\%0_%FM,?/M/
M#8N=F>57R(EM!_X^Y8?G7V/^T5^S[X?_ &D/A_)X9UV2:T>*47-CJ%N 9+68
M @, >&!!(*GJ#U!P1524*4</3GK&UW\W=BIJ52K7G%V?PKU2W^\^4?"/_!-J
M/XC^#=/\5>+OB?XAO?'&I6T=ZNHQ2+/# [H'4$N2\NW(^8.F>V*^GO@+X4\3
M_ WX/7%G\2O&*^)9M*DN;@ZQ*[OY=DO*;W<;B0H+').,[02%%?$NL:A\?/\
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MV:1!+B^LUU2Z;'+27'[SGW"LB_117R]_P5VU";[/\-+ '%NTE],P]6 A4'\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKX<_X*8^"_&OQ/A^'7A;PKX7UC7+9[R:YN[K3[&6>&W?"1Q^8R@JG#R'+$<
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MV:_#-W/J%W'K'C75]K:EJ4>XQHH.1#&6Y*@DDL0"QY(& !XKXT^&7B[XE?\
M!2;1-:O/"^L0^#M 2$Q:S-92K9OY-NTJ[92-A)G<# /8^AK[U]*3:.">M3'%
MU/:NM+5M->EU;3T'+"P=+V,=%=7\];_B13R?9X7?:S[ 3M09)P.@'<U\)?\
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MY!!#?<Z@#@'BEI%K*MB)5VFU9+9+9%T:$:.J=V]V]V/HHHK Z0HHHH ****
M$KR[28QKGCB9OO1-)*Y/^S@A?Z5W?B;4QI.BW,^<2;=D?^\>!_C^%<Q\,M._
MX^[]A_TQ3^;?^RUK#2+9E+621T7BW1O[;T>6)!F>/]Y%_O#M^(R*YSX=ZYY;
M2:5.VTY+P[O7^)?Z_G7?5YWXV\/RZ;>#5K'*(6#2;.L;Y^]]"?U^M$&I+D82
M5GS(]%I"*Y_PKXHBUZUVN52\C'[R/U_VA[?RKH:S:<79FB=U<****0PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ I*6B@ HHHH **** "BBB@ HHHH **** "BBB@
M!*6BB@ I*6B@!*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ I*6B@!*6BB@ HHHH **** "DI:* "BBB@ HHH
MH **** "BBB@ I*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** $HI:* "BBB@ HHHH *2EHH **** "BBB@ HHHH ****
M "BBB@ I*6B@ HHHH **** "BBB@!*6BB@ HHHH **** "BBB@ I**Y+QEXL
M72H6L[5P;V089A_RR'K]?3\Z<8N3LA-J*NS"\<:L^MZM#IMK^]2)]N%_BD/'
MZ=/SKNM&TM-)TJ"T7#!%PQ]6ZD_G7+> ?#+0*-3NTQ*P_<JW4 _Q?C7<BM)M
M?"NAG!/XF+44L:31M'(H=&&&5AD$>E2T5D:GF?B#PI=>'+K^T=-9_(0[LJ<M
M%]?4?Y-;?AWQY;Z@JP7S+;7'3>>$;_ UU_L:Y/7? %KJ#-+:-]CG/)4#]VQ^
MG;\/RK524E:9ERN+O$ZM6W $<@]*=7EH'B/PCP!)]G4_]=(O_K?I6C9_$^15
M NK%7/\ >A?;^AS_ #H]F^FH>T770]"HKCE^)FG?Q6UT#[*I_P#9J7_A96E_
M\\+S_OE/_BJGV<NQ7/'N=A17'_\ "RM+_P">%Y_WRG_Q5'_"RM+_ .>%Y_WR
MG_Q5'LY=@YX]SL**X_\ X65I?_/"\_[Y3_XJC_A96E_\\+S_ +Y3_P"*H]G+
ML'/'N=A17'_\+*TO_GA>?]\I_P#%4?\ "RM+_P">%Y_WRG_Q5'LY=@YX]SL*
M*X__ (65I?\ SPO/^^4_^*H_X65I?_/"\_[Y3_XJCV<NP<\>YV%%<?\ \+*T
MO_GA>?\ ?*?_ !5'_"RM+_YX7G_?*?\ Q5'LY=@YX]SL**X__A96E_\ /"\_
M[Y3_ .*H_P"%E:7_ ,\+S_OE/_BJ/9R[!SQ[G845Q_\ PLK2_P#GA>?]\I_\
M51_PLK2_^>%Y_P!\I_\ %4>SEV#GCW.PHKC_ /A96E_\\+S_ +Y3_P"*H_X6
M5I?_ #PO/^^4_P#BJ/9R[!SQ[G845Q__  LK2_\ GA>?]\I_\51_PLK2_P#G
MA>?]\I_\51[.78.>/<["BN/_ .%E:7_SPO/^^4_^*H_X65I?_/"\_P"^4_\
MBJ/9R[!SQ[G845Q__"RM+_YX7G_?*?\ Q5'_  LK2_\ GA>?]\I_\51[.78.
M>/<["BN/_P"%E:7_ ,\+S_OE/_BJ/^%E:7_SPO/^^4_^*H]G+L'/'N=A17'_
M /"RM+_YX7G_ 'RG_P 51_PLK2_^>%Y_WRG_ ,51[.78.>/<["BN/_X65I?_
M #PO/^^4_P#BJ/\ A96E_P#/"\_[Y3_XJCV<NP<\>YV%%<?_ ,+*TO\ YX7G
M_?*?_%4?\+*TO_GA>?\ ?*?_ !5'LY=@YX]SL**X_P#X65I?_/"\_P"^4_\
MBJ/^%E:7_P \+S_OE/\ XJCV<NP<\>YV%%<?_P +*TO_ )X7G_?*?_%4?\+*
MTO\ YX7G_?*?_%4>SEV#GCW.PHKC_P#A96E_\\+S_OE/_BJ/^%E:7_SPO/\
MOE/_ (JCV<NP<\>YV%%<?_PLK2_^>%Y_WRG_ ,51_P +*TO_ )X7G_?*?_%4
M>SEV#GCW.PHKC_\ A96E_P#/"\_[Y3_XJC_A96E_\\+S_OE/_BJ/9R[!SQ[G
M845Q_P#PLK2_^>%Y_P!\I_\ %4?\+*TO_GA>?]\I_P#%4>SEV#GCW.PHKC_^
M%E:7_P \+S_OE/\ XJC_ (65I?\ SPO/^^4_^*H]G+L'/'N=A17'_P#"RM+_
M .>%Y_WRG_Q5'_"RM+_YX7G_ 'RG_P 51[.78.>/<["BN/\ ^%E:7_SPO/\
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M**X__A96E_\ /"\_[Y3_ .*H_P"%E:7_ ,\+S_OE/_BJ/9R[!SQ[G845Q_\
MPLK2_P#GA>?]\I_\51_PLK2_^>%Y_P!\I_\ %4>SEV#GCW.PHKC_ /A96E_\
M\+S_ +Y3_P"*H_X65I?_ #PO/^^4_P#BJ/9R[!SQ[G845Q__  LK2_\ GA>?
M]\I_\51_PLK2_P#GA>?]\I_\51[.78.>/<["BN/_ .%E:7_SPO/^^4_^*H_X
M65I?_/"\_P"^4_\ BJ/9R[!SQ[G845Q__"RM+_YX7G_?*?\ Q5'_  LK2_\
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MN/\ ^%E:7_SPO/\ OE/_ (JC_A96E_\ /"\_[Y3_ .*H]G+L'/'N=A17'_\
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M+*TO_GA>?]\I_P#%4>SEV#GCW.PHKC_^%E:7_P \+S_OE/\ XJC_ (65I?\
MSPO/^^4_^*H]G+L'/'N=A17'_P#"RM+_ .>%Y_WRG_Q5'_"RM+_YX7G_ 'RG
M_P 51[.78.>/<["BN/\ ^%E:7_SPO/\ OE/_ (JC_A96E_\ /"\_[Y3_ .*H
M]G+L'/'N=A17'_\ "RM+_P">%Y_WRG_Q5'_"RM+_ .>%Y_WRG_Q5'LY=@YX]
MSL**X_\ X65I?_/"\_[Y3_XJC_A96E_\\+S_ +Y3_P"*H]G+L'/'N=A17'_\
M+*TO_GA>?]\I_P#%4?\ "RM+_P">%Y_WRG_Q5'LY=@YX]SL**X__ (65I?\
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MJDNF>(O%C*UP9%@)R&F^1![A>_Y57LWO+07M%]G4U_$?C](U>VTP[Y#P;C'
M_P!T=S[U7\*^"Y+N5;_5%8J3O6&3[SGU;V]N];N@>";+1F6:3_2KH<B1QPOT
M']:Z7Z4.2BK0$HN3O(6BBBLC4**** "BBB@ JA>:'I][N,]E!(QZLT8W?GUH
MHI@9TG@G16ZV(_[^/_C2?\(+H?\ SY'_ +_2?_%445?,S"R#_A!=#_Y\C_W^
MD_\ BJ/^$%T/_GR/_?Z3_P"*HHHYGW'9!_P@NA_\^1_[_2?_ !5'_""Z'_SY
M'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60
M?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'
M_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'
M_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5
M%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (
M+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[
M_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D
M?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S
M[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@
MNA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?
M\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2
M?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<
MS[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_
M[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\
MSY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)
M_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P
M@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4
M?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\
M/D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444
M<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_
M +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_
M  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O]
M)_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+
MH?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\
M2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z
M'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',
M^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_
M #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_
M !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_T
MG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!
M_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\
M^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H
M?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%4
M44<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9
M!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?
M_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_
M +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%
M444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_
M\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+
MH?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^
M_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A
M9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2
M?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @N
MA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\
M%444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\
MSY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\
MQ5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY
M'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60
M?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'
M_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'
M_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5
M%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (
M+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[
M_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D
M?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S
M[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@
MNA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?
M\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2
M?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<
MS[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P@NA_\^1_
M[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\
MSY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\ /D?^_P!)
M_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444<S[A9!_P
M@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_ +_2?_%4
M?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_  @NA_\
M/D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O])_\ %444
M<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+H?\ SY'_
M +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\ 2?\ Q5'_
M  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z'_SY'_O]
M)_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',^X60?\(+
MH?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_ #Y'_O\
M2?\ Q5'_  @NA_\ /D?^_P!)_P#%444<S[A9!_P@NA_\^1_[_2?_ !5'_""Z
M'_SY'_O])_\ %444<S[A9!_P@NA_\^1_[_2?_%4?\(+H?_/D?^_TG_Q5%%',
M^X60?\(+H?\ SY'_ +_2?_%4?\(+H?\ SY'_ +_2?_%444<S[A9!_P (+H?_
M #Y'_O\ 2?\ Q5/3P7HL?2P4_P"\['^9HHHYGW"R-*UTFRL?FM[2&%O[R( ?
1SJY1169L%%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img226925499_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img226925499_5.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 6%!=D# 2(  A$! Q$!_\0
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MA?\ 87^"'QC_ &6/!/C#QAX)_M?Q%J7V[[5>?VM?0>9Y=]<1)\D4ZH,)&@X
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M.ROV:_\ HF__ )7=2_\ DFCZW#LP]A(_!VBOWB_X=E?LU_\ 1-__ "NZE_\
M)-'_  [*_9K_ .B;_P#E=U+_ .2:/K<.S#V$C\':*_>+_AV5^S7_ -$W_P#*
M[J7_ ,DT?\.ROV:_^B;_ /E=U+_Y)H^MP[,/82/P=HK]XO\ AV5^S7_T3?\
M\KNI?_)-'_#LK]FO_HF__E=U+_Y)H^MP[,/82/P=HK]XO^'97[-?_1-__*[J
M7_R31_P[*_9K_P"B;_\ E=U+_P"2:/K<.S#V$C\':*_>+_AV5^S7_P!$W_\
M*[J7_P DT?\ #LK]FO\ Z)O_ .5W4O\ Y)H^MP[,/82/P=HK]XO^'97[-?\
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M2:/K<.S#V$C\':*_>+_AV5^S7_T3?_RNZE_\DT?\.ROV:_\ HF__ )7=2_\
MDFCZW#LP]A(_!VBOWB_X=E?LU_\ 1-__ "NZE_\ )-'_  [*_9K_ .B;_P#E
M=U+_ .2:/K<.S#V$C\':*_>+_AV5^S7_ -$W_P#*[J7_ ,DT?\.ROV:_^B;_
M /E=U+_Y)H^MP[,/82/P=HK]XO\ AV5^S7_T3?\ \KNI?_)-'_#LK]FO_HF_
M_E=U+_Y)H^MP[,/82/P=HK]XO^'97[-?_1-__*[J7_R31_P[*_9K_P"B;_\
ME=U+_P"2:/K<.S#V$C\':*_>+_AV5^S7_P!$W_\ *[J7_P DT?\ #LK]FO\
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M.ROV:_\ HF__ )7=2_\ DFCZW#LP]A(_!VBOWB_X=E?LU_\ 1-__ "NZE_\
M)-'_  [*_9K_ .B;_P#E=U+_ .2:/K<.S#V$C\':*_>+_AV5^S7_ -$W_P#*
M[J7_ ,DT?\.ROV:_^B;_ /E=U+_Y)H^MP[,/82/P=HK]XO\ AV5^S7_T3?\
M\KNI?_)-'_#LK]FO_HF__E=U+_Y)H^MP[,/82/P=HK]XO^'97[-?_1-__*[J
M7_R31_P[*_9K_P"B;_\ E=U+_P"2:/K<.S#V$C\':*_>+_AV5^S7_P!$W_\
M*[J7_P DT?\ #LK]FO\ Z)O_ .5W4O\ Y)H^MP[,/82/P=HK]XO^'97[-?\
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M2:/K<.S#V$C\':*_>+_AV5^S7_T3?_RNZE_\DT?\.ROV:_\ HF__ )7=2_\
MDFCZW#LP]A(_!VBOWB_X=E?LU_\ 1-__ "NZE_\ )-'_  [*_9K_ .B;_P#E
M=U+_ .2:/K<.S#V$C\':*_>+_AV5^S7_ -$W_P#*[J7_ ,DT?\.ROV:_^B;_
M /E=U+_Y)H^MP[,/82/P=HK]XO\ AV5^S7_T3?\ \KNI?_)-'_#LK]FO_HF_
M_E=U+_Y)H^MP[,/82/P=HK]XO^'97[-?_1-__*[J7_R31_P[*_9K_P"B;_\
ME=U+_P"2:/K<.S#V$C\':*_>+_AV5^S7_P!$W_\ *[J7_P DT?\ #LK]FO\
MZ)O_ .5W4O\ Y)H^MP[,/82/P=HK]XO^'97[-?\ T3?_ ,KNI?\ R31_P[*_
M9K_Z)O\ ^5W4O_DFCZW#LP]A(_!VBOWB_P"'97[-?_1-_P#RNZE_\DT?\.RO
MV:_^B;_^5W4O_DFCZW#LP]A(_!VBOWB_X=E?LU_]$W_\KNI?_)-'_#LK]FO_
M *)O_P"5W4O_ ))H^MP[,/82/P=HK]XO^'97[-?_ $3?_P KNI?_ "31_P .
MROV:_P#HF_\ Y7=2_P#DFCZW#LP]A(_!VBOWB_X=E?LU_P#1-_\ RNZE_P#)
M-'_#LK]FO_HF_P#Y7=2_^2:/K<.S#V$C\':*_>+_ (=E?LU_]$W_ /*[J7_R
M31_P[*_9K_Z)O_Y7=2_^2:/K<.S#V$C\':*_>+_AV5^S7_T3?_RNZE_\DT?\
M.ROV:_\ HF__ )7=2_\ DFCZW#LP]A(_!VBOWB_X=E?LU_\ 1-__ "NZE_\
M)-'_  [*_9K_ .B;_P#E=U+_ .2:/K<.S#V$C\':*_>+_AV5^S7_ -$W_P#*
M[J7_ ,DT?\.ROV:_^B;_ /E=U+_Y)H^MP[,/82/P=HK]XO\ AV5^S7_T3?\
M\KNI?_)-'_#LK]FO_HF__E=U+_Y)H^MP[,/82/P=HK]XO^'97[-?_1-__*[J
M7_R31_P[*_9K_P"B;_\ E=U+_P"2:/K<.S#V$C\':*_>+_AV5^S7_P!$W_\
M*[J7_P DT?\ #LK]FO\ Z)O_ .5W4O\ Y)H^MP[,/82/P=HK]XO^'97[-?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KR[]J?_DV'XO?]B?K'_I%-7J->7?M3_P#)L/Q>_P"Q/UC_ -(I
MJJ/Q(4MF?SFT445]">6%?O%_P3*_Y,A^&_\ W$O_ $Y75?@[7[Q?\$RO^3(?
MAO\ ]Q+_ -.5U7%B_@7J=%#XCZAHHHKR3M"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O+OVI_P#DV'XO?]B?K'_I%-7J
M->7?M3_\FP_%[_L3]8_](IJJ/Q(4MF?SFT445]">6%?O%_P3*_Y,A^&__<2_
M].5U7X.U^\7_  3*_P"3(?AO_P!Q+_TY75<6+^!>IT4/B/J&BBBO).T****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\N_:
MG_Y-A^+W_8GZQ_Z135ZC7EW[4_\ R;#\7O\ L3]8_P#2*:JC\2%+9G\YM%%%
M?0GEA7[Q?\$RO^3(?AO_ -Q+_P!.5U7X.U^\7_!,K_DR'X;_ /<2_P#3E=5Q
M8OX%ZG10^(^H:***\D[0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KR[]J?\ Y-A^+W_8GZQ_Z135ZC7EW[4__)L/Q>_[
M$_6/_2*:JC\2%+9G\YM%%%?0GEA7[Q?\$RO^3(?AO_W$O_3E=5^#M?O%_P $
MRO\ DR'X;_\ <2_].5U7%B_@7J=%#XCZAHHHKR3M"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5Y)\2/VH/ WPK\1OH>NSWRWZHLC+;VK2@ C(Y!KE?^&[/A7G'VK5<^G]GO\
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MK4X3C3E*TI;+O;<[BBBBL#4**** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#YY_;H_P"2%WW_ %WC_P#0A7JOP=_Y)3X2_P"P9;_^@"O*OVZ/
M^2%WW_7>/_T(5ZK\'?\ DE/A+_L&6_\ Z *^MK_\D_0_Z^S_ /28GSU+_D<5
M?\$?S9U5]_QYS_\ 7-OY5\;_ +)_@'PWXV\:?% Z_H=CK#0:IB)KR$2% 6?(
M&>E?9%[_ ,><_P#US;^5?GG\*?CAKOP?\<?$"/1O",WB<7VI,TC0B7]SM=\
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M/XXQE*/JFFO\CZ_MM3M]:\/QZA:2"6UNK8312#HRLN0?R-?,'[ __($\8_\
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MVY-JRYE;1+?4PQ=2OFRAAUAY0:DFY2225G=V?7L6?VYL_P#"B;G=][SXL_\
M?0KU'X:V*ZI\&O#EFY*K/H\,98=1F("N8_:E^&VN?%3X7SZ)X?AAGOWFC<+-
M*(QM# GD^U=_\/=&NO#O@70-+O55+RSL88)E1MP#J@!P>_(KP*V(I_V+0I1D
MN=5).W5*T;.QZ].C/^TZM24?=<(J_3=GRI^Q;XG3P7\0?&GP_P!3<6]U)=O<
MP!SCS&&!M'OMYK[,KYU_: _9:;X@:VGB[PI??V-XJ@ ;*_*MPPZ$G(P:XM/
M?[2_BJ-=&US7K73=)N!Y=Q=0O SJG?&T!B?QKV\?0P6?5%F-/$PI2DESQFVF
MFE9N.GO7/+PE7$Y3!X.="4TF^5QU5GLGKI8^G;CQQH[:-K5]:ZA!/'I:N+AD
M;(C<+G:??I^=?#OP9^%_Q'^+-]XC^('A+Q/!X:74[^4.TC.'D.XM_"#TW5]
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MV-25/F4K-JZU3\UY'U=.?M(*=FKK9[KU"BBBL30**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /GG]NC_DA=]_UWC_ /0A7JOP=_Y)3X2_[!EO_P"@"N2_:B^&^M_%+X7W
M&B:!#%/?O,CA)91&-H8$\FO%-&\)_M2Z#I-GIMG=V$=I:1+!$AFMCM51@#)'
MI7WN%PU',<FIX?ZQ3IRC.3M.5M&DNS/DJ]>I@\SG6]C.<902]U7U39]A7O\
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MZUYV05Z.'K8AU)**=*:5]+MK1>K.S-Z52M2HJ$;M3BW;LGJ_0^B*^2OVKO\
MDN?PH_Z_E_\ 0UKZUKY_^/GP?\3>/OBCX"UO1[:"73](NEENGDG5&50RG@'K
MP#TJ.':]+#X_GK245RSU>F\78O.:4ZV$Y:<;OFCM_B1Z[\1O^1#U[_KTD_E7
MA_[ _P#R1.?_ +"D_P#):]Z\9:9<:UX5U6QM55KFXMWCC#' +$<<UYA^R?\
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M=H/LTR%5&2#NY8\\5N?&KX)Q_&'^P2^J-IO]E77VD;8O,W]..HQTJ\7#$8W
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MB/QG_9?TWXM>*K'74U)M(NX5"S;( _G8.03R.<<56=8"KBZ:GAU[ZT]4]_\
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M<1BJLVJ]#D7?F3_(PQ^#R_#TU+"8OVLK[<DHZ=[LZNBBBO3/!"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\N_:G_Y-A^+W_8GZQ_Z135ZC7EW
M[4__ ";#\7O^Q/UC_P!(IJJ/Q(4MF?SFT445]">6%?O%_P $RO\ DR'X;_\
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MC34='U^5]#[AHIKNL:,[L%51DLQP /6O#;S]M;X1V/CI_"4OB3_B:QS>0[K
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M?QRUMOVL)/AB;.S_ +#71EU$7.&\_P PLXQUQCY1VKW.OD>'_E(U-_V*Z?\
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M#>:FPH!LP<?Q'K7(?!C]LO5?'WQ%T_P?XL^'>I>#+[4D9[*:1FFBDPI8@L%
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M7_LV^&S?-F^TXRZ=*N<X\J1D7]%%?05<E:G[*I*GV9U4I^TIQGW05Y=^U/\
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MJKVY+62=M>M]O-^9*E&=5T]+\U[MK\M_^ ?:5%%%?-GOA1110 4444 %%%%
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M*+]J\IO*W;I>-V,9]JQOVJ/"_B_X0_&S1/CMX-TAM?M[:U-EKFGQ$"22#Y0
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MYHJV^GW'FRP;DY*ZY6[[:_>:ENKQV\2R'<ZJ Q]3CFI***\@],P?&?@3P_\
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M_$E'_"]/B9_T3BZ_[\25]#T4_;4_^?:_$7LI_P [_ ^>/^%Z?$S_ *)Q=?\
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M14.47T+2?<RO[=;_ *!]W_W[K44[E!QC/K2T5!04444AA1110 4444 %%%%
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M_G?X'SQ_PO3XF?\ 1.+K_OQ)1_PO3XF?]$XNO^_$E?0]%/VU/_GVOQ%[*?\
M._P/GC_A>GQ,_P"B<77_ 'XDH_X7I\3/^B<77_?B2OH>BCVU/_GVOQ#V4_YW
M^!\\?\+T^)G_ $3BZ_[\24?\+T^)G_1.+K_OQ)7T/11[:G_S[7XA[*?\[_ ^
M9_\ AI;QS_;AT;_A!I/[6$?F_8_+?S-F,[MN<XQ6C_PO3XF?]$XNO^_$E:$9
M/_#7DG_8'_\ 9!7N];5)4Z?+:"U2?4RIQJ3O>;T=CYX_X7I\3/\ HG%U_P!^
M)*/^%Z?$S_HG%U_WXDKZ'HK'VU/_ )]K\37V4_YW^!\\?\+T^)G_ $3BZ_[\
M24?\+T^)G_1.+K_OQ)7T/11[:G_S[7XA[*?\[_ ^>/\ A>GQ,_Z)Q=?]^)*!
M\=/B7D9^'%UC_KA)7T/11[:G_P ^U^(>RG_._P #QM/BUXU9%)\#7H)'(\EO
M\:7_ (6SXT_Z$>]_[\M_C7L=%1[2'\B+]G+^<\<_X6SXT_Z$>]_[\M_C4UG\
M5?&,UU$DO@J\CC9L,WDMP/SKUVBCVD/Y$'LY?S'!_P#"=ZW_ -"W>?\ ?LU:
MTWQIJES>)'<:!>0Q'J_EGBNRHJ.:/\I?++N97]NM_P! ^[_[]U/9ZF;R8H;6
MXAXSND3 ^E7J*BZ[%ZA1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "O+OVI_^38?B]_V)^L?^D4U>HUY=^U/_ ,FP_%[_ +$_6/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KF/B?_R3?Q3_ -@NY_\ 135T]<Q\3_\ DF_BG_L%W/\
MZ*:KA\2(G\+.6_9I_P"2-Z)_OW'_ */DKU"O+_V:?^2-Z)_OW'_H^2O4*TQ'
M\6?JR*/\*/H@HHHK V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#P>/_ ).\D_[
M_P#[(*]XKP>/_D[R3_L#_P#L@KWBNK$?8_PHYJ'V_5A1117*=(4444 %%%%
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \'C_Y.\D_[ _\
M[(*]XKP>/_D[R3_L#_\ L@KWBNK$?8_PHYJ'V_5A1117*=(4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %>7?M3_\FP_%[_L3]8_](IJ]1KR[]J?_ )-A^+W_ &)^L?\
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MHO\ X[1]5?\ /'[P^LK^5_<?2M%?-7_"5?M _P#0$M__  &B_P#CM'_"5?M
M_P#0$M__  &B_P#CM'U5_P \?O#ZROY7]Q]*T5\U?\)5^T#_ - 2W_\  :+_
M ..T?\)5^T#_ - 2W_\  :+_ ..T?57_ #Q^\/K*_E?W'TK17S5_PE7[0/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>7?M3_\ )L/Q>_[$_6/_ $BFKU&O+OVI
M_P#DV'XO?]B?K'_I%-51^)"ELS^<VBBBOH3RPK]XO^"97_)D/PW_ .XE_P"G
M*ZK\':_>+_@F5_R9#\-_^XE_Z<KJN+%_ O4Z*'Q'U#1117DG:%%%% !1110
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M^#M?O%_P3*_Y,A^&_P#W$O\ TY75<6+^!>IT4/B/J&BBBO).T**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KP?]JW_CQ\%_]AA?_037O%>#_M6_\>/@O_L,+_Z":ZL+_&B<V)_A
M2/>****Y3I/"/^;O!_V!_P#V2O=Z\(_YN\'_ &!__9*]WKJQ'V/\*.:C]OU8
M4445RG2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%(6"]2!0 M%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G
M1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G
M1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G
M1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G
M1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G
M1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U%-\Q/[R_G
M1YB?WE_.@!U%-\Q/[R_G1YB?WE_.@!U-9A&I9CA5&23VH\Q/[R_G7D?Q[^,5
MIX*T.;1M.E6Z\1WZ^1#;Q\E-W&X_J![UI3IRJ248D3FJ<7)G-?">X;QS\?O&
M'B:,[[.P3[!%)GAADKQ_WS7T'7G/P%\ 2?#WX>V=I=IMU*X_TBYR/F#-SM)]
MJ]&K2O)2G[NRT^XSHQ<8:[O4****YS<**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O+O
MVI_^38?B]_V)^L?^D4U>HUY=^U/_ ,FP_%[_ +$_6/\ TBFJH_$A2V9_.;11
M17T)Y85^\7_!,K_DR'X;_P#<2_\ 3E=5^#M?O%_P3*_Y,A^&_P#W$O\ TY75
M<6+^!>IT4/B/J&BBBO).T**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KP?]JW_CQ\%_]AA?_037
MO%>#_M6_\>/@O_L,+_Z":ZL+_&B<V)_A2/>****Y3I/"/^;O!_V!_P#V2O=Z
M\(_YN\'_ &!__9*]WKJQ'V/\*.:C]OU84445RG2%%%% !1110 4444 %%%%
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M@7J=%#XCZAHHHKR3M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *\'_ &K?^/'P7_V&%_\ 037J
M/C7XC:)X _L_^V+I;;[;.(8\]L]6/L.*\L_:HD6;3?!$B,'1M71E8=""O!KL
MPL6JL6T<F(DG2DD>]45E^)O$ECX3T2ZU749E@M+="[,QZ^P]ZPO 7Q6\/_$:
M2\CT>[6:2U(WIW*D#YA[9.*YE"37,EH=/-%/E;U/.?\ F[P?]@?_ -DKW>O"
M/^;O!_V!_P#V2O3IOB3H</CB'PH;M3JTD7F",'.#UVGWQS736BY<EE]E'/1D
MH\U_YF=31117&=04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !7!?';6KCP_\(_$U_:G$\=L I_WG53^AKO:\W_:,C\[X+^)D)P&BC4_0S)6
MU%7J13[HRJZ4Y/R9#^S?HL>B_"'0Q& /M,?VIO<N 37IU<;\&E"_"?PD ,#^
MS(/_ $ 5V5*J^:I)^8Z:M"*\CRG]I#XCO\/?A_-]DE$>IW^;>#/4 CYF'N 1
M7Q/X/\$:[\3-<>STJ!KNZ8&1V=L >[,:];_;(\2R:AX^M=)#[K>QM@P&>CN?
MF_\ 017KO[(?@^/0_AVVKE 9]4E9PY'(125 ^G&:]BG+ZKAN=+5GDU(_6<1R
M=$>%?\,B_$#_ )\K3_P,2C_AD7X@?\^5I_X&)7W717+_ &A6[(Z?J-+S/A3_
M (9%^('_ #Y6G_@8E'_#(OQ _P"?*T_\#$K[KHH_M"MV0?4:7F?"G_#(OQ _
MY\K3_P #$H_X9%^('_/E:?\ @8E?==%']H5NR#ZC2\SX4_X9%^('_/E:?^!B
M4?\ #(OQ _Y\K3_P,2ONNBC^T*W9!]1I>9\*?\,B_$#_ )\K3_P,2C_AD7X@
M?\^5I_X&)7W711_:%;L@^HTO,^%/^&1?B!_SY6G_ (&)1_PR+\0/^?*T_P#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KR[]J?\ Y-A^+W_8GZQ_Z135ZC7EW[4__)L/Q>_[
M$_6/_2*:JC\2%+9G\YM%%%?0GEA7[Q?\$RO^3(?AO_W$O_3E=5^#M?O%_P $
MRO\ DR'X;_\ <2_].5U7%B_@7J=%#XCZAHHHKR3M"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_%J\4[1C_,_/R74K^'_AR9+G^TM?G>^OG._8['"$\X]Z[B*&.W7;%&D0](U
MI]%<D8J.QUXG%UL5+FJOT71>B#)HHHJSC"BBB@ HHHH **** "BBB@ HHHH
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M?_L\Z>-CO!V?^&6C^[?Y'V+13(I!+$CCHP!'XT^OS\^N"BBB@ HHHH ****
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MO5^%J2<6TKV4EI<^G:*X;X9_%"R\=?"C2/&=Q)#:P7%DMS=,&_=Q.%_>#)[
MY%> ? K]L#Q9\??C=J.@Z#X>L(_!5BSO+?S>8+A8L$(3@[<EATQT-;2Q-.+@
MF_BV/,H9)C<1'$3C&T:'QMNR6MK>;[)'UQ117S;^TC^V%:_"'6H/"?AC33XG
M\;W('EV,8+1QDG[K[3G=CG K2K6A0CSU'9''E^78G-*ZP^%CS2?W)=6WLDNY
M])45\0^"/V\O&&D?$S3O#'Q5\%)X5BORJ1R1QR1NC,0 S!V^[SU%>V_M)?M4
M>'_V?=(LEEC;5->U)"UE80X)*]G<9!VDC''>N>.-H3A*I>R6]]#V,1PQFF'Q
M5+!^SYI5%>/*U)-=;-::=3W&BO@B7]OKXG>";W2K_P >?#5=&\-7QW)<)#*D
MCIURA=MIXKWWXU?'3QCHW@'POXA^%OA-O&AUAM[@1/(L,6PG)V'KNXJ88ZC.
M,I1OITL[_<:XCA7,L+5I4JBC:I=1ESQY;K=.5[)KS/>J*^!_$G[:'[0/@_1Y
MM5UKX20:9IL/^LNKFUN$1?J2U>M?L;_M->,?VCY->NM:T/3M-TC3PL27%EYF
MYIC@[3N)'W3FE3Q]&K45)7N^Z:-<9PEF6!PD\=4<'3CNXSC+?IH]SZ>HHHKT
M3XL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "O+OVI_^38?B]_V)^L?^D4U>HUY=^U/_
M ,FP_%[_ +$_6/\ TBFJH_$A2V9_.;1117T)Y85^\7_!,K_DR'X;_P#<2_\
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MIOM&28M'"'(&,8!P PQSU%-8234?>6NWF)XJ*;5GIN??>TD$@$CUQ25\>_M
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M",_K7LM>=_M$0I-\#?&H?@+ISD'T.1S77E-1TLPH37\\?S,<PBIX2K%_RO\
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M.OBA\.6;X>ZP+$W%]?[8_*MXADO\ZYX^F:T_ _PYA'@O01>37%K=BRC\Z!@
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MZ_Z%;5?_  %;_"NUYSB7_P NU]S/E%X>\/\ _08__ H'ZV_\-H?"'_H;(O\
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M#\3/V1_%7AB_D\I-0U*\@$F,B)RB@-CT!.<5SOAOXG?%;]B6VBT#QKH+^)/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5Y=^U/_R;#\7O^Q/UC_TBFKU&O+OVI_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>7?M3_ /)L/Q>_[$_6/_2*:O4:\N_:G_Y-A^+W_8GZQ_Z1354?
MB0I;,_G-HHHKZ$\L*_>+_@F5_P F0_#?_N)?^G*ZK\':_>+_ ()E?\F0_#?_
M +B7_IRNJXL7\"]3HH?$?4-%%%>2=H4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% ",H92K#*D8(/>N?O/AYX7U#=]J\/
M:9<;CEO-M$;/UR*Z&BM(5)T]82:]")0C/XE<Y/\ X5+X)_Z%'1?_   B_P#B
M:/\ A4O@G_H4M%_\ (O_ (FNLHK?ZYB?^?DOO9E]7H_R+[D<G_PJ7P3_ -"E
MHO\ X 1?_$T?\*E\$_\ 0I:+_P" $7_Q-=911]<Q/_/R7WL/J]'^1?<CD_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR[]J?_DV'XO?]B?K
M'_I%-7J->7?M3_\ )L/Q>_[$_6/_ $BFJH_$A2V9_.;1117T)Y85^\7_  3*
M_P"3(?AO_P!Q+_TY75?@[7[Q?\$RO^3(?AO_ -Q+_P!.5U7%B_@7J=%#XCZA
MHHHKR3M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "O!_AM_R<Y\1?^O=/_08*]XKP?X;?
M\G.?$7_KW3_T&"NJC\-3T_5'-6^*'K^C/>****Y3I"BBB@ HHHH **** "BB
MB@ HHHH **** .?\>?\ (KW?U7_T(5Y5X-_Y&J7_ *XM_2O5?'G_ "*]W]5_
M]"%>5>#?^1JE_P"N+?TK*O\ PCBQ'0[^BBBO'.0**** "AONM]**&^ZWTI <
M;KTQFU6?T5L"L^K&I-NU"X/^V:KU[<%:*1ZT5:*05X+^TG^U5I/P1LGTVP*:
MCXKE3,=KU$&?NLX[CV]J]J\0ZY;^&M!O]5NFVP6<+3,?H./UQ7YX_L\^#?\
MAI[]H36_%/B"!KC1K>9KR:)\X!8DQ1_3(->Q@</3J<U:M\$/Q\CS\96G#EI4
MOBE^ RS^,'[0OCYI=6TZRFD@D^?_ $>,QH![ FO0?@C^V=XKT_QI8>$/B'IN
M6NKA+2&>.+RVC=CM!8G[W)'2OMNWM;>UA2&"WBABC4(J(@ "@8 Z>E<CXV^$
M/A;X@:AI.H:MI<,E_I=S'<VMPB[65E8'MUZ#K70\=AZJ<*E%)=+;HQ6#K4VI
MPJMOSV8OQ@^)5K\(_ .J>)KJW>\2T3*01G!D8G  _.OB>3XO?M#?'!IM1\,:
M-,NE@D1?8U$)"CUR1D^]?>OB?PKI/C/29-+UJR2_T^0@M Y(!P<BK]G9V^GV
M\<%K!';PQKM5(U"@#\*X\/B:>'A_#4I=WM8ZJ^'G7E\;4?(^ /AK^V!X]^&/
MCB'P[\1;?=8[UBG61/WT1/1MW<?2OT!M[B.[MXIX7$D4BAT8="#7PO\ \%(-
M-L(-<\'7D<21ZE+"X+*,%U#]3^.*^N/@JUQ)\(?![78(NCIL?F ]=W-=>.A3
MG0IXF$>5RO='-@Y3A5J8>4KJ.QVE XYHHKPSUSL/#\WFZ<J]2A(_6M*L3PL^
MZVF'HPK;KQZJM-GEU%:;"BBBLC,**** "BBB@ HHHH *X/X[_P#)(_$7_7./
M_P!&K7>5P?QW_P"21^(O^N<?_HU:Z<+_ !Z?JOS(G\+-7X7?\DS\*_\ 8-A_
M]!KIZYCX7?\ ),_"O_8-A_\ 0:Z>LZW\67J_S''9!1116104444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'A7[77_ ")FA?\ 7^W_ *+-8_['OW?%
M/^[;_P WK8_:Z_Y$S0O^O]O_ $6:Q_V/?N^*?]VW_F]?31_Y%,O7_P!N1R/^
M/_78]B^(O_(,L_\ KO\ TKH/A3]R^^D?]:Y_XB_\@RS_ .N_]*Z#X4_<OOI'
M_6O-POP,]2A\1Z#11172=X4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7EW[4__ ";#\7O^Q/UC
M_P!(IJ]1KR[]J?\ Y-A^+W_8GZQ_Z1354?B0I;,_G-HHHKZ$\L*_>+_@F5_R
M9#\-_P#N)?\ IRNJ_!VOWB_X)E?\F0_#?_N)?^G*ZKBQ?P+U.BA\1]0T445Y
M)VA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MYUN5D>&8]MFYQC<U:]>16UJ,\RK\;"BBBL3(**** "BBB@ HHHH *X/X[_\
M)(_$7_7./_T:M=Y7!_'?_DD?B+_KG'_Z-6NG"_QZ?JOS(G\+-7X7?\DS\*_]
M@V'_ -!KIZYCX7?\DS\*_P#8-A_]!KIZSK?Q9>K_ #''9!1116104444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% 'A7[77_(F:%_U_M_Z+-8_['OW?
M%/\ NV_\WK8_:Z_Y$S0O^O\ ;_T6:Q_V/?N^*?\ =M_YO7TT?^13+U_]N1R/
M^/\ UV/</&&CSZU96\5O]])=Q^F,5TW@+P]=:''<FXQ^]5-N/;-5U^\/K78V
M_P#J(_\ =%>3A9.S1ZN'6K)****[3N"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\N_:G_ .38
M?B]_V)^L?^D4U>HUY=^U/_R;#\7O^Q/UC_TBFJH_$A2V9_.;1117T)Y85^\7
M_!,K_DR'X;_]Q+_TY75?@[7[Q?\ !,K_ ),A^&__ '$O_3E=5Q8OX%ZG10^(
M^H:***\D[0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KP?X;?\G.?$7_KW3_T&"O>*\'^
M&W_)SGQ%_P"O=/\ T&"NJC\-3T_5'-6^*'K^C/>****Y3I"BBB@ HHHH ***
M* "BBB@ HHHH **** "N3U3_ (_I?K765R>J?\?TOUKCQ/PHY<1\**M%%%><
M<(4444 %(WW6^E+2-]UOI0!RGB:'R]1+@</D_K6374>)+7SH&D'WHV)_"N7K
MU:$N:FO(]&C+F@C.\1:'!XET'4-*NEWP7D#PL#[@X_7%?G%\"_B W[*?QZUK
M0M=\Q=%DG:RNGZ#"DB.7W49)K]+J\4_:$_9>\/\ QTL?M)QIGB&%<17\:Y+@
M?PL.G/K7NX'$4Z?-1K_!/\/,Y,90G4Y:M+XHGK6B>(M+\2:>E]IFH6]W:. R
MR+( ,$9'4UYO\1/VF_!GP]U[2]#:Z_M?6+Z[CM?L=HPW0[V"AV/3'/Z5\?R?
ML)_&&QO7M]/OH3ISC8THU(H=N?[N:]D^!_["MIX1URS\1>,M1?5]2M766*S+
M96.13E6WYYP>U=$L+@J5YRK<RZ);F*Q&+J6C&ERONSZ,\>?$SP]\,],T[4?$
M=\FFV-]<K:QS29P)&4L ?P!K?TW5++6+**\LKN&XMI1N219!@CUZUP?QX^"N
MG_'CP0OAZ_NFL3#.+JWN(UW&.0*5!Q]":^/I/V,?C;X5O)(/#.K13V!!4237
M^PD'@_*>G%<M##X>M3]ZKRR\]CHK5J]*?NT^:/D>R_MZ?$[2=#^%<OAA+B*X
MUC4Y50VZ,"R1X)+_ )@#\:Z?]B'PO<>%_@#IHN8FA;4+A[]5<8)5PH!_\=KQ
M_P"&?[ ^JW/B*+5/B-JINHX2'-HDOFB4CG:6SD"OM6TM8;"UAMK>-88(5")&
MHP% Z 5OBJE&EAUA:,N;6[9CAZ=6K7>(JQY=+)$U*N-PSTSS25;TNU-W>1H/
M7GZ5XC=E=GJMV5V=9I,'V?3X5]MWY\U;H50J@#H.!17B-W=SR6[NX4444A!1
M110 4444 %%%% !7!_'?_DD?B+_KG'_Z-6N\K@_CO_R2/Q%_USC_ /1JUTX7
M^/3]5^9$_A9J_"[_ ))GX5_[!L/_ *#73US'PN_Y)GX5_P"P;#_Z#73UG6_B
MR]7^8X[(****R*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \*_
M:Z_Y$S0O^O\ ;_T6:Q_V/?N^*?\ =M_YO6Q^UU_R)FA?]?[?^BS6/^Q[]WQ3
M_NV_\WKZ:/\ R*9>O_MR.1_Q_P"NQ]'+]X?6NQM_]1'_ +HKC#(L94LP49[F
MNQM9$DA3:ZMA1]TYKQ\+U/6P^[)J***[SM"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\N_:G_
M .38?B]_V)^L?^D4U>HUY=^U/_R;#\7O^Q/UC_TBFJH_$A2V9_.;1117T)Y8
M5^\7_!,K_DR'X;_]Q+_TY75?@[7[Q?\ !,K_ ),A^&__ '$O_3E=5Q8OX%ZG
M10^(^H:***\D[0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?O5Y'^%;4*GLY6>S-:-3DE9[,Y2BE92C%6&&'44E>N>F%%%% !1110 4444
M%=/X;L3%"9W&"W"Y]/6LG1],:^G!8?NQ]X_TKL54*H & .E<6(J:<B.2M/3E
M04445YYQ!1110 4444 %%%% !1110 5P?QW_ .21^(O^N<?_ *-6N\K@_CO_
M ,DC\1?]<X__ $:M=.%_CT_5?F1/X6:OPN_Y)GX5_P"P;#_Z#73US'PN_P"2
M9^%?^P;#_P"@UT]9UOXLO5_F..R"BBBLB@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /"OVNO\ D3-"_P"O]O\ T6:Q_P!CW[OBG_=M_P";UL?M
M=?\ (F:%_P!?[?\ HLUC_L>_=\4_[MO_ #>OIH_\BF7K_P"W(Y'_ !_Z['LG
MQ"E>'3;0QNR$S]5/M71?"VXEF2]\R1GP(\;CTZUS?Q%_Y!EG_P!=_P"E=!\*
M?N7WTC_K7FX7X&>I0^)GH-%%%=)WA1110 4444 %%%% !1110 4444 %%%%
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M#XCT&BBBND[PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O+OVI_P#DV'XO?]B?K'_I%-7J->7?
MM3_\FP_%[_L3]8_](IJJ/Q(4MF?SFT445]">6%?O%_P3*_Y,A^&__<2_].5U
M7X.U^\7_  3*_P"3(?AO_P!Q+_TY75<6+^!>IT4/B/J&BBBO).T**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *\&^&YV_M._$0'@FW3'O\L%>\U\[^#]22+]K#Q;%D1F2!
M8=O]XA(VS_GTKKH:QJ>GZHY:WQ0]?T9]$4445R'4%%%% !1110 4444 %%%%
M !1110 4444 <_X\_P"17N_JO_H0KRKP;_R-4O\ UQ;^E>X7-K'>0M%,@>-N
MJFN-N=)M+'4Y9((1&_3(]*Y\1*U.QR8A:)BT445Y1Q!1110 4C?=;Z4M(WW6
M^E $4G^L;ZFFTZ3_ %C?4TVH("BBB@ J*[NH;"UFNKF18;>%#))(W1% R2?H
M*EK!^('_ "(7B3_L'3_^@&KA'FDH]P>QI:/K5AXATV'4-,NH[ZQFSY=Q$<JV
M#@X_&KE>;_LX@+\%_#H P,2_^C&KTBM*]-4JLJ:Z-H47=)E@?<3_ '?ZFB@?
M<3_=_J:*R- HHHI@%%%% !1110 4444 %%%% !1110 5P?QW_P"21^(O^N<?
M_HU:[RN"^/# ?"3Q#DX_=QX_[^+73A?X]/U7YD3^%FM\+O\ DF?A7_L&P_\
MH-=/7,_"]2OPU\+ C!&G0Y_[YKIJSK?Q9>K_ #''9!1116104444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'A7[77_(F:%_U_M_Z+-8_['OW?%/\
MNV_\WK8_:Z_Y$S0O^O\ ;_T6:Q_V/?N^*?\ =M_YO7TT?^13+U_]N1R/^/\
MUV/>?$.AC7K:&$OY?ER;\_ABNH\(^&!X=CE(E\SSE7\,9_QK,7[P^M=C;_ZB
M/_=%>1A9/5'K8=:LDHHHKN.T**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$_AC^+Z(RF[^ZNI[5H>EC1-%L-/4[EM85A!^@Q5VBBN!MMW9J%%%%( HHHH
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M=?<>*_\ #9/A7_H%:E^<7_Q='_#9/A7_ *!6I?G%_P#%U[5_PBFB?] ?3_\
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MKG_".Z1_T";'_P !T_PH_P"$=TC_ *!-C_X#I_A1[7!_\^G_ .!?\ .6IW_
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M_0+U+\T_QH_X:Q\+?] O4OS3_&O7/^$=TC_H$V/_ (#I_A1_PCND?] FQ_\
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M5VI'&, 5;R3UYI*YZV(G6LGHELEL5&*B%%%%<I84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!X5^UU_P B9H7_ %_M_P"BS6/^Q[]WQ3_N
MV_\ -ZV/VNO^1,T+_K_;_P!%FL?]CW[OBG_=M_YO7TT?^13+U_\ ;D<C_C_U
MV/8OB-SI=G_UW_I70?"C[E]](_ZUS_Q%_P"099_]=_Z5T'PI^Y??2/\ K7FX
M7X&>I0^(]!HHHKI.\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR[]J?\ Y-A^+W_8GZQ_Z135
MZC7EW[4__)L/Q>_[$_6/_2*:JC\2%+9G\YM%%%?0GEA7[Q?\$RO^3(?AO_W$
MO_3E=5^#M?O%_P $RO\ DR'X;_\ <2_].5U7%B_@7J=%#XCZAHHHKR3M"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "O!_AM_R<Y\1?^O=/_08*]XKP?X;?\G.?$7_ *]T
M_P#08*ZJ/PU/3]4<U;XH>OZ,]XHHHKE.D**** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[O\ (][HID<B31J\;*Z,,AE.0?QI]?3GP04444 %%%% !1110 4444 %%%%
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M-8V9K=%NBJG]K6/_ #^6_P#W]7_&C^UK'_G\M_\ OZO^-%F%T6Z*J?VM8_\
M/Y;_ /?U?\:/[6L?^?RW_P"_J_XT6871;HJI_:UC_P _EO\ ]_5_QH_M:Q_Y
M_+?_ +^K_C19A=%NBJG]K6/_ #^6_P#W]7_&C^UK'_G\M_\ OZO^-%F%T6Z*
MJ?VM8_\ /Y;_ /?U?\:/[6L?^?RW_P"_J_XT68714\4ZC+I6AW%S#_K$VXS[
MD"O-]#\3WFL>(IH+@C9Y;-^(Q7;>.-2LY?#-VJWEN3\O_+5?[P]Z\N\'75NO
MBJ4FY@ \EN3*N.WO6&(C^ZV.3$/8]#HJ+[9:_P#/Y;?]_E_QH^V6O_/Y;?\
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MWNDS\S1*P'MR*[^N!\7QKI_C33+P\"XB:WS_ +7)_I0!3UR\33[6 2Q"59)
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MN?'U85JW-!W5E^1O@Z<Z5+EFK.[_ #-.BBBO..X**** "BBB@ HHHH ****
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M7?M3_P#)L/Q>_P"Q/UC_ -(IJJ/Q(4MF?SFT445]">6%?O%_P3*_Y,A^&_\
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MO45)C=)&21208V#+AA^=?5HR"#BN/T7X4:)H'BZZ\26INO[2N P<2/F/D@G
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M<(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7EW[4__ ";#\7O^Q/UC_P!(IJ]1KR[]J?\ Y-A^+W_8GZQ_Z1354?B0I;,_
MG-HHHKZ$\L*_>+_@F5_R9#\-_P#N)?\ IRNJ_!VOWB_X)E?\F0_#?_N)?^G*
MZKBQ?P+U.BA\1]0T445Y)VA1110 4444 %%%% !1110 4444 %%%% !1110
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M>\5X/\-O^3G/B+_U[I_Z#!751^&IZ?JCFK?%#U_1GO%%%%<ITA1110 4444
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M5TX&K1HU7*NKJW:YR5(RDK1/FG_AH/Q]_P!##/\ ]\)_\31_PT'X^_Z&&?\
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M?P5_SUU+_OZO^%'U[+OY/_)4'LZO?\3P/_AH/Q]_T,,__?"?_$T?\-!^/O\
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MXB_\@RS_ .N_]*Z#X4_<OOI'_6EA?@9WT/B/0:***Z3O"BBB@ HHHH ****
M"BBB@ KD?B!\3M#^'.GF?4[@><P_=V\>&D8]N/3/>HOBI\2K+X:>&Y+^?$EU
M)\EO!GEVQU^@KX5\7>+]2\;:W/J>ISM-/*>F3M0=E ["OF<WSB. 7LJ6M1_A
MZGW?#?#4LWE[>O[M)?>WV7ZL] \>_M(>)O%EU-':3G2].<;1;P$'(]22,UY7
M+J%Q.Q,DSN3U+')J"BOS.OB:V)ESUI-L_=\)@<-@:?L\-345Y?J^HX2,IR&P
M:N:?KE_I=S'/:W4L,L9RK(V*HT5@FT[H[)14E:2NCWOX:_M2:MHUU';>(V;4
MK!B 9L?O8U]@  :^I_#/BG3/%^EQZAI=TES;O_=(RI]&'8U^;M=U\*?BMJ7P
MSUM9[=VEL96_TBU).''J!G@^]?699GU7#R5/$OFAWZK_ #/SG/N$</C(2KX&
M/)4[+9_Y/\#ZF_:0\!-XR\!2W%M")=0T[,\?&24Q\ZCU)P/RKX@9/+8J1@CV
MQ7Z0>&/$=CXR\/VNJ6+B6UNHPV.N,CE3[BOD7]HKX0R>"]??5M/@)T:];=E1
MQ"YZJ?KUKOXAP/M$L=1U5M?T9Y/!>;>PE+*<3H[OEOWZQ_5?,\8I-H]!2T5\
M$?KP4FT>@I:* $HQ[4M% ";1Z5[]^RA\/VU?Q-+XAN8?]$T\$0L1UF..GT&:
M\@\%>#=1\<^(+72].A:265AN8#B-<\L?8"OOSP1X0L_ WANSTBR0+'"GS-W=
MNY/XU]7D&7O$5UB)KW8_B_\ @'Y[QAG,<%A'@Z;_ 'E3\(]?OV1O4445^H'X
M"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>7?M3_ /)L/Q>_[$_6/_2*:O4:\N_:G_Y-A^+W_8GZQ_Z1354?B0I;
M,_G-HHHKZ$\L*_>+_@F5_P F0_#?_N)?^G*ZK\':_>+_ ()E?\F0_#?_ +B7
M_IRNJXL7\"]3HH?$?4-%%%>2=H45\S?%#]HKQ3X/_:P\!?#BQAL&T#7 /M3R
MQDS#_=;.!^5?3-;5*4J:BY?:5T90J1J.271V"BBDK$U,7Q!XV\/>$VC&MZ[I
MND&3[@OKI(=WTW$9IO\ PG?AOS+"/^W],\S4%WVB_:X\W"^L8S\PX/3TK\^O
M"/PKMOVV/VGOB3/XWU"_D\/^&[AK*SM+.?8H*L47&00 0A)QUJS\;OAGI7PE
M_:2^ 7A32);JXTW38/*@:\D\R0+YDAQG [FO9^HT^94W/W[7>FFUSR?KE3E=
M11]V]EKYV/T9HHHKQCU@HHHH **** "BBB@ HHHH **** "BBN1UWXM>$/#/
MC/2?"6J:];6?B/5O^/'3Y-WF3_[N!C\S51C*6D5<F4E'5NQUU%87CK7I_"_@
MO7=8M;<W=S864US' HR79$+ ?F*\9_8U_:"U_P#:'\$:OK&OZ2NES6EY]GC\
MM"JR#!SU[C&#6D:,Y4W56R_4AU8QJ*F]V?0=%%%8FH4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5X/\-O^3G/B+_U[I_Z#!7O%>#_  V_Y.<^(O\ U[I_Z#!751^&IZ?JCFK?
M%#U_1GO%%%%<ITA1110 4444 %%%% !1110 4444 %%%% '/^//^17N_JO\
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ME'_+0[CFD_LGXQ?\_$?Y-_C1]2C_ ,_8_>+VGDSZ$VGT-&T^AKY[_LGXQ?\
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MVJ>,]/T2W#3K;VX?RXQEC(S'( ^BBOK>O%K'PW8_\+&\8^-=6@6>WTG,5NK
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M]GA6//Y"GS6\-U&8YX8[B)NL<R!U/U!I]%,"O-IMC=1HD]A:3QIPB2P*RK]
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MK<]*G)2]FTDK7VNM7;S//_V>? =CXR\62W&JC=I>F1&>53T)'(!_6O0U^/\
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M1110 4444 %%%% !1110 4444 %%%% !1110 5Y=^U/_ ,FP_%[_ +$_6/\
MTBFKU&O+OVI_^38?B]_V)^L?^D4U5'XD*6S/YS:***^A/+"OWB_X)E?\F0_#
M?_N)?^G*ZK\':_>+_@F5_P F0_#?_N)?^G*ZKBQ?P+U.BA\1]0T445Y)VA11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME3U/6MV*)88PB#"BG45Q5*DJCU.2=1SW"BBBLC,**** "BBB@ HHHH ****
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M_2O(J,UKQG6]A2_AT]%^K^;#A["3IX;ZWB-:U;WI/UV7HD%%%%>(?4A1110
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M6&<L/33>SE^A@J4O:27H;O\ PG.C?\_+?]^S1_PG.C?\_+?]^S6%_P ()?\
M_0-G_P"^:/\ A!+_ /Z!L_\ WS7-]3\S7V,SJ=,\16&L2M':2F1U&X@KCBM+
M-9G@'PC+8ZA.]U9RP*8\!G&!U%=S_8MO_=K&6%DGH4J,CF<UEZCXGT[2KCR+
MF9DEQNP%)XKNO[%M_P"[7GOCCP?/>:T)+:REFC\L#<JY&<TXX63>H.C)#?\
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MR9R2DJ56\MI?F?2]%06=Y!J%K'<VTJ3V\@W))&<JP]0:GKC.L**** "BBB@
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M@ HHHH **** "O+OVI_^38?B]_V)^L?^D4U>HUY=^U/_ ,FP_%[_ +$_6/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :Z+(C(PW*PP0>XKP?
M]F&-;;6_B1;QY$,>L-L7L/WDPX_(5[U7@_[,_P#R,GQ,_P"PPW_HV>NJG_"J
M?+\SFJ?Q8?/\CWBBBBN4Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH K:CI]OJUC/9W4:S6\R%'1AP0:^$?C
M'\+;WX;^)IHC&SZ;,V^VG X*^GL1T_"OO>L3QAX0T[QMHDVF:G")89!\K8Y1
MNS#WKP\URV.8TK+2:V?Z'UG#V>SR7$7EK3E\2_5>:/SBHKU'XH_ 77/A[-)<
M1QMJ&DY9EN8ER44?WP!P:\O92O48K\HKX>KAING5C9G]$83&4,=25;#34HOL
M)1117.=@44H4MT%>L?"O]GW6O'TT=U=QOIVD9!::0$-(O^P".:Z</AZN*FJ=
M&-V<6,QN'P%)UL3-1BOZT[E#X(_">Z^)'B:$RQ,FD6S![F8C@@<[![G&*^Z+
M.SAT^TAMK=!'!"@1$4<  8%9WA?POIW@_1H-,TR!8+:,=%'+'N3[FM>OUC*\
MMCEU*V\GN_T/YUX@SR>=8CF2M3C\*_5^;"BBBO:/E@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR[]J?_DV'XO?]
MB?K'_I%-7J->7?M3_P#)L/Q>_P"Q/UC_ -(IJJ/Q(4MF?SFT445]">6%?O%_
MP3*_Y,A^&_\ W$O_ $Y75?@[7[Q?\$RO^3(?AO\ ]Q+_ -.5U7%B_@7J=%#X
MCZAHHHKR3M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** &AU9B P)'4 ]*\)^&W_)SGQ%_Z
M]T_]!@J+Q5X@USX,_%C^U]1NI]0\'ZZZQR.PR+1\\ ^@&3C\:H^#/$FG:+\?
M/B;K5S=1KIT-DLS3;AM*[8,8/OTKT*=-QC)K5-?JCAJ5%*44]+/]&?1.Y=VW
M(W>F>:=7BGP7N_$/Q"\6:IXYOYYK+0YA]GT_3\8$B#/[P@^V,8]37M=<=2'L
MY<MSJISYUS6"BBBLS0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJIJJW3:;<BQ*B[*'RBYPN
M[MF@"W7@_P"S/_R,GQ,_[##?^C9ZU/AM\7K^WUY_!WCF)=/\01MMM[EN(KM<
M\%2>I[<5S/P+\16'A.\^*FIZI<):VD&K,6=R!SYL_ ]Z[XTY0A4B_+\SBE4C
M*<)+S_(^BJ*\?^%/COQ7\2O%%YK1LAI_@W:8K5)@5DE(S^\ [Y_I7L%<DX.F
M^5[G5":FKH****S+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@".XMXKJ%XIHTFB<8:.10RD>A!KS#QE^SIX3
M\5L\Z6S:?=D85K<[$'_ 17J=%<U?#T<3'EK137F=V%QV)P,^?#5'%^3/F*\_
M8WD=@;77XD7)R)86;Z="*6Q_8W=&S=:_%(,](H67C\2:^G**\G^PLOO?V?XO
M_,^C_P!;LYY>7VWX1_.QYAX-_9Y\)>$F2<VAO[L#YGNCO4_137ID,,=O$L42
M+%&HPJ(, #V%/HKUZ.'I8>/+2BDO(^;Q6-Q.-GSXFHY/S84445T'$%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7EW[4_P#R;#\7O^Q/UC_TBFKU&O+OVI_^38?B]_V)^L?^D4U5'XD*6S/Y
MS:***^A/+"OWB_X)E?\ )D/PW_[B7_IRNJ_!VOWB_P""97_)D/PW_P"XE_Z<
MKJN+%_ O4Z*'Q'U#1117DG:%%%% !1110 4444 %%%% !1110 4444 %%%%
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M(?VW/_H$J?<O\S[7HKXH_P"$+_:B_P"AXM?_  )C_P#C='_"%_M1?]#Q:_\
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M *#J?]_5_P#B:/LOQ0_Z#J?]_5_^)H^N+^1A_8"_Z"J?WO\ R/?Z*\ ^S_%
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M HHJEK&K6^AZ;->W3[(8ER?4^P]ZF4E%.4MD*4E%7>PW6M:M-!LFNKN39&.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^5NW-;2_]==CZOKF_B)9+?>$;Y7&1&!(/JO-=(1M)%9GBA!)X:U4'I]ED/\
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MBI._+3ZOY_JCTZBBBOI3\/"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-,+'RH4 ?Q>E=O\ MT?"G4/B+\'S?:!$[ZUX?F6^MHH5RS(O+*H'4\# KF?
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MJI?[Y'Y ?LK^'=.\6?M#^"M(U:TCOM.NK_9-;RKE778QP1^%?JU_PR;\*O\
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M'?A/_P! $?\ CO\ A1_PP[\)_P#H C_QW_"O?J*GZK0_D7W&W]OYK_T$S_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7EW[4__ ";#\7O^Q/UC_P!(IJ]1
MKR[]J?\ Y-A^+W_8GZQ_Z1354?B0I;,_G-HHHKZ$\L*_>+_@F5_R9#\-_P#N
M)?\ IRNJ_!VOWB_X)E?\F0_#?_N)?^G*ZKBQ?P+U.BA\1]0T445Y)VA1110
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M$S75PESK#)_H^GQD&1SV/TKR"X^.GQ/^+EW)IG@'PO-I4;?*NH7 *JX/?+C
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MV]SCC:.?Z"N= STKW3X1^%7T?26O[A"D]T!M4_PI_0FM,MPKQ6(C&VBU9Z.
MP[Q%=+HM6=^BB-551A5& *=117Z8??A1110 4444 %%%% !1110 4444 %%%
M% '&?$KX>P^.--4QM]GU*WRUO..Q]#7FOA?QK+IMV^A>(Q]COX#M623^/T^M
M>^URWC3X=Z5XVMR+J+R[I5Q'<Q\,I]?>N&OAW)^TI[_F?39?F=.-+ZGC4W3Z
M-;Q?EY=T8_! (.0?2EKS^YT'QI\.=ZQ(=7TI#^["G+$?3DU):_%RP5%&I6LU
MC-_$GEL=OZ5P>TY7::LSVGEE6HN?"M58]X[_ #6Z.\HKCS\6O#8 /GW'/_3
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG_T)&B_^ JUZ)11_:6-_Y_S_ / G_F'U/"_\^H_<CSO_ (9W^&?_ $)&B_\
M@*M'_#._PS_Z$C1?_ 5:]$HH_M+&_P#/^?\ X$_\P^IX7_GU'[D>.^//@O\
M#KPGX+US6;;P)H,MQ86<MQ&DMH"A95) /M5/X6_"/X?>.? >DZY?>!/#\5W=
MJYD6WLPJ?+(R\ DXX4=Z[SXR?\DG\7?]@RX_] -9?[//_)'/#G_7.7_T=)71
M_:&,]CS>VE>_\S[>IA]4P_MN7V<;6[+OZ#O^&=_AG_T)&B_^ JT?\,[_  S_
M .A(T7_P%6O1**Y_[2QO_/\ G_X$_P#,W^IX7_GU'[D>=_\ #._PS_Z$C1?_
M  %6C_AG?X9_]"1HO_@*M>B44?VEC?\ G_/_ ,"?^8?4\+_SZC]R/._^&=_A
MG_T)&B_^ JT?\,[_  S_ .A(T7_P%6O1**/[2QO_ #_G_P"!/_,/J>%_Y]1^
MY'G?_#._PS_Z$C1?_ 5:M6/P+^'VF$FU\(:3;DG)\NV45W5%)YAC)*SK2_\
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M</2P\>6E&R/8I4:=%<M-6"BBBN@V"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O!M+_Y.^U;_ + __LD%>\UX-I?_
M "=]JW_8'_\ 9(*ZJ&T_1_H<U;>'JCWFBBBN4Z0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *\N_:G_Y-A^+W_8GZQ_Z135ZC7EW[4__ ";#
M\7O^Q/UC_P!(IJJ/Q(4MF?SFT445]">6%?O%_P $RO\ DR'X;_\ <2_].5U7
MX.U^\7_!,K_DR'X;_P#<2_\ 3E=5Q8OX%ZG10^(^H:***\D[0HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBL?6O%FEZ"I-W<JI'\*#<WY"@#8
MHKB9/BA9L?\ 1[*[F3^]Y+#^E/A^*6E9 NH[FU). 6@;'YXH [.BJ.GZU9:H
MFZVN8Y?]D-S^57J "BBB@ HHHH **** "BBB@ HJGJ>K6FCVKW%W,L,:C)R>
M?P%>=Z]\:((6:+3K=I/2:7*C\L5QXC&4,*OWLK?F<M;%4<.OWDK'J%%>%3?&
M76F?,9A5?39G^E6K'XU:C&R&YBBF Z@?+G]*\U9UA&[7?W' LVPS=KO[CVNB
MN0\.?$S2M>:.)F-I<OT20$#_ +ZZ5UP8, 0<@]Z]BE6IUX\U.5T>I3JPK+FI
MNZ%HHHK8U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y[XA6#:I
MX%UZS1=[3V4L87URI%<#^RSJJWWPGL[7.9;&:2"0>C;BW]:]>8!@01D'J#7S
ME\+;\?"+XR:_X-U"4PZ;JTOVG3Y)!@.Y [_0$?A773]^E*"W6IRU'R5(R>ST
M/HZBBBN0Z@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BO,OC)\2-8^&DFD:C;Z6;W0O-VW\R'YD4Y'3&1V.:[S0-?L?$^D
M6VIZ;<+<V=P@=)%/8^OH?:M'"2BI]&0IIR<>J-&BBBLRS)MO%>CWGB"ZT*#4
M8)=8M8Q+/9JW[R-#C#$>G(_.M:OGWP2H_P"&PO'AP,_V1!SCVBKZ"K:K!4VD
MNJ3^\RIS<TV^C:"BBBL34**\T^,GQ?@^'=C#96,?V_Q'>D):V<?)Y_B-=UX=
MN+ZZT.RFU.W%KJ$D2M-"K!@C=QD5HX2C%2>S(4TY.*Z&C1116984444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@/@^Y77OV
MJ?$VH6ZEH+33Q:L_8-B,8_-37JWQ(\<67P]\(W^KWDJQF.,B%>I>0\* ._)%
M>>_LP^%;RR\.:EXFU0$:CK]P;DJPY5,L1^!W9KKIKEISF^NARU'S5(P734]J
MHHHKD.H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY7]X<M?^9?<>;_\ #7W@G^Y>_P#?L?XT?\-?>"?[E[_W['^->D?\*O\ "O\
MT [/_ORO^%'_  J_PK_T [/_ +\K_A1S8?\ E?WARU_YE]QYO_PU]X)_N7O_
M '['^-'_  U]X)_N7O\ W['^->D?\*O\*_\ 0#L_^_*_X4?\*O\ "O\ T [/
M_ORO^%'-A_Y7]X<M?^9?<>;_ /#7W@G^Y>_]^Q_C1_PU]X)_N7O_ '['^->D
M?\*O\*_] .S_ ._*_P"%'_"K_"O_ $ [/_ORO^%'-A_Y7]X<M?\ F7W'F_\
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M"?[E[_W['^-'_#7W@G^Y>_\ ?L?XUZ1_PJ_PK_T [/\ [\K_ (4?\*O\*_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU^\7_!,K_DR'X;_]Q+_TY75<6+^!>IT4/B/J&BBBO).T**** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\SDYP3C%?68'%0HUZ$Z&)A3P]E>.G,W;7FTOOUO:P'UUX:_Y%S2?^O2'_P!
M%?0OP7T\V_AV6Z((\Z3 !] !S7@?ABPF73=*LW0K<+!%$R]<,% Q^=?5?AO2
M1H>AV=D.L,85CZG')KXO)J//BIU>BO\ B>[D])RK.IT2_,TZJ:II=KK6GW%C
M>PK<6MPACDC<<,I&#5NBOMS[$\+^'_@KQ/\ "7XD/HNGAM1\%7X:9&DS_HIS
MT^N?TKW2BBM:E1U'=[F=."IJRV"BBBLC0**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#Y^\$_P#)X/CO_L$0?RBKZ!KY^\$_\G@^._\ L$0?
MRBKZ!KJQ'Q1]%^1S8?:7J_S"BBBN4Z0HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **AM[J&ZW^5(
MLFP[6VG.#Z5R.N?$J#1?'VE>%_L,T\U]&9/M"_<C SUX]JQJ5J=**E-V3:7S
M9U4<+6Q$G"E&[2;?HE=L[2BBBMCE"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KR[]J?_DV'XO?]B?K'_I%-7J->7?M3_P#)L/Q>_P"Q/UC_ -(I
MJJ/Q(4MF?SFT445]">6%?O%_P3*_Y,A^&_\ W$O_ $Y75?@[7[Q?\$RO^3(?
MAO\ ]Q+_ -.5U7%B_@7J=%#XCZAHHHKR3M"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "L[4O#^G:PN+NUCF[9(P:T:* .-;X7Z9'N^R2S
M6@8YPA)_K3%^&46[YM4NG'H<5VM% '-:7\/=&TR4S"V\Z<G)DD))S^==(JA5
M 4  =A2T4 %%%% !1110 4444 <[XI\#Z=XJA/G)Y-SC"SH/F'M[UY1K_P (
M]6TW?);JMW#GC8?F_+%>\T5Y6*RW#XI\TE:7='G8C 4,2[R5GW1\QMX-UA6*
MMI]PI'_3)C_(5/9> ];O)%5=/F4,<;G4J/U%?2M%>6L@I7UFSSEDM*^LV>4>
M&_@OY<B2ZM*#M.3#'R&]B:]0LK&#3K=(+:)884& JBIZ*]W#8.CA5:E'_,]B
MAA:6&5J:"BBBNPZ@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *1E#*01D'@@UD:[XLTWPZ@-Y<*LC#Y8UR2?RKSW5/C<?-(L
MK3:@R,R$$GWK@KX[#X9VJ2U['%6QE"AI.6IS^H_LM:;>?$Y-727R_#CG[3-I
MH.%,V>F/[IR37N\,*6\21QJ$C4855& !7B:_&O5MPS%!C/\ =K<TCXV1/($O
MK0@,<!XV'R_45C_;F&KM1E/;NCBHX_!IOE=KGJ=%9NC^(+#7H3)97"R@<%>A
M!],&M*O3C*,US1=T>Q&2FN:+N@HHHJB@HHHH **** "BBB@ HHHH ***K7FI
M6NGQ[[B=(ESCYC2;45=B;2U99HK!D\=:%&Q5M1B##KU_PJW9>)-,U!E6WO(Y
M&;D#.*R5:E)V4E?U,U5IR=E)?>:=%("&Y!R*6MC4**** "BBB@ HHHH ****
M "BBB@ HJ*:YAME+32I$H&278 5QFJ_&SP1HFX7OB*TAVG:>2>?P%9RJ0I_&
M[$2G&'Q.QW%%>3_\-4?"[_H:[?\ [\R__$T?\-4?"[_H:X/^_,O_ ,36'US#
M?\_(_>C'ZU0_Y^+[T>L45Y/_ ,-4?"[_ *&N#_OS+_\ $T?\-4?"[_H:X/\
MOS+_ /$T?7,-_P _(_>@^M4/^?B^]'K%%>3_ /#5'PN_Z&N#_OS+_P#$T?\
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M?>1("P.S<>N:]35MR@^HS7IX.=Z:A*3<EO?SU/!S.DHUG5A!1@VTK;>[H_\
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MB$C*RK( RD]#@#\JYO98:T*]-/EO9J^OD='M,1>5&;5[73/"_P#@G_\ M9>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>+]3E=X+ DB-5W'+2N/N#D<FL31O'_CNQUVPM/&7@ZTTNROG,,-SI%RUT5D
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M;_$#XM7.@^)K'PIX7TN/Q!XLNE\TVDSF."&+^](X^[SZ^M>D5\]>$[U-%_;
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MQJ6CSQ;=SJ-Z?[PZ4 >B45B>#=4.L>&[*X<YE\L+)_O <UMT %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7EW[4_P#R;#\7O^Q/UC_TBFKU&O+OVI_^38?B]_V)^L?^
MD4U5'XD*6S/YS:***^A/+"OWB_X)E?\ )D/PW_[B7_IRNJ_!VOWB_P""97_)
MD/PW_P"XE_Z<KJN+%_ O4Z*'Q'U#1117DG:%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKO=MN[?SZ>2/>R>FY5W/LC<HHHKZ4^R/+OC1\3K[PK'::#X?M9+OQ-JI\NU
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTQ^JFOC:V05XO]U)-?<?+5<FK1?[MIK[C\]Z*^__ /A@KP-_T%-7_P"^XO\
MXBC_ (8*\#?]!35_^^XO_B*Y_P"P\9V7WF/]D8KLOO/@"BOO_P#X8*\#?]!3
M5_\ ON+_ .(H_P"&"O W_04U?_ON+_XBC^P\9V7WA_9&*[+[SX HK[__ .&"
MO W_ $%-7_[[B_\ B*/^&"O W_04U?\ [[B_^(H_L/&=E]X?V1BNR^\^ **^
M_P#_ (8*\#?]!35_^^XO_B*/^&"O W_04U?_ +[B_P#B*/[#QG9?>']D8KLO
MO/@"BOO_ /X8*\#?]!35_P#ON+_XBC_A@KP-_P!!35_^^XO_ (BC^P\9V7WA
M_9&*[+[SX HK[_\ ^&"O W_04U?_ +[B_P#B*/\ A@KP-_T%-7_[[B_^(H_L
M/&=E]X?V1BNR^\^ *DAMY+B14CC:1V. JJ237W];_L'^!(9E=M0U:55.=C/'
M@_DM>A^!?V;? G@/Y[71H;RY!RMS=H'D7Z'%:T\AQ,G[[27WFD,GQ$G[[21\
M;_ _]DWQ!\3)8M0U57T70P>9)5Q*^#T"'!P1WK] /"/A'2_ ^@VNCZ/:K:6-
MN@1%7J<=R>Y]S6PJB-0JC:JC  [4M?78++Z6!C[FK>[/I<)@J>$7NZON%%%%
M>F>@%%%% !1110!!>64&H6[P7$:RQ.,%6%>>:EX/U3PM,USHK_:K'JUFYY4=
M\$UZ510!YGIOBRSOF\N4-9W .#',"O/MGK6RN& (8$?6MO6O">F:\I-W:H\G
M:3'S#\:YJ7X:SVDKR:?JDJAND<Q!4?3B@"WM;T/Y4;?7CZUE-X3\7H<)J-H5
M[9!J1? 6MW\92_U54#=3;]?U% $6L>)+;2AL3-Q=-PD,8R2:T_!/A6XAN'UG
M5OFOYA^[CZB%?0>]:F@>!]-T"3SHX_/NN]Q+R_YUT- !1110 4444 %%%% '
MD'[6UC<ZE^SSXTMK2VFN[B2QD5(8$+NQVG@ =:^'_@+^VAXZ^"/PJT3P9'\'
M=6U1=-5U%XT=Q&9-SEL[?*..OK7Z?T5Z-#%0ITG2J4^97ONU^1P5L-.I452G
M/E=K;7/AV\^*&N_MJ_ GXEZ!K?@"[\(3:79+?6C77F8GD3<X"ET7!&T=/6O,
M_P#@FGX9U/XA?%37O&_B.1[ZXT&RCTF!I?\ EDP"A0,=PJ8K[-_:V^)0^%7P
M!\6:TI"SO:M9PGN'E!0$?3-</_P3U^'I\$_LZZ5>7,'EZMK<LE_=2,/F?+MY
M9/OM(KN6(4<'4<(\JD[)?+4XW1<L534I7:5W^A/^TM\7OBG\$_%5CK_A[PK_
M ,)?X):V$=U90-B=)LMEQ@%B,%?RKYM^(7C?XC_M\W>B>#++X?W7@_0[*]CO
M+S4M1#*P !!P'5<XR> 3FOTDHKBHXN-%)JFN=;/7\CLJX655M.;Y7NO^"?"W
M[17A/4X?VPO@Q]BTN]N]/L+-(9+J&W9XH]I8?,P&!^->B?M#?';XJ_ ?X@R:
MG9>#6\9> KJ%$ACLV_?V\H4;R0JECSGKZU]2T5/UI/D4X)J*M^-_D/ZLUS.$
M[-NY^<NL:I\0OV]/B-X.C?P1/X+\+>&;];V>[OMPD?!!P RKG. ,#/6OT7BC
M6&)(T&%4!0/84^BL\1B/;<L8QY8QV1I1H>RO*4KR>["O"OVT/A/XC^-'P-O_
M  QX6MX;G5IKJ&58YYA$NU=V?F/'>O=:*PI5'2FJD=T;5*:JP<);,YGX9Z'>
M>&?A_H&E7Z+'>V=G'#,J-N 8#G![UTU%%1)\S;9:7*DD%%%%2,**** "BBB@
M HHHH **** "BBB@ HHHH *\N_:G_P"38?B]_P!B?K'_ *135ZC7EW[4_P#R
M;#\7O^Q/UC_TBFJH_$A2V9_.;1117T)Y85^\7_!,K_DR'X;_ /<2_P#3E=5^
M#M?O%_P3*_Y,A^&__<2_].5U7%B_@7J=%#XCZAHHHKR3M"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH K:AIEGJUL;>^M(+VW8Y,5Q&L
MB''3@C%2V]O%:0I#!$D,2#"QQJ%51Z #I4E%/R ****0!1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]\.?"VA2Z[=:)86\L%U=BT9E:ZB$14Q$@C )8'\*\,_X*8_\>?PL_P"PZ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *\N_:G_Y-A^+W_8GZQ_Z135ZC7EW
M[4__ ";#\7O^Q/UC_P!(IJJ/Q(4MF?SFT445]">6%?O%_P $RO\ DR'X;_\
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MT?5:@>V@?LE17XV_\/E/C3_T+'@/_P %][_\ET?\/E/C3_T+'@/_ ,%][_\
M)='U6H'MH'[)45^-O_#Y3XT_]"QX#_\ !?>__)='_#Y3XT_]"QX#_P#!?>__
M "71]5J![:!^R5%?C;_P^4^-/_0L> __  7WO_R71_P^4^-/_0L> _\ P7WO
M_P ET?5:@>V@?LE17XV_\/E/C3_T+'@/_P %][_\ET?\/E/C3_T+'@/_ ,%]
M[_\ )='U6H'MH'[)45^-O_#Y3XT_]"QX#_\ !?>__)='_#Y3XT_]"QX#_P#!
M?>__ "71]5J![:!^R5%?C;_P^4^-/_0L> __  7WO_R71_P^4^-/_0L> _\
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M][_\ET?\/E/C3_T+'@/_ ,%][_\ )='U6H'MH'[)45^-O_#Y3XT_]"QX#_\
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MT?5:@>V@?LE17XV_\/E/C3_T+'@/_P %][_\ET?\/E/C3_T+'@/_ ,%][_\
M)='U6H'MH'[)45^-O_#Y3XT_]"QX#_\ !?>__)='_#Y3XT_]"QX#_P#!?>__
M "71]5J![:!^R5%?C;_P^4^-/_0L> __  7WO_R71_P^4^-/_0L> _\ P7WO
M_P ET?5:@>V@?LE17XV_\/E/C3_T+'@/_P %][_\ET?\/E/C3_T+'@/_ ,%]
M[_\ )='U6H'MH'[)45^-O_#Y3XT_]"QX#_\ !?>__)='_#Y3XT_]"QX#_P#!
M?>__ "71]5J![:!^R5%?C;_P^4^-/_0L> __  7WO_R71_P^4^-/_0L> _\
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M][_\ET?\/E/C3_T+'@/_ ,%][_\ )='U6H'MH'[)45^-O_#Y3XT_]"QX#_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
2444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img226925499_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img226925499_6.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M?<77[M=OW:;]C>YLV=6JH5&[6*YM-$1W$B2*N[[U'F;H_P#9ID=FW\5/B/\
M!1'25D3\17&H)"VQ?O4Z3SOOO]VIKC24^_M^:AM-N)(?FD^6CFANR^6^FQ3:
M1&DW-]ZG6]P\DC?W:/+2/Y'7<WK4EO;_ &C<J?+2EATES&WN4WH0M:+<72LW
M2K&H1_9[?]VO%-LX6AFVO\U6-4N$CMU5:RE**M%BJ4[VD9,D<S;&_A_BJ5=\
MTBHOW*6\\S='L^[_ !5*L;>8JQ_*U5[1*"BD3RJ0R-MLC(W\-1R2XD^:B:-X
MKCYF^:I)(U:/GYFK/VG2)7M)1ZE==+ADE9T_UE-C_P!'D95^]1;[K>X9FI8X
M_.\QJ/?Y?(KV:6X7#--%M>DTVW;<^[[G\-+Y;3)MW?-4UK"\GR[ONUE4J<JY
M43&7NC+>S\D-_=IEQ&D<GRU+)O\ X6^6LZ_D>/YMWRU%.GKS7%NM";[8T++'
MV:K+Z@L<?EK]ZLVRMVN)-[_=6K$TT?VC:J_-ZU4HQZ.YOR^Z5H;=DN'9_P"*
MI5TO[1\ZU))&RG<S;EJ./4&^XORT2CU0;R(&C^SS?[536^^-6W_Q?=J/YFO&
MW?-5J1O+C^?[W\-8RY?A"-_ME.:W6/YOXZ431W"LJ_?6F^6TC;V^[44-OY=P
MS+\M'V>2X>[=NX2221JV[K4T=PLEJJM]ZJUYO:2G']W&O]ZB/J.7NA;[;?<O
M\+4MQNCCW1T&S>2-GJ"2\\FWV_Q5G[SEH./OD?V=;AE/\7\5.O-/;R_,1?D6
MFQQO+&S)\K46<DBV;QNVZCV>J<C2/*I"6\?V>-9/[U$:,\FZ3_@-,A=O,V-\
MR+5B>;S"K+_#2J?%[I-2,X[C;R%HXOD^[56WVK,K?Q5<,<EQ'N5OEJG]C>WD
MRU9;Q9I'D+5U<-<3+OH6[2+<M0_-)\O\5.:%?+VM]^L8T;1'+7W1LTRR%G?^
M&H(_+N&\Q6^:I4C6.)E?YJ2WMXXF^7[E.7)?4OVDDM=C.9'N+AF7^&K<C+);
M_/\ ZRD:X2WD?;2QV_VBW+?Q5<M_?V,_<M[HC7'V>U55^]45G+^[=5_BI)-L
M>U6^]4WE+\K1_*O\591_N&D>;;H0QW#P_(_W*A6ZDN&;^[']VK4FV?Y%7YJ?
M]G7R]B?>_BK7H/EBY%#S/MBL7^_3?]EJT+>S2WX;[U1M9K]H8M]VL92][W12
MIRYD0^8S;=WW*CDGVR;4^9:N36_F1_*U9]Y;M:Q[JR^!!_R]LM@D=9/E_BIM
MO;O&VY?O58CC2&-69?F:HV9_M''RTI5.97Z%[2]W9D:RO'<-YWRK_#4UQ-&U
MN?,^5_X:;?;?E5OF;=4.J7$?R;EI\JYDT+FU]U"6\B2_+2Q[;/=_>:DCC7[/
MO5:BDD^SR;I/F7^&LI<WR-H_#J1M9R"3<U6;>-H_O?=I_F?:H]RU5NI)(_XJ
M4I?9F3[S5R9;>.\W.OS,M?L#_P &F[_O_C\O]W_A'O\ W*5^/6G,MQ&WE_*U
M?L1_P:=0^5/\?<_>QX>_]RE?+<6?\BJI_P!N_P#I2/9R'3'07K^1^Q5%%%?C
M9^BGYE_\'4EG]K_X)^>#4W;?^+A61_\ *;J=?@I#&EO VY=[5^]W_!T\N?\
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M<JU6U"1OM&Y%H]@FRJ?*GH2S+Y=NB_Q5%+=K'%L5=SM4ORR6_P![]Y5./?\
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M4PY+J2\CW,NU:DCADEV[ONU>U3PWJ&C_ +EX9%C7_8HWR1V;*R[6VU?M(R^
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M+=-/7>K;FJO>:LTQ152OKN:6RV/!I^^+Y/\ I"R+]U:G>1)/O+\U$<BV]O\
MWJ2XM]T*NO\ %5T>5Z]2^;WERA)(S#_9I0RR1[47:U-^T-;[49-U6/E\K^[6
MOLW<RJ<_7J-DOFCC\M?O5$L3?<?[U+]Z9?EW;:L7C>9(K*M5RW22W-+<FC(3
M9RR;55OE6K/V=_+W;ONU+'MAAW;MS-56XF>SC9?O>95\TW&QE'FYB1M/DO+?
M*M\U%Q&\,:*IIVDEIEVLVRII(_L9;_EINJ*FCMU"I);1(;>%H9%9ON5:2XW2
M-Y;;:C\QA#M9*KW%F\.V16VU6G-KL13O*9H?ZM?NU#))')'M1=KU)9W+7$/^
MKJ&2V\ZXV_=J=I$U.52YB/[0_P RK4UO(TEOM:K$EFL"K_%2R;(X=RUKS0E!
M:%1J1<A]BS,-J?+1<6Z?Q46LWEKNV[:;>77VQMJ+6M..H2^+R);>XCMHU1%V
MM2O,T?S;OO5!9V[;MK+\U&HV_P!GD0[MRU4J<7*QG*7,]-R2:/[1;[U^5J@>
M.2UCW;OO5I6\:W%OO^ZM1R2K)N7[U7&1.MK=2KI^Z2-JO1Z6ZPK(K?-4-G9[
M(':K%O<?N]N_=[5=2SC>GN5'X=$-19%D7:W^]3;R18Y-RT[RV9Z9+][[M%.G
M;0RCL3V<:2*KO\U27RI=?,B[=M-DC\BW5O[W:FV_[OY6HCKJA5.:Q-:_N[?Y
MA\U1R1N\NY?EJ\LR0QK\NZC[2EY&VU=FVJC%+W^A+]V.Q1DO)%.UFW5#)<-'
M(N[YE:KEO&LGR-][UHFC2WD56^>M(RN[=2M&TNH*OV1/D^5:8N^63YONU;FC
M^SV+/]ZH[>3[99KM7:U$;\UT3S2=^Q.MPMO'\_S+3;3?>2;XVVK523]W)_>7
M^*KD,>Z/>C;:N4>A'O*7,-6S=[AOF^:IH]/=E^1MK5-M\N-6W;FJ'[0\GR_<
MJZ,;IW+E+F8EO9LTVUOF?UJ>=?L>U3\VZH[>;[/(R_?;UIQD9]S/\U&C(C&,
MY%FSD_<[E^[51M\-PS-]UJL6H_=[]VU:+YU^6JIT]>1B]WX4/CLUN&6;^[3Y
MKS^%:CANFN%V+\JU8CMTC7YFJ>:7PL?9L:O^E;66F2:?^]W+4LFGX5G62F[7
MCM_,^][56_NHP]G+J]@CM?+^]_%4T:M9PLC?-NJOY;7"[MVUJL6D?F0MO;YJ
MZ/L6?0<I6^(DN-K6J;/O41_Z/'M7[[5')#]C^9GW+3;>X9IE^6I]G)Z$2E&-
M@6.:W^^WS5:T_=<9I+BS^;<S5/92)Y+#[K54OAU*E4YXV@M2-MD<GSKN:J\D
M;K)O_AJUYBV]NR,N]ZDMV7[/M=:JG4L91BWJ]RMY;22(RT^;S9I-JM\U'ENS
M?+]VI$L_+'F;ZU]I'1(/[Q!;V,D4FYFJY)"LD.YOF:DFV_+M:J\DS1R*N[=3
MIQOI$R^-%I?+FC5-OS+4DFS[0BLNZC['NMUD5OFIMK<+M977YO6C;S*E319_
MLUOM&Y&VK45K(MK(ZNNYJ@N+QXS\OS4^WN/-^^OS4<L[68;2U+$=QY=59+A[
MBX,2?*S?+5CR]O\ %N6K_@W3UUWQEIMLJ[?,N%7_ ,>I^T2BY(GE;J71^E?_
M  1*_8E\/_$;X?:EK7BK3H[UH9/W?F+7V3^T5^P7\/?$'PMO#IN@VL-S&A9'
MC7=NXK!_9[\-K^S9^Q#JFJ1K]G=K,2J1\O\ #5W]@G]J^S^/_A^;1[B>.:Y*
M.&!;<U?S_FV-Q^*Q=7,:,WR0D?JV!P^'I4(X::]Z2/PU^,G@M_!/Q8URP:/9
M#;S,BC_@5>@?L#^$;#QA^T=I>GZA#YUG(R[D->P?\%@?V?'^"GQ4DU%8<)JE
MP6^[[UY?_P $Y[A9/VIM)5?[RU^R4\9]9R9XFF_L'Y_+!RI9@H5.Y^P7Q"^#
M'P7^ 'PMM=:USPW!-"8]W"?,W%?/?AG]N/\ 95\:>*%T2'PE'#<,_E;S'\M>
M\?\ !1.W6X_9=LU9=P\C_P!EK\(?$&_3_&%^UJWV>;SVVR)]Y?FK\^X0R*.;
M4)U*U:?/?^9GU.?9C+!5H4Z4%9^1^V?C_P#X)S_#C]H;P')J7@^RL;=YDRFW
M%?E]XT_9SN/V7_VE+./Q-'YFE1WOS)M^7;NKZ\_X(H_M,ZQJ/CN/POJ%]<7,
M*Q?QM74_\%TOA1;06NFZQ;QK'+\SL0M=&4XS&9=FLLGQ,[PGLS+'8>AC,#]>
MHJTHGT+\./V;?A+^TM\"8[[0=#MXW,&W=M^8/MK\??VK/@?<?#?]H[4-%CA9
M+9KCRHAM^7[U??7_  11_:GMY-*C\)WUTJR2.PV.U>X_M0?\$V;/XT_%"U\0
M0-''MNEG8X^]S7)E^;3R/,ZV'Q<VX/X;FF*RZ.9X&G5HKW^MCAO^"9O[!'A7
MPM\%IM6\6:3;W4T@\T/,OW5Q7P3_ ,%0+CPOIOQ\U+3?#%M';V\;<;/NU^KG
M[:GQET;]F7]F*^TF"[A@U%+'RH8PP5F^6OPE\=>.+CXD>*KC5+IF::9VY?[U
M>WP+]:QN+JYI6;Y-HH\_B+ZOA,-#!TU[QAQV[2;-[;JL36_E;5W5''9M&S-N
MW5,VGO>1Q;?O>:J_^/5^J:6W/C+6LXGV%_P3$_86D_:+\7M-J,.ZQM=LC&1?
MEVU]Q?M">-OV=_V(+NPT/Q%X=AN[R2(9*1UW'_!.[X;6_P +/V0;?7+>)4O+
MC33*6"_-\J[J_(7]O3XP7WQ<^+.H7%]-)(UG<,B[SN_BK\?P\:_$.<U*4IN-
M*GI:+L?=U94\IRZ$E'FJ3[GZN6_[*7PE_;"^#?\ PD'A'2+>U:YB)C&T;J_)
M/X[_ +-^L?#OXV7/AZ565KRZ:*W_ .^J_0;_ ((>_%R^U>U707>3[-'!]S/R
MT_\ X*)_"/3YOVO? \R^7"TEZK/_ +7S49/F&*RG-:V7SGSQM>-]1YA@Z..P
M5/%1AROJ:7[ _P#P30T/P7\+X_$'CFSM[C:N]C(O\-=+'^TC^S3)\19O!W_"
M-P?;89?(\SRUVLWW:]<_X*)7E]X(_8MO5T-I89HX$5?*^]]VOPNT?Q1?_P#"
MX-/O)+ADOOM2L^6^9OFK+(<OK\0JOCL16E&U[*,K6+S;%4\J=*A0IKS/U2_X
M*$?\$TO#>L_"6\\5^$;.WMUCM_.557YOFKX'_84^(_@W]F?XOW5U\2M-_M+3
M_F7R]NZOV$_9_P!<G^*G[(L\&H;G_P!%\OY_I7XK_ME>'[?0_P!HC5=/2%?)
MC9N-M>CP3BJ^-C7RG%S;Y>M];>IR\14:5"5+'T5J??LG_!2O]E.2-F_X0WA?
M^F5=S^S?^U'^S?\ M2>/X?#>@^#FCNIONR&+Y:_'B/2X[K=#';JSR?*HVU^N
M7_!%W]CG3_#?P\M/&UY;QPWI.%!3YJKBSAW 91@7B/:5.;[/O]0R/,L3CL2J
M;A#EZZ'4_P#!2;X _#;X1_"+[9#HMO:W4P=8]B_[-?C-<>9<:Y>>6VV/S6V?
M2OT6_P""UW[54?C+4(_#=C)M_L^78X1J_//<L:[5^])\U>]P#A<12RQ5<4VW
M/N>3Q3B*4L9[/#K8JR1S37$<*[G>1MBXK]!O^":?_!,&;XEV?]M^)H8WL_E=
M?-7^&OD[]D7X9CXF?%BSM73S%CG5F'_ J_;OXKZO#\ OV0+J33T6SDM]-^7R
M_E;=MZUP\?<05L/[/+\)I.?4Z.&<IHUKXG$+2!X#\</B9^SK^Q_J']CZ]X?M
M[VXA7YC&JM7/^'?BA^SO^UAX9U*/0=!M["XMXF93(JK7Y9?%SXH:I\8/&%UJ
M>J74EQ^]9<2-NK&T?Q!JWAE';2;^2P63[WEMMW5MA> U]7C/V\_:=[NWW!/B
M9>UY8TU[/T.^_:H\(V'@_P"(DEMIOEK;;VV[/NUYK%;W%U)LCMII%_V%KL?@
M_P#"_P 0?M&?$2ST7_2+IKQMOG_>VU^JOP$_X)8>$?@WX"M;WQ9J=C \BKN-
MQM7_ -"KVLXXBP^2T:=*O/GGV./"916QTW4IKEB?CO>:;=0R+OL[A4_BRM+Y
M?F1[4^1O2OVWU#_@G?\ #7XOZ'<VNAZII<\DB[=T6UMO_?-?F/\ MW_L6:E^
MRE\4Y+)4DN-.+;EN ORUCD?&F#S&JZ/P3[&>/X=Q.&A[5^]$\#CM[RU5F^SS
M3)_L+3HXY+B)L6\C-Z;:_2S_ ()N?L9Z'\<OA_=2WT=N[M;X4NOW:])T/_@D
MQX,\!>)'U#7M>T^RCC?=Y4K*M<N*X]P.&JSP]1/GC^)MA>&,34I1JPV9^2$E
MO<?8T5[69/=UJ&?4)G3;#'))M[)7[4>/_P#@E5X0^*WA G0[NRV2)^[FB4;6
MKQG]GS_@DAX:^%NL:E-XNURSMU67<B7+*NY?^!5RX?Q!RZI2<W\2^R=%3A7%
M0J*/1]3\MX_M/V?S'M;B/W=::JR2?=^:OVB^*?\ P2J\&_&/X=R+X;O[(KMW
M++!CYF6ORG\??"N;X1_M"#PK=1LT=O>>1YA7[WS5[>0\6X3-'.-)6</LG#F>
M0UL&E?9]3SJWMYOM"[K694_OD?+5E;&X\QMEM-(G\.Q=U?J]H_\ P3:TGXG?
MLNS36<$,>H21!E94^:M+X!?\$Z?AY\-?"EK'XEU[2TU"3Y6BG9=V[_@5>15X
M^P,%-Q3YHNUCJ_U9Q3G&ST:W/R'6.1I&22WDC;_;7;7NG_!,?S-/_:JMEW5]
MY?MF?\$EM%U;X9:EXF\/WD"MI]LT\<<2_P"L6OA7_@G'I=SH?[6B6=Y&T=Q&
M^W#_ 'OO5O'B##9OE=>I0^RM4*>5UL%C*4:G5GZB?\%2M3D'[.%G@_?MV8_]
M\U^'MG>>9>WRM]_SVK]P/^"GT8/[.ECN_P"?;_V6OQ[_ &=O@'??M"?&#^P;
M-)$CN+AE\P+]WYJ\7PWQ%"AE=2K5Z,[>+:56KC(4Z6YYSYDUO>-MM;B3W1:M
MS6]U>1J_V6XC5?[Z[:_8OX7_ /!*CP3\(?!EK/XJU.PA?;\S7&U?_0JTO&/_
M  33^'GQL\+W-OX7UG2YIMNW=;LK?^@UVU/$C <_N*5N_0BIPKC.5-6YNQ^+
MC2?9X_N[V]J2W^U1QO\ Z'<*K=]E>K?M'? N\_8[_:(;0;^VDOK-90/-=?E^
M]7Z>?#+_ ()_^#/C?^S'::CIZV7V^]LM[!%7*MMKV,TXHP^ I4\3-7A4V9Q8
M/):N(E.E#2:W1^,<<KP[E56=_2D_TQF^:UN%'J5KZN^''["&H:5^VY8>";RV
MD>SO)=WFNOR_>KZ@_P""C_[*OA']E'X+V=U;PV=Q=3?NVRH5J6(XJPD,72PU
M%<[J+0RHY'B)T95:ONJ&Y^7L%OY=JS/]Y:I1RM=7'S?=J]JEPMYJ$VWY(Y&R
MHJE_R#Y-JKOKZ:G47*^[/+ERV=A;V-]R;&PM-DD\EMO\-0M>223?=9:L26_G
M1[ZCV;2]XRE\6Y7DU"-OEVU%'</;_-NJ>2%(5W;=S5 L;7P;Y=BU7+S;'14L
M]66]S7$.]:B\QWW*K5/;[8[=4W5#]G\N3[U<_P +9G3E33Y"OSN^;[M3QQJL
M>YOXJMPVZW#;?NUFZFKQS,B_-MH]HI:D\O\ .%Q;K"K*O\5-LX_X7I]O-_H[
M,RU-';K=6^Y6V5C4YH[E^;$M[-[C?N;Y5J&\C98VCW?+4GV=K5699-U00HUP
M^]FVT4X_;N;<L?B*EK<+9S.K?Q46^V2Z5OX:DO+59&VK1';_ &.1=U7[&/)S
M"Y;_  DUQMMVW+]VJTUN_F!MWWJMS;72JMO<>8S*S?=K*.GND4^MRO?:1YC;
MU^]4/F/;X5OFK2:Z_NU7\Q9I-NRGR_S&D?A4XHK^8EQ\K+\U.:W62/9_%3KZ
M-;+YEID,?F1[]WWJY].6RW'[1#(SYGRK_#4;V?VJZ^7[U3>3]G5F6H[>X\N3
M<:.:5KP.BGROX0DA2-=LB[MM$.WRV55^6II#]N;^[3O+7R]RM]VG]GE9GT*'
MDQF=MJ[:?#&GS>6-IJ&ZLW\SS%;[U6?]1&NVIE=Z-C]I%:=2"2-?,V/]ZED7
M['M]&I]Q9_:(O,W[6J%K/SE7<_W:GE4IKL+XKQ([S='\B?Q5%&%\O:RU;VKY
MBKNW5')(C2;%6L^9P-J=U%!'+OMY*I_:'CCVK5B\N/LNW:M-L_WEQYC)\M%2
M/\P>\O?L5[=6FD_N_P!ZI+B6.&96VTU[?=<.RMMI+>WW#:]9RC]H5.7+J)<+
M))\\?RBG>=)Y:JS5:AD2/Y/O55U"Z^P_,%WUGS:B^/W8E-KS[/<?,/FJW#>+
M-]Q=K4R&Z2^CW,FVB.^2'<NW\:):IZ'3S24.4IZIYF[--5?,MU_O5>DC2X_B
MW-5::W:/Y56IE%2B',HOD&"-[=E56^]3IMMO\S_-3EE9?E9=S421>9'\]9PY
MK.Y'+(:RIY;.JU1CN)))/E;Y*O2?Z''_ ,]-U-M]/W?O-VU?2JY8\NH2C-:C
M+?=<2;:?<:6\:[F.Z@?-<-M7:OK3I)FDA9=U<TO[I+E*_O&?_9;22;RU226*
MQQKMJ(,_F;=VU:?)>-YB)]ZG/FN;RC[Z<1OVA;-MU'RR;G_O5+JFGK)]UJJ-
M=+8QJGWJN4;K8UIQ?(Y#H]J[E5?E_BI\<:3_ "*NU:8W[IE95SNI]O>?Z5LV
MUEROYDTZDG[Y6O'\N955:9?R$1[F^[5RX=?,;<OS4OV5;F'=4U-9IR*J:ZF/
MN6/:R_Q58FMW;#;OEJ3["L,C?Q4)N:-O[M36O\9,:+MN1V]O'<2;%7YJLW"_
M*J54CMV5]ZM2W&^V^?=OJ*D91:5S3EZS&W4?V-&W4D>HJT>U5^]5JW5=4M]S
M_+5:.Q1+AMOS5E&UVIERJ19"T;6<FY?XJ_87_@U!+&;X^.S;MP\/?^Y2OR#>
M19+A48?C7Z__ /!J-!Y%S\?%!W#'A[_W*5\YQA)?V14_[=_]*1Z>0ROF$+>?
MY,_86BBBOQ0_2C\U_P#@Z./_ !@)X._[*!9_^FW4J_ B:-EN-J-]ZOWO_P"#
MI\L?^"?_ (-V_>_X6#9_^FW4J_!FSV>6V[[]?K'!<?\ A/N_YG^A\+Q!+_:7
M'R(9(W9=G\--MX4^;?\ +3KJ=HTJ17BDC7=]ZOL)5+;H\+X;,:VWR6"_-3H]
M0W1^7_=J7R8_LK;?]94/V/;&&7[_ /%6<8\UA\O-L2QW'G2;7^6ENH?.^1:2
MW\O^/[]2)NCN-W\-=7*H;(SC[HZ.T6WC7;\S4V.5OXEHN_,_AJ/[/,5^;[U$
M?>ZF<N[ZDTFR/YF:H?MOF2?.OW:BN%?Y5;[U3R1PKLW_ 'JT]FMKG1$M0_O%
MW?=6KBV_W67YJJQQ[K==G2G274EO]W[M9[72.>6JNF%U<.&V[:9\UTNU_EVU
M+'<)<1[OXJ)+A%VJU:>\[=":<D];6(K>\DM9-NRIK>3[1=,[<4R16;:W\-.M
MPTDG^S6GN[R,Y4XD\<C7&_=\OI4*MY,FUONT^\N/L<B?[5.F19(=U.6L_=V)
MYERW:)/,^V1[?X5J&WWV\FU5W4U;CY56/[U6/]7\S?>IQE)>YT*Y=FQMQ=31
MMN"_-5[[$MU;J[-\U9MU)--\T=36^H21;$?[S4<L^C,Y:R:CN3'?#^[7[M/L
M[/RI&>I5F2&15?[].DN493L^]3ES-:=2M_>&W4RK&R+5?3[-+>9I&?YJC%O)
M))N_AJ;[')LSVK:GRP]V^K*J1:1/8WBW$S;ONU-<;-VY?F:JD<*1_=JQ')&J
M;OXJKWHRT,:DE;0KPWBS2,DGR^E3"'S/O?+3FT])/G_BJ:WMVD.UOO?PTYU/
M+0TYDX^Z5KBX^PQJJU9M[=6@\QF^:H]4TMVC7^]4D8;[.JUM*,7#<YY2^R,\
MMI/F3K3[>W:X9F?^&GV_[FVWT6ZR2,S?PM4ZN-BXT^XDEPODLFZI]/?RX_F7
MY:B:S1?F;K4KR)]G55K6G_*+EARZ,3R4B#_-]ZI%_=V?R?,U5RO\521R-_!3
MY>1;F=/^5#HY7X^6I+AEDMVV_>J%;IX9/F_&K"20R1[A6DN9+4*T92=D0V<<
MD8W,M6(YOW;+4;7$GW4^[3K-?+#>=]YONT?(?+9:C8Y)I&V*ORU<N+-9+=?[
MU.CVPINJU\DENS)UV_-1S<TD+127F9\*M#$RHNYJD$;R6ZM_'_$*+>1EC?\
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M\F?L91117XF?HQ^:7_!TPN?V /!P_P"J@V?_ *;=3K\"KBZ:&X5<?+7[Y?\
M!U!G_A@#P;M_Z*#9_P#IMU.OP0DN%*_=W5^M<%RC_9]G_,_T/A>(*EL5]Q.N
MVXC^[4:Q[=U6-/D6XAV?=J+R]EQM;[M?81I^[8\&4O>YTA(Y/+^;M4TFI+]W
M91<,EO(J+\U1_*?X:GFM%,G?WDR2,K+(ORTMQ&WF;5:HKEFCC;;3M,7[1\K-
M^-:>\O>Z![-S5QXO/F1=NXU--O@DVL:9;VRV\C,OS[:F\S^T/E8;:>D5>QSU
M+<Z:"X5+BW7:NUZ=9QIY+/(N[;1'I_EJWS_=HM]0:2-XV3:OK51E=61O&[;3
M(_MRW$FR/Y%J2XO/L\:KMW5#';K;O\K5:CO$B^\NZKG&/V14N6,]!MG(G]S;
M3;RS:.17W;EJQ_KH_N[:;<1_=7=NK2-34Q]H$R-<;'3Y47[PIOVC]Y\J_+5J
MWVV]OM^]NI/,_A\NLXVGL+VT%JR5;=;I5WK]VH?]7?*C?,M274GF1KM^6FV\
M2S2?,WS5M3E%2%+EC\Q)E6UN%=5^7=5N\FCN%38NVJMQ&6^55W;:;;[T;YEV
MU4J=VN4=.,5&\AWEM'4,BM<7",OWJO1W'M388_O/_%3IQO'EV9EK\18%NJ_.
M_P S5#:Q^9=/_"M364/VS[[;*;)9LS[5^55[T_S1I4T=F%S<*?D6K$>Z2WV;
MJADM_N[?FIUNSV\C,R_+2CR6B3]GE17^:27;5B2/[/\ [5$$BW4C-]W;4\97
M_>KKEV9,H\MNI"DK6RLS_=I;&Z>XFW5)<?Z1\JU)I]NL?S?=J8\MB8U+0;9<
M/[Q6S_=K+CWW%RRKPJM6E>?NX]RM5%9OFV[?O4\/+^8SIQO'FD6F7S/W:_=J
M&3S+-E'WEJ223RH-J_,U36+>8OS+\U7&2^%DQE:)!N:2^1?X:GN-OF-&J[6I
M'M_WFZE6-9/FW5-.,G[PX^R(7A>SW;_F6G1S+''N5=M7))$O(U5?F\NF26R_
M9_O5U:/<CF=M1GVB.ZC5=GS59LU2&-E9:@MS]G5OEHMY&W?,M3[/F*C4]ZQ8
MM[=9+AOE^6B2S:.969MRU)#<)'\N[YJ;-\BLRMOW54:G*'->\$/D7Y=W\-/L
MY_L^[^ZU0JO^A[G^5J+.;S-R[=U5O=P)Y;:LDCV_:/\ 9J:;R\?=W5!&ZM-M
M;Y:G;3EM_P!XK[V]*TC3D',TR:.U6./>W\-0_->3;E^5*=9W#ZCN1UV?PT^1
MEMSY:T2,^51E[Q/;[I(_F;<JTS[<DAV;?WE16DC0R-\WRTVXM?MDGF)\RT1B
MHZRV'4CT-)=C6?R_?JCY+R2,NZFV\<EO\V[=[427#M(NU?E_BK2/*949?9+U
MG9[8]F[YJDCD2UW*R[JS[>1S=?[-:31HT:[FHE3Y-7LS.IS0F56DB63:R?-Z
MU8CN/W>U6^6EN+-)+-OF_&JGEM';JOWO]JM-'K$TIU$X79)'#]GW-]ZECN!)
M]U?FI([CRY%!^;=5I;=([CS%_*MMU9AS-:]2:&Q$<>YOF\RH9MUO+L5J?'>M
M\R-]UJ9'I[1W&[=NJHQ:>IE[R5[$2J]O)N9MU6&;<RLM#6ZQR,S/\U,M;=Y)
M-_\ "M3*I)ZB]IIRE^VVR?>^]5*6S?4+AU9OE6EDO'CN-R+N6GW%TUNJLJ_,
MW6M(TYWMU95.7N^Z.T>S6WU*..1=R;UW5^W?["'Q?\)_##]E.%Q=6=O>-8,&
M&]5;[M?B1I_[QO,W5J6?C3Q%'OMX=:O(;9?^6:.VVOG>(L@6:)49RLHGI93F
MOU&HZEKW/2/VX/'D?Q@^+%]<2-]H6&X?8=W^U7D-EID>EW%K<QIM>.=6S5[Y
MIM[23>9(WWB:C\QC)L9?EKW</A8T:*H+9'E8C$RG5=4_;7_@GY^UOX?\<_L_
M0Z!J5Y;PM;6@@_>R*O\ #7QU\0KC1/AS_P %$-/N;.XMVL=VYG0KM^]7Q#I?
MB[6]%A=-/U:ZM5](W9:J+KFL75Y]JN;^XFNE^[*[-NKY+ \%PH8BM5A4TJ)Z
M>I]!7XCE7HTX2CK _H+U+XL^!OBA\-+6QU2\T^:/9MV/(/[M>4VO[/?P/TO4
M'OI+/17.[<WS)7XNVGQ,\4>9Y:^(=01%^[^]:K&J?$#Q9\NWQ%J#)_UU:O'I
M^'LZ$G"AB7%,[)<61J_Q:6I^MW[0/_!3OP%^SAX.F\.^%[&.":-"BM!VK\[O
MA_X@O/VJ/VF+'6-;U!6T^.]65DE;^'=7ALVI7FK'??74ET_^VVZETRZNM#WO
M:W4EJ_8HVVOILLX3PV7X><:+_>3^T>3C,ZKXJHIU%[D>A^XW[1G[4WA/]FW]
ME:2+P[=6:S1VRJ$@<;L[:_%?XD?$B;XA?%*3Q/)(Q>2?S>?O?>K&O/&7B#6H
M?L]]K%Y>6[?P2.S+522S^SQJR_-[5T<,\+T<I4[OGG/J/.,YEC%&VBB?L=_P
M2D_;5T?Q3\(YK#7+R.!K?Y%$KK7Q_P#\%=/AWI<WQ$OO%FE7EK-;W#_+'$59
MJ^0M/\1ZOH</_$OU*XL5_B2-F6I;SQ1JGB2UV:EJEQ=)Z2.S5QX'A!8/-)X_
M#RLI="L1Q#]8P2PU:.J,_3]DVG[F7YMM.M=OV/[OS;J;#)YDFS;M7^&I;A?L
M\.W;\M?:<LN;0^=CMHCZ_P#^"87[>\G[.'C%K36Y9+FPO,1(N[Y5K]$/B19_
M"/\ :6FL]6U6/2Y)F3=^\9=U?AO]J>WMT>/Y'7[KU+_PLCQ5\HCU[4(47L)6
MKXO-^"88[$_7L//V=3R/HLMXEG1I?5ZJYT?L5^T)^W)X(_9'^$;Z-X8AMT=5
M9%^SLM?E)XL^,%S\3/C(NMZM(US:R7'F['_N[JXW4O$&J:Q;_P"GZA<7W_71
MMU5[&/S/F^[MKT,AX5P^70G=\TY[LQS'.JF,LW[L(]#]:OV7_#?PA^*GPCCD
MU&PTN.YVJK>;MW5Z-I7A_P""?[/D<FM+I^DR36Z^:FS;N^6OQEM_&6O:7#Y=
MCK%U;1_W(W95INJ>//$VH6ZQW&MWTR>CNWS5X=3@&K7JRG]8DH2Z'=1XFA"/
M\)774^OO^"B?_!3-_P!H._?1-!>:ST>-?(DBS\K5\9:3:M>:U9VZ-M3SUW?]
M]5%)NEC9G^__ 'Z=I<C6\G'WOX37VV5Y/A\OPWU?#JR1\_CLQK8BJZU;5G[8
M?L'^/O!_P/\ @:DC7=G'-);K(X#JK,V*_.O_ (*F?'RY^,_Q_GN+&YWZ7MV[
M WRU\[V_CSQ-\T::U?1V_P#=#MMJ)M<N+JZV7#-<-_?>OG<GX,IX+'U,RJ2Y
MVSTLPX@GBL)##0C9(IV\S?*C?=6I9&W?*K?+3;JU5I&96^:H[6S:/YV;YE[5
M]G&,?BB?.RM)W&S3/I\\,D;;7C?>M?H)_P $\?\ @J\OPTLXO#?BQIKZ"XVQ
M1;F^55KX#DMUN/F=ME+;[H_GC_=O']UQ7DYYDN&S+#_5\2KGJ97F5;!S]K19
M^V_B_0_@S\>]NK7-GI/G2+N^=EW5Q/CJ_P#@E^SGX3O)FTG2[IYHFV>7M;;7
MY'V_CSQ,OR1Z]?0IZ"1JBUGQ1KFM*L=YK%U<Q_[;LU?$4> :D)*'UF7)VU/I
M*G$T9KF]DKGTCX/_ &]+#X??M'V?B'1;>2UT.SG^>W3[K?-7Z.:7^TI\,?VU
MO -K_;%M9CS!NVSLM?B3'IZ6Z_+\S5:L_%FMZ/\ )8ZK=6L?]R-V6O6SC@G"
M8UPJ4&X3A]H\K+^)ZE",HU%S0?0_;#0O$?PD_90\-WVI:;;Z:LT*[QY++NK\
MT?\ @H%^VY??M0>/Y$L[B1-'W[?*W?+7@5YXX\1:I;M'<ZW>31M]X.[50M[-
M;=<L^YJTR+@NA@*SQ>(J>TJ=V+'\0SQ=-8>FN2'8_5C_ (),_&/0_ _P]O+>
M^O+>%_L^%WN%KXK_ ."LGBBV\:?'*.:SFCFCW=5;_:KPFW\1:QHP_P!#U:XM
M5;LDC+67JEY>:QJ"RWUS)<O_ 'W:MLOX7CA<TGF7/=RZ&E?.O;X18/ELD?JU
M_P $D?C)HO@KX9I;WU];PO\ 9]OSNJU\??\ !6OQ%8^./B8MS8RQS(KM]QMW
M>OG6QU[6M(3_ $'5;JU3T1V6H=0U"\UC_C\NI+I_5VW5>7<)PPN9SS-5+N70
MQQN?1JX-8-K8_4C_ ((X_&?1?!/PBAM[ZZM[>38W#NJU\O?\%"O&5CXN_:@L
M)K.2.9&U'<I1MW\5?*^G^*-:\/MY=CJEQ:Q_W$=EJ[X/UBZU#XE:+-J%S)<;
M;A69W;_:KFH\*PPV85LRC._/<JMG4JF#IX51T1^]/[.'BF/P)^S/'JDB[H[>
M -C_ (#7D]QJGPA^.'C22ZU2PT]-2C?S6>7;NW5TGP]^)'AR/]CV>VDU2W67
M[-]W=\W2OQW_ &@_&&L1_&W5?[-UJZMK;S&V^6[*M?F?#/#<\PQ5=\[IR4MS
M[#-LZAA:-'F7.F?I]^W7_P %'/"7P-^$USX1T..-YKRV\B%X&^6/BOSK_83^
M(C7G[42ZQJMQ_K'W;W;_ &J\6UC5+_Q%\VH7TEX\?W3(VZJ>GW%UHMQOLY)(
M7_OHU?J65\'X? 8&IAH/WI[R/D<=GE7%8B-5_8V1^Q?_  4=^-^A^+/@)9V=
MG?VLDGV?:P20-_#7YO?L9_M7WW[*_P 8([YII&TM9]SQ)]UOFKR2X\6:YK'R
MWFL7DT:_P.[;:S[B\'F?PLWK4Y7PG1P> G@9/GA,C,,ZKXC$0Q-+1Q/W$?XQ
M_"G]L/X>V=]K%KI_F7"JS"5EW5REY\*?@9\(]VL-INCW"6OS[4V[FK\<-/\
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MYSC*7_"/52[Q_P#2D>SD,5]?A\_R9^P=%%%?ANI^D'YI_P#!TI+L_8%\'?\
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MPT1W#/\ -_=K+V<E$Q]G:5UL1_V:K77S-39+=K>9=OS5-\\DGF47$GF!=O\
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MYVM7B_[0%YM^.VO?-_RU->Q_\$NW#>#59?1J\._:(N-OQZU[_KJU?&Y#3?\
M;F*4NWZGTF:6664>4R/M;4?:VK-^TBC[2*^X]B?-^T.]_9_N?,^-&@_-_P O
M"T[_ (*A7"_\-!QAO^?9:S_V>[C_ (O9X?\ ^OA:U/\ @IW9K+^T'$S?\^R_
M^@U\OB(I<04K_P C/7HR3RRI?NCG?V U:/QW<LJ_+NKT/]MRX\OXD:;_ +E<
M-^P/#Y?C2Y;^'=76_MS7&WXF:?\ [E'L^;B#7L*G*7]E:]SSG[6U'VMJSOM
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M_@X?]5!L_P#TVZE7X,1Q-_$:_7>";_V:[?S/]#X'B*-L9>_0/F5MT/6EW/\
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MOYZI7Y I]_<WR[:_7S_@U-E\R;X]?]R__P"Y2OD>,M<IJO\ P_\ I2/9X?\
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M/:IXN%>'LJVJ9^&OQ,^&]]\&_&%]I.H0M;K'*R1;U^\M8RCRX]K?=]:_3_\
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M+7P7B5D7]I9)4IQ^)';@?9U8SP[ZG1Q:HRR3(WRM&[+2_P!J?[5:GQ\\%O\
M"_X@/9O\JW3>:N?[K5R0O-P^]7^?F*<Z-25*>\3X2K>G4=*>Z-AM08?Q4G]H
M-_>_6L=KK'\5-^V?[5<_U@Q]L;']I>]-^W_[58_VC_:IOVIO6I]L3[0UO[0;
M^]^M'V[_ &JQ_M'^U1]H_P!JCVPO:&K_ &AO'RTGV_\ VJR?M-'VFI]LQ>T/
M0/@/KTD?Q&2W9_W.QN*_/C]MCR8?VDO$3JO#3M7W'\)]2_L_Q\DQ_N-7P/\
MMD7WV[]H#6Y-WWIVK^J_HTXB4Y8FC)Z;GT>55KX5KS//?,61EV_*/2K%OY/W
M=NVJZV:S,K[MNWM1)'^\^5J_K+;0Z91@XMK<=);LMPK?[53W%XTGRM]VH(Y/
MMDBKNVM'2ZM(R;?E^;=MJ_>YM0][2+/JC_@D_P# 5?BQ\4+J_ND5X]%9;E=_
M^S\U?9_[7GQH3XD>)M/MK%MEOI<7V=A_N_+7E?\ P2?\-K\-_!>L:HZ[6U"T
M;_T&LNXNC<>(-2=VW[KAV^;_ 'J_BOZ1/$TZV8QP$'I'<QSK%.EA88>/7?\
M0U(YMM6H;SA?FK'CDJ:.;YE^:OYQC4/EXU#>@O/F^]6A;ZAM/WJYR&XVM]ZK
M=O>5TTZQTTZAU5GJ7R_>K2L]6QM^:N/M[S_:J[9WW'WJ[:>(.FGB#NK'6/N_
M-6WI^N?[5>>V>H?[5:UGJG^U7HT<4=]/$'I.G>(-FWFO5?V;-:^U?$RQ7=7S
MS9:QY<>[=7L'[.]Y<VLBZM9HUS-;_=05]+D-9U<93I+JSWLKQ$IXB,3\VO\
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M]Z=J^5X8C_PMXJ7E^I[^=2_X3J)SVXT;C245^@'R9U7P+O/L?QDT%_[MP/\
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M$_\ @I1>:!<;I-*^TKZ/7W']E<3*',K7^1Y<L;D[ERH^4?'7[(?BWX=W#_\
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M&-8RD8RD/:XIFXTSS*3<:S(YB[X7E\OQA8-_$K_+1_P4@MUNO@/-=-_KN*/
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ML<9G;O;[)Z^'R?#X;WIN\CZR^%?_  68\0_#O6-Z27GV.-_]4&;;7T]\.?\
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MD]C7?)=]3\+]'\%^)DB3_B0WR_+_ ,\FK2D\!>))FW+H=XO_  !J_7:/XM?
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M^F^I_$'_  4Z^-DD;(GBJZV-_MU^<2^C1A/:_P ;0XOJ>3;VF?>VJ? _P?\
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M9"M?4X7'X?$17LIW]#SJV%JT?=JJQ](?\$L[=KK]I#P]\N__ $Q/_0J^RO\
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MN?M&?'2V^&?A^'PCX;:/[,T7D7!3^%E^6OG6/5VC7YG9CNZFOB\OP.(S&O\
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MP'I>[_H&_P#LM?B=X@MTM_$^L.K?\O3_ /H5?E7!T;U,1![*?ZGVN?:*E/\
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M,NM3[H,5E?$C_@G%\*?VAO@Y=:I\.+*-;DI^[/'6OB;_ (+$?'36_%/Q6O\
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M1[?Y8\+MKSNU\6?*OS5_-?U.6-KUL35U;DS];6(6'I4Z,-K(]DM_''W?G_\
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MKQ_,K-5B3]Q]SYJ=#>*R[7^]73[35<I/LXRD5/M7V:%G9J^QO^"1_P"PO?\
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M>,/BI;0ZMX7U#3;.UG5_-,17O7:?!?\ X+!^-_AW,_F1V\B2/N_>+NKUB?\
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MEM+[+[,]#*\Q>$K*HM8]2Q^VI^S%<_LS_$AK>VCDN-/O/W_F[?E7=7C^E_\
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M\_>+TC+Y:NR_=JM)J'VR38J,[?W16KX;\/:KXXO$MK"PDN%D^7*+7V9^R/\
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M;M:.IEV^7M5M[57^63=_#1&M_.*49?"MB/[8TB;335D?[5#<)\LEN=R'^ZU
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M14W]LU_%/%7B!C<]Q+JUI<L.BZ(_KSAS@/"93AU3I1YI]6=L_B3=_'3?[?\
M]JN+_MFC^V:^/^O'TG]E':?V_P#[5']O_P"U7%_VS1_;-:?7BO[+\CM/[?\
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M>93HY/FJ.H[J3R[=VH^T!B?M!ZQJ4?PP*67F+\W\%>%:8OBJ\M5\N&\D_P"
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MXK^G?;T>Y_%GLY]CR[RE_NTWRU]*] O/V3_B)9_?T.X5?]QJQ]0^ WC32_\
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M_@'#Q7#V&2[%KSFH\YJJ^=1YU>#S'UOLRUYS4><U5?.H\ZCF#V9<\QJ^:O\
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MG3IQ;OV*]FTA)KS]XJ?Q5^Q/_!J%.TA^/2M_"/#P_P#3I7X_1VZ>6S-]^OV
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M:29O^!5T1S2B92P-4_,_^T;?_GJM.6]A;[LBM7WYK'_!'&QAS]F29JXC7O\
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MTC>RUM:'\,_$7B"1431[Y=W^PU &317K'A3]B?Q1XID1?LMY#N]4:O5/"?\
MP2C\0ZPJ.\\B[O5:QEB*:W9K&C.70^3IKKR?X&:H?[49ONV\Q_X#7Z'>!_\
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M]#^!?@WP,0^GV,:.O^S716LMMI_S6J1AO]VH8]06'Y73?45YJD-O\[JL<?\
M>-8_$:&K_;5UG;NCV_[M0W'B21?D;;NK/M_$%CJB[;:\AD?T1J=';^7\S\M4
M\I7,31ZM<2;F5OD_BIO]K?OMRTV34!;_ "+'NW4Z.9%CW>35!S$DDBQKO_B:
MGV^H/,-K-\M5ED\P?,ORT23+)'M'R4!S%IKEL;6;Y:;\T>Y8_E9JI^:\:[?O
M^].CN&;_ &6H#F+2V-];_O&?Y:)+Z/\ Y:?,]1_VH\<.QCNIT?ES1[F7YJGE
M#F'_ -J++3/M%Q-)M5ODJ-HTD5F7Y:([CR_EJ@YB=E%OM=OO4R2\2X^;^*HX
M[S[/]_\ >+4=QJ"?>5-M <QUWPY^+FO?#/4%FT^Y:--WS?-7U!\,?^"A]G!:
MQPZQ)YDGW6KXQCO&N(]NW;38]/"MO_BK.I3C,J-:4#])]-^-?@7XRV"PW4<,
MBR?WP*Y[Q#^PM\'/B7N>XTBSN&D[@K_A7P-'XTU70]OV.YDC^C5T&A_M >*M
M%C^74KK_ +Z:BG[6E_"G8J4X3^.)]0:__P $8/@GKF[_ (DL*[O]E:YYO^"%
M'P5>3=_8]O\ ]\UY'IO[7GBBW7Y]0NF_X$U;$?[;FN>6J->7&?7=75',LQAM
M59E]7PC^*FCUS0_^"*/P4T==O]BPM_P$5V7AS_@EC\&_"Y4QZ!"Q7Z+7S?<?
MMLZ]Y+(MU<-[[JQ=4_:\\3W\>$U"Z1O]ZIEC<?+XJK'&AA(_#%'W1X8_9B^'
M?P[7S+/3K.W\O_:%:VI?%SPKX(MMBM"J1_W%6OSFU#]H3Q9>0ONUBX;=_MUA
M2^//$&L?-<:E,_\ O-7'*G4J.\Y<QO[:G#X(GW_XE_;M\+Z'N56W,M>2?$C_
M (*$2:A&_P#8EPT;?PU\GS7$M]N\R3=_>J".-(Y/E6B.'BA2Q$CM_B%\=?$G
MQ N'?4+II(V_VJY'[8DGS-NWU']L^RR99=Z^E-NM01MNV/;6W+$RYOYBU'<S
M;=RM2-JCV_WF^:JL-\TGRJNVHI-0TV*3;-J%NDG\*%OFJN07,6X[^:9OD:DN
MM4;:JO\ ?IGVY+==RKN7VI8[Q)MSM#NHY0YAT<BW4>]OX:DCU!_NK]VJOVAM
MWRIM6I?.7[NW;4\H<Q/)>-']UOO?>I#&N[>GWJI^88V8[M]'VQF^7&*H.8M_
MV??7#;UD^6ECNFC;9<?-45OJ#V_\?RT6EPMQ)EUH)///&FH0R>+'MT^6J'W*
MK?M-V-QX7T;^V+-&D=I/F"?>K,^'_BZ/Q9H<.UO](C3YT_B6OYW\0N&ZN"Q?
MUV"_=S_,_M#P;XTH9GED<NJR_>TM+>70V]QHW&DHK\W/V@7<:-QI** %W&C<
M:2B@!=QHW&DHH 7<:-QI** %W&C<:2B@!=QHW&DHH 7<:-QI** %W&GV\;32
M*NZHZYOXJ?$2'X;^$;J\=MUQ&NY8_P")JVPV&JXFLJ%!7E+8YL5BJ.%HRQ&(
M=H1U8V;6&USQPVDPMNFA;=7O=GJ#V>@VT,WS/&FVOG3]D?0[KQAX@;QG<I(L
M-U]V-UKZ(_M!+F9OW/RJU?U9PUD7]EY?##/X]WZG\#<?<4?V[G%3%0^".B]$
M+;W'VQ=C?=I\5Y]E;8E1W%U^\^2/90MPL?WE^:O>Y3XOF+4=TWW]WS4QMEQ\
MS??JHSM]Y6S[4GVQL_<9:GE#F+<EM=7O^I;:JT*9K'Y;AMRU#;WDD?S+)MI9
M-0^T7&UOF6CE#F)8]32.3Y*62\;_ )9_?IDBQK]U5J.2-;<_>W-5!S$\<;W/
M^N;=1]L2#Y*@^T-)_'2C5$D7:T?S+_%4\H<Q+'<-]U/E6G?;)(_OFJ7]H>7)
M\J4K*UTN[=MHY0YB:36))&VK]ZI/[2DCC_??,M0V\:0+NV[J;)J2W$FSRVJ@
MYF9OC"X\[29IF^Y&NZO.]/OEU"W:5&^7=7IOBB/^U/#=S:QQ[7F7;7SYI/CS
M_A$?'C>&[I&3^+S7^[7Y1XE<,SQ%%9AAU>4-_3N?T-X&\94L+6EE&+G:,_A]
M>QWNXT;C2?*WS(VY/X317X,?U@+N-&XTE% "[C1N-)10 NXT;C244 +N-&XT
ME% "[C1N-)10 NXT;C244 +N-&XTE% "[C1N-)3O]7&\C?*L:[FH S_%VJ+H
MWA>ZN&;:T:\5TW[/-X-4\)QZI_&WRYKY[^(7C2Y^(GQ4TW1]+9GLY'V3[/F6
MOJKP)X/C\!^%8;$,K;5W5_1'ASPO/!8/Z[B/CJ;>A_'_ (V\;4L?C5E6$=X4
M]_4V_.FN)&WMN5J/M"V/RK5?S3_>IT>I)')Y;Q[_ 'K](/PGF)?MGS;E^\U.
M^U31_P 7RU2N-059/E2GBX:Z7^[0',6)M8:/Y:;#J%Q\S,WR5#'"L<FYOFIT
MFJ+'\GE[JGE#F!M47S?DI?,6WD6X3Y9/O4R69(X]JP_-ZT6\G]Y?EHY0YCU+
MX/\ [5OB;X?W$<?VIEM=WS#=7U%\-?V]]#U2WCM[]]TW\1KX+N)%F^7[M1QS
MS6?^I^5O45G*BF:1K-'ZF6OBWPK\6]*:&;[/+%,/X\5YA\2/^"9'PC^*@D>^
MT.!Y)/XQAJ^&M!^)WB319%:WU2:-5[!J]*\&_MHZYX7C1;J\N+C;_M55'V])
M\U&=BI3I5/XJ-#XH_P#! _X?ZG(\FC:7;HS?=KQ'QA_P;Y7@WG3[6%1VKZP\
M-?\ !2'[+;KYT4DC>]=5IG_!22PGCW/:UZU+B+,Z7V[G'4RO SZ'YM>)/^"
M/CR,-]ECC5:QO^' _P 3/[L=?JE9_P#!0W1[A?FMPOXU</\ P4 T5$_X]\_\
M"KMCQEF:['+_ &!@F?D^_P#P0)^)F?N1UUG@W_@W]\83LG]H0QLO\5?I/?\
M_!1#2((VVVV[_@59%U_P4HL(_NV;4I<7YG-6T*CD.!1\V_"'_@W^\-VC1GQ#
MI]O(/XJ^K/A#_P $R_A'\!H8[BRT>WCFA&6=L5Y_XK_X*/F[1EMXI(OI7C?Q
M$_:_\0^*I'6WO+B-&[;FKR\1FV88C^+4=CLHX7"4O@@?8GQ*_:[\+?"/37L+
M+:'C&R/:ORU\7_'3X\:A\6-<DN))F>U;M7#WGB2\UJ1GOWDN&D[FJL;;?X/E
MKSZ=%+WC:I6E(M0WC^6JK]VG"Z?[C?<JOYRR?*OR5'YCQ_P[EK8SYBYM:/\
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M:M>2W>/[VVOQ>M1J49NE5CRM=#^B:-:E7@JM"7,GU1'11169H%%%% !1110
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MB>3?UC;:M"ZA]G7_ &ZIQZ@T<GW?EJ5;A9/FVT<H<PL<K[F9NE2?NY/N_?\
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MS5F7>?NU-/!RJ)S02K<LK'U0WC"XCD99+C9]:6W\227DFW[2K_\  J^4W_:
M\1?%3Q1=6=AI\RVUNWR2I_%3;?XX:Y\,_&%M:ZE:S1V<GWY7^ZM:?V=/YB^M
M,^K9/%DUE)L>;:M2_P#"9B1?GDVU\]_M&?M ?\([\,['6M/;SDFD7YTKSF3]
MI3Q#XXT^V72=/FN?D^<Q_P -%/+9RCSB>*2=CZ2^/GQ@?P+\/WOX;KYU;LU4
M?V?_ (U7'Q$T]7FO/X=WS-7R?\:/%7BR\\%LE_874=ONZNK4?L_^)/$EJT"6
M=G</&WWBE=G]G1^K^9C]:?.??3:]<?>\[<OM4=QXN;R_FN52O(?$'Q+OO ?P
MON+YH6FOXUW+$?O-7B7_  N3QIXPMGODTFZC7[VP*U<-/+W(VEB+'V?9ZW<7
MGS0W.ZI)=8NK>/=)<_+7R5\ _P!JC5;CQ(NDZK:R6TDC[%WUV'[1/[15SX'A
M_L^QC^T73?P#[U$L!-5/9V#ZQ'EN>_1^,/,9E^V1_+VW4-XHFC^8/O7VKY1T
M_5O%3Z?:ZDMM=?Z1\S)\U>P^%_B@^@_#N;5=5C^SO;K]QZFI@^32.I4:USTY
MO%G[O=))Y?UIJ^)Y)I-MO<JWTKY2N/VB->^+GBFXM-/L)%M8_N2Q_=:JD?QY
M\0?"/Q9:VM_9S?9KAOGD?^&M?[.G\R?K1]:2>*+R.XV-(U-;Q%=2-L>1F6N=
M\'^,(?&^BI?VS+)&R_?%:TF[;\JUQ>SY=S;F9-->?9I-NW=2IJL/\<>ZJT=Q
MY*[=N^G>6LWS?=:@>I-]L1Y/E7:M3M-YD=4X;99/O';1-)]G^Y\U N8N;E7Y
MFI)=422/Y4JJJ^8=S-MW4DDD<<FU&W4!S%NUD6Y^[\K5-Y+IRS[EK%DFFCD;
M:K*M.^UW'\2M0',:7VI&DV[:4W4<?\/W:H+NN%_NTYI%L_FW;VH#F+7]J1W'
M_+.F_:EW?(NUJKQZHUQ\OE[:61?)7>O+-0',2W&H/'*J_>J-KSS)/F7BHUN'
M9ON;J?,OF1_=^:@.8?)<+I^UE7=N]*DCUB%_E>.J<<_V?^'?4GEK<1[ONM0'
M,3_;(Y&^5=JU,+C]WM6J4=ON^]\M+)-]G^ZVZ@.8M_\ +.C[<C+A5^9:J1LT
MR[F;;1(R0_=?<U <Q9MY%N)-J_*U6/LSQ_>?<M8LDTD<GRK\M'VRX_B5MM <
MQJ27BQR*FVE^T1Q_P[FJA&S3?>I_RVZ_?RU <Q;74HY/X*CDNH_,^1=K55_M
M1I&V^7MIWD_QK\S>E N8L7%X]O&O\50R7F[Y=M0_:'\S[FZI9/WD?W?FH'S$
MLDBVD>]5W-1'JT?\:56\[R?]KVI_F+<?>78W\-+E%S$TE]#)]U,+4\=P[1XC
M1G^E7?!?PQU3QQJB6\-M)Y+?QA:^H/A!^Q_8Z);PW-Y,KO\ >9'K@QF84,/\
M;U/4P.5XK%?PXZ'SGX%^$VJ_$.Z6.&WFA\QMN2M>\> _^">>J:A CS7,:_6O
MH?PYH^D^%;=4AL[?<O\ &%6MC_A*O+_U;;%]FKY^MQ$Y?!H?3X?A:T?WFIY1
MX?\ V"['2U7[2EO(U=1I_P"Q_P"';7:LEG;O_P !KL/^$M?_ )Z-_P!]4W_A
M*&_OUR?VQ-]3K_U=AV.7O/V1?"\L>U=/MU;_ ':Q]8_8ET6\C;[/;6Z-_NUZ
M!_PE#?WZ/^$J?_GI4_VQ/N5_J_'^4\-\1_\ !/-[Z%OLTT*5XK\5/V,]8^'<
M;S*[7 7YOD6OM[_A+7_YZ-_WU4-QK%KJ,3)=0QS+_MUTT^()Q^(YJG"ZG'W=
M#\Q[[[?I,C)<6MPNWN5J!M0;Y=W\5??_ ,1/@7HGCV-U6&WMF;T6OE_XX?LO
MW7@>1YM/CDNT]EKW,'G6'KNVS/ QO#^)PZY[71Y&MRD4>]5^:B/74=OGCJ&2
MWN-+N&2YC\MU;[AI_P MXWS+LKV#P-2>2^AE^XFVI+>X\L_+5/[/Y;;:DVK;
MQ_*VYJ YBPG^L9MU'VA+?Y67+>M58[AIOE;Y:)-D:[F?YJ YB3[0))-NWYJN
M1V[_ ,,GRUD7#-Y>47=44=Y<?W6H#F->XF^S_>^9J3[0FW=BL^.X>3[ZU+'&
MJ;F9J YBW_:*;MOE4V6ZA_N55;5/+^18\^].7]_\Q^6@.8F-XWELR_=6H_[0
M:2/=4<DSK\JI2Q[I%^9=OM0',2KMC7>WS4V/6%_B3=59]RMRU2^9]H^5DVT"
MYBQ)J$,GW4^:I+>X7^&J+6_EM_>6I$C6./=N^:@?,6_,W29I/MBV;?,N[=5.
M.X:;Y6^6G-&BKN9Z YB:2Z7S-NVK$=N\D>Y'VUE22-(NY%W4S[9<1]FH#F-:
M23[/'\_S-38[A&CWM6='=22_*RU*L:[MS-M6@7,6O[42/Y?+W4274<GS;*J_
MVI]G&U8]].5UN?F;Y*!\Q-'>-_#\JU'_ &@TBLW]VJ\DCQ_*JY6G1NS?>3;0
M/4FCD68;ROS4+JBQMM9=RU78LK?W:D^U?:-JLFWWH)YB=M3MV^['\U+#=+_#
M\M5Y+=8_F7YJDBMT6/<S[6H$69#YCJU'VI+4[V7=5*.=C\M.\M/XWH*YB6YU
M!=R_+\K59AA:2/<C^76;))YF[9\U5_M%QM^56H%S&T_^CK\S;JCBN$DC;=6?
M'<2-]Y6J18UD;<QVK0',7%ODA_@W427D+*W[NJDM]]EX1?,6D6;[9]Y=M ^8
ML1W']SY5J/\ M!I)&7^[4<DC6_RJNY:(9&_B7;0',20LMQ\S?PT2:HMO)MV[
MEJO,K;O[JT[[1YB;-F[WH#F+7]J6\D?^K^:B&X7=N6J_V3^)?FI8[=?OLVV@
M7,6Y)/-VM0TBQ_.WS*M4VNB)-JK\M/\ +5_O/\M ^8GFO%V[U7Y:DMXVN%W(
MVRL^210VQ/F6H3<3*/E5J!<QL/NM_OMNJ..Z21FW+6;'>32-\RM4G^LVLS;*
M!\Q>;4(X?X*/[125=WE[J;I>EWVL7B0V-LUSN]%KZ$^"_P"R&NO6<-YJ3?9G
M;YBCK7'BL91PZO49W8/+\1BG:DCP?PWX;U+Q9?+;VMK<(K-MSMKW+X=_L#ZW
MXJMTF>Z\M6[/7TAX#^'>B> [=46UMY&7^/:M=9'XECMUVPKY2^U?/UN(KZ4C
MZC#\+2C_ !6>+^'_ /@GM'IZI]L:&9J[/2_V-/#UG;[)+.W=O]VNW_X2QC_R
MT;_OJF_\)0W]^N"6=3>[.^/#L%LCF?\ AD/PDT.UM-M]W^[6?J'[&?AZX_U-
MG;HW^[7;?\)0W]^C_A*&_OU/]L3[E?ZOQ['COB3_ ()_IK$++9R0PM7D7Q*_
M8/UCP?&\RW'G+'\V$K[!_P"$M?\ YZ-_WU39?$4-TNV=%F7WK>GGTX&%3AF$
MMC\T?$FCWWANX:.2SN-J_+G;5.W_ 'Z[O]6WO7Z&>./AQHOCJ!XVM;>%F[[5
MKYO^.'['[:/;O>:7(TS?>V)7LX7/J%5VEHSP\9PWB:2YX:H\+\MHUW.^ZH?M
M"R2;?NK534-/U30[QX;RVDAVMM^>DC/VB/[VVO;]V7O1/FY<T?=D7/M"0M]S
M-*=0CF7YHZIM<+9K\OSM3/[0:Z^5DV50<Q86X59/W:[:;)J#"3;U:F2+Y,:L
MOS-3(YG\P?)\M ]21;CS)-C_ #5))J"V_P!U=U0W$;2?,/SJ..X\GC;OH%S%
MN/6(9%^:.A;R.1OE7Y:@\E9EW?=;THCM\2?,VV@.8O>=YT=-\O\ =_,U59)O
M)^Y\U D\[[S;: YBTUXDB[57[M%O(MQ]WY:J2,D/W7W-5:222.3Y5:@.8VC;
MO'\S/N%5VO%\S;MK/6\N/NLK5-&WF+\WRT!S%UKB./\ AW4G]H1R?>CJIN2W
MCW;M[4S^U&N/D\O;0',6OM">;\B[:2XU!H_O?-4$D?E1[E^9JC\QY-OR4!S%
MC[1YCJK?=:ON/_@C5&L3_$8+_P!0S_V[KX9F_>1_+7V__P $7OO?$@;MW_(,
M_P#;RN/'_P %G5@OXR/N;=11BBOGSZ ^5/\ @L%*L?[-6ALWW?\ A)K?_P!)
M;JOS>2\>3<$^9:_1S_@L8H/[-&@[O^AG@_\ 26[K\V8XY(_F#?+7OY;_  3P
M<P_C$WEONW=Z=)))\O\ =IOV@]=WS4W[0W\5>CRG"6%CAD'SM0LB6?\ J_FJ
MG&V[YC]VGKK5K_JU7YUH GDN+F/[B?>J-;B:/YI%VU5FUAO,PO\ P&GK?/)'
M^\^:@GF)S<(VYG:BWO$D^5:@.H6W\<=$FK6?E[HT9:"B_P#:4Q]ZFOJ"1K_M
M5GQR-J'W/EI[1K']_P"9JGE L_V@TGS/PM3><MS'\S?*M9\EPFW;CY:=;V\E
MQ]UMJT<I/,6([Q=WS?<IWVQFD98_F6J\MFT:[6;Y:9'&ZM\AVT<H<Q9?>W^]
M28FV;=M-^U-G[WS4BWC_ 'F;Y:H.8G6-).';;2QR)9_ZOYJI>9YDK5)'K%M'
M^[9?GHY0YBQ)<7'WD2D\ZX^\Z[:IW&L-')M'W:6/4'D7YV^6CE#F+;3K)]]M
MM0PWD:R,JMNJ)=0MU;:ZTLFH6>W<B?-047OM"1Q_>^:F_P!H)%]ZLV.\6^DV
MI\K5+Y/E_P"L^:@GF+?]J.\GW?W=>(_M[7#7'POL]OW//6O9/,6-=O\ #7GG
M[2G@>3QY\/VAC7/E_/6^%?+64B*NL&B?]F?6+>X\"V:1MN\N(;J]'6Z7S-L?
MS5\C?L:?&1?"?B#4M%U;<K+)Y46_[M?4D>L6VU7CN8=NW=]ZKQN'E&JR*-2+
M@<-^U9XHF\-^!Y%W;/M",O\ X[7FW_!/OPK')H.J7SHLTGGLWS_-77?M4:A#
MXV\)R6]O^\:U1F;%<-^P/\1+;1]'O]/N&\N1IV7Y_EKLIQ_V-\IG*7[Y'T?X
MX\+V/C+PW<V]U;PQ^7$S+A:^8_V;=07PWJ'BVU1V:-965:^@OB9\3+#P?X?N
M)))HW\R)E54:OG?]F>./4)/%EY<1MMF=G3*UGA8R5&7-L56DN=6(OA7X'A\2
M?M"1W4B[F]#]VOJ#QQI_D^"=0MVM85CC@95^7_9KYV^"NH?9OC9&R?=KZ&\>
M:I-)X7U3<WR^0W_H-3C)2]K ,/R\C/FG]ENZ\OQ)?:6W_'O<7#;A6#<1O\*_
MVK+Z[3Y+:9MJUK?LRWD=O\2)MZ[O](;_ -"KJOVX/#=MI^FVVL6<>VX\U69Q
M7?*25?D[HQ^QS=CI?VIO'BQ_#^WLT?\ >:I!\O\ M5XU?:.W@O\ 9;D61=ES
MY^[_ &J@\0>/&^+7B3PE:PLSK:[$EKUG]JSX=M9_!/RX4^7Y6P*5/]URTY=6
M#]^\CG/V??V@?#_P_P#"EJ[21M<R)\^5K*_:L^-ND_$SP7<QV;K]I9?EV+\U
M:W[-7@[P!XX\-PV=U:JM];I^]+_+7I&L? OX?Z7:M<-;PLD?;=6=2I1IUN:S
MN5&,W"USYM\5SS?\,NZ#9S,S-YJKS7T+^QOX-L_"OA-9(5CF:X16;>NZO/?V
MO]%TW3_A3I3Z5'Y=KYZ[17JO[,<;2>![9D_YY+_Z#1BJG-A^:/5A3C[Y+^V0
MRR?!V3]Q&J[NH6L']C?]WH_RPQM\G=:U_P!KQY)/@W(FW<V[M7.?L9^((?L?
MDM)&C1K\P<US4[_5'ZFDOXAZOXXT_1X[=[_6G6&WC^]_=KAM0_:<\$^'=/>V
MTV:W==NW[M>9?MK?$+4O^$TAT>VD;[!<+\^/NUV7P;^!_@63X9PWFJ6\;W+)
MN;+54:$8TU.H'M&Y6@>):MXXM?%'QVT>YT]EV_:-S;/]ZO1?VF/A_KEOJB>)
M]/M_.=57C^&O./%UKHFF_'328]!C\F)9]K?]]5].R?&#1]4U1/#-\/GV+NS]
MVNNO4<91E!=#&GK=2.9^"/[5^B2:79Z7KSPPW2JJ;,?Q53_;9\5V]Q\,;J.Q
M?"2+N797/_M+?"/PQH.D_P!J:4D:WD:[U*-WKSG2]4U#QY^S?K%UJ"R27%N^
MQ,K_  UG1P]-S5:/<J51\K@SL?V6_CAX>^'W@.S:XDC^V;?GRM,_:8^-VB?$
M[0)OLSK]I5-J;%I_[*_A'P+XP\&VMGJ%KMU)5^<O\M>LWGP#^'^AV[W$EO"Z
MK\V-U54J4H5V[.XH\[A:YD?L/ZI>6_PCAMYMS?/WKV^WO5;<J_\  JY/X=V^
MCVFAJVCP^3:_PBMQ69Y?W?R[J\G$2YJC9UT](\I=DF2W;Y:3[8O\#?/5?[#(
MOWFIGE_O/E^]7/RE<Q<D\UJ8OF1_=7Y:CCNGCX=J&N'^ZK57*',3+ND_UGRT
MHM;>-MRM\U5I+AI/EW41WD.G_--S1RE%K[9))\J+NJ.2XNI6^Y\M0S:PFW?"
MNU:CCUB23[K?+1RD\Q<^T,ORM44UQ#&R_-\U0R:@D8W/\U*NJ6.WYT^:@.8M
MV]PD@W?PT_[8B_[M9LFI0_<C7%.CB;[S-\M'*',7&U1ND?S4ZWOL_*WWZI;D
MC^95IGF>9)N3[U <Q?DD2W;<K?-3?MB[=V[YZ@_L]]NYVIDD/_?53RE%MY9)
M(]VVFJKQ_=^:H8II(?O-\M'VA_X6HY0+$<CM)\_RK2_9[?&[/S56DN&V[6^]
M1'.EG\TW*T<H%K[0WW$7=4<DETW"I4+:Q"\>^%=M0QZU-)(RHVVJY2>8N1W3
M)\K_ "TR:XC7YMWS5#]J7[S_ #4?VA8D?.E <Q<AN(Y-NW[M.DNECDW+69)J
MUNK;8U9:ECC>9=ZM\M <Q9_M3RV;9]ZGVU__  O]ZJGRQ_[U1W%QW3[U <Q?
MN)(XVW?QM7H?P9^"MUXXO$FO(V%NK;L_[-9_P5^$\GBG4$N;Q-UMU7=7TMX?
M6V\+Z>EO:KL51M:OC.(.)H87_9Z/QGZ-PEP74QUL7B5:'YG1> _"^F_#^R2.
MU2-OJM=!)XD#-NW;?I7$_P!O?[5']O?[5?G53,9SES3>I^L4LEITX\E-61VO
M_"1#^]^M'_"1#^]^M<5_;W^U1_;W^U4?7#3^R?([7_A(A_>_6C_A(A_>_6N*
M_M[_ &J/[>_VJ?UP/[)\CM?^$B'][]:/^$B'][]:XK^WO]JC^WO]JCZX']D^
M1VO_  D0_O?K1_PD0_O?K7%?V]_M4?V]_M4?7 _LGR.T_P"$A_VJ+C7([RW>
M.1(V61=O-<7_ &]_M4?V]_M4OKP?V3?='#_&[]GNS\00R7U@FZY^\H%?-NN:
M7<>&=0>VOE\MXZ^S(_$&WY=WRUYK\9OA3:^-K)[BVC7[5]YC7UN1\5\DU1Q+
MT[GPO$W OM:;Q&#7O+IW/G&.X>X^[]W^&FMO^]_%1JFEW/AO4)(9?E56Q3/M
M38W;OFK],CRSCS1/QNI"4).,]T/_ 'G&Y:>T$,OS._S5!]H=>M1QMY?SO]VC
ME)+GVKR?E3YEILEQ=_PI4/\ ;%M-\J#:RU7;7)!)M5JHGF+BW$D2_O%VM1)<
M1R+N=JK?;'D_UGS4L>I6OW73=1RAS%BWO$9=NZI)+A?+7:?FJC-JMIC]W'MH
MM]UY)\G% <Q=DU1?^!?PTQ=49I-TGRU7\L1_?^9J221)%V_Q4%%^21)X]S?\
M!J%;M3\K?=JO#;27"_>^6B2W\M?F^:@GF+:WSR?(OS+3/WF[<WWJK1QR1_,K
M<5-]L9OFW?=HY0YAY>3^):D^SQW"_O#MJ#[4Q^9ONU%')YC,S?=H#F+:R);_
M "Q\K227%Q_"ORU#_:UK_JU7YZAFUAH_E6IY0YBXMQ-'_K%VT-<1R1_.V*J?
M;'D^^VZE_M&V63:Z;J.4.8EM[R/<PJ?[0FSK5*XU&S5?D3YJBAG^V2?)\M4'
M,:4FH+''4?\ :4DTFYUVK5:6-8_E:AIAMVM0',7_ +0CK\WW:B^V+NV_PU5A
MMY)OEW?+2R6OE_?:@.8M_:<MMC^9:23?(WS54CC>-_D:I?MC'[S?-4\H<Q)F
M2I(XTN%_>-MJOY[R#=N^6H_,\Z3_ &:.4HM^8EG_ *OFDDN+AN53Y:A_MBVC
M^1E^>H;C5VC;:GW:H"UYEQ]YU^6C[2K1_.U5H]2DD7YF^6C^T+>-OWB[J">8
MEAO(UEV[MRU:CN$5?F:J,FI6/E;D3YJB^U+=-M2@.8T?MR+][[M-;5&D;'\'
M:JJP^7_K/F6DDD2,_P"S_#047_M"W$?S-\M0_:EMVVK]VJL$3S?*OW:DDLVB
M^\WRT<H%A=0_AC^;=]ZB17D^]]VJBQM'\R-MJ7[0_E[6;YJ.4GF)-TB_+M^6
MGQ[)/ED;;5:.=F;;N^5::TGF25/*',6PL=FW[MMU->YFQ\BYJ#^UK:U.QUW-
M3+C6%A3<GW:KE#F)_M%Q'\\B[4KIOAW\/[[XA:DL<4;-#NYJA\,_#=UX\UQ(
M=K-"U?47P_\ "]CX#T]%MU5)MOSU\KQ!Q!2P,?90UFS[7A7A&MF<O;5-*:-/
MX1_!W2OAS;QR(JR3?>^>O1I/%"R?=VK]*X?^WMW\5']O?[5?FE;-)U9\]5ZG
M[-AN'Z6'AR4E9':?\)#_ +5+_P )$/[WZUQ7]O?[5']O?[58_7#?^R?([7_A
M(A_>_6C_ (2(?WOUKBO[>_VJ/[>_VJ/K@?V3Y':_\)$/[WZT?\)$/[WZUQ7]
MO?[5']O?[5/ZX']D^1VO_"1#^]^M'_"1#^]^M<5_;W^U1_;W^U1]<#^R?([3
M_A(O]JI(_$B_,K*KJWK7#_V]_M4?V]_M4?7 _LGR*/Q8^$.E^/+.2945;G;\
MH%?*WC[P+>> ]8>*XCV6Z]Z^MX_$'EMN5JYWX@>#[#Q]8.MQ'OFVU]%D_%4\
M//DK:P/D^(.!H8NG[7#JTSY&^U0K)N5L[JG^T))\W\-:7Q$\-P^!]6D22)MF
M[:ORUS?]I1W'RHNVOU&C4A6@JM/5,_$<3AZF'JNA55FC2CO5W?[--DU1L[4^
M9/XJJ+;LL>[^&E\Q(_N_=_BK<Q+D.H*T>P4V2X6W^Y][^*J?S2-NC^6I/L+Q
M[69J.4GF+/V],;D;YZ&DDD^9E^]5.2W_ 'GR4];B2/Y6:IY2B;YX_N_-3K?=
M_'\M0_:'+?*U-DN&^[_%5 69+>WC;>K_ #4?:I)/N+\U5([R&Q.Z;YJ=)K""
M+?'0!,9KJ3^"G&XS]ZJ,>LR2?=;;3_MJQ_,_S5/*3S$TEQ#')N5OFJ:.Z215
MJI'J5C(OS+\U0OJD,C%45JHHTOMBK)39-4;[L?S?WJJ6]N\D>_=\M#,J_<Z_
MQ4$\Q=M[P;=N[[U?<W_!&#;YGQ(V_P#4,_\ ;RO@O<LC+Y?RM7W=_P $5H7C
M/Q*+MNW?V9_[>5P8^/[EG9@?XR/NZBBBOGCZ(^2?^"Q\>_\ 9GT$=/\ BIX/
M_22\K\UQ(WF*F[;7Z1_\%G)VA_9DT%D7<?\ A*+?_P!)+ROS4>X\Q5_AKZ+*
M?X)\[F4OWQ;DT_R?F\SY:K37GF?*J_=IC2>9#M5]U)'<-;_+MS7I'G\Q8C;[
M1'\K;:A\E;>1FV_-33-]G^=OEJ:WN!=_>^5: YAUO>1W'R^5M:H;BX:UD^[E
M:=/^[^Y3%U!I(O+V;J YB?S86C5MGS-35N(X9-OE[JJKO\SYOEJ:2X_=_=H#
MF+2NOWD^6HY%:/YBV^L^XN)(?FA^=OXJDAU"0_P[J YB]#(DGWEJ20,WRH^R
ML]FD#;E%/CW_ 'F^6@.8MQV;XRTFZAI/+^6J=Q<21_-&NY:=]H\V%=WWJ YB
MW)I_\?F5!)>_P*NZHXY%\IEWU&LS6[;MNZ@HLQS+,FW[K5%)"L,FYA\U-W>7
M^\/RU)#>+>MN;[M #K>\CN&V,GXU'>3-9R<+O6I)-JGY*C^V[?DV[FH)YB:&
MXCFC\QDJ.2YCBD7]WNW5#)OW?=VK4L<_[O:RT!S%H+'Y>]-J-22;OO,VZLV>
M1E7='\S^E.@U!UC7<OS4$EZ.=9/EQ3KNW2ZMVC;YE9=M49&D:165:?'OD;YO
ME6@KF/(OB)^QVOBV^>ZTFYCL+B1MV]*YB/\ 8U\:6<>S_A*IO^^Z^A+B>2'_
M %>YJ([YY+?:WRO75'%U$N6YC[.!P?PW_9WN?#.GR+JE_P#;FD3#;VW5Q'CS
M]CN\U#7/M&@W_P#9J[MS"/Y:]TCD7_GI\WI35D>WDW?>J8XJHG=,KV<=CY_T
MO]CKQ))>+_:7B"2ZA5ON.U>N>'_A/9^%_"\UA;QQI)<)M9Q7227#3_.QVTZ/
M4/M,BJM%3$3EN$:<4>8?#W]G^3P7\0%U62;S$]*])\66_P#:FEW5NB_\?",E
M7)MOE[5^:JT>H-;MM8;JSG4E*7-(J/*O=/*/A'^S7)\/_$#ZA-<^9NEWXKN/
MC-X#C^*7AO[!M5&_A-;TC-))N9=JT]9FC7:!Q52Q$Y3YWN'+'EY3PWX'_L5S
M?#/Q!)J%Y?+<JS[T']VO;_%'A^'Q1I+6MPJR1[=NPTV2X9MVUN>PIMO>2;=S
MK\_I14Q$ZDN>9,:<5[J/"?$'[&FJW&M27.BZK_9JR-T1MM6-'_8]\56>H1R7
M7B22XMU^\A;[U>Z2232;2NZE\V27[VZM/KM2W+<7LX'FGQ4_9@N/BAX'L='2
M^6%K-U?-=E\+? 3_  OT&.Q>3S&C3;NK8N))(U_=LVZBWNGDC99/E:LI5IN'
M(]BN6/-S!XH\*P^.-">UN-K*W8U\_P!Q^QGKVC^*I+[3=<:VMY'W>6C5] QR
M*K?,^UO2C<T<FY69J=/$3A\ Y14OB/-M8^ ?_"2>$WLKZ19M29=JW#_>6N-M
M_P!C_P 3Z=;K#'X@D^SK_!NKWMI&N&W-\M+'J66\M6W54<556B)]G$\ L_V,
M[JU\::;JKWF[[&^Y_P#:KJ_BU^S7<^-KS[?IMU]CN=NW</O5ZY)M\OY6W-4$
M>HM;R?-5?6ZCDG<GV:V/GC2_V0/$EY?1MJ&N27%O&WS([?>KV32_AGI6B^$7
MTI;./RY%VN-OWJWI))';=C:M/CN&7^'=4U,1.6Y4:<4>#>(/V,]0U369+G1=
M4_LM6[)\M.TG]C_Q99:A')=>)I+B&/[R9^]7NDDS;C\VVH[>_F&[?N7^[5?7
M*G<7L8$?@S15\+Z/'8M\VWO6MA5'RMMJB\TEQ'NV_-1'YDOWE^[7*67OL\DG
MS>=2M^Y_BW54DD=8_E^]3;>\?=M==M!7,7(X/MR[M^VHY&_L_P"5FWU 9%63
MYGVTR;_6;E;=0',6([CRY-S+]ZBXM_,;GYEJ+[2UPJKMV[:/[05?W:_-0',/
M6X6U^39N6I+B0>7O1?PH:-?+W?Q5 ;AK>3YONT!S#[/4$D.V2/;]:?<20_>5
M*ANKAKA=RKMID,C1_P"U0',6K:2.X_@V-4DD.[Y5?:M49)%W?>VM4<=Y)YFU
MOE3^$T!S%U;CRVVE:GCV_>^[5'[0]Q_#1ND8;-M <Q<^SR3-_KOEHDC:W_BW
M55^:./[WS4V&\D63:Z_+0',7(5^V;EW;:;)'_9[;F??5;S%\QMS;5I+C=)\R
MMNH#F)/MG[SS&7Y:?<1^:O\ >6H/,::/9MVTL5XMK\F[<U <PJ3)8K]S<M3"
M1+B/>B[&HCVR1[F^]4$EQ]G;=_#0',$.H?OMKI\M3W$D/\*5!-<->?,J4R-F
M#T!S%F&XAN/E\O;MJ;;_ '7VK5"23=_LU UY-'<;=O[OUH#F-!I/+^\NZNE^
M'/A5?%&L1_+^[W?-7*VLDVIW"0JFY6;;FO;OA;X73POI>YOOR?-7RO%F?0RW
M"63]^6Q]WP#PM5SG')M?NX;GHOA^UM_"^FI;1JJLJ]JN?VQ]*YG^U3_>I/[2
M]Z_!:F,J3E[2;U/ZIHY53I4XTZ2Y5$Z?^V/I1_;'TKF/[2]Z/[2]ZS^M,O\
ML\Z?^V/I1_;'TKF/[2]Z/[2]Z/K0?V>=/_;'TH_MCZ5S']I>]']I>]'UH?\
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M7$575J/5G]<8'(J.$H1P]%62.G_MCZ4?VQ]*YC^TO>C^TO>N;ZTSK_L\Z?\
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MRU8^T/<?+M^6@.8O1;=ORU]U?\$4L[_B5EMW_(+_ /;RO@=/,7Y-OWJ^]?\
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M26\<AW;:3[/]D^;^%ONT<H"QF:3Y7^[1)=-9_*M(TCR?=;;38[J/[CKN:CE
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MBQ[;G[U+'JWE_(OW:2.\6ZD976@6:2*VW[U !)<22-^[^]0DCR?,WWEI(_\
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MZM1>6K2'YMPHDW6_^K^9J ".X>.3YE;%6)&63;M^6F1W#W$:JZ[6H6-/NLU
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MO,[*V)J<7<54,MA5E3P_(G%)VZ'RC\8+KQ/I-]_9_B!V:3=\U?8W_!/N18]
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MS;_=9?+\ST<K_P!YC_70_0VBBBOC3[ ^,?\ @N#<1V_[*_AYI%RO_"66R_\
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M<1SO*(X.L_WU+3Y=#2\RCS*;17YB?M0[S*/,IM% #O,H\RFT4 .\RCS*;10
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M?Q5!;[OXEHN+A?N[=K4 +<3-']W[M26TWR[MM5X[IXY/FC^6IKBX\Z-55-M
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M*R?(NVC="OS,/FH MKK3QK\T,;+_ +M->\AN/F:&/=_NU5DNE;Y1]VF^<D=
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M\S<TFU:E74(XE:-&W;J %DO/F^5=WM4B[9%W;=E0V\?V?YV^]3MPNC\S;5H
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M;JVUI-JU-'9VL,>])-[^E $,G[OYU2A)/-7=Y>RG1WC6\C,RTDFI-<?*4VT
M']H+;_>7=1_:"O\ P;:([>.9OG;:M2S+#(ORM]V@!D=PTDVUOSJ6.W625MSK
M4+,DD/S-MJ"2-?EVO0!<DV*VQ6VK44EG]G;<K[Z@VQR)M9_FI]OY-KRS[FH
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M5H N?94MX]N_=43-Y9^YNIOVBWD^7?\ -4,FJ/"VQ: )H]TGS,NRIO)62/\
MUFVJ:W$DWWUVK3O,CW;6;;0!+&J2-M9JGV)&FW?5*:2WC^Z_S5$)&N)/D^:@
M#2^T1QQ\U!'>?:I/N[-M0>3_ '_EI))&V_+0!?\ *21=S/3?EW8W;?>J-O'<
M7'R[?EHDMWC^5_EH O;?WVU9-R_WJ)+/_II6?&)D^Y\RU+YC?>:@"9H63[II
M_P!G:XC^:38U0QW#L?\ 9IC2O))_LT 6ULUMS_K-U-D;;\P3<M1_;+?[K/\
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MQ(R[?XJ +8TL?>\[=39(P/F7YFJ".\2'_6-MHDO$C^>,[J '23-]WRZ7R_\
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MOS+7SO$W$5'*L-[2?Q/9'UO!O">(SS%JE#X([L[#]F/]E/1_AGI=O?W]LO\
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M>J+%\C)NJ9O+DC^Y\U :C;@*L>Z'[M1V]PDWWZ/MGV/^'*^E,N)/M&UD7%!
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MU"^D;;<6[(OO5YKQ;=MRC=4]YK'VR15?Y:B:WA^]_#0!'#J7VC=O7;3&D?\
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MJ+<OF?[- #;RX>SC80IO:JFGZA?R3;9K=D3UK5CN(=VY?O+3[S6&DCV,J[:
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MNW;3OW</R_QT-/\ ]\T -BO/M4FQT55]:>TS6_W/FIDEQ#)'N_BIMO=(#MH
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ME^]O56KW+PO\$?!GAN-5_L2Q++WV+7RN(XQPT':DKGU6'X*Q<]:KL?CGX?\
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M"\/W6J'_ $B23Y6KZ(\$T8UCC7YF^:H9/*,C;V^6J_V>3[[M\M/\A9?F;[M
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MN[Y:9N\S[U/:W:1?E:@ \JWA^9'W-5FW^S/_ *Q]M5HHXX_OKN:D^R+<?=H
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M4B6\?RH]0?V?YGS)\M"V;+_%0!8\QIEV_P -'V-/+VM563SH_NM346XD^\]
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M_EFNVG?;*SY)OF;YJ;YW^U7\6>WE+WC_ $8CA8P7+$TOME'VRLWSO]JCSO\
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MR2?,VY:ADD2W^ZU-7=)\U2!8DO47Y5%51;R3/N5]JU+Y"J=V[<U+)(T?W5H
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MQ]WYJ=_:'DR?W:O4"O/I<D.W][_O5+"K0_,WS+4_GQR?>?YJKW-XUNVQ5W5
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M=7\J;_PD32GYH8S^%%%'MI]P]A#L<]XG^%NB_$JV:/4+.,K)UVJ*^+OVW/\
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M3^G^%&\^I_3_  HHKC/0#>?4_I_A1O/J?T_PHHH -Y]3^G^%&\^I_3_"BB@
MWGU/Z?X4;SZG]/\ "BB@ WGU/Z?X4;SZG]/\*** #>?4_I_A1O/J?T_PHHH
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/?J=YE%%%?G9^C>TD?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img226925499_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img226925499_7.jpg
M_]C_X0P517AI9@  34T *@    @ " $2  ,    !  $   $:  4    !
M;@$;  4    !    =@$H  ,    !  (   $Q  (    ?    ?@$R  (    4
M    G0$[  (    )    L8=I  0    !    O    .@ #J8    G$  .I@
M "<0061O8F4@4&AO=&]S:&]P(#(U+CD@*%=I;F1O=W,I #(P,C0Z,3$Z,3D@
M,#,Z,#<Z,#( <G(T,34P-#<      Z !  ,    !__\  * "  0    !   "
M6* #  0    !    W0         & 0,  P    $ !@   1H !0    $   $V
M 1L !0    $   $^ 2@  P    $  @   @$ !     $   %& @( !     $
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M  GK+0PV9;,9C<Q[;<@3O>QNUIU.V&_R6;4B/%3824>Z8'W%OA!^^?[D%/\
M_]#TOIS0,=Q!!#[KG:?RK;';?[*SNK'-?U#IH:/2]][9:T6M'Z,MQ[K'$,?5
MMMV?0_XJQ:'33^KO!=N(NN!.O(L?XJGUC%%]] M LK#<B026PU]7HN;(/N;[
M_>@3_;Y?I)!HVW,.ZN^AM9W.;L8YCG\O8X!S'_UO])_PB)CE];6TVDEX$M<=
M21YG]]JI=/R2_'%=^T/K##8:SK6]S&O<7U_X*M^[U*O\'Z7LL]-6;"]U#?7E
MVK7"V@$Z[A#FL&ZS_P ^(_R_WD$</]WH?#]V7]9MI*NVYX<  +F09>TC<(B
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M;R!0<FEN=&5R #A"24T$)0      $+$+LA1R*S[S1:T8MBF!8FHX0DE-!#H
M     /<    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O
M; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E
M;D)I=&)O;VP     "W!R:6YT97).86UE5$585     H 00!D &\ 8@!E "
M4 !$ $8       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q 6             IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ !@     0 ! &     !  $X0DE-
M!"8       X             /X   #A"24T#\@      "@  ________   X
M0DE-! T       0   !:.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         !.$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$         @  .$))300"       &
M.$))300P       # 0$! #A"24T$+0      !@ !     3A"24T$"
M$     $   )    "0      X0DE-!$0      !     "   "0    D
M.$))300>       $     #A"24T$&@     #10    8              -T
M  )8    " !& &D 9P!U '( 90 R #,    !
M  $              E@   #=                      $
M            $     $       !N=6QL     @    9B;W5N9'-/8FIC
M 0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M        0G1O;6QO;F<   #=     %)G:'1L;VYG   "6     9S;&EC97-6
M;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG
M          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI
M8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI
M8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M    W0    !29VAT;&]N9P   E@    #=7)L5$585     $       !N=6QL
M5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M 0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
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M971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M  $! #A"24T$%       !     0X0DE-! P     "N,    !    H    #L
M  '@  !NH   "L< &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$( #L H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q
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MR/YZ.T?SG_@N_P#E_GI*;F+DC(:Z=H>PPYK';A_G;6(Z!A^GZ(]/?M_X3?/
M^CZ_Z38CI*86O+ ([_#^+FJE=GVUWEOMV-:U[A W0?I>[U=JT$DE-!_6*&-W
M%CB!'!9WX^D]K?\ I(]&5]HJ%E0TD@C0^;==S6^YI_-5A))3EY&)8ZVUS<5C
M@XM<';1),>]W](9^\_\ <415ETN%M&(UKP8.C9V_^Q/[RUDDE(*[,@UM-E</
MU#@(['0_SA^E_70;+>I!S]E0+0Z&&&F6^/\ 2&*ZDDISWW]5$%M (G40V8G_
M ,,M_-5RA]KZ@;6>G9PYNG^=[7/^E_61$DE/_]D .$))300A      !7
M 0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    % !! &0
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MH8]H[LW%)5)BL?N/:U15U!J-OQ1@"L0!)&-B0+"'V[\#.J>\NA?C3\G/Y>^
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MJLKC,3)02;H6G=6Q5-0P8ZE\,<:/IDDD4LW3F2^077?87\IO>&8^('?E=1?
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M8?\ '"'_ ))?_H_W[KWY=>]^\P_XX0_\DO\ ]'^_=>_+KWOWF'_'"'_DE_\
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M\=[>6=8S6I6*FH#%*Y&.%>) K1HJ.U,53;AR^$DP6XFH<!NW!;'S>Z81M^?
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MB%HS^&Y^G'^<Y'OW7ORZ][Q>8?\ '"'_ ))?_H_W[KWY=>]^\P_XX0_\DO\
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MB!38*6MI%R62DK]FYS;N6@2CB?D&I,-V&M6]-M@1%6660*@"]QQ2K 'U]?\
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MI):#;])V#L*FW/*(ZJ.C*R[<K]QTF<IV\[K8/3H7#*1<'W=W"*Y8@(JEF)&
M!Q)-*?X>B=[8K97%^]Q"EG'"9)"SH-$:?$[ FH'F:_;URJ:F"C@EJ:J58:>"
M-I9IGN(XHD4N\DC $)&BJ2S&P ^OLT7SHR?:?57RH[=ZWW_ALIC\4U=B'KME
M;AH104];A\GMK$RT^1QU5XWG03+,QI:^GD;Z$ E"\7M^,S1&2UN"S2QN596
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M/,PA4Z(^9'%O&MN$C_P]^\^O=>]X_,?^.</_ %*7_BGOU.O=>]^\Q_XYP_\
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MO&4E$E/Y)GA$,+Q9&O-58P$ZSX3S]/;8J:UZU(BJ$TN22*\*?Y3U[VG/,_\
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MM+D_\*DA<_\ &&/7KWY'(]IF3:F[H1KFVMGXXS^EY,#6(AO_ +6U"%/MYED
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MSR4S1QW$,0RN5D6G,,0X55D"K^!;V7V=K-=^);;=:S7#1_%'!#)*R?-A$C%
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MXWDR97;+MGN(!Z4M>PWT>XM?RK%M=E:SR=G:ICC4EF(;B:9!;-2234DGQO\
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M\G_]'>_8ZU7Y]>]^U5'^KJ/^3_\ H[W['7J_/KWO)*U0'X>?],7T+@?YM/\
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M++X3>NV V]#11[V3')_'<ED,5U]N3:V8J<?N.FF7,4@DD6C2MDJ8UC/VBGW
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MM[C7"76_"Y3"%6 ^2K<W*J/L"J% X   8 Z-?<>9;GF SQX1D:GV"XG"C\@
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M17%Q';OKA0T0\-0\OL_G]@ZEF/,,1:HD_AIC_#U[V(?7':>=ZOJLF=O9'[[
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M-=>]\A'+XW]+?YQ?]5;A)+_VO>^O=>]\?'/_ $F_VQ_Z.]ZJ/7KW7O?O'/\
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MR&$Q&_</D]P9REV_BJ*+*-/755+EJQ;SXFOHX85@PN/R=8TLCU0 M'IYY/\
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M_P#8?\8N'Y]^UR&@\(XX9'^?KWTUGC_=BF/Z$G_0/7ONZC_G5U__ %,QG/\
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MU];44]**+' 4\(C5?'!Z%LO'NH50:A0#TX\\\BA))G9!Y$DC]AZXHB1@A$5
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M:"OK6%1AL-D<?CZ:E:)6FEKZFAIRC:4D:5DC:DL@AC>1V(7L%?\ FK)%"O\
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MV=;L,)69K^/_ ']?E:NC1J&EPN'GKHO,DU/&:K/,:'P@/V^E?^*Z=DVNQC+
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M&R'[+VS/18E\YJJ2*2DJJ^6:EIUQBMDO?4R#!CX4%?GZ_9_J^R_[CMF=:7!
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MR?R+'_;CWOK77O?7OW7NO>QBVQWSV[L@[&;9>^<MM.HZXER3[0K=N1T6$R5
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MN_Z%1/\ CD<:_P"E1%X* ')+NXFC$,DI,6JM, $]U": 5(U,!7@&8"@)ZD6
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M#]^UG_?;?R_S]>^F7_E+B_:W_0/7O?/_ $<X?QL/]+?5URR'_@1O@<#R@_\
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M )3(OVM_T#UW[R+UUB '_P",M=7^I;?\"M[<M_7_ (\FVH?U_P ?>M1_@/\
M+_/UKZ5/^4N+]K?] ]>]\/\ 1SB?^?M=8_T_X%;T^EK6_P"/*_I[WJ/\!_E_
MGZW]*G_*9%^UO^@>O>^O]'&(_P"?M=8?^=6]/_L)]^U'^$_R_P _7OI4_P"4
MR+]K?] ]>]R=R]7MMW:..W8=];#S&/RE5DZ3$TF%K=P39')2XF?&0Y1:>GK=
MM8](EHCD8F9IWAUJ&\?D]Z#58C2:]>EM3%"LWCQE232A-32E>('"O7O?_]30
M N?ZG^GU_%[V_P!OS[]U[K?X]]>_=>Z][][]U[KWOWOW7NO>_>_=>Z][]?\
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M;,3Z:9"Z_8H/G4E$PB"6AC_M"G>/(,))%%/],BHY^;$>5.E /]B>3];?U/\
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MO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[WW<_U/^W]^Z]4YZ][]J;Z7-O\
M7/\ A_Q3W[KWJ?,]>]^!(^A(^OT)_/U_V_OW7NO>_7/]3_MS[W4@@@Y'7NO>
M^];6MJ:WTM<V_'^/^ ]ZJ1P/7JG^7^SU[W[4W^J;\_D_G@_[<>_=>.<GCU[W
M[4W^J;_;G^EO]Z'OWIU[SKY]>]^+L18LQ']"3;ZW_K_7W[Y>76ZGN%<$Y^?V
M]>]]7/\ 4_U^I^H^G^VO[]UKB:GCU[WWK?\ U3<?3U'C_>??A@$#AUNIQGT_
MEP_9Y=>]]7/]3_M_Z^_=:X\>O>_:F_U1_P!N?\/^*>_=>]>O>_:F_J?]N?Q:
MW^VM[W4^O7O*GEU[W[4W^J//UY/-_K_O7O77O3KWOKW[KW7O?O?NO=>]^]^Z
M]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?
MNO=>]^]^Z]U[W[W[KW7O?=S_ %/]/K^+WM_M^??NO=>]^N?ZG_;_ .O_ ,5/
MOW7NO>_:C_4_4'ZGZBY!_P!<$^_=>Z][]<VM<V_I^/Q_Q3W[KW7O?KG^I_WP
MM_O0]^Z]U[WZY_J?S^?Z_7_;^_=>Z][Z]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U
M[WZY_J?S_O/U_P!O[]U[KWONYM:YMQQ?CCZ?[:_OW7NO>^O?NO=>]^]^Z]U[
MW[W[KW7O?KG^I_WQO_O?OW7NO>S:XGXL9/>FR<#NKK7<]/N:MR..VYD\QC<_
M'MO8=#AUW-N3>.S,;2093/[V>HS-5/NS9-5#%XJ-8S32QS3/!=HT9,H4D.*?
MS_R=&B;8TT2/;2ZF(!(("TJ67B6SW*0,?/'6%YTC8(RRW;R%2D,TJVC0.Q9H
MD=8R0;*&L6;A;GVD,O\ '#>NSLIC:3?M7M[ TE;A=X9^I?%[BVWNS,8W&[-)
MBJOXCMO"9I\KC:C,U<E.F.%8*1*M*I)5=84F>/?BJ02M?+^?33;=-$X6<A11
MB:$$@+\@?/%*TX_;UQBJHYIJF!%J ](\22M+254$+F6%)U--43PQT]:@1P&:
M%I%1[HQ#@J%WO7X:]B;;R&5I,!E-L;QI\%1YRORU=C=P[8A@IJ;%[X[%VA1I
M"8-Q9*.JR%?#UK6UDM*K&HH5=89T$HYTLRGB"/V^@^7SZ>EVB=2PB=7"UKD#
M@S#U-3VDD>7 YZZIZJ.I4LB5"6* BHI:FF8^2""H%EJ(HRP5*A0Q'"R!D-F1
M@,<7PN[>IMT97:^X5VYAJS U?\)SJTVXL'N"JPV:KL)DLKM_'9''8;(SU=-)
MG:FEIJ6-W"I#-71Z_P!$J)[QTH"*TZ\NSW1D,;E13CD&AH2 0/7 _,?/KE3U
M,-5!%4T[^6"=%DAE *K)$W*R+K"WC93J4_1EY%P1[AUWQ2W)E,M5T/6>X,?O
M>@P^!DSV?R^7IZ;8='C*.EVOM[>5;6++F\M-3UF'IL#NBC9JD31RI/K26"$-
M3O4;\4#XA0_M\Z=>?:I"S"WE#JHJ2>VF WF3448?Y0,5R/(D8#.=(9TC'!-W
MD<1H+*"?4S#_  'U/'M,[R^-6_NO\'GLMNV7"T=1A*2:M..H<KC\S)*U!7[-
MQV>Q>1DQM9-+@\]AI]]4!>CJH4E]-0K%'BC$WEE5B*>?^S_FZ:EVV>&.1Y"*
MJ*T!KYJ#7T(U#'V_GY)$D4.AU*;Z6L0& ) 9;@:D:UP1PPY%P0?9=/;O1?US
M]^]^Z]U[W[W[KW7O?O?NO=>]]W/]3_MS_C_Q7W[KW7O?KDFY))_K?G_;^_=>
MZ][Z]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[WWJ;^I_/Y/YO?\ V]S_ +?W[KW7
MO?7OW7NO>_>_=>Z][][]U[KWOWOW7NO>^]36M<V_I<V_'X_Y!'^V]^Z]U[W_
M /_6^?\ ^_=>ZW^/?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW
M7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z
M]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?
MNO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[
MW[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]
M^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[VYT^+R%53U%92X^LJ:.DT"JJX*2>6F
MI6D6:2/SS1JT,)D2!V&MK6C<_13[U4<*YZL$<@L%)4<>O>X:QN[!$C+MZSI1
M7+$*C-<* 7(0 W_UO5[WU4"O#CU[WUI ^O ;Z$V) N1^#R%'Y_J"/?NO=>]X
M??NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[
MV(V#W]VIA<4]-MK>O8.*PE$N/H9*?![DW'0XJEC@R5?E\5220X^LBI8!#F:^
MJJZ>,BR551)(H#LY:I5"<@5Z?2>Z5*1S2!!3@33C4</F21\^NM*DWTB_)O87
MY%CS_B./];WS.[.TYZW%YZ?.;UR-8S9G$X;(Y2JR^6,K9V.HH\_C:*3(FKBJ
M/XFE;*E5"@)G\KAU-S[]1*4H*=6\6[)20NY.0":GCQ KZ^8Z[]Q)]^]DZZJ6
MIWGOD31Y!):UIMP[@#IE6S.0W'')5-)5EER2[BFJ<@K.?(:QY9_\ZSL?:5_A
M'53/<BM9GXYR>-2?VUJ?MJ>O>\57O[L/+^=*_>V],J:V:CJJE*O<><KOO*G#
MPQQXVHJ%FJW,\V.HHU6!S=X8U 4JH'OVE1Y#K1GN7K69S4^I/#\_+KWMTCWU
MVO05>'SS;IWT:F/"_P!V<-D*_*9FLAJ-M1QJIVO3+7RSTE?M=H)!'+C2LM%+
M"[(T;(Q'OVE<B@ZN)KM623Q)*TH"2>'IGB/EP^776E;6TK;4&M86U!M0:W^J
M#"]_Z^VG*]@[WS5/EZ7+[HS62I\[5UN0RD%76SU$-74Y/+0[ARDJQREEITR>
M:I*>LJDC$:U-1!#+*&>*,KX*HI0=4:XG<.KRL58DFOS-3]E3DTXD"O ==@6X
M' '  _'M)_:U*R10O3S)+.L30QM!()9EG(\31(5#.)&("$>EK\?7W;IJAJ!0
MU/7O<^JP&;Q\!J:_"Y6BIU9 9ZS'5=-"ID%T1IIH42[ZETWX-Q_7G50>!ZLT
M<BBK1L!]AZ][9?>^J=>]^]^Z]U[W[W[KW7O<^.AJY8/N8J*IDIS**<5*4\SP
MM.P4"%)0GB\K&1 %-VNX_J/>OSZV%8BH4TZ][SG$91(\?*V+R BRI9,5*U%4
MB/),CA'7'N82*UUDD5#X]8#&WUL??JCUZWH?M[#0\,<?L]>O>XDE+-"95E@E
MC:"80SK+'(AAF(>T4MU!C<M&UE/J8 _D>]]:((K4=>]]P4D]4_AIJ>:ID*32
M:((GEET0HTTKA(U9BD4"%V/(51>]N#[KP!8T )/7O<D8;*F.DE&+KRE>VBA?
M[*IT5CL'(2E?3_E#"UQIN?K]0/>JCUZMX;]IT&AX8X_9U[VW6^H _J?H+\BY
M^@  "B_Y"^]]4Z][D/33QR+%+3RQ2NL3I%)"Z22+.BR0ND;*&83*RLI%E*D6
M^OOW6R"#0@UZ][GUN S>-B\V1PN5H804#3UF.K*2(&2YB DGACC7R@6%_P C
MWJH/ ]6:.115HV ^8/7O;)[WU3KWOWOW7NO>_>_=>Z][_]?Y_P#[]U[K?X]J
M+!X"KS]2]'1U&&IIDC>8MFL[A-O4VF,QJR+79VLQ]$TK-*MD\GD(!L/K[-]E
MV2\WVZ^BLI+59J5K/=VEHE.'QW<\"5]!JJ?(&AH9[3M-UO-U]'926R7%-6J>
MXM[:.@-/CN98DKG K4\0#0T][$BFZ*WI68&OW%3UFQ9<;CJB*">:/L38\L(#
M^(2R&MASLN/A6E:I@#K-+%+>H32K6?1(]M[(\\7>S[COL-UL9L+4@.PW?:RM
M3Y>(+LVX(JM0TH/<* YH.;?VEYMNMHO=[AFV@[=;D!B-TVXY/']07!B&FJU#
M2 ]ZT!S3WM$979F2PTN-CJZO;M6<I4FF@7 ;JVKNF99 \*MYX=OYNO-*Q,X$
M?E\:RV-CP?8%WCEF_P!ADMA?7%C('_Y1;VRON'&OTMQ.!\JD5\N@;O7+][L*
MQM>W%I(&_P"4>ZM;KAZ_332T^5:5\NO>STY;X((_:F)VEA=^08CKW<&'D3!]
ME[XI:';=#7;ORFY-R;(V+M6MQ&X*S;&6VWG=S;EP5\AC,A!#D\/1T^2EIXLM
M%015%<%(9F=;Z)U'CQ:B@'^BE-&I8SQ.G5P;2YQKAA)(#1VW]94DE$<2&DS-
MCP=!C#E^%2I;(45;(&JE2DI]S3PX5\B<34?Q&C6EFR>&6/*5L\4$=+093.?P
MF3"X;+R[BJ*'$53FD6DA>*NKA'2>2&61C&E\Q\0Z;"["EK]R8_LSKO>>'Z,W
M3VYN2KWSAH:+96,W)L[M+>?6=9U;DS48O$Y3;^X=Q5&T2<5+)+5RSY2K@Q[4
MH1VK8Z27B^$T\ $D0D@';W,5N/ T,!P[#-XCYH+9)),L-/3J[31 EP'BN!%,
M[%OA!C:<(E* ZI/#CID_'P(IU)H=QTV5D#8N?$U]%_%*:B%73YB*85-)6;9I
M=QTU9CUIZ>>&LGFBKX66'R(K41:I61K+$Z=;XK05L^R=K8&MW9E=R[SZRVIV
M=C]Z1[>,O5=3'G=E0=@[@V?15V/2NS61SVR,+#78^?[):RLK]S4,N)@QXF59
M97S(Y:\8)V1-1A0:C^GJ!4 D"IHT=31HR)93" 5"2WLC/%'I67Q'4,&TU3^T
M\(C&<,-((J3+^CI#9.?%YZ+)4,]>^.S.,6#.Y;!&ER6,J(:]Y,7N*KVY'DEI
M(5J)?X-EGI5K:2J-HY,;/%4L4C8E5YG?@%O"'![8K-O;AP];7QXG)UF_#)#N
MFOI*:*FSO<+TF?VS#0;*2LJ*&?:?5V@X:8MN(9J1Z9J.-SX8G+AD@\,QKK)@
M+4KQ?Q;I//@NFV+5(I0@Y##I5'L\DMJLL<@^I"EF7)[/"M9!2@R^JY5=/Q5U
M#&D]=4^<B>JGIJA1$ZSQQ)$CT\U13L]/@#]O6P4]343><5&=2[QJT$<15G=5
M9&=#;U^&6X.OMK;TS^Y.Q=DS5VU^N*SLO&X#;^,WSDZK/X.@[IH>E)Q_$:S:
MN(Q>(GBS%4U5+%-,]721*L57#3S&58+W"):^ TCAQ)PTGTDFBSZ=T$N?Z*^;
M@=,IMCM;W%Q-,J^&FJ@!-1IA\Z <9TKY@AJ@<>H%+NV"KK_X='BLDL\6XXMM
M5Q>HP17'U4NR(=\"JJ!#FII9*5:6IBI"L2R5'W3AQ$:3_*O:!Q_00SDWQ8H,
M3F*NDJ_D?+)C'K<SBTAQ.!RX[>S_ %H#0305$DN5H(*3'TU7*6$3"25XQP%/
MM,79)KF-P#HMS<4''127L/\ 3K ]!BH=,>916\33+&TG8'N3&#3 71"=7[93
M7_2CSZ>5R0 S3RI%X\/.8R*:H^XG>-,50Y)_/"8H1257^5D+%JD#1A)-0\FE
M7'=?0./H^IL1V7M3(9O+2Y<4&7BP\M!#6AMNY6K[B^Z@I*K&0ZZK*]?X?I]Z
MW<$OCCA@3(\I#'3":KW).8[A(2@\'],:QP+-!#(:5\M<AC]?$&G/'I6NWZ[0
M72NV14#Y5=2,<64(96\O".K!&9_E/E\90V(<B1;E!H$%DD)"A)7,QTKS=5)O
M^!(J_C/4UG;E;U=MS<4='%1]-;9[DFS.\\'G:::/#Y'I/;G<>?H#B]IXK=M?
M][CZ7*U%-3*$T2M3@221LUO;B,LHOW HL5R8Z?9<FU!\L599#_0SF@Z82U9Y
MX85)'B1AP6!_WRTAP 3BA_,>O3='EHS1FL=8BO\ %I<4!3U4$B^1<Z^#C9IJ
MDT<8E$H!DB%W5]42>5PH<2,[_+\[/VS)O3^-;RZ^I*?9>W-QYFIJ#_?<#+93
M;6Z.Y]E5&U,13U.RJ6KGW!7[JZ+S%#2+(D4%1/441631.S1);>]BGMENE4F,
MZ!\_U(1)7C_H8/>?+Y]*UVF;]6LR452<:LE2P91VC-4.GUJ*<>F2AWOB,Q"T
MV CJ=P&.MPM)+%BI<9(T<.9I=JY,9+RU61I:27'X[!;OI<A.T<CRM2J_@2:4
MQQ23*?X.YG=^SNLMU; S"_9[LRNX-G9G*9]<AD\&=W;7RNZZ?*5U!5[6VS6_
MW?VK44&U9C0R99H6R4Z2)1R5#0U2TRII%6>UA8?I36WU"M3_ $+5>*S^5>RT
M+B,5(JQX*^E^/:!-:P3PRUG:<H0<CC$ 108 UOJJ<T'\<6MY_CF-_C$F!-5'
M_%5H6R4=&08Y)J..6EIYWIGET1UDE)/6P"H6$N:455,9A&*FG,J(V9T%UOCM
MQ=Q8WMK=&X:[:?3^]MC;6S_8'5%,E=@(,5N+>;[3S>Z88MP[=7(9+'4$2BKH
MT,=&U8J%%(,R$5<A4@8L 6O?IZ$YJ;:]E1Z5^$26R!_Z#'\0'2!;>..>Y28.
MPB@68Z?B +1*4*D%=0,U.--24%5H>NQ79&IP2Y&BQ+4V9J<0*ZCP&?K8<<\.
M2EHQ/#B,SD,2FX8*%HJEA#4S4RUR1$,T8F  9BWC\?<=M:B[.V_-7SIV+TOM
M"+?&_(ERF,R^U*G&Y+M3;77F'Q>WZ_&4$'W%=68G?F%RR5(J)Z>6*22,*LA"
MII) \4<CT21=",IQJD*RF0+DU:(JJ$?BTS-6D0,UKFU2VF>W8DNU2I_"$T:D
M+'%"P[P:T.N)*5)ZR296GC.&!BJR,Y4_:TFJEF@>%_X57Y<-7P52P5-$/M\<
MZ%702+*RHR@DV*?[OT@Z<_8H;)ZLW!OZDK:O#9CK?&QT,Z02Q;T[8ZOZ\K)W
M>,RJU!1[]W7MVJK80HL9(DDB#<%K^Z]S2I"B,SD<>T*/M9F4=!/F3G/:^5I+
M6*_VS=YI9.!L]LW#<%&?Q_16TX7_ &U,=>]C/G?AAW!MS;VVMSY?)=,4.'W5
M#)+BJNI^0W1='!*$TS1JM?7=@TV,K&JJ&:.HC%+/4'Q2+>S7 ;659)A!$R/*
M<T5T8^0-55V9*$Z?U%3/[>H[VK[PGM]O6];ML&W6?,,NZ6-/&1=CWEB,T^%;
M%G6C#0?$1.^M*KGKWM(]<]*4F<[DQ?6.]]RX7&4,^*S^6R&X-CYG&=GXFECP
M^T\QN2E2;,=7KV!!3T$]3C$BR-93T^1;#4DDM7-32+3M&S]7\*>2*T>0JA.G
M4(V./+4K"ORIQP2F2)?Y:W6UYGMK6]L;3<(H'D(TSV5S;ST'K:W<<$]#Z^'P
M[E62E#!R-7)14K5$5.*J034D2TYJ:>D:7[FK@IBD,U4\=.:G3*?%&S()9-*:
MEU7 P5/PDW;3T?;\T=5/-G^MZ[+Y3;'7^O;LV\.S=@;+RE/1=D;GVQ#A\]G/
MO$VE25RU7FHH,ACY8,=E=4\<U 8)&6GCM[6.6\8>*9A&0O#,O@ UQ\4](A2O
M>?- 6Z$B;:\@FHW>(M:KBK$1"9AQ-*1'5Y]P*?%CIHJ=ST5-+@V=)A09JJIL
M?][-!64IQN1R=(:O"T^5@JZ2$8U<F4^V J'AG6NJ*2G$3252:7OLSX?[7VYN
M=,'B]TYK85.ORI'QF^[[@AQV/I,OCY:^NHW[>P&2HZ;#I5[3VTM$#N& P,N(
M-=C[5E0:PI!J.=?J;"U;*RPRN[@56,Q?3U#&M09/&K$*9$<OIU6[M!;V-U?!
M67PQ"J*U*R%XYFD93@44I&.!RX[O6#3[N,^&&<AQ<F4@?9E)NZGH=O54>7RM
M89Z6>K&+HZ62*@@EDR"(B8Z4S*M;()@5A$0:1,4_Q%R.[\MN;$;*3=NUJK9&
MX*O;&?'<6W:G;<595-4U%%MS)TT^$H,M_=ZDR]7B:]<I)E4BPVVG%(E7EYON
MD96TNS^[3N<B+]/041363_<>68T4]S$+#(W:.)1:$T)4R;4SW,EK:B0*IIJ=
M:5S&H-0#2K/4UPJ::L:]*/\ B$8^W.EIEJ:3[N*2C6:K@>-#")BE2D"T[>FI
M1HEU^:H368XSH;VL]]? '=V,W/FTVGN'&Q;*$LL. R&[J7=%/D8LC;<4J[>W
M)4TFS*6@Q\E##MR4UN;98MNTIGI_-5Q"< +K_P *RDW45+1PF4J!0LR))<JM
M!YNPM)<#C3RJ=%3M%PXM##31)X*M6O8\D5JSU.G"*;N*K&BC5Q)"Z_)D%8(O
MAFD9PC(\*QR030_Y$'J8YEF>)(@:T%8Y&6>14<QHX'(/=M?%G+]2PXJEK=\[
M3W!GZWM;<G4F1QV.HMT8/%X/-;>PNR<S]_D=Q[XP&TZ&"AK(-[PW=TC2-(FE
M\C('\56,0=H@_P"J)9%(_P":<AC/_&A_GH>F;C;S!!'.9E,Q$8* $ &2(.,F
M@\_L\Z\:1L9F%RA0QT-73PR8?$9>*IEFQ<]/*N6-?:BB?'9&N,E50I1*TK@&
MF=9X_#++^X(U?VI\*]T;#VQV+O\ P>Z,-N/976VVNIMP9&MFIJNCR.;3L;:G
M4N7R,F AQT6:P=11[;SO;F/I7\F0CG>E9:AHTUJKU<B,K')B0SL@I_ -5'/R
M(7]IZW-MDD23,L@9$B5OF=06I%*C!;UK3/I5NQNZZ*L^TCJQ'15>0W%N7;M#
M3>9Y6GJ-OY#<E/&Y$U/1SJV0QVUZFI4"-HU$;JLDBJLCI.K^/6-I,/VO+)D\
MFF1ZPZ[V?NQLK*E)!MC<F>SXVCD\GM["U55!3TLCT>#W<9*5?O6J:R+'FI@B
ME^[2FI]-*L8N6E%(XI_ 2@!+RB;P"34BJ5&L%!*VDK6(1F2>*B6:!1J9CKME
M=".&HP^,5:M!4#MXY;414A%D4LDC(\"B-G$LK1NR_2%1#-*)'X_26B"?CU./
M:BQOPA[(S'65%V?C=Q[0JL;7;-EWO'B4H>P4R<>.79V[]^)1RU<VQ8=O?>G;
M?7^9D9UK&I!+2QQB6\\9+=Q<Q07GT>DL]8ACU?Z,?X;Z&OV2<=&;+M<[V:WH
MD704U4[@:4O33X:5I83USYQ?[\'4>7(4M/*(JF2.F+O''$9IJ=!,TM12TB")
M?,9"6JJV&, J"7E4?5A=;8GX-5>.[<;IW=6[L)G]SY3:.^*K;YV/E'Q^+I=Y
M[8V9V!N48[<.9WI@<7108G$5.S:,9*1=$45-FJ60U$1\BJHMQ'<%E#$'P\_T
M6\(2 ?FS(OYM_#T\=H:.XLK>64%Y9/":AIH?Q60UU#@$1GQY:/XNF?);DAQV
M';-3TU1#2"MPM/&98S42UD.7KL91QRT-)C#7UM1.[Y'QPP",3S5"Z%0AD9@>
M[2^+.Y^H=B0[]W5N7;A2??-;LFDV><;O; ;XK'Q>9WE@LKE9,!NK:&$J<-28
M[);)GAGBK1!6P&LI0].'D=(T\<RR?3E%-)DU*<$:?2H_%D4I6OKTQ<;;)#!-
M.9 0)- %"#JJ<T(!"X_F,>74VAS5/DWH'QL4E?C<ACGR,6<HZC&U.(5&CQ51
M00>>&O>>J?+4>4\U-+31STS14\A>5"81**7:_P :NINOWWY7T&9WU-C.H-_[
MSZ\[0Q6<R&V*#<=/D*C 1Y#I/+;;@&%@DK<9V/DZ+*157^2S'&18R220Z)(6
ME<GK:W*V[NKH9IHJKG]2WE*2(3P =-!C:M6*ST!\,ZM);V\]E#=1:T<0PRNK
MD Z)H%D0 4RPD;0YH=(*5_M 5X8[,?Q"2D"P**:OPM#F*"LBJ4J(*L3L?O8(
MC$O"T,<U,XD:RSBI&@'0]BI]K;"3KK>=5MN*NCR='+@MF;IQ-3I1*K^"]@;,
MV_OO TN4IX_32YW'X?<L$%?".(JR.51<+[;AE\43+I(:*:6$UQ5H9FC8Y]2I
M_+SZ33PF$Q*36L,3?[VH;/SH:'Y].L$ZU"-(J2H%FJ("LT3PN6IJB6F=PD@5
MC%(T1:-_TNA#"X(/L,/;O3'6;W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?N
MO=>]^]^Z]U[V[X=JV*NCDH*&+(5:K)HI9\;3Y:)T,,@=VH*JGJH)3&OJ!*FQ
M%_=))(HT+S.%3U)H/V].1*[,-"U/I2O\NO>U?][O#_GC\9_Z+O"__63VF^MV
M[_HX1_[V/\_2C3<?\HP_W@?YNO>_?>[P_P">/QG_ *+O"_\ UD]^^MV[_HX1
M_P"]C_/U[3<?\HP_W@?YNO>S'?&O<'=N&VCV51]7[-VYN7#9_<NSL7OJCR62
MQM#7USY_%[WZ\V_M2&ADR^+R@QV;K^PY9)4HU'G-*B3%J5*A?;SA)63.:8I^
MVO\ +_4>E>W27:1SFWA5E+*&!(%:AE I48):N/2G"O4*HI::2IIZF?R,\$<T
M4:EI&I0'FHZTS30<TQFAEQT9BE<:HC<(P+FXQU7:7=V%R\.X,3\?^A=J56Y,
MK5X]L3A\-L^+-8"II>Q=TX[<LU?229*;+[(QF<S6!R.*K9IHZ6B:@I!'=:8E
M96],9QXC8_S=+1<WB,KI80J2:4Q4=Q!KFH!(().*#KC!30".GA66MD7'F-(W
MEJZXO*11"%6GG>4'**89]1:0R@S>LGRI=0#[0VGV]VC!-FL=TKMG&838>%S.
MX*W-]18JAKMJ9+!5V:PO\0K,3F-OU^7Q>X<9M:KW#11524$U0V,EJ9VJA$S2
MK&XA1.+Y/KT@NH[JY 9;-0D8)J@J""1P()! J*TK3-:>4EZBGB:&.2:*.2HD
M\,$<KK')/*(IIO'$CE6DD,--(]@"2B,?H"?881?';NUZO:U%D.L=W;;DWMN1
MMH;4FW=AJK:%)G-R++4T_P#",?6[DCQE+45C5=))3JHD-ZF-HK^2Z^[^(F:-
M6@Z2"QNZQJT#*6;2-7;4^F:?ZL=8HZ^AE:J2*LI97H?']ZD=1"[T?E@2JB^Z
M57+4_DII%D77;5&P8<$'VVTG2W8%9C]JY.#&8IZ+>E7'1X.0;EVRKZY*K<M*
MLF3@?+"KPM(6V?D'\]4D40AIS)KTL-?O$7.>'^K_ "];%E<%8F"C2YH,CY\<
MX^$YX8ZE @ZASZ38W5ASI#>DD ,+-]1<7X^H/N9_LO7>3UGV5'U%V/EG?<V7
MV?25&"V;G<[C<GN?;]5DJ#,83"Y?#4%?C<U74%9B*I'6EEE!%.YO921[Q(_-
MQPKQZU]%>5(%M(<D84D5%0:$"AI0\/3J-/745,L[U-92TZ4M.U95-/410K34
MBABU54&1U$-.H0W=K*+'GCWGSGQU[MV_04.6R'66[)\56[4J-[-D\-BI<]C<
M;MNBER$>5K,[D,)_$*7;M1@VQE1]_3USP5% L8:H2-2+^$B'@PK6G6WL+R,!
MFMVTZ=50*@#YD5 I3(-"//KF:FG77JE1-$\=,WD/C'GF$9BB4OI#O+YE"@7U
M%@!S[<=Y_&GMC86#R&X=RXS;=+C<:N?:I^RWULO+U9_NSNC';,SZ4U!B\[65
MU8V*W#E(89?$DEE;R#]OU^]"5&( )K]GY]7EVZZA0R.JZ17\0)P0#@'R)Z[C
MG24*5$P#!"/)3SQ&TD?E74)8T*>G@WMI;TFS<>P>PLE=%7!L;CX,G4^.1135
M.(I\U&RG3K844]-51%H_P^FX_%O9MME_+METMREM;3,,:9HTE3\UD!6OY=)H
MMP7:Y/JY6MPHQ654://R<%:_EUF]JK[_ 'A_SQV*_P#1=X7_ .L?L1_URW?_
M *,^S_\ <LL/^V?I5_7:+_?^T_\ 9-8?]:>O>^S7[PL;[-Q0'Y/^CO"BW^Q_
M@?'O7]=-VI_R1]G_ .Y9M_\ VS]>_KO%_P I&T_]DUA_UIZ][,3\>-Q]LX38
MVZGV'U]M?>6'BWMLH9 9O<$L=1%NK([@P,>R*&EV=)N>@H\P\NZL=12QQKCI
MQ6"&9:GSTU.ZTP%?07#,WD?LZ5;=-<K%+)!;J\>M:@GS)&GMK3C3RSYU QAF
M,9 CD+CRZT!C\BLH\3L[&6*S4X" CR:ELQ !U$ B1N'<O=5=78RKJ^K=A8/,
M5$_:>.W/C*??$6/F-.]1V50]I9G.;9;=R)L&GAR]9GZDY."&AI:-D44P6$)'
M)0! #WD\/\E/+[.E#27ATGZ9%)UANZG\8<D:NW.HZN \OGZ%8UB14D>2-5C$
M;O(\I9 J^,^=RSSZA;U,S,Q/))]O&([#^0%#LS<4+_&79W8.W(-[X27.Y]\-
ME>Q*3>6?J,QV+1[?R<6:ILWG9NR\&,]-5^/,T]57TYKK!ZR^4$=1HK&2/U2#
M3[/3[*?ZO3K:W%ZL3?[K5= PJ:%M1JU#7.H5\P3GB>[J,'II9J1U:2.22EF\
M"-3O"PA8T<LD<GF@66EF"A/VF*.1<E24NC7G]S_([<V2ZHP4WQFQVQ'R^X^T
M,!L2ACV=D^M(=TYO>&T3M/? KJVKGV[2UIQ^)R=-+69&J/C0T[>>?PI)&FP(
MQK/BUX>=:>G5'GOI'MT_=P0EF"BA6I*E6K6GD<GY?;UP6JQRSY!8ZJ.:JIH:
M:JKZ6*H>LJ::"19GI)#0H\TT"5 @D,01!Y2K:02#[C3;S[8RN%VQ3XWK>&B3
MI/ ]:9'.XO?&>&TMT--U?U+F:UCC<#5;AQ&6RVVJ_:E3E,O))3T@J)::NAA)
M*10M-O2F:MAJ\,\3UOQKEHX@MM3P%6H8Z3V(> J*BA)X5((' =30R+;U7NT@
M#*I*AC*$*EE!4.'8"Q-R0?Z&RUZGWSO3J[&;?V9O/X@[>WYANG\+F]QYS?6Q
M.O\ %[NWCAIL[5;IHJ?([]W-AZ7)X9Z;%Y7%U]$\&6D$<$V.D6=*J&GFH9J.
MJO4B:A)X$T_9U>VFEM0D,VVAUC6I90&85J*DY'D0:^GG3IDK:*C6JGU9NOQ]
M5G6HX8X/XLP67^''S34^)HJMY8Z-ZVD#1U+4:Q3F-C(KQS*LJO5=O7NO<O5^
M\<?NSXDYMMYU$^Q]J[4S&$V=7MO7#14>YJWL6@QV7P&6CK]YX?;N6Q>7I:+'
MU]+21PS4-#'0TTJ:'9?:4# K+VY^STZ<,]V]O*9=M;Q*JHH,C.K(/<!3 (%/
M+'E)C6GDJ?OHLK*]-')7O)3QU,34)GB6&@GU.BZ@,=)22AXM>A9Y7:1=80H@
M,SB/D+W)L?.R9[:F.HI=P8G$[,V_BY=X;5V_-0U5=W[#AD?=^-W1NJ+<D&YZ
M3/[3HMI44512P3-C\;$TDBQ41:2P\-&6AX?(^G[/GTRXOKN"7Q(@-0"@5 H?
M$IW FNJH""H\OEU+$\$1EMYR#.P;335+H'^T%6QC:.$KXFC!.L$H96*7\AT^
MZ\L6]7!67HZ*"OJ%5P*>;'091"H!UN:6H@J8B4_KIX]G6W7L]C=":TMX99/X
M984G7_>)$<?RZ#;V;WP^G7Q?$/\ OLL&_:I!ZF>U+_$-S?\ /+XS_P! 7"__
M %H]B7^L&^_],[M__<MMO^M'2?\ JM)_OO</^<]S_P!!]>]]FOW/^=L8P?\
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MI&R5T-4 #ST321N/^;<D3%QZBJUZ:3;KMK6:8NJQ(NK3J&03#P J,B2,#R(
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MNEGHJYL=V/F.R:#;V=E*U5;3297+R=4Y.;)4R$M2)+2_N5#O4+2T\1(W6T1
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MX=JK6J>(6"%3WMAZ(I,E20!4L.E\MO?SSQQ2NS2W"@Y+?K!O#"Z=0!DJ2@)
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M"NHL%1R8W"TE76U-33XC'S5U7E):#&032O'04<N3KYZAHH@D9GGDD(UNQ.J
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M]:?HOW7J'^Y7A>%JS3^V[*\:>?&G2FU^LUGZ+Q/$I^#56GG\.:<.O>S88/\
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M_P"VX5\ZT\^J7>KP[SQ/#\'Q&U::4K3.BO?2E.&*4KUAA_AW\9K_ !:_XO\
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M5[=%/$UTQI\.OEUJZ^K\39L1>+1/"I2E>SPJ:^T8T>#2I^#2:Z>I(\'VLO\
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J]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W[W[KW7O?O?NO=>]^]^Z]U[W__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img226925499_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img226925499_8.jpg
M_]C_X0MB17AI9@  34T *@    @ " $2  ,    !  $   $:  4    !
M;@$;  4    !    =@$H  ,    !  (   $Q  (    ?    ?@$R  (    4
M    G0$[  (    )    L8=I  0    !    O    .@ #J8    G$  .I@
M "<0061O8F4@4&AO=&]S:&]P(#(U+CD@*%=I;F1O=W,I #(P,C0Z,3$Z,3D@
M,#,Z,#<Z,C< <G(T,34P-#<      Z !  ,    !__\  * "  0    !   "
M6* #  0    !    R          & 0,  P    $ !@   1H !0    $   $V
M 1L !0    $   $^ 2@  P    $  @   @$ !     $   %& @( !     $
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M "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6T
M   ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0
M     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP
M     $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N
M=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V]L
M      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P    ,
M    4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $)L
M("!D;W5B0&_@            0G)D5%5N=$8C4FQT                0FQD
M(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0%@            *
M=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P
M  !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
M      !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG
M8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE
M9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E
M8W14;W!L;VYG       X0DE- ^T      !  8     $  0!@     0 !.$))
M300F       .             #^    X0DE- _(       H  /_______P
M.$))300-       $    6CA"24T$&0      !    !XX0DE- _,       D
M          $ .$))32<0       *  $          3A"24T#]0      2  O
M9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M!@       0 U     0 M    !@       3A"24T#^       <   ________
M_____________________P/H     /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H   X0DE-!         (  #A"24T$ @      !@
M #A"24T$,        P$! 0 X0DE-!"T       8  0    $X0DE-! @
M !     !   "0    D      .$))301$       0     @   D    )
M #A"24T$'@      !      X0DE-!!H      T4    &              #(
M   "6     @ 1@!I &< =0!R &4 ,@ T     0
M   !              )8    R                      !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG    R     !29VAT;&]N9P   E@    &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   ,@     4F=H=&QO;F<   )8     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    $.$))300,      HP     0   )\    U
M   !X   8V    H4 !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1"  U )\# 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
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ME<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$
M/P#TZC(]2E]I$ECGM+6:GV.<SC][VIZLFJUVP2UX:'ECP6N#7%S&;I_>=6Y0
MP7$T.)Y%MPU\K;&K.R\C';U']>/V<_9FN!U<6GU8:_>P;-K'^GN>_P#?251.
MD19.P=I#R+Z<:BS(O>*Z:6E]CSP&M&YSDS+V^F76_HBTP[<0!SM:[^J_\Q2<
M*K :WAKPX:L,$$?U4E;L,3,QLVD9&+8+J22!8W4$M.Q\'^2]NQ&5:B['%CZJ
MF; 7NES6@-<_1]NK?S]SOSE92*E*KU+#=FX;\9MIH<YS'"UNI:6/;;[=6_N?
M^=JTDDIY]WU:O:VMPZB^GT*_3%E8-9+=[[=]KVV>]S_4_3_Z>WTLBW])6E1T
M3)9EU.KZQ:]U-K7WU$N(>&!LU6M;<-CG-V>]_P!/_"^LM;J8:>GY =]'89^'
M_23>H6Y%CG%CFL#R!7](#]%_.:_31XBJFU(2E0:X.$C0Q)'<2H77L:X5AWO)
M;[1S!(\4+31NE\G,QL5K7Y%@J:]XK:YW!>[Z#/[2KNZYTAMIJ=F5!P<6'W#:
M'-:ZU['6?S;7,96YS_<IVOIO:ZJYK'-]0-+'#=(T^G6YI\5!U'2GM+;**2SU
M2(+&.'J/^D[: ?TED^_<D*0L>N]%:\L.=C@M$DFQH:/[>[9N_DI[.N=(JLMK
MLRZFOH:7VC=]%K14YSG?^Q-'_;B=F!TJQK@W%H+9+7CTFQ)U?,M_.13A89+R
M:*R;8]0[&^Z#O;OT]^U_N1T\5('==Z,UQ:<VD%K@TC>.3PKE=M=K&V5O#ZWC
M<U[2""#^<UP0!T[IXB,6D0($5MT'M_D_R&(M-=553::&M954W8QC= T-]K6-
M ^CL2-=%))"4A,D@I__0],Z>X.QI'[]@\.+'CS59@GK[M\;VXC>/!UK^W]AJ
ML81-F*XA^KK+H>-8FRSC>/S$*IKF]6?N=O<,9@D@ _SEO.U)(-,K<,4T[:&;
MFATAL!SAN?ZC]OJ^W9[OYO\ [91 ^EUOOK&X-/Z2- );+'%WOKW_ +JL:^"@
MZICW!Y:-X!:'C1P!();N^E^:DHZZG?NH8] K=6&#982YP\2X[G._M.2BUKAM
MAS-9#N?*"JSZ[,:JQP<[;+G[F %S=QW_ ,U]!ZL67/8Z!2^SCW-VQK_7>Q*U
M4?[>C)MH)AP+#,#=W_JE35=UQ<?2=CV%K]'$AA;!.WW>]'XT"2&MU.?V?D0)
M(82!XGP5?-^T-;>::ZS86OVAL[B#Z7T_;_.JSU*?L&1&AV'68C3G<G#",LNV
M,:'!T.;])VE0_2>W^S_422&LVZXX]WZ/Z-0)!,D2USMNX>]R'<,G]H&' 5AS
M=K=#)+JCN+G_ $-E>_;6KUK!LL>T0\M,GQ !T*AM!S28X8=?,^F-$%<2-V-8
M 9@3>UX@&=OL'TIW;O:AX^$YM]UKF^XY&YA=K[-M6YS?ZSF?2^FM!)%5L+&.
M<6N88<")/BWP=^\DT7:[G-YT]IX[=VJ8[?)))3';8?SA_F_[5!C+/=[R/<[\
MT>**E_M24PV6?Z3_ *(3L:X-(<[<9)F.Q^C_ )JDDDI__]'TZG&+*#58XN+G
MO>2TN!]SW6M:'3N]F[8HC#9ZNZ7;0P-!%EF[0EWN._W<JRDDISLEV/C--=N0
M66_2!?98&[2[^O\ N^U0.9T[U _[4/LY!&[U;/IC:Z-V[T_H.5^V\5-+BUQ
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MVF>%9I]'[._9ZNS6=_J;^/=L]3]-_FKY=224_P#_V3A"24T$(0      5P
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M::&;PTND+2:.T/(6H*T%<@VO+FV:WO[79[C;;/ZIM3L+N=F.:X)5:9K\J$@
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M$8%?\F*'YU\\<#TV3I"<KCY'IM4T=-7I#5EJ(")932M/3JLK_?%YO"C?M+H
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M4T4?[8L ?</>WUSON\KS=S)M),45[=HT:W5LR%A]-&-8[J=V3C4H)(IY],J
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M:$5S++*>/E6G$^9Z]["V0)JF];<PQ7]'^-/_ ,W/\?;70S_S=>]]N%O^MO\
M@,O]C_:/K[]UKKWO#,$TQ68EO':VC3QY)/?NO>G7O>(*EO4Y5OZ:";?['WOK
MW7O8CU?6&]\=MJAWE/@Y*C;>1U?:Y3&Y#$Y6-C%'YI%J(<3DJRMHV@CYD$L<
M?C_MV]L_40R,ZJSA3Q)C=0/]LR!3^WHFL>8=LW+<+W:[&2=KNW_M:P3Q@?\
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MQ?O8>H(?%/\ N2<JG^ZD_P".B?\ -_Z>SKTZ,,9Z][Q*L.H?N2?J_P".2?\
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M]]C[AAI<?54M;V#MZ2IFP^8VGOJOH<-5;EA>JI*C,4%?F<B(?MY9/+*3'?\
MSGO+;DMQL-SM%EM\WAS"B#PXTA+\ <(B#R_9PZE/E?G+:-NO-KLK:\^GN"XA
M_6@EM3("14$RPQ'/J/+K/)8HX:VDHU[FPM8WN?P+>R4@1><>J35YO]0EKZ_^
M6GNG1OUS]\)!#Y']4GZF_L)];_\ +0>_9Z]U[V^87-56WZZFR-#)ZUAF@F@G
MB2:DKJ.?R)64%=!Y+34=7 3')&>"#[8N+>.ZC,4E:5K48((X$'R(Z;FC29-#
MUZ]['? XK;0V%VKNC%[7PV<PZ;6Q]7CZS+QY2?*[$W+DM[[*PU3AI9*3*4M/
M/#)C,A5-CJBHC9:J&[BT\,\<8)W&\ODWSE/;+G=Y8KIKEE95"A;J-;.[?4 5
M-"'53(%(TE0/A85))IIC?[?9RW,L5QXW_.1/"F.OT&?CQD@4^7O9:U6&X]4G
MU']E/^OGL?9Z/^O>US'LEI]G5F]1G\%%1T>3IL3-B99JT9LY"LCR%130QP"@
M>D(DIL?(]_/QQ[*FW95W==G_ '?-XA4MJH-&D$ FNJN":<./21KL)>?2?3R_
M;3'^;RZ][13^/QP>J33XW_L)_P =G_YN<<^S3I9Z=>]\$6&TGJE/[=SZ4X]<
M?_-SW[K77O?2"'6EGD_4O]A/Z_\ +3W[KW7O?<@A\C^J3]3?V$^M_P#EH/?L
M]>Z][Y%$(CMYCZ>-,/\ M<G_ #=//OW7NO>W^@VQGLB)!CL%GJXE./M,36U/
M^[4%_P!B&0_7VCFW&PM_]RMPB3[74?X2.F3<VT?]K<Q5_+KWM8[>ZI[+J\OB
M32=<=@5(_B%'S!LO<,ZG_*([ >&B)-_\/9-?<W<J0VLQ?F/;E[3QNHAY?-L=
M%]QN^U)%/_NSM_\ G+'_ )^O>UAV3TYVQ+V+OZ2/JWLIU?>FZI$,>Q-SD%6S
M>0975CC>(Q;\_3\^R7ESG7D^/E[8 >;]L_W BS]9#GL45KJS]OGTQMN[;4FW
M[;_NRM_["/\ T6/T_P!6?7KWM%OTSVT8XA_HK[+X5_\ F!-S?\=+'_EW?U]G
M7]=>4<G^M^V?]E</_072O]\;5_T<H/\ G+'U[WT.F>V[2?\ &*^S/T\_[\'<
M_P#QTC_ZMW]?>OZZ\H?]-?MG_97#_P!!=;_?&U?]'&W_ .<L?^?KWOI.F>V]
M2_\ &*^S/U?\\#N;_P"MWO?]=>4#_P [?MG_ &5P_P#076OWQM7EN5O_ ,Y8
M^O>^Y.F>VS))_P 8K[,N9'!_WX6YOKK_ .U=_7WK^NO* _YV_:_^RN'_ *"Z
MN=WVK_HXP?\ .2/KWOS],=N:(Q_HK[,XU_\ , [G_P#K=[W_ %UY1_Z;#;/^
MRN'_ *"ZI^^-JKG<;?\ YRQ]>]]Q],]M 2_\8K[,YCN/]^%N?Z>2/_JW_P!3
M[\>=>4<?\B_;/^RN'_H+K?[XVJG_ "4K?_G+'U[VI=P=:1[2ZRI\]NG879FV
M-VU6YVP%'6;A?^#[>JTBI/XA45-/ALELJER,\E/#^R43)?YS]S_FW[1;?S*N
M[\TO8;5OVV7FS+9"4B.CR@EM(JZW16AXC]+Y5KQ36^X_5[KX%KN-O+;>!XGZ
M=-?'C_:G&>/A_GU[V!L@A\DGJDOK?C2EAZ_^6G^/L9='77O?*3Q^.'268^NU
MU_VO_EI[]U[KWO\ _]#3FZ=W]!3=([LVCY]R461HMLYG*14=+B,+]_O'"Y'<
M,& J-N;/S53G<;75^(3([@^\RV+_ (5FP8:.KJ^$IRD>F,% 6^*O[/\ -T;V
M<H$#Q]VH*30 58$THIKD5-6%&X$_+K?SDD5'@5ED8S2-$A2&655<0RS:I7CC
M=*>/1"P#R%$+E4!U.H)&/>^BCK+[][]U[KWOWOW7NO>Q@S&ZMA9+ ]0XVHVM
M7O+L[:^Y,-O9L4^%VQ7;FR%?O;=NX</7QY]<5N"2LFH,5FJ2F>6LHFF\5)X$
MM&(RC<<;B:=Z]K)CY$*V:?L^VGETZ@@C6C1DGQ26I12:I&!FAX4\QPZQ1QZ'
MG;6[>:4269W81VAAAT1JS,L:'Q:K*%74Q-KDDVM]#8NDP7\MSYR;@V7LW=FW
M\?EZ?HK(5-3O3,8'+XS,T=5O&LH<A1X3(56TMK_<3T^&$^KQ^?\ SRA$#_4.
M;DDG[SMP=R<%X@"$#C/CRA*Z3Z:*_F<#J-/<"'9(]^]M/JUNEO[G<21X9FII
M%O?".IB"K077@5+8SQXU"C<M5CX^Y>J:.H:A.0J=J=JSXZ.02G):*67K]*V:
METS>(42)5(LY:(G6\(#I<K)2)[$_4C="Y[][]U[KWOWOW7NO>Q?VKV'2Q8FE
MV5O_ !L^Z]@K*?LZ6.L2GW)LHU%2M=D*_K[,5D-=382?)3@FNI9*:>AKA<R1
MK4".IB8DB<EY87_QG3Y@Y] RU&JGX6KJ6OFO807O?*DTE]/S'RO>+9<TZ:$D
M$VUU04CCOHE,9E$8_LI1(LL/X6,6J*3WL7]@]/\ :_AW1N/I:IP6^]EQ[*W#
MG\MNB3<&(VG!AL+MW'82NW0V9QNX<_@*W"[EVJ=P11K&_E^Y)>6A-53_ +WO
M:7WA"82HZ2T%1IU@]S@,K $,&TMI;XA70X5SIZ,N5_O16_L_>75AO#3[5S%N
MIBVWZ0PWMSXLMY+-%:2VLE@*2&3P93#,3^CJ,=RL,I,77O9=SFZ3+(R[GHWF
MJV25H\Y0%8LIY?!3T]*N1B<&BRE+$(-;C3'5R%RQG_'M4'5JJ\6IZ&A&'^&B
MU_"R^?!6-3W]2F>8K+>M2\UV337AJ?K(:"ZKX06(3 _I3Q K4U$4[$DFX\C[
MW#R>WI*.'[^BJ(,QB&DJ%AR5 2VE(IHXM>0H'"UN+DD,BZ5J$B\A/H9O=70Q
M\)%(]0<\:=R_$E?+4!7RJ,](MVY;GL(3N.W7D%_LI+4GA\@#3]:(_K6I-103
M*NJOZ189Z][8WIZF*.*:2":.&97,$KHR12Z3ZS"[^A['_4^VR, E2 ?ET1/;
MSQ1)<36["WEX$@@'[#Y]>]P?=NF.O>_>_=>Z][][]U[KWOWOW7NO>_>_=>Z]
M[][]U[KWM?[:W7%238[$[I@DS^S(ZES4X>H+U#4$%;-2'(UNWV^ZI9,;E)DI
M(_7')%Y=.AS;V4;EM;3":YVMA;[F1AAP)%0HFQW+GS%1Y=5X4"92O#[:5IZ'
M'E3KWM9]E4W3.<W;E:GJ;(97;&VY7HABL1O"CJM*M+'*:U8\O2Y#/2B*B<)&
M&G2+S7,EHU_;!/RU)SE9;/9#FNUCNMU .MK8C\NU@F3QHI-!C/$U5G"$FH]
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M7%9&6(EE\HR6 &/?MKS1[PV?N/[N;+SIL&[[ER?975E%MUV88(28O ACFEC
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M[Q4W_*T?^I#?]'^_?EU['KU[W[Q4W_*T?^I#?]'^_?EU['KU[W[Q4W_*T?\
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M<>7Z_N);^Q_7W[/6_7KWO&&AU#]IOU?\=?\ L&./>\]:Z][[=H=;_M-^I_\
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M)%FMSY+>5=2&MG:F;<F6J8JS(911/+))%4U%7!%(QUW,L,<G+QHXTD:H  .
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MN#<<>R__ .RJ]R_\J77W_H[.E?\ [8/M_P 5/G^P_P";J1?W;>?[[7_>X_\
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M[+-[4](>I/L?NB-KYZ?<!['PE3M&H_T3Y';>[Z[;>X=[83:&7W!0PYVC@=<
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M_I^Y^/?OSZ]U[WVCC3-^U'_F_P#FY_QUC_/D]^_/K?KU[WC5UU#]J/\ 4/\
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M%9B<U1U^(R5/?ZQ5$$L3?D>W$<H>O(Q1@ZTJ/4 C]A!!_,=>(N".>>."0?\
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M2S)^L*_^T?Z_OW7J=>]C!WJY'957Z$/^_6ZS]6CZ_P#&--H?[S[;C^ ?:?\
M">ENX?[E/_I4_P".+U[V$TC_ .?NB<3?ZC_EIR?\?=_3I%U[WRE>S5'H4^L?
M\1Q;W[KQX]>]]2/ZI?0OIAB/^OS![]UOKWOQ?U'T);[=;?\ 4F/_ &%O?NM'
MKWO#,^I(1I4?MW]/_+206][Z]Z=>]\/(/^.:?[8?\4]^Z]U[VJ<CN:;)8C$X
M=\7B:6'$"84U720U25LPJ#KJ/N)'K)8I?/)9WLOU'']/9W>[V]_8;=M[;?:H
MEJ"%*J0QJ:G42QK4YX='-YO3WNV[?M;6%LL=M725!U9-34EB#4YX<>O>TU$_
M[T?H3_.)_8M;UC^A]DG1,.(Z][XN_K?T1?J?\>_=>Z][Y-)Z8O0G^;/]C_F_
M)Q_K>_=>/EU[WW&X\4WH7A4/T_VM!_Q'OW7O7KWOC&X\B>B/]2?C_C?UO[]U
M[KWOBS^H^B+]7]/]?_'W[KW7O>1W&F'T1_YO_KL_^\>_=>/EU[WTC^B4Z(^%
M2_ M^O\ I?W[KW7O?HWO)&-$?^<3Z#Z>O\<^]=>Z][ZD<>1_1'^I_P ?\;^M
M_>^O=>]]L_HC]$7*M_8/X=_I_A[]U[KWON-_VIO1'^E/Q_S<2UQ>WOW7O7KW
MO&K^H>B+]7]/];_'W[KW7O?;OZW]$7ZG_'OW7NO>\DC_ +<+:$MH?C_I\WX_
MU_?NO>G7O?!)+B2T:<1\_P"MKC_WKW[KW7O?2/ZT]$7ZD_'OW7NO>^Y''D?T
M1_J?\?\ &_K?W[KW7O?;N-$?HC_2WXO_ &Y/I_MO?NO=>]]HXTS>B/\ S?\
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M3(J*</(]=1LCK=+:59X^!8!HG:-UMQ^EU(_IQ[#'_3#VU_S]#L3_ -#?<_\
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M!=R5)I\3>?Y]>]F,['V!\B*OIG+9K=_9U/G]F=;9/-XG+X2IW3ORJRF1KT[
MBVYD99:'/8J'%YVGQ^XWC\%4)/"?6D<CU%/41Q-HT>L!5H3]GITON+?<#9NT
MMP&@C)!&IJDZJ>8H:'@?\H/7 % QL+,UKL%_4=)M=@.2%4_ZP_UQ[__4^?\
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M/C\[DZ.*DBI\E-EH8Z=*>JCC@BBRE3)4QA +5,CR#UDGWK2I\ATXLTR !)6
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M*7MZPD*:U^W_ !*GEC^VG^?^+G\E'T-AHN4^O3Q@PH<4I^N",,>/AQ,""?B
MZE--,%E=:6201K(RH)(5FJ"L221K3K(Z1!I'8I^[)$%=?]2=7M%9;HKH3#X"
M?)CY"G+YFIV[O[(8O;E#@=I0O09[:NQ=I;EPV#W!EH.QLK2))N;/[CJ,;32T
M<=1#,V-E,;F6\$:A74VYGIW5I0<?[:):\.&F0G-/@],]-+9V22.)[W.AB*:>
M($I"DZCQ,8 I4'Q.(/&*E3DFR%32MCH4HX:;'S05_P!ZY%3)4UF4BK:80?9
MQR4%'24\M];"1JDIZ1'K=SZQZ?\ C-G^M\-7[T[MHL7OK<U/NBFKJ:BJ/#_<
M&LI-T=+1;>GJ\#N2DVM2YT';FX]RRUL@RX@E%+_DGE:CE\GGJ!@<#^T:$/\
MA)'Y?/KUI:VLD0,ER!(0:YIII&Q%0:5SQ-:?PUSU'DJ,V<O/3PT4 Q4-'CIX
MJR<QC[VJG&X$KJ**2*M>IIVHY*;'N7>E*:)V"&1M7@1W7O5W5N338-5O/>32
M[4S&ZMZX?>6XJ#-T> I=F8_$28BDP,\5'F**:NJ*C/\ \2.1T"EFJ6I(R8J>
M1J2K3VGDGD6-PJ=_T_C <29.X&.E:'A""PP/$'58+>T:2 235B:Y8,P.G3$
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M2!]2!]/J?ZFP_P!N3[Y4_0W=%7!-44O5>_:BGI<G_!*JH@VOEY8(,MX(:O\
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M/GDD@IY)C'XY%DTL;Z0"Q_:?3IV:]M?%8QQ I0K70E#5JUH1Q"X'"N*]9A$
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0KWOWOW7NO>_>_=>Z][__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>17
<FILENAME>qttb-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-03-10T15:13:35.1873+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.q32bio.com/20241231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:qttb="http://www.q32bio.com/20241231" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2022-03-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" namespace="http://xbrl.sec.gov/cyd/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CoverPage" id="CoverPage">
        <link:definition>100000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1" id="StatementConsolidatedBalanceSheets1">
        <link:definition>100010 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureDebtSummaryOfLongtermDebtBalanceDetail2" id="DisclosureDebtSummaryOfLongtermDebtBalanceDetail2">
        <link:definition>100020 - Disclosure - Debt - Summary of Long-term Debt Balance (Detail) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" id="StatementConsolidatedStatementsOfOperationsUnaudited">
        <link:definition>100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" id="StatementConsolidatedStatementsOfComprehensiveLossUnaudited">
        <link:definition>100050 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" id="StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited">
        <link:definition>100060 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" id="DisclosureCybersecurityRiskManagementStrategyAndGovernance">
        <link:definition>995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusiness" id="NatureOfTheBusiness">
        <link:definition>995465 - Disclosure - Nature of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
        <link:definition>995475 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMerger" id="DisclosureAccountingForTheMerger">
        <link:definition>995485 - Disclosure - Accounting for the Merger</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestments" id="DisclosureShorttermInvestments">
        <link:definition>995495 - Disclosure - Short-Term Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurements" id="FairValueMeasurements">
        <link:definition>995505 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecurities" id="DisclosureInvestmentInEquitySecurities">
        <link:definition>995515 - Disclosure - Investment in Equity Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
        <link:definition>995525 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssets" id="PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssets">
        <link:definition>995535 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilities" id="AccruedExpensesAndOtherCurrentLiabilities">
        <link:definition>995545 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>995555 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/Debt" id="Debt">
        <link:definition>995565 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStock" id="ConvertiblePreferredStock">
        <link:definition>995575 - Disclosure - Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommonStock" id="CommonStock">
        <link:definition>995585 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensation" id="StockBasedCompensation">
        <link:definition>995595 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizon" id="AgreementsWithHorizon">
        <link:definition>995605 - Disclosure - Agreements with Horizon</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>995615 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DefinedContributionPlan" id="DefinedContributionPlan">
        <link:definition>995625 - Disclosure - Defined Contribution Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>995635 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShare" id="DisclosureNetIncomeLossPerShare">
        <link:definition>995645 - Disclosure - Net Income (Loss) per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReporting" id="DisclosureSegmentReporting">
        <link:definition>995655 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>995665 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>995675 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
        <link:definition>995685 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerTables" id="DisclosureAccountingForTheMergerTables">
        <link:definition>995695 - Disclosure - Accounting for the Merger (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables" id="DisclosureShorttermInvestmentsTables">
        <link:definition>995705 - Disclosure - Short-Term Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
        <link:definition>995715 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
        <link:definition>995725 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTables" id="PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTables">
        <link:definition>995735 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" id="AccruedExpensesAndOtherCurrentLiabilitiesTables">
        <link:definition>995745 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
        <link:definition>995755 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DebtTables" id="DebtTables">
        <link:definition>995765 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommonStockTables" id="CommonStockTables">
        <link:definition>995775 - Disclosure - Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationTables" id="StockBasedCompensationTables">
        <link:definition>995785 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonTables" id="AgreementsWithHorizonTables">
        <link:definition>995795 - Disclosure - Agreements with Horizon (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesTables" id="IncomeTaxesTables">
        <link:definition>995805 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables" id="DisclosureNetIncomeLossPerShareTables">
        <link:definition>995815 - Disclosure - Net Income (Loss) per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" id="DisclosureSegmentReportingTables">
        <link:definition>995825 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail" id="NatureOfTheBusinessAdditionalInformationDetail">
        <link:definition>995835 - Disclosure - Nature of the Business - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails">
        <link:definition>995845 - Disclosure - Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" id="SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
        <link:definition>995855 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail" id="SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail">
        <link:definition>995865 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Life of Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails" id="DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails">
        <link:definition>995875 - Disclosure - Accounting for the Merger - Summary of Recapitalization of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails" id="DisclosureAccountingForTheMergerAdditionalInformationDetails">
        <link:definition>995885 - Disclosure - Accounting for the Merger - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails" id="DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails">
        <link:definition>995895 - Disclosure - Short-Term Investments - Summary of Short-Term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetails" id="DisclosureShorttermInvestmentsAdditionalInformationDetails">
        <link:definition>995905 - Disclosure - Short-Term Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" id="DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
        <link:definition>995915 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail" id="FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail">
        <link:definition>995925 - Disclosure - Fair Value Measurements - Summary of Fair Value Measurement Significant Inputs (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail" id="FairValueMeasurementsAdditionalInformationDetail">
        <link:definition>995935 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails" id="DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails">
        <link:definition>995945 - Disclosure - Investment in Equity Securities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail" id="PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail">
        <link:definition>995955 - Disclosure - Property and Equipment, Net - Schedule of Property Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail" id="PropertyAndEquipmentNetAdditionalInformationDetail">
        <link:definition>995965 - Disclosure - Property and Equipment, Net - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail" id="DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail">
        <link:definition>995975 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Current Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail" id="DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail">
        <link:definition>995985 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Noncurrent Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail" id="AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail">
        <link:definition>995995 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail" id="CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail">
        <link:definition>996005 - Disclosure - Commitments and Contingencies  Summary of  Amounts Reported in the Balance Sheet in Respect of Operating Lease Assets and Corresponding Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail" id="CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail">
        <link:definition>996015 - Disclosure - Commitments and Contingencies - Schedule of Operating Lease Cost and Variable Lease Costs and Sub Lease Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail" id="CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail">
        <link:definition>996025 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail" id="CommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>996035 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail" id="DebtAdditionalInformationDetail">
        <link:definition>996045 - Disclosure - Debt - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail" id="DebtSummaryOfLongTermDebtBalanceDetail">
        <link:definition>996055 - Disclosure - Debt - Summary of Long-term Debt Balance (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail" id="ConvertiblePreferredStockAdditionalInformationDetail">
        <link:definition>996065 - Disclosure - Convertible Preferred Stock - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail" id="DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail">
        <link:definition>996075 - Disclosure - Common Stock - Schedule of Shares of Common Stock for Future Issuance (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail" id="CommonStockAdditionalInformationDetail">
        <link:definition>996085 - Disclosure - Common Stock - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail" id="DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail">
        <link:definition>996095 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail" id="DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail">
        <link:definition>996105 - Disclosure - Stock-Based Compensation - Summary of Assumptions Used to Value Stock Options Granted (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" id="StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail">
        <link:definition>996115 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail" id="StockBasedCompensationAdditionalInformationDetail">
        <link:definition>996125 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail" id="AgreementsWithHorizonAdditionalInformationDetail">
        <link:definition>996135 - Disclosure - Agreements with Horizon - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail" id="AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail">
        <link:definition>996145 - Disclosure - Agreements with Horizon - Summary of the Transaction Price Allocated to Each Performance Obligation (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail" id="RelatedPartyTransactionsAdditionalInformationDetail">
        <link:definition>996155 - Disclosure - Related Party Transactions - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail" id="IncomeTaxesAdditionalInformationDetail">
        <link:definition>996165 - Disclosure - Income Taxes - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails" id="DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails">
        <link:definition>996175 - Disclosure - Income Taxes - Schedule of loss from operations before Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails" id="DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails">
        <link:definition>996185 - Disclosure - Income Taxes - Schedule of components of provision for income taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails" id="DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails">
        <link:definition>996195 - Disclosure - Income Taxes - Schedule of reconciliation of income tax expense (benefit) computed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" id="DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>996205 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails" id="DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails">
        <link:definition>996215 - Disclosure - Net Income (Loss) per Share - Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail" id="DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail">
        <link:definition>996225 - Disclosure - Net Income (Loss) per Share - Summary of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareAdditionalInformationDetail" id="DisclosureNetIncomeLossPerShareAdditionalInformationDetail">
        <link:definition>996235 - Disclosure - Net Income (Loss) per Share - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails" id="DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails">
        <link:definition>996245 - Disclosure - Segment Reporting - Summary of the Company's segment expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>996255 - Disclosure - Subsequent Events (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CoverPage" xlink:href="qttb-20241231.xsd#CoverPage" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1" xlink:href="qttb-20241231.xsd#StatementConsolidatedBalanceSheets1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="qttb-20241231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" xlink:href="qttb-20241231.xsd#StatementConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" xlink:href="qttb-20241231.xsd#StatementConsolidatedStatementsOfComprehensiveLossUnaudited" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" xlink:href="qttb-20241231.xsd#StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="qttb-20241231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:href="qttb-20241231.xsd#DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusiness" xlink:href="qttb-20241231.xsd#NatureOfTheBusiness" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPolicies" xlink:href="qttb-20241231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMerger" xlink:href="qttb-20241231.xsd#DisclosureAccountingForTheMerger" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestments" xlink:href="qttb-20241231.xsd#DisclosureShorttermInvestments" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurements" xlink:href="qttb-20241231.xsd#FairValueMeasurements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecurities" xlink:href="qttb-20241231.xsd#DisclosureInvestmentInEquitySecurities" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNet" xlink:href="qttb-20241231.xsd#PropertyAndEquipmentNet" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssets" xlink:href="qttb-20241231.xsd#PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssets" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="qttb-20241231.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingencies" xlink:href="qttb-20241231.xsd#CommitmentsAndContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/Debt" xlink:href="qttb-20241231.xsd#Debt" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStock" xlink:href="qttb-20241231.xsd#ConvertiblePreferredStock" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommonStock" xlink:href="qttb-20241231.xsd#CommonStock" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensation" xlink:href="qttb-20241231.xsd#StockBasedCompensation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizon" xlink:href="qttb-20241231.xsd#AgreementsWithHorizon" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactions" xlink:href="qttb-20241231.xsd#RelatedPartyTransactions" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DefinedContributionPlan" xlink:href="qttb-20241231.xsd#DefinedContributionPlan" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxes" xlink:href="qttb-20241231.xsd#IncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShare" xlink:href="qttb-20241231.xsd#DisclosureNetIncomeLossPerShare" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReporting" xlink:href="qttb-20241231.xsd#DisclosureSegmentReporting" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/SubsequentEvents" xlink:href="qttb-20241231.xsd#SubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="qttb-20241231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="qttb-20241231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerTables" xlink:href="qttb-20241231.xsd#DisclosureAccountingForTheMergerTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables" xlink:href="qttb-20241231.xsd#DisclosureShorttermInvestmentsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsTables" xlink:href="qttb-20241231.xsd#FairValueMeasurementsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetTables" xlink:href="qttb-20241231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTables" xlink:href="qttb-20241231.xsd#PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="qttb-20241231.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesTables" xlink:href="qttb-20241231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DebtTables" xlink:href="qttb-20241231.xsd#DebtTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommonStockTables" xlink:href="qttb-20241231.xsd#CommonStockTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationTables" xlink:href="qttb-20241231.xsd#StockBasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonTables" xlink:href="qttb-20241231.xsd#AgreementsWithHorizonTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesTables" xlink:href="qttb-20241231.xsd#IncomeTaxesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables" xlink:href="qttb-20241231.xsd#DisclosureNetIncomeLossPerShareTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:href="qttb-20241231.xsd#DisclosureSegmentReportingTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#NatureOfTheBusinessAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails" xlink:href="qttb-20241231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail" xlink:href="qttb-20241231.xsd#SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails" xlink:href="qttb-20241231.xsd#DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails" xlink:href="qttb-20241231.xsd#DisclosureAccountingForTheMergerAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails" xlink:href="qttb-20241231.xsd#DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetails" xlink:href="qttb-20241231.xsd#DisclosureShorttermInvestmentsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" xlink:href="qttb-20241231.xsd#DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail" xlink:href="qttb-20241231.xsd#FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails" xlink:href="qttb-20241231.xsd#DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail" xlink:href="qttb-20241231.xsd#PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#PropertyAndEquipmentNetAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:href="qttb-20241231.xsd#DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail" xlink:href="qttb-20241231.xsd#DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail" xlink:href="qttb-20241231.xsd#AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail" xlink:href="qttb-20241231.xsd#CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail" xlink:href="qttb-20241231.xsd#CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail" xlink:href="qttb-20241231.xsd#CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#DebtAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail" xlink:href="qttb-20241231.xsd#DebtSummaryOfLongTermDebtBalanceDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#ConvertiblePreferredStockAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail" xlink:href="qttb-20241231.xsd#DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#CommonStockAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail" xlink:href="qttb-20241231.xsd#DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail" xlink:href="qttb-20241231.xsd#DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" xlink:href="qttb-20241231.xsd#StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#StockBasedCompensationAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#AgreementsWithHorizonAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail" xlink:href="qttb-20241231.xsd#AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#RelatedPartyTransactionsAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#IncomeTaxesAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails" xlink:href="qttb-20241231.xsd#DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails" xlink:href="qttb-20241231.xsd#DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails" xlink:href="qttb-20241231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="qttb-20241231.xsd#DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails" xlink:href="qttb-20241231.xsd#DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail" xlink:href="qttb-20241231.xsd#DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareAdditionalInformationDetail" xlink:href="qttb-20241231.xsd#DisclosureNetIncomeLossPerShareAdditionalInformationDetail" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails" xlink:href="qttb-20241231.xsd#DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="qttb-20241231.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.q32bio.com/20241231/taxonomy/role/DisclosureDebtSummaryOfLongtermDebtBalanceDetail2" xlink:href="qttb-20241231.xsd#DisclosureDebtSummaryOfLongtermDebtBalanceDetail2" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#axisDefault" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HomologyMember" xlink:label="qttb_HomologyMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CommercialMilestonePaymentPayable" xlink:label="qttb_CommercialMilestonePaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccountingPoliciesLineItems" xlink:label="qttb_AccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncentiveFromLessor" xlink:label="us-gaap_IncentiveFromLessor"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AnnualRentOperatingLeaseAggregateAfterIncrease" xlink:label="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EventAxis" xlink:label="qttb_EventAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NatureOfBusinessLineItems" xlink:label="qttb_NatureOfBusinessLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponReceiptOfWaiverOfMilestoneConditionsMember" xlink:label="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheDomain" xlink:label="qttb_TrancheDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NonRule10B51ArrModifiedFlag" xlink:label="qttb_NonRule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HorizonCollaborationAgreementMember" xlink:label="qttb_HorizonCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityMember" xlink:label="qttb_TemporaryEquityMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash" xlink:label="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LeaseExpirationDateYearAndMonth" xlink:label="qttb_LeaseExpirationDateYearAndMonth"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OtherSegmentItemsMember" xlink:label="qttb_OtherSegmentItemsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CashConsiderationMember" xlink:label="qttb_CashConsiderationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="us-gaap_CommonStockSharesSubscriptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_WarrantsIssuedToSiliconValleyBankMember" xlink:label="qttb_WarrantsIssuedToSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_USStatutoryTaxRate" xlink:label="qttb_USStatutoryTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LossOnImpairmentOfEquityInvestment" xlink:label="qttb_LossOnImpairmentOfEquityInvestment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LegacyQ32Member" xlink:label="qttb_LegacyQ32Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember" xlink:label="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember" xlink:label="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CumulativeChangesOwnershipInterest" xlink:label="qttb_CumulativeChangesOwnershipInterest"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CompanysEffectiveTaxRate" xlink:label="qttb_CompanysEffectiveTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncomeTaxDisclosureTable" xlink:label="qttb_IncomeTaxDisclosureTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed" xlink:label="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SubleaseAggregateBaseRentObligation" xlink:label="qttb_SubleaseAggregateBaseRentObligation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:label="us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AgreementDomain" xlink:label="qttb_AgreementDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TotalDeferred" xlink:label="qttb_TotalDeferred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction" xlink:label="us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConsultingAndAdvisoryAgreementsMember" xlink:label="qttb_ConsultingAndAdvisoryAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheAxis" xlink:label="qttb_TrancheAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_WalthamMassauchetsMember" xlink:label="qttb_WalthamMassauchetsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember" xlink:label="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock" xlink:label="us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PersonnelRelatedCostsExcludingStockBasedCompensation" xlink:label="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UpfrontPaymentMade" xlink:label="qttb_UpfrontPaymentMade"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CommitmentAndContingenciesTable" xlink:label="qttb_CommitmentAndContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ChangeInFairValueOfEquityInvestment" xlink:label="qttb_ChangeInFairValueOfEquityInvestment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MeasurementInputProbabilityOfEachScenarioMember" xlink:label="qttb_MeasurementInputProbabilityOfEachScenarioMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_GainOnConvertibleNotes" xlink:label="qttb_GainOnConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheTwoMilestoneMember" xlink:label="qttb_TrancheTwoMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PatentsCostsPolicyTextBlock" xlink:label="qttb_PatentsCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BempikibartMember" xlink:label="qttb_BempikibartMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityFrequencyOfPayments" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CommitmentAndContingenciesLineItems" xlink:label="qttb_CommitmentAndContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="us-gaap_DefinedContributionPlanAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBConvertiblePreferredStockMember" xlink:label="qttb_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConvertibleDebtAgreementMember" xlink:label="qttb_ConvertibleDebtAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReceivedAdvancePayment" xlink:label="qttb_ReceivedAdvancePayment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FacilitiesITAndInsuranceMember" xlink:label="qttb_FacilitiesITAndInsuranceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AchievementOfSpecifiedMilestonesMember" xlink:label="qttb_AchievementOfSpecifiedMilestonesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock" xlink:label="qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PayrollTaxCredit" xlink:label="qttb_PayrollTaxCredit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergersAndAquisitionsAbstract" xlink:label="qttb_MergersAndAquisitionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborationAgreementContingentPayment" xlink:label="qttb_CollaborationAgreementContingentPayment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromCollaborators" xlink:label="us-gaap_ProceedsFromCollaborators"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FacilitiesITAndInsurance" xlink:label="qttb_FacilitiesITAndInsurance"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCommonStocksFromRsuVesting" xlink:label="qttb_IssuanceOfCommonStocksFromRsuVesting"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncomeLossBeforeProvisionForIncomeTaxes" xlink:label="qttb_IncomeLossBeforeProvisionForIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheOneMilestoneMember" xlink:label="qttb_TrancheOneMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityDividendRate" xlink:label="qttb_TemporaryEquityDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsFrequentFlierLiability" xlink:label="us-gaap_DeferredTaxAssetsFrequentFlierLiability"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RestrictedCashAndCashEquivalentsNonCurrentMember" xlink:label="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesARedeemablePreferredStockMember" xlink:label="qttb_SeriesARedeemablePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NatureOfBusinessTable" xlink:label="qttb_NatureOfBusinessTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OperatingLeaseAssetsLesseeAbstract" xlink:label="qttb_OperatingLeaseAssetsLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ParentCompanyMember" xlink:label="srt_ParentCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PercentageOfSublicenseFees" xlink:label="qttb_PercentageOfSublicenseFees"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock" xlink:label="qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FutureMinimumLeasePaymentDueUnderThisSublease" xlink:label="qttb_FutureMinimumLeasePaymentDueUnderThisSublease"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfVentureDebtTable" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DevelopmentMilestonePaymentPayable" xlink:label="qttb_DevelopmentMilestonePaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesBRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PersonnelRelatedAndConsultingMember" xlink:label="qttb_PersonnelRelatedAndConsultingMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AmountOfRefundLiability" xlink:label="qttb_AmountOfRefundLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_InvestmentMaturityTerm" xlink:label="qttb_InvestmentMaturityTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:label="qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DeferredTaxLiabilitiesFixedAssets" xlink:label="qttb_DeferredTaxLiabilitiesFixedAssets"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccountingPoliciesTable" xlink:label="qttb_AccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RevenueUsedToDetermineTransactionPrice" xlink:label="qttb_RevenueUsedToDetermineTransactionPrice"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NumberOfCommonStockUnderlyingShares" xlink:label="qttb_NumberOfCommonStockUnderlyingShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="qttb_AccruedResearchAndDevelopmentExpensesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesARedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TaxCreditCarryforwardsExpirationYear" xlink:label="qttb_TaxCreditCarryforwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember" xlink:label="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:label="us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="us-gaap_DebtInstrumentCollateralAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IndirectResearchAndDevelopmentMember" xlink:label="qttb_IndirectResearchAndDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CvrLiability" xlink:label="qttb_CvrLiability"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SalesBasedMilestoneMember" xlink:label="qttb_SalesBasedMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" xlink:label="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember" xlink:label="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PaymentOfReverseRecapitalizationTransactionCosts" xlink:label="qttb_PaymentOfReverseRecapitalizationTransactionCosts"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LicenseAgreementWithTheUniversityOfColoradoMember" xlink:label="qttb_LicenseAgreementWithTheUniversityOfColoradoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodAxis" xlink:label="qttb_PeriodAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionTable" xlink:label="qttb_MergerAndAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ADXZeroNineSevenMember" xlink:label="qttb_ADXZeroNineSevenMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AAPhaseTwoResearchServicesMember" xlink:label="qttb_AAPhaseTwoResearchServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_InvestmentsDisclosureAbstract" xlink:label="qttb_InvestmentsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodOfObligationToPayRoyalties" xlink:label="qttb_PeriodOfObligationToPayRoyalties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityStockIssuanceCosts" xlink:label="qttb_TemporaryEquityStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived" xlink:label="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OperatingLeaseLiabilitiesLesseeAbstract" xlink:label="qttb_OperatingLeaseLiabilitiesLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent" xlink:label="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LongTermDebtBalloonPaymentPercentage" xlink:label="qttb_LongTermDebtBalloonPaymentPercentage"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization" xlink:label="qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock" xlink:label="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeventhAmendmentToTheLoanAgreementMember" xlink:label="qttb_SeventhAmendmentToTheLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RestrictedCashNonCurrentMember" xlink:label="qttb_RestrictedCashNonCurrentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock" xlink:label="qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember" xlink:label="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares" xlink:label="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeDuringPeriodFairValueDisclosureMember" xlink:label="us-gaap_ChangeDuringPeriodFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScenarioTwoMember" xlink:label="qttb_ScenarioTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScenarioOneMember" xlink:label="qttb_ScenarioOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DebtInstrumentConversionPricePercentage" xlink:label="qttb_DebtInstrumentConversionPricePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborativeArrangementMilestonePayments" xlink:label="qttb_CollaborativeArrangementMilestonePayments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" xlink:label="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ExerciseOfCallOptionDescription" xlink:label="qttb_ExerciseOfCallOptionDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ADPhaseTwoResearchServicesMember" xlink:label="qttb_ADPhaseTwoResearchServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" xlink:label="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NumberOfDirectorsEntitledToBeElected" xlink:label="qttb_NumberOfDirectorsEntitledToBeElected"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PhaseDomain" xlink:label="qttb_PhaseDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TotalCurrentExpenseBenifit" xlink:label="qttb_TotalCurrentExpenseBenifit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FairValueOfInterestExpenses" xlink:label="qttb_FairValueOfInterestExpenses"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CurrentLiabilitiesMember" xlink:label="qttb_CurrentLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ChangeInFairValueOfConvertibleNotes" xlink:label="qttb_ChangeInFairValueOfConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1" xlink:label="us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EstimatedAggregateProceedsFromEquity" xlink:label="qttb_EstimatedAggregateProceedsFromEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember" xlink:label="us-gaap_AllOtherSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock" xlink:label="qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TotalSegmentNetLoss" xlink:label="qttb_TotalSegmentNetLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PhaseAxis" xlink:label="qttb_PhaseAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice" xlink:label="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RecivedLoanAgreement" xlink:label="qttb_RecivedLoanAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NetOperatingLossCarryForwardsExpirationYear" xlink:label="qttb_NetOperatingLossCarryForwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_Non-CashExpensesMember" xlink:label="qttb_Non-CashExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedExpensesAndOtherLiabilitiesCurrent" xlink:label="qttb_AccruedExpensesAndOtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConvertibleNotesMember" xlink:label="qttb_ConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender" xlink:label="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PrepaidExternalResearchAndDevelopmentCurrent" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember" xlink:label="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EventDomain" xlink:label="qttb_EventDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DiscoveryAndOtherMember" xlink:label="qttb_DiscoveryAndOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScenarioThreeMember" xlink:label="qttb_ScenarioThreeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" xlink:label="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OtherGAExpensesMember" xlink:label="qttb_OtherGAExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained" xlink:label="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DevelopmentAndSalesMilestonePaymentPayable" xlink:label="qttb_DevelopmentAndSalesMilestonePaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncomeTaxDisclosureLineItems" xlink:label="qttb_IncomeTaxDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTextBlock" xlink:label="us-gaap_DefinedContributionPlanTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IndirectResearchAndDevelopmentExpense" xlink:label="qttb_IndirectResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CurrentLiabilitiesLesseeAbstract" xlink:label="qttb_CurrentLiabilitiesLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CapitalizedIntangibleAssets" xlink:label="qttb_CapitalizedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodDomain" xlink:label="qttb_PeriodDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NonCurrentLiabilitiesLesseeAbstract" xlink:label="qttb_NonCurrentLiabilitiesLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RoyaltyAsAPercentageOfNetSales" xlink:label="qttb_RoyaltyAsAPercentageOfNetSales"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInEntiretyOfTemporaryEquity" xlink:label="qttb_DisclosureInEntiretyOfTemporaryEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheThreeMilestoneMember" xlink:label="qttb_TrancheThreeMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EighthAmendmentToTheLoanAgreementMember" xlink:label="qttb_EighthAmendmentToTheLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PropertyPlantAndEquipmentUsefulLife1" xlink:label="qttb_PropertyPlantAndEquipmentUsefulLife1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionLineItems" xlink:label="qttb_MergerAndAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ExcessOfAccruedRightToPurchaseStock" xlink:label="qttb_ExcessOfAccruedRightToPurchaseStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ProceedsFromReverseRecapitalization" xlink:label="qttb_ProceedsFromReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborationAgreementTransactionPrice" xlink:label="qttb_CollaborationAgreementTransactionPrice"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember" xlink:label="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCvrAtFairValue" xlink:label="qttb_IssuanceOfCvrAtFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PrepaidExternalResearchAndDevelopmentNonurrent" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentNonurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncreaseDecreaseInContingentLiability" xlink:label="qttb_IncreaseDecreaseInContingentLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" xlink:label="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_Rule10B51ArrModifiedFlag" xlink:label="qttb_Rule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HorizonTherapeuticsIrelandDacMember" xlink:label="qttb_HorizonTherapeuticsIrelandDacMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance" xlink:label="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EstimatedAggregateProceedsFromDebtAndEquity" xlink:label="qttb_EstimatedAggregateProceedsFromDebtAndEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAConvertiblePreferredStockMember" xlink:label="qttb_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FacilitiesITAndOtherAllocatedCostsMember" xlink:label="qttb_FacilitiesITAndOtherAllocatedCostsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OxbSolutionsMember" xlink:label="qttb_OxbSolutionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" xlink:label="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AgreementAxis" xlink:label="qttb_AgreementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OtherGAExpenses" xlink:label="qttb_OtherGAExpenses"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DeferredTaxAssetsLeaseLiability" xlink:label="qttb_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityConversionPricePerShare" xlink:label="qttb_TemporaryEquityConversionPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract" xlink:label="us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PaymentToHorizon" xlink:label="qttb_PaymentToHorizon"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandAndTwentyTermALoanAdvanceMember" xlink:label="qttb_TwoThousandAndTwentyTermALoanAdvanceMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SixthAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LeaseholdImprovements" xlink:label="qttb_LeaseholdImprovements"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_HomologyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Homology.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_HomologyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Homology [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_HomologyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Homology</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CommercialMilestonePaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commercial milestone payment payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CommercialMilestonePaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Milestone Payment Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CommercialMilestonePaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial milestone payment payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Addresses, Address Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncentiveFromLessor_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incentive from Lessor</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncentiveFromLessor_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee tenant improvement allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Liquidation Preference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock liquidation preference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual rent operating lease aggregate after increase.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Annual rent operating lease aggregate after increase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual Rent Operating lease Aggregate After Increase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EventAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Event.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EventAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Event [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EventAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Event [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Short Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue, Remaining Performance Obligation, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NatureOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Nature of business.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NatureOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature Of Business [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Components of in process research and development expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components Of In Process Research And Development Expenses [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss before income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before provision for income taxes and loss from equity method investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price, Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upon receipt of waiver of milestone conditions.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upon Receipt Of Waiver Of Milestone Conditions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Upon Receipt Of Waiver Of Milestone Conditions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Reverse Stock Split</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity, reverse stock split</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A One Convertible Preferred Stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A One Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A-1 convertible preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series A-1 convertible preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred, Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Other Observable Inputs (Level 2) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Gross [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Area of Real Estate Property</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AreaOfRealEstateProperty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office space leased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Other Segment Item, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingOtherItemAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other segment items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-Rule 10b5-1 Arrangement Modified [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-Rule 10b5-1 Arr Modified [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-Rule 10b5-1 Arrangement Modified</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Current Maturities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_HorizonCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Horizon collaboration agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_HorizonCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Horizon Collaboration Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_HorizonCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Horizon collaboration agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary Equity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of outstanding debt to be maintained with the lender by way of cash.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Outstanding Debt To Be Maintained With The Lender By Way Of Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of outstanding debt to be maintained with the lender by way of cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upon the conversion of authorized series a1 redeemable convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upon The Conversion Of Authorized Series A1 Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved upon the conversion of authorized Series A-1 preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LeaseExpirationDateYearAndMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease expiration date year and month.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LeaseExpirationDateYearAndMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date Year And Month</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LeaseExpirationDateYearAndMonth_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease expiration year and month</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right of use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Other Finite-Lived Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right of use asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OtherSegmentItemsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other segment items [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OtherSegmentItemsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other segment items</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal amount of term loans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit remaining borrowing capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_BusinessContactMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Contact [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CashConsiderationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash Consideration.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CashConsiderationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Consideration [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved for warrants [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants to purchase common stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible debt interest rate percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Shares, Cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Opinion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesSubscriptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Subscriptions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesSubscriptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, aggregate purchase price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_WarrantsIssuedToSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants issued to silicon valley bank.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_WarrantsIssuedToSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants Issued To Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_WarrantsIssuedToSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants Issued To Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_USStatutoryTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Statutory Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_USStatutoryTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">US Statutory Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_USStatutoryTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. statutory tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Aggregate Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity method investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LossOnImpairmentOfEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loss on impairment of equity investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LossOnImpairmentOfEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss on impairment of equity investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LossOnImpairmentOfEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss on impairment of equity investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Convertible Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of convertible debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from convertible debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate range, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Expected Dividend Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Required market rates of return [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LegacyQ32Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Legacy Q32 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LegacyQ32Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legacy Q32 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LegacyQ32Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legacy Q32</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Description and Basis of Presentation [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nature of the Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Foreign exchange contracts option contracts and other foreign exchange hedging arrangements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Exchange Contracts Option Contracts And Other Foreign Exchange Hedging Arrangements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign exchange contracts &amp; other forign heding arrangements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Before First Of July Two Thousand And Twenty Five [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Before First Of July Two Thousand And Twenty Five [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Dividends, Adjustment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, dividends, adjustment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of Purchase Price of Convertible notes to Common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt, Fair Value Disclosures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible debt, fair value disclosures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible debt at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CumulativeChangesOwnershipInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative Changes Ownership Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CumulativeChangesOwnershipInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Changes Ownership Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CumulativeChangesOwnershipInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cumulative Changes Ownership Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CompanysEffectiveTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Company's Effective Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CompanysEffectiveTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Company's Effective Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CompanysEffectiveTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Company's effective tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" xlink:role="http://fasb.org/us-gaap/role/label/axisDefault">Portion at Fair Value Measurement [Member] [Default]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Portion at Fair Value Measurement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Face value of debt instrument that may be contingently borrowed.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Face Value of Debt Instrument That May Be Contingently Borrowed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Face value of debt instrument that may be contingently borrowed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible note revaluation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment in Equity Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SubleaseAggregateBaseRentObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sublease aggregate base rent obligation.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SubleaseAggregateBaseRentObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sublease Aggregate Base Rent Obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SubleaseAggregateBaseRentObligation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sublease aggregate base rent obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share - basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net income (loss) per share-basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AgreementDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AgreementDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Agreement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AgreementDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Agreement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance period increase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments, Unrealized Gains</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Notes Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal balance of convertible notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TotalDeferred_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total deferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TotalDeferred_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total deferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TotalDeferred_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total deferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due to related parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteSpinoffTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note, Spinoff Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteSpinoffTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse recapitalization transaction costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConsultingAndAdvisoryAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Consulting and advisory agreements.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConsultingAndAdvisoryAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consulting And Advisory Agreements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConsultingAndAdvisoryAgreementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consulting and Advisory Agreements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_WalthamMassauchetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Waltham massauchets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_WalthamMassauchetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Waltham Massauchets [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_WalthamMassauchetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Waltham Massauchets [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Carrying amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Material right for the purchase of ADX nine hundred and fourteen.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Material Right For The Purchase Of ADX Nine Hundred And Fourteen [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Material right for the purchase of ADX-914</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Off-Balance-Sheet Credit Exposure, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Off-Balance&#160;Sheet Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of Shares, Outstanding at Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of Shares, Outstanding at Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Personnel Related Costs Excluding Stock Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Personnel Related Costs Excluding Stock Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Personnel-related costs (excluding stock-based compensation)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock capital shares reserved for future issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share based awards, common stock reserved for issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UpfrontPaymentMade_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront payment made.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UpfrontPaymentMade_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Payment Made</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UpfrontPaymentMade_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront payment made</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">components of in process research and development expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components Of In Process Research And Development Expenses [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CommitmentAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitment and contingencies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CommitmentAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitment And Contingencies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ChangeInFairValueOfEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change In Fair Value Of Equity Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ChangeInFairValueOfEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Fair Value Of Equity Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ChangeInFairValueOfEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of CVR liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MeasurementInputProbabilityOfEachScenarioMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Measurement input probability of each scenario member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MeasurementInputProbabilityOfEachScenarioMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Probability Of Each Scenario [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MeasurementInputProbabilityOfEachScenarioMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Probability of each scenario [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_GainOnConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Gain On Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_GainOnConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain On Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_GainOnConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on conversion of convertible notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_GainOnConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on convertible notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheTwoMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche two milestone.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheTwoMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Two Milestone [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheTwoMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Measurements, Recurring [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Financial Assets And Liabilities Measured At Fair Value On A Recurring Basis</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares reserved for stock option exercises [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in unrealized gain (loss) on available for sale securities, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PatentsCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patents costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PatentsCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patents Costs [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PatentsCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount retained</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Taxes Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued taxes payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved upon the conversion of the convertible notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity method investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BempikibartMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Bempikibart [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BempikibartMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Bempikibart [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BempikibartMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Bempikibart [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Purchases from Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party transaction expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of warrants or rights number of securities covered by warrants or rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share Based Compensation Arrangement By Share Based Payment Award Stock Offering Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Stock Offering Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock offering period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation and related expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reserved For Future Issuance Under Two Thousand And Twenty Four Stock Plan Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reserved For Future Issuance Under Two Thousand And Twenty Four Stock Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved for future issuance under the 2024 Stock Incentive Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant and Equipment [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Frequency of Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility frequency of payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income (expense), net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of computation of diluted net loss per share attributable to common stockholders</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit maximum borrowing capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate range</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CommitmentAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Commitment and contingencies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CommitmentAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitment And Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Research and development tax credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Notes Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain on conversion of the Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Notes Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current, Federal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">In process research and development expense recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of common stock shares reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Common Stock Shares Reserved For Future Issuance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B Convertible Preferred Stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B convertible preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series B convertible preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConvertibleDebtAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible debt agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConvertibleDebtAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConvertibleDebtAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Debt Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of stock issue price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series a one redeemable convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A One Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series A One Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net income (loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from option exercises, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of Shares, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued during period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Shares, Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReceivedAdvancePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Received advance payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReceivedAdvancePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Received Advance Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReceivedAdvancePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Received Advance Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FacilitiesITAndInsuranceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Facilities, IT and insurance [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FacilitiesITAndInsuranceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Facilities, IT and insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Line of Credit, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermLineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Venture debt, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Interest expenses on convertible debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense), net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other income (expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State and Local Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share based awards, maximum contractual term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and fixtures [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AchievementOfSpecifiedMilestonesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Achievement of specified milestones.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AchievementOfSpecifiedMilestonesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Achievement Of Specified Milestones [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AchievementOfSpecifiedMilestonesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Achievement Of Specified Milestones [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of estimated useful life of assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Estimated Useful Life Of Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Estimated Useful Life of Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Likelihood of Unfavorable Settlement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of common stock options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PayrollTaxCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payroll tax credit.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PayrollTaxCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payroll Tax Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PayrollTaxCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payroll tax credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MergersAndAquisitionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Mergers and Aquisitions Abstract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MergersAndAquisitionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Mergers and Aquisitions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable and Accrued Liabilities, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accounts payable and accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborationAgreementContingentPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration agreement contingent payment.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborationAgreementContingentPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Agreement Contingent Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborationAgreementContingentPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement, contingent payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for conversion of convertible notes, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payables and Accruals [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-Term Investments, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reserved for future issuance under two thousand and seventeen stock plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reserved For Future Issuance Under Two Thousand And Seventeen Stock Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved for future issuance under the 2017 Stock Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate range, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price, Cancelled</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Redeemable Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from redeemable convertible preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromCollaborators_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Collaborators</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromCollaborators_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Received amount from Horizon</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period Value to Homology Shareholders Reverse Recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value to Homology Shareholders Reverse Recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock to Homology shareholders in reverse recapitalization, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeveranceCosts1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Severance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeveranceCosts1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment Related to Severance Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Purchase of Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issued during period shares purchase of assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreements with Horizon</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock shares outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Considerations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income (Expense), Operating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Income (Expense), Operating, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest (income) expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of components of provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FacilitiesITAndInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Facilities IT And Insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FacilitiesITAndInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Facilities IT And Insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FacilitiesITAndInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Facilities, IT and insurance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upon the conversion of authorized series b redeemable convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upon The Conversion Of Authorized Series B Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved upon the conversion of authorized Series B preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCommonStocksFromRsuVesting_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of Common Stocks from RSU Vesting</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCommonStocksFromRsuVesting_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stocks from RSU Vesting</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCommonStocksFromRsuVesting_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance Of Common Stocks From Rsu Vesting, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncomeLossBeforeProvisionForIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss before provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncomeLossBeforeProvisionForIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) Before Provision For Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncomeLossBeforeProvisionForIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income (loss) before provision for income taxes.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncomeLossBeforeProvisionForIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheOneMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche one milestone.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheOneMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche One Milestone [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheOneMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche One Milestone [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheOneMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Tranche One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Foreign Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity dividend rate.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity dividend rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsFrequentFlierLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsFrequentFlierLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Frequent Flier Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash and cash equivalents non current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents Non Current [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash And Cash Equivalents Non Current [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments in Equity Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of Common Stock During Period Pre-Closing Net of Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock During Period Pre-Closing Net of Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in the pre-closing financing, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesARedeemablePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series a redeemable preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesARedeemablePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Redeemable Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NatureOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Nature of business.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NatureOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature Of Business [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash, cash equivalents, restricted cash and restricted cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Tax Credit Carryforward [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OperatingLeaseAssetsLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease assets lessee [Abstract].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OperatingLeaseAssetsLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Assets Lessee [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OperatingLeaseAssetsLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Payment Terms</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument terms of payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets, Fair Value Disclosure, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ParentCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Parent company [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ParentCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Parent Company [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Maturities of Operating Lease Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PercentageOfSublicenseFees_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">percentage of sublicense fees.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PercentageOfSublicenseFees_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Sublicense Fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PercentageOfSublicenseFees_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of sublicense fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share based awards, shares available for future grant</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of amounts reported in the balance sheet in respect of operating lease assets and corresponding liabilities [Table Text Block].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Amounts Reported In The Balance Sheet In Respect Of Operating Lease Assets And Corresponding Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Amounts Reported In The Balance Sheet In Respect Of Operating Lease Assets And Corresponding Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Unrecognised compensation cost, recognition period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent differences</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Permanent Differences Income Taxes, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective Income Tax Rate Reconciliation, Permanent Differences Income Taxes, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FutureMinimumLeasePaymentDueUnderThisSublease_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Future minimum lease payment due under this sublease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FutureMinimumLeasePaymentDueUnderThisSublease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Future minimum lease payment due under this sublease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FutureMinimumLeasePaymentDueUnderThisSublease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future minimum lease payment due under this sublease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of venture debt.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Venture Debt [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Basis [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Debt [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net assets acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (years) range</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Long-Term Lines of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from long term line of credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from borrowings under loan and security agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Measurement Input</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, measurement input</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash and restricted cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restricted Cash and Cash Equivalents, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DevelopmentMilestonePaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Development Milestone Payment Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DevelopmentMilestonePaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Development Milestone Payment Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DevelopmentMilestonePaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development Milestone Payment Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss from equity method investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from equity method investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segments [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series b redeemable convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series B Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PersonnelRelatedAndConsultingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Personnel Related and Consulting [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PersonnelRelatedAndConsultingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Personnel Related and Consulting [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PersonnelRelatedAndConsultingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Personnel Related and Consulting [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AmountOfRefundLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of refund liability.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AmountOfRefundLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amount Of Refund Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AmountOfRefundLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Refund liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Face Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument face value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_InvestmentMaturityTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Investment Maturity Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_InvestmentMaturityTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Maturity Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_InvestmentMaturityTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contractual maturity date of investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Charges, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Transaction Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current State and Local Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current, State</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease weighted average discount rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclousre of prepaid expenses other current assets and other noncurrent assets text block.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclousre Of Prepaid Expenses Other Current Assets and Other Noncurrent Assets [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses, Other Current Assets and Other Noncurrent Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Net of Valuation Allowance, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting for the Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock from option exercises</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long term debt balloon payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Operating Lease Cost and Variable Lease Costs and Sub Lease Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DeferredTaxLiabilitiesFixedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DeferredTaxLiabilitiesFixedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Fixed assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DeferredTaxLiabilitiesFixedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Liabilities Fixed assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total intrinsic value of options exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized R&amp;D expenditures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and development expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total segment and consolidated research and development expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total segment and consolidated research and development expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Excluding Current Maturities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-term debt, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Other-than-Temporary Impairment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment charge</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of common stock shares reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Common Stock Shares Reserved For Future Issuance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RevenueUsedToDetermineTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue used to determine transaction price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RevenueUsedToDetermineTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Used To Determine Transaction Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RevenueUsedToDetermineTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction price to be determined</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NumberOfCommonStockUnderlyingShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of common stock underlying shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NumberOfCommonStockUnderlyingShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Common Stock Underlying Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NumberOfCommonStockUnderlyingShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of Common Stock Underlying Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Shares, Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share based compensation by share based award options granted during the period shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restricted Cash and Cash Equivalents, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AddressTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Address Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expenses current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Expenses Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued external research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, FDIC Insured Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash FDIC insured amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Assumed in Reverse Recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Assumed in Reverse Recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Assumed in reverse recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series a redeemable convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TaxCreditCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforwards expiration year.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TaxCreditCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforwards Expiration Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TaxCreditCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards expiration year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Expected Term [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected Term (years) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Assumptions Used to Value Stock Options Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Estimate of Fair Value Measurement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty and two thousand and twenty three term a loan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty And Two Thousand And Twenty Three Term A Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Two Thousand And Twenty And Two Thousand And Twenty Three Term A Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReclassificationsOfTemporaryToPermanentEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassifications of Temporary to Permanent Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReclassificationsOfTemporaryToPermanentEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity converted into permanent equity value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCollateralAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Collateral Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCollateralAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument collateral given</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, by Class of Stock [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of warrants or rights exercise price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IndirectResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indirect Research and Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IndirectResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Indirect Research and Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IndirectResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indirect Research and Development [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Contingent Consideration, Asset, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination, intial consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CvrLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CVR Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CvrLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CVR Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CvrLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CVR liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SalesBasedMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales based milestone.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SalesBasedMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales Based Milestone [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SalesBasedMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales-based milestone</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Comprehensive Income [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits, settlements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of reconciliation of income tax expense (benefit) computed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of the transaction price allocated to each performance obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand seventeen stock option and grant plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Seventeen Stock Option and Grant Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2017 Stock Option and Grant Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Before thirty first of march two thousand and twenty six.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Before Thirty First Of March Two Thousand And Twenty Six [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Before Thirty First Of March Two Thousand And Twenty Six [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of prepaid expenses and other current assets table text block.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Prepaid Expenses And Other Current Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Prepaid Expenses and Other Current Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Venture debt two thousand twenty and two thousand and twenty three term a loan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Venture Debt Two Thousand Twenty And Two Thousand And Twenty Three Term A Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PaymentOfReverseRecapitalizationTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment Of Reverse Recapitalization Transaction Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PaymentOfReverseRecapitalizationTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment Of Reverse Recapitalization Transaction Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PaymentOfReverseRecapitalizationTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of reverse recapitalization transaction costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LicenseAgreementWithTheUniversityOfColoradoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement with the university of colorado.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LicenseAgreementWithTheUniversityOfColoradoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement With The University Of Colorado [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PeriodAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PeriodAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Period [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities, convertible preferred stock and stockholders' equity (deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MergerAndAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of information about merger and acquisition.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MergerAndAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Merger and Acquisition [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ADXZeroNineSevenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ADX Zero Nine Seven [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ADXZeroNineSevenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ADX Zero Nine Seven [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ADXZeroNineSevenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ADX-097 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options to purchase common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Ownership Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity method investment, ownership, percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Consideration Received on Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reverse recapitalization transaction costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AAPhaseTwoResearchServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">AA phase two research services.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AAPhaseTwoResearchServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AA Phase Two Research Services [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AAPhaseTwoResearchServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">AA phase 2 research services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of Common Stock During Period Pre-Closing Financing, Net of Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Common Stock During Period Pre-Closing Financing, Net of Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in the pre-closing financing, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indirect research and development expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Direct research and development expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_InvestmentsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Investments Disclosure Abstract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_InvestmentsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments Disclosure Abstract</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_InvestmentsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PeriodOfObligationToPayRoyalties_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period of obligation to pay royalties.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PeriodOfObligationToPayRoyalties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Period Of Obligation To Pay Royalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PeriodOfObligationToPayRoyalties_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period of obligation to pay royalties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for tax expense (benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total income tax provision</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan and security fourth amendment agreement with silicon valley bank.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan And Security Fourth Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan And Security Fourth Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock issuance costs.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity stock issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on disposal of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue, Performance Obligation Satisfied over Time [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity (deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration agreement contingent payment payable excess of cash received.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Agreement Contingent Payment Payable Excess Of Cash Received</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement, contingent payment payable excess of cash received</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OperatingLeaseLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease liabilities lessee [Abstract].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OperatingLeaseLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Liabilities Lessee [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OperatingLeaseLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee operating lease not yet commenced increase in percentage of base rent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee Operating Lease Not Yet Commenced Increase In Percentage Of Base Rent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage increase in initial annual base rent per square foot.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LongTermDebtBalloonPaymentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term debt balloon payment percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LongTermDebtBalloonPaymentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Balloon Payment Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LongTermDebtBalloonPaymentPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long term debt balloon payment percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short Term Investments Acquired In reverse recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Investments Acquired In reverse recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short Term Investments Acquired In reverse recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net deferred tax assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total gross deferred tax assets before valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination shares conversion into rights to purchase common stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Shares Conversion Into Rights To Purchase Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination shares conversion into rights to purchase common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeventhAmendmentToTheLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Seventh amendment to the loan agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeventhAmendmentToTheLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Seventh Amendment To The Loan Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeventhAmendmentToTheLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Seventh Amendment To The Loan Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RestrictedCashNonCurrentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash non current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RestrictedCashNonCurrentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Non Current [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RestrictedCashNonCurrentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash Non Current [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other noncurrent liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Convertible, Conversion Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument conversion price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Deferred Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long term debt variable interest rate percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tabular disclosure of recapitalization of assets and liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Recapitalization of Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Recapitalization of Assets and Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upon the conversion of authorized series a redeemable convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upon The Conversion Of Authorized Series A Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved upon the conversion of authorized Series A preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty three term a loan advance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Three Term A Loan Advance [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Two Thousand And Twenty Three Term A Loan Advance [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Deposit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SecurityDeposit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security deposit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Temporary Equity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of temporary equity into permanent equity shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Temporary Equity Into Permanent Equity Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of temporary equity into permanent equity shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeDuringPeriodFairValueDisclosureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Changes Measurement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeDuringPeriodFairValueDisclosureMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Income Tax Expense (Benefit), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current and deferred income tax expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScenarioTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Scenario two member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScenarioTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario Two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScenarioTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario two [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments, Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Short-term investments, Unrealized Losses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognised compensation cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Costs, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred transaction costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lab equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Of Common Stock Through Payroll Deductions Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Of Common Stock Through Payroll Deductions Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of common stock through payroll deductions expressed in percentage of fair market value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Operating Income (Expense), Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income (expense), net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock in connection with the Merger, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected stock price volatility range, minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScenarioOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Scenario one member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScenarioOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario One [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScenarioOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario one [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DebtInstrumentConversionPricePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument conversion price percentage.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DebtInstrumentConversionPricePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Conversion Price Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DebtInstrumentConversionPricePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument conversion price percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborativeArrangementMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaborative arrangement milestone payments.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborativeArrangementMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Milestone Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborativeArrangementMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement, Aggregate amount of sales milestone</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement with bristol mayers equib company.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement With Bristol Mayers Equib Company [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">License Agreement With Bristol Mayers Equib Company [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ExerciseOfCallOptionDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercise of Call Option Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ExerciseOfCallOptionDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise of Call Option Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ExerciseOfCallOptionDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of call option description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Credit Carryforwards, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Acquiree [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average grant date fair value, options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ADPhaseTwoResearchServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">AD phase two research services.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ADPhaseTwoResearchServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AD phase two research services [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ADPhaseTwoResearchServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">AD phase 2 research services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase In Number Of Shares Reserved For Issuance Percent Of Common Stock Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase In Number Of Shares Reserved For Issuance Percent Of Common Stock Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in number of shares reserved for issuance, percent of common stock outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NumberOfDirectorsEntitledToBeElected_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of directors entitled to be elected.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NumberOfDirectorsEntitledToBeElected_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Directors Entitled To Be Elected</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NumberOfDirectorsEntitledToBeElected_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of directors entitled to be elected</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less accumulated depreciation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Stock, Shares Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Stock, Shares Converted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities, convertible preferred stock and stockholders' equity (deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan and security fifth amendment agreement with silicon valley bank.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan And Security Fifth Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan And Security Fifth Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use asset, operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Liabilities Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of warrants issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prime Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reserved For Future Issuance Under Two Thousand And Twenty Four Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reserved For Future Issuance Under Two Thousand And Twenty Four Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved for future issuance under the 2024 Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PhaseDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Phase.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PhaseDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Phase [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share - diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net income (loss) per share-diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Before thirty first of march two thousand and twenty four.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Before Thirty First Of March Two Thousand And Twenty Four [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Before Thirty First Of March Two Thousand And Twenty Four [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TotalCurrentExpenseBenifit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TotalCurrentExpenseBenifit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Current Expense Benifit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TotalCurrentExpenseBenifit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total Current Expense Benifit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Commitment Fee Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility commitment fee amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FairValueOfInterestExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value of interest expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FairValueOfInterestExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair value Of Interest Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FairValueOfInterestExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value Of Interest Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan and security agreement with silicon valley bank.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan And Security Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan And Security Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock issued during the period new issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share based awards, vesting period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument converted into equity number of shares issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CurrentLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Current liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CurrentLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Liabilities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CurrentLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Liabilities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income (loss) attributable to common stockholders, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss) Available to Common Stockholders, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net income (loss)-diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan and security third amendment agreement with silicon valley bank.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan And Security Third Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Loan And Security Third Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of options vested</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Self Insurance Reserve</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Executive insurance reserve</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock par value per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Aggregate Intrinsic Value, Outstanding Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Aggregate Intrinsic Value, Outstanding Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Outstanding Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ChangeInFairValueOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in Fair Value Of Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ChangeInFairValueOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Fair Value Of Convertible Notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ChangeInFairValueOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of convertible notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ChangeInFairValueOfConvertibleNotes_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Change in fair value of convertible notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Date of First Required Payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility date of first required payment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EstimatedAggregateProceedsFromEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Estimated aggregate proceeds from equity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EstimatedAggregateProceedsFromEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Estimated Aggregate Proceeds From Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EstimatedAggregateProceedsFromEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated aggregate proceeds from equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Income (Loss) per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments and Joint Ventures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Method Investment [Abstarct]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares - basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average common shares outstanding-basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation and other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Equity Method Investments [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllOtherSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Operating Segment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of CVR at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued expenses and other current liabilities disclosure.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Expenses And Other Current Liabilities Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses and Other Current Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected stock price volatility range, maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Useful Life (Years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of common stock in pre-closing financing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Before thirty first of march two thousand and twenty five.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Before Thirty First Of March Two Thousand And Twenty Five [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Before Thirty First Of March Two Thousand And Twenty Five [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TotalSegmentNetLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Segment Net Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TotalSegmentNetLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total Segment Net Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TotalSegmentNetLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total Segment Net Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Quoted Prices in Active Markets (Level 1) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price, Vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price, Granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt and Warrant Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PhaseAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Phase.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PhaseAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Phase [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment, Long-Lived Asset, Held-for-Use</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment, long-lived asset, held-for-use</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Role of Management [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series a two redeemable convertible preferred stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Two Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series A Two Redeemable Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments, Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-Sale, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' deficit:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense Other, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding common stock of the combined company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of non-cash operating, investing and financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Assumed in reverse recapitalization, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Assumed in reverse recapitalization, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price, Assumed in reverse recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RecivedLoanAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Received loan agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RecivedLoanAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recived Loan Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RecivedLoanAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recived Loan Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property Plant and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term, Vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NetOperatingLossCarryForwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carryforwards expiration year.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NetOperatingLossCarryForwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carry forwards Expiration Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NetOperatingLossCarryForwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards, expiration year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_Non-CashExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non-cash expenses [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_Non-CashExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-cash expenses [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedExpensesAndOtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued Expenses And Other Liabilities Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedExpensesAndOtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Expenses And Other Liabilities Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedExpensesAndOtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ConvertibleNotesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Notes [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of consolidated cash to be maintained with the lender.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Consolidated Cash To Be Maintained With The Lender</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of consolidated cash to be maintained with the lender</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of warrants or rights term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income taxes, net of federal benefit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued penalties and provisions for interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Penalties and Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Examination, Penalties and Interest Expense, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Operating and Nonoperating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected stock price volatility range</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Fair Value Measurement Significant Inputs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Effective Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument effective rate of interest percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income (loss) attributable to common stockholders- basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss) Available to Common Stockholders, Basic, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net income (loss)-basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term, Exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Realized Gain (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized gains and losses on available-for-sale securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-Sale, Realized Gain (Loss), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid external research and development current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid External Research And Development Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid external research and development</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand Twenty Four Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Four Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EventDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Event.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EventDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Event [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EventDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Event [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Acquisition, Contingent Consideration, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent payment liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Asset Acquisition, Contingent Consideration, Liability, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">CVR liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DiscoveryAndOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Discovery and Other [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DiscoveryAndOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Discovery and Other [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DiscoveryAndOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Discovery and Other [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred but Not yet Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest payments on venture debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScenarioThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Scenario three member.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScenarioThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ScenarioThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credit carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued professional fees and other accrued liabilities current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees And Other Accrued Liabilities Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional services and other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OtherGAExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other G&amp;A expenses [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OtherGAExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other G&amp;A expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrestricted and unencumbered cash percentage to be maintained.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrestricted And Unencumbered Cash Percentage To Be Maintained</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrestricted and unencumbered cash percentage to be maintained</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DevelopmentAndSalesMilestonePaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Development and sales milestone payment payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DevelopmentAndSalesMilestonePaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Development And Sales Milestone Payment Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DevelopmentAndSalesMilestonePaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Development and sales milestone payment payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. statutory tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Federal income tax expense at statutory rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of convertible preferred stock to common stock in connection with the Merge, Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, and Short-Term Investments [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement Inputs and Valuation Techniques [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IndirectResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indirect research and development expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IndirectResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indirect Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IndirectResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Indirect Research and Development Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain/loss on convertible note conversion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Gain loss On Convertible Note Conversion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective Income Tax Rate Reconciliation Gain loss On Convertible Note Conversion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CurrentLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Current liabilities lessee [Abstract].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CurrentLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Liabilities Lessee [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CurrentLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of loss from operations before income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments, Amortized Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-Sale, Amortized Cost, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Deferred Tax Assets and Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability, current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Lease liability, current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of venture debt.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure in tabular form of venture debt [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CapitalizedIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capitalized Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CapitalizedIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Capitalized Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CapitalizedIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PeriodDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PeriodDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Period [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NonCurrentLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non current liabilities lessee [Abstract].</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NonCurrentLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Current Liabilities Lessee [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_NonCurrentLiabilitiesLesseeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncurrent:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Jurisdiction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RoyaltyAsAPercentageOfNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty as a percentage of net sales.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RoyaltyAsAPercentageOfNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty As A Percentage Of Net Sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_RoyaltyAsAPercentageOfNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty as a percentage of sales</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Debt Issuance Costs and Discounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt discount and issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of common stock shares reserved for future issuance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Common Stock Shares Reserved For Future Issuance [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Shares of Common Stock for Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInEntiretyOfTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in entirety of temporary equity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInEntiretyOfTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Entirety Of Temporary Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInEntiretyOfTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheThreeMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche three milestone.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheThreeMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Three Milestone [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TrancheThreeMilestoneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche Three [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EighthAmendmentToTheLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Eighth Amendment To The Loan Agreement Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EighthAmendmentToTheLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Eighth Amendment to the Loan Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PropertyPlantAndEquipmentUsefulLife1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Property plant and equipment useful life 1.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PropertyPlantAndEquipmentUsefulLife1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant And Equipment Useful Life 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PropertyPlantAndEquipmentUsefulLife1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Useful Life (Years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period Value to Homology Shareholders in Reverse Recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value to Homology Shareholders in Reverse Recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock to Homology shareholders in reverse recapitalization, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted- Average Exercise Price, Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MergerAndAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Merger and Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MergerAndAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Merger and Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_MergerAndAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Merger and Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Credit Risk and Significant Suppliers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unamortized debt discount and issuance costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share Reconciliation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Noncurrent Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other noncurrent assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash&#160;lease expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Currency Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ExcessOfAccruedRightToPurchaseStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Excess of accrued right to purchase stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ExcessOfAccruedRightToPurchaseStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Excess of accrued right to purchase stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ExcessOfAccruedRightToPurchaseStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Excess of accrued right to purchase stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net income loss to net cash used in operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property, Plant and Equipment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income (loss):</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other noncurrent assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other noncurrent assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ProceedsFromReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from Reverse Recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ProceedsFromReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Reverse Recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_ProceedsFromReverseRecapitalization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash acquired in connection with reverse recapitalization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborationAgreementTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaboration agreement transaction price.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborationAgreementTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaboration Agreement Transaction Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_CollaborationAgreementTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration agreement, transaction price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand Twenty Four Stock Option and Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Four Stock Option and Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Stock Option and Incentive Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCvrAtFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance Of CVR At Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCvrAtFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of CVR At Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IssuanceOfCvrAtFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of CVR at fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentNonurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">prepaid external research and development nonurrent.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentNonurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">prepaid external research and development nonurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentNonurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid external research and development - long term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses and other current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseDecreaseInContingentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseDecreaseInContingentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Contingent Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseDecreaseInContingentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase Decrease In Contingent Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseDecreaseInContingentLiability_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Contingent liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future minimum lease payments due under this sublease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line of credit facility amount that may be contingently borrowed.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Amount That May Be Contingently Borrowed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility amount that may be contingently borrowed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Rule 10b5-1 Arrangement Modified [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Rule 10b5-1 Arr Modified [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rule 10b5-1 Arrangement Modified</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_HorizonTherapeuticsIrelandDacMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Horizon Therapeutics Ireland DAC Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_HorizonTherapeuticsIrelandDacMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Horizon Therapeutics Ireland DAC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_HorizonTherapeuticsIrelandDacMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Horizon Therapeutics Ireland DAC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase In Common Stock Capital Shares Reserved For Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase In Common Stock Capital Shares Reserved For Future Issuance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in number of shares reserved for issuance (shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">United States</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan and security second amendment agreement with silicon valley bank.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan And Security Second Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Loan And Security Second Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Transaction Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value; 400,000,000 shares authorized, 12,197,615 and 359,569 shares issued and outstanding at December 31, 2024 2023, respectively</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock for conversion of Convertible Notes, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EstimatedAggregateProceedsFromDebtAndEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Estimated aggregate proceeds from debt and equity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EstimatedAggregateProceedsFromDebtAndEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Estimated Aggregate Proceeds From Debt And Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_EstimatedAggregateProceedsFromDebtAndEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated aggregate proceeds from debt and equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Venture debt, current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LinesOfCreditCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Line of credit facility outstanding current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of Prepaid Expenses and Other Noncurrent Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Prepaid Expenses and Other Noncurrent Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Prepaid Expenses and Other Noncurrent Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses and Other Current Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 10)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares - diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average common shares outstanding-diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Debt, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertibleDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Segment Reporting Information Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Vested and expected to vest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total minimum lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A Convertible Preferred Stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Convertible Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A convertible preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series A convertible preferred stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FacilitiesITAndOtherAllocatedCostsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Facilities, IT and other allocated costs [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_FacilitiesITAndOtherAllocatedCostsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Facilities, IT and other allocated costs [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Noncurrent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Basis Spread on Variable Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument variable interest spread</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OxbSolutionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Oxb Solutions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OxbSolutionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Oxb Solutions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OxbSolutionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Oxb Solutions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryforwards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Revenues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration arrangement revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">US Treasury securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line of credit facility aggregate amount including balloon repayment payable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Aggregate Amount Including Balloon Repayment Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility aggregate amount including balloon repayment payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting of restricted stock, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of premium on short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of premium on short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure in tabular form of venture debt.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disclosure In Tabular Form Of Venture Debt [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Long-term Debt Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Compensation Related Costs, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AgreementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AgreementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Agreement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_AgreementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Agreement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted- Average Exercise Price, Outstanding at Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted- Average Exercise Price, Outstanding at Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dilutive securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OtherGAExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other G&amp;A expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_OtherGAExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other G&amp;A expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred Tax Assets Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityConversionPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity conversion price per share.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityConversionPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Conversion Price Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TemporaryEquityConversionPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity conversion price per share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Commitment Fee Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility commitment fee percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Recognized Amount [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PaymentToHorizon_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment To Horizon</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PaymentToHorizon_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment to Horizon</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_PaymentToHorizon_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment to horizon</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: Valuation allowance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock shares outsstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, operating lease, lease not yet commenced, renewal term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive gain (loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Other Unobservable Inputs (Level 3) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease weighted average remaining lease term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandAndTwentyTermALoanAdvanceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty term a loan advance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandAndTwentyTermALoanAdvanceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Term A Loan Advance [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_TwoThousandAndTwentyTermALoanAdvanceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Two Thousand And Twenty Term A Loan Advance [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sixth amendment agreement with silicon valley bank.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sixth Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Sixth Amendment Agreement With Silicon Valley Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Long-Term Lines of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments on borrowings under loan and security agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments on borrowings under loan and security agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accruals and Reserves</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Short-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturities of short-term investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LeaseholdImprovements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="qttb_LeaseholdImprovements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Leasehold Improvements</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_HomologyMember" xlink:to="qttb_HomologyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CommercialMilestonePaymentPayable" xlink:to="qttb_CommercialMilestonePaymentPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AccountingPoliciesLineItems" xlink:to="qttb_AccountingPoliciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncentiveFromLessor" xlink:to="us-gaap_IncentiveFromLessor_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease" xlink:to="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_EventAxis" xlink:to="qttb_EventAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="qttb_NatureOfBusinessLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" xlink:to="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember" xlink:to="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SeriesAOneConvertiblePreferredStockMember" xlink:to="qttb_SeriesAOneConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfRealEstateProperty" xlink:to="us-gaap_AreaOfRealEstateProperty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingOtherItemAmount" xlink:to="us-gaap_SegmentReportingOtherItemAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_NonRule10B51ArrModifiedFlag" xlink:to="qttb_NonRule10B51ArrModifiedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_HorizonCollaborationAgreementMember" xlink:to="qttb_HorizonCollaborationAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TemporaryEquityMember" xlink:to="qttb_TemporaryEquityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash" xlink:to="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember" xlink:to="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LeaseExpirationDateYearAndMonth" xlink:to="qttb_LeaseExpirationDateYearAndMonth_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:to="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_OtherSegmentItemsMember" xlink:to="qttb_OtherSegmentItemsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CashConsiderationMember" xlink:to="qttb_CashConsiderationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesSubscriptions" xlink:to="us-gaap_CommonStockSharesSubscriptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_WarrantsIssuedToSiliconValleyBankMember" xlink:to="qttb_WarrantsIssuedToSiliconValleyBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_USStatutoryTaxRate" xlink:to="qttb_USStatutoryTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LossOnImpairmentOfEquityInvestment" xlink:to="qttb_LossOnImpairmentOfEquityInvestment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LegacyQ32Member" xlink:to="qttb_LegacyQ32Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember" xlink:to="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember" xlink:to="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDividendsAdjustment" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CumulativeChangesOwnershipInterest" xlink:to="qttb_CumulativeChangesOwnershipInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CompanysEffectiveTaxRate" xlink:to="qttb_CompanysEffectiveTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IncomeTaxDisclosureTable" xlink:to="qttb_IncomeTaxDisclosureTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed" xlink:to="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SubleaseAggregateBaseRentObligation" xlink:to="qttb_SubleaseAggregateBaseRentObligation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:to="us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AgreementDomain" xlink:to="qttb_AgreementDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TotalDeferred" xlink:to="qttb_TotalDeferred_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteSpinoffTransaction" xlink:to="us-gaap_StockholdersEquityNoteSpinoffTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ConsultingAndAdvisoryAgreementsMember" xlink:to="qttb_ConsultingAndAdvisoryAgreementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TrancheAxis" xlink:to="qttb_TrancheAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_WalthamMassauchetsMember" xlink:to="qttb_WalthamMassauchetsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember" xlink:to="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock" xlink:to="us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation" xlink:to="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:to="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_UpfrontPaymentMade" xlink:to="qttb_UpfrontPaymentMade_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" xlink:to="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="qttb_CommitmentAndContingenciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ChangeInFairValueOfEquityInvestment" xlink:to="qttb_ChangeInFairValueOfEquityInvestment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_MeasurementInputProbabilityOfEachScenarioMember" xlink:to="qttb_MeasurementInputProbabilityOfEachScenarioMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_GainOnConvertibleNotes" xlink:to="qttb_GainOnConvertibleNotes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TrancheTwoMilestoneMember" xlink:to="qttb_TrancheTwoMilestoneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PatentsCostsPolicyTextBlock" xlink:to="qttb_PatentsCostsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiability" xlink:to="us-gaap_ContractWithCustomerLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_BempikibartMember" xlink:to="qttb_BempikibartMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod" xlink:to="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember" xlink:to="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityFrequencyOfPayments" xlink:to="us-gaap_LineOfCreditFacilityFrequencyOfPayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_CommitmentAndContingenciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanAbstract" xlink:to="us-gaap_DefinedContributionPlanAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" xlink:to="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SeriesBConvertiblePreferredStockMember" xlink:to="qttb_SeriesBConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ConvertibleDebtAgreementMember" xlink:to="qttb_ConvertibleDebtAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:to="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ReceivedAdvancePayment" xlink:to="qttb_ReceivedAdvancePayment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_FacilitiesITAndInsuranceMember" xlink:to="qttb_FacilitiesITAndInsuranceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLineOfCredit" xlink:to="us-gaap_LongTermLineOfCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AchievementOfSpecifiedMilestonesMember" xlink:to="qttb_AchievementOfSpecifiedMilestonesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock" xlink:to="qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PayrollTaxCredit" xlink:to="qttb_PayrollTaxCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_MergersAndAquisitionsAbstract" xlink:to="qttb_MergersAndAquisitionsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CollaborationAgreementContingentPayment" xlink:to="qttb_CollaborationAgreementContingentPayment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember" xlink:to="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromCollaborators" xlink:to="us-gaap_ProceedsFromCollaborators_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" xlink:to="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeveranceCosts1" xlink:to="us-gaap_SeveranceCosts1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNet" xlink:to="us-gaap_InterestIncomeExpenseNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_FacilitiesITAndInsurance" xlink:to="qttb_FacilitiesITAndInsurance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember" xlink:to="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IssuanceOfCommonStocksFromRsuVesting" xlink:to="qttb_IssuanceOfCommonStocksFromRsuVesting_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IncomeLossBeforeProvisionForIncomeTaxes" xlink:to="qttb_IncomeLossBeforeProvisionForIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TrancheOneMilestoneMember" xlink:to="qttb_TrancheOneMilestoneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TemporaryEquityDividendRate" xlink:to="qttb_TemporaryEquityDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsFrequentFlierLiability" xlink:to="us-gaap_DeferredTaxAssetsFrequentFlierLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember" xlink:to="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" xlink:to="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SeriesARedeemablePreferredStockMember" xlink:to="qttb_SeriesARedeemablePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_NatureOfBusinessTable" xlink:to="qttb_NatureOfBusinessTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_OperatingLeaseAssetsLesseeAbstract" xlink:to="qttb_OperatingLeaseAssetsLesseeAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPaymentTerms" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ParentCompanyMember" xlink:to="srt_ParentCompanyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PercentageOfSublicenseFees" xlink:to="qttb_PercentageOfSublicenseFees_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock" xlink:to="qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_FutureMinimumLeasePaymentDueUnderThisSublease" xlink:to="qttb_FutureMinimumLeasePaymentDueUnderThisSublease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtTable" xlink:to="qttb_DisclosureInTabularFormOfVentureDebtTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DevelopmentMilestonePaymentPayable" xlink:to="qttb_DevelopmentMilestonePaymentPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SeriesBRedeemableConvertiblePreferredStockMember" xlink:to="qttb_SeriesBRedeemableConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PersonnelRelatedAndConsultingMember" xlink:to="qttb_PersonnelRelatedAndConsultingMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AmountOfRefundLiability" xlink:to="qttb_AmountOfRefundLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_InvestmentMaturityTerm" xlink:to="qttb_InvestmentMaturityTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:to="qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DeferredTaxLiabilitiesFixedAssets" xlink:to="qttb_DeferredTaxLiabilitiesFixedAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AccountingPoliciesTable" xlink:to="qttb_AccountingPoliciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_RevenueUsedToDetermineTransactionPrice" xlink:to="qttb_RevenueUsedToDetermineTransactionPrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_NumberOfCommonStockUnderlyingShares" xlink:to="qttb_NumberOfCommonStockUnderlyingShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalents" xlink:to="us-gaap_RestrictedCashAndCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AccruedResearchAndDevelopmentExpensesCurrent" xlink:to="qttb_AccruedResearchAndDevelopmentExpensesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization" xlink:to="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SeriesARedeemableConvertiblePreferredStockMember" xlink:to="qttb_SeriesARedeemableConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TaxCreditCarryforwardsExpirationYear" xlink:to="qttb_TaxCreditCarryforwardsExpirationYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember" xlink:to="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:to="us-gaap_ReclassificationsOfTemporaryToPermanentEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCollateralAmount" xlink:to="us-gaap_DebtInstrumentCollateralAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IndirectResearchAndDevelopmentMember" xlink:to="qttb_IndirectResearchAndDevelopmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CvrLiability" xlink:to="qttb_CvrLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SalesBasedMilestoneMember" xlink:to="qttb_SalesBasedMilestoneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" xlink:to="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember" xlink:to="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:to="qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember" xlink:to="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PaymentOfReverseRecapitalizationTransactionCosts" xlink:to="qttb_PaymentOfReverseRecapitalizationTransactionCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LicenseAgreementWithTheUniversityOfColoradoMember" xlink:to="qttb_LicenseAgreementWithTheUniversityOfColoradoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PeriodAxis" xlink:to="qttb_PeriodAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_MergerAndAcquisitionTable" xlink:to="qttb_MergerAndAcquisitionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ADXZeroNineSevenMember" xlink:to="qttb_ADXZeroNineSevenMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AAPhaseTwoResearchServicesMember" xlink:to="qttb_AAPhaseTwoResearchServicesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts" xlink:to="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherResearchAndDevelopmentExpense" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_InvestmentsDisclosureAbstract" xlink:to="qttb_InvestmentsDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PeriodOfObligationToPayRoyalties" xlink:to="qttb_PeriodOfObligationToPayRoyalties_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember" xlink:to="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TemporaryEquityStockIssuanceCosts" xlink:to="qttb_TemporaryEquityStockIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract" xlink:to="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived" xlink:to="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_OperatingLeaseLiabilitiesLesseeAbstract" xlink:to="qttb_OperatingLeaseLiabilitiesLesseeAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent" xlink:to="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LongTermDebtBalloonPaymentPercentage" xlink:to="qttb_LongTermDebtBalloonPaymentPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization" xlink:to="qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock" xlink:to="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SeventhAmendmentToTheLoanAgreementMember" xlink:to="qttb_SeventhAmendmentToTheLoanAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_RestrictedCashNonCurrentMember" xlink:to="qttb_RestrictedCashNonCurrentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:to="us-gaap_LongTermDebtPercentageBearingVariableInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock" xlink:to="qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember" xlink:to="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember" xlink:to="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares" xlink:to="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeDuringPeriodFairValueDisclosureMember" xlink:to="us-gaap_ChangeDuringPeriodFairValueDisclosureMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ScenarioTwoMember" xlink:to="qttb_ScenarioTwoMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCosts" xlink:to="us-gaap_DeferredCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage" xlink:to="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ScenarioOneMember" xlink:to="qttb_ScenarioOneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DebtInstrumentConversionPricePercentage" xlink:to="qttb_DebtInstrumentConversionPricePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CollaborativeArrangementMilestonePayments" xlink:to="qttb_CollaborativeArrangementMilestonePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" xlink:to="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ExerciseOfCallOptionDescription" xlink:to="qttb_ExerciseOfCallOptionDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ADPhaseTwoResearchServicesMember" xlink:to="qttb_ADPhaseTwoResearchServicesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" xlink:to="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_NumberOfDirectorsEntitledToBeElected" xlink:to="qttb_NumberOfDirectorsEntitledToBeElected_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember" xlink:to="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember" xlink:to="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PhaseDomain" xlink:to="qttb_PhaseDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember" xlink:to="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TotalCurrentExpenseBenifit" xlink:to="qttb_TotalCurrentExpenseBenifit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_FairValueOfInterestExpenses" xlink:to="qttb_FairValueOfInterestExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember" xlink:to="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CurrentLiabilitiesMember" xlink:to="qttb_CurrentLiabilitiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember" xlink:to="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ChangeInFairValueOfConvertibleNotes" xlink:to="qttb_ChangeInFairValueOfConvertibleNotes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1" xlink:to="us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_EstimatedAggregateProceedsFromEquity" xlink:to="qttb_EstimatedAggregateProceedsFromEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllOtherSegmentsMember" xlink:to="us-gaap_AllOtherSegmentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock" xlink:to="qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember" xlink:to="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TotalSegmentNetLoss" xlink:to="qttb_TotalSegmentNetLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PhaseAxis" xlink:to="qttb_PhaseAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:to="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseOtherNoncurrent" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:to="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice" xlink:to="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_RecivedLoanAgreement" xlink:to="qttb_RecivedLoanAgreement_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_NetOperatingLossCarryForwardsExpirationYear" xlink:to="qttb_NetOperatingLossCarryForwardsExpirationYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_Non-CashExpensesMember" xlink:to="qttb_Non-CashExpensesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AccruedExpensesAndOtherLiabilitiesCurrent" xlink:to="qttb_AccruedExpensesAndOtherLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ConvertibleNotesMember" xlink:to="qttb_ConvertibleNotesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender" xlink:to="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PrepaidExternalResearchAndDevelopmentCurrent" xlink:to="qttb_PrepaidExternalResearchAndDevelopmentCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember" xlink:to="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_EventDomain" xlink:to="qttb_EventDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DiscoveryAndOtherMember" xlink:to="qttb_DiscoveryAndOtherMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ScenarioThreeMember" xlink:to="qttb_ScenarioThreeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" xlink:to="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_OtherGAExpensesMember" xlink:to="qttb_OtherGAExpensesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained" xlink:to="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DevelopmentAndSalesMilestonePaymentPayable" xlink:to="qttb_DevelopmentAndSalesMilestonePaymentPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_IncomeTaxDisclosureLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanTextBlock" xlink:to="us-gaap_DefinedContributionPlanTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:to="us-gaap_FairValueInputsQuantitativeInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IndirectResearchAndDevelopmentExpense" xlink:to="qttb_IndirectResearchAndDevelopmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CurrentLiabilitiesLesseeAbstract" xlink:to="qttb_CurrentLiabilitiesLesseeAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="qttb_DisclosureInTabularFormOfVentureDebtLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CapitalizedIntangibleAssets" xlink:to="qttb_CapitalizedIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PeriodDomain" xlink:to="qttb_PeriodDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_NonCurrentLiabilitiesLesseeAbstract" xlink:to="qttb_NonCurrentLiabilitiesLesseeAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_RoyaltyAsAPercentageOfNetSales" xlink:to="qttb_RoyaltyAsAPercentageOfNetSales_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" xlink:to="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DisclosureInEntiretyOfTemporaryEquity" xlink:to="qttb_DisclosureInEntiretyOfTemporaryEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TrancheThreeMilestoneMember" xlink:to="qttb_TrancheThreeMilestoneMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_EighthAmendmentToTheLoanAgreementMember" xlink:to="qttb_EighthAmendmentToTheLoanAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PropertyPlantAndEquipmentUsefulLife1" xlink:to="qttb_PropertyPlantAndEquipmentUsefulLife1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization" xlink:to="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="qttb_MergerAndAcquisitionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="us-gaap_EarningsPerShareReconciliationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ExcessOfAccruedRightToPurchaseStock" xlink:to="qttb_ExcessOfAccruedRightToPurchaseStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_ProceedsFromReverseRecapitalization" xlink:to="qttb_ProceedsFromReverseRecapitalization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_CollaborationAgreementTransactionPrice" xlink:to="qttb_CollaborationAgreementTransactionPrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember" xlink:to="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IssuanceOfCvrAtFairValue" xlink:to="qttb_IssuanceOfCvrAtFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PrepaidExternalResearchAndDevelopmentNonurrent" xlink:to="qttb_PrepaidExternalResearchAndDevelopmentNonurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IncreaseDecreaseInContingentLiability" xlink:to="qttb_IncreaseDecreaseInContingentLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" xlink:to="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_Rule10B51ArrModifiedFlag" xlink:to="qttb_Rule10B51ArrModifiedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_HorizonTherapeuticsIrelandDacMember" xlink:to="qttb_HorizonTherapeuticsIrelandDacMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance" xlink:to="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember" xlink:to="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_EstimatedAggregateProceedsFromDebtAndEquity" xlink:to="qttb_EstimatedAggregateProceedsFromDebtAndEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LinesOfCreditCurrent" xlink:to="us-gaap_LinesOfCreditCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock" xlink:to="qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtNoncurrent" xlink:to="us-gaap_ConvertibleDebtNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SeriesAConvertiblePreferredStockMember" xlink:to="qttb_SeriesAConvertiblePreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_FacilitiesITAndOtherAllocatedCostsMember" xlink:to="qttb_FacilitiesITAndOtherAllocatedCostsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_OxbSolutionsMember" xlink:to="qttb_OxbSolutionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" xlink:to="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock" xlink:to="qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_AgreementAxis" xlink:to="qttb_AgreementAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_OtherGAExpenses" xlink:to="qttb_OtherGAExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_DeferredTaxAssetsLeaseLiability" xlink:to="qttb_DeferredTaxAssetsLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TemporaryEquityConversionPricePerShare" xlink:to="qttb_TemporaryEquityConversionPricePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract" xlink:to="us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_PaymentToHorizon" xlink:to="qttb_PaymentToHorizon_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_TwoThousandAndTwentyTermALoanAdvanceMember" xlink:to="qttb_TwoThousandAndTwentyTermALoanAdvanceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember" xlink:to="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="us-gaap_RepaymentsOfLongTermLinesOfCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="qttb_LeaseholdImprovements" xlink:to="qttb_LeaseholdImprovements_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CoverPage" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentInformationTable" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAConvertiblePreferredStockMember" xlink:label="qttb_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedExpensesAndOtherLiabilitiesCurrent" xlink:label="qttb_AccruedExpensesAndOtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBConvertiblePreferredStockMember" xlink:label="qttb_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CvrLiability" xlink:label="qttb_CvrLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAOneConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="qttb_AccruedExpensesAndOtherLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="qttb_CvrLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermLineOfCredit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LinesOfCreditCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ConvertibleDebtNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAConvertiblePreferredStockMember" xlink:label="qttb_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBConvertiblePreferredStockMember" xlink:label="qttb_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAOneConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ChangeInFairValueOfConvertibleNotes" xlink:label="qttb_ChangeInFairValueOfConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_Revenues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="qttb_ChangeInFairValueOfConvertibleNotes" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAConvertiblePreferredStockMember" xlink:label="qttb_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBConvertiblePreferredStockMember" xlink:label="qttb_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction" xlink:label="us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCommonStocksFromRsuVesting" xlink:label="qttb_IssuanceOfCommonStocksFromRsuVesting"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_22"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_23"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_24"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_25"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAOneConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteSpinoffTransaction" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_IssuanceOfCommonStocksFromRsuVesting" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_22" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_23" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_24" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_25" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization" xlink:label="qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCvrAtFairValue" xlink:label="qttb_IssuanceOfCvrAtFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ProceedsFromReverseRecapitalization" xlink:label="qttb_ProceedsFromReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PaymentOfReverseRecapitalizationTransactionCosts" xlink:label="qttb_PaymentOfReverseRecapitalizationTransactionCosts"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncreaseDecreaseInContingentLiability" xlink:label="qttb_IncreaseDecreaseInContingentLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LossOnImpairmentOfEquityInvestment" xlink:label="qttb_LossOnImpairmentOfEquityInvestment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ChangeInFairValueOfEquityInvestment" xlink:label="qttb_ChangeInFairValueOfEquityInvestment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ChangeInFairValueOfConvertibleNotes" xlink:label="qttb_ChangeInFairValueOfConvertibleNotes"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfLongTermLinesOfCredit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="qttb_IssuanceOfCvrAtFairValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="qttb_ProceedsFromReverseRecapitalization" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="qttb_PaymentOfReverseRecapitalizationTransactionCosts" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="qttb_IncreaseDecreaseInContingentLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="qttb_LossOnImpairmentOfEquityInvestment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="qttb_ChangeInFairValueOfEquityInvestment" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="qttb_ChangeInFairValueOfConvertibleNotes" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_Rule10B51ArrModifiedFlag" xlink:label="qttb_Rule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NonRule10B51ArrModifiedFlag" xlink:label="qttb_NonRule10B51ArrModifiedFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="qttb_Rule10B51ArrModifiedFlag" order="14.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="qttb_NonRule10B51ArrModifiedFlag" order="15.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusiness" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMerger" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergersAndAquisitionsAbstract" xlink:label="qttb_MergersAndAquisitionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergersAndAquisitionsAbstract" xlink:to="us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestments" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_InvestmentsDisclosureAbstract" xlink:label="qttb_InvestmentsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_InvestmentsDisclosureAbstract" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecurities" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNet" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssets" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" xlink:label="qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock" xlink:label="qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/Debt" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStock" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInEntiretyOfTemporaryEquity" xlink:label="qttb_DisclosureInEntiretyOfTemporaryEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="qttb_DisclosureInEntiretyOfTemporaryEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommonStock" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizon" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DefinedContributionPlan" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanAbstract" xlink:label="us-gaap_DefinedContributionPlanAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTextBlock" xlink:label="us-gaap_DefinedContributionPlanTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DefinedContributionPlanAbstract" xlink:to="us-gaap_DefinedContributionPlanTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShare" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReporting" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/SubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock" xlink:label="us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PatentsCostsPolicyTextBlock" xlink:label="qttb_PatentsCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsPolicyPolicyTextBlock" xlink:label="us-gaap_SubsequentEventsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsPolicy" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DebtPolicyTextBlock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="qttb_PatentsCostsPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SubsequentEventsPolicyPolicyTextBlock" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock" xlink:label="qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergersAndAquisitionsAbstract" xlink:label="qttb_MergersAndAquisitionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock" xlink:label="qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergersAndAquisitionsAbstract" xlink:to="qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_InvestmentsDisclosureAbstract" xlink:label="qttb_InvestmentsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_InvestmentsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock" xlink:label="qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock" xlink:label="qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DebtTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommonStockTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NatureOfBusinessLineItems" xlink:label="qttb_NatureOfBusinessLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="us-gaap_CommonStockSharesSubscriptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NatureOfBusinessTable" xlink:label="qttb_NatureOfBusinessTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ParentCompanyMember" xlink:label="srt_ParentCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HomologyMember" xlink:label="qttb_HomologyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock" xlink:label="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_CommonStockSharesSubscriptions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ParentCompanyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="qttb_HomologyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="qttb_NatureOfBusinessTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessTable" xlink:to="qttb_NatureOfBusinessLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_NetIncomeLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalents" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccountingPoliciesLineItems" xlink:label="qttb_AccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccountingPoliciesTable" xlink:label="qttb_AccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember" xlink:label="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_AccountingPoliciesLineItems" xlink:to="us-gaap_CashFDICInsuredAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_AccountingPoliciesTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="qttb_AccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_AccountingPoliciesLineItems" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_AccountingPoliciesTable" xlink:to="qttb_AccountingPoliciesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_AccountingPoliciesLineItems" xlink:to="us-gaap_IncomeTaxExaminationDescription" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PropertyPlantAndEquipmentUsefulLife1" xlink:label="qttb_PropertyPlantAndEquipmentUsefulLife1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="qttb_PropertyPlantAndEquipmentUsefulLife1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergersAndAquisitionsAbstract" xlink:label="qttb_MergersAndAquisitionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionTable" xlink:label="qttb_MergerAndAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LegacyQ32Member" xlink:label="qttb_LegacyQ32Member"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionLineItems" xlink:label="qttb_MergerAndAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergersAndAquisitionsAbstract" xlink:to="qttb_MergerAndAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="qttb_LegacyQ32Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionTable" xlink:to="qttb_MergerAndAcquisitionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_Assets" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergersAndAquisitionsAbstract" xlink:label="qttb_MergersAndAquisitionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionTable" xlink:label="qttb_MergerAndAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionLineItems" xlink:label="qttb_MergerAndAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" order="0" priority="2" use="optional" preferredLabel="http://fasb.org/us-gaap/role/label/axisDefault"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergersAndAquisitionsAbstract" xlink:to="qttb_MergerAndAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionTable" xlink:to="qttb_MergerAndAcquisitionLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_SeveranceCosts1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_InvestmentsDisclosureAbstract" xlink:label="qttb_InvestmentsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_InvestmentsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ShortTermDebtLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_InvestmentsDisclosureAbstract" xlink:label="qttb_InvestmentsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_InvestmentMaturityTerm" xlink:label="qttb_InvestmentMaturityTerm"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_InvestmentsDisclosureAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_InvestmentsDisclosureAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_InvestmentsDisclosureAbstract" xlink:to="qttb_InvestmentMaturityTerm" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CvrLiability" xlink:label="qttb_CvrLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="qttb_CvrLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleDebtCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MeasurementInputProbabilityOfEachScenarioMember" xlink:label="qttb_MeasurementInputProbabilityOfEachScenarioMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:label="us-gaap_FairValueInputsQuantitativeInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScenarioOneMember" xlink:label="qttb_ScenarioOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScenarioTwoMember" xlink:label="qttb_ScenarioTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScenarioThreeMember" xlink:label="qttb_ScenarioThreeMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="qttb_MeasurementInputProbabilityOfEachScenarioMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentMeasurementInput" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueInputsQuantitativeInformationAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="qttb_ScenarioOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_StatementScenarioAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="qttb_ScenarioTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="qttb_ScenarioThreeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConvertibleNotesMember" xlink:label="qttb_ConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FairValueOfInterestExpenses" xlink:label="qttb_FairValueOfInterestExpenses"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CvrLiability" xlink:label="qttb_CvrLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_GainOnConvertibleNotes" xlink:label="qttb_GainOnConvertibleNotes"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_ConvertibleNotesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="qttb_FairValueOfInterestExpenses" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="qttb_CvrLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="qttb_GainOnConvertibleNotes" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HomologyMember" xlink:label="qttb_HomologyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OxbSolutionsMember" xlink:label="qttb_OxbSolutionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="qttb_HomologyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="qttb_OxbSolutionsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PrepaidExternalResearchAndDevelopmentCurrent" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PayrollTaxCredit" xlink:label="qttb_PayrollTaxCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="qttb_PrepaidExternalResearchAndDevelopmentCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="qttb_PayrollTaxCredit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PrepaidExternalResearchAndDevelopmentNonurrent" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentNonurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_DeferredCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract" xlink:to="qttb_PrepaidExternalResearchAndDevelopmentNonurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="qttb_AccruedResearchAndDevelopmentExpensesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" xlink:label="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="qttb_AccruedResearchAndDevelopmentExpensesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_TaxesPayableCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OperatingLeaseAssetsLesseeAbstract" xlink:label="qttb_OperatingLeaseAssetsLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OperatingLeaseLiabilitiesLesseeAbstract" xlink:label="qttb_OperatingLeaseLiabilitiesLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CurrentLiabilitiesLesseeAbstract" xlink:label="qttb_CurrentLiabilitiesLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NonCurrentLiabilitiesLesseeAbstract" xlink:label="qttb_NonCurrentLiabilitiesLesseeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_OperatingLeaseAssetsLesseeAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_OperatingLeaseLiabilitiesLesseeAbstract" xlink:to="qttb_CurrentLiabilitiesLesseeAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CurrentLiabilitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="qttb_OperatingLeaseAssetsLesseeAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_NonCurrentLiabilitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_OperatingLeaseLiabilitiesLesseeAbstract" xlink:to="qttb_NonCurrentLiabilitiesLesseeAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CurrentLiabilitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="qttb_OperatingLeaseLiabilitiesLesseeAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_OperatingLeaseLiabilitiesLesseeAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_VariableLeaseCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LeaseCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability_11"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability_11" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheDomain" xlink:label="qttb_TrancheDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheOneMilestoneMember" xlink:label="qttb_TrancheOneMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LicenseAgreementWithTheUniversityOfColoradoMember" xlink:label="qttb_LicenseAgreementWithTheUniversityOfColoradoMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheAxis" xlink:label="qttb_TrancheAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CashConsiderationMember" xlink:label="qttb_CashConsiderationMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CommitmentAndContingenciesTable" xlink:label="qttb_CommitmentAndContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CommitmentAndContingenciesLineItems" xlink:label="qttb_CommitmentAndContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesARedeemablePreferredStockMember" xlink:label="qttb_SeriesARedeemablePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RestrictedCashAndCashEquivalentsNonCurrentMember" xlink:label="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_WalthamMassauchetsMember" xlink:label="qttb_WalthamMassauchetsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheTwoMilestoneMember" xlink:label="qttb_TrancheTwoMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" xlink:label="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityMember" xlink:label="qttb_TemporaryEquityMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LeaseExpirationDateYearAndMonth" xlink:label="qttb_LeaseExpirationDateYearAndMonth"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheThreeMilestoneMember" xlink:label="qttb_TrancheThreeMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SubleaseAggregateBaseRentObligation" xlink:label="qttb_SubleaseAggregateBaseRentObligation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent" xlink:label="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AnnualRentOperatingLeaseAggregateAfterIncrease" xlink:label="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncentiveFromLessor" xlink:label="us-gaap_IncentiveFromLessor"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DevelopmentAndSalesMilestonePaymentPayable" xlink:label="qttb_DevelopmentAndSalesMilestonePaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PercentageOfSublicenseFees" xlink:label="qttb_PercentageOfSublicenseFees"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodOfObligationToPayRoyalties" xlink:label="qttb_PeriodOfObligationToPayRoyalties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FutureMinimumLeasePaymentDueUnderThisSublease" xlink:label="qttb_FutureMinimumLeasePaymentDueUnderThisSublease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UpfrontPaymentMade" xlink:label="qttb_UpfrontPaymentMade"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CommercialMilestonePaymentPayable" xlink:label="qttb_CommercialMilestonePaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RoyaltyAsAPercentageOfNetSales" xlink:label="qttb_RoyaltyAsAPercentageOfNetSales"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DevelopmentMilestonePaymentPayable" xlink:label="qttb_DevelopmentMilestonePaymentPayable"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" xlink:to="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheOneMilestoneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LicenseAgreementWithTheUniversityOfColoradoMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_TrancheAxis" xlink:to="qttb_TrancheDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" xlink:to="qttb_CashConsiderationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesARedeemablePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="qttb_WalthamMassauchetsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="qttb_CommitmentAndContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheTwoMilestoneMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" xlink:to="qttb_TemporaryEquityMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_LeaseExpirationDateYearAndMonth" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheThreeMilestoneMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_SubleaseAggregateBaseRentObligation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="qttb_TrancheAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="qttb_CommitmentAndContingenciesLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_SecurityDeposit" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_IncentiveFromLessor" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_DevelopmentAndSalesMilestonePaymentPayable" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_PercentageOfSublicenseFees" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_PeriodOfObligationToPayRoyalties" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_FutureMinimumLeasePaymentDueUnderThisSublease" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_UpfrontPaymentMade" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_CommercialMilestonePaymentPayable" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_RoyaltyAsAPercentageOfNetSales" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_SelfInsuranceReserve" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_DevelopmentMilestonePaymentPayable" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheDomain" xlink:label="qttb_TrancheDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheOneMilestoneMember" xlink:label="qttb_TrancheOneMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheAxis" xlink:label="qttb_TrancheAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandAndTwentyTermALoanAdvanceMember" xlink:label="qttb_TwoThousandAndTwentyTermALoanAdvanceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesBRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RestrictedCashNonCurrentMember" xlink:label="qttb_RestrictedCashNonCurrentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodAxis" xlink:label="qttb_PeriodAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodDomain" xlink:label="qttb_PeriodDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_WarrantsIssuedToSiliconValleyBankMember" xlink:label="qttb_WarrantsIssuedToSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheTwoMilestoneMember" xlink:label="qttb_TrancheTwoMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeDuringPeriodFairValueDisclosureMember" xlink:label="us-gaap_ChangeDuringPeriodFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember" xlink:label="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CurrentLiabilitiesMember" xlink:label="qttb_CurrentLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember" xlink:label="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConvertibleDebtAgreementMember" xlink:label="qttb_ConvertibleDebtAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember" xlink:label="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1" xlink:label="us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SixthAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeventhAmendmentToTheLoanAgreementMember" xlink:label="qttb_SeventhAmendmentToTheLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EighthAmendmentToTheLoanAgreementMember" xlink:label="qttb_EighthAmendmentToTheLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LongTermDebtBalloonPaymentPercentage" xlink:label="qttb_LongTermDebtBalloonPaymentPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityFrequencyOfPayments" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="us-gaap_DebtInstrumentCollateralAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender" xlink:label="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained" xlink:label="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash" xlink:label="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" xlink:label="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" xlink:label="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed" xlink:label="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EstimatedAggregateProceedsFromDebtAndEquity" xlink:label="qttb_EstimatedAggregateProceedsFromDebtAndEquity"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EstimatedAggregateProceedsFromEquity" xlink:label="qttb_EstimatedAggregateProceedsFromEquity"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReceivedAdvancePayment" xlink:label="qttb_ReceivedAdvancePayment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RecivedLoanAgreement" xlink:label="qttb_RecivedLoanAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DebtInstrumentConversionPricePercentage" xlink:label="qttb_DebtInstrumentConversionPricePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheOneMilestoneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" order="0" priority="2" use="optional" preferredLabel="http://fasb.org/us-gaap/role/label/axisDefault"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_TrancheAxis" xlink:to="qttb_TrancheDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_TwoThousandAndTwentyTermALoanAdvanceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBRedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="qttb_RestrictedCashNonCurrentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_PeriodAxis" xlink:to="qttb_PeriodDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="qttb_WarrantsIssuedToSiliconValleyBankMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_PeriodDomain" xlink:to="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheTwoMilestoneMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_ChangeDuringPeriodFairValueDisclosureMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="qttb_CurrentLiabilitiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_PeriodDomain" xlink:to="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_PeriodDomain" xlink:to="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtPercentageBearingVariableInterestRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_ConvertibleDebtAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="qttb_PeriodAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_PeriodDomain" xlink:to="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_SeventhAmendmentToTheLoanAgreementMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_EighthAmendmentToTheLoanAgreementMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeePercentage" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_LongTermDebtBalloonPaymentPercentage" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="qttb_TrancheAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityFrequencyOfPayments" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCollateralAmount" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LinesOfCreditCurrent" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_EstimatedAggregateProceedsFromDebtAndEquity" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_EstimatedAggregateProceedsFromEquity" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_ReceivedAdvancePayment" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_RecivedLoanAgreement" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpense" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_DebtInstrumentConversionPricePercentage" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="39" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableCurrent" order="40" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember" xlink:label="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfVentureDebtTable" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="qttb_DisclosureInTabularFormOfVentureDebtTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtTable" xlink:to="qttb_DisclosureInTabularFormOfVentureDebtLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_LongTermDebt" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_LongTermDebtCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EventAxis" xlink:label="qttb_EventAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EventDomain" xlink:label="qttb_EventDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AgreementDomain" xlink:label="qttb_AgreementDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" xlink:label="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesARedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AchievementOfSpecifiedMilestonesMember" xlink:label="qttb_AchievementOfSpecifiedMilestonesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AgreementAxis" xlink:label="qttb_AgreementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponReceiptOfWaiverOfMilestoneConditionsMember" xlink:label="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityStockIssuanceCosts" xlink:label="qttb_TemporaryEquityStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesBRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NumberOfDirectorsEntitledToBeElected" xlink:label="qttb_NumberOfDirectorsEntitledToBeElected"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityConversionPricePerShare" xlink:label="qttb_TemporaryEquityConversionPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityDividendRate" xlink:label="qttb_TemporaryEquityDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares" xlink:label="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:label="us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_EventAxis" xlink:to="qttb_EventDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_AgreementDomain" xlink:to="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesARedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_EventDomain" xlink:to="qttb_AchievementOfSpecifiedMilestonesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_AgreementAxis" xlink:to="qttb_AgreementDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="qttb_EventAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_EventDomain" xlink:to="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="qttb_AgreementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_TemporaryEquityStockIssuanceCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBRedeemableConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_NumberOfDirectorsEntitledToBeElected" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_TemporaryEquityConversionPricePerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_TemporaryEquityDividendRate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ReclassificationsOfTemporaryToPermanentEquity" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_AwardTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" xlink:label="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:label="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice" xlink:label="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_13" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_20" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract" xlink:label="us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" xlink:label="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract" xlink:label="us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember" xlink:label="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember" xlink:label="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance" xlink:label="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" xlink:label="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ExcessOfAccruedRightToPurchaseStock" xlink:label="qttb_ExcessOfAccruedRightToPurchaseStock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ExcessOfAccruedRightToPurchaseStock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HorizonCollaborationAgreementMember" xlink:label="qttb_HorizonCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SalesBasedMilestoneMember" xlink:label="qttb_SalesBasedMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LegacyQ32Member" xlink:label="qttb_LegacyQ32Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborationAgreementTransactionPrice" xlink:label="qttb_CollaborationAgreementTransactionPrice"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HorizonTherapeuticsIrelandDacMember" xlink:label="qttb_HorizonTherapeuticsIrelandDacMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborativeArrangementMilestonePayments" xlink:label="qttb_CollaborativeArrangementMilestonePayments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RevenueUsedToDetermineTransactionPrice" xlink:label="qttb_RevenueUsedToDetermineTransactionPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromCollaborators" xlink:label="us-gaap_ProceedsFromCollaborators"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:label="us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborationAgreementContingentPayment" xlink:label="qttb_CollaborationAgreementContingentPayment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived" xlink:label="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AmountOfRefundLiability" xlink:label="qttb_AmountOfRefundLiability"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PaymentToHorizon" xlink:label="qttb_PaymentToHorizon"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_HorizonCollaborationAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="qttb_SalesBasedMilestoneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="qttb_LegacyQ32Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_CollaborationAgreementTransactionPrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_HorizonTherapeuticsIrelandDacMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_CollaborativeArrangementMilestonePayments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_RevenueUsedToDetermineTransactionPrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromCollaborators" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_CollaborationAgreementContingentPayment" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_AmountOfRefundLiability" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_PaymentToHorizon" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PhaseAxis" xlink:label="qttb_PhaseAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract" xlink:label="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PhaseDomain" xlink:label="qttb_PhaseDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ADPhaseTwoResearchServicesMember" xlink:label="qttb_ADPhaseTwoResearchServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AAPhaseTwoResearchServicesMember" xlink:label="qttb_AAPhaseTwoResearchServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember" xlink:label="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="qttb_PhaseAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_PhaseDomain" xlink:to="qttb_ADPhaseTwoResearchServicesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_PhaseAxis" xlink:to="qttb_PhaseDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_PhaseDomain" xlink:to="qttb_AAPhaseTwoResearchServicesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_PhaseDomain" xlink:to="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConsultingAndAdvisoryAgreementsMember" xlink:label="qttb_ConsultingAndAdvisoryAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="qttb_ConsultingAndAdvisoryAgreementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncomeTaxDisclosureTable" xlink:label="qttb_IncomeTaxDisclosureTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncomeTaxDisclosureLineItems" xlink:label="qttb_IncomeTaxDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NetOperatingLossCarryForwardsExpirationYear" xlink:label="qttb_NetOperatingLossCarryForwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TaxCreditCarryforwardsExpirationYear" xlink:label="qttb_TaxCreditCarryforwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CompanysEffectiveTaxRate" xlink:label="qttb_CompanysEffectiveTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_USStatutoryTaxRate" xlink:label="qttb_USStatutoryTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CumulativeChangesOwnershipInterest" xlink:label="qttb_CumulativeChangesOwnershipInterest"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_IncomeTaxDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureTable" xlink:to="qttb_IncomeTaxDisclosureLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_NetOperatingLossCarryForwardsExpirationYear" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_TaxCreditCarryforwardsExpirationYear" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_CompanysEffectiveTaxRate" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_USStatutoryTaxRate" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_CumulativeChangesOwnershipInterest" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncomeLossBeforeProvisionForIncomeTaxes" xlink:label="qttb_IncomeLossBeforeProvisionForIncomeTaxes"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_IncomeLossBeforeProvisionForIncomeTaxes" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TotalCurrentExpenseBenifit" xlink:label="qttb_TotalCurrentExpenseBenifit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TotalDeferred" xlink:label="qttb_TotalDeferred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_TotalCurrentExpenseBenifit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_TotalDeferred" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNetAbstract" xlink:label="us-gaap_DeferredTaxAssetsNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsFrequentFlierLiability" xlink:label="us-gaap_DeferredTaxAssetsFrequentFlierLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CapitalizedIntangibleAssets" xlink:label="qttb_CapitalizedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DeferredTaxAssetsLeaseLiability" xlink:label="qttb_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DeferredTaxLiabilitiesFixedAssets" xlink:label="qttb_DeferredTaxLiabilitiesFixedAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" xlink:label="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNetAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsFrequentFlierLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_CapitalizedIntangibleAssets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_DeferredTaxAssetsLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="qttb_DeferredTaxLiabilitiesFixedAssets" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareReconciliationAbstract" xlink:label="us-gaap_EarningsPerShareReconciliationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareReconciliationAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAConvertiblePreferredStockMember" xlink:label="qttb_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBConvertiblePreferredStockMember" xlink:label="qttb_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="qttb_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="qttb_SeriesAOneConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="qttb_SeriesBConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareAdditionalInformationDetail" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ConvertibleNotesPayable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember" xlink:label="us-gaap_AllOtherSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IndirectResearchAndDevelopmentMember" xlink:label="qttb_IndirectResearchAndDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ADXZeroNineSevenMember" xlink:label="qttb_ADXZeroNineSevenMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IndirectResearchAndDevelopmentExpense" xlink:label="qttb_IndirectResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BempikibartMember" xlink:label="qttb_BempikibartMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PersonnelRelatedCostsExcludingStockBasedCompensation" xlink:label="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DiscoveryAndOtherMember" xlink:label="qttb_DiscoveryAndOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FacilitiesITAndInsurance" xlink:label="qttb_FacilitiesITAndInsurance"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PersonnelRelatedAndConsultingMember" xlink:label="qttb_PersonnelRelatedAndConsultingMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OtherGAExpenses" xlink:label="qttb_OtherGAExpenses"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FacilitiesITAndInsuranceMember" xlink:label="qttb_FacilitiesITAndInsuranceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OtherGAExpensesMember" xlink:label="qttb_OtherGAExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FacilitiesITAndOtherAllocatedCostsMember" xlink:label="qttb_FacilitiesITAndOtherAllocatedCostsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TotalSegmentNetLoss" xlink:label="qttb_TotalSegmentNetLoss"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_Non-CashExpensesMember" xlink:label="qttb_Non-CashExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OtherSegmentItemsMember" xlink:label="qttb_OtherSegmentItemsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_AllOtherSegmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="qttb_IndirectResearchAndDevelopmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_ADXZeroNineSevenMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_IndirectResearchAndDevelopmentExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_BempikibartMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_DiscoveryAndOtherMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_FacilitiesITAndInsurance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_PersonnelRelatedAndConsultingMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_OtherGAExpenses" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_FacilitiesITAndInsuranceMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_InterestIncomeExpenseNet" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_OtherGAExpensesMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingOtherItemAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_FacilitiesITAndOtherAllocatedCostsMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_TotalSegmentNetLoss" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_Non-CashExpensesMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_OtherSegmentItemsMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NumberOfCommonStockUnderlyingShares" xlink:label="qttb_NumberOfCommonStockUnderlyingShares"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ExerciseOfCallOptionDescription" xlink:label="qttb_ExerciseOfCallOptionDescription"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SeveranceCosts1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="qttb_NumberOfCommonStockUnderlyingShares" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="qttb_ExerciseOfCallOptionDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CoverPage">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="dei_AddressTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_AddressTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_EntityAddressesAddressTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_AddressTypeDomain" xlink:to="dei_BusinessContactMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="38" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorOpinionTextBlock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAConvertiblePreferredStockMember" xlink:label="qttb_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedExpensesAndOtherLiabilitiesCurrent" xlink:label="qttb_AccruedExpensesAndOtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBConvertiblePreferredStockMember" xlink:label="qttb_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CvrLiability" xlink:label="qttb_CvrLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAOneConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="qttb_AccruedExpensesAndOtherLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="qttb_CvrLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermLineOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LinesOfCreditCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ConvertibleDebtNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAConvertiblePreferredStockMember" xlink:label="qttb_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBConvertiblePreferredStockMember" xlink:label="qttb_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAOneConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAConvertiblePreferredStockMember" xlink:label="qttb_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertiblePreferredStockMember" xlink:label="us-gaap_ConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBConvertiblePreferredStockMember" xlink:label="qttb_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" xlink:label="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" xlink:label="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteSpinoffTransaction" xlink:label="us-gaap_StockholdersEquityNoteSpinoffTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IssuanceOfCommonStocksFromRsuVesting" xlink:label="qttb_IssuanceOfCommonStocksFromRsuVesting"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAOneConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityNoteSpinoffTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="qttb_IssuanceOfCommonStocksFromRsuVesting" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NatureOfBusinessLineItems" xlink:label="qttb_NatureOfBusinessLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NatureOfBusinessTable" xlink:label="qttb_NatureOfBusinessTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="us-gaap_CommonStockSharesSubscriptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ParentCompanyMember" xlink:label="srt_ParentCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HomologyMember" xlink:label="qttb_HomologyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock" xlink:label="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" xlink:label="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="qttb_NatureOfBusinessTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_CommonStockSharesSubscriptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_NatureOfBusinessTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ParentCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="qttb_HomologyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_NatureOfBusinessTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_NatureOfBusinessTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_NatureOfBusinessLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccountingPoliciesLineItems" xlink:label="qttb_AccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccountingPoliciesTable" xlink:label="qttb_AccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember" xlink:label="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" xlink:label="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="qttb_AccountingPoliciesLineItems" xlink:to="qttb_AccountingPoliciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_AccountingPoliciesLineItems" xlink:to="us-gaap_CashFDICInsuredAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_AccountingPoliciesTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_AccountingPoliciesLineItems" xlink:to="us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_AccountingPoliciesLineItems" xlink:to="us-gaap_IncomeTaxExaminationDescription" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PropertyPlantAndEquipmentUsefulLife1" xlink:label="qttb_PropertyPlantAndEquipmentUsefulLife1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="qttb_PropertyPlantAndEquipmentUsefulLife1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionLineItems" xlink:label="qttb_MergerAndAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionTable" xlink:label="qttb_MergerAndAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LegacyQ32Member" xlink:label="qttb_LegacyQ32Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="qttb_MergerAndAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="qttb_LegacyQ32Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_MergerAndAcquisitionTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionLineItems" xlink:label="qttb_MergerAndAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MergerAndAcquisitionTable" xlink:label="qttb_MergerAndAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiability" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="qttb_MergerAndAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_MergerAndAcquisitionTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_MergerAndAcquisitionTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_SeveranceCosts1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_MergerAndAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ScheduleOfShortTermDebtTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CvrLiability" xlink:label="qttb_CvrLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="qttb_CvrLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleDebtCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MeasurementInputProbabilityOfEachScenarioMember" xlink:label="qttb_MeasurementInputProbabilityOfEachScenarioMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScenarioOneMember" xlink:label="qttb_ScenarioOneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScenarioTwoMember" xlink:label="qttb_ScenarioTwoMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ScenarioThreeMember" xlink:label="qttb_ScenarioThreeMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="us-gaap_MeasurementInputTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="qttb_MeasurementInputProbabilityOfEachScenarioMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentMeasurementInput" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="qttb_ScenarioOneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="qttb_ScenarioTwoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="qttb_ScenarioThreeMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConvertibleNotesMember" xlink:label="qttb_ConvertibleNotesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FairValueOfInterestExpenses" xlink:label="qttb_FairValueOfInterestExpenses"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CvrLiability" xlink:label="qttb_CvrLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_GainOnConvertibleNotes" xlink:label="qttb_GainOnConvertibleNotes"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_ConvertibleNotesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_InterestExpenseDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="qttb_FairValueOfInterestExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="qttb_CvrLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="qttb_GainOnConvertibleNotes" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HomologyMember" xlink:label="qttb_HomologyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OxbSolutionsMember" xlink:label="qttb_OxbSolutionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="qttb_HomologyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="qttb_OxbSolutionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_Depreciation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CommitmentAndContingenciesLineItems" xlink:label="qttb_CommitmentAndContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CommitmentAndContingenciesTable" xlink:label="qttb_CommitmentAndContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" xlink:label="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheDomain" xlink:label="qttb_TrancheDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheOneMilestoneMember" xlink:label="qttb_TrancheOneMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LicenseAgreementWithTheUniversityOfColoradoMember" xlink:label="qttb_LicenseAgreementWithTheUniversityOfColoradoMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheAxis" xlink:label="qttb_TrancheAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheDomain" xlink:label="qttb_TrancheDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CashConsiderationMember" xlink:label="qttb_CashConsiderationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfRealEstateProperty" xlink:label="us-gaap_AreaOfRealEstateProperty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesARedeemablePreferredStockMember" xlink:label="qttb_SeriesARedeemablePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RestrictedCashAndCashEquivalentsNonCurrentMember" xlink:label="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_WalthamMassauchetsMember" xlink:label="qttb_WalthamMassauchetsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheTwoMilestoneMember" xlink:label="qttb_TrancheTwoMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" xlink:label="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityMember" xlink:label="qttb_TemporaryEquityMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LeaseExpirationDateYearAndMonth" xlink:label="qttb_LeaseExpirationDateYearAndMonth"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheThreeMilestoneMember" xlink:label="qttb_TrancheThreeMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" xlink:label="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SubleaseAggregateBaseRentObligation" xlink:label="qttb_SubleaseAggregateBaseRentObligation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent" xlink:label="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AnnualRentOperatingLeaseAggregateAfterIncrease" xlink:label="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncentiveFromLessor" xlink:label="us-gaap_IncentiveFromLessor"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DevelopmentAndSalesMilestonePaymentPayable" xlink:label="qttb_DevelopmentAndSalesMilestonePaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PercentageOfSublicenseFees" xlink:label="qttb_PercentageOfSublicenseFees"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodOfObligationToPayRoyalties" xlink:label="qttb_PeriodOfObligationToPayRoyalties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FutureMinimumLeasePaymentDueUnderThisSublease" xlink:label="qttb_FutureMinimumLeasePaymentDueUnderThisSublease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UpfrontPaymentMade" xlink:label="qttb_UpfrontPaymentMade"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" xlink:label="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CommercialMilestonePaymentPayable" xlink:label="qttb_CommercialMilestonePaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RoyaltyAsAPercentageOfNetSales" xlink:label="qttb_RoyaltyAsAPercentageOfNetSales"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:label="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DevelopmentMilestonePaymentPayable" xlink:label="qttb_DevelopmentMilestonePaymentPayable"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_CommitmentAndContingenciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" xlink:to="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" xlink:to="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheOneMilestoneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LicenseAgreementWithTheUniversityOfColoradoMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="qttb_TrancheAxis" xlink:to="qttb_TrancheDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="qttb_TrancheAxis" xlink:to="qttb_TrancheDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" xlink:to="qttb_CashConsiderationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_AreaOfRealEstateProperty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesARedeemablePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="qttb_WalthamMassauchetsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheTwoMilestoneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" xlink:to="qttb_TemporaryEquityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_LeaseExpirationDateYearAndMonth" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheThreeMilestoneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_SubleaseAggregateBaseRentObligation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_CommitmentAndContingenciesTable" xlink:to="qttb_TrancheAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_SecurityDeposit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_IncentiveFromLessor" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_DevelopmentAndSalesMilestonePaymentPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_PercentageOfSublicenseFees" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_PeriodOfObligationToPayRoyalties" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_FutureMinimumLeasePaymentDueUnderThisSublease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_UpfrontPaymentMade" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_CommercialMilestonePaymentPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_RoyaltyAsAPercentageOfNetSales" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="us-gaap_SelfInsuranceReserve" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_CommitmentAndContingenciesLineItems" xlink:to="qttb_DevelopmentMilestonePaymentPayable" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheDomain" xlink:label="qttb_TrancheDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheOneMilestoneMember" xlink:label="qttb_TrancheOneMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureItemAmountsDomain" xlink:label="us-gaap_FairValueDisclosureItemAmountsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheAxis" xlink:label="qttb_TrancheAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandAndTwentyTermALoanAdvanceMember" xlink:label="qttb_TwoThousandAndTwentyTermALoanAdvanceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesBRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RestrictedCashNonCurrentMember" xlink:label="qttb_RestrictedCashNonCurrentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodAxis" xlink:label="qttb_PeriodAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodDomain" xlink:label="qttb_PeriodDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PeriodDomain" xlink:label="qttb_PeriodDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_WarrantsIssuedToSiliconValleyBankMember" xlink:label="qttb_WarrantsIssuedToSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TrancheTwoMilestoneMember" xlink:label="qttb_TrancheTwoMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeDuringPeriodFairValueDisclosureMember" xlink:label="us-gaap_ChangeDuringPeriodFairValueDisclosureMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember" xlink:label="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CurrentLiabilitiesMember" xlink:label="qttb_CurrentLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember" xlink:label="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember" xlink:label="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtPercentageBearingVariableInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingVariableInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConvertibleDebtAgreementMember" xlink:label="qttb_ConvertibleDebtAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember" xlink:label="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1" xlink:label="us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SixthAmendmentAgreementWithSiliconValleyBankMember" xlink:label="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeventhAmendmentToTheLoanAgreementMember" xlink:label="qttb_SeventhAmendmentToTheLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EighthAmendmentToTheLoanAgreementMember" xlink:label="qttb_EighthAmendmentToTheLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LongTermDebtBalloonPaymentPercentage" xlink:label="qttb_LongTermDebtBalloonPaymentPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityFrequencyOfPayments" xlink:label="us-gaap_LineOfCreditFacilityFrequencyOfPayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCollateralAmount" xlink:label="us-gaap_DebtInstrumentCollateralAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender" xlink:label="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained" xlink:label="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash" xlink:label="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" xlink:label="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" xlink:label="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed" xlink:label="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EstimatedAggregateProceedsFromDebtAndEquity" xlink:label="qttb_EstimatedAggregateProceedsFromDebtAndEquity"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EstimatedAggregateProceedsFromEquity" xlink:label="qttb_EstimatedAggregateProceedsFromEquity"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReceivedAdvancePayment" xlink:label="qttb_ReceivedAdvancePayment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RecivedLoanAgreement" xlink:label="qttb_RecivedLoanAgreement"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:label="us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DebtInstrumentConversionPricePercentage" xlink:label="qttb_DebtInstrumentConversionPricePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="us-gaap_ConvertibleDebtFairValueDisclosures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInNotesPayableCurrent" xlink:label="us-gaap_IncreaseDecreaseInNotesPayableCurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheOneMilestoneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="qttb_TrancheAxis" xlink:to="qttb_TrancheDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_TwoThousandAndTwentyTermALoanAdvanceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueDisclosureItemAmountsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="qttb_RestrictedCashNonCurrentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="qttb_PeriodAxis" xlink:to="qttb_PeriodDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="qttb_PeriodAxis" xlink:to="qttb_PeriodDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="qttb_WarrantsIssuedToSiliconValleyBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_PeriodDomain" xlink:to="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_TrancheDomain" xlink:to="qttb_TrancheTwoMilestoneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="us-gaap_ChangeDuringPeriodFairValueDisclosureMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="qttb_CurrentLiabilitiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_PeriodDomain" xlink:to="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_PeriodDomain" xlink:to="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtPercentageBearingVariableInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_ConvertibleDebtAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="qttb_PeriodAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_PeriodDomain" xlink:to="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_SeventhAmendmentToTheLoanAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeeAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_EighthAmendmentToTheLoanAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCommitmentFeePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_LongTermDebtBalloonPaymentPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="qttb_TrancheAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityFrequencyOfPayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCollateralAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LinesOfCreditCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_EstimatedAggregateProceedsFromDebtAndEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_EstimatedAggregateProceedsFromEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_ReceivedAdvancePayment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_RecivedLoanAgreement" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtPercentageBearingFixedInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromConvertibleDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="qttb_DebtInstrumentConversionPricePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="36" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="37" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConvertibleDebtFairValueDisclosures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="38" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="39" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="40" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_IncreaseDecreaseInNotesPayableCurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfVentureDebtTable" xlink:label="qttb_DisclosureInTabularFormOfVentureDebtTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember" xlink:label="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="qttb_DisclosureInTabularFormOfVentureDebtTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_LongTermDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_LongTermDebtCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_DisclosureInTabularFormOfVentureDebtLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EventAxis" xlink:label="qttb_EventAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EventDomain" xlink:label="qttb_EventDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EventDomain" xlink:label="qttb_EventDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AgreementDomain" xlink:label="qttb_AgreementDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" xlink:label="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesARedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesARedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AchievementOfSpecifiedMilestonesMember" xlink:label="qttb_AchievementOfSpecifiedMilestonesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AgreementAxis" xlink:label="qttb_AgreementAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AgreementDomain" xlink:label="qttb_AgreementDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponReceiptOfWaiverOfMilestoneConditionsMember" xlink:label="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityStockIssuanceCosts" xlink:label="qttb_TemporaryEquityStockIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="qttb_SeriesBRedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NumberOfDirectorsEntitledToBeElected" xlink:label="qttb_NumberOfDirectorsEntitledToBeElected"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityConversionPricePerShare" xlink:label="qttb_TemporaryEquityConversionPricePerShare"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TemporaryEquityDividendRate" xlink:label="qttb_TemporaryEquityDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityDividendsAdjustment" xlink:label="us-gaap_TemporaryEquityDividendsAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares" xlink:label="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:label="us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="qttb_EventAxis" xlink:to="qttb_EventDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="qttb_EventAxis" xlink:to="qttb_EventDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_AgreementDomain" xlink:to="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesARedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_EventDomain" xlink:to="qttb_AchievementOfSpecifiedMilestonesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="qttb_AgreementAxis" xlink:to="qttb_AgreementDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="qttb_AgreementAxis" xlink:to="qttb_AgreementDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="qttb_EventAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_EventDomain" xlink:to="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="qttb_AgreementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_TemporaryEquityStockIssuanceCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_NumberOfDirectorsEntitledToBeElected" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_TemporaryEquityConversionPricePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_TemporaryEquityDividendRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityDividendsAdjustment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_ReclassificationsOfTemporaryToPermanentEquity" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:label="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember" xlink:label="us-gaap_ConvertibleDebtSecuritiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember" xlink:label="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember" xlink:label="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" xlink:to="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ConvertibleDebtSecuritiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" xlink:label="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice" xlink:label="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" xlink:label="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember" xlink:label="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember" xlink:label="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance" xlink:label="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" xlink:label="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod" xlink:label="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ExcessOfAccruedRightToPurchaseStock" xlink:label="qttb_ExcessOfAccruedRightToPurchaseStock"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="qttb_ExcessOfAccruedRightToPurchaseStock" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HorizonCollaborationAgreementMember" xlink:label="qttb_HorizonCollaborationAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SalesBasedMilestoneMember" xlink:label="qttb_SalesBasedMilestoneMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LegacyQ32Member" xlink:label="qttb_LegacyQ32Member"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborationAgreementTransactionPrice" xlink:label="qttb_CollaborationAgreementTransactionPrice"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_HorizonTherapeuticsIrelandDacMember" xlink:label="qttb_HorizonTherapeuticsIrelandDacMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborativeArrangementMilestonePayments" xlink:label="qttb_CollaborativeArrangementMilestonePayments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_RevenueUsedToDetermineTransactionPrice" xlink:label="qttb_RevenueUsedToDetermineTransactionPrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromCollaborators" xlink:label="us-gaap_ProceedsFromCollaborators"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:label="us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability" xlink:label="us-gaap_ContractWithCustomerLiability"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborationAgreementContingentPayment" xlink:label="qttb_CollaborationAgreementContingentPayment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived" xlink:label="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AmountOfRefundLiability" xlink:label="qttb_AmountOfRefundLiability"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PaymentToHorizon" xlink:label="qttb_PaymentToHorizon"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_HorizonCollaborationAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="qttb_SalesBasedMilestoneMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="qttb_LegacyQ32Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_CollaborationAgreementTransactionPrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="qttb_HorizonTherapeuticsIrelandDacMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_CollaborativeArrangementMilestonePayments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_RevenueUsedToDetermineTransactionPrice" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromCollaborators" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAssetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_CollaborationAgreementContingentPayment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_AmountOfRefundLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="qttb_PaymentToHorizon" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PhaseAxis" xlink:label="qttb_PhaseAxis"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PhaseDomain" xlink:label="qttb_PhaseDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ADPhaseTwoResearchServicesMember" xlink:label="qttb_ADPhaseTwoResearchServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PhaseDomain" xlink:label="qttb_PhaseDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AAPhaseTwoResearchServicesMember" xlink:label="qttb_AAPhaseTwoResearchServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember" xlink:label="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="qttb_PhaseAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_PhaseDomain" xlink:to="qttb_ADPhaseTwoResearchServicesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="qttb_PhaseAxis" xlink:to="qttb_PhaseDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="qttb_PhaseAxis" xlink:to="qttb_PhaseDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_PhaseDomain" xlink:to="qttb_AAPhaseTwoResearchServicesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_PhaseDomain" xlink:to="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:label="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ConsultingAndAdvisoryAgreementsMember" xlink:label="qttb_ConsultingAndAdvisoryAgreementsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="qttb_ConsultingAndAdvisoryAgreementsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail">
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncomeTaxDisclosureLineItems" xlink:label="qttb_IncomeTaxDisclosureLineItems"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncomeTaxDisclosureTable" xlink:label="qttb_IncomeTaxDisclosureTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NetOperatingLossCarryForwardsExpirationYear" xlink:label="qttb_NetOperatingLossCarryForwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TaxCreditCarryforwardsExpirationYear" xlink:label="qttb_TaxCreditCarryforwardsExpirationYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CompanysEffectiveTaxRate" xlink:label="qttb_CompanysEffectiveTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_USStatutoryTaxRate" xlink:label="qttb_USStatutoryTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CumulativeChangesOwnershipInterest" xlink:label="qttb_CumulativeChangesOwnershipInterest"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_IncomeTaxDisclosureTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_IncomeTaxDisclosureTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="qttb_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_NetOperatingLossCarryForwardsExpirationYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_TaxCreditCarryforwardsExpirationYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_CompanysEffectiveTaxRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_USStatutoryTaxRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="qttb_IncomeTaxDisclosureLineItems" xlink:to="qttb_CumulativeChangesOwnershipInterest" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAConvertiblePreferredStockMember" xlink:label="qttb_SeriesAConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesAOneConvertiblePreferredStockMember" xlink:label="qttb_SeriesAOneConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_SeriesBConvertiblePreferredStockMember" xlink:label="qttb_SeriesBConvertiblePreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="qttb_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="qttb_SeriesAOneConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="qttb_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember" xlink:label="us-gaap_AllOtherSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IndirectResearchAndDevelopmentMember" xlink:label="qttb_IndirectResearchAndDevelopmentMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ADXZeroNineSevenMember" xlink:label="qttb_ADXZeroNineSevenMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IndirectResearchAndDevelopmentExpense" xlink:label="qttb_IndirectResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_BempikibartMember" xlink:label="qttb_BempikibartMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PersonnelRelatedCostsExcludingStockBasedCompensation" xlink:label="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DiscoveryAndOtherMember" xlink:label="qttb_DiscoveryAndOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FacilitiesITAndInsurance" xlink:label="qttb_FacilitiesITAndInsurance"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PersonnelRelatedAndConsultingMember" xlink:label="qttb_PersonnelRelatedAndConsultingMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OtherGAExpenses" xlink:label="qttb_OtherGAExpenses"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FacilitiesITAndInsuranceMember" xlink:label="qttb_FacilitiesITAndInsuranceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OtherGAExpensesMember" xlink:label="qttb_OtherGAExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount" xlink:label="us-gaap_SegmentReportingOtherItemAmount"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_FacilitiesITAndOtherAllocatedCostsMember" xlink:label="qttb_FacilitiesITAndOtherAllocatedCostsMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TotalSegmentNetLoss" xlink:label="qttb_TotalSegmentNetLoss"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_Non-CashExpensesMember" xlink:label="qttb_Non-CashExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_OtherSegmentItemsMember" xlink:label="qttb_OtherSegmentItemsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_AllOtherSegmentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="qttb_IndirectResearchAndDevelopmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_ADXZeroNineSevenMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_IndirectResearchAndDevelopmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_BempikibartMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_DiscoveryAndOtherMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_FacilitiesITAndInsurance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_PersonnelRelatedAndConsultingMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_OtherGAExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_FacilitiesITAndInsuranceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_InterestIncomeExpenseNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_OtherGAExpensesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingOtherItemAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_FacilitiesITAndOtherAllocatedCostsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="qttb_TotalSegmentNetLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_Non-CashExpensesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="qttb_OtherSegmentItemsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1" xlink:label="us-gaap_SeveranceCosts1"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_NumberOfCommonStockUnderlyingShares" xlink:label="qttb_NumberOfCommonStockUnderlyingShares"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ExerciseOfCallOptionDescription" xlink:label="qttb_ExerciseOfCallOptionDescription"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SeveranceCosts1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="qttb_NumberOfCommonStockUnderlyingShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="qttb_ExerciseOfCallOptionDescription" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedExpensesAndOtherLiabilitiesCurrent" xlink:label="qttb_AccruedExpensesAndOtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:label="us-gaap_UsefulLifeDescriptionOfTermDomain"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LeaseholdImprovements" xlink:label="qttb_LeaseholdImprovements"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="qttb_AccruedExpensesAndOtherLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_UsefulLifeDescriptionOfTermDomain" xlink:to="qttb_LeaseholdImprovements" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ConvertibleDebtNoncurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="qttb_AccruedExpensesAndOtherLiabilitiesCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermLineOfCredit" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LinesOfCreditCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="qttb_CvrLiability" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_EquityMethodInvestmentAggregateCost" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="us-gaap_ConvertibleDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedExpensesAndOtherLiabilitiesCurrent" xlink:label="qttb_AccruedExpensesAndOtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermLineOfCredit" xlink:label="us-gaap_LongTermLineOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="us-gaap_LinesOfCreditCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CvrLiability" xlink:label="qttb_CvrLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentAggregateCost" xlink:label="us-gaap_EquityMethodInvestmentAggregateCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureDebtSummaryOfLongtermDebtBalanceDetail2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebtNoncurrent" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_NonoperatingIncomeExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="qttb_ChangeInFairValueOfConvertibleNotes" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ChangeInFairValueOfConvertibleNotes" xlink:label="qttb_ChangeInFairValueOfConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromLongTermLinesOfCredit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfLongTermLinesOfCredit" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfShortTermInvestments" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="qttb_ProceedsFromReverseRecapitalization" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="qttb_PaymentOfReverseRecapitalizationTransactionCosts" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="6" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="qttb_LossOnImpairmentOfEquityInvestment" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="qttb_ChangeInFairValueOfEquityInvestment" order="8" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="qttb_ChangeInFairValueOfConvertibleNotes" order="9" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="10" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" order="11" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="12" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="13" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" order="14" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="qttb_IncreaseDecreaseInContingentLiability" order="15" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue" order="16" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:label="us-gaap_ProceedsFromLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:label="us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:label="us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ProceedsFromReverseRecapitalization" xlink:label="qttb_ProceedsFromReverseRecapitalization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PaymentOfReverseRecapitalizationTransactionCosts" xlink:label="qttb_PaymentOfReverseRecapitalizationTransactionCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_LossOnImpairmentOfEquityInvestment" xlink:label="qttb_LossOnImpairmentOfEquityInvestment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ChangeInFairValueOfEquityInvestment" xlink:label="qttb_ChangeInFairValueOfEquityInvestment"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_ChangeInFairValueOfConvertibleNotes" xlink:label="qttb_ChangeInFairValueOfConvertibleNotes"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_IncreaseDecreaseInContingentLiability" xlink:label="qttb_IncreaseDecreaseInContingentLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_ConvertibleDebtCurrent" order="0" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="qttb_PayrollTaxCredit" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="qttb_PrepaidExternalResearchAndDevelopmentCurrent" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PayrollTaxCredit" xlink:label="qttb_PayrollTaxCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PrepaidExternalResearchAndDevelopmentCurrent" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="qttb_PrepaidExternalResearchAndDevelopmentNonurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_DeferredCosts" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_PrepaidExternalResearchAndDevelopmentNonurrent" xlink:label="qttb_PrepaidExternalResearchAndDevelopmentNonurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCosts" xlink:label="us-gaap_DeferredCosts"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="qttb_AccruedResearchAndDevelopmentExpensesCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_TaxesPayableCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" order="4" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="qttb_AccruedResearchAndDevelopmentExpensesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" xlink:label="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_VariableLeaseCost" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="4" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" xlink:label="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsFrequentFlierLiability" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="qttb_CapitalizedIntangibleAssets" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="qttb_DeferredTaxAssetsLeaseLiability" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" order="9" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsFrequentFlierLiability" xlink:label="us-gaap_DeferredTaxAssetsFrequentFlierLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_CapitalizedIntangibleAssets" xlink:label="qttb_CapitalizedIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_DeferredTaxAssetsLeaseLiability" xlink:label="qttb_DeferredTaxAssetsLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="qttb_TotalSegmentNetLoss" xlink:to="us-gaap_OtherResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="qttb-20241231.xsd#qttb_TotalSegmentNetLoss" xlink:label="qttb_TotalSegmentNetLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherResearchAndDevelopmentExpense" xlink:label="us-gaap_OtherResearchAndDevelopmentExpense"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="qttb_PeriodAxis" name="PeriodAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_EighthAmendmentToTheLoanAgreementMember" name="EighthAmendmentToTheLoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_OtherGAExpenses" name="OtherGAExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_FairValueOfInterestExpenses" name="FairValueOfInterestExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_CommitmentAndContingenciesTable" name="CommitmentAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_IndirectResearchAndDevelopmentMember" name="IndirectResearchAndDevelopmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_RoyaltyAsAPercentageOfNetSales" name="RoyaltyAsAPercentageOfNetSales" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_LeaseholdImprovements" name="LeaseholdImprovements" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_TaxCreditCarryforwardsExpirationYear" name="TaxCreditCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_EstimatedAggregateProceedsFromEquity" name="EstimatedAggregateProceedsFromEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_MeasurementInputProbabilityOfEachScenarioMember" name="MeasurementInputProbabilityOfEachScenarioMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed" name="FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_DevelopmentMilestonePaymentPayable" name="DevelopmentMilestonePaymentPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_MergerAndAcquisitionTable" name="MergerAndAcquisitionTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_DisclosureInTabularFormOfVentureDebtLineItems" name="DisclosureInTabularFormOfVentureDebtLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember" name="UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember" name="ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_CumulativeChangesOwnershipInterest" name="CumulativeChangesOwnershipInterest" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_IssuanceOfCvrAtFairValue" name="IssuanceOfCvrAtFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_SeriesARedeemablePreferredStockMember" name="SeriesARedeemablePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ReceivedAdvancePayment" name="ReceivedAdvancePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_IncomeTaxDisclosureLineItems" name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock" name="SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_HorizonCollaborationAgreementMember" name="HorizonCollaborationAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_OperatingLeaseLiabilitiesLesseeAbstract" name="OperatingLeaseLiabilitiesLesseeAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ADPhaseTwoResearchServicesMember" name="ADPhaseTwoResearchServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_TrancheTwoMilestoneMember" name="TrancheTwoMilestoneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_AgreementDomain" name="AgreementDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock" name="AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts" name="IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_SixthAmendmentAgreementWithSiliconValleyBankMember" name="SixthAmendmentAgreementWithSiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_OxbSolutionsMember" name="OxbSolutionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_PersonnelRelatedAndConsultingMember" name="PersonnelRelatedAndConsultingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_SeriesAOneConvertiblePreferredStockMember" name="SeriesAOneConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember" name="LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_DisclosureInEntiretyOfTemporaryEquity" name="DisclosureInEntiretyOfTemporaryEquity" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance" name="IncreaseInCommonStockCapitalSharesReservedForFutureIssuance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_SeriesBRedeemableConvertiblePreferredStockMember" name="SeriesBRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ScenarioOneMember" name="ScenarioOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_IssuanceOfCommonStocksFromRsuVesting" name="IssuanceOfCommonStocksFromRsuVesting" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember" name="BeforeFirstOfJulyTwoThousandAndTwentyFiveMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" name="AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember" name="TwoThousandTwentyFourEmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" name="SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_TemporaryEquityConversionPricePerShare" name="TemporaryEquityConversionPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="qttb_EstimatedAggregateProceedsFromDebtAndEquity" name="EstimatedAggregateProceedsFromDebtAndEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember" name="TwoThousandTwentyFourStockOptionAndIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_WarrantsIssuedToSiliconValleyBankMember" name="WarrantsIssuedToSiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_FacilitiesITAndOtherAllocatedCostsMember" name="FacilitiesITAndOtherAllocatedCostsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_PatentsCostsPolicyTextBlock" name="PatentsCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_InvestmentsDisclosureAbstract" name="InvestmentsDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ChangeInFairValueOfConvertibleNotes" name="ChangeInFairValueOfConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_WalthamMassauchetsMember" name="WalthamMassauchetsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent" name="EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_CurrentLiabilitiesLesseeAbstract" name="CurrentLiabilitiesLesseeAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember" name="UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_UponReceiptOfWaiverOfMilestoneConditionsMember" name="UponReceiptOfWaiverOfMilestoneConditionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_PhaseAxis" name="PhaseAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember" name="ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_Non-CashExpensesMember" name="Non-CashExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_TemporaryEquityStockIssuanceCosts" name="TemporaryEquityStockIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_NatureOfBusinessTable" name="NatureOfBusinessTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_LossOnImpairmentOfEquityInvestment" name="LossOnImpairmentOfEquityInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_FacilitiesITAndInsuranceMember" name="FacilitiesITAndInsuranceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_CommercialMilestonePaymentPayable" name="CommercialMilestonePaymentPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_TotalCurrentExpenseBenifit" name="TotalCurrentExpenseBenifit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_SeriesARedeemableConvertiblePreferredStockMember" name="SeriesARedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock" name="DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_NumberOfDirectorsEntitledToBeElected" name="NumberOfDirectorsEntitledToBeElected" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="qttb_LeaseExpirationDateYearAndMonth" name="LeaseExpirationDateYearAndMonth" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_PaymentToHorizon" name="PaymentToHorizon" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_AgreementAxis" name="AgreementAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization" name="ShortTermInvestmentsAcquiredInReverseRecapitalization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_CashConsiderationMember" name="CashConsiderationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember" name="VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_UpfrontPaymentMade" name="UpfrontPaymentMade" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash" name="PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="qttb_TemporaryEquityDividendRate" name="TemporaryEquityDividendRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_IndirectResearchAndDevelopmentExpense" name="IndirectResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived" name="CollaborationAgreementContingentPaymentPayableExcessOfCashReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" name="EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember" name="LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_InvestmentMaturityTerm" name="InvestmentMaturityTerm" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_OtherSegmentItemsMember" name="OtherSegmentItemsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_AccountingPoliciesLineItems" name="AccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_TrancheOneMilestoneMember" name="TrancheOneMilestoneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_IncomeLossBeforeProvisionForIncomeTaxes" name="IncomeLossBeforeProvisionForIncomeTaxes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_SeventhAmendmentToTheLoanAgreementMember" name="SeventhAmendmentToTheLoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_LicenseAgreementWithTheUniversityOfColoradoMember" name="LicenseAgreementWithTheUniversityOfColoradoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember" name="TwoThousandSeventeenStockOptionAndGrantPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_AnnualRentOperatingLeaseAggregateAfterIncrease" name="AnnualRentOperatingLeaseAggregateAfterIncrease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_LicenseAgreementWithBristolMayersEquibCompanyMember" name="LicenseAgreementWithBristolMayersEquibCompanyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember" name="LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_NumberOfCommonStockUnderlyingShares" name="NumberOfCommonStockUnderlyingShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_EventAxis" name="EventAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization" name="StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" name="StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" name="ComponentsOfInProcessResearchAndDevelopmentExpensesAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_USStatutoryTaxRate" name="USStatutoryTaxRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" name="DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_FutureMinimumLeasePaymentDueUnderThisSublease" name="FutureMinimumLeasePaymentDueUnderThisSublease" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_ScenarioTwoMember" name="ScenarioTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_OperatingLeaseAssetsLesseeAbstract" name="OperatingLeaseAssetsLesseeAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_TwoThousandAndTwentyTermALoanAdvanceMember" name="TwoThousandAndTwentyTermALoanAdvanceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock" name="DisclosureInTabularFormOfVentureDebtTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_MergersAndAquisitionsAbstract" name="MergersAndAquisitionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_MergerAndAcquisitionLineItems" name="MergerAndAcquisitionLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ProceedsFromReverseRecapitalization" name="ProceedsFromReverseRecapitalization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_DevelopmentAndSalesMilestonePaymentPayable" name="DevelopmentAndSalesMilestonePaymentPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_AchievementOfSpecifiedMilestonesMember" name="AchievementOfSpecifiedMilestonesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_NatureOfBusinessLineItems" name="NatureOfBusinessLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_DebtInstrumentConversionPricePercentage" name="DebtInstrumentConversionPricePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="qttb_ExerciseOfCallOptionDescription" name="ExerciseOfCallOptionDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember" name="TwoThousandAndTwentyThreeTermALoanAdvanceMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" name="ComponentsOfInProcessResearchAndDevelopmentExpensesDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_SalesBasedMilestoneMember" name="SalesBasedMilestoneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_Rule10B51ArrModifiedFlag" name="Rule10B51ArrModifiedFlag" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender" name="PercentageOfConsolidatedCashToBeMaintainedWithTheLender" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="qttb_PhaseDomain" name="PhaseDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_DiscoveryAndOtherMember" name="DiscoveryAndOtherMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember" name="BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" name="DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_HorizonTherapeuticsIrelandDacMember" name="HorizonTherapeuticsIrelandDacMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember" name="BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_SeriesAOneRedeemableConvertiblePreferredStockMember" name="SeriesAOneRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_RecivedLoanAgreement" name="RecivedLoanAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_SeriesATwoRedeemableConvertiblePreferredStockMember" name="SeriesATwoRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_IncreaseDecreaseInContingentLiability" name="IncreaseDecreaseInContingentLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_PercentageOfSublicenseFees" name="PercentageOfSublicenseFees" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_NonCurrentLiabilitiesLesseeAbstract" name="NonCurrentLiabilitiesLesseeAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember" name="MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_CompanysEffectiveTaxRate" name="CompanysEffectiveTaxRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_TrancheThreeMilestoneMember" name="TrancheThreeMilestoneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_FacilitiesITAndInsurance" name="FacilitiesITAndInsurance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember" name="ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_RestrictedCashAndCashEquivalentsNonCurrentMember" name="RestrictedCashAndCashEquivalentsNonCurrentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" name="DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_TotalSegmentNetLoss" name="TotalSegmentNetLoss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_TrancheDomain" name="TrancheDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock" name="ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_CollaborationAgreementContingentPayment" name="CollaborationAgreementContingentPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_GainOnConvertibleNotes" name="GainOnConvertibleNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" name="IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_RestrictedCashNonCurrentMember" name="RestrictedCashNonCurrentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember" name="ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_HomologyMember" name="HomologyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_PrepaidExternalResearchAndDevelopmentCurrent" name="PrepaidExternalResearchAndDevelopmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_AmountOfRefundLiability" name="AmountOfRefundLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_ExcessOfAccruedRightToPurchaseStock" name="ExcessOfAccruedRightToPurchaseStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_NetOperatingLossCarryForwardsExpirationYear" name="NetOperatingLossCarryForwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_PeriodOfObligationToPayRoyalties" name="PeriodOfObligationToPayRoyalties" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" name="IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_PropertyPlantAndEquipmentUsefulLife1" name="PropertyPlantAndEquipmentUsefulLife1" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock" name="BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_AccruedExpensesAndOtherLiabilitiesCurrent" name="AccruedExpensesAndOtherLiabilitiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_OtherGAExpensesMember" name="OtherGAExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_AccruedResearchAndDevelopmentExpensesCurrent" name="AccruedResearchAndDevelopmentExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_NonRule10B51ArrModifiedFlag" name="NonRule10B51ArrModifiedFlag" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_ScenarioThreeMember" name="ScenarioThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ChangeInFairValueOfEquityInvestment" name="ChangeInFairValueOfEquityInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" name="DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_CvrLiability" name="CvrLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_RevenueUsedToDetermineTransactionPrice" name="RevenueUsedToDetermineTransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained" name="UnrestrictedAndUnencumberedCashPercentageToBeMaintained" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember" name="LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_LongTermDebtBalloonPaymentPercentage" name="LongTermDebtBalloonPaymentPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember" name="TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" name="EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares" name="ConversionOfTemporaryEquityIntoPermanentEquityShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_DeferredTaxAssetsLeaseLiability" name="DeferredTaxAssetsLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember" name="LoanAndSecurityAgreementWithSiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_TrancheAxis" name="TrancheAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_CapitalizedIntangibleAssets" name="CapitalizedIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock" name="SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion" name="EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_PersonnelRelatedCostsExcludingStockBasedCompensation" name="PersonnelRelatedCostsExcludingStockBasedCompensation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_IncomeTaxDisclosureTable" name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_AAPhaseTwoResearchServicesMember" name="AAPhaseTwoResearchServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ADXZeroNineSevenMember" name="ADXZeroNineSevenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_TemporaryEquityMember" name="TemporaryEquityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_PaymentOfReverseRecapitalizationTransactionCosts" name="PaymentOfReverseRecapitalizationTransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" name="LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_CommitmentAndContingenciesLineItems" name="CommitmentAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ConvertibleNotesMember" name="ConvertibleNotesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_SeriesAConvertiblePreferredStockMember" name="SeriesAConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_DeferredTaxLiabilitiesFixedAssets" name="DeferredTaxLiabilitiesFixedAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_CollaborationAgreementTransactionPrice" name="CollaborationAgreementTransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember" name="BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ConvertibleDebtAgreementMember" name="ConvertibleDebtAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_CollaborativeArrangementMilestonePayments" name="CollaborativeArrangementMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_LegacyQ32Member" name="LegacyQ32Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_TotalDeferred" name="TotalDeferred" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent" name="LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="qttb_SubleaseAggregateBaseRentObligation" name="SubleaseAggregateBaseRentObligation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_DisclosureInTabularFormOfVentureDebtTable" name="DisclosureInTabularFormOfVentureDebtTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" name="LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="qttb_PeriodDomain" name="PeriodDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_CurrentLiabilitiesMember" name="CurrentLiabilitiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_BempikibartMember" name="BempikibartMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_EventDomain" name="EventDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember" name="UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_PrepaidExternalResearchAndDevelopmentNonurrent" name="PrepaidExternalResearchAndDevelopmentNonurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_PayrollTaxCredit" name="PayrollTaxCredit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="qttb_AccountingPoliciesTable" name="AccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="qttb_ConsultingAndAdvisoryAgreementsMember" name="ConsultingAndAdvisoryAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821155702448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 03, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Q32 Bio Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001661998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3468154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">830 Winter Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Waltham<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">999-0232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">QTTB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,197,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain portions of the information required to be furnished pursuant to Part III of this Annual Report on Form 10-K will be set forth in, and incorporated by reference from, the Registrant&#8217;s definitive proxy statement for the annual meeting of stockholders or an amendment to this Annual Report on Form 10-K which will be filed with the Securities and Exchange Commission no later than 120 days after the end of the fiscal year ended December 31, 2024.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts, USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151352320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 77,965<span></span>
</td>
<td class="nump">$ 25,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">3,912<span></span>
</td>
<td class="nump">3,099<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">81,877<span></span>
</td>
<td class="nump">28,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity method investment</a></td>
<td class="nump">2,600<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">1,782<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use asset, operating leases</a></td>
<td class="nump">5,722<span></span>
</td>
<td class="nump">6,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash and restricted cash equivalents</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">5,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">4,611<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">92,332<span></span>
</td>
<td class="nump">47,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,989<span></span>
</td>
<td class="nump">3,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_AccruedExpensesAndOtherLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">7,479<span></span>
</td>
<td class="nump">9,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CvrLiability', window );">CVR liability</a></td>
<td class="nump">2,900<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Venture debt, current portion</a></td>
<td class="nump">3,097<span></span>
</td>
<td class="nump">878<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">16,465<span></span>
</td>
<td class="nump">14,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="nump">5,636<span></span>
</td>
<td class="nump">6,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLineOfCredit', window );">Venture debt, net of current portion</a></td>
<td class="nump">9,556<span></span>
</td>
<td class="nump">4,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible notes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">38,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other noncurrent liabilities</a></td>
<td class="nump">55,000<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">86,657<span></span>
</td>
<td class="nump">118,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">111,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 400,000,000 shares authorized, 12,197,615 and 359,569 shares issued and outstanding at December 31, 2024 2023, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">240,487<span></span>
</td>
<td class="nump">4,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(234,814)<span></span>
</td>
<td class="num">(187,081)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">5,675<span></span>
</td>
<td class="num">(182,921)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock and stockholders' equity (deficit)</a></td>
<td class="nump">92,332<span></span>
</td>
<td class="nump">47,057<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAConvertiblePreferredStockMember', window );">Series A convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">47,458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAOneConvertiblePreferredStockMember', window );">Series A-1 convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,132<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesBConvertiblePreferredStockMember', window );">Series B convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total convertible preferred stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 59,855<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_AccruedExpensesAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Expenses And Other Liabilities Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_AccruedExpensesAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CvrLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>CVR Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CvrLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481573/470-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAOneConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesAOneConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149908512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares issued</a></td>
<td class="nump">12,197,615<span></span>
</td>
<td class="nump">359,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="nump">12,197,615<span></span>
</td>
<td class="nump">359,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAConvertiblePreferredStockMember', window );">Series A convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Preferred stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,286,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred stock shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,286,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock shares outsstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,286,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Preferred stock liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAOneConvertiblePreferredStockMember', window );">Series A-1 convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Preferred stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">312,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred stock shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">312,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock shares outsstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">312,094<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Preferred stock liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesBConvertiblePreferredStockMember', window );">Series B convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Preferred stock par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred stock shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,625,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred stock shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,625,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock shares outsstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,625,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Preferred stock liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAOneConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesAOneConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149970416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Collaboration arrangement revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (6,651)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">48,143<span></span>
</td>
<td class="nump">31,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">17,959<span></span>
</td>
<td class="nump">9,875<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">66,102<span></span>
</td>
<td class="nump">41,604<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(66,102)<span></span>
</td>
<td class="num">(48,255)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="nump">15,890<span></span>
</td>
<td class="num">(6,193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">4,125<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">20,015<span></span>
</td>
<td class="num">(5,170)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before provision for income taxes and loss from equity method investment</a></td>
<td class="num">(46,087)<span></span>
</td>
<td class="num">(53,425)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(318)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investment</a></td>
<td class="num">(1,625)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (47,733)<span></span>
</td>
<td class="num">$ (53,743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic</a></td>
<td class="num">$ (5.12)<span></span>
</td>
<td class="num">$ (153.96)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted</a></td>
<td class="num">$ (6.58)<span></span>
</td>
<td class="num">$ (153.96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares - basic</a></td>
<td class="nump">9,320,884<span></span>
</td>
<td class="nump">349,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares - diluted</a></td>
<td class="nump">9,657,696<span></span>
</td>
<td class="nump">349,060<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Fair Value Of Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250976304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (47,733)<span></span>
</td>
<td class="num">$ (53,743)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Change in unrealized gain (loss) on available for sale securities, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive gain (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (47,733)<span></span>
</td>
<td class="num">$ (53,743)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821152018656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series A convertible preferred stock [Member]</div></th>
<th class="th"><div>Series A-1 convertible preferred stock [Member]</div></th>
<th class="th"><div>Series B convertible preferred stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,458<span></span>
</td>
<td class="nump">$ 4,132<span></span>
</td>
<td class="nump">$ 59,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,286,873<span></span>
</td>
<td class="nump">312,094<span></span>
</td>
<td class="nump">2,625,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, Shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="num">$ (130,712)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 2,625<span></span>
</td>
<td class="num">$ (133,338)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from option exercises, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from option exercises</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="nump">1,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(53,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,743)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,286,873<span></span>
</td>
<td class="nump">312,094<span></span>
</td>
<td class="nump">2,625,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,458<span></span>
</td>
<td class="nump">$ 4,132<span></span>
</td>
<td class="nump">$ 59,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, Shares at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="num">(182,921)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">4,159<span></span>
</td>
<td class="num">(187,081)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock to common stock in connection with the Merge, Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,286,873)<span></span>
</td>
<td class="num">(312,094)<span></span>
</td>
<td class="num">(2,625,896)<span></span>
</td>
<td class="nump">5,224,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible preferred stock to common stock in connection with the Merger, Value</a></td>
<td class="nump">111,445<span></span>
</td>
<td class="num">$ (47,458)<span></span>
</td>
<td class="num">$ (4,132)<span></span>
</td>
<td class="num">$ (59,855)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">111,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts', window );">Issuance of common stock in the pre-closing financing, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,682,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts', window );">Issuance of common stock in the pre-closing financing, Value</a></td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Issuance of common stock for conversion of convertible notes, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,433,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Issuance of common stock for conversion of Convertible Notes, Value</a></td>
<td class="nump">22,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization', window );">Issuance of common stock to Homology shareholders in reverse recapitalization, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,229,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization', window );">Issuance of common stock to Homology shareholders in reverse recapitalization, Value</a></td>
<td class="nump">64,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteSpinoffTransaction', window );">Reverse recapitalization transaction costs</a></td>
<td class="num">(10,013)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,013)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Issuance of CVR at fair value</a></td>
<td class="num">$ (180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(180)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from option exercises, Shares</a></td>
<td class="nump">255,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from option exercises</a></td>
<td class="nump">$ 1,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IssuanceOfCommonStocksFromRsuVesting', window );">Issuance Of Common Stocks From Rsu Vesting, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Stock-based compensation expense</a></td>
<td class="nump">4,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(47,733)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,733)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance, Shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, Shares at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,197,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2024</a></td>
<td class="nump">$ 5,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 240,487<span></span>
</td>
<td class="num">$ (234,814)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Common Stock During Period Pre-Closing Financing, Net of Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Common Stock During Period Pre-Closing Net of Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_IssuanceOfCommonStocksFromRsuVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of Common Stocks from RSU Vesting</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_IssuanceOfCommonStocksFromRsuVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Value to Homology Shareholders in Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Value to Homology Shareholders Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteSpinoffTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 60<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481423/505-60-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteSpinoffTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151807904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (47,733)<span></span>
</td>
<td class="num">$ (53,743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance costs</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on short-term investments</a></td>
<td class="num">(221)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">487<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">4,386<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash&#160;lease expense</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investment</a></td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_LossOnImpairmentOfEquityInvestment', window );">Loss on impairment of equity investment</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ChangeInFairValueOfEquityInvestment', window );">Change in fair value of CVR liability</a></td>
<td class="num">(2,180)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ChangeInFairValueOfConvertibleNotes', window );">Change in fair value of convertible notes</a></td>
<td class="num">(15,890)<span></span>
</td>
<td class="nump">6,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">276<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other noncurrent assets</a></td>
<td class="nump">386<span></span>
</td>
<td class="num">(4,503)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(1,043)<span></span>
</td>
<td class="nump">2,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(1,542)<span></span>
</td>
<td class="num">(471)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other current liabilities</a></td>
<td class="num">(7,714)<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncreaseDecreaseInContingentLiability', window );">Contingent liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">55,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(25,849)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(67,715)<span></span>
</td>
<td class="num">(18,677)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Maturities of short-term investments</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">19,925<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from borrowings under loan and security agreement</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Payments on borrowings under loan and security agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock in pre-closing financing</a></td>
<td class="nump">42,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ProceedsFromReverseRecapitalization', window );">Cash acquired in connection with reverse recapitalization</a></td>
<td class="nump">53,158<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PaymentOfReverseRecapitalizationTransactionCosts', window );">Payment of reverse recapitalization transaction costs</a></td>
<td class="num">(8,714)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of common stock options</a></td>
<td class="nump">1,694<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">95,138<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">47,348<span></span>
</td>
<td class="num">(18,276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period</a></td>
<td class="nump">31,264<span></span>
</td>
<td class="nump">49,540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period</a></td>
<td class="nump">78,612<span></span>
</td>
<td class="nump">31,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosure of non-cash operating, investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Interest payments on venture debt</a></td>
<td class="nump">856<span></span>
</td>
<td class="nump">422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization', window );">Short Term Investments Acquired In reverse recapitalization</a></td>
<td class="nump">19,905<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IssuanceOfCvrAtFairValue', window );">Issuance of CVR at fair value</a></td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ChangeInFairValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in Fair Value Of Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ChangeInFairValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ChangeInFairValueOfEquityInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value Of Equity Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ChangeInFairValueOfEquityInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_IncreaseDecreaseInContingentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Contingent Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_IncreaseDecreaseInContingentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_IssuanceOfCvrAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance Of CVR At Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_IssuanceOfCvrAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_LossOnImpairmentOfEquityInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on impairment of equity investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_LossOnImpairmentOfEquityInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PaymentOfReverseRecapitalizationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Of Reverse Recapitalization Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PaymentOfReverseRecapitalizationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ProceedsFromReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ProceedsFromReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short Term Investments Acquired In reverse recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150531296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (47,733)<span></span>
</td>
<td class="num">$ (53,743)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149967872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_Rule10B51ArrModifiedFlag', window );">Rule 10b5-1 Arrangement Modified</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_NonRule10B51ArrModifiedFlag', window );">Non-Rule 10b5-1 Arrangement Modified</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_NonRule10B51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Rule 10b5-1 Arrangement Modified [Flag]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_NonRule10B51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_Rule10B51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rule 10b5-1 Arrangement Modified [Flag]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_Rule10B51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151357600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management, Strategy, and Governance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1C. Cyb</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ersecurity.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity Risk Management and Strategy</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We designed and assess our program based on the National Institute of Standards and Technology Cybersecurity Framework (NIST CSF).</span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management program is </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into our overall risk management program, and shares common methodologies, reporting channels and governance processes that apply across the risk management program to other legal, compliance, strategic, operational, and financial risk areas.</span></p></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We leverage the support of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">third-party information technology and security providers</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, including for periodic security testing, as part of our risk management process, designed to identify, assess, and manage cybersecurity risks. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We maintain an incident response and notification plan designed to assist us in identifying, responding to, and recovering from cybersecurity incidents, and we have a process to assess the security practices of certain third-party vendors. We have also engaged a third-party with specialized expertise in cybersecurity to conduct an audit, which resulted in no notable findings, and reported the results to the Audit Committee.</span></span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We, like other companies in our industry, face a number of cybersecurity risks in connection with our business. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although such risks have not materially affected us, including our business strategy, results of operations or financial condition, to date, we and/or our vendors have, from time to time, experienced threats to, or security incidents, related to our data and systems or that had the potential to otherwise impact our business.</span></span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cybersecurity Governance</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board considers cybersecurity risk as part of its risk oversight function and has delegated to</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the Audit Committee (the &#8220;Committee&#8221;) oversight of cybersecurity risks, including oversight of management&#8217;s implementation of our cybersecurity risk management program.</span></span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee receives periodic reports from management on our cybersecurity risks. In addition, management updates the Committee, as necessary, regarding any significant cybersecurity incidents.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee reports to the full Board regarding its activities, including those related to cybersecurity.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The full Board also periodically receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our management team as part of the Board&#8217;s continuing education on topics that impact public companies.</span></p></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team, with the assistance of the Company&#8217;s third-party information technology providers, is responsible for assessing and managing our material risks from cybersecurity threats. Internal personnel, including our Senior Vice President, Finance, have primary responsibility for our overall cybersecurity risk management program and supervise both our internal cybersecurity personnel and our retained external cybersecurity consultants. Members of our senior management do not have direct cybersecurity expertise obtained through certifications, but their experience managing the Company, which includes consulting and coordinating as necessary with third-party information technology and cybersecurity experts, enables them to assess and manage material risks from cybersecurity threats.</span></p></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team stays informed about and monitors efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include:</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in our IT environment.</span></span></p></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cybersecurity risk management program is </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">integrated</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> into our overall risk management program, and shares common methodologies, reporting channels and governance processes that apply across the risk management program to other legal, compliance, strategic, operational, and financial risk areas.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our Board considers cybersecurity risk as part of its risk oversight function and has delegated to</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the Audit Committee (the &#8220;Committee&#8221;) oversight of cybersecurity risks, including oversight of management&#8217;s implementation of our cybersecurity risk management program.</span></span></p><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee receives periodic reports from management on our cybersecurity risks. In addition, management updates the Committee, as necessary, regarding any significant cybersecurity incidents.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee reports to the full Board regarding its activities, including those related to cybersecurity.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The full Board also periodically receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our management team as part of the Board&#8217;s continuing education on topics that impact public companies.</span></p></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team, with the assistance of the Company&#8217;s third-party information technology providers, is responsible for assessing and managing our material risks from cybersecurity threats. Internal personnel, including our Senior Vice President, Finance, have primary responsibility for our overall cybersecurity risk management program and supervise both our internal cybersecurity personnel and our retained external cybersecurity consultants. Members of our senior management do not have direct cybersecurity expertise obtained through certifications, but their experience managing the Company, which includes consulting and coordinating as necessary with third-party information technology and cybersecurity experts, enables them to assess and manage material risks from cybersecurity threats.</span></p></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team stays informed about and monitors efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include:</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in our IT environment.</span></span></p></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the Audit Committee (the &#8220;Committee&#8221;) oversight of cybersecurity risks, including oversight of management&#8217;s implementation of our cybersecurity risk management program.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee receives periodic reports from management on our cybersecurity risks. In addition, management updates the Committee, as necessary, regarding any significant cybersecurity incidents.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee reports to the full Board regarding its activities, including those related to cybersecurity.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The full Board also periodically receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our management team as part of the Board&#8217;s continuing education on topics that impact public companies.</span></p></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team, with the assistance of the Company&#8217;s third-party information technology providers, is responsible for assessing and managing our material risks from cybersecurity threats. Internal personnel, including our Senior Vice President, Finance, have primary responsibility for our overall cybersecurity risk management program and supervise both our internal cybersecurity personnel and our retained external cybersecurity consultants. Members of our senior management do not have direct cybersecurity expertise obtained through certifications, but their experience managing the Company, which includes consulting and coordinating as necessary with third-party information technology and cybersecurity experts, enables them to assess and manage material risks from cybersecurity threats.</span></p></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team stays informed about and monitors efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include:</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in our IT environment.</span></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Committee reports to the full Board regarding its activities, including those related to cybersecurity.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The full Board also periodically receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our management team as part of the Board&#8217;s continuing education on topics that impact public companies.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team, with the assistance of the Company&#8217;s third-party information technology providers, is responsible for assessing and managing our material risks from cybersecurity threats. Internal personnel, including our Senior Vice President, Finance, have primary responsibility for our overall cybersecurity risk management program and supervise both our internal cybersecurity personnel and our retained external cybersecurity consultants. Members of our senior management do not have direct cybersecurity expertise obtained through certifications, but their experience managing the Company, which includes consulting and coordinating as necessary with third-party information technology and cybersecurity experts, enables them to assess and manage material risks from cybersecurity threats.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our management team stays informed about and monitors efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include:</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in our IT environment.</span></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250989904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Nature of the Business</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1. Nature of the Business</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Q32 Bio Inc. (&#8220;Q32&#8221; or the &#8220;Company&#8221;) is a clinical stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. Q32 has multiple product candidates across a variety of autoimmune and inflammatory diseases. The Company was formed in 2017 as Admirx, Inc. under the laws of the state of Delaware and is headquartered in Waltham, Massachusetts. On March 20, 2020, the Company changed its name to Q32 Bio Inc.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Merger with Homology</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 25, 2024, Kenobi Merger Sub, Inc. (&#8220;Merger Sub&#8221;), a wholly-owned subsidiary of Homology Medicines, Inc. (&#8220;Homology&#8221;), completed its merger with and into Q32 Bio Operations Inc. (previously named Q32 Bio Inc. and referred to herein as &#8220;Legacy Q32&#8221;), with Legacy Q32 continuing as the surviving entity as a wholly-owned subsidiary of Homology. This transaction is referred to as the &#8220;Merger.&#8221; Homology changed its name to Q32 Bio Inc., and Legacy Q32, which remains as a wholly-owned subsidiary of the Company, changed its name to Q32 Bio Operations, Inc. The Merger was effected pursuant to an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;), dated as of November 16, 2023, by and among Homology, Legacy Q32, and Merger Sub. In connection with the Merger Agreement, certain parties entered into a subscription agreement with the Company to purchase shares of Legacy Q32&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s common stock for an aggregate purchase price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million (the &#8220;Pre-Closing Financing&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 25, 2024 (the &#8220;Closing Date&#8221;), the Pre-Closing Financing closed immediately prior to the consummation of the Merger. Shares of Legacy Q32&#8217;s common stock issued pursuant to the Pre-Closing Financing were converted into the right to receive </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,682,045</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Homology common stock after taking into account the Reverse Stock Split. On March 25, 2024, Homology effected a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one-for-eighteen</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reverse stock split of its then outstanding common stock </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(the &#8220;Reverse Stock Split&#8221;) where </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">all issued and outstanding shares of Legacy Q32&#8217;s common stock (including common stock issued upon the conversion of all Legacy Q32&#8217;s Series A, Series A-1 and Series B preferred stock, conversion of Legacy Q32 convertible notes, but excluding the common stock issued in Pre-Closing Financing) converted into the right to receive an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,017,842</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Homology&#8217;s common stock based on the final exchange ratio of 0.0480 (the &#8220;Exchange Ratio&#8221;). Lastly, each option to purchase the Legacy Q32&#8217;s shares that was outstanding and unexercised immediately prior to the Merger was converted into an option to purchase shares of Homology based on the Exchange Ratio. Immediately following the Merger, Legacy Q32 stockholders owned approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding common stock of the combined company.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Merger was accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). For accounting purposes, Legacy Q32 is considered the accounting acquirer and Homology is the acquired company based on the terms of the Merger Agreement and other factors, such as relative voting rights and the composition of the combined company&#8217;s board of directors and senior management. Accordingly, the Merger was treated as the equivalent of Legacy Q32&#8217;s issuing stock to acquire the net assets of Homology. As a result of the Merger, the net assets of Homology were recorded at their acquisition-date fair value in the financial statements of the combined company and the reported operating results prior to the Merger are those of Legacy Q32. Legacy Q32&#8217;s historical financial statements became the historical consolidated financial statements of the combined company. All issued and outstanding Legacy Q32 common stock, convertible preferred stock and options prior to the effective date of the Merger have been retroactively adjusted to reflect the Exchange Ratio, which reflects the impact of the reverse stock split, for all periods presented.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the effective time of the Merger, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#8217;s common stock received a contractual contingent value right (&#8220;CVR&#8221;) issued by Homology representing the contractual right to receive cash payments from the combined company upon the receipt of certain proceeds from a disposition of Homology&#8217;s pre-merger assets (see Note 3 for more details surrounding the accounting for the Merger and the CVRs).</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risks and Uncertainties</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including but not limited to, risks associated with completing preclinical studies and clinical trials, obtaining regulatory approvals for product candidates, development by competitors of new biopharmaceutical products, dependence on key personnel, protection of proprietary technology, compliance with government regulations and the ability to secure additional capital to fund operations. Programs currently under development will require significant additional research and development efforts, including preclinical</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and clinical testing, and will need to obtain regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel and infrastructure and extensive compliance-reporting capabilities. Even if the Company&#8217;s product development efforts are successful, it is uncertain when, if ever, the Company will realize revenue from product sales. Since its inception, the Company&#8217;s operations have been focused on organizing and staffing, business planning, raising capital, establishing the Company&#8217;s intellectual property portfolio and performing research and development of its product candidates, programs and platform. The Company has primarily funded its operations with proceeds from the sale of convertible preferred stock, convertible notes, venture debt, the Merger with Homology and accompanying Pre-Closing Financing and its collaboration arrangement with Horizon.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liquidity and Going Concern</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Update (&#8220;ASU&#8221;) 2014-15, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Disclosure of Uncertainties about an Entity&#8217;s ability to Continue as a Going Concern (Subtopic 205-40)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has evaluated whether they are conditions and events, considered in the aggregate, that raise substantial doubt about the Company&#8217;s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company had an accumulated deficit of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">234.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and cash and cash equivalents of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company expects that its cash and cash equivalents will be sufficient to fund its operating expenditures and capital expenditure requirements necessary to advance its research efforts and clinical trials for at least one year from the date of issuance of these consolidated financial statements.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has incurred recurring operating losses since its inception. During the year ended December 31, 2024, the Company incurred a net loss of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company expects its operating losses and negative operating cash flows to continue into the foreseeable future. The future viability of the Company is dependent on its ability to raise additional capital to finance its operations. The Company&#8217;s inability to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies. There can be no assurance that the current operating plan will be achieved or that additional funding will be available on terms acceptable to the Company, or at all.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250956224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2. Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in conformity with GAAP and have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements include those of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in the consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could materially differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the fair value of the common stock and convertible notes prior to the effective date of the Merger, the fair value of CVR liability, and the prepaid and accrued research and development expenses. The Company utilizes certain estimates to record expenses relating to research and development contracts. These contract estimates, which are primarily related to the length of service of each contract and the amount of service provided as of each measurement date, are determined by the Company based on input from internal project management, as well as from service providers. Estimates are periodically reviewed considering changes in circumstances, facts and historical experience. Actual results may differ from the Company&#8217;s estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker (&#8220;CODM&#8221;), or decision-making group, in determining how to allocate resources and in assessing performance. The Company has one reporting segment (see Note 20). The segment consists of the development of clinical and preclinical product candidates for the development of the Company&#8217;s novel biologics. The Company&#8217;s chief operating decision maker is the chief executive officer (&#8220;CEO&#8221;).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss, which is reported on the income statement. The measure of segment assets is reported on the balance sheet as total consolidated assets.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM uses cash forecast models in deciding how to invest into the segment. Such cash forecast models are reviewed to assess the entity-wide operating results and performance. Net loss is used to monitor budget versus actual results. Monitoring budget versus actual results is used in assessing the performance of the segment and in establishing management&#8217;s compensation, along with cash forecast model.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Currency Translations</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s functional currency is the United States dollar. Foreign currency transaction gains and losses are recorded in the consolidated statement of operations.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risk and Significant Suppliers</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments that potentially expose the Company to credit risk primarily consist of cash, cash equivalents, restricted cash and restricted cash equivalents. The Company maintains its cash, cash equivalents, restricted cash and restricted cash equivalents balances with accredited financial institutions and, consequently, the Company does not believe it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s cash management limits investment to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. The Company maintains its cash in bank deposit accounts that are Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insured up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. At times, the Company&#8217;s bank accounts may exceed the federal insurance limit.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is dependent on contract development and manufacturing organizations (&#8220;CDMOs&#8221;) to supply products for research and development activities in its programs. In particular, the Company relies and expects to continue to rely on a small number of manufacturers to supply it with its requirements for the active pharmaceutical ingredients, other raw materials and formulated drugs related to these programs. These programs could be adversely affected by a significant interruption in the supply of active pharmaceutical ingredients, other raw materials and formulated drugs. The Company is also dependent on contract research organizations (&#8220;CROs&#8221;) which provide services related to the research and development activities in its programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Off Balance Sheet Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had no off balance sheet risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Income (Loss)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive income (loss) includes net loss as well as other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders.</span></p></div><div><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments that are readily convertible into cash with maturities of three months or less at the date of purchase to be cash equivalents. Cash equivalents are comprised of money market accounts invested in U.S. Treasury securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted cash and restricted cash equivalents are comprised of deposits held by financial institutions as collateral for the company&#8217;s venture debt and used to collateralize letters of credit related to the Company&#8217;s lease arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company includes the restricted cash and restricted cash equivalents balance together with its cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, restricted cash and restricted cash equivalents consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:66.993%;box-sizing:content-box;"></td>
          <td style="width:1.62%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.62%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77,965</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,617</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash and cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">647</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,647</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents, restricted cash and restricted<br/>&#160;&#160;&#160;cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78,612</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,264</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></div></div><div></div><p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-Term Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Short-term investments represent holdings of available-for-sale marketable securities in accordance with the Company&#8217;s investment policy and cash management strategy. Short-term investments have maturities of greater than 90 days at the time of purchase and mature within one year from the balance sheet date. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#8217; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the underlying security. Such amortization and accretion, together with interest on securities, are included in interest income in the Company&#8217;s consolidated statements of operations. The cost of marketable securities sold is determined based on the specific identification method and any realized gains or losses on the sale of investments are reflected as a component of other income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#8217;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#8217;s industry, and any significant deterioration in economic conditions.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Transaction Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings as deferred transaction costs until such financings are consummated. After consummation of an equity financing, these costs are recorded as a reduction of the proceeds from the transaction, either as a reduction of the carrying value of the preferred stock or in stockholders&#8217; deficit as a reduction of additional paid-in capital generated as a result of the transaction. Should the in-process equity financing be abandoned, the deferred transaction costs would be expensed immediately as a charge to operating expenses in the consolidated statements of operations.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 1 &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Quoted prices in active markets for identical assets or liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 2 &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 3 &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in Equity Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the equity method of accounting to account for an investment in an entity that it does not control, but in which it has the ability to exercise significant influence over operating and financial policies. The Company's proportionate share of the net income or loss of the entity is included in consolidated net income (loss). Judgments regarding the level of influence over the equity method investment include consideration of key factors such as the Company's ownership interest, representation on the board of directors or other management body and participation in policy-making decisions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the equity method of accounting, the Company&#8217;s investment is initially recorded at fair value on the consolidated balance sheets. Upon initial investment, the Company evaluates whether there are basis differences between the carrying value and fair value of the Company&#8217;s proportionate share of the investee&#8217;s underlying net assets. Typically, the Company amortizes basis differences identified on a straight-line basis over the underlying assets&#8217; estimated useful lives when calculating the attributable earnings or losses, excluding the basis differences attributable to in-process research and development that has no alternative future use. If the Company is unable to attribute all of the basis differences to specific assets or liabilities of the investee, the residual excess of the cost of the investment over the proportional fair value of the investee&#8217;s assets and liabilities is considered to be equity method goodwill and is recognized within the equity investment balance, which is tracked separately within the Company&#8217;s memo accounts. The Company subsequently records in the statements of operations its share of income or loss of the other entity within other income/expense, which results in an increase or decrease to the carrying value of the investment. If the share of losses exceeds the carrying value of the Company&#8217;s investment, the Company will suspend recognizing additional losses and will continue to do so unless it commits to providing additional funding; however, if there are intra-entity profits this can cause the investment balance to go negative.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that a decline in value has occurred that is other than temporary. Evidence considered in this evaluation includes, but would not necessarily be limited to, the financial condition and near-term prospects of the investee, recent operating trends and forecasted performance of the investee, market conditions in the geographic area or industry in which the investee operates and the Company&#8217;s strategic plans for holding the investment in relation to the period of time expected for an anticipated recovery of its carrying value. If the investment is determined to have a decline in value deemed to be other than temporary it is written down to estimated fair value.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the cost method to account for an investment in an entity in which it does not have the ability to exercise significant influence over operating and financial policies. Investments recorded using the cost method will be assessed for any decrease in value that has occurred that is other than temporary and the other than temporary decrease in value shall be recognized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As and when circumstances and facts change, the Company will evaluate the Company&#8217;s ability to significantly influence operational and financial policy to establish a basis for converting the investment accounted for using the cost method to the equity method of accounting and vice versa.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company accounted for its investment in Oxford Biomedica (US) LLC (&#8220;OXB (US) LLC&#8221;) using the cost method (see Note 6).</span></p></div><div><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. Upon retirement or sale,</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:70.32%;box-sizing:content-box;"></td>
          <td style="width:1.7%;box-sizing:content-box;"></td>
          <td style="width:27.98%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Useful Life (Years)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_4b3c95c9-00db-4ff5-871a-392543c3c948;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of useful life or<br/>term of<br/>associated lease</span></span></span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates whether an arrangement is or contains a lease at contract inception. If a contract is or contains a lease, lease classification is determined at lease commencement, which represents the date at which the underlying asset is made available for use by the Company. The Company&#8217;s lease terms are generally measured at the respective lease&#8217;s noncancelable term and exclude any optional extension terms as the Company is not reasonably certain to exercise such options. The Company elected the short-term lease exemption and therefore does not recognize lease liabilities and right of use assets for lease arrangements with original lease terms of twelve months or less.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lease liabilities represent the Company&#8217;s obligation to make lease payments under a lease arrangement. Lease liabilities are measured as the present value of fixed lease payments, discounted using an incremental borrowing rate, as interest rates implicit in the Company&#8217;s lease arrangements are generally not readily determinable. The Company elected the practical expedient to not separate lease and non-lease components for its real estate leases and therefore both are considered when determining the lease payments in a lease arrangement. Variable lease costs are expensed as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The incremental borrowing rate represents the interest rate at which the Company could borrow a fully collateralized amount equal to the lease payments, over a similar term, in a similar economic environment. The Company determines the incremental borrowing rate at lease commencement, generally using a synthetic credit rating based on the Company&#8217;s financial position and negative cash flows, factoring in adjustments for additional risks based on the Company&#8217;s economic condition, a survey of comparable companies with similar credit and financial profiles, as well as additional market risks, as may be applicable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Right-of-use assets represent the Company&#8217;s right to use an underlying asset over its lease term. Right-of-use assets are initially measured as the associated lease liability, adjusted for prepaid rent and tenant incentives. The Company remeasures right-of-use assets and lease liabilities when a lease is modified, and the modification is not accounted for as a separate contract. A modification is accounted for as a separate contract if the modification grants the Company an additional right of use not included in the original lease agreement and the increase in lease payments is commensurate with the additional right of use. The Company assesses its right-of-use assets for impairment consistent with its policy for impairment of long-lived assets held and used in operations.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may be impaired, and assesses their recoverability based upon estimated future undiscounted future cash flows expected to be generated by the long-lived assets. If the estimated aggregate undiscounted cash flows are less than the carrying amount of the long-lived assets, an impairment charge, calculated as the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets, is recorded. The estimated fair value of the long-lived assets is determined based on the estimated discounted cash flows expected to be generated from the long-lived assets.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt and Warrant Issuance Costs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying value of the Company&#8217;s venture debt was recorded net of issuance costs and discount relating to the issuance of warrants. The amounts are amortized over the term of the debt using the effective interest method and recognized as interest expense.</span></p></div><div><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and Development expenses are comprised of costs incurred in performing research and development activities, including salaries, stock-based compensation and benefits, costs for clinical research organizations and other outsourced activities; laboratory supplies; technology licenses, software and other information technology support; facilities and depreciation.  Upfront payments and milestone payments made for the licensing of technology are expensed as research and development expenses in the period in which they are incurred. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related goods are delivered or the services are performed.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company has entered into various research and development related contracts with external parties. The payments under these agreements are recorded as research and development expenses as the underlying services are performed or the goods are received. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued and prepaid balances at</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">end of any reporting period. Actual results could differ from the Company&#8217;s estimates. The Company&#8217;s historical accrual estimates have not been materially different from the actual costs.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Costs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expenses all costs as incurred in connection with patent applications, including direct application fees, and the legal and consulting expenses related to making such applications, and such costs are included in general and administrative expenses within the Company&#8217;s statement of operations.</span></p></div><div><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under FASB Accounting Standards Codification (&#8220;ASC&#8221; Topic 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 606), an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Arrangements that include rights to additional goods or services that are exercisable at a customer&#8217;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. The identification of material rights requires judgments related to the determination of the value of the underlying good or service relative to the option exercise price. The exercise of a material right is accounted for as a contract modification for accounting purposes.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the license terms, the research, manufacturing and commercialization capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The transaction price is determined and allocated to the identified performance obligations in proportion to their stand-alone selling prices (SSP) on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The amount of variable consideration included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty related to the variable consideration is resolved. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#8217;s control or the licensee&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time recognition is based on the use of an output or input method.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for stock-based awards in accordance with FASB ASC Topic 718, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compensation &#8211; Stock Compensation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ASC 718). ASC 718 requires all stock-based awards issued to employees and members of the Company&#8217;s board of directors for their services to be recognized as expense in the statements of operations based on their grant date fair values. For stock options and time-based restricted stock awards, the Company expenses the fair value of the awards on a straight-line basis over each award&#8217;s service period, which is generally the period in which the related services are received. For performance-based stock awards, the Company uses the accelerated attribution method to expense the awards over the implicit service period based on the probability of achieving the performance conditions. The Company accounts for stock-based awards to non-employees consistently with the accounting for awards to employees and measures stock-based awards granted to non-employees based on their grant date fair value and recognizes the resulting value as stock-based compensation expense during the period the related services are rendered. The Company has not issued any stock-based awards with market-based vesting conditions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of options on the date of grant is calculated using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company&#8217;s estimates of these assumptions are primarily based on the trading price of the Company&#8217;s stock, historical data, peer company data and judgment regarding future trends and factors. The Company accounts for forfeitures as they occur.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s equity incentive plan allows for the issuance of restricted stock awards to employees and non-employee consultants that may be subject to vesting. The unvested shares of any restricted stock awards are held in escrow as the stock award vests or until award holder termination, whichever occurs first. In the event of a sale of the Company, the Company has the obligation to repurchase at cost, the portion of unvested stock awards from the award holder. For all unvested stock awards, a liability is established related to the Company&#8217;s obligation for unvested awards at cost.</span></p></div><div><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income taxes are recorded in accordance with FASB ASC Topic 740, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 740), which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. Should the actual amounts differ from these estimates, the amount of the Company&#8217;s valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to the tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income taxes are accounted for using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial carrying</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applicable to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance against deferred tax assets is recorded if, based upon the weight of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Event Considerations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that require additional disclosure. The Company has evaluated events occurring after the date of its consolidated balance sheet through the date these consolidated financial statements were issued (see Note 21).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280)&#8212;Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASU 2023-07&#8221;). The amendments in this update improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses. All disclosure requirements of the update are required for entities with a single reportable segment. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and should be applied on a retrospective basis to all periods presented. The Company adopted this standard as of January 1, 2024. The Company determined that adopting the amendments in ASU 2023-07 had no impact on the Company&#8217;s reportable segment identified and additional required disclosures have been included.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Standards Not Yet Adopted</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 14, 2023, the FASB issued ASU No. 2023-09,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Income Taxes (Topic 740)&#8212;Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASU 2023-09&#8221;). ASU 2023-09 provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and incomes taxes paid information. For public companies, the amendments are effective for annual periods beginning after December 15, 2024 and should be applied prospectively. The Company has determined that the effects of adopting the amendments in ASU 2023-09 will only impact its disclosures and not have a material impact on its consolidated financial position and the results of its operations when such amendment is adopted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250892144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting for the Merger<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_MergersAndAquisitionsAbstract', window );"><strong>Mergers and Aquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Accounting for the Merger</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3. Accounting for the Merger</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As described in Note 1, Merger Sub merged with and into Legacy Q32, with Legacy Q32 surviving as a wholly-owned subsidiary of the Company on March 25, 2024. The Merger was accounted for as a reverse recapitalization in accordance with GAAP with Legacy Q32 as the accounting acquirer of Homology. Legacy Q32 was determined to be the accounting acquirer based on the terms of the Merger Agreement and other factors, including: (i) Legacy Q32&#8217;s shareholders own a majority of the voting rights in the combined company; (ii) Legacy Q32 designated a majority (seven of nine) of the initial members of the board of directors of the combined company; (iii) Legacy Q32's executive management team became the management team of the combined company; (iv) the pre-combination assets of Homology were primarily cash and cash equivalents, short-term investments, and other non-operating assets; and (v) the combined company was named Q32 Bio Inc. and is headquartered in Legacy Q32&#8217;s office in Waltham, Massachusetts.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the effective time of the Merger, substantially all of the assets of Homology consisted of cash and cash equivalents, short-term investments, as well as other non-operating assets. Under such reverse recapitalization accounting, the assets and liabilities of Homology were recorded at their fair value in the Company&#8217;s financial statements at the effective time of the Merger, which approximated book value due to the short-term nature, except for the equity method investment as described below. Homology&#8217;s development programs had ceased prior to the Merger and were deemed to be de minimis in value at the transaction date. No goodwill or intangible assets were recognized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Consequently, the consolidated financial statements of the Company reflect the operations of Legacy Q32 for accounting purposes together with a deemed issuance of shares, equivalent to the shares held by the former stockholders Homology, the legal acquirer, and a recapitalization of the equity of Legacy Q32, the accounting acquirer.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the recapitalization, the Company obtained the assets and liabilities listed below:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.823%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,158</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,905</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">964</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity method investment</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,900</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,903</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CVR liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,080</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net assets acquired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,944</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in personnel cost related to severance payments and retention bonuses to Homology employees and this amount was recorded in general and administrative expense in the accompanying consolidated statement of operations for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company also incurred transaction costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and this amount is recorded in additional paid-in capital in the accompanying consolidated statements of convertible preferred stock and stockholders&#8217; equity (deficit) for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">With respect to the CVRs issued in connection with the Merger, each CVR represents the contractual right to receive payments from the Company upon the actual receipt by the Company or its subsidiaries of certain contingent proceeds derived from any cash consideration that is paid to the Company or its subsidiaries as a result of the sale, transfer, license, assignment or other divestiture, disposition or commercialization of any of the Company&#8217;s assets, rights and interests relating to the following pre-merger assets of Homology: HMI-103, HMI-204, capsids and human hematopoietic stem cell-derived adeno-associated virus vector (&#8220;AAVHSC&#8221;) platform, including any equity interests held directly or indirectly by the Company in OXB (US) LLC.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company believes that the achievement of the milestones outlined in the CVR agreement related to Homology&#8217;s HMI-103, HMI-204, capsids and AAVHSC platform are highly susceptible to factors outside the Company's influence that are not expected to be resolved for a long period of time, if at all. In particular, these amounts are primarily influenced by the actions and judgments of third parties and the licensors of such assets and are based on the licensors of such assets progressing the in-process research and development assets, and in the case of one of the draft agreements, to certain milestones. As of March 25, 2024, the date of the Merger, the Company recorded a CVR liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the balance sheet relating to such contingent payments.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the portion of the CVR agreement that is related to Homology's equity interest in OXB (US) LLC, the Company recorded a CVR liability of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million representing its estimated fair value as of the date of the Merger. Pursuant to the Amended and Restated Limited Liability Company Agreement of OXB (US) LLC, at any time following the three-year anniversary of the closing of the transaction between OXB (US) LLC, Oxford Biomedica (US), Inc. and the Company (formerly known as Homology Medicines, Inc.) on March 10, 2022, (i) Oxford Biomedica (US), Inc. will have an option to cause the Company to sell and transfer to Oxford Biomedica (US), Inc., and (ii) the Company will have an option to cause Oxford Biomedica (US), Inc. to purchase from the Company, in each case, all of the Company&#8217;s equity ownership interest in OXB (US) LLC based on the Company's pro rata share of OXB (US) LLC (10%) times a predetermined multiple of revenue for the immediately preceding 12-month period increased by OXB (US) LLC's cash balance and decreased by OXB (US) LLC's debt balance as of the exercise date (together, the &#8220;Options&#8221;), subject to a maximum amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">74.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company utilized a monte carlo simulation model, also known as a probability simulation, to estimate the fair value of the CVR liability. For each simulated path of future revenue, a market approach using the predetermined revenue multiple was employed to determine the future value of the equity interest, which was then discounted to present value using OXB (US) LLC's estimated cost of debt.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to a change in control provision in the Amended and Restated Limited Liability Company Agreement of OXB (US) LLC, on March 1, 2025, Oxford Biomedica (US), Inc. caused the Company to sell and transfer to Oxford Biomedica (US), Inc., all of the Company's equity interest in OXB (US) LLC. See Note 21.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_MergersAndAquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mergers and Aquisitions Abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_MergersAndAquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821148988736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_InvestmentsDisclosureAbstract', window );"><strong>Investments Disclosure Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock', window );">Short-Term Investments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4. Short-Term Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company may invest its excess cash in fixed income instruments denominated and payable in U.S. dollars, including U.S. treasury securities, commercial paper, corporate debt securities and asset-backed securities in accordance with the Company&#8217;s investment policy that primarily seeks to maintain adequate liquidity and preserve capital.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t have any short-term investments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_InvestmentsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments Disclosure Abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_InvestmentsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the components of cash, cash equivalents, and short-term investments. Short-term investments may include current marketable securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156442320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying values of the Company&#8217;s prepaid expenses and other current assets, accounts payable, and accrued expenses and other current liabilities approximate their fair value due to their short-term nature. The carrying value of the Company&#8217;s term loan as of December 31, 2024 (see Note 11) approximated fair value based on interest rates currently available to the Company.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The tables below present information about the Company&#8217;s assets and liabilities that are regularly measured and carried at fair value on a recurring basis at December 31, 2024 and December 31, 2023 and indicate the level within the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value, which is described further within Note 2, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Summary of Significant Accounting Policies</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are summarized as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.38%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as<br/>of December 31,<br/>2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CVR liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 are summarized as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.239%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.325000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as<br/>of December 31,<br/>2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted cash equivalents:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total restricted cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible notes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,595</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,595</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,595</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,595</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Money market funds were valued by the Company using quoted prices in active markets for identical securities, which represent a Level 1 measurement within the fair value hierarchy.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Notes 1 and 3, at the effective time of the Merger, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#8217;s common stock received a CVR, issued by Homology subject to and in accordance with the terms and conditions of a CVR Agreement, representing the contractual right to receive cash payments from the combined company upon the receipt of certain proceeds from a disposition of Homology&#8217;s pre-merger assets, calculated in accordance with the CVR Agreement. The Company concluded that the CVR liability is a derivative liability and is accounted for at fair value. The fair value of the CVR liability is based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. For the portion of the CVR liability that is related to Homology's equity interest in OXB (US) LLC, the Company utilized a monte carlo simulation model, also known as a probability simulation, to estimate the fair value of the CVR liability. This model requires the use of estimates and assumptions including estimated future revenues and discount rates. For the portion of the CVR liability related to Homology's HMI-103, HMI-204, capsids and AAVHSC platform, the Company's fair value assessment includes judgments around the probability of progressing the in-process research and development assets, and in the case of one of the draft agreements, to certain milestones.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CVR liability had an estimated fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company recorded in other income (expense), net, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the change in estimated fair value during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023, there were no transfers between Level 1, Level 2 and Level 3 measurements. There have been no impairments of the Company&#8217;s assets measured and carried at fair value during the years ended December 31, 2024 and 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legacy Q32 issued convertible notes (the &#8220;Convertible Notes&#8221;) totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the year ended December 31, 2022. Legacy Q32 concluded that the Convertible Notes and its related features are within the scope of FASB ASC Topic 825, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financial Instruments </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ASC 825), as a combined financial instrument, and Legacy Q32 elected the fair value option where changes in fair value of the Convertible Notes are measured through the accompanying consolidated statement of operations until settlement. The Convertible Notes liability represents a Level 3 measurement within the fair value hierarchy as it has been valued using certain unobservable inputs. These inputs include the underlying fair value of the equity instrument into which the Convertible Notes are convertible.</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The fair value is based on significant inputs not observable in the market, namely potential financing scenarios, the likelihood of such scenarios, the expected time for each scenario to occur, and the required market rates of return utilized in modeling these scenarios. </span></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:12.775%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:12.775%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:12.775%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scenario 1</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scenario 2</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scenario 3</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Probability of each scenario</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected Term (years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.25</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.25</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.42</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Required market rates of return</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Convertible Notes had an estimated fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of December 31, 2023. The Company recorded in other income (expense), net, an interest expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and a charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the change in estimated fair value during the year ended December 31, 2023. There was no change in fair value attributable to the instrument-specific credit risk for the year ended December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon closing of the Merger, Legacy Q32 converted the outstanding Convertible Notes plus accrued interest into shares of common stock at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the purchase price of the mandatory conversion event. As the Convertible Notes are recorded at fair value, a gain of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on the change in the fair value prior to the conversion of convertible notes is reflected in the consolidated statement of operations for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (see Note 11).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821148987872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Equity Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investment in Equity Securities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6. Investment in Equity Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the Merger, the Company obtained Homology's </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in OXB (US) LLC, an AAV vector process development and manufacturing services company. At that time, the Company had significant influence over, but did not control, OXB (US) LLC through its noncontrolling representation on OXB (US) LLC&#8217;s board of directors and the Company&#8217;s equity interest in OXB (US) LLC. Accordingly, the Company did not consolidate the financial statements of OXB (US) LLC and accounted for its investment using the equity method of accounting.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recorded its equity method investment in OXB (US) LLC at fair value upon the effective date of the Merger. The fair value of the equity method investment was determined based on the market approach. This approach estimated the fair value of OXB (US) LLC based on the implied value for the entity, including the Options (as defined in Note 3 above), for a controlling interest in OXB (US) LLC at the entity&#8217;s formation. As part of its fair value analysis, the Company determined that the Options are embedded in the Company&#8217;s ownership units of OXB (US) LLC because the Options are not legally detachable or separately exercisable. Accordingly, the equity method investment and the Options represent one unit of account and the fair value recorded reflects the value of the equity interest and the Options (refer to Note 3 for more information for how the fair value was determined).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a result of transactions by OXB (US) LLC, the Company&#8217;s investment was diluted to a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in OXB (US) LLC on May 22, 2024, and the Company no longer has the ability to exert significant influence over the operating and financial policies of OXB (US) LLC. The Company discontinued the equity method of accounting for the investment in OXB (US) LLC on May 22, 2024 and determined the remaining investment to be an equity security accounted for in accordance with FASB ASC Topic 321, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments&#8212;Equity Securities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 321) at the date the investment no longer qualifies for the equity method of accounting. The Company recorded the equity instrument at fair value and applied the measurement alternative under ASC 321 such that the Company would not change the amount recorded for the equity instrument unless the Company identified observable price changes in orderly transactions for the identical or similar investment of the same issuer or the equity instrument was otherwise deemed to be impaired.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At each reporting period, the Company is required to make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. If deemed impaired, the Company is required to estimate the fair value of the investment and recognize an impairment loss equal to the difference between the fair value of the investment and its carry amount. As of September 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company performed an assessment to evaluate whether the investment was impaired and determined that the fair value of its investment in OXB (US) LLC was negatively impacted due to a change in OXB (US) LLC's forecasted performance. The Company utilized a monte carlo simulation model, also known as a probability simulation, to estimate the fair value of its investment. This model requires the use of estimates and assumptions including estimated future revenues and discount rates which are significant unobservable inputs representing Level 3 measurements within the fair value hierarchy. The Company determined that the decline in value was deemed to be other than temporary and recorded an impairment charge of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to reduce its investment to fair value. The impairment charge is included in other income (expense), net in the Company's consolidated statements of operations. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the carrying value of the equity investment was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the Company determined that the investment was not impaired.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to May 22, 2024, the Company was recording its share of income or losses from OXB (US) LLC on a quarterly basis under the equity method of accounting.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478156/740-323-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 323<br> -Publisher FASB<br> -URI https://asc.fasb.org/323/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821148987616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7. Property and Equipment, Net</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">P</span><span style="font-size:12pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">roperty and equipment, net consisted of the following as of (in thousands): </span></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,382</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,382</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">351</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">341</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">940</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,748</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less accumulated depreciation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">966</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,370</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation expense for the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in each period</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairment losses occurred in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> losses on disposal of fixed assets in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149036800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses, Other Current Assets and Other Noncurrent Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock', window );">Prepaid Expenses, Other Current Assets and Other Noncurrent Assets</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8. Prepaid Expenses, Other Current Assets and Other Noncurrent Assets</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following as of (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid external research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,076</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,834</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payroll tax credit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">555</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">755</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">885</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">396</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,099</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other noncurrent assets consisted of the following as of (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred transaction costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid external research and development - long term</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">676</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other noncurrent assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclousre of prepaid expenses other current assets and other noncurrent assets text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821255274160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9. Accrued Expenses and Other Current Liabilities</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following as of (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and related expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,003</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued external research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,578</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services and other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,474</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,328</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a45e6167-40b6-49f4-9625-e8ce6cbfd3a5;"><span style="-sec-ix-hidden:F_cb90d7dd-2025-4f37-8452-ccbb5dfb30b4;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability, current</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">538</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued taxes payable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,479</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,763</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses and other current liabilities disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250993552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10. Commitments and Contingencies</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company had several ongoing clinical studies in various clinical trial stages. Its most significant contracts relate to agreements with CROs for clinical trials and preclinical studies and CDMOs for manufacturing which the Company enters into in the normal course of business. The contracts with CROs and CDMOs are generally cancellable, with notice, at the Company&#8217;s option.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating lease</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2021 the Company entered into a long-term operating lease agreement for its current corporate headquarters in Waltham, Massachusetts (&#8220;headquarters lease&#8221;). The headquarters lease provides approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> square feet for general office use and research lab facilities. The lease commencement date was January 1, 2022 and the Company did not take control or have the right to use the leased property until this time. The lease term ends in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_a1c527db-8fab-40c5-be93-17f92684f3c3;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 2031</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has an option to extend the lease term for an additional </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The initial rent for the office space is approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per year, increasing every year by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% for total aggregate payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Upon the commencement date, the Company established a right-of-use asset and lease liability on the consolidated balance sheet. As part of the agreement, the Company arranged for a letter of credit for $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as a security for lease, which is considered restricted cash and included as restricted cash and restricted cash equivalents in the consolidated balance sheet. The Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in a tenant improvement allowance that was applied against the right-of-use asset.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company&#8217;s headquarters lease had a weighted-average remaining lease term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7.0</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years and weighted average incremental borrowing rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts reported in the consolidated balance sheet for leases where the Company is the lessee as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and December 31, 2023 were as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,722</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,301</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,722</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,301</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">538</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncurrent:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,786</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes operating lease costs for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,029</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">999</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Variable lease costs were primarily related to operating expenses, taxes and insurances associated with the operating lease, which were assessed based on the Company&#8217;s proportionate share of such costs for the leased premises. As these costs are generally variable in nature, they were not included in the measurement of the operating lease right-of-use asset and related lease liability. Total lease costs are included as operating expenses in the Company&#8217;s consolidated statements of operations.</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Future minimum lease payments under non-cancelable lease agreement as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and a reconciliation to the carrying amount of the lease liabilities presented in the consolidated balance sheet are as follows (in thousands): </span></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.823%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Minimum<br/>Rental<br/>Payments</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,092</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,124</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,158</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,494</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,121</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,873</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability, current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prior to the Merger, Homology was subleasing office and research and development laboratory space in Bedford, Massachusetts, under a sublease agreement with OXB (US) LLC that expired in December 2024. During the first quarter of 2024, prior to the Merger, Homology had fully abandoned the space and accordingly, had shortened the remaining useful of its right-of-use asset to equal the time remaining until the planned abandonment date. At the effective time of the Merger, the Company recorded a liability of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million representing the present value of the future minimum lease payments due under</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">this sublease. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there are no future lease payments due under the Homology sublease and therefore </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> liability on the Company's consolidated balance sheet.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">License Agreements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">License Agreement with the University of Colorado</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In August 2017, the Company entered into an exclusive license agreement, as amended in February 2018, September 2018, and April 2019 (the &#8220;Colorado License Agreement&#8221;), with The Regents of the University of Colorado (&#8220;Colorado&#8221;), pursuant to which the Company obtained worldwide, royalty-bearing, sublicensable licenses under certain patents and know-how owned by Colorado and Medical University of South Carolina (&#8220;MUSC&#8221;) relating to the research, development and commercialization of ADX-097. The licenses granted to the Company are exclusive with respect to certain patent families and know-how and non-exclusive with certain other patent families and know-how. The licenses granted to the Company are also subject to certain customary retained rights of Colorado and MUSC and rights of the United States government owing to federal funding giving rise to inventions covered by the licensed patents. The Company agreed to use commercially reasonable efforts to develop, manufacture and commercialize ADX-097, including by using commercially reasonable efforts to achieve specified development and regulatory milestones by specified dates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, the Company agreed to pay Colorado (i) development and sales milestone payments in an aggregate amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per licensed product for the first three products, (ii) tiered royalty rates on cumulative net sales of licensed products in the low single digit percentages, (iii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of sublicense income and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents. The Company&#8217;s obligation to pay royalties to Colorado commences, on a licensed product-by-licensed product and country-by-country basis, from the first commercial sale of a licensed product in any country and expires on the later of (a) the last to expire valid claim within the licensed patents covering such licensed product in such country, and (b) </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years following the effective date of the Colorado License Agreement, or April 2037 (the &#8220;Royalty Term&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless earlier terminated by either party pursuant to its terms, the Colorado License Agreement will expire upon the expiration of the Royalty Term in all countries. The Company may terminate the Colorado License Agreement for convenience upon providing prior written notice to Colorado. Colorado may terminate the Colorado License Agreement or convert the Company&#8217;s exclusive license to a non-exclusive license if the Company breaches certain obligations under the Colorado License Agreement and fails to cure such breach. The Colorado License Agreement will terminate automatically upon the Company&#8217;s dissolution, insolvency, or bankruptcy.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">zero</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> research and development expense for any milestone related to the Colorado License Agreement. The financial statements as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 do not include liabilities with respect to royalty fees on the license agreement as the Company has not yet generated revenue and the achievement of certain milestones is not yet probable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">License Agreement with Bristol-Myers Squibb Company</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In September 2019, the Company entered into a license agreement, as amended in August 2021 and July 2022 (the BMS License Agreement), with Bristol-Myers Squibb Company (&#8220;BMS&#8221;), pursuant to which the Company obtained sublicensable licenses from BMS to research, develop and commercialize licensed products, including bempikibart, for any and all uses worldwide. The licenses granted to the Company are exclusive with respect to BMS&#8217;s patent rights and know-how relating to certain antibody fragments (including certain fragments of bempikibart) and non-exclusive with respect to BMS&#8217;s patent rights and know-how relating to the composition of matter and use of a specific region of bempikibart. BMS retained the right for it and its affiliates to use the exclusively licensed patents and know-how for internal, preclinical research purposes. Under the BMS License Agreement, the Company is prohibited from engaging in certain clinical development or commercialization of any antibody other than a licensed compound with the same mechanism of action until the earlier of the expiration of Q32&#8217;s obligation to pay BMS royalties or September 2029.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In consideration for the license, the Company made an upfront payment to BMS of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,628,788</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Series A preferred shares to BMS and agreed to use commercially reasonable efforts to develop and commercialize at least one licensed product in key geographic markets. In addition, the Company agreed to pay BMS (i) development and regulatory milestone payments in aggregate amounts ranging from $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per indication for the first three indications and commercial milestone payments in an aggregate amount of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">215</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million on net sales of licensed products, (ii) tiered royalties ranging from rates in the mid-single digit percentages to up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of net sales, with increasing rates depending on the cumulative net sales, (iii) up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of sublicense income, which percentage decreases based on the development stage of</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">bempikibart at the time of the sublicensing event, and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s obligation to pay BMS royalties under subsection (ii) above commences, on a licensed product-by-licensed product and country-by-country basis on the first commercial sale of a licensed product in a country and expires on the later of (x) </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years from the first commercial sale of such Licensed Product in such country, (y) the last to expire licensed patent right covering bempikibart or such licensed product in such country, and (z) the expiration or regulatory or marketing exclusivity for such licensed product in such country (Royalty Term). If the Company undergoes a change of control prior to certain specified phase of development, the development and milestone payments are subject to increase by a low double digit percentage and the royalty rates are subject to increase by a low sub single digit percentage.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless terminated earlier by either party pursuant to its terms, the BMS License Agreement will expire on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last to expire Royalty Term with respect to such licensed product in such country. Either party may terminate the BMS License Agreement for the other party&#8217;s material breach, subject to a specified notice and cure period. BMS may terminate the BMS License Agreement if the Company fails to meet its diligence obligations under the BMS License Agreement, for the Company&#8217;s insolvency, or if the Company or its affiliates challenges the validity, scope, enforceability, or patentability of any of the licensed patents. The Company may terminate the BMS License Agreement for any reason upon prior written notice to BMS, with a longer notice period if a licensed product has received regulatory approval. If the BMS Agreement is terminated for the Company&#8217;s material breach, BMS will regain rights to bempikibart and the Company must grant BMS an exclusive license under the Company&#8217;s patent rights covering bempikibart, subject to a low single digit percentage royalty on net sales of bempikibart payable to the Company by BMS.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2024, the Company made a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million development milestone payment to BMS and recorded it as research and development expenses. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, no further events have occurred that would require payment of milestones, royalties or sublicense fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legal Proceedings</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is not currently party to any material legal proceedings. The Company accounts for estimated losses with respect to legal proceedings and claims when such losses are probable and reasonably estimable. Legal costs associated with these matters are expensed when incurred.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indemnification Arrangements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As permitted under Delaware law, the Company has agreements whereby it indemnifies certain of its investors, stockholders, employees, officers, and directors (collectively, the &#8220;Indemnified Parties&#8221;) for certain events or occurrences while the Indemnified Parties are, or were serving, at its request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has an Executive Liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company believes the estimated fair value of these indemnification agreements is minimal. The Company enters into standard indemnification agreements in the ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless, and agrees to reimburse the Indemnified Parties for losses suffered or incurred by the Indemnified Parties, generally the Company&#8217;s business partners or customers, in connection with any U.S. patent or any copyright or other intellectual property infringement claim by any third party with respect to the Company&#8217;s products. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149064800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11. Debt</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Venture Debt</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 11, 2020, the Company entered into a Loan and Security Agreement with Silicon Valley Bank, a California corporation (&#8220;Loan Agreement&#8221;) for a lending facility of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon execution of the Agreement (&#8220;2020 Term A Loan Advance&#8221;) and had the ability to draw up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in three separate term loan advances if certain performance milestones are met. The term loan bears interest at an annual rate equal to the greater of the prime rate or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%. The Loan Agreement provides for interest-only payments until April 30, 2022, and repayment of the aggregate outstanding principal balance of the term loan in monthly installments starting on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 1, 2022</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 1, 2023</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The commencement of principal payments and the maturity date will be deferred by one year upon the occurrence of a contingent event. In addition, the Company paid a fee of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon closing and is required to pay a fee of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of the aggregate</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amount </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of advances under the Loan Agreement at maturity. At its option, the Company may elect to prepay all or a portion of the outstanding advances by paying the principal balance, and all accrued and unpaid interest, and a prepayment premium. In connection with the Loan Agreement, the Company granted the lender a security interest in all of its personal property now owned or hereafter acquired, excluding intellectual property (but including the rights to payment and proceeds from the sale, licensing or disposition of intellectual property), and a negative pledge on intellectual property. The Loan Agreement also contains certain events of default, representations, warranties and non-financial covenants of the Company. If the Company fails to make payments when due or breaches any operational covenant or has any event of default, this could have a material adverse effect on its business and financial condition. The Company was in compliance with all covenants at December 31, 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On June 30, 2022, a second amendment to the Loan Agreement was entered into with the lender that extended the interest-only payment until December 31, 2022 followed by </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24 equal monthly payments of principal plus interest, with a loan maturity date of</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The amendment increased the final payment from </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the advanced payment and modified the prepayment premium.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On August 10, 2022, a third amendment to the Loan Agreement was entered into with the lender. Per the terms of the amendment and in conjunction with the Collaboration Agreement (as defined below), the Company transferred $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million into a restricted cash collateral money market account which is included as Restricted cash and restricted cash equivalents on the balance sheet. This restricted cash equivalent covers the amount of the debt outstanding as of the third amendment effective date.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 21, 2022, a fourth amendment to the Loan Agreement was entered into with the lender that extended the interest-only payment until July 1, 2023 followed by </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 equal monthly payments of principal plus interest, with a loan maturity date of</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 1, 2024</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 26, 2023, a fifth amendment to the Loan Agreement was entered into with the lender. The amendment provides that the Company must maintain at least </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of its consolidated cash with the lender. In addition, the Company shall at all times have on deposit in operating and depository accounts maintained with the lender, unrestricted and unencumbered cash in an amount equal to the lesser of (i) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the dollar value of the Company&#8217;s consolidated cash and (ii) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">110</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the then-outstanding obligations of the Company to the bank. So long as the Company is in compliance with those terms, the Company shall be permitted to maintain accounts with other banks or financial institutions.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 12, 2023, a sixth amendment to the Loan Agreement was entered into with the lender. The amendment provides for one term loan advance (the &#8220;2023 Term A Loan Advance&#8221;) in an original principal amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and required the Company to repay the outstanding 2020 Term A Loan Advance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, including the final payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. Upon the occurrence of a contingent event, the lender shall make up to three additional term loan advances at the Company&#8217;s request in original principal amounts of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The amounts must be drawn by the Company before March 31, 2024, March 31, 2025 and July 1, 2025, respectively. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The interest-only period was extended through June 30, 2024 followed by 36 equal monthly payments of principal plus interest.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The term loan bears interest at an annual rate equal to the greater of the prime rate minus </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% or </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On November 2, 2023, a seventh amendment to the Loan Agreement was entered into with the lender. The additional loan advance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, the first advance stated in the sixth amendment to the Loan Agreement, could be drawn down once the company received net cash proceeds of at least $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from (a) the issuance and sale of its equity securities to investors satisfactory to the lender and/or (b) a business development transaction satisfactory to the lender; provided that, at least, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of such net cash proceeds must be received from the issuance and sale of equity securities to investors satisfactory to the lender. The seventh amendment extended the time the Company has to receive the net proceeds to March 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 21, 2024, an eighth amendment to the Loan Agreement was entered into with the lender. The eighth amendment extended the time the Company had to receive the net proceeds to May 31, 2024 and also extended the time the Company could draw down on the first advanced payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million from March 31, 2024 to May 31, 2024. The date changes were adjusted to align the milestone in the Loan Agreement with the closing of the Merger. On March 26, 2024, the Company received the first advance payment of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million per the terms of the Loan Agreement.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 19, 2024, a ninth amendment to the Loan Agreement was entered into with the lender that extends the interest-only period through July 1, 2025 followed by </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24 equal monthly payments of principal plus interest.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The loan matures on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 1, 2027</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In conjunction with the Loan Agreement, the Company issued warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,988</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the lender at a per share price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.87</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with a maximum contractual term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrants had a total relative fair value of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> thousand upon issuance and were recorded as a debt discount.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In conjunction with the sixth amendment, the Company issued warrants to purchase </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,156</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the lender at a per share price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with a maximum contractual term of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10 years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The warrants were issued in two separate tranches of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,078</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> based upon certain milestone events. The warrants had a </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">de minimis</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> total relative fair value at the time of issuance.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to FASB ASC Topic 480, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Distinguishing Liabilities from Equity </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and FASB ASC Topic 815, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivatives and Hedging</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the warrants were classified as equity and were initially measured at fair value. Subsequent changes to fair value will not be recognized so long as the instrument continues to be equity classified.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023, respectively</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The effective rate on the Loan Agreement, including the amortization of the debt discount and issuance costs was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.55</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, respectively, at each of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of the long-term debt balance are as follows (in thousands): </span></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal amount of term loans</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unamortized debt discount and issuance costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Carrying amount</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,653</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,459</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,097</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">878</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,556</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,581</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Convertible Notes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On May 20, 2022, the Company entered into an agreement with the existing investors of the Company to issue, and for the existing investors to purchase, the Convertible Notes for up to an aggregate of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Convertible Notes bear interest at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% per annum. The Convertible Notes become due on demand of the Convertible Noteholders one year from the date of issuance. On April 27, 2023, the Company amended the maturity dates for the Convertible Notes. On May 20, August 5 and December 23, 2022, the Company received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, in exchange for issuance of the Convertible Notes. Interest expense was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023, respectively. The Convertible Notes converted into share of common stock in March 2024 per the Merger (see discussion below and in Note 1).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Convertible Notes contain mandatory conversion features whereby the total outstanding amount of principal and accrued and unpaid interest of the Convertible Notes shall automatically convert into shares of common stock upon certain qualified financings. The total outstanding amount of principal and accrued and unpaid interest of the Convertible Notes convert into shares of common stock at </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the purchase price of the mandatory conversion events. If the mandatory conversion events do not occur the holders of the Convertible Notes may request the Convertible Notes plus accrued interest be converted into Series B preferred stock at the Series B convertible price of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0971</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company elected to account for the Convertible Notes at fair value where changes in fair value of the notes are measured through the consolidated statements of operations until settlement. Subsequent to December 31, 2023 and per the Merger further discussed in Note 1, the Convertibles Notes converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,433,410</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. The Company recorded a gain on the change in fair value prior to the conversion of the Convertible Notes of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in other income (expense), net during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the Convertible Notes were settled with equity securities subsequent to December 31, 2023 but prior to the issuance of the financial statements, per FASB ASC Topic 470, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded the Convertible Notes at the fair value totaling $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as a long-term liability on its consolidated balance sheet as of December 31, 2023. The Company recorded in other income (expense), net interest expense of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and a charge of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the change in estimated fair value during the year ended December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250966464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInEntiretyOfTemporaryEquity', window );">Convertible Preferred Stock</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12. Convertible Preferred Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 25, 2024, immediately prior to completing the Merger, all classes of convertible preferred stock of Legacy Q32 were converted to Legacy Q32 common stock, and then exchanged in the Merger for shares of the Company&#8217;s common stock using the Exchange Ratio. The Series A convertible preferred stock converted into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,286,873</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Legacy Q32 common stock, the Series A-1 convertible preferred stock converted into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">312,094</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of Legacy Q32</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">common </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">stock and the Series B convertible preferred stock converted into an aggregate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,625,896</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Legacy Q32 common stock. The conversion of the Legacy Q32 preferred stock into shares of Legacy Q32 common stock resulted in an increase of less than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to common stock and an increase of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to additional paid-in-capital immediately prior to completing the Merger.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DisclosureInEntiretyOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in entirety of temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DisclosureInEntiretyOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821251032224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13. Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company&#8217;s Certificate of Incorporation, as amended, authorized the Company to issue </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">400,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.0001</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> par value per share.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has reserved the following shares of common stock for future issuance:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of authorized<br/>&#160;&#160;&#160;Series A preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,286,873</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of authorized<br/>&#160;&#160;&#160;Series A-1 preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">312,094</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of authorized<br/>&#160;&#160;&#160;Series B preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,625,896</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future issuance under the 2017 Stock<br/>&#160;&#160;&#160;Incentive Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56,065</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future issuance under the 2024 Stock<br/>&#160;&#160;&#160;Incentive Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,760,657</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future issuance under the 2024<br/>&#160;&#160;&#160;Employee Stock Purchase Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,836</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of the convertible<br/>&#160;&#160;&#160;notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,433,411</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for stock option exercises</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,942,920</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,112,275</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,144</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,144</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,842,557</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,844,758</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250943568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14. Stock-Based Compensation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2017 Stock Option and Grant Plan</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legacy Q32 adopted the 2017 Stock Option and Grant Plan and subsequent amendments (the &#8220;2017 Plan&#8221;) with </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,246,290</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock reserved for issuance to employees, directors, and consultants. The 2017 Plan allowed for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock unit awards and other stock awards. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> additional shares available for future grant under the 2017 Plan.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 Stock Option and Incentive Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 15, 2024, Homology&#8217;s board of directors adopted and subsequently, Homology&#8217;s stockholders approved the Q32 Inc. 2024 Stock Option and Incentive Plan (the &#8220;2024 Plan&#8221;), which became effective upon the closing of the Merger. The 2024 Plan replaced the 2017 Plan, as well as the Homology 2015 Stock Incentive Plan (the &#8220;Homology 2015 Plan&#8221;), and the Homology 2018 Plan (together with the Homology 2015 Plan, the &#8220;Homology Incentive Plans.&#8221;) Upon effectiveness of the 2024 Plan, the Company ceased granting new awards under the 2017 Plan and the Homology Incentive Plans.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2024 Plan provides for the grant of incentive stock options, nonqualified stock options, restricted stock awards, restricted stock units, stock appreciation rights and other stock or cash-based awards to officers, employees, directors and consultants of the Company. The number of shares of common stock initially available for issuance under the 2024 Plan was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,839,888</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. The 2024 Plan provides that the number of shares reserved and available for issuance under the 2024 Plan will automatically increase each January 1, beginning on January 1, 2025, by </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding number of shares on the immediately preceding December 31, or such lesser amount as determined by the plan administrator. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,760,657</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares available for future grant under the 2024 Plan.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024 Employee Stock Purchase Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 15, 2024, Homology&#8217;s board of directors adopted and subsequently, Homology&#8217;s stockholders approved the Q32 Inc. 2024 Employee Stock Purchase Plan (the &#8220;2024 ESPP&#8221;). The 2024 ESPP allows employees to buy Company stock through after-tax payroll deductions at a discount from market value. The 2024 ESPP is intended to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Internal Revenue Code. The number of shares of common stock initially available for issuance under the 2024 ESPP was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,836</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock. The 2024 ESPP provides that the number of shares reserved and available for issuance under the plan will automatically increase each January 1, beginning on January 1, 2025, by the lesser of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">241,677</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, a number of shares equal </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the outstanding number of shares on the immediately preceding December 31, or such lesser amount as determined by the plan administrator.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the 2024 ESPP, employees may purchase common stock through after-tax payroll deductions at a price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the lower of the fair market value on the first trading day of an offering period or the last trading day of an offering period. The 2024 ESPP generally provides for offering periods of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">six months</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in duration that end on the final trading day of each February and August. In accordance with the Internal Revenue Code, no employee will be permitted to accrue the right to purchase stock under the 2024 ESPP at a rate in excess of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> worth of shares during any calendar year during which such a purchase right is outstanding (based on the fair market value per share of the Company&#8217;s common stock as of the first day of the offering period).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued under the 2024 ESPP during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock Options</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock options granted by the Company typically vest over a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> period and have a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> contractual term. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company&#8217;s stock option activity during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024: </span></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.11%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.662%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.662%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.182%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Shares</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(In Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in<br/>thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,112,275</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.50</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.87</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,712</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed in reverse recapitalization</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,685</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.56</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,071,073</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.27</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,486</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.81</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,627</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.63</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,942,920</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.93</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.33</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,380</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest at<br/>&#160;&#160;&#160;December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,942,920</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.93</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.33</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,380</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">673,356</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.43</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.04</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,380</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The per share weighted-average grant date fair value per share of options granted in the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.42</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The total fair value of options vested during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, total unrecognized compensation costs to the unvested stock options were approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2.7</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years. The total intrinsic value of options exercised during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation Expense</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the purpose of calculating stock-based compensation, the Company estimates the fair value of stock options using the Black-Scholes option-pricing model. This model incorporates various assumptions, including the expected volatility, expected term, and interest rates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The underlying assumptions used to value stock options granted using the Black-Scholes option-pricing model during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023 were as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate range</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.48</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.34</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.59</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.67</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (years) range</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.17 </span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.11</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.08 </span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.12</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility range</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88.9</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk-Free Interest Rate &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#8217;s stock options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Dividend &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Term &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The expected term of stock options represents the weighted average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term, which calculates the expected term as the average time-to-vesting and the contractual life of the options for stock options issued to employees. The expected term for options granted to non-employees is based on the contractual life of the options.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Expected Volatility &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to the Company&#8217;s limited operating history and lack of sufficient company-specific historical or implied volatility, the expected volatility assumption was determined by examining the historical volatilities of a group of industry peers whose share prices are publicly available. The Company expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value of Common Stock</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#8211; Prior to the Merger, as there had been no public market for the Company&#8217;s common stock, the estimated fair value of its common stock was determined by the Company using estimates and assumptions on the respective grant dates of the awards. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of preferred securities and the superior likelihood of achieving a liquidity event, such as an IPO or sale. Significant changes to the key assumptions used in the valuations could result in different fair values of common stock at each valuation date.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recorded stock-based compensation expense in the following expense categories of its statements of operations (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,105</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,281</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">928</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,386</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,428</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150526928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreements with Horizon<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Agreements with Horizon</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5. Agreements with Horizon </span><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From August 2022 until November 2023, Legacy Q32 was a party to the Collaboration and Option Agreement (the &#8220;Horizon Collaboration Agreement&#8221;) and the Asset Purchase Agreement (the &#8220;Purchase Agreement&#8221;), and together with the Horizon Collaboration Agreement, the &#8220;Horizon Agreements&#8221;), each between Legacy Q32 and Horizon Therapeutics Ireland DAC (&#8220;Horizon&#8221;), pursuant to which Legacy Q32 received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in initial consideration and staged development funding for the completion of the two ongoing Phase 2 trials for bempikibart, and Horizon had an option to acquire the bempikibart program at a prespecified price, subject to certain adjustments.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">T</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he Company has received $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">transaction price from Horizon. In October 2023, Amgen Inc. (&#8220;Amgen&#8221;) completed its acquisition of Horizon Therapeutics public limited company (&#8220;Horizon plc&#8221;). Following the closing of Amgen&#8217;s acquisition of Horizon plc, the Company agreed with Amgen to mutually terminate the Horizon Agreements and in November 2023, the Company and Horizon entered into a termination agreement (the &#8220;Horizon Termination Agreement&#8221;), pursuant to which Horizon&#8217;s option to acquire the bempikibart program was terminated. As a result, the Company retained all</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">initial </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consideration and development funding received under the Horizon Collaboration Agreement (as defined below) and regained full development and commercial rights to bempikibart. In consideration for the Horizon Termination Agreement, the Company agreed to pay Horizon regulatory and sales milestones payments of up to an aggregate amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million upon the first achievement of certain regulatory and sales milestones with respect to bempikibart.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company concluded that the consideration allocated to the research service performance obligations should be recognized over time as Horizon received the benefit of the research activities as the activities were performed. The Company has determined that this method was most appropriate as progress towards completion of research is largely driven by time and effort spent and costs incurred to perform this research. The Horizon Termination Agreement is accounted for as a modification because it does not result in the addition of distinct goods or services. Since the two performance obligations and the material right are terminated with no further performance obligations aside from the contingent payments to Horizon of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, the Company recognized the remaining deferred revenue in the fourth quarter of 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon the execution of the Horizon Termination Agreement, the Company became obligated to pay Horizon up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">75.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million contingent on regulatory and sales-based milestones or up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in excess of the cash received. These potential payments to Horizon are not in exchange for a distinct good or service; therefore, the Company accounts for consideration payable to Horizon as a reduction of the transaction price under ASC 606</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company concluded that the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of arrangement consideration previously recognized should be fully constrained as a result of the contingent consideration payable to Horizon, and accordingly, all amounts previously recognized as revenue were reversed in the fourth quarter of 2023 and a refund liability was established for the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million cash received during the term of the Horizon Collaboration Agreement. No amounts have been recognized related to the remaining potential payment to Horizon (up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million) as it is not probable that the respective milestones will be achieved at this time.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821251032720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16. Related Party Transactions</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has consulting and advisory agreements with certain investors and board members which are considered to be related party transactions. The Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">t incur expense for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 related to services provided by these investors and board members.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> amounts were due to related parties at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 or December 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821261520784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanAbstract', window );"><strong>Defined Contribution Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanTextBlock', window );">Defined Contribution Plan</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17. Defined Contribution Plan</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has a defined contribution savings plan under Section 401(k) of the Internal Revenue Code (the 401(k) Plan). The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants the option to elect to defer a portion of their annual compensation on a pretax basis, as well as Roth post tax deferrals. As currently designed, the Company is not required to make and has not made any contributions to the 401(k) Plan.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715-70/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821251046432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18. Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the years ended December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company recorded current and deferred income tax expense of less than $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively. The Company&#8217;s effective tax rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% differs from the U.S. statutory tax rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% primarily as a result of the valuation allowance maintained against the Company&#8217;s net deferred tax assets.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For financial reporting purposes, loss from operations before income taxes includes the following components (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pretax loss:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,716</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,430</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss before provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,712</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,425</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of the Company's provision for income taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;">
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax provision</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of income tax expense (benefit) computed at the statutory federal income tax rate to income ta</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">xes as reflected in the financial statements is as follows:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.2%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.08%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.08%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="9" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal income tax expense at statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent differences</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain/loss on convertible note conversion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible note revaluation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effective income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The significant components of the Company&#8217;s deferred tax assets and liabilities consisted of the following (in thousands): </span></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,412</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,086</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,801</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">743</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">818</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized intangible assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,828</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credit carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,978</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,762</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized R&amp;D expenditures</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,552</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,546</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,682</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,835</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock compensation and other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">544</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total gross deferred tax assets before valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">108,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57,121</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,078</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,758</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,043</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">339</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right of use asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,540</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,704</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had gross deferred tax assets before valuation allowances of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">108.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, principally attributable to net operating losses, the contingent liability and capitalized R&amp;D expenditures. The Company has provided a valuation allowance for the full amount of the deferred tax assets as, based on all available evidence, it is considered more likely than not that all the recorded deferred tax assets will not be realized in a future period. The Company recorded an increase to the valuation allowance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 as a result of the 2024 book losses and the Merger with Homology.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">121.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of federal net operating loss carryforwards which can be carried forward indefinitely, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">112.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of state net operating loss carryforwards that expire at various dates beginning in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2040</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subject to the limitations described below, as of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had federal and state research and development tax credit carryforwards of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively available to reduce future tax liabilities which start to expire in </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2038</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company has generated federal and state research and development credits but has not conducted a study to document the qualified activity. This study may result in an adjustment to the Company&#8217;s research and development credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts are being presented as uncertain tax position. A full valuation allowance has been provided against the Company&#8217;s research and development credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the deferred tax asset established for the research and development credit carryforwards and the valuation allowance.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Realization of the future tax benefits is dependent on many factors, including the Company&#8217;s ability to generate taxable income within the net operating loss carryforward period. Under the provisions of the Internal Revenue Code, the net operating loss and tax credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service (IRS) and state tax authorities. Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a three-year period in excess of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, as defined under Sections 382 and 383 of the Internal Revenue Code, respectively, as well as similar state provisions. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382 of the Internal Revenue Code, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section 382 of the Internal Revenue Code, which is determined by first multiplying the value of the Company&#8217;s stock at the time of the ownership change by the applicable long-term-tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitations may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. Further, until a study is completed by the Company and any limitation is known, no amounts are being presented as an uncertain tax position</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company files income tax returns in the United States, Australia and Massachusetts. The statute of limitations for assessment by the IRS and state tax authorities is closed prior to 2021, although carryforward attributes that were generated prior to tax year 2021 may still be adjusted upon examination by the IRS or state tax authorities if they either have been or will be used in a future period. The Company is currently not under examination by the IRS or any other jurisdictions for any tax years. The statute of limitations for assessment by the Australian Taxation Office is four years from the date of return filing. The Company is not currently under examination by the Australian Taxation Office for any tax years.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s current intention is to permanently reinvest the total amount of its unremitted earnings in the local international jurisdiction. As such, the Company has not provided for taxes on the unremitted earnings of its international subsidiary. As of December 31, 2024, the Company&#8217;s foreign subsidiary does not have any unremitted foreign earnings.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company establishes reserves for uncertain tax positions based on management&#8217;s assessment of exposures associated with tax positions taken on tax return filings. The tax reserves are analyzed periodically, and adjustments are made as events occur to warrant adjustments to the reserve.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> gross unrecognized tax benefits. The Company does not expect the unrecognized tax benefits to change significantly over the next 12 months. The Company recognizes both interest and penalties associated with uncertain tax positions as a component of income tax expense. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> accrued penalties and provisions for interest</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149007504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) per Share</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19. Net Income (Loss) per Share</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the applicable period. In computing diluted net income (loss) per share, only potential shares of common stock that are dilutive are included. The Company considered each issue or series of issues of potential shares of common stock separately when determining whether potential shares of common stock are dilutive or antidilutive. The Company made such determination in sequence from the most dilutive to the least dilutive and concluded that its Convertible Notes are dilutive to net income per share for the year ended December 31, 2024. Pursuant to FASB ASC Topic 260, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Earnings Per Share</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company applied the if-converted method to determine the effect of its Convertible Notes on the diluted earnings per share calculations. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to such method, the Company adjusted the numerator for the gains or losses recognized during the period </span></span><span style=""></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">net income from the Convertible Notes and the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the Convertible Notes were converted as of the beginning the period.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands, except per share amounts)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss)-basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,743</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss)-diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,533</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,743</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Denominator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding-basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,320,884</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">349,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">336,812</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_e5dd5eea-55d7-4cae-a2e1-4551e45e0690;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding-diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,657,696</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">349,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss) per share-basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.12</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">153.96</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss) per share-diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.58</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">153.96</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024, the Company&#8217;s potentially dilutive securities, which include stock options and warrants, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. As of December 31, 2023, the Company&#8217;s potentially dilutive securities, which include convertible preferred stock, convertible notes, stock options and warrants, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A convertible preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,286,874</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A-1 convertible preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">312,094</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B convertible preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,625,897</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,942,920</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,120,014</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,145</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,145</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, during the year ended December 31, 2022, Legacy Q32 issued the Convertible Notes with a principal balance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. As described in Note 11, the Convertible Notes contained conversion features whereby the Convertible Notes and any accrued interest may have converted into either a variable number of shares of common stock or into shares of Series B preferred stock based on a fixed exchange ratio. Any shares of Series B preferred stock issued to settle the Convertible Notes would then be convertible into shares of common stock. The Convertible Notes were excluded from the computation of diluted net loss per share attributable to common stockholders for the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2023, because including them would have had an anti-dilutive effect</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Per the Merger further discussed in Note 1, the Convertible Notes converted into </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,433,410</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock at the effective date of the Merger.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150570864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Segment Reporting </span><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company operates as one operating segment, focused on research, development, and discovering, developing and delivering therapies for its novel biologics. The Company&#8217;s CEO, as the chief operating decision maker ("CODM"), manages and allocates resources to the operations of the Company on a consolidated basis. Managing and allocating resources on a total-company basis enables the CODM to assess the overall level of resources available and how to best deploy those resources across research and development projects that are in line with our long-term company-wide strategic goals. Consistent with this decision-making process, the Company&#8217;s CODM uses consolidated, single-segment financial information for purposes of evaluating performance, forecasting future period financial results, allocating resources and setting incentive targets. When evaluating the Company&#8217;s overall performance, the CODM is focused on the timing and progress of its preclinical and clinical development activities. The CODM regularly reviews total expenses, as well as direct research and development expenses by program and makes decisions using this information on a company-wide basis.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accounting policies of the reportable segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance and decides how to allocate resources based on consolidated net loss. This measure is</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">used to monitor budget versus actual results to assess performance of the segment. The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets.</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents reportable segment net loss, including significant expenses regularly provided to the CODM, attributable to the Company&#8217;s reportable segment for the years ended December 31, 2024 and 2023:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Direct research and development expense by program:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Bempikibart</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,726</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,722</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADX-097</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,253</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,185</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Discovery and other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">856</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related costs (excluding stock-based compensation)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,122</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,166</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other G&amp;A expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,586</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,824</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest (income) expense, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,832</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">693</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment items (1)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,978</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,645</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total segment net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,743</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) Other segment items are included in order to reconcile to total segment net loss. Other segment items include non-cash items such as depreciation and amortization expense and stock-based compensation expense, gains and losses on the change in fair value of convertible notes, change in fair value of contingent value rights and loss from equity method investment. In 2023, other segment items also includes the reversal of collaboration arrangement revenue related to the termination of the Horizon Agreement (see Note 15).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150512224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21. Subsequent Events</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Strategic Restructuring</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 10, 2025, the Company notified its employees of a strategic restructuring plan adopted by the Company&#8217;s board of directors to focus its resources on the advancement of bempikibart in patients with AA (the &#8220;Restructuring Plan&#8221;). In connection with the Restructuring Plan, the Company is discontinuing its Phase 2 renal basket clinical trial of ADX-097 and is evaluating strategic options for its tissue-targeted complement inhibitor platform, inclusive of ADX-097 and early-stage assets, in combination with other cost-saving measures. The Restructuring Plan includes a reduction in force, which the Company expects to substantially complete by the end of the second quarter of 2025. As part of this Restructuring Plan, the Company expects to incur severance and severance-related charges of approximately $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The Company may also incur other charges or cash expenditures not currently contemplated or that cannot be currently estimated due to events that may occur as a result of, or be associated with, the Restructuring Plan.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Option Repricing</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 23, 2025, the Company's board of directors approved a stock option repricing (the &#8220;Option Repricing&#8221;), which was effective on February 24, 2025 (the &#8220;Repricing Date&#8221;). The Option Repricing applied to outstanding options to purchase shares of common stock of the Company granted under the Company&#8217;s 2017 Plan and 2024 Plan (collectively, &#8220;the Plans&#8221;), which, as of the Repricing Date, were held by current employees and non-employee directors of the Company and had an exercise price in excess of the current trading price of the common stock (so-called &#8220;underwater options&#8221;) with grant dates prior to February 23, 2025 (the &#8220;Eligible Options&#8221;). As of the Repricing Date, the Eligible Options were repriced such that the exercise price per share for such Eligible Options was reduced to the closing price of the common stock on the Nasdaq Global Market on the Repricing Date (the &#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Repriced Exercise Price&#8221;). The total number of shares of common stock underlying all Eligible Options was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,904,998</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Eligible Options will revert to the original exercise price (the &#8220;Original Price&#8221;) if (i) such Eligible Options are exercised prior to the one-year anniversary of the Repricing Date (the &#8220;Retention Date&#8221;), (ii) an Eligible Option holder's employment is terminated by the Company for Cause (as defined in the 2024 Plan) prior to the Retention Date, or (iii) an Eligible Option holder resigns for any reason prior to the Retention Date. If an Eligible Option holder is terminated by the Company other than for Cause prior to the Retention Date (a &#8220;Terminated Employee&#8221;), any Eligible Options vested as of the date of such termination shall be exercisable at the Repriced Exercise Price (the &#8220;Terminated Employee Vested Options&#8221;), even prior to the Retention Date; provided that any unvested Eligible Options as of the date of such termination shall revert to the Original Price as of the date of termination. The deadline to exercise any Terminated Employee Vested Options, and any other Eligible Options held by a Terminated Employee that may become vested, shall be extended (but not truncated) to the later of (a) the one-year anniversary of the Terminated Employee&#8217;s termination date and (b) to align with the Eligible Option holder&#8217;s severance period (whether now or later implemented); provided that no extension shall exceed the Terminated Employee Vested Option&#8217;s expiration date, if earlier. In the event of a change-in-control prior to the Retention Date, each Eligible Option shall retain the Repriced Exercise Price to the extent it has not otherwise reverted to the Original Price. For the avoidance of doubt, the Eligible Options as modified by the Option Repricing are subject to the severance or change-in-control provisions in the current or future employment agreements, programs, policies or plans the Company has entered into or implemented or will enter into or implement with its directors, executive officers and other employees. There were no changes to the number of shares, the vesting schedule, or the expiration date of the Repriced Options except as outlined above.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Plans, the Company's board of directors, as the administrator of the Plans, has discretionary authority, exercisable on such terms and conditions that it deems appropriate under the circumstances, to reduce the exercise price in effect for or effect repricing through cancellation and re-grants of outstanding options under the Plans. In approving the Option Repricing, the board of directors considered the impact of the Original Price of outstanding stock options on the incentives provided to employees and directors, the lack of retention value provided by the outstanding stock options to employees and directors, and the impact of such options on the capital structure of the Company.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expects that the Option Repricing will result in additional share-based compensation expense that will be recognized in the Company&#8217;s statements of operations in future periods; however, the amount of additional share-based compensation expense and the periods over which it will be recognized have not yet been determined.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Exercise of Call Option by OXB (US) LLC</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As discussed in Notes 1 and 3, at the effective time of the merger with Homology, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#8217;s common stock received a CVR issued by Homology representing the contractual right to receive cash payments, if any, from the combined company upon the receipt of certain proceeds, net of permitted deductions for expenses incurred in connection with pre-merger Homology assets, from a disposition of Homology&#8217;s pre-merger assets, including any equity interests held directly or indirectly by the Company in OXB (US) LLC. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 1, 2025, Oxford Biomedica (US), Inc. exercised its option to cause the Company to sell and transfer to Oxford Biomedica (US), Inc. all of the Company&#8217;s equity ownership interest in OXB (US) LLC. The sale price is based on a formula using the Company's pro rata share of OXB (US) LLC (10%), times a predetermined multiple of revenue for the immediately preceding 12-month period increased by OXB (US) LLC's cash balance and decreased by OXB (US) LLC's debt balance as of the exercise date.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The Company and Oxford Biomedica (US), Inc. expect to finalize the transaction and pay the CVR holders by the end of the second quarter of 2025.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149922512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in conformity with GAAP and have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying consolidated financial statements include those of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in the consolidated financial statements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could materially differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the fair value of the common stock and convertible notes prior to the effective date of the Merger, the fair value of CVR liability, and the prepaid and accrued research and development expenses. The Company utilizes certain estimates to record expenses relating to research and development contracts. These contract estimates, which are primarily related to the length of service of each contract and the amount of service provided as of each measurement date, are determined by the Company based on input from internal project management, as well as from service providers. Estimates are periodically reviewed considering changes in circumstances, facts and historical experience. Actual results may differ from the Company&#8217;s estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker (&#8220;CODM&#8221;), or decision-making group, in determining how to allocate resources and in assessing performance. The Company has one reporting segment (see Note 20). The segment consists of the development of clinical and preclinical product candidates for the development of the Company&#8217;s novel biologics. The Company&#8217;s chief operating decision maker is the chief executive officer (&#8220;CEO&#8221;).</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss, which is reported on the income statement. The measure of segment assets is reported on the balance sheet as total consolidated assets.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The CODM uses cash forecast models in deciding how to invest into the segment. Such cash forecast models are reviewed to assess the entity-wide operating results and performance. Net loss is used to monitor budget versus actual results. Monitoring budget versus actual results is used in assessing the performance of the segment and in establishing management&#8217;s compensation, along with cash forecast model.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transactions</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Foreign Currency Translations</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s functional currency is the United States dollar. Foreign currency transaction gains and losses are recorded in the consolidated statement of operations.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and Significant Suppliers</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risk and Significant Suppliers</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial instruments that potentially expose the Company to credit risk primarily consist of cash, cash equivalents, restricted cash and restricted cash equivalents. The Company maintains its cash, cash equivalents, restricted cash and restricted cash equivalents balances with accredited financial institutions and, consequently, the Company does not believe it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s cash management limits investment to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. The Company maintains its cash in bank deposit accounts that are Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insured up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. At times, the Company&#8217;s bank accounts may exceed the federal insurance limit.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is dependent on contract development and manufacturing organizations (&#8220;CDMOs&#8221;) to supply products for research and development activities in its programs. In particular, the Company relies and expects to continue to rely on a small number of manufacturers to supply it with its requirements for the active pharmaceutical ingredients, other raw materials and formulated drugs related to these programs. These programs could be adversely affected by a significant interruption in the supply of active pharmaceutical ingredients, other raw materials and formulated drugs. The Company is also dependent on contract research organizations (&#8220;CROs&#8221;) which provide services related to the research and development activities in its programs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock', window );">Off-Balance&#160;Sheet Risk</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Off Balance Sheet Risk</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of December 31, 2024 and 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had no off balance sheet risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Comprehensive Income (Loss)</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Comprehensive income (loss) includes net loss as well as other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers all highly liquid investments that are readily convertible into cash with maturities of three months or less at the date of purchase to be cash equivalents. Cash equivalents are comprised of money market accounts invested in U.S. Treasury securities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restricted cash and restricted cash equivalents are comprised of deposits held by financial institutions as collateral for the company&#8217;s venture debt and used to collateralize letters of credit related to the Company&#8217;s lease arrangements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company includes the restricted cash and restricted cash equivalents balance together with its cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, restricted cash and restricted cash equivalents consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:66.993%;box-sizing:content-box;"></td>
          <td style="width:1.62%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.62%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77,965</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,617</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash and cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">647</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,647</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents, restricted cash and restricted<br/>&#160;&#160;&#160;cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78,612</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,264</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Short-Term Investments</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Short-Term Investments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Short-term investments represent holdings of available-for-sale marketable securities in accordance with the Company&#8217;s investment policy and cash management strategy. Short-term investments have maturities of greater than 90 days at the time of purchase and mature within one year from the balance sheet date. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#8217; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the underlying security. Such amortization and accretion, together with interest on securities, are included in interest income in the Company&#8217;s consolidated statements of operations. The cost of marketable securities sold is determined based on the specific identification method and any realized gains or losses on the sale of investments are reflected as a component of other income.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#8217;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#8217;s industry, and any significant deterioration in economic conditions.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Transaction Costs</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Transaction Costs</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings as deferred transaction costs until such financings are consummated. After consummation of an equity financing, these costs are recorded as a reduction of the proceeds from the transaction, either as a reduction of the carrying value of the preferred stock or in stockholders&#8217; deficit as a reduction of additional paid-in capital generated as a result of the transaction. Should the in-process equity financing be abandoned, the deferred transaction costs would be expensed immediately as a charge to operating expenses in the consolidated statements of operations.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 1 &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Quoted prices in active markets for identical assets or liabilities.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 2 &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Level 3 &#8211; </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Investments in Equity Securities</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in Equity Securities</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the equity method of accounting to account for an investment in an entity that it does not control, but in which it has the ability to exercise significant influence over operating and financial policies. The Company's proportionate share of the net income or loss of the entity is included in consolidated net income (loss). Judgments regarding the level of influence over the equity method investment include consideration of key factors such as the Company's ownership interest, representation on the board of directors or other management body and participation in policy-making decisions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under the equity method of accounting, the Company&#8217;s investment is initially recorded at fair value on the consolidated balance sheets. Upon initial investment, the Company evaluates whether there are basis differences between the carrying value and fair value of the Company&#8217;s proportionate share of the investee&#8217;s underlying net assets. Typically, the Company amortizes basis differences identified on a straight-line basis over the underlying assets&#8217; estimated useful lives when calculating the attributable earnings or losses, excluding the basis differences attributable to in-process research and development that has no alternative future use. If the Company is unable to attribute all of the basis differences to specific assets or liabilities of the investee, the residual excess of the cost of the investment over the proportional fair value of the investee&#8217;s assets and liabilities is considered to be equity method goodwill and is recognized within the equity investment balance, which is tracked separately within the Company&#8217;s memo accounts. The Company subsequently records in the statements of operations its share of income or loss of the other entity within other income/expense, which results in an increase or decrease to the carrying value of the investment. If the share of losses exceeds the carrying value of the Company&#8217;s investment, the Company will suspend recognizing additional losses and will continue to do so unless it commits to providing additional funding; however, if there are intra-entity profits this can cause the investment balance to go negative.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that a decline in value has occurred that is other than temporary. Evidence considered in this evaluation includes, but would not necessarily be limited to, the financial condition and near-term prospects of the investee, recent operating trends and forecasted performance of the investee, market conditions in the geographic area or industry in which the investee operates and the Company&#8217;s strategic plans for holding the investment in relation to the period of time expected for an anticipated recovery of its carrying value. If the investment is determined to have a decline in value deemed to be other than temporary it is written down to estimated fair value.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the cost method to account for an investment in an entity in which it does not have the ability to exercise significant influence over operating and financial policies. Investments recorded using the cost method will be assessed for any decrease in value that has occurred that is other than temporary and the other than temporary decrease in value shall be recognized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As and when circumstances and facts change, the Company will evaluate the Company&#8217;s ability to significantly influence operational and financial policy to establish a basis for converting the investment accounted for using the cost method to the equity method of accounting and vice versa.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company accounted for its investment in Oxford Biomedica (US) LLC (&#8220;OXB (US) LLC&#8221;) using the cost method (see Note 6).</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Property and Equipment</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. Upon retirement or sale,</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.</span></span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:70.32%;box-sizing:content-box;"></td>
          <td style="width:1.7%;box-sizing:content-box;"></td>
          <td style="width:27.98%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Useful Life (Years)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_4b3c95c9-00db-4ff5-871a-392543c3c948;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of useful life or<br/>term of<br/>associated lease</span></span></span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leases</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company evaluates whether an arrangement is or contains a lease at contract inception. If a contract is or contains a lease, lease classification is determined at lease commencement, which represents the date at which the underlying asset is made available for use by the Company. The Company&#8217;s lease terms are generally measured at the respective lease&#8217;s noncancelable term and exclude any optional extension terms as the Company is not reasonably certain to exercise such options. The Company elected the short-term lease exemption and therefore does not recognize lease liabilities and right of use assets for lease arrangements with original lease terms of twelve months or less.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Lease liabilities represent the Company&#8217;s obligation to make lease payments under a lease arrangement. Lease liabilities are measured as the present value of fixed lease payments, discounted using an incremental borrowing rate, as interest rates implicit in the Company&#8217;s lease arrangements are generally not readily determinable. The Company elected the practical expedient to not separate lease and non-lease components for its real estate leases and therefore both are considered when determining the lease payments in a lease arrangement. Variable lease costs are expensed as incurred.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The incremental borrowing rate represents the interest rate at which the Company could borrow a fully collateralized amount equal to the lease payments, over a similar term, in a similar economic environment. The Company determines the incremental borrowing rate at lease commencement, generally using a synthetic credit rating based on the Company&#8217;s financial position and negative cash flows, factoring in adjustments for additional risks based on the Company&#8217;s economic condition, a survey of comparable companies with similar credit and financial profiles, as well as additional market risks, as may be applicable.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Right-of-use assets represent the Company&#8217;s right to use an underlying asset over its lease term. Right-of-use assets are initially measured as the associated lease liability, adjusted for prepaid rent and tenant incentives. The Company remeasures right-of-use assets and lease liabilities when a lease is modified, and the modification is not accounted for as a separate contract. A modification is accounted for as a separate contract if the modification grants the Company an additional right of use not included in the original lease agreement and the increase in lease payments is commensurate with the additional right of use. The Company assesses its right-of-use assets for impairment consistent with its policy for impairment of long-lived assets held and used in operations.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may be impaired, and assesses their recoverability based upon estimated future undiscounted future cash flows expected to be generated by the long-lived assets. If the estimated aggregate undiscounted cash flows are less than the carrying amount of the long-lived assets, an impairment charge, calculated as the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets, is recorded. The estimated fair value of the long-lived assets is determined based on the estimated discounted cash flows expected to be generated from the long-lived assets.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt and Warrant Issuance Costs</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Debt and Warrant Issuance Costs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying value of the Company&#8217;s venture debt was recorded net of issuance costs and discount relating to the issuance of warrants. The amounts are amortized over the term of the debt using the effective interest method and recognized as interest expense.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Research and development costs are expensed as incurred. Research and Development expenses are comprised of costs incurred in performing research and development activities, including salaries, stock-based compensation and benefits, costs for clinical research organizations and other outsourced activities; laboratory supplies; technology licenses, software and other information technology support; facilities and depreciation.  Upfront payments and milestone payments made for the licensing of technology are expensed as research and development expenses in the period in which they are incurred. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related goods are delivered or the services are performed.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company has entered into various research and development related contracts with external parties. The payments under these agreements are recorded as research and development expenses as the underlying services are performed or the goods are received. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued and prepaid balances at</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">end of any reporting period. Actual results could differ from the Company&#8217;s estimates. The Company&#8217;s historical accrual estimates have not been materially different from the actual costs.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PatentsCostsPolicyTextBlock', window );">Patent Costs</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Patent Costs</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company expenses all costs as incurred in connection with patent applications, including direct application fees, and the legal and consulting expenses related to making such applications, and such costs are included in general and administrative expenses within the Company&#8217;s statement of operations.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Under FASB Accounting Standards Codification (&#8220;ASC&#8221; Topic 606, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue from Contracts with Customers</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 606), an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Arrangements that include rights to additional goods or services that are exercisable at a customer&#8217;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. The identification of material rights requires judgments related to the determination of the value of the underlying good or service relative to the option exercise price. The exercise of a material right is accounted for as a contract modification for accounting purposes.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the license terms, the research, manufacturing and commercialization capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The transaction price is determined and allocated to the identified performance obligations in proportion to their stand-alone selling prices (SSP) on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The amount of variable consideration included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty related to the variable consideration is resolved. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#8217;s control or the licensee&#8217;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time recognition is based on the use of an output or input method.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for stock-based awards in accordance with FASB ASC Topic 718, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Compensation &#8211; Stock Compensation </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(ASC 718). ASC 718 requires all stock-based awards issued to employees and members of the Company&#8217;s board of directors for their services to be recognized as expense in the statements of operations based on their grant date fair values. For stock options and time-based restricted stock awards, the Company expenses the fair value of the awards on a straight-line basis over each award&#8217;s service period, which is generally the period in which the related services are received. For performance-based stock awards, the Company uses the accelerated attribution method to expense the awards over the implicit service period based on the probability of achieving the performance conditions. The Company accounts for stock-based awards to non-employees consistently with the accounting for awards to employees and measures stock-based awards granted to non-employees based on their grant date fair value and recognizes the resulting value as stock-based compensation expense during the period the related services are rendered. The Company has not issued any stock-based awards with market-based vesting conditions.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The fair value of options on the date of grant is calculated using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company&#8217;s estimates of these assumptions are primarily based on the trading price of the Company&#8217;s stock, historical data, peer company data and judgment regarding future trends and factors. The Company accounts for forfeitures as they occur.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s equity incentive plan allows for the issuance of restricted stock awards to employees and non-employee consultants that may be subject to vesting. The unvested shares of any restricted stock awards are held in escrow as the stock award vests or until award holder termination, whichever occurs first. In the event of a sale of the Company, the Company has the obligation to repurchase at cost, the portion of unvested stock awards from the award holder. For all unvested stock awards, a liability is established related to the Company&#8217;s obligation for unvested awards at cost.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income taxes are recorded in accordance with FASB ASC Topic 740, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (ASC 740), which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. Should the actual amounts differ from these estimates, the amount of the Company&#8217;s valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to the tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income taxes are accounted for using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial carrying</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applicable to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance against deferred tax assets is recorded if, based upon the weight of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock', window );">Subsequent Event Considerations</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Subsequent Event Considerations</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that require additional disclosure. The Company has evaluated events occurring after the date of its consolidated balance sheet through the date these consolidated financial statements were issued (see Note 21).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segment Reporting (Topic 280)&#8212;Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASU 2023-07&#8221;). The amendments in this update improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses. All disclosure requirements of the update are required for entities with a single reportable segment. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and should be applied on a retrospective basis to all periods presented. The Company adopted this standard as of January 1, 2024. The Company determined that adopting the amendments in ASU 2023-07 had no impact on the Company&#8217;s reportable segment identified and additional required disclosures have been included.</span></p><p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Recently Issued Accounting Standards Not Yet Adopted</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On December 14, 2023, the FASB issued ASU No. 2023-09,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> Income Taxes (Topic 740)&#8212;Improvements to Income Tax Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;ASU 2023-09&#8221;). ASU 2023-09 provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and incomes taxes paid information. For public companies, the amendments are effective for annual periods beginning after December 15, 2024 and should be applied prospectively. The Company has determined that the effects of adopting the amendments in ASU 2023-09 will only impact its disclosures and not have a material impact on its consolidated financial position and the results of its operations when such amendment is adopted.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PatentsCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Patents costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PatentsCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policies and methodologies used to estimate the entity's liability for off-balance sheet credit exposures and related charges for those credit exposures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 36<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-36<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting subsequent events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821256601600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock', window );">Summary of Estimated Useful Life of Assets</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.</span><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:70.32%;box-sizing:content-box;"></td>
          <td style="width:1.7%;box-sizing:content-box;"></td>
          <td style="width:27.98%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Estimated Useful Life (Years)</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
          <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="-sec-ix-hidden:F_4b3c95c9-00db-4ff5-871a-392543c3c948;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shorter of useful life or<br/>term of<br/>associated lease</span></span></span></p></td>
         </tr>
        </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Summary of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, restricted cash and restricted cash equivalents consisted of the following (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:66.993%;box-sizing:content-box;"></td>
          <td style="width:1.62%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:1.62%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
          <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
          <td style="width:1%;box-sizing:content-box;"></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
          <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77,965</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,617</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash and cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">647</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,647</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
         <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents, restricted cash and restricted<br/>&#160;&#160;&#160;cash equivalents</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78,612</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
          <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,264</span></p></td>
          <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of estimated useful life of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821255263056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting for the Merger (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_MergersAndAquisitionsAbstract', window );"><strong>Mergers and Aquisitions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Recapitalization of Assets and Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As part of the recapitalization, the Company obtained the assets and liabilities listed below:</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.823%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,158</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Short-term investments</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,905</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">964</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Equity method investment</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,900</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,903</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CVR liability</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,080</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net assets acquired</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">65,944</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_MergersAndAquisitionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mergers and Aquisitions Abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_MergersAndAquisitionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of recapitalization of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821251044096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Financial Assets And Liabilities Measured At Fair Value On A Recurring Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities measured at fair value on a recurring basis as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 are summarized as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.38%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as<br/>of December 31,<br/>2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">76,089</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CVR liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,900</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 are summarized as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.239%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:11.325000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance as<br/>of December 31,<br/>2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Quoted<br/>Prices in<br/>Active<br/>Markets<br/>(Level 1)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Significant<br/>Other<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Cash equivalents:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted cash equivalents:</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market funds</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total restricted cash equivalents</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial assets</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,100</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible notes</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,595</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,595</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total financial liabilities</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,595</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,595</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Summary of Fair Value Measurement Significant Inputs</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The fair value is based on significant inputs not observable in the market, namely potential financing scenarios, the likelihood of such scenarios, the expected time for each scenario to occur, and the required market rates of return utilized in modeling these scenarios. </span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.477%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:12.775%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:12.775%;box-sizing:content-box;"></td>
        <td style="width:1.399%;box-sizing:content-box;"></td>
        <td style="width:12.775%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Year Ended December 31, 2023</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scenario 1</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scenario 2</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Scenario 3</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Probability of each scenario</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">80</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected Term (years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.25</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.25</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.42</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Required market rates of return</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821338746688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property Plant and Equipment</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">roperty and equipment, net consisted of the following as of (in thousands): </span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lab equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,382</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,382</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Furniture and fixtures</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">351</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">341</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Computer equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,001</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">940</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total property and equipment</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,823</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,748</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less accumulated depreciation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,453</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">966</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,370</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149015616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses, Other Current Assets and Other Noncurrent Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Summary of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets consisted of the following as of (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid external research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,076</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,834</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payroll tax credit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">555</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">755</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">885</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">427</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">396</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total prepaid expenses and other current assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,099</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock', window );">Summary of Prepaid Expenses and Other Noncurrent Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other noncurrent assets consisted of the following as of (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred transaction costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,912</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid external research and development - long term</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">676</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other noncurrent assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of prepaid expenses and other current assets table text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of Prepaid Expenses and Other Noncurrent Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156478368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accrued expenses and other current liabilities consisted of the following as of (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation and related expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,782</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,003</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued external research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,611</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,578</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued professional services and other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,474</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,328</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_a45e6167-40b6-49f4-9625-e8ce6cbfd3a5;"><span style="-sec-ix-hidden:F_cb90d7dd-2025-4f37-8452-ccbb5dfb30b4;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liability, current</span></span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">538</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued taxes payable</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accrued expenses and other current liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,479</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,763</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149048128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock', window );">Schedule of Amounts Reported In The Balance Sheet In Respect Of Operating Lease Assets And Corresponding Liabilities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts reported in the consolidated balance sheet for leases where the Company is the lessee as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and December 31, 2023 were as follows (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,722</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,301</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease right-of-use assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,722</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,301</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">538</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncurrent:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total operating lease liabilities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,786</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Operating Lease Cost and Variable Lease Costs and Sub Lease Income</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes operating lease costs for the years ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and 2023 (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,029</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">999</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,072</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Operating Lease Liabilities</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Future minimum lease payments under non-cancelable lease agreement as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024 and a reconciliation to the carrying amount of the lease liabilities presented in the consolidated balance sheet are as follows (in thousands): </span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.236%;box-sizing:content-box;"></td>
        <td style="width:1.94%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:15.823%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Minimum<br/>Rental<br/>Payments</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,092</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,124</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,158</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,193</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,494</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total minimum lease payments</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,121</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less imputed interest</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,873</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability, current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">612</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability, net of current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,636</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,248</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of amounts reported in the balance sheet in respect of operating lease assets and corresponding liabilities [Table Text Block].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821251046176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock', window );">Summary of Long-term Debt Balance</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of the long-term debt balance are as follows (in thousands): </span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Principal amount of term loans</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unamortized debt discount and issuance costs</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">153</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Carrying amount</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,653</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,459</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less current portion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,097</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">878</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,556</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,581</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of venture debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250966464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock', window );">Schedule of Shares of Common Stock for Future Issuance</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has reserved the following shares of common stock for future issuance:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of authorized<br/>&#160;&#160;&#160;Series A preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,286,873</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of authorized<br/>&#160;&#160;&#160;Series A-1 preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">312,094</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of authorized<br/>&#160;&#160;&#160;Series B preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,625,896</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future issuance under the 2017 Stock<br/>&#160;&#160;&#160;Incentive Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56,065</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future issuance under the 2024 Stock<br/>&#160;&#160;&#160;Incentive Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,760,657</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for future issuance under the 2024<br/>&#160;&#160;&#160;Employee Stock Purchase Plan</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,836</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved upon the conversion of the convertible<br/>&#160;&#160;&#160;notes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,433,411</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for stock option exercises</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,942,920</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,112,275</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares reserved for warrants</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,144</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,144</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,842,557</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,844,758</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of common stock shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149036304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the Company&#8217;s stock option activity during the year ended </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024: </span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:50.11%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.662%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:8.942%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.662%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.22%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:9.182%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Number of<br/>Shares</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Exercise<br/>Price</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Term<br/>(In Years)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value<br/>(in<br/>thousands)</span></p></td>
        <td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2023</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,112,275</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.50</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.87</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,712</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assumed in reverse recapitalization</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,685</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.56</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Granted</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,071,073</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.27</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercised</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">255,486</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.81</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cancelled</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,627</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.63</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Outstanding at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,942,920</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.93</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.33</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,380</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Vested and expected to vest at<br/>&#160;&#160;&#160;December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,942,920</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.93</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.33</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,380</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exercisable at December 31, 2024</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">673,356</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.43</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.04</span></span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,380</span></p></td>
        <td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Assumptions Used to Value Stock Options Granted</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The underlying assumptions used to value stock options granted using the Black-Scholes option-pricing model during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">years ended December 31, 2024 and 2023 were as follows:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk-free interest rate range</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.48</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.34</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.59</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.67</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected dividend rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected term (years) range</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.17 </span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.11</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.08 </span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">- </span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.12</span></span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expected stock price volatility range</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94.1</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">88.9</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94.0</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company recorded stock-based compensation expense in the following expense categories of its statements of operations (in thousands):</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,105</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,281</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">928</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,386</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,428</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250995360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of loss from operations before income taxes</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For financial reporting purposes, loss from operations before income taxes includes the following components (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pretax loss:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">United States</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,716</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,430</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss before provision for income taxes</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,712</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,425</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of provision for income taxes</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of the Company's provision for income taxes </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">316</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Foreign</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total income tax provision</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of income tax expense (benefit) computed at the statutory federal income tax rate to income ta</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of reconciliation of income tax expense (benefit) computed</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A reconciliation of income tax expense (benefit) computed at the statutory federal income tax rate to income ta</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">xes as reflected in the financial statements is as follows:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.2%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.08%;box-sizing:content-box;"></td>
        <td style="width:1.08%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.74%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:2.08%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="9" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal income tax expense at statutory rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.9</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Permanent differences</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation expense</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Gain/loss on convertible note conversion</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Convertible note revaluation</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Research and development tax credits</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42.2</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Effective income tax rate</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The significant components of the Company&#8217;s deferred tax assets and liabilities consisted of the following (in thousands): </span><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax assets:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Federal net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,468</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,412</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">State net operating loss carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,086</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,500</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,801</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accruals and reserves</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">743</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">818</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized intangible assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,591</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,828</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tax credit carryforwards</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,978</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,762</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitalized R&amp;D expenditures</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,552</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,546</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Lease liability</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,682</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,835</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock compensation and other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">544</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total gross deferred tax assets before valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">108,634</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57,121</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Valuation allowance</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,876</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,078</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,758</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,043</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liabilities:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fixed assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">339</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right of use asset</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,540</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,704</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821251016624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">to such method, the Company adjusted the numerator for the gains or losses recognized during the period </span><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">in </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">net income from the Convertible Notes and the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the Convertible Notes were converted as of the beginning the period.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands, except per share amounts)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Numerator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss)-basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,743</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss)-diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,533</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,743</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">Denominator:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding-basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,320,884</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">349,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dilutive securities</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">336,812</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="-sec-ix-hidden:F_e5dd5eea-55d7-4cae-a2e1-4551e45e0690;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></span></span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted-average common shares outstanding-diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,657,696</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">349,060</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss) per share-basic</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.12</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">153.96</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income (loss) per share-diluted</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.58</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">153.96</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of computation of diluted net loss per share attributable to common stockholders</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.967%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.16%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:13.357%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A convertible preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,286,874</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A-1 convertible preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">312,094</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B convertible preferred stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,625,897</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Options to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,942,920</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,120,014</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Warrants to purchase common stock</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,145</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,145</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250903952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information Expenses</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents reportable segment net loss, including significant expenses regularly provided to the CODM, attributable to the Company&#8217;s reportable segment for the years ended December 31, 2024 and 2023:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.993%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:1.62%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
        <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
        <td style="width:1%;box-sizing:content-box;"></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Years Ended December 31,</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2023</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;">
        <td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Direct research and development expense by program:</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Bempikibart</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,726</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,722</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADX-097</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,253</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,185</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Discovery and other</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">856</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">894</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Personnel-related costs (excluding stock-based compensation)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,122</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,166</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other G&amp;A expenses</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,586</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,824</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest (income) expense, net</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,832</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">693</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other segment items (1)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,978</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,645</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total segment net loss</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,733</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
        <td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,743</span></p></td>
        <td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151816832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Business - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 25, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 16, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_NatureOfBusinessLineItems', window );"><strong>Nature Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Common stock, aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (47,733)<span></span>
</td>
<td class="num">$ (53,743)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(234,814)<span></span>
</td>
<td class="num">(187,081)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,965<span></span>
</td>
<td class="nump">$ 25,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=qttb_HomologyMember', window );">Homology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_NatureOfBusinessLineItems', window );"><strong>Nature Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock', window );">Business combination shares conversion into rights to purchase common stock</a></td>
<td class="nump">1,682,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' equity, reverse stock split</a></td>
<td class="text">one-for-eighteen<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage', window );">Outstanding common stock of the combined company</a></td>
<td class="nump">74.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of Stock, Shares Converted</a></td>
<td class="nump">7,017,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_NatureOfBusinessLineItems', window );"><strong>Nature Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination shares conversion into rights to purchase common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_NatureOfBusinessLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_NatureOfBusinessLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscriptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481142/505-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscriptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=qttb_HomologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=qttb_HomologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149023312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 77,965<span></span>
</td>
<td class="nump">$ 25,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and cash equivalents</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">5,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, restricted cash and restricted cash equivalents</a></td>
<td class="nump">$ 78,612<span></span>
</td>
<td class="nump">$ 31,264<span></span>
</td>
<td class="nump">$ 49,540<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821253536176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_AccountingPoliciesLineItems', window );"><strong>Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash FDIC insured amount</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income Tax Description</a></td>
<td class="text">First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_AccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_AccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151062352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Estimated Useful Life of Assets (Detail)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated Useful Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration', window );">Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]</a></td>
<td class="text">Leasehold Improvements<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482190/360-10-35-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151364080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounting for the Merger - Summary of Recapitalization of Assets and Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 25, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_MergerAndAcquisitionLineItems', window );"><strong>Merger and Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 77,965,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,617,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity method investment</a></td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 74,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiability', window );">CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Net assets acquired</a></td>
<td class="nump">92,332,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,057,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=qttb_LegacyQ32Member', window );">Legacy Q32</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_MergerAndAcquisitionLineItems', window );"><strong>Merger and Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">53,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">19,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent', window );">Prepaid expenses</a></td>
<td class="nump">964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity method investment</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(7,903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiability', window );">CVR liability</a></td>
<td class="num">(5,080)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Net assets acquired</a></td>
<td class="nump">$ 65,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_MergerAndAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger and Acquisition [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_MergerAndAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized from contingent consideration in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=qttb_LegacyQ32Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=qttb_LegacyQ32Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250970960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting for the Merger - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 25, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_MergerAndAcquisitionLineItems', window );"><strong>Merger and Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiability', window );">Contingent payment liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Equity investment</a></td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 74,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction Costs</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_MergerAndAcquisitionLineItems', window );"><strong>Merger and Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiability', window );">Contingent payment liability</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_MergerAndAcquisitionLineItems', window );"><strong>Merger and Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Payment Related to Severance Cost</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_MergerAndAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger and Acquisition [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_MergerAndAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized from contingent consideration in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821155744480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Short-Term Investments - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_InvestmentsDisclosureAbstract', window );"><strong>Investments Disclosure Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_InvestmentsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments Disclosure Abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_InvestmentsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156499632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 77,965,000<span></span>
</td>
<td class="nump">$ 25,617,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-Term Investments, Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="nump">647,000<span></span>
</td>
<td class="nump">5,647,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CvrLiability', window );">CVR liability</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">76,089,000<span></span>
</td>
<td class="nump">24,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CvrLiability', window );">CVR liability</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure, Total</a></td>
<td class="nump">76,089,000<span></span>
</td>
<td class="nump">29,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,595,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">38,595,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">76,089,000<span></span>
</td>
<td class="nump">24,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Quoted Prices in Active Markets (Level 1) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">76,089,000<span></span>
</td>
<td class="nump">24,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, Fair Value Disclosure, Total</a></td>
<td class="nump">76,089,000<span></span>
</td>
<td class="nump">29,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Quoted Prices in Active Markets (Level 1) [Member] | Money Market Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">76,089,000<span></span>
</td>
<td class="nump">24,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring [Member] | Significant Other Unobservable Inputs (Level 3) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CvrLiability', window );">CVR liability</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,595,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">$ 38,595,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CvrLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>CVR Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CvrLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151731520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Fair Value Measurement Significant Inputs (Detail)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=qttb_MeasurementInputProbabilityOfEachScenarioMember', window );">Probability of each scenario [Member] | Scenario one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=qttb_MeasurementInputProbabilityOfEachScenarioMember', window );">Probability of each scenario [Member] | Scenario two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=qttb_MeasurementInputProbabilityOfEachScenarioMember', window );">Probability of each scenario [Member] | Scenario three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Term (years) [Member] | Scenario one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Term (years) [Member] | Scenario two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Expected Term (years) [Member] | Scenario three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">0.42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Required market rates of return [Member] | Scenario one [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Required market rates of return [Member] | Scenario two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Required market rates of return [Member] | Scenario three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt instrument, measurement input</a></td>
<td class="nump">15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=qttb_MeasurementInputProbabilityOfEachScenarioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=qttb_MeasurementInputProbabilityOfEachScenarioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=qttb_ScenarioOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=qttb_ScenarioOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=qttb_ScenarioTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=qttb_ScenarioTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=qttb_ScenarioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=qttb_ScenarioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156476208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 23, 2022</div></th>
<th class="th"><div>Aug. 05, 2022</div></th>
<th class="th"><div>May 20, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="nump">$ 16,700<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible debt, fair value disclosures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_FairValueOfInterestExpenses', window );">Fair value Of Interest Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CvrLiability', window );">CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=qttb_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Percentage of Purchase Price of Convertible notes to Common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_GainOnConvertibleNotes', window );">Gain on conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CvrLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>CVR Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CvrLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_FairValueOfInterestExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of interest expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_FairValueOfInterestExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_GainOnConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain On Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_GainOnConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=qttb_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=qttb_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156160384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Equity Securities - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 22, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss from equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,625)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment charge</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=qttb_HomologyMember', window );">Homology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=qttb_OxbSolutionsMember', window );">Oxb Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=qttb_HomologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=qttb_HomologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=qttb_OxbSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=qttb_OxbSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151274688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Schedule of Property Plant and Equipment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 2,823<span></span>
</td>
<td class="nump">$ 2,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(1,453)<span></span>
</td>
<td class="num">(966)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">1,782<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,382<span></span>
</td>
<td class="nump">1,382<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 1,001<span></span>
</td>
<td class="nump">$ 940<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250705264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 487,000<span></span>
</td>
<td class="nump">$ 499,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment, long-lived asset, held-for-use</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150127824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Current Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PrepaidExternalResearchAndDevelopmentCurrent', window );">Prepaid external research and development</a></td>
<td class="nump">$ 2,076<span></span>
</td>
<td class="nump">$ 1,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PayrollTaxCredit', window );">Payroll tax credit</a></td>
<td class="nump">555<span></span>
</td>
<td class="nump">755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">885<span></span>
</td>
<td class="nump">427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 3,912<span></span>
</td>
<td class="nump">$ 3,099<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PayrollTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payroll tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PayrollTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PrepaidExternalResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid external research and development current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PrepaidExternalResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150084848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Noncurrent Assets (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred transaction costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PrepaidExternalResearchAndDevelopmentNonurrent', window );">Prepaid external research and development - long term</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other noncurrent assets</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="nump">$ 4,611<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PrepaidExternalResearchAndDevelopmentNonurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>prepaid external research and development nonurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PrepaidExternalResearchAndDevelopmentNonurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149973232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and related expenses</a></td>
<td class="nump">$ 2,782<span></span>
</td>
<td class="nump">$ 3,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_AccruedResearchAndDevelopmentExpensesCurrent', window );">Accrued external research and development</a></td>
<td class="nump">2,611<span></span>
</td>
<td class="nump">3,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent', window );">Accrued professional services and other</a></td>
<td class="nump">1,474<span></span>
</td>
<td class="nump">2,328<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Accrued taxes payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses and other current liabilities</a></td>
<td class="nump">$ 7,479<span></span>
</td>
<td class="nump">$ 9,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued Expenses And Other Liabilities Current<span></span>
</td>
<td class="text">Accrued Expenses And Other Liabilities Current<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued professional fees and other accrued liabilities current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_AccruedResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expenses current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_AccruedResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151029152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies  Summary of  Amounts Reported in the Balance Sheet in Respect of Operating Lease Assets and Corresponding Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_OperatingLeaseAssetsLesseeAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 5,722<span></span>
</td>
<td class="nump">$ 6,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CurrentLiabilitiesLesseeAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">$ 612<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued Expenses And Other Liabilities Current<span></span>
</td>
<td class="text">Accrued Expenses And Other Liabilities Current<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_NonCurrentLiabilitiesLesseeAbstract', window );"><strong>Noncurrent:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="nump">$ 5,636<span></span>
</td>
<td class="nump">$ 6,248<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 6,248<span></span>
</td>
<td class="nump">$ 6,786<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CurrentLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current liabilities lessee [Abstract].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CurrentLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_NonCurrentLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non current liabilities lessee [Abstract].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_NonCurrentLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_OperatingLeaseAssetsLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease assets lessee [Abstract].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_OperatingLeaseAssetsLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250983440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Operating Lease Cost and Variable Lease Costs and Sub Lease Income (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Fixed lease costs</a></td>
<td class="nump">$ 1,029<span></span>
</td>
<td class="nump">$ 999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">$ 1,072<span></span>
</td>
<td class="nump">$ 1,072<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151249392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 1,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">1,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">1,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">1,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">8,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(1,873)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">6,248<span></span>
</td>
<td class="nump">$ 6,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability, current portion</a></td>
<td class="nump">612<span></span>
</td>
<td class="nump">538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability, net of current portion</a></td>
<td class="nump">5,636<span></span>
</td>
<td class="nump">6,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 6,248<span></span>
</td>
<td class="nump">$ 6,786<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821154325344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jul. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 612,000<span></span>
</td>
<td class="nump">$ 538,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,143,000<span></span>
</td>
<td class="nump">31,729,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Executive insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LicenseAgreementWithTheUniversityOfColoradoMember', window );">License Agreement With The University Of Colorado [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DevelopmentAndSalesMilestonePaymentPayable', window );">Development and sales milestone payment payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PercentageOfSublicenseFees', window );">Percentage of sublicense fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PeriodOfObligationToPayRoyalties', window );">Period of obligation to pay royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LicenseAgreementWithBristolMayersEquibCompanyMember', window );">License Agreement With Bristol Mayers Equib Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PercentageOfSublicenseFees', window );">Percentage of sublicense fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PeriodOfObligationToPayRoyalties', window );">Period of obligation to pay royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_UpfrontPaymentMade', window );">Upfront payment made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CommercialMilestonePaymentPayable', window );">Commercial milestone payment payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 215,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_RoyaltyAsAPercentageOfNetSales', window );">Royalty as a percentage of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DevelopmentMilestonePaymentPayable', window );">Development Milestone Payment Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LicenseAgreementWithBristolMayersEquibCompanyMember', window );">License Agreement With Bristol Mayers Equib Company [Member] | Maximum [Member] | Tranche Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DevelopmentAndSalesMilestonePaymentPayable', window );">Development and sales milestone payment payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LicenseAgreementWithBristolMayersEquibCompanyMember', window );">License Agreement With Bristol Mayers Equib Company [Member] | Minimum [Member] | Tranche Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DevelopmentAndSalesMilestonePaymentPayable', window );">Development and sales milestone payment payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LicenseAgreementWithBristolMayersEquibCompanyMember', window );">License Agreement With Bristol Mayers Equib Company [Member] | Series A Redeemable Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets', window );">Stock issued during period shares purchase of assets | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,628,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=qttb_WalthamMassauchetsMember', window );">Waltham Massauchets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Office space leased | ft&#178;</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1', window );">Lessee, operating lease, lease not yet commenced, renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_SubleaseAggregateBaseRentObligation', window );">Sublease aggregate base rent obligation</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent', window );">Percentage increase in initial annual base rent per square foot.</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_AnnualRentOperatingLeaseAggregateAfterIncrease', window );">Annual Rent Operating lease Aggregate After Increase</a></td>
<td class="nump">$ 11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_FutureMinimumLeasePaymentDueUnderThisSublease', window );">Future minimum lease payment due under this sublease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=qttb_WalthamMassauchetsMember', window );">Waltham Massauchets [Member] | Restricted Cash And Cash Equivalents Non Current [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CommitmentAndContingenciesLineItems', window );"><strong>Commitment And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncentiveFromLessor', window );">Lessee tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_AnnualRentOperatingLeaseAggregateAfterIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual rent operating lease aggregate after increase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_AnnualRentOperatingLeaseAggregateAfterIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CommercialMilestonePaymentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial milestone payment payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CommercialMilestonePaymentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CommitmentAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitment and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CommitmentAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DevelopmentAndSalesMilestonePaymentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development and sales milestone payment payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DevelopmentAndSalesMilestonePaymentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DevelopmentMilestonePaymentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development Milestone Payment Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DevelopmentMilestonePaymentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_FutureMinimumLeasePaymentDueUnderThisSublease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future minimum lease payment due under this sublease</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_FutureMinimumLeasePaymentDueUnderThisSublease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee operating lease not yet commenced increase in percentage of base rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PercentageOfSublicenseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>percentage of sublicense fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PercentageOfSublicenseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PeriodOfObligationToPayRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of obligation to pay royalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PeriodOfObligationToPayRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_RoyaltyAsAPercentageOfNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty as a percentage of net sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_RoyaltyAsAPercentageOfNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_SubleaseAggregateBaseRentObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sublease aggregate base rent obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_SubleaseAggregateBaseRentObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_UpfrontPaymentMade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payment made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_UpfrontPaymentMade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncentiveFromLessor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of incentive received by lessee from lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481475/840-20-55-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481178/840-20-25-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 5<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479924/842-10-30-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncentiveFromLessor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal for lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_LicenseAgreementWithTheUniversityOfColoradoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_LicenseAgreementWithTheUniversityOfColoradoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_LicenseAgreementWithBristolMayersEquibCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_LicenseAgreementWithBristolMayersEquibCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_TrancheAxis=qttb_TrancheThreeMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_TrancheAxis=qttb_TrancheThreeMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesARedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesARedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=qttb_WalthamMassauchetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=qttb_WalthamMassauchetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=qttb_RestrictedCashAndCashEquivalentsNonCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=qttb_RestrictedCashAndCashEquivalentsNonCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821140637232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 19, 2024</div></th>
<th class="th"><div>Nov. 02, 2023</div></th>
<th class="th"><div>Jul. 12, 2023</div></th>
<th class="th"><div>Dec. 23, 2022</div></th>
<th class="th"><div>Dec. 21, 2022</div></th>
<th class="th"><div>Aug. 05, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>May 20, 2022</div></th>
<th class="th"><div>Dec. 11, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 26, 2024</div></th>
<th class="th"><div>Mar. 21, 2024</div></th>
<th class="th"><div>Apr. 26, 2023</div></th>
<th class="th"><div>Oct. 08, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from long term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit facility outstanding current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,097<span></span>
</td>
<td class="nump">878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expenses on convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible debt, fair value disclosures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,125<span></span>
</td>
<td class="nump">$ 1,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt instrument converted into equity number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,433,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent', window );">Gain on conversion of the Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_ChangeDuringPeriodFairValueDisclosureMember', window );">Change in fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember', window );">Two Thousand And Twenty And Two Thousand And Twenty Three Term A Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument effective rate of interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.55%<span></span>
</td>
<td class="nump">10.42%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=qttb_ConvertibleDebtAgreementMember', window );">Convertible Debt Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Convertible debt interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expenses on convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DebtInstrumentConversionPricePercentage', window );">Debt instrument conversion price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt instrument converted into equity number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,433,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=qttb_ConvertibleDebtAgreementMember', window );">Convertible Debt Agreement [Member] | Series B Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt instrument conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=qttb_ConvertibleDebtAgreementMember', window );">Convertible Debt Agreement [Member] | Current Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Convertible debt, fair value disclosures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember', window );">Loan And Security Agreement With Silicon Valley Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrants or rights number of securities covered by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrants or rights exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Class of warrants or rights term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember', window );">Loan And Security Agreement With Silicon Valley Bank [Member] | Tranche Two Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Fair value of warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember', window );">Loan And Security Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Term A Loan Advance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from long term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of credit remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1', window );">Line of credit facility date of first required payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit facility expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Line of credit facility commitment fee amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Line of credit facility commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_LongTermDebtBalloonPaymentPercentage', window );">Long term debt balloon payment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember', window );">Loan And Security Second Amendment Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Term A Loan Advance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate', window );">Long term debt variable interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit facility expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_LongTermDebtBalloonPaymentPercentage', window );">Long term debt balloon payment percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFrequencyOfPayments', window );">Line of credit facility frequency of payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">24 equal monthly payments of principal plus interest, with a loan maturity date of<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember', window );">Loan And Security Third Amendment Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Term A Loan Advance [Member] | Restricted Cash Non Current [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCollateralAmount', window );">Debt instrument collateral given</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember', window );">Loan And Security Fourth Amendment Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Term A Loan Advance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit facility expiration date</a></td>
<td class="text">Jul.  01,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Debt instrument terms of payment</a></td>
<td class="text">24 equal monthly payments of principal plus interest.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 equal monthly payments of principal plus interest, with a loan maturity date of<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember', window );">Loan And Security Fifth Amendment Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Term A Loan Advance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender', window );">Percentage of consolidated cash to be maintained with the lender</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained', window );">Unrestricted and unencumbered cash percentage to be maintained</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash', window );">Percentage of outstanding debt to be maintained with the lender by way of cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_SixthAmendmentAgreementWithSiliconValleyBankMember', window );">Sixth Amendment Agreement With Silicon Valley Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrants or rights number of securities covered by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrants or rights exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Class of warrants or rights term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_SixthAmendmentAgreementWithSiliconValleyBankMember', window );">Sixth Amendment Agreement With Silicon Valley Bank [Member] | Tranche Two Milestone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrants or rights number of securities covered by warrants or rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_SixthAmendmentAgreementWithSiliconValleyBankMember', window );">Sixth Amendment Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Term A Loan Advance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable', window );">Line of credit facility aggregate amount including balloon repayment payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit facility outstanding current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Long term debt balloon payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_SixthAmendmentAgreementWithSiliconValleyBankMember', window );">Sixth Amendment Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Three Term A Loan Advance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate', window );">Long term debt variable interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Debt instrument terms of payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The interest-only period was extended through June 30, 2024 followed by 36 equal monthly payments of principal plus interest.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument variable interest spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_SixthAmendmentAgreementWithSiliconValleyBankMember', window );">Sixth Amendment Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Three Term A Loan Advance [Member] | Before Thirty First Of March Two Thousand And Twenty Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed', window );">Line of credit facility amount that may be contingently borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_SixthAmendmentAgreementWithSiliconValleyBankMember', window );">Sixth Amendment Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Three Term A Loan Advance [Member] | Before Thirty First Of March Two Thousand And Twenty Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed', window );">Line of credit facility amount that may be contingently borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_SixthAmendmentAgreementWithSiliconValleyBankMember', window );">Sixth Amendment Agreement With Silicon Valley Bank [Member] | Two Thousand And Twenty Three Term A Loan Advance [Member] | Before First Of July Two Thousand And Twenty Five [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed', window );">Line of credit facility amount that may be contingently borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_SeventhAmendmentToTheLoanAgreementMember', window );">Seventh Amendment To The Loan Agreement [Member] | Two Thousand And Twenty Three Term A Loan Advance [Member] | Before Thirty First Of March Two Thousand And Twenty Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed', window );">Face value of debt instrument that may be contingently borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_EstimatedAggregateProceedsFromDebtAndEquity', window );">Estimated aggregate proceeds from debt and equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_EstimatedAggregateProceedsFromEquity', window );">Estimated aggregate proceeds from equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_EighthAmendmentToTheLoanAgreementMember', window );">Eighth Amendment to the Loan Agreement [Member] | Two Thousand And Twenty Three Term A Loan Advance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable', window );">Line of credit facility aggregate amount including balloon repayment payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ReceivedAdvancePayment', window );">Received advance payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DebtInstrumentConversionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument conversion price percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DebtInstrumentConversionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_EstimatedAggregateProceedsFromDebtAndEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated aggregate proceeds from debt and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_EstimatedAggregateProceedsFromDebtAndEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_EstimatedAggregateProceedsFromEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated aggregate proceeds from equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_EstimatedAggregateProceedsFromEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face value of debt instrument that may be contingently borrowed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility aggregate amount including balloon repayment payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility amount that may be contingently borrowed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_LongTermDebtBalloonPaymentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt balloon payment percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_LongTermDebtBalloonPaymentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of consolidated cash to be maintained with the lender.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding debt to be maintained with the lender by way of cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ReceivedAdvancePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Received Advance Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ReceivedAdvancePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrestricted and unencumbered cash percentage to be maintained.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCollateralAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets pledged to secure a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCollateralAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the first payment under the line of credit must be paid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFrequencyOfPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments, which may be presented in a variety of ways (for example, monthly, quarterly, annually).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFrequencyOfPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_ChangeDuringPeriodFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_ChangeDuringPeriodFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=qttb_ConvertibleDebtAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=qttb_ConvertibleDebtAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=qttb_CurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=qttb_CurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_TrancheAxis=qttb_TrancheTwoMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_TrancheAxis=qttb_TrancheTwoMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=qttb_TwoThousandAndTwentyTermALoanAdvanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=qttb_TwoThousandAndTwentyTermALoanAdvanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=qttb_RestrictedCashNonCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=qttb_RestrictedCashNonCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_SixthAmendmentAgreementWithSiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_SixthAmendmentAgreementWithSiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PeriodAxis=qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PeriodAxis=qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PeriodAxis=qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PeriodAxis=qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PeriodAxis=qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PeriodAxis=qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_SeventhAmendmentToTheLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_SeventhAmendmentToTheLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_EighthAmendmentToTheLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_EighthAmendmentToTheLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821250810128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Summary of Long-term Debt Balance (Detail) - Venture Debt Two Thousand Twenty And Two Thousand And Twenty Three Term A Loan [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfVentureDebtLineItems', window );"><strong>Disclosure in tabular form of venture debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount of term loans</a></td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized debt discount and issuance costs</a></td>
<td class="nump">153<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount</a></td>
<td class="nump">12,653<span></span>
</td>
<td class="nump">5,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion</a></td>
<td class="num">(3,097)<span></span>
</td>
<td class="num">(878)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net</a></td>
<td class="nump">$ 9,556<span></span>
</td>
<td class="nump">$ 4,581<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DisclosureInTabularFormOfVentureDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of venture debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DisclosureInTabularFormOfVentureDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821155702480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Preferred Stock - Additional Information (Detail)<br></strong></div></th>
<th class="th">
<div>Mar. 25, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Temporary equity converted into permanent equity value | $</a></td>
<td class="nump">$ 111,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Temporary equity converted into permanent equity value | $</a></td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAOneRedeemableConvertiblePreferredStockMember', window );">Series A One Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares', window );">Conversion of temporary equity into permanent equity shares</a></td>
<td class="nump">2,286,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesATwoRedeemableConvertiblePreferredStockMember', window );">Series A Two Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares', window );">Conversion of temporary equity into permanent equity shares</a></td>
<td class="nump">312,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares', window );">Conversion of temporary equity into permanent equity shares</a></td>
<td class="nump">2,625,896<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of temporary equity into permanent equity shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesAOneRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesAOneRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesATwoRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesATwoRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156447632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Schedule of Shares of Common Stock for Future Issuance (Detail) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">3,842,557<span></span>
</td>
<td class="nump">7,844,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Shares reserved for warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">18,144<span></span>
</td>
<td class="nump">18,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Shares reserved for stock option exercises [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">1,942,920<span></span>
</td>
<td class="nump">1,112,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Shares reserved upon the conversion of the convertible notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,433,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember', window );">Shares reserved for future issuance under the 2017 Stock Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">56,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember', window );">Shares reserved for future issuance under the 2024 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">1,760,657<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember', window );">Shares reserved for future issuance under the 2024 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">120,836<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember', window );">Shares reserved upon the conversion of authorized Series A preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,286,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember', window );">Shares reserved upon the conversion of authorized Series A-1 preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">312,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember', window );">Shares reserved upon the conversion of authorized Series B preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems', window );"><strong>Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock capital shares reserved for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,625,896<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure in tabular form of common stock shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151790128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Additional Information (Detail) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150640432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock Option Activity (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding at Beginning Balance</a></td>
<td class="nump">1,112,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization', window );">Number of shares, Assumed in reverse recapitalization</a></td>
<td class="nump">32,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Granted</a></td>
<td class="nump">1,071,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Shares, Exercised</a></td>
<td class="num">(255,486)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Shares, Cancelled</a></td>
<td class="num">(17,627)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Shares, Outstanding at Ending Balance</a></td>
<td class="nump">1,942,920<span></span>
</td>
<td class="nump">1,112,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares, Vested and expected to vest</a></td>
<td class="nump">1,942,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Shares, Exercisable</a></td>
<td class="nump">673,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price, Outstanding at Beginning Balance</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price, Assumed in reverse recapitalization</a></td>
<td class="nump">7.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price, Granted</a></td>
<td class="nump">17.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price, Exercised</a></td>
<td class="nump">6.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price, Cancelled</a></td>
<td class="nump">17.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price, Outstanding at Ending Balance</a></td>
<td class="nump">12.93<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price, Vested and expected to vest</a></td>
<td class="nump">12.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted- Average Exercise Price, Exercisable</a></td>
<td class="nump">$ 8.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Outstanding</a></td>
<td class="text">8 years 3 months 29 days<span></span>
</td>
<td class="text">6 years 10 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Vested and expected to vest</a></td>
<td class="text">8 years 3 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Exercisable</a></td>
<td class="text">7 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning Balance</a></td>
<td class="nump">$ 10,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending Balance</a></td>
<td class="nump">12,380<span></span>
</td>
<td class="nump">$ 10,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Vested and expected to vest</a></td>
<td class="nump">12,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable</a></td>
<td class="nump">$ 12,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Assumed in Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Assumed in reverse recapitalization, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821152538528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Assumptions Used to Value Stock Options Granted (Detail)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate range, Minimum</a></td>
<td class="nump">3.48%<span></span>
</td>
<td class="nump">3.59%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate range, Maximum</a></td>
<td class="nump">4.34%<span></span>
</td>
<td class="nump">4.67%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected stock price volatility range, minimum</a></td>
<td class="nump">92.00%<span></span>
</td>
<td class="nump">88.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected stock price volatility range, maximum</a></td>
<td class="nump">94.10%<span></span>
</td>
<td class="nump">94.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years) range</a></td>
<td class="text">6 years 1 month 9 days<span></span>
</td>
<td class="text">6 years 1 month 13 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years) range</a></td>
<td class="text">5 years 2 months 1 day<span></span>
</td>
<td class="text">5 years 29 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150540480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 4,386<span></span>
</td>
<td class="nump">$ 1,428<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 3,281<span></span>
</td>
<td class="nump">$ 928<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821149206912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 15, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Share based awards, common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,842,557<span></span>
</td>
<td class="nump">7,844,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Share based compensation by share based award options granted during the period shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share based awards, maximum contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Share based awards, common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,942,920<span></span>
</td>
<td class="nump">1,112,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share based awards, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value, options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognised compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognised compensation cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember', window );">2017 Stock Option and Grant Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Share based awards, common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,246,290<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share based awards, shares available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember', window );">2024 Stock Option and Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Share based awards, common stock reserved for issuance</a></td>
<td class="nump">2,839,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Share based awards, shares available for future grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,760,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding', window );">Increase in number of shares reserved for issuance, percent of common stock outstanding</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember', window );">2024 Employee Stock Purchase Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Share based awards, common stock reserved for issuance</a></td>
<td class="nump">120,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance', window );">Increase in number of shares reserved for issuance (shares)</a></td>
<td class="nump">241,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding', window );">Increase in number of shares reserved for issuance, percent of common stock outstanding</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage', window );">Purchase of common stock through payroll deductions expressed in percentage of fair market value</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod', window );">Common stock offering period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ExcessOfAccruedRightToPurchaseStock', window );">Excess of accrued right to purchase stock</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ExcessOfAccruedRightToPurchaseStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Excess of accrued right to purchase stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ExcessOfAccruedRightToPurchaseStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase In Common Stock Capital Shares Reserved For Future Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase In Number Of Shares Reserved For Issuance Percent Of Common Stock Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Of Common Stock Through Payroll Deductions Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Stock Offering Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156157712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Agreements with Horizon - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=qttb_HorizonCollaborationAgreementMember', window );">Horizon collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CollaborationAgreementTransactionPrice', window );">Collaboration agreement, transaction price</a></td>
<td class="nump">$ 55.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CollaborativeArrangementMilestonePayments', window );">Collaboration agreement, Aggregate amount of sales milestone</a></td>
<td class="nump">75.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Received amount from Horizon</a></td>
<td class="nump">55.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CollaborationAgreementContingentPayment', window );">Collaboration agreement, contingent payment</a></td>
<td class="nump">75.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_AmountOfRefundLiability', window );">Refund liability</a></td>
<td class="nump">55.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PaymentToHorizon', window );">Payment to horizon</a></td>
<td class="nump">20.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=qttb_LegacyQ32Member', window );">Legacy Q32</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent', window );">Business combination, intial consideration</a></td>
<td class="nump">55.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=qttb_SalesBasedMilestoneMember', window );">Sales-based milestone | Horizon collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CollaborationAgreementContingentPayment', window );">Collaboration agreement, contingent payment</a></td>
<td class="nump">75.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived', window );">Collaboration agreement, contingent payment payable excess of cash received</a></td>
<td class="nump">$ 20.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_AmountOfRefundLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of refund liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_AmountOfRefundLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CollaborationAgreementContingentPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration agreement contingent payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CollaborationAgreementContingentPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration agreement contingent payment payable excess of cash received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CollaborationAgreementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration agreement transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CollaborationAgreementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CollaborativeArrangementMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CollaborativeArrangementMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PaymentToHorizon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment To Horizon</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PaymentToHorizon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAssetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination, expected to be realized within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAssetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=qttb_HorizonCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=qttb_HorizonCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=qttb_LegacyQ32Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=qttb_LegacyQ32Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=qttb_SalesBasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=qttb_SalesBasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821257457456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Detail) - Consulting and Advisory Agreements - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Related party transaction expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=qttb_ConsultingAndAdvisoryAgreementsMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Due to related parties</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=qttb_ConsultingAndAdvisoryAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=qttb_ConsultingAndAdvisoryAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151799376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance period increase</a></td>
<td class="nump">$ 51,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_TaxCreditCarryforwardsExpirationYear', window );">Tax credit carryforwards expiration year</a></td>
<td class="text">2038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Accrued penalties and provisions for interest</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Current and deferred income tax expense</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CompanysEffectiveTaxRate', window );">Company's effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_USStatutoryTaxRate', window );">U.S. statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets before valuation allowance</a></td>
<td class="nump">$ 108,634,000<span></span>
</td>
<td class="nump">$ 57,121,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CumulativeChangesOwnershipInterest', window );">Cumulative Changes Ownership Interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 121,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 112,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_NetOperatingLossCarryForwardsExpirationYear', window );">Net operating loss carryforwards, expiration year</a></td>
<td class="text">2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward [Member] | Domestic Tax Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research and development tax credit carryforwards</a></td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research Tax Credit Carryforward [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Research and development tax credit carryforwards</a></td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CompanysEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Company's Effective Tax Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CompanysEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CumulativeChangesOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative Changes Ownership Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CumulativeChangesOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_NetOperatingLossCarryForwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_NetOperatingLossCarryForwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_TaxCreditCarryforwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforwards expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_TaxCreditCarryforwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_USStatutoryTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>US Statutory Tax Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_USStatutoryTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821148985280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of loss from operations before Income Tax (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="num">(47,716)<span></span>
</td>
<td class="num">(53,430)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Loss before provision for income taxes and loss from equity method investment</a></td>
<td class="num">(46,087)<span></span>
</td>
<td class="num">(53,425)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_IncomeLossBeforeProvisionForIncomeTaxes', window );">Loss before provision for income taxes</a></td>
<td class="num">$ (47,712)<span></span>
</td>
<td class="num">$ (53,425)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_IncomeLossBeforeProvisionForIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (loss) before provision for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_IncomeLossBeforeProvisionForIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151814800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of components of provision for income taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Current, Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">Current, State</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Current Foreign</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_TotalCurrentExpenseBenifit', window );">Total current</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax provision</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 318<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_TotalCurrentExpenseBenifit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Current Expense Benifit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_TotalCurrentExpenseBenifit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150679024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of reconciliation of income tax expense (benefit) computed (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal income tax expense at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">9.10%<span></span>
</td>
<td class="nump">5.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent', window );">Permanent differences</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent', window );">Stock-based compensation expense</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion', window );">Gain/loss on convertible note conversion</a></td>
<td class="nump">7.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent', window );">Convertible note revaluation</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="num">(1.80%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(42.20%)<span></span>
</td>
<td class="num">(27.60%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation Gain loss On Convertible Note Conversion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Permanent Differences Income Taxes, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156274480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">$ 25,468<span></span>
</td>
<td class="nump">$ 13,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State net operating loss carryforwards</a></td>
<td class="nump">7,086<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsFrequentFlierLiability', window );">Contingent liability</a></td>
<td class="nump">14,801<span></span>
</td>
<td class="nump">14,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves', window );">Accruals and Reserves</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_CapitalizedIntangibleAssets', window );">Capitalized intangible assets</a></td>
<td class="nump">3,591<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credit carryforwards</a></td>
<td class="nump">7,978<span></span>
</td>
<td class="nump">5,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Capitalized R&amp;D expenditures</a></td>
<td class="nump">46,552<span></span>
</td>
<td class="nump">13,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">1,682<span></span>
</td>
<td class="nump">1,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther', window );">Stock compensation and other</a></td>
<td class="nump">733<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets before valuation allowance</a></td>
<td class="nump">108,634<span></span>
</td>
<td class="nump">57,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: Valuation allowance</a></td>
<td class="num">(106,876)<span></span>
</td>
<td class="num">(55,078)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets, Net, Total</a></td>
<td class="nump">1,758<span></span>
</td>
<td class="nump">2,043<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_DeferredTaxLiabilitiesFixedAssets', window );">Fixed assets</a></td>
<td class="num">(218)<span></span>
</td>
<td class="num">(339)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets', window );">Right of use asset</a></td>
<td class="num">(1,540)<span></span>
</td>
<td class="num">(1,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_CapitalizedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_CapitalizedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_DeferredTaxLiabilitiesFixedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Fixed assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_DeferredTaxLiabilitiesFixedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsFrequentFlierLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from frequent flier obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsFrequentFlierLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from loss reserves other than estimated credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150631216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) per Share - Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss)-basic</a></td>
<td class="num">$ (47,733)<span></span>
</td>
<td class="num">$ (53,743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income (loss)-diluted</a></td>
<td class="num">$ (63,533)<span></span>
</td>
<td class="num">$ (53,743)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding-basic</a></td>
<td class="nump">9,320,884<span></span>
</td>
<td class="nump">349,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive securities</a></td>
<td class="nump">336,812<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding-diluted</a></td>
<td class="nump">9,657,696<span></span>
</td>
<td class="nump">349,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income (loss) per share-basic</a></td>
<td class="num">$ (5.12)<span></span>
</td>
<td class="num">$ (153.96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income (loss) per share-diluted</a></td>
<td class="num">$ (6.58)<span></span>
</td>
<td class="num">$ (153.96)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156098800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) per Share - Summary of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Detail) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=qttb_SeriesAConvertiblePreferredStockMember', window );">Series A convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Options to purchase common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,286,874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=qttb_SeriesAOneConvertiblePreferredStockMember', window );">Series A-1 convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Options to purchase common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">312,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=qttb_SeriesBConvertiblePreferredStockMember', window );">Series B convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Options to purchase common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,625,897<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Options to purchase common stock</a></td>
<td class="nump">1,942,920<span></span>
</td>
<td class="nump">1,120,014<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to purchase common stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Options to purchase common stock</a></td>
<td class="nump">18,145<span></span>
</td>
<td class="nump">18,145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=qttb_SeriesAConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=qttb_SeriesAConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=qttb_SeriesAOneConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=qttb_SeriesAOneConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=qttb_SeriesBConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=qttb_SeriesBConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821156453968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) per Share - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Principal balance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt instrument converted into equity number of shares issued</a></td>
<td class="nump">1,433,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821151349856">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Summary of the Company's segment expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_PersonnelRelatedCostsExcludingStockBasedCompensation', window );">Personnel-related costs (excluding stock-based compensation)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 16,122<span></span>
</td>
<td class="nump">$ 13,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_OtherGAExpenses', window );">Other G&amp;A expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,586<span></span>
</td>
<td class="nump">5,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest (income) expense, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,832)<span></span>
</td>
<td class="num">(693)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(9,978)<span></span>
</td>
<td class="nump">15,645<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_TotalSegmentNetLoss', window );">Total Segment Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47,733<span></span>
</td>
<td class="nump">53,743<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=qttb_ADXZeroNineSevenMember', window );">ADX Zero Nine Seven [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Direct research and development expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,253<span></span>
</td>
<td class="nump">7,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=qttb_BempikibartMember', window );">Bempikibart [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Direct research and development expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,726<span></span>
</td>
<td class="nump">11,722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=qttb_DiscoveryAndOtherMember', window );">Discovery and Other [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherResearchAndDevelopmentExpense', window );">Direct research and development expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 856<span></span>
</td>
<td class="nump">$ 894<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) Other segment items are included in order to reconcile to total segment net loss. Other segment items include non-cash items such as depreciation and amortization expense and stock-based compensation expense, gains and losses on the change in fair value of convertible notes, change in fair value of contingent value rights and loss from equity method investment. In 2023, other segment items also includes the reversal of collaboration arrangement revenue related to the termination of the Horizon Agreement (see Note 15).</span></p></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_OtherGAExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other G&amp;A expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_OtherGAExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_PersonnelRelatedCostsExcludingStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Personnel Related Costs Excluding Stock Based Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_PersonnelRelatedCostsExcludingStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_TotalSegmentNetLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Segment Net Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_TotalSegmentNetLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=qttb_ADXZeroNineSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=qttb_ADXZeroNineSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=qttb_BempikibartMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=qttb_BempikibartMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=qttb_DiscoveryAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=qttb_DiscoveryAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45821150101872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Additional Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Feb. 23, 2025</div></th>
<th class="th"><div>Feb. 10, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,197,615<span></span>
</td>
<td class="nump">359,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Payment Related to Severance Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_NumberOfCommonStockUnderlyingShares', window );">Number of common stock underlying shares</a></td>
<td class="nump">1,904,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_qttb_ExerciseOfCallOptionDescription', window );">Exercise of call option description</a></td>
<td class="text">On March 1, 2025, Oxford Biomedica (US), Inc. exercised its option to cause the Company to sell and transfer to Oxford Biomedica (US), Inc. all of the Company&#8217;s equity ownership interest in OXB (US) LLC. The sale price is based on a formula using the Company's pro rata share of OXB (US) LLC (10%), times a predetermined multiple of revenue for the immediately preceding 12-month period increased by OXB (US) LLC's cash balance and decreased by OXB (US) LLC's debt balance as of the exercise date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_ExerciseOfCallOptionDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise of Call Option Description</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_ExerciseOfCallOptionDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_qttb_NumberOfCommonStockUnderlyingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Common Stock Underlying Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">qttb_NumberOfCommonStockUnderlyingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>qttb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>105
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M9R':*>^I K<_;]2OL\I#99ZP(&,6?:>A7%UTAAT4DB5.(WG/7O\B185.E%[
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MAG4(4^!5IL#;RQ1,8\*?U5#_)RC(%0QE\1HG^C9G%FQ\)F6.:XWM$#; KVR
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MYB*D4IV*C1GO!% _30H#DUB68X:41<9DE'ZV$),1W\N 1; 0*-Z'(17_/D#
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M:)6=2+Y+G_NLN)0\3 ^W0'T028#Z?LVY/)TDCY**1X>3_P%02P,$%     @
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M/W,IR4KP_ V5%T;$J#/YV,1H,'-#V^M92VKMBY$UG#@2G2ET65FQ5) =R[9
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M"<49!['-,L)_]S!E^X[1, X;S\DZEGK#]-L;LL8 Y6(SXVIE5BQ1DB$5":/
M<=4QNHV'OJ?C\X"7!/?B: [:R9*Q5[T811W#TH(PQ5!J!J*&'?8Q3361DO&K
MY#2J(S7P>'Y@_Y%[5UZ61&"?I3^32,8=XYL!$:[(-I7/;/^(I9^FY@M9*O(O
M[,M8RX!P*R3+2K!2D"6T&,E;>0]'@$;K#, N ?9'@'L&X)0 )S=:*,MM#8@D
M?INS/7 =K=CT)+^;'*W<)%1G,9!<_4T43OK]Z228/HT&W?EP ,%<#>/A9![
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MO:>2S(L^4BPDV^2E>,FD*NSY-%:M%[D.4/]7C,G#0A]0-7/_+U!+ P04
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MMG^3)]OR>56/29XGF_)P38,E38L ]OTJ2?+7-\4CL [/>;OX/U!+ P04
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M7DPN\=DZ('I!)?%GRIYD[S/2ICQP_D-_N4XN)IY&Q#(6*ZV"PK\#6[,LTYH
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MH] 1:P'X?<NY>OFB;]"^1+/Z'U!+ P04    " !&.FM:,(/FQDH"  "D!0
M&    'AL+W=O<FMS:&5E=',O<VAE970X+GAM;*U4;6_:,!#^*U963:VTDE=@
M8DFD IM6:9U06;?/)CF(5<?.;(>T_WZV$U):!31-^T)\YWN>N^?P7=QP\2@+
M (6>2LIDXA1*53/7E5D!)98C7@'3-ULN2JRT*7:NK 3@W()*Z@:>-W%+3)B3
MQM:W$FG,:T4)@Y5 LBY++)[G0'F3.+YS<-R37:&,PTWC"N]@#>JA6@EMN3U+
M3DI@DG"&!&P3Y\:?+2(3;P-^$FCDT1D9)1O.'XUQFR>.9PH""IDR#%A_]K
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M6Z;78OL==OD,+2\73+E?M.W6]B<1RENE1;T+-@8UY=T7O^WJ<!!@.,<#TEU
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MR(*T"\Q\(83>=^P&_MG./@!02P,$%     @ 1CIK6K9,P5.9"0  @S8  !D
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M&? CGC.-#+(FS8B.T]\J#O%P,"<EF,^H/0E6H3@J9:;JP$<F.KR[4B975#E
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M($2:P=HVU<!\>#,V?+I^)_EB^<4]$K^)R>*(N'D/>JRKG <T65:7A.N*0A/
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M0;WS#2#"G=XB:O@%MRS0+>(GV," ^RMTBE$',^QHH8#;[/OLL^_8 +(VVO4
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MG?QO"5_,NYP16X$  X025>,BBNZ.198E9BH(Z Z[H<-<>+A$XN;HM&HH#SL
M\'%;NE ">6,A#P6-?$\%.9XK'#@Q/EH+RUW@H^=8YP?,V*XP=!B%J,<\\[G@
M&L,;M!;V4:"%5^2#5&!-*0IWW#8@^[;$QBEI1+F-ZRTI5#' 8T 2A14"&1+#
M[6+I,T4JJ1*7#4"\:Y*7\&",KS4%%<&)E>C35+/;8PU.>[S(?L6" CQ3&MLD
M/)AXK.8(V7!BAQ;MJ=JAR.!*M+6;=@K,1/#P;FN0DYR/ <1W7*@RD4WH+:/
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MZD#B]]CC@/%M2F^TW"K:Q:PYV\' Y16E(1?\YQD4I]0J9$-UI<IK2(_+]'%
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MMLU51,01-RFU&OU(QK.Q(<GY3!5BOFV="XU0@7G%$1V+PD[8%INN>E/0NP!
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M1Q[2%8LP-&4%E>XNTZ"^DL@+5?9X>*NPVUG;>68#]AH*7>U-\VU$ZJ$8>"/
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M+<QW8-<M6/(7L#B!.R5M:>"]++!X"1!29%UXR3Z\Z^0DXBWF TCC/B11DIW
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MT+&>" _&6(5ZY8>UH;^KD;:=:-UM]QY<M6/P6;U]3.Z87G%I0."23*/!:!B
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MY.KUA@,'9-T&ZH46E2V]2Z&ID-MI1IT3I3&@\Y40>K<P!&TOGOT"4$L#!!0
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MX;#WHH8;C!>UNBH5 @3]>K;5!.^$5)O,,BIRW%*TM49 AC8(%ZG1D&K\3S5
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M:3 .(,,E6PE[K=8?L<GGP.&E2AC_"^O:=W 40+HR5I5-,"DHN:R_[*'9AT[
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M5"=$(;&-QQMYG47Q3:2N#9F2@P)[K?"!6_TQ"I7JU.?SEAE"PQM&OF%*V*X
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M>Z#C /(OK0W[#1<X_(_&?P%02P,$%     @ 1CIK6L]3F!H0#0  @B4  !D
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MOQ+C:#H:45K1,/)88\Y.Q)-H/HKYS^QJ\"9-;2US;W,@'A R&8LY(.BMW&B
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MW2T4[S1)C9(M=Q"=@K9*XD!$PXS3E'*H1@^&IT""/+@@_M>AZCT;X0>#@OM
MR^6!!S7-_+-&,F24U+0-Z1YN39U3+2 SE]0\%[O3_C_&4:$<=1[MU@W#73^8
M-P?5T*#8"=<,Q34C<[N-\TVE3?RP>>%=5::H8=$J&%I0!)=(,V/16_R^OH'=
M0X<VG1 V-L5 PKG< J,F9 V;N@=PJNT:GZ&+]T:[1VT)]P<DBRU1:M?P35F3
M2IF*SHEG_YR#$LI"UP$=-DET0$M3D'K.4],NC(O=Z?5OP'$U,;</US=/>@#
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MA'O7;@#;:SN;YGV!S2:Y%FB:1=+F"ASN R71%B^2J)"4'=^OOV>&U)OM=7)
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MY37'*T+LTAS:-8-3RO:T"4WW>@T\;>@=0RYW_22S! S@3@EQ&<QW+32'+44
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M'!U_;>&'=I-F^G-9I.NB+#H\5E@9OE(A59<P<-^T#M]9]RW IVW/%@[H>W]
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M129%EBO+MM&9C);-]$>^#?M-PZHR!ED[$HR;CB2O/-)DUFHTW\JG!+7=4!M
MO@NKZ#-+$K1PE[=!]S"+7"6N8 8U^6T&M@H)RRAI" 2X;)?SAA WIUT-XF*8
M&%W3W(B\BOP4TT3$<0[4@F(O;$C9]F#MI+_UGN/-GA"Y)-=P_B".\I5$\6?/
MZU:]F*)' %/8[X%+PX((,9!K[])F2Z9RB,_Z3*/%J-M0JB\18,@POEA.,7Z+
M#/3O=$"_A42A:>K[AOSBF>&3*Z$[DW!MDZL)PP%]BJ&:RCH8Y;6B!+52!=&E
MXG-G,20.0&#%:-@BF?KC :QWH)Z2PY<2\W 9Q+<QL0R9,Q[MAF6O9J ECY"B
MO@)&TI G(==3>3T,L$=Q WP:V"AP;C @U:GAW>LZ51@7X0!XW9!V&6'5VG6W
MSJDV+W$"F(J0@6<?IG>=$;B9"70NVU7%[[TST7W)?C @I23%??JUV*-?@A1=
M3D&NUWB**?N(#KV<$RHGPS?[:O3NF8F.SISR] F3QL6.I!(^E,PF]("#O@_*
M#NM):!2-K'9V5I%^Y3-7K(90 .V ?0!2#WXTVDG1  2ZV]IS5M''S*8TYZ[$
ME((BTMKLYG]*?L79DXN$N-C%\^1_]352,:&,V*(4GN CY; +Z]19@)1!#W)Q
M\:"7?M#WHY-Y9+RJNH3?[=0G*^\C__T>2VKAC,NTF5[0:CR$?NO%(89O9=QX
MBW</[I59V9L?TYP'O".13Y!?3;VNF>F#YF1>$K(!LD@5AM]Y&'X>XVR8":-)
M;.BNT:':=3QE50<?I<F!#I\9)<K8%ZJ.C5-H9R 0,K,1PI3_0JD_*V_TJN,'
M76)BA%'*F(0+%<*! RQ'AD+-P\5RT</ S?"&Q>6U-R0G!<=?&S+.W&W%PRF"
M6NQ/"OMY=0USHO@O9?#&IF%NRXE2?'+ T7W&@=0!<"HTO"K)91V9%W1BP6)R
M7S&!H'6#V.0&SI>RFM"'$(0\Q1<]2QSDO_'N_CL%\LBNK;&@)6EW:3 \,&8C
MW@"QJ_47V4SAS3XMG I:A/F88T%GR7]*)0%:EMNTR15+B7^RD1YM90SU"*IL
M;RI?]%KH%Q?J,Y0!==&6L1"HP9P+;T&MHMS^VON'US4LDSSVI&OCD)Y7&!_=
MNLZ9+KV\5#N&'7N:<*IIDW (GTFMN .OIA,5+!#PK\+7#TSYV29=W9$_#U=S
MH.722&;\V,DAC@W7>C\!_H?E)]F[DO?L*#%'-8D)Q9P0<\29AMM<0$P)TSC_
MKG&45:X+"9+' R=]QQM1!T [L6R3W,Q9#J =88GL*3(1>=\CIYF6I_3^1$GP
MIEC,IB^!V=XX"6# @C#SPIO,:=<U!1 _EU^D3<7^9G5DK5"Q%-[,KMCADJ,!
MR-/HC8O9@#ZQ(>0P%68Z4ZX]2TXN+X%5GR7OXFHZ3*RL= Z=TU$<4(YEO#3,
M E$_WJ3D&9[H2GU?[,+"#)S ==2A./ 9^>,P&%-.(-@(:V:TQ%C98LTP)M)M
M7>>W1<E94Y3$F]7 D/\(;FI#V&:E0G8F@QCS KZ@S26NZO)H1QB2Q-[MO: 9
M!..PK%%SVX03>.MNSJ COYHGK&E.S[Q.^+W&!XQ_]+&8DKHGGX9;L13,&HHB
M<O8]_UM<4=/6>H"61T"_0O&0<EI6NS#(/,>,&0&=8=NWF%WC#Y&H.=C[ZI;%
M8C%\W29#Y8#>F!I(#L"BHQ2_@G.F.-5F,!8FT,&CYYB*#<38K- -')AH@6DB
MIP)K] S16%ARAYIGEO:2TSG&*)QQ6P/OVQ(9QZ@1^#:.-R=0Q3 (SF5D5KA(
MGT71S%;)D->9BB58,<6S)GX)+P9?:9U16K!HKT6<E^'VF-77',^2-YBBA'N*
M_=0$!^-;U^@S*TYL:*,^53ED&9S;NG;CHK();RR>;05\DF-K /B64]]&O FM
M>&0X7L726D'.Y*+T;Y=/99J',42=#WY-I5(PWK=->M@AJP1"83\5.TV#7FC'
MDG5HK?($WDOL$$8\ )KP"4M$<XA(1>6S495 )7RNWG!?#*DNC$I4'9>/G/4Q
M67I*CC47$_G!: "&,2<P)W? NI0-3V&,Y.K>@NZ.998YAO=15_8B.$B"LVG-
MGN2*$,3]-7FKJWMMGG;Q_T5K?Q?%IT73ZWUU@]T#\:FU"[$AWLDQL& /7:\'
MW(LX/:)-_C@>'3@WKR0(R#/,PI/*VR$78;T0*8\9S02S5EXVB>X&Y@;4F((:
M@&TJC"<@?13,X3(00$=6:1!^FL T)AW!%X'S])%H0>J"#4FUS>@YQ)!+2G''
M<:KB0)&-9A[DA<,IO/^ZP;K25T6-/N$L31Y]OCY)?OWURB>)OO_?K_Q#GRPZ
MO850N?;T9-$5'.H6+Y9K#C\T>!SBTD KG'3328-^<:"Y3A-3HR?18^<?DS.E
M8S]^1_M>D2G!9^13#G(T$S'60A[]U^8O4AM%M8\H,[8@].B]?3MM*8C8@,T<
M)&E?;9K?TG\B-><J/7 ;:TKM"L'M$'#*GW/^O:M(&G'6#HIX7\8&.@PR+A#\
MH+&0HD8A3W$^FF2$T5HXAX##"[F)+TCF&@AHXBAB76)V@GB-T2&7ED+>A&*\
M+H;<'+A-NY2\: ^UY-)Q3&E?WVB<FKBO)O2%- %42ZGH$Z, JN0.'!CTC 8Q
M48\';_P1?>8C^A6A\NB_0&-H3Q[\FJX-&GW_X&T/%AP94<Q?ON*_V^2[!TBT
M/8;-PMO?/?@5&28%PN4 3%X2I]5[M-C0X2P17J@KNUBN!*-9ISUG]_EP1KOT
MV0.531HD64+LDXM 4LTK#!7L> ;NP"0%FD)J?IC\=B5#J+L^\P1H5 H87]["
MNAN8@-5_M5+$V\,* .65IIW1L8:6/0Z^Q\J:N#89-?*XFGVZBH=7@FMC N6@
M(3IM)#SB\S<,E=%'IDZWRI"&>7+25#D_@=U@>!2<;DYF<R<=R&3*R .&>T&2
M]UT?CCXJ'6DKZ#OC(0>VII/,&3;.?%(:;Q*^Y]80JBPT#E7CH")Y74 ^B,)P
MR >060KF*\%O*!%XF([*T>X:/BC(4C- 1IYUZ\J;828Q>N6'DX9LORFEH@95
M8.OU8LK X(DTST(BA.EX@5.3X>F',V\U0DW3>QL6N 8F!$731)YXEBYJ8./O
M6%6&<0D*2S7<=:$-&2)L)P"/*2G"/>-?F !QC*V"-I31K;2&^#B/'P>D8]\S
M@<IA$(XXD$_/DVG1"JNK4T^UVE9 =1O,E"+E3#]I!RBVKKO=,*)&:N8P+#(X
M0%3KIT[O[V!%$K7IDC2'P0?;(S'WB=3"N?,8\ISH:&+F$Y+M*7I,P\ *00Q0
M(KU)ZM;F2"A3L'5-/;&]%2L;J0G1-/L5;UH?A8J)ZJ9HZBH4K_L*2>6LNOK9
M?<XPWH!$@KQ)>P3*!*T@\_GH; %%:8"CDF2CL+?6?&?/ATG;7DD4 (?$S>;_
M[*VGP[AEL)ZG79YVG(^TPAWTH&F2T4LY^0TA"Z?G^])+!;'L<6!TH).GI'3,
M4!9C5B;. EH@O8-EB6C984%PQI1'+2DQW=WPRV66QAP6BUJ)[,;"CA &22ZP
MU.EYV&NE 8@A7S-Y23&KQRPP.@ZQ7+3!3J-9@J2OLEY0X;$.!!"B'DTE>QFN
MJAI.6*CS7>D<Q7F=DY\_]/GA)T&;X(BR-;&&:<6LIH"M-OKV/M^)]R_^=MND
MRB)"'[L86XU\)-7=:+!DG,<",=TVSOG24T^\8J@/66$K9(MEKIU)7I]90'PN
MOJ$&L>N)DQFX&+4>HC(EHF*'#]XD[V^U/2TIB49&H^H97_"":OW]<I5"CX"+
MY28![Z(%_(H+^)46\)(6,*E _Z41A[56Z&EFTN+N%ZW/NL1*@3EO++EP6'AX
MQZSWR&D=S"1$A;TPX)4T_*D"'A2-^OK4V<)LLT<3S[C<)(Q4&9U%G@4&/6RO
M%C+I1*4>K<\[$L-,Z7:+P>1N,)F9!7G4($,WAH4:N*/I5J1A&70E4W=ES7SE
M=#P0K#M(\9E9!-(VB#'EJHQ?7VF4";U^49^YR8_&![N0:!\&FH;?["EY:WM\
M3DN=<D--\.5R%>]KK6?[!VEE7?*N;7OI 3"3K_O71N2JA7M%E**:N]O4N&3%
M:53HR*(U5@&\47LWXL?Z+B:)\<I$X"FQ(@Z'M'7O/"*SRW>+@I4$KU-H?><5
M35,Y80*6UDH0O7;Q^$(!\N5RR?!'&WM^;6+/;R3Y=/( _^*8R<?Y=GG+VOOL
MT#Y7=E3&R4/J$)3NP9$?:8%T5RV]3;MJTY):TJXX,_F42=1V'!)/7^4P++B2
MR<DSK8W 9AH"A%SRNN^XEUEN5O$\*5/*9L.D_I9;S<!#2N3"#"],1\L( K"V
M>M/=IN+;TC!PZ-UFOI%\MN>HA%OK/G:@?CX $\'Z-]4_.-\3V'6'^9;^,;E>
M-*&5EZ-E#&'*X=G>V:+1Y]-RH,L&V8Y:'R78\;>Z B,31 SG9F*Z;6;6ATO#
MI #R,_CN"MHU5%)_M7\MRT%U'U'@[>ZV"\/4>569XW:3OE.EX1L6).QA8M'%
MZ^76C,B\*?]4>Y_)#J1Y(IZPRAW;XLX1XZ!"E!KX)4"Q7P"[3AS:(9#2A\XJ
M;O6(R5-^)[%WI:,J J_*CN%Q]V'+]J.:NJEM*A "?/0$AT8()UEH1U!K:U#?
M0B]703S6$4L@VCU+_H$6B8:T-1LH1U,^.WKY/QY]$ ,"T!W_<-*1PV3+!(A,
M,AQ"_)WD9B"?*9UZV5G'Q)=O:FD3(BCL&Q>G7 G,^[B>Z!8LG1BB-IQ$Q<78
M':-[E,:&A,&A#S?;L!B1J#?BR]="/";<F2[/?Z()YY3+UM1CT?K8]R2[H3 O
M]XNB9/E!/VG$.Q.+H,4QK)8D:^@S<;G<9^)#2B;3O!9T_\]COYTGE;)4>1G+
M-SC[2BZF(-H]\%#BCB!Q8W&,LR;MSU3"%"QNKBL3K-((3=P&5ZH(.(&2\SFC
MV2CYN%>B&I6UBMN)#9D<D8Z2(E Q\O,L9%Q]0P>ZRU#=?KE<E/X1"0UTS(^L
MC<TU;OWSHTAVZ=N7UZ_LG1C78!_F*?*L*^MQT%CPRVL- 2>?ZD.1)4_/GV*W
M$!Z>\/DJ9MU7=-,'-I5X!!_C^R<KDR'AM4P\2AZ%G#"4(2*?)O6:8SN2!TVE
MZ3 5Z5@CD;J2% S;UUHJ>365PV8#T^_,/6A!IJ>5L#2J-=3"'58PL$',:&+@
M$;9Z5[?3&)B3G\>ZSCD7RD/#>%#34&M/XC8#S,*-"Q!7=LV^M)AT!U]YLL'%
MMYT[M#\ECXH3S5L]*A3HF!ZU)U)E[^']'-X>OA[E*_EPART.H]'H4_@V@(%L
M$%,]1-49E@'<J <].I>55#_C@#<GH=/NY' F&^E^BT1*?P3#ACA3A'R/R!UW
M8D',MVZ0EC4S32SYZPIKZUA1EJ2R&W>*A\%5$]HS32B%43[ASOEK#M\-$%,R
M"\M2+S\8X'$=4HV*EC_B N A\DZ@+GZDU66^#EC1X2QY3WD!4<@U3LQ:WP-7
M1P[ Z95XPI8!QUW&HS #]["42I>9\P?A/Z(Y+0T@#R1MV7@O)]1TG4)"GZSB
M=X9HO#B0WM5DC46!,5O#-14R#9Y1O9M!7O,]V5*O1@3_O#TISC7>@ FV"@:*
MF786/A26BGLH4%,&.YGOS-<:!6[0'LC'^VS);>0D,:HU0MD 65P>-YZ:I3.:
M#S83J8MC2Y^ANC<$RK1GW:-0Y$G?< <.WP"Z;S!I9.Y@-'N!<#*20'8?E-\.
M:F"5A0)+&9B\/L)6)WL.SS,M7)+OY2#)6S=UB8E TH*4[C"P!R"Q\H6;5HPF
M3FW8V?/ONT/,"UE-SR-PL,:%R5%. UQ>LV4'0!IGR^J>6"$/_4W/,//*SDB*
MF[7 ##)[&/O[!9!(6=)%1,$E>>03">L:'IH4C=>L>5#[IV;0)47Z,_I6[Z/^
M92'O8TB7CR1C<C4Y-V6%';B"< -+9;68=W?"LJHHK#2R]2\(KJ@X>&J&X7JP
M;VVH)E#*#R?'6Y711Z@XV,Y]%V'IPD@+NO[J:S?$C1.^.\:WYPY]1^Y#>+'(
M"1WIIHJ^Q'7%62&^N(3LXM6@#2M;(=JC5WOKT.$-BE4H!+_6;A7HMJB$/Y.]
MQYC"T9'@Q==(*%T=T16M[["C%@K'>@]E.KQ,@%J AFUVDCR -])YW!\ ."G^
M/'C_ M)(VM;2Z&@LAP,T6=1>]$C+NOV:-4M PN$PAE(7N!>WL$!-24NY4$2L
M03@Q#<XH  ;!&/QC37208(86I:BN7DB:\K$%WA\*E>2[HD%+L\I/L:D\\MJR
MU%I<6-^CZ^L/)UR.YN4H/.+DY#/ZYRCW;9Q;I\5*>!+](==5B_GDHXE:MS<S
M &FS2Z*-9(4HU#FFR,:^'EPLA?QG/O<2;>H**F(;@WNR=, YU7V.6X04BHF2
M#,E'=3=T]Q%?<> +V83/6#M'60\W?7"-<#Z^^(_T],IMZZXP?CX?E?<A]DC3
M"]Y#<;)9C@!:EUST<1^0KH_6R:C,P$2/<1"LFAU=G15UK-*IR%:1:@U[2!QQ
MTJBB4(;F[9I\T-BT\0TGT/ES*!?T_'>>Q9G//1^@=":+L]R:,@TF*/L,!B6M
MX1:F$,6ER,Z<^:6U%?,VF(C)QNN \ZP*+1-CBMDC'N1;A:5-F]1XR";XIR%;
MZ;<A.><LNJEA2%E\H08Q/"R_8$.."S,-TTTF^21^@GGO56"-,C#"R!JSL4T<
MHQ0:[DV;DE-(DL*1]PV\+UQVB;W(@;-1'4O@4GTEJ:W=Z-ZKN>U1+ &5[YP[
MQ@?G,YD&H=!RY(@>]E(_#;G1711H_V;(AG1V'TIA,'<KM0^U_LWG6$G9GTSN
MZSIOR'(=S\%=#UF',BES4;R%1)$Y$"#T;'?:'Z1<)@ZK4?LD'8@UA4&"N!+K
ML$V^:38VC@G>HS8]?#4R,#S6>:6\P=,5L3[)%M@5<O<9!3)<H+1WFWNB/^.Y
MD$&H<B0T7PUURP EWZ3HSO6>);^-XZU14Y4%][AWVMK(K*FP]LTM5"<W1TK7
M9<(ZI8XD3C)>/*H4+YK"<)1V"T3KVP\W"-F]';IE2=YJ2)L+GT'I11U(S&(N
M#XH\25BNTDI,OJF/:3F,IDW$K*,D&]_B@D8R 1"Q3TA_,X6.+#A<7J.]CS0"
MRD3<X= O0YC!D/D$USN]>/381':WV8\E$F9WE%^,BT5SV[-2Y3GTK2(@ )?L
MUSO4PJFE'T,#Q:!&^T=&A7PWCAA..)TC-Z0POIB]JK^&%15OS5%QJ_=C<5_P
MPO\D:0;^5,4A$2=HBH_=TJXQS'QKMX&$UX((N4TK6&E>C=EQWJ@9-K2)"QU+
M9;$L]"559-( *,0V]MYGX="J@\DF??J=4'.H+_8N@-"L;T&UB<=0Q<DW%_85
M&9^F\38-4:-8 YIFNVK$C4PR4U$S@YQ17(#]?],O(@ 5+T,O0F3;A[K@DDMN
MK]Q(CA;\X06S?Q)%C8H!HY#^9MB>K>_P.LQ:NE*IZ%B*/(8NF)?+C2NO*<?H
M%4U\97*,)L./WS94[,+0>CSJ]&42G-+;5!I5##MF<_#R^DIBD<\N?EC%XVM;
M+5I _!-%(^&+D[-$_A7L2E1ZIE: [4H)9]!JJX^*]GLJP/7,8G1IT+A!D+"9
M8BH1R"3=:>/GNWIT6.R ,2D]G O60MYGRV).^EL>@@V+Z*9B*S1KE_MS:>,#
M-4I#XOAP(AF58;7<&(<(B-X,472]H%749-_^) A]PXZB9@=>ZEA/<2S=#;'*
M7N<WZ&O^ =W OI?&G=+,I@CMI:D0C@_(;EP3+WTA5;RSF)19<?%^0-9:IB(#
MIL?MGZ(:JJ.J3@/"AGQZZ2.C6]48"#E*_,=#3)>2BHF9".N8/.(9[X.=<<:I
MORY"LCWDE78^[U$/(N\; SVZV6$>02I2'L<I:U0PP;1.;7/&>Y4[2= E)#]@
M23V+W/B<8@)1NI/3U[M*&"1SQ>&ORA3FO\YV-2E5!R_0? N^ .*ABT9U:L9V
M48."Z6^N2??7>>$14C'/IPE>-KQTO(TO4X\OD8XP'5B![QTXFS)-RUS9O"IL
MD[B"LY0F_J04P2-:K[]U/K2*BRY;]\TBZF:):N!_&U=P"3:'!(ZLNLZ 0%LV
M2=T1]4TAE>(VW%=FT[5GN.J8NBS9:+)3ZDTMJ;LP]PT*SO$R>[V6AEHAM2$1
M;GIR/"FJC:$[33.J'FQ%ROC7: ;2V=B*XH?<$3DQ@4;AUM0)B"#7<OM2TLM)
M[[R1]*C4-]LWQS^\4HO7$5L&C0N746CO!:)R\9%3OU>%@-UHR+$SBQ>3#\3\
MY$>KJ,-NT89V'R[T()BY$<<LF])W=7R%.R]^444+?9(OE_LDRQU;G]*O,YGR
M]_]<[^OJZ(_AK:MW*5Y/SE=)-!IK5T_.3U20>YMH0VV^M%DUO>PKE;FRT/9:
M$Q< R,59&\ .-M>NS9MUOC^1\ GXQ-_XF3'52/64=+T!^B9;<^@CB5HEAF)-
MJZ(U-'SC8":4!J_OL4[.M)ZNP0D]\^*^B7<LA'4\F%+4K\W<W'P*KN*T75HZ
M%X17ZK97*))I%FE@4:O!QD7U0.R9<F?)58@FW.?,IF[^)2QJE;8*@[(S&1ML
M7WYQ9;&K:VU<U$TCC5J?4KSFI'HIH(HTY=6K65:^8P_?_U#XJV&QX5@H><-7
M;IT61(8D 2=-S%:Z+*XX;9SZ ZD8#941=K65Y$-++<LCV,]MA7./$[T\9$6!
M#FV-1O**"'K WKI=4_?;7=04/@#:E_\D'_0N8;ED-#3WFEI0Z,OFJ'1/] C?
M@SB&L?:U\VBDV;_HJ&$EHL\5MS>@D]*5<3@=RF+R &E;,\0,TU1?DDZT]F&0
M_]T&![S8!+%'853A-0%.?V>HR?C&^L",+D6XBB)J=CZ2[W(S -X]$/4!XUK<
MUK9(].X3VK:G"XIQ#8TDT@+C/'N.1@4["]8#;$J\QWQ?QT1OW[.QF)CK;#7%
MR]6S'1K;SK^U^E-,0FQFY5!S['W8!G6N&:WI #A1$^N^%JSLSRV*76%4!^O]
M2L*"Y>?0RXTOO!0>+0T :%+8"ZD,]Y<<OK9^CI6;>#8B3\S1A,4B<V\M=Z<,
MR]# ;8'31[R3''W8HEQK47WH]S[G2JJB1$QQ84$:19U4XRB2=<=+. U!8&XA
M>#E)LBG="]7-,:X@A#9+?!T;,TSP]KO8>BOD97KDWI>C+]@T-J9)%W<9JAW#
M[VYE9LW)S$P)>"L!IS)K#^%1$H#AFXCWXN@>^KCP.H9&-7GB8]JO@ZY_P!"Z
M%QJC*<9BW4OP%K[FN#+7G&OUF/N:^N14<6##K+2G'A!=[^Z4+()H02'X@D=Y
MRD=YBD=Y2D=91_-.[*@@C-24JZD-!9@9>(4,]?N>U3!$CQ_Y 8TA:=% %"64
M]]AIS51.<'@ANBSP^_/_9H%OHZ/<;X: CJX;"B8S%PC=8N9UN 'MAA!,W)V-
MM6KJX,?W,N %:7XO!M_:50A2FF A612'IJ!&-*&EBG44L>23BF<J.0-.0I&T
M1<,M7%APN7R[P'5($'ASPX56)@HU;<LMCCC=WO".:69N[0V]?*-;DPF4G#J1
M;CJ1W^-+'ZG5[@$OZIHJ78^%JV$POAURU$9$V2C7,$L#,N.#HCE\G0H\[)QF
M6(DSWXXF=[6 B)PH4_6,1K=/S4Z)-_C=JK^NZ :7',9@4!7:?]+)_59W<5G*
M"A//8VBE>7EQLGA/QF5HIGFYW$SS(_<F-N5>'YJZJGMIP#2-=]_05O.N>9*W
MI'!CG MQA")@E;N-,O'C#]( &&'<Y(+P%RVT4K9&W(8:1-5Y87.TT[P^F+8A
MP5!4K)34/40 WQ:!E8;/W+N;)KK%I%S$HQYY>.RX4N,OQ$Y9[V<?8,8>=]E$
MZ\OLHC2*H^O,]%[F2R:=KW/0<3E9?:+=%5ED7.@:1XJ(-1,LN)-B!2AVP_UC
M\>[@50"M+/3E]6=XY8Q^/3U_MDJN'?M</_K$ID?L!+K\X?R$+*/+Y^]LGTHX
M87Z7%"/]_+6GQ=84%W[6>;3/K HS5^6^#QMU^>;L5-^2M DSM#)#H';E!9JW
MPM3IJAW2;&Y>U#((:WSI<*&(_F59S@ZN52Z\NC3\S+8)903ZME\8MJ^VY=3J
M1_LF7=MC!KFM80EPYJRO^UNNA5OYKL 7WZ_D9"G$C#*MV(O"[*M:_]103Z2>
M=J>&+E>YY9I\W$EO=%PG^YPPA1%@II-*V[&1_BH42L?KZ9D)]#_3JD?K0UH<
MSZ1!ZIU'A-YJAD:H8S ,B H][H:6IBS\";PRZ=M<,!R:7NE16XP:NQ"QCXAP
M@W="9%/UM\#[D_\"?O!2X/*^,D?Q9'4O>OUQZ);U_MHY4@VOWT&B/P82-0^#
MGY<L'E(@#BG:BT>A+>-+BMJ""%46@_68URU40Y!IX(Z7-HIR_WMHBL+CM*)H
M4OL ,[T$B?MU2>W[I#G?:HA!8R),JXHRP@2U[Z2=&=(Y!)HICV/E9(CA0_7X
M/@C_(XL3JDL5G"^X37)@?E5^#W$SH\9$K19#^+95?<D((<JEX<BD+I:R<AC1
MIW6=QZ1:O4Z[],7/>P=VRA6H[=3&H0*]!!L.^:=8KH!]VWYZ>?GP,7P97G_Q
M\R'=NM_ S,%J\M)MX-/SLV??/^3*0?VCJP\X)/8*[>H]_7/G4M"-\07X?5.#
M6B9_X 2W=?.%EO?B_P%02P,$%     @ 1CIK6A@Y.7%F P  (P@  !D   !X
M;"]W;W)K<VAE971S+W-H965T,S,N>&ULG59M:QLY$/[N7S'L'4<")FNOW]J<
M;7#2E!92"'%[1SGN@ZR=]8IJI:U&&Z?_OB.M[?K:K2D'QM;+S/,\HYF1/-]9
M]XE*1 _/E3:T2$KOZ^LT)5EB)>C*UFAXI["N$IZG;IM2[5#DT:G2:3883--*
M*),LYW'MP2WGMO%:&7QP0$U5"??E!K7=+9)A<EAX5-O2AX5T.:_%%M?H/]0/
MCF?I$257%1I2UH##8I&LAM<WDV ?#?Y2N*.3,81(-M9^"I.W^2(9!$&H4?J
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MU\'5C-/JVB>IG7A;QV=@8ST_*G%8\BN.+ACP?F&M/TP"P?%_P?(K4$L#!!0
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MJ&P W2^E-(>#+5#_'8S^ 5!+ P04    " !&.FM:Z\+Z"#D$  !.#   &0
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M('*$4&!N'0*CX1DO4 @'1#2>UIA!=Z0+W)YOT*^]=M(R9P8OE/C-"UM.@E$
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M%!H='@\#T&V;:@VK:M\:YLI2H_'3DCH[:N= ^PNE[,9P!W3_BND_4$L#!!0
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M,UQBIPM"'\#].>=J.]$.=KWS^%]02P,$%     @ 1CIK6G%<ON"Z!0   0\
M !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULO5?;;MLX$'W75Q#N91-
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M!=;,:+H%P[ /M'2RN$BD1E)QVE_?(R7+3NL8&; OEHZZE^>.]YQOOA7R014
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M&3#""&63P0[7&DN&-:59QDQ]:=D64-FZBZK"DB,?TP?4IQJG35-FI*"/0-8
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M'XZQ$66[>;6"%K7==M9"X^YD7PM<5D$:!?R>"QS$G6 "].OO\AM02P,$%
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M6QFBE10W)7DB8O%'M?;SUPN19\O8H%IZP+;Y\([Z/VR"T:7(SRZKE!@A/)B
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MI@B*XYFL()ZO">&'"]E ^^%F\1]02P,$%     @ 1CIK6H=P(C*V @  @0@
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MN!A+'$TXVR&N6RN:/C'N&[7RBU ]4>XE5_\2I9/1+$W9ADI"5TC-.B1S0#?
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M@.L&ZO\E8_+Y0@=H-N>B_P%02P,$%     @ 1CIK6G ]N_P: @  "04  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULK511;YLP$/XKEC=-K;3&!-)T
MR@ I332M#Y.BINV>';@$JP8S^Q+:?S_;$$:EI.K#7L#GN^_S?7<^QXW2SZ8
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MG:?+RPV0&+@.4,_7C,GG@3Y4-W^BA/\#4$L#!!0    ( $8Z:UH&;*.RNP(
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MFV+'RO;(TBZTJ.VNOQ$:SQ#VLL!3'DAC@,^W0NCGA3E(N'/CXA]02P,$%
M  @ 1CIK6N"WPF!1 P  O@H  !D   !X;"]W;W)K<VAE971S+W-H965T-C(N
M>&ULM5;O;]HP$/U7K&R:6HDVD$"@'42B::M-VH^JK-N':1],.,"J8V>V4[K_
M?F<GS: $U$WL"\3)O9?W[LX7#U=2W>LE@"&/&1=ZY"V-R<]]7Z=+R*@^E3D(
M?#*7*J,&EVKAZUP!G3E0QOV@W8[\C#+AQ4-W[T;%0UD8S@3<***++*/JUP5P
MN1IY'>_IQBU;+(V]X<?#G"Y@ N8NOU&X\FN6&<M :"8%43 ?>>/.>7)FXUW
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M*)JJQ\8L,?4V!"*@0VT3*,V&TAPHS872/"B-UK1V=]\RM0&]<4G,GUK'<6I
MO^=I455>DSONR_2%*,EMRI<\3;E/[D6R^*:/Z5#S!4JSH30'2G.A- ]*HRB:
MJNC&H3%?<06(";5IH#0;2G.@-!=*\Z TBJ*I>UHT3HZE=W*J2C#(LES6B'Z>
M%DN^-]6DB&J7$K+)T\6Z6 .>+ G+,BXR6;,>W,'D1I]?7XW6M'9G<3(Q9]/9
M;,?I@6;K0&DNE.9!:11%4^77.#V6WNGYRD*Q9I&,Y%G&<MG3ENK2160]KK>Z
MH 8/E.9 :2Z4YD%I%$53)=BX0);Y>A'9@MHX4)H-I3E0F@NE>5 :1=%4/;:V
MF=*O*?FT7,I>#RFSJ'9?\67 U6RK=5,#VT&RG.BAALBY/M_>ZL)N'(7=.>JD
M"^)!,Z4HFBJ;QFVQ]&[+!R[;9OP-2=2=>][4&_C$B2#/7)!%,4,L7G#_#4EY
MS)]82 1/HTY9Z3,\.S@G=:Y/V5MI4*,%2G-_^AIYT')0%$T57V.\6'KCY3Y_
MJ&3&5JN4KYC@Y2:DA<1$:V9UI\KV]UPRNB:+S/5%Z"TJJ"4"I;FG7A(/FBU%
MT50--6Z'=?(RCR!>I*6<@EC^#T0QGY7%<2X?&EG)>HYDWW/9#R7+)!%O.\75
MN79C9.U*"^IN0&D.E.9":1Z41E$T57^-NV'IW8WK2F!WA;9VM[^[WE9KUTL9
M+LG[6J"=FML?#C<,H[-&@]H74)H#I;E0F@>E411-E5UC<5AZB^.>+_*TV(W*
MYYLD"SKW5=0C>O<RH3Z$M;^D9-*UTPHT5Q=*\Z TBJ*I@FH<!DN_!F2W[GHJ
MMWR7G4CV*#]8%=&SV >_.>!@^Q_J-D!I]I%K,#V\-P:T'"Z4YD%I%$53MREN
MG(6QWEDXJD,_R!9)+J-M>F@'8ZB5 *79-:W85:G=LISN[@$$S=6%TCPHC:)H
MJMP:)V&L=Q+<7.2R*Q#5<_@JS;W,2/%S3O+8ERTWL0ZR<@WYH>:;/IO>HH,Z
M#./]A16='4,'FJT+I7E0&D715-4UYL%8OX3DY_;)UD-[:PSJ&M2T]MCIGKJ@
M5@"4YD%I%$53U=58 6.]%:!S1\G?LJN:B318%#%USK)U95\53XH)48\L+&\$
M\]\D)O-*BEIG55^4WIJ$>@U0F@.EN5":!Z51%$V5;^M.%>/7<U;'R/'Q.91F
M0VD.E.9":1Z41E$T58^-2S$^LCRDM,AD?S=F4I)!M$F3QVI6*0O#Y*G8>;Y3
MB="5'5":/=ZW"L:=#4*H00&E>5 :1=$JC0U;=V.+>+HJ[\R7D;+?6MU5;/ON
M]NY_U^4][W;>MXUW;G4/OP93W5+P(TM709S)!N12(D=OI_($TNHN?=4+D6S*
M>[X])$(D4?ETS9GLS!0'R,\+]^/E19'!]EZ)5_\'4$L#!!0    ( $8Z:UK<
M"3C96A\  $!$ @ 9    >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;-7=:V_;
M5H+&\:]"> >+&2 3ZVK)W31 &M[O9-*9%X-]0<NT150278JR8Z ??DF9-G4D
M^LAJ_YG.ONB,8HN_0UG.$^KP/.2'A[SX93U/TU+YMERLUC^>S<OR[H?S\_5L
MGBZ3]?O\+EU5W[G)BV525G\L;L_7=T6:7&\W6B[.![W>Q?DRR59G'S]LOQ86
M'S_DFW*1K=*P4-:;Y3(I'G]*%_G#CV?]L^<OQ-GMO*R_</[QPUURFWY)RY_O
MPJ+ZT_F+<ITMT]4ZRU=*D=[\>/:I_T/<[XWJ+;9/^4>6/JQW'BOU:[G*\U_J
M/UC7/Y[UZEU*%^FLK(VD^K_[]'.Z6-14M2._-NK9RZ#UAKN/GW5]^^JK5W.5
MK-//^>*?V74Y__%L>J9<IS?)9E'&^8.9-J]H7'NS?+'>_J_RT#RW=Z;,-NLR
M7S8;5WNPS%9/_Y]\:WX2.QN,1Z]L,&@V&.QMT']M@V&SP7!O@U=W:=1L,'KK
M".-F@_%;1[AH-KAXZPB39H/)6T>8-AM,]T<8OK+!9;/!Y5MWJ=][?N=Z^YM<
MO+;)RYN]_VZ_OLGSV]U_\_O=?W[#^_OO^.N;/+_E_3>_Y_WG-[V__ZZ_OLGS
MV]Y_\_O>?W[C^_OO_.N;/+_U_>U[?_[T5W'[]UA-RN3CAR)_4(KZ^957/]B&
MP7;[ZJ]OMJJ#ZTM95-_-JNW*CVIZ52I_5SY=7V=UCB0+Q5H]Q6&=*G]5TS+)
M%G^KGO'S%U7YZU_^IOQ%.5?6\Z1(UTJV4GY>9>7Z7?7%ZO'7>;Y9)ZOK]8?S
MLMJSVC^?-7OA/.W%X)6]Z"M>OBKG:T5;7:?7'=N[1[8?2(#SZD?R\G,9//]<
M?AI(17NS>*_T+]\I@]Y@U+%#G^6;^_G]>Z4WV&X^[-A<?<OHKV^NR3=7T]E[
M93#<;C[HV%Q_R^;]5S<WY)M_VMQ6KWW\ZN;FL=>^>J\,>Z]N;LDW]Y+':LM7
MM[;?\-+[3R^]U_5[_(;-AZ]O[KY]\ZY?.N_MFW?]UOAOW[SK1Q<<^\$7U6_-
MQ:L['[YE\]=?>W3DE^ZN';WKM<?RS8-96?W.3KM>NQ ?PY=8'6Z]H2Q6K=6Z
M+#;545ZI_,NMGJ!89;I<_V_'WOWTI(VZM?K@]8?U73)+?SRKCD[7:7&?GGW\
M[__J7_3^IRN:2$PE,8W$=!(S2,PD,8O$;!)S2,PE,8_$?!(+2"PDL8C$8@@3
MLG?TDKTCF?XQ+/)9FEZOE9LB7RJ+?'6KE&E1/:HC.+]19D5:'>QVI;#4/36%
M24PE,8W$=!(S2,PD,8O$;!)S2,Q]PB9;K)[SNO\XZ?6J(]G[W70]?-)XO/\D
MG]RM@,1"$HM(+(8P(37'+ZDYEJ:F*Z2C<I/,LD56/BKYIER7U:?ZK(K1V:8H
MJJ/9KNB4XJ=&)XFI)*:1F$YB!HF9)&:1F$UB#HFY3]C%3BH.>Y>3O>@\?-)T
M,MU+3G*O A(+22PBL1C"A.2\>$G.BQ..-V?YZCXMRNQJD2K7Z55G6$J]4\.2
MQ%02TRX.CA/Z%Y/] P6='-(X'')\</QBDB-:AR-.A_LCVN2(#HFY).:1F'_X
M@ZU^KOL_V8 <,B2QB,1B"!/R;?*2;Q-IOEFKZN-SNBZ5]-M=NEJG:R5?O2GF
MI.RI,4=B*HEI)*:3F$%B)HE9)&:3F$-B+HEYDX-CQ_[AQVYRQ(#$0A*+2"R&
M,"%<IR_A.I6&Z^>]''U7??+."N4^66RJ+V3KV2)?;ZIAN_)5*I^:KR2FDIA&
M8CJ)&21FDIA%8C:).23FDI@W/?P /[TX"%ARR(#$0A*+2"R&,"%@+U\"]E(:
ML$$Y3PLE6\WR9:K\M3F$_5M7G$J=4^.4Q%02TTA,)S&#Q$P2LTC,)C&'Q-S+
M@P0<]0?CO2G,R\-9G>V2&R$ER=T*2"PDL8C$8@@34K+?>XG)>D6O)">W*Y:R
M=L52\P$_O:Z^6.9*^NNF/ANTVBROJCC-;U[6@*[7F\X5FS_)QSLU3U%-134-
MU714,U#-1#4+U6Q4<U#-136OT829@-%P..KO'ZNBPP:H%J):A&HQI8E1O+,D
MOR^-8B/)5NT<Z[8B5 5N=1RK[,X6^'G9/2T@UT\.7E)344U#-1W5#%0S4<U"
M-1O5'%1S&TV<-+T\6-&$#NJC6H!J(:I%J!93FAB[@S9V!_*IV'FRNDWK)E,[
M!=N9KU+FY'PE-175-%334<U -1/5+%2S4<U!-1?5/%3S42U M1#5(E2+*4V,
MX;8YU6>K4WVT.X5J*JIIJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C6H!J(:I%J!93
MFAC';9FJOM3 *:N_.C-8:IR<P:2FHIJ&:CJJ&:AFHIJ%:C:J.:CFHIK7:+NG
MVT8':ZA]=,P U4)4BU MIC0Q6]O*55_>N7K[V@0Y='+ H@4K5--034<U ]5,
M5+-0S48U!]5<5//ZAY6LCF6UZ)@!JH6H%J%:3&EBP+;-K+Z\FO7U(7^Y+)7R
MJ?KOZT.Z*A^;A]W?^SHOTE3Y6E\QX)/BYLE*^9>7UJL>NF<?T"X7JJFHIJ&:
MCFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:3&EB@+?5L_Z$G0Q&.V>HIJ*:
MAFHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):A&HQI8EQW);5^O*VVMLF@]%>
M&JJIJ*:AFHYJ!JJ9J&:AFHUJ#JJYC2:T)?J'R\\.G]4Q!8$VSU M1+4(U6)*
M$R.SK9_UY?VS_5Y%>G.3;J_5KQ1)N;WB5O8<JG=I,:N>DMQV+SM#^VFHIJ*:
MAFHZJAFH9J*:A6HVJCFHYC9:O4[_)3%[[WN7X_VR6O<3^[W18#]=T<8:JH6H
M%J%:3&GB1?K;UMI WEK;+41LD_;3;9&F3U,%DEE;N7IJEJ*:BFH:JNFH9J":
MB6H6JMFHYJ":BVH>JOFH%J!:B&H1JL64)J9R6V ;]-%9VP':6$,U%=4T5--1
MS4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(LI38SC01O'\F+;_A3$3374Z_4V
M.79R&*/U-E334$U'-0/53%2S&NW(I5EM=% 'U5Q4\U#-1[4 U4)4BU MIC0Q
M9=O>VD!:Q#BXDF,[K[N=Z)5/[LKMDT,7+;&AFH9J.JH9J&:BFM5H_8$XY3G>
M#UVTG89J+JIYJ.:C6H!J(:I%J!93FABZ;3NM>GC2@H2W7IM<[IX<N*2FHIJ&
M:CJJ&:AFHIJ%:C:J.:CF-MK>\?S>F;2.)W7T)- ="U M1+4(U6)*$V.T+:(-
MY$6T[HL_;J\\=E=DLZ-'KV@[#=545--034<U ]5,5+,:;>_H]7+_X!5MG:&:
MBVH>JOFH%J!:B&H1JL64)J9NVTX;R-MI^"5WY>.=G,-H&0W5-%334<U -1/5
M+%2S4<U!-;?1CEXDUT.']5$M0+40U2)4BRE-C.*V9S:0W^/L#>O(E-^4+VF1
M50'\DQ*GU]5WD_K9NUN&17J3%D45X%_*?/:+? D:VE1#-175-%334<U -1/5
M+%2S4<U!-1?5/%3S42U M1#5(E2+*4T,]+:I-IBR2]#0TAJJJ:BFH9J.:@:J
MF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5I,:6(<MRVXP6DMN*X)YJ?YC<YP1JMO
MJ*:BFH9J.JH9J&:BFM5HT]U/^^][EY/^_@PS6FI#-1?5/%3S42U M1#5(E2+
M*4V(W6%;CQO^X7J<\IOR>5,4]9?<++G*%EE9SW'(IB[D@YX:QZBFHIJ&:CJJ
M&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&EB:'=MN>&;'MNB+;G4$U%-0W5
M=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C58DH3XWC0QO&1V\+MK29^MW-[
M..4Z6\\6^7I3=%\*34Z?',UHEP[5-%334<U -1/5+%2S4<U!-1?5O&%'!W%Z
M<; >&1TT0+40U2)4BRE-S-RV2S>4=^FVEUVOK\G^)9UMBGH57#MQ\<^LG"M?
MLD4VRU?*/Y+%(GU4?DI6\M46\O%.#F*T7X=J&JKIJ&:@FHEJ%JK9J.:@FHMJ
M'JKYJ!:@6HAJ$:K%E";F=5O#JQZB4Q8C-(Y)344U#=5T5#-0S40U"]5L5'-0
MS44U#]5\5 M0+42U"-5B2A/CN*WS#>5UOL^+9+VN&R,/25$DJ[)Z7"A%=CNO
M'NW429Z.K>NS?;/\/JV7+5\]=FS2&>!HXP_55%334$U'-0/53%2S4,T>'MZE
M;7(YG8J?]AUT3!?5/%3S42U M1#5(E2+*4T,YK;Q-Y0W_F3!G'Y+BUFV3M^R
M($X^S,GQBQ;]4$U#-1W5#%0S4<U"-;O1+G?B]^+]=+(?OVB!#]4\5/-1+4"U
M$-4B5(LI38S?MN4W/-+RD\1OF1;+SJA%>WJHIJ*:AFHZJAFH9J*:A6KVD5_A
M?D]Y3).BZT.9@^Z(BVH>JOFH%J!:B&H1JL64)N9O6\H;RF\?]X=.ZRF_*5^K
MT)[-T^VMF[ULD:[+?)7*S_NAM3Y44U%-0S4=U0Q4,U'-0C4;U1Q4<U'-0S4?
MU0)4"U$M0K68TL1 ;VM]PTOVO!]:Y$,U%=4T5--1S4 U$]4L5+-1S4$U%]4\
M5/-1+4"U$-4B5(LI38CC45OW&\GK?GJ[,'EWDN/U"\;)O5/S&-545--034<U
M ]5,5+-0S6XT8=7NWD5 '71$%]4\5/-1+4"U$-4B5(LI34S9MI\WDA9._O@L
MQD.N?)WGFW52&;7S]:':]%'YFA9+Y9/RQ%_?)ZN9?&Y#OILGAS?:^T,U#=5T
M5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B2A-C?M#&_ "=VQBA73]44U%-
M0S4=U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"U$M0K68TL0X;BN!HR.5P#I]\QME
M5J376:DLDV_9<K-4KO*BHK+5K3)+JM&KH_'.;$;K?ZBFHIJ&:CJJ&:AFHIJ%
M:G:C[2Y7'HP/[I#JH(.ZJ.:AFH]J :J%J!:A6DQI8NBVO;[JH2QTPR*?I>GU
M6KDI\J6RR*N8K=?)*0LAC#L35PJ?G+BDIJ*:AFHZJAFH9J*:A6IVH^TF;E?@
MDF.ZJ.:AFH]J :J%J!:A6DQI8N"VS;V1O+FW=Y1;I,LD6]5'MV\\SD5K>:BF
MHIJ&:CJJ&:AFHIJ%:C:J.8VV>W9PT#L(<1<=U$,U']4"5 M1+4*UF-+$V&U[
M>2-Y+V\O=F^J@%W4)_:NDW+[]9NL6-=I_.LFJVO2=\EC/27<F<!H,P_55%33
M4$U'-0/53%2S4,U&->?(7Q-[LWBO*+W^.T49] :#SF-BM+6':CZJ!:@6HEJ$
M:C&EB>'<MO9&\LK3:^&<?KO+BJ2L[R%2YW1G&J/E/51344U#-1W5#%0S4<U"
M-1O5G"-_+]1TMI/&P\XT1CM\J.:C6H!J(:I%J!93FIC&;8=O=*3#]TH:S_+E
M,BNW*R5NTE1)EOGFE2-DM)*':BJJ::BFHYJ!:B:J6:AF-]KNK$+_<&(8;=JA
MFH=J/JH%J!:B6H1J,:6)L=LV[4;R&^B],7;OTF)6/4YNNP^'T?H=JJFHIJ&:
MCFH&JIFH9J&:W6C]P4[V]M[W!OOAB_;J4,U#-1_5 E0+42U"M9C2A/ =M[VZ
ML;Q7Y[XL?*AO *)<)8M%7M^Y]&D:^$CHRNU30Q?55%334$U'-0/53%2S4,U&
M-:?1CD2XBP[JH9J/:@&JA:@6H5I,:6+HMC6[\:DUN^I!7E?FJM"]W@;OG].[
MD^_WR8&.]NY034,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*UF-+$W!^T
MN<_V[L9H[P[55%334$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"VF-#&.
MV][=^-BM^(2YC_NDR)+Z5JC9JOIB6J^*J]?('9D"0>MWJ*:BFH9J.JH9J&:B
MFH5J-JHYC=;OB5,@P\%X?Q($+>"AFH]J :J%J!:A6DQI8OJV!;SJX7=:^R:7
M3PY=4E-134,U'=4,5#./_+9L5X0-FP5AH\Z<)7?'1C4'U5Q4\U#-1[4 U4)4
MBU MIC0QC-MRWOA(.>\/G09$JWFHIJ*:AFHZJAFH9C;:_LFQD7A<:*&#VJCF
MH)J+:AZJ^:@6H%J(:A&JQ90FAFY;S1O_OFK>3=W&2U>SQ_J;301WWJI4[I\<
MO&@C#]4T5--1S4 U\\COS&"D5+\<R4)9YJMROGA\^?W8_JX4V6J6W57?O5ML
MUB_S6.^4A_H<<J(LZO/ RZ1\.N?<-$ [CZ71(A^J.:CFHIJ':CZJ!:@6HEJ$
M:C&EB;'>EOK&1TI]!ZL[OLZSXM^[N*/:+*[^YA?9K$ROE<_)>J[XU0B?-T6Q
M/?$H6P."%@M1344U#=5T5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B2A/_
M=6A+AN,INP8$[12BFHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%
ME";&<5L^',O+A]LXSMHXGN6+1?6YN*@^0]]F]^FJ,Y+1KB&JJ:BFH9J.:@:J
MF:AFH9J-:@ZJN:CFH9J/:@&JA:@6H5K<:+N7%1 N."M$[45;-;PX5C7<GQ?1
M\TU1SO_TUHM\OT_-<U1344U#-1W5#%0S4<U"-1O5'%1S4<U#-1_5 E0+42U"
MM9C2Q-QOVXX7?73&XP(M(:*:BFH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:
MB&H1JL64)L;QH(UC::OFCZR[/B*+U]"==*8QVD%$-0W5]",_*_$*EUT+F@UT
M?TQ4LU#-1C4'U5Q4\U#-1[4 U4)4BU MIC0Q@=O>X86\=[@_YURONU[OK/7K
MC%XY^7N6A;WO#&BT@8AJ&JKI1WZB_>F_8:&=@;XD$]4L5+-1S4$U%]4\5/-1
M+4"U$-4B5(LI3<SXMMU8/3QQLCN[^4^8ZY;N]LF3*Z2FHIJ&:CJJ&:AFHIJ%
M:C:J.:CFHIJ':CZJ!:@6HEJ$:C&EB;'?]B@OQNQ<-UJ=1#45U314TU'-0#43
MU2Q4LU'-0347U3Q4\U$M0+40U2)4BRE-C..V87DA;\N%+[WU[8QWOEKGBZS^
M.'ZMS.I.3)DK5ZE2WXBVK/ZKOKK]_%[.4V51'::G16=DHZ5+5%-134,U'=4,
M5#-1S4(U&]4<5'-1S4,U']4"5 M1+6JTO6LU[%W"*Z;&%*.X;45>R%N1/Z^*
MMI!83V)L5NEJMJDG*I[3N+W*R$$P=P8Q6E1$-175-%334<U -1/5+%2S4<U!
M-1?5/%3S42U M1#5HD83@KB_'\/?HWYXT=8/+^3W.!2/B/--N2ZK,,Y6MT\7
M?CIV0*Q</2H/R?;")'5D=\8R6EA$-175-%334<U -1/5+%2S4<U!-1?5/%3S
M42U M1#5HD838_G]03!_CR+B15M$O) 7$;]DWW[OZ<'.%$8[BJBFHIJ&:CJJ
M&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEJ$:C&E"6D]:;N,DQYZGF^"5@Q1344U
M#=5T5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B2A/CN*T83N0W5/R\2-;;
MA;D/25$DVT6ZA5)DM_/JT6H[QUQ_<_VT%"]+U\HLO]_..V^G,_8WZ0QPM)2(
M:FJC7>Q^O.GUQQ?B!QP-'51'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+4"VF
M-#&9!VTRRWMNLF1.OZ7%+%NG=9UBMKW1EK*>)T5G]5 ^S,GYB]80&VV\D[^3
M_=.O&CJDCFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:3&EB^K9-PXF\Q"9+
MW[IUV)FTZ!T-44T]\G+[/>4Q38JN W@-W1$=U0Q4,U'-0C4;U1Q4<U'-0S4?
MU0)4"U$M0K68TL3\;5N U</O=%*O[OQ5D3V;I]ONGY<MTG69K^3M/OGNG)S=
MI*:BFH9J.JH9J&:BFH5J-JHYJ.:BFH=J/JH%J!:B6H1J,:6)<=ZV^R9LNV^"
MMOM0344U#=5T5#-0S40U"]5L5'-0S44U#]5\5 M0+42U"-5B2A/CN&WW3>3M
MOG_#63^TZX=J:J/MGO4;]R;3_6EGM,.':@:JF:AFH9J-:@ZJN:CFH9J/:@&J
MA:@6H5I,:6(PMUV_B;SK]P>G/:!+'<EW\N3P1ON!J*:AFHYJ!JJ9J&:AFHUJ
M#JJYJ.:AFH]J :J%J!:A6DQI8LBW3<()>R/#"=H+1#45U314TU'-0#43U2Q4
MLU'-0347U3Q4\U$M0+40U2)4BRE-C..V/SB1]P>WZ=MQ6?_DMCKXOJVO0)PL
M\\VJOO#T;+'9-KZOJN/OO#H.+]+FVL;U-8Z3JT7W CRT4(AJZJ3CAF7CG1N6
M-;&,%@51S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(LI38CE:5L4G!ZYZ>$K
ML;Q[Y8W9IBA>N>R_7#\U=5%-;31Q OH@==$Q=50S4,U$-0O5;%1S4,U%-0_5
M?%0+4"U$M0C58DH34[?M T[E?4 WKV*U7N#\=%6CYP-=R?U5Y.#)08OV^QIM
M]_!V<)BS:+L/U0Q4,U'-0C4;U1Q4<U'-0S4?U0)4"U$M0K68TL2<';0Y*V_W
M?:<3??-*.?ETGWQ73TYPM"&(:AJJZ:AFH)J):A:JV:CFH)J+:AZJ^:@6H%J(
M:A&JQ90F1GU;)9P.T=-]4[1&B&HJJFFHIJ.:@6HFJEFH9J.:@VHNJGFHYJ-:
M@&HAJD6H%E.:&,=ML[!Z>,(,QWU29/69NY=;D2I%?<JOO:)^9T1+AS@YHDE-
M;;2]>QKT]I<WHX/JJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@6HAJ$:K%E"9F;UL#
MG$I[+;_K_MUR\N2L1:N 1U[NUWG[S\K?\U5]*^RTR/)KY2&IK^%4UC<&N%;*
M>9%O;N>*O:D^%@Q[[Y1!;S!2;O+%(G]XJMP,+YA[E&OHJ]=1S4 U$]4L5+-1
MS4$U%]4\5/-1+4"U$-4B5(LI30S]MFPXE9<-]T/_\(A[78V;=-ZI2DZ?'/YH
MC;#1^CWQ0+LWV+^ '3JLCFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:3&EB
MZK9-PNF?TB0\>H*QVOBG]"8OJF?-LZ+:1,^**N*#&\5+BMG\55G/-X7\+"5:
M2D0U%=4T5--1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(LI3?SWHBTE3ME2
MXA0M):*:BFH:JNFH9J":B6H6JMFHYJ":BVH>JOFH%J!:B&H1JL64)L9Q6TJ<
M_LY2XE,5L9PGI;),'NM[SE:'\66VNJU">U'].2^*>MJX,[+1(B*JJ=/#(N*D
MHQ*#%A%1S4 U$]4L5+-1S4$U%]4\5/-1+4"U$-4B5(LI38CBR[:(>"DO(OZ_
MFTG)[N7KO>6O]]1_!U!-134-U714,U#-1#4+U6Q4<U#-134/U7Q4"U M1+4(
MU6)*$_^]:"N4EWUT)N42+5"BFHIJ&JKIJ&:@FHEJ%JK9J.:@FHMJ'JKYJ!:@
M6HAJ$:K%E";&\:"-8WG3\GO,I,B'/#FRT<9DH^U>7&1R>$DG=$P=U0Q4,U'-
M0C4;U1Q4<U'-0S4?U0)4"U$M0K68TL0H;IN0E_*[#/[Y,RDO4RCVIHKXWS^#
M@E8T44U%-0W5=%0S4,U$-0O5;%1S4,U%-0_5?%0+4"U$M0C58DH3_YUH*YK5
M0W0&983&,:FIJ*:AFHYJ!JJ9J&:AFHUJ#JJYJ.:AFH]J :J%J!:A6DQI8ARW
MK<U+>8WQN\R@H*U.5%,;3;@H]N%:%'1,'=4,5#-1S4(U&]4<5'-1S4,U']4"
M5 M1+4*UF-+$*&Z[E)?R+N67]+[*UMTYE*_U%$;:S'N\S*?\9U=YY"_RY/!'
M6YVHIJ&:CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:3&GB/Q)M]?-RPDZ?
MH,U*5%-134,U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1+4*UF-+$.&Z;E9?2
MJM!'O:*5^V2QV4ZB7.]? NMWS9Z@Y<M&DW=O5'1,#=5T5#-0S40U"]5L5'-0
MS44U#]5\5 M0+42U"-5B2A.3N"U57LI+E=JZS)9)F5[OW-OQKLAG:7J]5FZ*
MO+DD;#V=D?ZZR<K'SNQ%6Y2-MK]:[R!\R4$U5--1S4 U$]4L5+-1S4$U%]4\
M5/-1+4"U$-4B5(LI30C??J_M4=:/_UC\OIZZ1^Q38_>9VSWF'1XNDU;98366
MTUG.8#F3Y2R6LUG.83F7Y3R6\UDN8+F0Y2*6BS%N+X;[.S$LO\6CEMW.A5.(
M9:Z4W^D48G>4HX5'EE-93F,YG>4,EC-9SF(YF^4<EG-9SF,YG^4"E@M9+F*Y
M&./V$G^PD_@#](3@LX<E-%IP9#F-Y726,UC.9#F+Y6R6<UC.93F/Y7R6"U@N
M9+F(Y6*,VTOHX4Y"RYN1VT#N6F+],E'2++;.5K/%YCI;W;[<FKU(F[O!U'>%
MJ>^KT)WH:&.1Y526TUA.9SF#Y4R6LUC.9CF'Y5R6\UC.9[F Y<)G3KYJ(&)'
MC3%N+ZE'.TD]DB9UG,[2[+Z>PVZF.B2W+CMBG9ZZ)*>RG,9R.LL9+&>RG,5R
M-LLY+.>RG,=R/LL%SYP\)D-VU(CE8HQ[2MWS]3Q-2S4IDX\?EFEQFWY.%XNU
M,JL/<'\\JZ<U7KY:'=W>U*'\PZ?!V?G!U]W^#WZ__OIYRWS\<)?<IEY2W&:K
MM;)(;RJR]WXR/E.*>M[[^0]E?E?E_IERE9=EOMP^G*?)=5K43ZB^?Y/GY?,?
MZ@$>\N*7[6Y__#]02P,$%     @ 1CIK6EA"/QX# P  )P@  !D   !X;"]W
M;W)K<VAE971S+W-H965T-C<N>&ULK59=3]LP%/TK5H8F)@%)\]7"VDBEU30D
MD"I:V /BP4UN6PO'SFRGA?WZV4[( @T5#WMI_''/\;GG^J/#'1=/<@.@T'-.
MF1PY&Z6*"]>5Z09R+,]X 4S/K+C(L=)=L79E(0!G%I13U_>\V,TQ84XRM&,S
MD0QYJ2AA,!-(EGF.Q<LE4+X;.3WG=>"6K#?*#+C)L,!KF(.Z*V9"]]R&)2,Y
M,$DX0P)6(V?<NYCT3;P-N">PDZTV,IDL.7\RG:MLY'A&$%!(E6' ^K.%"5!J
MB+2,WS6GTRQI@.WV*_L/F[O.98DE3#C]13*U&3D#!V6PPB55MWSW$^I\(L.7
M<BKM+]K5L9Z#TE(JGM=@K2 GK/KBY]J'%J 7?@#P:X#_64!0 P*;:*7,IC7%
M"B=#P7=(F&C-9AK6&XO6V1!FJCA70L\2C5/)%)8*G:)Y543$5^B:L_6I I$C
M.W>)*68IH.,I*$SH-QU\#TR5 JKYQ8ZCQ8:7$K-,=_34"QK;9FM\_&]NL1$
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M*U9639VT-K&! !U$*G33*JT:*NWV4.W!)!>P&L>I;:"5]N-G)R&P%J()A?%
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MY"05"@++?QMR2_)<(<DZ_FE G79,E;A__(K^J6Y>-C/'G-S2_*]L(583)W'
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M>U4)*7I_!,S%AR+9K=J[T0;( " ?47U-0&.4X*.PRGX;D!]:D)J2@[/DH/M
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M H] NP5X?ZZ4?3QQ!LIO,)/_ 5!+ P04    " !&.FM:U4E-G>0"  #T!P
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MIGBO@S0!.+\40F\[9H'FGT+T%U!+ P04    " !&.FM:XC[V8K,#  #L"P
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M OA^*81^NRD_T/Y[8/XO4$L#!!0    ( $8Z:UI"(AOW80,  $@+   9
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M4]9M6SW18F,[GWNAL8^RPQQ;79#& +^OA-#[B=F@;9[G?P!02P,$%     @
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M90-P?R&Q%+J)/:#_EZ5_ 5!+ P04    " !&.FM:U*ZA,3@%  #3$P  &0
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M[8RHD*NR5RX'1N:N&5Q+0ZVENTV04;FS!O1^(Z5Y'MC^LO[#8O8O4$L#!!0
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M78YN1M.K"4M^32:+! !Z"*#7&2 [F7, Z2.0_B=")@O[<3N96L#93S:;3^X
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M9R<0$S.-3VP:E^7O^\L7.&>-628@M@S,I0_"8:8)J$US)*E^!868F&D"8M/
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MC#V>\BR=:^8^7$D#+PC=MMIUE657]MBLN%%\M?^/N_U_"U[\"U!+ P04
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M.ZD>+^?6V^6ORZ^=DWO\BG.XKQB>_P)02P,$%     @ 1CIK6H/1K $N @
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M4$L! A0#%     @ 1CIK6@=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !&.FM:(L =7NT    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" !&.FM:F5R<(Q &  "<)P  $P              @ '+ 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( $8Z:UI3&X__X @  "PU   8
M      " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" !&.FM:8$ZA%=T&  !^(0  &               @($B$0  >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 1CIK6D?NTY8%!   1A0  !@
M             ("!-1@  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    ( $8Z:UH4QOP3R 0  !P1   8              " @7 <  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !&.FM:.>B.NN0"  #8
M!P  &               @(%N(0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ 1CIK6JF+(8_N"   \TT  !@              ("!B"0
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( $8Z:UI:9[9/
M^P<  % C   8              " @:PM  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    " !&.FM:,(/FQDH"  "D!0  &
M@('=-0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ 1CIK
M6E1%U=AA @  P@<  !@              ("!73@  'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    ( $8Z:UJV3,%3F0D  (,V   9
M      " @?0Z  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ 1CIK6GMDM821#0  X20  !D              ("!Q$0  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !&.FM:[ZTY]PLI  !;A@
M&0              @(&,4@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    ( $8Z:UH'($ES2 L  *(=   9              " @<Y[  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ 1CIK6HI)<O?I
M @  <P8  !D              ("!38<  'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    " !&.FM:CU._$@<*  "?'0  &0
M@(%MB@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( $8Z
M:UH!V)%HR0<  /84   9              " @:N4  !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ 1CIK6IU ^/,U P  ,0<  !D
M         ("!JYP  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    " !&.FM:0Z6?L?D"  "7!P  &0              @($7H   >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( $8Z:UHX!E!VY@(  +\&
M   9              " @4>C  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ 1CIK6JA.8BQ=$P  NCL  !D              ("!9*8
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !&.FM:P\][
M_MH.  !.+@  &0              @('XN0  >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    ( $8Z:UK2),1(.0,  $$(   9
M  " @0G)  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
M1CIK6B=]O\]= P  80@  !D              ("!><P  'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    " !&.FM:F&D=)ID,  "[)   &0
M            @($-T   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    ( $8Z:UJTQW%G10<  (03   9              " @=W<  !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 1CIK6MW=DA.M @
M5P8  !D              ("!6>0  'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    " !&.FM:LH=XQNX"  ";!@  &0              @($]
MYP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( $8Z:UK/
M4Y@:$ T  ((E   9              " @6+J  !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ 1CIK6B8_5!*P!@  *1,  !D
M     ("!J?<  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M" !&.FM:*%E6G[8&  "4#P  &0              @(&0_@  >&PO=V]R:W-H
M965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( $8Z:UI&ZE_Z30L  !,?   9
M              " @7T% 0!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L!
M A0#%     @ 1CIK6LAWC^<<+P  =*0  !D              ("! 1$! 'AL
M+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !&.FM:&#DY<68#
M   C"   &0              @(%40 $ >&PO=V]R:W-H965T<R]S:&5E=#,S
M+GAM;%!+ 0(4 Q0    ( $8Z:UHO3E^]W (  !H&   9              "
M@?%# 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ 1CIK
M6NO"^@@Y!   3@P  !D              ("!!$<! 'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    " !&.FM:.>S%,=("   W!@  &0
M        @(%T2P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   ( $8Z:UHH!N%+&0,   T(   9              " @7U. 0!X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ 1CIK6NQM"P?Q @  H@8
M !D              ("!S5$! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    " !&.FM:2XN:B5,$  "E"P  &0              @('U5 $
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( $8Z:UI9E N1
MQ0(  -\%   9              " @7]9 0!X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ 1CIK6N%4,G D P  R0<  !D
M ("!>UP! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " !&
M.FM:N)& #K $  !'"P  &0              @('67P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( $8Z:UIQ7+[@N@4   $/   9
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M970T-RYX;6Q02P$"% ,4    " !&.FM:(#OBU4<#  !)!P  &0
M    @($ >P$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (
M $8Z:UHA2N&G\0(  &,+   9              " @7Y^ 0!X;"]W;W)K<VAE
M971S+W-H965T-#DN>&UL4$L! A0#%     @ 1CIK6H]Z.MM4!   61D  !D
M             ("!IH$! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"
M% ,4    " !&.FM:?7:4J\,#  "H$P  &0              @($QA@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( $8Z:UIP/;O\&@(
M  D%   9              " @2N* 0!X;"]W;W)K<VAE971S+W-H965T-3(N
M>&UL4$L! A0#%     @ 1CIK6@OD02(M!0  I1\  !D              ("!
M?(P! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " !&.FM:
M6$: _] #  "9%P  &0              @('@D0$ >&PO=V]R:W-H965T<R]S
M:&5E=#4T+GAM;%!+ 0(4 Q0    ( $8Z:UJ;G#UDNP0  +<<   9
M      " @>>5 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%
M  @ 1CIK6F^]ZWK% P  9Q0  !D              ("!V9H! 'AL+W=O<FMS
M:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " !&.FM:&AV%7Y4#  !0$0
M&0              @('5G@$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+
M 0(4 Q0    ( $8Z:UH&;*.RNP(  "<'   9              " @:&B 0!X
M;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 1CIK6O-I>.#3
M @  $@@  !D              ("!DZ4! 'AL+W=O<FMS:&5E=',O<VAE970U
M.2YX;6Q02P$"% ,4    " !&.FM:>QY+,[<"  !Y!P  &0
M@(&=J $ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( $8Z
M:UI6)DD.: ,  $,*   9              " @8NK 0!X;"]W;W)K<VAE971S
M+W-H965T-C$N>&UL4$L! A0#%     @ 1CIK6N"WPF!1 P  O@H  !D
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M=#8V+GAM;%!+ 0(4 Q0    ( $8Z:UI80C\> P,  "<(   9
M  " @?CC 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @
M1CIK6GNM-X8Z P  A T  !D              ("!,N<! 'AL+W=O<FMS:&5E
M=',O<VAE970V."YX;6Q02P$"% ,4    " !&.FM:B$:F'MD$   ((@  &0
M            @(&CZ@$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4
M Q0    ( $8Z:UH=V]QA60(  ','   9              " @;/O 0!X;"]W
M;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ 1CIK6OR7E/8A!0
M0AH  !D              ("!0_(! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX
M;6Q02P$"% ,4    " !&.FM:^?WS(K,#   >#P  &0              @(&;
M]P$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( $8Z:UKU
M:PZP+P,  -4+   9              " @87[ 0!X;"]W;W)K<VAE971S+W-H
M965T-S,N>&UL4$L! A0#%     @ 1CIK6OA--6O$!@  >RP  !D
M     ("!Z_X! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $8Z:UJ\DVRMU0(  #4(   9              "
M@?P4 @!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ 1CIK
M6N(^]F*S P  [ L  !D              ("!"!@" 'AL+W=O<FMS:&5E=',O
M<VAE970X,"YX;6Q02P$"% ,4    " !&.FM:0.K"8'@$   J$   &0
M        @('R&P( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0
M   ( $8Z:UI"(AOW80,  $@+   9              " @:$@ @!X;"]W;W)K
M<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ 1CIK6NLPCAW9 P  \1(
M !D              ("!.20" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q0
M2P$"% ,4    " !&.FM:V6*,HZX"  #7!@  &0              @(%)* (
M>&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( $8Z:UK4KJ$Q
M. 4  -,3   9              " @2XK @!X;"]W;W)K<VAE971S+W-H965T
M.#4N>&UL4$L! A0#%     @ 1CIK6CB5)[I)!   O!   !D
M ("!G3 " 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4    " !&
M.FM:;^\_MD@#  #,%   #0              @ $=-0( >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( $8Z:UJ7BKL<P    !,"   +              "  9 X
M @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( $8Z:UKN7I<.6P8  +$X   /
M          "  7DY @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !&.FM:
M4C7&HXH"  "Y,@  &@              @ $!0 ( >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " !&.FM:@]&L 2X"  !$,0  $P
M        @ '#0@( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     7@!> ,D9
(   B10(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>198</ContextCount>
  <ElementCount>455</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>88</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100050 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100060 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance</Role>
      <ShortName>Cybersecurity Risk Management, Strategy, and Governance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Nature of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusiness</Role>
      <ShortName>Nature of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995485 - Disclosure - Accounting for the Merger</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMerger</Role>
      <ShortName>Accounting for the Merger</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995495 - Disclosure - Short-Term Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestments</Role>
      <ShortName>Short-Term Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995505 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995515 - Disclosure - Investment in Equity Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecurities</Role>
      <ShortName>Investment in Equity Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995525 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995535 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssets</Role>
      <ShortName>Prepaid Expenses, Other Current Assets and Other Noncurrent Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995545 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995555 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995565 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995575 - Disclosure - Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStock</Role>
      <ShortName>Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995585 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995595 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995605 - Disclosure - Agreements with Horizon</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizon</Role>
      <ShortName>Agreements with Horizon</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995615 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Defined Contribution Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DefinedContributionPlan</Role>
      <ShortName>Defined Contribution Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995645 - Disclosure - Net Income (Loss) per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995655 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995665 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995675 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995685 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995695 - Disclosure - Accounting for the Merger (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerTables</Role>
      <ShortName>Accounting for the Merger (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMerger</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995715 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurements</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995725 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNet</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995735 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTables</Role>
      <ShortName>Prepaid Expenses, Other Current Assets and Other Noncurrent Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssets</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995745 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilities</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995755 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingencies</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995765 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/Debt</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995775 - Disclosure - Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CommonStockTables</Role>
      <ShortName>Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/CommonStock</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995785 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensation</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995805 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995815 - Disclosure - Net Income (Loss) per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShare</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995825 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReporting</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995835 - Disclosure - Nature of the Business - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail</Role>
      <ShortName>Nature of the Business - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995845 - Disclosure - Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995855 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995865 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Life of Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail</Role>
      <ShortName>Summary of Significant Accounting Policies - Estimated Useful Life of Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995875 - Disclosure - Accounting for the Merger - Summary of Recapitalization of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails</Role>
      <ShortName>Accounting for the Merger - Summary of Recapitalization of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995885 - Disclosure - Accounting for the Merger - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails</Role>
      <ShortName>Accounting for the Merger - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995905 - Disclosure - Short-Term Investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Short-Term Investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995915 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995925 - Disclosure - Fair Value Measurements - Summary of Fair Value Measurement Significant Inputs (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail</Role>
      <ShortName>Fair Value Measurements - Summary of Fair Value Measurement Significant Inputs (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995935 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995945 - Disclosure - Investment in Equity Securities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails</Role>
      <ShortName>Investment in Equity Securities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995955 - Disclosure - Property and Equipment, Net - Schedule of Property Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail</Role>
      <ShortName>Property and Equipment, Net - Schedule of Property Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995965 - Disclosure - Property and Equipment, Net - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail</Role>
      <ShortName>Property and Equipment, Net - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995975 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Current Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail</Role>
      <ShortName>Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Current Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995985 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Noncurrent Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail</Role>
      <ShortName>Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Noncurrent Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995995 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Commitments and Contingencies  Summary of  Amounts Reported in the Balance Sheet in Respect of Operating Lease Assets and Corresponding Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail</Role>
      <ShortName>Commitments and Contingencies  Summary of  Amounts Reported in the Balance Sheet in Respect of Operating Lease Assets and Corresponding Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Commitments and Contingencies - Schedule of Operating Lease Cost and Variable Lease Costs and Sub Lease Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Operating Lease Cost and Variable Lease Costs and Sub Lease Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail</Role>
      <ShortName>Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Debt - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail</Role>
      <ShortName>Debt - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996055 - Disclosure - Debt - Summary of Long-term Debt Balance (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail</Role>
      <ShortName>Debt - Summary of Long-term Debt Balance (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996065 - Disclosure - Convertible Preferred Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail</Role>
      <ShortName>Convertible Preferred Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996075 - Disclosure - Common Stock - Schedule of Shares of Common Stock for Future Issuance (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail</Role>
      <ShortName>Common Stock - Schedule of Shares of Common Stock for Future Issuance (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996085 - Disclosure - Common Stock - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail</Role>
      <ShortName>Common Stock - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996095 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock Option Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996105 - Disclosure - Stock-Based Compensation - Summary of Assumptions Used to Value Stock Options Granted (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Assumptions Used to Value Stock Options Granted (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996115 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996125 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996135 - Disclosure - Agreements with Horizon - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail</Role>
      <ShortName>Agreements with Horizon - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996155 - Disclosure - Related Party Transactions - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail</Role>
      <ShortName>Related Party Transactions - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>996165 - Disclosure - Income Taxes - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail</Role>
      <ShortName>Income Taxes - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>996175 - Disclosure - Income Taxes - Schedule of loss from operations before Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails</Role>
      <ShortName>Income Taxes - Schedule of loss from operations before Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>996185 - Disclosure - Income Taxes - Schedule of components of provision for income taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of components of provision for income taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>996195 - Disclosure - Income Taxes - Schedule of reconciliation of income tax expense (benefit) computed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails</Role>
      <ShortName>Income Taxes - Schedule of reconciliation of income tax expense (benefit) computed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>996205 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>996215 - Disclosure - Net Income (Loss) per Share - Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails</Role>
      <ShortName>Net Income (Loss) per Share - Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>996225 - Disclosure - Net Income (Loss) per Share - Summary of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail</Role>
      <ShortName>Net Income (Loss) per Share - Summary of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>996235 - Disclosure - Net Income (Loss) per Share - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareAdditionalInformationDetail</Role>
      <ShortName>Net Income (Loss) per Share - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>996245 - Disclosure - Segment Reporting - Summary of the Company's segment expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails</Role>
      <ShortName>Segment Reporting - Summary of the Company's segment expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="qttb-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>996255 - Disclosure - Subsequent Events (Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events (Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.q32bio.com/20241231/taxonomy/role/SubsequentEvents</ParentRole>
      <Position>86</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="qttb-20241231.htm">qttb-20241231.htm</File>
    <File>qttb-20241231.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img226925499_0.jpg</File>
    <File>img226925499_1.jpg</File>
    <File>img226925499_2.jpg</File>
    <File>img226925499_3.jpg</File>
    <File>img226925499_4.jpg</File>
    <File>img226925499_5.jpg</File>
    <File>img226925499_6.jpg</File>
    <File>img226925499_7.jpg</File>
    <File>img226925499_8.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="686">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>112
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "qttb-20241231.htm": {
   "nsprefix": "qttb",
   "nsuri": "http://www.q32bio.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "qttb-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "qttb-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 364,
   "keyCustom": 91,
   "axisStandard": 28,
   "axisCustom": 2,
   "memberStandard": 28,
   "memberCustom": 54,
   "hidden": {
    "total": 15,
    "http://xbrl.sec.gov/dei/2024": 8,
    "http://fasb.org/us-gaap/2024": 7
   },
   "contextCount": 198,
   "entityCount": 1,
   "segmentCount": 88,
   "elementCount": 889,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 686,
    "http://xbrl.sec.gov/dei/2024": 38,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CoverPage",
     "longName": "100000 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1",
     "longName": "100010 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "longName": "100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:CommonStockSharesOutstanding",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited",
     "longName": "100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:Revenues",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited",
     "longName": "100050 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited",
     "longName": "100060 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)",
     "shortName": "CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_4cbc437d-5afa-447b-9f58-e212caafd669",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4cbc437d-5afa-447b-9f58-e212caafd669",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "longName": "100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:AmortizationOfFinancingCostsAndDiscounts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance",
     "longName": "995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance",
     "shortName": "Cybersecurity Risk Management, Strategy, and Governance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusiness",
     "longName": "995465 - Disclosure - Nature of the Business",
     "shortName": "Nature of the Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPolicies",
     "longName": "995475 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMerger",
     "longName": "995485 - Disclosure - Accounting for the Merger",
     "shortName": "Accounting for the Merger",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestments",
     "longName": "995495 - Disclosure - Short-Term Investments",
     "shortName": "Short-Term Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurements",
     "longName": "995505 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecurities",
     "longName": "995515 - Disclosure - Investment in Equity Securities",
     "shortName": "Investment in Equity Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNet",
     "longName": "995525 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssets",
     "longName": "995535 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets",
     "shortName": "Prepaid Expenses, Other Current Assets and Other Noncurrent Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilities",
     "longName": "995545 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingencies",
     "longName": "995555 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/Debt",
     "longName": "995565 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStock",
     "longName": "995575 - Disclosure - Convertible Preferred Stock",
     "shortName": "Convertible Preferred Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclosureInEntiretyOfTemporaryEquity",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclosureInEntiretyOfTemporaryEquity",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CommonStock",
     "longName": "995585 - Disclosure - Common Stock",
     "shortName": "Common Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensation",
     "longName": "995595 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizon",
     "longName": "995605 - Disclosure - Agreements with Horizon",
     "shortName": "Agreements with Horizon",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactions",
     "longName": "995615 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DefinedContributionPlan",
     "longName": "995625 - Disclosure - Defined Contribution Plan",
     "shortName": "Defined Contribution Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxes",
     "longName": "995635 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShare",
     "longName": "995645 - Disclosure - Net Income (Loss) per Share",
     "shortName": "Net Income (Loss) per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReporting",
     "longName": "995655 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/SubsequentEvents",
     "longName": "995665 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "995675 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "995685 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerTables",
     "longName": "995695 - Disclosure - Accounting for the Merger (Tables)",
     "shortName": "Accounting for the Merger (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsTables",
     "longName": "995715 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetTables",
     "longName": "995725 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTables",
     "longName": "995735 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets (Tables)",
     "shortName": "Prepaid Expenses, Other Current Assets and Other Noncurrent Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesTables",
     "longName": "995745 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesTables",
     "longName": "995755 - Disclosure - Commitments and Contingencies (Tables)",
     "shortName": "Commitments and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DebtTables",
     "longName": "995765 - Disclosure - Debt (Tables)",
     "shortName": "Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclosureInTabularFormOfVentureDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclosureInTabularFormOfVentureDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CommonStockTables",
     "longName": "995775 - Disclosure - Common Stock (Tables)",
     "shortName": "Common Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationTables",
     "longName": "995785 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesTables",
     "longName": "995805 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables",
     "longName": "995815 - Disclosure - Net Income (Loss) per Share (Tables)",
     "shortName": "Net Income (Loss) per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingTables",
     "longName": "995825 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail",
     "longName": "995835 - Disclosure - Nature of the Business - Additional Information (Detail)",
     "shortName": "Nature of the Business - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_01c6b47c-31c0-4923-b0b0-6e5450394be0",
      "name": "us-gaap:CommonStockSharesSubscriptions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_01c6b47c-31c0-4923-b0b0-6e5450394be0",
      "name": "us-gaap:CommonStockSharesSubscriptions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails",
     "longName": "995845 - Disclosure - Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details)",
     "shortName": "Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail",
     "longName": "995855 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CashFDICInsuredAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CashFDICInsuredAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail",
     "longName": "995865 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Life of Assets (Detail)",
     "shortName": "Summary of Significant Accounting Policies - Estimated Useful Life of Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_36fe52b2-0dba-48bb-aaf0-4023627944b9",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_36fe52b2-0dba-48bb-aaf0-4023627944b9",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails",
     "longName": "995875 - Disclosure - Accounting for the Merger - Summary of Recapitalization of Assets and Liabilities (Details)",
     "shortName": "Accounting for the Merger - Summary of Recapitalization of Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4baf7b07-b9a1-4675-83ec-31a34c768bc3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "qttb:ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails",
     "longName": "995885 - Disclosure - Accounting for the Merger - Additional Information (Details)",
     "shortName": "Accounting for the Merger - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_302992f5-5a2f-4079-b1ae-a9f51ed191d0",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationLiability",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetails",
     "longName": "995905 - Disclosure - Short-Term Investments - Additional Information (Details)",
     "shortName": "Short-Term Investments - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:ShortTermInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R53": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
     "longName": "995915 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)",
     "shortName": "Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7bb2bb04-b139-49f5-801e-31f1d770bc43",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail",
     "longName": "995925 - Disclosure - Fair Value Measurements - Summary of Fair Value Measurement Significant Inputs (Detail)",
     "shortName": "Fair Value Measurements - Summary of Fair Value Measurement Significant Inputs (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_2aef5253-5673-488f-b176-618a6a1a9ffa",
      "name": "us-gaap:DebtInstrumentMeasurementInput",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2aef5253-5673-488f-b176-618a6a1a9ffa",
      "name": "us-gaap:DebtInstrumentMeasurementInput",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail",
     "longName": "995935 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_7fe7497c-530e-4a3f-be8e-af26a160d3fa",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_02ea8933-41dc-4b18-b84c-1e05c9afde3e",
      "name": "qttb:FairValueOfInterestExpenses",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails",
     "longName": "995945 - Disclosure - Investment in Equity Securities - Additional Information (Details)",
     "shortName": "Investment in Equity Securities - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e0d1d750-c63b-49fa-8efe-0c104dbe276f",
      "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
     "longName": "995955 - Disclosure - Property and Equipment, Net - Schedule of Property Plant and Equipment (Detail)",
     "shortName": "Property and Equipment, Net - Schedule of Property Plant and Equipment (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail",
     "longName": "995965 - Disclosure - Property and Equipment, Net - Additional Information (Detail)",
     "shortName": "Property and Equipment, Net - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:Depreciation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsHeldForUse",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail",
     "longName": "995975 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Current Assets (Detail)",
     "shortName": "Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Current Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "qttb:PrepaidExternalResearchAndDevelopmentCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "qttb:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "div",
       "qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "qttb:PrepaidExternalResearchAndDevelopmentCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "qttb:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "div",
       "qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail",
     "longName": "995985 - Disclosure - Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Noncurrent Assets (Detail)",
     "shortName": "Prepaid Expenses, Other Current Assets and Other Noncurrent Assets - Summary of Prepaid Expenses and Other Noncurrent Assets (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:DeferredCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "qttb:SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock",
       "div",
       "qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:DeferredCosts",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "qttb:SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock",
       "div",
       "qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail",
     "longName": "995995 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail)",
     "shortName": "Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail",
     "longName": "996005 - Disclosure - Commitments and Contingencies  Summary of  Amounts Reported in the Balance Sheet in Respect of Operating Lease Assets and Corresponding Liabilities (Detail)",
     "shortName": "Commitments and Contingencies  Summary of  Amounts Reported in the Balance Sheet in Respect of Operating Lease Assets and Corresponding Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R63": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail",
     "longName": "996015 - Disclosure - Commitments and Contingencies - Schedule of Operating Lease Cost and Variable Lease Costs and Sub Lease Income (Detail)",
     "shortName": "Commitments and Contingencies - Schedule of Operating Lease Cost and Variable Lease Costs and Sub Lease Income (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail",
     "longName": "996025 - Disclosure - Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Detail)",
     "shortName": "Commitments and Contingencies - Schedule of Maturities of Operating Lease Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
     "longName": "996035 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:SelfInsuranceReserve",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
     "longName": "996045 - Disclosure - Debt - Additional Information (Detail)",
     "shortName": "Debt - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ProceedsFromLongTermLinesOfCredit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:IncreaseDecreaseInNotesPayableCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail",
     "longName": "996055 - Disclosure - Debt - Summary of Long-term Debt Balance (Detail)",
     "shortName": "Debt - Summary of Long-term Debt Balance (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_60e298bc-492e-4648-ae4c-77f0946662a4",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_60e298bc-492e-4648-ae4c-77f0946662a4",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
     "longName": "996065 - Disclosure - Convertible Preferred Stock - Additional Information (Detail)",
     "shortName": "Convertible Preferred Stock - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_354585ed-60d7-4f70-a77e-d50cc01415c0",
      "name": "us-gaap:ReclassificationsOfTemporaryToPermanentEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_354585ed-60d7-4f70-a77e-d50cc01415c0",
      "name": "us-gaap:ReclassificationsOfTemporaryToPermanentEquity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
     "longName": "996075 - Disclosure - Common Stock - Schedule of Shares of Common Stock for Future Issuance (Detail)",
     "shortName": "Common Stock - Schedule of Shares of Common Stock for Future Issuance (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "qttb:DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_bdaefca0-fea1-4732-b40e-bf35def7a224",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "qttb:DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail",
     "longName": "996085 - Disclosure - Common Stock - Additional Information (Detail)",
     "shortName": "Common Stock - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b5c40c56-08b5-4a22-b751-a8f232a74aca",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail",
     "longName": "996095 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail)",
     "shortName": "Stock-Based Compensation - Summary of Stock Option Activity (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_2314494c-9a8c-4bc3-a189-e525b43dfad3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail",
     "longName": "996105 - Disclosure - Stock-Based Compensation - Summary of Assumptions Used to Value Stock Options Granted (Detail)",
     "shortName": "Stock-Based Compensation - Summary of Assumptions Used to Value Stock Options Granted (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail",
     "longName": "996115 - Disclosure - Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail)",
     "shortName": "Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail",
     "longName": "996125 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "qttb:DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail",
     "longName": "996135 - Disclosure - Agreements with Horizon - Additional Information (Detail)",
     "shortName": "Agreements with Horizon - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "C_130917d7-9d2c-4093-8e70-15724bdc27cd",
      "name": "qttb:CollaborationAgreementTransactionPrice",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_130917d7-9d2c-4093-8e70-15724bdc27cd",
      "name": "qttb:CollaborationAgreementTransactionPrice",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail",
     "longName": "996155 - Disclosure - Related Party Transactions - Additional Information (Detail)",
     "shortName": "Related Party Transactions - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "C_3e39319d-0b8a-4d79-9a97-72ff6fa10227",
      "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_3e39319d-0b8a-4d79-9a97-72ff6fa10227",
      "name": "us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail",
     "longName": "996165 - Disclosure - Income Taxes - Additional Information (Detail)",
     "shortName": "Income Taxes - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails",
     "longName": "996175 - Disclosure - Income Taxes - Schedule of loss from operations before Income Tax (Details)",
     "shortName": "Income Taxes - Schedule of loss from operations before Income Tax (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails",
     "longName": "996185 - Disclosure - Income Taxes - Schedule of components of provision for income taxes (Details)",
     "shortName": "Income Taxes - Schedule of components of provision for income taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails",
     "longName": "996195 - Disclosure - Income Taxes - Schedule of reconciliation of income tax expense (benefit) computed (Details)",
     "shortName": "Income Taxes - Schedule of reconciliation of income tax expense (benefit) computed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails",
     "longName": "996205 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails",
     "longName": "996215 - Disclosure - Net Income (Loss) per Share - Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes (Details)",
     "shortName": "Net Income (Loss) per Share - Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail",
     "longName": "996225 - Disclosure - Net Income (Loss) per Share - Summary of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Detail)",
     "shortName": "Net Income (Loss) per Share - Summary of Computation of Diluted Net Loss Per Share Attributable to Common Stockholders (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "C_5dad7a66-e70c-49a5-aa41-6710e38a1a05",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5dad7a66-e70c-49a5-aa41-6710e38a1a05",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareAdditionalInformationDetail",
     "longName": "996235 - Disclosure - Net Income (Loss) per Share - Additional Information (Detail)",
     "shortName": "Net Income (Loss) per Share - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "C_e26a9287-f885-4441-9d0e-9148098a8888",
      "name": "us-gaap:ConvertibleNotesPayable",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_e26a9287-f885-4441-9d0e-9148098a8888",
      "name": "us-gaap:ConvertibleNotesPayable",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails",
     "longName": "996245 - Disclosure - Segment Reporting - Summary of the Company's segment expenses (Details)",
     "shortName": "Segment Reporting - Summary of the Company's segment expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:PersonnelRelatedCostsExcludingStockBasedCompensation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1f079b94-52d3-4513-9e59-1f9abf527de4",
      "name": "qttb:PersonnelRelatedCostsExcludingStockBasedCompensation",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "longName": "996255 - Disclosure - Subsequent Events (Additional Information) (Details)",
     "shortName": "Subsequent Events (Additional Information) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "C_b58f761f-bef4-4b59-803e-8a93d0543c79",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2f4b5de3-a9e7-4c16-bcfe-43adba24582e",
      "name": "us-gaap:SeveranceCosts1",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "qttb-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "qttb_AAPhaseTwoResearchServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AAPhaseTwoResearchServicesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AA phase two research services.",
        "label": "AA Phase Two Research Services [Member]",
        "terseLabel": "AA phase 2 research services"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ADPhaseTwoResearchServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ADPhaseTwoResearchServicesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AD phase two research services.",
        "label": "AD phase two research services [Member]",
        "terseLabel": "AD phase 2 research services"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ADXZeroNineSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ADXZeroNineSevenMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ADX Zero Nine Seven [Member]",
        "documentation": "ADX Zero Nine Seven [Member]",
        "terseLabel": "ADX-097 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_AccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AccountingPoliciesLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting policies.",
        "label": "Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_AccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AccountingPoliciesTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting policies.",
        "label": "Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities",
        "totalLabel": "Accounts Payable and Accrued Liabilities, Total",
        "negatedLabel": "Accounts payable and accrued liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r921"
     ]
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "terseLabel": "Amortization of premium on short-term investments",
        "negatedLabel": "Amortization of premium on short-term investments",
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "qttb_AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses and other current liabilities disclosure.",
        "label": "Accrued Expenses And Other Current Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_AccruedExpensesAndOtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AccruedExpensesAndOtherLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Expenses And Other Liabilities Current",
        "label": "Accrued Expenses And Other Liabilities Current",
        "terseLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Total accrued expenses and other current liabilities",
        "totalLabel": "Total accrued expenses and other current liabilities",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "qttb_AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued professional fees and other accrued liabilities current.",
        "label": "Accrued Professional Fees And Other Accrued Liabilities Current",
        "terseLabel": "Accrued professional services and other"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_AccruedResearchAndDevelopmentExpensesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AccruedResearchAndDevelopmentExpensesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expenses current.",
        "label": "Accrued Research And Development Expenses Current",
        "terseLabel": "Accrued external research and development"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r172",
      "r706"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r85",
      "r180",
      "r701",
      "r743",
      "r744"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r10",
      "r18",
      "r549",
      "r552",
      "r610",
      "r739",
      "r740",
      "r1083",
      "r1084",
      "r1085",
      "r1093",
      "r1094",
      "r1095",
      "r1097"
     ]
    },
    "qttb_AchievementOfSpecifiedMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AchievementOfSpecifiedMilestonesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Achievement of specified milestones.",
        "label": "Achievement Of Specified Milestones [Member]",
        "verboseLabel": "Achievement Of Specified Milestones [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r921",
      "r1239"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r1093",
      "r1094",
      "r1095",
      "r1097",
      "r1175",
      "r1240"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r969",
      "r980",
      "r990",
      "r1023"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r972",
      "r983",
      "r993",
      "r1026"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "qttb_AgreementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AgreementAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement.",
        "label": "Agreement [Axis]",
        "verboseLabel": "Agreement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_AgreementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AgreementDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement.",
        "label": "Agreement [Domain]",
        "verboseLabel": "Agreement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r1018"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r973",
      "r984",
      "r994",
      "r1018",
      "r1027",
      "r1031",
      "r1039"
     ]
    },
    "us-gaap_AllOtherSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllOtherSegmentsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Segment [Member]",
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r287",
      "r881",
      "r882"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r494"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance costs",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r415",
      "r893",
      "r894",
      "r1087",
      "r1186"
     ]
    },
    "qttb_AmountOfRefundLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AmountOfRefundLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of refund liability.",
        "label": "Amount Of Refund Liability",
        "terseLabel": "Refund liability"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_AnnualRentOperatingLeaseAggregateAfterIncrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "AnnualRentOperatingLeaseAggregateAfterIncrease",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual rent operating lease aggregate after increase.",
        "label": "Annual rent operating lease aggregate after increase",
        "terseLabel": "Annual Rent Operating lease Aggregate After Increase"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Options to purchase common stock",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Area of Real Estate Property",
        "terseLabel": "Office space leased",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r543"
     ]
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionContingentConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Acquisition, Contingent Consideration, Liability",
        "terseLabel": "Contingent payment liability",
        "totalLabel": "Asset Acquisition, Contingent Consideration, Liability, Total",
        "negatedLabel": "CVR liability",
        "documentation": "Amount of liability recognized from contingent consideration in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "terseLabel": "Net assets acquired",
        "totalLabel": "Total assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r140",
      "r174",
      "r205",
      "r248",
      "r256",
      "r282",
      "r286",
      "r332",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r544",
      "r546",
      "r584",
      "r694",
      "r795",
      "r881",
      "r882",
      "r921",
      "r947",
      "r1124",
      "r1125",
      "r1192"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r183",
      "r205",
      "r332",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r544",
      "r546",
      "r584",
      "r921",
      "r1124",
      "r1125",
      "r1192"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Assets, Fair Value Disclosure, Total",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r561",
      "r908"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r952",
      "r953",
      "r976"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r952",
      "r953",
      "r976"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r952",
      "r953",
      "r976"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]",
        "terseLabel": "Auditor Opinion"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Short-term investments, Unrealized Gains",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r300"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "terseLabel": "Short-term investments, Unrealized Losses",
        "negatedLabel": "Short-term investments, Unrealized Losses",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Short-term investments, Amortized Cost",
        "totalLabel": "Debt Securities, Available-for-Sale, Amortized Cost, Total",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r342",
      "r693"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Short-term investments, Fair Value",
        "totalLabel": "Debt Securities, Available-for-Sale, Total",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r342",
      "r560",
      "r687",
      "r908",
      "r912",
      "r1106",
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r1206",
      "r1207"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position Location, Balance [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r372",
      "r1206",
      "r1207"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_BeforeFirstOfJulyTwoThousandAndTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "BeforeFirstOfJulyTwoThousandAndTwentyFiveMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Before First Of July Two Thousand And Twenty Five [Member]",
        "documentation": "Before First Of July Two Thousand And Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Before thirty first of march two thousand and twenty five.",
        "label": "Before Thirty First Of March Two Thousand And Twenty Five [Member]",
        "terseLabel": "Before Thirty First Of March Two Thousand And Twenty Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Before thirty first of march two thousand and twenty four.",
        "label": "Before Thirty First Of March Two Thousand And Twenty Four [Member]",
        "terseLabel": "Before Thirty First Of March Two Thousand And Twenty Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "BeforeThirtyFirstOfMarchTwoThousandAndTwentySixMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Before thirty first of march two thousand and twenty six.",
        "label": "Before Thirty First Of March Two Thousand And Twenty Six [Member]",
        "terseLabel": "Before Thirty First Of March Two Thousand And Twenty Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_BempikibartMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "BempikibartMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bempikibart [Member]",
        "documentation": "Bempikibart [Member]",
        "terseLabel": "Bempikibart [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r539",
      "r901",
      "r902"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r539",
      "r901",
      "r902"
     ]
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Transaction Costs",
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Issuance of CVR at fair value",
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement."
       }
      }
     },
     "auth_ref": [
      "r540",
      "r1086"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationAssetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationAssetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration, Asset, Current",
        "terseLabel": "Business combination, intial consideration",
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination, expected to be realized within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r120"
     ]
    },
    "qttb_BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business combination shares conversion into rights to purchase common stock.",
        "label": "Business Combination Shares Conversion Into Rights To Purchase Common Stock",
        "terseLabel": "Business combination shares conversion into rights to purchase common stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage",
        "terseLabel": "Outstanding common stock of the combined company",
        "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date."
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r953",
      "r976"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Nature of the Business",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r98",
      "r99"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Interest payments on venture debt",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "qttb_CapitalizedIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CapitalizedIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capitalized Intangible Assets",
        "documentation": "Capitalized Intangible Assets",
        "terseLabel": "Capitalized intangible assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total",
        "verboseLabel": "Cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r170",
      "r868"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r123"
     ]
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsAndShortTermInvestmentsTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, and Short-Term Investments [Text Block]",
        "terseLabel": "Short-Term Investments",
        "documentation": "The entire disclosure of the components of cash, cash equivalents, and short-term investments. Short-term investments may include current marketable securities."
       }
      }
     },
     "auth_ref": [
      "r1105"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period",
        "periodStartLabel": "Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period",
        "totalLabel": "Total cash, cash equivalents, restricted cash and restricted cash equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r94",
      "r201"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r94"
     ]
    },
    "qttb_CashConsiderationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CashConsiderationMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Consideration.",
        "label": "Cash Consideration [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, FDIC Insured Amount",
        "terseLabel": "Cash FDIC insured amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash operating, investing and financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ChangeDuringPeriodFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ChangeDuringPeriodFairValueDisclosureMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes Measurement [Member]",
        "terseLabel": "Change in fair value",
        "documentation": "Measure of change in fair value."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "qttb_ChangeInFairValueOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ChangeInFairValueOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Fair Value Of Convertible Notes",
        "label": "Change in Fair Value Of Convertible Notes",
        "terseLabel": "Change in fair value of convertible notes",
        "negatedLabel": "Change in fair value of convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ChangeInFairValueOfEquityInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ChangeInFairValueOfEquityInvestment",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Fair Value Of Equity Investment",
        "label": "Change In Fair Value Of Equity Investment",
        "negatedLabel": "Change in fair value of CVR liability"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1006"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "verboseLabel": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r177",
      "r178",
      "r179",
      "r205",
      "r230",
      "r234",
      "r241",
      "r243",
      "r250",
      "r251",
      "r332",
      "r384",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r426",
      "r427",
      "r429",
      "r432",
      "r439",
      "r584",
      "r748",
      "r749",
      "r750",
      "r751",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r782",
      "r804",
      "r826",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r1062",
      "r1088",
      "r1098"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Class of warrants or rights exercise price per share",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Class of warrants or rights number of securities covered by warrants or rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r440"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "qttb_CollaborationAgreementContingentPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CollaborationAgreementContingentPayment",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration agreement contingent payment.",
        "label": "Collaboration Agreement Contingent Payment",
        "terseLabel": "Collaboration agreement, contingent payment"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_CollaborationAgreementContingentPaymentPayableExcessOfCashReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CollaborationAgreementContingentPaymentPayableExcessOfCashReceived",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration agreement contingent payment payable excess of cash received.",
        "label": "Collaboration Agreement Contingent Payment Payable Excess Of Cash Received",
        "terseLabel": "Collaboration agreement, contingent payment payable excess of cash received"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_CollaborationAgreementTransactionPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CollaborationAgreementTransactionPrice",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration agreement transaction price.",
        "label": "Collaboration Agreement Transaction Price",
        "terseLabel": "Collaboration agreement, transaction price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizon"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Agreements with Horizon",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r151",
      "r163"
     ]
    },
    "qttb_CollaborativeArrangementMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CollaborativeArrangementMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement milestone payments.",
        "label": "Collaborative Arrangement Milestone Payments",
        "terseLabel": "Collaboration agreement, Aggregate amount of sales milestone"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r543"
     ]
    },
    "qttb_CommercialMilestonePaymentPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CommercialMilestonePaymentPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial milestone payment payable.",
        "label": "Commercial Milestone Payment Payable",
        "terseLabel": "Commercial milestone payment payable"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_CommitmentAndContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CommitmentAndContingenciesLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment and contingencies.",
        "label": "Commitment And Contingencies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_CommitmentAndContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CommitmentAndContingenciesTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitment and contingencies.",
        "label": "Commitment And Contingencies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r131",
      "r697",
      "r781"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r376",
      "r377",
      "r850",
      "r1115",
      "r1120"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock capital shares reserved for future issuance",
        "verboseLabel": "Share based awards, common stock reserved for issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r938",
      "r939",
      "r940",
      "r942",
      "r943",
      "r944",
      "r945",
      "r1093",
      "r1094",
      "r1097",
      "r1175",
      "r1237",
      "r1240"
     ]
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value per share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r782"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "terseLabel": "Common stock shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r79",
      "r782",
      "r801",
      "r1240",
      "r1241"
     ]
    },
    "us-gaap_CommonStockSharesSubscriptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesSubscriptions",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Value, Subscriptions",
        "terseLabel": "Common stock, aggregate purchase price",
        "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r79"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 400,000,000 shares authorized, 12,197,615 and 359,569 shares issued and outstanding at December 31, 2024 2023, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r699",
      "r921"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r1015"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r1014"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r1013"
     ]
    },
    "qttb_CompanysEffectiveTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CompanysEffectiveTaxRate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company's Effective Tax Rate",
        "documentation": "Company's Effective Tax Rate",
        "terseLabel": "Company's effective tax rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r116"
     ]
    },
    "qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ComponentsOfInProcessResearchAndDevelopmentExpensesAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of in process research and development expenses.",
        "label": "Components Of In Process Research And Development Expenses [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ComponentsOfInProcessResearchAndDevelopmentExpensesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ComponentsOfInProcessResearchAndDevelopmentExpensesDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "components of in process research and development expenses.",
        "label": "Components Of In Process Research And Development Expenses [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r188",
      "r190",
      "r196",
      "r689",
      "r712",
      "r713"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk and Significant Suppliers",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r153"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r210",
      "r544",
      "r545",
      "r546",
      "r547",
      "r619",
      "r855",
      "r1123",
      "r1126",
      "r1127"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r210",
      "r544",
      "r545",
      "r546",
      "r547",
      "r619",
      "r855",
      "r1123",
      "r1126",
      "r1127"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r870"
     ]
    },
    "qttb_ConsultingAndAdvisoryAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ConsultingAndAdvisoryAgreementsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consulting and advisory agreements.",
        "label": "Consulting And Advisory Agreements [Member]",
        "terseLabel": "Consulting and Advisory Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability",
        "terseLabel": "Amount retained",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r444"
     ]
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Conversion of Stock, Shares Converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ]
    },
    "qttb_ConversionOfTemporaryEquityIntoPermanentEquityShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ConversionOfTemporaryEquityIntoPermanentEquityShares",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of temporary equity into permanent equity shares.",
        "label": "Conversion Of Temporary Equity Into Permanent Equity Shares",
        "terseLabel": "Conversion of temporary equity into permanent equity shares"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ConvertibleDebtAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ConvertibleDebtAgreementMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible debt agreement.",
        "label": "Convertible Debt Agreement [Member]",
        "terseLabel": "Convertible Debt Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt, Current",
        "terseLabel": "Convertible notes",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Convertible debt, fair value disclosures",
        "verboseLabel": "Convertible debt at fair value",
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182"
     ]
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible notes",
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtSecuritiesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Shares reserved upon the conversion of the convertible notes [Member]",
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "qttb_ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ConvertibleNotesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Notes [Member]",
        "label": "Convertible Notes [Member]",
        "terseLabel": "Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes Payable",
        "terseLabel": "Principal balance of convertible notes",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r130",
      "r1203"
     ]
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r427",
      "r429",
      "r942",
      "r943",
      "r944",
      "r945"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_CumulativeChangesOwnershipInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CumulativeChangesOwnershipInterest",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Changes Ownership Interest",
        "label": "Cumulative Changes Ownership Interest",
        "documentation": "Cumulative Changes Ownership Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Current, Federal",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1071",
      "r1091",
      "r1168"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1071",
      "r1091"
     ]
    },
    "qttb_CurrentLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CurrentLiabilitiesLesseeAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current liabilities lessee [Abstract].",
        "label": "Current Liabilities Lessee [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_CurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CurrentLiabilitiesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current liabilities.",
        "label": "Current Liabilities [Member]",
        "terseLabel": "Current Liabilities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "Current, State",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1071",
      "r1091",
      "r1168"
     ]
    },
    "qttb_CvrLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "CvrLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CVR Liability",
        "label": "CVR Liability",
        "terseLabel": "CVR liability"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r961",
      "r1050"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r961",
      "r1050"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r1052"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r1052"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r965",
      "r1054"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r963",
      "r1052"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r956",
      "r1045"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r957",
      "r1046"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r957",
      "r1046"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r955",
      "r1044"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r955",
      "r1044"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r955",
      "r1044"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r958",
      "r1047"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r960",
      "r1049"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r960",
      "r1049"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r961",
      "r1050"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r964",
      "r1053"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r962",
      "r1051"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r959",
      "r1048"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Debt instrument converted into equity number of shares issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r26"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r203",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r382",
      "r383",
      "r393",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r409",
      "r416",
      "r417",
      "r419",
      "r595"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r67",
      "r68",
      "r126",
      "r130",
      "r210",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r400",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r919",
      "r1089",
      "r1116",
      "r1117",
      "r1118",
      "r1185",
      "r1187"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument variable interest spread",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Principal amount of term loans",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r130",
      "r420"
     ]
    },
    "us-gaap_DebtInstrumentCollateralAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCollateralAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Collateral Amount",
        "terseLabel": "Debt instrument collateral given",
        "documentation": "Amount of assets pledged to secure a debt instrument."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "qttb_DebtInstrumentConversionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DebtInstrumentConversionPricePercentage",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument conversion price percentage.",
        "label": "Debt Instrument Conversion Price Percentage",
        "terseLabel": "Debt instrument conversion price percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Debt instrument conversion price per share",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r396"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Percentage of Purchase Price of Convertible notes to Common stock",
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt instrument face value",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r595",
      "r596",
      "r891",
      "r892",
      "r919"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Debt instrument effective rate of interest percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r423",
      "r595",
      "r596",
      "r919"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r400",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r418",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r919",
      "r1089",
      "r1185",
      "r1187"
     ]
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMeasurementInput",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Measurement Input",
        "terseLabel": "Debt instrument, measurement input",
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt."
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r210",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r400",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r919",
      "r1089",
      "r1116",
      "r1117",
      "r1118",
      "r1185",
      "r1187"
     ]
    },
    "us-gaap_DebtInstrumentPaymentTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPaymentTerms",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Payment Terms",
        "terseLabel": "Debt instrument terms of payment",
        "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r71"
     ]
    },
    "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid",
        "terseLabel": "Long term debt balloon payment",
        "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r41",
      "r42",
      "r58",
      "r110",
      "r111",
      "r210",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r400",
      "r405",
      "r406",
      "r407",
      "r408",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r418",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r919",
      "r1089",
      "r1185",
      "r1187"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Unamortized debt discount and issuance costs",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r421",
      "r594",
      "r595",
      "r596",
      "r891",
      "r892",
      "r919"
     ]
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Debt and Warrant Issuance Costs",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Realized Gain (Loss)",
        "terseLabel": "Realized gains and losses on available-for-sale securities",
        "totalLabel": "Debt Securities, Available-for-Sale, Realized Gain (Loss), Total",
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1107"
     ]
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredChargesPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Deferred Transaction Costs",
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_DeferredCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Noncurrent",
        "terseLabel": "Deferred transaction costs",
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r1080"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Deferred, Federal",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1091",
      "r1167",
      "r1168"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1091",
      "r1167"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Deferred Income Tax Expense (Benefit), Total",
        "terseLabel": "Current and deferred income tax expense",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r160",
      "r1091"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1091",
      "r1167",
      "r1168"
     ]
    },
    "us-gaap_DeferredTaxAssetsFrequentFlierLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsFrequentFlierLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent liability",
        "label": "Deferred Tax Assets, Frequent Flier Liability",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from frequent flier obligations."
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross, Total",
        "terseLabel": "Net deferred tax assets",
        "totalLabel": "Total gross deferred tax assets before valuation allowance",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "qttb_DeferredTaxAssetsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DeferredTaxAssetsLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets Lease Liability",
        "documentation": "Deferred Tax Assets Lease Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Deferred Tax Assets, Net, Total",
        "terseLabel": "Net deferred tax assets",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred Tax Assets, Net of Valuation Allowance, Total",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNetAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal net operating loss carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforwards",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Capitalized R&amp;D expenditures",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock compensation and other",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from compensation and benefits, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves",
        "terseLabel": "Accruals and Reserves",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from loss reserves other than estimated credit losses."
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Valuation Allowance",
        "terseLabel": "Less: Valuation allowance",
        "negatedLabel": "Less: Valuation allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DeferredTaxLiabilitiesFixedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DeferredTaxLiabilitiesFixedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed assets",
        "label": "Deferred Tax Liabilities Fixed assets",
        "documentation": "Deferred Tax Liabilities Fixed assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesOtherFiniteLivedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesOtherFiniteLivedAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right of use asset",
        "label": "Deferred Tax Liabilities, Other Finite-Lived Assets",
        "negatedLabel": "Right of use asset",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from long-lived assets other than property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "us-gaap_DefinedContributionPlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DefinedContributionPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plan [Text Block]",
        "terseLabel": "Defined Contribution Plan",
        "documentation": "The entire disclosure for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "terseLabel": "Depreciation expense",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r35"
     ]
    },
    "qttb_DevelopmentAndSalesMilestonePaymentPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DevelopmentAndSalesMilestonePaymentPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development and sales milestone payment payable.",
        "label": "Development And Sales Milestone Payment Payable",
        "terseLabel": "Development and sales milestone payment payable"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DevelopmentMilestonePaymentPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DevelopmentMilestonePaymentPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Development Milestone Payment Payable",
        "label": "Development Milestone Payment Payable",
        "terseLabel": "Development Milestone Payment Payable"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DisclosureInEntiretyOfTemporaryEquity": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DisclosureInEntiretyOfTemporaryEquity",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in entirety of temporary equity.",
        "label": "Disclosure In Entirety Of Temporary Equity",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of amounts reported in the balance sheet in respect of operating lease assets and corresponding liabilities [Table Text Block].",
        "label": "Disclosure In Tabular Form Of Amounts Reported In The Balance Sheet In Respect Of Operating Lease Assets And Corresponding Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Amounts Reported In The Balance Sheet In Respect Of Operating Lease Assets And Corresponding Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of common stock shares reserved for future issuance.",
        "label": "Disclosure In Tabular Form Of Common Stock Shares Reserved For Future Issuance [Line Items]",
        "terseLabel": "Disclosure in Tabular form of Common Stock Shares Reserved for Future Issuance [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of common stock shares reserved for future issuance.",
        "label": "Disclosure In Tabular Form Of Common Stock Shares Reserved For Future Issuance [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommonStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of common stock shares reserved for future issuance.",
        "label": "Disclosure In Tabular Form Of Common Stock Shares Reserved For Future Issuance [Table Text Block]",
        "terseLabel": "Schedule of Shares of Common Stock for Future Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DisclosureInTabularFormOfVentureDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DisclosureInTabularFormOfVentureDebtLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of venture debt.",
        "label": "Disclosure in tabular form of venture debt [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DisclosureInTabularFormOfVentureDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DisclosureInTabularFormOfVentureDebtTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of venture debt.",
        "label": "Disclosure In Tabular Form Of Venture Debt [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DisclosureInTabularFormOfVentureDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DisclosureInTabularFormOfVentureDebtTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure in tabular form of venture debt.",
        "label": "Disclosure In Tabular Form Of Venture Debt [Table Text Block]",
        "terseLabel": "Summary of Long-term Debt Balance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r457",
      "r461",
      "r489",
      "r490",
      "r492",
      "r904"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclousre of prepaid expenses other current assets and other noncurrent assets text block.",
        "label": "Disclousre Of Prepaid Expenses Other Current Assets and Other Noncurrent Assets [Text Block]",
        "terseLabel": "Prepaid Expenses, Other Current Assets and Other Noncurrent Assets"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_DiscoveryAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "DiscoveryAndOtherMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discovery and Other [Member]",
        "documentation": "Discovery and Other [Member]",
        "terseLabel": "Discovery and Other [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r952",
      "r953",
      "r976"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r952",
      "r953",
      "r976",
      "r1019"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r950"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1008"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share - basic",
        "totalLabel": "Earnings Per Share, Basic, Total",
        "verboseLabel": "Net income (loss) per share-basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r227",
      "r230",
      "r241",
      "r242",
      "r243",
      "r247",
      "r537",
      "r542",
      "r557",
      "r558",
      "r690",
      "r714",
      "r873"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share - diluted",
        "totalLabel": "Earnings Per Share, Diluted, Total",
        "verboseLabel": "Net income (loss) per share-diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r230",
      "r241",
      "r242",
      "r243",
      "r247",
      "r537",
      "r542",
      "r557",
      "r558",
      "r690",
      "r714",
      "r873"
     ]
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareReconciliationAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) per Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r244",
      "r245",
      "r246"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent, Total",
        "terseLabel": "Effective income tax rate",
        "totalLabel": "Effective income tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r907"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. statutory tax rate",
        "verboseLabel": "Federal income tax expense at statutory rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r504",
      "r527",
      "r907"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r508",
      "r907",
      "r1092",
      "r1159"
     ]
    },
    "qttb_EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent",
        "documentation": "EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent",
        "terseLabel": "Convertible note revaluation"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain/loss on convertible note conversion",
        "label": "Effective Income Tax Rate Reconciliation Gain loss On Convertible Note Conversion",
        "documentation": "Effective Income Tax Rate Reconciliation Gain loss On Convertible Note Conversion"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Permanent differences",
        "label": "Effective Income Tax Rate Reconciliation, Permanent Differences Income Taxes, Percent",
        "documentation": "Effective Income Tax Rate Reconciliation, Permanent Differences Income Taxes, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r507",
      "r907",
      "r1092",
      "r1159"
     ]
    },
    "qttb_EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent",
        "documentation": "EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseBenefitComputedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "terseLabel": "Research and development tax credits",
        "negatedLabel": "Research and development tax credits",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r907",
      "r1092",
      "r1159",
      "r1160"
     ]
    },
    "qttb_EighthAmendmentToTheLoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "EighthAmendmentToTheLoanAgreementMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eighth Amendment To The Loan Agreement Member",
        "label": "Eighth Amendment to the Loan Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and related expenses",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "verboseLabel": "Unrecognised compensation cost, recognition period",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognised compensation cost",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1157"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Shares reserved for stock option exercises [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r949"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1055"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r1055"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1055"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment [Member]",
        "terseLabel": "Lab equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r165",
      "r192",
      "r193",
      "r194",
      "r211",
      "r212",
      "r213",
      "r215",
      "r220",
      "r222",
      "r224",
      "r249",
      "r334",
      "r335",
      "r364",
      "r441",
      "r525",
      "r526",
      "r534",
      "r535",
      "r536",
      "r538",
      "r541",
      "r542",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r556",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r597",
      "r598",
      "r610",
      "r710",
      "r739",
      "r740",
      "r741",
      "r757",
      "r826"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r328",
      "r329",
      "r331",
      "r533",
      "r1064",
      "r1065",
      "r1066",
      "r1169",
      "r1170",
      "r1171",
      "r1172"
     ]
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentAggregateCost",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Equity method investment",
        "verboseLabel": "Equity investment",
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Other-than-Temporary Impairment",
        "terseLabel": "Impairment charge",
        "documentation": "Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r1111"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership, percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r267",
      "r286",
      "r327",
      "r1079",
      "r1112"
     ]
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investment [Abstarct]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investment in Equity Securities",
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r330",
      "r333",
      "r1066"
     ]
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsPolicy",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Investments in Equity Securities",
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r53",
      "r329"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1012"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r969",
      "r980",
      "r990",
      "r1023"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r966",
      "r977",
      "r987",
      "r1020"
     ]
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r583",
      "r891",
      "r892"
     ]
    },
    "qttb_EstimatedAggregateProceedsFromDebtAndEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "EstimatedAggregateProceedsFromDebtAndEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated aggregate proceeds from debt and equity.",
        "label": "Estimated Aggregate Proceeds From Debt And Equity",
        "terseLabel": "Estimated aggregate proceeds from debt and equity"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_EstimatedAggregateProceedsFromEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "EstimatedAggregateProceedsFromEquity",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated aggregate proceeds from equity.",
        "label": "Estimated Aggregate Proceeds From Equity",
        "terseLabel": "Estimated aggregate proceeds from equity"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_EventAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "EventAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event.",
        "label": "Event [Axis]",
        "verboseLabel": "Event [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_EventDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "EventDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event.",
        "label": "Event [Domain]",
        "terseLabel": "Event [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ExcessOfAccruedRightToPurchaseStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ExcessOfAccruedRightToPurchaseStock",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of accrued right to purchase stock",
        "label": "Excess of accrued right to purchase stock",
        "terseLabel": "Excess of accrued right to purchase stock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r1018"
     ]
    },
    "qttb_ExerciseOfCallOptionDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ExerciseOfCallOptionDescription",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of Call Option Description",
        "documentation": "Exercise of Call Option Description",
        "terseLabel": "Exercise of call option description"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face value of debt instrument that may be contingently borrowed.",
        "label": "Face Value of Debt Instrument That May Be Contingently Borrowed",
        "terseLabel": "Face value of debt instrument that may be contingently borrowed"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_FacilitiesITAndInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "FacilitiesITAndInsurance",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Facilities IT And Insurance",
        "documentation": "Facilities IT And Insurance",
        "terseLabel": "Facilities, IT and insurance"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_FacilitiesITAndInsuranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "FacilitiesITAndInsuranceMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Facilities, IT and insurance [Member]",
        "documentation": "Facilities, IT and insurance"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_FacilitiesITAndOtherAllocatedCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "FacilitiesITAndOtherAllocatedCostsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Facilities, IT and other allocated costs [Member]",
        "documentation": "Facilities, IT and other allocated costs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r561",
      "r574",
      "r908"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r561",
      "r574",
      "r908"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r563",
      "r564",
      "r912"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Summary of Fair Value Measurement Significant Inputs",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r563",
      "r912"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r575",
      "r910"
     ]
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r575",
      "r910"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r559",
      "r561",
      "r562",
      "r563",
      "r564",
      "r573",
      "r574",
      "r576",
      "r626",
      "r627",
      "r628",
      "r891",
      "r892",
      "r898",
      "r899",
      "r900",
      "r908",
      "r912"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r891",
      "r892"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r561",
      "r562",
      "r564",
      "r908",
      "r1180",
      "r1183"
     ]
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r891",
      "r892"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r569",
      "r571",
      "r572",
      "r573",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r686",
      "r908",
      "r913"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets (Level 1) [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r446",
      "r451",
      "r561",
      "r574",
      "r626",
      "r898",
      "r899",
      "r900",
      "r908"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs (Level 2) [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r446",
      "r451",
      "r561",
      "r562",
      "r574",
      "r627",
      "r891",
      "r892",
      "r898",
      "r899",
      "r900",
      "r908"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Other Unobservable Inputs (Level 3) [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r561",
      "r562",
      "r563",
      "r564",
      "r574",
      "r628",
      "r891",
      "r892",
      "r898",
      "r899",
      "r900",
      "r908",
      "r912"
     ]
    },
    "us-gaap_FairValueInputsQuantitativeInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsQuantitativeInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r561",
      "r562",
      "r564",
      "r908",
      "r1180",
      "r1183"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r559",
      "r561",
      "r562",
      "r563",
      "r564",
      "r573",
      "r574",
      "r576",
      "r626",
      "r627",
      "r628",
      "r891",
      "r892",
      "r898",
      "r899",
      "r900",
      "r908",
      "r912"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r908",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1183"
     ]
    },
    "qttb_FairValueOfInterestExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "FairValueOfInterestExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of interest expenses.",
        "label": "Fair value Of Interest Expenses",
        "terseLabel": "Fair value Of Interest Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r336",
      "r337",
      "r338",
      "r339",
      "r341",
      "r343",
      "r344",
      "r345",
      "r418",
      "r437",
      "r554",
      "r581",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r711",
      "r888",
      "r908",
      "r910",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r922",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1176",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183"
     ]
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Fair value of warrants issued",
        "totalLabel": "Total",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": [
      "r1177",
      "r1178",
      "r1182"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transactions",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "qttb_ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ForeignExchangeContractsOptionContractsAndOtherForeignExchangeHedgingArrangementsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange contracts option contracts and other foreign exchange hedging arrangements.",
        "label": "Foreign Exchange Contracts Option Contracts And Other Foreign Exchange Hedging Arrangements [Member]",
        "terseLabel": "Foreign exchange contracts &amp; other forign heding arrangements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r973",
      "r984",
      "r994",
      "r1027"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r973",
      "r984",
      "r994",
      "r1027"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r973",
      "r984",
      "r994",
      "r1027"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r973",
      "r984",
      "r994",
      "r1027"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r973",
      "r984",
      "r994",
      "r1027"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1007"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_FutureMinimumLeasePaymentDueUnderThisSublease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "FutureMinimumLeasePaymentDueUnderThisSublease",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future minimum lease payment due under this sublease",
        "label": "Future minimum lease payment due under this sublease",
        "terseLabel": "Future minimum lease payment due under this sublease"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on disposal of property and equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "qttb_GainOnConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "GainOnConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain On Convertible Notes",
        "label": "Gain On Convertible Notes",
        "terseLabel": "Gain on conversion of convertible notes",
        "negatedLabel": "Gain on convertible notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r806"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "qttb_HomologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "HomologyMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Homology.",
        "label": "Homology [Member]",
        "terseLabel": "Homology"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_HorizonCollaborationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "HorizonCollaborationAgreementMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Horizon collaboration agreement.",
        "label": "Horizon Collaboration Agreement [Member]",
        "terseLabel": "Horizon collaboration agreement"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_HorizonTherapeuticsIrelandDacMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "HorizonTherapeuticsIrelandDacMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Horizon Therapeutics Ireland DAC Member",
        "label": "Horizon Therapeutics Ireland DAC [Member]",
        "terseLabel": "Horizon Therapeutics Ireland DAC"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r952",
      "r953",
      "r976"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment, long-lived asset, held-for-use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r34",
      "r103",
      "r909"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r104"
     ]
    },
    "us-gaap_IncentiveFromLessor": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncentiveFromLessor",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive from Lessor",
        "terseLabel": "Lessee tenant improvement allowance",
        "documentation": "Amount of incentive received by lessee from lessor."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r143",
      "r145",
      "r1068"
     ]
    },
    "qttb_IncomeLossBeforeProvisionForIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IncomeLossBeforeProvisionForIncomeTaxes",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss before provision for income taxes",
        "label": "Income (Loss) Before Provision For Income Taxes",
        "documentation": "Income (loss) before provision for income taxes.",
        "totalLabel": "Loss before provision for income taxes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r503"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r503"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfLossFromOperationsBeforeIncomeTaxDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Loss before income taxes",
        "totalLabel": "Loss before provision for income taxes and loss from equity method investment",
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r715",
      "r875",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Loss from equity method investment",
        "terseLabel": "Loss from equity method investment",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r86",
      "r135",
      "r248",
      "r263",
      "r286",
      "r327",
      "r708"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r372",
      "r373",
      "r566",
      "r570",
      "r575",
      "r736",
      "r738",
      "r811",
      "r863",
      "r911",
      "r1208"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r373",
      "r566",
      "r570",
      "r575",
      "r736",
      "r738",
      "r811",
      "r863",
      "r911",
      "r1208"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r504",
      "r505",
      "r512",
      "r522",
      "r907",
      "r1164"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r504",
      "r505",
      "r512",
      "r522",
      "r907",
      "r1164"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_IncomeTaxDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IncomeTaxDisclosureLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_IncomeTaxDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IncomeTaxDisclosureTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax disclosure.",
        "label": "Income Tax Disclosure [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r498",
      "r504",
      "r509",
      "r510",
      "r511",
      "r515",
      "r521",
      "r528",
      "r530",
      "r531",
      "r532",
      "r753",
      "r907"
     ]
    },
    "us-gaap_IncomeTaxExaminationDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationDescription",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Description",
        "label": "Income Tax Examination, Description",
        "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings."
       }
      }
     },
     "auth_ref": [
      "r1162"
     ]
    },
    "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Examination, Likelihood of Unfavorable Settlement",
        "terseLabel": "Income Tax Description",
        "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority."
       }
      }
     },
     "auth_ref": [
      "r1162"
     ]
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued penalties and provisions for interest",
        "label": "Income Tax Examination, Penalties and Interest Expense",
        "totalLabel": "Income Tax Examination, Penalties and Interest Expense, Total",
        "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations."
       }
      }
     },
     "auth_ref": [
      "r1161"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for tax expense (benefit)",
        "totalLabel": "Total income tax provision",
        "verboseLabel": "Provision for income taxes",
        "negatedLabel": "Provision for income taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r161",
      "r223",
      "r224",
      "r248",
      "r264",
      "r286",
      "r502",
      "r504",
      "r529",
      "r716",
      "r907"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r500",
      "r501",
      "r515",
      "r516",
      "r520",
      "r524",
      "r747"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other current liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "qttb_IncreaseDecreaseInContingentLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IncreaseDecreaseInContingentLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent liability",
        "label": "Increase Decrease In Contingent Liability",
        "documentation": "Increase Decrease In Contingent Liability",
        "negatedLabel": "Contingent liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_IncreaseDecreaseInNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInNotesPayableCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Notes Payable, Current",
        "terseLabel": "Gain on conversion of the Convertible Notes",
        "totalLabel": "Increase (Decrease) in Notes Payable, Current, Total",
        "documentation": "The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1070",
      "r1086"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other noncurrent assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "qttb_IncreaseInCommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IncreaseInCommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase In Common Stock Capital Shares Reserved For Future Issuance",
        "label": "Increase In Common Stock Capital Shares Reserved For Future Issuance",
        "terseLabel": "Increase in number of shares reserved for issuance (shares)"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase In Number Of Shares Reserved For Issuance Percent Of Common Stock Outstanding",
        "label": "Increase In Number Of Shares Reserved For Issuance Percent Of Common Stock Outstanding",
        "terseLabel": "Increase in number of shares reserved for issuance, percent of common stock outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive securities",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r233",
      "r243",
      "r460"
     ]
    },
    "qttb_IndirectResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IndirectResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indirect research and development expense",
        "label": "Indirect Research and Development Expense",
        "documentation": "Indirect Research and Development Expense"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_IndirectResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IndirectResearchAndDevelopmentMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indirect Research and Development [Member]",
        "documentation": "Indirect Research and Development [Member]",
        "terseLabel": "Indirect Research and Development [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r973",
      "r984",
      "r994",
      "r1018",
      "r1027",
      "r1031",
      "r1039"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r954",
      "r1043"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r954",
      "r1043"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r954",
      "r1043"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense, Operating and Nonoperating",
        "terseLabel": "Interest expenses",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r256",
      "r260",
      "r266",
      "r286",
      "r593",
      "r881",
      "r882"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense",
        "verboseLabel": "Interest expenses on convertible debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r413",
      "r424",
      "r893",
      "r894"
     ]
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeExpenseNet",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income (Expense), Operating",
        "totalLabel": "Interest Income (Expense), Operating, Total",
        "negatedLabel": "Interest (income) expense, net",
        "documentation": "Amount of interest income (expense) classified as operating."
       }
      }
     },
     "auth_ref": [
      "r688",
      "r1101"
     ]
    },
    "qttb_InvestmentMaturityTerm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "InvestmentMaturityTerm",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Maturity Term",
        "label": "Investment Maturity Term",
        "terseLabel": "Contractual maturity date of investments"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_InvestmentsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "InvestmentsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments Disclosure Abstract",
        "label": "Investments Disclosure Abstract",
        "terseLabel": "Investments Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of Common Stock During Period Pre-Closing Financing, Net of Issuance Costs",
        "label": "Issuance of Common Stock During Period Pre-Closing Financing, Net of Issuance Costs",
        "terseLabel": "Issuance of common stock in the pre-closing financing, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of Common Stock During Period Pre-Closing Net of Issuance Costs",
        "label": "Issuance of Common Stock During Period Pre-Closing Net of Issuance Costs",
        "terseLabel": "Issuance of common stock in the pre-closing financing, Value"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_IssuanceOfCommonStocksFromRsuVesting": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IssuanceOfCommonStocksFromRsuVesting",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of Common Stocks from RSU Vesting",
        "label": "Issuance of Common Stocks from RSU Vesting",
        "terseLabel": "Issuance Of Common Stocks From Rsu Vesting, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_IssuanceOfCvrAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "IssuanceOfCvrAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance Of CVR At Fair Value",
        "label": "Issuance Of CVR At Fair Value",
        "terseLabel": "Issuance of CVR at fair value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost, Total",
        "totalLabel": "Total lease costs",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r603",
      "r920"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Cost and Variable Lease Costs and Sub Lease Income",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1189"
     ]
    },
    "us-gaap_LeaseExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseExpirationDate1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expiration date",
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_LeaseExpirationDateYearAndMonth": {
     "xbrltype": "gYearMonthItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LeaseExpirationDateYearAndMonth",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease expiration date year and month.",
        "label": "Lease Expiration Date Year And Month",
        "terseLabel": "Operating lease expiration year and month"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r609"
     ]
    },
    "qttb_LegacyQ32Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LegacyQ32Member",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legacy Q32 [Member]",
        "label": "Legacy Q32 [Member]",
        "terseLabel": "Legacy Q32"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Renewal Term",
        "terseLabel": "Lessee, operating lease, lease not yet commenced, renewal term",
        "documentation": "Term of lessee's operating lease renewal for lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1188"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Operating Lease Liabilities",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1190"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Total",
        "terseLabel": "Total minimum lease payments",
        "totalLabel": "Total minimum lease payments",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2025",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2029",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "qttb_LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee operating lease not yet commenced increase in percentage of base rent.",
        "label": "Lessee Operating Lease Not Yet Commenced Increase In Percentage Of Base Rent",
        "terseLabel": "Percentage increase in initial annual base rent per square foot."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r67",
      "r68",
      "r69",
      "r73",
      "r74",
      "r75",
      "r76",
      "r205",
      "r332",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r545",
      "r546",
      "r547",
      "r584",
      "r780",
      "r874",
      "r947",
      "r1124",
      "r1192",
      "r1193"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, convertible preferred stock and stockholders' equity (deficit)",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r132",
      "r703",
      "r921",
      "r1090",
      "r1113",
      "r1184"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, convertible preferred stock and stockholders' equity (deficit)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r169",
      "r205",
      "r332",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r545",
      "r546",
      "r547",
      "r584",
      "r921",
      "r1124",
      "r1192",
      "r1193"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_LicenseAgreementWithBristolMayersEquibCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LicenseAgreementWithBristolMayersEquibCompanyMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement with bristol mayers equib company.",
        "label": "License Agreement With Bristol Mayers Equib Company [Member]",
        "verboseLabel": "License Agreement With Bristol Mayers Equib Company [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_LicenseAgreementWithTheUniversityOfColoradoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LicenseAgreementWithTheUniversityOfColoradoMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement with the university of colorado.",
        "label": "License Agreement With The University Of Colorado [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility aggregate amount including balloon repayment payable.",
        "label": "Line Of Credit Facility Aggregate Amount Including Balloon Repayment Payable",
        "terseLabel": "Line of credit facility aggregate amount including balloon repayment payable"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility amount that may be contingently borrowed.",
        "label": "Line Of Credit Facility Amount That May Be Contingently Borrowed",
        "terseLabel": "Line of credit facility amount that may be contingently borrowed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Line of credit facility commitment fee amount",
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r72",
      "r383"
     ]
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Line of credit facility commitment fee percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityDateOfFirstRequiredPayment1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityDateOfFirstRequiredPayment1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Date of First Required Payment",
        "terseLabel": "Line of credit facility date of first required payment",
        "documentation": "Date the first payment under the line of credit must be paid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r72"
     ]
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityExpirationDate1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Expiration Date",
        "terseLabel": "Line of credit facility expiration date",
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r72"
     ]
    },
    "us-gaap_LineOfCreditFacilityFrequencyOfPayments": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityFrequencyOfPayments",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Frequency of Payments",
        "terseLabel": "Line of credit facility frequency of payments",
        "documentation": "Description of the frequency of periodic payments, which may be presented in a variety of ways (for example, monthly, quarterly, annually)."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r72"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit maximum borrowing capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r72"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of credit remaining borrowing capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r72",
      "r383"
     ]
    },
    "us-gaap_LinesOfCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LinesOfCreditCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit, Current",
        "terseLabel": "Venture debt, current portion",
        "verboseLabel": "Line of credit facility outstanding current",
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r126"
     ]
    },
    "qttb_LoanAndSecurityAgreementWithSiliconValleyBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LoanAndSecurityAgreementWithSiliconValleyBankMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan and security agreement with silicon valley bank.",
        "label": "Loan And Security Agreement With Silicon Valley Bank [Member]",
        "terseLabel": "Loan And Security Agreement With Silicon Valley Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan and security fifth amendment agreement with silicon valley bank.",
        "label": "Loan And Security Fifth Amendment Agreement With Silicon Valley Bank [Member]",
        "terseLabel": "Loan And Security Fifth Amendment Agreement With Silicon Valley Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan and security fourth amendment agreement with silicon valley bank.",
        "label": "Loan And Security Fourth Amendment Agreement With Silicon Valley Bank [Member]",
        "terseLabel": "Loan And Security Fourth Amendment Agreement With Silicon Valley Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan and security second amendment agreement with silicon valley bank.",
        "label": "Loan And Security Second Amendment Agreement With Silicon Valley Bank [Member]",
        "verboseLabel": "Loan And Security Second Amendment Agreement With Silicon Valley Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan and security third amendment agreement with silicon valley bank.",
        "label": "Loan And Security Third Amendment Agreement With Silicon Valley Bank [Member]",
        "verboseLabel": "Loan And Security Third Amendment Agreement With Silicon Valley Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt",
        "totalLabel": "Carrying amount",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r130",
      "r406",
      "r422",
      "r891",
      "r892",
      "r919",
      "r1203"
     ]
    },
    "qttb_LongTermDebtBalloonPaymentPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LongTermDebtBalloonPaymentPercentage",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt balloon payment percentage.",
        "label": "Long Term Debt Balloon Payment Percentage",
        "terseLabel": "Long term debt balloon payment percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Current Maturities",
        "negatedLabel": "Less current portion",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Excluding Current Maturities",
        "totalLabel": "Long-term debt, net",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Convertible debt interest rate percentage",
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtPercentageBearingVariableInterestRate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate",
        "terseLabel": "Long term debt variable interest rate percentage",
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_LongTermLineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermLineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Line of Credit, Noncurrent",
        "terseLabel": "Venture debt, net of current portion",
        "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r37",
      "r38"
     ]
    },
    "qttb_LossOnImpairmentOfEquityInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "LossOnImpairmentOfEquityInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss on impairment of equity investment",
        "label": "Loss on impairment of equity investment",
        "terseLabel": "Loss on impairment of equity investment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Short-Term Investments",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "qttb_MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "MaterialRightForThePurchaseOfADXNineHundredAndFourteenMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material right for the purchase of ADX nine hundred and fourteen.",
        "label": "Material Right For The Purchase Of ADX Nine Hundred And Fourteen [Member]",
        "terseLabel": "Material right for the purchase of ADX-914"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r381",
      "r455",
      "r495",
      "r564",
      "r654",
      "r735",
      "r737",
      "r745",
      "r772",
      "r773",
      "r834",
      "r836",
      "r838",
      "r839",
      "r841",
      "r861",
      "r862",
      "r887",
      "r895",
      "r903",
      "r912",
      "r913",
      "r917",
      "r918",
      "r932",
      "r1128",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Required market rates of return [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputExpectedTermMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Expected Term (years) [Member]",
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date."
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "qttb_MeasurementInputProbabilityOfEachScenarioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "MeasurementInputProbabilityOfEachScenarioMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input probability of each scenario member.",
        "label": "Measurement Input Probability Of Each Scenario [Member]",
        "terseLabel": "Probability of each scenario [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r563",
      "r564",
      "r912"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r563",
      "r564",
      "r912"
     ]
    },
    "qttb_MergerAndAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "MergerAndAcquisitionLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger and Acquisition [Line Items]",
        "label": "Merger and Acquisition [Line Items]",
        "terseLabel": "Merger and Acquisition [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_MergerAndAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "MergerAndAcquisitionTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about merger and acquisition.",
        "label": "Merger and Acquisition [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMerger"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Accounting for the Merger",
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r119"
     ]
    },
    "qttb_MergersAndAquisitionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "MergersAndAquisitionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mergers and Aquisitions Abstract",
        "label": "Mergers and Aquisitions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r381",
      "r455",
      "r495",
      "r564",
      "r654",
      "r735",
      "r737",
      "r745",
      "r772",
      "r773",
      "r834",
      "r836",
      "r838",
      "r839",
      "r841",
      "r861",
      "r862",
      "r887",
      "r895",
      "r903",
      "r912",
      "r913",
      "r917",
      "r932",
      "r1128",
      "r1194",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "qttb_NatureOfBusinessLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "NatureOfBusinessLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of business.",
        "label": "Nature Of Business [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_NatureOfBusinessTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "NatureOfBusinessTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of business.",
        "label": "Nature Of Business [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r95",
      "r97"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss",
        "negatedLabel": "Net income (loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r97",
      "r136",
      "r167",
      "r186",
      "r189",
      "r194",
      "r205",
      "r214",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r223",
      "r224",
      "r239",
      "r332",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r537",
      "r542",
      "r558",
      "r584",
      "r709",
      "r803",
      "r824",
      "r825",
      "r946",
      "r1124"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income (loss) attributable to common stockholders- basic",
        "totalLabel": "Net Income (Loss) Available to Common Stockholders, Basic, Total",
        "verboseLabel": "Net income (loss)-basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r216",
      "r217",
      "r218",
      "r219",
      "r227",
      "r228",
      "r240",
      "r243",
      "r542"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted, Total",
        "terseLabel": "Net income (loss) attributable to common stockholders, Diluted",
        "totalLabel": "Net Income (Loss) Available to Common Stockholders, Diluted, Total",
        "verboseLabel": "Net income (loss)-diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r229",
      "r235",
      "r236",
      "r237",
      "r238",
      "r240",
      "r243"
     ]
    },
    "qttb_NetOperatingLossCarryForwardsExpirationYear": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "NetOperatingLossCarryForwardsExpirationYear",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards expiration year.",
        "label": "Net Operating Loss Carry forwards Expiration Year",
        "terseLabel": "Net operating loss carryforwards, expiration year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_Non-CashExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "Non-CashExpensesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash expenses [Member]",
        "documentation": "Non-cash expenses [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_NonCurrentLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "NonCurrentLiabilitiesLesseeAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non current liabilities lessee [Abstract].",
        "label": "Non Current Liabilities Lessee [Abstract]",
        "terseLabel": "Noncurrent:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r973",
      "r984",
      "r994",
      "r1018",
      "r1027"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r1018"
     ]
    },
    "qttb_NonRule10B51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "NonRule10B51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Rule 10b5-1 Arrangement Modified [Flag]",
        "label": "Non-Rule 10b5-1 Arr Modified [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Modified"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (expense), net",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "qttb_NumberOfCommonStockUnderlyingShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "NumberOfCommonStockUnderlyingShares",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of common stock underlying shares",
        "label": "Number of Common Stock Underlying Shares",
        "documentation": "Number of Common Stock Underlying Shares"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_NumberOfDirectorsEntitledToBeElected": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "NumberOfDirectorsEntitledToBeElected",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of directors entitled to be elected.",
        "label": "Number Of Directors Entitled To Be Elected",
        "terseLabel": "Number of directors entitled to be elected"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OffBalanceSheetCreditExposurePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OffBalanceSheetCreditExposurePolicyPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Off-Balance-Sheet Credit Exposure, Policy [Policy Text Block]",
        "terseLabel": "Off-Balance\u00a0Sheet Risk",
        "documentation": "Description of accounting policies and methodologies used to estimate the entity's liability for off-balance sheet credit exposures and related charges for those credit exposures."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r340"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r875",
      "r1100",
      "r1101",
      "r1102",
      "r1103",
      "r1104"
     ]
    },
    "qttb_OperatingLeaseAssetsLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "OperatingLeaseAssetsLesseeAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease assets lessee [Abstract].",
        "label": "Operating Lease Assets Lessee [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "terseLabel": "Fixed lease costs",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r920"
     ]
    },
    "qttb_OperatingLeaseLiabilitiesLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "OperatingLeaseLiabilitiesLesseeAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease liabilities lessee [Abstract].",
        "label": "Operating Lease Liabilities Lessee [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability",
        "terseLabel": "Total",
        "totalLabel": "Total operating lease liabilities",
        "verboseLabel": "Total lease liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability, current",
        "verboseLabel": "Lease liability, current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMaturitiesOfOperatingLeaseLiabilitiesDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liability, net of current portion",
        "verboseLabel": "Operating lease liabilities, net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesSummaryOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use asset, operating leases",
        "verboseLabel": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "terseLabel": "Non-cash\u00a0lease expense",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1087"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating lease weighted average discount rate",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r607",
      "r920"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease weighted average remaining lease term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r920"
     ]
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals",
        "terseLabel": "Future minimum lease payments due under this sublease",
        "documentation": "Contractually required future rental payments receivable on noncancelable subleasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Loss Carryforwards",
        "verboseLabel": "Net operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Current",
        "terseLabel": "Other",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r921"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other noncurrent assets",
        "totalLabel": "Total other noncurrent assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive loss",
        "totalLabel": "Total other comprehensive gain (loss)",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r10",
      "r121",
      "r187",
      "r190",
      "r220"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Change in unrealized gain (loss) on available for sale securities, net",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r185",
      "r326"
     ]
    },
    "qttb_OtherGAExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "OtherGAExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other G&amp;A expenses",
        "documentation": "Other G&amp;A expenses"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_OtherGAExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "OtherGAExpensesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other G&amp;A expenses [Member]",
        "documentation": "Other G&amp;A expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities",
        "terseLabel": "Due to related parties",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r695",
      "r776",
      "r777",
      "r947",
      "r1204",
      "r1238"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other noncurrent liabilities",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net",
        "totalLabel": "Other Nonoperating Income (Expense), Total",
        "verboseLabel": "Other income (expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherOperatingIncomeExpenseNet",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Income (Expense), Net",
        "terseLabel": "Other income (expense), net",
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1010"
     ]
    },
    "us-gaap_OtherResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Research and Development Expense",
        "terseLabel": "Indirect research and development expense",
        "verboseLabel": "Direct research and development expense",
        "documentation": "Amount of other research and development expense."
       }
      }
     },
     "auth_ref": [
      "r1158"
     ]
    },
    "qttb_OtherSegmentItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "OtherSegmentItemsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other segment items [Member]",
        "documentation": "Other segment items"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r971",
      "r982",
      "r992",
      "r1025"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r974",
      "r985",
      "r995",
      "r1028"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r974",
      "r985",
      "r995",
      "r1028"
     ]
    },
    "qttb_OxbSolutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "OxbSolutionsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oxb Solutions [Member]",
        "label": "Oxb Solutions [Member]",
        "terseLabel": "Oxb Solutions"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ParentCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ParentCompanyMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parent company [Member]",
        "label": "Parent Company [Member]"
       }
      }
     },
     "auth_ref": [
      "r210"
     ]
    },
    "qttb_PatentsCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PatentsCostsPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents costs.",
        "label": "Patents Costs [Policy Text Block]",
        "terseLabel": "Patent Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PaymentOfReverseRecapitalizationTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PaymentOfReverseRecapitalizationTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Of Reverse Recapitalization Transaction Costs",
        "label": "Payment Of Reverse Recapitalization Transaction Costs",
        "terseLabel": "Payment of reverse recapitalization transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PaymentToHorizon": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PaymentToHorizon",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment To Horizon",
        "label": "Payment to Horizon",
        "terseLabel": "Payment to horizon"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "qttb_PayrollTaxCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PayrollTaxCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payroll tax credit.",
        "label": "Payroll Tax Credit",
        "terseLabel": "Payroll tax credit"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r1018"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1011"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1000"
     ]
    },
    "qttb_PercentageOfConsolidatedCashToBeMaintainedWithTheLender": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PercentageOfConsolidatedCashToBeMaintainedWithTheLender",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of consolidated cash to be maintained with the lender.",
        "label": "Percentage Of Consolidated Cash To Be Maintained With The Lender",
        "terseLabel": "Percentage of consolidated cash to be maintained with the lender"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of outstanding debt to be maintained with the lender by way of cash.",
        "label": "Percentage Of Outstanding Debt To Be Maintained With The Lender By Way Of Cash",
        "terseLabel": "Percentage of outstanding debt to be maintained with the lender by way of cash"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PercentageOfSublicenseFees": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PercentageOfSublicenseFees",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "percentage of sublicense fees.",
        "label": "Percentage Of Sublicense Fees",
        "terseLabel": "Percentage of sublicense fees"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PeriodAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period.",
        "label": "Period [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PeriodDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period.",
        "label": "Period [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PeriodOfObligationToPayRoyalties": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PeriodOfObligationToPayRoyalties",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of obligation to pay royalties.",
        "label": "Period Of Obligation To Pay Royalties",
        "terseLabel": "Period of obligation to pay royalties"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PersonnelRelatedAndConsultingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PersonnelRelatedAndConsultingMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personnel Related and Consulting [Member]",
        "label": "Personnel Related and Consulting [Member]",
        "documentation": "Personnel Related and Consulting [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PersonnelRelatedCostsExcludingStockBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PersonnelRelatedCostsExcludingStockBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Personnel Related Costs Excluding Stock Based Compensation",
        "documentation": "Personnel Related Costs Excluding Stock Based Compensation",
        "terseLabel": "Personnel-related costs (excluding stock-based compensation)"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PhaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PhaseAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase.",
        "label": "Phase [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PhaseDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PhaseDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase.",
        "label": "Phase [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1131",
      "r1132",
      "r1133",
      "r1134",
      "r1135",
      "r1136",
      "r1137",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1142",
      "r1143",
      "r1144",
      "r1145",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1156"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1058"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "axisDefault": "Portion at Fair Value Measurement [Member] [Default]",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r938",
      "r939",
      "r942",
      "r943",
      "r944",
      "r945",
      "r1237",
      "r1240"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1082"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsNoncurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Noncurrent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r346",
      "r347",
      "r869"
     ]
    },
    "us-gaap_PrepaidExpenseCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrentAndNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense",
        "terseLabel": "Prepaid expenses",
        "documentation": "Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r181",
      "r794",
      "r1202"
     ]
    },
    "us-gaap_PrepaidExpenseOtherNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseOtherNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense Other, Noncurrent",
        "verboseLabel": "Other",
        "documentation": "Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "qttb_PrepaidExternalResearchAndDevelopmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PrepaidExternalResearchAndDevelopmentCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid external research and development current.",
        "label": "Prepaid External Research And Development Current",
        "terseLabel": "Prepaid external research and development"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PrepaidExternalResearchAndDevelopmentNonurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PrepaidExternalResearchAndDevelopmentNonurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosurePrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsSummaryOfPrepaidExpensesAndOtherNoncurrentAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "prepaid external research and development nonurrent.",
        "label": "prepaid external research and development nonurrent",
        "terseLabel": "Prepaid external research and development - long term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrimeRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrimeRateMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate [Member]",
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromCollaborators": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromCollaborators",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Collaborators",
        "terseLabel": "Received amount from Horizon",
        "documentation": "Cash received from collaborators during the current period."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible debt",
        "verboseLabel": "Proceeds from convertible debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock",
        "verboseLabel": "Proceeds from issuance of common stock in pre-closing financing",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Proceeds from redeemable convertible preferred stock",
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Long-Term Lines of Credit",
        "verboseLabel": "Proceeds from long term line of credit",
        "terseLabel": "Proceeds from borrowings under loan and security agreement",
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "qttb_ProceedsFromReverseRecapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ProceedsFromReverseRecapitalization",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Reverse Recapitalization",
        "label": "Proceeds from Reverse Recapitalization",
        "terseLabel": "Cash acquired in connection with reverse recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Sale of Short-Term Investments",
        "terseLabel": "Maturities of short-term investments",
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of common stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r14"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r655",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r866",
      "r896",
      "r931",
      "r932",
      "r933",
      "r936",
      "r937",
      "r1121",
      "r1122",
      "r1129",
      "r1205",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r655",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r866",
      "r896",
      "r931",
      "r932",
      "r933",
      "r936",
      "r937",
      "r1121",
      "r1122",
      "r1129",
      "r1205",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r609"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r154",
      "r158",
      "r159"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Total property and equipment",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r171",
      "r707"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property, Plant and Equipment [Member]",
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r609",
      "r692",
      "r707",
      "r921"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r154",
      "r158",
      "r705"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property Plant and Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r609"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated Useful Life (Years)",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_PropertyPlantAndEquipmentUsefulLife1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "PropertyPlantAndEquipmentUsefulLife1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property plant and equipment useful life 1.",
        "label": "Property Plant And Equipment Useful Life 1",
        "terseLabel": "Estimated Useful Life (Years)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]",
        "documentation": "Indicates description of term of useful life for property, plant, and equipment when not stated as numeric value."
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r999"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r381",
      "r445",
      "r455",
      "r484",
      "r485",
      "r486",
      "r495",
      "r564",
      "r629",
      "r638",
      "r654",
      "r735",
      "r737",
      "r745",
      "r772",
      "r773",
      "r834",
      "r836",
      "r838",
      "r839",
      "r841",
      "r861",
      "r862",
      "r887",
      "r895",
      "r903",
      "r912",
      "r913",
      "r917",
      "r918",
      "r932",
      "r940",
      "r1119",
      "r1128",
      "r1180",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r381",
      "r445",
      "r455",
      "r484",
      "r485",
      "r486",
      "r495",
      "r564",
      "r629",
      "r638",
      "r654",
      "r735",
      "r737",
      "r745",
      "r772",
      "r773",
      "r834",
      "r836",
      "r838",
      "r839",
      "r841",
      "r861",
      "r862",
      "r887",
      "r895",
      "r903",
      "r912",
      "r913",
      "r917",
      "r918",
      "r932",
      "r940",
      "r1119",
      "r1128",
      "r1180",
      "r1195",
      "r1196",
      "r1197",
      "r1198",
      "r1199"
     ]
    },
    "qttb_ReceivedAdvancePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ReceivedAdvancePayment",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Received advance payment",
        "label": "Received Advance Payment",
        "documentation": "Received Advance Payment"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_RecivedLoanAgreement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "RecivedLoanAgreement",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Received loan agreement",
        "label": "Recived Loan Agreement",
        "documentation": "Recived Loan Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReclassificationsOfTemporaryToPermanentEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassifications of Temporary to Permanent Equity",
        "terseLabel": "Temporary equity converted into permanent equity value",
        "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r122"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r966",
      "r977",
      "r987",
      "r1020"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r452",
      "r614",
      "r615",
      "r696",
      "r704",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r800",
      "r802",
      "r833"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "terseLabel": "Related Party",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209",
      "r614",
      "r615",
      "r616",
      "r617",
      "r696",
      "r704",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r800",
      "r802",
      "r833"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r614",
      "r615",
      "r1191"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r807",
      "r808",
      "r811"
     ]
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction, Purchases from Related Party",
        "terseLabel": "Related party transaction expense",
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r295",
      "r452",
      "r614",
      "r615",
      "r696",
      "r704",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r800",
      "r802",
      "r833",
      "r1191"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r612",
      "r613",
      "r615",
      "r618",
      "r754",
      "r755",
      "r756",
      "r809",
      "r810",
      "r811",
      "r830",
      "r832"
     ]
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Long-Term Lines of Credit",
        "terseLabel": "Payments on borrowings under loan and security agreement",
        "negatedLabel": "Payments on borrowings under loan and security agreement",
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff",
        "terseLabel": "In process research and development expense recognized",
        "documentation": "Amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r863",
      "r1158"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "verboseLabel": "Research and development expenses",
        "totalLabel": "Total segment and consolidated research and development expenses",
        "negatedLabel": "Total segment and consolidated research and development expenses",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r863",
      "r881",
      "r1200"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_ResearchMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research Tax Credit Carryforward [Member]",
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes."
       }
      }
     },
     "auth_ref": [
      "r1164"
     ]
    },
    "qttb_ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserved for future issuance under two thousand and seventeen stock plan.",
        "label": "Reserved For Future Issuance Under Two Thousand And Seventeen Stock Plan [Member]",
        "terseLabel": "Shares reserved for future issuance under the 2017 Stock Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserved For Future Issuance Under Two Thousand And Twenty Four Employee Stock Purchase Plan [Member]",
        "label": "Reserved For Future Issuance Under Two Thousand And Twenty Four Employee Stock Purchase Plan [Member]",
        "terseLabel": "Shares reserved for future issuance under the 2024 Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reserved For Future Issuance Under Two Thousand And Twenty Four Stock Plan Member",
        "label": "Reserved For Future Issuance Under Two Thousand And Twenty Four Stock Plan [Member]",
        "terseLabel": "Shares reserved for future issuance under the 2024 Stock Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r967",
      "r978",
      "r988",
      "r1021"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r968",
      "r979",
      "r989",
      "r1022"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r975",
      "r986",
      "r996",
      "r1029"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash and cash equivalents",
        "totalLabel": "Restricted Cash and Cash Equivalents, Total",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r123",
      "r170",
      "r201",
      "r698"
     ]
    },
    "qttb_RestrictedCashAndCashEquivalentsNonCurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "RestrictedCashAndCashEquivalentsNonCurrentMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash and cash equivalents non current.",
        "label": "Restricted Cash And Cash Equivalents Non Current [Member]",
        "terseLabel": "Restricted Cash And Cash Equivalents Non Current [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash and restricted cash equivalents",
        "totalLabel": "Restricted Cash and Cash Equivalents, Noncurrent, Total",
        "verboseLabel": "Restricted cash equivalents",
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r148",
      "r201"
     ]
    },
    "qttb_RestrictedCashNonCurrentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "RestrictedCashNonCurrentMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash non current.",
        "label": "Restricted Cash Non Current [Member]",
        "terseLabel": "Restricted Cash Non Current [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r112",
      "r702",
      "r742",
      "r744",
      "r752",
      "r783",
      "r921"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r211",
      "r212",
      "r213",
      "r215",
      "r220",
      "r222",
      "r224",
      "r334",
      "r335",
      "r364",
      "r525",
      "r526",
      "r534",
      "r535",
      "r536",
      "r538",
      "r541",
      "r542",
      "r548",
      "r550",
      "r551",
      "r553",
      "r556",
      "r597",
      "r598",
      "r739",
      "r741",
      "r757",
      "r1240"
     ]
    },
    "us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer",
        "terseLabel": "Collaboration agreement revenue",
        "documentation": "Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r1174"
     ]
    },
    "us-gaap_RevenuePerformanceObligationSatisfiedOverTimeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuePerformanceObligationSatisfiedOverTimeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Performance Obligation Satisfied over Time [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r805",
      "r865",
      "r871"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Transaction Price",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonSummaryOfTheTransactionPriceAllocatedToEachPerformanceObligationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]",
        "terseLabel": "Summary of the transaction price allocated to each performance obligation",
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation."
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "qttb_RevenueUsedToDetermineTransactionPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "RevenueUsedToDetermineTransactionPrice",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue used to determine transaction price.",
        "label": "Revenue Used To Determine Transaction Price",
        "terseLabel": "Transaction price to be determined"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues",
        "terseLabel": "Collaboration arrangement revenue",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138",
      "r195",
      "r205",
      "r248",
      "r257",
      "r258",
      "r280",
      "r286",
      "r290",
      "r292",
      "r294",
      "r332",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r584",
      "r691",
      "r881",
      "r1124"
     ]
    },
    "qttb_RoyaltyAsAPercentageOfNetSales": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "RoyaltyAsAPercentageOfNetSales",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty as a percentage of net sales.",
        "label": "Royalty As A Percentage Of Net Sales",
        "terseLabel": "Royalty as a percentage of sales"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_Rule10B51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "Rule10B51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rule 10b5-1 Arrangement Modified [Flag]",
        "label": "Rule 10b5-1 Arr Modified [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Modified"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Reverse recapitalization transaction costs",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock issue price per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SalesBasedMilestoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SalesBasedMilestoneMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales based milestone.",
        "label": "Sales Based Milestone [Member]",
        "terseLabel": "Sales-based milestone"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ScenarioOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ScenarioOneMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario one member.",
        "label": "Scenario One [Member]",
        "terseLabel": "Scenario one [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ScenarioThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ScenarioThreeMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario three member.",
        "label": "Scenario Three [Member]",
        "terseLabel": "Scenario three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_ScenarioTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ScenarioTwoMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario two member.",
        "label": "Scenario Two [Member]",
        "terseLabel": "Scenario two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r225",
      "r456",
      "r1063",
      "r1096"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of computation of diluted net loss per share attributable to common stockholders",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Summary of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "documentation": "Tabular disclosure of the components of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Summary of Short Term Investments",
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r543"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of components of provision for income taxes",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1166"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Summary of calculation of diluted net income (loss) per share, the numerator is adjusted for any changes",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1099"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of income tax expense (benefit) computed",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r506",
      "r907",
      "r1159"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r328",
      "r329",
      "r331",
      "r533",
      "r1064",
      "r1065",
      "r1066",
      "r1169",
      "r1170",
      "r1171",
      "r1172"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Equity Method Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r328",
      "r329",
      "r331",
      "r332",
      "r584"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureInvestmentInEquitySecuritiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment [Table]",
        "documentation": "Disclosure of information about equity method investment. Includes, but is not limited to, name of investee or group of investees, percentage ownership, difference between investment and value of underlying equity in net assets."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r205",
      "r328",
      "r329",
      "r331",
      "r332",
      "r584"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets And Liabilities Measured At Fair Value On A Recurring Basis",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1177",
      "r1178"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of loss from operations before income taxes",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyPlantAndEquipmentDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfAssetsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r609"
     ]
    },
    "qttb_ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of recapitalization of assets and liabilities.",
        "label": "Schedule of Recapitalization of Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Recapitalization of Assets and Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r807",
      "r808",
      "r811"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information Expenses",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r459",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r115"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Assumptions Used to Value Stock Options Granted",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Deposit",
        "terseLabel": "Security deposit",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r951"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r140",
      "r248",
      "r253",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r294",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r363",
      "r374",
      "r375",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r878",
      "r881",
      "r882",
      "r889",
      "r935",
      "r1205",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r292",
      "r293",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r769",
      "r770",
      "r771",
      "r835",
      "r837",
      "r840",
      "r842",
      "r849",
      "r851",
      "r852",
      "r853",
      "r854",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r867",
      "r897",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r934",
      "r940",
      "r1129",
      "r1205",
      "r1209",
      "r1210",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r248",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r269",
      "r271",
      "r272",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r294",
      "r876",
      "r879",
      "r880",
      "r881",
      "r883",
      "r885",
      "r886"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Other Segment Item, Amount",
        "terseLabel": "Other segment items",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r271",
      "r272",
      "r286",
      "r881"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r289",
      "r292",
      "r877",
      "r878",
      "r884"
     ]
    },
    "us-gaap_SelfInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SelfInsuranceReserve",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Self Insurance Reserve",
        "verboseLabel": "Executive insurance reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "qttb_SeriesAConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SeriesAConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Convertible Preferred Stock.",
        "label": "Series A Convertible Preferred Stock [Member]",
        "terseLabel": "Series A convertible preferred stock [Member]",
        "verboseLabel": "Series A convertible preferred stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SeriesAOneConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SeriesAOneConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A One Convertible Preferred Stock.",
        "label": "Series A One Convertible Preferred Stock [Member]",
        "terseLabel": "Series A-1 convertible preferred stock [Member]",
        "verboseLabel": "Series A-1 convertible preferred stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SeriesAOneRedeemableConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SeriesAOneRedeemableConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series a one redeemable convertible preferred stock.",
        "label": "Series A One Redeemable Convertible Preferred Stock [Member]",
        "verboseLabel": "Series A One Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SeriesARedeemableConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SeriesARedeemableConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series a redeemable convertible preferred stock.",
        "label": "Series A Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SeriesARedeemablePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SeriesARedeemablePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series a redeemable preferred stock.",
        "label": "Series A Redeemable Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SeriesATwoRedeemableConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SeriesATwoRedeemableConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series a two redeemable convertible preferred stock.",
        "label": "Series A Two Redeemable Convertible Preferred Stock [Member]",
        "verboseLabel": "Series A Two Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SeriesBConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SeriesBConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B Convertible Preferred Stock.",
        "label": "Series B Convertible Preferred Stock [Member]",
        "terseLabel": "Series B convertible preferred stock [Member]",
        "verboseLabel": "Series B convertible preferred stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SeriesBRedeemableConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SeriesBRedeemableConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series b redeemable convertible preferred stock.",
        "label": "Series B Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Series B Redeemable Convertible Preferred Stock [Member]",
        "verboseLabel": "Series B Redeemable Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SeventhAmendmentToTheLoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SeventhAmendmentToTheLoanAgreementMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Seventh amendment to the loan agreement.",
        "label": "Seventh Amendment To The Loan Agreement [Member]",
        "verboseLabel": "Seventh Amendment To The Loan Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Severance Costs",
        "terseLabel": "Payment Related to Severance Cost",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Recognized Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "verboseLabel": "Share based awards, vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility range",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected stock price volatility range, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected stock price volatility range, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate range",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate range, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate range, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r459",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "verboseLabel": "Share based awards, shares available for future grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Assumed in Reverse Recapitalization",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Assumed in Reverse Recapitalization",
        "terseLabel": "Number of shares, Assumed in reverse recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Number of Shares, Exercisable",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price, Exercisable",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r467"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of options exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of Shares, Cancelled",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r471"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Stock options granted",
        "totalLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r1138"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of Shares, Granted",
        "verboseLabel": "Share based compensation by share based award options granted during the period shares",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Ending Balance",
        "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning Balance",
        "terseLabel": "Aggregate Intrinsic Value, Outstanding Ending Balance",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of Shares, Outstanding at Ending Balance",
        "periodStartLabel": "Number of Shares, Outstanding at Beginning Balance",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r466"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted- Average Exercise Price, Outstanding at Ending Balance",
        "periodStartLabel": "Weighted- Average Exercise Price, Outstanding at Beginning Balance",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r465",
      "r466"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Vested and expected to vest",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number of shares, Vested and expected to vest",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price, Vested and expected to vest",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Of Common Stock Through Payroll Deductions Percentage",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Purchase Price Of Common Stock Through Payroll Deductions Percentage",
        "terseLabel": "Purchase of common stock through payroll deductions expressed in percentage of fair market value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued during period",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "qttb_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Stock Offering Period",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Stock Offering Period",
        "terseLabel": "Common stock offering period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487"
     ]
    },
    "qttb_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Assumed in reverse recapitalization, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Assumed in reverse recapitalization, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price, Assumed in reverse recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price, Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r470"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price, Cancelled",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r471"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted- Average Exercise Price, Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "verboseLabel": "Share based awards, maximum contractual term",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfAssumptionsUsedToValueStockOptionsGrantedDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years) range",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term, Exercisable",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term, Outstanding",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term, Vested and expected to vest",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of options vested",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average grant date fair value, options granted",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, Shares",
        "periodStartLabel": "Beginning balance, Shares",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureAccountingForTheMergerSummaryOfRecapitalizationOfAssetsAndLiabilitiesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Investments",
        "terseLabel": "Short-term investments",
        "totalLabel": "Short-Term Investments, Total",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134",
      "r1081"
     ]
    },
    "qttb_ShortTermInvestmentsAcquiredInReverseRecapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "ShortTermInvestmentsAcquiredInReverseRecapitalization",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short Term Investments Acquired In reverse recapitalization",
        "label": "Short Term Investments Acquired In reverse recapitalization",
        "terseLabel": "Short Term Investments Acquired In reverse recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r202"
     ]
    },
    "qttb_SixthAmendmentAgreementWithSiliconValleyBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SixthAmendmentAgreementWithSiliconValleyBankMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sixth amendment agreement with silicon valley bank.",
        "label": "Sixth Amendment Agreement With Silicon Valley Bank [Member]",
        "verboseLabel": "Sixth Amendment Agreement With Silicon Valley Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r504"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r138",
      "r139",
      "r140",
      "r166",
      "r248",
      "r253",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r287",
      "r288",
      "r294",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r363",
      "r366",
      "r374",
      "r375",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r878",
      "r881",
      "r882",
      "r889",
      "r935",
      "r1205",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "verboseLabel": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r177",
      "r178",
      "r179",
      "r205",
      "r230",
      "r234",
      "r241",
      "r243",
      "r250",
      "r251",
      "r332",
      "r384",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r426",
      "r427",
      "r429",
      "r432",
      "r439",
      "r584",
      "r748",
      "r749",
      "r750",
      "r751",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r782",
      "r804",
      "r826",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r1062",
      "r1088",
      "r1098"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r79",
      "r82",
      "r83",
      "r165",
      "r192",
      "r193",
      "r194",
      "r211",
      "r212",
      "r213",
      "r215",
      "r220",
      "r222",
      "r224",
      "r249",
      "r334",
      "r335",
      "r364",
      "r441",
      "r525",
      "r526",
      "r534",
      "r535",
      "r536",
      "r538",
      "r541",
      "r542",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r556",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r597",
      "r598",
      "r610",
      "r710",
      "r739",
      "r740",
      "r741",
      "r757",
      "r826"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r292",
      "r293",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r769",
      "r770",
      "r771",
      "r835",
      "r837",
      "r840",
      "r842",
      "r849",
      "r851",
      "r852",
      "r853",
      "r854",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r867",
      "r897",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r934",
      "r940",
      "r1129",
      "r1205",
      "r1209",
      "r1210",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r249",
      "r598",
      "r655",
      "r746",
      "r768",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r782",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r802",
      "r805",
      "r806",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r941"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/FairValueMeasurementsSummaryOfFairValueMeasurementSignificantInputsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r225",
      "r456",
      "r1063",
      "r1067",
      "r1096"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommonStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r249",
      "r295",
      "r598",
      "r655",
      "r746",
      "r768",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r782",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r802",
      "r805",
      "r806",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r826",
      "r941"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r970",
      "r981",
      "r991",
      "r1024"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock to common stock in connection with the Merge, Share",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r41",
      "r79",
      "r82",
      "r112",
      "r410"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Issuance of common stock for conversion of convertible notes, Shares",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r41",
      "r78",
      "r79",
      "r112"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock issued during the period new issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r78",
      "r79",
      "r112",
      "r748",
      "r826",
      "r844"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Purchase of Assets",
        "terseLabel": "Stock issued during period shares purchase of assets",
        "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Vesting of restricted stock, Shares",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r78",
      "r79",
      "r112"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Issuance of common stock from option exercises, Shares",
        "negatedLabel": "Number of Shares, Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r78",
      "r79",
      "r112",
      "r470"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible preferred stock to common stock in connection with the Merger, Value",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r79",
      "r82",
      "r83",
      "r112"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "terseLabel": "Issuance of common stock for conversion of Convertible Notes, Value",
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r79",
      "r82",
      "r83",
      "r112"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock from option exercises",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r79",
      "r82",
      "r83",
      "r112"
     ]
    },
    "qttb_StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Value to Homology Shareholders in Reverse Recapitalization",
        "label": "Stock Issued During Period Value to Homology Shareholders in Reverse Recapitalization",
        "terseLabel": "Issuance of common stock to Homology shareholders in reverse recapitalization, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Value to Homology Shareholders Reverse Recapitalization",
        "label": "Stock Issued During Period Value to Homology Shareholders Reverse Recapitalization",
        "terseLabel": "Issuance of common stock to Homology shareholders in reverse recapitalization, Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity (deficit)",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r82",
      "r83",
      "r100",
      "r784",
      "r801",
      "r827",
      "r828",
      "r921",
      "r947",
      "r1090",
      "r1113",
      "r1184",
      "r1240"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' deficit:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommonStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "Common Stock",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r204",
      "r425",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r441",
      "r555",
      "r829",
      "r831",
      "r848"
     ]
    },
    "us-gaap_StockholdersEquityNoteSpinoffTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteSpinoffTransaction",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note, Spinoff Transaction",
        "terseLabel": "Reverse recapitalization transaction costs",
        "documentation": "The change in equity as a result of a spin-off transaction (a regular or reverse spin-off) which is based on the recorded amounts."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Reverse Stock Split",
        "terseLabel": "Stockholders' equity, reverse stock split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "qttb_SubleaseAggregateBaseRentObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SubleaseAggregateBaseRentObligation",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sublease aggregate base rent obligation.",
        "label": "Sublease Aggregate Base Rent Obligation",
        "terseLabel": "Sublease aggregate base rent obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r621"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r621"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r621"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r621"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/NatureOfTheBusinessAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r621"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events, Policy [Policy Text Block]",
        "terseLabel": "Subsequent Event Considerations",
        "documentation": "Disclosure of accounting policy for reporting subsequent events."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r620",
      "r622"
     ]
    },
    "qttb_SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of estimated useful life of assets.",
        "label": "Summary Of Estimated Useful Life Of Assets [Table Text Block]",
        "terseLabel": "Summary of Estimated Useful Life of Assets"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of prepaid expenses and other current assets table text block.",
        "label": "Summary Of Prepaid Expenses And Other Current Assets [Table Text Block]",
        "terseLabel": "Summary of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/PrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of Prepaid Expenses and Other Noncurrent Assets [Table Text Block]",
        "label": "Summary of Prepaid Expenses and Other Noncurrent Assets [Table Text Block]",
        "terseLabel": "Summary of Prepaid Expenses and Other Noncurrent Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r1017"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Research and development tax credit carryforwards",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "qttb_TaxCreditCarryforwardsExpirationYear": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TaxCreditCarryforwardsExpirationYear",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforwards expiration year.",
        "label": "Tax Credit Carryforwards Expiration Year",
        "terseLabel": "Tax credit carryforwards expiration year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes Payable, Current",
        "terseLabel": "Accrued taxes payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68"
     ]
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityByClassOfStockTable",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, by Class of Stock [Table]",
        "documentation": "Disclosure of information about equity instrument classified as temporary equity. Includes, but not is limited to, description of share, value, share authorized, issued, and outstanding, redemption price per share, and subscription receivable."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r39"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "terseLabel": "Total convertible preferred stock",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r493",
      "r700"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r205",
      "r332",
      "r584"
     ]
    },
    "qttb_TemporaryEquityConversionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TemporaryEquityConversionPricePerShare",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity conversion price per share.",
        "label": "Temporary Equity Conversion Price Per Share",
        "terseLabel": "Temporary equity conversion price per share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TemporaryEquityDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TemporaryEquityDividendRate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity dividend rate.",
        "label": "Temporary Equity Dividend Rate",
        "terseLabel": "Temporary equity dividend rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityDividendsAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityDividendsAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Dividends, Adjustment",
        "terseLabel": "Temporary equity, dividends, adjustment",
        "documentation": "Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityLineItems",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Line Items]",
        "verboseLabel": "Temporary Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityLiquidationPreference",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Liquidation Preference",
        "terseLabel": "Preferred stock liquidation preference",
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TemporaryEquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TemporaryEquityMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity.",
        "label": "Temporary Equity [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock par value per share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r39"
     ]
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Preferred stock shares authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Preferred stock shares issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredStockAndStockholdersEquityDeficitUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Ending balance, Shares",
        "periodStartLabel": "Beginning balance, Shares",
        "terseLabel": "Preferred stock shares outsstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "qttb_TemporaryEquityStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TemporaryEquityStockIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Stock Issuance Costs",
        "documentation": "Temporary equity stock issuance costs.",
        "terseLabel": "Temporary equity stock issuance costs"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TotalCurrentExpenseBenifit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TotalCurrentExpenseBenifit",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total current",
        "label": "Total Current Expense Benifit",
        "documentation": "Total Current Expense Benifit"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TotalDeferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TotalDeferred",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total deferred",
        "label": "Total deferred",
        "documentation": "Total deferred"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TotalSegmentNetLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TotalSegmentNetLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureSegmentReportingSummaryOfTheCompanysSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Segment Net Loss",
        "documentation": "Total Segment Net Loss",
        "totalLabel": "Total Segment Net Loss"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1009"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r1016"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TrancheAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TrancheAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche.",
        "label": "Tranche [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TrancheDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TrancheDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche.",
        "label": "Tranche [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TrancheOneMilestoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TrancheOneMilestoneMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche one milestone.",
        "label": "Tranche One Milestone [Member]",
        "terseLabel": "Tranche One Milestone [Member]",
        "verboseLabel": "Tranche One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TrancheThreeMilestoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TrancheThreeMilestoneMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche three milestone.",
        "label": "Tranche Three Milestone [Member]",
        "terseLabel": "Tranche Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TrancheTwoMilestoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TrancheTwoMilestoneMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche two milestone.",
        "label": "Tranche Two Milestone [Member]",
        "terseLabel": "Tranche Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r418",
      "r437",
      "r554",
      "r581",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r639",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r711",
      "r908",
      "r910",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r922",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1176",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "qttb_TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and twenty and two thousand and twenty three term a loan.",
        "label": "Two Thousand And Twenty And Two Thousand And Twenty Three Term A Loan [Member]",
        "terseLabel": "Two Thousand And Twenty And Two Thousand And Twenty Three Term A Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TwoThousandAndTwentyTermALoanAdvanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TwoThousandAndTwentyTermALoanAdvanceMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and twenty term a loan advance.",
        "label": "Two Thousand And Twenty Term A Loan Advance [Member]",
        "verboseLabel": "Two Thousand And Twenty Term A Loan Advance [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TwoThousandAndTwentyThreeTermALoanAdvanceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TwoThousandAndTwentyThreeTermALoanAdvanceMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and twenty three term a loan advance.",
        "label": "Two Thousand And Twenty Three Term A Loan Advance [Member]",
        "terseLabel": "Two Thousand And Twenty Three Term A Loan Advance [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TwoThousandSeventeenStockOptionAndGrantPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TwoThousandSeventeenStockOptionAndGrantPlanMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand seventeen stock option and grant plan.",
        "label": "Two Thousand Seventeen Stock Option and Grant Plan [Member]",
        "terseLabel": "2017 Stock Option and Grant Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TwoThousandTwentyFourEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TwoThousandTwentyFourEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty Four Employee Stock Purchase Plan [Member]",
        "label": "Two Thousand Twenty Four Employee Stock Purchase Plan [Member]",
        "terseLabel": "2024 Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_TwoThousandTwentyFourStockOptionAndIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "TwoThousandTwentyFourStockOptionAndIncentivePlanMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty Four Stock Option and Incentive Plan [Member]",
        "label": "Two Thousand Twenty Four Stock Option and Incentive Plan [Member]",
        "terseLabel": "2024 Stock Option and Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/AgreementsWithHorizonAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r543"
     ]
    },
    "qttb_USStatutoryTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "USStatutoryTaxRate",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Statutory Tax Rate",
        "documentation": "US Statutory Tax Rate",
        "terseLabel": "U.S. statutory tax rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureShorttermInvestmentsSummaryOfShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US Treasury securities",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r872",
      "r898",
      "r900",
      "r908",
      "r1201"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r499",
      "r513",
      "r906"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "terseLabel": "Unrecognized tax benefits, settlements",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r906"
     ]
    },
    "qttb_UnrestrictedAndUnencumberedCashPercentageToBeMaintained": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "UnrestrictedAndUnencumberedCashPercentageToBeMaintained",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrestricted and unencumbered cash percentage to be maintained.",
        "label": "Unrestricted And Unencumbered Cash Percentage To Be Maintained",
        "terseLabel": "Unrestricted and unencumbered cash percentage to be maintained"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_UpfrontPaymentMade": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "UpfrontPaymentMade",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payment made.",
        "label": "Upfront Payment Made",
        "terseLabel": "Upfront payment made"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_UponReceiptOfWaiverOfMilestoneConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "UponReceiptOfWaiverOfMilestoneConditionsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/ConvertiblePreferredStockAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upon receipt of waiver of milestone conditions.",
        "label": "Upon Receipt Of Waiver Of Milestone Conditions [Member]",
        "verboseLabel": "Upon Receipt Of Waiver Of Milestone Conditions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upon the conversion of authorized series a1 redeemable convertible preferred stock.",
        "label": "Upon The Conversion Of Authorized Series A1 Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Shares reserved upon the conversion of authorized Series A-1 preferred stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upon the conversion of authorized series a redeemable convertible preferred stock.",
        "label": "Upon The Conversion Of Authorized Series A Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Shares reserved upon the conversion of authorized Series A preferred stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "qttb_UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upon the conversion of authorized series b redeemable convertible preferred stock.",
        "label": "Upon The Conversion Of Authorized Series B Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Shares reserved upon the conversion of authorized Series B preferred stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r150",
      "r152",
      "r155",
      "r156"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/IncomeTaxesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Valuation allowance period increase",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesScheduleOfOperatingLeaseCostAndVariableLeaseCostsAndSubLeaseIncomeDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r605",
      "r920"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "qttb_VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtSummaryOfLongTermDebtBalanceDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Venture debt two thousand twenty and two thousand and twenty three term a loan.",
        "label": "Venture Debt Two Thousand Twenty And Two Thousand And Twenty Three Term A Loan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1005"
     ]
    },
    "qttb_WalthamMassauchetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "WalthamMassauchetsMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Waltham massauchets.",
        "label": "Waltham Massauchets [Member]",
        "terseLabel": "Waltham Massauchets [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureCommonStockScheduleOfSharesOfCommonStockForFutureIssuanceDetail",
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "terseLabel": "Shares reserved for warrants [Member]",
        "verboseLabel": "Warrants to purchase common stock [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r938",
      "r939",
      "r942",
      "r943",
      "r944",
      "r945"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Class of warrants or rights term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1179",
      "r1180",
      "r1181"
     ]
    },
    "qttb_WarrantsIssuedToSiliconValleyBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.q32bio.com/20241231",
     "localname": "WarrantsIssuedToSiliconValleyBankMember",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DebtAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants issued to silicon valley bank.",
        "label": "Warrants Issued To Silicon Valley Bank [Member]",
        "terseLabel": "Warrants Issued To Silicon Valley Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average common shares - diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total",
        "verboseLabel": "Weighted-average common shares outstanding-diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r243"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails",
      "http://www.q32bio.com/20241231/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average common shares - basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total",
        "verboseLabel": "Weighted-average common shares outstanding-basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r243"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.q32bio.com/20241231/taxonomy/role/DisclosureNetIncomeLossPerShareSummaryOfCalculationOfDilutedNetIncomeLossPerShareTheNumeratorIsAdjustedForAnyChangesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1003"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21D"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-13"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-14"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "60",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481423/505-60-25-2"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-7"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-20/tableOfContent"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-3"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-9"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481178/840-20-25-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481178/840-20-25-6"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481501/840-20-50-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481475/840-20-55-3"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479428/808-10-45-3"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/323/tableOfContent"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/808/tableOfContent"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-21"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715-70/tableOfContent"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479924/842-10-30-5"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(1)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482190/360-10-35-3"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>113
<FILENAME>0000950170-25-036823-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-036823-xbrl.zip
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M;^A8CLD6>[+1)Y773;<JR.\I$;KXG2U86TY.$B)1-\6J(9Z=7$/FWDA?75_
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M(<FDX8R=7>G6_S6"&E3-(Q$4?2B8 $>""HFHN@PF"U3 47H7S!/")O#G)ZC
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M%M2Y@%C%UAV"&5Z7G+2.<' -TTU_DUF()0<QO;.\\>) 3]-;"8<8Y/EOE[J
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M3W,/5ZU0@8T'*2;*7:SAP4FCI#=?$'6W\R8MH:&)X@>='F_ TJ\?<Q4[>/"
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MB>TC)INSPYW,@Y_:GVJSYK6&M )OI;P/54R,S.!AV)V6]>=)>9CA,BSA6]M
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M?\Q +JNRD=DJL5XP Z')>GA3M$2@WZ-O;I>J367^N]N+_ETGUC\M+!$4P+X
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M=VI(D0K*4%;L/GCG=N/>9^3)AC?]!W6$ 9H[\7@U-HG//*]T:9@J7B#1*13
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MUVE)!Q!CQA37 AQ=K&I*[,BYD7I!8_J;Z_ZES*WE 2X*8*EZ7X%ET[C(RKK
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M>1.Q*,UC%#'A )=-^E&-G GMT. 8/;([.Z29KI-FM9;6'^BRZ^AO?MXXZA&
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MX^XD'<?WYO:5JBQDC"GC+M?P^,56D]B5PW(:]!,8C'0&3Y&;,>?4KT#A0.Q
MR>_*H7L_TPNL[A2WBUY12.!0%#O^X=A-7J'/@*G83D0GD@%UEYUFV7==SE)T
M*DI&2WIL_[Z:'XD9D2B4^/GVHDSCK>QV\T"PF*"G6RNP#<I?^**&-$TX!0N2
MD"5]H!2]KB0_B&M;\9*96#5-N+B03W@8H]F4_;0^:K3VU;GC@;JWL6(_%^)F
MK9&"49="<W/[)JHMB =>5,@RL&WFS&"=$%S!'-]:_KK<PB;G%7%(L^F[8)!
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MK?R:O=K.#%UW=N6MS)R5A>..;/K><9UIMSTC\<XLK5M-+<8H8?ORA/3EX;S
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MCA@;\[+>.4+30[\@/DH!.'4J!8"PZ;C((Y^9QJ_)_=^"0'5VN >(-D2,=-_
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MT^$EU6PA!4(#DA?,'02\C7;9+$)N=UZ<UM+=1/R1]5M,!]:NGELMZ'164:8
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M6TC7(D0*HAHB1#X<_E_8:%U>2_GNT^R0"N M:+T2!3!; D%@+W13 %F7!_%
M.W*)Z4(8\0R"JIJKJ?9FE=JGMYW!Z5CHBH;_(PAYD\2T[0V<2OWQ.ZUVJV)4
MNY<(FV"=27O^E/I\^N&_O/0Q0?@W#@_W/D0VP=)GYX$G#*7^=2GDW11T%(EB
M;"[@NV?3D 8D#_9;IQ8(OELK0Z.,C9]4/XPSG/"\TG(%/VSH2F D0MX%HZT,
M22%."-R.GYQX7]38Z_B]-">''T95D818-JJE]^N"KS)B)J<8I;Y5(]:EK"F
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MXS6L'#21*B=?_S5RTF@G#[B%"5A4B0;/0=VVLEBWP;_>\\MKLOPN0AEM3/?
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MI -(!Y .(!U .H!T .D T@&D T@'D/[9(<U/B%CM;-^&UJN00<^[G_WI_7Q
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MWGM'-?5M:\-;45&*"%*D1@5%04"E2DE4?G0A5)$:!9$F($HG)"K2FX" U*B
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M;AKP?&3)K2G5(F9LC3"O:UR_Y>CMUSYDSU+)_L/BM8'%@%ALVZX?R8+*Y#&
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M6N/>6[!^17%C8\>JF/<'%#4$B,A,N$9LQRLU^B'#:F2GYSXM)ZWVN'AXBBO
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M<U0@TV<F3;W04P7O.\?319(C4AI":RFPO4C_ A/AGA*%8"H=,%6\LO9BBYG
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MZ[)_86(%.0BB16%9>H=YP8E(E0",[=QR);'Z]0C'O-P5BU[J+B_*D\9.>A
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MG 8X)SB>N]TKYG@HM@?Q>(+&OMI?"4]#%97\/%H9,.1Z,EM>TC!_<$2+PD"
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M[)9F3-<9HON4((/HFA/$COT[0,"7^,)<NZ**\E__H=E?G]!4=69P@Q,E"73
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MQET>T]FI<LJ]U]2F?U?+OHH/)=@$^,[($Q6QKV8NS">,NRA5_SC\>B=H).#
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MQ7U74--+)K&X17U7 =@/$>+V7+>]Q"B]ALG=K*8U"J!4*/QJV^9,E+A? P4
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M0GU7FZZIUF<?><Z2Z,$9\?W&4(RK:,+C"GI:#;:\)QVQB"XH*K(/B,TG?^L
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M$[>)27!>"N _!H0AOE*1SAJ^XH</I !>$& DKI2-)8PN]%0$HO2?+9##*L^
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MS>] )+:G*%& 0W@UU^54_XJSL,4@M&9I-P9[&>?;'1\3R%2"JO_<=RNBY$Z
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MCT,V2X>2 55-&0IJI[[\#WB59KPL2V\??OW,P35U[C1>2484[_[[7Y%_0%M
M,:Y@>K<@9,RE/G7N[6'/@\ *"B!!3P<%<J$BF*(FPVP '3)6X&[. I6T\CUY
MG 3E_4J[7\4&T82N(]X<L6$.PCFEXG3+ELS6YIN("J?,UX8LN'>0NXY>!AK[
MW76'0$VX"W!6L!=88Y>;OQ3PW4!J:\+,.?Y.;7/$%ZV;[_4TCY[P\<4ZO DL
M@5PE3]JIX%]B8%T@9G51R0X;?.@!1UUC@\3$W-Z5I'(&%6;1O?="B1_C'PMM
MC>#%O:)37D,$\*YO;%>:)AV. ;1Q0(V14PLJ_M%64YD-[<6Q#;^FH.^;+<]2
M'^3VJS\F@RTM>:OD/7#[>] '6S9O0<MVO7H16XA?$$0UB&NZ:$?F:AC=/L3"
MZ&@2N\0+H>8>ASHKYCN!RG<W)BIV*Y8Y+8+<%^6VK@G='6CZ=*?GK?9!Y]?8
MM1KX2R"7F\ UTH\65AQW]LW)/<,L7Y;D>LLBXTLO_UYD6#)C/S,AA 24@.\0
MQ /&?AWZ7D)-%- UIIHQ4@#Q>\ P")68VM6)-\$6!-, .VW;45>9OV[&WA,.
M3WY ]QOT+"5,L:9N_:4VI50E,4<(B^WL2;CY\23W=!8(/P ZN>1'XY<W#-W1
MSM$%&& GG!4?KCV7:9?E'9C[+BX=\LT"V?OQG5H"/_[PT=B)?)I53Q%CB6=A
M;778R-K4&5467;B,3<0D[-2@W^G0:U8(\SB CY>N2P'W/P41(S%,,>@A]Z[I
MSG9SGB$*(-(#.OZ-W!;N*H6:T=EG[;^ <!5:XU>&%?]9'M@5#Y)N!DT>R&G_
MO6'@N4<F<:Z,;)SGVCV*4Q&Z(+DK^8KA\M72R(+&'0 [?IX !GN.DQ7!_CGK
M]QLY,SEBW)ILZ\8%D_S,G9*TCHV'[VET?!R-+@A!"LY%H!\)SLRUIF$?6M2D
MO_>H&VD@?<W%M1RP'L("2-D4 #)==157X5I.M,SDE]8/Z\K%),P.B_SZU4ZH
M[O]4Z!(PW.,D)"066/2068?.9!Y1FF4-/DLV;MDVP<E_.]9(^'>%97CY7Q].
M!2_V+5><.59D*9<Y4Q$]S2X6[S/*(9O[G3D(WXL;)976&<U=[CWQXPE9^8GG
MU,_.GRA/C-0/-[[?^)FY96CX+VGJ.I.^\Y$/;AP;"A8AI8!-WWVQIA$I#%+X
MXH>\V56=R,'&E&4O&1MDL4:WXX@9GD?W[O*C&'G(-S0SKNS^L.WI%,.V?3<H
M]+_27QJ2/O7BU#L@^M=<S./=5<?3(J_?R7;X)_*W'Z)3*0"ELV92KSM2$"\J
M374GD0+T#5B)NZX\ZA;/Z'=K25:[Z.:,2_T_S>)2WJK2.6I^LXC&UQ-ZR.?&
MCXW"R-?=AQ2'!TRL![(YUB^\:C)U8/JMS0 W4WY9>]@.6U(E&I :U=_DJ)-^
MJ'OX7RE3J$CIV/Q<?=1U2<B+" :NFWWL->U&\ZMTOYTCI[HM(09]?_[,TYD3
MW9?4\*3&XC+9ZB_!@DROBZ0 =N ?<T2QK+WUMM86!]<B"6/W>98I ($DH_Z6
MPW_H17.K LE\6>?Z/)L2SY>Q]6;97F[@25=N!JP"^ I.ET!+'J#BUYUJZSAU
M-Q:'%WN_G+)RO[T!,A#_4E$K-@!.9J%Z,U"#^0)3@H?']V*-:1DAJB?^213/
MAM8Z(<CF%,"!V<#IS'CN7C6. "/=63IH; ?+U6$I@)XX.EV\!C)&Y7M-TH&M
M.>Y2KH-QOY]T[AL2K7?^=6[R3>^D?O&=D5DEW$7L4CLHMK.+?.OWF"/5*TEQ
M](3(;ND"QXN,),X+*%P7JTGR1G -!:4162.0"\6=\/?U$)'4"^0%['/"Z\.[
MO*E_Y22N?=QLD#[^?,9PUAK;R;>LFAZDU[< 5)S*7:@^VM%FO5)\::ID9?S(
M'P2A .0P2[@D4F:+&4%Y.],6'N,;(FC6.FUL7:AJ>JAWSQQ0F^.@&ZK/9Z_!
MZ 89$:SZUS7.U8/9;(HH!\UWQ05Y],_]F6LYU+;MWSM5_Y6K3.NLO"5.53.A
MF0'-9!;IN5?+AKK^W?FNJ=/6/FU^%YV(T""@&,&>3-],#1=>BP)P'.+973Y8
MFX91C<!RDM*I'G0__0M9X6^5[XVTT@-\SA(D]_1.G-[=@!&'^NTE#R@+-<I:
M!(FMW!K!3PH$Z%4W#I[XYG+;PJ3Z]&&,SA6W1V[<8UQ?:Y(/X@LF%(ZRV2P&
MS"O4M72,O^^3N7 EQG%<;Q^^@&51 )XC<Y? E_%ROAS9WJL!!5WGRN61Q>M1
MCTG_'BM?4!?<ET6,^5L\>VZM[^U]LY/VL4.2CK+94UE=C??L^!@""!R4A0O%
M#Y6Z/^WOO5=]J_=QY/KY!7K2FH;-:L(DTU3K9<;CTGYFE!7<< G8CZZPWCI:
M,/RM 45ZG?BKPF9$D3?P"]BFZ7WCAD.B FJ\*3ZOQ5'DL^#?CA!_Y3[^*9XF
M9OR=]8B>1,*3WUN]=;X&-Z=7ZC4/I? )FURP0%(\!> R,DO !>/EBET0K<J/
ML")8@M_/[4)0O>@+&0[4.5KM;]*TH0^O3;<HD1E$L#6H]5YIE@ E<\RMUJ:_
MJ7[)<XL40)Z-=7K/,95NIWLRAATVOUJ,#OL6IS\8!2<V_<ZN]X<JIB$#)NT-
ME?7B^GST%L#3N;ZSQPU$5N8N^#RH1G5SM7I.$^;KGJ#ED<P\;0*RL5B'$5ET
MND(-A-#2$;.-T<'Z&PA$T!]JNGP370?EF:'7$E>[1X9']O6/U3 L:]]:LH@4
MP!^B&:E16OT^C#PE(,M35(3N;]!W+^X4]CBTS@]+&*!]6S'@/5D%&X?/6*"&
MJS"=.'?,=!K,>LBQU$8><3 [?"F MIKCD1AD<[XV9<?RX[#[TL:/'(6!RWQB
M<14>P?-GC<53B&E^OY/6;#BJGN%V(4Q^!WB#"M_?<V2IWBX-E_9KPM@6LV'E
M\3MU;%2-1@X"_/T,;S$CB'D"I*, .C0(BA2 6Y-'FLV4IU3GM;XXQ0YXN=<I
M8LUK]P)Z>7DD7D %T7":N.C.*<G*A(UBH(K!^%+$+MW.U+_DOD<&X.D>R9P:
MSV_@]F67N5)&=47)FKL@ ] )MZVR;PKL\"07';#4-2A, 5 !-J()3K/,3)40
ML?HV8""FT*NCXM\=H\ER[]QQJU,@:B12'8J]W.X'NJA.X^@KZ^9_L,7SB<.K
M#D;56"P-YU[&/15,7Y;0W;4](;(%]]!T ^L$&CQX]V*T:NLGTG)D_T\G0'A(
MIH=AC$?:@+0OL)\P=Q!$TR>[<LR9:F:OJK0USK7[;/\*8IA@OOWR[<9DYN]C
M.X]F6"?H<Q7?E'?.,-.T^='$(M$:)'=( >#>DQ*(@02EC4S%"G3:>&6YK\H3
M^EMI;PY.9<,65OL:.6G?S\PG'N2X;P#QPDLQQUR:-P-Z.\\[>=Q:?V+[J,-R
M]WE!RM6[_%'/+VDV6XPW[^/%+:(+&C"@]T1EWI,&_\.EGW3X5['71R8'H6)K
M4&02A%76C0*X"C;<[+IK[5JE5(D+Y(,N)Y)]B]0?8;D84MP#*0"JLNV#"XE-
MVNNP&K*=3!PB,)JE5&ZQ4><E2.+W5C3[O"0Y#1,F,Q;L@?AM&:+XH0Z.!A.%
M]=]]AIQR6+J8>>AFC/T:^$SF(=6",5C, #%F^US\2BA@F+H*7S/(;,IJ[=&(
M))],[L2[DE.+%&C[+?!-:<@-:@Q'!+1SOW?;\PH,R6?%:V#IMFT:O?9^^I8%
MS>]54[]3EM*@QEEM"=3J-Y0VA)T0!!DDWR7EO\N]DLNTK:J94;SQ8&OM0,,N
M,-]<HJ0N;2#JX)[.=JSS7\2*7UK12+G;=*;'-Y:_"X:IF ]?Y6HN@ 8308V"
M=?XQ"1\H &?!2-5JW=4G34^FL9IO'B4EW/'>3V,_O4/@P0/)K- Y'Q0N9^PT
M\6&))+& F_>%B9+F4C,-MN*M5=P#[[1.?B@UPR]?EH]>C2W JL&:IHG/]UO9
M_TVN)6HE=#699IY$MHC)FS7&P2#=/C[":U?;?FFY^QIW.5SYR8>8IB+E4R '
M,QVYOU4L7O':0 F7_)^('TE:?X'[84%GFJTTU ^JQ7?NM#)C1,/&C3(/SD(>
M/*)&]5Y,;H\3L:R?JC6V)DLF]\D&Y$M[Q=HY''(EC+MD/Z)1%A3Y]=]/AY\*
M<-]'*Y\K=198V6P9]=)<^T</C:9D]K,$P@.P\P3Y'/'.-/@E),9;I/I2^>YE
M^UTEZ2YODES?D9G]7*O(O[9^>)W!J=;K ?F/*8#)=H_OG:*$G?''0.P?"D U
M@<PPM'SJA !?0_XHZKIJW5=FHZW67!5]$_*!^M;6LM%!^^.OONH:!%%\'YF.
MXQQ!C%T<ONT /[!?_JUOBMW?U<"^M#/Q14,YW7U.W[1%A/%]CJ2?YW.1#19[
MK[OGCM 4AK:K:4H1Y3"OR2(Y_*+6=74Q(TUU8Y4YUC'O:"2Z!>2O<+9V],(-
MW:EPC$R&7ZG(1/1H G]%V6TZ&O ,S4#+;,LDNH*SQYC;SA#S4-X6=\Y.V"?-
MNUCA2E:"FOZO3-G@OI^1O>A5G64K^ZJ)]KYGG=W!)="V1TC, ">A?P0-Q4A!
MV/$#O5840)>!WO!)%T_L7-WQ[T+%:T8J Z?/XGX4GESW5\\YA<UZ!"-S8*7D
M7BQ8!G,\59]5KHN:]Y!Q:G%Z_/&UD5*@V2L:,!(I^!N4"*TY^634Q1QO=W$T
M&SRS7Q?CK2RD$ON8QXCH:P4/$JN)NFU2;*AA#?4GJ@E)-U?<P>E"[5)UD%X]
MT$^9L+:E2*N$C[[-NVI/IR0X%'-LI72%/W'>0]U_]_ SEW,T#O21FE%&7E&"
M/*W\FYJR8W4@1DO7S/3$;Q$F3;]T,4GR#I\_JR*_"+],X())D(K4;<"^6$+O
MW*C'IG>YC;".RJ#+FCP%T/O,'9>%-/H$1)W#2R,3F+\<K$X<!;L4V=B?M%IE
M,)..K!I@,64Z%PQA\REP<?AH) HE8;,I'0;"N/))=^1>WLRM@NW &>%1"I>*
M8SIQR2 W"_/368GAU7Z=S_0#LCV-@!QE[FZ(+?@QO@C+B9O MSL[1"FL=N^V
M1^B,7D_FP$7U+2MS,\@>"/S2  !"J%KC@BT^3#,!L]T!86[X\FT:YM#<:$:^
MC;Q<9U1_RD9Z:M$.!T TMZ$UQ;%2Z@:H75'MR6-=#ZLQ:\OPY^;L3L:#H2JL
M5_P^)!G1QA^/I$[X-F)K+)(]EQ"5.;HN7K%I5;%W1_ULH3 #\%X(58)B=+VN
M]:*4FKTB>7P"HEY*R4].+.WTW).KV;UX;V:WN9\HO@(-!;+4+7T$LA\!K[HT
ML+3[N_LEVMSG!3?<33O_V/*=X\O$XW:^]^Y+8%V"%V1,D+^V.8ZY\^Q97?26
M'%L?BE' /V,L_!*3E87-60G=8C-HEI5,OXX>@'&[D._BDQU)'_(W)T16>-0'
M>;8.M&Y\?OR-O$D#>.R5OLRK[6-;ZS:5-Z+^+DW:0WW_Y*MOGF$AV]TJ\ (%
M ,,+KIZ]K6B\W\[-W5Y$]9?)F__M+_]+_C*"3!^#6?0Z!V:<5K<MA<W\J_=I
M(CSQN#T?\YBMM''DGF4_)%UC&YT[SXO[/@5W28CD?&JU,$07*C^;J2%M9"Z6
MA$S$1=%AU7QB__G+%7(<^6^.M%$8L#HMZL;X,PG-*5I5D<*G[V/8WEZ-+:6[
M=Y/IHJK%&GSG/J9_'EV\*XHR4*3ZRZQ7^Z6VVIUBVX#%4ITW#@?M I^FD'^]
MS;:62R6%&E+2UE+@+.Y+ER/"!039&D[A4TM[JB,7*(!V9<V[^/GVNP'Q:B%"
MNIS7 G%G=B5^6#N]3XZ&8[QB+&IJ=_C;8,Q8I^)EHXNN2DM7P/=.,D-RLDJR
M&FNM*U-/[C-P@.Z9-?,IT>4P0@@(-/-NP?(G_ >"0<#VL]!G"N6<\!=A:=]G
MV%\I4P ?A 1[<ICY33@CWZVS#[B?/2]C:OW/YZ$KN]OO]O'0U ;-;2J)F <
M"8)(NP:8>K#3M&\$PPQA[$%T# 604%NW L>8YW+Q)G $,'=@!U)J:W*?I=Z%
M1NM<^D2^!EP'.9)[R<P"=*1,38'-,/5&D'X\SJR'Z;0OHV8_0P9OL:9$9!/M
M7N_.K=.)-K-^IVI\_[O.,&3E)14S!/TK RB VG]=K,6AH?^F!SR&;$O#?2F
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M/;1MP'DW7_SY=-:\:Q/DJ5$&PQ@16766C:(4'#Y:3<A3 /3//04<5W%Y5R@
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M&^%CXW;72.@!%^>U<HG35W)Q\]K!B$WGWI&(H(:ND5"(*,8K0FI7?DC'M)K
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M@C'1&6[XG.]CVN"R-9ME)JY&<Z4A_Z:DFE+X3+5L2Y?9S1%?\\1Q+"@=N6R
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M+CLYC.'G'Z'AI*:,L+)@HQ89EG5.*%NS^+I_PNN4PPZ5OXDZS,*->RRY>\]
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M-NY4K!J7\8PT%?39'-EX#U,$P8^PL#8H4T]Y0(-M]6!5ARIX(T79C[(N&#*
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M$Y1*8O&GZ"&BX9L:T/U,<6)8,S_5\:BST\.-\R>'(RA)G: W8W4PX@P%=/Q
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MAFTC4[RI"7GI]U>F:JC4XIWQ&_?)1RRWND98WJ@DGD$WKA!ET.-Q"ER4:WS
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MFR]I."O<#" V/W1;A>XT966H%20KBU>7="KP4Q[L8%^]3=;7N?R1+[UYSL\
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MRG2H,\@*-[3VOL!]G/<5J]T2TNZI?#XAH6OG4.OU3\/P FDN7LS!^.+3=MV
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M@:O/@F\(9/UF$?,L6'8K8!/1GVK<'Q,Y 87KKOBP#<=[:_0LW7%MW14[/>"
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M,3]8TB!0 A1S&-H$*BD-Y=56,LDN+3 )?GZ?7JHM'CU'O]':4LK=B)=$^4]
M5^"\] EY^@AA=G^C:L"D[Y $'H=.G)81G58,D;48LI\AA"D5GT/'^6)/0,$4
MVF%)#N\*3/G@_9)MX<4;=HN&C$8Z-3<C-S>6\,*R>X[UI'X3^M0L+<6>7?J[
MWVMC/_^W!L1_K__W%LJ4G JW5? GQ.+)Z)@\WBD[G&Q7H8._>]7 2OI[$97W
M*%3ELQ5V-X^T,F45$=<D.>0S>+,XQN80'Q;-,0^K=LS@4/K2GEO\8=[_C_O"
MB H'ZC!\N_(XQA!&AS.+P^VT^-F&20@IEPUYKNI?O&76Y"U0*\"7N9CZ#_6Q
M?9Y;L"AM*B_K0.)NX8.7U/W4]'WX7Q6G_(_1T L%A RB+W=&--!B[1:/G)T%
M1JRCN7=E8NA(O/ ^C$81/H%"S[) ,S\[F=U^MZ3N\IV;P[PK,A,W;'D.IQK]
MC)P4?HAP_]=M2*S3Z]H'>X&;Z$.*>J8Y#K&P$DLY]V_=@/O"^(4(Q>\17,/D
MR)FYW_GJ+XFKLZ[W_2P5CNDQ>$U".I"%S]9!Z. 1T:*2S@HWI/\.R91\L^$,
M&FP)+U:U:%JHA/TXG681P',"NHC81&'%\$?>[-DZ!3T[RQK-8#+1<!U#ND;3
M!+N.I]V<G>]U-!K>NE*4V\HY"?L^F)]Y[WE^%@L^7>I]XJK'YD6"&UO(#0O?
M.^I2&:CQJE187DI8RTB!NH9XM=A47O_XP%$RA8Y*/^C]*4P_JWF<72,IKT-'
MUB.#IGJ:9X2E$HB]M?^@RU,9#2ZH87H2'SG9"H,@1 -.GF->=939<I[ZC9_=
MWY_L3]0K3J"FZQ;[[NV.Q&C.G(!"Z@.74SRW<R\YNW92;@BU09P0,4-45,A:
MO)&D&WXPU2*Q=?_0:)%VA6?[KO=Q_@'*%=7G"@C!PU?VT%QV@FTF+/5HKTWH
MP^_()E;21D?KD-Y&2\($IMF!RLC\AI'EGPK?0V-[\+_P*YMDG*T!.4=19(W"
M6ET7+_Z^WSM_79?F5M#Y1_&O$O8>\IU)Z)'I6I$\-BJA.B>: >KSJ*)$L55W
M6#(DS,H/-W(GR>,FIUQ'[])5G1?Y#9Z=QG@$P(<(P=H $?/2CUVN&=OC%1_I
M*5K%0IAX22&!*/S&?&)8,_)3YAV\]7X16UFEF].GN9YWK4YJ"CUQ@!4!Y2K5
MKI>G]_+[9)F)_7L"F04A()K-'C&261T84$UR@3$#:<J*''B1DAR.\)W+(?_&
MD':?N.(WW>N3%6+%%"N)2)R!4A7PD@@!-%J.QL8N\SP)U:SE^!!B 1;BZ71#
MM?-\4F1-F)=NI^)U.UT;F]'**!]^@?2B[OHNDC0[.8A<37I,N4Y.#("[T?BZ
M2L8;B2CP)]XV/P$%U)9&S[PB2.3/[":0/#5WG*+1#S+Y/30&H0GP[ZJ+*YVS
MT>PK6[?PD2<@LZ]:#^IKKJ=J9]8J/N>H:F="[' N'I<S0ZEN68[<Y,$=8KV#
MG#!80=Q,ROSL==.GJ/PW#H0U;P9=QH1K#VL$6;15-EU<<A9 ,#=*.S=7<#ND
M4KJU1^B+T6W-/>_*.N9S.F*47Y'DQH(_>0?&KW$CGM \DL+./T.]@]3ADE?0
MC?U5F,ZI( 0-\ H+CFEX6.2C^3SL6>7X-^06>V#AYL<[X7G][%>N/OAL=471
MC):_T9]"=V?>L1YUF:2$(\6+&QE-&YNU?,*A!'\C$/DA$,$]5T"P,[;DH#\J
MDQW7V_!=96!_+&GN'C&^K[D*&1@>1CEOUD7U*R3NS:1!RPZK3ZI=M\BO E7G
M,Y"VS[=ZP,Y#/X\+OJ>G=5NMRZ&1 #<R;$[/)Q<1&50U>ZR-&?=HHD+/ D7^
M$4G(Y)5.E4Q5]O?).4^=OT.\/8M[>1$>(53$_-:@%-XL2[J$$^^ 7X;U%-F;
M\>!9VU0S;="_QDOF:U(L&0+*S[D'T3M-:M[LFW^B(#0-<>+Y.ZY%_E%!5-!N
M.58 =QA[JG X3KRHD&:TBKO6Y [B^]S*9X7S@"9!6!7/ T2"%UZR$14IT;6?
MTG.4))M1G/8MO: /R#5;" X.96,[FT2?*PCHA2PO)6'2X!#)6L,:;1;*SV2Q
MX=TJS#*L=@W^"]F"! >\'B3!LP ?.^..KWWXR;5=W_<NFR%*%3(W6<XMV QF
MJDGVPIN5&LP"!(CW?5(EWB6L#TVM%61B%QGFX$V,&WV8N72>BL-PM*A]W7@0
MR=27OZ1P];.JEWWA<V\MR5KGZ/AJO-BO-P\70U?B$KJI.<ZXP>PF;O9#@$A,
M[^GDAMLK%7:_\B@Q\.Z&B8$B3E-Y!8- O49I>)"M-?O(DH;7M^+-G0UGR'5$
M)F8N#7;:29I&R![<GI!N_3YAZB#<"=K<I>8R[J\\+1@-C"/B!O(LI1=S55(O
MH3N-**)I:.C%I!5NP!.-S T(H=H['A?AB I7O!LG\[IJV!Q>8,_'DZ.WAL2]
M/@'=H,(B$NV0YXU9I@V_!O-Q!8L08Z43$.+(:SP51F2CAV!UEK=/0!<\K#'U
MN;)HU#9T.>4(/E?"88*7CBB6T+G2*3_90458;X,XW)74EP-"/";4^+C_]OGT
MPK("I*DPWS) <B#@[!A:C-7L%EZY[5QO@9+W?49C-0.*X6VQ4'K_WQPR?2 9
M'EEXLQ")!AR.EG*$\=5^T,CD&09__B.^U"_GI,]-,?X#82=S UOSV#E(L*(4
M_L(6PCSG30_5WWYD&EV$['RO1+M%%N@<2IAFH+PP\628S2,7;DGK?@64JTCJ
M"<@4T9P6)7ZEY$[.94)0^==L:]J5UK=7%3:.SXQ(;L#/ 4R!EH;)W55#%0L>
MWKR<GW]UUO8K )) (%$2> ;L42G+!T]]J)1<C,7TLJ[XU[BV>/A"_NAQW@GH
M/"V>C\)!_D(R<^XR$HUIC# G3_ _7L"_:,47]HG>'?R>64)YK^8+%RK1S2VY
MAMH=Q33S?.%AE@^<YYEDG5\BU'J6S3@<+ZVWVMJ4U/?HO_W<E-G$ O5(^#>^
M9M R"_##6[9HFZJJT!(_:_"B$4OADM.[T/YS[WZKWJ/OZ*8O6'WS4*:?K0F
M4^C(6)^ ET0]X)'+5?7+'VM&Z./BZF3>9)%X[$E"!/?M=0X.HU(7:S5AK$J\
MNM7;PL@+FDQ^H'LV7IE,5UL' PK'AZMZH D"M.#BT0SCU U@IWK:$G<"(E0
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M)JHL<F<]M/;;6B;_T,JP5XSLL-YPZ86)XIUO1EF?;66LWCY9]+Z6JJ/ZZV5
MZ<J\P68>+G5CX7#KS+<U5K5#_=MSZWX-Q>(4! =M@C=Q4T^Q5.CP\FO!#Q=
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M[TVQ-)3@WDQQ7KXZ--<@[VJLLR!%O_55_Z<31FEM;[LY^0PO&[8A)F-"?")
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MGZG*DK$]X=N$&!M>THR9=YR[J7OEDOW3'=RL%U(M)=&")D(\%L/ZT;Q3G0R
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M&."KYC;%^,?^3[")+CC#$%$K.SYVSH/QE_%.7%D^\\J(O[@J#@P;4EE(5\B
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M_SVB!F-0) JDVZB)X:!5,[8AZ*LR[?5MO<NNS%GLL3*,>T.,[W]+!FRW+^)
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M1OQI9>T_R=P@H>,5@VLN^EGDS82DS]E%]0Z$'Q/X_I#H@A;0#O3A7*YH^$W
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M6V;O)U*.5RQ@0'8(.]\U>(#;I6Q[#\26YZT&,5K4@Z\QJ\"D[ KVS>]OW^O
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M^U4AB)+_3A9V!*,;6D1:"^_78G:3J #G./IQ_P)L],>%2F/HF-6HIG*#!W<
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M'PF<-/M<=HT*J*3Q35UW#825=1<ITI-"ZMRR77Y7%<*/NHJ%5^5CUW0T5&R
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MO(8LFI;$A5$UV&;(*![8H#!^JA;XP2E%R5C&@?LZ%0 1F>'=()] /@)/.D[
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M?G#/[O_[/3L#T%1<%!6 I2<X%HX++E<G@TM'B+L)P6_CWK:30%A&.O/$)N)
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MKYCU9O+8CT[FO94A6%+32T?_&TR,MPI@]B'QL],_DH&'KW@6!7V&>@BAKOZ
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MLL^!GU:,)U)Z?-^,9[*+._$][[)SD*FX*W>Z@7:CM7:6S1O9CN;T-TW\HRQ
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MZZZA9YV'OCY5X?*V?7SLSO%=,XL40:9"W7!^IZWB5,<WZ!+FZMYR5BG6)>S
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M1] >I (==@5M0<U=^2J+-2JI1X&$3 W2L&@V1,8=JT79%N\^ED>T24(&2%2
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MTC+\:^/;W#B<,-K[$-D<H:/"L/;]];][+-P_^@\6 \-8B_&4ID+XK;;0B5.
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MOQPO)1I[,9TJ?I;"I8?3" "_AA.*W,_C)PX&FI*&!)'9AW0BXFC-_]3-9S!
M<:[].=?SDI9'VF"\NN.'D\%,J=/,#BE,E*:BF6TXPO%)%YDB9!*]-4=/M"J_
MFZ@[7LWW27 -J:N^_2,8<!TGY(F3&S\D72G=]FH(TM")D:Z.^VQ)\[X[)T56
MZ:M.IL,0*49!FAY53VZXYY)R1>.9$6XF)3!8XP0UE"&!O6S!@,F %;]88!R>
M7+[24,;Y@*A%L01^W^56T9,AP.##\PT>E+HU9YJ<;)WDGF3!RU2<& 3I.YU=
M6Y-</M:5<#-K+'%.[7JVS"OZKFT'<+B<H;AUR+M@$:D@CUEK36'UEC#4286H
MOJY#&DIBM#\>UBGH+ GQMW^R133%2H'V9+I(FL%1$'.5W(U:)I&/86C&^*9D
M_<QE 0O&N,K6\;;1S6%D=@-Q2$%>(ZWI>52V>N 98"$>$]ZYXTD(6)R+L*'P
M4'Y8\\)?-0OZ1?)H[W<3'8%B 10N%+GC)Q3:&F1U_PR0>!W_TF_V 18$:#P-
M75LTGB-J!L>B35MS-\I^([D9RXJ U@:=^_1N]1Y&T>::RZC-E9,<LTQ2\4/X
M)POODR;0Y4!EP@M'Z!2$J=K:<(8]K=,!,:7/R'D\)'DXL#UUSAEOB'>'*AJL
M&@Z$,T$[HIUD.4:$ %8JC_=3HWGAG&U@*BKA&6A>RYW8'ASA:ZG. @P[A$FJ
M7LDK.0]H_!2'>:V4J.*(#@T_$(FO#M1UU9!<^14%'[*8D\Z?CP.0*KV0(NJ8
MW<^PWA%UCZWM'_QG@'752I E.YW7<<21-^3(O=,AAHP5G#N]CF(E&/BF*08L
M?D _6GQ6U>-5<U]+[6M"+XCF=S##+J0B]A,I%5,D_]-,*<M+\.1\G[ZF((=
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M+&STDH9@[U,$F'TX_;MQU;7!]<$L<QI^7X5-J:W,GY\V*S)EI-JN+@FBG;&
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M!.T$D1=5(E2U\\1TRO&/B4'LFFLZXPU9?L =G P[34#X=D )!.++J5_YRR9
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MX2WZ>(T%0KI:HREAJ^YI9>^G<M_;!I<4*10(*%8L%PX"NDFT#H)+1[(,[*A
MA]"=?1,,3^:EOS2Z;UB$N89V6KI)%*HRI=MW]W%7^3L03IIB>PT47 2$EY/
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MKK[R_4<Q_)EZYUWW"5]#VC 1F->5GJ:55P,\G+ AW468(3!KHX31>9.C>%A
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MW?K?_@&%[W[,,#_!PY9_H" LE8LUG6LHCG6\N9DF_SC:)S<K1E>??7WE[L[
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M.YC*.'.$#?(O%:X03W.W_-+G3I4LH":"!=T7W,/Z WVYD_A%6:N*;G7?CN<
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M>2#S+Z?4/YR3+G:J5#3N#(CT;.M9DC$M0 [P-3K@K$SL00:_8<G%']9,=,"
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M[-'V9<24F7]Q[<9OJK7-&^,X79/,PZ!R-JCCDU5>(;%<Z%G=\SD%3JCTM\3
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M_K(963?91-&M1;H2=7XTDPG2BVT3"\\2ZE%PIM3"4>B42'\,"&8:C3(U'PI
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MW'*A]2.'=DVI(K@=5$9A!+5"0*OG)>>VT7P,Z/:["UQ*E#9O2UB?+ZF)H#$
M+H7?5-X4![ZHBWX8\/+A(U(0RG!4B>L7+'1!:,1#6<X@A=VJP\>>NYN]Z-0K
M6.%%KHL6XH/_BGZMZ>CWX=? _KOSD,*XI7RQYMY*F2$CJ*\WW)='7@FY485R
MZ?-(Z"6,4&U#[Z:C?Y%>I?_WZRS^H_3F?Z3T)BW?<?)-X/D$@V$GZ;7DC)G>
M8F&*<6BBAIJE3KMV9E'7@1%OXB+J\B;D])P._EP<0M$C=)0@?)/*U#RZ?#7V
M377Z3DCXH@RL]LMU(]G"15WFMU+'#U)KL^V'$'V*M>U8EXX?^K&+9WUJK^CK
M06)*9-\6S ";)\%?7_;&Y8UOO(;C2ZLT7 \GM>U?"F8659SOT+ 47[N;_MMA
MDIKXJ[G$P3<B.X7+PZ]Z]!;BQIW8S'24D(WL(,26!#K=AF7^4JXPR@5F76=W
MO]<0>9&8$C7/6;GV+YM)MY;O,Z9O"0+"@UM5&RS/CI2G5?96AK& /.R-MQ_M
M=@ _R,3Y]C<-QCDDJUE00F-C#6(KU%^J^4?@@A==FJ%<_D\'I7/+/U>7)EF,
M797Y*7)&\SXE[[0\M_L8VV&/^RO7LGTFE=EH>\O)8__9X)1/;4-MK0:925K:
MB(5Q.HY:X_VFI^8#C0*_W;WDKXSG)PFF.>:9SS[,&^1Z9FW#%2O)86?9[%5D
M_E0DZ(;(RY5TI#OG2.["0I^1D7J>GC&:&6\;%:FD8%>XCGY;6J/_XGFM^:NX
M6^&I\T>%>>O:&A;L%UHS#>=W?NBI7>_ZS]W]H%CF9B?VA>RPDZR"[LZ"J=N?
M6#A-D@>>JJ\\.UU<:)IR_D&<17I-C/#3JVXQ)>IZ:OY]0MNYSN),.9\S'?WQ
M? X 666O8]B)XRR%&;L)Y2%"=,?>941S^36+\B5PQ0:)/&JKDNGXW"U9M3+*
MZS\ZYWF<$<S\X[6K@<=:[[9O<IF>FJ_0K_\]38LMA7W(9C#Q/L/XCD*9X'OM
M5O;QL\J)C&?V!;?@;&U0CN#&JM:R8?,*#'1C5=E?3?2^?B%(T,^"C:=NW?.,
M^U-O]3O!!N$V5[_K0YPGI3R&((_4V,Q>#(N5)7/LNMA%3@Z>N:\E'<P4^B#:
MP5;@^K*039!)>I48XV+E1W^M_*9L^]E;H8X3R3:N=:S-/+6 W@^L?I?V+;;M
M-,L?#*QF"0C,*/X8*M0I<?X96S@Q?3<]='C\7UJ!HWCQZMOJ"Q),L* C]>JR
MD9RJTM@FT7C<4X/W\O)BMX3V4 ;]AV$(EK<$TY0T:T<?)MVKKH'E'_CXBE>J
M)8DU-XML'SL8S;;)*+WD+!?09-71\K!,#P45K/]W>S[N82;SJ=HHK,M)V!B&
M)) _ NJD 1Q0Q[*8$ Q!PI(&6(LO_$T#W%#YW9O3<,+<T_=O&S57@?^KQLU7
M^L!+CJ$T (K.0P83B3M\Q*%#!%T)V; __I>G'@,<R1P;ER4^>Y)9X<82\:]I
M (9PYI,<J !D&%QL)C=!L62>GGFK/G;-C@09?+^5U)U;=$1)W%ER<^0Y.TOW
M\RI)=/D0KAW^'Z_]^X_UOWPQ+/6QP-NI8B,R9'+[8<H=XR)G7I?[]@(F5U:$
MXJY^3PUP'(%?H?:27)JX4-M:M:AM)Q=[P^0W[?-GW/_8+!&F_;S8-H<AP8$=
M[XTYR*8OCN)[:J=(N]5+JB*-!H7;QRZ@.<@PW6J/F,W_9UK__YLQ -_PP8W0
M"\0CO2 :P'(0/>=Y":ZO4!4',(\)!WT<3AT9&S >R= I6<YG$U@I>K+>F&DN
M6%1[/SLARV3-U__&C1L#DR931>UI(5YY4:^-UM(K1(35^.,_JEU_(?E_\!S^
M V_]MWCK=U%1>G%Y$M;[:A.3=.1J^F\.H;U<QPX:P#[J)J(1A$/OG<^<\,Z3
M+(U*]4HUI_/V6U%$MO>+Q2#&H%R+DSCB >7YAF'$3<U,@B8-X(I?C:PS<%^,
M8M](JNO>XTJ<6=37F."%O^3]<)=M#5A" T1 F\"LA04"B?%M+PT<VHVW67E?
M+([Q 7$B2((%CEM%$A^4YN['GOC:]LT:'2)U,IVB ?P3P%]\XLMS9HC EB,O
MOW#O)-N)EZYC;G*720S0V-<!168&S#\,?;4Q9D+V 1NKRTA,:*3-D3L"3@.X
MC_A'#7+B@9,;6&,X^U2!F[2C8!JGO-&M^UON@1OW&9<M<^<QK&I8&N#"NFDW
M__6Z2I-GP,;QXP3<NZC&.B0!0S]9:[HX7]^E 0[,XTCB]-]<D"U$NIP( ].Q
M&R(_..-N';@Z^0_L17WVYR@@;KZD]O1O46?\EA/]43)\QT_ONRU=6:SW])X[
MI<+W]BI7-FY[<GM5UEU=*JI13NB@*(9 /Z/HWW.'"W+[IN2G:"BH_3UQFOL>
MZ\_8%$)YF9/7B6YD9TF>_,:50@WIH8KXK;JZOD\4'OQ4Z^PI]'E/4!@9-O4N
MGC-9.JSM)1?:!OP8M,4<3 .P2$>%S5Z-WAGRL+0JKY_)D-N]927Y5-V*^?+<
MYC>E*$(5T?T-2917O/3CZ_K0EY_PWUU7,MX7S,[/V_63(<GP+A50PB-BBLLK
MFSM#+R,*EY[CS$^WPZMOTJDMYYQ$,U92_B@.N]S'\39YW]2L8]LYRD4E[V4Q
MQU-9>8>8E<^%CL?K")!R[S6L4"!*A8<X]&)0R&[.17#-;LTF?"^2N>K$'?J:
MV@=F12R\AK&RU23 "[.QDYM"*ZY1T;K-S-V<JQB'J" ,+A:F[?_(]L:VEH:^
M#9-"]/1>$_4TW"5[XWAJ/JHY$-?7=F-L2 IA.\U<.IOW">&E.]OFEL.XS[.9
M?%9O22'V3SET9W6$!EA"+9<>HX/T=06[?1)PJ\=@JAJ5-V< 6*[;'(_#?+'J
M%WUS;^-!D7^K:E#D-#"92@)+#'G"4%M=\XI1[/ZJE<,_ZKPX%<6Z2X3Y/!*/
MKZDLV9 9S%V:=6]:^FOC9W9RBV>*LJZ:-BB ;LI',&(.!=&C1#G<#C@(?:YT
M2!,UM<P;L!1(S'IU7VHM@TDE]1!MQF''\;-XGW@;1P-LY], SG!X-F9/OKL(
M$ZQ[0 /($7UY>J[K0=.0;CYS;<!0A@7OP*2=.>N-2NTED]9%/J_[YI$+ZAMJ
M_A G.ZQ+:*K@:]:9S<F65HL0Q4AE#261J :FPZBIBZ:.?;SV-6^MER<F&*=2
MY119=9?R+=JV7'XU,7XYK'_U2XZ=_?&XK,+YT"M@5AK@%ZIGH]%DQ4E)1D-&
M)^7 TA2<'. '9/ZAZ1-DS<TL\PO3N4W]>MS7"KSLKXL[_.7DIY&L:Z+#E^#;
M_OFP]8#?;DH!]0ML.Q<^1AJ9@FF9USA6&TD)1'3W))Z'UG,(%3'>0CY6!@V#
MWUZ^(N:^(/25]5E3?1W8(7Q1P.3\NZ@F/CPJ@LJR$9%!T<'U#%8T2&"?*K1U
M]I0'+VFKB;AU2/G"?-V<KU6<)%>@[3=/I&*NJ9+9V74\;(XMCPY'$-]W@65S
MK=NJJL/,GP\N)I3^>,I+VKO1'/B^/4(7A__T;/6;LF,;FM?_(A[2PJ7@R:-D
M-F7B B+4/S9Z^;WV2V,IL.C>K@F"0S!Z$9L3:JFO10.\U:S[B>-B.#B-[B-R
M<5^E\..J*IGXR)PQE>3FZ+DB!S>*DON6A<-XM:*Z[<8!.?JX7B=2=_M=;Y9(
MS]YC@F7D7.06$=5BR8H7:F2^KG9V427E=^N9T2.CZ)\/5G?Y+O%FC)-"R8SS
MS"T<*D(PN9YZT G*"GNQ,.,4L;,C<BH(P>+XZ:14NCFFR1(X+$LE<%4&>H&_
MQ(![SKH!BRLR<<0^L^(9<O76DUK$I/H+YJ76FKT<I5K95/,LF.(4#7!J17=T
M4H4&>&\0UKG_;"![CG\[!W4,;CB$3G(MFB,O>XQ[] C$;A[]-K%Y==.L;0C.
M;"0DSQAY ?5#26@>R$YY,RKN+';#Z>F+N77.+P=M5C']4C^C X)TRQ47$5\S
M\7(M$BPS4KN1BO$58?W\B%O -'!$0 !NE(=Y(:I)^?0HB=JEN2\6C874IMR>
MX_O0K6%UWZ=M'L3$0IUK&2D,2<E5M?5S\0L@.!VNKWOZE+[S7^LURJ*'UB!D
M&(7YIXSNA%";:4!U_+G!0R'@7NOH>B!BZ8D>:6P8?%[:R:!I[K('CZ+)TRC]
MRL^9OW>X4;TMD%O?&^?A;*69Q*Z'^#.M/!+F0Y["KDCQP1T%LSU]1RLT1J)+
M<IQ=Y,>;;9!G3?_1'Q]GKHL&4R]<'%T\!Z@?H??@XU3)8P^72XTG[G[O?YT8
M22+PB\>0H7==G*7WF/+N:ZR=A?M2#/'6Q'VL("KOMOV=)(3(#&(]B?*;<?@2
M56;1546@Z3*WM%PRA9W"Q6'W YD_/VVT/[0\AAM:\0O><I_?$BS%^F1LAH'>
M\*T-7J4!(IE[Z\B$[+K41>PAY?[SW>LLCXOY[MT^]? 90X6&(+J8"%E@PX$_
M2#OQ.4^D?U"B[E5VTP"Y?#A4--@!>"R:A#IQ"Z0!U,1\)JC #9,WP"OH[K@3
M'YNY1?>VEM>S[$+AO-O95%\JEW^D=R/F+,5VT8G'4YO]*=DI4/%6PO:+MGC+
M\TWRX*Q'KD(1<-:-31?^260PBGW5T,3D9=OOOY.;QZ$D%$&?'I54_VD Y$XG
M72^CR*]-)C5P9.WJ[Y!M5VC>X[F6\N^5I[8;*%_<L26P5WM$:]PA?T[7!65$
M(FARU!&2O2I]/PGQ@C0M.+R-$ ,#FP=.4M'R/7CQV47-T2>.1:9/^?>MN8RP
M2A_,7!XV?/\FO_H!M/K/W ^JEFPE=0M($A"!3GBN0,.37H3ME$F%@&?VQFD
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M/1L%$54V/N5CQJ1]7'40%X?PX\_'/[WG2 B^T%0Y9M.RWX\AT3..0[@'_]0
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M$-GNK]PY%8+E2K3=IA"*Q^B_:M<AV;X?_S^.(#NC_^^5B&]LU6_NA5&9TF@
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MW">F9:G=<2DK<:GH:^-Z\>D4J6* ..9-?@5K(JNV<'H'I_FWY+2L=H/7\P^
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M&'J-2@^E>Q A&@ E#_Y>A ;1 &[!Q#%J#-]X'V+:=@,C-4,#V$H<\\MB#H_
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M[OJ.KLM9IOU_770%Z%]D#-Q?;O<D)=]O34S*W;Z1>8S=&W1><;14"N%]MJ8
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MERE=B=&1N')9M*DI(O\D,7ZL9"LO+/E>;B)LH&R&$G"TYG/#T"JLHR^ *DW
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M :YZQI9)E'#!_3<0.052^>-^Z_<;Z@'_;+FY^MKI]7P\$M^!^CG^.G'V^7.
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M5OPP7,/J'@#97%PT7_3'S&6\6S<KS[)I>ZWI'6:<< Q[>]5_^MGQ2J(?O>Y
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M,_FYL9A#'[2N#;2^NXYL7Z8+D*VI]F<Z #QX+21K8^1;4-UEP 6O4\!??^%
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MDLO-V71UI:YR:(QJ/6?0L-3V!DT81Y4664/MW5"KB*RPS_11SKUIV.V&O;P
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M1UQSK#]W?7_6;P=YW-/CN:7= 1^VHAVU[3*Y>*&/LK@'=U;L$H7.>#6PO2S
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MLHYT97FI# GSY=1,<T>-H 8Y(D#?J9M-9&!N)N."06B9SK8OAAT[]C?D%."
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MQ$CCI0,LGX*<3P&).G,Y5NK"DG9/5*=HUVD&.'2FJDRF2$_G[?#M'"WP6C&
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M@_I?LF-?55<&/#B-C[$][WW#\\6MR17T:V@$1Q-_@!J)2RU:0;J7^5\PFRN
M*G/$8)0@-W)FI(;>;R8740>S;)]I;^VST:7E+VVZ$S6-3'Z&V.\8W?$I4[KH
M:7AT:<+#3VJDB\%1.BYYC:W#A6WO@P+?5WQ.P[G%HRJN-+LS OT]]"_NW+=Q
M:_71G4:V/KATY]3JZPH2.XYLJ>LBZ7$]62_)^5XUG8SS@ZP'*!QMFMP66>5#
MV[-HT:7A4]45;FZX.G5N^XKEB1M2M="#'CU+AN*MSQV[B_9Z9UXL?HI/C)UA
MQX6]KY,R^=+MKBH;S(22PW"A?$#L%G<O[U#8V8%%VST'+DD]IPE"=+^]&?LD
M2I&&JU>5)@U.D(R'74H981NT*[!J.V]*-/F*O./D3%HK.ZB1M =TO;K<3VB6
M5,7$3M(/)JYZ1LT1\4U+76Q?F.\;I0RE4,=K.JU=J>G2"3U=9ON<I]@(H?-;
MM16#_?4FDXJ=[NL>&XU:59?!O/W)_C/11:[C1;1Z@8'?#:&QR*6I9Q=B\C5R
M+NN_[C<OM/9T]%SH[MQQY!9UV#)BY3HQL9+GU#I<A*F%;O6'-A!OMSTLIN=;
MECA?0NH?WE%TH'EEQYT#$(NAZIV,8&II]2@\],:D/K1$TL_"]D/G<<>3B])C
MB59WNU5OTRM@\K'FD1NGUN//</T(;NB=4I<76%;7=?/;/3JKV5.Y_06+JC/S
M5-5ZGBBMH[?*(%/EOB9C[G%4L9&L>JEDZL'&CS:Y0;O?YG8Y+[]O6EMU0/O.
MP1HU=YV V<][OXJ70H5--H:P<C57?(AY!**#K9A8XJJDHHQ >Q8?L#>J'X)R
M7Z "O4=@T%F5W2IO\>VYWE[+C_/7OY/01LC1$GL8,<3XV)M!+\1?;RE[EDZ6
M:!3NCT_$-@K'=K1,?(R0F-V/"\KMD[IT@Z4MHFSA7FZ]O+"R?[S>%U,$KX=Q
M;VCB.]+*@B_6F7H1'ZMEQ[9HBK?(<'-FGU^Q\3^G1%R'%4>T"]U1IENT+) .
M.QZV2!ZJY@.4Q_D!/OLV91YQ+U,1U/F;*I.D;=&?]?5H\,BY_26F*N[7/3WC
M;<)J_3:Z1[R*KEF[[PQ$6+S5OY\12$NZ[W/J\KV3%;UOE]'?YL\\>"U679@3
M:S%C-.(VOP%6%[>1/'AHW<=3RQT$TRC]/(.0K$_]J$X_ CWJ/D>2?9A);"!V
MI+-L2?*Q\T-VKB>O[-5[S/F$V73["?(J4Z2FPK..(&HS0;H"W0N//Y4TW_KK
MU.P<YBB0%XEEW)C)@<0VL%6N+GMBS.2YZCCAF+,U>/_I_?-T?4]N.D_<OVU$
M,NSM_ENFRI[%;+=CF[UO;K]Z^)K*XQF]G$IN@OXN5Z28KN1-S[='8UDQ@UVG
M:>E8]GDER]59LKK;:N?M<PQU]1%&HMBLL# /"SP;)@C#A2V30>ZC^U<(HKG]
M92]:.2>H+VB-P8<B1!TW-P<(68UY8,DAMNRKFXAU\;C:J%W.RYW6+13W<TX&
M46J]/>/A[-"C)V!T&>RH8'24BC&T/N<=?:&KC/YI<5-I[.6/WTAN!8MM,T74
M'%NJS^?<7+=8-1?<S0W]_76:PC&#Y<_S;E0]F&ZSGD+#4=L\L=9!)7,OY;S<
M8HTOP#4HBN&+^8GU,L>6]<ME*@U]JW"0?=(US?8;YX>6"8&$+@?CPT'2VDX/
M;C?,8Z;G]-=$40CUA-539Z[?0FZV&H0\;LN0RWTRB=\7#)?N[,"OX9Q@WLT.
M6&9(QL[^*N/.*)T)UVO")!  MSDLK#YT$Z7+...4,2QSB66U( GIJ*Y.+P]T
M]B*LYVV=Q&RX=:&T&.[:K5A;@?>I.VET5(3Z9@86S\W0%1]!ROA;G.E"Z5PM
M:_#@3-]7EW,2.FGK^8N,U?*L/<$P2$Q6V&C+ W^S$&GWSL\\I^HE8Q,Q:ON%
ML M=GU;&&2Y,]1%58)KT.G=DY_8"IU()JM%XH^RN_'WHWXZRTPBW6=)8F*V"
M]!]1<WF(#[S)]S_BO]?^8VS_U';S4W9.+C3XK&7>;L1(0T.^>\<DH\/FCLY6
MK:0>@G%#%%D5ZP-=/6DOW^DNEN,>N%.G_R@\2&+WL]W55IN%1A-O^^6YC4CD
M#RG0&)5H@A8)EZ[,FQN1I*_"\ZAG(G7A9*ZDZ<9B4E_#-B$N^1X\SVUA *>:
MD6"VQ3['=6X2-Z_9=B<M),3E.8*1M*$Z=]J1*4NQVTE.BBQI:2@+?<]ZMLE,
MS=ZFI )RXS. >\M;A]I6RK1XW:)7GQ68-ZAT<6XSZ@D.J:+^6;U[N8:.,T_%
MM^QO]NJ[59WNJ;P<I =)KAU[A]IMYN:GK()K7^ #)-GWM_E 1-4J#1S$>F/+
MH_UI 0[J<IC*LV87?@F:K9[^C'&"W^7)4Y$1"KTH0T%@\[;1]8)\#VP%0-*3
MR+4#2TNXC#=Y<3$=_CU1[N7[$S3+W'@Z"3&"^!A^_*"Z!ZVDTGF^OSQA1$6L
MOYXDRGOJJ^X>L/$H+_G !Z-WTTQ$G?Y^IL@H<L-4(2DO-""[/T3?LC=!^$RT
MJL.#U5F,7Q!#] M2L68&ZMZO^L-CX^P>1+5,7MMB[-%ZO8/F5.?9%UJ/WXL/
M"?(EF0J?%%';>??1&'3P_!2DTD&&JTR$%L$C<%67%5HWZ*CLGA?K0_>MMZ(,
M-PJU[%(M=9N5AL7JZ@0'!R.6[5ANI2SWUQ_[BS[;PN\ST*UETQE\0"7$8&OM
MAN/W7/<\,)\0687WYF;B1:<3]_:JH(Q2K/53+PS8#/0;?$ISD;^(8(9JUXQC
M62>P2T6;1'4_1A5D#RU7S 5:O3JD:RGY6Z#ZXK )4WTTP9JFDDK-R]E6\&$Z
M!W%7I-P)0)<L^]VC'Z0@U[L<,;\T?+DD4M*[/<;\'5<]OD]16#$#E3G:1AI:
M/%O04QPA:VBB^"2]S/38G%_""]@[A=H0V8&1JAU&:^IN?6W5'->S9"W0N]Q9
MB;MW[=\FYU%RJK+%C)A"X6GW]-?CM7I+A)HKJV.($[:C] ;T7::JD0R4&AGV
M^NX]-Z?MICSJ4<AT/#..;%3W,NFAC$[!VK7N>S\8OJMZ'O5X[ZO[;3E;PF]?
M9>"J8?H2=9\3I7W&&:2R5#Q!<WC@QM4#,=8E!4^1DE-S?,  RRRG=O:/Q-UW
M[$Q_9F/WX;V;37#YEB:A7>S-)^%(5R;[/!-&@]0>2:TZHI"Z6-^'73PIJL59
M;PU_CM8^M%PB/NFP<%K_"*ZL,IR=UM_H^,R[]8S?.3MS*@JSD:?$.89_Y$EO
MO3%E2#;+U7VX&5-]<%?@!I8).6Z&#SA1ZS$N4UL;WS"##?N_)>O;523FR 3(
M+3M$G1:[.=UM2;YAJ[D6W6=O(>BFV=2XOJ1"2NB;[-;R9C_MX7#I_;DCJB&L
MH;C4H_L/[7QW_Y34$XN]5AY?'T+]]$Q17"J"@:*A[]$DC7M\9I7W:; 57,(.
M?3JWM?9,^RIU/]D%W-N)/&RYG?27)H=KPQKNCETF)5V5<[Y7"EE6'Q_GF!/\
M2ON'[595$1@/J8F$44\@ E;7&[PP8O)FR.I3,W2N>UO/0VB@Y^VE#; BR9 0
MM? WIL49_3<K<@]9O\JJ3H]GT_5=N*]X(OYQM6B-E]8TB5>Q6^JNTVKT.W:%
M?ZY?A3ZAO?,FL5<P,#?T+A/1XCWDKK.GWIBX[/.=LMIOF[*Q>;(Y]S9,>H>T
M%4JQFSRL$D^P\V1.?_E6>VF2[,(^8DI:[F8VUA"*S")&:"%/-'%I\J]?B';?
M&#BY[$5H>KL>@$6?:LP(2C#<7LC!Q]J<ZDSS?8FOI--G'.ZV3)"WQR@,:V%4
MH_6UF ^HD!%%K&Y@GJNWLYM\]>!8M)%6_R7ARW#E6J_;#B5!"#(2DK2!J678
MN4,I^G.G=GI_T]!VC\;1^,'4PI:%BL.>.NG]-TKFOV+D!_Q1^%B9*MH6]X^(
M:LX@>\UV<_ORR0<_^*9;3(8(2@1R-G3!*UZ$BV7P 1;"#YE3^+,%@PN>\8$J
MW(D YCRYZ 4?"/;C \W.1,R,71(?,';/H>NW<9UQ;1"F(H83&^'':^CC _37
M)(*!X(?5BU5'+L=-W!/F;"O_8T'@/*UC$[#"(G9JU<WV_1V&VX6L?_84@DVX
MN6R*WHSN0"YX(;<19IQ[X/0\:]:^E\RG=-U7=91'#"1G6Q?O9&0)'W#8).B]
MJ3L2,0F?7H-*^?F*P?;7=+C?T)D>.YD'=;B0N5P?"2XLKITW133W['PG%MWP
MEZ_R\!?C3\NH3,7\\"'<A6Y,&/2\DP49'?H>7A#U/@@YJO6^[(A\:PR.H=)%
ML@VJ'M32*7BV_4O$DY)&VYM)N8'SG(-MX7Q@0C&9#Y"/#W.NE>.8<HV<:-Q.
MS!<7./TWQ* EY=LKG3M9$3GG3@V=<Y_NF>(#ZN/*5[\84RT5$H9?T(@_'B&*
MZ9 DQ0?:S8[Q@9I'!&9K4)AA &:J%]G'_4;XHKV_;5[_"!\(.4Q+XJZF0SGK
M7O*!\ Y!FGUS%,Y:/P%G;M'B U*X N<TKG4+&UX%S_>R2QI"^?RX1QIOQ_@'
M#'U;.X:ZQY.GCKS28<0JB6-@_#&7R)7P*N;TW__=Z,=NXAM2HY;<5&=X5%YM
MK2\FX!\3 OU=!X5[+WB&MSB*^W$/*+517YT/)"?>XP-WMV%H\6P)++SG+:&(
M7<<66=/''6]$_K@'G!*)<N(#Q_1$^, J!3XP>HBALAV3<Q'CM!S*$-M8Q&Z+
M)/RXBP:F;A>SC1=\&\);;<H'/KC-6"OQ@0N%O+9YR,PN2:?EI-T_[.'\XQDG
M?BDVY^4Z<I.&H. U^5>])KI1C,.TNYY)ENW=F"*-1C[@LJ&G2Q!-12\803UH
M*@D5?*"KNO(CYES)DH^X-^53A4X#X>7>PQ)K/"5XUZE1$%Z3_K:NY_I909B<
M=SS1]^O:R 0MGIY]$04CQ RL]5JYK1#EEDF[)V?^[02KO 5:W[LD/DU9X.R7
MM-;H#&)QV8D)NR1V0G*5Y/@ E."5BH6UZ_R&54I>!>+? FM--]@:R)U[XS]V
M[FUFRNI+V,59.".(B<EP/3O<[^^K41YR;-]UHOJ1$)%?9IU@1%+U5NS[6\KG
MHU^17]IHQA!3(HPU<FQ(AL:#/>^Q2KFMP?_3$IX\.Q)S.49V];D.DZ =,CZ>
M;%V.7FGWUB7=PU"2A-D!C_(73WUO+F^<Y1S$TJV5WF:=S0B-4MFAA)/W;/J0
M('W^Y:V1F.7"DN]]C_BQ[ZNG:R?MO>$ST]2YD=DY9)WWRMO^R/X7/3=Y$RCT
M#MS)U/(IR@31I2<XIK3";/%@UHD$1]<GYY802LX58B\IE:L+.]^ZT]G'QPP\
M=QBV935:S 7DT,UM<L6?I%])+;_R5M#<Z[/_Q&PG0MNKIQ?">!L$F97B^F3,
M%YPG'\CP\V%5JM[FI KRP3>8YO?.4,;WUSDG[08#I<S8'^E.29&\C8>3?IX3
M<JC_21:9=H@/!* ?'H#7ZB2().=];)O#CMZ2":Z$P2M@C7JK9@6)BGC>SV8O
MK%R&WR)21&;%!5U<0]/A?8BP$!SU*RZUF? (;M#\27]'DB,?J-6#CSV<1C(.
MM/&!]-Z>)?137C[B(Y1J9K:RYPB1&RX(TY.'2H*0Z7S@K?@W!\*0TY0OA7!O
M&^&//+$\Z(_$\<[DOO_*K#'_E_"G21'LL_Z\.I^[$;-@Z82/OL@$2C"RK'XN
M2,LM1SW9HHJ\A\;L;+S@:@6?QC3OI95Q0YX*]I</ZK&[&,KN_G2 4/O0W%!\
M/.'R7_T('P2(OQBKS_VL*)^:^6E0GG&$S\,Z$M$ZS'W?,.0$/K!@?4A0OWV?
MK_6E*Q=2Q >L88MUO/7#?$ ^S4YPH_IBN,JEN'8V?"DUG,C]ROJE1G"CSOTM
MZ$;\4;3C=M$W%IL; A?*V:\)Z^#.N!5MU4?## W7)!9"!3T_\)-Y9O%A"CPY
M+D3Q /-*4-S/:W*D$N:G(?E%I& 82,KJ#^%M.L,'#-@Y=H8$XZ]T>$5)MPT]
M3SB]X%_@JORE^"?705TTXVQUX)U"1!!F-))8O\+FLID(WOJ#?$ NY\,P0]J,
MNSEFV=+G&G3>XL![/K#V5\/MB$2?'QTC$"#^W0"ZI*!+^G?XIUS25CCU5-2*
MO+TF'\COQ$S<QU7D4) _&J ]SS'5I^LV<G8\V&YN']#[LQG)0(#X=X+A3WT%
M=%[+3X*Q_0<+WD*UU/@H(?BST\_36H(N_.>)L%(K9@B9N@E"/3/^1[!]-_B'
MZT!K.UHI2+36N"55N%'O,;!\X&DP4W 0AQ-9@C3[!G&.^_-/:B8*/4?,VA=N
M0D(4^S _]Q460G\>D@.>SR^_8"6\\R37S_\MU47^D?N2CYC\U1?EK\8_-RVC
M!A^H58"/Q?CW\^I.\8'4K?@IW ,,^2ETP;C*G0]<%ER)CO5('\2%R[PE]4VJ
MU"N")@+&K?YJ4P4$B+\8H-D+FKU_ FCV@@#Q/P'0[ 7-WA\ FKT@0/SW S1[
M0;/W[P":O2! _#<#-'M!L_=/ ,U>$"#^^_'O9_:6S?\\]AZ7=26:>=2)U]R*
M=4YO2MMS1P)[&JNF) 1N_,MMN/UI0CJ<11,.QLU^R ="W)@O!47:TCSOD2LI
MBN8P%3Z%@K2OY/S) $$I"VJB%W]G4>?LJ2B"+&<]OXRYM^7W!JL6WUHKJRDU
M):])?;HG' N &^ &N %N_)_;6/?U)Y/2]C1;7?F]!!/AJ6T[*JAZK@CJ+>.Y
MZ2\?,4.(-%V.'_5B*Z96AP^,%;L1&/L% V^&9@\+ZL0K1HP+JAX"S^1$I2 4
M"]("EH4[,J47,VTHA6.WT(_=Y:T?=-9;XWL!<PNQ\X\I:^T/3T@ZIV*!W)]9
M7%SR._9K@@@?^/LG$4$2IIQ3+)DSEZGU+"A#FYN,6D/-I'ADIOMGVO-:NJ_U
M.E9&0@L&3)_'K]NN.3%Z>?E)B'HB;'@&XVYVS^N=ZN@F"'NM/886SRE+K3;N
MLY/N\I$;',Y<V76>5J+<8"B?PII\C1Y*$I[M7J_K7L:C:#4*.G!A#$X]ZWEG
MZC"-R#NGR@>8#6BM#BM!<4?A R]XT#$DXX%]"VLEJ9! I>+N#-/U^,!7&3[
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M.4CG]"]*PE#VH2!E>!&"75+P%:M;<'0''^C+X9) !F1 !F1 !F1 !F1 !F1
M!F1 !F1 !F1 !F3^248*]AJ78;;[N7U/2KYY\=G5YO42K\VQRLY *E9)F-_W
M_P!02P,$%     @ 1CIK6I%+P]QJ^ @ 8 ,* !(   !I;6<R,C8Y,C4T.3E?
M,2YJ<&?LO0=84UNW+AQ$14%$E(X0!2E2%0E%@=@  0'IG8A(;R(= MDJ15"(
M=.G2#2W2.U&J@O02>I7>$FH@[0;WWM_WW;/W?_YSS[G/W?>>9Z^'P3/7G'/,
M.<98<XWUOFLND3Q,G@:<4U5240)040Y5*E4 @#P&N >@/G;LZ(=R'*?\G#AU
MXL3QXR=H:6A.GCI#>^8,'2T='?W9\^?HSS*>I:,[QW*.\0(3,S/S&096-A8F
MMO-,S$Q'@U!14W2.GSA]XL1I)GHZ>J;_Y8/\&<!XZN0B_7EJ*A[ ,48J:D8J
M<C, " !0G:#Z>0!^.ZB.46P\27/J-"T=I4/Y.< Q*FKJ8\>ICZRFM/I3V@''
M&4^<OWS]SLD+6A8T/*Y,$B\BTT_QWBW^PJS=B[ERX\GSEZ=I65C9V#GX^ 4$
MKPI)@J2D961OWKNOJ*3\0$551U=/W\#0R-CRJ96UC:V=O9N[AZ>7MX_OJ\"@
MX)#7H6%1T3&Q<?'O$Q(S,K.R<W(_(O)*2LO**RJKJFL:FYI;6MN^?FOOZQ\8
M'$(/CXS.S,[]F%]87%I>P6YM[^SN[>,.#H_\H@)04_U^_*E?C!2_CAT_3GV<
MYL@OJF->1QT8CY^X?/WD^3M:-!:N%W@D7IQBNAN97OSE-.\-;0SSD^>]M"Q7
M)&?XL$>N_?3L/^;8R_^49_]P[)]^C0+.4%-1+AXU(P ,(#[("!/6/A8F^.&G
MQ.I6WDED<GXLW-X@#C75#/$ZQA]MP0LJ%](I5'@@^G!%-UQPN]MRL*YB)[/#
M1?5  SS:\[6:E0F+-R@F ^)VEV%/9\F F&UP^2?(-A:H>^"TK!PW&;O51@!9
MD@'=OA"<?0)XL5Y\K0"R!<>;T) !8,9=Z;C)&!^G98@HPVBB#AD@VG*+Q!%%
MZ2X:!!PQ1,XSK)L"MS-7P*+U@EMC?0UF9$!P1AK)CQ:"LUM]1>F%@%G-HF)@
MH^\U%Y4'%$Q\M>8KLZ$H,H!>UHT,D$<T[274@+=&X6MU!ELA>SD7#GIW]G^;
M\#JL26V"8I:]%T$R>Y&PFTV,#R-ID0%V,[#D0Q>*?W(5.\@$V$P6$K98*$Z0
M]-\G[#+!K)_XT>RELAYTYT!_BT(FB4."#"#YAD%PMH7*)-]>8E+H&GA=1'P[
M3<WGUPAL0PB24EFP^6P@IB<QC;"334QZO08<-7194(BA> 47K1=>Z,7?7K$A
M&>N@9F#V:=M]\7O.O)_(@+)G4]_]+U-\XC;Q->@"8E @R&8?&=!X. C']A)3
MCD9A@RTH1/PVRN)E[)@AN$V## A:+B # N!K*\008GH(R7()]5L$/2AM\X6P
M@!0R@*[6F$047SN<(_4TD0'7=Y1_BXP<0WCB#$GH&:Z_"#B;B5>H\@\(<5N"
M_#: 'V6 ;B3,-Y[$RE]/7 &7KM*@/WHIO/K=A%[L&XC\\A2FDG#7EP/RJ/ '
M&*FUX4_UFP^_,+Q)Y9%?ALTX><.'X!^'MAB*>C?\?KLFYI0E00=I3BW+G,T-
MU?2%:.7_ !=I;_A-_=9,1VE6;IXLV\0930KL9JZ H*]68^#>O\W<")ZQ]O[0
M']*<QI0(T<Z?8*"T>?S>1@;,6.(^D@&'"-C,$^\B.&)@(V2WQJ;ZMS4Z,X7Y
M5&?HITT)[6>L2S90!S%!,X1(G?G-ZM>4>I_9356M.21KI3V$TLJP^DB^\K=%
M<H$,"!QK(<6@,(G>S7N9*]$;KU:OK?E!?K-:1,YRCI<@B<+$>W?CRQH0"DLP
M([BUWV_1-K\F9S2G1.* X%2A3L11A7SQA3N[K_=L2G];.W,P3+3W.&5!BQ.N
MI,J0YL7S.@[>D8JYO^]1[HFK[*J[;$C.:JQR>*'C0G6D*Y.J$;S<$0K$)4^=
M$RUZ"*]Y8&+I;Z=&)_.E:SE+!OTV*W,P-5Z1R>!R#Y.6(N!O^5O^N\A-<(-"
M^9;T>B1'12&W4H#JX<+/"O!Z)!EP69<,>%Z?G$G<$HA-A%5_/[#N8MJJ\<IW
M8 J(U>C2G @ V7&C]&UFX@<^%2LOZXA</]3SB,HQ*$CIO" BHG6HNTKK>U2A
M(BQEGV#! \>72]P#9ANH"'E AQP')3R"P1L#JV?\X_(+8B6?ZSLO?/STKHTX
MFF!!Z6AF4O\P2E]C 1''PD8&U.ID72<#/"G])+X9E>IVT)VQP=D_/5(_M2M1
M;]VI97'Y#;Y<J FX;W\\*E>I8*+S@D $&ZJ68A',,Z]\0 JW#;%2/]'L5K24
M]/QPR'%$HN^HKT>P^,:@A^M #TA85^8&0-FX,S%CJXEUW]Z*,O2@@]_K(IG0
MRC3[,FFE8=Z3I:"'L1:4622^4#3#5CQ?[+''@/?=#&)295;[2D#WL3\57U)&
MY$=55#B5M#/6G\Y_]+U$\.FMF/V/UA]++U)LR3'Q1M7J]:ZT1_%.?@[<&$R2
MO/_M.&0"$4<QUNC3ZNC3?F**6&PNUR-NAX?.BF>4F'9 D25\#WA(ZP_CL##/
MC#?N(?/L"H,B;T4-W"EA@>@\VK!/N#G60HF:Z QIW2#"*O+>U?;4X%R#%NL-
M^S=T9RACZT^*;PQP/[\'3!!VU-S4?6?6Y/I=XZ*?_L-!B;X[#!2;*RE>F9GG
M1JAV)N9H<M6!)Q!#IV"U>H-8'64^2FQ_#I]ZRQM6^TA8-Y]?B(MR<:^<HUR.
M'+6C.MZ!K[O1U27%%DX4 QY68"@-'PP0D?E2]J%]D\"-@0X7RAPG?!,@H*3J
MO*?+1V<>E2&4&;ESC82EW70UXHY4*(&AC'4E6;>WGF)X@DDSQ=U&@7SZ5T ;
MV+PY#5Z@E8*4G-8I:^&!RZ+YP:PR&1"F:4 &(#U)>M.H$KBZ"ZF!\R!QA_+H
MWXBMU^K4P>V0;/J4R_FNKJN8JRR=8-*Z_;?\+?]=Y"Q\$UX(#<=;P;YJ@<>1
M19;XN54(#VDD;>N"YK[PR#<R8(K'QPB)3R8RQ*QS,I) 3FSZ'OD!F]A\K?*
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M4FV Z/)=+E9P3/)&^+0$!,H/AKY;((WR$EN?G2K$:"$$:\JY%Z4LA!Y%I:M
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MY ;^O?2P@=]-OC%,\..5HUO+LO,BKX3,G4TC-^^Q)JD^21T'*>SW^D=5G6Y
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MJVZE1-J!39UU6<7\O;./=ER,YZDH7.7N#2B$#.!1J"4#S+O)@ ^)!TU[7&2
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M/3-1<UX)9?X;Y0>K&-[IKMPY>&B-0=C3\YP.LE2\*3FH!]G#4J<&A(*HCS7
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M!E'F.1TVV<X0#9"K]370O;;EVW&?)@LJ@]W++ J@W%!2=D++^,]0ACC4_4W
M^3,P=X-OD&*&)K6#.G&Q\EDG<3Q8.WS[7.2S9D_0[JOK;M$0 7BR@-F68["U
M]__G]E\O28P,B 2:46"A#1G0HP[MP#.MLG \\0YUWF!AP>L\OKX/>LOU:5=\
M@HNIW]4.:,$]$!L#-<N@+-@=6 H0$V^+VB8"%\TADGZQW\1:"YGCY PRN>-[
M2>XH3*PM&;"-!RXJ2_J%B-1RN.O;$/B,P012V\'1'ZW6RH)UK\%2+O9N4.(C
M^;%@$Z=2!C\@:';!*07D42'":ES6:K@WHY0,F.'IZR;4YRZJ4:)[,HD, *L=
M]"_<Z1!K.12"[^TEP^;G83>?K^J+[SLSI15>_*KO_R9&SV.@T"2K'<;A7?>B
MY@']K>"L,IWCV+39[.T+^(%3'DP]*Q/T8#OYCU2"N8XNJE+2V12\\32>L8E4
M7#'H.;B6B4?3@CG$0A#.8=G$ZER*O^TD]Z99=5$-^E'JW>SO(>UX#B8]/K3D
M'CNKD/)0:F)Y3-IS#W#XS\EU=54\SKP2F@Y+T/WT]8?.N1B="NEL_J;EVZ?_
M5S_5-S(7P\HC7]:!_(O,W4YD68WXNXZ6>YW@?#_#&N4O/ /&"2JORT"Y7(!!
M93XL&[>6VC5Z*^YRM)8K:IQ]N-+4&^L;=NK@PEX5CA*RUN[7V^;+)7(<=PG!
MXZEGA=\3DTDT4U!O;$M#2F[[9:GGH<!Q:G-3RX3D U6K*)4;< 1R$#GLLN?9
M0SJ/T^ANJ[P9/-:I>K'.J=?-G%FP9E=</&%W."SR2\]\,)YW!4F->P(\A=-\
MV,\3KJWFK2]M=3'JY.G"'"O-NB\!Y8N3DKAZAP\E,)L:LXW5"%?3>63+BUG9
M^P8/19FKNES-.Y :W.O=T8:^Y?)X[L\NA:S!-6^!^T':@W)WG++;ZAZ4X*]V
M^JA/!>^L'KQ=14J\ZJ(>BDO+,#19G\CSF8;YE!H1+?9 AH:%(\5>6$].?=ZU
M\PJW7NAFXL:8^@XLU=_[30_%^ 8'V:?SV:J0 ;:TSU<FN;J!-C1+PF 'A86P
M</'Y\^(7%8K9&6]CTEP-1V.#:Q'GG9 <(O@A-.'*)/#UN\ISZ7LM\E"3#!LZ
M/^Z LN3Q2BNEQ)"F"Q&0$[CR:A+:I2M9[L+LU"%=Y:)9!BY>W2VP1CN@_)X.
M5G2PSJKP\HW#)Z4E&YT^:4_=8)A 7"GI9>=!/^>7AJN0^L+UPW+9ADO>*0DQ
M=N<MBUL<[*1J<M^PLH;RI6Y^;#GM=DLX,+L=*<P&P81[ATESUMW.Y:H<&N"6
M2&L\]\)S'3I,XK;WPHG73'\C(J3[70M3P#/U]:ER(PV]\,UMD[LI]W=D%XW?
MQJ:BA-FN0UW#QVS[%A3PZLY+9,!Y'<.82\51(OL69EP5(;EC;67&]_WWPCY5
M2!5O<Y79^L<8Z%IJN?!&:6?MP6=5. \B\^?8<[7Z7R@ZN_T#QM]U61O\Y)Q!
M/^[,+$S?6T,&>#^IFUR=[C"#=+H1"R5".6]Y<0O+MFOA]#KM6L^C;A4OO=SK
MK3%MA4W?3=E[S:#20P+]4+B$\_AHZ\I:6ILX_\OT4_0-%W#H>A;G>LY(:BZH
M:[5=K$O@X;/>Q#IK?]H2I0DNS3F-U;XZ5X+CH6B>9)2UX_.L_H( ,8?X4P$=
M.9)+X->TR(*FCPT('7<_EOYE%?.'*.:Z^Q=I>D>4\>4#2PTRB;MWZMY0"+%Q
MU5!@F=+SIH&P6F4+14OIMY+>S_CJPQFJ<Y%O):678>P$!W/;_>L_XBV-P[K@
MS36ZXWRSU_= SL)?Q<"#7SF7-9:CK2OO#VBO*\34<O:]#^Y5*SO4/KIETU6.
M=K>R'VNI20/TH9.7^IV2'"L?A&_8F5W.FFPY%+Y:!\D0-\&US6E1<J##!TK.
MO2O>%?]K]NQD?D/);Q6O*%GZ%&HS#SPCU0-;NLQ*W%66\PNY4LNIJR]-X!]E
M(![G(2S#9B1_-B[^UL:DKTS@-P82R("V@U[**!$4' /&DMS=E*N>JQ4C%9]2
MIK/(@'43CK+V>]NT;3+@'YEY0-^ P#<J3M%5_JGK3#$#W/NK;D=QOJ(51=?H
M'RD_SG;J*.7_IAMSE-5]I7_J]L&9[&BR_TU2E\Q9]DY+D7,8=7.OT<%1LG8[
MGO5C'F3,$[B-0:6([PV^( /B8PE+"W=+UTPS\HH0-I<;N[*(]E\?-_%&/CR1
M$2;X;[]T^56. K[FH@IP8EH/7U9JW3EBU<.3,8[_V:HDS6P*%Z_5S.;\GPM'
M2]U2DM+U-GU&DLB;4]]#;/.>.]2X U?%]& <!@\\79[L,L=-BO3&%^Y88G-@
MC5;I$964P%=GCA<9>8*6"F X=<G+9,#U4ZB;8,I%@ZO?!7=%>.^?5?&4$BQX
M,4?/6 .A/!'3V&Q?D2"9A*5%^+.?JZZ-# CLO\OE,D=8XK[1TZU&2>$W9>?&
M9?F&AS.*N]_N7$8_@F]G'?UG W?(@ ]O(2D7L1L7H]8<>W6=RHE2^R?ILJ*7
M[&>_EOCW)]KE%DLYN YH*5[_<S+N*?"I(/Q>RZA2*G)A4JE$'!.M4E;)H6%\
MQ?'QH0Z';29^*P]6Y_!U=S/")7?21_]302\,JO,8JXA\>[FS97^$J^:7X2*;
MU\$=;B4RQG%UL9&K$)?2158M(.Y<@9EEJ^?A@ROB*?"-;7,[AL =G#-=N'^2
MZW)##2<]6*.T+<&7\GBO<S,B/M%\ZK!K6SCQ30#7>P:X?3:&2)71/<?DM5EF
MMY4[P-'@H<G0MH6*3'LF:&;3].VK+2N&.:T\;9O#CP/2SFK.4S5H26RLNQ*V
M*%XFSCAUX8<]/;?_:A:W4 _K"X_S)-U=K//;<;XUG\.!=@V3DDQF^@S7_.DT
M%LKM9T:YTY[C!%I0.RR6.+1SXF[RYP.=_#1+T[WJ.7KS+Y]+2QQ>K)Q0C/>T
MS9JZ;P4\?I2]OX,Y0NLNS[KC#S&0_,'74*=9D]:M--5(*I*(_A:.9:XYSN'*
MOK;)K>>ZYZ]^K(9*,^6D8PT7RXC")OU/IQ0J2O.2UZ>,2Z&&')RGGE;XQ9&V
MW@[LP4ZVY,?=C"F2_U;T1A,CFA(AUV+T=:,)5'=UT.36Q4&A1W&')!J0"S9/
M]BNUVGO89W6/1(8WK&;L+.NL^,9RWCY'WD<GDB'[7Q%1DVRPP68$::GH?:L=
M_ON/9 0J6 JHR*3?^CNJ.'8C[\S_H.V]HYK<WCW.6%$1(R*@*$1$ 4% I D"
M41$0$*-T:5$1:4*D2DU$#B U @("0J1))_0.47KO14"(";TGU  I\\9SSN_>
MF3MWS:Q9:_Y@K2RR]UOW\WT^WV?O]TWU$;YO*?3>(@8(4X%;2];?"I/8-^Y_
MH-C 10BKKSA"$2>M/<]YJ"&_WUST)0U3E6]_K%YK,AJML6^9XU(9"KA:?XDQ
M?B5!%<I(H%T=]_#F^6,E'OEW=F2X0C+M"@OM?J;Y<W\ILP/G2B_W]1=D:Y(C
MU@Y$5]V07H9HD@,HR8)?"&*X_HMN7::P8/KE2*6VU&)LODA=\4%DEMY6#413
M<WT"2OQ6Z2@[NEE\9BY?M'C ^^GAWK5JUW?[PQ%YQU]W6MY+DU.C<88!:O4M
M("\ %RHWG ;GFL_KWY.B#'_I6[7Z Z-J8EZ/*A@@?:>\31D'^4A$Q7C6Q,W7
MPU/S_R"?)%M*K,UF&K/PZ(;1!&E>BX+Q9J]&EX$]O]*%^P4(:P(L2\Q0T%X.
M$Q'EK[%,QC*56_N_!9VX]8YHI%E8O"@WG2.,A?Z>G>Z"JD?\D75H=^S_E&WU
M,&F!@<<A&QD]? 3@$)LX(X SB/E'JYG: :@L]8^  K%LU_<4^E]:3;VZ)_2W
M1'?]Z5O*&0WT=?M'JU'U_T(YLV_1LFW?4Q0@U7_H'.@:+_>?KAWBS>F<<4!7
M S30M9#NDMK$H^)2@]Y(C7O+#2BZGH$G)43+(=9F=X !*I?>Z ?8VKM5'OYB
MA?/!4KSGNH,>4CK5N,!!%0!B9_ZGV^)/'JOX(!SI^8_QFDF?F8KR_G_6==]H
M,S7U0G^LA>?C0];_1=QNS9NI_Y_^91;8'Y;1_^Y,L%G&?WT(9?^'L,7[O?Y.
M#IPG1SZ:,$!Y'X6&LZ%!TIGA?"L']OJK5(J]!-2"VQ'<UCG#>]#N!.9-"(#.
M\D/FM.*5V@']-0]N_O<N_P5/%"9_"YB0F/I7G%\$M\'/66<PY7H!'.H"-))@
M9LN6OS.M!9 M;9)1?P8 G4,,3$?]IZ-Y<(NR=&^@&9#RHQ4MDQ^,&SX.!?P*
M^>^;K9\\F.<0\"+.U$O_HW-_YL?_-?7]_UXI_,_31-B</R]AOX8<@*_K2N-W
M#*K?H)IVN7E[G"DO]KT%3HN<X_QQ4K2#+H;LY&$)L:@9M+?H3K]T/=G3 :M-
ML6& +H="-!>&@K\$VZ9EZ3GY%<LGS<W6H(I9F@(&9]'+D/GDUM IBIU$(P/$
M1KW[VR-4H09V,6?D(.YQW<0-ND1_Y837]WAP</K-Q3([1_[%!]A728[&"MJ"
M_B^1\ 6L8+KSMA="NF,@.7_G(04\!6<WV2TS6/T>&KS_;>#W6]^27>J2CZ!T
MK'SWV)++A.R(^IT8QP^?'$,-BKNS?3X$MU*)4=O/*;GB1\<%)4<*J%*T3PZS
M ZLS9#VV"ZJ';NWYPBUI9? U9#3G<I=@1):#/!! J&F[@'R;H,SR\J]#Z(XU
M_SU%I! 9'[19JT)7>BWX,G">S5-UKH%-V 3W\7A4J2/J*&HZRWV$7@??'2E6
MIQ?5;AFG1U5(3:^%QGOTJY86GAM7 +(Z[0&%FP&ZXE>/W_H!C49:(OO@ZV<#
MZ=78#>P W!>U_D!1C $RY=@U/.JT]BCAV+(W@@$Z<M0>=[9$BMZ:__:'^?'2
MX5R+R@K(-<Y>!NC'/>ATYCQF-;B8-$Y7=:='3_A'A9]@8\TRWR>$A\?(Z32#
MXPLC,:8Z]$Y@,X9$MPCB-9G,GC'[1/\RJ.:B VZJ?8K60,WI15D<!X^Z]NS-
MHQ*=7I Y;?IK7DK-X;F1'3CVRX,7;;A>#^\2,T?IG;@SR6B?B53A0X*X!ZK3
M.=\1_0E7&SK336=@I6]4Y!I53=0$UAF@1C[68:I0A2U[:X(GL<"%,C,L"-RN
MT.FI9.Q G@5A)%#Q+F:%E3-!R4E4O.<WVG=S]'#,V$-KFG-9U;"KJ!VO2C2$
M16AYB<S]=&!X0ZO8YK)#'.>$-R<MDJJ:8^LDAQ9[>$/-F4]T-5%9>#/!M;SD
MX"W#%.*W2*(&DDP3#<^W^Y#]Q<"O=\X;_-M>@C ;N\TK+K/^T^G!;'EF2HW;
M^-MG9Y^H\O]+1*?A1@U9QK6U]:+-2R4!Y[$?Z^21+:G:-;%ZI+-L8EOC7'&P
M.W;+FM[.TG 78I7P2%9@K(RLU(9!R[8-)1UQ-LJ6ZZJ [D]#,:QU>1UWA;7$
M\/T(S]\\-+VD5U4?6OA_A0V^J*"9$,!^6PNA(WLOM/\>V*[ZWH[WBJ"W2GA9
M=<BB'Y:YU"RV\AOHY\N)?*DL"5:VG<=:L372V+_H9WJ-9,*_?"S8Y!PR)K;?
M^$C-60AVZLZF??A:!)6[CGH%#@[S3/$27)?J\APNW1?KR:"H#<\\@XY=>O4<
M;O7WB/8G+B3L\TW/8:XS0")3,59!65?S:EF22=^B26N:\>KAIKM]%V_L9%+-
M?O/*P?HLJ_V4G<)%LP90TS)9#-"("G41>DZ< 0(_5,J9?V[@H+FL'N-]M8=Z
M-2BI>FGS0B-^_;X,;(^,H!W%09'<^3WG18 \0K/;9/UOW]1X3U'(NZ>$9N0:
MC.*]PEY)SX0-3&W(;((#D!<7=N(UM5TDY9?,N4EFBEU>>O ]3\2LW6*8+%2D
MRS"#<Y-32'@@^"'?7#C5J/^ZXOELZS<F%UE'8V2IVEX['W"6MV9)8>FK(<>]
MJC\<]EM4L_N.LI'8/5?#RP#! 4E*/D&[1NH,@_AM7CX%[=,%O!8GT:)0/\O)
MJ=5-?>XLOAC<A"X_':,];16,<]R7I^RKEVY@Q>+4;MIM>IL_=&>!^M_U.39H
ML;ZJZ^G);J1^JU%=+4)6?<:MU,+C:]?T9!#GGHL,--!;(LN];,&^9"ABUN$]
M3EU&PB^);?CEAH1T231-<R@,0H#Y>\N]*>=Q^U*@67M.S(4!LM<<4W\\HSXW
MG+-_DVHT<<'HIT-HN3QO#I[.CFRI\IDNXRD/Y;?>$KUY176EPG#XR40;C[^N
M[V;F=$3:3+A=5U[<"]%\@^6: *'V@J:3UH5IFNSW0M]<$TZI*9"J,0.4^%'E
M?U:^<6QKDV8"*L7K'$:CZ8/?G^W'[RTUX=>OV&'^F2N.QEET\?@\@K++5-L_
M=Z% @_*^>!24&L;??E,T8X^YCZK']C^2%$#A]7"D'&D 6<0NT/>RQV)]O76E
M.!"H A_;+R@P]27.2Z=G"B[?)C&C!+.!S,ER$Y(^UUY!["^B*0955COC]+W<
MXM]KG T[6 VJC45_S5U;9[&&&ZD U0@[9Y1T':4X9IP*9X 2I:F*1;SG :%\
MK1"VDJ3X>XVB7TJ.O%=AYW%\[TE[U==9G_,/J=!2<X!*$X6HEVZ<"L4G/D5=
M5,.+C#\ ]R?3QZIJH%6&\/KHV+L;RKD(ZJ5Y!2FD"X[T5_0\;$Y]VZ'<@Y[]
MRG10AR+:I"NNPP AIF"19J=KTSS;SD!86OVP2_H2)1NIS2\C/H/SQ+"^BG#>
M[S8RO&T+\8NOJ0+.5Y[+<'-(>&8.?*DR"M+_R_/7AAIY*^UA>Y'L##'1ALCF
M;/Q9/(;5K[]66_DBQ=OIM5[A4I/-0AWOP*;;T>X#[+RW\CA/Q.ZD65[7%O4J
M'"3GZ1J0P_]*7K482UR0QH6<R?&O?G%LJ<G+=3L!D:U>M B5])$T<J;>ZA5L
MVS_SWB<[D2=HOTCP5K".P1?D5'PA)3EC\L6YEX+.O;I;;,Z-Z^)+G ;F0\ER
M]30%[@VQ2T8SO&R6MDG'R%+YXZ)X8;?93[6EI=03(5\G,4$8OM*I"09(6JL,
MJY[KWD))-<X ^WI;5^"SYL@Y*%*P^[>1V<C]-YQAV;L)YNB/.\J7ZH@$QT<^
M!V==X5)NR!)UP2PK>N4H^1'L_ 7!R]974/4QM6IYVZ\5H"<"X)_+YYY ?;]&
ME)\9W1L,(Y\XHH/L$)IYB";*U"2*78&0>(Q=12?G%6#'=QW]0\OGM,T.KD_
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MD"7-%/64@A\2NR-6JA*6IQJVAZ"??^,(&O.\;S5V!X@4J>1[XY_:,'EO]70
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MFL(<Z=@H]7)KY=RXQ2>4MO/OQGUU;/FN!N7^$B5\V,(*6,OL7MQ]/.V6F3Y
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MS49/R,T!"?2%>XSTA11$=SAP,L)./;O=:]I]*0.&7N:[^UX<)JS8!;KYJ)A
MU*)HIT#(T])+#T*Y<3+I=IE-#M\GE/OP\?TRE6YJ9Y*[<M[>EE?4R&AN%(^&
MC%AG<31WV.+FQ]QA.ZK/6H@(\)$#JT<7XR6XW9T.1;QA@Y?YM.Y5+7>=5[Z*
M5_O)XP6ICP."18$!8N9;/3@)X_ZVIF/W,>ZTHD)&T-\S.('+ M34#$IJEFI8
ME07F3^@5_E-L+?Q3* 7PK.^/JIA#H.O )W-F(@<LB $BV#B$-*9R8T]/F\SC
MH;SMAZ&PP?\C) #O;/Z+">"?+;LG9\F$YSV!GYC+720HC_2K*/8PZL'2?Q5"
M@BH4SYS"25^!;+ 4H=?C1*>Z:A5OI=(/Z*B3#^R %)6YZ0>,H23,_"'*P'K:
MG]V IP '!5S=STJ O_&C<[1QTY]]17VWN=#B7S7_E;DB6D.9W]U]"S!I(?\I
M??SC59+P37VFAW"J=]';MJKDJWY.8XIW&* *D0RFO8E RZ-$\H1"O.4%K%9
MNMO8"J\CH_%+Q)Q;]-78<WMB<+^F/I'W91V07L-K0L$UBMPS%8>';!1AZ9VY
MES]SC*%?[X<L+FS>3B=780BYL-/N*6::LN\O6_203Q#]!P<DURO;B*G6KB/>
M*J<(.DMM.9P7I5^L/J2SU59];'<-.BU'6LT0>@=^ZOHJ=I K6\J&?BW*U\'Q
M2;X?$;O[>RAL9#WQ8A'=PDP1_/P0PB[Z\-L\D]LF%V1 ML&?5ZHJ94D]0?G<
M8-8#6RDCA/!T1\$%:E-/K;)E/W_[7N=JX(?KN:@9&I +??6&Z3>+$M_MW[-:
M,IW U0N/JL==><=T*FZH8\O\SYJM6G>R:ZK/5[3LAGD%B6T=::UA]_O%TU)#
M,E4(ZME>BV:BS"<2;XK:6<V?>X/VI+TNW$R-'SE/VJNQR\Q>X+"WI*\'D"5B
M&2!(GH]H/0\R_FZ"Z=-"VFP&)%!6G5G26 C[U[?XMY=]4+81E:>SZ-I.0OQE
M2TB:J+$FC5EWTXV0A[0C3F^H4H6AD>)7YFC9"*KHA=.-M!2FC@%F!4A5<8G!
M782F_6^#2/T78KKJ@32SQFOTA?PKWG*%$&9]1D>BH5IF01&3J).[?[P7O<%;
M[!ZH;<ZS)PF< ?.%.'Y:2]M_SQ\YU%T8TT;CVUKV]=40 6TS'XLUF,_-K,S\
MY.*!='K*4:_$W]O" 727]M_)@[R/\=\YV?(ZTH*VV%1-L<CA5]9@+L?/YKN,
M:K<N^(0?5UJBG[&'_#.]@R=]7 BMU&IESN_(4A!$Q=_7,3M#IJ4D2+"8GGU8
MSU VLE1B1A0@#N?)\<881:(K-$S-&V9;>U67,A+01<!SC'GWW[^S-_0*HU=.
M-/7;^E8HY77_3X&]'\6M<J[]XY )G</RTLK#>/*2O2/!]"&%:F<'([N%(?P<
MG<[NS.:,Z_D<(+P(7_:^%^4,+M[\ID$^,_.XZ"D75?0+_(*[[L6)?&3I*\B'
M22Y?MY!/ DOJ)9_KL) 9:2CA%?[/) ] ^;87I[0M*/IWR:+U^(T-7B5E(7<S
M!5/U/9VYK%_(>D@[&UE7%[[K+T^]]I\I'@P@)M!Z0$PFH?W12$'*\PH.-92(
MZ=!M],^&W6-_G,V?=M%(D45 7&]D4+.GD;=[7^U' LT^4@;N-[]MV0-PP_6C
M%V!KDO"<,C) Y .T@2&5EOZA#4-8>,G5Q85=7=0_FL)D![ %>%KDO_D8+7 3
MF^:C*@MP_7\Q#Y3PS)KU3PWD[+_E4PRI&+&'LI*;4?_7R3V!-H+!')TYN[I
M<_>W?Y",Z8  -HE_3%6IBKS9]=*0E,5-/)PK7][T4@[M??MR],:G$]F3HJ1Q
M6>0 ;%QYF@9PB0N45'#E%\OHWE 3^>O8<31G\R_WG+N/%2M_R&BN-7*]%:6'
M"4ZIE]ME,BT-(-P<>O3YK!5O$]Z&TS^?F.N\K(E#.<G)J&[#V37HV1?[MN(
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M,X:1\!]09_"H)A)YE2'VER:%G65-JNF7ZQ"5?5@R;;?4_?AIRF#UFKF^A%'
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M/ F9O9)XX'FA.0<6G7"_6E31N3&VA1D^OQ+$Q&)JVFU+!EVP;$4RH.Z?C"]
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MA@W=A28^NA?W'E)<_IHC):4N-64@NWCIUNN,Z6LYUZJ H/WGO"CF>U0NAEK
M TG!CW#KIV:U*_8>E5DS]9(<(Q 8WNP@C7&.'W0!PB#/E*9-K7H@YC]II(L:
M=:S'E?) 9>;+>LG^S'?+IU_..DC<?\T5(8D_/7139D1>>$;[W(4_R)+:A74E
MC!_(0L;P-%P-(T497;PR-WL9,UJ+F8]#V+H@VNHQ<J022M'Z61[(,/KJ8=^L
M,,8QB7TA+\DYHG:7&]:./:[HU#,$8AC!&=<M3F0SE49-]!B>>MUJDBXPIDW<
M"5'L@T+BFPQ.3H[4PS3^.0O\,T\AA#470,!!G-$*3CGM++-&AJZ>&ZXA$?=#
M<G7A#;0$@E_;AN<LZJV, 8KQ G\[-(0>]\"]*&/P7M5/R<8T*NO:P&R3._=9
M(_\A;8P; K.T"[X^AJ]G0*^&#G8XT@C!E9AH<<QI*X#M3=<] :OTP8-K%FA+
M%6!7QW)964(,STO+'-E6I$7KF&NF;S)L[' J._5*YW(]=.P0<;5)RVTY9CI-
M:=0BM^+F:D:\]'680>T7]X-V9UWO72!:V_LOZXLCSF8^F:P'VF]9M61PUD7@
M5?D!^' _,GC<1.>3#\$*VB8=BJ<\S9\+";2(@1+=LIAF:I+'GYG-=Q=EW1WJ
MR3BS4F(ZW02/_Z9A-CP.6ELT)B=IMNHE#OB$5UW4P3EGQV=E&0:<5XR'6B^5
M,!T^?.^)TT87YK$A+</K>1T>5XG.6WR::L-GWLZER$RY)-_L!\9;OAH-T2_Z
M54,3)941]:WL#DHJ=>8=ND]2R#UYRG//8B,KKCVPZLF;+YP1XCN\*[:Z^ :J
M@R/7X/Q9KU5OU"QC]_1CS:L^$F:8LD5P38>)CZB-?>)#MI'?CX?9&*_+^A5K
MP@U971]1A=C$GF\:S EI=I,*=S=Q-P_TV/T'M66=_(&=OBC\@9WA=QSJKD@B
MX^@O?0(;ZKJ(*OS] $5IX+DF5MR:U(]S$U YV&F@,NP=_Y[&O,4V'YD:H<Y[
MX*"L,TQ1&RG<^47(?.*M)7"T!+_&E:M:%>62NP@"G:+S%=4,R%;2"Z_M989*
M8XC^D; [ZU_-]CI_UE^-A09(-NVP<"3G3Z@QEF/@/SJM3KD#,3VF#0T8KJCJ
M8A/.2+K$MVZ'Y?"TKL>JYA&+/2>ZO>)@/SJ4C927W_% *O"+:D^7 J</7^2!
MA);4-6KD4%'R/:2\P6*/H)2:DC^SEG/ZSDK<'/DS=BNY%&\-"'GX!PSYC$DM
M??Q227V8&3A'\/WK!*>"UWF/(ZX<^U,[NLCQT&Q8<29ITF*.K?1PU^7X(X=+
ML_4+X0=TCYY=/ +/L8L[-F4CP;6;PA\XB1%\%:;'18IR6=GP/.;(HT1H<[([
MTTC!^%["F>6TIA%%N*I;;(<EU]9RX5-\SHTG5DJC5A3"R8X9TMJ=X(>4-"PM
M-: BWE']XW26J/Q$D/6JQ>QM8!!?Z8[YK'&3C[G.9PS/R\MIPB%\/"YN!8;Z
M74I1$2!+'?E_I8:@*6#)(O<7:&$_F_B#0W8&*@=O"SP,7@U@YGR$5%:["9HH
M5VM_P3?@NM>'BY,9_K6KXD8=_7=37]3>WORYR='$X$QKPDT7XU38$PVI;XJI
MB)PK<Y-OHS1?PGY0]>GDKVK0?4C+;5A'"</3#WHL2N,#UH_[NANL2ZP(,AU\
M/_I4#9!$7^V*J1:#5.__T:;54+#RP$.[G^EPH&"0!PI\8AS"B<E<R0LXCM>2
M_\CMI?! $WR$.O4AS5HM[GUC>4Z:]]#&7A&YF4M+UIY@E7G]@3<YG))<3(LZ
M$,-T<Q$)T ( \@!C#;DY)19I$6N:%!=?8;72V[]8PQL<PPQM(DK;8Q<R8J8M
M;S6_)T:+]A_I4%)9$1-Q3+U[$.FNXA;LL\)QWM7_LJPIT[L]BLOZI+4\@T'7
MB]*SR7G,P67@R\JQFN">B""VI5[4+GS>^/WMM*OHVG=SC&"R'RW$->7\UMP8
M:O6QO[0I#2C?-/+@8<GA\QW@NLRVVV-8TV:WHC[M>U*SYR"Q3UQS16;*W+]2
MTW !:]L\1Q>7,Y*9[A\5_R#=J#_&21'>YZIA<?O8EXCR9<@05$Q;EIS*BO-*
MZ(D/.&^EZR$_ >Z&U71;5@]L[24E?\9:@1\3E)C.@RCW8>^0DDO9J^=7C6$7
M59K\WCW>JK_^I%QJ9#&[^SK<O)H-\S0=4JMRM:&MY(N[:] Z<:OY9XU;XS@@
MIC,==YEI\T'ZG?,6;YV7AM\_O'8A5<,#GUA6VVW;Z:JQYW#UAWT,]LVQLN!E
M%XK7X1@2>>AS0_!83/[6GH,U+E+P.3S@.W(]OYS\& SZ_WKUHIP^/MV3_-)]
MF7Y\F!OW)_4EN@5>8!_+$*]R=6G=\N3]SO5RGY>;Q5<-'GD<?*^\+%ET(\J_
MXMJ4:=C-A7IPS-J5#)KPLW[EQ7L!;6-GOSTKNTT88NHRVF!!UK8WNG1$J.FE
M,9#-P3GK>LA-Q<R@)'*Z\VZE%9:80G@G U,]((;@@38C'YW*23ECN^.B[?@G
ME2;75TF'7+6=)H\_'&28*V?V%E#BH5<D;"G5>SCO@3$H\XN?1MF96IN'+0*R
MG(JCW ?.A(J=F0YW&6*6?GS"C5Z ]3V^SY%6:)*]HJ%<2H60UP24.(OZG-)<
M-7!7%L > +G12U1MZ2YMS+6&-945C\V/FQ3.1^,7WC6B<J!VZABYU[8NX[G\
MYLPK.XK6?W!>FDE&WW!%/NIE :1M,%R2A!^?,FQTGH *.KA8RJ_. @/OQ[IP
MV/NGBR1LCO//B2?MP[,>1Y?'PG1AQ\XR_JCFYNW'"#9T:!K=ZQ(^8CUSFYZ0
M4L^-*BQ!NX@1#DW$@E&;V$ZCK]\D=2R&A%G4#9\K^[9&N3QRQB@A%L847XX&
MN"CI>_@G>&"9W",@F-;'SMXNUCR3G5NR.^J[7D>[0[N7NL2H+PQ@(BI ;0 3
M#=,).-&^\-C\NWZ/?+SP+[W48Z7U]6@N2^B='>\?+.!JJ,5Z*39ZK5"#! 4'
M[%QZEEE$?#;Y3\RF:6C5/7:3CLRSY<X):6@0_L-FA\_L#&^<#LMTY:I]OQY9
MX!OZ*+DO?E%UE.[^Z@K:B@A$<59@"]K,E_]6&0DNB748QS(OLG4Y  M=9"K5
MJ(\"-:*$Q\ ZK!L;;S.O4;?ML+AA^MDO?<@A9EP"<F<6E@"0$=ZW'R4P:N0>
MGPZ.AMX)F$WQT4S\LT,*OAPY/N42VB_1<0Q@EP+TO4I.-BTJ$]OP(>I28=3\
M":5[+[.TT\B1SMYYRW$ #3DKS+5S;?0!XML%VS'9AIJ8.D#7?L-Q2%^Y1G3#
M)G;-[<O&L^+"W Y]WVP\Z#U&\'</C)-?#C63&0I_WG=;I/)-R I#TX4B<;&A
M;C)HJ<DKSC9D-  [OK\/7WUXJ\11$-OY'MVN*),'2IH5*#8R^=0:GR5V\#%"
M_B]4 FS(NJ7ZL>AHOB[3PFXU<'E)O3!:8-C<@E3'H!< 0P-J9HS-*)M&5YX2
M7?CD> .\0$NF9ZL!:M#A8:(FROD615/OWL"DIRS)WKE7'27T"6=B'V/(,C/R
MS?2O#>:KM\W(2X:[M5N^)BYK0D55PXCJXY.7AWMM\V?.% G]A6E\#I11K<Y$
M&'YO[^ _63[ 5FC:^YYXX)$%#[1L6L;]:T,7EN;P0"T0(%)[K_07 6#J!,2>
MRP+[>FL/#]0) ^]3??E+[\UOZ+T,OM[C@=RF?PF^PEC:E<B.+FUIYSU>JLZ]
MIWB@-\W_H@AP3]P 9W/L0I8KP^:R_:>W Z*J,'A;"'Y#ZWGF(ORYMW[I1U=$
MY,,-0%MA:75A4J"TN)CA.GGDNX*[ L5.[5^LEH/TW2$;>A!FM>Q -09:+IB3
M9MP=QB3]>(IR@10QR+[#[$G;QTL0Z^'KV/F?Q[@BY%GGY/65*6+ =:PQ(S1?
M6,.I876L^#X;BI+6[IA ^2;?< J=K# 2<=$-L*XF,!1"]HJCB@:(SY<:7T@Z
MF?2Q,DW8RBV?[N<[,I+JKHE\\"VJ74ZH2HC5@UK7?LG?59M<%K6(=X"]?"*"
M>0REI,%!$PS.SRFM^'O!A1:D%T5A0\WU*="@--T4ERBU@5BPJ?T20:A]7XK7
M;>BNF[6KIDO)7:=7IO-HNWTL36+!%;&+$&>D<,87EOUM]*?*(M5&GS6E25.2
MH-ZJF7FF$_8^>7O4U[*?D^/H>UDES[T8+=<P^^ 7W;7]%Y)] 9TF6;^SYSMK
M^)]:L/,5$DS;6G)77A%=-,_E*SG)C;=Z8;[<([*/HH]R9P;>I<D\K[A BHY?
MA"RIO06PIK?QEJ\S._J3?I*],R>1X#WF<I>NF$E$I0)X].;C\5J$!:QB*_0>
M'X\G2"\@V]?TE<9<0LNVLE%W@9M8VCG9 HC!I<P%'W0#O *7:IABDM/+FIU1
M2OZE!3]$GB^</A7(@"Q),*%&4=E>^WSV777+ZUB7MLXMPVG5'Y]>3<7\:+/I
M%9,V]^U5\HQ;765Z?M2GG.%+6'P+=/QMQHJ)?$_-@I:&Q-5/NTI.S4X8>5&4
M5>1F0T^O6=X%5[ONDKQQ 6K]?+XJ_T**5?ZSGKBB;:%]5[\GW2M0$2K.' AP
MUE2KS+9<R-Z9(%Q[O3[>^;IPSM$"!LEYF#U%N-3-N5%8?4,@9"L[8Z>+/ ^D
M"+R0E'WXL!R"L^-%HG4>@F9D3^9"3YB&%]JJ^]UL1X09\=7@C:*5;(V;@&.Z
MCJ_=*6_U1^]9E L5@)LH)83TI?0N._5QA]>S]QM2L-WR)F68!WKK@6,* ;8H
MH/2C*956%\P6'C6>Y@LB,P _ZY-9OW&&@"\)\8T5-JA;)PT;9*T/.*4#Q ;'
M#<O%_XM_[F_O50CH*X=)\WT <EL&6],>4%D&X)XR/OZXK.3?#FS#\A%..65T
M !9M+&CZ,G5Q5QO79',N K=11]2ZJ4U$_B. 3Y>)-1QIQM/0Q>N 'UI8A-[R
M$IN\DG 0T;E'@9+?QR^A<S9CP!BV/I8O#A5OKJE6]4,7$N_\PB&\(^N)>)BO
M'W@@WYPMIY*C:5LA1PRP+&I#WI#'I!J*'6;E-,*$5#^@<MYP5>7S'UT1&@A6
MZ+QZ.^NF:-P*3F6WV]FX)?V*'2FV*+KPL+G$$/HI21KP7N?JPXRW+TID*+B)
MCI2[?Z6H4I2^O)V[ Q"3"^SEVG&4%,?%BRX= >X+3^[*YP P?%X4QKI_/!)7
MTQF/$C:+!VL"KLL;6R5^'R65M6?B[$-.!T<V\\)T+BE(=Y!C< V]X/ZC8_QK
M60&*\I8K75EZZBCV([8A[?*>I3_P7<G0^^3-  AI2XM8FLLV.OS5IB$^E0GQ
M71F6[Z9B\W57%F:0#!YH._P5IEQMS'F _I(9Z-[+!YC2OP"69U<]O??OY5PN
MT:]4]%T"O-42F%_BRB)@T+0BA0$/]RSM&21W#+@L(OV%B^%JXBUFW*IKUPQ4
M+FA(7YL.$.,&$(_W[^^0(L^?8#==C[U,#%T\!=SGAP&#XJA,;K0U[,^?AJN1
M:5TB6=[:R,CF!2C+56;,I1R5\:119@PQ<85N'RMS<TJ:OBN<XY#QBQ03:>;3
M*MQ[.5;YU[X:/FC0+IK#T]LOOF:W"KJSY84V<WV?&79=1??+O)UH[>DF3'Q2
MWO>3:N[2MON,8 G@7=C0-E?J:;F7:Q34ZLNBK5NL-82-73JL5<9-#C2+]6QU
MW4,4+#@VH-3W69=IJ?D(=_ K#U0:=YIH;5'(H,*UH<TA+$'J5!B1^98'(C_'
M5KVNSU R/,'.$IB5/%UXO]?X!<IE2?M,>1Y6S4-6*N?\A]&[E/).$0PIDFN^
MA]!)3>4SH^I/]"GGO.(N+,2!>V L9(,4N2;E+M952Y]->:!-25Z5KE>@!99<
M5I8\8,P@<FSSUI1)=OHO3DSEE.1@-B@1_D_.HSQEQJ>(/V!&I\0]\>8#4.B?
MB%+]9_JC,!Y@PY!(EVW,G&09:]6Y Y@&T__!AD";,GSL7=O _EJK%[L::--_
MW=-V<H,"=Z8C3/8E\*U3"Y9V(F !DQP1-6U5TEU<Y!OA((<UL ^%3&5?4X2@
MUSRX9O/G37?&M+_&?$4<=JWPV!"DQNNB80,O 0'A1$R?J0B3[E <7E\))@8
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MGQ1'-0R\_),4MMS%3.;J[#4/@Y1(/8 *XFE8UA9]NS"/H>X%S;C(,;QG)%V
M'3"*O^!>@2"S-_% 1WT1+1+SX@NGX55G<QA!ET4L?9_^;9IV$_G?5C5TSA_&
M?%=WP59CEKW!UD.!ZTM& W2KKAN7]R\Y_H\97OXK4G^DKLWAO&\M\N[Z19\W
M</;-]N'=;^JV(69FRPFF+?RM>- X$>A^U3%S$*.[[#1U96(B%7$>=Q$).?C?
MMN*IK'JG$:0PHOOUKI3J6N#U[Y^_2/F/JBVD[V%5,A#<'8T?D0;,I*QI#V:C
M<5',W,6ZOK%-S];NY1_E@9Y#M:J"%"#E?J_6-8HO(^,9D4JOM!4YGY!6CD/G
MFTRX"_V3";=*WM$SS_]UR/(+<R=74(CAOH)85_0?A@KIBRB#ML0^'7E6=P6!
M,Z[K3@R28>_I7[G2Z/)ZG#-C68+^S@-]/DR:(=+Z'&O:!_2\QJPU73(]+GS+
M71TDSD[2IVFB+X<K*6Q]Q*?^8I4=4?N73F!?/>*!1)@6JS?:<@-F7Q3/.+RS
M.<+^E'&B5*%@$3O(3O2NQ?W'>H:#3!7>_^/M/<.:V-JVX5BQ;(TH14")BH*
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M>NXN."'H\+,A]<R?L4'2STUUPN>2\1\3'^P%7"DRK"<KXYQ4#2VV[&24=E/
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M@9*]&! BC^OSQ# 6@WML+MOZ]RXLJLS #$9U'R ZVQ3F#K! 7.,+YK!>W\*
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M$*SO5S+>,5#5[5!3:1Y0Y0T6H:/J28[6O<\2?KR9%5%V:#;ST_G)?+E4W;N
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MCWF5F85D>((V<+ ,+Z?@R J'4)K#!$@T&ZR4#1J?)KZ46A5;B*L)9X>RS$<
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MOP]DFL9^**3 @MID@C)+\.BZ"[];+7&U\G\I:MY$2!<P ^ T>9%7F#N8U?J
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M_GAY7[OY3.F1OEIJP\:=FRSA]N&K76*(^@Q(3<G$KF\7>+!V9+1DT3OLDB;
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ML"16A-F['&RLC?TNN6)W9U LY$?8C=W6,T,B[;)7:[WO1.YY<3"0<P^_=VA
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M>.".%HL@C!V8;M(3O.ZZ#O-[-$P'I F'U?LFNI#%]()XN_!L=!=>7B"@9LX
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M_OUCN:B]'TG"X:7]8VQ@WYYC]V#[8REAHZ#?06_4DE*O,<PRGW6E%W%9RNQ
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M\YZ&^@1Y?(?Z0F7DO_N3(3+<SX=^B+QE-=O;)-+QQ2XS?XMT-<MLXU*AXSQ
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MPO$-L[3)4)0@0&'(WRVPKSC?>$5*DERU8*3-3^/7*2IQ>=64R9%TO^*R>O@
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MGNH<^STCY\4</4*<Q$TL!%;BTNRB@15X%G;_,T#BJ*^SN6@6H=D");R@9J"
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M41IM$2J YVC&&7S5CDM0R3;ARZ!LOQ/4F:Z5BUY&0&^O[;RB/!A"6"B_U45
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MM9C@>Q3N? $%@Y*?HJD34U3?VFK'#?P]U2\(\UVX=M=1-8!, <&Q=/$<FES
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MT::BG<48]/OX@:>+R$=*'H08)3_[5$#,EN$A%K5"ZQK)B613C4B+)?SJ(:5
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M*(_7/N[%,WQG$[ID,_0EBE9>I.BO3:R>AJNK>S@.%>-A@[L:5.-M'*FGC:-
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M88SCL+-)'4"^)PPAD5O/G PS^T),HUGVT:Z)GF&Z1O)M42M5L'_>MO]JS-D
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M([]H(YVW_N5Q_O$@X",JX&(E+EC[+<WV:1!( 4JO\)+XX4:^[!&:*:[+Q--
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M'X''BEB638QKX ^UU\2@UYPP?6[K>N*\A(74@0VUTR%,(H/7Q4MW6W1J_%,
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MW"G#V$GCV$-92Z*)#PS9P/=[YUVTL8S-6#G"8UIC 0'AA]V:NR75'P]IE';
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MT%E\+C_6P/I>\N'/!?QRXY<*WLOA^RJ'"!/!(9J3O;:,:3O#A4&[^Z5:!^F
M_$XL2EOZ*#&6^57Y4;X!H,WZB[W=I5E&U4F1P>YY5$:QQO#8C<8T*OH96,?.
MM -+?P/2Y#A!!_&I;N#LB@+#PS$5[S)QKF#IW]7O.69_-CZR=IK*@NG,?^NG
MN:$W+LI"8"LS,9#1$P(KV)]$DSSH@N,S[;NSWC[YGNA^A RKW^*,<."JF\C2
M$-+N+_Z_Y8#E*[2%XJ+SM+_QP(64R'0((+_M1/[6S^S1A8$5S-O?L\"&CWF
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M5-NY3K]A&>H@OXZ0"C(]T^*<66Y&=CQ?=_]NYIWY))!46LI-K:.0/-7_D!Z
M#]X(DW+U-_FVT.TW.O2BH!(IKMZ:^5^(OCLD+ [(2:MCFSR@:WM!$G35G-_:
M+N'2R4K!S;G!Y<Q,7::H[U<WC99("\S1RBNWK6(0=):K [HTTM>WJ^4B[VUL
M$@BOVR3L=VC!DF&W<Y4Y81E;+\."LJ83]>O>8]7>)F'+&:I%N$I1>^B9T'W
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MON;VN+!<UB#M,("$?>29R.,@T6DHA%"+MQU']23MQ8E9G!YDA3:7]-NSKVM
M3]Y7A+)_Z.[VK7S0$J,T!ZJ(RY7+J9ANG+UX12I[Z$0.C<#EO;<M,]BW5*\#
MR]IO@!#"X4N57[L%QS-\2,[C%B@/C\3M?2O<<,^6SJQQ9?'W;D7?T3QN&G7/
M]OPWM 60RI:YP>Q Y8\+HT!#S--[@%(7KIF?WSM-;,(<%G)UK9KV;+JTZ*\H
M& 4))7\ ,[;&IG@.2B(%P;127>4"P@3U0.D8>T+-TSH?EXX#?TM^$NK1G5M:
M;EXZB6>L?-;0^$%K6?%)3&WQ"9?N;1,O3[>7F]/$EUG6<7H<\J::E[L,J%H@
ML%-PJSEC6V#-S6EZL4H!@+R67 0C.BE4_WELM/4)ZMD'8#S3O;9[WO5WN!?_
M/$Q+G7TZV?-V#:)*7W-9W;&HXP,(Y#9"D5)V$@1S^R(/-M \T58@Z2@%(]Z.
M#.YN6A>JEX+8#\$J 97?&4DSA5 0 UV/49JZ=F4CI,CXA<_C.HW<E?!_L>&]
MGS\P:_TABB+L288T,R'HR]5!6!DO54F@RE]S4B8/7'PKS:^ZH+"4D0YF%(SR
M_?VZ1T=P%&S8L2)1>OZJ?ERD+?Q]H?*L+0XQT_>PP'&5!R32]!6H:[H[@SIL
M3ICEQ::<K;^ IR$>K'/0^;98(D6^+6KFX&6)925F/UL+\2ZFA.RED$SL//1.
M=>3/G^",MT1-KKM@N"<@;J3C*10&OG_S-*BKN7>985R[\K<E&3BJ,?MI?'Y%
M;6(R_4?')U"X6Q!^&H=_:S.I>C*0][DB^(K"FZA^T5P\^*TM^HJ"5HMX"C91
ML"?3EQA0SVA3&VA;X#Z_Z-K_3JMR&Q,Z 2_HB1=1Z,9969MH)R9Y/%$VLNJ+
MDF0U?*3'#E1_B6IEK>#)?3Z;6R)JO !+;MA.&IUU 4$.[AP;_8W14-<M<P&U
M*/ !9,Z;AHW,4#[Q4@.]@+#&WE&-Z[G< 38KGM<E%11DXDZE7XA-TY&\SC0
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M=^GR%0)1+T+2/T%Q;#P5*ON'!K)V2?5 1-3Y>NZ+#>Y_CH#%C6K4NM4%TCA
M.3DJ&Z._Z.=)T!U_6*XX:=)2_IF<Z8?R=S*^>!JT=<=[J*T(LG4[CEE#:1N6
M/A1 RQA1'(BA9\B0_KQSIE16*+*9PFGV.U(1XND23@S-]A19'K'B76M$=II
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MV1%P?)X5*?)/</[>S7/]?7Z%H2OH-Q /::D<#-M:M,261RUZ6$644$ ZXZ:
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MQ"$?O:%EU<V#X" +35@VE1]@N?3)6'2!'/:S1 >7&\I3232A==<7_!/B<&B
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M#49C7]5/JP(/Z>PO;H?55D2591,=#YAK=I1;HS 3\X)3QN'4@&.%R.>5<I:
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M)B1,8V'*2J0C%65\\A2=]S%3DM][PVS(*\LD4EL[?P$B&*>'6ZS!]*L<:_Z
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MJ1>!OD60F8=T\)\.#(/ G#VEBR^<Y5;I1L_2*Y-$:M;"C0N_.2I.;KN: *X
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MX%4("X*KLA^3>(,Z!2<D6F>?523R4ZO4C*Q\^/6^MO-)SXF\T9:5#4'PN)8
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M<W:5F^\#5DW E0$\^EWU4M.?I*>)8BWS28(+AL*P!LV!J16K] K5#"?'G24
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MXB9<IELK]]ZT()E>O:P\M;!=RM>^ @29-<OS-+O-0JO9$CS;)$F/_2_&)ZX
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MP]-D5*X CAW6?]V2;WFIYBYC"_8-YO(4M\O,+X:LNZ2X,S:CF8ZLGI>'-$O
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MS$ -RQ!%<:G-\4'8S"Q(K7"78OAB:8#7&X$L'PJ-JV0SOG?''-DF<L&M:JL
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MG760XON2/"-S0"&CL 6I9A1:S86>SL[PEW4S5(!Y/^'5@EBS 6]@?Y$A"Q7
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M%7EUJ>FF[0 @V+_(3/1&N,^;EY7.WSPJ-_,T026*RCF%R=G=YO,2T9H?1]+
MKGY^BXQLSU8\;DLL'6$\*4Q4@*=1$NEAZ<?3Q7TO2^78I,.D[J3!U3*+F1H:
M)GT?^O*9SBW$>&LV/#?<Y3II)%H&+37-D<\7>?]S45>O3)&[;;?@5_-'3JN%
MR@6][(##@E,ABZ@. SO?A"MR)WF]'O(OVQ6B-RR$RQ>21L56=0U9$$)&N:<&
M-_T:VNA^^HJ^%MCM!*?Z5#^?RIA /@-VU\([.#[$MIZ_O>:$&JT+?4$%?-7,
M)GXL"J]-K!U)_X];_&MFIC&=IN,^X<(LF*@>8!]Z'IHK=G76X]6*59R+)V2R
M?&XNFS_+]6ZC"S1^4JB[34OM4O;W>GUOX:80M1>F:Z5D+95H@RG$G!%#%;/#
M=&\^PT__ 9572"5"ENN:B3JRSH*UY6AB0<- Z7'!WI=7N[^_+B4-8!7@K2$T
M>X@NF&TO,8R+AJF!9W__OO5(E$AGD%C0B"4]0>!AN'&TR_=KBRR7RJ:;:AP#
M;D[5W V2^9"FZ><3104XN(8VT%LLCGGIER=JR2Q[8?I=$9#RXZAZ0<)@ #PT
M9F;"83 U=_^K<#JE#<@2)*9N74!((^X8[O^.CO^^QN5XHDM(3%!(:"X,\&E'
M$H0NH7X6H+ A,Z)+Y_9Q2?L8.LH,G#N([].EL,S[*_N7;E$!:,@S7T8\)\$G
M<Z.(ORBSH$+XAR2W'\8"BVQJN (#>P72-HE.^,/*0(-T-I"2E-0IL)(B!$L%
MX(,)\;"A30Y][$ED; E/1@DY*NC^G'!R34!K/^3[V.8+1X^.X[-EF>.ID'*V
M"O@,>J,7E:+#@8%>S$'O!AE/49J"9&H[)C7W3TFKF=5GB %&0/.2AQ/:&N:D
M3ROPV7A2#E&#&&1@OHVTN[5OT? :S-KB>K\D\'<P^\GW87_&;9%%45-^'FAC
MX]*YWJ#?6SXW9<)](ES&W=K\Q-][$9,#/;:+96?A+_H,S$U5!WZRJY3,4P$$
MGXXP*F -?4S&VU,!H3 "BN(_!Y^S;3!(6FCQ)N6"!BES\= ==F1)V(FV+.G6
M7BNN%=);OT0N,9G#-E'XJ("TBH;C"<RH69A-$LN3")3CRNZDF0/B.E@X3#]&
M3,JJOS=2'$\S<N\-/CF\#;B7M"W50!!(_3Q.-" O4@%3RA!?S@00*EZJNV-H
M/P=?+(5_ 'H^> 9,DKG/5Y;1!^1:**9%+(]EP^3(4;4WL+LKW)WW5^#UDI9_
M-!W6\4$V-2FP,L7]!-VZ%-Z_@P.'2K)JI<\7?I<W<L&*DAKV,5?"V0YU/FA>
ML&_<T#!E_[!B[(_8A]^V+W(X'<EJ(=5D]F]9%ED&XGPTTT[I_,Z S#?SI+[T
MOY.QQP4^'%[=,R9/]9=ISA>,L6.+3\UV>+3E*B1N&]D9L'JY\U69/3' W.>M
M7:E&E*A(:/DOJ7DYJ58Q,^(-.HY%LC/XL^-9__1YSZE%3]T4HW&>G,C*##!*
M0DGIO6BMDF'ZE_^J2AQ!V[O0D% (11="%I]U,8:>G(0]FI0?UK U!_&]@0G6
MRW(N"MRC\1?"2&(C!)KHN(X6BQ 'NVY#TAL/-6_C"L)Y%D+\!T,0?[SNSXRV
MK&=.-\Q!^A+<X?TJI"WE!^E?JQE/[!M2'_Z*A$<$>;Z/0;R?4>N7-CFJM.[3
MQZETV-KK&*,7:][JPLH7\]67\A^=GAD3\6(V(!-O>?ENW.N9A:FR7<,2HT7F
M\ >0>_M:\H9BN87:.;YIW1,^=$+:?8POS+O6$3I00W?XM55?V,N[L.#> !C*
M-VE5T>OG1C5#U%B2C6/"CPAFQ1$XP^:8CD.TN>6WP.8HB.V)L4? V[ZH<L0:
M%; @52I:JCIQ^B^*J_ G8N2)WAGD*/%&M%NXV5@T7A>"EY];NA0>*B(C6(#<
MX3^4@CN ZU@9]"P1G91!N/^E]+71U):XL3S_MFT9>5B/I+/#];Q -P/^I%7?
MSB\+^3'#BN*+7$_7NQ2)/Y3CV7/<MQ$1!D>V>TTSW'LOD*\",L>+JVR.V0L;
MVH#[5V**:CD+V!9EQ@2.P_<C1OL1X.7K1X/;OW?$.E Z%:;[<N( >*>EZ>$E
M8GLM%?#_NWKSTI!X3>?8[#XJ%4%X2$9G?&M-DB(T+.7/,3N.)13-S:1T%LDP
M4<J.>MU-*]K@C.L)_79>?A<], 9V@+$,EH&^_NBSP?=3 5<:UO!4 .64"M@:
MLCUK!D2Z9V^L$A"XZCT]#9<_;:&P&H6 URAS% HM)H<$PZ8A[>Y-'V/]["6\
M.R6-^MJL]XT>#VIOBQ(M7]P-AK3@4L-%&_O]R4BL+,(*U_'I<,?_]I4]ZYN%
ML]^E"?%$&,QV""0!LPZ ,ZH>/$R%CT0<8\:!$]Z39N")XZ:_?PJ*LV(N&6X9
MW/-,OC"4DXYHS$C[']E%\_^WHQ(MC,?KR0WS)<7I")'UOO^*(?X_/^?IGR <
MCJ\]NJM>"&RYT9'C5W'KCE]TI?6PD>L9YNP46R.WD/+#L!!2P#2\'OJM?'VG
M9;OO<XS_?Z<<U=E[3,-\ ?*$O05$+X"/+)I7$@E.M$IP._K%>_624;36K_.[
MH%(74&G<J_,:'.;/MH3WS#VEE[?N[29@S-6<1:3<RV5RUT5&X2O)5$ U] ^)
M4:@!9YL95?-1KATJY%+@3)_:UZ.&G2G+O+L69AM-<8H>+&THV8F#_<ZC,%MG
M,QE^DUAU^E,U0-H^<5XAB\BXTLX\=Z]0@7-LV&=UAV0.M,WXLKY*WG6\AHKT
MX!;#%I8M$(UM$7B-F)V/>=K,6WZ9;XT6AA\=NCAR2?5$JB:VK ?1#[/TL<\>
M?7HNH9\6'[39?*!M'F9J;F0P]*$Q<Y+Q%;V1\-,UYY1KLV+U0_"5074X+9+"
M<N^H^WM[*L^M=C?+3RO/_%M#L1E=GRB^:E0 #&&.J3S)&%]25( JM6=PK8QN
M"_6-H@,#GI9!#_*?"(<5';.B'1UC3!VJ815C$>5XMVLUAXV8*+B#Z]2M%C##
M8=4JMKX@X33-^XNL;9F9>^8;@3V/*N-3AZ#[]O*.FMRY.2TVV C*T?M>6 NN
M@D*KDT%2:) ')5@E%0S&Y/.))A'&=. (<&G645W'^*XS6NSVS;_+[S0#3; !
ME*O9/RSNI94LBDST'CY^%&7I#N<H-.[P\9 5TGYKO=H0!BY=:^T/BY$;V"ZC
MNQC[,^)!?L/E>EJ2&6'$#Z^IW7H:DLHBF9CX'C-D<7E>/ 2FX/A5Q>[B!U6)
M5T;JKO-U8 V+46]<<PO%KU H0*U8A<AWY ZBKSSC(","4O_Q6)"T7X_7=.N0
M$WP^)L%P_W)"JX;@,:9&K(S><DSDVLM&SX*,1133_2:59*:C7'POX^;&-@SY
M;_NC! %LR&N?"[9_<E9H*PKGQ+QQ;:ZO+QWS^O;*[OV//</+D?=WIIR'*6:!
M#D2U:25D])E6)MV"J(?N:5Z -T*UYBA7QWXJ1S;/-,SSU&=P@P9\ *X L.G?
MDK&",D;",0J^I%9ZP/C6);3G$_X"=@9=4"Q=5^)D3FXRYF8E1RG*%D >L1@2
M>6$W?AN-IO&,Q71+5QBMNGX]V#+?2:T-NC9R-]2GU]?'8T]'2'TKD"Z"M\2T
MI->9"K#"7%&.G'R;#V^D<3"C=%!H0SE+H:I40+E5W73^:^[Q7P=&WFK"V[XK
M#=NY\\_=:AZ7N!)M172G\ Z$0-?(68[_%(<.5$1^%RMV:T]T+.P7N2TD*_K[
M6>55-,X!5*?4/N\P@#>^8HPR)QMFF$59"JJY]8!G!A2@Y-R9&$O-.>OJ:9EH
M$( $,I?#MJ&&>IC7S8R(Z=\^US9O%76(-P%#7_R -PM94P%!P0H4INR6AE/F
M^_"]OX7UB/QB.9U.>',\P8\*>)J%))\R<XTUS86RX(OWL&T1;^/>PXHL4M_!
MF<LDH:XVO^O9,P&+OW17C,0>Z'H_#.(FL6.](L9ZQ4-W4DW"-#L?,4]FMX O
MJQU[TAF<WD%KLC"':Y2[C?R]=6(PR9M^U:3F>^Z\^#6U8ZD K],[Z4O-\DSO
M0+TR]Y:*$9._.NMMG.K+GCY2&?#L'-\NU>G/>EGN743N?$H6>4K4"O"[JA-W
ME&?"'/)K8:5=7E1LY#"S,YM'*I16PN%:77JY>,C5PI1.C^%14/RODT?Q[<#!
M,JCQMK5HQTD_>4D[:O&Q=I^_OM3R9E"\#3=P\>J]V/;!A>^I1SO^SL,MFN6<
M4[N(?=<2=$=4X9/E78QQN45Y$>9'@<-N7U+A!D__9!;E)&-'=YZTEJ6BAG;R
MN+V;D:<M]2?-^HTV6H^H/W<PT"!?EF]"3GNZ1(A\5<"]]G0\84</WJ]*6B?J
M-_RK12"4!4(VC5<,9Z>-M*W][K6>"^=80;^1?/GC6L28#I0Q^KJ.T2TY%L5V
M"N['\XDMS?0RR4?@L&K75.M[ ^Q3L^448/D>[91>K>]';;KI_X>P_XYJJ@O>
MAN'80%'$ B@=I1,!Z9V(=!"1#J$I14HHTGNB(B"A"0@("$BO 2FA0Z3W7D+O
M()V$&DCAQ?OYOO>WUO.V/Y*SLD\R9];)WM?,=6;/S%6@\-+ +P8-^"3C<OGT
M^YE1:5[N3*2@,#)_<,I-LN2#H=4S2YOI.> #O*JUT_"=]8I8D? -&VU=9,3V
M.#>M<+5B<2\K8I JBU=.F1>1\&T$M*\\!/23:%.G43(UU&$_I\J$:]/)%ND*
M268]?(E-BQ TURZPPVPTB56E\ 9)MOL=M.!#:=8L:$5,+@"[JL<WV3BY.]GI
M>W+18CE8HZ,-9X,]CA@_RW2C)H#Q?H/PG6))N>,A8HC%'@F9.6[:81!N]_E;
MY"RSDA'^#FJ.:/??NSU\H^#$)UJ/.C"!Y6P=Q%M]0H>J/Q\1S0X?@U8&I?25
ME&7#/%U?YPGM;A.V;@FPAN[7L$1>XRCTFV]D"?8H\%0+L?KZP-WT% YE-<9!
MMZ8%>7>^+44I^9[NBF,5E"IP3XK5;/P0OFNIA0P_EW-Z5:Q46W:YQ@@=Q&(9
MM4<139(.4L6L-U>M1K=-!U( !Y;7B@Q%/)6QM-FGWBJG$9VE$W4FLB\GYA9[
M,;E-4)1(VM?S\]?WX)H[$#.3[MS@EZ\9W]>D0IVJ3=S'ENLM'N"26PY4U7M0
MO(?P0]0]BV;9(R>&-<6/Z3E*].[K./4"<#)>E4AY"9=N.#&M.PNF6]6J;T.6
M0?$S'R%[2:(: H*HD:SM;0ON@%NX;4R<!DXC8W++G#6D]PV<E>/-'S'([[B5
MSF:#@8"WZ:<'39]_VCS.L5K='@M6C]),PQ-SWB]XK3%@\U?'LI2>98L!6_@N
M '8"GQ,0-3[-5,1*A.H%P*$TZ!X_: GX)?JT2$.C;&#MQMB> (F#@:&]&L_#
M$77#XUZ[&,+2.?L]\I4M7[N/P"5?<: *$A*87L0^$W"EZBNDTC7=/=U=6HRT
M:A6GU2IJOX4OU%M<+KSO=TCA!G83GD)5',NZF\8.S"\K??3X84M64MK*](Z=
M?2OV_G%IFD?Z3'VSW]UO"4-;W^I+L6FY%?\VFF2!&24/7#(=XM7/*W5+G1[*
MY8?^$=_\Q#&C*AT$3F"FTJ"[G@'R)>ZX6]R?AS5K."US]21S$H#T?TD4OA]J
M[]\TP13J):640O,V3),5Q6_2^KN(;_&RX)0]2--^_[8WG VZ_MO1AR8+2/%)
M(5TS3F3!Z&G1N:]N#HL3R$JGRF4+S;1&UC#$3.(,*VA15,C>M?/4Z81$<^8N
M3J!A69;;G[,;_GT!<(L!+>:S4%OCZZAM29?8.Y$U5>9O#<T)%S./$5][?:]'
MB@VJ?P8C)U#'+1/1YZ5WLVR)T22D7?/EQ:_@5CQ)12T]"R>7OB="A8W*(7ID
M'>DKX3,5.E(#^CJME_"!KR--,XZ[-_YQ?X L^6X]7GX.5HCYX'@!& 61D#IH
MD#W5M'#;22Q[VEV;R)!;-QUL-"M-';(':TD,6P92R(A$J> 6V3:5*ZLR\)U5
MK%@DU7F_#O7Y[])>3:Z.]$HVA6=>T,<_BGZF%CJ$%$#PR@Y)"TLSE8._1%8H
M1=]))?JQ'2MK,?J\!QTGKQ4&6M-<"U#&N!'W'QA3X1V !UPZ.#/\R\N?9"UP
M!@J;'I(&+)CWUHEK(=F%6C)(BZ=[-KLL5B?*6G#FFV%N 5J6H-UR-'"Y=%J@
M&4I?D>!S/",=HL3ET-. 7N<*15E9P/U*%G8?%BBDH:1AD?ZVGR^G0*KVUG#>
MR4DU[ K(%ZQ $OEI66VEDS+%9!$.6BP"&P05JN5-VQ7YX>$%"C_180'FQ!(Y
MC@"KZA@9Z26BAJ:QA/$3@^6FR&'8X@_879%4G5%=J8:X_MMDTW]9T>/F=W"P
MI85;]F&V]GG@@:^"C5G7+P"\DIE5=]4:CT#\)&I2!^P>RLXF6$8?,==\[ZQG
MSI8%$=B/$3X1P)2V,+@(Z/Q&CK_7#H[Y1G].R5I=?0&(]K?;O20.R9]>/]/2
M37ZM&4_OP"X5&%D2Z<QWA#.8H-IC_5,PLQYYZGZ0K&[QK\/<7G*0[I_2+"]L
M7(A3#\<B5'1?; '[UQDT2;-DB#J0!!$]2<B]A,LA<OSGWWECFXAR]DO/WOT'
M=V9F[+H$%&_YD2.S"&9O H-FP]<E22OOO^UTNVE2:[^2C].H.971T7[!>-(P
MM&'II"SQ)^4=0RB8D$$L9C89#$_6G(TR4LOGN9R#/H9;6FU%^Q4;!\$@,2J:
M,T^\-F%>!G.8WN 2=VG^J3=1OID0 5=5H@U&H!=SVIKB<P%0^"^/O7!!W!S"
M]0=UH!4@>0$POUQ,&T^1F\^C6F5^X'_E-OY\$(AKU:O4X<Z=YD_GFD<J@]3E
M,S:+1D9 /27#2M_V!G3;YJ^&FB:05\\XLTFR>A=1+DG2BJB^/\ (MGMXZ!T@
M>OXF=-)X+IJ]=#]PN(.*U+!?3'VYP( D<^FHOS.<+'F/F!W%H%?7@"%EW:B@
M3>"1.VI,J..IFMO$<UP -"O9XK=X)Y!.3.MQK@_S>_G%O6FZ[?U.3_ACIS4S
M\$K-,F2KHY%Q%9RF(VIM!Z!HEFL-;%@K#3Q9>J:)L0/@4.K7G 5U@"+Q!_1I
M 'GMHS26\7U^)Y9UB'_ "O-/PRWER"6)\:8Y4*\KU[.T^/)SI>]_;NUF_82-
M*I&5",<^]5CAJP;Q0VE(,^<++?99H6W,##4+=,VQGFS8]:8MG!+>R$=A.3>%
M<GP@SSY7C74PD?WC?34LY$0=$]UQ=?U 8B?\#G0-4!H/E8(UBRUAM()'+LEN
M'>)X(IM!3M$9UE'@AF*3E"RI!LGO>!+9C"XYH%<6Y5^BVUN'"T LT4M,+OX,
MN&CF?_()=YNA9HC?V6F%;NXYUR?ST,4%'$\>W!+]:[3!Q(8YE=FKGJ:#VS7P
M>B%?TKE:9=18_&%5*/Y#@-080C\'_<3X*[YVWTSE(\AN\#:N7B]-9,S*KN*
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MM5[X E >FQW^ZI/[NG+I<=%W[;?UPOPRLK9L+E$WU*2?TZ3DXY3-U$%\?SE
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M:'6WC1:-G_0N-!<:WF,K\_?Y5[O J[P!X>722[:3M&!_.K3E5>1ZNS1A3K(
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M=SS"=E/V51OTJ4*D'(&99VOR<=[SQ=:E["Z/>LD&IA421*:Y$1%74QE#Q+H
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MK;/(G^DX9V=W,;WF^0KF:;*$^>CLD6?T _BHM5_<<+.@_A @)G[GXU1)55F
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MI)7UKY<>8CR(PF3?^ RV+P=,OA1O0WB!)2&6+L639&N:DB<&KO&*3K*QNG=
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M9KMG'C5'^\+">?K[9K*^7F&N)UIAAMQ_;TTW*OYV^>$A>L];:<S >X_&4,<
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M Q X)?XZ$\TC<:0];Z]W=.T0[WI.NP+DO8Z7SKM,I[L[/>I\&(8*4#BBWH+
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MGH#[8ZOT>X4W@_E7:WV@X,679@D/OI/KN%-)V2OJ<G;G8$0F3NX N+.&;=K
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MN8?^I8PR$S2_NUM,[M.;VS5=[5@ D11*M,D]5M,.QY'MV-5 =EZ7.Z6%C<H
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M.1C?)%*F+93,US#PI$@WC!*NJX@)= ;'UKSLAK$8BW+(4NJSM>#U+>K!&^\
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M8-Y-$ @F(OY4;9$'59"4Y*8&K_.- $BFD6XO&\<5'L38LQG2P]7AG^>WN^R
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MRSV<R.N4VHN[B/?D%W0RO]"8ZQ^_I;7S&"E/$AQ081WS2A@>BT)VN^6YM!G
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M6I1 FCK5EK7X$Z!^Q '+8.M)[ZB.2Z+83_P8<M\171Y!"7WP?EG'B%'\";>
M#]G0'P:TZ+.&[V4$;PE]M[O:Y5R@27=(!+2673KTQ+DDCI&AET3,$%?;7QUN
M\#0],T&!DAU3GUM<+X'#K0]# '<H5\%@(@()!/?#5><,S=?7BSI*-QT0:"WK
M6/4Q*#I"7WU!4L@BZR[KW2/CZK;L^O8I+4\>[J'%$(=%L.F](8-VO_Z4[JD'
MY%EAW!:W(T_"^E21TSIWX%>YUS4R@E!386P(QP<>1$YM&&V'YTJ$=;-2D.T@
M]8R_#%:T>/NT>1OQ-\8LQ:RL*86_,WU*<-]X/(.4,N4'%2TC=)'>5%[W6;\M
MZ^[^9-)B9'IK\Y<ZZ=E*8@<OE]OG]?)D+G.-QJFQT/TKUMT\>9[=D3,!Y^RI
M=+(X5M&!&F#?WNQ P20W2W"AZ^T(^&;EM!D+T*+UD6K%L$7UNVM(Z5B'"+O6
M?TM>.-K&EY;5[2-V:9%.BY'H=-"6C209=V7#5S4K9_(S\L-2&:S"X1;D%QY@
MCP=(=%\I3LG>D6:ZP0NJBL@G1E][?O6[5<-ATUV>P;_1ZDH??"-&:V9N8&R?
M8Z-.V%W'>0\E9)&1V-J6@!)IA.<Z*SQ*ZSR"6%IZ[;NC%H&[W@&Q=TN8X5K4
M\#VX*ANL6WB:N,M#46I;[XCUI%B)Q<CAL::R3BD$(7U%E9%L9ING!)7:6VJH
MT&J*?H5Q1[/2SY:9)&8N$QLL6I5_5W&;A'VM&Y)%(:<.\0 !66,]$%L=H[M=
MC[ZT?(\9RK#]!4X GF)W7,H?W8FNLJ_R[&[47H6@U1]Y?U$\>X8,(LH5[LM5
MUO3]6?_"-!\(48/T/ ZM \M\'N?[Z5%DQG]A;&HH#24>#/6LBTBS3Z+@9E*\
M5[2?R5#HKSJ;I!_N^.X]_V5>F5.#A8>UHI%(4 :"EZ/5V78;Q9CS+^F[?\UE
M1_Y!MAYUF%@0UB"I;P+7']23E;X$PKXKSE,ZU_=9;<<#I+0/<P^7ME?R5U42
MSKCATM&R-9B[=9^?K;C!^&06Q4!'I9WI3+*?*Z>3':V/*,!<HG07G]KG'E<W
MZ#63EH.9/7SU_S17O_0+>M!Q!WA^J9\2KCX;[E>Q*9C$'.@"R?&W*E2[SE\J
MKD==EG<9!'H,53\J':XM)9-;?V[1?;O.(?>WIJF539%)]&O&@?+#;NT_F+<R
M&*2$5WO%>@VRZN(2QVF[&ZUIS%[M[+#;65-BCAP6COM;<?!1"9N;^UWL2.&H
M%#U_JQ,/H-PAQ?TN[4F?O'R%&\:$)*P):KVZVCYQ^KWL%/J>>2?LQ!8/H%]Q
M7N9GH+YN<"R)2O<HTS^^ULS\SOISNAX^D-4HF<[GR?4'S>7*.28'-A]/EAH/
M+G1,*'_A^T#.2E^L9%:E38].OULJTU*:P"TIC76<+_4ZF%R$?-\\+A9<4.7!
M6V+0^52)3Y,AZ $(<MFF8?1Z$-KKVB,4(EX*JCPPS4=B/ZXU'SW]UDA&X'7!
M'+Q;*6C(9N<V6429RQ?2(Q"M'=* 1C%JMVEL!0\HCL]<]WD@)_WM+]8HUE6?
MN42\0'X%4T3<C[MIJ&5&5DVL;B=<4O!9MZ2)O=NA';<7[:64^;37F3PW75!H
MW>?/Y5MO:W?A>\Z2)%I_T2)+$:F>4O4:!W.(K XKHT(.5NRKHL#G8TD:PSOO
MDX/\D8+T"-^-Z2ME^FU3?0Q'*V9B1BX@U=%_&67UO 9!%N:JE=2 DN96T&2*
ML:5\9P^$5OA+^C&NQ3FRVN^^@NB63ZSYA5!JJKX"OW+S82Q?3"$UU(9%Y=\7
MY'+\/FHD^ASI#1LA7RP6F9ITE1H@8.CR+YG(2B;I%G24BU$O8GO].B*-X-4U
M(E_NJ2$R6R[J\V@2\9I1752._E.7@^%Y2(V0N@N;PP:IBE.FIM)>'S_)[.]Y
MBE(32S.V8WN,:5:;$(4X<,G7\SM<(<(:%3F1Q40OA:Z X &=)193%7EG\JC$
M@L1_%./VC^&<()\/1;Y1.;SZ*^*@$ ^?9R-6WX!D>ISRZ^JG/YK7,_)YAJIG
MW\&B9^;G0+R-(]-5J^*Y??J<:$U#N&,)GXSA6WJ4W5@RZEU66&% X9^\Y0&'
MV@R24H:NQZU'7U8L<BW]Q2MTRY02G$FMKUYB=!L[DGD$E&IB3)A;/09#GEB,
MES>NN1LEIN6K^@Z!@64#,OSU')=?FI_A 0[\YSP2^M>?J?& U\"+$>K9N.M6
ML]CFJCARK#&=655&\\7#XB]K($]9[2MB/(#MK#7]9)T9%\QM^F_Q^98&?^L\
M&>G\X7^'#$'/V>P)URKJ0$H3*)6:BQ'=3WP*RA +:I>3O/)O]V@<*2LU",2/
MC8A_3*J5.SG>L<AUT9YEOK=],$USM;$B/CNAGU$Z!UR=!X(X$2>V[S^**K:&
M#3@EF-!K&^\G&C$FYF)X)@JHJII<<%NCIX%<=6.9Y,_JY6E<<_3T/QP[81-S
M5X?7%D[TD!704S!SB+&-9G&5C=9/REV:-)>E#4?XA62D#%6U[FK"/5&=.OYH
MT/T5(T/W\_NX\WN-Q% OL&P(1P+U%>9E8 (#\JP6"DM*[ AH:K9A(9=P#QD\
M*"O&]#/\IID1.T5:Z&"][(I,Z+_\'*I(Y6Q7/:WV!57U@@43:&CSO4;UPB=_
M\HUL*AF;(&N7Q-G:$FO,<J$*2QZHI>-SM;DH2SYY=TI]J2:9(<.JZQSKDM((
MX2^TU'<HSY-<7%7*RA1>*BV0Y949=4!N@&%2#+RPR#N3S\&$A[Z?YX7MFIS.
MREP;DR!&%]&4(EWIQBU)8LF4,(CE4&MH*NLQ?J$5> #J,/$.7 JP>I><?M9O
MBEI4$PFX-\L3'+B.7#;H>*M5.R)6Y+*Z91S:2O4W<B#LR"N. >Z #K7\J:A4
MY6M>M8&HU>SM&Z#87^R_;@N)TW9GAH3C@!VY1.N7FM.8TI?]0*FOI7:L ]DF
M*G+^CY]U<+7ZOVZN?AI48>G44M]?X)N5WA+7&X[SSE]5X-[H'$C;6#O& ZB-
MYUH8=Z8$_<Q1R^-/IDCV;DQJ W0_B=EV-(# 8@OWZ)/AXLK-X#@K?/+F$G$J
M;#'&DR<6M<IP<4>/L'\$OO+D@ 0BY%-U)!4A_@>DK34F!;9M@TSMW\FGK(7/
MDB?(AOQL[.MU<N"N<.#*B4 S+OIHMU-7]$I8(:97V<OX&^2*:<8\Q!I" KF+
M#Z0C/!,/I11D;-CS4Y+A8H?RZRJ;_ZU?U56Y!-=\Q1SYCM5QWNKJA['QO-*.
MAH35G6<J)=D!U2K%#"O@@TEE^:)N/XF,/@A"9Q-3SR@ OPL0/RJ_9CK_7@=Z
MV3+>XRPX(^1K?1_=_4U[.!T,M'YO+-KN2:A6I<=H6A_3[Y/4KJ;21_779J]+
M]B=880\^/&Z[=04T=Q">F*8AR:KC*LS" [JH!J//K643C(JBOGZ3_%62_E!Q
MJ C@ A\OF86.(5D)Y#V'>$,8!WS#Z%?MF2KUV!<5 _R&AXN2Z:&'MG=RAI1@
M,F_53(O@.KQ.4. 74B/$> >Y,])OB2IHD;*FD[V.K@>CVSQU+)[5X:9L1"9+
M(76VR/<+39UN)>4 W"8]B_3>;Z4/*L=V>->]TR\3G0-1XAY#QM?^*G_9FM_5
MI 2!@)D?>V8-NDD^<\5R 6.6%BA0Z 22G(=<$7!A+1&E A=AK3WOP0ZGCS+,
MV*'%;Y63)4_5E#H")WI$ SW.5S'<"_G10=:,YM(JX)J&^K(O:AUB;M6VXJ5H
ML6/;+(??1[H-FHN,HNU3PA<!NY5ORY^J]66DP11%&6D3% NAU3+^UY%!L&O6
MY?70:?51."^K;IDF=1PK8/C74E.J]Y24(\T@2S.GK.W@9$I;4(53]#M,^D?6
MFL1QSL 1B4Q)!?'2FVYGF3[-#<;N9OS)AWG%&&$10>Y5GX)=])\7F[)KQC7F
MUAXW,GC14IX_]3:S((?#>\M4F #;&O8N,@(CEL/[U,8A/>WD[$__CE>'7IG=
MJ\[/'6U_1[JMZ9VM]VM4N+;D;FTREMB8V]M"VX'782'R\[N51P9*-8UD!>UO
M11)#BX)@!B>76A;;J@YN:J;5,9]P)SZ)20N-\NJQRWVZ)_V.K0=IXQ[SO*-%
M\_NZ;DK'3UL>S?ZTG#HISWN78.T$!H468L?7.@EXZ,PR"MWG"0UL70FI2; [
M'=5:AX-[B_1;G%L*=77&:SM7ACZ%_GE#BX,HF>V6:GCZ/A4F:] >K96F35("
M)?R5/[*ZQS ^L6K?0.\%_=VX+78&JB:+HT-.?DC:UM_(RXKA4XO' \J$Y\^/
MH@^S+SG4/U,9V2Z+74X4)P#;;B\)?EYX%.8)G%S#\51'=2C$SX8WN!:F[A3-
MD6.3>-S".5D$[XG-^.GKX@%$4]UYB?+)$]VCCXT["A?]U$FA,:UWK%+7:E?[
M&=_6^<>=J:M7I^P^_$8HIZ5/GHL-NV@Y,)I1J.H*8G176NKG'!AR%M4;BK6F
MR'_>J(D 6S6'"7=U0)P)7DM9Y'1-:RU0Y;LK<.\XO+O0F.<WY4X=!16?1@=\
M#K3=U:V\5H$TFE?KX2#7G&Y/#R6--U9'2Q;$8A<?7CS6,(9I\%@A9FUNOFAD
MP((B*/'(.GG9Z25T+7*1.(#B93>WTLZHJ5REWX_J-*E&0SK@R#RCJ'E!:Z89
M-AC#$:L?QH>!'\OR\6&>RBJ;%$D\9U8V+BUFEE!YX^:"?;LUI]KJ/=0A^YG.
M:)_.U-NI]_-TX[ -R2PLIP"YH+2S%I%5(?A=D%NEVY^G9RBI#>F<QH;)340$
M.>2WWG:J6?B%HX 5#/MS6.5.?5W]R/[]J"'L4"!#)1,[/#/C>&NE:W"\<<0[
M1J.PJ]V"5KQJM;91L>/!<WL%Q@8-DC<?"5%*-1=#8.@[ON5MI?^R1Q:P-7WA
MHRW3Q /LIO& P(1.:Z-\GHA:P'=RR!?)KVNK9%#EN\[-P"8BK-/2^A<G]^)K
MB5GDWL,B$\4/Y7YKS:(RSP+[FR2O$SU\^*_$"TS-#.0OVZC.IZ-;FO6#E!%%
M=B*^LRG3)M,*@C5/DC2@R^P1JP2L*T&3?J=](S(\FS8M3>P"&Q>1.4:&2'J2
M_LU^O_W69(JYM?WN-6HW5*<\[;896>#$?)E([J+1&B:_=2S-Z(@C74HC%G G
M;6PDL&T>M=K\E8^ZI4FHQHC1^A[50=L,U?MVU67/7(K-T7+GM/4-4LIS%MM$
MP?FV6LH>P/.LHKEYWJRTP,"6[[T\?WQ3M?TW\( F[K04@T1'@7:=2[F] :AX
M^*K$ZKM9,CM8<JA>(A.@WWYBB]@]X_'EH'(N6]O2D.<_I4?NC]CLYS C#U;G
M.3'DM2\Z^DINE#]%\Q N.U-\E5=>L!-94-QUPDB@?BI=RF /]*U1HS9$7Z6(
MX7IQT1]$+5!><GN%^U'0I;VO\?;M66'R[XJ4-G5>5NIY=" 8?"8F60I%&OG?
M:_>%K5J? ,/):OH" PF@KSP86ZXBX5XU<-M_,:!/<HU%>V9*<Y_9F'D'CRBE
M6[5]%,O]->QDT8>*?J2T&$W3S_;FUPV=W34-R=X4,'V9A(9R")'VT/]$K:*U
M[2ZJ(]GA=D%#1]_'MB]T=TO&7<".EPGR!%;W9D<F-@IJM>R@QE&@K^^I;4_S
M_\V>Z'6^J(]&T$<CGE'>(DGT/ HJ^69\&19^R:Q.RS(F=%SLKL4X&1VP:$3\
MV\7QPS4WV?)BR6,*G:*PW><Y2S]&X6(@+*1H\C&)KUYN]>?E88NYE_&E8NT>
MM-G;_42<]F1J>ZYR'=QVSJQ);P^7&6CO+^B%;1\8\R=30KNWN'"(G-82 R7H
M%J4LYE:_\XL9]H^^4ZI.-?QNXUENJ;X_A>V&"K,A/X%GX9E5-%\>"9WI[AIV
M*M1CXJXS) WOXIB2BYF !S,P/][>G].UK?KF0(WW.L]/\YGL^+T'_+\G[0V%
MYWG;V6<^D/19'RLZ^'N\UVP9[87DV@7JR4OU14EZ9YD4TN@> ^].28?\EG$H
M$C\#.H:9UXM+&_T^,G6Q<W?0EN+"Z. !B\S-!UNAHOQN49/(I8A[6T(GA:OR
M84[6SF8'OTH7?LA=I["2I929D/U<LO#,1+(<$A;KH?\A2=5KKL3\;+FBUQ86
MJ]&G=H9G9+9-GT8,1U8<LK8$YY*+H2VO$B1#7+3\A:LKOL_(N;#*&EL7F4+3
MGHWD&.SR^G=UTK)$65?+K:@OVF0^]!O6)[995I-_\'K+Q8>U&8@BCQ:V>X%P
M%;W0UE)->L":D54XO76:]($F9X9+)5)YJETUKD:GTWC,.$4H'C-J8QI%KTA_
M%M/TEKMXQ%SDPJ%2H:C@7DTSL>I9VHNZY$ _Z\L<M.^\]ZB"B1I'EB;%OUBH
M,$ANTC3K@+->;2VK[<07&F1'X9R=RYS(\I^">$=C*XL?6:C<(<_KF6%P5J+L
M"Y:*5:LC5EZ-+N=[L.QAAZL4EYIWP]-V D8+46JF"%;Z1YS&_]PB9&Y+K X'
M/P>AZSBJ301IJA?-PADB^EMD--$,4?IBA^PB.6H9WNN3D@^U4?S'5 H_RAGC
M =$2YW&G+9C: _V/)F_2#&N_Q94:AUTDKLTZ9D_,<B]$8[ELTO.P;JV8/%W+
M.*?Q6/W8!\I_+8(6DA.MKL27C!+Q@,2*"IQU4V]I$AZPD"[!.21UQ]/0,UE'
M=--,?45'!YNL4QE,574E>69:MOAQ_=U#ZSHUD3[#SCVH.8K/B/KFQ2>Z\I%!
M741GN%KXDLS#V1(1:I?'W=_1+B5\NU08OWC0LNG=4?8RS)-*5J)#/4'/6 E.
MI*T2TR)8XA6JF<C!WBW&1&'=J,X7S>L"/1UXQ>"+-M$P-LP=!CIR62)UK"SB
MLJJL_XX%KH/H;'.C^\BX9?3L^B*0-T@3YB9?]J(:/GNI,SXEI?$K,'^X$C#U
M@BN;*:?')"0K3".W6$[H!S;$GE_X%>T)TJQ%,8TTQO"K3!!PV%^NB>H"DN/?
M6Y]K7A5;5Y7BP/VS7%[TUK[Q&&.NN]=0J!2=36;'G#UT^7NK,*IELXEMU'Y&
MP85IVF/9"^40U.*3U3%M64LT5@2WX2E4YK?PR5'$73I<C#0=G #7364PJUD*
MUN[G#7TUL]'*6R7^VN]!D;44JSTD(VOZOU+IE%*8WCB,W1(NIBN=-=:#P8A9
MUA[7C-%'JN@9_\B8D71YNY&FY^ZGGDNOGNNB!4MC,=Y%#2ZJD-4N45^>UEQQ
MNK'4TDY2$)IR2K4Q0G[Q[GEPHL_*'$!V#M;Q[P\Y9XSS/D&I8O" DIHWC(>P
MSY@J!.$W43MGP?+"P1^HQH"%'R#%GFZAO !2;10VR"&'\T6]XORNCDIR,2LD
M<(#OT#*(O.&E8[4=V.7T?>0<:DH_:9H'1SH.]Z$VGQ&Y!=K\6Y8X)R[;4)M_
M;]=:3:>VE#%44YD2'K5DB3(9_ED,H8G.)AS^E8^IBB&FO'PY/P*4WVY+.F,&
M?0Z$^HX>L8S2CCO(Q/]H=^%&8N,\2?.9E:O)"A%]^7W54WXN*LF$K!+?V*.
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MOL^'_ZDW]O\F5[;X_T&N3 L/^&[UGUP9<*$BQ2_ZK-^S+OTJ>"]H1K:G)IT
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M3>R:B;D0\_?Q'#S@L8NAVF*'7ZN'DZO4SFI8FIJ5.(=%5@(G=\4(S]*E=+P
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MO:,&VWGU%NY1NH5KN86AWG#?Y72TH*E6+$\JZ^R"16OLVG3[!.DD:S N\XJ
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M,85_[+O3XR4^BTL:Q"$KJ"5\V.'YPE3'(-P>9O1==@4ADTT&B/6*SN!&O%6
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M(L&D+#\_B']-B-@@&5&6TKHGC9[7X;"ZPEM? UQ#EKGJ0*X9 RFL[T.O1CV
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MT>G#8J1JJP,U>\N1[R;,XLED/"J'SJ0/H9-3A>SV9&L8$I?O =8I$XH5Y9<
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MW25E'=4GA=3Q\Q2X$YB]"4^/=T@-NY/[76ZB?B/+C._"I%&@H$<.LDRDX<&
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M.DA?X"++?._AF7OPDY+,FRN*OX][K3N$G.^TSW6@/4^^2#%G9_%()H7W97Y
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M]S-ONO1<8(^P+7MQGVNWPW?YNCD,1^]_K/1OSE2'J,\]FXN0K?(@I@H'Z=:
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M+E3AHWCL"37(;>97-MI'U"UXMTM E-Q5I(\1-*R0#J/0=M8A,#50L/][TNO
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ML0GC_$;''3;*GF[ZMXP$[9I;SWWPFN.&3Q)"/\J^;YP87_6(%\#3S5QM';C
M$F\F_=O)J.-P?Z;;^2,I:J"*]E>]%/6*?R.(@U_AF[I+$GM6QI"SPG#I^R[(
M:F7?!0 ANX\=ZQ\[9_.8I*#CS.J)&5ICSQ@VI(Q'<$M*Z/8JZ\OW+E#!&4'*
M40!<2@-+$I+^G&NB*&6W^MN4T<@$&'W.!+,6GM.IA8GH3VSVI_*^-=;L%/OD
M;TT%M&M(_S7+GBR-3%<;NWLOG1-=5'2729]TZ9VE5GCM]SQZ76Y2C5.=GT&
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M8^!RC&#/C<CX_<2SQ]6M=8EGO#=026-H]3WWNR%_4I(<9H??_9B+GCX/:KH
M1-7Z(W[]=W/[UBZQ&P<=OQ%%E^,)L\'<N0MP??X"$$&B[?37!,_V7R9XI>I9
MX+[I9O %@+']R@*O0]B%/Q&]  04K/L):A%6KH7)[VH.FU!MWD&Z0[,^WZD,
M(.,FO2^7C> F!82]PB,K-<SN>$-(E S8*<,4.)!O_Q$RN,I<N\EX92]);U2Z
MO.+]$P21LBQ J)%+<_C5W31AZ'UO*PC[(^)V:<RL0I0N93&7@C4VG$\UEMFK
M1W;'F(Z)LZ<MWVG59IQ:4]?"59U"%O;4*N07R7$-#)'$(;E8V#6.!OKE='G1
M=U\ G @[9-)T@@$DP0D<U/-EJ3EC!4UYS_,O !Q3PT;?HC$;&PF,ZU,]LL+3
MLJX/0:=^[5^8:[1XCUT,.%A=>A]'+IV&PLS\]:\!.<_:F*)E-6Y(F0<2O"#>
M,K0!3D[J6=]ODFJH_-.P@*G*&05"8<6_^%/S;C7>VMNCH?&(\;A3LP[JJIQA
MQR5W/%&*J2SK8IT?;/R@L6;IJ,BU+QF<Z4G2%N/IHLK%M6,KM[YF6U;2;:&^
M7<(QEJ6K^S+6V<-,OZYQK<HXL$@WWASWA3PZ/L[RFI+A [$?FQU3SYUMV;/*
M!.^1)?'7JA&3?OLD&L'SI\^^/M*@1-<AZM'#RS+V52]\HHV8%(DXZ8I]T-=V
M_P&%T=%]+?Z-6(WO\M77N0!\U8D4&33XN=G/<:9(F]@BM ]4SCTDV^@_CO \
M_C6'NP#4G.J57C:_0-/C(E][3J*^:- CB]F\XG,[\J1I\ I9T7B'PWMU?G4F
M<A$J3'9V9I<WU_7WV7E,,-*W_([R36*^U6(1]GHB.6\&7[SGRZH318E1]GTL
M'B2UZ6H7O8E*"[:/Y1F:C<]3@B$^PRS8[G+(N\HH*?T^J1OH;R I9""9%CSA
M3^='F*(%$&-/ 6>=DMIHG=VP7WC8(AH<ZE-VQE@#)]Y0]K+_KC1>H['/ZXVW
M Q(J;H8$'B<0&@=3BY3'^Z*WAE8EJ<]DD^7J"/W(, 6ZJL[^85D?@_)NR&H+
M,GQ1;]!@(++:8NN1;TQ7[]:.L6F;5,CCXIX<$R<F6N(94'_7GS'+75+=1HV)
MH';A9FNA5>\9H3Y3):<N!UFR_=LEUR/C-+<DG+0=$$4TC]\<$]%X/WGE8)RS
MSZ1[;5'[-&D9&$5N9'@31.D_!)O6$\+ I'W22:;7']<;JC]>TA+N?]2HR"[O
M;ML]XIP02B5%>F;M6&PJ]4U'**V^2ZEK="N@XN @N-*\=H=H,E6_&9%G;C4@
M F-X G+,Z7HL5Q^^8G;4[S<C2C_PLNVU7?7ANF^C4MJ(6O:)-^GB_IDBW*##
M,0&AVUXH2GU,S*9<-6P_,HMZ1NK9H[%A--@6<$=^?HJ\)F"VL7LN@8[?.,*W
MTS9,9[E "V>!2U?^U.9#Z3*(L?"V1,?YFL2 Y37+%"S'(>,?#N'Z1W !7.8\
MOBKM[F:V+23E.R)-B[V-@H)MNJ&5+X$N/PYF8?ANV-PXFQ93)K !Q09 #/7B
MA7*"P3I@P_9"Z0B.;EJ_R>HFWH>&1(8QC(TF*L8=?@$5(TI@X3YY:S^2>,TX
MYISXI/&C5$D"M^8 5_Z/1T\'AB>+A0QVTV_B6E?:# +U9[^4QB*(T&53T_)>
M]Q2?..I289J8: (3'K@'$$VDFP9UR#\B@IW&/- ^Y^KV=10ZFH4>^3=IH4O9
MY$[U L?G@(,1A\+)WXN=3+ZIJAVR:?C%NX0)I!9TTDVPX*TURRLD&(@@AQ<
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M\>-G#^Q$5_G_KK;][S,2LS51D7-["HCFTV60W=7L!%_1F8@WO0[^4GGO+F/
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M/']7G/3,*:3:'_S;_BZ^MTX08_^9><02O:4^/0WD?:(7RA/ZN88 F+T1ZD(
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M86!@<Z@VHW\LLKM 3=W+9E21WD[+-':_!1%<#Q0G-S.#KXMN8/1G<+\B$PK
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ME'JPFDZ&C,==ASF# F1# TBGC@/KL-08F(N31+\"[9W41)G';0/*J9]"SJ\
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M'+ YQ.F45SO4%8\UU8)P>^N58$UVW)0^K\V^J4WJ?"T5QK2)Z$^^LQ*';D<
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M4YT??X>KAMNLK8HZR[I<4T,4\;97*1$FX7B$2#@_ J9ZU2/+I' [AM^Y'0)
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M1Y 6,_IRK$RD2(/8S4HB.NH.N_3R@4 WA"T*&C(R\]21DWE=.2;6@N5GCM6
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M4,R2&@\SX1*_GV1&M43&WKX*GVY1^<T:;+/D9C94T[@_G:Y2C*U:A@CXOKQ
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M%1"57ELU+_F!)VWOB)NIV]8A)[_M&"F_QK9"2^IGI9[S4Z%6VZ"F=@:VRWM
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MR PPQ:Z_RC=9U:_$F70-M@0>,]@%1JXTCQ%5>)Z(GGR;P&SY,IFW&RZ."S'
MT\>\6U,9,F8/LQB[RXY*E[/"@9LX$,&&F:71[$W6ON<\4'J4OB&'SJKW?)6*
M/[LC+1J>D;,:9!@?",I)9D.8*^^(I66\3UG3$/BE*&<F*MG2)(%BK:QHC_92
ML$6#0F>LOUHNANV3ZL62R'1HBW'%9 1S*,LAM!-4NM7LO5=DY$M^,#9X-3A:
M57D:A9(Z/6?0_N@R:\GM)ZHB;UU.VNBB.%Q&6NWZ3 B>7IR**F&'!2BC'4@(
ME/Z[RDZKCS.>8T&LJ3LI"6S/97, V4Q::V H<6:H)(YTV,.VZ6GFVJ-FZPUF
M&XPA#HMC:1BN7E3)YQ%_EHWQ*)P_!YC.I#;(/S8D\F#R;#50-[BH=<U48-<V
MX9177D+&DQ&9M)$,V2LRT?/A;%MG,W/'AC C(Z _;IG%T)RF@GR>VU3 .];X
M7Z*OMRW_GT]')7'R5/S_=#JJ;1B"/3OF7&,/>DH%F)KL-;"@&/'Q-I\'L>PK
M88H K=_)$Q->7^YNL[LMY."B8;5;\'@Y1:TG(_V]G%N!0T8FV/B&J]KU&VI!
MF7L%O=P/!HY&\U)T M(&HM\^]]&7JIY+=G2=;.;?#-@L'U1ERGHT 'TDI,:4
M)-(S'R_>X\[(\K1?CW<H4UQ NC-+)F??X=DJK-H"//CXN;Y2T5P$MV- ;8R[
MS],V)7T]:*_3\Y1Y5X^:WE1\RT4GR5>V12=Q&O$A).]V]*A9^MR&Z<0!8^1H
MEULV&6NU9%/@^0C?M.TWH(*7@#/#;OECD9?E%'',#F>JQ2("TL H<H*<XSQ3
ME-G91$/QP_"HR"1X_]+BDE+=])8\6K[84/_DY#*#X7++N$M<EV&9H/3Q2F'X
M79>;YB(4\^F<F+G-R-+"-M!T8,J@7J[R@N/1Y1K4>F92C:E5,;-YY9333&OX
MV ")^705VY LS;N=E >CHD'"QX]MYS;.?S'P*TCPZI3L!EK*JOG&SU6J?#AY
MKV%6+W2A5>TK4;?[$OB[J\S5QQ;M$^7J7!9?5.ST(L^V=FR\/:&;IZ<H$(E/
M>B? Y5F8+,O+7&NG>/QU&GJCBE:Z>B$C4BL\\%E&N!% 3="E]<;O^=46.":0
M]>7XZ[,"G_N/*1L9W1,XEC.8Z;";5Y4=OX16EHNE._OF$6T^Z^UN  L-VZ4_
M?+)#1R0UK/5"X^7!7F5OOCR6MU:-T$?[>I^B8ZJ?KB.Z-;!C[ U+;[)M=MB/
M&,ETC4IPFAH=3SQ3Y7&$S0II$?)?WXN0._"2S4R.&K5I"76-ZA\<Y7HW3;!8
M"1H3MGG"2_>UR-XX=XMW,@3XJTMJQ"XZ5T/#1H,FU59!_]B>IN=NY4*X:2D"
MN#S^"F>R=D>$KL_=[IFPY%Y)A,:./1J$7/5NM;(]\IL)=SY11P6\L(Z7_&)1
MU"M\43Q5\63N&K>",Q#F^!%8JO/!9;K^[/<187.5V'NGQ9!&,;^W=6<-S$VN
M[1:=GD?=88:-RPK'ML4EUX).F\[(W,R;NOP<F@!_2&"W*C3I+/PAJ^A]T*+U
M4MRL-':IL*W6/N13NZZG4M+[,CG..4R[*IP_3RH$?SKJ]IAQ=]F+A9X-4_I6
MIG/=^ ?[G(PR)REM-;"TU:L=(",LX1L.HD3(RW@\^*W6,.A,F4L;MIU^!Y4B
M)XM7;ITI@X:4@QB]-K=Z1Y8M]R^9O4PML'.;\O9?])T*R],SMR0>;'J2SR-:
M9M"("(@U[!*DF7Q-M'Q%:OF:M[?S]_J)6<2&L=6"8 *V)9%YO(=@T.:3=)BC
MFZQ!F*AWK(AAE3+,]C\%[M@L0LF!BU4=U*^3DUUN>$V"5_,6/SIH@)YCA14Q
M"(+E0K[UY3IN=R/1I(B)RIP\XDFTA*U02ON5R9SQ9!B0T@LJSVI, C$1NG[V
MNH-/;R3+'1MO&*Q, E?I&SR'ZK,?/K&?=_%2^R@3G:I'!9P@\XNV#_0(Y*-A
MW5]7!29Z3T"95TZR9OV1JU; 2*.N_YB)9XOOBQIU;63CF.28XZ'F8#6CL4Z(
M]AWFJ]V/[A;FURH&+/K+5>WL,=Q#O+7 2"/L,CCGZZI0=0V"]L*67Z;->,WG
MZ$]AI!4$[0>],EL'I]4F9CS$S4Y"?#)C#^(O9KW->12G =N5[BLWS)6@X9_M
MF!4=K$2EM<R/<9S!U/SI( \,B](4MT)YF]=UQ/SG4*PU7I9R_\S>%]C#;NQF
MN&/CU!G616)&L&F7XHD4QX/NW+_NG8UYB]GF)[PBMZ)Z4[4\5M_%_''O['LX
MS2V.%6_.(0<5)\V<,\0&3.>D[TJ$]Q:MO'4;!P_"*@>KA!7$)$<^Y&3D%F^]
MC+W/+6:VR/261!/??BWUBM?E@\>UE*;]5M3^2./[&@WXH!5M^[?"[V,Q6FKZ
MO_/[?G:2YK9A>&(:[CJD%$+.##^^S#R_%4EA)L#;*1<9%1V&N:QR<2%M,R>]
MR*']Y2J;'6O!J$^(V9PTYL$-"E-K_D0G>[VMMQCF!D:2 B*9XC6;/^KM@MN#
M/GEWZP_D]$2KZB\FQA+WS@F_3%_X!BL"&]>X@XK\!0PI4Q"VW;VS-;6LW $H
M%!7P'#G.VPYC*Q>XB5J.GZJ^V1S^)-DHD6/U23O&?P3$(MK Y>7QPZ#8?XQ8
M@8HIVBU(U18L9Q+UV#:-P281&?8_$ZQSO7::*C+.2518PI%!<#_K8I,57-^S
MHJ]7?W3Y5:%&JC3'R-IFW0L-.3M;83S8M0_U]>34U*+)K->W3].7NXX'1?Q8
M&V6[I=(OEOK$4GH3G/?=5?6@&*8U?'(:DSW14@1F>'OB2A_^+#%I]*<GY'KW
M74H9Z(6?']Z^">>UIHQ+)0\7OA]K?/MLK[%8TP"OF!;G7/[E^'.38TF51!W[
M1,H%W$%@G/H41[=3FC7/R%Q2<"#*:TU3V/P64>O7*]A'JP_>>3+O/:*F&G:(
MYSVUWOB.^3]8-<HNP\NV('Y0.,)03@?S!L/6#)/8"2J@;*LQ%3(['5KYM#95
M;8_.I&VF::K5&[,>0?\&#?Z6W6J_2)B7:!UICF9:@&D_IE-I[X$Z[*"Q?4N$
MHWBK/;=J"PS+0+-V)%1RLV.GE]4Q"PR3\#E%'PV72A/ C9"K/0PC'_..^Z1
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M2AD#77KAS2/OI*?DD,L<%[ R6JR7R69Y3D$/QLSC_KRN#ZMZU2:9<?3CJ84
MV%7_3DQY(R'@IXW9U=1D([IE;VE&LQG\SD)Q!$ZS6=0E]\[69G_$"]B697BY
M]NT8L4X=>J-4F,5H3@&CPHM?],NJ^^R>CHU]HQ@^2>>)A_-1F^FN^S(ML1.?
MSD3IJ9N_:O?!)N_/X7_ADHRH !N5I$8X>ZB\O#VHL'&/1SEL2-<_7\+9^5K)
M;%X?<)H -9:);QBK C>B8C%6FJ$^!S&D._8NQ9K+/0.+R=,-$?U;/-BG4:QS
M#*^,;:4G=_)VS,';JFF)RA;R-OH7A6+[6/7I^X&.UJ8@VH\6>IWL,;":G&%H
MHGTRIJ)0;.@E2EN1/(G8#-]Q<4'';?K=4-?JDKPZ>//Q@'IE$KO]ZZ/[ ED3
M 0^* #=L,ITE"C-^7R&"$3Z+!GS*^"!\+E,"\$$[?IZV 'W*TIM*\6!/AXY7
MP\*FK\4U-7#>>5F!M:P,'XT7U$^Q;?=XM"KD\BJA8P<9P?,[%73&D;!"TX,^
M)T*L[K"'QYJ](T?NL8H=P_&3X>BH_-?P">2GL*) F&,WA\3" T[1OKSMP>2\
M.]JFCS+"P;<?A N!NW/7GXFK--ML:-R8>G=QJ()CT5GABNWJV6S/449LS V1
MQT[WBCN>K6EF1:8:%.=\<9 8WRF \704RF'YH \M%Z84%NQ F$<X]_3!V?S6
M/1DUP6NQUE'/'YR6*&^Q^V.3/&8^B,W(WCC:("V^5&94H?C11>_> W%C+<(0
M:X5\Q-SDC8EOHUI?O^D5AY>0V*[US25#S=[J=PN@PEI,1Y/]QO;<T&\=?Z@)
M>LP^+3#@.)-$PSA@X=]9]_V-@#;'Q!6/V:I%TE9O-6CX\?[C+R('\P<JDVC(
MW-!F(N#>&25;/5NI'1K@+<R(P@@#)*.4[!PSBY1^%(0%/8*^<P<:*1:X"D/C
MO8I#T]P?/7WG7HQH'76%V=RYT"0./B]F>C/V(+\PT\.^^,,AWY<:'@V;-/NY
M6L^AW<6*%,>///>+C/J&,ZLC6B^J+5\B%SQ\Z:2L=O#B$ GQTQ#L3KI*0]LO
M @QK]I,21V^7+ Z[&.DZGKLU)3NB]$18]4Q! 8^XA*@S+U\@O<3X.LETKO*%
M?:YR!SCR:OS7^\ ]UOS\@27E5(&J6AI6-[[P)T)7OO[ZK : 7Y]A*OJD#_\;
M=$Y)^8M/8K6Q2=TXS%O#,2<1K%B:?FW\H=93OY%9:%1DBZ"H-5UQO*QO#YBI
M-1A6]NUG9.J"9$W#7G(Z<D/8Q]B[[==0EC=Z!NPNRZ&7>)/]ARU#E-0$Q->F
MUZXIH^ ;(/($R,VMX&M[.&Y5;:,L*5+]0I%1F-WEA,(V,9/W\N$V\1XI9RZH
MU(]4 ]OA1H0[<S-1/"QQ]X8WKI8'5.]<N\=1*ZFE'=2$E;7./#UY>+#O2(YU
M8QK#M"1%42+$N_=C*Y=0G\<.Q.ZNVMJFVTM-3*Y&ZKK=KYV.) [&LW]&L8:S
M*.PZ'60QJ%QZS3B]:ST=5?VY""#0N:+W8L31\:=8YQ7]W5YMO-_/&N?@S>)G
MLE:*'9([&I@P.=7Y7I<-QQSROI_]6*,5BI-=UU5-3%KL<OD#M3.F9:M,&]VB
MAZL0&4C%.F8YE[2VW(9#18U\=;I[-$ %G,9$40'+"WO%,^M)H!WR9;)K)>G(
MNA\QX0';&?9W0SB.(?JT#K%]2%R$UPS%'V*D25 D.5,!$% 1:$P"LGS$AA6B
M OJR_<Z0JZVH 'GE9>7]Q432'B@5?DAK'?5GZYD4YM]!V+[V-4WBC1 :,+V_
MUX79V4#2@.^?'0R0*_^L#5.@ IKX%V(."61;Q-Q%_#<J(#%F-&8]'+)#IO^C
MJPH_NO_6%15 ZRLD&K&,65.3XUZ(HP)$?]/'BE@^8BH>H0*0#@=4P$;MO["A
M$3''B,>22/YH#"[(:YT*Z&Y?4]Y7!!U2@O;&:<2E$?^]&R\0Z:J"+*VUF-$4
M.<:%YO_0"^K?.OF&F3N)7R:1F+[3,!^$AT9^(^D7I>-W_+'?SR>'1+2N^P>+
M^VM&DJOT/ER2OXLZS7,,O_+'N$O<$02U.F"AP8U,A4?%8H%Z7 DINT&Z8Z*W
M4MP_<"@/S7AB6-,."S'GIE416>U\.<)H_>)):(^:W'L7/R:+VTNJZ3('F0J[
MM;X#E9*\+/A,?%:[G5@X0+,MIBW126 BC69-MA1%Q%LO?SYQD('D4IPX7A?8
M#BJ_$TCAL7^_(O.^UO31RPE%^R<?5AN,[-8E?7FJE=5V8D*H #13L,(-M8&5
MMVU0U*=6'_UK0J>K0@,I_5DRKMF'+PJ_33F)3S<\(]?>D#KB"=>[-W5E&8_*
M'97N@& B >('0? 8HIE7K09^MFQ@=Z=AJ4MS^H[=[NV.RO! =8MT/(^.U7>D
M@]_3WZ?"'+)E52SE]>[E8'_1_[Z/]]AWKU7N<:Y!RTJCPSO[8<_D@$RUT#&C
M^IC][+3]*4]H@-?"MPH9=%^VG99S -/Q:CSKE)KKFU5K;9&7+J::X75WYE5)
M=]R7&V^/]7J,'[07O6KAD%V)#H^5V>C:0]'D.NCZ''/[CU892" /2U"@\.<3
MOM"0<^>%F!<CUS\MMS,9"749\5S'Q<S5[Y<7*WKZ.G2;8WN<EAH"\)IO-B2G
MCJTGQYYEOG#0ZK R>LMF7]W6+OV*62 0HK8G8'Y5"<D[2DQU^]66XJT9N2F\
M!PLQX[O8R?#PII,AG9MYTI;Q?MRH6=\IR1U\Y7A]<TO:L0&XZ;7NO'M\L3XN
M!O8XY:;D;4<E<)_!3<5+(^QCXLFK>[85>=T/ETU!&B.4JUX?IQY%;J,#)E%.
MOE!LC<D-K')9 .&]Q#&,4"]NZ\UNS)F.0=MWH6-5<OK==_0EI]XVU<DX/=E(
M914@\DWXE"[%V+@S*E[1>F\_(>&K8YG=?NRR$/B[/XC@[[W%.PQH4?/%YM4Z
M.6 SHM/16HJWSJ9[N]#,S6,3W&# T<C1,EPE3G5>X\3#H0V&6I#1)_A-ILIR
M\(9U,^:L50-NY&OUZ*5)B5L+6US0+BW_?D2YN//4;/^M%J:I?5+!)N9\8X4_
MSY#4.=#55X=GAX@Z:=V'T"5\T>4[7CFK7N6_U-!QD9-^3 &(N<\(.\@1BS*9
M2 6L:5$!C'1$VG=_$F1KA@HP:C@DZAR)+BJ/(P<00D-K%VCZ:+-TE*IY2!1M
M)L4$8/ZEMAZW\0)LXW[A@]C.67+Z$R]-2KE_(#F/S+:=N:'Y"Q,/,@@A$1\<
MQ=-J\^XDM\+8(39DZ$-?;LNFI0D-P0K#X\Q!>RMFQ_:AJE;"$F_T':J6@U$_
M-IZ,<CMU&:M7C<Q^<+2:&*_KQ;P A:!XJX?87J6VKYF-PI*'OK6I#LV4[!QF
M/X1R"W3J^7A"1$F)5$#:H#_:+\E002])HSW'B RA H)A!%\JX%XKS5($"?GW
M0)@RGS4_-HE6],&L 45_RBDVZ:%(FCVDVDMW/"#"PT."3I]Z13@IOIU'V%7Y
MY?6A6<;[\=E#>N$X(0SI=E\SZNADN-:\D)J@-%"!I4A0*M_?>HGNU#@"P;]F
M%H_KTZW^BDO+C>WD;6G<_&Z_!2-8(4-@NPQ _^9]#YS4)_OK: XOE>=S0:[S
M.UT&22+O@Y?3$UYN.)P72;NF)Y+1U]EWP4RR+6-"AP$C)^S[&,*>:(R[A)SK
M'GM\P2@ C:(/)Z93 59,P:5BEMG'-<O%*>S@N4]4P$<K>&&^DBKO$1O9\EMW
MXO@#[<5Q,E.@)3XZD<ON#?YKG39M+;#-1O0M0*<AN$[(.2K@%[LRZ;9F,^3H
MY*C9R@BEPAP12VZGK1&X)-N/D)6H(ZP[3G:>/D)"=JV-X.XPWE**0.F?V$ 5
M(>;>^[/_/NQ6@PF!T).$<='J87!QFXHMR%%/Y%+2HC'7Y4V^YOFOVYD<GLX-
M[6\03>.$GY.5(5]]2>@M@A&&\S)\G)XB"].KGRCA9Z "X,.B+RD1A[IW1=J;
MNMF8#G=8%N/P#Q?$_3880#B.<.>PF<L><>20/F+YWKG$\Z^:*'I/U$.6@T@%
M@JH>TCGA(:2CL&]PA1')(N?F-\LM4C3N#".6TX3Z0I^)V^X\<].VSZCI">$O
MLEIEI@(^3P9.,;JJ')*4,;U9,;0QG, >=#%-N8)-:T;Y0QR3L/K#W2XU#R/)
M]BX%XK-7_4U5TI(U[:RN_HY[1C/,#R)+[^^ASA&JJ0 ^C"$54*Q\"!T 74#O
M#]_4H9-5LO_F?]5FAQ#QK28[SIX* (D+ZN7'M,3PH&HCWBZ6#^ @3<Z'W,+^
MF%',?;@X%7!%'?89]:'N#/$VH?8^GNM.HBK'0W8*RVA#Z8!C6KO&FS,*1^?M
M42P"G<7ZOG+W0S-#4TP%!7U 4I0QS%HA9BH7804A[, ."JK(&126-0C+]7)'
M?EOFZ(>ZL.,4YC4$T]Q$WL;W]5D=G9BOBPU9A1J@]2#EU%<>5\DE5,!/932-
M_#?5J!\UCX*YM0W/_TA,D%R!H96;IW3FH<&.Z^AWYP:J+#@;P,D$3ER(&0$Q
MM^$Z\70\\8Y+?*BH9?C'+H7FA*./@RAE(G>_JTGOQHX8P@81O69Y;OQ&G(#7
MEQ/B@C\Y\,Z!,TP9^)FPBX[^JE>'-'M>6!Y$N8WGK%<N%.D\K:I*?AXT^:Y'
M=4'2HWT?3DC.&H^P-QR5AGX^56.QTL15DI!3_\!+3H3MQ]R:HNIF7^ZNHWUS
MTGFD8Y9!]V65>X^LVHQJ&+]EGI-ACH5=7T'0402,5_=?:;SZ:/E.G#15!C,P
M5NK,'F^9[(D-0A2]U V/_K[<NO!U-U=B95C'^54_A=NX,J74,GQW9EZR@R1;
M>B:#+_+6"/9\>=@O<\MN#6!YS.&)2:9]^Q+"[62Y6XU4@$]5D?:SGHJQI2?@
M(7^0K?7C@;H,L;@D]O597KCR[5_1-<>,+N!UT\WBT\_Y@0V0YH_+3\\7-4?O
M&4E.A*,#MVE.PMLS6"[=M? PMJS'^6!=CQ;W:^15CW' 3SWN4PU(2G'NGPGY
MB$Q[[@__N+R\%MOH[4(%>)GET.-F* ^U*9(KP@=1WI5_NZ.FES'&F)WTE.:.
M/0S]YRU:X8!%RA5$AYA091-LSQ-F5(:GH]P/T_O]UYN"FJ-A94+(<\SD%\]A
M+46/-,#?-JK^ZQ-UH/'<CNYV.-:YQOX&%4!^5@B&\YN!YH4V#C*=ZX6!+3Y0
M%N=Z3EN;SR(W9GRDB(,#]TPT&G8=LS(";#K&;)/M?)S&!\33M,"'\*4,K]6Q
MQTF6YT<RK.4RM&UZQ3))=FLW-,0R]XM8HVWO?3;/EI#T:D\RCT9]_#8DZ'TC
MUE(V1'YU+G*WE0'4([VEUV.U'O,=20"[(6X$UB(3ZG4H9P)!)$/.GI=WL!^I
M@&^FB0X^],3R59KE4B^?PBGLD(]$BWJ](9Y=?H8_X]1_$O7J0[(%IV'E(I;7
M50IC?89:O H8N"'=NUD]#GGO3D<]+AE.EE[1-%B3ZETXEOMA[XEMUYD%UCT3
M?<=4L=#^X+0"]3>^.@52WS^V:* =#[(R/D_^.=+75<E^OR:VU!6/N4@1!RJG
M$\*/SSO^Y@[KR9:)+:49'R,!AK"*J(9=]%.VW\SR6_G-K?$'Z%6II:3GJB:A
M14K=.J7##G5XHVS73F":3$!FJXF5)(N2O>YWU99,/G?3S*)3,>/IL=('17'2
MUG2@IT/FF,@O':!H\?&J5,UO!T;^:QTO%(Q>+:)\=CTCC_2\K_6=>.[#L9$9
M&B]<(6W%QN;FG8U$E3>O)[&<7JD.!AN^"-?<<P63&1WMTRX'&E:(/7N(G#<#
M)R8WE1%<Y4>#BCG[=\Q2[+0+<+^('$KEZ-CT7F"LM7>^F.4K!TNM&>"SM82G
M^)O?C ?SAMY[&!UQGW5)Z,$HZFC8M6G6WI*\/7V??PH^O-WI%%%S(R/=OL.2
MV!<>M%<@0-EM?)K)7\J0L<@U L3>?#%_-_!.UGUWSSR4U.B2XEZK=@YX;&7U
M88IEK<2XP0(58#"G4/XIUUYI+/9J:.\2=VUBBEZ$\[E)KVBFW?K1C>'Y(B][
M(UP3K#/+:$;9W8^^"Q_WGO%QSI.THX89W!-;"YE'^)@PY"51!7;2_7ZT<:J4
M<;VLEOG2U(;L5?IA[,"XK*VGAYAJIDFKIT/7&9O35T!/A!(C*2#;F0MP<<_T
MF?M<"(<';[;HX-Z;C/#.+[15TY H8 _"1?UHEBJ8,R5.:".%(_=[78;S\6>Q
M(VYW8;?CE_,5:J*YW&E"Y3K#2.']A;AXL]^V,LPEU['G7=Z*:<R'CE8#\Y!3
M=6.FLN(#.:PC_6'<!BHKO-'9>H6<LG/,_8N7+[QLQ-G_I (F.&>ELA8B8@AJ
M<['%'+W204JJJ,(W'''=T8IC-]6%>/*;KY4W6^2\S<\?FF( !N9$9_S2&T-&
M[U<F)82Y-YSR$R$;GZOG!*YHOLHF&0S,E_&8)><9%5M5^Y_+;OA(SL0\3Y;W
M,48";<+;M9W\NR\O;*-"RK?.K_ESC_0816K;4M1=(J-&#H;QNJ\$!+4]<C&H
M3X=1#HSP["_IAJ^T?(_\(TL*O3QV%#&&GR=OO"4E MS:X=A^) !A!YXYVWLJ
MM?#QP6<N=JZ?T(]>B-9+24>*EGGK;XX?1^<4R]N+MTW3)=Y[-[-R-6= &6+/
M+6ZDFZ/)!BJP!&;-')$B<T<* I"CN(MU,B@"*.\H?@[!:DNY-9C>4%(5K1_K
M:JETHLAN0_X(NZ39B(GF$<"=+^>T*5'-;[[*(%2AHKAIO\O0A&&7$YZW5Y?@
M^( 8CQ/8$6YV+9J$-BY)G[':N\NWZPO*?W[XOC>WYL/\%O?NT);L;R4^R.,+
MFF^;B]P6C%_DF>K_2Y]?MG<=0IK-]"S/?5U-:H9,79FO!QG74?K*=LZT>14K
M[:MDE%0A7S_7,2F?#HPN5?54>$ZHE^4/V%LY0TPOV/GT12;X\P9E#-7?%P4]
M#@&L=9-G1PX7Y_9F_&=I: <;IJS2B?QLV2!P_<=J$;2[4B]/8*(RG$EMZ>[Y
MD,8U*H"E*LI]A@7S\P+2J!%W/<_^2T(EA1_1P:V !O9O[Q$S4M CO[_"[G+;
M(%KF0;\SROA'PGD;HA>^U9P%']=BDSP<*&(B) E2 0[0"419=O:!$9^ \36)
MR\7YF!.&0V\2MZ[S+(_M5W:?#]L/NBM0/D)X0%A-NOW=S\7,?K;:6!>W,6R=
M-O*+<J;RDA%'\XSDVER6&USI!K*D2$ A<O(/TV;" :Y:_KO]&RQTF'%C>:)W
MLQ$:"G<E9\;-G<_</WU<W:<[/JPF:3R*'9N4HV%:ELP<FA.4O3KBH;*WAKGP
MJ\8M&-RK/3UN/L+W[KB0,;?QDU%Q<JH?<,6L0>=4^R(L<>:BG%8!21N;/2HB
M6GSS^8>?K9SO3KIA3E#$[&%T3EFW.F_D,;9?9/]8,0!3%^%N54+>GBG!?YU?
MYRIPK<T]@*BJQ7Z;CVK86Z("3E/NV()8;MXGZEKL4@'=U^77AJ:_&V!O5@&W
M=][F=;:I]1"-W/-&PE.XAZX:C#7\XE]YJ&2I/6AUP=U"!OJ:\F,&K80BWB4X
M:PY+V$O6I2U6Q)LG'9HBG&*BD!?0U8YN2/I/VE9MA(6[2T&G^M7RG[3_BL)&
MPL4M6D7*)Z2Y$.?>YTHVDAZ0,TF\L[)L51IFWW=SOP_':_B_Z,5I+EBW.E\2
M_EYFG6?[KL-U@@$ _H4\25O9;A?!'V8K2M7.&^_&!QO=>8=<@W8EK/>-/S'F
M53>@ M[DK/2;:ECE$)S45XZ-%UWX;M_JS^^/I0*8&ZYU-2OB]O.R"\BC!C^@
MHR!&*F V3>$\P3FWW2L1YOS<\<='NJ2C)WU-22>C:AXE74]@M510HWGL7 /&
M5P6^J^O[J]C2F PF.0W1K-+;$/T&*8'@^R?;UIF^-]CC+[V?YL0#E\(HI?-C
M/>:^)4#R*1-;?="8Y\!]RW,W^V\]#:67ECQ,QOGN7QUIX/7O-[N&K3.U%DDV
MM_5Y43Y99:BT/M+F.]GEMJ^RS32&W%?%-HC8C6+'@PK'_7+-/WPZ?4[>?L]W
M3O2;*<,<),02758:Y)S^./FMF29PS+9& 9EI8&PT-O;0Z>OG>Y;WQ ,BA['0
M,"O'FW%2(T)*&E:"=[DO9'^.^21WGZC'1Y&HPU65V$IU_JP+S#%YD>>ULV]9
MBK_ILF:D7^Y\XKWHQ]%5)56Y^>H(S(FQ%3.%T7*5COCBE)38(4E[Y;+J 7>;
MK=$CVT>.50]Z/,C@C5RM@K=:!8&)-XM0GW8.@]D8DN[WMS4G0<*E96&O949+
M4(CG:)1-2 SZ5F-Q63.$'BTZ%JB+;$DBDS'A1O<_E'=8LA]!<^V0P&))XU<7
M2J/9)BI[M )A=TB/<745;._MMNU83+S;;[!?CH<UU=/#;O5P9)F9E/A.Y"U8
MD>3CK6[O?_0R,[,N-R)IXPXV5.U?99L8*6>B(;5O5+]*'5G4!<)P3B4X_I8(
M9QLKK,/'3>(C0&GD?D>A,YW7"]&+1B;JUFZC@^U4@-P3, :GV=IKW>19,"=O
MJ:Z>>DDG9-B)[28FK/!Z2$& \VI?$K<E17DH/[:P2$=Y<@!77&\N+I5C,?!C
M=4<$1'\>#/N&8"]'OE40B,8:[)1WN-L^R-Q^9"AO+]H.H]_-XZ5)3$0C1Z ]
M1QU2?$QI[*Q"_'<;!0G?NT$Y$46#;9OB%6)7ECW+-45 (/KL^IH,OR.F#F+Q
MC/[09F:EH#=SDMOY:^?$^QST9JZ7!<]B6\;;RO*]_)3#W0P7Z^O*V<,G7*YB
MSAX]G!-M*W"^Y'4)JXN7;<]:'82CG+Q:X0GBH@5!)MVZ/JSXL_8]NWO'Q1)D
M==TMS>[@95LUW1<T(*JEOY,&+%VU9H9W*52AGF++U55V=99Z%[_Y)//&*614
M]1TCG,<V9BPIOILI;_Y$U]UI<@0]Q</U?7WG%<=@I)ZTNWC#52_L$\+#V1V1
MQ(N33^A)@7.+&"%"Y?Y[3,Q^:$AS[(H/V C6ZHIR35=P>&XMN8MM0YV-.3&I
MND"X;C^!K-UGOZO91:/"&G9N<MH>.BT\C!Z.EOUR^_28O]X1]'/?M4MOEI1S
M"(@' W4,N'8-=5F;(LG+&ZR7A\U3WXP^B9V?8GG0_P4O\C56L;#IAX%5X[N8
MM@+"FR-19E67><ED!QGQ2S8?2%4\Y7A,FW-H%![:1H,54I[")^L@M;<>O SA
M&=']U0V$6''7()7?6>F)<Y F>'<]OS7(#9#<LQZZ6_F=2WQR>[2CL90"[$<[
M8+R8]U!=L* &F5'_,X32Y18?OQ[LUJWV,=,P+0(4"RO#;'QRQK,]K2K!US9G
MF-8ZHJ.J=AC-P[M7S:=&<X_@S8*H ,_RA<DC7T=..^>KI)(K[$KL]..9J)NX
MS3N.G+;#3^D\!BI2%0'_-X5AUX=IBAJ*8CD6:4-KM,4I2848'EZ\5/DGZ.[*
MJCE[RX:[;>.@V'B>J3>[!;,!U3/!M(@FJD=2 >7&_92;FN*WJ8!7>;^LQEVL
M+^SG"<G2_.J(%6TH&O[8X[XBJXZ 'K&I09EF<..I@,YC=4=8+,/ON"L5<!),
M!;RG\][+13;UXJB UK!M$(D%3%$3*:("3#!9?EA\-T65+1RR%D$%"!%HC@NM
M@>ML^C3/&S;8L$98I +X(EI!>ZU40+PI:(Y'P9H*X#VY#>&4XYQ#$![+.22]
MV,@P3(ZC[/D7D$ $^CG-\W 1V^>#G]]39"VF_0=2%HK\+>%L-!J*;*D TV0J
MX 'J!Q/=DF;P=IO";L*B,A:8P"$XE1;MJ>_R,](TEH#'*[=@[\RPH+YG\IJ.
M&YK=_G+.ZRR3V@'RK/\HZ#SZ=U3(>LKK%&=R:BU\_DV=^D)(P![D%/SQL#&T
MW-?7MR#[O93YP8>D T0@B-[_' '3C+3#BX:E#VV)40J_ B.]JY.4\T+W>=HN
M)CEZ(QH5_&H)KZ/P#RD7A8__6+F@?FN"%6YYHR&67"EW7Z0>5]D8]UA=K2/K
MX\%\B=P=7-G<BR*\[2X0?P(Q=J'"LHI^BV=D#/'M?MT=Q[F94UYJV"<(B.;;
MD]%:I(?<=A^,WB;?7=1/P4M8L@[M[,J*$OB=FQ ,A,#&@P.S*X-7A[.M;Q9=
M"PQ8,6,FNGJ!E''MT<N./%VRE^D %\7"]V$$?FR[Z&F"Z#?LJ-F-$<NAQ?,/
M0AR>^V"#_"= %]$QG/ '*3:>]M[/C:\IWBU(%"U1EC\]2AE,]JR<]7,A7N2>
MOE &V>U "!WY7]K>C"<SPK\1+T8U,)>!_GCITH _PII" D"2T4,LO$-N[+VM
MKRU>0==XFR#;9XI\.C=]/R EI<O >C$>J.>(<>!*.,0#J;8CKZ]1TQJZ9VZ6
M5+T]M&+F(;Z.5'WO#!TY4SG]VXF$IO@I_M.O_/.=]E\/.G\]_.%JNE !K V\
MS;C*9D^?%KQWIS/[.U3Q*?N2I6I0V,QYQP9^@L>:2NV[5F#+B]O-DSK&81OI
MN!8,SM#Q(F=>AL*E=X5.NK= OMQK$?A$$C#Y,5[?TOE\A_#.N[<NIOLY5, )
M/YP#^)4'A;=*]V9?I<LQWWF,%,9&,V@?<L9?R(Z'?6C3:'5T\G5I2>==/FCZ
M Z</]5D*(8EZJL6&( <C&JS1=4LVU@V"2Q/NOQ8S2\?%[/\::A!N!RMGD>,7
M'+,TC? SP0B<!I*1,#/W/6:>O?S3?-+^E?6 Z%.*/LL!&(MZEMGB$&]WZUS5
M5_S3UZ-5Y^M#ZQ["!W_LC&?'QX;@P92SDCEP*;Q$DO@O1]>!R,3CU>8T384.
M1ARCH<"U@%T43>WMF*;A^G4\$PBCH\PY&(D%U:P@38!F$]*VC)(8(G(##\T[
MV*^51*GMW5B@50=Z^-*_H2&HSPT\^)2!IGW\^)GS#&)TP%^)9C=A;%^KAE G
M]H-<'SO&PA*1:.MO8CB(6?#@]TW#:Q]2I.;!,Q +4+AV<S:B25:NS?I#R:F'
M[^FS?*L=/=59UL68#VI3O$)?Z2P']J_X7_,?UX<PP8V]TSN_E#=/<$F\ABKC
M//<SAAI$IS2=]^^;\UE?=MK#*V_(@A+QR::@C9@U ]AIN([G'(9C)>WA1K1]
M$!2P4&])1H4&"S8Y3SUI)>M?S'$KAT ]WGS>Y[U6S10^<S&=\' .N=&9L0.%
M>-1L*#QO&'(PNS%5 ^3?1B5 ')&A^G?,F!5 JL-3;0MBRTE'A58(\Y#X1WL5
M(9_4N':T7AP$(6:S1O?OX+])Q?+%JGSSY!E#E2M<(JD%SF<'2X*]ZN+'.1W]
M@2N\'CEVD)4,*D"&_)S\#GY?!#E7Y= X62JPC$-%-PT717](2<O=LU-BU58Y
M\@_7O]P^^!Y]!<S;BJ@=9">WVH_R1R&[<:202?UA]P+@TN.&2[Z09H\=.;;G
MTP6F/#,^2PJ7*C_-&M-1>MV!>*\B\+"9PU&2Z('+[@/'/R-4/8Y_B\H<_'M8
MYF_*\CLN\^6OA^S__.96ENK]WVE^PM?+3\2.Y(D_+7U_MVA(^D;X;66]Z]'H
MYV;E1BIK&3=W[![]K#//4,C+67]]Z!J8VE0])0)7$E9W>B]R&9O1A1$\8<T+
M7#;C&Q"1@WCN=U\7/V,L2NE 63/HI"FT8AX&W]YWQ5KL 1E3?T+[@\,JOX+N
ME.05>"1Y6-MH*;*^5M:+59.>;(CO6S-CCM%^^#. >2WIETW156W=J?E6@3R;
M/J'A.GF7[(K^(OY^/::222J@CYY4\*/'A398XU5!E#.#((]V3%.]P-)%]>FH
M[Y[WW:RCR0D+%*_*1?5]V;B82<BB624YE9ZT ^O*-C#7H^N$=14M<6>(FB]Y
M%R?/W=V[^MV29M<R"6K<DO<^/?JBC].#U:3[?RAOA[)I9R?S&@Q&/M([G?[4
M\7Z_]H!6[ZW*H"^4#1>.#WL%F8R?F+FZR0.CE23!G/P?[:Z=%1Y</U\9U%SZ
MX*ZAZCQQG1ZW7[PMT(0K"%@QM+ 34/[S"HKEX41T?$+S7.1(1V;N/,RNC",)
M__-[C0M?E(N^OMP0K\Z*SA7)WS=0]"^J?1!EC4@[)?BCD,^'%:OUCYGO&?_?
M3KT.PT<%!1!>Q8P*J(5)DX2OP]U^+,3!E E$RB/BS(']TA]9^;?E*H>Q/Q9!
MFY)]3.R4/96#3C['C5ZQY\Y;''RP:4EFI<'4_-OV;<8\0PZ:DF4'40*Q-9N2
M-RM8&FM3;S6@NWUM13B9BQ?T+![M@(AM::6W*+R/1@>-W_&9HOL%?VC$7)3R
MWY/_W=A;][Q+G_@:+!$^7PQ!(*]AWO 2QL*RF%CQ>\<[J(!I"3P-9W@-*CMM
MJSP5,7!GS^EUO%Y[[-I&MLIB_)&3Y*W8DH.H^ZPOE)JV[7H24$Z?.VKOK_3>
M-DA[1:LU-&A-P><PG!F[\_;0[Y66P#+KZ=(R!7\\BHU :"WOY>2'2%/<UW-O
MC2Q ># _[V8B&B"I/I^<B4V[B-AOD1260YZ2V1$J($P.MAE.\_T-&L[U[<LA
M-L,G4!^*2(8^:?60@'\L4/JG$O\9YOQ[4/C@=ZPTBLY$, ID><'?CG1 :'T6
M@<_4#M$M[?W*SW:;Z0-%\HBUVDS1>Z95,Z!&LS5*>F+J%CKQ[LX[\Y@%LVS3
M\.A+*(E]JS8U49WY'W.^ER=MQ"-H0&1>4BJVV*M/7=]P;R*LU.LP!CA)6)@5
MJ9V5?FMT$ET3JA6Y(+FL/H<,Z_D).J\>B=_F( *-&4)CQ.V7W,QN2Y;'L'K5
M$#6W%[ O*IVVJL+;AGX\4)\R*YH:(&Y?ZI2<A,L2E.<Q[&L,EJB54MM]Q]''
M%O6>FN10-.?=Z^]6WY<DOSFS8E+6-G<+%>_\4SW% DX$MMSA:A;JCJY]XJ)9
MU!>!I-NDG+7W&/CE_R+=_*6G!OA5Z=>$1['W'\9.U\M(IIN=?>G#(2@(3K?)
M"/]A40"\"VPC8)LR*)?2Q(A#G;Q%'A(O&]_<%J!;/DSW->2XRYIG=C<;6DB(
M:=P_^N(LE%IZ_A[W6J^H!'CMTJN;-W-SBH7N92KR?VQ .\., $:"#1;1>Q:C
M;?/D-Q/IL?6YQ[E&*T-VV<N-T5T7/BV'C^%F7K\8%A&#1YU%7:OGU1A\-IC)
MW/9Y(7+H*\.7E<XOXZ>?/K,H&E"\]3LY"!L7RR]Q4_Y&Q.EV/*Q51[E:=V4+
M@[0TT:_/IP(LQPHQ,[((F8.9L3M-'M.,20N&2=HY6B:O_=9Z>X1DO+Q=-ZWO
MV/SR$W-F&EN?K>P[RCISJ%-!'/K!LF,9_%/'?F<HX?_=/O\G@?H/P?>#3$=:
M*QV?O"19!/.F-!XULW[JO9;R)K^CW$<QOU34IS,E3MSZ2?F#I=L#-6F18D9Q
M@DYVD5U^X#1EI!8/(_XBA*#D7NL6Y;(?O P4]QM1R)3$PI_BNE8'A(GG'=M6
M9W=-5>P\"F>7S2<,D2QAV2O0][_VA25O1>IF?VSZLF0ID)DDP!=\-&DRUO/V
M>7PCZOPH>DPB>87NIY-#^$' ;K%..P_0U(+%-?#BE3EEG_-<>B!;SJ*!GQMR
MD;=,8A_G:)Y+>/]QR30F[<,X$YVYOE+,9HHVFH95O.(T,EX#3=I<<T[%?[%>
M_)CDR J@ M"JY!WE<3[*8;:V-2O# TVT:N!.BGY,\&[[L+N*_X.!Y:2\'%M/
MCJ*F]N-L)G.AP'4%%MRD$6/:Y"D/=K[]SQO-3]VO^P?71R49&!>JW*KZ)32X
MGRTL\[!T6FF33:(O0ZWCVPAOPD*KD5W[^^1@%YJ9M'2Z$BS)!<^HBYAS1)+X
M/%_UR>S0X<WZSB(3?UA$C6U:N9''="D6PV*[!;ATH-'4$WJ@!U"R3C,G.T*L
MR##*1U<,98<.5W2*_G7QI)QNOF"!=K$?^&'IL1B?X]N"MK;)DR-?J0"H(>7/
MPU;IE@=@R']M@L529/:D(7\_:=7[.T5XAQVLK?YZ [[8QL'G1]]\$*N6$=?]
MOR6&H1?]EWVO$60H:/N<6A$ND6R*'<V M,A>IRSR-F2$@]&XXW]+W?A?GU)G
MS&CX:&'!UMZ;KT4E(R&$KF&T5OA"R:\P11&!C,;KPJQ:SRZ&F[@H"7P]HRA\
MZO5E/\4;]#YQ7-J.O7H]DRH?=<X>Y'7-O\D$>MYR 0/IRGF5.+,T%Y?BG.R*
MK3OT!1_D]&",D-V=609M.+'IU(Z?D/]%W'M&-15U:Z-15$001'I70:J(2J]1
ME"Z]A!X!J2'T$B $&Z!4Z4J+]!HB)?0BO?<2Z1"DUU!"Z!_ZGO.-<\:]]_?]
MD>R]Y]YC9]4YYS.?K#4E+IU,]$?J%8XM;,&EHRP( I(X V?1E]K_0^/CWZ?
M\TW?_M.[C>)P\EK@YNBLO*1G\4%E1"QOWIB<W6Z?PV/[#H6?NA_PK6HE<5;M
MLGFF65=%P<;^0"=?G<W<JOS/7;YH7[.RRKRJ,BL+WJQ6.NX/.H,*]%<N3VD-
MKV6E?_A;C<<2/VX]NOI7#LC,:J>U# 7$7EZ\X^/[KUI>/BG2XZJC ^T75?ZB
M^$<PLBW=M\0@PQ-%(VE]MT#PU>!2T;.(.!8EXVRWKH?<FL:!&06][ [TD8F#
MPO%Z74)LBH/O)]!EIGI0!HQ=IEO7]P1/APIE[9$W8]>QS6?\FZ$=.9Z>FY0.
MPK<]Y,M63RG;I;/=R.?8Q*;@(0%2<7"A:T!7#8$\.WN99(,&H]S#N([%!$6W
MS7D8]\FZMOB[_<D(-G7/=.I5U9^#!XFA]J2/JDMC*H@!61/*;+1+U>00_7*M
MW!MR<>Z=>?0T1AIE:W"-17ZS#FKEZ39Q"N:C"\""4J.ZB4(R,71^K63-:<9Z
MG*="%ZQ0Z"GR)E\DX-<"17UZ2;@&R,-^0R_N^YY0(W+B0R>&MU88-\[DF<?2
M%<E)XJUZ+-S*3EN,MPGQ"->WBN^SGJZ2E#G!!ITBSA(VX=:V8@7S=AG#GM]&
MRKQO/7GIBZ4^$3L?,$:^@[]@:.IG_U*$47(2#8W@U/[]=BPZ)'$YI\&B:7^Q
M$V0[\HN8M8-LY[AR$(6&2]QFRXOQ..(ZWZ[SY]LA72A_CQ^6WQ49#R;TI;YW
M;DE&[-4#F;=DS#RMV".YW )''FW16"HGYW4<H,-.M4^>PBKFX^N D:=TN6))
MF;^6UG;;*#Y*?8Q^JMW+/%BV[\_4P/5S=^E#]5IDY0@4EZEM;K5#M7 >@Q]N
MRCY+9V9;S-LU'EO9C.I8N,=\H*]=P1FU;BJL(11ODHKA88[2B>AYSM>M6E"=
M8+_?:MGWNT7?/Q.?C.^%;;<YCV^_(K[/F=*(GYM]4S(70.=W6TA 7[5PI5,C
MJ90;<POV6<K3RJ._8_L+D,K3.4AJ8?5X1"/=X&Q0NTW JE%.^OL;,"6$)R#8
M)%[KV>BQ(-YOKBT2K]M\:+ [T7Z6VV' $L2:A@Y[= &PK8D<GVP)1\&J$@P&
M!Y#3J:#$D\_+A@Y$ [RQ*G!T\*A[OA;*ZF'QSG0PZ3R&*OA<@!@PQ[*I^/Q6
MLX@UYY1D)]V2X,+-?> =\S4IVKX*]'V_@*2PY9 1?'#S9QDH6@5E'],.R9H1
MWWK33Y88HW7V';U/5S%R 2B__XUWYH'!\BJ8+#*_^"NA#Y2P$J#VY\@ %#W/
MJ9%<=P377G5?0XY[$[(UZ5Y2!9[:7B)U.M.<.\?03;!6+W60^J</_@H('4V(
M:,JN SU3R5C:O8?MBHSH$@0 ,;3CD"B(#O9,?SMJP1B]]?*PH+<9IU?7N>53
M-?/BD30L^4&M5-'L#E5&;NZFTR8ZS4@P1Z79?9<5ES6Y9UE',M\'P7%? #9$
MQP\K0-=QW=C2 >A["1M3YFVXDC\=7@S85HM-/M7DL"TNBQS U?:\+?.29:WF
MSWY,;=L#+"/](B@R2[9&[R[&\YUR$$P.\U1NL#H?1*<#':<-3#3O&#T/DY?:
M%?A5QNCZQ&'O394]N.J@LDK2H,(JW;G6'G6H+ED]#-Y*_/-45F!^LVA31"WB
M0*BE_X@D9RR+Z'T!N$=SD(&CO;&@HL]>UKWB8WPVJ&%>EN1U6A^K]:)O/9Z8
MU'O8ZR]]<A^"RO<OFDK^/%3O@K\:66);YQ>\(>^>[U %;#83FDF'! Y3TR(^
MP'G-)LQ^'1;-OAK3]GQOA4P:JIV=3TTCN. #? K*!O<)8,;0:)=O11M<=;^1
M3Q-;VYG$CE,_3SW-'H[L:8F(C=LPW'V5'A^F_8:#ZGCT&+LLOCD9 (7B)S6,
MKJ7:-':L@M/7O,K]!=KKI1%]OMYMH4R)$AFA1@*?M[ZY8=:L*[_-/Z7.$XPD
MEVI4X_@8QROK+7?%Z%IWG88B/VHLO "R%E 2\OG!$CQU5*F5O@)\"^[M/5?W
M(KQWNMQ;9=UTJ;1@W:7+1#E1.8WG,$U6=GW_M9?T68A^KJQFCQM%FF5IHB&K
M<8FS+F8'&7K <7W]:T"3N,##KHK>F+:U S#Y^>\9V0$93U;$XVJ.WW\"CR#+
M4"$]HYN)9( 4WZ\^O0HXV>?3C^Z:523/6.X@,$>OUS0RJ[*W^C<GX+)Q0TV/
M9*54N"K6$(60U"L[[9O4<]/\%P#CT/[2-UPAF%.F'60SDFI!;P@:);\CSBN:
M= *<,NG=^=B\3K%Z_PYZ:^1/R/Y5/D@Q,=S!-<?8U8SE5:]GI55W6, O!V[H
M]+MC'<OWREUC=T.,>7^VY#&;==T8Y7CQ^M+"O+M;Y?PEOJ(BE<5N_P)P<#"J
M$PN*T+?XJC>JL%O6TO]U*RV>/%CM \7"MIX^>\6\F>U+_!C*SZM?,*SH-22"
M5@<U79#ZV(JG<DH"/<C;)\K7ICVR8\O )-*I[6U;03>/9(2_+7:80"2WE*BX
M%%>:P[CK:-K,A3^J86"6<:^^S3<6:<X)?4 N!+>0H;8=WRJC6'I,ONAM.OHR
MK[L9^NJ@Y3ZUR>QJ*PV P("^F'G_2U>B$0\]T2-_V.>OW.O3\'FI)-2 G6G,
MRL*/QZ5AK'Y\V+$M)G/2?@VA?$>IO>+2IS^<9P]?(.>S#AJ2P'P\?%S<@0YO
M6BK- <XX-- ,YP7K@(R%%VHR\>"FR<":'36+SI::/L69@]GQ:3B06)?Y&?-S
M=B?A>E/4K[V ,X]M#F* +A&4DS&MP)U5N2EGV.OJFQ"(&_48]$^'%H]DFC4&
M4Z# S^?5F.@,8JNLIQ$Y#V+SY(Q0%&<F+_'!C9M*YSR__86E8VQ[=[V*8E3&
MRAJ8C<^RI[_?>%:0#!^E:N;XHC[/1/D%SSVC>;<6M:M^;XK.GQ_;$OE)T*47
MMWUSS672OL2MVO21.'J.W^I+G*0?JR6&D*#(HZ[BKBM<*[X YE#':5OC[+WM
MZ(<LL:1$=[ 9T<\(@RWK,!]MO/F.';( I"(>'5R7<LJS?Y@\>#O='FMG1<3^
M@(FW),S0Q&Q>W=ZD_['U-*V?KC/TE]'>H E!IO:5+9^[H&:&:/_M<6))RSCX
MW9OU7K?$@^E>#"K[X[S+U5>-W+_.V0_ZA%H[$)Q2*V/1X7=M+@ )>1&CI^NC
M</(Y-%%I7B4[12@E6)RLPQF.[3>(R<@POL246?9&!:^.0(3*,8QFX%BYL6:P
M27?9*.<%0).M4Q:R!+RU O%Q/4-F"S!E2D=L&Y^4$@J)]WWPI!UXP;JN5NNL
MG.\B/,1?:'IBP'R=F$3 O,B':8.^D0V[YW^BS!6M6XCF++_RAR-%)C$UI0=A
M.4R:Y,%Z+L6'QQ7%>PE?1#MD.')%X],+N77+\"JN69-KH E$95BWI\.K^!,-
MR36!%2$:&/@Y<='?+5Y*JZ):RZ3'&DV1T)@8_,%3NL"DD[RE4)\TRY=5M!6&
MX-+)Z>S4D6[=BMHGRC09?C^AD-<XD0LC@*^=3\@)[<Q460-#MX"XY(HK7)-8
M.W3-*<D"B@.'#-RL5?K1@\Z>HOI:W(CN\EMG\=<91VTMT#R?UAK#!L)]<-O7
MVNDB G.[G3/EO04SWRY<K9LR!S'Y[9?)%'8'CVR#R#,VSY76!N<64'1S#:4<
MF^+V^/0Q,_:U+G6Q/0WUDBE3>+J\=!BV= W!]7-XWN=!5<2*$%CP/3HZ-H-\
M>@/.F:$C3'"22O1("Y@@P:,EZHF=CL)W3<2VDHI-V])PFVIZ7A#[U#N^H 30
ML^;A\:G]O$7/97R1[F32S6=F 5)IKD7&$^5LP<OF]YP.".N(%G][?0P3<&R*
M'F@\'^].54J#LA8CYG/[79L1&Q8\/QEY>OI\Z*T$E;GRV)[*X:2G^,:C!N^/
MIA> 23JA3/6&DA5/1T*W\UTCLST6@S WKNXXS_:Q6D;_\H<MNG39_CEFNKO@
MGQS&,Y)=)Z[/XG60S=(<S^DX9G2)PY!F01F5@M4-9DC"5\KQHAQ-8NNU>PJ"
MI<(>TR%;68D6:W#-V#]Y<=C(QFU?]CB%MW;GO*5C#T![]*P$*^/YN"I%2ED%
MWZA8&S2#>U?L0U)[@>NTVGK/__T53WGHY:WX5.L/3T>GYD#(\5.7 >=::V"P
MSA(;WG79B5$TT[[+>Q'T,_)%>I2A"J.'=%3UDQ5[R-/ 2_PC>QWP\,'D=[)F
M_G?"G85(>EB-^H[Y>^_\F:F6]&DUGT>_A/TLZYF)XR=0-5R!="CP=EFBQQ$_
MEV[(_I-*_M\Y6X+2H8GM T":"X!#/SE,W-B,Z3%P>$@]^@W>'#VWS6@(&U;Y
ML-;:O/6\MQ^#D.OQ=&98ZQ:)ZLY=HP'V/KC:PF%\1G,6=DJ*H[I!]/(:VS*W
M3GFI&'G*.527C#!3(G\A*N2WQ_IV4BZLZ"7.BFYPGO/D 'LR)A[B,;LI*,,M
M7+94>TM=T3[Y]YI3$;-+Q"9K7:04G&,K)+' <)IK\H=Y\8Y#KY]ML]*;]!"^
M6/X#=.H% .K\2>X^L7\GWI^J.8K,^7L)[2'ZQ^I.ST[Y'VEU[J)"/:[YAUP(
MI_-6<*EXA-P-XM %0 MOECC>_,B/3F\9V56?04S+[,=%!E<OQ=@(>WJR/+*:
M"CD LBL)R)<\G8TQ-2[6N3DW-H*+?12);-=/QLL-^:T@('#QLY!Z+I@W[GI]
MEK=-\7@[G^7<[@O18[YY-CDSSN9R@GN8ZKNK E TMW6CFX*\BDRB2W;>AJ(
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M0@*"$\V'EWA$"[*)-NU*7V6K+8)1]H//*6VF?]^"_I=2>YWH4?:IE^^( <7
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M_3P2YXCOM84+$0-P5/2P8S,!M<@>#"EIZFCGJ9)3SE#W69!@Q0F&R*%QWAU
M)SJ.X2OT(/X9LYHN-UBLK3Z1$I6VLF'T,HU:@2RD6,T[1P!M)<K.=.=;OZ62
M[1PW*PN7>;?Z!3=S3- TUTM5A/PVO0"T]-PNX5M8WC:?9FETZUU#J"<J,H:@
M:0(C*T^<]S:,ZHV \Q*Q?S:*(+BRI(R*_6FSK30'("850>SU46KIU=VD[OJQ
MQR"ZA$-6]Y3 )"T7'@X0@80Q:V<Z^TD-A#%^FE)HBK1HFY \.@O"BSSL\W(U
M-0B\=/JO5BYN#2DU&.V!8D1X]6<:_>WY_>CVA-+!NJ9-LIJ_!LZ0"I,@SW4P
MQC!N_;W&P(\3V1"T!O]TUU9%S-G$;<T[M68)T>BTW/RVK+8<%^!$_CX3K6CK
MM&W(^@7 UID=^+[VN:7^-"'^%B2Q.GCS3EPAF*('"K?.X5TX7 ,:KV5MOVB)
MXR'+XSP0^E7]_L3ZRP4@]9?XLGEKGGF K7SIE7Y6;!",X5Q.Y.6E-YEP=(O0
M3RWO](A."0/YY"O<WY\>!Q,=92N/>EH]?#\VU= &!<TWYPAK39_D6Z-'4V '
M!".__=6O/EEMO__$?LUCG&HYOF7A*C9/CJRLC3'WQP,7#")WEIL.$\.S1D#&
MR?<VRJ:[.;)@2NW;$P2);1/EG8<=E=%7K>H(LNN+0$98A3X^L#&:C.U \:0X
MVA6LEK!(64+X'=Q]G8AD25SN^GA<3NT^$N!&=5<E#PXA1GGB3,@Y70NG:):,
M?G1JKYLMQ<SU"C1E"Y!W4A>)<BZ:%AQ\E&$>(()=D.1EUMC] P/\IX)R6/);
M (1/1/H2!GDG9J-R.&7_&,5O7&DZQM5G#8?;N8EV*B!XWG],TZ72M[0Y*JCS
M!\ZE6N/WYMF"&\U\1^%/<U/<QO#P<3,->9H^@?B=AD#G6B-8J2:+$JDI 6V\
MLX6TQ9&;Y/+81&58AB^YO: ;6O4U99;-+:_0_NG=ZJ(4;->FJ@'-V.\_..0X
M  5?JBNTO[_FV[//V]LHS]!-,8+/[3*!\B?+(2=7$AXIR]@TR(I0T4/,Z;"%
MP&(0M[V^]:_-Q+.K0UP^^])D;R\ )ERJ_0>M,,D9-JT6<RGN2''!%M4Z@=[I
MJ>*_)@W4S_[KKZ'KI?UGZ$2TGOXSS^Z;S\-0 <WTB/O#RYCHAXIQJD??_MC4
M"Q$Q)U+K]5=&V<KXG$25MU3<*WB<,?Y=[A.QT',NT-\=TA$T;":D L.^7D_S
M5$7%Y:[O #?&B^#RJ=)0>]N?\FYF[^D(%>_@)-EPZ9WI[ 1K9\9$N@DL_P_A
M,W6/[^:#^6?7>41AM4WUPJJ1&DTYBK0$&N<Z1LZT5D&Z)7%K+X\[9O;QQI]T
ME+PA;+]<(V=X)="D>-M?EVU,B"C(5C[444E0\URA^H'^(5<VOI7^$Q.]9IG.
M&+0TO2(@Q5A=QM.O_FTD[&W=PGR!$5+/:%/FQ=MJKXS*0DN%9NIUT]:(!-0I
M-UX;_Q#5<MQ:P^K__G<LR2I8!U;1;,Y K,F[ #BN]E;O3BZR*-Y0@/&$>Q;,
M!B,>Q)QXR28J>A58B1["3#UE3&53#+<'4[FR;DJW*6^<JOC-<T3.<+QSJ! [
MIQV9-^MDA2E&U0ET613CP<W=04%FSR#A+$#\T;V'7L<CJ0^(?CG$:FFHGT;T
MBP=(*4 .(#6]9O;FJ6.JV2TS$IR4DG.65==,P9[CJO&)5.5#7_938$+^OOA2
M.#A4T17!-[1_.6+/F9B=$O(#;$VW;B]/EH\ME"OX!?R:#4V881G8K.4KX)2M
M3TY2/VU_^&M+';:$VO'=PJUB&@+?3:^ 8<+L_FOEWQ>ZO7S*!"W"I.(IW %/
M-QS6=)N71(ZLJD\&$F3I_4-Q0+H5\)UZYG7\BF^L]V#AHU+&)&FJ.GCISFP;
M^_5!&6'/>9-+W]&DV9.K\+7&@BP$8(=X2+2: ]\QA,O-NC\N"C-4=N]$2YPE
M!-AR4,!J6M5(6\:7,?B1$GIE_9^9-@VTN-=)I,@N'T^IF3-Q/]3^[H8_.WV6
M(Y>^C])TU+Y9RECXO(G/%EQ0QA<STV0N477/%]M3_PQ/Q)=7>;*T_.PG_[HF
M]1'\XYST+/%48&?LV&=_@;/SF:/%_8Y&-!GQ[(1G-96=P;<],$/(W^-U-!^P
MU7@'H? RR&$$;9P1FY/AW$'8D4P!HIK<PZ,GVKMTQ..K9$#Y<*8=$["#_#$,
MWFW 9OAW=7 OY:XFH\+\!8 :'><N, _*H3M07_Y=ST#4MW++ YA>E<)6M,F\
MV%AY*?BKW@%37F$[V7-&Z3FRX.!7&DILQ9%KWACG,KZJ9.TJWLTY^2X'W^K#
MTQP0F<J[TQ_Y""[)Y0Y>Q0Y1/5N25WX]*D0/BU9WUZZJC"IU)+,^UM_^A& :
ME;''%:A-BU%SQY&_%_GV!V1 =:_)6E*(6]AH8K-B=,,5EZL3R&YO_WAY(O1V
M05LDY3AMKG2QQJV"P>?9$[_;<R8SGR3_T![+G(#LD2P+3;T>5"L;+!M@)E-X
M/*PX_'>_/Z]$L42 O=:THCW*F8;J ((TU4M29U$GJ?HNER M1RQ*?2(YD5W-
MQHE3./]</"ER0\^<'*,]8<_\],%7)>.5+',40R^IA;I\R6)^4:3A(-S,HD"Q
MIHC.QGFNUPFZ(%NPW/"S'OFD$F.SI_>' @N=#_CB]FJ=LFB22O48_MB>.773
MC&D.Y]9.U_]BVFO-UVM";!CJQ%E?;O)9V2XI1^3X4).T,U7[1.OW6L4LZ8'R
MOB[/)"$EU< ;M)B=4@@+;CKNX3[>P@DJ2KK?LY&N/D1/T <)?'K:DY;!^;4Y
MY'3EK.2<? JF9%Z#5ZX8MY*^4Y@1<ER;0'-SEDJTBN)XF>!*K(/B>9KBRR'\
M=:V%SR5)8]I]#S;K#XZ$3F1/P2/U#+#T'B-E!=2?$.XI/YL&;90<EYW@/"W^
M6H7JHP>?1?I3@UFQR.]OK(-06RCV7]\'OW6E><V3<F$#3P/.<CV0GPB\U0HM
M4G%'$M%TDGSF9/@:PL2(8K$[9)YLS$QD\26H4_PX/FU!DUJV!?6HXA =7AM5
MB460\K@Y9',J3)XVEE836_$7 &,B)K=PUU3-XM9!H&&@0]9.^QSZ<SV7@S9C
MV3CEM^6D+'.@%&'[(T>Q>6F!;%U[*)3"(,;B_07 IGYCA^.]"#*HGBU28>@^
MN"3WI,4]<:O5QL/E*\'0VIMXJSWRO'^V)#5\)^.<.T%:E/Q+PIEI%^6P^<I/
M!<I73PO5QO7>Z%>'*,@JP -5#P3Z4S-J1",^F=AS/1_HH)+4U4C_4=JUX9@Y
MY DI1_*7B'<G8@\+S('#18^YRN.O']U9_)PO=DCNSLCK7O8&6Z&!&")#(L<R
M#AR&LH9S>J)#>%&O_Z;EO%6=G5H=7B/@Q0KZ;C[1:>NR_F"#"5=G_O-4)>UQ
M%OL!.,57O\U YM2<8Z+(;BM2+CVS"A/=)Q\=)N8@-75TF!W&FQ[[V.?'M2P#
M@8$HQ>&P(:UK-/:^T$FGJN(0[_.]7.ZL($9!!FB9VM4 3PG:-?^ZV@0=Q\_6
M];%4H!^C!HG/,Z(A=3NID006MR$AP8Y>_4LL$]@"BYYW\<7J-N5J#Q@\2WCE
M9_A:.'*;FS;ZR9W.]0@^B)!IJK6AP63\U)7"?E6=19 H@FE2G16+DKI##L_$
M>I?GK8SAV.1NM+'%VA2YFS\TVNOM.$F^355@L:!Q>+L,FI&HF]BQ5?G/'I/(
MKOR%R!'V&GY:#/\\J/:Z_Z?LAVT=P)V#]H&]#&EN?EAY\VG!T07@+'N/J@VJ
M#_Y00G'B!CEF'=U0S,ON=FB^WW8;3HV7)G 2W1=F0T#B4H712HC>JE$6P!ED
MJC$/U-SU25SC L#9V6I,1Z>TXINS06BL)R%J12B-8X] :@M41W3. =/ KLR=
M_N!-.,O\I.R-YG.9PA&N@!<&:!2-3FGT&/A AX+Y -MLU;.&X#L?=N>$&]8W
MV]HO[Z&'^@/'!%Q/GJU0ESJKA;H@O^7)6)U</Q7'+Y4?EZ?O"@ZS_C3X!33>
M3YHEF23J-HJQLP_=<'1\1[9/N[NB&L&3:/(4&QTGS;EK14@FRC?<@AM$-TL#
M)U.R6,^&?'#U@6>?$8^,*X+[@YVV7U5L&?(KCSN"2D^UB4SSLZ%8:K':F]&S
M@9.M;V L!-!.0#.26J'(7D?9"7>2;Q)RD&=]\/-W/U1Q*G)7TMJ<CL]-TWV^
M?T*7^A0Z5N)";]U?(4H -;*(CLG=G3&Z4I>-F0#RC^*#-Y!S#>RP:*BWMCW]
MKLW4O,85M/Q.Y >/;1*CA]DIYWF*@XFUW&"#B >>/!!57(&Y< XC:O (@@<V
M"A,96AGHQ9DH>OI(*,?1F 8K<&!\O/EU,#WG1YFOY4I_<XRU:(XCFX!THH$C
M!VZ#4[GM6WT"U3N:GQP1[$2H!YO0N8R^5V26(CD_#*Z7KS:_(O4[3B<Q9.KT
M%S'-I03^9G0J56ZZ\U0!$7S>,TC>3_7B;O+6B],"Y!C0:OOJ>N+^1&^W1'7<
MZ9@I'IGE=_D[P5XSS+L)ZCK0A87$Y,>41;<\!?0P*>TZ91#>)A[TBE? ^+%O
MD\.!9(3K?C8VA4]2G-NIS( .L5,8'WD"-E<7EYR>P,1]^,F394M4;5MR#J''
M\E95L*F;<CRR?=Q9G-7+6[1Q"*1<;1@W%A&K$[LU,*F9)&=+.YPZNC,4$^/F
MKYD;'EWRW^/Y_M]0B[NJ^\2[?Q.A3W:%:?LYV?^2]9*( "Z/2B+NSTTOYT/L
MTG_"2;&V=3PBUYLOWZ/AI]WWG[GRWS+1F!"??@=>>=^X":GP85'[V!'';,SK
M/[&JSFP@&.1%PF(NL]2X<(06KXQ1_M!S1HN@^16(>D8NLW!J7$E4JY0M#T[H
M9FN1?&[P1JO/5"U(V"?3C.@@6]Z%-4*KP_P=N(,YFJA&0)XR>C]BS0N*N[MY
M-WQ24M/<UJNW: "'>1%H2Q8..],S2/E(F;*G1(];T97](O]ZAM6PDY+Q8^Q;
M5]J'A?O[ A.=3F&C]>7.-;PB*)^K!U\-E,)K%>9F ZOCD3F0"F[R @*94]6:
MNA?'3J!1/X7.7HD"1<-+I?(T_W'$I-KO1JAQ)R7S_(OCP8?$Z&=CP7W.+XS[
M=_I?)V]9CA^/9<?,G:BS+K$B49(&/^)PDV_][&6CVHS*LPIHG$5+Y0M=:^CJ
MTHFW1=;39**_MYNA.HKJ+%EOYP-OQ5D0BHR_58F,T$71QQX**#B&-MU[L<+?
MXX++,M1TPO"W#]4><L)TF5@]I93B<Q[9BC[+EJ +^SYY\V8Q+DL_BWHD/[O$
M<?/3*_V<P"S]22714%M3_8__W4>KS'][-D-V5?+'8Q:[R<L>#@'\Q2%+_SF(
M: DCB>\:\$K_X?2V VN)J_79]='$2ROVP'_[!+/GW#1[Q)ZT#@;'7@ JL3*O
MP2>]G#.9%P!#!&8NH!QT&E47<%XIOHN&?[71/4"3G)4T_ F_Q,4'C0UQL&DJ
M<S_A/> Y&?8"P".:?L9R%')\<GYK[_+=&E$7 #/L4<@1Z?^Z>P$XOW7P/VX'
M[@A' YML0*=WR<^?RSV\Q#_8%0X4PO0"T"A\ ;!SOG;*-'CP&Z[O0[!-^:+A
MBQU'G_C 6<.<H(96$NL@^D)[#;4X!_,S- +H@"P%-Y\XWUDAD.A4?F_Z]MM%
M=GV!^@)PW0T_&U-S3BVQ%[8UX7I:L"T(TMQQWGPQ=^+820B_?VXWB7+C)# 3
MG4N[=^M-K;+$,@E6T3'>H5QG$9<%V 03XG?,9JH*5IM?IY+RT_ER^!ZJ>[<D
M.G_:_^[)YDLT-,R/O]OQ^]HQB&,.&(Q@(I+/CR_\/!O[WJT,V?,^OT5R\F:*
MV+6VW6BL,'C>'5YIUW=;>A?UHCM>:LN]H2)A,\H?CS8%D]M%RQB(N?M 'I92
M+U/,4<I"QB\ <TD7@!+_KM_=N 9:^^T<<\5SZ,\4E[Y+U_PQHN6<FNB<1VR#
MZN*@W9.3QB7=D*I*&]8](G;M,"@ LOUI(FXLY<?JX6!1ZYV6O/=?;URWY?#9
M4VZ3VUN*VJ)?E^F.,^#/*[-LD  Z4WUJN"NC#]N%>1[<37]]Y")-<>)JS%'.
ML.F/%Y^G"GV;U+1"%13T]#[=.**[84=KFPJ&ZP6U@>YD34&^D^3.C44[&-/Q
M\=DAS->8P:$(&MBVXHB,<[8Y0T6L<K'#M9\NTN[@<F#Q82M*&'<!:*KT5".7
M\&A5(/OS'$#*H7JZ>@'XD %WV_%N<V:PNPM3A2VKB0H(WR-)YE ]MCHGT[;R
M%V_,>WQ'?)S>YEK%6&E0='&R1UQD#6@;%';J>P'XNA1^3CSWW&1UQM6"%["G
MP2+.A^U[:&_!OSO=1>X^:0L@2ZV9:S@B43A?.=>O*O]Y2@_$J3.<I%= %@4"
M[BH5:,[)_XNMCSW\%Y_^!]YC;2+L[OS5D@HD?U6JPE]@3\R@NG<-KRY9!,*-
M-7C/:P9+9:-RH@@==V([\\-,_Z17!T?M@3<5\&Y[IEB>G6O*;P(U$ -UD,ZR
MR6M#&U;!!8I/AKQ%#;H-:_"C"\10@\N2QSR]D3V*478T%O")8%\YLB/-0P^Z
M5'H&9:9!?5/PD?P_;QX(W5FCMC]6*#5KOC_)]5FXO&YO?GLCE")>)2# _\'K
M9F[NH@J"+5&%Y\.^C[,H+\ /.:-0:?O1?*E=]H9<W)[$1I=;4B#/VPC[$>\2
M.5,\>L/Y:JOH66H6IVJ&RQ=-W57S*US5R* #LD+1$\7A,;%)<N6GM;[8U;M(
MK=L^RZW]'ZIY6B% J6/9A/+UDY3DMR-S>RK#"8)0+<4",#4^V:F4F]BW>$"+
M<6Y#DI\:[6P=;=F6"Z0I(FS;'9J&X2I6A2HEXU_D%N@.1M::RGQ^;$5D#O\>
M2D_6BE2%.CSYOVD78A]#A+7Q;/$Q]]0^-"9EW[ C48T(T<P1#:J7&$JTH%RB
M]'UKT*5:0>^F',S?Y?J<5@1)M0:DAJO8VF>_VGO!^M[FZ2Z@W_>D>WZ[65W@
MER^K0?%D^Z.(=Z5T3#?J'<\^_C:&R#U@N.+6X[5]C/TMF#*^"69*LN3A[XOH
M9(U[>U0(.N\MN0 @#??6RT!".,W@KVN#M8.=B\_@704SU<?:;;=A47F\TJW?
M37?JAG[WC1U^^5,IH36]9J,%LXA:@0S(^,_7F*R+CRPR1E^)*J_%-:V 7RQ1
M?F_U$UGC+UY2S)MF8:<: <YSC"2J<'-+4EY].@<J;)OQX+NWTBPZ7^&UA(/
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MBX53K6V=!P?@ @ EWQZ?;2RUBR\7="L:[RB* '5;A:NX3YW]F H.C#(\)E&
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MD.[\!<"XP3B..V70+<2AER,!S+!Y"CT1.E54)VD\3K)/I&CW,VG[32K:"%O
M,82<NCWXJ#W"[,H9>!3N%[GYI[5>T,3VY$.]KW.UINO ,6A-THDY^>?/Y(3:
MT>V14Q/QUM$(,8\,GFX&B,=)I$'UV3?,ID CH1IGWN['&N43Q*NQQ&I3FZ$>
MO:3NZK@E,ODI3&S,ZV5Y?>6EUP3K]$.900;6Q87RC'-;7/J\^2/3T'ER]^ \
M.\N?97@"K&PS3$S,7U..9X3=(,6*SN%*'368W9LO&_-@7$/]0XLF54261XSZ
MP?@:PHN*<O7<4)//T.IR%F\,XVD4B9(X/H7I*@LX'",P*=I$S&@&[KQ?'UJ)
M[EW2^)3J.V9_Y:V*ZF*&='R]K%ZB*6HE0!=7<LINJY;2Z%#F-7(F45$5<=['
M4FEFQFTVQ[>:Z D#;Z 65@ZF;\!$67Z5YG2SNHGSK)IO:_6WXPU]YB&J88<O
M^9PX0[7+HOLV7\5'AY?<9U.0"E'BPU\ VB)_;^N-R3A6YWQZJW:;@<G/M4W=
M)_V4#H_=Z"]$LIB:8?J0 E:=P='7$4%;TE[17L?Z_B\U2\8*9X:UR]5JO!BI
M.YY==SLS1XH_&T0JL!XR;,2S%RP%FV_ZIAKMB!."!A"2*X?,KN2V7/8EL*V;
MNMR^[Q,7SKG.^^WGS[36Z^^$>ZQH;;O4OCW&?COU/?OF&7 =,DAL;F(8-GE8
M<):V@7*[]DURXCG:C"A\(M^.S_@E;E!]2O)\#'H!<(F/3I:I7)  JL*QIAAQ
M13J^$\8SVVO;I-6;Y[:Z<T9%6S(B:,0YM&^*'LV"[VU&$[J+.\(-0PX%V7^O
M)EI\(<YA/\*.*HR([R*/EF:[:DT-.O9+;COH(Y26&5K"[8@?6Q)8E[N_1HZE
M9+19E@+&;B]ORV@CR/JW)X^PFK>.7-_Q"T@KO%J+*''T-QW4$RMVI%(?U2@3
M8316-Q]_UW';-#NX[)&EQ #EM\RO-DS Z1QD-5(5$E#P'TITE+8HS_W\P  %
MO"-O.<+-925H%,M$?BJX7V2E#DU]4FS5QD-Z4(3$KIJ6I]].P4U1YGK?6DFK
M471?Z1]R#JXN7V>3<CFIK<3F#-4'#3@%H;(?]>Y1@%HX2BJ^+.'%/SF]C8VV
M/%*$;%(%HVN:'1QV#L.FR/JLF+_9@=:+QV"ZYF;R!)-+.!BO/V*5#"*98Y-%
MP16\^5;.!" XI19UX?F$(&=/R.3GL2W&[F:'S:#8XRM@!06I+P\+Y!YD+JA+
MJHQS@DRQCVIE+0]!(.KL0:3@-Q(P-V((C.%TF!!8F;E;"2%?Y%+G=F'R>V].
MO8",K+X<:=MW.O-^#=O7&*;_YN.\Y]WJ(I@Y#6LV-#&:+ERN<-G2O%X\4;],
M$J?;G&7"4+#*L0>4Z1'._[TJ\QA<8100-0%G(4I[XI^L^9Z5A5H1A)?,?=IO
MP-U<$T>JBX>=10.KAE"G>6^D;[WOY*RS6Y]Y]M5.;,Q80LJ14+QIER:MWDE2
M+X7-.^\.(-F&0ST9PC"3WL-R?<03BH+W//4"6)2V5FB+Y4RH7=3[7VT<-<T%
MG:<Z 6F=1.>YOCH\\])]B^HAQP\;"TQT!]OOSJE64LEV:E8)A"_L:>X,"9Z\
M'/"H7J\!>X*89OW0F+1-&]#KA]Z1=.E,O0#;]]$V:=D'U1S.@8VZS8*B_OW]
MSI$SY,";IU V3'AL^/5AG[!!/L[$Q1CSN_R?*J+^R#AJ]R+"8:%-QIHA4&/I
M$T8G;D[R1R%D=$L(AK/$L@9*XL!ZR9'W':]R:US=%+<_LX<>?]LF@B?J<Y>U
M3D&<I)%P'] 6&'@!F  %:XVBNE\IKHRV/ZC/4;C3%L7;=.\7[=?QB7$\Q"E^
M_6R$,4]@Z>FWJ@7^ZE+9#3%V"0>'9,5+PUZID?;_:?8UK)3S#7>$33VST/R,
M=^^*>TG<%&?>Z6>&2/6WHGP%@<W"F+BLV"1GNLH]!AFL&KX9=RV58= B5!%<
ML?9,^:X:K,J:=*R "-';V7ZW?R+0&Z#S\57MR"\YTQ[::#^0S=WPLR/V&Q9?
MEA!-5",-.9T_B(]W9U7+](+6GHN[=SKMP[;GBX(7SF3G1U!#\['.C01T#$(8
M-FQ8=H:2$7;./*JH9TFPCR<\>PT9SD/_U)D9ZUM3UUJ[7_@G%+"UP 7*3:H/
MCN1WX#,]0GGXR)CY^&?"3/VC1%Y_U_(FP;@7/T[!4PZMS1RW+OBY67K%N48+
MS 387@"N]*?#7^"Y\[A>$[P+6PTC&)FW3OUW;-7QIL]NRTGLM\.WGO(RR6$F
M@WK9R-PT]:<(+@,IQORZ@\C[1$U#O'@3U% 4M<Y!CC;1DZ0;=3"X[,?TQ^FA
M35Z<RECH9$]U52QT3Q8"-!XZ"+@.JZL5]<GN],R*/$)X=F%?Y!!MR.DA=>P6
M]D^.DCKG*BKH.EN,^FCXTBC,ZE9K!!"YA&>G;*9O%U5DZ;.+:CPN +?WB6_B
MN5/F344^/WLFC4T%^\@]1I[?9:/7P^!I;?\@)3CIQ@.:-H.4_^P4H;/2(O8.
MU7-5@:.$/DB_C.=.8#WS[T[4_V'MO<.:ZKI]T=A00>150'H1I#?I2%<$! 2D
MAAX%J1$0Z1 2%0%!BDA36N@]A-XATE6D!T)OH4A/J %"N.%]]W>>[^RS]]WG
M>>[]8ZTD8V7.->988XWQ&[,- LC<-4 ,M:0Z&:945\H:+/#]Y;Z@K<NT=FF1
M(4:S05Z\KD1#1CRKI?]QX'8;6=$<!JN2!KS?'LIOIC[ND;4>H^_VT\>F8;KT
MZ5WNR)3W@EWM!( 2-R@ F$2B+&XFFS5\0:=8-CHP_5YXTF>E]1G$WJG@;%O#
MAPFV$O%9J<>HSQDR&[Z=4/,%"AAK15;^VQ']Q\=\HZ?]@4(9JT.&R8<-QU[*
MUJ?Y350E+BITKU[BT+,.#1/BKU'>^J-E31YYA-G6=,K0]8[#+V#QVQ1</<#J
M'O9,FM8TWV?H5]/>3Z:;"E]RR#%M6@-;%0)A=!"1:E>W$7=S5.@+^(H5JW3Z
M2$%SM5^74;:030]&K[M0(^?/Z,'G@&;]F%<.<88G-[2<17LJ&-R&NX+ &[/!
M*C1A[3$WC^X^.BWTG0L<#0W&830']J^7ZJ8:"K%V-6K^W"M%EG&TR5T::NF7
M[^=)WFD32A3"*]W0$S1+3!F\*^"4U6*V0"ME.*AZ/HOV?**LZO5D"_Z,R]E2
M5<\N.A3-...G13=13?O%7H8"L@Q>9CADE"A1S*L<I*#CI(<&:1\H"(TA-[/3
M>2_+]5U8M>%0:K 297JH5(0)@9AXSELNO3<<5A.R\_0RL#FX=-\+7E&TI[CA
M<-V6H2H'(?;[8&*9Q$5@T"5$S=?O39M>J0MY5B%TDX!89QGS%O).GNX(C]9&
MSY&LUS?N\MW)IX"DEJ8EJW!"12#*#01/K-# CQ<UM^&<MR)OC(@1+-F%Y>\E
MJQP$I\D8A(7Y&H R4-68C4-W/+@=^ZQRTEGI/1/+\U8(<+EZ']$7'J0H>U]"
M2JR,@NTU>,_J)B_CA%:/.;<DDJ"# YD36A=XAJ3J%FON;4G**<#D3WKFDC:"
M<P@W'R=U^ R"K-7?QV"6]W-/HQ2!\PBU[XD^IF63W:7O=NDO_49F+XK5A=V#
M!QS][KF/%/R2U8Q^=ZW4D"[<+XIBA/&/0)4!Z('M :7\H/H=JL\-FU(3WS"*
MPX(]ZN!U#U]'85!'^\4F#)@00!Q_>MWYIIH/TJC4MW."OZ$Z\.NPUYH<-GF]
M';V8D/X;OZLHA+QBR$$'X[Z&'UC^4K#J^[CC[M?-5&^C422P!))C_[N4SD#]
MRA5VM($JTW%BN#ODPP:[(^(-<.9F?4A/,20]86;@]:S?2Q,!J3<C[4;%#>B=
ME!2!5SOFC.\VK6HRQ$JE'R<RW?!9'P'/B")<9V:>=N1@AYJR.PQ*9#L-?&(>
M6M?YY"I(^1%2Q<ICE/I 6F4CF Y]#^%E'>XA<>O<EA1I[+QQP;$QG 9K7HVH
M$-WO5K/Y=F#&;5?# \K(_9@DO!$6TG;BY%GS>A1*5>\+=#@*C%BK.KTYT?EP
M3+'?8NBD68XNH6MQ?'VXW2BW@D'1KIJ'[O4#13&$%EI&*W%&8GLHKDT>/+-^
MNU=NULW?P)CW-CBI7>_C+198ST.;\.Q5YYPQ33=E!X.> (PH5_X]?].-[1[<
M]BW+">FM[EW1YX(AK/RK6OI937$;7?]]:!D!X'9%Q-G<PLNV8IAIPNWQ:F4R
M?1Y5WDC?$GTF@KFB?5;U)U3BU=[DO=>,\*)10QC5X#%K7;+R1%H#(H:MJHXA
ML;ROF=4AMT2!)=PKR *KTZ1V^7Y:^8\I"L3L(WGVA'UZ[E][XQM^5+^U7PV&
M9WHI;C'2K0F)IS]<B*'ISYJ1K!.N8(WT*7$Y.%73^V1<ZY3[S#ST$OO($HD3
ME] 5YV5(Y_QY-Q:D^Z%+HV@Q/7*N4*O;I/R=NG!LDTB-^MA,:$I= *;(DTJ=
M:K=F9/'8-!2>.3W[E*[M%WRF\VE.%I)7*F4,8>_,L]3&5<B9RKP_>_//>O9X
MR*4KH2[(4*+8S1C&V.^Q7WTW+6=_M8"9(@[ZORBP[17NK!U2\F=/[;&!>^0I
MY?=;:P:WK&_R4.U$[X]#KE:>P$*C3M&.FW?+J&Z"W_HMCS89O& K8OGD^EVG
M]K-R]9X-/*\UUT*3N@I\VY7)A+[GZXCQZ[48<_#JHL_<:KVQMSR7K6<OCW+$
MD=KD_W4'P+^3#.DI<K*2?7B*$\9=9 P%AT6=0X+ C_O\'Q?\[->.PAX5+?<)
MA(H>_9U*)&O0V)4]T&0A/E1^^.M*@J129MY'THO]XB[A(6&5^]AFH'A<'N3N
M&> *G17$C.!\!@!IG0$R@9,UK\\ '3'D[\B7I$<M@N1 +4IT]A/L!FI]565/
M\"3ZEQCA\RK'_@;\A\'OF_"&6*.?^24FK]1T%H>7;^>9W HT+DH?D>^ZHK44
M$6UG\K2T/-:PQ*_05#X@;S8@C-OONVU^0,#;!X7TSI-",GT?.UPB3P5.!7HZ
M11S&1QC'R"T5U/GOQ+#2P@G[ 0\D;4(F<;4DS3QDKC+G&>!'6A!I%9FB?(?\
M]6#6"/3BGU$@J[]'@3B47YQ'/3""'0QO-T\JS'0>NE;JELU?$GA;:'AY02.O
MJ]/_*D63?9%2?N'1^HG &:!5B>B+4\.RPQ>:W;:F-T3>7&P?><>-5![9.@/4
M C<F%V@FP.VC,C9LZ7)\M9\?[ :P H<V/80_A?J\^*,KS>L7\T,;;J<I6!U9
M?]LJ?Y&,R5MY27Q%,7LG]P/G./ Y<:3KLGCUI"54)9]*!PT!L^X^L7P&2$<<
M#2?NP([6S@!I8HZWE>+U64Z_0FG64%>@+*LS["-YM-.3_*;//9,/'OZ4ZMW8
M3"3;WS>C*<R;F?V0I[A-3*0B55#VN$J2M_QGQ"HH&2IQ/A^>J(WG"Q>M9O1F
M<8CVF3[IT]\]7S3]@)4YS6V9]3HC5"K5N);+P'"*^ 5$N'?8^1'CXE*SEEUF
MJX+P MT\ \Q]5:%7Y,,&20(;1E[(C%9<#2IY$]2 67.9T3\#*(%V\X-*'>9^
M=00Y"WIPCW?@X!&@2FEX!_+#YOSZ1T-=J[S9!V$08*M%+?%VTH)/;$&/3$*A
M&G7C%X;+H:V;G\'[Y=8)%==[]0_"6:G[.H)<4NEJK]+U_SKO7VOE4_2^^LEK
M<O;6M,74ZG7^P*_=0!LL II.E"?XSI\!0MA9PM1PG<EC9A\N8 W>6M:7QFQ*
M8-GM[(:E/HU^[-1\P5_PI3L5\^^C*QL_H"YX>(S*#OL@:I:CKQE2>SH?H/(#
MVP6[3HP!X4#$=PMG "_3:3L_,9)J.:Q!)<$-^ M(NA>C#?\>2M:_<JG_K).&
M@HEREWC+O<78_,#JB4_<JP,#P?%,X@IOG0OJG3XS#SVI&:C:\6"%I&*ZS@!5
MF(Y>?2M\4$M:CLVM[-H>16T_Z1&BR6E1,GW#X%Z/?E6WG#C5QZ,NOU[(&2!G
MM=*B:M=:#V/8U]GJYK-2':1A_C;>?K,(J9:7)AM8L=]<8EJ^\?'54T?Z>IQL
M*QYB@T^MJ53UR&_!]<G-8=@6A%:QM4_V"+V]X\\5<Q876OI.TZ',[?,J5!-@
M#7'JS<7G/[ZV<ECL[0KKEV4-!51:?%D*7TL<3+%D";09X'Q(\-#+3S=+%IKK
MNQ6?L?F ;HW_8FAMYBJ)OSQ0A(Q?JCU"'\EC>CF840X]0<H#TWZV]RJF_+KI
M]^6Z\:R4NV(L?H750MU#;2^X%94"& 437A@=NNOE?795HOEL1^!;F+YSIZ&Q
M:3?[DL\ &-Z$IW5^:I?8YRC4JJ ;Y%^FQ1C]L#G@^2C8#Z0U@ASZOEJV;'1X
M$'%L9K?<HJ27((L^HB7=8:Y*,=*M\R3]HCW/X0:C@A0["JEX4_U HA2%<,#V
M9#HC'9EO[@]NT>YR*A4OQ+QK$1R&Z)P\(32JPW7"$8A2)@/MR)M@ <?[^M,A
M@Y'E @IF*Y-=-A9NX.O=([J:=MAWA=94?AM\IDJ_DD\P'1S7JJ@?=8K:#C]_
M5)Q6%)P\=P:8_VO0ZR@BC9=QD>W@QFA9+[>!C3AZQ.3I47\[[+JB+EYF]^>0
M&W7I<.)T-_U>?KO8>)+VT"MSB"68/=LS)N%CGU & >3HFKMNU.141K$:+31B
M7KN;&CV"Q9:/Y(H^WHAT?*!$PX6OW>B9I_9LWVW-=HZ=6'MIS].M35A>&\6V
M0<4;<9UC=CPM#Z%=*"UNF$B%T!+-!&H^-?G&U4[F5Q1K6_,D[X<_$!)-+[.-
MQM&^3[WRABL5P>WI/,TXL4BIP?P?ST,77BS'#D1B_LC$%EJN35B7C.[>&X^\
M,^;9)[1;PX\Q'C*Q7&Q\N3Y-[8VZKBP'YKBZ11'SIL*E[/?X;FI<50 P_]N<
M_4?M7*5!Q!-/EYC&5:$87'[G+#4A1CMT&6M46]T +:M\J^YC\"/IKY)!&8*9
MO967-'[H0\8FCUT,.F)A1N$'\_4D+]U6BQTD/<&U2N$@<81R_ SP&HA ,R3>
MGWUD%WO)<;0ZVWP(JLYGU]'Y8_8Z(*UWJ!G6?I WVB4!"_<T\T%18VO1%HL_
MZZ__T-=>QQJPN@1G19J.190G:W/'(\LF!/: U_^KD8'_DW19UT"6J=C:A=="
MXXVZIE7R>_7BW\U%=Z(SLY.?]+_L-$D4'HW+<VF*'77C$\ZR_\FX5Q3WB(GI
MVA'+>R';)^HFB<R='4OQ^F+XL'9^;[F703+BU(-_2/O+<?V!<[L'2EKLR_:*
M#9$1Q[H+DT.58EX*+--=@2\3?IS\%N)-5A36 S''I*?'X!0M)M:$"FX_:Y6E
M:>A.3G)_[6DICVDU%Q7-:PS=SS+8%083BS^BQ:K3*/]8\J;PM-V4G1M2E*]:
M,R )ZTX\I<P'%_S"A36$;:P,UA6J5)<$L,1?75>/K!)V98]W94\ G5B233:\
MBOB'A!D^ ZQLJ?1]#FSN8:2K!IV8#A*BO3W_4#NZ),]DVP>[YC=_5T(;T7IH
M+V-^H?S;3L%"IGA6>>TS0)'S[O<Q25,OV/4U&Z5J=Z67PU_Q_?1_E&\3@.[S
M8R-BC*!;I_CDF\EF 2.D*_:SI NM3NF71HA:]X"N=RTU%9IJ]O:0M@,0!<?Y
M$Y.(OKMW-/O?H4<1S26O^<T^:P1G(2RB:;H*A>!J(:V/0HN!4]%R+FB/$R-L
M:$DWHW2);<#@Q['L3O-H1<-NCFHSL_67T74=W!;ITIE >BZ$4^PPG2 Z.Y?R
M/=S8J]/[W%3;1^;F&\R\E1(F+3D0_A[12D-.E_0SP7Y0:F^>7+VL$L-A%/SO
MZ^.:)N=1Q-!<(GC(<IMY.;0;&4GB-U"GS^SX)UWT/\>;,\!?*HN,"9;S8L>-
M2(3Y^104SHZBV>NPD>D@%VZB6@5HRU!AC3^K41_P[^GG_G4(R6R?/D<(]I%1
M@;G9R-AJ)OXOP[FA9*'XK;H)@>^VD9[)%[%.G7*#JE:N=/,:P^0/QGQZWB2*
M3U>Z;"/\*.*<LUH]JFS3JH8^.Y59.?#GSPU=X2)?P\201E0N;4 5(0I)3YNM
M1+*8'AKT7VS^Y-SG_-)(I IWD$#)T94\\,T%I@CE'P*V0T5&O)RZN"OB.^K9
MP^A'B1=QK"JT+<+.4/8&0]=21@I.8 NL58-TM1T'MPDS'GXU]K-0/#92)_4+
M> (V]VWVLE>S>QL*]W5V3,(E<0@2PS6'T91)DHL/6N=X#1$EP%QQM:TR4-:*
M,X#!Q4B@ON&/+LVI(($0K5*[>B=9.EMXL"K%IYM8_GQ7*5<I,U$R)?UA-L7;
MNE]D"43O7>D:C/#(>DN61]O?XG!^[?RDEXY,U:.S.__9P^3P?5V;P?-"*HW%
M#BP2QOR*R/7%*?&I7CGGT3T]5<2?%VNVO(7#P)=Z6>\;Y<\ ]$2- 2('W?OC
M5=NO-P17FB';"S&,?BD+ZGN?IQ_;#AW:"M!&(LE10L#-XH63_EJ_+VH>E]B^
M.S2.V>F8W;X6RO4PA/Z $<(F? =%=[)G$Q9C22N8K&G'T-YRJQHWQ</M^<!-
M*RYY$DLP%AN*$,HS?./K>(VL-IQT!CO1I=GXDC2CCH/D)[R@E%5=]9_C%Q#J
M;YSQLCJ?/]^J.T\=T-96%K=52)]?7C@&*5ES*C4BW6&+A/EKY=5V;(HJ%Z #
MF=."$])<Z8/S"$/=)MWQ,J=@'UDMNOO>Q#4>!K:!D P[0KSL:(2@ZLK^&>"R
M.2'DTT]NU6G-I$XS'*83=<N/UVFO<:P\YY%/3B\Z8JRH(>^;>\GD5[>D &Q$
MX1N3&!Y[[R/FX4)!M]7TS7D.1F>H;-GN7GW'TM7M!W_ CN[2.S>_>2,@PJ/<
M#</V3GM!DZ7<5PN0^40J;*_"PIW(Y*AW8]E+_-.>(+'HGAGZW>%1&J2[T7BV
MM8EI8,J2T^2FW@MU_ZNFP3XGAJ[+Z?S;JN8W)G4B/)BR/G<M1+S./G^F$3[\
M4E>Z%N#G&PL./:NW !#/ *>-BF)%UA#M,,.(VZ/\<,F%%B<'%BTD>CL&3@E:
MB'GKOK<I;2+]C>'PC:P+$84/>[</#Y5O=Y+O;*J<:2,XJM_S1J)^23*>F@_#
M.]F2/'=9L;P)5FVW/U6Y*%F.<VB1VJ&*@TU7/8IK*E^+?&A?Y&L.<G4_>>1W
MUZS11>=S$'@7I3F<I2M_]7[3C1ZB&KWGA@=\&^J-_SIE7.Z]9*K="Q\T=[P\
M5V8F9Q!EKB2[CSZ^A%V&SW$PZ\J@YIO5-I6YH667.OVX2CZ=U(>.)X5:2*%)
M/QMD93I*IB5T31O>'QJ/W'T"IYU2GCI)Q@YICL_AAK\;'5A-#5B"R#$*DF!4
M;#U.?#;HRNECMAA/ <"/HC1+N<2OO5LO W8TN&_ L5_WO-!>D_$QP)<TKJ+0
MU36A:D+0B98U1"!1Y2+QB4Z46N?;,T!W!SBAV\T%;:G9ZIC>?[^DZ/E$7/2J
M^_J.<GI6L5,#HK0YMQWF*D@7_U(3_C5(W9([5STF>GP\JI,QGYF?OJO*V8-%
M71C,)7OY?J^?6!3TNA,,5UDB3<@#@S_J/1;'Y:\)S=K-A_AO1SWWP:M7QC2:
MF=;RYJ'7]%(@T1BF!:ILZF]0N*C0"NBC16=I6BY8Q)NW_=Y3AMF(0QB'55"*
M^BR($3K"W)$,#;L>57,4G'Q$U&R6IEW?L=_ [98TTWQ:/%V)<#=[@WC O5M:
MG*><\-.,M&LHAD[L]<ZO5@\:?+W&XSUSH=RR\,:'EX6E&HUG@-!;6^\]MZV6
MBST;-I3CTS[N9R4&J_5"[YI]THI]VX5-7A1J)A2> 43W6Y\Y'%)^QTL%<O47
M2*/,6O@-!Y!#U;GX[ >O@M1.&)X4STT_U%JL#OJ)6W,G?,X"KO!M()$Z+T@?
M8JKO08'2AX?MO4#:;L?T<83=UJCOFHV,:(W-EQ,^ RP'7>]<K]*VR'>)"['[
MR ]0!<CS$>A]OZR9H:,)$6W><?!EF/<15OI0MB.-K;J97>=)ET.L=E?0=59@
M(I'^-,92YY/Q",3ZMC4XY'?R*]1N_U#++D_7LS8-SU1WZ7+"C.^[CN7;^=JI
MF[I$S1@G]DM#BG?G9$:\'?[R.]*P+=\ 8NA#YE0H9R%J>#KXBV!HF9Y#N*;V
MEK(@A!Z?'][T7/A%'(GOP\(#U >1('T<WUQS?CO-38M^?THXK83MLL<49L28
M#-D-#Z:F]GD(L.]R94=@5-D'?^=N_.Z^XB$YY-JHM/,/ A>N_QJ8MKAO'U/.
M/=KRV3B:WRZ",9$1:YW!^;V0Z7=J>M4@B.%CQTBG3GIQ_7Z54]L'_^<E,A&^
M ==ZWZ0QL$38.#O];<@[&3/.K7ZJ4X:H3,1KQNSF"V2G]A^_LEF7R;;?BME0
M4IU,-0KA-OY94%S&W8<U5Y;"7_23;3=:IZ4WRUK3*E(6QW?&?,#^-55G&:ZY
MU05>0GYB%NN8#4\.KRD;N:-RL[Y'M?<]>,ECO.6J2+R-3%&,K*?]HVHGE&UI
MOP,!EF.YGEPU<U_CY-%4H2#RUW(3\" /MQT*Y1+2QT9INW(\*^MQCOW>^3A2
MGO) [/T,9_6@%POLZB_Q()?[?0$<7240,P)H'L4>!#^QP6PR&)P!"EZ,8<:>
MX_T@WM=&VWJU:8J4);S6YM?J1DUCET 5P& '/+S]Y _DX;7;W/&UW[K[R[P>
M( W14I:NCR9)?YTJ^WP!N\_(*LX9>>G>WOT.I:DG>UU-Z!E@S0-#OSQ+K\P)
MOT"X-CVFN^0W0C*W[^?1]?YUK*%0^4J4V8_X*/=*8!IO]8FQDPU=2QDN+\Z#
M-3FD^*-;4MT*17,X5,+/\$YY=?JIZ<'J!>-^0W6HWOHPE:[9>G_=.D-4BY;D
M2/&:"AE]:RGSX]*Z:DN+]0LL(K^OE"&_+4QYR3D"RK4\=5?=9:!)X3\SPQ($
M!=9&\TM(TR &3IQC*]4G!)-MDHGC!:A!0Q/-_"@<#P(2W+/\/ND-3=@W/AN^
M+2_B*_GG%M%PE"*EM&O8S*T/L]H9]' .1NM$8L4U05G+PWZ][Q,3D9#K$L(2
M/#]FIAM[>5(:>.;5HQK==Q6G-)C]+!45TW+SO^V$?:R:% 'KG(CF0?O]UL-]
M<":-& Y<XAF@0_D.(=9]/D4N:COLW@-_A^7F=1LRX@D,]"_XR;!E9]MO RL@
MJ)CBI;L/X,%Y.F:8MQW8Y)/(]4\5J_8[^1^C$C&!?$,S0<'4"0OWO4?4Q1H]
MI\6$%V*\P+>%7XGOO+,!8JE ?Q$H[&0_9,AVS2V;N*D6S=#4XN'!R);AA9Z1
MIBHH_;/E9MN958<0AX]1I1)7H.I,SR4CK&I-N&)R1W4J%6%/1IK<L2J$!$+P
M4TMK9;=[@G5(@X$J%O<;JX7Y9,$7Z"7D#$O>8(4:_]INFW=ZOGHBK$AGMS1R
M>(7%97J,#"9&G_U7.8G_=1C+FBXLW%%#1U=+TX6F58OZ,73&$=R.I%8M3V_%
M"(]L?)Y2]_\K^5(#]P#FW9HIS.G#5T)2.5*5 %[X4?I"ETOCE&CW!;Q:T>30
MTN8^L",I+%C(46)D0<83DLW),PJ3_B*Y3!$&U2T)1RLGSL1K:"F.VZ7(S GW
MP1'??DXV:FC8_8FNLB;/>4:(YWQ@,[NQ*6TAQWUD7:MM[H>BO)HU2/V1+N[2
M@A>*"N+/7DVW69[R0D-%; E4;',=_Y)="C>2F,]2K/7ZW5<!Y,_9Z/3+9X 0
M3SSSRF,S9KDLV];R'<P@K S9I6LH8K&N@[D\9%8P[M[Z'9G;>[^\8] L.7 2
M=^LP@4[H.K<YPQ:**X*0]?Y\WE@V=ZIQ?-2Z+K6$/*B@EY\QFW4T9&H!8CUO
M?EL#[;4OXJ4O-$D?E>^BXZ68)%<':FE)6&,?Z?;[U%KOT# ,[/FZ>W>_]%AZ
M<^OI4:J/#3HM@&H$%DL&W::N+3FN#B=*;>40K'1A][.'I;MMAH8L.L':3AF9
M=5FIDAHWG2XJQ! .XE9M=!;<CZYQ( *FNXF!J*&FN(XCTH"*Q48;T?';5]AE
M%&Z7I 8/"0@\Q=J\P&V3U,)6;3*.9IQM41^98#BHG8!'IP =J^OB.ZNP/$Z;
M_&K'&6N6L!,I#G$W@1A_4<1KUY)VH<)V]I$Q/_>V8MLLR]QIV6=@P01ZZ=+E
M,8@B_LU26/O(IWG0S2B9<1N3TWTO7>UQ*>8='CX^GR $LT'F%3V6N^*J=%4
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MF3?]?W@#$0RA4F< >.S1\'$-%0F6<=Q[SILA.^^P)K&&(TW1+T6W_WC^")-
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MV)MM![QV"4R*>G6Z&&5&XBH<=N8]_@9SF$\:T_QJ1KPY)/SR9MP#;C3&,9\
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MMQ6#BI*G<-<9N3@ II@CI$%[\87FO'[,O,PWSE]%L7MT@3<.2>\9IL+V(Q/
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M=0ZX="9&)LT)\Q[7EK?AE<0Z$FK;?6]Q:-!ZV8X<>STY/ZE29Z6I V0BO.D
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M.MG%"9=L?M8 ,Q9JB^ID5KXV--B"Q@85' \>9*\;O_PM;.3S),\_?3^I2O;
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MFY,619->Y"X)O=ZAA_=4V'>0.36WUJU_H*ZA% .K4QI\O4>M/EZ#GM!?!P7
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MD7TW;>.Y1 *I5V(.\63_K=*NF@Y4KK7X>MY$F<28K+V6BD&S2/"T^&MHHZ,
MB[V Y64FCE$8'THRHS-2%>+!C82+%+09]:QZ52:";&\]7 +V;?&(N<?)8S!
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M#(A315RB*E-8\V$J-,"EL43Z[ O:R"_5:QBDSQ2H+KWMG5VC5LJEV/6I>;3
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MD+ KIR+Q *Z7%UZVS. [5,VO>%_GRYT2;S[?+4C>5HT@8DBFR8?,A[(#GR+
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M%.G_ =?][]1-V?P99,4_X?[!C'_ _4=_?_'*A_T'W#_PBH'7F,U+\M!74Z[
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MN'B2Q1/]!FXC-02= K^_5)Q<]\!D]#YQ4^2FXLYL#;P!O:ZM8M@(85HE0W%
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M<@OA/]&YP+TGXZTH1:(UJ4/;!+0UBD[T#:<_J*8OY9BC5"-\5_UX[(.!31I
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M5>EE*%#-N1PJ9'X[OGWNS.HUY*144=T*>V69GL:>EN[K5TH#=(,,3@2?@J5
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MP(,7EVH?YBKQITOTOS@I568R->G3-;LO+?IK9VL4J>P'(.IA^H-!=DB6C:3
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M8,Y$T/(;Z,2D]M[ZG2(L<E?AKHZWX0?B;7PWEAF=$%&T4%4JOJ9J:OKXVZ>
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M#9Z5&QI928W! :&%*[R,^U*"!S4B.7^%1M#E*@1ZDV*QT_5*CC:6W/D_5G/
M&^;4N7(^NZ6[#HC(1ZK?FX7,'>T9-^PD%86E&VFKU2=61B;H0XJ@#ZQCV^\L
M!;D'&/] -SKB7?/M)YQ#A80L#7R>LSA90C3*]H\-N]!O3@&&:2*/]J?J;I8.
M>VU95[-<M.,?:V5WB&K_?AL=X:(99OI'N>*B2A9A-/Z^/7G&/Y;52I:]LKD8
MZVS)D= HB?NYEI4\Y'>._.@$1Y:,7RYBK0#K!,8?&3^ER36$"3(S,-)]_I'=
M*LI6H8..K"@\+\5ZI<;RPX96F\-[_-%WS^"'>$B>N:?.\,R&2T3KI17)38&Q
MK9VLD-7:5"!H=>=?!N2LS LK+7=Z/^#^6)!W'9P"R-Q**Y!Z9L;6N"U)"%%5
M\;9-]=*6N1AF%O<)U<B$3]9'5:P&3*V+LUIQ?OPZ,C[6GFB^LL.<S)P [._C
M]Q2([O6S]NL%5B6T.(>G,4FF\*R V^ 2E#'/Y W7ZIIN3V3F4#Z-U(OE,J94
M8,F:U&B]Y/W;6P>=P&AT,2KHPV@"H\7[JP?I^>Z#"Y*4;;AT.S)^SOUQ-]\J
M $AK?CA4JAZA>X[/WJS"(IRR!>0>N*/5RL-WCLJ8WIB,% /J$)]G\F>U_;0?
MT R3'BRYI,K7SIK=*JR@6V)JFY5K0484\U6LJFQV*TONBQ_OK</<^<4T?G*S
MD--G*+Z?:Q'+:"0L_3E"9RN[S;;$U$DVMYWU[AN[WZH<)=X62#F07=ID.#KX
M%RPT*3[%,8O_=_K;VRD)19*A;TL;SFS4(?BZM"O(OQ7M0T\?G03GO($M_/$7
M$PQC13KL,$ ]L!<#B^QQ^1>.%?V-F%3/W5IN<#[C=E.AVB.1.;$Y=F*][\)*
M5</JJV2+V,1UU-.*"NML*:16D.6SX5(['$3!H0,XP\0)W/"+]>/2",,,2Z:4
MR-@?7<9DC,0%NXBI_CVC'J@(\TVJ^*.OA8EIM=F201WH95SG-Q*6C-".DM#*
M2/%?N/_/ ZPJ_S 9.4X2*O)D_$5F_A&MG?ARM7=4_!=LN?Y.RO92)+F1A^BW
MY]\:PC9;"LEU_C'ALX,."_^8;F>$4[8-_+E&GZ7(#:A)ZN9EO_@QU,JR\$>[
M:,OZMXY0\4RAN'EFQSVL\S]TDJU_&A"6]O^[JH6(WQ?MNA2N0 1_,[,^0*<M
M)2F6WS>UYFNS(SW/["9/#6WP;B_G\V_"$HQX2+?C<./SK-U>P)]] G=.TA9B
MFV3,Y<K#M]@"I%GU_>R)R$%'<X+>T/YX<)S44$A7]3/U5MBC5%F,$KR%GF[*
MSCML^WWZ3\6],&(-'D1@ZU_HG] T-].9WJKH%5[M?-TERDZ;-*!$<[>XOQSY
M$O(!C@'/;Q3V+DM_RWCFLBX!4;>,&)*<9!IZEZS @KKL?+T-="XLN5N*9E2>
MYN; GWYFZ;=QDB=B[I$UG P0RT7;?V*LJOQD>%Z>@:%;&O;O.MK6_X#P,VI
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M-Z4N..E7WJ)?%MC7;49>@G*C16C6L/;2_@_N4M=1;T%2&B7!"@MQN_F$B2\
MTAVDB1\MGC4=LYT@U'PT'OB8:NVY5=\5-[F1 R;UMUE^+TC#$"H+,@T5R'_G
M Q-0VY2W:/Q]\L%/'M;DF]D\3_4I(+=%V1 !(L\\?U,[',[#(/I.=GNN]Z[(
MF*K#I)E/R^"8$_.=GJU7&U_9YI?UL,ZQUKP[0W6@)XU2=\DKRR7BXS4/NH/
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M7KM8]&?4R'=B2 ]F6V1RZ"C5D2#4885?FS]T>IYSEW37<#6-R&A">MHW2:*
MI(#*FBGQ\_,S+H19#&+ &<_7?(X@9_)J8?L4<&^M_12 '! EBSTU(R ^HE0Z
M&/WT;;]6-6L\^GX 5FH3R *S@C!"!4NKD+7!TH--=^_2C15+S#G<PL,SG6X!
M*WA 8I!2)$LCFPE1#P^^&#. F,@MUX^R4-[I-C,BOBN)RT>4'4IT8YZU#J4<
MKOK9D=H@%73Y<VEL1JO>@3M$W==R'W%2QS;?[0V.9S](A1,DDNV*C') TX@V
M1#B$]D#$OU$A337>7>*^Q]WN-B_$;_HQ%"ZB')\]#\,_% %4U5977ZLH R+;
M!'IZWY0F&=4JN)T"),8[L6]SE@(*#]9(:BL1$S\QLZT"*:KW?YK,UD5'^6$1
M([/CAVT&IX ;?@SA!"^]]W72L?T:>!,<"D_O@MEK^]2;,Z[NZNQIK!H_(][,
MBV)J)U*=9$G!/AS:.8CWO8XN&ZV/(#%-AV64TTC::T_-_4)Y.=U[5P 5/.R/
MA)0J9Q<['!<C 1-1;(_VT(W*F-3X"7 KK7QK?R_E;AOX-VH$<ATVEPY>H*7<
M?/V:I]S:++O6'?&EGB)G?>8./C%[1BUWJL>FX3EKO/C]"P=] E#@J*6&)D-.
MTDW\[/>^"G-F,S>0I3)G\XJG>Z<,Y4D7L<=S#2+I-PZL_&Q^89 ;LQ+H1(1?
M+7B=I"+'[LVV#XZ:N5>+=\70>6UQ._@,5U]XG$OIB>B<=FWQF.$9!6H/KS@4
M)+(+;[X%2\TO?6%!\VSHC2O!8=(]W$'^Z6!UJ9I5X&4_1GSXPF$4VU^0"@&M
M,O,GT[\427''[9C<>?, #*SYJEWM!6I C*C-0H%E$IYZGGXK?!X1*'_WQJ@R
M^^YV$V6\[3!T9;3A^BSIBKJ-5!/7ZNZ]V,BV6M<KLCUZ-9;4#V[6.+ZFHU/<
M2UD^3NTD>,,Z+R5L0!)A5TX!BQZ#R(U:F!CDVRF@XA!^!Y] X"]&LGGQWR;D
M(&45!<@$J$FIV'B6:>;V)V7EH-K=+^HO;:@:QMN_]HFW-CDX<!T*--DC,9&K
M/EGZG ]WP95^UK!?]Q75N8C&/X8LXEY]Y-$:BC9N%#VIWW%#7.2)S#;NM7,O
M"8G1E_W5)F%..0^[X%F]8!B1[K^PY<$LD9:ZC1:_#S1>Z<9(- V[;:Q&?>T6
M#1+^_&:?:2;X]RQ&BU;8!MM6-OA7-PVN3;3EC:?4)FJV1#D%[<P,F4DV:UIV
M=\4GX9#OD9?V9P,;J88*%RH??+]#&3^O)F2^,_^#<]1V/'GG)BHZM(<'RY"O
M,G'LVYZO>4XK]3KCAD E8L9/T&\40K5%HH:JLG%4^.EXF6"/#'_#RD\!F[JY
MT"=XF]R-(>-@+Q1W00J9+L=YP@Q'E!6HPQVEU]=G.R;*'C'(\G)%4?HV$!@F
MS>V0Y;A0RD5QX[X\B9L!%PQ+P]KT@RZF/.Z>L>F;QPPOA>=?%KK:/P['N9;A
M*5U@W%G*NF9OVD<;RI_VI(I7P/.L\Y?CZJNLY5I-,-(QQSDUM.L1A8X0*2W=
M%C07O_VV[YT(T7TKQ^M/<#_0NUQZ-UTTP='5HL>Z#OM<\]7#&ORVWRYDA!D#
MSB+GO(>P3YB$[,Z)_5$!55R=KG#,U;Y/.ZE1HTHC'V;,1Q&&S?V%H($^:"0X
ME=ISUTR^_VG8-GL5:9/&LM8HWF#&?FWU9QJWP\YZ!Y;GHUOWC3">W6PN]H*A
M7POK\U:90Z7+:$Q8/5"D!6J)0<XCPB4A%9%O5:+!QR7T&AO.BI==!)S=$'I#
MR@SK)%:"V](TP3R]^ZY7GT!O_0.LZN&C!@?G3<W0G[)35Y,.;PA+97N6SY6R
M^CY6MH^N[#* T%M7Q_9%OCGXO:;,M&O:L"R[:. <[,=GOH':L#L)=7&ZW(;^
M:)AC#[E<*7*=.W"Z8:U2_W8J2'M-6Y>!!?J$SZJ\H)#+5:39CV,8H:ANY_%R
M=^POF%>K3RS=E_WOQM)QG'"KFY>^B3YCB5I&&/99",@/U1R.W;S3I+MDTM#V
M1S1<5KKV?TT/EQ7,'H6YLG!SR/:;VB*0R,B.\T ILB],J[4G7/N0-?,8VI Y
MVJA<'7@@'35SCK#6=M4GZ:3OI,2/NA/;/!^19 HNF:00ZR\Y!6P8+E']!+^7
MF9'&3U7=.(J95:FG%L_KN"5E;$UK[[MU"K@PB6=WGI\-IO^^X9XX0NQIVY2C
M&&U$O:[FR</#'I5AML.M["R=JCI*[\5I1[VY=Z(I'?)G5CQ._W^N@?Q/"6:!
M#L0GY%SZ+& )'XD9L,&<U$;JLT,CJ+A5?'WU#S19W)3NX29>71>,%G^OEB?)
M( 1?D3_N,J-;]Z%&X/&51Z^.PXXM<:PG:0=((%%[L/Y9],YOQRQ.=Q576"75
MY@GL3*#=_-W7(ESS[J];V(BD$\F3CW[4O1CG^>?E#>RY-2WI(9LJ)MXLV?G[
M5@T?V5Y==K;UE]4#,.KBAO+R9/[N),N_/ANR$,0(^/]IXKZ.W7#!8?XE--$7
M>WZHZ8;@X,W' KTH7%B%%=5A,"8/:?N-MNX\*$2__R)>3>4'IBBB;*QM5YRF
ME.F T?:E[;RE<:&)8ZK;AGX1WT.#4BJBI'[NB>29=Y&@L(I30$Y:G#/]Q55>
MTDLL22\-$[2J!"I?(.;[/*$B'L.\$"4M9+90%#F?401:RUU2^Z=P@2=>Y@%P
MCQZ^^\U3Y@&9?8;"XD!V[T\!:> =^I>AI'=DB:U9Q1@V!.Z"XVT+P,=V1P:'
MQ-M)]"<4Y+J;?WF3(YG$O)6?L/[<P^ _;<B= O[)J7T*H&6R.P4\!=U;A<W3
M_ :M<@"7'N)%'H#VZ."[F6<J8>6T&<YV!N+J2OL6LT-'R]<(3@$N-7SU-T_8
MLQ_(L@\QZW/+JN.C==%S#12@77*A[%/ 1Y'[Y'Z^@\7=Q-,?[9.P/C3@O<RO
M9TBHY)6-W<WZ$]N/W2U.)EUMH "22Y&.<M7F4L@B2(\\J"M-F8+D"ZI7BN(]
M&NC^ ]RQ^M\]=5CC73(S)-Y6!O83 S*)^;.8CYXPTH<!DI[K'&AEB-"ZZ0+J
MBP*3V.ZA!O]&!T0==&\#]9/$2>[0:]AAKQR4?G[G^&+[D7;O/RBT)*/0918S
M8- 8XZ<'^[LQPU>*_V33"Y]SIDL["E(Y!4 '^O\I8G56!/1/D56R0%H $F46
M+IA]4SP-O3P_=0KH$!<A+-=GXL(PVPF9=NZ1EK;QF],:8:O-0S_1][YK)!N*
M?2]E_+:\F )WQ8A$"4*]7J"DJ02 M&8\$UCG<?V'>(L="J"4CQET6S[B#3YQ
M,*ACLWG8C3__\1\]6S%#UO\7'=W_9B*;6E.CXMS1 ,&#'M^Y$Y1V<'8@A,IM
MX*HT[* 3]@G1US^))&GYS.>>0'/W$ ./80MM0Z0:D5TF,YJ$%IZS2O*E_D])
MVH3=\#.*H6Q+_)_-.DT&H#\>IUZ3&-A@;?#\7\1_._+!W!$S2WJD0Y):$SJ,
M?-ML.=8&8^2?K2$)?'EV+/'>#O3QA-9/S@]UE?C6&6X\2^1*:BRBBS$Y%'#J
MN::F5&J<V1];!K)$NIP"0&]@LQ99_B:>631.<UPG6(@_T/HD\Q2PJE0$FR4+
MQ!#=!%SDX*;Y5F61N[Z6AJI1VI*^)3// ,YY*YM 0;R/7\(&.5_'N^]VC-4%
ML7XZ?]&O\C#X%_"*N2?U/&]PO4)>B<\&NUN4@>ZGQXAF<. LB[*D9VQ[?!)-
MH^1(Q9$'7%PA]YZ:DEC8R3#^84(T4?0WZEF-3$(3TYX3RV)-N_&3O/%UMW?:
M*NHUW?_5390-FHH8<+T RGT*,'0[R(-CZ3IA-8]W\C+"MA3_RTZW?X4<W;7*
MKSC)(+2VIHJ%$S=CQ;/SVBI"@/]51//L[)#_143E7WG($1L\_#'DJJVAL<.;
M\GQ=8\8E!2,V%R<A2:Z%Y ((_C[T-50&*,90)S5L_XA-.!=^-#?;50N9$/@E
M.F;4C>Y^!W)^%!$V1P3E2U?.C5=_G09?-O5!-\ZDJ(1DLG4/'*<^-=KM(+K@
M1TX!W-X+I$8X*1!"IA_EX(^.4!CFGAG=_E95HASO&H0;JG421N+Q#$<SM>5;
MO>(<61$N6I5((J3AG#$&^9B=GX^>C Q9C<H;1@?F<AN8=C_2B-&ZUT,L.\E1
MIK>'72'=60^)UVG-\OKBOZ3*5!"(-]"$:F#&%=.JR5]^NN%Z_U8L1H>PP-R,
M?RTIX!:K;3#EN=S(@P%M2F#!C[!MX3[*\?D.SN]B.ODL?]+&M@G$5[$]*]@6
MR'P\K"6?6GD*H*1UK$HBT]W<NZ2'/V!XWO9F7Y .-F]D)T[XL*7C]J?SE#ZS
M6Y$$$+X</5V<U @,Z+5UC)?AG+N23V G]2N+XM7SU&1";EW-6/DP49LBIPB6
M,&;=$[%Q2),A32++NXC<V%>-M\O<'[M1!]R*H(^CK_1Q)C+L+ 1%^V1,>;JV
MR/O3:ACN;HVJ+AY;2AT8MH,_RLNTI=%,3ZR[7!:^$W&2#$>W,QV-S,/',M$K
M'XE>%PM>YE[2Z5OI";*RC*E9@&=?SU54<M.)J:7DEC5^,GW2J'QA71F(U4>%
MM;SU_?#S9/XF6R:!FS108HOB^@M[86!B3(7SNJHBT)ZP"PS>)9KCS165L#S<
M7L]%QV[N(P(;16&_E(EJSL4:4&:K%:,@!0J&CJ*[WW\7'81I'$[323Q]VW$H
M$I9VH_'&.I#6K</1JL3A*-TQ\.$V+Q,&])-5VT_(+O(K_Z>%/<3C8!P5OE2P
MHVSM Y>2B8LLHAAD Q]SOH^)K)#/#2GJVG#QG=7037EM9:OU;&E)($G4)%Y9
M@&A3B=>=$_.@">5N":W(WVKU>^L9WHH",A =V=<3(IFR6_""X$M9!XC?H(D%
MW$L4$9;13/5QBWBH3L'(ZT\)S4*6R+1^I3CY1!;ZZFW;APN,,R)TEQYH:5=N
M^[)B='7Q$ SX@::"H_4$#OWFKD_PK;+20\0W*#M:A(*H';4]J8$:7-'9-?JB
MO>MMN((@BH);D<>4<,(FJMZO#50V"V^\3M1+?HYE2A@75.X;.%^HA?:VKLVW
M+! V=LGM"DT00K@N CE5.,.Q&]KJD-<&Q]^FVDLN&*Z#/R+MTH(Y.3%* ;"F
M1^?J@J;5XDW=6J%/L<XX;GP:&A[:>'OD];O*^*[=M9RPA^V?8%>6BT O0&$Q
M?07*7TO54HVN.W3GWANVXF4Q7]*,MS/[ JDT;,W!UV#E%]?*?#/&D^U#CJ9\
M!;818VDXUQ*\S3P[B+'."Y7T\5%O:/L3E!B&%T?_NUZ!MF$E5&ALG;]SNM?7
M(WLM_OA&,EV:K?3D0U'_6LP^=]_Z\%17UDB-Q5L0>X799>6K^'B7C(F[C9I
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MEBOV%81@9Q8+G"S><DV_%2H.ZM[-IDK1V#&S6AEJ(Q,)1"N+6F$9+L&@P,!
MJ@!-T1Y>2/:?.,D;6U83H(5-7TQ60JPL'WGD$[@NMG]^(S='']DI=R4_(F]I
M8D+[^]W/(THJ;/$XN]DN/E3]#N^56PS!9&EES/A%M[#-*O10XNQ:K!IV.%6#
M*B^%,CVY!4Y!O0RY]ST:N@FFMFQF'G,UR=O>ED\X%)="VG*83VE9*:1J+SX6
M9IS6N<A197\^>TF#DSP[]5J-VG72>OSE$D\HKOOM.A_BS?(=_0_#-C+#^79Q
M_I<Z$$(/L$T\._S5QV -XCO8E&3M5=P,--A8FZ,B8TDEZ4:PI* 0(WY2&P@0
M=;I?.@O6J;Q[Y$$M98+8J!SH?63;A3DTYU ;>O29ONF;Z9 7#XVR&E30D*VU
M#(K9Q,C+DB>T6R2^/Q=RG!:0>Z_BJ[LF#PW5]8PGE&P=,MA(:]DH:+_>E[IU
M] 77=19Z_[VP[2;RA6E'&48W(F/D&A.THG5X*P=\4DWD3,]I 4^0'S+E>:V'
M4H-QHS&I.#Y9 RN&,XL89]NH3)SJU C+_# 9F'G;M:&E+K>$X# H/[-2#X1U
MU_\NB'4Y![N89QD)NSL[2["7*K_IX+AU5$E9V,UBU-S+2++L]%7#:-,">?(:
M]],T1Y7I/UUTA()X:B<$M90GP[+<TN4A/M(&\[KYA_N^I7]PX:^;N>)(%6ZA
M;<AW^"6Z"TCJ3FKZU1)&8;P->GTUDDDJWZ-6ZD>@U_0M2WH?5"F!I3U/55I[
M#WUEA_'PH):>77]9*'S689&B8G5A\]K#5<M]?Q3P/M/3/!=EY.YS#^#U]/H=
MV_&CYN[H\##L&3^[9Z;%->HTT]RC8M/'Y\\6'(_7D=#V5K#WT[.O&$:>^Z[;
MX>;AGL3>]A@'):V:;E6)]A8/27?O_RS#*KS4I4 Y=>IY0X])-U$I[T;C@!=?
MG-&FMD;\@#NKINRTMCR0O73(3@/YBZQ&7/9 9*.ZYGWR+$,S +^C[[IIGKKW
M6C3;=7JOS1/;#64W<'UBAL9%LEH3VG&TVJL.]TGF(5I]=QT.IH&!M":BBB)
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M&^H79B5GKR1O-,J/E$'E)KYF<%?W'!M<5-0 [:EAU)ZN28S^2P^C^O;*%:=
MZ;^+#X;:\BAN\P.9$.\H)W3P4PWKP=692G*ORNVJWIZ:,\BKF:MSP]!I6Y\\
M=.NCU!I#U&J@EJ)16*8#R;#]19@SS.;VYG2^+",P\=<.#A?=%EJ [$]+]E;N
MM5Q;AV+LIAP^03UBDJSE^0DR.XR^R-N@ J=1 8CZ"?V*(;?;D?RAH ?=J^*T
M;\KGAMH1QQ;]F"",_=[6EY<.>L!0V]-R+?7\>&->LH5A 6R7-UH*4YB@(P.)
M3)!&^][NCB.=OW^:15[(VD-C';WB@*Z_"C#3]9EAPLGN!-]<PL<[ KFQA'P
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MT:$/M3C3DLD.'W"-G%$<@RT="%6?KB[_I(DVT4Z2H0:&; =XOFPB))QVQJ[
MQOG2R[Y[G&P<B@]\<-A:#5072I8>S3AM,?JFE7T)HR@X:DK-*E.@1A*VK0S(
M 6FCS2NYQR[R'AZI@(9B63P1X8G[ \TFE.=8]OVX<XNV-*[@RN;97ZRF2C(F
MY^<BK]&3IT7$8JSR[S;6?7BS?B*,5D@L^2R[RNLA,AFW?#D&,G4?[XR>-K1
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M8U%7-(E9]4[Y5E_%@M[L"T)),KY#@!PFE,&R;.8](9[D4%T+576/@:IMPK/
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M[6/E&(B=08'MI%O8-\.<"WF0/,HU*MO/ CCW_4OO;3P.-&ZC1AN]98:7&<]
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M0B_8,0%/L%-A-)Y^AH8Q?', N^C/!'Q*H#=#W@*)AOH4S@=PEIEVGWS[T^.
M!-J)688>$] "6=WU_\)=NBE2 DCL#G8<1]1%4)28 %YX'6ZHX2 =!9HJ<X9#
M%A^T3VAYD.]1P=3S+!&6D\&,>BS%)/<%6&<=,2RIGZ0_G-/$QY[LK1:8SX*I
M)2L\)^[#K&M.MB[:I ZHLN'=3UC0,^[WN&X*HBCSYQY%^8&79:DZ9,\M&W+
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MZRJ20B6+G&%55Y@ V@%T[U870G9</0'OV;^;N8KS9#LC\!=M$%7DKZ!(^^Z
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MB(:AZ?M P[M@H@P!\;X6Q>T.3VJHOU?V\ EKTF9-;2Y8AM$VUP\,D>L [>#
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M)*<7)UQZ!O.+9GOO87HP\*/&@<&4WLU/%W/UM[/+?4T&0R7ZQF\L<+W/(*%
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M+W=8:FD)T?I0741/SG,BY><NA%.0 658LHT)B!FLGC@F/W[G0"\YTT<GZJI
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ME35L?*:X0^3IOH(YZ\^'APM\3YO8X5X7;$30R1OHK[&4<P[<DLWBFF1HYIA
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M2A?>\^<=;3<QN3I;J[,$4$#J-I)QJ(RJ,HOAI3B[$V4;E#K()TY)N/)S]6*
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M&YF!.^H%H:+>-9\*+)-/QX/]$"*4SQ/M&*"QX?!6VT>1H1O[X1.+X4>A(2\
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M3]\C9RK. ;*B#KBY+[&-9M\OWHOAI\2OFKV_>'_X&Y5C(:,F N_-4W!R0^\
MQH9>&N2:;P4O:DX7XD?8)13&B79]N'A\[P-8I'!D*!NWIO&=S%+7&Y'HL\:^
M%Y .NQD4_"(QP/';-I]M5-(>CS4NV,5C>6BRA-$EVZ9WUX_DORM73%=O1 .0
M A3/R>28DJ"SF7-M(X-XG=JWDPGC50AI"F*\MZVO!2-BDC=?\8FSPN><EBRY
M7N'YJPZ'MV4^MUQN46S&QYV+0"(90G(FK[W#\=!#R'M('K@E\5$>0< ^8?&A
MG:"_Y#Z/KN "PFY4?1-#FOP^@?AZP&JC!*1RZU"[86,EA0[#VXH>-JCIDZS!
M-)CKI9F)>ZV\L33*#Y(COR\A&H,MW@]<M1&6\I<S>NB]!*W3S>.5WT$=D_Z:
MG?JDSD9);X8P&.)?;)#9HK]9* ]:4=\9E$C.H%T>JI)]':S'57NNW>W=0N50
MD15-BC15^E9%/$]O)!RH/+9VYXE4M'9^4_Y'GC=UHLHDSX#8976%,"3G.BIT
M4^E*;I&3TX0X6%*% *QL;[YSN#GY!$W[S;L&=M=VPYV #U@@1:*S?5STM2$V
MVO'Q]DAS TR[*,?D^OI+'H=.W@Q2#):#4M?LY=8MY7\*HGHNEB J.X1TC!6$
M5Q.=FY!\+IBSUYJ;A$;Z_&X[[*WO=N/;1)SOI\EY>G0W.AERQL@F]K*48S@W
MT3GL5+<*9'&)@X W)CAS-&M.8S -X.+N2C^;+"F,A7ZNZZ7J)I0P2Q/J^[PF
M\KYOUM@OK-4&VZQE-\($-!?FSD]?CO_A_'2P%C="Q<O1!TN +>Z7&*H5U>$Z
MBW>W&8F-<#NR"NYPH_^9R'.C?M)?;[CVO?&"^ZK-TJ]0BZG-S7X)\V+ ON52
MK\WP#,O@!D5=UZ&OV/+8B*H&>U$;+C=J5PS?J*=P]4GGJF!>J+#-ZRR3QM=Y
M/CRF)V(@>XM !<Z"S6,?\WJR3>BP/4GYA9%%UNI-X[9EZ\?1E(%$1]_/+YK[
M1?KV])OHGOSWNY;\"4*?A4NNG#GK+RK3=?9ZYJN^,L.(]&O^G^9NQD4TYE:K
MWB"P%#;Q7Y"G$%)!IJ251BP'A,!]PDXNYPGG@65;41E<B\)S(<NFE4/CK+<Z
MP;VDT./>)TY$XK8T6:-=[!(= U(QQI?L77;1/%F^;.0GZ;2GY'3=BV\K@O Z
M@CZ-QX%0UN/C,@X],%<-1IR_Y6_]@V&^@Z2":7M(0XLKD]\J/;EM%Q5EJEJB
MMR*)J&85_L4MTHEFY)[Z$PYYLSOW55.37Q3X*<;<\]A&FVC&!Z:>E6\RJGGY
M2]C%WZ1?] *+U%_P)T*?@<YTK\]:$!B; YGA L[36@MK?IN29+\6[L=0X&F*
M.>$9WWM%PZ\F,1<EL!:$G\KW!EA.6])X;"=CHX,4R'L8BK-"L<-R2Y_1GQ_
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M!%R 'D!\!?.IH(?!1-^7M4TWWI=-&CB?.BF2?D3#<@1,NC4A9!MD0$_3%"3
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M...18)G[[3ZJ$7?R>J/S>E^T9":[KF>Y_K)9_>^%]+($"%5]H[ BD&,V-/E
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M:%)35RMEQTNE&.'%QJ]6SSY@,>.LE,N\L'C%;*$(^C7I&6'IUGHG%=LZHX2
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M(>[UU[&B#TSQ=D FY!K/*)X9EL%T[[!9$E[Q^G7?X?DAT1X%VCLM/O/P?;]
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MNCP:;RXS;EEHM+\G%CT^_O1X3/F%B]K3VD "PYL2/ J$8A%\!N<9)_O[;A?
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M"J=96USEV[$R/D516N5D'A#*)Z'Y0:29@SI)9T.H4W>8AJ5L2-X2L\4:4)"
M5^I@D?5XL@$#VN\X:L$43U)E)CL6ABG%:-_3"D OR#+.N<% 6:.LN=2-7=4B
M[DJ8%+X)F+&!0]@0+_QAH$UC"VI/@)^*]=;:QWHJVPEOF+:L-*8!A6%5XG5
M4;,YU?\EJR'W .9LF9#&-3MEF!%LY"5*2 D:*<I77M@E'FA==_I=:D$';D >
M48>S93U!\M*<1['5 S8M6[WD21L<KO16;NF9 DEU]^8/XLWS02_2NLR:1)U$
MG<Q7U*=7U.=..;H?1/Q0^Y'[FR-IOYOOW)S>_''8N4+4N>)PI4/;*WL+AG;Q
M$C<(RB_:)X&N* G9OK>LNAB^]M,BYG4)"V/S<^U> C"DWS4/; =!.2< D>[*
M^8'C !?Z@=.P7OX9P!O[MI' V"NG.;7B# R8=/V14E;D*#3^?PCC_O_=_9_:
MW:>JJ29,B<^6T1#8&[^2M3QIJASE8'PZ3=D(?;TBMO\24_JP!0YHA^[AJ5GB
M?NJ@>9S\;OG[&O:I!QMR&QWY[<[Z+H^LAF=)Y_W&;UD,3"R_@V]9"VS1&J1_
M,L[1YU](/Y2^P(;0KJDILR$7+5%+[W28DJ*'P"CV";;^$QL! ETD"&?;7A!S
M07@-$T!-_?#JP3+.<X% GC LEV<!0MVK#"^ MXT[-KD<OCX$);^A!0./*"BB
M+T62J=!62Z0OIZR!"'Z*M,2D&VRTLU)#09JY)9X_:)T!7LQ>-N2G-90Q;<2&
M[*H/8T.FI7E8J](D+YHS)@J_,J$\I_-W3W^.#;7=?#[\BMI!FZN.ZC1_@OJ>
M[24:X/MME@*EB2#TP31XA>(/(#(W'TJ'!=+*P,8FR$*4\TW4U :C>BX!1/N=
M&D/A]8!([&6OA8#/W$@6PH3AB6S9@"[PCKE[N W4N+L>URV8.$*YCJI68X*Y
M!.8$WMJ(H<:T6;HI'>)C(E.P2]S9+F3,LI_B;_IJ57(>FT[S'T%7#LCM3O4\
M9PT=DVT)R@E8J<XE6#QE0[[/D1Q!6ML%Q],;M^/_TD>GE>=^Z9-S9 &"-*CF
MS) "4 5M8?7,VG=L""[T!&4JW"8/NQ]$;X0:_%\&0/^E&,-_2QTB =[?9G]B
M:/S_5!W]<) DR.TGFL:_=ZR-N\3.7HP-V8:-0/VK68">GY=CLB'P@)![>.:&
M\P"*_"; /XM:;LF&(.,0_J/=,SDUL!$SBMP_F04N(-LQ!/,GH)ZRX2(TD D*
MSS_GN^]O4:5 C5D\W!S9]Y^-_-O\6P-ZPH$-OM$Q(@]W<KDFP D_\(O-8;^(
MW]<+IP,X\L8$BK[:5HP?52,O^K"P!U'$=^7^HSUS.36H?RKR;XL&G/CV<HQ%
M-,U0355U4V81A.X_E%E#E3QVS]?%D+G3+,2D#CCD(4K1SMGE*/1]4%V:M/37
M#-%$MD$%].*H)]!3!DZ]-FR(2 CI-^Y;>+B&-'T96BYM>QY=5HC5Z<'KN:^,
MC6#FQ\92>4D2KW+FSLH>OJYRVT%Z=5=FW1E[\T!5GP_7%">"Q4IDHM-WE>;8
M/6__S;D16JS>=/\G>]!+7Q)51-S;D,>82#*JJG1W /HZXY!4(RGAT50+YG]<
MPD Z;//0-]")Y\&=01PM[%"3S<E+1Y2(WC0;VX9&N?U@/4"YPK8@CI*'UO"1
M2EJ?X\8@O&U7_=XKK!V(',$),-W(]77JLFM0+C@7X[***R2/V*HX+_T'BYW_
M(=E)?V_B"Y680W\KHG" 9B#U7[*)_[_IVF)B!6(O<3:$Y>TU 9=E2GK@9,K9
M$.QCYMRL@3-P(8D-6:O%)R"PY-QBVI<5H PS!<=0!!A4WFX@?/ 6=#$ &[<Z
M9U#%.H&[%VM5Q6.>+6Q0Z<WJI^M0EUD?C]!X1Z[4)1T;FO4/#&^*P=V2C$[>
MN#68&C>B*Y53,-,27"\L%R[;[YYZK6M!2/JW+W>DCZ(B-:"46Q+Z'GH]I[E/
M=VQAN9.#1S>8%JQWY4;W%!>\3)Z?F-1PU;5*/&UX=?><QAG$7EH)&6K@/DJ2
M-5A=N[YTLN$'YYB=:(M]RZQ/L';W/')1MDL^;]HYU@E8O;7?]!33(--UH9@$
M#!]<]=^*/POBK&1H46+^6,M=&J]]PJ)D[. 7.SVZG"$K#]C&U*?X1V:D7"!@
M<W.9'9>JFG<H+%@M]]OF)J_8JS7:LH38D"=CE\%8G)O%8O'AR2DN^%7^0C8$
M_P@O[,A*P"E2\+5!:7(^%7/?-<0"4D@"U3 ^VVE_I$R7O4M0W!G^M*R6M-N>
MZ;$4V+LYN?VN&YE+7^PUO4N6 CVY3YY@VKWO+^XK.N32Z^<*P;; :>*#R/-?
MPVLWL$^GNHYW'B^0]1 ?.[-]+%L"=Y7U44.*UF1(BPO9(WJL(FSP*L/XA-[Z
M!],ER4,Q786FR;# ^;44V8O* W;5*FQ(YIV]EBLY%#8$V%7 T Y(LJ25907H
M6^+?;.SZTG0\SQ)0VEA'R?>STDR O/WE+ YGQ9'YEA.-!K9A#'A^AR574X-'
MU/T#IX6R/1!6&<2K1TNZ9"=?K%Z^:X#40U5>@[E$@9:UML.&*<UXW"P:C!=_
M78:\.1>YS(;T"I#@44K8?I]J/\(WUL+0I]#RALP77XK/]!>:$N64FH>T6IH<
MUW>LV'WIU/;,2RN!KK8_^(@AITQC?E=K&EX5M-<'>WD"\YP#ID\UM_;1*U.H
M^(_7WG!^Q'XRH186^\4^,XZ4:GCP\63-I[JGG9-H!<<7=">PU[J!6F&MOBU*
M-C#&!JP.R_7DF6>DV2L8+OP8'H./L(?2^LAO2(;%L\ESEF\;R[1#'L^Z+Z%I
M$B!*3 VD'.AI&L7E'AIRNYXY%G*TZ72:Z:"%O#^?F[VY6_VT<ZI.ZO7F8=/H
MU+MNL+.EI;%YQ@3PO\P0_6K]YQX_*YHRFC+S4NZ/;TE_>8[+WE?U'#Z@?/TC
MTD/U'"H ;^UF'16O.47LO[CNSK7*OP#=#AM_;1D"JRHWH49Z]'_6J*K CH0S
MXV-@,P _A7X>AWJZRC):$RI^)<X#_[F8G1;).LW\?]A[[["FGG5?/(J*BH@*
M" @2%:4*6*B"Y&M!! 0$%) 6I4,$!*2'Q 9(,U(C12(=1(A(;XGT3J1&0(30
M.PDE+$B[X;OWV6?O<\^^]SG//??WN_>YYX]YLK+6S%HS:[WS>3_O.S/OD/\A
MI.RF@A$+Q,60Y.C [?JHP8#J5)2YZODK*9*H O]9NC+Z#8^8+@Y"YF#RSR#+
M^*1\)U'<FM?";&#Q1PI:U8D]['?A,;Y]<:-^>'_^R1>\M"("_T8^]^N,T!RC
M+R(IV&)U=]>W>2;/<L['K*G( ^ZH/1*\%]]K,]J.<N_N6L^#Q+%)*C0&3[XO
M-?4#XNSJTZ?K\ZT8)6IYZ6.:__7\YHU5+OJM?MG)ZI(^1=A;X9E')ZX\(/+F
MHR7<;>7I!^>H?M708?D*1C=;M6Z0U5B@O+(*#+,RD@72,0#<>0X>K;+:8K!5
M"EZ<R<WL(R(YW!)&FJQY86U>[\NE7FG]("Z@EF8G4/O9A/NH#<726JBTA+L%
M/1W>R]OAF)XE7Y.H)00NPTT:,(4;ZEB@C2.U;!IG .Q.&":-LT [!ZQ9H#$)
MNDPU- 3!A] *+6AEZR6;#W@>=6&QIWI'!S TG%E!I2<+M+TI7X.BXF>A'@TL
M4(.?'X3Y$HW?:F.!#D-(-;O1./[H&*--L4#!OD9P17**(S=IT7ZG6<J4A'WS
MP<X/\9,%&KFL)0=E4X>LK5 :=!U;0?HW!>7IRCFOT SOC_U<C/D#G&N%JTQ^
M[!M;^W5UR-.,ZY/\:Z;+\^,8B>\!D8CC9"HM0^CG8-$ZICX;.D0QI1K1FG%E
MHY7$7X%$NG+Y2RCC]E5+\-UM9AR&_%OC&!NR[,DLT L,&<OF/.,I^"/>8X!.
MC+N@$_I GP17H!"S=,= N0%Z2-M# DU:=!!:%LP20+=!AW17#UVTM&+?]AF$
M_-MZ]SZN6XPU9'WL/[Y.4T_$:3]52S$GDS2"YEJ3'K@!<BB;P10M,RR9O!R.
ML\0S@W17^2G(;MSD2_9WII*ED84A,.3.?,M&!E.XK^X$,K>DLE*TB*T2=.@;
MC%HXSX2S^MVO@$5#.0PV>\R\6ZR/C$W#CZ>RJ5CF#X2HBR_NZH].HHSHM$7N
M]ORJ69[]BB6N&>H/KRC!+@O\"F)3<.XQ$L_._C'D&"==:O=%GQV[MUM7'L"T
M \G+ KG+<\(5@0@6Z& ._<Q)(L<S8^4$E;:F( _V:](EHQI1P5Y M+JR*\>H
M>?%YA%FKFO[E!UD)M7D=J^(_FVJ(OQR0#7 _CAS"#)*@'C5VSPC9X ?LBD0F
MDLT.![&MQN,\(FPYT7%EU@]H-#&*^MJ0$FUCBWV"V&&&,JF<S:N_;M3N["]"
M+\WCMVQ5OW=)ZLICZ%7HWZI: N!M/]QD./L]D<E(!H<\<C66R8?\!Y%;%2"A
M@H57 )]?NV)U#QJJP>,@6<5=Y#$ +S)?FV:!UA>@_LI-; 5+>R?,%&ZI&]T8
M&1#-0N[TX\ECHGM$+D5#:9GKYBP0KX8HX$;X'A!7ACC]$LM_M,FLV8 ?V)R$
M@.@W!IA*RD,EW'>X(=V"7+S^@5Z/]!_!(=/]N+4,$4O\] 0--0@C )(\+R_R
M76\J;;R<&@,!,>,2D.3[\GM=#NME%32UGKX'9W]1 ,\\S$VJ=C_$[$S==^F1
M'"8/5_=L0:GZ>;<+D7X"VK"##%> '%<JLJF*:1(_UEE=AFK.2-ZSK!H45[!@
M*B>30%]<T=B%AS7R,]JPZP2/40U2>AEWG-F7>@KH*M#+FC^N+4+A[L)50B)%
M]Y!+RU^LV)7TN$Y^X @Q:X8U0IZ,F"TC+B\L1+_]?F><IR! GO-U_IL\ZSAS
MCW55C:*W.=9\.>?[UC2V[8?O9N9H;W4IX>YOW?QW5E'OYYRV;[[U#-96*C]D
M0$K%3MS 6CD9MN6%J?<H!PUU!YA^,?RC6WFB4\J=3+@?<OGMY%MIU)/OA9SC
ML,DZ2I!> $\SS[;$M1Q:_"QDGP'=D(*L@9&*6*"U:SE,SFV,/7HQKI\%.D5'
MZ:[+8( H"?K]*LQN'+0R7T\8QX08LHDKCP4B7J7G]QD8![?<(L=27[! ,=2Q
MS9_(:XQ+P(<A1B1=F06RGMPVG4$N@[PH\_C%KTSOG4<4-F5M/@5X,6M#U[#Z
MA3_4AW4?8>+!1YY'R 9.EH7E+.@4V'I\/CC#W><LH4CSPQ<AOR<4ESCT/B>;
M7U KQW:UF-,%DRQ^PI_(S/]V'$F8CM0P_3V:>MFZXK<4L#5]AX=^_@9(&.G#
MD#%_[UGZ\5V IV%5$>W).'1HEI13[[0995HW'%1;2D\H/'7WKD3:!K;. '6D
M#VY'\5"]./P&TXW79??K@)9&O9MZ5G ;]"+/3PQ3H^%HRR!>7>/L+?Z6Y<OY
M3>="@TO3A0QN*A]NCYI4%5^!69AI?C18"J*L6@&JE%MW7HRUN7]JNZ1LTO5=
M;!"O!1G/3+WR%0BFB344S$=5]3H80:2!6&HNX^.*6,\R')KVB)'0_'OH7K9B
M_8;(E&^ANS6C8*P)_*T)4[^8RV5ID>IFMN;Q8)(@V7W.>N(9NM5WZ;P5_ F"
MXG'EY5<:<1#*#W'5\QT/P=MF+2KS7FNMO'^UGMB.)QO\ H>9/8F[(JZ%/5>;
MSSQ,&/=QY_4+-.M;*AMI<=GW)6)AO]3P0W^[!_*G+%L9)QG)",D;%!0ITUI,
MBS$BI?:!9MJ YV?#\Z?RU./ 4"#)SR&^@%1]<IJX\DI?NF6)0.G3!YQI1]U.
M17HLZ%;":\<5X1%D,(E[=MF9LG@_50U;_-F2*T]82#Z$L/$E35^JK</.68IM
MN-4^H@6.JW5\-*@/<,CRI#&)>]LAQY/P6#:2G*C4B.<,V5A= A^>OZ:M%A7'
M=33HV>4[-<@)4XG>FBK"K^@%(^L--W_?[^N8\&'T#V*OWE84?(BLS-0IR]I0
MW$@.FC0CE]/8.,J'OU(1R]A$AD"B&^G.;,ETST-66W+6B;>\66:6COWME'4@
M^0$+U"2SW],!O"OZ//V+'2S0E"&$P@S-:?(AE[<C=;9GJ?/]%V+'M=Z^CT:=
MK0XTQ;FIY<\B1^+Q$\U^H<P*Y36L Z81)9=I*N,X4TX_L>,02OW4FZC/$X?\
MB)@<=3G!*"F\<X53AZZPNV$<"]36[0S=[&2C(:.VRI8ZR207IAAO==]3>)"!
M3=Q=.[0_QG7L&/P*<CZ,^9"BB*WC1JR3(G&J80]+/B1SMRA2R^DGU9@ZG"&0
M17:&>4@1ODX&.LQ%!>/(L=>&#=3*Y"[W5HD9#_5&J(XJ7HOR/PVF\^934WOI
M0>3F==+0J"LR>[Y3.V[\> EQ]HB+&"-?YW6%'*Y!C#%I6GJH='6(<X**S[#H
M.A]SI\#-36!:KH8H1"8\B+4 1M.@[=HQD\:/!#%&L+L-\96RB2?B^VVVM);8
M-/73"-[6RH!90V2!;F [4#\Y)\LB:!"Z@_NQQ7#SK@)Z(01,P?9#1M@&0+.P
M"W)S!K_#C=!DMD.*4\9*"(VV)"=OGJ7!X_ZI/E<7F?S!PH&J4%L7(C6Z:*?
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MX5F@0EEZ_C0D1$+T8NU?W/;K*^?9_;T^ /^#5BC* CUO@J.REKLGD(N)S(<
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M"LZ@)#,/X4G(J&M]+KX!C8/&)V7? HOW\V\^5,UTF6OGVS;<-J:IT&UZ$4>
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MV1"J1:)'^0G1@5'$,*18!%RZ/S59A&ADKNTP9(HJ.)Q2>5'B L%K!@.(+_(
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M5GY;HHP%VNS"QS\A2*A9CD1+/D7 =R>^%Z\&:RC#8H: Z-/IO$_W'SUZ%8I
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MXISF#!T^ZIXB;<7'!Q8!(AZ#66LLLGU$2)&?T9LO>/1*!S)C[C:*N*Y#/_&
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MSR.U@=-/4F^V>?%Y/FV[P=Y8WJGA-QTQ988NKM$77)[EGO(XU$3F>^ANX]9
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M5-=)GK0@57O*]?D$GJK]735'KYT;]V: "FN[&P#"=6R(4MV)L@2+ZM)8_8B
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M<-P(4"^XL9@'#:*+*GPA!+^-&Y6/MG!>"GM"BE<;(\=YB?@8S<5VQX_5YA&
MID@ ][%P!$6*VN2F5!/Y604:O$_>C"VN?FJ& T*H*GG*R]J>^ 8CU/#%L=))
M/JX/7K*UI<441>)=S632U?XP\'; <P8H$C/) %$YT;^%D?)Z='_-Z7+)QZZR
MT9(Q-=)RX1![[A[0O?@MO:.>\W%%S050'"*" ;H'#B<ZGW7DL0Q$)B=HHQ5>
M9&YT7?++#I_-,(*XUETL1/A.+&LH:I^R DJ*C<5 WZ0)SO7PAU"D1OI\^!/
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M,M#JSEW8,@/$SH[GH>T#B,,!1D0@ EF@]E1Z[(A R(Q19H>P^P:^[C6]#<D
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MQX>?*S.'^R.+2Z?>:2ZS-][_^;K&/^G_BK1\F7/T2/?.%':'-5=*I7N;91S
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M1BH')^U=N37U9*Y^ -J45NF5B&EC\7M#NJ;1[0M@WAJ9K,[OUK8N7A=.Y3)
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M0CJX7\5)7PTU[9\P/5)U(_#+6$_V90,A1L!JRO_MS8K_[_-__KGM EWAK>1
M"APW[ZP?2-E^: %^:PJ(N<X6OH.20L9E'L$+RA-8:FS<!)1RY^D;V+A )6F
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M^3\.3#QZNYE\>O/ZNG*,&WY_U6".MJ#%"$;X""(KP'WVWNCQBO)"RCJK_7U
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M;Z*YF<?L9*S@WL,;M4WZ=X\\_^?%F&MP5;I-"?-1+RJSYD,-!X*VV!+;S&I
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MZ#,UQZLZW8J_KUL-W$T[_K65Y=K!WH,:$<.V$%Z;>ZD6)P0&U*H$3"8LLC5
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M&/>AF?^)-5$9> 0=>FK(2E=Q/L2664NZ.?RZ*N1!G.JZ>'FP6HW9I25L V9
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M:8WV3"R5[-N$YM%/- >&X/Q]O5)</'U6A!T8ZLE@%F^-O-!JZ-:/T].1E6'
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MW\P7RF4>(Q;YQ(GJZN+'^;3/PDK/-%TV/1\L9?P,^M+(:%\I6B/_#&4_;>%
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M?Q DB.UX*$H),4FKZ*]23N7CA0]>.M?8K<_S3N_"C\G/\W!?Q F:5R_>$3-
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M9RYFS .F'>Q[5\#[RGI-%J&':!.A2[] TFXQ7[_;<H@M/9'5"0:HT(F:MS-
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M7_ N,7/KVZ*ZM5^C9(;=!RC+ SS>13.0/9,*=OMDX2M_V=/HVD(S0M.E/(N
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M;YSMZ0!KOL(WS'9VR4@L%GNK5SJIIDMG%9^P>&!2BXF!Q@3VAQC6O1"1,V6
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M.76SY:L^QSJ:=ZA>"6Z9N*M=]C5^V?":/69LY:%_:S,RLIJ$NHA*+*B[TXS
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M$-V*EAG'I)9A@+X@3_RB0/H_6ZRN]5?.WQ9@FR<J&2#,8^1RQQ ]*)X.PG1
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MB.<WD:P%'=D9T\^7%.[?UY$ ?P03C) [\DJ8I4QX.;/AO/92!D\>VUP/72_
MC:)(JP2#5F10%M;LX(G*J&_:(IG60,.ES?8QGGO$^DJYVC@"]HFET@7#?8VD
MPE@>_N,RB=2MV"@L_6@G\:4YH;#<!A\H[78FF"KRO:'S&6J_*L\$P(=H&5)&
M?)R7R[)]ZI:XLST5'U6.&7DYE6N?(Y6@8EF76=/FKLYL.7\(E4-E*B7TL80G
M[I2FL_W"K)_C#T%D >R*U2'NY;99]Z2W4*T4.A8XG8\ T;O-WO% !22F(78W
M6]$0FC]-@%8BQ0,ER_AD:W7XF 3W4TXE4OW(L81*)C(\B+A@+O+Z37F_@GV7
M1]"!DUA5FOCFW*1=<Z?X9/QR?;1#Q"=S"=DK&8+KIS^5N2IV\MRV7/[8U99D
MH7OO255O 9NTWF45*-IL]PV=%4.4P>(.TU5U/29[*[JUCP3#!^9_[M(<UZ@<
MK?BAD%HWHARD<GEP749&<I O!^**' 8,R3)$L;7FW2=LX-!+5= 0N8E/QUTO
MW];KM5.U$FTVTEH>*,QT+C3%YIK&OFV9=WUSYF@BLDGH; \5_/&G4V*M-ZG:
MJSKNK<7'4S 1>B.F/"Z2:(!O__&HJB0>.]@^=V%YW],3 \2Y%0K%P3%%G2@[
M+D0H3+_XZ459J]O1%,$H\>^1?#KPK%3E8J/^<'!%UXI# ;U'7;J*P!-\@0(+
MX?Y->$3ZX6Q]+^TY8,L&O*#SA#8=*Y0[HW/25FH3W87Y,=HBM)_L7*@QR<YK
MFKFX=7;BP] "IA$V:OV% >*2@I2H0ERGFUF/OFG=7RTNPKM^P][Z=F^\ZGC^
M+M=G6_4LV7>WQY]</DLIE!9%*VX&PVK5RZ<!'F#ZHR] (UI687RAT=1?5Y&Z
M_EQ%VEK_CU:1])7#:4<A1]4/K7[7FO2)"'U)%<]6*PN7BPNN;^6C7[[6#$^8
M"#S0 A.0/7/3()Q8GKF6:#)FK0+X?(=D!O"LJ*4M^H<4?WQDJA1U1%"V8)1O
M[1&DF:W3S.!$LH8F1MN$$WO$7)7.11YZK=0".:2JSL;R8#@WWL7"<\%C0?J#
MFEBXEYCXCQFX,Q["1>4B%)2W-GHZU5D]V:_Y;G5'I8>B#S<9]$*&(HY7WH0V
M<8@59@D"C:T%3^'@^B'++HKN(\S#@FE#T(<I5$MUUTO@F'.MZ62!RUS35;8E
M[\?.[]<Q]\W(;BG6>8^7?B,.J.5^0G<.KF527\IC#5^=,TDL[SK81^=Q\##5
MD(WGV"DY:[>#-,,14%C*<0&H^7N1=VV0VI;ZN%HR3[4M13E7$_4NP$0A3/W8
M3P=EU>UKWZ*ESZF$D=#CI:IV0T5R1<6Q'R:'QN$D?IU(7V.G6ZO/1H*3U)+R
MOGF73(7,UJ9,X1'Q%_M+^&9_=L9L\$\ 3R"G??,F82LB4^!CCM79*/UBVU/"
M"F<"H#_=X2SQ'4^Y5(>P!!,+:*BP^:B10<JHG]"X!S+KO:*[9IZ/.I0!"C;-
M!+K\,&OI6E2Q3G%Z0"<3<O#O)M$Y[V*6!Z%AZMQ:^&2U3Y]%%2+SNOQI4A0S
MM>$-?7FHW??CA"P=XZ]5\71*-@;_<.'@U H'@+M=)]*(.T35]<K7]G+S%&I&
MN1<"(76&<_C I!_+41<YI@3J%BV=[?HG=CM<"2A9H#&KE^1"N?6#"8X2&*"C
MI<Q0+F6#64U-0%<P_1P9F&P=+ ] E=D;)N>XJ-C6H>Z2%6CEGQJR;W(]3O;)
MW08-,$!.DLOSZ89R<8DRLV"R<2*4NIU$WV76G-^+F:O%;?>@<S#X6^WT3FF#
MYQN58V*7 2>M&F4E]G@ ;[P VR JT#8=F$6'/XM."PX($$QA+%K3*(;D/V"^
MVI&&(N4#[Y78DR%XHS_IMQX-(6O9'?!CZDH%+A=_MJ)2ZK-B2!Z#8W?,8UF6
M+/<1EQHK$5S!SH52PHG7?ZP/E&AZX4L/F>7_]O[#TT(_J: "6Z;78_&4/M46
M41$3U_=3!8$W**9PL$&8_UW+:WW=G1)E1S\+-=:&XE$A^T=JAU@3WMO*J^7]
M5.4@EK0W>L,(2-\@EMK*WR<*I:]!(W(,4\XKAJNT K+/)@F_M^!G;@8",I-G
M1!ZA=*ODH2]^3VTX"+VIJFE=>7%I!?P:7 J\0HB3O;P@)P3T)!== -\&/=]
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M)6EP3I3-,RM/28.3@9(1.JGWOZW.%TT,$+\,4OO+*]?\)USGHT9JHF9WF1^
M0$0=)"WT&*8+7#8'$M:DO9S9W,51,$ MZ!J*NHU0_=V!F$*LC\(-^_X5(?3>
M2G;5B:'3_XH7^IH]BI(H,QVES,S7562U8GS5ZAR$P^2VA>6RWI'(X?G@FQN]
MC\D5D;-D9$29K@BJ/7GC=(PS3OF]YODZ-;S.'PC&2>8Y_$Z:L5EBR]/@^,N4
MF'/7I1,\NM (;Z7HD(@XZXQA!*P:)SAN2#[@P,J&"[F#Q<E2?VH;8Y)^!V"
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M%7L,,^<ABQGL %.K$05_;8/*RG<WW%6"BX38)R=MV0@IYBJ. W K!/*/TNZ
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M=(HO^V9>WESVU^56Q4LTC=NL2K:*$9GFIC1KQ!ONWNU%M8-]._ .#WZ%M0W
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MN,#&/4?PP$].3E1)4T<P;DG/P$%V&"@:-O\=P24",R(F6L4#+$/6<[!1R^(
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MM$?3\XJ0B1'ZG6]*O*=>7,4XEU7%TD?D\LX8'2P0.1/(4PN_9W_?T-\R[9.
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MJ"_-.GIOTN;3TO ].PNVD[,_BI0.83)P>V8<P%$B5^#5()*>W<\4W &-^G,
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M&7U\!A2Y$>!SDH!^)>_9M^GI\U#E$%P;YD[+)2+'!XF'<CX_\CGO6E["2G,
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M64&CK=XSI0?]Y4+3*IS7+=^9ZNJ'<0 Y[6=L'#X-_)6G8)W(7L+@?.(=Q,G
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M77(XL JB_1IIES%;<X+"ZF1/(1="'T 8A/]FE]W#4%DTLP*F'<W6+6?Y='>
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M?G(.&8O%(U9W:T25, !4EG<%O!39I*YJ9>LTUG2ZV"UOK*6Q5=%S&Z6S+Y1
M?=JHLH6M,";V1.P!&L]#\V18CUF?;<"RZ:DST$,QF%PRG@FI7\$,D\H#PU<6
M&0"QN<(MA8WOWS?FE0S!O7MJ:JAW^&"0R8)3WXJ_\(^J/6.XPV]XSX%=TPI*
MV[(.. -YP'\\GX9@9OUJ1V>U2>KA5 (PT2H]-62]ZK"*Z;MG1RS,-?#UQVF?
M0<ZI6LOX;08@\M*T4^4[0I[T^FB4GJHU8KMBD6EG+DY5RT:Q+AL_MY^MM!99
M6X\9CU/[&( PS<)*D%,*?5<>2<A10.^2F(<*>^:TA&P&H.<=:.='!D7"D %
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M4PU[T&2_^0@&8$$=2-O6_L\64+WZ^YWTU:%KX2JH5:CS)NPP_.$4*($(TF
M_HHE.P(#0#V58=>_[;+F/#S]_OR9=^/2ZQ[_6=FXR^N9@:QU(COBT'')BTNU
MG>!#+L8!>HT5*GKU.Q7Z+_.]NR%6CKPSZK8CZS*\;Q@ Y3J7S93ACYJG^?_J
M^ #=F^GR%0NO1ETZL/[7NS?_ +F"=CE=D.M1:[6@@SV9FL*ASW@$@&%/T65)
MU'!YP_VE:VX1QN%$Z7!: QAI9-Y%!)/69X+')TH*%'LVE=V1+]!<<@H9!?JX
M,><A_IEQ'J'\VRU(5K6STZL:DTW-06HJB:F5)UJD9F1\:RZ.@&\Z!21;M24B
M1DQPQY@,OE+IH-.BTMI(#F33KS;'5Z$2SCS828N6(,_QO@IDW;A-L=HD T""
MD!_EP]OFPU:=F.Z4A8D$7IN2;S/Q=G 2C<*[]-Q+ZY?Z&J[C5/<6< 2#0[[:
M/C]8!F>W&@%G3R3+ Z+*\5POTP!$WY]5P[4@R',EU="?+SYA?$MBR\K'8:L%
M3HN"(HAPCXR*@3/6U@&ON7D>'K!IBX4=);/A'3?  ?E-I+UR?,SQ"S?N%LU[
M7ARYI>_V>F7H8S0.>VR!SCX@-N C+?_M&V*MB?\';W9)]HC6J$W&7#%KVZ9Y
M M4'2!1G %Y&;6\;)M<F3#>N]B*8*9':TO7];RIBOH+WOZDP^8]O*E+_#[^I
M>/(VLZ_L&4=?Y6$S<30755DU*4$_,F6PT+//8/6)!*],7P_34*L)/;2#3(Q?
M[U:12VAJ\A_U:"E9?)/_,\RT8H/#5]YD+GYXAJ($E](P&P0YI-[2:W]<AKYK
M[R<NZ\9%=@AVIH?D[F*&5<<&Z3Y_,J0:=-D5Z56!8+LDAYGUO]RPOXXFI( !
MZ#4%J>RU[1OJ?]R,)+V6V U=&JP!2L";A)9!6[R&W>DU-$3Y<VNAR#%3PXFS
MP57++Y/WQOYDVR;6DZ-',GGBL<YON"@S?;0OD>AFN?S^%=@#L-9>1=7S[/5Q
MC\=7BK<;BK(-B9?)OAGE'<V8$Z@+Y^<5?KH4V[G058F"2T;\:F/9&SN<M1C'
M2Q?;(WO58+']Z!L/IHV3C0=W!?MB9@;?7HBFW'=-L&E#WXT?O_;P-#\J'W9Z
M%-UR;%6!Y66A?2@G&V?Y)K@1'N*'%5(SH:7X'QM8*31,+M7Z/A'G!?Y<ST^8
M1;WR4567ZN,U'KV<\J/A">?7>G/Y7-UHTH,=58( ]$'B@P+T-7VMWWV@ZBN:
M/.:=P/O[..,OVY%<(\&J*BN)MKMI/F%/ [VC]FZWV $->5SE',2>F*W;G?6G
M*)?Y]ZN7S[R9H<TJ=4$Y?4-:]2YGQ#0-S-U?? [T2)B^7/QCJ-$<*9WT=EDN
MS[4&L>>C#J^5=!C:FK'7I(K%!./L-)D3LOM\?U=S!&6A[Z]/!O;F7!F &\C=
MR_3\)'BO.5TW8'TUD,)&AI->A4'4E/T=LI9;]3=LBP4@A5 <#DP6MRO\NDSB
MLT)'/9$M./O6SN4!XM.A@<+@&70I;2]XPFH6%N>*)7S>/H6QJ 81KED5-%V/
M*FED &9:#0^]UYG PS=,0"W@ V5W88>P 6P-?.^K>;>;K5F:G_#-M5GMAI+<
M]C^S6H(?K[_ Q4-&-U=85<=0\W[$>P_.;+@O]5% 8,F?0YX'ML==K:<X/S=Q
MY$]PK\W%M\WE6CX";3RJ/6TQ"K<<HV2C+);]!(-KKQ/=3F1>>2BU)LQ*GB>-
MTV)D06X]IRS=!9TC/)YD52#L=V.D1] XI!Q\0=)K?_WX9U0 VK FWP;5UW7/
M:Z3 =O@4 W!!^)OEX_U]'V:RNQ6!W^+J%%?&@(U$_!CDBOBFXKI0$,W=FR1
MB]H&CNBU[+VO+ J(ZJ:L&@6Z?7L#: U>'D?C;BP)E=)0ODC;N=?D0SF@R:$U
MZZ69H6#X]?+]+":!;4G9<6"O9\J%W@L\6BM 7&Y0^?HQ)UJY/#+]<7GUFQ![
MB2RH-^4R ]"@#-4D".%GDZ+EJ)8.ZF'%2E&G =]Z8(&H@K852E!MK-D4<"=6
MN1ZPQ'[9]WFZ^GB_!75(^I($_1X7RWM%>,'^$ K<K-)2@[.63J?33V NE]U8
M$WYLC[Y^B0&82MI;K6R-H-I#S>U]9@=A$[-K0G22UR?,")K0DX3>XMG?)SX6
M1.<1S8B!/[%U& A,5UH95MT7>P?+>SVH(5W7 QJ .9)*>(;S*;RE,'CFA5:A
M$/L,NWDS\!NVT=90FY:^S26RG/S"J=JL_<UF5_!+B95UKZ=9$H,7DL6&^.,Y
MKLJ-E'L$EG^/']_[TJ(0UW72?8FIE_59[RN0P^@-D]^H;8YSY)[#.V]T('(G
MSSYZ+9I(G%\%40X'Z$W?02B&S1;W93^*7[JQ6^>^/Z>0O\RI*0VYCEE;PH@M
MS'U5&A^673[.E#D/(?!)8AK3T9[7.$EPIIZ\;=*WO2"[C>"QL!W5&JO-.N.\
MW!6\C-M_KLU# #?I(3C)7JOR$[KXWPTRS8\/-L<\D)@230]:YM.F'W%%$GHJ
M1WI(A:WP207CMKE^+#,[2#@ES&DI4@S:E=PXV@@G7S#(G^**'JZ_4D_43VVI
MJYNV%7=K4BM6VUP'9Q;BW?6+PP:_"-V7W T+&"&SY'"',O6:OLO$7TT:=DP_
M:CQ-WY//BNMRK-_7QV-3)3]7(QF =D-56@7H<>PU4EKODPP"_8OC5_?+[7,Z
MSV;VL[-->"CHFU\Y81V'BH!>R0_(&]WPT#TE?*_H\D>@U9X"W)FR->OKGKBG
MG 4"^!Y15JGK ZTGP\%=QI5#H(V'>^\M89 _*4PW U"2M"(43%$CY_H&:S=7
M5+J<QY;;^* RX*[KKU1 J]Q3B!6^^HK#/I>:^M,A+U1"?8?6$$-=S![&9A?S
MQKDR! U%DBOA>?"9)HM+Q=+!SOM"5]D/>8='B=F-$&'MW,4TU<K*OLF;I)3'
M[[BN7X8MSJ=)CZ)=X;_-&\&"/M^3;K[ON#=H=J90X\9YFCL&C;NY)(%8C2Z
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MB=/W;N:S.IV"]P#>Q\C<5!3T**0:CS>%AM:?M^\(>1ZUX&I9V,ICWH@EW&<
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MT4:N8L4,^ (J1Q&'7AW,&%13SZ.J5*)C0UM\_?'\<N*1X5I::<X7@S&\Q0P
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M'D/E_C(RT37?G8]W<7(%\A^N3;CVD#-427BZT)@!"(=2#S  7]@8 &G!< 8
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MXRR3E$-J;+55YR?(X#>6E68\I"V-D@2][E52R8:@$R@"JA8$POS.4<"BHH)
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M2N]'E[0!%P]/Z8/KXA,2,<(1SW[23/Y8,G7#.7ZYE?:2Z_Z V#=X-WBV8$4
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M=3\9DOX"2M%<?_5B-'DB4GLO]<9R\F)YT.,IJ78N(A#+7.#(Y&NAQIP@/_>
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MW0<HL\\I/[.P?-4I7L:5I_RV=YI@EF[8G-DQO#,MIM@T)]CN1:D'6O_H%*!
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MP%)S7YY^M.T-0X>8L3+A^$CZ-PP[-Y9O"<VR;Y<<U*%,*88\>K8]&2(G-"
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M2H#-X+1,Q[:U\^JRXN"_TJJZS>I+U!E<$TCAM[6K47&U9$_4*>"Z[K'9Q"F
MCA88\'.PH1"9'L0BJ^)"RE9)"[KIPX"OG_&EPMG7@+Z.KR:\X@)9J_"7<E-K
M[:#:]-:B#:H8>E+:RUT&-< [XIF?8*G1W6AQW>=3U8I]0V&P9[V@74G_)P\&
MRFX8C 1-GF,P)2@\"_Q03^9>A7_\YR-)':!91*W@GVK\3M3#$;$T"*FZ=^!?
MC;E"?!7B!_NM"4 1$T@*Q&;PZ/70.))QDF$L3[N,>.KUYJ]T)5/\=!-UM ^-
MGH:T0VJL[WS#U;B:!=XI3I?U4K28L- KVBY5NB[!ZZ0N^R18G8EPL87O%K$P
M&LGW@4JS5#FG@%O/_S9=2D&8(0O+X:#Y,_BB/-Q:SPPP]O:7_*<CGLLM[Q[)
ME_>V;7O9J6AV3:[+QM!LE34Q6"F5>5/H,EXCM^C9T3?SPM:N:U6]%GP.(L[C
MY_W1O/"%3R!6JH0;=\A$LD_P0JOE>GQ*@JJIOL[[/>N..<8#;</M7+?>?SY$
MITML@/PL( [D#]6DL]\DI)++QDKBVNVOMK:.VJ+SN@4TH.K9A14]Q$TJ4R_*
M^AM1H<W=0?@H,&L;"R!U7EK#O3>;GV<;0]8A&/YF11:?M=PP"[@)]C_W/"+1
M-,%BS"'U=5>B[CKD%O0V[9^Y0*5QLF4N)1L-? UQGMO3#N;^C*9J-@MO^ <2
M[JDG-0T:'UU U0IXJW"M+!5&K!IV5H34!PR;'#>6MJHQ:W&:904@,B#_O0;!
M%6J+PT09U@BE%GS\':*K'@4B;ND>CR.)HN+OX+6:XD&=74E"*Z.W:VO_=>U>
M58>W_3N#+R=.D^C)&D3\\@""VVT&$;WEKY^Y'&LRZG7-/%J+J4#Z/4J%+H\.
M)=5"I".I!.D0O'[YL\IUH#TS72]+3YI9?AB0'DD[)R%J8@Q@;&.ZDW5TP_Z&
M45L3\Y(+50[27O.C(BK'6J^$X$?FH!@.P.9L;]*TCC+!!E_>3W)&A]^>.FX7
M<^'B/P4(R!V;K6#:0/^&-]UQFF\;H(%-K=5Z#$,[7>$%IP#, [,MVD]P>*X0
M)4^= \6-ESZ)J'OSNW!FH&BP2J]:XKFJHZ,P2]!5 O(F48%TEJQ(%%XND[NR
MKAQ"*"FSH"<I$^I^@P4>]S[]9K[T.*=<1W537[;'J..^)_QR"#0=D8!)S%._
M'R]<AZ!)]07SDR=H8=KO(LU_TBR.D)IAH#-W):K(:GI[2S#\(_K -:D#;2WU
MART6C0.#(K'<+6%E0<VFXRU@YY*-5XR>PE4MK[6^2]B>>Z]*!_#)6FPWCA"X
M7_+, 8%M6/6M;'&\(_]..8#40&%?Q>)T3P$,E*0VF#)>H8CO%& 8V<Z3M!BI
ML0:DP7MAF"-^OQN+"R=SXE$M%T6J1V1M97U(G;PT08")'3L%T,/8B($+SN$>
MT!N+T3O<!N'SST3':-C?NR:],T4GGOCZ(CV7VU)#IX;X,O=K?PB#6XI-9^&&
M7HG"5+_P!P]_G[IHX=+$S[&WQO-CD3<J<C+Z^RZ_+<+A8M/7L?A&HD+>NL+F
MS'CD1_?"2CE/X?H$'57GY_F'BI2S+_G4-85^^<U)3GDT5-4G3MQ4DY0P/&$Z
M3EW<)5\.781THGE=-$4:4'BQLL BZ\*Y%KZT%3&@(H_\+?:.=XNO57ZJK"D>
MZK.VO9UOKI%VOW4KWL4/368;6^YX4:S]Z@,5@OP+XX&-"?T+EGW".SRA&HFZ
MX>^2%U/S"<.^EWH*$+P'^0K"@1$,"$;J (PGT"!UHYH&FSZ3T(BGIP L0QH&
M F^7I7)@74>QFE5+J_N%\K7,<,]GJ2GR'@/VU/.(D).R#ACW:,OEQ02ISI.'
M(.>1@V;SK>TOTN;E+_.,.8+%Z4HVGZ!D/WSS[AR=L]K1)V]9OS18*K2T<J72
MO!2WI@\M=9.#T%1VQ'22<;79M%)=F$=QY9TT[)^&=79@ LR7BH'],QBSA$PB
MO+C:*U9#UZN IW?V[,?$,'1@4@_:$OZ2;7JH$U@;%>5'X>_FMBPL;(WH:XHT
MD/6+Z4R3^GG@+WR.4 E: &^!</N$,+QO4/:][Q-U&I#>T*"B\1W[]_<K.CW,
ME^ZEJ/0-\1:^IH7R<!;\L@>R4908*?\.S_$FL<_M:),(O#>Y[$7FY*<%43IL
M+%=<2RUOQ/ZM01)B1YL7C3\*H:0@/Y##:-0^3[3'7^[)PL0<LMIWFQ[-5(QE
M9+!;8N^M!B=V9WL2>5_WK3=]QRFZ_*HL-9X6/UH_L5[OTC:1^/X@8'+N%,!F
M_Z^69T'4(0$7/!LJ[WADF$\(2-GO:C%)RE$U'8K^>5J_[&9LN.7Y%?::60NW
MJKI..5QDI(E16,,E$#O$B"Q#=,XC"^%D,Q;E+FI)WWF26UX5O!><<LM)=O#'
M[W2[D#-# *;69?BYOVCV%JF2(*\NI1M?_YZ\LS7I;GF7T/GU:N*]<V<95BZQ
MJFN+&G>'!FUED=+0#Y\()=7D;Q6.@WI. 7]@O&0N8AD<!UZ"12P;*,VHS>;(
MFMJ[*7!9Y#LX^(GX]=<\7Z!]+7/MHFOIR9Q2/0A!=4TJUZ]:8UQD,DP]^ZN'
MI^7&QI:0.E+![@5_4^G*P4]&^M]0+=KB90S+'KJ(_J)>Q[ID^2J93I#T]1LY
M0X+CI)_3@E%Q!P2 OX!'0<X<,OAGVGW'R\5\^:/QS&1&J]D^E>6NQP/J\._.
M3XJA_E69?"UU8HU9TW!+F',VF"VFX/?S;1AZHGB%+5Y=M"2(N\LL1*B*?MI?
MW^#-$E;UEMKU*NU3@$O@\\0N=D@-J K\OW,^YYV&CWVMI^$O=7L8%9KU%$X!
M9_R!$=XH%=H6^4!O$L.76ZVZ+7/+EB):QV7G"7_F^?^>$YV+N\G_699;O&A'
M:GT.J%OWZW:<H'R/G%A_/\/VYWB!K01.R:2V,]8J@U ?GI>CD"L)%.R?G[$J
M9GK-B&FSAL._L!?_]IC\@E*&C^N$">D,AFBGKMU9*TCMI0$<QA[\LQE(%!EZ
MIV]+/ 5T<X@S"M9G,]N3N@O>PY>K)G]A:<CW'!V%%FP)#5S:#GR&%TPL\1?P
MZ6_R^"W%SA#.&9'"+?SZCH!9(9F9R+SH-;W6OD<,["@+F*CY7??[B'N?T2GK
M?FFC'9?.OU,9\H;+\HUG;:$,9/!A(+S$_^63RALF<*:&!?3@5HMAI=8B@F7C
MI&OK"JOFB%LC;]/YA_^N91XB5)2 *UPGLR(&O!J;<]:26VVFJD ?D5@T'U$/
M@T&Q3T"52SY&YI3.Z#I[>V =<JU*3&?F$EFAS7FT!Y>CLO]M&B_Z/),1Z\_5
MD.9X)2/C5[#<V_<5U>?=?:8CG-.7;KPH5C79]**IN;PB^4^;S^)=CN"%Z&=_
MX6]@'/_=/$#_5EW3S#TK(-GMW%L>RD)"(**[!I)^"L 9#@%LB3J$U''_X!<^
MQ<18!B^/HJO;3N83-[@U\]YS:/"&N1WB6%C.A%N#NX?>:K(3%Q<#?D$AA6+Y
M3OR#D5IVJ59]\5X)&$GX@U]O5"I#5(KUN0XC&UHI0NB<!$$N:= WM):7"04F
M_D=GRYGD]8"D\K<I*1*J]67.38B_J4FY2K^XFO)EQJBT\FPCTT:[&3'CG%#C
M\KJ,&Y6I$;?#K.TAWF$KWMJ(&1#<F+6ZIKE5W:M#V3<7NDX+-OV_@6;E)]Q=
M-@\,:H<&KN05%OZ_ME=W$4L4P415.-/;$B-*-FB@[?MD-+_6Z\<\9-6VU?4C
M[+KMA =V[13 $GRPOO2U\I$,VWU*\BG ?8@=-HKF(-\K^K$8RDK?V120)6O<
MK3#D+29?6EH;Y?K>N+'M+LRV[K B&-EV"J %"JAF/L:W. CT).5"B\1D1L,S
M7D]9BWM,-DD %D3:75NP0-9!*?Z6?/X-ZJ*EQ,%+[=(X?YM9IE5-Z: **#,.
MTYU[S6F6\K'P]YP<J8^?"YC)-3X)PM.UG4"ZD.<W-:],I)N.'%HYU7_?@]A'
M:(PW7_+6&?E>T/AE],["L4,V"""27)"<D_C'/B7,(&P4-T1E\O?"#2VN1:G?
M<,.AMV_^)5R:9GZ+W-K7NWJ^G_)AV>?<LCC2DH D^H,[O$YXH,ZG@/!Z!#E.
MAWRG>%&9PJ))R^:V63!5"UE9D=ANEB2J7[>O">-QUU+UQ?C^V8W%XI[!H^=5
M1IU'6Q2+IXC79QRGCI0J)Y5?"^4Y/N<*VKET<X,!F4.#0C$\$I/$+:C0><=Q
MHJ'$0/RC?^ U,95 CL<U_4%/GSS1[=.0#T*.)3'2@EL%QDAT<DA?TQF#:EU7
M6J5.C E4^N::RLD\(ER-/1'O%+H\K'ZYH+N0"']4-4Q3=/H&FG/7XH767%_+
MAX5.RF,6O_65*VI 3P%EV0.LMC6V,Y9PB'#_*< 1,9VA3<F",OEM!AKH="G/
M.H[[/\U44!&X[IS,M[(0V">>BJDSU I2=/U9^_O/SO3ZLV(^PZ>)F!4,F7.S
M8TV+DI\_-JZ$*7>Y<L0?%7A_&#A\!?7(12290WZKMW&F(.5"R(+9!!QGB$W(
M8NOVBC.]H_TFQI<M\GIZ?Y@NOY3Z8%N3'$G"C'='/Z G +20@Z[>)4L/74%V
M =EG=G ]42HD3@[D0&C0=V&D<=*;,*N76QVH9CI#P[8>?S^]4X#_'.K034A,
MT7?)^D59 $1-BC('+H<_AT^WHNC)<M3I"0\HDCLHP6AIW0&H4<XS^#140' 0
MU#(%\C,+)%E"@YHH.:A+0TLYFC]IF& <VBN][;&K'/SXIZ['["/UZYHW0Y9:
M<UM(RX%M6!;8+R%F33Z\L9G8#R>K3/&:C($LQKN.%PO>*$2^B#SG.X*RK BT
M1=>5U$W.A:&6I_-U#8O[A(9VZT\!P8N@B_"%(B CU# ?(QZSAL(Y%96J;X;&
MZ7HNR21"&Z^9BL+G333']Z.VMTGV0?K+&9$'2/H@\6V^R!R/$$7F',L@OO,!
MQGX/$P0N8'9Y4MK\>"ZT BUIN:VWKLS]>$:G*WN6WYU<-;_.^&IY8^#V?WSW
MBTA/931;\+BXIY;$%51L@M?K:4<->#!-/1#_"E5H!.XT(4(.\RDYO*6E8 ,/
MBMS8(DHAK6/ 1HX"3UX$X1XCWC9EQ%!O-B0Y-@35REWLE'9YU1:1OF$^:*>H
M0<BO 3Y&'D6$P,E<J=WSMJD+0.;\_=N3?!_*J$OE+^'X8Y D"=V!NCS<PO;9
M\F4N<%2F-D%L..">LPO/HU_.XN%CJ2FZ*RFZ?UI""6\H"61VTB/BVR<3+0;P
MRBFL^6Q8BD+!G!9?;>C'_\\L^X[U]*#DN8HJ&&BYT+!<4B&@EG_?!\*)7I"C
M!;$"#<A$,>_@]2@-UZS92KMAOV +*T'1M E%&NU!^RD62" EEQ;KZ//4'P$S
MU4$6=5)E"4\QA.Q6(_]T4^.Y.NTN+8"79]S/X+]24U+2G9<%3$PDW-/0D+$@
M/?F\"X7-@33GQ$9/^0X]$X;G)SCC Q!%#X^X"25"^9RWWEB"Q;0"G](_^Z9$
M7P&[0Z3OR8KJ1/"_A$F,Q"8\T&U.W&._VE\C3%?7&KU N@SYQ6;+"LW#9U 9
M.W'8I<BJP H7;NY<YO'*S#Z)T32'VF VT4&97XB'CD+3?^H&JI([&N^[S860
M":1Z%B?@)KOIG,L>%7GT*?W_[+=]YN_08J1:+D-:DP7'S\M F?O3'-BFB>M2
M)8MP_J4YJV0\8_4I@'/NR] <A.WUU F%YO$D#^&1")R!7$3N^7$/10W395.\
MQURS=-S%/$F,6\NE!\$^7\63CRQB<Q<F]:F#<7_&C]U. 73[-R$V=;5D$++M
M)+#])(U0L_CO39\+^C9Z.SV,.Y_C+U7U#Y?=B4_QYDGNTY#:,Z,R*2XT(YFI
MHUD_\T0>UV=MU[526MY!*Z(GQ $GD?%4._1S'8&+YX-V,=BW6%;XRZ!M,O=2
M,\F<K'/.(_AY?48RIL3JVD)O]*O'#I47C4LP7\\%9[K?SXLQ21FU44<<6X1A
MW-?W?_D5'(Y"%*FAT*$?;-,ZA%_C:"=!D,5(5-0B7BGN:[^L5IE-MEFD=YY^
MV1;T3=Z]\_!WSQ-],TCW:!I=@U(J-\CM+8M8G%,5VM/@!DO;Q1@+_%! H-H$
M/%7H5)XR^Q[*%),YP(\-3!R:B!F!2MEHL7E!0?M,9'&6TPM$&"+" 3:M>8'H
M1I*!#2TOG@+>7G]$UE]R^\JZW=WUQ>IXV\YC==6=]:O-T_-/2Y\\$N [<HYI
M'ZO@^[#\P["6ICC@?6Y[Q[D>=U2B[S_U_&7F1:5';D"E%H L?<M@ 6+HW7=7
M4HW'9+8R@ <C_]["B*ZO'YZ>Z?1B>A<IPOXE,?QN&S -1M.:[2 HO7(BR 7+
M,GA-WN+O&P/3Q:J.8]>'SE3J;7^2N/F:HF(Q>)QR @O/T+$8&H8A]W66,-OC
MA3;KD#JSI/._W1$O&V.7Q#R3^!_P&FDTPRXT>4U[$?[07*\3\KQK+B]--=D"
M.::MYQ2W:S3P]6[!O%SF0!HHJW$NKVH$KR7]&IK1)X!PSML2Z0TAM1EW0-'N
MRWL5AZ&"A8/!(CK7;W9^%4G^%?^)/161"]7X3\3+^&NE6A,3PDI<%O:]7A06
M%A3/#KHX HG;/% G/G.3J"X_7?^)67>7Z,YQPDZ=;"4U81<]M (-P^LO0;I
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M6RK$_DY(3*4[]?PYW]L+"/6!9*,;UOZW)].J[JB]*/B..VS>VJT%CG4_/!G
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MY/[:*$$Q8@$=(:#=O@[/^_7BS_"]X#Z MY?)S3#:TQ?X*/'-XA3$X[,AE@H
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MR)\XOWXHXO/3WCL3J)-5I ^/>#:NO*\$HTEV5<&P(CHC:IJG/VW;FH.>@6(
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M./V'YGJ?[4(_ANR@>0Y3FQW0[)1V_=$MQ2DCQ<Z6Z\6!^EX^X J>+\0U-I-
M;A-!D^G..X3;PJ#<MC[2G0N.4&N/ >I3\D <4L$)Q4*[:>M][76?J 2W)P'"
M:?'3E::U.;>.2Q*E+M<!L9)X^^3Q" 4^17[^C847['6$A\!"!?#QP(:A.E /
M55OMMF5,"G$@TK7QZ7.A7Q^#AS[>/-U\ WE59_Y,99I*X.E?\8_,@J\SD6PQ
M*8<AWFF.CP>K&'\)?>9]6^/_F&%=5SSKW3\ZY]683WZ7K(<"Z ZE*NG[5_G!
M"%S&]'-G]J@+?S*!24< ^\-7SAC)1L_>/XN'"Q ([5%S[%R[)YUTSTW]L.A/
M=TL]I(.U.2I)K/U&/5NW^UQ) &\'D)WF8:W8-S,:IN;9L_I0<V R_DDCYC"O
M2M11BJ5,';X.>4HS.\Q54R7N]5<FVI%S;BF2XC;N"-%  EN<CUWG +[Q-KFD
M.C5)WEB9%$BT;FB]0Y#J "-]DBX\6G5)Z.=*KV=P?<-6+%UTT!L8GNB?M@ K
M^QQR:: $&8CPJB66)F293\-M.4]UW?F.;VK'F]3YH:AR%,_^5Y:LZ<B/S'O'
M 4P9::=S$7\*O#DE*GA#,G8,[)[!BG)+DYY]Y<Y-?E>UK*,0@I-.OX%T(HU]
M0SF @C @DF\'-*7)9KQ_L7:@!!"X-2_#I8WO.\U*Z;EV^;4\1!'5>@_M+H5@
MRB\^:XKX=$MC=]<@'$>589_(S8VV><(L6[0*$?_;KDK^",!"[H;-S76/*X2]
M.BZO&RM9E-YV$]^D(<E>T>>?XB&WX6"R$W'O]2Y38V6P4;CR:8P01=*/]$*A
MR"C;ZGOBE-:@_# FEP+% ]]::#;1TJ^FS8+%%WP")8((R&O(83H_Q<Z9;'ZU
MHXQ6:SS"W087(6.)8[F%UTT]974,?LUT(M:)J'88:6IAK"$?NE]7%FN"+0YP
M:)(A5QZF(=3GP:RK2>G\E3SCURY.^SN>?B=<1+5<.P?- .[T3FG/G6J^\2X0
MVHTY5TCO;;QP!"@$__BV"[HP0PEIJ;>)][Z$JLCD4QRB7;-.]%U?Y: _Z7AR
M&*?;3;K7&:.$:,Y0(R\WV<WWE^"BMB*2L:LMK 6+,/GD/Z#)8X+M;"$E4<M1
M(F:H"DRA= K)M_N\N[+)N[BQ((TJ2AU5%^Z)2ZO5BVCV2T54K<RR'E8WR@<6
MBM[T5)K\).$8FX<)H, R>TCK> PZ?]VOMJHFE6"B7@&Y2WMP&.VE%R4D1Y-S
M^#9S^X?5RO"[?C$R[9?4+@'8MF<2A[DF9/Y@3QEM>YBZRZ< /C$UX#7%(=5^
M(<-E?X%<3R1GXP)YV\C^P3\ZOF>G[N4A'E!"_>;GP@YT)[[;F6>>(*U&GO(_
M L0TNQX!V">@Y\VQ_;YWJ9!C6H4PHYS<&/ ?/KGFG;8'*>DC&(A))D3%/7)5
M]]MY>>L?Q4]V]\L,*: B&Z?F<_DJP,_<J?%$Y6-G<FC\.6ECT[]T!"*-L/U%
MDX/AH=S-_)]^G-R>4]R)31+IPWT2?;>L%2*UVXDX0S70OTRAZF(--(:;#[B9
M70^2NC,J0>'T\W!?W9O#KK%FXXXCW,L6&80>7&=M4*>\GZL6M*/9=5WDJQG\
M_$SYXSL"W_H"-#,V:N;)E/N*.J[!#99@V9N8Z4&1.207S7X((V'.K]!SLUS:
M,GE'@$8_#-YE+0%WTB^63R,'+OPLJ",D'P),!!F$&2^E!Y**NM[!(:W8:%><
M^]70!+ $+66P40??BXJR7=:QI_+7S\SQS4!LZ'.@8Z;M;\B:S*D+_70]V-!B
MFTVO2Y@AKITU@(NO\=S63!R^4U:#1H1%2M&>$@GVH7NZB0V0]4B*7O=0(J4U
M[T0&Y4#H"(!%FQV&:4AH+@#9X+'\HC^T^!_)H:4H2?0HD@1VA5K##TH[X4F8
MXT=8#"%Y*19MUH]?EBO6$XX+6+ED*P'E#@-JE%]RAO3.Q*::1M*'A"^/(MP6
M@,RK&#O%%"X=7O6BWS N9 _R3!7%42,;]JRHH-MQQ2^=ZGE;> IG&(F]&=TH
M[U'LO'TZ[-0T;0?-10(2*G#6T@$I$-6]H3)(TAC&E\*X8&W8G@XD^7Q6*%F*
M^1VB7G23[$W1SZ%ID9[^K&_4>%75VK^P=1ND"^<DCQ/[2XHU\Z<?(E;G7-SW
MT%E5$+[5 X/7WN:YD(HWVRKD3H04U0AQZN^B9[;FJ)JJ&_FY,/^W0,F/I/SN
M- L84$BY5/ [AZMDA@O@@*D#4CT0;OLKTM( 49 "C"0;OCD"7/ "1PHXUY9]
M>JZR.+Z2U*XZ!YBFJ)JI--7%/WXGI[7>=Q.'CJJ",#E;1-=+ZK 5V&K;?&2F
MYB\P$>[@!L)\3_Y8ANV$@Z1GH7%$)L(77(F=6;A^74+C_I2+XRP&3K'$/:4<
MXJ.@?5Z!>;=RVMTU=G= ,6"[0%%XN/YHHZ++-[Z7.OW*7%VN"%>26!C:NT&L
MH5U57,+3.B.8YOR% FGUO;GF,W7WII)ZT1(D+MDF'Y?!;89=DTH$,+:B]8B?
M(PU#_>.FV-T:*VHY']RO[R94X?9&^0D.SV&<SXLF-3AI\$&DF%G$=0?&>F]T
MV*3&!2#36JN;IU]B.]"BB"I)B753[4H<\SG;X[0=.$WNDP4;AI=X9G H=A+G
MWBBRW4EQ"I5/_OU<.11(%=DW_3E7K=WIA)#$L=W3]5.J+,OX*/ A+@1Y'9[2
M*2Q-*0-&>NW;N]T8,TP+OC4_OBJS4;&0O1 'R&W7P=QO43S6X6UQPA1Q&MNX
MW>CSF<)J_)O8@/$OR XP'Z'$FWG'+&?RPO"\B+%]QD.$_6%>(Y@8]UC)/[5!
M=*<8%(ZJ<HA:F+DKXBS)=Z9U0'>_F?R3N&$C?IBI,'5F/+!Q8KKNP/3;'.(2
M<:NM.6CO ),"6USCT&RR\L<'J:(BYZKBPM4X_:^K'0'FWG?-'DLF%I3+ ! ^
M?" EVT?_?*EM4Y$(:0<+P .Z++:FU&Q*7CV^R^Z'K]R57&>%Q0H$=H?8P:]_
MC/UXXD"1)+^ #"6NC1E6]U)GZOC0W$/-;FXGMTRLMS,J-EO[7FDH-X[LZMWQ
MP$-F"PP_<?;!XSJOJ3%!B0=_UN_4R,V*[YOY#\H3MMY"A'8:XL)X_?L3Y&X]
M? VL0M@1,\C??E6AHZK)\5;?Q[H><E#&451%;/<"</( IRC[@NU]G\<<,Y(+
MC@3&\7CDUC+;TRN9J5$=QPIZ1X:5XE;%6L@L\5D17XVJG@U6RKDB7S-Y\]DR
MFCYT8!#Z9?,U"?!MXN95Z-+6VSDB.HORW%,ZSO7Q7L6)V>",'! 0<]DY@T/!
M:U1AE>'^[.ZO\?:Y;^$1,$?B857%@X>J]0X8W%]EE"/[7UO&^J=0:HKW0>%8
M1CT.?ZQ]S2O,[_YJKN,F.R,8S7$;E#K';F%&!SL3RH(XO;N; GFI#@CND"X,
M:]/8QCQ;T3T>[J"57/_0\)9#!L/Q[%^V54:O8FJ5)#&CE1.*4'XI:5[$C;,W
MDFW! J@7#4)0?<K<\WPHZZ7X_I9IX,/Q85"E;\@NZ!3-OH+DDLTJZ&UBFX6I
MJSA,I5W+HWR5\L'VG-]4FA;D'H=/X3 Q"TW*!&_5%Q]O$'JX3OR!132[@=DI
M(3BIL32&!][&H,1;6S8>Q!4</1>/.JV'#W@[F:#C^AZB,TGO0@*K1]N/_;5X
MB(\A]T8]I#U0\#YQRBG1IU?H,]]4)("2/7\]=HYO V,"4%+FGD9B[V"&E'[9
M_8E]C7E+W&M- [8?M+DHC?V(+_SN:A(>H\&WJJ'D<)-XO6Z7Z\0BZ,3-(T#[
MS9YW]]S4. @0,$+4&87+DRJ/9OH\+KR[YQ,R'PB^39P<(F2=<=%2PM<1Q.9+
M0W+@G[T+I!+<1Q<UQ/EQD.J\Y?)4M^M*L:\;D93UZB- Q5FTO;7M3F?@^ (L
M[  2LV#?_$876/"5B+@R:-KF>#O@J=)#66,N9MH!Q8XD@JN*:RN#X05-4.<\
M$T52QV0VUHO,UB"5:IZK[U7,SWMT!B9X4P4H2FZ/OBLL_=$9T%VC"5+E*8:M
M*N5K MZ1G2H[SZZ]I1P!S(!B!(29B-NT<K<0=$>UO?D/2_CAD)4>#3@H2H*1
MJ1;H*<\T"OI^3; ;CB.SY>2[@6 P=(!GFK+=46/#%A) FYC"5F/.(KO+4&V<
M#-/8.,6DID#%0*),^T%2E*!U^B\+0JR>;=/YKBXIE5]2..NRS!:N$_OO_[9H
M&8><1+R0B7##.258;HF7R+P5OH'B1RB_)H4T]K>+71B?HVM08#FTVR/8J<?!
M+^Y-1"X^/Q:(BL(?$T%VD$L&=_%!RG/AEN-DY_)30K.F#P-,>R%G%II0L>/-
M=B;F=2O<!V?R*1K=!D2LTY 68U8T8RFLO9EQ!P2D1.K;S$Z:+-57BS-LCZ'.
M3SJ!*WURZ,HQR\/MPLSX,J0*?+L%6]4_P&JI\.S[21QTAP$OMM&+,Q2TT4$I
M1C9-AU^?6/Y6C+*#G-*$\0<JJOU27GS$U(]4(S+2*ZB*JS=-G.YG2@JL(UGH
MX_[ 8#5&-UR)40IA;(A+S>L6&D$IR5K%L%)@PNF7.S_:G;B-?MNH4XI0K*I+
MR/D&JU:ZX^J;>1?!3XH&<8"=" [XB<TPZRF4Q0 E@3@,!M#TFTBGF]W[\G2N
M:G,/(X\M/<OF%4JK4MT+5NV\'Z_JA(JV#(41@L2]#C:9C?JTK+Y=KK,40F,@
M\?%"FX^&=?@!]-R9J=D2Y)!)_9,Y9J^4$H'S97*,/I'D)C&R*C&ABKCMM4M5
M22WH]/>I(CJV8VO"GPT+#^D7W\+69LW[Y6_$#J/:./A>WJ&"/2#RSBX$J@X4
M(F(WH+8PVWQ;362^ <AL%@45?^,1.A5L]1-\2H$9H:-47OU5.M?M)R63O;M=
M#8X<I]>-MZ-J;%4#WS(Z",-_JZ]O65J^J*IY\.CYDV>FP 5TR(%8G!+*:>KZ
ME.7+[SFG41LD*"]-PII5_,9S_N]D= 9J/LNG ",X?-9CJ7&)FCV+:2)NAL)P
M35=969],GA)Q*2@-P(NULXGA%1L?K;V[WLO_8]&882&#1QK3?*J2,SOI[B7C
MJ^IR5F)MX+=S[)6%BGP(8Y=A%PW+T]?!4=P'0"AQ0"O\GKX<(:%DR(>Q^XZ-
M7B&]&WFN\5=>@X#_\KT/MS.U.R" W1*E(P!^_.V5X2_V%8XPF=A?OS'RYH)F
M=SG*EOT#QL>%SQTF(2[-]R0O&)8]R$,UWBZAHE\+L"T&+U8];EG)!2#T2 1[
M 9DPV6@4/*VI,W"=F!"%4![T'-_H-?O[0;E#AHYS%IV>+J75BUS?5R.WO&*4
MI$3T7_=S3W%)5FE7,;!!Z'=N-N]V'@%V."')_B^2IQ&VHZ?*RB"5Z=FSS?H.
MT?JL7=-%UXPIX\GM1+'VP?7S+I(N6;YNG66S[X0@H3N6BL3-5+6$6S$&'A 5
M^C3H+ SAG+-:X\.Q.$DC5/H+'"2/S;BY98>>YC[->.>KLQ*V+R=QSRA"Q.,U
M&X/&!0HGU<()PS@$\[)VR]DFX/^,VM5RKYALV]"'9A5JZ\I-/V!GW=;?3RGN
MHB+ =D< YC6!^)D[^:6K@M(>-L'$N7G?,+I@V]QD(I3K S U^*%V1X:0PKY"
MDUX[3X"@UXW+J<![ILU0S?=?**@J/MJ0%TB7>J]C[CAYN2":GKZNY3J"[L:Q
M.^G7*3*9E#HO4H!+>6"<L(WVPT=,/\"51!1%"\$=:D>MW0XF/&G4),YN=PES
M5C57Q<1-7F*'[W"3>2/H'$X8\:KRUW]F[/4>G?(3DK,4, S:Z9/1^]!Y25BO
MM*V6<!O$31]HKM**(RZ/F(Q4+8BE,4ND^G)/P!W)46,:DI8NZ[GZ8I.\+UN%
MBH9H1M1+E'M/1@66A=0])=V1*N.P^6//SD=DB_XV87[=YF7[_".F#B6?<FOX
MYR_V=@K#\Z0YQ0'Z$(A-.Q2AF6FS]DW>O$(2P^1R" B?CPUASY/A^85HF0KN
M=(9OXWC#Z9?,<@1RLW[:61<\6'VHW0TA?D,R]^6NCI69H?+>_C(CT*^;#A\7
MD&)_&;+5'R>2WZ-O_7*12UYS$RMM/@>?TG9VVZJUN3?3>8G(SSA6.5A>ZV*>
M;. J>]<,E]&#Y__D4I.-(57'D<Y-JSWUQS]0<DQ2K"-=J)JDE.XF/8*XOZ-P
M@KBWD>0BB&]/BMX%PTTGFKG<%N+;/2O$Q9P)A*=J5XA1FL2P8MA&R9CR$:"1
MT4<@+X6GR&7P8<.[$8[]*:KRO1OT88'OP?P&@DP@B^5&-S3J&<W_5R[I:R-6
M[)-/X073.3HO13*38MDQ C5)+!*:SO!K*<Z(R*A A](OPM*7.VV6^LT62@!(
M!')X5H/B5TK1^@%DM;AAM1^28+&S)?!P!/F3?L$ZVI+U?5QN(*\CE0\NTA/C
M,/+HH_*B:>8L@F/0G08^'4O^ZHKK^M4)0,06' &(7[V&RBJ^^92.D.]N@W%R
MJ3>^"1H:0;2.%7C:$+@\NXQZ8U]<EI?;LPU\UBN#:5:Q,YKU0LQH\&VA-$3(
M$8#QO F,837X:<I>4WA38* 5JL/PN/AW0/E*JA[<'^IZ=8(KB+0U*:]9$=\J
M &V$@#\"+S=U=\SRUXQ6!M1^D!7*>@:6@+U!\-KA6/D(Q5D<W7PM)^LY!X0*
M^/=#YV/<M\BO*+@2J,J/>K,^2;>6O>-1IA_F*Z"CTH6&=XX ;/P:@\-L-/_D
M@RV\=@OH+.+NFY0I;C^=GEOK5JCCT=E#F'[[MCE[+5UB-XVTU? ?IPO-P"&X
M_O=?K;1F[7_GI)HDM<5L.2*F+#_%P5RH8ATH8&7S.2?R@>L@ Y2Y[:J*B<W[
MXY<ZA/=Z/?-$MA4?I*%RF/!T',\4W:,%NIZF758,F6S0#S1>8(J]-#'I\.YL
M7$E@'0X2D@P*]6:=:E!]$6N9>>^=RO)GG$R("NB-]WK3XQ^3=K5UMM9!Z\D
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MQ50DGWO!!U6&?G/I5VCKR+A@Q7"0AL]A&EUPS7\\&&'Y=5:$Z^6?2\^G2CS
M)^F*SG,L-&M/X9P'FK7*W6/-]]0T<4*JK2#6W5[UR].W,U[ ZI753%M )Y'
M"<1MDO17;%KA>\S@Q+3ZZMO59J<M+$L[?B6Z4A((_'S6_2DDS@(5AW(,U!UH
MO_?$"?A^">:N7K0&8J+W8(!#[E+H]%;DD#"_@>3$K@S;Q!KVSHC[)=/J:\>1
M^9A_OY,HUCG'XB7$^KB&I/@^H$.4K=>F!A=PK,7O$M-SW7!%^A\>L*![;=)*
MZ=WI'/7-SFX[NV<N]9)L(HA;\W'A&B#L1EG%$[N^DQKLQ.X(L<,4-3=&3+&0
MU(LD#X!/7T!&)-A-4CV@4\ D!5=H;WCS1.TF=(I^A3Z Y*-$X_'T'OO:.W]2
M36_.-T^"VVQ HR*8>$-(Y?W)>Y'2\BN&<:86B25X@DJ@H5=TB^RM'-+Y]6\(
M=4SB]_J)Z]K^D521CF/1"CYOU:Y _M%WK@5? @RM%_DM[PQSS9M]BFWG:J&1
M*,;'YB@MH^W0?0Y2Z3BF\RQ:6[DX8[+9K'Q4X\ID=1IGSFF/6%4'S/?:P^A&
M@?%B8P/(E2FI3N]9SL-DM2OS)7<%2VYTVL+[[YQ\)URDCC=SIB,R/,YQ[ILN
MSQ%T"F81CRA+S[,MF0+,4T5D7 ZO-E9:-MP,#GL:)CD@0N' C9%$54:PUYHB
M:B2/R0YUG,,;AHSID=5YO^[^K'/9/P)84+P#B*"%L<1$4J5)U$4QF.ZAWDXI
M;Q?J^+X$7"(*(%/7:\1EBS5Y&>:/ )'I5S2D*83L6:W2UKNO/7;0:(0';K+1
MFLA.;V/\^>=>\+Y),;AB(&S\22QE$IT>'M;I_S0QCC$M?)*;*3[:+1/X QVF
MI'&>8HI_G@_O'TJ+SDF-\S_@U")IM^E#NWU\#M@2>U( 0DWK,_1+R)_"G*3<
MU>;$5HOU<6Y0T!'@Q1& %6YRH'H$^/9UINM5R;%I7B&'Q3\>1$K<N=)R+++"
M6#,OV!;0C(^M23EU?I=0&N_06YC0<BE@_#=3+)V%XMG- Q,B?&A(:!$U_62!
M[,2P_$F^5OE+W,"0ZP0>7-9UJ#>/J![*9K)]R5QJW(91KB3R$BXY0@LE3X)&
M9C'K1)G6&=86I<N]#ZO-2L*)P58UD6"'##;H['5KO^*/L]>^(QZ)+!EBT9T"
ML34+:,)M>QA;J.!'?U.1!6 $A%5:X[05UGSRVYA<D,]V,G7.G"*(VSH']]ZA
M]BH&]L9J^C75;%C.-_(MC3SI,'C0R:!F2#[39%[L=E=$?*8+!T&.IU& \Z7!
MQ&W;5:4B%IF'+#NZ]_ZVR_Z?#?**6^P3\.2?V+5S$3AP&_3[KN$DN%4E,=/1
M39%93%URZG<FNV7K'-L.F&$JQ]\ZJ[W2[J*I\7_?_<+_)DY8/OX6]:0L>>QY
M_353*-!EL5&2F'27&-,1;V9YW8!0^TZR.BN(,U?JW]Z5^K_QO_$75Z0 7$::
M_VOAL4/BO\Z+_SCLAXOEU*)O/^47'8GH%LN%,Q%X21%JX+QNN[R?R,&!JFIA
MYYMN6@E]1:AH(VBZ1,:#*JGE^Q.BIJ6KF\/F'7U[;Y<;;\Z#VDUBC#M\"_@W
MDU!]8TVK3\0!9UF,FA\A[PYI<M_]U^_QGT(_Z72)<%2.U:QNJXFH5)]U;9K4
M%S][52,M'70B70UA$6C8D9A\.DE2P3-#JEI8PK)<P%2=MQ7,'1ZSRVOY>$HD
M,*\I5&/M4/*G!@OMAB'CZE7S!6.%>0UDXWC!D.#4(Q],L";74^9_?C/WOX-K
M;%*.4.Q2=4A^K[?GY:RL#S><&&(IO23=7EQXN,#F:MCJG:?\RQA#RA5<DQY^
MI:.W3^^)E,;'3?L(R#O)-Y0O)%;CPR\8$4-<C(J.@*3S(;P+NMG\^@@ )""
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M^6*B)1L8L/78K3=^(O9^":(K8E>/7:GYI_\)UF[^$9@J+AP!^.[,-P,'4,H
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M!;KD4D=:,UHX6/8->M_Z7F8U(NMTR]5N>AJ*]MSV]N&W(\"D<.UXC5$6:B\
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MU;>S?-X9-5+0VB9+ZVNZ]7!RA4+K 4:H/B@I@B"@?/3+,N\#GGN@I:%MCX\
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M0?IT=AJ,?M_TJ_'WD6%L]>'5X=(1 :-L?@X!\TY8H5<HHOUT4]>WL=N]>-R
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M_?/+G':;W G-UKM]VV-)@4K/Q*M^Y"ST>7A:6EF(Q"3\?-J;WW/W;"[772:
M<<^_B!A?2G\GN1L$G9 [,0TK+2BG!MV2TZ1BHWS\]0<F F:)/;!22#DURZ_<
MR45^*S118VT%++0SF="86DL'/4DH;.\/*.D_Y%Q,6U\68U82+C\"N*(X@.RT
M>U>!I:5^!V"MJ1:DU,#<,J#3#[JV1 )*=XV<G?Q9#R!V.9D&X:$Q[BAAEH7&
MQ(\M*W8UW[8J?Q^XWO'KJ)J+M*=E,.W\1#C>$L)TNM(@3<L0B;ZWO >+ASX-
M ;&[SQ IAW\"SO8P[K F^6Y$!E^GZFMN@@4W1$):58E2Y A]/L/WJY/\AK'
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MF[*K*&>*?!MYLM$,K73U> F:PAT'HHLH+//NLY?E]Y_2M5P;M6FFU_/LSQV
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M5<U(Z R"3=K9B@M9'T)P4_6C*\Q201,CZ ""46WM>X5]5$ZIWD"C0.,G:-8
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M<5Y&/=6;VQXROY[R+>_]@V=B_"!$V.=E^D/W/RW[YA(/XP:4 &;CXUUALJV
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M6\6#)SOV[(P;:D2M5IGVDK7+7J=?Q]'+H[A1?.2\$H@<%(9!M,E_]\&I@;Y
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M1AJW%+,#=G9 $S.5GYR6YP0_$,]\[1','5U+2X5>U(RW=KY4WF_]G1:OD+7
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M2*@BY;66Q[N?711,'K3O\T13Q]?(NSO>J$;8J>5H2/:$,1?CR;HY-M>S@]O
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M\-MW[+OON'N?>^Z^9]]O_WC72-98<\XU9GG>YYGSG7.M,O/E-"><S#ZR2&R
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MP>'RELT9<X3Z2"JT7)&A^V*V/FB\NQP^B7I4%1BT>1@7\O%RO4M23$"&^+;
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MVX2Q)M6+WB]7JJ4/$5$"V0'04T!;?%00"D7-[<7[(]/%C<15.P3J#Q'E1U*
M<CV.K.ZGW4%):X14OUW(!-8#^SZF3>A-@Z2V#J^%F,M_@[,H_]/!'UV,6QX-
M0M5[T.] 7DS7T.-%6L$&^G5O:5.EU&@C)%1"O];\'1M0;MT'+0#>77E2?Y4B
ME$=JN$B_9[6:LH,^&3K;5#P!-EFV%R5].5SU!@\BVJO'_IBN%F&BEV'&46!5
ML0U+J05Y7$?=U*LD3F:6K:C_E-#<%B+8>R+4T38ZU,N&]@V,X\D13-R #*&+
MD&ET01PKS0U9,"O32'%<A;FSVA30X*%:0JTB&S K%@IGK2/YR+ GN/,F]5&[
M?945)5O^$[!;#*O.*QDAA 9_NZDQ*\>>%7H^FIFB*R3?RG-W%3O2(%MZ'5FP
M[+;;2?6S?P >VO9 9 >H=$,F_QZ#L?_T6/I_;_H?_3]Q9"9X4W@]Q3+#-'MG
MWZ7;/V^\"3L<M/2Z_&9ZJ!N]=';VP,S\[N!9L:/8<(;]*C.ODZ?>3DW+YQ2X
MDN/S0??MC9=FSTL\MODF$%:I:ZPSF,E]QQA',Q16Q$68?=^PX\$ET55?/FK&
M*J1'CM:/6Z[1W"VK7H1:TW+"@SK-(=M]C6GF>13J!*'[.ALP<).Q<HQ!@)T!
M+V"^OTIE08B-DWQ["O1S>:P.R#K//"SM+_[_8S//DO/:&,%&_DA08$^]!O1G
M+\2 \JT\)/?E1S;@J"BFM7MUP7TVP?[:#,5I*"G0;JB(;$@-([%R?*^H;![\
M>1NT,,K36G1ARO2^A*>J4\, WU&F1:NL\;>0[;R?FINWF0+,=,+F=AL;$% ?
MWZ!!@]"M:$HW!KH"E3PD',/M7Z$\Y _,L0'9&/I*@X_#RMB,,[]Z_36"Q  X
M++,AE V(Z"<!&8S]?C9(AXU!O@="?<:*>GO/?]]]"1U:80-DU)#9&NE,G8<T
MKU9+^\NE-F^D)D2.+U04<)<YI;[D-;OM\"]$I2/[E&Y/R*5N #B*- 4,'6P0
M)G%&%6X;[CZW'5<9$L(Z_*(4($.:9 H"CL=?<D"' /HRZWH)23ACGAF/0<N]
MC_GQMQ45W;"1+*VE&M8SW_R;YZ[>J'W]2:_ S%:UF>?U'JJE5N--M-9.MFS9
M(!A,*_D<Q,^2@>-&UQ4O"4WUV88FD*6,&DD3;24+!SR.C.- !+ $LU13U0O1
M-&JI<,O[]R>]@4%H/$.>F8'0(I_FL[F/"KES&#X,C4MO>_;FOP'/^W>YGQ#9
M@1JD.T<79C#):\\H1Y68*_356=Y43:#/-FB7/BLU\>6VB;B_5P04>V9E<^)J
MHM!OAE2T<9>5Z.IPPZ7;#TB:N?N09&]#BK8HOO =:TSKFH2&24+64 9[5VR&
M,&?>#I>9=&*B$H(;5#[^(0T?B["OO@6GRWWX\X>_4:V H0^$Z]%\SM7N2S5P
M^8[4FO/)UCPJ-F*=#?@#7 -TX0PK#YL*F5HYEL+\PM3Z8@WC_@1]HMX'IJ[7
M2']Z/'@"IL.P?FANE^8#N]9<2P]<6*UI6,BEE[W=A$6)Y8Y,E7YC? 6Z[8DU
M/&6F[>>IO8W-D)D7+_GLRMHZ]_>)T/]TF,7_DTE?CLDK'%TB"7E*6)AMV,IE
MD#>:A?V*SE8"%>E1@.T4 _(J9C2\286(AD!>%7$+4%^3BBLOX/YB Z[]">(\
MM7(M)[\F-.MPKGO"]YF^"%UNZ[^#E@]J1&P2YQV&[F'Z&]4A+NC1U!:6(%EK
M/B8YI._5G$P8<G7;<HNEN;C/O3T8!9L"U)CR&)-7HY]GV !9]!;V4X?W-MDJ
MQR"S[Z-5=8WW@FX=L#RW14BV;[]A)>9"4H*8A0WGV(!?-TRZ\&DCOW]0U5CV
M0U)4!' ".X0:^LCCV+0W?V?1A( :5<6)259N%LO;X5?@/<4,8X+,2%W'Q8>^
M*5,V@@*9 PW= CGW@KPX!+K>?^[K*E% 2SS.X$>3-5JMA<.YF^6F0BKS&"%X
M36UGV>*L)ST'9_\:Y($?C3!)*@]^_S7/RU=%;:'.:.MR1GB30:&J/+>U?T&Q
M8^*@3<^0I^1ZE['.G7<+3LJC#([UWH%94D8<8[0\B>D'[&FHB0^^PA!POZ V
M(:"V!VW?%Y[MUIVL&IY%F)W]>3'N,LAV.^KRSB9L%@/9[]?<8M*Y2ZA1X9P!
M(]7'Z)#].GAAP.?^HD"="U@YSH2[EW1@E\^"3[_(TZD2WUJ^H[_4@_03B%P_
M"!&&K04WCC)6G_ID^12Q<B-9MTPT:S] ?F_N3*"+'-VXY5()LEI93Z[.:M+Q
MSGX]PYM_T>=\["$$8U5[#[>39^<Q<XS5MFY'0R[M&C^OT$['S.A%V<>.E &J
M&1EQ)LA.O"I-^U1,[FC]4)U=KLRI12R3 DL"<K!$&0Z#95]'05UOQ"9;\)\J
MFU!HFQC/N1ZD<>@9BRWCTA6';+,]KGW?$; _9+3PK+TLUFFB!NOIG_08""D?
MK,D&](YCDK-8?'HXS"X]80L4%PC1;IR1&VA<K-EGK?=037:YJ%Y_-J"A8&OQ
M7Y]21C5]H6VQ 9 GH4YAU7O<_Z:$3-0IJPFK+L=DF[>.H-T-J3^O=$)NOG<0
M#R?USDRUB5XV4;*ICBL:^O8]H3^L>AI8Z92$DF\UEK$H'1=_?KTE? /F'HIK
M/ V9.4<+O((O=5XK"0L$:L.NA?8)N\'3)0<*)>SPIT]&KEJI8]%R*.=H+3]^
MIY>4OW:O;Z0\5$1YP@1AM%F"Q>N!1TX5T145 ZTAF*;:@!*:3$&M\ZL3P52L
M!FGCY2.R961P(:SM4>S!E2Z9OE"1"636#/!5QKD9LY< E]"V1F"=PC13P+)D
M,,=EWA7==6W=+9<H0NYM3E<FMZ5Z/>AJF='66M6@0FA\N;11W+W:JK"3I6=+
MD6Z-N(WG5# W[5FN_G&1@-@GTL<;"VE3IOUE*K^(.8]CEA4JP>7+C:6]:U,S
MO2>#%-<] MJ- Y6\<15/\:]I&)./XS8K#C9KU!4NGV6856AW*&3 WXO#1"W1
M[#Q]A/J)1ZV"F?IGCPWCUK=JTJ:@W\M8 ;-EF*WUNDU0.'+Z$[!8IM7?:Q2F
M$]EF6</+DWSQ09VO/=YS\I%"X\X[84#\O[/-X7^+Y>-W^ER'OYE(-YWK* "U
M,FRKWH]]KRF,.ZO>U )L"E-&@&:[E5K-.T3?I8XJA7?;#S/T73]]7OT\JI!>
M3DY:LR$?=,+[MU/TMUY_D)O=L,^@&P6MJ_E1#*]%;$8**A_8 (N2+9)>9\6M
M37G?J1ON1N31+P7-;.\/UU75D+*W'6(VU]:N%:0D$9&9'07JU]=*FN94%Z^C
M<_QE;\C*]1@F5\4H)%B%"I)9R82V./</"4(_NGU2O-JX!0A2SR@R!2K'XUH"
MMXCV'J1(@F1"SO)>_1Z9K[8D%,E]M9K"Q[=9CR86S1!]6Q26W[MWT:D^%&QV
MF:B5F_5#NX1-Q?7LP^5ZRDU'4G27LD $-H /XBK+\UT5XIAB9#1^[ <)2S3.
M6'U/=)1VJDI] ;%^$/)XI\WX=+-=I$$<V5?&PRQEPR+\DL.OM_@%/ []JKD)
M(J"<&N&TV1DA"-K6>\$&N'L<IIL/^"4;'IVW,*L) Z=GUFVTP82VO8XM3[H7
M&BIZ"F(O[H,:O)Y_U2YF5/^(I;OO]=[L<@]S;@&3E,V9BN:3XVUUZ6/4=%(K
M&_#J8;_'>%GQF&\* >*R$1UK3)HR8W7&?>T[DP@>VD2O+1,\U+>:*_?:LD3T
MO]P\+RV5<Q!BZK&1477K<5RH0ZR2I<Q69/-4N621#_GNG0&.+LQCYV-0K8)M
M5>U!O,7 @S3?K7-2R@>R=$#CNCGH@]^*Z\P<G"4[)"V\ G@CX'U6*%*R*V:+
MA-GYE<4Z(ZO$"CW#VN,]4*WCP 8T/?Z,ZFU"3=U TXS*>G=I)O0ET\/S?)'[
MP/(^>1]GCK(!R&.0&<4!R.(,9"/CNL@[2R!#TMJ9P9!B;E_:A^E.(S8 LU]?
M#2\!GF;_IJ1/0<U&D,V_?YV SCX:0XA[:Q5,R_/>%M[=:I^ >3/<R1%I\B^E
M=)*Y'.E#I,_U!=8=B+F:V< BOQG(Y 6D_>&^[UT4^1=FV-13!VM1:"7!4+$>
MWV>5>U >4I+UMYC;WU8XAROW_3/ZS'W5YMT^B1MC3X5W?*+M]5H(H)9;C!YR
MUNZD9&+C*"C5$J&GWEM\^_OB LBZ43V/7$I<9AQYOOIG0F425K*/MAG60#>:
MRI\;?SZ7O._T8Y&Y_?7'*VDX="H*0,6^X4I,\K*%]L1&L"87Z4/;D:TON^MR
M]F6==[05_"-E N8#98[>FL/P:IF40IQ1U9S]#9'8?5AVMMQ]L ?MX]N,^SV@
MS 8$Q_Z1=?'_O$S[CXUO=DJ8I>&*XO'+2^H]../[:WBQ#?WZ)$*+-)XD>TGO
M7$SY;@;9D'!QHT4T8#[=\6+MZ>O=&D=J9]&CG2WIY_#%%RH;4-_B ][BQ5&S
MT5[W3-1Z6E,3NH.'UA.H\*;V:]U^)6Z_K%U_%NV0HQY>D8^6TVQ*:&_%U8-[
MVU*&4_TDR],2?>.ZGW [:!''C# ^,3JP%)$W5H=GKZ.+P ="AP1&/3/XBDL"
MNOEOA!DC=V8@O-:T OWGFQ/-1P6TX&03_9BG-N\^GK[J"_,.;6\423?65NX<
MV3H-R-#_Y#R^?<^R\FC@04.AGU?;\]P,SM>Q >C]IEY-15UFO&)FG44UM0UQ
M,E6\%F%8@<N/*A/U+&] #!C#S"PVX#$;P$]+:(56CKK%?KMM]0#Z:^[#*X<2
M@QR]3+42']_<1T$ZJ3PEN/9E\WW96\.%&C$A7+#)C!_G"8D-_8DZR0:,8H<A
MPYH\OHNL@KLE/<?%"$E>53EDU>]3(D'F6CM&WZ% 9CA!2;*;F.)#.,L[D?EG
M_QWY;!VC1O2I8T="7'\=NC4A.- <"1_PP[P$7QU^MWL%=Z$:!62(XNND3V+,
M.+E[0=.+NT7'+8_=FZFN./$VCW A.[C4M_NBN I>>L(53CI1R 1KG#^'H[:B
M_Z9GWP>SO&@W9 4/7G\A!DXDKT$V^;^Q 0B4.A-($YC1D.>G65[".IZ6?\<)
M,=CY%MAYOP.CM<_33DBU[L&BB$4@P^PXP9.X+T6ZY/+WLS^PF>!+B+_Z_ I>
M.U64W[NBKPE-=0%R^=&+]!V#M$5*8%]1A:7-?29)MQ!4$<F\M_"X]> =AB0U
M+<N79HYJ\H*S 9J836P]ZS3K)Y@7[WXK2>7(HF<PWY3JFN-T-T[8/6A?.5=#
MA5!^3<46ZDK>7HY;5X(F\=[,04SB(S=[R7!3,G]*2;/4%+!Y Y8'([6!C[,!
MGQZA=KK5IZ@*)%MHG DS56RI1WOL_A!A VX\X#/>_7CSSHXLJT.!2,I4&7<Z
M/XB46>)^P^S;M11XP0 ^GA$!57Y[I1OF>+!R=2LD_FYJ_,I3;]N2VU[O&R>
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MCR_<W?.Q4XG!<ADS3*46ZSO5P3FZI[+&C9_*1X0>7NV<B;;3U?9WAT:[-)Y
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M-JDW#P_36U445!/\?@(H6$TR-@I4KWN3/\N['_ TA<KO.]?1ZT;V$MD*FMJ
M=OG('>*)_&[@-YSK"3,W;VE;N,P3*[9=)K57HH/2 G[9OGG>B_;1B@W :S-6
M5XGZM]*/EG+&S:'G8>?UT,0W\GM+D#2D3] <3:4+]>>#DE,=J!C$NB]#.?CP
MZQGZ49#,>Y=O3^ .=1H."?2,*.PG[)Y_K]:J.U8JA97:/!!9@JY!]TI0%%.;
M]N#^+\Q133*?4;T'K,>0RRKTJ*D1W*Z9JI,IJ3BY*G3:DK]TIAL\U:+N$W/N
M!-DN!=MUC:^7]LR'P W!S )[JA7>$;YN[1B&(]J9UYAQ4.>7]TZD6[$2MV41
MNW1Q-J"]$++Z ?MI=7?@%.,^$&8RK:W#"[WVQ4P_Q='H]=!@J/*!B[RMB1+T
M0I[9._M:ZY_?7/N_:H<6O$8E$79W&H8VU8ELP(OP*XJJT"%(F5\C^>K'$S+S
M;Z 6^ ,^<37UFI4TXB[03E:1AKF%4'BK;)8H*(B]PBR1X)KA*IGB6\4<IY:=
M>K=_[S3SFY1X<Z5K^M! =.A<;\3S!@7@@=$MH;U!"@=F+XN2MSK-4[ND'<@J
M1,+W2_P]K,V*RNUO.%?W=P@+%;,&]P;WN>3VUVO6TG#HE()?X,^TCXU+BHZ?
M919D+0)67E G8'<1M]&AZ7,AT,Z0S<0AD0%_Y)Q_ED3PB&;A[ I2A*[<R0:<
M"=)SV]ML4&:F%*NL>A<A$T0\3>%S27?Q/9 83.Q*Q,*,[/G@1^Z7WPX.+<+.
MUMU&J$XO>_)5I.M(@RU\VW*,AU*>KR">TBT0#E7#_H;UPI.^)8+1U=B4!^CY
M$XR.\6%<#$AON,[&QZ^[UO=,2A<VN4#5W*.4NL8OK&9P*I>7%Q_G8-<5E!/7
M<OE^#52D&.XE$7W6XZVE'L+1]\EJB^F-WQNF4E$9DE7#@;'S,<:26I<]/=K1
MMTJ'S]=,^Q>8WY!LC@G8LO?@'J]8.U8A\^V7/[HL]SUN :?<_LXCCP@\BH*_
MI,'\J1XW],5X12RTB[=:@!46.Z\'*V(]Q7EV]AV>-VDGPJ^ &"+9^.RQ;JS_
M'GXYL GSK.% -<D^53/D"H^X+I?"V86&<$XS@[,%&;M2)Q_DFV&)Z?U@530.
MQH>P.<_J'?1TY!Y(N%OY8RI&[-(/X;K?7I:@/>Y<A@)I,@E=ZEK2BM:VXRA.
M]7("1%R\KL41B)%VW%J\R8QE24\H5N2&]I]?K2YH[&,#'D+*-4T*Q[+7<J5
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MY"[+:V;N<M&^S_.XJJ9PSMWE+_:S:.N'SEG+OHE59=[!DS+;;  U9-!Z]4?
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M#8/Y*0C"1BQ=[TQ30M BP<\RQVRNP5\=]-%E/]-F,P6,KN"5D11#165H'ZM
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M?I;.^9>I.HA6(TO$03_X;+/>Z)*!S.@*\'O]"H"Z'@%$XU> ]1?@O5H /I4
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MEH/?*E]DR+,'"*5JFAQZI%08^@[QW@DS5>!ALU8EK'7$HR$SB4ILC)NOBNW
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MS0L_HE,/-62\ZV]!#V-O]\E.K-T/DR@""+:3,=9,$1:K_MK'A+!$.LKIE99
MV7#&UX> 4=G*'."Y>&H/3UYD]CKSL8N4J5D\2[@1!5]9+T.&L<BM\)T\A :C
MS!3SJ??7HUCC'H@<)7L.DP_(.*SL@E;DR"^$K8CW?UO"2DF^]0DT(=+6F6J
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M'E!^L@HYL5;[_L:+JY!',QC+16)3.5=Z+\"R1K/^7ZS.+^&:] 'M,CTO2H?
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MWVP&J-QWQ;<S%/G=F+OVW0%C?1SVD-CT?N2W.P7[-=\7NHL='+W#KQ+:AEX
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M=.QQ<:!EU/Q\3[VL4 !@7S;;LC[S* )3#8(WOP"O3+?=\@3I<U5P\*07BO2
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ML$(G-ITSA:0VHVT61BH]#;CIO)BET"GH_0$:)E%"&@FD6ZNG)Y5*[BO'&"E
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M9X[>E 1P:X8&4//($%NOFZ@S]BD-E/A,W#)NC6[>WIFX1^QU*52K--[ZYJ8
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MO39,>,GC#.+[0]!%-;?ZG*@0'VX@4-8M@V+GC!:FX[$1B?"IRG6B%SMHTG>
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MN;15SPFM6L+62:/6%I7 NJ-68RB>9:3?1,52T:.4U.L<1C\>]\U3J'U>;*>
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M<K-,<RSR*V0:$ORDP$1LG:=7WOH2(!I\"0C_!!\'7P+ZABX!GI.C6>0$WTO
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M1/N.[8?=O'KN[K4(.9W0'PP@?^ZN=B5< N*HC4]8%+ 4@[Y;M:3$^L]99[>
M'Y2]NT-Y=FF\_NT)2;886[\$O"Z<5R,>[<#+#)R*\LY'7RP:<N7D('4TK-_E
M)/WV69MOY%:H+R@;&[Z8SH/D4NGHO+390.ZJ@X[]8\;@>X,=9Q,QK7%RSYQC
M4I&_+@'E'\'$CQ1O=%YMMIOF*17<=ODR.P.SF-S%KJ4%?%G\$T5V"6!FJRU5
MD."^=O+R30"R*>7B%A&YJF\D]].+LTG+SY*G?R?SY ?A:OSY[UT&<J_&OZI.
M;(J;:' **'1E?_!,S+/;7^X=7=#;%HN2A_ZA$QD\\1-H4U^FO8B^K)&Z@J0N
MPH.*'KD&H:7$N()"!-5PB\"VC,^#_?XQMDO CQ"G2\"BTEF(.2X$JZHR\=HJ
M2>5G.N;A\EY6KA<!:^'\DMG1?V;[]V'QFZW1B4D+54ME\=?6K_J4>%?N>U#(
MU,6R_A\H;M+#6B(Y%5;;#)^/U>[((I$#":[599(6%DM<KQ6Y_S;F]\:7H@>2
MYVV7 (K - SWDFL8$0"].=01Q()4ME%VFCUXKQF@H.# (7\Z2*;,1([GQRG/
M8F6)Y,!E5ZJMZ]H"45O)&-IUNA3G4=#S!-)-2('!%AKTLT,W&U1=G[^V>&IZ
M5M%%N8#FTP]0/D D[:\3K8TD_BZ8]KNZ/]"^7JS[(N]5WY;*+5;,,^:27K!]
M7(P)9*<,$WBU<"B\J[.S;8A6Y7"9C:D4\=W[8D5A97U#J3L$*<0;Q/M+P%))
M"UO2MAK><VGVU8C9%NVHQ;>Q _7B+KJ>^L16/G2'GG=)>_RY)CR-(.BM'U^@
M9< Y#,:#8N(J6^X1GJ:A$>U70\:W!/)LQ)7.""S]%#TEZM;X$,Z-?(S(]F*1
MJV"DY*XO[<YL.51#-:1] %VFT7GWW-+T$E!YRE?ZJ4!!;^_QH(K4^8_FQE\*
MS%&_B!1_JWEN/AI]S%JIG>=>3+D*(8$%6&(]B>0&2T)WBV@?IMZNHE:1)NVC
M\&,%?] QA_I[E5CY.9\WUKKNE1#.F1(RU*&2DMCIP+U%C/9?(6I\&"4YU-1@
M4HCVX8QS>FT"#[B#@=8RZ[OX@<*5%]T0QC3">!7X)YJ$W N<:(T.IAV"F*N:
M:?7,B_FH1:5CKCO4XPYN<VJ1OED>@[L@:.'MC.>/\6O>;ZL@IC_26.[=%GU1
M44N4,3U 4%P"@AV)?\Y<OBPUPB/]+U+GMU._> U/H)3NR-J\_:%/EMMX\[11
M\,E)K.'#1%Z=(I.:WKQF7Z>ULD6-6=WML71.K0SY^?U-)/&<<"0_B3.X*!0$
M.YB"'@QX+O4CR'ISM&DHF;NFTU\,ED[UQHJ0AUZ/AM]'R [#EW(7'L2#00O;
M,S0S"@FHQJZ*BJ0[OSS=2_H&>.XPF=[G[J=ZJ_&9]&YFRID2>C(RH0U^AV".
MYI*]EY8_-Q_&]*"7&DCP " &+P%X+L3.9 'A^=@Q*$*!K]I<56O$I64H?WJ.
MQSZ_<89!+46;XJ>(5<UR9C'?QF@V9&;\JY\53<.BT>S>*>1W9'R1BA@Z2RQO
M,2F*R.RW<9[U*N@/O.;K8K5='!),4=MQOG^GQZ$@0T5V-FI12@WT[=-WQ-<T
M#9??ORP/4L]\$NSGT^\NT^>7DU=^G-_L2?2?VRR@[U+P@ZQ:K2_.CG8M7\6>
MRIX8:\-9B6P:_W=0J:$,MA+X<MHE@._*_(+=\& B%63:5:D>2J@_+FG,4,.O
M!!-U0>=H3G",'YP C.KJ'D(M!C<]H?F6H#N6UPR=+'G\9)?^$O#A)9AOA1-_
MYQP"D\ ;N:32QKUS$8N1Z7K.P!+CH3SG%CK8N>B2\D:6K)<].O6H4 ^BF^"A
MLY:T[\1)M!.W)59I<LPG^)C.-P:IOKZR)C-L;,PEX!;EQR8.!$5/!/=8U]G3
M5K&*IQ4-#UF][@Y^]]^5VH08!@T&4;=BA-KB2#9D\FP%5'I>U,:BV2>D):[]
M#OPE1>!'#>&YM3_ *+%176>3T7*6OB70-+1+E(S9SD3!H24@7=6MOE^-+;%G
MT*W @52*?9=R)A>]DT5*O('/ZI+(5RF@89OI</M]_KR4BI$9E]!()-4 @DIT
MC:6VN?8N3"HUSN9XP*4&N/WGR4++/HO'%=V$@(NZ)DJ,JL4EX*/MPLQAMX((
M!S=.,):4+OUB/$G+IX*X%>:B\O0W0A!Y-=?)DN'>_;*03XNWY%27Y!5VT+*]
M>7ZF](#:9([[23J?M4:T*Q 9<*M+P$P62KN-D0)BCK6-0$/NPY3'RSD"8BSN
M./DELG$_>J#&;=C/5%4S%_]T_5KC4"R<4<[I'+KA#P]68"((C#_ZV[*0K.LT
MD_,^4O^^R)*?.TE=PF&5\-*]GI(MG5QQ+?W3I.0$'PN?H\.YCFV%$4%U6..T
MR2ZN%9'4LS$1A::0[32A2$+^6%#VS;>8S1]O'@'%OTA1X@\.N.\Y $M;AN-Y
M)F(HH\H)TIC)-O_%+L99"9M,9[%JM\\%-W)YF<JW*!DC 0$/I!$6D)"SUE"P
M#3V1R=Z7Z-/HBDKQZ@]H[E*:HS-^D'?QURS=_YH\/WIQRA67ADG>&79"P&3P
M7_+,\1I&@9H_D@V2QM,H*O259#XT^^SV?28GK,OZ9\K0^7MS&R4OKD[[&B&)
M>]W'?(,T1?7VJXV[^9< VKFS5IS3166UZPQUITQ6Z#IFH@A%2>OPDS$M1N3\
M)&(U3/^=&E)KR=RC--*/;DCJC.6G%UV3./IV-C8HAB6E4!MN7Z%:-EWJ(8<[
MG2OFLG@M.B@:/7'L-N'F<<+>/^^7(386?Y(?-/3[7?QCG:IZ\D@1XR. T3HM
M@?H"@O;==<":HIGJDSA,PR+.;];7]\%7I+X9S<*K5:-:4:1XVN5F;U/KFE3Y
MWD_KH"9KOBS\H0!LX!)P/1\3CC/ZA7B #QU]E]J"6,FU*G53^0Y?'E$[-;*@
MG,NW0-CGM>ZN(Y8L(T\R^ )7X80;YD%V5<0Q")(#7N6/UZ)KDEK@'FM2AD[\
M-!$XF?:Y,7-G[V 1+%K836:!7&^E 2_E9#)@ACZ5'U%>@^KIX].*I]9WXQU<
MK*JC0 'OBN-%EXX?29P]05P1D.!0TRTX'=AQ'P"3&N;HVC)1NNXZ^"@)K?MG
MG3F1BNZ<_'QV:?(7XB[A#D8^.0PF:IV$PQ1*TBJK9O@**CC8N**M3DG>"P.
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M,V](9MQ>L(9=%]ZB?'N+$E]AA=H/AU<-10N\&15X!Y,OL*>U3[K_O.C^LSN
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M9+%=@=J]A* ^-J;D[.32XO!SL?WWEFBR-"/[EMKU:.\1J@PU/J_QV0VN9>
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M(6P-'4XTPP]!/@:I\A\#UN.ZFQ/:9>XJ #$_HG)F"U^(;?,XL[\2OM;]0?4
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MG69SDLE7SIA[JG>PCY\PH#%"T'63#QNJEOW;Z\H0"[__GQQ&(G5]ADTJ0TV
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M$.8#T/G0KA5T)8?':7NJN)FDZL26TO)G9OS?ZEK_HU%(\GQ<@:=+$H_J7WI
M<_%AWH9*O8WV(Z 4(:?9LX&A_OYD,<& O.4.%$2N0)D:T@?+NDU?]JH;5X%M
M3%X7@K2WS1[,TP=5)@O*]J:R'73GR?^((7.T 9SCM3>G_VWA3-#BR5#%R_/(
M;N(=7U^P+,-?X_VB=^P,HX?88Z'TZL.P^)T<[ER@H#M(K2#73LMG]*0D.H(L
M/A;2HG[Y1&CY%?"2P/;7AQ<P0+,BY.@FRH8=GD4H60&U5X-?Q40(WVE=B'VM
M(1%^;*1KKBSS1:6O/XM6X*>\$@-XZ=M_9G>2IHK-J(@P6.==E[.21#A@#W.6
M:! [TUTV')8H%.%&\Z-QVX<$'7)PS*RKC/;B-OSXSE%?\9T2K-X4% AS]<1*
M^]=A7G8L^Z>GKZ] .UMG=>N/C>0ZXD*;\GP'R^!(1&;NRO'0Y_J72>#G82^=
M>K0^<D29H5&V;6/I%S2%?JU,5_C];4;^+#R 7(4]Z(<]-M(!C@DAB15O_T+E
MKD![RM%OQX>3?PQWU;R5C52AIP!@J%6S924 K-XS9\IVAZ&Z(GDJ1/L68_X1
M9_F^V+M/W16/]3DC174M<4L)HE9[$V"YSXP4 "W@".6\G[=9Z.C$<K>^KK1D
MDXV)K+<7:<;1G_$ J5&NN'83@BOH:XVY>$N 7HDE@YYZ0(Z%$/C\FT1 'SW>
MY#YDH,AV'"8>N&FF6QGE4KDMIFAW,IN\A[YL]Z/G0-#BP_40\U$?/6ECJ_)(
M_H5#N;*_EAMN$>SM-\?G-6*6:$5^?N_V.UMEFB/%=<8=[3ZT[PMG:MMR-+:C
M^_O08D6P7=Q!\41'.WV]RP#6WMO*\G<MKDK?=(K(Y\%\<;VV\6V.$H/^0+N
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M5H6ZNE2EMW/[_;Q8 W_IBW%M9C2WHXV??UKMPL>NUP@%GY7R(0_3JXL[)5,
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MP<3WB"CO(1^:;Z>.FE%\=/- ^51C^ZN%$4TQW>'D,\A7F>&""\CXWY[6_RG
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M^TG#T,+&.(O%EH1K[42V:S*JY1Z+:I[I5X*6B96M23";6^N5JMU#NTJB  7
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M]WQ?<SYE+<Z6SGX?O0&7#084YS?*=XE4+98E.^XF;N]!AG,JWWR#F^VB6BD
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MNA %%1%0$ 4A*@@( A9ZBXIT 1$! 2$J2A40Z34*TH5(5UJ4(IV(-*E!JHB
M]%Y"[R24$$BR\A;_WN>>L_>XX]_GOC?N..>,]Z_!'"-?UC=[^>9<":$-TB8!
M5DU5#56 #KHNTUT& -H(H S0'SBP_P==!Z&_0X</'3IX\-!11D:&P\>.'CO&
M=)2)B?GX"5;FXVS'F9A83[&RG63GX. XQL)Y^A3[Z1/L'.S[1.CH(9R#AXX<
M.G2$G9F)F?W_^*+5 6R'&8:8ZNGI+@ 'V.CHV>AHC0 , .@.T?UQ 7^_Z Y
M,C(P'CYRE G:4,H*'*"CIS]PD'Y?:NBN+W0?.,AVZ,3YJS<93NH]9KS@Q'[M
M==2GPWRWBKYSW.O"\U]_\M+_R-%3G*?/<%T4$!2Z)"PA*24M(RNG?%M%54U=
M0U/_OH&AT0-C$XNGSRRMK&ULG5U<W=P]/+T"W@0&!8>$AD7'Q,;%)[S_D)B6
MGI'Y.2L[)_=K<4EI6?FWBLKZAL:FYI8?K3^[>WK[^@<&AX9Q4],SLW/S"XM+
MA(W-K6WB#FEW;U\O.H">[M^N_ZU>;)!>!PX>I#_(N*\7W0'W_0UL!P^=O\IP
MXJ8>XV.GDQ>NO3[,?BOJ4]'W(WS7[^$YGKSL.GJ*7P)WD;"OVA^:_><4\_]_
MI=G_4NS?]1H&CM'30<ZC9P/@ %4]+4SDWH$PH8]_P5_P_W<X;C2%;-1B"30_
MBB5(93DZN3ZSM&#AR-8_/XYCD&:5^[)NSHLM+P\8NXDXYA'U>H;M&)SRLI(&
MC B"VA.-V/5A&K!XVQ7O]IX&+)R:V&Y'QOD&Z<8_)L3R:.:,R3O.H% =F[:[
M]NJYAL5J@VC\N#D;#?B$:,3N3(F#LEHT@!F'$]_CJ-:F 7X7:,!TW,8]#7V1
M@7)JH#]HM(.6!DN>D/F6: #)@08<H0&_\Z8<R01.&G VDP8$K>&SJ$=3!6A
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M.EU0K$)]5NES%F0AW5X\>G.=8!DNT;B#<-IG8+4(VSI/:H,8Z$,,TD%N><C
MGYB:$20 33%[M"_F\OEM2=C]>F0GMBF!FAFR5CMM 7)?AR3\Q/CW;>(4*<,X
M*!H8W]( /!V<5-FNH9N3TZ^\9*M4$$@#T,AP4<O3J#D*$Q(_)(>@GJ0!7,C)
M&OB^'Y]'7 =#:4 $'&^.I9@IG\WJ[0N,W4M$Y^&0\Q-3;7M$OETL'1Q75#*Q
M)S@N20.^>T$^<\'B!Q/=J2<GN&C 9 625/GA(E]%WI%+VY)*+4PT0(D&;%B:
M-#^!)^&AH&YXO$@#MG05[&F _RQD_T4D[DL^?"&%-$(##D&*-_4G_O#5UHE&
MZ^NM?,%NKM, @6?Y!NY$+#TWR'V@!0P=B("T,L'N>W* B-C2J88"TK\/HI3W
MR9@E)R?]/22NU;Z:B-WKHD]$:(#TI#,</] /;?5Q^OO6'"0. T7O0K('%#F'
MPB&N1B9?RW<BM,^V]/:^Q&'G!\ [;0;+-  ^Z83%#QABM[0ISA#N=VBG'N1.
M9SL:<'NB!4ZZ#*,8N&M<]TI,$7#4UP?;(6VQ&Y;6N0,@LFX32@V[<,<]@7$Y
MR% /_L:VH !BFTB"2!^"\C(,HZJ1U-O;>AWIT8M@_ANR20IRGL(VA\;WOT-V
M21 FP*-0O'.H4223X5MW*.Z0%$7[\N:T[".UB7@EICZ7INS1@-8/F@98-%X-
MBLP&8ZA2W&YK09.$(?G$*9)OD%MWJCTAU$_[J!BU?8&?.:YSH6R"($/!=Z]+
M:)93*!2V:02^KQ5";6G!_ANJ+0WHND)8!X\BR<+$;W,.'R3E-"?&)7E']L5%
M0N)&..[NDOCJ2AU'3NK^=MD5+X4'ITKUK$PWD\,+9)]$O'QQ[=?D2[LQ"5$3
M4:1R3ZDZVW00<5P^5N-JA4'O%48>O%T+W%Y0E"Q/"A"$UY9!W-K,4_ #H$9G
M('*% [)SFF%AR24M9J[>Z9\C=MXK";N!E^X;I,C^7&I=77)QT5/Q#+;64V$'
M_H*_X+\8Z*;09;J4)&PH<J*4!G2'+$]&2&)_0X5N.9$&"),GB%!JQ;@3Q,E$
M[)X>C\^AK+++DS2@T(Z2M^5PE@:X))#0,ZA?I')2+!7^JS=BJ5Y13S4G*F^)
M2^G(M0U)7>X^H>'/JOF)DG>J"_3YH$66:OZP5+@XW_T??9K2.7UY A$Q^XMM
M%:Y\/D-MKL_F:CE12]&2.F]%I/;O]"YLW^3-%S'4YA: [DQ?# &>]AVRQ2-'
M3*>>I]*1Y"]&Q#68+B6N+%LQ-3>9\2%2#0\Z_Q:>0?H87?0*BY"]'_]CI:$[
M_D*^C9J;+V]5#'<LIO=^;M]N'YF98M9;@@Z/]G T[758LW<=<687\;RNU/:&
MNX<;Q9WP8N>BW99J'];W- VP1LK-UD_QA6>M7LAWF[[R];L!\9[[\LLM&T%8
ME2-YIG?BVO3+N+VW1C,)02Y(;I^'I-9L#WUE@F13RFS3V,CM@83-#.%LLQ!Y
M=[:ZZ0,UW$VI1TADLM!PTY0+02%A6/>]_YRI?*O8:EQH?7Z79GI LI7#-;5S
M4]6#<V(:G4-*!E6*GL]LK]VG?IWS%ORT9\Q]]A6#[0^CF_&&]*-&(3X,I-9,
MOQ[XT;7/WP)6$@*Y=?OR'[_+B?APM>+TV<!'&OJ]K&JVI&)M BJ,!CR%#]NM
MF*P59-LFBE:/WZ^?<H]R<-G5;1.ZIS[*P$V=N5!6$!8A4V]C?FUY</Z3?XJQ
M3I);LI<[7&_ZB3KP=,_@77[ Y7S&;TT^WF1W\+?&Y$00D9<+/Y?!4#!EW>_L
M:B?8SA/I7*.^.'=62.DUP03]!=' ;-$  D@NCW@0W+Q/.'"IV'\#-\-J'!#W
M*"/J TL[>BUP6U:7-=-TL,E\I+;A@=59>+_ JOO3*K1Q>B^A1D\5$X^%FMEA
M?2/2=5R-2 -XJD)*Z4)_WXSWUG=O4]=S)SXLK.C06[PZ+CMC8!N5SBC[//23
MCL&2L-,8VJS0W;ZE_>WJNK[J]JX3XTHX(7$>ITG1T#T]QF-3@"PU4B<_:QDY
M)N_S:[U#H1TKU=D@.U4;2_6'V]B;3AL%ENJRD#[/K]9>_.TO4^O#6%7V\H95
MBY'A:='(FP\WDPG*;.V21UKB:E"W/G-&'W>9RX@'U08T^Q2>N\V?/4["A,-M
MQ$>8IEC\:T5LX<S@60])2=\GW:<O>J]?,&UE2>)2,F0'A+CKVDY<N[YJ?I-\
MAO*<%$I0)A9^"6X>%^AU52W_6JO_['K(9&@]<",04)$U;RB]771%_W[_3E'&
ME3@>:8,JD8=462,H5<(4/096G<C*IF G_(BXZP-^58) >F6G6KF#;K+:M:@Q
M"T:G;7DUKW[[6V*Z3Q_KB&7$6E0I[AKTN;,_4E27V+:E>%(#?)RF%)V)A?AD
MN=2:G F52Y4V3RJJHKI00S,*.3++B"^'^]I4TPIXG^:[&:;A-_0<9@?'LPQS
MA?KD%*V[CB1$ZS1#*^$^!<?AK]9]US84=2+NQ^4^M6U-O]_V8UM.$JH'77G[
MR2P");,*5]:_58/TOM/#6890-;@G+G*?T'K?PBO%Y*OUT/46Y/,Y&O#6G<!(
M==L_6O/,L_[Q:*U&$W\^!SN5SL&VAJ$&3+7 JZ4!L2NHQ$$#OAA@P%"3+4$0
MQT+0V@B-@.]\0 ;Z/5]82 O;B,2GA0D!?\%?\%\,]$WPY^A=:>0)&H"% CJ3
M;6!^-AR9U@!.02<NE9[Z%3DS1M$"J1@P5@V1VF\/HCC) ;M&BPK2X+(X =X*
M>^^$)%S:0W[(0!FR+?DKZJ 0][IV]YXMC.?SS67O'YE)JJT)<;DNT3E\O3_Z
M8E1SH(7'>';+19T"XY+G'SRYLM1RV6H>J.4G2MVI1D&)>'@\2VT_*VLCH,5!
MKR^H/[:9UQZDYDKFH2,0)?%QDRE7?WUYH'4J-DGV@-6C'BR%40:^_6M@N%:>
M$(=]Y<-10 I;>'TJR79S%=Y8YQ.FV,8!B_!S]!$D.1*8I@7#)'V]Z]T9)HR*
M$U:O+\&>2Q5^U31=4W*.V711%)DKMJEX^7BJ<&:M>P6+J=O[%9V(*FG2SDC+
M3QI>WZ/HWJ,6^4!3&J.?F(=N4RKOVV%3R9J*5Y]O:*RZ?3S#F\VW'K/)11ZH
MJQ4I)90'N>BR/OABIZTY+I)!'*43]OW^0VER8-ZQB65H?OJY$EMU'\4L3ZM@
MT>2.O1MAU$[;Q0)X_$$O=)[':="H%IIXE/SX:("CQP%R?<*UM:K?:[??B?!J
M5V>DRBX4<F=I-_17X%W/7GWYYN-45JXN=MLYCT?E?EU]AN7GQ87A%1J0X6&U
MDNQ$?G2>!GS>2P!?B_J2"<X:903&>C3GXHY=Y;BOP,R5/=5?ARDW,!TT8 C;
M:&(4B+3]W%N:HCJ@V3/]K9=^S/Q.D6I&_JL#OVZ<X3^ZITQ,IN93>![C)TSP
M.X';WR3'O.^_&@KJ&:PV)'QKJ(CUR5C]0:<QLQG6=L@P14%4Q[T/5-T-Y"HM
MBNV3J8FO*55H X_DY3Q4AD;&TP_RWYBT9ZK)MPQ6WLDM(!TYZR>YC,7?10:;
MJ(4H<=R<:EU[_+7?Q3A>B%>'N?>EU#&^WOEYWO>.)O/8R53XT74%>5R!57-B
M1-6-O=]:IH>BU"W+;QFCJ?WVWVB \WAU K&.E.-+F)@"T9/B3/&U/2XCGYXY
MGA44<?5JL6M=N$7][0VT?,HOR4S([C5I>T;UG>MW+5:3<_@ICU7![/(^PS,V
M7/5Y3AK \= WR57Q*!QZQ93 WWI,R%@T?3IB<)BQ8OT[59/T@>!<CZ6G2%OE
MD*(]):AB&H8==/8.W;BR:';A2," *K+90TRE)CL@K<XHG)G2/?ZP?>;PIZ I
MHL*<J.K5;S]8'I%^P%82R7RX?LSD^@CG9$>$]Y2]&+/>ZNR!O99V%U;S-%S(
M<!TNP.',RGCOHVDY,1?>..G>![NW*K-"M"M-;7XG--" <NEZ73:[1+<8B_P)
M#6^D,T_^X6&77"ZU1[E'^"+5YVH]H*$UQ8-W0YP#"MC%L]$/M)\./_Q*%QMV
MVRWJYM9E?D?R5&U2%]2/(=^8\!8\RWE DAH?W^MPJ?!_5ID<&W7Z6MFQ]S+G
M>.UZ?)ZE6_/RXVO3+::2M.3'&-3;QEJRZ6;>F&L5P=U/=ZSX7TT.6\ZY56![
M+] 2T]W"<5G[F*)U[\>4RO&6CCWI52J^5C< WYZ]),U*BK4QOS/,;_@RX7H(
MD4-#:M=;8^;$F-QFDP<CY23S>Q_W 4(]^GA[%!3\4MN]E(>5U _@T87AU/3)
M)$7I)B7);X$)VD'CA/75YS//A 7X8V"MR8$7(V\L]E?2 )( NEYD@IGD:$:8
MRWK^F\?F7J?."8$S!5WA"@'4>-^/7BOMGFW#]QOUWR;ZU&#U^_Q^QI_*^)AX
M;WT/]G*XY:PT,[]U*/];ILKL0S^ 8ZD4 'Z44DT-&H&5I2P2^^!)1HM;UWS:
MMC%MZX,N-*#9VAQMK[];ZAB.J,E<!M6DCH!SY5F[Z)R!X;C"F,?.OMY./)DI
M^?82.R?*>B,E#Q:?' 2.8#JP#$-CX 0-*'T#GNM]G !R) 1J[AIN'.# ';OC
MQ$;=?<_I@+O)$^CK2+Y/@1/4FAQ?[\T'5I^7<++CW+CQ1LMIAO]=*%W4&=03
M1IUM CP0_@0U[/C]U$MC#\=&Q."IZ-:Y:BY$:.H0#YYA*ON&('",;.A1Z"[3
M$O=MS2Y@YFYL<G=,%^)3 EE<N(4&'#J>HG=+>#FQSD#O%8-@'7TWUIBMW>\T
M10XOW@AG]7&/:3#GZOM<3'HE[H"SOZ6H\3&F0QMT]OUX=F;5S[G#=YD8CO-+
MRK=&'O>YFN41A"O<7M:6.BP^[_FV6:,/<+O&^S"^\Y=7OXS Z-."WH66IDLJ
M$Y^&^7I_]JGPYO,-.*LE?W#ES^G+#2O5/1L7 QT4Z='Y(@:';%-EH8E+7UQU
MOV,SS.E:%HAXLM^^*>H9+>JG]]OOSU]Y;#5WU?ZXI?^WENV>Y@>38NOARQOB
M(SS%9"7H,-O^>T>V_H\=&6%BA*V8#+>;!I-,D0M]F"<D:"__?#V6>!2:.KM$
MS.+@HX_!2WYZ BCR+VP]5NJ/AR2":>QZ*L!?\!?\5X-'UFH,#1!8GT+LK"*W
MTN0H^%+'435P 338@Y&?TH#6*E("E8R@"D5BY0H0.U=11+4-3/<W*VH_8@H9
M#1>;9IG2!ZL2A;:OE=[;SZ!E$[C\G2KNWH4^#?//&B)_/ 3I>V.;AM+G^R/5
M5'.FO3+V%_M/1 RA15KT_:6^_;8N*O>I5^;9.+F:IUU?G\W8IG!E-T-)^K0K
MUTJ6H(\KR&KJ/-R*&Z'>6M?]&O\TWK!XI(:8'"C+^'82//"1=!7OJ$*Z^-%L
MT4MB@%/+W8D86BA65!/Y^^,+H(Y^6W(P?2I+K=#X[N<E;U/OL8Z%*5NR^)/,
MM?4G9K>:F2VTJXHJ=*\-+W'ZW]\VO)?AIUJ=,-FY4O[1YR3!V2/@=G^IQJP'
M[[B6772J?AZK9QWCN5<J7C..4.UP%>I)CITI[&^.)7!<JK\_+7+)<<YG+!NL
M\SO25RI2->2Z:O.TXL/<,_U3=):7;^QZ.9MQ^B,?3P29G^@]7UM95DLX1N!I
MX\VZ<L5*]F#S1X>]JWS#-7WF^?QQ3=MG)1#7_"LFJ)GAL9YF:D\4337 ;CQU
M/,[.52!:H-S.>NURG_)(CMG'YL-UYURFZ<,(-"" !A1-!-2R>O3#V8T1MEQE
MZ<<<WM$ :W:1D](,-U\I/7_J3)T>KRDP^1RI61E[J4/SI9&=A9Q'6.RTT"U#
M7>1USBFUAC&^J7)_5SC3LG7[8Y]79_A:/IST/_KCS=8C%2<$'0VP-(--'L_,
M>;A@ A9X.F;?+AHU-H^]>DH_SJGDV)76,UL"-69<D-=E]=Y\SI7,E0JZD&%3
MJ6F^O&"NFJLD]#N-8!6X[7O")G&<1[7;5"W^"M.%RCA^^E'+?)'>'UNSW'E7
M5;7ET^=9@B?PNJ@@WN.]CVI[.SY-5>#LEX^G7\BLX/N\\)MYXI:ZXG=,]F5<
M4,>XT+G0<^6AM]38;3GT;M3=903HAG,SXN047]:_O21R\\%R3DB.\7A&(2)2
M.Y_90[H>,3A2CSY<*]0Z77#]05_A]J5#=5([YH@X\LK:PD="JBS&"8K@)4&=
MZS:MMA&7^I-/OC6+&87F^1:!;F8]#6%7+RXNJP 2(_$2'@7U2A$L!+$6X[ZL
M?JZU)?SP+XL-:5WL"YSSZ^KIU/K:MVJY>JWZ>48*-LV))0:1.09Q:IY5T+#R
MU"O];-QCDQCE_><$(@;\,1S[(?[UV1_/'83[GNP?53%B+8(6AARY_G\[QW(2
MHI9<O3(*]/G_6*3O9T;>WT>AJ"5H^DF'%M"=5"WR(RD_8'EB>QAJ!U3#B,@@
M[(:.CP@->)2'H)XHG4*63EM-\E;#%PNP8 3'*IH9.9-,,@*_&V+W+MKEEI/?
MPIO$6X\'DQMK..<Z(L.$,&>W#_PW^&3Z+_@+6-C_\=E!4M'X9=MT&YG3F*[U
M$4VB&9SH1%# [_H]J<GF?6IW8=/I]$)=&*6)!KS)NZ_PII0/K(8&URF1M8VS
M1E\:-*7(B#0E]^L_H*8YZXS&0HU.J"L_K*[OPA(!@Y=TAN/C;-&;'5"W!^PC
M"?U!A :DNDV0Z%AH !M"@YH^XX%=LH?/(;SE,@<N('8M:4"F>NVY$-<(&J Y
M@\0)]\'G4\I!0)D&-.K1@".&.31 816+/P #+R00_5>,]E)8(&3YBP1^*#TO
M9U"%50AWZ,$'K7M&)_]I.XJD6:J[.V]/ UZQT@ "!]P<]9@&Y+*!SW:*JQ"G
M1C"4HH2M',YFPP;P@=8>,N(%[%^(K[5<!-[#]G%0VM:M/F$B"HS !]H0GGJM
M7 EBUSUIBP9P;?X34W9DO4$NLE/>D0($TX"0G+T9>"QF6QMYC3RT:#=-ODH#
MQ'IHP#1V^IYXH]9%&I!@BJ*X4^Q^P?_<$/TX2B8R%SN."%T*)UQH1+85M(#R
MH.0%RITOB%U7:/9N0397H\$3!?J@YPAR\B"<HO)/REWRM45OH*B&R%_8D_T#
M4Q'^-* ML_-O1 Q[!L"':UC"! %S[I]MH$:Y:))%V2RC 76'D:0P=+[^ODG<
M*6T$Q2@_49L&\&'A/F(.YQ28B-V8=:<!D5"]]\#^(]H_JG>/N(5-((A0C1,V
MQ1N)3:36SRR[3E5_*)&!B. R@40+G =E04D<#?A7+AK1 Q&-R*51&O#!3[ 2
MT]PNBIRMWZ0!9R'G>%%>=*M1&M:1A$X"AO%?:6:GMHL8-]JK@&(U=#V/,*"!
MV TVAWR%GM:%\9:\I@%71M;W/TL/PZ!IP)^[2Y%E%@G-_WW#Z [LR045$C4=
M0VEPQ!(Z0>%,Q#"+*FSS&!92%T[*W1WY4Z<YWP6-=N) 3!_H2D*K8E99TC"4
M^FT6"A1;3??#R:K6X9!8-9 ,T&Z"P:;[GUG]_@0+!;,.(QYRG$>$;N6"W5Q<
M-."7R%T:\ -),5#'EGP.PFX>[45NP&@ !^+Z/P9R^C^(*4Y$SB(]$8,&V!0_
MP9X\\IT%9?"Q7 ((L9G*-:!FE4 SWWO53!H ]520CNY_JN-+'#:..HM\/+"O
MH[[XJLI'<<KW;7@''!3.0 RC&Y8A%7UU_Z[B!N9/5=QXC(R":#V9@D."];5!
M [@'\A?W?<K4OF JU'P%!>PF0Q]\@W-?10$:\&<Z6@6":CLH,C<;99F@5(88
M[FD( !]58L!;?Z-5J""#W3S8A_T;K0M_3NO9&XA6'#4J=%]'A/BJ+ZX(TDK;
M%-(*23"X  Z:<\$VZ?NP,EA2+FGGS\PE[!MY<A<V;D34$=GM(LJ!@^-G$+NO
MEVC +A,-",_A)/[$UT'&/P71?X<E59)Z_KPH(!@I*"@FS/>)>8'#O)R(W5?+
ML&0$Q4P=6Y85V$*I<T5UP$"QVLO_*GWR'M& ?=M;/J$!*3 [S&H1[ADD"$,Q
M) B25!F'M.\\BMI-V,;\08[O7Y!#&'Q'\I%_@AW-R,XFJ@^J?("(PZ=!\5I3
MX/=B_]M6%\#1\9.P3;%E1#*<8N8C^^=G 7MMCO\?WH2?H0%POAUDG5(>"4<V
M\/"><F\PTVHHXY+*L7%]29!K=YY]SGWV:D>_8*EO^3]^XH3EF2%8?BXJNF3+
M(#^X'VU&*](-E[@<@\9/1A55E"2IRM^@%^!8D3-"):G&R5W)4C$VPW[G8;]2
MFJW=D1]361:LI<)NU);R787]+MU?\!?\%P/C&[]1V,9S4)@&^$$MB:9%8?ED
M-(JDKT0_B?S!T%).E<]\B2AGI"3!P[ 3)32@^_UR 0GJ6/BMZI!$.JB\=+M@
M5.%K>13=C9OBKU:E4#=W]4J\6'[&A\U=.6F]!8OC5OM(R;'^>'!8D7%6M6L!
M+FPB1/<?=@':Z;_][MOS!FQDIKWZ7PBYM9]RC!>E0-_MT5-W'8[,/=0L*IS^
M_33U<[X(P]V?RI?.'#P;<"/@/Y!_LD\A??\-478@"7HO>Y^?E@H@L,]RG]^]
MKAM']EE&[/,KN7O@_S)"J4&IEM#VP2]V;:ZUKN-EGPU.?-U[TZ%.$6*S^O\B
M-F,G#2A_!,.W#T_0@_#G9&3/8_,Q?#FH@7H#7V&Q@0K4O6HUX@H-B+'OIP'+
M1&B[VE'B>B!VXXX/5.H?>>M23\1UZ5.'X5/(:#D^O$]'*C2V*MS\;Q")?\%?
M\+^K1@F4*#0=#1AD:*$!&MT5XB,!H#:Z";$^C%R\X]I/.4$#HJ]/PLG ( U8
ME#-*A^T8@(*[YQ+JW$KT5)S/XOXCA_NN[2\;&N0DUPIRQ]0LLHP;>QX^U'R1
M'0!U#'2C[PX]C+X=)!VM]F#ZAG%*Y('7K?Q$#KS:ZE7";JV(G4C: D8(_QDM
MQ3=X?%7UA5NH5&1>*IM7\EJS.GW5D<!4L2Q^%S/$4\]O%)<K$C49I8[/QI*A
M[KPS-'%]E6.ZS=14_I)5L4UM>]I"V#4=Y&QZ0,O[AGB+>J$6X(1?=(^?M(<I
MT:7+YRI^LY$KD%B1M]B?<RK=US+\LN'EEA=&EH\:A9X?NON+S>C<4Z.HH1:6
M%<SD=NTW]7E2\123/M';O4$@U+HE_O&X,JHI2&DIVI,&# U,VG<V.YYLSUF:
ML\#EB:"DP-G6"=\7.INL#C,Q'[A_3^<]]=ZV^9VGN3Z6SES52@,0GALEPE/6
M [.HFI"<?$R)Q<C>(!4(>OHM\&)HOWK&W86%E_D93UF]_2]M]:I$<+ 9L-TP
M,#@-''_%HNGJ$[7S^C_M9HYV'V72ZPQ(V<PY;('FO7ZZ-T$*9QSXX6Y"+6X6
MI.,:=0?[5,6T51Q:8V-/QJ9$7U&2\;'X0I+$G<R^$^Z>9W8J6.>+*$KIAJSE
M&MM+)MC')14?"WQP0RT?J8D0H:#BZM?5]OAE8B%FZLA5KN'FK//*+@\#A?.2
M#XWJ O-R&\M-Z)+RIL##:6:F=R\^#HFVWUHV4*2RT;4J&J/RCBZ 5TB;*OB$
M0&BV,_3@G2P/7C%+>MC72E=J^FGG.U^^K9IBY._TV8?HO/1 #P^J.5=?8A\-
M$ 9K-W%79?K"T?VY4MD]?DO+LDC$2Z4L/,NJ].1ZJ+G,-WQ'M'CT]/'^<G?6
M7-/Q0[/5Q=^^3$?50/ZTK+&L?4*- @]HXP8?$^9#+D3SW%LZ46G_-H!AG//L
MSVGRFAP+3G_)8\^MUIOCJ,32M[ON6IM*5?3Z;(;^J1<O"G:Y+6X>%4K[UO$?
MO])$/T\#1HI![7)HM,",P*EG149J3]& UJOX8.KK5?B6IE$(.(;>L*^<H/H-
MT8 %W#\?(I7"R"HUZ$Q7N^/'\J&G2X5C/D0H+0SX"_Z"_VK H_[\!+A(?H%L
M+2;E4<FZU$N1E1/^B U5'T:H]^&&404UMRS )6PCU+^>(!WO#Q,JM$C>IZEJ
MGZNQP.!Q!D-/&%B-P<$/VQHE/BM$%=@FQN6]SPS3<BS*E:([L_EB< 9Y_,5+
M.HPO)@AN72/RW?P,J2)_S'9U"G/"UKU)S*3OCJ%4$3K6T^Y%5[%Z[L=C%UBO
MT?D.893I-5-LJ^-.^JEO% OW?=F276A5,WM85KX]T]"$+)N/V!9Z;^/FI19T
M_@=UCGDTO=?1-Z^3_"ILAB(_A0JG :P**L_R'DQX9#VTDP^9L;&(5G_^3B1(
M>.;Y:X\?NQ7?UQ\(3F68<%DTU++C)X*^G/8M-+7('IM,GN^H%-^UY_M]M*P,
MSEY[O<B")92B[T!Z]'3ST$?#Z1G&YS<5WSWR,NKU-6=/SY3Y[AY3!=9:-5(=
M"CSS^E-4*V\:(Q'$Q65LJ=$JC"5D.NG[.'NM?L9D!.)N><PE>$&ES%( :?#%
MA/OGI5F0B^2M2Q+$R2-#0?%2C>V\3+[Z5-C[QV,_II940 Y@QFHMIW/\&;W5
M]XGB\R3OC#&/^:F0\F"5KB?2R,%3W:&IL[W@FNQIG_>B)0?ON9\"WEUC>;^4
MF!".M1$/N_H\T+)O'15G;_N&BM8ITT^MB:)KDS:T6+IOI"C4Y3)V]!IUU#6Y
M:A=I=CRW3Z0YMW&*C[QHH\-3/;&-Q5G@:,!KBC99S4>KTBYOZ&*B%:=)\Y?I
M<(_0NJ-R#N?L(^0 13K,;PP3R>H.WBIXQ46;M^]RR8A0X]WZ@/*7NFZ"_#&M
M_#$/D$=!SD78$04^QT^+&C7%<V/C,@>T*D*X,QS; )>[ ,>@44!$$]560\6$
M;0BF'S]YZNAQ??<<T:?U4&\M0?R7C^N_^NA-V8DS+AAYU::):<?E<L:LQ']]
M* ,\30G)F.[=XM$X4)HGWL3U<IF7N^^Y^<:T3N1<_X/4I3YEK1-?WQG?9.0_
M1I3HWPL='X;)>"01U[IP]VJY\$UKGUL.6?5^-GWP@R^F5+E,[3.@E%8=T(0H
MW6E$LOY\4MYWF:+(+<ZZ:)@W]\(/;\-4KE-3&]?Z\*$/'/^KV'B8A#0C:#<>
MZSI3?=/-9?!KP>LD#\9$&5C3A51/$P-2YQ2W<41Y$*Y;X8* I?HD?OP#NS3C
MB^:#&1*916-G-##%F0'I'.TZ$929E=I5)-]F[F[DA7M.>2'EL1P3$UESG0^I
M*3YZT_##I++-1E"FNG^%<D;R3?W\7<+9C7S5.^FWGQA'/D2_ISOQSMUBN'I]
M:KZ)QYOXAK"=61.8V5CFYU36)?$4IF0:P$<#RNJ>QNRW45>OV" /@9<HNE5!
M>V9,)EA/O\?9=MTE-YQ+HGO*)I''HI;-D[))YO AIGJ[/ W1LB*"N+FQZ&7+
MMY8C6F_HYGZ\_O(PXJ<TZS7-MW3)+6LVAL1WLW%&:7I#GHG($L,&LG#R[X^E
ML9E5&S1 ]!?BC-TI=#$F8!X/"UKG0[=X9=B.7QP0-9TKO76M[$NY@0S\[A&'
M,T'BX$]X\01%0#I^_!J!.8T&U$M;[_;DSYB+9^HWOJV9NB73.?YX078&;K7N
MSXGDKC9P\LSC#L*W9S1KZVR/AHH+6'RKQPPX6SE_66#).^;G;SPTLDA\86)R
MDZ<T_W"1RC%A#KX;5SAN+ "%"I9\2U\\O!PV$UK$?V^]7.%K[I#)+2J5H;!1
M$=MY FEA(G.H(JA+>/4?00E)K8+/C+AB]ZC%-*"KOJ8*YTB)@1U&#O)"O??M
M3 _4*M0;"(P4T("!5308R;$ZP82<>4]2!NN(Z+V+(FE9Y!+D?BEU:9G<35%D
MUS/W\/]O\,G77_ 7L!RF?H//#%$,0&H6&-MBYOA=?)=/B9X&?&%&@3'_1T^T
MK#%2I.^$S0880WIQ66_B]'W"\8]'>BCPS(_Q&\N,W/[SAU]MNY_WVD3(D\);
M$"?]+LV6CGE26-(U?OSV$;]J3-P^8#?**-BKRNHT$"V\@+,U[+.N>@_3(TU,
MS?O7<F?3@#?H)B[S")&S%VN:?NYV.+T[=36>/_+5<;MV29:1D_4]0KQ<^/DP
M!:,*)G[BGDUQ^>7C4A_$[G@HD=5W,"?PT/&F ,>YVTB,"0PSQ<,4>\0_*"3/
MS\5];>]42!SG+^>?JQ&:O(0)+6,T]23K4&Y@HW0^3/)PWREW990K*]EH/[->
M<3XDA\+[C>70J >&F$\:4PJ??M-="CM,4NU6J8VYI;$2+9_S\WV:\;&W&S)'
M-@&#&SS7/+L1U3+M;FB\;M4#) Z-+#T8JO0IS\XK<&RK[G&BH[0#]ZAPF.NG
M8Y)*7K:==E%R+_(XS^05MGPA&4UVOJX^R?]R89RC1U2,[WST[,<3=PK>.IQ0
M>@![H>+F*4-?RFX4>$E6OG64[_3WETW&O##R,UN!EDG[&>6+CI),6I:\Z9Y^
M2'9&/":F^N2472>]CPA!M2C=S,S&9)58;)&AECVL\55]DK7]Y5)6&62D:J^C
M>[K$N;Z(K 9%%MV1N-J^ <&>MC UCHVQQBYEO+1V2/FZHX*^\Q6$G;=,# UP
MB/#501RZS/^D/SJ1(DEE"6FWE9G.E*F2Z4$*K&'UEQT'YYM3SQ/*7VVWH5EM
M=TQ^Q2?FE 9Y-[,((2Y<.BP:J?IT6FE[/6X27:23<"CANX4GFX7 I]PQ;3'O
M:QRO+$#ZHP,U Z_?SCX("Q/^N;*77-.*NR1;5<[.T4QYW*]@C%L/\@)S)L.9
M%/4;B6XTP+JTN/:8Q7L1^@LX8PW[U\2W;\MD"W\&RCQ2,YD-+[ZSI8M28"0;
M^6@3! -7MG](8!E)8<,$]^:HTOY$@H5_Y.GVS0.'X9IK^33 +KSM&";$CVO9
M2?B<J-/'L9O9?%>7.)C4!!AS.";'Z8H#5 D[335<]2HQ&E\(]H.E;&_53N%Y
MIO1&[$[ CZ[E+:2>>M.W^_SZ2 EL&(-SJ_'E"2>E*IZ\Z\X6;N8U;*;X*YA$
M]\'@0219@W=[J7^'==RTQ<GQLONI#>96"3&>LUY!9]FV,!'B^?:E6D9E->5!
M&V/-_6%35Q;JM@^RA7WOIIQWG:PJ]I[49;4U/UPU5O.Q9V;S\D7X5G=7Z]M(
M8/=6LLN%"JL$3)%XM=I8B=&OVB/4@L)J:7?[#!_CGM4MI^LA]A3CSPYR3W_I
M "FZ[<];>J-3IVK?1]Y.E(R6-N9[=,;L\/G7"S=Y5#Q=+^G$E/P^#AV';(?8
M]6[\#8Q>4W2HN042O@X[]>-T/?K-YI=*'(4WW&);/MM@%A7J>-;@\\F>"H_B
MYKEZLH0Q\4>G%3>+!%\Q:&QAKA*L5J_B&[XGH)YE>]0W>Y-^3#S+S)OHJ%BX
M\T+D"R\)\V%[5;P1>8+_NL\-@AD-"&'[@BQ:,<MW^4:>;GT[=X=5-NH](?6:
MBK7U'F\*;EG//G/09+%L.L/M7;Y6ISG[T>U+L\N@N=8:?9\XUNY'(?\0U,X&
MIPKT#OP:=) 4%]0.YTGVC'R(058ENQ7JFU(_*PDR2VW,*3)]![G"QKCT73T]
MG7URPULOAQ6YP<;S-3?APTHV?"3% K6S<T,.YN/#QJ_KU&=2.%J)W\]1[;[*
MR(E\Y"TG2U'X J;+ G)\=$CH]$SPTQ2SIE:-G(2GZ&1\IVV:O&G0Y(F,PJD6
MAVX=;5\X#GN0Y/W]R_L2T9.ZW6ROC*3<EKEE>*2OG'GN'6,D(<_D*Z+<\[R
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M&?[%H<"ST.<NJ<6K2.5XTO7%U0NW9#B53.G1OA6=-;XIB.MAGW,,8UD[T33
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M7U'1 CWW*U[78G%A*OCUD.>[90-G.C,"L86V-<5+H42F#)1R6C75DI")/O!
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MM/N=>^;A*%R*\K@_ L9:W$LO?/]AO/QQF*2\'O74N[1GM-SFSA *5SGAN,&
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MJUN%MG1OE+!KS '<(O'P?Q[H0>(U;L@D+[U0CBN%\?7^P/S/H87E>%2Z0&Z
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M]A[MY#5=OX2A&WNVK>,7$S>?T5GZ:<GM,;A9B74A]2.GRC@(XZ-8:*$$3+?
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M7-]7@F.Z>SO/W2GOQ)]-JJ'-7\*/5>&^?Y$F6 ?L2FT@A'F<GH!62ZAEK!=
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MFM!M@P[\*NVM ^7-2BCV'2O;/&$UL*C%3FJ[N=^K04]>H$-G'."+2,>U0[,
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MHC9=QD:3*O+=+>KB*GVN-8$F28.13XF+H3Z(RIQ2WP)A:4CU\X(25LV2QT
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M25X>@9JD/H[ =$O+P?R1Z>-?E!E]40L'397BSM].J5W-";+#KK0A9>-P.9C
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M^ ;S;<&8Y-)^]#NZS@+3+PFQ[2>%4+,5GJKR,YO<G"V0!@?;G54_Y@_Y#/U
MH5S*W:.1GP6S>$_>\0GML_@>LX$=T>BG"2+9(\-S1H09Y4^1KP1>=IZLU07E
M_<;BI%\07>'9;!B7H7PEEXNB'<FAB6-;1;+Q\)E<^WG"#J"L;+ 4A5&L_8:?
MZ;,L8QSG50[RI9HT1$6ND*IK6<; L"!HE7>CJW5/YIK(NWRLE'=(N+^[??=
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M'WG# BZ<]V<016LG5<??$P$O],MBUC0BFX=)-'6(V2C*2&-64V=0IV?K)R%
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MQGY?T1/ZZQ0>.P,>^SHA<BZT7#OZBT?]*!VH&SNMN2WY>/-I<GY7AUJ"PN)
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M$AB;)";P**+1^X@#G-@!03<LJ\;+.N]SY12>\RI.<</T7*-]QAS$UO#HW/+
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M,HCNR5!.I2ZMG?GR+"@R*)3Q &C*W*X'G>? X$"N%:+UT+^!?$S#\%62!YU
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M1(?Y2<916TB!?2X2+0SG_*#3LU'[M.[43D=OF#[F]I]6Q@U:T0I97P.-,^D
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M#=K@0':1^PIA N@Z#H1OR5LMR8^,+RF(',7%\G5W7(/OTH$%HSWI0C0NUE?
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MZU7ZSK.O 0) O\HT!Z*CC#8"JH[#)R8*1QDBN?"UH KTY_E1P0M:GK2 [O*
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M+M4CR%?U&; %57;O-F#=S?@6M L>0']/V?8)DF@NF@2)D@^-F1)*6IJP?YM
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MM-*$'@Q,?T=_AB@#-$IG0N5$<7>6W;(P)L/*K!;ID_/&>P$?R( ]!W:NR@I
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MYR8!0GZ9\4>Y=]3<F_"_=Z_?^VC7+.OFB8OF1!&5$2'@-=+EK*(0V>O6I=B
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M;>.BIQ2OO_RK-)(DE0S?;L71;?)Q?RMC?$'F_!.)_$PH05)TASRF7"J:Z<^
M\">$4V(!BQO7MB-P?P54B*,#'[$)_:C(2=D<2<JSC"FA\]$(._4M#9;UQ"_'
MH\B2>Q&9 GWY&9^[:9I)(\95)W2LNN[Z:U5-]R.-GO'.77[=K?,WU%_M/T/]
M?0@43TMW+\>[ANW)>ES-X<5<4IOI<Q-9T;9E871.FF!N)-W,2U6BO$G><(M/
MRL Y.'+BJ]Z.R!^@XBRBSX_B[LBTFZ7I0,_CV^VWDT=>%QE2*:EKFCAOQ_E2
MOUZQ]U/>%8IG>F-=&+&Y(<U2"M2:W]Q+]Q)S]T1SZOE7/4YTDCID#N_+2L*'
MOMR1DV"*5\#+)T1?@N=[J:^OK5BGH4.0;^(N!:J%J+]LLRN)XP%:7C<@],EC
M_QW #ZD1.]2.! /&#A#V&I:P]KL35<#''6\8L.4#9G^CR\'S!H<)M0P8_ZOG
MW[KNZE]->#]WEE>65/B%V%\EO1:RE?SE=?B9=I6E/ ?XEPLAXC>&=?@$#B3;
MSK!0/-V6Z9"\&%]AP*KN,&!345LB=0AF*][;%(=)N^-U.H )<30QI<TV=83;
MOV@]:^2QZP;WS)/]WF:_\/Z$B;<,F!E\]YHC S9A9\J U?:HQ,8[%FEV(B96
MQO*V:70T!"X/3C%@$3JU0.'VRMUQ[! P]3=\Y=>ZS6F]!1]N%=]4_1WF6>Z*
MJ0..C57X9,3_&K-WA(7,1H_87+%%EN50L#Q%/PT5;[!"@U@_'_ZA?4AA__3T
MVU^98Z)_"IH+[P62)QFP]RGC1?2P;F#AKHZD$>?*+Q5T['B\#)RB9-$!'HB9
MLUTD K^P'1NW922GW&C^XLA=$@,VR.Q%H/(S8$VY-%$&[.=Y NB+.H6Q8\#>
M):<Q8,8(ZD5\$0/VW[D 3_HID [*?H/1HSX&FD9H\@P87G6OC&A7A68-L"Z\
M &PM<8)O!)L9,&N6G;N$(,+60@JP(*V3CG8 Y4=$_BO<O_2KSO]'6#]MC5+!
M@%WL\ ?(=Q> 76Z=>3_<$O>2\4G3<EFSTR%7\1?DY-G5]OV_?5""M+WJ2%&8
M,Q25J1&'*O!"<7^W7N<J<];OPJ[:]VLPMH*BL @OP<40"C EL&Q+O8'>GHP.
MQLA-B? V)%-2U,I$;<X$UGURK;_VF MUK=_I%1-3S!=4O'J1I@K(.T)% !T0
MW20^15!FT/B5: ;LT!G*75(-V8X4Z(.YY9A=69(N5%QDT";9'#I=$J+0XG!G
M1XV<'0N>A9,A YP0#0?/],%IJG#B+^BML73V8L@<%/[<"U@6P72/W+,%CT)L
M\XKI!)9Z9!&^*]//G TT36 @(<CV0((?A+P4J9(T*:)(-<YO%PB4Y5Y,U"=^
M9>O@Y_15BZ"(ELW*S=;O_RIIVE5IV(^8)E:*0QKDG@"T/F<JOA9->>/2+ZZV
M)WD3\3&9P'3V7@G)G,H:!DPQR^LZ :W3IHU8UY&%H.S &+0+$_LJ8^#5:?.*
MFEL(8VA3\"9!FP)2@?.'"5<9,,AD[S!1D&"I"!A@N^7\?WG@WR'](?^_0OJ#
MH05LIF@S8-J40Q-"-D,2'UH4^QW=\ME^JAY]9C8O*?PG;I7)8](;,G=5"K+G
MBY:EK">P1Q8U@&H@%>T]5K-N?=SVAN53>G.-3)RI6NR##+^AVIF/XR;]0X@"
MQ3H1?P*S]UE5ICIB%T41]6[!R2#K:_0E[>NH@P*MQ<??U9R]8#);:4F!IOQ@
M$H4K"V45)Y775ZZ(1R/5 Y@U&N0KS2.D+K[7?MRG>(S_^K,P?+-[O>UTC-OO
M_-X"./2=&J)$*%76N\4CL!9W;DR7\AS!89358G,N/]3^_6#\K6&?E8CS86&)
ME3-\4OCS]&_EZI94>:!*IP ?Q,N*O%N]B]%Q4UAK,3]=78@RT[MY_T)9:>')
MDZ(+*"_O;D3>,@I>N7\1P2RVHCQ67=A_N.?AJT]Q+[5)-9=^R@?KH:M7SO)Q
M/"3KTM_3N*@":.T-56)G<4^!JGS4UGD;B@C.L6CU^P$_^::+BDY* GDS;H^E
M/F62=Z\FY(O^330&_B\MD]Q%5OK_*U/ $D("H>)H#/-$\53%"_GNK"@YK0LL
M0E[R"K<-B__97"G'*31G=5.'E1SN BDX-KI096X*19T<_HH!:ZU)PM,+D."5
M<F.SC.C6E?GL:T\A>=@0M?8%AU*@APVW&D+%/R=_X$O-6WE>EGC<-V)\*DG8
M--7Y98=V(E-7N3?R]&*N2X\P@HEO1\M=W';!FSZ]LO6NB^Q/%?A#=C4AH%=V
M25JS/<LK#%C?2 V<VK6/;MLPOB$"?QGM<Y&^\"V';OMTN*;P]I1WB55@IQ9V
MHXYG[:>G6)$E(!GZ&NV]1;.DMQ:M<SP @J2?Z U8?&; <C^#+N$.XW2.-V-9
M?#BR$>=.3%\!T?YM/?]&!]V-!WRV=D50CEU8]HJ K+PO_"'_9SHLLPP;Y/%C
MD'5'8HK^L8EN6Q1:<^[1_4,_WU!_=FQDY"ST0>*?4>#O_3Y$2'BB[5"N3$%!
M.%)-H+VLXKW714UL-_N2D;!>+&)0IPBU5J(&D,:6C+/3^2;NJR_?4E&)+&.Q
M'N1UX8WTN'F)6"L(]K2WT8:R:Y*6,D"\<E<\A-38^;W=LR=#LI\A$>_KF5EJ
M->$Q!MS ]D5HWB&)]7- H:LE<LZE;&O+L/S6,9+G234<560?W5=>_+(C?75K
M*)!F#4SHUWN3XR%Q*S2CV>8G1#SC6;\S1M%V)6Q0)>GK^8D36<F*N^8-X/Z"
M@4[%ZR?=W:3.4!R>MR*'L@\CD=&T:RE[\*.D89PP8>3/[O1]+MHY" APG)LF
MF(*;)A#<?$;Q=&;:_?9OV,&3ZMVER"'@YU)GE+/$A<H0LE AKCVSX&\[&-A3
M E'MS9"KT_?3Q=P!VH7=WO*WB<%<'Z=O-R*R# P 3CUZI^R]$'$/(?:24_3$
M1:RLD6>=*P/F/:0#7S&8V]' PFWZ5H*7^1#/7HC/L_L_=.&B79WQJFLMXWF"
M8&/[T7>"L*J$F[V^B6!]72*[:RB_=1]XGQU@)ST$;'WJ1% [?9]ERTC^4 5S
MZ_]X02SD:=?J_\/>FX=#^?W_X].J?5)H$5,H26BQ%'$7V2LAA)A*98M)UH0[
M"1%-)1359 MI2+:L8U?9]Q!CR[[,6,:8Y9[O&;UZ;9_/Y_W]7M?O=_VNZW==
MWS]<U]SCGC/W.>=Y'LOSG#EG6^#5-5ZV<6>!DO-%Q\6A1TUBVF7'\?/N;1/>
M)TJBJG(ICG[B\9BI6OR0O?!LJ>+.7?M2/Q(T7.U,GDP*N.LZ\1'<+G:-%+>\
M&7AJ:>+4-[Y][2'[;.+\!O1H5,VS_KO'@\N\FI:QG)2LYA/J!TTRBFIHGI*5
M[=B6 6:>_Q?0)^\2L'QCX\WG7['-9>^>%OZZH.P3/.-18/$ATFC;Q!&GB/7X
MGQ9K/[>;X"?94J3)3["_BHONN[8),-Q$)W>"$?PR4!?+M".PSAZ'<\0&D"T.
MA^ N8#3[;6>W5@^Y99J$U?9W7Q?SJ'M;FQ4\=?+S,65-?K,_!YY(8J<(.TP%
MQR9F^?;5=SKKMK[9]_*@PQPS;N>K;6M%#Z.8 _RMF"X"(.68<[/ '35SSTD]
M3=T6F$G:5LN7-_3:_H/N&LE=D>D'/[R=1[UI?6U/B2R)W!A F0I$@18_R18H
M*HIPO>\BT92FGK/*8<=L^)%7.BF*S]^+Q4^G5\)ESK:$.8D>N-<,YIX4^+<K
MN5%C\@JO9?(*'1YWT+'?DY'+QH6D"2:E\1[Y2BR(HAN=_,C53*2U&AHN)U&X
M&5^IRK1%KZ)I.@_^/Q4[12-G#)<B\G1K+>#[V_?7P7O,G%@\=$>_%<6,M8R.
M/<C5%*8A\%6$+4P.JO?I_ 8<BXUUFDUC*<B_Y*!47P\CJ[C@IOFO:ZPF7/J(
M>T:HJDP@$ 46V^@&0/+]\QU#I)G[N$4<%%V$$:" ^*1]7BQ#!*/_T;IQ_WXC
M+8[4I\XZ#M[:!MB>+OV(!0C:?QME&'F !?ZJ-T^&$L?4^_.) UL.DV;GO:OJ
M(,J/3FOV.G<"78# E2Q_O_+F'I NTU?/7E,$6*_$!=NGR=I/"H3F1.@P$$6-
ML#^F\XXUBQY)!IRH$A,*"D^94@$,$##4#(T8%G!0Q9D@QFS^_8;]R#1=']X$
MCZ@#TXJL!\YV'?3OA_^K$?;\;ES\_U'C.O^M*?7_R_/3WIAR4"I[%\ E.LD*
M'AYCXE_!?;F9]0R^:8@B!=&CH']<,900/FP9@<'K!0'!,D(JC?S7-7[R1 ;B
MI3L-KC#G*SFH^M8%S+'_%%IS[O]N0THLL@LHXT=@F+*VJ2-\L.U/PFP_%F9M
M_MW]5?^W^_]/NO^_#*5?_=_^O^E_Z#_U_SX<,*0;XYG(F@83=I<8=E!299SF
M30>,-BLY0H'SMZ"'H["=+W\W ]Q!)R\RB@:&F=-==\\4I.?F"/,7&,J>%9[.
M$M^QTCJQ4 %9NS S[B,G[DLSUP]K5AKL+WP_W8LNVWMUJUYCC$JHPU98QX?
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MQRW?UD9@,2)_>,/J7KYLP,R@'1^G<[N.R\*=$*!)%GT<0U\!/EW>.+\*M!+
M7U^>_W]]*N9__-2R_S>_RV\;HYP13(^F76E.S=+#O]ESOP[.J![L>=;U\,ML
M^V/):W;83,83]<?I! 9E27_$LY^IH.GD4A)?%K39(UHMM\GA3:7140L'PX.?
MM!+7+:-=O;NNR66T[Y:'_X%T1UU=I;"U==G['ET8_,"(Z[E&=W]_C2#/ TT3
M*$G;2CQ_QL?T^^NF:6ABQRUCU'U<O^"S:<].C%I175]\"_HR)[@S'KO9XSV9
M??W#8QZ+MD$DMG!UL%?1E?IN81_29KEC@C=IO 1L^//6))]]ZJ_.7AY'!H'@
M."29=4#PO=\\OZ7#D2;':UG<PVA#]&W=M\G>W;X90%M\Y?P;F??6BSL+T2&9
M=_(LWV,TC3%-\9\I;7@%1O5^/J87Z5N&8X'@6Q+U#F:J'CF>,,WSN?:S*U%E
M@&TQF<\6X[>]\5@O7T2AT3=UW72IV<[TM1\^:#9VF'U*E154NGUFY\\4'ZXW
M/?[R4M!$O5%L@46:M,.UZ\$S&BOB-$4OMZ3T;SP'Y2==PC-M;.^>XB9B%"6_
MF%28Y<VU[(,,HS+L^VMOV#_LW_FX=F*;BZ];R(*XT/YA5=J9>3/)ATR-O *@
M*ZS)=7J4N/IV0>2&E!0\^1Y(XTOEMQ=? ^4QU=:A#? L^DROM; =>+\V)T0N
MH)?\E8Z"$J1= I)S;]:;<5-#GGI;[)8<ZMHU[V?L(C]Y,W.[QO<D3*X'(F=R
M0XD/=?W\L?<9=FWR'-0X;C>>/8I"L@;=&K-&RW.^KIE_W<7::&=&Q^E%"\YW
M&=&,H'8^YX] 5-2-X;;;4.:+-%0>KH?W7)!6$;%U@E-,AZ")=]#KZUUTI=,W
M<6T":B.?1-JRTOQ<A.7[G:=5X'"EK\$-&A95Y65?[E>-7 MC+&/;2P]4,8A5
M:ZCF?AS4B6;Q^5IW?0][[4>"!W=_F0?\KY@O%)H)W^[9R]@=%V%1%K7^VAUS
M.[/',025(<9Y..#0+5C?T&STR!?WC3MGQI$\K0L^]V#%>?7S!<LR[SK]S@K=
M$0Z#/Z\I..J *:CA9H4J$L;'D;2S35> )MNO-Y_:R4T**3RE1$Z6)8X9>P)3
MD-!BS*\MM>^"Q_D#UQ0'KRVK-0NDC45MM\(CO(+.Z:K#3*U97_SB,-:AQY:6
M]\ NTNVCA<@K_S=[;Z&35AIAZ1HN.,8* -GTM1BNZ#8-K*7,45HH\TFSM[&6
M]H[3WQ>_+;K:MK^V,SI^A]A !]:E"&;P20%HOP;3NS&4;F!9&F)P')2?* =5
M.3XQ_:\2-5FBB@KL97-@S*_$ \@DPED?,7,;.:BPH]#$!!9P&J!7O1"X+W\8
M& 95(+I7 ^$?V@A4.AEBKQ, Y1R!6(Y%=2""K#4XJ+<J )'O/>6@J++H#2,=
M&*HX &+*%@A _^1-'O8*>+ &RDB'9[GE[E4Y#,S*- 'Q7P^S=F 0!> QO#BH
MN?WF@** OJ#F,940WM>"R#T&C"S7Y*(1![6F#E#,26_@!Y>)<NT.TE8,-R@@
M9\J82ML 4G%0,X8#&+HC(*R1\SG =X!'&7"!R]SK@5'Q)R$;0"4%TS)(?3L:
M22-HP->]8C#7B86,D.=X_N^C_J='E:$[@K 9T?O[HP+N4/7^_:B?KE$"_&7(
M#7-M')1G'7BXY$M>$.4#>5Q6Z##<G:..J$;2BG@07WC&&E%#ZBI@4%%6.&8/
M<%__* C8[3R8L77RCR#V-G*EU)> *VEY-PYJZ@$2FSY5M,OC[/:)W/1''7U!
MI 0]6N52L>Z(^H>,+4"8 J/+/5)L,>>?)8'A -JM@?#G<"!+%ZQ_6Q;&7Q>V
M>TZ^&--X]EHV_HJ]Y$'CB#,\U"K'%Q!]4H_6ME2VF]DW)[V;FHB.1Q5+P>4?
M[0G]:W"T9WUPTEQPF*QB?]2C)$>H6T;0 L?M>8'XLT$Z0;O*<-M5_'>[EI'^
M-V.K<*K.T,F93W+UZQUN747FQU3QMW5<B,UOOQ3<0015D#,8EKH)K6X%XHM%
M5GZ]8RF%LX![Q6M E?\Y]D?^&178,_#E?-<\2B<'U;4=H@<+EN%_9GCGE 7:
MB"_??L0[<&H$Z0#/*@D4VDNHXT4:8PV6OG86^G<L_9>ZY\DU.&[,BNR[O@;4
MUVZMP''%KBYPLR)ZU)"=!;CV+9;U,@J^UL]!@<^!UGS!S@>A':/RNX VW(3U
MG7V%5 [J8MO*?<>N9^2_,=AD+"H6K!K!TEJHN)L9Y?"<X/.MM2A[%.%WUFV<
M-+SE/S'72[X[V)$_GNFL;W*B+(]_?T/,MR&BCSWBW_QU_,#'9..L%@N:\F,'
MRTHRVV$0]$3A[O>&'F6:@<29PW,GS1?7]3D4*"16AS(FWQ/4#=E.9C1D4T.=
MPOAZ\4]?'F$E:NKA"$EG@X'^?9$"7EEOK"9>(#<RI%7V"9\66-$1OT0^QNTE
M>6A!I^,+!.A;9A^E)TQ _J+YH+MDE,\L?V_>+J$J_+S]XRU:Q!(.ZHUM&&,H
M.3LFR6['[)3,.QZZE:$?@X/2F=>:<!C8KNOQ_.[NY.*NXNW"+;E88Q771F$C
MVWA=\5KV(W=7#LI"[ !T4E)'6?S\CY66.[/P/5?-%[,\A?@65TUNVB<E@]5_
M.->]#P/O/<H*579!;ZY>2+T)7(<;'U>(9<02)$[T:(KT[&A_=_Z3_>')%<M4
M7=@'XEAR=Q-EG+V>'1[KT1*?3QT*]DHZ3E#[JB+*6I%-;;\O=Y:/C%&T"<J^
M$;)*._)%_<>Z9;1]12OI[@-2YKWX\BYO]<G!X.ESKXFXB>C[U.&;Z02?(\K%
M<@PB5M2G@Y3Q(^]3+75%642HU _@+K8^NI@K'7Q(7/_'/=1EQ1#ARL)7>06V
M.1IW=6=5L(JEYS*-]Q$J,-7(LKG'OFD7/>+4/[7.Y3_/;YX6,8UYN4E- A,C
MM&;B%'\,%H748C)ODM:E!02EGH@4WIH7YM:K(!<2^"%8*0;9R](\SC-]=SW3
MP:!R?;72PZE)Z<W:?)2/UYYJ?=G].#9_K-FE.T_8&,.[DYI'3E;FT[_X^G^>
M_M[MTTG>'D>HIJP./^8=DC&6&GBO[$4?<@;N%6TKE*&%L.,/%O&/SH[DR2:[
M]X^&K4L),-^MR?@*=5;M@;=6>%VG3!=[)E:D;9,]>S!-4'MX;.>#!^GGSVF+
MS;L=K^*@S/)&U0TM.]\%"=\0B4_1OI*4\I6#PE*& 0I\A$O=9[/0F#$!>HBD
MJ>W=*@.X[9MRWFZ52>QUDR"Z#V.@M%,N(BRACA;E^DIWP^8]?7PNF.&V[)M>
MAD0+"_7E8ZJB>RH7[_L+#SZM\*H4Y9\/?GR362#,,^;"+\;VUC.,_>SGE)J&
MZ6*8+LP:LO;/SE=R4"\?G?F5=+I2XSK#E8=EU?NRGWP59XE%V=\TZ#*^\+5X
M1,4RJT[AT7S ."S>BT*>YTX8O/N9H>P8@M&AME.%D\4M5 <0A/>\]GM+[86I
M8=R'0);M7=7"L*F[2HJ)/9=)AL$I\NE6."1[!D!$SQ.39UVE.+B-7 6NWM61
M>^T-VLL\O<IQ[0XF'1<XJ$OZ=64="?E*0056<65M\]L9(A%(N"IW* I[98*A
M& V__- %KQZQ7I7E&O9=ZW[6I)=@S"TC+Y9G+>'GN9EKG6N^?*:_^/'PX 7/
M'1CH+:;MT]0)[Y1+N\32BZ'1J&M(;NJ,S,91_<L)_D6:WB]3TK]W51Z*H.ZG
MG=(\F(_GBD1#K-U./(/Y:'&6M3_1E@TGG+4&P[%&5C>?P!C=H\]89OE^=0^J
MF!8;*?[B[KDOLU_F7JO=XO6P:X/N!.&&6MV4EP;EY#[TTJ!T:S&Z'58[Z,1-
M/R^-SEX.ZC9W=-J94.H*C_B'F:J^O8QZS?/3PI7O=HSST6 @(;V=CM[P/I_#
M3((KGWO)/6!/J@+?C,(,6"1P9_Z>5L&EF<!H$3HXJ.GP1$U*9ZW8RNZ:LN;E
M>8QMQ%U)RO'YKP)9DN8RB\S/K$B6!)'25H^1&NQE^LO],;5XS(U^@U22=(A1
MP4&U)Z;=P^WFH Q3'(".XV7;9\4^O@#9BC[\3/')%7E1^4%8I3=#ZH8V9?K"
M8-!NF+Z#.W?XGKOY[<X3I1#/>/:1.T]45SP.>28-FV7'5= L5@YZHHB60>K2
MIR&;GI'9G]1MP:#D-C.M7MCG.P=U^!SVH5F(^-91ZBO7XNMRY":^C:VG&$N;
MUD9><+K%.A.(F%_\0I@Z!M6L*T272QW0(PV7>S=#7]KF.BU>=1PQ4QUF)U7H
M?Z;4A1YF_WR^#NY8A)_&<M-,5S[2RS2CMQ>IJSQ>!] U?U/Z%2<DE=;-074_
M,=[8[N<B<'SV!'[!&M.6/E4@'BNA))>)[PC.F4FX@XXX.-UF0Y[Z$CIWV9:N
M$OYSVTXA8O:9G=TI'!3Y)'*OS;TKE7A-DG_B ;K_L49)0MW2#&*P9-6V<K-8
MEQ9I37:FW %ZBHEEU(.J,6?-S%,3!.?VI#2I9I8^T=)"<_F8_5IG_!&'&$VA
MK_PYM%!7#X3<5$^*(O3IO=S<^VL6\9=1.[QDU&3#=(E5.#$2Y9EM?;JN@[:A
M4]5E^?G$&FGLT<^Q!4\+L!^.#2&GYE"PSGT]7KMGWI.J(*:Z5 ]XQ\K2SM .
M8G3LP;"[CEUX+%E!OE 0-FU10S;=J.W@B".UD2NX@VZ*W&M#\YTHJ#>+OO@1
MJ#OSNXZ$::T#(3U'&OO&/5.]>;61\+).NOTYKG73GW@/ITI>)9?D[2AQL+A.
MV[([[N4CP(X: _W2+S$,[I", 4.R&A^$_W*_0C-.:Y$-?&"Z?>\DS_U@<2 ,
M'<C?,F,H4^%K5QV4FE&:6$TH8 13+#:M'JB*RJI3K=VU GE953]NM'.&@SJ/
M&=U*KB?TG70CM#-,WE=9X3 _<H)\'AZX,D,YMD2/D$W$EYEJ91&3Q8! 5^?I
M@PF:(ZMLJN+'5@6&]Z5H%0[M)46;Q.CK/3D74Z&90+\G+=H\]T*9];Q^1O8G
MA8-Z>(W9;GR+>5 "B.!V:W45@SL%CS7T-HRWH]:Z/M^] ;65@R*>ATL+WSA:
MMV[GH/((;,])F[AP'J41)ZN^>/%I[#>X=P7+EDPA2D'#-!SSI_VGI9G\*>>=
M>F5,<Z%S;;T69X8D^$N?H,1V3DO*D]FWO>UU\D;$TJP>%[R*^JROSM]RVY]/
M_^2J/_YV\7.3YTJZXP\W9M99/7WR492'A_\22R=CTOHX!^6[;B15=J.\?="U
MN]MW= 3=V'_DG&<+EA)JBYU#^R'TM".7VG_,7^US>.S%.I,]::7 IDG@J4=D
M>C_"=#X_EF0LL&A8;>[B5&BA5E/F@>P=W]65<@L&FO-)F?F1'F['W]%?RE"^
MBP\ 0;[N,CW4^ZA#<*D\[J1IRFV]0,9I@NN^$ XJ8P^295JTRW3%BZDI*\@(
M:@I_9S1*.U(5<D)-R6?LBU7V;BL#V-XC#Y=O-X9F'UZQV I4[*DI@'9X!\=^
MZ*0S>V>4"[05J,[DUH@K(\,L=2E/_X&FJD"DK:P\E((N/YMTYWZS=S:EXB0'
M9?FBU[F=?Q)>21H,H:.18GF(<2Y\@(/*HE)%?.H1L;,G3].B)W,^3=8SZ%1&
M?Z%?;R3K*6$9!_5]=15W!5V1WT9D:&E)XQUZ4: ]8/,[B?S4M#X6F1_93*\J
MB5AX.MH\WFE4^2K2>8^+?[QJS,-=3XXVF Q%LHZK56#G+F1"+(%Z[AK[<7[^
M(\$1/R7DTA>5.*A-YZDF;'XI- >U*@.(8*.X/A)=5"98%L-KZQGF=:YQG[E2
M4NH&J[.O!-;TI2_D]Y,NV"33G"1?$Z1\?FS,+R>O,F\OS\"P(N7J3-28CAS4
MEZ\4/:12FS3WJET9J^^'K/2!7_($L/[SPL%^PN-O]X=Z4Q5>*^<@9_%-16W_
MVD8XI1;V/8-^!/VG98-WL']L(BSX>Q-AHI"1RR-^M>>;-?CP9V/S8Y!QW0:+
M<UO[%UB!*B ZOT\G  _H@(W= G_ $7W<6=QU:L.E)*;0'(F],65.E;LM=AK/
MH1[,X2#U_[A7<"T'U;D>6:O6+Q.*W7G"8B :^]!3(Q*7BI7K-*V_<K3@Y#WY
M")Z5U$Z2UOZ$_<F.!@XW?<X!I_C\A!$'I:ZK!DSH36 ?C3"4GVA^N-&@ 1@>
M<V"H^+$?+ERX>RR\KGXG^VG1\AZ?6FA%9MHR[!B-,5D;7EM;4I@5%*NQY<NE
MC1^<JW06Z_^U-R^SLFC3O]?Y>9%T0N_X)+W^'];Y*;;7K4LB[539^;#.2OA(
M^CK-Q#>'L;KHO@MSXLF,L'_NRPN#>&'YL4"Y%L#_J<DQ<O_Q_W!L1I18A,^V
M+;M0V_%)/S3'@V=FO-\SX!<N*M%Q-""?P_*H>':P (EAJ([)P+)>MX? $^>S
M.*BFJ.:MK!T;^J'>#,P,K@A$9GH(/'HBW+R7NQ%,+\'7AY<N6N;YW$=<\3$^
MYOOH@HK&2T'-H8KE&DR]J",*$B7%*1#%%+^H0.8!?5P)S;W1R:=@D;5/*8*5
M)!ZO]?U")NIMUUKF'=95(J,#K8/JM@DYFK?Y-JT>.N&6]M1]R$VVJ3,:HBRD
MW2/-UE<0Z > C\>;>%,4D'6"E$3: _HCJ]ZT=9K]RXB6ZK*-T<R5P5+I,6[5
M:[<_7E;%7PN7)<'6,&.9/8&N&,F2S*$K,%=X"=/7#W1!V^F03JN4:Y?6SV )
MZ:SC^TY^VJ/Q31B]LE7Z[IAX=0-C7_!^XH;2X/UOT00.RK%^47X2AY! 8,S=
M2IWM(_G.!2%"=#.3 -7I!+,,G_F\%\_;>9AN\-?L<7B>:<U!Q?E[)I8IC;O2
M<7V'K!_RQG=>PV%F*^R<W!B9,JSZ&<V$  =-U6'6;D\9%B.=@\HF(K*!Q>""
M>6SI0BZ+-HY;I#]"F'S>>5V(CPCWR$^/;$UKV?P7#KU"@#.J=_ T&9[!!>9I
MCPZG->DA63AVT>\;9<>,_8@MHD@GF@I(13;_U:S7\6:TMJ,F:R-,C[+R4FBN
M[\[]C#%(9)BHLU.N*78#\PCST)O/95TNQ#E4L;.PU(1JWEFMH>B^UVGV'8$L
ME"&Z[)@2%A@(GRIZNT[/[J;VU!B (K"Z*G*@270\28V^!0Z7OHB/LCY&WF!"
MQW%0H!Z,N7JZ\6UT?M)^4"=KEKTWRR%.G%4$<,E5D'6@@+#9Q75D5J$)0@HE
M3WJU;L#3310>?;.S@WH/0D05:.7X(?A]*VB;%4XFT?UR@:R,[-S(D3B6'40_
MEYK8WZ7^.;+Y.'(?[^+^DH<EZK-7+S^%>R*'.4NB.MXC6R8_J9)L>I35]@[I
MILI5,5[ON"K\Z1I\9#\3>I2F,D<Q0].<GC)VRHXZ6<RG"VH.;-?<HJ;PL8-]
M\KV)Y:'VN8@N=_MU!%HS:Z,-7(IYWPU7]>1*\+RORL?4& [0G:^TF4>_-,_]
M@FEZI/MV6OB=(DNG$./9MIJQY4"3EW:DC51B\H(IQ&A]1T*[Q+370[1F[@\@
MMQ4SCH".2\<MO&JT]1^E':XJ+T<D5[/$N+\4BNR_AJFPVBU<)WG30T$#NWC;
M<-X*D9VGO'GR^J (Z[9MI\77 B70[Y1/'_([ZR#><Y@M!Y6Z+J&K6?8W/7"Z
MF)D^'C;UG#"FF8?UV1S(R72]GBG)LO3[Y"T'C1X*9'SD2567_8OOR;A-HR'E
MT6O6*ON<.@OHVUZ'2]^8A0I)W<^60H]A1.!ZCOT.TG2Z/HD[(7N_A-1K@*:D
MXA%>;W'$%R@<LAQ?$;IQ:+O\_J(Q+233S*+J%\\K4+YKTK_ I4]]1,AU6@&E
M\M#$E%UG6!_R5+Q;.XZ#<E-CV^5['?]D7&,2>9B0])OFVRN0/9^AO$_"WWU#
MM=G)_:.5 JT-POV;H==8\'3[:&@ZK5UZ:\,N7X:< G-;A3QIS/7T"T]0%5Y=
MRQB/N?33Z@,[2,&G0=5$&EST!"YY,[.Q'WKA _G#]-*N#X=^H!U(2W.K<5CN
MCMBQ E4NQJ#1&Q/- PH/&@AO;/_)09DF^8+P^0$4/=1G03Z+Y.BKS6]H=?79
ML[U.VB6YG[&+@SITH 7:/)=\#%;<BC19+^I/^0]_K\$&8,DMT/0+$._S1UA'
M<S">#,.Y$/2XN3Z]2B,L80:]$!XXE[*VW^+ N2C_SQS4G6+$]5*Z>-2-G2SY
M=(SG4"];'C]J(%/V^I!KQ" '5=S.398/MAT48T9F3\Z%PY4)3.\<%G?YOG>P
M5_HVV<?>/L*VHFF=:'8F-VZJRMB[X.KC>':67/Y_@QDJ%Z1MW0_#?2L:2<,/
M I'.+)E?F)/#9N.H1$*..5Q?CEWX'C?91IZE;F/3]G_:!.[7NS>'7:0Y+0TG
M6V+OQM]X8TYPS :&\"$(#,VN2=)POPQS0O_:KJ:IRPIEW6)SL^VC@(#,XG"!
MBE=&I4#<^*9Q4%LMUK80><R3@'G!#)Q5)#X9=^=ALS #NA%[:J6'CY$W3J"Y
M8&21R+C@0*EKSYHH0U"2"8JM]^<+<S"T5KCRQ=_@9E<Z1K;.MFA'22>B5WD8
MD1/T.HPI@Q>!*&M/?:S';\L[WP)DQ[UG</A)1+XQ#,$JP'FA"!^1=_9,,3"\
MUB+L[E.:[ QH0),E&5W!C(K"T]>CQ\UFO%0;V^-J."BM,0'ZH\MP:]>EZCE]
M1):X/.U\'.:^ZPNHU:Y+DSD!]#PEE!X!_8:: S#]G/0P5X(*]&.="2/[D1]4
MN7K&:R$1 #:8EF#E'M]I5Q$+T8IT[VX-!>$9ZT7B\3AJB*B(U@V:()0$['D&
M/6]V^M(I&_0"%XZ@OHTM4Z2!V4O/_5JM?FC.\GE>,IFV4ARO-*-%=$E/7M$
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MX-?+T;]!)I6#ND9/;6<;)^P::,33@U5:^YFX0H>-Q;3UB C>_%%3A6B,1^H
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MVF86KHY*9(9HSO^"^5=_>4P)$N5CEJ3_/L$U]7D!-XU;"&B72&:1%]=DCI&
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M.-.82<7LMWULN'+ZKE"W_E8"EADEJ<BSU-KOJK]_(I#>FIS30-RA%L8=9\%
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MA&Z6Q@ZUP97)D2 45&#30/->7+\MF/:-R*VN61;Y'X2OU/7@/'I80Z!&U(\
M3=B"9Z#)&S\&J1_O "')Q;4N(;F[8R2KL #P=C>&?'UM+B'0X6BD/*L :'(+
M9Z6+O2WOPU\+IS(2&^H^+/C"_X@YM1BN-G^#NT_!@C2ZL^X$X<*FF$LXF?X<
MP6YFNOW'K(N3>XU*3-+R*0;"AHTNTN4!Q0@-X8J!]1_Z8IPU'"RDXODML9=S
MU@3)@#T:3D*CG!2=BO*#7;+G$TRO]FB6.[-ZG^ X%B<X<]H:VBD:_1^IGR<,
MUY ?/#CT+WR?FOX"2<ZCKH\C:]YS+MI)BV[H@'BSN/ZL+RA-J'(3M6Z2,?ZI
MM+FW#(2?^Z79R+_Y71Y8E>1,V1*RD872["S IBV_5@!ZC#)#^1TOF4+H$C4"
MY<><#:&0VO9?>I<G-\#TCH3Z [*$ B7=?=9H*O3!XF4.52^@ U'_#;<T!?OW
MC["</_PC9Y4*P+GTGB/*AK@::@@,;:;R$3:QF%>G'UC1$.E9!#Q^XR]XIW$J
M$A7B<-.4%YM2%MF$-Y80,4OR@N$-5F[JW:6'3Z**@8B[<-U[SS,@=A\X.B?%
M_9?<$QV/V!].BXGE>,IKL'M[((G53=7>74(7_CQFR/(]"F_: ISVO0;N75B)
M<DQTA),>,461R'\0&6-^+J2W^8Z3WJ=_:_D?=">5@!G;Z"(M/CO:NYSW8M;>
M=H60!Y3#DH9'-L$MV(%._L0R^C.=I%;1E/'/$)Q. ]Z4_ZSO75AW[H?TCW>?
M3IF\5&+BJ2KB&GUA>M;GS:F^0T_8(VLH]U:9*_O@[G3ESEPX2V^^R#G#!5\X
MXZ_RNVW=L(HW&_4M6*VWKSX[NWKEYC(_KP 3W^\5-@&^^X@2S4]E_2+20  @
M;-/)&69_]]]@WN/_-\#M54/H4[KPKOA>9I_\6^G'4$WITL\+F"1GWR1Y](W@
M*79#9-1[B5^FL/3[(NE]?Z2B\(OO1AZW868$P5@7!Q'A9ME4$G_&MPR#!M*2
MV):?$^5GTAPV\'D?:D!7-LISYG30+V<?;BG;^R=D591$O!#^1S.Z&ARZST"(
M9#&5S4!,+#VFIFIHQ.M.6H.6[ND#=+.4+>FSCQ0Q86ZD",-\!X5-1^U?XK?+
M]U(VY+[/=;\C;@1816P&]!H<[-T<P+$I12\/IOA3A&H-].D^6">V]:^0>VI#
M0"$U(=#[2+;'866H)!%F0N&.%BWF>!N0;5,^?4D\@RA10V15#>..MFFC:D]M
MZ#96W$UH[=A@9R *]C 09TT&XW9W%[(,N3YY4#I7 %Y&I-TE6SVG/_C8 LQ\
M<(>L IL_9^V?TN&K3/Y&<EQHHQ=RR-H=SO,>>&\\<RS[D80_EQT#D1D]BB8?
M0,_<_"_.1V$Y7A=Z77;=']IY:N#=ZAV0:P)9XXG$EY9H?D+AF:]&N&ZGMRI/
M@"+BU%W_AKD3)H6!,(N$.$:R4QXQ1]ZVK#D55O_,WE>5L#\7#64^,(3R5IY;
M9L<1LA; 8,J$_Z>ZS<^Y+*.-54B+_.B,@&S*8@QJ&%>$IMJ)LL%%;T^*@YOT
MK\O@]1B( WJ[^X+&UI1UGE]M2.+-HZU\J$H0KNO'L'?7B6F@7#,]$:%),@=Z
M,C0(4S==Z5V=M=Z-CC.ZW/B6M[2>_N >!L+V+"U(PCU#L=2VBM^X^(#!8(OG
MPUW2L,&R6@K4V'\%ZHIY!5U-,.6LX_(8'=$*T+KD1%>2*40>[M]6]5W4=_;C
M(0J7OK>*S>IN-.<( \%^07W^-AMM]@+A9IHW X&*KCD#5$N?H>6=6AC;=Z];
MI5]2CR1R!%2\B1D];0=T2,Z]:J.>@!N\_' "J8S_8M71@:ESPTT,Q.)'U)A>
M&&Q!F'<6*)^WXKF(9I5@('V\;5GJ <!MTT$0AP-UQ0L=DEKE54D"7W#">POS
MV;_2N?/O='[A'5WJ#^!PG6'@[?P/5I=289V?ZC\QK*1*$TVL/W/Z.+"TMRL#
M3S_K86"\.?@VVQ1$,C6>OI+2;7C([39&+2]PT? +3K6!"?1=,SO-(82('1S*
M::_\57^ 7Y1D[FDN2HR?ZI(PNJ.X?@G<P'/2":<4:AP8" 7F4A*Y$(<\^]-L
MESGEK5@.._^=E,.QC\HM\GS]\[;1TNE'%-[MGZ]W9)EN92#$A17>;,9R%Z;N
MW39C^4P6O_*Y[^GRC>R9_BW4#P,T^8Z8Q0TB_43KY9']"^\FN:E_X=RL7IQO
M>4BS(A"2,G)DM]6BSY$UJ5G8">8LLU82M..4)!S-<R[?&^4&1"50)>KT&(C9
M-6'K38>^Q?.O#,3UH?E4C5MAHQ?>8]TNO58(8%F1K!P>(V&O'H(-'!IGO:\1
M-02KGCG6_C+7@3G6SCW6K;B-%B1)4SYXX:?DMZ35#0;BXVX_HOXK\9C#_6<U
MKS:.]++G](5;=Q^$E<\9&,CZ"E.$7*DS\A_='2(H+=>.78>]_9ZVNZ,+EVGM
M7[<\?/JR.Z=NE7>O?M%<7/D5Z/(VI7&>S[,NN>XXF.FKYO1?L(G/_Y>DFVL(
MK=OH"]0S#,0].?"\_G&R4W(*Y5OV25C)NZ!W2^*UA?NGE,O\,K%NDX<IJB)7
MY#0Z;@/*'*W2-;&GRJ1@E\<<:C]*=KQ+DY;^<U6 QHSQ!9ZQ9A/R1U#UL<]G
M3'S)SH@MWS[R+X5OCHM?XM*HZ?)Q;02K*WC7-L?B9D"\::W'K+[0\I:%+V@,
M[.[R5DU-K"K"+ U>P^ESM"#]#^,:O!^-$=(.X;]'X)XLHJ#=+*OQR\Q!/(>U
MA0M )7@?6$A-7R87J_@OH>O!H6;P^&T<'CW#[93GF!/%0/2DKWA=[!S2C)0D
M8A]Q8=Q]IA[5CAR0?%4U'_H-FK>F=.N17S^@7;GK+#TNDN$E$X&,[M7N'UD0
M!,*OEP$!]]E9/<F6.XI17;>'E8QX_P3PHCTY%PM^#(*%,-"3).M&YZ \V)S_
M2!78^-'O'^AP><2<X\N:+LL&ES+Q98Y=PH+LB>>#NU$=@23>\A,"9)1V)6HF
MNKET==M[GT1MSII+3BW%><5P%"=WCI$##V)6-\/; _C"&_J/\H4+C:Q\@I,X
M<Z+J7=2OKPE3-]"58C5T ^2,GLX7#]G@.R%5>5P13)6[E ] RVQZ^K5E.JM=
MQVC&'&8STE&&7H<2)&BE4[-3-#OW?Y3<W5AX2>:E>9D?',.3#;6KYM(H;#<;
M8QH3JU"_#3O':0_==^"C[[LHRCB\WG2*A6@>VR;$&0@$^U)^+3 1"H[P)\;[
MLCIRG2;BV;V&GF9=;X5M@ G6J",[7?ZFT<#'^ #1Q,D]PO%/__IWL;EM/SG.
M?L#_^>V7%X_VA6A:"OF2[ "R$DW/8^X YB. -XDH)<3U:O7D+ :G/.'6D OE
M,+EC^?H+;?8564V29\ ]8/G0P 30[G?WM)PCD:_+?#''DW#)^1>63;4OS+0A
M>ZB+@2#KEX7M_3;ZIW^V-!CTL--=I;[G88&;CTBTA0"W15079'V1-A?:XR4]
MYMY=U=7O-^_=\EA,F):/[?AT5]]9M>-=53\5H]LE=\CV0?DB39OGCNOYBPS$
M:$9TUW%"Y2M!S<-?CZ\&",+.=*PT1S!H5_@H[)N-U/EWK%QM,3<GAY@%XBM5
MONB?#CSYK$^3@=!\D0=W-\.&*?TU [%6[\#@; V*01N.N/OYCGL]D&<-U)JF
M32FT!N_;Z0?KWVR?+.4-%$6.B_;-NPR)"1B>SKI?[8K<:8MIT85B+Z;,GQ)_
M-A4P[>Y7A1V;^5E8%6C+%=<K JR;Z^NHD-\CEA<*8IQG<VN@W94!Z6@S;LMM
M*M]'DHQ2=A4H]C,0KGP.?.%$=6N:7^:O]3?"D/I-Z!LYHF]HE /.,E,TT;Q0
MVQ,RUE8TV_)72_I-Y<B8;]X->Z$CQ/',&U7'(H6R>][> JO%QMAG1EEA%XP[
MZ<%;]>GTZ7,#G252G[-*K[ \;SWCRC6-$<:H$"MQ@\2]??!Y*87N)2U[N5?*
M76V8PT*"E3<#]$Q?K\>I+B=W00*&GT^!'#]Y8ZS7M.%O_D+VLRI/['!X<!F:
MOJ4YOC;+#N^N7.[\\SCY>Q@X=_I-9/_,=JPX?G%'ADH)J*AWEYXHZ?JEHD.*
M6V^I.H028N9?^*3Q"$5?/IN<4&/TZ!TNKL,*M5RG=7WD+0LJ2,*:Y0?P6"*7
M_&Y!0<']YHJO'!&E9LY*M[="OJ9(=;#X?P\'*GQ5&8@?&2VN&N:7>Y,L.VA<
MCA9R?[+M!>/WI"31+A$E^JLZK6W*%&XJ6PWXSG1AO\<;^'RODY5<&.A:@ZO.
MH!]-6RF#SXPY Q&0 !V^ '<>N6S<DB\D50-6%Q%W?\(4DX.>+N8^ )(O)\$'
M)+;S0VNFR75P[BVJ);IM=BD3MP.PULRX!,)?Y4@CEC(052S,"?CJ.\&IH#;Z
M,E!?,@WMF6GBA@2EKXWQ<M).^?_*BE_ARWCDG_LS&9.!FZ3MZ.M8=+,>E?(G
M#)@4TW:"04*TT^K.I/OB,<O9\CY'[(J "]C1P/<Q/Q:O4*1N=5=(C$UJ%QN'
M$F_?>:*O<11ZYVV&;N'[CK1Z?,Y+.?AL6+*)\)K5#HJ>:V^]**L>OZHN,N'&
M><J>Y7WVUXC[,@YW9>4$ Q.),;'@4K:2!CZ0@=@_4#1D?;,D-A\J/-F(TAW;
MZ,Z4?L)%-[M0!?G'F]!\.L>:LF(TYC\U0@:93R#9DSW7^-BEQ7Y8G6V;,=7T
M=ZC@33T&M3RK5H;&4L6!W9-E[QWN%IKF*O(HMA^06$Z9OU-<>C@%E>>^&G>6
MJ)"S8DC>/O38Y7$0 U%[^YPM<&!M5].TD?=;8,A2AU*:<S\^HZ\3TJ9>*PJ0
MDP407HIE85.E^84LW5V^&SOTQLCZ8WJ3F@?Z:\&?@^"ZMAG6-55-X-RGG[$7
M9^T^W1L,U4#G8RS0!9&6)!X43:3M:'@#[>3\<WJ$$RU-I1KD)!$3:R 6"7*O
M>VB%M4B=9FZ6O,)&LH+Q\L]&1Z/LVT77J&KB(TZ3]H2VAK-@!K$ &_@-DCI'
MEAB5.[:3&*=2+DW63]>^WIRKT&,:.?@$3>.'':' A)PQ-U89KI_:CB>HPPL&
M8]J%97SSV%^BW39)S7Q?%X"RJK%O6#-R@L4(KM"P%WJ?#6I'IPEAY#1VEG0Y
MY#@T>/OAJBM#X\O*GWT7.-G2_O4(=,I F&['*^+HPD,$+?G,S<>RSLT4#<V5
MA8<L51VL82!X'6=,Q8*C/LVU/!NI/ZLIX&*XOX?V?C(?KFA>LM)C :.ZC.ON
MM5JG6*"=*LO9(BMJ,;4-T F(S?.$T.MBW,I%(VS&E0V.^8W";N^&;-2+[%\<
MW3MV_-@ Z1Y!50<&P?T)G+0] K ";'SV$>MB<>%\!?WW42MM"Z=_TE@TJPN,
M\<$9GBMH]^1EZZ7FXEFC?$JFY_ME-6#4A^4:[)Q<=S$7P%K;*R)%-L\<R!7N
M@1M![U7-%:,OZ.=N=+1!A?D(8D^$X_.B^[F^Z<-!&<'#*30;^"N"VV!OM2/!
MO]I,()^!T+^;?';M)[8GZX3/F8(CIN(_,.L7& CE[#->Q\^L..8,7P6'&(C=
MS)ERK]),D].XP$ AR_KMS0*8255V;T.7MZ42ZY&#W[\6:AY6(:U>ABWW,S#K
M=BFQ*"TE3=KC^E46TT6]BEY]0B_FP-GHV?6-2QO2;\:@C;;5[ NC/9/UTZ#-
M@(GPT$IB^5OL_9#;GW'#4D$[23;KAI"T[7K42CQ&(#7X:L,JA[)C_WEE_\69
MWC#4^F[@/8<_OE+QBW.FK7-*82*]?R;J!Y;DO\8Q(_L@/+Y ]&104J!*\(F7
MDD!J^CI;\,)SOXM+AYTDJ(KRG;LZ*T3!APW)ZV.K'-Q>>L3ZCR/3<9S&2FL?
M#E%"13O#K[Y!(-;9=:D7Q5^LZ!A?7IZ1,R3RS3A-&/5/4:O,5&9M#ZZ,[JJ>
MU+ 3EG^*GBZ<B70.M'GLL#/,UZ#SQ@KJP]1 H5' ?. M=%/P>>N@1.JPD, ,
M[(]3+=II^I>L--E;Y-TB./J?V-/;-V[_&)04>OH'-+<WP"MA<CX$=LW5,J-G
M&XD:]> P2$Q122!G'VYR3[Y/C9":U?HCY;6)<H)"=>(R+( X^XT]UZAH@18Y
M+%?.$%$1E0K@57NK@,*C@8;!4WW/& C='*UE'6K@QJT-6WHW+<W0C;, W82!
MW<F+L5'>>%K/X<C+8%X4$!;PB&9+E(<S9+*[LII3=\+>!$IOL@-Z$=/T3N)C
MTC>^ZDE_ X'6!'I"UO%14DV_7_GC?F5 2X2>L_#GQZ$[K/:OC*&8AX#<O3(-
M^UHC\<BCILJ+?<!,S-V?L!-6UG@RF3^:L\^NXTBFW!G74QXL!K0<^DZKE)_U
MQC9&?C+>_J385DS=SFYPK/IK-@,Q%[8(?,S $B+L5O8*^2<[03\<"3G\!025
MUQ(2NWJPR0IO9'.66BS!\V5EJP3PS5+"[4JB17O*U=S6XT#R>4.Y\U6A_+<_
MQ@7Q7HN,;FVC-;UR'HIO6TW/B9_CO*%*J$P_1)\08""L.-JP+Q[!<1?%=[SB
M/6D#K O2<"1X=,CLX-5;"_YC89!-?;8Y\_5$0#_Z.0-Q_CIZ^UPQKV2@#3#T
M#DF/#@7\*(/8)V*PK?% $W;G&?\:RB',D@*\OTA*5 ]=[9S,(RJ-B\MZ3] 5
M.RB9X'N?4!KP*U8,5VU/>RZV>A;L/=,")ID"^\2S>@5,W1NJ+D.N-78*G,39
M:H' VD=#]97;!RL<-I@/X ?T2J(X%,-2:U)O)H0N"%S'O1>,KL[&<SE'#JCD
MC$P[S<@UCPD?8R"R\\%U75_/T6;3\Q-HKA/C;B]E4&L[.";*>'NBK-W!PLR3
M%1C U5)8G]  Q'I$OK0FB!&U[1WL=TYA1(@^CC5N5VBBFNE?'9U5U,-&'6@A
M_LY$H[43HO:>CY],ZUY]OK&BK3+6QHMVMDP9;*R,*@:)4G,7>BX4I2NT.>X5
M :?>V26L9K!W<]E_DOMA?&TYO$OAM)EE@KJGJ[STPDX?*\QGFF'IW7*#XF+4
M?!ZH)#7;'>/M,W,\&(CD-:XT>N%Q/#TVOFKL^\#7D8/)DYJ<]<_ID8Z08$@5
MK_NL)7TJ",6[7MY[O^,\3_Y![U;^\E--N2P_NQ\UY)HLY5&#=T%(]WA\OG1@
MHO.B!=#SR?%9E0#J<9T, ^$.D'O3#4;*57,;'^_^)>W1$=_\N;*@EW9V3)WP
MN,Z)WG:H%AS62W3TXY/$++H']+4E/$!1Q3REV$O-^U@'U)L7Y6X!.VF*G1;F
M/-&N</Y.CD%"+W89J;>]ZE=@=7>^4;H#>G+YC>:X_4^;M/6'D-9Z\;#PLBNY
M<(Q7:/M2=>!!TJFCJ*;,&B+D/?# )?(%J>D0+<CC?FCBV<B0[@.NUA>WES 0
M!]S'JB,&(L8'9F_MOZ#T1^2: "I+PIPE;]<WB<]*YL1XT<&=S[8WD$W[D+.B
M/@ WNO$3+E?059Y+OA;5P#$A/6)-%#W3[L4S4PX96W[A(Q_1WNC!^'MQCGE+
MJ19VH=2"RG+Z;P)+(2&&S?OZKXAH%3OJ=(!XV5@?Z+4[L(/Y?JH7RW#'@P8\
M' "SE2!>^WY_64R@^+A"P/>:M;O,F;>D67F:,X<:A\M5R-%8IGW:2X^%;<4E
M)-E 2V*X,SMR&;9Q4I%$(Q.)7Z)ACL_U!*50_9%14]A(F@B*K'/F4XML:Y=U
M[QV@,4 AA[[T13Y68<J:@6 5N+FTZPN-97."TX9_S-M7PE0M%R@+OI[X AU]
M[+MA$5#=(\<[YE4NWU6<_D1!HQ=-WJ^$TH]<V7?K^:R'/>UFAP!UU *^UL(,
M1%]Z4$-]&ZNQ=4OY'94[[-@?O7YV1O)K;_P7UIUKAUK:0["UO;KXF+8='*IK
M8L?QD15Y,B'(B3<^NO$UCT.*NW^%K_GX.SE1K[E?Y[BT;[6A_1BJ*^![S/J;
MW)B)S@+>JS-M&E^V4:S*@KB5"76UHH(QELDML='"[:_HYXV=!A0//@U1?NJR
MYZ/.NI:R7F)5,[7M@N,;/K&N,Z<K3CNLT'1.":SQ1P^?([]VJ3 V,MXQ+3"V
M8FX6.Y%#4IFX$15ZI*_IC?!JQCCF[HIB(MLDVRSJ0/9YG&X \BL0W[% '* O
ML?UB(/) *M="<D7HO4<#*B1]7ZWN1]F-59:TU%'+#J__@ZGW#&NB>Z.]HZBH
MJ!%I2HL* E)%!*3&1A,QTCM1D1J*]$Y4! 3$" @H"*'W@/1.E!:JM-!!(*'7
M! ($2'G#\S_ON<Z'?,H59L_,GOO^K36+O1W>NM,$$FDG>\!?<^#-,KB1)=H5
ML=B9+2W+=>,KC]R+-:H=Q\KKCIZ9EX;Q<GO_:LRT9%V $CZ3\639 Q-_&4TU
M,5\H)A;>H\?%*&K*=,!ZY9JGP;@W5V50#%[&5PK3G: ==0V1*0+J,?0F;+6:
MC(+&DP)K-HO?(2F^QM6ZVK% SY!)U0X"0JH](2L*>2D<H\_O=FB;54UDK]JV
MUAW:="+X2>??IQ"ME@P8ZN'Y(%X"[G.*947L K(E/V_OWLPXJ$+O2#AU)56P
MWZ4KGWAK.H1_Z,%LL*-F,?I9_Y )'? 5^OEU'7C:]!PX ?9UM,%A3JG]SN1R
MB-$WDG2S0!\^>B;;0V>.S]J\1JMB!B@7=U7APAL;BCOFX#R$Y5(24VXO:F/-
M>@(^=Y[("_>PZL/*2C>(X8;O6UK)\==_HL6WF)(U,%<FB^3YA1,FKDM7NO E
M[X#P>O+- 85?7!JT_&3X&]@.$XIH1>CO+3&H^29\!92%7"^@6 3?9ZBX\_$-
M,KCVU^HHP#4\9:.8+_CB!)P3Y1_\G7VEZ=*$3"EWY7)GW_U[-!1H$21*<_V]
M00?,<1+-O49>@1[ FS,9'1G4>A>$M,0<U1=&@,YM.A]4$F_-"WH>:-)T=.H(
M)5^<-R;$7-FUW4#[9G/#:!G:O2;&0"P06:-3/G!"B1=?;6(KVXF9$O*(5>;L
M)(]RXTSD:P2V!P\^Y/!3KYR;N=:.VAO(L]*83O#^'OQQ5.E-ORD4N"&FX"(
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MUB09T[GY+/QP-$W\<_A_WC</RV(\I59!)0DINLX_"(,%8;Y5_X&R(NIQ/^F
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M.=!:7(")@.>!V31QVS(A0E,V[ER"CE2+3C;F9]C=.U031+]!PSU0S-#Z9DE
M$*9$OEE!R?$E]348KRO?S(.<P[X"FR#(HP*YOMH8L(V)(%$PX>V73Y)\'10&
M%&$876.TUP\'Z_R^.X?X+[C@7RYI*K%$YF.CW,(:;UI.5F/OT+Z-T;C7O#//
MWCL(\]BA8';-ED9GITN(COOA*^^?Q\TN9,JP%EI]"9@=V#79YT.CR7Q/K*X1
M)5*546 =)_^;<+,R%)Y'%[%>_UJ%S97DB,,TFZ8=&PNL5H\T((S>I\Y>[JO]
M7[PM]7:"I[)SK)W^P4_\3N;J=):D-C5[7Z;4&=IVYW-G^B9H/80F2_39<#BR
M#=0A@XF%&H21CQ/!*3D6$^;=XO)R,)E-O_.E%_S?BDU5EEPD3\BZ5E:E!X#<
M$_\7C4.KP)T^S5>3#])0K>YB$JCB^:^7W1:19MF/$XTVU1P#OQW$'2&P,.27
M),MDD-SE*5+$#SK@:X%,\,#$$^>/@R6YX'4 .$67L)DY*Y9C&-LFGMM':;K2
M30<$V8%2_/F^).?<%*_RKGH/U/@@BUD\#?WUV:>V/OK^%N=;G:,'5O^J[LV<
M_0=9?F--Y<QDU*T?^+4]H9F67Q/"K@I^E/'P[1+(2O_KR&)-R0^+.57O%V)]
MD3B54=#R"'KS.(FBZX%?290JQG"5O:=R-O+3UM97.0Q<774'R[(\I+M39LR:
M#,<YL]#QO Z(]K*@+?8[=( /'3#\0BX<]\-<"O<#,X"DP*K&T-.@>)/JNCN_
M+J0/U;QZWK*T'O/[/]_@J.F8PYJ0%$?-"C3GY';J[435!<1.B;Y)ILVIF[,[
M@XF=")I?R?QMMHU Q)UMBA/:IW4]F'$B*$TOR"<YIPO^/^7?>;]$8L_O F^#
M:]#Q4@GH:6A7?.*K #5*WO8*[4;@X](/&HHZJ"'16("APGW\9J.OU/HD'7 :
M0+1K![&N)067S&ZHO!Y"&;UEW$ZTD [ZCA,1:BMZ^^4=Q4/C1:EU+D6*#+5,
M&3J[XM+\^)[_E^\YKO&Y 7[50LSY!MZ'3"_F^#$J6AJIJIOA_]QH@XJO9RWM
M_4/K?18T43Q0Q 3'TCGV&*36EYD5L[K]2(I"KM@M:F]1#W@A,B\>?>-GL.Q2
M74YUQMIVV8KJ95@M\*2:7@CMX"G?V6[G2PQB;^J&R@Q*!-_4RL,LFJ[H36&H
MRV._J*>?_Q,9D3S#U5+&N';VTK3X!3.I]Q3+BZ,3XJPD2XP UZT[*O<%:5[8
MZO<4P_P3U'3<9'3CB(*@P'8'1U0+>O%_00CQN#5YZ(ZH1M]^1D'T'-5V+68N
MV4 8ZTP'C(>^9. H\LJ.:J/?[=U)FB"VE,)7;NBT6MT:\Z5P5>2P;$WJMT6I
MN38!ONB@-7O1>ZZ<^L.5^:C\Q+'UX EE\<I7W1\_7I?K$?QKD37!Y?2BBBT1
M:/T.CE((YEZ3.T[2%=8D]R<^/)25*L <?.AC=%2FW$HRQ+_FKJ-T*WPEJ12,
MY'!HXIV:F*W^Q'^+<9;QC&$5OAMND"6>2(QVAPWKOE^PK+#;QM4XP]3_%ZC;
M^B]0]Q,^8Q&9'6J)X=9/G-0HG7$@. A&!#H[G^-+=4+VCUQ<BMZHV.X&1?5V
M2]FG?PTAQT3.-D@%S=5[LQ2ME/\=IP,L8F/!'/B#T0*R]]"?B0],.0]?B<'=
ML%R@$ _C77N)3?W<3J(E%<,CW^:L\QU5-)JH40JX0 M+ '%3'C78P'3DW!N3
M'K3";UB57RR2ZZX2L8X(8CU)!X@F)&7J>'+=4WRR'5]+KGR;%E;Y#E[Q H0=
M+$XDOEY!^Q5/3MXFV="BK I-N<P^QDH;*+%-YJ/8!<8<<^U+:ABBZ#P9(74X
M<[7 [JAX9DX''D:[G^(F%2V(.1+?G>24P,8]/4[3]: ?&W;SMWET9S?A^Y)G
M^R)L!3MQXU>1>DN'6&>"<6O4?J >$ LFCQ:M[*/>/@6+GWFX6UA15,\RJ0-O
MX9=E-$IX6_Z^LLXY_E7L"-D8;U^+@%9^/933H'5;]:E!Q -N!#CX!6$B'\])
M?9IP>923'"B#_.?G3/E=&+,&8O7T/D&1RIUB3 /EE_J''V"CR]GK<Y3T#=<&
MW0468G*;&<RID5#S$;AY S2",J? ;9T@.17"U"SA S8KA)??Z9_JVC\R/T@/
M9[_,W"WF@1)'/QI[.L,X4;?Q3B]. BEG$0O:8\WFUY]>.3J] <9MKU[@Y/&]
MY4%1?:5_P&H.PVL33@2=QX/6PQBGL2W6*P2_@B3'D;76OZ8*2=(!/7.P]'X*
M")^L!!=2<2:-@9>0$Z:E)*;<N?^E(.Z8V_O,$%*>H@/4&D#O_]N^0M7P:,)P
MC (^'.Z0;^'3.UI$$W7F^V827;&5LL$7)OFAQO^EZ/YO *)H'3SWVKSDW]#F
M?_D'E4]'(]5,!!#>(FOFS'J*-9-^ X\Q'Q<6"R+D<H)WN1>P&K1:.B#DO&HQ
M'9!, )7G3C%4Q__C/$#_7S-AE#.0"1>MHEE*E*G#G[ 5!Z<^*+8S)L"C!2[8
MPI*Q6_-37* $>/9_*0C=D(#40N$V"<[+SW),?M/V!H[]N" ,1NJ\N5W05/@X
MNS3UHJ].._)6]&^N$7<A8$]L_J.@,C4?59XF GM!A%]64*SKUA3;3;M5<!Y*
M%>4\7MC2+'I87EA#S52^?98Z")V2S_C-O./8E[CW23N')9OL<KB"H)!F@]^-
M6F>O\(-B.1(AY4,I2EJG-.$OQ$Q?10>O.ZI&BC9^XWHL-2U53DZUG>%H<,B3
M/Q0.BQV&KY3%'2:P=RJ;$CE7WEX9F9Q^ L?!L,J5M&5* 4]MPHC$GX?6OW&%
M"2J7#]('179D&\@A;VN#;$4@:2Q4SL1N(C8E4%WC"$TKV+A5$^O:,,Z?4J#(
MT$O'$8BY^8% &R4;BH9<4 IFFU%F/EJW48U;Y07_BV&?DH]M]G5";%;?K'KU
M7>=*S2SK\^:]:$^-N)(PBB?:Q]('M)$HL,L^KBR&[]2@?$1-4ADB[8A[=T+4
MJ9YEHJF#Z-# @R>W6\<V>RP_8-[E.%4';-4<%=8L_0K<5*0#-$K>9N2._]G\
M2BU?1YR=P:U!R4>$N=^KW?6@-%F5Q,B;H6C<J]/3$9NOG]$!=\6F%#9,N4<_
M55A*WJV+GBZC X;D6ABBY=WG).0K'>K7);VA;WA2H^O#)AM=W'C1Y%$UJR*P
M[SX5AAIJD/(HT%AT:!+[LJ%B[3[3,8J$J8H21DIO1$$(?[ YRWP"VV@2:U)'
M.0$<(5ER')>KBOIK<+!X%_UC6FONU=!#19^1O=W2]1E"&#D!7%L<=KB9-]E,
MD[S87L@#M%RBB'V&,OMV'<J:SW#T<EN?MO[1295.<J6("B?35 ,?^LE3F"DF
M(W CRS?6G?^T-Y4VA%N:1*JQJ.PZ;&: Y]M!$:>%@"_Q$\9?R79SEE5Q)0[[
M4?G3781G9:><G.^K7/3?A3U/RIEXOG3FEBG*=?N7KAI'?BN[KAK@__^\E3_\
M.+ J?_W.]:<MIP*2$D9U3;\+1$=/]@_SZ=,>&4-WA]$_<DW&&V(+OQJR+PDW
M.@A,1=?JEJJQ&[T6FW'8J_MFJU1O7ZQ_5);FNF01AB(@GF#E9:N3<SO@2\DN
MD XZ(-J;I%^OIJ[WI8>X3P!&-MR21FK4'3V5NO_^%V08R+R+TA'&84?T6:"7
MQ[1<16:[N2_#V<&#C7<+5KDM4U'G(K<GQ+Y3!5^XD4@%BTV+J0/:^"?^5M6O
M4"V+)M,:[HW-\CVJF7GY)>)M@U^\ZTBRK:O0L^MFKA4.\G$K'E^,89RZI$VP
M8OZB[WXS'> G,"IA3&XZLB:Y+CWM3G//)92C8MM]#]LA=3LZG.6@@S=T0+R'
MW,S5C0Q7*;W!3:=%OD<[A[S<H]7DW+E.C'P)*RF6$S28FMXMVS]:/3C]_9JJ
M&FG++,T9<"D^!(0(5!&==QS!4W$:.QRG^UH1E\SRA?5,@5F:/?"'VGH*;P[Y
M9#F6?$"<@EC!.\MFLFVD1B;-2^ ;R*5GM'8B.@*-IQW<"S!:XU664[G30+/]
M8K40(-<D<:G;F*@>GWY;OGK@40O-='-JB792H?@1'A>Z6"+P<*Z7'X9967J&
M%MG_3<NI\(2'*DHF-6O'Q^DA\V$AVTO4 :J'9> =#>>K7ZZ.B(QFJ*<_H)SF
MOMX@4)6;P@ 1+AR2[?+$8NF>)A!L6ZU N7,'K#RR&$? /!BL*JT\>I-)WGS.
M$(F!I.*R2(7O*5I.=Z]:5W\6U"W25!0582+E#JAI??_\QR#V[6D[G4+>F"N?
MX7X%I(&#_CH[GC"Q*S"_ZTZ*,5L32;=-OCNR_:20\?WZ^.%;^COO\-NRNO"H
M%<V"OV_3XC8,#&/J7=]6LVY"6_T-*O4A53#?2?B%Z4;1::T3)A/5(17.KD);
MD-"?=$#W$Q[0#D>Y&B#9G-^F,) +X9.<M0ID^6*D]$5CMB7FP%#$"\+M"UIH
MJ Y2;X-'H'T!>VX=%-A(7F[OU.A$8W8^QA[,7F%I[>31X;D6TMZ-J$?:KAS@
MZLCSII<5[W@JA^E_A0'-"*I1)2[R<IIER -G(&,.?U\CCXK2 1=WD<#2N)8Z
M;&1MW_BBTD/:2YJ!?7-_PE\,S"NG"C?@#E1RS#3K:;B:O%VLT^"%0UZBU(V$
M+[4K]IT5('9T,4 %;4>,>ESS.TDI69\VZ )*S[55U2)A9[05D%E.J@U&T?&(
M\;(>]WGK%9.WE*>$^;'VK$(:@\M[#,.(2^'Q/GQF,_P].A*:CI;1AV*?L:KB
MRYR.@3]L&X.[+[P!]N#*T',R1.BG[3K)J#U-B-;F&;C1;^I%WB(.!:]^DH.@
MB;64@.CU^7+>$^11,53@\WY2=$?BF4,W3**C_ 4ZH'&PU)H,*X 5E9&CS&-=
M/.8?N#/C?$'OBLO5""Z(M--R"=(1S)2JN"5X#XDBTN_]T<=' 4365+;!%=]K
M5/%,5E]1G@G@KWU%"=6!$9 ;9>=V-XSP+Y+S#5YS[2@SSITD*K*XSC]0$OY8
M^"DA-2;C_9Z*ZM5)FC_'%!WP8[$R+R,FV7F3XW3OH%F>1#=_E/[PQ:<#BS>?
M\'RZ*O;@9D-25N_^VY"5)'6LL"52U7>3.;\@^^E/UI"G=("7*A([S&W*+7>8
M9LLBNL$ 6D_4^>;JRMBYL#-<]?SQ-9F.[U?T.EYC?3B)ENK6J8)),I2[(J\.
ML=_T!.=E74/KSN369E;#K@&)YG+,U&W?8CUXF-5UPE0[_A$V<-VCTKP;WLI_
MT7^8PZ)GV"!6N0F#"\M/[ZGZ)S DJ'=_)T9.?I0/. NK&P@TS/9][V'MQUOR
M3T[) OX;(IOI ;NX+B3V2<\781#S&#A2LP&=DT,$TIQ_Q#U#*IQAB^_K)U$N
MJES=.N>:/C8U&?6I2Y[O#ZDHW_,@$^SCNVLV#RZC>,W!R3MU.H[#_H)(&>OE
MMW"!Y^&X^82[?HI_H]P<1+9 9#EP"F<04PPUY7GF^B =T"?,0!H=R*5D\8\N
M/%PS*.L)B@EAHSEZ_^YO>+V@!%7&&$=^/S?>M%EXE@X($*.T23S!J[:3=#]9
M&UA]0%K,TP&LRDHNYYSUA.B XE?)!^>;&\B-,,$P/N'G==A<%57+PH,+2>*M
M^9TDE9/YJV9M7Q!</X)\.(ZWBU7_ WZ('3U7CDD5 LMHI)M54TZ7'E9O%]:Y
M-CLK*C10]1:#S/#HI%8I,O)OE&3F0B3Y!\=^FV^QD-P$9XI;@87GQ8I02K@P
MJ0#SD)@;68MU'=6H=/G5TF(]Q$+5\3^=@'3.:;Y94?UE0IHB+:)K)()^N:1+
MUFUW@)\C*9T!OBU;E?&24 K,HC+O%I<-ML] /FG 3GD3$7,1)Q&#N1GQDS<Z
MN[W9=37]KF9IJ>,-6$M-VG'@3Z2"E;R_??O$/\O,V6IN=K?J>3^7V'+P0N$$
M<%?>8,>OI*SN41C0S4RN.LHSE_?.:F78"1= )TI%;AAG+1!=>_7D^WO1YT4R
MLD+D#0C_$E&WN:HN/X<WZ%^D X(NP3Z/J%X8LSCCK+BIK;'!F]D#(9:H911L
M<%WK4I+!9 X%PF;5IUV;MGO]B^S^'B\YXX]HKE-AQNVE^#]1_*F3:^$I\6%@
MZ0#17K_:.:(LE@WK"IZT83_>*A P@:>=4LCUW+^W]+E)T'[2HL7O?*^K*(3-
MG5_N A GBEI,M;46M%M4,=@O%L+/6?Y-%( PA&B _-\G>J5_*!J['&R^R>VI
MUZYB2=G8-.B!\^6E'>BJ2/4K=V%&4X1I)8;P!#/=BW*0>7O3M?5U[1KX<]*S
M&O-"\T)CFM2W^Z!1$LH^6(CLX@1OQ=@=$>_3OCGREEM>+%11;L9I 7L410IW
M/S0I$XXDMS9@@?#&WA=-Y.RY2=E;+A,+Z/I3;VBY3+O9^;QE09>J(G?"R%'%
ML![]!_U9HOZ0^X)! <"1^$ @SI4U<&*S:H3(7[6W!&8\R0<#W5,E=JX18RM>
M)2#[),Z%U%V;[_!N'GA*T\^W8.Y%<PS_+:+T[33[Q7],O^MJKE'<@Z%+EIQ1
MA)W'_7L5WJ]QK^@ "9=@CP-/4+QGR#O [*4/T4Q)K.,6.WE-5U<5L1]<66$>
M%OQ-SP2_JI0=USVD%D$R/&-#[C#0]3H=D% >3$1;(4-=!]3&?LZ3+@<6 *XR
MI;%7Z.K9:MSK=KWFHVSDF504O<]^G=)KCJZ"?0J;:<B]OUL4IA[]J\O@:/@F
M_C5F[^.11M_A^20^T[)3!6=WS=*"EW/;6'K&U(1G*J7'>;K^8._^#.FX5\G7
M8/5,Y,??TUHO;.6>F+[(+*CC+VBY68LRGVM_7[AI6\8YB#QP</(&=>>N6*JP
M;\H*\R%$FL@:^0X>09E/L/N*VQR=$73 5OH?ZFWG0#@.?+[N#^ZBHO8G#7XW
M2Q3YSH&.?Z6<YJ!]EV;D\A3'JZ_P\\4NBTV#AUH6S?V!7IF^48Z3ED4>U91?
MR?/PEE$":ES@BKIN^ 6QN)$FKF7_IJ4OG+^^[S2-S=I-0T!=I> Y3B(B[+EG
M] M'HVXZ0%Q(F7IG*E@](84IX2[9LO%YN[.<25^7<MO>VHN@).@!H[[L=Q8;
M!M]V-%/^(.'S*/;,\ILH4>"L+Q5F-(1;"M]DWA),'3O48@4?7G(81R0$1>>1
M#K+ /O:[CMBJ:LZ!#6;A?-E08"OD4N^^EV8BE=!-:5-U!9']61.&7[KNWYWI
MT,.&7U,-?ZCV-BF\;4-4:'M=8M/K&N(\JUS(P<ZAH=0&F,\WF:8BCA]P3LZ*
MO2"GFHOLT.W"K"^,/NYWE7(FD9]5ZV-<+Z\._M(]'.4KH)@,2<QOWQL3&BZ&
MG+^IQXXLO@L_\<*4(J*=GQ#DH5^#75Q](6U(Z0,GB)4.DE3 :@B;Z)]&+>DB
M:.G#U)QHIBG$C^:#8 6BW3][$H_<NJHQ9G6FJW@%?9948Z&=-V7AZ+'[>MT0
MLM"W9CG-[N$-M#^TUQ\B!? )W4DP^CHI195Y %PR%LF(^6JHA'KH//DZ>FNF
MW["KHZD\QL;NA>G5I2_8BQ>=GWHO_PG^D'CTU,LCX8+,E.%3HZ.EM6?U E8C
M5)=+@W+H7)1Y$4JUES(<$S9LY;=E5O'IE<'NQ9L8H\_9&UGR8G2 SF6V@^$N
M$=8_JS/,%5&]O7:"(U>\ 5N0CIW#45DZX"P\BL)U(UG[Y_2CAOAJY]\(WSY2
MR:L,I(R<X9L*_U37#(J5VE=S6)6KS?VY[.CG,INY,8>C0;FK"4D5)V%BWS=?
M@]MX['9(>;LZ5UK,$#:[6<8":9(-B/15L<]-9*T+,CS17'HU0T+KV5%20P+(
M)?7/*IU^?(T;B1._NM[B=XM&RY)42^-(B[52&T ^LC5-U=EZ!)58]$E>3C63
M>>=,3B6Y\[6J-E5U=?!5R^D3[R@$QL2)M915U(7)>$:@1:N=<^1F!REI<* _
M)AR'"%L$$2D#2*T;;E31^6!E BDJIM#\/6V(55O/+-$Z.')ALTG(UWU 2_'=
M\9;E[+;"I*+;3;>M'/^^[K^GL#F9%OM"DQ).'K"]]1R2OER)*"+7:_8_/'(F
M.1Q7B:<^X'FQK]"+Y+[6AM6DC!7OC9&KP/N'4KNRY9F!4OVDA"O:+(YLNW<M
M?C+*??W03B^GI4;WU4T:_B8T0C&G7N#Q7"^W:2UF0MCB/?D2,PXV2P>019:B
ME1]ZH<CFO^43%P^II7E]UJY"CY3B>%GC>5W TA@+#I4U$@1C)3<0S$D6,")*
MEHN.+Q_JU$,D?Y]YL!RI5,XKPI]EO$@'K"?.\1GO_:(6RL(C^84J[]H?&H[N
M_>PZD(XX-#,'OGAW1F!05:-77WB =S<G:<_-'.E-N4AFRPR4(%O/!5T*$*S%
M.CE9F_\0Z@8J1P]^S7TG7QXDAL5'OW[PJ>"3HNCG\SY6.NS=*R]S.F^V9W^?
M/>_UV.M<S?NOO/S8=]ER1:TX68!_Y1/9<WO2,RMCAGXW?,TO9>NPT%!TP/E,
M[9M39D61P5X75&IDLR]TWWN%G>?^\T4NYE>!R9%1;W1M=3@L".=N_]I;7!=[
MV8\Y+R,R]@*?^>\)_LK:XGODD<>,TGZ#.AEL78*WL$(1+#-=Y;6PYW\M6-=<
M%5ANH8AA\PH6[0=E;_']F)>C72>&OW^;%%V46*7=OJ+ZEKG\"S(ZT)@..*U
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M^#G*1>-(7*LH^C%N,=2AK3:5]KR;W49C$5O4,1^W[(WMS-'V[8FMPW!OFW8
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M@X:+2*V&*,56(:SK4;RJ,-!.-/Q[8-J=/]:PM'>).KI;N1;?V]]$$S*5EA_
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MI%R<7CA*2:U#'.C$^FF._.ANMSHR/)GJ>>Y@7FOW_V>)Y@H0!7,1M;DF)52
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MX: !*N"73WXLWD[_2W17GNFCM$+O4DBL7\]PRX1JS8[?&6-="TTI ZP\9U1
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M/=W>"31RJ_/_I$,$,(;.)@$'>NI^0<SK#0K40]NK0R5N)$)0@,XQ'-#*'UV
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M\V9[BUU!I *D6$]ONC\+= D&B%T0,@Y@GSH:IK:NVR I?)"+V5'?^X ZQ4?
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M&FCVX<)/U<]90!X3!O!1T$?K5+;#DOG>Y? PQ>EBUU8<?A[!"BR8096$&G
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MK/UM; 6>L\!;!;QIG0ZH'9W#.N\F>2<??5GZ8R_^GYJ( YC_50K$(^X//SB
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MG^W\]S&H3NDH<8W59Q[ 3LP'!O)I1QWF2";POYF,_$\FI^!6RO=E6MI(5@$
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MIYG-RB<IE[.1(E8_%#Z<6.QR?7$S09\[/DM'3D+*(:#K^DA<4)3,&AB[)F7
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M$3<HL0-+25(Q31OQOCP-3R;=-W.36=5P/T!-@WXZZY)LI^6 XX]\1HSXT5/
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MH0H-[^^.*?"C^9V8R9"/\+YP5G'YY#['C3&GR1;V[A+ETV]WN][HG1K*U^[
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MZ*V'V(YNMGM1_3.LUCB?(I%6CUOT*.6$,N51[1? >"@,C_(G/F:);P6J^F4
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M7-,3OI9]&<<0Z]>O0%KX5^6Y&I,U>#W9ZM:@K5GQ:Z D'D$F*^81CZK:QT2
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M;.L$>5V\>>%[PQ,&GM_E5RX+HOS:DP\?CR<"QMQO!Z/I0?FZ->CZ"!R$*Z7
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M;\T5<)0B\>1B/;=R)+P3>>U$LO-Y.:?GQ;$! @.G9#+:J6<(*35^CKQMRI\
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M,L'Y.FIJV>-_(0^?F 3;5/36"57@ZJ")($U!I96T5F]T\*MZATK&J*Y=AG?
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MW<44S'7X5"8IR7V%G.%2QB.3Q&;$&5>TGD= KFK40G5E0%&+-&E4[#XEC41
MEGV8YSD.+(A94X0U]X_M%;:X=AZ\^T($"!D9PSI =W?D?\ZIV6YAX>MS%P;
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M638;JG>488ZD@[JOI\"'8=U5%"$T-5;D&:/5[1OZMU4S-P?@RJFU\0I@P0,
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M<DS%/CP9*NNMZWP.EV:QR:!>%=YP;>HE^,MOH$IU6ZT'W'>Y1EBQ9%=2M_/
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M)G/H4,M[[0> G\?]T[/31\B)FCA(9R6PSSH0X+&LFB]?:?GFI!DR]FUH>ZM
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MCV8J,6;D/DO!*!'NSW<7?9=H/,RO;(G\]"61?'>7!C4_.@[#)YBMOR0@,?<
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M[I+NAM'=Z48.V,87WY_?[X]=?^YVVZ[G>9S'_3KG.N=\!(6.L24_6V_)85Y
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M_T 9\WO>\<O;X8EXJ?HD+\ FP_0SG]G-U:,SA/_?S>2>:(K.<5Q%!= QQ5E
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M0<Z[8A&'2@\K&HL<@0:<;97D1QA1K8*^[/UQS! E!1;PIJ?4]-K] \_>?W>
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M [HE6Q[E>Z^CC_W;QWTEBZTC$:DT >9NG!7)MVZ]F!@MX5LP5=_'6Z%+G3M
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M%$9D37F:&Y+,%6S/KE\%3Y*VYCH#K:@^81B'!W_Q].A$H+P*7%-VO !4QKB
M(K2BHX?;[R49,_D&.U/K#@:Q__P3O8VD:MJ"(T?HAY0?Z>OVO,&>L8[M:GM
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M#5$BB;AH*<,M=WR6>K-/_*$><B;O_Q\ZA^Z'EBDF>P-X#VU]6T8+@I%PF:V
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M._5P+[_4^HO[/=@WQ?HHL/I4HL74$=!!W3X8_15<=VPWE2QH8)40@<=8UK,
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MZDD7X^N% [K[-)).BGO&=V!M(B#SM##CN](<J 1MY'0@RXC07C/]7)O$DOX
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MJ$%,0<7ILWOO]^N_<Z,%>(E:(YSEA_6/X_4F<4I@BZ\S8Y9W[0H,=/NA66>
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M3.@<&N*AO1*'$@HH;'6K9<[<SE[-W-(KA1O.X6WYK^D#GHS,2*KK:4.>R=9
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M>Y',=D.\(A' 1@ ><;D.\Y+J&SUT^2 0I/&P1PH*-S3MU./8;RJ[<8$BDE+
M:Z#VS'\;66B/IQ[3U9WBH_[S;^37Z@OOWO%CIO+&5>+@ UH*T\*1:4\DNX@:
M##MX\\2P/U:1I,NH(I[@?P-]T.Z3DI AZ9;WVV7QE\^B4U<L&=L+/'CU&J>*
M++S+:#)]"YE*1!TQ'+EHKI?)SX7V<J2"*8S6U^CF\PBS)?]1F\))QK#)[+QI
M549=/XP4%0!1O=#SD=9T;!5#K"?%WM!US@6C?7:5;%L7PT^O-<KJO5-4)\^;
M8P[K4E\IW-C>_VCL<=+^X.0 HC+K_; ;?UM]#BU="5GV=!1>/Q?[+_S6;)HU
MNY-).37:"6O*3!O"N;>!0R1;B-?]L6+]X_]B;X; M@MQS4<ZPHO#QB+VGWT#
M[=7EVE?50+O3N[!L,R.;QT,:(G.9X9$YA8D&;[])X-6=IF4_*\]E+;0D7IMK
M'H Z+3)S]PXK9_NN,C!K($7BUNB2J;>F7/)R_8<.6L[8^=2? =__]C:[3FJ/
M[0#--9PL-H^^JVCD$9-P_ ,*=/LA]#7:4$_6EU!6$LJE.JFCS>FZ*C%("ZD?
M.=3U3O9\+'.Q7;INZ$MNP.-,:QQAZMG27_#6EN=K&]=#32S%>.&#]S+W&&48
M."+S,^:@?%?N_ ] [>LXOU]BY]+LW<$=(2V3I^<6> WO /6EAGL)5A1,0SB=
M3_&J,;[0>%@(V6Q-_R#W*DP5A?T4#PKI?=YN/59_!AD^^^?=1"(31&#?;K:*
M]78R6(F?+W3\/C"X!:"YR-58QNW?CZ6%Q"]WF#B!5W'=H&>Y<RX&U;I_!W^V
M:9E+H3*F=6EXSS#02< #M=)@+8H/;UK&%A12P1W.'_D4<DL+LO_-[@6-?>>K
ME B3_QBF&Z+%H+2B_:*V*RD8$M1%,LY\E21W+#RXAR,W74O@XKM;@""6O'B+
M\E2$MTG__W+7/VPQO8;P(R&%13%):K_421A],I_!P-OZE(Q/QZK0Y-6Z]##R
M5O[B+W>_ /Z<D5O1TF?7^F^V_ 07&TF-GY]$EV4B<69PY^ @HS+PD[]PF/#?
M CX.Y6)?]PLS@-/!6-PA9PW4JO6$LNH64.+?N'MB=]>:9;J(4 *XS OS.D_:
M*$32GWO=)U?7^8G[>?U_%Z-4,:SGTPVVL?<6D$Z;IO3FZ<P9V]VB7;V/L=I-
M[C[YB4. 6X#51$&&,$$FP*54*:5\)N!]LZIXMW?B';-0E2?-X&I+#X?.452H
MQ3SA:Z0IA_[G9]OXH$"H*H%!.U(Y?=VQ^L<94][<S$X+76W<^H>JT$C=%#@H
M-#M=3V>TP"NUW#JS8\M0F9DAH5!T1)NW$(7JN058CF4(*"+N6N!:;YES&9FI
M>&QP.4ZX:",?/9_V(IGE%M#D[7M?PIVA,3P6,B5IR"R7*V];Y!ST\Q>IU/ 9
M17F6!T>'ZIU-XQKPXB:]Y0QD7YWE:9%C1L;+/UK4=RO.X60S?]V?RCJ9+3];
M/.%Q@VO*73]K?6M=%3W7/M#U*?2!TM_?']QJ(=-(SYH3!2'/[HVVK=^31=H&
M8^:UNFY<?00]8@PR^#LZ<])PMB"NS9"A%_%NO1Q\Y'?@0U\9R%2)5/U[<H_3
MOXE&"_ I9=H3U#PLXG!Q$GI'H_8PH^U3:OK*+->6J!?+ ?35=B_W2=I'6'JN
M=8L0W^"%J@69I=.K4_Y D#&X5'FG>.MT57LGM?I!=M;<[O&5]ONB@$H7\VM:
MW@7W0ST%77(!/G.3J#XG8F['B"PH(X4I:S)[<\60WN(5\S$VH[H*1J.S^S-2
M_N;%L"Q]$]$-+3?N-=CLTGZC-<Q<6!#IB<WO!H]ECE5[VUDL#-ML1C%D\;4]
MB-!7^:Y;[JW[G4/DH?GNP[\V#(2RP3+55B9NL<[VEGY98V-MV6&:W::)DPU;
MR6A0A)VA;O;(O\6O0"ULC\/5+G^:LHE32@$-#S->B;-^-7%UAAX\(5Y*9V+B
MF_/TDJ _PH#6^?7!*8=0>M"=5P>H:5G=4P^_]NWW^K/<<24?_(%L>7\5_]K$
M5Z_3$3,[/;C1PM%UO&,J_L1%;DO'LJECHJG&P)N\C4KZ.P8EQ>N?+6Y8HY\V
MU9M^?4:C?L9P"X@S4V"L7 ]U9O9-ZI *(CO&(DOZ%4;LA%ZYZ2-.HT^5%RK]
MA,[TX7+UPS,H'E]Y$_?BA:8Q46GE6O G7&]R%?'RK4FC5K%B#E2XI (6<Q]L
MZ/D6U9*)S&32_5P7UI:?+G:=,5+YM/R\@S/\Z8X*A%M7;,*.>'N6N%-^&^M)
M25?@=K)^]9/C)HHSOO[8&=;^>BYW[LLWI6WRML74NN$<F_W3YL[ GQC\;,I]
M2I&8-=95,^/?PG'%'AH(W?X*3RJ&G/"/6.9F2#&WP$YB^#OG;IG,CS-;TQI3
MDDSM$ANB%S1_$M64X:5GPA/67ETYY22)4+XH=Z/P5G7(K&P^Y,Z/8QF:!_41
MFFT?52^:64U-7<3F'CV$=5RI9S*&[[XL41[NIJ*U;9\VJ+%B^<NFM7(3C9%S
MI:Q]O_3F16V<1?B9F1AYL8E>%S5:R40DS^4\612PGMN?]NYZO-H,U A;I8>8
MM_JOUR+O3,BU\1\)/"P?6C_:,:3[':U<UB-T]I?61>S\ICVF*EGI"JO$)T6M
MF3XV24U#!ZOA>UEWJ)*;'CGIO)Q47+IG_7L&D[UNK?0Q+,PQ]KR8HQ26.[\;
MOT68]ZV<[!>CV/D@DZ*0ZB<I9[!*7ESFO3@S>T6FTBEGE5R/3UWO*_3^U'/4
M]X+4-J8Y\SS&;G22]Y,D'R?7+8?77YZIJTW/N+4@P,4>,?VRLMO25^6=[/W
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M_B1*1[!F?!WBZ1.JN@Z[2$)B[8J 5BGT"-2E,-:.T!Z<J]!%JH*Y^?"IA>[
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ME+;0!(B]F>*Z+2G.*38K_FP"V_5%)NYYB1ZW2ARC"@3\RVSB(MCZ%K_MD>2
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MDS;KA6Q.;-DF:1];'M4T!W@:W@'83T&#][BY?:U6Q!$\=OUQN@'\(2^[@K(
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M?!"+]NW7_K?)%ANQYG^=5M45F*,V%4.2U/GZY7)(0'3+MADC7@S9BKKH]U7
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MTM?P;6>@U$2-XB[9!MT5\9%8K[@\9*O8U^M[:S!R766T+2'MSL@)YO:Y&MW
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M?):XSD[0*LA"8LOU/3V0;/TI,0WCDP' SGV]D<'\] _?.(^)'W/6ON@=]=6
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MW7NJ/LQ,3;KTP%/[#A[@&E&D-)K%\I%JR3@8T!<PMT$Y'K D10,^G^:2*:T
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M>SP 0.7@6RW]SCL=#ZB)A$WRRTX4GW>RXP%5@H3/U87N]B[UZ^3P]OXX)X%
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MM34\(RCT)\8D?'.>K+GDUOK)IC-TP3WPL_ K"<U*N?9HQZ8F ;/KYPW#ZW@
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MQJFT;B&-//[[[O+,O^TNIUN7(%;78;O!0>G(^,S\V=<P?YJ#*V^"VVVWI8]
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M(</A!#P9%0'*>[I8W))$20L.*8*0=7ORW?-JD2>;,QYNH[P_4E +O8%5:LO
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MG\4EU1( V^8F^XY[QQ@EL!K*$1WHL29*;M$O_#X2?G"Q$?FC_2/"+B645!8
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M48UR4$]>9#=H'SS,C^4GYR,"V+\M$7SGCWBB.+6N2REJ&U@;%#;W<6C#$2J
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M']S39Q;;5)\E=\ZD?VF:W]B(>Z-V[\WO18QN 8<Y+I:H*WRQ9./0FUB22=]
MU8:V644KUH!*W&DYF=5[#A[Z5W-TG];16;O'8S]AWSFB@QPQTN <>&5-BFJ6
MK'3 F^<YK:;'J*PH2')*THND?9 :Y*<H\?G"'3U]$4F6+;BIHD,?)B[WI+-O
M31S6=GH['%,&<762?Y1QZ#0DHPI:;U7)NP?/V8+AB2M8D)KNSNM^M!6K4"=&
M0>;5">.#V$.BYO]BZ011T!EE ?2?N;R?\U*+?@;FC<]YG0F 9S66IR\ CJ>
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M#1&][K[[/.O*JQ3R]UI3OS5,0Q1&8K; )*+ I+YY9'WX ;_3XLCDU5&=0?[
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M_OR<CGNE%5=X\QZM5-Y;H,W>@J1M..UI<(UE[EJS?F&_N9\2M3!_=:.!942
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MS/KMZ7[,(3B?G%?+[VW4VK6OORF]%CSSK"_P^<P:>;&X6IL7",=HB?'"GEZ
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M)TMW^4R7%"*YL+4'81JUPEXI=_>W"[,WBH]*,C0NNIPV=8&-0MEB_K=QLD1
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MYTQCMOI,-D6:<W\IZ:O!^HB .)+!&S?R=0ZV,!MT+01KRUPIO1<JU'L4VM6
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M]G7/0@TSM0+;];226(M*[^]GVIVKHK/<JK90GO*+%_P*MF27+<^TD-N&4H0
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M/O@712 GP@[UE5"M])GLDMM,;1#*5S<*M:\1 8:G,F^?VH4VUXXD&L%72DZ
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M5J*MXU;K8O"6[;NF<A<QIG:DE9/:6K&EYG??KL9-LQP0=5<.8^_]Z-8'PMN
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MRHG]4HSJ3UG123Y*H["N9QK=Q])8T%NT-K*^-^>[W +<F[>_F*KY2[.;_(>
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MS;F\XH(JS<;6\RN Y16@,SM\EW=%?T[W6TS 6G@WC(ZG_D;EVSG5%<-N_$$
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MD_HM>AHZDW^(?&X?K3+S].*AXLF=DE0QG20$D?NQ8(&F\#N,ZB2O.CF^R%]
MTK*1/&OFT?8-%%M@W9]-8J8FHWVFZ@5#W12>]WV CPZ-?E*%->DGX49O?Z'X
M<Z"AP3DV='IB?"NK/PF@4K-*R[\T[ZRYG.9+D_?PKN!;@Y5BRP>/'1QZW*\
MX!=8A)8+.G73-/$H0%E165- WI9^-XG8EDQ6L^^Q=%YN_OM+%$B9P\S04-W0
M%,MZ7XUQ\]M2P%M-UN-<;)Y6[+C@\*+R5)2-CW9L&-DCFT]AH/N:(P.TI)U"
M7^YNM V'7'0MP#J)SA(6_D#SE<A^N,X&.S^\D2K.\]OG6/H*H&$FZJ9)]KQ"
M4FJ)OC20\+("S2LJ3#(O^>J 13Y(]LSU]&9C2A<1@QLQL*K:;/5(NO1Y_VI
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MRG!GHL?6Q_ MRJ_GI $&$Y:KAS2(@(O3$ -=E=?D C63-^,CK]0[)V'D%%$
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MG8.6QX[+KI<XR&5=(>I(B4O"[)NXED&@#"O3*N_6>^>1-FLEI(5TY<B/[T5
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MF7&&=['1ZB]C&'O^25GD=W-#)Q%ZGGHX1+1N%1';]KJSJU3@PVLMYT5+F%&
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MF"L85&D.<GZ6JKPN C!=CV^8TR1H,N \,#FT%KZ^N]7OM;77+-EKCXGT3I&
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M9B 570<4MD%R<QA3*FKR"R4<-):W:+8C=3&[:?:J(B]0FI]+TK5%DI",!ZZ
M(9$C\]..M0U>,0_%58I[W=\=7>$S_N/5CFL-RCQCW8]N;J=="M1V3'IF#4S
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MI1;$W!#YD?TGS!U%8;_BA;ODFG7EE2:NHPO\!B8=KC?*=43N;*23 +?M(TB
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M>\9XJHLO5B_*Z]LP_:%@O X.,__Q3(E6[W^79.-3C0_O*^9G.<_Z$3&]8"9
M)KR$4.1, BB$"9\EH?!G9KXV I.*,<?S?UJ."$YC.Q5U ]>K*UF_,0"93=(9
MWGSGC-FT2'WHMP92EQSYF*>D8^DTG<)1B7C.X^HT!PLBW*1[#<E/!9KPOF;
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MYU\YYEN<"'SXE17[[[I5")  :Q+<N"%S'ST&725V$4,!+:"RF@+@M.A^S17
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MW%GFI\ \<DSI+#2[^@<Q:8!],-LJ'-EC^'C7:+7,E'6"K?W]Y7@2DT\1/UV
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MUUQ!,<8C-IU/P"6OH==CG#3+NQ$++HCV4L>1"U_=>VNV1/%&%@7*?S5)(LO
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M$'X*[)#5RN1TR*VIAM--C[W383X=#-)'#UT!^:>35<FHU\:_:S7RDG5_L5I
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M1[E:70Y^##GVJ_A#]R*NOS$8M*(PV"00\,EZ0RC3FDJ:&%X_@ZT[^XN=+G.
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M=.GEK8CWP?Z.$F.6U6FA.:J,208?= UL*.2,2[&SFH$*CNOD-'/4(AZ+]22
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M-/!\3 %1&.IG;7MX:-8'R-V0(S\@ ,)H$658:5S8FPZ\W$G\82=3H\4LCF?
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M[)#TJ]]K?.<W#(O@8=*28!JV1"6+W5S]+2U##<U>QLO[);5'2W_F>+M:\K?
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M(\JCA_F,G4$8#U^.'?'CJA-T3!Q+(0!X_W LDK_"%EU^T*KW3@]H2:RMF9[
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M]\POQ>*EY"390I:% /B5,\WX>Z4.$5(9A=]V,.D2,A7E6P-_+$.V0UI^!.!
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M!APA#U#Q'HA$_N..#_QA* C/F=FVM$PS7ILK60K _D+\GZC,6MV/$0V0+X
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MJ/@?KSC,1/I#CJ2[P9BPO)F":$^J+%*;F%=?*<?'YIB[H;@!D_KB<O;UPK0
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MNX)J02WD0\1B@H3*,:AMQ"$6U<E ]#F-I+MX=TAZ7_N[7MP0E 2#LCVN8S7
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M0Z;9N#>\@YIE-E5A&[QJ:4-//,;)$G-9!C0GVT^2="^(H,[]AK:56F#:P;X
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M_M0#OFG]?H[DU9>")#$TV#2KK!-@_^BJX.7CO,46<*G$DXVR9QY8-<@!Z J
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MJYJ<\8MX*L] _EM+XZFB,G$:9*I>+9+<9NQ\:*^%_FFZ%PA"INX%]9 "B?1
M=@)#_N:H2)(5?W?OY*<;PJ!*(M)!1;.ZKR>%07[P0;= YO^1D?]]:.BM@WKU
MB<W,/Q/XO]VF 7NC7'UK%>,#*FADAOHFQ/(;;-E+[VQXZ]&DJ#A$)KF1,V=S
M9M$@(E=F9'760Q5Q$[Z[W^D3)5G&O1'6C!,9QYLQX.'QLN%@5I(2_7;')<]M
M<GIQWO==NIF#DP8Q&MJ^_8@&;5]K>^92ZHX5,-=6Z[$F9A#M&7X%,.MD.M_,
MHAG_ CR+[V- [,(.?]#\M&1KO(ZK7/D65!TLFE@.#ZV';[F+,PZS,7;V]"3B
M'X.?XE0/= B37 $2X<7;%AV^ ]9;5,Z31F..["=^FD.<84K?Z*J637R5U+2<
M[>*D*7X2%S*]NBM-AN*J'6:(RY9&/MFCRHGG9"M+$JOT_KJQLU)>X=![6?1M
MCE!I*YHWD@=\T0/' #W](J(42PW.C#,VNV5+\S-D?R+J(0J0VX^8];U(_D8B
MF?\GF7!+?HY.PLCYW@3O=S('(QUDPQ#7$FFHEF"C@#VB''X<JV!QW'2TW[J/
MII_Z6R9],_X8W_!/=]=_'@*ZD$MW \2H*2KB?2M.@K-NLPC:H78:O+9U'8A-
ME57>_7H-TE=*>VM#DX\73<Z<2;YXT;B?Y4- 18N49+]QY-$8HOD8WXJ-AR+3
MLI>3@I^/R.#%3AE;"."@Y:$5+L*7HM -B'(V8$TH[<\_>SGR&+'HNJ51'"MB
MK,KE"I#<[=K]*?&I&##S4O:4;1%!N$Z /\S_FW&A8VA:6+:Z59=C!3!G5DN,
MYP:BOP(T,&XE5YXJ+8:]6 KZS$5)"SH]D;^(NGB5<5X5$[;7[;YX<1?7X\F.
MC:M^L&!-W]R;7C.3DH6> HU'L?-8D;+2-27/+5&??_X]EN)&M:\U@W_&<>(A
M#=9&CCT0=N^<M& R&E"<]+ID@R$Y/1ZP;@A&GNRFCNSG)=Z?(BUG< :RE_S5
M>TM',N2JJFAVYPK@R<\TFI2SCODP,-GC_3WD-"(3"2M\K$?LRII6FT8VIB&A
MGCAMNPY;_]=B.+);&JI1'44_3XR*/?DJ/?)+2J&M72ZVZ-?N[IN=YB*!._"^
MC+[_217=HHWL5SQ9A)TCLQA_V$S?9NH;/F>9#NS&M?\"'VF\K]/^$J(<D!K:
M 9[8U%A+GE.Y^#@$WF2__[0@?L@Z]\7>4NW.&V]M]?;G<OYTP(#R%,EG_BVK
MZA.#QC0V5>I+);Q**BO3A8&<L>JWUD14CH5?:7::T3^GC?[>40))U;VO;1>4
MEO@%I,T__$--_OK<[E#<[]GI2;HQW9(<N0),@_VXGB<G+M6ER49BQW!D]>R#
MIR'S:C=5BC=?)MD9P5NQL=D; 5@"@W2PMJ7=3W.VTNFXX<W]WKF,R[3')[@6
M/;.;U(W&1N2O*JODD]6CO([9KXG[X0JS%U2.B5@*NS=3'>EK6+W,7 I6DC2%
MUU24?$&$ZFI+WUJW62(DR6[]P@>*<6'.XO+@@/!/@+1DY$_"[FCKD23PC,$>
MFK5[2$)/JAN[]\_FJZ18=17(<WSH+UX:-R>4NB\!I3B+]WOD;W2K"1*_#*6&
M!U3%>,.&I3+Q_)2K;R&U;YCH,\+N@9 H_B'PM#NR[Q<$*> DI,QCR4&Y7*(^
M1 GBD'[>(L*R9A$XDO=\+WIR<5I#?*X,?+JI@6X5L^=0&0XHR.,X3:)UDF >
MW"E,XT!/3)?N.V=-\1[=P4&'_4\GMG]D5'1:@O>)PY_Z_@&?].5Y$%( B&[5
M P^P%PH>'_E4WG[NW"^R:UOR+,_3WVU>[OU6#<Z8%>]IX&/54K:OHGR6J.NC
M8ZQ1&>,H('T9QF#"L5&G!IV$E2B=659A^Q097*&5^QT?;36$46Q$=KN9J$/@
MZIJQNK7I&,=K8P^!P>3RJFJ]D9'9YVO;4]#([PR4'V!/%U >"0H$O%J_1(O!
M?X=<'_1E]D]/3U6S<Q$&/#29,QN<J;X"M,P0(Q[.=N9HU@^NGX#X!YY-]=5=
M'MZ^R*@5T4A9Y\U)G[OUU<")I,8<EI^Y7C@4KW6 2^/1L[#Y22JJ1\(*?.]<
M] F0YS(X9ZGSP%QW^\N"NK&')&#$(\/708=8=H/\_&.Q8 !3S]L&J@V9-,N1
MB.SL[\Q)';J3I-V,#=XCJ,=*3+$.017MZ:/"T:HHH/!=LG UO*'/+C]V9A*A
M?ZP+25R+5*\!+;!!_=>GN_:R^,D%N4> LBP&C@\ :[9+?K.M*(W$S672C!/Z
M[/R6&3V('=\G%R0]$;4,4[ HS#?AN8^H8;!<&VYC#OK%8?*+JS3E>1G_1W7F
M>LJGPX^1/V/?I3CRSNQ/&*]>=(V!H[-_6'I0G/_ISSMQ[QH9!BHH^I@ M3\:
M<GY(8 [!#Z-$?=;6F823&]^*'G] T.,,TAU>4>Y0#_1I  9V6=N^^!:?\]F]
M K?IE%'UOT-CS"E"F^]XG^U(DB3'%K(Y\&W\U_Q["#,B>P6PJ(O0M-RLH(ND
ML0+8167?Y\O?H%D*X;$]B_" #U#U]4. >(3,Z56^NK$ 1Z!6+N7A0E@/0ML)
M;QA(9D\PMPO_YZT&T']*'9$(%M3C1>0C?L.G!,88))!*ZUJ5U)?[B<?J4/;H
M;CAS<NKK?X6'FP=?9])X<Z5Y7PG$VEA78C$VQ;X<;^_0MCH67*)=R&[J@FZ.
MMX+J2SO37]2&ISW]P$03.V"I\FKR6="V[E,GA\O-_91C&<,KP*X*"5E1@)0-
M_^ ^483H1!T4,R_KE,PQ3%#W"F&2>"8[B@1O+NI? ?HF?,.=>,)5X:WKT^FY
M 4OQ7J[W[[XY0O,_#P<*TWWC)QI1UO4X'4I4:<BN&R^<^#U21(IK/.1WI=&B
MYH.29E%ZZD1KTV/G>$K@+(O1IH*P<VK)?VJ4_[0]8][/O^VG__S]HO5I^1JK
MAVSAY.,B%R'AWKP2X^7%W_J&/3PY]4?'W:IO^%.*!=''/ZJKREZ([:8,I%KS
MC/N+_9&(AT88;E"]?TU%5NS58PT$+\<7RF!BOQ=/MKD@%YTO[R%'DA-Y;X,P
MVGYELR%=H.W5,_5^R]"$E]*!%_;:ZB-!#!=MZ".JY,U\(O]M*MP2<F9\)2V[
MT")RP/$;R<F7S+HB?0[#<H=KN5=!5HR'!<:/1CG5;28]YCP9B(\=KGKHS')N
M^H.+<YA.\"3$3A@G6'].&+P)4[M]QKQE=U+@Q3H=J*^8*C=KH[0HW79_[89T
MH7FLK8[Y37]Z-=X-E21;RXJ=O<@X2,?^KLGV"D9+Q5$DI/\2DK(?&@KWNIF0
M5!FAP1+=&BK/L*#'XM_?EL/"Z:Q#(AZ!9GJ76$<2JJR,K@#._'IW^PINWMJ\
M3[-<0*#")XE/'MFL?R0>7@&^)KB_'\GETZ.9CPK(X:<IJ6;+LGP\H5W]?3D+
MV_4R_*D"WA*B\+=]ZTI/6@J<FC<93DX!(WG6P3Y$3&JT(7@K%N>W>0#&$4Y?
M >A'&^LN\/40:_.R+:FNB?27@HDML\3NUG^^U$GU\W^L&]@VJ?8>Z% MO#4L
M-_DU)S7KB-B@2@)_SR,CY)(F^?377V&CDF%VDTI9,ZE?D/+/P1D_.SZGNOIH
M&3QP.;6<F[\"*+MQ8A]%C/7IFG1<WXP773HJRYM$XEI^UC VXM@Q,";0\T5I
M=BI7ZL>I5&IMUK?7*F*,+\)Z\?%#^!.;Z6_\&GBLZM=A0Q5=L0V'2OK@_?":
MX[I)7<CB"\@VA19RM1GYO$_V8K8X>:K#GQJP&CBOE(DZ2K0SHVO)(JQ@?:EZ
MFU.YL49D%:-MWMA[IT/$1LBV(ZYD"W^#[3F_0M8I$E_BE)^YI+;\"J ##J^;
M?E^,F?IXQAA,&N6HE)6-1D%^%[!US2"9?\A]Y8TD@!W9P_K)N?V44_J(5/L(
M/3\>7@&<^+P]-)?ZL;$#B+SR7TI&-_-OG]B:,R8;3XQUKY'-)..V-X3,E\><
MOEROD-EH1XLBP?K'VP>VLCW&)J-T(R6Y8K,OJ^-=?A=I%5HX/Y'NYKN()_*C
MXU6O;M'S4?:?'R8M7#*C1/&'FN'\:)V?.^NT"529A!MAV;0T>?S5?KJ2*O3A
M)_\S#I<<N\%F%\, /=Z1?-ROCBAFB,.)8\9;3Q*]9<9MML&C2LMY)\97 &HG
M*O[F0X$Z#YSM=AYC46KLHG*$K%>T^M+S.5 6FL:-DOU,';^N>BJV0!*(&\[:
ME1D?0M@39)2,R,485?UH"ZW=1#Q0'=(0^,_6H#=K<%KC\R<= 99J?$' 6+IT
M@Y@VW%I:,+\_US>!S)Q.MLC8<S#?\@@OU24Q_/\C[3W#HFJ:=M$EB"B(B((D
M8510DH!DB2,B620.2!P51!@$!"0*#(*@(D% 0%')&8:<TQ"4C.2<<\YI8-)9
MP_.\[_=]S[OWV?M<YX=>KO::7MU5M:KON[NZJE=[7I]%7__D,H*G!!&@L"("
MX1)3F]@+$H0/"&QX#2MHV$7(%M8M5_Q[\-\/Q$YK3LN6'C 0@0AE# ACGAQ!
M]Q*-#CVV0H<,"!J0Z3B\WQP1Z/EH,[YTU9L>- H*4GH2I@KE%K>&<MUCEI%L
M8TB$_E-"[PGERCNIYZ[UJ#NBAQ1?$=1UN@^&+(+(ZR0GX$-3 #E2-&)BY<R
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M@/T.$IF3>0(R@AR/ON>**7)I/<_=&R_?3>/]JH\??.'\#,'[?BBME B$NK?
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MX73$)<]'6R61%'M=1BUI?+=Y.'C/L;M?+">O(0LZIFJ#YH>&Z(41@7,NWXD
M,@>)B3F6,H3Q:/DCBK^X5Q@1@8SIOO84EH(4*I.Q&N06;5EC+J/;/&2+Q?4@
MFPMC001J^*;C,.;0JR!!&4TE I.K<81;H6 #&[)K_%_/65@^:B(@ST<$3B$7
ME \B[8^V"$0 0SDV.1+F$F).!(!D6Z.;1"#*<1'?BK$G, TVP?<DEB</"8M$
M@+3@!8AL=Z_.K(N"N-B&U/]:MB#^="Z.@@A\11=E(3O?'Q*!6KDEXT]906=O
M)TLN]= D?E' ?^<=,XUP>#VF3&_NGQL G0ZN<B<""@$@!4-N@!/5Q)AKLKV
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MT+'30,F$G%<29-C_IIW8H\K?@<;8Y0:@=YO,0!'1$X'9+\@&9T\Q<"F5.B0
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M-W'YTT,GJK;_/ZK:T."_5-W^B18TE=_9=J$7*GU_!3U.T\0>Z2.G*VI80*_
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MYAXR(6N#31,_O?TQP@FM_Y.V)7;9*D>DY(']87AQ>N+:>=V4,>5#;>_T.<A
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M),1Q?B"OQCD\G;5G6JYAJ:KJCX^=8%UXTA/_+N.IO\R+P&7T5!*ZA*N>"'R
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MC\\UH3*.[[#ZV=\R>@]D]A^X4Z@T[VEPF7T!M.4I/()( 225CT3\ ADW:5'
M&7'M\&1:$QV#N<DUZ+9TH]PU?(5=4;#![YB%M)3;%7E7)&*^]-2*;X[NB##,
MDE]U,%O&:EM-%CL/KLLGM6R-+&K!R<M+L=2&:I_,SY[R) (E9^0J"\L\VWS*
M)1E\L]QV.:U;4#E>TXH\V"8V'CZG.__.8>N34G&^&QQ*BMK^:1T0V KT!DW-
M+C]Z_RV),JP,*058!_O.99 /TD<>B6%OXAYMAQ2#A)PN^D&?C&$.?*D!-G@9
M*[6J$Z/NE<'0(C]?R% _]<0\B K_?$29\XG^JSBI<IU0OCR#1F2Q >Z'($C:
M5P= AZG&F5O(-T,$1GZ)>'IO812*"4W/BZMIXV[1O"G7Q#;LO?@60K@$NOJ:
M+P-ANIO"N7TS94^GRC:BO0@)[NY\%QZWO,50P;:NA$C]YO-ZCL 08&-8^ OV
M1<O!@9;#G*?P;!^D$:RZU-.V[&-A[P4:A]4I+V8'P@?- 27H0,"60-#DSDK#
M,@?MJC+OQM6P#9=/-]#CS^T3.J3*],$^/11Y\3<1FACYEXRLMRI#\<.A&.W6
MRO<DP)@RXL4',I)WO#>Q,5&)L5_CWA[K$(%Z+N%%R_(,P0$=J_E=6LO*GQT,
M#6 K-+/1B?'#)B6VE78_97@F&+KX7N>]%GFV =U4*;CD#J:T+0B^&/YYH:KI
M\)J'$ &68E=I.PM9"YTW\4<'7C;[WAQ^I:C&WX&_<O_J/GMBY?6==';?CU;A
M(N$.W9\4GR#8I;M?+S_4=%UHO<M'%HU7IF^#?V!A:+/%VH=/1%R'#S)ES'N]
M;^%?>\UIQR3+6_4Y<KDYN;C_=J[2DTK?IX1?/OV9YWATH\2]?5%//'2Z'<Z'
M"#'MBQYS)Y_2@JO/C:B-;[_%].W_1*F7,/5B.R(PNL9!EN^O7%*5/0BM+^8M
M^0F)>,&TH32+Z8]AG^+UFC\>G'^QYOT;.97$SM.$P]E,'K,:K,2<M,/7WA(!
M'L9M3;PGJ5E'.&H)KY08R-M!%D>];F_^,/$SHU6\MLXI10:*^:9AVW$B\"D1
M;T4N3%"JK*&[/OVH;G_#QHPIBJF?_JG>LT)1&Z_V7HF[1P:K8P/%NFMWXGT:
M3EMH*ZH$K?YDXY2>EM,]=@%M3$\UW>1Q7L@RM:#E)BAJ%.)E6'8@K$\XMC$3
MWRA._6&#\?5+)N_$;Z^J G"\P8V?NTN_(>8U#YUPP<)L1BI?FUZ_._[QI-NN
MUC@QTJ6]<L9V=;U/Y\FQ[D7=)-,-2L256W9#Q_U?9^ER**ZQ/1Y8/T ]CTO7
M4<'=9<ARX(JP!^&_LVKV^ 69HX*X0^5=4?[OS*B_,D(DN?MN28J>NLD 7Z=9
MXFESP$\'/M%0!!;#_JJ+Q6U#4S(A,NFVD-(S:!MD-@M%&0R&'LN8X]'+!K<'
M;9,YNA4-Y"-.(MM(87.X9M!M5B*;C[96"742\&-)F[T)M#!T*F=R1\Y3"B3.
M&H.$$*/S*YY<2^_K-X]NR=&";?S1A ]JRZM?,:9$@+.IC@@<4(#PJ_N<J2P%
MRC>^QO3 B?9 0_/A3U>%:T3 @@CP4HGLB6#+G5J:H2G6 TJ^3<)^8SP$YUP8
M?RUWXG=.7[&6C(LK#T.-,GM$]D5'2"4F8#>?;X8MZ\/\<A2O72'1N8)D.(>1
MTOHUPE>44<> 7EK8W95@O0!K;95L9H4+[RRCDA_H*E>&#63UCY@KY?8Y/9J"
M)::&WYW1V<#JN8II&QEO7#O#Y,%,.P%5,[\9OL,'C?YV"UI;;1WWHKQFP67G
M&1&(M1[<SA(?<##*;49+N,A$Z/:4T378LU6L!Y.%]O5]^2OPE<+V_N3ZE9QX
MS[9=P3Z8QI79ZS/03<%]E%K##S:H]OF[)AL0A3X8/RS 3OO>=1^.SU89%_4,
M:/S)!U).]NUXWC+\?6Q0)IM1I$4QPIT83Y9O"^TN?O;SE"5\A0^1[_RP+ITS
MJ8SF"*:<UY')37F-KB<PC.)D ],B]$7=)B5=+]8!O:=@,,ZP-4D"Y"J3?NBU
MNY/'U]-O(,^M(?\9T0UHDL=L:PX9,J MD 'N !'X57.RTSG&K5U;F^;09*%\
M7MI=%F&4XHQ:'I"48!S81E9?RWX3^B&&GK_8+M:)"#Q\9J[X74P[8IB-GR$X
M&=.@,F!!-VHF^,-#^1IWTW)L<:'2KZ*!H);!:#E5]B!HI'7M:$(0$2B 1CH0
M1+=%%)RO_$RM.^A0SA+<>G!VI3%KU- M?&5"_+O)E4GN(_Y9)O;AK'E;#IA&
ML6O">,_4L0$-$3@[D<!U/'EQ4@*+%MP'"6K]M4Y"H6%?G"S26U$ ?N? IGQ<
MYX[^RJD<5L+%[Y;SF_N4T'40-PPD@UZ5]N'=B<%+R&JAM-;*T.&F\E$1>7;'
M[ARI^??TC7W\ES=-[Z,-Z9%&L]&U'G=73P?O1Z(;D^&GK=J(@(#[<27D;V_N
MW.;UD@BX+%PY5J'=S]!71%:T3BK$S(S6'HN\P%\,30Z"HI0FR+H[55+@R:B_
M?N(*4WY,!$*U"9@<=0(=SVLB,+$L%=F1W-9LX-7L]2%+W^Q6A%YI>./Q=?M,
MXSP!OZ0@K_FDZ'R!*_W2/\4CB0"[$%YS-\NY;86=VY2]9Z1GX/*;C/;RD'$/
M[LX)>WD]N:89X\D)$YO[':%RL")SZO48$Y1OZD2N0FEB663)MF+I,0K!TY2\
M%;J5EH.::;-'6S]U@0X]2]L7=<S'2HRM)OM(</AI']&:U&['HNR) $2.[>OQ
M5TX:/,_J]HV.N^6]F^NA7MT6VFW7WTBZ2#TOA?Y"/-=*(G]KLE_ZB^;,W.QZ
M_:V]2&9D*M^S0?V"&G"B;YJYB(#C/83I\>>9@:5B17H=SL 538$)@SU=P^.K
MR%4X^R=],==1BX;*BT76=.N%E$QCJIE+<OZ@S2<_,("L$ &67/TYTU9%O4Q2
M"IH[5(64Q_FP+U?NLB%F<OK)4GQ(>^S":2$;=4:P'S+N+33P;Q#J(="J*1[W
M,^T\JLZ(( (^!0;+.862KH\92[E6APP67C3<Q<5A>"<R?[JLCGPF BV&O+&_
M-!..(T'/&?6O'*)BLX;T6>G/98-?M*3*\"\8J6@1@5>Q--;:CV9%IOO%T=&.
ML>K'!UDKI.I''H$6 ]MC L/T=S)I;!S2P@?6%YKZ&L>MEVK14ALFQS!$^!^"
M=/[;G6:IA#354ROH2++KB;[)SO3SP=_CX\^DC]52E24AWCX,%!2,:$DKI-#1
ME.^X)FQ)!%0&(CW>-2UWV S(17S+3?UR?/DH9BA-H('J)!);:%YOM24]N,$%
MT*((Y*4HVX=$/LQFLKC:1=J3!V"R:M ]I)A;%$>Y<;5)YO';WU\F-WH5KO?,
M[=9T"ZUR?LOJ5U T>>RWTIC;=0@D_J/VM-26#:O*D3VS%_W;HX&.9T.A@OI(
MQ_J,EXU_!3OS,/L&Q48:+E@>T-<6AJVJZV6T<0@J*/J4*@I+GO:;K)8[8:/,
M1@5'KOJ]M":0/\6(6!3C-XO%"L_^9Q.:XF<GL:TT<GZ<Z7:,UR12-!2OTZ=G
M))=NH".5YTL/-;1HTI0JARZ,+Q<\8YB\?K9F_Y+8[ZE?UT9!I"/+N@E)(><W
M@2O:-K!U#C-&:!BKMS4/+T M?,ZO0SQ#EQ^R*-:,76P?'\KON+5<5'S7):8[
M@)DUO'R#UW1]X^,13?>47LFNT*ZDS.%O*QC;K7L#$V;N0;-;:XA]B;*_"YSG
MBGX/H50#PM)@A\<ZU/X;9S/W8(^I ^L"Y#OX=96YAQEL'PO[\@!%[WS.R5S8
M*[K(=%%)/IE2_"JJ[6;EE! W:]KI@?T4]+#M@,Q&$^> 61:BI(/U027]=E/Z
M0C%J_O+]<-H9YJRH!L[DIV47K:W2Z32^9#WI@97*7ZM+-QJOO-IO<C9K5UQQ
MG'2M2YX(:*<0@5Y3[^^H2M>[N>WEC/8XANY[1""^E0@LI^N(Q"GLK1L@WI(2
M-9-E(%8K?H<Z7R,4NZ2O&K@<>+SL,>FX2K>.[1&73"UE851^.<R]D:UHFL.A
M@?F8.-ITVT:F]#SKW8 ;;][,9,=]4)>X4B&>X+"\8YOIX"IZX+CFW&? /L$[
MN &=G;Q'1[NI>0>2QL!JABE9K(FSA Y3A*[&2#Y^(]&W?I8RO4.B#;X1VEJ6
ME.868O=\^U30L<)%^DF,TCXS=, MX @]?H1$7:TQ/_!^X51TK&W"L_6IQG75
M*.(%X3N=,NZZ^/KA/@TXUXDX(H#2C&[W[G"5SCQ!O[0:]C6'PJ"?7OB,,5M4
MP1]\2M<\G=49)K(1C$\G(> *D6*2FY$D%8#.64;NT)00@9QGY<&,O_Q,>C;>
M=>-CC\?H8\EQ7/GLC17!=\P?E5#F1D$CQ1+OKG*Q,5N"F&'NOR>6E&E[H'NK
M'+7R1_A%A943OM^,\N@@)^SQG69)AK I?('1"B6S?E5T[D"QL>;#!0DW_-N9
M3 VS]@/!+B\&R)#%^JO)2,BS[\5U.$6-P5==X8&A:]'D*;70+1;-PK&0\.O'
M@:(;IXOTI.T&,70U 1$=W[SW*[WI&S7AK(3AR1U]&=!5FM&=!.(/05Y2'R:%
M>2?6R. +GAO6\+EIY3@<,#5Q$&+9*[?@C=A.WUG[H\MM.&U<9TX<:>MV\2 D
MO[R/"+P@ A\&HEQVQL<[X\V4Z2]>=PT+>DB6&:(JYUO-UK=A1VND@5JR>==O
MM>&MB*P3(+!@*NOCBLDF;;P9!HK>0-:DAPB]R+2.TV\^/!18U!+VXBL'D5^I
M&^4OPAU,Q-2Y(L@%Q,C8G:5>S@+K >$Q7HG8IO/:CRY(L^!ECCI-&]^6O6Y.
M:4L)B;/#IQ7E8ZJW#@_"\5G>C!@^E:VT]S@H:M2J0D].,5O8S7#N^<,(WT:9
M6-55L]"MIH,*?';QY$<Y^E[G:B[]4*6J?EO;34/<[>[TM_.PS]$[!.VBV#<&
M*Q-P?*8<\B##\2AXX!/VK(W7;,BW9) JT;!J)F1)TOX1Q/ >9&Q+_#)"^^-H
MIKVXC/H\(6(^?;E)/2]O?K,LWTU6-#2DG^--S-,=+UP.#2< F(;9TK5^IXQQ
MC.!TQYY'0'S6U<&1]_ZIY3_-KQY9M<?Q1OC>6[G7*0^O4'BU'*8>30002='&
M/QURVRX\TMU1)[#F'M02@00Y)(X#Q!4S?,NA&)Y;GV8@[-XM<A!U-G8L;,"R
M[Z6='?]+?G95AB !DS4ME5.ATW#$/,A(DQLN^/26?KN0N:"A-"!W$12TJIN"
MZ1:R?A-2EVM5$?)19J2CLHD]R>9FI=2'LS<5WH;%SOP$_8(&/L:.P.5V617S
M=AHE8*O\JX*<6KK2AL_I]J&X#O0TKV_'?/-PXX4KRC)/!L>3A5;.)=E<:/QD
M_?2-P;IL(@F:^QJY'39>D:/N]V9V:VNH6 @7#;<OLJG^?RA[[[ FOZ5=.(J(
M4A5!Z4&*=)#>"8H(B(#T*E'IO4DO$9$B+10!0272.XB4T /24:3WWCLDU$#:
M";^]W^^\9Y]S?=<Y?W$!3U:>-6O-S#UKS=RCW65O9<^*" 38O1 K]PW-5($#
M14"^^O%'$QZY1!E+9MU)4_A:&N2+BL%K_U8G "J^R9\+!7<0 /XM-<B#+IUS
M>45.?,O;@]6:LSN7)VBV HMYF_XL/-@@""Z( ! E>I:C@<'?#VM7-PJ+^"G<
MEHNVE2]IPU3\W87*YK5Q@+/2.?[9OUT:2M8JK8H4;/G)1I\'W'\4R&LKE3H9
MS=]V(W^*^,5?J\)U6=VH5S>\DBP$W(=M'<(*BTGVF)RL<"9G:S1HHS5.7IO[
M[]A/)8T9M1<,XA_?U5U%(%2.)7VJ-H9;>]^]D^_"%A$ Y$6L';4BU5=AQWTJ
MW8OV\%=2.](&N)/.FCK\ R)^ 'TSJVV)7GW%6BZ7XTW_5):TJYK!L_@&V2:O
MLM._"GXDOGRY+/C1^W?)=R7EES2RPN)CM,X!*;L0\1%V^ABHN!D9#K%*!.S.
MEP>7XCZSZT64,^ F@</(_R2R/,0M@3^!2$%KO&F(4[$=T(7P<FY?8,Z)3^)G
MWMXM34.;Y,! GWS[("V,FSH7>F(1"QE4HL'Q)[7 (4T+9N=W3B<)@*21)1H,
M&3'0RM,SGG [^[(#-H_Z7\XPP8GGEPQ5Q#\F=2]",5>D\=" B[!6")*(BT-A
MMT)(T=I.B.MQ(*,Q"6;FCS5.S%/C2[9^MZ>5&:?$3)+CZC98C(D0&&D"/1<,
MN4&,\.Y -L\JAF'O"(!#E1!6R&0]$89O"7HO=O$;<K\-$*JAMSJ$GWJ@[*)
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MCZH*7XQ)BHJ/SPF <2:;?PC-;KY*=G)1I#(I-O2Y+*2TZRWZS1*KU+=FL*)
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M>#SOI69G &0A>D#_$6XA$7I8UO>X[1%/J+(E)B=]K"GHM4FRWK#KKC)7&DE
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M,A?D #UX#,2-&*N0#(9IZJ3'KT-FKN+0<TK9L-/"J+\HXX"3POXFU9]6%@1
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MJA<6IIW>OREE-G?:Z$#^)FRY4NS3_9)?D$.5 OOYY>.JJ[[NGQ)@,MUG-L!
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MYPS]N5D1!UJZC\N#;-Y9%L'2B_S3L(P+5%V!NQJD>JGD!,"RD\CN! $ >DT
MA-+LP([WP1ZG+^E1!?_YF#T!\"'R-(4 ^*X3A4 :("[[MU7@0XAQP56:<LA(
M?7#WU%OC+A@R 3^,.+Z)NH<G)UK)CX4$P!(_+N?L-NY;Q:H=)T8HT!O/!*H"
M8W&1\T + J# $P.M-E.S:;/E',QP"0G:6J@>Z)A[@Y_OZN[P?#EOH<X1<<-E
MQ2ZQM]60V9]KPI< N$FV1X2<RK#;D,4B"#JCWD8?VJDGL/Y?@_U?3=GQ7V^
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M[)K0JEV%&$)PDEH#6/A:F_]I'2TET;-SO<1FC;+0X[R,H46MA.[(S9%7@ S
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MG?-KP@-8BE8K??=.61Z)XP'&=PG8D]03J.H6?[U6+HR[X"'Q?Y5 I)'^VZO
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MZRNIO3F- 1_]"*E;G/D%/QCQ!&3]0U%*573PW.$S/Q >\,I("'OMR]":-+?
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M*M&:E7SG6> ]2+"U%@\[ZJ3 &JO?-EKXVY^E#>121V6A\;QI14E607MH]]G
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MGY4XR5WYB,$41E*7ZQ1D;3V^NH1H];GO\OK\YT;_OS^@^@OC04.APE2=1KE
M=>("_;QA=])O-,=>,EL0[]RZ+TVODUP.=56M%I_J1_CZC'1^?3'TJAI[5!(\
M;-VC%26]10VLJ;0ZM';B9+G"R=##W:&NP=5M?[S5D%]JI[M_@/"%N#_,#?FR
MZO;H4,5?]+UN6EG('/:E7<Y8G6XP;=?LK'_+N5@ #)4W>O;H14?=5,_)Z[G1
MX@&%A@L4^>],ANQ.8[+$"^J,9? ]MID6!S[R%YVNE]OSJ[_ )P6BR'L1(GA
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M9IAY54RUW[;W"X26GD 9\L.N>1U"5G<]?<'C#U^E]]HGUEK9Q>;2B)7K'TA
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M3OQ]$Z.H0)D&LG+^N,M=Q LTXZUC)"F":8T"_VOYW=08?&$//@87+D;76@H
MBGR@_P$46>1?8G);62!+K$=JK $-L:_B@),T1F4!MS$=< #@YO3V$6/%%P3P
MPW__G"))_9GJ+_J/^"=E"O^8!GHF"#1/X:/MNNA&9:&9)8YW[QY*34"\B,CW
M;#/@-M;G=&$F\320EC=0#"5,03"6P>=>F6]V. %?:%/;_G# 0]1T&.$4[.#4
MGQEX&/0G7#%_7$(*HC)/M<4<<,( (BL%GE'[ S" F(D",0,LRZ5$')%0P)U\
MAP'(?WGCQQ\F:N:..U?0 ,6=65M_W<?KK37[!1X& /5EF+ =Y'P OVUX.CP\
M5[;W>&G9*R@F]S55\'>#"Y[8W*+=B"G-4J^VF;$W57Y!/I^V\[U$8$YW14V9
M_7T5&34=16!>:AM,YU3S ;(#\G#-879@#5?U[H4T!H!_G,D?Q3^T\/[&R.+'
MM&N'%;A)+ZA;^ND;JT^J4FR-BP#0%G80;\KMEX-;[FG;4?B61LEAQI@^?FTH
M\:BRWH(2LFR(34RU+E&9FVRITMHSSA;]/;RN(B$@,X.1$/"4U"[K4<RW5[BX
M_Y*AV-:>;$%Q4SR(V6YS-U*HM2H=VQ_6*<XF)66+#GH4,IP?1KGN]=% ;KLL
MP?DV'@,F_J6]:FX]#[PO/KI]=H][I3CW*U9;MJXE.3K7CP7:]=M7U-6$K'!K
ML,127?[UR-A8&=:=_^-'\PU9SA6)FX$K'+<<)ZS"QNS$TZ*ROHQ_$8^(7DC)
MCWJ8__W$\<1PP3/T#JB5L67-;"3SL<?A^MK%#W**CK[A<]P77F=G9ZE>!MJ$
MYA^_-S$;G"(Q.?VJJ3(=V]*>H^[45R4M7VZ4D%K24\4<<]C!MR3XH;-"NEI-
M."]. 8:.-]K5T:@T]G5W\-LX9E>MMG%\.CWH#SIRHV1(KEL%7%D^T O)=;4^
M9ZST3?JE#<:W_KCF /J!H0A^$4=/ _TZVNW-2HIDX' [VD6[:;$1*J2=2U]>
MF/VKU%\12/.["$68B%0+#006-0V DCDT@%0CW2?[ BFY#\%;2=KN"L#%8*.Z
MJ*5K?(.'T,SLH\(JPXO&J) [@!'QX^/@P#2"AVD_1AW(18$"BK)I!R5!G1K(
M2_%#%Q+_1M;SO--3W*+D#F 4_(@<G"(]\GL-69"7HIZWREX1WP"/Z@)DY!K$
M96>A+J\K(F@/E6M:IEWU*A)<(S0WAC[K-9K@:1_/X[MR,<4M@)WPK1U%D$?D
M44Y:%1Y$KM?00-^.;KR0:"#8G57'OTMW_SK)M;V%:H$!D\024]R8. 'U3.#3
MS4:PIXA7U"Z@\T$P1T5_,/L/T%22X8OL('>40O#F(K>7%<3-ZM;1U/,W\B@(
MA1E*/)0*1P+M<'?C'_[^QFV*'9!H>B31>40.*,H'8T@R4Q+9AHHN&(>/ M 6
ML;I! P7Z!_WMX'V#CA!T&Z!0-8P$%B4-\(RUU:M2)^OIJ*BC[Y- RE<\F=;>
MP]&[0 4K--77A#!;)=1%.IZX^:W"NZ$HFZ,7<]D:4^F7=",OS#'+VW+8Z1._
M,'S DB^FO1$Z?;HRWTXFH(187UO:>JGUA6U:K;9>&(<<,/.*5V9N*$LY=%](
M.*2_6,(9KF9,D">&.VB?S3;@9G_YV<QE^MC<!=W"=8-T.>Z6/!^;,_E9X1GT
M*>/NDA<++-X.EUQ;>RIPFUN)6?>-KI0';N5TY.X*4V9!86EVH9'MW07?KOXS
MH1YRB.>RO\6C$:^&[9./_57.(D(9WLLV)N@C,MOEEOU&QS:,6[9E [A1G(LB
MDNLZK5E;(H+@,MLM55?O5Z@[3$0EXWZ_2WFVMUYJ7:_6Z!Y7'7WAWRBX@VJP
MRTAJ?UHO@PS;'[24>9D>L)[&MQ?'1(S9/]!O_YR=6W&<_86QN@M9:"]U/*4O
M?)A?4R_ >9-'0P.:FB72G<7!+$"_KH05V-$R_&"]BGV\*N-0M1BFL.-(&>86
M2L K% ][QMDF@:_$ABDYSWSPGR?;UR%E"<UCV-6SKO:O4#9.EJJ]CZ67AM3+
MBN4WW78>9Q;;'\!"'?47]0?7=HH\' /M5]\%G_,Y_>*T?Y%H,_5*(R8W8;[R
MV;J>1QB _MA7A'";)/[!?K59--U8>5FP6Q>W!=_\^8&_-.55]<C!TNT;'<DQ
MK7(L=/H8NZDPHC59!'H2&!_S,YODHYNW!'<575+N=/6%=4)HZ!A20_\$#52.
MZ:P"XZ%"$:M<Q@B2AL@ .NS&&/&X2^V#CLF]@E3JV0&7:#E[)_@&#YQ4.! G
MC[[PTJN'$GB(+H#/6'L!+':=#IAB'^ $-WAS+]Z9PH!EHC)<.6(A\\XD3W<T
MA3$1F%T@X&+(S 0&LB,#Z#$-L#U<_GS,:X"5BP',UW]Q"((O;^ "R)M'$%#L
MJA!2'>0_I;MO59-EZQ:IH>IP,@A"U@.FX@]9)\,R .B5H*@@,%4P^MD>T_H3
M9S()YDUD0+5!3XDT/"=UMWQ?!V^S5 /KK4!)1ND C\WL;IDBW3WZS>KL)LE3
MHX/". QH* H(!>,W4F,.N$N OF8&*&P2NZ%"3)>B^HDV'"P<SK*]K3AT%2*A
M%#]8<YD/9GB0@S"7<.C(27I,R8RJ.T7,,JR+<0\/THU6F3HP0"/^4Q9@O!1X
M1_;(>  ?$'0'+<9K%CYUKJZQ3?I#9Y@BTIE2%8-OR9EF*@G?BPR35&7^(,,#
M&]C7Q_RO$!)RX'BH<6B-F%3D^N BQ^&1+PLQ9-DOL]10>SB9#0&X0G7OQH+7
M\.:1<,"?YW1^0';N>0&-]S1@Z=')X)5REP!?)X6B\(X <VS#=$S]W[6MY1V'
M8;VF]K>:MM? _^W&)0#!%$PC#BXWR .QLX=3;S4IT$"A;N/PW^N ]$  X;3I
MP*AGQX3AOAVLW;M? 4]?CMT 'PG$ P(A_Q\$2CJ3^%IV8%R* %^WUG2F"J8A
M\)IC^PJ;$5=/4(HN0HAV]WC'(15EJ.UY_\71_V7@@#$.%7A!'<Q!\@59TD"M
MPW\G/K#JR=DFY\99=3T:J)H5<B@)C!K&F5I F4D *IU:I('"LQ/EVR@%D4#C
M%=I4R,9/M<:<7#4:(A;XXZ:8VNSGN9Y=3=5]PZJS%W:*A-XM#,*%!OMQW0$<
MUVR<:2>C*':[B['(J5\),</K[X?^W\*IW"VN@**-*.HYX%T6]42IQ@Y@M49*
M>'7![I^=><<\X<VP''^%41[XCF 45<'KF(]7WA-X[CALJ&@>1?)D05.86(_R
M%W!*S'^^1 C+QASJL-% "I MBV4B):/AM(Q7C*;SH7\H#121/T8,P4LY>GRG
M@<9V@6&'3=CF(\N& R46 601$ <6E?]Z*2P;2BP5!<J!?.; GLIY[L?FGF24
M6..=@K$82OI'/V]\M[537LZ%S>(Q)DK*T7.'4!<3('4)_TH" S#!E<B;.@-K
MF8"UB>+RW5D&AIZ-B20_W'_>Z.DRC!#V#3>L$A3H^JUO9CW)FBY<WU09OC*E
M6%-;E:S8(=D0<4TF/?C9*Y7^7( _IL^_8@S.G]NA]"$O ^)?C_=(?5??B3-P
M"S6KC;[Q\OJU_:=WAW8X7DKO\@TWY?:\UO3[YE*V/D,(F/QHMX5=VM[MVT6R
MWHY>.9&];#D_%&WUP<?7P""?Y(1^^CLZ8?Y]27-PC+,N;R;/;I&2A4"5O6#T
MD^V$(62#:(2&TZ1RE,*SS4SMSMDJ_Y5QA5M]B],PY;R^K<J)VT=;(_@$Z3I)
M,(BO*G@@'/EJPUS)14H&=1+$@HU(?G<AV9A=SZ==U+4W0[';;@N)LS.;H1MW
M/M_CI8%*GW23H[2=0V3LMAW=_6U\O5U=#L)1MA<;<\Y]U'?U8M(&0A #O6#"
MI)1\@FGQ:5,,KIM'WYA;304?.U]&U=W/.DCP:DQ&*CU7PS&H (SK0W2P^YG-
MZ[R_8/VU4V _S0@E?,+$0L(U@%@67;ON>0&1Y/H\S>TZ?<<%(W:[.TA(B$"U
M,V]6U%F<H/)'J?CJ21\&<U+OX5H N 8TL]"J3MJEW#'CRO-3(64686\,1=XQ
M'1.[^C)44UDG**@39O0RL\1/>RCE9MV J.76=@7\Y9O3OM.B1ONJ!'U6-36M
M? S)8!^A2'EK)EY1V +=A'^71\Y0$*,[^FF1DJW!J&/?J94#!KU5 ?PDI(4]
M=P.G.ZZ-'9M]* 9=K0*@W3LT;I%R8A."UT>1-0P.!D* :F2!X,&D:XE*AO6'
M1G 2&_G$TF.A113I"?46_+<"D&VG[/_94![1ACZ@FX1/E\!)*;!592ZJG^[1
MH:/3\90@8VK  /!OU#3/OK<]\=ULJ!EBQO!6%!?+<]T#3@+BOX0-6!(\VY*5
MP1IUYINY2!KH$I1BVP)'AR-(3.2+@"+P;NP?148+\,W;=P<YD!< S9-P &NZ
M!;359X#J3YINDZHY9]Q6*WFP1D=/O6F@X30I,JD (%7 / ,3N9WW#X'8'3\B
M6<><G41FZ>_)]ZC#@#;8;$UPI;[=0Y"$CG;3_R_-!FF@$G;G_6T=&@B8!H%0
M(H/S/N5?<LX^"[@]U)N4*ZX\YG0+XI'>4DNFVT8"7>'=P+]Y]>6*45+K^@NK
MQ-4G3;%#'N=MIT$*;VU+^0$#4XX,O-!QM<C?[A]O#4QS7U%TV-NHL57N+!^E
M@[=BC&%RBKC-"'W"=:UEC-W[XX51(EXGJ">@_Q4[\*HFX/_!/_Y_]TUPRY-8
M ;A&E$3W^Z,!&HY/)@/](L-_D4J/^?-@YQ(D K'#!$R@'W^\A1J._#_.XCL\
M74VF (#[+?R[PKNL)M__,@C\W](H-O\*UE_4'\"@@P#@?AJ&9\KX&3(=&>.C
M%&6PD0]^ %/X?_%U'[7"'+78 R734<_ GP/S%#'XMPD57JGW*X9F0]1FQX0=
MMWK C$W[A1_L?:J#OR:M8$M39$R5(3Y!E,PI\K;9 [Y(!9'.7&/-!D& Y+8>
M9:8=J1SW\U9?WN3LU!-@U0H3O>#*S_2HH]2B@;X6&?660,CGJ,=VG)*+C.Q9
MFWWO#7NA31M5RK@+)_S*G//]-"H'&=:;DOR=7_E\<L,7!A2RG:ZD@6;D2"B@
M_4O!28)0ZDW !<T[V09_)XDE*:!RI^1?27)5]2?'*_M%)A)4X38<'35%I8__
M.P+H2/#VK"?P_P%&AK.%_WN:B>X&H/XG B%QU])GAY-A"O!F;T(0U<\)<(HN
MXB@,G_T &H,XAR*S\/UGS0!DQF 5(%A_5\V27A0BHT@L(\IE'_,+F]<F&FXD
M@L1*GDS\.?4*>M=?\L)KG_,)JVV^22VBS":DCA\R 05>^=7:I]7DRH)O/(M\
M.R:-5!1%O]I/L [-XU!6@TWJ#VQ:L]X10+[-*=+4^FA<7;>)''>7T%+R/XMC
MV3T74XZM9VH(T#M(*<@:6U?YM+=OL/QTI3^Y5)]YT1F,YS7ZW7HUF)>;^461
MI=C.T2:4L9]$=<*C;:OP,D.OU59[9(\YJ.:1@F4*=&8_9BXF9'TWR@H7 .D)
M2*J[V_Y5=KZ66W8(6Y2O>*$R 2LIS)PVFV+_RTKD#,,V#^EXY2J;:KEA:N_X
M]VR7:++^T#VG/Q\X/\6L%;OZ/U_%8#_ K2<*T&6"DR1+N/9CB^!>)W0K\_>,
M0CHFS+677WLGBAT@?\+I2X-$M)18KEWX)!AGERWFT550RO3SU /=HQ/'GJN?
M3S6V7=873##1J7U +'@NPJRE>EY]J2=J*8'NY 9X4/_7$5\S4SP_R$:<LJNV
M OOY=>\6ILBWWP%PD3<\OW#B_&!6N. C9CUYG6?E?8Z_]N*+!<;DC4<8=W_V
ME-CS\/]<7L)JION,_X3XS%)BQ\C;NEFC.<_G"S F*ZQ5?B8F+<=VXN[G[19<
MJ0E9EFH1=N7;RW[>LE-Z5Y1N^>Z*$8[7\^IA_[C8"PT=1+,3DAAUW%:B.WAI
M++J#V&8@N $KCWG=UK#J/JMAAX,FKQ.-6VOFSL-WBUP<<VL7=.;S]NA@[0!J
MH5]1=\;9Q[Y.UVM;8#6=^&(&,=K,?UW5UJU^M:R][-;@TZS/2BS)GW2EI(0<
M>:#"/O0I94@K\7&Q-6GF]DHNR=;XNX8U.^M:6DI:F2\FB:K/+#>@&RG#T4H)
M)P0Z)8,,=FHU%R)WVI5NJBM'L:@;#S+&9\.F3E[DLO>^>4;SA*.VRX%!KP>,
M/>"JO8C0B/1GW?G$R2[VFSZ,[ZCN2^:O6%Q</F;TJ]>7M1A?HF=05JLZY!D@
MG%/?OA)"H1.C;CR!N^U WE+=RV<<=0X-5,+&%VQH('>^PQ843NB[LYP_07QC
M^)EU=7)FK,=7&1]&R&9*=@X)@SO]H?^<](+.K6,ZEB5Q,NXL8Y08_:G6T*-[
M>^C#AXQW7R7]N0,1';[?0F65:A/=GX%0S\7_\^@EBJ!.]0*J/G#N3SU;'#6P
M#T?/7"[L+L&O-\TNK0@M@DG/$,RHQ7< C+P%/>J P$L:Z/^\7O.9VMX" SSL
M8 <2!W/9<6?93B(+0\+AVYLN_T@&# D.)4"I_AL0O,E1&QC912W. ;V5=.R?
M=;!"BZ*D9S 6R.+D+-!:N_XY-N8[J>AHNW_P_UXI$5C)RMHK_%'H0Y3U89,Z
M$SK7BX,43-#R&1MG.@P]:BYZFV13@NRSZBWK\KHX[A_AI>D9%^5?5< MAOYE
MY?&.@::R/_XARO/<D^,9UC9U8N7\R#]IOGSYTQ*<:=$T_*O[^1SQ] >7@V"R
MDUZ'N*K,E\/5K'?4G5I.W^T?8*>!FNS%T4:DU+S2;GO'Q\S4%:S+_HLDHKQ3
MY=6CV]E@XKL;#59PQ>6?]JIED?6",?K2R.0%3 #_.+PX5-?YT*-CBR6FT"NF
MG9.WY5;1R=]"U3]OK1-#.[16]_6$$RL^?\11X?A3E$PUN\&F31+?8+Q]BCOJ
MH'O5G0:J L:>8"Y?E 3@W'D\A.+Z$)X+P\>$5F@8M/AH%E!BG9F3$F--Q"\W
M]2^Q1R)*W+XNZ^N3E:R=P8=E_-2$[6]Q[]*,AKB;AAE,>8.=N9<-FR6VP$1S
M"7BSH\VH@#U0PY\@![M+CPNSZ3.8S#7SB4T/U@TLT) 9489F6\Y4!$#$&OGK
M,97H\>4#D\0SXUQ%Z"2;W1/#C><DM-9]K_HZ=7;B,:%7\1-AP>P]<J%^ ]63
M'D"!#N8-""[55XUV:=7*?LT*%\KH_->V?4<_>GDZ^I]-] )X;=98\'SA-- <
MY3HP\-)@!ZJ5>Q-^9W&H?8@:9(V/C1HGXG_S ?DQ$$1XYNP"@D&4P+M:QY\5
M6Q TB^2V@3'X\>634ENQX;8RK.GA>P9QO'6MQ2MO$NX_FT]6 >T6BP+IRRUW
MEH"&#HH"8OG]E.SS?GZ=4#M_Z1&O!]?'  )SVMLQR84_!_G<082A=A<!VI+[
MR@ -QBO30/LW::"+D#41  %D&96YVF6%^35MBA'IVF*PZC/5WR<>-G=T!/!'
MM%1+$22(1?*YK8&Z.I7O;6:MIF=Y[\WY8&QGP&PV5#E\;RH.S+3RUTK=K=PS
M-14-0;(W%,<MCS,^./G7F2N!QUBF8=5[:T :G3N<9LQ)\:]):N/AF2A<ME+I
MN3E$68/@)>A.'/ZLG ;CU< QO+IXU'L%%KN]J[?< K&E28MW(7TC.*]]ZNPZ
M/+OZB5;OX+[9KWLZ47U$YS8$EG>FXWMMQ4B#)ZX>QMB37]18K*,DC!3,/);J
M8-,*4N60IJMT,V,C1<T@.;QXIMIE-$O.-['5!)=:#-UB6<\2$[C2Z?<[Y]:#
MN3="6W=P5@N90,F"*'67'O7GQ3;<X483_2OZTDJ:4IW44N#W33:?^YO22;/L
MT:U7'DKX*9)Z\)O-8"8JV_C2 ?B=!%",&N4-]7%,MY4+$PEO\L=BE6?1?CQV
M>FJ/UT4N: H8WJEMI#2BK"D*!\9J 7RVCL+0LA0NWV0+/NRC]T5,KU3WD"_Q
MB$@W41Z;NP>8D-T(;E_5&G2";UYO^:,1:=[7\9U7 F7"28@?  11FPH91IW%
M51+T-H#*2>_^53]4O.DQAAUWN/[^=RFGI+SZ^:\FY%KD::!O:9):C/ TT#H=
M#G9RS*S+?Z:[YR[.NY^W[IC$Q2O1TSZ68B;1]9A[WW,*-=0$2EH21:1X0E<U
MO!%M<*S.3-+W]<<=4 (Z8HT,\?>_D#XY^>Q+PN1MCXUK$H[9]TY(]S+>"3(U
M:(6";:;.^3&5>)6WLET;4.EW3%G :<XQOL^NO_-7AN=U@VGD^EG"B3;493DK
M;X)ZJ\>W'Q;(2;1]GA,ZX?*K,S20"X_/^^%G/W@#G^WUZ!FE]]C69/(XHB=6
MD1$*%\M(+Q2NHDM4P$$,<7:\^ELY D3/]M&[IZ:":ERJY7:00(<,#:2B83LZ
M#G#\<0#/1@ZB3E)Y;"&L$/.I8R2(Z>']OMV8LR-C)I3$!Y?K[_+Z%3_X\3.Z
MO6&6RJV(%QIH Y,DH51)C=HEW(WNP1U1DI?HVBX-I'2W Y@\HA!2CV]2,%GC
MB]= B\]+5)9I"36F8"QWXG._$'\B'X?^L3>\5_9 &%S>^M5#>9*4!J50 ADT
M=08WZ.3$:>\OL^7X<,D$_D5UU.^OB$I>9:ZZ'>?'%'52WS3JLA<3T3RH&7SJ
M/,$K6Z.ZK+^BBW=KKUBPZW*TD4DA^6V81><*H](30;7)U1>YS"5.>:5>1>V<
M3&_=DB6A%^V- M[F*8MCC!+ZC=M/WS_LO;]RGVP[R4+0CY^-81RQQS+L^*3'
MP,&?[;T9/1XG\[[JI.,XC;H(MX>/3N'0S:92+=2; #+_B-GU]['5NBKSKKK\
MOI9NU9YY!<_]9M;+[D@@F4<05 VI&6O*6PL:Z'=*FN ]M;8B>BTUL\4"4DM[
M"ET+Y?2L,>%NN47&,BOIHMG*I6(Q ?G3S[:@S^_)%W6XH<?0TZ=+\A6MG0F0
MQX9?' LQM\>-.Q#$G+@;2CQK]Y'OX-.EZ>+#E:+19ESXCYB+2C.KW#>%NKU>
M/W*4Z,6IG5E2/5.4WJ)0B:4.0_!06 @82&6K"<5V!7#C8%*KC(3^-TG*T$@<
M]_TN89>O I&W/.<]#D"NPU_T;GC^K.(,_X;2V6F?Q $"\P*?+0;J,5TNNVWE
MSGLE4/I*-*[!MV.J2NH',GA2!(7O"/=SM\U>'3YUJN=C8M*MODTE]^[K3_($
M5[SD5YOATW&3XL-^&H>RJYP>!:Z2$U_"2B33T_L_3^J*G'_-_E8^2.R*Q\1;
M&)\]C*$"C;6FTIOC:*#S7N$XKQW#W:*1C;G*!(OXKLK@CXZOSUQ^U# ]D*#R
M,\TG,+P>FGG 0 ,QG:*DHY:^C #=_^C&&0?2 T]$Y9&0]P?<&V_..[N5/,;*
M=JLGZ&L)B_.[O6(_?DR;Z0J//6Z"CGHV_E"*5&;MR-0J,_SMZ[UHG3RO0.QL
MM_F0L:4*W0BF#WR)+(J+ 5%[/)NX2$^<8L(JHJZ-/?G];%_[B5PY\^-GG7<O
MS0>J\7)#6;1<ASH3LW_OQ%SPBE?%1R?<RBM=J3*ZE4J?&+?YM$;UVE.9N-[[
MA9,,A-)@ E-+%78OI%):\C/G_&?SILKK'3?;!<?4+K_Y'KDCC4,![-M>=!0]
M"VU!TBT'R)!^X"J'D>X:]Y^U6=W,N[%&D$I<KXV6JV2_#U*6]WV!.AIZG^%;
MU@$@&N@U0)D>6^;21VO/V[5\U#:HW0EFUC).1EP+F$!L<>#A%)\)^)(+9E!*
M!D-T?K-C[#7FV-86*2BOYU?914W8VEL'R/!5!!T-A"G!4$.Y?3N"+6&7[D96
MBPN[<-GHV%_V*XP(YEFHWP;O79:B-.XG) CA5JLI ]7XFQ%$V4N^UW#V;[=.
MD,6(Y .,#B9<Z6DABS*('>21BTQ4"*NO3[A1QE7=/*GCXR%Y3J-:;+SCC5>O
M^)<*6P[% GT.GI "]1J3A1OX@=%?3CNR7P86Y3YUB$'*6)RZ.QBLQ<?LJ[XT
M6S2/B_:<.URLM&F,>.1I7 49<4HXV</0ZGAJ7*@"K_W@@]U.K(^Z:T:(S0:O
MX37WN+L<YT.O4"6ZB]XZ.FWQ9+R2UWBUGM6=W3FPY/.V@B_>_NK4I0#N G![
M?V%LZ6C7EW7V:*536;%UUO*%WD\FI(CN,E$\XUU"O>.S;S>@.D:[!NIQ',(O
M[+VU;8@44N^#(CTFURL L3L3,N<_\%2OVG1%2<]*\)7=A[-*S#J@HO#;&;I_
M=<37[!2Q"!\OLH-OG6^@@4HOPI=N%@\Y0JD/DA"[S5#*R<'NEP(.Z&B4=<($
MKL30WQ' <9V!3>'(=)0URP1NW>3 R)H&ND9_P-H$%::!/&+0VPIW1&D@3]CM
MG-SBS0MVLRU4GB%)_?>]57?C)MB#'$7+SCFB'68YD+H[$6MCMJGH_B8%2BI\
M.DL?7&'=YLMT<HS$NO@@<6,2-[O^;25"!IG X>=PX99KI+4DACH\5>6.6,LN
M\++K76UV)7U<?:HAWB"UZCBW[U 4>-XY;8.X;.1[#Y:(3>H2VAK3619IS]&?
M,+,_5""_")U=;/8'M^-MH5EM^<FZAFK2R=FC5Z%-+*YIUKD^_-<Y0XK7.GUL
M-)2X;7*.#]DJ&'_P;S,LI9MU;HMBFPYM:;1H]P&F3J9MGY,JRQO?Y+#65U_@
M8:DG1BR)F79K0?Z,U(\&[:AR!)G9%TK)5!"V5: +^BXE<[EZ^4[$J*3>9YWN
M* 372:&T]0ZC0\$PI;;1:"T7CQ>#UINZ"=RJ;[0QOR"5>>LHJT,!$N)!7VD#
MV 6G4_2L<BF%^X'C.Z\/7\;9I^3OI(7OHH+@[-=(*+R%&BF(]>.!B5%P3K4B
MU+NU.)6C?>)0V;6\E,ZHFLWR@.7GNFN?  '3!C\&G\XU\NR 1LHPO<D@P=VS
M>XK4)5Y0-0Q?/FNH27_R\:]2U_G9_%68W0T!0*MW6;/9U[/B$C-B?08%#FMO
M!R1(OJ9"2+$ST! CPT&R(4Y$JF7XF70<=<9"-+H3Y8W^%FB;6=JAIPZ[O@S'
M:\-">6Z1ZF?@(!($.B2G<K<\7^DYMIR_LC+4NWV>(2F>KFJ(KMQ@>'">C;L=
M-UM34;FMLBY_Z.-UCF@]&!+LXNB.BV%E-@2K#LP]&YY0/?6DO^KA1<:'P1:_
M/QSK\1O(IH%^6+*OQ$49S(0S2%1O]"06^LV;[#KVK5M$MSCY*YG8:CY>9F-7
M*\H)2+(4O3ZM"W=X?]D2D8&\0[I$F&J&5'@&&;0V,0]>KWW+];.NK$:+NRVM
M!ITD>/R5R^_ !VL:/B_6S4#D0L[R<I:26F'/LWP33OZ"_",-6[%=O0*<XVI=
M^\95_,  \*N:+OMQT,]AKE.[@(!=\#*@TKM_(2%F*Q$M>B1O=V?Y]AHL'S%V
M:"A!]6/'@G> :N>LK&> Y :X,FE=RO%0D,2D09#$A%H1!,U6CG\W5O00";\8
M>5C-[$<9M^!>F;AW,]XXX>>FQ=AR<P,O49E2L ZW9SIMGWZE C\^R:DA^I3U
M]*3]C]>6-R7]QP)O*A#%PO=\$M-,/Z5419J.("-VF4;H#)H&;VVH1 KK:MSY
MR8R%<'U*\]_T.91)JQP-:=?_,='G49O#Q^_'UP;&;YI:4T.%F,@GX%3!SS00
MX\XP9.GU5X +2@%$N&@5S>4U]I#D/*,!;6VZ,9C9+R$OPRO9,[XXK[0$.I'X
M0O68RO4/IP("R/<!"-JYS"H3.4RE)_FZ%!IUW!QL&D8^XK&+SE'B+(,Y5 \R
M)BQUW.U VP:<(T<-&2$M^B$SDS)H"J,'F 1,?;*>*%D690A46&\+@,BF:*#P
M+W[' :G%7G0X9-A:PSW<YXN+WU."5XOO8LI-2MHB.KWH-RN-A./?J JM-#?A
M?O3*]B<ZQT1'PP(OE6@Y>0,FP(*WR=PD9^N9B%32[KV,FG0+E_-6S/O1S\Y?
MPC:>8T?>)2$/5<AW2&"G?B],NXQ3E#17<$SJP@2* W>R>WOE/L_N J0\:7UB
M!HR%X]IKIS?/+/GDL!J9?3J((;9G=8$1538X[-?(#TPI['=NRSW/1U[+*=3_
M6-CM623NF3"'_C*<8Q1FIU1\TJ\^&]XUK$X#F7.@=@R1!?;S)5Q4S6^PPS,]
M "/K\5<WG*.!6HJH4@<<<Z@_?Y]BUC+;WWF@I.CN?2I263TLCIFZG:;/3Y X
MR D1N01-I-1Q?'((@W/2O71C22WPBH#V_]C>,(#;_-YP)=$[*- /5<)2#88B
MQ=*KAA5/+!E5NR'HECEO<6)[SF=3C;JW40L^ 2R,+H_N-2N\9 O926UT-8@Q
M'KQJ;^^E++R.V'0EOZQ_^71%[XV5W%_*#W*S:N?Y^%Q3M%][BN7@G4(EOBCW
MK^]=2K]T8NNR?E0IPOY%O6-)9C5,=?8<N;"-N;3MU^0:0(X?_<?>+/^7'Q:D
MQ)C& X]Q;,LKR'*..>JS*P;!L./]J<NAW':+:&][AL+@KJLG(%DN\EAK%"%
M'9GD'I2 A>AKW,UW7NO-93\G:/YCA+38^)+\UU!*QXQ'R,V*3P^J-,HSQO/V
M2DSSU@$?7X^' K2\&'9P8MAZ;0\-<"NF0/&[0$"RS9H.S_)18H$$_$Q5:;98
MH($J+:>VL@/D[=H?C=^R.$')#M*;&[PQ] F['-YK'%K#2Q]46QIBRMIL*]68
M)CR9>RK 9")@=(J]F 9R4,%?YQ'=:N!ODN&4'L!HE(.,_%$_M_;VC:F+7-5.
MFVF84X\)>?8EO86WW9%= [4'BKG+A.6ZW?FZM'V7*R=W[X'B]X>'_,8 <GJ>
ME(!#!Z+.K,L93Y>8+-55I!2S7NR]$N[0WB5DX1#>/40GC6;I!+KA/:J<U^IL
M=8B?H^=LE-MJ$J?[?+%^J:-Y4+>!VKGSCR+2$KA=^V,<>=RA!5EY MK$1J:O
M#*)VBNK8:O&'C)4,;?FIB+K)RMNK)O"VS? ZMA_0T+KJ2#DEWB^I>1D*)O<Y
M^&*C+UZG(WTBH$\43.MVC9HF,8]]DYH<UJ-RMV#C9 V-(5?!9D);"_ Q!#&:
M1)CE6 _@L-VR_:J2:"JE-,#;8#.[]C)1U\E+CIRQTW:T_QR9V7B6J1G!_9D7
MEYLYO#;[205N[9O78>7O(-VE\3[HRNL3 G281A=_.\3G^L]3^@7SKKLRDX.*
M7?.HA&=VBU\(Q+>.TW=FU239DUIXH9Q(P%E!:^V0VY F@^H96,JD'- PWON9
MDW[,9F:2KPQ<[ULW>BB\OBY\D4B=40[PEBH2C'S^@>T<97:XHL!(8MU5T"U7
MFPC1KM<Q#"QX*?U47", JG3H0>U#G" [<B>UVG ]/43>BB^U=3&ZTY%N=._:
M([GIJ*G;G<NPK$DF$BK'SY1DG>F%N&_+VF%8O1WYVN+7FT ]G /\K^<&4QR7
M.757E;._C==J?13QC_HRA=.P/W$-/,]. W%N([&5^A F+Q==1[VZ#R!9OX0U
M!>Z!@!;K!>G6 ;^>-5EZ @V$;:'>5^"A@9 %D!UZXNNIO9]PC&)7#_CP.B9O
M(2:7>H$&ZA+">U+>KD-V'F,,31#-D/T; 8Q HLOG4<.,5H5F">!V1!$97=\"
M/X[((@>&VZL6['T2'?S]38@RS+ CV>L6?73^_#?E>.6^SHAKMW_H<YRN/4.6
M=<^<@-X*?NUH.5%;8GDO_,'.NFF405WE]M<ECY^-3,A*$],**V7].VZ;/(J+
MYTS-3O=O'#@%O'#.]CC:J56[^!N_U=6$$$6!3LF>"16&\9>3U%-6\I\L W@2
MDC-[^(+=.]W:8W/[D:[$UQTW^:@;_I!6'9>5P*<:9GPN2LSZUM*CO!<9O10J
M33.MUE,JE6X+GC$A%F2'6O/%:_<=]0O5XV6W4 .2MX,2SE_"7T[!U'Q4/-<)
M?_>R7,(FXLE6M:PRY-)P@2<'\FB?EOWRV3QRH@:86H.%+PTCGR777FM(G2WK
M:)?G_>=7!O&;G ?TX.:8S%VOF#T'"$G5+".^47/7]!"C+;=UT\X"$^<U0*PB
M*>%IH#8V*C>!+JJXHL>N_0%+3UK93Z.[5RY?9(Y^YUFZU\XC\[N!;H8+><G^
M(-+'*=B>4TUR[6UX5AE]'NA2E]7Z9##_JO77C]DEZ>WU@QHF?"V0F'00J<<]
MWY@DVEJ%W1F^4)PD<%QFWZXUF.]U= [GQDOMG_>E)5WLC+)5*V^XZ=8?9GV"
M#"'[(X*MP&(])RA&%"&SX-C&AT-W#.+\GE *%%C)-QI2.EK3;Y=7#V;20(9Y
MV)#:&NA+U1]8_V@&1JWPAL]ONY3,-#N^=-I5O-LV@^$/B84D/8(^]1R8R:N]
MUU$YX%I9/8.C7&B?_GUQ_U#)%:;)4O'(!-R&KA6'4-OXVT+6ZP9,!*%9##">
MWSF5>96WW971&[L:ZQ#!<8O#WZ_B5*B9^&E? ]YI&FCLT@Q=C.BUBH$&:WMG
M=Z%]EY8"96+PR ZH$T3N@=AK*!C<<*G[ $WH,B'>=1ADT+9>($IRZ2_D<NM0
M'^Q!=GM0L:4=1+O0WM]^&F^WA7_?)K.L1@]!YL"N-)#)V#[G!@UD!=\_38JA
MUC^@@3(:O0V3@.B4+BHY[[,-[\8LQ%CT64^<>^13T'G V5>L"O\M*9(7W#OU
M?:>D;C_1S^OHD1.O#4N=B\:A]*ZD)#-HZ/[G4S+A_*#\4J?,\N"%=-V0&QS6
MKF\$8?T-1#6Z2/=[I:43T?'.5Z,GQWENF ]%Z5JXJG:DNC[>[KACIRW9]-8&
MX_Q[XO'=UG3J[F,F1DK6$C2_%UN: 4=12R$9)=V^=VV&6$Y5UDPK!YU&*M(_
MK-=Z);B1758R&'"AZO<Y&WW))4$C_N+W]/Q?)/H*?KC3K=YGRHHU-=[XZIR9
MFW'\JP5>/^FRYXFNR6VG_?&Y+_[R8L:#3R6P(]MHABGUF48?=:[LJGM</^'W
MIYJG%&$WX3^44'-9)$7J#T=@O&&;.@C$J$7CTNR+9$+4M]D"LPZ\)'YSO:^H
MJ@2W2<=Q+YU;+,N5LO;D%?R"\0"IU*MVL_'MQP;,@O],!L#SZ( 1B52%[YPJ
M&E(!7/V!,8D&,OM  RV=@R7 \4^AV&K<5#,2&]IJ=AF/B*Z49U*LKBCS*BZI
M<E#VM1GM_!G??1'.&1^79E*ALG*H4A_[XXN#\V,"4UB #*8"/I)G0'!/S)-$
MA9GCC5;$5M1BQ)P8"E') QSC:LNP*\!T$X?;.H?10!Q-,O98J2@_JWRO"/5J
M_!K&Q6AB#?LM(M6=\7;VY](60N[KC\8:B-QF<?]"I:<5%3IWZ/ESS9X]/:X%
MBX1?1-F+8ME:IRJ2(ANN3H,Y5JOYJ!?/'<H+J0[H2]WDS_T@F#'6>2;Y@'XP
MOA55_<ZDEH"C./(>/5XR&1M56%P=K3K4F/NAB=$[S]2H6IUN[)#FK<UD%M(@
M2F2-Q[EC?MRL(=5(:N'V!A?I#E_<CJ>DG=PB@5P^CR S<Z*L3&1">&8E3-HU
M>]OH&H,AD6"KA91R*.3@$R.D@4S?R%TL=CGG<=Z(07P )N#6L!S=H03Y(8$I
M='.^?[<$\L2VQ/E*.PGA$]7"R_%#PD1M8I0G36(?@(K&+A5P#S'MCMRQCBZ-
MQ:%H^^TDZEEG ,JJDS $G78CYV@Y\WRON':T(MM=O)G#V&6$39@G0^$];&N
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M+A.OC!X#>6:=.>8OC>@+NG%2H<S138KA?/67E86[CY9]!@[KTHXD\2(F'10
M"U&,5%B-BDI.EK;:J(LWG;>P:F0/%FMZ%=(+>3^46'*N6TU.D7L'Y"B)%W4(
MA8I :+&TH?=!E[<FLFYBKX686J9O\LM-_%BXPF6FN_[@]SSMZR"Q*^\:M%/_
MCLA7KJJD_OO]#5$##UL&3IWUZ&+D8N>!"6I?58N=$O36G[N;NLM4?^7I_"IP
MXZJ;*& F$@.[#FN[4P-B)U)M)\ED*> NO-AJUOKYQ+174)6T@MLGCJG8IT+*
MC2;JU.U+P3]<8KQ$E,:F1-9\%1HI;3:2:#9__Z[;P#CR8B+/!T9,<CI]S\,K
M&RX];BA7R1A0I?PN;^$&@A/IC>3TLP<J7JQ)Z-=3N72SP]>=8&2YP(!?35R(
MO=_LS_\[8C+UH&H(Y R?<@"3@HE&BT!.O%AW78K<24)O;5W;Q9;Q:NQBY#T#
MH^%$N&WP9>3XT-3^DA?1'G]G88A[D&YF=IL[0,>3^ZKH0%Y>D^:);Z[M#-NI
M#<$).F&+^SO9S+& #IMG'[_6DMD9<\'D<JFWO_?=L7/Z5^BR-;UFUP%>9PF$
M!Q"I>KP,1JA-A;XYSJYUY/U*[.:75<B)H-8CY9^^KQC?7E0T7H<TT?FNFLR>
M:I/IKU$  C)M,)P4G"28UI)"OC))];R^"XPG=U%'WY]AD7AQ>>*7H8M4UNL&
M':4YX\!X(3 Q%?T!--M( 8RDBN82'3:$,/R;5+IK? Z/ [FC3J_Y@<@M[JBC
M!]M;H# H2TT-YGNHE^?U0'15QSU(7'7B!<;V5DM2$VA%9H%JK8^I[_-G&5G^
M#[MOEU'5M/4+V$9-V4X_J8,Z-P_HZWX>TQ\4 &ZS6)W5I!_XE-706CW:[JOP
M26'KW"7/->CG#T+?FUUN=@C;[ EKL:OWE=OLZGZ[/#$MH& Z!LQ7+YS.WTTL
M_W<:G5 B?<TL)_.X_D8:'KR#;Q@N6QT5VHOTX@%ZE_("NWQ?;#%MILV*7>O,
M4/,"GC4$M<2 D\>7O_RZI+"2O6E*%OPH*\&WI' NTB]E, 9N;^TG6Q9_?\1<
MICJGO'J(Y=]O\R0=?H"?EQ=KR%?L=00#]OQ*AO"ZDDCI,_=0Y2X4IE\F_"3H
MDIB*\>ML01_6Z.S/EP??O26JU85^"L@/G4BC .;MYA%?R\+T)L2]C>:<?-E^
M'FEP$1M'JAY[)OH^H0 <P(;/RD4)).=G(M?_X\9@FI8)?<,>,R/S>J0+XUN_
ML&K+Z@UZ^]T=!P9.RJ$2J0>^.U1!P&]<0UU1&.&ER1_OP_7_>N0%]<B!OP.A
M\I3LT&U' >QMK[$-0J@2(]Y["4&X: 7;2"E+;D!%T( 8F@VI\)*.(C$?;TL,
M:;E#'U,Q4XJJ5O:40-072&H4@%962P*9GHJ\_* .QC-L*P4P7&$2\W\VS(LL
M_1",U3]F)+(@R3H<;8C].:J049L<\3[T^.^'C'I $1D)^-3;0=/>$#6",WEN
M7I+TE2RV26;]HP3ZME7KR_U$,4JGJ&3MQ;YX[TO7.(U9C8<."=9V& \R7026
M9DFS"WD);T#=K"R.FLJ)XT K%:?=D96G$>(_0E/>=[J?J^^]76208")AF& "
MTJ95,EFEW6W ^IJ22J$JIA 1#$_Z',WCY)=HK@$3#N$2][NF\%,'[F)AE0%8
MN,D$&/,".>T'H<4;G+%'^*_ZC78.M]1D1V#O9-9*2?30BOI/AQ$ZXTY<>F"O
M/#ZULN(-,0Z66'1XS2 W%242=#,E2M=;PG4<[,J3#/)6K37.A1]=5G;>+#/Z
M3597?5?F Z'JC0LS5HA:VE .A9EK"T.DIA;H.!WQ.14I?;<F%.5WW1;36QX?
MS+</WVZ>\_02[>%>HZ41[Z0CE58UUXU)V#369#U,=TI4\GJ\.#QV="OL0F"D
M%/"Z,3YB,[J%8+CIDOB36$I]KY^P7P9X*G^\4H =96]O4S,?27Z>T@[$76[Z
M]Y-AY!?40KEVW5)*QS[A'%5JY3."P>0N9[T=[44:"N!%%(K$8+Z=@LEYWX]W
M)(Y0WP\*^[7N1T-N]0 =Q0>04/H?P>% C![J5)DQC (X/O2G /(2)O<NBFMV
MAH*7'H],BF$MNNI4SN%MEY#,4QW7NN;CONL%LLIS'<SE/OXI=_F!@,_M?VWH
M%O?1+* -;0R<1*#.:_DXVJDOD$N#P0)8\AJE2!: M=V'N&!'E]>CB!9+(,XI
MQU;>,6^1.U7TK0<[%O$^PFHUAC2<5G\!D\/H"OBN4!ET!$'G3M0K<U*$9A:J
M%6F]*7=RN1GU.N>>4*#4T$ @#AFH5SW0W]"IG14U\6E5IXFUH:@*TX_S&+;%
M('9+%UIX!9VR1R&6M5$RT1RFZ\*<'_]D-B#GV)K];_CKVWF=(/*A-R%L^A3
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M5_AA7H*=\#,+_K*2.8O. /?/>?-6 A[34H<*Q(M>TN;X*/.AF1JVT0700?<
M!*TS;JN':4W/KTN[=6B_99^QYS&!3&G(^9Z\\R9+?$(6F?)TE-Q_CIKVQ;]!
MUU'DQHA2HK9[J^.DK>^6;?RM<H+Q4-8H;_G=?1Q<U:#GM;Q[:O,D2;0ZPE?[
MC1<&WTX^>!@CC9MRE33G.-@#K6:@1 BMQPX_)^ZU+3:Q@S/[X@?F?-^LE>&C
MGEJ!M>-OUF=)M;+SJC%BRV"+>T44 ) ;$G:!19P*'LL=AX6M:9<RRGJ<J&C(
M%7HA]$+6139#@R]YYS2Q-UY<M"A>2TQ2JP$9&@GG%(X9O2X0?:J24[WC =F/
M(U, MMMF[W]T<=Y;"$F[,#YX)E)1]S6R(YNKX&5J3+QLFES,F/0]T;[ $' F
MJLXG?EJRT^W\W^AOY?8Q+2_[/,$Y21A-(JL%^9G0)] .._I,N=@<QK3HH$?Z
MK#T(=9B>9B1^>(\Z.Z(*5O52J A5HNC#5@[^-=^W-O<EQZN#JU68ZM&+)#EI
M?XNGGD=_Q;"!9+HH*M F+"'/#D911_&B!G\CJ>IV!!Z%/H#K>)%_'< VN4W:
M01A-U*D"(POL;[$GU5?XU)SX=NV?:GYOH #>G(*.8L06@7A^-#$C+ *U8T3-
MJI$F<RM]?;P ]*?!B,D7\H0U+[8@JO4\/D43[Q_H58#O7N\E7,7Y?O]MU]D[
M5/M"%?Q%'AI@Q"EA!0=/!XF6Y?^8V:CUY4B1K!7SFZ9BIK>J[1D=\2L<9T*J
M_V[5T=4J3%,+<1&F *;'SR0(,GB.SE864M:1!,O2IQ%G/B%MIZ7Q@C%DS(QB
M$XI11FI6[A[7D*Z(9=$=OCH0)\H>'#/-T8:8OJ/"[Q<_0C#6!M;.6G0XU TD
MKQG9&9C% F[-2 S]F9R;9Z3R1)O?^4.KS\#K?CR6(SMY"2[.3%::[VW ^YR8
M/#*M2NHF6-W/%L=!RCQ"<,JA\OTXU)N;3)_#7J5Y!=JG*OU:>?J[J>D-YB'
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MW-PNWS7^[R+ET  UG(/O\DN'8$V*>H@?J=GG!KEHBRFQAOCJA8&F']+X?=H
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M$ED]E3:]KE?QJ>,J<U$'_^!-&G[2A[G+O;*''!UHO(A\YWXLL-JA8XC!0K7
M3[N],25<?+?,U=7VL""+/4E-(.%70LC0[)6VML$@3R$BR_("N0&KUJGR 'LW
M-7"IU,1BS&[L3NW8W<CISA&YI>(;-N_.;=8C()-K0NV\*I-:5,T2X@?M[IM_
MJ"T&#G_,*;'XHNB&"^3QCX]_  ":Z8J$I/&!-RNIA'1/U,ZAO_^AG-RL]V\&
MD#DQ=JS9B. ;\VS'H@W+LD/V.@U\WRJW]Z!G[\R6[6Q+5+W4TK\Q3<N2Z#/6
M'$CPWCCS'B=A\:$.MBXL>LJ=9XY/EV(TS%*C_0  79=ZZB0"H:- 'J@L=,3<
M.F8)R+W52 %\WMTI<S^F=XG)>J&N4V@:"NS^%1N0=@+#BQ;TP/$FH N[Q&O?
M9_T#)J.M<M)M3N/;I:^B='9KE+NQ.O^:'!/I*8!0&,;@I"?M$X\LC/,9]_GM
MS]J<4>)^.-^[<Y7G VC,S [-9,0")QI.%"=CR".( \8_J.T2Q-EEY!MS+&K:
MD*QZQD'R2:  5-GV[%#[;T_)FBHR>&9R8]8Z9IM,7;K/L!TN-VIL)S>*KD-Y
M8;] F"%2B 3JR&!2'2P&QE<=PU+S01\OLNJ;LO_'==:^(.E&QV.9K_KJ;"/V
M__7JJ^AH4;%NF2B*J=J'#L_2!3N QL/^ZDJ2!,P)>ZT7L& B(@^!8Z$&JA9[
M:\)-\AT8!O0'>ZCW.04?=SS'JO]TK!\K'WH$XW:4#Q!$?3??5E1>"JVO: W7
MOOKMWBLN/=JKWTB/D K4"3_%WZ&Z0$0[$"\<1A2;*"QR4N[Q\;>#[Q1C7'2:
MZYJJ\1:+#UV*_=E-OT<]BS"7-TQZY=EV@<9*'M[*A.=?RIU"13<+Y>*S2^JB
M[,=+F;T8B!XS]9Z9Q8AO9;61"B:OFH0W O@0BYE\_5HCKM]&WS<))].[/'QY
MA56JL#VG< 'PT.@7OU:NWXIZO/Q%LQOG2QA?J&Z)C!DRK9Z@*]%M<X;Z:>3]
M1=BG/4G[+_T"0WD=#5\S5H@M+B/B]PE6HK_%M'E,Q4MO\=C6U<;8QM!^,P(P
MMI?HJ\?_M;%,@:O\FV!<I8H4)@N^%&+;;$Y-ZZD\L@:I">=^P\%YG=<G<MLQ
M-ZA3_\^1,JA#43DY(6]*]?NFC[XX^X1/(;.PK7ZHNOY/@$_9X^T%8(?%/B>0
MW1+/V''")R1_&[-UL(FM^?7U^I/TWM\+C]:GFZ:%*P$YD2(?^_"'BR8A4.$.
M)\9H)8D\?):8G'V=CO&X$!,[0,JJ(WH!:E1#I2)&)RC+L.M1$(=>W4AU\0-B
ML8O8TT[/QR%X(TV ESFKP>'Y[T5Y?[?3(!.*24FMV7;W9N[4S&J+NRN/?[S4
MO*]%2B$S;IA37R@@WL-DYN\V>43Z'7U5XP^ )[>H1(IG+=='9K\4_? C]]S+
M5P#%<Z8JTGC8(CR\\=5HL]'BKDRGS\T5BRV?",60#&S]C7>T>L_0.1]O>'PD
M7_6C7<P<F%1AQEB'+C:E?A9(?UX>R\7Y*MJ=YL$*V7M*7YW'E59^&?&YE06?
M66#QUZ^I(\ AHL1M]7"Q;EPB^7WL<[9Y&@:&*UPGQ?/LF*RHA2"Z&74,+LDI
MQXE]YA.[G-3E;+A Q73NQW@MHHMYI,38^4CA[[2]B#H'XF<(U6A;UX'/;GCC
M@)\H@!6C8=AV'R.)O0:[_N\2UW_I0184M@@Z97L//CL(^7?ZUF<-O,?I00@\
M%)*@  *0%(![6LW%U:&IY=Y5N*KAA#+QL_9WWI2/X'M!TK?B-9+JI&:=JO5?
M.JHHF+//AEVJV76_V!G8>&\ALJO8_'WH7<!.!VN$XP15D#RE&\!*=/HT\J[$
M"]NL)G$=*S&NFWMW0=3'&&8L6!6$3LIH5W)/1RV2V/SY0>TJO D&L2*K7G<R
MOQXLU"8D2HRG'Y>-69[ZF1GV*;>(3/,A2"EYTS.V5R.2*0"_ YAY8Q_OVY],
M&\ZG34DB5DEF!GZ8MC=J?Z,C>YHQ[BGOYU\_=K/?O=/$"EJT8';:S.CL%L1M
M/O>H5CT9'03O2YKG$:X\=!UX.7*\*TE6DLU59(BSOKMX.K:]-.C>$45B&=*?
MT)8?VAQTUO2^D>$^/1_3I:WY@P_^_D4=/B:W=T;(J>0->;?SB2V6J[1)QT6O
MM6=JWVUMZ%'E5;(10K;91*S6,=[HR/M2I3N$)W?N3?J=QX'=SR@ T:R7>N)F
M4X$3M)%Y<RYO47-U7\@"3*91"[B:M0[CUJH>]4-Y8:(84'_"VXIUH+&)?OM*
MB(8DOZ4T;P%/Z%TKWO D9=[417"5+S'&?))$9<A=?;#JY!"J"D8]0-WC A#I
MA]C,GNRVWXI49Z5E_?9J]$?\9*\=;(]J_Q",*8*8K7G[3"\$$S4\,O'%Y#9Y
MV-F=K7VB ""(\#"4*//RN+A?PE<=-7K78.N!I-M*;5SN(TZQ(@-594R0V$25
MLHHQ]#&L3:I[?WJY@P+ ,8Z!CE*W__4(+$_E$\+;($[_1]WJ,/H\ZC7C9V#5
M?J<+B OO:XS5F2ARN?I'P#P/HW7%['HN,S.K0MN#M4;XM!K.&@\CZ*,WY*'B
MX[(S5]X[YG^>=9+NNFX7E_2U%8\0$I6*-M$N;,E)4<OO1QNH0$G1,-?]3V"J
MX'< 7<7;=O$)N3VTJ'()4:ZO3--I^FX/3GT9TL:V5PO"O$!\F)S\8M&QK,#G
MGVD; ZIR5WC]B&8O(.T@E,IGIA FC]-4B!T%\#$938PR/D+C[TRVN4F^J&D)
MZVR5E)[I2[@9.//ZBO$%!Q)/ 9LTS@UM8![B.T80,\2T1I1:7CF6X- 9<S#Z
M>Z>Y*M*!3H%&/&\YH:=%U6T!<6UJ5E,9%78_T'_Y%;:? 4&G>&_E^N,5IBW1
M91=CV"'5(O/>%ZRRWX4_!.Z+G&\X5M@9BD>Y(/]>VL8A\*DN2S,P'M7%889,
MMBCSP0+9MCM<OQ?:U;M]W_<X8ZQLR5>N%#DIZNQB\;D.PK4?UX3OF_#4%KDZ
M_,8A1[M>]=%]4=U0-YJ0L$6->+C9O_XR1-^YDW>>+3%8L_6:$W=5;$2::+PY
M/^8ASAO/+[E[$>NKC1%7; ZXD=(O0[\I,="79>E* ;R57G_H.=D"_6/FPG>#
M] 7E@&!06Y9P2M?$S"65)<D57,RM2R/>+H_PO7>!Y&EMAM'$L>#=,))+ZO 8
MB'PA/O?%>(FQ>NS#[:]\-&NW-'I-V1JE>FZ7PQ8*Y^5K1T'VMKE6FBMSV^:E
MU3Z%INX>PJF\%1L  ,(8;#[Q#A>O;\']BZ!UY\\9>($"Z$9>)OIAJN=O8ZRS
M!0OR.GQP>O=K]\\Q_\B5WGW+J,6!"-@K7@'C!>N"96$7R/T!EI-T-]U\R,LF
ML0HI5RO*GWXA<=E<!<TCBXA-/81)"]B<I8E23F*:!G-,9MSIOU,P5*2,S\<0
MR#_?40";VI.3B JW3GUH9]9UQMM%Y-ZFA2PHL<8+]YD4I<1!>+X]K5&Z-&@!
MKFT8E3 ?81O9NQ7#19]R)Z1S74$HFVT#?;65P1%,!^7:)-..V#4WC)104RC6
M9=TDHSA9(/Y',>+KD;[Y,ZTVS8K<^+?Z( [4&V!X&D<[;-JC744,*SMCNA'@
MW=5O.2ON=NO1Q$$.\<<5D(PPT>68#;60!SKO=8"OJ2!/(#PI@$X3P+]>N["0
M@Z<#WOM<=K&ZDJ6P4^X$,J\()I <0I:A 'YN@\D:I0ZB7K[V\4D*#ZLVT)]
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M:O>L-E*$E(I[MDD>C&(_IE0_5QB^&QM[4"P'S38G]7OTTF_RG[:J7J65>>K
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M6SZDM+*U7,+@I0?_JYOA=6T+!,$LAY!/683?_7 [QL.H$RC?4!Y>6I4NHOO
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M'TP:SO^YGDK;Y6?N(5\XG+OH#$H0TRH$C^D@CWNNWPJ_HVSBW#)60P5.NK3
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M\I]>QJ8M8>G^[57,V@<Z\H%"%P;?>'A*R4=,$!I_!0[>5OCOHTB=4O8>W;T
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M:$LF+\OM;2[?G9D;DSBNPWLH4"\J_^XE%SV3Z80X./:4"DP-87/J6FTAQ$Q
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M>,%+IVYLT8LRFFK#,MZ]E:3C:==U)]9 M?*CY'DM-T4%H_>ZR\;YR^C<+*P
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M&/'JT:AQ(I\F?/D*CFR;]9/D9B#*F'(R02ES)QI#R50GL1V\Y8("4X](G$,
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MSCR'F+TVKUXLWXGZ7#$"#1JF?$;0>%Q^=Y2P%J)J_:*,=:^=LFEZC63AA^>
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M#J-<5<>5^)ADNIG4.W\8N#.+51_45DMKIYD].66F,/'G@ @.>&;L:F+Q:RH
M^^FU57!7NKM/\:XTOH%#V2Q=HARMD+&%7$RE O9=[P:0P_>0ATIP!7(5<D4
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M-#1XEBDU43#2A[YW6?_#F<W3H*?6+Z+_V7Z^\NY@</'<>F?6'U&&/NBRVWX
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M,XS)6LFVZV<6M>-;O!\(^="T; :0P<_=&J]-2/5\%]&VT+7GY5J@*R_$Q3/
MEI6PU?('4]YNE[>T0!#O_NU^UB*48B!K/6'&V;3]+CO?BN%>W85A/LRH/]M;
MM\T=%8/JX6JB&XO&A*"@H,4$GW09AKV;XT9;<>$B0(W)*RRS(9]55_(Q*81F
MB0&0-W^!3LAX.\6_&N)/* +Z1,_M$P\/46=]ZT)Q"<</#ZZ(?/'HHCNK+C3R
M;W, 0OD5LD:E:^@<V'.I912<@6IC^_7@7K,,S^H^VJC!X<_%W^?B7/@&O9)
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MK8!HHA=V@)RVZ][SFE[D7Q6%8P(\-]_\DNWO=*33^V2QN':V8 $H"'2&G8=
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M5,!BHH#WO+:8O-WK9PO7=&Y#&I3.3X7$?;^-M[==^PA=3-3@'H$8N0?3^)M
M9%0UV$9M(^WT]73U[TL/%1%N63_?^A=JA)F/0ZNUM_><<).+-E3 Q>T:,6Q:
M]I#KLN&Y+UGNF ^M%A/W-KJXV%JZ6S1T>WH-?'GES71._E4TYZ0"KO>50Z?&
M_:B G[6I:!C6TO!$",%'!4QI'%,!6MT@CY >D2J]D%[:;?>:146BOG6T;3U/
M-R$Z6 :G>Q!^)#H/R1TD2JH.X7S1]<@90?S56'SMA+H"5"(.UM:M69=!)[ 1
MNC=XP&^M>F#BH7RXIEK\66S#^X@C>:T!3074!I!R#9?6R&^'@8</X%'-DL0K
MA*I.9-7E"AQ,OR%B=>A)BYSP+6[G>F4<3O%D75D.E%[^MSON!:42XDQ.$24T
M$97!04N2X)SJGR,</<":SO=?^O"^TY22?AN/K>.$>UL__J5YNP1!IX<6]\'G
M#>PA)N[X;]$_&S+^W*^4ZEZ-SYU?C/.:S#PL2I6XZ5834=!;K5Y 85P@FB6B
MSBY%DD111PM?,3"6QY_F^-F&@MR/'>HO_WPA25R$M8!X"$B*<0,5X)-:1_DH
M'.R _3>AM0L,B+O=.,[?4(ZUOV4Y+8$__JX.D]8IO6MKU8'GVO8>_BQ4\[Y=
M4#C@MB6"-03[>:)**+S:) E/VDJ\Z:9Y\DLJP#%"Y(K1RLE\0# RR"7D\YU!
M(]VR+W8W:Q-2\'OD,AH6.$,C6=Q^&G(AU"?9?XPL_KD^?O?>:*+F>FY3T%F0
M#+15B<($MAH\-8P785<WRJ&%+!M]T5>U5ME%@"RAE%4[/>&#YN16GZ%Y#W3+
M&K[TW^]%FL1G$%,-Q93N??!;<H0@^\O&^XT +8O=A;4"VSDY.]7_C#"%R85K
M0;97GJK7-AP>[S24N<[?(,=3)&S64?'9\#=I-P3<F,.RZ#@[=*3"XCZ@$#19
M&?J ,--^"GRO<77#*J&F8&.2QGN>V4;)RB3SO((DYW6AY>E,4F9B3E/P'N3D
M0R2-RIZK04:<YI<B%$?\8J.7&UU+$;V751TL4/(_M+>1X-OJ^$[(<!FT50BB
MZH?6+?>%1]]-R_JAWI3<YBXMD26ZFQV0\?T8\!D3M];TV:4__U-*?*:UAA_A
M!)TEVB6"-78ST'XTYG[D#J1P!-_B;JS^I,M9J7AKR>+MU LM;2'S']!61^1R
M*42#"OC%A3PU/MKY2P/2FR2Y[R1C;'<,1 &C5B9J\'>ULE[ MBM3QK$A^;Q9
M0"!I!?"G+YN3.9L._H!<@;0'4P%N(&X"U HJ4!>>D/(2__#<2.?"MT9C8EW@
M,&;/@0]HE>BBPN]:(INAHG7<Z7FB/4\+V8[[(N1K"8A_>]D4R'LQ5("!PLGL
MY!SB%N$AXCJ!+A#;L9D_+:.NGL&&+Y@^YF9FZEP]"8H(V?7?W8N;3 _IHC'+
M.&BE*LXRL7, #=M9>L.Z<\<J\++A5]J=0/Z0H3<."#=SWB'>J:&OWM40_G^U
M%ZB E!G:R'!I62K@H=+6 M:,#271=9D#I_4!N]".2IT/_SGG6E*T,&NI]S)Y
MN[H\FM^OE0EA)'9V<"D[=0=474#B1,FB1#&.P$NP[L3OU6^MVLF9C??K&7K$
MUOH/)N'$YJ#)_)!QD4J1,.CK =8N86_TFO:DXE]TNT7ELZ%+'GIW+PLS C!7
M<*W\A;YK>]9%D.&_!!_T\;8@]N,2<!ON@SN#Z4Y'U<6(CV :?M7K$WTKD8W!
M2#&Y$Z>Y$(?A'HR$L"1--8:JTUA%),Z0@G!''CY/K5@"$<1X(WR)P9KJCW!L
MQI/3VRN1AA:^.#?NG_UQ/,X@I?YONA>YN.D3= >"S+>A1-X>XG5:O+'D"E'V
MY+)RPSW,YQVA]"VK!U'>0M;F/A%$SWY?_>S:8Z!F(2[>.SY$"_($\:$X12!#
MR%BZL5MC37X2"SXZP,53:?O'C7D'*1E.G[>,S]\XXKNM\$,$R;5.-M8M*Y'W
M)-'\U[7OLDO.S9[&]_O[_$2Z&'S@TACQ3Q/_Q0:\60YO0V*UJ8 +4U9;2>#(
M;O/3L?1/YRKJJT;#<Z=Z!35<Y/^(T4/R=(2]+RBY+"62."1;*5RXX'PX>D'
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M8W!PAI\*7&JP7U%177'EYG!#W-W4;-040L8$2A20M]V,PNJ(UF2.FJ*H DI
M3/!K4%=)V+G1IT+>9@OX:UJ!W+^U47%A-,ADKP%#</=="U54*"H7@H,9'=&*
M*[=JUI^(84ZK5XZX,"-\9TS5A"U&T9K!$U1B0@+#1BE'@%[%*UXSTNRB/-AL
MHBLSHR",TKE3DVE.R "60<XR)IL6#5NA=?L710UAIU',%1FFX79*H.+*>T8Q
MH^4-S/1WC(W23 ]^ WH-I#T8"PR/'[<P*EK3Y]*V,$JLF1&D-=S+@X1;'@4
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M0!(P1J8@^\F^S&E4 4@&Y+-6ZBO'GW2RG.XI;C@M>LMH-2%-[R1SIV> H):
MKS98V2.G.44KC90OOWFH<@&J +]]X#+G<_P)7CM(M8$  _H1G7=6VUY%)6[C
M/+D!MP_"VQM05:GUYZ*4]!41_L'5!K>,VY=^_JR<?!3=6,'H!'E0 XQG;Y-
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M+@V%N10\(>_Y.\8-,*_3+$#F[C\=J7(S-'$1=9X"@>[72LQ))[0>$:JD-O>
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ME'1>FX$OS"YY2&-?L8VHTZ@_DB\E<=["*E"[%TBTWX1724G33"3+*?D6XME
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M5:*V'^;J"\*5X6,.F=D-@+H.H Z)8@#UNPQ\TE)8% DUTO#%<$F;*P!R(AT
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M/"E)/.LXQ#$BI&.D:O[P >K(3X'L/4TP-GDZ7421PWAS ,;.:4;: +:U(CJ
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MH#;[_1#PJ9Q\Z&?@]H?+()EV 'WZ19BWO&- .JK;$/0!+D&+12#QV;QT4#>
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M_S?[P\L[J*#^MGUN_?\4\WZH?\ ,_@^P_G?,MTP W5B>(\8)_D._H+-ST^P
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M$^\D/U!!+Q%)N\7;!*-I>H!LZG>!4*%#$9+Q)K!P+?=67%!=[(?ZSH!8[__
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M+AE)@+2B+D ?ZXZE;3KB^$N+N6AR+'VR1_BU+742$S7-1M5$#:-GCK_>5/:
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MG6&+1-I%68G0>(?#^6X8@7:TYH:Q<IK U,J+AT+$>X7=!IB-.N*UN C,-UU
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MR[,BE6NXL_&JSL^Z.#;>YF!D'H Y&KV,^U\(5 1Y^8A3=#/Z*1T=0%X817H
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MV\,'R//.U7O9CUA4AUV^>BT(.<4\5IJ5/WP?C2RB=,YQ4G@V:GC@[8CSTH4
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M*&7-57KF9>6C^\6]U^\+)[9MB$5 ECV*OK<42VB4LX2+()SL>ZPWH XD->Q
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M/NA9&>[^2!DV,^=)W=K#J0X/SUHWU)$4"SHOG+L<+.+G(<18=%,D$\#O]FN
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MJZ^N&DUZ4-WX#?D\*UTQ-(VQUAQ0S);\'E-P!@ELI)]'Q("_.6U;^OCD$$S
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M/LI3PF2L<B&FW%>3?N0'#]3P3O'+IGLJ?\LV2:'86Q?F?(G.YEB8(T@&O3Q
M7B*=Q<:6OLAVY9D9A8I8VO*KCNWPFVQ5Q'8^8#^CS7U8 B*(LKTZ@#-0^GDZ
M,QMRP,Z''HMJ;TXW9[MCU2Y' 'C=GFF+G(?;@YV+RWV_/B3R<*?U6Z0 5_)3
MK=/WB!E12Z!M0YK2$@GQ6/!BS"R0(.\$*W(6=/'0'?-_2@48#"W]L'M^AON=
M7]5[ 94G,^6PA7PJP(/&8$,@9@,&.)[I6<TGRDI0[HLU<M(WR8?OE?A@[-O
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M9</64 @><@-R*64-CK\$)G.*ALIL95,!8GOSB.-]+S+//@Z\4W8@UPI##I!
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M3G>_:4Q@SEID:GT<<3-.UG.>_1P[_6T;&1('J+T>$0ERXGVK8?]'X[!G?T.
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M@\';F_N(L6C3A-1G'6SVUN-MF@C)M\L^Z"[_317;C4/@+7)V,SVA'=/=B@1
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M#.4$CP39K>MW0</7>D6/+""7=&<" E9S4&Z71+Y#HL]3Q@T,1\TGP2<H?%1
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MT63#2<R(F9B79N+C'M#5J5^E=S&7WF(&U97%X!Q40/X&H[TI_?MX HTY73[
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M9\NEX1WK5F;9*".(GX_274I[K%043L'WBF+_'C3@Y9]KUE<>5 C?+"W ONF
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M^@0W($OF0%^0543%.J'>=:#C4*:,+^__S+ER_>OX01F&_(K43TY!V3@.V4@
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MF.SV:OW<>I/O&??DR+WFZ^0!(9DAMZ:WCE#CSI6[!\%.'-V5#5[P8>'U5*"
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MLH[<G$(>*,)-X7+_O%UBBZ:'GK?0Y8K[;*'+"?S70 *0^3=@L/\;\+^#A8T
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M]X183=+F]]P4R_E5S\(6FZ)D9P]U3EQ_L&837OOG>2@7IZT(UKTW%@7M-./
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MW;Y.QN17D><OIGJW%EB\$5^2>!1-UU-TMV#G[<;E@K3[NA(R_T?T).E9Z2]
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M KD&&28!S#M05Q(P?4\'Y;T^(:-M'.%JD/?H1QR_P"M_8"[&5F>#5LLD;)?
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M[\#D%%I,TTGZ_C&?18-T_?9S@L6>HIN 8ND#M:JY'?CL6>D$:)DKB 0XY9*
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MG2\BEZ_3A :XN)V"B$-$D;-"@EL@*H7)93W+%H>3_:R94_%5GRW)1?$BSU)
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M@VE+>^(0[,G&SK2VU:=W;:SN_,IUM[V\(1CWH(1>#VTFF9=Y&+O-BRUTP)
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MK0Q<3K7)@FY!3KB.;9??WE=_>^!0>&6A[:Q]H2*>%3;D@I8Q]6B@I3  GG)
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MX!1Q%GS  F4*_! 3#<R/( IK,#06HPV.W7 0,X@3M=]G-3[^9S6 YQHUV1B
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M@Z7I(&0UI-G]MD.,=:9:4%;DJ8@W2?[;IS]9CXAGVYVVOX11E"Y,?3NTBEJ
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M#O4$51BBD[2GQHL(0:0[V,8KB#:;>1/3K>;F_?I=V6U'AP7:%D2#>_?D=?$
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M^SPKHM:#F$L_3@G6@&,SV9R47GX.G5':O)I(.^V_';)U:*D:/>[-C>BL8YH
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M]3/!?Q4#B#L_->6P!Y8,^XM&A -XRV, [)4"KQ=_"]"HN:SFOZN2SHU:Q:S
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M^K+KN$?T?%08IEHZ@M<$TOA,/@3>[+T!U6,T*V^4DXE=?21LX/<^R6$,KJ4
M!6/[YPI>-$D0'D.8 NZ8U8Q6%E[,3N4N5I\Y;G#7FH/K!,_G8RVTV6R_@D9O
MQN9,VGT>J+3GR+]:_Q'< 6,%B(LI9&$Z1)X*LC5&41*GH>.8OVSV^\/ATA5/
M!?DCLI>I(*PN%70@B0+HU.0=*DB777K7<PTF]Y>>&%L HP84KE)!DO=EL9>7
M49>']=6\>?XC'?2G(IL&@YSSE5103-.I$46#Z8MEN(*H+46M\AX:1ZSS%\T
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M*:!G#AY!N;CR,T1H2%R\0:/86=.&?U0F<L[%,5WVT:J$ZI,BV2^MX7K<S%,
MS-,*X9,'8RL;V!.(%UVI(,)OWR86 #F3?/,SM=N"%C/G&.3N/0)L]+#_#0_0
M^?J?B:_IYI4Z;"Y^?__F-U?^E*./O+IVJKA)V%7* *:B/Y9"BXRL@H"=7X7.
MZ;&*=4RU\P9;:!^[ SX<>W5Y0?#.>SL&5&!%UPJ,Q.))!74*$BS\B3I;E#?=
M?U "2]0_Q0/S-(9R 1\!&&.R#A:%'/> [Q9I'=[:RW_Y/473_?=0=V6 5&&1
M?$R$7\UR+#P&]L4^K<MCG$\?UQ];-0:?O2A3_=-L^3"8+>L.ITU$DD2[T_OW
M@IJ3@8;H[W WCU_>L_ V^+/TFM@&CH\ZL[UZZHZ6N40?-+,EW_?$%!O)KV=E
M%]CXLOM<IN#ND'%8!Z0"\EQ1OC@ =G]P:VD8.3WZ>"0[]5ZN/H<U*/ZNPBN>
M_ML!NZ1) K#Z(1KDG$I'*0]F"Z?#QU'<,5+I[C'N VJB"75]EE,9/+>G8G=B
MG[IDT.AQF"<.96:SNQUZU!@6<!C2J_6,JVZ[U'0[!^N1SL.MAL4HD@$(]6@'
M2D_=S_'5@,!Q^^B 5)G#9]>>XY CTFPX=A*+1AN$W@>@UN@P-IPXB5]9LOXA
M%53UHK>L*FM4XDD9_]WW7;4[5Y(NSLLUTVR,+_86B;PM-#4;5?OMN="VNN4/
M5_EK"O<'LX/_F]8D*ZCR'\1NY!_$;@7\K[PN@4CW#[<T/2P94=%%8@T@T1!4
M/@2P4-AFT/#RL $JB(5Q UEQT.367@$O)BIL=+VKV>*>5W1@.V*'1Q%X=P%A
MNZY'62B=5#>/+C1[$BOEUHB&&\9'0AC./(C-+]+.70^+'X"]AV,)?,#3;^"S
MF@";? -OFTD@GP<4T LA*N@)%(*WDCR L%$>4T'C#V&+)(Y#>;4P+V"'__-3
MP"]C.&174X/"BB!WZQ'%.4B(:"I(@C+82@7)SO0/?!?=2:" 3\"7DQ)(PA!B
M4@(AA)D*RM&"8/.HH$TM2#D.T4U [C!N7!/?"3M+YLY! 1MW%JM!>765"FI-
MIH*^ K]1+>!#_EPJZ PPJ=S__8[_@>_@7'?9]IYA).6+ R:J#-F..!0Y;.1!
MS7PYB5I,9ORCAP8H7@'G3[HF3K@JDSB7ZX)GW.B%F@XW=2\>9&ED.@4*]A*X
MJC<[/25C9Z!A7+0P!MV*8BXK\2*Y&Q>+C%<-C'X':_I#'OU5=+]5RE^$]W?_
MXZQ$Z?X_UP90^DOC_//GY2^UH[N$*LV%JB'>.>FZ+/Y)7.M#6FN%UU_E\)\/
MK]+LI<TA-LA8#S6":.E*V#'<'2N7GORJ^&2'4^_\&5-_*]9.^"2*/'T:N492
MA"[\6G;LMKJ*5*!_5O#\B:?;5P_OG^VV0B]C;?F3XD=OH2(H"HC9J'8D0T#I
M\-?D>TV1OT?.G4TL9EBA@H[K]!#0*UN=F EM?!"A$.O1D74AN;/D6MW'=]?T
M57V"-WJ4IP:XWZK^MCOS1/?F+?1"D]?/@;4.77% JUW]6IV^BIJ->M%IU%H]
MDXSRWO#XI8"?&E*F6]D) '>)2UFQI9K4EH]<B<N7N2E[/3Z:_N*OG903Q2PM
M#"F'F#E^6#FL,\YJHGU:!$VB+UR-CE8;<NEV48P&C0L8O>.\#SK%S7WN!BQ>
MRN>SZ&_/8L,)5=WSFW&.\TM:O-_U#1(>AU80@\(&,0Q-EP)$VV ,81SF7=?C
M<F"A95O72IIZ[7E_+<0]>B%!SS@M>:'9ZA2]W?PGP/ &4<:F.0G>LVD$[_F>
MO8'/MK6!NR5FUB$O=KC$3^0Q)B\*/$>D+5K?:^Y?PCL%ZF>-%/6LA%K._O;+
M*ME#><O&(:J-<Y)<[M8])+\@Q,WUC]WJZH!A*ZL:H2UUZ&A7_+?DE;250"^I
MF*>Q;ME/RN_)M=79>RI;L_-QS7J06-MF_5]^]HU!7G2.F^5@UT]2NM6J39_Q
MCN'MW5^;V,ZUQHQ /D5/^<[Y X%>MB[N=(20F&;-0& 0CT&OB+>WJK#_SBU4
M#.^E"IQ#AQZ'2WIP97I808G5](1"H8EC7N;4:=K7GFW1Y&ODEU20&^2850C?
MSP:>.2J(^2'!MIWS9/F8J'-23'!P3 #E8:: ;86G3I'1ZR=YSZ))GPX'$1D?
MD'>8PPM>?OBDG5^R_7,N/R:3LZ_2/Q@_3&8C(Z7 8_ V*HBVP18^\XXD&CB?
M^<C1;'BY#C%A9ZJX%WA&Y-O:\75,9K;*RN29'^27<(]&^MFMY^LD&MR5P/7U
M:\HZDA;WTNWBSVLR_2BB!^7-/CPNX>G)+K2SDZB][D)G_P5_[H6IO.#62GY*
M7$%"1C%GY5P.VKUF,PP5,-&**EOJ<+-I4$&N4HXC#&H%3=TOXS@?*OX(%+O2
MH1C\=O_::>DE"&^88E@O%42O?)HPU (YQS?@[EOBH9VL]Y DZ\AO<CW?1+.T
MK*IU"1*:,9%.ZNR@X5G+XM =2#&5*TW[.6Z:G+)0V$G>^*2OQK:5=0G@/LU_
M!2P/H7@& L"@S_C/P5^1U*7Z-SS$V\I5\!Z0[CYBCTKFA/E')=&-!$* .17T
M,P)%D(.0'C4!NBG<BN!_'W<4L/K0^="WM-AN^F*MMT?@&1T.&W^'YU7/.-@.
MP\+H2,H 1*33B()CH;3 -[,2"'FLKUX<+WMF5:\NV<RO7.G60XO12M8O 2_H
M\%YZ5OL.O2@LMHL*RCX-QWK""1W@?_Q'!Y\!V DN^E"/PIK0MG7(_$==D4\0
M0CID]AY)&7@"W(8BB "J[-5G2&6 /^4IF$(KOB-#Z9]C/#P+(YP!4.UB/R'
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ML"3\,[R[=@6"OV$.7XZ)7H+/),&VM1K<J"";-U30 +TE.XG-EJ+3!?"_LF@
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MA=#!EU,#Q*F@TT0]BJQ5BMH3HN8^/'!HO9 *$E%$4S@*9AG)Y_M/4D&S$"<
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M4-ZQ(>N%71%6QV6J*+)1!20&-R:$[X6*GWF+7P<=W I9+U4TX4M\^K7YBJ_
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MZJ_")0Y%J=]!+ .S@TK*C&\\>.0O5IDLU]TH+P\VB3!^I?FE4C"F768;O1Y
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M(T #<#_Q".!DA]X&' $($B3&:<LG2#C"@_9 XC[-,A :D;_5+PGBI\G,Z"-
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MI[!&(F=R@)O/BGX=D^!H2QI?,T=E^E6.=J,%>;!/N]QGAU&C(=9T9$=Q^Q'
MJAI*.6&Z%4GBAY#?UK,= 587:%?O)-:29<FHU2/ &^1Z5C#J"! 5SDJ[JQSH
M1-8C#F.:C@"A(#ZBQ0*H-_U[EQ=-8KA%HG-V[!K(,$*$SAE2Y.R)F#E6GJJ
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M?,\Y3;3O,'XZD2$S@RS&O,8L#'ING+;\YGPB_/E9SHN+S*TOH1^%'AS@ZGY
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M=1AH/1CSH>F8\2/ ;53))U5I^Z 4Y1]8G&?7@8?25SV#;*M5M5DW#:J.YU(
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MN6W_;&Y/:22S=C'584_>H^3UF4[KY7%>(<[)T%&>ZB?:3$IOTF1/%] 3LDO
MZ<L]W3#*'.1\RKO'54D+@U"-"T6.L_=]7TX=9?M@:;5VZL\ZM)VBS$MK#*0A
MEW.@'<KC2?O]BB6'TBXP(PW[X_5**>.56X+?,33=9<6SUWG>,X7H3QYK,_TX
MAK,-0ZRE-8T^ST[Z2HWS'C_OP8G,IMPOW'Y!,OWJF (]GNA4PSEZZIS<,CV
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MC'G7?ZV#58+&EKF%;K^=.!-T98W556,>5F;ZN:T^U=5?>4"?W7H%"=^372$
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MM&>2](1S)W4K3UGH7=95LT:&H9R;_&\"JYCDJ76ZV_Z)3NV_H6/;,[ER844
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MIK4"3X?S8Z9SX*<0'&!H]PC=*F9H7LMSENMU95@^G2*AE#5[[+,[&^\V3NN
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M.,D+O6M_\*QW^Z>EI),,TMA_>DQ/4[O#6]6&Q#1K*]8(8RV2=7-\]+WH4>N
M*,?%9".&Z4<A\JMZ02QK H2Q)K0B"2'CQKA;J=OAGIWB-Y+S_*YIA] ET8U
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MM@RDPNA7TQ\]]:_RC_^[1_G^GUQ;9&EE%H#BQX=KP/_T.W;U&"/_PJYTR%_
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M)%73FKQ (,!80PCLS]ZD,E\<O2MFW;4-DY\8U7+T%5]]9!FKK5JY)XU7;9.
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MB&A+DKQ0_)>>X"$06522,F;HD$AF K<4&RG;@G#."G"LK":"W%63E0YQ8JD
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M[,ADAC&#M$L-$\1)6AY24W[*@5];<]ALRI4?1/@L]TBZ=(C:P@L8_D@O'9(
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MATXJ'%VJ&B[]*LGT_4Z\1:F98<+7\3MQ.IO<PDG"7W6,K-Z^T&Z2_[S8LWZ
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M2(*HIF(#JZ!%(8)DDGM/'5FQ]U9,H\J3!*%$*%YQM;E>,8/ \;'<;&-RX8+
MV ;JCNM*4"8SB >2\#US:$5";Z1RE?51-T4>@;-0D01MN6GHG9.]@X'8<(K-
MD#O@LCYV[F=_FS/_@/GP;+_XG U4LO_*R8!G8W<KD,]1V+AP.N10O1 ^KJD
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MI/2"$.ZLPULCX$ ( BME%^S^OK\RW2D?UI&G"3BMN35Z!+Q48J3\_G+ -09
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M/G)LP,S*7;L ?.4/@V%8* FR2GCQ?G_0&OD"$$\2> & ZU_*<0J?WZGG>A>
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M4YE+;&B49WS<QNNE8$Q<;GX7CW*VKXA2IE;_T.=BMB?=3[6%;BSIRR[LAK$
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MNLHV_DO&ZP'8L#/!D.XJ.- @P=I%FR/R>\(GGCV\5F?O=.6**EIE!:LRGQ7
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M2 !?Z9N?:;X^#J57IY7=5PLLOVL0^]&..E7L.<0^M5IX&"XU5KP""I1UC2T
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MVL5I7I!9C? R-/,:]5P#KKPGS_U22N$09Y@_RZ=U]I/!UB^_%)^X8GIQZ82
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M 00^SQO>72VX<T8A=TEZG2N#W2N\N4&(KR?#J)X@%$D7Q^#:O,^BC0=AYF9
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M+1PA9MUGK)HZ*P=[%AU^G=^J6UVQP6SO<FQ'EIT7:082Q*T,;95]U7UR^YY
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M]'@LMBN0MF;[RWN#!T4+$8L0DOU@")H0 =0X1'KVJ[%/\TW_M33'CL3&WA%
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M448OGX.'1_R*P'I9O^Q^],5APBL'S_$7DRGD_MXU8-GHAC2.<TX R$(V<Y,
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M\RBGJ78>XRMVU?GM8\+C#5 D40>OZL?D*IVUK52CVT4/$[-)][-ROM3$]9W
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M<9+$;TPT?[=[46^Z*O%7)%4W\[NE'A$SRLOD#34421,V3%!X674,N!5W7M?
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MNRM7F:.1LXB$!<%?(X;;JFL#<$?CPW+2#<1H!AM1" _O1-S!>R05K4$GJ7C
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MV0$&NWJ%$YY0JO8D S-8\ G;X63A? @CA[?90-UE8_]IKA,BL>V #Q6!/?N
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MPX\P061Q+$_9.?*U0=.7!W(+P1GO/T1>#=(3[:Y*>.!1&)&AWI>W> R8X.A
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M7U1=%U9?'$AW5=341/;X^'C8>C6PW!A0#[MRK-1#E653A"RFWW+3;Q;;@N?
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M2/M9&0?H-OT) =*[JGBM 74N[!GOAOB%7M@E&>L;':U,WO%U'\X&MKPNG68
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M>L?%Y),#Q4Z\T=*]IWC279J[VZL)777V%O=Z1W7Q,&G7T,08UQ#H@@K:50_
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M(N(;0W/ADJ+_:\.*$MY4X:R@VE[[XY&!55I*T. 7N1_Y!_RO:+K5B-+I0/(
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MOF!:0GMZ+[:[1F(R@?0(2H\8LP'O7RA 5,B_=RVOVM?_>'+W=OYJ66Y*9[7
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M(,0J:G?B"W>A?*ZA[/&:!NE(U**M&!60'I9%$>2"/:2J7%*P:#/:!7G,YX'
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MK_BP;NU3DD _*;-L[^*S$/4^6D\6 _67CI0?X/_-?%\BN%$59T7\A!>O-LG
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MX9BCD_N[[>(=[>$"&RX?]TG<G*=T=+HT=T*MZ=H>XC:]F2XXH B+Q8FX>='
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M&Y&^"Q-/0)E,T,,_E-.WA0@7$BU. N<A]8LU;74KK&CO;_8G17+,EUX3VUZ
M?-(*I6K/<,;>F&TA"=P=)PO?0>A\2EX^>^T+]L"\+^>- --!8&5*4Q!L1JLY
M"'*/$.LJ&4U5^JB1;R9S_-*]T(L+F"X9_RL/B(J+N%NX==C I=O>A&WI"7-+
M OWM/(RG0=EO?8:S6=2CL7V:,]:N8N@\O2.?I/YP7QS:??&BS#@#X)#.P\1
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M>8Y90]#KR#,B=Z9W?*J^^9NNJC( XHBV7HJ0)+,RQ=E#Q5Y!@;1*\!F_>PQ
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MYZFK?^@[\A5.%&Y)29[_@9;T]SCYV&T#KO^U7CI:+P?VQH7;UFF:.;"J(PS
MHB6:Z0J/JKQZ>:RLS0M3A(SGN!.[_+TQ&NIO;&\,V3Z3H7AC%H%,%!R\HGD$
MNFB@&R>&3R^^J#62DY5](R3Z7,[%_^)WY/N+MHFE1J>/.'[SC$RYLC>LO\94
MXWT0CD8ILI!:E-6S-">ZT1(U915UNM-Q?KM!,@ITGB(/>GA=+X7DBLXJN@WI
MTI?YX6]20E1M]?&]G=S @:Z&N^OXZV('B^XQ35PVJ[_'M0Y;[X;%!8KR!0]
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M6&D%L-GV1ACIA"WM !;]!\<J8*,ZO1M%X&_M1/],,(E-D._KK+07# #I]DX
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MPX_6F.V>VUPMG*=<3OLNU_U<[_ .BP@%VS^,DRI4JN%;]X9EMIZ@V>$2![/
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M'7SBH/J$'>D3%=G^>#48E(8M,9P41^K5Q!O5.'#$A8N_!CVB^^46#6=@OZ9
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MM1HT5W^?Z=^P^V,70/GG00+T'.$;[.1:W_W]NT(8.U/CH9[K!G U^&VA5JE
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M6JT/FSS2\!_@F"?1DYB7#DI#S/'N^>7!F%NV^H)EG:.=UV.EP4$L8^+C$\>
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M%EML^,J%QHH?0QX2YP(NBN1]/M\>PD[W(W8B"UIRQZV?6K6765MWEG<)L ,
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M/YSS:T[Z'-&MD.D (]234XU4C(Y6Y[[D=]/+F_/3'M^70$I0]STIJX,KW<<
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MOY? EZRQ/JJ E%YT7N>6^MYVCKU5L$'R2-?O&%";G/]3S%OY.]M.9#/7J+S
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MP,8_9Q2PDPMX#$!^15$8=F"8%YG- $\@!\&& J*P35L"V/M+I>9IT<[@ EW
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M7%J@ZV-4D$1!^.@*Y4$7'04%?).+;2.'>V\$(<8K*+8P5<@^4R>:"K)1X*9
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M*,/.HS(-EUG8O)-D\I<Y.:T'-J7MX-^0FJ=R-,EC=DMFUNZ3JE]3LUP*LV(
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M(79G7T(![&84GNRD>NGT,_[IRO-R7DTK1B]\DT<7/Q65/W8+JD&!@1N>"$]
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MN3/#W$"U^81[SEMN4!.NL&=ZH?56*=$! \B HO#.2LELDF#$&6E&74<U4'@
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MQJI';FWOC#,W9C+M/<^(6%NJ<]HL*HKBF#!HO,CQ8?#MG/CD>%7"W>AIU^6
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MMHV5YF&N:]M#96OT58,OK(3_G4\4./F_ ]0]GI/.;GCKX1**'7.C]W3^JVT
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MUC)9B9/HX4"//(P<RM>#&EK/F@I^5K1M,'Y;H_]6346(WOA:P@^]'V5'^7%
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M')X4P4X&[+[^S5.(!*)2"<QD@**/"/X$@5(GB"%"$6N5!60 U)0@-'^"M2+
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M$P<.R:T!]9]2/K_7B=]-(YYT'X+$NVY+)2AKJX(93M &KMRA:=$ +=%M;57
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M"2>\\,V;OH3&&T8L=VN(1>U<5_8WP/UHW38HH](%L%8MVA=>\G@1>FKN?MO
MGO*^Q2?9/ILB2%&S,2X.+X8C Y;2XVK?@/67G A U+LB]ZVL8."E>1/_N=#S
M,H?PXJ/+YP>9>_W;%^%A).Y^3NN;$]O> 7Q6O^K9>T#60IDRI9]+!G6$,BIC
M,(?2_H'ZD7S+QZ9^N$">BYN9]#' 9X@8)9XO-1CF>03*RD15.\P;.E$BKW59
M<V90(=!T!%9GV^.!E\+%/QE8]@D/.<E$(^-:;L5@O^)J4< +_IR5>:A^,91]
MRSCCCA#5^WC\2X^1BJ#T[52WMY#^ENNAHK67'T0K13*O&R6G6BJ4BLR#0 CM
MX_>7-0TK2Q!>17,5\3"L;=PRCA'%5=I/BI*CFRC\+.% 5Z#[I1-,C<[3PG7C
ME<'20]Z[-)M = C.1C.F+TS_YM#.[,MVST/ VEXE8D&W$\Y%N(7[@;S0PF?5
M4RX\8-YG_"XM0 Y5SYA4$7O*<@PMEK*A):ZCM5U9)R>P.!S+&*,Y!2H8K!%^
MWRV6N$ET*:O4$7US+[C3)R=U;[(R4HWW-WMXF^>_6LJ/L^CO)*6-\R14K#2.
MN++PB=V#\=$7>(/H[JS5:B/E;B6\?.2V.][\2.3;0"8/HWSC_ZR%60IUH5S%
MB0QP",X%U@= W!-A6?8>L/&*GW]$K_I6EMT.+I(=_9\%WG[?"A)@OU4 YR46
M*KP@,>+ V)_B-\<+D0YJ7.EQ%$Q6:6GLCW(<J*F+ED>S:2YAC- _YW60:T>\
MJR)Q/%<J(;S^C8L+=7>$IW)KHSA?O5KR&UT"QKUD$F=YKFO8SXPK<!Z!&Q@[
MR]=!C9Y].D![VT3F5K"57:,8,L9_9T4^@DWY+;[.I(Z*C!2QHV"X8/QSKNX=
M[4EZ^ &\O#:.>\1ZQ.%32XB;L+U59:S0OI=N2];CIHB-N1]>#U!#D7K*WX'O
MX#\'(R$"NNS^(EIC/YFE&< ;@1$&1J1<A"KJAT-=P9V;CP-\#[8@_%W'[F,>
MEW\XKO?GU>\+P_HAZKTP5H2#E6GK$>,&QT/W8B>ZJ5.GQ-23?Q;W7 N<B%5P
M9;^>4GE)E@T^8J*W81QA%'O9I5_!#J_DK]TY]78*ZF#I">Z[Q\@_&NME9H-S
MS]3Q5W?G/Q'/$UA*<#BK+A;CB]>&9I(!O"@YH757=:SL5R>V*1??C8:%1W$C
M:&9S)%9Z##R(=$FS$"6</R:J@F=ZQ,]L;Y$!S"2'V>[HSW[<[FXM:R3U@?LL
M"W29FR0>@O $Y(8S[;DLYWE=TR]OF>/4 M;8^*=;,M )6V6H.:XEF%':8S44
M_>QW!EAQM^26N5K,LP]3%9793A=3&P_BF6@0;^$NU.T^MJ-5.GV?9X_!(_&.
MAC$1(&XGOT!*Z/R^O@T9'@AJ%^94=LYU60?L[[P##P0KAOL>Z(,^&!307#9:
M+^.#2$=U&'>.I0;NK2;/48R^^?O6_[9E','"F$V2 1<ZYA>P('"W6W=Z;V8!
MU,5SR=_0>!@EQ_W1X>;*?/G^MHO/_8Y7[X[?S&S.-\4L31#RY5&L/Z%:K<1Z
MA>M%N"-L"\[TPT;OL-/$RP^9DMT#N6KR.D&<3_&F0UW9<I6QSA6R/!O^!B5R
MSN4ENP,(%740!9YD.=<UYM>?Z+9S/3CZMGF7T>J+9MX<"X0DY;H^XQ,T&$UY
M//MBD*_2H PD+G]/7?;@@E1HM;:$YW6^<W0 /@;K],6$R,:+W>U<VFU5Z[Y5
MCA$]*(OK;'NI#][3F?:!T-I!#<DH8$P--OBGN<OGJ,@CR,/OW+.FXB?-6G=K
M;L\D5MP]U$40J'RVU\>,BN3W^2OJ'(^3L4[$_*8 ]%(WC*%6F KU/N=F\W@M
ME4>08Y)<%NO\<N&#]WL=7NO6:_A'SND<R&U]-*O>UUJ7JUE91FG:]IN,+."*
M%V1 *W .@?(B^+/CIV<<2*0^/=(DSUX ]"P9,$L&3,TW"R;'5L6+QL&$)DAS
M,K?;]-L*5WQ^U) !]0D?$)2(<=I+DPAS]>YSDOBZ[=<A]^GM^HE=[,7K6?;2
MMG#=)D0V>)V5P!36%<@Y/@&YBP-"/^ @ZB!Q/26/O9]U8BK7 'A&D!G!'!/9
MOAOQ:1)7W[6_/L[X)"V^=V_[5*K9)ZTNC[<Z0\>F760 #V+A(X@.<@LLBM%]
M;:@R)@*9.Q5QFQT0^^E:V3+V#)6U[Z44YTZ1IRMSR#WY*N.;.H_Q=MR]R QL
M? '&5#<9=1&94"/<6!"Z7E$\\]&UY?GK628RP)L,$#Q^!EPHT .!@<.5WO!S
MLRY*\BUSM]&D'&OOZ,LK?N*E29?4'QDCIN)/7'9Q_/'%]JY=0K2X=.*8]6T8
M^I%(Q,FY+'3N;B=FJCSGVNC=Y7CM'B96C>ZK3%C*LV#N'$YSKTPP<74E]6VV
M\UB!CL1<0YZO*Y@2V89&.G)+9%E^PI!2P%3E3I\D!Z<JV:OXG,7:UVC\O-N6
M,A>;'I,!9R5')?J?SCLA+TK2PJ@"6EFM&S2?7\H ?+DJ1<$$8[V0*21-#9"!
M- VZZ.KNJF>&BW[RK.7)JXL")I9K$[+P&J5[.,;[[J_FKZ/7A[>[8MP+-:Y7
M,\2]J=*TI(=+YB^]+EP?G$+""K#K15XR3<:J,EXSR17UAW>G"+;#3:IH>V@4
MA)MBP.-AQ,R3UZ*RDQ;.+)/(.<4X<"LU@>GS/"6ZWLGV*?*76S+!K&QJ]*'F
M%)HV.06WLN;&-*EY"^7'="<_!]@37X%-^!+?\V-S*Y>R\_HXZ9T;R( S")S[
M!S."Y&C3TSO#H,OS\YJTUAH?:CQ"U3H40S8/2TZ:Z>1*-]2STDQ4@YS'LF]2
MNSG.95&Z01<^3O/$B1QFBRR>BP>?*GMR_TC[;+L27QQ3&H^,P=4ACWZ/%D&*
M=C-!ZXWM\TX\%WUH=ZG>/*AL]DQ^R"4>VKXL1 8DF-[&OR0(#RFHX$%@T="]
M*9:)#O%VU\ ;>ARJINR#E<KP6@B_/U7[)EK>$OV=HK=(]\)&58>5N&AF33;N
MAM52%VK=I*)J!%#[5Z.C0)/1,6K03:=N]BL*%L?-CC%MT\=<&5B9:2][?K2G
M-#BO%I7UGIF$IBH YY5#6U6;S$J0_=*A2I>=6Z[_9-;N+M;E' IXDU-Z^C*4
MRH(,0#_";1^Z3YF<C!A?\"F2*O)CJK($#QVK,GJ^A4:>P5A )(B(EDN$ZYD\
M]+\*:F."'K6O.%:1-D[GAS;+<X[K?^3PV3"(X]<OPH'C;IH;"[3EEWK>BJ_'
MNA,K)9 ))SKU[L14J3>+VUQF.][:KU1.A=6?>:7Y_5JL!XB&X$S,);A40,9R
M:#&2:^T9=WS@EP8P9DYGE_GU3KT[=P9>I$!E'8Z_2S ::KD-00;"HPCB-E)9
M!9LLXCT2T@#J@-.B=^\?+C;38Q-]R8#(4/#%M8\R9$!W66.JG/^+1WD]31;5
M08X[\7*I_%'M799X31$KXXQ-X!F@$ST'00N-C*WE80'+0B_<C;&=N*<J4=ZV
M%?[<=%4_X>O)^-I6*F:&Q+KV"EX[B%-W!4L)[W(CM\8KV2W.Q'6'##*O(QB!
MR^]Q1:16/]#)[;(E]TG3CBLX4ZP>9AP.F),LZ!^-4MP[7"DVK%#SBGVQRU2_
M$7C7L,#D<DIE^8Q\0@*L?BRR/8$-^+J)$35%"%B4][VQ,3\JJX&9H N)L9DT
MH6XC W "RW+UL>4$(.9J:[WUZ33<Z[I,NV0741GV^;+PHU($^A$P\@2,I*]%
M\"#-*[JC#H5U',,//DB$7F-]%1B;)EN91Z+11D^H8Z2_!<$9^EVNN)C?*1%N
M_J6_^F+-.X"TOI3@O(GUUQ@_R8M,ESQ$%':+*-TR:JDI6NMS%=YL^$4&U+)N
M<XEL[?\N7K#QUNGR!L9Y.M2L(=/K2D>D^^![3K1+.SB88B]N-(299(I$(NCA
M30X%TW'U@0GI8AU)]$VE^FR7+P7L6GO@#?VCUQ;5MQS0NH:CR[Y?1G=X-9<'
M+)(NYP2'!X^@35'UD1!NL/"0MQ7]XXCA+FVVV-[B4]F9H@VPT??OB2Y !Y6+
M:F)EEYRL*K9J[-\?5C';<7BMQ"7/- Q"^H$UA6%X#=P#*T-M]>I184[5()MK
MJ_S?%!Q*]\>;(UHN$..]OQ"8\8Y@9_3J^S?N!5VL=DTVYQ$R+T)F*H*W+65Z
M]?),1K%.DONF\O=2;YJDKC4V_L[AKV3\]$_O=?[?G/5!1\]9 J6;"R'U4%9T
M>(!NV "2N><O(6@E[K,X?^3.J,\,;+S)KSTI0.F.M4>S%,DGU1TEGL#P6?$*
M!>]P+OW[B[K^B<LU AXCP-Z:TKH\UFR':YLAB>:&X.I'C6[#CP@DW#8?Y +Q
M2],I.%(@M OEQ_X.K4D7IO1^L66&EWF!I^XWT[P7)JM-:F+Z.F]'IOSQ>#1P
MI30L&V;Y?N(M3AZ+;<(YY*F@D&\@]&.K&*ZHO1QMO;(&=4!=8'T)O":5W<;1
MT-LGQ3AS<[DG3@/E\MAX6,Q/=U]I;EJ#CRYDO&F?LC3(@ 61F,;PYJ,8;Y52
M*XNB]*LQD0FTZ^&2RV3 !1(?00NWC;G5#>)X2&+!!3V[JDMC>7>B1>8:[].%
M/2^<B50SWL4%=H&@4NJ$O$R@+KZC/RLVU5^46]K# C&15=S,87OT4-!S&+)G
MQ=T"6W6_\YC]P2%K([[B$C4V%G<-:)=Q,!B%I'.W'>*U**C/[)8?,XI-3MM\
M;X.!/R/F*QB!/?"<L[A7G5C?45?A'8YKGI>3_/O]'3KIHTFWB74BWNZT.)%V
MZ4;W"-X&L\H=$28W-7;VYT"*Z=R,/D).A[6_])?&:B)^;A]IGH.YN[L5L?/=
MEES7S="FYR #.E:/9PH&SN_56@WCA/<0B;.0'U51+50X9>/3])_7:$1Q$R&0
M\=M<B&T@NG3UW(WCU7#.4P/]2SSC#=!P6 WT#=0.2;W>R).@  RNQ 6Z>,,T
M1U^8GGT=S?-,F#B[A*Z@#\4JW2(6(1R+6_@W.5S6YQF'\V9L.#?CEK)?06LN
M] "U]#[>471^]P;A.6A]].M*!<?!QP= %I@0C\_#".UR&WX_8+;/C0;B+: <
M6G9#K*N1!O=>^RA)D5/E*(G&+ZW[;7Y"P4U_>"R8$<.KA]$I\LK?1-J-V+VK
M;9*?6;:\)"0G,68RFI^WX=%KV7PW")1&!LRY]R8(DP&-R%3P,1E <[0X2*1K
M)^&=@2AK B7B_/@.BG2U@AH6D0' /%SB-L]>]2_@7]IS4YR5#T+P>)_$O-L)
M.V&/)&)'H6W-N&HR0.4>&= RG5!"><I@0P25:>"*PT_(7YHKU),V(<;[:P0A
M9 SP0)P>OUU,!H0'81Q($<_(@.!:GO]QJ\@::._@!\+OUD8![L1Q0MG:(,X4
MP0+]9<]S-*/_UT-5*M(E0=4Q]!0LF@I3/O[=N'@/B:\X-AV$H>&0.Y2G_P=P
MMR[OK\89K ,CD!(6N8?( "&EL#\:ZZ\@CBSVX+"_%ES]KT9YD@T\)O)T*.:1
M3(*I_VB;UP?=J5\!*?U9Z+\:Y*$<=/\$&!6D3B@_H?^CL?I?--X"_K/,?SW*
M#8JU6CN 7L8F')L=\/R#,Z0^NDX&#/XB7?__Y@1-(^> J;=&?KE0;J$.$:'(
MVOA8]6X*M$_ERVHRGG^)E4!0/Y;&#1T*4+0P25S$YCPZ870ZD'!5BF@)(O7@
M.BDC9B ])DE ;0G/*2)'42),,H!#*1^QM@5!_R^T[IMM%\H)BMX2'KUSNTM)
M?[KED17_$@LJ)FH?ID9I.F/%LY19?'KC&C4>N63E#[X11P8$L.[+.8Y[(!H'
MBQSA[\B STJRE,'.@G!'N"%B(F:0!%FD>!9$UU=()2*;"_0$^GVP2."_:IA0
M!E]3/HPDQ&XK28'%QVS'A E>J-OY,1WF_N<TE&\ZQ%Y24\HN@^-T,5K=BVZA
M=WEY[$<7B',K,6B,S&;K&O.2- O/U>UK20%P5#3;:/57-\ EXF8H3KH0U]>!
M9 +6U43L;=LT&H_>W0[1L->;>JKNJ2PYLF6T+GE;Q,_AA),TDY:[$C-1M!'<
M\/L%?> S$!]D_.1@NBCV@'AE5F+3W8VG+]8N-K;[&GUN],E\DWEWNR\07=5D
MLV1E?C8'J?G#9.,;I]CMYVI!"[&FX5E#.;=>.ZK.9&S@;Y8IU4=@)- R)3:"
MZAEM=_N:LC1%.M 7>;#.F)V&HLZ L^$UHEK2@K,#O- .CL4FLX4*AV\G,68N
M+.ZN@N\OW'OT CKE=CCN/[*T%@,VKN@)<"J;<Y+*BHJ8'WX09N\_J^AAX ]?
M,AZ,;^&Y&U8Y0UNA=4'% A32"V?O4?S>#_$QD?7.$QCR-+"0=@'N 5^TCP[D
M&3!V=%VZ$E@\CT%8-',U9I NX7B6Z+F>9/6+Z!K5;QVYKYP[8M\0%.$$LV-
M[5]E*@^S9#IK(MVS7I">P_$=WF4<Z=U -M"ZN6^V>XE4LKO-E7:>2;8N,R,
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MQ<^-@65.?;4G,S^/V[&-:$XR@ YJAPB=9VWHGI:8P3U+I@9*K? ?3\R3Z,B
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M=;/^?.!QH"IC))*O,5'@UM'<+";@8EF "DU<59G]P, +N-5S !:EVCH7:<W
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M:_/=GKE)^UBE5^$2^;W_;1%Y^+7,W K#S,D(KN]KJ5L123(;O[Z=])YA DI
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M2JM M%'[V&?PER!92ICW9:3^"$0%X/K.-)@!>D/%9F*7*I\;JELHF7[9>Q!
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MX!.062+U'N?&EGXQQ"4=/'6."3!;\+ G.QO)KC5BZC(.1% /-%1)Y3'$Q:8
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M>I "57>9"3@Y/4L AQ7(>MW=2(M:3_7K].V*=>/Q%=U"?T<X8D[0 @;G!\I
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MH)7+O*#7YK2A)^@SP@R+F4E67217K$T]X@9.6]OW'[+=,8D$]R#*CM2"!)D
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M&/K,^9W-6DA^)9_@8XBG\%D:!/,RZ&2#SGSO)=*T)-@'=0=&M_%R5>*LQP&
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M W:$NXU!L6A.)1GAJ"^'XAW0POP]GQ^[UWZH-*6*C#7<R4%T"&"*/?HFCYM
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M4N%.H,ZB:SOW*W^NMY1<>J^QL<'("WN;]LS<^SO7Q-4>W  0A=4>A#+?,N0
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M[S%KEM,@',7;K2"8427]+X;-]KMM4)_,0.<MZXG("GPG]EZZ;_8J2[7793+
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ML._GG'0Z#*SXYEP"[$1':21%%C]A"#KS2A[,(O%7PJ))16RW"&12.?(D82_
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MOQ'3F>U#3HA+&^4ZSK]D7'PYOXA0!O*4@/MC4XMMIF8N+ 63/!.)<\U1/WQ
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M8&R\"<97*6?MV9);O&-*XK#WG=)*7;W0E6.</4'^6]GEY!R2#K@1#:9A[.B
M@9# !Q2WQWL#5-E$^6D!?[\7MA/1<=M[__,C:A2/*WO@,,7K=$ K.NPT7Y<-
M!GC4UW!4>Y":PKQO@=W;^OTR:"!1BSQ,5&F<DQU>Z)V7FG["SWF;8P-P".\
M1]L'C29T$2DXY%L:CX5K^-"9ZH9H\'+&C^V@++1WVD]49"$:=7X]]<K(F%);
M5L8N"YQM>[MJ_E#Z-\;K*!/^BJ9&;D!AW1V"ST=G74^.+HFM!EK\*3&^L0LI
M;*.,LN@M-6#39S_D PLHWB0C+7#\<BEYG?;8MPD+.4HI<-R[02ST 9TEN8=+
M%..&3?:/6"ZL?KW=4G['[G.'@2BPXTHY]B<=\([__H7:,_HQR=\X&,M( P^(
M_7OF1.3[^>DS<X5VU2E/D5_G.97]-]E^H)4+K@IZ,T*W7#I'+5+4K8MNG-E'
M/_MY%$N5RET?6!NDF@VWDF:.<D%>:KZ;_%O&_=,MS9?7+"3#ZFSM5'T]WNXY
M%]^X$?]XP;:3"EW0*VVKY#XKNH$,P0,CTDKV/\BJY)^R60FR'Y30/'%"BGE@
M7((/+6:L7.5DN.0*\=FUR97C^D)B77OZ7LD-5>N?X?[QSO%(VH//K^V]= QN
MBC?_>NG-V2<(%M$%E\.D/6MR[W=$LS"".-S!S,JEV_VE,M6]NFN)&;.I;CW:
M\"RI"QTN49YVS7F0[)<&?[[@]T5]LR4*GWLE+-66P[1E;>.SM>'](@U89S.:
MUSH66J;9%1"Z8>\X%%_?L/=FB,8'D[PW6"<\?Y!@,NJ:+8-=^Q[Z<O[=%<5=
M):IHJVAKD=9@&K\S>F+;97C/8-&-]E:=U>3L7SGMLW3 &Z_V,;ACIOF/!&>W
MS!-W^_S8#E<O3[,PWQ7="=A3)@; <A<T4EX]+;>PD%M?A-==_@ZDK/]!#6E3
M,,"<!0UOH.D!T"YVV"-;!(/:9KR5@<D[Y(\F)_%$YDQ8:79\]LE&4@0N.RN<
M96SYU'C%<N[6D$;U]SES.H#U@T_:@ZFJ?B87\)2RJOI;\_2CF0_^P8K?+UIL
MHSZF,B18#B^,O<S<D2C2F+SB7TH'?+8IT&3*NC.3]2Q_Q>D4/F6VAF]^EY7G
M#T_)/+,A1!-6-N_V&<\=5EWVF0+R57JF:)&+TWL3;\'W/<$_9 "SW6<@U=F/
M<3J51=9-[_I.OMDG$CKYXE>VGGXJ].=QMP&V=QM/H5D!!@L^FGDW8^."B-_/
M8=@[;Y2-;'C2 7S[;H@M%!U@[+/;!%<P/$+A%8#>Q6?!%EM._[RD=1*3GF>Q
M:O+:VF:FQ1'*,;/S!'=%,]^N,<?9'_VQVHYW,\7/'>$H+.(!O=W%'<BI=;8.
MN=?ZE XH0WQ\P(3<. #_N6I%!VR<ZMC(G$<=+DO1 9U%UC9M@9!I2%'#J:1I
ML/M&T=#RP!]#X]'P$V_YBR^*W-#0.UG]),8I)YPMX<9;ONHL<_V/;"-I=G=9
M-]$$^>9#;I64^V-SF^Z[/MN_"OB/6),3&R#25+>C>.^M"&"Y\+NZ0#M\WI]Z
M2<U'8PMZ#@AIW8^6BQVGE "_,=_$6.V3F?WGLFYPM+6;NB/X.;1??_F2:5^Q
M<RW"I1.Y;VZYXCSZ]J>^NE]_1W^TA6\C<Y@O2')4EE*D/70^]JJ[@Y&2>#(P
M*<K#])QVUI>;Q9-_LV>R2]6X(CJ)"1]P)-]0KUZ7.>%@[I5K7A_UZKY'S5/&
MZG5T5:1RO;U8]=5O_(?,X/_XRK7_RRK@_L9RJ-X\C(MUJ>BJL?0(-_*%0%[+
MV C=X[GR#F+>Q=7%S1_=W7*:#U\G@P>W?)/E3#QL4UC=?&W$O*LY0#%M7U8*
M:!ASEH3L@"QEFU2.GB?NT@$R_7G9JCP&IIUI=_Z1=;!HR'_FJ1;HG6R$ @_C
MKF0H^)+%*G[4FV.O,4M6ZLY2YTK'5 VQRN7KCX@4.3H L-J"6PY/?'^I$N?^
M?KJE1C+M555M30L;N+$^Q&<D17%5!Y+[-)-'37$HM//H;/2MP9S\#OMC.VXO
M_YGBX-?1#KF4='1;7%OP5_RDZ932[0#::482UV$[C+\F!!]WJGT!*NIU$^-'
M.HX00L3BO"6C)!'+.UW31]@\5&0?T4WZ\-<U)&('I"??C)8LU'2L[AI49]MV
M[/WOT\DXDEO$^T(> ?= H)3G-LK .6NZE$NWEC^#[(D;(S&$BX_DW[G_L)3'
MXXWGN]V;F$ACQN\GWBB>K&XX0=8&,SJM<CYU6SJ1@X!['3*N0O_ 46>)7\0E
MP]>._912UW!AUT4^H77_>/VK?S?RC]MY2QAAF 06S_[6._#L/)/UW6YDU)>@
M[TC_-:?\+T;X!?%OTA')5B_*P+R[14+K]T:+R]<G+"X4.#.]UE@X\^B'W-XX
M(8D"QA06+02>',RJ4:<#PJ,NH\0R:18+U3S+$Z:MHP<F"N=5>1V?6'H%#AZ,
MB3*+B9L^@=PX1D(XQ;;%UY>8B[3D9GO'L.56_1[EMO!5SCWDO<]MZNJG!(/7
M\*.1EC.Z+UN?E4NS"OCS&+UL^QHO^'5;2TDH-@+P=<ZJ7/1\37)C@\]5T9>0
MC.63X5L2;L&1D?F;)U]E.)LW'TG#\IPR-D[FA&[_GN6]49-Z.HCS9MP7A9%3
MO0_4 ;P[R7S?]PL0T\I?K3.-,!>&W:<@P+X?^NI3$V<$RJX]-T<*?EU,U/ZW
M@E\Z6C:S%"GX^6HR"K\B*>DZ ?-IOR?86@@RYWC-SU>] !JMYY)I-3*:1SN,
MY&N7CRJ*F__9VC E-E&YB83=VHD(%ZX6OXCB*B?\Z1#@@R94QIHH%%9(P%<&
MRT5P?+JID7G"B D 9HQO,&YY^I$KREDS_5".\7;(K6'DW8P(T:P9T5ZXKL,<
M,PFX]_>6-$O/0GCC*D\JII%D$V>,O@BZ:-!G:?FU]6?GG>[F-TKJ+V+8!BOY
MF8)%H"FI*JBP_="I=>_V:/Z@W\LT/SJ@='1 7<SW2OA-#P''3)'O#/]T5P/5
M2%:WC5<_LCZ3#<:$(R2!79&Z%=Q;DI8]QGN;3J<\<=[57*S[;J" @K!/0&."
M=9S!X)^)/X$28]V2U:=M&>9O$_ZO+"!8/R'D>/W#+2 I#%UTP/?$9<0SN8N4
M6[!;?*$B831UEY6&EY('"LP\B F0WM'I<34*@ [HRH<)TZI[Z(!,BWHYVM_#
ME4,^!+5=DDC+#8<+CJ(E@\&56Y%UP+P97:$8?&?T;%J:C&)TD \2D)H5+#H#
M=MOZ$$W<W_,@\7QZ,K8_]=4:-/9H&AH.3'ZW_@;:WC"?/@6D7N=3)$-)/ET\
MNMEK5Z:Q-8A^P-I=JN\=JDL"P1/_D$PA1<Y7MD Y%9P.2\+,ZJ]L#VX^[4IS
M+3H<3^>"7C&(]D6CZ8#*)YRZ@R$6H@&K=( [CV\4FID++DJ^2O3$A284ZF9"
M^>33?HVBN<-URH-L]<M5^*3& >,Y9,<]=E)#4\-E9Y @4:^U]X'1".Z;^E)J
M1F9W*O]^M<-UOI2"*; S:A*A>_2]CCUGE30GCRQRRNT=0F4J7M%Z<W:#:>$-
M#)7X!X5,XZ #[+!7G&UXR"7N=,!YS7<.7^^Q?^!G&F+Q!VSXGYCX.+(ZEGHS
M)4_NUQ8,W? G1%D_TV#W\])0KY<"'>!R\?XA=F^"##YYC "N-JIV/O\6KZ"2
M]N/=.XNT"E2TJC$>%3EW@JR$._*ND['#W]2E?;_#S<DQ!=O0 XPQ$)2\>?<)
M)<3GOZ]AF<8*;M[9S/[ZS@9+,0GJ+J$-F$R9%&6MH7!T *=3M;);1J&Q4>PE
M;J?^I\I&&EZK-2SYN34T/4OI)<X1XR_@;_"Q!,UDJLI1)-6=".S@DJ^=IP,^
M)$R-9FKSCWH=:=TUO[G9;8Y4\V>D"&'.$Q4(XB33/0_RVPP8PX(<<B\GTN_V
ME#DL0DYP^7G3 W;AWYS\Z,"5CZ6W2S]UMUS_N-OTT;@Z\W:1RL:X8=G9U==5
M0[J67H=LN^(&/>IEL3M/:X/;A\ -'IZW.[@6%^*?'Z.)1W1 \ ?83HOR_D;_
MCREG#/^0]X6<NC<?Q-TSXCJYRT),A##1Y"8B2IL\2MPW(@95BK=RN:67]<8.
M-G?*5WD$W^,U\D'U-TPM[S$1V1M1P?MSH@-H<8<%_6#\K7B5+CNGSI?+UZ^K
MU4.M:F1YS92Z\B'J[B/]O+>[D[_<3'8MJ-YG:&H(M[E<2;;%63JKFF8(-D^T
MA@J-V#)Q\]ZQ5$*9:)JS67-(_^Q\H73:M!G+A)A/1##M]C/"/%M9UJ;(M:D<
MQ9,FL&:W^05N&60[!C]<:#?L18$^BN28C[8SF'UU]BPTB8U+*F$S:VZ_IF0P
M-,Y9<[]$IZ)2[#CX-/O\AQN,_P5E_MD,!<*%HK(^%(?]^-F9.WB7#XI'O=L[
M?!_MD0/^M"S0.),O7+4<L6-MVNC?]UDR03SY8Z.CU,66/ZCL6RB&*Y]QZQ@G
M"JJ'BN3"F-XO^XVLH2+C$3_=*19/]'*_'-",2S*IRF/>X?(=+H-O_)R#]",.
ME2,60^]I@8-<456_/^KH@OU=DQG>8ZY.KI2*]Y+8?0&;1AW=83N_:Y?^H=#/
M"^ Q&(3<>\"L<Y%/6[MS;V4@][YJ^6APQ*WBSZ_^1Y&&'\KM2&CQA(ZS+T>L
M,,<^'QZE;W@K7YA3-$=$7<M\ \80%<0)(?LE.K$5%ZD\>B<&RJBJ"!G\<!NF
MJ&HZ]CC]2[ T\VE3N2*XZJ!<0Z*.>NCCQ:[+)Z+AJ:(W#=S,?-V%:8Z]SZ6]
ML'(,[D)P[!-CAY6LHS,!N5210&[AE_N,,LGPL(,B\Y]D]71S[>(NP3XL[FLP
M\ZK-R]>JECX^$)FW+SCB=ROG8,7AN(*CH*4;Y6^SQ =_WD?FK]K@YMW#XN?8
M'JAFZ<%;MNS>\[VC0O-+APGE$_ ",Y9S=$#-NY.%IH/SKQ/-3/N%>R4[]U]]
M<U6568XO_0MWAB?^1[45;@%G65>>#\51=X[7"N1]T074U-4]N=CM[9U6$*/Q
M$4ZZ-^=JN:2/O=)F@.G$'U,^T?,ZG)>T"V@G>CZT&+8]B,\ \WJ+\U$>53E)
MN@JCOVF=$8K^1-IE,V@PI[X@IC6G@C[>*W*JJ/RLV)BR<%8=]/UP'(D-:L:<
MK/LD;>UB,@L+'P;^2"1/39Z!-<QJR>T#Q4V%BM@I%8D49+^_Z!8=0'Z&.H48
M,#2E S#'@1!_BPX(920J')V10U V)6DWJ^F GZ24A#F[HYB(#<S././_@]\@
M-U0=7^R'[6F(EE+ZW]Q"-= !N."Z8P^]IPNA42*/E]Y,&H=H(_8/ZR@=L%75
M0(X _\,&<)*CN&<+!,C T '_^LI_-4EK:?>!P!#VSVLEZ\@G(RATP+^^\E]-
M4I@Y)P-Q_Y^[<?N1ZV)5C('BE*;=FV/@ D%8TIIHIT-?^(S(.1L_\9'I>'<@
M[@]\BW# GH0Q+Z,'T^NJ&40]?=XN0M+;H'HW6KLH!,']Q ?"K5H4@@#<G0C>
MTR4QM'8]'Y$S#F1_P/!-T$J;K':2A^?*7,-=57X<KV3CX<5B9.94479TS6EU
MFUS>KLW WI>W/XS<COXK/#^"WIT0P\2?!?TNVNS/;GZ6CV.O+=C\FQ+N^/V?
MV.B>WXNSZ6Y$*XW2UH4S9J:I+C;,HZKB,E8KJ+T"OB*'Y3A>HJZ_\3%S\G>/
M%-M*ZODBE]*H*/6+<8>0BBZM>G;NF>98Q2[J_&KB]F=?%Z2PL]0.<WMU?A!7
MO[-H5^Y:;)Y;S*][^G_P;\0)[@\.]"O'D44O%-Y3;<+.YTVQ$3ZYJ!.O52(X
M=8Z,GRH8NH_OLIZX5H+7<;WU\O&,M<)Y)CN!Q&&B7HC;C:I 1Y,#U&]@+3(O
M))"AWL6)CV'8Z[SJRL+.9NV,3@_->V#@?Q+T^10T-J:@G+"QLZ #U7$NWA0H
MB3'@N%Q;,@4#>*/":"=I4WS*9'YBP4.B/8+!VU7?:]2;/9JWU4&WSU(%GOD1
M@SY$J/O+2CW-U1K*U_MF0T$?\+#]',[7-\H%F4)=/7'3_1%<6X0"HC#>YFT1
M^>16\U5G'YU IW$;!^$8!45&:_;3KKQJT%]TP'QB$.<([0;<:+S.':_$=[AP
MKQ2I]3:;#HA_?#+D%&]SCN@&=FH:_Y1L3&1H2QSZ5%9?8-X<$/:%]72@C!68
M>G4<MTK4VUC/MK%J6EJ;FBF%S#YJ^0VO];.G$&[6QM_09-!O5OWQI N.5IQE
M%S.6$['.]CV\2AO"LF-$J%=)QA\;<%N,=$ S9#Z^XLJL^=V)%*&>%^TGGM\Q
MW48E!=V 8?%@PHYO!DRZ!W<T_NZ/BNC$EJ2<^$/IGX#+KWA-%;OFKR8>"614
MY>$7U(7RB[W+QK=5;N->&)?_/K!9IYTG5A+8<&I/@-,7YCLFRFNGZT'-O3=B
MU[A]8)E39O!?9QD6;,(I#^ ^Y (B$,^4F)+PSK+=YF1-" O'QO3^WG8(=Q=C
M-E)I?1UB,&BXFW7 .I\84;F ^$0K')=YOS%=?=!3Z))VN<%=[\/<I6CJ%7 P
M51R7M%N?NDEY%4.\U\A4D#S/Q+2+&H1EFCU_-&!K=.;4A.%*(8D#Z=K#T1$O
M-<FEG[Z!$M'>#OB)8CPJ!UTE(Q<T&Z?I ":8Q1QWB@4T[X79\M>'M:8^078=
M_OL6HHS&O"(_8F:YC7)^-#5;RGPC.Z;/P1QQM+?9D(R. $=''IG;\O,<EUX%
MC.NJL[' >RLLK/(%CGWH4?-_\G(%_]7^_5:4YQSOCRZIQ)0'[\U^?&QZI?"#
MQW"PE,'T=)LSXX/36DR/[I2TIQMK?C^5K:4.OOY74N3_U6GX?X'5_RS--)5J
M0-Z9Q[Y+F!),B_ ^+Y8[)GQM#\IS46A?&,#"P'-,J(])#%%_ZX"'QDP'3#B
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MS77=U_6Y[_OZO.[WY_-:KMO^W/X?P-=1X:!PP >.BOH@"@"P+P+VA%W)S0(
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M!+3BO%9K?I3D[U:E41G\5A1JC\;,.ALGSJ*^GNWP%UBB+8)E1L?C/VHA+-#
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MS9+6NTNH,!7D/IBU@IC%/,BHR2MG@=7.3]RCJHV]U6?7P8TH8"XMIT8H9B6
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M[*3>-P'I@:$FJQC-Q1V_"OIC=@I/E'' 095H\P^=%F&2>\\5Q"R"WFT>O!X
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MMY)D\\0,26X>'(I7[;D/*M37MC4Z4JRXDD-MDG17=_E#NBJ+J@1/XJ2IF/J
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MEL-J^?+X@C$75C[*IBKIW1OB$VHX*[ W9$:VAPT"-DJ2R*B[D@'=; %29AR
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M3$EFNFF64'"9S?7JP7PT0?09E7S:,ZK#2/N4C/]-(>DKC&D<>BHEQ/L2KT(
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MN7>K"675'!O<[U.% S[J;[D_Z+K+)V/X1(K(C"GJ:?)!"Y AK!,I2$-;%#?
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MY;8C/87A1WE%2'81769F_LU+Y:%IH-',3EA>OF<-,H=N>;.K/=AR7C7[03Z
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M-K0:3^CER)):&%_?]^P?Z$,O[Q(=6!)='>>Y45I[W#-U6/+E@>ZBG,T'](?
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M4_97)06SA;U&V]/0&8CD#JS/7U16CW>?#Z9^3IJ,'SW/MI-5XW(YD"#TGR=
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M[/@K.+7^-7V9KYC)LYHDH*(7GN+5I3&V"1?^9P&FV^RTSJN"\E,'EMG4JC(
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MS'3(8'!W$O82 P7-:$YD' VO/A8])A[KZX\@NA7@ >HT!G/:2NXM-1Q7KQ-
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M:P.[3<H?S)KACS),7[?H(0/<1X,;!2VS89C!V:<9:OCU993B*M5FPG9TI"Z
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MCULF92I3C_ZMV%(!?J4Z)G-VV6]!V@=U*+A'IT> !)&_0!<,A\QT 'AVA)C
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MM$1G52N^<'+QZSJ X\L73>4O@8ZH:00#I0M*L0Y";.[:#+$K).H60EJ9"NT
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M*LU[_9BRM&\P<*,.!>&<K:R_^OF]/-#B\6.HIA7D[%<+5B37>CM([:)7"B*
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M!P:7]1T,-WNWW2JD!^:_\A]<H!SO.WP1RFC$CNN5%@5B/O&/4ZQJ-H:!Z:,
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M5#H1"I  OK%[9"[%=,ZGGO%^]&J3GQ7#_7!(#]5"_08E#"]'S [&VE+ F[N
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M7@/.NS%K9BO NY##&)9C26,U!?&=.Q[Q$(]Q7:P+("LN*Q-6)@,49?'9"Q,
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M=58)+[-S >%0_R]2+#SM):WD;%@TQ =7P2_+(XW'L((I'\:%+H)FY(2-/MA
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M"YP$XJI*6>6'^C7IBZMW3!ZTE,KZRV]E-5S\;C6C\EG\@8=!+H"1-7IZ;W<
MJ(X&_VXW)1*O>E@6[/BL93CZZ07X:4[U?\J4<$&+%;]7U2:N?27P<!DP?-SK
MM[3A+4YT3&PY5-QTI^T13'0#**B]<$1J+QS^<31=Q20;M=#+2Z?Z"4!AVSNV
MN'AX8U6&=^2]HAWJZ SKN-5-U:"26K<7PQNB[]M1!Z7F]TI*Q19?H!&,0OP)
M*%J0+Z5:W?8$ C>I_CQ';Y"6BJ1@U:\?*9&7L,'. )3T2O?[@Z_(?;6T8FQ2
M\#+I$$^#E7?NYE">U]8K1O'5)27!7=<1%K]-D)3H7-)HWWE5DY T1UC# W-)
MBP,KYX0;1>;8FCBI$!!>KD\:UA#SW,JSY[5='=&:3!<G ;E%X+WQ)#%$\/[
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M<S/QK\Y>*7&\CF(@?O:61M.DVYSS:VPOZ,O'?QX!!Y>;0>NFC1&5N?"A[5Y
M>4/N#<2I;<2IMP4R;VFNWWU'[P0-B8GTL,Z>?[Y]3:0N D?@_#_%' @*AFVC
M$<HSN5-%ED&9RU[#G3JFV$*_MS_X/SG@C($2@6ART\LXKMF].R:OH1]KCI(-
MLP>W+/*Q8>HS1S:%JONS7*$(]ZC.1Q/? ]=_WC-0I /;13PWS.!7MC4K26#-
M]NZG3@Z.]90/[DY/!\G7P'P_44];XB,\+<3N[I"S2[X8XCTE9@V@I$!(*_Y8
M9?J@%QTEA9X+1-4K\_HG'X;U:%!1^0.K-5%UHXI/LU;%V3(X/83OYXXS0^\Y
M*4S^Z7KX1]L8WB@TO;>J@<;V'$D$:2 -"O+P"YFVR_XQ7-%P^"V!;@VUO?@N
MT/+BN"+S>D"R!*EPX]9XS;42A8@6VO']]C71<V@(\R<QSK$AN+/U #V'&3+>
M;%4J]6UNK+3D8M11#9C $H#RB&RFI7%@0E5Z_1S+95PQ.\AZBV0IV!T(5/*
M)URA$&:WJZ\\U;,C^C!ZB^1-]C&Z/1C2+>7 #=Z6&ENWV=G)<,/%$8!#_>AD
ME1G"0&'"L:11J,2/:B;C%+U+2.(*<[&O+!RBM>Q,\+(K9K-M8I]9]"MR2+ +
M C\K@62-L/E])!Y+*^&K4P3NO==QKF71GV$%2<8-LM98MJ<?D\O.\)_>+5D2
M'/P!ZG99R\$Y+0;^^#3QJ[; 4T0_N'H0\BJ%)SV:)LQ+$UX?OTVR7M8!,$Y6
MK1<SH),4[52W.U/!B3RNM\S4$:EYDV6I-!L^47TLP__:1PVZL$LR^.[.FK??
MSS1GA[=+VHHORA 0HBT4;2U4IUYGB5L)@&36N*PJK^TTX.55^HGLZ=7Z=+T,
MLII-NCW!5$,:AAF+\!,$6=A(W+N&A*>_EOZA)?GHDLZK;6<N=7M-=J%3D#PS
MV5R>[G2%8?IZFO=K>K084N!3V@@RF-8 .S7#Q/"> ,M$@VW- ]^&BMI'6->2
M:@F2X<0**CC64PZ[.G/)8H*Q:?NVY833_4%X5V'[6/OXX.]<VA$7%QC)W0WU
M,]^"WW3IB]->%/4[5=FCS("VA) R>!>R^'I,I*P8%$4.B#?\=GS[;!7 N<-&
M0%+:P;/-#LENJ)P$C?P8=QP-SKSN"C>7"G-KK,#MNAV3W'95=@6]5'[Z:$^,
M-+BJH0S>1U9P$A-+?!*TG-Q <%>TIOAZE%N.KZ(PO-QYM0?NV;0Y(WN99K#-
M6H7:?&(,@$1\1HY.29QMH73%C#%.0IAO S0@M/.%!$VJY^@@C/'GU=WN>>!^
M*HMITW/%DU1VIH@$*#LU)@1$/$2F8W 2HBJWG#PWHJ4ZC'*M\&IT=EM]3,[/
M9YO?J<_T<+RGTL:$"")Y@.Z7K,*LM%#L9WQB=TQ0=66^9?/C45,54?Q]JAR(
MS]TT[Z0$317>2IC2 _JYNQK:Q/J;BY/N<XQ#0@]?%];[+'_AE*NXUW[&]F4'
MB;O0-L]7&-F$T+_ >'DYYXL=$W<UU"GYS!&+Y-386W[Z*G*6$N 6F$VKS-9Q
MW*>L:A*/'T;\.]OHTP5UNOAGU91CD9&>8RHC _Q/NF;VHOL$]3AO/XVI;HGO
MX5FZY*^-N 74IP8'75$X+:QJHJK3;W=$:0@O?49X?RI"D^[[);</2F-$Y$\8
M;B"^\I!],;R81)]LD83?R($1TUF2W2Z 'B-5K$K2E]$!1\-GEIK@%I\NT9%=
M6J_O18)"_ .O^(#C&?JU6WC["+BZ^2DC[^<KH1*QG:;XS!13/6#+6?DC3 ,I
M[B]2L=:C#KN6^RC1_TEI36W@/ZJC.5]E\(D1ASUQP>;""L@:WW4WBS\AFR6!
M0T;B5GI$C=VVHQ(_Q0/^?[L:7;[:H<N=D(I>"G?/GA>1KP"T! 3TXUO#@2O]
MT9U;HE,1AD-ZH2:,@A,=U'P%VC&AH3_4Y^K<;3XN@/^__.U'A$:+*N'FG?)Z
M]!\V]RI'Q$9E^W]D>HVQQ[+4N&Y@.G@ O7FG;!_P)Z>_I_W_P56Z8X*P=.)3
MYK9M8O8P^G?3N.\6$K1P]U+7G)H80IZXN3ZI#([??26X=@PFUE$!_0$G4W&2
MP1'@$GLKGKGEG$7S%VD,D.!NHJZY:[V8].4<O K321[H8P@@Q(S^?!$V9FGB
M^].HK>Q9FD$+U3%]^KWOW-(.2IT%5UF]@U(0L.CI3)-+SF//= W:6=?E2Z:_
M2EHB!1D% "%/'EJ/V=@@DGO"Y%XW-''W.V*M\#F4"3;NE2I=:I%%O&"M=",V
M!-WVG'+:)M42Z*<OQ+.>QSJ9!F;Y:*):HQNE="->G";2U*F*Z"Z/Z!Q!70L(
M@'W0*_6DY\MX6'RZ.P[RA.'\*2S#?R9:8V_TJP*@M1=%"?(E.(TDA_!5%O"+
MX_O3M,*700HUDJ5N[BS&9^@Y+9;EXSV+:BSQ>J?ZJMC&-4K9S9,F&DR?P[4C
MO'"C[#@.M73D%L"QK&Y,55==L&9$@XCZXYW,,O+HB1P0Z1'WPJ%X30XHR.(6
MGD9AA4L3]#R9!K^=.C>3\]A\C7.@=XEQ#E+%1TV92S38EG&SV""E$;B 2WTV
M0OZ5:H_4#&(&XW[6,-O]&*\;E%B^H8V,$!M,.YN=;<88#C=H)<#.)GX2^;WB
M^]@3LRW>0^D:VG?R4IK#$3\M%;Y,@EE\LD/2(;6DF.@-7O>C1>'35VX22?[^
MP[Y_/%+IV)JC]3V@*>;UU%OX0H]0RO$-=S,.C1W:61FG?/V;82L2+.']N+B$
MR$ *G3D8)^FQY1V3QT;W413-MW.?I X $2Y?LW%N#R1]X'X2-95V;+^EI<&5
M-S[X.MM66OO#S)[=JOV .N;A[/GF]2+7> ,G$ ZIB;9S"-,"*Y7R%K(Z0"&K
MC5'$K=M&:_&_DEO3E_(G\'"<C45V8REZL2D-[&0DVX$+_E493P>F.WZ8T\8U
M::,#X+VH*,JI4:X$+".GL$X'?#D<A=[[:8F(/GCNFE -Z\7)08W]-T1\4VFC
M7[K$=[Q3-K,@-0"&H18/:_Z\F)][&HKI'&^R;\57$_='1_2\S6%>+IF)<:Z5
M1>7WIJC3-*F^!&[O44MS<$Z&_ZI_@GY%%@5["7B9AA%?L;*SR@MFAD1.=J_K
MU^9JBOC.+6/D8^-U!8"N9)Z2?,F<6;#$#%96K03AL\E?#D:,1S"M?W'E39?Q
M1K9>K)&'W5[Y4C4$293W;(<721E6.JXBY;?2HW#VE.>TE\^MRKR&'BN1%9Y;
M#?WWQC6I1VZE;_"5878_;>FTE<3\IH'46Y?C]]AA6W=,YEP\0-"I#T4/[AIB
MN\9%:(?(:%C,C'1^',:*O7X=(W?\.91_JP#NG&+X>.-)_Z]$"E._EH/3V:E3
MNY6(R7=&1UU8'/BO+$9YLM)6]V'13%J>S^^*Y'7E%%)FVI;\3A)LW;BSVN;J
MJM+#';?IMOZB@#1O.3/D[R*L%U.-Q4,'(R-/9%/(9]=KW_T<$A$!_WZV$TDD
M*V;K:=#H[%+(*3>WDI48'3.\GLXWYS-LR/"-U0_F0VX9^9T2< 4Q936I& O$
M:=F\E.NH1$@6XY.W[&,(;M&.BSB P>"VB4.$7HQ8RXE;EVCFQ9 <KJG_O)A4
MO#0P"TQ=Z$RVGM,04RT-#IP]-/D@*.J&*&45Q@IL>T+(JXR)]!Q@]J+0RRWE
M=PC#1NEBF6H-"JZ$C"ZJG(0:$CSG::7O946TX6U6KE!W9'VHR&C2W/C GOAV
M$+8_JPV8S:OJ&CR^/1'\U^T57@BXG)DEZ=WJ 4+OM03V)3VU6@X_:HY--H+7
M8R?OQ4W9JZWHC$F&UN%N3C'%>\>$%?=@$S/\6O<O?5F_1]87-0DS_VKUT^WM
M)XW@P/VE.1$:^4A8XL.1L#KO)WH[UY:[+7Y$3_4PSL)#&9>_LF\P24/Z8\MG
ME&7#BC'OM1%H2 KD"[\7(JO,OGJ"2_B!+3(LY*JL-5H$=GE4JOQ8&)K/)8?;
M$&DA,&Z=W)\'+?#[JCCX(>H4^ACR\DSK4?>&(6)QG%Z+0H9W;A_7>BPA/;H3
M TGW(UZ$&$9W3/;,OC <Y" CR91%?'"P49D4T28-3MA!9WW7H'L,\N[VT*=:
M>GZ-4!WMCF0XH&/U)[;W-MR*?O7=Y^-(FSGQ!\%^D[5 40OMN83KQ> YA/ON
MICV% 1@"N C<EUJ%VE:C#P2E+98Q^F/=,U^JL1L%_F (7<<*@>"*S&O&&'P2
M7L/KS.#$A@"IT1U2GF+NJ0@1YYLA%K>K:;K#Q>; ?74NZ-Q>BY*J.J<1%EQB
M#!+DV(>ZPZ^$&X+#P?CMJ'Z&2/*<)BKH5:*9X90I!1<UZSTDI*WE^SHW.<8&
M/DU6M1@^6G";M)PI=&K>M+Y!#H[\Z/)2-=J /,A>0-Z8/IZCHT6MH-\TKW6@
MIK<ZG5BK#E#D9X-)V\//V^2:NU'#1H)\[L_4^H\J=(SDJ*W4V=6IEAV3?]?<
M)X+M6M:>@+=M#'/;CS,-G^;IJ 73>WXB,B 'S;3=!"]\=H=PR-$H<?*A\SLF
M,+LIIY6]572&N(PM.JM,?H] W7O)OC[Q099N-+XF+1L-(<@CO(P#]%/A!O((
MH9[R6U!(52<,(S$ *$8\_^4!K$=?H3.CRQ&7=DR^ISS[6&2<#2#>$$7.WZ=%
M\ZAO-PAO"BP<%W"[=VM>?:OKV3AN1QO<,;&<^9,]:';H'</EC1;J5K)<.2B-
MPC"5)R)SPK(5]D_&Z>*/3:.F+VV82G+^E'TOIOK)TZR; >E&X6D*BZH[LUJ5
MSW;_KIO?1HZH+^UGD2PFV"1(H3<<SRUR;WBRUE-?^>GZ)F8D&TU]N#$+:T!2
MTI=Y#I--^@K*KW('BR .Y9NLA!1Q8@R'8:3_T=%M/Q&IV&TMJ)L[J[%P09+Z
M!NI4<]M[!4>W]G2WUS=Q7;6/^C4)Q2@0'_SVX4SH2VYE=JJ>]!!,K_QPXI>[
M&R>_2Q>8 E]OOF,T!.\)I>%?%4="EH"Y#&Q=K_*ZZRTCZ@XTT/AMV5,-::D9
M\;#LY=7LZQZQ>Y=I#CF&(STPIC*BZEU&OM"X$/N78(D:TOO-HP?1GSD$QV\&
MO<5AJ@;0L1S&LL4V$*#LYB@J,W=,_D+Y<M.3E7Z[E#+)BH5+Z5M_M7@(;.<Q
MGK4OZ?F$87#GW?P'6!?G.E^O2/4-TZ6G-J$=0"O4^9B 5N2MK:\F=DRLRCO1
M(LZH*QQNS>>0VR#%K5"<.V'X-J^J>32-;#,I+$8_7\C->' V9 ,S 0E[1KPP
M4"AM&C>S?V*$B?I^N+-0K.5!ADIW3+Z48VM3=#V+M+2F<]!4#/::-21Z_&1>
M]> 5@I3U11Y8$JZENA+>8_,NAB;.ZGIF#5'7QS_;PA"OE@A8:8[N^9P6)WL1
M;3^-[',R([\!%4NZ6N5N-(<2<7/+L>J5"$>:!2)MWBP274 RH@]&WU<5=&E2
M2U*GJK;([.C*;FKRB2COS1:E[\6G]3.O.,E:JF=&&HU+5DQG67L'\2!=Z53*
M5EK4A211LR;B&[<QF;MMVWQ4@2#X6V? 10]WS!W\X$>0@&FMIWH.ROM@<B_+
M]C-B^@]".JQKQZ2C8Z25U<... Q<U$UD/6/]4T.ZX/NG*?;QJ2'GF)C\-8?E
MK%(U(.@M ICSEBB]O6[IQGWE51OL(N[_O"- ]=B%)HXJ37A"66J6]&A])2!>
MR*A%)5SIQ(I4-$'KGD\XV@9GG #F*W9,A*Y_+ [TR;*;-R1)U14/@A (G44V
MJ>I*D$.A(&Y3V&6/KT!]O"1N_;43UKQ*RXMM8WCYSQ/HFO#VEBOK57][@HAO
M.;UV:!1")"EG?RJ7/EK7@4[N%GN C#%V&ZRQ#CSI183^&ZSU(LNZ:9."KO)%
M&5P-@7<A"'9.K/7K7W.-2A<0W-_$<HE"$B<NQ??KUVJ173%^JA$%#<GY(IU6
M)M6%(6![^@;E55U/$VHO3L_SXZLLK/]%M7<[EYY.WX;4SP"9"OV:9:5.6BAT
M4I-J(N(4KAAWIW[3@IICH@SV\3+[,MM:*2_"<JD#*57,+-D&.'?SNP::?E*'
ME[E(5]%=SD9)K27E/V$ SJS"SKR$:?+7K"*4WNCE!KGUH6U$D:W1FA@%5=,4
M[%3 F?EQ RLL/-5=]Q'7"<L<:PDK^3?<<BE-,PBY4]H/H^>P?ER4E04QLEN7
M]O!H.:S &]K6D.T/IXVAP"SLNQ%:Z0886R80)4F%#LZ!!4H:98):X<\D\-V:
M3NU=<[;ZCFB%=M:O9;66Q2")O-"95@M'?[6'(Z0NQC7'CHJ*>IP9S/_[K#I_
M67V=S.!K.2>ST=L??6< PZ(T37@C1LU2NKE-VS4O7("E.ELX,<LAR"Z_SK=<
M>B3JX\4UGU0W<@0F8SHX-$7Z^SKBF]YPC=L ,-.W\9&1@\2U,T."!#)=W)9;
M*BEO)[@#QYI.,6/2D@RFWY1/ED-TY/5  /W,",>H5= =9(:6W<*^XME8C0BU
M'6\&]..! ]>[F/ [)%U0:'Y%FE4X'/N<#<RYVX!*;+*M_B*>-95PAC.4(LR4
MM-3-ZIC9B7 L*>A.AR.? 0AH6G)-[^L,#WFB<757H9.N0H/$Q14@]P!+8[B4
M.''?6Y7FZ B J_6RHB>(FV[GYU^!L;@?>7!J"U,[[I[/+5F#RY%&D">$] Y.
M^KI.X/[>3,\)!1R8<F1Q?H;-K'E-" $14. R7QF.G%<'-$TVR9\HP@'7U;10
M^3?:4_@P-VVKQ+A^'?/@6Z41<&8P=EBAKVW$FTLGA=F_#VHJC88(_Q$S'MO,
M"9W,;VVM>);*5U;!'0(2;HAF049D>+^:2 MB# <M#@KCPW[ET<HF.(#3W \V
MTKAAT!/9$ON=S+-Z8K==_6#4Z'XDKXH4YSSZ->^*)R5@;W?'&L!^-C- !_BD
MV3'9V^ *<QJ=<LC>+1E.WS&QK=#L[88II+ )CG:/\7:SGQ%N7ZC-L@G;OZ)E
MUP8CBBTM-H@,E=SP%)/Y<'60?LV;40X$-]<6&O7661U[Q^1>_93N)YO=SE'_
M+5D>0OGSKJA$X),$T:\;;]:^4>Z8_(392]$'JXQ(?*ZO K5GS:*_!Q2U>[09
M^=GIW7IL>X8\IXXGKL;TP*D!"CVWP.P\-[A:U3&=W'?"&TX/ZBF-+\^,6/1=
M7_*;DM_MR.L]%G \$]9R2Z3]H2(N_/?H8_U@Y[;%T=51XQ[-**/9'LRR"BUY
M3U;[Z1Q"7-(>PC?9: <VBR8/FX$5>I'5I&NIL4&U%QJV]GV!2N+2X3=9ZA8S
M9@';N"D*YW\L^WJQNF7"<Z8W T>_"PF0[(<61)7K8\98:DCU4)'U/'@@8H6:
M5Y3/">G[Y5O<G\WCWP0R68P_+Y<9MD*WPQ_!N!>(%ZPPDXD&VV:E@_D(&Y+7
M?7*:4BU!'S@S,,IM3(17A!/,A7W"C&IS@I;%5$-2V=#(WT:7<\LNW2%D9AVY
MY=3MQ@QS+QV%GJ9LA56AYGM6^BROK?^0^!7UL</0H7%3'2_NOO DDL+\,<"<
MUYBD)4590$I6IO15+9EG^7LNY#VKWNO(R_(%KY R?+%:< XK<L:@3!+2PY-*
M$Q+]-%7$F*7F$O!JXJ-EZ /E44A?*U9;PNUMDH<OZKYB_0!WZ&;/TG/KHK*C
M@F^V/)8S[@JSR7ZFT2.M9"4H168FHRRUU#_H@2^3B7Z:7PC#-T=5#RLMF,J0
MT?1N(%X^:]DIRLT7KC0%= #"(><4U/BR!H^\H>Q/J/?FOC#&<*C?Z24W,8PM
M69K;,;'A0[*J,3*:@S=LOPK+P9JN>=R=AR(Y9E=GW?G$#J(&CRXD1X]U;^J$
MN=TJE+S/+_AN^RF\^ROVHB6XKU@9ZK!:)9+1Q@,^"]5_PIQSOE!+-5/EE#3&
M#D9)M>R%5;3+'8(SNWVC+#R!C*AKS_/CGRGY7ATM#T,;+=$?9C3^F8!TTS&B
M$$5(P]P6;LR5%E./>O $IP[T(>"KW9+F^-W3#6 L.5+:57YSQ^1H4%:*U%JN
M28Z::.ARD:S&?0_=?\E<!1X(*G,K<S,<;T+LF*2 G0R(V;I2FH[CR5<?=V7G
M<WI22:H+[D!!BY/#W(H/6L8!]:0ZG8B6L4OY+@%4!H?CBR\ZV=N5[QOC2[MW
MDQIL7BX>P:=:%0)=[D"5('QVF4NL6=;1H @7,[?M9!]04X#VI3)LWJ(?D[O;
M]%/LCJ5<"2FGCF%N#)5Y?%7BEMM^BE$)E]BP?M2W>(<9/@8I1Q5-_";'1/-X
MX*T&6>T3K-+/6@7&MEUJ=IHH5J>V\[W^3$#W=:WGG9=XX&3ASYBX^ "9+.!N
MZVL*3NGPO4TUG!HJ:<Q_+NI/ /=&>+\>C,N>>RJC^9VZ4IQW'ZN][X$N_%WC
MVDN3:>H;:,(L&Z--1Y/N]&NBY7X1:ZEV9Q<BG0ZO)"[Q(,/]W\F2^(HY9/:Z
M!)9(FK$=3:,BE]K5<8V>W=A?+ITLE?&4#BFC[I_,Y\!5G?'L[E-%.I!7C8)'
MD'%^(/2)_ZE*S^G!*A 9SA0!I'V5'MV5APHGJDOU-3X)!ML:K^_K-'%M->\L
M'>YW4L-**WB0:4-;[(MZK<>XT0?M_]&!^UWOH#16ZH2H@K)S/JTN<4[5O$](
M1--#$8]MEIH"S&QUU(8+43&-N8"D&S0^W)JM::X<3#+H_:#I8ATK"',']P7G
MN\*@L1<7K[PKX3?2RL6QTT:K"#Q)@/3OF-QL+/$M<2MF%#:TS^HJ@8MD2\?4
MV#NGKCR&5)[Z6)7FRU>&ICF8KO%#TSA\.B#C_/#0$Y8ZO*XL> 5,!UWK,ASY
MFMW?ZP[T1;\I0U.M4#8T_)^?*D86-MXL_A5KL%4)GPR:]6^BFG=,4H,>W^:5
MZ[DZS#9PRPZT[2*"YD=?J7S.L^UGN&_.KQ_?$&J#M_-4;S9/NCE8P=JBA_ZP
MI,,T),W#$<I!.Q#<]3\O]%.]S.]*AY=19!OY*-R%Z1F0KNZ>/]06H":QO2_H
MSG)07T$R+B$';U)T2@VV'QW!]F2QQ&,,$&5E:>39^Z#9YM:I9Y.6MIFWJSJ_
MH^ZS,W]/X^BO*/6/S0Q_B_1.J&I8^?X+%WAI-X4)!H!H#@?WUJ7YY#$?T()8
M<0W:[PRLB[AA^#\<5,_3QFM?#$*8!FD.X6_HG_%:LH7A</!A $/EQ9BR]4#R
MH%7Z!B \Z,AR#<;]?O]?;!;;+&.+"_7PE\'[7+Q/#[]H\#\_&UTC 9<3LX=$
M'Q[Z<"H9FS\>Y#D*+[V6]ILM/[9,H 9W+B'0:A;2R]0^P_,)C^N[M$CZQ,:9
M2JA9+7&=7BP1/).^3<3]5JIKM=/;++>9OTSX[>Q/MTG^=?AO1Z>.@(3+)8)?
M6C'FDD1-5".-!B-(?^QP8'MDZX7T@"9-Z7B?K^;88,G%D;=[\=BJ+9B4$RWG
MQ/ZPC'K%LF IE-<&0#T]25=*5OBP#:&>VSR<F5'YGI0LM-@,'#\6O(<D>PN-
M*#*\/HY'>4"%[CHJ8 .]&4@[\(:3^ &R*>>>%L%'R7F&/BHR[9)1Q:;=?$I'
M-<TD82,3S4,MI3 _+K<3-7-6ZT_I4=FPM)<&] 09<JK8]"!KQ\1I_[5=D(YQ
MTKF>_)GQ=A$*5.7U[)@4+2[OF'S:CC(&[E^J%UL972>O"I4;C$\'D(.GSZ7O
ML3/"JU>N<[!]"^K=6_1/@!1=3L8$PW'M Y"7(6)NES;NF/3&N&\</(@3!6(-
MISASAJ5Y,Y1UZHZ)[/J&IN=>W(NF<^A$Z)*20*5:0"&OM/^J-XZN6653+MT'
M*)KBC^Z8Q(8/_J[O2V.(#GD>U4L>H#^8:CQN].B7@!\YT#4&K\2Z1U_F^7F$
MX2[%< ]L-Q3&3N\QCLI#ATFVFS_XZ .X<K-AX%GIZ.D.Z1('&EP\F$A""\*U
MG/WHY[N'650UT\S&IG]?:UHL_>KB0YS$D5OED=5#51XK)8NJW!+ 5<7 .V@Z
MO/<&NR/BVI\;[((]Y<%L!\KSI !R=&Z\EJ.>VLC3^D8:7H,_7]T$/S8'L!T'
M_>_II=3-A-G\N@S*)D?^EVTCU"QC'C^?:[5*D3OP5K\AK9Y_^>"VS@<;_%EA
MM,ZF!1M?8]Y ^(_:;YI@X?VW->$>7>1M2MIXO4S/)@C:' 4_N\U%?0I\ Y3&
M+@.YY2]O;Z.'6VFF;?Q>H*#5@GM$]<_Y05,_/04RW8USUC1;PI8B-!4K-@\N
M4+X0V9SXOB__!.>WA$_YR9_)9W484]JM\)'=9.HT@::N//ZE,;HRLKL_K%/H
MVEZ@O$HW4B2[R^9Y'/@RF!X[6M#F.4".2V]8,[\FY(\)-TW53D;1]L:[?>O*
M5@(ML80+K-9-X<24IHEF-N5Z2(-Y4IX&=K$BZ7E0;,WCS8,OU!?%"D@T\+4]
M[PY%S]5<,GS>HKUBU(L!HOV$OR\LP6?GITG\'1,HA;?_LAZG.YZ^''LL$1/2
M7Q1_"RZBL Y^=;=J?;3FF_(?V=7U_;]V)C'H_0<V)6U[+;B5OW2^P\1[C-A[
M6ZS=B96H742TE%O3Z$5BI_^6KBBJS'?4&( /'*_*'3T]@+ZBO=QG<7"3*3BW
ME%;RRLU@"W5F64QP[-7[TBVP# 2D@B!;33!8MXIR2'X1G?TY^ZRR-(=04>UP
M2P1ZMVM>TO2X,1*81R-9.KN8CUZR N=&]J/5GGCKT5C2]9CH<9NEV!>_QC@,
M\?"RF9BU8JA!>FCFW.F6D?4?:#BC/-Y@IP4OPZOJM0D9_G5&0!+$]C\-O+'
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M>>1?A8=@2._Q)GY ^I(S-1[]9Y"W8PQJ8L?D"ZGPQ=;X3^H#8D0IDJJ9U5Y
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M,>78A1OZ[>#U@\!OT6:P[]\--CWAR;^A#66!A1$-PGYV!V4)K[*32<Q8>PR
MJWP_?WIQ15_F/Y0(L8J+O#:*RS7%_U-4^"+6F1N0 ]4M)GF>=&DJO*E_<[M
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M-7*?#,TOO726B(_(4X%2%.#<,HL/B=.3;2P4<40"Q@>V283M4+5[BN4U>7&
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M$WN5WQ)^>BUW% U):$_<0>L+%W04S^/I&>CS8Y'4OL\93Z9D-RX5& !?UZG
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M806N?ZM)F:Q+N/?<'W(NH;/  LO_M[D7:9^??A>9MF8 +)U1.&TWHMCI2P9
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M+\KIS&+"OAAA4&2$[F]UCO!.R'BX^Z I#X';<;[A[2RN!9H\0@JJ9D^4G3$
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M0KTFK(EQFY3Q2\B9'"99ISMR+H.:T@%]XWU5VX:D.R>[='=EZV1,GW=3J0;
M_*=ZI&1FZ=D*'5X_81,BU2U( E2V%77K*MO5T39U&^,K6=@;W $W ^"E8HJA
M,P!<&&&QFF_1&735Y?4*P7AH*?(3"Y20ABIIQ2' =^,C5+<P\Z =M3SJYM8T
MD6<L#P9Z"*[_D!(:9168X'BO*=_()>SZ=LRM@3K*KO2PBW0#(.KJ:Z%T C=-
M$&X8%>@ K4LQ\?F,FA7OV$_HS? <6;?RQ?!2A^@X14^7?D+UFAB1)BTIFM,3
M=E1H=+_H1UQ8G%T&0&8'Z;YYKZJW'X9"$>$2FB7CR/IR0Z9-_CMVT??O/[>,
M&3,@^!/8'(9"4K4N*,7[XD55^66Q3?^T7$KS4 4LQ*MP"]V>5PV B<'K/1GZ
MCQS,3DV\"NRGXNB(C>F)L5UE G[:?5WJ%/Y^W3.UY.2FY[[:^J7@FF51X];E
MT@T'TZOIH$MTV*?<$SM9_#K>F1Z8.GH#QX3!)/6Z4LLM+81H<$C4VUK-?+>?
MXK]3++KGOU6)4ZC/=.@B>LO[S?4M]TN$(0: #UW#6_[0#_KWZ:3])Z-:,DH4
M#G3_C$<"Z+N<"_EK$ZN]@V.5A]F-][Y.V3Y@_E3+*RD<6I#V;UJ7W5NKFZ5O
M#V\80\7Q+MTF_](;3)I7^N^SUCAR0V>I_HB;FLU_%;ERHY@EQ$.]R'?"G^H4
MN"'+U3,I6_?UR/CD-J=CKOW0<7P\0:[E^BI+W;ZN)7=NRYR^",GKZO>J\=7C
MMZ,[:D:2K"/"@\7U505:NE>4(/:&9GFHOX+C<&6H+169SE1>@YTM:)@:GN$$
M1_"H73#P8&B\T)H$XC]U8F)NE6B*7(O%F$DU6?F'-CIC;63 '"EZG+<_[SJS
MS:T[WN:)XM2=> U]%=P2L*H$]N%W86@0/BH6.+*')*!MN=]RS2;\C_J<X0/U
MU?4]EJ:'($?O?EA2%'OB-:'Z-_^>AE><Z4(<\BH,Z%8B^K'[]'V7]JE@MH0;
M.QK_9BK10]1P_;XI\)Q9L]_VB&QW8LJ[=I?1!.S/:,>E?:SWH=J]N>O@?=N*
M?XH-/?'34 2P>L3T],Y!NV?*>8:'7R_N.^WV^%T@K57;*=8L=(DP!_ICDXUR
MZ (;Q_<9702%Y8%YC22?]=Y_LCR2+ZO8/R=W4?QD'N<\[?"]@[L"C'3^PD,+
M7+</*#P5<>K4[H/:ZD#$/&N&J?]64H<^2F_G?LI= HU_-W^\I.?SJ!:[+M$M
M@+3;.B6@@;^$$>JTHS[7\PP #T^XSN1>5]#P6K+OA/C>E?72\[ '=ZHZ8F>U
MWZS[W-F$?1WIT?.DE@./1G84I$[ZE(KWQ*%*6' 6G/0.^)+5ZG/7$?7C18FL
M-+SX2A1=O7M]Y3WPON?7JOGE@9"FPIF7)\)_+YB2.>#.KMW;]WM+)XQ97-,)
MK(@/WQ'Y]>/NQ<^/,1-VPC01G&;S42%3DX>S+!#VB="H\[]IG%:OL=;#9B16
M'Y;&$R&Q&5::7RD.IT6,4CW7/]J-8!$2UNR.Z_)Z"AM"LI@_%D@+B&GL@';U
MM7"BN,ZJ/>N^\@PS'#[PJ"5AF*/LMM\73&_<)OS7J#>G:\D-61L)SSO8W*R;
M*2T[=2KVIKH*U67W(->VC#D.I\>OZJ2(<M,3P:*8$GEBU(0FKQG 2DOQ.]3)
MX\D"2G5V3QDSC;O3V!OHB6#1I/=-=4AB]D)+Q#$E(S0].B*WEJ^$<Y126?%.
MA@^#&M95M)H%!1-3XMFVN\\FXX^:BCH'OIRU._^&6U64*%.97NS4B5[:HYGD
M -"@.DSZ>:(8^,>?">8CHE"^;CDZ0CVJ'N+&()%#FT'S<PUZ+W&+B/4R'BB]
M]VY&J"3VQ-5A,QR-8@DI6'S@MA[J"S(_8=HVRM9JB,F# T&B5T[>PJR4L"(E
M#J0DGY%5S/6$\B&)1]Z26] -7+S]+=%?(GL?2*QQ%3H: *#DB3S;4O/NBUT%
ME^^Q8\F\"+;:AQU\J>8Q\_O'3\WDS@7--/8Y>1JZ@5?_3)87[CH>(TSD$I<?
M+*,AV7O?H0?=0'QHA<"YO0CA^E/^ M!16$SN-EZNJPA5DI]X=V*>E_BK ,E
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M^1M]:GW?)[5IP0I!5P^.8YE@)X0FJ /4!0Q$\,W59ZR!MO8\4)\P3=S(>F$
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M 9%U<UJ94")WS\QR"6Z?(-VI%Q5/N;X6A(BR?FM)LNMGDLO[QF?1E##TJZ(
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M0K0L['UHTT!!\ \H6/H=HHKBN!&I$;I<OH38H5M^DD)Q4U+8]0_</S^JA&Y
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M1+O+69<O,-O!E(6UH?W6H[W6MU^($@Y<.F ,WT14R\>F+Z\'-[;,?\@V!^=
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M9-L_YJ2E+X=_E#PO##Q.6]V3H0GE8$Y*;&0A>A5V7&U!.(PP)4L1;\[:9\Q
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MNE0BKZ;V9MVAR3IJK 7R6#I0N9_KAMQ3FDYGT/M0MR?LE3<F"I*4Q%AE73:
ML?@B0X&NF ZH.A;YO/4)AUFK6@:1H JZAL+!-[6(&R,J@GIR)5PZ[@-<V5Z%
M^F72P.=1D>=6G6@EW%_#8<XC;23WPS:UQ)WP:IDY/@6G:QO(T@"OB99AV?'!
M+ VG,L.QUG3K!VXI"U6G-[7BBR*JS\SGKKN!5K>;*T./YV$>3%">J:KLL.:]
M!JE\IJ*,4(RYDE4K^M?B/%,,:49/%E4\F\W:*OI8!,\;H^3N'VHHGB7!%7<
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M- 4OE6&$U%!9CHUU,<(&G\[);8HKDI;QW\3ZHY;\QC^H!V$=Y'F\O7!6Q9
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M)%+T$7>;;\S&T<(E.D\::@):K_JQ*PH??A"-OQE?XGR2WYZA@%T-20&)4AT
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M[ZF4M2-&5 Q\1'Q*!=NJY^D0_%0S;VF-B"K0O94!ZS[M,5,O_.;L1+:I>E!
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ML'=O*Y9;0ZZ%)BZ+5B)T3I4?&V^?,-PC!KM.5'+8U1"# D4@+KX2\LK_Q_B
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M $'L7SJNCS1*1!'UD8W]K\A2WZ'T?2-&)G^'WLP&/?=-,(U_G^4W[2YYDCY
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M0OVO*04/QD>L1/K6HDRQW9 OJ,8,](6;GE&(@;JS/FH)?*_@;E"1" ENU[C
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MWD1M3& -;B7'G14ZY8:O_JPB\[R0<$CJ#74P?U450V17_]R2F&!"TH,+_IG
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M\?;_]J,F/_5V=CL ATC2D5W /F<_,^K:GD\3KBU?XZ8:@!+G\=6-N'C)!;J
MA"2](QD4<(78+W"U(XZ(D(F#*7^JB$#J]^N3*HI\HZ8]LRK3%B&%$WEKG]<G
MIP3]\7 Y*,7#0?-U&RNG.-;CG_<-]OC&2*/D5%N#P.*HE7\B']YY@#5Q/8\Z
M%S.-7 Z([.U +TC@;4XH7J-'07*R@\XDM!UG:,H@=S#;1<BFLO.Z@UFM9><H
M]VZ:*<D$,5T?K#NUQAR2U%!I!PW[6%X*W_=";'ZDHP/+TO)E4-Y/Y&F=$*:
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M/TE-1.0>1@7V!100-KO4NW='AT6LX0^E]["^5YBNXLW'9WMP!/?Y!H& N?2
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M" H#LU S@V*[7+Z6\E$?M(IZ%?&OXF==$3-US^:K-ZPG<<&./;2=RIOU<+.
MRW.>F)=*DAC-]]9: ;8&[/&R6O1;&\RR>#=E88,K;$YVNC<6AW@J =<FX'Y
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MN+5 2[9^;_0;'GDA_U9SM$E^G!^2:Z<!Q+2S$(?0)%]341@ZI3TEV7PU17?
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M'%5=:B[Z]5KP>;7L>2U?S8AJ&3QKD/X\:)[;1*>_MTL]7$U^:)?;8"X(W-(
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MVBSE>\I'TI9^I5C_,AQ/!^:41*[;C_KN!JXRSN6J (P:_1!T_R#ZDI8\990
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MFCBO#:B%[@;N4?ZGO*,W8[%EM=!12C?$#YB 3\]=1UJL8>9= ]/_J[1)?+3
M6G(NGW7%BACDF>6D8KN8A?,Q;@VC;A:=KM&3?]?-*G04?X/.)\)%FI++J0MN
M!X>024G5UW/SE7XF"*6.?$3@]-S</FGQ>P)<G+55KRM1PEH%\,7'#8(8'Q)Y
MTC!KY4\$M)  ^EZRAQR!KYXU^[PDW9@<B&Z9/]-&QUE'P-@Q^;K8%V>K8Z?.
M'?VX@YW&SQ=:S"6F=S\5>8^K "FAP*W^P(H>MV?YX!^M>98I5Q' ?HX12PH'
M]P399^N9:9C1B>5MFP\@)B*L6<=SJDED:0]$4C)W0QAUK/R[E/TI.M '[PB<
M4$5UD:A0[)!Q(?7-VZD"I?&T!#Z?H0(\*[%Z/_Y@(<*T_I1G;A]_R@2IU]N0
MJD%H;'(VX$J]*0,2Z$*'D>B"Y'Q*G>2)T\&&5.2JSZJ,"5^59-B\@%Z9H*^[
M7<-ZG/V'[.5"N^$4[ZE&^=/3RF[,OT_SE<\$_?46D0&86FF-$-Y=8CQA'U?K
M6@<[=$-LF]G1I;;>\4 ]<+@&?&GUN9EUIK?KMDFC^=#V8DN1G8XP>JJH2QK<
M.2YJR82-> \_'_]%Q!/#9Q\_/:#7.11YIPCA="+;O_A)>W99]E!PYC/%NI6L
M%H6'.G,-$%J<WL"]BM:R@B,0Q;K_$SEM)'^E;-M[;BD:<]BK?$:C5R0C8)LG
M1Z>-X94E8=,"T@HL?U@&&:"[<9]:=Y'X$T32=RJ M9?KRU>.=]!E1)G.0BDR
M%])Q1="<8Z'@O(W0.CW;W- O2OE3N>%%*UZ'&'].!F].R7Z%X9J W2ZI?B.Q
M65N>VQDH@CB,^Z_Y3+#HE03\+I'4A0Z<K(O29IC?RU#ZR@G2@EH_Q5LWT<6I
M,2K?#<L\B'RD;YAS;;(>O BML6!68K9(-.A97(@0>SKB$;0CO4?!F19MS[J_
MU#_4KF#*C_]E9MC4ECVW$.]\ -'C8+U?[,:$SAM>#/P",N1/I#07G!2N&M!K
M5G53KW*UMC2@+B^7*I?X-"TW_'SB]*8]GU!\MFAT'<CU*!0.,H4(!+-&FZN^
MDXMVZE6 >S$ICBG83DQ&Q.*()BO\XN3,R7!R)8I=I)3B\S#A^$<D\'YYG"@V
MK7!XC<SB8#H">XA5IS*7$WXDSI@RHZ<2%@/O32U!NMJ?[+C6U55O_D'>WV+W
M6XWBWC.Q_L:.PX5%@Z>EF[ MHGV8*%#Q%J\"A&&>?&+Y7W*&)YWL_NS/\<*W
MJ !PZ*-D;>Y9_EQ?C[Y&. _/Y<J9:8^:U(55SA+L?<'0)]C@++B%<QU4D:6B
MV1P<]BHR5K:!E>2Q;'D)<K9I4@$%"F5T6?V#.00,DV;-Y"_^/<]/5->M;Y4'
M%/G*GQ-+5W,NM_@D!*,97U(U14=:U0 VD0U/TFZHQ3\#\CV'DD?\4S#[G#5%
M:'8^!V]%!\^_!6I9'W@,KS* 6FXMME441AT\:2]X?A;?/7SA7/W+5MWHL#>2
M)M%5RN@2\KW3J6YJI\E('/;W.8NQ%=J:I;&3\"S3MT$YIP]J:CF$]%9#%[T*
MC!S1AKE74J"SI+E.2+RVQ?!9)W&U^4KT9.>\L4M>3OB7D32,MEG=%SORJ<7O
MO/)O*R:EZ%"L@J&VX4OB+K#$&V2?]>#XNR89<X-A;R*(^4=YH4D6LEJLJ '.
M=JKU[-*2VV-3>0B?@*];RG;!BN'8C9_R#!CC6(,4/&CUU[L>,RDV/ 3UHS2'
M9JO%P^3'>1:"9XF3-8=A^@'9_C>R3;JV%8S'<R&%-H%U067WEA\ZNK]HU"OO
M4JR7W*!SH(4U 3<$U=4*1K;=D9M;,GH=+$KR5XI;W,?'VXXR1[JL.2NOP-<7
M[5>XPB(/J0!=MV<#4.T&<OB9-=ZQB<HO4=?N]%:S32+]\C<IH=SFJQ7D^,T:
M<94!179Z&=/A,80X6N$91V\LPVU08"6NVT[;]=ZEV5:R$3="2_#I'EFN1=7#
ME4S\M)OID81(J9J&I D>R+(;:E).+E[&-EBJ 2YLJ'Q:4>;A?A_\P(<931ID
M)S_.*I662JD==Q1YUM(I2;6;7:Q$!9BK&&<!S0I_R(GKW IAT']*R><@"V#.
M];;^O)N/;7)H2%&U_:<4.]23G>_<;]!)J/8:AM)P3Y/D0%DCD=L?I)N(U:".
MB!,@>+E/2S;P=QTS=@LMR#&* /9H-\\L-T$$_^/MQO[(YGJ6A'AY*Y94@(Y;
M0A.SW\Y]?Y8.Q73H*CZO_+OG4BK$]PP;,K@':U&\.J&/',L9%%<,[BG/SG]8
M+4O330/]=B[RR$_C20EYM';>S1I7H<.Z[E/PXMV[*D#@E)KPWY7_;2#B*;_7
M7B#PP9NC>/;;A3("6P5X,;6:P*4NB@1.?;2BO >-3:;H N4_QYH53PC]VG@1
M1DF#9@.;;6H9V!Z7/I8*8.I'U:6!4PH7C6\HF&EKVPO_N5\NEGD9)@PIUGMD
M3C(O(X;:%U1P0*^8V-M] H])*9$TY/,T:ENQGL!@5+S45)>0^5S;(2/NS_?:
MJ8\I?!7@C[?H3\GI_Z@ Z<FI0Z^S?\X9+1JC@JCS.0E!85SS>X3==MEMU#Y^
M?N_( 3^FI!29 V2I56-3%/NFX#(=XI3_I+&Z'D53 ;YM43194S,+L=/(4GA&
MTBD&DP);I,[CYS3'8S6U?=C^3B<LG9.+_C!OFZ)3FY";I'GD'[L!F?,CILB$
M2+<B28V0K=R?J0)\+P?KF"X+#OTRJF240!0[OISM<G^+E3=;;SR:J^>,/N.[
M))P)\#V[0T?8AH70 ?#\ 6@>R%"1@SZ;V![42AZ3V\;%P,9(PU706FJ3%[<N
M?Y-T-RI5!="/FC8!R]KAR\P1R=D)C(8*$.XF<8HEDE2 /Q/BV07P$WBM)^7>
MC5U]KSSO3Q1G\4G/0;J2T@54D?W5BO[?6* XI@]_ VP^AY\R9[#GC=(QX2/_
MO=K-#LM\)SO;ZGV=*;>6L&IF;7(7#\B0"_]OPXGUZ-<?@G]CU2[&WZD:.5R.
M]5/,2&O4(?!<GSU/?5K+4OH_*8!_#*:?EWM5:3\M<N.#JG1(N]VPG=1,SN%\
MRXJAM$HRMB NP[IIZO1U63OC3=M[F?V#-7I5G,F[EBE#=>B;7.K+=C[D)M%(
M'<MQR<*-H(=(M$\CV8MN341.S=$&12/+"[UC]T>7;FKIEB>8H35330;'59</
M?9H*W[YF;LH<]&:*(QBIJ_E1K4JNS;9L&+LLHVN0D48#.Z#A .PKC^>0*G6]
M7/N!)HYQ.;78I1SW='=D$O'\44[O:*3R(FV)T'9$SR>+5&QP-+"Y!(X:J+ES
M8P3(*A?JTJ01$Y+:K.;PM:'HZUAQ"E%.UXVH,3!!PN**NYQM)F7-4RT^R["2
M"(<?.'?^UE*4(&K9ID:,0\['CQ.?^=H&^C:IW3YO?ZU)6\5,YQS?\V6Y22,\
M\_(#Y0UE7'9U$G8E\NT%I7>H4B>#BR-+*=Q?@[?:]7[ZS%P\U=X1'G\.3DV8
M*\L&YZ=J^5,'-\:*6AEN(A-PTU:.V2WX/X^WA(.9'EOC93F#(5[22@28>PA%
MC<]>M"6$>,G87=?MSH9#3)?!FR9& A1=CT,M(&#:O>OHP226+;NZ,,6ZI[M(
MN:Y@#)>5B[]-(AZ&]P$'V\.S%\@=U*[;&]ICCK7:6^/-*L"7RBG9Q$WYLV79
M!>'9'"<984!.WQ6J 'M+Y5,8H*8B@RU[B?]XZ2EH)/8)-8ZR@Z:JW7+5&^^E
MI<FY/Q-35(#HW&W[$!-.')C+'M(7754!#+[S']D.VSSRTQWH,UP9L$ %X,>.
MR%_M>X39_-OW_YW-X>_[[RUO:"$U&3R_-A5._4US;^YQ%2#CT?\;7]J#'FV%
M9!)V1_:,K_R#88Y\ >F"29-F(!=?0VPTP0S7QJ*$5IKR@%S=XV@_<T/D KZ)
M$VG_G \"/B%5WBB)EK=738I_G#7K<:TG',0:%9^>.2RPOK?+,L@BV@YQ?2,.
M))SVW&D$BC!;!.U?LYAR6FMU<[1E+]OZHFY""U91R.0&YAB_'A@]Y^LKS6J*
MK#F:DF=S7>I7P^22$-6R=6=SFP!C"R[4+WHEKS?.\"PI/DM=Q'Y],;*I E@2
MU\_QCD<")?F3KQK5EBXR]\Z*L079Y:'32NJD--6XO+LDL/<P1UH=',D.G\O<
MWKUCD91M3B,V5R"?# <,&_]GS IRH'WER+F_I$4P9"-^1IRZ4KZM'/DW\8SH
M]23G(+PO!W[$:'R._:"(9.H:C!HSXRV4R:[B![JB"5JSM=&I[#SB2Z1@?_&-
M;49(T9.YA2P2JGE-=Q!1=9V3AZ!GB9-R-5YG!@/S22G)DU:<TSE/I)&Y&5E,
M+G9%6H4+3\K-!F?!;D12XZEF$?F08Z20 X0:!'ITQ+WX76M06B)MAL+)6:DS
MO>A8 (Q!#7D^V$0QXT(QA14-BN4B6P33R_C9G>8[%>;GS;,GZ]HEX7PY)>S9
M.;%\8 RO3',/<!;%,4EQEFXYF\F<Y\^IQ@-U_H[N-U?,9U%CH"I!:,GD133.
MT(1@G\8*D,'TPP000CAEG]L37%/'2D=D^Y3;HY6[2BY*$)RTXB]GI\2ARL_&
M$-N!'?=S#2#?W((W-)W:<1+Q1#5@[I$3^5#KV.B2AC>GEA#(0LHKM8QXS"(5
ME?:@=BJG;6H@.@!5!W53Q_+I+5LE75]/!:C?"+ KP\P8)Q^?E!S?[9/%H,>#
M]BA>VQ\_^F8)821S'\(.%"5 BI3]7Y<SXO]4 8XA'7,7 DUC$]H11?NKM^JU
ME0?:%^JN=N/VO,&Z-60+Q >U$B K*L"F$Q_3!^1_*M%."33;G9R\5":\:6"L
M6)<\()WN@M"*(P;&=NS7K7XV1@W*,,K]))GNN@ZZ]:O.1)_+,SF)>@H-4-+F
M#) 'T3WQD+5MYX/%'9@9*5Q3N=]C,47S!^4 (B+)"I$@^[OA$JKOV;3DFZ\[
MV1IMNNV_@K/N+1QX F;A;>J2Z!\\O"[>[+[I.@X!FZ&<93&)S !%C<']2;.C
MPW-K.9'JQ_9%N/@O:":U :5],9W'^GMV$,/"?PR\*L((0G$R+T6)ZU&!00OY
M'+Z!V@&M9S!5@,X*Q1/$XH1FEM$,4:X"W!0U#<0&;SJD=R/\\UV :2K 3Z;Y
MSI*".G_\0-:L!5:V_EXY[@<]:AU"!YV!QY@/9@<TF2MV?$ AZ'1'<#OV_)J>
MTX?V^ F012+B,,]Z'?/9!=H(YM^YCCSP]>PL9-U]9"'"SE\%T,,/:$XC/T0G
M\I;>/1M]IP(TSAG8*G:@%4"^'_6$TP)O)C,V+15_^G5-D_(;J&D16FC=Y8Z-
M69$45IP^BDY?J,>>WDAE<X&*_?5)N44+ZG)WB,X2DZR#A"8[K5OHPWI/[0=<
M>TN%Z)=#.R=Z#GN@!K"INI]7@&>-"IP*;DLI7SRQ+[/*WO$JY0/V P$?!IPI
M1) FRY3:.[0O@26<?"\?&)6$12W+[XT:*C=K[G@'+7VQ2N_&)BK>_PR5W-19
M0*_FD2&9_K/GHO RKW5V\\K?N[T=I,B):<*2TL6)M"+U)M+LT'7'' 8%\7$X
MN^3K0A!RX=VL!=/Q.'K'26]U2V2\5<7=5'X"(?,ZCCME0^R";X&_H]EI\RPF
M,K69I]DD3E7%BY^!-'%>D5[OM(@KK7+\)"YXW8P],RW:"H'F(\"#<9>^SAQD
MKMRH)H"G,0GBFO#^2\[/_$W.JP#Q>IOLY#<-6$4PV.1*]YB\B%@],2F"-09C
M:-?*S--GM2+M6\$)VW7F/-/[D-#9.K>6M. <CK0J.^!<%)%74)G96DO<#UJN
M)YQ[HOPT=V\BVG'T(_X.8RO;89/IC24F8;I:X>$J0.RK7J$X8\Q""MNDQM<X
M5Z8VNCY[SE6,^E%T^:*:I8QNXOOWV0OWI=$9T%#T1W76N<0+KGGO$ALL_2U1
M0S]E0,$E43;?G*G@GO<@96V&V#MD#M9$?_I=,)*FU-G0!Y%=4BX=*),2>=/T
M+_D?,!)#%> YY>>D!&CX]IUV!_1SE+4")S?B4X9,IUR:"I:D"9M^7PXXP$9<
M,MTGCW&G1DT$@\Q>V%@0[1M=LTW%)7-^QV7A(FLDFZ*K#L83XVZD3 *^B66A
MV)QZGXA4?D^:#]2W\L\\39_!S. #U<@V^0 A+%+NOK/-,+PK=$ =->C^8;*Y
M8Y<:M?.3Q&B/7E5)2M37XXTE2/.Y3UP,[UFO8)_\,/*?Y-<IB-@4'Z:"L8.7
MW/27?:'R\VS%&WGV$05&&)A2&/'P\9&^_!G<&=0-=4VS9V[D;>WZ,9B[$-K7
M@?GY[))?^)H%,1H#9+CPKLF.B_*P;P-I&"E;?],RQ25\-V-6ZO]?-AM?-B#W
M'N(WBLL'L4"]A=Y]6L"XZ"9^10]T_PY^SYPU@9,YWD9DR73:L#/B7MH"]:@#
MH;,904):[VXL\?Y :TN>?M/)"'QMX2Q/.4JQ5%2"YPO5+^CIG%GKVP"K%V-;
MVXM^"I>?!5"S0<.J>RI @@W*+&IA^-+>X@=@2M9BT'](*9=$+7&,?(U6&!87
M5"7(6*C;H3Z*';&8O*$_?&HN7K&^?6QYUE^!RZ/&]@LF!"TA?D5@D\%?=G[9
M81FG82U*V\CAP:%>8<@MS8X[_5&<WJ&@+IDNZEMD1@FXB4J%&CF1,.R;2V*X
M_\H%AL\)>X$UT?%"@+W@B)>.?],8YA[R=R)(CX YGEAX;+APU+([QUP &58!
M2$;<NS&R_TL<_5('BCCL.LH)SP*G(U)LY3\EB"K?\TM*5("#J/.&< VLG/Q_
M[&2*P0NW#EMVMAME1SH'V?]J]NI0@PF$;_9Q]WEGV2\31[\YJ$#->*\/U=V7
M^G-*W8H?+,?#XKI+8B=FFE-KJ)@%*%0G(W_.WJ=O\P8!B2)I-4X@=+J$GD<C
M9 .I0UW.IP>J/#F7^;=ZRC/CU?X8R'!?(!.AA06F?2(T>Y'E+C6X+9WB5%:<
MA7XLS(H(0(J2B5RJZ<6Y*<[_1]M[AC69=6W#F7%F'!N,.HJ"DADI%@1&JDK)
M6  1$2FA0T:1%@@1D"8I,Q90$#. $ $AMW02BI0DU&2D2A,I(20AA"(H)9"
MI)#VA7F>Y_C>X_C>[\?[X_UW'7OO*[FRL\^USO-:>Z]UOL+@K (P+/<R(WJ,
MK(*&I\S$J(B&DD&]R5:K\^ND9#];@KJ4:FJA%PEOB1A_4>I'\:?!N&"YESEZ
MW_XJZ>S+0%[54_G$B.ZHHQ>0>VOR9+].TV2RI.IWS/PD]4%Q/062XV56-YXQ
M/]5EHU^(H8+^@#"C'415T_4\8=<!_4'YFW6;LU7K>/HK.0W]G8'U;NFUUFNN
M%R/6TFGH.,AID4^W>O*?4B]XI:>C=I0/N;^.>L-:)>R!(7=4 F*%D+$_=50Q
MWBVT%LOYI"H$,B(\66.S'/UM67>+]6?J^_J]H+<X_J]D7#H_A9V ,]586NMT
M^IZ-,.8_$>0E'$LO-JJ[NK8NS@O3&Z@9*6^DE>)=QXVLC1 ?L=ID??VND/B(
M]6N;3Z4D)BUI(R&RW@,\C=Q'?:M+/X):I:^YG^]MSU*[D'M;7&*2WB&-3^KF
MR'X%H]A:B,\B0B_QQQ'[_<5^O=++)+EV&%93BT_K;Q\\<8USQJ,0-82NLR;S
M">Y/#"I7]?\(2)OWB6"*6]TM]F%G*+4I%7V8J&R_9UWNM]H[<NK[OE+W34+5
M]LAP8<:&DCW^^;PU@1'?J=OAZ2S9OBI/\H&X=9RG*MCY$:6ZR.N]/R[\0#7>
M":Z)_?B5O;,C$L]<)/'(^#-5*+V">);M@?OK7Z;83J-1-7LB#Z94I,6N6VN*
MMFNGP_D[&7-(EZ6C:FO1_I(9D$@'E_35Y[YZ5EI5-Z=MG=YF,[<3(_--4U<
MVJ[$M]L!32HY::C 5_%Y>;,E@V=>4W*!L"?3Q_8=6=PQ^)4J.DGM:#N&6K,A
M>FRR_+1!=9C'<R.H]O&?Q!8/8-6I\@.E\DT@[Z726'5ACP0=$.&IK:N87;?=
MQX;V\(>D!]8Z4#J-N0Y[-#S]G01AG]>>@WBV;%A !LQ@X<CH1X^IY;E=/R'J
MZN0FP",FN.7C^>BI&LB.V:#()P_<%OR#?]#[\S?3N6 -X'/0S]0[Z,,(K5S;
M9OOJPZ!5_02K3NSAN+3C7?F=UCZP_FJF;)K_ _:-*)<]LNQ(SHOKQX*A8LD<
M77J0TT$]?+\EY^SX5+NMOYER^K#IHL'+)15!SN0<_M&R)XU/;?I_6/N$<D:^
M6?6!]JZ[]-;1@_N;<ML\YGI6D-4(5;HNF4QJ;"5AY-Y<<=A[=.+Q#NU^XIRD
M0T*46.\P[0@H/S/AM:&U87G3![(+%/@4HZ<]=GANP#U-4&5VWIS+V;"Z,8#=
MO\HA$1CRU1D%X%E8G5'FA?G3MMX9]NH-*577Z+N@+# *JIV\9FS&?&BO-L 2
MX@.<\MQ/VY>]9:4^22=QQ7A[\RME=?5N=;9YSM24"JA:VC%<7(SFA]./R6-)
M#@F&6F*-"*:?H>P$>R3"NX0AB(_;KB082,'-KXKEPD'P$5DWZVJV SB#<V?$
MYT,&:FVU[N.X A L%M*LINZSLD@C\ZG/]G].?,Z_"@L.;LN+6O7>=$K+?:@
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M<-!Y<;VT8%#JAGQ=SFK.UWE%MD&REG&YDA<7+X_<C3;/T=V2H12 1RXGO12
M&01,#A39*0#"TQ!,;O%VL%R&5';>O (402S:_JO@A+CZ-P4@W<K)4QXB:(P
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MC^$S6=E4ITH&$?/(^B1K T:&RWZ@&AM8@F)JXNOFG&K=S0_XFCL)"1*/+PI
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M\_>TG^8-=7(HDY53X=QU>GOW!R=]+]=Y;X;('%[AR#_ 6=&\:Z2G%X%9\_C
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M4P >*OGYN_/:8W/HP_&QQZM,DKQ:B\5/4+Z]QW+]/F633WT<C&#]1I,!10K
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MPL\265L3,@\9"3V=DNGI:%8[O0?4T'-O8&Y?2XK(M8=3!\+(U2:O-9-PVF%
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M#&3:COED,CM1WL7/"9"W5![TF+6/](&2[_Y7$A"1+.&$^%EM+'UEIU3]4<N
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M'G_!KDO(,H9J;!\;RS>:Y?3ZX3G+I_7#F< 6'WW7D.Z2Z@LP</%D"GYYBMA
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MP",3Q7&*H%"GJEM?;VC-VDU;X)W;92?]RU\3K3,9.!52 ISH6=;>X#P#(YR
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MK[L7R#QA!2/QTYD27)L/I=QX<.;\BA=9&#<CO633 .F4 Y">/Y2)+826M^4
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M-/#L.KK>T>E>B@=Y])*CPQ1U:>-!W$7E0<V7;#&]$$'A[%<\%Z_2,4XI412
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ME;CL WQ'V1OO[>'/E6%-3:3G?+X&R);,SUEU-P0Q!=5Y8U4V$XVA[Y"GJJU
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M(TT1]V]8(O.\. =8)LSJ@TLJ^Y.\!48G7O>#.--0JF4_72=QD5K_BE08;HF
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MHJPRM:9MZKYYAI*&5#&<Y7B9!S%3;2+,(%JA*=5HCNO32 JSBGT\T2FJ'U'
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MDD/>\P+-;3UXN3+QZI%?J?MD<(M)UW3_^G6K<7P,QH$RM !7EI'VU"?C^E0
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M!8WC9M]XK*&!$3&3R&W^IG\*ZIPA2J) BC*:M0JS<!3'\R#9#T_=+HE9<RK
MLB&<2IUQ%E$,3]?:_ ,UTUQIVRA=19Z=@&2Z3!(.]$'7+^#9A-:8_FPW'"0[
M@W3AYM5C%]=W3S/[R"%Y%1?'QC(>(>90>; =I\?1M]ZM[AS ^J[]M2J\OKY5
MPCC]TS#U+0R@#W%#;+^+$XV!!>S0DDP@WZXFU_S]^A3]8#WNK."7MCR/4#L(
M+AZM@>];(.''FO2@+YKN"17_73/I1>R(#'T3+[>E,K %U6O^:-WA!/*WFG/H
MA-HP]IZ_R?A@=5T8X2)";-_@N#CM%NI\CV2!KO/3@U[$6B$K?*ARH62W^E?"
M"]?55_UAX[Q7\"IDN<VK"]K';N[SN=#I*^70!'+ANT, K-HAFQYTF\NH*B=6
M,:'8WPE?:&#7-A*9J8GL ,)%/2@W&/R]TWIF$RPK?9@C(_01=V8\DS^_5*(P
M\>6M+"Y.X$=T5FO[ZGXM3DLW,L/-%4UKR\%UJOO:>#D9!^E*4G9*AB2^,QGM
MG:PRD5]G5@_86-JY>94YIWH8WS0?.?2]FAVU#V".A7T5O]"N+8PE5B*[GMH$
M;W/K>LD-R0%?G%Y*-R$[N;A2X*DY=1E*>(IL:@ ) @PB-VB^)Z=JD?8L'&ZY
M'+G^!C\*:PT<N3ZK&VDF2DQ\-%]*?0]^Q4%<_/U33V;BM8_X7^2[2R3YFB[Z
M6<%/9;#[T'5%T[TKVO!>1#5WT1N=JLN7.V YRU"3C0>?C+K;J9%!L):N#FU_
M;>V-A;&C1:93QXYTAJJ[QN B;7S=7.;^0G37('V,Z=>F?>0LS:GXN:UU?-DJ
M/$2WT*R=I.1K,M<VOX#M"N,*I]F*A%NJ!<)L Z&E6FZ]Y#E9D/%(YIJ;:^D?
MWA/L!^G/+TTH7R7<_7&->:=$,?S,8TC9FP!G8 :IO<NJ=(CXPG@4KLR'D>[W
MI,YHK;^CSC-IH9'/^" (8\MQDP^N%N*:+1!%:0UGQC/S.8?1Q8C.M%$G\D4U
MV?D+L5UBH*JL(-+7BB@Z1:D3[QGFI?O!K9(&J&:I_QH.I^8GXJ6#')>"#T-0
M47WH_K(C9JAG#:Z2='!/PZ\IIDB41V$BUS_5G-"M1/VQTH9<&2\[V:*B8U!?
MWJ=J:_?T:UJ>:&O3L3E42N?5R@@L,XH;:C(0N33D_*]A[Z0:MV2*=C&WR6T
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M,$I4N,;RE@#-EBN;,/2NH)DZ/>B+1L0LGTF,?U@7MZJ"L%[8)(56(/D:1MU
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M0+.M5.W&7[TU'QS'0^&X#VPS2\"94Z)*R8%1C22P<J(J'Q^KBM.]IN>R,AC
M=!:;O9R,9-!MP_)F=^)C*0ZH(&C0 J+LD=J/#YEX<"073-^KE3)\T+Y5EPB;
M492G*L(2-*:JX,1=/:A%X[0#J3X^XRDW;-"H1?-06F[=5PB7059:50'[D2%B
M#6ZZ.0&[!2.E"QZ=S(0J^90<,T^Y);H6_UH7-8DIR_/+S';Q8MD)B\D6 ]!0
M,W107EHLCR$*2X"+X?Z#YKU/FZ?I*[Q4YY78_I?M-3!J0\.9_DCVZ;;)73MF
MR&EU@#YTHTG@D;V24Q^8>S0PYL;-VH-)'NSO5E!9W;!M_ QYA%=:RW'.NDDW
M$*O>;!@A3M(#X33-NJSSMYX=3P\ISDY>4D?MG#6=_KN+ZO-S)6(6_)QO,\ON
M3-Y;7XB35G29(G8<)*>CM#99.@%?$V (),BR(+9U$'8]JGKY32+X<5;6OGT7
MTLBK?P%XR_O_"0T1P097-U0.T5X6JJU?2@B?0TT<$!MN$ZZM-]H8P@G,$%>6
MKFL+%])8GP-5*^'%"5C7IZF=GZ,)$%;\/[TE7%#]_T6S -SG:#6N,[974+PT
M7BR'9W5U5Z>,_D]KW_5_@&#WDR9DP_WQANP5O&AG8IKF0?"@ +IJ^^Z_ZUEW
MYHX5+PF8=&*/17AB4&/ZW.8;RVZXWY>2+%2TJ=$+FD W-Y5-PI<+&S>N/\RI
MEEQ>'(=ZJ -L]HLNK=3J7A=@A=UAR._=7(RNK\<;>Y%B)76R*1?MXSW]@SDT
MEF^EW\X'E'&.XYKY&8LG%G4/ T,K3[ER^#HVQ,>WA0J]H#M00UMN7M&9(@]9
MJEGI&W4IQ@M'_VB]M@GB?9.N)E_;H)#9EHE$42WTQ9HD%G4$+CZH[3K4;O;N
M854!HK1$&GC$%HA@,O]) )L$H2K\LID9.BG[#)VO(=BZ*[)L952(]RTUJS=@
M4ZFM9!Z]:$APJ )$&\LY($]FMKT#4U:^_^D?MFNOO^I+J(7]\7>BHY)R]^IP
M 6Z2AU"C^N4PMO\@XI!3R7_Z]XLP94_R/E@%4O(7@QSLAUG.QS]5.1P*"*+\
M-*8^7W]OVME#W:P1"BC%"JG5-26VU?& ]A6K]S>W7MZUY_1$:1<RA?#\!XB*
M; S1@R8<@51@\[9KR-*^1$;% ?SXJZ";\S#C')I$.$U69T;\L*$3E=\' X1Z
M\:='S(Q/E@ODC8/8:X"OX[ZZH@?=J3#26G4VL9,L,^^0:%,?P)I=R6E9B@NO
M0TV2 .-Z9.#:]C9RWQ6W7N1LTZ-!PA_8E1A[X:Z%<0V9-*Q"M4Y57!RL4\;G
M6I=^Q\%-Y,\XLX;HSA\L"(?.0]0G"#;H&FP1/9^$8?LXXL@ L7Q";S,A7!.%
M?7D_M6LA'6Q?1*68Y=RB%JZ(XL=UTA5_D[/Q>V6*Q ='LC5OPIS19$?_H+G#
M%WBB%4H=:UC%#"OS)O*UW"_OMS:R,J%A>2?C=.=Y2]"Y.2]\'#Y-=Z!@SW%W
MC6O-=^<_.EB1,U'P+UT&B<]:IJNVM9^$'@/TRP0>3-]#FK?=OVB*L!=1TDV,
M/>4>C.)R!1&RDZ\$&LZ4$=9415^5L/ZIZZC,.RDK39](< RG21@U/[68#SF@
MU0V^\&^Z]XO!SB[I)>INV<1? MNE1 SCU^_HG7FS- >\\YX%]D7KK5TH.*16
M=0!&DZ@@*Z@MXOVWYHY4RG<?.&(7?>>D5B#A?$M2XOAU?OVP%<4S  0]:%9=
M&T<Y6Y&8<L@BN\(CD \>UMU[[[PY9"I9,V$<E9=:*.H]NL*W:^!"5$4E:-_\
MJOB=1?%KTGPFIBC.YK[,_C:YF;M!4ZVTDNXOVUFA>6/MM_6@:*1I:'^+SKB6
M)>WX9#R7^:,>%-Q>DZ=:H'.%-E,!2:G&HG9BR_7G&A=M^0K6L?IEQV,]B%=V
MHAN#YO1DR!6NG1/.(ZUQ+GK0=!TCY=^Z,*77 E+U07[5/\B37I@NJ,T[\"C]
M=-/%/43R1]:;I9Z"*'M%R6VKCIOA*Z[!C1F$V6/DFQI[YYN=254E6ZA_!\/W
M=2/DS;PSQ+/JTW?J3IX^(6KS^-M7##8B7%2YF:S]*S5TOWS[6)=U+Y!6N661
MG Y[#=9R7P0)4T+%HQHL'DQ*J+<67Z7N^SG%JT;6=$5&_)/0$D$VTOSZZ<\I
M:.R']#D&\:[@2^)<R2W=<ZHOZ\_)CW?'X.TEJ/')V-RTZ[T!S=OOJ02S0Q91
M_MWXS;K>%*SCVE=E-T6RF3KH1S"_";/V?S/WYE%-G?W^:&RUUCK0.F 5)%4F
M!8%71A5(M%9#I,@,,N95YF 2 0$C)+&#.%!("0("E8C,0Z ,28! \BH*,HD(
M 4D(*4."#$D@@828@;OI.>?>L\[YG=^]:]W[QUTK:Z^L_=W/N+_#Y[/W\WTV
M[/[4RB72*/VK1A@=W>E&FBI,&IW[LYP[":<GU _. SU><"T*[_K#OXVX8V7[
M4DSU1*Q7\,>V>CGR#>\;&CL#+'=>\2TJUL\+-2)-\_!2715;3 *B]V5QF2P\
M3X*F0!A>$_2#33\)R0>@D3N)CPRV-PR]5UZ+=? ?2$+L3-T*Q)75;Y="W4^5
MN#%JKD_##1&\)O3SR?G9C%SWG)H3?H7W#3_4794E;'_D9*Z3:6M*;>'T\C)2
M-T!QJD.+'.BC4N9P8A>-GJ7 1K-7=\6;T?M50>\S!O0+<_*KAE]= 8,$!ZP>
MR%!A?X'51D7[4LSG=5'P/.0$=#)P!@7HRP9HW_SHXB[\=]E+BVJ]FDG.I1;4
M@/1]=U5$.Q7%]GSM&W@,]X<[J$GSFYB2&E.^4(]E+&%:@9M55S\]MC26,!,[
M2)^G(\):N?2;*O8B"275^DVPM]Y)#^J1^>+0):1DTW$*L<B6-?[YJ[R\(5IQ
M'3P.HY?Z1J2H&;=EI=WQ2Y\Z^#[W+=3R(F<&,TF9-\KB)ME3((YIB"F>M_<W
M9] ^,:\-=D_K?!CT8-OE6]X*\599!#6F-HM,Y="5B-S-B3<A37^KE49)_-O@
M-FBH/2=S4GN-@1=H1?YC9LD'&WX"_V+KN\PD'DE/Y::,T@[ >KG(] 'C5RDT
M]0A,Z*K($X^=B) T]9@.S'G1Q83T1!\2[*H6T>%&;\=Q0Y+>^9^*/PV98-!%
ME;.8I0U03B'N7+AOMA#7W,,:1?OQSB7H&K9(9R?Z%)4M=)D>.1]IU4Q]62WB
MTHBB;0A>_<"Y!)V@>U2E/3J0-'U>(+FH/AX]UL=3^VYIB<5" $>2H-,TLO<"
MS46NB5'LO:#(,=.K26L)Z67$_/YF", $0/V4TLR9=7L[N)$CTQ=7XQ.>E8P3
M43R[L:;Y5*:/=A] N?QF^E!ER-MR &GYX-\IP)V7YK^]P04$D$&C 2U#\-R%
MPU^G^R(*3FL5 VYITHO9L?6;CWN/(FCH$&Y,(TQ3Q,U7L#&G4KLFN'ZDF5MD
MZ\V7OMDB<KOL$#X0]PJ/!+PI4N=4.3&2U]P0:E'?PTCPT']9VG.=E1 _\O*'
M%N(=RZ[GSHVP5N;:>>/N<6[R\CO]%WN*5:(ZLH5[G!'T9<[6L=U8F9FW8:0.
M,*1K+6DS JE<5+7Y\%M.\2"Y\9=&=F-MD_62M)+1NT);P%U++!?F\?KKOJF>
MM3"I5I(\$$RIS48F[_BJ7!#)+9!+[C$/NN^<3RF4],C\>U<B<;OH.\(URALX
M/FB9&CRG7XA@I,T]7\>/\E]^0@9=JJZMX=01;N#,\[5LZ&2I]KVB_@4RS.Q*
MZ'N,]Z?R3-\K.:>'2UM]KI!58?,P>??[5J+(Z@ZTN6,12K$&H.K;_WK^XZ=W
MA*BG4. ,440L2P!S0E<),2E#:\4;H*BF"NV'3YZ:AM6Z,)7KY&8!2#-X?&E^
M T2#/-[LPQ.@^9)-$66[/.4L :@ S 5?%FY6NRE9/*\I^O<&62B^Q7]4/OSI
M7[@?YIC6J6>(KW0EB1B:/5&(7'',L&N6HR2R._Y#R0?3L>AWN<KP^KWK-5/)
M[]?N9SE@$S^QMJP8UFA?/+BS"MV^XOJ+GX&YS<MN6.L /$6(4L8,:'\OS&$B
MQ.RKXL-V7+K$N^3W '7_Q-C"]BEU9ZX=':5"7A7OE6D#1$B+V:",?K[9B!=<
M@(Y  *J[M>#^^.R'GK9:[+M><ERR+T'T10L162ZL#)MH3!W9?@KI^&#4+0,\
MXZV,5>^F50V:+HLV,00)IJ4D>^AWI8T2A9%\+]@Q5QE*6?V;_Z"TNDXB\52]
MSDX"8C[K6#,Y3CXDMU=UN;$#3X_[)]CYDZ:CPY7^\1Z;ZVKY20]M-T 6R4KR
M/>^8]C=CJA%&S@RJ_ES"WAZL$$;UR[57_4BPZJ,]RXRDJFK:"N<V$4E>XI9^
M./4Z2@5!YDY.6>;G9*.,.UY..@Q(*0?!AJF/MY\Z\GHFH(<>*:C*G3ZT+\%J
MP*.[$IO5*)I@?\D3IO+- 296*0FC9^_>(V*'[5!D/RHS(EOQ*HVR9HBW",Y;
M^D.SXS/ZN57O)D[R.Q^5[%Y4QDK%2-*E/,FV9V?2&]&8'##*] -"8EM877J4
M"R D$@!FM'/]S=M/)8@,@@MC@MQD3((-RCMSYBU1J!I!^RM]M<C-=\&4ZC<U
M;4"(O\UP0"$I^A0TS\&[73*)S9"^T^\LX*4.]+.L1VB*K!Z33O#,CVDR$=AJ
M>;BB"W_Y*SVLPWCX1$TKT@5=3((^A2!_/G(AUMI:7$G&9I]L>59T?3@8ID]>
M4%BX"[IZRR";7P= $<4CUBX?>'IHH&V6T0T6ENX=UA( \0LL^Z+XF&9-61U@
MA(7\DP%0XD6=/"1MM#3(X7?U>W1UEB2+;G?PX-X+VOK-5_76+D.-%*@**MK9
M$<[UF6F/?:!-Y(Q8O-0 R-5N2_^5,7+41+K,SL@&"TPBDM)*$9QDV1F$P55=
M2M_HX[FNB3)(!$_BG^J(T5"K+R ;Q % CQZTJRZ-!*Y9_<+\VO4J1QBA9$J%
M[:'?O3V:-W4$JP[1>3X5"J[Y(_+KSA<I'>[P]>0I1\RV>9?J]#F<:.W]!NA&
MRIB-IBJ#9>< 6""KJ.'0T^"+_GXE;/+8M_J/,O?^>G/5E_3?;+(.0[&I5SG]
MKTT8.PS4BCL.&+W_*4V9!";/ZP '@O]O+/N_N)+_K<^HJ46I*E#Q0-C]=R_S
M[-,#_D,#G::5M%RI;:SP$J-FCN?MZF8IF@G_ -#[3WHJ[WA1I#*PO6D&]K-:
M-"9?5/B+'VET?FK)'O?[5'3THQQJN&+SLZ9.3P7;J8-W_*2_*U>DH(L1EZ,X
MNO:^$;7<H)[<2P$'48$Q!C/KL7)OY6!^7AJ/9;6?W]ACNKDESA_X,/5]0971
M1)::T@H Z<Z:@/I)WF7 GZ/!A-T^1]M)?MQCHBK=B "]!!2@"7L)KSIH8IG9
MJ425J)^ZZZ?V@3Z9Q[!==P\=M:7?+4XGGUHH#-2=.JD-8>0^SU3ZSZH&O!OK
M\\C3S\[\[$8Q6-7#5>N%G(]$U1\Q#+7K,'Z5$:<XN+G<%(B9#$$F>7>_@RN]
M[T.?CXB5K&7OA6LD.:RTNT*KU,E0 2;O?;X\@XR-/>LX7Y(=:]7G!P%BI"4_
M%Y!?I&/Z$(F$%_N;6--^0<GJGS= <BESN_LIO!OK#G-M _2S<7TN?^]]S=^"
ME@2P(BDI0KJ9XCH)=NC8_\E<Z%X.N0!<-CB!(\O#W@5IR],!)D7*RU&FT;O@
M]O4\I.8T(!X.-F8MO7C65"< :%;Y!&&V3( /UU1_JUWP?Q\!_1<DRE9[^F0&
MQJK/"QYG5)CT'G:3A<U]:"R#A"MC1YS>(];7B;'LH$$J-L6B,FAP$L7UAMV:
MQ/1R ^^:?Z@KB]T @0T%-6!TYB$'J\F*$&2&T:-ZF85=<>9%'NWNEVM6I^F*
M*F9$)T["@'U@#LH(NT^2G-*E- [(,WXT)0"O6/%)6]'3( +KC_3BQ@\F6J.^
M=\0>1'ILE8:Z@?O4MN-V:?/G6D*^AV8+D,2E133?8>#<'E5B?SP:L68'EO]B
MUXFJ@E(-$=F1@@I<XR0T/^S9Y_'<QA%2L&U6*O7P!,RTO\^U-5)%M@"YZMGV
MT2[78X^\NMD8A%N(#15EHSD%CET\*>WPW1/CYZNYM/F\V1IRM,LR__65=O;3
M,(^!UIAZP8"!J!ED63R'6\#DV\!%;BH#-E\-^/]3^7@_[KF=0MS#9&#DL+,#
ML@W0D0OR>[^)LI*]T79;Z9S>XY^]&LO[6@W05E*LSN$EK=GU4,MG#'\!,NK#
MZ!D(X0D[_B<K;N0$!<S3FCU"P4M;)A[+1\)H2M_CJHMMZLD0_6>[3?.H&Z"'
M5:(XHRQU<_I-$DZ@C)8! !T2>.9<8OMO&R!S#0=>DI*(,9786;L23068_*JA
M26PA(2W3PRSH=37,?@Y!JH,?JZZ!\JO0=MO3H/ET"YBJIC(G/UH "G%]JPS,
M*@,(-D0 'E?EW:&Q2_I1#-_J<XAU1<B<Q//(=(_,@5\9GE6"F4SM^V',H]M
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M.SVV&3(<QZ]%!>YMAK<2>]F'6EQFQX^),8&_FV1&J!85G*<FQ;8$JV6V:[J
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M&.LPB<1PG&@?:EJ=8VK:W$:VA/7?V !A8Q[>:73IH:-L1,3#(J[,4Q_:;0K
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M%>U3-\>(T_/:XG7W^'A2:I];[B38Z@;*$QVA)*3]E*!;G&4)D:&>NY92E;[
M7.]=0N3'.!CJY%>"3R%= ;\X6DMV*(-C;*SXB-PJ;K=^G-C""UZ)>PX] 4T#
M8 JN297.)+DUIFYN@1[48TSOI2)YU[*%^;1WI_P6^\#)B<"8NCA\BXM.6<V%
M8:@^=RZ:A:W\#!Y^T1<UPF^V>T5(CO4.H]-:5(-:D5UI8G;R,@7DJB_%I@2:
M17&<FEK]2EI&3=ZR$:0'L'P%<Q&WL*W?W8 J3"T[_7P:8S7G7LC)>49'Y!RN
MR>@SM%I^9]WOL#-.48@ZF?D[;I3G$PZX.9D7)H1EXV%Y?>!U;7RJ-FI@/BAT
M1SY@M-\$B<?.8/9.Y1=04ZUJC.X\/T9-5>A>T]#<'_R\-%C_EW[4G]/Z%C#U
MQU6W54QE6/8MY(AH3>VUFEKQ*< @P/C8YEG%$#/O'TJXPW"X9A6E=RO[$?J3
MP]!;_8HN!/W^OU)4Q+W&VJ<8(\ J'WU5K#JA'2.E.I.@.@N5M"&NFC')?#?:
M?-7I8D4'M?=2C^ED[QCI=K9\^W)4NIUI6P'<$,!Y38)Z3B/A:^L__*XTXK_[
MY6;: ')P;DG1J3^W@^RD2C,S/B,N>N!T374C^I-S 8V<@$F,.Z:N/-QB#ET_
MGM2J:?F3%[T!BFK@:9LI28%1ZGV#+^XXKR:?X@4[=G$?Z]8U!6MR4VVF+<!+
M-I8?-!>Q(S++'9W:A?T5GJY)[()5Y\OY[@^NUHP\C?:*&S>]I0GXI1K/.;P+
MLH\TA1%IW_4P^GB(P^H?QNS G+#NR41*H2U2%9^.".S9 &V=6G9Z;V/'[AY.
M3"+LV@!%$':I#2-0SJE=B,*Y>HSQC,&!-X9>3)\*LT;.PB@D^<%IG=]:BF[]
MV3I\[^PW_!Q>DW #]!OY<XDM>)SEEF$Q&_M$&^E&+50=U [E\K??8JA2>@SA
M!]<-F*,KIO=$J0$55,I[*U(?73Q&G 3HBJ-:IQ+I%6+[WO -]\D757VIEWI7
M6B."&9 KP\E#B*H ^KTS0$?>#9Q&U;S\RD!&ZQV#^&MJ( [!ZJLKAB&UCC?&
M6:.$W3@+U9;^QMNX))J$YP^/4^U:ARR>UPXD:]Z*N*Q'# 2 K+Y8K?]%CK^2
MR\U&<P8?W5XT>CV[\WC?\S%+SJVSIQTZ\4?_M6(^: ,WJ6!V7.DH55;R/=&V
MC,45@[!/WV;C]!:<5PLS]%_TGJ_[<6B<R>9)QXIZ;O*CDR*4='_/F<'])MGH
M!Q097#IF0-_M5,A=K_D4]*)=?UY ->])O:$]^>FB\.NJ/]YW7ES<ILRV;!70
M!@JK8XP"#"=9YH2D?'E*!#'%8=##A1E,-N75?R#.77?!%/S 6:25*PU#N'3?
M,X<(Z1*?N+,;H .?"2W?5.%9-J)R6!LX!Q)1G7X8;CJI1';+?PY05X_L:I*7
M#7;8U3D-YN1%>$GY_7QOV,VQW51MX+9^5_UT,$]91: Z-=%11OQ(NJ^4.U?>
MW<", 5C%8CP))^3^F#DCY #^5, %*JUPPQQI$]%07.;:Y_O[Y5+T#WR781M[
MH1O%DQ -CP*_:1^&C"B"&]4C6QSDG4'V/$;UR_Z\;\2J#-^9M".%?,FPB:_J
MS<C.)[F. _V]? LW0;= S)?YI;9HH;G9 L2T,OI0'"TTM59E/W*9@C$90:WY
MN9'^P6%?P^SM%M, !W(U]AZ'-5FFNI8MB.#ZZ.%>%45<H>\V-*/SGIUY&)85
MEJT: 7A! )<&\,&+X%Z^,\Q@'#IZLWGGDP+'UX6 @P=S4UL/><\5,]]N@"PE
M!4^-VV]VM_'HT!6 9;UWBD>?;RLT>LNW*>=<GX1'*?R%I;'C5I!/[R#7S]?8
ML9;%527M095:3%;U:<I45K(+-P O@MG&*+(E'J?Z[O29C"+R1FM3,V28:@SM
MAY"UPV]8R8F?"2VH+WEX42'RT[ 3JXGV@8M?J#$955&\N^..%)B;;Z;]."4;
M!*<$"9"0=X-2D1)9]HI8Z?"$E93K^-"^&AA:\&MB#C0]$;SYQ$]4QD7II^2S
ML)Z7^DPG5<W[+]-=X\8$Y78ON0-4/=Q>7*%87('+G/Q6T<4M?1;\HA4 ^<IJ
MX?V; (',DKCE/#TRF\NRYQ>0*Q;>NU8: @JZ)\:=\\^%%XGISD[$KZLB;<TV
M0"<!ZA317OC,K\J![6;I;N,.JU*,+8O-(&_;I]2-T.$E9@7UI5?5Y D2I@0'
M8V:L#?8G2O_]_VK"]A,FGQQ&4C[R8?^(_W]Y\MXK\D>)5G3S;-F,W4QUG:2@
M3;(?V5,RKRI%5;,!^(;&&B4AV@80S-OF]_(D#4=LH8_QI"<?@W;_NEAE"T3L
MY(%Y5_F@)33GQ-%,7E[J +7:ZI115@Y$@%\GG-C;78DEFW]U8VPGN)\BN^.=
MQ(4I"DK3..Q?[!= 3J,M6GT[JR)M:!=1L%893G*9Y=$%VL-PNX RY=74QUM,
MN4[DJ8K !7XTJA:""'QD%* WIZ*>?/>2?!(E??<9+QA'%KKGQX1EH>T%-'9B
MY$2?V@[<RZ!1M\H.&DRAM+ZH/L^>J(.?7F?'K5:KLON4!>F^+ITVY+)MNC/Y
MBE1^4IX(P0L!#  F>B@HT]5&L/H -+(71<AG^M6_JU__KK_HG^L5&Z";9$U'
M_: CPA)3,$4;^XA1?YTX'8,WQYK&$UX!8DSLP "+%R%5#\+,-T!8XMH[S>[G
MC\QGW/^$G (XU%\3,(S*?!U;&ERO-L[MVP"1DJG*J+BX6'H\#%$%7@YN)W2>
M6"<D:W;G\C_!4A Y$,0@(B1K \0 '_V#T/Y\)'FGZ80R,*]/MGU 4:VS!GWM
MJ2?,CM=PY&?<CP]ES-#=:EEV_K'W9 [6:HJOUC=$O-HP>2R#?R?3PU0ZKKWF
MC<WJ!DL.)OA"15]H]U?5KFU#K#V$'>^8=DVB:XV5R%<)@=W2)6'EP#';0CIJ
M_[S=FREB5%YK1[3@4.2T*W3Z\L]GG*BH#K/CPJ!!.?*,4?2LTE]0\CATQ8B$
M5C7#!(WB"&65X1.'R1"J?H;JM=GF-Z<END='CFKM@,KSDC#@-V0[;]*\$8IA
M/_+W!^,]<Y_GZTR [<Y<$O;A%JH;E 3[A?"\W]ZC$&\S/2R[>C ,'"P.JX]J
MS1-4\SMS232G[5/W5[I81QJMW@R,-K[ROW<83?&/V'?#\G"=26VTIW^\(_@G
MPA=BR'>Q6?WSV@P]M)#9M\PD1_VE,=&+W7]57F?0@DG3@NG+T#21:.8BO"38
MYM&D=GP#%+M6/R<VF:Z*_#;MF>;-$L'O)F:K=^]R5D+&@O/;&E5,!R$02BL<
M6ZOS5T5IZD>)(K*<%:@D4\!AFJ+,_TD.:02/?UQ@;9XO^?L2 8%&X&BB_ZW!
MO_.M_N>RS?_[LD?_MV6A2ZN)"*[;XB<VZB9W/=N--#F?7)M.C2WZ]^)_7US]
M[=BAA(OY@V89+M)>R+S,0;1CV0"S8U$'ARQ$):/_J=O>->GJJ\R'(%6(+MTD
M[<EE]6B3&>,-ZX3=R@;HE42'=5?M&:?W?=<1_@FN=$R4>N#U3K#K IMIMTY^
MBS>\^6-C&RNDTXHWN!P9G!&KADO99XP1S7A!4IF-ZKP59$$4&#X@4%<S:B1*
M]]YN)?=I90;)G27S-FSA*?)0]FZLE^QS5S.G3P=M9D6%M3=)N;<(=IY!KS.=
M&0X.E%,Y$7JY%8]WNL492+*2WO&97(:8C4M75#5.VA*2A26/=Q8%=BT,*&(L
M+?>MXT7> 8?/R^S9)8/N-FC12/Q/4?$3.J32C%062V;A>_A^GL+OJ>;9@&E_
MH5^F9\HK*1S=+0C,/63!E)DLI,4^$.]#UHU6_C5BV(1@,#,]\TI)HQ=53ZH;
MX?KQ5B0&\H1=>+NCK[U7,*&D6ZIFGX,;OU0^T9K=CV]_DEC>G2!5]WC9/E3;
M.3T[@S:DHQCX0.H17@UNMMK\=E8W/5)83AM3YF9Z6,#C]FP.A5&**!2S;\\$
M0,?+>VX-J6MDOEL2^MQS6/=BQ@[^3I] Y%9B,[Y3<?VR13MVHGAMP"0PK[LP
M/%!(BYD(#%#4G8925;FCSM,M9Y71@L_Z24%O5+YF+MH!-;RM./:-V/!##;4#
M:9[R:Y.*;Z?_++I9'D_H.UN18-Q.6/"/]8F/]>3!FV&-I$M7Q^+K@)G<1HKP
M:.:?"72C*&(:)M"JGBM9.7D"%?N<8W\F7TRYFB9E,S_YGJXC\24FGY)[XF0H
MKG?O5EEPD%AY4%"2X,):8KM;]6^ (O]0@*,0><)-GQ%S%&$1,[:OJ[(Z748X
MX"DKP!0F<3 <7?#TQ$C\;U3Y@UFE+_[.K6BN%EE-_QG:1C65_V+/)V5ZG)QP
MPTCK!@MR)[@;H+WBRC'/3)> 0_9TRH5=#S$F0A3[7 PVEZ(^$.KV_9A;=O\/
M7.,+)JU'_L5I$)6GDB[U\QVH$7Z_F@WGG!$9!EL>NWUGJ'[W3!5OW?VUG_8[
M^M49S.0EEMT-_U_6$:^&4QU6'N<=W#6 N:WR ;=1Q7[)WRSHQ@WL5*8?$T^S
M,D\OWEN8'?]M7O,0F:_-N!W6=>MTNDE%(/35STVAOQ9%&$38/UIO6O6<_/L?
M*#D?EN_V_.X1H:?0._K9=NQC[&/.\2W_DY";_JJ)CCU"JYM<!0RDCQ6C\YON
M)'B9.T]K,N>+50_X=G<"(/Y!IUYW;C\?0L,>DL?=[_WSP*D/>;W/ZJ[!ID\X
MQ<VX+N*X)51";ENVT3\ZFS"#P8A.9V?*:C,S*\GM%J.HS?U4F#)?B]2.]\2W
M89.^*MI3U(-W=I?!'B4LC#-C_,%!(M?ECX&R&14051SZDJ 6W],?*FCBBMWG
M2Q Y#OX5O;>W$:V_G5*.);SOE!.F$;G/J2/?$$;+[-V*(C4J__>9'E8PXTIE
MDD_R[L@:!01YC_IFAHC)D]T9<3TVD3H2?W<#9"/ B(</3Z5V]"FJ3UCJ]:O(
M%G"A>7T_ WGW%CZP3H@H**,RZ=+-O.+J@A[:Y93@DWRK/-I=*^?7A3!5L[*Z
M[0U% 0FL5Q!X%81NUHJ'U6VJ?JRBX*E^ U<\P1*SM[7'Z*&L^A1//^K<;C!^
M:8Z**(DEZ/"J5WB6/&ZR#QD3H:KQ[K6>[M&/HS]A%)1DNF(AD8C<8OK(P>3^
MQ]EM<),U5 WL^,&C+53B^O&66'LES1<C>B.:X0K$BG+*2QY-TM8<_].Q 5DJ
M*[XD)J<DTK=RMB6:BR3F_I&W4WT!I?_L:R5*UBBNN( #YU/'!)7JUWZ (9#E
MK[(%X^OL+:@Z2BJ%"T'>%WV^;E;']M-*AW-^ *)@D8?%27Q4/]O(^@+&9"ZD
M+T"X0D<5RS73J_$_Q;L^&'7K9UDM#P<ITELA(K_,*>ADF78H0E6U&<UG]<*(
MBO2V?#!I0('\=FU73^NPH*P]Q]+(#Y$%A/+X,Q9A8&M/H]Q:BM37=]202D0/
MK';>SD-TTC(]P,)R48.ZRBWVGEY.3!-\EL8.&8&9*C878GV]E"U,K"KI2#L#
MB=#P?$D791 $PVOG&W5'H4/*4.^V86S8,7J?C+#;3_5]4RK+W!=7H[85W,<,
MM@$V2Y?8#\_X9%Y,4E'/2PX%H6W<>>H?57Z95SNVG#&]_13SBQJ+J0P%.'A]
M[]"8=^B^>J3;7ZI7S'MT+)':$/KZ+\#2 ]=++J:Y8DORV?B;%$6L$OI*?"#7
M_XGK@8MX<3D+4J$8^[D]3E]R/'-/DV;- A*RV\J::%UX$7\=/^+87])?/G1N
MC^RX[$2SQ^?MO4Z]J/T@R=]RT/\D)(,EAY_78:8'7^U$W-?JM+2E/!@5VBFO
M\V1VMZ[=9,?9E7S_B)%[W]+QD.N.[V]72P6_VD5]LY(P?6RQH%ONW(27\K1(
M.N98=]17&R!=\T'MH7EI;)%1X2MO]*UV524AC2%IQDFR!?6B/5]/?0A71CB=
M3)X,K=T G79RF1Y?^2+97U?[Y3SX!\?^ *,/(Q(J;'MOC6</O5>)7]MY.^MI
M[?_!VYO')9FW_Z,T6T]3C=]JRDE-GDG3R5R><LM<:&H4R3%WS2V>R31%D;3$
M%6B6<M)11DA,F21SU\A10504OM.B*3*F@28(C M8)J"0(+%X;N?[G/-[G7->
MK_,ZYY_S!W]PKY_KOJ[K?;W?]W)]R.UO^D)^<H'F7[$7GRL)^KEHO )-C29F
ML$\\DFC26/!J0SP _6*EJS)<E\Z0M64GY.,<##Q_&]C?*Q:G]SQO:S5 "LBR
M!HF#64T;IL[)E"ALW01E7& M ^Z\RZ\G+C42TC$<N@-;\R-L:)0BG^#N=.92
MMV(L0=@ACB..T85:AY\\=UQ1NZ(TS<":J\RB0?I9L"WIK;TB)CT<EMVN9:V?
MD3#QV09N</G<5C&M#07;EDP"(A)A_"^ $^]H^W+C80OD];Y-$(.OF[%QT;:_
M@YC^8:4??X9JJMA:*)-)% 0=]DICY=;47>]?8TLG_/>O79D!?X[[(^=@C"9X
M5;Q PSV.1VZ"&F+HNO-=GE7PMDW0:N)/,,CE\<]0>O8J28A[LU^.#1NV"> 8
M!?I=Q<97&RMOC=+/U)#B7&Z 5H>-NUX+%S=##\MU[0*IS_>V+Z?4LBM"F":G
M4Q?&",>TRS2M6-$5V\(8)35P=\ER^L4*A0AVY"FQ:(R,H-4\40C8JQ8UWB.V
M\-H;9MT/*1C-A#4_D=D6<DK$,AYY]JS&>?'^CFA;E393>-XT$3C58FR66Q;U
MP[L=.L:U+1_$IN@O4UR1<15)(2XR%#.*7Q%CK,D6CF1I"T(_%,Q=8VQ@4F/)
M&UNMZ3['2XF*ES'9FZ!V/0VD]-1SZ2UJ\$;TK3);70W)JP<0"Z=W'L%K;ES0
M(O-/=F"-9)-U<_&[QOYJ7!Z+OL#^[!UE(]#'/W.42?#4M;]I]\0'=9>?9%W0
M3"^R[+/V/7D9BW$2+RG%GZX6/)LBI<>GII83@B/&4(/!IDGM0[#\:ZCF?L=C
M3*?1:]VU\#^] /XP\3['(3[MR !'>++_IY? ?[:L%V[G<97_Z56R71\:9FS9
M^L[I_[JG[^^8;\7_:5GP.X[^,5CP _[__<'N!T>@UF(^7%/_L;I1_\1[POQ/
M.!D@];S]A^2/+\8]+P-0N.#@1:3/ 8<O[OKB74[-O<\O_[3ILP>3@3J/H$CZ
M .$ DFJ);(:B*XS+LQN#<^R-@/7AY$1V*I+/&39;@X@ZWCHR#NY*.?!%"0H&
M_B-_"![C,L1['!U]-;FT[*P<[$#U^&)8E*)#''I.584R%7X73'*T=1KDMYZ5
M4?:)EWX3W8HBB;@Q/9J!7VIRZ' Z%//59X2YZA[&*.V5B(5DNWNA RD @,,.
M0"J_DFZ+\GO!M)0V(-V=IK-9L@;"PA51,[0U/H#-0M4T?!2#UE5>ZVDDAM;X
M;X)B>MI%B!TH4X>"?L+W3!H+]=?][8;)HH?"-$I*H//^2JU3D,Q^C4=>,;#)
MRM /D\ILD<(>7N>L+22?X12>_MPT/_D0>6]<F_J!:*A.MOMG^O[^31#]6SQB
M1(41^*6@1,9E$ %V0,2"UY!ECU9NZ0:/8H?6FI9:^!&Y(T#<PFQ1\[JT'P+*
M@ WN6<^8+SWPVF\KH($Z;_7.4E4O!#[H39!G=5_KY6I<L3(<VG(6_'X99-.+
MZV]G(OT2SZ29HZKH"*_U?\SIYO34T.$6F&L1&WW#5E=,=^4$H6<[^AOU9S9!
M8%'K@:#C8*ZV95OG$*'H;PL:F1@Y)W*Q_Y:'X$[%T%;/ % ".1S>7]K_H"P7
MQLSEO@F51^KOK!-E %Z"8+:E*/6QS*;2.GLN<^E=HVD<QUK?<POB*M6_VV9;
M9:8%S/MNRP:P\F#EZ\2*57;!C?V7T_RTG"!CA84"3935-47AC6T9N17X=0FZ
M_<XV7"_;/9!!#&#Z]%^>[GEKK<<-AD+;N*Y%E(*&'3508IN\I:Q_AZ=2UQ:6
MQ53R)D:N&*YOLP@D?)S(=UZ\R8J>I9]/Y^1=%MSYF>HY!MCL:K)-.SI//33
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MW!AVGA$UP(BUR9OQTXH;DH7PWSRF^\>GPC-]GI_[ZL'W'W\>=OI__2+JRQH
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MREJ2-T&!NL0>7N$!B8+UW@OFY%&WBY+C(6_!"@A^<HK36>D Q4-":HH*9A<
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M;#O:5=ZC955H.?W]TB;HXW5_HN;TZO1=(=1@=T#RWA\#_[7]T$ 9O4% UR9
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MD[3:O5>B'RW[=G+FND+(Z.Q^::DZ1 1UZB.O+,(T0*., ^7Q^[MD9V'M^4$
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M \)0IHW'D9?UY C&,*V :R0&0_;$M:I)$>-NZUFX,S=4'!=J<A6&4&.%*KT
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M7647&\&?*S[(I]QS?$VG,YEG H6_L5"].G.*S$#7XJ_TA#R^T-D;A6_+7[2
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MWN/!DI4LWW9W=]?]#Y17Q!4S=I;-5"Z-E[T7+\/U+86K;9<H?VHK,A'[9XA
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MTRV_III&VLN$R";VXC5R&;ZGRTCEKM!9_%<;Y<S/]B()W4AYEL[GD_N7#\!
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M;<S<5-R\<G"]O@S>SM%4J\KOP5GGAZV<196RT-G7D)T+N:&,50C+U\/,PW)
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MSJ)\!547OO/U+05CWT4K-0C3\LDBWRN/OHK-B+8]]7S'PXO+$7FJ\-C[6*+
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M?-.86+Y M%209%6;+\5*(-,33%]H4IX2Z-5^X=! @DUI=='YUM\)EKVD33%
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M>J?D5(]Q/P?_./\GJKS.,WP(Q?I74/[J/KZWOTM;@3,?3?21?5.)%#(]C'+
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M^WXRA*!'R%#!ZE.OC@H; M-.;WE-QTZ$^6$CB\LY G@U7)#O];<,%CZ>EP[
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M@ZG,^.=<ZQRA$58]_G\ 4$L#!!0    ( $8Z:UJ_"9\M'KP! %?O 0 2
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M.5'*Y[O[ =<G*0NI+K#ZESB.07<KS[YU3:9"/X=9;/7%H\80+U?VR:9L5S
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M*QOBZ K[F3_^57!P.2Y3G/#J0CV.*:Y#D<<\OV5"7&Y9PB!ZBD9Z6! )( ^
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M"'&Q1$+ )]K?=?JYU)!\)SZ&'&-483:L_Q?LQW-U<?BQ8/WA_+]"-! VD+]
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MNB'_8VK$\:F17P>"@+NZ@""*;E@UV7^SZT#^'</_.3N6_(3924K!!6*)A-S
M/C)LQTW-*R#"*RBF)R I)20@)2K!(R J)2SP!RGV](H]6LNP:>F>-)@H']C!
M@15[$$8<-YTHGQ"?T'=B#3@8:GWW#[F"@KR"DGH_/X'Y4ZX&ME>"+9&6_RDQ
MMA&EM%S@8%<0Q 7;>4$N<"M+).L-* ()=7" N+ *"O!AVTWL]\<W;*Q@D)0U
MW 5FB74N%&9I ^&W<X+88"7];#.IDP,Y5EELS2(GZFAH2*DZ(I"6CL?1%ADV
M+(0/"@5+@<4DA<4EK$1XA80$Q7BMA$3$>"7$! 5X146$A 4DQ<6MP:*_^&_
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M2*-!&ERH3W):F17:@P':A*<QP%T8>=98C;WS%OFXS]$0*L)S2[9[_+#1#Y6
M 2I-;?M7N+V.!H9JKIN8Y.6[?6V2KX!DQW9Q%87V:IP*SS>+TT+%>L]]Y3.M
M'\];Y767]'4;37-'*-AV$U2&:4=-AVI?3[1_6X1_(,(D:-_JV3AM$)[I5R=E
M]^3\97"C"E['@X@Y"F:1YDIT @@6E/A.(S2KO<O-7Y/RV;CHN0-"\X*'=AB
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M?=2;I?J:1Z&F;>5HI/>RBNMNN[&12F/<^: '\M-U/$_1[,4HF#35T]/&I,_
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M3NE\K?\*@(;PYZK:Q2^"-DY)SY[1WEDUU (;;3A%1_?F5"68J3L"LG40#)Z
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M 7+WR-KI6+3<%U<5N!@I>H.8M#\Y2RWGIR)^D)KE@Q:5;!)BLUI"+$WLU^T
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M7"ZS^>=;(F.S1S^5E9X#VM\UY&\K HTAKQS\W7('$N<B7YO)MG>)I,P&1[7
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M,4FUJ%U,**E!-![V[0C]==9I<;\LHQJKE8,J@)50W.%8_O<-[)<CW7WO XC
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M*!U:6E]&:\2E*G%9,;3&)=Q<F<YGCE(\H_0=W*P0U-"]-HPUB)SF.!R@,J$
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MD,37G"Z8SC^463&@KC7&BTX0/KZ8$!O83"8\5&$)^R"ZO!3%)25I]DFS_Q;
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MD6YN:<'D>@0_PF0CWL5_^8T4*=!P+Y^#9+8X7=:[VSFG-N&(V9O]^]B$"')
M1)/6U]L3=)E2: <6LVG+*%W'('5[6!_^#T6B(]3*+")<,P[]B\+XLSGH!7-H
M.OO AB6L.*U,5:\0:5524 8UN(PW#OCVQQ]81M;U?&UX\H+TY.S04>;Z-&'%
M_[@L:7SRIG]NP#$O+Z2)DWF\#?>R2<A WT!W=*+FT<8=@+%/:EWJ,YT=CXJ#
M#V\B(;FAI/V!N(^3EL2S(EU=/T[&-Y^*+_\LHIW=;@2AW?6BU?<U1_J5U*H
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M1[)0QOEIRF]MX"RL6"\DVR]SK)C3.KYCX0EW&>]WPW.NO$@_NXR>B<C885]
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MAXG?\8- RLY508T6>U17@NB#BQ"4^+QEBU>3Y1U :]B<@4(/7:20"Y*_W)@
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M3B>V6Q+7H08]OWER'^[CNBTOW41*K6E.>EU'D\'09'(3@[B +^5KR::B&?J
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M3*@*4%B@61,Z5URK$5[_:?,?4F=;G.^*WVBZXI9S?&9.68WR+L[V-1-+INX
MM;<?K_#-<0DT-L><0JB;ZJFMRX#7./-&T.XL8NUD,+!N.&A[%W+\I=F4--6D
ME)[4'(O8=:[ZW7>851N/GE=?-#>&"LI+4YZFX^5F9(N41,#BN3'V^N0O0"-]
M8_5+7S]$9> 0.9:=-?!V-$=+!%ODEGSH>)J3&I5YO[+Q#M%CUH%3KZ%RKY<W
MC82VP*?JWZA9OCSHKXPFN$:FFN,(?=>%&S/#10VRJ\LJ!\?B^0ST0,;)B4->
M[H1J((IZ%?9<)]-GKK Z]$TL.K4:W*3ATL)7^=&2BIU[,+\1\*KD]^=6A9;"
M\N;EPD[&]K]RMLH2_YS%_O^QV83NY6DDK!IR."9P[95Y6PQ':/G_)Q+!5C=8
MY<*;,O$C7&Z'_ YP&'@CO_V?P'6@7]!:Q?*9*.+RZ^1_W2I>9%CV'P\$D).8
M=:XEI5PNGQPBI?UK+(D=G?Z9[BJB<ZWAOYL7A06Z>[W^+0+&+[##J'/'"5*<
M?$OVW_-B1##LLD;\UI L%P\11:61PS-<:\;1KI?L?Q+)TIU WID[0$KEX9(_
M;/8?J?H?2\@$7 ++[*K2 W;-(!BUXB0-SF-4;RP_F].]ZIM.Q-19G>;[?[O
MW$%NK;#SOP^%S5;JGAWZZ3AT>N*L[P!BP%W7@;7E?UOE[+]N)AUS#'GMK8.=
M+Q(6]-):_8>SQ:J?&;VT<MZ/F:1;VRTM*RG/#2&>_#X\,1FPQ&X=AV+CC!T?
M&'R?PKQCG1X<*S74YLVN)H9[]J:W'%_'F%I9TDQOIG#;AHC3<[QC$@&&B"1H
M-)D^7K?A5B-P4WH\(,$<Y]#[X6R<^@X )IV"PN2@]AF+H68N9IK.!P_/$D=
MXF$2I7G'4ZKF%D040PPR(H0"!/%E9:4U $/(W'2,=>U% G#+7(:R'<HCW$;>
M.UMULQ*__JK/CSZJ(]?HX@X@?M:)\#M[=WEV&'0W-3FT*K:]V"!BM* 9=03G
MF*/[2@Q22!C Z2-WOU\!/WL5L9NYL*7MC(=@TBJG9^<*"Q.9=.S+6*+PC"<'
MQM@_E1+T/T^A,WH)[>>=^#6N&C\5:=OT9WL5M*5]_&<6?#F+]Z)IVOGQ@:(V
M2Z(Q&4\8S];?Y-_O_9=57K_DSBB&GL^L/Y^KFQ8Q7'S/#Q-^1,"]B!!:=U*4
M6,@PR!V:M19ZRH0I=MAY8<]USY#BPFS #G[)O0W\G[5)KJ:6=Z"GESE%AZ[8
MVQM0]-]=3([ V7_R\%9CR(S(,O.??J4LL 2+WT8BA*"(=\/*K*)TG1<4F4&>
MILD@NZL C9$?$+"V'DP#NZ;Q%=K]N7S[6.[W+F;T#C!BFM*[!%E;M^TI[+>V
MW8LIF)L/[/O*EC:H6UR>EY((ML3)2E$+Z?<8\,GPD\02#,;9Y]M$ALXM6>(2
MVA@W!GZ,X (ZUWV;RE<. J?=?.PW7IG<8R/_GM?Z3<A,F")V_F-Z$A=%1'8H
MB :/[Y#SA*E1"L?1 S<-LO!&=4+P!=^*]J\^!N?'?"OZDY+_I)#P>5\;2H$V
MCJ9IE0T">4#O/$;OZVS,VE#W?CA*X7ZYR#%*I%Z8L\7;V_8R 2@[7/WN.J1L
M'L'!9+,EUOCH8O[<-:KFEVU-B_V+1$%*9;H-.^126WQ)X8 NNRD9^ D62_<L
ML6]6\]G/=.>WTXW"WS?#,;P!V-?L-P,+LKNF0_ #'!6D?^5,ZI-G^O-MLT[7
M3;$0J9+XU/[8CUZ\GKYOT3OD1N.9A"LKI$NW=X#+@N';R^-VR_E*%_B#S[5E
M);SPU9\2RKG[1D21\9]?)20!'([,'R,Z?RYO!W71!RF,U:F-!WQM[,"[3L^!
M@!')M\./?J*<I6=QCUYH?__I$CN^VX$J,.8%!PDJ-'MCSHH2:5+0Y/K:Z^[Z
MHA+#O9[C0([L2-]T#E9/WL]]'QL.4S,5W<W0[U!^=J+L?P]89_'ZZG4Y;2@]
M*5I%1IXI>3)8?BHEQ3C-=UCC?.+"68YGI8DC_RP;FZLTL^EH<#^FZX_5L"(>
MJ>^3',K[%KW^PH@\N$RE \YT)*=P=OTTX.OKJM+YK!:SU$4YVAP>D(FVD8D%
MQQNP7XECFP*Q\O TK=A+!08U:!_VEC];#![%I*F1#=-S\46&O*STA)9HZ(1X
M&ZZ>:Z>EH%RX8PT!UJ+FJY36HMPEJM&NSEM5']:EG(C+,8K!?/I/OP; 23*=
MZXATSM@%7LX*6W7XL=5Y*$=-IR@V,ESQ3"#9=*1U\F(5;55B>EA[NRI6DF_L
M=P;!CR^O=!PB'Q&?%/MGZ*7HD530F+06J$W)*NJ2_0OQ3I65\R:3-K]FM5RB
M&WP'G2-1Q"9$YK1EQ:J%3"WW9_5_Z<ZHO-_CUWG]-A%%C?-=_'DR1,?='A)3
M&*-[0?Z$*9Y!C3[] "D'";(*@A^'73'\$&>.X,(K1RFO4AGE^U&^YZ;\PL'F
M=?B9Q--YZXL9*N3YPF;='<#7.XEB*A1](J;@5!M.;'9+J#SW4[:PL\U1V?Q\
M^\1<+DWB#N#'<U)M<%OG 14B?9!Q8>,,5[@#///N4RU'"KLLI21<6(XWW0%T
M#,\.?6%S9Y-=HN"%DOREYDO?$27%M(\\UB4?Y,M4!C_81=)/4Y )[/Y0/$V]
M?!?PIW=%XZE@?WAXU:O )8U):O/% T^T*;@]S^_154-O45:EX?G?DM59*J%[
M7N35:VG*V(*047]<@Y,"2U1:.DCK3*B&"' :%Z39<@O'Z1DQ--PKF1S,66$
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M%-+!4<#-$;NA3M-MH#UN/7\4F5D);B((JF]\#^N_.UC_%NNR=I0;&CM +*]
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M&^U3MJ7:AOL9:<ENNLU1TV>KNWF.)IY04JM(IN+<A8?RGG>C'H$K0/<N7S)
M36O+IC.^13NW)1-677Q"T\KACZDR"C-?(O6".0GQ>#<O.#HU$BVF,Y/HC@_'
M@\V]JJ07\Y,@'U^\[_1(>Z:=MSR>*):I0+6^;!#&4L]RO+*<CEM(E4+E+L3N
M*;[2O4[G\(%7<*66WX>KJ2 F.<V0*%)PC#40L\*A0!>9V_CUV^=@?3:2HAYU
M-[XM-0H[>^-/+T5SW!G'AUJ54MZ '\TI$%6@<-WXNN,R%8_W'L>RQ1^LP=,B
M@ G&\ ,L*[9)I1H6\RSK2/&F!<\7Q7%SLK?:.)^GI5B?G&Z7#,AAHQI!&@<2
M6UHL=YKA0LRMQ#F KWCRNF.^C\",6=9;4XB?KI?4TP:>26F$EG6L3RHRU5)H
M_1\7,@:E ?^>U>JH%& DM#^0=]A<Z]ZL3=2LFLY5>W]2UX23G%R2I:]"6U[>
MZ80M95=;/?EK<\7$E*T@WF:>/I7>G$$!ESP2L*,8^3D+G5+:<+SAH/7G-">B
MSJ3+T>?T,)DDS46"LE14" -W]_BV#UY@!RS\\+F(JKYJC#S,3Z[4CJ2B1/#I
M G$Q+!1'SC*1N=HC6C/A]!;2$J%%3Y#$/:8=%&7R!;AV?NH+R*1K-(COT(G<
M(=?NH%GH>'CFED-SEM3YTY;FU8@5X@^Z TN$6GG^B#4CB@S(GV6K[J/(<:KW
MEE=.3LA]BX^>RX^24)$4I$LE[XB#YZ8L"S!)\S[!4K[7/-T-RL3?6E!@[0>V
M>.8-?<'^^7$A;W]2NPB@>VK?6O/C#W(<K.OX43_F\3M/$?RL]L$CUJA9^/<P
M@:PP,G%.]G9M=H<)=$YQX>ONO,0V-_MC=6 NUI1XH\;!B+7-2<'00J\3D2J7
M%OOC-^1)Z.@?=UB=,KYZE9ME?-ZS4%(TD\56PBZ6WRE_0B%(^,#0ZZZL_]D2
M&'"^!Q"?%^7S/9#'E;;:>T ?&+K>> ^(O+DP+GYX_D\4V!L5P$Q<DA AC"50
MUW*8P=^K?_YM^47[/UC_9BBX+:H"[+C79.5^%P2M7+^9-?Z?A.%_A6^&0*#F
MUZ+4!L>@ONR $^U;R;#!KRRS;5T!M%NS\"U\YH\=;F^7M4!ZKU&.#T[=BEUN
MUI^LG>Q9)*B#@0_01_3?7-7_:^=N(QLEK' /8.BXU5EI^4M4+Y+!5K,[OB I
M0SMH90RHYP&[5#3^M;YZ/'H/H&2X!\2OH-@._>W^$N61IU/VXLW0D:$S6PZ4
MY8/VE98YIDI(U[]IG?Y'\X3] >9,F%QQW -6V__50.D%M['M):-D45,I#9\>
MT(/?R3_Y./5_EKV8^2O;X?MO^3CX1SXVT\%M$]%N!@8&TS34E=<FRRWSC$7_
M;GWY^A_6TX4LZ=Y9)-PB7NR!#ILN*OZQ_/>_!;2@7?^M4I^U*!SK@?_'0R]W
M7M\F/KAA MGSARS;DMURV7$N%_,1F.QYU!\>&D$J(??3T]17]K)A*6QS]@DE
M>81]B7/$O(E"\N(+E=^2<1RLS4:3*F.>U?9KC/>E]IEWX0AQNPZL>9LKJAOI
M9S0U9OG@=-8.>?G3QRS= W9OJWW10_3L,#Z5JPD_WV==7[Q\ Z8/:M(#QEZ6
MIJXEB"=16_FM1+%1',2EVMEMGT8XBY'U/-'+[HW3:#RRDT_]X"[W?<DCT^[;
M(H'8=$>C,+X'\K]/WS0Y6Q5-VY3[T_I*>.6]=F]856T= @H@XL4L 85K.?D7
MD?;+$%U.'G+.\DL>E'_L1KWKV-J1;CS/QG",>68#<M3YNX]8B1LXD<.+3T3J
M3J:J5$6;EN9E)M=VMFX^*UD2(H>E.14(K"+]0LJZUKE.P,K=8)KTS)&Y4/%1
M(8U4SBMSWX7&/9LN\!/:-1!&''?J>DC?XQC=M#P/FE)Z8II@Y4\-&1M][">?
M##;*)-)?!8V071JSO%2L:OIEGBS@LR1'&S<O1W.&3M1YY#-+,#U,%13]:?H/
M'X='3O$:G?Z"3E#23LGZXV,9L\]Y\3CE9;@ZVNLWV9C5**E3).?I?O"LV-#$
M'&YH+UB 4[GU9=-Y$M7^#Z5:?OL13']I$KH/E4<#7#R3P\4RK!:MA:DIV@I.
MQB.(PWBG\Z\K=2HMNA*U/<UNF9N_:%OX7=JJ>ZS.RSQ?O4I;C2M;M_FL9N^M
M][)+3=?YD'A@$O+JIV'(\&T'AK9A4=O2 +=\+I$]O&+W"9/ 2S !JKGA>1_[
M]PFI=#RU/Y\C\)4PDIYKB<K9V<;[Y'RM/.@C5HD]H-/YW:;!^R+99&*$/,-(
M KLCQ-^D-L#$9 W+\7!AN=6_;#YS?,)@B[J>]2)Y(]9EG3XK3V1"<TZ7%695
M\N,<X[2(-B9Z2[?Z)BAI!E-[6+O_MO.B(ZUQU&K@ I34;.2-[D6PXMY@.[/
M$$F\OZB7IL147]+%A6[8$,.7?"WW12&#2-M@M:=^>9'7G94W^9B94S YGM5%
M>( S6JV@7KV@7RCU"R<F*J6YJOX*M(]5P]31$  I%<%R<VC+G]2P/M<.J'RI
M)NIQ9:ADQ!? #0$6IC I1 ^O[KV/T]'4>MZIAI&G&%DFF'E.>3"4>FZ =]S9
M-6_432;'VID$QXDO*^H/DL2-$<,ZW$]B:*YNDHY3TOI(:NHB^9@"6PC#+Z:5
MXN3./^K/>=8(LE7U0W P76NZ])'JQ?)<3E MA &,9HNHY[]*CDRH=XUE&)XG
M24_QH(TK\%L,DB1&+W]^Q\VMSSP!IB4+9_NB'/P%;>0Y#J%B+VLO:4K<!4K2
MW!LI]8<RD5*EQHB'(X_3,P#91)YAG[@FA6:)B"8F>?KNT$L,R=4J+G9N-=\U
MZ[1H]=CQ;J9NJJ-;HZ'E.H6EN679P;4X-&5()SN*4H5SH5]:0P-')7I8,GI(
M3116SUN5HM#&& 5.FRNS?QW*AX>KW]3)Q[H2,JLN]BS4#%\V [_E:T:;26>U
ML1-;_4GPT&_47H<-\@*PSD5.>R2_V-M)W=5<!\D WPKA$K:'[BU_CU4%:4#F
MCB4ZQDRNJ9T\Z<;4LXP@R_I^)>E"JR7YL*SDPBSI9)Q(W_P@'TL-SWB6/,MX
M(:)C;)K8 (QB3!=9>0[.BC+.]VW5S?&O^N>X11W4QL,>:ZN3R1W3! E?U+[(
M/$R/GJRI%N%Q1W[\&DM.XSVLY:28*,2R$2/LD5S"6R!G2]6@ADVGGUI*R7GQ
MVNL<-OJJYU>=W=1W,SGZ0%YL8K;/+W4*E.Q4]%X/F_BL_:0(J3E^+>@&7A1/
M9+9O:$^S2BQG[?L1K=IHF_/5T+9XMBQA%AZ*_J*&^SL4=Y$OPZFX^89C5FZZ
MCM7I;20%:J4 !LO2N <(5-=5WP/J;W*!3FC1L)4)&'4<H/@>X ##.O(DC,Y
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M+/ P>Z!<\([?P/0(NY-A*Z:7O^6?[KX<T8I0%D1L*]%U<<B1L"K2JNQ6RT+
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MLCWQQOG=$>F-,,?U ((@C@:5B@NU/:".HX2L<"7N#L_3L]37(E@+M3=;K39
M;:0V+[7*J::7:C^W(=^?H?Y47B_?R5)@T]^9[/Z>J5_HZ"&D]RM^@%F^#O>
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M9CN^'FU):VE!)C-A)#3I/G#QW(A5VM65LG4O!._YGRG1]M&M\V<%J2>XTB5
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M*<.*G_WN&B=8\>S0[$)>(\W[@%=39D2%4LS22/W->S]1OQX#W=Y!!Y+XE_<
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MA]E+IHBS30)4F+RR?_0]>88R2=#XVF3QL+)RHY9&+@BD)F@2 9@. *"(_@P
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M?K=<?:X$69B>G]EG2TRM6D<"0(:)97E2.04_5[<JOX[$ _MLZD:L/I&+.!:
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M!)@6'*E:>B9M[X)K%I>^-L5;7;Q>WSM(S5S14^(4D&YH ILZF+H(I-OW3:L
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MJ;9V<JY!0'?"-7TF!@87%$23R!P\H8N@ $)?HC':/&Y#A$@@ 6!IPGLKD3!
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MV%-0^DM0)T+:+W&O1ST> 5+G1T'P^]'K!9+.1P",B23DE'I)@=LE^\_/@T?
M)6?](Z!<+."F\B^KE5F4V!8;O7\VTY91"0W(:#L.0'_S$"-\Y.B,5#CX*-/
M:Q@TB%%7*Y8-^UXF$IR7:KMQ*2<.M%N(E-<3CNPG8^1WTC(P9:5-27HIG.N$
M60+>[,MVH3C^K?%^I@LEY^)<IEJ+42^3 )V_=EM5U3TNB=6,;_5@Z&W5ENRR
M>=GYT6735#D<6NO^_.F%> 954,M6@[[+S-@!UJ*&CJ-80^@0]EVB1=5"Z^!3
M]F=:T=?/*-6H]* U'H/FTX1I2VV-#4E5PQ+S:A0&!5]?@]'\PU5CK1_,[0Y.
M=X\X%YXKULEIJP-="1.A 2S8Z?W=]U1-M"K5_+ :V1UR?J0%USQ-D*+>.ZMT
M@^;%PAE#UMZH<":)D+L/^;/)?];7#L=66FSCJEP3-WR"Q-&!LPDN8J/BVRO4
M2SN6RX1^Y;W,UI8$KD U!C]E"/(JUD#1K-34TVVTG">%&BE5/*=.7;._.^SA
M7\5]OUA)X@8G1D%0AP@4>Q1J^V>Y^K<7"#,# _7QUJ2)WQ_/);MX:R>:8"^T
M&")\M<9VWI?EQO;_.:)M:E?:OGRKKZ%U(HQ3P!T062^H/M!I):"^L\<F_*.-
M"=U>_'APBDO<D0CD*")<_":J@N^'"M"=0?7T]?M+I"QZ<+DO.OP^>W.OSV&'
ML4&BQ3/9E@W OL&F@8U-EL5,NHJR1_*H&>I3" G[L6MGX[.S]@;J#., 07+F
MQ_TIR1OQ.D7:.KSR-_JC!9\8<FILB&\/L9<%*UQ)J*J-C"J^9A2Y)_O&GL/)
M1807PNS/EYTN3B?6>46B<?03YJY'JBCUC/(4$;1^X-W\+VE]^)#8<31+XZ>M
MXLNMB::**>/]3FF>^"0[0) XB$B;30,K3(,ME=%W8Y4:=#=<(:%=JL ,!7&A
MTPU2I)HR+/\ZZ:P>1?ADG<Z)A-@>J(V>\%E<$)+K,#;6.[_DF<GP@#BK+_P\
M'/I!O%U>A(!3:/Z8/HP!J5$M#:IA>B9Y)6$U3O(8I5G 4Y 52!4\5HQM48G9
MG6$_FP8HR^8"*'1*2O-EHLPF/!1M1+04;E-1 27)JFZY*K<512G(V_FQ&Y98
M1D78N-(5EH-968@+2?-*?#%X!V#F!@F6,$%_I_4EL?QO+3K/6H(9K2V6SD4$
M5,V>!3P"/(OFSW7S*P1?2==X_EHM7QD*WG.3VBCLXQ+!W1S"4C7QG3<RL'D!
M4MFEJTX0=/(-ZK"[:;WYEG6X1OXIT=&"*0;(>OPUJB$[F;B8$*"=7WCKC8@H
MRF9E2%J30T+89(ADM4,(H\@@0B8ZLF=83VU@00H3$R**/_$XT&-^2# $2UKX
M5,PNM@4E=AV*GMOVY\Y?F0Z:*WQ#Z+SYNKC4,<?O5:HQ*Q1%,;U90DCNWD$J
M9X@_2&BP*-PMNIH;;OWM>)VM$\EW=HH^?&^X$R$X,SZ*'9^<$#5&4*"9ZM(#
M\7W-NM'!5?1B)R<Y%U<4IEBC?J-=E,=_"\H/U9W"%Q/C^*1!:B ?$9_J)0-^
M3DO>8;=5+P"^>/B+2SBBK 0.WV,'ZY##\U-)F[T?F#U7V7('+1W866R(?$VF
M^ L84F.:8O\,E.5*TH8KO/J\^675@_Q.]QEI)R F+F%75[M@R!3CHVR-;&""
MRDN'4#!-_*=T>@]2&%_A]TFZN:1DFJ3LMC\KAF+_1H,?Q_YOYR.(EW\>&AVM
M+@3@)HSH_P8_3+Y1 =KHAW)'37RFT7,/,[AY>7;@E+(2U*BHW3>AE'W#IG%&
M2;?HP]D ^;!XF)K0[8P#Y,/4N,PW:SL(PI7WX4"!#)_?K/N2*1-#V2+>^??:
MSVO+6EAXG0UZ4\_J[,O@TGEDS"TN*0S[=&%<=<CM7%]LGSW+R0](/+C3Z;7W
M:_^N(HB+4GT$B+<=L'^=S>AW&I1L272R<S7O*?2UMQY:9[>?0*Q[*HFB[40K
MK?(^F4>G\J4:J+@HO:]7U/=H"'!?R^]1T+C^\S4P4F'!G&>?O,?C87NYW%E/
M&')<@*O1T%(9(+B^^L;5-D"'>NJ6W$W'Y;-[AE&#YWO!=JJ\?-IJ/DT+][I;
M*Z?NSS\/YLL'8Y/Y,F)96<#1:A1I"@-L6_2]@VKQT/B4Y>V>-YN_6-W(X84O
M_ !<A#DY)R^O[*2B>Y5J'P'1@]RY=#4-0Z=RY*]E2]"8DB15WT<"WVGOQ%1'
M$9"\V^$Q;G%[MX^COEK)JSFV'GOV(@$6_48<GX1?+0DY%$)0EE\<FOTR]JVQ
M" ?4)O_SL#HS[NN$%P\?W#.BK<8V$"(OZ?6;0L:*MH^&1C*;N),]288HJZI\
M?A[/DA<3:#1F2"2U[^64S .!_&.ZFIJ=(/5E6LVZ"&%#$YC!P9H?P2V1;RKU
M\219Q;-XF)>&9'/VDS:Q/SY\1$J%+@@>%=I7KS#$!7)+8%[: H#7(E%0,1$N
M23'9,49.E:C 4*OMY$ R.C#/-VOMPN0B0[.T^RYI3_;F@1DV>ARZZJD_3-ZA
M^6@UK#Y1NA=<"I7>'6Z33BRL#N"+<^*))7)<\GG/\YU6IG)H1+9@0_-\K6UU
MJ)&1OY&1/4,46W-4\O&M6Z'K69V$.O5?N*9@F',+:2]29;')]X0^O[/7RF\6
M_K/[\GL(.&>K%H-J/0J++)F^)*UM,.+'F$IB7KEY5:10VH*+F*[[6-RZ >>P
M:2TOH7)=U??#E66*P*3CZM#D9RJRIJ:D*<:1:X)>%J[&YO0*^J_DD,?)MV&>
MXY0C'PJ+Y^+'-EIXVT5W2N,\]"K,[76=7M4A1IF<2=8*[3?Q:/RD:^N;8.1J
MO*)A6J:BSWK71W%#<=%7T'&5X8%".];&3ML?&GC:&%%*IKH3H2(^!(EFS_IE
MS$1?!1;*P6*+LEA3#Z9L%7<*W 32$U;[B,[XX^4H*56F-CXIH?/ U 2-;Y+Q
M6XK75MR=<-J:/6XG:L"KK!=9W2+W59-'BU0NK/!Y8%!ZS.YYQ7>M@_F[10\=
M:T%O0ZJGF3NYI>%&]LLJ.4'?\ H<D\>F +AB!$KD<=<-#*HF_E'E_F"!O?HZ
MN.5N%=WN9(DU 2Z C9<A!I<.@!XN'$ZUV:>BCT,HW5:<RMW(A!L],,E!^FR!
MV;LD';F#^%[\\$KOM*)D.K<56W;H=QE)>Q'R9Z74A".TN^C'T:O)I>H#T>"%
MK#A@ ]*;:Y4TJ$;IRR"3=&&1T5)3TH S-:&A,.@39S!7.S!V.I,I0SL!N[HV
M]#,M?NI/O=A2PCMA$JIW,AOZ11A4'-YY0G6D!K$,K]$.J+/C2ZC#Y3T4WI3;
MVY03$=:]GM :[S:\DX7[L4+0X:.-11$LQ?XG(,DDY.E>N)5UE@3YP#(HRNQ^
ME^-!Q%IF_ERDU8[E\JD,7FJ)<K/A[](,RMEKZ&#.PMR<\I3>I%+R\."4D%"U
M[H"*-D-M1Y/FD69M[0F^H+&L)$908>!';H8]#0[9'>EW[R9[7E5<'$[#3+X,
M?^)29]4DZ2Z-(Z!+MNA7(RL@4!('G7$P4#K"A.\Y].@!'IV-6UYW(>870KQB
M+V;1_2V]EQ='QFW9^#)5GCEI;E>+Y+L<_ C,H,I&TT__J<I'% #+?V'"C;>Z
M1Y>2%=6,]$J)4O;YPDZ7!<.Y6C7WX!%RP1P3XU51I*/+L;O'>\%,%J)_2_50
M>U$M/VTIA,:K0)];SE+U148S44KN2S]XX."JE"2FB<SV \H(84743P'ZS;Z>
M<2BO<&4@X<3(B[HO1<VEY"LLM D1E*8]CX^ZJOA\'?:-5>1I)#50_%4B7KW'
M;9SO3,75'*A2+FZ^+K.F_FP'.H)=&&0FPJ=B.FU<23$LQ>\Q*D:O@TC816A[
M#HN5U>^.;['U 0"3=S:Z (5\5K2._+ /_L'D05W$C;$DF%@O;=182]YOA/)_
MZV55UB_ZLYCF-]9*@ )A(ONUFK77W;W<^\757*LG2-\7YZ?8YQKX8#),*@_1
M%87/&\+?K24GOJ)>S_9T@JM_6[HW;31G-6Z!7,K/A&+'& 3J"5#N-6R/:KJ(
M)7^.%$P>7KUL-=@W$X# O]&H::F1U8F(_ED#331X%;UL33D=R(=^GJK(+ZGL
MXJ=_+<=B0^/*7)R_<$0?.KU+BG"?P7FN(Z6 YJ5=$/$CIOA)KJ_/6&.1=$(I
M.\]64>(12VY^&3R635MY@(5]OHB-;;=9$Z.V]MQ+ETBK9X,P?E*I\(L"2'W<
MB\K*^^(9Q%*DOR';VN;"^\^<"'G0(75=T8I(,+22L?$1T-3A!JOH<59UHB#W
ML"+C;F;%SQ/V5\3P/&'K^W+P&4Y84YO$O#/HM[JA&3J^I&@>KD) ^"F+LQ+D
MD=1./N+A0=1S8VII2/Z1##N^7T8:P+[6Q[I!E$JX1YB.[WIJ4_6'J$G:K3(A
MKT^*@I^4(YK,"J0F@^W75*7[QVOJT^<IR$:1XH:#\OB''B9!:D7GI?2& '(T
MPZ^#E@W>G5TZ1^*S>V4I AQNW:OVMTQA92=,@;%<=C2\<Y^&#A>=(%JU>#TL
M[M1N%)6Y7D?]^ 4TG%(V'KL4N6QRDKD@]Z)TLN^/@.#/=?Q,J!$P0Z&U;1XK
M23+>R]+0%X#J79MGA'HT=V1-7XO$9^N-2C;C@"R1;X#BR#1VRJIS/Y#]+NNT
M@=Z;G%R87$*:_#2 QU93^1'0XAF&>$"E958UUGQAN IDTF#%QN?P4)*1T]).
M4)8O5/!=\Y*QN*_@/$!]*9BV(@N-^95]]?NW7(U[)/\9@^ ;BH[AAH:$W@CN
M;H;O5/S"1#7J;0?Z.E.F82HJE!8+I I0C;I67=3DJ):Z VO[*9HH3ZD*B;^E
MP;%GUJO$_A9@P5 )E0"PZ%T"P@LKRC)?8G54AGW%1FSR6W7$@YE:N_WF\3&=
MK=N:PAI7+7I#S2841P;:=C!9+MS/VBI"C_?MU! IWE*)+!JV?F7GI3OA=&/T
MM.?]J>&N@<W =G5 "$X4<E@M1EE8Z10X>^?I!<(#@DR![_S6RWL\C#/BR.:E
MZ&)R]#@?3N4KTXL"/W#*TN#T6RUYFW9?JM]:  M_D;4*Y7O&6^;\GC3*9DO8
MC&>3I4AV7V>!L"^G-%<+Z^*//!5(4;Y9!W@1X4^.22$KFG9R.6DC,%**-,-I
MH8;*\EWG^KT5.WU.#ZO+%7S'EO[LXFE!@^Q6/I1<D$"K#7L"-SONVK/)7GG6
M8XU&GN1D30V0!@>J"0V$FP+':OJE@CT@RFHJ_2Q592(Y[ER4+0N 2_#']Q$
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M2/RXMN'7/QHO8]@X]K#EM0O>;0<*TB/%UTQ/Z*G<N:4GL==3X;28<*%0Z,E
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M&'''_ L(QU?N"V0K?F5H5;E<MM66TD877RO"AP$*PXYK>S)'MT/C^<W"L)M
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MHZ@]AP[C"?T)<S-S\X 7C=C.E(YC&WVD0F>A)T)H ( #S\!(G %8:@BF$T@
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MJ$+KPJ _)LUI:O[_6C ?U"%;V!S\.C"O--":7=0[P5: Q')$ E^.CMK8*"Z
M+0;2F&J0=R6=^<YNLV+<8F?8KR0=7SG^Y0BZ21-X@.[=^WLVWGM<!=^($YZ$
MW%K.?[&@S^/./J"IMN2%RSP3X"BQ;/:B$3:BYV544,%O&=&8E>(\$7NAGE5"
M;F&ZRY!?KP#K4$G2RX;$@!<$A7 %O:\S:-7CDDV0B)G#VQW5X=*,*VT>#EW3
MFK4I-1F>H\@N]3S&I)*??LT?[;9,KGJB:P:85H;Y5;A4@23XN8#KF0H/_NA/
M UDK8_?3+N"4*A3CF H&VM:GUC<IP_?B4N.[%\*OZF6S:;*KA(R"-),IP!>?
MTU8R)]:SRDK+_1]BV%$!+Q<O5HC\8\5% !'DQ,U)6E?;W[1&;UZ[+Y,'Q! T
MHC]T<W4:U3V1Z0IO/G[->W;VO&PRW"'%A+M-0_Q,JM8WEH_76M=0%D)!I.RF
M;%9>%3D:T\\GQD$C S&EO0U1-@R"I"60ZR16#=="8:F%E;7#ZEM5]FPO:Q"?
M2K,JPS,X4L.C"W5[#=5FQQG$_6C7BFH_7V,!7RY^;8&J_*GL0%>;,Y/5L/+*
M#-P:LW(.TH_SVQPD'[[33H1A 66M5-\3T#C#/LGKP]XLJ K@GL6Z21X+Z@39
MLH#R0!#<M.3<.\$"=@)V\D"K"[V(I-;+]:9AI_'4M?9%+_II?H,MD=?QM@SI
MKSS'9N4MDID]B.LI@Q/VCS:;'TE.GGIF)[[4H7-/E</$S6,!EY;_GF]XG)4^
M^!BZJFW"A>UM6^('*_BOQ"68V;\>N&<#G7<Y=GWMUAXV*B5!DK?O8)F3 ;LM
MG%BQ6D9LM?WPT;T*#-/'8*B$0V*R6;UXJT'< )(9<ZJM%Z@A#V&.YC4F/BTB
MN[/U%D)#_^+>%9X[;699MD:N$$@I#9!Q]Y%"FZ#UX8KF8L=$?W,K]^,4-G)'
M*U6/!\D#TY861 H5\$N!4QD2]9@@<TZ):W+R'1F7.5#D(W6=HX+A/82G2LLY
M?E_7A-?CJ5Y=J.$/.]9PVQ)>6H6'EHG!R__8Q;L]JQ\G]GO1D+<JNXLYJ<>\
M>HQ#&<FAM4AMV=1)QE2]>ZSAI<DB1/ \JE"=3<QR1Q1S)$=_-?@;#WY,^[#5
MBM!$)73&N^GMD$OUA.18&XB"5AD+$+T\,8^ 'RC^"K=RZ@S[:<E>X6Z.E^8I
M,/>UGUL.K#ZMQ'"'XE]&/ZVRM/."P=TQ-< E1#2_;NT>X0A+Q(W_CPTQAN%K
M46E'L]#,X^W6W,WI^<2K0I[#A%#2>Q7")1RH1^+=1\-=&XMPK]V%_JV*UD"_
MH+S.QNR/VK-:1]>"ATO/.YMN6NV.V>@*BG&8GI-8:4-)--?;M\\T5;:[,Q9S
MC7J=8AP:5LW62S+<<BTHWYF2O,>S'0TTH9UW[UW$X)KN%=^&C;Y=.IH*".5Y
MV__V)!%V0V>E0%^,U(&G^%SN%F8GA.!,)1R*5VF<6+TD=M@:5>LA+>R@*M:2
M7[S^*_!>Z[FZPG:T+DN\[4Y8D5FU<'W\ A9 :TO7FG6FU1).A.2)D^R6?V8N
M]*8%J+35M7A:H;\P&EX4<<=!<^+_8!Z$+>915XI1UE0BK;QLM+0D9 _[=W_]
M)B?OG=%QFY7@^NOFQ^FM=,Q&(9 ,.4HO=/#KRBKA.?QP=M;\:=DQK&^-AVAV
MFK5LZB$8(F16V/1+RGYTC"+A$W>:<;3W47)_QC'RB6,K*N8'4[5V2=IA?K6:
M?7B3D,>C5.7EPLX0NJH?NK?"11*"'U69*R>&R$'+VYN?PK(4%-/[S=D].T39
M9YHK>0J>L3V4N.0%/(TO<Y[W [89%+UJ./"JFIERIJ[--/SVUB^P;C!Z/?7\
M..MS<<[CTMHJ@E=7!LL/QEOA0U7/PW(J9[B<\!OWHYC@W/>N.3SSSX<%CJI*
MMU*/S._H3/!1OF+_GE+-JY#>DS;CO3*@2_>8R3*EA<=F\<@Q]8Z<BE[#S>+T
M]OYY<W.;8W75@IA*9<G0KFW#'%EUPU/&RY&'#0DPE[)ZX%L/\)O:\PW]<P%D
MO""*VN%2G:/&T2E88*X"A"= @!\N!/WC3!F_L^%XN^+/0JH=S&^B)JX^I%+2
MBZBWAS,P?\'DX]2R:GWFN)C]<Z-XD[9D$G(/;7I^ 50[2BAWGW;._;74IK*5
M-KJ#P$B)*=!8YQJV] W-SZI5O9TDP?]SI/]E*;.R(NU)O/[U0[.$G>HG',&[
M&.<8AZ[VIM7@,O>99>>B9+B#6KJ,'I/9F>'U'YW"G)EO[:$N#>W=&:Y\GU.V
M?B!S+=!/9/@CT.60O S#A#N^/,B#.161'#_Y95P(J_E\AL/V96!J]XUO+$:*
M3DLEI6C-R&U1++Z307!WE5A$<73B:]U94U-FEE3:\ B(A*$%R*#ZNZT\1#\&
MQ;HB,G[.-2PJ].9(6SM@+A?F6U)=E$4I>A^/0V\H^7ZB<OI _N.FX,R8[)9:
MV\[=@)S1 7WH8-ODS>E[B28NV?/H@PCY K1\9'Z-]'"I1&-*BD#+*7E4K+5A
M[:M72:F#*CIRA,DMT;@9O.J6P+&*32ZZZ93@@YC'NYA9:J$98NIG9XVUIP(K
M0Q&\&?TG*H77RD?&-(V$S:[N6("?FP+WVHB%!\F;!2UG^S[4APPF$BY&EDO&
M$XPIK5V;1ZO8&?CD6"/<0*7A6EG!S<7K)J<?S]F<=G-$GP(+L+TJ363O6T)*
MW%#'<YLM<1TOCUH3DC;,<;;35P82,4<1%-S7<WL_%#]W3S_7*YF'CY\O(D*U
MESW5=,IN3[M^L%<(H8P$69W<.L/&^V,/HROX+:UPWM8'K]MO\95$&Y>F2S1D
MEG]0<?F.\._$7^JJ]@F CFP=X[/_V+NUZOM%-JJ;,E/'27GXXM@@[LON66!>
M977ROWO9%RDF39?94.J*M95)V[W=U0030=BX "GH%8GJ*62UW;NX:&S+H>Y:
MN$!>B.L^H5'<3P7B$!!K_4V0<X;7]EJV9SUZL>I"N_EAC%;4TX*'ED.N3ZC8
M3"0K AITH8-_-/I"O@0G)HQ_A,=>>YTX4B;0QO[ZK=2%6!/WY,<8'!LURSSS
M10PZ*1_6:UE8^$>5.%4DIGWQW.[>MY9\*EFG(!(6-CCW;:SQF%LWX7!;W I@
M*42PH)8^['I,&_E(<%H);VCZT *-#T+NH0D0X$'4HG\(+3$6T,["GG=<C 7$
M1V$!0IC<7]VB;X;\D5V*=0>T[2P'=^UW5,\$?0*Q@ 1LP_!;+T=N\M"S>0L8
M ]2"_C#$&#DQST,%;&?AK;OK3GOK#;[NQ= @Y^'QW2?1G'26ER/C8/@(<&[X
MW^"M=[#MKKU8UZNL%C1[-RNF]VP=VC$OX8_LE:<[ ]XUKO\3!8(%+$!O$/_J
M,:1*@:LI%ZUW$72N%[B'!?2O=T!%D;WT@Z4NJRFWBUB 5]FM=PS&!84TOI.Z
M%5VC]8AT8V!624DE,>&D(%Q1/(Y(<VH\C>@)M549">$!*?A HJ@GKJ0Q1VM)
M-2OD.?[;T!F-VG)FA@1C1,$109WQ#VAJ$]D!IP U_MXOBW+X5:7+(Q(!+GS9
MRO@<>KGRM&KZR%<..=9[YT<X7$V0NL/I23&ENW,V/FZOVQ#.F"<)=%$XQ,N3
M<6!,N8KH([_$ DPQ-D=WB)V/TYA5PCTXXS]Y/0.P@$YTCF?K'4:X*OQ!"C+\
M=K<\5"EH0_ Y& 8.@"W^NXJ*T/??1BM@#D P+( +#:NQ6( $'*N]2O^G]Q86
MT)&"-KEM0?:TV&DL="/&".)Y5E-0X+LE;=U#_OMZ]O(D:*#^4>8U(Q; !UZS
MN_;% G:Q@.[++AM(P$ 5?@EZ!'B@#KZ+9,'_YKO^27\VYL>X \4"FO+N=GVG
M#5FP4 _[=TLW9!ZA5 ]LOTE[$=P3W!" U!\V1F(79EXZ6;H'Z!2=BD5_O0EU
MTP$I=;+5B8C_>A9@)32LR3NN/:6U:5XS".[%C>%H']1LGN7=_5/.0=RC[Q.M
M% "B2S"0<[M/EI6*?J^!&,*';#M,%=9,_AY\W>Y22A&!$)C2^*Z8W\;<#,CR
MUZBYI1"A\2U^.2M%]?C=*?MT)H=X4KEV6BZYO<[1\DZ@"\GR3?.S !;C64^=
MV?_[?[VL36,!/+^^Y]^9"BXP,UZ.5JN]KEUZ"6W<N&#>2/8WUN]IE8\,]UIM
MB.A$JQZU./]2%(U_9+I<LB\]87B"3N*7ZZ2-<*-<L6R18J7.@=:D*4;6)(5-
M :8I^@>UD47&Q4P*TP2X'J]:Q)N/7['H*W0Y=CJ>Z;EHGT](;+^<^#-(5<]^
M18-W^IES2L7G%>SJ]-O+)_P2#U#]! (VSA>[^NRW07P;Y0&<FFJ:"FK4P1^H
MTED>/<XB>*[L.BNGPB]_+L.ISO,WD<3VD[^!-:<2;<4-BM0K.)S I8TS=='P
M%RV/LI8]KYXB9RS>F>9W\5DOWEEIR_1P>8?">P4W YOOT2$$3<@W,CXN'@_G
M?L/3Q/&?O+[5HFVE9NF,..!R-@7^32+<V4=+3IYYG7@+G7-L<_=="RQ>^<KN
MK9#1_C%RJWM#9H2N9^M\0+"@U=SFW)6?X/G'QWA\=<5=8@;YUOE02P)?B$F!
M^,W[]W@F'BI"UZ.FQU.C\X$=9Y-VCM8Y6U^$S8?>O8XT&*)/EIZ?V !8\5%S
MWMP*:CD?6B.44KO[$9,ISLE;CNWIRT%;GKE.'196ER9; <4S4EY.'@[ Z8_+
M8YNK*TKZ8Y%6T5]4IF,>C%$VTJJUOV)<!#?%P-$X'>A?&T(\QL=^]>W\@=H!
M!.HI<A(D030?GLL'IEY>K;;0ES92IN9G$L$U9U3XB<K8!SP.5?#*X;#XYMKG
MY&2TF:;4(+PW#TTO4PPA$X1KS OC7<WM'6_H"E.?FJ<+4G%0?;:*?K]'%4WF
MRE"+KA'L^9E_Z'LFT-91TF?)Z]MN\W/C3W%ZK7B<EC@>?/)+Y"SZ5W2Y7:[B
M@#<Z2L$W(F+J?E/"X#TI@?M$ 5Z:"8BYGU6NA=OE,Z<@\8*CN8B.*9=7*($_
M*T@#2@W.^1 &UJR/;YQPXC:G/O$9A@^PH%Z8B9HBZYQUL]AHA$AM<XI<P7,<
MMF9'H2%R91^_1%JD#OB&JG:?X/1ZJ?Y?WGX'GG]>$INI]B%Y?+ D,E+7WN48
M(\ DMS*U;=?/$64F0':8(V'-!^D#'K].9R8<?9"@B[,DBQI# ?ET1YI=O)]Y
MF/X(4PF\VOX8'4M!%2H5WP68)8/3YIT)PZ S(M\F@L$<!E]'5=GYR"F^LE>6
MZ-KM6_B5F!L,@Y2HB)OJ61!$_(1#G( '2W'-S=UI'?HK7 QJ[]XFK*0LE$N1
MBH.,$6-'_PYF+=PHHOM-ILT*/V5(FU.% U%+D;-FAX[33<<7-_IF9XIZ=M[+
MI*@@?\:XB)0%IT 46\>BM]C*SEJMX+98OA&]*]L;FL^#9/[:7;SZ%C4D> (+
MK3-CM-S4 >LDH8Y[9G,@<0.3-_5$%UY*:MQ0"''FYIF$Y#L%'8.$44L'\R97
M<>L4S=;S/K*G1Y-$F-_(A/*F,_I<ULG,DB</HJC7I\3](>[1\^%YK>=;&ON*
M@</XW4<Q;\-&CFZNX7[1;.4<^P/!\BST.^STT86YEK[C29,@<2+&),58BW1Z
M\J>/,7/Z:P;0[ZV"#3A1;828RE#CU]M>I@J,A%(+W?4HM?F;_Y]33:^.J$K!
M J=E0::\8DHXR3^<OB'A$A/M5<CYY12VU@.F\<V=?.&CL(R"<>N_C&,RB6^&
M3=[?<AP/J,OME<,57C7MAG@)")257?N+1>4@_"QT/VL),-:5_V(M?KDW8(<"
MJ7TM0J5^L,)_\:;)HUJE:A3PEI7XC"_,HB"&Y,^B(9%4=_G?E K)_PE$(39E
MC@4H:(F/5*%JY@5QZUN!?R=M5MUX_B]EI*#_LXSTZRU\E6PRQM<)V>O=[&03
M 78<%_P5(1)3,+C!P?=1 ^GDY.3E32-.C;<T[BV85O$]=M:WI#SUFH?,MJ0;
M.M+IU+@LWFG8@F@8("^F5ZZAOZ=A7#)W7O;=5VLJF6D5P8HP\?0#6S:L<%>[
MV.RL+.UD1C72+NA]IC(W8S2F*V>9IOI]5:_PZAZC$\-0@^SD"PU.L\_)0*9Q
MJUG*?-?2!2J,9.X/24Q(7J"WB]4.+]F!/M=(Q.JU;:-!P/.8PF&IY,$^([[2
M[?Z/%J9%4FJD53NO==O:*F(073]R1,>GZN'6<'H"YHR+URGKRGXTY_L%G4T.
M4D?-.\<SHX$I5AU&3UM&6JX>O@7W;)>AXIB$$SCL5%7$V< Z/^#MJ.<!X?'^
M*INDE5D=<=F67@725:7).*S=/HUS3<4A?'*)=EB P4I=5?%KA7,L@.##L4*T
MKU_0X(]$U:UV\-KH"23@&9E<%8SE]K')8=F,W,+M7N<%U[\4T/B)GPO:1_&9
MT94MI04O:^RMI+_&T"<M!24!S"X;KPIED+H]' FMF$#5&$?JK#V_1U&T>EB
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MD7E]Y2G9ENK"A^^-$=1G2T_B":"N78QSQ#9.RJ/1>C%<6A@CMC!OR_,PEXG
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M>;^Z#[^G5LVWST9[YP'[Q!N'6),VALCB04WD"5]R+#)42XSCDTO0%/-V,VY
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M(J"SU<Z)U+-<,#H]<@YZ%"=Y[L->(&%<XC+S#I_NOZ#E-60ES5W6MTV[003
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MWE\&-L(_TD "DG4&D6[+U@U/_*$,CWY)[UY]:#X,;I.N<Y3UUQ]/[KD2';>
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MQ652::H;0?,")Q&^$@!]#3BL'PC.L"ATM%/V(^QM>ES2ABXD'W[(GH09"M%
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MORY-U;254?PMB$),8HSNO)MK#1_9'?0#G?T8B_NUR8PP[8(ESW=Y2[(CM:1
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M5%%#4DM-ACV>_ZQJ7$>MCX^(ODIM:FSP>(!< /Y6$H-([,]6:7$51>X+&Z4
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MT&-:JBDZH1:J5@K$2 BD^7XS?2=\^V6ZI8!ZSM++PMV+.D/.BU:CN;YT<?'
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MX2921MZ$Q$%^C"-/1]QS"\OT07[V [_HVRSU$D/A3=>;>..<[<PHU;$R[8B
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M;M"[GNA0XB>X5X$[&LKO](QLS&-DJWBR8*0I624@>CN5*A%I"CG3S&9Z2:,
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MME:9*ECQ0#U]@%\Z/?^%(V:YK^YB[F/]MU9P13W8K$RVN*)PG1(BUEA_L\#
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M/=N_)C#=HS]G/^3.1@[]YFQ17[96VJL^))G68[Y31;+/Z)A+JFB0G-63(E(
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M,MI)S6F[N"F:'Q25-=-,0)O8K\V[\J69)\,^'C;U'5\/>':2$J59&>U6#[6
M3HDFHE;?QX9@RA%A4V6>NVPCX+V@!F7'KVQT9 F).I]^ZC\0B?G9Q*E4C7?
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M<.F=5-YI%3 DU5,.<XIWDDBI"I)F@ 2:YEH^PCS%7A5]>HKU7*U7(:;S6!W
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MC\JHTAF56"&-8<5($3Q"J@C$TIQKQ0N6^MZN<WU'OBHRG$7QUB4Q^N\C\PL
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M/9@3]V&\3(4R*F U2EO@7DQY1HGT-B->@"IEF:&2]]97^.-6#;J<5M;,%<(
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M"75=_XR_$T%@7= _3@%G_.&+Q)PI\$^>G,2-B";7U;%?L TW]O5-\(0(^L
ME=[0@ON6+[FP'GGW:?O#=#:;;>%WO.U%I&'PFL@&2QMYZ;L]+9C0,BW E&(:
M#!\L4!R4)& V*QFRPELM7B1CBP"H$1I++%!<_Q4DXRXE(F,I43Y3A 7@2R'C
MA?-PSU"C*>1\N?ZVLM&"Q;6VOG8QH^1O4Y&;ZZA?5WK\2(C&7<CGU0*F%M89
M/^&6MLFGH?_Y0H>TZ#^YP$FQ@?A$^#H\2P;ZK!JUZWK45J^[AS-*UV"XQ]=;
MM"./&K_>^",-EIZ'%\*SX>'UY,G'95/&8E=GZY.KQQ?!56XJ'?'AXH^SQL/X
M&SKKX=4UMZC\IGM^>=76%QLU-F&PEZ\<F1/X/&)JK[^NQW\)'KBBV7/&$AA#
MT1=E]6 L%W#XHG+B50]@"ETO67_:\?N53[Z\3W;.#D$*__2RT<.&-(! X3KL
MQFJ)/C4%F)ZXRZB48*OJU)(@BRQ/\SP7NE@4=F\,AR,]V/9'5=V"G5S5A[K]
M\XL2OK;Q%M2F&A@]&%0MC/BB-/"6(*,*D;^^&;I!_MQ2!4?U$<5NU8<;'S]^
MV?@MV=[Z_&E[-_G\97OGR\;'W63W4P)&P"XP_82ER:?MA&4_N9^33^^2W;]N
M)3/VP=0VV-C<Q=-,I>(JMK+<KTBN&NP)ZL!/1-)'2B47-PV]J^JD/?!)*!L0
M\^3,ZSKQ0^?=#?3RIA9<@U! +I5S#A>V@^FJ;RB12E*P7.LB9SG7V:(0ZG-T
M8F]UKNTYB%K'G5?)(;SE &\C3I\1_'+BAST=IK?>=HLS*7NYG)'!K9!SKQVA
M3&N,]XCA.3GQAL;M8WPA]*)&YET4MK]#C[^#(TU/^QS7'6^:1FYG&#Q#7/FT
MO5# 7W#KDA7G?E2<^PYJLGS6G:G,8O0'*2PN^&191I3+*&&IYX%;327W"_.8
MX,Z3<5VGI\Q;])!Y+UAZEMN+N]L;'W?>1Y*]%/Z](L,WD^%VJF5)%PD1UX&3
MO8O_)6UU^>"*!$S[$R/YR@9#B9)W)4RP@ 7 8=>70V 99[D-6-I82$F$9@4Q
M@2O@LT7(9&88Y^JN,+P50W'P6[I/Z6F_4\I(*D6:KAS8-RK7(UR&FO'.W[1D
M>8VN>!W2#(L7F]PQC%%Q1!7:$)H7-A1:,^/<8G1EV^^7#>)IBW&C"]67&S_^
M]D/[GRE/WI15\GYHUQ9FV_5J<7N!"Q=;I]JV<:"3*B3G YSH)FF.O,7H19>4
MPZ1LFV3S0-?P,1<7.5:0\_16S!;\[=^TT6?%)EKD"S/:YZ0AWG<G,SZCWV_'
MWWS/XNSXRV/_G899)T57V6:30_4X+)&RY:^QW31A8N]<,R=BV*8N3 #J*+ X
M"%!'K:TCN<B5E\QK&>YLQG=S(NX/58/U'N-?8P3P>">HS<KYRQ9]@U?@;N3X
MG,5YJ&_I=Q[H$XV!W,LPZI^.[%BJ11",A(#!Q%FAB0%KA/C42,883Y6\<]!,
M)SN[^O3].$6@V\5JL8;(K81"%"05N639C>[Q*WP-5T!6\1@AJ^@GV;L=A8N@
MDU1U4F'9V^0?H[IL7&FCQZ,*L\/WQ+Z\G(7>V 'UOAZ6_XI__]P'.'O,O?O3
M^[7MM9VU9+RY3_V$!6D>A)./U=J5TO/4B=H2?1O?F&Z+3 I'#<RON2Z(,#!_
MF@+WC76YU2Y0!5QM,=/MAG.U;YKQC]_*H6?W*F8RI<GO)794LM/6WK>WF'%[
MRI&D+00S*27*H,_)2DF,%8JDK.",VM0Z8Q<Z:)M8T+#>K4[NES+_K@?M@3Z\
M8:"6X-FY5>MN$SURG8,]4*$+Z8A3*I:08$3J @;#,RH"9CC8!1E(XP&,+.53
M_1E,'YBW%^8\O%4_?=A8F3S?E ;/,FFI-,3F7((TY(YH'LWE(O<\5U)YNE!I
M^%R!(3SX/^51M)+O4Q8HAZ:N3)U'R=-^&DL/NJJ/:H"1\D@/$G_J;=R\%PX#
MA_/-BOK?M9]!,1/4S&_2X%6@0==;YXLF__X'R5GQNDE:/_!'!W!3,HP>G9<)
M".M@A+*3:$ $@%+GUY.?EK)VG@*95E9S4MC B<A91HQSFCA 9,Z=$M[PNX(Y
MTK$-^)!%PO>"AZ60-\%\'UO]\Y("@CEC&>>*%,RA4[S(B0I WRT5A:!<:IG>
M629^JP!"/Z/4]SJ>0BE%*$_Y*IRB!VN;#Q3-%]NRN/32\]W@DCI.!K[V+CD:
MU;CE38N!97!%="TQ_I/Y&>D+1J9MV';]@9>#'U9 'N<J<"J_?Q68_< MV;V\
M1MSXFD=A <UC)HTE7SK4?'KT?+=L!S%<QVM[D%BLXK8TB^?:?DW^$.)_-'V0
M'KZ^3W\,CNZIUYZB--8:/_\)+P]UV2,_+=&OL-*RE99]NRL_CB,T(^3[4WN
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M!/2X*#PMA!6+6O)# ;K*"_88YKK;+!$^*P3!ZF!Z?Q^F$H21PU@9;%Q"<HP
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M9[1_T)'RL4&P/]*UAI'P7=4U"WQ9V[/(ZV-8(HS1. >Y&=F#V7;$F0EI!&8
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M"Y!O3TXO-@$^2(,ET6$-HR7T!'J$WV9R/*8B"26S3D_Q6Z>SO4=RH?\[CH5
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MH#NY@/,E\E <'8G>0B5CRSO-7DTF+7W61(*X[]YJP9(=FUEZ6<D)6**^-9V
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MT)F-F3&9BJXQ]W213WF)C/)+>ZZ+G)3>>JS7F6L$+& Y6G&_OT"B._E[7A7
M HZ2\XO]E_NCY%4E#".X6S[@_01^ \!-_@LNN.LV@^QH/QT?)&L:&8MA>WL\
MZ;?!.0GH2CN8,8KK^W)59[07RXR;JB;OLD;I"%#(OB(+/OD[#8T4S?/DO](&
M7"@I?>"\3$?)&_X:_2CYD#?:R'K+5QR>^*\(1A^T92^TK;U$^_J KT9B2Q/\
M<Y8E/Z5%==5\S&D@M8Q]%4SLJ[S$D[LC.@IFL\AGI/TG-H]R-J+1:;\@FJ5+
MV!;8'6X*SUZ]C5JYV=JX;:";/,E0H;9V9TV<I_=I6V",'SO3^ %6P743>=0_
MD7:B25BT*)>3OC+,QEV5VV#$S0*SOJ!-.FD+'3!]!O-^WQ&=?"\MWK=*&P^#
M"O1(: B_\OP\1D)O>] U"V0I1R>>S&7N,RH;$A59D"(0&$QH\BQYDT\NTJQ(
M?D0[@$;..S_JOZKFHDU)1K<D^4H3!*Y5Z*\E-Z+7O@-GF)YT*IU[WZ\R<((D
M'ZH%[486X[SQ_<TF0>*'O*_:U06)GKJBVU)6#VN&ZR])+64Z=F$ER@JV3+L1
MQ0 Y%.<1Q-<:]OG.[O/?I,)#*5[$%C!!I^*VU Y!Y24W2FJN5<Q!'OYM/<YI
MPXUB34<_CNFO5_0VLHE>O'E/OYA4=9F\R*M+N81.P]L&%D*P35&]7_)!.?LU
M^9'K'2<8^.NRK#22_:HMIRKXRVJ6VPOOB)2]IY[/>RUX'+R?NR(QF(8Z%ZXI
MR56KR1-CY#G*8JW5K$!9+>9 72#\';?6TT+6VWDR&(RO)!-*0O@J0NBUJH;$
M]!#&_XN%\7]G7?SIYU/G]+0X91*=4P0M:"NFXZSP$<;DP=N?O]^I[@%19UB5
M#9 FUPP_0+=P]CM=Q#.F9?HDP&A4)0/C:[)4V G5N>$NM$P1!WJXK&:".'WN
M7KN,>HD*IVTR:VMFM<V*=J)Q8_@8K6N.2_<H!8A(0Y\^K+-%ON+HC-1"]7\S
M'D>?M[7)[,GS(=,XB*B_D(C:X/GZ6JPEMW6Z/J-AM9,6_V8_ZE#0*,-,--6@
M43U5? )S2"#V-0FH03=[4P]B8Q ;?[K8>",H "Z;;3=8(#Z;46*WP@5W@FU!
M84X!4>/"U@3O^6/613AGO.BJ(M=/243V;Q9(0XWB7:A1?#C4*-[M,-'O[X_R
M5PYWG@M_5G,WPYT[%]O\XE/QHFL?2YN!EW=S_>YCN#I<0:Y :Q(:\D6G,^%D
MO:H^,J&RZW5HI+#[<FE172$3RO;7!9E8%[1\VEB!G51I6=$(!0-"->PV%0R#
M7.7H.+?(R7#*RLN\KDH![9&MM:A6]C+0[) E\V'/L=IP$XQ96TZD$ OXB0E-
MPX<?C_A/GMS5D?XJ I$OE[ YFU%* L/I9Z3ZV$2\9'@C$$?*"_PA["S#7P/B
M&AIY2"TTDND HZX,/_.Q>>NXL@F.V4]>K&7Z\;7\!#?33#QG1F[HD/;:J;19
M=)29(T!"TK+.QFFA0!?<%$SC=_1#\&4,MY+P&$_.YOCS\K+ZB/1!D=6(2(R4
M.9/64>"K'_9X::;9,BL%%$-?[!;!0G5 6F%S2>\)VV%LQNO4^;6DB:+AUOR=
M;AQ^-7EY<*D^)6@D0I/YD!?E1(9)_SH\=BA3>4OXA2.FE,K!!5O[.I]LB1Y)
MB[S!-O/!1HY0N!W+')+YHBWR_<[Y\<>&86O<6\1@+MS*Q+-1E^TBJX$BOA6F
MRJ>3*\902<\IK<-V5TE,2$2ST4VAFW,C7;>3O"A:\17X8Q?9Y"+5G@H&OLLV
MNIF$\GZWG,(_I3%S^.6[THGZLQ3:7\*LUB[E1\^24+']J)+R/)24+[BI[X<?
M#_?XF/YXM/>RYCXZ+[5USKEKK\1;_4YL\3]OQ;]F1[ =Z[Y^N*W[^F%/]_6'
M3QZ'W=<??W;W]:^Z:E]+4OT)JW:T;=6.>E;M^/&17[7C1T]W>]6^\%D;HH5W
M+%IX,D0+[[99<T.T\%Y"<]74.[Z%J?>&_$3VB%^+^W3&H8C783_+%PAZG$ZL
M*/U,^Q6>OA0S4"E^?T<_K+^2X/\SU?7Q-G5]W&MD!>KZZ,G!UU/7O\\A_ NO
MV\-MZ_:P9]V.GAZ$ZW:R9=WNI;Q[729O)ZO*MU$_72!L^KJ<[$MG+_PX"AL'
M@J$?K<U]8;:UYUX6$[2Z#K%\VZ_L:_?-*!@9 -+9[:KE,);KDKZEK_SG=(._
ML0UYU!=^:/B^RPW?FSO6\7UT0\OWW]-4O=/(?!=$RMVHMOE3VGN&-N5YT"2*
MC4/[X66Z2N_$>M[WS"8$NF\;R$#11JI3F9,@N<Q7=07" N[VP2)[06*24R(&
M)P^[0-!=2/#L68+'IQISM,5$Q@KYHZ #YE]OF_Q5[*I@G[ =E9(V -E,T]9D
M#J3@3GC_XO#A:',3H9$B;R9I&;BHIEFA.VI;QC=?K<F<L.XR>*)K+TC_GF9B
M=4B=J=$)9>5T6>5,*.33?9K;\YUJ%O2C%(=RDE50%*,XB^B2K$'FE&LLM \4
MMTK=Z:TZA![O6.CQT1!ZO-OB<0@];L[)>4_7T*!W8^A2GO\T2LY?:B7;IWPB
M"65N+#M):S)! /7F""2]<>^'JB+?05P)".SS&O(="!M23#_\?$Y^";V@R)B_
MGQ]*OT0#VRQ=R>]L.*2%'C%A)BF$XSTR9E87C:!>'NE/7$ G/=7(*5R7U:(J
MYNAB7I4?,^"Z0@,J^T1' ^%6J"PC#832&E?*>PU";?CNYS\% ##E,,(7\C52
M'KCD"AQZ*S<-$.T)Y=<LP:8+)3A9<84@FO#N8_IL<@&F%QU(;Q)(&7O22VZ"
M/IFTM#DFTNC\W=M1C\7&#MOA<X&*@::A:NA_]=JS<[S_</KAA)^PU']R\W4U
M\!*M0RJ"9N]X[KMMAI_,.4WH!;K&%?EBF:V2"[(N)VOZ\))?]-///^[9B/2C
M NA4%S;% !Y=B329I9>T63!9TK1:!!===Y$OM5@I*M!T=BT6XC_GJ^=/3[[A
MN:*9>7)P\OSIP3>=:9-ID!YZ[+@_H4L<2DZN2:-O>#W_P8]VEZV)^RW%N@Z2
MT. CC,>]BP7>9_X2_:*O5S(=VDF=CTT2:"?!:L^LVKUT"HJ23-&&TBJ+-_TO
M;T^__WEDM7,JE%B<X=EB&Q^>'"2+^7<?Z13A(C0BR1H5=.CT#;@E;W$GGK"C
M3PX^24233LXD7PH"E&R%(-0V :>I8?OX<=C--"WT\>,,1Z-=Y07-]]0%R*IR
M7N$/UMI79^!N[.^=BN=\[J?_SKHWZ_?MHC4?N,SS'8=Q_ZT*@R\_]B&0$Y<#
M^Z1&ZOJXNZI=\$PVC1(2H 1OQ%87%!8IQ+A7=<+N0D1%SM+H_=FHV_V())/Q
MLER2OTBC(4&VC]>#V8DT<IF")3DE/;\&R)8LGBLX[L'+?%4VB9KW9]9UB8/8
M[,2KS?3N;8A&#\R5Y*:XTDC"!D&P:KR^G55#GR<P;?JFTY4.;8X!LXP$8:+)
MWGX#(@M;Z'(Z@CX#TC*%F$])3@MCNR1]K&![Q*&W95H+UP3F3CKG@BX.6J9L
MD1L2=L3U@CYCLC;B8O\S%A =R^/A( #3K$;\+7O>@A+5TTCBHUFYS!'CNJV&
M6X)^LAQ12DB7&V;[W9#U]]*6>2^UMUR7KP>1"PFV;MW0<M;"765QQ_X-O*Q&
MK=[0 /%10+8=:*L^E+.B.3KGCO$VUG,4M3%H0O%"F_D?V*'.LL?_E96.:X]-
M>GR0DR9,K\@]EHU4'%=G$BZD$Z@<4:??@U)<B.M&RL1)LY"2\W<WMO).F2U_
M2AH*YO0[>(ZF$%Q)R=W!I._4*GXE \XOS6#!83:XR$L97C.?+2-!QD%51X<'
MTYQ%8YK720$>!4[HDQ*&A54M4(%(@TEKI#SH.BX,7%Z0$:&!-<:EO-Q/WJN#
M*HT,A(O!E((C3):*OX6@ YFZDV$ EV@NYVA=.HS%C@.&APC>JGQBCX(;F5^2
M#IG#9"V*=-EDZD^FB %9T$B?/*G:6M2'<N9**:""%(4;-F@UQP6362.L-\W'
MO)16U?FXA8&D*HHA+#XP8P^]$X+B7EHN+-51RLE%@;!=2H&H;&S$90!$E9VH
M989DQ-J2YS!7K !TVNU21N=0-I <*\U;^EA.8!\%P=(@%CDAA\&00WYW19M.
M"%'0%X=Q2&9\\Y'A2.E__J^G#T^>!\[.?G+6+EK)MQ3K$=OV@.7R[9?*"-^T
M\SF97DJ<N>DIV6/1J63,+';R9I3QN@-N1TWK4WT9)YY)I['@3G521LMAJR2E
MDY_1A]R- [13FO9/L9?.VIK;@'YPMO+/M"&;2;J4=,FOY2);T9/E5-T1 ^I>
MRD5G,P1ES_17B2+(B4U5MD2:6$,%63IEG>@,"3A7>1,\ I+"J'GQL'*=@%1;
M6R8P"4*3?<HT:R8(SXE*(Y8C>>,$H)/?&0K Q=)@&7[TC<F<9;4T@JFKJBZF
M],T:+K>'<#8,$,ZJ1.&Y?ASMW6(I)/HI2U3^(A;?Y#QRAQ"VBQP-7ITQ]7X"
MV:8A+DC5A?8^RHU:@24VQ\]4QM&_8>8VR0/^A[[93>"W#(ZQ:UOA'@^OYRR5
MOSS^.*QETU03L?N$R9BV'-J. +3[SS8U)D_NB9$OEO0@!VSMN3N5ON32:YWS
M5,UZ<E'Q14RX7M7C'$L=D@%,,].4^\FI35_7AL1BEM5*%A2!+>P3"*Z4_>B.
M/2B&G&TJ&J@S;L?K&'UC9?4+W5*@5H ^PR!6LE=)64'!KSBN..UP"W"3K5)A
MU-#[3M,;:]GO,"%D*%]'S8)#31K-_:.MU\Z^'DS4'1?%+\C=FM V*/.Q!+B
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M!&ZAQEL/O#+8O.K6:*!#.3"L&X&+R.4>FL$EXL:'^\R]Z@':PC].IB2<O[7
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MW]O@ /;$??_LSWJMO15X-;(>-OUT#OS&'IHS;AA:(1@ [['U8C:N&0'4K&%
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M#.W=G'0GU6U&=>ID)>ILD?KI9)E,5MRUPGH_>4/?B.D:1>_1A=/Y\9\PDAY
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M:XS<S2D]29)_?;OJ\9]D5UUCS-XPHY\YH3?G^N["W#W'5P_NYJ ]_HPH,/E
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MN[K(RI!N'XCK<J[ME1;I-!N.RG!4OO!1<4%91AV%D)F0B(P#W@R^'5=I+<V
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MNJC=YX4K3!-)1^4B&#F[FM$K7,B"O]'EP&F9.+,QUH3<5*2=[$Y>/AGP%E0
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MKF;)J+9B'?R]WVH[2&$<3UXET8R>]V6QFD]6)5R>Z)L<M#4((ZZ6@E\-GJ$
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M".P,*9N:[R_S"2P%[+ZFY TR XC_]DNG-%V-HY<7BB&D9@90X+ HJ8XF8:+
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MY";.A="4B'6GE,V [S8(SHB@R'<\-SPA%^*#Q6XCPVL\FQ #)T6=L_!V0LD
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MQ/M;WU">O:CJIYG5S\T\225>ZE.@OM@[D0QDE"S4UJ3+6 8W.9J8ZYL)X8!
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M75")PR\;[,?6GIS*B^ _GSZ6GV6L4)PV$+>&/]5;MXQPV1B]NC*[5Y/GQ:Q
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MUL9%^YH#W5B@N@< $3A2L7TFBLZ=!#2-R)2D2:C_M3JRA=&YT%^0J!MS0[
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M_:_C8'ATA@HA@YP-</@3T0QL)$$>2R(A+_N;QU&6>]LRDP8V1G$L(&:+P*Q
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M1*^0U/.8R"W(8<SK/1%8!DJI"'_+]__@0. #2F$26<T[Y"*Z!.-]+YOD\R2
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ME%&B*/-5,791.;:U R2H;#K1I(4)7@5AMWU?A2B^M")FMCUJK&75_,BQ)"1
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MCA0R+^%3]U#,T#"#*I54N:"$'\XJ(#(0X19J&G[E=6KCM4]MP_/3LTA$H8O
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M/$#$32-9-"M]"CDF$"A3:$<,[\,<#M?V[K(!$,ZILP>#P2KB.4""P1#_!<Y
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MCOMM32N1\K3K5]ER N9--/;.;6.NI2<\/XZW@H4YRDY ?W*6T;(QY!B["EK
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M:6Q#_SH+M/>9KN_XKLAS&37"V,])IS'7"OQ@K08RD1VQD-2515KJ6II&FF4
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MFI:L^"_92)<0\]DO& F$"Q!O'6BNC4?A0 5%K\>7I/^"OJA0R?%V_K80EQS
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M(5Z;J521J!;NBWJ&(\_+EW:>W_6I\/U!4J:P&^NOO_U>A\3(-Z,KO6XH2]V
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MF2C\LK&K+J.=]&K#76>GZ3[IT:HVRDYN7CRPYT);++Z)<S"8</M8;MC.,*9
M#=F (X&&BJ&+8 7;B]'@>9NKX<L+C!/*B!/;I72$^8P9YIPE:J>KX^8Z])1P
MO.;D,<0TZNLJ.KP<22HN<JW%[(RQ&.YA'3<)$SEJ<\1  AYPK)PFV!1#K)5
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M$S/$FNQ]B#1V:W0$%K\X45ZS=L:&GG#9=U51Y[3T!;OXM.+8!]N0$2)K2C@
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M\#CC>8E^@E,5Z7=,Y3U\RK^]SX?Q7+N?:_=O9V4%$H?C-GI>45RAG[ FKM!
MU"YIET&_$M\G7P;:JA4'3$0P4@<H<#Y;S#"4>2F_TZ6\R9D<H#QXW!^YRJ[,
M.2H$/T7H,Z_1>8V^XS5:5%KJ+([]KFGCY3>+^@A>,7%8DL6-3DWTWMBSIA1+
M=2*GB!+6U=%'AF-C/:_D>26_XY6L9I9IQ&JN+DWY#8@6*!*Y*=:4'0N=]I),
M?'D-/6IC!0J_Q"?M$K'VU$^DK3)NB[A01"EG$Z^RLQ!#V-GL-_/NF'?'.]X=
M*8D0?U=#!%22&;E01%%K%)P6M&DV8K'/BW5>K+]>#,B=?.1'4P9*Z">XL8?\
M:2IYU%(IVX+>0=QHP2I.F^<ME[>D?T%)07%PT :@8AO"1<I(9BE#4!Q1>F;>
M!/,F>,>;0*E6AFGKA::C]_'!::T&+0<#<KDY$G8F3E;\P\3*51WW7;DB66:Y
MU%1J-/[MMB627&30.QK4O.CG1?]KN"FWNX9K,Y38*P@FR35L6<*$PW4K]2'+
M<NZ<N8C.F8_GSIG+KO=.=\[,Y\-\/KRE=*4F*<^5F EO"XK>.(YM:%OU@ACT
M0GT5S 40'-L!4CF-J;7X^C]?A<"[#)N1I#TW1"\!FB:T2N:>F7* ;P59 9F-
M(>2--9NR E/D3O0"2&8A'FJ[\L YHD,#+;YX_,4A]F45&.[0$O#!PZ6EY T7
M+^$A/",8 Z&#B#C<<%+K7+J6'G;V]N;=_"N%."'3K:!_.QW$N("K0.2PGWQR
M]<FG?]!OQ+VHC'= 2 X#&!,) 3M>Q9MO3=>A_H,]M=ZPBD @#*G(,.:24$""
M[*R!C*%)5^<VQILAO?X3]^U].OJ_;=I 72@)!72K1&P*\6*N7T49+O4+U_2S
M^IPLUP^2T7GZ^"-]\U]\_>(?:EXUENWREQ^MJ%17B8V:V2B>_,76CA>K$9LN
MZN&4ZR1@F73+K9O]BM'!:) Y$EBG(J-_O3NKS[FB1E7N!1F"NL!FPP8;8"A?
M&XZO<- YHOBQ73QNX@I<E9N."VZT;5AV10\'/A3D!*S#=7PFPD)95\_8QF=2
M.MR.0R>(Z-20>%!HE:U 07+TCDP2B(;2-?M<YV8 "'O74*V>(-_O!JLUG3XT
MZOSN-5!L;PG,^JLAJC](^W4O@EKV*A\YR\6QKD"0&#0]AI(*-0<S!A,>G8=U
M$(JZBB=)S?B/N&2.^Z4=/!LI%U)G;US[?4)+XD)-Q8C^:,VJ8V>_9U")7((%
MEBVG)V+$3H<D%Z3R[BGG78;?(=?BR:?/?/-%L\*MB@277?PSNLJP!VE$Y&X<
MZ706HZG,EVX;)7&RN.6KYA0"OA7W2=U?2./!O$W>PC:9WA6TYE_0-J#KO]A1
M#:BU5IH?>KFQ]2N4W?V[I,.OT-E0%:7P'_^Q_!-.GKC:RQL>0;%6(+GT>=)
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M.75)D?LM FZ.F/M(9"#U3^00I.4#U<HF*:OD(34%:&2%->RG.*.J4"HYE@$
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MY*&R 7;#/H=M]5[+;;T=<^&1) +\EEG]IBQ!U'X#+OLF+"C^AA_[#>$#0%M
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M)0>P?\(\[*P0BL\J='4$;;>8#\]OV_HB@47-.>@9YX&=<^-XDC$VO&/N.XZ
M%G@GT$*AI&96R*1Q@I)"I 43X,<D2!TS,WV$3789YSHB-0K>M]#>-T1(H7XN
M<)NR?)41E)F'X1-@#W,,T2[@W]3A+_,84G;D?Y?KXQIKI9&OWU+Z1&6]?:"&
M9F?QBA0+";7RRN@@_'>ZNPW(TDMLYBX5QOAL\,#Q'7/?X4^R#7GJO04"\(:#
MWM\=BS'[]4F@E]$["1)6-A$I76O'AO^\O,(9@A<#!9KTG "'.EY@7PXB&?5J
M[KB1!98J.POG8B6WAY0(J09(QF3U0<&>,+BYG )B?D_17>H#S*/IPS.FNBU&
MP)2/JEQI,&M0M&0;W]V;577O>.[\EOS.P?^/G-+BI.IN0<K[C@S=W[K__*?A
M9' 31]<MYB9,OGQ!,R4_%U%7KPUI1Y.^]_]^$A;W[^1481?_/Q=CW_,8^]#%
MV/=;GG0B_7[Z91D%G6:IT[YEG>D([)NX"#O-8ZNB4(!7QVF0K(N8C(FWVB'U
M6CFDI,6I_5<?KDYN?F0]D6YHZ!,L1)8DV06J^.A>M#8]L#:]WKDPK&U\>X)F
M<48YGIQ^BO[<4T'>/0VMB6%'Q.(CFZ^M+[SNBJB0-\!B@96# @EF"*$])(7@
M.@(&@+W4B/<^XP.-);+#$7-EBAT< >3D1 _((LLO@CSJ)5F&3=KM.3/:!.<0
M6P6M52J!:AE;A))T@\)^T0"14 ^,A,I<L_F_N/5FP:B08:G<LN0FYYW&\5=Y
M]B_6( K.[#6N6#H;3KB-XL5"Y#;\I<Q=Q@A2)(HPC^>RN#$GY+"87;7<]7C[
MJOO>6^FSI>7SQ[B!;):S:SB>5Z5JBGHF)X)>L4)%R+C(/I"&:1(O8P9;\=7T
M^.1X>A9\&O7+D9]7 ;-"PKA^AV_GL261WI!!_)XFU);%H(2FB!A3<F!'9@_@
M:JQ'9!D,N?[U*</)RP,SC8+5<=%C&IRG%J.Q,[X7U%SX59Q9_-U[CK7F6!F>
MK/6?WZ5A_R>N(R^+.I_!(&P<Q< _$+G,SH)0&0_,T5KF;:,\J)G+/UV(YF^J
MHOD;N-7J-X;S%$#F29#+XAWZ[#6V ==9VX"_94L&B7@OX)3P=9\>(NA8]<>K
M=F9M202S,0^26=]1Q021 L]C<?%$=(M=793(NP,/>Q-S#ZP2$4?F<6:!EX0R
M-V&1 2_G%"+9P0NI+<W@G_@&MD@)Z>[IWM.);-$0+ 35O6&?94QIP"+#-<BJ
M997"QX(DD*V65W!=2*Z2OH&&F7Q&MN1* LQXRH#:0; (<E1'.7R'8C;P\AE/
M C,@^+UH72@,5M EL,SN3-;W@8 YS:@P4LZ+\DJRI<A@"U!_PJ(\?!]$?,6:
MC!R3$9I]U3D\B,Y1":((=!G/LVC=XQY8R"N"E:A*Q*["B#*#(]JX_&"6@H+E
ME1>9AU9VCLA L JT/'%B012LJ(4W+S_%:#=- @',*)M%/U&;&Y5YXM )'QX%
M;V&\SST:Z54O%$GB23@/D/GP4X4,C?5'7H1N+U"\Q/*?A/NDV).POQ9@._@"
M-8"4G*@1,$5L32"6"+V FY.(ZFL6KG$'E!ZUS%+^#8)(AGFV.@/:@Q]2V#/\
M*4ZHK44:48,VFB8S5IA#A7OU-4X21)&G/W"WG5QL0#>%B=0\B4!.A52^]*HC
M,0>53[;(R*)*EHS5-\M0T4;Y*9VAY+NPY*]B73M$0XF2DE#'P0R)7:A;I@0D
M\3F[^15!<=*$%.LD8>C&T%)!;5T"4>'QXDW 2E>E?6']*XDM7YXI@0_AW"LB
M^'D5)UCJ-L^S@+.NHIBKNU;Q2M#ARI&2#!<,(YE^#4NL'ELE0D)QE#;1R_Y'
M 2'"".Z]M\L&/!E-;R=V_0JN4_PUGB.HWO/C-__L'0W'/_D,0@9L2[(B$6V>
M@"\O:87FPUFUQ$X8<-')K3!\227@>$'ANU-"_UN56"V8P(TD+>3=K[WIIS__
MZ6A\^!+O"<B(+,6&(G2#$RJ,UGS#YF^P&XI];K JC8V-*6V(YT36";P:$$%J
M[C1?>[7YZ0GYTM1<+[%O#G",)4PC62]79]DJB_%*TJ.?3W[]:(B4NFH),E*
MZ7ZDD-S(DG\EFEB%)\Z#I&(^,#>;_M([>??7WXY_[1T?T_W#BU!B2B C+0))
M8U=+,(BI"U?)>W=\S!-5K[[9\BH!'\+N40)#B0P)7WX#AJ%5 3\<<-Q.=B=(
MLXK[#60KNIS*<"0#D:'<%I(M\<((C/<"&5I0:)BW5.4R2?JQE]P^65@_+DFD
M.2B=1FI3GS7LO..]4BG)9L-H CK[BJ3%69 @0 "EB+J;7JNT,5MJ;>-V>J78
M<$1RG@3!:#!8GJ)U$%9ED(JL8G(Z>>W7#A>3_M9T$RZ$D,C.+:?F>^-Q0S<K
M\%5FW#2&_!G>H*DP96#!LEZ)-46DJ=&8O\D][,AVD7\)4AMP83B2SV6+14\3
M8=\[YN2ZT;B'?\;X-EQZ1"^[0&1 #ID!?T)U,X@Q3^XTSRY01*(RF\O.L0F<
MY#QC6J;L/4:0C$"[0.U!JT"V;BH5+]D\KCZX%'.KQNDQZ4O$4]FA:XEXDX)O
M*JT -J3D<_ .)LA%5S$E-\JAYH*\3(N%5 /6=HA_..)=X'WL52L)$TL'>ORF
M?NA8#"#YF]0,+C+VIOE\>8^]Y\-#_66V/.6M?CX<3,Q?@*U*+0)KYQE64;$@
M.NY""-)U>%@N3%#@E>K$:#[4WT64^ME7CAW44NI-^TC-QR7]TT77? 'O%\L&
M-G08HA-%,I*\ENQ9&%:PK'!-7.'3!Y90^MHL@O.,;P H ""/0G0="E0[Z?F/
M?_>]G_6?HG4*RPOY+T!J!M;(Y]89!2Y"(66B4U!#+_"TAPUN1H7M\5+J%+TH
MK[1I18.26#Q&.$$D,3UI^ZXYO;&1%VGA]5NM2/'B*WJRV2:V-CUEK@=V/54T
MYD7+80I;,83[B^_%!4/*2E#N=4V1(Y4$WT.EC*OP?K4TSDT!]$8)H!I7%P&N
M&9193%C/V5*"N:+E]?EL9,\9C=[C3R#UWIW^PD0.]GV<*N-2P#4Q^!;,LM!9
M7Y028-MN3P W3ILXB$%"W NMV=-3!.@X)]'!;9IX?7%Z%L\9X6*K8+77%7BO
MWQS\/]YG,DWUTA1L)K))0@"_[@S]]BG2SMM3_,SQ MG\CG>C>>8<SD 1QIX+
M;L^G\T=M<B"=/HBV)PP]R:LH.3G!,]=UN+J0QF9!<Y2>K#$!=0\/!D8;*+.>
MA(I2?87 %...9TA'AH$SJ@E;2ED"BH.$L $NO0#1+4&TT\S[:PYGY1T@=SV+
M3]'-K0)X&N#EG-4?,*6HP20Z^M@ :!1?#6S]#4C=S%K"PH)^HW0ZRZY GXC2
M,VK(5_6+LT4'ML! 8:28.J514S62-M;K_(%M=LC$@7#L>X+0R"4([3>/O")!
MZ$G*#= ?WHIYKD 2#QL.(."&JHR%2[>JL)3F8<9Q&U7X+7T\RI-SI:NG;O8?
M'SMQ7A/G;_[9&QRA*U+))<+O+W463()I-!ON6-,SA?V14OZ1+I91'DF)E4S2
M:TO^6JH*(X/H]4'4YG@EPVAY/,<Z/Y*<\-52Q*#8R4GB8'7G+(?CK"E8$0KI
M&N:.TZ4XY=B4Z>;2&@E2+RE!'X :2O4,K"Z2[BZ-A*W3DML *A*AC)/6*N,I
M]E3)ON"I(J(IJL(@TV7<()+?+21BJ7FOI\T1%2Y<TR:K<"7N] (VIA;G43-%
M36NC%RL%()4_)S):B3: R!J*HERUQ*8L&9,70.D8&BO"U,SREL8A:U=@J'!>
MPR;!D%5GJD+C="$3:;A!I21$"@,MI';GD5&-JJ7TOV'V!^UJ!)1.J"^Z&:X)
MF9IP9H+A7XYN&0/",88ZOX8/6&'UBIT7BI0BW&1*K^(&[:JAL:3;G[/\-)"!
MRIINKUR3\EY]_#M[Y]Y8;I>V8$>PQ=="SGQU#U,=F3\'=156HN$%M&,@SD,5
M'_WX]Y_ALTT#L771;,#"K<)@8W'&]LQY?)Y)UA)S0%!.Q' &8_*>91=D<,P%
M12]Z;,N4$AJBMD-+Z3Q"'Y&CR9JP,E89YN5EY+@GGTB0 Z/+558',1?5&&0W
M2:41,_CH)B@024X=S[50>/UIV!!-DC!JQV<3$-EO1;5"HTXZ+S #2F(%9*NS
M$BRW)>=\V,'P>I2+<K;49'@"*HT@S=BI: 00Z4!TMWI:9K6R7$=:UU!/9?TB
MI6<0Z>G>;\8-/ +M TES'A0(0K2=3Y$\Q1B3B='*7N_8,63%@E7UPKKZ+.OZ
M%I)Q(6G-_B!>D76/LZ-(PRM\[ID39YB=\A].CS&4:]VDAI9-782??:HIZ5C&
M_^PGCBQM_L7TI0I@CU"3E"DD,.?0^ >%],YQOJX-6Z/D@"K@18 )J7D4 M/"
M/<1L+QEH@H*QWK'=NP\4I,U9^?4O$J8QAP$#U?-%_]13OB10_O)3+B^N.XU^
M&/:'P+J31.78(+@S\7X>F&^Q?CUGS W\/":U([(LQ9",(D6TN5PE)NLU( 4<
MGYK;&I<&5P;92KG.[.?B%W 6&"S!!G"T^QC<@MG[#.N#I)"%K$^B^.,(U^9>
MN3Q,JQ@=QR=5UDIGZ71)B^=21FN<_D-89MR.870 &NWR5*0F89E^].T\&W0Z
MA/^N8@,G_C<$.8%_?K83VF3+)U5#$*K6?)0$S<^ODK#OO:WE.5LC^YY)4O>"
MTURH9 B>(?:!J+"\ NZ\PO 1L@M@ B97)D&'D'%]("GB'>,@R,-]E3>O9E)_
MQ7I.F5O'Y 50H @M([7]B;WT=LG-3M^T']*_5M&MN2@O,(Y@[PU\IO4(WB&;
MAC^^.7YM[SM%KWX#=7%I3MT:CKR_I--3RJR-CQ2HV?!JY'@;N_G9>L5:UZK*
M$0"'Q O+./F"KH9C:<]6*I4O<!*^)6U5ETLT)?2I1R3?%#NO+49WLV0?!\<1
MR,B)A$4@MGQ'<"O.?*"NN38HPQ5')V,6I[(-6I74%0=N/:D:AX YKQBGM4 Z
MF_K\%KOM[N9ED6A6ZCWI#,IRE<2-Z"' /=!ME!+L%M= P86N5G0&>."GN!Z,
M3"U!]R/]X8?IH9'M#&QE0B_2NZ 4)5EO=<6WI3,2TW.D]F'O2)>0:FY'=#P6
M*X$CS,9[IDD(3E!1G:HE R(0WS@1@;/"R&4"RF#IG689J73HE(BEJDFM+Q"K
MS;<;NU);G0J_L."2-NN:P,?9DV)]NZYA2Q49(9 +[IR!^K[&X\*_F;+68_X2
M,H(3Q(\+\JC@EM?$[MX>G[SRVQ_Z?<49NB@\,4'O,R6"3@:3K@-.?4)-N9+.
M[-<90\G)N_FZ@INZ[!YN%.TQ;BX;6P9VDTVL2#=2\7XX/.P/--M"@R7/D1J)
M535(R11S(4SG*3OK32TMIUV'[.0@7E^W)G1)'JR@9?0-0O5EADU(O6M.DS43
M/;/<8LMT*)\#6[SF5CGF FQD.*VZ^7? PV-E&U"ZU?>&,@<M+YZ2-/6M(LM,
M"T,K2Y$:;\G57B$9$8M1KX=\F90,82U'692R\"X72]A9JO)HLA?[AC]G2?7#
M:&!$TD]X&MR\!QE/O8$/CTUR!KT"-1$D41Y5IIUJ18:9-_LAA)Z@]<EUD4H=
M79KNW!]A'J^3C'I#2:Z>GCZ467I#ANP,5;O>T[)9AA/_*KNEJ9:3XPUQK)E@
M&*N"HC+Q?V1P3'(_^82E6F]2U]]%FLUC]>A)-5<EO@$B08-TZ&47:;V>E^QD
M'H(^9=YET:4H.2@L8QM8' -OHPN6 -[0T-165/MTS<C>$O\IS68NRH*WS)[)
MI5F;:+ER97"TJ$ K.\=?J+I1DB;%-99J%3";;61=D&N@$6<;UV/75-.;-$?\
M7FW.9#NRA"BNG F]<MG'K#IVJN7^H/=\HHIS) #_G&2]W 9MM-8@OKD#)J@%
M#"*QO44 +8__X%L**-CM7[$D?7O7@,]V63JL;_/P1*'.SGJNRP+,Y>3M6T[>
M@<O)VV]I>F/0KD>B3;1Q])H<)BSIDF%605B 194 BR 3:2'0EDL(:QI%2? -
M79LKSKY!:02_Z2U '(.,LC4,B\UC<E%<J)2A$YG@<S"9/0]^4B;5NY02IA Q
MA^WRUUE$<<SAT6Q"(7$09#@_Y3-,Y3#:T[RI&BA_',8",4[>\/6BY SS>-7F
M[.6*<HU[:UI=9,UF.:KH3_L.]4OL;D$?XGAD+$SC0V_3V??#]'J2_K\/3>U4
MGZ0ZQ3?D"3-0-A0D/L>L@#7136& R3F'8V[P<[2"93_D;R<4#WN2,JP'YP0F
MZSJXT/862WWO1)-S'1EI4\.3+6Q6#36\?4JJZ.8<[IVZ9N2"0.G$29OD5_&&
M_F0V\@=CNW..495K3610,@*+^<K)@;+7./KF.5;-Q1V$^.Z=K)*XM#5:?4[Q
M!L?P)819;</(#FGI2*6G)E2B6P#*KNC!U>^1Y&7O#L^%YUW@7#2!M,S35_E
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MUN^[0H..XSF.YSC>D^-XHZ/[#L0])A)TB#'[YZSXU:6H/":)YAS]SM%_^W;
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M$<I?,Z+E3U18M^:J6<0IZ+L8BM5.&^T5CCR1%.+B#+WOI$N#GGZ<IA4\_$F
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MACG@N'G,D[@*G[BQ$L(?YM0_+NB1T,(T,]489I5GIWF 4)-17ITB%F>8@3B
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M OX0XI<R.#NLV0)"T1FD[C9U]C9]SB@E-Q$RN;+!PK<("Y(#0#!5G'#9B(K
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M0@$L KTP1I+UCH)<110X!%MKTZ,^8M/&(%40JW;-NE1V\$<&GN)/KWT/P;9
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MRU2@M%F\7F@EVZ4WT5?)'TUG#ADN4R$TM(O+.J^XHK>4WK*CTGS"4!C]0^:
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M?R]+)9I':AG[30*6G&9]9/TF:[KA "G:BO(\C1(X14954$^:.3;8ZEI/=L(
M0*>-%CFBX'JU)M%!2%9/=DH0KB/SIE";G$ CYG-D6E1NG933/&)"HB%+"=_
MD76,RVYSS%6,7?"3EO6_0I>\$G7H-!!=%EF7)3G::B%9T[R=Z2W>6!43ZC<Z
M,JE/&H[@F>R<=IH"HY=@R#([V>^7:EYD';8&'9__\?8+@$=\I1V=SJG$LM<9
ML<*T*+4Z;9H$S2;8):ANP K( C@A\__PSF)1ZB(UA(P>+Z0%9=QVVU==DZ G
MKE_,:2Y#1Z;)7O R_UEC'X$F-(->%&+(I*Y%C2T'9&[K"B#SE0DU:PD[QX"A
M3.ZEU3:4ENL107OR3PO:5YTD-<K^4J7,1571T59+TT!#\]ZU4?TF?8RT1)+0
M=$Q$0P&-'FM/I>A2(18@'DC3Z.01YUC9(_(HNTY)2F\6YY9$"  S?H*1(5OT
M5.!I"Q0E_7J6=BJ#&NH9(-@6$!![2P&K9?>+I,=E!0.;?C7>WQ_+28VBBDDR
M-ND+*H._$9 QUN@W9[8I:1/]Z#$&>"'ZIK4#VE4TG 0SBH%VF]?<_Y^+]'RJ
MBO69S.*D?AG4^3T5BHS6&Z/3K4VG15'JZUR?FKFBS=Q8HI70G.@-W>(,<^K,
M^;&XE!WGE+6!D0S-&%Y7S](.AH3- _S+JPM16K#<<%=!_(3K)5*JH":O1:?#
M&?:V S4.IQ2TK> ;9!%YO[H2? L^6;,8.<M!+T%4]82K):D;ZU#9.AFX\GC5
MP5&KS.D(*T7DIBO&RAW@#Q]9E;+?#R.[O7_U?WN9K"8#=ZHN!!CI. 6V$G/4
M%.=]+HM9@=A+86O3I^%0L!(,+%XE93Y78-8$:O-VOZ5$U:H ) -HT#/O,(#5
MSFY!)9YIW:'PUJ @RUZH;0LR%6O3^M0N%_OGS?@+0F9L 6-Y*B7HQN$XJ 1P
M,4R'3RI^26UWR9L$]SV>S;#[Z1?J-(9 ]:XHIY;KV'^C0F=Z$PWXFBFKVFQ9
MC%R05;M$"BD/)#E8F]FDR#"[;OTWDV6C\-\E?EEY*ES$9R-V]COV;,YKBI">
MP3KQ@XGZ.^CE>T"[VU7RX*3KT?&1]3_-"_0:N:2F_#\M=:TW8/5,BHJJ[H]C
M,*JL7X6.\P6,H^VHA4\$Z;!= <XSLJHI@! OM:Z"TF)'/2CEF=!LKJPO.#S)
M]6+;4TJ>5B7Y]H=L5'6<4!:8._8#D<E2BAE1^N@MV8);MO9K)R$N6@<?'J7E
M[3+9+8>6W1*9[);#!HE[]QA^X-NWXC0Z:V3_6:N[H%3MM12-CJQWC<YRVFLI
MJBF$@->G."^"_H[V^1M6,R,UEQQ]:Y5I7;[%^)O)TOP.$FN"-X3@G<N!#NJ[
MS2HWW!!H,Y,#11#^K'>V>P174&^*'T(>8SW8VJ7EZ(M?4&& 6( ['(# OLCC
M7&ZZQJI->\M3.2\1.Y9E-QH%^]6YQV<R2'B6STCA!NG>)HWW&BC&1];)!>LU
M0"!AQ52*%/5K;1H,^=RT_B#($YH3I,M:K6IN$*7CG9UM)L@C'1]V1E-ZB@D)
MUC.:;INB#=7OHP.6ZHE<-_':9UAWKT^2(.H]=GM/O+YS@ORZ&GAZVRF^:$%C
M=:L%-0V6=&SZ*8;ZT#F9MI1+=,JUA]MZJ1GX< 4:^)7E^LQVAR_Y*_JU.TSE
MW]J)"KJM_\IJ9AFE'*.!LBGJC!XL6GEI%OZ2EB37*!XO:G_G- %-J$_8B7(1
M3_.Z[DQTZ/@:9.M_[*@]4&.Y\8_58@J;)MJGBFAJ0>W0M01H?427'"O0-OT^
M?7O2L&1)A,';X)M4JM<^35>CH&O[@CEU4E],94:&2,Q2P[[%>^OMV-JJ.'S[
MDXN<9_!Z/%F0,^M3EN4)O/3+>0D_S.>8K-5\68@OQ3:)*UM9N^;*5C545U*@
M2TL@&% RP 1G4"%I,* *1*G(U5SR<U;*49QR"UL&HP%I8ON5V.?R%,LWNYD9
M.S/&F@Z>:E36[&KS=3,D:8T]>BY@Y92BT; B_E9XAI$GL->9\CU1>EC)657,
M9'8'K$YE67:;IN+=2MF[#5;0]B*JQ&0XV?QHT/SX?"9:_MYX *<+ZB5$K=YD
MR#&I&V=ZR66'T0I(*!JV4M-;&FS?L.#F"?>,)O^I0#X-CFMWA7)&^0Q.O_"?
M-YDOF]:Z-!\M+^4 =Q-J7THLU<]W$R$7T]S@("K!=MUYO^9$#]0>RMQ$$6_!
M)'>M@\(M.$\TOEJ94( _&^AA;& IW@AD:A\IXTW$>_@P&AB!Q2G-\<!VQ2W:
MM&[EZ\1-UA$WV69Q<XG-L-5+;WH-BE%ATG\N>BQJ[16U>-,E9]^(;%+XW/Y-
MM.K[MGEG(RX:FM/U38I/:Q?5V,X=P.-4SK(1S2;7W(EU;:F5!8+D*1EV,TLH
MT2S-4_*U"PRG3GXIX 'EA@$M@)^5@+QI;5:ZH(.N$DRK!;)?CC ":%IAUL6D
M#00N<87(T'TXE7&KY3JZV"@SD"8YJ :BGS@!9"7'XZ9M=!&O:[--FBX)+1F$
M;B!V<WEEE,(X%9E%ND#!-MQTODDF+.83J5:HS*HV(:]9&,9D<?8(Y]UV#=V%
M= YKDW^#TZ+27*@3F]C]> V]UQPW&;[9=+8H3Q0OH5KF*YG.#DP2:PV0F^_5
M!.[;;RAI2YITRT5F62.#A0P2"8HR8:EYK6E>=4>O8*:/\$<5DJGRZ7K_5Q-P
MC@4HB)W#%'!>BT11:B@O=1[J)+\7@[RG-MH7R7\T=T1.* 9^/DY3ZMKSJ]JA
M?TC&,P:9UCY<-)+'0SH0L(6@Q+YA)KXU6] I)GU3)'0 60%<0$,5R'6R5!1Q
M^Y-&WCIM@'"#(=U>,@HK!@V4Z]@FF_17'<M.K>].4*X;.A56HIYC,8*0I"B7
M*HPOM^DOL$K.IGK"-?\Q5U-]NQE^9)3I%Z'>FZ9ZPVE*OA"R?_UU+4RK)%J2
M9@!."]*<U6,[SY& GY>I)7I^HG:^F @W*($7HAD>D%H?RH;IJT"2BJ0:V!QY
MU='@13-H"B>0O!:Y]QOT!Z-Y=UT?.N\J8UU([R)9R,\E^Z8;)*_.J/(7UHR5
MHB>-U!9PX*!V#9XF*HP:2)M+B7\<%PD\>*Y2\RN1:;U.GBD-9XWT(BU+?S,^
MNT N[&CSY%7XAI/92RXGUO"YF$\1\US,B513QBOB5ZV<B5ZB>S,A&,GL;K.S
M,/]--SS%Y27F55#5 )C5"QHP7Y(U+?6EJ@6'RQD7C7IU[U"WAF&@:9H#U<RJ
M:;XN#P76,K%O]%J@G_(CZQ-YCAHMJ5&C"-%(AY+986HJR9(^FXLJ9/('47OY
M9;UVT/:+QP1E!#1%@DJWL4JN/:FQ4B977:*M48VKVVAY1B=I3ON)"/=11%,)
MH1-="+6&\Q<EA(Q>TM(/]'X^E^(&SOR<_$_ZP,%J4W9] T6=B2BEIB/"H13>
MYT5%0RQBV)"!U/C;$SDK]"?=S3#4S/D-!0FMSZ(5O4T*F_ XI!V/ _Q-ODK'
MNRR\'#BUASR>[5@@K'C%7N"S^J+:-.Y12_K5BE1$QPXN*O^$?T\:0%>B*\*5
M@/.E"P9WHY')G3OTW+FQR9T[;(R]=^[<5D/[\1D-OS[3@E1]%>HBJ/\+Z'.P
MXE['\4O0.AIR'DXX?]MD>,E>W4JI>@8*U3VS>)[(V[^,7QUX!>-33; 1&J\3
M#VW7^BH+4H_+$A7<3F6B.;^63BJT8:AR'4>0ZE^HHEZFT7!@=2,M),<")WJ9
MD%'QA9]C-@C:(J?VWP:B_G_=<;G#BP'5\A_X1A\7-,2-!/Z[,QXZPV$<QG;L
M\<0.&'?L*!PF=I3XPR@>IE&6#%^(&70_ZB\\^\N+D[/$9;$;Q($=L7%D!YG'
M[#%/X5T=WP]X/$[&CO?"FK$IK) GZ6ND!A+#!3:2A:_O)NS\A7"WU:!W_ #U
M/O_!4UC\I.(;ENIZXS +O-#V/%AO$"5#>SP>^K8;.%X6C0,W9,%#EPJ@?(_5
M]H$=94%I<SH[%%SS]_Y@[_HA@ ]G[3&+4_R_/8P<QPYX&MN1[P]M'L<\X^'0
M'V?I0_CE][J.)6__0MSR:Y&2B^$^S.V'S(]9$MI^F, Y]-W 'J?!V&9Q$,7^
MR(^C=/3@Q3;<?;?U]H%)IG*M!\G?(!5VQ>+^<,S'CIT-'0Y<XV<V\V#GPN$P
M==)AZ+BILTWT_EI.9_6]^)LG7NI%H\B.AMG0#ES7L^,X3>%/7A1P6'@2/GBE
M2^!]N\7V@4/4P.B#9&\*Q(I4,])_A.^O*)MQQB>JF]<,OB551F8JZK$BY=F5
M+F4MN-3T.),-_JZ:-H#8% 'S/J>@4V$&#S86:&^Q' J/J6$,95F6JKV^YI[M
M$TEOXRK>=P%(<M;F#)XUN;YG<-# 0)F=_7-1]M7 $4ZCDR.]4N!+O[U'*I/Z
MG:"N]=_ MU6:JQP0#!I\%FE*.)EY+GSOMPSW/PM3K5;]R^+)BM/%!#H.+-#A
M.HZ)=!SVB7S\+@&*A4F$83[+69[G?151GX^_?.VU0++>OW]_#P7DP9ECK0+B
M.F>-(G?6U#B=*4VT]^T>7 <5D$83524=O=[UIMY$Y+6=%.6\H%ZQ_X5)!93J
M: JUEUH_K*UE7&I;)-NR*7*F%MI'^0Q-GZ8GN&K21E[CG$I9P$CZ<=4F_G5Z
M1V@N9#<X5LU>EZ]0#2E%\623"Z-U:<)];O);P*3")$2\*2;':V/N7<^Q4I"5
M%@E.D14TT<8-9Z!J@Y5WQ5G94X/&=344T?K']AM$W"-"CEZCAJA4.]%:\AJ0
M,"!QF"#AG2DOU)E(3K[(YZ!SG,G^GF=QO^'".U+;=F5]NISU&C8$<9$W3F3S
MU%^H^%C4MHK,<&2\MB$$_?6++,T[;8=S8,$1,-R6RA\,[!C8>6S8\1N $2Z$
M8H9GXP",'/^H.;UT,/O='5:2M8,C7TL&6HMPJ YD0RMAM5GOFT(38_<8;#E4
M; G.FHXO9VW%X%G&>][+RPV.K,]-KQKL(==K;)&%F.^X9*Y37G['&D #' 8X
MM@,<)HYU<'$LU\2Q#ANP>A''^MY7.?WYN-<B^<M7Z_W?]QS%&IYQV59Y7=?R
MOFZL[ E]U/2$'F#Y=*\W>W.WZHT:V-)T[D/7P.C.=Q]?]=)]M:[;MU%<=2*]
MHQX1..M=93VN[ZNNNIX)?75@87NO]]20O<E:U&88K2.[WL_]%FW6!UT].9]U
M^LKK^O)VCL&^^D<\PCGPUIZ#6^#(<SP0QQ.]?VRE:*0W6)%=>F.>L$7%NTV/
MEAKDRFGJ[7A3V7+WYHEE<EHD6%_4&198'<W"$F\ZZV0%XH?J\>8HW' 4_%>-
MY+^'^VJKFO_CL?2__HL;.C\OO6Y-O+.&/<@2ZYK@^#+X<QL,ZV(A?R*>Y#K.
MD?-G]7O8Z0F;5_QUQ4'#!UY61*$)TN*Z%_AX>'YC)7[/52?$U^IZ^2/X5=J0
M2SS._;-NN\EW%,;;3QNN\8X<[^Y71>'1.+KILO_XJ2Z77T=:GGB&<*3U>8GS
M2&QY!C+Z9_T9N 0:"NOWM;"!\8,UE.C:OHX+!NYW;+26L(ED-\&"*]X/^&%C
M[$I_B#><UQ8AD:7.I[JJE 8T/6 -+Z\Y+]&63<4M:>2W;!-$L*";Q4_L#3]2
M#\:.W5^GC\9=@O,=?SU_[9:?'B*4[N%->42J/N\S^Z:=7[MN ZY!9Y*N^X)G
M^&;=/M_A8/3")7FK+?*.W']_^.'H.<4>2*,5_>SI4(E9%R76Q%[4];QZ_=-/
MEY>71Q5/CLZ+[S\=E\D%MAK]B:?GK/P);"'VDQN&[G@<_02<Y[ICW_6&GN^-
MPRAR?DK'?N1%3LI_>.[113W=S+6;3C"M+\4)*F2?O:;8'$8@!)K>Q4A4<\'$
M@![L EADUJ^\/,>Q!:G6VO)C\5T$O]R0@E_^ 'T7-"UV6LS.K;\64UCX^15<
MG.8)=DH?6.]GR=' ^AN?%7$N;VJ=+F+QA1@#['O6+WF!'U@O.WZ2Y4"B5&LL
M.(?*P?.%G^<X7$,;1*0^$IT[VM[C,ZH_MD[M0 8.FUB>&XG7L5Z^@R_@-8\L
MW_=M;Q0Z8__5J]:X8@:3^X;)_I'[),'&0/+C0+(;N0Y\%OZ4#OVA[XP DOV]
M0_(73LZSE-+V:-)(33D)[QMTI*DNV*09.YS.:IR5,I.=BV\)HOZU($JNZ\C^
MFX3*XWF93RP?8=*--)@$,MI^%/@&)?N.DMZ3//\&)1])<0V<T6CL@^(:N:X;
MC7N!DDO@>(P-2/2V_/2!G"EP*T1=ZI5B8S.'LD+'<I%\LZKY)!<Z,EO4%X68
M45A=8"MH %SL!LV5NOPK ZI:WE#VD]X!(,LGC-03#"(?'"+[3Q)K#"+O#Y&]
M)X_(V&9,=JEZ(-9Z!FO[=BAVB+7!DT01@[6/A+6.[[E!$/V4AF,OB'JA_*Z%
MTE^N)NRR>DS'P+(/U3'P>'#P&!@7JH''AZFBXV 4 CQ&CN-Y'N!CL'=\U,+I
MLIG[,I)IY6*W \;@9F#$9-^?CCM.4]<S>N.! J/KF("_@<8M6^FNLW=L/%W$
M+3@VX7]E4-\4Y5?Q^D]B8B;VOJ58_DN:5%J"QJE%](_$M#[9.(-&F.9:#OCM
M@!?/H3'7^W8Z=@F[GH%= [M;AMV]>T<[B4E?D+#5*OIVW9E]@%[C*>W="=DE
M])JPE$'>+2.OOV_D)9@"%/M0)-_LW^8MZMX>!7V#@GWCUEVBH D8&13<,@H&
M^T;!DX*ZGR'L_9U-%GQ%!^VJH/Z2"AKS^A)+QE>S_-M<_K>_+ZC-E_6U7%1U
M.W3JPX>3VT-M8*"V;T=BEU [_)<GB2(&:_>(M>&^L59IG-A69CH3Z4T=;RL6
M([6#/."7NN5^>ZP,#5;VC:5WB96AP4J#E5O&RM%A8.4;?:+I_<!R9,"R;SR]
M2[ <&; T8+EEL(SV#98=Y/,<=R1FK.#?X0?87QLK^,6,A$P"*[O$H<M,P:F,
M 8ENWK<&S\B 9]]X?)?@&1GP-."Y9? <]PP\ 9L$>'X2J5"(F3O'T;'!T;ZQ
M^RYQ=&QPU.#HMA-(G?X!Z=OI?%)<<2X1]?,"7H]5 D7OD.;I&'3L&Q/O-+W>
M,?!HX'';\+CW!/L./'XL9G:#CLW80GT2L_49[I]<W0$F33I\[YAYIS#I&I@T
M,+EMF-Q[0GP')D_Y+ =<?/N#)W)6/:LN-'/\EV*VJ.ZJ3CYV[CK\%V<+F$F
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MFJ?IA/=D)_K E\^#(,\"!S&*N!S]&S7A/TN=^,>,L;X!N?A:-G-TQ4"CX:$
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M]+_+^Q)[P1]1$4=R2IDP*ZQJ@>JO>'"_;.#] \73@L:HV^&G9^#X2<?#9+)
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M1$$B/8&-QKE1.Y9J>,F[CRK*9;NU\[6T5<7M\9L<UL.EL<CJU]9+]Y7T])(
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M[Z,\P2!V/[;(4.I^N.P97-XF+F.EJ\%C<]A[12ESV'=VV'USV/==&[JJ?25
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M8SN,PH"-4F\8KXY5VMJKF3C2KD]EZ 3#+ BXS<<N;!6'?T4A!Y0=CF+?BUG
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M/ <@A.8!XR1",!XX<!T0.]!Z+(8)#YQ0Q"4/B.NDD*4)(V%=3-&IQ%VZ3_.
M;L[+95'(23KJ2D*Z JSVQ7)Q]KI=_V-3^7'O7@&$3B0V4'I5L0\"S5=DNCHA
M!LD"@'!P$ +/562Z.B$&/ <@'!R$P',5F:Y.B '/ 0@'!R'P7$6FJQ-BP',
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M.^>0%1PC1J.,A"2#G>AM,CRL(NS1*@+,B*^K0<#5&?%'_WC=V%63['1Y0W^
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MH6#)%1P1DC; 796X>P !D-86ID^9^S%&/+$<<YLL #D)(\G+%%-(?21M0PD
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MB5]<(#CG=O(RXRVH42?#7L>TT&W!>Z];D.]L"%=J$%Z8S=%:+\L'P;H'3^#
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MT,JYZ.VV'U@QR?MN:09\'SC<Y]';#Z!B22.T/,]ZFC$'GM6G:AKRE5CCO"C
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M>LM&S/>""EA?FB3&Q%574?;BP&O&T=MF#4X&EQDH-1;N"H,E8H/%KX+Z"8Q
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MHBO:>H/6[B<;NT>B;&_4SA#B$6D]>&F?-R)P&^+ <?GU%&CZN!S\/5^"G2S
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M<M@77J"V]4_*2'Q\Q8+OJJ7XR,JZ%<3&KT L[%;K[\JZVRSY]2O\ZQ[WG47
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M/&MQ^QKC1L!,_$M@/C!T&+._;-GX._J'M5P"E+6\N&S9I/3T@?S07P,;O5S
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M)*:*N<IMPL%LR 1A0@BB7*X(5PE+N>&Q=./$AQBD;&[AR@)L%,;BG(B4,E+
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MP!*P"61,=)9K8-@,+&H1^/4I$6+@UZGP:\JE2G1LB<DY)4Q91A16\,C!5%<
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M^UBCA\87<5+DDRA)\SSQY<#=[N[<&RITNQMTN[MFPC>]])O=S<18&E,E04H
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MN9@"4RWGB]\Q+M*:UW>UJ&]-SS[-)@V^WTX7(V_*9XOT#! ><PS/+.DR W&
M\ :@M$&*UC\]N'Y^1=+7;F8_$U."\HF[\ KFN+R8OS9E<SF35Z_PVU':X6E6
MSOU@NV-@[0?_6#:+TEWUX_:W$CLWK[WA@<_VJ1J@R[U6U6=<))SX*G_Q\QWS
M$1^"]@]K2;_O;7U+ID1D--V@LC9WLJ>M\]7)OVYUR_FLG,/ %H#ZK^1R4;W>
M_ +VO?VX)45__$^B>^65G'V25\WK;_ZVG3:XF1B+%#6@TA&U[9>HOLJIO\.*
MB3NDN=XQ8_%>B8YT4^ \7)FS3(.VB=568XV0R'/"9<:(@W_!?N2YH2.'R9?D
MA'H7X3KK\Z?Y!ZF6,UF_!1Q[Y]Y<(!(VO]O+"M1< ]^>V^]:4_X]6O(_S7^W
MS27(T'=NR[F(%E>;75K7<$DU1R(?Y*5_P!2OZW),G[U)U"X[V WMNM_N4EG[
M>)KHT[FM[8;S$',%?-@8(POHTKE&&_SJ ?K>^//J[?:G*2B\M1^^J] )T$0O
M_+I4RP8N;UZ^FM*4]F#@/VJ>_/YFOBM/OCT,@BR_!:@XU!8Q-_4VG!!>3D ;
MJY;=)>W;BO@T_K:_'+9W)B\;^ZJQEQ(-G7Y=VB,?_K9O=AWE_U@V9>NC?]4_
MXYHS^NU;\_Q4B/3;(=QV4V[Q]F\WW)N<YO2>=][S-GK*>1JO_[OO<\)\Q[?=
M4AR"WU@;8A<7[BX8,>;G.QZK.L2!4KXGR?0P2V24!'P/_?#NQ]..;QT/?S(7
M=@J_]4&'/:S<7FM"'3.-#E6=0Y/KG@OZ'#%)!TE^5-L55NO^\IH&>;U/>3T,
M4 8Y'1A_<JL5&/]@C)\&QI^(@G9+1?^[:VCWU<B>2!W&^[%"Z^)_-2&A?>1E
MK_8LLR=<<>EXM86P?H%Q ^,>(>$]@_4+5:NG4[5ZNV7M.!T]%*D^_B*B4^YB
M<<PE1$,[B]&Q=4EEHD1&K,.<?B$*(A1+B<ASKG62)H4;G3Q^>*_;WW&V[]P?
M73[7OMH?GA1T$LUNGV-KBX N 5T"N@1TV2Q/;9)<YYDE+HDE85Q1PA/IB,U3
M8V.A5#QNNO?P[KJ'09?\)(VO+STP#69^LN@26O!.QP1M&R=M%V@,ANA35!5"
M-XO0S>+QU(7$)3PK)%B?QG+"4E40SC-#0$O0A5,T5VQ4"S 8HZ&C1<"8@#$!
M8P+&W*E_;VY-RAB6OE8,>]%8HBC/21YG5"F::+ U@TD:,.;@<=&017;0+++!
MD?"02A8R4J:541$R4B:\?H%Q ^$%QIU2*EE(O#^$?=1U< W:41"RTQ(20<A.
M>/T"XP;""XP[)>UH/XGVPPIB_D6'3'L8%NGR+QN^/7ZLTF4'3<R?K?U/(49U
MA#&JJ:S?<<6?)BRY'R&VE!<IM=1EI,AB09A4EDB=%40K5PB:\MBH46SIX?D+
MO:?[JC/H]A5<2B:1OC 5/@R)"4'H!Z$?A/ZX=Z.UA>).$X.]BEFJ')%&6)+9
MPJ@LL<:Q;/\)!0<2^EG*@]"?2J9 <'L?@HM_K>8Z>+Z# VV*#J#@0)OP^@7&
M#807&#=XOH/G^\Z>[Y-H;GT#ZD[CBK#M#-@4TS%3GZ10?XPD[RD7$3@*7UVH
M'7"S7X6EA:)*6.+BV!%F<DJ$E)RDE&JK8TZ=2@[H3%^;B7L[$)BGUW=YGP8?
M/]FC&@%8 K \%W(,P'(SL*A$%-SF.8EIP0GC64Q48BGA:4)S )4B*T:GS/?H
ML-\[L.0GE$W":_\<@244IIF.(;J[,$U(Q'I*VD$H%A"*!3R>JA#3.,]C"O8D
MISEAV*1;YH:2Q*:BT%FAM*4'M$&?MH+P7,H$!'0)Z!+0):#+CMK;KLBHXR0M
M*!BB69(!2&1@)"C#L/)V8N4(7?9HB.X-70H^0;_F<T&7H0$*OV-O^W_O=^/7
MY86M2PU_F_+C8(K#F",[S=+TV\<*/%[/1^MWW_2ZAZP:K,$U>WS3&U?,VRUF
M7]F8.RW30A*1%9CJGRDB5)807MB$)<QE6NEMWDU<7 @E&,FH29'?4R(LJ(>)
M$U*YC!;&LFW>]2S[?=4L/N#.?H"'?3>K])_?1!:8]1+WLE[:;^Z[M_26R1_(
MFM_W7G\XMR"C9K/J$YK]G@>B9GD!HX<7-2./@(;E;%"H10NX\<K*NHDLK)A9
M=72?PJ2&K;LC[ L;R;G!7]+H13F'H5?+!CYI7KZ:TJBC(<=-1PD]N'3I)7!'
M?.-D#[E<5#U$X0CQ%3 AO)S,Y%6U["YIWU8 ,'W;7PY[.9.7C7W5V$L)E&S[
M=6DQS-_VS2XGY,>R*5NL?]4_XQKO8OO6/#\5(L7W?L85PR%V4X8M^/SZF[_=
M<&]RFM-[WGG/V^@IYVF\_N^^SPGS'=\6.MC?7S)]C?;!T80R8H^X+_!F2FP>
M6ESODT:'"DUH=3V1S-H@R2?&)4&23_9P0Y#DW=*C-1HD^$2B'X'Q ^,_(N.G
M@?$GHKJ%W+)'S"U[6WZV9N@_#M'^(XSV3V7]CBN2_[RC]((EN>%Y0F2A<\+B
M3!.5N90(FBF:&*6,&:6+WR?2MQFEQY#?G@+TR4E,Q10"]%/AOI#8%41]$/5!
MU(]$O3,L ;&>$&-H1AC')-XT%\2RE"FC."WH2-3'U$HN4I#RB<&$K(03Q9DF
MB06D$-(9F]I'$_5"!$$_F4,^^ZE.$0RQS9WZNZQ+GV,1;+'C!NAPZO> Z=;A
MU.\VMFMFBT(82C(.%ASC*2<BSK'O9ZSC)*-QC#C]<#.NET_[AG:63@'9G^,1
MWX B 46>"SD&%+D911*E$A#)!:$2 (0Y6X"%*&*B<V=BZKB2=I3V?Q\+\5 H
M4@04.2H;,@3S#L';;:&(8$ ^)>@/1W?#T=W'TP,RGL:)T)1(:7*P#&U.5,XE
M*51AJ(@9X['9Z_&__<4"BTFT]7F>AW4#G@0\"7@2\&2<9%*XM$BH(CQW@"<,
MD(4SL#"MS 2-LZ10:;H/NS+@R238]Q!&Y5V+/WQU%#A\I8=G70QA5X T^F1K
M&UW6)99$F%U%M9W)A371HAH41["?+^V\P:+]"_D97H[E!LIYLZSE7..?35/I
MTM_VJ5R<^]H)6Y453B*8ICYOWP;76_B?B93$?ZNYO^/[Z@+6Z.I__R].D^)U
M V.JNIX \.2H.9=P9^6B9@F/V:S3X-]@X 9[4<*33Z,W#7Z^FB+>>6;G,* 9
MS/!COPKE'$3@8EG#X.#JJW9L\VH!7^C9$HL^E.W(+N#Y<-D%MBF $>R87N3%
M!JD<63;M_!9^D?K5W*PW>74:C?P,?I"K%\MFQ^KWP]E>*-A@[R+S;VH6\ -'
MVN!0NX? !:>[2D%\ 95=4^S$9C'G4H"IHI4@3 A+> $0E;/<")&DCL=[B9W]
MC 1CKRE7] ON(OR\L1"*'T0Y7UKS9G'7D?]/,A'.C=XND5 C^+Z\6%YTA',I
MK]J=7H(<JX%TYT0C1\X&3"[/:MM2KO04,:6*(+OKF$C@&KA&P]9ZTD51A&2O
M95U?(3_(BVJYYL11*5>4 PVJA"O^W6 0)6>X1B!0+#*I%T==B9AFNWS*^L3E
M-G".%_&;#=WF(16%.D*5 R7PSL3ZC+!\SW55\J]25X7'IS3-[UMG1+#'K3.2
MG7)ZWR(PH;;(TSOT%TZDAX.I4Z?17UJ5Z=]4_;=__QT^DC/_ZV^=[A3.K(8S
MJ\\OS W*=A8B$4<8B9C*^AU7E.%Y1Q"T3#674A$J8D584EBB>&Y(+ECBLA1L
M2[.7=GDW^FAZO/UA:7^%UWSX9&<?[2_PSO-F?P&'/)Y"P&$J/!K..$UB&_8-
MW/ET1&@ [J-;O^/-5WD^>,VXCO%P,:/"$L9R1P1&[YU+:"IR*W3QJ'C]WU;6
M'SY5^X-I,8F\@*?&D<&^GA1,%].1G &FCV[] DQ/'J9%GNF4<TTR(2A@M0*S
MNN" NYE*!<UBIN6H),C!8?J\MG9O0)U@+=< U-, ZF!/'PBH^71D9P#JHUN_
M -23!VHMM=9*IL3F:%1S!%UK*3':(DHSFXX;LAT:J-]6RWI_.)U-HH?O4V/)
M8%!/"J?%=$1GP.FC6[^ TY/':6-%8G6A2>X K)G.,X(E58@V3DI! 7+C1S>H
MWY8?]VA/BTG46'EJ+!GLZ>G@](=S"ZOH0$I-1X &M XUTT+-M"DB?JX=HWDA
M,!]-$5900.]<&)(FCL<JSR5C^6,B_AL47'N&?7K"Q"3<Z*&T6C#AOWYIM=TG
M6(.R<(3*PE36[RA4@><-]-;Q/&%I06R&Q5%%H8BTF24)3W+IF"EH/BIB<TB@
MWQ.V\Y.$)E/ ]J?&BL&DGPYN(T]%Y<7ELJVH %+*-HOIR-  V,&Z#];]UP7]
M%P^I*O, M8+%H$"X3!&E!:@5C!9$%4E*J%!.&LU <3A\9/^/N2D;C25IK/GQ
MLX9+W_@"-7L+&_!0FOVQCJ>^#(Z$Z2LDP]IIJY)J02$Y>H4DU-4-=74?3W>0
M1L5*%1EQUCC"M&5$6B5(DB6&2BV44GN)/5RC->Q).\A/*)M$\E^HLAO\%%_;
M3[&A$)Q$>EG76/BRJR(;-(0CU!"FLGY'X9!XWH"N:5:X5%FB,X!DELN4B)09
M0EG,K4XIC45Q0$#_OI4V^\+U))R1GPQ>!S/^4?!Z;GU1YP#;QP_;(=(0(@V/
M"/TTBU-C)2<9M6#+6U40(5E!XH*:G!MJ><H/"/V_5G.]5_3/3O(TGP+^'Y//
M_RG8],.N-/Y%AU0:AK7R_<N&;X]O:(<S79W"AP:"QG#T&D,(!810P..I#XXY
M3JE)".4T)\P(1Z26BA0FM46N4B-M" 6$4, ]&^X-V_G\>VBY][Q:[OU6E]BD
MKNU@]8NMSVQ]$OUG=0'#.;N*/LDF:I O9 -/BBKG2FV[QG&-E;4^]W\8^]'.
MJDO?Q6LF@;WDHJJO(C]^[''UG34@&<Q)](ML&JG/EXU=+)J3KBV8[%\Q; ;F
M^_2]^Z_OHA=_O'\9_?SS]S! N<!6<V7=-LY:->?"QERGT0_+&H>(TW!EW2RB
MOY:R!DQ CPU><8(]!&^8ZKDTD5MB_SVI8$ZP9L9?V$["]_W2&B8!+YE=G?C+
MF_,*WM!?6-L+6>*"1S ]>!*^N%PTNSKOP1@L#&_F[UO W@UO!F9LO[B<R3D^
MO!N/7Q9L$78:O5GX"ZQS%H3HQ^X97;^Q?F:#3GR^85GM^_:M_5EXO;R\K*O/
M()X7%B;^+[NRY+Z ZA[#ARYDD3.=$QO;C# 9(ZHQ1G+FT@PL:2/R44*=P_YC
MS F2.A,#>AI'1,YR(HL4 #'-8BIUCX1_+1;J5=O+KNO+XJ&PR\S_86G_0)+]
M<%XV[SN:O18<\PUPS&[+HCN]OC3\%.1$!/?/<!]JV[6OZ[FM^S/Z*&?+%1&Z
M&]L!&KC0\_ZD9K@!G+MQ$>#3=\[3,V!DU$O.+-ELX/;-1FN]?WHX^?R*I*_=
MS'XF!H27WUMLOK:\F+\V90-L?O4*OQVI*J<9:!PXW,ZR;S_XQ[)9E.ZJ'[F_
ME=BY>7U9-:5_MF_J"6)AV-!LI?-\OJ,.DSP X![61FG?&_N63(G,L&3E@,Z\
MMK6BK?-ZR_=1SF?E' :V "QKN_IM?@'[WG[<DJ+WZ/CJ!J_D[).\:KKF=4.:
MW%2FD:(&5#JBMOT2U5=QS!Q64 S%PI=#YC?7-=1D:4R5S"TI<@P6,V:(H*DC
MJ4JL4P7C&<W_AXZ:QM[IMO1NF_5$--P%@/5*P_2MEZ?>979*@_-Z)/:@]:VG
M>UR_#L\]]J]4ZK5:/S?M8T %LCO7?EI:)F.QR>,D(QG#AD1" 1>YC).D8)**
M.,U=*A^B93XP4V-3L\PW-$O26(W:);KU02W[YM_GU;3URH$]LM$]_%^;&]HB
MG^ZTWV]09OC7D66CCI#[7KZ?P1Z? X>]Z0WGYB&;>_#A1E^X;_GD(<@_^56Y
M@)?JA^Q;Z_! ^O]C#EI6W706^O<X9&FJ1^+9>TYG][Y^D3]M^EM]IY7X:1Z]
M69Z!B09(GA2;7AAO%;5GE"O Q,A^UK-E@_Z;64<.*__7"39]!ZR8F];9]=:J
M>BGK*WPJ/XG>V\M%[_S"OQ%@WUS6Y0S_%M$+?.O__E^<TOAU3T#1B.3\!<GK
MER<M[7V >WZW9Q[0.RM^-RE&+[8>O7[0Y;)NEG+N/5RPYOI\8_Z56L@2/5H
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M,<3>GTK;?18-GM#Y3U'XP43J_LMVNW )=FAFF'5>6VW!2-X(D?MZUK **^C
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M#O[\9 :S"E6]7<AQLDZ 6O=A+@]RL1O3Q4!'H!PF4'9'>:OX^2S.ZECR_P[
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M.,.G$F,]2<E39(T0@/I4(Z.,1M;AZ((CU)*>CPI+96(N$0\0;Q /1B(KK49
M)(P33R0V;A!40O Q'W:=SV^W0;4<^X[6?[C*P?GH[95Z4F%(HWRH FP2J)HS
MC!$1TF2GK$66&]!\K7*)8>FL$SW5*&%EG.%(T   *D!'-E$81)*Q+H%*%2+?
M.J)VD8_UZ^R]=:NI7?P"Q/TF_0,F!Y^6K@KY9.9[>,F/T[G_\YLJ EN<9;-K
ML6IS&[,!&5XM;SKJ_R$#L:'>M^4_X)KV@$T)9\YS_D>.*16AW'6BS#%-6[='
MH>KJNW+ LDGNJK]_4=TBYO'-OV^:L1O))[<FFDO2*6Z\ 5\[(>7K;>O__3\@
M#5YNK/&_5>6_ORXS)>_D$.6A-DE"VZEJ>4+Y<C2UY_-5>TGS-H6/\;?=Y:4I
MZED=7W3QHFY=%B5/J-SV33<"&,(ZA^GCI)X4[^#YB^X9&Q?"E6&]<N6M4AX;
MP[[=S#!JI]RD&/WPA7O)L:1WO/..M]%C#2K?Q7]W?<XXW_YM?_UAN;B,HMK4
M- V,Y*S_\V0!MD1 +;BF\M_EX)JCR$UZW(LF22Y_< D_7S;N[80Y3":SEQ\C
MF#>@.K4W-P#1R]_,Z7/M1XLVI:[<?3DTZ3TAT_V2+S\U*^SFTW#GE+AE>+KK
M>$]KH0?<_=6"G<K?%D_-'E9NG:/9Y12?+:O2?ZOJB&$P:_NP-+JI:S\TN7YA
MT1N4PFPXR_Z@)#TB^4%MU[A:=\=K.N+U/O%ZJ]WTB-,CXP]MM4;&?S#&9R/C
M#T1!*TZKOH;F8862OT(9N['R=>G$=O80+K\GS@SB$-K-4@,O:<JY[CM1WY$G
M;K+(>\'S1_*M/KSPVWSW;'Z8Z[=-IS=?N+\,A^HNQ<F'7,?R]@=E^"M2AC0F
M3-&(7,C=] 3FR!'.D,9*)R6H-J(7%Y,X4J.=1]S C5SF0Q&1>Z14PH9+*:F]
M)L7@M5TLSF'$31W3/14O(/1(?*%YQC-DQ$? K!'UGRNQC:A_.*CO8@C&R("4
MY@3QR',Y+L!_8KRT0E,L;*_!H;;4.*<3\L+DKBR:(8.E!,'!3*126\?](Z"^
M&$'_84#_;L9:YTX?C;5]<O'?9VV6:PS7YK8.!TY'(?XX#KF#@)<')<<[+N>S
MD?\"*P]"FR)E,)AQDFJP^FQ$V@1E01/ V*3]6WT;*/93BU]O%_%TLCI]-0OE
MTA;(7F<<^SW>0D6H837AM^LL1,&&H"GLV2$\LOM0%FN4/B,YCM)G8Q.^N\_1
M@OL<BQ4B62,=4M'E(Z[>(AT(0P(30B)FC*B>?+N_??N \NV+8HU??8IV&" R
M.*EV5U_5]V-D<_C&<N=F:@.;HT9R@!K)4-;O(/2-YZ)-7-6X5BA'A0 )GSN7
M*,612<HAQCEC@B2P67L-)>YBR_YMWE0.S()\?Q%+.0R3=.2W URL$=R?*[$]
M'W#G+M!$"%(",\2)5\BE(%%TR@*Z>^_=7@RY!P!W<<3%U>TT1G8; Y-/P-;Z
M6ZSKRJ\6BUS][BP[/^:SX<#D*)-'%_#H GZ>+F"%?5+)D=Q=*R&NL^80<G_+
M0+GC+!$:>E61[FL6OFZ <%_-N(ZPN;I3X#"PX>E[=D>I-4JM46J-4NOK2*V
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M33!Q<0C"W'!Z9"@>A?E3X,@1_@]N_0Z7V)X-_ OOK$PD(A*D0UQRAK16$6;
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M:WW?U0+6;0Z;GY?V!M4D,24 S(+&@(*@/EL']$4X)5%%0J7NQ8#NHG*_SG4
M !1*<'JC^O5/D]I/Y_5J$6]:)>0F(RXL,,@M$<?5JY-%;,MKE *S_SE?3/X%
M''Z+=FW?_/L.D7\!,FZX7G=:9GKG8BR/Q'+[WLY?%O/3ZM7J9%4O*XHI;>NJ
M_3[_V!PLSD=,CJJ_Q1/KSZO_8K24BK+5F5TLSR]*V:U9 S8MIW*\:8K)K0FE
M^BY?ERM54?RR(Y?MV];7EJO(R^_7E99>U75<5F]7"_\!=(\K'MK_NGO.4?.@
M^4G,A;4N2B)?,XRF6M3.D"\H_^+II8*2B\M/N5C7QD+EMW;WO8<W R"L0/6H
MJU\7<9J__.G5Z^J[[1=<//5LM:A7N1X4K'%3J&KCT8OH(Z!0J/YR&6_=@DZ^
M@I9:X!2("-&4L=8+C'1@$I%@A<<B*4-Z^,R=3<IAA9RQ!%A7":19](@1R[A7
M4CO?BZ+\F*N4Q;H&U=1-9F4S7Q= .('1O<XEL4-;!JC0T^O5(I?'NE)KE5M:
MJ[@N4T_LN>/ WJL+P?W3LBGY?Y/EQ$Z;.N'=HC25U9;V)&Z=GZG2JA2371>=
MRV[R:>P*+Y<2Y)_FU7QV,L]7O2TL2*OE E[05'-U\?1L\N?$ 6 <;?%$+G '
M"]/46LUD;OT_5Y-%+ _=N*LZ6\Q/%O8T5RNSN29;6_ 2!EIJN1UU!>%*G4A0
M[RW,T8;_!40KG+I5SNR9%]X:$DGN5.@^*$RC5@H)2$8(,8AC(1"HDP1Y%X*0
M'!N0FCV=DV%#5%#(! HZ"38L1X;A$4)1[H*GRH==3'N[F/L80YV%](68FB_J
M9P=;+=8< &V0W)Q9"X*<]2#O@G+(&&J0U39PQZD-L6^/W((V_KE<NA=;.LM:
M*7D/1DG=#.9M1L9G1R5#&M3R8C/:)J\IJ]JM]#NN?IU5;_QR?J%COSH%304^
M]L=KK;!\M-:'6]&;ZW^"Y56D93WI)/&EFF9;-[8K+=U6C-Y5.JNSJ>]><ES]
MLJZO6,0]F+;Y=WC#>C"EV.P5KX=''6V55+69.$.C=3<S!"E]NLHEUZ?G55-Q
M-M=JWM3(-^S+K#" .-\Q1[9>L*%2%'=OJ8^:U8GUTXMZ\T53Y/W&E9<8$'UE
M?$-?+\MQ<RTFVT_K:0<PIK,YU11NW9[8(F9-)O<!F$Z'1-C;U7.^Z 0$\K%U
MG5VS)Q%MEW#\9JNT[+^**O;Y!6(OTS1^1@%6L+!.+K^X.IV]#)/Z;&K/7^1O
M>][:8S&9E>&VF33-!UD!G*3S;N3E5A1GX>79O*';%]D.R]Z<S;)^:[?OYQNZ
M<>^C&]ZO9L3>70%H2&3&R!:=-2[GCK8^K).GVM6=S*; *P@,F$5;UW/["]CW
MYN.&%$L&E4VP^"_L]),]K]L2CILTN1U/R!2U0:4]:MLO40V]3=<=@&(3%FZO
MN'US+^<@?7A6'M+"=P;^D-BY[VRXS,NP-@+A[[BXB9NN^JZ4KD]-W7IXX*?&
M<9A[/93/TFHZW7I7_C9708\+GQ>I1.[JIGW.6EH7]6Q[R)T#Y(LJPZ6Z3]M>
MJKL11I:[Z'2=/7(%^#IKL+%>P@+6^=IUZ>K565$ILOIRDF>4>\6=SE<P"_CR
M$(RAB+'4D:,DC41<)X\,9A%I)ICP5'#LY3Z-H:W(S&_=FK9-2?=E-2NQYP[?
M#V8/K<[:U@QILJB7;6^"AFUR*X#65W8=01;=O6WNL,LG@YKVZ.B[K,(^?%HZ
M:N1@BEUV?:\VP;C+[^CB.8NNF%+==$W('<@*1\S@]SF8E"=M.?WZ0VD[X6(I
MX]^T3:C 5%NL6_)<@%X+[(U9- / 7G9.G?7K,BM];+MLM.W$+CXIK2W;@62[
M:;?#WT;[DG:>D[KK<)9MKM-YYH S,,/ &F^:;C8V6:PS^I?N)#O>[?7 X$E3
MV/@(%FM8P#1FI4-*F6)N1IA@3,L*^&,M7>IE:62R*LU#,OXWXVX&U3VVF<,7
MY4E^L_4^(WYL&K65Z-OI/)1V(>5B%[U=Y?X(RXO&AA>-0,HJAK VU,&0 A4*
M&/ED/H<)YQ8DS2;7N0U)WN#.IW_5IG=AN=R^9;&6H*6ATX5=VX#&; [B=U'"
M;E<^+1-BXQKI.K(U(9L+.0CKURW26B0>@.QCD6%+G$#24Y!]41GD/ F(,NJD
M)BR*9![($7@1^&I%WW.3?+N>E#4X-7AS:IN&9J'K[[/(#7I6&SU&,M56_UR!
MB&LZ$&6_TRCLABGL_MYI.?%S]*O-T.0M=/6,HJ=K:.IK[0<#.S@FD9@SR#.3
MS\3[@%P0#@E*A.68X:A)[TQ\,MI+H9!6."$N '&T@+NI30D[0R3':82=&RC<
M&^+K"DNO/6VVH5Z#"#X8XJ*<B:B"! ,N:<1I )F&(]ASW!K)!3?2QZ]%7/!/
M3D_]^3/H+O6;]-K6'_YHM<P]T1W%AT)WDWQD,:]#AWP>5F.M='=-]\[F^;ZL
MLEVF6V4%KFF*G9]5NM U&N>VSKBA,KYL6A7"17''\=&HK$T"R+:Q<=;LVM:+
MFPA(6/FMM))>_*SQ";UZ][J26 YI&[:-D4OLK0/@;*P8,:!F(F^5 BZE(1=(
MR651&#612&5PKX#:&+;>6W*#O7!;[3(,Z*:3^:J>;NFQ%Y9W]F\6HLN%LYIX
MX45$<0T'%W+I.G9LDK0R!Y=6N=/SH^P@:-V.]17#*?D[C0I=[/3\QV*C4^7E
M"G7S)K@XNW^KZ<0V+=>*N0[2$08VJ3^T=N^!L!$WW%F6.+(DUXR($EB" X<(
MPX$G+-':W=_H>U7V(O>JS OWMV[=GAW?; FY*JP67=9"Z0B_8P-<$3\XKGZ?
MKXG[@_T8FZ:[&[1= GJ;SK'.>NR)TTVA]MW!Z'0A,0G$&9"1PB >HD1.)X-2
M(,F"/L=<"/<FV59G>S]OU^>Y:6C?M_W))XU_[FPQ=PWN=BK"1O/D+=<[0*^+
MG><^5)UC,SL?A^N/N"8KY*[AW][9'VPU3R$$1"C0+P_2(L!?C$SDP9E(O51J
M'V=__F@@X&T^]+"AK=37G_VY6=Q9/]7C6_*X:M>N*HM7;:[>?<CWP8>^!__:
M$SDAM!MHR0HDJ)99 C956S].ZN+BV#D5UH47)[./&<X63>3 S>TB5*<EFZ]N
MD^FRY=FII8V@+1&EAF[:DT8;=+-M;H5)N#3185A"5L5 J$L1@61TB'O +..H
M0XHRS'PBD5'6JT\=F0&C+"#LM,V9Q 89:Q3<DY),EF!*U0V1JCL=53+)-Z_I
MR^$+Z8NWA"^JH\\".->=JN/LJHE&&ZA5@2!EO$2<:(5 Y_6@7'@K89XAX5[1
M-.](<"EDI5ER@.2L302X$30,3JR4)&GWB!.=S2]1,0:L<RR;T..Z/WIG/IV7
MQJ&Q- X=TG@WFYAFNY 7H"@&XH;NW84IL^[T<9+GD&.PQ:_U!809X.&?80$3
M]M;PZ#VRDF#@5QJ1R^=9N*1!,AP3P;QW/,\KL&2Q1B&G]G#.@5]52DA;1774
MS/% =_GU3785=J;J)%Z2BW-/X$F$&0!7@Y2 H7 O W*Y\F+T)()Y0V.*_8D$
MH:1WH/QA^,&E)<AYRY T*OI@F)&N5PUCCQ/Y_<" 96TG%Q]/6!6WT::<+ID;
MRX&#"Z#A[H=L2",>MEG7JP.R=Z-.ZQ %RVX%[P&1$F@\EI&$DB0L^J0C,7U/
M]!V,NI^:I-$<5UI,7(D;OYW:V6C)76K)J>.J7;!J<\6JO&2CJ72%J637F<E^
M<\UJ^Q$>!9H,K%T;U7K7''>I.";?_?E]Y[O\-1\/F=DI&-&-<_WU/,3F %-[
M85[^[QN#:.,3>%WVOQ?'?3P]F\[/8W8F?9B#6A27ZT'E=ANGJU.PW)I$MB[=
M;Q'+$::+$U@Y0_!3W4"\G\#TEO]_>^_:W#B.I M_/[^"46=[MSI"\)  2 *N
MW8FHKNK>[8B9KGZ[:G;/?IK C65.RZ)&I%SE_O5O)DA*E"6[?)%LRD9'A\N6
M> $2>7DRD<ALT_/6IY[<M$L.]2DU>$Z[6@QV\TKX:#9;^D/G@S*KN/F'.PJ-
M^AII59?U!,-D7QSN-]1 ?? BYYBVA]^WN3I@5OV1*=,>W\>$/%<#&SB[N0-9
M]GEP?B8>0)ZKW]MIXLK@E^?*X@>7&XM3]W'> 3E/;JL$=RNT)#?@V*"SIPO<
M6@/@I(M"D(PGCCJ>.FZW?+_[*+2?9T!<]TE]O7M)FML,T9>D>=$Z4."Q *1Q
M!$1V(7YU'$KYIQWN[_4NYYC UW86XP('W^F^[A!-E\%8MHR)FK+W^T'U3GUR
M\QE,Y0@VHCBE5*:4$ZH+<"MU;(D$/4@8+UB:TXPQMY5<=$_@YVFVTI==!<,?
MVK3T/6U-'<O.E&>C(^".A!DNBP26UF2.<"$,$5(X8DUBN4IBIV2ZCVJ7C\4=
M["BX8S+8F)Q>;D3>5V??75%T.Y>H?19XM@)4S_@YRJ5&B1B8B<58J4.FX&BF
M 'ILS*SFP%<J?A NZU*>/+'J'WLB 4?]!B3:X*,Y0+45(Q$ZY"3Z+48:-1M]
M%]D2)@YV=W7"XV\G'T^PT%2S](FQQ\4RP/$TRV))"HQ(<*D%44841,=QKET:
M)WFVG2MQ5Y;YV\>//7GVS"QTW";I.TST!%0)3]F5Q':AILOUB;4O_B@1YN+T
M93+PP&_=##'32D7-6J^WA4K(<@IKP&WN#NPUB"6S.+/6Y:2@+B7<:$:$D1E)
M9!QK%A<N*;:R\.^#93Z:,V>74_>A:.W5#SX;=^T)PC\U^.QO9Q9@,/@<LT^8
M=G*+&->+/$F"KD)1SH"S_+DVYX,8F.FU7,RKVM63"-SJ3I=5\RZ'LHZT)_H
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M>-^U?3E#V<E1*O 1Y\J,"#4$^@6I#5)[;%P7Z#>F@TW#3!7ZF)4XZ#.IQ.$
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MO0J/XZ3VC1PX.GSVO(7ZV"W]=T\=(1H[^P:['U1$L/LCB1/QHM"Y<H;DTJ:
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M>JUW>87)@?/*!:Q"M[B7/:[8Q? KD%$WE?D=R85?>G)U%U[E[=Y&J_E\"AR
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MA^&))%$.'$M)=%%8/,C'B8YS1VR>@A.:*_/ Y-%54_DKK>2]4OP9=.';<[!
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M..F;&7/>!5X+C)/ 4-I37LAYW8XW/@+4<KOHH.A;<U+?/D/TJFL83GP%Y_
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MTV/HVGCA>8$-0=&KX-JRMX\XI#-.Q+CEB^=NVFT,30TT[*$*2%#E'I+>#;#
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M<'N7Y.Y4IQEO23\;5^EG/[<?:D>"_4:YMJ(7"K691.<;R]JS46'L[#Y<O\>
MH4>NE6N>*X(B$4>U^&4E>C"X#]B+(_@&B$<9G!DT,WR19,#6/[#^^W@#0M.=
M]8);0!4#3JI<#=!>_W#^Z?/YI]_3;E91TSG;'A#^8+V#;YT"M;C?_%:0K.\W
M[<D=^<1+ SWE7/_ >T\*IM3=&"JD9/*M8MA0#G8D'.JTX<#.%:5"?5"!<=MR
M(N";;![X%W]+H?](W_ M^9CN9-KC/WU34_!#STZ73SA\\[>?@UW@!9O#?0[\
MF'>CJH3F]H%/P"'X@=Z[9,_$1,)ZM XP9/(/L!)576JNU+>7@Y<6[L5;/XK#
M!+JS(!M?L;05!;5T6@ WV@<.W$@^9-TD?_RM!&UX$5BA VQ=B&U"/%J^DM_=
MS39>D9-RX4EH.GP,?:EHWCOE\ W5>6HLKG7J'>RRJ2<?LJDG?_SMFC0?'PBO
M$.(HHKHF^ "(^14[I44%8]L<_# ?K!V^RB&\%[9XH9"QSA)&G1PQ]Q6#2NN.
MS%]0O.CJ2AKK]@KO"&M-N"[F#7SGDG\<BVF<09> )=C1PCA:5=5]&GT_L;PG
M,G\%!ZG-)J2,RV)-&$<RPR%\6WE NU'0W'_*QU<<P\*/)FZ*QR"*+>__NOO+
MP"G.7$-A8[M74IR6PS'!M0N":585,">J1T<C8:,/+?-PBC%>AD2(M,5?3]1W
MD(HY-T$XX GN2]_83GG"Y' EI(/P2L#K7&4[4VR&=G4UWQ0BCEL$<==R'>K"
MQB8\C;2I"[U:^FFX%2GP$/AA+OIJ5<&;ZZ<_Z64+^KP0GDWJU0"2UR7PB^&A
M]M:MKV6.0<LYW MG?3K1W.->Q;0U5]0O J:&M5O"H 0V.2;DNL)6:$.H_A4Y
MXUZPEQ6)JF>Z+RF3K"G7(0/'R=Q=$W(&E(97<H!</PCIQB/,$*:^TWDJC.>[
MQ_$V<"HPNLLL[V0],,>,@':^[,*3Y2VX.&1%N"IA\0;R+'/FNGX'=4,$=]*O
M&)Y-["S("VIM,/\%4R<0%<<R4>N:S^47<I3('8W=?;Q<_VH1J2A<KE.%RR4$
M.M#NJ55''2F8VQZE?"/ 5Q#6BCF_[LG+I530-=<TN^NC91(3@8!&I=3MSUPY
MS3OI&8?@O[^D:U[M7JW>1.TKFV>H+@[IQY]=<D+)JW.X@S>G1A'8LO)$K- "
M\NL$(:AM*E@>^5>#*E:V]#>8G#JPMU5ZF2C5KJTJ:SX X#!'Q-9*;5E%@;FH
MG-C% &[]6<:E>DU3KH;Y\\@P$>@A^EQYP[2I<7Q<BTH@U4C8_-I*[E:D1SQ^
MLU8?W:JJ\6N-7$:2N+QXB>+0LINN,T4E8X-9A-@"AT#+NXY )A90!XIA*(N;
M.WL%[Q8::)WM%M7!:JBE6Q%%V.O$PY\^7OSXB9S>^\!QURYYVSRKR.HU%C<V
MT7($X66M9J*JI+F7TGJ_).?.C2^M,#P0 1FNQT:+6%,MPWH(R@=9.]?GWDN1
M';K[&NUK4RWMO@HT#.,R\$@_N,8M#=2H<V!HKF9LXFOBG;-7JLDDTI&(;N8V
MSP*J%Z*ZH.;>/.(0;+C6!H &,I&68E$'%_B>'+/8@FPK$-BSVN([< 4*+PZ_
M6APYM*KGPXGJW6!1&$N;B_R5;2SRQ]_(\^DD=KP,B>S\"L%)9>E366P$)1)U
M"/6IQ8FB12;Q%HXD$=Z9:/_IB0AC> ?ZK1[Z <TM3+I0944IQLI'I$4%@_Q>
ME@*6&0NL[!LY7*Q6"NM*Q:#)LC(8KDGN:JRF^?!1[XGK][W+'KTKTOA?L!62
MJ;TG;T3E3==492(UU%5@)PP*+W6FKK(XUA8U9>7/,@5S Q2.P%*R"6EX:!=[
M?DM*,]*;/P0Q;L^WM*\_,ZF<RG4WKN_&^,Y]Q4X^OV<K&5U!PB@CR@-V'A*X
M7076![FMF#&?HXUER].DG!A$TMQ$>%84@;D*GA["'#V!Q:U&?Z\NK_DVIU/%
M-0STN5#S1*JB,W&+IM(O.'[4Z5)JJYA35Y"WFK#T5(B_L2#8%4Q^W/OH(@C#
MX(U\N+3VY#>ENJLCD8G>7.&A!/(C.8&5NTM=;E)7G4NR(ZCUQL'O_XZ+TZPN
MI]MS!1P0P:G.X;X2ZA.I*FIL(_/[JI8?SY>9A8HPD\0O"%L*8/SN.\ U,D^4
M)\(8M= >MB!R?$8?[BQR$X1K[(+/(>$5R4#=0&6Z&Z.E::W4RSVY,0F[KV S
MZTK.@<]BS!!$D@J-J9+'J*]D4FU,??&O,/OWUD\]]R]9CI &%K$# <UW-[_;
MN*UZ%3R35]@.?,*7>OAP8?DU&J>V576KTI[!O30AQ0]$E*BXZE2EYK/7:UT)
M5*6-=;_:C3&-1@&06L50VM34K>L)B!3BW^[VEAM"8\LUZT36?*6ZI[G6#")(
MKG=[+SA@S/74BH>+(7!1!3 @T6Q\4 "S=XGB"=>YK(_3ED'O[\#&V!$NO4+A
M#;R/TNU;7>/X>"$Y D'@-()"[2;$6&;S[@E7L$MVNAFDKLV;=Z89$*D!]9G6
M%=M;W_U[@D</#E$V:6PBI9PUU(,,W DAN>"5^THD/M^AJUTG:G4@,"-NCP>+
M" TG=Z(4:KU:K6A/8MHM)!O+/OS'#]7>@95%C$V_T+M('A9D<NB!H DV(A!I
MXQIY:  ADW%,35;@VJ*&/6I2 (]F.:BRM(EH8]J+94@Q#LLAYHW%-9_0FR#$
M[L:_?K<I6ALH'6%F(J:$2/\4UT2A^,_8V< C(AF6U2=]K*8TSPB+Q[IQPXBP
MZW].O,/J+5AM@R2R?(?T;?5&FC[<N*_5#TXO$G-Q2!>O(0?RJY!J.E2<BS$D
MX[97I($([*&ROQ&]S6B URIT-QOE]3>4JD$M04[<J/#25JO%FFOJ5ODG.XH[
M^8HY>N3RS<=AM'7W@K&OU/XWUQHAJ!80^*[7:PSP_;A&9:0L:^[5!_=IPI5D
M2UJQMO7,0 <*FJ<^ TG.'!E42%;*LKI?4<O&+(WJ.G]/K+96?&\=+G#J-1I[
M!V:"+"GJAE#2#=8BMFHZ@;!A\P#$TNT ;B5/^%6(C5(L,[\3JT:JO8V9*3([
M.!AW(* [=#0A4RMC (&RA4($J:!!6E>;E0]!WN7N4P?'@6)-L]JZ4LJ4LKKL
MI3G,G;R*H>M'KDUO&M5LC-B@:3 <IH9- Q9>L30J(G!X";B?Y\HRX03\SR\)
M@TNN'M7+J+.%B<33RX!<L@H)NOR[N0.0QP2^:XK"5!4WQXF7 ;6>R%U/I(28
MG#'R Y$-\U]()9GUHZC62[>2$)/A#64OJXJIG[83)HVC^Q!O =I8L!@4E_+
M_MLBYJ===7-<AQ6"/UN*C@X*1EO%8%26U8U0*(*^U''XQ2+&)B\U<8"I\8W!
M;.?S1S!)\M:O=:+L3,9<!,FKY7H60Z=[MIA _\Q\X2&"Q[:9"(V=G\(@BK[X
MY&![8'3]B2P34V>1$:GB2K30-C8UJ4M,BEE5KTQ6EY^#C@?DI*@:W+FIM.[
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M.&Q7$;5+Z2_25,78IB'\,<B\U O4P<[%X4L$$;6I*G(!GA1UVJL.!'0O ]>
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MX.HB!YHB>BGS-!=*S5-,E!(94=:BCY18HF$P=+DZM7/[G.]=*!B-T"Z@ C:
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M5%^8[BT5 ]"5BNXX!!Z=[2PV1)K8D$^$1;,Q=B)(YE3I$=.^WJ2:E">\<4'
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M0_QNK[KVM=$V#]>>@3(IEJFJY'P=](:'/I@+NIA6P'C>8L]KBG[-%3+O=#T
MFRE%7%QA>^N[1-:,6AG[IFG;J%-=YE<IKF38C>D=UVB#Z49CTDU.;N9;AS3L
MKEV;KD"#2*TJ;QA;N<GZGB]D3FO/$G]Q86$94E&A%L"[KL:D&X7+[JDV GC$
MI/@D-A8_ I3&NF#SKE2.5G'-+6XP.L,:ZCX],?I89.Y)13>F)PP&3NS\1+I=
MPT]V)*);]R/\)\@C1:1:D4*3O-I7$)@54--,C1:P4WW=\7)9J.&@O#*]Z,S/
M\M9>U=R)Q%S,)4V/OK+XI$GEN!;_)QQL0FN_)5R35_G@UY>=.'HM@[:](=]4
MO?*JDKIU%+!RZN1)\L]F.5#),ZH)=:*.1^U"1O-4PU$/R,MZ$(8;]?VH*FK0
M&X9Z#U'=D>-2:*9;YO/G7"3Q0Q#_!<>/Y%52>KZTK&[<?5!.Q:[6>*I*Z_9+
M(Q*K%;H!39Q:X[E>46QFRN,Z"-^Z&E-ADX,W;HBMR\"IQ".7?Q['(DP8A#79
M4&0C6=X-SHR[_.=.!N+NM.:0*:P^>]/X1FXZ13\MFGTSJ@MJ[@VDM!%^@63]
MOOB8W)?0$+/L9MJLO(VWJK]]2>E^_C+I!/(5$$DKNG?)?^+ QUPL)?]4>.AT
MK3UK0_ BOL' :7A47T/Z<,@5'F /;J*L>3DK@C+N%)!RS>5-H@;"7J<*#O<E
MH;9F(J(UAW<W5)MG5C YD[GDJ=,8+C:0J%$?[B*2$+D\MD$8@QY+ C-L6O ^
ME,Q95L.-Y7-'_\PEB,%3/I(5@]L^INN5.A^D#@E-,K\>VA.Q==0UYG%+G@BE
MT:54Q)R42Z11!Q(/D6L^.SS7[Q CA!W *P/];B*FM^BJIKI\M9,W-T&.0R4M
MLEY$5+SUN5"I&J^BM'D3,D/A^H_$ CN.Q5YU(O7LK!:.0QV):'_S'3<DC$BU
MSKG:UZ9#10/N-T+)O_0+GJO9J];7^Z8-:?.N>ARBLC;5@J+PZ$GJ6&X?Q8EH
M5\?\!+?$TE 5GT'L.NL;0Y_,N'CR3Q2[-H1LDN_=C=\Q<+T?5:-HL&Z*49^J
MCNU.8:^=:!@<:A?LC+:U9@.54;#^[L!]XK\98@]UE5+Q$UW)S.#DEM#K\[YC
M'4]L-VKF_4KSN>#JU8L-E>:2=JWU5=-<;V*#I\2=JB25QN(CV./8I-S",Y-X
M8&(-=\LU3SX")[Q6I=6-@&YV2<3S0Y1_;/D;N'G9N:SDE&J*ZP]N<@-';5/.
M_:X_PK(/']FFFGE6,F6_:QT:E<5UPSH$!\LCHD"TD$/0'G!,E?-5L]Q0PR#F
M(;-X")U'+9^C*&R.O6&<1U[I!BY[$7V@KW@"5"5;T[;Z5)=O*8D"3WT* L%-
M M>J@.VO95]&:L2<#QI'D%P%'#U(Z5&F\D!K3V#$I0;?Y1#'A^6ZP*$T+9^Z
MXL2,#$5G=!G4)[A>US QI:*ZO3$A-? 6,[</80RM<;JL*6[. : N?[/8LU<)
M!@>XU5N@\@[H2$6WIA'<IK<+THI#USV ,&L9QDB]*&VK:G=";LSM4O0W;U]O
M!I+O0&M'.WQ7+8WH=AFK-M52F\$J^#G8!5ZP80$!/)!"B1%6Z6JFD?Q\0SB;
MT-4$7)K1- O=.J%YF]WC<(-#0(7//"!K9>7Z"B9UG2"(,,]?0"UFGHCP2:WG
M5-:820SE%]\2ZDC!OS^&>.<F.VIW(T4Y<TNY?")_U<3)#*$Z$6>V2,C\$[[=
M#7>W10>X\N^3QB;<NSXDL:M\_LN_SP8EI^!8U@TS1U'9J.6&RWH-!HQB.7/K
M(2*AB$Q*+F_%4^'1QBEKP=,ND*/)G@)Z!%7W\5BMS/<]'YSX*DUA?PL.?T2H
MLRG'T_=I'ZT_TP9>-60(+G^+\8.UJTKL,IB<2>5L"-+F%6;_WOH%1.Q*E7S7
MVC,QIM'8^.6:R'HLEDK2'=8#[70F,S<GL_K,TK5U)@41^!5[WK_[P9O_3"8Z
M\+%#934UVH2JO#DO.>;VP:PQ]D'.A0+)3>%/C^Z4EDEJ^M/3K2-ZMS$ 3? @
M''H&5H$(<ZY*6=NZFL'#\E^)<'L.!-^'<Q@.JX#&F(3!J^M KD5RZ,D)2>^#
M#.6]"6!DC*;F%U%>>\\TU3+W2M"<Z837"?&67-^I7R2L"N $K\&QC;*,Q0>O
MR=M\.&'#9MO4^?V.L]$M;+>J.K-7TC^0RW/UAKU7?!_X\5;%]?0F9W:#,UZL
M,3]*=5G]^OLTC7D']6V;:J:!G&L/2+Z,=ICC-"%;D!E@))9!F:^C9<TIT%BD
MU$\4+!64E0!_UAV/I9G2',YC@U]?N:#NF BN]5RN+U_#19P&:%2&0:C*3@LT
M5G1^D!0+2D&AMI()A"1RMP[$2,HHS$A[4([1%]'[V7N9_=9:K="1K/Y8X4)_
M,NP5%6I+AXKS8^,S:_@5CNS0W3,%*H2*PIXDG.R+AZ_]9,<Q9[HR_)WIST2!
M%#'G*F[VD%B]W/?/">D]Z(G 1=!K1 4>0%GS/@==.+G;J4'PQK+I[F1 )JNM
M%=];APN<[5_O<!&$8?!6#=K0EY0Y !T(>J!Z"CD-9\O42RTKZ_9@33S\Z>/%
MCY\687@?..[:Q<Z-9Q4?P?JRFOOT<Q"Z_QWX*W(S6WN<Q*X=W8:8G'_GRK+5
M#%R;:A,;!Q@FT1<_VF.;3I<:E4U9=J1W")Z1E)WAVMH&/]"ZUZD/.<-J"5"@
M, <E.&X).7'\.@W\J!"3AR,1E5>KM.A'4?<%#)YSOL.=L0[/H"=T4N>Z5#"#
M3"C/Y$HEOQ+^V\.'"\NOR0RM@>J<<,W ; MW+?4"=AA[+XFJU*JKNJ=[4IN#
M\;_.8ELJ9K##@W/&WS78_;4V,3>@&[I\,B3-%]]5;N=N-'0;A,@%N(-,3:DQ
M7];.@4,5Y_BK1:,NU0W"NY';0K"Q30!O%45U.\<FNYT5'I;K? [K5!8NVMV;
M(TP&4IR)6-:$G*HJ;1Y+Y>+ $V!0J-R0HA';=5@6;6K.P7^]I*_I&*S=2&".
M2 HUK[.JAL&@P5?L)QE&/GDZ:,@RJ'=?/'>3NK-0!RYW!PSQ^IE\&ZW9(]KT
M3&MLP-@D%5S2&<36<GT%01/8:=(^]Z5B[ORZ&Y_F;2'7?5Z5 >>OZ>RVJSP'
M6!#@+AKMH.KR,[A?BZE?);R!BP/_L?UEVXW:5^PG6PFS-WGSL_>3&.@7H9TM
M)E(/85F[X?YTJ:G5O&D?'+86Y$.V!.2/OUT>7L"C@6EI("#GWO(M+KQNW9#L
MJ3 ^7/L;\EV5GK<7"<U+P57]9%)O5REL-W/!9]A"-;C4K>L:M)?)0E+:QX*O
M3(-/6$<BDYK6GW>6YPDEF=*6GB]EVM^FZM5JXDU;535_ZJE&) +C8$ W2!1!
M7UEVO0/+E$@+0PIITK:EQ@$>L:&9! U2$]SSGG3.6?J_6*$+XB*@6JKRCK6N
M;G2 [5,TJ4KK3C/P_O(<>!0RO"['0+F428ST/.Y;QJ$$420G[6BR%/6A9%K
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M&@F*D^A02IXKS!@(WK49D!/W?G26_A/<%B&++WX(_%#\28-Q5P,4T- ^HAV
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M)[_U=C>DXBD9%O>%$.W(L(1I4TBT==PCSV&S\.';;/AA.NB7=-#VR(,&*4E
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MXCW^1YWYO ]G]-OY&N8H;YVA?9QLIG3DPH/ZS,<<VUO?_7N"-24+S&'!<71
M>%O2!E'6XE2/B]0EVB-X].P8.U?NJ^M@WZ&[8XC:J31F]K!"&T@T0D_39/;;
M\8:<.P_ 7('[[\X*?\/L,%"?R1#'23B=$T196\RSW0EG8,[F"/?803[/"FUY
M(5F@Y X[C=_SR'-0:4\LYA2D@P[HH 7VD37JX'EDT,:R#__Q0T^LTU( %U!#
MA-PT>M.!O1?2W7'U.B>VI5T?^X@(AS\)#8F<!OH>+M>/X$7$=\%0$W7J62BU
M1,\&2_Q*+DBYM4GC=\:?@QQ.79H#&D*91=OCRR;: MNGCDK7.81JN.UIQ\$
MR6A:8,JP#S94 [Q92FX"@W3FL[MP'%(FHHTOPT=(P.CW3D#(77<Y32EQLJ [
MZNU]$X38W?C7[S8U@(/_,TQBQ/R.TC\%JU H_C-V-B!62"'S6EY>W@SA)E@[
MR!8=00&[0K,O,D9C7:RU9=U#4@#_R/GT9C*=0A;C$R+HH[0#W!U.^F*1,JFE
M6KQ;LF9AHJBAF4QG+C6,>FO^+VNW_]_97H129 <6-^ T,\?2U-ZX810OUW].
MO,/J+5AM@R0BQX5,U^J-=.5PX[X.DW99*X@V R@OT! B+2'1%-U6K#%T0T$K
MOH+!%RZK^4V"(F&'D/BCA?-?R2 +4CD124K[#&74CV]\\DG/!BDR.SK9(*W)
M!ED(U,NTX*LMJ0GQ]S(Z&N7I:/;<%;F -KU/-H6 RYH]D\TF9RAM&N7!T1A'
M29M'O/VO;'K4P'"/PA.4#1_B R6+A1^ /BP.D.R\,;[O2<X:4Y$!I+^K;]Z(
MEC,F2.2/<(1UH1AG: W#?*7#=(YZF'E36RGFQ(JEH8X;?Y?L$H\B6G$?W.6;
M3Y9@Z^Z%R6;0"J;4D7#Q3>FGYJTC&Y_W]0ZM& MJ?HC!;F_YA^AZO<8V=&28
M1RLG]T\12@E.XQ6J:QS%!3KV\13\*OE@<#J8J1Q>'UEBB$5VMU=<\@WBRMJ*
M7NCP.%%IYWVPWMWH"J^MQ(L)X\(:@TM>E;J+2RCHK[S2^&I.#1/0H,!M/>I1
M=VZ:[D%"RNIC;R^<1*X0A?V:,2;C*KMTC22OTJ79-V1T_%$= YB:R;(QW0W+
M=5Z<6&VM^-XZ7. 4O3[V#@Q,H[L+=U''"<F]&"=)9 4>Z"L:!KS/&.VL V!+
MVU+C'&0#.R/K,2>9$:&FA)GX1<Q$0?)$T"(B3:(+C.1&D6CU*YB(?.[I0?MB
MU-E(7]OTZ,.;"[ZJ/B#.6%PK*T0)P -\PJ_"WR>MA",N.O<UF6CNQE<]9X5K
MYS1W&G0!H,U!8=:2F? -C<EJ5.$WS+SVY\ E5\\OY&^*FF H=\UXDY#/ 28H
M@RL7GY=GABL[=N::Y^2%P@ZG<3G@X?H$T1$OGKNQ^F0#*YQ^T8(4P?X"?U('
MK2!M95SF8H1A\FV<#B\+&@/:Z(D"J:?4CVUT.:"C=BMH FXN#\G]23>Z7@%Q
M_ A'6(.BM^8M%/'B)_&U?VGVM7]1 --<OY.7U8U 1KOUXY!PJJY-^>6^RZ\3
MZD?JW!E*N\=$C7^<B<W!S*271F$Z<I,U?D:)5^PGF 4,22DMI-FY?K>]!'PG
M<F69IP4D>;I,HI@P=WUU09RJB A3Y.* 2>'=0(4:K"<LUY/HRU<\;7E&N#)I
M(_##T.28[G>7 6'!!\-8$QH3XM< !!'^>P*+0^8GOAN8-B4CARB]2;*EI'9(
MP,HD_P>VF @_P'X_$6XY="&@!'Y8^$[^"ZDD"V0M!B>D.U9X;8&$Q^2^ 1"<
M9S0G'9):!W1>T3'$BH!H4_@R7X/U&%6$><@W0^HG1\-Z6-?_L1<B#F++X[?%
M P9!2DR@(\?)V'05X+_4PR:=]C!;$_HCK%/Q.ZG"! @>^Q!OR1.>*B(> \^U
M#^R_&O+$9N01HT^V'J6-_LK_G39%["C#+5K:BF-&WT+4_G>C:Q&L$,"JX1"(
M(%+7[JLUX;3@HF ,Z1F-Z["/8A"YZ QR2CT 3=@#GCZ01.<@5Q[+4*0+1[DH
M9V@%Q8YB0'GO''Z'TD,"J_1=MDSGHRX256BD>;_[Y?,K:* 6T^1G']AI3XA+
M:=;UD9/MZ>AT?M-,UW>Q\]/ ;@ R>0,X"BD##PTR94X\M_Z@=!E9_'C:SAG*
MI1^B;9U5\VVLZ6.?"OGNSN;#$HW!_>!2@"DV[M%S9KY:K@>:@YL@?+:8DV*F
M,U_8-O/CP@Y-;?+%)YVBV#(_D6W)W.?)M SQ5,X:(RLL.G-.")]#=\AW61=8
M>A64=0)!+\[0"W/C)QWY*F<K#Y8?A/$YS<J2@2&1F2O,R>B<=0KDR@/2AV:H
MRF!J!<$)Y7QM@ZG.1RD"ZT=#GZWP-09[:O1H'08X]<A64TH.<7I',HSJU$8O
MEE>%MD2=_$?E$"@'*YZ20<$M0 @YG-)\^^P=5W<+S.XTW4YO((@\E " !N6(
MD^C,O=_ROKY*,$39A#RY]-X*QQR!G*UWX?N)Y3WA/7E;^[(R(E,OHX48L=$5
MU)5Y7)_WKA^LUU)>[KX*:XG\/PF'"FCA#/$VY.3?QSK8/!;2*_Q%-J$M8!09
M?QY+2<YM '0<V47>CQ(O9K!?"^?5C8+PD$J%>@+ULS:HEM;BK616H9'C[4<9
M8\:ZB+%! *^@CC+RTSB,CS+&@F>;O(@5 QWWP26GPM[B/@E:B\\MHS3NEAO0
M7<',, HC9X\M@]!RNU#!&D3]ZX<:,40CU'%'V&R*!C7NRS^E,6/<P>?]LG8[
MB!7G$]#" -ED?QQ=#<'@AK%3C;?)Q=B1X8:/<Y!E28K&<Y]39QY(TY>Y+>%Q
MQ\GSBWCQUMK=6U%D)63':WK<.5FTR^B.G1%&SSCX'A3]E^A-E>]%SSCR"5ZF
M'TQ5[D,M"1[GW&'9EBC28O-<UJ-NFGMR2X4ND2 AL_Q-$*ZV6$!*+->+J_]\
M<'W\<^([(08,FQM")\983\I=T30*:59[R)T*('UI;C/RII$.(!\<C;:L"_3Q
M6O-.C'LK3#DQ?+>F$T+;!$0L1%K-(#Z6;$*@9<2;IC*":'R::V;*B9&OHG;;
MY?P/GWXW/OA+WJ@6/>#>P((Y+9*P)D(X+<.M'5WOKG,L7F$8J5&4<*'@3#"=
M5>0)QQ;9AH[PBI"L6Z1WKNWV'9L@C%)_CV]E(Q\G/KH[D?[QY=RUI1$YC-P1
M#DAZ4%NNVD2N.H^DXH.U&R++ PD$-":2YI?K]04S/CUO,8Y9> J18F@ G$ZW
M1-+0.6_IG#8E G)$8R9]%,>?A9P1-IN*__4_/_W^X_]F\P$I($;77^ -\&G,
M$  :P&$/ B>'4GI3^L$/3(&]3.(H)EPGZ35+7CV# ".I3^1AI;WZZJ>1N19=
M^^I,XE(3 +9RS3[Q$_0/,C_/L17&;6?H F]<WY]@DJC8\$BNML#WL??$C*0T
MM5CJ_4\-9*7YZ_LZBJ80;XOF<(RDX F&&%D^C4<_ P41^Q]X)@J0F:R]<V&A
MIW90]"U.YT&E21V=E6<"TB7+5C+PH17"%J<VX3.K911Y!$4Y?<L$[F=IOER>
MA)!=FD\XPN$K=FZ"\"8!'(I;GO*N?]B-E!-8I+5G;2'1&-5ML.:0:._H)T"9
M2IA[*XB4PJ$\"6LV">[7,@EY7WE*'+$[QP)F@!Q=6YZ:W%Q,-0D9GR)#V*^"
MY0L(T3\%@0/(]SREZ%#?V4:#G8SZ,OIMQC*9[]=AX,>\-_>6,S@9.R.(]GQ\
M.T)R7-WU\"'PY1%=%TL#I&;>\UP:^8J9GQ@TF;]CV@"O.;WC&$4=D-787FB[
M?>##Q;5<0R*Z@%Q5]!JW0AL<,J[P*_:"/0,O8"[N6N+,[+1=$+Q<'^U9T_0J
MA[:I!<O)6D\][,?V6)MH/C(^1\S#<HUN(3LAFP?1)C5<2:U*L1-3Q+S!2^^R
M;/2^DV(IVF[/+*1E?&).G2ZW+=,??9UUCDOB6OEX8-ER=*?*H?J 8W!5HNFI
M'.Q<'+X0GN'63T-5%H#8-\0!'2Q4U!E*- 'JN&^A%7*.OT-93$S6TO&.N8B5
M0-$-$C96%*1#M48?*MNU/"HQQ5Y>KIF7= :+-_1$,JP,<A%)(,SD9N*.X5D[
MQS9.<4*_NO%5YGOEPR1[5,J( ;Z/OSPACX=R',;U?BCD-29G\X6W2P9KV=MG
M&_M6Z 9Z7&0DF' 7F@-^0K0' \>D113Q)M&.MCFR7\RX$\#W<RFA-9+:H1L;
M!BZ:FLCQ9=R1YV/^:E9Y[,%&8?PWT@$G83GNA*0_B!_D]"@[Q E.!A @F?II
MS%<%U Q@P)!G<+GN'Q N.Q2P6+8:N!GF#T-6=HJX[W&'KW(<X5FX<W, *"+'
M/ER)<>J]Y!,YFN2AX^\&0L 5$?*G1(!+.5Z82NH>NPY"JC$='+,/%%&.Y/$,
MIHS7D['N%%?)GF)<]'$$Y(9E$15]:&05$$5+'Y7"^8]@*'RC'?,0Y*N=CH-E
M0(8P4_!<F1R&8."H*B6*_+@F&$F68!W.:GP 5SY0UH"@1#5AY!CW9[(HR3-$
MB5)F*R5+WY]C&E2!'Z9TZ9!P-B3_R(8D,0\&AW2'HPCC[!D"K"8!A'#@II?H
M*L%_P58(_OM]@V]H,V>2YHRV=):"/)"-&@>04N;1<ITS!,W16(9C'[^\<S]_
M_/PO\U$3#K36]E"13NB#,OXTY.Q9, ]K+WB+&#AWE=)T-+<5.21\]1;<NQZ.
MXL#7DUE<!(K';P':"<J31+</'PK?J&((D \]I3B-EDC;4'+1OM)XI@J_3)6X
MDMXK>@+ N)#L\D'+D^FH(3R=4SSJ@>53J66CDYLP,=8,B2 =-7/5(YR,A'W$
MN^DL_;2+ ""K'Z5!GAO6$<K_2%T14^8 5YY-&.V.42@' Q.80WJ09]'UR7T
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MIYG+I.8NGM3>GF0SMZ$SQA#A ?Y9S#,[OF2>420MPP3ZC!7>[8/0"@_,V4#
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M_/;!LT"/4I,>W"/T3L.0/9-?L#]GV3Q];6OQ<FI$D)L0( A=%X"D<U_H@FV
M6ZRNFQ4K"ETG-AE=L0N42J/I5#DVG5W<5/ L1#F9KS(R^PK3@&+0WVVE$9CX
MM.2L;0R,39A02@'IO^921HK!:0G9U"IM4!%5-$U".3[29Q2K2X1.D' <A#,
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M@9VK#1AYPO4%XA!!5/\F*5+>/7>>WHMZ4".'O"OR=TT_1MXZ-Q=82)A9@'W
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M^-=1O@AB $JY2L++]EW?I/W Z7$L&$81(8:]Y7=P3PC3OF4:8<Y'.$L>8$;
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MJOFDB,(HWH+5IC>WJ^_0;YN&UUFZAA*VK9SD,JYU5Z/&9&]L_40.@,,9&4.
M>:Y#P_9H!DW#$./);,*#*+Q)1'B^K084-<PE@!U>$#P1.2S_O18&JDO.X+CR
M(XP"?N&0*?^U#: */^"7$=6TK^.&U!8&QP]4^TT21AFS#.IKAGI!3.0,FFO"
M?  ).A$S+DEHA95-9XQCT%EW$I8<B..0]!B'@:SNG"6E!A':BNZRJ('\OV)/
ML#2Q3/&$L1 ?Y*[[7@^DAS?ZV'C9*^IJEEB7-AB&<:=[C[IJPL@<N\XJ,-;3
M;<%N$I"ITCZ]SI#Y/YG)EH?1PE>&G8AI&U'N6YKGM'6'E7+_GFJDF\3(P#C&
MW893^I90WJ:%9&8>R6U9LI,2S'*I<-I_\?8:]=-&6[](0_;/[DLHVUC4'2J<
M>_)$D^?9DG,]I\SBU^?#)?M/7D0+9D==L\^CYZ074$RSM;20]@D9$W-6)7.T
MKP3[ 8 Q/:NHJ05W7 -1++5F-OAP[KM+U^N(>]"8R*KT9L'V)!U<Z;KA:AXX
M^187*X;C#6W0L#_NI:<9W>"]]8M39$4EO:]\Z3(V3 DY9@T0?/^ \$Y>(,BK
M2[0@Q8T NU.7O.J#AFY,[&U5/NAW)_%;<8%L\7WU8U$[^J5XY<"XKX$][OVP
MD_S0_A>(J=B:RK LASSAG.JCZ60[0BG>V@G<TH"-459[=DMA-KK% U6K3M93
M1G._<ID3J(6+@;2ND)W(E.?3DLW.AKEMD(D@(*U[E\.<KAFG(-M!A+38]698
M*;J$$_9K2YD0'$9HX;9C)$Q!<!@TO82U5'DPU^ -6/[;&$!%LO5L^8V7@,(Q
MV%K"FAIH,5M1PLQ]Y ;M[-:PCYHUIX[35EW*+&?U:%G]S;6(\X&]<L,F)7D&
MPYV?6-W*I=$"TB2)6T3ROF4I.P+?@TR6A\P0*-("!>X%XGE5O>#\<%+.VSNW
M'JYX(3@)/U _=VGBV"=^!Y&QX?WB#@05TP4"#N\>=R"?A5:?)@O?3G(5:^KT
M-C5&FWR\7@_I+HB+W32?FKW.[VB!I1\=WRQ!G&W")#"+EIAM  V.L>K#[4O5
MKWABPJ18TYQ,S<JTV1*P%GGYS@E)9>$--,]8[E(L^6H]4%[&)G/@.CEN)3&=
M4>?+7=N/&*72\>V:6==0% CY]HNH\.=\YOX_.Q$6,/IS]#TA4-(V:6U>F^2Y
MJPEZ:>7YEK&AZ'+DKB;%YU3EM>:S)#3>D4)!&<6-I 86P'>8JZ+10X37#4 Z
M5?9"(8IVO87+G9RG;E['-UVAK8J!'(>%*7LP+FP;O\21*04.=,WVI;OJ5?PF
M(6(D$)%=P[ED=JD152I$C@<>(GQ$^K7SY^ >AQ:;_-Y"5VE)A<NJRIS#2 OD
MLGF*H%\9;<25;GNKD]!H14H$"U("U)[8V-(G*'(M>J3$0\=YWI@PVM2UJ)75
M?Y443-!B-UN6_,N][JE4< &!"^5OILC(WW[9FZRU>Z"D#OM?V:=^>B)6"^QJ
M,Q)\A 7F69!PS$'>_*]K2$#3$]T$W39@8-S8!L_Q\R3B0#^]-SAE"64H:;M]
MGWH41\:?A!@<U%##4/AIC]&?..8;8\ODZ^+$O5L-,5!YN%UN*>#1SU_3ME5U
MR 7ZQC6'LCE,#!1"33CZ/6-WXM*7FIS\N]NL?&@AMYJR(8>X Z;S%;U-@V3Z
MS-83?-++!L*Y$,4&L(X8(P*<B&)%.*]3E%>LV(J<18IUWB4YO6PXC2;EUYPN
MM_%MM*1O[CY8:3HF+,J-:DJC[$JR138D9GS()]?=QOH75=X=I(B\[\[4ZKO#
MR9-;%/'D)+0:1N1%M$8?G"G3!]C!W'=,U!E@':N:YQVPJNHJFG<37=!\=?](
M+H)X :Y*#&(@,\>0R/5(%UC).D]_2==IG#[SEJ2B$^X-LURA, GJJF3<&,?;
M%<VZ$1M$U-6RC4Z.AY@#@CN9&!(IC^F]ZDZLJ-]UUG(S4KZZLD_45%A>4E@F
M%):5!B*Q:YQO8L#E?$_OX%PT#S[?WSP8>@1PM9=:",OO[[-HT7:3.Z:)<_[&
M+LX4U2^!@BH]B>53!,?]8\]"7?/FLP9-:?VZA;Y$"**,F11&QX7;GC(&.6VT
M"ZU^#K>>,N9ZE4V\0N]*)G-!#BB84>8$<7E>7_80Y7_CG0?@K_8E3IHB 4(3
MV4R!_V.XXLT>A2VY4#59'M_1\G((KN@YB9;1 NXSC]O-)H[8S]W#]#T5-TE>
M9+@_?$T"67HC@\[W&5U'VS5B9K!'A0F H>D[VMH3BQ%WQ79"#,8J[$X^"-X?
M!99&)4KOI=6H+PW5!HI,O0P5L0=/_'3+EFJ:74?9^J8MZK:@08 (N;ETV5?U
M2Y1$Z^VZD\](T/#FNRU?FDLPK]TR,FL@ODJX&OZ*9MT(:J5FLE>5;;1IYCPS
MT\@6Z%CR:\3ZO35]ZSIX^WP;0 +5QIRW-&FX9<3,;A">*5AK[)1EVRF_1> N
MW=7TK+V4Z:O-1$(_<71]HVY ]HKR:LP=O(H=N(E]HSGO30!20<^ >0H?S;9%
M7C#YV)L]?7[.\!2[ 7C>)(\6Z*EP>#<^]FK,Q\YS2L3HP7D!'[.GM 1L8J0,
M1 G!O4._3T]=<F&3MBR54T/E4.SNT@+0OFN>_?"%%JLTU$"OU4\IO0O6M!.(
MDR3.[%)&RC%ZDU$<D$&D\Y+R_]XDV-%&ER=T*D63U,D'2?\CN)5XTQS-PW$=
MERM9:VUN+ENB97-;TE5?N?P 7JC9\FO.*]7,[-UND(R5H#UR.DN79XP7G\:)
M\!JRE_B!O40+'[7-KJ4O5>Z<05N;?_K_/OW[3__!*]4=(VT>P(CM9#N6$&_/
M-.*MOX3]/L5J ,#U+1M<>R&9KMC]2N/X_R3I:_+(EDJ:T!!#,:US$9 F :)G
M?P.J1)+E,2GG$-4"D(K7QBUVF P7X$L.Q0;X3QY+S?O!9),@79(A,3FB86#R
M'-#SYTTQY@K?JQVW*3??%S3/9TO1)!+WW'DJ4Y/Q(M<UO0@Y@*]3-B#-@ G8
M?QO!AD<03TU.^2J_5_FL%)2AA=2'S/]N90.(5#J-Z!TM>#TKX-/.4VR2EZ4O
M44C#\QTS(-AII&R+*2#,<E"K;NXT8RB@!S48+,<4Y;4?8$ ?X6O>4% ,"JZJ
M'V!<S(S^:*10ZK%Y=,6-0:7V<6_I-5-ZA>I=@6>(D(?L2_@(FQ-NN3(E B+3
M9: &Y=P!V)@ ULFD*U7!V$4PWJRZGF4S)WH< N)-#]PL&5TQZU]A8,.Z9R_!
M; D0KG@5*E\\NW9BP2NFQ=G>-C"R!7LN%.G[VP_\*\1"#T.M+"RMB)?^ [SU
M'ST!+:AN-[?";]P);4%1,W!M)>$).0]B7O[H&'OAK3GR=\RVG;_2^(5^29-B
MU=9]U*I48)8XOX?[4D.I9N"/7EY@[@333K%.FQ0G-C%\?2<A0W5?\>_0ZT6.
M2N_XU*\T,LU]06F80Z:WFT1FR8&#60^29>M 2&W.O4/A;# T9H@'O&8ZK.NJ
MV)0&[#R<1I]AE74[P3F-W ] TD4:LW^F/%%,U2897J%6*:YE-#Z3"0E4!52A
MV9 -\''<FL.)K&+:;!EUE9=!WFWRLT,1[<R+VKF<5"?3;2'M:SI?I=N<7>68
MQ904NVOV*'J?>&2:72!O, 62F?5PZ>NG OH5"A8Y5\+9$N K\E X9[Q=*MZB
M%;*7VF(O*A'+_7=55,SM?QM<]AI;L"-\N&64^P(,[SSZBCGNMN&?R(N=+2]>
MLFFA>EEV[?$GTVT!W^C; YD61'>P/ F!Q"(Z?4&:RM) FJ @2Y#FQ:4T.CI<
M 8PR4JVZA8C-E$I9+F=FJ9V6;%9,:5@!Q8V(0D_=J^]L8$D0/]0V!V47]W8;
M7FGKV'!FA INS2U?$\G1=6F^2^G%.FXA]0D+;<<WCI7\C,1I\DR@!Y#_[#D1
M,C;PD9DN\'S6KE']7;\IA(*W!1 -RN$6CN$P]M?PQ;>"2GBKJ Z1B,9UP7U]
M-5CA;@_IBAI4JS4%I=T53DR0T]U43D^B\O*6Q $*SI#P]G0EK/2X?G^2UF8
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M,OU7$.GY%F+EF2BX3<NQ66&.@FB\CBDHP))64!1[TQ2FH0"O4+]N3I5@3V@
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M7IMM]?8U"F-!GT'CGT&!OJ[@;L&+)9UC77'((H'!J-<V3W 'V+^C69==J33
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M'(F"Z%[H\3OQCO64=(E[<P)OSV.0.O^@GC_4FDR[ND@";O1700%\)4XHK='
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MD%QFHZG:']\I.Z#+_>+X/CG=.($H,^'\)>VCI1'L6%2C$[\KG3-0D.Q7QPM
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M,VN,VA2TOXX"V14_GDK#%<EP%. (?1;?8K(Y^D_>AJN\*$S# EZA$7-[W@N
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MQ7[N?SC[S)CU2@+'SQI(-"IX2HVX:DN@ +O0(R&I.PMK>@VS3G]2$V_W/!0
M<CLRBB*[A(-1@*)$@GA(+,VN5^(+5+AJV>XR$++7H_6JF%H8Q<D6&EE9\XYW
MNIQA*+8_0NZ2T"0P[&>1J&#O.^+[T@3ZZ@@4-&&BIEU16W=%UKO H]I]W.U
M'N7#*%!<;V:>LWX@VX(YROUW6@L@N0J4T3^Z=$?>QENS(Y*9)@2#49Q>1IZR
M^(_:"!2;SAJ'9BK.,F(*CKC'A&0X$G+*K!Z%V0?DVF/,IR;^6!3GHEXN5UCK
M0G,)%&"?ZQ3(O+@ J$W?1(]MH$!_/<*N&8GW1L!Y3MRO% *11*NW@GUUIH@$
MHD\E5>SS]N!4AKB#Y,N0N?5$-EB=R?9!K20O]^\9UV<1%*0M]-DJNA-TYJ,
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M=KM+5G1G-WZ[M%??58PDW_<%$((\O"0A9!F]'S_6^=_>2'R MH14<'H(HS-
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M6JJNC!X+(+GLW0?'5[>[$31AV1 ZE'JI 1?<JB'S)Y+@4B-$). H-]_06V/
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MSRQ*GURF&[W8OK(E638#@5"?;N^&4((EY5;I?^+$6R\"-ZO'K:GR]%L5 3I
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M(C(LNE7*=DP:;;)+U77UJ@PN;SOUY\EJ4X:%CS[USG(DS^H9E<H>3YI%TX;
M(/*[K"F&:-5KFR$ZA6*)V/LT!)8P<<;.4G><R*::>W.ZCX=9J:12CF\6-\_P
MD]NK.&"&:*.]2-$A6N?%U2\O.$,42A[=KK*&,\16ZTUMN?^&0,HEO0\:52:G
MBJJA'H4>12\S%(_08AG-%=76PJ1U,V>(0*'>T';N#X&=*=W@/A5.,YS^[6HZ
MD5W:5M74(=!VJ1>U,VQR"&1-ZMXJE[[-,/D_K[=5=ENYA76'0-VEWEA)RMT0
M:)K2756NB9PA\M^GBDB3=[1:XF((O%WJ/16FZEV)2Z.@=8ZM_Y@S2;5SB(?
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MCRF*@GAS%ZRELH!PFCW,]HZU>>PKY6=(-9J3#>_ZA>1P%N@;EDI6"=8F4'K
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M0CP:,\TURCI;PC^OT:BFB.G5'<#]FB?K7V^"#&T(?\+LJNFAA#G7F5 KK>T
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ME ['86A6( <K'0ZBW*P #U8:'$3060$>K S(B<ZS@@2 4N XXL\*Y #%OT%
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M,9+J1^],P^H25:,5"20<T+:7:]D2$X4JV((.9+#5HF&E<KN;K/*Y@J*560"
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MF[:$E3E[=]MXO(1RN#<6SN<TP4)3?EK$&P+GD?KP4=YBK![P' 5QWAWE.+&
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M0%BR*GNHM B^%<S DE+90[LU\ZT@ 994JA1%S:B[;P4UL$145N;IJ$J_%3S
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M9I(MO\<HS?;AL>8<S".6S_+.\ZUL=^HVO>88@D ;SN6V844EOV_Z[-MA(&-
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M4A>KV>X-VB9I9<Y8!1\H^Q+&-!^DKJ=&2\QU5V$+54P7&3[1I)9I>W79O&&
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M2BEY7Y-X0B)?9Q84)BI]7+'@GF+A'FOOY5/1,58._NX-2..NISWI@/LS8%F
ME(TM(K)GTF-@\QYF2=HZX,<F-97!3F_G?_R!P)FM]YB5_'__/U!+ P04
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MMB!V(3=E4,Y=OIY;DXG^9(JA7+6+3,%'*R>F?FHE%U4A0XP49KHF2<=>*%5
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M[DN7X?Q?,J,T? '>"YSL+Z5F!2*NCV_7?O=!*F;97B<J# V3$3/C>:PG.=D
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M9Z">_NWDX^FG#_#_+C;:>7AXI[C](-KC9GI##Q>;650&P6*KO.6S1(82)E&
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M#6[G(7!0H#YMJOS N_W@7;"7O+MP%GV;&91*S5=R]LEF_MW#9U)TJWP_TT2
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MJC:K]>8CJ[:./M=C_$>N8U.>[@T9 AK>C*28\,@I9!_;G\VR7YJ=[%_'/-B
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M'DVF=*[L'JI3,S>:SIYU:O8NU%]02P,$%     @ 1CIK6J@:HIG3!0  #24
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M.3(U-#DY7S,N:G!G4$L! A0#%     @ 1CIK6A'DT;*:L@( J+\# !(
M         ( !R=<9 &EM9S(R-CDR-30Y.5\T+FIP9U!+ 0(4 Q0    ( $8Z
M:UI(.*]3*QH" /C: @ 2              "  9.*' !I;6<R,C8Y,C4T.3E?
M-2YJ<&=02P$"% ,4    " !&.FM:_9PH=CPX! !%7 0 $@
M@ 'NI!X :6UG,C(V.3(U-#DY7S8N:G!G4$L! A0#%     @ 1CIK6K\)GRT>
MO $ 5^\! !(              ( !6MTB &EM9S(R-CDR-30Y.5\W+FIP9U!+
M 0(4 Q0    ( $8Z:UI+' '4Z$L! ()] 0 2              "  :B9) !I
M;6<R,C8Y,C4T.3E?."YJ<&=02P$"% ,4    " !&.FM:KJL9XC+8! "5<30
M$0              @ ' Y24 <71T8BTR,#(T,3(S,2YH=&U02P$"% ,4
M" !&.FM:W.SVA__J 0!Q'1P $0              @ $AOBH <71T8BTR,#(T
M,3(S,2YX<V102P$"% ,4    " !&.FM:)%6%UM1    SX ( #P
M    @ %/J2P <71T8BUE>#$Y7S$N:'1M4$L! A0#%     @ 1CIK6N[N7 I5
M!   !!T   \              ( !4.HL '%T=&(M97@R,U\Q+FAT;5!+ 0(4
M Q0    ( $8Z:UI)<%/-DPD  /]$   /              "  =+N+ !Q='1B
M+65X,S%?,2YH=&U02P$"% ,4    " !&.FM:5LPE/98)  "I1   #P
M        @ &2^"P <71T8BUE>#,Q7S(N:'1M4$L! A0#%     @ 1CIK6H-Z
M_SW5!0  $B4   \              ( !50(M '%T=&(M97@S,E\Q+FAT;5!+
M 0(4 Q0    ( $8Z:UJH&J*9TP4   TE   /              "  5<(+0!Q
D='1B+65X,S)?,BYH=&U02P4&     !$ $0 L!   5PXM

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>qttb-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:qttb="http://www.q32bio.com/20241231"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="qttb-20241231.xsd" xlink:type="simple"/>
    <context id="C_81e3e422-e365-4f92-a2df-f3bed9e3c0f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_82ffbe69-bdc0-46ed-85f6-2f2135943e2a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeThirtyFirstOfMarchTwoThousandAndTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-12</instant>
        </period>
    </context>
    <context id="C_854a149a-1eef-4a0c-9335-f2a517e54274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">qttb:WalthamMassauchetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_85eed7d4-bc70-4689-9015-4f85ad5cfc18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_8a29bb8f-c595-4983-9066-bd39e268ab4c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8aa53aac-d504-4db3-8d89-b2114c402b69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:BempikibartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_8b219b81-3c35-41c8-a792-9c9b2b87e1e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-12</startDate>
            <endDate>2023-07-12</endDate>
        </period>
    </context>
    <context id="C_8cb16126-e20f-478a-92f3-f4ef3f29dcee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:EighthAmendmentToTheLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-26</instant>
        </period>
    </context>
    <context id="C_8e0c7ce3-b7e7-477e-b694-44fd0989eef1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_99f336ed-ce75-4357-a041-46da4ea43896">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <startDate>2022-08-05</startDate>
            <endDate>2022-08-05</endDate>
        </period>
    </context>
    <context id="C_9f64b245-b6aa-4495-a613-76961dbfa794">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a0bd1a63-9f30-4e12-871d-7a9578431c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a3049491-9ddc-4b12-9eb9-4faf6e1e2fec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">qttb:WalthamMassauchetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">qttb:RestrictedCashAndCashEquivalentsNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a37febd5-2c47-4a82-98a5-85fdad081713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_a865d4dd-0f4a-4429-92aa-0aae67bd396c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_aab7e459-1871-48ff-b109-9c732f133214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ad732baa-4828-4c30-98cf-2d02dbdb87b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_afa19969-608f-48e9-9aca-73182815530d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b2dac488-8c36-4522-ba90-ecd7c08b1ede">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b2f6b4cb-fe35-486b-9f70-f7fd1fa0f798">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_b39ec590-34ba-4ee9-954b-860129dbb68c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b5225717-0e5a-4c67-907b-047d72ad665b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b555dfd2-6633-4e32-b92f-2a1f6100178b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithTheUniversityOfColoradoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b56ad3a0-64a3-4549-bf92-0952e7e3df5b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_b58f761f-bef4-4b59-803e-8a93d0543c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b5c40c56-08b5-4a22-b751-a8f232a74aca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b8978390-12c0-4352-9c18-d59c00c5a494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_bb6c3e3c-07de-46ab-8b95-1ab3fb082d09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_bdaefca0-fea1-4732-b40e-bf35def7a224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_bdd74796-2135-43f6-a03b-39e6bd90c9b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-11</instant>
        </period>
    </context>
    <context id="C_be2666e6-1b34-4583-add6-12ea7a5cce3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_bf697f63-fffd-47b1-a9e7-28e55b7595fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SeventhAmendmentToTheLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-02</startDate>
            <endDate>2023-11-02</endDate>
        </period>
    </context>
    <context id="C_c11e5447-4a20-4d83-b060-fbc22d8f5724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c18fd5f0-cb42-4f14-9f5c-4fb10a0505bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c38a2141-3bcb-42d1-8a58-cef5d94d0819">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_c3c34d76-204f-422a-8542-9570869264f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c58e837a-179e-40c1-aa34-7a9794f2d652">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c73c0232-3eb2-4afd-9b9d-d70bdfd8a5f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">qttb:MeasurementInputProbabilityOfEachScenarioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_c8e96e70-b220-40a4-8caa-3388400e3cae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_c8ee0693-2174-48d4-893c-58e9b89264b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c995ff6f-a52c-4c87-a8d6-71a52474fd48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="C_ca4b638b-76d0-401e-9369-6f2d51d1cb2f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">qttb:HomologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-25</instant>
        </period>
    </context>
    <context id="C_cb1dbfd4-a164-4593-8d87-17d41a661f8b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">qttb:ConsultingAndAdvisoryAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_cbe1c2b6-e46f-4db2-a96d-16d62994fde1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesARedeemablePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_cc753916-5b65-451d-90ed-193a32758aa9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <instant>2022-03-10</instant>
        </period>
    </context>
    <context id="C_cd0b4904-8ce8-4c84-a53a-8d845df8dc43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_cd782b8d-e977-40bc-a2ef-507ab008dfca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <startDate>2022-05-20</startDate>
            <endDate>2022-05-20</endDate>
        </period>
    </context>
    <context id="C_cda9fef4-e02f-4ed8-8897-35539a06a8b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-12</instant>
        </period>
    </context>
    <context id="C_ce9f954b-cafc-43d9-af6e-e2bba9ac13af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cec18033-5a14-4ccd-b752-d0126402b130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_cf98c657-870f-4570-8592-2aff0b91640f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">qttb:SalesBasedMilestoneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:HorizonCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_cfdb4851-27cb-4dd2-a181-f26f91524080">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="qttb:TrancheAxis">qttb:TrancheThreeMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d1e4c313-5593-44fa-8319-69d7287a8c1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeFirstOfJulyTwoThousandAndTwentyFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-12</instant>
        </period>
    </context>
    <context id="C_d3e98f3d-7cf9-4d47-9a53-26eaa914cc76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d5a319e9-4550-4a20-9794-c5a7a6ad12aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-25</startDate>
            <endDate>2025-03-25</endDate>
        </period>
    </context>
    <context id="C_d63b5539-4625-4fac-978b-86e1f8037d8e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d6eb1df1-653a-48d1-820d-e7936097d20b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d70d9c60-682f-4b4c-8180-b6b1535a6f0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="qttb:TrancheAxis">qttb:TrancheThreeMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="C_da508a90-18ff-4feb-864f-c062a92713e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-19</startDate>
            <endDate>2024-07-19</endDate>
        </period>
    </context>
    <context id="C_db8118be-101e-441a-a13b-f4b57e3c5a64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_df3c79d3-1293-482f-9102-cd57669625a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_e0d1d750-c63b-49fa-8efe-0c104dbe276f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="C_e112c2ce-ff85-4995-a056-7c0f11496a6f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SeventhAmendmentToTheLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-02</instant>
        </period>
    </context>
    <context id="C_e26a9287-f885-4441-9d0e-9148098a8888">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_e48e03f7-6e15-41e5-8e77-78e73c096383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_e59a1e86-c7f5-494a-9d42-f6faee31d00f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-15</startDate>
            <endDate>2024-03-15</endDate>
        </period>
    </context>
    <context id="C_e5fdb991-d520-4075-b2d8-b05c3d677e35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_eac1650d-1927-493f-a242-2bc1e837c904">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_ec27399a-2953-4340-94d1-aa507faddcf4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_edd2dd2b-4bf5-49ec-8e4a-ca61edc70f98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-23</startDate>
            <endDate>2025-02-23</endDate>
        </period>
    </context>
    <context id="C_f0a36e6a-206a-49c7-88ab-7db254725cf3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_f316cace-cb53-4a10-84c5-1335a8b032e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f497268d-14c0-4133-8bfb-04326a1ba996">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f5ea5ca1-ed8b-413d-bbea-b4a5e23ee94a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-25</startDate>
            <endDate>2025-03-25</endDate>
        </period>
    </context>
    <context id="C_f6927f9d-eca2-421d-8a4f-efa4995457ae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-15</startDate>
            <endDate>2024-03-15</endDate>
        </period>
    </context>
    <context id="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">qttb:WalthamMassauchetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f94caa77-06ab-4033-aaf4-c31aca13beda">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-12</instant>
        </period>
    </context>
    <context id="C_fdc54320-1c67-4e15-8365-d084e65e9e52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-20</instant>
        </period>
    </context>
    <context id="C_00125eea-3c46-4a9a-8949-a3a86ae55b5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_012ce485-8c2e-404f-b146-20b8651d7c1b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandSeventeenStockOptionAndGrantPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_01c6b47c-31c0-4923-b0b0-6e5450394be0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <instant>2023-11-16</instant>
        </period>
    </context>
    <context id="C_01f11a58-84ba-4030-8559-1f45b7816019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_02ecb717-f14e-405e-8487-adc80c2116b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_05094c91-23e2-4d70-8075-18f488df283f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <instant>2025-03-03</instant>
        </period>
    </context>
    <context id="C_0679ebcb-aaa9-4d96-a6a8-350341c1609b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_0708f559-d98c-480b-8223-bba4a0a87863">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">qttb:OxbSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-22</instant>
        </period>
    </context>
    <context id="C_09d4667e-d0d3-40c4-96f5-1346195ceecb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithTheUniversityOfColoradoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_09e3fcc5-c0b6-4005-8960-a3541b369346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0beb16c7-e3a6-42dc-8c19-40c1f98d5c9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0e4b5ed3-9477-4f24-a78d-80cd55c51631">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="C_1080c6e9-b757-4406-9324-738d36ed0c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_130917d7-9d2c-4093-8e70-15724bdc27cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:HorizonCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_13bab75d-170f-40f3-93c6-4fd2884489bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_13ef4388-e7d7-4520-984c-b50faaa55355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_15a4f89a-2a77-4b59-9f76-99dff39d02e8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_186a100e-16ef-48da-90b9-7456802bc057">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="C_1a893f00-2a32-48ba-a06a-042beb70f237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1ae14b8d-dea6-450a-bd61-6382bf1f8395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithBristolMayersEquibCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_1ec25630-4304-4291-a5ab-390b64487da5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1f079b94-52d3-4513-9e59-1f9abf527de4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_2018c79e-e353-411e-9686-5d75f0b411cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:ADXZeroNineSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_20e3aba0-5377-41a2-bf8e-222ee59cf7b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_21aa18f8-fcb9-4858-ab9d-ae3b4a5f7444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_223d39dc-f768-49d4-88fb-37a27c35a8a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesA1RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2314494c-9a8c-4bc3-a189-e525b43dfad3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_24eebe14-f497-4909-b6f9-5294ab34c796">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:ADXZeroNineSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_2636fb0b-847b-44cc-8769-e36df6784f40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2747d7eb-c32e-4ac2-b584-639f88844157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_29d5eced-fc9f-4f1c-ae83-4350d8af4754">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2ac02e70-62cb-4d11-bf94-77b56c0a5fb8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:DiscoveryAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_2aef5253-5673-488f-b176-618a6a1a9ffa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">qttb:MeasurementInputProbabilityOfEachScenarioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_2b84e1db-55c0-4034-aafc-134bb2bada3d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-12</instant>
        </period>
    </context>
    <context id="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2f4b5de3-a9e7-4c16-bcfe-43adba24582e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-10</startDate>
            <endDate>2025-02-10</endDate>
        </period>
    </context>
    <context id="C_2f60cbad-ab1b-4beb-9829-e1cf73ad1860">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesARedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_2f8c0c8d-9454-4f58-ba8a-5a0c25ee32f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_302992f5-5a2f-4079-b1ae-a9f51ed191d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <instant>2024-03-25</instant>
        </period>
    </context>
    <context id="C_31964b05-1da6-44db-b544-4f27ff581508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3543f0be-6692-47f6-a4e8-a5c6d56417eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:ChangeDuringPeriodFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_354585ed-60d7-4f70-a77e-d50cc01415c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-25</startDate>
            <endDate>2025-03-25</endDate>
        </period>
    </context>
    <context id="C_36984301-045f-4eac-9a05-c4a64d0c8422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_36ec1662-19ea-4f36-95c0-480643ad7851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:EighthAmendmentToTheLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-21</instant>
        </period>
    </context>
    <context id="C_36fe52b2-0dba-48bb-aaf0-4023627944b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_370a860c-228f-4147-bdf4-dcb48b39a303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_37196b4a-4692-492f-b903-2a6e19a6a232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_37c8672c-5d7c-4a2e-802c-2bb52b924851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">qttb:MeasurementInputProbabilityOfEachScenarioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_385a8942-b234-40ba-9087-cb65594b34d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_393ed9e3-2fa2-4a7b-b49b-0b0d93cbf89e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">qttb:RestrictedCashNonCurrentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityThirdAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-08</instant>
        </period>
    </context>
    <context id="C_3e39319d-0b8a-4d79-9a97-72ff6fa10227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">qttb:ConsultingAndAdvisoryAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4260d2af-256d-45f6-b503-aace9db4b45f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndSeventeenStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_42dc6c69-0cf8-467e-b208-73239c144b07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_440034cc-e9c7-4544-91a9-9d19b1167f0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-11</startDate>
            <endDate>2020-12-11</endDate>
        </period>
    </context>
    <context id="C_44dc2e47-aa49-4844-acd8-9cb650ca6caf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyThreeTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="qttb:PeriodAxis">qttb:BeforeThirtyFirstOfMarchTwoThousandAndTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-12</instant>
        </period>
    </context>
    <context id="C_482f7b29-7345-4d72-8fd8-5f3199ef1c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_49e1f5d1-7824-4873-b567-c71038b76681">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4a20caa7-c241-467a-98e1-fba745a92230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4a798c23-fd95-415f-8bab-1a4a602a0895">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">qttb:HomologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-25</startDate>
            <endDate>2024-03-25</endDate>
        </period>
    </context>
    <context id="C_4a91fccb-1956-4e07-b38a-1f2ba2811311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4b875fb6-8c1f-48c4-8ed9-bb8c9bf74e9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:BempikibartMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">qttb:LegacyQ32Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4c2e3250-49a3-4f3c-9ba7-60f0718101be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4c584b28-2bfc-476b-9e14-f321da0f4ddb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_4c7a1808-d8e4-4443-87ff-8a728e83b4d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">qttb:ConsultingAndAdvisoryAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4cbc437d-5afa-447b-9f58-e212caafd669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4d576cb9-10b9-46a1-bca3-697ecd9396be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">qttb:ConsultingAndAdvisoryAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4de6188d-bc41-4c0b-986d-59e12a08b2a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4ea385ae-a09a-44a7-ba4f-9e1d5dfc76b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecuritySecondAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_5062bd0a-61c4-478f-887d-27fbcabc427e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_50665618-c890-4c3e-9bd9-6c41d79b5f14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_53138904-18f8-426d-9bb6-72a8e8db3721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">qttb:WalthamMassauchetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_538446b8-7409-4894-a71d-dabb73e1ef55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_53fa66be-5ca3-40fc-8c45-f08ab061bfff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_548856aa-e248-42ff-bd02-f8b3fa277e06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="qttb:TrancheAxis">qttb:TrancheTwoMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-11</instant>
        </period>
    </context>
    <context id="C_56ea366c-6225-4b69-bccd-5ec940307d3b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_57c23963-7764-4e09-9834-07d94af003db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourStockOptionAndIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-15</instant>
        </period>
    </context>
    <context id="C_58806157-945d-4f05-9b65-2c51d8ce8b75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:UponTheConversionOfAuthorizedSeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5a0e9c05-aa5e-42de-ac3a-a0fb7d656d48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_5d6ee64c-bb12-4d4b-a81c-6f731ee26fbf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5d9c9fa2-97d6-4b1c-b918-3a60f9e20e25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">qttb:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5dad7a66-e70c-49a5-aa41-6710e38a1a05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">qttb:SeriesAConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_5e588eaa-63cf-4ef1-8b8e-0d333a72ff23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5f1339d1-c9c7-4c62-85fe-43ee887e097f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">qttb:OxbSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5f18540e-b79b-4adf-83b8-c467b6d3c37d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:TwoThousandTwentyFourEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-15</instant>
        </period>
    </context>
    <context id="C_60e298bc-492e-4648-ae4c-77f0946662a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:VentureDebtTwoThousandTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_61d6fc78-c8ec-418e-a4dc-fcee1281ac6c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-11</instant>
        </period>
    </context>
    <context id="C_62c12364-19f9-412d-b7a5-93a8a2255606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_63d3da21-2d2f-4d33-8fc7-fd05ece7069d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_64e18bd2-6e71-4f81-8713-6d9b2f8a6ed2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyAndTwoThousandAndTwentyThreeTermALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_65695aa9-2863-4310-b8da-f3be3d8e4280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-25</startDate>
            <endDate>2025-03-25</endDate>
        </period>
    </context>
    <context id="C_6881a1d6-1e0a-490c-8f2b-d88e0d5e92d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6a7ed391-5281-4830-b9f9-03de3a4d8b00">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">qttb:DiscoveryAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_6acff699-1bcb-4e5c-83d0-0ecc48abc809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityFifthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="C_6b897fb9-c5ec-48c3-9610-95cfe8b4cd07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6d5ea821-818d-4edc-977d-9c88e7922cd7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">qttb:ReservedForFutureIssuanceUnderTwoThousandAndTwentyFourStockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6e7474c2-50c6-4141-93a0-c56ced950809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_6f68a357-a32f-44ae-979a-875bc449d3b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_71403a30-e992-4c00-b708-e2cd6dde2a39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-25</startDate>
            <endDate>2025-03-25</endDate>
        </period>
    </context>
    <context id="C_7173717f-2d2d-4169-9a96-9df1da9fef47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LicenseAgreementWithTheUniversityOfColoradoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_742e9ad2-7322-4178-acf9-30981e53d1af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:SixthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="qttb:TrancheAxis">qttb:TrancheTwoMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-12</instant>
        </period>
    </context>
    <context id="C_75a6ef14-59cd-493d-a00e-544f5be1fdf1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7794054f-4239-439e-b660-23e5bc99154a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_79b9f15f-c77c-4650-8ec5-e400e55b0820">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">qttb:ScenarioTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_79f15b34-ea52-436c-a16f-c67bd97ffb1d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:TwoThousandAndTwentyTermALoanAdvanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">qttb:LoanAndSecurityFourthAmendmentAgreementWithSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-21</startDate>
            <endDate>2022-12-21</endDate>
        </period>
    </context>
    <context id="C_7a96c710-1576-4302-aade-91b06ff915be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesAOneConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7bb2bb04-b139-49f5-801e-31f1d770bc43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7cdabbbf-9d0e-48aa-9f1d-1c17d1a6755a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="C_7d9baed7-c6de-4298-867d-06f8f3ee91b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_7ec0ac51-4871-4881-a34d-77b8a09d8ea0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7f47faa6-d3bb-45d0-9ae1-b46cda818a27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">qttb:HomologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_7f536b74-399c-4e82-9152-d5daf6993f87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">qttb:ConvertibleDebtAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">qttb:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-20</instant>
        </period>
    </context>
    <context id="C_7fe7497c-530e-4a3f-be8e-af26a160d3fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001661998</identifier>
        </entity>
        <period>
            <startDate>2022-12-23</startDate>
            <endDate>2022-12-23</endDate>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_9cfbe1f8-5f8f-41d0-b3db-4798c26e5880">FY</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_578c6acd-83ad-45ff-8794-1ccd67233baf">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_776eeb8c-fd57-4258-935e-ce8e81fd9305">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_9fa94d41-e9a3-4418-8238-b9101b45bc6c">0001661998</dei:EntityCentralIndexKey>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_6994ebc2-a8e4-4d70-b9c8-221efdc299c3">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_1e63f389-cf78-44fa-a0c8-964947c90695">Yes</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_4ca2bbca-c47f-48be-bdab-b2587e4a03f9">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_693f647c-0866-4ea0-a41f-1b369dedf0a1">Yes</dei:EntityInteractiveDataCurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      id="F_af1eeaf7-a09a-4e74-921e-8ff968478338"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      id="F_ac451028-dcee-467f-94e3-aef335ebd430"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration
      contextRef="C_5062bd0a-61c4-478f-887d-27fbcabc427e"
      id="F_4b3c95c9-00db-4ff5-871a-392543c3c948">http://www.q32bio.com/20241231#LeaseholdImprovements</us-gaap:PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      id="F_a45e6167-40b6-49f4-9625-e8ce6cbfd3a5">http://www.q32bio.com/20241231#AccruedExpensesAndOtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      id="F_cb90d7dd-2025-4f37-8452-ccbb5dfb30b4">http://www.q32bio.com/20241231#AccruedExpensesAndOtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_a0bd1a63-9f30-4e12-871d-7a9578431c43"
      id="F_a1c527db-8fab-40c5-be93-17f92684f3c3">2031-12-31</us-gaap:LeaseExpirationDate1>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      id="F_e5dd5eea-55d7-4cae-a2e1-4551e45e0690"
      unitRef="U_shares"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_a414a837-051a-4a6d-9f98-f5398f57eca4">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_d656e3b7-9856-4889-ba3c-f875636664a7">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_4149ddd3-12fb-4d33-9438-716aa76162a5">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_b8756ead-01aa-48a5-8016-eb0c41d7e74a">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_595c7faa-7c4e-4555-9d50-13e2f2ca082e">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_1216cf62-8488-4a17-bf29-017f585b1229">001-38433</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_eaf358bc-b6d1-43ad-97ab-067cf7aa1bdd">Q32 Bio Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_c6b5a7bf-4a42-4129-aacd-6469e81ea8fe">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_cc0a4f41-ff85-457a-b16c-e3b811123984">47-3468154</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_7584d0bc-e6a7-4bd3-b7de-ad6cadf09a8f">830 Winter Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_8c741b30-9bd1-4c88-bc49-317210c3cdbc">Waltham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_1f04a78d-d99e-4291-8a79-1e104f2054ce">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_e158c08b-c628-426d-a2cd-6476e26989e0">02451</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_30bc9ca2-7cf2-4615-bdda-d7de22d94eb2">781</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_b2115229-71df-4a76-9f30-c0474028a832">999-0232</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_028c41ac-920f-4cc1-97eb-b2fa22e438f3">Common stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_7f7697d9-6f31-48e6-9721-60a1d2363ec0">QTTB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_85be0b74-4b92-4f23-8886-376d28dcc279">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityFilerCategory
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_15c7fce3-8ccd-4a1c-922c-f0e5742cb406">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_d6fdf467-499c-424a-bf84-af41e2ebb862">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_b8a2e11b-8729-469c-994b-252280328775">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_212545f6-87f8-479b-8a90-c2d448835ae1">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_5ed79d7e-f93a-41e6-871e-58980843a3b3">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_b0311362-009f-43fd-9bdc-24077e074c42">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_0e4b5ed3-9477-4f24-a78d-80cd55c51631"
      decimals="-5"
      id="F_6a7651cd-9527-4f51-9ab9-fb8cf698271a"
      unitRef="U_USD">136400000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_05094c91-23e2-4d70-8075-18f488df283f"
      decimals="0"
      id="F_03b79603-40f4-4bf4-abf4-e40292a5647a"
      unitRef="U_shares">12197615</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_bb22069c-7845-48f1-b250-c8c7930f76ba">&lt;p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain portions of the information required to be furnished pursuant to Part III of this Annual Report on Form 10-K will be set forth in, and incorporated by reference from, the Registrant&#x2019;s definitive proxy statement for the annual meeting of stockholders or an amendment to this Annual Report on Form 10-K which will be filed with the Securities and Exchange Commission no later than 120 days after the end of the fiscal year ended December 31, 2024.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_8dca468f-d969-4622-9bb0-0e8040e24b67">42</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_d180beb4-f6b5-4262-826d-8626addcab59">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_85e29998-e432-4ee9-b82b-cae15ddac35b">Boston, Massachusetts, USA</dei:AuditorLocation>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_a1267dba-76a3-497c-b449-35fb9ec7a5e1">&lt;p id="item_1c_cybersecurity" style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Item 1C. Cyb&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ersecurity.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity Risk Management and Strategy&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We designed and assess our program based on the National Institute of Standards and Technology Cybersecurity Framework (NIST CSF).&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk management program is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrated&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; into our overall risk management program, and shares common methodologies, reporting channels and governance processes that apply across the risk management program to other legal, compliance, strategic, operational, and financial risk areas.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We leverage the support of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;third-party information technology and security providers&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, including for periodic security testing, as part of our risk management process, designed to identify, assess, and manage cybersecurity risks. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We maintain an incident response and notification plan designed to assist us in identifying, responding to, and recovering from cybersecurity incidents, and we have a process to assess the security practices of certain third-party vendors. We have also engaged a third-party with specialized expertise in cybersecurity to conduct an audit, which resulted in no notable findings, and reported the results to the Audit Committee.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;We, like other companies in our industry, face a number of cybersecurity risks in connection with our business. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Although such risks have not materially affected us, including our business strategy, results of operations or financial condition, to date, we and/or our vendors have, from time to time, experienced threats to, or security incidents, related to our data and systems or that had the potential to otherwise impact our business.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cybersecurity Governance&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board considers cybersecurity risk as part of its risk oversight function and has delegated to&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the Audit Committee (the &#x201c;Committee&#x201d;) oversight of cybersecurity risks, including oversight of management&#x2019;s implementation of our cybersecurity risk management program.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Committee receives periodic reports from management on our cybersecurity risks. In addition, management updates the Committee, as necessary, regarding any significant cybersecurity incidents.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Committee reports to the full Board regarding its activities, including those related to cybersecurity.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The full Board also periodically receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our management team as part of the Board&#x2019;s continuing education on topics that impact public companies.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team, with the assistance of the Company&#x2019;s third-party information technology providers, is responsible for assessing and managing our material risks from cybersecurity threats. Internal personnel, including our Senior Vice President, Finance, have primary responsibility for our overall cybersecurity risk management program and supervise both our internal cybersecurity personnel and our retained external cybersecurity consultants. Members of our senior management do not have direct cybersecurity expertise obtained through certifications, but their experience managing the Company, which includes consulting and coordinating as necessary with third-party information technology and cybersecurity experts, enables them to assess and manage material risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team stays informed about and monitors efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include:&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in our IT environment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_f821c872-a0bf-4acb-853f-5bc36ec0b110">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our cybersecurity risk management program is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;integrated&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; into our overall risk management program, and shares common methodologies, reporting channels and governance processes that apply across the risk management program to other legal, compliance, strategic, operational, and financial risk areas.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_f5446b3c-e2ed-4151-9cb3-5bb8e96ba70b">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_0d337897-b41f-4846-a2b1-92a15ddb0d08">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_9c129179-cc84-4262-9527-fe8f2ad062a1">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_fc799ae2-bfcc-4a07-8955-87f88166d321">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_0509b216-80d0-4149-abc8-db7d2acc8745">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our Board considers cybersecurity risk as part of its risk oversight function and has delegated to&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the Audit Committee (the &#x201c;Committee&#x201d;) oversight of cybersecurity risks, including oversight of management&#x2019;s implementation of our cybersecurity risk management program.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Committee receives periodic reports from management on our cybersecurity risks. In addition, management updates the Committee, as necessary, regarding any significant cybersecurity incidents.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Committee reports to the full Board regarding its activities, including those related to cybersecurity.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The full Board also periodically receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our management team as part of the Board&#x2019;s continuing education on topics that impact public companies.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team, with the assistance of the Company&#x2019;s third-party information technology providers, is responsible for assessing and managing our material risks from cybersecurity threats. Internal personnel, including our Senior Vice President, Finance, have primary responsibility for our overall cybersecurity risk management program and supervise both our internal cybersecurity personnel and our retained external cybersecurity consultants. Members of our senior management do not have direct cybersecurity expertise obtained through certifications, but their experience managing the Company, which includes consulting and coordinating as necessary with third-party information technology and cybersecurity experts, enables them to assess and manage material risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team stays informed about and monitors efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include:&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in our IT environment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_c6d61b3d-a05c-499d-951b-54e2df426356">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the Audit Committee (the &#x201c;Committee&#x201d;) oversight of cybersecurity risks, including oversight of management&#x2019;s implementation of our cybersecurity risk management program.&lt;/span&gt;</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_f9936a7e-ac2d-424e-b38b-238bc941bc67">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Committee receives periodic reports from management on our cybersecurity risks. In addition, management updates the Committee, as necessary, regarding any significant cybersecurity incidents.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_6beecce7-c5aa-4644-98fd-2b123d79422b">&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Committee reports to the full Board regarding its activities, including those related to cybersecurity.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The full Board also periodically receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our management team as part of the Board&#x2019;s continuing education on topics that impact public companies.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team, with the assistance of the Company&#x2019;s third-party information technology providers, is responsible for assessing and managing our material risks from cybersecurity threats. Internal personnel, including our Senior Vice President, Finance, have primary responsibility for our overall cybersecurity risk management program and supervise both our internal cybersecurity personnel and our retained external cybersecurity consultants. Members of our senior management do not have direct cybersecurity expertise obtained through certifications, but their experience managing the Company, which includes consulting and coordinating as necessary with third-party information technology and cybersecurity experts, enables them to assess and manage material risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team stays informed about and monitors efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include:&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in our IT environment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_69ddef0e-6a34-4ecb-9b1f-7a0ca954389f">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Committee reports to the full Board regarding its activities, including those related to cybersecurity.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The full Board also periodically receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our management team as part of the Board&#x2019;s continuing education on topics that impact public companies.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_09f4d41d-6377-4527-b0cf-5a654e6d0d15">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_d8b1387a-069c-4845-8d62-8eb0789daa3c">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team, with the assistance of the Company&#x2019;s third-party information technology providers, is responsible for assessing and managing our material risks from cybersecurity threats. Internal personnel, including our Senior Vice President, Finance, have primary responsibility for our overall cybersecurity risk management program and supervise both our internal cybersecurity personnel and our retained external cybersecurity consultants. Members of our senior management do not have direct cybersecurity expertise obtained through certifications, but their experience managing the Company, which includes consulting and coordinating as necessary with third-party information technology and cybersecurity experts, enables them to assess and manage material risks from cybersecurity threats.&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_499f138d-72cf-4bbb-bbb9-45a4e134ce6e">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Our management team stays informed about and monitors efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include:&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources; and alerts and reports produced by security tools deployed in our IT environment.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_c2c011e6-04e0-4e82-be86-7cedb123a43c">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902"
      id="F_e6055b6b-b2ec-4ae0-865c-8c358b5d8fc5">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902"
      id="F_1296f426-226b-48c5-9953-1402f89416a4">false</ecd:NonRule10b51ArrAdoptedFlag>
    <qttb:Rule10B51ArrModifiedFlag
      contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902"
      id="F_9abd9abd-5800-4edb-8335-ebbefe6539fd">false</qttb:Rule10B51ArrModifiedFlag>
    <qttb:NonRule10B51ArrModifiedFlag
      contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902"
      id="F_36a3bac6-36cc-4314-9d49-ab48b373b8d7">false</qttb:NonRule10B51ArrModifiedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902"
      id="F_9a359e90-f50e-433f-a2ed-655d0d5601d0">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_c1ab14b4-8a98-4f2a-9ed5-10334eb9c902"
      id="F_ec2d2878-85f5-4112-bbdd-41284e33fc60">false</ecd:NonRule10b51ArrTrmntdFlag>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_8ca6e009-fb86-4ecb-ae86-d1b4cc69a9cc"
      unitRef="U_USD">77965000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_4607e1a5-b047-43c8-b7a7-996651964cd0"
      unitRef="U_USD">25617000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_4d9f36e1-54e8-4035-9449-39c2f07b6d7a"
      unitRef="U_USD">3912000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_d965a6d9-eaff-423d-b252-ab222ec4f2e0"
      unitRef="U_USD">3099000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_dc99f168-8c06-4183-ba24-afcc74bd06c4"
      unitRef="U_USD">81877000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_3a6a6f57-0346-4e65-8bb9-b1947ae20ee0"
      unitRef="U_USD">28716000</us-gaap:AssetsCurrent>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_8d03dffc-e96b-437a-8560-31abc683acf8"
      unitRef="U_USD">2600000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_0b236670-178d-4e90-b038-46e28fda8259"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_76927634-b565-4cc1-9428-58e00c83d3b9"
      unitRef="U_USD">1370000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_d670dc2d-0afe-45fd-93eb-e2db3f4da003"
      unitRef="U_USD">1782000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_9932bdb0-32d6-4445-ad0d-5dbdfec55a66"
      unitRef="U_USD">5722000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_ca8d5e12-0dba-4443-a55f-64b84cd5888a"
      unitRef="U_USD">6301000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_db435d5e-a84e-4525-90aa-15b1bfbdd3f8"
      unitRef="U_USD">647000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_df6b64c3-b50d-4ed9-bcf6-7a39776b71a8"
      unitRef="U_USD">5647000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_a616f496-4c1f-4e3e-acfb-29d8b6d470c5"
      unitRef="U_USD">116000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_e369317d-899e-4e16-acc5-e7b2d8263796"
      unitRef="U_USD">4611000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_631763ee-f6f7-4b87-b323-8e434289bffa"
      unitRef="U_USD">92332000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_c3b06374-cf0b-46d7-9724-573c8ab82f6f"
      unitRef="U_USD">47057000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_75bc6b5a-8e87-4f7f-8f33-f1abfb9e9aa7"
      unitRef="U_USD">2989000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_6f30b304-0394-464d-acde-e06a0d14c82f"
      unitRef="U_USD">3468000</us-gaap:AccountsPayableCurrent>
    <qttb:AccruedExpensesAndOtherLiabilitiesCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_4fca669a-05fd-4bc2-8a29-1c9e3b3e49a9"
      unitRef="U_USD">7479000</qttb:AccruedExpensesAndOtherLiabilitiesCurrent>
    <qttb:AccruedExpensesAndOtherLiabilitiesCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_901131b1-6609-49b8-82ec-b6dfbbbb131c"
      unitRef="U_USD">9763000</qttb:AccruedExpensesAndOtherLiabilitiesCurrent>
    <qttb:CvrLiability
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_054b086e-c78c-4c36-93e8-f7ad0bf5d404"
      unitRef="U_USD">2900000</qttb:CvrLiability>
    <qttb:CvrLiability
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_f67b182f-f89f-4dd1-947e-744d01e8515f"
      unitRef="U_USD">0</qttb:CvrLiability>
    <us-gaap:LinesOfCreditCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_f3fb315c-cebd-4f1b-a8bb-a4a1095411bc"
      unitRef="U_USD">3097000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_bf1fc506-095a-47b2-bc68-56cd9dd4913f"
      unitRef="U_USD">878000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_8e799cd2-6536-4b39-8801-764c4950f693"
      unitRef="U_USD">16465000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_b8797161-32e7-45de-8bf1-f5c31e4f4e74"
      unitRef="U_USD">14109000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_bb83105c-7f36-47f0-841d-abbdae1c3d2b"
      unitRef="U_USD">5636000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_5bddd185-db1c-47dc-9de6-0393e422e066"
      unitRef="U_USD">6248000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermLineOfCredit
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_f8c5eedc-7744-4533-becc-cae170a9d39c"
      unitRef="U_USD">9556000</us-gaap:LongTermLineOfCredit>
    <us-gaap:LongTermLineOfCredit
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_72f14b07-fa23-4091-b3f0-05a7d0d2304e"
      unitRef="U_USD">4581000</us-gaap:LongTermLineOfCredit>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_d5897cf1-8908-441f-9862-aa2e5eb35ac7"
      unitRef="U_USD">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_5c4cbe22-83aa-4fd1-a75d-fe3b88b6c7b8"
      unitRef="U_USD">38595000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_372a094a-efea-4b7c-9b6f-44b8aa8e7287"
      unitRef="U_USD">55000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_322bfbd2-5c0e-4720-9346-084ffc0573d7"
      unitRef="U_USD">55000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_b311f8e8-2aa1-4967-a8b5-854f9edc50e1"
      unitRef="U_USD">86657000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_f399152b-de48-4fe1-81b6-73ebb216220d"
      unitRef="U_USD">118533000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5"
      decimals="4"
      id="F_1fd6e230-2f31-4daa-88fd-e54008a08701"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc"
      decimals="4"
      id="F_78ad2d98-e511-480a-a52c-cd804fcafcf5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5"
      decimals="0"
      id="F_776c1df0-89ea-48e5-b63c-bb1631e16283"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5"
      decimals="0"
      id="F_f7bcc499-fb60-4646-976e-b40bfa661af0"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5"
      decimals="0"
      id="F_adb31f5e-e847-4245-8556-ac53af959e04"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc"
      decimals="0"
      id="F_ca415837-eaec-45b7-b1a6-b06bdc9522bf"
      unitRef="U_shares">2286873</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc"
      decimals="0"
      id="F_fbcaefb5-32bb-4009-a083-8be4ac451cfd"
      unitRef="U_shares">2286873</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc"
      decimals="0"
      id="F_b2703f92-36e0-4dfd-a316-c5678c998220"
      unitRef="U_shares">2286873</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc"
      decimals="0"
      id="F_868974b6-ee7e-4a44-ad2f-b7e9479ec456"
      unitRef="U_USD">47629</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_d0ad8c2c-b9e2-4947-8c2f-942ce050d3f5"
      decimals="-3"
      id="F_508eeb4c-207d-462a-aa6c-d445a606ce25"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc"
      decimals="-3"
      id="F_376d281f-0c24-46b3-8202-cec19ec3266b"
      unitRef="U_USD">47458000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8"
      decimals="4"
      id="F_a6c8c486-759e-4818-9583-20e376d6e8ec"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_7a96c710-1576-4302-aade-91b06ff915be"
      decimals="4"
      id="F_3498ebf6-7638-482e-8508-f6e8653ef8e9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8"
      decimals="0"
      id="F_5237202a-3757-4c57-92bf-81786af430f1"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8"
      decimals="0"
      id="F_8484a4b0-cda2-4152-b2f2-ce7d97c44f27"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8"
      decimals="0"
      id="F_ad29569d-0cfb-4c2c-9c09-6864a7d25b2b"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7a96c710-1576-4302-aade-91b06ff915be"
      decimals="0"
      id="F_6045f44e-e912-4e12-86ee-957b32ba4ef3"
      unitRef="U_shares">312094</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_7a96c710-1576-4302-aade-91b06ff915be"
      decimals="0"
      id="F_28f6f013-0c2b-4494-9db2-8f2284060fd7"
      unitRef="U_shares">312094</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_7a96c710-1576-4302-aade-91b06ff915be"
      decimals="0"
      id="F_6aeb7360-9eb2-48a1-bb2a-8fa92452aa57"
      unitRef="U_shares">312094</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_7a96c710-1576-4302-aade-91b06ff915be"
      decimals="0"
      id="F_d5b0c5b2-ba77-437d-8cd2-691c9b745da0"
      unitRef="U_USD">5753</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_a813db75-fdc2-4ad1-b2d0-4a2a580855d8"
      decimals="-3"
      id="F_0331407b-6a4a-4d68-8de2-0955043b8f0a"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_7a96c710-1576-4302-aade-91b06ff915be"
      decimals="-3"
      id="F_67756376-bb54-4e1a-a73f-48a8f7174571"
      unitRef="U_USD">4132000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f"
      decimals="4"
      id="F_1a22d64a-f2c6-4d5d-a8ae-1dc87af66fa6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14"
      decimals="4"
      id="F_843dcf4c-2e3e-46a1-bc62-268df0482635"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f"
      decimals="0"
      id="F_dcb2ea0a-50c5-4de8-b9b0-3cad6f432436"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f"
      decimals="0"
      id="F_c8f1bc72-eddd-4588-ba6f-d748e51942f5"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f"
      decimals="0"
      id="F_91c8aaa2-578e-4425-beac-f8ce4b175656"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14"
      decimals="0"
      id="F_eecd9ecd-126e-4f95-900e-47bdbe789e42"
      unitRef="U_shares">2625896</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14"
      decimals="0"
      id="F_c45b5bb0-f066-4192-9b13-327afe3a6ab2"
      unitRef="U_shares">2625896</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14"
      decimals="0"
      id="F_db8bc435-13c8-44bc-bfa0-559f78edf250"
      unitRef="U_shares">2625896</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14"
      decimals="0"
      id="F_ca65d5a3-9344-488c-88c9-7306f534c1a5"
      unitRef="U_USD">60000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_2c7188da-fb0c-4c2a-bdc4-86089c5dc06f"
      decimals="-3"
      id="F_2a5977b1-da32-4a91-9a40-d8dc8fb96037"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14"
      decimals="-3"
      id="F_878cab6e-e22d-450c-87a4-416aa42352fc"
      unitRef="U_USD">59855000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_815cc3a3-a876-4d94-b8e7-b2bf38d632b8"
      unitRef="U_USD">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_82e2d106-d6ad-4034-a356-6b302923a983"
      unitRef="U_USD">111445000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="4"
      id="F_5f67e9a8-7a14-4817-9d76-2f2fa56371cc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="4"
      id="F_974ef59e-b0c9-40cf-a670-b49b6aa2667b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_34789ae4-785a-414e-a2b6-2f7e64856508"
      unitRef="U_shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="0"
      id="F_66e1f8db-3508-47c1-99bd-9db35fa5202d"
      unitRef="U_shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_2d46e4e6-0ae6-406e-b769-447740eb4dfd"
      unitRef="U_shares">12197615</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_15de671c-4335-49f3-bb8e-07852d49a449"
      unitRef="U_shares">12197615</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="0"
      id="F_d7416a7e-8704-405d-b42c-b772af69468d"
      unitRef="U_shares">359569</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="0"
      id="F_2eef5a64-5839-453f-ac8a-21563b479d1e"
      unitRef="U_shares">359569</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_9fb70284-c3e3-4f0d-83cb-f99f2fc4cb3e"
      unitRef="U_USD">2000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_97282515-4dac-4721-a4c8-8e5543c3b332"
      unitRef="U_USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_5be90240-f63b-41fe-b09c-a4d55b3fcdbb"
      unitRef="U_USD">240487000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_b2f70f75-628c-4f6a-8667-c0f257a3ddd2"
      unitRef="U_USD">4159000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_adf3f90e-6932-4b2d-ada7-4248b7494901"
      unitRef="U_USD">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_b744fb22-8609-4f0d-aba1-d5acadf10c28"
      unitRef="U_USD">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_74e8f460-751d-4b22-9eae-ada01d91d088"
      unitRef="U_USD">-234814000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_0dd9fee1-9a4c-452e-9d14-c9403b767ed6"
      unitRef="U_USD">-187081000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_a9e247d9-468c-40b9-8938-577ea344d9a2"
      unitRef="U_USD">5675000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_d373dcff-911d-458a-885d-897cb3eb8f40"
      unitRef="U_USD">-182921000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_98208a3b-6fef-4433-8a3c-0fb9f25d5d99"
      unitRef="U_USD">92332000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_4f4d98cf-13e1-4504-87f4-334301c1b9ab"
      unitRef="U_USD">47057000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_c616afc0-415b-457a-8938-9c37b970014a"
      unitRef="U_USD">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_b1315e26-f99d-448a-9aa9-7cd731794653"
      unitRef="U_USD">-6651000</us-gaap:Revenues>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_a673744a-322b-4c72-910a-a66bc429f4a4"
      unitRef="U_USD">48143000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_bacbe10a-a566-4ac6-b0a7-69c7a5eed264"
      unitRef="U_USD">31729000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_71629f4f-8d7b-4441-b4e0-299c51e3de01"
      unitRef="U_USD">17959000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_d230b1bb-5e07-4fbc-9088-8801d2082a46"
      unitRef="U_USD">9875000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_7f11763c-ded6-43af-b9b0-f7830ac7236b"
      unitRef="U_USD">66102000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_e1682740-9c36-4453-9d1c-26d83f8d1351"
      unitRef="U_USD">41604000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_18084279-9b5d-409f-8901-47c3e5591b39"
      unitRef="U_USD">-66102000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_301d3f10-d3f0-49ec-bd61-10ba4f280789"
      unitRef="U_USD">-48255000</us-gaap:OperatingIncomeLoss>
    <qttb:ChangeInFairValueOfConvertibleNotes
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_18bf44a2-eac8-4347-958e-8576562072df"
      unitRef="U_USD">15890000</qttb:ChangeInFairValueOfConvertibleNotes>
    <qttb:ChangeInFairValueOfConvertibleNotes
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_90b8a3d5-9375-47ce-84c5-3dca0eb0fadc"
      unitRef="U_USD">-6193000</qttb:ChangeInFairValueOfConvertibleNotes>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_5d69d0db-f0e0-4f99-94c1-a52e733d734f"
      unitRef="U_USD">4125000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_a0ea5235-59a7-4326-89b5-37a58ca62f4d"
      unitRef="U_USD">1023000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_40c23fa9-bd59-4fe3-9bf3-72cf2f29eaeb"
      unitRef="U_USD">20015000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_9f33ba99-1f7e-4ec9-811c-d73edcab2992"
      unitRef="U_USD">-5170000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_e3053650-eec5-4dec-8474-9c87daf7b3d9"
      unitRef="U_USD">-46087000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_5b5c0a95-773b-4cdd-9760-363f40a4d5e4"
      unitRef="U_USD">-53425000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_7df6c119-bdc6-485a-850c-97825609d545"
      unitRef="U_USD">21000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_faa439a8-d5f3-4f89-966e-9748902012b6"
      unitRef="U_USD">318000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_87864e62-63f1-4663-a80c-99325aaea4a5"
      unitRef="U_USD">-1625000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_c24fe8e9-6102-44e7-a181-c91b83ef2863"
      unitRef="U_USD">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:NetIncomeLoss
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_0eedc531-6f21-4ba5-b8b3-98848f51774c"
      unitRef="U_USD">-47733000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_7a943663-6c18-413c-bfe7-3666fb4abc86"
      unitRef="U_USD">-53743000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_05a8110c-49b2-4768-9e97-6ff1722b2a1f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-5.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="2"
      id="F_f9c0ea3b-4d19-42f8-aaae-36480a2cf509"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-153.96</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_9e1707cd-85c9-4d95-a69f-2f7d2ebd24d8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-6.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="2"
      id="F_ec821f72-1ede-43f3-a3e8-15cc4a7e9a70"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-153.96</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_8ae787f1-2f71-4bfe-80e2-c73ac14c9eba"
      unitRef="U_shares">9320884</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="0"
      id="F_dc6ab5f2-b975-4ae4-812a-d08071b01039"
      unitRef="U_shares">349060</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_ff4b3076-37df-4040-b787-7638cea9a2d5"
      unitRef="U_shares">9657696</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="0"
      id="F_df031f7d-1f05-40a8-9b34-88999836d7af"
      unitRef="U_shares">349060</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_719add18-386c-406e-a905-944e64f349fa"
      unitRef="U_USD">-47733000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_b3dc6d78-66af-4270-a6f6-5af1db57546c"
      unitRef="U_USD">-53743000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_9ed2d696-e656-45f7-a0ea-abca2c3a5082"
      unitRef="U_USD">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_15a24a6c-0668-487f-b51b-d03f0ea51237"
      unitRef="U_USD">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_4f287177-433c-4bb3-bc05-5d0593315fe8"
      unitRef="U_USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_ff16bbe8-e0ef-4a74-ac63-aaac365265f2"
      unitRef="U_USD">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_9aaec9a9-6ae6-4d82-b128-0f2fed602723"
      unitRef="U_USD">-47733000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_ecaa97d8-bdf6-49e8-a313-208a69a9670f"
      unitRef="U_USD">-53743000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_4cbc437d-5afa-447b-9f58-e212caafd669"
      decimals="INF"
      id="F_cff3cf45-6281-42a2-956c-688ac5534cf6"
      unitRef="U_shares">2286873</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_4cbc437d-5afa-447b-9f58-e212caafd669"
      decimals="-3"
      id="F_06cb4e2a-af45-434e-a2fb-6c16841e8c49"
      unitRef="U_USD">47458000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_afa19969-608f-48e9-9aca-73182815530d"
      decimals="INF"
      id="F_976476ec-5b96-4ffa-bacf-51a9ce3edb8b"
      unitRef="U_shares">312094</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_afa19969-608f-48e9-9aca-73182815530d"
      decimals="-3"
      id="F_f22d024f-a404-4c8a-a1af-c1f5bc6b4e47"
      unitRef="U_USD">4132000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_e5fdb991-d520-4075-b2d8-b05c3d677e35"
      decimals="INF"
      id="F_0182e92f-d323-480b-a655-5adf9caec375"
      unitRef="U_shares">2625896</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_e5fdb991-d520-4075-b2d8-b05c3d677e35"
      decimals="-3"
      id="F_385a13be-8ba9-47a1-84e5-3ed7d9b723b0"
      unitRef="U_USD">59855000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="C_7ec0ac51-4871-4881-a34d-77b8a09d8ea0"
      decimals="INF"
      id="F_57aaeb6b-9779-43f5-a823-9a0fc6bf1ab8"
      unitRef="U_shares">343550</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_7ec0ac51-4871-4881-a34d-77b8a09d8ea0"
      decimals="-3"
      id="F_066a9338-9e57-4790-a69f-a3d6cacf25c6"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_37196b4a-4692-492f-b903-2a6e19a6a232"
      decimals="-3"
      id="F_7bd1be78-9df3-405c-90dc-a06e97abc83a"
      unitRef="U_USD">2625000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b5225717-0e5a-4c67-907b-047d72ad665b"
      decimals="-3"
      id="F_c890abbc-c4bb-4689-8ce7-0d3ef4bdb976"
      unitRef="U_USD">-133338000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_e26a9287-f885-4441-9d0e-9148098a8888"
      decimals="-3"
      id="F_6da27eae-40eb-4c08-98b8-74dd70f24b6a"
      unitRef="U_USD">-130712000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_00125eea-3c46-4a9a-8949-a3a86ae55b5a"
      decimals="INF"
      id="F_25071d61-22be-47e6-ba20-d84397109a25"
      unitRef="U_shares">16019</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_7cdabbbf-9d0e-48aa-9f1d-1c17d1a6755a"
      decimals="-3"
      id="F_d2a5ddf0-a420-4594-b2b3-d47524043daf"
      unitRef="U_USD">106000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_72582ce2-7800-4f2b-9b07-721c8f2587e9"
      unitRef="U_USD">106000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="C_7cdabbbf-9d0e-48aa-9f1d-1c17d1a6755a"
      decimals="-3"
      id="F_236549d9-8fcd-40b9-95e8-5a03769b2512"
      unitRef="U_USD">1428000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_045959f8-a2ec-42f9-8e79-ca960af1f002"
      unitRef="U_USD">1428000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="C_62c12364-19f9-412d-b7a5-93a8a2255606"
      decimals="-3"
      id="F_ec67d721-3d23-4118-a4be-016c2483fe1a"
      unitRef="U_USD">-53743000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_b8670d0d-acf0-471f-b1cc-2949389fe916"
      unitRef="U_USD">-53743000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc"
      decimals="INF"
      id="F_07fc39a0-36a2-4298-88aa-32fb322d3c2e"
      unitRef="U_shares">2286873</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_13bab75d-170f-40f3-93c6-4fd2884489bc"
      decimals="-3"
      id="F_db0fa9f1-de37-437b-9924-4c2dd652211c"
      unitRef="U_USD">47458000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_7a96c710-1576-4302-aade-91b06ff915be"
      decimals="INF"
      id="F_2e82ad4f-b1f9-4cf0-b17a-c9b6d3a37e20"
      unitRef="U_shares">312094</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_7a96c710-1576-4302-aade-91b06ff915be"
      decimals="-3"
      id="F_a2d73bf1-b2bd-4986-a8c6-48416f6b22fd"
      unitRef="U_USD">4132000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14"
      decimals="INF"
      id="F_2d8a1d8e-dfcb-4856-bba4-fa109dd4deae"
      unitRef="U_shares">2625896</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_50665618-c890-4c3e-9bd9-6c41d79b5f14"
      decimals="-3"
      id="F_18d41eea-7575-4a51-9f4c-f9c08a7bac41"
      unitRef="U_USD">59855000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="C_4a91fccb-1956-4e07-b38a-1f2ba2811311"
      decimals="INF"
      id="F_ef958ad6-f6f4-4ba4-abf3-59c7d3a10600"
      unitRef="U_shares">359569</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_4a91fccb-1956-4e07-b38a-1f2ba2811311"
      decimals="-3"
      id="F_a388fac3-cb3c-460e-ac55-8fbeb7dd44e1"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_75a6ef14-59cd-493d-a00e-544f5be1fdf1"
      decimals="-3"
      id="F_6f990199-8939-40c4-9256-e18fba2605a2"
      unitRef="U_USD">4159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_482f7b29-7345-4d72-8fd8-5f3199ef1c23"
      decimals="-3"
      id="F_0abb56d3-38bf-4cd1-aa8e-9eb74eb27de4"
      unitRef="U_USD">-187081000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_1649ab8d-4664-4fe7-a3e4-914e08dc7852"
      unitRef="U_USD">-182921000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_be2666e6-1b34-4583-add6-12ea7a5cce3f"
      decimals="INF"
      id="F_e236b967-0b54-43cb-b5ea-b4b28c3878e4"
      unitRef="U_shares">-2286873</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_be2666e6-1b34-4583-add6-12ea7a5cce3f"
      decimals="-3"
      id="F_eda1cfcc-94cf-46b1-ba4f-1b5ea94cfedf"
      unitRef="U_USD">-47458000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_01f11a58-84ba-4030-8559-1f45b7816019"
      decimals="INF"
      id="F_f9acbf39-4023-4d3d-9027-0afe41ec588a"
      unitRef="U_shares">-312094</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_01f11a58-84ba-4030-8559-1f45b7816019"
      decimals="-3"
      id="F_693c8fcb-0ba2-4992-8931-fa0604a3924e"
      unitRef="U_USD">-4132000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_1ec25630-4304-4291-a5ab-390b64487da5"
      decimals="INF"
      id="F_52d930c0-945a-4720-ad61-460a237c3e4b"
      unitRef="U_shares">-2625896</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_1ec25630-4304-4291-a5ab-390b64487da5"
      decimals="-3"
      id="F_8e521aa6-2868-4479-9e4b-e3c45664109f"
      unitRef="U_USD">-59855000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230"
      decimals="INF"
      id="F_d895a6a7-bce8-4717-ac9f-b2e9d68bfff5"
      unitRef="U_shares">5224863</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230"
      decimals="-3"
      id="F_b771d575-b682-4d36-8bee-8010c9e398ea"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d"
      decimals="-3"
      id="F_2ff083eb-418b-4646-95cd-46abf45d5eab"
      unitRef="U_USD">111444000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_324f4e7d-5de6-4516-b2b6-96d64873154e"
      unitRef="U_USD">111445000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <qttb:IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts
      contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230"
      decimals="INF"
      id="F_7d4a90ba-3291-4b83-bb70-0116c2c9f6ff"
      unitRef="U_shares">1682045</qttb:IssuanceOfCommonStockDuringPeriodPreClosingFinancingNetOfIssuanceCosts>
    <qttb:IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts
      contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d"
      decimals="-3"
      id="F_205f5f80-ede4-49b0-b7b1-557d4bb527ae"
      unitRef="U_USD">42000000</qttb:IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts>
    <qttb:IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_79fa872d-8c06-4340-b6bd-c6f5ca760185"
      unitRef="U_USD">42000000</qttb:IssuanceOfCommonStockDuringPeriodPreClosingNetOfIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230"
      decimals="INF"
      id="F_482d968e-012a-4ed1-a4fd-95b9ff493ed1"
      unitRef="U_shares">1433410</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d"
      decimals="-3"
      id="F_fb2f74a5-6bef-48fd-a2ca-c82563ab2738"
      unitRef="U_USD">22705000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_8e0e88a1-4950-44b2-887e-67ac3a0dbe63"
      unitRef="U_USD">22705000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <qttb:StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization
      contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230"
      decimals="INF"
      id="F_3ac74443-1f22-4989-a2d2-c8461b19b28a"
      unitRef="U_shares">3229633</qttb:StockIssuedDuringPeriodValueToHomologyShareholdersInReverseRecapitalization>
    <qttb:StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization
      contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d"
      decimals="-3"
      id="F_1345c95c-4444-4a3e-80f4-cc2c15b6a81e"
      unitRef="U_USD">64292000</qttb:StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization>
    <qttb:StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_5cbc8bd0-6936-4da7-95ec-f58565b91df5"
      unitRef="U_USD">64292000</qttb:StockIssuedDuringPeriodValueToHomologyShareholdersReverseRecapitalization>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230"
      decimals="INF"
      id="F_391c16aa-4639-4b6a-bd2c-071491975b65"
      unitRef="U_shares">255486</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d"
      decimals="-3"
      id="F_e2b29761-b0a1-4991-80c8-2eca253b3ceb"
      unitRef="U_USD">1694000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_91fd79f6-e5fa-4074-ba09-6edcd7b454a2"
      unitRef="U_USD">1694000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <qttb:IssuanceOfCommonStocksFromRsuVesting
      contextRef="C_4a20caa7-c241-467a-98e1-fba745a92230"
      decimals="INF"
      id="F_3014d412-464d-48f7-a2f0-5abefeb7f4bf"
      unitRef="U_shares">12609</qttb:IssuanceOfCommonStocksFromRsuVesting>
    <us-gaap:StockholdersEquityNoteSpinoffTransaction
      contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d"
      decimals="-3"
      id="F_c8494345-1cdf-46d6-a195-3046fe94af53"
      unitRef="U_USD">-10013000</us-gaap:StockholdersEquityNoteSpinoffTransaction>
    <us-gaap:StockholdersEquityNoteSpinoffTransaction
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_e809cab0-9fa0-4bbb-a540-32e6e11f90b5"
      unitRef="U_USD">-10013000</us-gaap:StockholdersEquityNoteSpinoffTransaction>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d"
      decimals="-3"
      id="F_862f090e-da03-4251-9ba5-bec9c56ef243"
      unitRef="U_USD">-180000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_a26b7bfb-0e22-49d7-b0ea-5b1494b4cb72"
      unitRef="U_USD">-180000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="C_15ac1628-7ad1-4ce0-8f6d-47908bb70a3d"
      decimals="-3"
      id="F_26d8a979-860c-40c2-8953-2c39e2bd7e6f"
      unitRef="U_USD">4386000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_36530d7e-f15a-481c-a6f0-1cad5d605100"
      unitRef="U_USD">4386000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss
      contextRef="C_7d9baed7-c6de-4298-867d-06f8f3ee91b1"
      decimals="-3"
      id="F_d270e629-0edf-4e29-a694-e06ea2b5c128"
      unitRef="U_USD">-47733000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_ecf00a65-6c7d-46c0-8eb2-c376639f203e"
      unitRef="U_USD">-47733000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="C_b5c40c56-08b5-4a22-b751-a8f232a74aca"
      decimals="INF"
      id="F_b233e31a-7af1-418d-8767-6609413bfe20"
      unitRef="U_shares">12197615</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_b5c40c56-08b5-4a22-b751-a8f232a74aca"
      decimals="-3"
      id="F_feb4e501-4220-4a2b-961a-ce8c92fa72c7"
      unitRef="U_USD">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_ce9f954b-cafc-43d9-af6e-e2bba9ac13af"
      decimals="-3"
      id="F_26665af4-1ebe-4cee-8c21-fbda2ddee23b"
      unitRef="U_USD">240487000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_c18fd5f0-cb42-4f14-9f5c-4fb10a0505bc"
      decimals="-3"
      id="F_f5b72964-e0fe-41af-b62b-8046c90f6671"
      unitRef="U_USD">-234814000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_357dbc0f-2c29-4fc8-9805-548706d18a83"
      unitRef="U_USD">5675000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_0774c4b1-0344-487e-9042-e69e6c5b158e"
      unitRef="U_USD">-47733000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_8c1108bd-6d9e-4dac-9d68-eb8bd31ee4a3"
      unitRef="U_USD">-53743000</us-gaap:NetIncomeLoss>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_c3725427-80b0-46da-afff-00a354a72320"
      unitRef="U_USD">194000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_b19b8a8f-5aa0-40d8-8384-7eb705a80e7d"
      unitRef="U_USD">87000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_0cc15d07-ebe5-4acf-a00c-beede27594c0"
      unitRef="U_USD">221000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_0bedd1f7-4dc0-43a3-8860-78e07068568d"
      unitRef="U_USD">0</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:Depreciation
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_0fd46f73-de8f-483f-afee-9a14808aee95"
      unitRef="U_USD">487000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_894f9370-1ef5-4ed7-832b-62aa5646740b"
      unitRef="U_USD">499000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_8cc21201-ac38-4ffb-aa74-9473b19bfc25"
      unitRef="U_USD">4386000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_f68e88ea-34ee-4e8f-b5dd-dc8540ca620b"
      unitRef="U_USD">1428000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_23fe2022-6c7c-47d1-bdf9-0416964b4fa6"
      unitRef="U_USD">579000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_6aa1696f-4700-4f3d-b9f9-84c1fc6fefdf"
      unitRef="U_USD">544000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_9cdde02b-93ed-4b1e-aa9c-c432558948fd"
      unitRef="U_USD">-1625000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_ff427190-73d5-43d6-b8dc-e71fa4f62df6"
      unitRef="U_USD">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <qttb:LossOnImpairmentOfEquityInvestment
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_54bd0405-4b37-4e8d-abeb-3ab431829cf0"
      unitRef="U_USD">675000</qttb:LossOnImpairmentOfEquityInvestment>
    <qttb:LossOnImpairmentOfEquityInvestment
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_2f61e976-4ffc-4a6c-98a7-6e8af547cfa9"
      unitRef="U_USD">0</qttb:LossOnImpairmentOfEquityInvestment>
    <qttb:ChangeInFairValueOfEquityInvestment
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_db49f4c1-ec43-4e75-811b-aacb6db1c36b"
      unitRef="U_USD">2180000</qttb:ChangeInFairValueOfEquityInvestment>
    <qttb:ChangeInFairValueOfEquityInvestment
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_ec5def19-be41-41f9-957f-e2ff66daa537"
      unitRef="U_USD">0</qttb:ChangeInFairValueOfEquityInvestment>
    <qttb:ChangeInFairValueOfConvertibleNotes
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_d179ed81-4ce5-46b4-b58e-37f9fda0552d"
      unitRef="U_USD">15890000</qttb:ChangeInFairValueOfConvertibleNotes>
    <qttb:ChangeInFairValueOfConvertibleNotes
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_07a381d4-ec1d-4647-ad53-fabde20f1e08"
      unitRef="U_USD">-6193000</qttb:ChangeInFairValueOfConvertibleNotes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_e5c01dff-1a38-4bbc-8064-04c5353a293b"
      unitRef="U_USD">-276000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_3909fd33-1c7e-488c-a07a-ed69106a8b6a"
      unitRef="U_USD">94000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_5b8517ad-ba64-439f-9948-e88cb5470d31"
      unitRef="U_USD">-386000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_70ba7e9d-0f55-4680-97e4-a8e32ab1e43d"
      unitRef="U_USD">4503000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_3802fe35-f67c-40aa-9a9c-64f96bc3dd8f"
      unitRef="U_USD">-1043000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_0701afde-8d2b-461a-84ae-c4e8938b609f"
      unitRef="U_USD">2033000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_a2f408de-7e49-4fb1-93a9-31e7bcc42327"
      unitRef="U_USD">-1542000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_7788b9ac-942b-4b41-a8d8-f78dad6761f4"
      unitRef="U_USD">-471000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_d9a306c2-e9f4-43d2-bf88-5c6fe097a66c"
      unitRef="U_USD">-7714000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_af963bb0-c146-486f-bb8f-2312236cd01c"
      unitRef="U_USD">199000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <qttb:IncreaseDecreaseInContingentLiability
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_c40a3f64-ff8c-4d67-b241-a25e3ee1694a"
      unitRef="U_USD">0</qttb:IncreaseDecreaseInContingentLiability>
    <qttb:IncreaseDecreaseInContingentLiability
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_97391e2d-0b87-48dc-a755-18ea4289e9b2"
      unitRef="U_USD">-55000000</qttb:IncreaseDecreaseInContingentLiability>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_09c0f5e8-62b9-46bc-8d6f-4c1c59ea4740"
      unitRef="U_USD">0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_e44f67f3-02d5-44a8-a9a6-284ea1034ee4"
      unitRef="U_USD">-25849000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_8f78a58d-cf68-4e8e-bb80-8a30ad30d55e"
      unitRef="U_USD">-67715000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_652d8ebc-fab2-40aa-8287-928551f846f4"
      unitRef="U_USD">-18677000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_0451d125-c725-4e0a-aa8d-5f749fb733a3"
      unitRef="U_USD">75000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_acd7e7ed-5cd5-4cf4-b336-30e38a17544f"
      unitRef="U_USD">5000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_e3ba180e-5f33-4207-bd3b-d6cce2c57cef"
      unitRef="U_USD">20000000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_7f019ca2-0aec-4c23-b48c-4349c08473f3"
      unitRef="U_USD">0</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_fe747830-ab2c-4e39-8c47-5995839d8a6c"
      unitRef="U_USD">19925000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_0ad6d514-5ddf-45d4-bdb5-abeb3eacb5a3"
      unitRef="U_USD">-5000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_8f73fbae-cfbb-4751-ae6d-426aaed2e937"
      unitRef="U_USD">7000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_a089aa87-0068-4dfe-ad96-a9af70326606"
      unitRef="U_USD">5500000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_5cffd3c5-a6df-48c8-875a-300a967913b4"
      unitRef="U_USD">0</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_c2f2c7bd-8222-4c69-8694-9c22a747225e"
      unitRef="U_USD">5200000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_44e8c4e8-2a78-4391-9a14-17ba1433bc09"
      unitRef="U_USD">42000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_be17c921-3bd6-41bf-a89d-7aa8269bbe85"
      unitRef="U_USD">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <qttb:ProceedsFromReverseRecapitalization
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_f7136ebe-f803-4cbe-aba4-6054b9a4e236"
      unitRef="U_USD">53158000</qttb:ProceedsFromReverseRecapitalization>
    <qttb:ProceedsFromReverseRecapitalization
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_743b77b2-3663-42cc-8fbe-aae905e30b05"
      unitRef="U_USD">0</qttb:ProceedsFromReverseRecapitalization>
    <qttb:PaymentOfReverseRecapitalizationTransactionCosts
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_347ef51e-c675-460f-a2e0-555d50c945d6"
      unitRef="U_USD">-8714000</qttb:PaymentOfReverseRecapitalizationTransactionCosts>
    <qttb:PaymentOfReverseRecapitalizationTransactionCosts
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_543ab4b6-f573-454e-8f7e-1e3599bd96fd"
      unitRef="U_USD">0</qttb:PaymentOfReverseRecapitalizationTransactionCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_714e9906-8a63-4aac-933f-acbcc15d80a5"
      unitRef="U_USD">1694000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_ef6a1da8-2b88-4671-b632-416cdd1ebd6d"
      unitRef="U_USD">106000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_4dc0d729-a647-4237-b4ae-0b9d7779620b"
      unitRef="U_USD">95138000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_99463a9c-09a0-48da-9048-7596df6a0d71"
      unitRef="U_USD">406000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_6aa067e4-c131-4fdd-b398-216c6abae811"
      unitRef="U_USD">47348000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_01321fcc-a233-4396-9c87-29a55322ea8e"
      unitRef="U_USD">-18276000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_7e341aaf-8945-47b0-b74b-9121e5612310"
      unitRef="U_USD">31264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_e26a9287-f885-4441-9d0e-9148098a8888"
      decimals="-3"
      id="F_38413a9c-5fc4-49e6-8dff-6fc977001acc"
      unitRef="U_USD">49540000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_1bd277ed-0ec0-4192-bc1b-552d6eddf8e1"
      unitRef="U_USD">78612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_ecf358de-e7a0-4961-a890-e67d50c2a3ad"
      unitRef="U_USD">31264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_97a03012-d999-411d-b606-ade748ed7021"
      unitRef="U_USD">856000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_c6a64c41-011d-4e0c-b3f0-bdeb6e8782ee"
      unitRef="U_USD">422000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <qttb:ShortTermInvestmentsAcquiredInReverseRecapitalization
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_96621368-41a0-46b4-8c87-471a6757bb76"
      unitRef="U_USD">19905000</qttb:ShortTermInvestmentsAcquiredInReverseRecapitalization>
    <qttb:ShortTermInvestmentsAcquiredInReverseRecapitalization
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_1261b80a-49a7-4ae5-9fdd-6e970e2007ac"
      unitRef="U_USD">0</qttb:ShortTermInvestmentsAcquiredInReverseRecapitalization>
    <qttb:IssuanceOfCvrAtFairValue
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_c8d18359-48f6-4068-9d6e-912378c48db4"
      unitRef="U_USD">180000</qttb:IssuanceOfCvrAtFairValue>
    <qttb:IssuanceOfCvrAtFairValue
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_bc76373b-d044-4cf5-8287-250a719a18a9"
      unitRef="U_USD">0</qttb:IssuanceOfCvrAtFairValue>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_78a3ea18-7754-483e-9225-11f338007891">&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;1. Nature of the Business&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Q32 Bio Inc. (&#x201c;Q32&#x201d; or the &#x201c;Company&#x201d;) is a clinical stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. Q32 has multiple product candidates across a variety of autoimmune and inflammatory diseases. The Company was formed in 2017 as Admirx, Inc. under the laws of the state of Delaware and is headquartered in Waltham, Massachusetts. On March 20, 2020, the Company changed its name to Q32 Bio Inc.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Merger with Homology&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 25, 2024, Kenobi Merger Sub, Inc. (&#x201c;Merger Sub&#x201d;), a wholly-owned subsidiary of Homology Medicines, Inc. (&#x201c;Homology&#x201d;), completed its merger with and into Q32 Bio Operations Inc. (previously named Q32 Bio Inc. and referred to herein as &#x201c;Legacy Q32&#x201d;), with Legacy Q32 continuing as the surviving entity as a wholly-owned subsidiary of Homology. This transaction is referred to as the &#x201c;Merger.&#x201d; Homology changed its name to Q32 Bio Inc., and Legacy Q32, which remains as a wholly-owned subsidiary of the Company, changed its name to Q32 Bio Operations, Inc. The Merger was effected pursuant to an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;), dated as of November 16, 2023, by and among Homology, Legacy Q32, and Merger Sub. In connection with the Merger Agreement, certain parties entered into a subscription agreement with the Company to purchase shares of Legacy Q32&#x2019;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;s common stock for an aggregate purchase price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million (the &#x201c;Pre-Closing Financing&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 25, 2024 (the &#x201c;Closing Date&#x201d;), the Pre-Closing Financing closed immediately prior to the consummation of the Merger. Shares of Legacy Q32&#x2019;s common stock issued pursuant to the Pre-Closing Financing were converted into the right to receive &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,682,045&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Homology common stock after taking into account the Reverse Stock Split. On March 25, 2024, Homology effected a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;one-for-eighteen&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reverse stock split of its then outstanding common stock &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(the &#x201c;Reverse Stock Split&#x201d;) where &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;all issued and outstanding shares of Legacy Q32&#x2019;s common stock (including common stock issued upon the conversion of all Legacy Q32&#x2019;s Series A, Series A-1 and Series B preferred stock, conversion of Legacy Q32 convertible notes, but excluding the common stock issued in Pre-Closing Financing) converted into the right to receive an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,017,842&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Homology&#x2019;s common stock based on the final exchange ratio of 0.0480 (the &#x201c;Exchange Ratio&#x201d;). Lastly, each option to purchase the Legacy Q32&#x2019;s shares that was outstanding and unexercised immediately prior to the Merger was converted into an option to purchase shares of Homology based on the Exchange Ratio. Immediately following the Merger, Legacy Q32 stockholders owned approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the outstanding common stock of the combined company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Merger was accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). For accounting purposes, Legacy Q32 is considered the accounting acquirer and Homology is the acquired company based on the terms of the Merger Agreement and other factors, such as relative voting rights and the composition of the combined company&#x2019;s board of directors and senior management. Accordingly, the Merger was treated as the equivalent of Legacy Q32&#x2019;s issuing stock to acquire the net assets of Homology. As a result of the Merger, the net assets of Homology were recorded at their acquisition-date fair value in the financial statements of the combined company and the reported operating results prior to the Merger are those of Legacy Q32. Legacy Q32&#x2019;s historical financial statements became the historical consolidated financial statements of the combined company. All issued and outstanding Legacy Q32 common stock, convertible preferred stock and options prior to the effective date of the Merger have been retroactively adjusted to reflect the Exchange Ratio, which reflects the impact of the reverse stock split, for all periods presented.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At the effective time of the Merger, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#x2019;s common stock received a contractual contingent value right (&#x201c;CVR&#x201d;) issued by Homology representing the contractual right to receive cash payments from the combined company upon the receipt of certain proceeds from a disposition of Homology&#x2019;s pre-merger assets (see Note 3 for more details surrounding the accounting for the Merger and the CVRs).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to risks and uncertainties common to early-stage companies in the biotechnology industry, including but not limited to, risks associated with completing preclinical studies and clinical trials, obtaining regulatory approvals for product candidates, development by competitors of new biopharmaceutical products, dependence on key personnel, protection of proprietary technology, compliance with government regulations and the ability to secure additional capital to fund operations. Programs currently under development will require significant additional research and development efforts, including preclinical&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and clinical testing, and will need to obtain regulatory approval prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel and infrastructure and extensive compliance-reporting capabilities. Even if the Company&#x2019;s product development efforts are successful, it is uncertain when, if ever, the Company will realize revenue from product sales. Since its inception, the Company&#x2019;s operations have been focused on organizing and staffing, business planning, raising capital, establishing the Company&#x2019;s intellectual property portfolio and performing research and development of its product candidates, programs and platform. The Company has primarily funded its operations with proceeds from the sale of convertible preferred stock, convertible notes, venture debt, the Merger with Homology and accompanying Pre-Closing Financing and its collaboration arrangement with Horizon.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liquidity and Going Concern&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In accordance with the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Update (&#x201c;ASU&#x201d;) 2014-15, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Disclosure of Uncertainties about an Entity&#x2019;s ability to Continue as a Going Concern (Subtopic 205-40)&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has evaluated whether they are conditions and events, considered in the aggregate, that raise substantial doubt about the Company&#x2019;s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the Company had an accumulated deficit of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;234.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and cash and cash equivalents of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company expects that its cash and cash equivalents will be sufficient to fund its operating expenditures and capital expenditure requirements necessary to advance its research efforts and clinical trials for at least one year from the date of issuance of these consolidated financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has incurred recurring operating losses since its inception. During the year ended December 31, 2024, the Company incurred a net loss of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company expects its operating losses and negative operating cash flows to continue into the foreseeable future. The future viability of the Company is dependent on its ability to raise additional capital to finance its operations. The Company&#x2019;s inability to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies. There can be no assurance that the current operating plan will be achieved or that additional funding will be available on terms acceptable to the Company, or at all.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:CommonStockSharesSubscriptions
      contextRef="C_01c6b47c-31c0-4923-b0b0-6e5450394be0"
      decimals="-5"
      id="F_f02f7fa6-fb1d-432d-a1a9-471e5c1f397a"
      unitRef="U_USD">42000000</us-gaap:CommonStockSharesSubscriptions>
    <qttb:BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock
      contextRef="C_4a798c23-fd95-415f-8bab-1a4a602a0895"
      decimals="INF"
      id="F_1ae8fafc-51d6-426f-84df-75f849256eea"
      unitRef="U_shares">1682045</qttb:BusinessCombinationSharesConversionIntoRightsToPurchaseCommonStock>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_4a798c23-fd95-415f-8bab-1a4a602a0895"
      id="F_d7f9976c-5ef9-473e-bf30-75d699017866">one-for-eighteen</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="C_4a798c23-fd95-415f-8bab-1a4a602a0895"
      decimals="INF"
      id="F_fc67827f-5873-40f7-9543-9b0f55406140"
      unitRef="U_shares">7017842</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage
      contextRef="C_ca4b638b-76d0-401e-9369-6f2d51d1cb2f"
      decimals="3"
      id="F_f73e0291-7156-47d5-8a90-35c1ddef81d4"
      unitRef="U_pure">0.744</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-5"
      id="F_549e37c8-0856-4e0c-9ca5-02983ab7b319"
      unitRef="U_USD">-234800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_f316cace-cb53-4a10-84c5-1335a8b032e1"
      decimals="-5"
      id="F_b40d973f-a72f-425b-a68b-c983cb58ffb6"
      unitRef="U_USD">78000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-5"
      id="F_a661cfce-80b1-4f5f-ad54-284978b21f6b"
      unitRef="U_USD">-47700000</us-gaap:NetIncomeLoss>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_0726c143-1135-42c3-ac00-f6acfb02987f">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared in conformity with GAAP and have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements include those of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in the consolidated financial statements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could materially differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the fair value of the common stock and convertible notes prior to the effective date of the Merger, the fair value of CVR liability, and the prepaid and accrued research and development expenses. The Company utilizes certain estimates to record expenses relating to research and development contracts. These contract estimates, which are primarily related to the length of service of each contract and the amount of service provided as of each measurement date, are determined by the Company based on input from internal project management, as well as from service providers. Estimates are periodically reviewed considering changes in circumstances, facts and historical experience. Actual results may differ from the Company&#x2019;s estimates.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker (&#x201c;CODM&#x201d;), or decision-making group, in determining how to allocate resources and in assessing performance. The Company has one reporting segment (see Note 20). The segment consists of the development of clinical and preclinical product candidates for the development of the Company&#x2019;s novel biologics. The Company&#x2019;s chief operating decision maker is the chief executive officer (&#x201c;CEO&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss, which is reported on the income statement. The measure of segment assets is reported on the balance sheet as total consolidated assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CODM uses cash forecast models in deciding how to invest into the segment. Such cash forecast models are reviewed to assess the entity-wide operating results and performance. Net loss is used to monitor budget versus actual results. Monitoring budget versus actual results is used in assessing the performance of the segment and in establishing management&#x2019;s compensation, along with cash forecast model.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Foreign Currency Translations&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s functional currency is the United States dollar. Foreign currency transaction gains and losses are recorded in the consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentrations of Credit Risk and Significant Suppliers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments that potentially expose the Company to credit risk primarily consist of cash, cash equivalents, restricted cash and restricted cash equivalents. The Company maintains its cash, cash equivalents, restricted cash and restricted cash equivalents balances with accredited financial institutions and, consequently, the Company does not believe it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s cash management limits investment to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. The Company maintains its cash in bank deposit accounts that are Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insured up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. At times, the Company&#x2019;s bank accounts may exceed the federal insurance limit.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is dependent on contract development and manufacturing organizations (&#x201c;CDMOs&#x201d;) to supply products for research and development activities in its programs. In particular, the Company relies and expects to continue to rely on a small number of manufacturers to supply it with its requirements for the active pharmaceutical ingredients, other raw materials and formulated drugs related to these programs. These programs could be adversely affected by a significant interruption in the supply of active pharmaceutical ingredients, other raw materials and formulated drugs. The Company is also dependent on contract research organizations (&#x201c;CROs&#x201d;) which provide services related to the research and development activities in its programs.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Off Balance Sheet Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had no off balance sheet risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive income (loss) includes net loss as well as other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid investments that are readily convertible into cash with maturities of three months or less at the date of purchase to be cash equivalents. Cash equivalents are comprised of money market accounts invested in U.S. Treasury securities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted cash and restricted cash equivalents are comprised of deposits held by financial institutions as collateral for the company&#x2019;s venture debt and used to collateralize letters of credit related to the Company&#x2019;s lease arrangements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company includes the restricted cash and restricted cash equivalents balance together with its cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash, cash equivalents, restricted cash and restricted cash equivalents consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77,965&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash, cash equivalents, restricted cash and restricted&lt;br/&gt;&#160;&#160;&#160;cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Short-term investments represent holdings of available-for-sale marketable securities in accordance with the Company&#x2019;s investment policy and cash management strategy. Short-term investments have maturities of greater than 90 days at the time of purchase and mature within one year from the balance sheet date. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#x2019; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the underlying security. Such amortization and accretion, together with interest on securities, are included in interest income in the Company&#x2019;s consolidated statements of operations. The cost of marketable securities sold is determined based on the specific identification method and any realized gains or losses on the sale of investments are reflected as a component of other income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#x2019;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#x2019;s industry, and any significant deterioration in economic conditions.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Deferred Transaction Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings as deferred transaction costs until such financings are consummated. After consummation of an equity financing, these costs are recorded as a reduction of the proceeds from the transaction, either as a reduction of the carrying value of the preferred stock or in stockholders&#x2019; deficit as a reduction of additional paid-in capital generated as a result of the transaction. Should the in-process equity financing be abandoned, the deferred transaction costs would be expensed immediately as a charge to operating expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 1 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 2 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 3 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments in Equity Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses the equity method of accounting to account for an investment in an entity that it does not control, but in which it has the ability to exercise significant influence over operating and financial policies. The Company's proportionate share of the net income or loss of the entity is included in consolidated net income (loss). Judgments regarding the level of influence over the equity method investment include consideration of key factors such as the Company's ownership interest, representation on the board of directors or other management body and participation in policy-making decisions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the equity method of accounting, the Company&#x2019;s investment is initially recorded at fair value on the consolidated balance sheets. Upon initial investment, the Company evaluates whether there are basis differences between the carrying value and fair value of the Company&#x2019;s proportionate share of the investee&#x2019;s underlying net assets. Typically, the Company amortizes basis differences identified on a straight-line basis over the underlying assets&#x2019; estimated useful lives when calculating the attributable earnings or losses, excluding the basis differences attributable to in-process research and development that has no alternative future use. If the Company is unable to attribute all of the basis differences to specific assets or liabilities of the investee, the residual excess of the cost of the investment over the proportional fair value of the investee&#x2019;s assets and liabilities is considered to be equity method goodwill and is recognized within the equity investment balance, which is tracked separately within the Company&#x2019;s memo accounts. The Company subsequently records in the statements of operations its share of income or loss of the other entity within other income/expense, which results in an increase or decrease to the carrying value of the investment. If the share of losses exceeds the carrying value of the Company&#x2019;s investment, the Company will suspend recognizing additional losses and will continue to do so unless it commits to providing additional funding; however, if there are intra-entity profits this can cause the investment balance to go negative.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that a decline in value has occurred that is other than temporary. Evidence considered in this evaluation includes, but would not necessarily be limited to, the financial condition and near-term prospects of the investee, recent operating trends and forecasted performance of the investee, market conditions in the geographic area or industry in which the investee operates and the Company&#x2019;s strategic plans for holding the investment in relation to the period of time expected for an anticipated recovery of its carrying value. If the investment is determined to have a decline in value deemed to be other than temporary it is written down to estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses the cost method to account for an investment in an entity in which it does not have the ability to exercise significant influence over operating and financial policies. Investments recorded using the cost method will be assessed for any decrease in value that has occurred that is other than temporary and the other than temporary decrease in value shall be recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As and when circumstances and facts change, the Company will evaluate the Company&#x2019;s ability to significantly influence operational and financial policy to establish a basis for converting the investment accounted for using the cost method to the equity method of accounting and vice versa.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company accounted for its investment in Oxford Biomedica (US) LLC (&#x201c;OXB (US) LLC&#x201d;) using the cost method (see Note 6).&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. Upon retirement or sale,&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:70.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:27.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated Useful Life (Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_4b3c95c9-00db-4ff5-871a-392543c3c948;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of useful life or&lt;br/&gt;term of&lt;br/&gt;associated lease&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates whether an arrangement is or contains a lease at contract inception. If a contract is or contains a lease, lease classification is determined at lease commencement, which represents the date at which the underlying asset is made available for use by the Company. The Company&#x2019;s lease terms are generally measured at the respective lease&#x2019;s noncancelable term and exclude any optional extension terms as the Company is not reasonably certain to exercise such options. The Company elected the short-term lease exemption and therefore does not recognize lease liabilities and right of use assets for lease arrangements with original lease terms of twelve months or less.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Lease liabilities represent the Company&#x2019;s obligation to make lease payments under a lease arrangement. Lease liabilities are measured as the present value of fixed lease payments, discounted using an incremental borrowing rate, as interest rates implicit in the Company&#x2019;s lease arrangements are generally not readily determinable. The Company elected the practical expedient to not separate lease and non-lease components for its real estate leases and therefore both are considered when determining the lease payments in a lease arrangement. Variable lease costs are expensed as incurred.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The incremental borrowing rate represents the interest rate at which the Company could borrow a fully collateralized amount equal to the lease payments, over a similar term, in a similar economic environment. The Company determines the incremental borrowing rate at lease commencement, generally using a synthetic credit rating based on the Company&#x2019;s financial position and negative cash flows, factoring in adjustments for additional risks based on the Company&#x2019;s economic condition, a survey of comparable companies with similar credit and financial profiles, as well as additional market risks, as may be applicable.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets represent the Company&#x2019;s right to use an underlying asset over its lease term. Right-of-use assets are initially measured as the associated lease liability, adjusted for prepaid rent and tenant incentives. The Company remeasures right-of-use assets and lease liabilities when a lease is modified, and the modification is not accounted for as a separate contract. A modification is accounted for as a separate contract if the modification grants the Company an additional right of use not included in the original lease agreement and the increase in lease payments is commensurate with the additional right of use. The Company assesses its right-of-use assets for impairment consistent with its policy for impairment of long-lived assets held and used in operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may be impaired, and assesses their recoverability based upon estimated future undiscounted future cash flows expected to be generated by the long-lived assets. If the estimated aggregate undiscounted cash flows are less than the carrying amount of the long-lived assets, an impairment charge, calculated as the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets, is recorded. The estimated fair value of the long-lived assets is determined based on the estimated discounted cash flows expected to be generated from the long-lived assets.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt and Warrant Issuance Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying value of the Company&#x2019;s venture debt was recorded net of issuance costs and discount relating to the issuance of warrants. The amounts are amortized over the term of the debt using the effective interest method and recognized as interest expense.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development costs are expensed as incurred. Research and Development expenses are comprised of costs incurred in performing research and development activities, including salaries, stock-based compensation and benefits, costs for clinical research organizations and other outsourced activities; laboratory supplies; technology licenses, software and other information technology support; facilities and depreciation.  Upfront payments and milestone payments made for the licensing of technology are expensed as research and development expenses in the period in which they are incurred. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company has entered into various research and development related contracts with external parties. The payments under these agreements are recorded as research and development expenses as the underlying services are performed or the goods are received. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued and prepaid balances at&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;end of any reporting period. Actual results could differ from the Company&#x2019;s estimates. The Company&#x2019;s historical accrual estimates have not been materially different from the actual costs.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company expenses all costs as incurred in connection with patent applications, including direct application fees, and the legal and consulting expenses related to making such applications, and such costs are included in general and administrative expenses within the Company&#x2019;s statement of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under FASB Accounting Standards Codification (&#x201c;ASC&#x201d; Topic 606, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (ASC 606), an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Arrangements that include rights to additional goods or services that are exercisable at a customer&#x2019;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. The identification of material rights requires judgments related to the determination of the value of the underlying good or service relative to the option exercise price. The exercise of a material right is accounted for as a contract modification for accounting purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#x2019;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the license terms, the research, manufacturing and commercialization capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The transaction price is determined and allocated to the identified performance obligations in proportion to their stand-alone selling prices (SSP) on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The amount of variable consideration included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty related to the variable consideration is resolved. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time recognition is based on the use of an output or input method.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for stock-based awards in accordance with FASB ASC Topic 718, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Compensation &#x2013; Stock Compensation &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(ASC 718). ASC 718 requires all stock-based awards issued to employees and members of the Company&#x2019;s board of directors for their services to be recognized as expense in the statements of operations based on their grant date fair values. For stock options and time-based restricted stock awards, the Company expenses the fair value of the awards on a straight-line basis over each award&#x2019;s service period, which is generally the period in which the related services are received. For performance-based stock awards, the Company uses the accelerated attribution method to expense the awards over the implicit service period based on the probability of achieving the performance conditions. The Company accounts for stock-based awards to non-employees consistently with the accounting for awards to employees and measures stock-based awards granted to non-employees based on their grant date fair value and recognizes the resulting value as stock-based compensation expense during the period the related services are rendered. The Company has not issued any stock-based awards with market-based vesting conditions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of options on the date of grant is calculated using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company&#x2019;s estimates of these assumptions are primarily based on the trading price of the Company&#x2019;s stock, historical data, peer company data and judgment regarding future trends and factors. The Company accounts for forfeitures as they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s equity incentive plan allows for the issuance of restricted stock awards to employees and non-employee consultants that may be subject to vesting. The unvested shares of any restricted stock awards are held in escrow as the stock award vests or until award holder termination, whichever occurs first. In the event of a sale of the Company, the Company has the obligation to repurchase at cost, the portion of unvested stock awards from the award holder. For all unvested stock awards, a liability is established related to the Company&#x2019;s obligation for unvested awards at cost.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income taxes are recorded in accordance with FASB ASC Topic 740, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (ASC 740), which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. Should the actual amounts differ from these estimates, the amount of the Company&#x2019;s valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to the tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income taxes are accounted for using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial carrying&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applicable to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance against deferred tax assets is recorded if, based upon the weight of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Event Considerations&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that require additional disclosure. The Company has evaluated events occurring after the date of its consolidated balance sheet through the date these consolidated financial statements were issued (see Note 21).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued ASU No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting (Topic 280)&#x2014;Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASU 2023-07&#x201d;). The amendments in this update improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses. All disclosure requirements of the update are required for entities with a single reportable segment. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and should be applied on a retrospective basis to all periods presented. The Company adopted this standard as of January 1, 2024. The Company determined that adopting the amendments in ASU 2023-07 had no impact on the Company&#x2019;s reportable segment identified and additional required disclosures have been included.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On December 14, 2023, the FASB issued ASU No. 2023-09,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Income Taxes (Topic 740)&#x2014;Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and incomes taxes paid information. For public companies, the amendments are effective for annual periods beginning after December 15, 2024 and should be applied prospectively. The Company has determined that the effects of adopting the amendments in ASU 2023-09 will only impact its disclosures and not have a material impact on its consolidated financial position and the results of its operations when such amendment is adopted.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_d1efdf49-7c40-4006-8cbe-7d922e497956">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared in conformity with GAAP and have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_b7d664c0-e1b1-4826-906a-8c34ed97b8a3">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying consolidated financial statements include those of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in the consolidated financial statements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_9bf7576c-31f0-489f-9188-b8a44c08920f">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results could materially differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes and management must select an amount that falls within that range of reasonable estimates. Significant estimates and assumptions reflected in these consolidated financial statements include, but are not limited to, the fair value of the common stock and convertible notes prior to the effective date of the Merger, the fair value of CVR liability, and the prepaid and accrued research and development expenses. The Company utilizes certain estimates to record expenses relating to research and development contracts. These contract estimates, which are primarily related to the length of service of each contract and the amount of service provided as of each measurement date, are determined by the Company based on input from internal project management, as well as from service providers. Estimates are periodically reviewed considering changes in circumstances, facts and historical experience. Actual results may differ from the Company&#x2019;s estimates.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_9032364d-e342-4d84-8163-bd9c7395ab71">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker (&#x201c;CODM&#x201d;), or decision-making group, in determining how to allocate resources and in assessing performance. The Company has one reporting segment (see Note 20). The segment consists of the development of clinical and preclinical product candidates for the development of the Company&#x2019;s novel biologics. The Company&#x2019;s chief operating decision maker is the chief executive officer (&#x201c;CEO&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance for the segment based on net loss, which is reported on the income statement. The measure of segment assets is reported on the balance sheet as total consolidated assets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CODM uses cash forecast models in deciding how to invest into the segment. Such cash forecast models are reviewed to assess the entity-wide operating results and performance. Net loss is used to monitor budget versus actual results. Monitoring budget versus actual results is used in assessing the performance of the segment and in establishing management&#x2019;s compensation, along with cash forecast model.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_f0041f05-d1e6-4ecd-a4e9-41581e49c426">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Foreign Currency Translations&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s functional currency is the United States dollar. Foreign currency transaction gains and losses are recorded in the consolidated statement of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_cba4b75a-b557-4fa2-b40e-5b578782ba36">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentrations of Credit Risk and Significant Suppliers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial instruments that potentially expose the Company to credit risk primarily consist of cash, cash equivalents, restricted cash and restricted cash equivalents. The Company maintains its cash, cash equivalents, restricted cash and restricted cash equivalents balances with accredited financial institutions and, consequently, the Company does not believe it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s cash management limits investment to investment-grade securities with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations. The Company maintains its cash in bank deposit accounts that are Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) insured up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. At times, the Company&#x2019;s bank accounts may exceed the federal insurance limit.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is dependent on contract development and manufacturing organizations (&#x201c;CDMOs&#x201d;) to supply products for research and development activities in its programs. In particular, the Company relies and expects to continue to rely on a small number of manufacturers to supply it with its requirements for the active pharmaceutical ingredients, other raw materials and formulated drugs related to these programs. These programs could be adversely affected by a significant interruption in the supply of active pharmaceutical ingredients, other raw materials and formulated drugs. The Company is also dependent on contract research organizations (&#x201c;CROs&#x201d;) which provide services related to the research and development activities in its programs.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_18423f7e-db86-47fb-bd1b-7eb99cb5a96b"
      unitRef="U_USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:OffBalanceSheetCreditExposurePolicyPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_e4c32571-0457-44b9-98d2-101fd9b17fa8">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Off Balance Sheet Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had no off balance sheet risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.&lt;/span&gt;&lt;/p&gt;</us-gaap:OffBalanceSheetCreditExposurePolicyPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_33126e08-b3d2-4b83-b5ec-d7f96ca90ff0">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Comprehensive Income (Loss)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Comprehensive income (loss) includes net loss as well as other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_d0240cbb-8cd0-49fb-9268-4ea5602efc83">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers all highly liquid investments that are readily convertible into cash with maturities of three months or less at the date of purchase to be cash equivalents. Cash equivalents are comprised of money market accounts invested in U.S. Treasury securities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Restricted cash and restricted cash equivalents are comprised of deposits held by financial institutions as collateral for the company&#x2019;s venture debt and used to collateralize letters of credit related to the Company&#x2019;s lease arrangements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company includes the restricted cash and restricted cash equivalents balance together with its cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the consolidated statements of cash flows.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash, cash equivalents, restricted cash and restricted cash equivalents consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77,965&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash, cash equivalents, restricted cash and restricted&lt;br/&gt;&#160;&#160;&#160;cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_e3238ddf-39d6-464d-8aa1-09bd5bb8a22c">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Cash, cash equivalents, restricted cash and restricted cash equivalents consisted of the following (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77,965&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash, cash equivalents, restricted cash and restricted&lt;br/&gt;&#160;&#160;&#160;cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_86beda87-a956-4b59-b5ca-3d1731714a01"
      unitRef="U_USD">77965000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_33caf2c4-f263-46c1-bc5f-22538cd53e33"
      unitRef="U_USD">25617000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_ea228d15-bd35-469f-baf5-e25b92d14857"
      unitRef="U_USD">647000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_e0e8972d-affc-4573-9e3a-8d8c174bdc36"
      unitRef="U_USD">5647000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_22b50a80-ebd8-4d22-8751-88803b6e5a92"
      unitRef="U_USD">78612000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_7a99b4f8-dd13-435b-9b99-9eaea07f4254"
      unitRef="U_USD">31264000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_0e8adb5e-8fb9-4c60-8831-5b9b7e1fafc8">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Short-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Short-term investments represent holdings of available-for-sale marketable securities in accordance with the Company&#x2019;s investment policy and cash management strategy. Short-term investments have maturities of greater than 90 days at the time of purchase and mature within one year from the balance sheet date. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#x2019; equity until realized. Any premium or discount arising at purchase is amortized and/or accreted to interest income and/or expense over the life of the underlying security. Such amortization and accretion, together with interest on securities, are included in interest income in the Company&#x2019;s consolidated statements of operations. The cost of marketable securities sold is determined based on the specific identification method and any realized gains or losses on the sale of investments are reflected as a component of other income.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company&#x2019;s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer&#x2019;s industry, and any significant deterioration in economic conditions.&lt;/span&gt;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_a174e3cd-90ed-4619-8d4d-7eb09fdfde30">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Deferred Transaction Costs&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process equity financings as deferred transaction costs until such financings are consummated. After consummation of an equity financing, these costs are recorded as a reduction of the proceeds from the transaction, either as a reduction of the carrying value of the preferred stock or in stockholders&#x2019; deficit as a reduction of additional paid-in capital generated as a result of the transaction. Should the in-process equity financing be abandoned, the deferred transaction costs would be expensed immediately as a charge to operating expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_8b4f3657-89e0-4417-be26-ea1ef56ab577">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 1 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 2 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Level 3 &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_ce488d96-882c-4035-af80-8e7ad57f209c">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments in Equity Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses the equity method of accounting to account for an investment in an entity that it does not control, but in which it has the ability to exercise significant influence over operating and financial policies. The Company's proportionate share of the net income or loss of the entity is included in consolidated net income (loss). Judgments regarding the level of influence over the equity method investment include consideration of key factors such as the Company's ownership interest, representation on the board of directors or other management body and participation in policy-making decisions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the equity method of accounting, the Company&#x2019;s investment is initially recorded at fair value on the consolidated balance sheets. Upon initial investment, the Company evaluates whether there are basis differences between the carrying value and fair value of the Company&#x2019;s proportionate share of the investee&#x2019;s underlying net assets. Typically, the Company amortizes basis differences identified on a straight-line basis over the underlying assets&#x2019; estimated useful lives when calculating the attributable earnings or losses, excluding the basis differences attributable to in-process research and development that has no alternative future use. If the Company is unable to attribute all of the basis differences to specific assets or liabilities of the investee, the residual excess of the cost of the investment over the proportional fair value of the investee&#x2019;s assets and liabilities is considered to be equity method goodwill and is recognized within the equity investment balance, which is tracked separately within the Company&#x2019;s memo accounts. The Company subsequently records in the statements of operations its share of income or loss of the other entity within other income/expense, which results in an increase or decrease to the carrying value of the investment. If the share of losses exceeds the carrying value of the Company&#x2019;s investment, the Company will suspend recognizing additional losses and will continue to do so unless it commits to providing additional funding; however, if there are intra-entity profits this can cause the investment balance to go negative.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that a decline in value has occurred that is other than temporary. Evidence considered in this evaluation includes, but would not necessarily be limited to, the financial condition and near-term prospects of the investee, recent operating trends and forecasted performance of the investee, market conditions in the geographic area or industry in which the investee operates and the Company&#x2019;s strategic plans for holding the investment in relation to the period of time expected for an anticipated recovery of its carrying value. If the investment is determined to have a decline in value deemed to be other than temporary it is written down to estimated fair value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses the cost method to account for an investment in an entity in which it does not have the ability to exercise significant influence over operating and financial policies. Investments recorded using the cost method will be assessed for any decrease in value that has occurred that is other than temporary and the other than temporary decrease in value shall be recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As and when circumstances and facts change, the Company will evaluate the Company&#x2019;s ability to significantly influence operational and financial policy to establish a basis for converting the investment accounted for using the cost method to the equity method of accounting and vice versa.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company accounted for its investment in Oxford Biomedica (US) LLC (&#x201c;OXB (US) LLC&#x201d;) using the cost method (see Note 6).&lt;/span&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_e6e8bb3a-2f85-416c-8ee4-3831946073b2">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Property and Equipment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the respective assets. Major additions and betterments are capitalized; maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to operations as incurred. Upon retirement or sale,&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:70.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:27.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated Useful Life (Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_4b3c95c9-00db-4ff5-871a-392543c3c948;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of useful life or&lt;br/&gt;term of&lt;br/&gt;associated lease&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <qttb:SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_7e337e4b-f1e8-4bfc-be50-8780ef779ec0">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain or loss is included in loss from operations.&lt;/span&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:70.32%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:1.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;td style="width:27.98%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Estimated Useful Life (Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
          &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="padding-top:0.01in;vertical-align:middle;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_4b3c95c9-00db-4ff5-871a-392543c3c948;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shorter of useful life or&lt;br/&gt;term of&lt;br/&gt;associated lease&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</qttb:SummaryOfEstimatedUsefulLifeOfAssetsTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_36fe52b2-0dba-48bb-aaf0-4023627944b9"
      id="F_71bb4923-c015-49a9-978b-94d2327038f7">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_42dc6c69-0cf8-467e-b208-73239c144b07"
      id="F_70a794c0-153c-4128-9fcf-6e44f92337f6">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_c8ee0693-2174-48d4-893c-58e9b89264b1"
      id="F_9051aa1a-dc3a-4cd2-a8d3-26ebae2192a8">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_0ade1c58-1a24-42d6-90b2-e7fb28440d9e">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company evaluates whether an arrangement is or contains a lease at contract inception. If a contract is or contains a lease, lease classification is determined at lease commencement, which represents the date at which the underlying asset is made available for use by the Company. The Company&#x2019;s lease terms are generally measured at the respective lease&#x2019;s noncancelable term and exclude any optional extension terms as the Company is not reasonably certain to exercise such options. The Company elected the short-term lease exemption and therefore does not recognize lease liabilities and right of use assets for lease arrangements with original lease terms of twelve months or less.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Lease liabilities represent the Company&#x2019;s obligation to make lease payments under a lease arrangement. Lease liabilities are measured as the present value of fixed lease payments, discounted using an incremental borrowing rate, as interest rates implicit in the Company&#x2019;s lease arrangements are generally not readily determinable. The Company elected the practical expedient to not separate lease and non-lease components for its real estate leases and therefore both are considered when determining the lease payments in a lease arrangement. Variable lease costs are expensed as incurred.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The incremental borrowing rate represents the interest rate at which the Company could borrow a fully collateralized amount equal to the lease payments, over a similar term, in a similar economic environment. The Company determines the incremental borrowing rate at lease commencement, generally using a synthetic credit rating based on the Company&#x2019;s financial position and negative cash flows, factoring in adjustments for additional risks based on the Company&#x2019;s economic condition, a survey of comparable companies with similar credit and financial profiles, as well as additional market risks, as may be applicable.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Right-of-use assets represent the Company&#x2019;s right to use an underlying asset over its lease term. Right-of-use assets are initially measured as the associated lease liability, adjusted for prepaid rent and tenant incentives. The Company remeasures right-of-use assets and lease liabilities when a lease is modified, and the modification is not accounted for as a separate contract. A modification is accounted for as a separate contract if the modification grants the Company an additional right of use not included in the original lease agreement and the increase in lease payments is commensurate with the additional right of use. The Company assesses its right-of-use assets for impairment consistent with its policy for impairment of long-lived assets held and used in operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_d2d8658e-601b-4702-bffc-5eb2080a524b">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company continually monitors events and changes in circumstances that could indicate carrying amounts of long-lived assets may be impaired, and assesses their recoverability based upon estimated future undiscounted future cash flows expected to be generated by the long-lived assets. If the estimated aggregate undiscounted cash flows are less than the carrying amount of the long-lived assets, an impairment charge, calculated as the amount by which the carrying amount of the assets exceeds the estimated fair value of the assets, is recorded. The estimated fair value of the long-lived assets is determined based on the estimated discounted cash flows expected to be generated from the long-lived assets.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_5f47bbe5-baa7-4083-8ccb-048b53a8f32d">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt and Warrant Issuance Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying value of the Company&#x2019;s venture debt was recorded net of issuance costs and discount relating to the issuance of warrants. The amounts are amortized over the term of the debt using the effective interest method and recognized as interest expense.&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_dbbfff14-79e0-438a-848e-b27b64e55ec5">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Research and development costs are expensed as incurred. Research and Development expenses are comprised of costs incurred in performing research and development activities, including salaries, stock-based compensation and benefits, costs for clinical research organizations and other outsourced activities; laboratory supplies; technology licenses, software and other information technology support; facilities and depreciation.  Upfront payments and milestone payments made for the licensing of technology are expensed as research and development expenses in the period in which they are incurred. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are recorded as prepaid expenses. The prepaid amounts are expensed as the related goods are delivered or the services are performed.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Company has entered into various research and development related contracts with external parties. The payments under these agreements are recorded as research and development expenses as the underlying services are performed or the goods are received. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes progress of the research activities, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued and prepaid balances at&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;end of any reporting period. Actual results could differ from the Company&#x2019;s estimates. The Company&#x2019;s historical accrual estimates have not been materially different from the actual costs.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <qttb:PatentsCostsPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_a37d2670-3970-4a95-b8d5-6efdccc5201b">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Patent Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company expenses all costs as incurred in connection with patent applications, including direct application fees, and the legal and consulting expenses related to making such applications, and such costs are included in general and administrative expenses within the Company&#x2019;s statement of operations.&lt;/span&gt;&lt;/p&gt;</qttb:PatentsCostsPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_7c19df42-5955-4f69-b333-14ea93fba7ef">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under FASB Accounting Standards Codification (&#x201c;ASC&#x201d; Topic 606, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (ASC 606), an entity recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To determine revenue recognition for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services it transfers to the customer.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Arrangements that include rights to additional goods or services that are exercisable at a customer&#x2019;s discretion are generally considered options. The Company assesses if these options provide a material right to the customer and if so, they are considered performance obligations. The identification of material rights requires judgments related to the determination of the value of the underlying good or service relative to the option exercise price. The exercise of a material right is accounted for as a contract modification for accounting purposes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#x2019;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the license terms, the research, manufacturing and commercialization capabilities of the collaboration partner and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The transaction price is determined and allocated to the identified performance obligations in proportion to their stand-alone selling prices (SSP) on a relative SSP basis. SSP is determined at contract inception and is not updated to reflect changes between contract inception and when the performance obligations are satisfied. Determining the SSP for performance obligations requires significant judgment. In developing the SSP for a performance obligation, the Company considers applicable market conditions and relevant entity-specific factors, including factors that were contemplated in negotiating the agreement with the customer and estimated costs. The Company validates the SSP for performance obligations by evaluating whether changes in the key assumptions used to determine the SSP will have a significant effect on the allocation of arrangement consideration between multiple performance obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The amount of variable consideration included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty related to the variable consideration is resolved. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company&#x2019;s control or the licensee&#x2019;s control, such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For arrangements with licenses of intellectual property that include sales-based royalties, including milestone payments based on the level of sales, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In determining the transaction price, the Company adjusts consideration for the effects of the time value of money if the timing of payments provides the Company with a significant benefit of financing. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time, and if over time recognition is based on the use of an output or input method.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_eb3bd713-2846-4118-8056-8b4f286ef38f">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for stock-based awards in accordance with FASB ASC Topic 718, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Compensation &#x2013; Stock Compensation &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(ASC 718). ASC 718 requires all stock-based awards issued to employees and members of the Company&#x2019;s board of directors for their services to be recognized as expense in the statements of operations based on their grant date fair values. For stock options and time-based restricted stock awards, the Company expenses the fair value of the awards on a straight-line basis over each award&#x2019;s service period, which is generally the period in which the related services are received. For performance-based stock awards, the Company uses the accelerated attribution method to expense the awards over the implicit service period based on the probability of achieving the performance conditions. The Company accounts for stock-based awards to non-employees consistently with the accounting for awards to employees and measures stock-based awards granted to non-employees based on their grant date fair value and recognizes the resulting value as stock-based compensation expense during the period the related services are rendered. The Company has not issued any stock-based awards with market-based vesting conditions.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The fair value of options on the date of grant is calculated using the Black-Scholes option pricing model based on key assumptions such as stock price, expected volatility and expected term. The Company&#x2019;s estimates of these assumptions are primarily based on the trading price of the Company&#x2019;s stock, historical data, peer company data and judgment regarding future trends and factors. The Company accounts for forfeitures as they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s equity incentive plan allows for the issuance of restricted stock awards to employees and non-employee consultants that may be subject to vesting. The unvested shares of any restricted stock awards are held in escrow as the stock award vests or until award holder termination, whichever occurs first. In the event of a sale of the Company, the Company has the obligation to repurchase at cost, the portion of unvested stock awards from the award holder. For all unvested stock awards, a liability is established related to the Company&#x2019;s obligation for unvested awards at cost.&lt;/span&gt;&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_f75db224-cf29-4174-8b73-77338400e838">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income taxes are recorded in accordance with FASB ASC Topic 740, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (ASC 740), which provides for deferred taxes using an asset and liability approach. The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are determined based on the difference between the consolidated financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. Should the actual amounts differ from these estimates, the amount of the Company&#x2019;s valuation allowance could be materially impacted. Changes in these estimates may result in significant increases or decreases to the tax provision in a period in which such estimates are changed, which in turn would affect net income or loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income taxes are accounted for using the asset and liability method. Under the asset and liability method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial carrying&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applicable to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. A valuation allowance against deferred tax assets is recorded if, based upon the weight of all available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for uncertainty in income taxes recognized in the consolidated financial statements by applying a two-step process to determine the amount of tax benefit to be recognized. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits, that are considered appropriate as well as the related net interest and penalties.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:IncomeTaxExaminationDescription
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_60049988-ff82-46d6-b001-993ef846baf5">First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing authorities. If the tax position is deemed more-likely-than-not to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the consolidated financial statements. The amount of the benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement.</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:SubsequentEventsPolicyPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_3b676183-fe40-4fb2-b42b-4c71aabe582e">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Subsequent Event Considerations&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that require additional disclosure. The Company has evaluated events occurring after the date of its consolidated balance sheet through the date these consolidated financial statements were issued (see Note 21).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_07a74bbe-c031-47f5-b769-e16de8930ede">&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2023, the FASB issued ASU No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segment Reporting (Topic 280)&#x2014;Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASU 2023-07&#x201d;). The amendments in this update improve reportable segment disclosure requirements through enhanced disclosures about significant segment expenses. All disclosure requirements of the update are required for entities with a single reportable segment. The amendments are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and should be applied on a retrospective basis to all periods presented. The Company adopted this standard as of January 1, 2024. The Company determined that adopting the amendments in ASU 2023-07 had no impact on the Company&#x2019;s reportable segment identified and additional required disclosures have been included.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Recently Issued Accounting Standards Not Yet Adopted&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On December 14, 2023, the FASB issued ASU No. 2023-09,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; Income Taxes (Topic 740)&#x2014;Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 provides more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and incomes taxes paid information. For public companies, the amendments are effective for annual periods beginning after December 15, 2024 and should be applied prospectively. The Company has determined that the effects of adopting the amendments in ASU 2023-09 will only impact its disclosures and not have a material impact on its consolidated financial position and the results of its operations when such amendment is adopted.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_cb2a1b5c-b2cb-4e62-ab8c-67896668433e">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;3. Accounting for the Merger&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As described in Note 1, Merger Sub merged with and into Legacy Q32, with Legacy Q32 surviving as a wholly-owned subsidiary of the Company on March 25, 2024. The Merger was accounted for as a reverse recapitalization in accordance with GAAP with Legacy Q32 as the accounting acquirer of Homology. Legacy Q32 was determined to be the accounting acquirer based on the terms of the Merger Agreement and other factors, including: (i) Legacy Q32&#x2019;s shareholders own a majority of the voting rights in the combined company; (ii) Legacy Q32 designated a majority (seven of nine) of the initial members of the board of directors of the combined company; (iii) Legacy Q32's executive management team became the management team of the combined company; (iv) the pre-combination assets of Homology were primarily cash and cash equivalents, short-term investments, and other non-operating assets; and (v) the combined company was named Q32 Bio Inc. and is headquartered in Legacy Q32&#x2019;s office in Waltham, Massachusetts.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At the effective time of the Merger, substantially all of the assets of Homology consisted of cash and cash equivalents, short-term investments, as well as other non-operating assets. Under such reverse recapitalization accounting, the assets and liabilities of Homology were recorded at their fair value in the Company&#x2019;s financial statements at the effective time of the Merger, which approximated book value due to the short-term nature, except for the equity method investment as described below. Homology&#x2019;s development programs had ceased prior to the Merger and were deemed to be de minimis in value at the transaction date. No goodwill or intangible assets were recognized.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Consequently, the consolidated financial statements of the Company reflect the operations of Legacy Q32 for accounting purposes together with a deemed issuance of shares, equivalent to the shares held by the former stockholders Homology, the legal acquirer, and a recapitalization of the equity of Legacy Q32, the accounting acquirer.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of the recapitalization, the Company obtained the assets and liabilities listed below:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.823%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;964&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity method investment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,903&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CVR liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, the Company recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in personnel cost related to severance payments and retention bonuses to Homology employees and this amount was recorded in general and administrative expense in the accompanying consolidated statement of operations for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company also incurred transaction costs of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and this amount is recorded in additional paid-in capital in the accompanying consolidated statements of convertible preferred stock and stockholders&#x2019; equity (deficit) for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;With respect to the CVRs issued in connection with the Merger, each CVR represents the contractual right to receive payments from the Company upon the actual receipt by the Company or its subsidiaries of certain contingent proceeds derived from any cash consideration that is paid to the Company or its subsidiaries as a result of the sale, transfer, license, assignment or other divestiture, disposition or commercialization of any of the Company&#x2019;s assets, rights and interests relating to the following pre-merger assets of Homology: HMI-103, HMI-204, capsids and human hematopoietic stem cell-derived adeno-associated virus vector (&#x201c;AAVHSC&#x201d;) platform, including any equity interests held directly or indirectly by the Company in OXB (US) LLC.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company believes that the achievement of the milestones outlined in the CVR agreement related to Homology&#x2019;s HMI-103, HMI-204, capsids and AAVHSC platform are highly susceptible to factors outside the Company's influence that are not expected to be resolved for a long period of time, if at all. In particular, these amounts are primarily influenced by the actions and judgments of third parties and the licensors of such assets and are based on the licensors of such assets progressing the in-process research and development assets, and in the case of one of the draft agreements, to certain milestones. As of March 25, 2024, the date of the Merger, the Company recorded a CVR liability of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million on the balance sheet relating to such contingent payments.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the portion of the CVR agreement that is related to Homology's equity interest in OXB (US) LLC, the Company recorded a CVR liability of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million representing its estimated fair value as of the date of the Merger. Pursuant to the Amended and Restated Limited Liability Company Agreement of OXB (US) LLC, at any time following the three-year anniversary of the closing of the transaction between OXB (US) LLC, Oxford Biomedica (US), Inc. and the Company (formerly known as Homology Medicines, Inc.) on March 10, 2022, (i) Oxford Biomedica (US), Inc. will have an option to cause the Company to sell and transfer to Oxford Biomedica (US), Inc., and (ii) the Company will have an option to cause Oxford Biomedica (US), Inc. to purchase from the Company, in each case, all of the Company&#x2019;s equity ownership interest in OXB (US) LLC based on the Company's pro rata share of OXB (US) LLC (10%) times a predetermined multiple of revenue for the immediately preceding 12-month period increased by OXB (US) LLC's cash balance and decreased by OXB (US) LLC's debt balance as of the exercise date (together, the &#x201c;Options&#x201d;), subject to a maximum amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;74.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company utilized a monte carlo simulation model, also known as a probability simulation, to estimate the fair value of the CVR liability. For each simulated path of future revenue, a market approach using the predetermined revenue multiple was employed to determine the future value of the equity interest, which was then discounted to present value using OXB (US) LLC's estimated cost of debt.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to a change in control provision in the Amended and Restated Limited Liability Company Agreement of OXB (US) LLC, on March 1, 2025, Oxford Biomedica (US), Inc. caused the Company to sell and transfer to Oxford Biomedica (US), Inc., all of the Company's equity interest in OXB (US) LLC. See Note 21.&lt;/span&gt;&lt;/p&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <qttb:ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_b0486b63-8a4c-4629-9f1b-5ca5b497c84e">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of the recapitalization, the Company obtained the assets and liabilities listed below:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.823%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Short-term investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;964&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Equity method investment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,903&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CVR liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;65,944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</qttb:ScheduleOfRecapitalizationOfAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3"
      decimals="0"
      id="F_65d55440-afa7-4cf6-a479-1bb0ac671314"
      unitRef="U_USD">53158</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3"
      decimals="0"
      id="F_dfa26754-6e01-482c-9c7e-7a6bd1dc3bc5"
      unitRef="U_USD">19905</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent
      contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3"
      decimals="0"
      id="F_c7a92f85-a4fe-4be6-8a5f-86cafa72e4ad"
      unitRef="U_USD">964</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3"
      decimals="0"
      id="F_1309cea5-b8bc-4016-82d6-01e90a85ed13"
      unitRef="U_USD">4900</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
      contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3"
      decimals="0"
      id="F_917ab1d4-658a-46f4-964a-9dde21466852"
      unitRef="U_USD">7903</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AssetAcquisitionContingentConsiderationLiability
      contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3"
      decimals="0"
      id="F_39b91968-c7bd-486a-b6bd-64bbbf2dd209"
      unitRef="U_USD">5080</us-gaap:AssetAcquisitionContingentConsiderationLiability>
    <us-gaap:Assets
      contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3"
      decimals="0"
      id="F_ae4188e2-e4d2-430d-9277-88a4881d6627"
      unitRef="U_USD">65944</us-gaap:Assets>
    <us-gaap:SeveranceCosts1
      contextRef="C_c8e96e70-b220-40a4-8caa-3388400e3cae"
      decimals="-5"
      id="F_7623376b-70ef-43e3-a7ee-5db826d97e8f"
      unitRef="U_USD">2100000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-5"
      id="F_eff845b8-f466-4f72-a169-0901fd1b4295"
      unitRef="U_USD">10000000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:AssetAcquisitionContingentConsiderationLiability
      contextRef="C_302992f5-5a2f-4079-b1ae-a9f51ed191d0"
      decimals="-5"
      id="F_f9600afa-9cd8-4ae2-b992-ee05c47b07ed"
      unitRef="U_USD">200000</us-gaap:AssetAcquisitionContingentConsiderationLiability>
    <us-gaap:AssetAcquisitionContingentConsiderationLiability
      contextRef="C_6f68a357-a32f-44ae-979a-875bc449d3b4"
      decimals="-5"
      id="F_99d227fc-2a92-4fab-b41b-73b51be19221"
      unitRef="U_USD">4900000</us-gaap:AssetAcquisitionContingentConsiderationLiability>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="C_cc753916-5b65-451d-90ed-193a32758aa9"
      decimals="-5"
      id="F_21662f61-d6be-46d8-87e5-8b10f8b94ba2"
      unitRef="U_USD">74100000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_5e3804eb-8eb6-4a6a-bb6d-2fa2d5034037">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;4. Short-Term Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company may invest its excess cash in fixed income instruments denominated and payable in U.S. dollars, including U.S. treasury securities, commercial paper, corporate debt securities and asset-backed securities in accordance with the Company&#x2019;s investment policy that primarily seeks to maintain adequate liquidity and preserve capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t have any short-term investments as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashCashEquivalentsAndShortTermInvestmentsTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_6d7c0db8-f1b1-4d72-8920-33434374d2c0"
      unitRef="U_USD">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="0"
      id="F_488bcfac-1933-4db5-a3bc-44d921fab76c"
      unitRef="U_USD">0</us-gaap:ShortTermInvestments>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_d275b148-4b84-4edf-9d0d-7e81d0060c08">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;5. Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying values of the Company&#x2019;s prepaid expenses and other current assets, accounts payable, and accrued expenses and other current liabilities approximate their fair value due to their short-term nature. The carrying value of the Company&#x2019;s term loan as of December 31, 2024 (see Note 11) approximated fair value based on interest rates currently available to the Company.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The tables below present information about the Company&#x2019;s assets and liabilities that are regularly measured and carried at fair value on a recurring basis at December 31, 2024 and December 31, 2023 and indicate the level within the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value, which is described further within Note 2, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 are summarized as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Description&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance as&lt;br/&gt;of December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CVR liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 are summarized as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.239%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.325000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Description&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance as&lt;br/&gt;of December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total restricted cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Money market funds were valued by the Company using quoted prices in active markets for identical securities, which represent a Level 1 measurement within the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed in Notes 1 and 3, at the effective time of the Merger, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#x2019;s common stock received a CVR, issued by Homology subject to and in accordance with the terms and conditions of a CVR Agreement, representing the contractual right to receive cash payments from the combined company upon the receipt of certain proceeds from a disposition of Homology&#x2019;s pre-merger assets, calculated in accordance with the CVR Agreement. The Company concluded that the CVR liability is a derivative liability and is accounted for at fair value. The fair value of the CVR liability is based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. For the portion of the CVR liability that is related to Homology's equity interest in OXB (US) LLC, the Company utilized a monte carlo simulation model, also known as a probability simulation, to estimate the fair value of the CVR liability. This model requires the use of estimates and assumptions including estimated future revenues and discount rates. For the portion of the CVR liability related to Homology's HMI-103, HMI-204, capsids and AAVHSC platform, the Company's fair value assessment includes judgments around the probability of progressing the in-process research and development assets, and in the case of one of the draft agreements, to certain milestones.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The CVR liability had an estimated fair value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company recorded in other income (expense), net, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the change in estimated fair value during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the years ended December 31, 2024 and 2023, there were no transfers between Level 1, Level 2 and Level 3 measurements. There have been no impairments of the Company&#x2019;s assets measured and carried at fair value during the years ended December 31, 2024 and 2023.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Legacy Q32 issued convertible notes (the &#x201c;Convertible Notes&#x201d;) totaling $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during the year ended December 31, 2022. Legacy Q32 concluded that the Convertible Notes and its related features are within the scope of FASB ASC Topic 825, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Financial Instruments &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(ASC 825), as a combined financial instrument, and Legacy Q32 elected the fair value option where changes in fair value of the Convertible Notes are measured through the accompanying consolidated statement of operations until settlement. The Convertible Notes liability represents a Level 3 measurement within the fair value hierarchy as it has been valued using certain unobservable inputs. These inputs include the underlying fair value of the equity instrument into which the Convertible Notes are convertible.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The fair value is based on significant inputs not observable in the market, namely potential financing scenarios, the likelihood of such scenarios, the expected time for each scenario to occur, and the required market rates of return utilized in modeling these scenarios. &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.477%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.775%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.775%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.775%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Scenario 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Scenario 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Scenario 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Probability of each scenario&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected Term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Required market rates of return&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Convertible Notes had an estimated fair value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as of December 31, 2023. The Company recorded in other income (expense), net, an interest expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and a charge of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million on the change in estimated fair value during the year ended December 31, 2023. There was no change in fair value attributable to the instrument-specific credit risk for the year ended December 31, 2023.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon closing of the Merger, Legacy Q32 converted the outstanding Convertible Notes plus accrued interest into shares of common stock at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the purchase price of the mandatory conversion event. As the Convertible Notes are recorded at fair value, a gain of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million on the change in the fair value prior to the conversion of convertible notes is reflected in the consolidated statement of operations for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (see Note 11).&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_03b26b55-90c5-457e-bdde-4108a56a7c14">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 are summarized as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Description&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance as&lt;br/&gt;of December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;76,089&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CVR liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2023 are summarized as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.239%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:11.325000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Description&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Balance as&lt;br/&gt;of December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Quoted&lt;br/&gt;Prices in&lt;br/&gt;Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total restricted cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:30pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:30pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total financial liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_9f64b245-b6aa-4495-a613-76961dbfa794"
      decimals="-3"
      id="F_7632692c-7a7e-44bd-b4ba-e5a404abb34a"
      unitRef="U_USD">76089000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_49e1f5d1-7824-4873-b567-c71038b76681"
      decimals="-3"
      id="F_96ec3701-775c-4597-8907-154919d036b6"
      unitRef="U_USD">76089000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_7bb2bb04-b139-49f5-801e-31f1d770bc43"
      decimals="-3"
      id="F_d81b5746-8e9d-4cd8-8400-3b74275b6a4a"
      unitRef="U_USD">76089000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_c11e5447-4a20-4d83-b060-fbc22d8f5724"
      decimals="-3"
      id="F_9f72e230-d2ee-4f79-82b0-26cd37d3459e"
      unitRef="U_USD">76089000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_7bb2bb04-b139-49f5-801e-31f1d770bc43"
      decimals="-3"
      id="F_15ce5466-3605-4e36-83e7-26e0e48917d2"
      unitRef="U_USD">76089000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c11e5447-4a20-4d83-b060-fbc22d8f5724"
      decimals="-3"
      id="F_eb08b5e2-c48d-4abc-b201-5a03d9fbb32b"
      unitRef="U_USD">76089000</us-gaap:AssetsFairValueDisclosure>
    <qttb:CvrLiability
      contextRef="C_7bb2bb04-b139-49f5-801e-31f1d770bc43"
      decimals="-3"
      id="F_0097f7c4-3d3a-4a0c-973b-8f77e9d5631d"
      unitRef="U_USD">2900000</qttb:CvrLiability>
    <qttb:CvrLiability
      contextRef="C_20e3aba0-5377-41a2-bf8e-222ee59cf7b2"
      decimals="-3"
      id="F_8191bb9b-f0db-4174-bd7e-e0d59d7a5fba"
      unitRef="U_USD">2900000</qttb:CvrLiability>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_7bb2bb04-b139-49f5-801e-31f1d770bc43"
      decimals="-3"
      id="F_4372fd97-5b67-4df7-8096-cbc4d6e91c0a"
      unitRef="U_USD">2900000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_20e3aba0-5377-41a2-bf8e-222ee59cf7b2"
      decimals="-3"
      id="F_d5f68714-7732-4278-8228-f4e96f812590"
      unitRef="U_USD">2900000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_02ecb717-f14e-405e-8487-adc80c2116b1"
      decimals="-3"
      id="F_293c6c6d-baa9-40d2-8c90-c5fa0faa861e"
      unitRef="U_USD">24100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_21aa18f8-fcb9-4858-ab9d-ae3b4a5f7444"
      decimals="-3"
      id="F_5643a5ec-60a9-48bd-bce4-816426a1e8b8"
      unitRef="U_USD">24100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a"
      decimals="-3"
      id="F_52661613-0652-419f-aa9f-7092abe88bf8"
      unitRef="U_USD">24100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_c58e837a-179e-40c1-aa34-7a9794f2d652"
      decimals="-3"
      id="F_edac79c2-6fbd-427c-8060-87c9341149c5"
      unitRef="U_USD">24100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_02ecb717-f14e-405e-8487-adc80c2116b1"
      decimals="-3"
      id="F_a39f4f21-1c01-45e0-9fd4-c6e932a3a117"
      unitRef="U_USD">5000000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_21aa18f8-fcb9-4858-ab9d-ae3b4a5f7444"
      decimals="-3"
      id="F_a6c82b59-9bfe-4959-ad8c-dbd1c14c7d90"
      unitRef="U_USD">5000000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a"
      decimals="-3"
      id="F_9df7fff5-d512-41c2-954a-9d41833d1581"
      unitRef="U_USD">5000000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="C_c58e837a-179e-40c1-aa34-7a9794f2d652"
      decimals="-3"
      id="F_212f9f1b-dd9a-44ac-8d99-1af9d5f8fa8b"
      unitRef="U_USD">5000000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a"
      decimals="-3"
      id="F_f908a4e2-fefb-42c3-9087-01ed1aa783d0"
      unitRef="U_USD">29100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c58e837a-179e-40c1-aa34-7a9794f2d652"
      decimals="-3"
      id="F_5e87ed88-7929-4393-8360-695c6a7ec457"
      unitRef="U_USD">29100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a"
      decimals="-3"
      id="F_fdf2fbcd-4c6a-413c-87a7-99f42eda8194"
      unitRef="U_USD">38595000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="C_c3c34d76-204f-422a-8542-9570869264f0"
      decimals="-3"
      id="F_c3523a82-acb1-4818-bfab-ecdcef155559"
      unitRef="U_USD">38595000</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_f551957e-5cf9-4f21-a471-2e0b0437ea6a"
      decimals="-3"
      id="F_1fd80313-d16d-4e33-9bae-cb818faf67e6"
      unitRef="U_USD">38595000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_c3c34d76-204f-422a-8542-9570869264f0"
      decimals="-3"
      id="F_381bac0d-d87d-463d-bed8-bd9a7a47adab"
      unitRef="U_USD">38595000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <qttb:CvrLiability
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-5"
      id="F_496c69ba-dac3-4e42-8a21-6dd0fc0da69d"
      unitRef="U_USD">2900000</qttb:CvrLiability>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-5"
      id="F_58e47530-88a4-4d0f-bea7-7227b0b099ff"
      unitRef="U_USD">1500000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_d63b5539-4625-4fac-978b-86e1f8037d8e"
      decimals="-5"
      id="F_cfaa0187-bd9f-43a0-bccd-ae307dba921b"
      unitRef="U_USD">30000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_e032fdcd-84a1-4816-90ab-e8ec635ab41a">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The fair value is based on significant inputs not observable in the market, namely potential financing scenarios, the likelihood of such scenarios, the expected time for each scenario to occur, and the required market rates of return utilized in modeling these scenarios. &lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.477%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.775%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.775%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.399%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.775%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Scenario 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Scenario 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Scenario 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Probability of each scenario&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected Term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.25&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Required market rates of return&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_2aef5253-5673-488f-b176-618a6a1a9ffa"
      decimals="0"
      id="F_1923deae-57bd-4eb1-b057-328cbf485568"
      unitRef="U_pure">80</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_c73c0232-3eb2-4afd-9b9d-d70bdfd8a5f8"
      decimals="0"
      id="F_73c8aa3e-c80c-4a64-9920-35d084910432"
      unitRef="U_pure">15</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_37c8672c-5d7c-4a2e-802c-2bb52b924851"
      decimals="0"
      id="F_7180c8e8-c950-463c-ad9c-c0a6afc950b9"
      unitRef="U_pure">5</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_1080c6e9-b757-4406-9324-738d36ed0c95"
      decimals="2"
      id="F_b08b6e18-6159-4999-bf6b-8b1438d80afa"
      unitRef="U_pure">0.25</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_79b9f15f-c77c-4650-8ec5-e400e55b0820"
      decimals="2"
      id="F_73c4478b-41ee-45e6-af76-937c06c80d2d"
      unitRef="U_pure">0.25</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_db8118be-101e-441a-a13b-f4b57e3c5a64"
      decimals="2"
      id="F_df2497ef-6718-462a-8b2c-cbc4fa26b328"
      unitRef="U_pure">0.42</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_81e3e422-e365-4f92-a2df-f3bed9e3c0f4"
      decimals="1"
      id="F_73d407d0-b3f5-4f73-8cc8-5d0ecbeb9dd4"
      unitRef="U_pure">15</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_6e7474c2-50c6-4141-93a0-c56ced950809"
      decimals="1"
      id="F_a88d3359-0e49-49e2-8869-99aa4df6d9d1"
      unitRef="U_pure">15</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_1ae14b8d-dea6-450a-bd61-6382bf1f8395"
      decimals="1"
      id="F_38ab1c0e-d682-4be4-b61f-6447be3cfb13"
      unitRef="U_pure">15</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-5"
      id="F_a7b18ff3-ade4-4753-ab05-85c749363a06"
      unitRef="U_USD">38600000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:InterestExpenseDebt
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-5"
      id="F_5aa83c68-7a2a-4730-aca7-c96bb79e883e"
      unitRef="U_USD">1500000</us-gaap:InterestExpenseDebt>
    <qttb:FairValueOfInterestExpenses
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-5"
      id="F_f70227f2-9c21-47ce-aaaa-2aedce285a58"
      unitRef="U_USD">4700000</qttb:FairValueOfInterestExpenses>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="C_b56ad3a0-64a3-4549-bf92-0952e7e3df5b"
      decimals="2"
      id="F_d84b9910-6c2a-4bf6-9b02-07266a146991"
      unitRef="U_pure">0.90</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <qttb:GainOnConvertibleNotes
      contextRef="C_b56ad3a0-64a3-4549-bf92-0952e7e3df5b"
      decimals="-5"
      id="F_29567c23-350d-410a-afd0-f2a85499a4bb"
      unitRef="U_USD">15900000</qttb:GainOnConvertibleNotes>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_927ac097-5761-41e8-be1f-498db2d644f1">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;6. Investment in Equity Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As part of the Merger, the Company obtained Homology's &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity interest in OXB (US) LLC, an AAV vector process development and manufacturing services company. At that time, the Company had significant influence over, but did not control, OXB (US) LLC through its noncontrolling representation on OXB (US) LLC&#x2019;s board of directors and the Company&#x2019;s equity interest in OXB (US) LLC. Accordingly, the Company did not consolidate the financial statements of OXB (US) LLC and accounted for its investment using the equity method of accounting.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recorded its equity method investment in OXB (US) LLC at fair value upon the effective date of the Merger. The fair value of the equity method investment was determined based on the market approach. This approach estimated the fair value of OXB (US) LLC based on the implied value for the entity, including the Options (as defined in Note 3 above), for a controlling interest in OXB (US) LLC at the entity&#x2019;s formation. As part of its fair value analysis, the Company determined that the Options are embedded in the Company&#x2019;s ownership units of OXB (US) LLC because the Options are not legally detachable or separately exercisable. Accordingly, the equity method investment and the Options represent one unit of account and the fair value recorded reflects the value of the equity interest and the Options (refer to Note 3 for more information for how the fair value was determined).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a result of transactions by OXB (US) LLC, the Company&#x2019;s investment was diluted to a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity interest in OXB (US) LLC on May 22, 2024, and the Company no longer has the ability to exert significant influence over the operating and financial policies of OXB (US) LLC. The Company discontinued the equity method of accounting for the investment in OXB (US) LLC on May 22, 2024 and determined the remaining investment to be an equity security accounted for in accordance with FASB ASC Topic 321, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments&#x2014;Equity Securities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (ASC 321) at the date the investment no longer qualifies for the equity method of accounting. The Company recorded the equity instrument at fair value and applied the measurement alternative under ASC 321 such that the Company would not change the amount recorded for the equity instrument unless the Company identified observable price changes in orderly transactions for the identical or similar investment of the same issuer or the equity instrument was otherwise deemed to be impaired.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At each reporting period, the Company is required to make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. If deemed impaired, the Company is required to estimate the fair value of the investment and recognize an impairment loss equal to the difference between the fair value of the investment and its carry amount. As of September 30, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company performed an assessment to evaluate whether the investment was impaired and determined that the fair value of its investment in OXB (US) LLC was negatively impacted due to a change in OXB (US) LLC's forecasted performance. The Company utilized a monte carlo simulation model, also known as a probability simulation, to estimate the fair value of its investment. This model requires the use of estimates and assumptions including estimated future revenues and discount rates which are significant unobservable inputs representing Level 3 measurements within the fair value hierarchy. The Company determined that the decline in value was deemed to be other than temporary and recorded an impairment charge of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to reduce its investment to fair value. The impairment charge is included in other income (expense), net in the Company's consolidated statements of operations. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the carrying value of the equity investment was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;the Company determined that the investment was not impaired.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prior to May 22, 2024, the Company was recording its share of income or losses from OXB (US) LLC on a quarterly basis under the equity method of accounting.&lt;/span&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_7f47faa6-d3bb-45d0-9ae1-b46cda818a27"
      decimals="2"
      id="F_2e3597cf-fd13-40b5-86d9-2977f5ba15e5"
      unitRef="U_pure">0.20</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_0708f559-d98c-480b-8223-bba4a0a87863"
      decimals="2"
      id="F_52789693-4dce-4549-99ae-8681791af984"
      unitRef="U_pure">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="C_e0d1d750-c63b-49fa-8efe-0c104dbe276f"
      decimals="-5"
      id="F_9ac07c5a-7459-4080-8526-a04d208810cb"
      unitRef="U_USD">700000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestments
      contextRef="C_5f1339d1-c9c7-4c62-85fe-43ee887e097f"
      decimals="-5"
      id="F_cd0c266d-8d84-4e71-8cf1-99fed3bfce29"
      unitRef="U_USD">2600000</us-gaap:EquityMethodInvestments>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_65a78882-856e-4db2-953a-292f7cc8f49d">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7. Property and Equipment, Net&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;P&lt;/span&gt;&lt;span style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;roperty and equipment, net consisted of the following as of (in thousands): &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,382&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,382&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;341&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,748&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;966&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,370&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Depreciation expense for the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in each period&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impairment losses occurred in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; losses on disposal of fixed assets in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_52a91fbb-fa1c-4ec0-906f-e1cd128c9a06">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;roperty and equipment, net consisted of the following as of (in thousands): &lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,382&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,382&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Furniture and fixtures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;341&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total property and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,823&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,748&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,453&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;966&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,370&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_36fe52b2-0dba-48bb-aaf0-4023627944b9"
      decimals="-3"
      id="F_a2fbd784-d31d-41a4-8ce6-83a0188f0fae"
      unitRef="U_USD">1382000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_6b897fb9-c5ec-48c3-9610-95cfe8b4cd07"
      decimals="-3"
      id="F_aba230cb-05cb-423d-8d66-507b017e11f9"
      unitRef="U_USD">1382000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_42dc6c69-0cf8-467e-b208-73239c144b07"
      decimals="-3"
      id="F_79345f46-5a5f-43c1-8fc9-1c987b3aa7d2"
      unitRef="U_USD">351000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_538446b8-7409-4894-a71d-dabb73e1ef55"
      decimals="-3"
      id="F_69376da2-8e43-4f84-9a27-e85a060d6fd6"
      unitRef="U_USD">341000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_c8ee0693-2174-48d4-893c-58e9b89264b1"
      decimals="-3"
      id="F_f15a6d95-5763-4372-93be-446dadef57e4"
      unitRef="U_USD">89000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_bb6c3e3c-07de-46ab-8b95-1ab3fb082d09"
      decimals="-3"
      id="F_fd289575-34a4-4b12-aa82-44a5993d62a9"
      unitRef="U_USD">85000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_5062bd0a-61c4-478f-887d-27fbcabc427e"
      decimals="-3"
      id="F_ce64b9cc-16c4-414d-bc50-30c362476ff7"
      unitRef="U_USD">1001000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_4de6188d-bc41-4c0b-986d-59e12a08b2a6"
      decimals="-3"
      id="F_f4176b06-02e8-4fdd-a7a9-c568cbd146d4"
      unitRef="U_USD">940000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_1ec0ae50-8da5-43a7-bc79-48697fd1b222"
      unitRef="U_USD">2823000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_28e50ad3-358e-45a7-b712-ce34e7eacf80"
      unitRef="U_USD">2748000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_0827d83a-df92-4f10-8320-f28240305688"
      unitRef="U_USD">1453000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_d4a1a690-61e1-47f3-81a2-5cd031e55fe0"
      unitRef="U_USD">966000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_6e3500ab-7a91-473d-b500-bb3959ba5dec"
      unitRef="U_USD">1370000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_01ebbef4-b911-4fe1-bc75-bd7609de804b"
      unitRef="U_USD">1782000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-5"
      id="F_a1d6974d-cd8e-4b08-b313-eff84dc984af"
      unitRef="U_USD">500000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-5"
      id="F_6a760059-6eb0-4edd-84a9-bbe6ef9198ac"
      unitRef="U_USD">500000</us-gaap:Depreciation>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_3e730355-2c18-41f9-bb7e-c0f5b7e90330"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="0"
      id="F_88e9e379-f809-4d65-8842-028f4380ba7e"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_5e8a5418-a8c3-4ab6-8230-988bf28693e6"
      unitRef="U_USD">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="0"
      id="F_3c126560-f73d-4e04-802c-4d653b1fea46"
      unitRef="U_USD">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_6f31be50-27af-4445-8108-7d3e8e37e574">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;8. Prepaid Expenses, Other Current Assets and Other Noncurrent Assets&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following as of (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid external research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,834&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payroll tax credit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;755&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;885&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;396&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other noncurrent assets consisted of the following as of (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred transaction costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid external research and development - long term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;676&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total other noncurrent assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</qttb:DisclousreOfPrepaidExpensesOtherCurrentAssetsAndOtherNoncurrentAssetsTextBlock>
    <qttb:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_bdc86635-5cb0-439e-833b-e800f85aa99f">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets consisted of the following as of (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid external research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,834&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payroll tax credit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;555&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;755&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;885&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;427&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;396&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</qttb:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <qttb:PrepaidExternalResearchAndDevelopmentCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_0426f3ac-59a9-470c-9b23-91e7f3607d10"
      unitRef="U_USD">2076000</qttb:PrepaidExternalResearchAndDevelopmentCurrent>
    <qttb:PrepaidExternalResearchAndDevelopmentCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_6ac1b66c-b13b-4cb2-8eb1-d2bc298bb56d"
      unitRef="U_USD">1834000</qttb:PrepaidExternalResearchAndDevelopmentCurrent>
    <qttb:PayrollTaxCredit
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_20138887-11e5-4322-8995-1dfe8b0c6b4d"
      unitRef="U_USD">555000</qttb:PayrollTaxCredit>
    <qttb:PayrollTaxCredit
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_64a9f385-3219-4d40-8d33-fd25ed1c999f"
      unitRef="U_USD">755000</qttb:PayrollTaxCredit>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_92fe767b-f7f9-42ec-8d30-55595094b067"
      unitRef="U_USD">885000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_4e738e11-fdb3-419c-b469-e7ded90ccad8"
      unitRef="U_USD">427000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_50574ac5-eac3-486f-bf5b-349f6cce3b40"
      unitRef="U_USD">396000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_77c24549-54fe-49a0-ba63-8f1a6493da71"
      unitRef="U_USD">83000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_1b9993ef-f4e9-4b65-9760-761802e5320f"
      unitRef="U_USD">3912000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_94cf4f15-8ed4-453f-999f-dc28988a295a"
      unitRef="U_USD">3099000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <qttb:SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_71b1c3c4-ea91-42e6-9295-4cb910212c23">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other noncurrent assets consisted of the following as of (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred transaction costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,912&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid external research and development - long term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;676&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total other noncurrent assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</qttb:SummaryOfPrepaidExpensesAndOtherNoncurrentAssetsTableTextBlock>
    <us-gaap:DeferredCosts
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_86850839-162e-4552-a056-8fcfb025e1c0"
      unitRef="U_USD">0</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_c901472c-eb94-45b2-b983-77982664c6d8"
      unitRef="U_USD">3912000</us-gaap:DeferredCosts>
    <qttb:PrepaidExternalResearchAndDevelopmentNonurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_f9d15fe7-6ceb-407a-be49-eb35434cf199"
      unitRef="U_USD">116000</qttb:PrepaidExternalResearchAndDevelopmentNonurrent>
    <qttb:PrepaidExternalResearchAndDevelopmentNonurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_2d7b3a26-3b95-493e-8808-b62c5707d2ce"
      unitRef="U_USD">676000</qttb:PrepaidExternalResearchAndDevelopmentNonurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_d63fbcfe-d57f-48ca-a27d-d13aa56afdb2"
      unitRef="U_USD">0</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_e5b181c7-e3bd-44f6-bc75-2369c72887b4"
      unitRef="U_USD">23000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_e97acd62-397a-46ac-91c0-ff33beddcb01"
      unitRef="U_USD">116000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_5787c12b-bea9-4ac5-8a01-e33b911dbbfd"
      unitRef="U_USD">4611000</us-gaap:OtherAssetsNoncurrent>
    <qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_7e5f0523-4a01-4d0b-a632-8822ab484e6c">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;9. Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consisted of the following as of (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued external research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional services and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,474&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,328&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_a45e6167-40b6-49f4-9625-e8ce6cbfd3a5;"&gt;&lt;span style="-sec-ix-hidden:F_cb90d7dd-2025-4f37-8452-ccbb5dfb30b4;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liability, current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued taxes payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,763&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</qttb:AccruedExpensesAndOtherCurrentLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_c1f6ac02-0499-46d2-808b-0b48ea27625b">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accrued expenses and other current liabilities consisted of the following as of (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation and related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,782&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued external research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,578&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued professional services and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,474&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,328&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_a45e6167-40b6-49f4-9625-e8ce6cbfd3a5;"&gt;&lt;span style="-sec-ix-hidden:F_cb90d7dd-2025-4f37-8452-ccbb5dfb30b4;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liability, current&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued taxes payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,763&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_cc0fe0aa-dab0-40ca-b790-3a2764a436df"
      unitRef="U_USD">2782000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_d859ac57-9ee2-4913-8661-a3f25febfc67"
      unitRef="U_USD">3003000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <qttb:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_d6e7498e-7c15-46fc-a53a-3d9d7f7a0bd7"
      unitRef="U_USD">2611000</qttb:AccruedResearchAndDevelopmentExpensesCurrent>
    <qttb:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_256a05ea-26e5-4f89-b557-e3d4282b4c5b"
      unitRef="U_USD">3578000</qttb:AccruedResearchAndDevelopmentExpensesCurrent>
    <qttb:AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_ba5b5d0b-2d28-472e-af52-6df443127976"
      unitRef="U_USD">1474000</qttb:AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent>
    <qttb:AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_e72f8f1f-024d-4313-8195-e91c8377e0c2"
      unitRef="U_USD">2328000</qttb:AccruedProfessionalFeesAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_120fb633-3037-47a4-8d42-4e677d1691e2"
      unitRef="U_USD">612000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_03130ffa-3e91-4521-a4ff-e3f4b6f228b8"
      unitRef="U_USD">538000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_baa2c915-d9e2-403f-81d1-ac6ca3da874b"
      unitRef="U_USD">0</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_03476f4d-6579-45a2-bcf4-112148c4b2a4"
      unitRef="U_USD">316000</us-gaap:TaxesPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_6c8e383e-0960-4abd-940a-ec9a805649d9"
      unitRef="U_USD">7479000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_9f6b0c6e-bc4e-44d9-ad85-9981b600c1d1"
      unitRef="U_USD">9763000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_4302ba6e-763e-444d-923f-3b1efb748526">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the Company had several ongoing clinical studies in various clinical trial stages. Its most significant contracts relate to agreements with CROs for clinical trials and preclinical studies and CDMOs for manufacturing which the Company enters into in the normal course of business. The contracts with CROs and CDMOs are generally cancellable, with notice, at the Company&#x2019;s option.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Operating lease&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2021 the Company entered into a long-term operating lease agreement for its current corporate headquarters in Waltham, Massachusetts (&#x201c;headquarters lease&#x201d;). The headquarters lease provides approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; square feet for general office use and research lab facilities. The lease commencement date was January 1, 2022 and the Company did not take control or have the right to use the leased property until this time. The lease term ends in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_a1c527db-8fab-40c5-be93-17f92684f3c3;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 2031&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company has an option to extend the lease term for an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The initial rent for the office space is approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million per year, increasing every year by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% for total aggregate payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Upon the commencement date, the Company established a right-of-use asset and lease liability on the consolidated balance sheet. As part of the agreement, the Company arranged for a letter of credit for $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as a security for lease, which is considered restricted cash and included as restricted cash and restricted cash equivalents in the consolidated balance sheet. The Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in a tenant improvement allowance that was applied against the right-of-use asset.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company&#x2019;s headquarters lease had a weighted-average remaining lease term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years and weighted average incremental borrowing rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts reported in the consolidated balance sheet for leases where the Company is the lessee as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and December 31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncurrent:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,786&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes operating lease costs for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fixed lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;999&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Variable lease costs were primarily related to operating expenses, taxes and insurances associated with the operating lease, which were assessed based on the Company&#x2019;s proportionate share of such costs for the leased premises. As these costs are generally variable in nature, they were not included in the measurement of the operating lease right-of-use asset and related lease liability. Total lease costs are included as operating expenses in the Company&#x2019;s consolidated statements of operations.&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Future minimum lease payments under non-cancelable lease agreement as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and a reconciliation to the carrying amount of the lease liabilities presented in the consolidated balance sheet are as follows (in thousands): &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.823%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Minimum&lt;br/&gt;Rental&lt;br/&gt;Payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,092&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,124&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,494&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability, current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Prior to the Merger, Homology was subleasing office and research and development laboratory space in Bedford, Massachusetts, under a sublease agreement with OXB (US) LLC that expired in December 2024. During the first quarter of 2024, prior to the Merger, Homology had fully abandoned the space and accordingly, had shortened the remaining useful of its right-of-use asset to equal the time remaining until the planned abandonment date. At the effective time of the Merger, the Company recorded a liability of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million representing the present value of the future minimum lease payments due under&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;this sublease. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, there are no future lease payments due under the Homology sublease and therefore &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; liability on the Company's consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;License Agreements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;License Agreement with the University of Colorado&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In August 2017, the Company entered into an exclusive license agreement, as amended in February 2018, September 2018, and April 2019 (the &#x201c;Colorado License Agreement&#x201d;), with The Regents of the University of Colorado (&#x201c;Colorado&#x201d;), pursuant to which the Company obtained worldwide, royalty-bearing, sublicensable licenses under certain patents and know-how owned by Colorado and Medical University of South Carolina (&#x201c;MUSC&#x201d;) relating to the research, development and commercialization of ADX-097. The licenses granted to the Company are exclusive with respect to certain patent families and know-how and non-exclusive with certain other patent families and know-how. The licenses granted to the Company are also subject to certain customary retained rights of Colorado and MUSC and rights of the United States government owing to federal funding giving rise to inventions covered by the licensed patents. The Company agreed to use commercially reasonable efforts to develop, manufacture and commercialize ADX-097, including by using commercially reasonable efforts to achieve specified development and regulatory milestones by specified dates.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, the Company agreed to pay Colorado (i) development and sales milestone payments in an aggregate amount of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million per licensed product for the first three products, (ii) tiered royalty rates on cumulative net sales of licensed products in the low single digit percentages, (iii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of sublicense income and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents. The Company&#x2019;s obligation to pay royalties to Colorado commences, on a licensed product-by-licensed product and country-by-country basis, from the first commercial sale of a licensed product in any country and expires on the later of (a) the last to expire valid claim within the licensed patents covering such licensed product in such country, and (b) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years following the effective date of the Colorado License Agreement, or April 2037 (the &#x201c;Royalty Term&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Unless earlier terminated by either party pursuant to its terms, the Colorado License Agreement will expire upon the expiration of the Royalty Term in all countries. The Company may terminate the Colorado License Agreement for convenience upon providing prior written notice to Colorado. Colorado may terminate the Colorado License Agreement or convert the Company&#x2019;s exclusive license to a non-exclusive license if the Company breaches certain obligations under the Colorado License Agreement and fails to cure such breach. The Colorado License Agreement will terminate automatically upon the Company&#x2019;s dissolution, insolvency, or bankruptcy.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; research and development expense for any milestone related to the Colorado License Agreement. The financial statements as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 do not include liabilities with respect to royalty fees on the license agreement as the Company has not yet generated revenue and the achievement of certain milestones is not yet probable.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;License Agreement with Bristol-Myers Squibb Company&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In September 2019, the Company entered into a license agreement, as amended in August 2021 and July 2022 (the BMS License Agreement), with Bristol-Myers Squibb Company (&#x201c;BMS&#x201d;), pursuant to which the Company obtained sublicensable licenses from BMS to research, develop and commercialize licensed products, including bempikibart, for any and all uses worldwide. The licenses granted to the Company are exclusive with respect to BMS&#x2019;s patent rights and know-how relating to certain antibody fragments (including certain fragments of bempikibart) and non-exclusive with respect to BMS&#x2019;s patent rights and know-how relating to the composition of matter and use of a specific region of bempikibart. BMS retained the right for it and its affiliates to use the exclusively licensed patents and know-how for internal, preclinical research purposes. Under the BMS License Agreement, the Company is prohibited from engaging in certain clinical development or commercialization of any antibody other than a licensed compound with the same mechanism of action until the earlier of the expiration of Q32&#x2019;s obligation to pay BMS royalties or September 2029.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In consideration for the license, the Company made an upfront payment to BMS of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,628,788&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Series A preferred shares to BMS and agreed to use commercially reasonable efforts to develop and commercialize at least one licensed product in key geographic markets. In addition, the Company agreed to pay BMS (i) development and regulatory milestone payments in aggregate amounts ranging from $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;49&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million per indication for the first three indications and commercial milestone payments in an aggregate amount of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;215&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million on net sales of licensed products, (ii) tiered royalties ranging from rates in the mid-single digit percentages to up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of net sales, with increasing rates depending on the cumulative net sales, (iii) up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of sublicense income, which percentage decreases based on the development stage of&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;bempikibart at the time of the sublicensing event, and (iv) ongoing fees associated with the prosecution, maintenance, or filing of the licensed patents.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s obligation to pay BMS royalties under subsection (ii) above commences, on a licensed product-by-licensed product and country-by-country basis on the first commercial sale of a licensed product in a country and expires on the later of (x) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years from the first commercial sale of such Licensed Product in such country, (y) the last to expire licensed patent right covering bempikibart or such licensed product in such country, and (z) the expiration or regulatory or marketing exclusivity for such licensed product in such country (Royalty Term). If the Company undergoes a change of control prior to certain specified phase of development, the development and milestone payments are subject to increase by a low double digit percentage and the royalty rates are subject to increase by a low sub single digit percentage.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Unless terminated earlier by either party pursuant to its terms, the BMS License Agreement will expire on a country-by-country and licensed product-by-licensed product basis upon the expiration of the last to expire Royalty Term with respect to such licensed product in such country. Either party may terminate the BMS License Agreement for the other party&#x2019;s material breach, subject to a specified notice and cure period. BMS may terminate the BMS License Agreement if the Company fails to meet its diligence obligations under the BMS License Agreement, for the Company&#x2019;s insolvency, or if the Company or its affiliates challenges the validity, scope, enforceability, or patentability of any of the licensed patents. The Company may terminate the BMS License Agreement for any reason upon prior written notice to BMS, with a longer notice period if a licensed product has received regulatory approval. If the BMS Agreement is terminated for the Company&#x2019;s material breach, BMS will regain rights to bempikibart and the Company must grant BMS an exclusive license under the Company&#x2019;s patent rights covering bempikibart, subject to a low single digit percentage royalty on net sales of bempikibart payable to the Company by BMS.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In July 2024, the Company made a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million development milestone payment to BMS and recorded it as research and development expenses. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, no further events have occurred that would require payment of milestones, royalties or sublicense fees.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Legal Proceedings&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is not currently party to any material legal proceedings. The Company accounts for estimated losses with respect to legal proceedings and claims when such losses are probable and reasonably estimable. Legal costs associated with these matters are expensed when incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Indemnification Arrangements&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As permitted under Delaware law, the Company has agreements whereby it indemnifies certain of its investors, stockholders, employees, officers, and directors (collectively, the &#x201c;Indemnified Parties&#x201d;) for certain events or occurrences while the Indemnified Parties are, or were serving, at its request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has an Executive Liability insurance policy that limits its exposure and enables it to recover a portion of any future amounts paid up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company believes the estimated fair value of these indemnification agreements is minimal. The Company enters into standard indemnification agreements in the ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless, and agrees to reimburse the Indemnified Parties for losses suffered or incurred by the Indemnified Parties, generally the Company&#x2019;s business partners or customers, in connection with any U.S. patent or any copyright or other intellectual property infringement claim by any third party with respect to the Company&#x2019;s products. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="C_854a149a-1eef-4a0c-9335-f2a517e54274"
      decimals="0"
      id="F_843a1d22-71aa-4305-ab7b-04a14306f539"
      unitRef="U_sqft">15000</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1
      contextRef="C_854a149a-1eef-4a0c-9335-f2a517e54274"
      id="F_1cd3672d-f2c8-4a06-9960-bb2ca9d8f9c0">P5Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedRenewalTerm1>
    <qttb:SubleaseAggregateBaseRentObligation
      contextRef="C_854a149a-1eef-4a0c-9335-f2a517e54274"
      decimals="-5"
      id="F_a3cca82e-8cba-461f-9bf1-a81b29bdf5ad"
      unitRef="U_USD">1000000</qttb:SubleaseAggregateBaseRentObligation>
    <qttb:LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent
      contextRef="C_53138904-18f8-426d-9bb6-72a8e8db3721"
      decimals="2"
      id="F_589eb0f9-a37b-4698-8c59-6cd3febc20d4"
      unitRef="U_pure">0.03</qttb:LesseeOperatingLeaseNotYetCommencedIncreaseInPercentageOfBaseRent>
    <qttb:AnnualRentOperatingLeaseAggregateAfterIncrease
      contextRef="C_53138904-18f8-426d-9bb6-72a8e8db3721"
      decimals="-5"
      id="F_ea8f4f03-1e75-4d6e-a783-839f8d2ccbac"
      unitRef="U_USD">11100000</qttb:AnnualRentOperatingLeaseAggregateAfterIncrease>
    <us-gaap:SecurityDeposit
      contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac"
      decimals="-5"
      id="F_2d608a6b-bdfd-4a3e-82db-151718c00337"
      unitRef="U_USD">600000</us-gaap:SecurityDeposit>
    <us-gaap:IncentiveFromLessor
      contextRef="C_a3049491-9ddc-4b12-9eb9-4faf6e1e2fec"
      decimals="-5"
      id="F_d585ce01-f197-4e79-950d-9fda3f21a6ba"
      unitRef="U_USD">400000</us-gaap:IncentiveFromLessor>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac"
      id="F_ccdc4d7a-d716-4edf-9a8b-7fadecce0ec9">P7Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac"
      decimals="3"
      id="F_2a77063c-0d51-4fdd-ac6f-34eea81484fe"
      unitRef="U_pure">0.075</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <qttb:DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_e4c21752-c0c1-4f86-8a54-f8a5af686d27">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts reported in the consolidated balance sheet for leases where the Company is the lessee as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and December 31, 2023 were as follows (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Noncurrent:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,786&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</qttb:DisclosureInTabularFormOfAmountsReportedInTheBalanceSheetInRespectOfOperatingLeaseAssetsAndCorrespondingLiabilitiesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_aa2a1b95-ef16-4997-9b43-9668cc1317f4"
      unitRef="U_USD">5722000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_9d16c65e-f10a-48b2-81af-e63de09bb04b"
      unitRef="U_USD">6301000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_1f1857a3-9de8-43b7-885d-04bc7fb26b40"
      unitRef="U_USD">5722000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_06ed344b-04b4-46de-b286-6052bb21c189"
      unitRef="U_USD">6301000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_6732e2f5-7509-4abe-ac57-cbf792380db9"
      unitRef="U_USD">612000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_5ee7b8fc-d0c5-43bf-ad9e-5e7db51edf45"
      unitRef="U_USD">538000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_437b2b9e-f00f-4d62-9aa8-322cec082fb1"
      unitRef="U_USD">5636000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_b1978e66-0278-4850-b1e2-83126fb17570"
      unitRef="U_USD">6248000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_0206602f-b826-4a6e-a6d2-1e397c57bce2"
      unitRef="U_USD">6248000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_aaf752f8-3728-4515-8a5d-cbd413171ea2"
      unitRef="U_USD">6786000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_98fca37a-9579-4a5b-9b51-87e1414f5cbc">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:2pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes operating lease costs for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fixed lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;999&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_9416d861-a7c6-405c-b5f3-925b21dbbdd0"
      unitRef="U_USD">1029000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_fd419251-dd25-481f-b369-e434bdb82720"
      unitRef="U_USD">999000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_c4e779d2-585c-4838-9066-600c0152003e"
      unitRef="U_USD">43000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_1bb1dec7-2a38-4fe7-b390-c6fd02f8baec"
      unitRef="U_USD">73000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_583019c2-aad6-45e6-b68a-7b7d2904480d"
      unitRef="U_USD">1072000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_97f3712b-86f6-44c2-8438-ea5920517b33"
      unitRef="U_USD">1072000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_e5088a99-1cb9-499e-87c2-646d9913f80e">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Future minimum lease payments under non-cancelable lease agreement as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and a reconciliation to the carrying amount of the lease liabilities presented in the consolidated balance sheet are as follows (in thousands): &lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.236%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:15.823%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Minimum&lt;br/&gt;Rental&lt;br/&gt;Payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,092&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,124&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,193&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,494&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability, current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,636&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,248&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_ca3c8aab-290b-417e-b86d-6941f53e50d1"
      unitRef="U_USD">1060000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_c48c0369-429e-446f-984c-ff12396e9c71"
      unitRef="U_USD">1092000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_965c388c-5992-42be-b789-85b392504ca0"
      unitRef="U_USD">1124000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_cacccba3-e669-4859-8ee2-dce504c4e3bc"
      unitRef="U_USD">1158000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_de91ec7c-6fa3-4c65-b1de-cdfaa923c700"
      unitRef="U_USD">1193000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_6cf42679-b86b-4729-869d-31f80b66a446"
      unitRef="U_USD">2494000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_ef861437-e538-497b-ae5e-1816af4d7263"
      unitRef="U_USD">8121000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_40181f5b-bc98-4427-b713-29bfadc4ef4c"
      unitRef="U_USD">1873000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_adb0bb75-fedf-4ce4-aeb9-151d2ac9bbb6"
      unitRef="U_USD">6248000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_c257f3be-c53e-46a3-934d-2408ec322097"
      unitRef="U_USD">612000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_2503dea8-52ef-4eb7-9a47-072d68d2e838"
      unitRef="U_USD">5636000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_f4f822d1-2826-4d9f-acab-7d3e76b3dae6"
      unitRef="U_USD">6248000</us-gaap:OperatingLeaseLiability>
    <qttb:FutureMinimumLeasePaymentDueUnderThisSublease
      contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac"
      decimals="-5"
      id="F_c9a764c6-e0e5-4a09-8044-64f3568dd96c"
      unitRef="U_USD">1000000</qttb:FutureMinimumLeasePaymentDueUnderThisSublease>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_f913f4f9-3fd0-4ddf-9646-a7303e3502ac"
      decimals="-6"
      id="F_440d6015-540b-49bd-9f58-174a29036f3a"
      unitRef="U_USD">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <qttb:DevelopmentAndSalesMilestonePaymentPayable
      contextRef="C_b555dfd2-6633-4e32-b92f-2a1f6100178b"
      decimals="-5"
      id="F_f0f6d375-6edf-40cf-8923-2f0a56d5286b"
      unitRef="U_USD">2200000</qttb:DevelopmentAndSalesMilestonePaymentPayable>
    <qttb:PercentageOfSublicenseFees
      contextRef="C_7173717f-2d2d-4169-9a96-9df1da9fef47"
      decimals="2"
      id="F_ed9fcf6a-f3c0-4279-b454-e17ac051a82c"
      unitRef="U_pure">0.15</qttb:PercentageOfSublicenseFees>
    <qttb:PeriodOfObligationToPayRoyalties
      contextRef="C_7173717f-2d2d-4169-9a96-9df1da9fef47"
      id="F_6ef97dc5-574a-43b5-ad55-1331d6ce2c4a">P20Y</qttb:PeriodOfObligationToPayRoyalties>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_7173717f-2d2d-4169-9a96-9df1da9fef47"
      decimals="0"
      id="F_9dc339b0-b22b-436f-8008-7ef427fe7469"
      unitRef="U_USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_09d4667e-d0d3-40c4-96f5-1346195ceecb"
      decimals="0"
      id="F_7058c803-e7ac-467b-aca1-f8b30a402cfc"
      unitRef="U_USD">0</us-gaap:ResearchAndDevelopmentExpense>
    <qttb:UpfrontPaymentMade
      contextRef="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c"
      decimals="-6"
      id="F_9fcc65e1-8b0e-4a71-8b1c-90cf0460c624"
      unitRef="U_USD">8000000</qttb:UpfrontPaymentMade>
    <us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets
      contextRef="C_cbe1c2b6-e46f-4db2-a96d-16d62994fde1"
      decimals="INF"
      id="F_3c70bbf6-c3e0-4cf6-ae9f-385848f9153b"
      unitRef="U_shares">6628788</us-gaap:StockIssuedDuringPeriodSharesPurchaseOfAssets>
    <qttb:DevelopmentAndSalesMilestonePaymentPayable
      contextRef="C_cfdb4851-27cb-4dd2-a181-f26f91524080"
      decimals="-6"
      id="F_023d9827-de23-472d-bad5-508db5f7328a"
      unitRef="U_USD">32000000</qttb:DevelopmentAndSalesMilestonePaymentPayable>
    <qttb:DevelopmentAndSalesMilestonePaymentPayable
      contextRef="C_d70d9c60-682f-4b4c-8180-b6b1535a6f0c"
      decimals="-6"
      id="F_624ef7c9-b075-4eaa-9e87-88539d8fe6e7"
      unitRef="U_USD">49000000</qttb:DevelopmentAndSalesMilestonePaymentPayable>
    <qttb:CommercialMilestonePaymentPayable
      contextRef="C_c995ff6f-a52c-4c87-a8d6-71a52474fd48"
      decimals="-6"
      id="F_6171de62-a349-4a51-bc12-6c0038ca6ed8"
      unitRef="U_USD">215000000</qttb:CommercialMilestonePaymentPayable>
    <qttb:RoyaltyAsAPercentageOfNetSales
      contextRef="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c"
      decimals="2"
      id="F_53282364-d018-4051-8a98-6729265edc10"
      unitRef="U_pure">0.10</qttb:RoyaltyAsAPercentageOfNetSales>
    <qttb:PercentageOfSublicenseFees
      contextRef="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c"
      decimals="2"
      id="F_3e955e20-e721-4044-96cc-63af58fb841b"
      unitRef="U_pure">0.60</qttb:PercentageOfSublicenseFees>
    <qttb:PeriodOfObligationToPayRoyalties
      contextRef="C_1c3e1f36-06bd-4351-96c2-1e17aa84bd7c"
      id="F_d22e19fb-055a-4888-9987-c3d3c42441d1">P12Y</qttb:PeriodOfObligationToPayRoyalties>
    <qttb:DevelopmentMilestonePaymentPayable
      contextRef="C_186a100e-16ef-48da-90b9-7456802bc057"
      decimals="-5"
      id="F_27205ce3-e682-4b72-9e1e-f4e0df326795"
      unitRef="U_USD">4000000</qttb:DevelopmentMilestonePaymentPayable>
    <us-gaap:SelfInsuranceReserve
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-5"
      id="F_8f311f5a-5967-4ba4-a4d6-37617be48e3c"
      unitRef="U_USD">5000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_d8beea53-38ef-4f4d-92cb-362423989ee3">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;11. Debt&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Venture Debt&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On December 11, 2020, the Company entered into a Loan and Security Agreement with Silicon Valley Bank, a California corporation (&#x201c;Loan Agreement&#x201d;) for a lending facility of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million upon execution of the Agreement (&#x201c;2020 Term A Loan Advance&#x201d;) and had the ability to draw up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in three separate term loan advances if certain performance milestones are met. The term loan bears interest at an annual rate equal to the greater of the prime rate or &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%. The Loan Agreement provides for interest-only payments until April 30, 2022, and repayment of the aggregate outstanding principal balance of the term loan in monthly installments starting on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;July 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The commencement of principal payments and the maturity date will be deferred by one year upon the occurrence of a contingent event. In addition, the Company paid a fee of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million upon closing and is required to pay a fee of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of the aggregate&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;amount &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of advances under the Loan Agreement at maturity. At its option, the Company may elect to prepay all or a portion of the outstanding advances by paying the principal balance, and all accrued and unpaid interest, and a prepayment premium. In connection with the Loan Agreement, the Company granted the lender a security interest in all of its personal property now owned or hereafter acquired, excluding intellectual property (but including the rights to payment and proceeds from the sale, licensing or disposition of intellectual property), and a negative pledge on intellectual property. The Loan Agreement also contains certain events of default, representations, warranties and non-financial covenants of the Company. If the Company fails to make payments when due or breaches any operational covenant or has any event of default, this could have a material adverse effect on its business and financial condition. The Company was in compliance with all covenants at December 31, 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On June 30, 2022, a second amendment to the Loan Agreement was entered into with the lender that extended the interest-only payment until December 31, 2022 followed by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;24 equal monthly payments of principal plus interest, with a loan maturity date of&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The amendment increased the final payment from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the advanced payment and modified the prepayment premium.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On August 10, 2022, a third amendment to the Loan Agreement was entered into with the lender. Per the terms of the amendment and in conjunction with the Collaboration Agreement (as defined below), the Company transferred $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million into a restricted cash collateral money market account which is included as Restricted cash and restricted cash equivalents on the balance sheet. This restricted cash equivalent covers the amount of the debt outstanding as of the third amendment effective date.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On December 21, 2022, a fourth amendment to the Loan Agreement was entered into with the lender that extended the interest-only payment until July 1, 2023 followed by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;18 equal monthly payments of principal plus interest, with a loan maturity date of&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 26, 2023, a fifth amendment to the Loan Agreement was entered into with the lender. The amendment provides that the Company must maintain at least &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of its consolidated cash with the lender. In addition, the Company shall at all times have on deposit in operating and depository accounts maintained with the lender, unrestricted and unencumbered cash in an amount equal to the lesser of (i) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the dollar value of the Company&#x2019;s consolidated cash and (ii) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;110&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the then-outstanding obligations of the Company to the bank. So long as the Company is in compliance with those terms, the Company shall be permitted to maintain accounts with other banks or financial institutions.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 12, 2023, a sixth amendment to the Loan Agreement was entered into with the lender. The amendment provides for one term loan advance (the &#x201c;2023 Term A Loan Advance&#x201d;) in an original principal amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and required the Company to repay the outstanding 2020 Term A Loan Advance of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, including the final payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. Upon the occurrence of a contingent event, the lender shall make up to three additional term loan advances at the Company&#x2019;s request in original principal amounts of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The amounts must be drawn by the Company before March 31, 2024, March 31, 2025 and July 1, 2025, respectively. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The interest-only period was extended through June 30, 2024 followed by 36 equal monthly payments of principal plus interest.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The term loan bears interest at an annual rate equal to the greater of the prime rate minus &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% or &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On November 2, 2023, a seventh amendment to the Loan Agreement was entered into with the lender. The additional loan advance of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, the first advance stated in the sixth amendment to the Loan Agreement, could be drawn down once the company received net cash proceeds of at least $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from (a) the issuance and sale of its equity securities to investors satisfactory to the lender and/or (b) a business development transaction satisfactory to the lender; provided that, at least, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of such net cash proceeds must be received from the issuance and sale of equity securities to investors satisfactory to the lender. The seventh amendment extended the time the Company has to receive the net proceeds to March 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 21, 2024, an eighth amendment to the Loan Agreement was entered into with the lender. The eighth amendment extended the time the Company had to receive the net proceeds to May 31, 2024 and also extended the time the Company could draw down on the first advanced payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million from March 31, 2024 to May 31, 2024. The date changes were adjusted to align the milestone in the Loan Agreement with the closing of the Merger. On March 26, 2024, the Company received the first advance payment of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million per the terms of the Loan Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On July 19, 2024, a ninth amendment to the Loan Agreement was entered into with the lender that extends the interest-only period through July 1, 2025 followed by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;24 equal monthly payments of principal plus interest.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The loan matures on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;July 1, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In conjunction with the Loan Agreement, the Company issued warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,988&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the lender at a per share price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.87&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; with a maximum contractual term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The warrants had a total relative fair value of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; thousand upon issuance and were recorded as a debt discount.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In conjunction with the sixth amendment, the Company issued warrants to purchase &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,156&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the lender at a per share price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; with a maximum contractual term of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The warrants were issued in two separate tranches of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,078&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; based upon certain milestone events. The warrants had a &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;de minimis&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; total relative fair value at the time of issuance.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to FASB ASC Topic 480, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Distinguishing Liabilities from Equity &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and FASB ASC Topic 815, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the warrants were classified as equity and were initially measured at fair value. Subsequent changes to fair value will not be recognized so long as the instrument continues to be equity classified.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Interest expense was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;years ended December 31, 2024 and 2023, respectively&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The effective rate on the Loan Agreement, including the amortization of the debt discount and issuance costs was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.55&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.42&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, respectively, at each of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of the long-term debt balance are as follows (in thousands): &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Principal amount of term loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unamortized debt discount and issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Carrying amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term debt, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Convertible Notes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On May 20, 2022, the Company entered into an agreement with the existing investors of the Company to issue, and for the existing investors to purchase, the Convertible Notes for up to an aggregate of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Convertible Notes bear interest at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% per annum. The Convertible Notes become due on demand of the Convertible Noteholders one year from the date of issuance. On April 27, 2023, the Company amended the maturity dates for the Convertible Notes. On May 20, August 5 and December 23, 2022, the Company received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, in exchange for issuance of the Convertible Notes. Interest expense was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023, respectively. The Convertible Notes converted into share of common stock in March 2024 per the Merger (see discussion below and in Note 1).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Convertible Notes contain mandatory conversion features whereby the total outstanding amount of principal and accrued and unpaid interest of the Convertible Notes shall automatically convert into shares of common stock upon certain qualified financings. The total outstanding amount of principal and accrued and unpaid interest of the Convertible Notes convert into shares of common stock at &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the purchase price of the mandatory conversion events. If the mandatory conversion events do not occur the holders of the Convertible Notes may request the Convertible Notes plus accrued interest be converted into Series B preferred stock at the Series B convertible price of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0971&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company elected to account for the Convertible Notes at fair value where changes in fair value of the notes are measured through the consolidated statements of operations until settlement. Subsequent to December 31, 2023 and per the Merger further discussed in Note 1, the Convertibles Notes converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,433,410&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock. The Company recorded a gain on the change in fair value prior to the conversion of the Convertible Notes of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in other income (expense), net during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the Convertible Notes were settled with equity securities subsequent to December 31, 2023 but prior to the issuance of the financial statements, per FASB ASC Topic 470, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company recorded the Convertible Notes at the fair value totaling $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as a long-term liability on its consolidated balance sheet as of December 31, 2023. The Company recorded in other income (expense), net interest expense of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and a charge of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million related to the change in estimated fair value during the year ended December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_61d6fc78-c8ec-418e-a4dc-fcee1281ac6c"
      decimals="-6"
      id="F_e6991515-0728-4cb4-9ae3-9fc14cd9205b"
      unitRef="U_USD">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="C_440034cc-e9c7-4544-91a9-9d19b1167f0e"
      decimals="-5"
      id="F_fe9f9e1c-cb19-4b77-9c08-6b5401493551"
      unitRef="U_USD">5000000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="C_85eed7d4-bc70-4689-9015-4f85ad5cfc18"
      decimals="-5"
      id="F_b20bacee-b33b-4d01-ae40-b4384df5bb65"
      unitRef="U_USD">20000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LongTermDebtPercentageBearingVariableInterestRate
      contextRef="C_df3c79d3-1293-482f-9102-cd57669625a7"
      decimals="4"
      id="F_8c994b95-cf7e-45e5-9b7a-e789b6e46552"
      unitRef="U_pure">0.0325</us-gaap:LongTermDebtPercentageBearingVariableInterestRate>
    <us-gaap:LineOfCreditFacilityDateOfFirstRequiredPayment1
      contextRef="C_53fa66be-5ca3-40fc-8c45-f08ab061bfff"
      id="F_9165c3b7-be03-48e9-a2d1-0180950978ef">2022-07-01</us-gaap:LineOfCreditFacilityDateOfFirstRequiredPayment1>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="C_53fa66be-5ca3-40fc-8c45-f08ab061bfff"
      id="F_6a997c1b-7f12-4f6d-b97a-20c9f8f851fa">2023-12-01</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="C_440034cc-e9c7-4544-91a9-9d19b1167f0e"
      decimals="-5"
      id="F_d8ba5219-88f2-4f9b-bb3d-0c99ae0c8ff1"
      unitRef="U_USD">100000</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="C_440034cc-e9c7-4544-91a9-9d19b1167f0e"
      decimals="3"
      id="F_58f125df-7cce-4d72-a2b6-1bce9c5af517"
      unitRef="U_pure">0.02</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityFrequencyOfPayments
      contextRef="C_4ea385ae-a09a-44a7-ba4f-9e1d5dfc76b2"
      id="F_5459a2bd-76a9-45e7-b47a-c9629fc22470">24 equal monthly payments of principal plus interest, with a loan maturity date of</us-gaap:LineOfCreditFacilityFrequencyOfPayments>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="C_4ea385ae-a09a-44a7-ba4f-9e1d5dfc76b2"
      id="F_0f38565a-48ce-40de-920f-1439e9e2bfb4">2024-12-31</us-gaap:LineOfCreditFacilityExpirationDate1>
    <qttb:LongTermDebtBalloonPaymentPercentage
      contextRef="C_85eed7d4-bc70-4689-9015-4f85ad5cfc18"
      decimals="3"
      id="F_b272a697-e05c-4366-a183-2db46945bf8c"
      unitRef="U_pure">0.02</qttb:LongTermDebtBalloonPaymentPercentage>
    <qttb:LongTermDebtBalloonPaymentPercentage
      contextRef="C_4c584b28-2bfc-476b-9e14-f321da0f4ddb"
      decimals="3"
      id="F_e831359a-7715-482b-8198-9dc15ebf2786"
      unitRef="U_pure">0.04</qttb:LongTermDebtBalloonPaymentPercentage>
    <us-gaap:DebtInstrumentCollateralAmount
      contextRef="C_393ed9e3-2fa2-4a7b-b49b-0b0d93cbf89e"
      decimals="-5"
      id="F_b88b68c5-f4d4-4746-9549-9f07d14eeef3"
      unitRef="U_USD">5000000</us-gaap:DebtInstrumentCollateralAmount>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="C_79f15b34-ea52-436c-a16f-c67bd97ffb1d"
      id="F_e686f873-ee9b-44c6-b1af-cc04f0728667">18 equal monthly payments of principal plus interest, with a loan maturity date of</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="C_79f15b34-ea52-436c-a16f-c67bd97ffb1d"
      id="F_fd482a46-adb0-46a7-9a28-cbf2497d29d7">2024-12-01</us-gaap:LineOfCreditFacilityExpirationDate1>
    <qttb:PercentageOfConsolidatedCashToBeMaintainedWithTheLender
      contextRef="C_6acff699-1bcb-4e5c-83d0-0ecc48abc809"
      decimals="2"
      id="F_7f80de71-43bc-40ae-90a7-af2fbd9fe663"
      unitRef="U_pure">0.50</qttb:PercentageOfConsolidatedCashToBeMaintainedWithTheLender>
    <qttb:UnrestrictedAndUnencumberedCashPercentageToBeMaintained
      contextRef="C_6acff699-1bcb-4e5c-83d0-0ecc48abc809"
      decimals="2"
      id="F_0b2617d5-1072-440c-aedb-c2e42149e20c"
      unitRef="U_pure">1</qttb:UnrestrictedAndUnencumberedCashPercentageToBeMaintained>
    <qttb:PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash
      contextRef="C_6acff699-1bcb-4e5c-83d0-0ecc48abc809"
      decimals="2"
      id="F_f0fe247d-f2c9-40a6-9c83-a2d34b2364fb"
      unitRef="U_pure">1.10</qttb:PercentageOfOutstandingDebtToBeMaintainedWithTheLenderByWayOfCash>
    <qttb:LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable
      contextRef="C_f94caa77-06ab-4033-aaf4-c31aca13beda"
      decimals="-5"
      id="F_6b692f8e-e163-4322-bd18-b470f7c5be12"
      unitRef="U_USD">5500000</qttb:LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable>
    <us-gaap:LinesOfCreditCurrent
      contextRef="C_f94caa77-06ab-4033-aaf4-c31aca13beda"
      decimals="-5"
      id="F_4d80554a-30f6-4df6-8170-809fd4a98894"
      unitRef="U_USD">5000000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
      contextRef="C_f94caa77-06ab-4033-aaf4-c31aca13beda"
      decimals="-5"
      id="F_f384d613-7463-4fc1-a4da-a86abbe294a1"
      unitRef="U_USD">200000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
    <qttb:LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed
      contextRef="C_44dc2e47-aa49-4844-acd8-9cb650ca6caf"
      decimals="-5"
      id="F_5ac9762a-8b2d-431c-bce6-af663d609f2e"
      unitRef="U_USD">7000000</qttb:LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed>
    <qttb:LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed
      contextRef="C_82ffbe69-bdc0-46ed-85f6-2f2135943e2a"
      decimals="-5"
      id="F_73bb0e00-d96f-4b44-bf8d-6b893a7bdaed"
      unitRef="U_USD">7500000</qttb:LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed>
    <qttb:LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed
      contextRef="C_d1e4c313-5593-44fa-8319-69d7287a8c1a"
      decimals="-5"
      id="F_729ab7f4-761b-4998-bb64-dcf07bf43943"
      unitRef="U_USD">5000000</qttb:LineOfCreditFacilityAmountThatMayBeContingentlyBorrowed>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="C_8b219b81-3c35-41c8-a792-9c9b2b87e1e7"
      id="F_547837bb-cc86-473f-b3ce-316ad9fc1169">The interest-only period was extended through June 30, 2024 followed by 36 equal monthly payments of principal plus interest.</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_8b219b81-3c35-41c8-a792-9c9b2b87e1e7"
      decimals="4"
      id="F_98c10281-33e2-4ca6-848b-e62d10928c94"
      unitRef="U_pure">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongTermDebtPercentageBearingVariableInterestRate
      contextRef="C_cda9fef4-e02f-4ed8-8897-35539a06a8b8"
      decimals="4"
      id="F_a576c7c9-580d-4e99-881b-c0b2d64bf554"
      unitRef="U_pure">0.08</us-gaap:LongTermDebtPercentageBearingVariableInterestRate>
    <qttb:FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed
      contextRef="C_e112c2ce-ff85-4995-a056-7c0f11496a6f"
      decimals="-5"
      id="F_6083c2cf-27c8-4fb7-aaed-d82324294630"
      unitRef="U_USD">7000000</qttb:FaceValueOfDebtInstrumentThatMayBeContingentlyBorrowed>
    <qttb:EstimatedAggregateProceedsFromDebtAndEquity
      contextRef="C_bf697f63-fffd-47b1-a9e7-28e55b7595fb"
      decimals="-5"
      id="F_f36244b7-d714-4fa3-8ce7-8d0d2f36aab7"
      unitRef="U_USD">75000000</qttb:EstimatedAggregateProceedsFromDebtAndEquity>
    <qttb:EstimatedAggregateProceedsFromEquity
      contextRef="C_bf697f63-fffd-47b1-a9e7-28e55b7595fb"
      decimals="-5"
      id="F_fe6b9947-0447-4f72-b2bc-9678715e4f6c"
      unitRef="U_USD">37500000</qttb:EstimatedAggregateProceedsFromEquity>
    <qttb:LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable
      contextRef="C_36ec1662-19ea-4f36-95c0-480643ad7851"
      decimals="-5"
      id="F_b6620072-f4e6-40ac-a8c1-2af57cc9ca88"
      unitRef="U_USD">7000000</qttb:LineOfCreditFacilityAggregateAmountIncludingBalloonRepaymentPayable>
    <qttb:ReceivedAdvancePayment
      contextRef="C_8cb16126-e20f-478a-92f3-f4ef3f29dcee"
      decimals="-5"
      id="F_c4a5fb72-9a87-45c0-87b2-fe7efc03dce1"
      unitRef="U_USD">7000000</qttb:ReceivedAdvancePayment>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="C_da508a90-18ff-4feb-864f-c062a92713e3"
      id="F_1b997391-6a15-4761-afcb-55aef8b9c18d">24 equal monthly payments of principal plus interest.</us-gaap:DebtInstrumentPaymentTerms>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="C_da508a90-18ff-4feb-864f-c062a92713e3"
      id="F_14a104a2-61e8-4394-9354-12ad265eca02">2027-07-01</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_bdd74796-2135-43f6-a03b-39e6bd90c9b9"
      decimals="0"
      id="F_8a2a1eb5-52e8-4b07-b25f-4960d0fc5f81"
      unitRef="U_shares">7988</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_bdd74796-2135-43f6-a03b-39e6bd90c9b9"
      decimals="2"
      id="F_150a5f8e-978a-4547-abfe-6f372a730961"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.87</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_bdd74796-2135-43f6-a03b-39e6bd90c9b9"
      id="F_3d9660c3-6eeb-4f3b-8bc9-f969b561b83e">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_548856aa-e248-42ff-bd02-f8b3fa277e06"
      decimals="-3"
      id="F_875bd5b1-1f32-4f48-aa71-0673fd1672c7"
      unitRef="U_USD">39000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_2b84e1db-55c0-4034-aafc-134bb2bada3d"
      decimals="0"
      id="F_7fc9378f-a901-45e9-9cea-021d54245e08"
      unitRef="U_shares">10156</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_2b84e1db-55c0-4034-aafc-134bb2bada3d"
      decimals="2"
      id="F_0aebe344-b8a8-4bd7-a7e5-1e3db16c8b6c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="C_2b84e1db-55c0-4034-aafc-134bb2bada3d"
      id="F_42965916-a239-400b-acf1-1fc1a91faa9c">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_742e9ad2-7322-4178-acf9-30981e53d1af"
      decimals="0"
      id="F_38c69a40-a5f0-4348-ac93-00cc8845a344"
      unitRef="U_shares">5078</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:InterestExpense
      contextRef="C_64e18bd2-6e71-4f81-8713-6d9b2f8a6ed2"
      decimals="-5"
      id="F_e40f1edb-693a-49b7-86e1-834ae25f1f17"
      unitRef="U_USD">1100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_13ef4388-e7d7-4520-984c-b50faaa55355"
      decimals="-5"
      id="F_5672d195-899b-4ac9-8cd5-665277fdd58a"
      unitRef="U_USD">500000</us-gaap:InterestExpense>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_29d5eced-fc9f-4f1c-ae83-4350d8af4754"
      decimals="4"
      id="F_c0444e1f-095d-43d1-a3e2-c830c8e73cb2"
      unitRef="U_pure">0.0955</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="C_0679ebcb-aaa9-4d96-a6a8-350341c1609b"
      decimals="4"
      id="F_9ac1ffc2-a955-4a28-9798-ab0ebdb12a14"
      unitRef="U_pure">0.1042</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <qttb:DisclosureInTabularFormOfVentureDebtTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_641c4300-1569-417a-a491-8a7bf306bab5">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of the long-term debt balance are as follows (in thousands): &lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Principal amount of term loans&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unamortized debt discount and issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;153&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Carrying amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,459&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term debt, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,581&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</qttb:DisclosureInTabularFormOfVentureDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4"
      decimals="-3"
      id="F_5801372e-bd2d-4504-b143-8078f7528955"
      unitRef="U_USD">12500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c"
      decimals="-3"
      id="F_bedd996d-7841-4e4e-972d-19c6a58205a3"
      unitRef="U_USD">5500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4"
      decimals="-3"
      id="F_507c9e22-790c-4628-b1ae-89d7a972009f"
      unitRef="U_USD">-153000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c"
      decimals="-3"
      id="F_e55fa96b-7eb1-4fca-8d13-50111e03317f"
      unitRef="U_USD">41000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4"
      decimals="-3"
      id="F_fe57b255-8de8-4774-9f7b-3443351f98b1"
      unitRef="U_USD">12653000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c"
      decimals="-3"
      id="F_f4bd2f11-7503-41c7-bfd6-eb7a335cccbf"
      unitRef="U_USD">5459000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4"
      decimals="-3"
      id="F_70cf7fb1-f8bf-48c7-bdb5-5d24b43f12d4"
      unitRef="U_USD">3097000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c"
      decimals="-3"
      id="F_d0298a94-d6cf-4001-87d6-2a4d9b80e35d"
      unitRef="U_USD">878000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_60e298bc-492e-4648-ae4c-77f0946662a4"
      decimals="-3"
      id="F_30923f5b-a64a-434f-92d1-add4d43a74f2"
      unitRef="U_USD">9556000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_8a29bb8f-c595-4983-9066-bd39e268ab4c"
      decimals="-3"
      id="F_b7fdf55d-0b1b-4b94-8b6c-c5c75887b485"
      unitRef="U_USD">4581000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_fdc54320-1c67-4e15-8365-d084e65e9e52"
      decimals="-5"
      id="F_b6437443-fe86-49a8-b5fe-f6f42b290d1a"
      unitRef="U_USD">30000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="C_fdc54320-1c67-4e15-8365-d084e65e9e52"
      decimals="3"
      id="F_e5767b9e-a26e-4c7b-8fe1-9dca2fd85fdf"
      unitRef="U_pure">0.05</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_cd782b8d-e977-40bc-a2ef-507ab008dfca"
      decimals="-5"
      id="F_60d564ca-8caf-4b07-88da-2a15c4a47235"
      unitRef="U_USD">8300000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_99f336ed-ce75-4357-a041-46da4ea43896"
      decimals="-5"
      id="F_8916e0da-2be8-4413-b1b5-3d817388ae12"
      unitRef="U_USD">5000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="C_7fe7497c-530e-4a3f-be8e-af26a160d3fa"
      decimals="-5"
      id="F_cf246f95-41a6-42e6-8585-ff1150cedcd6"
      unitRef="U_USD">16700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_385a8942-b234-40ba-9087-cb65594b34d3"
      decimals="-5"
      id="F_674b61ab-618c-4cac-a04c-55f105c75374"
      unitRef="U_USD">300000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="C_ad732baa-4828-4c30-98cf-2d02dbdb87b8"
      decimals="-5"
      id="F_62e04b5c-868d-41f7-b3e0-994a9a868c96"
      unitRef="U_USD">1500000</us-gaap:InterestExpenseDebt>
    <qttb:DebtInstrumentConversionPricePercentage
      contextRef="C_fdc54320-1c67-4e15-8365-d084e65e9e52"
      decimals="2"
      id="F_36a44d06-ac0a-426e-af03-2bff67ae1409"
      unitRef="U_pure">0.90</qttb:DebtInstrumentConversionPricePercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="C_7f536b74-399c-4e82-9152-d5daf6993f87"
      decimals="4"
      id="F_524d2e8c-8eb4-4c0c-be53-c9a828e14575"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.0971</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_385a8942-b234-40ba-9087-cb65594b34d3"
      decimals="0"
      id="F_da8adecd-8d56-41d2-aaef-2079542a8a2d"
      unitRef="U_shares">1433410</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:IncreaseDecreaseInNotesPayableCurrent
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-5"
      id="F_ede330ac-4bbd-4e9e-99ae-d59148d2f209"
      unitRef="U_USD">15900000</us-gaap:IncreaseDecreaseInNotesPayableCurrent>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="C_5d9c9fa2-97d6-4b1c-b918-3a60f9e20e25"
      decimals="-5"
      id="F_b733d402-c07f-4ff1-8b80-775be2c3182b"
      unitRef="U_USD">38600000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_3543f0be-6692-47f6-a4e8-a5c6d56417eb"
      decimals="-5"
      id="F_743250ea-67df-4ffd-96e7-c5827c82761f"
      unitRef="U_USD">1500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="C_3543f0be-6692-47f6-a4e8-a5c6d56417eb"
      decimals="-5"
      id="F_56058f92-b122-4042-b4e6-f8763ccc4cef"
      unitRef="U_USD">4700000</us-gaap:InterestExpense>
    <qttb:DisclosureInEntiretyOfTemporaryEquity
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_b3b49bbb-9f06-45b1-b8a7-345c5721866c">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;12. Convertible Preferred Stock&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 25, 2024, immediately prior to completing the Merger, all classes of convertible preferred stock of Legacy Q32 were converted to Legacy Q32 common stock, and then exchanged in the Merger for shares of the Company&#x2019;s common stock using the Exchange Ratio. The Series A convertible preferred stock converted into an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,286,873&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Legacy Q32 common stock, the Series A-1 convertible preferred stock converted into an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;312,094&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of Legacy Q32&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;common &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;stock and the Series B convertible preferred stock converted into an aggregate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,625,896&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Legacy Q32 common stock. The conversion of the Legacy Q32 preferred stock into shares of Legacy Q32 common stock resulted in an increase of less than $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to common stock and an increase of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to additional paid-in-capital immediately prior to completing the Merger.&lt;/span&gt;&lt;/p&gt;</qttb:DisclosureInEntiretyOfTemporaryEquity>
    <qttb:ConversionOfTemporaryEquityIntoPermanentEquityShares
      contextRef="C_d5a319e9-4550-4a20-9794-c5a7a6ad12aa"
      decimals="0"
      id="F_bb6e2fd6-3419-450b-9891-d2366420806a"
      unitRef="U_shares">2286873</qttb:ConversionOfTemporaryEquityIntoPermanentEquityShares>
    <qttb:ConversionOfTemporaryEquityIntoPermanentEquityShares
      contextRef="C_f5ea5ca1-ed8b-413d-bbea-b4a5e23ee94a"
      decimals="0"
      id="F_0f0e9fea-8579-4db5-94b5-07536fb686f9"
      unitRef="U_shares">312094</qttb:ConversionOfTemporaryEquityIntoPermanentEquityShares>
    <qttb:ConversionOfTemporaryEquityIntoPermanentEquityShares
      contextRef="C_71403a30-e992-4c00-b708-e2cd6dde2a39"
      decimals="0"
      id="F_f75ac85f-54d3-449d-85e5-b4f321ea582c"
      unitRef="U_shares">2625896</qttb:ConversionOfTemporaryEquityIntoPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="C_65695aa9-2863-4310-b8da-f3be3d8e4280"
      decimals="-2"
      id="F_c44533c4-cb42-4abc-a4c0-623b8cbce2a5"
      unitRef="U_USD">100</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="C_354585ed-60d7-4f70-a77e-d50cc01415c0"
      decimals="-5"
      id="F_a474d485-633e-4faa-a9f2-31f13878fe65"
      unitRef="U_USD">111400000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_f5c269b4-5d80-42bf-892e-adc6fb93340e">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;13. Common Stock&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company&#x2019;s Certificate of Incorporation, as amended, authorized the Company to issue &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;400,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.0001&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; par value per share.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has reserved the following shares of common stock for future issuance:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved upon the conversion of authorized&lt;br/&gt;&#160;&#160;&#160;Series A preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,286,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved upon the conversion of authorized&lt;br/&gt;&#160;&#160;&#160;Series A-1 preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;312,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved upon the conversion of authorized&lt;br/&gt;&#160;&#160;&#160;Series B preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,625,896&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future issuance under the 2017 Stock&lt;br/&gt;&#160;&#160;&#160;Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future issuance under the 2024 Stock&lt;br/&gt;&#160;&#160;&#160;Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,760,657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future issuance under the 2024&lt;br/&gt;&#160;&#160;&#160;Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,836&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved upon the conversion of the convertible&lt;br/&gt;&#160;&#160;&#160;notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,433,411&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for stock option exercises&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,942,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,112,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,842,557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,844,758&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_b5c40c56-08b5-4a22-b751-a8f232a74aca"
      decimals="INF"
      id="F_d4f053ed-1740-4cf8-9660-4dc53d3a1450"
      unitRef="U_shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_b5c40c56-08b5-4a22-b751-a8f232a74aca"
      decimals="4"
      id="F_38c9b686-35d8-4a6a-9735-0aa6d44934cf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <qttb:DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_09809ef5-c321-49d9-a16f-c4407e00eb58">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has reserved the following shares of common stock for future issuance:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved upon the conversion of authorized&lt;br/&gt;&#160;&#160;&#160;Series A preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,286,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved upon the conversion of authorized&lt;br/&gt;&#160;&#160;&#160;Series A-1 preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;312,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved upon the conversion of authorized&lt;br/&gt;&#160;&#160;&#160;Series B preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,625,896&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future issuance under the 2017 Stock&lt;br/&gt;&#160;&#160;&#160;Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56,065&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future issuance under the 2024 Stock&lt;br/&gt;&#160;&#160;&#160;Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,760,657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for future issuance under the 2024&lt;br/&gt;&#160;&#160;&#160;Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,836&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved upon the conversion of the convertible&lt;br/&gt;&#160;&#160;&#160;notes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,433,411&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for stock option exercises&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,942,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,112,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Shares reserved for warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,842,557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,844,758&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</qttb:DisclosureInTabularFormOfCommonStockSharesReservedForFutureIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_0beb16c7-e3a6-42dc-8c19-40c1f98d5c9a"
      decimals="INF"
      id="F_169e9909-00c9-4ff3-b66c-dcabf28774bf"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_2f60cbad-ab1b-4beb-9829-e1cf73ad1860"
      decimals="INF"
      id="F_216aa48e-fe4c-414a-9fb5-521de0b733c8"
      unitRef="U_shares">2286873</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_223d39dc-f768-49d4-88fb-37a27c35a8a0"
      decimals="INF"
      id="F_6163bf04-83d8-4c1d-ba5a-b966fd07c038"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_cd0b4904-8ce8-4c84-a53a-8d845df8dc43"
      decimals="INF"
      id="F_58239527-0a9d-4517-bba8-fba5a7c1ebb4"
      unitRef="U_shares">312094</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_58806157-945d-4f05-9b65-2c51d8ce8b75"
      decimals="INF"
      id="F_db10a901-45d4-4cfb-a5f7-0d1c79fa2e0f"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_ec27399a-2953-4340-94d1-aa507faddcf4"
      decimals="INF"
      id="F_9846569b-e7d2-49c7-9d08-88ccf6e2a671"
      unitRef="U_shares">2625896</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_36984301-045f-4eac-9a05-c4a64d0c8422"
      decimals="INF"
      id="F_d7300c2d-2737-4799-bf39-b5ed7aa0bb36"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_4260d2af-256d-45f6-b503-aace9db4b45f"
      decimals="INF"
      id="F_6b9e2878-917c-42aa-9d0d-d6c86e8cf417"
      unitRef="U_shares">56065</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_31964b05-1da6-44db-b544-4f27ff581508"
      decimals="INF"
      id="F_49434849-7bfe-4ffc-b335-e11eb0d77d3f"
      unitRef="U_shares">1760657</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_6d5ea821-818d-4edc-977d-9c88e7922cd7"
      decimals="INF"
      id="F_caf09832-2488-4d8b-940e-b6efcaa9bf3d"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_56ea366c-6225-4b69-bccd-5ec940307d3b"
      decimals="INF"
      id="F_2dc85bc5-77a4-4e83-8d47-61c24b6bf862"
      unitRef="U_shares">120836</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_d3e98f3d-7cf9-4d47-9a53-26eaa914cc76"
      decimals="INF"
      id="F_789d341a-392d-4f0f-aa69-134ae7bd8ea3"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_6881a1d6-1e0a-490c-8f2b-d88e0d5e92d3"
      decimals="INF"
      id="F_738f2a9c-aad0-468d-89b2-3dd8052efef1"
      unitRef="U_shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_5e588eaa-63cf-4ef1-8b8e-0d333a72ff23"
      decimals="INF"
      id="F_3b30f481-b494-4c36-b123-b85612c55a80"
      unitRef="U_shares">1433411</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_4c2e3250-49a3-4f3c-9ba7-60f0718101be"
      decimals="INF"
      id="F_edd25e45-c96f-4846-84e3-6d1fb3b93d0d"
      unitRef="U_shares">1942920</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_b2f6b4cb-fe35-486b-9f70-f7fd1fa0f798"
      decimals="INF"
      id="F_5cba6f1e-1d6b-4643-887e-fa374c3ca131"
      unitRef="U_shares">1112275</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_bdaefca0-fea1-4732-b40e-bf35def7a224"
      decimals="INF"
      id="F_49182ac8-22df-4d3e-af07-1dd545cc0a96"
      unitRef="U_shares">18144</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_63d3da21-2d2f-4d33-8fc7-fd05ece7069d"
      decimals="INF"
      id="F_81614d9b-1be2-4f09-b371-cee696da2bcc"
      unitRef="U_shares">18144</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="INF"
      id="F_6182d51b-d718-447a-81d4-15fc4fdf0908"
      unitRef="U_shares">3842557</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="INF"
      id="F_08668cd1-681b-4126-887e-4c3c33b1b4a4"
      unitRef="U_shares">7844758</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_0798f9ed-0dea-4159-a9d9-2e2e7d56916d">&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;14. Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2017 Stock Option and Grant Plan&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Legacy Q32 adopted the 2017 Stock Option and Grant Plan and subsequent amendments (the &#x201c;2017 Plan&#x201d;) with &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,246,290&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock reserved for issuance to employees, directors, and consultants. The 2017 Plan allowed for the grant of incentive stock options, non-statutory stock options, restricted stock awards, restricted stock unit awards and other stock awards. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; additional shares available for future grant under the 2017 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024 Stock Option and Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 15, 2024, Homology&#x2019;s board of directors adopted and subsequently, Homology&#x2019;s stockholders approved the Q32 Inc. 2024 Stock Option and Incentive Plan (the &#x201c;2024 Plan&#x201d;), which became effective upon the closing of the Merger. The 2024 Plan replaced the 2017 Plan, as well as the Homology 2015 Stock Incentive Plan (the &#x201c;Homology 2015 Plan&#x201d;), and the Homology 2018 Plan (together with the Homology 2015 Plan, the &#x201c;Homology Incentive Plans.&#x201d;) Upon effectiveness of the 2024 Plan, the Company ceased granting new awards under the 2017 Plan and the Homology Incentive Plans.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2024 Plan provides for the grant of incentive stock options, nonqualified stock options, restricted stock awards, restricted stock units, stock appreciation rights and other stock or cash-based awards to officers, employees, directors and consultants of the Company. The number of shares of common stock initially available for issuance under the 2024 Plan was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,839,888&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock. The 2024 Plan provides that the number of shares reserved and available for issuance under the 2024 Plan will automatically increase each January 1, beginning on January 1, 2025, by &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the outstanding number of shares on the immediately preceding December 31, or such lesser amount as determined by the plan administrator. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,760,657&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares available for future grant under the 2024 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024 Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 15, 2024, Homology&#x2019;s board of directors adopted and subsequently, Homology&#x2019;s stockholders approved the Q32 Inc. 2024 Employee Stock Purchase Plan (the &#x201c;2024 ESPP&#x201d;). The 2024 ESPP allows employees to buy Company stock through after-tax payroll deductions at a discount from market value. The 2024 ESPP is intended to qualify as an &#x201c;employee stock purchase plan&#x201d; under Section 423 of the Internal Revenue Code. The number of shares of common stock initially available for issuance under the 2024 ESPP was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,836&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock. The 2024 ESPP provides that the number of shares reserved and available for issuance under the plan will automatically increase each January 1, beginning on January 1, 2025, by the lesser of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;241,677&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares, a number of shares equal &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the outstanding number of shares on the immediately preceding December 31, or such lesser amount as determined by the plan administrator.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Under the 2024 ESPP, employees may purchase common stock through after-tax payroll deductions at a price equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the lower of the fair market value on the first trading day of an offering period or the last trading day of an offering period. The 2024 ESPP generally provides for offering periods of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;six months&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in duration that end on the final trading day of each February and August. In accordance with the Internal Revenue Code, no employee will be permitted to accrue the right to purchase stock under the 2024 ESPP at a rate in excess of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; worth of shares during any calendar year during which such a purchase right is outstanding (based on the fair market value per share of the Company&#x2019;s common stock as of the first day of the offering period).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares issued under the 2024 ESPP during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock options granted by the Company typically vest over a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;four-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; period and have a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ten-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; contractual term. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s stock option activity during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024: &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.11%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.662%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.662%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.182%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(In Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,112,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.87&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assumed in reverse recapitalization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,071,073&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;255,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,942,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.33&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and expected to vest at&lt;br/&gt;&#160;&#160;&#160;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,942,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.33&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercisable at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;673,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.04&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The per share weighted-average grant date fair value per share of options granted in the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.42&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The total fair value of options vested during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, total unrecognized compensation costs to the unvested stock options were approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years. The total intrinsic value of options exercised during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the purpose of calculating stock-based compensation, the Company estimates the fair value of stock options using the Black-Scholes option-pricing model. This model incorporates various assumptions, including the expected volatility, expected term, and interest rates.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The underlying assumptions used to value stock options granted using the Black-Scholes option-pricing model during the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;years ended December 31, 2024 and 2023 were as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.48&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.34&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.59&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.67&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (years) range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.17 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.11&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.08 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.12&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Risk-Free Interest Rate &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#x2019;s stock options.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Dividend &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The expected dividend assumption is based on the Company&#x2019;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Term &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The expected term of stock options represents the weighted average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected term, which calculates the expected term as the average time-to-vesting and the contractual life of the options for stock options issued to employees. The expected term for options granted to non-employees is based on the contractual life of the options.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Expected Volatility &#x2013; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Due to the Company&#x2019;s limited operating history and lack of sufficient company-specific historical or implied volatility, the expected volatility assumption was determined by examining the historical volatilities of a group of industry peers whose share prices are publicly available. The Company expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Fair Value of Common Stock&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &#x2013; Prior to the Merger, as there had been no public market for the Company&#x2019;s common stock, the estimated fair value of its common stock was determined by the Company using estimates and assumptions on the respective grant dates of the awards. These estimates and assumptions include a number of objective and subjective factors, including external market conditions, the prices at which the Company sold shares of preferred securities and the superior likelihood of achieving a liquidity event, such as an IPO or sale. Significant changes to the key assumptions used in the valuations could result in different fair values of common stock at each valuation date.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recorded stock-based compensation expense in the following expense categories of its statements of operations (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_012ce485-8c2e-404f-b146-20b8651d7c1b"
      decimals="0"
      id="F_4230b668-7f40-4431-8c06-f0436cf4b5d2"
      unitRef="U_shares">1246290</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_012ce485-8c2e-404f-b146-20b8651d7c1b"
      decimals="0"
      id="F_f942244d-e4d3-4436-867b-94286452f1c1"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_57c23963-7764-4e09-9834-07d94af003db"
      decimals="0"
      id="F_7dec0693-8f7b-44fe-9903-1eaed4eb1746"
      unitRef="U_shares">2839888</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <qttb:IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding
      contextRef="C_e59a1e86-c7f5-494a-9d42-f6faee31d00f"
      decimals="2"
      id="F_f5eb1653-aa4f-4fb5-ab4b-3e059f552b04"
      unitRef="U_pure">0.05</qttb:IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_2636fb0b-847b-44cc-8769-e36df6784f40"
      decimals="0"
      id="F_22584ae9-4c81-49de-8bfe-cdbd0f658df9"
      unitRef="U_shares">1760657</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_5f18540e-b79b-4adf-83b8-c467b6d3c37d"
      decimals="0"
      id="F_ecf481cf-91fa-4db1-bd04-63e6147be915"
      unitRef="U_shares">120836</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <qttb:IncreaseInCommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae"
      decimals="0"
      id="F_3bbbf425-ed53-4c3a-995a-ce5204efdc4f"
      unitRef="U_shares">241677</qttb:IncreaseInCommonStockCapitalSharesReservedForFutureIssuance>
    <qttb:IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding
      contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae"
      decimals="2"
      id="F_5a591292-485c-43b4-9a02-9f2830f236e3"
      unitRef="U_pure">0.01</qttb:IncreaseInNumberOfSharesReservedForIssuancePercentOfCommonStockOutstanding>
    <qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage
      contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae"
      decimals="2"
      id="F_da01492e-86c9-435f-91ff-2261b74dac6c"
      unitRef="U_pure">0.85</qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockThroughPayrollDeductionsPercentage>
    <qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod
      contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae"
      id="F_866a0093-9ab9-424c-a671-73a05ac4fe27">P6M</qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockOfferingPeriod>
    <qttb:ExcessOfAccruedRightToPurchaseStock
      contextRef="C_f6927f9d-eca2-421d-8a4f-efa4995457ae"
      decimals="0"
      id="F_b6846ca5-b5fc-45f1-b3db-ea161e7110ed"
      unitRef="U_USD">25000</qttb:ExcessOfAccruedRightToPurchaseStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_a37febd5-2c47-4a82-98a5-85fdad081713"
      decimals="0"
      id="F_dfc6c651-cb7d-45c9-9004-745ec3040baa"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b"
      id="F_f7328783-cab0-44e0-80af-d29638aa69d9">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_a0158b43-f799-444a-bb23-d015a3855373">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_007b3dfd-434c-45a9-a9e3-cec4824af081">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s stock option activity during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024: &lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:50.11%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.662%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:8.942%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.662%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:9.182%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Number of&lt;br/&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;br/&gt;(In Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in&lt;br/&gt;thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,112,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.87&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assumed in reverse recapitalization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,071,073&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;255,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.81&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cancelled&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,627&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,942,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.33&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Vested and expected to vest at&lt;br/&gt;&#160;&#160;&#160;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,942,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.33&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Exercisable at December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;673,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.43&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.04&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="0"
      id="F_ebaf5576-404b-4920-97f0-15df6e6cca67"
      unitRef="U_shares">1112275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="2"
      id="F_f5c44b40-fa2c-4cc9-89f1-525fbfd3e3c1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      id="F_821bcc7d-5985-4a58-a89f-29c78ec841bf">P6Y10M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="0"
      id="F_3285cbcc-1c59-4144-a9c7-c44a97eac4b6"
      unitRef="U_USD">10712</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_a8cf5585-617c-4684-b4af-c5c0d95c3be8"
      unitRef="U_shares">32685</qttb:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalization>
    <qttb:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_41591f3b-c32d-4258-8435-dd4e9f2f5932"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.56</qttb:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAssumedInReverseRecapitalizationWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_2db77cb6-0205-4003-8cf2-6d5853b20e57"
      unitRef="U_shares">1071073</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_e7978e71-596c-4dc1-95bf-15fba54e1fd3"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">17.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_1041042f-3684-477d-bafd-bb73aa7e5638"
      unitRef="U_shares">255486</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_319c74e8-334f-45e5-8027-37d38d61ea65"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.81</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_a38f6935-7cf4-47d5-bf98-78c4261f20a0"
      unitRef="U_shares">17627</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_c020fad6-5a1b-46e5-b461-2be7006a087a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">17.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_b3c175d1-c1c5-4655-a41e-55de288caf70"
      unitRef="U_shares">1942920</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="2"
      id="F_8ae83872-c6d4-4439-97bb-892ba22c0b3b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_9e7125bb-3463-49de-8690-68057fca0d71">P8Y3M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_8e7d7c31-d13c-414d-b12f-77b243444250"
      unitRef="U_USD">12380</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_e215a29b-64bd-4402-8db2-de11196506f0"
      unitRef="U_shares">1942920</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="2"
      id="F_01411c41-9f5a-4142-91ff-f9d26421ed36"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_ba879237-c23d-4991-9062-576e3c610857">P8Y3M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_3d85efab-9ec3-42fc-886e-7535e2a1c623"
      unitRef="U_USD">12380</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_2fe3bcc5-37e1-4d90-adde-812ae2102f0f"
      unitRef="U_shares">673356</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="2"
      id="F_e398d0ec-f25f-4038-8a39-f71389ebb376"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_66dcb45b-ae5f-473e-bf97-cc74fd44adcf">P7Y14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_530e673c-6dcb-47c6-a924-c8fc7318e456"
      unitRef="U_USD">12380</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b"
      decimals="2"
      id="F_492ea15b-4a5b-4760-b40d-b1889db0a42b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.42</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b"
      decimals="-5"
      id="F_a1887e9f-6b23-4453-9ac2-ed03528a0e56"
      unitRef="U_USD">2400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_4c2e3250-49a3-4f3c-9ba7-60f0718101be"
      decimals="-5"
      id="F_377b9db6-9572-433d-989d-3be6c4f185a8"
      unitRef="U_USD">12600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b"
      id="F_1dcbfa0b-85b6-4c01-b05b-5c3afc1d53cc">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_d6eb1df1-653a-48d1-820d-e7936097d20b"
      decimals="-5"
      id="F_95720daa-12fb-482d-8235-777bdc41da37"
      unitRef="U_USD">7000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_34eff0ec-d7fd-40ea-a85e-e347fb13c74d">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The underlying assumptions used to value stock options granted using the Black-Scholes option-pricing model during the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;years ended December 31, 2024 and 2023 were as follows:&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Risk-free interest rate range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.48&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.34&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.59&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.67&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected dividend rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected term (years) range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.17 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.11&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.08 &lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;- &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.12&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expected stock price volatility range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;88.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="4"
      id="F_8d0bede8-b43a-4e1a-886a-126f8c87b49c"
      unitRef="U_pure">0.0348</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="4"
      id="F_278fbe86-c34e-4414-861d-10cc1591aab6"
      unitRef="U_pure">0.0434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="4"
      id="F_5b985629-d322-497b-88d6-91477f14b3d8"
      unitRef="U_pure">0.0359</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="4"
      id="F_08683f4b-452d-45e1-b2c5-7638df036595"
      unitRef="U_pure">0.0467</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_93311895-8267-461f-aad2-85b34b2cdce6"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="2"
      id="F_3b77abcc-3a43-483f-a83e-51712a7ddc8a"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_8e0c7ce3-b7e7-477e-b694-44fd0989eef1"
      id="F_ab6ce522-567d-41b6-8938-b3472d002941">P5Y2M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_eac1650d-1927-493f-a242-2bc1e837c904"
      id="F_5c18bcc5-266e-4070-a6dd-3189b2b7b17d">P6Y1M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_7794054f-4239-439e-b660-23e5bc99154a"
      id="F_e8dab34e-a0cd-4ca3-bd6d-1c28c6a79f77">P5Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_5a0e9c05-aa5e-42de-ac3a-a0fb7d656d48"
      id="F_820d9556-3303-4c9b-bc58-d9a99de268a6">P6Y1M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_ee3166f8-fffc-4a69-a7a0-2e366e8e31ef"
      unitRef="U_pure">0.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_bc469a45-6c81-451d-860d-75346f7400ad"
      unitRef="U_pure">0.941</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_16005647-77af-4ff6-8f36-0c9f08fa5bac"
      unitRef="U_pure">0.889</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_3269e56b-efe5-48d5-8287-4314db703780"
      unitRef="U_pure">0.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_e3f993c9-c25a-4f1f-90f5-e7872574f0ac">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company recorded stock-based compensation expense in the following expense categories of its statements of operations (in thousands):&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,428&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_2f8c0c8d-9454-4f58-ba8a-5a0c25ee32f6"
      decimals="-3"
      id="F_2e365262-c330-43bc-a3f1-3167f4706820"
      unitRef="U_USD">1105000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_370a860c-228f-4147-bdf4-dcb48b39a303"
      decimals="-3"
      id="F_857665d7-b774-4710-9340-c23ed337475b"
      unitRef="U_USD">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c8e96e70-b220-40a4-8caa-3388400e3cae"
      decimals="-3"
      id="F_b2eadd44-60e2-44a6-93a7-d248eec18478"
      unitRef="U_USD">3281000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e48e03f7-6e15-41e5-8e77-78e73c096383"
      decimals="-3"
      id="F_c8316105-b7aa-4759-bb85-8a6863b717ea"
      unitRef="U_USD">928000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_bea699c8-aa8d-4c86-be3d-0841325f617c"
      unitRef="U_USD">4386000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_da430c44-c9e4-46fb-a4c3-e7dd1d013972"
      unitRef="U_USD">1428000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_a81f375c-4d80-4613-abc9-1421e7e12688">&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;5. Agreements with Horizon &lt;/span&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From August 2022 until November 2023, Legacy Q32 was a party to the Collaboration and Option Agreement (the &#x201c;Horizon Collaboration Agreement&#x201d;) and the Asset Purchase Agreement (the &#x201c;Purchase Agreement&#x201d;), and together with the Horizon Collaboration Agreement, the &#x201c;Horizon Agreements&#x201d;), each between Legacy Q32 and Horizon Therapeutics Ireland DAC (&#x201c;Horizon&#x201d;), pursuant to which Legacy Q32 received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in initial consideration and staged development funding for the completion of the two ongoing Phase 2 trials for bempikibart, and Horizon had an option to acquire the bempikibart program at a prespecified price, subject to certain adjustments.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;T&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;he Company has received $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;transaction price from Horizon. In October 2023, Amgen Inc. (&#x201c;Amgen&#x201d;) completed its acquisition of Horizon Therapeutics public limited company (&#x201c;Horizon plc&#x201d;). Following the closing of Amgen&#x2019;s acquisition of Horizon plc, the Company agreed with Amgen to mutually terminate the Horizon Agreements and in November 2023, the Company and Horizon entered into a termination agreement (the &#x201c;Horizon Termination Agreement&#x201d;), pursuant to which Horizon&#x2019;s option to acquire the bempikibart program was terminated. As a result, the Company retained all&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;initial &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;consideration and development funding received under the Horizon Collaboration Agreement (as defined below) and regained full development and commercial rights to bempikibart. In consideration for the Horizon Termination Agreement, the Company agreed to pay Horizon regulatory and sales milestones payments of up to an aggregate amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million upon the first achievement of certain regulatory and sales milestones with respect to bempikibart.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company concluded that the consideration allocated to the research service performance obligations should be recognized over time as Horizon received the benefit of the research activities as the activities were performed. The Company has determined that this method was most appropriate as progress towards completion of research is largely driven by time and effort spent and costs incurred to perform this research. The Horizon Termination Agreement is accounted for as a modification because it does not result in the addition of distinct goods or services. Since the two performance obligations and the material right are terminated with no further performance obligations aside from the contingent payments to Horizon of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, the Company recognized the remaining deferred revenue in the fourth quarter of 2023.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon the execution of the Horizon Termination Agreement, the Company became obligated to pay Horizon up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;75.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million contingent on regulatory and sales-based milestones or up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in excess of the cash received. These potential payments to Horizon are not in exchange for a distinct good or service; therefore, the Company accounts for consideration payable to Horizon as a reduction of the transaction price under ASC 606&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company concluded that the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of arrangement consideration previously recognized should be fully constrained as a result of the contingent consideration payable to Horizon, and accordingly, all amounts previously recognized as revenue were reversed in the fourth quarter of 2023 and a refund liability was established for the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million cash received during the term of the Horizon Collaboration Agreement. No amounts have been recognized related to the remaining potential payment to Horizon (up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million) as it is not probable that the respective milestones will be achieved at this time.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationAssetCurrent
      contextRef="C_4baf7b07-b9a1-4675-83ec-31a34c768bc3"
      decimals="-5"
      id="F_f527d023-2fd3-4c50-8d36-1da5c05f7918"
      unitRef="U_USD">55000000</us-gaap:BusinessCombinationContingentConsiderationAssetCurrent>
    <us-gaap:ProceedsFromCollaborators
      contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd"
      decimals="-5"
      id="F_f2a65650-1119-4055-9b91-cbdd56409202"
      unitRef="U_USD">55000000</us-gaap:ProceedsFromCollaborators>
    <qttb:CollaborationAgreementTransactionPrice
      contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd"
      decimals="-5"
      id="F_1154a851-bac3-4d7b-9929-a8ad4b42ade8"
      unitRef="U_USD">55000000</qttb:CollaborationAgreementTransactionPrice>
    <qttb:CollaborativeArrangementMilestonePayments
      contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd"
      decimals="-5"
      id="F_1e0068e4-f696-48fc-903e-83535c2540c6"
      unitRef="U_USD">75100000</qttb:CollaborativeArrangementMilestonePayments>
    <qttb:CollaborationAgreementContingentPayment
      contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd"
      decimals="-5"
      id="F_3e30a1b5-6c26-4e79-bc1d-232b6813e5f9"
      unitRef="U_USD">75100000</qttb:CollaborationAgreementContingentPayment>
    <qttb:CollaborationAgreementContingentPayment
      contextRef="C_cf98c657-870f-4570-8592-2aff0b91640f"
      decimals="-5"
      id="F_0ef5f3b9-c392-44cd-bd5b-5215a4030e81"
      unitRef="U_USD">75100000</qttb:CollaborationAgreementContingentPayment>
    <qttb:CollaborationAgreementContingentPaymentPayableExcessOfCashReceived
      contextRef="C_cf98c657-870f-4570-8592-2aff0b91640f"
      decimals="-5"
      id="F_2435e7d6-83f8-42d9-b0ee-84a9645496ce"
      unitRef="U_USD">20100000</qttb:CollaborationAgreementContingentPaymentPayableExcessOfCashReceived>
    <qttb:CollaborationAgreementTransactionPrice
      contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd"
      decimals="-5"
      id="F_07319157-ca77-452d-b22a-33329e16790b"
      unitRef="U_USD">55000000</qttb:CollaborationAgreementTransactionPrice>
    <qttb:AmountOfRefundLiability
      contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd"
      decimals="-5"
      id="F_494ba3f4-a1aa-4e63-84d7-594724a188b9"
      unitRef="U_USD">55000000</qttb:AmountOfRefundLiability>
    <qttb:PaymentToHorizon
      contextRef="C_130917d7-9d2c-4093-8e70-15724bdc27cd"
      decimals="-5"
      id="F_df36472d-9659-4de6-b8f9-fd1fa6ce3bdd"
      unitRef="U_USD">20100000</qttb:PaymentToHorizon>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_0a84fddd-122d-4d6a-94b0-9e4db9e2c677">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;16. Related Party Transactions&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has consulting and advisory agreements with certain investors and board members which are considered to be related party transactions. The Company did &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;t incur expense for the years ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023 related to services provided by these investors and board members.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; amounts were due to related parties at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 or December 31, 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="C_3e39319d-0b8a-4d79-9a97-72ff6fa10227"
      decimals="0"
      id="F_7ed12bfe-27cb-4cdd-9b2b-72303cf1e323"
      unitRef="U_USD">0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="C_cb1dbfd4-a164-4593-8d87-17d41a661f8b"
      decimals="0"
      id="F_ead2a7d1-79c6-4187-88bc-96ca6f1edf0a"
      unitRef="U_USD">0</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:OtherLiabilities
      contextRef="C_4c7a1808-d8e4-4443-87ff-8a728e83b4d2"
      decimals="0"
      id="F_0ca94ecc-a610-412e-b055-462d630ef104"
      unitRef="U_USD">0</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="C_4d576cb9-10b9-46a1-bca3-697ecd9396be"
      decimals="0"
      id="F_f13927c9-75ff-4c6d-be77-ec1e4722efe4"
      unitRef="U_USD">0</us-gaap:OtherLiabilities>
    <us-gaap:DefinedContributionPlanTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_88de532c-4cc0-4f97-a31f-f613ecf8e19b">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;17. Defined Contribution Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has a defined contribution savings plan under Section 401(k) of the Internal Revenue Code (the 401(k) Plan). The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants the option to elect to defer a portion of their annual compensation on a pretax basis, as well as Roth post tax deferrals. As currently designed, the Company is not required to make and has not made any contributions to the 401(k) Plan.&lt;/span&gt;&lt;/p&gt;</us-gaap:DefinedContributionPlanTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_17ca162b-7bf7-4508-bff8-641e2e45e4d3">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;18. Income Taxes&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the years ended December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company recorded current and deferred income tax expense of less than $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively. The Company&#x2019;s effective tax rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% differs from the U.S. statutory tax rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% primarily as a result of the valuation allowance maintained against the Company&#x2019;s net deferred tax assets.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For financial reporting purposes, loss from operations before income taxes includes the following components (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pretax loss:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,716&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss before provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,425&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of the Company's provision for income taxes &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;318&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;318&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of income tax expense (benefit) computed at the statutory federal income tax rate to income ta&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;xes as reflected in the financial statements is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="9" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal income tax expense at statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Permanent differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gain/loss on convertible note conversion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible note revaluation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The significant components of the Company&#x2019;s deferred tax assets and liabilities consisted of the following (in thousands): &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingent liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accruals and reserves&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitalized intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,762&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitalized R&amp;amp;D expenditures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,546&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,835&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock compensation and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;544&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total gross deferred tax assets before valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;108,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;57,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,758&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,043&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right of use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company had gross deferred tax assets before valuation allowances of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;108.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;57.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 and 2023&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, principally attributable to net operating losses, the contingent liability and capitalized R&amp;amp;D expenditures. The Company has provided a valuation allowance for the full amount of the deferred tax assets as, based on all available evidence, it is considered more likely than not that all the recorded deferred tax assets will not be realized in a future period. The Company recorded an increase to the valuation allowance of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million during the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024 as a result of the 2024 book losses and the Merger with Homology.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;121.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of federal net operating loss carryforwards which can be carried forward indefinitely, and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;112.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of state net operating loss carryforwards that expire at various dates beginning in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2040&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Subject to the limitations described below, as of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had federal and state research and development tax credit carryforwards of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively available to reduce future tax liabilities which start to expire in &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2038&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The Company has generated federal and state research and development credits but has not conducted a study to document the qualified activity. This study may result in an adjustment to the Company&#x2019;s research and development credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts are being presented as uncertain tax position. A full valuation allowance has been provided against the Company&#x2019;s research and development credits and, if an adjustment is required, this adjustment would be offset by an adjustment to the deferred tax asset established for the research and development credit carryforwards and the valuation allowance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Realization of the future tax benefits is dependent on many factors, including the Company&#x2019;s ability to generate taxable income within the net operating loss carryforward period. Under the provisions of the Internal Revenue Code, the net operating loss and tax credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service (IRS) and state tax authorities. Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a three-year period in excess of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, as defined under Sections 382 and 383 of the Internal Revenue Code, respectively, as well as similar state provisions. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost associated with such a study. If the Company has experienced a change of control, as defined by Section 382 of the Internal Revenue Code, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards would be subject to an annual limitation under Section 382 of the Internal Revenue Code, which is determined by first multiplying the value of the Company&#x2019;s stock at the time of the ownership change by the applicable long-term-tax-exempt rate, and then could be subject to additional adjustments, as required. Any limitations may result in expiration of a portion of the net operating loss carryforwards or research and development tax credit carryforwards before utilization. Further, until a study is completed by the Company and any limitation is known, no amounts are being presented as an uncertain tax position&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company files income tax returns in the United States, Australia and Massachusetts. The statute of limitations for assessment by the IRS and state tax authorities is closed prior to 2021, although carryforward attributes that were generated prior to tax year 2021 may still be adjusted upon examination by the IRS or state tax authorities if they either have been or will be used in a future period. The Company is currently not under examination by the IRS or any other jurisdictions for any tax years. The statute of limitations for assessment by the Australian Taxation Office is four years from the date of return filing. The Company is not currently under examination by the Australian Taxation Office for any tax years.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s current intention is to permanently reinvest the total amount of its unremitted earnings in the local international jurisdiction. As such, the Company has not provided for taxes on the unremitted earnings of its international subsidiary. As of December 31, 2024, the Company&#x2019;s foreign subsidiary does not have any unremitted foreign earnings.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company establishes reserves for uncertain tax positions based on management&#x2019;s assessment of exposures associated with tax positions taken on tax return filings. The tax reserves are analyzed periodically, and adjustments are made as events occur to warrant adjustments to the reserve.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; gross unrecognized tax benefits. The Company does not expect the unrecognized tax benefits to change significantly over the next 12 months. The Company recognizes both interest and penalties associated with uncertain tax positions as a component of income tax expense. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; accrued penalties and provisions for interest&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-5"
      id="F_42229524-2bf4-4b0d-91f0-34f3572633ee"
      unitRef="U_USD">100000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-5"
      id="F_13c49f19-1c6e-488c-898e-dc1d4a10ea95"
      unitRef="U_USD">300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <qttb:CompanysEffectiveTaxRate
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_e5ca806e-30c3-4957-a5f8-d03db4dc1a03"
      unitRef="U_pure">0</qttb:CompanysEffectiveTaxRate>
    <qttb:USStatutoryTaxRate
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_82126609-f31f-49b8-ac8f-b007be50176d"
      unitRef="U_pure">0.21</qttb:USStatutoryTaxRate>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_9606dde7-f2e5-4cb3-8c96-1900b30fe1f1">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For financial reporting purposes, loss from operations before income taxes includes the following components (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pretax loss:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,716&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Loss before provision for income taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,425&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_ae5507bc-9232-49fe-90c8-3b7f31275ab6"
      unitRef="U_USD">-47716000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_6b3fe2a8-7aab-4897-8335-9ffe74b15ca8"
      unitRef="U_USD">-53430000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_997fd2c3-9bba-4c72-9602-1c3b62c041b9"
      unitRef="U_USD">4000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_d5a4eabf-68d5-468a-9f5b-cb6e43c435c6"
      unitRef="U_USD">5000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <qttb:IncomeLossBeforeProvisionForIncomeTaxes
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_85eab5b6-fc61-41aa-a12e-ac24ac5af76d"
      unitRef="U_USD">-47712000</qttb:IncomeLossBeforeProvisionForIncomeTaxes>
    <qttb:IncomeLossBeforeProvisionForIncomeTaxes
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_7c7b102e-2b6b-4a79-9402-58bd243a39fd"
      unitRef="U_USD">-53425000</qttb:IncomeLossBeforeProvisionForIncomeTaxes>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_829defac-09c1-4150-9ca5-cee2a07cb0c8">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of the Company's provision for income taxes &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:20pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:20pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;318&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total income tax provision&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;318&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of income tax expense (benefit) computed at the statutory federal income tax rate to income ta&lt;/span&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_46651644-eae2-42e9-832b-49b7b5e063e7"
      unitRef="U_USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_c700081a-face-4a53-8476-c8bdb2255683"
      unitRef="U_USD">316000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_d771ca4c-b93c-4b72-a113-ce263bc5ebd1"
      unitRef="U_USD">20000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_b1931a96-e70d-4c03-9283-dd80b9dbe343"
      unitRef="U_USD">1000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_2554198f-5020-4c97-9002-a383ecd4f5d8"
      unitRef="U_USD">1000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_899131dd-003b-4255-aba1-ba0f177af2a4"
      unitRef="U_USD">1000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <qttb:TotalCurrentExpenseBenifit
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_2ecde6e7-5b11-46d7-b829-559707f2abd9"
      unitRef="U_USD">21000</qttb:TotalCurrentExpenseBenifit>
    <qttb:TotalCurrentExpenseBenifit
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_2d6ff448-c628-4a56-b527-5d7908b1bd6c"
      unitRef="U_USD">318000</qttb:TotalCurrentExpenseBenifit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_7989e1b4-3835-4d57-a5d2-9d128f88c114"
      unitRef="U_USD">21000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_9c4dba37-7260-4197-b31d-261567a2a1cd"
      unitRef="U_USD">318000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_e9f48f18-3500-4925-af3a-68a320857018">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;A reconciliation of income tax expense (benefit) computed at the statutory federal income tax rate to income ta&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;xes as reflected in the financial statements is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.74%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:2.08%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="9" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="4" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal income tax expense at statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Permanent differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Gain/loss on convertible note conversion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Convertible note revaluation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_7a8a2986-d31a-484f-a4a4-02ac73046a3c"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_9689429a-336a-4e12-b7f6-2d4b633d82e6"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_c05ef2a6-be23-4b56-8ecd-ba75d3000071"
      unitRef="U_pure">0.091</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_80831916-03ad-45e1-95c8-63d194669c1b"
      unitRef="U_pure">0.059</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <qttb:EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_a81e9569-708c-4cc1-bfd1-8df4b25c662e"
      unitRef="U_pure">0.008</qttb:EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent>
    <qttb:EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_449cd77d-9467-4902-b8e8-eb15d1a9fb7b"
      unitRef="U_pure">-0.01</qttb:EffectiveIncomeTaxRateReconciliationPermanentDifferencesIncomeTaxesPercent>
    <qttb:EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_8a5b337a-f61f-4da2-a8f4-426206f00fe5"
      unitRef="U_pure">0.013</qttb:EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent>
    <qttb:EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_1bbe424a-00c0-4608-9143-5c6358fcc686"
      unitRef="U_pure">-0.002</qttb:EffectiveIncomeTaxRateReconciliationStockBasedCompensationExpensePercent>
    <qttb:EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_303c663b-52eb-4c26-a2a2-55a693749742"
      unitRef="U_pure">0.071</qttb:EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion>
    <qttb:EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="2"
      id="F_c2c042d2-0097-4fb5-826d-158cfc989006"
      unitRef="U_pure">0</qttb:EffectiveIncomeTaxRateReconciliationGainLossOnConvertibleNoteConversion>
    <qttb:EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_f3259cff-9eaa-449a-9498-9dbad64f977a"
      unitRef="U_pure">0.007</qttb:EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent>
    <qttb:EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_23824749-e967-4572-85db-9944bc054216"
      unitRef="U_pure">-0.018</qttb:EffectiveIncomeTaxRateReconciliationConvertibleNoteRevaluationIncomeTaxesPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_ca7611c9-4e69-4c4e-8f5a-c77058a99b0f"
      unitRef="U_pure">-0.038</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_06e62142-ae0e-43c5-baf9-8ad59e8efe6d"
      unitRef="U_pure">-0.031</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="3"
      id="F_d7471823-9376-4c1e-8ded-42d5f10b22eb"
      unitRef="U_pure">-0.422</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_fb188285-b52f-455c-b470-f9d59c76580d"
      unitRef="U_pure">-0.276</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_64225f24-78f4-46f4-9cce-9468656efa37"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="3"
      id="F_4ffb7aec-79d5-45c6-b115-aa37b2b8634c"
      unitRef="U_pure">-0.006</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_a4285912-a701-46c9-b2fd-60311b207fa2">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The significant components of the Company&#x2019;s deferred tax assets and liabilities consisted of the following (in thousands): &lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;text-align:left;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Federal net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,468&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;State net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingent liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,801&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accruals and reserves&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitalized intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,828&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tax credit carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,762&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitalized R&amp;amp;D expenditures&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,546&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,835&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock compensation and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;544&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total gross deferred tax assets before valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;108,634&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;57,121&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,078&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,758&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,043&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Right of use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_1158a2f8-7719-4941-8dae-e22b2a489d28"
      unitRef="U_USD">25468000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_d496173c-5d4f-4042-97dd-bd2872b3efe3"
      unitRef="U_USD">13412000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_b9a34a16-c52d-4fe5-a4ea-e17918934af3"
      unitRef="U_USD">7086000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_78a4b161-4200-420c-9d34-80f2c9fecf91"
      unitRef="U_USD">3500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsFrequentFlierLiability
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_25bb827c-2c06-4565-8ee5-61af8729c69c"
      unitRef="U_USD">14801000</us-gaap:DeferredTaxAssetsFrequentFlierLiability>
    <us-gaap:DeferredTaxAssetsFrequentFlierLiability
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_7c13b145-20e4-4570-a5ca-dd0126e19835"
      unitRef="U_USD">14876000</us-gaap:DeferredTaxAssetsFrequentFlierLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_2ea1cc38-b1a4-4f15-b6f6-edd2c47076f3"
      unitRef="U_USD">743000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_8bf10b53-1c5d-4fa6-a5a6-ef4e03624e12"
      unitRef="U_USD">818000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves>
    <qttb:CapitalizedIntangibleAssets
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_5665f49b-d86b-46a9-a5ae-75fa6b15938f"
      unitRef="U_USD">3591000</qttb:CapitalizedIntangibleAssets>
    <qttb:CapitalizedIntangibleAssets
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_e758c2b1-7821-4ae2-9c13-cc17f27d5f36"
      unitRef="U_USD">2828000</qttb:CapitalizedIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_d7e5b4e9-6aba-4730-a3ae-f5cfafbc1408"
      unitRef="U_USD">7978000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_d4790d26-f70b-4335-b926-cdbf236f98bf"
      unitRef="U_USD">5762000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_facb05e3-eae6-402e-8e0d-2d889ac8d984"
      unitRef="U_USD">46552000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_a1d4d203-e350-4dc6-bb8d-71da89416378"
      unitRef="U_USD">13546000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <qttb:DeferredTaxAssetsLeaseLiability
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_bc249c88-0b59-409e-9b20-9f52f240c360"
      unitRef="U_USD">1682000</qttb:DeferredTaxAssetsLeaseLiability>
    <qttb:DeferredTaxAssetsLeaseLiability
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_5d928fdd-6b82-433e-bce7-c491095efaf0"
      unitRef="U_USD">1835000</qttb:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_9be88fbf-7235-46d1-bb1a-3d557bee377a"
      unitRef="U_USD">733000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_e653aa19-294b-4763-9567-1a09320b9669"
      unitRef="U_USD">544000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_55ee4a9e-dbe0-48bb-b977-ba768e68f4a6"
      unitRef="U_USD">108634000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_e5a7d2a1-d261-4daa-bb15-1a5b23487ca7"
      unitRef="U_USD">57121000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_b3139867-faec-4e54-b3a0-b9b66495282a"
      unitRef="U_USD">106876000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_0893307c-95f1-4a5f-9c70-993a4f522183"
      unitRef="U_USD">55078000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_ab56b68e-e122-41dd-9aaa-86561513c7f8"
      unitRef="U_USD">1758000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_e25095db-d4f6-4ea3-a5b0-acebda37c50a"
      unitRef="U_USD">2043000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <qttb:DeferredTaxLiabilitiesFixedAssets
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_fbf5d15b-4164-4728-8829-d29fd94b3dea"
      unitRef="U_USD">-218000</qttb:DeferredTaxLiabilitiesFixedAssets>
    <qttb:DeferredTaxLiabilitiesFixedAssets
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_cc002337-f1a3-440d-9838-2686d56e5ec5"
      unitRef="U_USD">-339000</qttb:DeferredTaxLiabilitiesFixedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_597ede79-ab34-4148-b1a4-93088fdb7772"
      unitRef="U_USD">1540000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_4cf35645-b945-4e03-a390-de664aa99ef7"
      unitRef="U_USD">1704000</us-gaap:DeferredTaxLiabilitiesOtherFiniteLivedAssets>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-3"
      id="F_0d3fb3fe-1551-4da1-a5be-4a8790ccd729"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-3"
      id="F_5c219217-7933-4d6b-9d45-476eaf9c3810"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="-5"
      id="F_f8462f5e-b85a-425f-9157-ab703176d5d9"
      unitRef="U_USD">108600000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_2314494c-9a8c-4bc3-a189-e525b43dfad3"
      decimals="-5"
      id="F_982a83dc-a67e-47a2-9efe-e35d5a4a36ca"
      unitRef="U_USD">57100000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-5"
      id="F_b2e0cfc4-8254-4e33-a6ad-899dcad4bcb9"
      unitRef="U_USD">51800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_15a4f89a-2a77-4b59-9f76-99dff39d02e8"
      decimals="-5"
      id="F_fe9ef927-431d-4c98-990d-11fb804d4821"
      unitRef="U_USD">121300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_aab7e459-1871-48ff-b109-9c732f133214"
      decimals="-5"
      id="F_f5b97396-23e0-43d4-9a0b-301aa2b3e7dd"
      unitRef="U_USD">112100000</us-gaap:OperatingLossCarryforwards>
    <qttb:NetOperatingLossCarryForwardsExpirationYear
      contextRef="C_a865d4dd-0f4a-4429-92aa-0aae67bd396c"
      id="F_dfb25997-c620-47ff-bb0c-11117644a596">2040</qttb:NetOperatingLossCarryForwardsExpirationYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_5d6ee64c-bb12-4d4b-a81c-6f731ee26fbf"
      decimals="-5"
      id="F_0930e738-5253-4f97-ae32-7eb6d99ed664"
      unitRef="U_USD">6200000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_b39ec590-34ba-4ee9-954b-860129dbb68c"
      decimals="-5"
      id="F_83fda379-cedb-410e-bdea-6990928d5d3f"
      unitRef="U_USD">2300000</us-gaap:TaxCreditCarryforwardAmount>
    <qttb:TaxCreditCarryforwardsExpirationYear
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_1d8b9c01-adb5-41b4-87ca-3100b37d5be6">2038</qttb:TaxCreditCarryforwardsExpirationYear>
    <qttb:CumulativeChangesOwnershipInterest
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_46d5f40e-68d6-499b-9ac4-bc4dd83714f6"
      unitRef="U_pure">0.50</qttb:CumulativeChangesOwnershipInterest>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_b58f761f-bef4-4b59-803e-8a93d0543c79"
      decimals="0"
      id="F_7f30352f-0110-4aad-ae09-7c64fec4a4be"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_57d2ac25-2c7d-47ec-b761-2dcc6cabdcbc"
      unitRef="U_USD">0</us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_addae78d-a3fb-45b6-a784-131d83ad2ed4">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;19. Net Income (Loss) per Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of shares of common stock outstanding during the applicable period. In computing diluted net income (loss) per share, only potential shares of common stock that are dilutive are included. The Company considered each issue or series of issues of potential shares of common stock separately when determining whether potential shares of common stock are dilutive or antidilutive. The Company made such determination in sequence from the most dilutive to the least dilutive and concluded that its Convertible Notes are dilutive to net income per share for the year ended December 31, 2024. Pursuant to FASB ASC Topic 260, &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Earnings Per Share&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company applied the if-converted method to determine the effect of its Convertible Notes on the diluted earnings per share calculations. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to such method, the Company adjusted the numerator for the gains or losses recognized during the period &lt;/span&gt;&lt;/span&gt;&lt;span style=""&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;net income from the Convertible Notes and the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the Convertible Notes were converted as of the beginning the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income (loss)-basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income (loss)-diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,533&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding-basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,320,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;349,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;336,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_e5dd5eea-55d7-4cae-a2e1-4551e45e0690;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding-diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,657,696&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;349,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income (loss) per share-basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;153.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income (loss) per share-diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;153.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of December 31, 2024, the Company&#x2019;s potentially dilutive securities, which include stock options and warrants, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. As of December 31, 2023, the Company&#x2019;s potentially dilutive securities, which include convertible preferred stock, convertible notes, stock options and warrants, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series A convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,286,874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series A-1 convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;312,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series B convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,625,897&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,942,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,120,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, during the year ended December 31, 2022, Legacy Q32 issued the Convertible Notes with a principal balance of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. As described in Note 11, the Convertible Notes contained conversion features whereby the Convertible Notes and any accrued interest may have converted into either a variable number of shares of common stock or into shares of Series B preferred stock based on a fixed exchange ratio. Any shares of Series B preferred stock issued to settle the Convertible Notes would then be convertible into shares of common stock. The Convertible Notes were excluded from the computation of diluted net loss per share attributable to common stockholders for the year ended &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2023, because including them would have had an anti-dilutive effect&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Per the Merger further discussed in Note 1, the Convertible Notes converted into &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,433,410&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock at the effective date of the Merger.&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_c5a775c8-bc9e-4717-b20b-8b148cc4bc5b">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;to such method, the Company adjusted the numerator for the gains or losses recognized during the period &lt;/span&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;in &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;net income from the Convertible Notes and the denominator is increased to include the number of additional shares of common stock that would have been outstanding if the Convertible Notes were converted as of the beginning the period.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income (loss)-basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income (loss)-diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,533&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding-basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,320,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;349,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dilutive securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;336,812&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="-sec-ix-hidden:F_e5dd5eea-55d7-4cae-a2e1-4551e45e0690;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted-average common shares outstanding-diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,657,696&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;349,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income (loss) per share-basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;153.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income (loss) per share-diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.58&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;153.96&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_0ce2901f-c76f-47f1-892d-a28fb16fbdbb"
      unitRef="U_USD">-47733</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="0"
      id="F_443c6b47-6743-47e1-a07e-b481e0bdbea0"
      unitRef="U_USD">-53743</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_3c58bbe5-3b03-4ef3-b0c3-86bd34e43ba8"
      unitRef="U_USD">-63533</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="0"
      id="F_9f104c82-664c-485e-876c-56bacaaf6a9b"
      unitRef="U_USD">-53743</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_2b4be1ae-3b61-4f22-80a5-97d0e709e1e8"
      unitRef="U_shares">9320884</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="0"
      id="F_a23c3e4c-8f68-4d67-9609-05629fd03fc8"
      unitRef="U_shares">349060</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_bec73222-ae24-4a9a-af9d-deea455c4423"
      unitRef="U_shares">336812</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="0"
      id="F_2aa8bcce-5c45-4a5f-a6fe-7a7055a532c2"
      unitRef="U_shares">9657696</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="0"
      id="F_10dfde50-a3b3-44e8-8fd0-a02d0fc4d7b9"
      unitRef="U_shares">349060</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_a2957811-2b30-4ee0-bc00-66f3066b0e09"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-5.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="2"
      id="F_236fd843-5425-452c-92bd-a0379c796805"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-153.96</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="2"
      id="F_5d46dc75-b302-4397-b19b-5b2d9f54ef6c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-6.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="2"
      id="F_e2acdbaf-e50c-4ad5-9b59-d6467fee1b94"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-153.96</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_a62ba70d-1ca9-4016-b7f6-bf9daba4dac5">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company excluded the following from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.967%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:13.357%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series A convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,286,874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series A-1 convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;312,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Series B convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,625,897&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,942,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,120,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_5dad7a66-e70c-49a5-aa41-6710e38a1a05"
      decimals="0"
      id="F_01b66bcf-eb6b-423e-9df2-19e00661016a"
      unitRef="U_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_2747d7eb-c32e-4ac2-b584-639f88844157"
      decimals="0"
      id="F_fa0b2de7-e742-4ff4-83a8-0b1f81884c5b"
      unitRef="U_shares">2286874</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_1a893f00-2a32-48ba-a06a-042beb70f237"
      decimals="0"
      id="F_1d0daa4b-705f-4330-87b6-b70e1092f004"
      unitRef="U_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_cec18033-5a14-4ccd-b752-d0126402b130"
      decimals="0"
      id="F_d82614df-04f7-4c0f-af02-1903e369e87e"
      unitRef="U_shares">312094</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b8978390-12c0-4352-9c18-d59c00c5a494"
      decimals="0"
      id="F_a5869d25-ab73-424c-a2fe-f014fdf64d6a"
      unitRef="U_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_f497268d-14c0-4133-8bfb-04326a1ba996"
      decimals="0"
      id="F_2a986332-835b-4182-9cf7-dd5f6b98ce52"
      unitRef="U_shares">2625897</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b2dac488-8c36-4522-ba90-ecd7c08b1ede"
      decimals="0"
      id="F_92322ead-45d6-4cf4-8802-225126182b35"
      unitRef="U_shares">1942920</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_f0a36e6a-206a-49c7-88ab-7db254725cf3"
      decimals="0"
      id="F_ab922ef7-4df0-4a32-9fc7-aeffeaf816af"
      unitRef="U_shares">1120014</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_09e3fcc5-c0b6-4005-8960-a3541b369346"
      decimals="0"
      id="F_a93a4e90-35bf-40eb-ad03-603bfc83e69c"
      unitRef="U_shares">18145</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_c38a2141-3bcb-42d1-8a58-cef5d94d0819"
      decimals="0"
      id="F_684b32a8-fe2e-4bbd-a3a9-b89b3115b513"
      unitRef="U_shares">18145</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ConvertibleNotesPayable
      contextRef="C_e26a9287-f885-4441-9d0e-9148098a8888"
      decimals="-5"
      id="F_38a2a222-5a9d-417e-91a7-9ae5f25f3d83"
      unitRef="U_USD">30000000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="0"
      id="F_b4a54939-305e-4c16-9d44-d9536ef943ec"
      unitRef="U_shares">1433410</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_debc60b8-06d1-4be1-bc0b-e5c2505da9e1">&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Segment Reporting &lt;/span&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company operates as one operating segment, focused on research, development, and discovering, developing and delivering therapies for its novel biologics. The Company&#x2019;s CEO, as the chief operating decision maker ("CODM"), manages and allocates resources to the operations of the Company on a consolidated basis. Managing and allocating resources on a total-company basis enables the CODM to assess the overall level of resources available and how to best deploy those resources across research and development projects that are in line with our long-term company-wide strategic goals. Consistent with this decision-making process, the Company&#x2019;s CODM uses consolidated, single-segment financial information for purposes of evaluating performance, forecasting future period financial results, allocating resources and setting incentive targets. When evaluating the Company&#x2019;s overall performance, the CODM is focused on the timing and progress of its preclinical and clinical development activities. The CODM regularly reviews total expenses, as well as direct research and development expenses by program and makes decisions using this information on a company-wide basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accounting policies of the reportable segment are the same as those described in the summary of significant accounting policies. The CODM assesses performance and decides how to allocate resources based on consolidated net loss. This measure is&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;used to monitor budget versus actual results to assess performance of the segment. The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents reportable segment net loss, including significant expenses regularly provided to the CODM, attributable to the Company&#x2019;s reportable segment for the years ended December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Direct research and development expense by program:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Bempikibart&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ADX-097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Discovery and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;856&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel-related costs (excluding stock-based compensation)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other G&amp;amp;A expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest (income) expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,832&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;693&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other segment items (1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total segment net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(1) Other segment items are included in order to reconcile to total segment net loss. Other segment items include non-cash items such as depreciation and amortization expense and stock-based compensation expense, gains and losses on the change in fair value of convertible notes, change in fair value of contingent value rights and loss from equity method investment. In 2023, other segment items also includes the reversal of collaboration arrangement revenue related to the termination of the Horizon Agreement (see Note 15).&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_6cd290f6-2609-4470-9d6a-3b37f442b7ee">&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents reportable segment net loss, including significant expenses regularly provided to the CODM, attributable to the Company&#x2019;s reportable segment for the years ended December 31, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;white-space:pre-wrap;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Direct research and development expense by program:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Bempikibart&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,722&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ADX-097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;text-indent:10pt;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Discovery and other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;856&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Personnel-related costs (excluding stock-based compensation)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other G&amp;amp;A expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,586&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest (income) expense, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,832&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;693&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other segment items (1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,978&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:top;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total segment net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,733&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:pre-wrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="padding-top:0.01in;white-space:nowrap;vertical-align:bottom;padding-bottom:0in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_4b875fb6-8c1f-48c4-8ed9-bb8c9bf74e9a"
      decimals="-3"
      id="F_5230178e-b216-4973-b7fc-f234fdbcf30c"
      unitRef="U_USD">28726000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_8aa53aac-d504-4db3-8d89-b2114c402b69"
      decimals="-3"
      id="F_915803ef-db58-4c61-a8f9-893be63041a8"
      unitRef="U_USD">11722000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_2018c79e-e353-411e-9686-5d75f0b411cc"
      decimals="-3"
      id="F_165facfd-ae78-4c9b-9b74-8b96b5263473"
      unitRef="U_USD">5253000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_24eebe14-f497-4909-b6f9-5294ab34c796"
      decimals="-3"
      id="F_deeacbdb-6b66-4a54-8007-d608e9f8f0a9"
      unitRef="U_USD">7185000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_2ac02e70-62cb-4d11-bf94-77b56c0a5fb8"
      decimals="-3"
      id="F_876795ae-161f-4b83-8293-b5f20b474de7"
      unitRef="U_USD">856000</us-gaap:OtherResearchAndDevelopmentExpense>
    <us-gaap:OtherResearchAndDevelopmentExpense
      contextRef="C_6a7ed391-5281-4830-b9f9-03de3a4d8b00"
      decimals="-3"
      id="F_2328acf2-ac43-43b1-82c7-ce6030b5fe0f"
      unitRef="U_USD">894000</us-gaap:OtherResearchAndDevelopmentExpense>
    <qttb:PersonnelRelatedCostsExcludingStockBasedCompensation
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_fe783eb4-218b-48f9-9fd4-c4ae9683816f"
      unitRef="U_USD">16122000</qttb:PersonnelRelatedCostsExcludingStockBasedCompensation>
    <qttb:PersonnelRelatedCostsExcludingStockBasedCompensation
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_4203ea00-4fb9-4d8b-bb22-589da1669b6c"
      unitRef="U_USD">13166000</qttb:PersonnelRelatedCostsExcludingStockBasedCompensation>
    <qttb:OtherGAExpenses
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_054cdadb-0696-410d-8b11-bdb5d90cb6b4"
      unitRef="U_USD">9586000</qttb:OtherGAExpenses>
    <qttb:OtherGAExpenses
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_4d4488a3-05a9-4e8a-8295-f1247eedaa08"
      unitRef="U_USD">5824000</qttb:OtherGAExpenses>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_3cc59c3c-7fbc-462e-9883-8826b1f381e1"
      unitRef="U_USD">2832000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_8a01b3d3-d80a-4735-bed5-9b2d3a7d8126"
      unitRef="U_USD">693000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_11ae9ab9-bffd-4d14-b07e-d75b947ac16f"
      unitRef="U_USD">-9978000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_bc6b58cf-984e-43a1-9d3e-ec625096065d"
      unitRef="U_USD">15645000</us-gaap:SegmentReportingOtherItemAmount>
    <qttb:TotalSegmentNetLoss
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      decimals="-3"
      id="F_510977ce-b83a-48e5-8fa3-972c2434bdce"
      unitRef="U_USD">47733000</qttb:TotalSegmentNetLoss>
    <qttb:TotalSegmentNetLoss
      contextRef="C_02ea8933-41dc-4b18-b84c-1e05c9afde3e"
      decimals="-3"
      id="F_e2a3c0db-afcf-491d-bd28-6a8a4b6e0cae"
      unitRef="U_USD">53743000</qttb:TotalSegmentNetLoss>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_1f079b94-52d3-4513-9e59-1f9abf527de4"
      id="F_99d49db2-f610-4d12-a291-d0559f20906e">&lt;p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;21. Subsequent Events&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Strategic Restructuring&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 10, 2025, the Company notified its employees of a strategic restructuring plan adopted by the Company&#x2019;s board of directors to focus its resources on the advancement of bempikibart in patients with AA (the &#x201c;Restructuring Plan&#x201d;). In connection with the Restructuring Plan, the Company is discontinuing its Phase 2 renal basket clinical trial of ADX-097 and is evaluating strategic options for its tissue-targeted complement inhibitor platform, inclusive of ADX-097 and early-stage assets, in combination with other cost-saving measures. The Restructuring Plan includes a reduction in force, which the Company expects to substantially complete by the end of the second quarter of 2025. As part of this Restructuring Plan, the Company expects to incur severance and severance-related charges of approximately $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The Company may also incur other charges or cash expenditures not currently contemplated or that cannot be currently estimated due to events that may occur as a result of, or be associated with, the Restructuring Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Option Repricing&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 23, 2025, the Company's board of directors approved a stock option repricing (the &#x201c;Option Repricing&#x201d;), which was effective on February 24, 2025 (the &#x201c;Repricing Date&#x201d;). The Option Repricing applied to outstanding options to purchase shares of common stock of the Company granted under the Company&#x2019;s 2017 Plan and 2024 Plan (collectively, &#x201c;the Plans&#x201d;), which, as of the Repricing Date, were held by current employees and non-employee directors of the Company and had an exercise price in excess of the current trading price of the common stock (so-called &#x201c;underwater options&#x201d;) with grant dates prior to February 23, 2025 (the &#x201c;Eligible Options&#x201d;). As of the Repricing Date, the Eligible Options were repriced such that the exercise price per share for such Eligible Options was reduced to the closing price of the common stock on the Nasdaq Global Market on the Repricing Date (the &#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Repriced Exercise Price&#x201d;). The total number of shares of common stock underlying all Eligible Options was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,904,998&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Eligible Options will revert to the original exercise price (the &#x201c;Original Price&#x201d;) if (i) such Eligible Options are exercised prior to the one-year anniversary of the Repricing Date (the &#x201c;Retention Date&#x201d;), (ii) an Eligible Option holder's employment is terminated by the Company for Cause (as defined in the 2024 Plan) prior to the Retention Date, or (iii) an Eligible Option holder resigns for any reason prior to the Retention Date. If an Eligible Option holder is terminated by the Company other than for Cause prior to the Retention Date (a &#x201c;Terminated Employee&#x201d;), any Eligible Options vested as of the date of such termination shall be exercisable at the Repriced Exercise Price (the &#x201c;Terminated Employee Vested Options&#x201d;), even prior to the Retention Date; provided that any unvested Eligible Options as of the date of such termination shall revert to the Original Price as of the date of termination. The deadline to exercise any Terminated Employee Vested Options, and any other Eligible Options held by a Terminated Employee that may become vested, shall be extended (but not truncated) to the later of (a) the one-year anniversary of the Terminated Employee&#x2019;s termination date and (b) to align with the Eligible Option holder&#x2019;s severance period (whether now or later implemented); provided that no extension shall exceed the Terminated Employee Vested Option&#x2019;s expiration date, if earlier. In the event of a change-in-control prior to the Retention Date, each Eligible Option shall retain the Repriced Exercise Price to the extent it has not otherwise reverted to the Original Price. For the avoidance of doubt, the Eligible Options as modified by the Option Repricing are subject to the severance or change-in-control provisions in the current or future employment agreements, programs, policies or plans the Company has entered into or implemented or will enter into or implement with its directors, executive officers and other employees. There were no changes to the number of shares, the vesting schedule, or the expiration date of the Repriced Options except as outlined above.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Pursuant to the Plans, the Company's board of directors, as the administrator of the Plans, has discretionary authority, exercisable on such terms and conditions that it deems appropriate under the circumstances, to reduce the exercise price in effect for or effect repricing through cancellation and re-grants of outstanding options under the Plans. In approving the Option Repricing, the board of directors considered the impact of the Original Price of outstanding stock options on the incentives provided to employees and directors, the lack of retention value provided by the outstanding stock options to employees and directors, and the impact of such options on the capital structure of the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company expects that the Option Repricing will result in additional share-based compensation expense that will be recognized in the Company&#x2019;s statements of operations in future periods; however, the amount of additional share-based compensation expense and the periods over which it will be recognized have not yet been determined.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Exercise of Call Option by OXB (US) LLC&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As discussed in Notes 1 and 3, at the effective time of the merger with Homology, each person who as of immediately prior to the effective time of the Merger was a stockholder of record of Homology or had the right to receive Homology&#x2019;s common stock received a CVR issued by Homology representing the contractual right to receive cash payments, if any, from the combined company upon the receipt of certain proceeds, net of permitted deductions for expenses incurred in connection with pre-merger Homology assets, from a disposition of Homology&#x2019;s pre-merger assets, including any equity interests held directly or indirectly by the Company in OXB (US) LLC. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 1, 2025, Oxford Biomedica (US), Inc. exercised its option to cause the Company to sell and transfer to Oxford Biomedica (US), Inc. all of the Company&#x2019;s equity ownership interest in OXB (US) LLC. The sale price is based on a formula using the Company's pro rata share of OXB (US) LLC (10%), times a predetermined multiple of revenue for the immediately preceding 12-month period increased by OXB (US) LLC's cash balance and decreased by OXB (US) LLC's debt balance as of the exercise date.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The Company and Oxford Biomedica (US), Inc. expect to finalize the transaction and pay the CVR holders by the end of the second quarter of 2025.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="C_2f4b5de3-a9e7-4c16-bcfe-43adba24582e"
      decimals="-5"
      id="F_91f6e502-9c66-4856-92aa-39fffa3c1e18"
      unitRef="U_USD">1100000</us-gaap:SeveranceCosts1>
    <qttb:NumberOfCommonStockUnderlyingShares
      contextRef="C_edd2dd2b-4bf5-49ec-8e4a-ca61edc70f98"
      decimals="0"
      id="F_2ea07825-142a-4452-9511-9565630842e2"
      unitRef="U_shares">1904998</qttb:NumberOfCommonStockUnderlyingShares>
    <qttb:ExerciseOfCallOptionDescription
      contextRef="C_edd2dd2b-4bf5-49ec-8e4a-ca61edc70f98"
      id="F_9565c5d8-bbd8-418c-a8fa-cdc4a6ce8dec">On March 1, 2025, Oxford Biomedica (US), Inc. exercised its option to cause the Company to sell and transfer to Oxford Biomedica (US), Inc. all of the Company&#x2019;s equity ownership interest in OXB (US) LLC. The sale price is based on a formula using the Company's pro rata share of OXB (US) LLC (10%), times a predetermined multiple of revenue for the immediately preceding 12-month period increased by OXB (US) LLC's cash balance and decreased by OXB (US) LLC's debt balance as of the exercise date.</qttb:ExerciseOfCallOptionDescription>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_11ae9ab9-bffd-4d14-b07e-d75b947ac16f"
          xlink:label="F_11ae9ab9-bffd-4d14-b07e-d75b947ac16f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_bc6b58cf-984e-43a1-9d3e-ec625096065d"
          xlink:label="F_bc6b58cf-984e-43a1-9d3e-ec625096065d"
          xlink:type="locator"/>
        <link:footnote id="FNT_b499c890-2785-42b0-a234-7b2081cf5a95" xlink:label="FNT_b499c890-2785-42b0-a234-7b2081cf5a95" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:p style="text-indent:4%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1) Other segment items are included in order to reconcile to total segment net loss. Other segment items include non-cash items such as depreciation and amortization expense and stock-based compensation expense, gains and losses on the change in fair value of convertible notes, change in fair value of contingent value rights and loss from equity method investment. In 2023, other segment items also includes the reversal of collaboration arrangement revenue related to the termination of the Horizon Agreement (see Note 15).</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_11ae9ab9-bffd-4d14-b07e-d75b947ac16f"
          xlink:to="FNT_b499c890-2785-42b0-a234-7b2081cf5a95"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_bc6b58cf-984e-43a1-9d3e-ec625096065d"
          xlink:to="FNT_b499c890-2785-42b0-a234-7b2081cf5a95"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
